{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ACCURAYINC_09_01_2010-EX-10.31-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ACCURAYINC_09_01_2010-EX-10.31-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"(a) All applicable export list numbers, including \", \"level\": 1, \"text\": \"(a) All applicable export list numbers, including the Export Control 11 To Accuray: To Distributor: Accuray Incorporated Siemens AG Attention: Chief Financial Officer Henkestr. 127 1310 Chesapeake Terrace 91054 Erlangen Sunnyvale, CA 94089 Germany Facsimile: +1 (408) 789-4205 Attn: Healthcare General Counsel, Ritva Sotamaa with cc to: General Counsel Facsimile: + 49/### - ## - #### respect to the subject matter hereof, and supersedes all prior understandings, representations and warranties, written and oral. If any part of the terms and conditions stated herein are held void or unenforceable, such part will be treated 21 as severable, leaving valid the remainder of the terms and conditions. In case of any contradiction between this Agreement and the Strategic Alliance Agreement, the terms of this Agreement shall prevail. 12.18. Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. SIGNATURE PAGE FOLLOWS 22 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the Effective Date by their duly authorized representatives. The parties acknowledge and agree that this Agreement does not become effective until it has been signed by all parties indicated below. SIGNATURE PAGE TO MULTIPLE LINAC AND MULTI-MODALITY DISTRIBUTOR AGREEMENT DISTRIBUTOR: ACCURAY INCORPORATED: By: /s/ Christian Klaussner By: /s/ Euan Thompson Print name: Christian Klaussner Print name: Euan Thomson Title: HIM OCS CFO Title: President and Chief Executive Officer Date: June 8, 2010 Date: June 7, 2010 By: /s/ Holger Schmidt By: /s/ Darren Milliken Print name: Holger Schmidt Print name: Darren Milliken Title: HIM OCS CEO Title: Senior Vice President and General Counsel Date: June 8, 2010 Date: June 7, 2010\"}, {\"id\": \"SCHEDULE 2.3.2\", \"title\": \"ACCEPTANCE PROCESS \u00b7 Accuray shall have 5 Business Days from date of the submission of a proposed Multiple LINAC Purchase or Multi-Modality Purchases by Siemens in which to either give or withhold approval of such purchase, with any failure to approve or disapprove of such purchase in such period constituting disapproval; \u00b7 Such approval may be given by either Accuray's applicable General Regional Manager or a corporate representative of Accuray, expressly designated with such approval authority in writing by Accuray to Siemens; \u00b7 Siemens' shall provide any information concerning such proposed purchase and the proposed purchaser as is reasonably requested by Accuray; \u00b7 Such approval of any such proposed purchase must not be unreasonably withheld or delayed; \u00b7 In determining whether to grant such approval, Accuray may consider, at a minimum: \u00b7 Existing exclusivity arrangements between Accuray and Third Parties; \u00b7 Prior and current contact with the proposed purchaser by either Party; \u00b7 Other commercial relationships that either Party may have with the proposed purchaser; \u00b7 Bona fide concerns about the suitability of the proposed purchaser; and \u00b7 Whether Accuray or any of its distributors have obtained any required regulatory clearances and/or import licenses required in connection with the proposed purchase.\", \"level\": 3, \"text\": \"SCHEDULE 2.3.2 ACCEPTANCE PROCESS \u00b7 Accuray shall have 5 Business Days from date of the submission of a proposed Multiple LINAC Purchase or Multi-Modality Purchases by Siemens in which to either give or withhold approval of such purchase, with any failure to approve or disapprove of such purchase in such period constituting disapproval; \u00b7 Such approval may be given by either Accuray's applicable General Regional Manager or a corporate representative of Accuray, expressly designated with such approval authority in writing by Accuray to Siemens; \u00b7 Siemens' shall provide any information concerning such proposed purchase and the proposed purchaser as is reasonably requested by Accuray; \u00b7 Such approval of any such proposed purchase must not be unreasonably withheld or delayed; \u00b7 In determining whether to grant such approval, Accuray may consider, at a minimum: \u00b7 Existing exclusivity arrangements between Accuray and Third Parties; \u00b7 Prior and current contact with the proposed purchaser by either Party; \u00b7 Other commercial relationships that either Party may have with the proposed purchaser; \u00b7 Bona fide concerns about the suitability of the proposed purchaser; and \u00b7 Whether Accuray or any of its distributors have obtained any required regulatory clearances and/or import licenses required in connection with the proposed purchase.\"}, {\"id\": \"EXHIBIT A\", \"title\": \"DISTRIBUTOR DISCOUNTS ON PRODUCTS AND SERVICES\", \"level\": 1, \"text\": \"EXHIBIT A DISTRIBUTOR DISCOUNTS ON PRODUCTS AND SERVICES * Siemens distributor channel discount. Siemens Bundled Sales Price= (List Price (1- (Volume Discount + Distributor Discount))\"}, {\"id\": \"EXHIBIT B\", \"title\": \"SIEMENS CODE OF CONDUCT SIEMENS Code of Conduct for Siemens Suppliers This Code of Conduct defines the basic requirements placed on Siemens' suppliers of goods and services concerning their responsibilities towards their stakeholders and the environment. Siemens reserves the right to reasonably change the requirements of this Code of Conduct due to changes of the Siemens Compliance Program. In such event Siemens expects the supplier to accept such reasonable changes. The supplier declares herewith: \u00b7 Legal compliance \u00b7 to comply with the laws of the applicable legal system(s). \u00b7 Prohibition of corruption and bribery \u00b7 to tolerate no form of and not to engage in any form of corruption or bribery, including any payment or other form of benefit conferred on any government official for the purpose of influencing decision making in violation of law. \u00b7 Respect for the basic human rights of employees \u00b7 to promote equal opportunities for and treatment of its employees irrespective of skin color, race, nationality, social background, disabilities, sexual orientation, political or religious conviction, sex or age; \u00b7 to respect the personal dignity, privacy and rights of each individual; \u00b7 to refuse to employ or make anyone work against his will; \u00b7 to refuse to tolerate any unacceptable treatment of employees, such as mental cruelty, sexual harassment or discrimination; \u00b7 to prohibit behavior including gestures, language and physical contact, that is sexual, coercive, threatening, abusive or exploitative; \u00b7 to provide fair remuneration and to guarantee the applicable national statutory minimum wage; \u00b7 to comply with the maximum number of working hours laid down in the applicable laws; \u00b7 to recognize, as far as legally possible, the right of free association of employees and to neither favor nor discriminate against members of employee organizations or trade unions. \u00b7 Prohibition of child labor \u00b7 to employ no workers under the age of 15 or, in those countries subject to the developing country exception of the ILO Convention 138, to employ no workers under the age of 14. \u00b7 Health and safety of employees \u00b7 to take responsibility for the health and safety of its employees; \u00b7 to control hazards and take the best reasonably possible precautionary measures against accidents and occupational diseases; \u00b7 to provide training and ensure that employees are educated in health and safety issues; \u00b7 to set up or use a reasonable occupational health & safety management system(1)\", \"level\": 1, \"text\": \"EXHIBIT B SIEMENS CODE OF CONDUCT SIEMENS Code of Conduct for Siemens Suppliers This Code of Conduct defines the basic requirements placed on Siemens' suppliers of goods and services concerning their responsibilities towards their stakeholders and the environment. Siemens reserves the right to reasonably change the requirements of this Code of Conduct due to changes of the Siemens Compliance Program. In such event Siemens expects the supplier to accept such reasonable changes. The supplier declares herewith: \u00b7 Legal compliance \u00b7 to comply with the laws of the applicable legal system(s). \u00b7 Prohibition of corruption and bribery \u00b7 to tolerate no form of and not to engage in any form of corruption or bribery, including any payment or other form of benefit conferred on any government official for the purpose of influencing decision making in violation of law. \u00b7 Respect for the basic human rights of employees \u00b7 to promote equal opportunities for and treatment of its employees irrespective of skin color, race, nationality, social background, disabilities, sexual orientation, political or religious conviction, sex or age; \u00b7 to respect the personal dignity, privacy and rights of each individual; \u00b7 to refuse to employ or make anyone work against his will; \u00b7 to refuse to tolerate any unacceptable treatment of employees, such as mental cruelty, sexual harassment or discrimination; \u00b7 to prohibit behavior including gestures, language and physical contact, that is sexual, coercive, threatening, abusive or exploitative; \u00b7 to provide fair remuneration and to guarantee the applicable national statutory minimum wage; \u00b7 to comply with the maximum number of working hours laid down in the applicable laws; \u00b7 to recognize, as far as legally possible, the right of free association of employees and to neither favor nor discriminate against members of employee organizations or trade unions. \u00b7 Prohibition of child labor \u00b7 to employ no workers under the age of 15 or, in those countries subject to the developing country exception of the ILO Convention 138, to employ no workers under the age of 14. \u00b7 Health and safety of employees \u00b7 to take responsibility for the health and safety of its employees; \u00b7 to control hazards and take the best reasonably possible precautionary measures against accidents and occupational diseases; \u00b7 to provide training and ensure that employees are educated in health and safety issues; \u00b7 to set up or use a reasonable occupational health & safety management system(1) Discount Type List Price Range USD Volume Discount Distributor Discount* Volume Discounts - Tier # 1 {*****} {*****} {*****} Volume Discounts - Tier # 2 {*****} {*****} {*****} Volume Discounts - Tier # 3 {*****} {*****} {*****} Volume Discounts - Tier # 4 {*****} {*****} {*****} Volume Discounts - Tier # 5 {*****} {*****} {*****} Volume Discounts - Tier # 6 {*****} {*****} {*****} Volume Discounts - Tier # 7 {*****} {*****} {*****} Volume Discounts - Tier # 8 {*****} {*****} {*****} Volume Discounts - Tier # 9 {*****} {*****} {*****} Volume Discounts - Tier # 10 {*****} {*****} {*****} Volume Discounts - Tier # 11 {*****} {*****} {*****} Volume Discounts - Tier # 12 {*****} {*****} {*****} \u00b7 Environmental protection \u00b7 to act in accordance with the applicable statutory and international standards regarding environmental protection; \u00b7 to minimize environmental pollution and make continuous improvements in environmental protection; \u00b7 to set up or use a reasonable environmental management system(1) \u00b7 Supply chain \u00b7 to use reasonable efforts to promote among its suppliers compliance with this Code of Conduct; \u00b7 to comply with the principles of non discrimination with regard to supplier selection and treatment. (1) For further information see www.siemens.com/procurement/cr/code-of-conduct\"}, {\"id\": \"EXHIBIT C\", \"title\": \"SIEMENS QUALITY ASSURANCE AGREEMENT Please see attached.\", \"level\": 1, \"text\": \"EXHIBIT C SIEMENS QUALITY ASSURANCE AGREEMENT Please see attached. SIEMENS For internal use only Copyright \u00a9 Siemens AG 2002. All rights reserved. Quality Requirement Med Identification of Products and basic requirements for packaging Requirements for Suppliers QR Med 1 A1 Siemens Medical Solutions and affiliated Companies Issued by Med Quality Management & Regulatory Affairs Released 2007-09-28 by the Med Quality Steering Board (QSB) Valid from 2007-11-01 04798372 AND 02S 04 1 2 Contents Author: Gabriele Franz AX QP Reviewer: Volker Glahn QM&RA Philippe Hoxter CSQ\"}, {\"id\": \"1\", \"title\": \"Purpose and scope For Siemens Medical Solutions it is a basic requirement that any part, component or system is iden\", \"level\": 1, \"text\": \"1 Purpose and scope For Siemens Medical Solutions it is a basic requirement that any part, component or system is identified the same way worldwide. This document lists the minimum requirements for suppliers of Siemens Medical Solutions describing \u00b7 how parts, components and systems are identified with their attributes and \u00b7 how attributes are labeled both as plain text as well as barcode on products and its packaging. Detailed specifications with regards to the labeling of products are defined for the individual product concerned. 2 Definitions and abbreviations 2.1 Material No. The Siemens Medical Solutions Material No. is used to uniquely identify products (parts, components and systems). It consists of an 8-digit identification no. assigned by Siemens Medical Solutions. Previously, the term \\\"Part no.\\\" was also used; it is replaced by the term \\\"Material No.\\\". 2.2 Revision The Revision (abbreviated \\\"Rev.\\\") serves to distinguish between different update statuses of hardware. It is assigned by Siemens Medical Solutions. The English term \\\"Revision\\\" replaces the German term \\\"Erzeugnisstand\\\" (abbreviated \\\"ES\\\") and \\\"Ausf\u00fchrungsstand\\\" (abbreviated \\\"AS\\\"). 2.3 Serial No. The Serial No. is an identifying attribute used to uniquely identify hardware or software with the same Material No. . For suppliers the Serial No. can consist of up to 15 alphanumeric digits; it is however recommended to use only a 6 digit numerical Serial No. where possible. The Serial No. may contain a dash (-) or a slash (/), but no other special characters (e.g. # + * ?). Spaces, lower-case letters or language-specific characters (e.g. \u00c4, \u00d6, \u00dc) are not allowed within the Serial No. . The characters \\\"L\\\", \\\"SxxL\\\" or \\\"Sxx\\\" at the end or the beginning of the Serial No. should be avoided (xx = any alphanumerical character). For any Serial No. that is numeric only (i.e. has no letters) it is allowed to omit printing of leading zeros (\u201e0\\\"). It is recommended to use the Serial No. of the supplier if it complies with the principles described above. 2.4 Data Identifier Data Identifiers are used in the barcode to indicate that the information following the Data Identifier is data of a certain attribute. The Data Identifier enables the barcode reading program to recognize that the following information represents a certain type of attribute. Data Identifiers to be used: 3 1P Material No. 2P Revision (for packaging only) S Serial No. Q Quantity (for packaging only) 14D Expiration date (for packaging only) T Batch (for packaging only) 5 Color Usually white label with black printing other colors are allowed as long as barcode/plain text can be read Barcode content 1P S Additionally for packaging only 2P Q It is not allowed to label Revision and Quantity on product identification labels! e.g.: 1P01234567 as barcode *) (1P) Model No. 01234567 S1001 as barcode *) (S) Serial No. 1001 Each symbol structure with start and stop character including Data Identifier (e.g. \\\"1P\\\" or \\\"S\\\"), but without symbol check character. No space allowed between Data Identifier and attribute. It is not allowed to print any other information in the barcode fields described above. Barcode type Code 39 according to ISO/IEC 16388 Narrow element (bar or space) Min. 0,17 mm Ratio of wide element to narrow element Min. 2,25 : 1 Barcode height Min. 2 mm, typical 4mm Plain text (below barcode) (1P) Model No.: (S) Serial No.: Additionally for packaging only (2P) Revision: (Q) Quantity: It is not allowed to label Revision and Quantity on product identification labels! Data Identifier (e.g. \\\"1P\\\" or \\\"S\\\") in brackets in front of data element title (e.g. ''Model No.\\\" or \\\"Serial No.\\\") in plain text! e.g.: (1P) Model No.: 01234567 *) (1p) Model No. 01234567 (S) Serial No.: 1001 *) (S) Serial No. 1001 Note: Due to 21CFR1020.30 section e) the term \\\"Model No.\\\" shall be used instead of the term \\\"Material No.\\\" in plain text on all labels. It is not allowed to print any other information near the data fields described above. If any other information is printed, it must be printed in a manner so that it can't be misinterpreted as being part of the fields described above; this can be done by printing other information at the very right side of the label. Additionally for products only For IVKs or System IVKs, the text \\\"IVK\\\" or \\\"SYSTEM IVK\\\" shall be printed on the very right side of the label. It has to be ensured that this text can't be misinterpreted as being part of the Serial No. ; this can be done by printing this text on a different level. [Siemens Medical Solutions decides and specifies whether a product is an IVK or System IVK.] Additionally for packing only The Expiration date of parts with Shelf life is fixed below the quantity as following: Expiration date: YYYYMMDD For parts which require a Batch, the batch is fixed below the Expiration date as following: AAAAAAAAAA For a transition period the batch can also be fixed above the material number Font Universe, if not possible use similar font (e.g. Helvetica) *) In case of limited space, it is possible to print the bar code next to (and not under) the clear text. 4.3 Spacing Minimum distances are:\"}, {\"id\": \"5\", \"title\": \"Expiration date and 6) Batch can be printed in barcode additionally\", \"level\": 1, \"text\": \"5) Expiration date and 6) Batch can be printed in barcode additionally. (A) Horizontal distance from edge (quiet zone) >5 mm (B) Vertical distance from edge >2 mm (C) Vertical distance between printing areas >1 mm Legend: a) printing area for barcode b) printing area for plain text For a transition period the batch can also be fixed above the material number 6\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ACCURAYINC_09_01_2010-EX-10.31-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"(a) All applicable export list numbers, including \", \"level\": 1, \"text\": \"(a) All applicable export list numbers, including the Export Control 11 To Accuray: To Distributor: Accuray Incorporated Siemens AG Attention: Chief Financial Officer Henkestr. 127 1310 Chesapeake Terrace 91054 Erlangen Sunnyvale, CA 94089 Germany Facsimile: +1 (408) 789-4205 Attn: Healthcare General Counsel, Ritva Sotamaa with cc to: General Counsel Facsimile: + 49/### - ## - #### respect to the subject matter hereof, and supersedes all prior understandings, representations and warranties, written and oral. If any part of the terms and conditions stated herein are held void or unenforceable, such part will be treated 21 as severable, leaving valid the remainder of the terms and conditions. In case of any contradiction between this Agreement and the Strategic Alliance Agreement, the terms of this Agreement shall prevail. 12.18. Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. SIGNATURE PAGE FOLLOWS 22 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the Effective Date by their duly authorized representatives. The parties acknowledge and agree that this Agreement does not become effective until it has been signed by all parties indicated below. SIGNATURE PAGE TO MULTIPLE LINAC AND MULTI-MODALITY DISTRIBUTOR AGREEMENT DISTRIBUTOR: ACCURAY INCORPORATED: By: /s/ Christian Klaussner By: /s/ Euan Thompson Print name: Christian Klaussner Print name: Euan Thomson Title: HIM OCS CFO Title: President and Chief Executive Officer Date: June 8, 2010 Date: June 7, 2010 By: /s/ Holger Schmidt By: /s/ Darren Milliken Print name: Holger Schmidt Print name: Darren Milliken Title: HIM OCS CEO Title: Senior Vice President and General Counsel Date: June 8, 2010 Date: June 7, 2010\"}}, {\"id\": \"party:Accuray Incorporated\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Accuray Incorporated\", \"role\": null, \"address\": \"1310 Chesapeake Terrace Sunnyvale, CA 94089\"}}, {\"id\": \"party:Siemens AG\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Siemens AG\", \"role\": \"Distributor\", \"address\": \"Henkestr. 127 91054 Erlangen Germany\"}}, {\"id\": \"SCHEDULE 2.3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACCEPTANCE PROCESS \u00b7 Accuray shall have 5 Business Days from date of the submission of a proposed Multiple LINAC Purchase or Multi-Modality Purchases by Siemens in which to either give or withhold approval of such purchase, with any failure to approve or disapprove of such purchase in such period constituting disapproval; \u00b7 Such approval may be given by either Accuray's applicable General Regional Manager or a corporate representative of Accuray, expressly designated with such approval authority in writing by Accuray to Siemens; \u00b7 Siemens' shall provide any information concerning such proposed purchase and the proposed purchaser as is reasonably requested by Accuray; \u00b7 Such approval of any such proposed purchase must not be unreasonably withheld or delayed; \u00b7 In determining whether to grant such approval, Accuray may consider, at a minimum: \u00b7 Existing exclusivity arrangements between Accuray and Third Parties; \u00b7 Prior and current contact with the proposed purchaser by either Party; \u00b7 Other commercial relationships that either Party may have with the proposed purchaser; \u00b7 Bona fide concerns about the suitability of the proposed purchaser; and \u00b7 Whether Accuray or any of its distributors have obtained any required regulatory clearances and/or import licenses required in connection with the proposed purchase.\", \"level\": 3, \"text\": \"SCHEDULE 2.3.2 ACCEPTANCE PROCESS \u00b7 Accuray shall have 5 Business Days from date of the submission of a proposed Multiple LINAC Purchase or Multi-Modality Purchases by Siemens in which to either give or withhold approval of such purchase, with any failure to approve or disapprove of such purchase in such period constituting disapproval; \u00b7 Such approval may be given by either Accuray's applicable General Regional Manager or a corporate representative of Accuray, expressly designated with such approval authority in writing by Accuray to Siemens; \u00b7 Siemens' shall provide any information concerning such proposed purchase and the proposed purchaser as is reasonably requested by Accuray; \u00b7 Such approval of any such proposed purchase must not be unreasonably withheld or delayed; \u00b7 In determining whether to grant such approval, Accuray may consider, at a minimum: \u00b7 Existing exclusivity arrangements between Accuray and Third Parties; \u00b7 Prior and current contact with the proposed purchaser by either Party; \u00b7 Other commercial relationships that either Party may have with the proposed purchaser; \u00b7 Bona fide concerns about the suitability of the proposed purchaser; and \u00b7 Whether Accuray or any of its distributors have obtained any required regulatory clearances and/or import licenses required in connection with the proposed purchase.\"}}, {\"id\": \"value:5 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 Business Days\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR DISCOUNTS ON PRODUCTS AND SERVICES\", \"level\": 1, \"text\": \"EXHIBIT A DISTRIBUTOR DISCOUNTS ON PRODUCTS AND SERVICES * Siemens distributor channel discount. Siemens Bundled Sales Price= (List Price (1- (Volume Discount + Distributor Discount))\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SIEMENS CODE OF CONDUCT SIEMENS Code of Conduct for Siemens Suppliers This Code of Conduct defines the basic requirements placed on Siemens' suppliers of goods and services concerning their responsibilities towards their stakeholders and the environment. Siemens reserves the right to reasonably change the requirements of this Code of Conduct due to changes of the Siemens Compliance Program. In such event Siemens expects the supplier to accept such reasonable changes. The supplier declares herewith: \u00b7 Legal compliance \u00b7 to comply with the laws of the applicable legal system(s). \u00b7 Prohibition of corruption and bribery \u00b7 to tolerate no form of and not to engage in any form of corruption or bribery, including any payment or other form of benefit conferred on any government official for the purpose of influencing decision making in violation of law. \u00b7 Respect for the basic human rights of employees \u00b7 to promote equal opportunities for and treatment of its employees irrespective of skin color, race, nationality, social background, disabilities, sexual orientation, political or religious conviction, sex or age; \u00b7 to respect the personal dignity, privacy and rights of each individual; \u00b7 to refuse to employ or make anyone work against his will; \u00b7 to refuse to tolerate any unacceptable treatment of employees, such as mental cruelty, sexual harassment or discrimination; \u00b7 to prohibit behavior including gestures, language and physical contact, that is sexual, coercive, threatening, abusive or exploitative; \u00b7 to provide fair remuneration and to guarantee the applicable national statutory minimum wage; \u00b7 to comply with the maximum number of working hours laid down in the applicable laws; \u00b7 to recognize, as far as legally possible, the right of free association of employees and to neither favor nor discriminate against members of employee organizations or trade unions. \u00b7 Prohibition of child labor \u00b7 to employ no workers under the age of 15 or, in those countries subject to the developing country exception of the ILO Convention 138, to employ no workers under the age of 14. \u00b7 Health and safety of employees \u00b7 to take responsibility for the health and safety of its employees; \u00b7 to control hazards and take the best reasonably possible precautionary measures against accidents and occupational diseases; \u00b7 to provide training and ensure that employees are educated in health and safety issues; \u00b7 to set up or use a reasonable occupational health & safety management system(1)\", \"level\": 1, \"text\": \"EXHIBIT B SIEMENS CODE OF CONDUCT SIEMENS Code of Conduct for Siemens Suppliers This Code of Conduct defines the basic requirements placed on Siemens' suppliers of goods and services concerning their responsibilities towards their stakeholders and the environment. Siemens reserves the right to reasonably change the requirements of this Code of Conduct due to changes of the Siemens Compliance Program. In such event Siemens expects the supplier to accept such reasonable changes. The supplier declares herewith: \u00b7 Legal compliance \u00b7 to comply with the laws of the applicable legal system(s). \u00b7 Prohibition of corruption and bribery \u00b7 to tolerate no form of and not to engage in any form of corruption or bribery, including any payment or other form of benefit conferred on any government official for the purpose of influencing decision making in violation of law. \u00b7 Respect for the basic human rights of employees \u00b7 to promote equal opportunities for and treatment of its employees irrespective of skin color, race, nationality, social background, disabilities, sexual orientation, political or religious conviction, sex or age; \u00b7 to respect the personal dignity, privacy and rights of each individual; \u00b7 to refuse to employ or make anyone work against his will; \u00b7 to refuse to tolerate any unacceptable treatment of employees, such as mental cruelty, sexual harassment or discrimination; \u00b7 to prohibit behavior including gestures, language and physical contact, that is sexual, coercive, threatening, abusive or exploitative; \u00b7 to provide fair remuneration and to guarantee the applicable national statutory minimum wage; \u00b7 to comply with the maximum number of working hours laid down in the applicable laws; \u00b7 to recognize, as far as legally possible, the right of free association of employees and to neither favor nor discriminate against members of employee organizations or trade unions. \u00b7 Prohibition of child labor \u00b7 to employ no workers under the age of 15 or, in those countries subject to the developing country exception of the ILO Convention 138, to employ no workers under the age of 14. \u00b7 Health and safety of employees \u00b7 to take responsibility for the health and safety of its employees; \u00b7 to control hazards and take the best reasonably possible precautionary measures against accidents and occupational diseases; \u00b7 to provide training and ensure that employees are educated in health and safety issues; \u00b7 to set up or use a reasonable occupational health & safety management system(1) Discount Type List Price Range USD Volume Discount Distributor Discount* Volume Discounts - Tier # 1 {*****} {*****} {*****} Volume Discounts - Tier # 2 {*****} {*****} {*****} Volume Discounts - Tier # 3 {*****} {*****} {*****} Volume Discounts - Tier # 4 {*****} {*****} {*****} Volume Discounts - Tier # 5 {*****} {*****} {*****} Volume Discounts - Tier # 6 {*****} {*****} {*****} Volume Discounts - Tier # 7 {*****} {*****} {*****} Volume Discounts - Tier # 8 {*****} {*****} {*****} Volume Discounts - Tier # 9 {*****} {*****} {*****} Volume Discounts - Tier # 10 {*****} {*****} {*****} Volume Discounts - Tier # 11 {*****} {*****} {*****} Volume Discounts - Tier # 12 {*****} {*****} {*****} \u00b7 Environmental protection \u00b7 to act in accordance with the applicable statutory and international standards regarding environmental protection; \u00b7 to minimize environmental pollution and make continuous improvements in environmental protection; \u00b7 to set up or use a reasonable environmental management system(1) \u00b7 Supply chain \u00b7 to use reasonable efforts to promote among its suppliers compliance with this Code of Conduct; \u00b7 to comply with the principles of non discrimination with regard to supplier selection and treatment. (1) For further information see www.siemens.com/procurement/cr/code-of-conduct\"}}, {\"id\": \"EXHIBIT C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SIEMENS QUALITY ASSURANCE AGREEMENT Please see attached.\", \"level\": 1, \"text\": \"EXHIBIT C SIEMENS QUALITY ASSURANCE AGREEMENT Please see attached. SIEMENS For internal use only Copyright \u00a9 Siemens AG 2002. All rights reserved. Quality Requirement Med Identification of Products and basic requirements for packaging Requirements for Suppliers QR Med 1 A1 Siemens Medical Solutions and affiliated Companies Issued by Med Quality Management & Regulatory Affairs Released 2007-09-28 by the Med Quality Steering Board (QSB) Valid from 2007-11-01 04798372 AND 02S 04 1 2 Contents Author: Gabriele Franz AX QP Reviewer: Volker Glahn QM&RA Philippe Hoxter CSQ\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purpose and scope For Siemens Medical Solutions it is a basic requirement that any part, component or system is iden\", \"level\": 1, \"text\": \"1 Purpose and scope For Siemens Medical Solutions it is a basic requirement that any part, component or system is identified the same way worldwide. This document lists the minimum requirements for suppliers of Siemens Medical Solutions describing \u00b7 how parts, components and systems are identified with their attributes and \u00b7 how attributes are labeled both as plain text as well as barcode on products and its packaging. Detailed specifications with regards to the labeling of products are defined for the individual product concerned. 2 Definitions and abbreviations 2.1 Material No. The Siemens Medical Solutions Material No. is used to uniquely identify products (parts, components and systems). It consists of an 8-digit identification no. assigned by Siemens Medical Solutions. Previously, the term \\\"Part no.\\\" was also used; it is replaced by the term \\\"Material No.\\\". 2.2 Revision The Revision (abbreviated \\\"Rev.\\\") serves to distinguish between different update statuses of hardware. It is assigned by Siemens Medical Solutions. The English term \\\"Revision\\\" replaces the German term \\\"Erzeugnisstand\\\" (abbreviated \\\"ES\\\") and \\\"Ausf\u00fchrungsstand\\\" (abbreviated \\\"AS\\\"). 2.3 Serial No. The Serial No. is an identifying attribute used to uniquely identify hardware or software with the same Material No. . For suppliers the Serial No. can consist of up to 15 alphanumeric digits; it is however recommended to use only a 6 digit numerical Serial No. where possible. The Serial No. may contain a dash (-) or a slash (/), but no other special characters (e.g. # + * ?). Spaces, lower-case letters or language-specific characters (e.g. \u00c4, \u00d6, \u00dc) are not allowed within the Serial No. . The characters \\\"L\\\", \\\"SxxL\\\" or \\\"Sxx\\\" at the end or the beginning of the Serial No. should be avoided (xx = any alphanumerical character). For any Serial No. that is numeric only (i.e. has no letters) it is allowed to omit printing of leading zeros (\u201e0\\\"). It is recommended to use the Serial No. of the supplier if it complies with the principles described above. 2.4 Data Identifier Data Identifiers are used in the barcode to indicate that the information following the Data Identifier is data of a certain attribute. The Data Identifier enables the barcode reading program to recognize that the following information represents a certain type of attribute. Data Identifiers to be used: 3 1P Material No. 2P Revision (for packaging only) S Serial No. Q Quantity (for packaging only) 14D Expiration date (for packaging only) T Batch (for packaging only) 5 Color Usually white label with black printing other colors are allowed as long as barcode/plain text can be read Barcode content 1P S Additionally for packaging only 2P Q It is not allowed to label Revision and Quantity on product identification labels! e.g.: 1P01234567 as barcode *) (1P) Model No. 01234567 S1001 as barcode *) (S) Serial No. 1001 Each symbol structure with start and stop character including Data Identifier (e.g. \\\"1P\\\" or \\\"S\\\"), but without symbol check character. No space allowed between Data Identifier and attribute. It is not allowed to print any other information in the barcode fields described above. Barcode type Code 39 according to ISO/IEC 16388 Narrow element (bar or space) Min. 0,17 mm Ratio of wide element to narrow element Min. 2,25 : 1 Barcode height Min. 2 mm, typical 4mm Plain text (below barcode) (1P) Model No.: (S) Serial No.: Additionally for packaging only (2P) Revision: (Q) Quantity: It is not allowed to label Revision and Quantity on product identification labels! Data Identifier (e.g. \\\"1P\\\" or \\\"S\\\") in brackets in front of data element title (e.g. ''Model No.\\\" or \\\"Serial No.\\\") in plain text! e.g.: (1P) Model No.: 01234567 *) (1p) Model No. 01234567 (S) Serial No.: 1001 *) (S) Serial No. 1001 Note: Due to 21CFR1020.30 section e) the term \\\"Model No.\\\" shall be used instead of the term \\\"Material No.\\\" in plain text on all labels. It is not allowed to print any other information near the data fields described above. If any other information is printed, it must be printed in a manner so that it can't be misinterpreted as being part of the fields described above; this can be done by printing other information at the very right side of the label. Additionally for products only For IVKs or System IVKs, the text \\\"IVK\\\" or \\\"SYSTEM IVK\\\" shall be printed on the very right side of the label. It has to be ensured that this text can't be misinterpreted as being part of the Serial No. ; this can be done by printing this text on a different level. [Siemens Medical Solutions decides and specifies whether a product is an IVK or System IVK.] Additionally for packing only The Expiration date of parts with Shelf life is fixed below the quantity as following: Expiration date: YYYYMMDD For parts which require a Batch, the batch is fixed below the Expiration date as following: AAAAAAAAAA For a transition period the batch can also be fixed above the material number Font Universe, if not possible use similar font (e.g. Helvetica) *) In case of limited space, it is possible to print the bar code next to (and not under) the clear text. 4.3 Spacing Minimum distances are:\"}}, {\"id\": \"term:Material No.\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Material No.\", \"text\": \"The Siemens Medical Solutions Material No. is used to uniquely identify products (parts, components and systems). It consists of an 8-digit identification no. assigned by Siemens Medical Solutions.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Revision\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Revision\", \"text\": \"The Revision (abbreviated \\\"Rev.\\\") serves to distinguish between different update statuses of hardware. It is assigned by Siemens Medical Solutions.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Serial No.\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Serial No.\", \"text\": \"The Serial No. is an identifying attribute used to uniquely identify hardware or software with the same Material No. .\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Data Identifier\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Data Identifier\", \"text\": \"Data Identifiers are used in the barcode to indicate that the information following the Data Identifier is data of a certain attribute. The Data Identifier enables the barcode reading program to recognize that the following information represents a certain type of attribute.\", \"definition_clause\": \"1\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Expiration date and 6) Batch can be printed in barcode additionally\", \"level\": 1, \"text\": \"5) Expiration date and 6) Batch can be printed in barcode additionally. (A) Horizontal distance from edge (quiet zone) >5 mm (B) Vertical distance from edge >2 mm (C) Vertical distance between printing areas >1 mm Legend: a) printing area for barcode b) printing area for plain text For a transition period the batch can also be fixed above the material number 6\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"REDACTED COPY\", \"level\": 1, \"text\": \"REDACTED COPY CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION 1 ENDORSEMENT AGREEMENT This Agreement is entered into on January 13, 2005 between professional golfer, TOM WATSON, (hereinafter referred to as \\\"CONSULTANT\\\") and ADAMS GOLF, LTD. (hereinafter referred to as \\\"ADAMS GOLF\\\"). WITNESSETH WHEREAS, ADAMS GOLF desires to obtain the right to use the name, likeness and ENDORSEMENT of CONSULTANT in connection with the advertisement and promotion of ADAMS GOLF'S PRODUCT; NOW THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: CONTRACT PERIOD\"}, {\"id\": \"1\", \"title\": \"TERM OF CONTRACT\", \"level\": 1, \"text\": \"1. TERM OF CONTRACT The Term of this Agreement shall be for a period of [* ****] years and [*****] months commencing the 1st day of September 2004 and terminating the [*****] day of [*****].\"}, {\"id\": \"2\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS As used in this Agreement, the following terms shall be defined as set forth below: A. CONSULTANT'S \\\"ENDORSEMENT\\\" means the right to use the CONSULTANT'S name, fame, nickname, autograph, voice, facsimile, signature, photograph, likeness, and image in connection with the marketing, advertising, promotion and sale of ADAMS GOLF'S PRODUCT. B.\\\"PRODUCT\\\" shall mean all golf clubs including, but not limited to, metal woods, drivers, fairway woods, irons, iron- woods, utility clubs, wedges, and putters, bags, and headwear. C.\\\"MANDATORY PRODUCTS\\\" shall mean the following ADAMS GOLF PRODUCTS that CONSULTANT must exclusively play/use in all Champions/Senior Professional Golf Association (SPGA) and Professional Golf Association (PGA) events at all times: [***** ] Confidential Material redacted and filed separately with the Commission. 2\"}, {\"id\": \"1\", \"title\": \"[*****] 2\", \"level\": 1, \"text\": \"1.[*****] 2.Sufficient [*****] to maintain total minimum of [*****] ADAMS GOLF [*****] (includes [*****])[*****] at all times 3.[*****] 4.[*****] (CONSULTANT may continue to place the [*****] logo on the [*****] consistent with historical practice.)\"}, {\"id\": \"D\", \"title\": \"\\\"CONTRACT TERRITORY\\\" shall mean the entire world\", \"level\": 1, \"text\": \"D. \\\"CONTRACT TERRITORY\\\" shall mean the entire world. CONSULTANT'S OBLIGATIONS\"}, {\"id\": \"3\", \"title\": \"CONSULTANT'S ENDORSEMENT\", \"level\": 1, \"text\": \"3. CONSULTANT'S ENDORSEMENT CONSULTANT hereby gives and grants to ADAMS GOLF the exclusive right and license to use CONSULTANT'S ENDORSEMENT in connection with the manufacture, sale, distribution, advertising and promotion of PRODUCT in the CONTRACT TERRITORY. 4. EXCLUSIVITY OF ENDORSEMENT During the term of this Agreement, unless otherwise authorized at the sole discretion of ADAMS GOLF in writing, CONSULTANT shall not: A.give the right to use or permit the use of CONSULTANT'S name, facsimile signature, nickname, voice or likeness to any other manufacturer or seller of PRODUCT; B.sponsor or endorse PRODUCT made or sold by any other manufacturer or seller; or\"}, {\"id\": \"C\", \"title\": \"serve as a CONSULTANT or advisor of any other manufacturer or seller of PRODUCT\", \"level\": 1, \"text\": \"C.serve as a CONSULTANT or advisor of any other manufacturer or seller of PRODUCT.\"}, {\"id\": \"D\", \"title\": \"Notwithstanding paragraphs 4A, 4B and 4C above, CONSULTANT shall be entitled to endorse and play the [*****]\", \"level\": 1, \"text\": \"D.Notwithstanding paragraphs 4A, 4B and 4C above, CONSULTANT shall be entitled to endorse and play the [*****]. The parties expressly agree that CONSULTANT may permit [*****] the use of CONSULTANT'S name and/or likeness in [*****] print and/or television advertisement provided that this is executed in a manner consistent with [*****] past [*****] advertising practice using similarly situated professional golfers with competing golf club endorsement agreements that include [*****]. If [*****] use of CONSULTANT varies from past practice of utilizing similarly situated professionals, CONSULTANT will take action to remedy the situation [*****]. If CONSULTANT participates directly in any [*****] sponsored photo shoots for advertising or PR, CONSULTANT shall wear his ADAMS GOLF [*****]. The parties further expressly agree that CONSULTANT'S endorsement of the [*****] shall not include the right to place a [*****] logo on his ADAMS GOLF [*****] or the ADAMS GOLF [*****]. If CONSULTANT'S relationship with [*****] terminates during this Agreement, CONSULTANT shall be permitted to replace the [*****] endorsement with another [*****] endorsement under the same terms and conditions expressed herein. [***** ] Confidential Material redacted and filed separately with the Commission. 3 E.Notwithstanding paragraphs 4A, 4B and 4C above, CONSULTANT shall not be required to wear ADAMS GOLF [*****] in [*****] ads.\"}, {\"id\": \"5\", \"title\": \"EXCLUSIVE USE OF PRODUCT\", \"level\": 1, \"text\": \"5. EXCLUSIVE USE OF PRODUCT During the term of this Agreement, CONSULTANT shall exclusively play/use the MANDATORY PRODUCT. (It is expressly understood by the parties that CONSULTANT may play [* ****] clubs in the bag other than ADAMS GOLF clubs including, but not limited to, a putter by a manufacturer other than ADAMS GOLF but may not endorse those clubs and/or putter.)\"}, {\"id\": \"6\", \"title\": \"CONSULTANT'S ENDORSEMENT OF NON-COMPETITIVE PRODUCT\", \"level\": 1, \"text\": \"6. CONSULTANT'S ENDORSEMENT OF NON-COMPETITIVE PRODUCT If CONSULTANT endorses or promotes a non-competitive product and in that endorsement or promotion CONSULTANT wears, plays, uses, holds or is in any way associated with a product that would constitute PRODUCT as defined under this Agreement, CONSULTANT shall use objectively reasonable best efforts to ensure that PRODUCT is an ADAMS GOLF PRODUCT and it shall not be altered or changed in appearance in the endorsement in any manner whatsoever without the express written consent of ADAMS GOLF. When endorsing a non-competitive product, under no circumstances shall CONSULTANT wear, play, use, hold or in any way be associated with an ADAMS GOLF competitor's Product.\"}, {\"id\": \"7\", \"title\": \"CONSULTANT'S SATISFACTION OF MANDATORY PRODUCT\", \"level\": 1, \"text\": \"7. CONSULTANT'S SATISFACTION OF MANDATORY PRODUCT It is particularly and expressly understood and agreed that if CONSULTANT shall find in his sincere best reasonable judgment that the MANDATORY PRODUCT so supplied is not suitable for his use in tournament competition, then he shall promptly notify ADAMS GOLF in writing of such fact and the reasons therefor. Thereafter, ADAMS GOLF shall have a period of thirty (30) days to either, at ADAMS GOLF'S sole discretion, supply CONSULTANT with MANDATORY PRODUCT that is acceptable to him or terminate the agreement. It is agreed that if the contract is terminated pursuant to this paragraph, the compensation due CONSULTANT shall be prorated from the date this Agreement is terminated. Proration of compensation shall be determined on the same repayment schedule as provide in paragraph 8A below. [***** ] Confidential Material redacted and filed separately with the Commission. 4\"}, {\"id\": \"8\", \"title\": \"MINIMUM NUMBER OF TOURNAMENTS AND POTENTIAL REPAYMENT OF BASE COMPENSATION\", \"level\": 1, \"text\": \"8. MINIMUM NUMBER OF TOURNAMENTS AND POTENTIAL REPAYMENT OF BASE COMPENSATION A. In each and every calendar year of this Agreement, CONSULTANT shall achieve a satisfactory record of play in a minimum of [* ****] professional golf association events on the SPGA and/or PGA tour (which shall include both the PGA and SPGA Tour Skins Games). If for any reason, CONSULTANT should achieve a satisfactory record of play in less than [*****] SPGA and/or PGA tour events in a calendar year, he shall repay ADAMS GOLF an amount per event for each event under [*****] achieved in the given calendar year as follows: The agreed upon repayment amount per event per calendar year:\"}, {\"id\": \"1\", \"title\": \"Year 1\", \"level\": 1, \"text\": \"1. Year 1. $[*****] 2. Year 2 $[*****] 3. Year 3 $[*****] 4. Year 4 $[*****] 5. Year 5 $[*****] B.Payment shall be made to ADAMS GOLF within one month following the end of the calendar year. For example, if in the calendar year 2005 CONSULTANT achieves a satisfactory record of play in [*****] events, he shall repay ADAMS GOLF [*****] dollars no later than January 31, 2006.\"}, {\"id\": \"C\", \"title\": \"In the event that CONSULTANT is prevented from competing for reasons outside his control, the parties agree to a good f\", \"level\": 1, \"text\": \"C.In the event that CONSULTANT is prevented from competing for reasons outside his control, the parties agree to a good faith attempt to resolve the issues. If a resolution can not be reached, ADAMS GOLF may, at its sole discretion, demand prorated repayment pursuant to the repayment schedule in paragraph 8A above.\"}, {\"id\": \"9\", \"title\": \"PRODUCT DESIGN During the term of this Agreement, CONSULTANT shall use best efforts to cooperate with ADAMS GOLF\", \"level\": 1, \"text\": \"9. PRODUCT DESIGN During the term of this Agreement, CONSULTANT shall use best efforts to cooperate with ADAMS GOLF in giving advice, suggestions and recommendations concerning the acceptability and playability of current ADAMS GOLF lines, the development of new ADAMS GOLF lines, and information about significant golf PRODUCT and golf market trends, and meet as reasonably requested with ADAMS GOLF'S Design/Testing Teams. 10. PROMOTION OF PRODUCT During the term of this Agreement, CONSULTANT shall use best efforts to wear the headwear and display ADAMS GOLF'S brand name and to demonstrate, discuss and emphasize the newest features of ADAMS GOLF PRODUCT at every opportunity including but not limited to all Senior PGA tour events and promotional and advertising events in which CONSULTANT takes part. [***** ] Confidential Material redacted and filed separately with the Commission. 5\"}, {\"id\": \"11\", \"title\": \"PROMOTIONAL APPEARANCES\", \"level\": 1, \"text\": \"11. PROMOTIONAL APPEARANCES A.During the term of this Agreement, CONSULTANT shall use best efforts to be available for such press interviews, radio or TV appearances arranged for CONSULTANT by ADAMS GOLF which are compatible with CONSULTANT'S own practice, play and personal time requirements. CONSULTANT will be required to be available after a tournament for selected interviews, either the Sunday afternoon or Monday morning following the tournament. In all such interviews and appearances, CONSULTANT will use his best efforts to make reference to the ADAMS GOLF PRODUCT and wear [*****] and display ADAMS GOLF'S brand name. B.During the term of this Agreement, CONSULTANT shall make himself available on not more than [*****] days for television and radio commercials, photo shoots, modeling and promotional appearances compatible with CONSULTANT'S own practice, play and personal time requirements. Said activities shall be directly related to the promotion of ADAMS GOLF PRODUCT. ADAMS GOLF shall reimburse CONSULTANT for reasonable travel expenses for CONSULTANT when making special appearances for ADAMS GOLF pursuant to this paragraph but ADAMS GOLF shall not pay CONSULTANT session fees, residual payments or the like for television appearances. Travel expenses shall include jet fuel or first-class round-trip airfare and lodging, meals and local transportation.\"}, {\"id\": \"12\", \"title\": \"BEHAVIOR\", \"level\": 1, \"text\": \"12. BEHAVIOR During the term of this Agreement, CONSULTANT will conduct himself at all times with due regard to public morals and conventions. If the value of CONSULTANT'S ENDORSEMENT is materially reduced or impaired because CONSULTANT: A.committed or shall commit any public act that involves moral turpitude, B.commits or violates any material foreign, U.S., federal, or other applicable state or local law, C.commits any act which brings him into public disrepute, contempt, scandal or ridicule, or which insults or offends the community, D.makes any statements in derogation, in any material respect, of ADAMS GOLF or any of its affiliates or any of their respective PRODUCT or services and such statement is made to the general public or becomes a matter of public knowledge, then at any time after the occurrence of such act, thing or statement, ADAMS GOLF shall have the right, in addition to its other legal and equitable remedies, to immediately terminate this Agreement, by giving written notice to CONSULTANT. ADAMS GOLF must exercise its right of termination within ninety (90) days of its senior management becoming aware of the conduct giving rise to the right of termination. [***** ] Confidential Material redacted and filed separately with the Commission. 6\"}, {\"id\": \"13\", \"title\": \"FREEDOM TO CONTRACT\", \"level\": 1, \"text\": \"13. FREEDOM TO CONTRACT CONSULTANT represents and warrants that CONSULTANT is free of all prior undertakings and obligations which would prevent or tend to impair either the full performance of CONSULTANT'S obligations hereunder or ADAMS GOLF'S full enjoyment of the rights and privileges granted to it by CONSULTANT.\"}, {\"id\": \"14\", \"title\": \"INDEMNITY\", \"level\": 1, \"text\": \"14. INDEMNITY CONSULTANT agrees to protect, indemnify and hold ADAMS GOLF harmless from any and all liability, claims, causes of action, suits, damages and expenses (including reasonable attorneys' fees and expenses) for which it becomes liable or is compelled to pay by reason of a breach of any covenant or representation by CONSULTANT in this Agreement.\"}, {\"id\": \"15\", \"title\": \"ABSENCE OF AGENCY\", \"level\": 1, \"text\": \"15. ABSENCE OF AGENCY CONSULTANT shall not and will not have the right or authority to bind ADAMS GOLF by any representation or in any other respect whatsoever or to incur any obligation or liability in the name of or on behalf of ADAMS GOLF.\"}, {\"id\": \"16\", \"title\": \"MEMBERSHIPS\", \"level\": 1, \"text\": \"16. MEMBERSHIPS CONSULTANT warrants and represents that during the term of this Agreement he is a member in good standing of SAG, AFTRA or any other organization having jurisdiction over CONSULTANT'S services hereunder. This Agreement is subject to all of the terms and conditions of the collective bargaining agreements with SAG, AFTRA, or any other union agreements or codes having jurisdiction over CONSULTANT'S services hereunder. Any and all payments required to be made to SAG or AFTRA or any other organization having jurisdiction over CONSULTANT'S services hereunder, shall be the sole responsibility of CONSULTANT. ADAMS GOLF'S OBLIGATIONS\"}, {\"id\": \"17\", \"title\": \"SUPPLY OF PRODUCT\", \"level\": 1, \"text\": \"17. SUPPLY OF PRODUCT A. During the term of this Agreement, ADAMS GOLF shall provide CONSULTANT with sufficient quantities of such MANDATORY PRODUCTS for CONSULTANT'S use as CONSULTANT may reasonably need to fulfill his obligations under this agreement. ADAMS GOLF shall pay all charges in connection with the delivery of MANDATORY PRODUCTS to CONSULTANT. B.In addition to paragraph 17A above, ADAMS GOLF shall provide CONSULTANT with [*****] sets of clubs for CONSULTANT'S family and friends each calendar year of this Agreement. [***** ] Confidential Material redacted and filed separately with the Commission. 7\"}, {\"id\": \"18\", \"title\": \"BASE COMPENSATION\", \"level\": 1, \"text\": \"18. BASE COMPENSATION For the entire term of this Agreement, from September 1, 2004 through [*****] ADAMS GOLF shall pay CONSULTANT a base compensation of [*****] dollars. The base compensation shall be paid [*****].\"}, {\"id\": \"19\", \"title\": \"PERFORMANCE BONUSES AND TOTAL COMPENSATION LIMITATION\", \"level\": 1, \"text\": \"19. PERFORMANCE BONUSES AND TOTAL COMPENSATION LIMITATION A. In addition to his base compensation, CONSULTANT shall also be entitled to bonuses based on performance in particular PGA and SPGA events and year-end standing as follows:\"}, {\"id\": \"1\", \"title\": \"If CONSULTANT wins a PGA Tour Major (consisting of the Masters, US Open, PGA and British Open) or the Champion's Tour (\", \"level\": 1, \"text\": \"1. If CONSULTANT wins a PGA Tour Major (consisting of the Masters, US Open, PGA and British Open) or the Champion's Tour (SPGA) US Open, CONSULTANT shall receive a bonus of $ [*****].\"}, {\"id\": \"2\", \"title\": \"If CONSULTANT wins a Champions/Seniors Tour (SPGA) major other than the US Open (which shall for the purposes of this a\", \"level\": 1, \"text\": \"2. If CONSULTANT wins a Champions/Seniors Tour (SPGA) major other than the US Open (which shall for the purposes of this agreement consist of the Senior PGA, Senior British, the Tradition and the Ford Seniors) CONSULTANT shall receive a bonus of $ [*****].\"}, {\"id\": \"3\", \"title\": \"If CONSULTANT finishes in the top [*****] on the official year end money list of the Champion's Tour (SPGA), CONSULTANT\", \"level\": 1, \"text\": \"3. If CONSULTANT finishes in the top [*****] on the official year end money list of the Champion's Tour (SPGA), CONSULTANT shall also be entitled to a year end performance bonus according to the following schedule: a.2005 $ [*****] b.2006$ [*****] c.2007$ [*****] d.2008$ [*****] e.2009$ [*****] B.Notwithstanding paragraph A and its subparts above, the maximum total annual bonuses shall in no case exceed the following schedule: (For example, if in the calendar year [*****]CONSULTANT wins every PGA tour major and finishes in the top [*****] on the official year end money list of the Champion's Tour (SPGA), CONSULTANT'S total bonuses shall be [*****] dollars. [***** ] Confidential Material redacted and filed separately with the Commission. 8\"}, {\"id\": \"C\", \"title\": \"In the event of ADAMS GOLF'S insolvency or bankruptcy, it is expressly agreed to by the parties that CONSULTANT shall\", \"level\": 1, \"text\": \"C. In the event of ADAMS GOLF'S insolvency or bankruptcy, it is expressly agreed to by the parties that CONSULTANT shall not be obligated to repay any money so long as CONSULTANT continues to fully perform his obligations under this Agreement. 20. APPROVAL OF ADVERTISING Prior to publishing or placing any advertising or promotional material which uses CONSULTANT'S name, facsimile signature, nickname, voice or likeness, ADAMS GOLF shall submit the same to CONSULTANT, or CONSULTANT'S designee, for approval, which approval shall not be unreasonably withheld or delayed. If CONSULTANT disapproves, the reasons therefore shall be given to ADAMS GOLF in writing within three (3) business days or shall be deemed approved. ADAMS GOLF agrees to protect, indemnify and hold CONSULTANT harmless from and against any and all expenses, damages, claims, suits, actions, judgments and costs whatsoever, arising out of, or in any way connected with, any advertising material furnished by, or on behalf of, the company.\"}, {\"id\": \"21\", \"title\": \"INDEMNITY\", \"level\": 1, \"text\": \"21. INDEMNITY ADAMS GOLF agrees to defend, indemnify and hold harmless CONSULTANT from any and all liability, claims, causes of action, suits, damages and expenses (including reasonable attorneys' fees and expenses) for which he becomes liable or is compelled to pay by reason of or arising out of any claim or action for personal injury, death or otherwise involving alleged defects in ADAMS GOLF'S PRODUCT, provided that ADAMS GOLF is promptly given notice in writing and is given complete authority and information required for the defense, and ADAMS GOLF shall pay all damages or costs awarded therein against CONSULTANT and any other cost incurred by CONSULTANT in defense of any suit, but shall not be responsible for any cost, expense or compromise incurred or made by CONSULTANT without ADAMS GOLF'S prior written consent. TERMINATION\"}, {\"id\": \"22\", \"title\": \"FAILURE TO PLAY\", \"level\": 1, \"text\": \"22. FAILURE TO PLAY Notwithstanding any other paragraph of this Agreement, in the event that CONSULTANT dies or is unable to play tour golf at all, ADAMS GOLF may terminate this Agreement on thirty (30) days' written notice. Upon such termination, CONSULTANT and/or CONSULTANT'S estate shall be required to repay ADAMS GOLF for that period of the Agreement not performed by CONSULTANT. The repayment amount shall be calculated in the same way as repayment is calculated under paragraph 8A. 9\"}, {\"id\": \"23\", \"title\": \"TERMINATION FOR CAUSE\", \"level\": 1, \"text\": \"23. TERMINATION FOR CAUSE Notwithstanding any other paragraph of this Agreement, if either party commits any material breach of this Agreement, the other party may terminate for cause upon giving fifteen (15) days written notice of such cause and provided the breach is not rectified within such fifteen (15) day period. Upon such termination, CONSULTANT shall be required to repay ADAMS GOLF for that period of the Agreement not performed by CONSULTANT. The repayment amount shall be calculated in the same way as repayment is calculated under paragraph 8A.\"}, {\"id\": \"24\", \"title\": \"ADAMS GOLF'S RIGHTS UPON TERMINATION\", \"level\": 1, \"text\": \"24. ADAMS GOLF'S RIGHTS UPON TERMINATION A.In the event of termination of this Agreement, ADAMS GOLF shall cease using the name and/or likeness of CONSULTANT in advertising within [*****] days. B.In the event of termination of this Agreement, ADAMS GOLF shall cease using the name and/or likeness of CONSULTANT on Product within [*****] months after termination of this Agreement. MISCELLANEOUS PROVISIONS\"}, {\"id\": \"24\", \"title\": \"SIGNIFICANCE OF HEADINGS\", \"level\": 1, \"text\": \"24. SIGNIFICANCE OF HEADINGS Section headings contained herein are solely for the purpose of aiding in speedy location of subject matter and are not in any sense to be given weight in the construction of this Agreement. Accordingly, in case of any question with respect to the construction of this Agreement, it is to be construed as though such section headings had been omitted.\"}, {\"id\": \"25\", \"title\": \"APPLICABLE LAW\", \"level\": 1, \"text\": \"25. APPLICABLE LAW This Agreement shall be governed and construed according to the laws of the State of Kansas.\"}, {\"id\": \"26\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"26. ENTIRE AGREEMENT The provisions of this Agreement are intended by the parties as a complete, conclusive and final expression of their agreement concerning the subject matter hereof, which Agreement supersedes all prior agreements concerning the subject matter, and no other statement, representation, agreement or understanding, oral or written, made prior to or at the execution hereof, shall vary or modify the written terms hereof. No amendments, modifications or releases from any provision hereof shall be effective unless in writing and signed by both parties.\"}, {\"id\": \"27\", \"title\": \"WAIVER\", \"level\": 1, \"text\": \"27. WAIVER Unless otherwise mutually agreed in writing, no departure from, waiver of, or omission to require compliance with any of the terms hereof by either party shall be deemed to authorize any prior or subsequent departure or waiver, or obligate either party to continue any departure or waiver. [***** ] Confidential Material redacted and filed separately with the Commission. 10\"}, {\"id\": \"28\", \"title\": \"EXECUTION AND DELIVERY REQUIRED\", \"level\": 1, \"text\": \"28. EXECUTION AND DELIVERY REQUIRED This instrument shall not be considered to be an agreement or contract nor shall it create any obligation whatsoever on the part of CONSULTANT or ADAMS GOLF unless and until it has been signed by CONSULTANT, or a duly authorized representative, and by duly authorized representatives of ADAMS GOLF and delivery has been made of a fully signed original to both parties.\"}, {\"id\": \"29\", \"title\": \"SEVERABILITY\", \"level\": 1, \"text\": \"29. SEVERABILITY Any provision or part of this Agreement prohibited by applicable law shall be ineffective to the extent of such prohibition without invalidating the remaining provisions or parts hereof.\"}, {\"id\": \"30\", \"title\": \"RELATIONSHIP\", \"level\": 1, \"text\": \"30. RELATIONSHIP Both parties agree that this Agreement does not constitute and shall not be construed as a constituting of a partnership or joint venture between ADAMS GOLF and CONSULTANT. Neither party shall have any right to obligate or bind the other party in any manner whatsoever, and nothing herein contained shall give or is intended to give any rights of any kind to any third person.\"}, {\"id\": \"31\", \"title\": \"ASSIGNMENT AND CHANGE OF CONTROL\", \"level\": 1, \"text\": \"31. ASSIGNMENT AND CHANGE OF CONTROL Neither ADAMS GOLF nor CONSULTANT shall have the right to grant sublicenses hereunder or to assign, alienate or otherwise transfer any of its rights or obligations hereunder.\"}, {\"id\": \"32\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"32. CONFIDENTIALITY Both parties understand that the contents of this Agreement, including, but not limited to, all amounts paid or to be paid and any additional consideration, are extremely confidential, and that disclosure of same to any third party could be detrimental to the interests of one or both parties. Therefore, both parties agree not to disclose the terms of this Agreement, without the permission of the other party, to any third party other than to CONSULTANT'S business, legal and financial advisors, and with respect to all such advisors, CONSULTANT shall take all reasonable steps to ensure such confidentiality to ADAMS GOLF. Furthermore, CONSULTANT recognizes that during the course of performing his duties hereunder he may become aware of proprietary, confidential information concerning ADAMS GOLF, its PRODUCT, methods, processes, billing practices, financial condition, etc., or information ADAMS GOLF designates as confidential (collectively \\\"Confidential Information\\\"). CONSULTANT agrees that he will maintain in confidence and not disclose to any third party at any time any such Confidential Information and shall not use any such information to the detriment of ADAMS GOLF or for any purpose not contemplated by the Agreement. 11\"}, {\"id\": \"33\", \"title\": \"ARBITRATION\", \"level\": 1, \"text\": \"33. ARBITRATION In the event a dispute arises under this Agreement which cannot be resolved, such dispute shall be submitted to arbitration and resolved by a panel of three arbitrators (who shall be lawyers), in a decision required by a majority of the arbitrators. If the parties cannot agree upon the panel of three arbitrators, then each party may pick an arbitrator and the two chosen arbitrators shall choose upon the three-arbitrator panel. The arbitration shall be conducted in accordance with the Arbitration Rules of the American Arbitration Association. Venue shall be Kansas. The award or decision rendered by the arbitration panel shall be final, binding and conclusive and judgment may be entered upon such award by any court of competent jurisdiction.\"}, {\"id\": \"34\", \"title\": \"NOTICE\", \"level\": 1, \"text\": \"34. NOTICE Every written notice or written report which may be served upon CONSULTANT, according to the terms of this Agreement, may be served by enclosing it in a postpaid envelope addressed to: Mr. Tom Watson C/O Assured Management Company 1901 W. 47th Place, Suite 200 Westwood, Kansas 66205 or at such other address as is given in writing to ADAMS GOLF by CONSULTANT. Every written notice which may be served upon ADAMS GOLF, according to the terms of this Agreement, shall be served by enclosing it in a postpaid envelope addressed to: Attention Legal Department ADAMS GOLF, LTD. 2801 East Plano Parkway Plano, Texas 75074 or at such other address as is given in writing by ADAMS GOLF to CONSULTANT. 12 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first set forth above. APPROVED FOR CONSULTANT By: /s/ Tom Watson Date: January 13, 2005 Tom Watson APPROVED FOR ADAMS GOLF, LTD. By: /s/ Oliver G. \\\"Chip\\\" Brewer III Date: January 13, 2005 Oliver G. (\\\"Chip\\\") Brewer III CEO, ADAMS GOLF 13\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ADAMSGOLFINC_03_21_2005-EX-10.17-ENDORSEMENT AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REDACTED COPY\", \"level\": 1, \"text\": \"REDACTED COPY CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION 1 ENDORSEMENT AGREEMENT This Agreement is entered into on January 13, 2005 between professional golfer, TOM WATSON, (hereinafter referred to as \\\"CONSULTANT\\\") and ADAMS GOLF, LTD. (hereinafter referred to as \\\"ADAMS GOLF\\\"). WITNESSETH WHEREAS, ADAMS GOLF desires to obtain the right to use the name, likeness and ENDORSEMENT of CONSULTANT in connection with the advertisement and promotion of ADAMS GOLF'S PRODUCT; NOW THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: CONTRACT PERIOD\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM OF CONTRACT\", \"level\": 1, \"text\": \"1. TERM OF CONTRACT The Term of this Agreement shall be for a period of [* ****] years and [*****] months commencing the 1st day of September 2004 and terminating the [*****] day of [*****].\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS As used in this Agreement, the following terms shall be defined as set forth below: A. CONSULTANT'S \\\"ENDORSEMENT\\\" means the right to use the CONSULTANT'S name, fame, nickname, autograph, voice, facsimile, signature, photograph, likeness, and image in connection with the marketing, advertising, promotion and sale of ADAMS GOLF'S PRODUCT. B.\\\"PRODUCT\\\" shall mean all golf clubs including, but not limited to, metal woods, drivers, fairway woods, irons, iron- woods, utility clubs, wedges, and putters, bags, and headwear. C.\\\"MANDATORY PRODUCTS\\\" shall mean the following ADAMS GOLF PRODUCTS that CONSULTANT must exclusively play/use in all Champions/Senior Professional Golf Association (SPGA) and Professional Golf Association (PGA) events at all times: [***** ] Confidential Material redacted and filed separately with the Commission. 2\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****] 2\", \"level\": 1, \"text\": \"1.[*****] 2.Sufficient [*****] to maintain total minimum of [*****] ADAMS GOLF [*****] (includes [*****])[*****] at all times 3.[*****] 4.[*****] (CONSULTANT may continue to place the [*****] logo on the [*****] consistent with historical practice.)\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"CONTRACT TERRITORY\\\" shall mean the entire world\", \"level\": 1, \"text\": \"D. \\\"CONTRACT TERRITORY\\\" shall mean the entire world. CONSULTANT'S OBLIGATIONS\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONSULTANT'S ENDORSEMENT\", \"level\": 1, \"text\": \"3. CONSULTANT'S ENDORSEMENT CONSULTANT hereby gives and grants to ADAMS GOLF the exclusive right and license to use CONSULTANT'S ENDORSEMENT in connection with the manufacture, sale, distribution, advertising and promotion of PRODUCT in the CONTRACT TERRITORY. 4. EXCLUSIVITY OF ENDORSEMENT During the term of this Agreement, unless otherwise authorized at the sole discretion of ADAMS GOLF in writing, CONSULTANT shall not: A.give the right to use or permit the use of CONSULTANT'S name, facsimile signature, nickname, voice or likeness to any other manufacturer or seller of PRODUCT; B.sponsor or endorse PRODUCT made or sold by any other manufacturer or seller; or\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"serve as a CONSULTANT or advisor of any other manufacturer or seller of PRODUCT\", \"level\": 1, \"text\": \"C.serve as a CONSULTANT or advisor of any other manufacturer or seller of PRODUCT.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding paragraphs 4A, 4B and 4C above, CONSULTANT shall be entitled to endorse and play the [*****]\", \"level\": 1, \"text\": \"D.Notwithstanding paragraphs 4A, 4B and 4C above, CONSULTANT shall be entitled to endorse and play the [*****]. The parties expressly agree that CONSULTANT may permit [*****] the use of CONSULTANT'S name and/or likeness in [*****] print and/or television advertisement provided that this is executed in a manner consistent with [*****] past [*****] advertising practice using similarly situated professional golfers with competing golf club endorsement agreements that include [*****]. If [*****] use of CONSULTANT varies from past practice of utilizing similarly situated professionals, CONSULTANT will take action to remedy the situation [*****]. If CONSULTANT participates directly in any [*****] sponsored photo shoots for advertising or PR, CONSULTANT shall wear his ADAMS GOLF [*****]. The parties further expressly agree that CONSULTANT'S endorsement of the [*****] shall not include the right to place a [*****] logo on his ADAMS GOLF [*****] or the ADAMS GOLF [*****]. If CONSULTANT'S relationship with [*****] terminates during this Agreement, CONSULTANT shall be permitted to replace the [*****] endorsement with another [*****] endorsement under the same terms and conditions expressed herein. [***** ] Confidential Material redacted and filed separately with the Commission. 3 E.Notwithstanding paragraphs 4A, 4B and 4C above, CONSULTANT shall not be required to wear ADAMS GOLF [*****] in [*****] ads.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVE USE OF PRODUCT\", \"level\": 1, \"text\": \"5. EXCLUSIVE USE OF PRODUCT During the term of this Agreement, CONSULTANT shall exclusively play/use the MANDATORY PRODUCT. (It is expressly understood by the parties that CONSULTANT may play [* ****] clubs in the bag other than ADAMS GOLF clubs including, but not limited to, a putter by a manufacturer other than ADAMS GOLF but may not endorse those clubs and/or putter.)\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONSULTANT'S ENDORSEMENT OF NON-COMPETITIVE PRODUCT\", \"level\": 1, \"text\": \"6. CONSULTANT'S ENDORSEMENT OF NON-COMPETITIVE PRODUCT If CONSULTANT endorses or promotes a non-competitive product and in that endorsement or promotion CONSULTANT wears, plays, uses, holds or is in any way associated with a product that would constitute PRODUCT as defined under this Agreement, CONSULTANT shall use objectively reasonable best efforts to ensure that PRODUCT is an ADAMS GOLF PRODUCT and it shall not be altered or changed in appearance in the endorsement in any manner whatsoever without the express written consent of ADAMS GOLF. When endorsing a non-competitive product, under no circumstances shall CONSULTANT wear, play, use, hold or in any way be associated with an ADAMS GOLF competitor's Product.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONSULTANT'S SATISFACTION OF MANDATORY PRODUCT\", \"level\": 1, \"text\": \"7. CONSULTANT'S SATISFACTION OF MANDATORY PRODUCT It is particularly and expressly understood and agreed that if CONSULTANT shall find in his sincere best reasonable judgment that the MANDATORY PRODUCT so supplied is not suitable for his use in tournament competition, then he shall promptly notify ADAMS GOLF in writing of such fact and the reasons therefor. Thereafter, ADAMS GOLF shall have a period of thirty (30) days to either, at ADAMS GOLF'S sole discretion, supply CONSULTANT with MANDATORY PRODUCT that is acceptable to him or terminate the agreement. It is agreed that if the contract is terminated pursuant to this paragraph, the compensation due CONSULTANT shall be prorated from the date this Agreement is terminated. Proration of compensation shall be determined on the same repayment schedule as provide in paragraph 8A below. [***** ] Confidential Material redacted and filed separately with the Commission. 4\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MINIMUM NUMBER OF TOURNAMENTS AND POTENTIAL REPAYMENT OF BASE COMPENSATION\", \"level\": 1, \"text\": \"8. MINIMUM NUMBER OF TOURNAMENTS AND POTENTIAL REPAYMENT OF BASE COMPENSATION A. In each and every calendar year of this Agreement, CONSULTANT shall achieve a satisfactory record of play in a minimum of [* ****] professional golf association events on the SPGA and/or PGA tour (which shall include both the PGA and SPGA Tour Skins Games). If for any reason, CONSULTANT should achieve a satisfactory record of play in less than [*****] SPGA and/or PGA tour events in a calendar year, he shall repay ADAMS GOLF an amount per event for each event under [*****] achieved in the given calendar year as follows: The agreed upon repayment amount per event per calendar year:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Year 1\", \"level\": 1, \"text\": \"1. Year 1. $[*****] 2. Year 2 $[*****] 3. Year 3 $[*****] 4. Year 4 $[*****] 5. Year 5 $[*****] B.Payment shall be made to ADAMS GOLF within one month following the end of the calendar year. For example, if in the calendar year 2005 CONSULTANT achieves a satisfactory record of play in [*****] events, he shall repay ADAMS GOLF [*****] dollars no later than January 31, 2006.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event that CONSULTANT is prevented from competing for reasons outside his control, the parties agree to a good f\", \"level\": 1, \"text\": \"C.In the event that CONSULTANT is prevented from competing for reasons outside his control, the parties agree to a good faith attempt to resolve the issues. If a resolution can not be reached, ADAMS GOLF may, at its sole discretion, demand prorated repayment pursuant to the repayment schedule in paragraph 8A above.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT DESIGN During the term of this Agreement, CONSULTANT shall use best efforts to cooperate with ADAMS GOLF\", \"level\": 1, \"text\": \"9. PRODUCT DESIGN During the term of this Agreement, CONSULTANT shall use best efforts to cooperate with ADAMS GOLF in giving advice, suggestions and recommendations concerning the acceptability and playability of current ADAMS GOLF lines, the development of new ADAMS GOLF lines, and information about significant golf PRODUCT and golf market trends, and meet as reasonably requested with ADAMS GOLF'S Design/Testing Teams. 10. PROMOTION OF PRODUCT During the term of this Agreement, CONSULTANT shall use best efforts to wear the headwear and display ADAMS GOLF'S brand name and to demonstrate, discuss and emphasize the newest features of ADAMS GOLF PRODUCT at every opportunity including but not limited to all Senior PGA tour events and promotional and advertising events in which CONSULTANT takes part. [***** ] Confidential Material redacted and filed separately with the Commission. 5\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROMOTIONAL APPEARANCES\", \"level\": 1, \"text\": \"11. PROMOTIONAL APPEARANCES A.During the term of this Agreement, CONSULTANT shall use best efforts to be available for such press interviews, radio or TV appearances arranged for CONSULTANT by ADAMS GOLF which are compatible with CONSULTANT'S own practice, play and personal time requirements. CONSULTANT will be required to be available after a tournament for selected interviews, either the Sunday afternoon or Monday morning following the tournament. In all such interviews and appearances, CONSULTANT will use his best efforts to make reference to the ADAMS GOLF PRODUCT and wear [*****] and display ADAMS GOLF'S brand name. B.During the term of this Agreement, CONSULTANT shall make himself available on not more than [*****] days for television and radio commercials, photo shoots, modeling and promotional appearances compatible with CONSULTANT'S own practice, play and personal time requirements. Said activities shall be directly related to the promotion of ADAMS GOLF PRODUCT. ADAMS GOLF shall reimburse CONSULTANT for reasonable travel expenses for CONSULTANT when making special appearances for ADAMS GOLF pursuant to this paragraph but ADAMS GOLF shall not pay CONSULTANT session fees, residual payments or the like for television appearances. Travel expenses shall include jet fuel or first-class round-trip airfare and lodging, meals and local transportation.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BEHAVIOR\", \"level\": 1, \"text\": \"12. BEHAVIOR During the term of this Agreement, CONSULTANT will conduct himself at all times with due regard to public morals and conventions. If the value of CONSULTANT'S ENDORSEMENT is materially reduced or impaired because CONSULTANT: A.committed or shall commit any public act that involves moral turpitude, B.commits or violates any material foreign, U.S., federal, or other applicable state or local law, C.commits any act which brings him into public disrepute, contempt, scandal or ridicule, or which insults or offends the community, D.makes any statements in derogation, in any material respect, of ADAMS GOLF or any of its affiliates or any of their respective PRODUCT or services and such statement is made to the general public or becomes a matter of public knowledge, then at any time after the occurrence of such act, thing or statement, ADAMS GOLF shall have the right, in addition to its other legal and equitable remedies, to immediately terminate this Agreement, by giving written notice to CONSULTANT. ADAMS GOLF must exercise its right of termination within ninety (90) days of its senior management becoming aware of the conduct giving rise to the right of termination. [***** ] Confidential Material redacted and filed separately with the Commission. 6\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FREEDOM TO CONTRACT\", \"level\": 1, \"text\": \"13. FREEDOM TO CONTRACT CONSULTANT represents and warrants that CONSULTANT is free of all prior undertakings and obligations which would prevent or tend to impair either the full performance of CONSULTANT'S obligations hereunder or ADAMS GOLF'S full enjoyment of the rights and privileges granted to it by CONSULTANT.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNITY\", \"level\": 1, \"text\": \"14. INDEMNITY CONSULTANT agrees to protect, indemnify and hold ADAMS GOLF harmless from any and all liability, claims, causes of action, suits, damages and expenses (including reasonable attorneys' fees and expenses) for which it becomes liable or is compelled to pay by reason of a breach of any covenant or representation by CONSULTANT in this Agreement.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ABSENCE OF AGENCY\", \"level\": 1, \"text\": \"15. ABSENCE OF AGENCY CONSULTANT shall not and will not have the right or authority to bind ADAMS GOLF by any representation or in any other respect whatsoever or to incur any obligation or liability in the name of or on behalf of ADAMS GOLF.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MEMBERSHIPS\", \"level\": 1, \"text\": \"16. MEMBERSHIPS CONSULTANT warrants and represents that during the term of this Agreement he is a member in good standing of SAG, AFTRA or any other organization having jurisdiction over CONSULTANT'S services hereunder. This Agreement is subject to all of the terms and conditions of the collective bargaining agreements with SAG, AFTRA, or any other union agreements or codes having jurisdiction over CONSULTANT'S services hereunder. Any and all payments required to be made to SAG or AFTRA or any other organization having jurisdiction over CONSULTANT'S services hereunder, shall be the sole responsibility of CONSULTANT. ADAMS GOLF'S OBLIGATIONS\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY OF PRODUCT\", \"level\": 1, \"text\": \"17. SUPPLY OF PRODUCT A. During the term of this Agreement, ADAMS GOLF shall provide CONSULTANT with sufficient quantities of such MANDATORY PRODUCTS for CONSULTANT'S use as CONSULTANT may reasonably need to fulfill his obligations under this agreement. ADAMS GOLF shall pay all charges in connection with the delivery of MANDATORY PRODUCTS to CONSULTANT. B.In addition to paragraph 17A above, ADAMS GOLF shall provide CONSULTANT with [*****] sets of clubs for CONSULTANT'S family and friends each calendar year of this Agreement. [***** ] Confidential Material redacted and filed separately with the Commission. 7\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BASE COMPENSATION\", \"level\": 1, \"text\": \"18. BASE COMPENSATION For the entire term of this Agreement, from September 1, 2004 through [*****] ADAMS GOLF shall pay CONSULTANT a base compensation of [*****] dollars. The base compensation shall be paid [*****].\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PERFORMANCE BONUSES AND TOTAL COMPENSATION LIMITATION\", \"level\": 1, \"text\": \"19. PERFORMANCE BONUSES AND TOTAL COMPENSATION LIMITATION A. In addition to his base compensation, CONSULTANT shall also be entitled to bonuses based on performance in particular PGA and SPGA events and year-end standing as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If CONSULTANT wins a PGA Tour Major (consisting of the Masters, US Open, PGA and British Open) or the Champion's Tour (\", \"level\": 1, \"text\": \"1. If CONSULTANT wins a PGA Tour Major (consisting of the Masters, US Open, PGA and British Open) or the Champion's Tour (SPGA) US Open, CONSULTANT shall receive a bonus of $ [*****].\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If CONSULTANT wins a Champions/Seniors Tour (SPGA) major other than the US Open (which shall for the purposes of this a\", \"level\": 1, \"text\": \"2. If CONSULTANT wins a Champions/Seniors Tour (SPGA) major other than the US Open (which shall for the purposes of this agreement consist of the Senior PGA, Senior British, the Tradition and the Ford Seniors) CONSULTANT shall receive a bonus of $ [*****].\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If CONSULTANT finishes in the top [*****] on the official year end money list of the Champion's Tour (SPGA), CONSULTANT\", \"level\": 1, \"text\": \"3. If CONSULTANT finishes in the top [*****] on the official year end money list of the Champion's Tour (SPGA), CONSULTANT shall also be entitled to a year end performance bonus according to the following schedule: a.2005 $ [*****] b.2006$ [*****] c.2007$ [*****] d.2008$ [*****] e.2009$ [*****] B.Notwithstanding paragraph A and its subparts above, the maximum total annual bonuses shall in no case exceed the following schedule: (For example, if in the calendar year [*****]CONSULTANT wins every PGA tour major and finishes in the top [*****] on the official year end money list of the Champion's Tour (SPGA), CONSULTANT'S total bonuses shall be [*****] dollars. [***** ] Confidential Material redacted and filed separately with the Commission. 8\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of ADAMS GOLF'S insolvency or bankruptcy, it is expressly agreed to by the parties that CONSULTANT shall\", \"level\": 1, \"text\": \"C. In the event of ADAMS GOLF'S insolvency or bankruptcy, it is expressly agreed to by the parties that CONSULTANT shall not be obligated to repay any money so long as CONSULTANT continues to fully perform his obligations under this Agreement. 20. APPROVAL OF ADVERTISING Prior to publishing or placing any advertising or promotional material which uses CONSULTANT'S name, facsimile signature, nickname, voice or likeness, ADAMS GOLF shall submit the same to CONSULTANT, or CONSULTANT'S designee, for approval, which approval shall not be unreasonably withheld or delayed. If CONSULTANT disapproves, the reasons therefore shall be given to ADAMS GOLF in writing within three (3) business days or shall be deemed approved. ADAMS GOLF agrees to protect, indemnify and hold CONSULTANT harmless from and against any and all expenses, damages, claims, suits, actions, judgments and costs whatsoever, arising out of, or in any way connected with, any advertising material furnished by, or on behalf of, the company.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNITY\", \"level\": 1, \"text\": \"21. INDEMNITY ADAMS GOLF agrees to defend, indemnify and hold harmless CONSULTANT from any and all liability, claims, causes of action, suits, damages and expenses (including reasonable attorneys' fees and expenses) for which he becomes liable or is compelled to pay by reason of or arising out of any claim or action for personal injury, death or otherwise involving alleged defects in ADAMS GOLF'S PRODUCT, provided that ADAMS GOLF is promptly given notice in writing and is given complete authority and information required for the defense, and ADAMS GOLF shall pay all damages or costs awarded therein against CONSULTANT and any other cost incurred by CONSULTANT in defense of any suit, but shall not be responsible for any cost, expense or compromise incurred or made by CONSULTANT without ADAMS GOLF'S prior written consent. TERMINATION\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FAILURE TO PLAY\", \"level\": 1, \"text\": \"22. FAILURE TO PLAY Notwithstanding any other paragraph of this Agreement, in the event that CONSULTANT dies or is unable to play tour golf at all, ADAMS GOLF may terminate this Agreement on thirty (30) days' written notice. Upon such termination, CONSULTANT and/or CONSULTANT'S estate shall be required to repay ADAMS GOLF for that period of the Agreement not performed by CONSULTANT. The repayment amount shall be calculated in the same way as repayment is calculated under paragraph 8A. 9\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION FOR CAUSE\", \"level\": 1, \"text\": \"23. TERMINATION FOR CAUSE Notwithstanding any other paragraph of this Agreement, if either party commits any material breach of this Agreement, the other party may terminate for cause upon giving fifteen (15) days written notice of such cause and provided the breach is not rectified within such fifteen (15) day period. Upon such termination, CONSULTANT shall be required to repay ADAMS GOLF for that period of the Agreement not performed by CONSULTANT. The repayment amount shall be calculated in the same way as repayment is calculated under paragraph 8A.\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ADAMS GOLF'S RIGHTS UPON TERMINATION\", \"level\": 1, \"text\": \"24. ADAMS GOLF'S RIGHTS UPON TERMINATION A.In the event of termination of this Agreement, ADAMS GOLF shall cease using the name and/or likeness of CONSULTANT in advertising within [*****] days. B.In the event of termination of this Agreement, ADAMS GOLF shall cease using the name and/or likeness of CONSULTANT on Product within [*****] months after termination of this Agreement. MISCELLANEOUS PROVISIONS\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SIGNIFICANCE OF HEADINGS\", \"level\": 1, \"text\": \"24. SIGNIFICANCE OF HEADINGS Section headings contained herein are solely for the purpose of aiding in speedy location of subject matter and are not in any sense to be given weight in the construction of this Agreement. Accordingly, in case of any question with respect to the construction of this Agreement, it is to be construed as though such section headings had been omitted.\"}}, {\"id\": \"25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPLICABLE LAW\", \"level\": 1, \"text\": \"25. APPLICABLE LAW This Agreement shall be governed and construed according to the laws of the State of Kansas.\"}}, {\"id\": \"26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"26. ENTIRE AGREEMENT The provisions of this Agreement are intended by the parties as a complete, conclusive and final expression of their agreement concerning the subject matter hereof, which Agreement supersedes all prior agreements concerning the subject matter, and no other statement, representation, agreement or understanding, oral or written, made prior to or at the execution hereof, shall vary or modify the written terms hereof. No amendments, modifications or releases from any provision hereof shall be effective unless in writing and signed by both parties.\"}}, {\"id\": \"27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WAIVER\", \"level\": 1, \"text\": \"27. WAIVER Unless otherwise mutually agreed in writing, no departure from, waiver of, or omission to require compliance with any of the terms hereof by either party shall be deemed to authorize any prior or subsequent departure or waiver, or obligate either party to continue any departure or waiver. [***** ] Confidential Material redacted and filed separately with the Commission. 10\"}}, {\"id\": \"28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXECUTION AND DELIVERY REQUIRED\", \"level\": 1, \"text\": \"28. EXECUTION AND DELIVERY REQUIRED This instrument shall not be considered to be an agreement or contract nor shall it create any obligation whatsoever on the part of CONSULTANT or ADAMS GOLF unless and until it has been signed by CONSULTANT, or a duly authorized representative, and by duly authorized representatives of ADAMS GOLF and delivery has been made of a fully signed original to both parties.\"}}, {\"id\": \"29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 1, \"text\": \"29. SEVERABILITY Any provision or part of this Agreement prohibited by applicable law shall be ineffective to the extent of such prohibition without invalidating the remaining provisions or parts hereof.\"}}, {\"id\": \"30\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RELATIONSHIP\", \"level\": 1, \"text\": \"30. RELATIONSHIP Both parties agree that this Agreement does not constitute and shall not be construed as a constituting of a partnership or joint venture between ADAMS GOLF and CONSULTANT. Neither party shall have any right to obligate or bind the other party in any manner whatsoever, and nothing herein contained shall give or is intended to give any rights of any kind to any third person.\"}}, {\"id\": \"31\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT AND CHANGE OF CONTROL\", \"level\": 1, \"text\": \"31. ASSIGNMENT AND CHANGE OF CONTROL Neither ADAMS GOLF nor CONSULTANT shall have the right to grant sublicenses hereunder or to assign, alienate or otherwise transfer any of its rights or obligations hereunder.\"}}, {\"id\": \"32\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"32. CONFIDENTIALITY Both parties understand that the contents of this Agreement, including, but not limited to, all amounts paid or to be paid and any additional consideration, are extremely confidential, and that disclosure of same to any third party could be detrimental to the interests of one or both parties. Therefore, both parties agree not to disclose the terms of this Agreement, without the permission of the other party, to any third party other than to CONSULTANT'S business, legal and financial advisors, and with respect to all such advisors, CONSULTANT shall take all reasonable steps to ensure such confidentiality to ADAMS GOLF. Furthermore, CONSULTANT recognizes that during the course of performing his duties hereunder he may become aware of proprietary, confidential information concerning ADAMS GOLF, its PRODUCT, methods, processes, billing practices, financial condition, etc., or information ADAMS GOLF designates as confidential (collectively \\\"Confidential Information\\\"). CONSULTANT agrees that he will maintain in confidence and not disclose to any third party at any time any such Confidential Information and shall not use any such information to the detriment of ADAMS GOLF or for any purpose not contemplated by the Agreement. 11\"}}, {\"id\": \"33\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ARBITRATION\", \"level\": 1, \"text\": \"33. ARBITRATION In the event a dispute arises under this Agreement which cannot be resolved, such dispute shall be submitted to arbitration and resolved by a panel of three arbitrators (who shall be lawyers), in a decision required by a majority of the arbitrators. If the parties cannot agree upon the panel of three arbitrators, then each party may pick an arbitrator and the two chosen arbitrators shall choose upon the three-arbitrator panel. The arbitration shall be conducted in accordance with the Arbitration Rules of the American Arbitration Association. Venue shall be Kansas. The award or decision rendered by the arbitration panel shall be final, binding and conclusive and judgment may be entered upon such award by any court of competent jurisdiction.\"}}, {\"id\": \"34\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICE\", \"level\": 1, \"text\": \"34. NOTICE Every written notice or written report which may be served upon CONSULTANT, according to the terms of this Agreement, may be served by enclosing it in a postpaid envelope addressed to: Mr. Tom Watson C/O Assured Management Company 1901 W. 47th Place, Suite 200 Westwood, Kansas 66205 or at such other address as is given in writing to ADAMS GOLF by CONSULTANT. Every written notice which may be served upon ADAMS GOLF, according to the terms of this Agreement, shall be served by enclosing it in a postpaid envelope addressed to: Attention Legal Department ADAMS GOLF, LTD. 2801 East Plano Parkway Plano, Texas 75074 or at such other address as is given in writing by ADAMS GOLF to CONSULTANT. 12 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first set forth above. APPROVED FOR CONSULTANT By: /s/ Tom Watson Date: January 13, 2005 Tom Watson APPROVED FOR ADAMS GOLF, LTD. By: /s/ Oliver G. \\\"Chip\\\" Brewer III Date: January 13, 2005 Oliver G. (\\\"Chip\\\") Brewer III CEO, ADAMS GOLF 13\"}}, {\"id\": \"party:TOM WATSON\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"TOM WATSON\", \"role\": \"CONSULTANT\", \"address\": \"Mr. Tom Watson C/O Assured Management Company 1901 W. 47th Place, Suite 200 Westwood, Kansas 66205\"}}, {\"id\": \"party:ADAMS GOLF, LTD.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ADAMS GOLF, LTD.\", \"role\": \"ADAMS GOLF\", \"address\": \"Attention Legal Department ADAMS GOLF, LTD. 2801 East Plano Parkway Plano, Texas 75074\"}}, {\"id\": \"term:ENDORSEMENT\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ENDORSEMENT\", \"text\": \"means the right to use the CONSULTANT'S name, fame, nickname, autograph, voice, facsimile, signature, photograph, likeness, and image in connection with the marketing, advertising, promotion and sale of ADAMS GOLF'S PRODUCT.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:PRODUCT\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PRODUCT\", \"text\": \"shall mean all golf clubs including, but not limited to, metal woods, drivers, fairway woods, irons, iron- woods, utility clubs, wedges, and putters, bags, and headwear.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:MANDATORY PRODUCTS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MANDATORY PRODUCTS\", \"text\": \"shall mean the following ADAMS GOLF PRODUCTS that CONSULTANT must exclusively play/use in all Champions/Senior Professional Golf Association (SPGA) and Professional Golf Association (PGA) events at all times: [***** ]\", \"definition_clause\": \"2\"}}, {\"id\": \"term:CONTRACT TERRITORY\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CONTRACT TERRITORY\", \"text\": \"shall mean the entire world.\", \"definition_clause\": \"D\"}}, {\"id\": \"value:[* ****] years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[* ****] years\"}}, {\"id\": \"value:[*****] months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[*****] months\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:one month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one month\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:[*****] dollars\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"[*****] dollars\"}}, {\"id\": \"value:$ [*****]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$ [*****]\"}}, {\"id\": \"value:three (3) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) business days\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:[*****] days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[*****] days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10d-2\", \"level\": 1, \"text\": \"Exhibit 10d-2 RESELLER AGREEMENT BY AND BETWEEN PIVX CORPORATION AND DETTO TECHNOLOGIES This Reseller Agreement is entered as of this ___ day of _________, 2004 (\\\"Effective Date\\\") by and between PivX Corporation, a California corporation, having its principal place of business at 23 Corporate Plaza Drive, Newport Beach, California, 92661 (\\\"PivX\\\") and Detto Technologies, a Washington corporation, having its principal place of business at 14320 NE 21st Street, Suite 11, Bellevue, Washington, 98007 (\\\"Detto\\\"). NOW THEREFORE, for good and valuable consideration, the parties hereby agree as follows:\"}, {\"id\": \"1\", \"title\": \"GRANT OF RIGHTS\", \"level\": 1, \"text\": \"1. GRANT OF RIGHTS\"}, {\"id\": \"1.1\", \"title\": \"LICENSE\", \"level\": 2, \"text\": \"1.1 LICENSE. Subject to the terms and conditions of this Agreement, PivX hereby grants to Detto a non-transferable, exclusive license to distribute PivX's Qwik-Fix Pro and any documentation supporting Qwik-Fix Pro provided from time to time by PivX (the \\\"Documentation\\\") within North America, solely to third parties to whom Detto licenses Qwik-Fix Pro (\\\"Third Parties\\\"), and as governed by the terms set forth in Exhibit A (PivX/Detto Reseller Agreement Addendum). PivX also hereby grants to Detto a non-transferable, non-exclusive license to distribute PivX's Qwik-Fix Pro and the Documentation outside of North America, solely to Third Parties and as governed by the terms in Exhibit A. Detto shall have no right to reproduce Qwik-Fix Pro or any part thereof. All copies of Qwik-Fix Pro distributed by Detto shall be distributed pursuant to PivX's current Enterprise License Agreement, as amended by PivX from time to time (the \\\"License\\\"), a copy of which PivX will provide Detto. Detto shall not distribute Qwik-Fix Pro to any Third Party unless the Third Party has accepted the terms of PivX's current License under penalty of perjury and in writing.\"}, {\"id\": \"1.2\", \"title\": \"OWNERSHIP\", \"level\": 2, \"text\": \"1.2 OWNERSHIP. As between PivX and Detto, PivX owns and retains all right, title, and interest in and to Qwik-Fix Pro and Documentation; all trademarks, service marks or trade names associated with Qwik-Fix Pro or Documentation (the \\\"Trademarks\\\"); all copyrights, patents, trade secret rights, and other intellectual property rights therein (collectively, together with Qwik-Fix Pro, Documentation, and Trademarks, the \\\"Property\\\"). Except as expressly granted herein, PivX does not grant to Detto any right or license, either express or implied, in Qwik-Fix Pro, Documentation or Property. Detto shall not reverse engineer, disassemble, decompile, or otherwise attempt to derive source code from Qwik-Fix Pro.\"}, {\"id\": \"1.3\", \"title\": \"PIVX CHANNELNET\", \"level\": 2, \"text\": \"1.3 PIVX CHANNELNET. PivX grants Detto access to PivX ChannelNet as governed by the terms set forth in Exhibit A.\"}, {\"id\": \"2\", \"title\": \"DETTO'S OBLIGATIONS\", \"level\": 1, \"text\": \"2. DETTO'S OBLIGATIONS\"}, {\"id\": \"2.1\", \"title\": \"DETTO'S MARKETING; PUBLIC RELATIONS\", \"level\": 2, \"text\": \"2.1 DETTO'S MARKETING; PUBLIC RELATIONS. Detto obligations for marketing and public relations are governed under the terms in Exhibit A.\"}, {\"id\": \"2.2\", \"title\": \"TRADEMARKS; PROPERTY\", \"level\": 2, \"text\": \"2.2 TRADEMARKS; PROPERTY. During the term of this Agreement, Detto shall have the right to use and reproduce the Trademarks in connection with Detto's marketing, advertising, promotion and distribution of Qwik-Fix Pro. Detto's use of the Trademarks shall not create any right, title or interest therein. Detto shall use the Trademarks only in a manner which complies in all material respects with PivX's reasonable policies in effect from time to time, and all 1 such use shall be for PivX's benefit. Detto shall not remove, obscure or alter PivX's copyright notice or the Trademarks from Qwik-Fix Pro or Documentation. If Detto, in the course of distributing Qwik-Fix Pro, acquires any goodwill or reputation in any of the Trademarks, all such goodwill or reputation shall automatically be transferred to and shall vest in PivX when and as, on an on-going basis, such acquisition of goodwill or reputation occurs, as well as at the expiration or termination of this Agreement, without any separate payment or other consideration of any kind to Detto, and Detto agrees to take all such actions necessary to effect such vesting. Detto shall not contest the validity of any of the Property or PivX's exclusive ownership of them. Detto shall not adopt, use, or register, whether as a corporate name, trademark, service mark or other indication of origin, any of the Trademarks, or any word or mark confusingly similar to the Trademarks in any jurisdiction.\"}, {\"id\": \"2.3\", \"title\": \"SUPPORT FOR QWIK-FIX PRO\", \"level\": 2, \"text\": \"2.3 SUPPORT FOR QWIK-FIX PRO. Detto shall provide for all customer support for Qwik-Fix Pro that it resells as governed by the terms set forth in Exhibit A.\"}, {\"id\": \"2.4\", \"title\": \"COMPLIANCE WITH APPLICABLE LAWS\", \"level\": 2, \"text\": \"2.4 COMPLIANCE WITH APPLICABLE LAWS. Detto shall comply with all laws and regulations applicable to Detto's marketing and distribution of Qwik-Fix Pro hereunder. Without limiting the generality of the foregoing, Detto shall, at its own expense, make, obtain, and maintain in force at all times during the term of this Agreement, all filings, registrations, licenses, permits and authorizations in North America required for Detto to perform its obligations under this Agreement.\"}, {\"id\": \"2.5\", \"title\": \"SECURITY ISSUES\", \"level\": 2, \"text\": \"2.5 SECURITY ISSUES. Detto shall take all action necessary to ensure that (a) Qwik-Fix Pro and Documentation on Detto's servers or computer systems is appropriately secured so that Qwik-Fix Pro and Documentation can only be viewed, copied, or utilized by licensed Third Parties; and (b) that the object code of the Courseware can only be accessed by employees authorized by PivX and cannot be copied or downloaded by any of Detto's licensees or by any other third party. In addition, Detto shall make its offices and equipment available in person, upon reasonable notice, and to the extent feasible, remotely, to PivX to inspect and test Detto's physical and technical set-up to ensure that Detto is complying with its obligations under this Section. Detto agrees to indemnify and hold PivX harmless in accordance with the provisions of Section 4.4 to the extent that Detto breaches its obligations under this Section 2.5.\"}, {\"id\": \"2.6\", \"title\": \"PROTECTION OF PROPRIETARY RIGHTS\", \"level\": 2, \"text\": \"2.6 PROTECTION OF PROPRIETARY RIGHTS. Detto shall cooperate without charge (provided that PivX will reimburse out of pocket expenses as agreed in advance in writing), in PivX's efforts to protect PivX's rights in the Property. Detto shall promptly notify PivX of any infringements of PivX's Property Rights that come to Detto's attention. PivX shall have the exclusive right to institute infringement or other appropriate legal action against alleged infringers of its Property Rights. PivX shall incur all expenses in connection therewith and shall retain all monetary recoveries received therefrom.\"}, {\"id\": \"2.7\", \"title\": \"NO EXCESS REPRESENTATIONS OR WARRANTIES\", \"level\": 2, \"text\": \"2.7 NO EXCESS REPRESENTATIONS OR WARRANTIES. Detto covenants that it shall not make any representations or warranties with respect to Qwik-Fix Pro or Documentation in excess of those provided by PivX herein. Detto agrees to indemnify and hold PivX harmless in accordance with the provisions of Section 4.4 to the extent that Detto breaches its covenant under this Section 2.7.\"}, {\"id\": \"2.8\", \"title\": \"FULFILLMENT OF DETTO'S OBLIGATIONS\", \"level\": 2, \"text\": \"2.8 FULFILLMENT OF DETTO'S OBLIGATIONS. Detto covenants that it will fulfill all of its contractual and legal obligations to its customers. Detto covenants that it will (a) provide its customers with first quality sales and technical support with respect to any copies or licenses of Qwik-Fix Pro sold by Detto, (b) promptly, courteously and appropriately respond to its customers questions, concerns and complaints, and (c) generally deal with its customers in a professional manner that shall add to the good reputation of Detto and PivX. To the extent that Detto fails to fulfill its contractual and legal obligations to its customers, Detto agrees that PivX may elect to fulfill those obligations, or any portion of them, and Detto shall reimburse PivX any costs and expenses so incurred by PivX. Detto agrees to indemnify and hold PivX harmless in accordance with the provisions of Section 4.4 to the extent that it breaches any of its covenants under this Section 2.8.\"}, {\"id\": \"2\", \"title\": \"9 U\", \"level\": 1, \"text\": \"2.9 U.S. GOVERNMENT - RESTRICTED RIGHTS. Detto covenants to require its customers to accept a click-wrap agreement that, among other things, provides that Qwik-Fix Pro and accompanying documentation are deemed to be \\\"commercial computer Software\\\" and \\\"commercial computer Software documentation,\\\" 2 respectively, pursuant to DFAR Section 227.7202 and FAR Section 12.212, as applicable. Any use, modification, reproduction release, performance, display or disclosure of Qwik-Fix Pro and accompanying documentation by the U.S. Government shall be governed solely by the terms of the Agreement and shall be prohibited except to the extent expressly permitted by the terms of this Agreement.\"}, {\"id\": \"2.10\", \"title\": \"BUSINESS DEVELOPMENT\", \"level\": 2, \"text\": \"2.10 BUSINESS DEVELOPMENT. Detto will engage in future business development with PivX as governed by the terms set forth in Exhibit A.\"}, {\"id\": \"2.11\", \"title\": \"SALES FORECASTING; SALES METRICS; SALES REPORTING\", \"level\": 2, \"text\": \"2.11 SALES FORECASTING; SALES METRICS; SALES REPORTING. Detto will provide sales forecasting, sales metrics and sales reporting to PivX as governed by the terms set forth in Exhibit A.\"}, {\"id\": \"3\", \"title\": \"PRICE AND PAYMENT; SHIPMENT AND DELIVERY\", \"level\": 1, \"text\": \"3. PRICE AND PAYMENT; SHIPMENT AND DELIVERY\"}, {\"id\": \"3.1\", \"title\": \"SUGGESTED THIRD PARTY PRICES\", \"level\": 2, \"text\": \"3.1 SUGGESTED THIRD PARTY PRICES. Third Party prices are governed by the terms set forth in Exhibit A.\"}, {\"id\": \"3.2\", \"title\": \"PER COPY FEES\", \"level\": 2, \"text\": \"3.2 PER COPY FEES. Detto shall pay to PivX for each unit of Qwik-Fix Pro distributed hereunder per copy fees (the \\\"Per Copy Fees\\\") as governed by the terms set forth in Exhibit A. In the event that PivX changes the Third Party prices, Per Copy Fees based on such changed prices shall apply to any order for Qwik-Fix Pro received by PivX after the effective date of the increase. PivX shall provide Detto with at least forty-five (45) days written notice of any increase in the Per Copy Fees.\"}, {\"id\": \"3.3\", \"title\": \"PAYMENT\", \"level\": 2, \"text\": \"3.3 PAYMENT. All payments to PivX shall be made within thirty (30) days after the receipt by Detto of the PivX's invoice. Detto shall pay PivX a late charge on outstanding amounts due equal to one and one-half percent (1.50%) per month or the maximum amount allowed by law, whichever is less. All payments shall be made in United States Dollars, free of any withholding tax and of any currency control or other restrictions to PivX. PivX shall have the right, at reasonable times and on reasonable notice, to inspect and audit the books and records of Detto to verify the accuracy of any statements. In the event that such an inspection discloses any error of any amount, the parties shall by appropriate payment promptly adjust for the error. If Detto fails to make payments when due, PivX shall be entitled to, in its sole discretion, to take any one or more of the following: (a) place Detto on credit hold, in which case, PivX may cease to fulfill Detto's orders to any new Third Parties; (b) rescind Detto's right to sell or distribute any additional Qwik-Fix Pro or Documentation hereunder; and (c) to require that Detto direct all future payments, for licenses sold in the past or in the future, from the Third Parties directly to PivX or a lock box or an account designated by PivX for such purpose, to be applied by PivX to the payment default (and interest thereon) until such defaults have been satisfied. All amounts received by PivX hereunder shall be nonrefundable except for any payments received or held under PivX's control pursuant to clause \\\"c\\\" of the last sentence after Detto's payment default has been satisfied.\"}, {\"id\": \"3.4\", \"title\": \"TAXES, TARIFFS, FEES\", \"level\": 2, \"text\": \"3.4 TAXES, TARIFFS, FEES. PivX's Suggested Prices and Per Copy Fees do not include any national, state or local sales, use, value added or other taxes, customs duties, or similar tariffs and fees which may be required to be paid or collected upon the delivery of Qwik-Fix Pro or upon collection of the prices for Qwik-Fix Pro or the Per Copy Fees. Should any tax or levy be made, Detto agrees to pay such tax or levy and indemnify PivX against any claim for such amount. Detto represents and warrants to PivX that all Qwik-Fix Pro acquired hereunder is for redistribution in the ordinary course of Detto's business, and Detto agrees to provide PivX with appropriate resale certificate numbers and other documentation satisfactory to the applicable taxing authorities to substantiate any claim of exemption from any such taxes or fees.\"}, {\"id\": \"3.5\", \"title\": \"SHIPMENT AND DELIVERY\", \"level\": 2, \"text\": \"3.5 SHIPMENT AND DELIVERY. PivX shall electronically deliver Qwik-Fix Pro to Detto. Detto shall inspect all software delivered to it, upon receipt and shall, within 10 days of receipt, give written notice to PivX of any claim of damage or missing portions. Should Detto fail to give such notice, or fail to obtain an extension of such 10-day period from PivX, the packages shall be deemed to be accepted by Detto. PivX will reasonably accommodate Detto's request to replace its master copy of software that becomes corrupted or damaged. Detto shall contractually require its Third Parties to report any claim of damage or shortages for Qwik-Fix Pro shipped to them within thirty (30) days of the Third Parties receipt of such package (or the time required by applicable law, if longer). PivX shall use commercially reasonable efforts to meet delivery dates requested by Detto, but in no event shall PivX be liable for its failure to meet such dates. In the event that PivX shall be unable to meet Detto's requested ship dates, PivX shall advise Detto of the change in or actual delivery schedule. 3\"}, {\"id\": \"3.6\", \"title\": \"SECURITY INTEREST\", \"level\": 2, \"text\": \"3.6 SECURITY INTEREST. Detto hereby grants PivX a purchase money security interest in all Qwik-Fix Pro licensed to Detto, all physical media on which Qwik-Fix Pro is located, and all rights licensed to Detto pursuant to this Agreement in the amount of the Total Purchase Price. Detto also grants PivX a security interest in Detto's address list of Third Parties to secure Detto's payment, indemnification, and other obligations hereunder. To secure its rights hereunder, PivX shall have the right to file one or more UCC financing statements and to make such other filings as PivX shall deem appropriate. Detto shall cooperate with PivX with respect to all such filings. Upon PivX's demand, Detto agrees to execute promptly any financing statement, security agreement, chattel mortgage, applications for registration and/or similar documents, and to take any other action deemed necessary for registration or otherwise deemed necessary or desirable by PivX in order to perfect PivX's security interest hereunder. In the event of Detto's default hereunder, PivX may foreclose its security interests and exercise such other rights as provided under the UCC.\"}, {\"id\": \"4\", \"title\": \"WARRANTY AND LIABILITY\", \"level\": 1, \"text\": \"4. WARRANTY AND LIABILITY\"}, {\"id\": \"4.1\", \"title\": \"PRODUCT WARRANTY\", \"level\": 2, \"text\": \"4.1 PRODUCT WARRANTY. With respect to Qwik-Fix Pro delivered by PivX to Detto on CD-Rom, PivX warrants that for a period of thirty (30) days following delivery to Detto, the media on which Qwik-Fix Pro is furnished to Detto will be free from defects in materials and workmanship during normal use. PivX warrants that Qwik-Fix Pro will substantially conform to the user documentation. EXCEPT AS EXPRESSLY SET FORTH ABOVE, QWIK-FIX PRO AND DOCUMENTATION ARE PROVIDED \\\"AS IS\\\". PIVX HEREBY DISCLAIMS ALL OTHER WARRANTIES, EXPRESS, IMPLIED, OR STATUTORY, INCLUDING WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.\"}, {\"id\": \"4.2\", \"title\": \"PRODUCT INDEMNITY\", \"level\": 2, \"text\": \"4.2 PRODUCT INDEMNITY. PivX will indemnify, defend and hold Detto and its subsidiaries (each, an \\\"Indemnified Party\\\"), harmless from and against any and all claims, losses, costs, liabilities and expenses (including reasonable attorneys' fees), arising as a result of or in connection with any claim that Qwik-Fix Pro or Documentation infringes any intellectual property right of a third party provided: (i) the Indemnified Party promptly gives written notice of any claim to PivX; (ii) the Indemnified Party provides any assistance which PivX may reasonably request for the defense of the claim (with reasonable out of pocket expenses paid by PivX); and (iii) PivX has the right to control of the defense or settlement of the claim, provided, however, that the Indemnified Party shall have the right to participate in, but not control, any litigation for which indemnification is sought with counsel of its own choosing, at its own expense. Additionally, if an injunction or order issues restricting the use or distribution of any of Qwik-Fix Pro or Documentation, or if PivX determines that Qwik-Fix Pro or Documentation are likely to become the subject of a claim of infringement or violation of any proprietary right of any third party, PivX shall in its discretion and, at its option (a) procure the right to continue using, reproducing, and distributing Qwik-Fix Pro and Documentation; (b) replace or modify Qwik-Fix Pro and Documentation so that they become noninfringing, provided such modification or replacement does not materially alter or affect the specifications for or the use or operation of Qwik-Fix Pro; require return of Qwik-Fix Pro to PivX and refund any licensing fees relating to the future use of Qwik-Fix Pro.\"}, {\"id\": \"4.3\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"4.3 LIMITATION OF LIABILITY. EXCEPT FOR PIVX'S OBLIGATIONS UNDER SECTION 4.2, IN NO EVENT SHALL PIVX'S OR ITS LICENSORS' LIABILITY TO DETTO OR ANY THIRD PARTY ARISING OUT OF THIS AGREEMENT EXCEED THE TOTAL AMOUNT ACTUALLY RECEIVED BY PIVX HEREUNDER DURING THE PREVIOUS SIX (6) MONTHS. IN NO EVENT SHALL ANY PARTY OR PIVX'S LICENSORS BE LIABLE TO ANOTHER PARTY OR ANY THIRD PARTY FOR LOSS OF DATA, COSTS OF PROCUREMENTS OF SUBSTITUTE GOODS OR SERVICES OR ANY INDIRECT, INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES UNDER ANY CAUSE OF ACTION, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE OF AN ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN. 4\"}, {\"id\": \"4.4\", \"title\": \"INDEMNIFICATION\", \"level\": 2, \"text\": \"4.4 INDEMNIFICATION. Detto shall indemnify and hold PivX harmless from and against any and all damages, liabilities, costs and expenses (including reasonable attorney's fees) which PivX incurs as a result of any claim based on any breach of any representation or warranty, covenant or agreement by Detto under this Agreement or any breach of this Agreement by Detto; provided: (i) that PivX promptly gives written notice of any claim to Detto; (ii) at Detto's expense, PivX provides reasonable assistance which Detto may reasonably request for the defense of the claim; and (iii) Detto has the right to control the defense or settlement of the claim, provided, however, that PivX shall have the right to participate in, but not control, any litigation for which indemnification is sought with counsel of its own choosing, at its own expense.\"}, {\"id\": \"5\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"5. TERM AND TERMINATION\"}, {\"id\": \"5.1\", \"title\": \"TERM OF AGREEMENT\", \"level\": 2, \"text\": \"5.1 TERM OF AGREEMENT. The term of this Agreement shall commence on the Effective Date and continue for six (6) months.\"}, {\"id\": \"5.2\", \"title\": \"TERMINATION OF AGREEMENT\", \"level\": 2, \"text\": \"5.2 TERMINATION OF AGREEMENT. PivX may terminate this Agreement for convenience by giving at least thirty (30) days written notice of termination to Detto. This Agreement may be terminated by either party in the event of a material breach of this Agreement by the other party that is not cured within thirty (30) days of the other party's receipt of written notice of such breach. If a material breach is cured within a thirty (30) day cure period this Agreement shall remain in effect as if no material breach had occurred. This Agreement shall terminate automatically without notice and without further action by the other party in the event that the other party becomes insolvent, which means it becomes unable to pay its debts in the ordinary course of business as they come due, or makes an assignment of this Agreement for the benefit of creditors.\"}, {\"id\": \"5.3\", \"title\": \"EFFECT OF TERMINATION\", \"level\": 2, \"text\": \"5.3 EFFECT OF TERMINATION. Upon the expiration or termination of this Agreement: (a) Detto shall, within thirty (30) days, pay to PivX all amounts due hereunder, return to PivX all products and demonstration copies received from PivX, erase any and all of the foregoing from all computer memories and storage devices within Detto's possession or control and, if requested, provide PivX with a signed written statement that Detto has complied with the foregoing obligations. All rights and licenses granted by PivX hereunder shall terminate, provided such termination shall not result in the termination of Licenses for copies of Qwik-Fix Pro which already have been purchased by Third Parties in accordance with the provisions of this Agreement.\"}, {\"id\": \"6\", \"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"6. GENERAL PROVISIONS\"}, {\"id\": \"6.1\", \"title\": \"CONFIDENTIALITY\", \"level\": 2, \"text\": \"6.1 CONFIDENTIALITY. By virtue of this Agreement, each party may have access to information that is confidential to the other (\\\"Confidential Information\\\"). Confidential Information shall include, but not be limited to, software, documentation, formulas, methods, know how, processes, designs, new products, developmental work, marketing requirements, marketing plans, customer names, prospective customer names, the terms and pricing under the Agreement, and any information clearly identified in writing at the time of disclosure as confidential. A party's Confidential Information shall not include information that (a) is or becomes a part of the public domain through no act or omission of the other party; or (b) is independently developed by the other party without 5 use of or reference to the first party's Confidential Information. In the event, Confidential Information is required to be disclosed by law or other governmental authority, a party hereunder shall not be prohibited from disclosing such information by this Section provided that the responding party shall first have given prompt notice to the other party hereto and shall have made a reasonable effort to obtain a protective order restricting or limiting the disclosure of the Confidential Information to the extent possible.\"}, {\"id\": \"6.2\", \"title\": \"THIS AGREEMENT CONTROLS; MERGER; AMENDMENT; WAIVER\", \"level\": 2, \"text\": \"6.2 THIS AGREEMENT CONTROLS; MERGER; AMENDMENT; WAIVER. This Agreement and Exhibit A to this Agreement shall control Detto's distribution of Qwik-Fix Pro and Documentation. All different or additional terms or conditions in any Detto purchase order or similar document shall be null and void. This Agreement, including Exhibit A, constitutes the final, complete, and exclusive agreement between the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous agreements. No modification, amendment, or waiver of any provision of this Agreement shall be effective unless in writing signed by both parties. The failure or delay by either party in exercising any right, power or remedy under this Agreement shall not operate as a waiver of any such right, power or remedy.\"}, {\"id\": \"6.3\", \"title\": \"NOTICES\", \"level\": 2, \"text\": \"6.3 NOTICES. All notices shall be given in writing and shall be considered effective when (a) personally delivered, (b) upon confirmed receipt if sent by electronic mail or facsimile; or (c) two (2) days after posting if sent by overnight registered private carrier (e.g. DHL, Federal Express, etc.).\"}, {\"id\": \"6.4\", \"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"6.4 ASSIGNMENT. Detto may not assign any of its rights or delegate any of its obligations hereunder, whether by operation of law or otherwise, without PivX's prior written consent. Subject to the foregoing, this Agreement shall bind and inure to the benefit of the parties, their respective successors and permitted assigns.\"}, {\"id\": \"6.5\", \"title\": \"FORCE MAJEURE\", \"level\": 2, \"text\": \"6.5 FORCE MAJEURE. PivX will not incur any liability to Detto or any other party on account of any loss or damage resulting from any delay or failure to perform all or any part of this Agreement (except for payment obligations) to the extent such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control, and without the negligence of, the parties. Such events, occurrences, or causes include, without limitation, acts of God, telecommunications outages, Internet outages, power outages, strikes, lockouts, riots, acts of war, floods, earthquakes, fires, and explosions.\"}, {\"id\": \"6.6\", \"title\": \"GENERAL\", \"level\": 2, \"text\": \"6.6 GENERAL. If any provision of this Agreement shall be held by a court of competent jurisdiction to be contrary to law, such provision shall be changed and interpreted so as to best accomplish the objectives of the original provision to the fullest extent allowed by law and the remaining provisions of this Agreement shall remain in full force and effect. Detto is an independent contractor, and nothing herein shall be construed to create an employer-employee, partnership, joint venture, or agency relationship between the parties. Detto shall have no authority, right or power to create any obligation or responsibility on behalf of PivX.\"}, {\"id\": \"6.7\", \"title\": \"GOVERNING LAW\", \"level\": 2, \"text\": \"6.7 GOVERNING LAW. This Agreement shall be governed by and construed under the laws of the State of California, excluding conflict of laws provisions and excluding the 1980 United Nations Convention on Contracts for the International Sale of Goods. The parties consent to the personal and exclusive jurisdiction of and venue in the state and federal courts of Orange County, California, U.S.A. for any disputes arising out of this Agreement. This Agreement may be executed simultaneously in two or more counterparts, each one of which shall be deemed an original, but all of which shall constitute one and the same instrument. IN WITNESS WHEREOF, the following duly authorized representatives have signed this Agreement on behalf of the entities indicated below, as of the date first above written. DETTO PIVX ----------------------------------------- -------------------------------------- ----------------------------------------- -------------------------------------- By: By: ----------------------------------------- -------------------------------------- Title: Title: ----------------------------------------- -------------------------------------- Date: Date: ----------------------------------------- -------------------------------------- 6\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ADIANUTRITION,INC_04_01_2005-EX-10.D2-RESELLER AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10d-2\", \"level\": 1, \"text\": \"Exhibit 10d-2 RESELLER AGREEMENT BY AND BETWEEN PIVX CORPORATION AND DETTO TECHNOLOGIES This Reseller Agreement is entered as of this ___ day of _________, 2004 (\\\"Effective Date\\\") by and between PivX Corporation, a California corporation, having its principal place of business at 23 Corporate Plaza Drive, Newport Beach, California, 92661 (\\\"PivX\\\") and Detto Technologies, a Washington corporation, having its principal place of business at 14320 NE 21st Street, Suite 11, Bellevue, Washington, 98007 (\\\"Detto\\\"). NOW THEREFORE, for good and valuable consideration, the parties hereby agree as follows:\"}}, {\"id\": \"party:PivX Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PivX Corporation\", \"role\": \"PivX\", \"address\": \"23 Corporate Plaza Drive, Newport Beach, California, 92661\"}}, {\"id\": \"party:Detto Technologies\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Detto Technologies\", \"role\": \"Detto\", \"address\": \"14320 NE 21st Street, Suite 11, Bellevue, Washington, 98007\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"This Reseller Agreement is entered as of this ___ day of _________, 2004 (\\\"Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GRANT OF RIGHTS\", \"level\": 1, \"text\": \"1. GRANT OF RIGHTS\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSE\", \"level\": 2, \"text\": \"1.1 LICENSE. Subject to the terms and conditions of this Agreement, PivX hereby grants to Detto a non-transferable, exclusive license to distribute PivX's Qwik-Fix Pro and any documentation supporting Qwik-Fix Pro provided from time to time by PivX (the \\\"Documentation\\\") within North America, solely to third parties to whom Detto licenses Qwik-Fix Pro (\\\"Third Parties\\\"), and as governed by the terms set forth in Exhibit A (PivX/Detto Reseller Agreement Addendum). PivX also hereby grants to Detto a non-transferable, non-exclusive license to distribute PivX's Qwik-Fix Pro and the Documentation outside of North America, solely to Third Parties and as governed by the terms in Exhibit A. Detto shall have no right to reproduce Qwik-Fix Pro or any part thereof. All copies of Qwik-Fix Pro distributed by Detto shall be distributed pursuant to PivX's current Enterprise License Agreement, as amended by PivX from time to time (the \\\"License\\\"), a copy of which PivX will provide Detto. Detto shall not distribute Qwik-Fix Pro to any Third Party unless the Third Party has accepted the terms of PivX's current License under penalty of perjury and in writing.\"}}, {\"id\": \"term:Documentation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Documentation\", \"text\": \"any documentation supporting Qwik-Fix Pro provided from time to time by PivX (the \\\"Documentation\\\")\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Third Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Parties\", \"text\": \"third parties to whom Detto licenses Qwik-Fix Pro (\\\"Third Parties\\\")\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:License\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"License\", \"text\": \"PivX's current Enterprise License Agreement, as amended by PivX from time to time (the \\\"License\\\")\", \"definition_clause\": \"1.1\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OWNERSHIP\", \"level\": 2, \"text\": \"1.2 OWNERSHIP. As between PivX and Detto, PivX owns and retains all right, title, and interest in and to Qwik-Fix Pro and Documentation; all trademarks, service marks or trade names associated with Qwik-Fix Pro or Documentation (the \\\"Trademarks\\\"); all copyrights, patents, trade secret rights, and other intellectual property rights therein (collectively, together with Qwik-Fix Pro, Documentation, and Trademarks, the \\\"Property\\\"). Except as expressly granted herein, PivX does not grant to Detto any right or license, either express or implied, in Qwik-Fix Pro, Documentation or Property. Detto shall not reverse engineer, disassemble, decompile, or otherwise attempt to derive source code from Qwik-Fix Pro.\"}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"all trademarks, service marks or trade names associated with Qwik-Fix Pro or Documentation (the \\\"Trademarks\\\")\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Property\", \"text\": \"all copyrights, patents, trade secret rights, and other intellectual property rights therein (collectively, together with Qwik-Fix Pro, Documentation, and Trademarks, the \\\"Property\\\")\", \"definition_clause\": \"1.2\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PIVX CHANNELNET\", \"level\": 2, \"text\": \"1.3 PIVX CHANNELNET. PivX grants Detto access to PivX ChannelNet as governed by the terms set forth in Exhibit A.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DETTO'S OBLIGATIONS\", \"level\": 1, \"text\": \"2. DETTO'S OBLIGATIONS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DETTO'S MARKETING; PUBLIC RELATIONS\", \"level\": 2, \"text\": \"2.1 DETTO'S MARKETING; PUBLIC RELATIONS. Detto obligations for marketing and public relations are governed under the terms in Exhibit A.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS; PROPERTY\", \"level\": 2, \"text\": \"2.2 TRADEMARKS; PROPERTY. During the term of this Agreement, Detto shall have the right to use and reproduce the Trademarks in connection with Detto's marketing, advertising, promotion and distribution of Qwik-Fix Pro. Detto's use of the Trademarks shall not create any right, title or interest therein. Detto shall use the Trademarks only in a manner which complies in all material respects with PivX's reasonable policies in effect from time to time, and all 1 such use shall be for PivX's benefit. Detto shall not remove, obscure or alter PivX's copyright notice or the Trademarks from Qwik-Fix Pro or Documentation. If Detto, in the course of distributing Qwik-Fix Pro, acquires any goodwill or reputation in any of the Trademarks, all such goodwill or reputation shall automatically be transferred to and shall vest in PivX when and as, on an on-going basis, such acquisition of goodwill or reputation occurs, as well as at the expiration or termination of this Agreement, without any separate payment or other consideration of any kind to Detto, and Detto agrees to take all such actions necessary to effect such vesting. Detto shall not contest the validity of any of the Property or PivX's exclusive ownership of them. Detto shall not adopt, use, or register, whether as a corporate name, trademark, service mark or other indication of origin, any of the Trademarks, or any word or mark confusingly similar to the Trademarks in any jurisdiction.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPORT FOR QWIK-FIX PRO\", \"level\": 2, \"text\": \"2.3 SUPPORT FOR QWIK-FIX PRO. Detto shall provide for all customer support for Qwik-Fix Pro that it resells as governed by the terms set forth in Exhibit A.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH APPLICABLE LAWS\", \"level\": 2, \"text\": \"2.4 COMPLIANCE WITH APPLICABLE LAWS. Detto shall comply with all laws and regulations applicable to Detto's marketing and distribution of Qwik-Fix Pro hereunder. Without limiting the generality of the foregoing, Detto shall, at its own expense, make, obtain, and maintain in force at all times during the term of this Agreement, all filings, registrations, licenses, permits and authorizations in North America required for Detto to perform its obligations under this Agreement.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SECURITY ISSUES\", \"level\": 2, \"text\": \"2.5 SECURITY ISSUES. Detto shall take all action necessary to ensure that (a) Qwik-Fix Pro and Documentation on Detto's servers or computer systems is appropriately secured so that Qwik-Fix Pro and Documentation can only be viewed, copied, or utilized by licensed Third Parties; and (b) that the object code of the Courseware can only be accessed by employees authorized by PivX and cannot be copied or downloaded by any of Detto's licensees or by any other third party. In addition, Detto shall make its offices and equipment available in person, upon reasonable notice, and to the extent feasible, remotely, to PivX to inspect and test Detto's physical and technical set-up to ensure that Detto is complying with its obligations under this Section. Detto agrees to indemnify and hold PivX harmless in accordance with the provisions of Section 4.4 to the extent that Detto breaches its obligations under this Section 2.5.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROTECTION OF PROPRIETARY RIGHTS\", \"level\": 2, \"text\": \"2.6 PROTECTION OF PROPRIETARY RIGHTS. Detto shall cooperate without charge (provided that PivX will reimburse out of pocket expenses as agreed in advance in writing), in PivX's efforts to protect PivX's rights in the Property. Detto shall promptly notify PivX of any infringements of PivX's Property Rights that come to Detto's attention. PivX shall have the exclusive right to institute infringement or other appropriate legal action against alleged infringers of its Property Rights. PivX shall incur all expenses in connection therewith and shall retain all monetary recoveries received therefrom.\"}}, {\"id\": \"2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO EXCESS REPRESENTATIONS OR WARRANTIES\", \"level\": 2, \"text\": \"2.7 NO EXCESS REPRESENTATIONS OR WARRANTIES. Detto covenants that it shall not make any representations or warranties with respect to Qwik-Fix Pro or Documentation in excess of those provided by PivX herein. Detto agrees to indemnify and hold PivX harmless in accordance with the provisions of Section 4.4 to the extent that Detto breaches its covenant under this Section 2.7.\"}}, {\"id\": \"2.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FULFILLMENT OF DETTO'S OBLIGATIONS\", \"level\": 2, \"text\": \"2.8 FULFILLMENT OF DETTO'S OBLIGATIONS. Detto covenants that it will fulfill all of its contractual and legal obligations to its customers. Detto covenants that it will (a) provide its customers with first quality sales and technical support with respect to any copies or licenses of Qwik-Fix Pro sold by Detto, (b) promptly, courteously and appropriately respond to its customers questions, concerns and complaints, and (c) generally deal with its customers in a professional manner that shall add to the good reputation of Detto and PivX. To the extent that Detto fails to fulfill its contractual and legal obligations to its customers, Detto agrees that PivX may elect to fulfill those obligations, or any portion of them, and Detto shall reimburse PivX any costs and expenses so incurred by PivX. Detto agrees to indemnify and hold PivX harmless in accordance with the provisions of Section 4.4 to the extent that it breaches any of its covenants under this Section 2.8.\"}}, {\"id\": \"2.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9 U\", \"level\": 1, \"text\": \"2.9 U.S. GOVERNMENT - RESTRICTED RIGHTS. Detto covenants to require its customers to accept a click-wrap agreement that, among other things, provides that Qwik-Fix Pro and accompanying documentation are deemed to be \\\"commercial computer Software\\\" and \\\"commercial computer Software documentation,\\\" 2 respectively, pursuant to DFAR Section 227.7202 and FAR Section 12.212, as applicable. Any use, modification, reproduction release, performance, display or disclosure of Qwik-Fix Pro and accompanying documentation by the U.S. Government shall be governed solely by the terms of the Agreement and shall be prohibited except to the extent expressly permitted by the terms of this Agreement.\"}}, {\"id\": \"2.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BUSINESS DEVELOPMENT\", \"level\": 2, \"text\": \"2.10 BUSINESS DEVELOPMENT. Detto will engage in future business development with PivX as governed by the terms set forth in Exhibit A.\"}}, {\"id\": \"2.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SALES FORECASTING; SALES METRICS; SALES REPORTING\", \"level\": 2, \"text\": \"2.11 SALES FORECASTING; SALES METRICS; SALES REPORTING. Detto will provide sales forecasting, sales metrics and sales reporting to PivX as governed by the terms set forth in Exhibit A.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE AND PAYMENT; SHIPMENT AND DELIVERY\", \"level\": 1, \"text\": \"3. PRICE AND PAYMENT; SHIPMENT AND DELIVERY\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUGGESTED THIRD PARTY PRICES\", \"level\": 2, \"text\": \"3.1 SUGGESTED THIRD PARTY PRICES. Third Party prices are governed by the terms set forth in Exhibit A.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PER COPY FEES\", \"level\": 2, \"text\": \"3.2 PER COPY FEES. Detto shall pay to PivX for each unit of Qwik-Fix Pro distributed hereunder per copy fees (the \\\"Per Copy Fees\\\") as governed by the terms set forth in Exhibit A. In the event that PivX changes the Third Party prices, Per Copy Fees based on such changed prices shall apply to any order for Qwik-Fix Pro received by PivX after the effective date of the increase. PivX shall provide Detto with at least forty-five (45) days written notice of any increase in the Per Copy Fees.\"}}, {\"id\": \"term:Per Copy Fees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Per Copy Fees\", \"text\": \"per copy fees (the \\\"Per Copy Fees\\\")\", \"definition_clause\": \"3.2\"}}, {\"id\": \"value:45 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT\", \"level\": 2, \"text\": \"3.3 PAYMENT. All payments to PivX shall be made within thirty (30) days after the receipt by Detto of the PivX's invoice. Detto shall pay PivX a late charge on outstanding amounts due equal to one and one-half percent (1.50%) per month or the maximum amount allowed by law, whichever is less. All payments shall be made in United States Dollars, free of any withholding tax and of any currency control or other restrictions to PivX. PivX shall have the right, at reasonable times and on reasonable notice, to inspect and audit the books and records of Detto to verify the accuracy of any statements. In the event that such an inspection discloses any error of any amount, the parties shall by appropriate payment promptly adjust for the error. If Detto fails to make payments when due, PivX shall be entitled to, in its sole discretion, to take any one or more of the following: (a) place Detto on credit hold, in which case, PivX may cease to fulfill Detto's orders to any new Third Parties; (b) rescind Detto's right to sell or distribute any additional Qwik-Fix Pro or Documentation hereunder; and (c) to require that Detto direct all future payments, for licenses sold in the past or in the future, from the Third Parties directly to PivX or a lock box or an account designated by PivX for such purpose, to be applied by PivX to the payment default (and interest thereon) until such defaults have been satisfied. All amounts received by PivX hereunder shall be nonrefundable except for any payments received or held under PivX's control pursuant to clause \\\"c\\\" of the last sentence after Detto's payment default has been satisfied.\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:1.50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one and one-half percent (1.50%)\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TAXES, TARIFFS, FEES\", \"level\": 2, \"text\": \"3.4 TAXES, TARIFFS, FEES. PivX's Suggested Prices and Per Copy Fees do not include any national, state or local sales, use, value added or other taxes, customs duties, or similar tariffs and fees which may be required to be paid or collected upon the delivery of Qwik-Fix Pro or upon collection of the prices for Qwik-Fix Pro or the Per Copy Fees. Should any tax or levy be made, Detto agrees to pay such tax or levy and indemnify PivX against any claim for such amount. Detto represents and warrants to PivX that all Qwik-Fix Pro acquired hereunder is for redistribution in the ordinary course of Detto's business, and Detto agrees to provide PivX with appropriate resale certificate numbers and other documentation satisfactory to the applicable taxing authorities to substantiate any claim of exemption from any such taxes or fees.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SHIPMENT AND DELIVERY\", \"level\": 2, \"text\": \"3.5 SHIPMENT AND DELIVERY. PivX shall electronically deliver Qwik-Fix Pro to Detto. Detto shall inspect all software delivered to it, upon receipt and shall, within 10 days of receipt, give written notice to PivX of any claim of damage or missing portions. Should Detto fail to give such notice, or fail to obtain an extension of such 10-day period from PivX, the packages shall be deemed to be accepted by Detto. PivX will reasonably accommodate Detto's request to replace its master copy of software that becomes corrupted or damaged. Detto shall contractually require its Third Parties to report any claim of damage or shortages for Qwik-Fix Pro shipped to them within thirty (30) days of the Third Parties receipt of such package (or the time required by applicable law, if longer). PivX shall use commercially reasonable efforts to meet delivery dates requested by Detto, but in no event shall PivX be liable for its failure to meet such dates. In the event that PivX shall be unable to meet Detto's requested ship dates, PivX shall advise Detto of the change in or actual delivery schedule. 3\"}}, {\"id\": \"value:10 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 days\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SECURITY INTEREST\", \"level\": 2, \"text\": \"3.6 SECURITY INTEREST. Detto hereby grants PivX a purchase money security interest in all Qwik-Fix Pro licensed to Detto, all physical media on which Qwik-Fix Pro is located, and all rights licensed to Detto pursuant to this Agreement in the amount of the Total Purchase Price. Detto also grants PivX a security interest in Detto's address list of Third Parties to secure Detto's payment, indemnification, and other obligations hereunder. To secure its rights hereunder, PivX shall have the right to file one or more UCC financing statements and to make such other filings as PivX shall deem appropriate. Detto shall cooperate with PivX with respect to all such filings. Upon PivX's demand, Detto agrees to execute promptly any financing statement, security agreement, chattel mortgage, applications for registration and/or similar documents, and to take any other action deemed necessary for registration or otherwise deemed necessary or desirable by PivX in order to perfect PivX's security interest hereunder. In the event of Detto's default hereunder, PivX may foreclose its security interests and exercise such other rights as provided under the UCC.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY AND LIABILITY\", \"level\": 1, \"text\": \"4. WARRANTY AND LIABILITY\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT WARRANTY\", \"level\": 2, \"text\": \"4.1 PRODUCT WARRANTY. With respect to Qwik-Fix Pro delivered by PivX to Detto on CD-Rom, PivX warrants that for a period of thirty (30) days following delivery to Detto, the media on which Qwik-Fix Pro is furnished to Detto will be free from defects in materials and workmanship during normal use. PivX warrants that Qwik-Fix Pro will substantially conform to the user documentation. EXCEPT AS EXPRESSLY SET FORTH ABOVE, QWIK-FIX PRO AND DOCUMENTATION ARE PROVIDED \\\"AS IS\\\". PIVX HEREBY DISCLAIMS ALL OTHER WARRANTIES, EXPRESS, IMPLIED, OR STATUTORY, INCLUDING WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT INDEMNITY\", \"level\": 2, \"text\": \"4.2 PRODUCT INDEMNITY. PivX will indemnify, defend and hold Detto and its subsidiaries (each, an \\\"Indemnified Party\\\"), harmless from and against any and all claims, losses, costs, liabilities and expenses (including reasonable attorneys' fees), arising as a result of or in connection with any claim that Qwik-Fix Pro or Documentation infringes any intellectual property right of a third party provided: (i) the Indemnified Party promptly gives written notice of any claim to PivX; (ii) the Indemnified Party provides any assistance which PivX may reasonably request for the defense of the claim (with reasonable out of pocket expenses paid by PivX); and (iii) PivX has the right to control of the defense or settlement of the claim, provided, however, that the Indemnified Party shall have the right to participate in, but not control, any litigation for which indemnification is sought with counsel of its own choosing, at its own expense. Additionally, if an injunction or order issues restricting the use or distribution of any of Qwik-Fix Pro or Documentation, or if PivX determines that Qwik-Fix Pro or Documentation are likely to become the subject of a claim of infringement or violation of any proprietary right of any third party, PivX shall in its discretion and, at its option (a) procure the right to continue using, reproducing, and distributing Qwik-Fix Pro and Documentation; (b) replace or modify Qwik-Fix Pro and Documentation so that they become noninfringing, provided such modification or replacement does not materially alter or affect the specifications for or the use or operation of Qwik-Fix Pro; require return of Qwik-Fix Pro to PivX and refund any licensing fees relating to the future use of Qwik-Fix Pro.\"}}, {\"id\": \"term:Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnified Party\", \"text\": \"Detto and its subsidiaries (each, an \\\"Indemnified Party\\\")\", \"definition_clause\": \"4.2\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"4.3 LIMITATION OF LIABILITY. EXCEPT FOR PIVX'S OBLIGATIONS UNDER SECTION 4.2, IN NO EVENT SHALL PIVX'S OR ITS LICENSORS' LIABILITY TO DETTO OR ANY THIRD PARTY ARISING OUT OF THIS AGREEMENT EXCEED THE TOTAL AMOUNT ACTUALLY RECEIVED BY PIVX HEREUNDER DURING THE PREVIOUS SIX (6) MONTHS. IN NO EVENT SHALL ANY PARTY OR PIVX'S LICENSORS BE LIABLE TO ANOTHER PARTY OR ANY THIRD PARTY FOR LOSS OF DATA, COSTS OF PROCUREMENTS OF SUBSTITUTE GOODS OR SERVICES OR ANY INDIRECT, INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES UNDER ANY CAUSE OF ACTION, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE OF AN ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN. 4\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 2, \"text\": \"4.4 INDEMNIFICATION. Detto shall indemnify and hold PivX harmless from and against any and all damages, liabilities, costs and expenses (including reasonable attorney's fees) which PivX incurs as a result of any claim based on any breach of any representation or warranty, covenant or agreement by Detto under this Agreement or any breach of this Agreement by Detto; provided: (i) that PivX promptly gives written notice of any claim to Detto; (ii) at Detto's expense, PivX provides reasonable assistance which Detto may reasonably request for the defense of the claim; and (iii) Detto has the right to control the defense or settlement of the claim, provided, however, that PivX shall have the right to participate in, but not control, any litigation for which indemnification is sought with counsel of its own choosing, at its own expense.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"5. TERM AND TERMINATION\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM OF AGREEMENT\", \"level\": 2, \"text\": \"5.1 TERM OF AGREEMENT. The term of this Agreement shall commence on the Effective Date and continue for six (6) months.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION OF AGREEMENT\", \"level\": 2, \"text\": \"5.2 TERMINATION OF AGREEMENT. PivX may terminate this Agreement for convenience by giving at least thirty (30) days written notice of termination to Detto. This Agreement may be terminated by either party in the event of a material breach of this Agreement by the other party that is not cured within thirty (30) days of the other party's receipt of written notice of such breach. If a material breach is cured within a thirty (30) day cure period this Agreement shall remain in effect as if no material breach had occurred. This Agreement shall terminate automatically without notice and without further action by the other party in the event that the other party becomes insolvent, which means it becomes unable to pay its debts in the ordinary course of business as they come due, or makes an assignment of this Agreement for the benefit of creditors.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECT OF TERMINATION\", \"level\": 2, \"text\": \"5.3 EFFECT OF TERMINATION. Upon the expiration or termination of this Agreement: (a) Detto shall, within thirty (30) days, pay to PivX all amounts due hereunder, return to PivX all products and demonstration copies received from PivX, erase any and all of the foregoing from all computer memories and storage devices within Detto's possession or control and, if requested, provide PivX with a signed written statement that Detto has complied with the foregoing obligations. All rights and licenses granted by PivX hereunder shall terminate, provided such termination shall not result in the termination of Licenses for copies of Qwik-Fix Pro which already have been purchased by Third Parties in accordance with the provisions of this Agreement.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"6. GENERAL PROVISIONS\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 2, \"text\": \"6.1 CONFIDENTIALITY. By virtue of this Agreement, each party may have access to information that is confidential to the other (\\\"Confidential Information\\\"). Confidential Information shall include, but not be limited to, software, documentation, formulas, methods, know how, processes, designs, new products, developmental work, marketing requirements, marketing plans, customer names, prospective customer names, the terms and pricing under the Agreement, and any information clearly identified in writing at the time of disclosure as confidential. A party's Confidential Information shall not include information that (a) is or becomes a part of the public domain through no act or omission of the other party; or (b) is independently developed by the other party without 5 use of or reference to the first party's Confidential Information. In the event, Confidential Information is required to be disclosed by law or other governmental authority, a party hereunder shall not be prohibited from disclosing such information by this Section provided that the responding party shall first have given prompt notice to the other party hereto and shall have made a reasonable effort to obtain a protective order restricting or limiting the disclosure of the Confidential Information to the extent possible.\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"information that is confidential to the other (\\\"Confidential Information\\\")\", \"definition_clause\": \"6.1\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THIS AGREEMENT CONTROLS; MERGER; AMENDMENT; WAIVER\", \"level\": 2, \"text\": \"6.2 THIS AGREEMENT CONTROLS; MERGER; AMENDMENT; WAIVER. This Agreement and Exhibit A to this Agreement shall control Detto's distribution of Qwik-Fix Pro and Documentation. All different or additional terms or conditions in any Detto purchase order or similar document shall be null and void. This Agreement, including Exhibit A, constitutes the final, complete, and exclusive agreement between the parties with respect to the subject matter hereof and supersedes all prior or contemporaneous agreements. No modification, amendment, or waiver of any provision of this Agreement shall be effective unless in writing signed by both parties. The failure or delay by either party in exercising any right, power or remedy under this Agreement shall not operate as a waiver of any such right, power or remedy.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 2, \"text\": \"6.3 NOTICES. All notices shall be given in writing and shall be considered effective when (a) personally delivered, (b) upon confirmed receipt if sent by electronic mail or facsimile; or (c) two (2) days after posting if sent by overnight registered private carrier (e.g. DHL, Federal Express, etc.).\"}}, {\"id\": \"value:2 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) days\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"6.4 ASSIGNMENT. Detto may not assign any of its rights or delegate any of its obligations hereunder, whether by operation of law or otherwise, without PivX's prior written consent. Subject to the foregoing, this Agreement shall bind and inure to the benefit of the parties, their respective successors and permitted assigns.\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE\", \"level\": 2, \"text\": \"6.5 FORCE MAJEURE. PivX will not incur any liability to Detto or any other party on account of any loss or damage resulting from any delay or failure to perform all or any part of this Agreement (except for payment obligations) to the extent such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control, and without the negligence of, the parties. Such events, occurrences, or causes include, without limitation, acts of God, telecommunications outages, Internet outages, power outages, strikes, lockouts, riots, acts of war, floods, earthquakes, fires, and explosions.\"}}, {\"id\": \"6.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 2, \"text\": \"6.6 GENERAL. If any provision of this Agreement shall be held by a court of competent jurisdiction to be contrary to law, such provision shall be changed and interpreted so as to best accomplish the objectives of the original provision to the fullest extent allowed by law and the remaining provisions of this Agreement shall remain in full force and effect. Detto is an independent contractor, and nothing herein shall be construed to create an employer-employee, partnership, joint venture, or agency relationship between the parties. Detto shall have no authority, right or power to create any obligation or responsibility on behalf of PivX.\"}}, {\"id\": \"6.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW\", \"level\": 2, \"text\": \"6.7 GOVERNING LAW. This Agreement shall be governed by and construed under the laws of the State of California, excluding conflict of laws provisions and excluding the 1980 United Nations Convention on Contracts for the International Sale of Goods. The parties consent to the personal and exclusive jurisdiction of and venue in the state and federal courts of Orange County, California, U.S.A. for any disputes arising out of this Agreement. This Agreement may be executed simultaneously in two or more counterparts, each one of which shall be deemed an original, but all of which shall constitute one and the same instrument. IN WITNESS WHEREOF, the following duly authorized representatives have signed this Agreement on behalf of the entities indicated below, as of the date first above written. DETTO PIVX ----------------------------------------- -------------------------------------- ----------------------------------------- -------------------------------------- By: By: ----------------------------------------- -------------------------------------- Title: Title: ----------------------------------------- -------------------------------------- Date: Date: ----------------------------------------- -------------------------------------- 6\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.5\", \"level\": 1, \"text\": \"Exhibit 10.5 Note: Portions of this exhibit indicated by\\\"[*]\\\" are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit have been filed with the Securities and Exchange Commission as part of this Company's confidential treatment request. Distributor Agreement --------------------- This Distributor Agreement (the \\\"Agreement\\\") is made effective as of the 31st day of March, 2000 (the \\\"Effective Date\\\"), by and between Airspan Networks Incorporated, a company incorporated under the laws of the State of Washington having its principal office at 777 108th Avenue NE, Suite 1895, Bellevue, Washington 98004 (\\\"Airspan\\\") and GLS LLC, (\\\"Distributor\\\") a limited liability company incorporated under the laws of the State of South Dakota having its principal office at 501 Fourth Street, Sergeant Bluff, IA 51054. WITNESSETH: WHEREAS, Airspan is engaged in the design and manufacture of various telecommunications product lines, including, among others, those product lines more completely described in Schedule I hereto (the product lines described in Schedule I, as from time to time amended in accordance with the provisions of this Agreement, are hereinafter called the \\\"Airspan Products\\\") the hardware components thereof are sometimes referred to separately as \\\"Equipment,\\\" the software components thereof are sometimes referred to separately as \\\"Software\\\" as defined in Section 11.1, and an arrangement of Equipment which, when interfaced with Software, is operable to perform predetermined functions, is referred to as a \\\"System\\\"); WHEREAS, Distributor is engaged in the promotion of sales of telecommunications products; and WHEREAS, Airspan desires to appoint Distributor as a Distributor for the Airspan Products for the territory described in Schedule II hereto (the \\\"Territory\\\"). NOW, THEREFORE, in consideration of the mutual promises herein contained, it is hereby agreed as follows:\"}, {\"id\": \"1\", \"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT. -----------\"}, {\"id\": \"1.1\", \"title\": \"Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributo\", \"level\": 2, \"text\": \"1.1 Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributor to assist Airspan in marketing the Airspan Products to customers in the Territory, and Distributor hereby accepts such appointment as of the Effective Date of this Agreement. Distributor's appointment as a distributor of the Airspan Products grants to Distributor only a license to resell the - ------------------------------------------------------------------------------- Page 1 Airspan Products to Distributor's customers in the Territory, and does not transfer any right, title, or interest in any of the Airspan Software to Distributor.\"}, {\"id\": \"1.2\", \"title\": \"Distributor's relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitu\", \"level\": 2, \"text\": \"1.2 Distributor's relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitute Distributor as the agent or employee of Airspan. Distributor shall have no authority to accept any order or make any offer (except as herein stated), or execute any instrument or make any commitment on behalf of Airspan. Specifically, without in any way limiting the generality of the foregoing, Distributor agrees not to make any representation, guarantee, or warranty on Airspan's behalf concerning the Airspan Products, but will refer customers to Airspan's printed literature. Nothing contained in this Agreement is to be construed as a limitation or restriction upon Airspan in the sale or other disposition of any of its products to any person, firm, or corporation inside or outside of the Territory. Airspan will pay no commissions under this Agreement. Distributor's compensation is to be obtained solely by the difference between the price Distributor pays to Airspan and the price Distributor charges its customers. The parties also acknowledge that this Agreement is not intended to create a joint venture or partnership between Airspan and Distributor.\"}, {\"id\": \"1.3\", \"title\": \"Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such\", \"level\": 2, \"text\": \"1.3 Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such attention, time, and effort as may be reasonably necessary to fully develop the available market potential. During the term of this Agreement, and for a period of three (3) months following the expiration or termination of this Agreement, Distributor agrees that neither it nor any organization or entity controlled or directed by it will, without Airspan's prior, written consent, represent a manufacturer or supplier of products similar in design or performance to or which are of such a nature as to be competitive with any products contained in the Airspan Products, nor will Distributor market or otherwise promote the sale of such products. Distributor will give Airspan thirty (30) days' prior, written notice of each new potential representation role being considered by Distributor, and Distributor will not undertake such representation without Airspan's prior, written consent, such consent not to be unreasonably withheld. Except as provided above, in no event will Airspan consent to Distributor's consultation for or representation of a manufacturer or supplier, which is directly or indirectly, a competitor of Airspan.\"}, {\"id\": \"1.4\", \"title\": \"Distributor shall maintain a place of business at the location specified in Section 21\", \"level\": 2, \"text\": \"1.4 Distributor shall maintain a place of business at the location specified in Section 21.10 where Distributor can be contacted by Airspan, customers, and prospective customers during regular business hours with a permanent mailing address and an accessible cellular telephone, and will provide Airspan with written notice promptly upon any change in address. Distributor agrees to assume all of the expenses of this place of business, including rent, stenographic services, and all other expenses except as specifically assumed in writing by Airspan. - -------------------------------------------------------------------------------- Page 2\"}, {\"id\": \"1.5\", \"title\": \"Airspan will provide Distributor with such commercial and technical assistance and training as may reasonably be necessa\", \"level\": 2, \"text\": \"1.5 Airspan will provide Distributor with such commercial and technical assistance and training as may reasonably be necessary, in Airspan's sole judgment, to enable Distributor to effectively carry out its activities under this Agreement and, in connection therewith, to provide such sales promotional materials, as Airspan may deem appropriate. Airspan will provide such technical support as is reasonable and necessary to maintain the product line as a viable competitor in the market.\"}, {\"id\": \"2\", \"title\": \"REPRESENTATIONS AND WARRANTIES\", \"level\": 1, \"text\": \"2. REPRESENTATIONS AND WARRANTIES. Distributor hereby represents and warrants as follows: a. Distributor has been duly registered in accordance with any and all relevant legislation, has received any and all necessary governmental authorizations to enter into and perform its obligations under this Agreement, and that its entry into and performance under this Agreement will not violate applicable legislation; b. Distributor is duly registered with all necessary tax authorities and is in compliance with all payment obligations in accordance with applicable legislation. No claims against or investigations of Distributor with respect to its tax obligations exist;\"}, {\"id\": \"c\", \"title\": \"Distributor is not currently involved in any litigation, arbitration, or other legal proceedings in which claims are\", \"level\": 1, \"text\": \"c. Distributor is not currently involved in any litigation, arbitration, or other legal proceedings in which claims are being asserted against Distributor which might affect its ability to perform its obligations under this Agreement, nor is Distributor aware of any unasserted claims against Distributor of this nature; and\"}, {\"id\": \"d\", \"title\": \"Distributor's bank accounts have been established and operated in accordance with applicable legislation\", \"level\": 1, \"text\": \"d. Distributor's bank accounts have been established and operated in accordance with applicable legislation. All transactions of Distributor required to be carried out through authorized banks have been so carried out. Distributor is not, has not, and warrants that it will not breach any currency regulation or currency control legislation. Distributor further warrants that it is not, has not, and will not breach any bank secrecy act, rules or regulations.\"}, {\"id\": \"3\", \"title\": \"SERVICES\", \"level\": 1, \"text\": \"3. SERVICES.\"}, {\"id\": \"3.1\", \"title\": \"In addition to the above, the Distributor will perform the following services under this Agreement\", \"level\": 2, \"text\": \"3.1 In addition to the above, the Distributor will perform the following services under this Agreement: a. In cooperation with Airspan, identify potential customers and project opportunities within the Territory that will lead to sales/licenses of Airspan Products and services; b. Prepare reports on the opportunities that will include: (1) description of the project; (2) assessment of the appropriate fit to Airspan Products and - -------------------------------------------------------------------------------- Page 3 services; (3) dollar size and timing of the project; (4) competitive assessment; and (5) identification of key decision makers and other technical and commercial contacts;\"}, {\"id\": \"c\", \"title\": \"Assist and advise Airspan in the preparation and delivery of appropriate marketing and sales programs;\", \"level\": 1, \"text\": \"c. Assist and advise Airspan in the preparation and delivery of appropriate marketing and sales programs;\"}, {\"id\": \"d\", \"title\": \"Initiate and coordinate meetings at all levels for the appropriate Airspan employees to evaluate the identified pr\", \"level\": 1, \"text\": \"d. Initiate and coordinate meetings at all levels for the appropriate Airspan employees to evaluate the identified projects; e. Initiate and assist in the preparation of sales and technical meetings with customers, and where appropriate, attend these meetings with Airspan personnel and provide administrative support and translation services;\"}, {\"id\": \"3.2\", \"title\": \"Distributor will use its best efforts to vigorously and aggressively promote the sale of Airspan Products within th\", \"level\": 2, \"text\": \"3.2 Distributor will use its best efforts to vigorously and aggressively promote the sale of Airspan Products within the Territory. Such efforts shall include, but shall not be limited to, that advertising within the Territory which is reasonably necessary. All such advertising shall follow the general statements made in advertising prepared by Airspan. All advertising shall contain a prominent reference to Airspan, indicating the actual commercial origin of Airspan Products so advertised. Distributor shall not make any claims in its advertising which exceed or contradict claims made by Airspan in its printed materials.\"}, {\"id\": \"3.3\", \"title\": \"Distributor will train and maintain a sufficient number of technical and sales personnel in order to\", \"level\": 2, \"text\": \"3.3 Distributor will train and maintain a sufficient number of technical and sales personnel in order to: (a) serve the demands and needs of its customers for Airspan Products, service, and support; and (b) carry out the obligations of Distributor under this Agreement.\"}, {\"id\": \"3.4\", \"title\": \"Distributor and its staff will be conversant with the technical language related to Airspan Products and will devel\", \"level\": 2, \"text\": \"3.4 Distributor and its staff will be conversant with the technical language related to Airspan Products and will develop sufficient knowledge of the industry, Airspan Products, and products competitive with Airspan Products (including specifications, features, and benefits) so as to be able to explain in detail to customers the differences between Airspan Products and competitive products. Distributor will conduct or provide for any training of its personnel which may be necessary to impart such knowledge.\"}, {\"id\": \"3.5\", \"title\": \"Distributor and its staff will research the technical requirements and specifications of the market for Airspan Pro\", \"level\": 2, \"text\": \"3.5 Distributor and its staff will research the technical requirements and specifications of the market for Airspan Products in the Territory and make information known to Airspan such that Airspan may, at its discretion, implement appropriate technical changes to the Products to enable them to be sold in the Territory. Airspan acknowledges that, subject to a further and separate Agreement, such changes may be implemented in the future by Distributor, with the assistance of Airspan. - ------------------------------------------------------------------------------ Page 4\"}, {\"id\": \"3.6\", \"title\": \"Distributor agrees to purchase and stock a comprehensive inventory of spare parts based upon the recommended list s\", \"level\": 2, \"text\": \"3.6 Distributor agrees to purchase and stock a comprehensive inventory of spare parts based upon the recommended list set forth in Schedule III to this Agreement.\"}, {\"id\": \"3.7\", \"title\": \"Distributor agrees to provide to its customers' installation services for all Airspan Products\", \"level\": 2, \"text\": \"3.7 Distributor agrees to provide to its customers' installation services for all Airspan Products. All such installation services shall be performed by Distributor in accordance with Airspan's latest installation standards as provided by Airspan.\"}, {\"id\": \"3.8\", \"title\": \"Distributor agrees to train and have readily available a maintenance staff to efficiently and expeditiously maintai\", \"level\": 2, \"text\": \"3.8 Distributor agrees to train and have readily available a maintenance staff to efficiently and expeditiously maintain or upgrade all Airspan Products purchased or licensed by Distributor from Airspan. Maintenance shall be performed in accordance with Airspan's latest maintenance standards for Airspan Products, as provided by Airspan, by Distributor's own personnel and may not be subcontracted or delegated to any other person or entity without Airspan's prior, written authorization.\"}, {\"id\": \"3.9\", \"title\": \"Distributor agrees to provide and maintain those facilities adequate to meet the obligations set forth in this sect\", \"level\": 2, \"text\": \"3.9 Distributor agrees to provide and maintain those facilities adequate to meet the obligations set forth in this section and of the Agreement. Distributor further agrees to provide all of the sales and support functions set forth in this section at no charge to Airspan.\"}, {\"id\": \"3.10\", \"title\": \"Distributor agrees not to actively seek to promote, rent, lease, sell, sublicense or authorize the rental, sale or\", \"level\": 2, \"text\": \"3.10 Distributor agrees not to actively seek to promote, rent, lease, sell, sublicense or authorize the rental, sale or sublicense of Airspan Products outside of the Territory [without the prior written approval of Airspan], but nothing in this Agreement shall prevent Distributor from renting, selling or sublicensing the Airspan Products to customers outside of the Territory in response to an unsolicited request from such customer.\"}, {\"id\": \"3.11\", \"title\": \"During the term of this Agreement Distributor agrees that neither it nor any organization or entity controlled or d\", \"level\": 2, \"text\": \"3.11 During the term of this Agreement Distributor agrees that neither it nor any organization or entity controlled or directed by it will, without Airspan's prior, written consent, represent a manufacturer or supplier of products similar in design or performance to or which are of such a nature as to be competitive with any products contained in the Airspan Products.\"}, {\"id\": \"3.12\", \"title\": \"The parties mutually agree that by April 30, 2000, the parties will negotiate and execute a National Accounts Consu\", \"level\": 2, \"text\": \"3.12 The parties mutually agree that by April 30, 2000, the parties will negotiate and execute a National Accounts Consulting Agreement whereby the Distributor will receive consulting fees and commissions for the sale and deployment of Airspan's products on a national basis. It is the intent of the parties to jointly pursue the sale of products to said companies and to enter into and complete contracts for the deployment of products in this manner. - -------------------------------------------------------------------------------- Page 5\"}, {\"id\": \"4\", \"title\": \"ORDERING PROCEDURE\", \"level\": 1, \"text\": \"4. ORDERING PROCEDURE.\"}, {\"id\": \"4.1\", \"title\": \"The following procedures shall be followed with respect to each purchase order issued by Distributor\", \"level\": 2, \"text\": \"4.1 The following procedures shall be followed with respect to each purchase order issued by Distributor: a. During the Term, Distributor will inform Airspan of its intent to purchase Equipment and Installation Services (but only if Airspan expressly agrees to perform such Installation Services) and to license Software, by sending to Airspan a written order. This written order (the \\\"Purchase Order\\\") will state the type of Equipment, System, or Installation Services that Distributor wants to purchase and the Software Distributor wants to license, the price of the ordered items (the \\\"Contract Price\\\") as set forth in Schedule IV, \\\"Price List\\\" (which is hereby incorporated by reference) and the proposed delivery and installation dates, if applicable. b. Each Purchase Order shall specifically incorporate by reference the terms and conditions of this Agreement, and no additional or different terms and conditions stated in a Purchase Order, any letter, or otherwise shall be binding unless expressly referred and agreed to by Airspan in writing. In the event of a conflict between the terms and conditions of this Agreement and of any Purchase Order issued hereunder, or if the Purchase Order does not reference the terms and conditions of this Agreement, the terms and conditions of this Agreement shall control.\"}, {\"id\": \"4.2\", \"title\": \"If a Purchase Order is accepted by Airspan, Airspan will issue an order acknowledgment to Distributor within five (\", \"level\": 2, \"text\": \"4.2 If a Purchase Order is accepted by Airspan, Airspan will issue an order acknowledgment to Distributor within five (5) business days of Airspan's receipt of the written Purchase Order from Distributor.\"}, {\"id\": \"5\", \"title\": \"RECORDS AND REPORTING\", \"level\": 1, \"text\": \"5. RECORDS AND REPORTING.\"}, {\"id\": \"5.1\", \"title\": \"At Airspan's request, within fifteen (15) days of the end of each calendar month, Distributor will provide to Airsp\", \"level\": 2, \"text\": \"5.1 At Airspan's request, within fifteen (15) days of the end of each calendar month, Distributor will provide to Airspan a written report showing, for the just-ended calendar month: (a) Distributor's shipments of Airspan Products by dollar volume, both in the aggregate and for such categories as Airspan may designate from time to time; (b) forecasts of Distributor's anticipated orders by product; (c) Distributor's current inventory levels of Airspan Products, in the aggregate and by product; and (d) any other information which Airspan may reasonably request.\"}, {\"id\": \"5.2\", \"title\": \"Distributor will promptly advise Airspan concerning any market information which comes to Distributor's attention r\", \"level\": 2, \"text\": \"5.2 Distributor will promptly advise Airspan concerning any market information which comes to Distributor's attention regarding Airspan, Airspan Products, Airspan's market position, or the continued competitiveness of Airspan Products in the marketplace. Distributor will confer with Airspan from - -------------------------------------------------------------------------------- Page 6 time to time, at Airspan's request, on matters relating to market conditions, distribution forecasting, and product planning.\"}, {\"id\": \"5.3\", \"title\": \"For at least two (2) years after termination of this Agreement, Distributor will maintain its records, contracts, a\", \"level\": 2, \"text\": \"5.3 For at least two (2) years after termination of this Agreement, Distributor will maintain its records, contracts, and accounts relating to distribution of Airspan Products, and will permit examination thereof by authorized representatives of Airspan at all reasonable times.\"}, {\"id\": \"6\", \"title\": \"CONTRACT PRICE\", \"level\": 1, \"text\": \"6. CONTRACT PRICE\"}, {\"id\": \"6.1\", \"title\": \"The Contract Price for each item of Equipment, Installation Services, or Software is as specified in Schedule IV an\", \"level\": 2, \"text\": \"6.1 The Contract Price for each item of Equipment, Installation Services, or Software is as specified in Schedule IV and shall be paid to Airspan in US Dollars (US$) free of any withholding tax and of any currency controls or other restrictions. The Contract Price includes: a. The price of the Equipment; b. The fee for the licensing of the Software;\"}, {\"id\": \"c\", \"title\": \"If Installation Services are ordered and such order is accepted by Airspan, the charges for installing\", \"level\": 1, \"text\": \"c. If Installation Services are ordered and such order is accepted by Airspan, the charges for installing and testing each unit of Equipment or Software;\"}, {\"id\": \"d\", \"title\": \"The charges for the warranty of the Equipment and Software in accordance with Sections 14 and 15; and\", \"level\": 1, \"text\": \"d. The charges for the warranty of the Equipment and Software in accordance with Sections 14 and 15; and e. Costs in accordance with delivery obligations set forth in Sections 8.1 and 8.2. [*] [*] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. - ------------------------------------------------------------------------------- Page 7 Airspan warrants that during the term of this Agreement, the prices at which Airspan sells to Distributor products supplied under this Agreement shall be no less favorable to the Distributor than those prices at which Airspan sells, at substantially the same time in the United States, similar products and pursuant to similar terms and conditions as those by which Airspan sells Products to the Distributor under this Agreement. Products shall only be deemed similar if they provide like functionality. The terms and conditions shall only be deemed similar if the product is supplied pursuant to an agreement or arrangement of similar duration and commitment, provides for similar warranties and after service commitments, involves similar spare part and support commitments, has the same payment and other financial terms, and otherwise has similar terms and conditions.\"}, {\"id\": \"6.2\", \"title\": \"The Contract Price is shown in Schedule IV and shall include applicable duties, taxes or imposts, including all exp\", \"level\": 2, \"text\": \"6.2 The Contract Price is shown in Schedule IV and shall include applicable duties, taxes or imposts, including all export or import duties. Sales taxes and contractor's excise taxes shall be itemized on all Purchase Orders. The parties agree that the Contract Price in Schedule IV shall be firm for a minimum period of twenty-four (24) months from the Effective Date. After the above period of twenty-four (24) months, Exhibit B may be revised by Airspan giving thirty (30) days written notice to Distributor.\"}, {\"id\": \"7\", \"title\": \"PAYMENT TERMS\", \"level\": 1, \"text\": \"7. PAYMENT TERMS.\"}, {\"id\": \"7.1\", \"title\": \"Airspan will issue an invoice (the \\\"Invoice\\\") to Distributor in accordance with the payment terms below\", \"level\": 2, \"text\": \"7.1 Airspan will issue an invoice (the \\\"Invoice\\\") to Distributor in accordance with the payment terms below. The Invoice specifically will identify the Equipment, Software, or other items shipped, and the Contract Price of such items. Any Installation Services or other services provided by Airspan will be invoiced separately following completion of such services. The Invoice also shall state the total due to Airspan from Distributor (the \\\"Invoice Total\\\"), which shall include the Contract Price, and any applicable taxes, duties, and other fees due pursuant to Section 6 of this Agreement. Payment of the Invoice Total is due (without any right of set-off) Net forty-five (45) days after the date of invoice.\"}, {\"id\": \"7.2\", \"title\": \"If Distributor disputes any invoice or part thereof, Distributor must notify Airspan in writing within twenty-five\", \"level\": 2, \"text\": \"7.2 If Distributor disputes any invoice or part thereof, Distributor must notify Airspan in writing within twenty-five (25) days of the invoice date giving details of the reason for such dispute. - ------------------------------------------------------------------------------- Page 8 Distributor and Airspan agree to work together in good faith to resolve the dispute as quickly as possible. Distributor may withhold payment of such disputed amounts until resolution of the dispute. Any parts of the invoice not under dispute shall be paid net forty-five (45) days after the date of invoice. On resolution of the dispute, Distributor shall immediately pay any amounts due in full.\"}, {\"id\": \"7.3\", \"title\": \"Distributor will make payment by wire or telegraphic transfer to the bank account set forth below or, on receipt of\", \"level\": 2, \"text\": \"7.3 Distributor will make payment by wire or telegraphic transfer to the bank account set forth below or, on receipt of written notification from Airspan, to another designated bank within the United States. Bank: Seafirst Bank, 10555 N.E. 8th, Bellevue, WA98004, USA. Account name: Airspan Networks Inc. Account number: 68777507 Routing Number: 125 - 0000 - 24 Further instructions: \\\"Reference (Distributor's name), Purchase Order number, Payment of Invoice number\\\" Payment will be deemed to have been made upon receipt of funds in Airspan's bank.\"}, {\"id\": \"7.4\", \"title\": \"If the cost to Airspan of performing this Agreement increases as a result of any change to the law or increase in i\", \"level\": 2, \"text\": \"7.4 If the cost to Airspan of performing this Agreement increases as a result of any change to the law or increase in import duty or freight duty, Airspan may, at any time, add such increase to the Contract Price by notifying Distributor in writing of such increase.\"}, {\"id\": \"8\", \"title\": \"DELIVERY, TITLE AND RISK OF LOSS\", \"level\": 1, \"text\": \"8. DELIVERY, TITLE AND RISK OF LOSS.\"}, {\"id\": \"8.1\", \"title\": \"All Equipment and Software will be delivered by Airspan CIP (as defined in Incoterms 2000) to an airport in South D\", \"level\": 2, \"text\": \"8.1 All Equipment and Software will be delivered by Airspan CIP (as defined in Incoterms 2000) to an airport in South Dakota that completes international customs clearances and shipped to a location within the city limits of the above arrival airport, such airport and delivery location are to be agreed upon in writing by the parties for each Purchase Order. Airspan will be responsible for and pay all packing, shipping, freight, and insurance charges to the agreed upon location within the city limits. If requested by Distributor, Airspan may arrange for shipment to be made to Distributor's identified warehouse facilities or freight forwarder outside of the city limits, subject to approval in writing by Airspan and agreement to any additional charges in advance of shipment. Unless specified in the Purchase Order, Airspan will select the mode of shipment and the carrier. In this Agreement, \\\"Incoterms\\\" means the most recent international rules for the interpretation of trade terms published by the International Chamber of Commerce as in force on the Effective Date. Unless the context otherwise requires, any term or expression which is defined in or given a particular meaning by the provisions of the Incoterms shall have the same meaning in this - -------------------------------------------------------------------------------- Page 9 Agreement, but if there is any conflict between the provisions of the Incoterms and this Agreement, the latter shall prevail.\"}, {\"id\": \"8.2\", \"title\": \"All risk of loss or damage to the Equipment and Software will pass to Distributor on collection by the freight forw\", \"level\": 2, \"text\": \"8.2 All risk of loss or damage to the Equipment and Software will pass to Distributor on collection by the freight forwarder from Airspan. However, Airspan will insure the Equipment against loss or damage in transit to the agreed to location as set forth in the Purchase Order within the city limits of the arrival airport as set forth in Paragraph 8.1.\"}, {\"id\": \"8.3\", \"title\": \"Title to the Equipment shall pass to Distributor on collection by the freight forwarder from Airspan\", \"level\": 2, \"text\": \"8.3 Title to the Equipment shall pass to Distributor on collection by the freight forwarder from Airspan.\"}, {\"id\": \"8.4\", \"title\": \"If Distributor has any Airspan owned Equipment in its possession\", \"level\": 2, \"text\": \"8.4 If Distributor has any Airspan owned Equipment in its possession: a. Distributor shall ensure that Equipment is clearly marked as the property of Airspan, and if asked, shall inform any third parties that the Equipment is the property of Airspan; b. Distributor shall not purport to create any security, mortgage, lien or pledge over the Equipment, or otherwise deal with the Equipment without Airspan's written consent;\"}, {\"id\": \"c\", \"title\": \"In the event of any threatened seizure of the Equipment by any third parties, and on termination or expiration o\", \"level\": 1, \"text\": \"c. In the event of any threatened seizure of the Equipment by any third parties, and on termination or expiration of this Agreement, or any Contract made pursuant to it, Airspan shall have the right, without prejudice to any other remedy, to enter without prior notice any premises and to repossess and take away or otherwise deal with the Equipment.\"}, {\"id\": \"8.5\", \"title\": \"The Software shall at all times remain the exclusive property of Airspan, subject to the uses provided herein\", \"level\": 2, \"text\": \"8.5 The Software shall at all times remain the exclusive property of Airspan, subject to the uses provided herein.\"}, {\"id\": \"8.6\", \"title\": \"Unless Distributor clearly advises Airspan to the contrary in writing, Airspan may make partial deliveries on accou\", \"level\": 2, \"text\": \"8.6 Unless Distributor clearly advises Airspan to the contrary in writing, Airspan may make partial deliveries on account of Purchase Orders. Delay in delivery of any installment shall not relieve Distributor of its obligation to accept said installment, provided that said delay does not exceed sixty (60) days from Airspan's scheduled ship date and unless Distributor has clearly advised Airspan to cancel the delayed installment in writing at least fifteen (15) days prior to its revised planned shipment date or its actual shipment date by Airspan.\"}, {\"id\": \"8.7\", \"title\": \"Airspan will use reasonable efforts to meet Distributor's requested delivery schedules for Equipment and Software,\", \"level\": 2, \"text\": \"8.7 Airspan will use reasonable efforts to meet Distributor's requested delivery schedules for Equipment and Software, but Airspan reserves the right to refuse, or delay delivery to Distributor when Distributor's credit is impaired, - -------------------------------------------------------------------------------- Page 10 when Distributor is delinquent in payments or fails to meet other credit or financial requirements reasonably established by Airspan, or when Distributor has failed to perform its obligations under this Agreement.\"}, {\"id\": \"8.8\", \"title\": \"Should orders for Equipment and Software exceed Airspan's available inventory, Airspan will allocate its available\", \"level\": 2, \"text\": \"8.8 Should orders for Equipment and Software exceed Airspan's available inventory, Airspan will allocate its available inventory and make deliveries on a basis that Airspan deems equitable, in its sole discretion, and without liability to Distributor on account of the method of allocation chosen or its implementation. In any event, Airspan shall not be liable for any direct, indirect, consequential, or special losses or damages (including, but not limited to, loss of income or profit and loss of data) that may be suffered by the Distributor or by any other person for failure to deliver or for any delay or error in delivery of Equipment or Software for any reason whatsoever.\"}, {\"id\": \"9\", \"title\": \"TRADEMARKS AND COPYRIGHTS\", \"level\": 1, \"text\": \"9. TRADEMARKS AND COPYRIGHTS.\"}, {\"id\": \"9.1\", \"title\": \"Distributor acknowledges Airspan's exclusive right, title, and interest in and to any trademarks, trade names, logos and\", \"level\": 2, \"text\": \"9.1 Distributor acknowledges Airspan's exclusive right, title, and interest in and to any trademarks, trade names, logos and designations which Airspan may at any time have adopted, used, or registered in the United States of America and in the Territory (the \\\"Trademarks\\\"), and will not at any time do or cause to be done any act or thing contesting or in any way impairing or tending to impair any part of said right, title, and interest. In connection with any reference to the Trademarks, Distributor shall not in any manner represent that it has an ownership interest in the Trademarks or registration(s) thereof, and Distributor acknowledges that no action by it or on its behalf shall create in Distributor's favor any right, title, or interest in or to the Trademarks.\"}, {\"id\": \"9.2\", \"title\": \"Distributor recognizes the validity of Airspan's copyright in any written material to which Airspan shall have made a cl\", \"level\": 2, \"text\": \"9.2 Distributor recognizes the validity of Airspan's copyright in any written material to which Airspan shall have made a claim to copyright protection, and Distributor specifically recognizes Airspan's exclusive right to copyright protection and/or registration of any translation of any advertising, promotional, or descriptive material furnished to Distributor by Airspan.\"}, {\"id\": \"9.3\", \"title\": \"Whenever Distributor refers to the Trademarks in advertising or in any other manner to identify the products, Distributo\", \"level\": 2, \"text\": \"9.3 Whenever Distributor refers to the Trademarks in advertising or in any other manner to identify the products, Distributor shall clearly indicate Airspan's ownership of the Trademarks and before distributing or publishing any advertising, descriptive, or promotional materials, Distributor shall affirmatively provide Airspan with an opportunity to inspect and approve such materials.\"}, {\"id\": \"9.4\", \"title\": \"Distributor agrees that when referring to the Trademarks, it shall diligently comply with all laws pertaining to the Tra\", \"level\": 2, \"text\": \"9.4 Distributor agrees that when referring to the Trademarks, it shall diligently comply with all laws pertaining to the Trademarks at any time in force in the Territory. - -------------------------------------------------------------------------------- Page 11\"}, {\"id\": \"9.5\", \"title\": \"Distributor shall promptly notify Airspan of any and all infringements, imitations, illegal uses, or misuses of the Trad\", \"level\": 2, \"text\": \"9.5 Distributor shall promptly notify Airspan of any and all infringements, imitations, illegal uses, or misuses of the Trademarks which come to Distributor's attention. Distributor also agrees that it shall not at any time take any action in the courts or before the administrative agencies of the Territory or otherwise to prevent the infringement, imitation, illegal use, or misuse of the Trademarks, it being clearly understood by Distributor that such action falls wholly within the authority of Airspan as sole owner of the Trademarks.\"}, {\"id\": \"9.6\", \"title\": \"Distributor agrees to render to Airspan all assistance in connection with any matter pertaining to the protection of the\", \"level\": 2, \"text\": \"9.6 Distributor agrees to render to Airspan all assistance in connection with any matter pertaining to the protection of the Trademarks, whether in the courts or before the administrative agencies of the Territory or otherwise, and to make promptly available to Airspan, its Distributors, and attorneys all of Distributor's files, records, and other information pertaining to the advertising, promotion, and sale of the Airspan Products. All assistance requested by Distributor in this paragraph shall be at AIRSPAN's expense. This Expense includes costs, attorneys' and consultants' fees, and reimbursement of time spent by officers, agents and employees of Distributor.\"}, {\"id\": \"9.7\", \"title\": \"Distributor agrees and undertakes that it will not at any time, whether during the term of this Agreement or after its e\", \"level\": 2, \"text\": \"9.7 Distributor agrees and undertakes that it will not at any time, whether during the term of this Agreement or after its expiration or termination, adopt, use, or register without Airspan's prior, written consent any work or symbol or combination thereof which is similar to any of the Trademarks.\"}, {\"id\": \"9.8\", \"title\": \"In the advertising and sale of Airspan Products, Distributor may use the Trademarks in relation to those Airspan Product\", \"level\": 2, \"text\": \"9.8 In the advertising and sale of Airspan Products, Distributor may use the Trademarks in relation to those Airspan Products. Distributor will not make or permit the alteration or removal of any tags, labels, or other identifying marks placed by Airspan on Airspan Products. Distributor will not use or give any third party permission to use the Trademarks. Distributor will not use, or give any third party permission to use, the names \\\"Airspan Communications Ltd.\\\", \\\"Airspan Networks Incorporated\\\", \\\"ACL\\\", \\\"ANI\\\" or abbreviations or derivations thereof in Distributor's corporate titles, or in any way which might result in confusion as to Airspan and Distributor being separate and distinct entities. Distributor admits Airspan's exclusive ownership of the name \\\"Airspan Networks Incorporated\\\", \\\"Airspan Communications Ltd.\\\", \\\"ANI\\\", \\\"ACL\\\", and any abbreviations or derivations thereof and all of Airspan's Trademarks (whether registered or not). Distributor shall not take any action inconsistent with Airspan's ownership of such Trademarks; therefore, Distributor shall treat all of Airspan's items distinctively (as to typography) and shall only use exact reproductions of all Airspan's symbols (including Airspan's logo). Distributor shall not adopt or use any Trademark or product name which may be confusingly similar to any Airspan Trademark. Distributor may use the Airspan logo as it appears on Airspan's letterhead.\"}, {\"id\": \"10\", \"title\": \"CONFIDENTIAL INFORMATION AND TRADE SECRETS\", \"level\": 1, \"text\": \"10. CONFIDENTIAL INFORMATION AND TRADE SECRETS. - ------------------------------------------------------------------------------- Page 12\"}, {\"id\": \"10.1\", \"title\": \"In this Agreement, the term \\\"Confidential Information\\\" shall mean the information of Airspan disclosed to Distributor in\", \"level\": 2, \"text\": \"10.1 In this Agreement, the term \\\"Confidential Information\\\" shall mean the information of Airspan disclosed to Distributor in connection with its performance under this Agreement, which is in written, recorded, photographic, machine-readable, or other physical form or oral information reduced to writing as soon as practicable after disclosure to Distributor, and which is conspicuously marked \\\"Confidential\\\", \\\"Proprietary\\\", \\\"Private\\\", or in any other manner indicating its confidential and/or proprietary nature. Without limitation, Confidential Information includes: (1) Airspan's software products, materials, data reports, programs, documentation, diagrams, and all related technical information; (2) all information relating to Airspan's business and products which is critical to Airspan's position in the marketplace, including future plans of Airspan relating to the fields of endeavor in which Distributor performs services for Airspan, the nature of certain work projects to which Distributor is exposed, and the identity of persons working on those projects; and (3) any improvements, enhancements, or modifications to the above made by or on behalf of Airspan during the performance under this Agreement which are provided, made available, or disclosed by or on behalf of Airspan to Distributor, or used by Airspan or any of Airspan's other Distributors in connection with their own sales activities.\"}, {\"id\": \"10.2\", \"title\": \"Trade secrets are confidential information that includes ideas, concepts, techniques, processes, inventions, knowledge,\", \"level\": 2, \"text\": \"10.2 Trade secrets are confidential information that includes ideas, concepts, techniques, processes, inventions, knowledge, and know-how developed by Airspan which: (1) derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and (2) is subject to the efforts of Airspan that are reasonable under the circumstances to maintain its secrecy. (This \\\"trade secret\\\" language comes from the Uniform Trade Secrets Act.)\"}, {\"id\": \"10.3\", \"title\": \"Distributor covenants and agrees that it will use the Confidential Information solely for the performance of services un\", \"level\": 2, \"text\": \"10.3 Distributor covenants and agrees that it will use the Confidential Information solely for the performance of services under this Agreement, and shall not disclose such Confidential Information to any other person (including Airspan employees in any other division, group, or entity), firm, or corporation.\"}, {\"id\": \"10.4\", \"title\": \"Distributor shall use the same degree of care in safeguarding the Confidential Information as it uses for its own confid\", \"level\": 2, \"text\": \"10.4 Distributor shall use the same degree of care in safeguarding the Confidential Information as it uses for its own confidential information of like importance, but no less than reasonable care. Upon discovery of any disclosure or misuse of Confidential Information, Distributor shall endeavor to prevent any further disclosure or misuse.\"}, {\"id\": \"10.5\", \"title\": \"All Confidential Information shall remain the property of Airspan, and such Confidential Information and all copies ther\", \"level\": 2, \"text\": \"10.5 All Confidential Information shall remain the property of Airspan, and such Confidential Information and all copies thereof shall promptly be returned to Airspan upon request or, at Airspan 's option, destroyed, in which case Airspan shall be notified in writing when it has been destroyed. - -------------------------------------------------------------------------------- Page 13\"}, {\"id\": \"10.6\", \"title\": \"Nothing contained in this Agreement shall be construed as granting to or conferring upon Distributor any rights, by lice\", \"level\": 2, \"text\": \"10.6 Nothing contained in this Agreement shall be construed as granting to or conferring upon Distributor any rights, by license or otherwise, express or implied, in Airspan's Confidential Information, other than the right to use the Confidential Information for the purpose of this Agreement.\"}, {\"id\": \"10.7\", \"title\": \"Any copies of the Confidential Information made by Distributor shall reproduce proprietary marking and legends included\", \"level\": 2, \"text\": \"10.7 Any copies of the Confidential Information made by Distributor shall reproduce proprietary marking and legends included therein, but the provisions of this Agreement supersede any provisions of such legends inconsistent herewith.\"}, {\"id\": \"10.8\", \"title\": \"The terms and conditions of this Agreement shall not be disclosed by Distributor to others, except with the prior, writt\", \"level\": 2, \"text\": \"10.8 The terms and conditions of this Agreement shall not be disclosed by Distributor to others, except with the prior, written consent of Airspan, or as may be required by law or as necessary to establish its rights hereunder.\"}, {\"id\": \"10.9\", \"title\": \"If, in connection with its performance, Distributor discloses to Airspan any ideas, developments, or inventions conceive\", \"level\": 2, \"text\": \"10.9 If, in connection with its performance, Distributor discloses to Airspan any ideas, developments, or inventions conceived or actually reduced to practice by Distributor prior to its performance hereunder, no relationship, confidential or otherwise, express or implied, is established with Airspan by the disclosure thereof. With respect to any such disclosure, no obligation of any kind is assumed by nor may be implied against Airspan, its subsidiary, or associated companies unless a formal, separate, written contract regarding the subject of disclosure is consummated by the parties, and then the obligation shall be only as expressed in the separate contract.\"}, {\"id\": \"10.10\", \"title\": \"Distributor agrees that any breach of the provisions of this Section by Distributor or Distributor's personnel, agents,\", \"level\": 2, \"text\": \"10.10 Distributor agrees that any breach of the provisions of this Section by Distributor or Distributor's personnel, agents, or subcontractors, or any third party providing products or services to Distributor will cause immediate and irreparable injury to Airspan and that, in the event of such breach, Airspan shall be entitled to injunctive relief and any and all other remedies available at law or in equity.\"}, {\"id\": \"10.11\", \"title\": \"After Distributor has received Airspan's Confidential Information and know-how, it will be impossible to segregate Airsp\", \"level\": 2, \"text\": \"10.11 After Distributor has received Airspan's Confidential Information and know-how, it will be impossible to segregate Airspan's knowledge and know- how from other knowledge acquired independently by Distributor. Accordingly, during the performance of this Agreement and for three (3) months after termination of services under this Agreement, Distributor will not offer services to third parties which compete with the services provided by Airspan under this Agreement, or otherwise use the knowledge acquired from Airspan in order to compete with Airspan or its customers. Notwithstanding anything to the contrary above, Distributor is not precluded from any activities which concern product sectors or industries other than those that concern products or services similar to those offered by Airspan in connection with this Agreement. Nothing in this paragraph will be construed to prevent Distributor from providing service to existing customers of Distributor which would result in their interruption of service to the public. - -------------------------------------------------------------------------------- Page 14\"}, {\"id\": \"10.12\", \"title\": \"During the performance of this Agreement and for three (3) months after termination of services under this Agreement, Ai\", \"level\": 2, \"text\": \"10.12 During the performance of this Agreement and for three (3) months after termination of services under this Agreement, Airspan will not offer products or services to third parties which compete with the products or services provided by Distributor under this Agreement, or otherwise use the knowledge acquired from Distributor in order to compete with Distributor its customers\"}, {\"id\": \"10.13\", \"title\": \"The obligations of this Section 10 shall survive the expiration or termination of this Agreement\", \"level\": 2, \"text\": \"10.13 The obligations of this Section 10 shall survive the expiration or termination of this Agreement.\"}, {\"id\": \"11\", \"title\": \"SOFTWARE LICENSE\", \"level\": 1, \"text\": \"11. SOFTWARE LICENSE.\"}, {\"id\": \"11.1\", \"title\": \"Airspan grants Distributor, and Distributor hereby accepts, a nonexclusive, non-transferable license to use, and to subl\", \"level\": 2, \"text\": \"11.1 Airspan grants Distributor, and Distributor hereby accepts, a nonexclusive, non-transferable license to use, and to sublicense as set forth below, Software provided by Airspan hereunder only on a single System or unit of Equipment, as may be applicable. No license is granted to use the Software on multiple Systems or in conjunction with Equipment furnished by a party other than Airspan, unless specifically agreed to in writing by Airspan. Software licensed under this Agreement is defined as: (a) any digital instruction sequence or control data contained on any media, including but not limited to, any magnetic-, electronic-, optical-, or organic device, and the term Software shall include any enhancement, modification, extension, part, portion or expansion thereof or implementation or downloading from network of any of the foregoing, for use exclusively on a System or a unit of Equipment; and (b) all associated documentation used to describe, maintain and use the Software.\"}, {\"id\": \"11.2\", \"title\": \"Any Software provided to Distributor by Airspan will be treated as the exclusive property of Airspan, and Distributor wi\", \"level\": 2, \"text\": \"11.2 Any Software provided to Distributor by Airspan will be treated as the exclusive property of Airspan, and Distributor will: (a) treat such Software as Confidential Information under Section 10 of this Agreement; (b) utilize such Software or any portions or aspects thereof (including any methods or concepts utilized therein) solely on Systems or Equipment provided by Airspan; (c) forthwith return to Airspan all memory media, documentation and/or other material that has been modified, updated or replaced; (d) except to the extent permitted by applicable law not modify, disassemble or decompile such Software, or reverse engineer any portion of the Software or functioning of Systems or Equipment, or permit others to do so, without Airspan's prior written consent; (e) except to the extent permitted by applicable law not reproduce or copy such Software in whole or in part except for backup and archival purposes or as otherwise permitted in writing by Airspan; (f) not perform or release benchmarks or other comparisons of the Software; and (g) not remove any trademark, tradename, copyright, notice or other proprietary notice from the Software and Distributor shall be responsible for the conservation of the same on any back-up copy of the Software. - -------------------------------------------------------------------------------- Page 15\"}, {\"id\": \"11.3\", \"title\": \"In the event of a breach of this license by Distributor, then Airspan may, in its discretion, terminate the license with\", \"level\": 2, \"text\": \"11.3 In the event of a breach of this license by Distributor, then Airspan may, in its discretion, terminate the license with immediate effect, whereupon Distributor shall return to Airspan all Software and copies thereof within ten (10) days.\"}, {\"id\": \"12\", \"title\": \"EXCUSABLE DELAY\", \"level\": 1, \"text\": \"12 EXCUSABLE DELAY. Airspan shall not suffer any liability for non-performance, defective performance, or late performance under this Agreement due to causes beyond its control and without its fault or negligence such as, but not limited to, acts of God, war (including civil war), civil unrest, acts of government, fire, floods, explosions, the elements, epidemics, quarantine, restrictions, strikes, lock- outs, plant shutdown, material shortages, or delays in transportation or delays of its suppliers or subcontractors for like cause. In the event of excusable delay as defined in the preceding sentence, then Airspan, upon giving prompt written notice to Distributor, shall be excused from such performance on a day-to-day basis to the extent of such prevention, restriction, or interference (and Distributor shall likewise be excused from performance of its obligations on a day-to-day basis to the extent Distributor's obligations relate to the performance so prevented, restricted, or interfered with), provided that Airspan shall use its best endeavors to avoid or remove such causes of non-performance and both parties shall proceed to perform with dispatch whenever such causes are removed or cease to exist.\"}, {\"id\": \"13\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"13. TERM AND TERMINATION.\"}, {\"id\": \"13.1\", \"title\": \"This Agreement shall remain in effect for sixty (60) months from the Effective Date (the \\\"Initial Term\\\")\", \"level\": 2, \"text\": \"13.1 This Agreement shall remain in effect for sixty (60) months from the Effective Date (the \\\"Initial Term\\\"). After the Initial Term, the term of the Agreement may be extended by a further period of five (5) years by mutual written agreement by the parties in the form of an amendment to this Agreement. If Distributor wishes to extend the term of the Agreement beyond the Initial Term, it must notify Airspan in writing at least six (6) months prior to then end of the Initial Term. However, nothing contained herein shall be interpreted as requiring either party to renew or extend this Agreement. Notwithstanding the provisions of this section or of any other provisions of this Agreement, this Agreement may be terminated prior to the expiration of its stated term as set forth below.\"}, {\"id\": \"13.2\", \"title\": \"Either party may terminate this Agreement at any time during the term of this Agreement if either party fails materiall\", \"level\": 2, \"text\": \"13.2 Either party may terminate this Agreement at any time during the term of this Agreement if either party fails materially to comply with any covenant, term, or provision of this Agreement, by written notice given to the other party not less than thirty (30) days prior to the effective date of such termination. Either party's right to terminate this Agreement under this Section 13.2 may not be exercised unless said - -------------------------------------------------------------------------------- Page 16 party shall have given the other party written notice of the failure, and the other party has not cured the failure within the thirty (30) day period following notice from said party.\"}, {\"id\": \"13.3\", \"title\": \"This Agreement terminates automatically for just cause, with no further act or action of either party if\", \"level\": 2, \"text\": \"13.3 This Agreement terminates automatically for just cause, with no further act or action of either party if: (a) a receiver is appointed for Distributor or its property; (b) Distributor&sbsp;makes an assignment for the benefit of its creditors; (c) any proceedings are commenced by, for, or against Distributor under any bankruptcy, insolvency, or debtor's relief law; or (d) Distributor is liquidated, dissolved, or otherwise terminates its activities.\"}, {\"id\": \"13.4\", \"title\": \"In the event of termination by either party for any reason, Distributor shall provide Airspan with lists of existing cus\", \"level\": 2, \"text\": \"13.4 In the event of termination by either party for any reason, Distributor shall provide Airspan with lists of existing customers as well as other information necessary for an orderly changeover of representation in the Territory.\"}, {\"id\": \"13.5\", \"title\": \"Upon termination, Distributor shall immediately return to Airspan all Confidential Information, and Distributor agrees t\", \"level\": 2, \"text\": \"13.5 Upon termination, Distributor shall immediately return to Airspan all Confidential Information, and Distributor agrees that neither it nor any company or organization controlled or directed by it shall divulge the contents of such material to any person at any time, notwithstanding the termination of this Agreement.\"}, {\"id\": \"13.6\", \"title\": \"Airspan shall not be liable to Distributor for damages of any kind, including incidental or consequential damages, on ac\", \"level\": 2, \"text\": \"13.6 Airspan shall not be liable to Distributor for damages of any kind, including incidental or consequential damages, on account of the termination of this agreement in accordance with this section 13. Airspan shall not be liable to Distributor on account of termination or expiration of this Agreement for reimbursement or damages for loss of goodwill, prospective profits, or anticipated orders, or on account of any expenditures, investments, leases, or commitments made by either party, or for any other reason whatsoever based upon or growing out of such termination or expiration. Airspan will recognize payments due to Distributor for orders received up to ninety (90) days after the termination or expiration of this Agreement.\"}, {\"id\": \"13.7\", \"title\": \"Distributor acknowledges and agrees that\", \"level\": 2, \"text\": \"13.7 Distributor acknowledges and agrees that: (a) Distributor has no expectation and has received no assurances that its business relationship with Airspan will continue beyond the states term of this agreement or its earlier termination in accordance with this section, that any investment by Distributor in the promotion of Airspan's Products will be recovered or recouped, or that Distributor shall obtain any anticipated amount of profits by virtue of this Agreement; and (b) Distributor shall not have or acquire by virtue of this Agreement or otherwise any vested, proprietary, or other right in the promotion of Airspan's Products or in any goodwill created by its efforts hereunder.\"}, {\"id\": \"13.8\", \"title\": \"This Section 13\", \"level\": 2, \"text\": \"13.8 This Section 13.8, as well as the provisions of Sections 9, 10, 11, 16, 17 and 18, shall survive the termination of this Agreement. - ------------------------------------------------------------------------------- Page 17\"}, {\"id\": \"14\", \"title\": \"WARRANTY\", \"level\": 1, \"text\": \"14. WARRANTY.\"}, {\"id\": \"14.1\", \"title\": \"THE WARRANTIES SET FORTH IN SECTIONS 14 AND 15 OF THIS AGREEMENT ARE IN LIEU OF, AND Airspan HEREBY DISCLAIMS, ALL OTHER\", \"level\": 2, \"text\": \"14.1 THE WARRANTIES SET FORTH IN SECTIONS 14 AND 15 OF THIS AGREEMENT ARE IN LIEU OF, AND Airspan HEREBY DISCLAIMS, ALL OTHER WARRANTIES AND CONDITIONS, WHETHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, THE IMPLIED TERMS AND WARRANTIES OF SATISFACTORY QUALITY, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.\"}, {\"id\": \"14.2\", \"title\": \"Subject to Sections 14\", \"level\": 2, \"text\": \"14.2 Subject to Sections 14.3 and 14.4, Airspan warrants that the Equipment sold to Distributor under this Agreement shall, under normal use and service, be free from defects in materials and faulty workmanship, and that the Software licensed to Distributor under this Agreement shall conform in all material respects to Airspan's published specifications therefor. The warranty period for any item of Equipment and related Software shall be twelve (12) months from the date of delivery of such Equipment and related Software to Distributor as set forth in Paragraph 8.1 (hereinafter, this period of time shall be referred to as the \\\"Initial Warranty Period.\\\")\"}, {\"id\": \"14.3\", \"title\": \"Airspan's obligation and Distributor's sole remedy under this warranty are limited to the replacement or repair, at Airs\", \"level\": 2, \"text\": \"14.3 Airspan's obligation and Distributor's sole remedy under this warranty are limited to the replacement or repair, at Airspan's option, of the defective Equipment or Software within the Initial Warranty Period. Airspan shall have no obligation to remedy any such defect if it can be shown that: (a) the Equipment or Software was altered, repaired, or reworked by any party other than Airspan without Airspan's prior written consent; (b) such defects were the result of Distributor's or a third party's improper storage, mishandling, abuse, or misuse of the Equipment or Software; (c) such defects were the result of Distributor's or a third party's use of the Equipment or Software in conjunction with equipment electronically or mechanically incompatible or of an inferior quality; or (d) the defect was the result of damage by fire, explosion, power failure, or any act of nature.\"}, {\"id\": \"14.4\", \"title\": \"In no event shall Airspan be obliged to provide on-site maintenance\", \"level\": 2, \"text\": \"14.4 In no event shall Airspan be obliged to provide on-site maintenance. Subject to the provisions of this warranty clause, defective parts or components must be returned by Distributor to Airspan's designated facility located within the contiguous 48 states in the United States, freight prepaid, within the Initial Warranty Period, and said defective parts will be repaired or replaced by Airspan at no charge to Distributor. In connection with such return by Distributor, Distributor shall comply with Airspan's Return Material Authorization (RMA) procedures. Risk of loss or damage to Equipment or Software returned to Airspan for repair or replacement shall be borne by Distributor until delivery to Airspan. Upon delivery of such Equipment or Software, Airspan shall assume the risk of loss or damage until that time that the Equipment or Software being repaired or replaced is returned and delivered to Distributor. Distributor will pay all transportation costs for Equipment or Software shipped to Airspan for repair or replacement. Airspan shall pay all transportation costs associated - ------------------------------------------------------------------------------- Page 18 with returning repaired or replaced Equipment or Software to Distributor unless there was no fault found (NFF), in which event, the Distributor shall pay such transportation costs, along with Airspan's then prevailing standard NFF charge.\"}, {\"id\": \"14.5\", \"title\": \"Airspan will charge Distributor for any maintenance carried out which is not covered by the warranties contained in Sect\", \"level\": 2, \"text\": \"14.5 Airspan will charge Distributor for any maintenance carried out which is not covered by the warranties contained in Section 14.2 or Section 15 at Airspan's then prevailing standard rates for such services.\"}, {\"id\": \"15\", \"title\": \"WARRANTY ON REPAIRED AND REPLACEMENT MATERIALS\", \"level\": 1, \"text\": \"15. WARRANTY ON REPAIRED AND REPLACEMENT MATERIALS. Airspan warrants that, following repair or replacement, the repaired or replaced Equipment or Software by Airspan shall be free from defects in materials and faulty workmanship and that the Software will conform in all material respects to Airspan's published specifications therefor for ninety (90) days from date of shipment from Airspan to Distributor or until the end of the Initial Warranty Period, whichever is longer.\"}, {\"id\": \"16\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"16. LIMITATION OF LIABILITY.\"}, {\"id\": \"16.1\", \"title\": \"WITHOUT PREJUDICE TO SECTION 16\", \"level\": 2, \"text\": \"16.1 WITHOUT PREJUDICE TO SECTION 16.4, NEITHER Airspan, NOR ANY OF ITS OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, REPRESENTATIVES, SHAREHOLDERS, OR AFFILIATES (Airspan AND SUCH OTHER PERSONS, THE \\\"Airspan PARTIES\\\"), SHALL HAVE ANY LIABILITY TO DISTRIBUTOR FOR LOSS OF PROFITS, INCOME, REVENUE OR DATA, OR INCIDENTAL, CONSEQUENTIAL, INDIRECT OR PUNITIVE DAMAGES OR LOSSES, ARISING FROM OR IN CONNECTION WITH THIS AGREEMENT, ANY PURCHASE ORDER PLACED PURSUANT TO THIS AGREEMENT OR ANY OTHER COLLATERAL CONTRACT, OR FROM OR IN CONNECTION WITH THE EQUIPMENT OR THE SOFTWARE OR THE USE THEREOF OR THE INABILITY TO USE THEM EITHER SEPARATELY OR IN COMBINATION WITH OTHER EQUIPMENT OR SOFTWARE, OR FROM ANY OTHER CAUSE, WHETHER CAUSED BY NEGLIGENCE, BREACH OF CONTRACT, STRICT LIABILITY, BREACH OF WARRANTY, ON GROUNDS OF FAILURE OF ESSENTIAL PURPOSE OR OTHERWISE.\"}, {\"id\": \"16.2\", \"title\": \"Without prejudice to Sections 16\", \"level\": 2, \"text\": \"16.2 Without prejudice to Sections 16.3 and 16.4, the liability of the Airspan Parties, taken as a whole, for each event or series of connected events arising out of or in connection with this Agreement, any purchase order placed pursuant to this Agreement, or any other collateral contract, or from or in connection with the Equipment or Software or the use thereof, or the inability to use them either separately or in combination with other equipment or software, or from any other cause, whether caused by negligence, breach of contract, strict liability, breach of warranty, on grounds of failure of essential purpose, or otherwise, shall in no circumstance exceed the total amount payable by Distributor to Airspan under this Agreement for the provision of - ------------------------------------------------------------------------------- Page 19 the Equipment or Software which gave rise to the loss or damage or in connection with which the loss or damage was incurred.\"}, {\"id\": \"16.3\", \"title\": \"Airspan Parties, taken as a whole, shall be liable for physical damage to Distributor's property resulting from Airspan'\", \"level\": 2, \"text\": \"16.3 Airspan Parties, taken as a whole, shall be liable for physical damage to Distributor's property resulting from Airspan's negligence under or in connection with this Agreement up to a maximum aggregate amount of one million US Dollars (US$1,000,000). And Distributor, taken as a whole, shall be liable for physical damage to Airspan's property resulting from Distributor's negligence under or in connection with this Agreement up to a maximum aggregate amount of one million US Dollars (US$1,000,000).\"}, {\"id\": \"16.4\", \"title\": \"Nothing in this Agreement shall exclude or in any way limit Airspan liability for death or personal injury caused by its\", \"level\": 2, \"text\": \"16.4 Nothing in this Agreement shall exclude or in any way limit Airspan liability for death or personal injury caused by its negligence.\"}, {\"id\": \"16.5\", \"title\": \"Save as provided for in Section 17 Distributor shall indemnify and hold harmless and defend the Airspan Parties from and\", \"level\": 2, \"text\": \"16.5 Save as provided for in Section 17 Distributor shall indemnify and hold harmless and defend the Airspan Parties from and against all claims, demands, actions, suits, proceedings, writs, judgments, orders and decrees brought, made or rendered against them or any of them and all damages, losses and expenses suffered or incurred by them or any of them howsoever arising out of or related to the breach by Distributor of any of the terms of this Agreement. Airspan shall notify Distributor forthwith of any claim, demand, action, suit, proceeding, writ, judgment, order or decree falling within the scope of this Section 16.5 and shall permit Distributor sole conduct of the same and shall provide reasonable assistance in relation thereto, subject to appropriate defense by Distributor and the payment by Distributor of Airspan's reasonable costs and expenses.\"}, {\"id\": \"16.6\", \"title\": \"Distributor shall include, in its agreements with its customers pursuant to which Distributor supplies Equipment or Soft\", \"level\": 2, \"text\": \"16.6 Distributor shall include, in its agreements with its customers pursuant to which Distributor supplies Equipment or Software, provisions pursuant to which such customers agree that the Airspan Parties shall have no liability for any of the types of damages referred to at Section 16.1 in connection with or arising from the Equipment or Software or the use thereof, or the inability to use them either separately or in combination with other equipment or software, or from any other causes.\"}, {\"id\": \"17\", \"title\": \"INTELLECTUAL PROPERTY RIGHTS INDEMNITY\", \"level\": 1, \"text\": \"17. INTELLECTUAL PROPERTY RIGHTS INDEMNITY.\"}, {\"id\": \"17.1\", \"title\": \"Airspan agrees to indemnify and hold Distributor harmless with respect to any suit, claim, or proceeding brought against\", \"level\": 2, \"text\": \"17.1 Airspan agrees to indemnify and hold Distributor harmless with respect to any suit, claim, or proceeding brought against Distributor by a third party alleging that Distributor's use of the Equipment or the Software, separately or in combination, as a whole or in part, constitutes an infringement of any patent or copyright or misuse of proprietary or trade secret information. Airspan agrees to defend Distributor against any such claims and to pay all litigation costs, reasonable attorney's fees, settlement payments, and any damages awarded or resulting from any such claim. - ------------------------------------------------------------------------------- Page 20\"}, {\"id\": \"17.2\", \"title\": \"Distributor shall promptly advise Airspan of any such suit, claim, or proceeding and shall co-operate with Airspan in th\", \"level\": 2, \"text\": \"17.2 Distributor shall promptly advise Airspan of any such suit, claim, or proceeding and shall co-operate with Airspan in the defense or settlement thereof. Airspan shall have sole control of the defense of any action involving such a claim and of all negotiations for its settlement or compromise.\"}, {\"id\": \"17.3\", \"title\": \"In the event that an injunction is obtained against Distributor's use of the Equipment and/or the Software, in whole or\", \"level\": 2, \"text\": \"17.3 In the event that an injunction is obtained against Distributor's use of the Equipment and/or the Software, in whole or in part, as a result of any such claim, Airspan shall use its best efforts to either: (a) procure for Distributor the right to continue using the portions of the Equipment or the Software enjoined from use; or (b) replace or modify the same with functionally equivalent or better Equipment and/or Software so that Distributor's use is not subject to any such injunction. In the event that Airspan cannot perform the remedies set forth in Sections 17.3(a) or 17.3(b), then Distributor shall have the right to return such Equipment and the Software to Airspan. In the event of such return, Airspan shall refund the depreciated value of the Equipment and the license to use the Software within thirty (30) days of the receipt by Airspan of the Equipment and the Software.\"}, {\"id\": \"17.4\", \"title\": \"This indemnity shall not apply to claims arising in respect to the use of the Equipment or Software supplied by Airspan\", \"level\": 2, \"text\": \"17.4 This indemnity shall not apply to claims arising in respect to the use of the Equipment or Software supplied by Airspan or manufactured by its suppliers in accordance with any design or any special instruction furnished by Distributor, or which is used by Distributor in a manner or for a purpose not contemplated by this Agreement.\"}, {\"id\": \"17.5\", \"title\": \"The provisions of this Section 17 set forth the entire obligation of Airspan with respect to any claim of patent infring\", \"level\": 2, \"text\": \"17.5 The provisions of this Section 17 set forth the entire obligation of Airspan with respect to any claim of patent infringement, copyright infringement, or misuse of proprietary or trade secret information.\"}, {\"id\": \"18\", \"title\": \"EXPORT CONTROLS AND LEGAL COMPLIANCE\", \"level\": 1, \"text\": \"18. EXPORT CONTROLS AND LEGAL COMPLIANCE.\"}, {\"id\": \"18.1\", \"title\": \"If any approval with respect to this Agreement, or the registration thereof, shall be required at any time during the te\", \"level\": 2, \"text\": \"18.1 If any approval with respect to this Agreement, or the registration thereof, shall be required at any time during the term of this Agreement, with respect to giving legal effect to this Agreement in the Territory, or with respect to compliance with exchange regulations or other requirements so as to assure the right of remittance abroad of United States dollars pursuant to Section 6 hereof, Distributor shall immediately take whatever steps may be necessary in this respect, and any charges incurred in connection therewith shall be for the account of Distributor. Distributor shall keep Airspan currently informed of its efforts in this connection. Airspan shall be under no obligation to ship Airspan Products to Distributor hereunder until Distributor has provided Airspan with satisfactory evidence that such approval or registration is not required or that it has been obtained.\"}, {\"id\": \"18.2\", \"title\": \"In the performance of its obligations under this Agreement, Distributor shall at all times strictly comply with all expo\", \"level\": 2, \"text\": \"18.2 In the performance of its obligations under this Agreement, Distributor shall at all times strictly comply with all export laws, regulations, and orders of the - ------------------------------------------------------------------------------- Page 21 United Kingdom and the United States of America. Distributor specifically acknowledges that Equipment, Software or technology supplied or licensed by Airspan under this Agreement are subject to U.K. and U.S. trade sanctions and export control laws and regulations including, but not limited to, the various Foreign Assets Control Regulations, the Export Administration Regulations, and the International Traffic in Arms Regulations. Distributor specifically acknowledges that Equipment, Software, or technology obtained from Airspan pursuant to this Agreement shall not be exported, re-exported, transshipped, disclosed, diverted, or transferred, directly or indirectly, contrary to U.K. and U.S. laws, orders or regulations. The provisions of this section shall survive any termination of this Agreement.\"}, {\"id\": \"19\", \"title\": \"TRAINING AND DOCUMENTATION\", \"level\": 1, \"text\": \"19. TRAINING AND DOCUMENTATION.\"}, {\"id\": \"19.1\", \"title\": \"Airspan shall provide a single technical course in the English language for up to two (2) qualified technicians of Distr\", \"level\": 2, \"text\": \"19.1 Airspan shall provide a single technical course in the English language for up to two (2) qualified technicians of Distributor during the first year of this Agreement. The training course so developed by Airspan shall be used to familiarize Distributor's technicians with the use and maintenance of Airspan Products. Training will be conducted at Airspan's facilities in Uxbridge, UK, unless otherwise agreed to by Airspan. The necessary instructors and training facilities will be provided by Airspan at no charge to Distributor. Distributor will pay all additional expenses of training including, but not limited to, travel and room and board. Additional training courses may be requested by Distributor at Airspan's then current rates for such courses.\"}, {\"id\": \"19.2\", \"title\": \"Airspan agrees to provide Distributor at no additional charge with its standard package of documentation related to the\", \"level\": 2, \"text\": \"19.2 Airspan agrees to provide Distributor at no additional charge with its standard package of documentation related to the use, maintenance, and installation of Airspan Products. In the event that such documentation is modified during the term of this Agreement, Airspan agrees to provide to Distributor at no additional charge all such modifications. In addition to the documentation described above, Airspan agrees to provide at no additional charge reasonable amounts of sales materials such as brochures, press releases, and fact sheets. All documentation provided by Airspan to Distributor shall be in the English language. All translation of such documentation provided by Airspan will be at Distributor's sole expense. All such translations and advertising material not supplied by Airspan relating to Airspan Products and services will be submitted to Airspan for approval before publication or dissemination.\"}, {\"id\": \"20\", \"title\": \"CONFLICT OF INTEREST\", \"level\": 1, \"text\": \"20. CONFLICT OF INTEREST. Distributor confirms that it has revealed all information pertaining to possible conflicts of interest created by the sale of competing products or services or arising from other positions or contracts held by Distributor, and represents that no conflict of interest exists. Any future circumstances which could create possible conflicts of interest will be revealed to Airspan as soon as they become known by informing Airspan of any business relationships, circumstances, or situations which could prejudice in any way - -------------------------------------------------------------------------------- Page 22 the conduct of Airspan marketing activities according to the highest ethical and business standards, or place Airspan or Distributor in any kind of embarrassing situation.\"}, {\"id\": \"21\", \"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"21. MISCELLANEOUS.\"}, {\"id\": \"21.1\", \"title\": \"Pursuant to the Foreign Corrupt Practices Act of the United States of America, directors, officers, or employees of Dist\", \"level\": 2, \"text\": \"21.1 Pursuant to the Foreign Corrupt Practices Act of the United States of America, directors, officers, or employees of Distributor shall not offer or pay any bribe to any individual or corporation in connection with the provision or support of any Airspan Products obtained under this Agreement. When other individuals or organizations are required to participate in the sales program covered by this Agreement, they shall be compensated fairly based on the tasks performed. In no circumstances are public servants or holders of public office to be offered or paid any bribe or other benefit, direct or indirect. No contribution in any way related to Airspan shall be made to candidates for public office or to political parties or other political organizations, regardless of whether such contributions are permitted by the laws of the Territory. The parties agree that both parties will comply fully with all of the terms, conditions, rules, regulations and statutes of the Foreign Corrupt Practices Act. The parties further agree that if either party violates any of the provisions of said Act, the party violating the Act will indemnify the other party from any and all liability thereunder, including costs, expenses, fines or legal fees.\"}, {\"id\": \"21.2\", \"title\": \"In performing this Agreement, the parties shall comply with all applicable laws, rules, and regulations, and shall inde\", \"level\": 2, \"text\": \"21.2 In performing this Agreement, the parties shall comply with all applicable laws, rules, and regulations, and shall indemnify, defend and save each other harmless from said party's failure to do so. Furthermore, if this Agreement, the relationship created hereby or the performance hereof is determined by either party to be contrary either to (a) the laws, rules or regulations applicable to the parties; or (b) the parties' representations as set forth herein, this Agreement will be null and void from its inception. The parties have entered into this Agreement in material reliance on the following representations made by each party that: a. Neither this Agreement, the relationship created hereby nor the performance hereof is contrary to any applicable law, rule or regulation; b. The parties have not refunded and will not refund either directly or indirectly, any funds to any director, officer, employee or other representative of either party (or of any subsidiary controlled by or affiliated with either party) or to such party's family; and\"}, {\"id\": \"c\", \"title\": \"The parties represent and covenant that they have not made and will not commit themselves to make, nor will they\", \"level\": 1, \"text\": \"c. The parties represent and covenant that they have not made and will not commit themselves to make, nor will they directly or indirectly make, any payments in connection with the business of the parties to any director, officer, official, employee or shareholder of any governmental or private - -------------------------------------------------------------------------------- Page 23 customer, or prospective customer, or of any political party, or to such party's family, or that are otherwise illegal under applicable law. Distributor understands and agrees that Airspan will comply with any legal provision requiring disclosure of, or request from a government or governmental or private customer to disclose, by affidavit or otherwise, the identity of payments made or to be made to Distributor.\"}, {\"id\": \"21.3\", \"title\": \"Neither party may assign this Agreement or subcontract its obligations under this Agreement to another party without the\", \"level\": 2, \"text\": \"21.3 Neither party may assign this Agreement or subcontract its obligations under this Agreement to another party without the other party's prior, written consent executed by a duly authorized officer. The parties agree that if said assignment is to a subsidiary or affiliate organization, said consent to assignment will not be unreasonably withheld.\"}, {\"id\": \"21.4\", \"title\": \"This Agreement shall be construed in accordance with and governed by the laws of the State of South Dakota\", \"level\": 2, \"text\": \"21.4 This Agreement shall be construed in accordance with and governed by the laws of the State of South Dakota.\"}, {\"id\": \"21.5\", \"title\": \"Any dispute, controversy or claim between the parties arising out of, or in connection with, this Agreement, or the brea\", \"level\": 2, \"text\": \"21.5 Any dispute, controversy or claim between the parties arising out of, or in connection with, this Agreement, or the breach, termination or validity thereof will be resolved by mutual agreement of the parties, provided that this shall not limit the ability of the parties to seek temporary or interim injunctive relief in the event of any breach or threatened or impending breach of the confidentiality provisions of this Agreement. If any dispute, controversy, or claim arising out of or relating to this Agreement, or the breach, termination or validity thereof is unable to be resolved by mutual agreement of the parties, each of the parties hereby (i) agrees that any action, suit or proceeding with respect to this Agreement against it or its properties or revenues must be brought exclusively in the federal and state courts siting in Minneapolis, MN, and (ii) irrevocably submits to the exclusive jurisdiction of any such court and any appellate court from any order or judgment thereof in any such action, suit or proceeding. The parties hereby irrevocably agree that all claims in respect of such action, suit or proceeding may be heard and determined in such courts. The parties hereby irrevocably waive, to the fullest extent they may effectively do so, the defense of an inconvenient forum to the maintenance of such action, suit or proceeding. The parties agree that a final judgment in any such action, suit, or proceeding will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.\"}, {\"id\": \"21.6\", \"title\": \"The parties' failure to enforce at any time any of the provisions of this Agreement or any right with respect thereto, o\", \"level\": 2, \"text\": \"21.6 The parties' failure to enforce at any time any of the provisions of this Agreement or any right with respect thereto, or to exercise any option herein provided shall in no way be construed to be a waiver of such provision, rights, or options, or in any way to affect the validity of this Agreement. The parties' exercise of any of their rights hereunder or of any options hereunder under the terms or covenants herein shall not preclude or prejudice the parties from thereafter exercising the same or any right - -------------------------------------------------------------------------------- Page 24 which they may have under this Agreement, irrespective of any previous action or proceeding taken by either party hereunder.\"}, {\"id\": \"21.7\", \"title\": \"In the advertising and sale of Airspan products, Distributor will utilize Airspan's regular trade names and trademarks o\", \"level\": 2, \"text\": \"21.7 In the advertising and sale of Airspan products, Distributor will utilize Airspan's regular trade names and trademarks only as permitted or directed by Airspan, will not make or permit alteration or removal of any tags, labels, or other identifying marks placed by Airspan on its products, and will not use the name \\\"Airspan Communications Corporation\\\" or abbreviations thereof in Distributor's corporate titles or in any other way which might result in confusion as to Airspan and Distributor being separate and distinct entities. Distributor will not register any Airspan trademark.\"}, {\"id\": \"21.8\", \"title\": \"This Agreement shall be binding upon the parties, their heirs, successors in interest and permitted assigns\", \"level\": 2, \"text\": \"21.8 This Agreement shall be binding upon the parties, their heirs, successors in interest and permitted assigns.\"}, {\"id\": \"21.9\", \"title\": \"This Agreement and any attachment hereto shall be modified only by an instrument in writing and signed by duly-authorize\", \"level\": 2, \"text\": \"21.9 This Agreement and any attachment hereto shall be modified only by an instrument in writing and signed by duly-authorized officers or agents of the parties.\"}, {\"id\": \"21.10\", \"title\": \"All notices, requests, consents, and other communications hereunder must be in writing and will be deemed to have been p\", \"level\": 2, \"text\": \"21.10 All notices, requests, consents, and other communications hereunder must be in writing and will be deemed to have been properly given when actually received by the party to whom sent, at the following addresses: To: Airspan To: Distributor Airspan Networks Inc. GLS LLC 777 108 Th. Avenue NE 501 Fourth Street Suite 1895 PO Box 67 Bellevue, Washington Sergeant Bluff, IA 98004 51054 Attn: Peter Stanway Attn: Jon Winkel Contracts Manager Fax No. 919-319-0106\"}, {\"id\": \"21.11\", \"title\": \"The provisions of this Agreement are severable, and if any provision is held invalid or unenforceable in whole or in par\", \"level\": 2, \"text\": \"21.11 The provisions of this Agreement are severable, and if any provision is held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability will affect only such provision or part thereof in such - ------------------------------------------------------------------------------ Page 25 jurisdiction, and will not in any manner affect the provision in any other jurisdiction, or any other provision in this Agreement in any other jurisdiction.\"}, {\"id\": \"21.12\", \"title\": \"Distributor agrees not to publish any press releases or otherwise publicize the existence, or any of the terms, of this\", \"level\": 2, \"text\": \"21.12 Distributor agrees not to publish any press releases or otherwise publicize the existence, or any of the terms, of this Agreement without the prior written consent of Airspan, such consent not unreasonably to be withheld or delayed.\"}, {\"id\": \"22\", \"title\": \"This document constitutes the entire agreement between the parties with respect to the subject matter hereof, and supe\", \"level\": 1, \"text\": \"22. This document constitutes the entire agreement between the parties with respect to the subject matter hereof, and supersedes all previous communications, representations, understandings, and agreements, either oral or written, between the parties or any official or Distributor thereof with respect to the subject matter hereof. - -------------------------------------------------------------------------------- Page 26 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the Effective Date, such parties acting by their officers, being thereunto duly authorized. Airspan Networks Inc. GLS LLC By: _______________________________ By: ______________________________ Name: ______________________________ Name: _____________________________ Title: ______________________________ Title: ____________________________ Page 27\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of AIRSPANNETWORKSINC_04_11_2000-EX-10.5-Distributor Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.5\", \"level\": 1, \"text\": \"Exhibit 10.5 Note: Portions of this exhibit indicated by\\\"[*]\\\" are subject to a confidential treatment request, and have been omitted from this exhibit. Complete, unredacted copies of this exhibit have been filed with the Securities and Exchange Commission as part of this Company's confidential treatment request. Distributor Agreement --------------------- This Distributor Agreement (the \\\"Agreement\\\") is made effective as of the 31st day of March, 2000 (the \\\"Effective Date\\\"), by and between Airspan Networks Incorporated, a company incorporated under the laws of the State of Washington having its principal office at 777 108th Avenue NE, Suite 1895, Bellevue, Washington 98004 (\\\"Airspan\\\") and GLS LLC, (\\\"Distributor\\\") a limited liability company incorporated under the laws of the State of South Dakota having its principal office at 501 Fourth Street, Sergeant Bluff, IA 51054. WITNESSETH: WHEREAS, Airspan is engaged in the design and manufacture of various telecommunications product lines, including, among others, those product lines more completely described in Schedule I hereto (the product lines described in Schedule I, as from time to time amended in accordance with the provisions of this Agreement, are hereinafter called the \\\"Airspan Products\\\") the hardware components thereof are sometimes referred to separately as \\\"Equipment,\\\" the software components thereof are sometimes referred to separately as \\\"Software\\\" as defined in Section 11.1, and an arrangement of Equipment which, when interfaced with Software, is operable to perform predetermined functions, is referred to as a \\\"System\\\"); WHEREAS, Distributor is engaged in the promotion of sales of telecommunications products; and WHEREAS, Airspan desires to appoint Distributor as a Distributor for the Airspan Products for the territory described in Schedule II hereto (the \\\"Territory\\\"). NOW, THEREFORE, in consideration of the mutual promises herein contained, it is hereby agreed as follows:\"}}, {\"id\": \"party:Airspan Networks Incorporated\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Airspan Networks Incorporated\", \"role\": \"Airspan\", \"address\": \"777 108th Avenue NE, Suite 1895, Bellevue, Washington 98004\"}}, {\"id\": \"party:GLS LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"GLS LLC\", \"role\": \"Distributor\", \"address\": \"501 Fourth Street, Sergeant Bluff, IA 51054\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Distributor Agreement\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the 31st day of March, 2000\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Airspan Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Airspan Products\", \"text\": \"the product lines described in Schedule I, as from time to time amended in accordance with the provisions of this Agreement\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Equipment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Equipment\", \"text\": \"the hardware components thereof\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System\", \"text\": \"an arrangement of Equipment which, when interfaced with Software, is operable to perform predetermined functions\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the territory described in Schedule II hereto\", \"definition_clause\": \"para_1\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT. -----------\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributo\", \"level\": 2, \"text\": \"1.1 Subject to the provisions of this Agreement, Airspan hereby appoints Distributor as an independent, exclusive distributor to assist Airspan in marketing the Airspan Products to customers in the Territory, and Distributor hereby accepts such appointment as of the Effective Date of this Agreement. Distributor's appointment as a distributor of the Airspan Products grants to Distributor only a license to resell the - ------------------------------------------------------------------------------- Page 1 Airspan Products to Distributor's customers in the Territory, and does not transfer any right, title, or interest in any of the Airspan Software to Distributor.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitu\", \"level\": 2, \"text\": \"1.2 Distributor's relationship to Airspan is that of an independent contractor, and nothing in this Agreement shall constitute Distributor as the agent or employee of Airspan. Distributor shall have no authority to accept any order or make any offer (except as herein stated), or execute any instrument or make any commitment on behalf of Airspan. Specifically, without in any way limiting the generality of the foregoing, Distributor agrees not to make any representation, guarantee, or warranty on Airspan's behalf concerning the Airspan Products, but will refer customers to Airspan's printed literature. Nothing contained in this Agreement is to be construed as a limitation or restriction upon Airspan in the sale or other disposition of any of its products to any person, firm, or corporation inside or outside of the Territory. Airspan will pay no commissions under this Agreement. Distributor's compensation is to be obtained solely by the difference between the price Distributor pays to Airspan and the price Distributor charges its customers. The parties also acknowledge that this Agreement is not intended to create a joint venture or partnership between Airspan and Distributor.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such\", \"level\": 2, \"text\": \"1.3 Distributor will use its best efforts to maintain and support the Airspan Products within the Territory by devoting such attention, time, and effort as may be reasonably necessary to fully develop the available market potential. During the term of this Agreement, and for a period of three (3) months following the expiration or termination of this Agreement, Distributor agrees that neither it nor any organization or entity controlled or directed by it will, without Airspan's prior, written consent, represent a manufacturer or supplier of products similar in design or performance to or which are of such a nature as to be competitive with any products contained in the Airspan Products, nor will Distributor market or otherwise promote the sale of such products. Distributor will give Airspan thirty (30) days' prior, written notice of each new potential representation role being considered by Distributor, and Distributor will not undertake such representation without Airspan's prior, written consent, such consent not to be unreasonably withheld. Except as provided above, in no event will Airspan consent to Distributor's consultation for or representation of a manufacturer or supplier, which is directly or indirectly, a competitor of Airspan.\"}}, {\"id\": \"value:three (3) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) months\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall maintain a place of business at the location specified in Section 21\", \"level\": 2, \"text\": \"1.4 Distributor shall maintain a place of business at the location specified in Section 21.10 where Distributor can be contacted by Airspan, customers, and prospective customers during regular business hours with a permanent mailing address and an accessible cellular telephone, and will provide Airspan with written notice promptly upon any change in address. Distributor agrees to assume all of the expenses of this place of business, including rent, stenographic services, and all other expenses except as specifically assumed in writing by Airspan. - -------------------------------------------------------------------------------- Page 2\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan will provide Distributor with such commercial and technical assistance and training as may reasonably be necessa\", \"level\": 2, \"text\": \"1.5 Airspan will provide Distributor with such commercial and technical assistance and training as may reasonably be necessary, in Airspan's sole judgment, to enable Distributor to effectively carry out its activities under this Agreement and, in connection therewith, to provide such sales promotional materials, as Airspan may deem appropriate. Airspan will provide such technical support as is reasonable and necessary to maintain the product line as a viable competitor in the market.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES\", \"level\": 1, \"text\": \"2. REPRESENTATIONS AND WARRANTIES. Distributor hereby represents and warrants as follows: a. Distributor has been duly registered in accordance with any and all relevant legislation, has received any and all necessary governmental authorizations to enter into and perform its obligations under this Agreement, and that its entry into and performance under this Agreement will not violate applicable legislation; b. Distributor is duly registered with all necessary tax authorities and is in compliance with all payment obligations in accordance with applicable legislation. No claims against or investigations of Distributor with respect to its tax obligations exist;\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor is not currently involved in any litigation, arbitration, or other legal proceedings in which claims are\", \"level\": 1, \"text\": \"c. Distributor is not currently involved in any litigation, arbitration, or other legal proceedings in which claims are being asserted against Distributor which might affect its ability to perform its obligations under this Agreement, nor is Distributor aware of any unasserted claims against Distributor of this nature; and\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's bank accounts have been established and operated in accordance with applicable legislation\", \"level\": 1, \"text\": \"d. Distributor's bank accounts have been established and operated in accordance with applicable legislation. All transactions of Distributor required to be carried out through authorized banks have been so carried out. Distributor is not, has not, and warrants that it will not breach any currency regulation or currency control legislation. Distributor further warrants that it is not, has not, and will not breach any bank secrecy act, rules or regulations.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SERVICES\", \"level\": 1, \"text\": \"3. SERVICES.\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In addition to the above, the Distributor will perform the following services under this Agreement\", \"level\": 2, \"text\": \"3.1 In addition to the above, the Distributor will perform the following services under this Agreement: a. In cooperation with Airspan, identify potential customers and project opportunities within the Territory that will lead to sales/licenses of Airspan Products and services; b. Prepare reports on the opportunities that will include: (1) description of the project; (2) assessment of the appropriate fit to Airspan Products and - -------------------------------------------------------------------------------- Page 3 services; (3) dollar size and timing of the project; (4) competitive assessment; and (5) identification of key decision makers and other technical and commercial contacts;\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will use its best efforts to vigorously and aggressively promote the sale of Airspan Products within th\", \"level\": 2, \"text\": \"3.2 Distributor will use its best efforts to vigorously and aggressively promote the sale of Airspan Products within the Territory. Such efforts shall include, but shall not be limited to, that advertising within the Territory which is reasonably necessary. All such advertising shall follow the general statements made in advertising prepared by Airspan. All advertising shall contain a prominent reference to Airspan, indicating the actual commercial origin of Airspan Products so advertised. Distributor shall not make any claims in its advertising which exceed or contradict claims made by Airspan in its printed materials.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will train and maintain a sufficient number of technical and sales personnel in order to\", \"level\": 2, \"text\": \"3.3 Distributor will train and maintain a sufficient number of technical and sales personnel in order to: (a) serve the demands and needs of its customers for Airspan Products, service, and support; and (b) carry out the obligations of Distributor under this Agreement.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor and its staff will be conversant with the technical language related to Airspan Products and will devel\", \"level\": 2, \"text\": \"3.4 Distributor and its staff will be conversant with the technical language related to Airspan Products and will develop sufficient knowledge of the industry, Airspan Products, and products competitive with Airspan Products (including specifications, features, and benefits) so as to be able to explain in detail to customers the differences between Airspan Products and competitive products. Distributor will conduct or provide for any training of its personnel which may be necessary to impart such knowledge.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor and its staff will research the technical requirements and specifications of the market for Airspan Pro\", \"level\": 2, \"text\": \"3.5 Distributor and its staff will research the technical requirements and specifications of the market for Airspan Products in the Territory and make information known to Airspan such that Airspan may, at its discretion, implement appropriate technical changes to the Products to enable them to be sold in the Territory. Airspan acknowledges that, subject to a further and separate Agreement, such changes may be implemented in the future by Distributor, with the assistance of Airspan. - ------------------------------------------------------------------------------ Page 4\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees to purchase and stock a comprehensive inventory of spare parts based upon the recommended list s\", \"level\": 2, \"text\": \"3.6 Distributor agrees to purchase and stock a comprehensive inventory of spare parts based upon the recommended list set forth in Schedule III to this Agreement.\"}}, {\"id\": \"3.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees to provide to its customers' installation services for all Airspan Products\", \"level\": 2, \"text\": \"3.7 Distributor agrees to provide to its customers' installation services for all Airspan Products. All such installation services shall be performed by Distributor in accordance with Airspan's latest installation standards as provided by Airspan.\"}}, {\"id\": \"3.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees to train and have readily available a maintenance staff to efficiently and expeditiously maintai\", \"level\": 2, \"text\": \"3.8 Distributor agrees to train and have readily available a maintenance staff to efficiently and expeditiously maintain or upgrade all Airspan Products purchased or licensed by Distributor from Airspan. Maintenance shall be performed in accordance with Airspan's latest maintenance standards for Airspan Products, as provided by Airspan, by Distributor's own personnel and may not be subcontracted or delegated to any other person or entity without Airspan's prior, written authorization.\"}}, {\"id\": \"3.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees to provide and maintain those facilities adequate to meet the obligations set forth in this sect\", \"level\": 2, \"text\": \"3.9 Distributor agrees to provide and maintain those facilities adequate to meet the obligations set forth in this section and of the Agreement. Distributor further agrees to provide all of the sales and support functions set forth in this section at no charge to Airspan.\"}}, {\"id\": \"3.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees not to actively seek to promote, rent, lease, sell, sublicense or authorize the rental, sale or\", \"level\": 2, \"text\": \"3.10 Distributor agrees not to actively seek to promote, rent, lease, sell, sublicense or authorize the rental, sale or sublicense of Airspan Products outside of the Territory [without the prior written approval of Airspan], but nothing in this Agreement shall prevent Distributor from renting, selling or sublicensing the Airspan Products to customers outside of the Territory in response to an unsolicited request from such customer.\"}}, {\"id\": \"3.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the term of this Agreement Distributor agrees that neither it nor any organization or entity controlled or d\", \"level\": 2, \"text\": \"3.11 During the term of this Agreement Distributor agrees that neither it nor any organization or entity controlled or directed by it will, without Airspan's prior, written consent, represent a manufacturer or supplier of products similar in design or performance to or which are of such a nature as to be competitive with any products contained in the Airspan Products.\"}}, {\"id\": \"3.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties mutually agree that by April 30, 2000, the parties will negotiate and execute a National Accounts Consu\", \"level\": 2, \"text\": \"3.12 The parties mutually agree that by April 30, 2000, the parties will negotiate and execute a National Accounts Consulting Agreement whereby the Distributor will receive consulting fees and commissions for the sale and deployment of Airspan's products on a national basis. It is the intent of the parties to jointly pursue the sale of products to said companies and to enter into and complete contracts for the deployment of products in this manner. - -------------------------------------------------------------------------------- Page 5\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDERING PROCEDURE\", \"level\": 1, \"text\": \"4. ORDERING PROCEDURE.\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following procedures shall be followed with respect to each purchase order issued by Distributor\", \"level\": 2, \"text\": \"4.1 The following procedures shall be followed with respect to each purchase order issued by Distributor: a. During the Term, Distributor will inform Airspan of its intent to purchase Equipment and Installation Services (but only if Airspan expressly agrees to perform such Installation Services) and to license Software, by sending to Airspan a written order. This written order (the \\\"Purchase Order\\\") will state the type of Equipment, System, or Installation Services that Distributor wants to purchase and the Software Distributor wants to license, the price of the ordered items (the \\\"Contract Price\\\") as set forth in Schedule IV, \\\"Price List\\\" (which is hereby incorporated by reference) and the proposed delivery and installation dates, if applicable. b. Each Purchase Order shall specifically incorporate by reference the terms and conditions of this Agreement, and no additional or different terms and conditions stated in a Purchase Order, any letter, or otherwise shall be binding unless expressly referred and agreed to by Airspan in writing. In the event of a conflict between the terms and conditions of this Agreement and of any Purchase Order issued hereunder, or if the Purchase Order does not reference the terms and conditions of this Agreement, the terms and conditions of this Agreement shall control.\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"This written order\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:Contract Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract Price\", \"text\": \"the price of the ordered items\", \"definition_clause\": \"4.1\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If a Purchase Order is accepted by Airspan, Airspan will issue an order acknowledgment to Distributor within five (\", \"level\": 2, \"text\": \"4.2 If a Purchase Order is accepted by Airspan, Airspan will issue an order acknowledgment to Distributor within five (5) business days of Airspan's receipt of the written Purchase Order from Distributor.\"}}, {\"id\": \"value:five (5) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) business days\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RECORDS AND REPORTING\", \"level\": 1, \"text\": \"5. RECORDS AND REPORTING.\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"At Airspan's request, within fifteen (15) days of the end of each calendar month, Distributor will provide to Airsp\", \"level\": 2, \"text\": \"5.1 At Airspan's request, within fifteen (15) days of the end of each calendar month, Distributor will provide to Airspan a written report showing, for the just-ended calendar month: (a) Distributor's shipments of Airspan Products by dollar volume, both in the aggregate and for such categories as Airspan may designate from time to time; (b) forecasts of Distributor's anticipated orders by product; (c) Distributor's current inventory levels of Airspan Products, in the aggregate and by product; and (d) any other information which Airspan may reasonably request.\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will promptly advise Airspan concerning any market information which comes to Distributor's attention r\", \"level\": 2, \"text\": \"5.2 Distributor will promptly advise Airspan concerning any market information which comes to Distributor's attention regarding Airspan, Airspan Products, Airspan's market position, or the continued competitiveness of Airspan Products in the marketplace. Distributor will confer with Airspan from - -------------------------------------------------------------------------------- Page 6 time to time, at Airspan's request, on matters relating to market conditions, distribution forecasting, and product planning.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For at least two (2) years after termination of this Agreement, Distributor will maintain its records, contracts, a\", \"level\": 2, \"text\": \"5.3 For at least two (2) years after termination of this Agreement, Distributor will maintain its records, contracts, and accounts relating to distribution of Airspan Products, and will permit examination thereof by authorized representatives of Airspan at all reasonable times.\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONTRACT PRICE\", \"level\": 1, \"text\": \"6. CONTRACT PRICE\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Contract Price for each item of Equipment, Installation Services, or Software is as specified in Schedule IV an\", \"level\": 2, \"text\": \"6.1 The Contract Price for each item of Equipment, Installation Services, or Software is as specified in Schedule IV and shall be paid to Airspan in US Dollars (US$) free of any withholding tax and of any currency controls or other restrictions. The Contract Price includes: a. The price of the Equipment; b. The fee for the licensing of the Software;\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Contract Price is shown in Schedule IV and shall include applicable duties, taxes or imposts, including all exp\", \"level\": 2, \"text\": \"6.2 The Contract Price is shown in Schedule IV and shall include applicable duties, taxes or imposts, including all export or import duties. Sales taxes and contractor's excise taxes shall be itemized on all Purchase Orders. The parties agree that the Contract Price in Schedule IV shall be firm for a minimum period of twenty-four (24) months from the Effective Date. After the above period of twenty-four (24) months, Exhibit B may be revised by Airspan giving thirty (30) days written notice to Distributor.\"}}, {\"id\": \"value:twenty-four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) months\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT TERMS\", \"level\": 1, \"text\": \"7. PAYMENT TERMS.\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan will issue an invoice (the \\\"Invoice\\\") to Distributor in accordance with the payment terms below\", \"level\": 2, \"text\": \"7.1 Airspan will issue an invoice (the \\\"Invoice\\\") to Distributor in accordance with the payment terms below. The Invoice specifically will identify the Equipment, Software, or other items shipped, and the Contract Price of such items. Any Installation Services or other services provided by Airspan will be invoiced separately following completion of such services. The Invoice also shall state the total due to Airspan from Distributor (the \\\"Invoice Total\\\"), which shall include the Contract Price, and any applicable taxes, duties, and other fees due pursuant to Section 6 of this Agreement. Payment of the Invoice Total is due (without any right of set-off) Net forty-five (45) days after the date of invoice.\"}}, {\"id\": \"term:Invoice\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Invoice\", \"text\": \"an invoice\", \"definition_clause\": \"7.1\"}}, {\"id\": \"term:Invoice Total\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Invoice Total\", \"text\": \"the total due to Airspan from Distributor\", \"definition_clause\": \"7.1\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Distributor disputes any invoice or part thereof, Distributor must notify Airspan in writing within twenty-five\", \"level\": 2, \"text\": \"7.2 If Distributor disputes any invoice or part thereof, Distributor must notify Airspan in writing within twenty-five (25) days of the invoice date giving details of the reason for such dispute. - ------------------------------------------------------------------------------- Page 8 Distributor and Airspan agree to work together in good faith to resolve the dispute as quickly as possible. Distributor may withhold payment of such disputed amounts until resolution of the dispute. Any parts of the invoice not under dispute shall be paid net forty-five (45) days after the date of invoice. On resolution of the dispute, Distributor shall immediately pay any amounts due in full.\"}}, {\"id\": \"value:twenty-five (25) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-five (25) days\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will make payment by wire or telegraphic transfer to the bank account set forth below or, on receipt of\", \"level\": 2, \"text\": \"7.3 Distributor will make payment by wire or telegraphic transfer to the bank account set forth below or, on receipt of written notification from Airspan, to another designated bank within the United States. Bank: Seafirst Bank, 10555 N.E. 8th, Bellevue, WA98004, USA. Account name: Airspan Networks Inc. Account number: 68777507 Routing Number: 125 - 0000 - 24 Further instructions: \\\"Reference (Distributor's name), Purchase Order number, Payment of Invoice number\\\" Payment will be deemed to have been made upon receipt of funds in Airspan's bank.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If the cost to Airspan of performing this Agreement increases as a result of any change to the law or increase in i\", \"level\": 2, \"text\": \"7.4 If the cost to Airspan of performing this Agreement increases as a result of any change to the law or increase in import duty or freight duty, Airspan may, at any time, add such increase to the Contract Price by notifying Distributor in writing of such increase.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DELIVERY, TITLE AND RISK OF LOSS\", \"level\": 1, \"text\": \"8. DELIVERY, TITLE AND RISK OF LOSS.\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All Equipment and Software will be delivered by Airspan CIP (as defined in Incoterms 2000) to an airport in South D\", \"level\": 2, \"text\": \"8.1 All Equipment and Software will be delivered by Airspan CIP (as defined in Incoterms 2000) to an airport in South Dakota that completes international customs clearances and shipped to a location within the city limits of the above arrival airport, such airport and delivery location are to be agreed upon in writing by the parties for each Purchase Order. Airspan will be responsible for and pay all packing, shipping, freight, and insurance charges to the agreed upon location within the city limits. If requested by Distributor, Airspan may arrange for shipment to be made to Distributor's identified warehouse facilities or freight forwarder outside of the city limits, subject to approval in writing by Airspan and agreement to any additional charges in advance of shipment. Unless specified in the Purchase Order, Airspan will select the mode of shipment and the carrier. In this Agreement, \\\"Incoterms\\\" means the most recent international rules for the interpretation of trade terms published by the International Chamber of Commerce as in force on the Effective Date. Unless the context otherwise requires, any term or expression which is defined in or given a particular meaning by the provisions of the Incoterms shall have the same meaning in this - -------------------------------------------------------------------------------- Page 9 Agreement, but if there is any conflict between the provisions of the Incoterms and this Agreement, the latter shall prevail.\"}}, {\"id\": \"term:Incoterms\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Incoterms\", \"text\": \"the most recent international rules for the interpretation of trade terms published by the International Chamber of Commerce as in force on the Effective Date\", \"definition_clause\": \"8.1\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All risk of loss or damage to the Equipment and Software will pass to Distributor on collection by the freight forw\", \"level\": 2, \"text\": \"8.2 All risk of loss or damage to the Equipment and Software will pass to Distributor on collection by the freight forwarder from Airspan. However, Airspan will insure the Equipment against loss or damage in transit to the agreed to location as set forth in the Purchase Order within the city limits of the arrival airport as set forth in Paragraph 8.1.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Title to the Equipment shall pass to Distributor on collection by the freight forwarder from Airspan\", \"level\": 2, \"text\": \"8.3 Title to the Equipment shall pass to Distributor on collection by the freight forwarder from Airspan.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Distributor has any Airspan owned Equipment in its possession\", \"level\": 2, \"text\": \"8.4 If Distributor has any Airspan owned Equipment in its possession: a. Distributor shall ensure that Equipment is clearly marked as the property of Airspan, and if asked, shall inform any third parties that the Equipment is the property of Airspan; b. Distributor shall not purport to create any security, mortgage, lien or pledge over the Equipment, or otherwise deal with the Equipment without Airspan's written consent;\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Software shall at all times remain the exclusive property of Airspan, subject to the uses provided herein\", \"level\": 2, \"text\": \"8.5 The Software shall at all times remain the exclusive property of Airspan, subject to the uses provided herein.\"}}, {\"id\": \"8.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unless Distributor clearly advises Airspan to the contrary in writing, Airspan may make partial deliveries on accou\", \"level\": 2, \"text\": \"8.6 Unless Distributor clearly advises Airspan to the contrary in writing, Airspan may make partial deliveries on account of Purchase Orders. Delay in delivery of any installment shall not relieve Distributor of its obligation to accept said installment, provided that said delay does not exceed sixty (60) days from Airspan's scheduled ship date and unless Distributor has clearly advised Airspan to cancel the delayed installment in writing at least fifteen (15) days prior to its revised planned shipment date or its actual shipment date by Airspan.\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"8.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan will use reasonable efforts to meet Distributor's requested delivery schedules for Equipment and Software,\", \"level\": 2, \"text\": \"8.7 Airspan will use reasonable efforts to meet Distributor's requested delivery schedules for Equipment and Software, but Airspan reserves the right to refuse, or delay delivery to Distributor when Distributor's credit is impaired, - -------------------------------------------------------------------------------- Page 10 when Distributor is delinquent in payments or fails to meet other credit or financial requirements reasonably established by Airspan, or when Distributor has failed to perform its obligations under this Agreement.\"}}, {\"id\": \"8.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Should orders for Equipment and Software exceed Airspan's available inventory, Airspan will allocate its available\", \"level\": 2, \"text\": \"8.8 Should orders for Equipment and Software exceed Airspan's available inventory, Airspan will allocate its available inventory and make deliveries on a basis that Airspan deems equitable, in its sole discretion, and without liability to Distributor on account of the method of allocation chosen or its implementation. In any event, Airspan shall not be liable for any direct, indirect, consequential, or special losses or damages (including, but not limited to, loss of income or profit and loss of data) that may be suffered by the Distributor or by any other person for failure to deliver or for any delay or error in delivery of Equipment or Software for any reason whatsoever.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS AND COPYRIGHTS\", \"level\": 1, \"text\": \"9. TRADEMARKS AND COPYRIGHTS.\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor acknowledges Airspan's exclusive right, title, and interest in and to any trademarks, trade names, logos and\", \"level\": 2, \"text\": \"9.1 Distributor acknowledges Airspan's exclusive right, title, and interest in and to any trademarks, trade names, logos and designations which Airspan may at any time have adopted, used, or registered in the United States of America and in the Territory (the \\\"Trademarks\\\"), and will not at any time do or cause to be done any act or thing contesting or in any way impairing or tending to impair any part of said right, title, and interest. In connection with any reference to the Trademarks, Distributor shall not in any manner represent that it has an ownership interest in the Trademarks or registration(s) thereof, and Distributor acknowledges that no action by it or on its behalf shall create in Distributor's favor any right, title, or interest in or to the Trademarks.\"}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"any trademarks, trade names, logos and designations which Airspan may at any time have adopted, used, or registered in the United States of America and in the Territory\", \"definition_clause\": \"9.1\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor recognizes the validity of Airspan's copyright in any written material to which Airspan shall have made a cl\", \"level\": 2, \"text\": \"9.2 Distributor recognizes the validity of Airspan's copyright in any written material to which Airspan shall have made a claim to copyright protection, and Distributor specifically recognizes Airspan's exclusive right to copyright protection and/or registration of any translation of any advertising, promotional, or descriptive material furnished to Distributor by Airspan.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Whenever Distributor refers to the Trademarks in advertising or in any other manner to identify the products, Distributo\", \"level\": 2, \"text\": \"9.3 Whenever Distributor refers to the Trademarks in advertising or in any other manner to identify the products, Distributor shall clearly indicate Airspan's ownership of the Trademarks and before distributing or publishing any advertising, descriptive, or promotional materials, Distributor shall affirmatively provide Airspan with an opportunity to inspect and approve such materials.\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees that when referring to the Trademarks, it shall diligently comply with all laws pertaining to the Tra\", \"level\": 2, \"text\": \"9.4 Distributor agrees that when referring to the Trademarks, it shall diligently comply with all laws pertaining to the Trademarks at any time in force in the Territory. - -------------------------------------------------------------------------------- Page 11\"}}, {\"id\": \"9.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall promptly notify Airspan of any and all infringements, imitations, illegal uses, or misuses of the Trad\", \"level\": 2, \"text\": \"9.5 Distributor shall promptly notify Airspan of any and all infringements, imitations, illegal uses, or misuses of the Trademarks which come to Distributor's attention. Distributor also agrees that it shall not at any time take any action in the courts or before the administrative agencies of the Territory or otherwise to prevent the infringement, imitation, illegal use, or misuse of the Trademarks, it being clearly understood by Distributor that such action falls wholly within the authority of Airspan as sole owner of the Trademarks.\"}}, {\"id\": \"9.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees to render to Airspan all assistance in connection with any matter pertaining to the protection of the\", \"level\": 2, \"text\": \"9.6 Distributor agrees to render to Airspan all assistance in connection with any matter pertaining to the protection of the Trademarks, whether in the courts or before the administrative agencies of the Territory or otherwise, and to make promptly available to Airspan, its Distributors, and attorneys all of Distributor's files, records, and other information pertaining to the advertising, promotion, and sale of the Airspan Products. All assistance requested by Distributor in this paragraph shall be at AIRSPAN's expense. This Expense includes costs, attorneys' and consultants' fees, and reimbursement of time spent by officers, agents and employees of Distributor.\"}}, {\"id\": \"9.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees and undertakes that it will not at any time, whether during the term of this Agreement or after its e\", \"level\": 2, \"text\": \"9.7 Distributor agrees and undertakes that it will not at any time, whether during the term of this Agreement or after its expiration or termination, adopt, use, or register without Airspan's prior, written consent any work or symbol or combination thereof which is similar to any of the Trademarks.\"}}, {\"id\": \"9.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the advertising and sale of Airspan Products, Distributor may use the Trademarks in relation to those Airspan Product\", \"level\": 2, \"text\": \"9.8 In the advertising and sale of Airspan Products, Distributor may use the Trademarks in relation to those Airspan Products. Distributor will not make or permit the alteration or removal of any tags, labels, or other identifying marks placed by Airspan on Airspan Products. Distributor will not use or give any third party permission to use the Trademarks. Distributor will not use, or give any third party permission to use, the names \\\"Airspan Communications Ltd.\\\", \\\"Airspan Networks Incorporated\\\", \\\"ACL\\\", \\\"ANI\\\" or abbreviations or derivations thereof in Distributor's corporate titles, or in any way which might result in confusion as to Airspan and Distributor being separate and distinct entities. Distributor admits Airspan's exclusive ownership of the name \\\"Airspan Networks Incorporated\\\", \\\"Airspan Communications Ltd.\\\", \\\"ANI\\\", \\\"ACL\\\", and any abbreviations or derivations thereof and all of Airspan's Trademarks (whether registered or not). Distributor shall not take any action inconsistent with Airspan's ownership of such Trademarks; therefore, Distributor shall treat all of Airspan's items distinctively (as to typography) and shall only use exact reproductions of all Airspan's symbols (including Airspan's logo). Distributor shall not adopt or use any Trademark or product name which may be confusingly similar to any Airspan Trademark. Distributor may use the Airspan logo as it appears on Airspan's letterhead.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION AND TRADE SECRETS\", \"level\": 1, \"text\": \"10. CONFIDENTIAL INFORMATION AND TRADE SECRETS. - ------------------------------------------------------------------------------- Page 12\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In this Agreement, the term \\\"Confidential Information\\\" shall mean the information of Airspan disclosed to Distributor in\", \"level\": 2, \"text\": \"10.1 In this Agreement, the term \\\"Confidential Information\\\" shall mean the information of Airspan disclosed to Distributor in connection with its performance under this Agreement, which is in written, recorded, photographic, machine-readable, or other physical form or oral information reduced to writing as soon as practicable after disclosure to Distributor, and which is conspicuously marked \\\"Confidential\\\", \\\"Proprietary\\\", \\\"Private\\\", or in any other manner indicating its confidential and/or proprietary nature. Without limitation, Confidential Information includes: (1) Airspan's software products, materials, data reports, programs, documentation, diagrams, and all related technical information; (2) all information relating to Airspan's business and products which is critical to Airspan's position in the marketplace, including future plans of Airspan relating to the fields of endeavor in which Distributor performs services for Airspan, the nature of certain work projects to which Distributor is exposed, and the identity of persons working on those projects; and (3) any improvements, enhancements, or modifications to the above made by or on behalf of Airspan during the performance under this Agreement which are provided, made available, or disclosed by or on behalf of Airspan to Distributor, or used by Airspan or any of Airspan's other Distributors in connection with their own sales activities.\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"the information of Airspan disclosed to Distributor in connection with its performance under this Agreement, which is in written, recorded, photographic, machine-readable, or other physical form or oral information reduced to writing as soon as practicable after disclosure to Distributor, and which is conspicuously marked \\\"Confidential\\\", \\\"Proprietary\\\", \\\"Private\\\", or in any other manner indicating its confidential and/or proprietary nature. Without limitation, Confidential Information includes: (1) Airspan's software products, materials, data reports, programs, documentation, diagrams, and all related technical information; (2) all information relating to Airspan's business and products which is critical to Airspan's position in the marketplace, including future plans of Airspan relating to the fields of endeavor in which Distributor performs services for Airspan, the nature of certain work projects to which Distributor is exposed, and the identity of persons working on those projects; and (3) any improvements, enhancements, or modifications to the above made by or on behalf of Airspan during the performance under this Agreement which are provided, made available, or disclosed by or on behalf of Airspan to Distributor, or used by Airspan or any of Airspan's other Distributors in connection with their own sales activities.\", \"definition_clause\": \"10.1\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trade secrets are confidential information that includes ideas, concepts, techniques, processes, inventions, knowledge,\", \"level\": 2, \"text\": \"10.2 Trade secrets are confidential information that includes ideas, concepts, techniques, processes, inventions, knowledge, and know-how developed by Airspan which: (1) derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and (2) is subject to the efforts of Airspan that are reasonable under the circumstances to maintain its secrecy. (This \\\"trade secret\\\" language comes from the Uniform Trade Secrets Act.)\"}}, {\"id\": \"term:Trade secrets\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trade secrets\", \"text\": \"confidential information that includes ideas, concepts, techniques, processes, inventions, knowledge, and know-how developed by Airspan which: (1) derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and (2) is subject to the efforts of Airspan that are reasonable under the circumstances to maintain its secrecy.\", \"definition_clause\": \"10.2\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor covenants and agrees that it will use the Confidential Information solely for the performance of services un\", \"level\": 2, \"text\": \"10.3 Distributor covenants and agrees that it will use the Confidential Information solely for the performance of services under this Agreement, and shall not disclose such Confidential Information to any other person (including Airspan employees in any other division, group, or entity), firm, or corporation.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall use the same degree of care in safeguarding the Confidential Information as it uses for its own confid\", \"level\": 2, \"text\": \"10.4 Distributor shall use the same degree of care in safeguarding the Confidential Information as it uses for its own confidential information of like importance, but no less than reasonable care. Upon discovery of any disclosure or misuse of Confidential Information, Distributor shall endeavor to prevent any further disclosure or misuse.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All Confidential Information shall remain the property of Airspan, and such Confidential Information and all copies ther\", \"level\": 2, \"text\": \"10.5 All Confidential Information shall remain the property of Airspan, and such Confidential Information and all copies thereof shall promptly be returned to Airspan upon request or, at Airspan 's option, destroyed, in which case Airspan shall be notified in writing when it has been destroyed. - -------------------------------------------------------------------------------- Page 13\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing contained in this Agreement shall be construed as granting to or conferring upon Distributor any rights, by lice\", \"level\": 2, \"text\": \"10.6 Nothing contained in this Agreement shall be construed as granting to or conferring upon Distributor any rights, by license or otherwise, express or implied, in Airspan's Confidential Information, other than the right to use the Confidential Information for the purpose of this Agreement.\"}}, {\"id\": \"10.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any copies of the Confidential Information made by Distributor shall reproduce proprietary marking and legends included\", \"level\": 2, \"text\": \"10.7 Any copies of the Confidential Information made by Distributor shall reproduce proprietary marking and legends included therein, but the provisions of this Agreement supersede any provisions of such legends inconsistent herewith.\"}}, {\"id\": \"10.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The terms and conditions of this Agreement shall not be disclosed by Distributor to others, except with the prior, writt\", \"level\": 2, \"text\": \"10.8 The terms and conditions of this Agreement shall not be disclosed by Distributor to others, except with the prior, written consent of Airspan, or as may be required by law or as necessary to establish its rights hereunder.\"}}, {\"id\": \"10.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If, in connection with its performance, Distributor discloses to Airspan any ideas, developments, or inventions conceive\", \"level\": 2, \"text\": \"10.9 If, in connection with its performance, Distributor discloses to Airspan any ideas, developments, or inventions conceived or actually reduced to practice by Distributor prior to its performance hereunder, no relationship, confidential or otherwise, express or implied, is established with Airspan by the disclosure thereof. With respect to any such disclosure, no obligation of any kind is assumed by nor may be implied against Airspan, its subsidiary, or associated companies unless a formal, separate, written contract regarding the subject of disclosure is consummated by the parties, and then the obligation shall be only as expressed in the separate contract.\"}}, {\"id\": \"10.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees that any breach of the provisions of this Section by Distributor or Distributor's personnel, agents,\", \"level\": 2, \"text\": \"10.10 Distributor agrees that any breach of the provisions of this Section by Distributor or Distributor's personnel, agents, or subcontractors, or any third party providing products or services to Distributor will cause immediate and irreparable injury to Airspan and that, in the event of such breach, Airspan shall be entitled to injunctive relief and any and all other remedies available at law or in equity.\"}}, {\"id\": \"10.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"After Distributor has received Airspan's Confidential Information and know-how, it will be impossible to segregate Airsp\", \"level\": 2, \"text\": \"10.11 After Distributor has received Airspan's Confidential Information and know-how, it will be impossible to segregate Airspan's knowledge and know- how from other knowledge acquired independently by Distributor. Accordingly, during the performance of this Agreement and for three (3) months after termination of services under this Agreement, Distributor will not offer services to third parties which compete with the services provided by Airspan under this Agreement, or otherwise use the knowledge acquired from Airspan in order to compete with Airspan or its customers. Notwithstanding anything to the contrary above, Distributor is not precluded from any activities which concern product sectors or industries other than those that concern products or services similar to those offered by Airspan in connection with this Agreement. Nothing in this paragraph will be construed to prevent Distributor from providing service to existing customers of Distributor which would result in their interruption of service to the public. - -------------------------------------------------------------------------------- Page 14\"}}, {\"id\": \"10.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the performance of this Agreement and for three (3) months after termination of services under this Agreement, Ai\", \"level\": 2, \"text\": \"10.12 During the performance of this Agreement and for three (3) months after termination of services under this Agreement, Airspan will not offer products or services to third parties which compete with the products or services provided by Distributor under this Agreement, or otherwise use the knowledge acquired from Distributor in order to compete with Distributor its customers\"}}, {\"id\": \"10.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The obligations of this Section 10 shall survive the expiration or termination of this Agreement\", \"level\": 2, \"text\": \"10.13 The obligations of this Section 10 shall survive the expiration or termination of this Agreement.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SOFTWARE LICENSE\", \"level\": 1, \"text\": \"11. SOFTWARE LICENSE.\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan grants Distributor, and Distributor hereby accepts, a nonexclusive, non-transferable license to use, and to subl\", \"level\": 2, \"text\": \"11.1 Airspan grants Distributor, and Distributor hereby accepts, a nonexclusive, non-transferable license to use, and to sublicense as set forth below, Software provided by Airspan hereunder only on a single System or unit of Equipment, as may be applicable. No license is granted to use the Software on multiple Systems or in conjunction with Equipment furnished by a party other than Airspan, unless specifically agreed to in writing by Airspan. Software licensed under this Agreement is defined as: (a) any digital instruction sequence or control data contained on any media, including but not limited to, any magnetic-, electronic-, optical-, or organic device, and the term Software shall include any enhancement, modification, extension, part, portion or expansion thereof or implementation or downloading from network of any of the foregoing, for use exclusively on a System or a unit of Equipment; and (b) all associated documentation used to describe, maintain and use the Software.\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"(a) any digital instruction sequence or control data contained on any media, including but not limited to, any magnetic-, electronic-, optical-, or organic device, and the term Software shall include any enhancement, modification, extension, part, portion or expansion thereof or implementation or downloading from network of any of the foregoing, for use exclusively on a System or a unit of Equipment; and (b) all associated documentation used to describe, maintain and use the Software.\", \"definition_clause\": \"11.1\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any Software provided to Distributor by Airspan will be treated as the exclusive property of Airspan, and Distributor wi\", \"level\": 2, \"text\": \"11.2 Any Software provided to Distributor by Airspan will be treated as the exclusive property of Airspan, and Distributor will: (a) treat such Software as Confidential Information under Section 10 of this Agreement; (b) utilize such Software or any portions or aspects thereof (including any methods or concepts utilized therein) solely on Systems or Equipment provided by Airspan; (c) forthwith return to Airspan all memory media, documentation and/or other material that has been modified, updated or replaced; (d) except to the extent permitted by applicable law not modify, disassemble or decompile such Software, or reverse engineer any portion of the Software or functioning of Systems or Equipment, or permit others to do so, without Airspan's prior written consent; (e) except to the extent permitted by applicable law not reproduce or copy such Software in whole or in part except for backup and archival purposes or as otherwise permitted in writing by Airspan; (f) not perform or release benchmarks or other comparisons of the Software; and (g) not remove any trademark, tradename, copyright, notice or other proprietary notice from the Software and Distributor shall be responsible for the conservation of the same on any back-up copy of the Software. - -------------------------------------------------------------------------------- Page 15\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of a breach of this license by Distributor, then Airspan may, in its discretion, terminate the license with\", \"level\": 2, \"text\": \"11.3 In the event of a breach of this license by Distributor, then Airspan may, in its discretion, terminate the license with immediate effect, whereupon Distributor shall return to Airspan all Software and copies thereof within ten (10) days.\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCUSABLE DELAY\", \"level\": 1, \"text\": \"12 EXCUSABLE DELAY. Airspan shall not suffer any liability for non-performance, defective performance, or late performance under this Agreement due to causes beyond its control and without its fault or negligence such as, but not limited to, acts of God, war (including civil war), civil unrest, acts of government, fire, floods, explosions, the elements, epidemics, quarantine, restrictions, strikes, lock- outs, plant shutdown, material shortages, or delays in transportation or delays of its suppliers or subcontractors for like cause. In the event of excusable delay as defined in the preceding sentence, then Airspan, upon giving prompt written notice to Distributor, shall be excused from such performance on a day-to-day basis to the extent of such prevention, restriction, or interference (and Distributor shall likewise be excused from performance of its obligations on a day-to-day basis to the extent Distributor's obligations relate to the performance so prevented, restricted, or interfered with), provided that Airspan shall use its best endeavors to avoid or remove such causes of non-performance and both parties shall proceed to perform with dispatch whenever such causes are removed or cease to exist.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"13. TERM AND TERMINATION.\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement shall remain in effect for sixty (60) months from the Effective Date (the \\\"Initial Term\\\")\", \"level\": 2, \"text\": \"13.1 This Agreement shall remain in effect for sixty (60) months from the Effective Date (the \\\"Initial Term\\\"). After the Initial Term, the term of the Agreement may be extended by a further period of five (5) years by mutual written agreement by the parties in the form of an amendment to this Agreement. If Distributor wishes to extend the term of the Agreement beyond the Initial Term, it must notify Airspan in writing at least six (6) months prior to then end of the Initial Term. However, nothing contained herein shall be interpreted as requiring either party to renew or extend this Agreement. Notwithstanding the provisions of this section or of any other provisions of this Agreement, this Agreement may be terminated prior to the expiration of its stated term as set forth below.\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"sixty (60) months from the Effective Date\", \"definition_clause\": \"13.1\"}}, {\"id\": \"value:sixty (60) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) months\"}}, {\"id\": \"value:five (5) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) years\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Either party may terminate this Agreement at any time during the term of this Agreement if either party fails materiall\", \"level\": 2, \"text\": \"13.2 Either party may terminate this Agreement at any time during the term of this Agreement if either party fails materially to comply with any covenant, term, or provision of this Agreement, by written notice given to the other party not less than thirty (30) days prior to the effective date of such termination. Either party's right to terminate this Agreement under this Section 13.2 may not be exercised unless said - -------------------------------------------------------------------------------- Page 16 party shall have given the other party written notice of the failure, and the other party has not cured the failure within the thirty (30) day period following notice from said party.\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement terminates automatically for just cause, with no further act or action of either party if\", \"level\": 2, \"text\": \"13.3 This Agreement terminates automatically for just cause, with no further act or action of either party if: (a) a receiver is appointed for Distributor or its property; (b) Distributor&sbsp;makes an assignment for the benefit of its creditors; (c) any proceedings are commenced by, for, or against Distributor under any bankruptcy, insolvency, or debtor's relief law; or (d) Distributor is liquidated, dissolved, or otherwise terminates its activities.\"}}, {\"id\": \"13.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of termination by either party for any reason, Distributor shall provide Airspan with lists of existing cus\", \"level\": 2, \"text\": \"13.4 In the event of termination by either party for any reason, Distributor shall provide Airspan with lists of existing customers as well as other information necessary for an orderly changeover of representation in the Territory.\"}}, {\"id\": \"13.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon termination, Distributor shall immediately return to Airspan all Confidential Information, and Distributor agrees t\", \"level\": 2, \"text\": \"13.5 Upon termination, Distributor shall immediately return to Airspan all Confidential Information, and Distributor agrees that neither it nor any company or organization controlled or directed by it shall divulge the contents of such material to any person at any time, notwithstanding the termination of this Agreement.\"}}, {\"id\": \"13.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan shall not be liable to Distributor for damages of any kind, including incidental or consequential damages, on ac\", \"level\": 2, \"text\": \"13.6 Airspan shall not be liable to Distributor for damages of any kind, including incidental or consequential damages, on account of the termination of this agreement in accordance with this section 13. Airspan shall not be liable to Distributor on account of termination or expiration of this Agreement for reimbursement or damages for loss of goodwill, prospective profits, or anticipated orders, or on account of any expenditures, investments, leases, or commitments made by either party, or for any other reason whatsoever based upon or growing out of such termination or expiration. Airspan will recognize payments due to Distributor for orders received up to ninety (90) days after the termination or expiration of this Agreement.\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"13.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor acknowledges and agrees that\", \"level\": 2, \"text\": \"13.7 Distributor acknowledges and agrees that: (a) Distributor has no expectation and has received no assurances that its business relationship with Airspan will continue beyond the states term of this agreement or its earlier termination in accordance with this section, that any investment by Distributor in the promotion of Airspan's Products will be recovered or recouped, or that Distributor shall obtain any anticipated amount of profits by virtue of this Agreement; and (b) Distributor shall not have or acquire by virtue of this Agreement or otherwise any vested, proprietary, or other right in the promotion of Airspan's Products or in any goodwill created by its efforts hereunder.\"}}, {\"id\": \"13.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Section 13\", \"level\": 2, \"text\": \"13.8 This Section 13.8, as well as the provisions of Sections 9, 10, 11, 16, 17 and 18, shall survive the termination of this Agreement. - ------------------------------------------------------------------------------- Page 17\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY\", \"level\": 1, \"text\": \"14. WARRANTY.\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE WARRANTIES SET FORTH IN SECTIONS 14 AND 15 OF THIS AGREEMENT ARE IN LIEU OF, AND Airspan HEREBY DISCLAIMS, ALL OTHER\", \"level\": 2, \"text\": \"14.1 THE WARRANTIES SET FORTH IN SECTIONS 14 AND 15 OF THIS AGREEMENT ARE IN LIEU OF, AND Airspan HEREBY DISCLAIMS, ALL OTHER WARRANTIES AND CONDITIONS, WHETHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, THE IMPLIED TERMS AND WARRANTIES OF SATISFACTORY QUALITY, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Sections 14\", \"level\": 2, \"text\": \"14.2 Subject to Sections 14.3 and 14.4, Airspan warrants that the Equipment sold to Distributor under this Agreement shall, under normal use and service, be free from defects in materials and faulty workmanship, and that the Software licensed to Distributor under this Agreement shall conform in all material respects to Airspan's published specifications therefor. The warranty period for any item of Equipment and related Software shall be twelve (12) months from the date of delivery of such Equipment and related Software to Distributor as set forth in Paragraph 8.1 (hereinafter, this period of time shall be referred to as the \\\"Initial Warranty Period.\\\")\"}}, {\"id\": \"term:Initial Warranty Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Warranty Period\", \"text\": \"twelve (12) months from the date of delivery of such Equipment and related Software to Distributor as set forth in Paragraph 8.1\", \"definition_clause\": \"14.2\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan's obligation and Distributor's sole remedy under this warranty are limited to the replacement or repair, at Airs\", \"level\": 2, \"text\": \"14.3 Airspan's obligation and Distributor's sole remedy under this warranty are limited to the replacement or repair, at Airspan's option, of the defective Equipment or Software within the Initial Warranty Period. Airspan shall have no obligation to remedy any such defect if it can be shown that: (a) the Equipment or Software was altered, repaired, or reworked by any party other than Airspan without Airspan's prior written consent; (b) such defects were the result of Distributor's or a third party's improper storage, mishandling, abuse, or misuse of the Equipment or Software; (c) such defects were the result of Distributor's or a third party's use of the Equipment or Software in conjunction with equipment electronically or mechanically incompatible or of an inferior quality; or (d) the defect was the result of damage by fire, explosion, power failure, or any act of nature.\"}}, {\"id\": \"14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In no event shall Airspan be obliged to provide on-site maintenance\", \"level\": 2, \"text\": \"14.4 In no event shall Airspan be obliged to provide on-site maintenance. Subject to the provisions of this warranty clause, defective parts or components must be returned by Distributor to Airspan's designated facility located within the contiguous 48 states in the United States, freight prepaid, within the Initial Warranty Period, and said defective parts will be repaired or replaced by Airspan at no charge to Distributor. In connection with such return by Distributor, Distributor shall comply with Airspan's Return Material Authorization (RMA) procedures. Risk of loss or damage to Equipment or Software returned to Airspan for repair or replacement shall be borne by Distributor until delivery to Airspan. Upon delivery of such Equipment or Software, Airspan shall assume the risk of loss or damage until that time that the Equipment or Software being repaired or replaced is returned and delivered to Distributor. Distributor will pay all transportation costs for Equipment or Software shipped to Airspan for repair or replacement. Airspan shall pay all transportation costs associated - ------------------------------------------------------------------------------- Page 18 with returning repaired or replaced Equipment or Software to Distributor unless there was no fault found (NFF), in which event, the Distributor shall pay such transportation costs, along with Airspan's then prevailing standard NFF charge.\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan will charge Distributor for any maintenance carried out which is not covered by the warranties contained in Sect\", \"level\": 2, \"text\": \"14.5 Airspan will charge Distributor for any maintenance carried out which is not covered by the warranties contained in Section 14.2 or Section 15 at Airspan's then prevailing standard rates for such services.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY ON REPAIRED AND REPLACEMENT MATERIALS\", \"level\": 1, \"text\": \"15. WARRANTY ON REPAIRED AND REPLACEMENT MATERIALS. Airspan warrants that, following repair or replacement, the repaired or replaced Equipment or Software by Airspan shall be free from defects in materials and faulty workmanship and that the Software will conform in all material respects to Airspan's published specifications therefor for ninety (90) days from date of shipment from Airspan to Distributor or until the end of the Initial Warranty Period, whichever is longer.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"16. LIMITATION OF LIABILITY.\"}}, {\"id\": \"16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WITHOUT PREJUDICE TO SECTION 16\", \"level\": 2, \"text\": \"16.1 WITHOUT PREJUDICE TO SECTION 16.4, NEITHER Airspan, NOR ANY OF ITS OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, REPRESENTATIVES, SHAREHOLDERS, OR AFFILIATES (Airspan AND SUCH OTHER PERSONS, THE \\\"Airspan PARTIES\\\"), SHALL HAVE ANY LIABILITY TO DISTRIBUTOR FOR LOSS OF PROFITS, INCOME, REVENUE OR DATA, OR INCIDENTAL, CONSEQUENTIAL, INDIRECT OR PUNITIVE DAMAGES OR LOSSES, ARISING FROM OR IN CONNECTION WITH THIS AGREEMENT, ANY PURCHASE ORDER PLACED PURSUANT TO THIS AGREEMENT OR ANY OTHER COLLATERAL CONTRACT, OR FROM OR IN CONNECTION WITH THE EQUIPMENT OR THE SOFTWARE OR THE USE THEREOF OR THE INABILITY TO USE THEM EITHER SEPARATELY OR IN COMBINATION WITH OTHER EQUIPMENT OR SOFTWARE, OR FROM ANY OTHER CAUSE, WHETHER CAUSED BY NEGLIGENCE, BREACH OF CONTRACT, STRICT LIABILITY, BREACH OF WARRANTY, ON GROUNDS OF FAILURE OF ESSENTIAL PURPOSE OR OTHERWISE.\"}}, {\"id\": \"term:Airspan PARTIES\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Airspan PARTIES\", \"text\": \"Airspan, NOR ANY OF ITS OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, REPRESENTATIVES, SHAREHOLDERS, OR AFFILIATES\", \"definition_clause\": \"16.1\"}}, {\"id\": \"16.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Without prejudice to Sections 16\", \"level\": 2, \"text\": \"16.2 Without prejudice to Sections 16.3 and 16.4, the liability of the Airspan Parties, taken as a whole, for each event or series of connected events arising out of or in connection with this Agreement, any purchase order placed pursuant to this Agreement, or any other collateral contract, or from or in connection with the Equipment or Software or the use thereof, or the inability to use them either separately or in combination with other equipment or software, or from any other cause, whether caused by negligence, breach of contract, strict liability, breach of warranty, on grounds of failure of essential purpose, or otherwise, shall in no circumstance exceed the total amount payable by Distributor to Airspan under this Agreement for the provision of - ------------------------------------------------------------------------------- Page 19 the Equipment or Software which gave rise to the loss or damage or in connection with which the loss or damage was incurred.\"}}, {\"id\": \"16.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan Parties, taken as a whole, shall be liable for physical damage to Distributor's property resulting from Airspan'\", \"level\": 2, \"text\": \"16.3 Airspan Parties, taken as a whole, shall be liable for physical damage to Distributor's property resulting from Airspan's negligence under or in connection with this Agreement up to a maximum aggregate amount of one million US Dollars (US$1,000,000). And Distributor, taken as a whole, shall be liable for physical damage to Airspan's property resulting from Distributor's negligence under or in connection with this Agreement up to a maximum aggregate amount of one million US Dollars (US$1,000,000).\"}}, {\"id\": \"value:US$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"one million US Dollars (US$1,000,000)\"}}, {\"id\": \"16.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing in this Agreement shall exclude or in any way limit Airspan liability for death or personal injury caused by its\", \"level\": 2, \"text\": \"16.4 Nothing in this Agreement shall exclude or in any way limit Airspan liability for death or personal injury caused by its negligence.\"}}, {\"id\": \"16.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Save as provided for in Section 17 Distributor shall indemnify and hold harmless and defend the Airspan Parties from and\", \"level\": 2, \"text\": \"16.5 Save as provided for in Section 17 Distributor shall indemnify and hold harmless and defend the Airspan Parties from and against all claims, demands, actions, suits, proceedings, writs, judgments, orders and decrees brought, made or rendered against them or any of them and all damages, losses and expenses suffered or incurred by them or any of them howsoever arising out of or related to the breach by Distributor of any of the terms of this Agreement. Airspan shall notify Distributor forthwith of any claim, demand, action, suit, proceeding, writ, judgment, order or decree falling within the scope of this Section 16.5 and shall permit Distributor sole conduct of the same and shall provide reasonable assistance in relation thereto, subject to appropriate defense by Distributor and the payment by Distributor of Airspan's reasonable costs and expenses.\"}}, {\"id\": \"16.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall include, in its agreements with its customers pursuant to which Distributor supplies Equipment or Soft\", \"level\": 2, \"text\": \"16.6 Distributor shall include, in its agreements with its customers pursuant to which Distributor supplies Equipment or Software, provisions pursuant to which such customers agree that the Airspan Parties shall have no liability for any of the types of damages referred to at Section 16.1 in connection with or arising from the Equipment or Software or the use thereof, or the inability to use them either separately or in combination with other equipment or software, or from any other causes.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY RIGHTS INDEMNITY\", \"level\": 1, \"text\": \"17. INTELLECTUAL PROPERTY RIGHTS INDEMNITY.\"}}, {\"id\": \"17.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan agrees to indemnify and hold Distributor harmless with respect to any suit, claim, or proceeding brought against\", \"level\": 2, \"text\": \"17.1 Airspan agrees to indemnify and hold Distributor harmless with respect to any suit, claim, or proceeding brought against Distributor by a third party alleging that Distributor's use of the Equipment or the Software, separately or in combination, as a whole or in part, constitutes an infringement of any patent or copyright or misuse of proprietary or trade secret information. Airspan agrees to defend Distributor against any such claims and to pay all litigation costs, reasonable attorney's fees, settlement payments, and any damages awarded or resulting from any such claim. - ------------------------------------------------------------------------------- Page 20\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall promptly advise Airspan of any such suit, claim, or proceeding and shall co-operate with Airspan in th\", \"level\": 2, \"text\": \"17.2 Distributor shall promptly advise Airspan of any such suit, claim, or proceeding and shall co-operate with Airspan in the defense or settlement thereof. Airspan shall have sole control of the defense of any action involving such a claim and of all negotiations for its settlement or compromise.\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event that an injunction is obtained against Distributor's use of the Equipment and/or the Software, in whole or\", \"level\": 2, \"text\": \"17.3 In the event that an injunction is obtained against Distributor's use of the Equipment and/or the Software, in whole or in part, as a result of any such claim, Airspan shall use its best efforts to either: (a) procure for Distributor the right to continue using the portions of the Equipment or the Software enjoined from use; or (b) replace or modify the same with functionally equivalent or better Equipment and/or Software so that Distributor's use is not subject to any such injunction. In the event that Airspan cannot perform the remedies set forth in Sections 17.3(a) or 17.3(b), then Distributor shall have the right to return such Equipment and the Software to Airspan. In the event of such return, Airspan shall refund the depreciated value of the Equipment and the license to use the Software within thirty (30) days of the receipt by Airspan of the Equipment and the Software.\"}}, {\"id\": \"17.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This indemnity shall not apply to claims arising in respect to the use of the Equipment or Software supplied by Airspan\", \"level\": 2, \"text\": \"17.4 This indemnity shall not apply to claims arising in respect to the use of the Equipment or Software supplied by Airspan or manufactured by its suppliers in accordance with any design or any special instruction furnished by Distributor, or which is used by Distributor in a manner or for a purpose not contemplated by this Agreement.\"}}, {\"id\": \"17.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The provisions of this Section 17 set forth the entire obligation of Airspan with respect to any claim of patent infring\", \"level\": 2, \"text\": \"17.5 The provisions of this Section 17 set forth the entire obligation of Airspan with respect to any claim of patent infringement, copyright infringement, or misuse of proprietary or trade secret information.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXPORT CONTROLS AND LEGAL COMPLIANCE\", \"level\": 1, \"text\": \"18. EXPORT CONTROLS AND LEGAL COMPLIANCE.\"}}, {\"id\": \"18.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If any approval with respect to this Agreement, or the registration thereof, shall be required at any time during the te\", \"level\": 2, \"text\": \"18.1 If any approval with respect to this Agreement, or the registration thereof, shall be required at any time during the term of this Agreement, with respect to giving legal effect to this Agreement in the Territory, or with respect to compliance with exchange regulations or other requirements so as to assure the right of remittance abroad of United States dollars pursuant to Section 6 hereof, Distributor shall immediately take whatever steps may be necessary in this respect, and any charges incurred in connection therewith shall be for the account of Distributor. Distributor shall keep Airspan currently informed of its efforts in this connection. Airspan shall be under no obligation to ship Airspan Products to Distributor hereunder until Distributor has provided Airspan with satisfactory evidence that such approval or registration is not required or that it has been obtained.\"}}, {\"id\": \"18.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the performance of its obligations under this Agreement, Distributor shall at all times strictly comply with all expo\", \"level\": 2, \"text\": \"18.2 In the performance of its obligations under this Agreement, Distributor shall at all times strictly comply with all export laws, regulations, and orders of the - ------------------------------------------------------------------------------- Page 21 United Kingdom and the United States of America. Distributor specifically acknowledges that Equipment, Software or technology supplied or licensed by Airspan under this Agreement are subject to U.K. and U.S. trade sanctions and export control laws and regulations including, but not limited to, the various Foreign Assets Control Regulations, the Export Administration Regulations, and the International Traffic in Arms Regulations. Distributor specifically acknowledges that Equipment, Software, or technology obtained from Airspan pursuant to this Agreement shall not be exported, re-exported, transshipped, disclosed, diverted, or transferred, directly or indirectly, contrary to U.K. and U.S. laws, orders or regulations. The provisions of this section shall survive any termination of this Agreement.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRAINING AND DOCUMENTATION\", \"level\": 1, \"text\": \"19. TRAINING AND DOCUMENTATION.\"}}, {\"id\": \"19.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan shall provide a single technical course in the English language for up to two (2) qualified technicians of Distr\", \"level\": 2, \"text\": \"19.1 Airspan shall provide a single technical course in the English language for up to two (2) qualified technicians of Distributor during the first year of this Agreement. The training course so developed by Airspan shall be used to familiarize Distributor's technicians with the use and maintenance of Airspan Products. Training will be conducted at Airspan's facilities in Uxbridge, UK, unless otherwise agreed to by Airspan. The necessary instructors and training facilities will be provided by Airspan at no charge to Distributor. Distributor will pay all additional expenses of training including, but not limited to, travel and room and board. Additional training courses may be requested by Distributor at Airspan's then current rates for such courses.\"}}, {\"id\": \"19.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Airspan agrees to provide Distributor at no additional charge with its standard package of documentation related to the\", \"level\": 2, \"text\": \"19.2 Airspan agrees to provide Distributor at no additional charge with its standard package of documentation related to the use, maintenance, and installation of Airspan Products. In the event that such documentation is modified during the term of this Agreement, Airspan agrees to provide to Distributor at no additional charge all such modifications. In addition to the documentation described above, Airspan agrees to provide at no additional charge reasonable amounts of sales materials such as brochures, press releases, and fact sheets. All documentation provided by Airspan to Distributor shall be in the English language. All translation of such documentation provided by Airspan will be at Distributor's sole expense. All such translations and advertising material not supplied by Airspan relating to Airspan Products and services will be submitted to Airspan for approval before publication or dissemination.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFLICT OF INTEREST\", \"level\": 1, \"text\": \"20. CONFLICT OF INTEREST. Distributor confirms that it has revealed all information pertaining to possible conflicts of interest created by the sale of competing products or services or arising from other positions or contracts held by Distributor, and represents that no conflict of interest exists. Any future circumstances which could create possible conflicts of interest will be revealed to Airspan as soon as they become known by informing Airspan of any business relationships, circumstances, or situations which could prejudice in any way - -------------------------------------------------------------------------------- Page 22 the conduct of Airspan marketing activities according to the highest ethical and business standards, or place Airspan or Distributor in any kind of embarrassing situation.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"21. MISCELLANEOUS.\"}}, {\"id\": \"21.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Pursuant to the Foreign Corrupt Practices Act of the United States of America, directors, officers, or employees of Dist\", \"level\": 2, \"text\": \"21.1 Pursuant to the Foreign Corrupt Practices Act of the United States of America, directors, officers, or employees of Distributor shall not offer or pay any bribe to any individual or corporation in connection with the provision or support of any Airspan Products obtained under this Agreement. When other individuals or organizations are required to participate in the sales program covered by this Agreement, they shall be compensated fairly based on the tasks performed. In no circumstances are public servants or holders of public office to be offered or paid any bribe or other benefit, direct or indirect. No contribution in any way related to Airspan shall be made to candidates for public office or to political parties or other political organizations, regardless of whether such contributions are permitted by the laws of the Territory. The parties agree that both parties will comply fully with all of the terms, conditions, rules, regulations and statutes of the Foreign Corrupt Practices Act. The parties further agree that if either party violates any of the provisions of said Act, the party violating the Act will indemnify the other party from any and all liability thereunder, including costs, expenses, fines or legal fees.\"}}, {\"id\": \"21.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In performing this Agreement, the parties shall comply with all applicable laws, rules, and regulations, and shall inde\", \"level\": 2, \"text\": \"21.2 In performing this Agreement, the parties shall comply with all applicable laws, rules, and regulations, and shall indemnify, defend and save each other harmless from said party's failure to do so. Furthermore, if this Agreement, the relationship created hereby or the performance hereof is determined by either party to be contrary either to (a) the laws, rules or regulations applicable to the parties; or (b) the parties' representations as set forth herein, this Agreement will be null and void from its inception. The parties have entered into this Agreement in material reliance on the following representations made by each party that: a. Neither this Agreement, the relationship created hereby nor the performance hereof is contrary to any applicable law, rule or regulation; b. The parties have not refunded and will not refund either directly or indirectly, any funds to any director, officer, employee or other representative of either party (or of any subsidiary controlled by or affiliated with either party) or to such party's family; and\"}}, {\"id\": \"21.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party may assign this Agreement or subcontract its obligations under this Agreement to another party without the\", \"level\": 2, \"text\": \"21.3 Neither party may assign this Agreement or subcontract its obligations under this Agreement to another party without the other party's prior, written consent executed by a duly authorized officer. The parties agree that if said assignment is to a subsidiary or affiliate organization, said consent to assignment will not be unreasonably withheld.\"}}, {\"id\": \"21.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement shall be construed in accordance with and governed by the laws of the State of South Dakota\", \"level\": 2, \"text\": \"21.4 This Agreement shall be construed in accordance with and governed by the laws of the State of South Dakota.\"}}, {\"id\": \"21.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any dispute, controversy or claim between the parties arising out of, or in connection with, this Agreement, or the brea\", \"level\": 2, \"text\": \"21.5 Any dispute, controversy or claim between the parties arising out of, or in connection with, this Agreement, or the breach, termination or validity thereof will be resolved by mutual agreement of the parties, provided that this shall not limit the ability of the parties to seek temporary or interim injunctive relief in the event of any breach or threatened or impending breach of the confidentiality provisions of this Agreement. If any dispute, controversy, or claim arising out of or relating to this Agreement, or the breach, termination or validity thereof is unable to be resolved by mutual agreement of the parties, each of the parties hereby (i) agrees that any action, suit or proceeding with respect to this Agreement against it or its properties or revenues must be brought exclusively in the federal and state courts siting in Minneapolis, MN, and (ii) irrevocably submits to the exclusive jurisdiction of any such court and any appellate court from any order or judgment thereof in any such action, suit or proceeding. The parties hereby irrevocably agree that all claims in respect of such action, suit or proceeding may be heard and determined in such courts. The parties hereby irrevocably waive, to the fullest extent they may effectively do so, the defense of an inconvenient forum to the maintenance of such action, suit or proceeding. The parties agree that a final judgment in any such action, suit, or proceeding will be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.\"}}, {\"id\": \"21.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties' failure to enforce at any time any of the provisions of this Agreement or any right with respect thereto, o\", \"level\": 2, \"text\": \"21.6 The parties' failure to enforce at any time any of the provisions of this Agreement or any right with respect thereto, or to exercise any option herein provided shall in no way be construed to be a waiver of such provision, rights, or options, or in any way to affect the validity of this Agreement. The parties' exercise of any of their rights hereunder or of any options hereunder under the terms or covenants herein shall not preclude or prejudice the parties from thereafter exercising the same or any right - -------------------------------------------------------------------------------- Page 24 which they may have under this Agreement, irrespective of any previous action or proceeding taken by either party hereunder.\"}}, {\"id\": \"21.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the advertising and sale of Airspan products, Distributor will utilize Airspan's regular trade names and trademarks o\", \"level\": 2, \"text\": \"21.7 In the advertising and sale of Airspan products, Distributor will utilize Airspan's regular trade names and trademarks only as permitted or directed by Airspan, will not make or permit alteration or removal of any tags, labels, or other identifying marks placed by Airspan on its products, and will not use the name \\\"Airspan Communications Corporation\\\" or abbreviations thereof in Distributor's corporate titles or in any other way which might result in confusion as to Airspan and Distributor being separate and distinct entities. Distributor will not register any Airspan trademark.\"}}, {\"id\": \"21.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement shall be binding upon the parties, their heirs, successors in interest and permitted assigns\", \"level\": 2, \"text\": \"21.8 This Agreement shall be binding upon the parties, their heirs, successors in interest and permitted assigns.\"}}, {\"id\": \"21.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement and any attachment hereto shall be modified only by an instrument in writing and signed by duly-authorize\", \"level\": 2, \"text\": \"21.9 This Agreement and any attachment hereto shall be modified only by an instrument in writing and signed by duly-authorized officers or agents of the parties.\"}}, {\"id\": \"21.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All notices, requests, consents, and other communications hereunder must be in writing and will be deemed to have been p\", \"level\": 2, \"text\": \"21.10 All notices, requests, consents, and other communications hereunder must be in writing and will be deemed to have been properly given when actually received by the party to whom sent, at the following addresses: To: Airspan To: Distributor Airspan Networks Inc. GLS LLC 777 108 Th. Avenue NE 501 Fourth Street Suite 1895 PO Box 67 Bellevue, Washington Sergeant Bluff, IA 98004 51054 Attn: Peter Stanway Attn: Jon Winkel Contracts Manager Fax No. 919-319-0106\"}}, {\"id\": \"21.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The provisions of this Agreement are severable, and if any provision is held invalid or unenforceable in whole or in par\", \"level\": 2, \"text\": \"21.11 The provisions of this Agreement are severable, and if any provision is held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability will affect only such provision or part thereof in such - ------------------------------------------------------------------------------ Page 25 jurisdiction, and will not in any manner affect the provision in any other jurisdiction, or any other provision in this Agreement in any other jurisdiction.\"}}, {\"id\": \"21.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees not to publish any press releases or otherwise publicize the existence, or any of the terms, of this\", \"level\": 2, \"text\": \"21.12 Distributor agrees not to publish any press releases or otherwise publicize the existence, or any of the terms, of this Agreement without the prior written consent of Airspan, such consent not unreasonably to be withheld or delayed.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This document constitutes the entire agreement between the parties with respect to the subject matter hereof, and supe\", \"level\": 1, \"text\": \"22. This document constitutes the entire agreement between the parties with respect to the subject matter hereof, and supersedes all previous communications, representations, understandings, and agreements, either oral or written, between the parties or any official or Distributor thereof with respect to the subject matter hereof. - -------------------------------------------------------------------------------- Page 26 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the Effective Date, such parties acting by their officers, being thereunto duly authorized. Airspan Networks Inc. GLS LLC By: _______________________________ By: ______________________________ Name: ______________________________ Name: _____________________________ Title: ______________________________ Title: ____________________________ Page 27\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"[LOGO]\", \"level\": 1, \"text\": \"[LOGO] EXHIBIT C AIRSOPURE FRANCHISE AGREEMENT THIS AGREEMENT is entered into on this ____ day of ___________, 2000, by and between Airsopure International Group, Inc., a Nevada corporation whose principal place of business is located at 15400 Knoll Trail, Suite 200, Dallas, Texas 75248 (hereinafter \\\"AIRSOPURE\\\" or by reference \\\"we\\\", \\\"us\\\", \\\"our\\\"), and You: , ------------------------------------ whose address is: - ---------------------------------------- - ---------------------------------------- (hereinafter \\\"You\\\" or by reference \\\"Franchisee\\\", or \\\"Your\\\"). Either Party or both Parties respectively may be referred to as \\\"Party\\\" or \\\"Parties.\\\" RECITALS A. AIRSOPURE and its affiliate design, manufacture and distribute indoor air cleaning systems under the name and mark \\\"AIRSOPURE\\\" (the \\\"Products\\\"). B. AIRSOPURE has developed a system for the establishment, development and operation of sales centers (\\\"AIRSOPURE Center(s)\\\" or \\\"Center(s)\\\") for the sale and servicing of AIRSOPURE's exclusive line of Products using the service mark \\\"AIRSOPURE\\\" and other trademarks, service marks (including but not limited to, \\\"The Essence of Clean Air\\\"), logos and identifying features designated from time to time by AIRSOPURE (the \\\"Licensed Marks\\\") and using AIRSOPURE's distinctive methods for establishing and operating AIRSOPURE Centers.\"}, {\"id\": \"C\", \"title\": \"You desire to establish an AIRSOPURE Center to be located in the following geographic area\", \"level\": 1, \"text\": \"C. You desire to establish an AIRSOPURE Center to be located in the following geographic area: - ---------------------------------------- - ---------------------------------------- (the \\\"Exclusive Territory\\\"), and AIRSOPURE desires to grant You the right to operate an AIRSOPURE Center at such location under the terms and conditions contained in this Agreement. NOW, THEREFORE, in consideration of the mutual rights, covenants and obligations set forth herein, the Parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"GRANT OF FRANCHISE\", \"level\": 1, \"text\": \"1. GRANT OF FRANCHISE\"}, {\"id\": \"1.01\", \"title\": \"AIRSOPURE grants to You, and You accept from AIRSOPURE, the right and license to operate an AIRSOPURE Center (or the \\\"F\", \"level\": 2, \"text\": \"1.01. AIRSOPURE grants to You, and You accept from AIRSOPURE, the right and license to operate an AIRSOPURE Center (or the \\\"Franchise\\\") for the sale or lease of AIRSOPURE's exclusive line of Products or at a location in the Exclusive Territory to be approved in writing by AIRSOPURE and listed in attached Exhibit A (the \\\"Exclusive Territory and Center Location\\\"), to purchase Products from AIRSOPURE or its affiliates for resale at the Center to customers in the Exclusive Territory, and to use the Licensed Marks only in connection with the operation of the Franchise in accordance with the terms and conditions of this Agreement. AIRSOPURE grants the Franchise to You hereunder in reliance upon Your agreement to at all times operate and manage the Franchise faithfully, honestly and diligently in strict conformance with AIRSOPURE's operating procedures and specifications, as set forth herein and as otherwise from time to time communicated to You, using Your best efforts to promote and enhance the performance and operation of the Franchise.\"}, {\"id\": \"1.02\", \"title\": \"AIRSOPURE hereby grants to You the exclusive right to solicit customers for the Products by direct mail advertising, or\", \"level\": 2, \"text\": \"1.02. AIRSOPURE hereby grants to You the exclusive right to solicit customers for the Products by direct mail advertising, or other approved means, but not including the World Wide Web (Internet) nor by printed catalogues, in 1 the Exclusive Territory described above and in Exhibit A. Other AIRSOPURE franchisees will not be permitted to solicit customers for Products by advertising in Your Exclusive Territory. Likewise, You may not target or solicit customers for Products by advertising in other Franchisees respective Exclusive Territories. Exclusive Territories will not overlap into other Exclusive Territories. You shall not purposely solicit sales and service to customers located outside Your Exclusive Territory, provided such activity in not within an assigned Exclusive Territory. You have been granted an exclusive trade area by this Agreement.\"}, {\"id\": \"2\", \"title\": \"TERM AND RENEWAL\", \"level\": 1, \"text\": \"2. TERM AND RENEWAL\"}, {\"id\": \"2.01\", \"title\": \"The term of this Agreement shall be for 10 years commencing on the date of execution of this Agreement by AIRSOPURE\", \"level\": 2, \"text\": \"2.01. The term of this Agreement shall be for 10 years commencing on the date of execution of this Agreement by AIRSOPURE.\"}, {\"id\": \"2.02\", \"title\": \"At the expiration of the term or any renewal term hereof, You may, at its option, renew the Franchise granted hereunder\", \"level\": 2, \"text\": \"2.02. At the expiration of the term or any renewal term hereof, You may, at its option, renew the Franchise granted hereunder for 2 additional terms of 10 years each on the following terms and conditions: A. You shall give AIRSOPURE notice in writing of Your election to renew this Agreement at least 3 months prior to the expiration of the then-current term. B. You shall not be in default of any provision of this Agreement or amendment hereto, including without limitation all payment obligations to AIRSOPURE and its affiliates.\"}, {\"id\": \"C\", \"title\": \"As a condition of renewal of the Franchise, You agree to execute AIRSOPURE's then-current form of franchise agreement a\", \"level\": 1, \"text\": \"C. As a condition of renewal of the Franchise, You agree to execute AIRSOPURE's then-current form of franchise agreement and to comply fully with all terms and conditions thereof, and to pay AIRSOPURE the then-current renewal fee, which is presently $1,000.00. You understand that AIRSOPURE may revise its franchise agreement for any renewal term, at AIRSOPURE's sole discretion, including without limitation to increase the royalty fees or other fees payable by You or to require other obligations of franchisees.\"}, {\"id\": \"D\", \"title\": \"You shall meet AIRSOPURE's then-current qualifications and training requirements\", \"level\": 1, \"text\": \"D. You shall meet AIRSOPURE's then-current qualifications and training requirements. E. You shall execute a general release in a form prescribed by AIRSOPURE releasing AIRSOPURE and its affiliates, directors, officers, employees and agents from all known and unknown claims and liabilities to the extent permitted by state and federal law. F. You may be required, at AIRSOPURE's sole discretion, to upgrade or remodel Your AIRSOPURE Center to conform to AIRSOPURE's then-current specifications and standards as specified in AIRSOPURE's Operating Manual of otherwise in writing, provided such upgrade or remodel is reasonable in terms of cost and implementation schedule.\"}, {\"id\": \"3\", \"title\": \"FEES\", \"level\": 1, \"text\": \"3. FEES\"}, {\"id\": \"3.01\", \"title\": \"In consideration of the Franchise rights and license granted herein, You agree to pay to AIRSOPURE the following fees\", \"level\": 2, \"text\": \"3.01. In consideration of the Franchise rights and license granted herein, You agree to pay to AIRSOPURE the following fees: A. You shall pay to AIRSOPURE an initial franchise fee of $25,000.00 upon execution of this Agreement. You agree that the initial franchise fee represents payment for the initial grant of the Franchise rights and license granted herein, shall be fully earned upon execution of this Agreement, and the said fee will not be refunded under any circumstances unless otherwise specifically set forth herein. You must find a suitable Center site within 90 days of signing the Franchise Agreement, unless we mutually agree otherwise. If we cannot agree on a Center location, within 4 months, we may a) extend your search time, b) exchange your territory, or c) terminate your Franchise and refund up to 70% of your Franchise Fee, at our sole discretion. There are no refunds under any other circumstances. B. You shall pay to AIRSOPURE a continuing non-refundable royalty fee on a monthly basis of 2 5% of Your total monthly gross sales, as defined below. This fee is due by the 7th of the month for the preceding month.\"}, {\"id\": \"C\", \"title\": \"You shall account to AIRSOPURE for Your continuing non-refundable local advertising fee of 2% of Your total monthly gro\", \"level\": 1, \"text\": \"C. You shall account to AIRSOPURE for Your continuing non-refundable local advertising fee of 2% of Your total monthly gross sales, which You must spend on the promotion of Your Center. This accounting is due by the 7th of the month for the preceding month.\"}, {\"id\": \"D\", \"title\": \"You shall pay to AIRSOPURE a continuing non-refundable Advertising Fund fee of 2% of Your total monthly gross sales, be\", \"level\": 1, \"text\": \"D. You shall pay to AIRSOPURE a continuing non-refundable Advertising Fund fee of 2% of Your total monthly gross sales, beginning January 1, 2001, or later at our sole option, as described in Section 10 hereof. This fee will be due by the 7th of the month for the preceding month. E. \\\"Gross sales\\\" as used in this Section 3.01 shall mean the amount of gross revenues received by You from all sources, including without limitation sales of Products, services or other merchandise of every kind or nature from, at or in connection with the operation of the AIRSOPURE Center granted herein, excluding state, federal or local sales taxes collected from customers and paid to the appropriate taxing authority. F. Fees payable under Paragraphs 3.01.B and 3.01.D above shall be due and payable monthly by the seventh day of each month, based on Your gross sales of the previous month. Delinquent fees shall bear interest at a rate of the lower of: (i) one and one-half percent (1.5%) per month, or (ii) the maximum rate permitted by applicable law.\"}, {\"id\": \"4\", \"title\": \"DUTIES OF AIRSOPURE\", \"level\": 1, \"text\": \"4. DUTIES OF AIRSOPURE\"}, {\"id\": \"4.01\", \"title\": \"Prior to the opening of the Franchise, AIRSOPURE shall\", \"level\": 2, \"text\": \"4.01. Prior to the opening of the Franchise, AIRSOPURE shall: A. Following receipt in writing from You of a request for approval of at least 3 possible locations as the Authorized Location for the Franchise, AIRSOPURE will promptly evaluate such locations and notify You in writing of its approval or rejection of such location(s) within 7 working days. B. Provide You with AIRSOPURE's specifications and requirements or other assistance deemed necessary by AIRSOPURE to assist You in opening the Center.\"}, {\"id\": \"C\", \"title\": \"Provide an initial training program for 2 people to be designated by You as described in AIRSOPURE's Operations Manual\", \"level\": 1, \"text\": \"C. Provide an initial training program for 2 people to be designated by You as described in AIRSOPURE's Operations Manual.\"}, {\"id\": \"D\", \"title\": \"Provide one copy, on loan to You, of AIRSOPURE's Operations Manual as described in Section 8 hereof for use solely in c\", \"level\": 1, \"text\": \"D. Provide one copy, on loan to You, of AIRSOPURE's Operations Manual as described in Section 8 hereof for use solely in connection with operation of the AIRSOPURE Center granted hereunder. E. Sell to You an opening order of Products for resale or lease at the Franchise as described in Paragraph 6.01 below.\"}, {\"id\": \"4.02\", \"title\": \"Following the opening of the Franchise, AIRSOPURE shall\", \"level\": 2, \"text\": \"4.02. Following the opening of the Franchise, AIRSOPURE shall: A. Provide daily consultation by telephone as reasonably requested by You during the first two weeks of operation of the AIRSOPURE Center Franchise. B. Provide continuing general advisory assistance as deemed necessary by AIRSOPURE regarding the operation and advertising of the Franchise.\"}, {\"id\": \"C\", \"title\": \"Provide updates, revisions and amendments to the AIRSOPURE Operating Manual and system as AIRSOPURE may from time to ti\", \"level\": 1, \"text\": \"C. Provide updates, revisions and amendments to the AIRSOPURE Operating Manual and system as AIRSOPURE may from time to time deem necessary or desirable.\"}, {\"id\": \"D\", \"title\": \"Fill Your orders for Products for resale at the Franchise in accordance with Section 6 below\", \"level\": 1, \"text\": \"D. Fill Your orders for Products for resale at the Franchise in accordance with Section 6 below. E. Provide training programs or seminars as AIRSOPURE may, from time to time in its sole discretion, deem appropriate. AIRSOPURE's training programs for franchisees is described in AIRSOPURE's Operations Manual, and is subject to change at any time in AIRSOPURE's sole 3 discretion. F. AIRSOPURE may, from time to time at its sole discretion, provide test customers or store visits by AIRSOPURE representatives to evaluate Your methods of operation and compliance with AIRSOPURE's standards and specifications.\"}, {\"id\": \"5\", \"title\": \"YOUR DUTIES\", \"level\": 1, \"text\": \"5. YOUR DUTIES\"}, {\"id\": \"5.01\", \"title\": \"You shall\", \"level\": 2, \"text\": \"5.01. You shall: A. You must find a suitable Center site within 90 days of signing the Franchise Agreement, unless we mutually agree otherwise, and attend (or if You are a corporation, Your majority shareholder will attend or Your Operating Principal or manager and one other employee) and successfully complete to AIRSOPURE's reasonable satisfaction AIRSOPURE's initial training program within 90 DAYS following execution of this Agreement. B. Obtain all federal, state and local business licenses, permits, certifications and bonds required for lawful operation of the Franchise and certify in writing to AIRSOPURE prior to opening that all such requirements have been obtained.\"}, {\"id\": \"C\", \"title\": \"Attend (with Your manager) and complete to AIRSOPURE's reasonable satisfaction such continuing training or educational\", \"level\": 1, \"text\": \"C. Attend (with Your manager) and complete to AIRSOPURE's reasonable satisfaction such continuing training or educational programs as AIRSOPURE may from time to time require in writing. AIRSOPURE will not charge You for the training programs, but You shall be responsible for the costs of meals, lodging, travel and all other expenses incurred by You or Your employees in attending such programs.\"}, {\"id\": \"D\", \"title\": \"Actively promote AIRSOPURE's Products and services and exert Your best efforts to fully develop and maximize the market\", \"level\": 1, \"text\": \"D. Actively promote AIRSOPURE's Products and services and exert Your best efforts to fully develop and maximize the market for AIRSOPURE's Products and services in Your Exclusive Territory. E. Devote Your full time (or if You are a corporation, designate a manager) to oversee the management and operation of the Center. F. Purchase and maintain and adequate supply for use in connection with the operation of the Franchise Business various copyrighted materials and forms which are the proprietary property of AIRSOPURE and which are an integral part of AIRSOPURE's system franchised hereunder. Other supplies and equipment necessary for operation of the Center may be purchased from third Party suppliers who meet AIRSOPURE's standards and specifications and have been approved in writing by AIRSOPURE in accordance with the procedures set forth in AIRSOPURE's Operating Manual, which may be amended from time to time by AIRSOPURE at its sole discretion. G. Purchase Products from AIRSOPURE for resale to customers in the Exclusive Territory in accordance with Section 6 below. H. Comply with all federal, state and local health and safety laws, rules and standards applicable to operation of the Franchise. You will forward copies of all notices of non-compliance by the Franchise with any law, rule, regulation or ordinance to AIRSOPURE within three days from receipt thereof accompanied by a summary of action You will take to comply.\"}, {\"id\": \"I\", \"title\": \"Maintain adequate working capital to operate the Franchise in accordance with the AIRSOPURE Operations Manual, as such\", \"level\": 1, \"text\": \"I. Maintain adequate working capital to operate the Franchise in accordance with the AIRSOPURE Operations Manual, as such may be amended by AIRSOPURE from time to time. J. Operate the Franchise in strict conformance with AIRSOPURE's policies, procedures, standards and specifications as may be prescribed by AIRSOPURE from time to time in the Operations Manual or otherwise in writing, including without limitation all changes specified by AIRSOPURE to its system or Products. . K. Display AIRSOPURE's Licensed Marks or logos on all marketing materials and at Your AIRSOPURE Center. AIRSOPURE reserves the 4 right to alter or change its Licensed Marks, logos or trade dress at any time, and You agree to use such Licensed Marks, logos or trade dress as specified from time to time by AIRSOPURE promptly upon receipt of notice in writing from AIRSOPURE.\"}, {\"id\": \"L\", \"title\": \"Maintain and supply to third Parties upon request information to be supplied by AIRSOPURE regarding the availability of\", \"level\": 1, \"text\": \"L. Maintain and supply to third Parties upon request information to be supplied by AIRSOPURE regarding the availability of franchises.\"}, {\"id\": \"M\", \"title\": \"Provide AIRSOPURE and its representatives with unlimited access to FRANCHISEE'S offices or its AIRSOPURE Center (person\", \"level\": 1, \"text\": \"M. Provide AIRSOPURE and its representatives with unlimited access to FRANCHISEE'S offices or its AIRSOPURE Center (personal residence excluded), including Your books, computer system (for sales and products only, unless we are auditing You) and records of the Franchise, during normal business hours for purposes of conducting inspections to fully examine and evaluate Your methods of doing business, including interviews with Your employees and customers. N. You acknowledge and agree that such inspections and evaluations are necessary for AIRSOPURE to insure the maintenance of its quality standards, and You agree to fully cooperate with any reasonable request by AIRSOPURE in connection with such inspections and evaluations. O. Diligently and immediately take such steps as are deemed reasonably necessary by AIRSOPURE to correct any deficiencies detected by AIRSOPURE in Your adherence to AIRSOPURE's operating policies, procedures, standards and specifications. P. In the event You are a corporation, comply with the following:\"}, {\"id\": \"1\", \"title\": \"You will provide in Your Articles of Incorporation that Your sole corporate purpose is the operation of the Franchise\", \"level\": 1, \"text\": \"1. You will provide in Your Articles of Incorporation that Your sole corporate purpose is the operation of the Franchise.\"}, {\"id\": \"2\", \"title\": \"Every certificate for shares of stock in the corporation will include the following legend printed thereon if sole purp\", \"level\": 1, \"text\": \"2. Every certificate for shares of stock in the corporation will include the following legend printed thereon if sole purpose of the corporation is to own and operate franchised business: \\\"THE TRANSFER, PLEDGE OR ASSIGNMENT OF THE SHARES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND RESTRICTIONS CONTAINED IN A FRANCHISE AGREEMENT BETWEEN THE HOLDER OF THESE SHARES AND AIRSOPURE FRANCHISE GROUP, INC.\\\"\"}, {\"id\": \"3\", \"title\": \"You agree to comply with the restrictions on transfer of ownership of the corporation set forth in Section 12\", \"level\": 1, \"text\": \"3. You agree to comply with the restrictions on transfer of ownership of the corporation set forth in Section 12.02 below.\"}, {\"id\": \"4\", \"title\": \"You will provide AIRSOPURE, prior to the opening of the Franchise, with copies of Your Articles of Incorporation, Bylaw\", \"level\": 1, \"text\": \"4. You will provide AIRSOPURE, prior to the opening of the Franchise, with copies of Your Articles of Incorporation, Bylaws and other governing documents, including all amendments thereto, and a copy of the resolutions by Your Board of Directors authorizing execution of this Agreement, certified by the Secretary of the corporation.\"}, {\"id\": \"5\", \"title\": \"You will provide AIRSOPURE with a current list of shareholders and will update such list from time to time as the list\", \"level\": 1, \"text\": \"5. You will provide AIRSOPURE with a current list of shareholders and will update such list from time to time as the list changes.\"}, {\"id\": \"6\", \"title\": \"Each shareholder of the corporation (if sole corporate purpose is the franchise), will execute a personal guarantee of\", \"level\": 1, \"text\": \"6. Each shareholder of the corporation (if sole corporate purpose is the franchise), will execute a personal guarantee of Your performance under this Agreement and all amounts owed by You to AIRSOPURE in the form of attached Exhibit B. Q. The Parties recognize the importance of fully developing the market for Products in the Exclusive Territory, and a substantial part of the consideration for and inducement to AIRSOPURE to enter into this Agreement is Your agreement to devote Your best efforts to market, sell and support Products to customers located in Your Exclusive Territory. You agree to concentrate Your marketing efforts to customers located in Your Territory, and You agree not to advertise the Products using media or publications whose primary coverage area is outside Your Exclusive Territory. 5 R. You may relocate Your Center at Your sole expense, within Your Exclusive Territory, provided You give us written notification at least 30 days prior to relocation stating the reasons for such a move.\"}, {\"id\": \"6\", \"title\": \"PURCHASE AND SALE OF PRODUCTS\", \"level\": 1, \"text\": \"6. PURCHASE AND SALE OF PRODUCTS\"}, {\"id\": \"6.01\", \"title\": \"You will purchase from AIRSOPURE and AIRSOPURE will sell to You for resale or lease at the Center to customers in the E\", \"level\": 2, \"text\": \"6.01. You will purchase from AIRSOPURE and AIRSOPURE will sell to You for resale or lease at the Center to customers in the Exclusive Territory an opening order of Products having an aggregate cost to You of from $5,000.00 to $10,000.00, by mutual agreement, based on market conditions. Such purchase must be consummated in its entirety before You open Your Center, unless AIRSOPURE agrees in writing to extend such time period.\"}, {\"id\": \"6.02\", \"title\": \"After the opening order contemplated by the preceding Paragraph, You will from time to time place orders for Products w\", \"level\": 2, \"text\": \"6.02. After the opening order contemplated by the preceding Paragraph, You will from time to time place orders for Products with AIRSOPURE on the following basis: A. All orders for Products shall be accompanied by payment, unless at AIRSOPURE's sole discretion, other payment terms are permitted. B. All orders will be shipped freight collect unless freight is paid in advance by You.\"}, {\"id\": \"C\", \"title\": \"You will pay the prices then prevailing at the time AIRSOPURE receives each order\", \"level\": 1, \"text\": \"C. You will pay the prices then prevailing at the time AIRSOPURE receives each order. Such prices are subject to change at any time by AIRSOPURE.\"}, {\"id\": \"D\", \"title\": \"All merchandise will be shipped to You at the Center for resale to customers\", \"level\": 1, \"text\": \"D. All merchandise will be shipped to You at the Center for resale to customers in the Exclusive Territory. You will sell Products only to end-user customers and not for resale. You will not sell or lease Products at any location other than within Your Exclusive Territory, engage in mail order sales of Products or supply Products to others for resale or lease at any other location. E. All orders for Products are subject to availability. In the event any Product is in short supply, AIRSOPURE shall have the right to allocate such Product on an equitable basis. F. You will not modify the Products, and You will not offer or carry any products or services other than AIRSOPURE's Products and services specified by AIRSOPURE without written approval from AIRSOPURE. G. Notwithstanding nationally advertised prices by AIRSOPURE, You may resell Products purchased under this Agreement at prices set by You. However, AIRSOPURE retains the right, to the extent permitted by law, to refuse to fill Your orders for Products if You fail to honor AIRSOPURE's suggested prices for the same Products sold by other franchise owners in Your region.\"}, {\"id\": \"7\", \"title\": \"LICENSED MARKS\", \"level\": 1, \"text\": \"7. LICENSED MARKS\"}, {\"id\": \"7.01\", \"title\": \"AIRSOPURE represents with respect to the Licensed Marks that\", \"level\": 2, \"text\": \"7.01. AIRSOPURE represents with respect to the Licensed Marks that: A. AIRSOPURE is the owner of all right, title and interest in and to the Licensed Marks or has the right and license to use and grant a license to You to use the said Licensed Marks. B. AIRSOPURE will take all steps reasonably necessary to preserve and protect the ownership and validity in and to the Licensed Marks.\"}, {\"id\": \"7.02\", \"title\": \"With respect to Your licensed use of the Licensed Marks pursuant to this Agreement, You agree that\", \"level\": 2, \"text\": \"7.02. With respect to Your licensed use of the Licensed Marks pursuant to this Agreement, You agree that: A. You shall use only the Licensed Marks designated by AIRSOPURE and shall use them only in the manner authorized and permitted by AIRSOPURE. B. You shall use the Licensed Marks only for the operation of the Franchise at the Authorized Location. 6\"}, {\"id\": \"C\", \"title\": \"During the term of this Agreement, You shall identify Yourself as the owner of the Franchise in conjunction with any us\", \"level\": 1, \"text\": \"C. During the term of this Agreement, You shall identify Yourself as the owner of the Franchise in conjunction with any use of the Licensed Marks, including, but not limited to, on invoices, order forms, receipts, business cards, contracts and at such conspicuous locations on the Center's premises or in the field as AIRSOPURE may specify. The identification shall be in a form which specifies Your name, followed by the term \\\"Independent Franchise Owner\\\" or such other identification as shall be approved by AIRSOPURE.\"}, {\"id\": \"D\", \"title\": \"You shall not use the Licensed Marks to incur any obligation or indebtedness on behalf of AIRSOPURE, and You shall not\", \"level\": 1, \"text\": \"D. You shall not use the Licensed Marks to incur any obligation or indebtedness on behalf of AIRSOPURE, and You shall not represent that Your Center is owned, operated by or affiliated with AIRSOPURE other than as a franchisee. E. You shall not use the Licensed Marks as part of Your corporate or other legal name, without the prior written consent of AIRSOPURE. F. You shall file an assumed name registration, and shall execute any documents deemed necessary by AIRSOPURE to obtain protection for the Licensed Marks or to maintain their continued validity and enforceability.\"}, {\"id\": \"7.03\", \"title\": \"You expressly understand and acknowledge that\", \"level\": 2, \"text\": \"7.03. You expressly understand and acknowledge that: A. As between the Parties hereto, AIRSOPURE, by its trademark License Agreement with Airsopure, Inc. is the licensor of all right, title and interest in and to the Licensed Marks and the goodwill associated with and symbolized by them. B. You shall not directly or indirectly contest the validity of the ownership of the Licensed Marks.\"}, {\"id\": \"C\", \"title\": \"Your use of the Licensed Marks pursuant to this Agreement does not give You any ownership interest or other interest in\", \"level\": 1, \"text\": \"C. Your use of the Licensed Marks pursuant to this Agreement does not give You any ownership interest or other interest in or to the Licensed Marks.\"}, {\"id\": \"D\", \"title\": \"Any and all goodwill arising from Your use of the Licensed Marks in the Franchise under AIRSOPURE's system shall inure\", \"level\": 1, \"text\": \"D. Any and all goodwill arising from Your use of the Licensed Marks in the Franchise under AIRSOPURE's system shall inure solely and exclusively to the benefit of AIRSOPURE, and upon expiration or termination of this Agreement and the Franchise herein granted, no monetary amount shall be assigned as attributable to any goodwill associated with Your use of the Licensed Marks. E. The right and license to use the Licensed Marks granted hereunder to You is nonexclusive, and AIRSOPURE may use and grant franchises to others to use the Licensed Marks in any manner except as expressly provided otherwise herein. F. AIRSOPURE reserves the right to substitute different Licensed Marks for use in identifying the System and the businesses operating thereunder, and You agree to comply with AIRSOPURE's requirements relating thereto.\"}, {\"id\": \"7.04\", \"title\": \"You shall promptly notify AIRSOPURE of any unauthorized use of the Licensed Marks or marks confusingly similar thereto,\", \"level\": 2, \"text\": \"7.04. You shall promptly notify AIRSOPURE of any unauthorized use of the Licensed Marks or marks confusingly similar thereto, any challenge to the validity of the Licensed Marks, or any challenge to AIRSOPURE's ownership of, or Your right to use, the Licensed Marks. You acknowledge that AIRSOPURE has the sole right to direct and control any administrative proceeding or litigation involving the Licensed Marks, including any settlement thereof. AIRSOPURE has the right, but not the obligation, to take action against uses by others that may constitute infringement of the Licensed Marks.\"}, {\"id\": \"7.05\", \"title\": \"Provided You have used the Licensed Marks in accordance with this Franchise Agreement and AIRSOPURE's Operations Manual\", \"level\": 2, \"text\": \"7.05. Provided You have used the Licensed Marks in accordance with this Franchise Agreement and AIRSOPURE's Operations Manual, AIRSOPURE will defend You at AIRSOPURE's expense against any third Party claim, suit or demand involving the Licensed Marks and arising out of Your use thereof. In the event that You have not used the Licensed Marks in accordance with this Agreement, AIRSOPURE shall defend You, at Your expense, against such third Party claims, suits or demands. 7\"}, {\"id\": \"7.06\", \"title\": \"In the event of any litigation or administrative proceeding relating to the Licensed Marks, You shall execute any and a\", \"level\": 2, \"text\": \"7.06. In the event of any litigation or administrative proceeding relating to the Licensed Marks, You shall execute any and all documents and do all acts as may, in the opinion of AIRSOPURE, be necessary to carry out such defense or prosecution, including, but not limited to, becoming a nominal Party to any legal action. Except to the extent that such litigation is the result of Your use of the Proprietary Marks in a manner inconsistent with the terms of this Agreement, AIRSOPURE agrees to reimburse You for its out-of-pocket costs in performing such acts, except that You shall bear the salary costs of its employees, and AIRSOPURE shall bear the cost of any judgment or settlement.\"}, {\"id\": \"8\", \"title\": \"OPERATIONS MANUAL\", \"level\": 1, \"text\": \"8. OPERATIONS MANUAL\"}, {\"id\": \"8.01\", \"title\": \"AIRSOPURE shall provide You with one copy of AIRSOPURE's Operations Manual covering the proper operating and marketing\", \"level\": 2, \"text\": \"8.01. AIRSOPURE shall provide You with one copy of AIRSOPURE's Operations Manual covering the proper operating and marketing techniques and the standards and specifications for operation of the Franchise. You agree to fully comply with the Operations Manual in its entirety as an essential aspect of Your obligations under this Agreement. Failure to so comply shall be treated as a breach of this Agreement.\"}, {\"id\": \"8.02\", \"title\": \"You shall at all times treat the Operations Manual, all supplements and revisions thereto, any other operations manual,\", \"level\": 2, \"text\": \"8.02. You shall at all times treat the Operations Manual, all supplements and revisions thereto, any other operations manual, brochure or memorandum created for or approved for use in the operation of the Franchise and the information contained therein as the confidential and proprietary information of AIRSOPURE, and shall use all reasonable efforts to maintain the confidentiality of such information. You shall not at any time, without AIRSOPURE's prior written consent, copy, duplicate, record, or otherwise reproduce the foregoing materials, in whole or in part, nor otherwise make the same available to any unauthorized person. You may disclose such information and materials only to such of Your employees or agents, or others who must have access to it in connection with their employment or the performance of this Agreement, in which event You shall obtain the agreement of such persons and entities to maintain the confidentiality thereof. The Operations Manual shall remain at all times the sole property of AIRSOPURE.\"}, {\"id\": \"8.03\", \"title\": \"AIRSOPURE may from time to time revise the contents of the Operations Manual, and You expressly agree to comply with ea\", \"level\": 2, \"text\": \"8.03. AIRSOPURE may from time to time revise the contents of the Operations Manual, and You expressly agree to comply with each new or changed standard, specification or procedure set forth therein. You shall at all times ensure that Your copy of the Operations Manual is kept current and up to date. In the event of any dispute as to the content of the Operations Manual, the terms of the master copy of the Operations Manual maintained by AIRSOPURE at AIRSOPURE's home office shall be controlling.\"}, {\"id\": \"9\", \"title\": \"ACCOUNTING AND RECORDS\", \"level\": 1, \"text\": \"9. ACCOUNTING AND RECORDS\"}, {\"id\": \"9.01\", \"title\": \"During the term of this Agreement, You shall maintain and preserve, for at least five years from the date of their prep\", \"level\": 2, \"text\": \"9.01. During the term of this Agreement, You shall maintain and preserve, for at least five years from the date of their preparation, full, complete, and accurate, books, records and accounts in the form and manner prescribed by AIRSOPURE from time to time in the Operations Manual or otherwise in writing.\"}, {\"id\": \"9.02\", \"title\": \"You shall, at Your expense, submit to AIRSOPURE, by the 7th day of each month, a monthly statement on forms prescribed\", \"level\": 2, \"text\": \"9.02. You shall, at Your expense, submit to AIRSOPURE, by the 7th day of each month, a monthly statement on forms prescribed by AIRSOPURE accurately reflecting gross sales of the Franchise for the preceding calendar month. Each statement shall accompany Your monthly royalty and advertising fund fee payments and shall be signed by You attesting that it is true and correct.\"}, {\"id\": \"9.03\", \"title\": \"You shall, at Your expense, submit to AIRSOPURE an annual financial statement for the Franchise, which includes an inco\", \"level\": 2, \"text\": \"9.03. You shall, at Your expense, submit to AIRSOPURE an annual financial statement for the Franchise, which includes an income statement prepared in accordance with generally accepted accounting principals, within 90 days of the end of each fiscal year during the term hereof. Each statement shall be signed by You attesting that it is true and correct.\"}, {\"id\": \"9.04\", \"title\": \"You shall submit to AIRSOPURE for review and auditing such other forms, reports,\", \"level\": 2, \"text\": \"9.04. You shall submit to AIRSOPURE for review and auditing such other forms, reports, 8 records, information and data, as AIRSOPURE may reasonably request in writing.\"}, {\"id\": \"9.05\", \"title\": \"AIRSOPURE or its designated agents shall have the right at all reasonable times to examine and copy, at its expense, al\", \"level\": 2, \"text\": \"9.05. AIRSOPURE or its designated agents shall have the right at all reasonable times to examine and copy, at its expense, all books, records, receipts and tax returns of Yours related to the Franchise and, at its option, to have an independent audit made, and thereupon be allowed to search Your computer accounting files. If an inspection or audit should reveal that payments have been understated in any report to AIRSOPURE, then You shall immediately pay to AIRSOPURE the amount understated upon demand, in addition to interest from the date such amount was due until paid, at the prime rate being charged by Bank of America on the date the payment was due plus 2%, or the maximum rate permitted by law, whichever is less. If an inspection discloses an underpayment to AIRSOPURE of 2% or more of the total amount that should have been paid to AIRSOPURE, You shall, in addition to repayment of such understated amount with interest, reimburse AIRSOPURE for any and all costs and expenses incurred in connection with the inspection or audit (including, without limitation, reasonable accounting and attorneys' fees). The foregoing remedies shall be in addition to any other remedies AIRSOPURE may have, including without limitation, the remedies for default.\"}, {\"id\": \"10\", \"title\": \"MARKETING AND ADVERTISING\", \"level\": 1, \"text\": \"10. MARKETING AND ADVERTISING\"}, {\"id\": \"10.01\", \"title\": \"You shall submit to AIRSOPURE for review prior to use samples of all advertising and promotional materials that have no\", \"level\": 2, \"text\": \"10.01. You shall submit to AIRSOPURE for review prior to use samples of all advertising and promotional materials that have not been previously approved by AIRSOPURE. AIRSOPURE shall notify You of its approval or disapproval within 7 days or less from the date of receipt by AIRSOPURE of such materials. Failure by You to obtain the prior approval in writing of AIRSOPURE for all advertising and promotional materials shall be a violation of this Agreement.\"}, {\"id\": \"10.02\", \"title\": \"AIRSOPURE has established an advertising fund (the \\\"Fund\\\") to build recognition of the Products and the Licensed Marks\", \"level\": 2, \"text\": \"10.02. AIRSOPURE has established an advertising fund (the \\\"Fund\\\") to build recognition of the Products and the Licensed Marks and to promote AIRSOPURE's Products and the Franchise. You shall participate in the Fund, in addition to Your obligation to conduct local advertising of the Franchise, on the basis described in Paragraph 3.01.D above.\"}, {\"id\": \"10.03\", \"title\": \"AIRSOPURE will administer the Fund as follows\", \"level\": 2, \"text\": \"10.03. AIRSOPURE will administer the Fund as follows: A. The Fund shall be maintained in a separate bank account. Upon request by You, AIRSOPURE will provide an annual accounting of amounts spent from the Fund, including a reasonable allocation to cover AIRSOPURE's overhead expenses for administration and management of the Fund. B. AIRSOPURE may allocate amounts held in the Fund at its discretion as AIRSOPURE deems appropriate. You are not guaranteed that any particular amount or percentage of the Fund will be spent in Your local market.\"}, {\"id\": \"C\", \"title\": \"AIRSOPURE shall have the right to terminate the Fund at any time\", \"level\": 1, \"text\": \"C. AIRSOPURE shall have the right to terminate the Fund at any time. However, the Fund will not be terminated until all moneys in the Fund have been expended for the purposes stated in Paragraph 10.02 above.\"}, {\"id\": \"D\", \"title\": \"AIRSOPURE may from time to time amend its policies or establish new policies and procedures for administration of the F\", \"level\": 1, \"text\": \"D. AIRSOPURE may from time to time amend its policies or establish new policies and procedures for administration of the Fund.\"}, {\"id\": \"10.04\", \"title\": \"In addition to its monthly contribution to the Fund, You shall spend an amount equal to at least 2% of Your total month\", \"level\": 2, \"text\": \"10.04. In addition to its monthly contribution to the Fund, You shall spend an amount equal to at least 2% of Your total monthly gross sales (as defined in Paragraph 3.01.C above) on local advertising in Your Exclusive Territory. You shall submit to AIRSOPURE a monthly report to accompany Your advertising fund fee and royalty fee payments accounting for and evidencing Your local advertising expenditures. Your local advertising shall comply with the procedures specified in Paragraph 10.01 above. 9\"}, {\"id\": \"11\", \"title\": \"INSURANCE\", \"level\": 1, \"text\": \"11. INSURANCE\"}, {\"id\": \"11.01\", \"title\": \"You shall procure and maintain in full force and effect during the term of this Agreement, at Your expense, insurance p\", \"level\": 2, \"text\": \"11.01. You shall procure and maintain in full force and effect during the term of this Agreement, at Your expense, insurance policies written by an insurance company satisfactory to AIRSOPURE in accordance with standards and specifications set forth in the Operations Manual or otherwise by AIRSOPURE in writing. Such policies shall name AIRSOPURE as an additional insured and shall include, at a minimum: A. Comprehensive general liability insurance in the amount of $1,000,000.00. B. Comprehensive automobile liability insurance, including collision, comprehensive, medical and liability to satisfy state law requirements.\"}, {\"id\": \"C\", \"title\": \"Additional coverage's and higher policy limits may be required from time to time by AIRSOPURE\", \"level\": 1, \"text\": \"C. Additional coverage's and higher policy limits may be required from time to time by AIRSOPURE.\"}, {\"id\": \"11.02\", \"title\": \"At least 7 days prior to the opening of the Center and on each policy renewal date thereafter, You shall submit to AIRS\", \"level\": 2, \"text\": \"11.02. At least 7 days prior to the opening of the Center and on each policy renewal date thereafter, You shall submit to AIRSOPURE copies of all policies and policy amendments. The evidence of insurance shall include a statement by the insurer that the policy or policies will not be canceled or materially altered without at least 30 days prior written notice to AIRSOPURE.\"}, {\"id\": \"11.03\", \"title\": \"Your obligation to obtain and maintain the foregoing policy or policies in the amounts specified shall not be limited i\", \"level\": 2, \"text\": \"11.03. Your obligation to obtain and maintain the foregoing policy or policies in the amounts specified shall not be limited in any way by reason of any insurance which may be maintained by AIRSOPURE, nor shall Your performance of that obligation relieve You of liability under the indemnity provisions set forth in Section 17 of this Agreement.\"}, {\"id\": \"11.04\", \"title\": \"Should You, for any reason, fail to procure or maintain the insurance required by this Agreement, AIRSOPURE shall have\", \"level\": 2, \"text\": \"11.04. Should You, for any reason, fail to procure or maintain the insurance required by this Agreement, AIRSOPURE shall have the right and authority (without, however, any obligation to do so) immediately to procure such insurance and to charge same to You, which charges, together with a reasonable fee for AIRSOPURE's expenses in so acting, shall be payable by You immediately upon notice. AIRSOPURE is not a licensed insurance agent or agency.\"}, {\"id\": \"12\", \"title\": \"TRANSFER OF INTEREST\", \"level\": 1, \"text\": \"12. TRANSFER OF INTEREST\"}, {\"id\": \"12.01\", \"title\": \"Transfer by AIRSOPURE\", \"level\": 2, \"text\": \"12.01. Transfer by AIRSOPURE A. AIRSOPURE shall have the right to transfer or assign all or any part of its rights or obligations in this Agreement to any person or legal entity. AIRSOPURE may sell or assign any of its assets, including without limitation the Licensed Marks, the system or Products, to any person or legal entity without liability or obligation to You. B. Nothing in this Agreement or otherwise shall obligate AIRSOPURE to remain in the indoor air purification business in the event AIRSOPURE should exercise its right to assign this Agreement or its assets which are the subject of this Agreement to a third Party.\"}, {\"id\": \"12.02\", \"title\": \"Transfer by You A\", \"level\": 2, \"text\": \"12.02. Transfer by You A. You agree that the rights and duties set forth in this Agreement are personal to You, and that AIRSOPURE has entered into this Agreement and granted the Franchise rights and license hereunder in reliance on Your business skill, financial capacity, and character. Accordingly, You shall not sell, assign, transfer, convey, give away, mortgage or otherwise encumber any direct or indirect interest in the Franchise without the prior written consent of AIRSOPURE. B. Any purported assignment or transfer, by operation of law or otherwise, not having the prior written consent of AIRSOPURE shall be null and void and shall constitute a material breach of this Agreement.\"}, {\"id\": \"C\", \"title\": \"AIRSOPURE shall not unreasonably withhold its consent to a transfer of any interest in Your Franchise or in this Agreem\", \"level\": 1, \"text\": \"C. AIRSOPURE shall not unreasonably withhold its consent to a transfer of any interest in Your Franchise or in this Agreement if the following conditions have been met:\"}, {\"id\": \"1\", \"title\": \"All of Your accrued monetary and other\", \"level\": 1, \"text\": \"1. All of Your accrued monetary and other 10 obligations to AIRSOPURE and its subsidiaries, affiliates and suppliers shall have been satisfied;\"}, {\"id\": \"2\", \"title\": \"You shall not be in default of any provisions of this Agreement or any other agreement between You and AIRSOPURE or its\", \"level\": 1, \"text\": \"2. You shall not be in default of any provisions of this Agreement or any other agreement between You and AIRSOPURE or its affiliates or suppliers;\"}, {\"id\": \"3\", \"title\": \"You shall have executed a general release, in a form satisfactory to AIRSOPURE, of any and all claims against AIRSOPURE\", \"level\": 1, \"text\": \"3. You shall have executed a general release, in a form satisfactory to AIRSOPURE, of any and all claims against AIRSOPURE and its officers, directors, shareholders and employees.\"}, {\"id\": \"4\", \"title\": \"You shall remain liable for all obligations to AIRSOPURE in connection with the Franchise prior to the effective date o\", \"level\": 1, \"text\": \"4. You shall remain liable for all obligations to AIRSOPURE in connection with the Franchise prior to the effective date of the transfer;\"}, {\"id\": \"5\", \"title\": \"The transferee shall enter into a written assignment in a form satisfactory to AIRSOPURE assuming and agreeing to disch\", \"level\": 1, \"text\": \"5. The transferee shall enter into a written assignment in a form satisfactory to AIRSOPURE assuming and agreeing to discharge all of Your obligations under this Agreement;\"}, {\"id\": \"6\", \"title\": \"The transferee shall demonstrate to AIRSOPURE's satisfaction that the transferee meets AIRSOPURE's then existing requir\", \"level\": 1, \"text\": \"6. The transferee shall demonstrate to AIRSOPURE's satisfaction that the transferee meets AIRSOPURE's then existing requirements and qualifications for the granting of an AIRSOPURE Franchise;\"}, {\"id\": \"7\", \"title\": \"The transferee shall execute for a term ending on the expiration date of this Agreement the standard form franchise agr\", \"level\": 1, \"text\": \"7. The transferee shall execute for a term ending on the expiration date of this Agreement the standard form franchise agreement then being offered to new franchisees and such other ancillary agreements and documents as AIRSOPURE may then require for the Franchise, which may include changes in required fee payments or other terms;\"}, {\"id\": \"8\", \"title\": \"The transferee shall agree to upgrade the Franchise to conform to the then current standards and specifications for AIR\", \"level\": 1, \"text\": \"8. The transferee shall agree to upgrade the Franchise to conform to the then current standards and specifications for AIRSOPURE franchises;\"}, {\"id\": \"9\", \"title\": \"Transferee and its employees shall complete such training programs as AIRSOPURE may reasonably require, at the transfer\", \"level\": 1, \"text\": \"9. Transferee and its employees shall complete such training programs as AIRSOPURE may reasonably require, at the transferee's expense;\"}, {\"id\": \"10\", \"title\": \"You shall pay AIRSOPURE a transfer fee of $1000\", \"level\": 1, \"text\": \"10. You shall pay AIRSOPURE a transfer fee of $1000.00 to cover AIRSOPURE's administrative expenses in connection with the transfer.\"}, {\"id\": \"12.03\", \"title\": \"Right of First Refusal\", \"level\": 2, \"text\": \"12.03. Right of First Refusal In the event You desire to sell the AIRSOPURE Center and Franchise rights and license granted herein, or any part of Your stock interest in a corporation that has been granted such rights, and receives a bona fide acceptable offer in writing, You agree to notify AIRSOPURE in writing of the terms and conditions of such offer. AIRSOPURE shall have the option, within 15 days after receipt of such written notice, to notify You that AIRSOPURE elects to purchase the rights and license granted herein or stock ownership on the same terms and conditions as the bona fide written offer. You agree to sell to AIRSOPURE on the same terms and conditions as the bona fide offer and to comply with all applicable laws relating to bulk transfers of assets. If AIRSOPURE fails to notify You of its election to exercise its right of first refusal granted herein within the thirty day period, then You may sell the franchise rights and license or the stock for the amount of the bona fide offer, subject to AIRSOPURE's rights under Section 12.02 above. Any material change in the terms or conditions of any offer prior to closing shall constitute a new offer subject to AIRSOPURE's right of first refusal described herein. If You fail to consummate the transaction within 30 days from the earlier of: (a) receipt of notice from AIRSOPURE that it elects not to exercise its right of first refusal, or (b) expiration of the 15 day period referred to herein, then You must resubmit the proposed transaction to AIRSOPURE, and AIRSOPURE shall have a new 15 day review period and right of first refusal.\"}, {\"id\": \"12.04\", \"title\": \"Transfer Upon Death or Mental Incapacity Upon Your death or mental incapacity, or a person owning all or controlling\", \"level\": 2, \"text\": \"12.04. Transfer Upon Death or Mental Incapacity Upon Your death or mental incapacity, or a person owning all or controlling interest in Your Franchise, AIRSOPURE shall consent to the transfer of such interest to Your spouse or heirs provided, in AIRSOPURE's sole determination, such person(s) meet AIRSOPURE's then existing requirements and qualifications for the granting of an AIRSOPURE Franchise. If the said transfer 11 shall not be approved by AIRSOPURE, Your executor, administrator or personal representative shall transfer Your interest to a third Party approved by AIRSOPURE within 6 months after Your death or the determination of Your mental incapacity. If Your interest is not disposed of within 6 months after such death or mental incapacity, AIRSOPURE may terminate this Agreement.\"}, {\"id\": \"12.05\", \"title\": \"Operation of Franchise by AIRSOPURE In order to prevent any interruption in the business that would cause harm to the\", \"level\": 2, \"text\": \"12.05. Operation of Franchise by AIRSOPURE In order to prevent any interruption in the business that would cause harm to the Franchise or AIRSOPURE, You authorize AIRSOPURE, at its option but not its obligation, in the event that You are absent or incapacitated by reason of illness, death or otherwise and are not, in AIRSOPURE's sole judgment, able to operate the Franchise for any extended period of time, to operate and manage the Franchise for so long as AIRSOPURE deems necessary, without waiving any of AIRSOPURE's other rights and remedies under this Agreement. All monies from the operation of the Franchise during such period of operation by AIRSOPURE shall be kept in a separate account, and the expenses of AIRSOPURE during such period for operating the Franchise, including reasonable compensation of AIRSOPURE and its employees or representatives, shall be charged to such account. You agree to save harmless and fully indemnify AIRSOPURE and its employees and representatives for and against all claims, losses or actions in connection with the operation and management of the Franchise hereunder.\"}, {\"id\": \"12.06\", \"title\": \"Non-Waiver of Claims AIRSOPURE's consent to a transfer of any interest in the Franchise granted herein shall not cons\", \"level\": 2, \"text\": \"12.06. Non-Waiver of Claims AIRSOPURE's consent to a transfer of any interest in the Franchise granted herein shall not constitute a waiver of any claims it may have against You, nor shall it be deemed a waiver of AIRSOPURE's right to demand exact compliance with any of the terms of this Agreement by the transferee.\"}, {\"id\": \"13\", \"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"13. CONFIDENTIAL INFORMATION\"}, {\"id\": \"13.01\", \"title\": \"You shall not, during the term of this Agreement or thereafter, communicate, divulge, or use for the benefit of any othe\", \"level\": 2, \"text\": \"13.01 You shall not, during the term of this Agreement or thereafter, communicate, divulge, or use for the benefit of any other person or entity any confidential information, knowledge, or know-how concerning AIRSOPURE's system, the Products or the operation of the Franchise, including without limitation the Operations Manual. You shall divulge such confidential information only to such of Your employees or agents as must have access to it in order to operate the Franchise. Any and all information, trade secrets, knowledge, know-how, or other data concerning AIRSOPURE's system, the Products or which AIRSOPURE designates as confidential shall be deemed confidential for purposes of this Agreement, except information which You can demonstrate came to Your attention prior to disclosure thereof by AIRSOPURE, or which, at or after the time of disclosure by AIRSOPURE to You, had become or later becomes a part of the public domain, through publication or communication by others. You agree to use such proprietary information of AIRSOPURE only for operation of the Franchise Business.\"}, {\"id\": \"13.02\", \"title\": \"You acknowledge that the provisions of this Section 13 are and have been a primary inducement to AIRSOPURE to enter int\", \"level\": 2, \"text\": \"13.02. You acknowledge that the provisions of this Section 13 are and have been a primary inducement to AIRSOPURE to enter into this Agreement, and that any failure to comply with the requirements of Section 13.01 will cause AIRSOPURE irreparable injury without an adequate remedy at law; and You agree to pay all court costs and reasonable attorneys' fees incurred by AIRSOPURE in obtaining specific performance of, or an injunction against any violation of, the requirements of Section 13.01.\"}, {\"id\": \"14\", \"title\": \"DEFAULT AND TERMINATION\", \"level\": 1, \"text\": \"14. DEFAULT AND TERMINATION\"}, {\"id\": \"14.01\", \"title\": \"AIRSOPURE may, at its option, terminate this Agreement and all rights granted hereunder, without affording You any oppo\", \"level\": 2, \"text\": \"14.01. AIRSOPURE may, at its option, terminate this Agreement and all rights granted hereunder, without affording You any opportunity to cure the defaults, effective immediately upon receipt of notice by You, upon the occurrence of any of the following: A. You become insolvent or makes a general assignment for the benefit of creditors; or if a 12 petition in bankruptcy is filed by You or such a petition is filed against and consented to by You; or if You are adjudicated a bankrupt; or if You are unable to pay commercial debts as they become due. B. You (or a principal shareholder if the Franchisee is a corporation) is convicted of a felony or any other crime or offense that is reasonably likely, in the sole opinion of AIRSOPURE, to adversely affect the goodwill or reputation of AIRSOPURE or the Licensed Marks.\"}, {\"id\": \"C\", \"title\": \"A judgment or consent decree is entered against You (or a principal shareholder if the Franchisee is a corporation) in\", \"level\": 1, \"text\": \"C. A judgment or consent decree is entered against You (or a principal shareholder if the Franchisee is a corporation) in a case involving allegations of fraud, racketeering, unfair or deceptive trade practices or similar allegations which, in AIRSOPURE's judgment, are likely to adversely affect AIRSOPURE, its Products, the Licensed Marks or the goodwill associated therewith.\"}, {\"id\": \"D\", \"title\": \"You or any partner or shareholder in You transfers any rights or obligations under this Agreement or any interest in Yo\", \"level\": 1, \"text\": \"D. You or any partner or shareholder in You transfers any rights or obligations under this Agreement or any interest in You or in the Franchise to any third Party without AIRSOPURE's prior written consent. E. You intentionally disclose the contents of the Operations Manual or&bbsp;other trade secrets or confidential information provided to You by AIRSOPURE to any unauthorized person or fails to exercise reasonable care to prevent such disclosure. F. You maintain false books or records of the Franchise or knowingly make any material false statements or omission to AIRSOPURE in connection with Your application for the franchise granted herein or in connection with any reports submitted to AIRSOPURE, including without limitation the understatement of gross sales by more than 2%. G. You fail to commence business within 4 months following the execution of this Agreement. H. You (and Your manager) fail to attend any scheduled training program which AIRSOPURE has indicated is mandatory.\"}, {\"id\": \"I\", \"title\": \"You operate the Franchise in such a manner which causes a threat or danger to public health or safety\", \"level\": 1, \"text\": \"I. You operate the Franchise in such a manner which causes a threat or danger to public health or safety. J. You receive 3 or more notices of default of this Agreement from AIRSOPURE for violations under Section 14.02 hereof.\"}, {\"id\": \"14.02\", \"title\": \"Except for violations of this Agreement listed in Section 13\", \"level\": 2, \"text\": \"14.02. Except for violations of this Agreement listed in Section 13.01 above, or violations specifically provided for elsewhere in this Agreement, You shall have 30 days from receipt from AIRSOPURE of a written Notice of Termination (citing the reason(s) therefor) within which to remedy any default listed in this Section 13.02, or any other violation of this Agreement. A. You fail to pay promptly any monies owing to AIRSOPURE or its subsidiaries or affiliates when due, or to submit the financial information or reports required by AIRSOPURE under this Agreement. B. You fail to meet or comply with any standards, specifications or procedures prescribed by AIRSOPURE in this Agreement, the Operations Manual or otherwise specified in writing from time to time by AIRSOPURE.\"}, {\"id\": \"C\", \"title\": \"You are convicted, plead guilty or enter into a consent agreement for violation of any federal, state or local law, ord\", \"level\": 1, \"text\": \"C. You are convicted, plead guilty or enter into a consent agreement for violation of any federal, state or local law, ordinance, rule or regulation that is reasonably likely, in the sole opinion of AIRSOPURE, to materially and unfavorably affect the Franchise or AIRSOPURE, the Licensed Marks or the goodwill associated therewith.\"}, {\"id\": \"D\", \"title\": \"You misuse or make any unauthorized use of the Proprietary Marks or otherwise impairs the\", \"level\": 1, \"text\": \"D. You misuse or make any unauthorized use of the Proprietary Marks or otherwise impairs the 13 goodwill associated therewith or AIRSOPURE's rights therein. E. You abandon the Franchise or fail to operate the Center during normal business hours without the consent in writing of AIRSOPURE. F. You fail to submit advertising or promotional materials to AIRSOPURE for approval in writing prior to use.\"}, {\"id\": \"14.03\", \"title\": \"No right or remedy of AIRSOPURE conferred herein shall be exclusive of any other right or remedy provided herein, at la\", \"level\": 2, \"text\": \"14.03. No right or remedy of AIRSOPURE conferred herein shall be exclusive of any other right or remedy provided herein, at law or in equity, unless specifically provided otherwise in this Agreement or any amendment hereto.\"}, {\"id\": \"14.04\", \"title\": \"In the event this Agreement is terminated by AIRSOPURE for violation of this Agreement by You, AIRSOPURE shall have the\", \"level\": 2, \"text\": \"14.04. In the event this Agreement is terminated by AIRSOPURE for violation of this Agreement by You, AIRSOPURE shall have the right, at its option, to purchase Your interest in the tangible assets of the Franchise at their fair market value.\"}, {\"id\": \"15\", \"title\": \"OBLIGATIONS UPON TERMINATION\", \"level\": 1, \"text\": \"15. OBLIGATIONS UPON TERMINATION\"}, {\"id\": \"15.01\", \"title\": \"Upon termination or expiration of this Agreement, this Agreement and all rights granted hereunder to You shall immediat\", \"level\": 2, \"text\": \"15.01. Upon termination or expiration of this Agreement, this Agreement and all rights granted hereunder to You shall immediately terminate, and: A. You shall immediately cease to operate the Franchise and shall not thereafter, directly or indirectly, represent to the public or hold itself out as a present or former franchisee of AIRSOPURE. B. You shall immediately and permanently cease to use, by advertising or in any other manner whatsoever, the Licensed Marks of AIRSOPURE, any other identifying characteristics or trade dress of the system, and all confidential methods, procedures and techniques associated with the Franchise.\"}, {\"id\": \"C\", \"title\": \"You shall take such action as may be necessary to cancel any assumed name or equivalent registrations or listings in te\", \"level\": 1, \"text\": \"C. You shall take such action as may be necessary to cancel any assumed name or equivalent registrations or listings in telephone or other directories which contain the names or Licensed Marks of AIRSOPURE, and You shall furnish AIRSOPURE with evidence satisfactory to AIRSOPURE of compliance with this obligation within 30 days after termination or expiration of this Agreement.\"}, {\"id\": \"D\", \"title\": \"You shall promptly pay all sums owing to AIRSOPURE and its subsidiaries and affiliates, including all damages, costs an\", \"level\": 1, \"text\": \"D. You shall promptly pay all sums owing to AIRSOPURE and its subsidiaries and affiliates, including all damages, costs and expenses, including reasonable attorneys' fees, incurred by AIRSOPURE as a result of the default. E. You shall pay to AIRSOPURE all damages, costs and expenses, including reasonable attorneys' fees, incurred by AIRSOPURE subsequent to the termination or expiration of the Franchise herein granted in obtaining injunctive or other relief for the enforcement of any provisions of this Agreement. F. You shall immediately turn over to AIRSOPURE the Operations Manual, records, files, instructions, software, correspondence, and all other materials provided by AIRSOPURE related to the operation of the Franchise, and all copies thereof (all of which are acknowledged to be AIRSOPURE's property), and shall retain no copy or record of any of the foregoing, except only Your copy of this Agreement and any correspondence between the Parties, and any other documents which You reasonably need for compliance with any applicable provision of law. G. AIRSOPURE shall have the right, but not the duty, to be exercised by notice of intent to do so within 30 days after termination or expiration, to purchase any or all signs, advertising materials, supplies and inventory and any other items bearing AIRSOPURE's Licensed Marks, at Your cost or at fair market value, whichever is less. If the Parties cannot agree on the fair market value of such items, the Parties will select and share the expense of an independent appraiser to determine fair market value. With respect to any purchase by AIRSOPURE as provided herein, AIRSOPURE shall have the right to set off against the purchase price all amounts due from 14 You under this Agreement.\"}, {\"id\": \"16\", \"title\": \"COVENANTS\", \"level\": 1, \"text\": \"16. COVENANTS\"}, {\"id\": \"16.01\", \"title\": \"You covenant and agree (or if Your Franchise is a corporation Your controlling shareholder agrees) to supervise and dev\", \"level\": 2, \"text\": \"16.01. You covenant and agree (or if Your Franchise is a corporation Your controlling shareholder agrees) to supervise and devote Your best efforts to manage and operate the Franchise.\"}, {\"id\": \"16.02\", \"title\": \"You acknowledge that, pursuant to this Agreement, You will receive valuable specialized training and confidential and p\", \"level\": 2, \"text\": \"16.02. You acknowledge that, pursuant to this Agreement, You will receive valuable specialized training and confidential and proprietary information of AIRSOPURE, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of AIRSOPURE and its system. You covenant and agree that during the term of this Agreement, and subject to the post-termination provisions contained herein, You shall not, except as otherwise approved in writing by AIRSOPURE, either directly or indirectly: A. Divert or attempt to divert any business or customer of the Franchise to any competitor, or competing business, by direct or indirect inducement or otherwise, or do or perform, directly or indirectly, any other act injurious or prejudicial to AIRSOPURE or the goodwill associated with the Licensed Marks and Products. B. Employ or seek to employ any person who is at that time employed by AIRSOPURE or by another AIRSOPURE franchisee or induce such person to leave his or her employment.\"}, {\"id\": \"C\", \"title\": \"Own, maintain, engage in, be employed by, advise, consult, assist, invest in or have any interest whatsoever in any bus\", \"level\": 1, \"text\": \"C. Own, maintain, engage in, be employed by, advise, consult, assist, invest in or have any interest whatsoever in any business or entity which competes with or offers products or services which are the same or similar to those of AIRSOPURE or the Franchise.\"}, {\"id\": \"16.03\", \"title\": \"You covenant and agree that You (or any shareholder if Your Franchise is a corporation) shall not, for a period of two\", \"level\": 2, \"text\": \"16.03. You covenant and agree that You (or any shareholder if Your Franchise is a corporation) shall not, for a period of two years following termination of this Agreement for any reason, either directly or indirectly own, maintain, engage in, be employed by, advise, consult, assist, invest in or have any interest whatsoever in any business or entity which competes with or offers products or services which are the same or similar to those of AIRSOPURE or the Franchise within a radius of 25 miles of Your Exclusive Territory. In the event a court of competent jurisdiction should hold this covenant to be unreasonable or overly broad, the Parties agree to reduce the scope of such covenant to the maximum restriction permitted by law, and You agree to be bound by such less restrictive terms of this covenant. If requested by AIRSOPURE, You agree to obtain and provide to AIRSOPURE executed covenants containing terms equivalent to those contained herein from any employee of Yours who has received training from AIRSOPURE, and, if Your Franchise is a corporation, from any director or shareholder of Your corporation.\"}, {\"id\": \"16.04\", \"title\": \"AIRSOPURE covenants and agrees that the restrictions set forth above in Paragraphs 16\", \"level\": 2, \"text\": \"16.04. AIRSOPURE covenants and agrees that the restrictions set forth above in Paragraphs 16.02.C and 16.03 shall not apply to ownership by You of less than a 5% beneficial interest in the outstanding equity securities of any publicly traded corporation, provided that You are not an employee, consultant or director of such corporation.\"}, {\"id\": \"16.05\", \"title\": \"You covenant and agree that its violation of any covenant contained herein would result in serious, immediate and irrep\", \"level\": 2, \"text\": \"16.05. You covenant and agree that its violation of any covenant contained herein would result in serious, immediate and irreparable injury to AIRSOPURE for which no adequate remedy at law will be available, and You consent, in addition to other remedies which may be available to AIRSOPURE, to the entry without opposition of an injunction prohibiting any conduct by You in violation of any covenant set forth herein.\"}, {\"id\": \"17\", \"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"17. INDEMNIFICATION\"}, {\"id\": \"17.01\", \"title\": \"You agree to defend, indemnify and hold AIRSOPURE and its affiliates, directors, officers, employees and agents harmles\", \"level\": 2, \"text\": \"17.01. You agree to defend, indemnify and hold AIRSOPURE and its affiliates, directors, officers, employees and agents harmless from all claims, losses, lawsuits and expenses arising from or relating to the Franchise and Your operation thereof, except for: (i) any claims of infringement 15 from third Parties due to Your use of the Licensed Marks, provided that You have used the said Licensed Marks as authorized by AIRSOPURE; and (ii) claims alleging that Products sold or leased by You are defective.\"}, {\"id\": \"17.02\", \"title\": \"AIRSOPURE agrees to defend, indemnify and hold You harmless from all claims, losses, lawsuits and expenses arising from\", \"level\": 2, \"text\": \"17.02. AIRSOPURE agrees to defend, indemnify and hold You harmless from all claims, losses, lawsuits and expenses arising from or relating to: (i) any claims of infringement from third Parties due to Your use of the Licensed Marks, provided that You have used the Licensed Marks as authorized by AIRSOPURE; and (ii) claims alleging that Products sold or leased by You are defective.\"}, {\"id\": \"18\", \"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"18. GENERAL PROVISIONS\"}, {\"id\": \"18.01\", \"title\": \"No failure of a Party to exercise any power reserved to it by this Agreement or to insist upon strict compliance by the\", \"level\": 2, \"text\": \"18.01. No failure of a Party to exercise any power reserved to it by this Agreement or to insist upon strict compliance by the other Party with any obligation or condition hereunder shall constitute a waiver of such Party's rights unless such waiver is in writing. Any waiver by either Party shall not constitute a waiver thereafter to demand exact compliance with any of the terms herein. Waiver by a Party of any particular default by the other Party shall not affect or impair such Party's rights with respect to any subsequent default of the same, similar or different nature; nor shall any delay, forbearance or omission of a Party to exercise any power or right arising out of any breach or default by the other Party of any of the terms, provisions, or covenants thereof, affect or impair such Party's right to exercise the same.\"}, {\"id\": \"18.02\", \"title\": \"Unforeseen Events\", \"level\": 2, \"text\": \"18.02. Unforeseen Events Delays in the performance of any duties hereunder which are not the fault of and are beyond the ability of the Party to control, including without limitation fires, floods, natural disasters, acts of God, labor disputes, riots or other similar events, shall not constitute a default in the Party's performance of this Agreement, and the Parties agree to extend the time of performance for a reasonable period of time to allow for such delays.\"}, {\"id\": \"18.03\", \"title\": \"The relationship between the Parties is that of independent contractors\", \"level\": 2, \"text\": \"18.03. The relationship between the Parties is that of independent contractors. No partnership, joint venture, employment or relationship of principal and agent is intended, and You may not commit or bind AIRSOPURE to any obligation whatsoever.\"}, {\"id\": \"18.04\", \"title\": \"Any and all notices required or permitted under this Agreement shall be in writing and shall be delivered by any means\", \"level\": 2, \"text\": \"18.04. Any and all notices required or permitted under this Agreement shall be in writing and shall be delivered by any means which will provide evidence of the date received, to the respective Parties at the following addresses unless and until a different address has been designated by written notice to the other Party: Notices to AIRSOPURE: Airsopure International Group, Inc. 15400 Knoll Trail, Suite 200 Dallas, Texas 75248 Attn: John Potter, President Notices to You: - -------------------------------- - -------------------------------- - -------------------------------- Any notice shall be deemed to have been given at the date and time it is received.\"}, {\"id\": \"18.05\", \"title\": \"This Agreement and the documents referred to herein constitute the entire Agreement between AIRSOPURE and You concernin\", \"level\": 2, \"text\": \"18.05. This Agreement and the documents referred to herein constitute the entire Agreement between AIRSOPURE and You concerning the subject matter hereof, and supersede all prior agreements, oral or written. No amendment, change or variance from this Agreement shall be binding on either Party unless executed by both Parties in writing.\"}, {\"id\": \"18.06\", \"title\": \"Except as expressly provided to the contrary herein, each provision of this Agreement shall be considered severable; an\", \"level\": 2, \"text\": \"18.06. Except as expressly provided to the contrary herein, each provision of this Agreement shall be considered severable; and if, for any reason, any provision herein is determined to be invalid under any law or by a court having valid jurisdiction, such shall not impair the operation of, or have any other effect upon, such other 16 provisions of this Agreement, and the latter shall continue to be given full force and effect and bind the Parties hereto, and the invalid provision shall be deemed not to be a part of this Agreement.\"}, {\"id\": \"18.07\", \"title\": \"This Agreement takes effect upon its acceptance and execution by AIRSOPURE in the State of Texas, and shall be interpre\", \"level\": 2, \"text\": \"18.07. This Agreement takes effect upon its acceptance and execution by AIRSOPURE in the State of Texas, and shall be interpreted and construed under the laws of the State of Texas.\"}, {\"id\": \"18.08\", \"title\": \"The Parties agree that any action brought by either Party against the other in any court, whether federal or state, sha\", \"level\": 2, \"text\": \"18.08. The Parties agree that any action brought by either Party against the other in any court, whether federal or state, shall be brought within the State of Texas in the judicial district in which AIRSOPURE has its principal place of business and do hereby waive all questions of personal jurisdiction or venue for the purpose of carrying out this provision.\"}, {\"id\": \"18.09\", \"title\": \"If either Party is required to resort to legal process to enforce any provision of this Agreement, the prevailing Party\", \"level\": 2, \"text\": \"18.09. If either Party is required to resort to legal process to enforce any provision of this Agreement, the prevailing Party will recover all costs, including reasonable attorneys fees, incurred in such legal proceeding.\"}, {\"id\": \"18.10\", \"title\": \"You represent to AIRSOPURE that You have conducted an independent investigation of the business franchised hereunder an\", \"level\": 2, \"text\": \"18.10. You represent to AIRSOPURE that You have conducted an independent investigation of the business franchised hereunder and recognizes that the business venture contemplated by this Agreement involves business risks, and that its success will be largely dependent upon Your ability as an independent business person. AIRSOPURE expressly disclaims the making of, and You acknowledge that You have not received, any representation or guarantee, express or implied, as to the potential volume, profits or success of the business venture contemplated by this Agreement.\"}, {\"id\": \"18.11\", \"title\": \"You acknowledge that You received a completed copy of this Agreement, the attachments hereto, if any, and agreements re\", \"level\": 2, \"text\": \"18.11. You acknowledge that You received a completed copy of this Agreement, the attachments hereto, if any, and agreements relating thereto, if any, at least 5 business days prior to the date on which this Agreement was executed. You further acknowledge that You have received the Offering Circular, as required by the Federal Trade Commission, at least 10 business days prior to the date on which this Agreement was executed.\"}, {\"id\": \"18.12\", \"title\": \"This Agreement contains various headings, but it is agreed that such headings are for convenience only and shall not af\", \"level\": 2, \"text\": \"18.12. This Agreement contains various headings, but it is agreed that such headings are for convenience only and shall not affect the meaning of the provisions of this Agreement.\"}, {\"id\": \"18.13\", \"title\": \"You acknowledge that You have read and understood this Agreement, the attachments hereto, if any, and agreements relati\", \"level\": 2, \"text\": \"18.13. You acknowledge that You have read and understood this Agreement, the attachments hereto, if any, and agreements relating thereto, if any, and that AIRSOPURE has accorded You ample time and opportunity to consult with advisors of Your own choosing about the potential benefits and risks of entering into this Agreement.\"}, {\"id\": \"19\", \"title\": \"APPLICABLE LAW AND MEDIATION\", \"level\": 1, \"text\": \"19. APPLICABLE LAW AND MEDIATION A. THE PARTIES AGREE TO SUBMIT ANY CLAIM, CONTROVERSY OR DISPUTE ARISING OUT OF OR RELATING TO THIS AGREEMENT (AND ATTACHMENTS) OR THE RELATIONSHIP CREATED BY THIS AGREEMENT TO NON-BINDING MEDIATION PRIOR TO BRINGING SUCH CLAIM, CONTROVERSY OR DISPUTE IN A COURT. THE MEDIATION SHALL BE CONDUCTED THROUGH EITHER AN INDIVIDUAL MEDIATOR OR A MEDIATOR APPOINTED BY A MEDIATION SERVICES ORGANIZATION OR BODY, EXPERIENCED IN THE MEDIATION OF DISPUTES IN THE AIR PURIFICATION SERVICE BUSINESS, AGREED UPON BY THE PARTIES AND, FAILING SUCH AGREEMENT WITHIN A REASONABLE PERIOD OF TIME AFTER EACH PARTY HAS NOTIFIED THE OTHER OF ITS DESIRE TO SEEK MEDIATION OF ANY CLAIM CONTROVERSY OR DISPUTE (NOT TO EXCEED 15 DAYS), THROUGH THE AMERICAN ARBITRATION ASSOCIATION IN ACCORDANCE THE RULES GOVERNING MEDIATION, AT AIRSOPURE CORPORATE HEADQUARTERS IN DALLAS, TEXAS. THE COSTS AND EXPENSES OF MEDIATION, INCLUDING COMPENSATION AND EXPENSES OF THE MEDIATOR, SHALL BE BORNE BY THE PARTIES EQUALLY. IF THE PARTIES ARE UNABLE TO RESOLVE THE CLAIM, CONTROVERSY OR DISPUTE 90 DAYS 17 AFTER THE MEDIATOR HAS BEEN APPOINTED, THEN EITHER PARTY MAY SUBMIT SUCH CLAIM, CONTROVERSY OR DISPUTE TO A COURT IN ACCORDANCE WITH SECTION 19.B. BELOW NOTWITHSTANDING THE FOREGOING, EITHER PARTY MAY BRING AN ACTION (1) FOR MONEYS OWED, (2) FOR INJUNCTIVE RELIEF, OR (3) INVOLVING THE POSSESSION OR DISPOSITION OF, OR OTHER RELIEF RELATING TO, REAL PROPERTY IN A COURT HAVING JURISDICTION AND IN ACCORDANCE WITH SECTION 19.B. BELOW, WITHOUT SUBMITTING SUCH ACTION TO MEDIATION. B. WITH RESPECT TO ANY CLAIMS, CONTROVERSIES OR DISPUTES WHICH ARE NOT FINALLY RESOLVED THROUGH MEDIATION, YOU HEREBY IRREVOCABLY SUBMIT YOURSELF TO THE NONEXCLUSIVE JURISDICTION OF THE STATE COURTS OF DALLAS COUNTY, TEXAS AND THE FEDERAL DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS, DALLAS DIVISION. YOU HEREBY IRREVOCABLY AGREE THAT SERVICE OF PROCESS MAY BE MADE UPON YOU IN ANY EACH PROCEEDING RELATING TO OR ARISING OUT OF THIS AGREEMENT OR THE RELATIONSHIP CREATED BY THIS AGREEMENT BY ANY MEANS ALLOWED BY TEXAS OR FEDERAL LAW. VENUE FOR ANY SUCH LEGAL PROCEEDING SHALL BE DALLAS COUNTY, TEXAS; PROVIDED, HOWEVER WITH RESPECT TO ANY ACTION (1) FOR MONEYS OWED, (2) FOR INJUNCTIVE OR OTHER EXTRAORDINARY RELIEF OR (3) INVOLVING POSSESSION OR DISPOSITION OF; OR OFFER RELIEF RELATING TO, REAL PROPERTY, AIRSOPURE MAY BRING SUCH ACTION IN ANY STATE OR FEDERAL DISTRICT COURT WHICH HAS JURISDICTION. YOU HEREBY WAIVE ALL QUESTIONS OF PERSONAL JURISDICTION FOR TITLE PURPOSE OF CARRYING OUT THIS PROVISION. WITH RESPECT TO ALL CLAIMS, CONTROVERSIES, DISPUTES OR ACTIONS, THIS AGREEMENT SHALL BE INTERPRETED AND CONSTRUED UNDER TEXAS LAW (EXCEPT FOR TEXAS CHOICE OF LAW RULES).\"}, {\"id\": \"C\", \"title\": \"YOU AND AIRSOPURE ACKNOWLEDGE THAT THE PARTIES' AGREEMENT REGARDING APPLICABLE STATE LAW AND FORUM SET FORTH IN SECTION\", \"level\": 1, \"text\": \"C. YOU AND AIRSOPURE ACKNOWLEDGE THAT THE PARTIES' AGREEMENT REGARDING APPLICABLE STATE LAW AND FORUM SET FORTH IN SECTION 19.B. ABOVE PROVIDE EACH OF THE PARTIES WITH THE MUTUAL BENEFIT OF UNIFORM INTERPRETATION OF THIS AGREEMENT AND ANY DISPUTE ARISING OUT OF THIS AGREEMENT OR THE PARTIES' RELATIONSHIP CREATED BY THIS AGREEMENT, EACH OF YOU AND AIRSOPURE FURTHER ACKNOWLEDGE THE RECEIPT AND SUFFICIENCY OF MUTUAL CONSIDERATION FOR SUCH BENEFIT.\"}, {\"id\": \"D\", \"title\": \"YOU AND AIRSOPURE ACKNOWLEDGE THAT THE EXECUTION OF THIS AGREEMENT OCCURRED IN DALLAS, TEXAS AND FURTHER ACKNOWLEDGE TH\", \"level\": 1, \"text\": \"D. YOU AND AIRSOPURE ACKNOWLEDGE THAT THE EXECUTION OF THIS AGREEMENT OCCURRED IN DALLAS, TEXAS AND FURTHER ACKNOWLEDGE THAT THE PERFORMANCE OF CERTAIN OBLIGATIONS OF YOU ARISING UNDER THIS AGREEMENT SHALL OCCUR IN DALLAS, TEXAS. IN WITNESS WHEREOF, the Parties hereto have duly executed, sealed, and delivered this Agreement on the day and year first above written. AIRSOPURE: By: --------------------------------- Title: ------------------------------ YOU: By: --------------------------------- Title: ------------------------------ 18 EXHIBIT F PERSONAL GUARANTEE For value received, and in consideration of the execution by Airsopure International Group, Inc. (\\\"Airsopure\\\") of a Franchise Agreement with - ---------------------------------------- (\\\"Franchisee\\\"), The undersigned - ---------------------------------------- (\\\"Guarantor\\\") hereby unconditionally guarantees to Airsopure all indebtedness, obligations and liabilities, direct or indirect, matured or immatured, primary or secondary, certain or contingent, of Franchisee to Airsopure, now or hereafter owing or incurred. This Guarantee is an absolute, unconditional, unlimited and continuing guarantee of the full and punctual payment by Franchisee of the foregoing indebtedness, obligations and liabilities and not of their collectibility only. Upon any default by Franchisee in such full and punctual payment, the liabilities and obligations of the Guarantor hereunder shall, at Airsopure's option, become forthwith due and payable without demand or notice of any nature, all of which are expressly waived by the Guarantor. Airsopure may deal with Franchisee in such manner as Airsopure in its sole discretion deems fit, and Guarantor gives to Airsopure full authority, in its sole discretion, to do any or all of the following things: a) extend credit, make loans and afford other financial accommodations to Franchisee at such times, in such amounts and on such terms as Airsopure may approve; b) vary the terms and grant extensions or renewals of any present or future indebtedness of Franchisee to Airsopure; c) grant time, waivers and other indulgences in respect thereto; d) vary, exchange, release or discharge, wholly or partially, or delay in or abstain from perfecting and enforcing any security or guaranty or other means of obtaining payment; e) accept partial payments from Franchisee; f) release or discharge, wholly or partially, any endorser or guarantor; g) compromise or make any settlement or other arrangement with Franchisee. Guarantor waives notice of acceptance hereof or of any action taken or omitted by Airsopure in reliance hereon and any requirement that Airsopure be diligent or prompt in making demands hereunder, giving notice of any default by Franchisee or asserting any other right hereunder. No provision of this Guaranty can be changed, waived, discharged or terminated except by an instrument in writing signed by Airsopure and Guarantor, and no such waiver shall extend to, affect or impair any other right of Airsopure hereunder. This Unlimited Guarantee shall inure to the benefit of Airsopure and its successors and assigns, and shall be binding on the Guarantor and the Guarantor's successors, heirs and assigns. EXECUTED on this ____ day of ____________, 2000. - ---------------------------------------- GUARANTOR - ---------------------------------------- WITNESS EXHIBIT G CONFIDENTIALITY AGREEMENT This Confidentiality and Noncompetition Agreement (the \\\"Agreement\\\") is made and entered into effective the _____day of ________________, 2000 by and between Airsopure International Group, Inc., a Nevada corporation, located at 15400 Knoll Trail, Suite 200, Dallas, Texas 75248 (the \\\"Company\\\") and - ----------------------------------------------- who resides at - ----------------------------------------------- - ----------------------------------------------- - ----------------------------------------------- - ----------------------------------------------- (the \\\"Associate\\\"). RECITALS A. Company sells franchises for the operation of air purification system business which operate under the name and service mark \\\"Airsopure\\\" (the \\\"Franchises\\\"); B. Company has developed a business method for operating Franchises utilizing certain Information, plans, methods, data, processes, marketing systems, techniques, operating procedures, trademarks, designs, information and know how of Company (the \\\"Confidential Information\\\"), and such Confidential Information may be further developed from time to time by Company:\"}, {\"id\": \"C\", \"title\": \"Company has established substantial goodwill and an excellent reputation with respect to the quality of services availa\", \"level\": 1, \"text\": \"C. Company has established substantial goodwill and an excellent reputation with respect to the quality of services available, which goodwill and reputation have been and will continue to be of Major benefit to Company;\"}, {\"id\": \"D\", \"title\": \"Associate is or will become involved with Company, or a franchise of Company, in the capacity of an officer, partner, d\", \"level\": 1, \"text\": \"D. Associate is or will become involved with Company, or a franchise of Company, in the capacity of an officer, partner, director or as beneficial owner of an Airsopure Franchise or an employee of a Franchise, and will become privileged to certain Confidential Information; and E. Associate and Company have reached an understanding with regard to nondisclosure by Associate of Confidential Information and Noncompetition by Associate with Company NOW THEREFORE, in consideration of the foregoing, the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, Associate and Company, intending legally to be bound, hereby agree as follows:\"}, {\"id\": \"1\", \"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"1. CONFIDENTIAL INFORMATION. Associate and Company acknowledge that the business plan and methods used in connection with the operation of the Franchise which utilize Company's Confidential Information, are confidential, unique, constitute the exclusive property of Company and are trade secrets of Company. Associate acknowledges that any disclosure of the Confidential Information would be wrong and would cause irreparable injury and harm to Company. Associate further acknowledges that Company has expended a great amount of effort and money in obtaining and developing the Confidential Information, the Company has taken numerous precautions to guard the secrecy of the Confidential Information and that it would be very costly for competitors to acquire or duplicate the Confidential Information.\"}, {\"id\": \"2\", \"title\": \"OPERATIONS MANUAL AS TRADE SECRET It is understood that Confidential Information, constituting \\\"trade secret\\\", as used\", \"level\": 1, \"text\": \"2. OPERATIONS MANUAL AS TRADE SECRET It is understood that Confidential Information, constituting \\\"trade secret\\\", as used in this Agreement is deemed to include, without initiation, any and all information contained in the Franchise Operations Manual, which may be provided AS one or more separate manuals, or written instructional guides, as the same are changed or supplemented from time to time, and any information of whatever nature which gives to Company an opportunity to obtain an advantage over its competitors who do not have access to, know or use such lists, written materials or information.\"}, {\"id\": \"3\", \"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"3. CONFIDENTIAL INFORMATION. Associate shall not at any time, publish, disclose, divulge or in any manner communicate to any person, firm' corporation, association. partnership or any other entity whatsoever or use, directly or indirectly, for its own benefit or for the benefit of any Person, firm, corporation or other entity, other than the use of Company, any of the Confidential Information of Company or its Affiliates.\"}, {\"id\": \"4\", \"title\": \"NO INTERFERENCE WITH BUSINESS\", \"level\": 1, \"text\": \"4. NO INTERFERENCE WITH BUSINESS. During the term of this Agreement, neither Associate nor any member of his or her immediate finally shall divert or attempt to divert: I) any business related to, or any customer or prospective customer of; the Franchise by direct inducement or otherwise, or 2) the employment of Company or another franchisee licensed by Company, 1 to any Competitive Business by any direct inducement or otherwise.\"}, {\"id\": \"5\", \"title\": \"REMEDIES\", \"level\": 1, \"text\": \"5. REMEDIES. Associate hereby acknowledges and agrees that in the event of any violations of this Agreement, Company shall be authorized and entitled, without posting a bond to obtain from any court of competent jurisdiction, preliminary and permanent injunctive relief as well as an equitable accounting of all profits or benefits arising out of any such violation, which rights and remedies shall be cumulative and in addition to any rights or remedies to which Company may be entitled.\"}, {\"id\": \"6\", \"title\": \"EFFECT OF WAVIER\", \"level\": 1, \"text\": \"6. EFFECT OF WAVIER. The waiver by Associate or company of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach thereof\"}, {\"id\": \"7\", \"title\": \"BINDING EFFECT\", \"level\": 1, \"text\": \"7. BINDING EFFECT. This Agreement shall be binding upon and inure to the benefit of Associate and Company and their respective heirs, executors, representatives successors and assigns.\"}, {\"id\": \"8\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"8. ENTIRE AGREEMENT. This instrument contains the entire agreement of Associate and Company relating to the matters set forth here It may not be changed orally, but only by an agreement in writing, signed by the party against whom enforcement of any waiver, change modification, extension or discharge is sought.\"}, {\"id\": \"9\", \"title\": \"GOVERNING LAW\", \"level\": 1, \"text\": \"9. GOVERNING LAW. This instrument shall be governed by and construed under the laws of the State of Texas.\"}, {\"id\": \"10\", \"title\": \"JURISDICTION AND VENUE\", \"level\": 1, \"text\": \"10. JURISDICTION AND VENUE. In the event of a breach or threatened breach by Associate of this Agreement, Associate hereby irrevocably submits to the jurisdiction of the State District Court in Dallas County, Texas and the Federal District Court for the Northern District of Texas, and irrevocably agrees that venue for any action or proceeding shall be in Dallas County, Texas. Notwithstanding the foregoing, in the event that the laws of the state where, Associate resides require that the jurisdiction or venue be elsewhere, then such other states laws shall control. but only to the extent that such other state's laws so require.\"}, {\"id\": \"11\", \"title\": \"SEVERABILITV\", \"level\": 1, \"text\": \"11. SEVERABILITV. Should anyone or more of the provisions hereof be determined to be illegal or unenforceable, all other provisions hereof shall be given separately therefrom and shall not be affected thereby.\"}, {\"id\": \"12\", \"title\": \"COST OF ENFORCEMENT\", \"level\": 1, \"text\": \"12. COST OF ENFORCEMENT. In any action at law or in equity to enforce any of the provisions or rights under this Agreement, the unsuccessful party in such litigation as determined by the court in a final judgment or decree, shall pay the successful party or parties all costs, expenses and reasonable attorney's fees incurred therein by such arty or parties (including without Initiation such as costs, expenses and fees on any appeals), plus, if applicable, interest at the highest rate allowable by law, accruing from the date of the breach of this Agreement. If such successful party shall recover judgement in any such action or proceeding, such costs, expenses. attorney's fees and interest shall be included as part of such judgment. IN WITNESS WHEREOF, the parties hereto have signed this Agreement on the date first above written. FOR AIRSOPURE (COMPANY): - -------------------------------------------- FOR FRANCHISEE OF AIRSOPURE: - -------------------------------------------- ASSOCIATE OF FRANCHISEE: - -------------------------------------------- ASSOCIATE'S WORK CAPACITY: - -------------------------------------------- 2\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of AIRTECHINTERNATIONALGROUPINC_05_08_2000-EX-10.4-FRANCHISE AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[LOGO]\", \"level\": 1, \"text\": \"[LOGO] EXHIBIT C AIRSOPURE FRANCHISE AGREEMENT THIS AGREEMENT is entered into on this ____ day of ___________, 2000, by and between Airsopure International Group, Inc., a Nevada corporation whose principal place of business is located at 15400 Knoll Trail, Suite 200, Dallas, Texas 75248 (hereinafter \\\"AIRSOPURE\\\" or by reference \\\"we\\\", \\\"us\\\", \\\"our\\\"), and You: , ------------------------------------ whose address is: - ---------------------------------------- - ---------------------------------------- (hereinafter \\\"You\\\" or by reference \\\"Franchisee\\\", or \\\"Your\\\"). Either Party or both Parties respectively may be referred to as \\\"Party\\\" or \\\"Parties.\\\" RECITALS A. AIRSOPURE and its affiliate design, manufacture and distribute indoor air cleaning systems under the name and mark \\\"AIRSOPURE\\\" (the \\\"Products\\\"). B. AIRSOPURE has developed a system for the establishment, development and operation of sales centers (\\\"AIRSOPURE Center(s)\\\" or \\\"Center(s)\\\") for the sale and servicing of AIRSOPURE's exclusive line of Products using the service mark \\\"AIRSOPURE\\\" and other trademarks, service marks (including but not limited to, \\\"The Essence of Clean Air\\\"), logos and identifying features designated from time to time by AIRSOPURE (the \\\"Licensed Marks\\\") and using AIRSOPURE's distinctive methods for establishing and operating AIRSOPURE Centers.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You desire to establish an AIRSOPURE Center to be located in the following geographic area\", \"level\": 1, \"text\": \"C. You desire to establish an AIRSOPURE Center to be located in the following geographic area: - ---------------------------------------- - ---------------------------------------- (the \\\"Exclusive Territory\\\"), and AIRSOPURE desires to grant You the right to operate an AIRSOPURE Center at such location under the terms and conditions contained in this Agreement. NOW, THEREFORE, in consideration of the mutual rights, covenants and obligations set forth herein, the Parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GRANT OF FRANCHISE\", \"level\": 1, \"text\": \"1. GRANT OF FRANCHISE\"}}, {\"id\": \"1.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE grants to You, and You accept from AIRSOPURE, the right and license to operate an AIRSOPURE Center (or the \\\"F\", \"level\": 2, \"text\": \"1.01. AIRSOPURE grants to You, and You accept from AIRSOPURE, the right and license to operate an AIRSOPURE Center (or the \\\"Franchise\\\") for the sale or lease of AIRSOPURE's exclusive line of Products or at a location in the Exclusive Territory to be approved in writing by AIRSOPURE and listed in attached Exhibit A (the \\\"Exclusive Territory and Center Location\\\"), to purchase Products from AIRSOPURE or its affiliates for resale at the Center to customers in the Exclusive Territory, and to use the Licensed Marks only in connection with the operation of the Franchise in accordance with the terms and conditions of this Agreement. AIRSOPURE grants the Franchise to You hereunder in reliance upon Your agreement to at all times operate and manage the Franchise faithfully, honestly and diligently in strict conformance with AIRSOPURE's operating procedures and specifications, as set forth herein and as otherwise from time to time communicated to You, using Your best efforts to promote and enhance the performance and operation of the Franchise.\"}}, {\"id\": \"1.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE hereby grants to You the exclusive right to solicit customers for the Products by direct mail advertising, or\", \"level\": 2, \"text\": \"1.02. AIRSOPURE hereby grants to You the exclusive right to solicit customers for the Products by direct mail advertising, or other approved means, but not including the World Wide Web (Internet) nor by printed catalogues, in 1 the Exclusive Territory described above and in Exhibit A. Other AIRSOPURE franchisees will not be permitted to solicit customers for Products by advertising in Your Exclusive Territory. Likewise, You may not target or solicit customers for Products by advertising in other Franchisees respective Exclusive Territories. Exclusive Territories will not overlap into other Exclusive Territories. You shall not purposely solicit sales and service to customers located outside Your Exclusive Territory, provided such activity in not within an assigned Exclusive Territory. You have been granted an exclusive trade area by this Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND RENEWAL\", \"level\": 1, \"text\": \"2. TERM AND RENEWAL\"}}, {\"id\": \"2.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The term of this Agreement shall be for 10 years commencing on the date of execution of this Agreement by AIRSOPURE\", \"level\": 2, \"text\": \"2.01. The term of this Agreement shall be for 10 years commencing on the date of execution of this Agreement by AIRSOPURE.\"}}, {\"id\": \"2.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"At the expiration of the term or any renewal term hereof, You may, at its option, renew the Franchise granted hereunder\", \"level\": 2, \"text\": \"2.02. At the expiration of the term or any renewal term hereof, You may, at its option, renew the Franchise granted hereunder for 2 additional terms of 10 years each on the following terms and conditions: A. You shall give AIRSOPURE notice in writing of Your election to renew this Agreement at least 3 months prior to the expiration of the then-current term. B. You shall not be in default of any provision of this Agreement or amendment hereto, including without limitation all payment obligations to AIRSOPURE and its affiliates.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As a condition of renewal of the Franchise, You agree to execute AIRSOPURE's then-current form of franchise agreement a\", \"level\": 1, \"text\": \"C. As a condition of renewal of the Franchise, You agree to execute AIRSOPURE's then-current form of franchise agreement and to comply fully with all terms and conditions thereof, and to pay AIRSOPURE the then-current renewal fee, which is presently $1,000.00. You understand that AIRSOPURE may revise its franchise agreement for any renewal term, at AIRSOPURE's sole discretion, including without limitation to increase the royalty fees or other fees payable by You or to require other obligations of franchisees.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall meet AIRSOPURE's then-current qualifications and training requirements\", \"level\": 1, \"text\": \"D. You shall meet AIRSOPURE's then-current qualifications and training requirements. E. You shall execute a general release in a form prescribed by AIRSOPURE releasing AIRSOPURE and its affiliates, directors, officers, employees and agents from all known and unknown claims and liabilities to the extent permitted by state and federal law. F. You may be required, at AIRSOPURE's sole discretion, to upgrade or remodel Your AIRSOPURE Center to conform to AIRSOPURE's then-current specifications and standards as specified in AIRSOPURE's Operating Manual of otherwise in writing, provided such upgrade or remodel is reasonable in terms of cost and implementation schedule.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FEES\", \"level\": 1, \"text\": \"3. FEES\"}}, {\"id\": \"3.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In consideration of the Franchise rights and license granted herein, You agree to pay to AIRSOPURE the following fees\", \"level\": 2, \"text\": \"3.01. In consideration of the Franchise rights and license granted herein, You agree to pay to AIRSOPURE the following fees: A. You shall pay to AIRSOPURE an initial franchise fee of $25,000.00 upon execution of this Agreement. You agree that the initial franchise fee represents payment for the initial grant of the Franchise rights and license granted herein, shall be fully earned upon execution of this Agreement, and the said fee will not be refunded under any circumstances unless otherwise specifically set forth herein. You must find a suitable Center site within 90 days of signing the Franchise Agreement, unless we mutually agree otherwise. If we cannot agree on a Center location, within 4 months, we may a) extend your search time, b) exchange your territory, or c) terminate your Franchise and refund up to 70% of your Franchise Fee, at our sole discretion. There are no refunds under any other circumstances. B. You shall pay to AIRSOPURE a continuing non-refundable royalty fee on a monthly basis of 2 5% of Your total monthly gross sales, as defined below. This fee is due by the 7th of the month for the preceding month.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall account to AIRSOPURE for Your continuing non-refundable local advertising fee of 2% of Your total monthly gro\", \"level\": 1, \"text\": \"C. You shall account to AIRSOPURE for Your continuing non-refundable local advertising fee of 2% of Your total monthly gross sales, which You must spend on the promotion of Your Center. This accounting is due by the 7th of the month for the preceding month.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall pay to AIRSOPURE a continuing non-refundable Advertising Fund fee of 2% of Your total monthly gross sales, be\", \"level\": 1, \"text\": \"D. You shall pay to AIRSOPURE a continuing non-refundable Advertising Fund fee of 2% of Your total monthly gross sales, beginning January 1, 2001, or later at our sole option, as described in Section 10 hereof. This fee will be due by the 7th of the month for the preceding month. E. \\\"Gross sales\\\" as used in this Section 3.01 shall mean the amount of gross revenues received by You from all sources, including without limitation sales of Products, services or other merchandise of every kind or nature from, at or in connection with the operation of the AIRSOPURE Center granted herein, excluding state, federal or local sales taxes collected from customers and paid to the appropriate taxing authority. F. Fees payable under Paragraphs 3.01.B and 3.01.D above shall be due and payable monthly by the seventh day of each month, based on Your gross sales of the previous month. Delinquent fees shall bear interest at a rate of the lower of: (i) one and one-half percent (1.5%) per month, or (ii) the maximum rate permitted by applicable law.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DUTIES OF AIRSOPURE\", \"level\": 1, \"text\": \"4. DUTIES OF AIRSOPURE\"}}, {\"id\": \"4.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prior to the opening of the Franchise, AIRSOPURE shall\", \"level\": 2, \"text\": \"4.01. Prior to the opening of the Franchise, AIRSOPURE shall: A. Following receipt in writing from You of a request for approval of at least 3 possible locations as the Authorized Location for the Franchise, AIRSOPURE will promptly evaluate such locations and notify You in writing of its approval or rejection of such location(s) within 7 working days. B. Provide You with AIRSOPURE's specifications and requirements or other assistance deemed necessary by AIRSOPURE to assist You in opening the Center.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Provide an initial training program for 2 people to be designated by You as described in AIRSOPURE's Operations Manual\", \"level\": 1, \"text\": \"C. Provide an initial training program for 2 people to be designated by You as described in AIRSOPURE's Operations Manual.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Provide one copy, on loan to You, of AIRSOPURE's Operations Manual as described in Section 8 hereof for use solely in c\", \"level\": 1, \"text\": \"D. Provide one copy, on loan to You, of AIRSOPURE's Operations Manual as described in Section 8 hereof for use solely in connection with operation of the AIRSOPURE Center granted hereunder. E. Sell to You an opening order of Products for resale or lease at the Franchise as described in Paragraph 6.01 below.\"}}, {\"id\": \"4.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Following the opening of the Franchise, AIRSOPURE shall\", \"level\": 2, \"text\": \"4.02. Following the opening of the Franchise, AIRSOPURE shall: A. Provide daily consultation by telephone as reasonably requested by You during the first two weeks of operation of the AIRSOPURE Center Franchise. B. Provide continuing general advisory assistance as deemed necessary by AIRSOPURE regarding the operation and advertising of the Franchise.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Provide updates, revisions and amendments to the AIRSOPURE Operating Manual and system as AIRSOPURE may from time to ti\", \"level\": 1, \"text\": \"C. Provide updates, revisions and amendments to the AIRSOPURE Operating Manual and system as AIRSOPURE may from time to time deem necessary or desirable.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Fill Your orders for Products for resale at the Franchise in accordance with Section 6 below\", \"level\": 1, \"text\": \"D. Fill Your orders for Products for resale at the Franchise in accordance with Section 6 below. E. Provide training programs or seminars as AIRSOPURE may, from time to time in its sole discretion, deem appropriate. AIRSOPURE's training programs for franchisees is described in AIRSOPURE's Operations Manual, and is subject to change at any time in AIRSOPURE's sole 3 discretion. F. AIRSOPURE may, from time to time at its sole discretion, provide test customers or store visits by AIRSOPURE representatives to evaluate Your methods of operation and compliance with AIRSOPURE's standards and specifications.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"YOUR DUTIES\", \"level\": 1, \"text\": \"5. YOUR DUTIES\"}}, {\"id\": \"5.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall\", \"level\": 2, \"text\": \"5.01. You shall: A. You must find a suitable Center site within 90 days of signing the Franchise Agreement, unless we mutually agree otherwise, and attend (or if You are a corporation, Your majority shareholder will attend or Your Operating Principal or manager and one other employee) and successfully complete to AIRSOPURE's reasonable satisfaction AIRSOPURE's initial training program within 90 DAYS following execution of this Agreement. B. Obtain all federal, state and local business licenses, permits, certifications and bonds required for lawful operation of the Franchise and certify in writing to AIRSOPURE prior to opening that all such requirements have been obtained.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Attend (with Your manager) and complete to AIRSOPURE's reasonable satisfaction such continuing training or educational\", \"level\": 1, \"text\": \"C. Attend (with Your manager) and complete to AIRSOPURE's reasonable satisfaction such continuing training or educational programs as AIRSOPURE may from time to time require in writing. AIRSOPURE will not charge You for the training programs, but You shall be responsible for the costs of meals, lodging, travel and all other expenses incurred by You or Your employees in attending such programs.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Actively promote AIRSOPURE's Products and services and exert Your best efforts to fully develop and maximize the market\", \"level\": 1, \"text\": \"D. Actively promote AIRSOPURE's Products and services and exert Your best efforts to fully develop and maximize the market for AIRSOPURE's Products and services in Your Exclusive Territory. E. Devote Your full time (or if You are a corporation, designate a manager) to oversee the management and operation of the Center. F. Purchase and maintain and adequate supply for use in connection with the operation of the Franchise Business various copyrighted materials and forms which are the proprietary property of AIRSOPURE and which are an integral part of AIRSOPURE's system franchised hereunder. Other supplies and equipment necessary for operation of the Center may be purchased from third Party suppliers who meet AIRSOPURE's standards and specifications and have been approved in writing by AIRSOPURE in accordance with the procedures set forth in AIRSOPURE's Operating Manual, which may be amended from time to time by AIRSOPURE at its sole discretion. G. Purchase Products from AIRSOPURE for resale to customers in the Exclusive Territory in accordance with Section 6 below. H. Comply with all federal, state and local health and safety laws, rules and standards applicable to operation of the Franchise. You will forward copies of all notices of non-compliance by the Franchise with any law, rule, regulation or ordinance to AIRSOPURE within three days from receipt thereof accompanied by a summary of action You will take to comply.\"}}, {\"id\": \"I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Maintain adequate working capital to operate the Franchise in accordance with the AIRSOPURE Operations Manual, as such\", \"level\": 1, \"text\": \"I. Maintain adequate working capital to operate the Franchise in accordance with the AIRSOPURE Operations Manual, as such may be amended by AIRSOPURE from time to time. J. Operate the Franchise in strict conformance with AIRSOPURE's policies, procedures, standards and specifications as may be prescribed by AIRSOPURE from time to time in the Operations Manual or otherwise in writing, including without limitation all changes specified by AIRSOPURE to its system or Products. . K. Display AIRSOPURE's Licensed Marks or logos on all marketing materials and at Your AIRSOPURE Center. AIRSOPURE reserves the 4 right to alter or change its Licensed Marks, logos or trade dress at any time, and You agree to use such Licensed Marks, logos or trade dress as specified from time to time by AIRSOPURE promptly upon receipt of notice in writing from AIRSOPURE.\"}}, {\"id\": \"L\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Maintain and supply to third Parties upon request information to be supplied by AIRSOPURE regarding the availability of\", \"level\": 1, \"text\": \"L. Maintain and supply to third Parties upon request information to be supplied by AIRSOPURE regarding the availability of franchises.\"}}, {\"id\": \"M\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Provide AIRSOPURE and its representatives with unlimited access to FRANCHISEE'S offices or its AIRSOPURE Center (person\", \"level\": 1, \"text\": \"M. Provide AIRSOPURE and its representatives with unlimited access to FRANCHISEE'S offices or its AIRSOPURE Center (personal residence excluded), including Your books, computer system (for sales and products only, unless we are auditing You) and records of the Franchise, during normal business hours for purposes of conducting inspections to fully examine and evaluate Your methods of doing business, including interviews with Your employees and customers. N. You acknowledge and agree that such inspections and evaluations are necessary for AIRSOPURE to insure the maintenance of its quality standards, and You agree to fully cooperate with any reasonable request by AIRSOPURE in connection with such inspections and evaluations. O. Diligently and immediately take such steps as are deemed reasonably necessary by AIRSOPURE to correct any deficiencies detected by AIRSOPURE in Your adherence to AIRSOPURE's operating policies, procedures, standards and specifications. P. In the event You are a corporation, comply with the following:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You will provide in Your Articles of Incorporation that Your sole corporate purpose is the operation of the Franchise\", \"level\": 1, \"text\": \"1. You will provide in Your Articles of Incorporation that Your sole corporate purpose is the operation of the Franchise.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Every certificate for shares of stock in the corporation will include the following legend printed thereon if sole purp\", \"level\": 1, \"text\": \"2. Every certificate for shares of stock in the corporation will include the following legend printed thereon if sole purpose of the corporation is to own and operate franchised business: \\\"THE TRANSFER, PLEDGE OR ASSIGNMENT OF THE SHARES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND RESTRICTIONS CONTAINED IN A FRANCHISE AGREEMENT BETWEEN THE HOLDER OF THESE SHARES AND AIRSOPURE FRANCHISE GROUP, INC.\\\"\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You agree to comply with the restrictions on transfer of ownership of the corporation set forth in Section 12\", \"level\": 1, \"text\": \"3. You agree to comply with the restrictions on transfer of ownership of the corporation set forth in Section 12.02 below.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You will provide AIRSOPURE, prior to the opening of the Franchise, with copies of Your Articles of Incorporation, Bylaw\", \"level\": 1, \"text\": \"4. You will provide AIRSOPURE, prior to the opening of the Franchise, with copies of Your Articles of Incorporation, Bylaws and other governing documents, including all amendments thereto, and a copy of the resolutions by Your Board of Directors authorizing execution of this Agreement, certified by the Secretary of the corporation.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You will provide AIRSOPURE with a current list of shareholders and will update such list from time to time as the list\", \"level\": 1, \"text\": \"5. You will provide AIRSOPURE with a current list of shareholders and will update such list from time to time as the list changes.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each shareholder of the corporation (if sole corporate purpose is the franchise), will execute a personal guarantee of\", \"level\": 1, \"text\": \"6. Each shareholder of the corporation (if sole corporate purpose is the franchise), will execute a personal guarantee of Your performance under this Agreement and all amounts owed by You to AIRSOPURE in the form of attached Exhibit B. Q. The Parties recognize the importance of fully developing the market for Products in the Exclusive Territory, and a substantial part of the consideration for and inducement to AIRSOPURE to enter into this Agreement is Your agreement to devote Your best efforts to market, sell and support Products to customers located in Your Exclusive Territory. You agree to concentrate Your marketing efforts to customers located in Your Territory, and You agree not to advertise the Products using media or publications whose primary coverage area is outside Your Exclusive Territory. 5 R. You may relocate Your Center at Your sole expense, within Your Exclusive Territory, provided You give us written notification at least 30 days prior to relocation stating the reasons for such a move.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PURCHASE AND SALE OF PRODUCTS\", \"level\": 1, \"text\": \"6. PURCHASE AND SALE OF PRODUCTS\"}}, {\"id\": \"6.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You will purchase from AIRSOPURE and AIRSOPURE will sell to You for resale or lease at the Center to customers in the E\", \"level\": 2, \"text\": \"6.01. You will purchase from AIRSOPURE and AIRSOPURE will sell to You for resale or lease at the Center to customers in the Exclusive Territory an opening order of Products having an aggregate cost to You of from $5,000.00 to $10,000.00, by mutual agreement, based on market conditions. Such purchase must be consummated in its entirety before You open Your Center, unless AIRSOPURE agrees in writing to extend such time period.\"}}, {\"id\": \"6.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"After the opening order contemplated by the preceding Paragraph, You will from time to time place orders for Products w\", \"level\": 2, \"text\": \"6.02. After the opening order contemplated by the preceding Paragraph, You will from time to time place orders for Products with AIRSOPURE on the following basis: A. All orders for Products shall be accompanied by payment, unless at AIRSOPURE's sole discretion, other payment terms are permitted. B. All orders will be shipped freight collect unless freight is paid in advance by You.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You will pay the prices then prevailing at the time AIRSOPURE receives each order\", \"level\": 1, \"text\": \"C. You will pay the prices then prevailing at the time AIRSOPURE receives each order. Such prices are subject to change at any time by AIRSOPURE.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All merchandise will be shipped to You at the Center for resale to customers\", \"level\": 1, \"text\": \"D. All merchandise will be shipped to You at the Center for resale to customers in the Exclusive Territory. You will sell Products only to end-user customers and not for resale. You will not sell or lease Products at any location other than within Your Exclusive Territory, engage in mail order sales of Products or supply Products to others for resale or lease at any other location. E. All orders for Products are subject to availability. In the event any Product is in short supply, AIRSOPURE shall have the right to allocate such Product on an equitable basis. F. You will not modify the Products, and You will not offer or carry any products or services other than AIRSOPURE's Products and services specified by AIRSOPURE without written approval from AIRSOPURE. G. Notwithstanding nationally advertised prices by AIRSOPURE, You may resell Products purchased under this Agreement at prices set by You. However, AIRSOPURE retains the right, to the extent permitted by law, to refuse to fill Your orders for Products if You fail to honor AIRSOPURE's suggested prices for the same Products sold by other franchise owners in Your region.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSED MARKS\", \"level\": 1, \"text\": \"7. LICENSED MARKS\"}}, {\"id\": \"7.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE represents with respect to the Licensed Marks that\", \"level\": 2, \"text\": \"7.01. AIRSOPURE represents with respect to the Licensed Marks that: A. AIRSOPURE is the owner of all right, title and interest in and to the Licensed Marks or has the right and license to use and grant a license to You to use the said Licensed Marks. B. AIRSOPURE will take all steps reasonably necessary to preserve and protect the ownership and validity in and to the Licensed Marks.\"}}, {\"id\": \"7.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"With respect to Your licensed use of the Licensed Marks pursuant to this Agreement, You agree that\", \"level\": 2, \"text\": \"7.02. With respect to Your licensed use of the Licensed Marks pursuant to this Agreement, You agree that: A. You shall use only the Licensed Marks designated by AIRSOPURE and shall use them only in the manner authorized and permitted by AIRSOPURE. B. You shall use the Licensed Marks only for the operation of the Franchise at the Authorized Location. 6\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the term of this Agreement, You shall identify Yourself as the owner of the Franchise in conjunction with any us\", \"level\": 1, \"text\": \"C. During the term of this Agreement, You shall identify Yourself as the owner of the Franchise in conjunction with any use of the Licensed Marks, including, but not limited to, on invoices, order forms, receipts, business cards, contracts and at such conspicuous locations on the Center's premises or in the field as AIRSOPURE may specify. The identification shall be in a form which specifies Your name, followed by the term \\\"Independent Franchise Owner\\\" or such other identification as shall be approved by AIRSOPURE.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall not use the Licensed Marks to incur any obligation or indebtedness on behalf of AIRSOPURE, and You shall not\", \"level\": 1, \"text\": \"D. You shall not use the Licensed Marks to incur any obligation or indebtedness on behalf of AIRSOPURE, and You shall not represent that Your Center is owned, operated by or affiliated with AIRSOPURE other than as a franchisee. E. You shall not use the Licensed Marks as part of Your corporate or other legal name, without the prior written consent of AIRSOPURE. F. You shall file an assumed name registration, and shall execute any documents deemed necessary by AIRSOPURE to obtain protection for the Licensed Marks or to maintain their continued validity and enforceability.\"}}, {\"id\": \"7.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You expressly understand and acknowledge that\", \"level\": 2, \"text\": \"7.03. You expressly understand and acknowledge that: A. As between the Parties hereto, AIRSOPURE, by its trademark License Agreement with Airsopure, Inc. is the licensor of all right, title and interest in and to the Licensed Marks and the goodwill associated with and symbolized by them. B. You shall not directly or indirectly contest the validity of the ownership of the Licensed Marks.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Your use of the Licensed Marks pursuant to this Agreement does not give You any ownership interest or other interest in\", \"level\": 1, \"text\": \"C. Your use of the Licensed Marks pursuant to this Agreement does not give You any ownership interest or other interest in or to the Licensed Marks.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any and all goodwill arising from Your use of the Licensed Marks in the Franchise under AIRSOPURE's system shall inure\", \"level\": 1, \"text\": \"D. Any and all goodwill arising from Your use of the Licensed Marks in the Franchise under AIRSOPURE's system shall inure solely and exclusively to the benefit of AIRSOPURE, and upon expiration or termination of this Agreement and the Franchise herein granted, no monetary amount shall be assigned as attributable to any goodwill associated with Your use of the Licensed Marks. E. The right and license to use the Licensed Marks granted hereunder to You is nonexclusive, and AIRSOPURE may use and grant franchises to others to use the Licensed Marks in any manner except as expressly provided otherwise herein. F. AIRSOPURE reserves the right to substitute different Licensed Marks for use in identifying the System and the businesses operating thereunder, and You agree to comply with AIRSOPURE's requirements relating thereto.\"}}, {\"id\": \"7.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall promptly notify AIRSOPURE of any unauthorized use of the Licensed Marks or marks confusingly similar thereto,\", \"level\": 2, \"text\": \"7.04. You shall promptly notify AIRSOPURE of any unauthorized use of the Licensed Marks or marks confusingly similar thereto, any challenge to the validity of the Licensed Marks, or any challenge to AIRSOPURE's ownership of, or Your right to use, the Licensed Marks. You acknowledge that AIRSOPURE has the sole right to direct and control any administrative proceeding or litigation involving the Licensed Marks, including any settlement thereof. AIRSOPURE has the right, but not the obligation, to take action against uses by others that may constitute infringement of the Licensed Marks.\"}}, {\"id\": \"7.05\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Provided You have used the Licensed Marks in accordance with this Franchise Agreement and AIRSOPURE's Operations Manual\", \"level\": 2, \"text\": \"7.05. Provided You have used the Licensed Marks in accordance with this Franchise Agreement and AIRSOPURE's Operations Manual, AIRSOPURE will defend You at AIRSOPURE's expense against any third Party claim, suit or demand involving the Licensed Marks and arising out of Your use thereof. In the event that You have not used the Licensed Marks in accordance with this Agreement, AIRSOPURE shall defend You, at Your expense, against such third Party claims, suits or demands. 7\"}}, {\"id\": \"7.06\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of any litigation or administrative proceeding relating to the Licensed Marks, You shall execute any and a\", \"level\": 2, \"text\": \"7.06. In the event of any litigation or administrative proceeding relating to the Licensed Marks, You shall execute any and all documents and do all acts as may, in the opinion of AIRSOPURE, be necessary to carry out such defense or prosecution, including, but not limited to, becoming a nominal Party to any legal action. Except to the extent that such litigation is the result of Your use of the Proprietary Marks in a manner inconsistent with the terms of this Agreement, AIRSOPURE agrees to reimburse You for its out-of-pocket costs in performing such acts, except that You shall bear the salary costs of its employees, and AIRSOPURE shall bear the cost of any judgment or settlement.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OPERATIONS MANUAL\", \"level\": 1, \"text\": \"8. OPERATIONS MANUAL\"}}, {\"id\": \"8.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE shall provide You with one copy of AIRSOPURE's Operations Manual covering the proper operating and marketing\", \"level\": 2, \"text\": \"8.01. AIRSOPURE shall provide You with one copy of AIRSOPURE's Operations Manual covering the proper operating and marketing techniques and the standards and specifications for operation of the Franchise. You agree to fully comply with the Operations Manual in its entirety as an essential aspect of Your obligations under this Agreement. Failure to so comply shall be treated as a breach of this Agreement.\"}}, {\"id\": \"8.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall at all times treat the Operations Manual, all supplements and revisions thereto, any other operations manual,\", \"level\": 2, \"text\": \"8.02. You shall at all times treat the Operations Manual, all supplements and revisions thereto, any other operations manual, brochure or memorandum created for or approved for use in the operation of the Franchise and the information contained therein as the confidential and proprietary information of AIRSOPURE, and shall use all reasonable efforts to maintain the confidentiality of such information. You shall not at any time, without AIRSOPURE's prior written consent, copy, duplicate, record, or otherwise reproduce the foregoing materials, in whole or in part, nor otherwise make the same available to any unauthorized person. You may disclose such information and materials only to such of Your employees or agents, or others who must have access to it in connection with their employment or the performance of this Agreement, in which event You shall obtain the agreement of such persons and entities to maintain the confidentiality thereof. The Operations Manual shall remain at all times the sole property of AIRSOPURE.\"}}, {\"id\": \"8.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE may from time to time revise the contents of the Operations Manual, and You expressly agree to comply with ea\", \"level\": 2, \"text\": \"8.03. AIRSOPURE may from time to time revise the contents of the Operations Manual, and You expressly agree to comply with each new or changed standard, specification or procedure set forth therein. You shall at all times ensure that Your copy of the Operations Manual is kept current and up to date. In the event of any dispute as to the content of the Operations Manual, the terms of the master copy of the Operations Manual maintained by AIRSOPURE at AIRSOPURE's home office shall be controlling.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACCOUNTING AND RECORDS\", \"level\": 1, \"text\": \"9. ACCOUNTING AND RECORDS\"}}, {\"id\": \"9.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the term of this Agreement, You shall maintain and preserve, for at least five years from the date of their prep\", \"level\": 2, \"text\": \"9.01. During the term of this Agreement, You shall maintain and preserve, for at least five years from the date of their preparation, full, complete, and accurate, books, records and accounts in the form and manner prescribed by AIRSOPURE from time to time in the Operations Manual or otherwise in writing.\"}}, {\"id\": \"9.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall, at Your expense, submit to AIRSOPURE, by the 7th day of each month, a monthly statement on forms prescribed\", \"level\": 2, \"text\": \"9.02. You shall, at Your expense, submit to AIRSOPURE, by the 7th day of each month, a monthly statement on forms prescribed by AIRSOPURE accurately reflecting gross sales of the Franchise for the preceding calendar month. Each statement shall accompany Your monthly royalty and advertising fund fee payments and shall be signed by You attesting that it is true and correct.\"}}, {\"id\": \"9.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall, at Your expense, submit to AIRSOPURE an annual financial statement for the Franchise, which includes an inco\", \"level\": 2, \"text\": \"9.03. You shall, at Your expense, submit to AIRSOPURE an annual financial statement for the Franchise, which includes an income statement prepared in accordance with generally accepted accounting principals, within 90 days of the end of each fiscal year during the term hereof. Each statement shall be signed by You attesting that it is true and correct.\"}}, {\"id\": \"9.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall submit to AIRSOPURE for review and auditing such other forms, reports,\", \"level\": 2, \"text\": \"9.04. You shall submit to AIRSOPURE for review and auditing such other forms, reports, 8 records, information and data, as AIRSOPURE may reasonably request in writing.\"}}, {\"id\": \"9.05\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE or its designated agents shall have the right at all reasonable times to examine and copy, at its expense, al\", \"level\": 2, \"text\": \"9.05. AIRSOPURE or its designated agents shall have the right at all reasonable times to examine and copy, at its expense, all books, records, receipts and tax returns of Yours related to the Franchise and, at its option, to have an independent audit made, and thereupon be allowed to search Your computer accounting files. If an inspection or audit should reveal that payments have been understated in any report to AIRSOPURE, then You shall immediately pay to AIRSOPURE the amount understated upon demand, in addition to interest from the date such amount was due until paid, at the prime rate being charged by Bank of America on the date the payment was due plus 2%, or the maximum rate permitted by law, whichever is less. If an inspection discloses an underpayment to AIRSOPURE of 2% or more of the total amount that should have been paid to AIRSOPURE, You shall, in addition to repayment of such understated amount with interest, reimburse AIRSOPURE for any and all costs and expenses incurred in connection with the inspection or audit (including, without limitation, reasonable accounting and attorneys' fees). The foregoing remedies shall be in addition to any other remedies AIRSOPURE may have, including without limitation, the remedies for default.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING AND ADVERTISING\", \"level\": 1, \"text\": \"10. MARKETING AND ADVERTISING\"}}, {\"id\": \"10.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall submit to AIRSOPURE for review prior to use samples of all advertising and promotional materials that have no\", \"level\": 2, \"text\": \"10.01. You shall submit to AIRSOPURE for review prior to use samples of all advertising and promotional materials that have not been previously approved by AIRSOPURE. AIRSOPURE shall notify You of its approval or disapproval within 7 days or less from the date of receipt by AIRSOPURE of such materials. Failure by You to obtain the prior approval in writing of AIRSOPURE for all advertising and promotional materials shall be a violation of this Agreement.\"}}, {\"id\": \"10.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE has established an advertising fund (the \\\"Fund\\\") to build recognition of the Products and the Licensed Marks\", \"level\": 2, \"text\": \"10.02. AIRSOPURE has established an advertising fund (the \\\"Fund\\\") to build recognition of the Products and the Licensed Marks and to promote AIRSOPURE's Products and the Franchise. You shall participate in the Fund, in addition to Your obligation to conduct local advertising of the Franchise, on the basis described in Paragraph 3.01.D above.\"}}, {\"id\": \"10.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE will administer the Fund as follows\", \"level\": 2, \"text\": \"10.03. AIRSOPURE will administer the Fund as follows: A. The Fund shall be maintained in a separate bank account. Upon request by You, AIRSOPURE will provide an annual accounting of amounts spent from the Fund, including a reasonable allocation to cover AIRSOPURE's overhead expenses for administration and management of the Fund. B. AIRSOPURE may allocate amounts held in the Fund at its discretion as AIRSOPURE deems appropriate. You are not guaranteed that any particular amount or percentage of the Fund will be spent in Your local market.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE shall have the right to terminate the Fund at any time\", \"level\": 1, \"text\": \"C. AIRSOPURE shall have the right to terminate the Fund at any time. However, the Fund will not be terminated until all moneys in the Fund have been expended for the purposes stated in Paragraph 10.02 above.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE may from time to time amend its policies or establish new policies and procedures for administration of the F\", \"level\": 1, \"text\": \"D. AIRSOPURE may from time to time amend its policies or establish new policies and procedures for administration of the Fund.\"}}, {\"id\": \"10.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In addition to its monthly contribution to the Fund, You shall spend an amount equal to at least 2% of Your total month\", \"level\": 2, \"text\": \"10.04. In addition to its monthly contribution to the Fund, You shall spend an amount equal to at least 2% of Your total monthly gross sales (as defined in Paragraph 3.01.C above) on local advertising in Your Exclusive Territory. You shall submit to AIRSOPURE a monthly report to accompany Your advertising fund fee and royalty fee payments accounting for and evidencing Your local advertising expenditures. Your local advertising shall comply with the procedures specified in Paragraph 10.01 above. 9\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSURANCE\", \"level\": 1, \"text\": \"11. INSURANCE\"}}, {\"id\": \"11.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall procure and maintain in full force and effect during the term of this Agreement, at Your expense, insurance p\", \"level\": 2, \"text\": \"11.01. You shall procure and maintain in full force and effect during the term of this Agreement, at Your expense, insurance policies written by an insurance company satisfactory to AIRSOPURE in accordance with standards and specifications set forth in the Operations Manual or otherwise by AIRSOPURE in writing. Such policies shall name AIRSOPURE as an additional insured and shall include, at a minimum: A. Comprehensive general liability insurance in the amount of $1,000,000.00. B. Comprehensive automobile liability insurance, including collision, comprehensive, medical and liability to satisfy state law requirements.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Additional coverage's and higher policy limits may be required from time to time by AIRSOPURE\", \"level\": 1, \"text\": \"C. Additional coverage's and higher policy limits may be required from time to time by AIRSOPURE.\"}}, {\"id\": \"11.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"At least 7 days prior to the opening of the Center and on each policy renewal date thereafter, You shall submit to AIRS\", \"level\": 2, \"text\": \"11.02. At least 7 days prior to the opening of the Center and on each policy renewal date thereafter, You shall submit to AIRSOPURE copies of all policies and policy amendments. The evidence of insurance shall include a statement by the insurer that the policy or policies will not be canceled or materially altered without at least 30 days prior written notice to AIRSOPURE.\"}}, {\"id\": \"11.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Your obligation to obtain and maintain the foregoing policy or policies in the amounts specified shall not be limited i\", \"level\": 2, \"text\": \"11.03. Your obligation to obtain and maintain the foregoing policy or policies in the amounts specified shall not be limited in any way by reason of any insurance which may be maintained by AIRSOPURE, nor shall Your performance of that obligation relieve You of liability under the indemnity provisions set forth in Section 17 of this Agreement.\"}}, {\"id\": \"11.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Should You, for any reason, fail to procure or maintain the insurance required by this Agreement, AIRSOPURE shall have\", \"level\": 2, \"text\": \"11.04. Should You, for any reason, fail to procure or maintain the insurance required by this Agreement, AIRSOPURE shall have the right and authority (without, however, any obligation to do so) immediately to procure such insurance and to charge same to You, which charges, together with a reasonable fee for AIRSOPURE's expenses in so acting, shall be payable by You immediately upon notice. AIRSOPURE is not a licensed insurance agent or agency.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRANSFER OF INTEREST\", \"level\": 1, \"text\": \"12. TRANSFER OF INTEREST\"}}, {\"id\": \"12.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer by AIRSOPURE\", \"level\": 2, \"text\": \"12.01. Transfer by AIRSOPURE A. AIRSOPURE shall have the right to transfer or assign all or any part of its rights or obligations in this Agreement to any person or legal entity. AIRSOPURE may sell or assign any of its assets, including without limitation the Licensed Marks, the system or Products, to any person or legal entity without liability or obligation to You. B. Nothing in this Agreement or otherwise shall obligate AIRSOPURE to remain in the indoor air purification business in the event AIRSOPURE should exercise its right to assign this Agreement or its assets which are the subject of this Agreement to a third Party.\"}}, {\"id\": \"12.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer by You A\", \"level\": 2, \"text\": \"12.02. Transfer by You A. You agree that the rights and duties set forth in this Agreement are personal to You, and that AIRSOPURE has entered into this Agreement and granted the Franchise rights and license hereunder in reliance on Your business skill, financial capacity, and character. Accordingly, You shall not sell, assign, transfer, convey, give away, mortgage or otherwise encumber any direct or indirect interest in the Franchise without the prior written consent of AIRSOPURE. B. Any purported assignment or transfer, by operation of law or otherwise, not having the prior written consent of AIRSOPURE shall be null and void and shall constitute a material breach of this Agreement.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE shall not unreasonably withhold its consent to a transfer of any interest in Your Franchise or in this Agreem\", \"level\": 1, \"text\": \"C. AIRSOPURE shall not unreasonably withhold its consent to a transfer of any interest in Your Franchise or in this Agreement if the following conditions have been met:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All of Your accrued monetary and other\", \"level\": 1, \"text\": \"1. All of Your accrued monetary and other 10 obligations to AIRSOPURE and its subsidiaries, affiliates and suppliers shall have been satisfied;\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall not be in default of any provisions of this Agreement or any other agreement between You and AIRSOPURE or its\", \"level\": 1, \"text\": \"2. You shall not be in default of any provisions of this Agreement or any other agreement between You and AIRSOPURE or its affiliates or suppliers;\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall have executed a general release, in a form satisfactory to AIRSOPURE, of any and all claims against AIRSOPURE\", \"level\": 1, \"text\": \"3. You shall have executed a general release, in a form satisfactory to AIRSOPURE, of any and all claims against AIRSOPURE and its officers, directors, shareholders and employees.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall remain liable for all obligations to AIRSOPURE in connection with the Franchise prior to the effective date o\", \"level\": 1, \"text\": \"4. You shall remain liable for all obligations to AIRSOPURE in connection with the Franchise prior to the effective date of the transfer;\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The transferee shall enter into a written assignment in a form satisfactory to AIRSOPURE assuming and agreeing to disch\", \"level\": 1, \"text\": \"5. The transferee shall enter into a written assignment in a form satisfactory to AIRSOPURE assuming and agreeing to discharge all of Your obligations under this Agreement;\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The transferee shall demonstrate to AIRSOPURE's satisfaction that the transferee meets AIRSOPURE's then existing requir\", \"level\": 1, \"text\": \"6. The transferee shall demonstrate to AIRSOPURE's satisfaction that the transferee meets AIRSOPURE's then existing requirements and qualifications for the granting of an AIRSOPURE Franchise;\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The transferee shall execute for a term ending on the expiration date of this Agreement the standard form franchise agr\", \"level\": 1, \"text\": \"7. The transferee shall execute for a term ending on the expiration date of this Agreement the standard form franchise agreement then being offered to new franchisees and such other ancillary agreements and documents as AIRSOPURE may then require for the Franchise, which may include changes in required fee payments or other terms;\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The transferee shall agree to upgrade the Franchise to conform to the then current standards and specifications for AIR\", \"level\": 1, \"text\": \"8. The transferee shall agree to upgrade the Franchise to conform to the then current standards and specifications for AIRSOPURE franchises;\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transferee and its employees shall complete such training programs as AIRSOPURE may reasonably require, at the transfer\", \"level\": 1, \"text\": \"9. Transferee and its employees shall complete such training programs as AIRSOPURE may reasonably require, at the transferee's expense;\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall pay AIRSOPURE a transfer fee of $1000\", \"level\": 1, \"text\": \"10. You shall pay AIRSOPURE a transfer fee of $1000.00 to cover AIRSOPURE's administrative expenses in connection with the transfer.\"}}, {\"id\": \"12.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Right of First Refusal\", \"level\": 2, \"text\": \"12.03. Right of First Refusal In the event You desire to sell the AIRSOPURE Center and Franchise rights and license granted herein, or any part of Your stock interest in a corporation that has been granted such rights, and receives a bona fide acceptable offer in writing, You agree to notify AIRSOPURE in writing of the terms and conditions of such offer. AIRSOPURE shall have the option, within 15 days after receipt of such written notice, to notify You that AIRSOPURE elects to purchase the rights and license granted herein or stock ownership on the same terms and conditions as the bona fide written offer. You agree to sell to AIRSOPURE on the same terms and conditions as the bona fide offer and to comply with all applicable laws relating to bulk transfers of assets. If AIRSOPURE fails to notify You of its election to exercise its right of first refusal granted herein within the thirty day period, then You may sell the franchise rights and license or the stock for the amount of the bona fide offer, subject to AIRSOPURE's rights under Section 12.02 above. Any material change in the terms or conditions of any offer prior to closing shall constitute a new offer subject to AIRSOPURE's right of first refusal described herein. If You fail to consummate the transaction within 30 days from the earlier of: (a) receipt of notice from AIRSOPURE that it elects not to exercise its right of first refusal, or (b) expiration of the 15 day period referred to herein, then You must resubmit the proposed transaction to AIRSOPURE, and AIRSOPURE shall have a new 15 day review period and right of first refusal.\"}}, {\"id\": \"12.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer Upon Death or Mental Incapacity Upon Your death or mental incapacity, or a person owning all or controlling\", \"level\": 2, \"text\": \"12.04. Transfer Upon Death or Mental Incapacity Upon Your death or mental incapacity, or a person owning all or controlling interest in Your Franchise, AIRSOPURE shall consent to the transfer of such interest to Your spouse or heirs provided, in AIRSOPURE's sole determination, such person(s) meet AIRSOPURE's then existing requirements and qualifications for the granting of an AIRSOPURE Franchise. If the said transfer 11 shall not be approved by AIRSOPURE, Your executor, administrator or personal representative shall transfer Your interest to a third Party approved by AIRSOPURE within 6 months after Your death or the determination of Your mental incapacity. If Your interest is not disposed of within 6 months after such death or mental incapacity, AIRSOPURE may terminate this Agreement.\"}}, {\"id\": \"12.05\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Operation of Franchise by AIRSOPURE In order to prevent any interruption in the business that would cause harm to the\", \"level\": 2, \"text\": \"12.05. Operation of Franchise by AIRSOPURE In order to prevent any interruption in the business that would cause harm to the Franchise or AIRSOPURE, You authorize AIRSOPURE, at its option but not its obligation, in the event that You are absent or incapacitated by reason of illness, death or otherwise and are not, in AIRSOPURE's sole judgment, able to operate the Franchise for any extended period of time, to operate and manage the Franchise for so long as AIRSOPURE deems necessary, without waiving any of AIRSOPURE's other rights and remedies under this Agreement. All monies from the operation of the Franchise during such period of operation by AIRSOPURE shall be kept in a separate account, and the expenses of AIRSOPURE during such period for operating the Franchise, including reasonable compensation of AIRSOPURE and its employees or representatives, shall be charged to such account. You agree to save harmless and fully indemnify AIRSOPURE and its employees and representatives for and against all claims, losses or actions in connection with the operation and management of the Franchise hereunder.\"}}, {\"id\": \"12.06\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Waiver of Claims AIRSOPURE's consent to a transfer of any interest in the Franchise granted herein shall not cons\", \"level\": 2, \"text\": \"12.06. Non-Waiver of Claims AIRSOPURE's consent to a transfer of any interest in the Franchise granted herein shall not constitute a waiver of any claims it may have against You, nor shall it be deemed a waiver of AIRSOPURE's right to demand exact compliance with any of the terms of this Agreement by the transferee.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"13. CONFIDENTIAL INFORMATION\"}}, {\"id\": \"13.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall not, during the term of this Agreement or thereafter, communicate, divulge, or use for the benefit of any othe\", \"level\": 2, \"text\": \"13.01 You shall not, during the term of this Agreement or thereafter, communicate, divulge, or use for the benefit of any other person or entity any confidential information, knowledge, or know-how concerning AIRSOPURE's system, the Products or the operation of the Franchise, including without limitation the Operations Manual. You shall divulge such confidential information only to such of Your employees or agents as must have access to it in order to operate the Franchise. Any and all information, trade secrets, knowledge, know-how, or other data concerning AIRSOPURE's system, the Products or which AIRSOPURE designates as confidential shall be deemed confidential for purposes of this Agreement, except information which You can demonstrate came to Your attention prior to disclosure thereof by AIRSOPURE, or which, at or after the time of disclosure by AIRSOPURE to You, had become or later becomes a part of the public domain, through publication or communication by others. You agree to use such proprietary information of AIRSOPURE only for operation of the Franchise Business.\"}}, {\"id\": \"13.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You acknowledge that the provisions of this Section 13 are and have been a primary inducement to AIRSOPURE to enter int\", \"level\": 2, \"text\": \"13.02. You acknowledge that the provisions of this Section 13 are and have been a primary inducement to AIRSOPURE to enter into this Agreement, and that any failure to comply with the requirements of Section 13.01 will cause AIRSOPURE irreparable injury without an adequate remedy at law; and You agree to pay all court costs and reasonable attorneys' fees incurred by AIRSOPURE in obtaining specific performance of, or an injunction against any violation of, the requirements of Section 13.01.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFAULT AND TERMINATION\", \"level\": 1, \"text\": \"14. DEFAULT AND TERMINATION\"}}, {\"id\": \"14.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE may, at its option, terminate this Agreement and all rights granted hereunder, without affording You any oppo\", \"level\": 2, \"text\": \"14.01. AIRSOPURE may, at its option, terminate this Agreement and all rights granted hereunder, without affording You any opportunity to cure the defaults, effective immediately upon receipt of notice by You, upon the occurrence of any of the following: A. You become insolvent or makes a general assignment for the benefit of creditors; or if a 12 petition in bankruptcy is filed by You or such a petition is filed against and consented to by You; or if You are adjudicated a bankrupt; or if You are unable to pay commercial debts as they become due. B. You (or a principal shareholder if the Franchisee is a corporation) is convicted of a felony or any other crime or offense that is reasonably likely, in the sole opinion of AIRSOPURE, to adversely affect the goodwill or reputation of AIRSOPURE or the Licensed Marks.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A judgment or consent decree is entered against You (or a principal shareholder if the Franchisee is a corporation) in\", \"level\": 1, \"text\": \"C. A judgment or consent decree is entered against You (or a principal shareholder if the Franchisee is a corporation) in a case involving allegations of fraud, racketeering, unfair or deceptive trade practices or similar allegations which, in AIRSOPURE's judgment, are likely to adversely affect AIRSOPURE, its Products, the Licensed Marks or the goodwill associated therewith.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You or any partner or shareholder in You transfers any rights or obligations under this Agreement or any interest in Yo\", \"level\": 1, \"text\": \"D. You or any partner or shareholder in You transfers any rights or obligations under this Agreement or any interest in You or in the Franchise to any third Party without AIRSOPURE's prior written consent. E. You intentionally disclose the contents of the Operations Manual or&bbsp;other trade secrets or confidential information provided to You by AIRSOPURE to any unauthorized person or fails to exercise reasonable care to prevent such disclosure. F. You maintain false books or records of the Franchise or knowingly make any material false statements or omission to AIRSOPURE in connection with Your application for the franchise granted herein or in connection with any reports submitted to AIRSOPURE, including without limitation the understatement of gross sales by more than 2%. G. You fail to commence business within 4 months following the execution of this Agreement. H. You (and Your manager) fail to attend any scheduled training program which AIRSOPURE has indicated is mandatory.\"}}, {\"id\": \"I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You operate the Franchise in such a manner which causes a threat or danger to public health or safety\", \"level\": 1, \"text\": \"I. You operate the Franchise in such a manner which causes a threat or danger to public health or safety. J. You receive 3 or more notices of default of this Agreement from AIRSOPURE for violations under Section 14.02 hereof.\"}}, {\"id\": \"14.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Except for violations of this Agreement listed in Section 13\", \"level\": 2, \"text\": \"14.02. Except for violations of this Agreement listed in Section 13.01 above, or violations specifically provided for elsewhere in this Agreement, You shall have 30 days from receipt from AIRSOPURE of a written Notice of Termination (citing the reason(s) therefor) within which to remedy any default listed in this Section 13.02, or any other violation of this Agreement. A. You fail to pay promptly any monies owing to AIRSOPURE or its subsidiaries or affiliates when due, or to submit the financial information or reports required by AIRSOPURE under this Agreement. B. You fail to meet or comply with any standards, specifications or procedures prescribed by AIRSOPURE in this Agreement, the Operations Manual or otherwise specified in writing from time to time by AIRSOPURE.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You are convicted, plead guilty or enter into a consent agreement for violation of any federal, state or local law, ord\", \"level\": 1, \"text\": \"C. You are convicted, plead guilty or enter into a consent agreement for violation of any federal, state or local law, ordinance, rule or regulation that is reasonably likely, in the sole opinion of AIRSOPURE, to materially and unfavorably affect the Franchise or AIRSOPURE, the Licensed Marks or the goodwill associated therewith.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You misuse or make any unauthorized use of the Proprietary Marks or otherwise impairs the\", \"level\": 1, \"text\": \"D. You misuse or make any unauthorized use of the Proprietary Marks or otherwise impairs the 13 goodwill associated therewith or AIRSOPURE's rights therein. E. You abandon the Franchise or fail to operate the Center during normal business hours without the consent in writing of AIRSOPURE. F. You fail to submit advertising or promotional materials to AIRSOPURE for approval in writing prior to use.\"}}, {\"id\": \"14.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No right or remedy of AIRSOPURE conferred herein shall be exclusive of any other right or remedy provided herein, at la\", \"level\": 2, \"text\": \"14.03. No right or remedy of AIRSOPURE conferred herein shall be exclusive of any other right or remedy provided herein, at law or in equity, unless specifically provided otherwise in this Agreement or any amendment hereto.\"}}, {\"id\": \"14.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event this Agreement is terminated by AIRSOPURE for violation of this Agreement by You, AIRSOPURE shall have the\", \"level\": 2, \"text\": \"14.04. In the event this Agreement is terminated by AIRSOPURE for violation of this Agreement by You, AIRSOPURE shall have the right, at its option, to purchase Your interest in the tangible assets of the Franchise at their fair market value.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OBLIGATIONS UPON TERMINATION\", \"level\": 1, \"text\": \"15. OBLIGATIONS UPON TERMINATION\"}}, {\"id\": \"15.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon termination or expiration of this Agreement, this Agreement and all rights granted hereunder to You shall immediat\", \"level\": 2, \"text\": \"15.01. Upon termination or expiration of this Agreement, this Agreement and all rights granted hereunder to You shall immediately terminate, and: A. You shall immediately cease to operate the Franchise and shall not thereafter, directly or indirectly, represent to the public or hold itself out as a present or former franchisee of AIRSOPURE. B. You shall immediately and permanently cease to use, by advertising or in any other manner whatsoever, the Licensed Marks of AIRSOPURE, any other identifying characteristics or trade dress of the system, and all confidential methods, procedures and techniques associated with the Franchise.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall take such action as may be necessary to cancel any assumed name or equivalent registrations or listings in te\", \"level\": 1, \"text\": \"C. You shall take such action as may be necessary to cancel any assumed name or equivalent registrations or listings in telephone or other directories which contain the names or Licensed Marks of AIRSOPURE, and You shall furnish AIRSOPURE with evidence satisfactory to AIRSOPURE of compliance with this obligation within 30 days after termination or expiration of this Agreement.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You shall promptly pay all sums owing to AIRSOPURE and its subsidiaries and affiliates, including all damages, costs an\", \"level\": 1, \"text\": \"D. You shall promptly pay all sums owing to AIRSOPURE and its subsidiaries and affiliates, including all damages, costs and expenses, including reasonable attorneys' fees, incurred by AIRSOPURE as a result of the default. E. You shall pay to AIRSOPURE all damages, costs and expenses, including reasonable attorneys' fees, incurred by AIRSOPURE subsequent to the termination or expiration of the Franchise herein granted in obtaining injunctive or other relief for the enforcement of any provisions of this Agreement. F. You shall immediately turn over to AIRSOPURE the Operations Manual, records, files, instructions, software, correspondence, and all other materials provided by AIRSOPURE related to the operation of the Franchise, and all copies thereof (all of which are acknowledged to be AIRSOPURE's property), and shall retain no copy or record of any of the foregoing, except only Your copy of this Agreement and any correspondence between the Parties, and any other documents which You reasonably need for compliance with any applicable provision of law. G. AIRSOPURE shall have the right, but not the duty, to be exercised by notice of intent to do so within 30 days after termination or expiration, to purchase any or all signs, advertising materials, supplies and inventory and any other items bearing AIRSOPURE's Licensed Marks, at Your cost or at fair market value, whichever is less. If the Parties cannot agree on the fair market value of such items, the Parties will select and share the expense of an independent appraiser to determine fair market value. With respect to any purchase by AIRSOPURE as provided herein, AIRSOPURE shall have the right to set off against the purchase price all amounts due from 14 You under this Agreement.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COVENANTS\", \"level\": 1, \"text\": \"16. COVENANTS\"}}, {\"id\": \"16.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You covenant and agree (or if Your Franchise is a corporation Your controlling shareholder agrees) to supervise and dev\", \"level\": 2, \"text\": \"16.01. You covenant and agree (or if Your Franchise is a corporation Your controlling shareholder agrees) to supervise and devote Your best efforts to manage and operate the Franchise.\"}}, {\"id\": \"16.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You acknowledge that, pursuant to this Agreement, You will receive valuable specialized training and confidential and p\", \"level\": 2, \"text\": \"16.02. You acknowledge that, pursuant to this Agreement, You will receive valuable specialized training and confidential and proprietary information of AIRSOPURE, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of AIRSOPURE and its system. You covenant and agree that during the term of this Agreement, and subject to the post-termination provisions contained herein, You shall not, except as otherwise approved in writing by AIRSOPURE, either directly or indirectly: A. Divert or attempt to divert any business or customer of the Franchise to any competitor, or competing business, by direct or indirect inducement or otherwise, or do or perform, directly or indirectly, any other act injurious or prejudicial to AIRSOPURE or the goodwill associated with the Licensed Marks and Products. B. Employ or seek to employ any person who is at that time employed by AIRSOPURE or by another AIRSOPURE franchisee or induce such person to leave his or her employment.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Own, maintain, engage in, be employed by, advise, consult, assist, invest in or have any interest whatsoever in any bus\", \"level\": 1, \"text\": \"C. Own, maintain, engage in, be employed by, advise, consult, assist, invest in or have any interest whatsoever in any business or entity which competes with or offers products or services which are the same or similar to those of AIRSOPURE or the Franchise.\"}}, {\"id\": \"16.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You covenant and agree that You (or any shareholder if Your Franchise is a corporation) shall not, for a period of two\", \"level\": 2, \"text\": \"16.03. You covenant and agree that You (or any shareholder if Your Franchise is a corporation) shall not, for a period of two years following termination of this Agreement for any reason, either directly or indirectly own, maintain, engage in, be employed by, advise, consult, assist, invest in or have any interest whatsoever in any business or entity which competes with or offers products or services which are the same or similar to those of AIRSOPURE or the Franchise within a radius of 25 miles of Your Exclusive Territory. In the event a court of competent jurisdiction should hold this covenant to be unreasonable or overly broad, the Parties agree to reduce the scope of such covenant to the maximum restriction permitted by law, and You agree to be bound by such less restrictive terms of this covenant. If requested by AIRSOPURE, You agree to obtain and provide to AIRSOPURE executed covenants containing terms equivalent to those contained herein from any employee of Yours who has received training from AIRSOPURE, and, if Your Franchise is a corporation, from any director or shareholder of Your corporation.\"}}, {\"id\": \"16.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE covenants and agrees that the restrictions set forth above in Paragraphs 16\", \"level\": 2, \"text\": \"16.04. AIRSOPURE covenants and agrees that the restrictions set forth above in Paragraphs 16.02.C and 16.03 shall not apply to ownership by You of less than a 5% beneficial interest in the outstanding equity securities of any publicly traded corporation, provided that You are not an employee, consultant or director of such corporation.\"}}, {\"id\": \"16.05\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You covenant and agree that its violation of any covenant contained herein would result in serious, immediate and irrep\", \"level\": 2, \"text\": \"16.05. You covenant and agree that its violation of any covenant contained herein would result in serious, immediate and irreparable injury to AIRSOPURE for which no adequate remedy at law will be available, and You consent, in addition to other remedies which may be available to AIRSOPURE, to the entry without opposition of an injunction prohibiting any conduct by You in violation of any covenant set forth herein.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"17. INDEMNIFICATION\"}}, {\"id\": \"17.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You agree to defend, indemnify and hold AIRSOPURE and its affiliates, directors, officers, employees and agents harmles\", \"level\": 2, \"text\": \"17.01. You agree to defend, indemnify and hold AIRSOPURE and its affiliates, directors, officers, employees and agents harmless from all claims, losses, lawsuits and expenses arising from or relating to the Franchise and Your operation thereof, except for: (i) any claims of infringement 15 from third Parties due to Your use of the Licensed Marks, provided that You have used the said Licensed Marks as authorized by AIRSOPURE; and (ii) claims alleging that Products sold or leased by You are defective.\"}}, {\"id\": \"17.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AIRSOPURE agrees to defend, indemnify and hold You harmless from all claims, losses, lawsuits and expenses arising from\", \"level\": 2, \"text\": \"17.02. AIRSOPURE agrees to defend, indemnify and hold You harmless from all claims, losses, lawsuits and expenses arising from or relating to: (i) any claims of infringement from third Parties due to Your use of the Licensed Marks, provided that You have used the Licensed Marks as authorized by AIRSOPURE; and (ii) claims alleging that Products sold or leased by You are defective.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"18. GENERAL PROVISIONS\"}}, {\"id\": \"18.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No failure of a Party to exercise any power reserved to it by this Agreement or to insist upon strict compliance by the\", \"level\": 2, \"text\": \"18.01. No failure of a Party to exercise any power reserved to it by this Agreement or to insist upon strict compliance by the other Party with any obligation or condition hereunder shall constitute a waiver of such Party's rights unless such waiver is in writing. Any waiver by either Party shall not constitute a waiver thereafter to demand exact compliance with any of the terms herein. Waiver by a Party of any particular default by the other Party shall not affect or impair such Party's rights with respect to any subsequent default of the same, similar or different nature; nor shall any delay, forbearance or omission of a Party to exercise any power or right arising out of any breach or default by the other Party of any of the terms, provisions, or covenants thereof, affect or impair such Party's right to exercise the same.\"}}, {\"id\": \"18.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unforeseen Events\", \"level\": 2, \"text\": \"18.02. Unforeseen Events Delays in the performance of any duties hereunder which are not the fault of and are beyond the ability of the Party to control, including without limitation fires, floods, natural disasters, acts of God, labor disputes, riots or other similar events, shall not constitute a default in the Party's performance of this Agreement, and the Parties agree to extend the time of performance for a reasonable period of time to allow for such delays.\"}}, {\"id\": \"18.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The relationship between the Parties is that of independent contractors\", \"level\": 2, \"text\": \"18.03. The relationship between the Parties is that of independent contractors. No partnership, joint venture, employment or relationship of principal and agent is intended, and You may not commit or bind AIRSOPURE to any obligation whatsoever.\"}}, {\"id\": \"18.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any and all notices required or permitted under this Agreement shall be in writing and shall be delivered by any means\", \"level\": 2, \"text\": \"18.04. Any and all notices required or permitted under this Agreement shall be in writing and shall be delivered by any means which will provide evidence of the date received, to the respective Parties at the following addresses unless and until a different address has been designated by written notice to the other Party: Notices to AIRSOPURE: Airsopure International Group, Inc. 15400 Knoll Trail, Suite 200 Dallas, Texas 75248 Attn: John Potter, President Notices to You: - -------------------------------- - -------------------------------- - -------------------------------- Any notice shall be deemed to have been given at the date and time it is received.\"}}, {\"id\": \"18.05\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement and the documents referred to herein constitute the entire Agreement between AIRSOPURE and You concernin\", \"level\": 2, \"text\": \"18.05. This Agreement and the documents referred to herein constitute the entire Agreement between AIRSOPURE and You concerning the subject matter hereof, and supersede all prior agreements, oral or written. No amendment, change or variance from this Agreement shall be binding on either Party unless executed by both Parties in writing.\"}}, {\"id\": \"18.06\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Except as expressly provided to the contrary herein, each provision of this Agreement shall be considered severable; an\", \"level\": 2, \"text\": \"18.06. Except as expressly provided to the contrary herein, each provision of this Agreement shall be considered severable; and if, for any reason, any provision herein is determined to be invalid under any law or by a court having valid jurisdiction, such shall not impair the operation of, or have any other effect upon, such other 16 provisions of this Agreement, and the latter shall continue to be given full force and effect and bind the Parties hereto, and the invalid provision shall be deemed not to be a part of this Agreement.\"}}, {\"id\": \"18.07\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement takes effect upon its acceptance and execution by AIRSOPURE in the State of Texas, and shall be interpre\", \"level\": 2, \"text\": \"18.07. This Agreement takes effect upon its acceptance and execution by AIRSOPURE in the State of Texas, and shall be interpreted and construed under the laws of the State of Texas.\"}}, {\"id\": \"18.08\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Parties agree that any action brought by either Party against the other in any court, whether federal or state, sha\", \"level\": 2, \"text\": \"18.08. The Parties agree that any action brought by either Party against the other in any court, whether federal or state, shall be brought within the State of Texas in the judicial district in which AIRSOPURE has its principal place of business and do hereby waive all questions of personal jurisdiction or venue for the purpose of carrying out this provision.\"}}, {\"id\": \"18.09\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If either Party is required to resort to legal process to enforce any provision of this Agreement, the prevailing Party\", \"level\": 2, \"text\": \"18.09. If either Party is required to resort to legal process to enforce any provision of this Agreement, the prevailing Party will recover all costs, including reasonable attorneys fees, incurred in such legal proceeding.\"}}, {\"id\": \"18.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You represent to AIRSOPURE that You have conducted an independent investigation of the business franchised hereunder an\", \"level\": 2, \"text\": \"18.10. You represent to AIRSOPURE that You have conducted an independent investigation of the business franchised hereunder and recognizes that the business venture contemplated by this Agreement involves business risks, and that its success will be largely dependent upon Your ability as an independent business person. AIRSOPURE expressly disclaims the making of, and You acknowledge that You have not received, any representation or guarantee, express or implied, as to the potential volume, profits or success of the business venture contemplated by this Agreement.\"}}, {\"id\": \"18.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You acknowledge that You received a completed copy of this Agreement, the attachments hereto, if any, and agreements re\", \"level\": 2, \"text\": \"18.11. You acknowledge that You received a completed copy of this Agreement, the attachments hereto, if any, and agreements relating thereto, if any, at least 5 business days prior to the date on which this Agreement was executed. You further acknowledge that You have received the Offering Circular, as required by the Federal Trade Commission, at least 10 business days prior to the date on which this Agreement was executed.\"}}, {\"id\": \"18.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement contains various headings, but it is agreed that such headings are for convenience only and shall not af\", \"level\": 2, \"text\": \"18.12. This Agreement contains various headings, but it is agreed that such headings are for convenience only and shall not affect the meaning of the provisions of this Agreement.\"}}, {\"id\": \"18.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You acknowledge that You have read and understood this Agreement, the attachments hereto, if any, and agreements relati\", \"level\": 2, \"text\": \"18.13. You acknowledge that You have read and understood this Agreement, the attachments hereto, if any, and agreements relating thereto, if any, and that AIRSOPURE has accorded You ample time and opportunity to consult with advisors of Your own choosing about the potential benefits and risks of entering into this Agreement.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPLICABLE LAW AND MEDIATION\", \"level\": 1, \"text\": \"19. APPLICABLE LAW AND MEDIATION A. THE PARTIES AGREE TO SUBMIT ANY CLAIM, CONTROVERSY OR DISPUTE ARISING OUT OF OR RELATING TO THIS AGREEMENT (AND ATTACHMENTS) OR THE RELATIONSHIP CREATED BY THIS AGREEMENT TO NON-BINDING MEDIATION PRIOR TO BRINGING SUCH CLAIM, CONTROVERSY OR DISPUTE IN A COURT. THE MEDIATION SHALL BE CONDUCTED THROUGH EITHER AN INDIVIDUAL MEDIATOR OR A MEDIATOR APPOINTED BY A MEDIATION SERVICES ORGANIZATION OR BODY, EXPERIENCED IN THE MEDIATION OF DISPUTES IN THE AIR PURIFICATION SERVICE BUSINESS, AGREED UPON BY THE PARTIES AND, FAILING SUCH AGREEMENT WITHIN A REASONABLE PERIOD OF TIME AFTER EACH PARTY HAS NOTIFIED THE OTHER OF ITS DESIRE TO SEEK MEDIATION OF ANY CLAIM CONTROVERSY OR DISPUTE (NOT TO EXCEED 15 DAYS), THROUGH THE AMERICAN ARBITRATION ASSOCIATION IN ACCORDANCE THE RULES GOVERNING MEDIATION, AT AIRSOPURE CORPORATE HEADQUARTERS IN DALLAS, TEXAS. THE COSTS AND EXPENSES OF MEDIATION, INCLUDING COMPENSATION AND EXPENSES OF THE MEDIATOR, SHALL BE BORNE BY THE PARTIES EQUALLY. IF THE PARTIES ARE UNABLE TO RESOLVE THE CLAIM, CONTROVERSY OR DISPUTE 90 DAYS 17 AFTER THE MEDIATOR HAS BEEN APPOINTED, THEN EITHER PARTY MAY SUBMIT SUCH CLAIM, CONTROVERSY OR DISPUTE TO A COURT IN ACCORDANCE WITH SECTION 19.B. BELOW NOTWITHSTANDING THE FOREGOING, EITHER PARTY MAY BRING AN ACTION (1) FOR MONEYS OWED, (2) FOR INJUNCTIVE RELIEF, OR (3) INVOLVING THE POSSESSION OR DISPOSITION OF, OR OTHER RELIEF RELATING TO, REAL PROPERTY IN A COURT HAVING JURISDICTION AND IN ACCORDANCE WITH SECTION 19.B. BELOW, WITHOUT SUBMITTING SUCH ACTION TO MEDIATION. B. WITH RESPECT TO ANY CLAIMS, CONTROVERSIES OR DISPUTES WHICH ARE NOT FINALLY RESOLVED THROUGH MEDIATION, YOU HEREBY IRREVOCABLY SUBMIT YOURSELF TO THE NONEXCLUSIVE JURISDICTION OF THE STATE COURTS OF DALLAS COUNTY, TEXAS AND THE FEDERAL DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS, DALLAS DIVISION. YOU HEREBY IRREVOCABLY AGREE THAT SERVICE OF PROCESS MAY BE MADE UPON YOU IN ANY EACH PROCEEDING RELATING TO OR ARISING OUT OF THIS AGREEMENT OR THE RELATIONSHIP CREATED BY THIS AGREEMENT BY ANY MEANS ALLOWED BY TEXAS OR FEDERAL LAW. VENUE FOR ANY SUCH LEGAL PROCEEDING SHALL BE DALLAS COUNTY, TEXAS; PROVIDED, HOWEVER WITH RESPECT TO ANY ACTION (1) FOR MONEYS OWED, (2) FOR INJUNCTIVE OR OTHER EXTRAORDINARY RELIEF OR (3) INVOLVING POSSESSION OR DISPOSITION OF; OR OFFER RELIEF RELATING TO, REAL PROPERTY, AIRSOPURE MAY BRING SUCH ACTION IN ANY STATE OR FEDERAL DISTRICT COURT WHICH HAS JURISDICTION. YOU HEREBY WAIVE ALL QUESTIONS OF PERSONAL JURISDICTION FOR TITLE PURPOSE OF CARRYING OUT THIS PROVISION. WITH RESPECT TO ALL CLAIMS, CONTROVERSIES, DISPUTES OR ACTIONS, THIS AGREEMENT SHALL BE INTERPRETED AND CONSTRUED UNDER TEXAS LAW (EXCEPT FOR TEXAS CHOICE OF LAW RULES).\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"YOU AND AIRSOPURE ACKNOWLEDGE THAT THE PARTIES' AGREEMENT REGARDING APPLICABLE STATE LAW AND FORUM SET FORTH IN SECTION\", \"level\": 1, \"text\": \"C. YOU AND AIRSOPURE ACKNOWLEDGE THAT THE PARTIES' AGREEMENT REGARDING APPLICABLE STATE LAW AND FORUM SET FORTH IN SECTION 19.B. ABOVE PROVIDE EACH OF THE PARTIES WITH THE MUTUAL BENEFIT OF UNIFORM INTERPRETATION OF THIS AGREEMENT AND ANY DISPUTE ARISING OUT OF THIS AGREEMENT OR THE PARTIES' RELATIONSHIP CREATED BY THIS AGREEMENT, EACH OF YOU AND AIRSOPURE FURTHER ACKNOWLEDGE THE RECEIPT AND SUFFICIENCY OF MUTUAL CONSIDERATION FOR SUCH BENEFIT.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"YOU AND AIRSOPURE ACKNOWLEDGE THAT THE EXECUTION OF THIS AGREEMENT OCCURRED IN DALLAS, TEXAS AND FURTHER ACKNOWLEDGE TH\", \"level\": 1, \"text\": \"D. YOU AND AIRSOPURE ACKNOWLEDGE THAT THE EXECUTION OF THIS AGREEMENT OCCURRED IN DALLAS, TEXAS AND FURTHER ACKNOWLEDGE THAT THE PERFORMANCE OF CERTAIN OBLIGATIONS OF YOU ARISING UNDER THIS AGREEMENT SHALL OCCUR IN DALLAS, TEXAS. IN WITNESS WHEREOF, the Parties hereto have duly executed, sealed, and delivered this Agreement on the day and year first above written. AIRSOPURE: By: --------------------------------- Title: ------------------------------ YOU: By: --------------------------------- Title: ------------------------------ 18 EXHIBIT F PERSONAL GUARANTEE For value received, and in consideration of the execution by Airsopure International Group, Inc. (\\\"Airsopure\\\") of a Franchise Agreement with - ---------------------------------------- (\\\"Franchisee\\\"), The undersigned - ---------------------------------------- (\\\"Guarantor\\\") hereby unconditionally guarantees to Airsopure all indebtedness, obligations and liabilities, direct or indirect, matured or immatured, primary or secondary, certain or contingent, of Franchisee to Airsopure, now or hereafter owing or incurred. This Guarantee is an absolute, unconditional, unlimited and continuing guarantee of the full and punctual payment by Franchisee of the foregoing indebtedness, obligations and liabilities and not of their collectibility only. Upon any default by Franchisee in such full and punctual payment, the liabilities and obligations of the Guarantor hereunder shall, at Airsopure's option, become forthwith due and payable without demand or notice of any nature, all of which are expressly waived by the Guarantor. Airsopure may deal with Franchisee in such manner as Airsopure in its sole discretion deems fit, and Guarantor gives to Airsopure full authority, in its sole discretion, to do any or all of the following things: a) extend credit, make loans and afford other financial accommodations to Franchisee at such times, in such amounts and on such terms as Airsopure may approve; b) vary the terms and grant extensions or renewals of any present or future indebtedness of Franchisee to Airsopure; c) grant time, waivers and other indulgences in respect thereto; d) vary, exchange, release or discharge, wholly or partially, or delay in or abstain from perfecting and enforcing any security or guaranty or other means of obtaining payment; e) accept partial payments from Franchisee; f) release or discharge, wholly or partially, any endorser or guarantor; g) compromise or make any settlement or other arrangement with Franchisee. Guarantor waives notice of acceptance hereof or of any action taken or omitted by Airsopure in reliance hereon and any requirement that Airsopure be diligent or prompt in making demands hereunder, giving notice of any default by Franchisee or asserting any other right hereunder. No provision of this Guaranty can be changed, waived, discharged or terminated except by an instrument in writing signed by Airsopure and Guarantor, and no such waiver shall extend to, affect or impair any other right of Airsopure hereunder. This Unlimited Guarantee shall inure to the benefit of Airsopure and its successors and assigns, and shall be binding on the Guarantor and the Guarantor's successors, heirs and assigns. EXECUTED on this ____ day of ____________, 2000. - ---------------------------------------- GUARANTOR - ---------------------------------------- WITNESS EXHIBIT G CONFIDENTIALITY AGREEMENT This Confidentiality and Noncompetition Agreement (the \\\"Agreement\\\") is made and entered into effective the _____day of ________________, 2000 by and between Airsopure International Group, Inc., a Nevada corporation, located at 15400 Knoll Trail, Suite 200, Dallas, Texas 75248 (the \\\"Company\\\") and - ----------------------------------------------- who resides at - ----------------------------------------------- - ----------------------------------------------- - ----------------------------------------------- - ----------------------------------------------- (the \\\"Associate\\\"). RECITALS A. Company sells franchises for the operation of air purification system business which operate under the name and service mark \\\"Airsopure\\\" (the \\\"Franchises\\\"); B. Company has developed a business method for operating Franchises utilizing certain Information, plans, methods, data, processes, marketing systems, techniques, operating procedures, trademarks, designs, information and know how of Company (the \\\"Confidential Information\\\"), and such Confidential Information may be further developed from time to time by Company:\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company has established substantial goodwill and an excellent reputation with respect to the quality of services availa\", \"level\": 1, \"text\": \"C. Company has established substantial goodwill and an excellent reputation with respect to the quality of services available, which goodwill and reputation have been and will continue to be of Major benefit to Company;\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Associate is or will become involved with Company, or a franchise of Company, in the capacity of an officer, partner, d\", \"level\": 1, \"text\": \"D. Associate is or will become involved with Company, or a franchise of Company, in the capacity of an officer, partner, director or as beneficial owner of an Airsopure Franchise or an employee of a Franchise, and will become privileged to certain Confidential Information; and E. Associate and Company have reached an understanding with regard to nondisclosure by Associate of Confidential Information and Noncompetition by Associate with Company NOW THEREFORE, in consideration of the foregoing, the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, Associate and Company, intending legally to be bound, hereby agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"1. CONFIDENTIAL INFORMATION. Associate and Company acknowledge that the business plan and methods used in connection with the operation of the Franchise which utilize Company's Confidential Information, are confidential, unique, constitute the exclusive property of Company and are trade secrets of Company. Associate acknowledges that any disclosure of the Confidential Information would be wrong and would cause irreparable injury and harm to Company. Associate further acknowledges that Company has expended a great amount of effort and money in obtaining and developing the Confidential Information, the Company has taken numerous precautions to guard the secrecy of the Confidential Information and that it would be very costly for competitors to acquire or duplicate the Confidential Information.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OPERATIONS MANUAL AS TRADE SECRET It is understood that Confidential Information, constituting \\\"trade secret\\\", as used\", \"level\": 1, \"text\": \"2. OPERATIONS MANUAL AS TRADE SECRET It is understood that Confidential Information, constituting \\\"trade secret\\\", as used in this Agreement is deemed to include, without initiation, any and all information contained in the Franchise Operations Manual, which may be provided AS one or more separate manuals, or written instructional guides, as the same are changed or supplemented from time to time, and any information of whatever nature which gives to Company an opportunity to obtain an advantage over its competitors who do not have access to, know or use such lists, written materials or information.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"3. CONFIDENTIAL INFORMATION. Associate shall not at any time, publish, disclose, divulge or in any manner communicate to any person, firm' corporation, association. partnership or any other entity whatsoever or use, directly or indirectly, for its own benefit or for the benefit of any Person, firm, corporation or other entity, other than the use of Company, any of the Confidential Information of Company or its Affiliates.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO INTERFERENCE WITH BUSINESS\", \"level\": 1, \"text\": \"4. NO INTERFERENCE WITH BUSINESS. During the term of this Agreement, neither Associate nor any member of his or her immediate finally shall divert or attempt to divert: I) any business related to, or any customer or prospective customer of; the Franchise by direct inducement or otherwise, or 2) the employment of Company or another franchisee licensed by Company, 1 to any Competitive Business by any direct inducement or otherwise.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REMEDIES\", \"level\": 1, \"text\": \"5. REMEDIES. Associate hereby acknowledges and agrees that in the event of any violations of this Agreement, Company shall be authorized and entitled, without posting a bond to obtain from any court of competent jurisdiction, preliminary and permanent injunctive relief as well as an equitable accounting of all profits or benefits arising out of any such violation, which rights and remedies shall be cumulative and in addition to any rights or remedies to which Company may be entitled.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECT OF WAVIER\", \"level\": 1, \"text\": \"6. EFFECT OF WAVIER. The waiver by Associate or company of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any subsequent breach thereof\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BINDING EFFECT\", \"level\": 1, \"text\": \"7. BINDING EFFECT. This Agreement shall be binding upon and inure to the benefit of Associate and Company and their respective heirs, executors, representatives successors and assigns.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"8. ENTIRE AGREEMENT. This instrument contains the entire agreement of Associate and Company relating to the matters set forth here It may not be changed orally, but only by an agreement in writing, signed by the party against whom enforcement of any waiver, change modification, extension or discharge is sought.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW\", \"level\": 1, \"text\": \"9. GOVERNING LAW. This instrument shall be governed by and construed under the laws of the State of Texas.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"JURISDICTION AND VENUE\", \"level\": 1, \"text\": \"10. JURISDICTION AND VENUE. In the event of a breach or threatened breach by Associate of this Agreement, Associate hereby irrevocably submits to the jurisdiction of the State District Court in Dallas County, Texas and the Federal District Court for the Northern District of Texas, and irrevocably agrees that venue for any action or proceeding shall be in Dallas County, Texas. Notwithstanding the foregoing, in the event that the laws of the state where, Associate resides require that the jurisdiction or venue be elsewhere, then such other states laws shall control. but only to the extent that such other state's laws so require.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITV\", \"level\": 1, \"text\": \"11. SEVERABILITV. Should anyone or more of the provisions hereof be determined to be illegal or unenforceable, all other provisions hereof shall be given separately therefrom and shall not be affected thereby.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COST OF ENFORCEMENT\", \"level\": 1, \"text\": \"12. COST OF ENFORCEMENT. In any action at law or in equity to enforce any of the provisions or rights under this Agreement, the unsuccessful party in such litigation as determined by the court in a final judgment or decree, shall pay the successful party or parties all costs, expenses and reasonable attorney's fees incurred therein by such arty or parties (including without Initiation such as costs, expenses and fees on any appeals), plus, if applicable, interest at the highest rate allowable by law, accruing from the date of the breach of this Agreement. If such successful party shall recover judgement in any such action or proceeding, such costs, expenses. attorney's fees and interest shall be included as part of such judgment. IN WITNESS WHEREOF, the parties hereto have signed this Agreement on the date first above written. FOR AIRSOPURE (COMPANY): - -------------------------------------------- FOR FRANCHISEE OF AIRSOPURE: - -------------------------------------------- ASSOCIATE OF FRANCHISEE: - -------------------------------------------- ASSOCIATE'S WORK CAPACITY: - -------------------------------------------- 2\"}}, {\"id\": \"party:Airsopure International Group, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Airsopure International Group, Inc.\", \"role\": \"Franchisor\", \"address\": \"15400 Knoll Trail, Suite 200, Dallas, Texas 75248\"}}, {\"id\": \"party:You\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"You\", \"role\": \"Franchisee\", \"address\": \"- ----------------------------------------\\n- ----------------------------------------\"}}, {\"id\": \"party:AIRSOPURE FRANCHISE GROUP, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"AIRSOPURE FRANCHISE GROUP, INC.\", \"role\": null, \"address\": null}}, {\"id\": \"party:Guarantor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Guarantor\", \"role\": \"Guarantor\", \"address\": null}}, {\"id\": \"party:Associate\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Associate\", \"role\": \"Associate\", \"address\": null}}, {\"id\": \"term:AIRSOPURE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AIRSOPURE\", \"text\": \"Airsopure International Group, Inc., a Nevada corporation whose principal place of business is located at 15400 Knoll Trail, Suite 200, Dallas, Texas 75248 (hereinafter \\\"AIRSOPURE\\\" or by reference \\\"we\\\", \\\"us\\\", \\\"our\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchisee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchisee\", \"text\": \"You: , ------------------------------------ whose address is: - ---------------------------------------- - ---------------------------------------- (hereinafter \\\"You\\\" or by reference \\\"Franchisee\\\", or \\\"Your\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"Either Party or both Parties respectively may be referred to as \\\"Party\\\" or \\\"Parties.\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"Either Party or both Parties respectively may be referred to as \\\"Party\\\" or \\\"Parties.\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"AIRSOPURE and its affiliate design, manufacture and distribute indoor air cleaning systems under the name and mark \\\"AIRSOPURE\\\" (the \\\"Products\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:AIRSOPURE Center(s)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AIRSOPURE Center(s)\", \"text\": \"AIRSOPURE has developed a system for the establishment, development and operation of sales centers (\\\"AIRSOPURE Center(s)\\\" or \\\"Center(s)\\\") for the sale and servicing of AIRSOPURE's exclusive line of Products\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Center(s)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Center(s)\", \"text\": \"AIRSOPURE has developed a system for the establishment, development and operation of sales centers (\\\"AIRSOPURE Center(s)\\\" or \\\"Center(s)\\\") for the sale and servicing of AIRSOPURE's exclusive line of Products\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Licensed Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Licensed Marks\", \"text\": \"using the service mark \\\"AIRSOPURE\\\" and other trademarks, service marks (including but not limited to, \\\"The Essence of Clean Air\\\"), logos and identifying features designated from time to time by AIRSOPURE (the \\\"Licensed Marks\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Exclusive Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Exclusive Territory\", \"text\": \"You desire to establish an AIRSOPURE Center to be located in the following geographic area: - ---------------------------------------- - ---------------------------------------- (the \\\"Exclusive Territory\\\")\", \"definition_clause\": \"C\"}}, {\"id\": \"term:Franchise\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchise\", \"text\": \"AIRSOPURE grants to You, and You accept from AIRSOPURE, the right and license to operate an AIRSOPURE Center (or the \\\"Franchise\\\") for the sale or lease of AIRSOPURE's exclusive line of Products or at a location in the Exclusive Territory to be approved in writing by AIRSOPURE and listed in attached Exhibit A\", \"definition_clause\": \"1.01\"}}, {\"id\": \"term:Exclusive Territory and Center Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Exclusive Territory and Center Location\", \"text\": \"a location in the Exclusive Territory to be approved in writing by AIRSOPURE and listed in attached Exhibit A (the \\\"Exclusive Territory and Center Location\\\")\", \"definition_clause\": \"1.01\"}}, {\"id\": \"term:Gross sales\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Gross sales\", \"text\": \"\\\"Gross sales\\\" as used in this Section 3.01 shall mean the amount of gross revenues received by You from all sources, including without limitation sales of Products, services or other merchandise of every kind or nature from, at or in connection with the operation of the AIRSOPURE Center granted herein, excluding state, federal or local sales taxes collected from customers and paid to the appropriate taxing authority.\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Fund\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fund\", \"text\": \"AIRSOPURE has established an advertising fund (the \\\"Fund\\\") to build recognition of the Products and the Licensed Marks and to promote AIRSOPURE's Products and the Franchise.\", \"definition_clause\": \"10.02\"}}, {\"id\": \"term:Airsopure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Airsopure\", \"text\": \"For value received, and in consideration of the execution by Airsopure International Group, Inc. (\\\"Airsopure\\\") of a Franchise Agreement\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Guarantor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Guarantor\", \"text\": \"The undersigned - ---------------------------------------- (\\\"Guarantor\\\") hereby unconditionally guarantees to Airsopure all indebtedness, obligations and liabilities...\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Confidentiality and Noncompetition Agreement (the \\\"Agreement\\\") is made and entered into...\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Company\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company\", \"text\": \"...by and between Airsopure International Group, Inc., a Nevada corporation, located at 15400 Knoll Trail, Suite 200, Dallas, Texas 75248 (the \\\"Company\\\")\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Associate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Associate\", \"text\": \"...and - ----------------------------------------------- who resides at - ----------------------------------------------- (the \\\"Associate\\\").\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Franchises\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchises\", \"text\": \"Company sells franchises for the operation of air purification system business which operate under the name and service mark \\\"Airsopure\\\" (the \\\"Franchises\\\");\", \"definition_clause\": \"D\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"Company has developed a business method for operating Franchises utilizing certain Information, plans, methods, data, processes, marketing systems, techniques, operating procedures, trademarks, designs, information and know how of Company (the \\\"Confidential Information\\\")\", \"definition_clause\": \"D\"}}, {\"id\": \"term:trade secret\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"trade secret\", \"text\": \"It is understood that Confidential Information, constituting \\\"trade secret\\\", as used in this Agreement is deemed to include, without initiation, any and all information contained in the Franchise Operations Manual...\", \"definition_clause\": \"2\"}}, {\"id\": \"value:10 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 years\"}}, {\"id\": \"value:3 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 months\"}}, {\"id\": \"value:$1,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000.00\"}}, {\"id\": \"value:$25,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$25,000.00\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:4 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"4 months\"}}, {\"id\": \"value:70%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"70%\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:the 7th of the month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"the 7th of the month\"}}, {\"id\": \"value:2%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"2%\"}}, {\"id\": \"value:seventh day of each month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seventh day of each month\"}}, {\"id\": \"value:1.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"1.5%\"}}, {\"id\": \"value:7 working days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"7 working days\"}}, {\"id\": \"value:two weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two weeks\"}}, {\"id\": \"value:90 DAYS\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 DAYS\"}}, {\"id\": \"value:three days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three days\"}}, {\"id\": \"value:$5,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5,000.00\"}}, {\"id\": \"value:$10,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$10,000.00\"}}, {\"id\": \"value:five years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five years\"}}, {\"id\": \"value:7th day of each month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"7th day of each month\"}}, {\"id\": \"value:7 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"7 days\"}}, {\"id\": \"value:$1,000,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000.00\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:$1000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1000.00\"}}, {\"id\": \"value:15 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"15 days\"}}, {\"id\": \"value:thirty day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty day period\"}}, {\"id\": \"value:6 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"6 months\"}}, {\"id\": \"value:two years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two years\"}}, {\"id\": \"value:5 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 business days\"}}, {\"id\": \"value:10 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 business days\"}}, {\"id\": \"value:15 DAYS\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"15 DAYS\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ASIANDRAGONGROUPINC_08_11_2005-EX-10.5-Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ASIANDRAGONGROUPINC_08_11_2005-EX-10.5-Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.5\", \"level\": 1, \"text\": \"Exhibit 10.5 Reseller Agreement This Agreement is made and entered into by and between 695014 B.C. Ltd. dba Galaxy Telecom, having a principal office at 200 - 375 Water Street, Vancouver, British Columbia V6B 5C6 Canada (\\\"Galaxy\\\") and Galaxy Telnet SRL, having a principal office at Aleea Malinului, Nr. 11, Bl. D, Scara C, Apt. 43, Constanta, Judetul Constanta, Romania (\\\"Telnet\\\") as of the 1s t day of June, 2004. WHEREAS: Galaxy is a wholesale provider of Voice over Internet Protocol (\\\"VoIP\\\") telephony and related services and products. Telnet is a provider of VoIP telephony and related services and products to Subscribers, as defined hereafter. Galaxy wishes to provide to Telnet and Telnet wishes to acquire from Galaxy VOIP related services and products from time to time for the purpose of providing them to Telnet's existing and future clients. NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the Parties, the Parties covenant and agree with each other as follows: 1. DEFINITIONS AND INTERPRETATION 1.1 Definitions In this agreement unless the context otherwise requires: \\\"Agreement\\\" means this agreement; \\\"Confidential Information\\\" means all information which one of the Parties will have access to or come into possession of which is confidential and proprietary to the other Party and which is either declared to be confidential or which the receiving Party should know, acting reasonably, is confidential or proprietary in nature and includes, but is not limited to, the terms and pricing for the Products and Services, all information contained on or accessible through the Partner Portal, as defined hereafter, any information disclosed by any third party which the third party is obligated to treat as confidential or proprietary to one of the Parties hereto, trade secrets, know-how, processes, standards, product specifications, marketing plans and techniques, cost and financial pricing figures, all client or customer information (including without limitation their names, financial information, address or telephone number), all systems software applications, all software/systems source and object code, data, documentation, program files, flow charts, and all operational procedures. \\\"Effective Date\\\" means the date first written above; \\\"Force Majeure\\\" shall include but not be limited to an Act of God, strike, lockout, labour dispute, act of a public enemy, war whether declared or undeclared, blockade, revolution, riot, insurrection, civil commotion, lightning, fire storms, flood, or other natural calamities, explosion, governmental restraint or restrictions, laws, regulations, orders, proclamations of any governmental entities, judgement or orders of any court of law, embargoes, unavailability of equipment and any other cause (other than a shortage or unavailability of funds) which is not reasonably within the control of the Party whose performance under this Agreement is affected by the cause; \\\"Partner Portal\\\" means Galaxy's web-based VoIP subscriber, management and business administration system; \\\"Party\\\" means either Galaxy or Telnet as is appropriate in context and \\\"Parties\\\" means both or either of Galaxy and Telnet as is appropriate in context; \\\"Product\\\" means one of and \\\"Products\\\" means some or all of the VoIP related devices offered for sale by Galaxy; \\\"Service\\\" means one of and \\\"Services\\\" means some or all of the VoIP services as listed in Schedule \\\"A\\\" attached hereto; \\\"Subscriber\\\" means a client of Telnet who is a consumer of the Products or Services as provided by Galaxy and sold by Telnet. 1.2 Currency All references to currency, unless otherwise specified, are to lawful money of the United States. 1.3 Headings The division of this Agreement into articles, sections, and/or subsections and the provision of headings for all or any of them are for convenience of reference only and shall not affect the interpretation of this Agreement. 1.4 Schedules The following schedules are attached to and form part of this Agreement: Schedule \\\"A\\\" Services and Products and Pricing Schedule \\\"B\\\" Tier 1 Subscriber Support Schedule \\\"C\\\" Subscriber Contract Clauses Whenever any provision of any schedule to this Agreement conflicts with any provision in the body of this Agreement, the provision in the body of this Agreement shall prevail. References herein to a schedule shall mean a schedule of this Agreement. Reference in any schedule of this Agreement to an agreement shall mean this Agreement. 1.5 Usage In this Agreement, unless there is something in the subject matter or context inconsistent therewith: words importing the singular shall include the plural and vice versa; and words importing gender shall include masculine, feminine and neuter genders. 1.6 Governing Law This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, excluding its conflict-of-laws rules. The parties expressly disclaim the application of the United Nations' Uniform Convention for the Sale of Goods convention, to this Agreement.\"}, {\"id\": \"2\", \"title\": \"RELATIONSHIP OF THE PARTIES 2\", \"level\": 1, \"text\": \"2. RELATIONSHIP OF THE PARTIES 2.1 Non-Exclusive Reseller Subject to the terms and conditions of this Agreement, Galaxy hereby appoints Telnet as a non-exclusive authorized reseller of the Products and Services and Telnet hereby accepts the appointment. 2.2 Not a Partnership This Agreement does not and shall not be construed to create a partnership, joint venture, agency or any other business relationship which would authorize either Party to act on behalf of the other or to have any authority to create any liability or obligations on behalf of or in the name of the other. Each of the Parties is and will remain completely independent of the other. Telnet may indicate to the public that it is an authorized seller of Galaxy Services and it may advertise Products and Services under Galaxy trademarks, logos, and symbols as provided for in this Agreement, but under no circumstances shall it represent itself to be an associate, franchisee, representative, servant or agent of Galaxy. becomes aware of.\"}, {\"id\": \"4\", \"title\": \"TELNET RECORDS 4\", \"level\": 1, \"text\": \"4. TELNET RECORDS 4.1 Maintain Records Telnet shall maintain complete and, to the best of its ability, accurate records on the Partner Portal (the \\\"Records\\\") of all Subscribers, including: (a) Name, location, contact information and date of activation; (b) Products purchased, including model and serial number and date of activation; (c) Services subscribed; including date of activation; and All service calls relating to Products or Services, showing Subscriber information, date and nature of call, Telnet response, service work performed and such other information as Galaxy may reasonably request. 4.2 Ownership and Privacy of Records Galaxy shall own the Records, but it shall use the information contained therein only as allowed by the terms and conditions and intent of this Agreement. Galaxy shall treat the Records as Confidential Information and it shall not provide to or allow access by any third party except as required or allowed by this Agreement. 4.3 911 Call Response Service Galaxy shall have the right to disclose Records to any third party providing emergency call response service to Subscribers as are required by such third party in order to provide the service.\"}, {\"id\": \"5\", \"title\": \"GALAXY RESPONSIBILITIES Services and Products Subject to the terms and conditions of this Agreement, Galaxy shall provi\", \"level\": 1, \"text\": \"5. GALAXY RESPONSIBILITIES Services and Products Subject to the terms and conditions of this Agreement, Galaxy shall provide the Products and Services to Telnet. 5.2 Network Galaxy shall establish a Telnet account within the Partner Portal and, subject to the terms and conditions of this Agreement, it shall provide Telnet with access thereto. 5.3 Materials Galaxy shall provide Telnet with access to electronic copies of sales and technical materials, user manuals, installation manuals and brochures and catalogues relating to the Products and Services which Galaxy has electronic versions of and which it, in its absolute discretion, is of the opinion are relevant. 5.4 Supporting Information Galaxy shall make available to Telnet such technical and commercial information which Galaxy has or which comes into Galaxy's possession and which, in Galaxy's opinion, may be of assistance to Telnet in selling and supporting the Products and Services. 5.5 Tier 2 Support Galaxy shall provide \\\"Tier 2\\\" technical support to Telnet which would include assistance with any technical issues related to the Services and Products that could not be resolved by Telnet's Tier 1 Subscriber support personnel.\"}, {\"id\": \"6\", \"title\": \"PRODUCTS 6\", \"level\": 1, \"text\": \"6. PRODUCTS 6.1 Approved Products Galaxy shall, at its sole discretion, determine the technical specifications and the brand and model of those devices which it will support in providing the Services and chooses to offer as Products; Telnet shall purchase from Galaxy all devices or Products used or to be used by it to enable the provisioning of the Services pursuant to this Agreement and Galaxy shall be required to support only those devices actually purchased from Galaxy by Telnet; Notwithstanding section 6.1(b), Telnet may request from Galaxy that it enable and support devices other than Products acquired by Telnet from Galaxy, and Galaxy shall not unreasonably refuse such request; and Galaxy shall have the right, at its sole discretion, to change the Products by discontinuing or adding new devices to the Products offered and by changing manufacturers, brands, models or technical or software specifications of any of them. 6.2 Pricing Prices for Products shall be as quoted at the time of order by Telnet and are subject to change at any time; Prices quoted shall be for the Products only and shall not include applicable taxes and shipping, insurance, expedition, import/export, brokerage and other fees, which shall be in addition to the quoted Product prices. 6.3 Ordering All Telnet orders of Products are subject to acceptance by Galaxy (upon acceptance, the \\\"Order\\\"). Galaxy shall have the right to not accept an order of Products from Telnet, in whole or in part, if Telnet is in breach of any term or condition of this Agreement; to change without notice. 7.7 Billing For Services Galaxy shall invoice Telnet once per month for the Services delivered, termination fees, 411 directory assistance and 911 emergency call service fees and any other fees or billings chargeable to Telnet; Galaxy shall deliver each invoice to Telnet's account in the Partner Portal; and Telnet shall give notice to Galaxy of all errors and inaccuracies in an invoice within 15 days of receipt by Telnet of the invoice at issue. Thereafter, Telnet will be deemed to have agreed with the accuracy of the invoice. 7.8 Payment of Services Invoice Telnet hereby covenants to pay all invoices rendered to its account by Galaxy within 15 days of the date of invoice; Interest shall accrue on overdue accounts at the rate of 1.5% per month calculated and payable from the date of invoice until the date of payment in full of the overdue amount. 7.9 Warranty Galaxy does not guarantee the integrity of data transmitted using the Products and Services or that the Products and Services will operate uninterrupted or error-free, including, without limitation, the degradation of voice transmission quality and the failure of an incoming or outgoing call, including emergency calls (911 or equivalent), to be connected or completed.\"}, {\"id\": \"9\", \"title\": \"USE OF NAME, LOGOS, TRADEMARKS AND LICENSED MATERIALS 9\", \"level\": 1, \"text\": \"9. USE OF NAME, LOGOS, TRADEMARKS AND LICENSED MATERIALS 9.1 News Releases Neither Party will use the name of the other in any news release, public announcement, advertisement or other form of publicity, without the prior written consent of the other Party. 9.2 Ownership and Use of Galaxy Trade Marks Telnet acknowledges Galaxy's exclusive ownership of the Galaxy name and logo as well as certain other trademarks and trade names which Galaxy uses in connection with the Products and Services (the \\\"Trademarked Material\\\") and agrees that Telnet will not acquire any interest in any of the Trademarked Material by virtue of this Agreement or anything done pursuant to it; While this Agreement is in effect, Telnet may indicate to the public its status of being an authorized seller of the Galaxy Products and Services; Except with the prior written consent of Galaxy, Telnet will not adopt or use any of the Trademarked Material, in whole or in part, or any confusingly similar word or symbol, as part of Telnet's name or, to the extent Telnet has knowledge of such use and the power to prevent such use, allow others to use the Trademarked Material; Nothing in this Agreement contains any transfer or license to Telnet of any Trademarked Material or other proprietary rights. 9.3 Review and Approval of Uses Galaxy shall have the right to review any use by Telnet of the Trademarked Material and to approve or disapprove, in its absolute discretion, Telnet's use of it and if Galaxy disapproves of Telnet's use of Trademarked Material, Telnet shall not use the Trademarked Material for such use. Telnet shall, at Galaxy's request, provide to Galaxy a copy of anything which Telnet is using or may use and which contains the Trademarked Material; Telnet must adhere to Galaxy's standards of use in respect to any of the Trademarked Material. Among other things, Telnet will be required to indicate explicitly Galaxy's ownership of the name or mark. 9.4 No Removal of Logos, Trademarks & Notices Unless Telnet first obtains express written consent from Galaxy, Telnet will not remove or alter any patent numbers, trade names, trademarks, copyright or other proprietary notices, serial numbers, labels, tags or other identifying marks, symbols or legends affixed to or included with any Product or portion thereof, whether on packaging, media, presentations or otherwise, or any related materials provided to Telnet by Galaxy.\"}, {\"id\": \"11\", \"title\": \"CONFIDENTIALITY 11\", \"level\": 1, \"text\": \"11. CONFIDENTIALITY 11.1 Confidential Information Each of the Parties acknowledges that in the course of their relationship pursuant to this Agreement, each (the \\\"Receiving Party\\\") will have access to or come into possession of Confidential Information of the other Party (the \\\"Disclosing Party\\\") and that the disclosure of such Confidential Information to third parties or to the general public would be detrimental to the best interests and business of the Disclosing Party.\"}, {\"id\": \"12\", \"title\": \"EXCLUSION FROM TERRITORIES 12\", \"level\": 1, \"text\": \"12. EXCLUSION FROM TERRITORIES 12.1 Right to Exclude Subject to section 12.2 Galaxy reserves the right to grant to any other person an exclusive territory (the \\\"Territory\\\") for the marketing, sales and distribution of the Services and, from that date which is 30 days after the date upon which Galaxy delivers notice in writing to Telnet of such grant of exclusivity over a Territory (the \\\"Exclusion Date\\\"), Telnet shall not sell, distribute or market the Services within the Territory. However, Telnet shall be entitled to continue to sell the Services to any Subscriber resident within the Territory who became a Subscriber prior to the Exclusion Date. 12.2 Territories From Which Telnet May Not Be Excluded During the term of this Agreement, Telnet may not be excluded pursuant to section 12.1, from the following areas: (a) Romania.\"}, {\"id\": \"13\", \"title\": \"MISCELLANEOUS 13\", \"level\": 1, \"text\": \"13. MISCELLANEOUS 13.1 No Waiver The failure by either Party to enforce or take advantage of any of the provisions of this Agreement shall not constitute nor be construed as a waiver of such provisions or of the right subsequently to enforce or take advantage of each and every such provision. 13.2 Default If either of the Parties should be in default (the \\\"Defaulting Party\\\") of any obligation or requirement under this Agreement, the Party affected may give written notice to the Defaulting Party specifying the default and will give the Defaulting Party a grace period of 30 days (the \\\"Grace Period\\\") to cure such default or to take such reasonable steps to cure without undue delay such default prior to seeking any remedy it may have on account of such default. The Defaulting Party shall lose no rights under this Agreement if it cures the stated default within the Grace Period. 13.3 Disputes Galaxy and Telnet will attempt to settle any claim or controversy relating to this Agreement through consultation and negotiation in good faith and a spirit of mutual cooperation. If those attempts fail, then a mutually acceptable mediator, chosen by Galaxy and Telnet within forty-five (45) days after written notice from one of the parties to the other, demanding mediation, will mediate the dispute. Neither party may unreasonably withhold consent to the selection of a mediator. Galaxy and Telnet will share the costs of the mediation equally and each shall bear its own costs. Any dispute which the parties cannot resolve between themselves through negotiation or mediation within ninety (90) days after the date of the initial demand for mediation may then be submitted to the courts for final resolution. Nothing in this paragraph will prevent either party from resorting to judicial proceedings if: good faith efforts to resolve the dispute under these procedures have been unsuccessful; or interim relief from a court is necessary to prevent serious and irreparable injury to one party or to others. 13.4 Notices Any formal notice between the Parties hereto will be in writing and will be either personally delivered or sent by facsimile or by registered mail to the appropriate party or parties at the address noted for that party on the first page of this Agreement, or such other address as may be designated by a party in a written notice sent to the other parties in accordance with this paragraph. Any notice or other communication will be effective seven calendar days from the day that it was sent, or if given by personal delivery or facsimile, the day following its receipt. 13.5 Assignment Neither party may assign this Agreement without the prior written consent of the other. However, Telnet agrees that Galaxy may assign this entire Agreement to an affiliate or sell, transfer or assign any account receivable under it to a financing institution to enforce the Galaxy's rights to receive payment from Telnet. This Agreement will be binding upon any authorized assignee or successor of Telnet or Galaxy. 13.6 Compliance with Law Each of the Parties agrees to comply with all applicable laws, rules and regulations of the jurisdictions in which it operates and to do nothing to cause the other to violate the law, rules and regulations of those jurisdictions. If this Agreement or the performance hereof, is determined to be contrary of the laws, rules or regulations of the Territory or of Canada, this Agreement will automatically terminate subject the terms of Termination outlined in this Agreement. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives as of the date first written above: 695014 B.C. LTD. GALAXY TELNET SRL Per: \\\"Peter Wiggans\\\" Per: \\\"Michael Stunden\\\" Authorized Signatory Authorized Signatory Peter Wiggans Michael Stunden (Print name) (Print name) Title: Chief Operating Officer Title: Chief Financial Officer SCHEDULE \\\"A\\\" SCHEDULE \\\"A\\\" PARTNER PRICING Galaxy Telnet Table 1 Business Partner Pricing VoIP Services One-Time Fee Monthly Service Fee VoIP Connectivity (per port charge) Includes: Unlimited VoIP calls, VoIP Caller ID, Call waiting, Basic voicemail $9.95 $5.95 VoIP Connectivity - Commpanion Galaxy Telecom Brand With i-box subscription Includes: Unlimited VoIP calls, VoIP Caller ID, Call waiting, Basic voicemail, 3-way Calling, Call forwarding, Do not disturb, Call hold, Auto answer, Call ignore, Call \\\"go to voicemail\\\", Redial, Mute $19.95 $1.95 VoIP Connectivity - i-box Commpanion Galaxy Telecom Brand Stand alone subscription Includes: Unlimited VoIP calls, VoIP Caller ID, Call waiting, Basic voicemail, 3-way Calling, Call forwarding, Do not disturb, Call hold, Auto answer, Call ignore, Call \\\"go to voicemail\\\", Redial, Mute $19.95 $5.95 VoIP to VoIP Termination included included VoIP to PSTN Termination (Long distance) included See Current Published Rates Basic Voicemail Service included included\"}, {\"id\": \"i\", \"title\": \"box CommCenter - Enhanced Voicemail\", \"level\": 1, \"text\": \"i-box CommCenter - Enhanced Voicemail Includes: Web interface, call forwarding, do not disturb, speed dial, call logs, email message notify management, time zone control, profile management, greeting management and password control included $2.00 Services Partner Portal included included Partner Portal Back-Office (API) included included Special Accounts Demonstration Accounts See note 3 free free Employee only Accounts See note 3 free $1.95 Promotion Accounts TBD Special Special Phone Numbers Direct Inward Dial (DID) - Canada $250 one time fee per order see note 1 $3.00 Direct Inward Dial (DID) - USA $250 one time fee per order see note 1 $2.50 Toll Free Dial (1-8XX) - Canada/USA $2.50 $2.50 plus usage ($.05 avg.) Use existing phone number see note 2 $10.00 $3.00 Bundles & Calling Zones Monthly 250 North America minute bundle n/a $2.95 Monthly 500 North America minute bundle n/a $5.95 Monthly 750 North America minute bundle n/a $8.95 Monthly 1000 North America minute bundle n/a $11.95 Local Calling Zone On-net locations only Includes: 750 minutes inbound and outbound local calls. Requires DID. Subscriber must reside in Local Calling area. included $6.95 Virtual Calling Zone On-net locations only Includes: 750 minutes inbound calls from virtual calling area. Requires DID Applies to North America-based subscribers only. See note 4 included $6.95 Custom Calling Zone Off-net locations Custom Quote Custom Quote Note 1 Not available in all areas, see Table 3, 25 DID number block minimum Note 2 Not available in all areas see Table 3 Note 3 Quantity to be agreed between parties, Long distance charges apply Note 4 Unlimited calling FROM Virtual Calling Zone only. Long distance charges apply when calling to VCZ. Table 2 i-box Commpanion Telecom Branded Version Note 1 Co-Branding one time charge $1,350.00 Table 3 Galaxy Telecom On-net locations Canada Province City Alberta Calgary Edmonton British Columbia Vancouver Victoria Kelowna Whistler Abbotsford Manitoba Winnipeg Nova Scotia Halifax Ontario Toronto Ottawa Hamilton Windsor Kitchener London Guelph Kingston Oshawa St. Catherines Waterloo Hespeler Quebec Montreal Quebec City Saskatchewan Regina USA State City Alabama Birmingham Arizona Phoenix California Los Angeles San Diego San Francisco Colorado Denver Florida Gainesville Miami Orlando Tampa Georgia Atlanta Illinois Chicago Indiana Indianapolis Maryland Baltimore Michigan Detroit Minnesota Minneapolis Missouri Kansas City St Louis New York New York City North Carolina Charlotte Fayetteville Greensboro Raleigh Ohio Cincinnati Cleveland Dayton Oregon Portland Pennsylvania Philadelphia Tennessee Nashville Texas Dallas Austin Houston San Antonio Utah Salt lake City Virginia Culpepper Washington Seattle Washington DC Washington DC SCHEDULE \\\"B\\\" TIER 1 SUBSCRIBER SUPPORT Under this Agreement the Telnet is required to maintain Tier 1 Subscriber Support (the \\\"Subscriber Support\\\") functioning as initial response for any direct Subscriber inquiries. Galaxy will provide Tier 2 technical support for technical inquiries from qualified resellers only. The Criteria for the Subscriber Support are as follows: Subscriber Satisfaction Telnet will use its best efforts to ensure that Subscribers achieve the highest levels of satisfaction with the Services delivered by Telnet. Telnet shall notify Galaxy immediately of any complaints by Subscribers, whether they involve sales, Service, Performance or other issues. Galaxy shall use Subscriber satisfaction surveys, field Service reports, and random audits, as it deems necessary to determine if the appropriate levels of Subscriber satisfaction are achieved. If Galaxy determines that an inappropriate level of Subscriber dissatisfaction exists, Galaxy and Telnet shall put in place an action plan as approved by Galaxy to continually improve and maintain Subscriber satisfaction levels. Staff Subscriber Support shall be staffed by fully qualified and trained personnel as per the following criteria: 1. Training Telnet shall maintain technically qualified Service personnel and use its best efforts to service Telnet subscribers in the Territory. 2. Technical Team (a) Language Capabilities Telnet shall employ at least one lead Service engineer who is fluent in English who will be responsible for communicating with Galaxy's technical staff and who can accurately translate all technical documentation from English. Service Staff Upon execution of this Agreement and annually thereafter, Telnet shall furnish Galaxy with a list of its Service management and other technical staff qualified to support Galaxy Services. (c) Help Desk Telnet shall ensure that the personnel staffing the Subscriber help desk, as set out in section 3.6, shall have a sufficient working knowledge of: networking in a TCP/IP WAN/LAN environment; configuring and maintaining network equipment; relevant operating systems (Macintosh, Windows, Linux); and both written and spoken English,. to be able to provide effective help to Subscribers, communicate and work with Galaxy's Tier 2 help desk to address those Subscriber issues which Telnet's help desk are unable to resolve and to communicate and work with Galaxy with regard to technical issues. SCHEDULE \\\"C\\\" SCHEDULE \\\"C\\\" SUBSCRIBER CONTRACT CLAUSES Telnet shall include as a term of any agreement between itself and a Subscriber with respect to any of the Services, the relevant clauses of the following: General The Subscriber will not use the Service for any purpose that is unlawful, abusive, intrusive on another's privacy, harassing, libellous, defamatory, threatening or hateful, or in any other way that would violate any applicable governmental law. Telnet offers the Service internationally. While the Service may be used to make and receive international calls, we do not represent that the use of the Service is legally appropriate in locations outside of Canada and the United States. If the Subscriber chooses to use the Service from or to a location outside of Canada and the United States, the Subscriber is responsible for compliance with any and all governing foreign and local laws. The Subscriber may not reverse engineer, distribute, publish, display, modify or in any way exploit the configuration parameters Telnet provides as a means to access the Service. The Subscriber acknowledges that any devices and embedded software or firmware (\\\"Products\\\") furnished by Telnet are exclusively for use with Telnet's Service. Residential Use of Service If you have subscribed to Residential Services, the Service is provided to you as a residential user, for your personal, residential, non-business and non-professional use. This means that you are not using the service for any commercial or governmental activities, profit-making or non-profit, including but not limited to business, sales, telecommuting, telemarketing, autodialing, continuous or extensive call forwarding, fax broadcast, fax blasting or any other activity that would be inconsistent with normal residential usage patterns. Telnet reserves the right to immediately terminate or modify the service, if Telnet determines, in its sole discretion, that the subscriber's service is being used for any of the aforementioned activities. The Service is offered on a monthly basis to the Subscriber. The monthly Service term begins on the date that Service is activated for the subscriber. Full monthly terms will renew automatically unless Telnet is otherwise notified of the intent to cancel the Service. Upon cancellation, the Subscriber will be responsible for charges for the full term of the then current billing period and any unbilled charges. Small Business Use of Service If you have subscribed to Small Business Services, the Service is provided to you as a small business user. You agree not to use the Service for auto-dialling, continuous or extensive call forwarding, telemarketing or fax broadcasting. Telnet reserves the right to immediately terminate or modify the service, if Telnet determines, in its sole discretion, that the subscriber's service is being used for any of the aforementioned activities. The Service is offered on a monthly basis to the Subscriber. The monthly Service term begins on the date that subscriber requests activation of the Service. Full monthly terms will renew automatically unless the Telnet and Galaxy is otherwise notified of the intent to cancel the Service. Upon cancellation, the Subscriber will be responsible for charges for the then current full monthly term and any unbilled charges Short Form Emergency Services, E911 and 911 The Service presently does not support 911, E911 or any other type of emergency Services; that calls to \\\"9-1-1\\\" cannot be connected; and that alternative arrangements need to be made to contact emergency Services in situations where emergency numbers would have to be dialled. Theft The Subscriber is responsible for cancelling the Service if Subscriber believes that the associated Products have been lost or stolen, or if the Subscriber becomes aware that the Service provided is being used or misused without Subscribers consent. Subscriber is liable for all charges accruing to Subscribers account for the Service until Subscriber cancels the Service. Service Termination The Provider reserves the right to terminate the Service at any time with or without notice and for any reason. The subscriber agrees that the provider shall not be liable to the subscriber or to any third party for any modification, suspension or discontinuance of the Service. Privacy Personal data and certain other information submitted by the subscriber is subject to our Privacy Policy. Voice over IP communications are transmitted over public networks including the Internet. The subscriber acknowledges that the provider is not liable for any loss of privacy arising out of use of the Service.\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ASIANDRAGONGROUPINC_08_11_2005-EX-10.5-Reseller Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.5\", \"level\": 1, \"text\": \"Exhibit 10.5 Reseller Agreement This Agreement is made and entered into by and between 695014 B.C. Ltd. dba Galaxy Telecom, having a principal office at 200 - 375 Water Street, Vancouver, British Columbia V6B 5C6 Canada (\\\"Galaxy\\\") and Galaxy Telnet SRL, having a principal office at Aleea Malinului, Nr. 11, Bl. D, Scara C, Apt. 43, Constanta, Judetul Constanta, Romania (\\\"Telnet\\\") as of the 1s t day of June, 2004. WHEREAS: Galaxy is a wholesale provider of Voice over Internet Protocol (\\\"VoIP\\\") telephony and related services and products. Telnet is a provider of VoIP telephony and related services and products to Subscribers, as defined hereafter. Galaxy wishes to provide to Telnet and Telnet wishes to acquire from Galaxy VOIP related services and products from time to time for the purpose of providing them to Telnet's existing and future clients. NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the Parties, the Parties covenant and agree with each other as follows: 1. DEFINITIONS AND INTERPRETATION 1.1 Definitions In this agreement unless the context otherwise requires: \\\"Agreement\\\" means this agreement; \\\"Confidential Information\\\" means all information which one of the Parties will have access to or come into possession of which is confidential and proprietary to the other Party and which is either declared to be confidential or which the receiving Party should know, acting reasonably, is confidential or proprietary in nature and includes, but is not limited to, the terms and pricing for the Products and Services, all information contained on or accessible through the Partner Portal, as defined hereafter, any information disclosed by any third party which the third party is obligated to treat as confidential or proprietary to one of the Parties hereto, trade secrets, know-how, processes, standards, product specifications, marketing plans and techniques, cost and financial pricing figures, all client or customer information (including without limitation their names, financial information, address or telephone number), all systems software applications, all software/systems source and object code, data, documentation, program files, flow charts, and all operational procedures. \\\"Effective Date\\\" means the date first written above; \\\"Force Majeure\\\" shall include but not be limited to an Act of God, strike, lockout, labour dispute, act of a public enemy, war whether declared or undeclared, blockade, revolution, riot, insurrection, civil commotion, lightning, fire storms, flood, or other natural calamities, explosion, governmental restraint or restrictions, laws, regulations, orders, proclamations of any governmental entities, judgement or orders of any court of law, embargoes, unavailability of equipment and any other cause (other than a shortage or unavailability of funds) which is not reasonably within the control of the Party whose performance under this Agreement is affected by the cause; \\\"Partner Portal\\\" means Galaxy's web-based VoIP subscriber, management and business administration system; \\\"Party\\\" means either Galaxy or Telnet as is appropriate in context and \\\"Parties\\\" means both or either of Galaxy and Telnet as is appropriate in context; \\\"Product\\\" means one of and \\\"Products\\\" means some or all of the VoIP related devices offered for sale by Galaxy; \\\"Service\\\" means one of and \\\"Services\\\" means some or all of the VoIP services as listed in Schedule \\\"A\\\" attached hereto; \\\"Subscriber\\\" means a client of Telnet who is a consumer of the Products or Services as provided by Galaxy and sold by Telnet. 1.2 Currency All references to currency, unless otherwise specified, are to lawful money of the United States. 1.3 Headings The division of this Agreement into articles, sections, and/or subsections and the provision of headings for all or any of them are for convenience of reference only and shall not affect the interpretation of this Agreement. 1.4 Schedules The following schedules are attached to and form part of this Agreement: Schedule \\\"A\\\" Services and Products and Pricing Schedule \\\"B\\\" Tier 1 Subscriber Support Schedule \\\"C\\\" Subscriber Contract Clauses Whenever any provision of any schedule to this Agreement conflicts with any provision in the body of this Agreement, the provision in the body of this Agreement shall prevail. References herein to a schedule shall mean a schedule of this Agreement. Reference in any schedule of this Agreement to an agreement shall mean this Agreement. 1.5 Usage In this Agreement, unless there is something in the subject matter or context inconsistent therewith: words importing the singular shall include the plural and vice versa; and words importing gender shall include masculine, feminine and neuter genders. 1.6 Governing Law This Agreement shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein, excluding its conflict-of-laws rules. The parties expressly disclaim the application of the United Nations' Uniform Convention for the Sale of Goods convention, to this Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RELATIONSHIP OF THE PARTIES 2\", \"level\": 1, \"text\": \"2. RELATIONSHIP OF THE PARTIES 2.1 Non-Exclusive Reseller Subject to the terms and conditions of this Agreement, Galaxy hereby appoints Telnet as a non-exclusive authorized reseller of the Products and Services and Telnet hereby accepts the appointment. 2.2 Not a Partnership This Agreement does not and shall not be construed to create a partnership, joint venture, agency or any other business relationship which would authorize either Party to act on behalf of the other or to have any authority to create any liability or obligations on behalf of or in the name of the other. Each of the Parties is and will remain completely independent of the other. Telnet may indicate to the public that it is an authorized seller of Galaxy Services and it may advertise Products and Services under Galaxy trademarks, logos, and symbols as provided for in this Agreement, but under no circumstances shall it represent itself to be an associate, franchisee, representative, servant or agent of Galaxy. becomes aware of.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TELNET RECORDS 4\", \"level\": 1, \"text\": \"4. TELNET RECORDS 4.1 Maintain Records Telnet shall maintain complete and, to the best of its ability, accurate records on the Partner Portal (the \\\"Records\\\") of all Subscribers, including: (a) Name, location, contact information and date of activation; (b) Products purchased, including model and serial number and date of activation; (c) Services subscribed; including date of activation; and All service calls relating to Products or Services, showing Subscriber information, date and nature of call, Telnet response, service work performed and such other information as Galaxy may reasonably request. 4.2 Ownership and Privacy of Records Galaxy shall own the Records, but it shall use the information contained therein only as allowed by the terms and conditions and intent of this Agreement. Galaxy shall treat the Records as Confidential Information and it shall not provide to or allow access by any third party except as required or allowed by this Agreement. 4.3 911 Call Response Service Galaxy shall have the right to disclose Records to any third party providing emergency call response service to Subscribers as are required by such third party in order to provide the service.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GALAXY RESPONSIBILITIES Services and Products Subject to the terms and conditions of this Agreement, Galaxy shall provi\", \"level\": 1, \"text\": \"5. GALAXY RESPONSIBILITIES Services and Products Subject to the terms and conditions of this Agreement, Galaxy shall provide the Products and Services to Telnet. 5.2 Network Galaxy shall establish a Telnet account within the Partner Portal and, subject to the terms and conditions of this Agreement, it shall provide Telnet with access thereto. 5.3 Materials Galaxy shall provide Telnet with access to electronic copies of sales and technical materials, user manuals, installation manuals and brochures and catalogues relating to the Products and Services which Galaxy has electronic versions of and which it, in its absolute discretion, is of the opinion are relevant. 5.4 Supporting Information Galaxy shall make available to Telnet such technical and commercial information which Galaxy has or which comes into Galaxy's possession and which, in Galaxy's opinion, may be of assistance to Telnet in selling and supporting the Products and Services. 5.5 Tier 2 Support Galaxy shall provide \\\"Tier 2\\\" technical support to Telnet which would include assistance with any technical issues related to the Services and Products that could not be resolved by Telnet's Tier 1 Subscriber support personnel.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCTS 6\", \"level\": 1, \"text\": \"6. PRODUCTS 6.1 Approved Products Galaxy shall, at its sole discretion, determine the technical specifications and the brand and model of those devices which it will support in providing the Services and chooses to offer as Products; Telnet shall purchase from Galaxy all devices or Products used or to be used by it to enable the provisioning of the Services pursuant to this Agreement and Galaxy shall be required to support only those devices actually purchased from Galaxy by Telnet; Notwithstanding section 6.1(b), Telnet may request from Galaxy that it enable and support devices other than Products acquired by Telnet from Galaxy, and Galaxy shall not unreasonably refuse such request; and Galaxy shall have the right, at its sole discretion, to change the Products by discontinuing or adding new devices to the Products offered and by changing manufacturers, brands, models or technical or software specifications of any of them. 6.2 Pricing Prices for Products shall be as quoted at the time of order by Telnet and are subject to change at any time; Prices quoted shall be for the Products only and shall not include applicable taxes and shipping, insurance, expedition, import/export, brokerage and other fees, which shall be in addition to the quoted Product prices. 6.3 Ordering All Telnet orders of Products are subject to acceptance by Galaxy (upon acceptance, the \\\"Order\\\"). Galaxy shall have the right to not accept an order of Products from Telnet, in whole or in part, if Telnet is in breach of any term or condition of this Agreement; to change without notice. 7.7 Billing For Services Galaxy shall invoice Telnet once per month for the Services delivered, termination fees, 411 directory assistance and 911 emergency call service fees and any other fees or billings chargeable to Telnet; Galaxy shall deliver each invoice to Telnet's account in the Partner Portal; and Telnet shall give notice to Galaxy of all errors and inaccuracies in an invoice within 15 days of receipt by Telnet of the invoice at issue. Thereafter, Telnet will be deemed to have agreed with the accuracy of the invoice. 7.8 Payment of Services Invoice Telnet hereby covenants to pay all invoices rendered to its account by Galaxy within 15 days of the date of invoice; Interest shall accrue on overdue accounts at the rate of 1.5% per month calculated and payable from the date of invoice until the date of payment in full of the overdue amount. 7.9 Warranty Galaxy does not guarantee the integrity of data transmitted using the Products and Services or that the Products and Services will operate uninterrupted or error-free, including, without limitation, the degradation of voice transmission quality and the failure of an incoming or outgoing call, including emergency calls (911 or equivalent), to be connected or completed.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"USE OF NAME, LOGOS, TRADEMARKS AND LICENSED MATERIALS 9\", \"level\": 1, \"text\": \"9. USE OF NAME, LOGOS, TRADEMARKS AND LICENSED MATERIALS 9.1 News Releases Neither Party will use the name of the other in any news release, public announcement, advertisement or other form of publicity, without the prior written consent of the other Party. 9.2 Ownership and Use of Galaxy Trade Marks Telnet acknowledges Galaxy's exclusive ownership of the Galaxy name and logo as well as certain other trademarks and trade names which Galaxy uses in connection with the Products and Services (the \\\"Trademarked Material\\\") and agrees that Telnet will not acquire any interest in any of the Trademarked Material by virtue of this Agreement or anything done pursuant to it; While this Agreement is in effect, Telnet may indicate to the public its status of being an authorized seller of the Galaxy Products and Services; Except with the prior written consent of Galaxy, Telnet will not adopt or use any of the Trademarked Material, in whole or in part, or any confusingly similar word or symbol, as part of Telnet's name or, to the extent Telnet has knowledge of such use and the power to prevent such use, allow others to use the Trademarked Material; Nothing in this Agreement contains any transfer or license to Telnet of any Trademarked Material or other proprietary rights. 9.3 Review and Approval of Uses Galaxy shall have the right to review any use by Telnet of the Trademarked Material and to approve or disapprove, in its absolute discretion, Telnet's use of it and if Galaxy disapproves of Telnet's use of Trademarked Material, Telnet shall not use the Trademarked Material for such use. Telnet shall, at Galaxy's request, provide to Galaxy a copy of anything which Telnet is using or may use and which contains the Trademarked Material; Telnet must adhere to Galaxy's standards of use in respect to any of the Trademarked Material. Among other things, Telnet will be required to indicate explicitly Galaxy's ownership of the name or mark. 9.4 No Removal of Logos, Trademarks & Notices Unless Telnet first obtains express written consent from Galaxy, Telnet will not remove or alter any patent numbers, trade names, trademarks, copyright or other proprietary notices, serial numbers, labels, tags or other identifying marks, symbols or legends affixed to or included with any Product or portion thereof, whether on packaging, media, presentations or otherwise, or any related materials provided to Telnet by Galaxy.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY 11\", \"level\": 1, \"text\": \"11. CONFIDENTIALITY 11.1 Confidential Information Each of the Parties acknowledges that in the course of their relationship pursuant to this Agreement, each (the \\\"Receiving Party\\\") will have access to or come into possession of Confidential Information of the other Party (the \\\"Disclosing Party\\\") and that the disclosure of such Confidential Information to third parties or to the general public would be detrimental to the best interests and business of the Disclosing Party.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSION FROM TERRITORIES 12\", \"level\": 1, \"text\": \"12. EXCLUSION FROM TERRITORIES 12.1 Right to Exclude Subject to section 12.2 Galaxy reserves the right to grant to any other person an exclusive territory (the \\\"Territory\\\") for the marketing, sales and distribution of the Services and, from that date which is 30 days after the date upon which Galaxy delivers notice in writing to Telnet of such grant of exclusivity over a Territory (the \\\"Exclusion Date\\\"), Telnet shall not sell, distribute or market the Services within the Territory. However, Telnet shall be entitled to continue to sell the Services to any Subscriber resident within the Territory who became a Subscriber prior to the Exclusion Date. 12.2 Territories From Which Telnet May Not Be Excluded During the term of this Agreement, Telnet may not be excluded pursuant to section 12.1, from the following areas: (a) Romania.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS 13\", \"level\": 1, \"text\": \"13. MISCELLANEOUS 13.1 No Waiver The failure by either Party to enforce or take advantage of any of the provisions of this Agreement shall not constitute nor be construed as a waiver of such provisions or of the right subsequently to enforce or take advantage of each and every such provision. 13.2 Default If either of the Parties should be in default (the \\\"Defaulting Party\\\") of any obligation or requirement under this Agreement, the Party affected may give written notice to the Defaulting Party specifying the default and will give the Defaulting Party a grace period of 30 days (the \\\"Grace Period\\\") to cure such default or to take such reasonable steps to cure without undue delay such default prior to seeking any remedy it may have on account of such default. The Defaulting Party shall lose no rights under this Agreement if it cures the stated default within the Grace Period. 13.3 Disputes Galaxy and Telnet will attempt to settle any claim or controversy relating to this Agreement through consultation and negotiation in good faith and a spirit of mutual cooperation. If those attempts fail, then a mutually acceptable mediator, chosen by Galaxy and Telnet within forty-five (45) days after written notice from one of the parties to the other, demanding mediation, will mediate the dispute. Neither party may unreasonably withhold consent to the selection of a mediator. Galaxy and Telnet will share the costs of the mediation equally and each shall bear its own costs. Any dispute which the parties cannot resolve between themselves through negotiation or mediation within ninety (90) days after the date of the initial demand for mediation may then be submitted to the courts for final resolution. Nothing in this paragraph will prevent either party from resorting to judicial proceedings if: good faith efforts to resolve the dispute under these procedures have been unsuccessful; or interim relief from a court is necessary to prevent serious and irreparable injury to one party or to others. 13.4 Notices Any formal notice between the Parties hereto will be in writing and will be either personally delivered or sent by facsimile or by registered mail to the appropriate party or parties at the address noted for that party on the first page of this Agreement, or such other address as may be designated by a party in a written notice sent to the other parties in accordance with this paragraph. Any notice or other communication will be effective seven calendar days from the day that it was sent, or if given by personal delivery or facsimile, the day following its receipt. 13.5 Assignment Neither party may assign this Agreement without the prior written consent of the other. However, Telnet agrees that Galaxy may assign this entire Agreement to an affiliate or sell, transfer or assign any account receivable under it to a financing institution to enforce the Galaxy's rights to receive payment from Telnet. This Agreement will be binding upon any authorized assignee or successor of Telnet or Galaxy. 13.6 Compliance with Law Each of the Parties agrees to comply with all applicable laws, rules and regulations of the jurisdictions in which it operates and to do nothing to cause the other to violate the law, rules and regulations of those jurisdictions. If this Agreement or the performance hereof, is determined to be contrary of the laws, rules or regulations of the Territory or of Canada, this Agreement will automatically terminate subject the terms of Termination outlined in this Agreement. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives as of the date first written above: 695014 B.C. LTD. GALAXY TELNET SRL Per: \\\"Peter Wiggans\\\" Per: \\\"Michael Stunden\\\" Authorized Signatory Authorized Signatory Peter Wiggans Michael Stunden (Print name) (Print name) Title: Chief Operating Officer Title: Chief Financial Officer SCHEDULE \\\"A\\\" SCHEDULE \\\"A\\\" PARTNER PRICING Galaxy Telnet Table 1 Business Partner Pricing VoIP Services One-Time Fee Monthly Service Fee VoIP Connectivity (per port charge) Includes: Unlimited VoIP calls, VoIP Caller ID, Call waiting, Basic voicemail $9.95 $5.95 VoIP Connectivity - Commpanion Galaxy Telecom Brand With i-box subscription Includes: Unlimited VoIP calls, VoIP Caller ID, Call waiting, Basic voicemail, 3-way Calling, Call forwarding, Do not disturb, Call hold, Auto answer, Call ignore, Call \\\"go to voicemail\\\", Redial, Mute $19.95 $1.95 VoIP Connectivity - i-box Commpanion Galaxy Telecom Brand Stand alone subscription Includes: Unlimited VoIP calls, VoIP Caller ID, Call waiting, Basic voicemail, 3-way Calling, Call forwarding, Do not disturb, Call hold, Auto answer, Call ignore, Call \\\"go to voicemail\\\", Redial, Mute $19.95 $5.95 VoIP to VoIP Termination included included VoIP to PSTN Termination (Long distance) included See Current Published Rates Basic Voicemail Service included included\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"box CommCenter - Enhanced Voicemail\", \"level\": 1, \"text\": \"i-box CommCenter - Enhanced Voicemail Includes: Web interface, call forwarding, do not disturb, speed dial, call logs, email message notify management, time zone control, profile management, greeting management and password control included $2.00 Services Partner Portal included included Partner Portal Back-Office (API) included included Special Accounts Demonstration Accounts See note 3 free free Employee only Accounts See note 3 free $1.95 Promotion Accounts TBD Special Special Phone Numbers Direct Inward Dial (DID) - Canada $250 one time fee per order see note 1 $3.00 Direct Inward Dial (DID) - USA $250 one time fee per order see note 1 $2.50 Toll Free Dial (1-8XX) - Canada/USA $2.50 $2.50 plus usage ($.05 avg.) Use existing phone number see note 2 $10.00 $3.00 Bundles & Calling Zones Monthly 250 North America minute bundle n/a $2.95 Monthly 500 North America minute bundle n/a $5.95 Monthly 750 North America minute bundle n/a $8.95 Monthly 1000 North America minute bundle n/a $11.95 Local Calling Zone On-net locations only Includes: 750 minutes inbound and outbound local calls. Requires DID. Subscriber must reside in Local Calling area. included $6.95 Virtual Calling Zone On-net locations only Includes: 750 minutes inbound calls from virtual calling area. Requires DID Applies to North America-based subscribers only. See note 4 included $6.95 Custom Calling Zone Off-net locations Custom Quote Custom Quote Note 1 Not available in all areas, see Table 3, 25 DID number block minimum Note 2 Not available in all areas see Table 3 Note 3 Quantity to be agreed between parties, Long distance charges apply Note 4 Unlimited calling FROM Virtual Calling Zone only. Long distance charges apply when calling to VCZ. Table 2 i-box Commpanion Telecom Branded Version Note 1 Co-Branding one time charge $1,350.00 Table 3 Galaxy Telecom On-net locations Canada Province City Alberta Calgary Edmonton British Columbia Vancouver Victoria Kelowna Whistler Abbotsford Manitoba Winnipeg Nova Scotia Halifax Ontario Toronto Ottawa Hamilton Windsor Kitchener London Guelph Kingston Oshawa St. Catherines Waterloo Hespeler Quebec Montreal Quebec City Saskatchewan Regina USA State City Alabama Birmingham Arizona Phoenix California Los Angeles San Diego San Francisco Colorado Denver Florida Gainesville Miami Orlando Tampa Georgia Atlanta Illinois Chicago Indiana Indianapolis Maryland Baltimore Michigan Detroit Minnesota Minneapolis Missouri Kansas City St Louis New York New York City North Carolina Charlotte Fayetteville Greensboro Raleigh Ohio Cincinnati Cleveland Dayton Oregon Portland Pennsylvania Philadelphia Tennessee Nashville Texas Dallas Austin Houston San Antonio Utah Salt lake City Virginia Culpepper Washington Seattle Washington DC Washington DC SCHEDULE \\\"B\\\" TIER 1 SUBSCRIBER SUPPORT Under this Agreement the Telnet is required to maintain Tier 1 Subscriber Support (the \\\"Subscriber Support\\\") functioning as initial response for any direct Subscriber inquiries. Galaxy will provide Tier 2 technical support for technical inquiries from qualified resellers only. The Criteria for the Subscriber Support are as follows: Subscriber Satisfaction Telnet will use its best efforts to ensure that Subscribers achieve the highest levels of satisfaction with the Services delivered by Telnet. Telnet shall notify Galaxy immediately of any complaints by Subscribers, whether they involve sales, Service, Performance or other issues. Galaxy shall use Subscriber satisfaction surveys, field Service reports, and random audits, as it deems necessary to determine if the appropriate levels of Subscriber satisfaction are achieved. If Galaxy determines that an inappropriate level of Subscriber dissatisfaction exists, Galaxy and Telnet shall put in place an action plan as approved by Galaxy to continually improve and maintain Subscriber satisfaction levels. Staff Subscriber Support shall be staffed by fully qualified and trained personnel as per the following criteria: 1. Training Telnet shall maintain technically qualified Service personnel and use its best efforts to service Telnet subscribers in the Territory. 2. Technical Team (a) Language Capabilities Telnet shall employ at least one lead Service engineer who is fluent in English who will be responsible for communicating with Galaxy's technical staff and who can accurately translate all technical documentation from English. Service Staff Upon execution of this Agreement and annually thereafter, Telnet shall furnish Galaxy with a list of its Service management and other technical staff qualified to support Galaxy Services. (c) Help Desk Telnet shall ensure that the personnel staffing the Subscriber help desk, as set out in section 3.6, shall have a sufficient working knowledge of: networking in a TCP/IP WAN/LAN environment; configuring and maintaining network equipment; relevant operating systems (Macintosh, Windows, Linux); and both written and spoken English,. to be able to provide effective help to Subscribers, communicate and work with Galaxy's Tier 2 help desk to address those Subscriber issues which Telnet's help desk are unable to resolve and to communicate and work with Galaxy with regard to technical issues. SCHEDULE \\\"C\\\" SCHEDULE \\\"C\\\" SUBSCRIBER CONTRACT CLAUSES Telnet shall include as a term of any agreement between itself and a Subscriber with respect to any of the Services, the relevant clauses of the following: General The Subscriber will not use the Service for any purpose that is unlawful, abusive, intrusive on another's privacy, harassing, libellous, defamatory, threatening or hateful, or in any other way that would violate any applicable governmental law. Telnet offers the Service internationally. While the Service may be used to make and receive international calls, we do not represent that the use of the Service is legally appropriate in locations outside of Canada and the United States. If the Subscriber chooses to use the Service from or to a location outside of Canada and the United States, the Subscriber is responsible for compliance with any and all governing foreign and local laws. The Subscriber may not reverse engineer, distribute, publish, display, modify or in any way exploit the configuration parameters Telnet provides as a means to access the Service. The Subscriber acknowledges that any devices and embedded software or firmware (\\\"Products\\\") furnished by Telnet are exclusively for use with Telnet's Service. Residential Use of Service If you have subscribed to Residential Services, the Service is provided to you as a residential user, for your personal, residential, non-business and non-professional use. This means that you are not using the service for any commercial or governmental activities, profit-making or non-profit, including but not limited to business, sales, telecommuting, telemarketing, autodialing, continuous or extensive call forwarding, fax broadcast, fax blasting or any other activity that would be inconsistent with normal residential usage patterns. Telnet reserves the right to immediately terminate or modify the service, if Telnet determines, in its sole discretion, that the subscriber's service is being used for any of the aforementioned activities. The Service is offered on a monthly basis to the Subscriber. The monthly Service term begins on the date that Service is activated for the subscriber. Full monthly terms will renew automatically unless Telnet is otherwise notified of the intent to cancel the Service. Upon cancellation, the Subscriber will be responsible for charges for the full term of the then current billing period and any unbilled charges. Small Business Use of Service If you have subscribed to Small Business Services, the Service is provided to you as a small business user. You agree not to use the Service for auto-dialling, continuous or extensive call forwarding, telemarketing or fax broadcasting. Telnet reserves the right to immediately terminate or modify the service, if Telnet determines, in its sole discretion, that the subscriber's service is being used for any of the aforementioned activities. The Service is offered on a monthly basis to the Subscriber. The monthly Service term begins on the date that subscriber requests activation of the Service. Full monthly terms will renew automatically unless the Telnet and Galaxy is otherwise notified of the intent to cancel the Service. Upon cancellation, the Subscriber will be responsible for charges for the then current full monthly term and any unbilled charges Short Form Emergency Services, E911 and 911 The Service presently does not support 911, E911 or any other type of emergency Services; that calls to \\\"9-1-1\\\" cannot be connected; and that alternative arrangements need to be made to contact emergency Services in situations where emergency numbers would have to be dialled. Theft The Subscriber is responsible for cancelling the Service if Subscriber believes that the associated Products have been lost or stolen, or if the Subscriber becomes aware that the Service provided is being used or misused without Subscribers consent. Subscriber is liable for all charges accruing to Subscribers account for the Service until Subscriber cancels the Service. Service Termination The Provider reserves the right to terminate the Service at any time with or without notice and for any reason. The subscriber agrees that the provider shall not be liable to the subscriber or to any third party for any modification, suspension or discontinuance of the Service. Privacy Personal data and certain other information submitted by the subscriber is subject to our Privacy Policy. Voice over IP communications are transmitted over public networks including the Internet. The subscriber acknowledges that the provider is not liable for any loss of privacy arising out of use of the Service.\"}}, {\"id\": \"party:695014 B.C. Ltd. dba Galaxy Telecom\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"695014 B.C. Ltd. dba Galaxy Telecom\", \"role\": \"Galaxy\", \"address\": \"200 - 375 Water Street, Vancouver, British Columbia V6B 5C6 Canada\"}}, {\"id\": \"party:Galaxy Telnet SRL\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Galaxy Telnet SRL\", \"role\": \"Telnet\", \"address\": \"Aleea Malinului, Nr. 11, Bl. D, Scara C, Apt. 43, Constanta, Judetul Constanta, Romania\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"this agreement;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"all information which one of the Parties will have access to or come into possession of which is confidential and proprietary to the other Party and which is either declared to be confidential or which the receiving Party should know, acting reasonably, is confidential or proprietary in nature and includes, but is not limited to, the terms and pricing for the Products and Services, all information contained on or accessible through the Partner Portal, as defined hereafter, any information disclosed by any third party which the third party is obligated to treat as confidential or proprietary to one of the Parties hereto, trade secrets, know-how, processes, standards, product specifications, marketing plans and techniques, cost and financial pricing figures, all client or customer information (including without limitation their names, financial information, address or telephone number), all systems software applications, all software/systems source and object code, data, documentation, program files, flow charts, and all operational procedures.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the date first written above;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"shall include but not be limited to an Act of God, strike, lockout, labour dispute, act of a public enemy, war whether declared or undeclared, blockade, revolution, riot, insurrection, civil commotion, lightning, fire storms, flood, or other natural calamities, explosion, governmental restraint or restrictions, laws, regulations, orders, proclamations of any governmental entities, judgement or orders of any court of law, embargoes, unavailability of equipment and any other cause (other than a shortage or unavailability of funds) which is not reasonably within the control of the Party whose performance under this Agreement is affected by the cause;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Partner Portal\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Partner Portal\", \"text\": \"Galaxy's web-based VoIP subscriber, management and business administration system;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"either Galaxy or Telnet as is appropriate in context and \\\"Parties\\\" means both or either of Galaxy and Telnet as is appropriate in context;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"one of and \\\"Products\\\" means some or all of the VoIP related devices offered for sale by Galaxy;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Service\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Service\", \"text\": \"one of and \\\"Services\\\" means some or all of the VoIP services as listed in Schedule \\\"A\\\" attached hereto;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Subscriber\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Subscriber\", \"text\": \"a client of Telnet who is a consumer of the Products or Services as provided by Galaxy and sold by Telnet.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Trademarked Material\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarked Material\", \"text\": \"the Galaxy name and logo as well as certain other trademarks and trade names which Galaxy uses in connection with the Products and Services\", \"definition_clause\": \"9\"}}, {\"id\": \"term:Receiving Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Receiving Party\", \"text\": \"Each of the Parties acknowledges that in the course of their relationship pursuant to this Agreement, each (the \\\"Receiving Party\\\") will have access to or come into possession of Confidential Information of the other Party\", \"definition_clause\": \"11\"}}, {\"id\": \"term:Disclosing Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disclosing Party\", \"text\": \"the other Party\", \"definition_clause\": \"11\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"an exclusive territory for the marketing, sales and distribution of the Services\", \"definition_clause\": \"12\"}}, {\"id\": \"term:Exclusion Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Exclusion Date\", \"text\": \"that date which is 30 days after the date upon which Galaxy delivers notice in writing to Telnet of such grant of exclusivity over a Territory\", \"definition_clause\": \"12\"}}, {\"id\": \"term:Defaulting Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Defaulting Party\", \"text\": \"either of the Parties should be in default (the \\\"Defaulting Party\\\") of any obligation or requirement under this Agreement\", \"definition_clause\": \"13\"}}, {\"id\": \"term:Grace Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Grace Period\", \"text\": \"a grace period of 30 days\", \"definition_clause\": \"13\"}}, {\"id\": \"term:Subscriber Support\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Subscriber Support\", \"text\": \"Tier 1 Subscriber Support functioning as initial response for any direct Subscriber inquiries\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"any devices and embedded software or firmware (\\\"Products\\\") furnished by Telnet are exclusively for use with Telnet's Service\", \"definition_clause\": \"i\"}}, {\"id\": \"value:15 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"15 days\"}}, {\"id\": \"value:1.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"1.5%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:seven calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven calendar days\"}}, {\"id\": \"value:$9.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$9.95\"}}, {\"id\": \"value:$5.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5.95\"}}, {\"id\": \"value:$19.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$19.95\"}}, {\"id\": \"value:$1.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1.95\"}}, {\"id\": \"value:$2.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2.00\"}}, {\"id\": \"value:$250\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$250\"}}, {\"id\": \"value:$3.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$3.00\"}}, {\"id\": \"value:$2.50\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2.50\"}}, {\"id\": \"value:$.05\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$.05\"}}, {\"id\": \"value:$10.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$10.00\"}}, {\"id\": \"value:$2.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2.95\"}}, {\"id\": \"value:$8.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$8.95\"}}, {\"id\": \"value:$11.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$11.95\"}}, {\"id\": \"value:$6.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$6.95\"}}, {\"id\": \"value:$1,350.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,350.00\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of AgapeAtpCorp_20191202_10-KA_EX-10.1_11911128_EX-10.1_Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of AgapeAtpCorp_20191202_10-KA_EX-10.1_11911128_EX-10.1_Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIO\", \"level\": 1, \"text\": \"ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu \\\"the Manufacturer\\\" -- AND -- AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong \\\"the Customer\\\" Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 ODM SUPPLY AGREEMENT THIS AGREEMENT is made on the 15t h day of January 2018. BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu ('the Manufacturer') of one part AND: AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong ('the Customer') of the other part. RECITALS a. The Manufacturer wishes to appoint the Customer to be the sole and exclusive agent for the promotion, sales, marketing distribution and administration of the Products listed in schedule A of this agreement. b. The Manufacturer and the Customer wish to record their agreement under the stipulations of this Agreement. NOW IT IS AGREED as follows:- 1. TERMS OF AGREEMENT 1.1 Commencement This agreement commences upon execution of this document. 1.2 Term This agreement is for a term of ten (10) years. 1.3 Renewal This agreement will be automatically renewed at the end of every ten (10) year term, with each subsequent term of renewal being for a ten (10) year term. A six (6) months notice must be given by either party of their intention to terminate relations due to any reason other than breach of this agreement. ODM Supply Agreement 2 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}, {\"id\": \"5\", \"title\": \"SHIPPING AND PAYMENT TERMS 5\", \"level\": 1, \"text\": \"5. SHIPPING AND PAYMENT TERMS 5.1 Shipping Products delivered pursuant to the terms of this Agreement shall be suitably packed for shipment in the Manufacturer's standard shipping cartons, marked for shipment to the destination specified in the Customer's Purchase Order, and delivered to the destination Ex Works. The Customer agrees to pay freight, insurance and any associated expenses. The Customer agrees to help the Manufacturer select the most appropriate carrier for each of the Territories. All freight, insurance, and other shipping expenses shall be paid by the Customer. 5.2 Guarantee of packaging quality The Manufacturer further guarantees that the Products, when shipped, are packaged in such a way as to be protected from any foreseeable damage during shipment. 5.3 Rejection of defective products The Customer shall inspect all Products promptly upon receipt thereof and may reject any defective Product, provided that the Customer shall within seven (7) days after receipt of such alleged defective Product, notify the Manufacturer of its rejection and either: (i) request to destroy in field for credit of the value of the defective product and the associated shipping costs (with approval), or (ii) request a Return Material Authorization (\\\"RMA\\\") number and within seven (7) days of receipt of the RMA number from the Manufacturer return such rejected Product to the Manufacturer. Products not rejected within the foregoing time periods shall be deemed accepted by the Customer. In the event that the Manufacturer determines that the returned Product is defective and properly rejected by the Customer, the Manufacturer shall credit to the Customer the value of the defective product and the associated shipping costs. 5.4 Payment terms Unless separate payment terms are agreed to outside of this Agreement by both parties in writing, payment terms will be as follows: (i) 50% of the Total Order Cost must be paid on placement of the customer's order. (ii) The remaining 50% of the total order cost must be paid prior to the goods leaving the warehouse of the manufacturer. The Manufacturer will notify the Customer when the goods are ready for shipment prior to the goods leaving the warehouse. ODM Supply Agreement 5 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 (e) If control of either party shall pass from the present shareholders or owners or controllers to other persons whom the other party shall in their absolute discretion regard as unsuitable. (f) Either parties voting stock is transferred to any third party to such extent as to result in a change in effective control of the company or its ownership or active management is changed in any other manner. The termination of this agreement shall be without prejudice to the rights of either party to payment or other claims due or accrued up to the termination of this agreement. For termination to be effective, written notice of termination must be served on the other party. Where valid, termination takes effect immediately upon service. 8. ARBITRATION 8.1 Any and all disputes, claims or differences arising out of or relating to this agreement or the alleged breach thereto shall be settled by mutual consultation between the parties in good faith as promptly as possible but failing such amicable settlement, shall be decided by Arbitration by the Arbitration Committee of the International Chamber of Commerce located in Switzerland. 8.2 The language to be used in the Arbitration proceedings shall be English. 8.3 The award/decision of the Arbitration Committee shall be final and binding on both the parties and enforceable in any jurisdiction. 9. COSTS Each of the parties shall bare its own legal costs and expenses incurred by it in connection with this agreement and any stamp duty payable under this agreement shall be borne by equally by both parties. 10. GOVERNING LAW This agreement shall be governed by the Laws of England (English common and statutory Law). 11. INTELLECTUAL PROPERTY The Manufacturer is the owner of the intellectual Property pertaining to the products listed in schedule A of this agreement as well as to the book 'How to Achieve Super Health beyond 2000 - Advanced Edition' ODM Supply Agreement 7 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}, {\"id\": \"14.5\", \"title\": \"No Implied Waivers The failure of either party at any time to require performance by the other of any provision hereof s\", \"level\": 2, \"text\": \"14.5 No Implied Waivers The failure of either party at any time to require performance by the other of any provision hereof shall not affect the right of such party to require performance at any time thereafter, nor shall the waiver of either party of a breach of any provision hereof be taken or held to be a waiver of a provision itself. 14.6 Assignment The Manufacturer may not transfer or assign any of its rights or obligations under this agreement without the prior written consent of the Customer. The Customer may not freely transfer or assign its rights or obligations under this agreement without the prior written consent of the Manufacturer. Subject to the foregoing, this agreement will be binding upon and inure to the benefit of the parties hereto, their successors and assignees. 14.7 Force Majeure Neither party to this agreement is liable to the other for a breach of this agreement when the breach is as a result of the occurrence of one of the events below: (i) The outbreak of hostilities (whether or not accompanied by any formal declaration of war), riot, civil disturbance, or acts of terrorism; or (ii) The act of any government or competent authority (including the cancellation or revocation of any approval, authority or permit); or (iii) Fire, explosion, flood, inclement weather, or natural disaster; or (iv) The declaration of a state of emergency or the invocation of martial law having an effect on commerce generally; or (v) Industrial action (including strikes and lock-outs) that is of a widespread nature affecting the Principal solely or the industry or sector of which the Principal is a part (whether in a vertical sense or horizontal sense); or (vi) Any other cause, impediment or circumstance beyond the reasonable control of any party. Where the occurrence of one of the above events is to any extent as a result of an act or omission of the breaching party, this section will not apply. 14.8 New Products Designed, Formulated and Supplied by the Manufacturer The Manufacturer agrees to maintain its focus on the design and formulation of new products and agrees to provide the Customer with one new product each quarter for a minimum of four (4) new products per year. The Manufacturer agrees to give the Customer exclusive rights to the marketing, promotion and sales of the new products should the Customer decide to take on the new products. ODM Supply Agreement 9 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}, {\"id\": \"14.9\", \"title\": \"Other products outside of the product range listed in schedule A of this document The Manufacturer agrees that the Custo\", \"level\": 2, \"text\": \"14.9 Other products outside of the product range listed in schedule A of this document The Manufacturer agrees that the Customer has the right under this agreement to consider, source, promote, market and sell other product outside of the products listed in Schedule A of this agreement in line with the following assumptions: That they are non-competing products to the range of products or those products listed in schedule A of this agreement. 14.10 HOW TO ACHIEVE SUPER HEALTH BEYOND 2000 - ADVANCED EDITION BOOK The Manufacturer has appointed the Customer the copyright holder of both the English and the Chinese version of the book How to achieve Super Health beyond 2000 - Advanced Edition, authored by Frank D.P. Ellis and Dr. Michael Tait M.D. This appointment shall be deemed valid provided the Customer fulfils and maintains the criteria of this agreement. The Customer will provide the Manufacturer with prior notification of printing runs of the book and the quantity of books to be printed in each run. The Customer will compensate the Manufacturer the amount of AUS $1.00 per book prior to printing. ODM Supply Agreement 10 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 EQUITY HOLDINGS LIMITED by the duly authorised Officer: __________________________________ ____________________________ Common Seal of Organic Preparations INC. was hereunto affixed in the presence of Duly authorized to sign on behalf of Organic Preparations INC. Date 15 JANAURY, 2018 In the presence of: Witness Signature ____________________ Date 15 JANAURY, 2018 Witness Name Mercy Saula Address 2nd Floor, Transpacific Hous, Port Vila, Vanuatu. Signed under common seal of Agape ATP International Holding Limited with authority of the board. Signature ______________ Name How Kok Choong ______________________ Common Seal of Agape ATP International Holding Limited Date 31 JANAURY, 2018 In the presence of: Witness Signature ___________________________ Date 31 JANAURY, 2018 Witness Name Ku Suat Hong Address 17-1, 17-2, 17-3, 17-4, Wisma Laxton, Jalan Desa,Taman Desa, Off Jalan Klang Lama, 58100 Kuala Lumpur. ODM Supply Agreement 11 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}, {\"id\": \"SCHEDULE A\", \"title\": \"- The Products at Commencement Product names: ATP 1S Survivor Select ATP 2 Energized Mineral Concentrate ATP 3 Ionized Cal-Mag ATP 4 Omega Blend ATP 5 BetaMaxx AGP 1 Iron YFA Young Formula ORYC Organic Soap SCHEDULE B - Minimum Annual Product Performance Requirements Performance targets have been discussed between the Manufacturer and the Customer to determine fair and reasonable performance targets. Minimum Annual Product Performance Requirements are listed below: Product Name: Agreed Quantity of Units to be purchased per Annum: ATP 1 S Survivor Select 150gm packaged 15,000 ATP 2 Energized Mineral Concentrate 29.5mL packaged 20,000 ATP 3 Ionized Cal-Mag 114gm packaged 15,000 ATP 4 Omega Blend 250mL packaged 15,000 ATP 5 BetaMaxx 150gm packaged 15,000 AGP 1 Iron 29.5mL packaged 1000 YFA Young Formula 450gm packaged 3000 ORYC Organic Soap 150gm packaged 2500 ODM Supply Agreement 12 Organic Preparations INC. & Agape ATP International Holding Limited\", \"level\": 1, \"text\": \"SCHEDULE A - The Products at Commencement Product names: ATP 1S Survivor Select ATP 2 Energized Mineral Concentrate ATP 3 Ionized Cal-Mag ATP 4 Omega Blend ATP 5 BetaMaxx AGP 1 Iron YFA Young Formula ORYC Organic Soap SCHEDULE B - Minimum Annual Product Performance Requirements Performance targets have been discussed between the Manufacturer and the Customer to determine fair and reasonable performance targets. Minimum Annual Product Performance Requirements are listed below: Product Name: Agreed Quantity of Units to be purchased per Annum: ATP 1 S Survivor Select 150gm packaged 15,000 ATP 2 Energized Mineral Concentrate 29.5mL packaged 20,000 ATP 3 Ionized Cal-Mag 114gm packaged 15,000 ATP 4 Omega Blend 250mL packaged 15,000 ATP 5 BetaMaxx 150gm packaged 15,000 AGP 1 Iron 29.5mL packaged 1000 YFA Young Formula 450gm packaged 3000 ORYC Organic Soap 150gm packaged 2500 ODM Supply Agreement 12 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}, {\"id\": \"SCHEDULE C\", \"title\": \"- THE TERRITORIES The Territories consisting of the following Countries: Global - All countries ODM Supply Agreement 13 Organic Preparations INC. & Agape ATP International Holding Limited\", \"level\": 1, \"text\": \"SCHEDULE C - THE TERRITORIES The Territories consisting of the following Countries: Global - All countries ODM Supply Agreement 13 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of AgapeAtpCorp_20191202_10-KA_EX-10.1_11911128_EX-10.1_Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIO\", \"level\": 1, \"text\": \"ODM - SUPPLY AGREEMENT BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu \\\"the Manufacturer\\\" -- AND -- AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong \\\"the Customer\\\" Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 ODM SUPPLY AGREEMENT THIS AGREEMENT is made on the 15t h day of January 2018. BETWEEN: ORGANIC PREPARATIONS INC. 2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu ('the Manufacturer') of one part AND: AGAPE ATP INTERNATIONAL HOLDING LIMITED Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong ('the Customer') of the other part. RECITALS a. The Manufacturer wishes to appoint the Customer to be the sole and exclusive agent for the promotion, sales, marketing distribution and administration of the Products listed in schedule A of this agreement. b. The Manufacturer and the Customer wish to record their agreement under the stipulations of this Agreement. NOW IT IS AGREED as follows:- 1. TERMS OF AGREEMENT 1.1 Commencement This agreement commences upon execution of this document. 1.2 Term This agreement is for a term of ten (10) years. 1.3 Renewal This agreement will be automatically renewed at the end of every ten (10) year term, with each subsequent term of renewal being for a ten (10) year term. A six (6) months notice must be given by either party of their intention to terminate relations due to any reason other than breach of this agreement. ODM Supply Agreement 2 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SHIPPING AND PAYMENT TERMS 5\", \"level\": 1, \"text\": \"5. SHIPPING AND PAYMENT TERMS 5.1 Shipping Products delivered pursuant to the terms of this Agreement shall be suitably packed for shipment in the Manufacturer's standard shipping cartons, marked for shipment to the destination specified in the Customer's Purchase Order, and delivered to the destination Ex Works. The Customer agrees to pay freight, insurance and any associated expenses. The Customer agrees to help the Manufacturer select the most appropriate carrier for each of the Territories. All freight, insurance, and other shipping expenses shall be paid by the Customer. 5.2 Guarantee of packaging quality The Manufacturer further guarantees that the Products, when shipped, are packaged in such a way as to be protected from any foreseeable damage during shipment. 5.3 Rejection of defective products The Customer shall inspect all Products promptly upon receipt thereof and may reject any defective Product, provided that the Customer shall within seven (7) days after receipt of such alleged defective Product, notify the Manufacturer of its rejection and either: (i) request to destroy in field for credit of the value of the defective product and the associated shipping costs (with approval), or (ii) request a Return Material Authorization (\\\"RMA\\\") number and within seven (7) days of receipt of the RMA number from the Manufacturer return such rejected Product to the Manufacturer. Products not rejected within the foregoing time periods shall be deemed accepted by the Customer. In the event that the Manufacturer determines that the returned Product is defective and properly rejected by the Customer, the Manufacturer shall credit to the Customer the value of the defective product and the associated shipping costs. 5.4 Payment terms Unless separate payment terms are agreed to outside of this Agreement by both parties in writing, payment terms will be as follows: (i) 50% of the Total Order Cost must be paid on placement of the customer's order. (ii) The remaining 50% of the total order cost must be paid prior to the goods leaving the warehouse of the manufacturer. The Manufacturer will notify the Customer when the goods are ready for shipment prior to the goods leaving the warehouse. ODM Supply Agreement 5 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 (e) If control of either party shall pass from the present shareholders or owners or controllers to other persons whom the other party shall in their absolute discretion regard as unsuitable. (f) Either parties voting stock is transferred to any third party to such extent as to result in a change in effective control of the company or its ownership or active management is changed in any other manner. The termination of this agreement shall be without prejudice to the rights of either party to payment or other claims due or accrued up to the termination of this agreement. For termination to be effective, written notice of termination must be served on the other party. Where valid, termination takes effect immediately upon service. 8. ARBITRATION 8.1 Any and all disputes, claims or differences arising out of or relating to this agreement or the alleged breach thereto shall be settled by mutual consultation between the parties in good faith as promptly as possible but failing such amicable settlement, shall be decided by Arbitration by the Arbitration Committee of the International Chamber of Commerce located in Switzerland. 8.2 The language to be used in the Arbitration proceedings shall be English. 8.3 The award/decision of the Arbitration Committee shall be final and binding on both the parties and enforceable in any jurisdiction. 9. COSTS Each of the parties shall bare its own legal costs and expenses incurred by it in connection with this agreement and any stamp duty payable under this agreement shall be borne by equally by both parties. 10. GOVERNING LAW This agreement shall be governed by the Laws of England (English common and statutory Law). 11. INTELLECTUAL PROPERTY The Manufacturer is the owner of the intellectual Property pertaining to the products listed in schedule A of this agreement as well as to the book 'How to Achieve Super Health beyond 2000 - Advanced Edition' ODM Supply Agreement 7 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Implied Waivers The failure of either party at any time to require performance by the other of any provision hereof s\", \"level\": 2, \"text\": \"14.5 No Implied Waivers The failure of either party at any time to require performance by the other of any provision hereof shall not affect the right of such party to require performance at any time thereafter, nor shall the waiver of either party of a breach of any provision hereof be taken or held to be a waiver of a provision itself. 14.6 Assignment The Manufacturer may not transfer or assign any of its rights or obligations under this agreement without the prior written consent of the Customer. The Customer may not freely transfer or assign its rights or obligations under this agreement without the prior written consent of the Manufacturer. Subject to the foregoing, this agreement will be binding upon and inure to the benefit of the parties hereto, their successors and assignees. 14.7 Force Majeure Neither party to this agreement is liable to the other for a breach of this agreement when the breach is as a result of the occurrence of one of the events below: (i) The outbreak of hostilities (whether or not accompanied by any formal declaration of war), riot, civil disturbance, or acts of terrorism; or (ii) The act of any government or competent authority (including the cancellation or revocation of any approval, authority or permit); or (iii) Fire, explosion, flood, inclement weather, or natural disaster; or (iv) The declaration of a state of emergency or the invocation of martial law having an effect on commerce generally; or (v) Industrial action (including strikes and lock-outs) that is of a widespread nature affecting the Principal solely or the industry or sector of which the Principal is a part (whether in a vertical sense or horizontal sense); or (vi) Any other cause, impediment or circumstance beyond the reasonable control of any party. Where the occurrence of one of the above events is to any extent as a result of an act or omission of the breaching party, this section will not apply. 14.8 New Products Designed, Formulated and Supplied by the Manufacturer The Manufacturer agrees to maintain its focus on the design and formulation of new products and agrees to provide the Customer with one new product each quarter for a minimum of four (4) new products per year. The Manufacturer agrees to give the Customer exclusive rights to the marketing, promotion and sales of the new products should the Customer decide to take on the new products. ODM Supply Agreement 9 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}}, {\"id\": \"14.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Other products outside of the product range listed in schedule A of this document The Manufacturer agrees that the Custo\", \"level\": 2, \"text\": \"14.9 Other products outside of the product range listed in schedule A of this document The Manufacturer agrees that the Customer has the right under this agreement to consider, source, promote, market and sell other product outside of the products listed in Schedule A of this agreement in line with the following assumptions: That they are non-competing products to the range of products or those products listed in schedule A of this agreement. 14.10 HOW TO ACHIEVE SUPER HEALTH BEYOND 2000 - ADVANCED EDITION BOOK The Manufacturer has appointed the Customer the copyright holder of both the English and the Chinese version of the book How to achieve Super Health beyond 2000 - Advanced Edition, authored by Frank D.P. Ellis and Dr. Michael Tait M.D. This appointment shall be deemed valid provided the Customer fulfils and maintains the criteria of this agreement. The Customer will provide the Manufacturer with prior notification of printing runs of the book and the quantity of books to be printed in each run. The Customer will compensate the Manufacturer the amount of AUS $1.00 per book prior to printing. ODM Supply Agreement 10 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019 EQUITY HOLDINGS LIMITED by the duly authorised Officer: __________________________________ ____________________________ Common Seal of Organic Preparations INC. was hereunto affixed in the presence of Duly authorized to sign on behalf of Organic Preparations INC. Date 15 JANAURY, 2018 In the presence of: Witness Signature ____________________ Date 15 JANAURY, 2018 Witness Name Mercy Saula Address 2nd Floor, Transpacific Hous, Port Vila, Vanuatu. Signed under common seal of Agape ATP International Holding Limited with authority of the board. Signature ______________ Name How Kok Choong ______________________ Common Seal of Agape ATP International Holding Limited Date 31 JANAURY, 2018 In the presence of: Witness Signature ___________________________ Date 31 JANAURY, 2018 Witness Name Ku Suat Hong Address 17-1, 17-2, 17-3, 17-4, Wisma Laxton, Jalan Desa,Taman Desa, Off Jalan Klang Lama, 58100 Kuala Lumpur. ODM Supply Agreement 11 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}}, {\"id\": \"SCHEDULE A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- The Products at Commencement Product names: ATP 1S Survivor Select ATP 2 Energized Mineral Concentrate ATP 3 Ionized Cal-Mag ATP 4 Omega Blend ATP 5 BetaMaxx AGP 1 Iron YFA Young Formula ORYC Organic Soap SCHEDULE B - Minimum Annual Product Performance Requirements Performance targets have been discussed between the Manufacturer and the Customer to determine fair and reasonable performance targets. Minimum Annual Product Performance Requirements are listed below: Product Name: Agreed Quantity of Units to be purchased per Annum: ATP 1 S Survivor Select 150gm packaged 15,000 ATP 2 Energized Mineral Concentrate 29.5mL packaged 20,000 ATP 3 Ionized Cal-Mag 114gm packaged 15,000 ATP 4 Omega Blend 250mL packaged 15,000 ATP 5 BetaMaxx 150gm packaged 15,000 AGP 1 Iron 29.5mL packaged 1000 YFA Young Formula 450gm packaged 3000 ORYC Organic Soap 150gm packaged 2500 ODM Supply Agreement 12 Organic Preparations INC. & Agape ATP International Holding Limited\", \"level\": 1, \"text\": \"SCHEDULE A - The Products at Commencement Product names: ATP 1S Survivor Select ATP 2 Energized Mineral Concentrate ATP 3 Ionized Cal-Mag ATP 4 Omega Blend ATP 5 BetaMaxx AGP 1 Iron YFA Young Formula ORYC Organic Soap SCHEDULE B - Minimum Annual Product Performance Requirements Performance targets have been discussed between the Manufacturer and the Customer to determine fair and reasonable performance targets. Minimum Annual Product Performance Requirements are listed below: Product Name: Agreed Quantity of Units to be purchased per Annum: ATP 1 S Survivor Select 150gm packaged 15,000 ATP 2 Energized Mineral Concentrate 29.5mL packaged 20,000 ATP 3 Ionized Cal-Mag 114gm packaged 15,000 ATP 4 Omega Blend 250mL packaged 15,000 ATP 5 BetaMaxx 150gm packaged 15,000 AGP 1 Iron 29.5mL packaged 1000 YFA Young Formula 450gm packaged 3000 ORYC Organic Soap 150gm packaged 2500 ODM Supply Agreement 12 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}}, {\"id\": \"SCHEDULE C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- THE TERRITORIES The Territories consisting of the following Countries: Global - All countries ODM Supply Agreement 13 Organic Preparations INC. & Agape ATP International Holding Limited\", \"level\": 1, \"text\": \"SCHEDULE C - THE TERRITORIES The Territories consisting of the following Countries: Global - All countries ODM Supply Agreement 13 Organic Preparations INC. & Agape ATP International Holding Limited Source: AGAPE ATP CORP, 10-K/A, 12/2/2019\"}}, {\"id\": \"party:ORGANIC PREPARATIONS INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ORGANIC PREPARATIONS INC.\", \"role\": \"Manufacturer\", \"address\": \"2nd Floor, Transpacific Haus Lini Highway, Port Vila. Vanuatu\"}}, {\"id\": \"party:AGAPE ATP INTERNATIONAL HOLDING LIMITED\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"AGAPE ATP INTERNATIONAL HOLDING LIMITED\", \"role\": \"Customer\", \"address\": \"Unit 05, 4F, Energy Plaza No. 92, Granville Road Tsim Sha Tsui East Kowloon, Hong Kong\"}}, {\"id\": \"term:RMA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"RMA\", \"text\": \"Return Material Authorization (\\\"RMA\\\")\", \"definition_clause\": \"5\"}}, {\"id\": \"value:ten (10) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) years\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:seven (7) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) days\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:AUS $1.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"AUS $1.00\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of AudibleInc_20001113_10-Q_EX-10.32_2599586_EX-10.32_Co-Branding Agreement_ Marketing Agreement_ Investment Distribution Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of AudibleInc_20001113_10-Q_EX-10.32_2599586_EX-10.32_Co-Branding Agreement_ Marketing Agreement_ Investment Distribution Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.32\", \"level\": 1, \"text\": \"EXHIBIT 10.32 CO-BRANDING, MARKETING AND DISTRIBUTION AGREEMENT This Agreement, dated as of January 30, 2000 (\\\"Effective Date\\\"), is made and entered into by and between Amazon.com Commerce Services, Inc., a Delaware corporation (\\\"ACSI\\\"), and Audible Inc. a Delaware corporation (\\\"Company\\\"). ACSI and Company are sometimes referred to collectively herein as the \\\"Parties\\\" and individually as a \\\"Party.\\\" ACSI and Company agree as follows:\"}, {\"id\": \"Section 1\", \"title\": \"Definitions\", \"level\": 1, \"text\": \"Section 1. Definitions Whenever used in this Agreement with initial letters capitalized, the following terms shall have the following specified meanings: \\\"ACSI Competitor\\\" means, collectively, such persons and entities as the Parties may agree upon from time to time. ACSI may update any agreed-upon list of ACSI Competitors no more frequently than once per quarter by written notice, provided that: (a) the number of entities specified on such list shall at no time [***]; (b) any entities added to such list must be [***]; and (c) no addition of any ACSI Competitor to such list shall require Company to breach any contractual or legal obligation to such ACSI Competitor by which Company is bound as of the date of such addition. \\\"ACSI Derivative Work\\\" means any Derivative Work (whether created by ACSI, Company, or the Parties jointly) of any ACSI Existing Intellectual Property or ACSI Future Intellectual Property. \\\"ACSI Existing Intellectual Property\\\" means, collectively, all of the following existing as of the Effective Date: (a) the Trademarks of ACSI and its Affiliates; and (b) the ACSI Site, including, without limitation, any and all content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\", ACSI Site Functionality, Trademarks and other items posted thereon or used in connection or associated with any of the foregoing. \\\"ACSI Future Intellectual Property\\\" means, collectively, all of the following which are invented, created, developed or first reduced to practice by ACSI or its Affiliates after the Effective Date without the participation of Company or its Affiliates: (a) any Trademarks; and (b) any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel,\\\" ACSI Site Functionality and other items (but excluding any Company Derivative Works). \\\"ACSI Intellectual Property\\\" means, collectively, any ACSI Existing Intellectual Property, ACSI Future Intellectual Property and ACSI Derivative Works, but excluding any Joint Works. --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -1- \\\"ACSI Product Section\\\" means a discrete group of products available on the ACSI Site which is identified by a tab or other top-level product category identifier on the ACSI Site Home Page, but excluding: (a) the ACSI Site Home Page itself; and (b) any mechanisms, areas or services on or through which third parties may sell products through the ACSI Site in connection with ACSI's and its Affiliates' programmatic selling initiatives (including, without limitation, the existing \\\"Auctions\\\", \\\"zShops\\\", \\\"Sothebys.amazon.com\\\" and \\\"Amazon.com Advantage\\\" areas and services of the ACSI Site, and any successors or replacements to any of them). \\\"ACSI Product Sub-Section\\\" means a discrete sub-set of products in any ACSI Product Section which is accessible by following or using a browse tree or hypertext links on the ACSI Site, and is identified by a permanent product category description on the ACSI Site (e.g., as opposed to a description generated in response to a user search query), but is not identified by a tab or other top-level product category identifier on the ACSI Site Home Page (e.g., as of the Effective Date, the \\\"business & investing\\\" or \\\"audio books\\\" sub-set of products included in, and accessible through the browse tree of, the ACSI Product Section identified by the \\\"Books\\\" tab on the ACSI Home Page (the \\\"Books Product Section\\\")). \\\"ACSI Site\\\" means that Web Site, the primary Home Page of which is identified by the URL www.amazon.com (and any successor or replacement Web -------------- Site). For the avoidance of doubt, the \\\"ACSI Site\\\" does not include any other Web Sites maintained by or for ACSI or its Affiliates (including, without limitation, those Web Sites, the primary Home Pages of which are identified by the URL's www.amazon.co.uk and www.amazon.de). ---------------- ------------- \\\"ACSI Site Functionality\\\" means, collectively: (a) tab, search and browse functionality available to users of the ACSI Site for navigating through ACSI Product Sections (including, without limitation, the layout and design thereof); (b) payment and transaction functionality available to users of the ACSI Site for purchasing products (including, without limitation, \\\"shopping cart\\\" and \\\"Payment with 1-Click\\\" functionality), (c) any other functionality available on the ACSI Site which ACSI may make available to Company from time to time, and (d) any future equivalents, improvements and enhancements of any of the foregoing. \\\"Affiliate\\\" means, with respect to any person or entity (including either Party), any other person or entity that directly or indirectly controls, is controlled by or is under common control with that person or entity, or which that person or entity beneficially owns at least fifty percent (50%) of the equity interests therein (provided, however, that with respect to the Parties, no individual or entity as to which the ultimate parent entity of a Party does not directly or indirectly control the operations or management thereof (e.g., in the case of ACSI as of the date of this Agreement, Gear.com, Inc.) shall be deemed to be an Affiliate of such Party for purposes of this Agreement). \\\"Annual Fee\\\" means the sum of [***], representing the fixed fee payable by Company to ACSI with respect to each Year. --------------- Source: AUDIBLE INC, 10-Q, 11/13/2000 ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -2- \\\"Change of Control\\\" means, with respect to Company, a transaction or series of related transactions that results in (a) a sale of all or substantially all of the assets of Company, (b) the transfer of fifty percent (50%) or more of the outstanding voting power of Company (other than directly or indirectly to a parent or wholly-owned subsidiary of Company), or (c) the acquisition by a person or entity, by reason of any contractual arrangement or understanding with one or more persons or entities, of the right or power to appoint or cause to be appointed a majority of the directors or officers of Company. \\\"Claim\\\" means any claim, action or proceeding instituted by a third party (other than an Affiliate of a Party), including, without limitation, any governmental authority. \\\"Closing\\\" means the consummation of the purchase of common stock of Company pursuant to the Securities Purchase Agreement between ACSI and Company dated on or about the Effective Date (the \\\"Securities Purchase Agreement\\\"). \\\"Company Derivative Work\\\" means any Derivative Work (whether created by ACSI, Company, or the Parties jointly) of any Company Existing Intellectual Property or Company Future Intellectual Property. \\\"Company Existing Intellectual Property\\\" means, collectively, all of the following existing as of the Effective Date: (a) the Trademarks of Company and its Affiliates; (b) the Company Site, including, without limitation, any and all content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel,\\\" Trademarks and other items posted thereon or used in connection or associated with any of the foregoing \\\"Company Future Intellectual Property\\\" means, collectively, all of the following which are invented, created, developed or first reduced to practice by Company or its Affiliates after the Effective Date without the participation of ACSI or its Affiliates: (a) any Trademarks; and (b) any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\" or other items (but excluding any ACSI Derivative Works). \\\"Company Intellectual Property\\\" means, collectively, any Company Existing Intellectual Property, Company Future Intellectual Property, and Company Derivative Works, but excluding any Joint Works. \\\"Company Site\\\" means, collectively: (a) that Web Site, the primary Home Page for which is identified by the URL www.audible.com (and any successor or replacement Web Site); and (b) any other Web Sites operated by or for Company or its Affiliates from time to time (excluding the Mirror Company Site) through which Spoken-Word Audio Products are sold or offered for sale. \\\"Confidential Information\\\" means, with respect to either Party, all information relating to such Party or its Affiliates that is designated as confidential or that, given the nature of the information or the circumstances surrounding its disclosure, reasonably should -3- be considered as confidential. Confidential Information includes, without limitation, (a) all information relating to a Party's or its Affiliates' technology, customers, business plans, promotional and marketing activities, finances and other business affairs; (b) all third party information that a Party or its Affiliates is obligated to keep confidential; and (c) the terms of this Agreement. Confidential Information may be contained in tangible materials, such as drawings, data, specifications, reports and computer programs, or may be in the nature of unwritten knowledge. Confidential Information does not include any information that (i) has become publicly available without breach of this Agreement, (ii) can be shown by documentation to have been known to the Receiving Party at the time of its receipt from the Disclosing Party or its Affiliates without a breach of confidentiality or other improper means, (iii) is received from a third party who did not acquire or disclose such information by a wrongful or tortious act or (iv) can be shown by documentation to have been independently developed by the Receiving Party without reference to any Confidential Information. \\\"Derivative Work\\\" means any adaptation, modification, enhancement, improvement or derivative work. \\\"Disclosing Party\\\" means a Party that discloses Confidential Information to the other Party in connection with this Agreement. \\\"Exclusive Spoken-Word Audio Products\\\" means: (a) spoken-word audio-only products, in a format suitable for digital download and/or streaming, [***] \\\"Existing ACSI Product Section\\\" means any ACSI Product Section identified on the ACSI Site Home Page as of the Effective Date, as shown in the screen shot attached as Exhibit A. \\\"Home Page\\\" means, with respect to a Web Site or section of a Web Site (e.g., any section of the ACSI Site primarily related to an ACSI Product Section or ACSI Product Sub-Section), the Web page designated by the operator of the Web Site as the initial and primary end user interface for such Web Site or section of a Web Site. \\\"Internet Radio Service\\\" means a service through which users may receive interactive or other broadcasts via the Internet or other public or private data networks. \\\"Joint Work\\\" means any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\" or other items which are invented, created, developed or first reduced to practice jointly by the Parties after the Effective Date, are protected or protectable by any Intellectual Property Rights and either: (a) include or incorporate both ACSI Existing Intellectual Property, ACSI Future Intellectual Property and/or ACSI Derivative Works, on the one hand, and/or Company Existing Intellectual Property, Company Future Intellectual Property and/or Company Derivative Works, on the other hand; or (b) include or incorporate no ACSI Existing Intellectual Property or ACSI Source: AUDIBLE INC, 10-Q, 11/13/2000 Derivative Works, on the one hand, or Company Existing Intellectual Property or Company Derivative Works, on the other hand; provided, however, that notwithstanding any other provision of this Agreement, to the extent that any such items incorporate in whole or in part any ACSI --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -4- Site Functionality or technology, software, code, user interfaces or \\\"look and feel\\\" related thereto or incorporated therein, such items shall be deemed ACSI Derivative Works in their entirety and not Joint Works or Company Intellectual Property. \\\"Incentive Offer\\\" means either (a) a discount in the purchase price of Spoken-Word Audio Products offered for sale from or through the Spoken-Word Audio Sub-Section or (b) an equivalent benefit upon purchase of a Spoken-Word Audio Product from or through the Spoken-Word Audio Sub-Section. \\\"Intellectual Property Right\\\" means any patent, copyright, trademark, trade dress, trade name or trade secret right and any other intellectual property or proprietary right. \\\"Launch Date\\\" means the date on which the Parties mutually agree to launch the Spoken-Word Audio Sub-Section, but in any event no later than 90 days after the Effective Date. \\\"Law\\\" means any law, ordinance, rule, regulation, order, license, permit and other requirement, now or hereafter in effect, of any governmental authority of competent jurisdiction. \\\"Mirror Company Site\\\" means a \\\"mirrored\\\" version of that Web Site, the primary Home Page for which is identified by the URL www.audible.com (and any successor or replacement Web Site). The primary home page of the Mirror Company Site shall be identified by the URL www.amazon.audible.com (or such other URL as ---------------------- the Parties may agree upon). \\\"Proration Percentage\\\" means, as of any date within the Refund Period, the following quantity, expressed as a percentage: (a) one (1); minus (b) the sum of: (i) the number of days of the Refund Period which have elapsed prior to such date; divided by (ii) the total number of days in the Refund Period. \\\"Non-Exclusive Spoken-Word Audio Products\\\" means spoken-word audio-only products, in a format suitable for digital download and/or streaming (excluding Exclusive Spoken-Word Audio Products and Related Products), [***] \\\"Receiving Party\\\" means a Party that receives Confidential Information from the other Party in connection with this Agreement. \\\"Referral Information\\\" means any information disclosing that a specific end-user traveled from the ACSI Site to the Mirror Company Site or purchased any products through the Spoken-Word Audio Sub-Section (however obtained), or other personally-identifying information regarding users of the ACSI Site (including the Spoken-Word Audio Sub-Section). --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -5- \\\"Refund Period\\\" means the period of time from the date upon which Company makes the payment called for by Section 5.2.1 [Annual Fees] (or is deemed to have made such payment pursuant to Section 5.3 [Waiver of Payment Obligations]) until the end of Year 2. \\\"Related Products\\\" means: [***] \\\"Site\\\" means either the ACSI Site, on the one hand, or the Mirror Company Site and Company Site collectively, on the other hand, as required by the context. \\\"Spoken-Word Audio Products\\\" means, collectively, Exclusive Spoken-Word Audio Products, Related Products and Non-Exclusive Spoken-Word Audio Products. \\\"Spoken-Word Audio Sub-Section\\\" means an ACSI Product Sub-Section, to be created pursuant to this Agreement, featuring Spoken-Word Audio Products (but subject to Section 9.2 with respect to Related Products) and which shall be identified on the ACSI Site by such heading as the Parties may agree upon. \\\"Term\\\" means the term of this Agreement as defined in Section 10. \\\"Trademark\\\" means any trademark, service mark, trade name, trade dress, proprietary logo or insignia or other source or business identifier. \\\"Web Site\\\" means any point of presence maintained on the Internet or on any other public or private data network. With respect to any Web Site maintained on the World Wide Web or any successor public data network, such Web Site includes all HTML pages (or similar unit of information presented in any relevant data protocol) that either (a) are identified by the same second-level domain (such as http://www.amazon.com) or by the same equivalent level identifier in any relevant address scheme, or (b) contain branding, graphics, navigation or other characteristics such that a user reasonably would conclude that the pages are part of an integrated information or service offering. \\\"Year\\\" means any period of twelve (12) consecutive months commencing on the Effective Date.\"}, {\"id\": \"Section 2\", \"title\": \"Spoken-Word Audio Sub-Section and Mirror Company Site\", \"level\": 1, \"text\": \"Section 2. Spoken-Word Audio Sub-Section and Mirror Company Site\"}, {\"id\": \"2.1\", \"title\": \"Spoken-Word Audio Sub-Section\", \"level\": 2, \"text\": \"2.1 Spoken-Word Audio Sub-Section. Pursuant to the implementation procedures set forth in Section 4, ACSI will establish and, upon and following the Launch Date, maintain (or cause one of its Affiliates to maintain) on the ACSI Site during the Term Source: AUDIBLE INC, 10-Q, 11/13/2000 -------- *** Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -6- the Spoken-Word Audio Sub-Section. In order to provide a harmonious and consistent user experience, the presentation, format, functionality and operation of the Spoken-Word Audio Sub-Section shall be generally consistent with that of other similar ACSI Product Sub-Sections (including, without limitation, by incorporating category headings and other navigational aids for specific types of Spoken-Word Audio Products offered by Company), except that ACSI will include prominent branding for Company where appropriate on pages of the Spoken-Word Audio Sub-Section. Subject to the foregoing and to Section 6, ACSI will determine the content, appearance, functionality and all aspects of the ACSI Site (including the Spoken-Word Audio Sub-Section) [***]\"}, {\"id\": \"2.2\", \"title\": \"Certain Company Obligations\", \"level\": 2, \"text\": \"2.2 Certain Company Obligations. As of and following the Launch Date, Company will (a) maintain the Mirror Company Site, [***], (b) ensure that every page of the Mirror Company Site displays prominent, above-the-fold, graphical hypertext links (to be designed by ACSI and subject to Company's prior approval, which shall not be unreasonably withheld or delayed) which, when clicked, return the user to the ACSI Site, together with such other branding and Trademarks of ACSI as ACSI and Company may agree upon to be appropriate (provided, that if the Parties cannot agree upon such branding and Trademarks, notwithstanding any other provision of this Agreement, ACSI shall have no obligation to establish or maintain the Spoken-Word Audio Sub-Section until such time as the Parties have agreed upon the same; and provided further, that any disagreement shall be subject to the escalation procedure specified in Section 2.8 [Escalation of Certain Disputes] below), (c) ensure that the Mirror Company Site does not contain links to any Web Site other than the ACSI Site (including, without limitation, to the Company Site), (d) ensure that substantially all Spoken-Word Audio Products (and any other products approved by ACSI) available through the Company Site are available through the Spoken-Word Audio Sub-Section (but subject to Section 9.2 with respect to Related Products), (e) [***], and (f) [***]. Subject to the foregoing, Company shall have the right to limit the number of promotional incentives (e.g. free give-aways, low-cost promotional offers and the like) that are offered through the Spoken-Word Audio Sub-Section based upon the volume of traffic if such volume were to place Company in commercially untenable position as solely determined by Company. Unless otherwise agreed by the Parties in writing, Company will be solely responsible for all pricing, delivery and fulfillment of any products, including Spoken-Word Audio Products offered by Company on or through the Spoken-Word Audio Sub-Section (including the Mirror Company Site).\"}, {\"id\": \"2.3\", \"title\": \"[***]\", \"level\": 2, \"text\": \"2.3 [***].\"}, {\"id\": \"2.4\", \"title\": \"Technical Standards; Customer Service\", \"level\": 2, \"text\": \"2.4 Technical Standards; Customer Service. Company will at all times comply with the technical and customer service requirements and Site standards (including, without limitation, user privacy policies and customer guarantees) to be agreed upon by the Parties within forty-five (45) days after the Effective Date and attached hereto as Exhibit B. Any dispute arising related to the creation of such requirements and standards shall be subject to the escalation procedure specified in Section 2.8 [Escalation of Certain Disputes] below. Without limiting the generality of the foregoing Company will: (a) at all times conduct its dealings with users of the Spoken-Word Audio Sub-Section in a professional and courteous manner which reflects favorably upon ACSI and its Affiliates and the ACSI Site; and (b) in any event ensure that the customer --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -7- service provided to users of the Spoken-Word Audio Sub-Section (including, without limitation, in regard to product fulfillment and responsiveness to customer inquiries) is of as high a standard as is commercially reasonably possible and as good or better than that generally provided by any other online seller of Spoken-Word Audio Products in a format suitable for digital download.\"}, {\"id\": \"2.5\", \"title\": \"Referral Information\", \"level\": 2, \"text\": \"2.5 Referral Information. Company will not disclose any Referral Information to any third party (except for third parties acting directly on behalf of Company in connection with Company's internal business and who have agreed in writing to maintain the same in confidence), or use or permit any third party to use any Referral Information to target communications specifically to users of the ACSI Site, primarily on the basis of such persons' being users of the ACSI Site, without ACSI's prior written consent (provided, however, that nothing in the foregoing shall prohibit Company from contacting its own customers generally (including contacting users of the ACSI Site as part of any such general contacts) or prohibit Company from using non-personal statistical information regarding such users in the aggregate for any purpose without ACSI's consent). [***]\"}, {\"id\": \"2.6\", \"title\": \"ACSI Site Re-Design\", \"level\": 2, \"text\": \"2.6 ACSI Site Re-Design. Notwithstanding any other provision of this Agreement, nothing in this Agreement shall limit ACSI's and its Affiliates' ability to re-design or modify the appearance, content and functionality of the ACSI Site (including any ACSI Product Section, ACSI Product Sub-Section, or any Home Pages); provided, however, that in the event that ACSI and/or its Affiliates redesign or revise the ACSI Site or any ACSI Product Section, the treatment of the Spoken-Word Audio Sub-Section in connection with such re-design or revision will be substantially similar to and consistent with the treatment of other ACSI Product Sub-Sections on the ACSI Site.\"}, {\"id\": \"2.7\", \"title\": \"Traffic Data\", \"level\": 2, \"text\": \"2.7 Traffic Data. Throughout the Term, on a monthly basis, Company will provide ACSI all relevant data requested from time to time by ACSI concerning behavior on the Mirror Company Site, to the extent such behavior reasonably relates to the online promotion or sale of products sold through the ACSI Site and/or Mirror Company Site and such data is reasonably available. ACSI and its Affiliates will hold such data in confidence and will not use it except in connection with their marketing efforts or as otherwise may be agreed by Company in writing. Notwithstanding anything contained in this Section 2.7 [Traffic Data], Company will not be required to deliver to ACSI any user data in contravention of any applicable Law or Company's privacy policy (provided, that if Company modifies its privacy policy, Company shall revise the same in a manner which provides it the maximum legally permissible flexibility to provide the data Source: AUDIBLE INC, 10-Q, 11/13/2000 specified in this Section 2.7 [Traffic Data] to ACSI). --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -8- following the written request of either Party (which will describe the nature of the dispute and other relevant information), the Parties' managers who are responsible for the ACSI/Company relationship will meet to resolve the dispute at a mutually convenient time and place. If the relationship managers are unable to resolve the dispute within two (2) days following their initial meeting, they will refer the matter to the Parties' divisional executives who are responsible for the administration of this Agreement, along with a written statement (or statements) describing the nature of the dispute and other relevant information. Within three (3) days following the referral of the matter to the Parties' divisional executives, the divisional executives will meet to resolve the dispute at a mutually convenient time and place. Additional representatives of the Parties (but not their relationship managers) may be present at the meeting. If the divisional executives are unable to resolve the dispute within two (2) days following their initial meeting, they will refer the matter to the Parties' Presidents, along with a written statement (or statements) describing the nature of the dispute and other relevant information. Within three (3) days following the referral of the matter to the Parties' Presidents (or equivalent officers), the Presidents will meet to resolve the dispute at a mutually convenient time and place. Additional representatives of the Parties (but not their relationship managers or divisional executives) may be present at the meeting. If the Presidents are unable to resolve the dispute within two (2) days following their initial meeting (or such later date as they may agree), the Parties will be free to exercise such rights and remedies as may be available to them at law or in equity. Any resolution of any dispute reached under this Section 2.8 [Escalation of Certain Disputes] will be reduced to writing and signed by the Parties. During any dispute resolution procedure conducted under this Section, the Parties will diligently perform all obligations hereunder that are not directly related to the dispute.\"}, {\"id\": \"Section 3\", \"title\": \"Promotional Activities\", \"level\": 1, \"text\": \"Section 3. Promotional Activities\"}, {\"id\": \"3.1\", \"title\": \"Press Releases\", \"level\": 2, \"text\": \"3.1 Press Releases. The Parties will issue a joint press release promptly upon concluding Advertising. this Agreement, which press release shall be subject to the Party's mutual approval, which shall in any event state that Company is the exclusive provider on the ACSI Site of premium spoken-word audio product for download or streaming over the world wide web. The Parties shall have the right to issue mutually agreeable additional press releases describing the nature of their relationship at such times as the Parties shall mutually agree. Neither Party will issue any other press releases, make any other disclosures regarding this Agreement or its terms or the relationship between the Parties, or use the other Party's Trademarks (except as permitted by Section 6), without the other Party's prior written consent, except that, each Party may, without the other Party's prior consent: (y) distribute or issue public relations materials or press releases that contain a description of the relationship between the Parties, provided that such description has been approved in advance by such other Party (which approval shall not be unreasonably withheld or delayed); and (z) speak in public regarding disclosures made pursuant to the first sentence of this Section 3.1 [Press Releases]. Parties will be able to include a description of this strategic partnership in the \\\"company descriptor\\\" section of standard releases, subject to initial mutual approvals. -9-\"}, {\"id\": \"3.2\", \"title\": \"Advertising\", \"level\": 2, \"text\": \"3.2 Advertising\"}, {\"id\": \"3.2.1\", \"title\": \"Amazon\", \"level\": 3, \"text\": \"3.2.1 Amazon.com Customer Base. During each Year of the Term following the Launch Date, ACSI (or one of its Affiliates) will deliver Amazon.com-branded e-mails and Amazon.com-branded in-product advertising materials related to the Spoken-Word Audio Sub-Section to selected members of the Amazon.com customer base in at least the following quantities: --------------------------------------------------------------------------------------------- Year Email Product Shipment ----------------------------- -------------------------- ------------------------------ --------------------------------------------------------------------------------------------- 1 [***] [***] --------------------------------------------------------------------------------------------- 2 [***] [***] --------------------------------------------------------------------------------------------- 3 [***] [***] --------------------------------------------------------------------------------------------- The Parties shall mutually agree on the nature of such advertising; [***]. With respect to all email advertising, ASCI and Company shall pre-test and plan such advertising in a manner generally consistent with the pre-testing and planning conducted by ACSI and its Affiliates with respect to advertising for other ACSI Product Sub-Sections, with the goal of achieving maximum commercial effectiveness for such advertisements (including, without limitation, by attempting to spread out such advertising in order to not unnecessarily \\\"bunch\\\" the same). [***]\"}, {\"id\": \"3.2.2\", \"title\": \"Customer Subscription Emails\", \"level\": 3, \"text\": \"3.2.2 Customer Subscription Emails. [***]\"}, {\"id\": \"3.2.3\", \"title\": \"Company\", \"level\": 3, \"text\": \"3.2.3 Company. [***]\"}, {\"id\": \"3.3\", \"title\": \"Certain Covenants\", \"level\": 2, \"text\": \"3.3 Certain Covenants. [***] Source: AUDIBLE INC, 10-Q, 11/13/2000\"}, {\"id\": \"Section 4\", \"title\": \"Implementation\", \"level\": 1, \"text\": \"Section 4. Implementation\"}, {\"id\": \"4.1\", \"title\": \"Spoken-Word Audio Sub-Section and Mirror Company Site\", \"level\": 2, \"text\": \"4.1 Spoken-Word Audio Sub-Section and Mirror Company Site.\"}, {\"id\": \"4.1.1\", \"title\": \"Generally\", \"level\": 3, \"text\": \"4.1.1 Generally. During the Term, the Parties will cooperate in good faith and use commercially reasonable efforts to provide a seamless customer experience of full interactivity between the Spoken-Word Audio Sub- Section and the Mirror Company Site. The Parties anticipate that the activities contemplated by this Section 4.1.1 [Generally] will be performed in two phases, as set forth in Section 4.1.2 [Implementation] and Section 4.1.3 [Phase II] below.\"}, {\"id\": \"4.1.2\", \"title\": \"Phase I\", \"level\": 3, \"text\": \"4.1.2 Phase I. Between the Effective Date and the Launch Date, the Parties shall perform such work as may be necessary to develop the Spoken-Word Audio Sub-Section (in the case of ACSI) and the Mirror Company Site (in the case of Company). Upon the Launch Date, ACSI will establish the Spoken-Word Audio Sub-Section under the browse tree (or equivalent navigation structure) of the Books Product Section, and Company will establish the Mirror Site. The Spoken- Word Audio Sub-Section will contain, among such --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -10- other content as may be contained therein pursuant to Section 2.1 [Spoken-Word Audio Sub-Section], multiple hypertext links that will allow users to navigate directly to the Mirror Company Site.\"}, {\"id\": \"4.1.3\", \"title\": \"Phase II\", \"level\": 3, \"text\": \"4.1.3 Phase II. [***], the Parties shall have fully integrated the ACSI Site Functionality into the Mirror Company Site pursuant to specifications and schedules (the \\\"Phase II Development Plan\\\") that shall be developed by ACSI in consultation with Company, which specification and schedules shall be attached hereto as Exhibit C, [***]. Any dispute arising related to the creation of the Phase II Development Plan shall be subject to the escalation procedure specified in Section 2.8 [Escalation of Certain Disputes].Without limiting the generality of the foregoing, ACSI and Company will cooperate to implement ACSI Site Functionality for the Spoken-Word Audio Sub-Section (including the Mirror Company Site) in a manner consistent with the ACSI Site Functionality provided in other ACSI Product Sub-Sections, and Company and ACSI will use commercially reasonable efforts to perform, in a timely and professional manner, all technical work necessary to seamlessly integrate the ACSI Site Functionality into the Mirror Company Site, in accordance with the Phase II Development Plan.\"}, {\"id\": \"4.1.4\", \"title\": \"Tax Matters\", \"level\": 3, \"text\": \"4.1.4 Tax Matters. [***]\"}, {\"id\": \"4.2\", \"title\": \"ACSI Site Links\", \"level\": 2, \"text\": \"4.2 ACSI Site Links. Upon the Launch Date, ACSI will post permanent and/or rotating links to the Home Page of the Spoken-Word Audio Sub-Section on relevant pages of the ACSI Site in a manner substantially similar to and generally consistent with the posting of links to other similar ACSI Product Sub-Sections (e.g., as of the Effective Date, the ACSI Product Sub-Section identified as \\\"Audiobooks\\\"). [***] The Parties shall consult together in connection with the specific nature, prominence and positioning of the links posted on the ACSI Site pursuant to this Section 4.2 [ACSI Site Links]; [***].\"}, {\"id\": \"4.3\", \"title\": \"Account Managers\", \"level\": 2, \"text\": \"4.3 Account Managers. Each Party will assign an account manager (which manager shall be subject to change from time to time by the assigning Party) to oversee the performance of such Party's obligations under this Agreement and to facilitate coordination of the Parties' performance of their respective obligations (including, without limitation, the establishment of the Spoken-Word Audio Sub-Section, the creation of the Co-Branded Pages, the integration of the ACSI Site Functionality with the Mirror Company Site, and the advertising activities contemplated in Section 3). The account managers will meet from time to time during the Term to review the implementation of this Agreement and to explore methods for improving performance.\"}, {\"id\": \"4.4\", \"title\": \"Regulatory Compliance\", \"level\": 2, \"text\": \"4.4 Regulatory Compliance\"}, {\"id\": \"4.4.1\", \"title\": \"Company will comply, and will ensure that the Mirror Company Site, the Spoken-Word Audio Products and all other activiti\", \"level\": 3, \"text\": \"4.4.1 Company will comply, and will ensure that the Mirror Company Site, the Spoken-Word Audio Products and all other activities undertaken through or in connection with the Mirror Company Site and this Agreement (including, without limitation, the participation of ACSI and its Affiliates as contemplated by this Agreement) comply with all applicable Laws. --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -11-\"}, {\"id\": \"4.4.2\", \"title\": \"Company will provide reasonable assistance to ACSI and ACSI's Affiliates in all regulatory compliance activities require\", \"level\": 3, \"text\": \"4.4.2 Company will provide reasonable assistance to ACSI and ACSI's Affiliates in all regulatory compliance activities required in connection with the advertising, operation, maintenance and sale of Spoken-Word Audio Products on and through the Spoken-Word Audio Sub-Section, including, but not necessarily limited to, assisting ACSI in identifying, obtaining and maintaining in force any and all licenses and permits necessary for ACSI and its Affiliates in connection with any of the foregoing. In connection with the foregoing regulatory compliance activities, Company will reimburse ACSI for any reasonable costs (including legal costs) incurred by ACSI or its Affiliates in connection with identifying and obtaining any and all such licenses and permits. Notwithstanding the foregoing, ACSI acknowledges and agrees that Company shall have no obligation to assist ACSI in any regulatory compliance activities related to, or reimburse ACSI for any costs incurred by ACSI or its Affiliates in connection with identifying or obtaining any licenses or permits required in connection with, any advertising, operation, maintenance or sale of Spoken-Word Audio Products or other products sold by ACSI or its Affiliates independently through the ACSI Site without the participation of Company.\"}, {\"id\": \"4.5\", \"title\": \"Staffing\", \"level\": 2, \"text\": \"4.5 Staffing. Each Party will dedicate during the Term the appropriate resources and personnel necessary for establishment of the Spoken-Word Audio Sub-Section, the integration of the ACSI Site Functionality into the Mirror Company Site and the performance of its other obligations under this Agreement. Each Party's designated employees will be subject to change from time to time by such Party in its sole discretion and promptly upon such change such Party shall Source: AUDIBLE INC, 10-Q, 11/13/2000 notify the other Party.\"}, {\"id\": \"Section 5\", \"title\": \"Compensation\", \"level\": 1, \"text\": \"Section 5. Compensation\"}, {\"id\": \"5.1\", \"title\": \"In consideration of the intangible rights granted and services to be performed by ACSI during the Term, Company will pay\", \"level\": 2, \"text\": \"5.1 In consideration of the intangible rights granted and services to be performed by ACSI during the Term, Company will pay ACSI the consideration specified in this Section.\"}, {\"id\": \"5.2\", \"title\": \"Annual Fees\", \"level\": 2, \"text\": \"5.2 Annual Fees.\"}, {\"id\": \"5.2.1\", \"title\": \"Upon the Closing, subject to Section 5\", \"level\": 3, \"text\": \"5.2.1 Upon the Closing, subject to Section 5.3 [Waiver of Payment Obligations], Company will pay ACSI via wire transfer the sum of [***] (the \\\"Company Closing Payment\\\"), representing payment of the Annual Fee for the first Year of the Term and a pre- payment of the Annual Fee for the second Year of the Term.\"}, {\"id\": \"5.2.2\", \"title\": \"On the first day of Year 3, Company will pay ACSI via wire transfer the sum of [***], representing the Annual Fee payabl\", \"level\": 3, \"text\": \"5.2.2 On the first day of Year 3, Company will pay ACSI via wire transfer the sum of [***], representing the Annual Fee payable with respect to Year 3; provided, however, that if ACSI so elects by written notice delivered to Company at least ten (10) days prior to the end of Year 2, Company shall instead issue at the beginning of Year 3 to ACSI (or such of its Affiliates as it may designate) shares of common stock of Company (or any publicly-traded Affiliate thereof) with a then-current fair market value equal to [***] as of the date of such written notice (the \\\"Year 3 Shares\\\").\"}, {\"id\": \"5.3\", \"title\": \"Waiver of Payment Obligations\", \"level\": 2, \"text\": \"5.3 Waiver of Payment Obligations. At the Closing, the Company Closing Payments due to ACSI pursuant to Section 5.2.1 [Annual Fees] hereof and the Shares Consideration (as defined in the Securities Purchase Agreement) due to the Company pursuant to Section 1.2 of --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -12- the Securities Purchase Agreement, which amounts are identical, shall offset each other solely for the purpose of determining the actual fund transfers required at Closing. ASCI acknowledges and agrees that the entire amount of the Company Closing Payments shall be deemed paid and received upon the issuance of the Common Stock (as defined in the Securities Purchase Agreement).\"}, {\"id\": \"5.4\", \"title\": \"Royalties\", \"level\": 2, \"text\": \"5.4 Royalties. In consideration for the intangible rights granted hereunder, for each Year in which the Spoken-Word Audio Sub-Section (including the Mirror Company Site) generates revenue of at [***] (the \\\"Revenue Threshold\\\"), Company will pay ACSI a royalty equal to [***] of all revenues generated from the Spoken-Word Audio Sub-Section (including, for the avoidance of doubt, any revenue received by Company from any Company customer who first links to the Mirror Company Site from the Spoken-Word Audio Sub-Section and who later accesses the Company Site directly) in excess of Revenue Threshold (the \\\"Royalties\\\") for each Year of the Term. Company will pay ACSI any Royalties payable pursuant to this Section 5.4 [Royalties] on an annual basis, in arrears, as follows: within thirty (30) days after the end of each Year as to which any Royalties are payable, Company will remit to ACSI the Royalties payable with respect to such Year, together with a report specifying in reasonable detail: (a) the gross revenue generated by the Spoken-Word Audio Sub-Section; and (b) Company's calculation of the Royalties.\"}, {\"id\": \"5.5\", \"title\": \"Overdue Payments\", \"level\": 2, \"text\": \"5.5 Overdue Payments. Payments called for by this Section 5 which are not received within five (5) business days after the date upon which payment is due will bear interest at a rate equal to the lesser of one and one-half percent (1- 1/2%) per month or the maximum legal rate permitted under the controlling Laws. Payment of such interest shall not cure or excuse any breach of any underlying payment obligation.\"}, {\"id\": \"5.6\", \"title\": \"Allocation of Payments\", \"level\": 2, \"text\": \"5.6 Allocation of Payments. The Parties acknowledge and agree that the Annual Fees shall be allocated as consideration for advertising services and intangible rights granted by ACSI to Company hereunder, including the rights granted under Section 2.1 [Spoken-Word Audio Sub-Section] and Section 4.2 [ACSI Site Links] and the licenses granted to Company under Section 6, as follows: Year Advertising Services Intangible Rights ---------------------------------------------------------------------------------------------- 1 [***] [***] ---------------------------------------------------------------------------------------------- 2 [***] [***] ---------------------------------------------------------------------------------------------- 3 [***] [***] ---------------------------------------------------------------------------------------------- --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -13-\"}, {\"id\": \"Section 6\", \"title\": \"Proprietary Rights\", \"level\": 1, \"text\": \"Section 6. Proprietary Rights\"}, {\"id\": \"6.1\", \"title\": \"Ownership\", \"level\": 2, \"text\": \"6.1 Ownership.\"}, {\"id\": \"6.1.1\", \"title\": \"As between the Parties, ACSI reserves all right, title and interest in and to the ACSI Intellectual Property, along with\", \"level\": 3, \"text\": \"6.1.1 As between the Parties, ACSI reserves all right, title and interest in and to the ACSI Intellectual Property, along with all Intellectual Property Rights associated therewith and no title to or ownership of any of the foregoing is transferred or, except as expressly set forth in Section 6.2 [ACSI License], licensed to Company or any other person or entity pursuant to this Agreement.\"}, {\"id\": \"6.1.2\", \"title\": \"As between the Parties, Company reserves all right, title and interest in and to the Company Intellectual Property, alon\", \"level\": 3, \"text\": \"6.1.2 As between the Parties, Company reserves all right, title and interest in and to the Company Intellectual Property, along with all Intellectual Property Rights associated therewith and no title to or ownership of any of the foregoing is transferred or, except as expressly set forth in Section 6.3 [Company License], licensed to ACSI or any other person or entity pursuant to this Agreement. Source: AUDIBLE INC, 10-Q, 11/13/2000\"}, {\"id\": \"6.1.3\", \"title\": \"To the maximum extent permitted by applicable Laws, any ACSI Derivative Works or Company Derivative Works, to the extent\", \"level\": 3, \"text\": \"6.1.3 To the maximum extent permitted by applicable Laws, any ACSI Derivative Works or Company Derivative Works, to the extent created by or for the other Party, shall be deemed \\\"works made for hire\\\", and all right, title and interest therein shall vest in ACSI (in the case of ACSI Derivative Works) or Company (in the case of Company Derivative Works) immediately upon creation thereof. To the extent that any such ACSI Derivative Works or Company Derivative Works are not \\\"works made for hire\\\", Company hereby assigns and agrees to assign to ACSI (or such of its Affiliates as it may designate) all right, title and interest to all ACSI Derivative Works and all associated Intellectual Property Rights, and ACSI hereby assigns and agrees to assign to Company (or such of its Affiliates as it may designate) all right, title and interest in and to all Company Derivative Works and all associated Intellectual Property Rights. Each Party shall take, at the other Party's expense, any actions (including, without limitation, execution and delivery of affidavits and other documents) reasonably requested by such other Party to effect, perfect or confirm its or its designee's ownership rights as set forth in this Section 6.1.3 [Ownership].\"}, {\"id\": \"6.1.4\", \"title\": \"To the extent that any Joint Works are created in the course of performance of this Agreement, each Party shall own a jo\", \"level\": 3, \"text\": \"6.1.4 To the extent that any Joint Works are created in the course of performance of this Agreement, each Party shall own a joint, equal and undivided ownership interest in and to such Joint Works and the associated Intellectual Property Rights, with no duty on the part of either Party to account to the other with respect to its use and exploitation of the same. Each Party shall own all right, title and interest in and to any Derivative Works of any Joint Works created by or for such Party and all Intellectual Property Rights associated therewith (to the extent not also associated with the Joint Works). Without limiting the generality of the foregoing, either Party may, without any duty to account to the other (including, without limitation, any duty to pay, share or account for any royalties): (a) make, manufacture, assemble, produce, market, sell, distribute, transfer, use, license and otherwise commercially and non-commercially exploit and deal with the Joint Works; provided, that neither Party shall seek or obtain any -14- registration of any Intellectual Property Rights associated with the Joint Works without the other Party's prior written consent; (b) make, manufacture, assemble, produce, market, sell, distribute, transfer, use, license, seek and obtain registrations of Intellectual Property Rights (subject to paragraph (a) above) and otherwise commercially and non-commercially exploit and deal with Derivative Works of any Joint Works created by or for such Party, whether or not competitive with any items created by or for the other Party; and (c) authorize any third party to take any action described in (a) or (b) above.\"}, {\"id\": \"6.2\", \"title\": \"ACSI License\", \"level\": 2, \"text\": \"6.2 ACSI License. ACSI hereby grants to Company, during the Term, a non- exclusive, non-transferable (except in accordance with Section 11.7 [Assignment]) license, which Company may sublicense only to its Affiliates, to use the ACSI Intellectual Property supplied by ACSI to Company as is reasonably necessary to perform its obligations under this Agreement; provided, however, that Company shall not use ACSI's Trademarks, including in any advertising, without ACSI's prior written consent, unless such use conforms to a written Trademark use policy previously furnished by ACSI to Company and not subsequently modified or revoked. All goodwill arising out of any use of any of ACSI's or its Affiliates' Trademarks by, through or under Company will inure solely to the benefit of ACSI and its Affiliates.\"}, {\"id\": \"6.3\", \"title\": \"Company License\", \"level\": 2, \"text\": \"6.3 Company License. Company hereby grants to ACSI, during the Term, a non-exclusive, non-transferable (except in accordance with Section 11.7 [Assignment]) license, which ACSI may sublicense only to its Affiliates, to use the Company Intellectual Property supplied by Company to ACSI as is reasonably necessary to perform its obligations under this Agreement; provided, however, that ACSI shall not use Company's Trademarks, including in any advertising, without Company's prior written consent, unless such use conforms to a written Trademark use policy previously furnished by Company to ACSI and not subsequently modified or revoked. All goodwill arising out of any use of any of Company's Trademarks by, through or under ACSI will inure solely to the benefit of Company.\"}, {\"id\": \"6.4\", \"title\": \"Non-Disparagement\", \"level\": 2, \"text\": \"6.4 Non-Disparagement. Neither Company nor ACSI will use the other Party's Trademarks in a manner that disparages the other Party or its products or services, and/or portrays the other Party or its products or services in a false, competitively adverse or poor light. Each of Company and ACSI will comply with the other Party's requests as to the use of the other Party's Trademarks and will avoid knowingly taking any action that diminishes the value of such Trademarks.\"}, {\"id\": \"Section 7\", \"title\": \"Representations; Indemnity\", \"level\": 1, \"text\": \"Section 7. Representations; Indemnity\"}, {\"id\": \"7.1\", \"title\": \"Representations\", \"level\": 2, \"text\": \"7.1 Representations. Each Party represents and warrants to the other that: (a) it has the full corporate right, power and authority to enter into this Agreement and perform its obligations hereunder; (b) its performance of this Agreement, and the other Party's exercise of such other Party's rights under this Agreement, will not conflict with or result in a breach -15- or violation of any of the terms or provisions or constitute a default under any agreement by which it is bound; (c) when executed and delivered, this Agreement will constitute its legal, valid and binding obligation enforceable against it in accordance with its terms; and (d) it will comply with all applicable Laws in its performance of this Agreement.\"}, {\"id\": \"7.2\", \"title\": \"Indemnity\", \"level\": 2, \"text\": \"7.2 Indemnity. Each Party (as applicable, the \\\"Indemnifying Party\\\") will defend, indemnify and hold harmless the other Party (the \\\"Indemnified Party\\\") and its Affiliates (and their respective employees, directors and representatives) from and against any and all claims, costs, losses, damages, judgments and expenses (including reasonable attorneys' fees) arising out of any Claim, to the extent it is based on (a) the operation or content of the Indemnifying Party's Site (other than any items or materials supplied, or operation or content required, by the Indemnified Party), (b) the offer, marketing or sale of any products or services through the Indemnifying Party's Site (other than any products offered, marketed or sold by the Indemnified Party Source: AUDIBLE INC, 10-Q, 11/13/2000 through such Site, the Parties acknowledging that Company shall be deemed the Indemnifying Party as to any Claim related to any products offered, marketed or sold by Company through the Spoken-Word Audio Sub-Section and/or Mirror Company Site, except to the extent that such Claim relates to any ACSI Site Functionality or other items or content provided by or for ACSI with respect to the Spoken-Word Audio Sub-Section and/or Mirror Company Site), (c) any actual or alleged breach of the Indemnifying Party's representations or warranties set forth in Section 7.1 [Representations] above, or, in the case of Company, its obligations under Section 4.4 [Regulatory Compliance] above, or (d) any actual or alleged infringement of any Intellectual Property Rights by any content, items or materials provided by the Indemnifying Party to the Indemnified Party for its use under this Agreement. Subject to Section 7.3 [Procedure], the Indemnifying Party will pay any award against the Indemnified Party and its Affiliates (and their respective employees, directors or representatives) and any costs and attorneys' fees reasonably incurred by them resulting from any such Claim.\"}, {\"id\": \"7.3\", \"title\": \"Procedure\", \"level\": 2, \"text\": \"7.3 Procedure. In connection with any Claim described in this Section 7, the Indemnified Party will (a) give the Indemnifying Party prompt written notice of the Claim, (b) cooperate with the Indemnifying Party (at the Indemnifying Party's expense) in connection with the defense and settlement of the Claim, and (c) permit the Indemnifying Party to control the defense and settlement of the Claim, provided that the Indemnifying Party may not settle the Claim without the Indemnified Party's prior written consent (which will not be unreasonably withheld). Further, the Indemnified Party (at its cost) may participate in the defense and settlement of the Claim with counsel of its own choosing. Unless the Indemnifying Party notifies the Indemnified Party in writing within five (5) days of its receipt of notice of any Claim that it irrevocably elects not to assume the defense of such Claim, the Indemnifying Party shall be deemed to have elected to assume the defense of such Claim. If the Indemnifying Party elects not to assume the defense of any Claim, or having assumed the defense of any Claim fails to pursue diligently the defense thereof, the Indemnifying Party shall be deemed to have irrevocably waived any right to participate in or control the defense or settlement of such Claim and the Indemnified Party shall be entitled to sole control of the defense and settlement of such Claim (without limitation of the Indemnifying Party's indemnity obligations under this Section 7). -16-\"}, {\"id\": \"Section 8\", \"title\": \"Disclaimers, Limitations and Reservations\", \"level\": 1, \"text\": \"Section 8. Disclaimers, Limitations and Reservations\"}, {\"id\": \"8.1\", \"title\": \"DISCLAIMER OF WARRANTIES\", \"level\": 2, \"text\": \"8.1 DISCLAIMER OF WARRANTIES. EXCEPT AS PROVIDED IN SECTION 7.1 [Representations] ABOVE, NEITHER PARTY MAKES, AND EACH PARTY HEREBY WAIVES AND DISCLAIMS, ANY REPRESENTATIONS OR WARRANTIES REGARDING THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, INCLUDING (WITHOUT LIMITATION) ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT OR IMPLIED WARRANTIES ARISING OUT OF COURSE OF DEALING, COURSE OF PERFORMANCE OR USAGE OF TRADE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, EACH PARTY SPECIFICALLY DISCLAIMS ANY REPRESENTATION OR WARRANTY REGARDING (A) THE AMOUNT OF SALES REVENUES THAT MAY OCCUR DURING THE TERM, AND (B) ANY ECONOMIC OR OTHER BENEFIT THAT THEY MIGHT OBTAIN THROUGH ITS PARTICIPATION IN THIS AGREEMENT (OTHER THAN THE SPECIFIC SUMS TO BE PAID PURSUANT TO THIS AGREEMENT).\"}, {\"id\": \"8.3\", \"title\": \"Limitation of Damages\", \"level\": 2, \"text\": \"8.3 Limitation of Damages. EXCEPT FOR LIABILITIES UNDER SECTION 7.2 [Indemnity], NEITHER PARTY'S AGGREGATE LIABILITY ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), WARRANTY OR OTHERWISE, SHALL EXCEED [***].\"}, {\"id\": \"8.4\", \"title\": \"Third Party Infringement Claims\", \"level\": 2, \"text\": \"8.4 Third Party Infringement Claims. In the event that either Party receives from a third party a bona fide claim of infringement concerning any advertising materials or other content supplied by the other Party, such Party may immediately remove such materials --------- *** Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -17- or content from its Web Site at its sole discretion, pending receipt of non- infringing replacement materials or content or satisfactory resolution of such claim, and any such removal shall not constitute a breach of this Agreement.\"}, {\"id\": \"Section 9\", \"title\": \"Exclusivity\", \"level\": 1, \"text\": \"Section 9. Exclusivity.\"}, {\"id\": \"9.1\", \"title\": \"ACSI\", \"level\": 2, \"text\": \"9.1 ACSI\"}, {\"id\": \"9.1.1\", \"title\": \"Exclusive Spoken-Word Audio Products\", \"level\": 3, \"text\": \"9.1.1 Exclusive Spoken-Word Audio Products. During the Term, [***], ACSI will not offer or sell through the ACSI Site, or authorize any third party to sell through the ACSI Site, any Exclusive Spoken-Word Audio Products; [***].\"}, {\"id\": \"9.1.2\", \"title\": \"[***]\", \"level\": 3, \"text\": \"9.1.2 [***]\"}, {\"id\": \"9.2\", \"title\": \"[***]\", \"level\": 2, \"text\": \"9.2 [***]\"}, {\"id\": \"9.3\", \"title\": \"[***]\", \"level\": 2, \"text\": \"9.3 [***]\"}, {\"id\": \"9.4\", \"title\": \"Records; Audit\", \"level\": 2, \"text\": \"9.4 Records; Audit. Each Party will, during the Term and for a period of one (1) year thereafter, maintain complete and accurate books and records sufficient to verify its compliance or non-compliance with the provisions of this Section 9 (and, in the case of Company, Section 5.4 [Royalties]). Each Party (the \\\"Audited Party') will, upon at least thirty (30) days' prior written request by the other Party (the \\\"Auditing Party\\\"), allow an independent certified public Source: AUDIBLE INC, 10-Q, 11/13/2000 accounting firm selected by the Auditing Party and reasonably acceptable to the Audited Party to audit such books and records at the Audited Party's premises to the extent necessary to verify the Audited Party's compliance or non-compliance with the provisions of this Section 9 (or, in the case of Company, Section 5.4 [Royalties]); provided, that: (a) any such audit is conducted during normal business hours and in a manner designed to not unreasonably interfere with the Audited Party's ordinary business operations; (b) audits may not occur more frequently than once every twelve (12) months; and (c) each such audit may only cover the period commencing after the period covered by the last audit conducted pursuant to this Section, if any. The Auditing Party agrees that any information learned or disclosed by its auditor in connection with such audit is Confidential Information of the Audited Party. If any such audit reveals any material non- compliance with the provisions of this Section 9 by the Audited Party, the Audited Party shall, within ten (10) days of its receipt of an invoice therefor, reimburse the Auditing Party for all reasonable out-of-pocket fees and expenses incurred by the Auditing Party in connection with the applicable audit. If any such audit reveals any underpayment of any sums payable pursuant to Section 5.4 [Royalties], Company will promptly remit to ACSI the amount of the underpayment; and, if the amount of such underpayment is five percent (5%) or more for any audited period, Company shall, within ten (10) days of its receipt of an invoice therefor, reimburse ACSI for all reasonable out-of-pocket fees and expenses incurred by ACSI and its Affiliates in connection with the applicable audit together with interest on any underpayment as provided in Section 5.5 [Overdue Payments]. --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -18-\"}, {\"id\": \"Section 10\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"Section 10. Term and Termination\"}, {\"id\": \"10.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"10.1 Term. The term of this Agreement will commence on the Effective Date, and unless earlier terminated as provided elsewhere in this Agreement, will end automatically upon the end of Year 3.\"}, {\"id\": \"10.3\", \"title\": \"ACSI Termination\", \"level\": 2, \"text\": \"10.3 ACSI Termination. In the event that: (a) Company at any time engages in any criminal conduct, fraud, dishonesty or other behavior that is materially harming the goodwill or reputation of ACSI or its Affiliates or the ACSI Site; (b) Company has consistently failed to abide by the technical and customer service requirements described in Section 2.4 [Technical Standards; Customer Service] or has failed to integrate the ACSI Site Functionality into the Spoken-Word Audio Sub-Section and/or Mirror Company Site as required by the Phase II Development Plan (so long as such failure is not a result of acts or omissions by ACSI); or (c) Company consistently fails to pay bona fide debts as they legally come due, institutes or has instituted against it any bankruptcy, reorganization, debt arrangement, assignment for the benefit of creditors, or other proceeding under any bankruptcy or insolvency Law or dissolution, receivership, or liquidation proceeding (and, if such proceeding is instituted against it, such proceeding is not dismissed within one hundred twenty (120) days), the same shall be deemed a material breach of this Agreement which is not susceptible to cure, and ACSI shall be entitled to terminate this Agreement upon written notice to Company. [***]\"}, {\"id\": \"10.4\", \"title\": \"Company Termination\", \"level\": 2, \"text\": \"10.4 Company Termination. In the event that (a) ACSI has failed to integrate the ACSI Site Functionality into the Spoken-Word Audio Sub-Section and/or Mirror Company Site as required by the Phase II Development Plan (so long as such failure is not a result of acts or omissions by Company); or (b) ACSI consistently fails to pay its bona fide debts as they legally come due, institutes or has instituted against it any bankruptcy, reorganization, debt arrangement, assignment for the benefit of creditors, or other proceeding under any bankruptcy or insolvency Law or dissolution, receivership, or liquidation proceeding (and, if such proceeding is instituted against it, such proceeding is not dismissed within one hundred twenty (120) days), the same shall be deemed a material breach of this Agreement which is --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -19- not susceptible to cure, and Company shall be entitled to terminate this Agreement upon written notice to ACSI.\"}, {\"id\": \"10.5\", \"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"10.5 Effect of Termination.\"}, {\"id\": \"10.5.1\", \"title\": \"General\", \"level\": 3, \"text\": \"10.5.1 General. Upon termination of this Agreement, each Party in receipt, possession or control of the other Party's intellectual or proprietary property, information and materials (including any Confidential Information) pursuant to this Agreement must return to the other Party (or at the other Party's written request, destroy and certify in writing such destruction) such property, information and materials. In addition, except as provided in Section 10.5.2 [Effect of Termination], Company will promptly upon any termination of this Agreement pay to ACSI a prorated portion of the Annual Fee due for the Year in which termination is effective; provided, however, that if Company terminates this Agreement by reason of ACSI's breach hereof, Company shall have no further payment obligation, and, if such termination occurs at any time during the Refund Source: AUDIBLE INC, 10-Q, 11/13/2000 Period, ACSI shall promptly either (a) refund to Company a percentage of the Annual Fees paid pursuant to Section 5.2.1 [Annual Fees] equal to the Proration Percentage, or, at ACSI's option, (b) cause the transfer and assignment to Company of a percentage of the Shares delivered pursuant to Section 5.3 [Waiver of Payment Obligations] equal to the Proration Percentage. Sections 6 through 8, 10 and 11 will survive the termination or expiration of this Agreement.\"}, {\"id\": \"10.5.2\", \"title\": \"[***]\", \"level\": 3, \"text\": \"10.5.2 [***]\"}, {\"id\": \"10.5.3\", \"title\": \"Construction by Court\", \"level\": 3, \"text\": \"10.5.3 Construction by Court. To the extent that any court of competent jurisdiction determines that any provision of Section 10.5.2 [Effect of Termination] is for any reason unlawful, invalid, in violation of public policy or otherwise unenforceable in whole or in part, such provision shall be narrowed in scope to the extent necessary to make the same lawful, valid and enforceable while as nearly as possible reflecting the intent of the Parties as expressed in this Agreement.\"}, {\"id\": \"10.5.4\", \"title\": \"User Transition\", \"level\": 3, \"text\": \"10.5.4 User Transition. Upon any termination or expiration of the Term the Parties will cooperate in good faith to promote a smooth customer transition, and in any event, Company will, at ACSI's option, continue to operate the Mirror Company Site and offer Spoken-Word Audio Products through the Spoken-Word Audio Sub-Section in accordance with the terms of this Agreement for a period of up to six (6) months following such termination.\"}, {\"id\": \"10.5.5\", \"title\": \"Phase II Development Plan\", \"level\": 3, \"text\": \"10.5.5 Phase II Development Plan. Notwithstanding any other provision of this Agreement, the Parties acknowledge and agree that no failure by the Parties to develop the Phase II Development Plan as contemplated by Section 4.1.3 [Phase II] shall be deemed, in itself, a breach of this Agreement by either Party (and therefore that such occurrence shall not, in itself, give rise to any of the remedies specified in Section 10.5.1 [General] or Section 10.5.2 [Effect of Termination]). --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -20-\"}, {\"id\": \"Section 11\", \"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"Section 11. Miscellaneous\"}, {\"id\": \"11.1\", \"title\": \"Tax Treatment\", \"level\": 2, \"text\": \"11.1 Tax Treatment.\"}, {\"id\": \"11.1.1\", \"title\": \"The Parties acknowledge and agree that this Agreement and the transactions contemplated hereby are not intended to creat\", \"level\": 3, \"text\": \"11.1.1 The Parties acknowledge and agree that this Agreement and the transactions contemplated hereby are not intended to create any jurisdiction or authority for any governmental authority to impose any obligation to collect any sales tax, use tax or similar tax in connection with any sales of products by either Party or its Affiliates. Accordingly, each Party agrees to take such action as the other Party may reasonably request (including, without limitation, execution of affidavits and other documents) to avoid or curtail the imposition, by reason of this Agreement or the transactions contemplated hereby, of any such obligation on such Party or its Affiliates, or the establishment of a nexus for tax purposes sufficient to grant any jurisdiction the authority to levy any sales tax, use tax or similar tax on sales of products by such Party or its Affiliates in connection with this Agreement; provided, however, that nothing in this Section 11.1.1 [Tax Treatment] shall limit Company's obligations under Section 11.1.2 [Tax Treatment].\"}, {\"id\": \"11.1.2\", \"title\": \"Company will collect and pay, and indemnify and hold harmless ACSI and its Affiliates from, any sales, use, excise, impo\", \"level\": 3, \"text\": \"11.1.2 Company will collect and pay, and indemnify and hold harmless ACSI and its Affiliates from, any sales, use, excise, import or export, value added or similar tax or duty not based on ACSI's or its Affiliates' net income, including penalties and interest, costs associated with the collection and withholding thereof and attorneys fees in connection therewith, arising out of or in connection with this Agreement or Company's advertisement, offer or sale of any products.\"}, {\"id\": \"11.2\", \"title\": \"Insurance\", \"level\": 2, \"text\": \"11.2 Insurance. Company will at its expense, prior to the Launch Date obtain, and thereafter throughout the Term and for a period of six (6) months thereafter maintain, such policy or policies of insurance as is commercially reasonable for the transactions and business contemplated by this Agreement. Without limiting the generality of the foregoing, Company will ensure that such policies contain a waiver of subrogation against ACSI, name ACSI and its assignees as additional insureds. Company will not modify or terminate any coverage without giving at least thirty (30) days' prior written notice to ACSI. Upon request from ACSI, Company will furnish to ACSI certificates of insurance and such other documentation relating to such policies as ACSI may reasonably request.\"}, {\"id\": \"11.3\", \"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"11.3 Independent Contractors. The Parties are entering this Agreement as independent contractors, and this Agreement will not be construed to create a partnership, joint venture or employment relationship between them. Neither Party will represent itself to be an employee or agent of the other or enter into any agreement or legally binding commitment or statement on the other's behalf of or in the other's name.\"}, {\"id\": \"11.4\", \"title\": \"Nondisclosure\", \"level\": 2, \"text\": \"11.4 Nondisclosure. Each Party will protect the Confidential Information of the other Party from misappropriation and unauthorized use or disclosure, and at a minimum, will take precautions at least as great as those taken to protect its own confidential information of a similar nature, but in no event with less than reasonable care. Without limiting the foregoing, the Receiving Party will: (a) use such Confidential Information solely for the purposes for which it has been disclosed; and (b) disclose such Confidential -21- Information only to those of its and its Affiliates' employees, agents, and consultants who have a need to know the same for the purpose of performing this Agreement and who are informed of and agree to a duty of nondisclosure. The Receiving Party may also disclose Confidential Information of the Disclosing Party to the extent necessary to comply with applicable Law or legal process or pursuant to a registration report or exhibits thereto filed or to be filed with the Securities and Exchange Commission, listing agency or any stock securities commission, or any other associated filings, provided that the Receiving Party uses gives the Disclosing Party not less than ten (10) days' prior written notice thereof and complies with all reasonable requests of the Disclosing Party to minimize the extent or scope of any such disclosure. Upon request of the other Party, or in any event upon any termination or expiration of the Term, each Party shall return to the other or destroy (and certify in writing such destruction) all materials, in any medium, which contain, embody, reflect or Source: AUDIBLE INC, 10-Q, 11/13/2000 reference all or any part of any Confidential Information of the other Party.\"}, {\"id\": \"11.5\", \"title\": \"Costs\", \"level\": 2, \"text\": \"11.5 Costs. Except as expressly provided herein, each Party will be responsible for all costs and expenses incurred by it in connection with the negotiation, execution, delivery and performance of this Agreement.\"}, {\"id\": \"11.6\", \"title\": \"Notices\", \"level\": 2, \"text\": \"11.6 Notices. Any notice or other communication under this Agreement given by either Party to the other Party will be in writing and, to be effective, must be sent to the intended recipient by prepaid registered letter, receipted commercial courier, or electronically receipted facsimile transmission (acknowledged in like manner by the intended recipient) at its address specified below its signature at the end of this Agreement, and in the case of ACSI, with a copy to Amazon.com, Inc., 1200 12th Avenue South, Suite 1200, Seattle, WA 98144, USA, Facsimile: (206) 266-7010 Attn: General Counsel and in the case of Company, with a copy to Audible Inc., Facsimile 973-890-0178, Attn: Vice President, Business & Legal Affairs; provided, that no notice of termination of this Agreement shall be deemed properly given unless sent by prepaid registered mail to such address(es) and to the attention of such officer(s). Either Party may from time to time change such address or individual by giving the other Party notice of such change in accordance with this Section 11.6 [Notices].\"}, {\"id\": \"11.7\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"11.7 Assignment. Company may not assign or delegate this Agreement or any of its rights or obligations hereunder, whether voluntarily, involuntarily, by operation of Law or otherwise, without ACSI's prior written consent, which consent shall not be unreasonably withheld or delayed, except that Company may assign this Agreement to any direct or indirect wholly owned subsidiary in connection with any corporate reorganization undertaken for the purpose of minimizing the tax liability of Company and its Affiliates or other bona fide corporate purpose or in connection with any Change of Control [***]. Subject to the preceding two sentences, this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their successors and assigns. ACSI may assign this Agreement to (a) any corporation or other entity resulting from any merger, consolidation, or other reorganization involving ACSI, (b) any of its Affiliates, or (c) any person or entity to which it transfers all or --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -22- substantially all of its assets relating to the Spoken-Word Audio Sub-Section; provided that the assignee agrees in writing to be bound by all the terms and conditions of this Agreement. Subject to the foregoing, this Agreement will be binding on and enforceable by the Parties and their respective successors and permitted assigns.\"}, {\"id\": \"11.8\", \"title\": \"Nonwaiver\", \"level\": 2, \"text\": \"11.8 Nonwaiver. To be effective, any waiver by a Party of any of its rights or the other Party's obligations under this Agreement must be made in a writing signed by the Party to be charged with the waiver. No failure or forbearance by either Party to insist upon or enforce performance by the other Party of any of the provisions of this Agreement or to exercise any rights or remedies under this Agreement or otherwise at law or in equity shall be construed as a waiver or relinquishment to any extent of such Party's right to assert or rely upon any such provision, right, or remedy in that or any other instance; rather the same shall be and remain in full force and effect.\"}, {\"id\": \"11.9\", \"title\": \"Counterparts; Transmitted Copies\", \"level\": 2, \"text\": \"11.9 Counterparts; Transmitted Copies. This Agreement may be executed in any number of counterparts, each of which will be deemed an original, but all of which taken together will constitute one and the same instrument. To expedite the process of entering into this Agreement, the Parties acknowledge that Transmitted Copies of the Agreement shall be equivalent to original documents until such time (if any) as original documents are completely executed and delivered. \\\"Transmitted Copies\\\" shall mean copies which are reproduced or transmitted via facsimile, or another process of complete and accurate reproduction and transmission.\"}, {\"id\": \"11.10\", \"title\": \"Headings\", \"level\": 2, \"text\": \"11.10 Headings. The headings of sections and subsections of this Agreement are for convenience of reference only and are not intended to restrict, affect or otherwise influence the interpretation or construction of any provision of this Agreement.\"}, {\"id\": \"11.11\", \"title\": \"Choice of Law\", \"level\": 2, \"text\": \"11.11 Choice of Law. This Agreement will be interpreted, construed and enforced in accordance with the Laws of the State of Washington, without reference to its choice of Laws rules.\"}, {\"id\": \"11.12\", \"title\": \"Venue\", \"level\": 2, \"text\": \"11.12 Venue. Company hereby irrevocably consents to non-exclusive personal jurisdiction and venue in the state and federal courts located in King County, Washington, with respect to any claim, action or proceeding arising out of or related to this Agreement and agrees not to commence or prosecute any such claim, action or proceeding other than in the aforementioned courts.\"}, {\"id\": \"11.13\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"11.13 Entire Agreement. This Agreement (a) represents the entire agreement between the Parties with respect to the subject matter hereof and supersedes any previous or contemporaneous oral or written agreements regarding such subject matter and (b) may be amended or modified only by a written instrument signed by a duly authorized agent of each Party. No breach of this Agreement by either Party shall affect the rights or obligations of either Party under any other Agreement between the Parties; rather, the same will remain in full force and effect. -23- ACSI Company: ---- -------- Amazon.com Commerce Services, Inc. Audible Inc. /s/ /s/ Don Katz ---------------------------------- -------------------------------------- By (Sign) By (Sign) Vice President Founder, Chairman, Acting CEO ---------------------------------- -------------------------------------- Title Title Source: AUDIBLE INC, 10-Q, 11/13/2000 1/30/2000 1/30/2000 ---------------------------------- -------------------------------------- Date Date Notice Address: Notice Address: [***] [***] --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -24- Source: AUDIBLE INC, 10-Q, 11/13/2000\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of AudibleInc_20001113_10-Q_EX-10.32_2599586_EX-10.32_Co-Branding Agreement_ Marketing Agreement_ Investment Distribution Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.32\", \"level\": 1, \"text\": \"EXHIBIT 10.32 CO-BRANDING, MARKETING AND DISTRIBUTION AGREEMENT This Agreement, dated as of January 30, 2000 (\\\"Effective Date\\\"), is made and entered into by and between Amazon.com Commerce Services, Inc., a Delaware corporation (\\\"ACSI\\\"), and Audible Inc. a Delaware corporation (\\\"Company\\\"). ACSI and Company are sometimes referred to collectively herein as the \\\"Parties\\\" and individually as a \\\"Party.\\\" ACSI and Company agree as follows:\"}}, {\"id\": \"Section 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definitions\", \"level\": 1, \"text\": \"Section 1. Definitions Whenever used in this Agreement with initial letters capitalized, the following terms shall have the following specified meanings: \\\"ACSI Competitor\\\" means, collectively, such persons and entities as the Parties may agree upon from time to time. ACSI may update any agreed-upon list of ACSI Competitors no more frequently than once per quarter by written notice, provided that: (a) the number of entities specified on such list shall at no time [***]; (b) any entities added to such list must be [***]; and (c) no addition of any ACSI Competitor to such list shall require Company to breach any contractual or legal obligation to such ACSI Competitor by which Company is bound as of the date of such addition. \\\"ACSI Derivative Work\\\" means any Derivative Work (whether created by ACSI, Company, or the Parties jointly) of any ACSI Existing Intellectual Property or ACSI Future Intellectual Property. \\\"ACSI Existing Intellectual Property\\\" means, collectively, all of the following existing as of the Effective Date: (a) the Trademarks of ACSI and its Affiliates; and (b) the ACSI Site, including, without limitation, any and all content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\", ACSI Site Functionality, Trademarks and other items posted thereon or used in connection or associated with any of the foregoing. \\\"ACSI Future Intellectual Property\\\" means, collectively, all of the following which are invented, created, developed or first reduced to practice by ACSI or its Affiliates after the Effective Date without the participation of Company or its Affiliates: (a) any Trademarks; and (b) any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel,\\\" ACSI Site Functionality and other items (but excluding any Company Derivative Works). \\\"ACSI Intellectual Property\\\" means, collectively, any ACSI Existing Intellectual Property, ACSI Future Intellectual Property and ACSI Derivative Works, but excluding any Joint Works. --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -1- \\\"ACSI Product Section\\\" means a discrete group of products available on the ACSI Site which is identified by a tab or other top-level product category identifier on the ACSI Site Home Page, but excluding: (a) the ACSI Site Home Page itself; and (b) any mechanisms, areas or services on or through which third parties may sell products through the ACSI Site in connection with ACSI's and its Affiliates' programmatic selling initiatives (including, without limitation, the existing \\\"Auctions\\\", \\\"zShops\\\", \\\"Sothebys.amazon.com\\\" and \\\"Amazon.com Advantage\\\" areas and services of the ACSI Site, and any successors or replacements to any of them). \\\"ACSI Product Sub-Section\\\" means a discrete sub-set of products in any ACSI Product Section which is accessible by following or using a browse tree or hypertext links on the ACSI Site, and is identified by a permanent product category description on the ACSI Site (e.g., as opposed to a description generated in response to a user search query), but is not identified by a tab or other top-level product category identifier on the ACSI Site Home Page (e.g., as of the Effective Date, the \\\"business & investing\\\" or \\\"audio books\\\" sub-set of products included in, and accessible through the browse tree of, the ACSI Product Section identified by the \\\"Books\\\" tab on the ACSI Home Page (the \\\"Books Product Section\\\")). \\\"ACSI Site\\\" means that Web Site, the primary Home Page of which is identified by the URL www.amazon.com (and any successor or replacement Web -------------- Site). For the avoidance of doubt, the \\\"ACSI Site\\\" does not include any other Web Sites maintained by or for ACSI or its Affiliates (including, without limitation, those Web Sites, the primary Home Pages of which are identified by the URL's www.amazon.co.uk and www.amazon.de). ---------------- ------------- \\\"ACSI Site Functionality\\\" means, collectively: (a) tab, search and browse functionality available to users of the ACSI Site for navigating through ACSI Product Sections (including, without limitation, the layout and design thereof); (b) payment and transaction functionality available to users of the ACSI Site for purchasing products (including, without limitation, \\\"shopping cart\\\" and \\\"Payment with 1-Click\\\" functionality), (c) any other functionality available on the ACSI Site which ACSI may make available to Company from time to time, and (d) any future equivalents, improvements and enhancements of any of the foregoing. \\\"Affiliate\\\" means, with respect to any person or entity (including either Party), any other person or entity that directly or indirectly controls, is controlled by or is under common control with that person or entity, or which that person or entity beneficially owns at least fifty percent (50%) of the equity interests therein (provided, however, that with respect to the Parties, no individual or entity as to which the ultimate parent entity of a Party does not directly or indirectly control the operations or management thereof (e.g., in the case of ACSI as of the date of this Agreement, Gear.com, Inc.) shall be deemed to be an Affiliate of such Party for purposes of this Agreement). \\\"Annual Fee\\\" means the sum of [***], representing the fixed fee payable by Company to ACSI with respect to each Year. --------------- Source: AUDIBLE INC, 10-Q, 11/13/2000 ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -2- \\\"Change of Control\\\" means, with respect to Company, a transaction or series of related transactions that results in (a) a sale of all or substantially all of the assets of Company, (b) the transfer of fifty percent (50%) or more of the outstanding voting power of Company (other than directly or indirectly to a parent or wholly-owned subsidiary of Company), or (c) the acquisition by a person or entity, by reason of any contractual arrangement or understanding with one or more persons or entities, of the right or power to appoint or cause to be appointed a majority of the directors or officers of Company. \\\"Claim\\\" means any claim, action or proceeding instituted by a third party (other than an Affiliate of a Party), including, without limitation, any governmental authority. \\\"Closing\\\" means the consummation of the purchase of common stock of Company pursuant to the Securities Purchase Agreement between ACSI and Company dated on or about the Effective Date (the \\\"Securities Purchase Agreement\\\"). \\\"Company Derivative Work\\\" means any Derivative Work (whether created by ACSI, Company, or the Parties jointly) of any Company Existing Intellectual Property or Company Future Intellectual Property. \\\"Company Existing Intellectual Property\\\" means, collectively, all of the following existing as of the Effective Date: (a) the Trademarks of Company and its Affiliates; (b) the Company Site, including, without limitation, any and all content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel,\\\" Trademarks and other items posted thereon or used in connection or associated with any of the foregoing \\\"Company Future Intellectual Property\\\" means, collectively, all of the following which are invented, created, developed or first reduced to practice by Company or its Affiliates after the Effective Date without the participation of ACSI or its Affiliates: (a) any Trademarks; and (b) any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\" or other items (but excluding any ACSI Derivative Works). \\\"Company Intellectual Property\\\" means, collectively, any Company Existing Intellectual Property, Company Future Intellectual Property, and Company Derivative Works, but excluding any Joint Works. \\\"Company Site\\\" means, collectively: (a) that Web Site, the primary Home Page for which is identified by the URL www.audible.com (and any successor or replacement Web Site); and (b) any other Web Sites operated by or for Company or its Affiliates from time to time (excluding the Mirror Company Site) through which Spoken-Word Audio Products are sold or offered for sale. \\\"Confidential Information\\\" means, with respect to either Party, all information relating to such Party or its Affiliates that is designated as confidential or that, given the nature of the information or the circumstances surrounding its disclosure, reasonably should -3- be considered as confidential. Confidential Information includes, without limitation, (a) all information relating to a Party's or its Affiliates' technology, customers, business plans, promotional and marketing activities, finances and other business affairs; (b) all third party information that a Party or its Affiliates is obligated to keep confidential; and (c) the terms of this Agreement. Confidential Information may be contained in tangible materials, such as drawings, data, specifications, reports and computer programs, or may be in the nature of unwritten knowledge. Confidential Information does not include any information that (i) has become publicly available without breach of this Agreement, (ii) can be shown by documentation to have been known to the Receiving Party at the time of its receipt from the Disclosing Party or its Affiliates without a breach of confidentiality or other improper means, (iii) is received from a third party who did not acquire or disclose such information by a wrongful or tortious act or (iv) can be shown by documentation to have been independently developed by the Receiving Party without reference to any Confidential Information. \\\"Derivative Work\\\" means any adaptation, modification, enhancement, improvement or derivative work. \\\"Disclosing Party\\\" means a Party that discloses Confidential Information to the other Party in connection with this Agreement. \\\"Exclusive Spoken-Word Audio Products\\\" means: (a) spoken-word audio-only products, in a format suitable for digital download and/or streaming, [***] \\\"Existing ACSI Product Section\\\" means any ACSI Product Section identified on the ACSI Site Home Page as of the Effective Date, as shown in the screen shot attached as Exhibit A. \\\"Home Page\\\" means, with respect to a Web Site or section of a Web Site (e.g., any section of the ACSI Site primarily related to an ACSI Product Section or ACSI Product Sub-Section), the Web page designated by the operator of the Web Site as the initial and primary end user interface for such Web Site or section of a Web Site. \\\"Internet Radio Service\\\" means a service through which users may receive interactive or other broadcasts via the Internet or other public or private data networks. \\\"Joint Work\\\" means any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\" or other items which are invented, created, developed or first reduced to practice jointly by the Parties after the Effective Date, are protected or protectable by any Intellectual Property Rights and either: (a) include or incorporate both ACSI Existing Intellectual Property, ACSI Future Intellectual Property and/or ACSI Derivative Works, on the one hand, and/or Company Existing Intellectual Property, Company Future Intellectual Property and/or Company Derivative Works, on the other hand; or (b) include or incorporate no ACSI Existing Intellectual Property or ACSI Source: AUDIBLE INC, 10-Q, 11/13/2000 Derivative Works, on the one hand, or Company Existing Intellectual Property or Company Derivative Works, on the other hand; provided, however, that notwithstanding any other provision of this Agreement, to the extent that any such items incorporate in whole or in part any ACSI --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -4- Site Functionality or technology, software, code, user interfaces or \\\"look and feel\\\" related thereto or incorporated therein, such items shall be deemed ACSI Derivative Works in their entirety and not Joint Works or Company Intellectual Property. \\\"Incentive Offer\\\" means either (a) a discount in the purchase price of Spoken-Word Audio Products offered for sale from or through the Spoken-Word Audio Sub-Section or (b) an equivalent benefit upon purchase of a Spoken-Word Audio Product from or through the Spoken-Word Audio Sub-Section. \\\"Intellectual Property Right\\\" means any patent, copyright, trademark, trade dress, trade name or trade secret right and any other intellectual property or proprietary right. \\\"Launch Date\\\" means the date on which the Parties mutually agree to launch the Spoken-Word Audio Sub-Section, but in any event no later than 90 days after the Effective Date. \\\"Law\\\" means any law, ordinance, rule, regulation, order, license, permit and other requirement, now or hereafter in effect, of any governmental authority of competent jurisdiction. \\\"Mirror Company Site\\\" means a \\\"mirrored\\\" version of that Web Site, the primary Home Page for which is identified by the URL www.audible.com (and any successor or replacement Web Site). The primary home page of the Mirror Company Site shall be identified by the URL www.amazon.audible.com (or such other URL as ---------------------- the Parties may agree upon). \\\"Proration Percentage\\\" means, as of any date within the Refund Period, the following quantity, expressed as a percentage: (a) one (1); minus (b) the sum of: (i) the number of days of the Refund Period which have elapsed prior to such date; divided by (ii) the total number of days in the Refund Period. \\\"Non-Exclusive Spoken-Word Audio Products\\\" means spoken-word audio-only products, in a format suitable for digital download and/or streaming (excluding Exclusive Spoken-Word Audio Products and Related Products), [***] \\\"Receiving Party\\\" means a Party that receives Confidential Information from the other Party in connection with this Agreement. \\\"Referral Information\\\" means any information disclosing that a specific end-user traveled from the ACSI Site to the Mirror Company Site or purchased any products through the Spoken-Word Audio Sub-Section (however obtained), or other personally-identifying information regarding users of the ACSI Site (including the Spoken-Word Audio Sub-Section). --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -5- \\\"Refund Period\\\" means the period of time from the date upon which Company makes the payment called for by Section 5.2.1 [Annual Fees] (or is deemed to have made such payment pursuant to Section 5.3 [Waiver of Payment Obligations]) until the end of Year 2. \\\"Related Products\\\" means: [***] \\\"Site\\\" means either the ACSI Site, on the one hand, or the Mirror Company Site and Company Site collectively, on the other hand, as required by the context. \\\"Spoken-Word Audio Products\\\" means, collectively, Exclusive Spoken-Word Audio Products, Related Products and Non-Exclusive Spoken-Word Audio Products. \\\"Spoken-Word Audio Sub-Section\\\" means an ACSI Product Sub-Section, to be created pursuant to this Agreement, featuring Spoken-Word Audio Products (but subject to Section 9.2 with respect to Related Products) and which shall be identified on the ACSI Site by such heading as the Parties may agree upon. \\\"Term\\\" means the term of this Agreement as defined in Section 10. \\\"Trademark\\\" means any trademark, service mark, trade name, trade dress, proprietary logo or insignia or other source or business identifier. \\\"Web Site\\\" means any point of presence maintained on the Internet or on any other public or private data network. With respect to any Web Site maintained on the World Wide Web or any successor public data network, such Web Site includes all HTML pages (or similar unit of information presented in any relevant data protocol) that either (a) are identified by the same second-level domain (such as http://www.amazon.com) or by the same equivalent level identifier in any relevant address scheme, or (b) contain branding, graphics, navigation or other characteristics such that a user reasonably would conclude that the pages are part of an integrated information or service offering. \\\"Year\\\" means any period of twelve (12) consecutive months commencing on the Effective Date.\"}}, {\"id\": \"Section 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Spoken-Word Audio Sub-Section and Mirror Company Site\", \"level\": 1, \"text\": \"Section 2. Spoken-Word Audio Sub-Section and Mirror Company Site\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Spoken-Word Audio Sub-Section\", \"level\": 2, \"text\": \"2.1 Spoken-Word Audio Sub-Section. Pursuant to the implementation procedures set forth in Section 4, ACSI will establish and, upon and following the Launch Date, maintain (or cause one of its Affiliates to maintain) on the ACSI Site during the Term Source: AUDIBLE INC, 10-Q, 11/13/2000 -------- *** Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -6- the Spoken-Word Audio Sub-Section. In order to provide a harmonious and consistent user experience, the presentation, format, functionality and operation of the Spoken-Word Audio Sub-Section shall be generally consistent with that of other similar ACSI Product Sub-Sections (including, without limitation, by incorporating category headings and other navigational aids for specific types of Spoken-Word Audio Products offered by Company), except that ACSI will include prominent branding for Company where appropriate on pages of the Spoken-Word Audio Sub-Section. Subject to the foregoing and to Section 6, ACSI will determine the content, appearance, functionality and all aspects of the ACSI Site (including the Spoken-Word Audio Sub-Section) [***]\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Certain Company Obligations\", \"level\": 2, \"text\": \"2.2 Certain Company Obligations. As of and following the Launch Date, Company will (a) maintain the Mirror Company Site, [***], (b) ensure that every page of the Mirror Company Site displays prominent, above-the-fold, graphical hypertext links (to be designed by ACSI and subject to Company's prior approval, which shall not be unreasonably withheld or delayed) which, when clicked, return the user to the ACSI Site, together with such other branding and Trademarks of ACSI as ACSI and Company may agree upon to be appropriate (provided, that if the Parties cannot agree upon such branding and Trademarks, notwithstanding any other provision of this Agreement, ACSI shall have no obligation to establish or maintain the Spoken-Word Audio Sub-Section until such time as the Parties have agreed upon the same; and provided further, that any disagreement shall be subject to the escalation procedure specified in Section 2.8 [Escalation of Certain Disputes] below), (c) ensure that the Mirror Company Site does not contain links to any Web Site other than the ACSI Site (including, without limitation, to the Company Site), (d) ensure that substantially all Spoken-Word Audio Products (and any other products approved by ACSI) available through the Company Site are available through the Spoken-Word Audio Sub-Section (but subject to Section 9.2 with respect to Related Products), (e) [***], and (f) [***]. Subject to the foregoing, Company shall have the right to limit the number of promotional incentives (e.g. free give-aways, low-cost promotional offers and the like) that are offered through the Spoken-Word Audio Sub-Section based upon the volume of traffic if such volume were to place Company in commercially untenable position as solely determined by Company. Unless otherwise agreed by the Parties in writing, Company will be solely responsible for all pricing, delivery and fulfillment of any products, including Spoken-Word Audio Products offered by Company on or through the Spoken-Word Audio Sub-Section (including the Mirror Company Site).\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[***]\", \"level\": 2, \"text\": \"2.3 [***].\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Technical Standards; Customer Service\", \"level\": 2, \"text\": \"2.4 Technical Standards; Customer Service. Company will at all times comply with the technical and customer service requirements and Site standards (including, without limitation, user privacy policies and customer guarantees) to be agreed upon by the Parties within forty-five (45) days after the Effective Date and attached hereto as Exhibit B. Any dispute arising related to the creation of such requirements and standards shall be subject to the escalation procedure specified in Section 2.8 [Escalation of Certain Disputes] below. Without limiting the generality of the foregoing Company will: (a) at all times conduct its dealings with users of the Spoken-Word Audio Sub-Section in a professional and courteous manner which reflects favorably upon ACSI and its Affiliates and the ACSI Site; and (b) in any event ensure that the customer --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -7- service provided to users of the Spoken-Word Audio Sub-Section (including, without limitation, in regard to product fulfillment and responsiveness to customer inquiries) is of as high a standard as is commercially reasonably possible and as good or better than that generally provided by any other online seller of Spoken-Word Audio Products in a format suitable for digital download.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Referral Information\", \"level\": 2, \"text\": \"2.5 Referral Information. Company will not disclose any Referral Information to any third party (except for third parties acting directly on behalf of Company in connection with Company's internal business and who have agreed in writing to maintain the same in confidence), or use or permit any third party to use any Referral Information to target communications specifically to users of the ACSI Site, primarily on the basis of such persons' being users of the ACSI Site, without ACSI's prior written consent (provided, however, that nothing in the foregoing shall prohibit Company from contacting its own customers generally (including contacting users of the ACSI Site as part of any such general contacts) or prohibit Company from using non-personal statistical information regarding such users in the aggregate for any purpose without ACSI's consent). [***]\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACSI Site Re-Design\", \"level\": 2, \"text\": \"2.6 ACSI Site Re-Design. Notwithstanding any other provision of this Agreement, nothing in this Agreement shall limit ACSI's and its Affiliates' ability to re-design or modify the appearance, content and functionality of the ACSI Site (including any ACSI Product Section, ACSI Product Sub-Section, or any Home Pages); provided, however, that in the event that ACSI and/or its Affiliates redesign or revise the ACSI Site or any ACSI Product Section, the treatment of the Spoken-Word Audio Sub-Section in connection with such re-design or revision will be substantially similar to and consistent with the treatment of other ACSI Product Sub-Sections on the ACSI Site.\"}}, {\"id\": \"2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Traffic Data\", \"level\": 2, \"text\": \"2.7 Traffic Data. Throughout the Term, on a monthly basis, Company will provide ACSI all relevant data requested from time to time by ACSI concerning behavior on the Mirror Company Site, to the extent such behavior reasonably relates to the online promotion or sale of products sold through the ACSI Site and/or Mirror Company Site and such data is reasonably available. ACSI and its Affiliates will hold such data in confidence and will not use it except in connection with their marketing efforts or as otherwise may be agreed by Company in writing. Notwithstanding anything contained in this Section 2.7 [Traffic Data], Company will not be required to deliver to ACSI any user data in contravention of any applicable Law or Company's privacy policy (provided, that if Company modifies its privacy policy, Company shall revise the same in a manner which provides it the maximum legally permissible flexibility to provide the data Source: AUDIBLE INC, 10-Q, 11/13/2000 specified in this Section 2.7 [Traffic Data] to ACSI). --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -8- following the written request of either Party (which will describe the nature of the dispute and other relevant information), the Parties' managers who are responsible for the ACSI/Company relationship will meet to resolve the dispute at a mutually convenient time and place. If the relationship managers are unable to resolve the dispute within two (2) days following their initial meeting, they will refer the matter to the Parties' divisional executives who are responsible for the administration of this Agreement, along with a written statement (or statements) describing the nature of the dispute and other relevant information. Within three (3) days following the referral of the matter to the Parties' divisional executives, the divisional executives will meet to resolve the dispute at a mutually convenient time and place. Additional representatives of the Parties (but not their relationship managers) may be present at the meeting. If the divisional executives are unable to resolve the dispute within two (2) days following their initial meeting, they will refer the matter to the Parties' Presidents, along with a written statement (or statements) describing the nature of the dispute and other relevant information. Within three (3) days following the referral of the matter to the Parties' Presidents (or equivalent officers), the Presidents will meet to resolve the dispute at a mutually convenient time and place. Additional representatives of the Parties (but not their relationship managers or divisional executives) may be present at the meeting. If the Presidents are unable to resolve the dispute within two (2) days following their initial meeting (or such later date as they may agree), the Parties will be free to exercise such rights and remedies as may be available to them at law or in equity. Any resolution of any dispute reached under this Section 2.8 [Escalation of Certain Disputes] will be reduced to writing and signed by the Parties. During any dispute resolution procedure conducted under this Section, the Parties will diligently perform all obligations hereunder that are not directly related to the dispute.\"}}, {\"id\": \"Section 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Promotional Activities\", \"level\": 1, \"text\": \"Section 3. Promotional Activities\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Press Releases\", \"level\": 2, \"text\": \"3.1 Press Releases. The Parties will issue a joint press release promptly upon concluding Advertising. this Agreement, which press release shall be subject to the Party's mutual approval, which shall in any event state that Company is the exclusive provider on the ACSI Site of premium spoken-word audio product for download or streaming over the world wide web. The Parties shall have the right to issue mutually agreeable additional press releases describing the nature of their relationship at such times as the Parties shall mutually agree. Neither Party will issue any other press releases, make any other disclosures regarding this Agreement or its terms or the relationship between the Parties, or use the other Party's Trademarks (except as permitted by Section 6), without the other Party's prior written consent, except that, each Party may, without the other Party's prior consent: (y) distribute or issue public relations materials or press releases that contain a description of the relationship between the Parties, provided that such description has been approved in advance by such other Party (which approval shall not be unreasonably withheld or delayed); and (z) speak in public regarding disclosures made pursuant to the first sentence of this Section 3.1 [Press Releases]. Parties will be able to include a description of this strategic partnership in the \\\"company descriptor\\\" section of standard releases, subject to initial mutual approvals. -9-\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Advertising\", \"level\": 2, \"text\": \"3.2 Advertising\"}}, {\"id\": \"3.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Amazon\", \"level\": 3, \"text\": \"3.2.1 Amazon.com Customer Base. During each Year of the Term following the Launch Date, ACSI (or one of its Affiliates) will deliver Amazon.com-branded e-mails and Amazon.com-branded in-product advertising materials related to the Spoken-Word Audio Sub-Section to selected members of the Amazon.com customer base in at least the following quantities: --------------------------------------------------------------------------------------------- Year Email Product Shipment ----------------------------- -------------------------- ------------------------------ --------------------------------------------------------------------------------------------- 1 [***] [***] --------------------------------------------------------------------------------------------- 2 [***] [***] --------------------------------------------------------------------------------------------- 3 [***] [***] --------------------------------------------------------------------------------------------- The Parties shall mutually agree on the nature of such advertising; [***]. With respect to all email advertising, ASCI and Company shall pre-test and plan such advertising in a manner generally consistent with the pre-testing and planning conducted by ACSI and its Affiliates with respect to advertising for other ACSI Product Sub-Sections, with the goal of achieving maximum commercial effectiveness for such advertisements (including, without limitation, by attempting to spread out such advertising in order to not unnecessarily \\\"bunch\\\" the same). [***]\"}}, {\"id\": \"3.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Customer Subscription Emails\", \"level\": 3, \"text\": \"3.2.2 Customer Subscription Emails. [***]\"}}, {\"id\": \"3.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company\", \"level\": 3, \"text\": \"3.2.3 Company. [***]\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Certain Covenants\", \"level\": 2, \"text\": \"3.3 Certain Covenants. [***] Source: AUDIBLE INC, 10-Q, 11/13/2000\"}}, {\"id\": \"Section 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Implementation\", \"level\": 1, \"text\": \"Section 4. Implementation\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Spoken-Word Audio Sub-Section and Mirror Company Site\", \"level\": 2, \"text\": \"4.1 Spoken-Word Audio Sub-Section and Mirror Company Site.\"}}, {\"id\": \"4.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Generally\", \"level\": 3, \"text\": \"4.1.1 Generally. During the Term, the Parties will cooperate in good faith and use commercially reasonable efforts to provide a seamless customer experience of full interactivity between the Spoken-Word Audio Sub- Section and the Mirror Company Site. The Parties anticipate that the activities contemplated by this Section 4.1.1 [Generally] will be performed in two phases, as set forth in Section 4.1.2 [Implementation] and Section 4.1.3 [Phase II] below.\"}}, {\"id\": \"4.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Phase I\", \"level\": 3, \"text\": \"4.1.2 Phase I. Between the Effective Date and the Launch Date, the Parties shall perform such work as may be necessary to develop the Spoken-Word Audio Sub-Section (in the case of ACSI) and the Mirror Company Site (in the case of Company). Upon the Launch Date, ACSI will establish the Spoken-Word Audio Sub-Section under the browse tree (or equivalent navigation structure) of the Books Product Section, and Company will establish the Mirror Site. The Spoken- Word Audio Sub-Section will contain, among such --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -10- other content as may be contained therein pursuant to Section 2.1 [Spoken-Word Audio Sub-Section], multiple hypertext links that will allow users to navigate directly to the Mirror Company Site.\"}}, {\"id\": \"4.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Phase II\", \"level\": 3, \"text\": \"4.1.3 Phase II. [***], the Parties shall have fully integrated the ACSI Site Functionality into the Mirror Company Site pursuant to specifications and schedules (the \\\"Phase II Development Plan\\\") that shall be developed by ACSI in consultation with Company, which specification and schedules shall be attached hereto as Exhibit C, [***]. Any dispute arising related to the creation of the Phase II Development Plan shall be subject to the escalation procedure specified in Section 2.8 [Escalation of Certain Disputes].Without limiting the generality of the foregoing, ACSI and Company will cooperate to implement ACSI Site Functionality for the Spoken-Word Audio Sub-Section (including the Mirror Company Site) in a manner consistent with the ACSI Site Functionality provided in other ACSI Product Sub-Sections, and Company and ACSI will use commercially reasonable efforts to perform, in a timely and professional manner, all technical work necessary to seamlessly integrate the ACSI Site Functionality into the Mirror Company Site, in accordance with the Phase II Development Plan.\"}}, {\"id\": \"4.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tax Matters\", \"level\": 3, \"text\": \"4.1.4 Tax Matters. [***]\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACSI Site Links\", \"level\": 2, \"text\": \"4.2 ACSI Site Links. Upon the Launch Date, ACSI will post permanent and/or rotating links to the Home Page of the Spoken-Word Audio Sub-Section on relevant pages of the ACSI Site in a manner substantially similar to and generally consistent with the posting of links to other similar ACSI Product Sub-Sections (e.g., as of the Effective Date, the ACSI Product Sub-Section identified as \\\"Audiobooks\\\"). [***] The Parties shall consult together in connection with the specific nature, prominence and positioning of the links posted on the ACSI Site pursuant to this Section 4.2 [ACSI Site Links]; [***].\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Account Managers\", \"level\": 2, \"text\": \"4.3 Account Managers. Each Party will assign an account manager (which manager shall be subject to change from time to time by the assigning Party) to oversee the performance of such Party's obligations under this Agreement and to facilitate coordination of the Parties' performance of their respective obligations (including, without limitation, the establishment of the Spoken-Word Audio Sub-Section, the creation of the Co-Branded Pages, the integration of the ACSI Site Functionality with the Mirror Company Site, and the advertising activities contemplated in Section 3). The account managers will meet from time to time during the Term to review the implementation of this Agreement and to explore methods for improving performance.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Compliance\", \"level\": 2, \"text\": \"4.4 Regulatory Compliance\"}}, {\"id\": \"4.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company will comply, and will ensure that the Mirror Company Site, the Spoken-Word Audio Products and all other activiti\", \"level\": 3, \"text\": \"4.4.1 Company will comply, and will ensure that the Mirror Company Site, the Spoken-Word Audio Products and all other activities undertaken through or in connection with the Mirror Company Site and this Agreement (including, without limitation, the participation of ACSI and its Affiliates as contemplated by this Agreement) comply with all applicable Laws. --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -11-\"}}, {\"id\": \"4.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company will provide reasonable assistance to ACSI and ACSI's Affiliates in all regulatory compliance activities require\", \"level\": 3, \"text\": \"4.4.2 Company will provide reasonable assistance to ACSI and ACSI's Affiliates in all regulatory compliance activities required in connection with the advertising, operation, maintenance and sale of Spoken-Word Audio Products on and through the Spoken-Word Audio Sub-Section, including, but not necessarily limited to, assisting ACSI in identifying, obtaining and maintaining in force any and all licenses and permits necessary for ACSI and its Affiliates in connection with any of the foregoing. In connection with the foregoing regulatory compliance activities, Company will reimburse ACSI for any reasonable costs (including legal costs) incurred by ACSI or its Affiliates in connection with identifying and obtaining any and all such licenses and permits. Notwithstanding the foregoing, ACSI acknowledges and agrees that Company shall have no obligation to assist ACSI in any regulatory compliance activities related to, or reimburse ACSI for any costs incurred by ACSI or its Affiliates in connection with identifying or obtaining any licenses or permits required in connection with, any advertising, operation, maintenance or sale of Spoken-Word Audio Products or other products sold by ACSI or its Affiliates independently through the ACSI Site without the participation of Company.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Staffing\", \"level\": 2, \"text\": \"4.5 Staffing. Each Party will dedicate during the Term the appropriate resources and personnel necessary for establishment of the Spoken-Word Audio Sub-Section, the integration of the ACSI Site Functionality into the Mirror Company Site and the performance of its other obligations under this Agreement. Each Party's designated employees will be subject to change from time to time by such Party in its sole discretion and promptly upon such change such Party shall Source: AUDIBLE INC, 10-Q, 11/13/2000 notify the other Party.\"}}, {\"id\": \"Section 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compensation\", \"level\": 1, \"text\": \"Section 5. Compensation\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In consideration of the intangible rights granted and services to be performed by ACSI during the Term, Company will pay\", \"level\": 2, \"text\": \"5.1 In consideration of the intangible rights granted and services to be performed by ACSI during the Term, Company will pay ACSI the consideration specified in this Section.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Annual Fees\", \"level\": 2, \"text\": \"5.2 Annual Fees.\"}}, {\"id\": \"5.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon the Closing, subject to Section 5\", \"level\": 3, \"text\": \"5.2.1 Upon the Closing, subject to Section 5.3 [Waiver of Payment Obligations], Company will pay ACSI via wire transfer the sum of [***] (the \\\"Company Closing Payment\\\"), representing payment of the Annual Fee for the first Year of the Term and a pre- payment of the Annual Fee for the second Year of the Term.\"}}, {\"id\": \"5.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"On the first day of Year 3, Company will pay ACSI via wire transfer the sum of [***], representing the Annual Fee payabl\", \"level\": 3, \"text\": \"5.2.2 On the first day of Year 3, Company will pay ACSI via wire transfer the sum of [***], representing the Annual Fee payable with respect to Year 3; provided, however, that if ACSI so elects by written notice delivered to Company at least ten (10) days prior to the end of Year 2, Company shall instead issue at the beginning of Year 3 to ACSI (or such of its Affiliates as it may designate) shares of common stock of Company (or any publicly-traded Affiliate thereof) with a then-current fair market value equal to [***] as of the date of such written notice (the \\\"Year 3 Shares\\\").\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Waiver of Payment Obligations\", \"level\": 2, \"text\": \"5.3 Waiver of Payment Obligations. At the Closing, the Company Closing Payments due to ACSI pursuant to Section 5.2.1 [Annual Fees] hereof and the Shares Consideration (as defined in the Securities Purchase Agreement) due to the Company pursuant to Section 1.2 of --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -12- the Securities Purchase Agreement, which amounts are identical, shall offset each other solely for the purpose of determining the actual fund transfers required at Closing. ASCI acknowledges and agrees that the entire amount of the Company Closing Payments shall be deemed paid and received upon the issuance of the Common Stock (as defined in the Securities Purchase Agreement).\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Royalties\", \"level\": 2, \"text\": \"5.4 Royalties. In consideration for the intangible rights granted hereunder, for each Year in which the Spoken-Word Audio Sub-Section (including the Mirror Company Site) generates revenue of at [***] (the \\\"Revenue Threshold\\\"), Company will pay ACSI a royalty equal to [***] of all revenues generated from the Spoken-Word Audio Sub-Section (including, for the avoidance of doubt, any revenue received by Company from any Company customer who first links to the Mirror Company Site from the Spoken-Word Audio Sub-Section and who later accesses the Company Site directly) in excess of Revenue Threshold (the \\\"Royalties\\\") for each Year of the Term. Company will pay ACSI any Royalties payable pursuant to this Section 5.4 [Royalties] on an annual basis, in arrears, as follows: within thirty (30) days after the end of each Year as to which any Royalties are payable, Company will remit to ACSI the Royalties payable with respect to such Year, together with a report specifying in reasonable detail: (a) the gross revenue generated by the Spoken-Word Audio Sub-Section; and (b) Company's calculation of the Royalties.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Overdue Payments\", \"level\": 2, \"text\": \"5.5 Overdue Payments. Payments called for by this Section 5 which are not received within five (5) business days after the date upon which payment is due will bear interest at a rate equal to the lesser of one and one-half percent (1- 1/2%) per month or the maximum legal rate permitted under the controlling Laws. Payment of such interest shall not cure or excuse any breach of any underlying payment obligation.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Allocation of Payments\", \"level\": 2, \"text\": \"5.6 Allocation of Payments. The Parties acknowledge and agree that the Annual Fees shall be allocated as consideration for advertising services and intangible rights granted by ACSI to Company hereunder, including the rights granted under Section 2.1 [Spoken-Word Audio Sub-Section] and Section 4.2 [ACSI Site Links] and the licenses granted to Company under Section 6, as follows: Year Advertising Services Intangible Rights ---------------------------------------------------------------------------------------------- 1 [***] [***] ---------------------------------------------------------------------------------------------- 2 [***] [***] ---------------------------------------------------------------------------------------------- 3 [***] [***] ---------------------------------------------------------------------------------------------- --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -13-\"}}, {\"id\": \"Section 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Proprietary Rights\", \"level\": 1, \"text\": \"Section 6. Proprietary Rights\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership\", \"level\": 2, \"text\": \"6.1 Ownership.\"}}, {\"id\": \"6.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As between the Parties, ACSI reserves all right, title and interest in and to the ACSI Intellectual Property, along with\", \"level\": 3, \"text\": \"6.1.1 As between the Parties, ACSI reserves all right, title and interest in and to the ACSI Intellectual Property, along with all Intellectual Property Rights associated therewith and no title to or ownership of any of the foregoing is transferred or, except as expressly set forth in Section 6.2 [ACSI License], licensed to Company or any other person or entity pursuant to this Agreement.\"}}, {\"id\": \"6.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As between the Parties, Company reserves all right, title and interest in and to the Company Intellectual Property, alon\", \"level\": 3, \"text\": \"6.1.2 As between the Parties, Company reserves all right, title and interest in and to the Company Intellectual Property, along with all Intellectual Property Rights associated therewith and no title to or ownership of any of the foregoing is transferred or, except as expressly set forth in Section 6.3 [Company License], licensed to ACSI or any other person or entity pursuant to this Agreement. Source: AUDIBLE INC, 10-Q, 11/13/2000\"}}, {\"id\": \"6.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To the maximum extent permitted by applicable Laws, any ACSI Derivative Works or Company Derivative Works, to the extent\", \"level\": 3, \"text\": \"6.1.3 To the maximum extent permitted by applicable Laws, any ACSI Derivative Works or Company Derivative Works, to the extent created by or for the other Party, shall be deemed \\\"works made for hire\\\", and all right, title and interest therein shall vest in ACSI (in the case of ACSI Derivative Works) or Company (in the case of Company Derivative Works) immediately upon creation thereof. To the extent that any such ACSI Derivative Works or Company Derivative Works are not \\\"works made for hire\\\", Company hereby assigns and agrees to assign to ACSI (or such of its Affiliates as it may designate) all right, title and interest to all ACSI Derivative Works and all associated Intellectual Property Rights, and ACSI hereby assigns and agrees to assign to Company (or such of its Affiliates as it may designate) all right, title and interest in and to all Company Derivative Works and all associated Intellectual Property Rights. Each Party shall take, at the other Party's expense, any actions (including, without limitation, execution and delivery of affidavits and other documents) reasonably requested by such other Party to effect, perfect or confirm its or its designee's ownership rights as set forth in this Section 6.1.3 [Ownership].\"}}, {\"id\": \"6.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To the extent that any Joint Works are created in the course of performance of this Agreement, each Party shall own a jo\", \"level\": 3, \"text\": \"6.1.4 To the extent that any Joint Works are created in the course of performance of this Agreement, each Party shall own a joint, equal and undivided ownership interest in and to such Joint Works and the associated Intellectual Property Rights, with no duty on the part of either Party to account to the other with respect to its use and exploitation of the same. Each Party shall own all right, title and interest in and to any Derivative Works of any Joint Works created by or for such Party and all Intellectual Property Rights associated therewith (to the extent not also associated with the Joint Works). Without limiting the generality of the foregoing, either Party may, without any duty to account to the other (including, without limitation, any duty to pay, share or account for any royalties): (a) make, manufacture, assemble, produce, market, sell, distribute, transfer, use, license and otherwise commercially and non-commercially exploit and deal with the Joint Works; provided, that neither Party shall seek or obtain any -14- registration of any Intellectual Property Rights associated with the Joint Works without the other Party's prior written consent; (b) make, manufacture, assemble, produce, market, sell, distribute, transfer, use, license, seek and obtain registrations of Intellectual Property Rights (subject to paragraph (a) above) and otherwise commercially and non-commercially exploit and deal with Derivative Works of any Joint Works created by or for such Party, whether or not competitive with any items created by or for the other Party; and (c) authorize any third party to take any action described in (a) or (b) above.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACSI License\", \"level\": 2, \"text\": \"6.2 ACSI License. ACSI hereby grants to Company, during the Term, a non- exclusive, non-transferable (except in accordance with Section 11.7 [Assignment]) license, which Company may sublicense only to its Affiliates, to use the ACSI Intellectual Property supplied by ACSI to Company as is reasonably necessary to perform its obligations under this Agreement; provided, however, that Company shall not use ACSI's Trademarks, including in any advertising, without ACSI's prior written consent, unless such use conforms to a written Trademark use policy previously furnished by ACSI to Company and not subsequently modified or revoked. All goodwill arising out of any use of any of ACSI's or its Affiliates' Trademarks by, through or under Company will inure solely to the benefit of ACSI and its Affiliates.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company License\", \"level\": 2, \"text\": \"6.3 Company License. Company hereby grants to ACSI, during the Term, a non-exclusive, non-transferable (except in accordance with Section 11.7 [Assignment]) license, which ACSI may sublicense only to its Affiliates, to use the Company Intellectual Property supplied by Company to ACSI as is reasonably necessary to perform its obligations under this Agreement; provided, however, that ACSI shall not use Company's Trademarks, including in any advertising, without Company's prior written consent, unless such use conforms to a written Trademark use policy previously furnished by Company to ACSI and not subsequently modified or revoked. All goodwill arising out of any use of any of Company's Trademarks by, through or under ACSI will inure solely to the benefit of Company.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Disparagement\", \"level\": 2, \"text\": \"6.4 Non-Disparagement. Neither Company nor ACSI will use the other Party's Trademarks in a manner that disparages the other Party or its products or services, and/or portrays the other Party or its products or services in a false, competitively adverse or poor light. Each of Company and ACSI will comply with the other Party's requests as to the use of the other Party's Trademarks and will avoid knowingly taking any action that diminishes the value of such Trademarks.\"}}, {\"id\": \"Section 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations; Indemnity\", \"level\": 1, \"text\": \"Section 7. Representations; Indemnity\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations\", \"level\": 2, \"text\": \"7.1 Representations. Each Party represents and warrants to the other that: (a) it has the full corporate right, power and authority to enter into this Agreement and perform its obligations hereunder; (b) its performance of this Agreement, and the other Party's exercise of such other Party's rights under this Agreement, will not conflict with or result in a breach -15- or violation of any of the terms or provisions or constitute a default under any agreement by which it is bound; (c) when executed and delivered, this Agreement will constitute its legal, valid and binding obligation enforceable against it in accordance with its terms; and (d) it will comply with all applicable Laws in its performance of this Agreement.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnity\", \"level\": 2, \"text\": \"7.2 Indemnity. Each Party (as applicable, the \\\"Indemnifying Party\\\") will defend, indemnify and hold harmless the other Party (the \\\"Indemnified Party\\\") and its Affiliates (and their respective employees, directors and representatives) from and against any and all claims, costs, losses, damages, judgments and expenses (including reasonable attorneys' fees) arising out of any Claim, to the extent it is based on (a) the operation or content of the Indemnifying Party's Site (other than any items or materials supplied, or operation or content required, by the Indemnified Party), (b) the offer, marketing or sale of any products or services through the Indemnifying Party's Site (other than any products offered, marketed or sold by the Indemnified Party Source: AUDIBLE INC, 10-Q, 11/13/2000 through such Site, the Parties acknowledging that Company shall be deemed the Indemnifying Party as to any Claim related to any products offered, marketed or sold by Company through the Spoken-Word Audio Sub-Section and/or Mirror Company Site, except to the extent that such Claim relates to any ACSI Site Functionality or other items or content provided by or for ACSI with respect to the Spoken-Word Audio Sub-Section and/or Mirror Company Site), (c) any actual or alleged breach of the Indemnifying Party's representations or warranties set forth in Section 7.1 [Representations] above, or, in the case of Company, its obligations under Section 4.4 [Regulatory Compliance] above, or (d) any actual or alleged infringement of any Intellectual Property Rights by any content, items or materials provided by the Indemnifying Party to the Indemnified Party for its use under this Agreement. Subject to Section 7.3 [Procedure], the Indemnifying Party will pay any award against the Indemnified Party and its Affiliates (and their respective employees, directors or representatives) and any costs and attorneys' fees reasonably incurred by them resulting from any such Claim.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Procedure\", \"level\": 2, \"text\": \"7.3 Procedure. In connection with any Claim described in this Section 7, the Indemnified Party will (a) give the Indemnifying Party prompt written notice of the Claim, (b) cooperate with the Indemnifying Party (at the Indemnifying Party's expense) in connection with the defense and settlement of the Claim, and (c) permit the Indemnifying Party to control the defense and settlement of the Claim, provided that the Indemnifying Party may not settle the Claim without the Indemnified Party's prior written consent (which will not be unreasonably withheld). Further, the Indemnified Party (at its cost) may participate in the defense and settlement of the Claim with counsel of its own choosing. Unless the Indemnifying Party notifies the Indemnified Party in writing within five (5) days of its receipt of notice of any Claim that it irrevocably elects not to assume the defense of such Claim, the Indemnifying Party shall be deemed to have elected to assume the defense of such Claim. If the Indemnifying Party elects not to assume the defense of any Claim, or having assumed the defense of any Claim fails to pursue diligently the defense thereof, the Indemnifying Party shall be deemed to have irrevocably waived any right to participate in or control the defense or settlement of such Claim and the Indemnified Party shall be entitled to sole control of the defense and settlement of such Claim (without limitation of the Indemnifying Party's indemnity obligations under this Section 7). -16-\"}}, {\"id\": \"Section 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimers, Limitations and Reservations\", \"level\": 1, \"text\": \"Section 8. Disclaimers, Limitations and Reservations\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISCLAIMER OF WARRANTIES\", \"level\": 2, \"text\": \"8.1 DISCLAIMER OF WARRANTIES. EXCEPT AS PROVIDED IN SECTION 7.1 [Representations] ABOVE, NEITHER PARTY MAKES, AND EACH PARTY HEREBY WAIVES AND DISCLAIMS, ANY REPRESENTATIONS OR WARRANTIES REGARDING THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, INCLUDING (WITHOUT LIMITATION) ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT OR IMPLIED WARRANTIES ARISING OUT OF COURSE OF DEALING, COURSE OF PERFORMANCE OR USAGE OF TRADE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, EACH PARTY SPECIFICALLY DISCLAIMS ANY REPRESENTATION OR WARRANTY REGARDING (A) THE AMOUNT OF SALES REVENUES THAT MAY OCCUR DURING THE TERM, AND (B) ANY ECONOMIC OR OTHER BENEFIT THAT THEY MIGHT OBTAIN THROUGH ITS PARTICIPATION IN THIS AGREEMENT (OTHER THAN THE SPECIFIC SUMS TO BE PAID PURSUANT TO THIS AGREEMENT).\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation of Damages\", \"level\": 2, \"text\": \"8.3 Limitation of Damages. EXCEPT FOR LIABILITIES UNDER SECTION 7.2 [Indemnity], NEITHER PARTY'S AGGREGATE LIABILITY ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, WHETHER IN CONTRACT, TORT (INCLUDING NEGLIGENCE), WARRANTY OR OTHERWISE, SHALL EXCEED [***].\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third Party Infringement Claims\", \"level\": 2, \"text\": \"8.4 Third Party Infringement Claims. In the event that either Party receives from a third party a bona fide claim of infringement concerning any advertising materials or other content supplied by the other Party, such Party may immediately remove such materials --------- *** Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -17- or content from its Web Site at its sole discretion, pending receipt of non- infringing replacement materials or content or satisfactory resolution of such claim, and any such removal shall not constitute a breach of this Agreement.\"}}, {\"id\": \"Section 9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exclusivity\", \"level\": 1, \"text\": \"Section 9. Exclusivity.\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACSI\", \"level\": 2, \"text\": \"9.1 ACSI\"}}, {\"id\": \"9.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exclusive Spoken-Word Audio Products\", \"level\": 3, \"text\": \"9.1.1 Exclusive Spoken-Word Audio Products. During the Term, [***], ACSI will not offer or sell through the ACSI Site, or authorize any third party to sell through the ACSI Site, any Exclusive Spoken-Word Audio Products; [***].\"}}, {\"id\": \"9.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[***]\", \"level\": 3, \"text\": \"9.1.2 [***]\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[***]\", \"level\": 2, \"text\": \"9.2 [***]\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[***]\", \"level\": 2, \"text\": \"9.3 [***]\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records; Audit\", \"level\": 2, \"text\": \"9.4 Records; Audit. Each Party will, during the Term and for a period of one (1) year thereafter, maintain complete and accurate books and records sufficient to verify its compliance or non-compliance with the provisions of this Section 9 (and, in the case of Company, Section 5.4 [Royalties]). Each Party (the \\\"Audited Party') will, upon at least thirty (30) days' prior written request by the other Party (the \\\"Auditing Party\\\"), allow an independent certified public Source: AUDIBLE INC, 10-Q, 11/13/2000 accounting firm selected by the Auditing Party and reasonably acceptable to the Audited Party to audit such books and records at the Audited Party's premises to the extent necessary to verify the Audited Party's compliance or non-compliance with the provisions of this Section 9 (or, in the case of Company, Section 5.4 [Royalties]); provided, that: (a) any such audit is conducted during normal business hours and in a manner designed to not unreasonably interfere with the Audited Party's ordinary business operations; (b) audits may not occur more frequently than once every twelve (12) months; and (c) each such audit may only cover the period commencing after the period covered by the last audit conducted pursuant to this Section, if any. The Auditing Party agrees that any information learned or disclosed by its auditor in connection with such audit is Confidential Information of the Audited Party. If any such audit reveals any material non- compliance with the provisions of this Section 9 by the Audited Party, the Audited Party shall, within ten (10) days of its receipt of an invoice therefor, reimburse the Auditing Party for all reasonable out-of-pocket fees and expenses incurred by the Auditing Party in connection with the applicable audit. If any such audit reveals any underpayment of any sums payable pursuant to Section 5.4 [Royalties], Company will promptly remit to ACSI the amount of the underpayment; and, if the amount of such underpayment is five percent (5%) or more for any audited period, Company shall, within ten (10) days of its receipt of an invoice therefor, reimburse ACSI for all reasonable out-of-pocket fees and expenses incurred by ACSI and its Affiliates in connection with the applicable audit together with interest on any underpayment as provided in Section 5.5 [Overdue Payments]. --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -18-\"}}, {\"id\": \"Section 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"Section 10. Term and Termination\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"10.1 Term. The term of this Agreement will commence on the Effective Date, and unless earlier terminated as provided elsewhere in this Agreement, will end automatically upon the end of Year 3.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACSI Termination\", \"level\": 2, \"text\": \"10.3 ACSI Termination. In the event that: (a) Company at any time engages in any criminal conduct, fraud, dishonesty or other behavior that is materially harming the goodwill or reputation of ACSI or its Affiliates or the ACSI Site; (b) Company has consistently failed to abide by the technical and customer service requirements described in Section 2.4 [Technical Standards; Customer Service] or has failed to integrate the ACSI Site Functionality into the Spoken-Word Audio Sub-Section and/or Mirror Company Site as required by the Phase II Development Plan (so long as such failure is not a result of acts or omissions by ACSI); or (c) Company consistently fails to pay bona fide debts as they legally come due, institutes or has instituted against it any bankruptcy, reorganization, debt arrangement, assignment for the benefit of creditors, or other proceeding under any bankruptcy or insolvency Law or dissolution, receivership, or liquidation proceeding (and, if such proceeding is instituted against it, such proceeding is not dismissed within one hundred twenty (120) days), the same shall be deemed a material breach of this Agreement which is not susceptible to cure, and ACSI shall be entitled to terminate this Agreement upon written notice to Company. [***]\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company Termination\", \"level\": 2, \"text\": \"10.4 Company Termination. In the event that (a) ACSI has failed to integrate the ACSI Site Functionality into the Spoken-Word Audio Sub-Section and/or Mirror Company Site as required by the Phase II Development Plan (so long as such failure is not a result of acts or omissions by Company); or (b) ACSI consistently fails to pay its bona fide debts as they legally come due, institutes or has instituted against it any bankruptcy, reorganization, debt arrangement, assignment for the benefit of creditors, or other proceeding under any bankruptcy or insolvency Law or dissolution, receivership, or liquidation proceeding (and, if such proceeding is instituted against it, such proceeding is not dismissed within one hundred twenty (120) days), the same shall be deemed a material breach of this Agreement which is --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -19- not susceptible to cure, and Company shall be entitled to terminate this Agreement upon written notice to ACSI.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"10.5 Effect of Termination.\"}}, {\"id\": \"10.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General\", \"level\": 3, \"text\": \"10.5.1 General. Upon termination of this Agreement, each Party in receipt, possession or control of the other Party's intellectual or proprietary property, information and materials (including any Confidential Information) pursuant to this Agreement must return to the other Party (or at the other Party's written request, destroy and certify in writing such destruction) such property, information and materials. In addition, except as provided in Section 10.5.2 [Effect of Termination], Company will promptly upon any termination of this Agreement pay to ACSI a prorated portion of the Annual Fee due for the Year in which termination is effective; provided, however, that if Company terminates this Agreement by reason of ACSI's breach hereof, Company shall have no further payment obligation, and, if such termination occurs at any time during the Refund Source: AUDIBLE INC, 10-Q, 11/13/2000 Period, ACSI shall promptly either (a) refund to Company a percentage of the Annual Fees paid pursuant to Section 5.2.1 [Annual Fees] equal to the Proration Percentage, or, at ACSI's option, (b) cause the transfer and assignment to Company of a percentage of the Shares delivered pursuant to Section 5.3 [Waiver of Payment Obligations] equal to the Proration Percentage. Sections 6 through 8, 10 and 11 will survive the termination or expiration of this Agreement.\"}}, {\"id\": \"10.5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[***]\", \"level\": 3, \"text\": \"10.5.2 [***]\"}}, {\"id\": \"10.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Construction by Court\", \"level\": 3, \"text\": \"10.5.3 Construction by Court. To the extent that any court of competent jurisdiction determines that any provision of Section 10.5.2 [Effect of Termination] is for any reason unlawful, invalid, in violation of public policy or otherwise unenforceable in whole or in part, such provision shall be narrowed in scope to the extent necessary to make the same lawful, valid and enforceable while as nearly as possible reflecting the intent of the Parties as expressed in this Agreement.\"}}, {\"id\": \"10.5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"User Transition\", \"level\": 3, \"text\": \"10.5.4 User Transition. Upon any termination or expiration of the Term the Parties will cooperate in good faith to promote a smooth customer transition, and in any event, Company will, at ACSI's option, continue to operate the Mirror Company Site and offer Spoken-Word Audio Products through the Spoken-Word Audio Sub-Section in accordance with the terms of this Agreement for a period of up to six (6) months following such termination.\"}}, {\"id\": \"10.5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Phase II Development Plan\", \"level\": 3, \"text\": \"10.5.5 Phase II Development Plan. Notwithstanding any other provision of this Agreement, the Parties acknowledge and agree that no failure by the Parties to develop the Phase II Development Plan as contemplated by Section 4.1.3 [Phase II] shall be deemed, in itself, a breach of this Agreement by either Party (and therefore that such occurrence shall not, in itself, give rise to any of the remedies specified in Section 10.5.1 [General] or Section 10.5.2 [Effect of Termination]). --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -20-\"}}, {\"id\": \"Section 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"Section 11. Miscellaneous\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tax Treatment\", \"level\": 2, \"text\": \"11.1 Tax Treatment.\"}}, {\"id\": \"11.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Parties acknowledge and agree that this Agreement and the transactions contemplated hereby are not intended to creat\", \"level\": 3, \"text\": \"11.1.1 The Parties acknowledge and agree that this Agreement and the transactions contemplated hereby are not intended to create any jurisdiction or authority for any governmental authority to impose any obligation to collect any sales tax, use tax or similar tax in connection with any sales of products by either Party or its Affiliates. Accordingly, each Party agrees to take such action as the other Party may reasonably request (including, without limitation, execution of affidavits and other documents) to avoid or curtail the imposition, by reason of this Agreement or the transactions contemplated hereby, of any such obligation on such Party or its Affiliates, or the establishment of a nexus for tax purposes sufficient to grant any jurisdiction the authority to levy any sales tax, use tax or similar tax on sales of products by such Party or its Affiliates in connection with this Agreement; provided, however, that nothing in this Section 11.1.1 [Tax Treatment] shall limit Company's obligations under Section 11.1.2 [Tax Treatment].\"}}, {\"id\": \"11.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company will collect and pay, and indemnify and hold harmless ACSI and its Affiliates from, any sales, use, excise, impo\", \"level\": 3, \"text\": \"11.1.2 Company will collect and pay, and indemnify and hold harmless ACSI and its Affiliates from, any sales, use, excise, import or export, value added or similar tax or duty not based on ACSI's or its Affiliates' net income, including penalties and interest, costs associated with the collection and withholding thereof and attorneys fees in connection therewith, arising out of or in connection with this Agreement or Company's advertisement, offer or sale of any products.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 2, \"text\": \"11.2 Insurance. Company will at its expense, prior to the Launch Date obtain, and thereafter throughout the Term and for a period of six (6) months thereafter maintain, such policy or policies of insurance as is commercially reasonable for the transactions and business contemplated by this Agreement. Without limiting the generality of the foregoing, Company will ensure that such policies contain a waiver of subrogation against ACSI, name ACSI and its assignees as additional insureds. Company will not modify or terminate any coverage without giving at least thirty (30) days' prior written notice to ACSI. Upon request from ACSI, Company will furnish to ACSI certificates of insurance and such other documentation relating to such policies as ACSI may reasonably request.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"11.3 Independent Contractors. The Parties are entering this Agreement as independent contractors, and this Agreement will not be construed to create a partnership, joint venture or employment relationship between them. Neither Party will represent itself to be an employee or agent of the other or enter into any agreement or legally binding commitment or statement on the other's behalf of or in the other's name.\"}}, {\"id\": \"11.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nondisclosure\", \"level\": 2, \"text\": \"11.4 Nondisclosure. Each Party will protect the Confidential Information of the other Party from misappropriation and unauthorized use or disclosure, and at a minimum, will take precautions at least as great as those taken to protect its own confidential information of a similar nature, but in no event with less than reasonable care. Without limiting the foregoing, the Receiving Party will: (a) use such Confidential Information solely for the purposes for which it has been disclosed; and (b) disclose such Confidential -21- Information only to those of its and its Affiliates' employees, agents, and consultants who have a need to know the same for the purpose of performing this Agreement and who are informed of and agree to a duty of nondisclosure. The Receiving Party may also disclose Confidential Information of the Disclosing Party to the extent necessary to comply with applicable Law or legal process or pursuant to a registration report or exhibits thereto filed or to be filed with the Securities and Exchange Commission, listing agency or any stock securities commission, or any other associated filings, provided that the Receiving Party uses gives the Disclosing Party not less than ten (10) days' prior written notice thereof and complies with all reasonable requests of the Disclosing Party to minimize the extent or scope of any such disclosure. Upon request of the other Party, or in any event upon any termination or expiration of the Term, each Party shall return to the other or destroy (and certify in writing such destruction) all materials, in any medium, which contain, embody, reflect or Source: AUDIBLE INC, 10-Q, 11/13/2000 reference all or any part of any Confidential Information of the other Party.\"}}, {\"id\": \"11.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Costs\", \"level\": 2, \"text\": \"11.5 Costs. Except as expressly provided herein, each Party will be responsible for all costs and expenses incurred by it in connection with the negotiation, execution, delivery and performance of this Agreement.\"}}, {\"id\": \"11.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"11.6 Notices. Any notice or other communication under this Agreement given by either Party to the other Party will be in writing and, to be effective, must be sent to the intended recipient by prepaid registered letter, receipted commercial courier, or electronically receipted facsimile transmission (acknowledged in like manner by the intended recipient) at its address specified below its signature at the end of this Agreement, and in the case of ACSI, with a copy to Amazon.com, Inc., 1200 12th Avenue South, Suite 1200, Seattle, WA 98144, USA, Facsimile: (206) 266-7010 Attn: General Counsel and in the case of Company, with a copy to Audible Inc., Facsimile 973-890-0178, Attn: Vice President, Business & Legal Affairs; provided, that no notice of termination of this Agreement shall be deemed properly given unless sent by prepaid registered mail to such address(es) and to the attention of such officer(s). Either Party may from time to time change such address or individual by giving the other Party notice of such change in accordance with this Section 11.6 [Notices].\"}}, {\"id\": \"11.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"11.7 Assignment. Company may not assign or delegate this Agreement or any of its rights or obligations hereunder, whether voluntarily, involuntarily, by operation of Law or otherwise, without ACSI's prior written consent, which consent shall not be unreasonably withheld or delayed, except that Company may assign this Agreement to any direct or indirect wholly owned subsidiary in connection with any corporate reorganization undertaken for the purpose of minimizing the tax liability of Company and its Affiliates or other bona fide corporate purpose or in connection with any Change of Control [***]. Subject to the preceding two sentences, this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their successors and assigns. ACSI may assign this Agreement to (a) any corporation or other entity resulting from any merger, consolidation, or other reorganization involving ACSI, (b) any of its Affiliates, or (c) any person or entity to which it transfers all or --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -22- substantially all of its assets relating to the Spoken-Word Audio Sub-Section; provided that the assignee agrees in writing to be bound by all the terms and conditions of this Agreement. Subject to the foregoing, this Agreement will be binding on and enforceable by the Parties and their respective successors and permitted assigns.\"}}, {\"id\": \"11.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonwaiver\", \"level\": 2, \"text\": \"11.8 Nonwaiver. To be effective, any waiver by a Party of any of its rights or the other Party's obligations under this Agreement must be made in a writing signed by the Party to be charged with the waiver. No failure or forbearance by either Party to insist upon or enforce performance by the other Party of any of the provisions of this Agreement or to exercise any rights or remedies under this Agreement or otherwise at law or in equity shall be construed as a waiver or relinquishment to any extent of such Party's right to assert or rely upon any such provision, right, or remedy in that or any other instance; rather the same shall be and remain in full force and effect.\"}}, {\"id\": \"11.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts; Transmitted Copies\", \"level\": 2, \"text\": \"11.9 Counterparts; Transmitted Copies. This Agreement may be executed in any number of counterparts, each of which will be deemed an original, but all of which taken together will constitute one and the same instrument. To expedite the process of entering into this Agreement, the Parties acknowledge that Transmitted Copies of the Agreement shall be equivalent to original documents until such time (if any) as original documents are completely executed and delivered. \\\"Transmitted Copies\\\" shall mean copies which are reproduced or transmitted via facsimile, or another process of complete and accurate reproduction and transmission.\"}}, {\"id\": \"11.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Headings\", \"level\": 2, \"text\": \"11.10 Headings. The headings of sections and subsections of this Agreement are for convenience of reference only and are not intended to restrict, affect or otherwise influence the interpretation or construction of any provision of this Agreement.\"}}, {\"id\": \"11.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Choice of Law\", \"level\": 2, \"text\": \"11.11 Choice of Law. This Agreement will be interpreted, construed and enforced in accordance with the Laws of the State of Washington, without reference to its choice of Laws rules.\"}}, {\"id\": \"11.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Venue\", \"level\": 2, \"text\": \"11.12 Venue. Company hereby irrevocably consents to non-exclusive personal jurisdiction and venue in the state and federal courts located in King County, Washington, with respect to any claim, action or proceeding arising out of or related to this Agreement and agrees not to commence or prosecute any such claim, action or proceeding other than in the aforementioned courts.\"}}, {\"id\": \"11.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"11.13 Entire Agreement. This Agreement (a) represents the entire agreement between the Parties with respect to the subject matter hereof and supersedes any previous or contemporaneous oral or written agreements regarding such subject matter and (b) may be amended or modified only by a written instrument signed by a duly authorized agent of each Party. No breach of this Agreement by either Party shall affect the rights or obligations of either Party under any other Agreement between the Parties; rather, the same will remain in full force and effect. -23- ACSI Company: ---- -------- Amazon.com Commerce Services, Inc. Audible Inc. /s/ /s/ Don Katz ---------------------------------- -------------------------------------- By (Sign) By (Sign) Vice President Founder, Chairman, Acting CEO ---------------------------------- -------------------------------------- Title Title Source: AUDIBLE INC, 10-Q, 11/13/2000 1/30/2000 1/30/2000 ---------------------------------- -------------------------------------- Date Date Notice Address: Notice Address: [***] [***] --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -24- Source: AUDIBLE INC, 10-Q, 11/13/2000\"}}, {\"id\": \"party:Amazon.com Commerce Services, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Amazon.com Commerce Services, Inc.\", \"role\": null, \"address\": \"a Delaware corporation\"}}, {\"id\": \"party:Audible Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Audible Inc.\", \"role\": \"Company\", \"address\": \"a Delaware corporation\"}}, {\"id\": \"term:ACSI Competitor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Competitor\", \"text\": \"\\\"ACSI Competitor\\\" means, collectively, such persons and entities as the Parties may agree upon from time to time.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Derivative Work\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Derivative Work\", \"text\": \"\\\"ACSI Derivative Work\\\" means any Derivative Work (whether created by ACSI, Company, or the Parties jointly) of any ACSI Existing Intellectual Property or ACSI Future Intellectual Property.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Existing Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Existing Intellectual Property\", \"text\": \"\\\"ACSI Existing Intellectual Property\\\" means, collectively, all of the following existing as of the Effective Date: (a) the Trademarks of ACSI and its Affiliates; and (b) the ACSI Site, including, without limitation, any and all content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\", ACSI Site Functionality, Trademarks and other items posted thereon or used in connection or associated with any of the foregoing.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Future Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Future Intellectual Property\", \"text\": \"\\\"ACSI Future Intellectual Property\\\" means, collectively, all of the following which are invented, created, developed or first reduced to practice by ACSI or its Affiliates after the Effective Date without the participation of Company or its Affiliates: (a) any Trademarks; and (b) any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel,\\\" ACSI Site Functionality and other items (but excluding any Company Derivative Works).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Intellectual Property\", \"text\": \"\\\"ACSI Intellectual Property\\\" means, collectively, any ACSI Existing Intellectual Property, ACSI Future Intellectual Property and ACSI Derivative Works, but excluding any Joint Works.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Product Section\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Product Section\", \"text\": \"\\\"ACSI Product Section\\\" means a discrete group of products available on the ACSI Site which is identified by a tab or other top-level product category identifier on the ACSI Site Home Page, but excluding: (a) the ACSI Site Home Page itself; and (b) any mechanisms, areas or services on or through which third parties may sell products through the ACSI Site in connection with ACSI's and its Affiliates' programmatic selling initiatives (including, without limitation, the existing \\\"Auctions\\\", \\\"zShops\\\", \\\"Sothebys.amazon.com\\\" and \\\"Amazon.com Advantage\\\" areas and services of the ACSI Site, and any successors or replacements to any of them).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Product Sub-Section\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Product Sub-Section\", \"text\": \"\\\"ACSI Product Sub-Section\\\" means a discrete sub-set of products in any ACSI Product Section which is accessible by following or using a browse tree or hypertext links on the ACSI Site, and is identified by a permanent product category description on the ACSI Site (e.g., as opposed to a description generated in response to a user search query), but is not identified by a tab or other top-level product category identifier on the ACSI Site Home Page (e.g., as of the Effective Date, the \\\"business & investing\\\" or \\\"audio books\\\" sub-set of products included in, and accessible through the browse tree of, the ACSI Product Section identified by the \\\"Books\\\" tab on the ACSI Home Page (the \\\"Books Product Section\\\")).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Site\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Site\", \"text\": \"\\\"ACSI Site\\\" means that Web Site, the primary Home Page of which is identified by the URL www.amazon.com (and any successor or replacement Web -------------- Site). For the avoidance of doubt, the \\\"ACSI Site\\\" does not include any other Web Sites maintained by or for ACSI or its Affiliates (including, without limitation, those Web Sites, the primary Home Pages of which are identified by the URL's www.amazon.co.uk and www.amazon.de).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:ACSI Site Functionality\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ACSI Site Functionality\", \"text\": \"\\\"ACSI Site Functionality\\\" means, collectively: (a) tab, search and browse functionality available to users of the ACSI Site for navigating through ACSI Product Sections (including, without limitation, the layout and design thereof); (b) payment and transaction functionality available to users of the ACSI Site for purchasing products (including, without limitation, \\\"shopping cart\\\" and \\\"Payment with 1-Click\\\" functionality), (c) any other functionality available on the ACSI Site which ACSI may make available to Company from time to time, and (d) any future equivalents, improvements and enhancements of any of the foregoing.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"\\\"Affiliate\\\" means, with respect to any person or entity (including either Party), any other person or entity that directly or indirectly controls, is controlled by or is under common control with that person or entity, or which that person or entity beneficially owns at least fifty percent (50%) of the equity interests therein (provided, however, that with respect to the Parties, no individual or entity as to which the ultimate parent entity of a Party does not directly or indirectly control the operations or management thereof (e.g., in the case of ACSI as of the date of this Agreement, Gear.com, Inc.) shall be deemed to be an Affiliate of such Party for purposes of this Agreement).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Annual Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Fee\", \"text\": \"\\\"Annual Fee\\\" means the sum of [***], representing the fixed fee payable by Company to ACSI with respect to each Year.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Change of Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change of Control\", \"text\": \"\\\"Change of Control\\\" means, with respect to Company, a transaction or series of related transactions that results in (a) a sale of all or substantially all of the assets of Company, (b) the transfer of fifty percent (50%) or more of the outstanding voting power of Company (other than directly or indirectly to a parent or wholly-owned subsidiary of Company), or (c) the acquisition by a person or entity, by reason of any contractual arrangement or understanding with one or more persons or entities, of the right or power to appoint or cause to be appointed a majority of the directors or officers of Company.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Claim\", \"text\": \"\\\"Claim\\\" means any claim, action or proceeding instituted by a third party (other than an Affiliate of a Party), including, without limitation, any governmental authority.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Closing\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Closing\", \"text\": \"\\\"Closing\\\" means the consummation of the purchase of common stock of Company pursuant to the Securities Purchase Agreement between ACSI and Company dated on or about the Effective Date (the \\\"Securities Purchase Agreement\\\").\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Company Derivative Work\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Derivative Work\", \"text\": \"\\\"Company Derivative Work\\\" means any Derivative Work (whether created by ACSI, Company, or the Parties jointly) of any Company Existing Intellectual Property or Company Future Intellectual Property.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Company Existing Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Existing Intellectual Property\", \"text\": \"\\\"Company Existing Intellectual Property\\\" means, collectively, all of the following existing as of the Effective Date: (a) the Trademarks of Company and its Affiliates; (b) the Company Site, including, without limitation, any and all content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel,\\\" Trademarks and other items posted thereon or used in connection or associated with any of the foregoing\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Company Future Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Future Intellectual Property\", \"text\": \"\\\"Company Future Intellectual Property\\\" means, collectively, all of the following which are invented, created, developed or first reduced to practice by Company or its Affiliates after the Effective Date without the participation of ACSI or its Affiliates: (a) any Trademarks; and (b) any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\" or other items (but excluding any ACSI Derivative Works).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Company Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Intellectual Property\", \"text\": \"\\\"Company Intellectual Property\\\" means, collectively, any Company Existing Intellectual Property, Company Future Intellectual Property, and Company Derivative Works, but excluding any Joint Works.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Company Site\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Site\", \"text\": \"\\\"Company Site\\\" means, collectively: (a) that Web Site, the primary Home Page for which is identified by the URL www.audible.com (and any successor or replacement Web Site); and (b) any other Web Sites operated by or for Company or its Affiliates from time to time (excluding the Mirror Company Site) through which Spoken-Word Audio Products are sold or offered for sale.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"\\\"Confidential Information\\\" means, with respect to either Party, all information relating to such Party or its Affiliates that is designated as confidential or that, given the nature of the information or the circumstances surrounding its disclosure, reasonably should -3- be considered as confidential. Confidential Information includes, without limitation, (a) all information relating to a Party's or its Affiliates' technology, customers, business plans, promotional and marketing activities, finances and other business affairs; (b) all third party information that a Party or its Affiliates is obligated to keep confidential; and (c) the terms of this Agreement. Confidential Information may be contained in tangible materials, such as drawings, data, specifications, reports and computer programs, or may be in the nature of unwritten knowledge. Confidential Information does not include any information that (i) has become publicly available without breach of this Agreement, (ii) can be shown by documentation to have been known to the Receiving Party at the time of its receipt from the Disclosing Party or its Affiliates without a breach of confidentiality or other improper means, (iii) is received from a third party who did not acquire or disclose such information by a wrongful or tortious act or (iv) can be shown by documentation to have been independently developed by the Receiving Party without reference to any Confidential Information.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Derivative Work\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Derivative Work\", \"text\": \"\\\"Derivative Work\\\" means any adaptation, modification, enhancement, improvement or derivative work.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Disclosing Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disclosing Party\", \"text\": \"\\\"Disclosing Party\\\" means a Party that discloses Confidential Information to the other Party in connection with this Agreement.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Exclusive Spoken-Word Audio Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Exclusive Spoken-Word Audio Products\", \"text\": \"\\\"Exclusive Spoken-Word Audio Products\\\" means: (a) spoken-word audio-only products, in a format suitable for digital download and/or streaming, [***]\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Existing ACSI Product Section\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Existing ACSI Product Section\", \"text\": \"\\\"Existing ACSI Product Section\\\" means any ACSI Product Section identified on the ACSI Site Home Page as of the Effective Date, as shown in the screen shot attached as Exhibit A.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Home Page\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Home Page\", \"text\": \"\\\"Home Page\\\" means, with respect to a Web Site or section of a Web Site (e.g., any section of the ACSI Site primarily related to an ACSI Product Section or ACSI Product Sub-Section), the Web page designated by the operator of the Web Site as the initial and primary end user interface for such Web Site or section of a Web Site.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Internet Radio Service\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Internet Radio Service\", \"text\": \"\\\"Internet Radio Service\\\" means a service through which users may receive interactive or other broadcasts via the Internet or other public or private data networks.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Joint Work\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Joint Work\", \"text\": \"\\\"Joint Work\\\" means any content, data, URLs, domain names, technology, software, code, user interfaces, \\\"look and feel\\\" or other items which are invented, created, developed or first reduced to practice jointly by the Parties after the Effective Date, are protected or protectable by any Intellectual Property Rights and either: (a) include or incorporate both ACSI Existing Intellectual Property, ACSI Future Intellectual Property and/or ACSI Derivative Works, on the one hand, and/or Company Existing Intellectual Property, Company Future Intellectual Property and/or Company Derivative Works, on the other hand; or (b) include or incorporate no ACSI Existing Intellectual Property or ACSI Source: AUDIBLE INC, 10-Q, 11/13/2000 Derivative Works, on the one hand, or Company Existing Intellectual Property or Company Derivative Works, on the other hand; provided, however, that notwithstanding any other provision of this Agreement, to the extent that any such items incorporate in whole or in part any ACSI --------------- ***Confidential Information has been omitted and has been filed separately with the Securities and Exchange Commission. -4- Site Functionality or technology, software, code, user interfaces or \\\"look and feel\\\" related thereto or incorporated therein, such items shall be deemed ACSI Derivative Works in their entirety and not Joint Works or Company Intellectual Property.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Incentive Offer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Incentive Offer\", \"text\": \"\\\"Incentive Offer\\\" means either (a) a discount in the purchase price of Spoken-Word Audio Products offered for sale from or through the Spoken-Word Audio Sub-Section or (b) an equivalent benefit upon purchase of a Spoken-Word Audio Product from or through the Spoken-Word Audio Sub-Section.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Intellectual Property Right\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property Right\", \"text\": \"\\\"Intellectual Property Right\\\" means any patent, copyright, trademark, trade dress, trade name or trade secret right and any other intellectual property or proprietary right.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Launch Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Launch Date\", \"text\": \"\\\"Launch Date\\\" means the date on which the Parties mutually agree to launch the Spoken-Word Audio Sub-Section, but in any event no later than 90 days after the Effective Date.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Law\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Law\", \"text\": \"\\\"Law\\\" means any law, ordinance, rule, regulation, order, license, permit and other requirement, now or hereafter in effect, of any governmental authority of competent jurisdiction.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Mirror Company Site\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Mirror Company Site\", \"text\": \"\\\"Mirror Company Site\\\" means a \\\"mirrored\\\" version of that Web Site, the primary Home Page for which is identified by the URL www.audible.com (and any successor or replacement Web Site). The primary home page of the Mirror Company Site shall be identified by the URL www.amazon.audible.com (or such other URL as ---------------------- the Parties may agree upon).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Proration Percentage\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proration Percentage\", \"text\": \"\\\"Proration Percentage\\\" means, as of any date within the Refund Period, the following quantity, expressed as a percentage: (a) one (1); minus (b) the sum of: (i) the number of days of the Refund Period which have elapsed prior to such date; divided by (ii) the total number of days in the Refund Period.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Non-Exclusive Spoken-Word Audio Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Non-Exclusive Spoken-Word Audio Products\", \"text\": \"\\\"Non-Exclusive Spoken-Word Audio Products\\\" means spoken-word audio-only products, in a format suitable for digital download and/or streaming (excluding Exclusive Spoken-Word Audio Products and Related Products), [***]\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Receiving Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Receiving Party\", \"text\": \"\\\"Receiving Party\\\" means a Party that receives Confidential Information from the other Party in connection with this Agreement.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Referral Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Referral Information\", \"text\": \"\\\"Referral Information\\\" means any information disclosing that a specific end-user traveled from the ACSI Site to the Mirror Company Site or purchased any products through the Spoken-Word Audio Sub-Section (however obtained), or other personally-identifying information regarding users of the ACSI Site (including the Spoken-Word Audio Sub-Section).\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Refund Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Refund Period\", \"text\": \"\\\"Refund Period\\\" means the period of time from the date upon which Company makes the payment called for by Section 5.2.1 [Annual Fees] (or is deemed to have made such payment pursuant to Section 5.3 [Waiver of Payment Obligations]) until the end of Year 2.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Related Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Related Products\", \"text\": \"\\\"Related Products\\\" means: [***]\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Site\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Site\", \"text\": \"\\\"Site\\\" means either the ACSI Site, on the one hand, or the Mirror Company Site and Company Site collectively, on the other hand, as required by the context.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Spoken-Word Audio Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Spoken-Word Audio Products\", \"text\": \"\\\"Spoken-Word Audio Products\\\" means, collectively, Exclusive Spoken-Word Audio Products, Related Products and Non-Exclusive Spoken-Word Audio Products.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Spoken-Word Audio Sub-Section\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Spoken-Word Audio Sub-Section\", \"text\": \"\\\"Spoken-Word Audio Sub-Section\\\" means an ACSI Product Sub-Section, to be created pursuant to this Agreement, featuring Spoken-Word Audio Products (but subject to Section 9.2 with respect to Related Products) and which shall be identified on the ACSI Site by such heading as the Parties may agree upon.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"\\\"Term\\\" means the term of this Agreement as defined in Section 10.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Trademark\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademark\", \"text\": \"\\\"Trademark\\\" means any trademark, service mark, trade name, trade dress, proprietary logo or insignia or other source or business identifier.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Web Site\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Web Site\", \"text\": \"\\\"Web Site\\\" means any point of presence maintained on the Internet or on any other public or private data network. With respect to any Web Site maintained on the World Wide Web or any successor public data network, such Web Site includes all HTML pages (or similar unit of information presented in any relevant data protocol) that either (a) are identified by the same second-level domain (such as http://www.amazon.com) or by the same equivalent level identifier in any relevant address scheme, or (b) contain branding, graphics, navigation or other characteristics such that a user reasonably would conclude that the pages are part of an integrated information or service offering.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Year\", \"text\": \"\\\"Year\\\" means any period of twelve (12) consecutive months commencing on the Effective Date.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"value:fifty percent (50%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:twelve (12) consecutive months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) consecutive months\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:two (2) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) days\"}}, {\"id\": \"value:three (3) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) days\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:five (5) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) business days\"}}, {\"id\": \"value:one and one-half percent (1- 1/2%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one and one-half percent (1- 1/2%)\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"value:five percent (5%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"five percent (5%)\"}}, {\"id\": \"value:one hundred twenty (120) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred twenty (120) days\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of BELLRINGBRANDS,INC_02_07_2020-EX-10.18-MASTER SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of BELLRINGBRANDS,INC_02_07_2020-EX-10.18-MASTER SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.18\", \"level\": 1, \"text\": \"EXHIBIT 10.18 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH \\\"[***]\\\", HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. MASTER SUPPLY AGREEMENT THIS MASTER SUPPLY AGREEMENT (\\\"Agreement\\\") is made as of 31 October 2019 (\\\"Effective Date\\\") by and between Premier Nutrition Company, LLC, a Delaware limited liability company with its headquarters located at 1222 67th Street, Suite 210, Emeryville, CA 94608 (\\\"Buyer\\\" or \\\"PNC\\\"), and Fonterra (USA) Inc., a California corporation with its principal place of business located at 8700 W. Bryn Mawr Avenue, Suite 500N, Chicago, IL 60631 (\\\"Supplier\\\" or \\\"Fonterra\\\") (each a \\\"Party\\\", collectively \\\"Parties\\\"). WHEREAS PNC produces, distributes, markets and sells products including ready to drink protein shakes and beverages, powdered protein shakes, nutrition bars, and dietary supplements (the \\\"Finished Products\\\"); and WHEREAS Supplier produces raw materials including protein powders used by PNC to produce at least some of the Finished Products; NOW THEREFORE in consideration of their respective rights and obligations as set forth in this Agreement, and for other good and valuable consideration, the adequacy and receipt of which are acknowledged, PNC and Supplier agree as follows:\"}, {\"id\": \"1\", \"title\": \"Supply of Ingredients\", \"level\": 1, \"text\": \"1 Supply of Ingredients\"}, {\"id\": \"1.1\", \"title\": \"Supplier will provide such materials to PNC or its Third Party Manufacturers (\\\"TPMs\\\") as are specified in any Master Pur\", \"level\": 2, \"text\": \"1.1 Supplier will provide such materials to PNC or its Third Party Manufacturers (\\\"TPMs\\\") as are specified in any Master Purchase Commitment or any other purchase orders that the Parties may execute from time to time during the term of this Agreement (\\\"Ingredients\\\"). Ingredients will be produced at Supplier's facilities listed in a Master Purchase Commitment, or any other of Supplier's facilities approved in advance, in writing by PNC.\"}, {\"id\": \"1.2\", \"title\": \"PNC or its TPMs will place specific orders for Ingredients from Supplier by issuing a purchase order that specifies, at\", \"level\": 2, \"text\": \"1.2 PNC or its TPMs will place specific orders for Ingredients from Supplier by issuing a purchase order that specifies, at minimum, the item, quantities, price, delivery dates, and delivery and payment terms (each a \\\"Purchase Order\\\").\"}, {\"id\": \"1.3\", \"title\": \"PNC and Supplier may enter certain Master Purchase Commitments from time to time during the Term of this Master Supply A\", \"level\": 2, \"text\": \"1.3 PNC and Supplier may enter certain Master Purchase Commitments from time to time during the Term of this Master Supply Agreement. Such Master Purchase Commitments and any Purchase Orders issued against such Commitments shall be subject exclusively to the terms and conditions of this Agreement. In the event the terms of any Master Purchase Commitment conflicts with the terms of this Agreement, the terms of the Master Purchase Commitment shall control.\"}, {\"id\": \"1.4\", \"title\": \"Supplier will receive Purchase Orders by telephone, USPS, overnight courier, email, and fax transmission, Monday through\", \"level\": 2, \"text\": \"1.4 Supplier will receive Purchase Orders by telephone, USPS, overnight courier, email, and fax transmission, Monday through Friday except on state or nationally recognized bank holidays. Purchase Orders not received by 3:00 p.m. Eastern Time are considered to be received on the following Page 1 business day. Supplier will confirm or reject Purchase Orders within [***] of receipt of the Purchase Order. Orders not rejected in writing within such time will be deemed confirmed and accepted by Supplier. Each Purchase Order issued by PNC or its TPMs and accepted by Supplier shall be governed by the terms and conditions of this Agreement. Additional terms included in acknowledgments, standard terms and conditions, or any other documents or communications exchanged by the Parties in connection with the sale or purchase of any Ingredients shall be void and of no force or effect. The Parties may only modify, add to or amend any of the terms or conditions of this Agreement by a writing signed by authorized representatives of both Parties.\"}, {\"id\": \"1.5\", \"title\": \"Supplier represents and warrants that at the time and date of delivery, the Ingredients will comply with all specificati\", \"level\": 2, \"text\": \"1.5 Supplier represents and warrants that at the time and date of delivery, the Ingredients will comply with all specifications (\\\"Specifications\\\"), a copy of which will be attached to the relevant Master Purchase Commitment or Purchase Order accordingly. A Specification may be updated from time to time by PNC in its sole discretion, provided PNC provides Supplier with reasonable prior notice on any updates (\\\"Change Notification\\\"). Within [***] from receipt of the Change Notification, Supplier will either: (1) accept the Specification change at the current price and terms; or (2) submit to PNC a proposal (\\\"Proposal\\\") setting forth the conditions of acceptance that may include a change in price and/or other terms, including documentation to support same. Within [***] the Parties will discuss the Proposal in good faith and exercise their best efforts to agree on the appropriate adjustment if any. PNC will not issue any Purchase Orders, nor be required to issue any Purchase Orders to Supplier until PNC and Supplier have agreed on required Ingredient Specifications and any associated price and/or term adjustment. In the event the Parties fail to agree on required Ingredient Specifications or price and/or term adjustments despite their best good faith efforts, neither Party will have any further obligation with regard to purchase or supply of those Ingredients under any Master Purchase Commitments except that PNC shall take and pay for [***] of Ingredient inventory manufactured according to the then-current Specification.\"}, {\"id\": \"1.6\", \"title\": \"Supplier will provide a Certificate of Analysis (\\\"COA\\\") completed in accordance with the Specifications with any shipmen\", \"level\": 2, \"text\": \"1.6 Supplier will provide a Certificate of Analysis (\\\"COA\\\") completed in accordance with the Specifications with any shipment of Ingredients.\"}, {\"id\": \"1.7\", \"title\": \"INTENTIONALLY LEFT BLANK\", \"level\": 2, \"text\": \"1.7 INTENTIONALLY LEFT BLANK\"}, {\"id\": \"1.8\", \"title\": \"This Agreement is nonexclusive and sets forth the terms and conditions under which the Parties will supply and purchase\", \"level\": 2, \"text\": \"1.8 This Agreement is nonexclusive and sets forth the terms and conditions under which the Parties will supply and purchase Ingredients from the other Party. Nothing herein is intended to, nor does, guarantee that either Party will supply or purchase any specific, item, in any specific quantity, or conclude any business transaction with the other.\"}, {\"id\": \"1.9\", \"title\": \"Supplier Performance metrics will be identified and tracked periodically through Supplier Performance Review meetings no\", \"level\": 2, \"text\": \"1.9 Supplier Performance metrics will be identified and tracked periodically through Supplier Performance Review meetings no more frequently than each calendar quarter during the Term. [***] Metric targets will be established by PNC and agreed by Fonterra and updated as needed. The ultimate goal is zero defects for quality and administrative compliance issues.\"}, {\"id\": \"1.10\", \"title\": \"Supplier agrees to make a good faith effort to provide Advance Ship Notices (\\\"ASN\\\") with bar-coded pallet labels; Invoic\", \"level\": 2, \"text\": \"1.10 Supplier agrees to make a good faith effort to provide Advance Ship Notices (\\\"ASN\\\") with bar-coded pallet labels; Invoices, Purchase Orders and other business transactions, as may be advised by PNC, for each Ingredient shipment. Supplier will provide, itself or through a third-party provider, the information via Electronic Data Interface (\\\"EDI\\\") if and as requested by PNC. The technical specifications for all required EDI transactions will be provided by PNC. 2\"}, {\"id\": \"2\", \"title\": \"Quality and Food Safety\", \"level\": 1, \"text\": \"2 Quality and Food Safety\"}, {\"id\": \"2.1\", \"title\": \"For the purposes set forth in Section 303(c) of the Federal Food, Drug, and Cosmetic Act (the \\\"Act\\\"), Supplier guarantee\", \"level\": 2, \"text\": \"2.1 For the purposes set forth in Section 303(c) of the Federal Food, Drug, and Cosmetic Act (the \\\"Act\\\"), Supplier guarantees to PNC that as of the time and date of delivery, all Ingredients will not be adulterated or misbranded within the meaning of the Act, nor will any Ingredients constitute an article that may not, under the provisions of Sections 404 and 505 of the Act, be introduced into interstate commerce. The Supplier further guarantees that as of the time and date of delivery, all of the Ingredients will be in compliance with all applicable laws, regulations, requirements and programs including those administered by the Food and Drug Administration (the \\\"FDA\\\"), the United States Department of Agriculture (the \\\"USDA\\\") and any state or local food or drug laws then in effect. This guarantee specifically includes Proposition 65 (California Safe Drinking Water and Toxic Enforcement Act), and Supplier hereby certifies that the Ingredients will not contain any non-naturally occurring chemicals subject to Proposition 65 or that any such chemicals pose \\\"no significant risk\\\" or cause \\\"no observable effect\\\" as set forth in the California Health and Safety Code, 22 CCR \u00a7\u00a7 12701 et seq. and 22 CCR \u00a7\u00a7 12801 et seq., as amended. Supplier shall comply with all applicable regulatory requirements for determining and documenting that all Ingredients are at or below no significant risk levels and no observable effect levels, as applicable.\"}, {\"id\": \"2.2\", \"title\": \"Supplier shall develop and maintain a food safety/food defense program as required under the Food Safety Modernization A\", \"level\": 2, \"text\": \"2.2 Supplier shall develop and maintain a food safety/food defense program as required under the Food Safety Modernization Act 21 USC \u00a7301 et seq and shall submit a copy of such plan (and any changes thereto) to PNC upon PNC's request. Supplier will conduct [***] third-party food safety/food defense audits (the \\\"Audits\\\") in compliance with, and consistent with, relevant audit schemes approved by the Global Food Safety Initiatives, AIB International, Silliker, or GMA SAFE. Supplier will submit summaries of audit reports to PNC's Quality Manager at [***] upon request. Failure to comply with the requirements of this Section 2.2 will constitute a material breach of this Agreement.\"}, {\"id\": \"2.3\", \"title\": \"Supplier will notify PNC immediately, by person-to-person voice communication or equivalent means, if any of the Ingredi\", \"level\": 2, \"text\": \"2.3 Supplier will notify PNC immediately, by person-to-person voice communication or equivalent means, if any of the Ingredients contain, or are reasonably suspected to contain, material hazardous to human health, including but not limited to, chemical, physical or biological hazards.\"}, {\"id\": \"2.4\", \"title\": \"PNC shall notify Supplier in writing if it determines any Ingredient fails to meet the Specifications\", \"level\": 2, \"text\": \"2.4 PNC shall notify Supplier in writing if it determines any Ingredient fails to meet the Specifications. Supplier shall be given an opportunity to and will promptly inspect and/or test such Ingredients to confirm compliance to Specification. If after any reasonable, good faith inspection and testing it is confirmed that certain Ingredients fail to meet the Specifications [***].\"}, {\"id\": \"2.5\", \"title\": \"Subject to the occurring of a Force Majeure Event, if Supplier fails to deliver the Ingredients in accordance with the S\", \"level\": 2, \"text\": \"2.5 Subject to the occurring of a Force Majeure Event, if Supplier fails to deliver the Ingredients in accordance with the Specifications, including within the time specified on the Purchase Order, in addition to any other remedies available, PNC may terminate the Purchase Order in whole or in part. In the event of such a termination, Supplier shall continue performance of any nonterminated portion of the Purchase Order, or any nonterminated Purchase Orders, and the quantity of Ingredient ordered and so terminated shall be deducted against any relevant Master Purchase Commitment.\"}, {\"id\": \"2.6\", \"title\": \"PNC or its contracted third-party auditors may enter and audit/inspect Supplier's facilities where the Ingredients are p\", \"level\": 2, \"text\": \"2.6 PNC or its contracted third-party auditors may enter and audit/inspect Supplier's facilities where the Ingredients are produced, stored, packaged or otherwise processed [***] unless food safety is at issue or PNC has a good faith reason to believe the Ingredients are being stored, packaged, or processed 3 in a way that is inconsistent with the Specifications, in which case an audit may be performed at any time during the Term. For routine visits and audits, PNC will provide [***] if facilities located in the US and with [***] if facilities are located [***], provided that such examination will be conducted during Supplier's normal business hours and in such a manner as to reasonably minimize disruption to Supplier's business, unless food safety is at issue, in which case such examination may be conducted at any time. Supplier shall cooperate in good faith with PNC during all such inspections. During qualification processes and on-site inspections, Supplier will present necessary documentation to ensure compliance with all applicable programs specified under 21 CFR Part 117 Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventative Controls for Human Food. Records of environmental monitoring activities by the Supplier, following Supplier's established environmental monitoring program and standard operating procedures will be made available upon request to PNC. Supplier will notify Buyer immediately via person-to- person voice communication in the event that any pathogen is found, or reasonably suspected, in the plant environment during any environmental monitoring activity that could have an impact on the quality or safety of PNC's Ingredients. In the event of an actual or suspected food safety concern, Supplier shall conduct sampling in all relevant areas and promptly provide results of such tests to PNC. If PNC or its representatives find that any of Supplier's facilities, processes, inventory, procedures or equipment are not in accordance or compliance with the requirements of this Agreement or applicable law or regulation, PNC will give notice to Supplier, and Supplier shall promptly take all reasonable steps to correct such deficiency as soon as possible. If correction of the deficiency cannot be affected within [***] of such notice, then Supplier shall promptly notify PNC with its plan to correct the deficiency including an estimated schedule. If the deficiency cannot be corrected within [***], unless otherwise agreed, then PNC shall have the right to terminate any Purchase Orders then outstanding, along with any Master Purchase Commitment related thereto.\"}, {\"id\": \"3\", \"title\": \"Business Continuity/Continuous Supply Assurances\", \"level\": 1, \"text\": \"3 Business Continuity/Continuous Supply Assurances. Supplier will develop and maintain a business continuity plan that identifies critical pathways and potential crisis situations that could interrupt the supply of Ingredients to PNC and establish contingency plans for dealing with each crisis situation. Upon PNC's written request, Supplier will submit the business continuity plan to PNC for PNC's review.\"}, {\"id\": \"4\", \"title\": \"Intellectual Property\", \"level\": 1, \"text\": \"4 Intellectual Property. 4.1 Each Party shall retain ownership of all Intellectual Property Rights (as defined below): (1) owned or licensed by that Party prior to the commencement date of this Agreement; or (2) developed or acquired independently of this Agreement by that Party or its licensors other than in connection with this Agreement. 4.2 Ownership in the Intellectual Property Rights, if any, of any developments and/or modifications to the Ingredients during the Term shall be [***]. 4.3 For purposes of this Section 4, the term \\\"Intellectual Property Rights\\\" shall mean all statutory, common law and proprietary intellectual property rights, including rights in know-how, confidential information, copyright works, designs, inventions, patents, plant varieties, trademarks and all other rights, whether registered or unregistered (including applications for such rights).\"}, {\"id\": \"5\", \"title\": \"Confidential Information\", \"level\": 1, \"text\": \"5 Confidential Information. \\\"Confidential Information\\\" means all business, financial and technical information of the Parties, or of a third- party as to whom a Party has an obligation of confidentiality, whether disclosed before or after the Effective Date and whether disclosed in writing, orally, by electronic delivery, or by inspection of tangible objects. Confidential Information includes, without limitation, trade secrets, ideas, 4 processes, formulae (including formula and specifications for Ingredients and Finished Products), computer software (including source code), algorithms, data, data structures, know-how, copyrightable material, improvements, inventions (whether or not patentable), techniques, strategies, business and product development plans, timetables, forecasts, customer and supplier information, and information relating to product designs, specifications and schematics, product costs, product prices, product names, financial information, marketing plans, business opportunities, personnel, research, development and know-how. Confidential Information includes that which is marked or otherwise identified as confidential, as well as that which by its nature and the circumstances of its disclosure are reasonably understood to be confidential.\"}, {\"id\": \"5.1\", \"title\": \"Maintenance of Confidentiality and Limitations on Use\", \"level\": 2, \"text\": \"5.1 Maintenance of Confidentiality and Limitations on Use. Each Party will hold in strict confidence and keep confidential all Confidential Information disclosed to it by the other. The Parties will use at least the same degree of care to avoid publication or dissemination of such Confidential Information as it uses with respect to similarly confidential information of its own, but in no event less than reasonable care. Use of such Confidential Information by such Party will be strictly limited to activities directly in support of its activities under this Agreement. The Parties will disclose such Confidential Information on a need-to-know basis only, and in all events only to such employees and independent contractors who are informed of the confidential nature of the Confidential Information and are bound by obligations substantially similar to those set forth herein applicable to such Confidential Information. Each Party hereby guarantees the performance of the provisions hereof by each person obtaining disclosure of such Confidential Information directly or indirectly from such Party.\"}, {\"id\": \"5.2\", \"title\": \"Copying and Return of Confidential Information\", \"level\": 2, \"text\": \"5.2 Copying and Return of Confidential Information. Each Party shall not make any copies or extracts of Confidential Information, or include such Confidential Information in its own materials except as reasonably required directly in support of its activities under this Agreement. When a Party no longer has need thereof in support of its activities under this Agreement or upon request of the other Party, whichever occurs first, such Party shall promptly cease using and shall return or destroy (and, if requested, certify destruction of) all such Confidential Information along with all tangible and electronic copies which it may have made, provided, however, that a Party is not obligated to remove Confidential Information from back up devices that have been made and are maintained in accordance with a corporate records retention policy.\"}, {\"id\": \"5.3\", \"title\": \"Certain Exceptions\", \"level\": 2, \"text\": \"5.3 Certain Exceptions. Information will not be, or will cease being, Confidential Information, as the case may be, if Supplier can show:\"}, {\"id\": \"5.3.1\", \"title\": \"that such information entered the public domain other than by breach of this Agreement on the part of any Party obligate\", \"level\": 3, \"text\": \"5.3.1 that such information entered the public domain other than by breach of this Agreement on the part of any Party obligated to confidentiality hereunder; 5.3.2 it is rightfully known to the receiving Party without obligation of confidentiality to any third-party prior to receipt of same from the disclosing Party as evidenced by bona fide written, dated documents; 5.3.3 it is independently developed by personnel of the receiving Party who have not had access to Confidential Information of the disclosing Party; and, 5.3.4 that it is generally made available to third-parties by the disclosing Party without obligation of confidentiality.\"}, {\"id\": \"5.4\", \"title\": \"Legally Required Disclosure\", \"level\": 2, \"text\": \"5.4 Legally Required Disclosure. A Party shall not be in breach hereof if it discloses Confidential Information pursuant to a judicial or governmental order, or as required by applicable law or the rules 5 of a recognized stock exchange, but any such disclosure shall be made only to the extent so ordered or required. In any such event, the Party (i) shall timely notify the other Party so that it may intervene in response to such order or take action to protect its interests (in which event such Party will cooperate in such effort), or (ii) if timely notice cannot be given, shall seek to obtain a protective order or confidential treatment from the court or government for such information.\"}, {\"id\": \"5.5\", \"title\": \"Defend Trade Secrets Act\", \"level\": 2, \"text\": \"5.5 Defend Trade Secrets Act. Notwithstanding anything in this agreement to the contrary, a receiving Party is hereby notified in accordance with the US Defend Trade Secrets Act of 2016 that it will not be held criminally or civilly liable under any US federal or state trade secret law for the disclosure of a trade secret that: (x) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (y) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding.\"}, {\"id\": \"5.6\", \"title\": \"Trading in Securities\", \"level\": 2, \"text\": \"5.6 Trading in Securities. Supplier acknowledges that it is aware, and agrees to advise its directors, officers, employees, agents and representatives who are informed as to the matters which are the subject of this Agreement, that the United States securities laws prohibit any person who has material, non-public information concerning PNC, its parent and affiliate companies including BellRing Brands, Inc. and Post Holdings, Inc. from purchasing or selling securities of those companies or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities.\"}, {\"id\": \"5.7\", \"title\": \"Title\", \"level\": 2, \"text\": \"5.7 Title. As between the Parties, title or right to possess Confidential Information of PNC, except as otherwise provided herein, shall remain in PNC. Nothing in this Agreement shall be construed as granting or conferring any rights to any Confidential Information, except as otherwise explicitly stated in this Agreement.\"}, {\"id\": \"5.8\", \"title\": \"No Representation or Warranty\", \"level\": 2, \"text\": \"5.8 No Representation or Warranty. Except as expressly set forth herein, neither Party makes any representations or warranties of any nature whatsoever with respect to any Confidential Information it may provide, including, without limitation, any warranties of merchantability, fitness for a particular purpose or accuracy. All Confidential Information is provided on an \\\"as-is\\\" basis, and the recipient assumes all responsibility for its use thereof or reliance thereon. Further, each Party understands and acknowledges that any confidential information received from the other Party concerning future plans may be tentative and may not represent firm decisions concerning such plans, and neither Party shall be liable to the other Party for inaccuracies in Confidential Information under any theory of liability.\"}, {\"id\": \"6\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"6 Term and Termination.\"}, {\"id\": \"6.1\", \"title\": \"This Agreement will commence on the Effective Date and continue for an Initial Term of five (5) years, and will automati\", \"level\": 2, \"text\": \"6.1 This Agreement will commence on the Effective Date and continue for an Initial Term of five (5) years, and will automatically renew for additional periods of five (5) years unless one Party notifies the other of its intention not to renew, no less than 12 months prior to the expiration of the then-current term, unless terminated as permitted under this Agreement.\"}, {\"id\": \"6.2\", \"title\": \"Either Party may terminate this Agreement for cause if the other Party fails to perform any material provision of this A\", \"level\": 2, \"text\": \"6.2 Either Party may terminate this Agreement for cause if the other Party fails to perform any material provision of this Agreement or commits a material breach of this Agreement which is not corrected within [***] after receiving written notice of the failure or breach. except that if the default is by 6 Supplier that creates an immediate public food safety risk, PNC may terminate this Agreement immediately without regard to any period for correction.\"}, {\"id\": \"6.3\", \"title\": \"This Agreement will automatically terminate if either Party becomes insolvent or files a petition in bankruptcy, if a Pa\", \"level\": 2, \"text\": \"6.3 This Agreement will automatically terminate if either Party becomes insolvent or files a petition in bankruptcy, if a Party makes an assignment for the benefit of a creditor, if a receiver is appointed to take possession of any part of a Party's assets or if a Party becomes unable generally to pay its debts as they become due, or otherwise ceases to do business.\"}, {\"id\": \"6.4\", \"title\": \"On the termination of this Agreement for any reason, all rights granted to Supplier under this Agreement will immediatel\", \"level\": 2, \"text\": \"6.4 On the termination of this Agreement for any reason, all rights granted to Supplier under this Agreement will immediately cease, and Supplier must deliver to PNC all written or recorded materials relating to the Confidential Information of PNC in the possession or control of Supplier or any of its related party, subject to Section 5.2.\"}, {\"id\": \"7.2\", \"title\": \"Except for a Party's gross negligence or intentional acts or omissions and its obligations of indemnity under this Agree\", \"level\": 2, \"text\": \"7.2 Except for a Party's gross negligence or intentional acts or omissions and its obligations of indemnity under this Agreement, under no circumstances will either Party be liable to the other Party for [***].\"}, {\"id\": \"7.3\", \"title\": \"Supplier agrees to indemnify and hold PNC harmless from any and all employment-related claims, payments, entitlements, t\", \"level\": 2, \"text\": \"7.3 Supplier agrees to indemnify and hold PNC harmless from any and all employment-related claims, payments, entitlements, taxes, interest and penalties assessed against or obtained from PNC by any individual or authority as a consequence of or related to the performance by any agent or employee of Supplier.\"}, {\"id\": \"7.4\", \"title\": \"Supplier shall maintain insurance with an insurance company with an equivalent of an A\", \"level\": 2, \"text\": \"7.4 Supplier shall maintain insurance with an insurance company with an equivalent of an A.M. Best rating of \\\"A\\\" or better, of the following kinds and in the following amounts during the term of this Agreement: 7.5 7.5.1 Comprehensive General Liability (CGL) Insurance with limits of not less than [***] each occurrence and [***] in the aggregate, including Contractual, Completed-Operations and 7 Product-Liability Coverage's with limits of not less than [***] for each occurrence, covering both bodily injury and property damage liability. 7.5.2 Umbrella/Excess Liability with limits of not less than [***]. 7.5.3 Workers' Compensation Coverage plus Occupational Disease Insurance if Occupational Disease coverage is required by the laws of the state where the Facility is located or work is to be performed. Employers Liability $500,000 each accident 7.5.4 Auto Liability $1,000,000 combined single limit.\"}, {\"id\": \"7.6\", \"title\": \"Supplier shall have Buyer named as an additional insured on its insurance policies in subparts 7\", \"level\": 2, \"text\": \"7.6 Supplier shall have Buyer named as an additional insured on its insurance policies in subparts 7.5.1 and 7.5.2 above. Supplier shall furnish Buyer with a certificate from its insurer verifying that it has the above insurance in effect during the duration of this Agreement and that insurer acknowledges (a) the contractual liability assumed by Supplier in this Agreement and (b) that Buyer is an additional insured on such policies and (c) Supplier's CGL policy is primary and Buyer's CGL policy is non-contributory and (d) a waiver of subrogation shall be provided in favor of Buyer on the CGL, Workers' Compensation and Auto policies. Said certificate of insurance shall require Supplier's insurance carrier to give Buyer no less than ten (10) days written notice of any cancellation or change in coverage. Failure to secure such insurance as of the date of execution of this Agreement shall constitute a breach of this Agreement. Supplier shall provide to PNC a certificate evidencing such insurance within thirty (30) days of a request for same from PNC.\"}, {\"id\": \"7.7\", \"title\": \"Supplier shall, at its own expense, maintain throughout the term of this Agreement, all insurance required by law or reg\", \"level\": 2, \"text\": \"7.7 Supplier shall, at its own expense, maintain throughout the term of this Agreement, all insurance required by law or regulation in all countries in which this Agreement will be performed.\"}, {\"id\": \"8\", \"title\": \"Recall\", \"level\": 1, \"text\": \"8 Recall. If Ingredients provided by Supplier under this Agreement are misbranded, contaminated, or otherwise unfit for human consumption at the time they are delivered to PNC or its TPM (\\\"Defect\\\"), PNC in its sole discretion will make a determination of the necessity of a recall, market withdrawal, inventory retrieval, or other action designed to prevent the distribution or sale of the affected Finished Products, plus the type, extent, method of handling, disposition of the Finished Products as well as any affected work in progress, and all other particulars involved in such an action (a \\\"Recall\\\"), and PNC will execute any Recall. Supplier, in its sole discretion, will make a determination of the necessity of a recall, market withdrawal, inventory retrieval or other action designed to prevent the distribution or sale of the Ingredients. Subject to Section 9.1, Supplier shall bear the complete responsibility for a Recall occasioned by a Defect in the Ingredient and shall indemnify PNC for [***] resulting from or related to the Recall. Any Recall occasioned by PNC labels or by tampering with the Ingredients after they have left Supplier's control, or by improper storing or handling by PNC, will not be considered a Defect.\"}, {\"id\": \"9\", \"title\": \"Limitation of Liability\", \"level\": 1, \"text\": \"9 Limitation of Liability.\"}, {\"id\": \"9.1\", \"title\": \"The maximum liability of one Party to the other Party and its affiliates in relation to this Agreement will be [***] (\\\"L\", \"level\": 2, \"text\": \"9.1 The maximum liability of one Party to the other Party and its affiliates in relation to this Agreement will be [***] (\\\"Liability Cap\\\"), provided however that: 8\"}, {\"id\": \"9.1.1\", \"title\": \"The Liability Cap will not apply to any (1) material confidentiality breach under Section 5, and/or (2) indemnification\", \"level\": 3, \"text\": \"9.1.1 The Liability Cap will not apply to any (1) material confidentiality breach under Section 5, and/or (2) indemnification obligations under Section 7.1. 9.1.2 The Liability Cap will not apply to intentional misconduct and/or gross negligence.\"}, {\"id\": \"9.2\", \"title\": \"For the purpose of this Section, \\\"liability\\\" means liability for any and all claims, causes of action, judgments, costs\", \"level\": 2, \"text\": \"9.2 For the purpose of this Section, \\\"liability\\\" means liability for any and all claims, causes of action, judgments, costs and expenses (including but not limited to reasonable attorney fees and expenses), reimbursements, losses, and any and all other liabilities and damages of any kind, whether in contract, tort (including negligence), equity, statute or otherwise arising out of, in relation to or as a result of this Agreement.\"}, {\"id\": \"10\", \"title\": \"Force Majeure\", \"level\": 1, \"text\": \"10 Force Majeure.\"}, {\"id\": \"10.1\", \"title\": \"Neither Party will be liable for any breach of its obligations under this Agreement resulting from causes beyond its rea\", \"level\": 2, \"text\": \"10.1 Neither Party will be liable for any breach of its obligations under this Agreement resulting from causes beyond its reasonable control, including, but not limited to, an act of nature, drought, outbreak of foot and mouth disease, port and other transport strikes, war, fires, quarantine restrictions, insurrections or riots, energy shortages, embargo or the inability to obtain supplies or raw materials because of a global shortage or governmental action (a \\\"Force Majeure Event\\\"). Notwithstanding anything herein to the contrary, in the event of a Force Majeure Event, or any other circumstance that limits Fonterra's ability to produce or deliver product, Supplier will exercise its best efforts to comply with its obligations hereunder, mitigate the adverse impact on and not disfavor PNC, and will treat it in parity with its other customers.\"}, {\"id\": \"10.2\", \"title\": \"Any obligation of either Party under this Agreement will be postponed until the cause underlying the Force Majeure Event\", \"level\": 2, \"text\": \"10.2 Any obligation of either Party under this Agreement will be postponed until the cause underlying the Force Majeure Event has been eliminated, at which time the obligation will again be in effect. Any loss of time by the Force Majeure Event will not be held against the Party who was unable to comply with its obligations under this Agreement because of the Force Majeure Event. The Party unable to comply with its obligations under this Agreement will immediately notify the other Party in writing that a Force Majeure Event has delayed its performance and will state, to the best of its knowledge, the revised date for performance. If a Force Majeure Event persists for longer than [***], the Party not directly affected by the Force Majeure Event may terminate this Agreement with regard to any relevant Master Purchase Commitments or Purchase Orders.\"}, {\"id\": \"10.3\", \"title\": \"Should Supplier be unable to comply with its obligations under this Agreement because of a Force Majeure Event, PNC may\", \"level\": 2, \"text\": \"10.3 Should Supplier be unable to comply with its obligations under this Agreement because of a Force Majeure Event, PNC may obtain elsewhere the Ingredients the Supplier was unable to deliver because of the Force Majeure Event and those Ingredients will be credited against any relevant Minimum Purchase Commitment. PNC will not be obligated to purchase those Ingredients from Supplier at a later time.\"}, {\"id\": \"11\", \"title\": \"Notices\", \"level\": 1, \"text\": \"11 Notices. Notices contemplated by this Agreement must be in writing and may be sent by registered or certified mail, postage prepaid, to the address specified in the first paragraph of this Agreement or to any other address designated by prior written notice.\"}, {\"id\": \"12\", \"title\": \"Governing Law; Dispute Resolution\", \"level\": 1, \"text\": \"12 Governing Law; Dispute Resolution. 9\"}, {\"id\": \"12.1\", \"title\": \"This Agreement will be governed by the laws of the State of Delaware without regard to its conflicts of law principles\", \"level\": 2, \"text\": \"12.1 This Agreement will be governed by the laws of the State of Delaware without regard to its conflicts of law principles.\"}, {\"id\": \"12.2\", \"title\": \"The Parties consent to, acknowledge, and agree that any dispute arising out of or relating to this Agreement, including\", \"level\": 2, \"text\": \"12.2 The Parties consent to, acknowledge, and agree that any dispute arising out of or relating to this Agreement, including the breach, termination or validity thereof, shall be brought exclusively before the state and federal courts in and for the City of Wilmington and County of New Castle, Delaware Each Party waives any objection based on forum non conveniens.\"}, {\"id\": \"13\", \"title\": \"Assignment\", \"level\": 1, \"text\": \"13 Assignment. Neither Party may transfer or assign any of its rights or obligations under this Agreement without the prior written consent of the other Party, except that either Party may assign this Agreement to any entity controlled by it, its parents, subsidiaries, or affiliates, or to any purchaser of the business to which this Agreement relates subject to the other Parties consent which will not be unreasonably withheld or delayed.\"}, {\"id\": \"14\", \"title\": \"Supplier Conduct\", \"level\": 1, \"text\": \"14 Supplier Conduct. Supplier agrees to engage in responsible and ethical business practices and conduct itself in full compliance with all applicable laws, rules, and regulations in every country in which it does business.\"}, {\"id\": \"15\", \"title\": \"California Transparency Act\", \"level\": 1, \"text\": \"15 California Transparency Act. PNC does not accept or support the use of illegal, abusive, or forced labor in our own facilities. Within its supply chain, Supplier will comply with all laws of the country they are doing business in and are subject to.\"}, {\"id\": \"17\", \"title\": \"Fair Labor Practices\", \"level\": 1, \"text\": \"17 Fair Labor Practices.\"}, {\"id\": \"17.1\", \"title\": \"Supplier shall provide workers with clean, safe and healthy work environments; recognize and respect the right of employ\", \"level\": 2, \"text\": \"17.1 Supplier shall provide workers with clean, safe and healthy work environments; recognize and respect the right of employees to free association and collective bargaining in accordance with law; comply with all applicable wage and hour laws; and properly verify the employment eligibility of its employees.\"}, {\"id\": \"17.2\", \"title\": \"Forced Labor\", \"level\": 2, \"text\": \"17.2 Forced Labor. Suppliers will not employ, use or otherwise benefit from involuntary labor, forced labor, or labor that results from slavery or human trafficking. Supplier hereby certifies that: (i) it is in compliance with this paragraph; and (ii) all materials incorporated into its products comply with all applicable laws addressing slavery, human trafficking and other forms of forced labor. Supplier shall provide PNC with documentation establishing compliance with this paragraph upon [***] notice. 10\"}, {\"id\": \"17.3\", \"title\": \"Child Labor\", \"level\": 2, \"text\": \"17.3 Child Labor. Supplier will not employ anyone under the legal working age defined by local law. Supplier will comply with all applicable laws addressing the working requirements and conditions for child workers.\"}, {\"id\": \"17.4\", \"title\": \"Respectful Workplace\", \"level\": 2, \"text\": \"17.4 Respectful Workplace. Supplier shall prohibit all forms of unlawful discrimination, abuse, harassment, violence and retaliation.\"}, {\"id\": \"18\", \"title\": \"Gifts and Entertainment\", \"level\": 1, \"text\": \"18 Gifts and Entertainment. Supplier will not offer any gift to a PNC employee, contractor, or agent that is: (i) more than a nominal value; (ii) more than an infrequent occurrence; (iii) cash or cash equivalents; or (iv) illegal, sexually oriented, offensive or otherwise inappropriate.\"}, {\"id\": \"19\", \"title\": \"Environment & Sustainability\", \"level\": 1, \"text\": \"19 Environment & Sustainability. Supplier will comply with all applicable environmental laws and reporting obligations, maintain all required permits, and strive to responsibly manage the impacts of their operations on the environment.\"}, {\"id\": \"20\", \"title\": \"Anticorruption\", \"level\": 1, \"text\": \"20 Anticorruption. Suppliers will not, directly or indirectly, offer improper gifts to government employees, engage in bribery or fraud, or take any other action that would cause a violation of the U.S. Foreign Corrupt Practices Act, the UK Bribery Act or any other applicable anti- corruption law.\"}, {\"id\": \"21\", \"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"21 Miscellaneous.\"}, {\"id\": \"21.1\", \"title\": \"If any provision of this Agreement is determined to be illegal or unenforceable, all other provisions will continue in f\", \"level\": 2, \"text\": \"21.1 If any provision of this Agreement is determined to be illegal or unenforceable, all other provisions will continue in full force and effect.\"}, {\"id\": \"21.2\", \"title\": \"This Agreement may be executed concurrently by original or facsimile signature in counterparts, each of which will be de\", \"level\": 2, \"text\": \"21.2 This Agreement may be executed concurrently by original or facsimile signature in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.\"}, {\"id\": \"21.3\", \"title\": \"Each right and remedy of each Party described in this Agreement is cumulative and in addition to every other right or re\", \"level\": 2, \"text\": \"21.3 Each right and remedy of each Party described in this Agreement is cumulative and in addition to every other right or remedy, express or implied, now or hereafter arising, available to such Party, at law or in equity, or under any other agreement. No delay or omission by either Party in the exercise of any right or remedy arising under this Agreement will impair any such right or remedy or the right of such Party to resort thereto at a later date or be construed to be a waiver of any default under this Agreement. The indemnities, representations and warranties of each Party will survive termination of this Agreement.\"}, {\"id\": \"21.4\", \"title\": \"This Agreement, together with any schedules and exhibits and any Purchase Orders, Specifications and COAs, constitutes t\", \"level\": 2, \"text\": \"21.4 This Agreement, together with any schedules and exhibits and any Purchase Orders, Specifications and COAs, constitutes the complete agreement between the Parties and supersedes all prior agreements between the Parties regarding this subject matter. The Parties hereby agree that any such prior agreements are hereby terminated. No other contracts, warranties, promises or representations, either oral or in writing, relating to this Agreement will bind either Party except for the Purchase Orders, Specifications and COAs. This Agreement may not be amended or modified except by a writing signed by an authorized representative of the Party against whom such amendment or modification is asserted. This Agreement will be binding upon, and will inure to the benefit of, the parties, their successors and permitted assigns. (signature page follows) 11 Agreed to and executed effective as of the date first above written. Fonterra (USA) Inc. Premier Nutrition Company, LLC By: [***] By: /s/ Paul Rode Title: President Title: CFO 12 Agreed to and executed effective as of the date first above written. Fonterra (USA) Inc. Premier Nutrition Company, LLC By: By: /s/ Paul Rode Title: Title: CFO\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of BELLRINGBRANDS,INC_02_07_2020-EX-10.18-MASTER SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.18\", \"level\": 1, \"text\": \"EXHIBIT 10.18 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED WITH \\\"[***]\\\", HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. MASTER SUPPLY AGREEMENT THIS MASTER SUPPLY AGREEMENT (\\\"Agreement\\\") is made as of 31 October 2019 (\\\"Effective Date\\\") by and between Premier Nutrition Company, LLC, a Delaware limited liability company with its headquarters located at 1222 67th Street, Suite 210, Emeryville, CA 94608 (\\\"Buyer\\\" or \\\"PNC\\\"), and Fonterra (USA) Inc., a California corporation with its principal place of business located at 8700 W. Bryn Mawr Avenue, Suite 500N, Chicago, IL 60631 (\\\"Supplier\\\" or \\\"Fonterra\\\") (each a \\\"Party\\\", collectively \\\"Parties\\\"). WHEREAS PNC produces, distributes, markets and sells products including ready to drink protein shakes and beverages, powdered protein shakes, nutrition bars, and dietary supplements (the \\\"Finished Products\\\"); and WHEREAS Supplier produces raw materials including protein powders used by PNC to produce at least some of the Finished Products; NOW THEREFORE in consideration of their respective rights and obligations as set forth in this Agreement, and for other good and valuable consideration, the adequacy and receipt of which are acknowledged, PNC and Supplier agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply of Ingredients\", \"level\": 1, \"text\": \"1 Supply of Ingredients\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier will provide such materials to PNC or its Third Party Manufacturers (\\\"TPMs\\\") as are specified in any Master Pur\", \"level\": 2, \"text\": \"1.1 Supplier will provide such materials to PNC or its Third Party Manufacturers (\\\"TPMs\\\") as are specified in any Master Purchase Commitment or any other purchase orders that the Parties may execute from time to time during the term of this Agreement (\\\"Ingredients\\\"). Ingredients will be produced at Supplier's facilities listed in a Master Purchase Commitment, or any other of Supplier's facilities approved in advance, in writing by PNC.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PNC or its TPMs will place specific orders for Ingredients from Supplier by issuing a purchase order that specifies, at\", \"level\": 2, \"text\": \"1.2 PNC or its TPMs will place specific orders for Ingredients from Supplier by issuing a purchase order that specifies, at minimum, the item, quantities, price, delivery dates, and delivery and payment terms (each a \\\"Purchase Order\\\").\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PNC and Supplier may enter certain Master Purchase Commitments from time to time during the Term of this Master Supply A\", \"level\": 2, \"text\": \"1.3 PNC and Supplier may enter certain Master Purchase Commitments from time to time during the Term of this Master Supply Agreement. Such Master Purchase Commitments and any Purchase Orders issued against such Commitments shall be subject exclusively to the terms and conditions of this Agreement. In the event the terms of any Master Purchase Commitment conflicts with the terms of this Agreement, the terms of the Master Purchase Commitment shall control.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier will receive Purchase Orders by telephone, USPS, overnight courier, email, and fax transmission, Monday through\", \"level\": 2, \"text\": \"1.4 Supplier will receive Purchase Orders by telephone, USPS, overnight courier, email, and fax transmission, Monday through Friday except on state or nationally recognized bank holidays. Purchase Orders not received by 3:00 p.m. Eastern Time are considered to be received on the following Page 1 business day. Supplier will confirm or reject Purchase Orders within [***] of receipt of the Purchase Order. Orders not rejected in writing within such time will be deemed confirmed and accepted by Supplier. Each Purchase Order issued by PNC or its TPMs and accepted by Supplier shall be governed by the terms and conditions of this Agreement. Additional terms included in acknowledgments, standard terms and conditions, or any other documents or communications exchanged by the Parties in connection with the sale or purchase of any Ingredients shall be void and of no force or effect. The Parties may only modify, add to or amend any of the terms or conditions of this Agreement by a writing signed by authorized representatives of both Parties.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier represents and warrants that at the time and date of delivery, the Ingredients will comply with all specificati\", \"level\": 2, \"text\": \"1.5 Supplier represents and warrants that at the time and date of delivery, the Ingredients will comply with all specifications (\\\"Specifications\\\"), a copy of which will be attached to the relevant Master Purchase Commitment or Purchase Order accordingly. A Specification may be updated from time to time by PNC in its sole discretion, provided PNC provides Supplier with reasonable prior notice on any updates (\\\"Change Notification\\\"). Within [***] from receipt of the Change Notification, Supplier will either: (1) accept the Specification change at the current price and terms; or (2) submit to PNC a proposal (\\\"Proposal\\\") setting forth the conditions of acceptance that may include a change in price and/or other terms, including documentation to support same. Within [***] the Parties will discuss the Proposal in good faith and exercise their best efforts to agree on the appropriate adjustment if any. PNC will not issue any Purchase Orders, nor be required to issue any Purchase Orders to Supplier until PNC and Supplier have agreed on required Ingredient Specifications and any associated price and/or term adjustment. In the event the Parties fail to agree on required Ingredient Specifications or price and/or term adjustments despite their best good faith efforts, neither Party will have any further obligation with regard to purchase or supply of those Ingredients under any Master Purchase Commitments except that PNC shall take and pay for [***] of Ingredient inventory manufactured according to the then-current Specification.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier will provide a Certificate of Analysis (\\\"COA\\\") completed in accordance with the Specifications with any shipmen\", \"level\": 2, \"text\": \"1.6 Supplier will provide a Certificate of Analysis (\\\"COA\\\") completed in accordance with the Specifications with any shipment of Ingredients.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTENTIONALLY LEFT BLANK\", \"level\": 2, \"text\": \"1.7 INTENTIONALLY LEFT BLANK\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement is nonexclusive and sets forth the terms and conditions under which the Parties will supply and purchase\", \"level\": 2, \"text\": \"1.8 This Agreement is nonexclusive and sets forth the terms and conditions under which the Parties will supply and purchase Ingredients from the other Party. Nothing herein is intended to, nor does, guarantee that either Party will supply or purchase any specific, item, in any specific quantity, or conclude any business transaction with the other.\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier Performance metrics will be identified and tracked periodically through Supplier Performance Review meetings no\", \"level\": 2, \"text\": \"1.9 Supplier Performance metrics will be identified and tracked periodically through Supplier Performance Review meetings no more frequently than each calendar quarter during the Term. [***] Metric targets will be established by PNC and agreed by Fonterra and updated as needed. The ultimate goal is zero defects for quality and administrative compliance issues.\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier agrees to make a good faith effort to provide Advance Ship Notices (\\\"ASN\\\") with bar-coded pallet labels; Invoic\", \"level\": 2, \"text\": \"1.10 Supplier agrees to make a good faith effort to provide Advance Ship Notices (\\\"ASN\\\") with bar-coded pallet labels; Invoices, Purchase Orders and other business transactions, as may be advised by PNC, for each Ingredient shipment. Supplier will provide, itself or through a third-party provider, the information via Electronic Data Interface (\\\"EDI\\\") if and as requested by PNC. The technical specifications for all required EDI transactions will be provided by PNC. 2\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Quality and Food Safety\", \"level\": 1, \"text\": \"2 Quality and Food Safety\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For the purposes set forth in Section 303(c) of the Federal Food, Drug, and Cosmetic Act (the \\\"Act\\\"), Supplier guarantee\", \"level\": 2, \"text\": \"2.1 For the purposes set forth in Section 303(c) of the Federal Food, Drug, and Cosmetic Act (the \\\"Act\\\"), Supplier guarantees to PNC that as of the time and date of delivery, all Ingredients will not be adulterated or misbranded within the meaning of the Act, nor will any Ingredients constitute an article that may not, under the provisions of Sections 404 and 505 of the Act, be introduced into interstate commerce. The Supplier further guarantees that as of the time and date of delivery, all of the Ingredients will be in compliance with all applicable laws, regulations, requirements and programs including those administered by the Food and Drug Administration (the \\\"FDA\\\"), the United States Department of Agriculture (the \\\"USDA\\\") and any state or local food or drug laws then in effect. This guarantee specifically includes Proposition 65 (California Safe Drinking Water and Toxic Enforcement Act), and Supplier hereby certifies that the Ingredients will not contain any non-naturally occurring chemicals subject to Proposition 65 or that any such chemicals pose \\\"no significant risk\\\" or cause \\\"no observable effect\\\" as set forth in the California Health and Safety Code, 22 CCR \u00a7\u00a7 12701 et seq. and 22 CCR \u00a7\u00a7 12801 et seq., as amended. Supplier shall comply with all applicable regulatory requirements for determining and documenting that all Ingredients are at or below no significant risk levels and no observable effect levels, as applicable.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier shall develop and maintain a food safety/food defense program as required under the Food Safety Modernization A\", \"level\": 2, \"text\": \"2.2 Supplier shall develop and maintain a food safety/food defense program as required under the Food Safety Modernization Act 21 USC \u00a7301 et seq and shall submit a copy of such plan (and any changes thereto) to PNC upon PNC's request. Supplier will conduct [***] third-party food safety/food defense audits (the \\\"Audits\\\") in compliance with, and consistent with, relevant audit schemes approved by the Global Food Safety Initiatives, AIB International, Silliker, or GMA SAFE. Supplier will submit summaries of audit reports to PNC's Quality Manager at [***] upon request. Failure to comply with the requirements of this Section 2.2 will constitute a material breach of this Agreement.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier will notify PNC immediately, by person-to-person voice communication or equivalent means, if any of the Ingredi\", \"level\": 2, \"text\": \"2.3 Supplier will notify PNC immediately, by person-to-person voice communication or equivalent means, if any of the Ingredients contain, or are reasonably suspected to contain, material hazardous to human health, including but not limited to, chemical, physical or biological hazards.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PNC shall notify Supplier in writing if it determines any Ingredient fails to meet the Specifications\", \"level\": 2, \"text\": \"2.4 PNC shall notify Supplier in writing if it determines any Ingredient fails to meet the Specifications. Supplier shall be given an opportunity to and will promptly inspect and/or test such Ingredients to confirm compliance to Specification. If after any reasonable, good faith inspection and testing it is confirmed that certain Ingredients fail to meet the Specifications [***].\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to the occurring of a Force Majeure Event, if Supplier fails to deliver the Ingredients in accordance with the S\", \"level\": 2, \"text\": \"2.5 Subject to the occurring of a Force Majeure Event, if Supplier fails to deliver the Ingredients in accordance with the Specifications, including within the time specified on the Purchase Order, in addition to any other remedies available, PNC may terminate the Purchase Order in whole or in part. In the event of such a termination, Supplier shall continue performance of any nonterminated portion of the Purchase Order, or any nonterminated Purchase Orders, and the quantity of Ingredient ordered and so terminated shall be deducted against any relevant Master Purchase Commitment.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PNC or its contracted third-party auditors may enter and audit/inspect Supplier's facilities where the Ingredients are p\", \"level\": 2, \"text\": \"2.6 PNC or its contracted third-party auditors may enter and audit/inspect Supplier's facilities where the Ingredients are produced, stored, packaged or otherwise processed [***] unless food safety is at issue or PNC has a good faith reason to believe the Ingredients are being stored, packaged, or processed 3 in a way that is inconsistent with the Specifications, in which case an audit may be performed at any time during the Term. For routine visits and audits, PNC will provide [***] if facilities located in the US and with [***] if facilities are located [***], provided that such examination will be conducted during Supplier's normal business hours and in such a manner as to reasonably minimize disruption to Supplier's business, unless food safety is at issue, in which case such examination may be conducted at any time. Supplier shall cooperate in good faith with PNC during all such inspections. During qualification processes and on-site inspections, Supplier will present necessary documentation to ensure compliance with all applicable programs specified under 21 CFR Part 117 Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventative Controls for Human Food. Records of environmental monitoring activities by the Supplier, following Supplier's established environmental monitoring program and standard operating procedures will be made available upon request to PNC. Supplier will notify Buyer immediately via person-to- person voice communication in the event that any pathogen is found, or reasonably suspected, in the plant environment during any environmental monitoring activity that could have an impact on the quality or safety of PNC's Ingredients. In the event of an actual or suspected food safety concern, Supplier shall conduct sampling in all relevant areas and promptly provide results of such tests to PNC. If PNC or its representatives find that any of Supplier's facilities, processes, inventory, procedures or equipment are not in accordance or compliance with the requirements of this Agreement or applicable law or regulation, PNC will give notice to Supplier, and Supplier shall promptly take all reasonable steps to correct such deficiency as soon as possible. If correction of the deficiency cannot be affected within [***] of such notice, then Supplier shall promptly notify PNC with its plan to correct the deficiency including an estimated schedule. If the deficiency cannot be corrected within [***], unless otherwise agreed, then PNC shall have the right to terminate any Purchase Orders then outstanding, along with any Master Purchase Commitment related thereto.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Business Continuity/Continuous Supply Assurances\", \"level\": 1, \"text\": \"3 Business Continuity/Continuous Supply Assurances. Supplier will develop and maintain a business continuity plan that identifies critical pathways and potential crisis situations that could interrupt the supply of Ingredients to PNC and establish contingency plans for dealing with each crisis situation. Upon PNC's written request, Supplier will submit the business continuity plan to PNC for PNC's review.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Intellectual Property\", \"level\": 1, \"text\": \"4 Intellectual Property. 4.1 Each Party shall retain ownership of all Intellectual Property Rights (as defined below): (1) owned or licensed by that Party prior to the commencement date of this Agreement; or (2) developed or acquired independently of this Agreement by that Party or its licensors other than in connection with this Agreement. 4.2 Ownership in the Intellectual Property Rights, if any, of any developments and/or modifications to the Ingredients during the Term shall be [***]. 4.3 For purposes of this Section 4, the term \\\"Intellectual Property Rights\\\" shall mean all statutory, common law and proprietary intellectual property rights, including rights in know-how, confidential information, copyright works, designs, inventions, patents, plant varieties, trademarks and all other rights, whether registered or unregistered (including applications for such rights).\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential Information\", \"level\": 1, \"text\": \"5 Confidential Information. \\\"Confidential Information\\\" means all business, financial and technical information of the Parties, or of a third- party as to whom a Party has an obligation of confidentiality, whether disclosed before or after the Effective Date and whether disclosed in writing, orally, by electronic delivery, or by inspection of tangible objects. Confidential Information includes, without limitation, trade secrets, ideas, 4 processes, formulae (including formula and specifications for Ingredients and Finished Products), computer software (including source code), algorithms, data, data structures, know-how, copyrightable material, improvements, inventions (whether or not patentable), techniques, strategies, business and product development plans, timetables, forecasts, customer and supplier information, and information relating to product designs, specifications and schematics, product costs, product prices, product names, financial information, marketing plans, business opportunities, personnel, research, development and know-how. Confidential Information includes that which is marked or otherwise identified as confidential, as well as that which by its nature and the circumstances of its disclosure are reasonably understood to be confidential.\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Maintenance of Confidentiality and Limitations on Use\", \"level\": 2, \"text\": \"5.1 Maintenance of Confidentiality and Limitations on Use. Each Party will hold in strict confidence and keep confidential all Confidential Information disclosed to it by the other. The Parties will use at least the same degree of care to avoid publication or dissemination of such Confidential Information as it uses with respect to similarly confidential information of its own, but in no event less than reasonable care. Use of such Confidential Information by such Party will be strictly limited to activities directly in support of its activities under this Agreement. The Parties will disclose such Confidential Information on a need-to-know basis only, and in all events only to such employees and independent contractors who are informed of the confidential nature of the Confidential Information and are bound by obligations substantially similar to those set forth herein applicable to such Confidential Information. Each Party hereby guarantees the performance of the provisions hereof by each person obtaining disclosure of such Confidential Information directly or indirectly from such Party.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Copying and Return of Confidential Information\", \"level\": 2, \"text\": \"5.2 Copying and Return of Confidential Information. Each Party shall not make any copies or extracts of Confidential Information, or include such Confidential Information in its own materials except as reasonably required directly in support of its activities under this Agreement. When a Party no longer has need thereof in support of its activities under this Agreement or upon request of the other Party, whichever occurs first, such Party shall promptly cease using and shall return or destroy (and, if requested, certify destruction of) all such Confidential Information along with all tangible and electronic copies which it may have made, provided, however, that a Party is not obligated to remove Confidential Information from back up devices that have been made and are maintained in accordance with a corporate records retention policy.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Certain Exceptions\", \"level\": 2, \"text\": \"5.3 Certain Exceptions. Information will not be, or will cease being, Confidential Information, as the case may be, if Supplier can show:\"}}, {\"id\": \"5.3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"that such information entered the public domain other than by breach of this Agreement on the part of any Party obligate\", \"level\": 3, \"text\": \"5.3.1 that such information entered the public domain other than by breach of this Agreement on the part of any Party obligated to confidentiality hereunder; 5.3.2 it is rightfully known to the receiving Party without obligation of confidentiality to any third-party prior to receipt of same from the disclosing Party as evidenced by bona fide written, dated documents; 5.3.3 it is independently developed by personnel of the receiving Party who have not had access to Confidential Information of the disclosing Party; and, 5.3.4 that it is generally made available to third-parties by the disclosing Party without obligation of confidentiality.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Legally Required Disclosure\", \"level\": 2, \"text\": \"5.4 Legally Required Disclosure. A Party shall not be in breach hereof if it discloses Confidential Information pursuant to a judicial or governmental order, or as required by applicable law or the rules 5 of a recognized stock exchange, but any such disclosure shall be made only to the extent so ordered or required. In any such event, the Party (i) shall timely notify the other Party so that it may intervene in response to such order or take action to protect its interests (in which event such Party will cooperate in such effort), or (ii) if timely notice cannot be given, shall seek to obtain a protective order or confidential treatment from the court or government for such information.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Defend Trade Secrets Act\", \"level\": 2, \"text\": \"5.5 Defend Trade Secrets Act. Notwithstanding anything in this agreement to the contrary, a receiving Party is hereby notified in accordance with the US Defend Trade Secrets Act of 2016 that it will not be held criminally or civilly liable under any US federal or state trade secret law for the disclosure of a trade secret that: (x) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (y) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trading in Securities\", \"level\": 2, \"text\": \"5.6 Trading in Securities. Supplier acknowledges that it is aware, and agrees to advise its directors, officers, employees, agents and representatives who are informed as to the matters which are the subject of this Agreement, that the United States securities laws prohibit any person who has material, non-public information concerning PNC, its parent and affiliate companies including BellRing Brands, Inc. and Post Holdings, Inc. from purchasing or selling securities of those companies or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities.\"}}, {\"id\": \"5.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Title\", \"level\": 2, \"text\": \"5.7 Title. As between the Parties, title or right to possess Confidential Information of PNC, except as otherwise provided herein, shall remain in PNC. Nothing in this Agreement shall be construed as granting or conferring any rights to any Confidential Information, except as otherwise explicitly stated in this Agreement.\"}}, {\"id\": \"5.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Representation or Warranty\", \"level\": 2, \"text\": \"5.8 No Representation or Warranty. Except as expressly set forth herein, neither Party makes any representations or warranties of any nature whatsoever with respect to any Confidential Information it may provide, including, without limitation, any warranties of merchantability, fitness for a particular purpose or accuracy. All Confidential Information is provided on an \\\"as-is\\\" basis, and the recipient assumes all responsibility for its use thereof or reliance thereon. Further, each Party understands and acknowledges that any confidential information received from the other Party concerning future plans may be tentative and may not represent firm decisions concerning such plans, and neither Party shall be liable to the other Party for inaccuracies in Confidential Information under any theory of liability.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"6 Term and Termination.\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement will commence on the Effective Date and continue for an Initial Term of five (5) years, and will automati\", \"level\": 2, \"text\": \"6.1 This Agreement will commence on the Effective Date and continue for an Initial Term of five (5) years, and will automatically renew for additional periods of five (5) years unless one Party notifies the other of its intention not to renew, no less than 12 months prior to the expiration of the then-current term, unless terminated as permitted under this Agreement.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Either Party may terminate this Agreement for cause if the other Party fails to perform any material provision of this A\", \"level\": 2, \"text\": \"6.2 Either Party may terminate this Agreement for cause if the other Party fails to perform any material provision of this Agreement or commits a material breach of this Agreement which is not corrected within [***] after receiving written notice of the failure or breach. except that if the default is by 6 Supplier that creates an immediate public food safety risk, PNC may terminate this Agreement immediately without regard to any period for correction.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement will automatically terminate if either Party becomes insolvent or files a petition in bankruptcy, if a Pa\", \"level\": 2, \"text\": \"6.3 This Agreement will automatically terminate if either Party becomes insolvent or files a petition in bankruptcy, if a Party makes an assignment for the benefit of a creditor, if a receiver is appointed to take possession of any part of a Party's assets or if a Party becomes unable generally to pay its debts as they become due, or otherwise ceases to do business.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"On the termination of this Agreement for any reason, all rights granted to Supplier under this Agreement will immediatel\", \"level\": 2, \"text\": \"6.4 On the termination of this Agreement for any reason, all rights granted to Supplier under this Agreement will immediately cease, and Supplier must deliver to PNC all written or recorded materials relating to the Confidential Information of PNC in the possession or control of Supplier or any of its related party, subject to Section 5.2.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Except for a Party's gross negligence or intentional acts or omissions and its obligations of indemnity under this Agree\", \"level\": 2, \"text\": \"7.2 Except for a Party's gross negligence or intentional acts or omissions and its obligations of indemnity under this Agreement, under no circumstances will either Party be liable to the other Party for [***].\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier agrees to indemnify and hold PNC harmless from any and all employment-related claims, payments, entitlements, t\", \"level\": 2, \"text\": \"7.3 Supplier agrees to indemnify and hold PNC harmless from any and all employment-related claims, payments, entitlements, taxes, interest and penalties assessed against or obtained from PNC by any individual or authority as a consequence of or related to the performance by any agent or employee of Supplier.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier shall maintain insurance with an insurance company with an equivalent of an A\", \"level\": 2, \"text\": \"7.4 Supplier shall maintain insurance with an insurance company with an equivalent of an A.M. Best rating of \\\"A\\\" or better, of the following kinds and in the following amounts during the term of this Agreement: 7.5 7.5.1 Comprehensive General Liability (CGL) Insurance with limits of not less than [***] each occurrence and [***] in the aggregate, including Contractual, Completed-Operations and 7 Product-Liability Coverage's with limits of not less than [***] for each occurrence, covering both bodily injury and property damage liability. 7.5.2 Umbrella/Excess Liability with limits of not less than [***]. 7.5.3 Workers' Compensation Coverage plus Occupational Disease Insurance if Occupational Disease coverage is required by the laws of the state where the Facility is located or work is to be performed. Employers Liability $500,000 each accident 7.5.4 Auto Liability $1,000,000 combined single limit.\"}}, {\"id\": \"7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier shall have Buyer named as an additional insured on its insurance policies in subparts 7\", \"level\": 2, \"text\": \"7.6 Supplier shall have Buyer named as an additional insured on its insurance policies in subparts 7.5.1 and 7.5.2 above. Supplier shall furnish Buyer with a certificate from its insurer verifying that it has the above insurance in effect during the duration of this Agreement and that insurer acknowledges (a) the contractual liability assumed by Supplier in this Agreement and (b) that Buyer is an additional insured on such policies and (c) Supplier's CGL policy is primary and Buyer's CGL policy is non-contributory and (d) a waiver of subrogation shall be provided in favor of Buyer on the CGL, Workers' Compensation and Auto policies. Said certificate of insurance shall require Supplier's insurance carrier to give Buyer no less than ten (10) days written notice of any cancellation or change in coverage. Failure to secure such insurance as of the date of execution of this Agreement shall constitute a breach of this Agreement. Supplier shall provide to PNC a certificate evidencing such insurance within thirty (30) days of a request for same from PNC.\"}}, {\"id\": \"7.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier shall, at its own expense, maintain throughout the term of this Agreement, all insurance required by law or reg\", \"level\": 2, \"text\": \"7.7 Supplier shall, at its own expense, maintain throughout the term of this Agreement, all insurance required by law or regulation in all countries in which this Agreement will be performed.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recall\", \"level\": 1, \"text\": \"8 Recall. If Ingredients provided by Supplier under this Agreement are misbranded, contaminated, or otherwise unfit for human consumption at the time they are delivered to PNC or its TPM (\\\"Defect\\\"), PNC in its sole discretion will make a determination of the necessity of a recall, market withdrawal, inventory retrieval, or other action designed to prevent the distribution or sale of the affected Finished Products, plus the type, extent, method of handling, disposition of the Finished Products as well as any affected work in progress, and all other particulars involved in such an action (a \\\"Recall\\\"), and PNC will execute any Recall. Supplier, in its sole discretion, will make a determination of the necessity of a recall, market withdrawal, inventory retrieval or other action designed to prevent the distribution or sale of the Ingredients. Subject to Section 9.1, Supplier shall bear the complete responsibility for a Recall occasioned by a Defect in the Ingredient and shall indemnify PNC for [***] resulting from or related to the Recall. Any Recall occasioned by PNC labels or by tampering with the Ingredients after they have left Supplier's control, or by improper storing or handling by PNC, will not be considered a Defect.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation of Liability\", \"level\": 1, \"text\": \"9 Limitation of Liability.\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The maximum liability of one Party to the other Party and its affiliates in relation to this Agreement will be [***] (\\\"L\", \"level\": 2, \"text\": \"9.1 The maximum liability of one Party to the other Party and its affiliates in relation to this Agreement will be [***] (\\\"Liability Cap\\\"), provided however that: 8\"}}, {\"id\": \"9.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Liability Cap will not apply to any (1) material confidentiality breach under Section 5, and/or (2) indemnification\", \"level\": 3, \"text\": \"9.1.1 The Liability Cap will not apply to any (1) material confidentiality breach under Section 5, and/or (2) indemnification obligations under Section 7.1. 9.1.2 The Liability Cap will not apply to intentional misconduct and/or gross negligence.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For the purpose of this Section, \\\"liability\\\" means liability for any and all claims, causes of action, judgments, costs\", \"level\": 2, \"text\": \"9.2 For the purpose of this Section, \\\"liability\\\" means liability for any and all claims, causes of action, judgments, costs and expenses (including but not limited to reasonable attorney fees and expenses), reimbursements, losses, and any and all other liabilities and damages of any kind, whether in contract, tort (including negligence), equity, statute or otherwise arising out of, in relation to or as a result of this Agreement.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 1, \"text\": \"10 Force Majeure.\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither Party will be liable for any breach of its obligations under this Agreement resulting from causes beyond its rea\", \"level\": 2, \"text\": \"10.1 Neither Party will be liable for any breach of its obligations under this Agreement resulting from causes beyond its reasonable control, including, but not limited to, an act of nature, drought, outbreak of foot and mouth disease, port and other transport strikes, war, fires, quarantine restrictions, insurrections or riots, energy shortages, embargo or the inability to obtain supplies or raw materials because of a global shortage or governmental action (a \\\"Force Majeure Event\\\"). Notwithstanding anything herein to the contrary, in the event of a Force Majeure Event, or any other circumstance that limits Fonterra's ability to produce or deliver product, Supplier will exercise its best efforts to comply with its obligations hereunder, mitigate the adverse impact on and not disfavor PNC, and will treat it in parity with its other customers.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any obligation of either Party under this Agreement will be postponed until the cause underlying the Force Majeure Event\", \"level\": 2, \"text\": \"10.2 Any obligation of either Party under this Agreement will be postponed until the cause underlying the Force Majeure Event has been eliminated, at which time the obligation will again be in effect. Any loss of time by the Force Majeure Event will not be held against the Party who was unable to comply with its obligations under this Agreement because of the Force Majeure Event. The Party unable to comply with its obligations under this Agreement will immediately notify the other Party in writing that a Force Majeure Event has delayed its performance and will state, to the best of its knowledge, the revised date for performance. If a Force Majeure Event persists for longer than [***], the Party not directly affected by the Force Majeure Event may terminate this Agreement with regard to any relevant Master Purchase Commitments or Purchase Orders.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Should Supplier be unable to comply with its obligations under this Agreement because of a Force Majeure Event, PNC may\", \"level\": 2, \"text\": \"10.3 Should Supplier be unable to comply with its obligations under this Agreement because of a Force Majeure Event, PNC may obtain elsewhere the Ingredients the Supplier was unable to deliver because of the Force Majeure Event and those Ingredients will be credited against any relevant Minimum Purchase Commitment. PNC will not be obligated to purchase those Ingredients from Supplier at a later time.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 1, \"text\": \"11 Notices. Notices contemplated by this Agreement must be in writing and may be sent by registered or certified mail, postage prepaid, to the address specified in the first paragraph of this Agreement or to any other address designated by prior written notice.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law; Dispute Resolution\", \"level\": 1, \"text\": \"12 Governing Law; Dispute Resolution. 9\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement will be governed by the laws of the State of Delaware without regard to its conflicts of law principles\", \"level\": 2, \"text\": \"12.1 This Agreement will be governed by the laws of the State of Delaware without regard to its conflicts of law principles.\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Parties consent to, acknowledge, and agree that any dispute arising out of or relating to this Agreement, including\", \"level\": 2, \"text\": \"12.2 The Parties consent to, acknowledge, and agree that any dispute arising out of or relating to this Agreement, including the breach, termination or validity thereof, shall be brought exclusively before the state and federal courts in and for the City of Wilmington and County of New Castle, Delaware Each Party waives any objection based on forum non conveniens.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 1, \"text\": \"13 Assignment. Neither Party may transfer or assign any of its rights or obligations under this Agreement without the prior written consent of the other Party, except that either Party may assign this Agreement to any entity controlled by it, its parents, subsidiaries, or affiliates, or to any purchaser of the business to which this Agreement relates subject to the other Parties consent which will not be unreasonably withheld or delayed.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier Conduct\", \"level\": 1, \"text\": \"14 Supplier Conduct. Supplier agrees to engage in responsible and ethical business practices and conduct itself in full compliance with all applicable laws, rules, and regulations in every country in which it does business.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"California Transparency Act\", \"level\": 1, \"text\": \"15 California Transparency Act. PNC does not accept or support the use of illegal, abusive, or forced labor in our own facilities. Within its supply chain, Supplier will comply with all laws of the country they are doing business in and are subject to.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Fair Labor Practices\", \"level\": 1, \"text\": \"17 Fair Labor Practices.\"}}, {\"id\": \"17.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier shall provide workers with clean, safe and healthy work environments; recognize and respect the right of employ\", \"level\": 2, \"text\": \"17.1 Supplier shall provide workers with clean, safe and healthy work environments; recognize and respect the right of employees to free association and collective bargaining in accordance with law; comply with all applicable wage and hour laws; and properly verify the employment eligibility of its employees.\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Forced Labor\", \"level\": 2, \"text\": \"17.2 Forced Labor. Suppliers will not employ, use or otherwise benefit from involuntary labor, forced labor, or labor that results from slavery or human trafficking. Supplier hereby certifies that: (i) it is in compliance with this paragraph; and (ii) all materials incorporated into its products comply with all applicable laws addressing slavery, human trafficking and other forms of forced labor. Supplier shall provide PNC with documentation establishing compliance with this paragraph upon [***] notice. 10\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Child Labor\", \"level\": 2, \"text\": \"17.3 Child Labor. Supplier will not employ anyone under the legal working age defined by local law. Supplier will comply with all applicable laws addressing the working requirements and conditions for child workers.\"}}, {\"id\": \"17.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Respectful Workplace\", \"level\": 2, \"text\": \"17.4 Respectful Workplace. Supplier shall prohibit all forms of unlawful discrimination, abuse, harassment, violence and retaliation.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Gifts and Entertainment\", \"level\": 1, \"text\": \"18 Gifts and Entertainment. Supplier will not offer any gift to a PNC employee, contractor, or agent that is: (i) more than a nominal value; (ii) more than an infrequent occurrence; (iii) cash or cash equivalents; or (iv) illegal, sexually oriented, offensive or otherwise inappropriate.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Environment & Sustainability\", \"level\": 1, \"text\": \"19 Environment & Sustainability. Supplier will comply with all applicable environmental laws and reporting obligations, maintain all required permits, and strive to responsibly manage the impacts of their operations on the environment.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Anticorruption\", \"level\": 1, \"text\": \"20 Anticorruption. Suppliers will not, directly or indirectly, offer improper gifts to government employees, engage in bribery or fraud, or take any other action that would cause a violation of the U.S. Foreign Corrupt Practices Act, the UK Bribery Act or any other applicable anti- corruption law.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"21 Miscellaneous.\"}}, {\"id\": \"21.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If any provision of this Agreement is determined to be illegal or unenforceable, all other provisions will continue in f\", \"level\": 2, \"text\": \"21.1 If any provision of this Agreement is determined to be illegal or unenforceable, all other provisions will continue in full force and effect.\"}}, {\"id\": \"21.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement may be executed concurrently by original or facsimile signature in counterparts, each of which will be de\", \"level\": 2, \"text\": \"21.2 This Agreement may be executed concurrently by original or facsimile signature in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.\"}}, {\"id\": \"21.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each right and remedy of each Party described in this Agreement is cumulative and in addition to every other right or re\", \"level\": 2, \"text\": \"21.3 Each right and remedy of each Party described in this Agreement is cumulative and in addition to every other right or remedy, express or implied, now or hereafter arising, available to such Party, at law or in equity, or under any other agreement. No delay or omission by either Party in the exercise of any right or remedy arising under this Agreement will impair any such right or remedy or the right of such Party to resort thereto at a later date or be construed to be a waiver of any default under this Agreement. The indemnities, representations and warranties of each Party will survive termination of this Agreement.\"}}, {\"id\": \"21.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement, together with any schedules and exhibits and any Purchase Orders, Specifications and COAs, constitutes t\", \"level\": 2, \"text\": \"21.4 This Agreement, together with any schedules and exhibits and any Purchase Orders, Specifications and COAs, constitutes the complete agreement between the Parties and supersedes all prior agreements between the Parties regarding this subject matter. The Parties hereby agree that any such prior agreements are hereby terminated. No other contracts, warranties, promises or representations, either oral or in writing, relating to this Agreement will bind either Party except for the Purchase Orders, Specifications and COAs. This Agreement may not be amended or modified except by a writing signed by an authorized representative of the Party against whom such amendment or modification is asserted. This Agreement will be binding upon, and will inure to the benefit of, the parties, their successors and permitted assigns. (signature page follows) 11 Agreed to and executed effective as of the date first above written. Fonterra (USA) Inc. Premier Nutrition Company, LLC By: [***] By: /s/ Paul Rode Title: President Title: CFO 12 Agreed to and executed effective as of the date first above written. Fonterra (USA) Inc. Premier Nutrition Company, LLC By: By: /s/ Paul Rode Title: Title: CFO\"}}, {\"id\": \"party:Premier Nutrition Company, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Premier Nutrition Company, LLC\", \"role\": \"Buyer\", \"address\": \"1222 67th Street, Suite 210, Emeryville, CA 94608\"}}, {\"id\": \"party:Fonterra (USA) Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Fonterra (USA) Inc.\", \"role\": \"Supplier\", \"address\": \"8700 W. Bryn Mawr Avenue, Suite 500N, Chicago, IL 60631\"}}, {\"id\": \"value:five (5) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) years\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 months\"}}, {\"id\": \"value:$500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$500,000\"}}, {\"id\": \"value:$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS MASTER SUPPLY AGREEMENT\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"31 October 2019\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Finished Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Finished Products\", \"text\": \"ready to drink protein shakes and beverages, powdered protein shakes, nutrition bars, and dietary supplements\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:TPMs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TPMs\", \"text\": \"Third Party Manufacturers\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Ingredients\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ingredients\", \"text\": \"any Master Purchase Commitment or any other purchase orders that the Parties may execute from time to time during the term of this Agreement\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"a purchase order that specifies, at minimum, the item, quantities, price, delivery dates, and delivery and payment terms\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:Specifications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specifications\", \"text\": \"all specifications\", \"definition_clause\": \"1.5\"}}, {\"id\": \"term:Change Notification\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change Notification\", \"text\": \"reasonable prior notice on any updates\", \"definition_clause\": \"1.5\"}}, {\"id\": \"term:Proposal\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proposal\", \"text\": \"a proposal\", \"definition_clause\": \"1.5\"}}, {\"id\": \"term:COA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"COA\", \"text\": \"Certificate of Analysis\", \"definition_clause\": \"1.6\"}}, {\"id\": \"term:ASN\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ASN\", \"text\": \"Advance Ship Notices\", \"definition_clause\": \"1.10\"}}, {\"id\": \"term:EDI\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EDI\", \"text\": \"Electronic Data Interface\", \"definition_clause\": \"1.10\"}}, {\"id\": \"term:Act\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Act\", \"text\": \"Federal Food, Drug, and Cosmetic Act\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:FDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDA\", \"text\": \"Food and Drug Administration\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:USDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"USDA\", \"text\": \"United States Department of Agriculture\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:Audits\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Audits\", \"text\": \"third-party food safety/food defense audits\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:Intellectual Property Rights\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property Rights\", \"text\": \"all statutory, common law and proprietary intellectual property rights, including rights in know-how, confidential information, copyright works, designs, inventions, patents, plant varieties, trademarks and all other rights, whether registered or unregistered (including applications for such rights)\", \"definition_clause\": \"4\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"all business, financial and technical information of the Parties, or of a third- party as to whom a Party has an obligation of confidentiality, whether disclosed before or after the Effective Date and whether disclosed in writing, orally, by electronic delivery, or by inspection of tangible objects. Confidential Information includes, without limitation, trade secrets, ideas, 4 processes, formulae (including formula and specifications for Ingredients and Finished Products), computer software (including source code), algorithms, data, data structures, know-how, copyrightable material, improvements, inventions (whether or not patentable), techniques, strategies, business and product development plans, timetables, forecasts, customer and supplier information, and information relating to product designs, specifications and schematics, product costs, product prices, product names, financial information, marketing plans, business opportunities, personnel, research, development and know-how. Confidential Information includes that which is marked or otherwise identified as confidential, as well as that which by its nature and the circumstances of its disclosure are reasonably understood to be confidential.\", \"definition_clause\": \"5\"}}, {\"id\": \"term:Defect\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Defect\", \"text\": \"Ingredients provided by Supplier under this Agreement are misbranded, contaminated, or otherwise unfit for human consumption at the time they are delivered to PNC or its TPM\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Recall\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Recall\", \"text\": \"a determination of the necessity of a recall, market withdrawal, inventory retrieval, or other action designed to prevent the distribution or sale of the affected Finished Products, plus the type, extent, method of handling, disposition of the Finished Products as well as any affected work in progress, and all other particulars involved in such an action\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Liability Cap\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Liability Cap\", \"text\": \"[***]\", \"definition_clause\": \"9.1\"}}, {\"id\": \"term:liability\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"liability\", \"text\": \"liability for any and all claims, causes of action, judgments, costs and expenses (including but not limited to reasonable attorney fees and expenses), reimbursements, losses, and any and all other liabilities and damages of any kind, whether in contract, tort (including negligence), equity, statute or otherwise arising out of, in relation to or as a result of this Agreement.\", \"definition_clause\": \"9.2\"}}, {\"id\": \"term:Force Majeure Event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure Event\", \"text\": \"an act of nature, drought, outbreak of foot and mouth disease, port and other transport strikes, war, fires, quarantine restrictions, insurrections or riots, energy shortages, embargo or the inability to obtain supplies or raw materials because of a global shortage or governmental action\", \"definition_clause\": \"10.1\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of BIOFRONTERAAG_04_29_2019-EX-4.17-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of BIOFRONTERAAG_04_29_2019-EX-4.17-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 4.17\", \"title\": \"EXECUTION COPY SUPPLY AGREEMENT FERRER INTERNACIONAL, S.A. AND CUTANEA LIFE SCIENCES, INC. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\", \"level\": 2, \"text\": \"Exhibit 4.17 EXECUTION COPY SUPPLY AGREEMENT FERRER INTERNACIONAL, S.A. AND CUTANEA LIFE SCIENCES, INC. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUPPLY AGREEMENT This Supply Agreement (the \\\"Agreement\\\") is made as of this ____ day of March, 2018 (the \\\"Effective Date\\\"), by and between Cutanea Life Sciences, Inc., a corporation duly organized and existing under the laws of the State of Delaware with its principal place of business at 1500 Liberty Ridge Drive, Suite 3000, Wayne, PA 19087 hereinafter referred to as \\\"CUTANEA\\\"), and Ferrer Internacional, S.A., a Spanish corporation with its principal place of business at Av. Diagonal, 549, 5t h floor, 08029 Barcelona (Spain) (hereinafter indistinctly referred to as \\\"Ferrer\\\" and/or \\\"Supplier\\\"). CUTANEA and Ferrer taken together hereinafter are referred to as \\\"PARTIES\\\". WITNESSETH: WHEREAS, CUTANEA is engaged in the distribution, promotion and sale of certain pharmaceutical, OTC and medical device products and in particular desires that Ferrer manufacture (directly and/or through a third party) and supply CUTANEA with the \\\"Products\\\" (as defined below); and WHEREAS, Ferrer and Medimetriks Pharmaceuticals, Inc. (hereinafter \\\"Medimetriks\\\") entered into a License and Supply Agreement dated March 10, 2014, as amended, (hereinafter referred as \\\"LSA\\\") pursuant to which among other things, Ferrer granted Medimetriks exclusive commercialization and distribution rights to the Product (as defined in the LSA) throughout the Territory (as defined in the LSA); and WHEREAS, with Ferrer's consent, CUTANEA has acquired and assumed the rights, duties and obligations of Medimetriks under the LSA; and WHEREAS, Ferrer desires to manufacture (directly and/or through a third party) and supply CUTANEA with such Products; NOW, THEREFORE, in consideration of the mutual covenants hereinafter expressed, the Parties, intending to be legally bound hereby, agree as follows: 1. DEFINITIONS 1.1 Act \\\"Act\\\" means the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated hereunder. 1.2 Business Day \\\"Business Day\\\" means any day other than a Saturday, Sunday or other day on which banks in Philadelphia, Pennsylvania and/ or Barcelona, Spain are permitted or required to close by any applicable law. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"2.6.2\", \"title\": \"In the event of a conflict between the test results of Supplier and the test results of CUTANEA with respect to any ship\", \"level\": 3, \"text\": \"2.6.2 In the event of a conflict between the test results of Supplier and the test results of CUTANEA with respect to any shipment of Product batch, within thirty (30) days following receipt by Supplier of CUTANEA's notice of rejection, sample of such Product batch shall be submitted by Supplier (and/or its nominee) to an independent laboratory designated by Supplier (and/or its nominee) and reasonably acceptable to CUTANEA, which shall perform an assessment and whose findings shall be conclusive. The cost of the assessment shall be borne by (i) CUTANEA if the findings indicate the Product met all Specifications or (ii) Supplier (or its nominee) if the findings indicate the Product failed to meet any Specifications. 2.7 Supply Price. The initial Supply Price for each Product (commercial trade and sample units) to be paid by CUTANEA to Supplier are listed in Schedule A. These Supply Prices are for finished forms of the Products [***] (except as otherwise set forth herein). 2.8 Quality Agreement. The Parties shall enter into a Quality Agreement for the Products. If there is any conflict between this Agreement and the Quality Agreement solely with respect to quality assurance matters, the Quality Agreement will prevail, and with respect to all other matters, this Agreement will prevail. 2.9 Pharmacovigilance Agreement. The Parties shall enter into a pharmacovigilance agreement with respect to the Products (the \\\"Pharmacovigilance Agreement\\\"). If there is any conflict between this Agreement and the Pharmacovigilance Agreement solely with respect to adverse events and patient safety, the Pharmacovigilance Agreement will prevail, and with respect to all other matters, this Agreement will prevail. 7 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"5.8.2\", \"title\": \"Each of the parties represents, warrants, certifies and covenants that to the best of its knowledge it has not and will\", \"level\": 3, \"text\": \"5.8.2 Each of the parties represents, warrants, certifies and covenants that to the best of its knowledge it has not and will not use in any capacity the services of any individual, corporation, partnership, or association which has been convicted or debarred under Section 306 of the Act or similar local law. In the event that a party becomes aware of or receives notice of the conviction or debarment of any individual, corporation, partnership, or association providing services to such party, which relates to the execution or performance of this Agreement, Supplier agrees to notify CUTANEA immediately. 6. PRODUCT RECALLS 6.1 Initiating and Effecting Recall. Supplier, as the NDA holder for the Product, shall make all decisions with respect to any complaint or \\\"adverse drug experience\\\", or any recall, market withdrawal or any other corrective action related to any Product. Supplier shall be responsible for processing and submitting to the applicable authorities or agencies all reports of adverse drug experiences and Product complaints in accordance with applicable Acts. Supplier shall investigate all complaints associated with the Manufacture, safety or efficacy of the Product. CUTANEA shall notify Supplier in accordance with the terms of the Quality Agreement and the Pharmacovigilance Agreement of any complaints received by CUTANEA concerning any Products. 6.2 Implementation of Recall. Supplier shall implement recalls of Products from the market or other corrective actions related to the Product. CUTANEA shall assist Supplier, to the extent necessary or relevant, in implementing withdrawals or recalls of Products from the market or other corrective actions related to Products. Upon the receipt by either party of any direction to withdraw or recall any Product from the market from any Governmental or Regulatory Authority having jurisdiction, the receiving party shall notify the other party as soon as practicable in accordance with the terms of this Agreement and the Quality Agreement. With respect to notice to CUTANEA, it should be sent to [ ].com or via phone at [ ]. To the extent any seizure, withdrawal, recall (whether voluntary or involuntary), or corrective action with respect to any Product (collectively, \\\"Product Action\\\") results from the adulteration or contamination (other than any naturally occurring contamination that can be traced back to the Manufacturing process) of Product while in the care and custody of CUTANEA, CUTANEA shall be responsible for the costs of the Product Action. Otherwise, Supplier shall be responsible for all of the costs of the Product Action. 12 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"7\", \"title\": \"FORCE MAJEURE The occurrence of an event which materially interferes with the ability of a party to perform its obligat\", \"level\": 1, \"text\": \"7. FORCE MAJEURE The occurrence of an event which materially interferes with the ability of a party to perform its obligations or duties hereunder which is not within the reasonable control of the party affected (or in the case of Supplier, any current manufacturer of the Product) not due to the affected party's malfeasance, and which could not with the exercise of reasonable due diligence have been avoided (\\\"Force Majeure\\\"), including, but not limited to, fire, accident, labor difficulty, strike, riot, terrorism, civil commotion, act of God, delay or errors by shipping companies or change in Law, Governmental or Regulatory Authority action or inaction, shall not excuse such party from the performance of its obligations or duties under this Agreement, but shall merely suspend such performance during the continuation of Force Majeure. The party prevented from performing its obligations or duties because of Force Majeure shall promptly notify the other party hereto (the \\\"Other Party\\\") of the occurrence and particulars of such Force Majeure and shall provide the Other Party, from time to time, with its best estimate of the duration of such Force Majeure and with notice of the termination thereof. The party so affected shall use its commercially reasonable efforts to avoid or remove such causes of nonperformance. Upon termination of Force Majeure, the performance of any suspended obligation or duty shall promptly recommence. Neither party shall be liable to the other party for any direct, indirect, consequential, incidental, special, punitive or exemplary damages arising out of or relating to the suspension or termination of any of its obligations or duties under this Agreement by reason of the occurrence of Force Majeure. 8. CHANGES 8.1 Changes by CUTANEA. Any changes to the Specifications requested by CUTANEA must be approved by Supplier (or its designee) in its reasonable discretion and shall be incorporated and all costs and expenses associated with such changes shall be borne by CUTANEA. 8.2 Changes by Supplier. Any changes to the Specifications requested by Supplier must be notified to CUTANEA in advance to its implementation, and shall be incorporated only after approval of Governmental or Regulatory Authorities. All costs and expenses associated with such changes shall be borne by Supplier. 8.3 Changes by Governmental or Regulatory Authorities. The costs and expenses of any changes to the Specifications requested by any Governmental or Regulatory Authority shall be borne by Supplier unless the change, in the opinion of the JSC (as that term is defined in the LSA), entails a benefit to CUTANEA, in which case the costs arising from the changes and its implementation shall be borne by CUTANEA. 8.4 Obsolete Inventory. Any CUTANEA-specific inventory including, but not limited to, raw materials, work-in-process, packaging and finished goods rendered obsolete as a result of Supplier's supplier minimum order quantities that exceed the binding quantities of Product of Forecasted Needs, formula, artwork or packaging changes not requested by CUTANEA or by changes required by any Governmental or Regulatory Authority shall be destroyed in accordance with all applicable laws and regulations and Supplier shall indemnify CUTANEA for any liability, costs or expenses, including attorney's fees and court costs, relating to Supplier's failure to dispose of such inventory in accordance with such laws and regulations. Supplier shall also provide CUTANEA with all manifests and other applicable evidence of proper destruction as may be requested by CUTANEA or required by applicable laws and regulations. Any other materials rendered obsolete that are not result of Supplier's supplier minimum order quantities that exceed the binding quantities of Product of Forecasted Needs, formula, artwork or packaging changes requested by CUTANEA shall be reimbursed to Supplier by CUTANEA. 13 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"9\", \"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"9. CONFIDENTIAL INFORMATION: INTELLECTUAL PROPERTY RIGHTS 9.1 Confidential Information. 9.1.1 All Confidential Information furnished by the Disclosing Party during the term of this Agreement shall be kept confidential and not used by the Receiving Party, except for purposes authorized by this Agreement, and shall not be disclosed to any person or firm, unless previously authorized in writing to do so, during the term of this Agreement and for an indefinite period thereafter. The Receiving Party may, however, disclose the same to its responsible officers and employees who require said information in order to perform such party's obligations under this Agreement, provided that said officers and employees shall have assumed like obligations of confidentiality. 9.1.2 Any other provisions hereof to the contrary notwithstanding, it is expressly understood and agreed by the Parties hereto that the obligations of confidence and nonuse herein assumed shall not apply to any information which may be demonstrated by documented means of sufficient evidence that: (1) is at the time of disclosure or thereafter becomes a part of the public domain through no fault, omission or other act of the Receiving Party or any individual or entity receiving such information, directly or indirectly, from the Receiving Party; or (2) was otherwise in the Receiving Party's lawful possession with no obligation or duty to maintain the confidentiality thereof prior to disclosure as shown by its written record; or (3) is hereafter disclosed to the Receiving Party by a third party lawfully entitled to possession of such Confidential Information and under no obligation or duty of confidentiality; or (4) is released from a confidential status by Disclosing Party as evidence by an instrument or agreement duly executed by Disclosing Party; or (5) is required to be disclosed pursuant to regulatory or legal requirements, provided that the Receiving Party provides reasonable advance notice to the Disclosing Party and the Receiving Party reasonably cooperates with the Disclosing Party to obtain confidentiality protection of such information. 14 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"10.2\", \"title\": \"Indemnification by CUTANEA\", \"level\": 2, \"text\": \"10.2 Indemnification by CUTANEA. CUTANEA shall indemnify, defend and hold Supplier harmless from any and all Losses, to which Supplier may become subject as a result of any Claim to the extent such Losses arise out of or in connection with: (i) the development, use, storage, handling, distribution, marketing or selling of the Products by CUTANEA and its Affiliates; (ii) the negligence or willful misconduct of CUTANEA and its Affiliates; (iii) the breach or non-fulfilment by CUTANEA of its obligations according to this Agreement and/or any law in force; or (iv) a breach by CUTANEA of any warranty, representation, covenant or agreement made by it in this Agreement; except, in each case, to the extent such Losses result from: (a) the negligence or willful misconduct of Supplier (b) the breach by Supplier of any warranty, representation, covenant or agreement made by it in this Agreement and to the extent that such negligence, willful misconduct or breach it is stated by a final court decision. Notwithstanding the foregoing, CUTANEA shall have no obligation to indemnify Supplier for reasonable lawyers' fees and other legal expenses incurred by Supplier after CUTANEA has taken over the defense of such claim, \\\"Action or Proceeding\\\" in accordance with Section 10.3 unless and then only to the extent otherwise agreed to in advance in writing by CUTANEA. 10.3 Assertion of Claim. In the event that any claim is asserted against any party hereto, or any party hereto is made a party defendant in any action or proceeding, and such claim, action or proceeding (which shall mean any action, claim, suit, proceeding, arbitration or Governmental or Regulatory Authority action, notification, investigation or audit, hereinafter referred to as an \\\"Action or Proceeding\\\") involves a matter which is subject to a claim for indemnification under this Section, then such party (an \\\"Indemnified Party\\\") shall promptly give written notice to the other party or parties (the \\\"Indemnifying Party\\\") of such claim, Action or Proceeding. If the Indemnifying Party agrees in writing to be bound by and to promptly pay the full amount of any final judgment from which no further appeal may be taken (or otherwise confirms its indemnification obligation responsibility to the satisfaction of the Indemnified Party) and if the Indemnified Party is reasonably assured of the Indemnifying Party's ability to satisfy such agreement, then such Indemnifying Party shall take over the defense of such claim, Action or Proceeding, except that, in such case, the Indemnified Party shall have the right to approve any attorney or counsel selected by the Indemnifying Party (which approval shall not be unreasonably delayed or withheld) and to join in the defense of said claim, Action or Proceeding at its own cost and expense. In no event shall the Indemnifying Party settle any such claim or potential claim, Action or Proceeding without the prior written consent of the Indemnified Party, which consent shall not be unreasonably withheld. 16 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"11.3\", \"title\": \"Anti-Corruption Undertaking Both parties shall comply with, and will not cause any party and its Affiliates, associates,\", \"level\": 2, \"text\": \"11.3 Anti-Corruption Undertaking Both parties shall comply with, and will not cause any party and its Affiliates, associates, directors, officers, shareholders, employees, representatives, sublicensees or agents worldwide to be in violation with any applicable anti-corruption laws, rules and regulations including but not limited to the United States Foreign Corrupt Practices Act (the \\\"FCPA\\\") or U.K. Bribery Act 2010. Without limiting the foregoing, neither party will, directly or indirectly, pay any money to, or offer or give anything of value to, any Government Official, in order to obtain or retain business or to secure any commercial or financial advantage for the other party or for itself or any of their respective Affiliates. Each of the parties undertakes not to bribe Government Officials or any private companies or individuals, \\\"bribes\\\" having the following definition: Offering, promising, or giving a financial or other advantage to another person where it is intended to bring about the improper performance of a relevant function or activity, or to reward such improper performance; acceptance of the advantage offered, promised or given in itself constitutes improper performance of a relevant function or activity. \\\"Improper Performance\\\" means a breach of expectations that a person will act in good faith, impartially, or in accordance with a position of trust. Both parties must also (1) make and keep books, records and accounts, which, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets of the company, (2) devise and maintain a system of internal accounting controls, and (3) at any time a party so requests in writing, but no more than once a year, grant to the other party commercially reasonable access to said books, records, systems and accounts to verify compliance. Such inspection shall be undertaken by an independent public accountant or accounting firm appointed by the requesting party and about whom the other party does not express a legitimate concern. For the avoidance of doubt, this restricted annual audit shall not apply to for-cause audits, which may be conducted at any time. 19 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"12\", \"title\": \"GENERAL PROVISIONS 12\", \"level\": 1, \"text\": \"12. GENERAL PROVISIONS 12.1 Notices. Except for invoices, which shall be sent in accordance with Schedule A, all notices required or permitted under this Agreement must be written and sent to the address or facsimile number identified in this Agreement or a subsequent notice. All notices must be given (a) by personal delivery, with receipt acknowledged, (b) by facsimile followed by hard copy delivered by the methods under (c) or (d), (c) by prepaid certified or registered mail, return receipt requested, or (d) by prepaid recognized next business day delivery service. Notices will be effective upon receipt or at such later time as stated in the notice. Notices shall be sent: If to Supplier: Ferrer Internacional, S.A. Attention: Legal Department Av. Diagonal, 549, 5t h Floor 08029 Barcelona, Spain If to CUTANEA: Cutanea Life Sciences, Inc. Attention: President and CEO 1500 Liberty Ridge Drive Suite 3000 Wayne, PA 19087 With a copy (which shall constitute notice) to: Cutanea Life Sciences, Inc. Attention: General Counsel 1500 Liberty Ridge Drive Suite 3000 Wayne, PA 19087 Fax: +1 484.652.0223 12.2 Entire Agreement; Amendment. The Parties hereto acknowledge that this Agreement, including the Quality Agreement and the Pharmacovigilance Agreement and any exhibits, schedules or other attachments hereto sets forth the entire agreement and understanding of the Parties and supersede all prior written or oral agreements or understandings with respect to the subject matter hereof. In the event of any conflict between this Agreement and the LSA, this Agreement will control with respect to issues of quality assurance, patient safety, Supply Unit Price and changes to it, and other terms and conditions customarily associated with supply agreements for commercial pharmaceutical products. Notwithstanding the precedent, in the event of any conflict between Quality Agreement and/or Pharmacovigilance Agreement and this Agreement, Quality Agreement or Pharmacovigilance Agreement shall prevail with respect to terms and conditions customarily associated with Quality or Pharmacovigilance as respectively applicable. No modification of any of the terms of this Agreement, or any amendments thereto, shall be deemed to be valid unless in writing and signed by the party against whom enforcement is sought. No course of dealing or usage of trade shall be used to modify the terms and conditions herein. 20 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"12.3\", \"title\": \"Waiver\", \"level\": 2, \"text\": \"12.3 Waiver. No waiver by either party of any default shall be effective unless in writing, nor shall any such waiver operate as a waiver of any other default or of the same default on a future occasion. 12.4 Assignment. This Agreement shall be assignable or transferable by either party hereto only with the consent in writing of the other party, such consent not to be unreasonably withheld. However, Supplier shall be free to assign this Agreement along with the LSA in favor of any third party, provided that the succeeding entity assumes all of the obligations under this Agreement and the LSA, and further provided that Supplier provides CUTANEA with prior written notice of such assignment. Any assignments, including but not limited to, sale, transfer, or license of brand or Products, shall not release the original party hereto from their duties and obligations under this Agreement. For the purposes of this Agreement, the terms \\\"subsidiaries\\\" and \\\"affiliates\\\" shall mean any entity controlling, controlled by, or under common control with, either of the Parties hereto. 12.5 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without reference to any principles of conflicts of law thereof. Any suit or proceeding arising in respect of this Agreement will be tried exclusively in the United States District Court of the Southern District of the State of New York or, if that court declines to accept or does not have jurisdiction over a particular matter, any other State Court in the State of New York or Federal court of the United States of America located in the State of New York, and both parties irrevocably and unconditionally agree to submit to the exclusive jurisdiction of, and to venue in, such courts (and agree not to commence any action, suit, or proceeding relating thereto except in such courts). Both parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any action, suit, or proceeding arising out of this Agreement in such court, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit, or proceeding brought in any such court has been brought in an inconvenient forum. Both parties further agree that service of any process, summons, notice or document by U.S. registered mail to the respective addresses set forth below shall be effective service of process for any action, suit or proceeding brought against the parties in any such court. BOTH PARTIES HEREBY IRREVOCABLY WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING REGARDING THE SUBJECT MATTER OF THIS AGREEMENT. 21 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"12.6\", \"title\": \"Severability\", \"level\": 2, \"text\": \"12.6 Severability. In the event that any term or provision of this Agreement shall violate any applicable statute, ordinance, or rule of law in any jurisdiction in which it is used, or otherwise be unenforceable, such provision shall be ineffective to the extent of such violation without invalidating any other provision hereof. 12.7 Headings, Interpretation. The headings used in this Agreement are for convenience only and are not a part of this Agreement. 12.8 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same original. 12.9 Independent Contractor. In performing its services hereunder, Supplier shall act as an independent contractor. [Signature page follows.] 22 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. IN WITNESS WHEREOF, the Parties hereto have each caused this Agreement to be executed by their duly authorized officers as of the date first above written. CUTANEA LIFE SCIENCES, INC. FERRER INTERNACIONAL, S.A. By: /s/ [***] By: /s/ [***] Its: [***] Its: [***] Date: Date: FERRER INTERNACIONAL, S.A. By: /s/ [***] Its: [***] Date: [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}, {\"id\": \"Schedule A\", \"title\": \"Capitalized terms in this Exhibit A are defined in LSA. The initial purchase price for trade units of the Products shall be set at $[***] per [***] sample tube of the Product, $[***] per [***] trade unit of the Product, $[***] per [***] trade unit of the Product, and $[***] per [***] trade unit of the Product, FCA manufacturing site (the \\\"Supply Unit Price\\\"). Notwithstanding the foregoing, after December 31, 2018 and during the term of this Agreement, Ferrer may change its Supply Unit Price on any or all the Products from time to time, but no more than once annually, based on documented actual increases to Ferrer's direct manufacturing and labor (but specifically excluding overhead) costs (or those charged by its nominee), provided that Ferrer furnishes the Company with at least thirty (30) days prior written notice of any such change. The increase shall apply to any order received by Ferrer after the communication date of the increase. In the event that the new Supply Unit Price for the Products may make the business not feasible, the Parties, in good faith and through the Joint Steering Committee, agree to meet and negotiate in good faith an alternative solution. The purchase price for the Products shall be paid in US Dollars by the Company and such payment terms shall be [***] following the date that the Products are received and accepted (as per Article 4.4 of the LSA) by the Company, by wire transfer into an account designated by Ferrer. Invoices shall be generated upon shipment of Product from Supplier. Invoices should be sent by email to the following address: invoice@cutanea.com. Failure to send invoices to the email address provided herein may cause a delay in approval and payment. In the event that the Company does not fulfill such terms, Parties agree to discuss in good faith alternative payment conditions. In case there is not an agreement between the Parties after 30 days, Ferrer will accept an irrevocable and guaranteed letter of credit payable as term of payment. Additionally, Parties agree to share exchange EUR/ USD rate fluctuations covering the payment of royalties. More concretely, within the first 30 days after every calendar year, Ferrer will calculate the average annual EUR/USD rate based on the EUR/USD rates published in the Financial Times the last business day of every month. Such EUR/USD average rate will be compared with the rate applied in every invoice during the year. If, as a result of this reconciliation, there arises a difference above or under [***]%, Parties agree to share the resulting amount on an equitable basis (50%). Ferrer will report the reconciliation to the Company for its acceptance and, after 15 business days, issue an invoice which will be debited/credited in the next 30 days by wire transfer into the accounts designated by the Parties. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\", \"level\": 1, \"text\": \"Schedule A Capitalized terms in this Exhibit A are defined in LSA. The initial purchase price for trade units of the Products shall be set at $[***] per [***] sample tube of the Product, $[***] per [***] trade unit of the Product, $[***] per [***] trade unit of the Product, and $[***] per [***] trade unit of the Product, FCA manufacturing site (the \\\"Supply Unit Price\\\"). Notwithstanding the foregoing, after December 31, 2018 and during the term of this Agreement, Ferrer may change its Supply Unit Price on any or all the Products from time to time, but no more than once annually, based on documented actual increases to Ferrer's direct manufacturing and labor (but specifically excluding overhead) costs (or those charged by its nominee), provided that Ferrer furnishes the Company with at least thirty (30) days prior written notice of any such change. The increase shall apply to any order received by Ferrer after the communication date of the increase. In the event that the new Supply Unit Price for the Products may make the business not feasible, the Parties, in good faith and through the Joint Steering Committee, agree to meet and negotiate in good faith an alternative solution. The purchase price for the Products shall be paid in US Dollars by the Company and such payment terms shall be [***] following the date that the Products are received and accepted (as per Article 4.4 of the LSA) by the Company, by wire transfer into an account designated by Ferrer. Invoices shall be generated upon shipment of Product from Supplier. Invoices should be sent by email to the following address: invoice@cutanea.com. Failure to send invoices to the email address provided herein may cause a delay in approval and payment. In the event that the Company does not fulfill such terms, Parties agree to discuss in good faith alternative payment conditions. In case there is not an agreement between the Parties after 30 days, Ferrer will accept an irrevocable and guaranteed letter of credit payable as term of payment. Additionally, Parties agree to share exchange EUR/ USD rate fluctuations covering the payment of royalties. More concretely, within the first 30 days after every calendar year, Ferrer will calculate the average annual EUR/USD rate based on the EUR/USD rates published in the Financial Times the last business day of every month. Such EUR/USD average rate will be compared with the rate applied in every invoice during the year. If, as a result of this reconciliation, there arises a difference above or under [***]%, Parties agree to share the resulting amount on an equitable basis (50%). Ferrer will report the reconciliation to the Company for its acceptance and, after 15 business days, issue an invoice which will be debited/credited in the next 30 days by wire transfer into the accounts designated by the Parties. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of BIOFRONTERAAG_04_29_2019-EX-4.17-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 4.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXECUTION COPY SUPPLY AGREEMENT FERRER INTERNACIONAL, S.A. AND CUTANEA LIFE SCIENCES, INC. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\", \"level\": 2, \"text\": \"Exhibit 4.17 EXECUTION COPY SUPPLY AGREEMENT FERRER INTERNACIONAL, S.A. AND CUTANEA LIFE SCIENCES, INC. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUPPLY AGREEMENT This Supply Agreement (the \\\"Agreement\\\") is made as of this ____ day of March, 2018 (the \\\"Effective Date\\\"), by and between Cutanea Life Sciences, Inc., a corporation duly organized and existing under the laws of the State of Delaware with its principal place of business at 1500 Liberty Ridge Drive, Suite 3000, Wayne, PA 19087 hereinafter referred to as \\\"CUTANEA\\\"), and Ferrer Internacional, S.A., a Spanish corporation with its principal place of business at Av. Diagonal, 549, 5t h floor, 08029 Barcelona (Spain) (hereinafter indistinctly referred to as \\\"Ferrer\\\" and/or \\\"Supplier\\\"). CUTANEA and Ferrer taken together hereinafter are referred to as \\\"PARTIES\\\". WITNESSETH: WHEREAS, CUTANEA is engaged in the distribution, promotion and sale of certain pharmaceutical, OTC and medical device products and in particular desires that Ferrer manufacture (directly and/or through a third party) and supply CUTANEA with the \\\"Products\\\" (as defined below); and WHEREAS, Ferrer and Medimetriks Pharmaceuticals, Inc. (hereinafter \\\"Medimetriks\\\") entered into a License and Supply Agreement dated March 10, 2014, as amended, (hereinafter referred as \\\"LSA\\\") pursuant to which among other things, Ferrer granted Medimetriks exclusive commercialization and distribution rights to the Product (as defined in the LSA) throughout the Territory (as defined in the LSA); and WHEREAS, with Ferrer's consent, CUTANEA has acquired and assumed the rights, duties and obligations of Medimetriks under the LSA; and WHEREAS, Ferrer desires to manufacture (directly and/or through a third party) and supply CUTANEA with such Products; NOW, THEREFORE, in consideration of the mutual covenants hereinafter expressed, the Parties, intending to be legally bound hereby, agree as follows: 1. DEFINITIONS 1.1 Act \\\"Act\\\" means the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated hereunder. 1.2 Business Day \\\"Business Day\\\" means any day other than a Saturday, Sunday or other day on which banks in Philadelphia, Pennsylvania and/ or Barcelona, Spain are permitted or required to close by any applicable law. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"party:Cutanea Life Sciences, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Cutanea Life Sciences, Inc.\", \"role\": \"CUTANEA\", \"address\": \"1500 Liberty Ridge Drive, Suite 3000, Wayne, PA 19087\"}}, {\"id\": \"party:Ferrer Internacional, S.A.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Ferrer Internacional, S.A.\", \"role\": \"Supplier\", \"address\": \"Av. Diagonal, 549, 5t h floor, 08029 Barcelona (Spain)\"}}, {\"id\": \"party:Medimetriks Pharmaceuticals, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Medimetriks Pharmaceuticals, Inc.\", \"role\": \"Medimetriks\", \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Supply Agreement\", \"definition_clause\": \"Exhibit 4.17\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"____ day of March, 2018\", \"definition_clause\": \"Exhibit 4.17\"}}, {\"id\": \"term:LSA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"LSA\", \"text\": \"License and Supply Agreement dated March 10, 2014, as amended,\", \"definition_clause\": \"Exhibit 4.17\"}}, {\"id\": \"term:Act\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Act\", \"text\": \"the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated hereunder.\", \"definition_clause\": \"Exhibit 4.17\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"any day other than a Saturday, Sunday or other day on which banks in Philadelphia, Pennsylvania and/ or Barcelona, Spain are permitted or required to close by any applicable law.\", \"definition_clause\": \"Exhibit 4.17\"}}, {\"id\": \"2.6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of a conflict between the test results of Supplier and the test results of CUTANEA with respect to any ship\", \"level\": 3, \"text\": \"2.6.2 In the event of a conflict between the test results of Supplier and the test results of CUTANEA with respect to any shipment of Product batch, within thirty (30) days following receipt by Supplier of CUTANEA's notice of rejection, sample of such Product batch shall be submitted by Supplier (and/or its nominee) to an independent laboratory designated by Supplier (and/or its nominee) and reasonably acceptable to CUTANEA, which shall perform an assessment and whose findings shall be conclusive. The cost of the assessment shall be borne by (i) CUTANEA if the findings indicate the Product met all Specifications or (ii) Supplier (or its nominee) if the findings indicate the Product failed to meet any Specifications. 2.7 Supply Price. The initial Supply Price for each Product (commercial trade and sample units) to be paid by CUTANEA to Supplier are listed in Schedule A. These Supply Prices are for finished forms of the Products [***] (except as otherwise set forth herein). 2.8 Quality Agreement. The Parties shall enter into a Quality Agreement for the Products. If there is any conflict between this Agreement and the Quality Agreement solely with respect to quality assurance matters, the Quality Agreement will prevail, and with respect to all other matters, this Agreement will prevail. 2.9 Pharmacovigilance Agreement. The Parties shall enter into a pharmacovigilance agreement with respect to the Products (the \\\"Pharmacovigilance Agreement\\\"). If there is any conflict between this Agreement and the Pharmacovigilance Agreement solely with respect to adverse events and patient safety, the Pharmacovigilance Agreement will prevail, and with respect to all other matters, this Agreement will prevail. 7 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"term:Pharmacovigilance Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Pharmacovigilance Agreement\", \"text\": \"a pharmacovigilance agreement with respect to the Products\", \"definition_clause\": \"2.6.2\"}}, {\"id\": \"5.8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each of the parties represents, warrants, certifies and covenants that to the best of its knowledge it has not and will\", \"level\": 3, \"text\": \"5.8.2 Each of the parties represents, warrants, certifies and covenants that to the best of its knowledge it has not and will not use in any capacity the services of any individual, corporation, partnership, or association which has been convicted or debarred under Section 306 of the Act or similar local law. In the event that a party becomes aware of or receives notice of the conviction or debarment of any individual, corporation, partnership, or association providing services to such party, which relates to the execution or performance of this Agreement, Supplier agrees to notify CUTANEA immediately. 6. PRODUCT RECALLS 6.1 Initiating and Effecting Recall. Supplier, as the NDA holder for the Product, shall make all decisions with respect to any complaint or \\\"adverse drug experience\\\", or any recall, market withdrawal or any other corrective action related to any Product. Supplier shall be responsible for processing and submitting to the applicable authorities or agencies all reports of adverse drug experiences and Product complaints in accordance with applicable Acts. Supplier shall investigate all complaints associated with the Manufacture, safety or efficacy of the Product. CUTANEA shall notify Supplier in accordance with the terms of the Quality Agreement and the Pharmacovigilance Agreement of any complaints received by CUTANEA concerning any Products. 6.2 Implementation of Recall. Supplier shall implement recalls of Products from the market or other corrective actions related to the Product. CUTANEA shall assist Supplier, to the extent necessary or relevant, in implementing withdrawals or recalls of Products from the market or other corrective actions related to Products. Upon the receipt by either party of any direction to withdraw or recall any Product from the market from any Governmental or Regulatory Authority having jurisdiction, the receiving party shall notify the other party as soon as practicable in accordance with the terms of this Agreement and the Quality Agreement. With respect to notice to CUTANEA, it should be sent to [ ].com or via phone at [ ]. To the extent any seizure, withdrawal, recall (whether voluntary or involuntary), or corrective action with respect to any Product (collectively, \\\"Product Action\\\") results from the adulteration or contamination (other than any naturally occurring contamination that can be traced back to the Manufacturing process) of Product while in the care and custody of CUTANEA, CUTANEA shall be responsible for the costs of the Product Action. Otherwise, Supplier shall be responsible for all of the costs of the Product Action. 12 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"term:Product Action\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Action\", \"text\": \"any seizure, withdrawal, recall (whether voluntary or involuntary), or corrective action with respect to any Product\", \"definition_clause\": \"5.8.2\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE The occurrence of an event which materially interferes with the ability of a party to perform its obligat\", \"level\": 1, \"text\": \"7. FORCE MAJEURE The occurrence of an event which materially interferes with the ability of a party to perform its obligations or duties hereunder which is not within the reasonable control of the party affected (or in the case of Supplier, any current manufacturer of the Product) not due to the affected party's malfeasance, and which could not with the exercise of reasonable due diligence have been avoided (\\\"Force Majeure\\\"), including, but not limited to, fire, accident, labor difficulty, strike, riot, terrorism, civil commotion, act of God, delay or errors by shipping companies or change in Law, Governmental or Regulatory Authority action or inaction, shall not excuse such party from the performance of its obligations or duties under this Agreement, but shall merely suspend such performance during the continuation of Force Majeure. The party prevented from performing its obligations or duties because of Force Majeure shall promptly notify the other party hereto (the \\\"Other Party\\\") of the occurrence and particulars of such Force Majeure and shall provide the Other Party, from time to time, with its best estimate of the duration of such Force Majeure and with notice of the termination thereof. The party so affected shall use its commercially reasonable efforts to avoid or remove such causes of nonperformance. Upon termination of Force Majeure, the performance of any suspended obligation or duty shall promptly recommence. Neither party shall be liable to the other party for any direct, indirect, consequential, incidental, special, punitive or exemplary damages arising out of or relating to the suspension or termination of any of its obligations or duties under this Agreement by reason of the occurrence of Force Majeure. 8. CHANGES 8.1 Changes by CUTANEA. Any changes to the Specifications requested by CUTANEA must be approved by Supplier (or its designee) in its reasonable discretion and shall be incorporated and all costs and expenses associated with such changes shall be borne by CUTANEA. 8.2 Changes by Supplier. Any changes to the Specifications requested by Supplier must be notified to CUTANEA in advance to its implementation, and shall be incorporated only after approval of Governmental or Regulatory Authorities. All costs and expenses associated with such changes shall be borne by Supplier. 8.3 Changes by Governmental or Regulatory Authorities. The costs and expenses of any changes to the Specifications requested by any Governmental or Regulatory Authority shall be borne by Supplier unless the change, in the opinion of the JSC (as that term is defined in the LSA), entails a benefit to CUTANEA, in which case the costs arising from the changes and its implementation shall be borne by CUTANEA. 8.4 Obsolete Inventory. Any CUTANEA-specific inventory including, but not limited to, raw materials, work-in-process, packaging and finished goods rendered obsolete as a result of Supplier's supplier minimum order quantities that exceed the binding quantities of Product of Forecasted Needs, formula, artwork or packaging changes not requested by CUTANEA or by changes required by any Governmental or Regulatory Authority shall be destroyed in accordance with all applicable laws and regulations and Supplier shall indemnify CUTANEA for any liability, costs or expenses, including attorney's fees and court costs, relating to Supplier's failure to dispose of such inventory in accordance with such laws and regulations. Supplier shall also provide CUTANEA with all manifests and other applicable evidence of proper destruction as may be requested by CUTANEA or required by applicable laws and regulations. Any other materials rendered obsolete that are not result of Supplier's supplier minimum order quantities that exceed the binding quantities of Product of Forecasted Needs, formula, artwork or packaging changes requested by CUTANEA shall be reimbursed to Supplier by CUTANEA. 13 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"The occurrence of an event which materially interferes with the ability of a party to perform its obligations or duties hereunder which is not within the reasonable control of the party affected (or in the case of Supplier, any current manufacturer of the Product) not due to the affected party's malfeasance, and which could not with the exercise of reasonable due diligence have been avoided\", \"definition_clause\": \"7\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"9. CONFIDENTIAL INFORMATION: INTELLECTUAL PROPERTY RIGHTS 9.1 Confidential Information. 9.1.1 All Confidential Information furnished by the Disclosing Party during the term of this Agreement shall be kept confidential and not used by the Receiving Party, except for purposes authorized by this Agreement, and shall not be disclosed to any person or firm, unless previously authorized in writing to do so, during the term of this Agreement and for an indefinite period thereafter. The Receiving Party may, however, disclose the same to its responsible officers and employees who require said information in order to perform such party's obligations under this Agreement, provided that said officers and employees shall have assumed like obligations of confidentiality. 9.1.2 Any other provisions hereof to the contrary notwithstanding, it is expressly understood and agreed by the Parties hereto that the obligations of confidence and nonuse herein assumed shall not apply to any information which may be demonstrated by documented means of sufficient evidence that: (1) is at the time of disclosure or thereafter becomes a part of the public domain through no fault, omission or other act of the Receiving Party or any individual or entity receiving such information, directly or indirectly, from the Receiving Party; or (2) was otherwise in the Receiving Party's lawful possession with no obligation or duty to maintain the confidentiality thereof prior to disclosure as shown by its written record; or (3) is hereafter disclosed to the Receiving Party by a third party lawfully entitled to possession of such Confidential Information and under no obligation or duty of confidentiality; or (4) is released from a confidential status by Disclosing Party as evidence by an instrument or agreement duly executed by Disclosing Party; or (5) is required to be disclosed pursuant to regulatory or legal requirements, provided that the Receiving Party provides reasonable advance notice to the Disclosing Party and the Receiving Party reasonably cooperates with the Disclosing Party to obtain confidentiality protection of such information. 14 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification by CUTANEA\", \"level\": 2, \"text\": \"10.2 Indemnification by CUTANEA. CUTANEA shall indemnify, defend and hold Supplier harmless from any and all Losses, to which Supplier may become subject as a result of any Claim to the extent such Losses arise out of or in connection with: (i) the development, use, storage, handling, distribution, marketing or selling of the Products by CUTANEA and its Affiliates; (ii) the negligence or willful misconduct of CUTANEA and its Affiliates; (iii) the breach or non-fulfilment by CUTANEA of its obligations according to this Agreement and/or any law in force; or (iv) a breach by CUTANEA of any warranty, representation, covenant or agreement made by it in this Agreement; except, in each case, to the extent such Losses result from: (a) the negligence or willful misconduct of Supplier (b) the breach by Supplier of any warranty, representation, covenant or agreement made by it in this Agreement and to the extent that such negligence, willful misconduct or breach it is stated by a final court decision. Notwithstanding the foregoing, CUTANEA shall have no obligation to indemnify Supplier for reasonable lawyers' fees and other legal expenses incurred by Supplier after CUTANEA has taken over the defense of such claim, \\\"Action or Proceeding\\\" in accordance with Section 10.3 unless and then only to the extent otherwise agreed to in advance in writing by CUTANEA. 10.3 Assertion of Claim. In the event that any claim is asserted against any party hereto, or any party hereto is made a party defendant in any action or proceeding, and such claim, action or proceeding (which shall mean any action, claim, suit, proceeding, arbitration or Governmental or Regulatory Authority action, notification, investigation or audit, hereinafter referred to as an \\\"Action or Proceeding\\\") involves a matter which is subject to a claim for indemnification under this Section, then such party (an \\\"Indemnified Party\\\") shall promptly give written notice to the other party or parties (the \\\"Indemnifying Party\\\") of such claim, Action or Proceeding. If the Indemnifying Party agrees in writing to be bound by and to promptly pay the full amount of any final judgment from which no further appeal may be taken (or otherwise confirms its indemnification obligation responsibility to the satisfaction of the Indemnified Party) and if the Indemnified Party is reasonably assured of the Indemnifying Party's ability to satisfy such agreement, then such Indemnifying Party shall take over the defense of such claim, Action or Proceeding, except that, in such case, the Indemnified Party shall have the right to approve any attorney or counsel selected by the Indemnifying Party (which approval shall not be unreasonably delayed or withheld) and to join in the defense of said claim, Action or Proceeding at its own cost and expense. In no event shall the Indemnifying Party settle any such claim or potential claim, Action or Proceeding without the prior written consent of the Indemnified Party, which consent shall not be unreasonably withheld. 16 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"term:Action or Proceeding\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Action or Proceeding\", \"text\": \"any action, claim, suit, proceeding, arbitration or Governmental or Regulatory Authority action, notification, investigation or audit\", \"definition_clause\": \"10.2\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Anti-Corruption Undertaking Both parties shall comply with, and will not cause any party and its Affiliates, associates,\", \"level\": 2, \"text\": \"11.3 Anti-Corruption Undertaking Both parties shall comply with, and will not cause any party and its Affiliates, associates, directors, officers, shareholders, employees, representatives, sublicensees or agents worldwide to be in violation with any applicable anti-corruption laws, rules and regulations including but not limited to the United States Foreign Corrupt Practices Act (the \\\"FCPA\\\") or U.K. Bribery Act 2010. Without limiting the foregoing, neither party will, directly or indirectly, pay any money to, or offer or give anything of value to, any Government Official, in order to obtain or retain business or to secure any commercial or financial advantage for the other party or for itself or any of their respective Affiliates. Each of the parties undertakes not to bribe Government Officials or any private companies or individuals, \\\"bribes\\\" having the following definition: Offering, promising, or giving a financial or other advantage to another person where it is intended to bring about the improper performance of a relevant function or activity, or to reward such improper performance; acceptance of the advantage offered, promised or given in itself constitutes improper performance of a relevant function or activity. \\\"Improper Performance\\\" means a breach of expectations that a person will act in good faith, impartially, or in accordance with a position of trust. Both parties must also (1) make and keep books, records and accounts, which, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets of the company, (2) devise and maintain a system of internal accounting controls, and (3) at any time a party so requests in writing, but no more than once a year, grant to the other party commercially reasonable access to said books, records, systems and accounts to verify compliance. Such inspection shall be undertaken by an independent public accountant or accounting firm appointed by the requesting party and about whom the other party does not express a legitimate concern. For the avoidance of doubt, this restricted annual audit shall not apply to for-cause audits, which may be conducted at any time. 19 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"term:FCPA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FCPA\", \"text\": \"the United States Foreign Corrupt Practices Act\", \"definition_clause\": \"11.3\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS 12\", \"level\": 1, \"text\": \"12. GENERAL PROVISIONS 12.1 Notices. Except for invoices, which shall be sent in accordance with Schedule A, all notices required or permitted under this Agreement must be written and sent to the address or facsimile number identified in this Agreement or a subsequent notice. All notices must be given (a) by personal delivery, with receipt acknowledged, (b) by facsimile followed by hard copy delivered by the methods under (c) or (d), (c) by prepaid certified or registered mail, return receipt requested, or (d) by prepaid recognized next business day delivery service. Notices will be effective upon receipt or at such later time as stated in the notice. Notices shall be sent: If to Supplier: Ferrer Internacional, S.A. Attention: Legal Department Av. Diagonal, 549, 5t h Floor 08029 Barcelona, Spain If to CUTANEA: Cutanea Life Sciences, Inc. Attention: President and CEO 1500 Liberty Ridge Drive Suite 3000 Wayne, PA 19087 With a copy (which shall constitute notice) to: Cutanea Life Sciences, Inc. Attention: General Counsel 1500 Liberty Ridge Drive Suite 3000 Wayne, PA 19087 Fax: +1 484.652.0223 12.2 Entire Agreement; Amendment. The Parties hereto acknowledge that this Agreement, including the Quality Agreement and the Pharmacovigilance Agreement and any exhibits, schedules or other attachments hereto sets forth the entire agreement and understanding of the Parties and supersede all prior written or oral agreements or understandings with respect to the subject matter hereof. In the event of any conflict between this Agreement and the LSA, this Agreement will control with respect to issues of quality assurance, patient safety, Supply Unit Price and changes to it, and other terms and conditions customarily associated with supply agreements for commercial pharmaceutical products. Notwithstanding the precedent, in the event of any conflict between Quality Agreement and/or Pharmacovigilance Agreement and this Agreement, Quality Agreement or Pharmacovigilance Agreement shall prevail with respect to terms and conditions customarily associated with Quality or Pharmacovigilance as respectively applicable. No modification of any of the terms of this Agreement, or any amendments thereto, shall be deemed to be valid unless in writing and signed by the party against whom enforcement is sought. No course of dealing or usage of trade shall be used to modify the terms and conditions herein. 20 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Waiver\", \"level\": 2, \"text\": \"12.3 Waiver. No waiver by either party of any default shall be effective unless in writing, nor shall any such waiver operate as a waiver of any other default or of the same default on a future occasion. 12.4 Assignment. This Agreement shall be assignable or transferable by either party hereto only with the consent in writing of the other party, such consent not to be unreasonably withheld. However, Supplier shall be free to assign this Agreement along with the LSA in favor of any third party, provided that the succeeding entity assumes all of the obligations under this Agreement and the LSA, and further provided that Supplier provides CUTANEA with prior written notice of such assignment. Any assignments, including but not limited to, sale, transfer, or license of brand or Products, shall not release the original party hereto from their duties and obligations under this Agreement. For the purposes of this Agreement, the terms \\\"subsidiaries\\\" and \\\"affiliates\\\" shall mean any entity controlling, controlled by, or under common control with, either of the Parties hereto. 12.5 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without reference to any principles of conflicts of law thereof. Any suit or proceeding arising in respect of this Agreement will be tried exclusively in the United States District Court of the Southern District of the State of New York or, if that court declines to accept or does not have jurisdiction over a particular matter, any other State Court in the State of New York or Federal court of the United States of America located in the State of New York, and both parties irrevocably and unconditionally agree to submit to the exclusive jurisdiction of, and to venue in, such courts (and agree not to commence any action, suit, or proceeding relating thereto except in such courts). Both parties hereby irrevocably and unconditionally waive any objection to the laying of venue of any action, suit, or proceeding arising out of this Agreement in such court, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit, or proceeding brought in any such court has been brought in an inconvenient forum. Both parties further agree that service of any process, summons, notice or document by U.S. registered mail to the respective addresses set forth below shall be effective service of process for any action, suit or proceeding brought against the parties in any such court. BOTH PARTIES HEREBY IRREVOCABLY WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING REGARDING THE SUBJECT MATTER OF THIS AGREEMENT. 21 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"term:subsidiaries\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"subsidiaries\", \"text\": \"any entity controlling, controlled by, or under common control with, either of the Parties hereto.\", \"definition_clause\": \"12.3\"}}, {\"id\": \"term:affiliates\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"affiliates\", \"text\": \"any entity controlling, controlled by, or under common control with, either of the Parties hereto.\", \"definition_clause\": \"12.3\"}}, {\"id\": \"12.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"12.6 Severability. In the event that any term or provision of this Agreement shall violate any applicable statute, ordinance, or rule of law in any jurisdiction in which it is used, or otherwise be unenforceable, such provision shall be ineffective to the extent of such violation without invalidating any other provision hereof. 12.7 Headings, Interpretation. The headings used in this Agreement are for convenience only and are not a part of this Agreement. 12.8 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same original. 12.9 Independent Contractor. In performing its services hereunder, Supplier shall act as an independent contractor. [Signature page follows.] 22 [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. IN WITNESS WHEREOF, the Parties hereto have each caused this Agreement to be executed by their duly authorized officers as of the date first above written. CUTANEA LIFE SCIENCES, INC. FERRER INTERNACIONAL, S.A. By: /s/ [***] By: /s/ [***] Its: [***] Its: [***] Date: Date: FERRER INTERNACIONAL, S.A. By: /s/ [***] Its: [***] Date: [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"Schedule A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Capitalized terms in this Exhibit A are defined in LSA. The initial purchase price for trade units of the Products shall be set at $[***] per [***] sample tube of the Product, $[***] per [***] trade unit of the Product, $[***] per [***] trade unit of the Product, and $[***] per [***] trade unit of the Product, FCA manufacturing site (the \\\"Supply Unit Price\\\"). Notwithstanding the foregoing, after December 31, 2018 and during the term of this Agreement, Ferrer may change its Supply Unit Price on any or all the Products from time to time, but no more than once annually, based on documented actual increases to Ferrer's direct manufacturing and labor (but specifically excluding overhead) costs (or those charged by its nominee), provided that Ferrer furnishes the Company with at least thirty (30) days prior written notice of any such change. The increase shall apply to any order received by Ferrer after the communication date of the increase. In the event that the new Supply Unit Price for the Products may make the business not feasible, the Parties, in good faith and through the Joint Steering Committee, agree to meet and negotiate in good faith an alternative solution. The purchase price for the Products shall be paid in US Dollars by the Company and such payment terms shall be [***] following the date that the Products are received and accepted (as per Article 4.4 of the LSA) by the Company, by wire transfer into an account designated by Ferrer. Invoices shall be generated upon shipment of Product from Supplier. Invoices should be sent by email to the following address: invoice@cutanea.com. Failure to send invoices to the email address provided herein may cause a delay in approval and payment. In the event that the Company does not fulfill such terms, Parties agree to discuss in good faith alternative payment conditions. In case there is not an agreement between the Parties after 30 days, Ferrer will accept an irrevocable and guaranteed letter of credit payable as term of payment. Additionally, Parties agree to share exchange EUR/ USD rate fluctuations covering the payment of royalties. More concretely, within the first 30 days after every calendar year, Ferrer will calculate the average annual EUR/USD rate based on the EUR/USD rates published in the Financial Times the last business day of every month. Such EUR/USD average rate will be compared with the rate applied in every invoice during the year. If, as a result of this reconciliation, there arises a difference above or under [***]%, Parties agree to share the resulting amount on an equitable basis (50%). Ferrer will report the reconciliation to the Company for its acceptance and, after 15 business days, issue an invoice which will be debited/credited in the next 30 days by wire transfer into the accounts designated by the Parties. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\", \"level\": 1, \"text\": \"Schedule A Capitalized terms in this Exhibit A are defined in LSA. The initial purchase price for trade units of the Products shall be set at $[***] per [***] sample tube of the Product, $[***] per [***] trade unit of the Product, $[***] per [***] trade unit of the Product, and $[***] per [***] trade unit of the Product, FCA manufacturing site (the \\\"Supply Unit Price\\\"). Notwithstanding the foregoing, after December 31, 2018 and during the term of this Agreement, Ferrer may change its Supply Unit Price on any or all the Products from time to time, but no more than once annually, based on documented actual increases to Ferrer's direct manufacturing and labor (but specifically excluding overhead) costs (or those charged by its nominee), provided that Ferrer furnishes the Company with at least thirty (30) days prior written notice of any such change. The increase shall apply to any order received by Ferrer after the communication date of the increase. In the event that the new Supply Unit Price for the Products may make the business not feasible, the Parties, in good faith and through the Joint Steering Committee, agree to meet and negotiate in good faith an alternative solution. The purchase price for the Products shall be paid in US Dollars by the Company and such payment terms shall be [***] following the date that the Products are received and accepted (as per Article 4.4 of the LSA) by the Company, by wire transfer into an account designated by Ferrer. Invoices shall be generated upon shipment of Product from Supplier. Invoices should be sent by email to the following address: invoice@cutanea.com. Failure to send invoices to the email address provided herein may cause a delay in approval and payment. In the event that the Company does not fulfill such terms, Parties agree to discuss in good faith alternative payment conditions. In case there is not an agreement between the Parties after 30 days, Ferrer will accept an irrevocable and guaranteed letter of credit payable as term of payment. Additionally, Parties agree to share exchange EUR/ USD rate fluctuations covering the payment of royalties. More concretely, within the first 30 days after every calendar year, Ferrer will calculate the average annual EUR/USD rate based on the EUR/USD rates published in the Financial Times the last business day of every month. Such EUR/USD average rate will be compared with the rate applied in every invoice during the year. If, as a result of this reconciliation, there arises a difference above or under [***]%, Parties agree to share the resulting amount on an equitable basis (50%). Ferrer will report the reconciliation to the Company for its acceptance and, after 15 business days, issue an invoice which will be debited/credited in the next 30 days by wire transfer into the accounts designated by the Parties. [***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.\"}}, {\"id\": \"term:Supply Unit Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Supply Unit Price\", \"text\": \"The initial purchase price for trade units of the Products shall be set at $[***] per [***] sample tube of the Product, $[***] per [***] trade unit of the Product, $[***] per [***] trade unit of the Product, and $[***] per [***] trade unit of the Product, FCA manufacturing site\", \"definition_clause\": \"Schedule A\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:15 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"15 business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of BLACKBOXSTOCKSINC_08_05_2014-EX-10.1-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of BLACKBOXSTOCKSINC_08_05_2014-EX-10.1-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.1\", \"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 2, \"text\": \"Exhibit 10.1 DISTRIBUTOR AGREEMENT THIS AGREEMENT is made this 1st day of August, 2013, (the \\\"Effective Date\\\"), by and between Snotarator LLC, a Texas limited liability company, with its principal place of business located at 2591 Dallas Parkway, Suite 102, Frisco, Texas 75034 (the \\\"Company\\\") and SMSA Ballinger Acquisition Corp., a Nevada corporation, with offices at 12890 Hilltop Road, Argyle, Texas 76226 (the \\\"Distributor\\\"). NOW, THEREFORE, in consideration of the promises hereinafter made by the parties hereto, it is agreed as follows: ARTICLE I APPOINTMENT OF DISTRIBUTORSHIP\"}, {\"id\": \"1.01\", \"title\": \"Distribution Right\", \"level\": 2, \"text\": \"1.01. Distribution Right. The Company hereby appoints and grants Distributor the exclusive right to sell the products of the Company, including the Snotarator\u2122 Nasal Aspirator, (\\\"Products\\\") listed in the current \\\"Price List\\\" (Exhibit \\\"A\\\" attached hereto). The distribution right shall be limited to all countries and all of their territories and possessions within the continent known as South America (\\\"Territory\\\") (Exhibit \\\"B\\\" attached hereto). Distributor agrees that the Products, including the name Snotarator \u2122 Nasal Aspirator (the \\\"Brand\\\") are the sole property of the Company and Distributor has no interest whatsoever in such Brand and Products, and Distributor shall use the Brand and Products only for so long as the rights granted hereby remains in full force and effect. Distributor shall not take any actions, or aid or assist any other party to take any actions that would infringe upon, harm or contest the proprietary rights of Company in and to the Brand and Products. Distributor shall not assign the rights granted in this Section 1.01 without the prior written consent of the Company.\"}, {\"id\": \"1.02\", \"title\": \"Prices\", \"level\": 2, \"text\": \"1.02 Prices. All prices stated are in United States dollars and FOB the Company's offices in Frisco, Texas. Prices do not include transportation costs which shall be borne by Distributor.\"}, {\"id\": \"1.03\", \"title\": \"Terms\", \"level\": 2, \"text\": \"1.03. Terms. Terms are net cash upon delivery.\"}, {\"id\": \"1.04\", \"title\": \"Competitive Products\", \"level\": 2, \"text\": \"1.04. Competitive Products. Distributor agrees not to represent or sell other products which are deemed to be competitive with the Company's Products unless agreed to by the Company by written notice.\"}, {\"id\": \"ARTICLE II\", \"title\": \"MARKETING AND SUPPORT\", \"level\": 1, \"text\": \"ARTICLE II MARKETING AND SUPPORT\"}, {\"id\": \"2.01\", \"title\": \"Sales\", \"level\": 2, \"text\": \"2.01. Sales. Distributor shall use commercially reasonable efforts to market, distribute and promote the Brand and Products in the Territory at its own cost.\"}, {\"id\": \"ARTICLE III\", \"title\": \"DELIVERY\", \"level\": 1, \"text\": \"ARTICLE III DELIVERY\"}, {\"id\": \"3.01\", \"title\": \"Purchase Orders\", \"level\": 2, \"text\": \"3.01. Purchase Orders. Distributor shall order Products by written notice to Company. Each order shall specify the number of units to be shipped, the type of units to be shipped (as identified by Company model number designations indicated in the Price List) including all optional features, the desired method of shipment. Company shall indicate its acceptance of such purchase order by returning a signed copy to Distributor. Company agrees to ship units to Distributor as close as possible to the delivery schedule set forth in each order as accepted by Company, unless Company otherwise indicates in writing\"}, {\"id\": \"3.02\", \"title\": \"Shipment\", \"level\": 2, \"text\": \"3.02. Shipment. All shipments of Products shall be made FOB Company's office and liability for loss or damage in transit, or thereafter, shall pass to Distributor upon Company's delivery of Products to a common carrier for shipment. Shipping dates are approximate and are based, to a great extent, on prompt receipt by Company of all necessary ordering information from Distributor. Distributor shall bear all costs of transportation and insurance and will promptly reimburse Company if Company prepays or otherwise pays for such expenses. Company shall not be in default by reason of any failure in its performance under this Agreement if such failure results from, whether directly or indirectly, fire, explosion, strike, freight embargo, Act of God or of the public enemy, war, civil disturbance, act of any government, de jure or de facto, or agency or official thereof, material or labor shortage, transportation contingencies, unusually severe weather, default of any other manufacturer or a supplier or subcontractor, quarantine, restriction, epidemic, or catastrophe, lack of timely instructions or essential information from Distributor, or otherwise arisen out of causes beyond the control of the Company. Nor shall the Company at any time be liable for any incidental, special or consequential damages.\"}, {\"id\": \"3.03\", \"title\": \"Cancellation\", \"level\": 2, \"text\": \"3.03. Cancellation. Distributor may, at any time prior to the scheduled date of shipment, cancel any or all Products on order upon giving timely written notice.\"}, {\"id\": \"ARTICLE IV\", \"title\": \"PATENT AND TRADEMARK INFRINGEMENT\", \"level\": 1, \"text\": \"ARTICLE IV PATENT AND TRADEMARK INFRINGEMENT\"}, {\"id\": \"4.01\", \"title\": \"Patent Infringement\", \"level\": 2, \"text\": \"4.01 Patent Infringement. Company agrees, at its own expense, to indemnify, defend and hold harmless each Distributor and its customers from and against every expense, damage, cost and loss (including attorneys' fees incurred) and to satisfy all judgments and decrees resulting from a claim, suit or proceeding insofar as it is based upon an allegation that any Product or any part thereof furnished by Company or any process which is practiced in the customary use of the Product is or has been infringing upon any patent, copyright or proprietary right, if Company is notified promptly of such claim in writing and given authority, and full and proper information and assistance (at Company's expense) for the defense of same. In case any Product, or any part thereof, if such suit is held to constitute an infringement and the use of said Product or part is enjoined, Company shall, in its sole discretion and at its own expense, either procure for the indemnitee the right to continue using said Product or provide or procure for the Distributor a similar product.\"}, {\"id\": \"4.02\", \"title\": \"Trademark Infringement\", \"level\": 2, \"text\": \"4.02 Trademark Infringement. The Company has registered the mark Snotarator \u2122 in the United States. Distributor agrees it will not at any time, either during the term of this Agreement or thereafter, use the Brand, Products or Snotarator\u2122 mark in any manner that might infringe upon the Company's ownership rights to same directly or indirectly. Distributor shall indemnify and hold the Company and its affiliates harmless from and against any and all claims, judgments, costs, awards, expenses (including reasonable attorney fees) and liabilities of every kind arising from Distributor's fault or negligence in its use of the Snotarator \u2122 mark and in the marketing and distribution of the Products within the Territory.\"}, {\"id\": \"ARTICLE V\", \"title\": \"WARRANTY\", \"level\": 1, \"text\": \"ARTICLE V WARRANTY\"}, {\"id\": \"5.01\", \"title\": \"Products Warranty\", \"level\": 2, \"text\": \"5.01. Products Warranty. Company warrants that Distributor shall acquire Products purchased hereunder free and clear of all liens and encumbrances except for Company's purchase money security interest defined in Section 1.03, above. Company further warrants all Products to be free from defects in material or workmanship under normal use and service for a period of ninety (90) days from the date of delivery. Any defects must be replaced by the Company within sixty (60) days within this scope of the warranty and all charges for labor and material, will be borne by Company. If it is determined that either no fault exists in Company, or the damage was caused by negligence of Distributor, its agents, employees or customers, Distributor agrees to pay all charges associated with each such replacement. THIS CONSTITUTES THE SOLE WARRANTY MADE BY COMPANY EITHER EXPRESSED OR IMPLIED. THERE ARE NO OTHER WARRANTIES EXPRESSED OR IMPLIED WHICH EXTEND BEYOND THE FACE HEREOF, HEREIN, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL COMPANY BE LIABLE FOR ANY INCIDENTAL OR CONSEQUENTIAL DAMAGES AND DISTRIBUTOR'S REMEDIES SHALL BE LIMITED TO REPAIR OR REPLACEMENT OF NONCONFORMING UNITS OR PARTS. 2\"}, {\"id\": \"ARTICLE VI\", \"title\": \"DURATION OF AGREEMENT\", \"level\": 1, \"text\": \"ARTICLE VI DURATION OF AGREEMENT\"}, {\"id\": \"6.01\", \"title\": \"Term\", \"level\": 2, \"text\": \"6.01. Term. The term of this Agreement shall terminate on May 31, 2015, unless sooner terminated. Termination shall not relieve either party of obligations incurred prior thereto. The term of this Agreement may be extended for an additional two year period with the written consent of both parties.\"}, {\"id\": \"6.02\", \"title\": \"Termination\", \"level\": 2, \"text\": \"6.02. Termination. This Agreement may be terminated only: (a) By either party for substantial breach of any material provision of this Agreement by the other, provided due notice has been given to the other of the alleged breach and such other party has not cured the breach within (30) days] thereof; or (b) By the Company if: there is an unacceptable change in the control or management of the Distributor; if the Distributor makes an assignment for the benefit of creditors; if a petition in bankruptcy is filed by or against the Distributor, resulting in an adjudication of bankruptcy; or, if the Distributor fails to pay its debts as they become due and provided due notice has been given by the Company to the Distributor and the Distributor has not cured such breach within thirty (30) days thereof; or (c) By the written consent of both parties; (d) Upon termination of this Agreement all further rights and obligations of the parties shall cease, except that Distributor shall not be relieved of (i) its obligation to pay any monies due, or to become due, as of or after the date of termination, and (ii) any other obligation set forth in this Agreement which is to take effect after the date of termination.\"}, {\"id\": \"ARTICLE VII\", \"title\": \"NOTICES\", \"level\": 1, \"text\": \"ARTICLE VII NOTICES\"}, {\"id\": \"7.01\", \"title\": \"Notice or Communication\", \"level\": 2, \"text\": \"7.01. Notice or Communication. Any notice or communication required or permitted hereunder shall be in writing and shall be sent by international courier or registered mail, return receipt requested, postage prepaid and addressed to the addresses set forth below or to such changed address as any party entitled to notice shall have communicated in writing to the other party. Purchase orders and other administrative notices may be sent by facsimile transmission or regular mail. Notices and communications to Company shall be sent to: Snotarator LLC 2591 Dallas Parkway Suite 102 Frisco, Texas 75034 Notices and communications to Distributor shall be sent to address shown on first page of this Agreement. Any notices or communications to either party hereunder shall be deemed to have been given when deposited in the mail, addressed to the then current address of such party.\"}, {\"id\": \"7\", \"title\": \"02\", \"level\": 1, \"text\": \"7.02 . Date of Effectiveness. Any such notice or communication so mailed shall be deemed delivered and effective seventy-two (72) hours after mailing thereof in the United States.\"}, {\"id\": \"ARTICLE VIII\", \"title\": \"CONFIDENTIALITY 3\", \"level\": 1, \"text\": \"ARTICLE VIII CONFIDENTIALITY 3\"}, {\"id\": \"8\", \"title\": \"01\", \"level\": 1, \"text\": \"8.01 . Confidentiality. Each party agrees to maintain in confidence and not to use except for the purpose of this Agreement any information of a confidential nature such as technical information and data, commercial information and know-how, price structures, administrative and operational costs, or other information relating to each other's business operations or in the case of Distributor to the Brand and Products whether disclosed prior to the Effective Date or thereafter. Each party's obligation of confidentiality and limitation upon use shall not apply to any information to the extent that the receiving party can show that such information: a) is or became generally available to the public otherwise than by reason of breach by the receiving party of the provisions of this Agreement; b) was known to the receiving party prior to the date of the Agreement provided that documentary evidence of such knowledge is provided to the disclosing party on request;\"}, {\"id\": \"c\", \"title\": \"was subsequently disclosed to the receiving party without obligation of confidentiality by a third party owing no such\", \"level\": 1, \"text\": \"c) was subsequently disclosed to the receiving party without obligation of confidentiality by a third party owing no such obligations to the disclosing party in respect of such information;\"}, {\"id\": \"d\", \"title\": \"is required by laws to be disclosed but then only when, to the extent reasonably practicable, prompt notice of this r\", \"level\": 1, \"text\": \"d) is required by laws to be disclosed but then only when, to the extent reasonably practicable, prompt notice of this requirement has been given to the original disclosing party so that it may seek appropriate relief to prevent or limit such disclosure. Except as required by applicable laws or court order or as otherwise permitted under this Agreement, all publicity, press releases and public announcements, in each case relating to the Brand and Products in the Territory and/or the transactions contemplated hereby shall be reviewed in advance by, and shall be subject to the written approval (such approval not to be unreasonably withhold) of both the Company and Distributor. The parties hereto may disclose the existence of this Agreement and the terms and conditions hereof, without the prior written consent of the other parties, as may be required by applicable laws, in which case the party seeking to disclose the information shall give the other parties reasonable advanced notice and review of any such disclosure and shall seek confidential treatment of such information to the extent possible under applicable law.\"}, {\"id\": \"ARTICLE IX\", \"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"ARTICLE IX GENERAL PROVISIONS\"}, {\"id\": \"9.01\", \"title\": \"Relationship of Parties\", \"level\": 2, \"text\": \"9.01. Relationship of Parties. The relationship between the parties established by this Agreement shall be solely that of vendor and vendee and all rights and powers not expressly granted to the Distributor are expressly reserved to the Company. The Distributor shall have no right, power or authority in any way to bind the Company to the fulfillment of any condition not herein contained, or to any contract or obligation, expressed or implied.\"}, {\"id\": \"9.02\", \"title\": \"Independence of Parties\", \"level\": 2, \"text\": \"9.02. Independence of Parties. Nothing contained in this Agreement shall be construed to make the Distributor the agent for the Company for any purpose, and neither party hereto shall have any right whatsoever to incur any liabilities or obligations on behalf or binding upon the other party. The Distributor specifically agrees that it shall have no power or authority to represent the Company in any manner; that it will solicit orders for Products as an independent contractor in accordance with the terms of this Agreement; and that it will not at any time represent the Company in any manner; that it will solicit orders for Products as an independent contractor in accordance with the terms of this Agreement; and that it will not at any time represent orally or in writing to any person or corporation or other business entity that it has any right, power or authority not expressly granted by this Agreement.\"}, {\"id\": \"9.03\", \"title\": \"Indemnity\", \"level\": 2, \"text\": \"9.03. Indemnity. The Distributor agrees to hold the Company free and harmless from any and all claims, damages, and expenses of every kind or nature whatsoever (a) arising from acts of the Distributor; (b) as a direct or indirect consequence of termination of this Agreement in accordance with its terms; or (c) arising from acts of third parties in relation to Products sold to the Distributor under this Agreement, including, but not limited to execution of liens and security interests by third parties with respect to any such Products. 4\"}, {\"id\": \"9.04\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"9.04. Entire Agreement. The entire Agreement between the Company and the Distributor covering the Products is set forth herein and any amendment or modification shall be in writing and shall be executed by duly authorized representatives in the same manner as this Agreement. The provisions of this Agreement are severable, and if any one or more such provisions are determined to be illegal or otherwise unenforceable, in whole or in part, under the laws of any jurisdiction, the remaining provisions or portions hereof shall, nevertheless, be binding on and enforceable by and between the parties hereto. Any provisions, terms or conditions of Distributor's purchaseoOrders which are, in any way contradicting of this Agreement, except those additional provisions specifying quantity and shipping instructions, shall not be binding upon Company and shall have no applicability to the sale of goods by Company to Distributor.\"}, {\"id\": \"9.05\", \"title\": \"Applicable Law\", \"level\": 2, \"text\": \"9.05. Applicable Law. This Agreement shall be governed by the laws of the State of Texas. All payments hereunder shall be made at Company's offices at Frisco, Texas. Company's rights granted hereby are cumulative and in addition to any rights it may have at law or equity.\"}, {\"id\": \"9.06\", \"title\": \"Separate Provisions\", \"level\": 2, \"text\": \"9.06. Separate Provisions. If any provision of this Agreement shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby.\"}, {\"id\": \"9.07\", \"title\": \"Successors and Assigns\", \"level\": 2, \"text\": \"9.07. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Distributor shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Company. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized officers as of the date and year indicated above. SNOTARATOR LLC By:/s/ Orsolya Peresztegi Orsolya Peresztegi Title: President and Manager DISTRIBUTOR SMSA Ballinger Acquisition Corp. By:/s/ Timothy P. Halter Timothy P. Halter Title: President and Sole Director 5 EXHIBIT A SNOTARATOR PRICE LIST AS OF AUGUST 1, 2013 Description of Product Snotarator\u00ae Nasal Aspirator Price per Unit 1,000 to 5,000 Units* - $4.50 per unit 5,000 to 10,000 Units - $4.15 per unit Over 10,000 Units - $3.95 per unit ____________________________________ *Minimum order of 1,000 Units EXHIBIT B DESCRIPTION OF THE TERRITORY The Territory which is subject to Section 1.01 of this Agreement includes all countries and all of their territories and possessions within the continent known as South America.\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of BLACKBOXSTOCKSINC_08_05_2014-EX-10.1-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 2, \"text\": \"Exhibit 10.1 DISTRIBUTOR AGREEMENT THIS AGREEMENT is made this 1st day of August, 2013, (the \\\"Effective Date\\\"), by and between Snotarator LLC, a Texas limited liability company, with its principal place of business located at 2591 Dallas Parkway, Suite 102, Frisco, Texas 75034 (the \\\"Company\\\") and SMSA Ballinger Acquisition Corp., a Nevada corporation, with offices at 12890 Hilltop Road, Argyle, Texas 76226 (the \\\"Distributor\\\"). NOW, THEREFORE, in consideration of the promises hereinafter made by the parties hereto, it is agreed as follows: ARTICLE I APPOINTMENT OF DISTRIBUTORSHIP\"}}, {\"id\": \"1.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distribution Right\", \"level\": 2, \"text\": \"1.01. Distribution Right. The Company hereby appoints and grants Distributor the exclusive right to sell the products of the Company, including the Snotarator\u2122 Nasal Aspirator, (\\\"Products\\\") listed in the current \\\"Price List\\\" (Exhibit \\\"A\\\" attached hereto). The distribution right shall be limited to all countries and all of their territories and possessions within the continent known as South America (\\\"Territory\\\") (Exhibit \\\"B\\\" attached hereto). Distributor agrees that the Products, including the name Snotarator \u2122 Nasal Aspirator (the \\\"Brand\\\") are the sole property of the Company and Distributor has no interest whatsoever in such Brand and Products, and Distributor shall use the Brand and Products only for so long as the rights granted hereby remains in full force and effect. Distributor shall not take any actions, or aid or assist any other party to take any actions that would infringe upon, harm or contest the proprietary rights of Company in and to the Brand and Products. Distributor shall not assign the rights granted in this Section 1.01 without the prior written consent of the Company.\"}}, {\"id\": \"1.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices\", \"level\": 2, \"text\": \"1.02 Prices. All prices stated are in United States dollars and FOB the Company's offices in Frisco, Texas. Prices do not include transportation costs which shall be borne by Distributor.\"}}, {\"id\": \"1.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Terms\", \"level\": 2, \"text\": \"1.03. Terms. Terms are net cash upon delivery.\"}}, {\"id\": \"1.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Competitive Products\", \"level\": 2, \"text\": \"1.04. Competitive Products. Distributor agrees not to represent or sell other products which are deemed to be competitive with the Company's Products unless agreed to by the Company by written notice.\"}}, {\"id\": \"ARTICLE II\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING AND SUPPORT\", \"level\": 1, \"text\": \"ARTICLE II MARKETING AND SUPPORT\"}}, {\"id\": \"2.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sales\", \"level\": 2, \"text\": \"2.01. Sales. Distributor shall use commercially reasonable efforts to market, distribute and promote the Brand and Products in the Territory at its own cost.\"}}, {\"id\": \"ARTICLE III\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DELIVERY\", \"level\": 1, \"text\": \"ARTICLE III DELIVERY\"}}, {\"id\": \"3.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Orders\", \"level\": 2, \"text\": \"3.01. Purchase Orders. Distributor shall order Products by written notice to Company. Each order shall specify the number of units to be shipped, the type of units to be shipped (as identified by Company model number designations indicated in the Price List) including all optional features, the desired method of shipment. Company shall indicate its acceptance of such purchase order by returning a signed copy to Distributor. Company agrees to ship units to Distributor as close as possible to the delivery schedule set forth in each order as accepted by Company, unless Company otherwise indicates in writing\"}}, {\"id\": \"3.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shipment\", \"level\": 2, \"text\": \"3.02. Shipment. All shipments of Products shall be made FOB Company's office and liability for loss or damage in transit, or thereafter, shall pass to Distributor upon Company's delivery of Products to a common carrier for shipment. Shipping dates are approximate and are based, to a great extent, on prompt receipt by Company of all necessary ordering information from Distributor. Distributor shall bear all costs of transportation and insurance and will promptly reimburse Company if Company prepays or otherwise pays for such expenses. Company shall not be in default by reason of any failure in its performance under this Agreement if such failure results from, whether directly or indirectly, fire, explosion, strike, freight embargo, Act of God or of the public enemy, war, civil disturbance, act of any government, de jure or de facto, or agency or official thereof, material or labor shortage, transportation contingencies, unusually severe weather, default of any other manufacturer or a supplier or subcontractor, quarantine, restriction, epidemic, or catastrophe, lack of timely instructions or essential information from Distributor, or otherwise arisen out of causes beyond the control of the Company. Nor shall the Company at any time be liable for any incidental, special or consequential damages.\"}}, {\"id\": \"3.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cancellation\", \"level\": 2, \"text\": \"3.03. Cancellation. Distributor may, at any time prior to the scheduled date of shipment, cancel any or all Products on order upon giving timely written notice.\"}}, {\"id\": \"ARTICLE IV\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PATENT AND TRADEMARK INFRINGEMENT\", \"level\": 1, \"text\": \"ARTICLE IV PATENT AND TRADEMARK INFRINGEMENT\"}}, {\"id\": \"4.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Patent Infringement\", \"level\": 2, \"text\": \"4.01 Patent Infringement. Company agrees, at its own expense, to indemnify, defend and hold harmless each Distributor and its customers from and against every expense, damage, cost and loss (including attorneys' fees incurred) and to satisfy all judgments and decrees resulting from a claim, suit or proceeding insofar as it is based upon an allegation that any Product or any part thereof furnished by Company or any process which is practiced in the customary use of the Product is or has been infringing upon any patent, copyright or proprietary right, if Company is notified promptly of such claim in writing and given authority, and full and proper information and assistance (at Company's expense) for the defense of same. In case any Product, or any part thereof, if such suit is held to constitute an infringement and the use of said Product or part is enjoined, Company shall, in its sole discretion and at its own expense, either procure for the indemnitee the right to continue using said Product or provide or procure for the Distributor a similar product.\"}}, {\"id\": \"4.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademark Infringement\", \"level\": 2, \"text\": \"4.02 Trademark Infringement. The Company has registered the mark Snotarator \u2122 in the United States. Distributor agrees it will not at any time, either during the term of this Agreement or thereafter, use the Brand, Products or Snotarator\u2122 mark in any manner that might infringe upon the Company's ownership rights to same directly or indirectly. Distributor shall indemnify and hold the Company and its affiliates harmless from and against any and all claims, judgments, costs, awards, expenses (including reasonable attorney fees) and liabilities of every kind arising from Distributor's fault or negligence in its use of the Snotarator \u2122 mark and in the marketing and distribution of the Products within the Territory.\"}}, {\"id\": \"ARTICLE V\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY\", \"level\": 1, \"text\": \"ARTICLE V WARRANTY\"}}, {\"id\": \"5.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Products Warranty\", \"level\": 2, \"text\": \"5.01. Products Warranty. Company warrants that Distributor shall acquire Products purchased hereunder free and clear of all liens and encumbrances except for Company's purchase money security interest defined in Section 1.03, above. Company further warrants all Products to be free from defects in material or workmanship under normal use and service for a period of ninety (90) days from the date of delivery. Any defects must be replaced by the Company within sixty (60) days within this scope of the warranty and all charges for labor and material, will be borne by Company. If it is determined that either no fault exists in Company, or the damage was caused by negligence of Distributor, its agents, employees or customers, Distributor agrees to pay all charges associated with each such replacement. THIS CONSTITUTES THE SOLE WARRANTY MADE BY COMPANY EITHER EXPRESSED OR IMPLIED. THERE ARE NO OTHER WARRANTIES EXPRESSED OR IMPLIED WHICH EXTEND BEYOND THE FACE HEREOF, HEREIN, INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL COMPANY BE LIABLE FOR ANY INCIDENTAL OR CONSEQUENTIAL DAMAGES AND DISTRIBUTOR'S REMEDIES SHALL BE LIMITED TO REPAIR OR REPLACEMENT OF NONCONFORMING UNITS OR PARTS. 2\"}}, {\"id\": \"ARTICLE VI\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DURATION OF AGREEMENT\", \"level\": 1, \"text\": \"ARTICLE VI DURATION OF AGREEMENT\"}}, {\"id\": \"6.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"6.01. Term. The term of this Agreement shall terminate on May 31, 2015, unless sooner terminated. Termination shall not relieve either party of obligations incurred prior thereto. The term of this Agreement may be extended for an additional two year period with the written consent of both parties.\"}}, {\"id\": \"6.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination\", \"level\": 2, \"text\": \"6.02. Termination. This Agreement may be terminated only: (a) By either party for substantial breach of any material provision of this Agreement by the other, provided due notice has been given to the other of the alleged breach and such other party has not cured the breach within (30) days] thereof; or (b) By the Company if: there is an unacceptable change in the control or management of the Distributor; if the Distributor makes an assignment for the benefit of creditors; if a petition in bankruptcy is filed by or against the Distributor, resulting in an adjudication of bankruptcy; or, if the Distributor fails to pay its debts as they become due and provided due notice has been given by the Company to the Distributor and the Distributor has not cured such breach within thirty (30) days thereof; or (c) By the written consent of both parties; (d) Upon termination of this Agreement all further rights and obligations of the parties shall cease, except that Distributor shall not be relieved of (i) its obligation to pay any monies due, or to become due, as of or after the date of termination, and (ii) any other obligation set forth in this Agreement which is to take effect after the date of termination.\"}}, {\"id\": \"ARTICLE VII\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 1, \"text\": \"ARTICLE VII NOTICES\"}}, {\"id\": \"7.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notice or Communication\", \"level\": 2, \"text\": \"7.01. Notice or Communication. Any notice or communication required or permitted hereunder shall be in writing and shall be sent by international courier or registered mail, return receipt requested, postage prepaid and addressed to the addresses set forth below or to such changed address as any party entitled to notice shall have communicated in writing to the other party. Purchase orders and other administrative notices may be sent by facsimile transmission or regular mail. Notices and communications to Company shall be sent to: Snotarator LLC 2591 Dallas Parkway Suite 102 Frisco, Texas 75034 Notices and communications to Distributor shall be sent to address shown on first page of this Agreement. Any notices or communications to either party hereunder shall be deemed to have been given when deposited in the mail, addressed to the then current address of such party.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"02\", \"level\": 1, \"text\": \"7.02 . Date of Effectiveness. Any such notice or communication so mailed shall be deemed delivered and effective seventy-two (72) hours after mailing thereof in the United States.\"}}, {\"id\": \"ARTICLE VIII\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY 3\", \"level\": 1, \"text\": \"ARTICLE VIII CONFIDENTIALITY 3\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"01\", \"level\": 1, \"text\": \"8.01 . Confidentiality. Each party agrees to maintain in confidence and not to use except for the purpose of this Agreement any information of a confidential nature such as technical information and data, commercial information and know-how, price structures, administrative and operational costs, or other information relating to each other's business operations or in the case of Distributor to the Brand and Products whether disclosed prior to the Effective Date or thereafter. Each party's obligation of confidentiality and limitation upon use shall not apply to any information to the extent that the receiving party can show that such information: a) is or became generally available to the public otherwise than by reason of breach by the receiving party of the provisions of this Agreement; b) was known to the receiving party prior to the date of the Agreement provided that documentary evidence of such knowledge is provided to the disclosing party on request;\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"was subsequently disclosed to the receiving party without obligation of confidentiality by a third party owing no such\", \"level\": 1, \"text\": \"c) was subsequently disclosed to the receiving party without obligation of confidentiality by a third party owing no such obligations to the disclosing party in respect of such information;\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"is required by laws to be disclosed but then only when, to the extent reasonably practicable, prompt notice of this r\", \"level\": 1, \"text\": \"d) is required by laws to be disclosed but then only when, to the extent reasonably practicable, prompt notice of this requirement has been given to the original disclosing party so that it may seek appropriate relief to prevent or limit such disclosure. Except as required by applicable laws or court order or as otherwise permitted under this Agreement, all publicity, press releases and public announcements, in each case relating to the Brand and Products in the Territory and/or the transactions contemplated hereby shall be reviewed in advance by, and shall be subject to the written approval (such approval not to be unreasonably withhold) of both the Company and Distributor. The parties hereto may disclose the existence of this Agreement and the terms and conditions hereof, without the prior written consent of the other parties, as may be required by applicable laws, in which case the party seeking to disclose the information shall give the other parties reasonable advanced notice and review of any such disclosure and shall seek confidential treatment of such information to the extent possible under applicable law.\"}}, {\"id\": \"ARTICLE IX\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"ARTICLE IX GENERAL PROVISIONS\"}}, {\"id\": \"9.01\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Relationship of Parties\", \"level\": 2, \"text\": \"9.01. Relationship of Parties. The relationship between the parties established by this Agreement shall be solely that of vendor and vendee and all rights and powers not expressly granted to the Distributor are expressly reserved to the Company. The Distributor shall have no right, power or authority in any way to bind the Company to the fulfillment of any condition not herein contained, or to any contract or obligation, expressed or implied.\"}}, {\"id\": \"9.02\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independence of Parties\", \"level\": 2, \"text\": \"9.02. Independence of Parties. Nothing contained in this Agreement shall be construed to make the Distributor the agent for the Company for any purpose, and neither party hereto shall have any right whatsoever to incur any liabilities or obligations on behalf or binding upon the other party. The Distributor specifically agrees that it shall have no power or authority to represent the Company in any manner; that it will solicit orders for Products as an independent contractor in accordance with the terms of this Agreement; and that it will not at any time represent the Company in any manner; that it will solicit orders for Products as an independent contractor in accordance with the terms of this Agreement; and that it will not at any time represent orally or in writing to any person or corporation or other business entity that it has any right, power or authority not expressly granted by this Agreement.\"}}, {\"id\": \"9.03\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnity\", \"level\": 2, \"text\": \"9.03. Indemnity. The Distributor agrees to hold the Company free and harmless from any and all claims, damages, and expenses of every kind or nature whatsoever (a) arising from acts of the Distributor; (b) as a direct or indirect consequence of termination of this Agreement in accordance with its terms; or (c) arising from acts of third parties in relation to Products sold to the Distributor under this Agreement, including, but not limited to execution of liens and security interests by third parties with respect to any such Products. 4\"}}, {\"id\": \"9.04\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"9.04. Entire Agreement. The entire Agreement between the Company and the Distributor covering the Products is set forth herein and any amendment or modification shall be in writing and shall be executed by duly authorized representatives in the same manner as this Agreement. The provisions of this Agreement are severable, and if any one or more such provisions are determined to be illegal or otherwise unenforceable, in whole or in part, under the laws of any jurisdiction, the remaining provisions or portions hereof shall, nevertheless, be binding on and enforceable by and between the parties hereto. Any provisions, terms or conditions of Distributor's purchaseoOrders which are, in any way contradicting of this Agreement, except those additional provisions specifying quantity and shipping instructions, shall not be binding upon Company and shall have no applicability to the sale of goods by Company to Distributor.\"}}, {\"id\": \"9.05\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Applicable Law\", \"level\": 2, \"text\": \"9.05. Applicable Law. This Agreement shall be governed by the laws of the State of Texas. All payments hereunder shall be made at Company's offices at Frisco, Texas. Company's rights granted hereby are cumulative and in addition to any rights it may have at law or equity.\"}}, {\"id\": \"9.06\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Separate Provisions\", \"level\": 2, \"text\": \"9.06. Separate Provisions. If any provision of this Agreement shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall in no way be affected or impaired thereby.\"}}, {\"id\": \"9.07\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Successors and Assigns\", \"level\": 2, \"text\": \"9.07. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Distributor shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Company. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized officers as of the date and year indicated above. SNOTARATOR LLC By:/s/ Orsolya Peresztegi Orsolya Peresztegi Title: President and Manager DISTRIBUTOR SMSA Ballinger Acquisition Corp. By:/s/ Timothy P. Halter Timothy P. Halter Title: President and Sole Director 5 EXHIBIT A SNOTARATOR PRICE LIST AS OF AUGUST 1, 2013 Description of Product Snotarator\u00ae Nasal Aspirator Price per Unit 1,000 to 5,000 Units* - $4.50 per unit 5,000 to 10,000 Units - $4.15 per unit Over 10,000 Units - $3.95 per unit ____________________________________ *Minimum order of 1,000 Units EXHIBIT B DESCRIPTION OF THE TERRITORY The Territory which is subject to Section 1.01 of this Agreement includes all countries and all of their territories and possessions within the continent known as South America.\"}}, {\"id\": \"party:Snotarator LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Snotarator LLC\", \"role\": \"Company\", \"address\": \"2591 Dallas Parkway, Suite 102, Frisco, Texas 75034\"}}, {\"id\": \"party:SMSA Ballinger Acquisition Corp.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"SMSA Ballinger Acquisition Corp.\", \"role\": \"Distributor\", \"address\": \"12890 Hilltop Road, Argyle, Texas 76226\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"this 1st day of August, 2013\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Company\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company\", \"text\": \"Snotarator LLC, a Texas limited liability company, with its principal place of business located at 2591 Dallas Parkway, Suite 102, Frisco, Texas 75034\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor\", \"text\": \"SMSA Ballinger Acquisition Corp., a Nevada corporation, with offices at 12890 Hilltop Road, Argyle, Texas 76226\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"The products of the Company, including the Snotarator\u2122 Nasal Aspirator\", \"definition_clause\": \"1.01\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"all countries and all of their territories and possessions within the continent known as South America\", \"definition_clause\": \"1.01\"}}, {\"id\": \"term:Brand\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Brand\", \"text\": \"the name Snotarator \u2122 Nasal Aspirator\", \"definition_clause\": \"1.01\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:(30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"(30) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:$4.50\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$4.50\"}}, {\"id\": \"value:$4.15\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$4.15\"}}, {\"id\": \"value:$3.95\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$3.95\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of BravatekSolutionsInc_20170418_8-K_EX-10.1_10205739_EX-10.1_Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of BravatekSolutionsInc_20170418_8-K_EX-10.1_10205739_EX-10.1_Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"EXHIBIT 10.1\", \"title\": \"RESELLER AGREEMENT THIS RESELLER AGREEMENT (this \\\"Agreement\\\") is made and entered into effect the 7th day of April, 2017 (\\\"Effective Date\\\"), by and between i3 Integrative Creative Solutions, LLC (\\\"i3 ICS\\\"), a Virginia limited liability company, having its offices at 6564 Loisdale Court Suite 1010B, Springfield, VA 22150 (\\\"Reseller\\\") and the company set forth below (\\\"Company\\\") (each, individually, a \\\"party\\\" and collectively, \\\"parties\\\"): Company: Bravatek Solutions, Inc. (BVTK) Telephone: 1-866-490-8590\", \"level\": 2, \"text\": \"EXHIBIT 10.1 RESELLER AGREEMENT THIS RESELLER AGREEMENT (this \\\"Agreement\\\") is made and entered into effect the 7th day of April, 2017 (\\\"Effective Date\\\"), by and between i3 Integrative Creative Solutions, LLC (\\\"i3 ICS\\\"), a Virginia limited liability company, having its offices at 6564 Loisdale Court Suite 1010B, Springfield, VA 22150 (\\\"Reseller\\\") and the company set forth below (\\\"Company\\\") (each, individually, a \\\"party\\\" and collectively, \\\"parties\\\"): Company: Bravatek Solutions, Inc. (BVTK) Telephone: 1-866-490-8590 Address:2028 E. Ben White Blvd., Suite 240-2835 Fax: N/A Austin, Texas 78741 E-mail: tom.cellucci@bravatek.com Territory: US Federal Government Civilian and Military Agencies/Customers in the U.S. Agreement Term: 1 Year Company Products: cybersecurity email software/telecom services Other Terms (not applicable if blank): Pricing: Reseller will obtain pricing quote from Company for each opportunity. Contract is renewable for 1 year extension by amendment to this agreement. Either Party may terminate this agreement for non-cause with a sixty (60) written notice. The parties agree as follows: 1. Definitions. a. \\\"Company\\\" shall have the meaning assigned in the preamble. b. \\\"Company Products\\\" shall have the meaning assigned in the preamble. c. \\\"Effective Date\\\" shall have the meaning assigned in the preamble. d. \\\"Marks\\\" shall have the meaning assigned in Section 7. e. \\\"Net Revenue\\\" shall mean gross receipts collected by Company or Reseller from the distribution of Company Products, [less third party commissions, equipment sales, delivery costs, taxes, refunds, and credits. f. \\\"Proprietary Information\\\" shall have the meaning assigned in Section 11. g. \\\"Registered Referral\\\" shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, provides Sales Assistance (as defined below), and (ii) which leads to a direct sale with the \\\"Company\\\". Registered Referrals may fall into two categories: Sales executed by the \\\"Company\\\", and via a third party's prime contract. h. \\\"Sales Assistance\\\" shall mean (i) introductions to and scheduling meetings with key executives at the Named Account (e.g., CxO, Vice President of Infrastructure and Vice President of Application Development), and (ii) generating and delivering proposals and providing other marketing and sales support necessary to close the opportunity and obtain an order from the Named Account. 1 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}, {\"id\": \"i\", \"title\": \"\\\"Registered Opportunity\\\" shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, and\", \"level\": 1, \"text\": \"i. \\\"Registered Opportunity\\\" shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, and (ii) the \\\"Reseller\\\" purchases directly from the \\\"Company\\\" at a discount and sells to the customer. j. \\\"Fulfillment Transaction\\\" shall mean a sale through the Reseller's contract vehicle to a Federal Agency entity that is not a Registered Referral or Registered Opportunity k. \\\"Referral Fee\\\" shall have the meaning assigned in Exhibit B. l. \\\"Reseller\\\" shall have the meaning assigned in the preamble. m. \\\"Territory\\\" shall have the meaning assigned in the preamble. 2. General Scope. Company develops or provides Company Products and desires that Reseller promote and solicit commitments to buy Company Products in the Territory. 3. Reseller Activity. Reseller shall have the right to solicit orders for Company Products within the Territory. In its activities under this Agreement, Reseller shall use the then-current names for the Company Products and any sales or marketing documentation or forms provided by Company. 4. Company Obligations. Company shall provide Reseller with the support described in Exhibit B. Company shall comply with good business practices and all applicable laws and regulations. During the term of this Agreement, Company shall notify reseller of any changes, modifications or the discontinuation of any of the Company Products within thirty (30) days. Company shall make reasonable accommodations for any ongoing sales or existing sales. 5. Exclusivity on Registered Referrals and Opportunities. During the Term hereof and for a period of six (6) months following the termination of this Agreement or the discontinuation of any of the Company Products, (i) the Reseller shall have the exclusive right to commission for any Registered Referrals, (ii) the Company shall not market, promote, sell, or distribute Company Products or solicit or procure orders for the Company Products, or for any product(s) or service(s) similar to the Company Products, in the Territory other than through the Reseller and pursuant to this Agreement, except with the prior written consent of the Reseller, and (iii) without limitation to the foregoing, the Company shall not, directly or through other parties (whether agents, representatives, intermediaries, resellers or other parties), market, promote, sell, distribute, solicit or procure orders to any existing or prospective customer of the Reseller. 6. Compensation. In the event that Reseller (i) refers a Registered Referral to Company, through delivery to Company of the lead form attached hereto as Exhibit A, and (ii) such Registered Referral executes an agreement to purchase any of such Company Products or services, then Company shall pay Reseller a Referral Fee, as specified in Exhibit B attached hereto. Referral Fees will be paid within thirty (30) days of the collection of receivables from the Registered Referral. In the event an opportunity is requested and the government elects to use a different contract vehicle as described in 1g, reseller will still receive Referral Fee outlined in exhibit B. 2 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}, {\"id\": \"7\", \"title\": \"Trademarks, Trade Names and Other Designations\", \"level\": 1, \"text\": \"7. Trademarks, Trade Names and Other Designations. Subject to the terms of this Agreement, Company grants Reseller the right to use and display the Company trademarks, tradenames and other designations of source, and proprietary notices, slogans, designs and distinct advertising as may appear on any documentation or other material with respect to Product (\\\"Marks\\\") with prior approval, that will not be unreasonable withheld. 8. Warranty Disclaimer. RESELLER SHALL MAKE NO REPRESENTATION, GUARANTEE, OR WARRANTY CONCERNING THE COMPANY PRODUCT EXCEPT AS EXPRESSLY AUTHORIZED IN ADVANCE BY COMPANY IN WRITING. TO THE EXTENT THE RESELLER HAS COMPLIED WITH THE OBLIGATIONS SET FORTH IN THIS SECTION, THE COMPANY SHALL INDEMNIFY AND HOLD HARMLESS THE RESELLER FOR ANY AND ALL LOSSES SUFFERED BY THE RESELLER OR ITS AFFILIATES (WHETHER DIRECTLY OR IN CONNECTION WITH A CLAIM BY A THIRD PARTY) AS A RESULT OF OR IN CONNECTION WITH THE COMPANY PRODUCTS. ADDITIONALLY, THE RESELLER SHALL INDEMNIFY AND HOLD HARMLESS THE COMPANY FOR ANY AND ALL LOSSES SUFFERED BY THE COMPANY OR ITS AFFILIATES (WHETHER DIRECTLY OR IN CONNECTION WITH A CLAIM BY A THIRD PARTY) AS A RESULT OF OR IN CONNECTION WITH THE RESELLER'S ACTIVITIES. 9. Relationship of Parties. The parties hereto expressly understand and agree that each party is an independent contractor in the performance of each and every part of this Agreement. 10. Termination. a. Unless terminated earlier as provided herein, this Agreement shall have the Term set forth above (which commences on the Effective Date). b. This Agreement may be terminated by Reseller for cause immediately upon the occurrence of any of the following events: (i) if the use or sale of Company Products are enjoined due to any claim of infringement of any U.S. patent or copyright or of any misappropriation of trade secrets; (ii) if Company ceases to do business, or otherwise terminates its business operations; or (iii) if Company breaches any provision of this Agreement and fails to fully cure such breach within fifteen (15) business days of written notice from Reseller describing the breach. c. This Agreement may be terminated by Company for cause immediately upon the occurrence of any of the following events: (i) if Reseller ceases to do business, or otherwise terminates its business operations; or (ii) if Reseller breaches any provision of this Agreement and fails to fully cure such breach within fifteen (15) business days of written notice from Company describing the breach. d. Neither party shall incur any liability whatsoever for any damage, loss or expenses of any kind suffered or incurred by the other party arising from or incident to any termination of this Agreement, which complies with the terms of the Agreement, whether or not the terminating party is aware of any such damage, loss or expenses. 3 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017 e. Upon termination or expiration of this Agreement, other than with respect to customers of the Reseller existing at any time prior to the termination or expiration and with respect to ongoing sales or prospective sales, Reseller (i) shall immediately discontinue any use of the name, logotype, Marks or slogans of Company, (ii) shall immediately discontinue all representations or statements from which it might be inferred that any relationship exists between the parties, (iii) will cease to promote, solicit orders for or procure orders for the Product, (iv) will immediately return to Company all Proprietary Information (as defined below) and any other information or materials of Company in its possession, custody or control in whatever form held (including copies or embodiments thereof relating thereto). Notwithstanding the foregoing, the right to payments accruing prior to the termination or expiration shall survive termination or expiration of this Agreement. 11. Proprietary Rights. Each party acknowledges that, in the course of performing its duties under this Agreement, it may obtain from the other party, certain business, technical or financial information, all of which is confidential and proprietary (\\\"Proprietary Information\\\"). The parties shall, at all times, both during the term of this Agreement and after its termination, keep in trust and confidence all such Proprietary Information of the other party, and shall not use such Proprietary Information other than in the course of its duties as expressly provided in this Agreement; nor shall a party or its employees disclose any such Proprietary Information of the other to any person without such other party's prior written consent. Neither party shall be bound by this Section with respect to information it can document has entered or later enters the public domain as a result of no act or omission of the receiving party, or is lawfully received by such party from third parties without restriction and without breach of any duty of nondisclosure by any such third party. 12. Liability Limitation. EXCEPT FOR IN THE EVENT OF WILLFUL MISCONDUCT OR GROSS NEGLIGENCE, THE RESELLER AND ITS AFFILIATES SHALL NOT BE LIABLE TO THE COMPANY, AND SHALL HAVE NO OBLIGATION TO INDEMNIFY OR HOLD HARMLESS THE COMPANY, WITH RESPECT TO OR IN CONNECTION WITH ANY LOSS RESULTING FROM OR CAUSED BY THE COMPANY PRODUCTS. 13. Indemnification. Company shall indemnify, defend and hold Reseller and its officers, directors, employees, shareholders, agents, successors and assigns, harmless from and against any claim, demand lawsuit, cause of action or losses of any nature whatsoever, including reasonable attorneys' fees, suffered or incurred by Reseller or any of them, arising out of, (i) any claim that the Company Products infringe any U.S. patent or copyright or that the Company Products incorporate any misappropriated trade secrets or (ii) any claim for injury or other loss to any person arising from the use of Company Products. Additionally, Reseller shall indemnify, defend and hold Company and its officers, directors, employees, shareholders, agents, successors and assigns, harmless from and against any claim, demand lawsuit, cause of action or losses of any nature whatsoever, including reasonable attorneys' fees, suffered or incurred by Company or any of them, arising out of, (i) any claim that the Reseller's Activities infringe any U.S. Business law or that the Reseller's Activities violate any U.S. government process, procedure or requirement or (ii) any claim for injury or other loss to any person arising from the use of Reseller's Activities. 4 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}, {\"id\": \"14\", \"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"14. Miscellaneous. If any provision of this Agreement is held to be illegal or unenforceable, that provision shall be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full force and effect and enforceable. Except as otherwise expressly provided herein, any provision of this Agreement may be amended or waived only with the written consent of both parties. This Agreement may be executed in separate counterparts, each of which so executed and delivered (including by emailed PDF) shall constitute an original, but all such counterparts shall together constitute one and the same instrument. This Agreement shall be governed by and construed under the laws of the Commonwealth of Virginia without regard to the conflicts of law provisions thereof. This Agreement supersedes all prior agreements or discussions between the parties with respect to the subject matter hereof. RESELLER Bravatek Solutions, Inc. I3 ICS, LLC By: /s/ Philip A. Oakley By: /s/ Thomas A. Cellucci Name:Philip A. Oakley Name:Thomas A. Cellucci Title: President Title: Chairman & CEO Date: April 17, 2017 Date: April 17, 2017 5 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}, {\"id\": \"EXHIBIT A\", \"title\": \"LEAD FORM Customer Info: Date:\", \"level\": 1, \"text\": \"EXHIBIT A LEAD FORM Customer Info: Date: Company Products: Purchase Price (in U.S. dollars): Total License Fee: Term: Evaluation Term: [YES OR NO] 6 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}, {\"id\": \"EXHIBIT B\", \"title\": \"RESELLER COMPENSATION Earned Commission: Reseller will be compensated for Registered Referrals and Registered Opportunities (as defined in Section 1g, 1i.) based on the following schedule: Registered Referral:\", \"level\": 1, \"text\": \"EXHIBIT B RESELLER COMPENSATION Earned Commission: Reseller will be compensated for Registered Referrals and Registered Opportunities (as defined in Section 1g, 1i.) based on the following schedule: Registered Referral: \u00b7 25% of Net Revenue (as defined in Section 1e.) with a COMPANY-RESELLER AGREED UPON SALE PRICE in writing, the case of COMPANY's software products. The Company's Telecom Services will be agreed upon on a case-by-case basis in writing. Registered Opportunity: \u00b7 \\\"Reseller\\\" will purchase directly from the \\\"Company\\\" at a 25% discount off the COMPANY-RESELLER AGREED UPONsale price. \u00b7 If sale is made through SEWP, there will be an additional 4% discount off the sale price to cover the Prime contractusage fee (typically 7-10%) off the COMPANY-RESELLAR AGREED UPON SALE PRICE. Fulfillment Transaction Discount (as defined in Section 1j): \u00b7 \\\"Reseller\\\" will purchase directly from the \\\"Company\\\" at a 7-10% discount off the sale price. Payment Terms: For a registered referral where the customer purchases directly from Company or another channel/contract vehicle other than Reseller, earned commissions are payable within thirty (30)days of when such amounts are collected by Company. For a Registered Opportunity where the customer purchases from Reseller, payment will be made by Reseller to Company within 5 days of receipt of payment (paid when paid). Expense Reimbursement: Reimbursement will be provided ONLY for expenses PRE-APPROVED in writing by Company. Marketing Expense: As may be agreed to by the parties in writing. 7 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017 COMPANY SUPPORT OBLIGATIONS Product Training: Training on the Company products as needed. Marketing Materials: Electronic and print copies of existing marketing material as needed. Company Personnel Resources: \u00b7 Access to technical resources for demonstrations and meetings \u00b7 Access to Company Customer Support Services 8 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of BravatekSolutionsInc_20170418_8-K_EX-10.1_10205739_EX-10.1_Reseller Agreement\", \"nodes\": [{\"id\": \"EXHIBIT 10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER AGREEMENT THIS RESELLER AGREEMENT (this \\\"Agreement\\\") is made and entered into effect the 7th day of April, 2017 (\\\"Effective Date\\\"), by and between i3 Integrative Creative Solutions, LLC (\\\"i3 ICS\\\"), a Virginia limited liability company, having its offices at 6564 Loisdale Court Suite 1010B, Springfield, VA 22150 (\\\"Reseller\\\") and the company set forth below (\\\"Company\\\") (each, individually, a \\\"party\\\" and collectively, \\\"parties\\\"): Company: Bravatek Solutions, Inc. (BVTK) Telephone: 1-866-490-8590\", \"level\": 2, \"text\": \"EXHIBIT 10.1 RESELLER AGREEMENT THIS RESELLER AGREEMENT (this \\\"Agreement\\\") is made and entered into effect the 7th day of April, 2017 (\\\"Effective Date\\\"), by and between i3 Integrative Creative Solutions, LLC (\\\"i3 ICS\\\"), a Virginia limited liability company, having its offices at 6564 Loisdale Court Suite 1010B, Springfield, VA 22150 (\\\"Reseller\\\") and the company set forth below (\\\"Company\\\") (each, individually, a \\\"party\\\" and collectively, \\\"parties\\\"): Company: Bravatek Solutions, Inc. (BVTK) Telephone: 1-866-490-8590 Address:2028 E. Ben White Blvd., Suite 240-2835 Fax: N/A Austin, Texas 78741 E-mail: tom.cellucci@bravatek.com Territory: US Federal Government Civilian and Military Agencies/Customers in the U.S. Agreement Term: 1 Year Company Products: cybersecurity email software/telecom services Other Terms (not applicable if blank): Pricing: Reseller will obtain pricing quote from Company for each opportunity. Contract is renewable for 1 year extension by amendment to this agreement. Either Party may terminate this agreement for non-cause with a sixty (60) written notice. The parties agree as follows: 1. Definitions. a. \\\"Company\\\" shall have the meaning assigned in the preamble. b. \\\"Company Products\\\" shall have the meaning assigned in the preamble. c. \\\"Effective Date\\\" shall have the meaning assigned in the preamble. d. \\\"Marks\\\" shall have the meaning assigned in Section 7. e. \\\"Net Revenue\\\" shall mean gross receipts collected by Company or Reseller from the distribution of Company Products, [less third party commissions, equipment sales, delivery costs, taxes, refunds, and credits. f. \\\"Proprietary Information\\\" shall have the meaning assigned in Section 11. g. \\\"Registered Referral\\\" shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, provides Sales Assistance (as defined below), and (ii) which leads to a direct sale with the \\\"Company\\\". Registered Referrals may fall into two categories: Sales executed by the \\\"Company\\\", and via a third party's prime contract. h. \\\"Sales Assistance\\\" shall mean (i) introductions to and scheduling meetings with key executives at the Named Account (e.g., CxO, Vice President of Infrastructure and Vice President of Application Development), and (ii) generating and delivering proposals and providing other marketing and sales support necessary to close the opportunity and obtain an order from the Named Account. 1 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}}, {\"id\": \"party:i3 Integrative Creative Solutions, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"i3 Integrative Creative Solutions, LLC\", \"role\": \"Reseller\", \"address\": \"6564 Loisdale Court Suite 1010B, Springfield, VA 22150\"}}, {\"id\": \"party:Bravatek Solutions, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Bravatek Solutions, Inc.\", \"role\": \"Company\", \"address\": \"2028 E. Ben White Blvd., Suite 240-2835 Fax: N/A Austin, Texas 78741\"}}, {\"id\": \"value:1 Year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"1 Year\"}}, {\"id\": \"value:1 year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"1 year\"}}, {\"id\": \"value:sixty (60) written notice\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) written notice\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS RESELLER AGREEMENT\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the 7th day of April, 2017\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"party\", \"text\": \"each, individually\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"parties\", \"text\": \"collectively\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:Company\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company\", \"text\": \"shall have the meaning assigned in the preamble.\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:Company Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Products\", \"text\": \"shall have the meaning assigned in the preamble.\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:Net Revenue\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Net Revenue\", \"text\": \"shall mean gross receipts collected by Company or Reseller from the distribution of Company Products, [less third party commissions, equipment sales, delivery costs, taxes, refunds, and credits.\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:Registered Referral\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Registered Referral\", \"text\": \"shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, provides Sales Assistance (as defined below), and (ii) which leads to a direct sale with the \\\"Company\\\". Registered Referrals may fall into two categories: Sales executed by the \\\"Company\\\", and via a third party's prime contract.\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"term:Sales Assistance\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sales Assistance\", \"text\": \"shall mean (i) introductions to and scheduling meetings with key executives at the Named Account (e.g., CxO, Vice President of Infrastructure and Vice President of Application Development), and (ii) generating and delivering proposals and providing other marketing and sales support necessary to close the opportunity and obtain an order from the Named Account.\", \"definition_clause\": \"EXHIBIT 10.1\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Registered Opportunity\\\" shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, and\", \"level\": 1, \"text\": \"i. \\\"Registered Opportunity\\\" shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, and (ii) the \\\"Reseller\\\" purchases directly from the \\\"Company\\\" at a discount and sells to the customer. j. \\\"Fulfillment Transaction\\\" shall mean a sale through the Reseller's contract vehicle to a Federal Agency entity that is not a Registered Referral or Registered Opportunity k. \\\"Referral Fee\\\" shall have the meaning assigned in Exhibit B. l. \\\"Reseller\\\" shall have the meaning assigned in the preamble. m. \\\"Territory\\\" shall have the meaning assigned in the preamble. 2. General Scope. Company develops or provides Company Products and desires that Reseller promote and solicit commitments to buy Company Products in the Territory. 3. Reseller Activity. Reseller shall have the right to solicit orders for Company Products within the Territory. In its activities under this Agreement, Reseller shall use the then-current names for the Company Products and any sales or marketing documentation or forms provided by Company. 4. Company Obligations. Company shall provide Reseller with the support described in Exhibit B. Company shall comply with good business practices and all applicable laws and regulations. During the term of this Agreement, Company shall notify reseller of any changes, modifications or the discontinuation of any of the Company Products within thirty (30) days. Company shall make reasonable accommodations for any ongoing sales or existing sales. 5. Exclusivity on Registered Referrals and Opportunities. During the Term hereof and for a period of six (6) months following the termination of this Agreement or the discontinuation of any of the Company Products, (i) the Reseller shall have the exclusive right to commission for any Registered Referrals, (ii) the Company shall not market, promote, sell, or distribute Company Products or solicit or procure orders for the Company Products, or for any product(s) or service(s) similar to the Company Products, in the Territory other than through the Reseller and pursuant to this Agreement, except with the prior written consent of the Reseller, and (iii) without limitation to the foregoing, the Company shall not, directly or through other parties (whether agents, representatives, intermediaries, resellers or other parties), market, promote, sell, distribute, solicit or procure orders to any existing or prospective customer of the Reseller. 6. Compensation. In the event that Reseller (i) refers a Registered Referral to Company, through delivery to Company of the lead form attached hereto as Exhibit A, and (ii) such Registered Referral executes an agreement to purchase any of such Company Products or services, then Company shall pay Reseller a Referral Fee, as specified in Exhibit B attached hereto. Referral Fees will be paid within thirty (30) days of the collection of receivables from the Registered Referral. In the event an opportunity is requested and the government elects to use a different contract vehicle as described in 1g, reseller will still receive Referral Fee outlined in exhibit B. 2 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}}, {\"id\": \"term:Registered Opportunity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Registered Opportunity\", \"text\": \"shall mean a Named Account (i) for which \\\"Reseller\\\" identifies & creates the opportunity, and (ii) the \\\"Reseller\\\" purchases directly from the \\\"Company\\\" at a discount and sells to the customer.\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Fulfillment Transaction\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fulfillment Transaction\", \"text\": \"shall mean a sale through the Reseller's contract vehicle to a Federal Agency entity that is not a Registered Referral or Registered Opportunity\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Referral Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Referral Fee\", \"text\": \"shall have the meaning assigned in Exhibit B.\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Reseller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reseller\", \"text\": \"shall have the meaning assigned in the preamble.\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"shall have the meaning assigned in the preamble.\", \"definition_clause\": \"i\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademarks, Trade Names and Other Designations\", \"level\": 1, \"text\": \"7. Trademarks, Trade Names and Other Designations. Subject to the terms of this Agreement, Company grants Reseller the right to use and display the Company trademarks, tradenames and other designations of source, and proprietary notices, slogans, designs and distinct advertising as may appear on any documentation or other material with respect to Product (\\\"Marks\\\") with prior approval, that will not be unreasonable withheld. 8. Warranty Disclaimer. RESELLER SHALL MAKE NO REPRESENTATION, GUARANTEE, OR WARRANTY CONCERNING THE COMPANY PRODUCT EXCEPT AS EXPRESSLY AUTHORIZED IN ADVANCE BY COMPANY IN WRITING. TO THE EXTENT THE RESELLER HAS COMPLIED WITH THE OBLIGATIONS SET FORTH IN THIS SECTION, THE COMPANY SHALL INDEMNIFY AND HOLD HARMLESS THE RESELLER FOR ANY AND ALL LOSSES SUFFERED BY THE RESELLER OR ITS AFFILIATES (WHETHER DIRECTLY OR IN CONNECTION WITH A CLAIM BY A THIRD PARTY) AS A RESULT OF OR IN CONNECTION WITH THE COMPANY PRODUCTS. ADDITIONALLY, THE RESELLER SHALL INDEMNIFY AND HOLD HARMLESS THE COMPANY FOR ANY AND ALL LOSSES SUFFERED BY THE COMPANY OR ITS AFFILIATES (WHETHER DIRECTLY OR IN CONNECTION WITH A CLAIM BY A THIRD PARTY) AS A RESULT OF OR IN CONNECTION WITH THE RESELLER'S ACTIVITIES. 9. Relationship of Parties. The parties hereto expressly understand and agree that each party is an independent contractor in the performance of each and every part of this Agreement. 10. Termination. a. Unless terminated earlier as provided herein, this Agreement shall have the Term set forth above (which commences on the Effective Date). b. This Agreement may be terminated by Reseller for cause immediately upon the occurrence of any of the following events: (i) if the use or sale of Company Products are enjoined due to any claim of infringement of any U.S. patent or copyright or of any misappropriation of trade secrets; (ii) if Company ceases to do business, or otherwise terminates its business operations; or (iii) if Company breaches any provision of this Agreement and fails to fully cure such breach within fifteen (15) business days of written notice from Reseller describing the breach. c. This Agreement may be terminated by Company for cause immediately upon the occurrence of any of the following events: (i) if Reseller ceases to do business, or otherwise terminates its business operations; or (ii) if Reseller breaches any provision of this Agreement and fails to fully cure such breach within fifteen (15) business days of written notice from Company describing the breach. d. Neither party shall incur any liability whatsoever for any damage, loss or expenses of any kind suffered or incurred by the other party arising from or incident to any termination of this Agreement, which complies with the terms of the Agreement, whether or not the terminating party is aware of any such damage, loss or expenses. 3 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017 e. Upon termination or expiration of this Agreement, other than with respect to customers of the Reseller existing at any time prior to the termination or expiration and with respect to ongoing sales or prospective sales, Reseller (i) shall immediately discontinue any use of the name, logotype, Marks or slogans of Company, (ii) shall immediately discontinue all representations or statements from which it might be inferred that any relationship exists between the parties, (iii) will cease to promote, solicit orders for or procure orders for the Product, (iv) will immediately return to Company all Proprietary Information (as defined below) and any other information or materials of Company in its possession, custody or control in whatever form held (including copies or embodiments thereof relating thereto). Notwithstanding the foregoing, the right to payments accruing prior to the termination or expiration shall survive termination or expiration of this Agreement. 11. Proprietary Rights. Each party acknowledges that, in the course of performing its duties under this Agreement, it may obtain from the other party, certain business, technical or financial information, all of which is confidential and proprietary (\\\"Proprietary Information\\\"). The parties shall, at all times, both during the term of this Agreement and after its termination, keep in trust and confidence all such Proprietary Information of the other party, and shall not use such Proprietary Information other than in the course of its duties as expressly provided in this Agreement; nor shall a party or its employees disclose any such Proprietary Information of the other to any person without such other party's prior written consent. Neither party shall be bound by this Section with respect to information it can document has entered or later enters the public domain as a result of no act or omission of the receiving party, or is lawfully received by such party from third parties without restriction and without breach of any duty of nondisclosure by any such third party. 12. Liability Limitation. EXCEPT FOR IN THE EVENT OF WILLFUL MISCONDUCT OR GROSS NEGLIGENCE, THE RESELLER AND ITS AFFILIATES SHALL NOT BE LIABLE TO THE COMPANY, AND SHALL HAVE NO OBLIGATION TO INDEMNIFY OR HOLD HARMLESS THE COMPANY, WITH RESPECT TO OR IN CONNECTION WITH ANY LOSS RESULTING FROM OR CAUSED BY THE COMPANY PRODUCTS. 13. Indemnification. Company shall indemnify, defend and hold Reseller and its officers, directors, employees, shareholders, agents, successors and assigns, harmless from and against any claim, demand lawsuit, cause of action or losses of any nature whatsoever, including reasonable attorneys' fees, suffered or incurred by Reseller or any of them, arising out of, (i) any claim that the Company Products infringe any U.S. patent or copyright or that the Company Products incorporate any misappropriated trade secrets or (ii) any claim for injury or other loss to any person arising from the use of Company Products. Additionally, Reseller shall indemnify, defend and hold Company and its officers, directors, employees, shareholders, agents, successors and assigns, harmless from and against any claim, demand lawsuit, cause of action or losses of any nature whatsoever, including reasonable attorneys' fees, suffered or incurred by Company or any of them, arising out of, (i) any claim that the Reseller's Activities infringe any U.S. Business law or that the Reseller's Activities violate any U.S. government process, procedure or requirement or (ii) any claim for injury or other loss to any person arising from the use of Reseller's Activities. 4 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}}, {\"id\": \"term:Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marks\", \"text\": \"Company trademarks, tradenames and other designations of source, and proprietary notices, slogans, designs and distinct advertising as may appear on any documentation or other material with respect to Product\", \"definition_clause\": \"7\"}}, {\"id\": \"value:fifteen (15) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) business days\"}}, {\"id\": \"term:Proprietary Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Information\", \"text\": \"certain business, technical or financial information, all of which is confidential and proprietary\", \"definition_clause\": \"7\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"14. Miscellaneous. If any provision of this Agreement is held to be illegal or unenforceable, that provision shall be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full force and effect and enforceable. Except as otherwise expressly provided herein, any provision of this Agreement may be amended or waived only with the written consent of both parties. This Agreement may be executed in separate counterparts, each of which so executed and delivered (including by emailed PDF) shall constitute an original, but all such counterparts shall together constitute one and the same instrument. This Agreement shall be governed by and construed under the laws of the Commonwealth of Virginia without regard to the conflicts of law provisions thereof. This Agreement supersedes all prior agreements or discussions between the parties with respect to the subject matter hereof. RESELLER Bravatek Solutions, Inc. I3 ICS, LLC By: /s/ Philip A. Oakley By: /s/ Thomas A. Cellucci Name:Philip A. Oakley Name:Thomas A. Cellucci Title: President Title: Chairman & CEO Date: April 17, 2017 Date: April 17, 2017 5 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LEAD FORM Customer Info: Date:\", \"level\": 1, \"text\": \"EXHIBIT A LEAD FORM Customer Info: Date: Company Products: Purchase Price (in U.S. dollars): Total License Fee: Term: Evaluation Term: [YES OR NO] 6 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}}, {\"id\": \"value:U.S. dollars\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"U.S. dollars\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER COMPENSATION Earned Commission: Reseller will be compensated for Registered Referrals and Registered Opportunities (as defined in Section 1g, 1i.) based on the following schedule: Registered Referral:\", \"level\": 1, \"text\": \"EXHIBIT B RESELLER COMPENSATION Earned Commission: Reseller will be compensated for Registered Referrals and Registered Opportunities (as defined in Section 1g, 1i.) based on the following schedule: Registered Referral: \u00b7 25% of Net Revenue (as defined in Section 1e.) with a COMPANY-RESELLER AGREED UPON SALE PRICE in writing, the case of COMPANY's software products. The Company's Telecom Services will be agreed upon on a case-by-case basis in writing. Registered Opportunity: \u00b7 \\\"Reseller\\\" will purchase directly from the \\\"Company\\\" at a 25% discount off the COMPANY-RESELLER AGREED UPONsale price. \u00b7 If sale is made through SEWP, there will be an additional 4% discount off the sale price to cover the Prime contractusage fee (typically 7-10%) off the COMPANY-RESELLAR AGREED UPON SALE PRICE. Fulfillment Transaction Discount (as defined in Section 1j): \u00b7 \\\"Reseller\\\" will purchase directly from the \\\"Company\\\" at a 7-10% discount off the sale price. Payment Terms: For a registered referral where the customer purchases directly from Company or another channel/contract vehicle other than Reseller, earned commissions are payable within thirty (30)days of when such amounts are collected by Company. For a Registered Opportunity where the customer purchases from Reseller, payment will be made by Reseller to Company within 5 days of receipt of payment (paid when paid). Expense Reimbursement: Reimbursement will be provided ONLY for expenses PRE-APPROVED in writing by Company. Marketing Expense: As may be agreed to by the parties in writing. 7 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017 COMPANY SUPPORT OBLIGATIONS Product Training: Training on the Company products as needed. Marketing Materials: Electronic and print copies of existing marketing material as needed. Company Personnel Resources: \u00b7 Access to technical resources for demonstrations and meetings \u00b7 Access to Company Customer Support Services 8 Source: BRAVATEK SOLUTIONS, INC., 8-K, 4/18/2017\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"25%\"}}, {\"id\": \"value:4%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"4%\"}}, {\"id\": \"value:7-10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"7-10%\"}}, {\"id\": \"value:5 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of Columbia Laboratories, (Bermuda) Ltd. - AMEND NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of Columbia Laboratories, (Bermuda) Ltd. - AMEND NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.1\", \"title\": \"CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \\\"Amendment\\\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \\\"Existing Agreement\\\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon's Court, 22 Victoria Street, Hamilton HM12, Bermuda (\\\"Columbia\\\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\\\"Fleet\\\") is entered into on 2018 (the \\\"Effective Date\\\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\", \"level\": 2, \"text\": \"Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \\\"Amendment\\\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \\\"Existing Agreement\\\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon's Court, 22 Victoria Street, Hamilton HM12, Bermuda (\\\"Columbia\\\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\\\"Fleet\\\") is entered into on 2018 (the \\\"Effective Date\\\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\"}, {\"id\": \"1\", \"title\": \"The following definitions shall be added to Section 1 of the Existing Agreement\", \"level\": 1, \"text\": \"1. The following definitions shall be added to Section 1 of the Existing Agreement: \\\"\\\"Ares Agreement\\\" means the supply agreement entered into between Columbia and Ares Trading S.A. (a subsidiary of Merck Serono S.A.) dated 7 January 2018.\\\" \\\"GDP\\\" means the EU guidelines for current Good Distribution Practice guidelines 2013/C 343/01 as amended.\\\"\"}, {\"id\": \"2\", \"title\": \"The definition of \\\"batch\\\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the\", \"level\": 1, \"text\": \"2. The definition of \\\"batch\\\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the following: \\\"\\\"Batch\\\" means a quantity of [***] kilograms of material (or such other quantity as the Parties may agree in writing from time to time) produced in a process or series of processes that is expected to be homogeneous within specified limits.\\\"\"}, {\"id\": \"3\", \"title\": \"The following shall be added to Section 2\", \"level\": 1, \"text\": \"3. The following shall be added to Section 2.1 of the Existing Agreement (Regulatory Requirements) as a new Section 2.1 (d): \\\"2.1 (d) Subject to the prior written consent of Columbia (such consent not to be unreasonably withheld, delayed or conditioned), Fleet may subcontract all or part of the activities to be performed by it under this Agreement to any subcontractor provided that the subcontracting of any activities shall not relieve Fleet of, and Fleet shall remain solely liable for, its obligations under this Agreement. Columbia may subcontract all or any part of the activities performed by it under this Agreement to any subcontractor without the consent of Fleet.\\\" 1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 4. The following new Sections 2.2 (b), 2.2 (c) and 2.2 (d) shall be added to Section 2.2 of the Existing Agreement (Regulatory Requirements): \\\"2.2 (b) Compliance with Brazilian Regulatory Authorities Regulations. Fleet hereby warrants that the facilities where the Product is manufactured complies in full with the relevant standards stipulated by the Brazil National Health Surveillance Agency (\\\"ANVISA\\\") and undertakes to ensure the facilities will continue to do so throughout the Term.\"}, {\"id\": \"2.2\", \"title\": \"(c) Compliance with Regulatory Approvals\", \"level\": 2, \"text\": \"2.2 (c) Compliance with Regulatory Approvals. To the extent required for regulatory purposes, Fleet grants to Columbia the right to refer to, and to grant any purchasers of Columbia's products containing the Product the right to refer to Fleet's batch manufacturing records relating to the Product. Fleet undertakes to notify Columbia and to provide Columbia with specific details of any changes to be made to the batch manufacturing records and any other filings made by Fleet with the Regulatory Authorities to the extent that they relate to the Product.\"}, {\"id\": \"2.2\", \"title\": \"(d) Material Change in Manufacturing Process\", \"level\": 2, \"text\": \"2.2 (d) Material Change in Manufacturing Process. Fleet shall provide reasonable notice to Columbia and shall consult with Columbia before Fleet makes any material change in any manufacturing process for the Product.\\\"\"}, {\"id\": \"5\", \"title\": \"Section 2\", \"level\": 1, \"text\": \"5. Section 2.3 (c) of the Existing Agreement (Raw Materials) shall be deleted and replaced by the following:\"}, {\"id\": \"2.3\", \"title\": \"(c) Raw Materials\", \"level\": 2, \"text\": \"2.3 (c) Raw Materials. Fleet shall be responsible for ordering [***] Raw Materials other than [***] and the [***] (which shall be provided by Columbia), as required to support Fleet's obligations under this Agreement. All right, title and interest in and to the Raw Materials provided by Columbia (including but not limited to the [***] and the [***]) shall remain with Columbia at all times. Fleet shall ensure that all Raw Materials are released for use at least [***] prior to their use in manufacturing the Product. Fleet shall maintain sufficient stocks of Raw Materials to meet its manufacturing and supply obligations to, and as set out in any Production Schedule by, Columbia; provided however that Fleet shall have a retest date in accordance with the relevant supplier's written instructions (or where none, Fleet's SOPs, which Fleet shall provide to Columbia upon request) for Raw Materials. Raw Materials shall not be used beyond their expiration date as provided by the Raw Materials supplier. (i) [***] costs of Raw Materials shall be included in the Purchase Price. Fleet shall be responsible for [***] of Raw Materials hereunder which Fleet supplies. For the avoidance of doubt, Columbia shall be responsible for all such costs only in respect of [***] and [***] provided by Columbia to Fleet. Fleet shall not use any Raw Materials purchased directly by Columbia except for the manufacture of Product hereunder. Columbia will be responsible for all retesting costs associated with the Raw Materials supplied by Columbia. (ii) Fleet shall notify Columbia of any Raw Materials that do not meet the specifications of the Raw Materials, and shall provide Columbia with full details within twenty-four (24) hours of completion of the investigation, but not more than twenty (20) business days from identification of the non-conformity with the specifications. 2 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 6. A new Section 2.3 (n) shall be inserted into the Existing Agreement as follows: \\\"2.3 (n) KPIs. As soon as practicable following the Effective Date the Parties shall agree in good faith key performance indicators the Supplier will agree to achieve when supplying the Products and such key performance indicators will be set out in an amendment agreed by the Parties to this Agreement.\\\"\"}, {\"id\": \"7\", \"title\": \"A new Section 3A shall be inserted into the Existing Agreement as follows\", \"level\": 1, \"text\": \"7. A new Section 3A shall be inserted into the Existing Agreement as follows: \\\"3A Machinery and Equipment 3A.1 Columbia has provided Fleet with the machinery, equipment and materials listed in Exhibit B, which Fleet uses to manufacture Products (\\\"Columbia Equipment\\\"). Any additional machinery, equipment and materials provided by Columbia to Fleet during the Term shall be Columbia Equipment unless otherwise agreed in writing by both Parties. During the Term, Columbia shall review and update Exhibit B in December of each year to include any additional machinery, equipment and materials provided to Fleet. 3A.2 The Parties confirm that Columbia owns title to all Columbia Equipment and that Columbia shall be regarded as the owner of the Columbia Equipment notwithstanding that the Columbia Equipment shall be retained at Fleet's premises. Fleet shall not do or permit or cause anything to be done whereby Columbia's rights in and title to the Columbia Equipment are or may become prejudiced including, without limitation, by ensuring that Columbia Equipment are clearly marked as the property of Columbia. No item of Columbia Equipment may be moved from Fleet's premises without the prior written consent of Columbia. 3A.3 Fleet shall not use the Columbia Equipment for any purpose other than supplying Columbia with the Product in accordance with the terms of this Agreement without Columbia's prior written consent. 3A.4 Fleet will at all times ensure that the Columbia Equipment meets and is operated and maintained in accordance with Applicable Laws and cGMP and GDP. 3A.5 Fleet shall maintain the Columbia Equipment, the reasonable costs of which shall be agreed by the Parties (acting reasonably) and paid by Columbia, and: (a) maintenance shall be carried out to at least the standards adopted in respect of Fleet's other machinery and equipment used by it at its premises and Fleet shall not prioritize the maintenance of its own equipment above that of the Columbia Equipment; (b) Fleet shall at all times ensure that it has sufficient trained and competent maintenance personnel available for such maintenance; (c) during the Term, on or before 1 January of each year, Fleet shall prepare and deliver to Columbia: (i) a maintenance plan setting out the maintenance activities to be performed by Fleet in respect of the Columbia Equipment for the following year; and 3 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. (ii) a maintenance report confirming that each of the maintenance activities set out in the previous year's maintenance plan have been carried out; (d) Columbia shall have the right to request a maintenance report in respect of any of the Columbia Equipment at any time during the Term which Fleet shall provide to Columbia within twenty-eight (28) days; (e) Fleet shall inform Columbia of the need for any overhauls, replacements and repairs and shall perform all such overhauls, replacements and repairs as reasonably instructed by Columbia (the reasonable agreed costs of which shall be borne by Columbia); and (f) if an overhaul of the Columbia Equipment is required, Fleet shall provide reasonable notice to Columbia and shall manufacture adequate stocks of Product in advance to ensure continuity of supply in accordance with orders placed by Columbia pursuant to the terms of this Agreement. 3A.6 Fleet shall keep the Columbia Equipment safe and in good working order and shall take all reasonable steps to ensure that the Columbia Equipment does not become contaminated or corroded. 3A.7 Fleet shall mark each individual unit of the Columbia Equipment in a conspicuous manner to indicate that such machinery and equipment is owned by Columbia. 3A.8 Fleet shall keep the Columbia Equipment free and clear of any lien, charge or encumbrance and Fleet shall obtain and deliver to Columbia a waiver of any of the foregoing in a form reasonably acceptable to Columbia. 3A.9 Columbia shall not be liable for any loss or damage due to the negligence or wilful misconduct of Fleet, its Affiliates, employees, contractors or representatives. In the event of any loss or damage of any item of the Columbia Equipment due to the negligence or wilful misconduct (including negligence or intentional misconduct in relation to the operation, inspection or maintenance of the Columbia Equipment) of Fleet, its Affiliates, employees, contractors or representatives, Fleet shall repair or replace such items of Columbia Equipment, at Fleet's sole cost and expense, promptly taking into account the quantities of stock held by Fleet at the time of such loss or damage.\\\"\"}, {\"id\": \"8\", \"title\": \"Section 3\", \"level\": 1, \"text\": \"8. Section 3.1 of the Existing Agreement (Production Schedules) shall be deleted and replaced by the following: \\\"3.1 Production Forecasts (a) Production Schedule. Each [***], before the [***], during the Term Columbia shall prepare and provide Fleet with a written Production Schedule of its requirements for Product (each, a \\\"Production Schedule\\\") for the following [***]. The amounts set forth for the [***] in each Production Schedule shall constitute a firm purchase order and shall be binding upon Columbia (each a \\\"Purchase Order\\\") unless otherwise agreed in writing by both parties. The amounts set forth for the following [***] shall constitute Columbia's non-binding, good faith estimate of the Product requirements of Columbia for such periods. Fleet shall manufacture, supply and deliver to 4 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Columbia all quantities of Product as Columbia orders in accordance with this Section 3.1. All right, title and interest in and to the Product shall remain with Columbia at all times. Fleet shall ensure that it has sufficient experienced production staff available to meet the requirements set out in each Production Schedule and at a minimum, to meet the expected non-binding forecast set out below: [***] [***] [***] [***] [***] [***] N u m b e r o f batches [***] [***] [***] [***] [***] [***] (b) Non-Active Product Orders. From time to time during the Term, Columbia may provide Fleet with a purchase order for a batch of Product that does not contain any active pharmaceutical ingredient provided that such purchase order is received at least ninety (90) days prior to the required delivery date. The batch size for any Product ordered pursuant to this Section 3.1 (b) shall be set out in the relevant purchase order. All provisions of this Agreement that relate to Products shall apply equally to any Products that do not contain any active pharmaceutical ingredient.\\\"\"}, {\"id\": \"9\", \"title\": \"Section 3\", \"level\": 1, \"text\": \"9. Section 3.3 (a) of the Existing Agreement (Delivery) shall be deleted and replaced by the following: \\\"3.3 (a) Delivery. All Product supplied under this Agreement shall be delivered EXW Fleet's Watford, UK facility. All risk of loss in the Product shall pass to Columbia upon receipt of the Product at Fleet's facility by the carrier designated by Columbia. The weights, tariffs and tests affixed by Fleet's invoice shall govern unless established to be incorrect. Claims relating to quantity, weight and loss or damage to any Product sold under this Agreement shall be waived by Columbia unless made within [***] of receipt of Product by Columbia.\\\"\"}, {\"id\": \"10\", \"title\": \"Section 4\", \"level\": 1, \"text\": \"10. Section 4.1 of the Existing Agreement (Audits) shall be deleted and replaced by the following: \\\"4.1 Audits. Columbia QA, any other person appointed by Columbia, Columbia's customer, and/or any Regulatory Authority may conduct inspections and audits of Fleet's manufacturing facility, Columbia Equipment, quality control laboratories, and other quality systems relating to the manufacture and storage of the Product according to Columbia's reasonable procedures upon reasonable prior written notice, during normal business hours, provided, however, that Columbia QA, any other person appointed by Columbia and/or any Regulatory Authority may conduct a \\\"For Cause\\\" audit during normal business hours upon three (3) business days prior written notice to Fleet. Any such audit undertaken by Columbia QA or any other person appointed by Columbia shall be at Columbia's sole cost and expense. Columbia or any other person appointed by Columbia shall have the right, in connection with any such audit, to inspect and obtain copies of any records or other documents and materials associated with or related to the manufacture of the Product. Fleet shall promptly notify Columbia of any proposed inspections by any governmental authority of the facilities at which Product is manufactured in sufficient time for Columbia to attend such inspection.\\\"\"}, {\"id\": \"11\", \"title\": \"Sections 5\", \"level\": 1, \"text\": \"11. Sections 5.1 (Price) and 5.2 (Invoicing) of the Existing Agreement shall be deleted and replaced by the following: 5 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. \\\"5.1 Price. During the Term, the purchase price for each Batch purchased by Columbia from Fleet in any [***] shall be determined in accordance with Part 1 of Exhibit A and the pricing model set out in Part 2 of Exhibit A attached hereto, as may be amended from time to time in accordance with the provisions of this Section 5.1. The Parties shall agree the applicable purchase price for each [***] in accordance with Part 1 of Exhibit A (as may be amended from time to time in accordance with this Section 5.1) and the production forecasts received by Fleet pursuant to Section 3.1. [***]. Any adjustments as set out in paragraphs (a), (b) and (c) below and any consequent adjustments to the volume discount model set out in Part 1 of Exhibit A and/or the pricing model set out in Part 2 of Exhibit A shall be agreed in writing by both Parties and shall take effect from 1 January the following calendar year. Exhibit A may be amended by the mutual written agreement of both parties as follows: (a) the [***] of Exhibit A shall only be amended to reflect the change in rate of the Consumer Price Index as published by the UK Office of National Statistics all item data series D7BT (the \\\"CPI\\\"). By way of example, if on 1 November in a calendar year during the Term, the CPI shows that there has been an increase in prices compared with the same index on 1 November the previous year [***], then [***] in the model as of 1 January in the following year [***] of the CPI increase as recorded on 1 November, [***]. (b) the [***] of Exhibit A shall only be amended to reflect [***] of the change in rate of the CPI. By way of example, if on 1 November in a calendar year during the Term, the CPI shows that there has been an increase in prices compared with the same index on 1 November the previous year [***], then [***] in the model as of 1 January in the following year [***] of the CPI increase as recorded on 1 November, i.e. by [***]. (c) the [***] of Exhibit A shall only be amended to reflect any [***] changes to the cost of any of the [***] set out in Part 4 of Exhibit A. If at any other time during a calendar year the [***] when compared with [***], Fleet shall have the right to amend the [***] for any future invoices by providing Columbia with at least three (3) months' prior written notice. Except as otherwise set out in Section 5.1 (c), the first period during which any adjustment set out in Section 5.1 (a), (b) or (c) above will be calculated shall be [***], with the adjusted costs to be applied to the pricing model in Exhibit A for the calendar year commencing [***]. Fleet shall provide Columbia with access to all books and records necessary to verify any changes to the purchase price.\"}, {\"id\": \"5.2\", \"title\": \"Invoicing\", \"level\": 2, \"text\": \"5.2 Invoicing. Upon delivery of Product to Columbia, Fleet shall submit invoices therefor to Columbia. Columbia shall pay each invoice in full within [***] after the date of receipt by Columbia of such invoice, which shall be issued no earlier than the date on which the Product is delivered to the carrier by Fleet. All payments shall be made in pounds sterling. In the event that any actual volume of Product purchased by Juniper in any calendar year means that a different purchase price should have applied to such volume of Product purchased in that calendar year (as calculated in accordance with the pricing model set out in Exhibit A), Fleet shall notify Juniper in writing of such pricing differential and shall apply a proportionate credit or debit (as applicable) to any invoices raised for the subsequent calendar year. Upon the expiration or earlier termination of this Agreement, 6 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Fleet shall determine the applicable purchase price for that calendar year and shall notify Juniper in writing of any underpayment or overpayment within [***] of expiration or termination (as applicable). In the event of any underpayment by Juniper, Juniper shall pay to Fleet an amount equal to the amount of any such underpayment within [***] of receipt by Juniper of such written notice. In the event of any overpayment by Juniper, Fleet shall pay to Juniper an amount equal to the amount of any overpayment within [***] of receipt by Juniper of such written notice. Fleet shall provide Columbia with access to all books and records necessary to verify any changes to the purchase price and any underpayment or overpayment.\\\"\"}, {\"id\": \"12\", \"title\": \"Section 8 of the Existing Agreement (Insurance) shall be deleted and replaced by the following\", \"level\": 1, \"text\": \"12. Section 8 of the Existing Agreement (Insurance) shall be deleted and replaced by the following: \\\"Fleet and Columbia shall maintain comprehensive general liability insurance, including product liability insurance against claims regarding the manufacture of Product under this Agreement and sufficient cover to meet its liabilities under this Agreement in respect of the Columbia Equipment, with insurers having an AM Best rating within the top 2 categories at the time (at the date of this Agreement known as \\\"superior\\\" or \\\"excellent\\\") or reasonably comparable coverage, in such amounts as it customarily maintains for similar products and activities, but in no event less than [***] per individual claim and [***] in the aggregate. Each party shall maintain such insurance during the Term and thereafter for so long as it customarily maintains insurance for itself for similar products and activities (but in no event less than [***] following termination or expiration).\\\"\"}, {\"id\": \"13\", \"title\": \"Section 10\", \"level\": 1, \"text\": \"13. Section 10.1 (a) of the Existing Agreement (Fleet's Indemnity Obligations) shall be deleted and replaced by the following: \\\"10.1(a) Fleet's Indemnity Obligations. Fleet shall defend, indemnify and hold harmless Columbia, its Affiliates and their respective successors and permitted assigns (and the respective officers, directors, stockholders, partners and employees of each) from and against any and all losses liabilities, claims, actions, proceedings, damages and expenses (including, without limitation, reasonable attorneys' and professional fees and disbursements and expenses of litigation, arbitration or investigation) (\\\"Damages\\\") relating to or arising from (i) any breach by Fleet or its Affiliates of its representations, warranties, covenants, agreements or obligations under this Agreement, including without limitation, the failure of Fleet to timely deliver all Product ordered or the failure of the Product to meet the Fleet Warranty and/or Product Specifications or the failure of Fleet to manufacture or warehouse the Product in accordance with the Product Specifications and Applicable Law (including those relating to cGMP); and (ii) any claims of infringement or misappropriation with respect to the manufacture of the Product, except to the extent such claim of infringement relates to the use of the Intellectual Property; and (iii) any personal injury or property damage to the extent that the injury or damage is the direct result of a failure by Fleet or its Affiliates or subcontractors to manufacture, package, or label the Product in accordance with the Specifications, GMP or Applicable Law.\\\"\"}, {\"id\": \"14\", \"title\": \"Section 10\", \"level\": 1, \"text\": \"14. Section 10.1 (b) of the Existing Agreement (Columbia's Indemnity Obligations) shall be deleted and replaced by the following: \\\"10.1 (b) Columbia's Indemnity Obligations. Columbia shall defend, indemnify and hold harmless Fleet and its Affiliates, and their respective successors and permitted assigns (and the respective officers, directors, 7 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. stockholders, partners and employees of each) from and against any and all Damages arising out of (i) the handling, possession, use, marketing, distribution or sale of any Product and finished pharmaceutical product containing a Product by Columbia or any of its distributors or agents after Fleet's delivery of the Product to Columbia (except to the extent such claims arise out of the circumstances described in Section 10.1(a) or Fleet's negligence or wilful misconduct); (ii) product liability claims, including, wrongful death, resulting from the use of a finished pharmaceutical product containing a Product (except to the extent such claims arise out of the circumstances described in Section 10.1(a) or Fleet's negligence or wilful misconduct); (iii) any breach by Columbia of its representations, warranties, covenants, agreements or obligations under this Agreement (except to the extent any such breach is due to the negligence, breach or wilful misconduct of Fleet); and (iv) any claims of infringement or misappropriation relating to the Intellectual Property.\\\"\"}, {\"id\": \"15\", \"title\": \"Sections 11\", \"level\": 1, \"text\": \"15. Sections 11.1 to 11.3 of the Existing Agreement (Confidentiality and Public Disclosure) shall be deleted and replaced by the following: \\\"11.1 Confidentiality. Each party will treat as confidential the Confidential Information of the other party and will take all necessary precautions to assure the confidentiality of such Confidential Information. Each party agrees to return to the other party upon the expiration or termination of this Agreement all Confidential Information acquired from such other party, except as to such information it may be required to retain under Applicable Law, and except for one copy of such information to be retained by such party's legal counsel. Neither party shall, during the period of this Agreement nor for five (5) years thereafter, without the other party's express prior written consent, other than as provided under this Agreement, use or disclose any such Confidential Information for any purpose other than to carry out its obligations hereunder. Each Party shall guard such Confidential Information using the same degree of care as it normally uses to guard its own confidential, proprietary information of like importance, but in any event no less than reasonable care.\"}, {\"id\": \"11.2\", \"title\": \"Permitted Disclosures\", \"level\": 2, \"text\": \"11.2 Permitted Disclosures. Notw i ths tand ing the ob l iga t ions o f confidentiality and non-use set out in Section 11.1, a Receiving Party may: (a) disclose Confidential Information to a regulatory authority as reasonably necessary to obtain registration in a particular jurisdiction; (b) disclose Confidential Information to the extent such disclosure is reasonably necessary to comply with the order of a court or is required to comply with any Applicable Law or other regulation, directive, instruction, direction or rule of any regulatory authority having jurisdiction over any activity under this Agreement, including to the extent such disclosure is required in publicly filed financial statements or other public statements under rules governing a stock exchange on which securities issued by either party may be listed; provided, to the extent possible, such party shall (i) notify the other party of the existence, terms and circumstances surrounding such a requirement; (ii) consult with the other party on the advisability of taking legally available steps to resist or narrow such requirement; (iii) provide the other party with a copy of the proposed text of such statements or disclosure ten (10) business days in advance of the date on which the disclosure is to be made to enable the other party to 8 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. review and provide comments, unless a shorter review time is agreed; and (iv) exercise its commercially reasonable efforts to obtain an order or other reliable assurance that confidential treatment will be accorded to such portion of the Confidential Information required to be disclosed; (c) disclose Confidential Information on a strict need to know basis to such Receiving Party's licensee's, employees, Affiliates, contractors (including clinical researchers), distributors, agents and consultants as such Receiving Party reasonably determines is necessary to receive the benefit of the licenses and rights granted or available to it under this Agreement or to fulfil its obligations pursuant to this Agreement; provided, however, any such person is bound in writing to observe confidentiality provisions at least as strict as those of this Agreement; (d) disclose Confidential Information: (i) to its actual or potential investment bankers; (ii) to existing and potential investors in connection with an offering or placement of securities for purposes of obtaining financing for its business and to actual and prospective lenders for the purpose of obtaining financing for its business; and (iii) to a bona fide potential acquirer or merger partner for the purposes of evaluating entering into a merger or acquisition, provided, however, any such persons must be obligated to substantially the same extent as set forth in Section 11.1 to hold in confidence and not make use of such Confidential Information for any purpose other than those permitted by this Agreement; and (e) disclose Confidential Information to its legal advisers for the purpose of seeking advice.\"}, {\"id\": \"11.3\", \"title\": \"Public Announcements\", \"level\": 2, \"text\": \"11.3 Public Announcements. Except for such disclosure as is permitted under Section 11.2 or as required by Applicable Law or the requirements of a national securities exchange or another similar regulatory body, no announcement, news release, public statement, publication, or presentation relating to this Agreement, the subject matter hereof or either party's performance hereunder will be made without the other party's prior written approval.\"}, {\"id\": \"16\", \"title\": \"Section 12\", \"level\": 1, \"text\": \"16. Section 12.1 of the Existing Agreement (Term) shall be deleted and replaced by the following: \\\"12.1 Term. Unless terminated earlier pursuant to Section 12.2 below, the initial term of this Agreement shall expire on 31 December 2024 (the \\\"Initial Term\\\") unless the Parties mutually agree in writing any extension to the Initial Term. Upon termination of this Agreement, Fleet agrees to perform its obligations under this Agreement until the earlier of [***].\\\"\"}, {\"id\": \"17\", \"title\": \"Section 12\", \"level\": 1, \"text\": \"17. Section 12.2 (b) of the Existing Agreement, regarding termination of the Existing Agreement by Columbia, shall be deleted and replaced by the following: \\\"12.2 (b) Columbia shall have the right to terminate this Agreement upon [***] notice to Fleet in the event: (i) Fleet fails to maintain its authorizations under Applicable law to manufacture the product, including without limitation those from MHRA; 9 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. (ii) a Change of Control Event with respect to Fleet occurs; (iii) Fleet cannot supply product at a Competitive Price; or (iv) the Ares Agreement is terminated.\\\"\"}, {\"id\": \"18\", \"title\": \"Section 12\", \"level\": 1, \"text\": \"18. Section 12.3 (b) of the Existing Agreement (Effect of Expiration and Termination) shall be deleted and replaced by the following: \\\"12.3 (b) Expiration or termination of this Agreement shall not relieve the parties of any obligation accruing prior to such expiration or termination. The provisions of Sections 1 (Definitions), 3A.2, 3A.3 and 3A.8 (Machinery and Equipment), 4.1 (Audits), 5.2 (Invoicing), 7 (Representations and Warranties), 8 (Insurance), 9 (Adverse Events; Recalls), 10 (Indemnification; Limitation of Liability), 11.1 (Confidentiality and Public Disclosure), 12 (Term and Termination) and 13 (General Provisions) shall survive any expiration or termination of this Agreement.\\\"\"}, {\"id\": \"19\", \"title\": \"Section 12\", \"level\": 1, \"text\": \"19. Section 12.3 (c) of the Existing Agreement (Effect of Expiration and Termination) shall be deleted and replaced by the following: \\\"12.3 (c) If Columbia terminates this Agreement under Section 12.2 (b)(ii) or (iii), Columbia shall reimburse Fleet for [***] purchased by Fleet under this Agreement in the period of [***] prior to the date of termination that are only used by Fleet in the manufacture of the Products.\\\"\"}, {\"id\": \"20\", \"title\": \"The following new Sections 12\", \"level\": 1, \"text\": \"20. The following new Sections 12.3 (d) and 12.3 (e) shall be added to Section 12.3 of the Existing Agreement (Effect of Expiration and Termination):\"}, {\"id\": \"12.3\", \"title\": \"(e) Fleet shall provide such assistance as Columbia may reasonably request to ensure the orderly transfer of the manufac\", \"level\": 2, \"text\": \"12.3 (e) Fleet shall provide such assistance as Columbia may reasonably request to ensure the orderly transfer of the manufacture of the Product to any alternative manufacturer. If requested by Columbia, Fleet shall transfer to Columbia or the alternative manufacturer all technology and know-how necessary or useful to give Columbia or the alternative manufacturer the capability of manufacturing the Product. Fleet shall communicate such technology to Columbia or the alternative manufacturer promptly, effectively and economically, so that Columbia or the alternative manufacturer can undertake the manufacture of the Product and continue the sale of the Product without interruption. Columbia undertakes to reimburse Fleet for its reasonable costs of providing such assistance and to pay to Fleet an amount for all inventory of Raw Materials and work in progress of Products and part completed Products used to provide such assistance.\\\" 10 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 21. Section 13.1 of the Existing Agreement (Notices) shall be amended such that any notice sent to Columbia under this Agreement shall not be copied to Columbia Laboratories, Inc. at 4 Liberty Square Fourth Floor, Boston, MA 02109 but shall instead be copied to the following address: \\\"Juniper Pharmaceuticals UK Limited 8 Orchard Place Nottingham Business Park Nottingham, England NG8 6PX Attention: Chief Operating Officer\\\"\"}, {\"id\": \"22\", \"title\": \"Section 13\", \"level\": 1, \"text\": \"22. Section 13.2 of the Existing Agreement (Assignment) shall be deleted and replaced by the following: \\\"13.2 Assignment. Neither party shall, without the prior written consent (not to be unreasonably withheld or delayed) of the other party having been obtained, assign or transfer this Agreement to any person or entity, in whole or in part (and any attempt to do so shall be void), provided that, each party may assign or transfer this Agreement without such consent to any Affiliate or to any successor by merger of such party, or upon a sale or other transfer of all or substantially all of such party's assets or business to which the subject matter of this Agreement pertains, provided that the acquirer of the business confirms to the Supplier in writing its agreement to be bound by all of the terms and conditions of this Agreement and that the assignor shall remain liable for the obligations hereunder. Notwithstanding the foregoing, it shall not be deemed unreasonable for Columbia to withhold consent, to any proposed or attempted assignment (including by merger or sale) by Fleet to a party which is not an Affiliate, if Columbia is not reasonably satisfied that the assignee possesses the management, finances, personnel, capabilities and facilities to perform fully the obligations of Fleet hereunder. All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns.\\\"\"}, {\"id\": \"23\", \"title\": \"Section 13\", \"level\": 1, \"text\": \"23. Section 13.12 of the Existing Agreement (Technical Agreement) shall be deleted and replaced by the following: \\\"13.12 Technical Agreement. Columbia and Fleet are parties to a certain technical agreement dated 18 March 2015 (as such agreement may be amended in accordance with its terms from time to time) (the \\\"Technical Agreement\\\"), the terms of which outline the responsibilities of Columbia and Fleet with respect to assuring the quality of the Product. Columbia and Fleet acknowledge and agree that in the event the terms of this Agreement and the Technical Agreement conflict or are inconsistent, the terms of this Agreement shall prevail over the terms of the Technical Agreement; provided however, that to the extent possible, the terms of both the Technical Agreement and this Agreement shall be read and considered to effect the intent of the parties.\\\"\"}, {\"id\": \"24\", \"title\": \"The following new Section 13\", \"level\": 1, \"text\": \"24. The following new Section 13.13 shall be added to Section 13 of the Existing Agreement (General Provisions): \\\"13.13 Anti-Bribery. (a) The parties agree: 11 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. (i) to comply with all Applicable Law, statutes and regulations relating to anti- bribery and anti-corruption including but not limited to the U.S. Foreign Corrupt Practices Act, US government health care compliance (HCC) policies, regulations and laws, US Export Administration Act of 1979 (50 App. U.S.C. \u00a72401 et. seq.) and the UK Bribery Act, as amended, and the regulations promulgated thereunder and any applicable similar laws and regulations in any other country) (collectively, the \\\"Relevant Laws\\\"); (ii) to have and maintain in place throughout the term of this Agreement their own policies and procedures to ensure compliance with the Relevant Laws and will appropriately enforce those policies and procedures; and (iii) that no employee, contractor, supplier, agent, broker, or entity will offer or pay anything of value to a public or private official intending to influence or induce an official act or decision or to obtain an improper advantage. (b) A material breach of this Section 13.13 shall be deemed a material breach of this Agreement. In the event of a material breach of this Section 13.13, the party not in breach shall have the right to terminate this Agreement, without any liability to the party in breach, with immediate effect. (c) This Agreement is made subject to any restrictions concerning the export of products or technical information from the United Kingdom or other countries which may be imposed upon or related to Fleet or Columbia from time to time. Each party agrees that it shall not export, directly or indirectly, any technical information acquired from the other party under this Agreement or any products using such technical information to a location or in a manner that at the time of export requires an export licence or other governmental approval, without first obtaining the written consent to do so from the appropriate agency or other governmental entity.\\\"\"}, {\"id\": \"25\", \"title\": \"All other terms and conditions of the Existing Agreement remain in full force and effect\", \"level\": 1, \"text\": \"25. All other terms and conditions of the Existing Agreement remain in full force and effect. Except as expressly provided in this Amendment, the Existing Agreement shall remain unmodified and is hereby ratified and affirmed. The execution, delivery, and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power, or remedy of Columbia or Fleet under the Existing Agreement.\"}, {\"id\": \"26\", \"title\": \"This Amendment, together with the Existing Agreement, sets forth the entire agreement and understanding between the Par\", \"level\": 1, \"text\": \"26. This Amendment, together with the Existing Agreement, sets forth the entire agreement and understanding between the Parties as to the subject matter hereof and thereof and merges all prior discussions and negotiations between them, and neither of the parties shall be bound by any conditions, definitions, warranties, understandings or representations with respect to such subject matter other than as expressly provided herein and therein or as duly set forth on or subsequent to the date hereof in writing and signed by a proper and duly authorized officer or representative of the Party to be bound thereby. 27. This Amendment may be signed in counterparts, each and every one of which shall be deemed an original, notwithstanding variations in format or file designation which may result from the electronic transmission, storage and printing of copies of this Amendment from separate computers or printers. Executed signature pages to this Amendment may be 12 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. delivered by facsimile or a portable document format (PDF) copy (including copy(ies) sent by e-mail) and all such shall be deemed as if actual signature pages had been delivered. 28. This Amendment and and any dispute or claim (including non-contractual disputes or claims) arising out of or in connection with it or its subject matter or formation shall be governed by and construed in accordance with the laws of England. Each Party irrevocably agrees that the English courts shall have sole and exclusive jurisdiction to settle any dispute or claim (including non-contractual disputes or claims) arising out of or in connection with this Amendment or its subject matter or formation. IN WITNESS WHEREOF, the parties have duly executed this Amendment as of the Effective Date. COLUMBIA LABORATORIES (BERMUDA), LTD. By: /s/ Alicia Secor ____________________________ Name: Alicia Secor_______________________________ Title: Chief Executive Officer_______________________ FLEET LABORATORIES LIMITED By: /s/ Tom Horner______________________________________ Name: Tom Horner_________________________________________ Title: Managing Director____________________________________ 13 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Exhibit A Part 1 - Volume adjusted purchase price [***] 14 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Part 2 - Pricing Model [***] 15 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Exhibit B Columbia Equipment [***] 16\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of Columbia Laboratories, (Bermuda) Ltd. - AMEND NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \\\"Amendment\\\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \\\"Existing Agreement\\\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon's Court, 22 Victoria Street, Hamilton HM12, Bermuda (\\\"Columbia\\\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\\\"Fleet\\\") is entered into on 2018 (the \\\"Effective Date\\\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\", \"level\": 2, \"text\": \"Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. AMENDMENT NO. 2 TO MANUFACTURING AND SUPPLY AGREEMENT THIS AMENDMENT NO. 2 (this \\\"Amendment\\\") to the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \\\"Existing Agreement\\\"), by and between Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon's Court, 22 Victoria Street, Hamilton HM12, Bermuda (\\\"Columbia\\\"), and Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\\\"Fleet\\\") is entered into on 2018 (the \\\"Effective Date\\\"). WHEREAS, Columbia and Fleet entered into the Existing Agreement pursuant to which Fleet has agreed to manufacture and supply to Columbia, and Columbia has agreed to purchase, certain Products; and WHEREAS, Columbia and Fleet wish to amend the Existing Agreement in accordance with the terms of this Amendment. NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Columbia and Fleet agree as follows: General Capitalised terms used but not defined in this Amendment shall have the same meanings ascribed to such terms in the Existing Agreement. The following amendments to the Existing Agreement shall have effect on and from the Effective Date.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following definitions shall be added to Section 1 of the Existing Agreement\", \"level\": 1, \"text\": \"1. The following definitions shall be added to Section 1 of the Existing Agreement: \\\"\\\"Ares Agreement\\\" means the supply agreement entered into between Columbia and Ares Trading S.A. (a subsidiary of Merck Serono S.A.) dated 7 January 2018.\\\" \\\"GDP\\\" means the EU guidelines for current Good Distribution Practice guidelines 2013/C 343/01 as amended.\\\"\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The definition of \\\"batch\\\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the\", \"level\": 1, \"text\": \"2. The definition of \\\"batch\\\" in Section 1 of the Existing Agreement shall be deleted in its entirety and replaced with the following: \\\"\\\"Batch\\\" means a quantity of [***] kilograms of material (or such other quantity as the Parties may agree in writing from time to time) produced in a process or series of processes that is expected to be homogeneous within specified limits.\\\"\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following shall be added to Section 2\", \"level\": 1, \"text\": \"3. The following shall be added to Section 2.1 of the Existing Agreement (Regulatory Requirements) as a new Section 2.1 (d): \\\"2.1 (d) Subject to the prior written consent of Columbia (such consent not to be unreasonably withheld, delayed or conditioned), Fleet may subcontract all or part of the activities to be performed by it under this Agreement to any subcontractor provided that the subcontracting of any activities shall not relieve Fleet of, and Fleet shall remain solely liable for, its obligations under this Agreement. Columbia may subcontract all or any part of the activities performed by it under this Agreement to any subcontractor without the consent of Fleet.\\\" 1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 4. The following new Sections 2.2 (b), 2.2 (c) and 2.2 (d) shall be added to Section 2.2 of the Existing Agreement (Regulatory Requirements): \\\"2.2 (b) Compliance with Brazilian Regulatory Authorities Regulations. Fleet hereby warrants that the facilities where the Product is manufactured complies in full with the relevant standards stipulated by the Brazil National Health Surveillance Agency (\\\"ANVISA\\\") and undertakes to ensure the facilities will continue to do so throughout the Term.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"(c) Compliance with Regulatory Approvals\", \"level\": 2, \"text\": \"2.2 (c) Compliance with Regulatory Approvals. To the extent required for regulatory purposes, Fleet grants to Columbia the right to refer to, and to grant any purchasers of Columbia's products containing the Product the right to refer to Fleet's batch manufacturing records relating to the Product. Fleet undertakes to notify Columbia and to provide Columbia with specific details of any changes to be made to the batch manufacturing records and any other filings made by Fleet with the Regulatory Authorities to the extent that they relate to the Product.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"(d) Material Change in Manufacturing Process\", \"level\": 2, \"text\": \"2.2 (d) Material Change in Manufacturing Process. Fleet shall provide reasonable notice to Columbia and shall consult with Columbia before Fleet makes any material change in any manufacturing process for the Product.\\\"\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2\", \"level\": 1, \"text\": \"5. Section 2.3 (c) of the Existing Agreement (Raw Materials) shall be deleted and replaced by the following:\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"(c) Raw Materials\", \"level\": 2, \"text\": \"2.3 (c) Raw Materials. Fleet shall be responsible for ordering [***] Raw Materials other than [***] and the [***] (which shall be provided by Columbia), as required to support Fleet's obligations under this Agreement. All right, title and interest in and to the Raw Materials provided by Columbia (including but not limited to the [***] and the [***]) shall remain with Columbia at all times. Fleet shall ensure that all Raw Materials are released for use at least [***] prior to their use in manufacturing the Product. Fleet shall maintain sufficient stocks of Raw Materials to meet its manufacturing and supply obligations to, and as set out in any Production Schedule by, Columbia; provided however that Fleet shall have a retest date in accordance with the relevant supplier's written instructions (or where none, Fleet's SOPs, which Fleet shall provide to Columbia upon request) for Raw Materials. Raw Materials shall not be used beyond their expiration date as provided by the Raw Materials supplier. (i) [***] costs of Raw Materials shall be included in the Purchase Price. Fleet shall be responsible for [***] of Raw Materials hereunder which Fleet supplies. For the avoidance of doubt, Columbia shall be responsible for all such costs only in respect of [***] and [***] provided by Columbia to Fleet. Fleet shall not use any Raw Materials purchased directly by Columbia except for the manufacture of Product hereunder. Columbia will be responsible for all retesting costs associated with the Raw Materials supplied by Columbia. (ii) Fleet shall notify Columbia of any Raw Materials that do not meet the specifications of the Raw Materials, and shall provide Columbia with full details within twenty-four (24) hours of completion of the investigation, but not more than twenty (20) business days from identification of the non-conformity with the specifications. 2 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 6. A new Section 2.3 (n) shall be inserted into the Existing Agreement as follows: \\\"2.3 (n) KPIs. As soon as practicable following the Effective Date the Parties shall agree in good faith key performance indicators the Supplier will agree to achieve when supplying the Products and such key performance indicators will be set out in an amendment agreed by the Parties to this Agreement.\\\"\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A new Section 3A shall be inserted into the Existing Agreement as follows\", \"level\": 1, \"text\": \"7. A new Section 3A shall be inserted into the Existing Agreement as follows: \\\"3A Machinery and Equipment 3A.1 Columbia has provided Fleet with the machinery, equipment and materials listed in Exhibit B, which Fleet uses to manufacture Products (\\\"Columbia Equipment\\\"). Any additional machinery, equipment and materials provided by Columbia to Fleet during the Term shall be Columbia Equipment unless otherwise agreed in writing by both Parties. During the Term, Columbia shall review and update Exhibit B in December of each year to include any additional machinery, equipment and materials provided to Fleet. 3A.2 The Parties confirm that Columbia owns title to all Columbia Equipment and that Columbia shall be regarded as the owner of the Columbia Equipment notwithstanding that the Columbia Equipment shall be retained at Fleet's premises. Fleet shall not do or permit or cause anything to be done whereby Columbia's rights in and title to the Columbia Equipment are or may become prejudiced including, without limitation, by ensuring that Columbia Equipment are clearly marked as the property of Columbia. No item of Columbia Equipment may be moved from Fleet's premises without the prior written consent of Columbia. 3A.3 Fleet shall not use the Columbia Equipment for any purpose other than supplying Columbia with the Product in accordance with the terms of this Agreement without Columbia's prior written consent. 3A.4 Fleet will at all times ensure that the Columbia Equipment meets and is operated and maintained in accordance with Applicable Laws and cGMP and GDP. 3A.5 Fleet shall maintain the Columbia Equipment, the reasonable costs of which shall be agreed by the Parties (acting reasonably) and paid by Columbia, and: (a) maintenance shall be carried out to at least the standards adopted in respect of Fleet's other machinery and equipment used by it at its premises and Fleet shall not prioritize the maintenance of its own equipment above that of the Columbia Equipment; (b) Fleet shall at all times ensure that it has sufficient trained and competent maintenance personnel available for such maintenance; (c) during the Term, on or before 1 January of each year, Fleet shall prepare and deliver to Columbia: (i) a maintenance plan setting out the maintenance activities to be performed by Fleet in respect of the Columbia Equipment for the following year; and 3 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. (ii) a maintenance report confirming that each of the maintenance activities set out in the previous year's maintenance plan have been carried out; (d) Columbia shall have the right to request a maintenance report in respect of any of the Columbia Equipment at any time during the Term which Fleet shall provide to Columbia within twenty-eight (28) days; (e) Fleet shall inform Columbia of the need for any overhauls, replacements and repairs and shall perform all such overhauls, replacements and repairs as reasonably instructed by Columbia (the reasonable agreed costs of which shall be borne by Columbia); and (f) if an overhaul of the Columbia Equipment is required, Fleet shall provide reasonable notice to Columbia and shall manufacture adequate stocks of Product in advance to ensure continuity of supply in accordance with orders placed by Columbia pursuant to the terms of this Agreement. 3A.6 Fleet shall keep the Columbia Equipment safe and in good working order and shall take all reasonable steps to ensure that the Columbia Equipment does not become contaminated or corroded. 3A.7 Fleet shall mark each individual unit of the Columbia Equipment in a conspicuous manner to indicate that such machinery and equipment is owned by Columbia. 3A.8 Fleet shall keep the Columbia Equipment free and clear of any lien, charge or encumbrance and Fleet shall obtain and deliver to Columbia a waiver of any of the foregoing in a form reasonably acceptable to Columbia. 3A.9 Columbia shall not be liable for any loss or damage due to the negligence or wilful misconduct of Fleet, its Affiliates, employees, contractors or representatives. In the event of any loss or damage of any item of the Columbia Equipment due to the negligence or wilful misconduct (including negligence or intentional misconduct in relation to the operation, inspection or maintenance of the Columbia Equipment) of Fleet, its Affiliates, employees, contractors or representatives, Fleet shall repair or replace such items of Columbia Equipment, at Fleet's sole cost and expense.\\\"\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 3\", \"level\": 1, \"text\": \"8. Section 3.1 of the Existing Agreement (Production Schedules) shall be deleted and replaced by the following: \\\"3.1 Production Forecasts (a) Production Schedule. Each [***], before the [***], during the Term Columbia shall prepare and provide Fleet with a written Production Schedule of its requirements for Product (each, a \\\"Production Schedule\\\") for the following [***]. The amounts set forth for the [***] in each Production Schedule shall constitute a firm purchase order and shall be binding upon Columbia (each a \\\"Purchase Order\\\") unless otherwise agreed in writing by both parties. The amounts set forth for the following [***] shall constitute Columbia's non-binding, good faith estimate of the Product requirements of Columbia for such periods. Fleet shall manufacture, supply and deliver to 4 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Columbia all quantities of Product as Columbia orders in accordance with this Section 3.1. All right, title and interest in and to the Product shall remain with Columbia at all times. Fleet shall ensure that it has sufficient experienced production staff available to meet the requirements set out in each Production Schedule and at a minimum, to meet the expected non-binding forecast set out below: [***] [***] [***] [***] [***] [***] N u m b e r o f batches [***] [***] [***] [***] [***] [***] (b) Non-Active Product Orders. From time to time during the Term, Columbia may provide Fleet with a purchase order for a batch of Product that does not contain any active pharmaceutical ingredient provided that such purchase order is received at least ninety (90) days prior to the required delivery date. The batch size for any Product ordered pursuant to this Section 3.1 (b) shall be set out in the relevant purchase order. All provisions of this Agreement that relate to Products shall apply equally to any Products that do not contain any active pharmaceutical ingredient.\\\"\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 3\", \"level\": 1, \"text\": \"9. Section 3.3 (a) of the Existing Agreement (Delivery) shall be deleted and replaced by the following: \\\"3.3 (a) Delivery. All Product supplied under this Agreement shall be delivered EXW Fleet's Watford, UK facility. All risk of loss in the Product shall pass to Columbia upon receipt of the Product at Fleet's facility by the carrier designated by Columbia. The weights, tariffs and tests affixed by Fleet's invoice shall govern unless established to be incorrect. Claims relating to quantity, weight and loss or damage to any Product sold under this Agreement shall be waived by Columbia unless made within [***] of receipt of Product by Columbia.\\\"\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 4\", \"level\": 1, \"text\": \"10. Section 4.1 of the Existing Agreement (Audits) shall be deleted and replaced by the following: \\\"4.1 Audits. Columbia QA, any other person appointed by Columbia, Columbia's customer, and/or any Regulatory Authority may conduct inspections and audits of Fleet's manufacturing facility, Columbia Equipment, quality control laboratories, and other quality systems relating to the manufacture and storage of the Product according to Columbia's reasonable procedures upon reasonable prior written notice, during normal business hours, provided, however, that Columbia QA, any other person appointed by Columbia and/or any Regulatory Authority may conduct a \\\"For Cause\\\" audit during normal business hours upon three (3) business days prior written notice to Fleet. Any such audit undertaken by Columbia QA or any other person appointed by Columbia shall be at Columbia's sole cost and expense. Columbia or any other person appointed by Columbia shall have the right, in connection with any such audit, to inspect and obtain copies of any records or other documents and materials associated with or related to the manufacture of the Product. Fleet shall promptly notify Columbia of any proposed inspections by any governmental authority of the facilities at which Product is manufactured in sufficient time for Columbia to attend such inspection.\\\"\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sections 5\", \"level\": 1, \"text\": \"11. Sections 5.1 (Price) and 5.2 (Invoicing) of the Existing Agreement shall be deleted and replaced by the following: 5 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. \\\"5.1 Price. During the Term, the purchase price for each Batch purchased by Columbia from Fleet in any [***] shall be determined in accordance with Part 1 of Exhibit A and the pricing model set out in Part 2 of Exhibit A attached hereto, as may be amended from time to time in accordance with the provisions of this Section 5.1. The Parties shall agree the applicable purchase price for each [***] in accordance with Part 1 of Exhibit A (as may be amended from time to time in accordance with this Section 5.1) and the production forecasts received by Fleet pursuant to Section 3.1. [***]. Any adjustments as set out in paragraphs (a), (b) and (c) below and any consequent adjustments to the volume discount model set out in Part 1 of Exhibit A and/or the pricing model set out in Part 2 of Exhibit A shall be agreed in writing by both Parties and shall take effect from 1 January the following calendar year. Exhibit A may be amended by the mutual written agreement of both parties as follows: (a) the [***] of Exhibit A shall only be amended to reflect the change in rate of the Consumer Price Index as published by the UK Office of National Statistics all item data series D7BT (the \\\"CPI\\\"). By way of example, if on 1 November in a calendar year during the Term, the CPI shows that there has been an increase in prices compared with the same index on 1 November the previous year [***], then [***] in the model as of 1 January in the following year [***] of the CPI increase as recorded on 1 November, [***]. (b) the [***] of Exhibit A shall only be amended to reflect [***] of the change in rate of the CPI. By way of example, if on 1 November in a calendar year during the Term, the CPI shows that there has been an increase in prices compared with the same index on 1 November the previous year [***], then [***] in the model as of 1 January in the following year [***] of the CPI increase as recorded on 1 November, i.e. by [***]. (c) the [***] of Exhibit A shall only be amended to reflect any [***] changes to the cost of any of the [***] set out in Part 4 of Exhibit A. If at any other time during a calendar year the [***] when compared with [***], Fleet shall have the right to amend the [***] for any future invoices by providing Columbia with at least three (3) months' prior written notice. Except as otherwise set out in Section 5.1 (c), the first period during which any adjustment set out in Section 5.1 (a), (b) or (c) above will be calculated shall be [***], with the adjusted costs to be applied to the pricing model in Exhibit A for the calendar year commencing [***]. Fleet shall provide Columbia with access to all books and records necessary to verify any changes to the purchase price.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Invoicing\", \"level\": 2, \"text\": \"5.2 Invoicing. Upon delivery of Product to Columbia, Fleet shall submit invoices therefor to Columbia. Columbia shall pay each invoice in full within [***] after the date of receipt by Columbia of such invoice, which shall be issued no earlier than the date on which the Product is delivered to the carrier by Fleet. All payments shall be made in pounds sterling. In the event that any actual volume of Product purchased by Juniper in any calendar year means that a different purchase price should have applied to such volume of Product purchased in that calendar year (as calculated in accordance with the pricing model set out in Exhibit A), Fleet shall notify Juniper in writing of such pricing differential and shall apply a proportionate credit or debit (as applicable) to any invoices raised for the subsequent calendar year. Upon the expiration or earlier termination of this Agreement, 6 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Fleet shall determine the applicable purchase price for that calendar year and shall notify Juniper in writing of any underpayment or overpayment within [***] of expiration or termination (as applicable). In the event of any underpayment by Juniper, Juniper shall pay to Fleet an amount equal to the amount of any such underpayment within [***] of receipt by Juniper of such written notice. In the event of any overpayment by Juniper, Fleet shall pay to Juniper an amount equal to the amount of any overpayment within [***] of receipt by Juniper of such written notice. Fleet shall provide Columbia with access to all books and records necessary to verify any changes to the purchase price and any underpayment or overpayment.\\\"\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 8 of the Existing Agreement (Insurance) shall be deleted and replaced by the following\", \"level\": 1, \"text\": \"12. Section 8 of the Existing Agreement (Insurance) shall be deleted and replaced by the following: \\\"Fleet and Columbia shall maintain comprehensive general liability insurance, including product liability insurance against claims regarding the manufacture of Product under this Agreement and sufficient cover to meet its liabilities under this Agreement in respect of the Columbia Equipment, with insurers having an AM Best rating within the top 2 categories at the time (at the date of this Agreement known as \\\"superior\\\" or \\\"excellent\\\") or reasonably comparable coverage, in such amounts as it customarily maintains for similar products and activities, but in no event less than [***] per individual claim and [***] in the aggregate. Each party shall maintain such insurance during the Term and thereafter for so long as it customarily maintains insurance for itself for similar products and activities (but in no event less than [***] following termination or expiration).\\\"\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 10\", \"level\": 1, \"text\": \"13. Section 10.1 (a) of the Existing Agreement (Fleet's Indemnity Obligations) shall be deleted and replaced by the following: \\\"10.1(a) Fleet's Indemnity Obligations. Fleet shall defend, indemnify and hold harmless Columbia, its Affiliates and their respective successors and permitted assigns (and the respective officers, directors, stockholders, partners and employees of each) from and against any and all losses liabilities, claims, actions, proceedings, damages and expenses (including, without limitation, reasonable attorneys' and professional fees and disbursements and expenses of litigation, arbitration or investigation) (\\\"Damages\\\") relating to or arising from (i) any breach by Fleet or its Affiliates of its representations, warranties, covenants, agreements or obligations under this Agreement, including without limitation, the failure of Fleet to timely deliver all Product ordered or the failure of the Product to meet the Fleet Warranty and/or Product Specifications or the failure of Fleet to manufacture or warehouse the Product in accordance with the Product Specifications and Applicable Law (including those relating to cGMP); and (ii) any claims of infringement or misappropriation with respect to the manufacture of the Product, except to the extent such claim of infringement relates to the use of the Intellectual Property; and (iii) any personal injury or property damage to the extent that the injury or damage is the direct result of a failure by Fleet or its Affiliates or subcontractors to manufacture, package, or label the Product in accordance with the Specifications, GMP or Applicable Law.\\\"\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 10\", \"level\": 1, \"text\": \"14. Section 10.1 (b) of the Existing Agreement (Columbia's Indemnity Obligations) shall be deleted and replaced by the following: \\\"10.1 (b) Columbia's Indemnity Obligations. Columbia shall defend, indemnify and hold harmless Fleet and its Affiliates, and their respective successors and permitted assigns (and the respective officers, directors, 7 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. stockholders, partners and employees of each) from and against any and all Damages arising out of (i) the handling, possession, use, marketing, distribution or sale of any Product and finished pharmaceutical product containing a Product by Columbia or any of its distributors or agents after Fleet's delivery of the Product to Columbia (except to the extent such claims arise out of the circumstances described in Section 10.1(a) or Fleet's negligence or wilful misconduct); (ii) product liability claims, including, wrongful death, resulting from the use of a finished pharmaceutical product containing a Product (except to the extent such claims arise out of the circumstances described in Section 10.1(a) or Fleet's negligence or wilful misconduct); (iii) any breach by Columbia of its representations, warranties, covenants, agreements or obligations under this Agreement (except to the extent any such breach is due to the negligence, breach or wilful misconduct of Fleet); and (iv) any claims of infringement or misappropriation relating to the Intellectual Property.\\\"\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sections 11\", \"level\": 1, \"text\": \"15. Sections 11.1 to 11.3 of the Existing Agreement (Confidentiality and Public Disclosure) shall be deleted and replaced by the following: \\\"11.1 Confidentiality. Each party will treat as confidential the Confidential Information of the other party and will take all necessary precautions to assure the confidentiality of such Confidential Information. Each party agrees to return to the other party upon the expiration or termination of this Agreement all Confidential Information acquired from such other party, except as to such information it may be required to retain under Applicable Law, and except for one copy of such information to be retained by such party's legal counsel. Neither party shall, during the period of this Agreement nor for five (5) years thereafter, without the other party's express prior written consent, other than as provided under this Agreement, use or disclose any such Confidential Information for any purpose other than to carry out its obligations hereunder. Each Party shall guard such Confidential Information using the same degree of care as it normally uses to guard its own confidential, proprietary information of like importance, but in any event no less than reasonable care.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Permitted Disclosures\", \"level\": 2, \"text\": \"11.2 Permitted Disclosures. Notw i ths tand ing the ob l iga t ions o f confidentiality and non-use set out in Section 11.1, a Receiving Party may: (a) disclose Confidential Information to a regulatory authority as reasonably necessary to obtain registration in a particular jurisdiction; (b) disclose Confidential Information to the extent such disclosure is reasonably necessary to comply with the order of a court or is required to comply with any Applicable Law or other regulation, directive, instruction, direction or rule of any regulatory authority having jurisdiction over any activity under this Agreement, including to the extent such disclosure is required in publicly filed financial statements or other public statements under rules governing a stock exchange on which securities issued by either party may be listed; provided, to the extent possible, such party shall (i) notify the other party of the existence, terms and circumstances surrounding such a requirement; (ii) consult with the other party on the advisability of taking legally available steps to resist or narrow such requirement; (iii) provide the other party with a copy of the proposed text of such statements or disclosure ten (10) business days in advance of the date on which the disclosure is to be made to enable the other party to 8 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. review and provide comments, unless a shorter review time is agreed; and (iv) exercise its commercially reasonable efforts to obtain an order or other reliable assurance that confidential treatment will be accorded to such portion of the Confidential Information required to be disclosed; (c) disclose Confidential Information on a strict need to know basis to such Receiving Party's licensee's, employees, Affiliates, contractors (including clinical researchers), distributors, agents and consultants as such Receiving Party reasonably determines is necessary to receive the benefit of the licenses and rights granted or available to it under this Agreement or to fulfil its obligations pursuant to this Agreement; provided, however, any such person is bound in writing to observe confidentiality provisions at least as strict as those of this Agreement; (d) disclose Confidential Information: (i) to its actual or potential investment bankers; (ii) to existing and potential investors in connection with an offering or placement of securities for purposes of obtaining financing for its business and to actual and prospective lenders for the purpose of obtaining financing for its business; and (iii) to a bona fide potential acquirer or merger partner for the purposes of evaluating entering into a merger or acquisition, provided, however, any such persons must be obligated to substantially the same extent as set forth in Section 11.1 to hold in confidence and not make use of such Confidential Information for any purpose other than those permitted by this Agreement; and (e) disclose Confidential Information to its legal advisers for the purpose of seeking advice.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Public Announcements\", \"level\": 2, \"text\": \"11.3 Public Announcements. Except for such disclosure as is permitted under Section 11.2 or as required by Applicable Law or the requirements of a national securities exchange or another similar regulatory body, no announcement, news release, public statement, publication, or presentation relating to this Agreement, the subject matter hereof or either party's performance hereunder will be made without the other party's prior written approval.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 12\", \"level\": 1, \"text\": \"16. Section 12.1 of the Existing Agreement (Term) shall be deleted and replaced by the following: \\\"12.1 Term. Unless terminated earlier pursuant to Section 12.2 below, the initial term of this Agreement shall expire on 31 December 2024 (the \\\"Initial Term\\\") unless the Parties mutually agree in writing any extension to the Initial Term. Upon termination of this Agreement, Fleet agrees to perform its obligations under this Agreement until the earlier of [***].\\\"\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 12\", \"level\": 1, \"text\": \"17. Section 12.2 (b) of the Existing Agreement, regarding termination of the Existing Agreement by Columbia, shall be deleted and replaced by the following: \\\"12.2 (b) Columbia shall have the right to terminate this Agreement upon [***] notice to Fleet in the event: (i) Fleet fails to maintain its authorizations under Applicable law to manufacture the product, including without limitation those from MHRA; 9 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. (ii) a Change of Control Event with respect to Fleet occurs; (iii) Fleet cannot supply product at a Competitive Price; or (iv) the Ares Agreement is terminated.\\\"\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 12\", \"level\": 1, \"text\": \"18. Section 12.3 (b) of the Existing Agreement (Effect of Expiration and Termination) shall be deleted and replaced by the following: \\\"12.3 (b) Expiration or termination of this Agreement shall not relieve the parties of any obligation accruing prior to such expiration or termination. The provisions of Sections 1 (Definitions), 3A.2, 3A.3 and 3A.8 (Machinery and Equipment), 4.1 (Audits), 5.2 (Invoicing), 7 (Representations and Warranties), 8 (Insurance), 9 (Adverse Events; Recalls), 10 (Indemnification; Limitation of Liability), 11.1 (Confidentiality and Public Disclosure), 12 (Term and Termination) and 13 (General Provisions) shall survive any expiration or termination of this Agreement.\\\"\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 12\", \"level\": 1, \"text\": \"19. Section 12.3 (c) of the Existing Agreement (Effect of Expiration and Termination) shall be deleted and replaced by the following: \\\"12.3 (c) If Columbia terminates this Agreement under Section 12.2 (b)(ii) or (iii), Columbia shall reimburse Fleet for [***] purchased by Fleet under this Agreement in the period of [***] prior to the date of termination that are only used by Fleet in the manufacture of the Products.\\\"\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following new Sections 12\", \"level\": 1, \"text\": \"20. The following new Sections 12.3 (d) and 12.3 (e) shall be added to Section 12.3 of the Existing Agreement (Effect of Expiration and Termination):\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"(e) Fleet shall provide such assistance as Columbia may reasonably request to ensure the orderly transfer of the manufac\", \"level\": 2, \"text\": \"12.3 (e) Fleet shall provide such assistance as Columbia may reasonably request to ensure the orderly transfer of the manufacture of the Product to any alternative manufacturer. If requested by Columbia, Fleet shall transfer to Columbia or the alternative manufacturer all technology and know-how necessary or useful to give Columbia or the alternative manufacturer the capability of manufacturing the Product. Fleet shall communicate such technology to Columbia or the alternative manufacturer promptly, effectively and economically, so that Columbia or the alternative manufacturer can undertake the manufacture of the Product and continue the sale of the Product without interruption. Columbia undertakes to reimburse Fleet for its reasonable costs of providing such assistance and to pay to Fleet an amount for all inventory of Raw Materials and work in progress of Products and part completed Products used to provide such assistance.\\\" 10 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. 21. Section 13.1 of the Existing Agreement (Notices) shall be amended such that any notice sent to Columbia under this Agreement shall not be copied to Columbia Laboratories, Inc. at 4 Liberty Square Fourth Floor, Boston, MA 02109 but shall instead be copied to the following address: \\\"Juniper Pharmaceuticals UK Limited 8 Orchard Place Nottingham Business Park Nottingham, England NG8 6PX Attention: Chief Operating Officer\\\"\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 13\", \"level\": 1, \"text\": \"22. Section 13.2 of the Existing Agreement (Assignment) shall be deleted and replaced by the following: \\\"13.2 Assignment. Neither party shall, without the prior written consent (not to be unreasonably withheld or delayed) of the other party having been obtained, assign or transfer this Agreement to any person or entity, in whole or in part (and any attempt to do so shall be void), provided that, each party may assign or transfer this Agreement without such consent to any Affiliate or to any successor by merger of such party, or upon a sale or other transfer of all or substantially all of such party's assets or business to which the subject matter of this Agreement pertains, provided that the acquirer of the business confirms to the Supplier in writing its agreement to be bound by all of the terms and conditions of this Agreement and that the assignor shall remain liable for the obligations hereunder. Notwithstanding the foregoing, it shall not be deemed unreasonable for Columbia to withhold consent, to any proposed or attempted assignment (including by merger or sale) by Fleet to a party which is not an Affiliate, if Columbia is not reasonably satisfied that the assignee possesses the management, finances, personnel, capabilities and facilities to perform fully the obligations of Fleet hereunder. All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns.\\\"\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 13\", \"level\": 1, \"text\": \"23. Section 13.12 of the Existing Agreement (Technical Agreement) shall be deleted and replaced by the following: \\\"13.12 Technical Agreement. Columbia and Fleet are parties to a certain technical agreement dated 18 March 2015 (as such agreement may be amended in accordance with its terms from time to time) (the \\\"Technical Agreement\\\"), the terms of which outline the responsibilities of Columbia and Fleet with respect to assuring the quality of the Product. Columbia and Fleet acknowledge and agree that in the event the terms of this Agreement and the Technical Agreement conflict or are inconsistent, the terms of this Agreement shall prevail over the terms of the Technical Agreement; provided however, that to the extent possible, the terms of both the Technical Agreement and this Agreement shall be read and considered to effect the intent of the parties.\\\"\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following new Section 13\", \"level\": 1, \"text\": \"24. The following new Section 13.13 shall be added to Section 13 of the Existing Agreement (General Provisions): \\\"13.13 Anti-Bribery. (a) The parties agree: 11 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. (i) to comply with all Applicable Law, statutes and regulations relating to anti- bribery and anti-corruption including but not limited to the U.S. Foreign Corrupt Practices Act, US government health care compliance (HCC) policies, regulations and laws, US Export Administration Act of 1979 (50 App. U.S.C. \u00a72401 et. seq.) and the UK Bribery Act, as amended, and the regulations promulgated thereunder and any applicable similar laws and regulations in any other country) (collectively, the \\\"Relevant Laws\\\"); (ii) to have and maintain in place throughout the term of this Agreement their own policies and procedures to ensure compliance with the Relevant Laws and will appropriately enforce those policies and procedures; and (iii) that no employee, contractor, supplier, agent, broker, or entity will offer or pay anything of value to a public or private official intending to influence or induce an official act or decision or to obtain an improper advantage. (b) A material breach of this Section 13.13 shall be deemed a material breach of this Agreement. In the event of a material breach of this Section 13.13, the party not in breach shall have the right to terminate this Agreement, without any liability to the party in breach, with immediate effect. (c) This Agreement is made subject to any restrictions concerning the export of products or technical information from the United Kingdom or other countries which may be imposed upon or related to Fleet or Columbia from time to time. Each party agrees that it shall not export, directly or indirectly, any technical information acquired from the other party under this Agreement or any products using such technical information to a location or in a manner that at the time of export requires an export licence or other governmental approval, without first obtaining the written consent to do so from the appropriate agency or other governmental entity.\\\"\"}}, {\"id\": \"25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All other terms and conditions of the Existing Agreement remain in full force and effect\", \"level\": 1, \"text\": \"25. All other terms and conditions of the Existing Agreement remain in full force and effect. Except as expressly provided in this Amendment, the Existing Agreement shall remain unmodified and is hereby ratified and affirmed. The execution, delivery, and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power, or remedy of Columbia or Fleet under the Existing Agreement.\"}}, {\"id\": \"26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Amendment, together with the Existing Agreement, sets forth the entire agreement and understanding between the Par\", \"level\": 1, \"text\": \"26. This Amendment, together with the Existing Agreement, sets forth the entire agreement and understanding between the Parties as to the subject matter hereof and thereof and merges all prior discussions and negotiations between them, and neither of the parties shall be bound by any conditions, definitions, warranties, understandings or representations with respect to such subject matter other than as expressly provided herein and therein or as duly set forth on or subsequent to the date hereof in writing and signed by a proper and duly authorized officer or representative of the Party to be bound thereby. 27. This Amendment may be signed in counterparts, each and every one of which shall be deemed an original, notwithstanding variations in format or file designation which may result from the electronic transmission, storage and printing of copies of this Amendment from separate computers or printers. Executed signature pages to this Amendment may be 12 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. delivered by facsimile or a portable document format (PDF) copy (including copy(ies) sent by e-mail) and all such shall be deemed as if actual signature pages had been delivered. 28. This Amendment and and any dispute or claim (including non-contractual disputes or claims) arising out of or in connection with it or its subject matter or formation shall be governed by and construed in accordance with the laws of England. Each Party irrevocably agrees that the English courts shall have sole and exclusive jurisdiction to settle any dispute or claim (including non-contractual disputes or claims) arising out of or in connection with this Amendment or its subject matter or formation. IN WITNESS WHEREOF, the parties have duly executed this Amendment as of the Effective Date. COLUMBIA LABORATORIES (BERMUDA), LTD. By: /s/ Alicia Secor ____________________________ Name: Alicia Secor_______________________________ Title: Chief Executive Officer_______________________ FLEET LABORATORIES LIMITED By: /s/ Tom Horner______________________________________ Name: Tom Horner_________________________________________ Title: Managing Director____________________________________ 13 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Exhibit A Part 1 - Volume adjusted purchase price [***] 14 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Part 2 - Pricing Model [***] 15 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \\\"[***]\\\". A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT to RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. Exhibit B Columbia Equipment [***] 16\"}}, {\"id\": \"party:Columbia Laboratories, (Bermuda) Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Columbia Laboratories, (Bermuda) Ltd.\", \"role\": null, \"address\": \"Canon's Court, 22 Victoria Street, Hamilton HM12, Bermuda\"}}, {\"id\": \"party:Fleet Laboratories Limited\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Fleet Laboratories Limited\", \"role\": null, \"address\": \"94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom\"}}, {\"id\": \"party:Ares Trading S.A.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Ares Trading S.A.\", \"role\": null, \"address\": null}}, {\"id\": \"party:Brazil National Health Surveillance Agency\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Brazil National Health Surveillance Agency\", \"role\": null, \"address\": null}}, {\"id\": \"party:Juniper Pharmaceuticals UK Limited\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Juniper Pharmaceuticals UK Limited\", \"role\": null, \"address\": \"8 Orchard Place Nottingham Business Park Nottingham, England NG8 6PX\"}}, {\"id\": \"term:Amendment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment\", \"text\": \"THIS AMENDMENT NO. 2 (this \\\"Amendment\\\") to the Manufacturing and Supply Agreement dated as of December 8, 2009\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Existing Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Existing Agreement\", \"text\": \"the Manufacturing and Supply Agreement dated as of December 8, 2009 (as amended by an amendment agreement dated 31 December 2013) (the \\\"Existing Agreement\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Columbia\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Columbia\", \"text\": \"Columbia Laboratories, (Bermuda) Ltd., a limited company existing and organised under the laws of Bermuda, having a place of business at Canon's Court, 22 Victoria Street, Hamilton HM12, Bermuda (\\\"Columbia\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Fleet\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fleet\", \"text\": \"Fleet Laboratories Limited, a limited private company existing and organised under the laws of England, having a place of business at 94 Rickmansworth Road, Watford Herts, WD18 7JJ, United Kingdom (\\\"Fleet\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"is entered into on 2018 (the \\\"Effective Date\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Ares Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ares Agreement\", \"text\": \"the supply agreement entered into between Columbia and Ares Trading S.A. (a subsidiary of Merck Serono S.A.) dated 7 January 2018.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:GDP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"GDP\", \"text\": \"the EU guidelines for current Good Distribution Practice guidelines 2013/C 343/01 as amended.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Batch\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Batch\", \"text\": \"a quantity of [***] kilograms of material (or such other quantity as the Parties may agree in writing from time to time) produced in a process or series of processes that is expected to be homogeneous within specified limits.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:ANVISA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ANVISA\", \"text\": \"Brazil National Health Surveillance Agency (\\\"ANVISA\\\")\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Columbia Equipment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Columbia Equipment\", \"text\": \"Columbia has provided Fleet with the machinery, equipment and materials listed in Exhibit B, which Fleet uses to manufacture Products (\\\"Columbia Equipment\\\")\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Production Schedule\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Production Schedule\", \"text\": \"Each [***], before the [***], during the Term Columbia shall prepare and provide Fleet with a written Production Schedule of its requirements for Product (each, a \\\"Production Schedule\\\") for the following [***].\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"The amounts set forth for the [***] in each Production Schedule shall constitute a firm purchase order and shall be binding upon Columbia (each a \\\"Purchase Order\\\") unless otherwise agreed in writing by both parties.\", \"definition_clause\": \"8\"}}, {\"id\": \"term:CPI\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CPI\", \"text\": \"the Consumer Price Index as published by the UK Office of National Statistics all item data series D7BT (the \\\"CPI\\\")\", \"definition_clause\": \"11\"}}, {\"id\": \"term:Damages\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Damages\", \"text\": \"losses liabilities, claims, actions, proceedings, damages and expenses (including, without limitation, reasonable attorneys' and professional fees and disbursements and expenses of litigation, arbitration or investigation) (\\\"Damages\\\")\", \"definition_clause\": \"13\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"Unless terminated earlier pursuant to Section 12.2 below, the initial term of this Agreement shall expire on 31 December 2024 (the \\\"Initial Term\\\")\", \"definition_clause\": \"16\"}}, {\"id\": \"term:Technical Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Technical Agreement\", \"text\": \"Columbia and Fleet are parties to a certain technical agreement dated 18 March 2015 (as such agreement may be amended in accordance with its terms from time to time) (the \\\"Technical Agreement\\\"), the terms of which outline the responsibilities of Columbia and Fleet with respect to assuring the quality of the Product.\", \"definition_clause\": \"23\"}}, {\"id\": \"term:Relevant Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Relevant Laws\", \"text\": \"all Applicable Law, statutes and regulations relating to anti- bribery and anti-corruption including but not limited to the U.S. Foreign Corrupt Practices Act, US government health care compliance (HCC) policies, regulations and laws, US Export Administration Act of 1979 (50 App. U.S.C. \u00a72401 et. seq.) and the UK Bribery Act, as amended, and the regulations promulgated thereunder and any applicable similar laws and regulations in any other country) (collectively, the \\\"Relevant Laws\\\")\", \"definition_clause\": \"24\"}}, {\"id\": \"value:twenty-four (24) hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) hours\"}}, {\"id\": \"value:twenty (20) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) business days\"}}, {\"id\": \"value:twenty-eight (28) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-eight (28) days\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:three (3) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) business days\"}}, {\"id\": \"value:three (3) months'\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) months'\"}}, {\"id\": \"value:ten (10) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of Copy of WaterNowInc_20191120_10-Q_EX-10.12_11900227_EX-10.12_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of Copy of WaterNowInc_20191120_10-Q_EX-10.12_11900227_EX-10.12_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.12\", \"title\": \"EXCLUSIVE DISTRIBUTOR AGREEMENT THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and entered into as of the 12th day of November, 2019 (the \\\"Effective Date\\\"), by and among WATER NOW, INC., a Texas corporation (\\\"Water Now\\\"), Hydraspin USA, Inc., a Texas corporation and a subsidiary of Water Now (the \\\"Subsidiary,\\\" and collectively with Water Now, \\\"Hydraspin\\\") and BESTEV MANAGEMENT, LLC, a Texas limited liability company (\\\"Distributor\\\"). Hydraspin and Distributor are sometimes hereinafter referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\" RECITALS: A. Hydraspin holds the exclusive distribution rights in the United States of America for certain commercial oil and gas products,and the associated technology, used to separate and remove Hydrocarbons from natural and injected water involved in the extraction process. B. Hydraspin desires to appoint Distributor, and Distributor desires to be appointed, as the exclusive distributor of products of Hydraspin in the Territory (as defined below), pursuant to the terms and conditions of this Agreement. NOW, THEREFORE, in consideration of the premises and the mutual promises and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: ARTICLE I. DEFINITIONS 1.1 For purposes of this Agreement, the following terms, where written with an initial capital letter, shall have the meanings assigned to them in this Article I unless the context otherwise requires: \\\"Affiliate\\\" means an individual or legal entity that directly or indirectly, through one or more intermediaries, controls or is controlled by, or is under common control with, another Person. The term \\\"Control\\\" as utilized herein means the possession, directly or indirectly, of the power to direct or cause direction of the management and policies of a Person, whether through management, ownership, by contract, or otherwise; provided, however, in no event shall Hydraspin be deemed an Affiliate of the Distributor. \\\"Change of Control\\\" means the sale, conveyance or disposition of all or substantially all of the assets of Hydraspin, the effectuation by Hydraspin of a transaction or series of transactions in which more than 50% of the voting power of Hydraspin is disposed of, or any consolidation, merger or other business combination of Hydraspin with or into any other Person or Persons where Hydraspin is not the survivor. \\\"Customer\\\" means any Person that is a customer of the Distributor and any Affiliate of Distributor that has an interest in or ultimately utilizes the Product (as defined below). \\\"Distributor Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that the Distributor is entitled to receive, as follows: (i) for the first ten (10) Products installed, 7.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 15% of Net Revenue. Notwithstanding anything to the contrary contained herein, the 1\", \"level\": 2, \"text\": \"Exhibit 10.12 EXCLUSIVE DISTRIBUTOR AGREEMENT THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and entered into as of the 12th day of November, 2019 (the \\\"Effective Date\\\"), by and among WATER NOW, INC., a Texas corporation (\\\"Water Now\\\"), Hydraspin USA, Inc., a Texas corporation and a subsidiary of Water Now (the \\\"Subsidiary,\\\" and collectively with Water Now, \\\"Hydraspin\\\") and BESTEV MANAGEMENT, LLC, a Texas limited liability company (\\\"Distributor\\\"). Hydraspin and Distributor are sometimes hereinafter referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\" RECITALS: A. Hydraspin holds the exclusive distribution rights in the United States of America for certain commercial oil and gas products,and the associated technology, used to separate and remove Hydrocarbons from natural and injected water involved in the extraction process. B. Hydraspin desires to appoint Distributor, and Distributor desires to be appointed, as the exclusive distributor of products of Hydraspin in the Territory (as defined below), pursuant to the terms and conditions of this Agreement. NOW, THEREFORE, in consideration of the premises and the mutual promises and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: ARTICLE I. DEFINITIONS 1.1 For purposes of this Agreement, the following terms, where written with an initial capital letter, shall have the meanings assigned to them in this Article I unless the context otherwise requires: \\\"Affiliate\\\" means an individual or legal entity that directly or indirectly, through one or more intermediaries, controls or is controlled by, or is under common control with, another Person. The term \\\"Control\\\" as utilized herein means the possession, directly or indirectly, of the power to direct or cause direction of the management and policies of a Person, whether through management, ownership, by contract, or otherwise; provided, however, in no event shall Hydraspin be deemed an Affiliate of the Distributor. \\\"Change of Control\\\" means the sale, conveyance or disposition of all or substantially all of the assets of Hydraspin, the effectuation by Hydraspin of a transaction or series of transactions in which more than 50% of the voting power of Hydraspin is disposed of, or any consolidation, merger or other business combination of Hydraspin with or into any other Person or Persons where Hydraspin is not the survivor. \\\"Customer\\\" means any Person that is a customer of the Distributor and any Affiliate of Distributor that has an interest in or ultimately utilizes the Product (as defined below). \\\"Distributor Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that the Distributor is entitled to receive, as follows: (i) for the first ten (10) Products installed, 7.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 15% of Net Revenue. Notwithstanding anything to the contrary contained herein, the 1 Source: WATER NOW, INC., 10-Q, 11/20/2019 Distributor Share with respect to the split of Net Revenue between Hydraspin and the Distributor with respect to any particular Production installation or group Product installation may be negotiated by Hydraspin and the Distributor and set forth in a separate written agreement between the Parties, and in such case, the Distributor Share set forth in the separate written agreement shall supersede and control over the Distributor Share set forth above. \\\"Governmental Entity\\\" means any and all federal, state or local governments, governmental institutions, public authorities and any other governmental entities of any nature whatsoever, and any subdivisions or instrumentalities thereof, including, but not limited to, departments, boards, bureaus and panels, and any divisions or instrumentalities thereof, whether permanent or ad hoc and whether now or hereafter constituted or existing. \\\"Hydraspin Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that Hydraspin is entitled to receive, as follows: (i) for the first ten (10) Products installed, 92.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 85% of Net Revenue. Notwithstanding anything to the contrary contained herein, the Hydraspin Share with respect to the split of Net Revenue between Hydraspin and the Distributor with respect to any particular Production installation or group Product installation may be negotiated by Hydraspin and the Distributor and set forth in a separate written agreement between the Parties, and in such case, the Hydraspin Share set forth in the separate written agreement shall supersede and control over the Hydraspin Share set forth above. \\\"Hydrocarbons\\\" means and includes oil, gas, casinghead gas, condensate, natural gas liquids, and all components of the foregoing. \\\"Law\\\" means any constitution, law, ordinance, principle of common law, regulation, order, statute or treaty of or issued by any Governmental Entity. \\\"Loss\\\" means any damage, deficiency, penalty, fine, cost, amount paid in settlement, liability, obligation, tax, loss, expense or fee, including court costs and reasonable attorneys' fees and expenses. \\\"Marks\\\" means mean the trademark(s), service mark(s) and/or logo(s) applicable to each Product and owned by either Hydraspin or African Horizon Technologies (PTY) Ltd (\\\"AHT\\\"). \\\"Net Revenue\\\" means the gross revenue derived from the sale of the Hydrocarbons resulting from the Products, less (i) the share of gross revenue due to the Customers under the agreements between the Customers and the Distributor or any Affiliate of the Distributor, which is generally 50%, but may be greater or less than 50%, and (ii) ordinary and customary costs, expenses and fees that are deducted from the gross revenue. \\\"Person\\\" means natural persons, corporations, ventures, limited liability companies, partnerships, trusts and all other entities and organizations. \\\"Performance Benchmarks\\\" shall mean the following requirements necessary for Distributor to maintain the exclusivity granted in Section 2.1 hereof: (a) the execution of contracts to deploy Products in 25 new locations approved in advance by Hydraspin (\\\"Customer Locations\\\") during each 12 month period following the Effective Date and (b) all Customer Locations in the aggregate shall generate an average of 7,500 barrels of fluid per day on a trailing 12 month basis. Customer Locations must be available for installation within 90 days of approval by Hydraspin to be applied toward the satisfaction of the Performance Benchmark. All Customer Locations in excess of 2 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}, {\"id\": \"25\", \"title\": \"secured during an applicable 12 month period shall be credited toward the satisfaction of the Performance Benchmark for\", \"level\": 1, \"text\": \"25 secured during an applicable 12 month period shall be credited toward the satisfaction of the Performance Benchmark for the subsequent 12 month period. If this Agreement is extended beyond the Initial Term, as hereinafter defined, the number of Customer Locations to be secured to maintain exclusivity during the pendency of the Agreement shall be increased to 50 from 25. \\\"Products\\\" shall mean, collectively, (i) the products listed on Exhibit A attached hereto, as such Exhibit may be amended from time to time by the Parties, (ii) all modifications, alterations, improvements, upgrades, and replacements to the products listed on Exhibit \\\"A\\\", now existing and existing in the future, and (iii) all other products, now existing and existing in the future, distributed by Hydraspin or any Affiliate thereof that perform substantially the same functions as the products listed on Exhibit \\\"A\\\", now existing and existing in the future. \\\"Revenue Event\\\" means any payment in cash, or by check or wire transfer resulting from the sale of Hydrocarbons to oil and gas companies or other third parties, due to the use of one or more Products to separate such Hydrocarbons from water during the extraction of such Hydrocarbons from the earth. \\\"Support Services\\\" shall mean (a) promptly responding to all inquiries from Customers, (b) servicing the Products, (c) educating Customers how to properly use and maintain the Products, (d) liaising between Customers, Distributor and Hydraspin, (d) distributing instructions for use, and any updates thereto, of each Product, and (e) any other related services performed for or on behalf of Customers. \\\"Territory\\\" shall mean the geographic territories described on Exhibit B attached hereto, as such Exhibit may be amended from time to time by the Parties. 1.2 Other Definitions. In addition to the terms defined in Section 1.1 hereof, certain other terms are defined elsewhere in this Agreement, and whenever such terms are used in this Agreement, they shall have their respective defined meanings, unless the context expressly or by necessary implication otherwise requires. ARTICLE II. APPOINTMENT 2.1 Exclusivity and Territory. Hydraspin hereby appoints Distributor, and Distributor hereby accepts appointment, as Hydraspin's exclusive distributor of the Products in the Territory during the term of this Agreement, subject to the terms and conditions of this Agreement, including, but not limited to, the satisfaction of the Performance Benchmarks. The Territory may be amended with the mutual agreement of both Parties from time to time to add or delete geographic territories by amending Exhibit B attached hereto. If Hydraspin desires to enter a new territory in the United States, Hydraspin will offer Distributor the first opportunity to become the exclusive distributor for the new territory. If the Parties are unable to reach an agreement on the terms of exclusivity within ten (10) business days of the date the opportunity is presented to Distributor, Hydraspin shall have no obligation to enter into a contract with Distributor regarding the new territory. In the event the Distributor loses exclusivity on a territory due to not meeting Performance Benchmarks, the Distributor shall maintain exclusivity on any and all existing Products that are in the field and operating at them time exclusivity if forfeited. 2.2 Sales Outside the Territory. Distributor shall be entitled to advertise, promote, market or 3 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}, {\"id\": \"ARTICLE IV\", \"title\": \"PRODUCT AND INVENTORY 4\", \"level\": 1, \"text\": \"ARTICLE IV. PRODUCT AND INVENTORY 4.1 Products. Hydraspin reserves the right, from time to time and in its sole discretion, to modify, alter, change, or improve any or all of the Products covered by this Agreement; provided, that this Agreement shall continue to apply to all Products in their altered, changed or improved state. Hydraspin shall promptly send Distributor written notice of any modification, alteration, change or improvement to any Product. 4 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 (a) Due Organization, Existence and Authority. Hydraspin (i) is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and (ii) has full power and authority to own its properties, carry on its business as presently conducted and as proposed to be conducted, and to enter into and perform its obligations under this Agreement. (b) Authorization. The execution and delivery by Hydraspin of this Agreement and the other documents related thereto and the full and timely performance of all obligations thereunder have been duly authorized by all necessary action under the constituent documents of Hydraspin and otherwise. (c) Valid, Binding and Enforceable. This has been duly and validly executed, issued and delivered by Hydraspin and constitutes the valid and legally binding obligations of Hydraspin, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency, reorganization or other similar laws relating to or affecting enforcement of creditor's rights. (d) No Violation. The execution, delivery and performance by Hydraspin of this Agreement does not and will not (i) contravene the constituent documents of Hydraspin, (ii) contravene any law, rule or regulation, or any order, writ, judgment, injunction or decree or any contractual restriction binding on or affecting Hydraspin or the Products, and (iii) require any approval or consent of any general partner, board, manager, member, lender or any other person or entity, other than approvals or consents that have been previously obtained and disclosed in writing to the Distributor, [including, without limitation, the consent of AHT.] No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required for the due execution, delivery and performance by Hydraspin of this Agreement, other than approvals or consents that have been previously obtained and disclosed in writing to the Distributor. 7.2 Representations of Distributor. Distributor represents and warrants to Hydraspin as follows: (a) Due Organization, Existence and Authority. Distributor (i) is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and (ii) has full power and authority to own its properties, carry on its business as presently conducted and as proposed to be conducted, and to enter into and perform its obligations under this Agreement. (b) Authorization. The execution and delivery by Distributor of this Agreement and the other documents related thereto and the full and timely performance of all obligations thereunder have been duly authorized by all necessary action under the constituent documents of Distributor and otherwise. (c) Valid, Binding and Enforceable. This has been duly and validly executed, issued and delivered by Distributor and constitutes the valid and legally binding obligations of Distributor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency, reorganization or other similar laws relating to or affecting enforcement of creditor's rights. (d) No Violation. The execution, delivery and performance by Distributor of this Agreement does not and will not (i) contravene the constituent documents of Distributor, (ii) contravene any law, rule or regulation, or any order, writ, judgment, injunction or decree or any contractual restriction binding on or affecting Distributor, or (iii) require any approval or consent of any general partner, board, manager, member, lender or any other person or entity, other than approvals or consents that have been previously obtained and disclosed in writing to the Hydraspin. 7 Source: WATER NOW, INC., 10-Q, 11/20/2019 No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required for the due execution, delivery and performance by Distributor of this Agreement, other than approvals or consents that have been previously obtained and disclosed in writing to Hydraspin. ARTICLE VIII.\"}, {\"id\": \"ARTICLE IX\", \"title\": \"CONFIDENTIAL AND/OR PROPRIETARY INFORMATION 9\", \"level\": 1, \"text\": \"ARTICLE IX. CONFIDENTIAL AND/OR PROPRIETARY INFORMATION 9.1 Confidentiality. Each Party acknowledges that in the course of performing its respective duties under this Agreement, such Party may obtain information related to the other Party, which is of a 8 Source: WATER NOW, INC., 10-Q, 11/20/2019 confidential or proprietary nature (\\\"Confidential Information\\\"). Each Party agrees not to use such other party's Confidential Information, either directly or indirectly, for any purpose other than as required for performance of such Party's obligations hereunder. Such Confidential Information may include but is not limited to copyright, trade secrets or other proprietary information, techniques, processes, schematics, software source documents, pricing and discount lists and schedules, customer lists, contract terms, customer leads, financial information, sales and marketing plans, and information regarding the responsibilities, skills and compensation of employees. Title to Confidential Information shall remain with the owner of the Confidential Information at all times. Each Party agrees to treat the Confidential Information with at least the degree of care and protection with which it treats its own confidential information, but in any event with no less than reasonable care and protection, and to use the Confidential Information only for the purpose set forth in this Agreement. Except as otherwise required by law, applicable regulations or the terms of this Agreement or as mutually agreed upon by the parties hereto, each Party shall treat as confidential the terms and conditions of this Agreement. Notwithstanding anything contained in this Agreement to the contrary, Confidential Information shall not include information that: (a) is or becomes available to the public other than through a disclosure in breach hereof by the receiving Party or any of its representatives; (b) was in the possession of the receiving Party or its representatives prior to the Effective Date; (c) was communicated by the disclosing Party to an unaffiliated third party free of any obligation of confidentiality, and the unaffiliated third party communicated the Confidential Information to the receiving Party or its representatives; (d) becomes available to the receiving Party or its representatives from a source other than the disclosing Party, provided, that such source is not known to the receiving Party or its representatives to have made such information available in violation of an obligation of confidentiality owed to the disclosing Party; or (e) is independently developed by or on behalf of a Party or its representatives without use of the Confidential Information of the other Party.\"}, {\"id\": \"9.2\", \"title\": \"Nondisclosure\", \"level\": 2, \"text\": \"9.2 Nondisclosure. Each Party agrees not to disclose or otherwise make such Confidential Information available to third parties without the other Party's prior written consent. Each Party agrees that it will take appropriate action by instruction, agreement, or otherwise with such Party's employees to satisfy its obligations under this Agreement with respect to the use, copying, modification, protection, and security of Confidential Information. Nothing in this section prohibits any disclosure required by applicable law, a valid court order or subpoena; provided, that the disclosing Party gives the other Party prior notice of, and if possible a reasonable opportunity to contest, such required disclosure. 9.3 Return of Confidential Information. Each Party will promptly return all Confidential Information to the other Party upon expiration or termination of this Agreement, or upon receipt by such Party of written notice from the other Party requesting return of such Confidential Information. Such Confidential Information shall be returned promptly and the non-disclosing Party shall not retain any documents or materials or copies thereof containing any Confidential Information. 9.4 Injunctive Relief. Any breach of the restrictions contained in this Article IX is a breach of this 9 Source: WATER NOW, INC., 10-Q, 11/20/2019 Agreement that may cause irreparable harm to a party and as such each Party is entitled to injunctive relief to enforce this Agreement without the need to post bond and that such relief shall be, in addition to, and not in lieu of, any monetary damages or other legal or equitable remedies that may be available. ARTICLE X. TERM AND TERMINATION 10.1 Term. The initial term of this Agreement shall commence on the Effective Date and end on the five (5) year anniversary of the Effective Date (the \\\"Initial Term\\\"), unless sooner terminated pursuant to the terms hereof. Upon expiration of the Initial Term of this Agreement, this Agreement will automatically renew for additional, successive five (5) year periods unless either Party provides the other Party written notice of its desire to terminate at least one hundred twenty (120) days prior to the end of the Initial Term or any renewal. 10.2 Termination. This Agreement may be terminated as follows: (a) In the event that the Parties mutually determine that the arrangements contemplated by this Agreement are no longer in the best interests of the Parties or the Parties are not otherwise compatible, the Parties may at any time, by mutual written agreement, terminate this Agreement. (b) Immediately upon the occurrence of any of the following events and effective upon delivery of notice: (1) by Hydraspin, i f Distributor ceases to do business, or otherwise terminates Distributor's business operations; (2) by Distributor, if Hydraspin ceases to do business, or otherwise terminates Hydraspin's business operations; (3) by Hydraspin, if Distributor fails to satisfy the Performance Thresholds; (4) by either Party, if any representation by the other Party made in this Agreement was false or misleading in any material respect when made; (5) by Distributor, if Hydraspin fails to secure or renew any license, permit, authorization, or approval for the conduct of Hydraspin's business or the distribution of the Products or if any such license, permit, authorization, or approval is revoked or suspended provided that such failure, revocation or suspension results in Hydraspin's failure or inability to perform substantially all of its obligations hereunder; (6) by either Party, if the other Party engages in fraud, criminal/negligent conduct in connection with this Agreement or the business relationship of the parties or if the other Party makes any material false representations, reports, or claims in connection with this Agreement or any Product; (7) by either Party, if the other Party breaches any of its obligations under this Agreement and such violation is not cured to the satisfaction of the non-breaching party within thirty (30) days after written notice is given from the non-breaching Party to the breaching Party; 10 Source: WATER NOW, INC., 10-Q, 11/20/2019 (8) by either Party, if Hydraspin undergoes a Change of Control; or (9) by either Party, if such other Party seeks protection under any bankruptcy, receivership, trustee, creditors arrangement, composition, or comparable proceeding, or if any such proceeding is instituted against such other Party. 10.3 Effect of Termination. (a) Termination or expiration of this Agreement will not relieve either Party of any obligation incurred hereunder prior to such termination or expiration. Each Party will be entitled to cancel any outstanding Orders, to the extent Products have not been delivered. Hydraspin shall be entitled to retrieve its Products from the Customers at its sole cost and expense. (b) If termination is the result of a Change of Control, Distributor shall be entitled to receive a onetime payment, within three (3) business days of the effective date of the Change of Control, equal to the greater of the following 1) the aggregate amount of the Distributor Share received during the 18 months prior to the effective date of such Change of Control or 2) the aggregate amount of the Distributor Share received on the 30 days prior to the effective date of such Change of Control multiplied by 18. (c) Neither Party will incur liability for any Losses of any kind suffered or incurred by the other Party arising from or incident to termination of this Agreement by such party as permitted by this Article X. ARTICLE XI. MISCELLANEOUS 11.1 Notices. (a) Manner of Notice. All notices, requests and other communications under this Agreement shall be in writing (including in portable document format (or similar format) delivered by email transmission) and shall be deemed to have been duly given if delivered personally, or sent by either certified or registered mail, return receipt requested, postage prepaid, or by overnight courier guaranteeing next day delivery, or by email transmission, addressed as follows: (i) If to Hydraspin: Water Now, Inc. Hydraspin USA, Inc. 5000 South Freeway, Suite 110 Fort Worth, Texas 76115 Attn: David King Email: dking@waternowinc.com or at such other address or email address as Hydraspin may have advised Distributor in writing; and (ii) If to Distributor: Bestev Management, LLC 11 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 respect to the matters addressed herein and supersede all prior representations, inducements, promises or agreements, oral or otherwise, which are not embodied herein or therein. 11.15 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original for all purposes and all of which shall be deemed collectively to be one agreement. Signatures given by facsimile or portable document format (or similar format) shall be binding and effective to the same extent as original signatures. 11.16 Third Party Beneficiaries. Nothing contained herein, express or implied, is intended to confer upon any person or entity other than the Parties and their respective successors in interest and permitted assigns any rights or remedies under or by reason of this Agreement. 11.17 Interpretation. This Agreement has been prepared in the English language which language shall be controlling in all respects. 14 Source: WATER NOW, INC., 10-Q, 11/20/2019 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Agreement as of the date first set forth above. WATER NOW: WATER NOW, INC. By: Name: David King Title: Chief Executive Officer HYDRASPIN: HYDRASPIN USA, INC. By: Name: David King Title: Chief Executive Officer WATER NOW: WATER NOW, INC. By: Name: Title: DISTRIBUTOR: BESTEV MANAGEMENT, LLC By: Name: Title: 15 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}, {\"id\": \"EXHIBIT A\", \"title\": \"PRODUCTS African Horizon Technologies Hydraspin Units\", \"level\": 1, \"text\": \"EXHIBIT A PRODUCTS African Horizon Technologies Hydraspin Units 16 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}, {\"id\": \"EXHIBIT B\", \"title\": \"TERRITORY The Territory consists of all of the following: A. The San Juan Basin located near the Four Corners region of the Southwestern United States. The San Juan Basin Territory includes, without limitation, that certain area covering 7,500 square miles and resides in northwestern New Mexico, southwestern Colorado, and parts of Utah and Arizona. Specifically, the San Juan Basin occupies space in the San Juan, Rio Arriba, Sandoval, and McKinley counties in New Mexico, and La Plata and Archuleta counties in Colorado. B. The Permian Basin located in the southwestern part of the United States. The Permian Basin Territory includes, without limitation, the Mid-Continent Oil Field province located in western Texas and southeastern New Mexico, reaching from just south of Lubbock, past Midland and Odessa, south nearly to the Rio Grande River in southern West Central Texas, and extending westward into the southeastern part of New Mexico. C. The Eagle Ford Group Basin (also called the Eagle Ford Shale Basin) covering much of the state of Texas. The Eagle Ford Group Basin Territory includes, without limitation, the Eagle Ford outcrop belt trending from the Oklahoma/Texas border southward to San Antonio, westward to the Rio Grande, Big Bend National Park, and the Quitman Mountains of West Texas.\", \"level\": 1, \"text\": \"EXHIBIT B TERRITORY The Territory consists of all of the following: A. The San Juan Basin located near the Four Corners region of the Southwestern United States. The San Juan Basin Territory includes, without limitation, that certain area covering 7,500 square miles and resides in northwestern New Mexico, southwestern Colorado, and parts of Utah and Arizona. Specifically, the San Juan Basin occupies space in the San Juan, Rio Arriba, Sandoval, and McKinley counties in New Mexico, and La Plata and Archuleta counties in Colorado. B. The Permian Basin located in the southwestern part of the United States. The Permian Basin Territory includes, without limitation, the Mid-Continent Oil Field province located in western Texas and southeastern New Mexico, reaching from just south of Lubbock, past Midland and Odessa, south nearly to the Rio Grande River in southern West Central Texas, and extending westward into the southeastern part of New Mexico. C. The Eagle Ford Group Basin (also called the Eagle Ford Shale Basin) covering much of the state of Texas. The Eagle Ford Group Basin Territory includes, without limitation, the Eagle Ford outcrop belt trending from the Oklahoma/Texas border southward to San Antonio, westward to the Rio Grande, Big Bend National Park, and the Quitman Mountains of West Texas. Source: WATER NOW, INC., 10-Q, 11/20/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of Copy of WaterNowInc_20191120_10-Q_EX-10.12_11900227_EX-10.12_Distributor Agreement\", \"nodes\": [{\"id\": \"Exhibit 10.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVE DISTRIBUTOR AGREEMENT THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and entered into as of the 12th day of November, 2019 (the \\\"Effective Date\\\"), by and among WATER NOW, INC., a Texas corporation (\\\"Water Now\\\"), Hydraspin USA, Inc., a Texas corporation and a subsidiary of Water Now (the \\\"Subsidiary,\\\" and collectively with Water Now, \\\"Hydraspin\\\") and BESTEV MANAGEMENT, LLC, a Texas limited liability company (\\\"Distributor\\\"). Hydraspin and Distributor are sometimes hereinafter referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\" RECITALS: A. Hydraspin holds the exclusive distribution rights in the United States of America for certain commercial oil and gas products,and the associated technology, used to separate and remove Hydrocarbons from natural and injected water involved in the extraction process. B. Hydraspin desires to appoint Distributor, and Distributor desires to be appointed, as the exclusive distributor of products of Hydraspin in the Territory (as defined below), pursuant to the terms and conditions of this Agreement. NOW, THEREFORE, in consideration of the premises and the mutual promises and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: ARTICLE I. DEFINITIONS 1.1 For purposes of this Agreement, the following terms, where written with an initial capital letter, shall have the meanings assigned to them in this Article I unless the context otherwise requires: \\\"Affiliate\\\" means an individual or legal entity that directly or indirectly, through one or more intermediaries, controls or is controlled by, or is under common control with, another Person. The term \\\"Control\\\" as utilized herein means the possession, directly or indirectly, of the power to direct or cause direction of the management and policies of a Person, whether through management, ownership, by contract, or otherwise; provided, however, in no event shall Hydraspin be deemed an Affiliate of the Distributor. \\\"Change of Control\\\" means the sale, conveyance or disposition of all or substantially all of the assets of Hydraspin, the effectuation by Hydraspin of a transaction or series of transactions in which more than 50% of the voting power of Hydraspin is disposed of, or any consolidation, merger or other business combination of Hydraspin with or into any other Person or Persons where Hydraspin is not the survivor. \\\"Customer\\\" means any Person that is a customer of the Distributor and any Affiliate of Distributor that has an interest in or ultimately utilizes the Product (as defined below). \\\"Distributor Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that the Distributor is entitled to receive, as follows: (i) for the first ten (10) Products installed, 7.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 15% of Net Revenue. Notwithstanding anything to the contrary contained herein, the 1\", \"level\": 2, \"text\": \"Exhibit 10.12 EXCLUSIVE DISTRIBUTOR AGREEMENT THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and entered into as of the 12th day of November, 2019 (the \\\"Effective Date\\\"), by and among WATER NOW, INC., a Texas corporation (\\\"Water Now\\\"), Hydraspin USA, Inc., a Texas corporation and a subsidiary of Water Now (the \\\"Subsidiary,\\\" and collectively with Water Now, \\\"Hydraspin\\\") and BESTEV MANAGEMENT, LLC, a Texas limited liability company (\\\"Distributor\\\"). Hydraspin and Distributor are sometimes hereinafter referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\" RECITALS: A. Hydraspin holds the exclusive distribution rights in the United States of America for certain commercial oil and gas products,and the associated technology, used to separate and remove Hydrocarbons from natural and injected water involved in the extraction process. B. Hydraspin desires to appoint Distributor, and Distributor desires to be appointed, as the exclusive distributor of products of Hydraspin in the Territory (as defined below), pursuant to the terms and conditions of this Agreement. NOW, THEREFORE, in consideration of the premises and the mutual promises and covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: ARTICLE I. DEFINITIONS 1.1 For purposes of this Agreement, the following terms, where written with an initial capital letter, shall have the meanings assigned to them in this Article I unless the context otherwise requires: \\\"Affiliate\\\" means an individual or legal entity that directly or indirectly, through one or more intermediaries, controls or is controlled by, or is under common control with, another Person. The term \\\"Control\\\" as utilized herein means the possession, directly or indirectly, of the power to direct or cause direction of the management and policies of a Person, whether through management, ownership, by contract, or otherwise; provided, however, in no event shall Hydraspin be deemed an Affiliate of the Distributor. \\\"Change of Control\\\" means the sale, conveyance or disposition of all or substantially all of the assets of Hydraspin, the effectuation by Hydraspin of a transaction or series of transactions in which more than 50% of the voting power of Hydraspin is disposed of, or any consolidation, merger or other business combination of Hydraspin with or into any other Person or Persons where Hydraspin is not the survivor. \\\"Customer\\\" means any Person that is a customer of the Distributor and any Affiliate of Distributor that has an interest in or ultimately utilizes the Product (as defined below). \\\"Distributor Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that the Distributor is entitled to receive, as follows: (i) for the first ten (10) Products installed, 7.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 15% of Net Revenue. Notwithstanding anything to the contrary contained herein, the 1 Source: WATER NOW, INC., 10-Q, 11/20/2019 Distributor Share with respect to the split of Net Revenue between Hydraspin and the Distributor with respect to any particular Production installation or group Product installation may be negotiated by Hydraspin and the Distributor and set forth in a separate written agreement between the Parties, and in such case, the Distributor Share set forth in the separate written agreement shall supersede and control over the Distributor Share set forth above. \\\"Governmental Entity\\\" means any and all federal, state or local governments, governmental institutions, public authorities and any other governmental entities of any nature whatsoever, and any subdivisions or instrumentalities thereof, including, but not limited to, departments, boards, bureaus and panels, and any divisions or instrumentalities thereof, whether permanent or ad hoc and whether now or hereafter constituted or existing. \\\"Hydraspin Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that Hydraspin is entitled to receive, as follows: (i) for the first ten (10) Products installed, 92.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 85% of Net Revenue. Notwithstanding anything to the contrary contained herein, the Hydraspin Share with respect to the split of Net Revenue between Hydraspin and the Distributor with respect to any particular Production installation or group Product installation may be negotiated by Hydraspin and the Distributor and set forth in a separate written agreement between the Parties, and in such case, the Hydraspin Share set forth in the separate written agreement shall supersede and control over the Hydraspin Share set forth above. \\\"Hydrocarbons\\\" means and includes oil, gas, casinghead gas, condensate, natural gas liquids, and all components of the foregoing. \\\"Law\\\" means any constitution, law, ordinance, principle of common law, regulation, order, statute or treaty of or issued by any Governmental Entity. \\\"Loss\\\" means any damage, deficiency, penalty, fine, cost, amount paid in settlement, liability, obligation, tax, loss, expense or fee, including court costs and reasonable attorneys' fees and expenses. \\\"Marks\\\" means mean the trademark(s), service mark(s) and/or logo(s) applicable to each Product and owned by either Hydraspin or African Horizon Technologies (PTY) Ltd (\\\"AHT\\\"). \\\"Net Revenue\\\" means the gross revenue derived from the sale of the Hydrocarbons resulting from the Products, less (i) the share of gross revenue due to the Customers under the agreements between the Customers and the Distributor or any Affiliate of the Distributor, which is generally 50%, but may be greater or less than 50%, and (ii) ordinary and customary costs, expenses and fees that are deducted from the gross revenue. \\\"Person\\\" means natural persons, corporations, ventures, limited liability companies, partnerships, trusts and all other entities and organizations. \\\"Performance Benchmarks\\\" shall mean the following requirements necessary for Distributor to maintain the exclusivity granted in Section 2.1 hereof: (a) the execution of contracts to deploy Products in 25 new locations approved in advance by Hydraspin (\\\"Customer Locations\\\") during each 12 month period following the Effective Date and (b) all Customer Locations in the aggregate shall generate an average of 7,500 barrels of fluid per day on a trailing 12 month basis. Customer Locations must be available for installation within 90 days of approval by Hydraspin to be applied toward the satisfaction of the Performance Benchmark. All Customer Locations in excess of 2 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}}, {\"id\": \"25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"secured during an applicable 12 month period shall be credited toward the satisfaction of the Performance Benchmark for\", \"level\": 1, \"text\": \"25 secured during an applicable 12 month period shall be credited toward the satisfaction of the Performance Benchmark for the subsequent 12 month period. If this Agreement is extended beyond the Initial Term, as hereinafter defined, the number of Customer Locations to be secured to maintain exclusivity during the pendency of the Agreement shall be increased to 50 from 25. \\\"Products\\\" shall mean, collectively, (i) the products listed on Exhibit A attached hereto, as such Exhibit may be amended from time to time by the Parties, (ii) all modifications, alterations, improvements, upgrades, and replacements to the products listed on Exhibit \\\"A\\\", now existing and existing in the future, and (iii) all other products, now existing and existing in the future, distributed by Hydraspin or any Affiliate thereof that perform substantially the same functions as the products listed on Exhibit \\\"A\\\", now existing and existing in the future. \\\"Revenue Event\\\" means any payment in cash, or by check or wire transfer resulting from the sale of Hydrocarbons to oil and gas companies or other third parties, due to the use of one or more Products to separate such Hydrocarbons from water during the extraction of such Hydrocarbons from the earth. \\\"Support Services\\\" shall mean (a) promptly responding to all inquiries from Customers, (b) servicing the Products, (c) educating Customers how to properly use and maintain the Products, (d) liaising between Customers, Distributor and Hydraspin, (d) distributing instructions for use, and any updates thereto, of each Product, and (e) any other related services performed for or on behalf of Customers. \\\"Territory\\\" shall mean the geographic territories described on Exhibit B attached hereto, as such Exhibit may be amended from time to time by the Parties. 1.2 Other Definitions. In addition to the terms defined in Section 1.1 hereof, certain other terms are defined elsewhere in this Agreement, and whenever such terms are used in this Agreement, they shall have their respective defined meanings, unless the context expressly or by necessary implication otherwise requires. ARTICLE II. APPOINTMENT 2.1 Exclusivity and Territory. Hydraspin hereby appoints Distributor, and Distributor hereby accepts appointment, as Hydraspin's exclusive distributor of the Products in the Territory during the term of this Agreement, subject to the terms and conditions of this Agreement, including, but not limited to, the satisfaction of the Performance Benchmarks. The Territory may be amended with the mutual agreement of both Parties from time to time to add or delete geographic territories by amending Exhibit B attached hereto. If Hydraspin desires to enter a new territory in the United States, Hydraspin will offer Distributor the first opportunity to become the exclusive distributor for the new territory. If the Parties are unable to reach an agreement on the terms of exclusivity within ten (10) business days of the date the opportunity is presented to Distributor, Hydraspin shall have no obligation to enter into a contract with Distributor regarding the new territory. In the event the Distributor loses exclusivity on a territory due to not meeting Performance Benchmarks, the Distributor shall maintain exclusivity on any and all existing Products that are in the field and operating at them time exclusivity if forfeited. 2.2 Sales Outside the Territory. Distributor shall be entitled to advertise, promote, market or 3 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}}, {\"id\": \"ARTICLE IV\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT AND INVENTORY 4\", \"level\": 1, \"text\": \"ARTICLE IV. PRODUCT AND INVENTORY 4.1 Products. Hydraspin reserves the right, from time to time and in its sole discretion, to modify, alter, change, or improve any or all of the Products covered by this Agreement; provided, that this Agreement shall continue to apply to all Products in their altered, changed or improved state. Hydraspin shall promptly send Distributor written notice of any modification, alteration, change or improvement to any Product. 4 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 (a) Due Organization, Existence and Authority. Hydraspin (i) is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and (ii) has full power and authority to own its properties, carry on its business as presently conducted and as proposed to be conducted, and to enter into and perform its obligations under this Agreement. (b) Authorization. The execution and delivery by Hydraspin of this Agreement and the other documents related thereto and the full and timely performance of all obligations thereunder have been duly authorized by all necessary action under the constituent documents of Hydraspin and otherwise. (c) Valid, Binding and Enforceable. This has been duly and validly executed, issued and delivered by Hydraspin and constitutes the valid and legally binding obligations of Hydraspin, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency, reorganization or other similar laws relating to or affecting enforcement of creditor's rights. (d) No Violation. The execution, delivery and performance by Hydraspin of this Agreement does not and will not (i) contravene the constituent documents of Hydraspin, (ii) contravene any law, rule or regulation, or any order, writ, judgment, injunction or decree or any contractual restriction binding on or affecting Hydraspin or the Products, and (iii) require any approval or consent of any general partner, board, manager, member, lender or any other person or entity, other than approvals or consents that have been previously obtained and disclosed in writing to the Distributor, [including, without limitation, the consent of AHT.] No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required for the due execution, delivery and performance by Hydraspin of this Agreement, other than approvals or consents that have been previously obtained and disclosed in writing to the Distributor. 7.2 Representations of Distributor. Distributor represents and warrants to Hydraspin as follows: (a) Due Organization, Existence and Authority. Distributor (i) is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and (ii) has full power and authority to own its properties, carry on its business as presently conducted and as proposed to be conducted, and to enter into and perform its obligations under this Agreement. (b) Authorization. The execution and delivery by Distributor of this Agreement and the other documents related thereto and the full and timely performance of all obligations thereunder have been duly authorized by all necessary action under the constituent documents of Distributor and otherwise. (c) Valid, Binding and Enforceable. This has been duly and validly executed, issued and delivered by Distributor and constitutes the valid and legally binding obligations of Distributor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency, reorganization or other similar laws relating to or affecting enforcement of creditor's rights. (d) No Violation. The execution, delivery and performance by Distributor of this Agreement does not and will not (i) contravene the constituent documents of Distributor, (ii) contravene any law, rule or regulation, or any order, writ, judgment, injunction or decree or any contractual restriction binding on or affecting Distributor, or (iii) require any approval or consent of any general partner, board, manager, member, lender or any other person or entity, other than approvals or consents that have been previously obtained and disclosed in writing to the Hydraspin. 7 Source: WATER NOW, INC., 10-Q, 11/20/2019 No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required for the due execution, delivery and performance by Distributor of this Agreement, other than approvals or consents that have been previously obtained and disclosed in writing to Hydraspin. ARTICLE VIII.\"}}, {\"id\": \"ARTICLE IX\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL AND/OR PROPRIETARY INFORMATION 9\", \"level\": 1, \"text\": \"ARTICLE IX. CONFIDENTIAL AND/OR PROPRIETARY INFORMATION 9.1 Confidentiality. Each Party acknowledges that in the course of performing its respective duties under this Agreement, such Party may obtain information related to the other Party, which is of a 8 Source: WATER NOW, INC., 10-Q, 11/20/2019 confidential or proprietary nature (\\\"Confidential Information\\\"). Each Party agrees not to use such other party's Confidential Information, either directly or indirectly, for any purpose other than as required for performance of such Party's obligations hereunder. Such Confidential Information may include but is not limited to copyright, trade secrets or other proprietary information, techniques, processes, schematics, software source documents, pricing and discount lists and schedules, customer lists, contract terms, customer leads, financial information, sales and marketing plans, and information regarding the responsibilities, skills and compensation of employees. Title to Confidential Information shall remain with the owner of the Confidential Information at all times. Each Party agrees to treat the Confidential Information with at least the degree of care and protection with which it treats its own confidential information, but in any event with no less than reasonable care and protection, and to use the Confidential Information only for the purpose set forth in this Agreement. Except as otherwise required by law, applicable regulations or the terms of this Agreement or as mutually agreed upon by the parties hereto, each Party shall treat as confidential the terms and conditions of this Agreement. Notwithstanding anything contained in this Agreement to the contrary, Confidential Information shall not include information that: (a) is or becomes available to the public other than through a disclosure in breach hereof by the receiving Party or any of its representatives; (b) was in the possession of the receiving Party or its representatives prior to the Effective Date; (c) was communicated by the disclosing Party to an unaffiliated third party free of any obligation of confidentiality, and the unaffiliated third party communicated the Confidential Information to the receiving Party or its representatives; (d) becomes available to the receiving Party or its representatives from a source other than the disclosing Party, provided, that such source is not known to the receiving Party or its representatives to have made such information available in violation of an obligation of confidentiality owed to the disclosing Party; or (e) is independently developed by or on behalf of a Party or its representatives without use of the Confidential Information of the other Party.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nondisclosure\", \"level\": 2, \"text\": \"9.2 Nondisclosure. Each Party agrees not to disclose or otherwise make such Confidential Information available to third parties without the other Party's prior written consent. Each Party agrees that it will take appropriate action by instruction, agreement, or otherwise with such Party's employees to satisfy its obligations under this Agreement with respect to the use, copying, modification, protection, and security of Confidential Information. Nothing in this section prohibits any disclosure required by applicable law, a valid court order or subpoena; provided, that the disclosing Party gives the other Party prior notice of, and if possible a reasonable opportunity to contest, such required disclosure. 9.3 Return of Confidential Information. Each Party will promptly return all Confidential Information to the other Party upon expiration or termination of this Agreement, or upon receipt by such Party of written notice from the other Party requesting return of such Confidential Information. Such Confidential Information shall be returned promptly and the non-disclosing Party shall not retain any documents or materials or copies thereof containing any Confidential Information. 9.4 Injunctive Relief. Any breach of the restrictions contained in this Article IX is a breach of this 9 Source: WATER NOW, INC., 10-Q, 11/20/2019 Agreement that may cause irreparable harm to a party and as such each Party is entitled to injunctive relief to enforce this Agreement without the need to post bond and that such relief shall be, in addition to, and not in lieu of, any monetary damages or other legal or equitable remedies that may be available. ARTICLE X. TERM AND TERMINATION 10.1 Term. The initial term of this Agreement shall commence on the Effective Date and end on the five (5) year anniversary of the Effective Date (the \\\"Initial Term\\\"), unless sooner terminated pursuant to the terms hereof. Upon expiration of the Initial Term of this Agreement, this Agreement will automatically renew for additional, successive five (5) year periods unless either Party provides the other Party written notice of its desire to terminate at least one hundred twenty (120) days prior to the end of the Initial Term or any renewal. 10.2 Termination. This Agreement may be terminated as follows: (a) In the event that the Parties mutually determine that the arrangements contemplated by this Agreement are no longer in the best interests of the Parties or the Parties are not otherwise compatible, the Parties may at any time, by mutual written agreement, terminate this Agreement. (b) Immediately upon the occurrence of any of the following events and effective upon delivery of notice: (1) by Hydraspin, i f Distributor ceases to do business, or otherwise terminates Distributor's business operations; (2) by Distributor, if Hydraspin ceases to do business, or otherwise terminates Hydraspin's business operations; (3) by Hydraspin, if Distributor fails to satisfy the Performance Thresholds; (4) by either Party, if any representation by the other Party made in this Agreement was false or misleading in any material respect when made; (5) by Distributor, if Hydraspin fails to secure or renew any license, permit, authorization, or approval for the conduct of Hydraspin's business or the distribution of the Products or if any such license, permit, authorization, or approval is revoked or suspended provided that such failure, revocation or suspension results in Hydraspin's failure or inability to perform substantially all of its obligations hereunder; (6) by either Party, if the other Party engages in fraud, criminal/negligent conduct in connection with this Agreement or the business relationship of the parties or if the other Party makes any material false representations, reports, or claims in connection with this Agreement or any Product; (7) by either Party, if the other Party breaches any of its obligations under this Agreement and such violation is not cured to the satisfaction of the non-breaching party within thirty (30) days after written notice is given from the non-breaching Party to the breaching Party; 10 Source: WATER NOW, INC., 10-Q, 11/20/2019 (8) by either Party, if Hydraspin undergoes a Change of Control; or (9) by either Party, if such other Party seeks protection under any bankruptcy, receivership, trustee, creditors arrangement, composition, or comparable proceeding, or if any such proceeding is instituted against such other Party. 10.3 Effect of Termination. (a) Termination or expiration of this Agreement will not relieve either Party of any obligation incurred hereunder prior to such termination or expiration. Each Party will be entitled to cancel any outstanding Orders, to the extent Products have not been delivered. Hydraspin shall be entitled to retrieve its Products from the Customers at its sole cost and expense. (b) If termination is the result of a Change of Control, Distributor shall be entitled to receive a onetime payment, within three (3) business days of the effective date of the Change of Control, equal to the greater of the following 1) the aggregate amount of the Distributor Share received during the 18 months prior to the effective date of such Change of Control or 2) the aggregate amount of the Distributor Share received on the 30 days prior to the effective date of such Change of Control multiplied by 18. (c) Neither Party will incur liability for any Losses of any kind suffered or incurred by the other Party arising from or incident to termination of this Agreement by such party as permitted by this Article X. ARTICLE XI. MISCELLANEOUS 11.1 Notices. (a) Manner of Notice. All notices, requests and other communications under this Agreement shall be in writing (including in portable document format (or similar format) delivered by email transmission) and shall be deemed to have been duly given if delivered personally, or sent by either certified or registered mail, return receipt requested, postage prepaid, or by overnight courier guaranteeing next day delivery, or by email transmission, addressed as follows: (i) If to Hydraspin: Water Now, Inc. Hydraspin USA, Inc. 5000 South Freeway, Suite 110 Fort Worth, Texas 76115 Attn: David King Email: dking@waternowinc.com or at such other address or email address as Hydraspin may have advised Distributor in writing; and (ii) If to Distributor: Bestev Management, LLC 11 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 Source: WATER NOW, INC., 10-Q, 11/20/2019 respect to the matters addressed herein and supersede all prior representations, inducements, promises or agreements, oral or otherwise, which are not embodied herein or therein. 11.15 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original for all purposes and all of which shall be deemed collectively to be one agreement. Signatures given by facsimile or portable document format (or similar format) shall be binding and effective to the same extent as original signatures. 11.16 Third Party Beneficiaries. Nothing contained herein, express or implied, is intended to confer upon any person or entity other than the Parties and their respective successors in interest and permitted assigns any rights or remedies under or by reason of this Agreement. 11.17 Interpretation. This Agreement has been prepared in the English language which language shall be controlling in all respects. 14 Source: WATER NOW, INC., 10-Q, 11/20/2019 IN WITNESS WHEREOF, the Parties have caused their authorized representatives to execute this Agreement as of the date first set forth above. WATER NOW: WATER NOW, INC. By: Name: David King Title: Chief Executive Officer HYDRASPIN: HYDRASPIN USA, INC. By: Name: David King Title: Chief Executive Officer WATER NOW: WATER NOW, INC. By: Name: Title: DISTRIBUTOR: BESTEV MANAGEMENT, LLC By: Name: Title: 15 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCTS African Horizon Technologies Hydraspin Units\", \"level\": 1, \"text\": \"EXHIBIT A PRODUCTS African Horizon Technologies Hydraspin Units 16 Source: WATER NOW, INC., 10-Q, 11/20/2019\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERRITORY The Territory consists of all of the following: A. The San Juan Basin located near the Four Corners region of the Southwestern United States. The San Juan Basin Territory includes, without limitation, that certain area covering 7,500 square miles and resides in northwestern New Mexico, southwestern Colorado, and parts of Utah and Arizona. Specifically, the San Juan Basin occupies space in the San Juan, Rio Arriba, Sandoval, and McKinley counties in New Mexico, and La Plata and Archuleta counties in Colorado. B. The Permian Basin located in the southwestern part of the United States. The Permian Basin Territory includes, without limitation, the Mid-Continent Oil Field province located in western Texas and southeastern New Mexico, reaching from just south of Lubbock, past Midland and Odessa, south nearly to the Rio Grande River in southern West Central Texas, and extending westward into the southeastern part of New Mexico. C. The Eagle Ford Group Basin (also called the Eagle Ford Shale Basin) covering much of the state of Texas. The Eagle Ford Group Basin Territory includes, without limitation, the Eagle Ford outcrop belt trending from the Oklahoma/Texas border southward to San Antonio, westward to the Rio Grande, Big Bend National Park, and the Quitman Mountains of West Texas.\", \"level\": 1, \"text\": \"EXHIBIT B TERRITORY The Territory consists of all of the following: A. The San Juan Basin located near the Four Corners region of the Southwestern United States. The San Juan Basin Territory includes, without limitation, that certain area covering 7,500 square miles and resides in northwestern New Mexico, southwestern Colorado, and parts of Utah and Arizona. Specifically, the San Juan Basin occupies space in the San Juan, Rio Arriba, Sandoval, and McKinley counties in New Mexico, and La Plata and Archuleta counties in Colorado. B. The Permian Basin located in the southwestern part of the United States. The Permian Basin Territory includes, without limitation, the Mid-Continent Oil Field province located in western Texas and southeastern New Mexico, reaching from just south of Lubbock, past Midland and Odessa, south nearly to the Rio Grande River in southern West Central Texas, and extending westward into the southeastern part of New Mexico. C. The Eagle Ford Group Basin (also called the Eagle Ford Shale Basin) covering much of the state of Texas. The Eagle Ford Group Basin Territory includes, without limitation, the Eagle Ford outcrop belt trending from the Oklahoma/Texas border southward to San Antonio, westward to the Rio Grande, Big Bend National Park, and the Quitman Mountains of West Texas. Source: WATER NOW, INC., 10-Q, 11/20/2019\"}}, {\"id\": \"party:WATER NOW, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"WATER NOW, INC.\", \"role\": \"Water Now\", \"address\": \"5000 South Freeway, Suite 110 Fort Worth, Texas 76115\"}}, {\"id\": \"party:Hydraspin USA, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Hydraspin USA, Inc.\", \"role\": \"Subsidiary\", \"address\": \"5000 South Freeway, Suite 110 Fort Worth, Texas 76115\"}}, {\"id\": \"party:BESTEV MANAGEMENT, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"BESTEV MANAGEMENT, LLC\", \"role\": \"Distributor\", \"address\": \"Bestev Management, LLC 11\"}}, {\"id\": \"party:Hydraspin\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Hydraspin\", \"role\": null, \"address\": \"5000 South Freeway, Suite 110 Fort Worth, Texas 76115\"}}, {\"id\": \"party:African Horizon Technologies (PTY) Ltd\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"African Horizon Technologies (PTY) Ltd\", \"role\": \"AHT\", \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\")\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the 12th day of November, 2019 (the \\\"Effective Date\\\")\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Hydraspin\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Hydraspin\", \"text\": \"Hydraspin USA, Inc., a Texas corporation and a subsidiary of Water Now (the \\\"Subsidiary,\\\" and collectively with Water Now, \\\"Hydraspin\\\")\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor\", \"text\": \"BESTEV MANAGEMENT, LLC, a Texas limited liability company (\\\"Distributor\\\")\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"Hydraspin and Distributor are sometimes hereinafter referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\"\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"\\\"Affiliate\\\" means an individual or legal entity that directly or indirectly, through one or more intermediaries, controls or is controlled by, or is under common control with, another Person.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Control\", \"text\": \"The term \\\"Control\\\" as utilized herein means the possession, directly or indirectly, of the power to direct or cause direction of the management and policies of a Person, whether through management, ownership, by contract, or otherwise; provided, however, in no event shall Hydraspin be deemed an Affiliate of the Distributor.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Change of Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change of Control\", \"text\": \"\\\"Change of Control\\\" means the sale, conveyance or disposition of all or substantially all of the assets of Hydraspin, the effectuation by Hydraspin of a transaction or series of transactions in which more than 50% of the voting power of Hydraspin is disposed of, or any consolidation, merger or other business combination of Hydraspin with or into any other Person or Persons where Hydraspin is not the survivor.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Customer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer\", \"text\": \"\\\"Customer\\\" means any Person that is a customer of the Distributor and any Affiliate of Distributor that has an interest in or ultimately utilizes the Product (as defined below).\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Distributor Share\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor Share\", \"text\": \"\\\"Distributor Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that the Distributor is entitled to receive, as follows: (i) for the first ten (10) Products installed, 7.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 15% of Net Revenue. Notwithstanding anything to the contrary contained herein, the 1 Source: WATER NOW, INC., 10-Q, 11/20/2019 Distributor Share with respect to the split of Net Revenue between Hydraspin and the Distributor with respect to any particular Production installation or group Product installation may be negotiated by Hydraspin and the Distributor and set forth in a separate written agreement between the Parties, and in such case, the Distributor Share set forth in the separate written agreement shall supersede and control over the Distributor Share set forth above.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Governmental Entity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Governmental Entity\", \"text\": \"\\\"Governmental Entity\\\" means any and all federal, state or local governments, governmental institutions, public authorities and any other governmental entities of any nature whatsoever, and any subdivisions or instrumentalities thereof, including, but not limited to, departments, boards, bureaus and panels, and any divisions or instrumentalities thereof, whether permanent or ad hoc and whether now or hereafter constituted or existing.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Hydraspin Share\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Hydraspin Share\", \"text\": \"\\\"Hydraspin Share\\\" means, with respect to Net Revenue, the percentage of Net Revenue that Hydraspin is entitled to receive, as follows: (i) for the first ten (10) Products installed, 92.5% of Net Revenue, and (ii) for the eleventh (11th) Product installed and all Products installed thereafter, 85% of Net Revenue. Notwithstanding anything to the contrary contained herein, the Hydraspin Share with respect to the split of Net Revenue between Hydraspin and the Distributor with respect to any particular Production installation or group Product installation may be negotiated by Hydraspin and the Distributor and set forth in a separate written agreement between the Parties, and in such case, the Hydraspin Share set forth in the separate written agreement shall supersede and control over the Hydraspin Share set forth above.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Hydrocarbons\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Hydrocarbons\", \"text\": \"\\\"Hydrocarbons\\\" means and includes oil, gas, casinghead gas, condensate, natural gas liquids, and all components of the foregoing.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Law\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Law\", \"text\": \"\\\"Law\\\" means any constitution, law, ordinance, principle of common law, regulation, order, statute or treaty of or issued by any Governmental Entity.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Loss\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Loss\", \"text\": \"\\\"Loss\\\" means any damage, deficiency, penalty, fine, cost, amount paid in settlement, liability, obligation, tax, loss, expense or fee, including court costs and reasonable attorneys' fees and expenses.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marks\", \"text\": \"\\\"Marks\\\" means mean the trademark(s), service mark(s) and/or logo(s) applicable to each Product and owned by either Hydraspin or African Horizon Technologies (PTY) Ltd (\\\"AHT\\\").\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Net Revenue\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Net Revenue\", \"text\": \"\\\"Net Revenue\\\" means the gross revenue derived from the sale of the Hydrocarbons resulting from the Products, less (i) the share of gross revenue due to the Customers under the agreements between the Customers and the Distributor or any Affiliate of the Distributor, which is generally 50%, but may be greater or less than 50%, and (ii) ordinary and customary costs, expenses and fees that are deducted from the gross revenue.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Person\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Person\", \"text\": \"\\\"Person\\\" means natural persons, corporations, ventures, limited liability companies, partnerships, trusts and all other entities and organizations.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Performance Benchmarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Performance Benchmarks\", \"text\": \"\\\"Performance Benchmarks\\\" shall mean the following requirements necessary for Distributor to maintain the exclusivity granted in Section 2.1 hereof: (a) the execution of contracts to deploy Products in 25 new locations approved in advance by Hydraspin (\\\"Customer Locations\\\") during each 12 month period following the Effective Date and (b) all Customer Locations in the aggregate shall generate an average of 7,500 barrels of fluid per day on a trailing 12 month basis. Customer Locations must be available for installation within 90 days of approval by Hydraspin to be applied toward the satisfaction of the Performance Benchmark. All Customer Locations in excess of 25 secured during an applicable 12 month period shall be credited toward the satisfaction of the Performance Benchmark for the subsequent 12 month period.\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Customer Locations\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer Locations\", \"text\": \"the execution of contracts to deploy Products in 25 new locations approved in advance by Hydraspin (\\\"Customer Locations\\\")\", \"definition_clause\": \"Exhibit 10.12\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"\\\"Products\\\" shall mean, collectively, (i) the products listed on Exhibit A attached hereto, as such Exhibit may be amended from time to time by the Parties, (ii) all modifications, alterations, improvements, upgrades, and replacements to the products listed on Exhibit \\\"A\\\", now existing and existing in the future, and (iii) all other products, now existing and existing in the future, distributed by Hydraspin or any Affiliate thereof that perform substantially the same functions as the products listed on Exhibit \\\"A\\\", now existing and existing in the future.\", \"definition_clause\": \"25\"}}, {\"id\": \"term:Revenue Event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Revenue Event\", \"text\": \"\\\"Revenue Event\\\" means any payment in cash, or by check or wire transfer resulting from the sale of Hydrocarbons to oil and gas companies or other third parties, due to the use of one or more Products to separate such Hydrocarbons from water during the extraction of such Hydrocarbons from the earth.\", \"definition_clause\": \"25\"}}, {\"id\": \"term:Support Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Support Services\", \"text\": \"\\\"Support Services\\\" shall mean (a) promptly responding to all inquiries from Customers, (b) servicing the Products, (c) educating Customers how to properly use and maintain the Products, (d) liaising between Customers, Distributor and Hydraspin, (d) distributing instructions for use, and any updates thereto, of each Product, and (e) any other related services performed for or on behalf of Customers.\", \"definition_clause\": \"25\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"\\\"Territory\\\" shall mean the geographic territories described on Exhibit B attached hereto, as such Exhibit may be amended from time to time by the Parties.\", \"definition_clause\": \"25\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"Each Party acknowledges that in the course of performing its respective duties under this Agreement, such Party may obtain information related to the other Party, which is of a confidential or proprietary nature (\\\"Confidential Information\\\").\", \"definition_clause\": \"ARTICLE IX\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"The initial term of this Agreement shall commence on the Effective Date and end on the five (5) year anniversary of the Effective Date (the \\\"Initial Term\\\"), unless sooner terminated pursuant to the terms hereof.\", \"definition_clause\": \"9.2\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:7.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"7.5%\"}}, {\"id\": \"value:15%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"15%\"}}, {\"id\": \"value:92.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"92.5%\"}}, {\"id\": \"value:85%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"85%\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:ten (10) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) business days\"}}, {\"id\": \"value:one hundred twenty (120) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred twenty (120) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:three (3) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) business days\"}}, {\"id\": \"value:18 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"18 months\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of Copy of WestPharmaceuticalServicesInc_20200116_8-K_EX-10.1_11947529_EX-10.1_Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of Copy of WestPharmaceuticalServicesInc_20200116_8-K_EX-10.1_11947529_EX-10.1_Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 [*****] Text omitted for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. GLOBAL MASTER SUPPLY AGREEMENT This Global Master Supply Agreement (\\\"Agreement\\\" or \\\"Contract\\\") is between ExxonMobil Chemical Company, a division of Exxon Mobil Corporation (\\\"Seller\\\"),on behalf of itself and in the interest of the ExxonMobil affiliates listed on Attachment B (each an \\\"ExxonMobil Selling Affiliate\\\" or \\\"EMCC/A\\\" or collectively, \\\"ExxonMobil Selling Affiliates\\\"), and West Pharmaceutical Services, Inc. (\\\"Buyer\\\"), on behalf of itself and the Buyer affiliates listed on Attachment C (each a \\\"Buyer Affiliate\\\" or \\\"West/A\\\" or collectively, \\\"Buyer Affiliates\\\"). PRODUCTS, QUANTITY, PRICE In accordance with the provisions of this Agreement, ExxonMobil Selling Affiliates agree to sell to Buyer Affiliates, and Buyer Affiliates agree to purchase from ExxonMobil Selling Affiliates, the following product(s) (collectively, \\\"Product\\\"): Products Quantity [Metric Tons / Year] Container PackageYear 2019 2020 2021 2022 2023 [*****] [*****] Minimum Maximum [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] Leased metal crates [*****] [*****] [*****] [*****] [*****] [*****] Leased metal crates [*****] not defined Leased metal crates Subject to this Agreement's terms and conditions, Buyer Affiliates shall purchase and ExxonMobil Selling Affiliates shall sell the yearly minimum amount of Product amounts (in the aggregate) listed above. Buyer or Buyer Affiliates may request to purchase amounts over the Product maximum amounts per year, however, it shall be solely within Seller or any ExxonMobil Selling Affiliate's discretion whether and under which conditions to accommodate Buyer's request. Buyer Affiliates shall issue a purchase order(s), or call off order(s) when purchasing Product from ExxonMobil Selling Affiliates in writing pursuant to this Contract (\\\"Purchase Order\\\"). Such Purchase Order(s) shall specify (a) the quantity of Product, and (b) general date of delivery. All Purchase Orders agreed to be filled by an ExxonMobil Selling affiliate shall be deemed to be a separate agreement between the relevant ExxonMobil Selling Affiliate and the relevant Buyer Affiliate, incorporating the terms of this Contract. Notwithstanding anything to the contrary in the attachments ExxonMobil and the ExxonMobil Selling Affiliates shall not unreasonably reject any Purchase Order that otherwise complies with the terms of this Agreement. Purchase Order(s), order acknowledgements and similar form documents evidencing the purchase or sale of Products, including any terms and conditions contained or referenced therein, shall not supersede, add to or amend in any way this Contract. In the event of any conflict between the terms of this Contract and the terms of any Purchase Order, order acknowledgement or similar document the terms of this Contract shall prevail. [*****] PRICING For calendar years 2019, 2020, 2021, 2022 and 2023, the price of Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates will comprise the Base Price, the crude adjustment and the freight cost depending on Incoterms. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Base price Requested delivery date 1.1.2019 - 28.2.2019: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.3.2019 - 31.12.2019: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2020 - 31.12.2020: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2021 - 31.12.2021: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2022 - 31.12.2022: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2023 - 31.12.2023: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t [*****] Base prices listed above are non-delivered pricing (i.e., Ex-Works designated Exxon Affiliate location (see Attachment B) - Incoterms 2010 (\\\"EXW\\\") and does not include freight or insurance. Seller and Buyer shall meet on or before December 31, [*****] to assess the requirements for a price and/or volume adjustment in good faith on the price for Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates for years [*****] and [*****]. Notwithstanding anything to the contrary in Attachments A, G and H to this Agreement, the parties agree that any permitted adjustments to the price, freight or payment terms for Products sold hereunder will be governed by the terms of the Pricing and Payment Terms sections of this Agreement. Buyer Affiliates shall pay ExxonMobil's Selling Affiliates invoice(s) not later than the days set forth in Attachment E hereto. All invoices shall be paid in full by wire transfer in accordance with the invoice's instructions. Crude Trigger Clause Product price(s) shall be subject to the Average Brent crude oil price evolution (as further detailed below) in order to reflect the cost of energy. Should the Average Brent crude oil price at any moment during the term of this Agreement move to a different Average Brent crude oil price bracket as mentioned below, Seller may increase or decrease the Product price by $[*****] for every $[*****] change in the Average Brent crude oil price. In no event shall the Product price's increase or decrease exceed $[*****] for every $[*****] change in the Average Brent crude oil price brackets. Each Average Brent crude oil bracket is calculated on a $5 range basis (e.g., $30-$35, $40-$45, $50-$55, etc.). The Average Brent crude oil price evolution shall be expressed as the three-month average spot price per barrel of the Brent crude Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 oil (as published in the Wall Street Journal). This average shall be calculated as the average of the prices for the immediate preceding three consecutive calendar months, with each month's price calculated as the average of the daily prices. Any conversion between United States Dollars and Euros will be carried out by using the average of the European Central Bank's daily foreign exchange rate as published in Reuter's screen ECB 37 for the period in question. Any Product price adjustment shall take effect the month immediately following Seller's notification of an increase or decrease in Product price. TITLE AND RISK OF LOSS - EXXONMOBIL CHEMICAL COMPANY AND EXXONMOBIL CHEMICAL SERVICES AMERICAS INC. Title to the Product(s) to be sold and delivered hereunder will transfer simultaneously with the risks upon delivery as per the applicable lncoterm (lncoterms 2010) in Attachment E with the exception of the following: For Product sold and/or sourced by ExxonMobil Chemical Company or ExxonMobil Chemical Services Americas Inc. that is shipped overseas to a non-U.S. location, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company or ExxonMobil Chemical Services Americas Inc. to Buyer Affiliates at the first point upon which the delivering marine vessel crosses the outer boundary of the United States Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea. For Product sold by ExxonMobil Chemical Company that is transported by land to Mexico, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company to Buyer Affiliates at the frontier between Laredo, Texas, U.S.A. and Mexico (not unloaded), but prior to the customs border of Mexico. LOCATIONS OF SUPPLY Buyer/Buyer Affiliates that may purchase Product from ExxonMobil Selling Affiliates are listed in Attachment C. Other products and locations may be added upon mutual agreement in writing. Any and all sales of Product between ExxonMobil Chemical Company and/or ExxonMobil Chemical Services Americas, Inc. and Buyer Affiliates in the U.S., Mexico and Brazil shall be subject to the terms and conditions set forth in Attachment A hereto. Any and all sales of Product between ExxonMobil Petroleum & Chemical and Buyer Affiliates in France, Germany, Denmark, Serbia, Ireland and the United Kingdom shall be subject to the terms and conditions set forth in Attachment H hereto. Any and all sales of Product between ExxonMobil Chemical Asia Pacific and Buyer Affiliates in Singapore, China and India shall be subject to the terms and conditions set forth in Attachment G hereto. Buyer/Buyer Affiliates are responsible for the Product and returnable crates in their custody at the sales value of the Product and the replacement value of the metal crates, respectively. The terms relating to the use and return of metal crates are set out in Attachment F. AFFILIATES ExxonMobil Selling Affiliates participating in this Agreement are listed in Attachment B. Buyer Affiliates participating in this Agreement are listed in Attachment C. Seller and Buyer each represent and warrant that each will cause its respective affiliates, so listed, to become bound to the terms of this Agreement. QUALITY Product shall conform to ExxonMobil Selling Affiliates' standard sales specifications as of the date of shipment. Sellers agrees to support the creation of purchasing specifications for Products by Buyer and agrees to supply Products in accordance to those purchasing specifications. Seller has the right to review each purchasing specification and needs to accept in writing before such purchasing specifications become effective. Seller has the right to take exceptions to terms and provisions in these purchasing specifications if in contradiction with Seller's Sales specifications, General Terms and Condition of Sales or other Seller's procedures and policies. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Buyer and Seller agree to enter into negotiations on an extended Quality Assurance Agreement. Provided that these negotiations will be successful, such agreement shall then be incorporated into this Contract as an amendment to it. AGREEMENT PERIOD Effective Date: January 1, 2019 Termination Date: December 31, 2023 PAYMENT TERMS Buyer/Buyer Affiliates shall pay for Product by Electronic Funds Transfer (EFT) through the Automated Clearing House (ACH) using the Corporate Trade Exchange (CTX) format, according to the payment terms described in Attachment E. TECHNICAL SUPPORT EMCC/A will provide technical expertise in the use of Products and will use its technical centers to enhance technical communications with West Pharmaceutical Services Affiliates technical centers. West/A will share its needs with EMCC/A and how they relate to West/A activities to help guide ExxonMobil Chemical Affiliates technical efforts. The parties have created and continue to entertain a research and development governance structure with a steering team, program management team and working team. The charter, roles and meeting frequencies are described in mutually agreed documents and will be reviewed periodically as deemed appropriate by the parties. SAFETY, HEALTH & ENVIRONMENT Safety, health and environment (SHE) professional representatives from both parties shall endeavor to meet once a year (face to face or via teleconference) to exchange and benchmark on best practices. The parties agree to notify each other on SHE related issues that may arise from the use of Products. The parties agree to explore the reuse/recycling of articles, manufacturing trim and scrap Buyer produces from Products purchased from Seller. AUDIT On request of Buyer, Buyer is allowed to carry out on-site manufacturing and quality audits in manufacturing units where Products are produced. The frequency of such audits shall not exceed one audit per site within three years SUPPLY SECURITY Buyer is seeking for an increased level of supply security and additional risk mitigation strategies and actions in case of short and long term supply disruptions of Products. Seller agrees to enter into discussions and negotiations with Buyer and to take reasonable efforts to enhance such risk mitigation and business continuity strategies. COLLABORATION PLANNING AND SUPPLY ASSURANCE, FORECAST Buyer and Seller agree to convene once every calendar year to discuss annual Product quantities. Buyer has provided Seller with an annual non- binding forecast for the respective contract year. As requested by the Seller, the Buyer will provide a quarterly forecast for the subsequent contract years. Seller will provide Buyer a quarterly overview of the planned production run of each Butyl grade purchased for Buyer. Seller shall acknowledge in writing the requested delivery and timing of Products and Volumes. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 CHANGE CONTROL Changes to the manufacturing process are carefully controlled and are subject to review and formal approval by EMCC/A or other affiliates of Exxon Mobil Corporation prior to implementation. Buyer will be informed at least six months in advance of any change determined by EMCC/A to result in a significant change to the chemical composition or performance of the Product. [*****] CREDIT If Seller/ExxonMobil Selling Affiliates' has reasonable grounds for insecurity with respect to the financial responsibility of Buyer/Buyer Affiliates, Seller/ExxonMobil Selling Affiliates may require advance cash payment or satisfactory security and may withhold Product shipments until receipt of such payment or security. Such action by Seller/ExxonMobil Selling Affiliates shall not constitute a change of payment terms hereunder. If amounts due hereunder are placed with an outside agency for collection, or if suit is brought for collection, or if collected through probate, bankruptcy or other judicial proceedings, then Buyer/Buyer Affiliates shall pay all costs of collection, including attorneys' fees, in addition to all other amounts due. SET-OFF AND RECOVERY With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Buyer Affiliates to Seller/ExxonMobil Selling Affiliates, Seller/ExxonMobil Selling Affiliates may (i) set-off such monetary amounts and/or product-exchange delivery imbalances against any monetary amounts and/or product-exchange delivery imbalances owing to Buyer/Buyer Affiliates; and/or (ii) recoup such monetary amounts and/or product-exchange delivery imbalances from any amounts paid and/or deliveries made to Buyer/Buyer Affiliates by Seller/ExxonMobil Selling Affiliates. For purposes hereof, any and all written agreements between Buyer and Seller shall be deemed to be part of an integrated agreement set forth herein. ECONOMIC CONDITIONS AND TRENDS CLAUSE It is understood and agreed that the basis for this Agreement is an extraordinary level of mutual trust and confidence between the parties, not only in matters of price, quality, and service relating to the quantities of Product purchased and sold hereunder, but also with respect to the accommodation of changes that may develop in the business environment or the pursuit of such mutual undertakings as may benefit either or both of the parties to this Agreement. Moreover, the terms relating to quantity and price presume the continuation of economic conditions and trends now prevailing, including but not limited to levels of industrial production, tire demand, labor rates, energy costs, and foreign exchange relationships. In the event that, in the view of either party, a significant change of any kind does occur which materially and significantly alters the value received by either party in this transaction, that party may, upon written notice of its election and reasons therefor, request that this Agreement be renegotiated and the other party will be obligated to enter into the renegotiation unless the request is formally withdrawn. Neither party shall unreasonably request such renegotiation FAILURE IN PERFORMANCE Notwithstanding anything to the contrary in Attachments A, G or H, no liability shall result to either party from delay in performance or non- performance of an obligation hereunder (including an obligation to make payment) in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to, acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, criminal enterprise, sabotage, diminishment, or failure of power, telecommunications, data systems or networks, shortage or inability to obtain Product or raw material for Product, or good-faith compliance with any governmental order or request (whether valid or invalid). Notwithstanding any other notice requirement in this Agreement, actual notice (e.g., phone, email, letter) to a counterparty of a delay or failure described in this provision will constitute effective notice for purposes of this provision. Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if, supplies of Product or distribution logistics for, or feedstock for making Product, from any of Seller's/ExxonMobil Selling Affiliates' existing sources are curtailed or are inadequate to meet Seller's/ExxonMobil Selling Affiliates' own requirements and/or its obligations to its customers, Seller's/ExxonMobil Selling Affiliates' obligation to deliver Product during such period shall be reduced to the extent necessary, in Seller's/ExxonMobil Selling Affiliates' reasonable judgment, to apportion fairly among Seller's/ExxonMobil Selling Affiliates' own requirements and its customers such Product as received and as may be available in the ordinary and usual course of Seller's/ExxonMobil Selling Affiliates' business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller/ExxonMobil Selling Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Affiliates shall not be obligated to purchase or obtain Product, or feedstock to make Product, to replace deliveries omitted or curtailed under this paragraph. CHANGE IN CIRCUMSTANCES Notwithstanding anything to the contrary in Attachments A, G or H, in connection with any Change in Circumstances (as defined below), and without limiting Seller's/ExxonMobil Selling Affiliate's other rights under this Agreement or applicable law, Seller/ExxonMobil Selling Affiliates shall have the right: (i) only if required to enable Seller/ExxonMobil Selling Affiliate to comply with applicable laws and regulations, to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable (ii) to modify the payment terms hereunder; and/or (iii) to require that Buyer/Buyer Affiliates pay in advance for shipments hereunder. Promptly after any public announcement regarding any proposed transaction that would result in a Change in Circumstances, Buyer/Buyer Affiliates shall notify Seller/ExxonMobil Selling Affiliates, in writing, of the nature of such transaction, the parties thereto and the proposed date of consummation. If Seller/ExxonMobil Selling Affiliates elects to exercise any of its rights under the preceding paragraph, Seller/ExxonMobil Selling Affiliates shall so notify Buyer/Buyer Affiliates, in writing, within forty-five (45) days after receipt of Buyer's/Buyer Affiliates' notice. As used above, \\\"Change in Circumstances\\\" means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest in Buyer/Buyer Affiliates (or of at least twenty-five percent (25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer/Buyer Affiliates (\\\"Buyer's Parent\\\")) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer's /Buyer Affiliates' (or Buyer's Parent's) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer's/Buyer Affiliates (or Buyer's Parent's) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities. WARRANTY DISPUTE RESOLUTION Notwithstanding anything to the contrary in Attachments A, G or H, if Buyer/Buyer Affiliates and Seller/ExxonMobil Selling Affiliates are unable to agree on the quality or quantity of Product delivered and received following their internal investigations and good faith efforts to resolve the dispute, the parties shall cooperate to have the Products in dispute analyzed by a mutually selected independent testing laboratory. The results of such laboratory testing shall be final and binding on the parties on the issue of conformance of the Products. If the Products are determined to be conforming, then Buyer/Buyer Affiliates shall bear the cost of such laboratory testing. If the Products are determined not to be conforming, then Seller/ExxonMobil Selling Affiliates shall bear the cost of such laboratory testing. US LAW AND REGULATION The Parties represent, warrant and undertake to each other on a continuous basis that they shall comply with all applicable anti-bribery and anti- money laundering laws, rules, and regulations of any government, including the U.S. Foreign Corrupt Practices Act, and the applicable country legislation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions as such laws and regulations may be amended or updated from time to time. DATA PRIVACY Seller informs Buyer that any information relating to an identified or identifiable natural person (\\\"individual\\\"), in particular business contact details of Buyer's personnel and contractors, which is communicated by or on behalf of Buyer to Seller (\\\"personal data\\\"), will be subject to data processing by Seller. To learn more about the processing of personal data and about individual's rights in relation to the processing, read the Seller data privacy notice at http://www.exxonmobil.be/en-be/company/locations/belgium/legal-information-belgium-only Buyer shall inform its personnel and contractors and other relevant individuals of the Seller data privacy notice. USE ACKNOWLEDGEMENT In accordance with Section 8 of Attachment A, the \\\"Warranties\\\" section of Attachment G and Section 14 of Attachment H, Seller hereby expressly acknowledges that Buyer has provided notice so Seller that Product(s) purchased hereunder will be used by Buyer in connection with only the following medical applications: Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 \u2022 Elastomeric components for pharmaceutical packaging and containment solutions, including stoppers, seals, plungers, and syringe components. TERMINATION Notwithstanding anything to the contrary in Attachments A, G or H, neither party can suspend its further performance, terminate this Agreement or require specific performance of the other party of this Agreement in whole or in part as a result of the other party's material breach of the terms and conditions of this Agreement without first providing notice to such party in writing and thirty (30) days' opportunity to cure the material breach (and then only if such party fails to cure such breach). TERMS AND CONDITIONS The following attachments are made part of this Agreement:\"}, {\"id\": \"Attachment A\", \"title\": \"- ExxonMobil Chemical Company and ExxonMobil Chemical Services Americas Inc. General Terms and Conditions of Sale Attachment B - List of ExxonMobil Affiliates/Divisions Attachment C - List of West Pharmaceutical Services Affiliates Attachment D - Notices Attachment E - Payment Terms Attachment F - Returnable Metal Crates Attachment G - ExxonMobil Chemical Asia Pacific - Terms and Conditions of Sale Attachment H - ExxonMobil Chemical Petroleum & Chemical BVBA - Terms and Conditions of Sale\", \"level\": 1, \"text\": \"Attachment A - ExxonMobil Chemical Company and ExxonMobil Chemical Services Americas Inc. General Terms and Conditions of Sale Attachment B - List of ExxonMobil Affiliates/Divisions Attachment C - List of West Pharmaceutical Services Affiliates Attachment D - Notices Attachment E - Payment Terms Attachment F - Returnable Metal Crates Attachment G - ExxonMobil Chemical Asia Pacific - Terms and Conditions of Sale Attachment H - ExxonMobil Chemical Petroleum & Chemical BVBA - Terms and Conditions of Sale GOVERNING LAW This Agreement shall be governed and construed in accordance with the law set forth in the ExxonMobil Selling Affiliate's general terms and conditions, as applicable. BINDING EFFECT Seller shall not be obligated by this Agreement unless Buyer executes and returns this Agreement to Seller no later than thirty (30) days from the date Seller signs below. ENTIRE AGREEMENT This Agreement and its attachments constitute the complete and exclusive statement of the terms of agreement between Seller and Buyer and supersede any and all agreements, representations and understandings, oral and written made prior to signing and relating to the subject matter of this Agreement. In no event shall either party be responsible for any special, punitive, or consequential damages whatsoever. No modification of this Agreement shall be of any force or effect unless such modification is in writing, expressly designated as an amendment hereto and signed by the parties' duly authorized representatives; and no modification shall be effected by the acknowledgment or acceptance of purchase order forms containing terms or conditions at variance with those set forth herein. None of the parties shall be legally bound by anything contained in this instrument, or any negotiations pursuant thereto, unless and until the companies have agreed to all terms and this instrument has been signed by authorized representatives of each company. ORDER OF PRECEDENCE In the event of conflict between this Agreement (including the Failure in Performance and Change in Circumstances clauses herein) and the Attachments hereto, this Agreement shall prevail, except with respect to the governing law specified in Attachments A, G and H, respectively, and as applicable to the appropriate ExxonMobil Selling Affiliate. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 BUYER SELLER ACCEPTED AND AGREED TO BY BUYER ExxonMobil Chemical Company, a division of DATE OF: Exxon Mobil Corporation January 10, 2020 Date: December 11, 2018 /s/ Eric M. Green /s/ Kurt Aerts BY: Eric M. Green BY: Kurt Aerts Title: President and CEO Title: Vice President, SERI Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT A West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Master Supply Agreement ExxonMobil Chemical Company (EMCC) & ExxonMobil Chemical Services Americas Inc. (EMCSA) Standard Terms and Conditions of Sales and Acceptance of Order\"}, {\"id\": \"1\", \"title\": \"PRICE AND QUANTITY; PRICE ADJUSTMENTS Except as otherwise provided in this Agreement, and without regard to any course\", \"level\": 1, \"text\": \"1. PRICE AND QUANTITY; PRICE ADJUSTMENTS Except as otherwise provided in this Agreement, and without regard to any course of dealing between the parties: (1) Seller shall not be obligated to sell or deliver any quantity of product(s) covered hereby (\\\"Product\\\") beyond the amount, if any, which in Seller's sole judgment, is available for such purpose as of the proposed date of shipment to Buyer; (2) the price of Product shall be Seller's price therefor as of the date of shipment; (3) Seller reserves the right to set minimums and/or premiums or to reject orders for unusual configurations, sizes and folds; (4) an overrun or underrun of up to ten percent (10%) shall constitute due performance of any order; (5) any freight allowances shall be those specified by Seller as of the date of shipment; and (6) Buyer shall allow Seller a reasonable period for delivery of shipments of Product. Seller may change any price, freight or payment term hereof upon no less than thirty (30) days' prior written notice; provided, however, that Seller may at any time institute or remove a temporary voluntary allowance of other similar competitive allowance without prior notice.\"}, {\"id\": \"2\", \"title\": \"PAYMENT Unless otherwise specified in Attachment E of the Agreement, Payment for Product shall be made in U\", \"level\": 1, \"text\": \"2. PAYMENT Unless otherwise specified in Attachment E of the Agreement, Payment for Product shall be made in U.S. Dollars and shall be due, in good funds in Seller's account, no later than thirty (30) days after the date of shipment. With respect to any monetary obligations of Buyer or Buyer's affiliates owed to Seller, Seller may (i) set-off such obligations against any sums owing to Buyer or Buyer's affiliates; and/or (ii) recoup such obligation from any amounts paid to Buyer or Buyer's affiliates by Seller.\"}, {\"id\": \"3\", \"title\": \"TAXES Any tax (except income taxes), excise or other governmental charge that now or in the future may be imposed, incr\", \"level\": 1, \"text\": \"3. TAXES Any tax (except income taxes), excise or other governmental charge that now or in the future may be imposed, increased or levied upon the production, value added, sale, transportation, storage, handling, delivery, use or disposal of Product sold hereunder which Seller may be required to pay, shall be paid by Buyer to Seller in addition to the purchase price. Buyer shall provide Seller, on request, with properly completed exemption certificates for any tax from which Buyer claims exemption.\"}, {\"id\": \"4\", \"title\": \"CREDIT If Seller has reasonable grounds for insecurity with respect to the financial responsibility of Buyer, Seller ma\", \"level\": 1, \"text\": \"4. CREDIT If Seller has reasonable grounds for insecurity with respect to the financial responsibility of Buyer, Seller may require advance cash payment or satisfactory security and may withhold Product shipments until receipt of such payment or security. Such action by Seller shall not constitute a change of payment terms hereunder. If amounts due hereunder are placed with an outside agency for collection, or if suit is brought for collection, or if collected through probate, bankruptcy or other judicial proceedings, then Buyer shall pay all costs of collection, including attorneys' fees, in addition to other amounts due.\"}, {\"id\": \"5\", \"title\": \"SET-OFF AND RECOVERY With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Bu\", \"level\": 1, \"text\": \"5. SET-OFF AND RECOVERY With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Buyer Affiliates to Seller/ExxonMobil Selling Affiliates, Seller/ExxonMobil Selling Affiliates may (i) set-off such monetary amounts and/or product-exchange delivery imbalances against any monetary amounts and/or product-exchange delivery imbalances owing to Buyer/Buyer Affiliates; and/or (ii) recoup such monetary amounts and/or product-exchange delivery imbalances from any amounts paid and/or deliveries made to Buyer/Buyer Affiliates by Seller/ExxonMobil Selling Affiliates. For purposes hereof, any and all agreements between Buyer and Seller, whether written or oral, shall be deemed to be part of an integrated agreement set forth herein.\"}, {\"id\": \"6\", \"title\": \"CHANGE IN CIRCUMSTANCES In connection with any Change in Circumstances (as defined below), and without limiting Seller'\", \"level\": 1, \"text\": \"6. CHANGE IN CIRCUMSTANCES In connection with any Change in Circumstances (as defined below), and without limiting Seller's other rights under this Agreement or applicable law, Seller shall have the right: (i) to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable; (ii) to modify the payment terms hereunder; and/or (iii) to require Buyer to pay in advance for shipments hereunder. Promptly after any public announcement regarding any proposed transaction that would result in a Change in Circumstances, Buyer shall notify Seller, in writing, of the nature of such transaction, the parties thereto and the proposed date of consummation. If Seller elects to exercise any of its rights under the preceding paragraph, Seller shall so notify Buyer, in writing, within forty-five (45) days after receipt of Buyer's notice. As used above, \\\"Change in Circumstances\\\" means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 in Buyer (or of at least twenty-five percent 25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer (\\\"Buyer's Parent\\\") to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer's (or Buyer's Parent's) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer's (or Buyer's Parent's) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities.\"}, {\"id\": \"7\", \"title\": \"TITLE; RISK OF LOSS Title to Product and risk of loss shall pass to Buyer at Seller's facilities upon delivery to a car\", \"level\": 1, \"text\": \"7. TITLE; RISK OF LOSS Title to Product and risk of loss shall pass to Buyer at Seller's facilities upon delivery to a carrier or into Buyer's transport unless otherwise specified in the agreement.\"}, {\"id\": \"8\", \"title\": \"LIMITED WARRANTY AND MEDICAL APPLICATIONS THERE ARE NO WARRANTIES WHICH EXTEND BEYOND THE PRODUCT DESCRIPTION HEREIN, A\", \"level\": 1, \"text\": \"8. LIMITED WARRANTY AND MEDICAL APPLICATIONS THERE ARE NO WARRANTIES WHICH EXTEND BEYOND THE PRODUCT DESCRIPTION HEREIN, AND SELLER MAKES NO WARRANTY, EXPRESS OR IMPLIED, OF FITNESS FOR PARTICULAR USE, MERCHANTABILITY OR OTHERWISE WITH RESPECT TO PRODUCT, WHETHER USED SINGLY OR IN COMBINATION WITH OTHER SUBSTANCES OR IN ANY PROCESS, EXCEPT THAT PRODUCT SOLD HEREUNDER SHALL CONFORM TO SELLER'S STANDARD SALES SPECIFICATIONS AS OF THE DATE OF SHIPMENT. Without limiting the foregoing, Seller does not recommend nor endorse the use of Product(s) in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise, with respect to Product(s)' use in any medical application. Buyer represents and warrants that no Product(s) purchased hereunder will be used in or resold into any commercial or developmental manner in connection with medical applications without Seller's prior express written acknowledgement. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that Seller recommends or endorses the use of Product(s) purchased hereunder in any medical application.\"}, {\"id\": \"9\", \"title\": \"INSPECTION AND LIMITATION OF LIABILITY Buyer shall inspect and test Product delivered hereunder for damage, defect or s\", \"level\": 1, \"text\": \"9. INSPECTION AND LIMITATION OF LIABILITY Buyer shall inspect and test Product delivered hereunder for damage, defect or shortage immediately upon receipt at Buyer's plant or such other location as determined by Buyer and provide Seller notice of any such damage, defect or shortage within ten (10) days of receipt. Any claims for shortages must be supported by certified railroad scale tickets (or similar documents if shipments were not by rail) and Seller shall have an opportunity to have an independent weighing. All claims for any cause whatsoever, whether based in contract, negligence or other tort, strict liability, breach of warranty or otherwise, shall be deemed waived unconditionally and absolutely unless Seller receives written notice of such claim not later than one hundred fifty (150) days after Buyer's receipt of Product as to which such claim is made. Defective or nonconforming Product shall be replaced by Seller without additional charge, or in lieu thereof, at Seller's option, Seller may refund the purchase price upon return of such Product at Seller's expense and such refund or replacement shall constitute Buyer's sole and exclusive remedy. NOTWITHSTANDING THE ABOVE AND REGARDLESS OF THE CIRCUMSTANCES, SELLER'S TOTAL LIABILITY TO BUYER FOR ANY AND ALL CLAIMS, LOSSES OR DAMAGES ARISING OUT OF ANY CAUSE WHATSOEVER, WHETHER BASED IN CONTRACT, NEGLIGENCE OR OTHER TORT, STRICT LIABILITY, BREACH OF WARRANTY OR OTHERWISE, SHALL IN NO EVENT EXCEED THE PURCHASE PRICE OF PRODUCT IN RESPECT TO WHICH SUCH CAUSE AROSE. IN NO EVENT SHALL SELLER BE LIABLE FOR SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES. Any cause of action that Buyer may have against Seller and which may arise in connection with the transaction(s) specified herein must be commenced within two (2) years after the cause of action has accrued.\"}, {\"id\": \"10\", \"title\": \"SAFETY, HEALTH AND INDEMNITY Seller shall furnish to Buyer Material Safety Data Sheets, including warnings and safety a\", \"level\": 1, \"text\": \"10. SAFETY, HEALTH AND INDEMNITY Seller shall furnish to Buyer Material Safety Data Sheets, including warnings and safety and health information concerning Products and/or the containers therefor. Buyer agrees to disseminate such information so as to give warning of possible hazards to persons who Buyer can reasonably foresee may be exposed to such hazards, including but not limited to Buyer's employees, agents, contractors or customers. Buyer shall instruct its employees, agents, contractors and customers on the safe handling, use, selling, storing, transportation and disposal practices for the Product. IF BUYER FAILS TO DISSEMINATE SUCH WARNINGS AND INFORMATION, BUYER AGREES TO DEFEND AND INDEMNIFY SELLER AGAINST ANY AND ALL LIABILITY ARISING OUT OF OR IN ANY WAY CONNECTED WITH SUCH FAILURE, INCLUDING BUT NOT LIMITED TO LIABILITY FOR INJURY, SICKNESS, DEATH AND PROPERTY DAMAGE; PROVIDED, HOWEVER, THAT IF SELLER IN THIS INSTANCE HAS CONTRIBUTED TO SUCH LIABILITY, BUYER'S INDEMNITY TO SELLER SHALL BE REDUCED BY THE PROPORTION IN WHICH SELLER CONTRIBUTED TO SUCH LIABILITY. Seller will provide Buyer with reasonable notice and opportunity to defend in the event any claim or demand is made on Seller as to which such indemnity relates.\"}, {\"id\": \"11\", \"title\": \"CARS, TRUCKS AND BARGES Buyer shall unload railroad cars, trucks and barges furnished by Seller within the free time sp\", \"level\": 1, \"text\": \"11. CARS, TRUCKS AND BARGES Buyer shall unload railroad cars, trucks and barges furnished by Seller within the free time specified by tariffs or time periods on file with applicable regulatory bodies, or promptly after receipt if no such tariffs or time periods are on file, and pay any charges Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 resulting from its failure to do so directly to the common carrier upon receipt of invoice therefor. Buyer shall pay Seller's daily charges for trip-leased tank cars for tank cars held longer than seven (7) days from constructive placement. BUYER ASSUMES FULL RESPONSIBILITY FOR USE AND CONDITION OF CARS, TRUCKS AND BARGES WHILE IN BUYER'S POSSESSION AND AGREES TO (1) COMPENSATE SELLER FOR LOSS OR DAMAGE TO SELLER'S PROPERTY AND (2) INDEMNIFY AND SAVE SELLER HARMLESS FROM ANY LOSS OR DAMAGE TO PROPERTY OTHER THAN SELLER'S AND FROM ANY INJURIES TO PERSONS RELATING IN ANY WAY TO THE USE OF SUCH CAR(S), TRUCK(S) AND BARGE(S) WHILE SUCH ARE IN BUYER'S POSSESSION. Buyer shall report to Seller promptly any damage that may be sustained by the car(s), truck(s) or barge(s) in Buyer's possession.\"}, {\"id\": \"12\", \"title\": \"LEASED TRACKS Seller may elect to provide rail cars of Product to Buyer on leased tracks\", \"level\": 1, \"text\": \"12. LEASED TRACKS Seller may elect to provide rail cars of Product to Buyer on leased tracks. If Seller does so, Buyer shall contact Seller to receive shipments of Product from the leased tracks and not request such shipment directly from the railroad.\"}, {\"id\": \"13\", \"title\": \"FAILURE IN PERFORMANCE No liability shall result to either party from delay in performance or non-performance in whole\", \"level\": 1, \"text\": \"13. FAILURE IN PERFORMANCE No liability shall result to either party from delay in performance or non-performance in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, criminal enterprise, sabotage, diminishment, or failure of power, telecommunications, data systems or networks, shortage or inability to obtain Product or raw material for Product, or good-faith compliance with any governmental order or request (whether valid or invalid). Notwithstanding any other notice requirement in this Agreement, actual notice (e.g., phone, email, letter) to a counterparty of a delay or failure described in this provision will constitute effective notice for purposes of this provision. Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if for any reason supplies of or distribution logistics for Product, or feedstock for making Product, from any of Seller's existing sources are curtailed or are inadequate to meet Seller's own requirements and/or its obligations to its customers, Seller's obligation to deliver Product during such period shall be reduced to the extent necessary, in Seller's sole judgment, to apportion fairly among Seller's own requirements and its customers (whether under contract or not) such Product as received and as may be available in the ordinary and usual course of Seller's business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller shall not be obligated to purchase or obtain Product, or feedstock to make Product, to replace deliveries omitted or curtailed under this paragraph.\"}, {\"id\": \"14\", \"title\": \"INTENTIONALLY OMITTED\", \"level\": 1, \"text\": \"14. INTENTIONALLY OMITTED\"}, {\"id\": \"15\", \"title\": \"EXPORT COMPLIANCE The transaction(s) specified herein, unless otherwise indicated, constitute domestic sales within the\", \"level\": 1, \"text\": \"15. EXPORT COMPLIANCE The transaction(s) specified herein, unless otherwise indicated, constitute domestic sales within the United States. For domestic U.S. sales, where Buyer chooses to subsequently export the Product, Buyer shall comply with all applicable laws relating to export controls and economic sanctions, including, but not limited to, those maintained by the US Department of the Treasury (Office of Foreign Assets Controls) and the US Department of Commerce (Bureau of Industry and Security). For U.S. domestic sales, if Buyer elects to export Product, Buyer shall constitute the U.S. Principal Party in Interest or Exporter for all purposes under applicable law.\"}, {\"id\": \"16\", \"title\": \"NON-US BUYERS If Buyer is a natural or legal person of any jurisdiction other than the United States and/or a State the\", \"level\": 1, \"text\": \"16. NON-US BUYERS If Buyer is a natural or legal person of any jurisdiction other than the United States and/or a State thereof, any dispute arising with respect to the transaction(s) specified herein shall be referred to three (3) arbitrators in accordance with the Rules of Arbitration of the International Chamber of Commerce as in effect on the date of such referral. The arbitration shall take place in Houston, Texas, U.S.A. The proceedings shall be in the English language. The American Arbitration Association shall act as appointing authority in the event required. Monetary awards shall be expressed in U.S. Dollars and all awards shall be final and binding on the parties. Judgment upon any award may be entered in any court having jurisdiction.\"}, {\"id\": \"17\", \"title\": \"AMENDMENT; CANCELLATION No modification of this Agreement shall be of any force or effect unless such modification is i\", \"level\": 1, \"text\": \"17. AMENDMENT; CANCELLATION No modification of this Agreement shall be of any force or effect unless such modification is in writing, expressly designated as an amendment hereto and signed by the parties' duly authorized representatives; and no modification shall be effected by the acknowledgment or acceptance of purchase order forms containing terms or conditions at variance with those set forth herein. Except as explicitly set forth in this Agreement, this Agreement and the transaction(s) specified herein can be cancelled only with both parties' written consent.\"}, {\"id\": \"18\", \"title\": \"GOVERNING LAW AND DISPUTE RESOLUTION The parties' rights and obligations hereunder shall be construed and enforced unde\", \"level\": 1, \"text\": \"18. GOVERNING LAW AND DISPUTE RESOLUTION The parties' rights and obligations hereunder shall be construed and enforced under the laws of the State of Texas, U.S.A., without regard to conflict of laws principles. Incoterms 2010 (or any subsequent revision thereof) (\\\"Incoterms\\\") shall also apply; provided, however, that Incoterms shall apply only to the extent specified in the agreement hereof, and provided, further, that in the event of a conflict between Incoterms and the laws of the State of Texas, U.S.A., the latter shall govern. The parties specifically exclude Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 application of the U.N. Convention on Contracts for the International Sale of Goods. For any dispute regarding this Agreement, the Parties agree to exclusive jurisdiction and venue in the district courts of Harris County, Texas, or the United States District Court for the Southern District of Texas (Houston Division).\"}, {\"id\": \"19\", \"title\": \"MISCELLANEOUS No waiver by either party of a right, default or breach of any of the terms and conditions herein shall b\", \"level\": 1, \"text\": \"19. MISCELLANEOUS No waiver by either party of a right, default or breach of any of the terms and conditions herein shall be effective unless in writing. No such waiver shall be deemed a waiver of any subsequent right, default or breach (whether similar or dissimilar) except as expressly stated therein.\"}, {\"id\": \"20\", \"title\": \"ASSIGNMENT This Agreement shall not be assigned in whole or in part by Buyer or Seller without the written consent of t\", \"level\": 1, \"text\": \"20. ASSIGNMENT This Agreement shall not be assigned in whole or in part by Buyer or Seller without the written consent of the other party and any attempted assignment without such consent shall be void and of no effect, except that Seller may assign all of its rights and obligations hereunder to any entity of which Exxon Mobil Corporation owns, directly or indirectly, at least fifty percent (50%) of the shares or other indicia of equity having the right to elect such entity's board of directors or other governing body. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT B West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Master Supply Agreement List of ExxonMobil Affiliates / Divisions At its sole discretion and with prior written notice to Buyer, Seller may designate a different selling entity from the ones listed in this Attachment. For Product purchases made by Buyer Affiliates in: U.S.A., Brazil, Mexico ExxonMobil Chemical Company, a division of Exxon Mobil Corporation (\\\"EMCC\\\") and/or ExxonMobil Chemical Services Americas, Inc. 22777 Springwoods Village Pkwy Spring, TX 77389 For Product purchases made by Buyer Affiliates i n: Denmark, France, Germany, United Kingdom, Serbia and Ireland ExxonMobil Petroleum & Chemical BVBA (EMPC) Polderdijkweg B - 2030 Antwerpen, Belgium For Product purchases made by Buyer Affiliates i n: Singapore, China, India ExxonMobil Affiliate: ExxonMobil Chemical Asia Pacific, a division of ExxonMobil Asia Pacific Pte Ltd (EMCAP) 1 Harbour Front Place #06-00HarbourFront Tower One Singapore 098633 Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT C West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Master Supply Agreement List of West Pharmaceutical Affiliates Buyer may update this list from time to time with written notice to Seller. Brazil West Pharmaceutical Services Brasil Ltda AV Nossa Senhora Das Gracas, 115 Diadema, Sao Paulo, Brazil 09980-000 China West Pharmaceutical Packaging (China) Co., Ltd No. 111 Tianchen Road Qingpu, Shanghai 201707 China Denmark West Pharmaceutical Services Denmark A/S Fuglevangsvej 51 Horsens, Denmark France West Pharmaceutical Services France,S.A. 38, Rue Robert Degon Le Nouvion EN Thierache 02170 Germany West Pharmaceutical Services Deutschland GmbH & Co. KG Stalberger Str. 21-41 Eschweiler 52249 Ireland West Pharmaceutical Products Ireland, Ltd. Carrickpherish Road Waterford, X91 R9V6 India West Pharmaceutical Packaging India Pvt. Ltd. 900 Peepul Boulevard-Sector 36-Sri City-Satyavedu (P.O) Chittoor District - A.P. - India - 517 546 Mexico West Pharmaceutical Services Mexico, S.A. de C.V. Calle 40 Sur No. 706, Esq. 36 Este Civac, Jiutepec Morelos - M\u00e9xicoC. P. 62500 Serbia West Pharmaceutical Services Beograd d.o.o. Kovin Crvenka 76 Kovin 26220, Serbia Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Singapore West Pharmaceutical Services Singapore Pte. Ltd. 15 Joo Koon Circle Jurong, Singapore 629046 U.S.A West Pharmaceutical Services, Inc. 530 Herman O. West Drive Exton, PA 19341-1147 West Pharmaceutical Services, Inc. 1028 Innovation Way Kinston, NC 28504-7616 West Pharmaceutical Services, Inc. 923 West Railroad Street Kearney, NE 68845-5128 West Pharmaceutical Services of Florida, Inc. 5111 Park Street North St. Petersburg, FL 33709-1109 West Pharmaceutical Services, Inc. 347 Oliver Street Jersey Shore, PA 17740-1923 Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}, {\"id\": \"ATTACHMENT D\", \"title\": \"West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement\", \"level\": 1, \"text\": \"ATTACHMENT D West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement Notices For all notices, communications, or questions regarding this Contract, the following addresses listed below shall be used; provided, however, that Seller and Buyer can each change any of its address information by providing written notice to the other party. ExxonMobil Chemical Company West Pharmaceutical Services, Inc. 22777 Springwoods Village Pkwy 530 W. Herman O. Drive Spring, TX 77389 Exton, PA 19341-1147 Attn: Gerd Merhof Attn: Oliver Steven ExxonMobil Chemical Central Europe West Pharmaceutical Services Deutschland GmbH & Co. KG Im Mediapark 2 Kiefernweg 5 50670 K\u00f6ln 52249 Eschweiler Germany Germany Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT E West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement Payment Terms Buyer Affiliates shall pay ExxonMobil Selling Affiliates' invoice(s) in full within the days set forth below: Location Payment Terms Delivery Terms - lncoterms 2010 Brazil [*****] [*****] China [*****] [*****] Denmark [*****] [*****] France [*****] [*****] Germany [*****] [*****] India [*****] [*****] Mexico [*****] [*****] Serbia [*****] [*****] Singapore [*****] [*****] U.S.A. [*****] [*****] Ireland [*****] [*****] * For Product sold and/or sourced from the US that is shipped overseas to a non-US location, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company or any other ExxonMobil Seller to Buyer at the first point upon which the delivering marine vessel crosses the outer boundary of the United States Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea. For U.S. sales to Brazil or Mexico, Seller shall constitute the U.S. Principal Party in interest or Exporter for all purposes under applicable law. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT F West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement Returnable Metal Crates\"}, {\"id\": \"Attachment F\", \"title\": \"documents Buyer's/Buyer Affiliates' responsibility for returnable metal crates (\\\"Metal Crates\\\") used in the supply of Butyl products from Seller/ExxonMobil Selling Affiliates (\\\"ExxonMobil\\\"). Buyer/Buyer Affiliates wishes to receive Butyl in Metal Crates and ExxonMobil is willing to supply Butyl in Metal Crates, subject to the following agreement.\", \"level\": 1, \"text\": \"Attachment F documents Buyer's/Buyer Affiliates' responsibility for returnable metal crates (\\\"Metal Crates\\\") used in the supply of Butyl products from Seller/ExxonMobil Selling Affiliates (\\\"ExxonMobil\\\"). Buyer/Buyer Affiliates wishes to receive Butyl in Metal Crates and ExxonMobil is willing to supply Butyl in Metal Crates, subject to the following agreement. Agreement Buyer/Buyer Affiliates is responsible for the Metal Crates in their custody at the replacement value of the Metal Crates. Buyer's /Buyer Affiliates' custody begins when Metal Crates are loaded onto the delivering carrier at the ExxonMobil or third party warehouse and ends when Metal Crates are loaded onto the carrier for return to Global Pallet Services Limited (GPS) USA, Inc. Buyer/Buyer Affiliates must implement a system to ensure Metal Crates are not lost or damaged, and are returned in undamaged condition (normal wear and tear excepted). Buyer/Buyer Affiliates will supply to ExxonMobil upon request copies of any Bills of Lading needed to verify return shipments of Metal Crates. For each Metal Crate not received back at Global Pallet Services Limited (GPS) and where a physical inventory determines that such Metal Crate is not in the custody of Buyer/Buyer Affiliates, Buyer/Affiliates will have 30 days from end of the calendar year to reimburse ExxonMobil as stated below. For the purposes of this agreement, a Metal Crate is considered to be in undamaged condition if the base and all four sides are in working condition. Buyer/Buyer Affiliates agrees to pay for all repairs for damage to any Metal Crate, or to pay the replacement charge of $[*****] per Metal Crate for any Metal Crate that is either permanently lost or damaged beyond repair while in the custody of Buyer/Buyer Affiliates, and a replacement charge ($[*****] per door) for any removable door missing from Metal Crates collected at Buyer's /Buyer Affiliates' location. A Metal Crate shall be deemed to have been damaged beyond repair if the documented repair costs to restore the damaged Metal Crate to fit-for-fill condition would exceed $[*****]. In addition, if any of the charges imposed by Global Pallet Services Limited (GPS) under the agreement between the ExxonMobil and Global Pallet Service Limited (GPS) for damage to or loss of Metal Crates, are revised, the aforesaid amount reimbursable by Buyer/Buyer Affiliates shall automatically be revised in similar manner. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT G The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates 2019-2023 Global Master Supply Agreement EMCAP STANDARD TERMS AND CONDITIONS OF SALE AND ACCEPTANCE OF ORDER ACCEPTANCE The acceptance of Buyer's order by Seller is expressly made conditional upon Buyer's assent to these Standard Terms and Conditions of Sale. Terms as specified in Seller's Order Confirmation (if any) and these Standard Terms and Conditions shall constitute the only binding contract terms and conditions between the parties (the \\\"Agreement\\\") in the absence of a written agreement as described in the Clause on Written Agreement. WRITTEN AGREEMENT If there is an executed written sales contract or agreement in effect between Buyer and Seller covering Buyer's order, the terms and conditions of that contract or agreement shall prevail over any conflicting term in Seller's Order Confirmation and/or these Standard Terms and Conditions and/or Buyer's purchase order. PRICE ADJUSTMENT [*****] Buyer's failure to deliver to Seller written objection to any such change at least ten (10) days before its effective date shall constitute acceptance. If Buyer does deliver such objections within the deadline, no delivery shall be made until parties agree on the new price, freight and/or payment terms. [*****] QUANTITY Quantity of all shipments shall be determined by Seller and shall have a shipping allowance of plus or minus five percent (+/-5%) of the quantity indicated in Seller's Order Confirmation or separate sales contract, or such other percentage as determined by Seller. To allow for standard tolerances of scales, Seller will not consider any claims for shortages of less than one half of one percent (0.5%) of the gross weight of any shipment of packaged product or less than one half of one percent (0.5%) of the net weight of bulk shipment. Seller shall have the right at all times to appoint an independent surveyor. TAXES All prices are exclusive of taxes, duties, or other governmental charges levied on or in respect of the product or delivery thereof. Buyer shall pay or reimburse Seller for such taxes, duties or charges. RISK AND TITLE TRANSFER Risk of loss of and damage to product shall pass to Buyer in accordance with the Incoterm specified in Seller's Order Confirmation or separate sales contract. Without negating Seller's warranty obligations hereunder, Buyer assumes all risk and liability for loss, damage, or injury to the person or property of Buyer or other parties arising out of the use or possession of any Product sold hereunder. Unless stated otherwise in Seller's Order Confirmation or separate sales contract, title in product shall pass to Buyer simultaneously with risk of loss of and damage to product. However, if the product is shipped by Seller from the US, such title and risk shall pass to Buyer at the first point at which the delivering vessel crosses the outer boundary of the US Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea or as such term is used in the said Convention. WARRANTIES There are no warranties which extend beyond the description on the face hereof, and Seller makes no warranty, expressed or implied, of satisfactory quality, merchantability, fitness for any particular use or otherwise, except that the products sold hereunder shall meet Seller's applicable standard specifications or such other specifications as may be notified by Seller to Buyer from time to time. Buyer assumes all risk whatsoever as a result of the use of the products purchased, whether used singly or in combination with other substances or in any process. Without limiting the foregoing, Seller does not recommend nor endorse the use of product in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise with respect to product's use in any medical application. Buyer represents and warrants that no product purchased hereunder will be Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 used or resold for use in any commercial or developmental manner in connection with medical applications without Seller's prior express written acknowledgment. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that Seller recommends or endorses the use of product purchased hereunder in any medical application. LIMITATION OF CLAIMS Seller's total liability for all claims arising hereunder or connected with the products sold hereunder, whether based in contract, tort or otherwise, shall be no greater than an amount equal to the purchase price of the products to which any such claims relate, or at the Seller's option, and only in the case of claims regarding defective or non-conforming product, to replacement of such products, provided that in all cases Buyer shall be under an obligation to mitigate any loss as far as possible. Seller shall not in any event be liable for any special, incidental, exemplary or consequential damages. Subject to the Clauses on Quantity, Transfer of Risk and Title Transfer, Buyer shall inspect and test product delivered hereunder for damage, defect or shortage immediately upon receipt and provide Seller notice of any such damage, defect or shortage within ten (10) days of receipt. Any claim must be accompanied by documents as required by Seller, including but not limited to a certified weigh scale ticket or an independent surveyor report, and Seller shall have an opportunity to an independent assessment. All claims for any cause whatsoever, whether based in contract, negligence or other tort, strict liability, breach of warranty or otherwise, shall be deemed waived unconditionally and absolutely unless Seller receives complete written details of such claim not later than [*****] after Buyer's receipt of product as to which such claim is made. Receipt will be deemed to have taken place for purposes of this subparagraph when the product has been loaded onto Buyer's transport, or offloaded from the vessel or other means of transport on which delivery has been made when delivery is arranged by Seller. LAYTIME AND DEMURRAGE Buyer shall unload tank containers, cars, trucks and barges furnished by Seller and clear products from port, or at delivery destination, within the free time specified by tariffs or time periods on file with applicable bodies, or promptly after receipt if no such tariffs or time periods are on file. Buyer shall pay charges resulting from its failure to do to Seller or directly to the common carrier upon receipt of invoice. For bulk marine shipment, demurrage charge at load port is for account of Seller and at discharge port for Buyer's account. For sales other than FOB sales, laytime allowed, demurrage rate and applicable charter party terms shall be as specified in Seller's vessel nomination to Buyer failing which, the terms in Seller's contract of affreightment with the vessel owner shall apply and Buyer shall pay Seller or the carrier the demurrage incurred at the discharge port by Seller's stipulated deadline. Subject to the foregoing, for the first discharge terminal, laytime shall commence six (6) hours after the vessel's notice of readiness is tendered to Buyer (or its agent) or upon the vessel being all fast to the discharge terminal, whichever occurs first, and for subsequent discharge terminal(s), laytime shall commence immediately when the vessel's notice of readiness is tendered to Buyer (or its agent). Laytime shall cease upon disconnection of all cargo hoses upon completion of discharge. For FOB sales, vessels nominated by Buyer are subject to Seller's screening, inspection and acceptance process and Seller's agreement to loading-date range duration / loading-date range narrowing profile / loading-date range communication leadtime and other shipping logistics, and any claim for demurrage by Buyer shall be waived unless notice in writing of such claim is received by Seller with full supporting documentation (including the invoice and time sheet issued by the vessel) by Seller's stipulated deadline. FAILURE IN PERFORMANCE Failure by Seller to deliver on a specific date shall not entitle Buyer to repudiate this Agreement. Buyer shall not be relieved of any obligations to accept or pay for products by reason of any delay in delivery or dispatch. Furthermore, no liability shall result to either party for delay in performance or non-performance of an obligation hereunder (except an obligation to make payment) in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, shortage or inability to obtain product or raw material for product, or good-faith compliance with any governmental order or request (whether valid or invalid) . Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if for any reason supplies of product or feedstock for making product, from any of Seller's existing sources are curtailed or are inadequate to meet Seller's own requirement and/or its obligation to its customers, Seller's obligation to deliver product during such period shall be reduced to the extent necessary, in Seller's sole judgment, to apportion fairly among Seller's own requirements and its customers (whether under contract or not) such products as received and as may be available in the ordinary and usual course of Seller's business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller shall not be obligated to purchase or obtain product, or feedstock to make product, to replace deliveries omitted or curtailed under this Paragraph. MODIFICATION AND AMENDMENTS There are no oral understandings, representations or warranties between the parties that conflict with these Standard Terms and Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Conditions or the details of price, payment, shipment or delivery schedule as communicated by Seller. No modification of any Standard Terms and Conditions shall be of any force or effect unless such modification is in writing and signed by the party to be bound thereby, and no modification of the same shall be effected by the acknowledgement of Buyer's purchase orders or equivalent forms containing terms and conditions at variance with those set forth herein and all such terms or conditions in Buyer's purchase orders or equivalent forms shall be considered null and void. GOVERNING LAW This Agreement shall be governed by Singapore law, without regard to its conflict of laws principles. Parties agree to exclude the application of the United Nations Convention on Contracts for the International Sale of Goods. A party that is not a party to this Agreement shall have no rights under the Contracts (Rights of Third Parties) Act (Cap 53B) to enforce any of the terms in this Agreement. ASSIGNMENT This Agreement shall not be assigned, in whole or in part, by either party without the prior consent of the other party, but shall be binding upon and shall inure to the benefit of the legal successors of the respective parties hereto; except that Seller may assign this Agreement, in whole or in part, to any affiliate. For purposes of this Clause, an \\\"affiliate\\\" of Seller means the ultimate holding company of Seller or any corporation of which fifty percent (50%) or more of the outstanding stock is held directly or indirectly by such ultimate holding company. DEFINITION To the extent not inconsistent with the terms hereof, Incoterms 2010 (\\\"Incoterms\\\") shall apply hereto. NO WAIVER No waiver by either party of any breach of these Standard Terms and Conditions shall be construed as a waiver of any succeeding breach of the same. CREDIT CLAUSE If Buyer fails to make payment when due or if Seller reasonably believes the financial status of Buyer is impaired due to any reason, Seller shall have the right, without prejudice to its other rights in contract or at law, upon notice to Buyer, to withhold further deliveries of product, modify or change any terms of payment or credit, suspend performance under this Agreement, accelerate payment obligations such that all amounts owed under prior deliveries and not paid shall become immediately due and payable, require Buyer to furnish security as deemed appropriate by Seller and/or exercise rights against any collateral and apply the proceeds against amounts due and owing. Seller shall in any event have the right to set- off any claim that Seller (or its affiliate) may have against Buyer (or its affiliate), against any sum which Seller may owe to Buyer (or its affiliate). In the event Seller requires a documentary letter of credit or a standby letter of credit, such letter of credit shall be issued by an international bank in form and substance acceptable to Seller. A clean letter of credit is to be received by Seller prior to the estimated shipment date or by such date as Seller shall agree. Seller shall have no obligation to deliver product if the letter of credit is not so received by Seller. Without prejudice to Seller's other rights in law and contract, it is agreed that Buyer shall indemnify and hold harmless the Seller from and against any dead-freight, vessel and/or port charges and payments, demurrage and/or any damages, losses or expenses incurred as a result of any delay in loading or non-delivery of any product under this Agreement arising from Buyer's failure or delay in providing the letter of credit in accordance with the terms of this Agreement. BUSINESS PRACTICES (a) Business Standards. Each party to this Agreement shall establish precautions to prevent its employees or subcontractors from making, receiving, providing or offering any substantial gifts, extravagant entertainment, payments, loans, or other considerations to the employees of the other party and/or their families and/or third parties in connection with this Agreement. (b) Compliance With Law. Each party agrees and will secure agreement by its subcontractors to comply with all applicable laws, regulations, decrees and judicial orders. Notwithstanding anything in this Agreement to the contrary, no provision shall be interpreted or applied so as to require any party to do, or refrain from doing, anything which would constitute a violation of, or result in a loss of economic benefit under, United States anti-boycott and other export laws and regulations. Each party represents to the other party that it shall not make any improper payments of money or anything of value to a government official (whether appointed, elected, honorary, or a career government employee) in connection with this Agreement, nor shall it make improper payments to a third party knowing or suspecting that the third party will give the payment, or a portion of it, to a government official. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 (c) Notice of Non-Compliance. Each party (\\\"the Relevant Party\\\") agrees to notify the other party promptly upon discovery of any instance where the Relevant Party fails to comply with this Clause. If either party discovers or is advised of any errors or exceptions related to its invoicing under this Agreement, both parties will together review the nature of the errors or exceptions, and will, if appropriate, promptly take corrective action that is necessary on its part and adjust the relevant invoice or refund overpayments. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}, {\"id\": \"ATTACHMENT H\", \"title\": \"The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates 2019-2023 Global Master Supply Agreement\", \"level\": 1, \"text\": \"ATTACHMENT H The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates 2019-2023 Global Master Supply Agreement EMPC STANDARD TERMS AND CONDITIONS OF SALE (hereafter referred to as \\\"EM\\\")\"}, {\"id\": \"1\", \"title\": \"Agreement(s) as used herein shall mean any order confirmation issued by EM or any other contractual arrangement between\", \"level\": 1, \"text\": \"1. Agreement(s) as used herein shall mean any order confirmation issued by EM or any other contractual arrangement between EM and Buyer. These general terms and conditions shall apply to and form part of all Agreements. The Agreement constitutes the complete and entire understanding and agreement between EM and Buyer. No other general terms and conditions will have an effect on the Agreement. Deviations from the Agreement, including these general terms and conditions, shall be valid only if expressly agreed in writing by the parties.\"}, {\"id\": \"2\", \"title\": \"Title to the product shall transfer from EM to Buyer simultaneously with the transfer of risks as per Incoterms\", \"level\": 1, \"text\": \"2. Title to the product shall transfer from EM to Buyer simultaneously with the transfer of risks as per Incoterms. All references to Incoterms shall mean ICC Incoterms 2010.\"}, {\"id\": \"3\", \"title\": \"EM will use reasonable efforts to meet the planned delivery date which shall be deemed to be only approximate\", \"level\": 1, \"text\": \"3. EM will use reasonable efforts to meet the planned delivery date which shall be deemed to be only approximate.\"}, {\"id\": \"4\", \"title\": \"If Buyer is responsible for the transport of products, Buyer shall ensure that the means of transport is clean and dry,\", \"level\": 1, \"text\": \"4. If Buyer is responsible for the transport of products, Buyer shall ensure that the means of transport is clean and dry, suitable for loading and carrying the products, and complies with the safety standards of EM and with the legal standards for such means of transport. In case of non- or incomplete compliance with the above requirements, EM will be entitled not to load or cause to load this means of transportation, without any obligation to compensation.\"}, {\"id\": \"5\", \"title\": \"If delivery takes place on reusable pallets (regardless of whether they are property of EM), Buyer will maintain these\", \"level\": 1, \"text\": \"5. If delivery takes place on reusable pallets (regardless of whether they are property of EM), Buyer will maintain these pallets in good condition and make them available on request for collection by or on behalf of EM.\"}, {\"id\": \"6\", \"title\": \"EM's determination of quantity and quality shall be binding for both parties\", \"level\": 1, \"text\": \"6. EM's determination of quantity and quality shall be binding for both parties. Without prejudice to the foregoing, Buyer has the right to have a representative present at said determination, at his own cost.\"}, {\"id\": \"7\", \"title\": \"Products shall be supplied by EM at the price valid on the planned delivery date\", \"level\": 1, \"text\": \"7. Products shall be supplied by EM at the price valid on the planned delivery date.\"}, {\"id\": \"8\", \"title\": \"Prices are exclusive of taxes (such as VAT), duties or other governmental charges\", \"level\": 1, \"text\": \"8. Prices are exclusive of taxes (such as VAT), duties or other governmental charges. In addition to the price of the product, EM shall have the right to charge any taxes, duties or other governmental charges that now or in the future may be levied, in connection with the manufacture, sale, transportation, storage, handling, delivery, use, possession of or disposal of the product or raw materials used in it. VAT and excise tax exemptions granted on request of Buyer in accordance with legislation or administrative regulations imposed by any lawful authority, shall be the exclusive responsibility of Buyer who shall indemnify EM in respect of any VAT or excise Tax liabilities arising therefrom.\"}, {\"id\": \"9\", \"title\": \"EM will invoice Buyer and Buyer will pay the invoice in the currency stated on the invoice, without any discount, deduc\", \"level\": 1, \"text\": \"9. EM will invoice Buyer and Buyer will pay the invoice in the currency stated on the invoice, without any discount, deduction or set off, so that EM's designated bank account is credited with the full invoiced amount within 30 days from the invoice date.\"}, {\"id\": \"10\", \"title\": \"Failure by Buyer to pay on the due date shall make all sums owing by Buyer to EM on any account whatsoever immediately\", \"level\": 1, \"text\": \"10. Failure by Buyer to pay on the due date shall make all sums owing by Buyer to EM on any account whatsoever immediately and automatically due and payable, without prejudice to EM's right to charge automatically and without giving any notice the statutory late payment interest rate as defined in applicable legislation on combating late payment in commercial transactions.\"}, {\"id\": \"11\", \"title\": \"EM and any of its Affiliates (as herein defined) may at any time without giving notice to or making demand upon Buyer,\", \"level\": 1, \"text\": \"11. EM and any of its Affiliates (as herein defined) may at any time without giving notice to or making demand upon Buyer, set off and apply any and all sums at any time owing by EM and/or by any of its Affiliates to Buyer or any of Buyer's Affiliates, against any and all sums owing by Buyer or any of Buyer's Affiliates to EM and/or to any of its Affiliates. An Affiliate is (1) for EM: Exxon Mobil Corporation or any company in which Exxon Mobil Corporation owns or controls, directly or indirectly, 50 % or more of the voting stock and (2) for the Buyer: any company in which its ultimate holding company owns or controls, directly or indirectly, 50 % or more of the voting stock.\"}, {\"id\": \"12\", \"title\": \"If one party has objective reasons to conclude that the financial status of the other party becomes impaired or unsatis\", \"level\": 1, \"text\": \"12. If one party has objective reasons to conclude that the financial status of the other party becomes impaired or unsatisfactory, or in case of late payment, it may require the other party to provide adequate securities, including cash in advance, for the timely payment of future deliveries, absent which it may suspend its supply obligations. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}, {\"id\": \"13\", \"title\": \"Health and safety information relating to handling and use of products are in the Safety Data Sheets (SDS) that EM has\", \"level\": 1, \"text\": \"13. Health and safety information relating to handling and use of products are in the Safety Data Sheets (SDS) that EM has sent or will send to Buyer. Buyer shall notify EM if Buyer has not received such information by the delivery date. EM will assume that Buyer has received the necessary information absent notification from Buyer. Buyer shall provide such health and safety information to anyone including without limitation its employees, contractors, agents or customers who may be exposed to the product. Buyer warrants that it possesses the necessary expertise for handling products of the type being supplied hereunder and that it will take the steps necessary to review and understand that information contained on the SDS for each product it purchases. Such data and statements are offered only for Buyer's and its users' and customers' considerations, investigation and verification.\"}, {\"id\": \"14\", \"title\": \"EM gives no guarantees or warranties, express or implied, as to the quality, merchantability, fitness for purpose or su\", \"level\": 1, \"text\": \"14. EM gives no guarantees or warranties, express or implied, as to the quality, merchantability, fitness for purpose or suitability of the products except that the product sold pursuant to the terms of this Agreement shall meet the relevant EM standard specification in force at the time of loading or such other specification or requirement which may be explicitly agreed in writing between the parties. Without limiting the foregoing, EM does not recommend nor endorse the use of product(s) in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise with respect to product(s)' use in any medical application. Buyer represents and warrants that no product(s) purchased hereunder will be used in or resold into any commercial or developmental manner in connection with medical applications without EM's prior express written acknowledgement. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that EM recommends or endorses the use of product(s) purchased hereunder in any medical application. EM's maximum liability for all claims for any reason is the sales price of the product involved and EM shall not be liable for indirect or consequential damage. Claims by Buyer are waived unless made in writing within 150 days from date of (non-) delivery. Buyer shall indemnity and hold EM harmless in respect of all claims for which Buyer is liable.\"}, {\"id\": \"15\", \"title\": \"EM makes no representation or warranty of any kind, express or implied, that the products sold hereunder, or the use of\", \"level\": 1, \"text\": \"15. EM makes no representation or warranty of any kind, express or implied, that the products sold hereunder, or the use of such products, or articles made therefrom, either alone or in conjunction with other materials, will not infringe any patent or trademark rights. Buyer agrees that it will promptly notify EM of any claim or suit involving Buyer in which patent or trademark infringement is alleged with respect to the products sold hereunder, and that Buyer will permit EM, at its option and expense, to control completely the defence or settlement of any such allegation of infringement.\"}, {\"id\": \"16\", \"title\": \"Neither party shall be liable for any delay in performance or non-performance in whole or in part caused by circumstanc\", \"level\": 1, \"text\": \"16. Neither party shall be liable for any delay in performance or non-performance in whole or in part caused by circumstances beyond the reasonable control of the party affected including but not limited to, acts of God, fire, flood, war, terrorist activity, or the threat of one of these events, criminal acts or sabotage, diminishment or failure of power, telecommunications, data systems or networks, accident, explosion, equipment breakdowns, labour disputes, shortage or inability to obtain energy, utilities, equipment, transportation, the Product, or the feedstock from which the Product is directly or indirectly derived; or good faith compliance with any regulation, direction r request (whether ultimately determined to be valid or invalid) made by governmental authority or any person or persons purporting to act for such an authority. Regardless of the occurrence or non-occurrence of any of the circumstances set forth above, if for any reason, supplies of or distribution logistics of the Product deliverable under this Agreement or of the feedstock from which the Product is directly or indirectly derived from any of EM's then existing sources of supply are curtailed or cut off, or otherwise inadequate to meet EM's own requirements and its obligations to its customers, EM shall have the option during such period of curtailment, or cessation to apportion fairly among its customers including EM's Affiliates and whether under contract or not, such Product as may be received in the ordinary course of business or manufactured at EM then existing sources. EM shall not be obliged to purchase or otherwise obtain alternative supplies of product deliverable under this Agreement, or the feedstock from which product directly or indirectly is derived. Nor shall EM be obliged to settle labour disputes, run down inventories below normal levels, adapt or vary its manufacturing plan except at its own sole discretion, or to take any steps other than in accordance with good business practice to make up inadequate supplies or to replace the supplies so curtailed or cut off. EM shall not be obliged to make up deliveries omitted or curtailed under this Agreement. Any such deficiencies in deliveries shall be cancelled with no liability to either party, it being agreed, however, that a force majeure situation hereunder shall not entitle either party to cancel this Agreement.\"}, {\"id\": \"17\", \"title\": \"In case of any material breach of the terms and conditions contained in the Agreement by one of the parties, the other\", \"level\": 1, \"text\": \"17. In case of any material breach of the terms and conditions contained in the Agreement by one of the parties, the other party may, without giving prior written notice in the event the material breach is not cured within such notice period or without undertaking any recourse to legal proceedings, suspend its further performance, terminate the Agreement or require specific performance by the other party of the Agreement in whole or in part, without prejudice to its right to damages for any losses incurred subject to Article 14.\"}, {\"id\": \"18\", \"title\": \"Neither party may assign this Agreement without the written consent of the other party save in the case where such assi\", \"level\": 1, \"text\": \"18. Neither party may assign this Agreement without the written consent of the other party save in the case where such assignment is to an EM Affiliate and prior written notice has been given to the Buyer. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}, {\"id\": \"19\", \"title\": \"EM informs Buyer that any information relating to an identified or identifiable natural person (\\\"individual\\\"), in parti\", \"level\": 1, \"text\": \"19. EM informs Buyer that any information relating to an identified or identifiable natural person (\\\"individual\\\"), in particular business contact details of Buyer's personnel and contractors, which is communicated by or on behalf of Buyer to EM (\\\"personal data\\\"), will be subject to data processing by EM. To learn more about the processing of personal data and about individual's rights in relation to the processing, read the EM data privacy notice at http://www.exxonmobil.be/enbe/company/locations/belgium/legal-information-belgium-only Buyer shall inform its personnel and contractors and other relevant individuals of the EM data privacy notice.\"}, {\"id\": \"20\", \"title\": \"Notwithstanding any other provision in this Agreement or any other document, neither this Agreement nor any other docum\", \"level\": 1, \"text\": \"20. Notwithstanding any other provision in this Agreement or any other document, neither this Agreement nor any other document shall constitute an agreement by EM to take any action or refrain from taking any action that is in conflict with, penalized under or compliance with which is prohibited by the laws or regulations of the United States, the European Union (EU), any EU member State, the United Kingdom and/or Norway, as applicable. The parties furthermore represent, warrant and undertake to each other on a continuous basis that they shall comply with all applicable anti-bribery and anti-money laundering laws, rules and regulations of any government relevant to the transaction, including the US Foreign Corrupt Practices Act and the applicable country legislation implementing OECD Convention on Combating Bribery of Foreign Public Officials in international business transactions as such laws and regulations may be updated or amended from time to time.\"}, {\"id\": \"21\", \"title\": \"To the extent permitted by law, in the event that a party becomes aware that it will or may undergo a Change of Control\", \"level\": 1, \"text\": \"21. To the extent permitted by law, in the event that a party becomes aware that it will or may undergo a Change of Control (\\\"Affected Party\\\") within the following three (3) Months, the Affected Party will notify the other party without delay after it becomes so aware. Together with such notification, the Affected Party will supply the other party with sufficient information to allow that other party to reasonably assess the impact that such Change of Control may have on it and/or its Affiliates, on the Affected Party's creditworthiness, and on the Affected Party's ability to perform its obligations under this Agreement. In the event that the other party concludes in its sole discretion that such Change of Control, if it is implemented: (a) may result in it and/or its Affiliates being subjected to any fact, matter, event, circumstance, condition or change which materially and adversely affects, or could reasonably be expected to materially and adversely affect, individually or in aggregate, the business, operations, assets, liabilities, condition (whether financial, trading or otherwise), prospects or operating results of it and/or its Affiliates; (b) that the Affected Party's creditworthiness may be reduced; and/or (c) that the Affected Party's ability to perform its obligations under the Agreement may be negatively affected; then the other party may (but is not obliged to) terminate this Agreement forthwith upon notice to the Affected Party. Such termination is without prejudice to the rights and obligations of the parties that have accrued up to and including the date of termination. As used above, \\\"Change of Control\\\" means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least fifty percent (50%) of the equity interest in a party (or of at least fifty percent (50%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in a party (\\\"Party's Parent\\\")) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in a Party's (or Party's Parent's) merging with one or more other entities.\"}, {\"id\": \"22\", \"title\": \"This Agreement between EM and Buyer shall be governed by the laws of Belgium (excluding its rules on conflict of laws)\", \"level\": 1, \"text\": \"22. This Agreement between EM and Buyer shall be governed by the laws of Belgium (excluding its rules on conflict of laws). Neither the Uniform Law on the International Sale of Goods ('ULIS'), nor the United Nations Convention on Contracts for the International Sale of Goods 1980 ('CISG') shall apply. (i) If Buyer's registered office is located within the territory of the European Economic Area ('EEA'), any disputes between EM and Buyer arising out of or in relation to this Agreement shall be of the exclusive jurisdiction of the Courts of Antwerp. (ii) If Buyer's registered office is located outside the territory of the EEA, any disputes arising out of or in relation to this Agreement shall be finally settled under the CEPANI Rules of Arbitration by three (3) arbitrators appointed in accordance with said Rules. The seat of the arbitration shall be Brussels. The arbitration shall be conducted in the English language. ________________________________ * Further information on ExxonMobil Petroleum & Chemical BVBA is available on: http://www.exxonmobil.be/en-be/company/locations/belgium/legal-information-belgium-only Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of Copy of WestPharmaceuticalServicesInc_20200116_8-K_EX-10.1_11947529_EX-10.1_Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 [*****] Text omitted for confidential treatment. The redacted information has been excluded because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. GLOBAL MASTER SUPPLY AGREEMENT This Global Master Supply Agreement (\\\"Agreement\\\" or \\\"Contract\\\") is between ExxonMobil Chemical Company, a division of Exxon Mobil Corporation (\\\"Seller\\\"),on behalf of itself and in the interest of the ExxonMobil affiliates listed on Attachment B (each an \\\"ExxonMobil Selling Affiliate\\\" or \\\"EMCC/A\\\" or collectively, \\\"ExxonMobil Selling Affiliates\\\"), and West Pharmaceutical Services, Inc. (\\\"Buyer\\\"), on behalf of itself and the Buyer affiliates listed on Attachment C (each a \\\"Buyer Affiliate\\\" or \\\"West/A\\\" or collectively, \\\"Buyer Affiliates\\\"). PRODUCTS, QUANTITY, PRICE In accordance with the provisions of this Agreement, ExxonMobil Selling Affiliates agree to sell to Buyer Affiliates, and Buyer Affiliates agree to purchase from ExxonMobil Selling Affiliates, the following product(s) (collectively, \\\"Product\\\"): Products Quantity [Metric Tons / Year] Container PackageYear 2019 2020 2021 2022 2023 [*****] [*****] Minimum Maximum [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] [*****] Leased metal crates [*****] [*****] [*****] [*****] [*****] [*****] Leased metal crates [*****] not defined Leased metal crates Subject to this Agreement's terms and conditions, Buyer Affiliates shall purchase and ExxonMobil Selling Affiliates shall sell the yearly minimum amount of Product amounts (in the aggregate) listed above. Buyer or Buyer Affiliates may request to purchase amounts over the Product maximum amounts per year, however, it shall be solely within Seller or any ExxonMobil Selling Affiliate's discretion whether and under which conditions to accommodate Buyer's request. Buyer Affiliates shall issue a purchase order(s), or call off order(s) when purchasing Product from ExxonMobil Selling Affiliates in writing pursuant to this Contract (\\\"Purchase Order\\\"). Such Purchase Order(s) shall specify (a) the quantity of Product, and (b) general date of delivery. All Purchase Orders agreed to be filled by an ExxonMobil Selling affiliate shall be deemed to be a separate agreement between the relevant ExxonMobil Selling Affiliate and the relevant Buyer Affiliate, incorporating the terms of this Contract. Notwithstanding anything to the contrary in the attachments ExxonMobil and the ExxonMobil Selling Affiliates shall not unreasonably reject any Purchase Order that otherwise complies with the terms of this Agreement. Purchase Order(s), order acknowledgements and similar form documents evidencing the purchase or sale of Products, including any terms and conditions contained or referenced therein, shall not supersede, add to or amend in any way this Contract. In the event of any conflict between the terms of this Contract and the terms of any Purchase Order, order acknowledgement or similar document the terms of this Contract shall prevail. [*****] PRICING For calendar years 2019, 2020, 2021, 2022 and 2023, the price of Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates will comprise the Base Price, the crude adjustment and the freight cost depending on Incoterms. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Base price Requested delivery date 1.1.2019 - 28.2.2019: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.3.2019 - 31.12.2019: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2020 - 31.12.2020: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2021 - 31.12.2021: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2022 - 31.12.2022: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t 1.1.2023 - 31.12.2023: All [*****] grades except [*****]: [*****] $/t [*****]: [*****] $/t [*****]: [*****] $/t [*****] Base prices listed above are non-delivered pricing (i.e., Ex-Works designated Exxon Affiliate location (see Attachment B) - Incoterms 2010 (\\\"EXW\\\") and does not include freight or insurance. Seller and Buyer shall meet on or before December 31, [*****] to assess the requirements for a price and/or volume adjustment in good faith on the price for Products sold by Seller/ExxonMobil Selling Affiliates to Buyer/Buyer Affiliates for years [*****] and [*****]. Notwithstanding anything to the contrary in Attachments A, G and H to this Agreement, the parties agree that any permitted adjustments to the price, freight or payment terms for Products sold hereunder will be governed by the terms of the Pricing and Payment Terms sections of this Agreement. Buyer Affiliates shall pay ExxonMobil's Selling Affiliates invoice(s) not later than the days set forth in Attachment E hereto. All invoices shall be paid in full by wire transfer in accordance with the invoice's instructions. Crude Trigger Clause Product price(s) shall be subject to the Average Brent crude oil price evolution (as further detailed below) in order to reflect the cost of energy. Should the Average Brent crude oil price at any moment during the term of this Agreement move to a different Average Brent crude oil price bracket as mentioned below, Seller may increase or decrease the Product price by $[*****] for every $[*****] change in the Average Brent crude oil price. In no event shall the Product price's increase or decrease exceed $[*****] for every $[*****] change in the Average Brent crude oil price brackets. Each Average Brent crude oil bracket is calculated on a $5 range basis (e.g., $30-$35, $40-$45, $50-$55, etc.). The Average Brent crude oil price evolution shall be expressed as the three-month average spot price per barrel of the Brent crude Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 oil (as published in the Wall Street Journal). This average shall be calculated as the average of the prices for the immediate preceding three consecutive calendar months, with each month's price calculated as the average of the daily prices. Any conversion between United States Dollars and Euros will be carried out by using the average of the European Central Bank's daily foreign exchange rate as published in Reuter's screen ECB 37 for the period in question. Any Product price adjustment shall take effect the month immediately following Seller's notification of an increase or decrease in Product price. TITLE AND RISK OF LOSS - EXXONMOBIL CHEMICAL COMPANY AND EXXONMOBIL CHEMICAL SERVICES AMERICAS INC. Title to the Product(s) to be sold and delivered hereunder will transfer simultaneously with the risks upon delivery as per the applicable lncoterm (lncoterms 2010) in Attachment E with the exception of the following: For Product sold and/or sourced by ExxonMobil Chemical Company or ExxonMobil Chemical Services Americas Inc. that is shipped overseas to a non-U.S. location, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company or ExxonMobil Chemical Services Americas Inc. to Buyer Affiliates at the first point upon which the delivering marine vessel crosses the outer boundary of the United States Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea. For Product sold by ExxonMobil Chemical Company that is transported by land to Mexico, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company to Buyer Affiliates at the frontier between Laredo, Texas, U.S.A. and Mexico (not unloaded), but prior to the customs border of Mexico. LOCATIONS OF SUPPLY Buyer/Buyer Affiliates that may purchase Product from ExxonMobil Selling Affiliates are listed in Attachment C. Other products and locations may be added upon mutual agreement in writing. Any and all sales of Product between ExxonMobil Chemical Company and/or ExxonMobil Chemical Services Americas, Inc. and Buyer Affiliates in the U.S., Mexico and Brazil shall be subject to the terms and conditions set forth in Attachment A hereto. Any and all sales of Product between ExxonMobil Petroleum & Chemical and Buyer Affiliates in France, Germany, Denmark, Serbia, Ireland and the United Kingdom shall be subject to the terms and conditions set forth in Attachment H hereto. Any and all sales of Product between ExxonMobil Chemical Asia Pacific and Buyer Affiliates in Singapore, China and India shall be subject to the terms and conditions set forth in Attachment G hereto. Buyer/Buyer Affiliates are responsible for the Product and returnable crates in their custody at the sales value of the Product and the replacement value of the metal crates, respectively. The terms relating to the use and return of metal crates are set out in Attachment F. AFFILIATES ExxonMobil Selling Affiliates participating in this Agreement are listed in Attachment B. Buyer Affiliates participating in this Agreement are listed in Attachment C. Seller and Buyer each represent and warrant that each will cause its respective affiliates, so listed, to become bound to the terms of this Agreement. QUALITY Product shall conform to ExxonMobil Selling Affiliates' standard sales specifications as of the date of shipment. Sellers agrees to support the creation of purchasing specifications for Products by Buyer and agrees to supply Products in accordance to those purchasing specifications. Seller has the right to review each purchasing specification and needs to accept in writing before such purchasing specifications become effective. Seller has the right to take exceptions to terms and provisions in these purchasing specifications if in contradiction with Seller's Sales specifications, General Terms and Condition of Sales or other Seller's procedures and policies. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Buyer and Seller agree to enter into negotiations on an extended Quality Assurance Agreement. Provided that these negotiations will be successful, such agreement shall then be incorporated into this Contract as an amendment to it. AGREEMENT PERIOD Effective Date: January 1, 2019 Termination Date: December 31, 2023 PAYMENT TERMS Buyer/Buyer Affiliates shall pay for Product by Electronic Funds Transfer (EFT) through the Automated Clearing House (ACH) using the Corporate Trade Exchange (CTX) format, according to the payment terms described in Attachment E. TECHNICAL SUPPORT EMCC/A will provide technical expertise in the use of Products and will use its technical centers to enhance technical communications with West Pharmaceutical Services Affiliates technical centers. West/A will share its needs with EMCC/A and how they relate to West/A activities to help guide ExxonMobil Chemical Affiliates technical efforts. The parties have created and continue to entertain a research and development governance structure with a steering team, program management team and working team. The charter, roles and meeting frequencies are described in mutually agreed documents and will be reviewed periodically as deemed appropriate by the parties. SAFETY, HEALTH & ENVIRONMENT Safety, health and environment (SHE) professional representatives from both parties shall endeavor to meet once a year (face to face or via teleconference) to exchange and benchmark on best practices. The parties agree to notify each other on SHE related issues that may arise from the use of Products. The parties agree to explore the reuse/recycling of articles, manufacturing trim and scrap Buyer produces from Products purchased from Seller. AUDIT On request of Buyer, Buyer is allowed to carry out on-site manufacturing and quality audits in manufacturing units where Products are produced. The frequency of such audits shall not exceed one audit per site within three years SUPPLY SECURITY Buyer is seeking for an increased level of supply security and additional risk mitigation strategies and actions in case of short and long term supply disruptions of Products. Seller agrees to enter into discussions and negotiations with Buyer and to take reasonable efforts to enhance such risk mitigation and business continuity strategies. COLLABORATION PLANNING AND SUPPLY ASSURANCE, FORECAST Buyer and Seller agree to convene once every calendar year to discuss annual Product quantities. Buyer has provided Seller with an annual non- binding forecast for the respective contract year. As requested by the Seller, the Buyer will provide a quarterly forecast for the subsequent contract years. Seller will provide Buyer a quarterly overview of the planned production run of each Butyl grade purchased for Buyer. Seller shall acknowledge in writing the requested delivery and timing of Products and Volumes. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 CHANGE CONTROL Changes to the manufacturing process are carefully controlled and are subject to review and formal approval by EMCC/A or other affiliates of Exxon Mobil Corporation prior to implementation. Buyer will be informed at least six months in advance of any change determined by EMCC/A to result in a significant change to the chemical composition or performance of the Product. [*****] CREDIT If Seller/ExxonMobil Selling Affiliates' has reasonable grounds for insecurity with respect to the financial responsibility of Buyer/Buyer Affiliates, Seller/ExxonMobil Selling Affiliates may require advance cash payment or satisfactory security and may withhold Product shipments until receipt of such payment or security. Such action by Seller/ExxonMobil Selling Affiliates shall not constitute a change of payment terms hereunder. If amounts due hereunder are placed with an outside agency for collection, or if suit is brought for collection, or if collected through probate, bankruptcy or other judicial proceedings, then Buyer/Buyer Affiliates shall pay all costs of collection, including attorneys' fees, in addition to all other amounts due. SET-OFF AND RECOVERY With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Buyer Affiliates to Seller/ExxonMobil Selling Affiliates, Seller/ExxonMobil Selling Affiliates may (i) set-off such monetary amounts and/or product-exchange delivery imbalances against any monetary amounts and/or product-exchange delivery imbalances owing to Buyer/Buyer Affiliates; and/or (ii) recoup such monetary amounts and/or product-exchange delivery imbalances from any amounts paid and/or deliveries made to Buyer/Buyer Affiliates by Seller/ExxonMobil Selling Affiliates. For purposes hereof, any and all written agreements between Buyer and Seller shall be deemed to be part of an integrated agreement set forth herein. ECONOMIC CONDITIONS AND TRENDS CLAUSE It is understood and agreed that the basis for this Agreement is an extraordinary level of mutual trust and confidence between the parties, not only in matters of price, quality, and service relating to the quantities of Product purchased and sold hereunder, but also with respect to the accommodation of changes that may develop in the business environment or the pursuit of such mutual undertakings as may benefit either or both of the parties to this Agreement. Moreover, the terms relating to quantity and price presume the continuation of economic conditions and trends now prevailing, including but not limited to levels of industrial production, tire demand, labor rates, energy costs, and foreign exchange relationships. In the event that, in the view of either party, a significant change of any kind does occur which materially and significantly alters the value received by either party in this transaction, that party may, upon written notice of its election and reasons therefor, request that this Agreement be renegotiated and the other party will be obligated to enter into the renegotiation unless the request is formally withdrawn. Neither party shall unreasonably request such renegotiation FAILURE IN PERFORMANCE Notwithstanding anything to the contrary in Attachments A, G or H, no liability shall result to either party from delay in performance or non- performance of an obligation hereunder (including an obligation to make payment) in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to, acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, criminal enterprise, sabotage, diminishment, or failure of power, telecommunications, data systems or networks, shortage or inability to obtain Product or raw material for Product, or good-faith compliance with any governmental order or request (whether valid or invalid). Notwithstanding any other notice requirement in this Agreement, actual notice (e.g., phone, email, letter) to a counterparty of a delay or failure described in this provision will constitute effective notice for purposes of this provision. Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if, supplies of Product or distribution logistics for, or feedstock for making Product, from any of Seller's/ExxonMobil Selling Affiliates' existing sources are curtailed or are inadequate to meet Seller's/ExxonMobil Selling Affiliates' own requirements and/or its obligations to its customers, Seller's/ExxonMobil Selling Affiliates' obligation to deliver Product during such period shall be reduced to the extent necessary, in Seller's/ExxonMobil Selling Affiliates' reasonable judgment, to apportion fairly among Seller's/ExxonMobil Selling Affiliates' own requirements and its customers such Product as received and as may be available in the ordinary and usual course of Seller's/ExxonMobil Selling Affiliates' business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller/ExxonMobil Selling Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Affiliates shall not be obligated to purchase or obtain Product, or feedstock to make Product, to replace deliveries omitted or curtailed under this paragraph. CHANGE IN CIRCUMSTANCES Notwithstanding anything to the contrary in Attachments A, G or H, in connection with any Change in Circumstances (as defined below), and without limiting Seller's/ExxonMobil Selling Affiliate's other rights under this Agreement or applicable law, Seller/ExxonMobil Selling Affiliates shall have the right: (i) only if required to enable Seller/ExxonMobil Selling Affiliate to comply with applicable laws and regulations, to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable (ii) to modify the payment terms hereunder; and/or (iii) to require that Buyer/Buyer Affiliates pay in advance for shipments hereunder. Promptly after any public announcement regarding any proposed transaction that would result in a Change in Circumstances, Buyer/Buyer Affiliates shall notify Seller/ExxonMobil Selling Affiliates, in writing, of the nature of such transaction, the parties thereto and the proposed date of consummation. If Seller/ExxonMobil Selling Affiliates elects to exercise any of its rights under the preceding paragraph, Seller/ExxonMobil Selling Affiliates shall so notify Buyer/Buyer Affiliates, in writing, within forty-five (45) days after receipt of Buyer's/Buyer Affiliates' notice. As used above, \\\"Change in Circumstances\\\" means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest in Buyer/Buyer Affiliates (or of at least twenty-five percent (25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer/Buyer Affiliates (\\\"Buyer's Parent\\\")) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer's /Buyer Affiliates' (or Buyer's Parent's) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer's/Buyer Affiliates (or Buyer's Parent's) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities. WARRANTY DISPUTE RESOLUTION Notwithstanding anything to the contrary in Attachments A, G or H, if Buyer/Buyer Affiliates and Seller/ExxonMobil Selling Affiliates are unable to agree on the quality or quantity of Product delivered and received following their internal investigations and good faith efforts to resolve the dispute, the parties shall cooperate to have the Products in dispute analyzed by a mutually selected independent testing laboratory. The results of such laboratory testing shall be final and binding on the parties on the issue of conformance of the Products. If the Products are determined to be conforming, then Buyer/Buyer Affiliates shall bear the cost of such laboratory testing. If the Products are determined not to be conforming, then Seller/ExxonMobil Selling Affiliates shall bear the cost of such laboratory testing. US LAW AND REGULATION The Parties represent, warrant and undertake to each other on a continuous basis that they shall comply with all applicable anti-bribery and anti- money laundering laws, rules, and regulations of any government, including the U.S. Foreign Corrupt Practices Act, and the applicable country legislation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions as such laws and regulations may be amended or updated from time to time. DATA PRIVACY Seller informs Buyer that any information relating to an identified or identifiable natural person (\\\"individual\\\"), in particular business contact details of Buyer's personnel and contractors, which is communicated by or on behalf of Buyer to Seller (\\\"personal data\\\"), will be subject to data processing by Seller. To learn more about the processing of personal data and about individual's rights in relation to the processing, read the Seller data privacy notice at http://www.exxonmobil.be/en-be/company/locations/belgium/legal-information-belgium-only Buyer shall inform its personnel and contractors and other relevant individuals of the Seller data privacy notice. USE ACKNOWLEDGEMENT In accordance with Section 8 of Attachment A, the \\\"Warranties\\\" section of Attachment G and Section 14 of Attachment H, Seller hereby expressly acknowledges that Buyer has provided notice so Seller that Product(s) purchased hereunder will be used by Buyer in connection with only the following medical applications: Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 \u2022 Elastomeric components for pharmaceutical packaging and containment solutions, including stoppers, seals, plungers, and syringe components. TERMINATION Notwithstanding anything to the contrary in Attachments A, G or H, neither party can suspend its further performance, terminate this Agreement or require specific performance of the other party of this Agreement in whole or in part as a result of the other party's material breach of the terms and conditions of this Agreement without first providing notice to such party in writing and thirty (30) days' opportunity to cure the material breach (and then only if such party fails to cure such breach). TERMS AND CONDITIONS The following attachments are made part of this Agreement:\"}}, {\"id\": \"Attachment A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- ExxonMobil Chemical Company and ExxonMobil Chemical Services Americas Inc. General Terms and Conditions of Sale Attachment B - List of ExxonMobil Affiliates/Divisions Attachment C - List of West Pharmaceutical Services Affiliates Attachment D - Notices Attachment E - Payment Terms Attachment F - Returnable Metal Crates Attachment G - ExxonMobil Chemical Asia Pacific - Terms and Conditions of Sale Attachment H - ExxonMobil Chemical Petroleum & Chemical BVBA - Terms and Conditions of Sale\", \"level\": 1, \"text\": \"Attachment A - ExxonMobil Chemical Company and ExxonMobil Chemical Services Americas Inc. General Terms and Conditions of Sale Attachment B - List of ExxonMobil Affiliates/Divisions Attachment C - List of West Pharmaceutical Services Affiliates Attachment D - Notices Attachment E - Payment Terms Attachment F - Returnable Metal Crates Attachment G - ExxonMobil Chemical Asia Pacific - Terms and Conditions of Sale Attachment H - ExxonMobil Chemical Petroleum & Chemical BVBA - Terms and Conditions of Sale GOVERNING LAW This Agreement shall be governed and construed in accordance with the law set forth in the ExxonMobil Selling Affiliate's general terms and conditions, as applicable. BINDING EFFECT Seller shall not be obligated by this Agreement unless Buyer executes and returns this Agreement to Seller no later than thirty (30) days from the date Seller signs below. ENTIRE AGREEMENT This Agreement and its attachments constitute the complete and exclusive statement of the terms of agreement between Seller and Buyer and supersede any and all agreements, representations and understandings, oral and written made prior to signing and relating to the subject matter of this Agreement. In no event shall either party be responsible for any special, punitive, or consequential damages whatsoever. No modification of this Agreement shall be of any force or effect unless such modification is in writing, expressly designated as an amendment hereto and signed by the parties' duly authorized representatives; and no modification shall be effected by the acknowledgment or acceptance of purchase order forms containing terms or conditions at variance with those set forth herein. None of the parties shall be legally bound by anything contained in this instrument, or any negotiations pursuant thereto, unless and until the companies have agreed to all terms and this instrument has been signed by authorized representatives of each company. ORDER OF PRECEDENCE In the event of conflict between this Agreement (including the Failure in Performance and Change in Circumstances clauses herein) and the Attachments hereto, this Agreement shall prevail, except with respect to the governing law specified in Attachments A, G and H, respectively, and as applicable to the appropriate ExxonMobil Selling Affiliate. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 BUYER SELLER ACCEPTED AND AGREED TO BY BUYER ExxonMobil Chemical Company, a division of DATE OF: Exxon Mobil Corporation January 10, 2020 Date: December 11, 2018 /s/ Eric M. Green /s/ Kurt Aerts BY: Eric M. Green BY: Kurt Aerts Title: President and CEO Title: Vice President, SERI Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT A West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Master Supply Agreement ExxonMobil Chemical Company (EMCC) & ExxonMobil Chemical Services Americas Inc. (EMCSA) Standard Terms and Conditions of Sales and Acceptance of Order\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE AND QUANTITY; PRICE ADJUSTMENTS Except as otherwise provided in this Agreement, and without regard to any course\", \"level\": 1, \"text\": \"1. PRICE AND QUANTITY; PRICE ADJUSTMENTS Except as otherwise provided in this Agreement, and without regard to any course of dealing between the parties: (1) Seller shall not be obligated to sell or deliver any quantity of product(s) covered hereby (\\\"Product\\\") beyond the amount, if any, which in Seller's sole judgment, is available for such purpose as of the proposed date of shipment to Buyer; (2) the price of Product shall be Seller's price therefor as of the date of shipment; (3) Seller reserves the right to set minimums and/or premiums or to reject orders for unusual configurations, sizes and folds; (4) an overrun or underrun of up to ten percent (10%) shall constitute due performance of any order; (5) any freight allowances shall be those specified by Seller as of the date of shipment; and (6) Buyer shall allow Seller a reasonable period for delivery of shipments of Product. Seller may change any price, freight or payment term hereof upon no less than thirty (30) days' prior written notice; provided, however, that Seller may at any time institute or remove a temporary voluntary allowance of other similar competitive allowance without prior notice.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT Unless otherwise specified in Attachment E of the Agreement, Payment for Product shall be made in U\", \"level\": 1, \"text\": \"2. PAYMENT Unless otherwise specified in Attachment E of the Agreement, Payment for Product shall be made in U.S. Dollars and shall be due, in good funds in Seller's account, no later than thirty (30) days after the date of shipment. With respect to any monetary obligations of Buyer or Buyer's affiliates owed to Seller, Seller may (i) set-off such obligations against any sums owing to Buyer or Buyer's affiliates; and/or (ii) recoup such obligation from any amounts paid to Buyer or Buyer's affiliates by Seller.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TAXES Any tax (except income taxes), excise or other governmental charge that now or in the future may be imposed, incr\", \"level\": 1, \"text\": \"3. TAXES Any tax (except income taxes), excise or other governmental charge that now or in the future may be imposed, increased or levied upon the production, value added, sale, transportation, storage, handling, delivery, use or disposal of Product sold hereunder which Seller may be required to pay, shall be paid by Buyer to Seller in addition to the purchase price. Buyer shall provide Seller, on request, with properly completed exemption certificates for any tax from which Buyer claims exemption.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CREDIT If Seller has reasonable grounds for insecurity with respect to the financial responsibility of Buyer, Seller ma\", \"level\": 1, \"text\": \"4. CREDIT If Seller has reasonable grounds for insecurity with respect to the financial responsibility of Buyer, Seller may require advance cash payment or satisfactory security and may withhold Product shipments until receipt of such payment or security. Such action by Seller shall not constitute a change of payment terms hereunder. If amounts due hereunder are placed with an outside agency for collection, or if suit is brought for collection, or if collected through probate, bankruptcy or other judicial proceedings, then Buyer shall pay all costs of collection, including attorneys' fees, in addition to other amounts due.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SET-OFF AND RECOVERY With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Bu\", \"level\": 1, \"text\": \"5. SET-OFF AND RECOVERY With respect to any monetary amounts and/or product-exchange delivery imbalances due from Buyer/Buyer Affiliates to Seller/ExxonMobil Selling Affiliates, Seller/ExxonMobil Selling Affiliates may (i) set-off such monetary amounts and/or product-exchange delivery imbalances against any monetary amounts and/or product-exchange delivery imbalances owing to Buyer/Buyer Affiliates; and/or (ii) recoup such monetary amounts and/or product-exchange delivery imbalances from any amounts paid and/or deliveries made to Buyer/Buyer Affiliates by Seller/ExxonMobil Selling Affiliates. For purposes hereof, any and all agreements between Buyer and Seller, whether written or oral, shall be deemed to be part of an integrated agreement set forth herein.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CHANGE IN CIRCUMSTANCES In connection with any Change in Circumstances (as defined below), and without limiting Seller'\", \"level\": 1, \"text\": \"6. CHANGE IN CIRCUMSTANCES In connection with any Change in Circumstances (as defined below), and without limiting Seller's other rights under this Agreement or applicable law, Seller shall have the right: (i) to terminate this Agreement and accelerate all amounts due from Buyer hereunder, making them immediately payable; (ii) to modify the payment terms hereunder; and/or (iii) to require Buyer to pay in advance for shipments hereunder. Promptly after any public announcement regarding any proposed transaction that would result in a Change in Circumstances, Buyer shall notify Seller, in writing, of the nature of such transaction, the parties thereto and the proposed date of consummation. If Seller elects to exercise any of its rights under the preceding paragraph, Seller shall so notify Buyer, in writing, within forty-five (45) days after receipt of Buyer's notice. As used above, \\\"Change in Circumstances\\\" means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 in Buyer (or of at least twenty-five percent 25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer (\\\"Buyer's Parent\\\") to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer's (or Buyer's Parent's) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer's (or Buyer's Parent's) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TITLE; RISK OF LOSS Title to Product and risk of loss shall pass to Buyer at Seller's facilities upon delivery to a car\", \"level\": 1, \"text\": \"7. TITLE; RISK OF LOSS Title to Product and risk of loss shall pass to Buyer at Seller's facilities upon delivery to a carrier or into Buyer's transport unless otherwise specified in the agreement.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITED WARRANTY AND MEDICAL APPLICATIONS THERE ARE NO WARRANTIES WHICH EXTEND BEYOND THE PRODUCT DESCRIPTION HEREIN, A\", \"level\": 1, \"text\": \"8. LIMITED WARRANTY AND MEDICAL APPLICATIONS THERE ARE NO WARRANTIES WHICH EXTEND BEYOND THE PRODUCT DESCRIPTION HEREIN, AND SELLER MAKES NO WARRANTY, EXPRESS OR IMPLIED, OF FITNESS FOR PARTICULAR USE, MERCHANTABILITY OR OTHERWISE WITH RESPECT TO PRODUCT, WHETHER USED SINGLY OR IN COMBINATION WITH OTHER SUBSTANCES OR IN ANY PROCESS, EXCEPT THAT PRODUCT SOLD HEREUNDER SHALL CONFORM TO SELLER'S STANDARD SALES SPECIFICATIONS AS OF THE DATE OF SHIPMENT. Without limiting the foregoing, Seller does not recommend nor endorse the use of Product(s) in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise, with respect to Product(s)' use in any medical application. Buyer represents and warrants that no Product(s) purchased hereunder will be used in or resold into any commercial or developmental manner in connection with medical applications without Seller's prior express written acknowledgement. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that Seller recommends or endorses the use of Product(s) purchased hereunder in any medical application.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSPECTION AND LIMITATION OF LIABILITY Buyer shall inspect and test Product delivered hereunder for damage, defect or s\", \"level\": 1, \"text\": \"9. INSPECTION AND LIMITATION OF LIABILITY Buyer shall inspect and test Product delivered hereunder for damage, defect or shortage immediately upon receipt at Buyer's plant or such other location as determined by Buyer and provide Seller notice of any such damage, defect or shortage within ten (10) days of receipt. Any claims for shortages must be supported by certified railroad scale tickets (or similar documents if shipments were not by rail) and Seller shall have an opportunity to have an independent weighing. All claims for any cause whatsoever, whether based in contract, negligence or other tort, strict liability, breach of warranty or otherwise, shall be deemed waived unconditionally and absolutely unless Seller receives written notice of such claim not later than one hundred fifty (150) days after Buyer's receipt of Product as to which such claim is made. Defective or nonconforming Product shall be replaced by Seller without additional charge, or in lieu thereof, at Seller's option, Seller may refund the purchase price upon return of such Product at Seller's expense and such refund or replacement shall constitute Buyer's sole and exclusive remedy. NOTWITHSTANDING THE ABOVE AND REGARDLESS OF THE CIRCUMSTANCES, SELLER'S TOTAL LIABILITY TO BUYER FOR ANY AND ALL CLAIMS, LOSSES OR DAMAGES ARISING OUT OF ANY CAUSE WHATSOEVER, WHETHER BASED IN CONTRACT, NEGLIGENCE OR OTHER TORT, STRICT LIABILITY, BREACH OF WARRANTY OR OTHERWISE, SHALL IN NO EVENT EXCEED THE PURCHASE PRICE OF PRODUCT IN RESPECT TO WHICH SUCH CAUSE AROSE. IN NO EVENT SHALL SELLER BE LIABLE FOR SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES. Any cause of action that Buyer may have against Seller and which may arise in connection with the transaction(s) specified herein must be commenced within two (2) years after the cause of action has accrued.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SAFETY, HEALTH AND INDEMNITY Seller shall furnish to Buyer Material Safety Data Sheets, including warnings and safety a\", \"level\": 1, \"text\": \"10. SAFETY, HEALTH AND INDEMNITY Seller shall furnish to Buyer Material Safety Data Sheets, including warnings and safety and health information concerning Products and/or the containers therefor. Buyer agrees to disseminate such information so as to give warning of possible hazards to persons who Buyer can reasonably foresee may be exposed to such hazards, including but not limited to Buyer's employees, agents, contractors or customers. Buyer shall instruct its employees, agents, contractors and customers on the safe handling, use, selling, storing, transportation and disposal practices for the Product. IF BUYER FAILS TO DISSEMINATE SUCH WARNINGS AND INFORMATION, BUYER AGREES TO DEFEND AND INDEMNIFY SELLER AGAINST ANY AND ALL LIABILITY ARISING OUT OF OR IN ANY WAY CONNECTED WITH SUCH FAILURE, INCLUDING BUT NOT LIMITED TO LIABILITY FOR INJURY, SICKNESS, DEATH AND PROPERTY DAMAGE; PROVIDED, HOWEVER, THAT IF SELLER IN THIS INSTANCE HAS CONTRIBUTED TO SUCH LIABILITY, BUYER'S INDEMNITY TO SELLER SHALL BE REDUCED BY THE PROPORTION IN WHICH SELLER CONTRIBUTED TO SUCH LIABILITY. Seller will provide Buyer with reasonable notice and opportunity to defend in the event any claim or demand is made on Seller as to which such indemnity relates.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CARS, TRUCKS AND BARGES Buyer shall unload railroad cars, trucks and barges furnished by Seller within the free time sp\", \"level\": 1, \"text\": \"11. CARS, TRUCKS AND BARGES Buyer shall unload railroad cars, trucks and barges furnished by Seller within the free time specified by tariffs or time periods on file with applicable regulatory bodies, or promptly after receipt if no such tariffs or time periods are on file, and pay any charges Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 resulting from its failure to do so directly to the common carrier upon receipt of invoice therefor. Buyer shall pay Seller's daily charges for trip-leased tank cars for tank cars held longer than seven (7) days from constructive placement. BUYER ASSUMES FULL RESPONSIBILITY FOR USE AND CONDITION OF CARS, TRUCKS AND BARGES WHILE IN BUYER'S POSSESSION AND AGREES TO (1) COMPENSATE SELLER FOR LOSS OR DAMAGE TO SELLER'S PROPERTY AND (2) INDEMNIFY AND SAVE SELLER HARMLESS FROM ANY LOSS OR DAMAGE TO PROPERTY OTHER THAN SELLER'S AND FROM ANY INJURIES TO PERSONS RELATING IN ANY WAY TO THE USE OF SUCH CAR(S), TRUCK(S) AND BARGE(S) WHILE SUCH ARE IN BUYER'S POSSESSION. Buyer shall report to Seller promptly any damage that may be sustained by the car(s), truck(s) or barge(s) in Buyer's possession.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LEASED TRACKS Seller may elect to provide rail cars of Product to Buyer on leased tracks\", \"level\": 1, \"text\": \"12. LEASED TRACKS Seller may elect to provide rail cars of Product to Buyer on leased tracks. If Seller does so, Buyer shall contact Seller to receive shipments of Product from the leased tracks and not request such shipment directly from the railroad.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FAILURE IN PERFORMANCE No liability shall result to either party from delay in performance or non-performance in whole\", \"level\": 1, \"text\": \"13. FAILURE IN PERFORMANCE No liability shall result to either party from delay in performance or non-performance in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, criminal enterprise, sabotage, diminishment, or failure of power, telecommunications, data systems or networks, shortage or inability to obtain Product or raw material for Product, or good-faith compliance with any governmental order or request (whether valid or invalid). Notwithstanding any other notice requirement in this Agreement, actual notice (e.g., phone, email, letter) to a counterparty of a delay or failure described in this provision will constitute effective notice for purposes of this provision. Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if for any reason supplies of or distribution logistics for Product, or feedstock for making Product, from any of Seller's existing sources are curtailed or are inadequate to meet Seller's own requirements and/or its obligations to its customers, Seller's obligation to deliver Product during such period shall be reduced to the extent necessary, in Seller's sole judgment, to apportion fairly among Seller's own requirements and its customers (whether under contract or not) such Product as received and as may be available in the ordinary and usual course of Seller's business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller shall not be obligated to purchase or obtain Product, or feedstock to make Product, to replace deliveries omitted or curtailed under this paragraph.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTENTIONALLY OMITTED\", \"level\": 1, \"text\": \"14. INTENTIONALLY OMITTED\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXPORT COMPLIANCE The transaction(s) specified herein, unless otherwise indicated, constitute domestic sales within the\", \"level\": 1, \"text\": \"15. EXPORT COMPLIANCE The transaction(s) specified herein, unless otherwise indicated, constitute domestic sales within the United States. For domestic U.S. sales, where Buyer chooses to subsequently export the Product, Buyer shall comply with all applicable laws relating to export controls and economic sanctions, including, but not limited to, those maintained by the US Department of the Treasury (Office of Foreign Assets Controls) and the US Department of Commerce (Bureau of Industry and Security). For U.S. domestic sales, if Buyer elects to export Product, Buyer shall constitute the U.S. Principal Party in Interest or Exporter for all purposes under applicable law.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NON-US BUYERS If Buyer is a natural or legal person of any jurisdiction other than the United States and/or a State the\", \"level\": 1, \"text\": \"16. NON-US BUYERS If Buyer is a natural or legal person of any jurisdiction other than the United States and/or a State thereof, any dispute arising with respect to the transaction(s) specified herein shall be referred to three (3) arbitrators in accordance with the Rules of Arbitration of the International Chamber of Commerce as in effect on the date of such referral. The arbitration shall take place in Houston, Texas, U.S.A. The proceedings shall be in the English language. The American Arbitration Association shall act as appointing authority in the event required. Monetary awards shall be expressed in U.S. Dollars and all awards shall be final and binding on the parties. Judgment upon any award may be entered in any court having jurisdiction.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT; CANCELLATION No modification of this Agreement shall be of any force or effect unless such modification is i\", \"level\": 1, \"text\": \"17. AMENDMENT; CANCELLATION No modification of this Agreement shall be of any force or effect unless such modification is in writing, expressly designated as an amendment hereto and signed by the parties' duly authorized representatives; and no modification shall be effected by the acknowledgment or acceptance of purchase order forms containing terms or conditions at variance with those set forth herein. Except as explicitly set forth in this Agreement, this Agreement and the transaction(s) specified herein can be cancelled only with both parties' written consent.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW AND DISPUTE RESOLUTION The parties' rights and obligations hereunder shall be construed and enforced unde\", \"level\": 1, \"text\": \"18. GOVERNING LAW AND DISPUTE RESOLUTION The parties' rights and obligations hereunder shall be construed and enforced under the laws of the State of Texas, U.S.A., without regard to conflict of laws principles. Incoterms 2010 (or any subsequent revision thereof) (\\\"Incoterms\\\") shall also apply; provided, however, that Incoterms shall apply only to the extent specified in the agreement hereof, and provided, further, that in the event of a conflict between Incoterms and the laws of the State of Texas, U.S.A., the latter shall govern. The parties specifically exclude Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 application of the U.N. Convention on Contracts for the International Sale of Goods. For any dispute regarding this Agreement, the Parties agree to exclusive jurisdiction and venue in the district courts of Harris County, Texas, or the United States District Court for the Southern District of Texas (Houston Division).\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS No waiver by either party of a right, default or breach of any of the terms and conditions herein shall b\", \"level\": 1, \"text\": \"19. MISCELLANEOUS No waiver by either party of a right, default or breach of any of the terms and conditions herein shall be effective unless in writing. No such waiver shall be deemed a waiver of any subsequent right, default or breach (whether similar or dissimilar) except as expressly stated therein.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT This Agreement shall not be assigned in whole or in part by Buyer or Seller without the written consent of t\", \"level\": 1, \"text\": \"20. ASSIGNMENT This Agreement shall not be assigned in whole or in part by Buyer or Seller without the written consent of the other party and any attempted assignment without such consent shall be void and of no effect, except that Seller may assign all of its rights and obligations hereunder to any entity of which Exxon Mobil Corporation owns, directly or indirectly, at least fifty percent (50%) of the shares or other indicia of equity having the right to elect such entity's board of directors or other governing body. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT B West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Master Supply Agreement List of ExxonMobil Affiliates / Divisions At its sole discretion and with prior written notice to Buyer, Seller may designate a different selling entity from the ones listed in this Attachment. For Product purchases made by Buyer Affiliates in: U.S.A., Brazil, Mexico ExxonMobil Chemical Company, a division of Exxon Mobil Corporation (\\\"EMCC\\\") and/or ExxonMobil Chemical Services Americas, Inc. 22777 Springwoods Village Pkwy Spring, TX 77389 For Product purchases made by Buyer Affiliates i n: Denmark, France, Germany, United Kingdom, Serbia and Ireland ExxonMobil Petroleum & Chemical BVBA (EMPC) Polderdijkweg B - 2030 Antwerpen, Belgium For Product purchases made by Buyer Affiliates i n: Singapore, China, India ExxonMobil Affiliate: ExxonMobil Chemical Asia Pacific, a division of ExxonMobil Asia Pacific Pte Ltd (EMCAP) 1 Harbour Front Place #06-00HarbourFront Tower One Singapore 098633 Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT C West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Master Supply Agreement List of West Pharmaceutical Affiliates Buyer may update this list from time to time with written notice to Seller. Brazil West Pharmaceutical Services Brasil Ltda AV Nossa Senhora Das Gracas, 115 Diadema, Sao Paulo, Brazil 09980-000 China West Pharmaceutical Packaging (China) Co., Ltd No. 111 Tianchen Road Qingpu, Shanghai 201707 China Denmark West Pharmaceutical Services Denmark A/S Fuglevangsvej 51 Horsens, Denmark France West Pharmaceutical Services France,S.A. 38, Rue Robert Degon Le Nouvion EN Thierache 02170 Germany West Pharmaceutical Services Deutschland GmbH & Co. KG Stalberger Str. 21-41 Eschweiler 52249 Ireland West Pharmaceutical Products Ireland, Ltd. Carrickpherish Road Waterford, X91 R9V6 India West Pharmaceutical Packaging India Pvt. Ltd. 900 Peepul Boulevard-Sector 36-Sri City-Satyavedu (P.O) Chittoor District - A.P. - India - 517 546 Mexico West Pharmaceutical Services Mexico, S.A. de C.V. Calle 40 Sur No. 706, Esq. 36 Este Civac, Jiutepec Morelos - M\u00e9xicoC. P. 62500 Serbia West Pharmaceutical Services Beograd d.o.o. Kovin Crvenka 76 Kovin 26220, Serbia Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Singapore West Pharmaceutical Services Singapore Pte. Ltd. 15 Joo Koon Circle Jurong, Singapore 629046 U.S.A West Pharmaceutical Services, Inc. 530 Herman O. West Drive Exton, PA 19341-1147 West Pharmaceutical Services, Inc. 1028 Innovation Way Kinston, NC 28504-7616 West Pharmaceutical Services, Inc. 923 West Railroad Street Kearney, NE 68845-5128 West Pharmaceutical Services of Florida, Inc. 5111 Park Street North St. Petersburg, FL 33709-1109 West Pharmaceutical Services, Inc. 347 Oliver Street Jersey Shore, PA 17740-1923 Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}}, {\"id\": \"ATTACHMENT D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement\", \"level\": 1, \"text\": \"ATTACHMENT D West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement Notices For all notices, communications, or questions regarding this Contract, the following addresses listed below shall be used; provided, however, that Seller and Buyer can each change any of its address information by providing written notice to the other party. ExxonMobil Chemical Company West Pharmaceutical Services, Inc. 22777 Springwoods Village Pkwy 530 W. Herman O. Drive Spring, TX 77389 Exton, PA 19341-1147 Attn: Gerd Merhof Attn: Oliver Steven ExxonMobil Chemical Central Europe West Pharmaceutical Services Deutschland GmbH & Co. KG Im Mediapark 2 Kiefernweg 5 50670 K\u00f6ln 52249 Eschweiler Germany Germany Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT E West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement Payment Terms Buyer Affiliates shall pay ExxonMobil Selling Affiliates' invoice(s) in full within the days set forth below: Location Payment Terms Delivery Terms - lncoterms 2010 Brazil [*****] [*****] China [*****] [*****] Denmark [*****] [*****] France [*****] [*****] Germany [*****] [*****] India [*****] [*****] Mexico [*****] [*****] Serbia [*****] [*****] Singapore [*****] [*****] U.S.A. [*****] [*****] Ireland [*****] [*****] * For Product sold and/or sourced from the US that is shipped overseas to a non-US location, title and risk of loss of Product shall transfer from ExxonMobil Chemical Company or any other ExxonMobil Seller to Buyer at the first point upon which the delivering marine vessel crosses the outer boundary of the United States Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea. For U.S. sales to Brazil or Mexico, Seller shall constitute the U.S. Principal Party in interest or Exporter for all purposes under applicable law. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT F West Pharmaceutical Services and ExxonMobil Chemical Company 2019-2023 Global Supply Master Agreement Returnable Metal Crates\"}}, {\"id\": \"Attachment F\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"documents Buyer's/Buyer Affiliates' responsibility for returnable metal crates (\\\"Metal Crates\\\") used in the supply of Butyl products from Seller/ExxonMobil Selling Affiliates (\\\"ExxonMobil\\\"). Buyer/Buyer Affiliates wishes to receive Butyl in Metal Crates and ExxonMobil is willing to supply Butyl in Metal Crates, subject to the following agreement.\", \"level\": 1, \"text\": \"Attachment F documents Buyer's/Buyer Affiliates' responsibility for returnable metal crates (\\\"Metal Crates\\\") used in the supply of Butyl products from Seller/ExxonMobil Selling Affiliates (\\\"ExxonMobil\\\"). Buyer/Buyer Affiliates wishes to receive Butyl in Metal Crates and ExxonMobil is willing to supply Butyl in Metal Crates, subject to the following agreement. Agreement Buyer/Buyer Affiliates is responsible for the Metal Crates in their custody at the replacement value of the Metal Crates. Buyer's /Buyer Affiliates' custody begins when Metal Crates are loaded onto the delivering carrier at the ExxonMobil or third party warehouse and ends when Metal Crates are loaded onto the carrier for return to Global Pallet Services Limited (GPS) USA, Inc. Buyer/Buyer Affiliates must implement a system to ensure Metal Crates are not lost or damaged, and are returned in undamaged condition (normal wear and tear excepted). Buyer/Buyer Affiliates will supply to ExxonMobil upon request copies of any Bills of Lading needed to verify return shipments of Metal Crates. For each Metal Crate not received back at Global Pallet Services Limited (GPS) and where a physical inventory determines that such Metal Crate is not in the custody of Buyer/Buyer Affiliates, Buyer/Affiliates will have 30 days from end of the calendar year to reimburse ExxonMobil as stated below. For the purposes of this agreement, a Metal Crate is considered to be in undamaged condition if the base and all four sides are in working condition. Buyer/Buyer Affiliates agrees to pay for all repairs for damage to any Metal Crate, or to pay the replacement charge of $[*****] per Metal Crate for any Metal Crate that is either permanently lost or damaged beyond repair while in the custody of Buyer/Buyer Affiliates, and a replacement charge ($[*****] per door) for any removable door missing from Metal Crates collected at Buyer's /Buyer Affiliates' location. A Metal Crate shall be deemed to have been damaged beyond repair if the documented repair costs to restore the damaged Metal Crate to fit-for-fill condition would exceed $[*****]. In addition, if any of the charges imposed by Global Pallet Services Limited (GPS) under the agreement between the ExxonMobil and Global Pallet Service Limited (GPS) for damage to or loss of Metal Crates, are revised, the aforesaid amount reimbursable by Buyer/Buyer Affiliates shall automatically be revised in similar manner. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 ATTACHMENT G The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates 2019-2023 Global Master Supply Agreement EMCAP STANDARD TERMS AND CONDITIONS OF SALE AND ACCEPTANCE OF ORDER ACCEPTANCE The acceptance of Buyer's order by Seller is expressly made conditional upon Buyer's assent to these Standard Terms and Conditions of Sale. Terms as specified in Seller's Order Confirmation (if any) and these Standard Terms and Conditions shall constitute the only binding contract terms and conditions between the parties (the \\\"Agreement\\\") in the absence of a written agreement as described in the Clause on Written Agreement. WRITTEN AGREEMENT If there is an executed written sales contract or agreement in effect between Buyer and Seller covering Buyer's order, the terms and conditions of that contract or agreement shall prevail over any conflicting term in Seller's Order Confirmation and/or these Standard Terms and Conditions and/or Buyer's purchase order. PRICE ADJUSTMENT [*****] Buyer's failure to deliver to Seller written objection to any such change at least ten (10) days before its effective date shall constitute acceptance. If Buyer does deliver such objections within the deadline, no delivery shall be made until parties agree on the new price, freight and/or payment terms. [*****] QUANTITY Quantity of all shipments shall be determined by Seller and shall have a shipping allowance of plus or minus five percent (+/-5%) of the quantity indicated in Seller's Order Confirmation or separate sales contract, or such other percentage as determined by Seller. To allow for standard tolerances of scales, Seller will not consider any claims for shortages of less than one half of one percent (0.5%) of the gross weight of any shipment of packaged product or less than one half of one percent (0.5%) of the net weight of bulk shipment. Seller shall have the right at all times to appoint an independent surveyor. TAXES All prices are exclusive of taxes, duties, or other governmental charges levied on or in respect of the product or delivery thereof. Buyer shall pay or reimburse Seller for such taxes, duties or charges. RISK AND TITLE TRANSFER Risk of loss of and damage to product shall pass to Buyer in accordance with the Incoterm specified in Seller's Order Confirmation or separate sales contract. Without negating Seller's warranty obligations hereunder, Buyer assumes all risk and liability for loss, damage, or injury to the person or property of Buyer or other parties arising out of the use or possession of any Product sold hereunder. Unless stated otherwise in Seller's Order Confirmation or separate sales contract, title in product shall pass to Buyer simultaneously with risk of loss of and damage to product. However, if the product is shipped by Seller from the US, such title and risk shall pass to Buyer at the first point at which the delivering vessel crosses the outer boundary of the US Exclusive Economic Zone (EEZ). The EEZ extends 200 nautical miles beyond the coastal baseline defined in the United Nations Convention on the Law of the Sea or as such term is used in the said Convention. WARRANTIES There are no warranties which extend beyond the description on the face hereof, and Seller makes no warranty, expressed or implied, of satisfactory quality, merchantability, fitness for any particular use or otherwise, except that the products sold hereunder shall meet Seller's applicable standard specifications or such other specifications as may be notified by Seller to Buyer from time to time. Buyer assumes all risk whatsoever as a result of the use of the products purchased, whether used singly or in combination with other substances or in any process. Without limiting the foregoing, Seller does not recommend nor endorse the use of product in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise with respect to product's use in any medical application. Buyer represents and warrants that no product purchased hereunder will be Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 used or resold for use in any commercial or developmental manner in connection with medical applications without Seller's prior express written acknowledgment. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that Seller recommends or endorses the use of product purchased hereunder in any medical application. LIMITATION OF CLAIMS Seller's total liability for all claims arising hereunder or connected with the products sold hereunder, whether based in contract, tort or otherwise, shall be no greater than an amount equal to the purchase price of the products to which any such claims relate, or at the Seller's option, and only in the case of claims regarding defective or non-conforming product, to replacement of such products, provided that in all cases Buyer shall be under an obligation to mitigate any loss as far as possible. Seller shall not in any event be liable for any special, incidental, exemplary or consequential damages. Subject to the Clauses on Quantity, Transfer of Risk and Title Transfer, Buyer shall inspect and test product delivered hereunder for damage, defect or shortage immediately upon receipt and provide Seller notice of any such damage, defect or shortage within ten (10) days of receipt. Any claim must be accompanied by documents as required by Seller, including but not limited to a certified weigh scale ticket or an independent surveyor report, and Seller shall have an opportunity to an independent assessment. All claims for any cause whatsoever, whether based in contract, negligence or other tort, strict liability, breach of warranty or otherwise, shall be deemed waived unconditionally and absolutely unless Seller receives complete written details of such claim not later than [*****] after Buyer's receipt of product as to which such claim is made. Receipt will be deemed to have taken place for purposes of this subparagraph when the product has been loaded onto Buyer's transport, or offloaded from the vessel or other means of transport on which delivery has been made when delivery is arranged by Seller. LAYTIME AND DEMURRAGE Buyer shall unload tank containers, cars, trucks and barges furnished by Seller and clear products from port, or at delivery destination, within the free time specified by tariffs or time periods on file with applicable bodies, or promptly after receipt if no such tariffs or time periods are on file. Buyer shall pay charges resulting from its failure to do to Seller or directly to the common carrier upon receipt of invoice. For bulk marine shipment, demurrage charge at load port is for account of Seller and at discharge port for Buyer's account. For sales other than FOB sales, laytime allowed, demurrage rate and applicable charter party terms shall be as specified in Seller's vessel nomination to Buyer failing which, the terms in Seller's contract of affreightment with the vessel owner shall apply and Buyer shall pay Seller or the carrier the demurrage incurred at the discharge port by Seller's stipulated deadline. Subject to the foregoing, for the first discharge terminal, laytime shall commence six (6) hours after the vessel's notice of readiness is tendered to Buyer (or its agent) or upon the vessel being all fast to the discharge terminal, whichever occurs first, and for subsequent discharge terminal(s), laytime shall commence immediately when the vessel's notice of readiness is tendered to Buyer (or its agent). Laytime shall cease upon disconnection of all cargo hoses upon completion of discharge. For FOB sales, vessels nominated by Buyer are subject to Seller's screening, inspection and acceptance process and Seller's agreement to loading-date range duration / loading-date range narrowing profile / loading-date range communication leadtime and other shipping logistics, and any claim for demurrage by Buyer shall be waived unless notice in writing of such claim is received by Seller with full supporting documentation (including the invoice and time sheet issued by the vessel) by Seller's stipulated deadline. FAILURE IN PERFORMANCE Failure by Seller to deliver on a specific date shall not entitle Buyer to repudiate this Agreement. Buyer shall not be relieved of any obligations to accept or pay for products by reason of any delay in delivery or dispatch. Furthermore, no liability shall result to either party for delay in performance or non-performance of an obligation hereunder (except an obligation to make payment) in whole or in part caused by circumstances reasonably beyond the control of the party affected, including but not limited to acts of God, terrorist activity, transportation failure, breakdowns, equipment failure, shortage or inability to obtain product or raw material for product, or good-faith compliance with any governmental order or request (whether valid or invalid) . Regardless, however, of the occurrence or nonoccurrence of any such circumstances, if for any reason supplies of product or feedstock for making product, from any of Seller's existing sources are curtailed or are inadequate to meet Seller's own requirement and/or its obligation to its customers, Seller's obligation to deliver product during such period shall be reduced to the extent necessary, in Seller's sole judgment, to apportion fairly among Seller's own requirements and its customers (whether under contract or not) such products as received and as may be available in the ordinary and usual course of Seller's business from any existing sources of supply at the location(s) from which deliveries like those covered hereby are normally shipped. Seller shall not be obligated to purchase or obtain product, or feedstock to make product, to replace deliveries omitted or curtailed under this Paragraph. MODIFICATION AND AMENDMENTS There are no oral understandings, representations or warranties between the parties that conflict with these Standard Terms and Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 Conditions or the details of price, payment, shipment or delivery schedule as communicated by Seller. No modification of any Standard Terms and Conditions shall be of any force or effect unless such modification is in writing and signed by the party to be bound thereby, and no modification of the same shall be effected by the acknowledgement of Buyer's purchase orders or equivalent forms containing terms and conditions at variance with those set forth herein and all such terms or conditions in Buyer's purchase orders or equivalent forms shall be considered null and void. GOVERNING LAW This Agreement shall be governed by Singapore law, without regard to its conflict of laws principles. Parties agree to exclude the application of the United Nations Convention on Contracts for the International Sale of Goods. A party that is not a party to this Agreement shall have no rights under the Contracts (Rights of Third Parties) Act (Cap 53B) to enforce any of the terms in this Agreement. ASSIGNMENT This Agreement shall not be assigned, in whole or in part, by either party without the prior consent of the other party, but shall be binding upon and shall inure to the benefit of the legal successors of the respective parties hereto; except that Seller may assign this Agreement, in whole or in part, to any affiliate. For purposes of this Clause, an \\\"affiliate\\\" of Seller means the ultimate holding company of Seller or any corporation of which fifty percent (50%) or more of the outstanding stock is held directly or indirectly by such ultimate holding company. DEFINITION To the extent not inconsistent with the terms hereof, Incoterms 2010 (\\\"Incoterms\\\") shall apply hereto. NO WAIVER No waiver by either party of any breach of these Standard Terms and Conditions shall be construed as a waiver of any succeeding breach of the same. CREDIT CLAUSE If Buyer fails to make payment when due or if Seller reasonably believes the financial status of Buyer is impaired due to any reason, Seller shall have the right, without prejudice to its other rights in contract or at law, upon notice to Buyer, to withhold further deliveries of product, modify or change any terms of payment or credit, suspend performance under this Agreement, accelerate payment obligations such that all amounts owed under prior deliveries and not paid shall become immediately due and payable, require Buyer to furnish security as deemed appropriate by Seller and/or exercise rights against any collateral and apply the proceeds against amounts due and owing. Seller shall in any event have the right to set- off any claim that Seller (or its affiliate) may have against Buyer (or its affiliate), against any sum which Seller may owe to Buyer (or its affiliate). In the event Seller requires a documentary letter of credit or a standby letter of credit, such letter of credit shall be issued by an international bank in form and substance acceptable to Seller. A clean letter of credit is to be received by Seller prior to the estimated shipment date or by such date as Seller shall agree. Seller shall have no obligation to deliver product if the letter of credit is not so received by Seller. Without prejudice to Seller's other rights in law and contract, it is agreed that Buyer shall indemnify and hold harmless the Seller from and against any dead-freight, vessel and/or port charges and payments, demurrage and/or any damages, losses or expenses incurred as a result of any delay in loading or non-delivery of any product under this Agreement arising from Buyer's failure or delay in providing the letter of credit in accordance with the terms of this Agreement. BUSINESS PRACTICES (a) Business Standards. Each party to this Agreement shall establish precautions to prevent its employees or subcontractors from making, receiving, providing or offering any substantial gifts, extravagant entertainment, payments, loans, or other considerations to the employees of the other party and/or their families and/or third parties in connection with this Agreement. (b) Compliance With Law. Each party agrees and will secure agreement by its subcontractors to comply with all applicable laws, regulations, decrees and judicial orders. Notwithstanding anything in this Agreement to the contrary, no provision shall be interpreted or applied so as to require any party to do, or refrain from doing, anything which would constitute a violation of, or result in a loss of economic benefit under, United States anti-boycott and other export laws and regulations. Each party represents to the other party that it shall not make any improper payments of money or anything of value to a government official (whether appointed, elected, honorary, or a career government employee) in connection with this Agreement, nor shall it make improper payments to a third party knowing or suspecting that the third party will give the payment, or a portion of it, to a government official. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020 (c) Notice of Non-Compliance. Each party (\\\"the Relevant Party\\\") agrees to notify the other party promptly upon discovery of any instance where the Relevant Party fails to comply with this Clause. If either party discovers or is advised of any errors or exceptions related to its invoicing under this Agreement, both parties will together review the nature of the errors or exceptions, and will, if appropriate, promptly take corrective action that is necessary on its part and adjust the relevant invoice or refund overpayments. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}}, {\"id\": \"ATTACHMENT H\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates 2019-2023 Global Master Supply Agreement\", \"level\": 1, \"text\": \"ATTACHMENT H The West Pharmaceutical Services and ExxonMobil Chemical Company/Affiliates 2019-2023 Global Master Supply Agreement EMPC STANDARD TERMS AND CONDITIONS OF SALE (hereafter referred to as \\\"EM\\\")\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Agreement(s) as used herein shall mean any order confirmation issued by EM or any other contractual arrangement between\", \"level\": 1, \"text\": \"1. Agreement(s) as used herein shall mean any order confirmation issued by EM or any other contractual arrangement between EM and Buyer. These general terms and conditions shall apply to and form part of all Agreements. The Agreement constitutes the complete and entire understanding and agreement between EM and Buyer. No other general terms and conditions will have an effect on the Agreement. Deviations from the Agreement, including these general terms and conditions, shall be valid only if expressly agreed in writing by the parties.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Title to the product shall transfer from EM to Buyer simultaneously with the transfer of risks as per Incoterms\", \"level\": 1, \"text\": \"2. Title to the product shall transfer from EM to Buyer simultaneously with the transfer of risks as per Incoterms. All references to Incoterms shall mean ICC Incoterms 2010.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM will use reasonable efforts to meet the planned delivery date which shall be deemed to be only approximate\", \"level\": 1, \"text\": \"3. EM will use reasonable efforts to meet the planned delivery date which shall be deemed to be only approximate.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Buyer is responsible for the transport of products, Buyer shall ensure that the means of transport is clean and dry,\", \"level\": 1, \"text\": \"4. If Buyer is responsible for the transport of products, Buyer shall ensure that the means of transport is clean and dry, suitable for loading and carrying the products, and complies with the safety standards of EM and with the legal standards for such means of transport. In case of non- or incomplete compliance with the above requirements, EM will be entitled not to load or cause to load this means of transportation, without any obligation to compensation.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If delivery takes place on reusable pallets (regardless of whether they are property of EM), Buyer will maintain these\", \"level\": 1, \"text\": \"5. If delivery takes place on reusable pallets (regardless of whether they are property of EM), Buyer will maintain these pallets in good condition and make them available on request for collection by or on behalf of EM.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM's determination of quantity and quality shall be binding for both parties\", \"level\": 1, \"text\": \"6. EM's determination of quantity and quality shall be binding for both parties. Without prejudice to the foregoing, Buyer has the right to have a representative present at said determination, at his own cost.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Products shall be supplied by EM at the price valid on the planned delivery date\", \"level\": 1, \"text\": \"7. Products shall be supplied by EM at the price valid on the planned delivery date.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices are exclusive of taxes (such as VAT), duties or other governmental charges\", \"level\": 1, \"text\": \"8. Prices are exclusive of taxes (such as VAT), duties or other governmental charges. In addition to the price of the product, EM shall have the right to charge any taxes, duties or other governmental charges that now or in the future may be levied, in connection with the manufacture, sale, transportation, storage, handling, delivery, use, possession of or disposal of the product or raw materials used in it. VAT and excise tax exemptions granted on request of Buyer in accordance with legislation or administrative regulations imposed by any lawful authority, shall be the exclusive responsibility of Buyer who shall indemnify EM in respect of any VAT or excise Tax liabilities arising therefrom.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM will invoice Buyer and Buyer will pay the invoice in the currency stated on the invoice, without any discount, deduc\", \"level\": 1, \"text\": \"9. EM will invoice Buyer and Buyer will pay the invoice in the currency stated on the invoice, without any discount, deduction or set off, so that EM's designated bank account is credited with the full invoiced amount within 30 days from the invoice date.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Failure by Buyer to pay on the due date shall make all sums owing by Buyer to EM on any account whatsoever immediately\", \"level\": 1, \"text\": \"10. Failure by Buyer to pay on the due date shall make all sums owing by Buyer to EM on any account whatsoever immediately and automatically due and payable, without prejudice to EM's right to charge automatically and without giving any notice the statutory late payment interest rate as defined in applicable legislation on combating late payment in commercial transactions.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM and any of its Affiliates (as herein defined) may at any time without giving notice to or making demand upon Buyer,\", \"level\": 1, \"text\": \"11. EM and any of its Affiliates (as herein defined) may at any time without giving notice to or making demand upon Buyer, set off and apply any and all sums at any time owing by EM and/or by any of its Affiliates to Buyer or any of Buyer's Affiliates, against any and all sums owing by Buyer or any of Buyer's Affiliates to EM and/or to any of its Affiliates. An Affiliate is (1) for EM: Exxon Mobil Corporation or any company in which Exxon Mobil Corporation owns or controls, directly or indirectly, 50 % or more of the voting stock and (2) for the Buyer: any company in which its ultimate holding company owns or controls, directly or indirectly, 50 % or more of the voting stock.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If one party has objective reasons to conclude that the financial status of the other party becomes impaired or unsatis\", \"level\": 1, \"text\": \"12. If one party has objective reasons to conclude that the financial status of the other party becomes impaired or unsatisfactory, or in case of late payment, it may require the other party to provide adequate securities, including cash in advance, for the timely payment of future deliveries, absent which it may suspend its supply obligations. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Health and safety information relating to handling and use of products are in the Safety Data Sheets (SDS) that EM has\", \"level\": 1, \"text\": \"13. Health and safety information relating to handling and use of products are in the Safety Data Sheets (SDS) that EM has sent or will send to Buyer. Buyer shall notify EM if Buyer has not received such information by the delivery date. EM will assume that Buyer has received the necessary information absent notification from Buyer. Buyer shall provide such health and safety information to anyone including without limitation its employees, contractors, agents or customers who may be exposed to the product. Buyer warrants that it possesses the necessary expertise for handling products of the type being supplied hereunder and that it will take the steps necessary to review and understand that information contained on the SDS for each product it purchases. Such data and statements are offered only for Buyer's and its users' and customers' considerations, investigation and verification.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM gives no guarantees or warranties, express or implied, as to the quality, merchantability, fitness for purpose or su\", \"level\": 1, \"text\": \"14. EM gives no guarantees or warranties, express or implied, as to the quality, merchantability, fitness for purpose or suitability of the products except that the product sold pursuant to the terms of this Agreement shall meet the relevant EM standard specification in force at the time of loading or such other specification or requirement which may be explicitly agreed in writing between the parties. Without limiting the foregoing, EM does not recommend nor endorse the use of product(s) in any medical application and specifically disclaims any representation or warranty, express or implied, of suitability or fitness for use, or otherwise with respect to product(s)' use in any medical application. Buyer represents and warrants that no product(s) purchased hereunder will be used in or resold into any commercial or developmental manner in connection with medical applications without EM's prior express written acknowledgement. Further, Buyer agrees that it will make no representations, express or implied, to any person to the effect that EM recommends or endorses the use of product(s) purchased hereunder in any medical application. EM's maximum liability for all claims for any reason is the sales price of the product involved and EM shall not be liable for indirect or consequential damage. Claims by Buyer are waived unless made in writing within 150 days from date of (non-) delivery. Buyer shall indemnity and hold EM harmless in respect of all claims for which Buyer is liable.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM makes no representation or warranty of any kind, express or implied, that the products sold hereunder, or the use of\", \"level\": 1, \"text\": \"15. EM makes no representation or warranty of any kind, express or implied, that the products sold hereunder, or the use of such products, or articles made therefrom, either alone or in conjunction with other materials, will not infringe any patent or trademark rights. Buyer agrees that it will promptly notify EM of any claim or suit involving Buyer in which patent or trademark infringement is alleged with respect to the products sold hereunder, and that Buyer will permit EM, at its option and expense, to control completely the defence or settlement of any such allegation of infringement.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party shall be liable for any delay in performance or non-performance in whole or in part caused by circumstanc\", \"level\": 1, \"text\": \"16. Neither party shall be liable for any delay in performance or non-performance in whole or in part caused by circumstances beyond the reasonable control of the party affected including but not limited to, acts of God, fire, flood, war, terrorist activity, or the threat of one of these events, criminal acts or sabotage, diminishment or failure of power, telecommunications, data systems or networks, accident, explosion, equipment breakdowns, labour disputes, shortage or inability to obtain energy, utilities, equipment, transportation, the Product, or the feedstock from which the Product is directly or indirectly derived; or good faith compliance with any regulation, direction r request (whether ultimately determined to be valid or invalid) made by governmental authority or any person or persons purporting to act for such an authority. Regardless of the occurrence or non-occurrence of any of the circumstances set forth above, if for any reason, supplies of or distribution logistics of the Product deliverable under this Agreement or of the feedstock from which the Product is directly or indirectly derived from any of EM's then existing sources of supply are curtailed or cut off, or otherwise inadequate to meet EM's own requirements and its obligations to its customers, EM shall have the option during such period of curtailment, or cessation to apportion fairly among its customers including EM's Affiliates and whether under contract or not, such Product as may be received in the ordinary course of business or manufactured at EM then existing sources. EM shall not be obliged to purchase or otherwise obtain alternative supplies of product deliverable under this Agreement, or the feedstock from which product directly or indirectly is derived. Nor shall EM be obliged to settle labour disputes, run down inventories below normal levels, adapt or vary its manufacturing plan except at its own sole discretion, or to take any steps other than in accordance with good business practice to make up inadequate supplies or to replace the supplies so curtailed or cut off. EM shall not be obliged to make up deliveries omitted or curtailed under this Agreement. Any such deficiencies in deliveries shall be cancelled with no liability to either party, it being agreed, however, that a force majeure situation hereunder shall not entitle either party to cancel this Agreement.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In case of any material breach of the terms and conditions contained in the Agreement by one of the parties, the other\", \"level\": 1, \"text\": \"17. In case of any material breach of the terms and conditions contained in the Agreement by one of the parties, the other party may, without giving prior written notice in the event the material breach is not cured within such notice period or without undertaking any recourse to legal proceedings, suspend its further performance, terminate the Agreement or require specific performance by the other party of the Agreement in whole or in part, without prejudice to its right to damages for any losses incurred subject to Article 14.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party may assign this Agreement without the written consent of the other party save in the case where such assi\", \"level\": 1, \"text\": \"18. Neither party may assign this Agreement without the written consent of the other party save in the case where such assignment is to an EM Affiliate and prior written notice has been given to the Buyer. Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EM informs Buyer that any information relating to an identified or identifiable natural person (\\\"individual\\\"), in parti\", \"level\": 1, \"text\": \"19. EM informs Buyer that any information relating to an identified or identifiable natural person (\\\"individual\\\"), in particular business contact details of Buyer's personnel and contractors, which is communicated by or on behalf of Buyer to EM (\\\"personal data\\\"), will be subject to data processing by EM. To learn more about the processing of personal data and about individual's rights in relation to the processing, read the EM data privacy notice at http://www.exxonmobil.be/enbe/company/locations/belgium/legal-information-belgium-only Buyer shall inform its personnel and contractors and other relevant individuals of the EM data privacy notice.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding any other provision in this Agreement or any other document, neither this Agreement nor any other docum\", \"level\": 1, \"text\": \"20. Notwithstanding any other provision in this Agreement or any other document, neither this Agreement nor any other document shall constitute an agreement by EM to take any action or refrain from taking any action that is in conflict with, penalized under or compliance with which is prohibited by the laws or regulations of the United States, the European Union (EU), any EU member State, the United Kingdom and/or Norway, as applicable. The parties furthermore represent, warrant and undertake to each other on a continuous basis that they shall comply with all applicable anti-bribery and anti-money laundering laws, rules and regulations of any government relevant to the transaction, including the US Foreign Corrupt Practices Act and the applicable country legislation implementing OECD Convention on Combating Bribery of Foreign Public Officials in international business transactions as such laws and regulations may be updated or amended from time to time.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To the extent permitted by law, in the event that a party becomes aware that it will or may undergo a Change of Control\", \"level\": 1, \"text\": \"21. To the extent permitted by law, in the event that a party becomes aware that it will or may undergo a Change of Control (\\\"Affected Party\\\") within the following three (3) Months, the Affected Party will notify the other party without delay after it becomes so aware. Together with such notification, the Affected Party will supply the other party with sufficient information to allow that other party to reasonably assess the impact that such Change of Control may have on it and/or its Affiliates, on the Affected Party's creditworthiness, and on the Affected Party's ability to perform its obligations under this Agreement. In the event that the other party concludes in its sole discretion that such Change of Control, if it is implemented: (a) may result in it and/or its Affiliates being subjected to any fact, matter, event, circumstance, condition or change which materially and adversely affects, or could reasonably be expected to materially and adversely affect, individually or in aggregate, the business, operations, assets, liabilities, condition (whether financial, trading or otherwise), prospects or operating results of it and/or its Affiliates; (b) that the Affected Party's creditworthiness may be reduced; and/or (c) that the Affected Party's ability to perform its obligations under the Agreement may be negatively affected; then the other party may (but is not obliged to) terminate this Agreement forthwith upon notice to the Affected Party. Such termination is without prejudice to the rights and obligations of the parties that have accrued up to and including the date of termination. As used above, \\\"Change of Control\\\" means any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least fifty percent (50%) of the equity interest in a party (or of at least fifty percent (50%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in a party (\\\"Party's Parent\\\")) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in a Party's (or Party's Parent's) merging with one or more other entities.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement between EM and Buyer shall be governed by the laws of Belgium (excluding its rules on conflict of laws)\", \"level\": 1, \"text\": \"22. This Agreement between EM and Buyer shall be governed by the laws of Belgium (excluding its rules on conflict of laws). Neither the Uniform Law on the International Sale of Goods ('ULIS'), nor the United Nations Convention on Contracts for the International Sale of Goods 1980 ('CISG') shall apply. (i) If Buyer's registered office is located within the territory of the European Economic Area ('EEA'), any disputes between EM and Buyer arising out of or in relation to this Agreement shall be of the exclusive jurisdiction of the Courts of Antwerp. (ii) If Buyer's registered office is located outside the territory of the EEA, any disputes arising out of or in relation to this Agreement shall be finally settled under the CEPANI Rules of Arbitration by three (3) arbitrators appointed in accordance with said Rules. The seat of the arbitration shall be Brussels. The arbitration shall be conducted in the English language. ________________________________ * Further information on ExxonMobil Petroleum & Chemical BVBA is available on: http://www.exxonmobil.be/en-be/company/locations/belgium/legal-information-belgium-only Source: WEST PHARMACEUTICAL SERVICES INC, 8-K, 1/16/2020\"}}, {\"id\": \"party:ExxonMobil Chemical Company\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ExxonMobil Chemical Company, a division of Exxon Mobil Corporation\", \"role\": \"Seller\", \"address\": \"22777 Springwoods Village Pkwy Spring, TX 77389\"}}, {\"id\": \"party:Exxon Mobil Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Exxon Mobil Corporation\", \"role\": null, \"address\": null}}, {\"id\": \"party:West Pharmaceutical Services, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services, Inc.\", \"role\": \"Buyer\", \"address\": \"530 Herman O. West Drive Exton, PA 19341-1147\"}}, {\"id\": \"party:ExxonMobil Chemical Services Americas, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ExxonMobil Chemical Services Americas, Inc.\", \"role\": \"Seller Affiliate\", \"address\": \"22777 Springwoods Village Pkwy Spring, TX 77389\"}}, {\"id\": \"party:ExxonMobil Petroleum & Chemical BVBA\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ExxonMobil Petroleum & Chemical BVBA (EMPC)\", \"role\": \"Seller Affiliate\", \"address\": \"Polderdijkweg B - 2030 Antwerpen, Belgium\"}}, {\"id\": \"party:ExxonMobil Chemical Asia Pacific\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ExxonMobil Chemical Asia Pacific, a division of ExxonMobil Asia Pacific Pte Ltd (EMCAP)\", \"role\": \"Seller Affiliate\", \"address\": \"1 Harbour Front Place #06-00HarbourFront Tower One Singapore 098633\"}}, {\"id\": \"party:West Pharmaceutical Services Brasil Ltda\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services Brasil Ltda\", \"role\": \"Buyer Affiliate\", \"address\": \"AV Nossa Senhora Das Gracas, 115 Diadema, Sao Paulo, Brazil 09980-000\"}}, {\"id\": \"party:West Pharmaceutical Packaging (China) Co., Ltd\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Packaging (China) Co., Ltd\", \"role\": \"Buyer Affiliate\", \"address\": \"No. 111 Tianchen Road Qingpu, Shanghai 201707 China\"}}, {\"id\": \"party:West Pharmaceutical Services Denmark A/S\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services Denmark A/S\", \"role\": \"Buyer Affiliate\", \"address\": \"Fuglevangsvej 51 Horsens, Denmark\"}}, {\"id\": \"party:West Pharmaceutical Services France,S.A.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services France,S.A.\", \"role\": \"Buyer Affiliate\", \"address\": \"38, Rue Robert Degon Le Nouvion EN Thierache 02170\"}}, {\"id\": \"party:West Pharmaceutical Services Deutschland GmbH & Co. KG\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services Deutschland GmbH & Co. KG\", \"role\": \"Buyer Affiliate\", \"address\": \"Stalberger Str. 21-41 Eschweiler 52249\"}}, {\"id\": \"party:West Pharmaceutical Products Ireland, Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Products Ireland, Ltd.\", \"role\": \"Buyer Affiliate\", \"address\": \"Carrickpherish Road Waterford, X91 R9V6\"}}, {\"id\": \"party:West Pharmaceutical Packaging India Pvt. Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Packaging India Pvt. Ltd.\", \"role\": \"Buyer Affiliate\", \"address\": \"900 Peepul Boulevard-Sector 36-Sri City-Satyavedu (P.O) Chittoor District - A.P. - India - 517 546\"}}, {\"id\": \"party:West Pharmaceutical Services Mexico, S.A. de C.V.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services Mexico, S.A. de C.V.\", \"role\": \"Buyer Affiliate\", \"address\": \"Calle 40 Sur No. 706, Esq. 36 Este Civac, Jiutepec Morelos - M\u00e9xicoC. P. 62500\"}}, {\"id\": \"party:West Pharmaceutical Services Beograd d.o.o. Kovin\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services Beograd d.o.o. Kovin\", \"role\": \"Buyer Affiliate\", \"address\": \"Crvenka 76 Kovin 26220, Serbia\"}}, {\"id\": \"party:West Pharmaceutical Services Singapore Pte. Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services Singapore Pte. Ltd.\", \"role\": \"Buyer Affiliate\", \"address\": \"15 Joo Koon Circle Jurong, Singapore 629046\"}}, {\"id\": \"party:West Pharmaceutical Services of Florida, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"West Pharmaceutical Services of Florida, Inc.\", \"role\": \"Buyer Affiliate\", \"address\": \"5111 Park Street North St. Petersburg, FL 33709-1109\"}}, {\"id\": \"party:Global Pallet Services Limited (GPS) USA, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Global Pallet Services Limited (GPS) USA, Inc.\", \"role\": null, \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Global Master Supply Agreement\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Contract\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract\", \"text\": \"This Global Master Supply Agreement\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:ExxonMobil Selling Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ExxonMobil Selling Affiliate\", \"text\": \"ExxonMobil affiliates listed on Attachment B\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:EMCC/A\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EMCC/A\", \"text\": \"ExxonMobil affiliates listed on Attachment B\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Buyer Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Buyer Affiliate\", \"text\": \"the Buyer affiliates listed on Attachment C\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:West/A\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"West/A\", \"text\": \"the Buyer affiliates listed on Attachment C\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"the following product(s)\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"a purchase order(s), or call off order(s) when purchasing Product from ExxonMobil Selling Affiliates in writing pursuant to this Contract\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:EXW\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EXW\", \"text\": \"Ex-Works designated Exxon Affiliate location (see Attachment B) - Incoterms 2010\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Change in Circumstances\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change in Circumstances\", \"text\": \"any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least twenty-five percent (25%) of the equity interest in Buyer/Buyer Affiliates (or of at least twenty-five percent (25%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer/Buyer Affiliates (\\\"Buyer's Parent\\\")) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in Buyer's /Buyer Affiliates' (or Buyer's Parent's) merging with one or more other entities; or (iii) any transaction not in the ordinary course of Buyer's/Buyer Affiliates (or Buyer's Parent's) business that calls for the sale, purchase or other transfer of one or more significant assets, including (without limitation) manufacturing facilities and ownership interests in other business entities\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Buyer's Parent\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Buyer's Parent\", \"text\": \"any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in Buyer/Buyer Affiliates\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:individual\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"individual\", \"text\": \"any information relating to an identified or identifiable natural person\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:personal data\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"personal data\", \"text\": \"any information relating to an identified or identifiable natural person (\\\"individual\\\"), in particular business contact details of Buyer's personnel and contractors, which is communicated by or on behalf of Buyer to Seller\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Incoterms\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Incoterms\", \"text\": \"Incoterms 2010 (or any subsequent revision thereof)\", \"definition_clause\": \"18\"}}, {\"id\": \"term:Metal Crates\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Metal Crates\", \"text\": \"returnable metal crates\", \"definition_clause\": \"Attachment F\"}}, {\"id\": \"term:ExxonMobil\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ExxonMobil\", \"text\": \"Seller/ExxonMobil Selling Affiliates\", \"definition_clause\": \"Attachment F\"}}, {\"id\": \"term:Agreement_EMCAP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"Terms as specified in Seller's Order Confirmation (if any) and these Standard Terms and Conditions\", \"definition_clause\": \"Attachment F\"}}, {\"id\": \"term:affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"affiliate\", \"text\": \"the ultimate holding company of Seller or any corporation of which fifty percent (50%) or more of the outstanding stock is held directly or indirectly by such ultimate holding company\", \"definition_clause\": \"Attachment F\"}}, {\"id\": \"term:the Relevant Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"the Relevant Party\", \"text\": \"Each party\", \"definition_clause\": \"Attachment F\"}}, {\"id\": \"term:Agreement(s)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement(s)\", \"text\": \"any order confirmation issued by EM or any other contractual arrangement between EM and Buyer\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"(1) for EM: Exxon Mobil Corporation or any company in which Exxon Mobil Corporation owns or controls, directly or indirectly, 50 % or more of the voting stock and (2) for the Buyer: any company in which its ultimate holding company owns or controls, directly or indirectly, 50 % or more of the voting stock\", \"definition_clause\": \"11\"}}, {\"id\": \"term:Affected Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affected Party\", \"text\": \"a party becomes aware that it will or may undergo a Change of Control\", \"definition_clause\": \"21\"}}, {\"id\": \"term:Change of Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change of Control\", \"text\": \"any of the following: (i) any transaction, or series of transactions, that would result in the transfer of at least fifty percent (50%) of the equity interest in a party (or of at least fifty percent (50%) of the equity interest in any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in a party (\\\"Party's Parent\\\")) to a single transferee or multiple transferees under common control; (ii) any transaction that would result in a Party's (or Party's Parent's) merging with one or more other entities\", \"definition_clause\": \"21\"}}, {\"id\": \"term:Party's Parent\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party's Parent\", \"text\": \"any business entity that owns or controls, directly or indirectly, at least fifty percent (50%) of the equity interest in a party\", \"definition_clause\": \"21\"}}, {\"id\": \"value:$[*****]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$[*****]\"}}, {\"id\": \"value:$5\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5\"}}, {\"id\": \"value:three years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three years\"}}, {\"id\": \"value:six months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six months\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"twenty-five percent (25%)\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ten percent (10%)\"}}, {\"id\": \"value:one hundred fifty (150) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred fifty (150) days\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:seven (7) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) days\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"five percent (+/-5%)\"}}, {\"id\": \"value:0.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one half of one percent (0.5%)\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:50 %\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50 %\"}}, {\"id\": \"value:150 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"150 days\"}}, {\"id\": \"value:three (3) Months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) Months\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of Copy of ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of Copy of ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.2\", \"level\": 1, \"text\": \"Exhibit 10.2 CERTAIN INFORMATION (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. Zogenix Inc. and Nippon Shinyaku Company Ltd. Distributorship Agreement US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Table of Contents i US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 ii US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 iii US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 List of Exhibits US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 DISTRIBUTORSHIP AGREEMENT This DISTRIBUTORSHIP AGREEMENT (\\\"Agreement\\\") is entered into as of March 18, 2019 (the \\\"Effective Date\\\") by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California 94608( \\\"Zogenix\\\") and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan (\\\"Distributor\\\"). Zogenix and Distributor may be referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties\\\". RECITALS WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla\u00ae. WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and distribute such product within the Territory; WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply agreement to be entered into by the Parties. NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor hereby agree as follows:\"}, {\"id\": \"ARTICLE 1\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"ARTICLE 1. DEFINITIONS\"}, {\"id\": \"1.1\", \"title\": \"\\\"Affiliate\\\" of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is c\", \"level\": 2, \"text\": \"1.1 \\\"Affiliate\\\" of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used in this Section 1.1, \\\"control\\\" means (a) to possess, directly or indirectly, the power to direct the management or policies of an entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"1.2\", \"title\": \"\\\"Alliance Manager\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.2 \\\"Alliance Manager\\\" has the meaning set forth in Section 3.3.\"}, {\"id\": \"1.3\", \"title\": \"\\\"Annual Report\\\" has the meaning set forth in Section 6\", \"level\": 2, \"text\": \"1.3 \\\"Annual Report\\\" has the meaning set forth in Section 6.5(c).\"}, {\"id\": \"1.4\", \"title\": \"\\\"Applicable Laws\\\" means the applicable provisions of any and all national, supranational, regional, state and local laws\", \"level\": 2, \"text\": \"1.4 \\\"Applicable Laws\\\" means the applicable provisions of any and all national, supranational, regional, state and local laws, treaties, statutes, rules, regulations, administrative codes, industry codes, guidance, ordinances, judgments, decrees, directives, injunctions, orders or permits (including Regulatory Approvals) of or from any court, arbitrator, Regulatory Authority or governmental agency or authority having jurisdiction over or related to the subject item, including the FCPA, export control, embargo, trade sanction and data privacy laws, regulations, rules and licenses, and other laws and regulations pertaining to domestic or international corruption, commercial bribery, fraud, embezzlement or money laundering.\"}, {\"id\": \"1.5\", \"title\": \"\\\"Business Day\\\" means a day other than a Saturday, Sunday, any public holiday, or any bank holiday in the United States o\", \"level\": 2, \"text\": \"1.5 \\\"Business Day\\\" means a day other than a Saturday, Sunday, any public holiday, or any bank holiday in the United States or Japan.\"}, {\"id\": \"1.6\", \"title\": \"\\\"Change of Control\\\" means any (a) direct or indirect acquisition of assets of a Party (i) equal to fifty percent (50%) o\", \"level\": 2, \"text\": \"1.6 \\\"Change of Control\\\" means any (a) direct or indirect acquisition of assets of a Party (i) equal to fifty percent (50%) or more of the fair market value of a Party's consolidated assets, or (ii) to which fifty percent (50%) or more of a Party's net revenues or net income on a consolidated basis are attributable, or (iii) representing substantially all of the properties or assets related to a Party's obligations under this Agreement, (b) direct or indirect acquisition by a Person, or group of Persons acting in concert, of fifty percent (50%) or more of the voting equity interests of a Party, (c) tender offer or exchange offer that if consummated would result in any Person, or group of Persons acting in concert, beneficially owning fifty percent (50%) or more of the voting equity interests of a Party, (d) merger, consolidation, other business combination or similar transaction involving a Party, pursuant to which any Person would own fifty percent (50%) or more of the consolidated assets, net revenues or net income of a Party, taken as a whole, or which results in the holders of the voting equity interests of a Party immediately prior to such merger, consolidation, business combination or similar transaction ceasing to hold fifty percent (50%) or more of the combined voting power of the surviving, purchasing or continuing entity immediately after such merger, consolidation, business combination or similar transaction, (e) liquidation or dissolution (or the adoption of a plan of liquidation or dissolution) of a Party, or (f) declaration or payment of an extraordinary dividend (whether in cash or other property) by a Party, where the amount of the dividend or the in specie property which is the subject of the dividend would otherwise come within the application of any of clauses (a)-(e) above, in all cases where such transaction is to be entered into with any Person other than the other Party.\"}, {\"id\": \"1.7\", \"title\": \"\\\"CMC\\\" means chemistry, manufacturing and controls\", \"level\": 2, \"text\": \"1.7 \\\"CMC\\\" means chemistry, manufacturing and controls.\"}, {\"id\": \"1.8\", \"title\": \"\\\"Commercialization\\\" means all activities directed to marketing, promoting, advertising, exhibiting, distributing (includ\", \"level\": 2, \"text\": \"1.8 \\\"Commercialization\\\" means all activities directed to marketing, promoting, advertising, exhibiting, distributing (including storage for distribution or inventory), detailing, selling, (and offering for sale or contracting to sell), or otherwise commercially exploiting the Product in the Field in the Territory.\"}, {\"id\": \"1.9\", \"title\": \"\\\"Commercialization Plan\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.9 \\\"Commercialization Plan\\\" has the meaning set forth in Section 5.1(b). 2 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"1.10\", \"title\": \"\\\"Commercially Reasonable Efforts\\\" means, with respect to a Party's specific obligations under this Agreement, that level\", \"level\": 2, \"text\": \"1.10 \\\"Commercially Reasonable Efforts\\\" means, with respect to a Party's specific obligations under this Agreement, that level of efforts and resources, [***]. Commercially Reasonable Efforts requires that the applicable Party: (i) [***], (ii) [***], and (iii) [***].\"}, {\"id\": \"1.11\", \"title\": \"\\\"Confidential Information\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.11 \\\"Confidential Information\\\" has the meaning set forth in Section 8.1.\"}, {\"id\": \"1.12\", \"title\": \"\\\"Confidentiality Agreement\\\" means that certain Mutual Confidential Disclosure Agreement, dated June 21, 2018, between Zo\", \"level\": 2, \"text\": \"1.12 \\\"Confidentiality Agreement\\\" means that certain Mutual Confidential Disclosure Agreement, dated June 21, 2018, between Zogenix and Distributor.\"}, {\"id\": \"1.13\", \"title\": \"\\\"Control\\\" (including any variations such as \\\"Controlled\\\" and \\\"Controlling\\\") means, with respect to any Information, Data\", \"level\": 2, \"text\": \"1.13 \\\"Control\\\" (including any variations such as \\\"Controlled\\\" and \\\"Controlling\\\") means, with respect to any Information, Data, Patent or other intellectual property rights, possession by a Party of the ability (whether by ownership or grant of rights, other than pursuant to this Agreement) to grant to the other Party the applicable access or other right under this Agreement without violating the terms of an agreement with a Third Party.\"}, {\"id\": \"1.14\", \"title\": \"\\\"Data\\\" means any and all scientific, technical or test data pertaining to the Product in the Field that is generated by\", \"level\": 2, \"text\": \"1.14 \\\"Data\\\" means any and all scientific, technical or test data pertaining to the Product in the Field that is generated by or under the authority of Distributor or its Affiliates, Sub-distributors or other subcontractors or by or under the authority of Zogenix or Zogenix ex-Territory Distributors before or during the Term, including research data, clinical pharmacology data, CMC data (including analytical and quality control data and stability data), preclinical data, clinical data and all submissions made in association with an IND or MAA filed in or outside the Territory with respect to the Product in the Field, in each case to the extent such data either (a) is Controlled by Zogenix on the Effective Date or (b) comes within a Party's Control during the Term.\"}, {\"id\": \"1.15\", \"title\": \"\\\"Development\\\" means all activities directed to research, non-clinical and preclinical studies and trials, CMC Data colle\", \"level\": 2, \"text\": \"1.15 \\\"Development\\\" means all activities directed to research, non-clinical and preclinical studies and trials, CMC Data collection, clinical studies and trials, Investigator Initiated Studies, toxicology studies, publication and presentation of study results, preparation and submission to Regulatory Authorities of an MAA concerning the Product, interacting with Regulatory Authorities prior to and following Regulatory Approval of the Product, and Product pricing negotiations and decisions concerning the Product.\"}, {\"id\": \"1.16\", \"title\": \"\\\"Disclosing Party\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.16 \\\"Disclosing Party\\\" has the meaning set forth in Section 8.1.\"}, {\"id\": \"1.17\", \"title\": \"\\\"Distribution Term\\\" means the period commencing on the first Regulatory Approval of the Product in the Territory and con\", \"level\": 2, \"text\": \"1.17 \\\"Distribution Term\\\" means the period commencing on the first Regulatory Approval of the Product in the Territory and continuing until [***], or if this Agreement is terminated earlier pursuant to Article 12, the effective date of such termination.\"}, {\"id\": \"1.18\", \"title\": \"\\\"Distributor Invention\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.18 \\\"Distributor Invention\\\" has the meaning set forth in Section 9.1(b)(i).\"}, {\"id\": \"1.19\", \"title\": \"\\\"Executives\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.19 \\\"Executives\\\" has the meaning set forth in Section 3.1(d).\"}, {\"id\": \"1.20\", \"title\": \"\\\"FCPA\\\" means the U\", \"level\": 2, \"text\": \"1.20 \\\"FCPA\\\" means the U.S. Foreign Corrupt Practices Act (15 U.S.C. \u00a7 78dd-1 et seq.), as amended.\"}, {\"id\": \"1.21\", \"title\": \"\\\"FDA\\\" means the Food and Drug Administration, or any successor agency thereto\", \"level\": 2, \"text\": \"1.21 \\\"FDA\\\" means the Food and Drug Administration, or any successor agency thereto 3 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 having the administrative authority to regulate the marketing of human pharmaceutical products in the United States.\"}, {\"id\": \"1.22\", \"title\": \"\\\"Field\\\" means the Indications of treatment for the Product in the Territory\", \"level\": 2, \"text\": \"1.22 \\\"Field\\\" means the Indications of treatment for the Product in the Territory.\"}, {\"id\": \"1.23\", \"title\": \"\\\"First Commercial Sale\\\" means the first bona fide, arm's-length sale of the Product in the Field in the Territory follow\", \"level\": 2, \"text\": \"1.23 \\\"First Commercial Sale\\\" means the first bona fide, arm's-length sale of the Product in the Field in the Territory following Regulatory Approval of the Product in the Field in the Territory.\"}, {\"id\": \"1.24\", \"title\": \"\\\"Fiscal Quarter\\\" means a period of three (3) consecutive months during a Fiscal Year beginning on and including April 1s\", \"level\": 2, \"text\": \"1.24 \\\"Fiscal Quarter\\\" means a period of three (3) consecutive months during a Fiscal Year beginning on and including April 1st, July 1st or October 1st or January 1st.\"}, {\"id\": \"1.25\", \"title\": \"\\\"Fiscal Year\\\" means a year that starts from April 1st and ends on March 31st\", \"level\": 2, \"text\": \"1.25 \\\"Fiscal Year\\\" means a year that starts from April 1st and ends on March 31st.\"}, {\"id\": \"1.26\", \"title\": \"\\\"Fully-Burdened Manufacturing Cost\\\" means the costs incurred by Zogenix that are directly attributable to and reasonably\", \"level\": 2, \"text\": \"1.26 \\\"Fully-Burdened Manufacturing Cost\\\" means the costs incurred by Zogenix that are directly attributable to and reasonably allocated to the manufacture and delivery of the Product to Distributor. Fully-Burdened Manufacturing Costs shall include the following: [***].\"}, {\"id\": \"1.27\", \"title\": \"\\\"Generic Product\\\" means a pharmaceutical product that (a) [***]; (b) [***]; (c) [***]; and (d) [***]\", \"level\": 2, \"text\": \"1.27 \\\"Generic Product\\\" means a pharmaceutical product that (a) [***]; (b) [***]; (c) [***]; and (d) [***].\"}, {\"id\": \"1.28\", \"title\": \"\\\"IFRS\\\" means international financial reporting standards, as may be amended from time to time\", \"level\": 2, \"text\": \"1.28 \\\"IFRS\\\" means international financial reporting standards, as may be amended from time to time.\"}, {\"id\": \"1.29\", \"title\": \"\\\"IND\\\" means any Investigational New Drug application, as defined in Title 21 of the Code of Federal Regulations, on file\", \"level\": 2, \"text\": \"1.29 \\\"IND\\\" means any Investigational New Drug application, as defined in Title 21 of the Code of Federal Regulations, on file with the FDA before the commencement of clinical trials of the Product in humans, or any comparable filing with any Regulatory Authority.\"}, {\"id\": \"1.30\", \"title\": \"\\\"Indemnitee\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.30 \\\"Indemnitee\\\" has the meaning set forth in Section 11.3.\"}, {\"id\": \"1.31\", \"title\": \"\\\"Indemnitor\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.31 \\\"Indemnitor\\\" has the meaning set forth in Section 11.3.\"}, {\"id\": \"1.32\", \"title\": \"\\\"Indication\\\" means the treatment of Dravet syndrome, Lennox-Gastaut syndrome, [***] during the Distribution Term\", \"level\": 2, \"text\": \"1.32 \\\"Indication\\\" means the treatment of Dravet syndrome, Lennox-Gastaut syndrome, [***] during the Distribution Term.\"}, {\"id\": \"1.33\", \"title\": \"\\\"Indirect Losses\\\" means any damages or other losses involving, but only to the extent of, any loss of profits, diminutio\", \"level\": 2, \"text\": \"1.33 \\\"Indirect Losses\\\" means any damages or other losses involving, but only to the extent of, any loss of profits, diminution in value, or incidental, indirect, consequential, special or punitive damages.\"}, {\"id\": \"1.34\", \"title\": \"\\\"Information\\\" means information, ideas, inventions, discoveries, concepts, formulas, practices, procedures, processes, m\", \"level\": 2, \"text\": \"1.34 \\\"Information\\\" means information, ideas, inventions, discoveries, concepts, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets, technology, inventories, machines, techniques, development, designs, drawings, computer programs, skill, experience, documents, apparatus, results, clinical and regulatory strategies, documentation, information and submissions pertaining to, or made in association with, filings with any Regulatory Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and descriptions, patent and legal data, 4 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 market data, financial data or descriptions, specifications and the like, in written, electronic or other form, now known or hereafter developed, whether or not patentable.\"}, {\"id\": \"1.35\", \"title\": \"\\\"Invention\\\" means any new and useful process, article of manufacture, composition of matter, formulation or apparatus, o\", \"level\": 2, \"text\": \"1.35 \\\"Invention\\\" means any new and useful process, article of manufacture, composition of matter, formulation or apparatus, or any improvement thereof, discovery or finding, whether or not patentable, as determined in accordance with the patent laws of the United States of America.\"}, {\"id\": \"1.36\", \"title\": \"\\\"Japan GAAP\\\" means Japan generally accepted accounting principles, as may be amended from time to time\", \"level\": 2, \"text\": \"1.36 \\\"Japan GAAP\\\" means Japan generally accepted accounting principles, as may be amended from time to time.\"}, {\"id\": \"1.37\", \"title\": \"\\\"Joint Steering Committee\\\" or \\\"JSC\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.37 \\\"Joint Steering Committee\\\" or \\\"JSC\\\" has the meaning set forth in Section 3.1.\"}, {\"id\": \"1.38\", \"title\": \"\\\"Losses\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.38 \\\"Losses\\\" has the meaning set forth in Section 11.1.\"}, {\"id\": \"1.39\", \"title\": \"\\\"MAA\\\" means a marketing authorization application or equivalent application, and all amendments and supplements thereto,\", \"level\": 2, \"text\": \"1.39 \\\"MAA\\\" means a marketing authorization application or equivalent application, and all amendments and supplements thereto, filed with a Regulatory Authority.\"}, {\"id\": \"1.40\", \"title\": \"\\\"MAH\\\" means a marketing authorization holder of the Product in the Field in the Territory\", \"level\": 2, \"text\": \"1.40 \\\"MAH\\\" means a marketing authorization holder of the Product in the Field in the Territory.\"}, {\"id\": \"1.41\", \"title\": \"\\\"MHLW\\\" means the Japanese Ministry of Health, Labor and Welfare\", \"level\": 2, \"text\": \"1.41 \\\"MHLW\\\" means the Japanese Ministry of Health, Labor and Welfare.\"}, {\"id\": \"1.42\", \"title\": \"\\\"Net Price\\\" means, for any Fiscal Year, the unit price of the Product in the Territory in the Field calculated by dividi\", \"level\": 2, \"text\": \"1.42 \\\"Net Price\\\" means, for any Fiscal Year, the unit price of the Product in the Territory in the Field calculated by dividing the aggregate Net Sales for the Product in the Territory in such Fiscal Year by the total number of units of the Product sold by or on behalf of Distributor or its Affiliate or Sub-distributor in the Territory in such Fiscal Year.\"}, {\"id\": \"1.43\", \"title\": \"\\\"Net Sales\\\" means, with respect to any period of time, the gross amounts invoiced for sales or other dispositions of the\", \"level\": 2, \"text\": \"1.43 \\\"Net Sales\\\" means, with respect to any period of time, the gross amounts invoiced for sales or other dispositions of the Product in the Territory by or on behalf of Distributor or its Affiliates or Sub-distributors to Third Parties (other than Sub- distributors) during such period, less the value added taxes levied on or measured by the billing amount for the Product to the extent included in the gross invoiced sales price for the Product or otherwise directly paid or incurred by Distributor or its Affiliates or Sub-distributors, as applicable, with respect to the sale or other disposition of the Product, less the following deductions to the extent actually allowed, paid, incurred or accrued during the applicable period, calculated in accordance with Japan GAAP or IFRS (consistently applied): [***] Net Sales shall be calculated in accordance with Japan GAAP or IFRS, consistently applied in the Territory and shall be consistent with net sales reported in Distributor's audited financial statements. If net sales reported in Distributor's audited financial statements include discounts for products sold in combination or bundled with other products, these discounts will not be included in the calculation of Net Sales of the Product. 5 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Sales of a Product for use in conducting clinical trials of the Product in the Territory in order to obtain Regulatory Approval of the Product in the Territory shall be excluded from Net Sales calculations for all purposes. Upon any sale or other disposition of the Product for any consideration other than exclusively monetary consideration on bona fide arm's-length terms, for purposes of calculating Net Sales under this Agreement, the Product shall be deemed to be sold exclusively for money at the average sales price during the applicable reporting period generally achieved for the Product in the Field in the Territory when the Product is sold alone and not with other products. Distributor and its Affiliates and Sub-distributors shall not sell the Product in combination with or as part of a bundle with other products, or offer packaged arrangements to customers that include the Product, in such a manner as to disproportionately discount the selling price of the Product as compared with the weighted-average discount applied to the other products, as a percent of the respective list prices (or if not available, a good faith estimate thereof) of such products and the Product prior to applying the discount.\"}, {\"id\": \"1.44\", \"title\": \"\\\"NHI\\\" means the Japanese national health insurance system, or its successor system\", \"level\": 2, \"text\": \"1.44 \\\"NHI\\\" means the Japanese national health insurance system, or its successor system.\"}, {\"id\": \"1.45\", \"title\": \"\\\"NHI Price\\\" means the reimbursement price of the maximum daily dose of Product for purposes of the NHI\", \"level\": 2, \"text\": \"1.45 \\\"NHI Price\\\" means the reimbursement price of the maximum daily dose of Product for purposes of the NHI.\"}, {\"id\": \"1.46\", \"title\": \"\\\"NHI Price Listing\\\" means the listing of the NHI Price by Central Social Insurance Medical Council (Chuikyo) of the MHLW\", \"level\": 2, \"text\": \"1.46 \\\"NHI Price Listing\\\" means the listing of the NHI Price by Central Social Insurance Medical Council (Chuikyo) of the MHLW.\"}, {\"id\": \"1.47\", \"title\": \"\\\"Out-of-Pocket Costs and Expenses\\\" means the costs and expenses incurred by one or both Parties (as applicable) that are\", \"level\": 2, \"text\": \"1.47 \\\"Out-of-Pocket Costs and Expenses\\\" means the costs and expenses incurred by one or both Parties (as applicable) that are directly attributable to and reasonably allocated to a specified project, program or task. Out-of-Pocket Costs and Expenses shall include payments made to third parties such as contract research organizations and investigators and the fully burdened cost of drug product. Out-of-Pocket Costs and Expenses shall not include a Party's employee costs.\"}, {\"id\": \"1.48\", \"title\": \"\\\"Patent\\\" means (a) any patent, certificate of invention, application for certificate of invention, priority patent filin\", \"level\": 2, \"text\": \"1.48 \\\"Patent\\\" means (a) any patent, certificate of invention, application for certificate of invention, priority patent filing and patent application, and (b) any renewal, division, continuation (in whole or in part) or request for continued examination of any of such patent, certificate of invention and patent application, and any patent or certificate of invention issuing thereon, and any reissue, reexamination, extension, restoration by any existing or future extension or restoration mechanism, division, renewal, substitution, confirmation, registration, revalidation, revision and addition of or to any of the foregoing.\"}, {\"id\": \"1.49\", \"title\": \"\\\"Person\\\" means any individual, corporation, partnership, limited liability company, trust or other entity\", \"level\": 2, \"text\": \"1.49 \\\"Person\\\" means any individual, corporation, partnership, limited liability company, trust or other entity.\"}, {\"id\": \"1.50\", \"title\": \"\\\"Pharmacovigilance Agreement\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.50 \\\"Pharmacovigilance Agreement\\\" has the meaning set forth in Section 4.5. 6 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"1.51\", \"title\": \"\\\"PMDA\\\" means the Japanese Pharmaceuticals and Medical Devices Agency, and local counterparts thereto, and any successor\", \"level\": 2, \"text\": \"1.51 \\\"PMDA\\\" means the Japanese Pharmaceuticals and Medical Devices Agency, and local counterparts thereto, and any successor agency(ies) or authority thereto having substantially the same function.\"}, {\"id\": \"1.52\", \"title\": \"\\\"Product\\\" means Zogenix's proprietary fenfluramine product, known as Fintepla\u00ae, or any drug product containing a salt, e\", \"level\": 2, \"text\": \"1.52 \\\"Product\\\" means Zogenix's proprietary fenfluramine product, known as Fintepla\u00ae, or any drug product containing a salt, enantiomer, or polymorph of fenfluramine.\"}, {\"id\": \"1.53\", \"title\": \"\\\"Product Invention\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.53 \\\"Product Invention\\\" has the meaning set forth in Section 9.1(b)(i).\"}, {\"id\": \"1.54\", \"title\": \"\\\"Product Trademark\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.54 \\\"Product Trademark\\\" has the meaning set forth in Section 9.8(a).\"}, {\"id\": \"1.55\", \"title\": \"\\\"Public Official or Entity\\\" means (a) any officer, employee (including physicians, hospital administrators or other heal\", \"level\": 2, \"text\": \"1.55 \\\"Public Official or Entity\\\" means (a) any officer, employee (including physicians, hospital administrators or other healthcare professionals), agent, representative, department, agency, de facto official, representative, corporate entity, instrumentality or subdivision of any government, military or international organization, including any ministry or department of health or any state-owned or affiliated company or hospital, or (b) any candidate for political office, any political party or any official of a political party.\"}, {\"id\": \"1.56\", \"title\": \"\\\"Transfer Price\\\" has the meaning set forth in Section 6\", \"level\": 2, \"text\": \"1.56 \\\"Transfer Price\\\" has the meaning set forth in Section 6.5(a).\"}, {\"id\": \"1.57\", \"title\": \"\\\"Receiving Party\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.57 \\\"Receiving Party\\\" has the meaning set forth in Section 8.1.\"}, {\"id\": \"1.58\", \"title\": \"\\\"Regulatory Approval\\\" means any and all approvals (except NHI Price Listing), licenses, registrations, or authorizations\", \"level\": 2, \"text\": \"1.58 \\\"Regulatory Approval\\\" means any and all approvals (except NHI Price Listing), licenses, registrations, or authorizations of Regulatory Authorities in the applicable regulatory jurisdiction that are necessary for the manufacture, use, storage, import, transport and/or sale of a pharmaceutical product in such regulatory jurisdiction.\"}, {\"id\": \"1.59\", \"title\": \"\\\"Regulatory Authority\\\" means any national, regional, state or local regulatory agency, department, bureau, commission, c\", \"level\": 2, \"text\": \"1.59 \\\"Regulatory Authority\\\" means any national, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity whose review and/or approval is necessary for the manufacture, packaging, use, storage, import, export, distribution or promotion of a pharmaceutical product in the applicable regulatory jurisdiction, including the PMDA in the Territory. If governmental approval is required for pricing or reimbursement by national health insurance (or its local equivalent), \\\"Regulatory Authority\\\" shall also include any national, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity whose review and/or approval of pricing or reimbursement is required.\"}, {\"id\": \"1.60\", \"title\": \"\\\"Regulatory Filings\\\" means all applications, approvals, licenses, notifications, registrations, submissions and authoriz\", \"level\": 2, \"text\": \"1.60 \\\"Regulatory Filings\\\" means all applications, approvals, licenses, notifications, registrations, submissions and authorizations made to or received from a Regulatory Authority in connection with the development, manufacture or commercialization of a pharmaceutical product, including any INDs, MAAs and Regulatory Approvals.\"}, {\"id\": \"1.61\", \"title\": \"\\\"Regulatory Plan\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.61 \\\"Regulatory Plan\\\" has the meaning set forth in Section 4.2(a).\"}, {\"id\": \"1.62\", \"title\": \"\\\"SEC\\\" means the U\", \"level\": 2, \"text\": \"1.62 \\\"SEC\\\" means the U.S. Securities and Exchange Commission or any successor agency. 7 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"1.63\", \"title\": \"\\\"Sub-distributor\\\" means any Person other than Distributor or its Affiliates that Distributor appoints to market, promote\", \"level\": 2, \"text\": \"1.63 \\\"Sub-distributor\\\" means any Person other than Distributor or its Affiliates that Distributor appoints to market, promote, offer for sale, sell, import or distribute the Product in the Field in the Territory, beyond the mere right to purchase the Product from Distributor or its Affiliates for end use.\"}, {\"id\": \"1.64\", \"title\": \"\\\"Supply Agreement\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.64 \\\"Supply Agreement\\\" has the meaning set forth in Section 5.2.\"}, {\"id\": \"1.65\", \"title\": \"\\\"Territory\\\" means Japan\", \"level\": 2, \"text\": \"1.65 \\\"Territory\\\" means Japan.\"}, {\"id\": \"1.66\", \"title\": \"\\\"Third Party\\\" means any governmental authority or Person other than Zogenix, Distributor and their respective Affiliates\", \"level\": 2, \"text\": \"1.66 \\\"Third Party\\\" means any governmental authority or Person other than Zogenix, Distributor and their respective Affiliates.\"}, {\"id\": \"1.67\", \"title\": \"\\\"Third Party Claims\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.67 \\\"Third Party Claims\\\" has the meaning set forth in Section 11.1.\"}, {\"id\": \"1.68\", \"title\": \"\\\"Trademark\\\" means any word, name, symbol, color, designation or device or any combination thereof, including any tradema\", \"level\": 2, \"text\": \"1.68 \\\"Trademark\\\" means any word, name, symbol, color, designation or device or any combination thereof, including any trademark, trade dress, brand mark, service mark, trade name, brand name, logo or business symbol, whether or not registered, as determined in accordance with the trademark laws of the Unites States of America.\"}, {\"id\": \"1.69\", \"title\": \"\\\"United States\\\" or \\\"U\", \"level\": 2, \"text\": \"1.69 \\\"United States\\\" or \\\"U.S.\\\" means the United States of America, including its territories and possessions and the District of Columbia.\"}, {\"id\": \"1.70\", \"title\": \"\\\"Unlabeled Drug Product\\\" means [***]\", \"level\": 2, \"text\": \"1.70 \\\"Unlabeled Drug Product\\\" means [***].\"}, {\"id\": \"1.71\", \"title\": \"\\\"Zogenix ex-Territory Distributor\\\" means a licensee, collaborator or distributor engaged by Zogenix or any of its Affili\", \"level\": 2, \"text\": \"1.71 \\\"Zogenix ex-Territory Distributor\\\" means a licensee, collaborator or distributor engaged by Zogenix or any of its Affiliates to market, promote or sell the Product outside the Territory.\"}, {\"id\": \"1.72\", \"title\": \"\\\"Zogenix Indemnitees\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.72 \\\"Zogenix Indemnitees\\\" has the meaning set forth in Section 11.1.\"}, {\"id\": \"1.73\", \"title\": \"\\\"Zogenix Know-How\\\" means all Information and Data that Zogenix Controls as of the Effective Date or during the Term, whi\", \"level\": 2, \"text\": \"1.73 \\\"Zogenix Know-How\\\" means all Information and Data that Zogenix Controls as of the Effective Date or during the Term, which Information is necessary or reasonably useful to file for, obtain or maintain Regulatory Approval or to market, promote, sell, offer for sale or import the Product in the Field in the Territory.\"}, {\"id\": \"1.74\", \"title\": \"\\\"Zogenix Patents\\\" means all Patents that Zogenix Controls as of the Effective Date or during the Term, which Patents wou\", \"level\": 2, \"text\": \"1.74 \\\"Zogenix Patents\\\" means all Patents that Zogenix Controls as of the Effective Date or during the Term, which Patents would be infringed, absent a license, by the use, sale, offer for sale or import of the Product in the Field in the Territory, including any Patents issuing from the applications listed in Exhibit 1.74.\"}, {\"id\": \"1.75\", \"title\": \"\\\"Zogenix Technology\\\" means the Zogenix Know-How and Zogenix Patents\", \"level\": 2, \"text\": \"1.75 \\\"Zogenix Technology\\\" means the Zogenix Know-How and Zogenix Patents.\"}, {\"id\": \"1.76\", \"title\": \"\\\"Zogenix Trademark\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.76 \\\"Zogenix Trademark\\\" has the meaning set forth in Section 9.7. 8 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"ARTICLE 2\", \"title\": \"GRANT OF RIGHTS\", \"level\": 1, \"text\": \"ARTICLE 2. GRANT OF RIGHTS\"}, {\"id\": \"2.1\", \"title\": \"Grant of Rights to Distributor\", \"level\": 2, \"text\": \"2.1 Grant of Rights to Distributor. Subject to the terms and conditions of this Agreement, Zogenix hereby appoints Distributor, and Distributor accepts appointment, as the exclusive distributor (even as to Zogenix) of the Product in the Field in the Territory during the Term, and grants to Distributor the exclusive rights to maintain Regulatory Approval of (while Distributor is the MAH Party), package, promote, market, offer for sale, sell, import and distribute the Product in the Field in the Territory during the Term. The Parties agree that the rights granted in this Section 2.1 do not grant any right or license to, and Distributor shall not, supply, sell, offer for sale or otherwise dispose of or provide access to the Product in the Territory unless and until the Product obtains Regulatory Approval in the Field in the Territory.\"}, {\"id\": \"2.2\", \"title\": \"Sub-distribution by Distributor\", \"level\": 2, \"text\": \"2.2 Sub-distribution by Distributor. Distributor shall not have the right to (a) appoint any Sub-distributors for the Product in the Field in the Territory or (b) otherwise subcontract any sales, marketing, distribution or promotional activities with respect to the Product in the Field in the Territory, including to any contract sales organization, in each case, except with the prior written approval of Zogenix. If Zogenix grants such approval, in accordance with this Section 2.2 and Section 4.8, any Sub- distributor agreement shall be in writing and, with the exception of the financial terms, on substantially the same terms as this Agreement, to the extent applicable to the Sub-distributor's activity, and shall provide for the assignment of all Data generated by such Sub-distributors to Distributor, and the right for Distributor to terminate such agreement immediately in the event of any violation by such Sub-distributor of the FCPA or other Applicable Laws. Distributor shall be responsible for the acts or omissions of its Sub-distributors under any Sub-distributors agreement, including any such act or omission that would constitute a breach hereunder. In the event of any such breach by a Sub-distributor of its obligations to comply with the FCPA or other Applicable Laws, Distributor shall immediately terminate the applicable Sub-distributor agreement(s), unless otherwise agreed to by Zogenix in writing. Within [***] after execution thereof, Distributor shall provide Zogenix with a full and complete copy of each Sub- distributor agreement (provided that Distributor may redact any confidential information contained therein that is not relevant to compliance with this Agreement). 9 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"2.4\", \"title\": \"No Other Rights; Other Limitations\", \"level\": 2, \"text\": \"2.4 No Other Rights; Other Limitations. Except for the rights expressly granted in this Agreement, Zogenix retains all rights under the Zogenix Technology and with respect to the Product, including the exclusive right to manufacture and sell the Product to Distributor, to develop the Product, and to promote, market and sell the Product outside the Territory, and all rights with respect to the Product outside the Field in the Territory. No rights shall be deemed granted by one Party to the other Party under this Agreement by implication, estoppel or otherwise. Distributor agrees not to use any Zogenix Technology except as necessary to file for and maintain Regulatory Approval of, promote, market, sell, offer for sale, distribute and import the Product in the Field in the Territory during the Term in accordance with the terms of this Agreement and the Supply Agreement. Without limiting the foregoing, Distributor agrees that in no event shall Distributor or its Affiliates manufacture or have manufactured the Product, or purchase the Product from any party other than Zogenix pursuant to the Supply Agreement. Without limiting the foregoing, Distributor further acknowledges that it has no right to and agrees that it will not perform any studies of the Product or allow its Affiliate or any Third Party to perform any studies of the Product (including any investigator-initiated studies) except with the prior written approval of Zogenix, which Zogenix may withhold in its sole discretion.\"}, {\"id\": \"2.5\", \"title\": \"Non-Compete Covenant\", \"level\": 2, \"text\": \"2.5 Non-Compete Covenant. During the Term, without the prior written approval of Zogenix, Distributor shall not, and shall cause its Affiliates not to, either directly or indirectly, file for Regulatory Approval of, promote, market, offer for sale, sell, import or distribute in the Territory any product containing fenfluramine or any salt, enantiomer, or polymorph of fenfluramine, or any product for [***].\"}, {\"id\": \"2.6\", \"title\": \"No Activities Outside the Territory or Field\", \"level\": 2, \"text\": \"2.6 No Activities Outside the Territory or Field. Distributor shall not, and shall cause its Affiliates and Sub-distributors not to, (a) actively seek customers for the Product outside the Territory or the Field, (b) establish or maintain a branch office, warehouse, or distribution facility for the Product outside the Territory, (c) engage in any advertising or promotional activities relating to the Product directed to customers outside the Territory or directed to any use outside the Field, or (d) solicit orders from any prospective purchaser with its principal place of business located outside the Territory. If Distributor receives any order from a prospective purchaser outside the Territory, Distributor shall not accept any such order but shall immediately refer that order to Zogenix.\"}, {\"id\": \"ARTICLE 3\", \"title\": \"GOVERNANCE\", \"level\": 1, \"text\": \"ARTICLE 3. GOVERNANCE\"}, {\"id\": \"3.1\", \"title\": \"Joint Steering Committee\", \"level\": 2, \"text\": \"3.1 Joint Steering Committee. The Parties shall establish a joint steering committee (the \\\"Joint Steering Committee\\\" or \\\"JSC\\\") to oversee the activities of the Parties pursuant to this Agreement. (a) Composition. The JSC will be comprised of [***] members appointed by Distributor and [***] members appointed by Zogenix, which members shall be senior level employees or representatives of each Party with decision-making authority. Each Party will 10 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 notify the other Party of its initial JSC members within [***] after the Effective Date. The Parties, through the JSC, may change the number of JSC members as long as an equal number of members from each of Distributor and Zogenix is maintained. Each Party may change its JSC members at any time by written notice to the other Party, which may be delivered at a scheduled meeting of the JSC. Any member of the JSC may designate a substitute to attend and perform the functions of that member at any meeting of the JSC. Zogenix shall appoint one (1) of its members as chair, whose role shall be to convene and preside at meetings of the JSC, but the chair shall not be entitled to prevent items from being discussed or to cast any tie-breaking vote. Each Party may, with the consent of the other Party, such consent not to be unreasonably withheld or delayed, invite non-member, non-voting representatives of such Party to attend meetings of the JSC. (b) Responsibilities. The JSC shall be responsible for oversight of the Parties' activities under this Agreement with respect to filing for, obtaining and maintaining Regulatory Approval and commercializing (including commercial supply to Distributor and marketing and sales) the Product in the Field in the Territory. Without limiting the foregoing, the JSC shall: (i) review, discuss and approve the Regulatory Plan, including all amendments thereto; (ii) review, discuss and approve the Commercialization Plan, including all amendments thereto; (iii) periodically review, discuss and assess the progress and results of the Parties under the Regulatory Plan and Commercialization Plan to ensure, to the extent reasonably practical, compliance with obligations under this Agreement; (iv) periodically discuss the status of the development and commercialization of the Product in the Field outside the Territory; (v) review Distributor's binding and non-binding forecasts for the Product and monitor the production capacity of Zogenix and its Third Party manufacturers; (vi) periodically review Distributor's and Zogenix's pharmacovigilance policies and procedures; (vii) facilitate the exchange of Data between the Parties; and (viii) perform such other duties as are specifically assigned by the Parties to the JSC in this Agreement. (c) Meetings. The JSC will hold meetings at such frequency as determined by the JSC members, but no less than twice every calendar year. Such meetings may be in person, via videoconference, or via teleconference; provided, that no fewer than two (2) JSC 11 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 meetings each calendar year prior to First Commercial Sale shall be in-person unless the Parties otherwise agree. The location of in-person JSC meetings will alternate between Zogenix's offices and Distributor's offices, unless the Parties otherwise agree. At least [***] prior to each JSC meeting, each Party shall provide written notice to the other Party of agenda items proposed by such Party for discussion or decision at such meeting, together with appropriate information related thereto. Reasonably detailed written minutes will be kept of all JSC meetings and will reflect material decisions made at such meetings. Meeting minutes will be prepared by each Party on an alternating basis and sent to each member of the JSC for review and approval within [***] after a meeting. Minutes will be deemed approved unless a member of the JSC objects to the accuracy of such minutes within [***] of receipt. (d) Decisions. The JSC may make decisions with respect to any subject matter that is within the JSC's responsibilities. Subject to this Section 3.1(d), all decisions of the JSC shall be made by unanimous vote, with Zogenix and Distributor each having, collectively, among its respective members, one (1) vote in all such decisions. If the JSC cannot reach consensus with regard to any matter to be decided by the JSC within [***] after such matter has been brought to the JSC's attention, then such matter shall be referred to the Chief Executive Officer of Zogenix and the Director, Member of the Board of Distributor (the \\\"Executives\\\") for resolution. If the Executives cannot resolve the issue within [***] after the matter has been brought to their attention then: (i) Subject to good faith consideration of the views of Distributor, Zogenix shall have the tie-breaking vote on all matters to be decided by the JSC relating to [***]; provided, however, [***]; and (ii) Subject to good faith consideration of the views of Zogenix and to Section 3.1(d)(iii), Distributor shall have the tie-breaking vote on all matters to be decided by the JSC relating to [***]; provided, however, [***]; and (iii) Subject to good faith consideration of the views of Zogenix and Section 12.2(g), Distributor shall have the tie-breaking vote on the decision of [***], unless otherwise mutually agreed between the Parties; and (iv) Subject to good faith consideration of the views of Distributor, Zogenix shall have the tie-breaking vote on all matters other than the decisions set forth in Section 3.1(d)(ii) and (iii) to be decided by the JSC that may affect commercialization outside the Territory; provided, however, that Zogenix shall not have power to amend or waive compliance with this Agreement or the Commercialization Plan. (e) Discontinuation of JSC Participation. The activities to be performed by the JSC relate solely to governance under this Agreement, and are not intended to be or involve the delivery of services. The JSC will continue to exist until the Parties mutually agreeing to disband the JSC. Once the Parties mutually agree to disband the JSC, the JSC shall have no further obligations under this Agreement and, thereafter, each Party shall designate a contact person for the exchange of information under this Agreement, and decisions of the JSC shall be 12 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 decisions as between the Parties, subject to the decision-making authority under Section 3.1(d) and other terms and conditions of this Agreement.\"}, {\"id\": \"3.2\", \"title\": \"Expenses\", \"level\": 2, \"text\": \"3.2 Expenses. Each Party shall bear all its own costs, including expenses incurred by the members nominated by it, in connection with its members' JSC representation and meetings.\"}, {\"id\": \"3.3\", \"title\": \"Alliance Managers\", \"level\": 2, \"text\": \"3.3 Alliance Managers. Promptly after the Effective Date, each Party shall appoint an individual to act as the alliance manager for such Party (the \\\"Alliance Manager\\\"). Each Alliance Manager will be permitted to attend meetings of the JSC as non-voting participants. The Alliance Managers will be the primary contact for the Parties regarding the activities contemplated by this Agreement and shall facilitate all such activities hereunder. Each Party may replace its Alliance Manager with an alternative representative at any time with prior written notice to the other Party. Any Alliance Manager may designate a substitute to temporarily perform the functions of that Alliance Manager.\"}, {\"id\": \"3.4\", \"title\": \"Scope of Governance\", \"level\": 2, \"text\": \"3.4 Scope of Governance. Notwithstanding the creation of the JSC, each Party shall retain the rights, powers and discretion granted to it hereunder, and the JSC shall not be delegated or vested with rights, powers or discretion unless such delegation or vesting is expressly provided herein or the Parties expressly so agree in writing. The JSC shall not have the power to amend or modify this Agreement, and no decision of the JSC shall be in contravention of any terms and conditions of this Agreement. It is understood and agreed that issues to be formally decided by the JSC are only those specific issues that are expressly provided in this Agreement to be decided by the JSC. In no event shall the JSC have any decision-making authority with respect to matters relating to the Product outside the Territory or outside the Field. For clarity, any decision of an Executive made in resolution of a dispute of the JSC pursuant to Section 3.1(d) shall be treated as decisions of the JSC for purposes of this Agreement. It is understood between the Parties that under no circumstances are the activities to be performed by the JSC intended or allowed to violate any Applicable Laws (including but not limited to any competition and/or antitrust law).\"}, {\"id\": \"ARTICLE 4\", \"title\": \"DEVELOPMENT AND REGULATORY ACTIVITIES\", \"level\": 1, \"text\": \"ARTICLE 4. DEVELOPMENT AND REGULATORY ACTIVITIES\"}, {\"id\": \"4.1\", \"title\": \"Nonclinical and Clinical Studies and CMC Requirements\", \"level\": 2, \"text\": \"4.1 Nonclinical and Clinical Studies and CMC Requirements. Promptly after the Effective Date, the JSC will discuss what nonclinical or clinical Development studies or CMC requirements are required to obtain Regulatory Approval of the Product for the treatment of Dravet syndrome and Lennox-Gastaut syndrome or would otherwise be useful for the Commercialization of the Product in the Field in the Territory, and if Zogenix agrees that such Development activities should be conducted, Zogenix will be responsible for conducting or having conducted all such Development activities. All non-clinical and clinical studies and CMC requirements completed or initiated by Zogenix as of the Effective Date or any such non-clinical and clinical studies and CMC requirements that are described in the initial version of Regulatory Plan, shall be conducted at Zogenix's own cost and expense, except for Distributor's payment 13 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 obligations under Section 6.2 and as otherwise expressly set forth herein. Any additional Territory-specific Development activities not set forth in the initial version of the Regulatory Plan, including those conducted at the suggestion or requirement of the MHLW or at [***] incurred by the Parties while conducting such Territory-specific Development activities. For clarity, Distributor shall have no right to conduct any Development activities for the Product unless otherwise agreed by Zogenix, and Zogenix shall have and retain all rights, in its sole discretion, to conduct any Development activities for the Product in the Territory outside the Field or any Development activities outside the Territory.\"}, {\"id\": \"4.2\", \"title\": \"Regulatory Activities\", \"level\": 2, \"text\": \"4.2 Regulatory Activities. (a) Regulatory Plan. All regulatory Development activities with respect to the Product in the Field in the Territory will be conducted in accordance with a comprehensive regulatory plan (as amended in accordance with this Agreement, the \\\"Regulatory Plan\\\") which sets forth [***]. The initial version of the Regulatory Plan prepared by Zogenix and agreed to by Distributor will be attached to this Agreement as Exhibit 4.2(a) [***]. Any changes and updates to the Regulatory Plan must be approved by the JSC, subject to the decision-making procedures set forth in Section 3.1(d). As between the Parties, Zogenix will have the sole right and obligation to conduct (itself or through an Affiliate or Third Party) nonclinical and clinical studies concerning the Product in the Field in or for the Territory. Zogenix shall provide updates to the JSC concerning its progress under the Regulatory Plan and copies of final nonclinical and clinical study reports following completion of such Development studies. The JSC shall discuss such activities, including any updates on the progress and results thereof provided by Zogenix. During the Term, Zogenix shall use Commercially Reasonable Efforts to Develop the Product in the Field in the Territory in accordance with the Regulatory Plan and the terms of this Agreement. (b) Global Clinical Studies for New Indications. In the event that Zogenix intends to conduct a global (including the Territory) clinical trial of the Product for indications other than Dravet syndrome and Lennox-Gastaut syndrome (a \\\"Global Study\\\"), Zogenix will provide a summary of such Global Study to Distributor for review. In the event Distributor agrees to participate in a Global Study, Zogenix (or its designee) will be responsible for conducting such Global Study, including in the Territory, [***]. (c) Conduct of Regulatory Activities. Subject to Section 4.2(d), Zogenix shall be the marketing authorization holder for the Product in the Territory, and Zogenix shall be deemed the MAH Party and Distributor deemed the Non-MAH Party for purposes of this Agreement. Zogenix shall use Commercially Reasonable Efforts to [***]. In addition, Zogenix shall use Commercially Reasonable Effort to ensure [***] shall have the capabilities and obtain the necessary licenses for filing an MAA for the Product in the Territory in advance of the planned MAA submission date in the initial version of Regulatory Plan. (i) Regulatory Approval Activities. Zogenix will be responsible for filing for and obtaining Regulatory Approval of the Product in the Field in the Territory. In connection with such activities, Zogenix shall be responsible for preparing and filing INDs and 14 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 other necessary Regulatory Filings and for communicating with Regulatory Authorities in the Territory, except as otherwise mutually agreed to by the Parties in writing. Zogenix shall be responsible for preparing, filing and obtaining Regulatory Approval of the Product in the Field in the Territory, all in accordance with the Regulatory Plan. Zogenix shall ensure that the Distributor is involved in the planning and conduct of all such activities and the decisions with respect thereto, including discussions with any Regulatory Authority and any decisions regarding the labeling of the Product in the Field in the Territory. Zogenix shall consider in good faith all input provided by the Distributor with respect to such regulatory approval activities. In connection with such activities, Zogenix shall: (i) timely inform the Distributor of any scheduled meetings with Regulatory Authorities in the Territory with respect to the Product in the Field as soon as practicable in order to allow the Distributor time to convey its opinion on the matter and (ii) use all reasonable efforts to ensure that the Distributor is afforded the opportunity to participate in such meetings. Zogenix shall keep the Distributor regularly and fully informed of the preparation, Regulatory Authority review and approval of submissions and communications with Regulatory Authorities with respect to the Product in the Field in the Territory. In particular, Zogenix shall promptly provide the Distributor with copies of all material documents, information and correspondence received from or provided to a Regulatory Authority with respect to the Product in the Field in the Territory and, upon reasonable request, with copies of any other documents, reports and communications from or to any Regulatory Authority relating to the Product in the Field in the Territory, as well as written summaries of all material oral communications with a Regulatory Authority with respect to the Product in the Field in the Territory. (ii) Post-Approval Regulatory Activities. Following the filing of the MAA for the Product in the Territory, Zogenix and Distributor shall collaborate in good faith concerning a pricing negotiation strategy for the Product. Following Regulatory Approval of the Product in the Field in the Territory, Zogenix will be responsible for negotiating and obtaining initial pricing approval for the Product with the applicable Regulatory Authority in accordance with such strategy. The MAH Party shall use Commercially Reasonable Efforts to maintain Regulatory Approval for the Product in the Field in the Territory. The MAH Party shall be responsible for all interactions with Regulatory Authorities with respect to the Product in the Field in the Territory during the Term and maintaining Regulatory Approval of the Product in the Field in the Territory. In connection with such activities, the MAH Party shall: (i) timely inform the Non-MAH Party of any scheduled meetings with Regulatory Authorities in the Territory with respect to the Product in the Field as soon as practicable in order to allow the Non-MAH Party time to convey its opinion on the matter and (ii) use all reasonable efforts to ensure that the Non-MAH Party is afforded the opportunity to participate in such meetings. The MAH Party shall keep the Non-MAH Party regularly and fully informed of the preparation of submissions and communications with Regulatory Authorities with respect to the Product in the Field in the Territory. In particular, the MAH Party shall promptly provide the Non-MAH Party with copies of all material documents, information and correspondence received from or provided to a Regulatory Authority with respect to the Product in the Field in the Territory and, upon reasonable request, with copies of any other documents, reports and communications from or to any Regulatory Authority relating to the Product in the Field in the Territory, as well as written 15 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 summaries of all material oral communications with a Regulatory Authority with respect to the Product in the Field in the Territory. (A) Post-Marketing Surveillance Studies. The MAH Party shall be responsible for conducting any post-marketing surveillance studies, including those required by the MHLW or Applicable Law, that are required to maintain the MAA. The MAH Party shall ensure that Non-MAH Party is involved in the planning and conduct of all such post-approval activities and the decisions with respect thereto, including discussions with any Regulatory Authority and any decisions regarding any post-marketing surveillance studies with respect to, the Product in Field in the Territory. The MAH Party shall consider in good faith all input provided by Zogenix with respect to such regulatory activities. The MAH Party shall be responsible for filing any post-marketing surveillance studies with the MHLW. (B) Post-Approval Clinical Studies. Zogenix shall be responsible for conducting any post- approval clinical study that is requested upon or after approval or otherwise required by the MHLW as a condition of or to maintain the MAA approval. [***] shall bear [***] the total Out-of-Pocket Costs and Expenses incurred by the Parties while conducting any such post-approval clinical study that is for the Territory. Zogenix shall ensure that Distributor is involved in the planning and conduct of all such post-approval clinical studies and the decisions with respect thereto, including discussions with any Regulatory Authority and any decisions regarding any post-approval clinical study with respect to, the Product in Field in the Territory. Zogenix shall consider in good faith all input provided by the Distributor with respect to such post-approval clinical study. The MAH Party shall be responsible for filing any post-approval clinical studies with the MHLW. (C) Risk Management Plan. Zogenix shall be responsible for filing the initial risk management plan, if any, and approving any subsequent changes thereto. The MAH Party shall be responsible for conducting or having conducted any risk management plan requested or required by the MHLW. The Distributor shall support and implement the risk management plan and cooperate with Zogenix, and the Parties shall share and discuss the results and data generated from any risk management plan required by MHLW. The Distributor shall collaborate with Zogenix to ensure global alignment and consistency with the safety specifications, pharmacovigilance planning and risk management commitments and activities. (d) Transfer of Marketing Authorization. Zogenix shall be the marketing authorization holder of the Product in the Territory for the [***] following Regulatory Approval of the Product in the Territory. Thereafter, Zogenix shall transfer the marketing authorization for the Product in the Territory to Distributor within [***] following [***], unless delayed or prohibited by a Regulatory Authority or Applicable Law or otherwise agreed by the Parties. Upon the transfer of the marketing authorization of the Product in the Territory to Distributor, then Distributor shall be deemed the MAH Party for purposes of this Agreement and Zogenix shall be deemed the Non-MAH Party. (e) Ownership of Regulatory Information. The Parties acknowledge and agree that Zogenix shall retain the full unfettered ownership of the Data and drug dossier 16 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 submitted to the PMDA for the Regulatory Approval (including but not limited to safety & efficacy data, clinical data package, drug formulation and method of administration). Notwithstanding the foregoing, if Zogenix asks Distributor to solely conduct any additional Territory-specific Development activities which are urgently required by the MHLW for the MAA in the Territory, Distributor shall retain co-ownership with Zogenix of any Data generated solely by Distributor. Distributor hereby grants Zogenix an irrevocable, perpetual, royalty-free, fully paid-up, exclusive license with the right to grant sublicenses to use such Data solely generated and co-owned by Distributor outside of the Territory and a co-exclusive license in the Territory upon expiration or termination of the Agreement. (f) Regulatory Cooperation. Each Party shall cooperate in good faith with any reasonable requests for assistance from the other Party with respect to obtaining or maintaining Regulatory Approval of the Product in and outside the Territory, including by providing to the other Party all Information in its possession and Control that is requested by, or needed to respond to inquiries of, a Regulatory Authority with respect to the Product.\"}, {\"id\": \"4.3\", \"title\": \"Distributor's Right to Use and Reference\", \"level\": 2, \"text\": \"4.3 Distributor's Right to Use and Reference. Distributor shall have the right to reference and use all Data and Regulatory Filings (including all Regulatory Approvals) for the purpose of fulfilling Distributor's obligations set forth in this Agreement. For clarity, in accordance with Section 4.2(b), [***].\"}, {\"id\": \"4.4\", \"title\": \"Zogenix's Right to Use and Reference\", \"level\": 2, \"text\": \"4.4 Zogenix's Right to Use and Reference. In the event that Distributor is responsible for filing for and obtaining Regulatory Approval of the Product in the Field in the Territory or Distributor otherwise is the holder of the Regulatory Approval for the Product in the Territory, Zogenix and its Affiliates and Zogenix ex-Territory Distributors shall have the royalty-free right to reference and use all Data and Regulatory Filings (including all Regulatory Approvals), including all data contained or referenced therein, provided by or to Distributor under this Article 4, such reference and use in connection with filing for, obtaining and maintaining Regulatory Approval and commercializing the Product outside the Territory and in the Territory outside the Field. Distributor shall, on written request by Zogenix, provide, or shall cause its applicable Affiliate to provide, to Zogenix and to any specified Regulatory Authority a letter, in the form reasonably required by Zogenix, acknowledging and confirming that Zogenix and its Affiliates and/or Zogenix ex-Territory Distributors, as applicable, have the rights of reference to any such Regulatory Filing (including any such Regulatory Approval) for all purposes consistent with the Development, Regulatory Approval and commercialization of the Product outside the Territory and in the Territory outside the Field. Distributor shall not, and shall cause its Affiliates not to, transfer or disclose any Regulatory Filings (including any Regulatory Approval) relating to the Product in the Territory to any Third Party without the prior written consent of Zogenix, and in any such permitted transfer Distributor shall require the transferee to acknowledge in writing to Zogenix, Zogenix's (and its Affiliates' and Zogenix ex-Territory Distributors') rights of reference to and right to use all such Regulatory Filings (including Regulatory Approvals) as provided in this Section 4.3.\"}, {\"id\": \"4.5\", \"title\": \"Adverse Event Reporting\", \"level\": 2, \"text\": \"4.5 Adverse Event Reporting. The MAH Party shall be responsible for the timely 17 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 reporting of all relevant adverse drug reactions/experiences, Product quality, Product complaints and safety data relating to the Product in the Field to the appropriate Regulatory Authorities in the Territory, all in accordance with Applicable Laws and requirements of Regulatory Authorities in the Territory. Zogenix (or its Affiliate, or Zogenix ex-Territory Distributors) shall be responsible for the timely reporting of all relevant adverse drug reactions/experiences, Product quality, Product complaints and safety data relating to the Product to the appropriate Regulatory Authorities outside the Territory. The details of such reporting shall be set forth in a pharmacovigilance agreement (as may be amended, the \\\"Pharmacovigilance Agreement\\\"), which will be agreed to by the Parties prior to the First Commercial Sale in the Territory. The Pharmacovigilance Agreement shall include, without limitation, governance provisions that set forth a process for communication and escalation, where necessary, of safety issues, label changes, and the like. Zogenix shall have the right to share any and all information received from Distributor under this Section 4.5, or the Pharmacovigilance Agreement, with Zogenix's Affiliates and Zogenix ex-Territory Distributors. The Pharmacovigilance Agreement shall identify the responsibilities of each Party regarding the information to be exchanged and the timeframes for such exchange, regulatory reporting, literature review, risk management, and labeling. Prior to executing the Pharmacovigilance Agreement, the Parties agree to work together in good faith to coordinate regarding pharmacovigilance activities with respect to the Product in the Field, including by exchanging Distributor's standard operating procedures and other Information relevant to such pharmacovigilance activities.\"}, {\"id\": \"4.6\", \"title\": \"Drug Safety and Pharmacovigilance System including Global Safety Database\", \"level\": 2, \"text\": \"4.6 Drug Safety and Pharmacovigilance System including Global Safety Database. Zogenix shall maintain a global system for monitoring and management of the risks associated with the Product. This system will provide signal management as well as the collection, identification, evaluation, and management of individual case safety reports and cumulative reports. As part of this pharmacovigilance system, Zogenix shall maintain the global safety database with respect to the Product, which shall serve as the reference database for all responses to safety queries and aggregate safety reports and be the main source for individual case safety report processing. Each Party shall cooperate, and shall cause its Affiliates, Sub-distributors and Zogenix ex-Territory Distributors, as applicable, to cooperate, in implementing and adhering to a pharmacovigilance mutual alert process with respect to the Product to comply with Applicable Laws, as set forth in the Pharmacovigilance Agreement. Notwithstanding anything to the contrary in this Agreement, Zogenix shall have final decision making authority over all issues that implicate global safety.\"}, {\"id\": \"4.7\", \"title\": \"Regulatory Audit\", \"level\": 2, \"text\": \"4.7 Regulatory Audit. Each Party shall notify the other Party within [***] of receipt of any notice of a MHLW audit of any of such Party or its Affiliate or subcontractor with respect to the Product in the Territory. Notwithstanding the foregoing, if a Party is subject to an unannounced audit from the MHLW or receives a notice of an imminent audit from the MHLW, in each case with respect to the Product in the Territory, such Party shall notify the other Party promptly, but in any event within [***]. Such other Party shall have the right to have its or its Affiliates' or its subcontractors' employees or consultants participate in any audits or other inspections to the extent permitted by Applicable Law. To the extent permitted by Applicable Law, the audited Party shall provide the other Party with the copies of any resulting document or 18 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 action pertaining to the Product in the Territory that results from such audit within [***] of their receipt.\"}, {\"id\": \"4.8\", \"title\": \"Use of Subcontractors\", \"level\": 2, \"text\": \"4.8 Use of Subcontractors. To the extent that Distributor performs any of its regulatory or commercial activities under this Agreement through one or more subcontractors (including a Sub-distributor), if and as permitted under the terms of this Agreement, Distributor shall ensure that (a) none of Zogenix's rights hereunder are diminished or otherwise adversely affected as a result of such subcontracting, (b) the subcontractor assigns to Distributor all Distributor Inventions and all data generated by such subcontractor that, if Controlled by Distributor, would be included in the definition of Data, (c) the subcontractor undertakes in writing obligations of confidentiality and non-use regarding Confidential Information and compliance with the FCPA and other Applicable Laws that are substantially the same as those undertaken by the Parties pursuant to Article 8 and Section 10.2, (d) the subcontractor does not have an adverse history or reputation, (e) the use of the subcontractor will not cause the Zogenix Indemnitees to be in violation of the FCPA or any other Applicable Laws, and (f) the use of the subcontractor will not cause reputational harm to the Zogenix Indemnitees. In the event that Distributor performs any of its regulatory activities hereunder through a subcontractor, Distributor will at all times be fully responsible for the performance and payment of such subcontractor.\"}, {\"id\": \"4.9\", \"title\": \"Recalls\", \"level\": 2, \"text\": \"4.9 Recalls. (a) In the event that the MHLW issues a request or orders a recall or takes similar action in connection with the Product in the Territory, or in the event either Party determines that an event, incident, or circumstance has occurred that may result in the need for a voluntary withdrawal of the Product in the Territory, the Party notified of such recall or desiring such voluntary withdrawal shall, within [***], advise the other Party thereof by telephone (and confirm by electronic mail or facsimile). Regarding any recall order or request from the MHLW, the Parties shall, to the extent practicable, discuss and endeavor to agree upon a plan for recalling the affected Product. Regarding any request for a voluntary withdrawal, the Parties shall discuss and endeavor to agree upon whether to voluntarily withdraw the Product in the Territory, and each Party shall review and consider in good faith all information provided by the other Party in connection with such discussion, including any assessment of safety and whether to withdraw the Product. (b) For all recalls requested or ordered by the MHLW, the MAH Party shall have the sole authority and responsibility to make all decisions with respect to such recall, subject to good faith consideration of the views of the non-MAH Party. For all voluntary withdrawals concerning quality defects, such as compliance, foreign substances, tampering and labeling defects, the MAH Party shall have the sole authority and responsibility to make all decisions with respect to such withdrawal, subject to good faith consideration of the views of non-MAH party. For all voluntary withdrawals concerning efficacy or safety, Zogenix shall have the sole authority and responsibility to make all decisions with respect to such withdrawal, subject to good faith consideration of the views of the Distributor. 19 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (c) Distributor shall be responsible for conducting any such recall or withdrawal, shall use Commercially Reasonable Efforts to minimize the expenses of any such recall or withdrawal and shall keep Zogenix fully informed of all actions taken in conducting such recall or withdrawal. If a recall or withdrawal is due to Zogenix's negligence, willful misconduct or breach of this Agreement, Zogenix shall reimburse Distributor for all of the reasonable costs and expenses actually incurred by Distributor in connection with such recall or withdrawal, including, but not limited to, costs of personnel expenses of Distributor's sales representatives, fees for consultation with the Regulatory Authority in the Territory and travel expenses for consultation, and its actual reasonable Out-of-Pocket Costs and Expenses incurred while retrieving Product already delivered to customers, costs and expenses Distributor is required to pay for notification, shipping and handling charges, and such other costs as may be reasonably related to the recall or withdrawal. If a recall or withdrawal is due to Distributor's negligence, willful misconduct or breach of this Agreement, Distributor shall reimburse Zogenix for all the reasonable costs and expenses described above actually incurred by Zogenix in connection with such recall or withdrawal, including administration of the recall and such other actual costs as may be reasonably related to the recall or withdrawal in the Territory. If a recall or withdrawal results from a cause other than the negligence in the Territory, willful misconduct or breach of this Agreement of or by Distributor or Zogenix, the parties hereto [***]. Prior to any reimbursements pursuant to this Section, the party claiming any reimbursement shall provide the other party with reasonably acceptable documentation of all reimbursable costs and expenses. Neither Party will be liable to the other for Indirect Losses in connection with any recall or withdrawal pursuant to this Section.\"}, {\"id\": \"4.10\", \"title\": \"Development Expenses\", \"level\": 2, \"text\": \"4.10 Development Expenses. Unless expressly stated otherwise, each Party shall bear its own Out-of-Pocket Costs and Expenses and any employee and overhead expenses incurred while performing its obligations under this Article 4.\"}, {\"id\": \"ARTICLE 5\", \"title\": \"COMMERCIALIZATION; SUPPLY\", \"level\": 1, \"text\": \"ARTICLE 5. COMMERCIALIZATION; SUPPLY: TRADEMARKS\"}, {\"id\": \"5.1\", \"title\": \"Commercialization of the Product\", \"level\": 2, \"text\": \"5.1 Commercialization of the Product. (a) Distributor Responsibilities. Distributor shall have the exclusive right to market, promote, sell, offer for sale, import, package and otherwise Commercialize the Product in the Field in the Territory, at its sole cost and expense, in accordance with Applicable Laws and the Commercialization Plan and subject to the terms and conditions of this Agreement. Without limiting the foregoing, Distributor will have the exclusive right and responsibility in the Field in the Territory for the following: (i) designing the Commercialization strategy and tactics for the Product, subject to JSC approval of the Commercialization Plan; (ii) undertaking all promotional activities for the Product; 20 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (iii) establishing and implementing post-marketing surveillance studies for the Product in the Territory as required or recommended by a Regulatory Authority; (iv) receiving, accepting and filling orders for the Product from customers; (v) warehousing and distributing the Product to customers; (vi) controlling invoicing, order processing and collection of accounts receivable for sales of the Product; (vii) recording sales of the Product in the Territory in its books of account for sales; and (viii) providing results of sales of the Product in the Territory for purposes of periodic safety reports and exposure estimates. Distributor shall provide updates regularly to the JSC relating to Commercialization activities for the Product in the Field in the Territory. (b) Commercialization Plan. Distributor shall be responsible for the creation and implementation of an annual plan for the Commercialization of the Product in the Field in the Territory, which shall identify proposed plans to address potential challenges with respect to Commercialization of the Product in the Field in the Territory (the \\\"Commercialization Plan\\\"). The Commercialization Plan shall set forth in reasonable detail the major Commercialization activities planned for the Product in the Territory for the applicable period, including [***]. Distributor shall prepare and submit to the JSC the initial Commercialization Plan no later than [***] after MAA filing for the Product in the Field in the Territory for review and approval by the JSC in accordance with the decision-making procedures set forth in Section 3.1(d). Distributor shall submit subsequent updated Commercialization Plans to the JSC on an annual basis on or before the end of each Fiscal Year for review and approval by the JSC. Through the JSC, Distributor shall regularly consult with and provide updates to Zogenix regarding the Commercialization strategy for and the Commercialization of the Product in the Field in the Territory. (c) Diligence. During the Term, Distributor shall use Commercially Reasonable Efforts to market, promote, sell, offer for sale, import, package, distribute and otherwise commercialize the Product in the Field in the Territory in accordance with the Commercialization Plan and the terms of this Agreement. Without limiting the foregoing, Distributor shall Submit the first purchase order of the Product in the Field in the Territory to Zogenix within [***], achieve First Commercial Sale of the Product in the Field in the Territory as soon as reasonably practicable after the Product is first available for delivery to Distributor in the Territory, and use Commercially Reasonable Efforts to timely accomplish all the activities set forth in the Commercialization Plan. 21 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (d) Distributor's Diligence Failure. (i) After [***] of the First Commercial Sale of the Product in the Territory, if Zogenix reasonably believes that Distributor has failed to achieve or maintain the diligence obligations set forth in Section 5.1(c), Zogenix shall provide written notice thereof to Distributor requesting a detailed written response concerning such failure and Distributor shall provide such detailed written response to Zogenix within [***] of the date of Zogenix's request. Zogenix's notice shall specify in reasonable detail the facts and circumstances constituting Zogenix's reasons for reaching such a determination. Following Zogenix's receipt of Distributor's response, the Parties shall promptly, and in any event within [***], discuss in good faith Distributor's obligations and its proposed actions to cure its failure to achieve its diligence obligations. Where remedy is possible and reasonably acceptable to Zogenix, Distributor shall use its Commercially Reasonable Efforts to start substantive steps within [***] of the date of Zogenix's notice to Distributor. If Distributor (A) fails to provide a detailed written response to Zogenix within [***] of the date of Zogenix's notice to Distributor, or (B) fails to use its Commercially Reasonable Efforts to start substantive steps to remedy such failure [***] of the date of Zogenix's notice to Distributor, Zogenix shall have the right, [***] effective upon written notice thereof by Zogenix to Distributor, to (1) [***] or (2) [***]. (ii) Any failure of Distributor to achieve the diligence obligations set forth in Section 5.1(c) shall not be considered Distributor's diligence failure as described in Section 5.1(d)(i) or a breach of this Agreement to the extent such failure was caused by (A) Zogenix's inability or failure to supply Product in accordance with the terms of the Supply Agreement, (B) any changes to the Regulatory Plan approved by the JSC in accordance with Section 4.2(a), or (C) any changes to the Commercialization Plan approved by the JSC in accordance with Section 5.1(b). (iii) This Section 5.1(d) shall not limit any other remedies or damages that Zogenix may have or seek under this Agreement or Applicable Laws.\"}, {\"id\": \"5.2\", \"title\": \"Supply\", \"level\": 2, \"text\": \"5.2 Supply. The Parties acknowledge and agree that Zogenix shall retain all rights to make and have made the Product in and for the Territory. Promptly after the Effective Date, the Parties shall commence negotiating a supply agreement containing reasonable and customary terms for an agreement of such type, governing Zogenix's supply of the Product to Distributor for sale in the Field in the Territory in accordance with the terms of this Agreement (as may be amended, the \\\"Supply Agreement\\\"), and shall use reasonable efforts to enter into the Supply Agreement within [***] after the Effective Date. Zogenix shall supply, or cause to be supplied, Product to Distributor in accordance with the Supply Agreement, and Distributor shall purchase all of its and its Affiliates' and Sub-distributors' requirements for the Product under the Supply Agreement. Distributor shall pay to Zogenix the Transfer Price for Product supplied under the Supply Agreement in accordance with Section 6.5. 22 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"5.3\", \"title\": \"Trademark Rights\", \"level\": 2, \"text\": \"5.3 Trademark Rights. (a) Product Trademarks. Subject to the terms and conditions of this Agreement, Zogenix hereby grants to Distributor an co-exclusive, royalty-free, limited right under the Product Trademarks solely to promote, market, sell, offer for sale, import, package and distribute the Product in Field in the Territory in accordance with the terms of this Agreement. (b) Zogenix Trademarks. Subject to the terms and conditions of this Agreement, Zogenix hereby grants to Distributor a non-exclusive, royalty-free, limited right under the Zogenix Trademarks solely to promote, market, sell, offer for sale, import, package and distribute the Product in Field in the Territory in accordance with the terms of this Agreement.\"}, {\"id\": \"5.4\", \"title\": \"Commercial Expenses\", \"level\": 2, \"text\": \"5.4 Commercial Expenses. Unless expressly stated otherwise, each Party shall bear its own Out-of-Pocket Costs and Expenses and all employee and overhead expenses incurred while performing its obligations under this Article 5.\"}, {\"id\": \"ARTICLE 6\", \"title\": \"PAYMENTS\", \"level\": 1, \"text\": \"ARTICLE 6. PAYMENTS\"}, {\"id\": \"6.1\", \"title\": \"Upfront Payment\", \"level\": 2, \"text\": \"6.1 Upfront Payment. Distributor shall pay to Zogenix, upon the receipt of the invoice from Zogenix after the Effective Date, a non-refundable, non-creditable upfront payment of Seven Million Five Hundred Thousand U.S. Dollars (US $7,500,000), which upfront payment shall consist of [***] in consideration for the exclusive right to distribute Product in the Territory for the treatment of Dravet syndrome and [***] in consideration for the exclusive right to distribute Product in the Territory for the treatment of Lennox-Gastaut syndrome. Distributor shall pay such payment to Zogenix within [***] of receipt of the invoice.\"}, {\"id\": \"6.2\", \"title\": \"Funding to Support Development of The Product\", \"level\": 2, \"text\": \"6.2 Funding to Support Development of The Product. Distributor shall pay to Zogenix Twelve Million Five Hundred Thousand U.S. Dollars (US $12,500,000) for support of Zogenix's global nonclinical and clinical Development studies concerning the Product for Dravet syndrome and Lennox-Gastaut syndrome as it relates to Regulatory Approval of the Product in the Territory. For clarity, the Six Million Five Hundred Thousand U.S. Dollar (US $6,500,000) payment is intended to support studies previously conducted by Zogenix and that will be included in the MAA for the Territory. The remaining Six Million U.S. Dollars (US 6,000,000) in payments are intended to support those studies conducted by Zogenix and indicated as being paid for by Zogenix under the initial Regulatory Plan during [***] after the Effective Date, and such payments will be made [***]. The five (5) Development payments pursuant to this Section 6.2 will be made according to the following schedule: (a) Within [***] after the Effective Date, a non-refundable, non-creditable one-time payment of [***]; (b) Within [***] after the Effective Date, a non-refundable, non-creditable 23 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 one-time payment of [***]; (c) On the [***] of the Effective Date, a non-refundable, non-creditable one-time payment of [***]; (d) On the [***] of the Effective Date, a non-refundable, non-creditable one-time payment of [***]; and (e) On the [***] of the Effective Date, a non-refundable, non-creditable one-time payment of [***]. For clarity, each of the foregoing payments to be made by Distributor to Zogenix shall be payable within [***] of receipt of the invoice therefor from Zogenix. In the event that Zogenix terminates the Development the Product in the Territory for both Dravet syndrome and Lennox-Gastaut syndrome prior to the due date for any of the foregoing payments any such payment whose due date is after such termination shall no longer be due and payable to Zogenix.\"}, {\"id\": \"6.3\", \"title\": \"Regulatory Milestones\", \"level\": 2, \"text\": \"6.3 Regulatory Milestones. Distributor shall pay to Zogenix the non-refundable, non-creditable milestone payments as set forth in this Section 6.3. Upon the occurrence of each milestone event in this Section 6.3 Zogenix shall issue an invoice to Distributor for the amount of the milestone payment corresponding to such achieved milestone event, and Distributor shall pay to Zogenix such invoiced amount within [***] of its receipt from Zogenix. 24 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Regulatory Milestone Event Milestone Payment [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] Each milestone payment set forth above shall be payable only once for the Product. For clarity, the total regulatory milestone payments set forth in this Section shall not exceed: (a) [***] if [***]; (b) [***] if [***]; and (c) [***].\"}, {\"id\": \"6.4\", \"title\": \"Sales Milestones\", \"level\": 2, \"text\": \"6.4 Sales Milestones. For each Fiscal Quarter in which aggregate annual Net Sales first reach a threshold indicated in the table below, Distributor shall inform Zogenix within [***] that the aggregated annual Net Sales first reached such threshold. Zogenix shall issue an invoice to Distributor for the applicable milestone payment, and Distributor shall pay such invoice within [***] of its receipt from Zogenix: Annual Net Sales Level Milestone Payment First Fiscal Year in which aggregate annual Net Sales of the Product in the Field in the Territory exceed [***] [***] First Fiscal Year in which aggregate annual Net Sales of the Product in the Field in the Territory exceed [***] [***] First Fiscal Year in which aggregate annual Net Sales of the Products in the Field in the Territory exceed [***] [***] The milestone payments set forth in this Section 6.4 shall be additive, such that if all three (3) 25 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 milestone events are achieved in the same Fiscal Year, Distributor shall pay to Zogenix all three (3) milestone payments.\"}, {\"id\": \"6.5\", \"title\": \"Supply Payments\", \"level\": 2, \"text\": \"6.5 Supply Payments. Amount of Product Supplied per Fiscal Year Net Price Markup For the portion of Product supplied less than or equal to the equivalent of [***] in Net Sales in such Fiscal Year [***] For the portion of Product supplied in excess of the equivalent of [***] in Net Sales and less than or equal to the equivalent of [***] in Net Sales in such Fiscal Year [***] For the portion of Product supplied in excess of the equivalent of [***] in Net Sales and less than or equal to the equivalent of [***] in Net Sales in such Fiscal Year [***] For the portion of Product supplied in excess of the equivalent of [***] in Net Sales in such Fiscal Year [***] The Net Sales equivalent described in the left column of the table above is calculated by determining the total number of units ordered in the applicable Fiscal Year and multiplying such number by the Net Price for such Fiscal Year. Following the expiration of the Distribution Term and during the remaining Term of this Agreement, for all Product supplied by Zogenix to Distributor under purchase orders submitted pursuant to the Supply Agreement in a particular Fiscal Year, Distributor shall pay to Zogenix the Transfer Price per unit of Product supplied shall be equal to the sum of (i) [***] of the Fully-Burdened Manufacturing Cost per unit of Product for such Fiscal Year, and (ii) [***] of aggregate annual Net Sales for such Fiscal Year. (b) Estimates. No later than [***] before the beginning of each Fiscal Year, starting with the Fiscal Year in which the First Commercial Sale is anticipated to occur, the Parties shall discuss in good faith and agree on a reasonable estimate of the Net Price for the Product for such Fiscal Year, which estimate will be based on a reasonable approximation of the aggregate Net Sales of Product to be recognized by Distributor and its Affiliates during such Fiscal Year. The agreed Net Price will be used to calculate the Transfer Price initially invoiced by Zogenix and payable by Distributor for the total number of units of the Product ordered by 26 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 and delivered to Distributor under the Supply Agreement during such Fiscal Year. (c) Reports. Within [***] after the end of each of the first three Fiscal Quarters in a Fiscal Year, starting with the Fiscal Quarter in which the First Commercial Sale occurs, Distributor shall deliver to Zogenix a report setting forth: (i) the total Net Sales of the Product in the Territory during such Fiscal Quarter, (ii) the detailed and total deductions from gross amounts invoiced to arrive at such Net Sales, (iii) the number of units of the Product sold in the Territory during such Fiscal Quarter and (iv) gross amounts invoiced for such sales. Within [***] after the end of each Fiscal Year, starting with the Fiscal Year in which the First Commercial Sale occurs, Distributor shall deliver to Zogenix a report setting forth: (A) the total Net Sales of the Product in the Territory during such Fiscal Year, (B) the detailed and total deductions from gross amounts invoiced to arrive at such Net Sales, (C) the number of units of the Product sold in the Territory during such Fiscal Year, (D) the gross amounts invoiced for such sales, (E) the calculation of actual Net Price for such Fiscal Year, (F) the total amount invoiced by Zogenix and paid by Distributor to Zogenix under the Supply Agreement for the total number of units of the Product ordered by and delivered to Distributor during such Fiscal Year, based on the estimated Net Price for such Fiscal Year, (G) the total amount actually owed to Zogenix for the total number of units of the Product ordered by and delivered to Distributor during such Fiscal Year based on the actual Net Price and (H) the difference between the amounts in clauses (F) and (G) (each such report, an \\\"Annual Report\\\"). (d) True-Up. For each Annual Report, if the amount in clause (G) of such Annual Report exceeds the amount in clause (F), then Distributor shall pay the amount in clause (H) to Zogenix concurrently with its delivery of such Annual Report to Zogenix. Otherwise, if the amount in clause (G) is less than the amount in clause (F), the amount in clause (H) will be credited against the subsequent payment(s) due from Distributor to Zogenix (or if no further payments will be due, paid by Zogenix to Distributor within [***] after Zogenix's receipt of such Annual Report from Distributor). In no event shall the effective Transfer Price for the Product in a Fiscal Year exceed [***] of the aggregate annual Net Sales of the Product in the Field in the Territory for such Fiscal Year.\"}, {\"id\": \"ARTICLE 7\", \"title\": \"PAYMENTS, BOOKS AND RECORDS\", \"level\": 1, \"text\": \"ARTICLE 7. PAYMENTS, BOOKS AND RECORDS\"}, {\"id\": \"7.1\", \"title\": \"Payment Method\", \"level\": 2, \"text\": \"7.1 Payment Method. All amounts specified to be payable under this Agreement are in United States dollars and shall be paid in United States dollars. All payments under this Agreement shall be made by bank wire transfer in immediately available funds to an account designated in writing by the payee Party or by such other means as directed by such Party in writing. Payments hereunder will be considered to be made as of the day on which they are received by the payee Party's designated bank. 27 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"7.2\", \"title\": \"Currency Conversion\", \"level\": 2, \"text\": \"7.2 Currency Conversion. For the purpose of calculating any sums due under this Agreement and determining the annual Net Sales levels in Section 6.5, conversion shall be made to U.S. dollars by using the arithmetic mean of the exchange rates for the purchase of United States dollars as published in The Wall Street Journal, Eastern Edition, for each Business Day in the Fiscal Quarter to which such calculations relate.\"}, {\"id\": \"7.3\", \"title\": \"Taxes\", \"level\": 2, \"text\": \"7.3 Taxes. Any taxes imposed on Distributor or with respect to Distributor's business operations or activities hereunder, including any value added taxes, consumption, transfer, sales, use or other such taxes relating to the transactions contemplated herein, shall be borne by Distributor, and Distributor shall timely pay, and indemnify and hold harmless, Zogenix from and against all such taxes, including any penalties or interest associated therewith. If Distributor is required by Applicable Law to deduct and withhold taxes from a payment due and payable to Zogenix hereunder (excluding national, state or local taxes based on income to Zogenix), Distributor shall: (a) promptly notify Zogenix of such requirement; (b) make such required deduction and withholding from the corresponding payment; (c) pay to the relevant Governmental Authority the full amount required to be so deducted and withheld; and (d) promptly forward to Zogenix an official receipt or other documentation reasonably acceptable to Zogenix evidencing such payment to such Governmental Authority(ies). The Parties acknowledge and agree that it is their mutual objective and intent to minimize, to the extent feasible under the Applicable Laws, any taxes payable in connection with this Agreement, and shall reasonably cooperate each other in good faith in accordance with Applicable Laws to minimize any Taxes in connection with this Agreement, including provision of any tax forms and other information that may be reasonably necessary in order for the paying Party not to withhold tax or to withhold tax at a reduced rate under an applicable bilateral income tax treaty.\"}, {\"id\": \"7.4\", \"title\": \"Records\", \"level\": 2, \"text\": \"7.4 Records. Distributor shall keep, and require its Affiliate and Sub-distributors to keep, complete, fair and true books of accounts and records for the purpose of (a) determining the amounts payable to Zogenix pursuant to this Agreement and the Supply Agreement and (b) ensuring that Distributor and its Affiliates and Sub-distributors do not otherwise cause any Zogenix Indemnitees to be in violation of the FCPA or other Applicable Laws. Such books and records shall be kept for such period of time required by Applicable Laws, but no less than three (3) years following the end of the Fiscal Year to which they pertain. Such records shall be subject to inspection in accordance with Section 7.5.\"}, {\"id\": \"7.5\", \"title\": \"Audits\", \"level\": 2, \"text\": \"7.5 Audits. Upon reasonable prior written notice, Distributor shall permit an independent, certified public accountant selected by Zogenix and reasonably acceptable to Distributor, which acceptance will not be unreasonably withheld or delayed, to audit or inspect those books or records of Distributor and its Affiliates and Sub-distributors that relate to Net Sales for the sole purpose of verifying: (a) the payments due hereunder and payments due under the Supply Agreement; (b) the withholding taxes, if any, required by Applicable Laws to be withheld; and (c) Distributor's compliance with Sections 10.1 and 10.2. Such accountant will disclose to Zogenix only the amount and accuracy of payments reported and actually paid or otherwise payable under this Agreement or the Supply Agreement, and will send a copy of the report to Distributor at the same time it is sent to Zogenix. Prompt adjustments (including 28 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 interest under Section 7.6 for underpaid amounts) shall be made by the Parties to reflect the results of such audit. Such inspections may be made no more than once each Fiscal Year (unless an audit or inspection reveals a material inaccuracy in reports made under this Agreement, in which case it may be repeated within such Fiscal Year), and during normal business hours, with reasonable efforts to minimize disruption of Distributor's normal business activities. Inspections conducted under this Section 7.5 shall be at the expense of Zogenix, unless a variation or error producing an underpayment in amounts payable exceeding [***] of the amount paid for a period covered by the inspection is established, in which case all reasonable costs relating to the inspection for such period shall be paid by Distributor. Absent manifest error, the accountant's report will be final and binding on the Parties.\"}, {\"id\": \"7.6\", \"title\": \"Late Payments\", \"level\": 2, \"text\": \"7.6 Late Payments. In the event that any payment due under this Agreement or the Supply Agreement is not made when due, the payment shall accrue interest from the date due at a rate per annum equal to [***] above the U.S. Prime Rate (as set forth in The Wall Street Journal, Eastern U.S. Edition) for the date on which payment was due, calculated daily on the basis of a 365-day year, or similar reputable data source; provided that in no event shall such rate exceed the maximum legal annual interest rate. The payment of such interest shall not limit a Party from exercising any other rights it may have as a consequence of the lateness of any payment.\"}, {\"id\": \"ARTICLE 8\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"ARTICLE 8. CONFIDENTIALITY\"}, {\"id\": \"8.1\", \"title\": \"Confidential Information\", \"level\": 2, \"text\": \"8.1 Confidential Information. Except to the extent expressly authorized by this Agreement or otherwise agreed in writing by the Parties, the Parties agree that during the Term and for [***] thereafter, the receiving Party (the \\\"Receiving Party\\\") shall keep confidential and shall not publish or otherwise disclose or use for any purpose other than as provided for in this Agreement or the Supply Agreement any Information or materials furnished to it or its Affiliates by or on behalf of the other Party (the \\\"Disclosing Party\\\") or its Affiliates pursuant to this Agreement, the Supply Agreement, the Confidentiality Agreement or any other written agreement between the Parties or their Affiliates, in any form (written, oral, photographic, electronic, magnetic, or otherwise), including all information concerning the Product and any other technical or business information of whatever nature (collectively, \\\"Confidential Information\\\" of the Disclosing Party). All Zogenix Technology (including, without limitation, all Product Inventions and Data) shall be deemed the Confidential Information of Zogenix. Distributor Inventions shall be deemed the Confidential Information of Distributor. Joint Inventions shall be deemed the Confidential Information of each of Zogenix and Distributor. Each Party may use the Confidential Information of the other Party only to the extent required to accomplish the purposes of this Agreement or the Supply Agreement (including to exercise its rights or fulfill its obligations under this Agreement or the Supply Agreement). Each Party will use at least the same standard of care as it uses to protect proprietary or confidential information of its own (but in no event less than reasonable care) to ensure that its employees, agents, consultants and other representatives do not disclose or make any unauthorized use of the 29 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Confidential Information of the other Party. Each Party will promptly notify the other upon discovery of any unauthorized use or disclosure of the Confidential Information of the other Party.\"}, {\"id\": \"8.2\", \"title\": \"Exceptions\", \"level\": 2, \"text\": \"8.2 Exceptions. Notwithstanding Section 8.1 above, the obligations of confidentiality and non\u2011use shall not apply to information that the Receiving Party can prove by competent written evidence: (a) is now, or hereafter becomes, through no act or failure to act on the part of the Receiving Party or any of its Affiliates, generally known or available; (b) is known by the Receiving Party or any of its Affiliates, other than under an obligation of confidentiality to the Disclosing Party, at the time of receiving such information; (c) is hereafter lawfully furnished to the Receiving Party or any of its Affiliates by a Third Party, which Third Party did not receive such information directly or indirectly from the Disclosing Party under an obligation of confidence; (d) is independently discovered or developed by the Receiving Party or any of its Affiliates without the use of Confidential Information belonging to the Disclosing Party; or (e) is the subject of a written permission to disclose provided by the Disclosing Party.\"}, {\"id\": \"8.3\", \"title\": \"Permitted Disclosures\", \"level\": 2, \"text\": \"8.3 Permitted Disclosures. Notwithstanding the provisions of Section 8.1, the Receiving Party may disclose Confidential Information of the Disclosing Party as expressly permitted by this Agreement or if and to the extent such disclosure is reasonably necessary in the following instances: (a) filing or prosecuting Patents as permitted by this Agreement; (b) prosecuting or defending litigation as permitted by this Agreement; (c) complying with applicable court orders, governmental regulations, applicable subpoenas or reasonable requests issued by governmental authorities in relation to compliance with the FCPA and other Applicable Laws; (d) in the case of Zogenix, disclosure under terms of confidentiality no less stringent than under this Agreement to potential or actual Zogenix ex-Territory Distributors; (e) disclosure to its and its Affiliates' contractors, employees and consultants, in each case who need to know such information for filing for, obtaining and maintaining Regulatory Approvals and Commercialization of Product in the Territory in accordance with this Agreement and manufacturing and supplying of Product in accordance with the Supply Agreement (or, in the case of disclosures by Zogenix, who need to know such information for the Development, manufacture and commercialization of the Product outside the Field or Territory), on the condition that any such Third Parties agree to be bound by confidentiality and non-use obligations that are no less stringent than those confidentiality and non-use provisions contained in this Agreement; and (f) disclosure to Third Parties in connection with due diligence or similar investigations by such Third Parties, and disclosure to potential Third Party investors in confidential financing documents, provided, in each case, that any such Third Party agrees to be 30 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 bound by confidentiality and non-use obligations that are no less stringent than those confidentiality and non-use provisions contained in this Agreement. Notwithstanding the foregoing, in the event a Party is required to make a disclosure of the other Party's Confidential Information pursuant to Section 8.3(b) or (c), it will, except where impracticable, give reasonable advance notice to the other Party of such disclosure and use efforts to secure confidential treatment of such information at least as diligent as such Party would use to protect its own confidential information, but in no event less than reasonable efforts. In any event, the Parties agree to take all reasonable action to avoid disclosure of Confidential Information hereunder.\"}, {\"id\": \"8.4\", \"title\": \"Confidentiality of this Agreement and its Terms\", \"level\": 2, \"text\": \"8.4 Confidentiality of this Agreement and its Terms. Except as otherwise provided in this Article 8, each Party agrees not to disclose to any Third Party the existence of this Agreement or the terms of this Agreement without the prior written consent of the other Party, except that each Party may disclose the terms of this Agreement that are not otherwise made public as contemplated by Section 8.5 as permitted under Section 8.3.\"}, {\"id\": \"8.5\", \"title\": \"Public Announcements\", \"level\": 2, \"text\": \"8.5 Public Announcements. (a) As soon as practicable following the Effective Date, the Parties may each issue a press release in English and/or Japanese, in the form attached hereto as Exhibit 8.5(a), announcing the existence of this Agreement. Except as required by Applicable Laws (including disclosure requirements of the SEC or any stock exchange on which securities issued by a Party or its Affiliates are traded), neither Party shall make any other public announcement concerning this Agreement or the subject matter hereof without the prior written consent of the other, which shall not be unreasonably withheld or delayed; provided that each Party may make any public statement in response to questions by the press, analysts, investors or those attending industry conferences or financial analyst calls, or issue press releases, so long as any such public statement or press release is not inconsistent with prior public disclosures or public statements approved by the other Party pursuant to this Section 8.5 and does not reveal non\u2011public information about the other Party; and provided further that Zogenix may make public statements regarding the results of Development and Commercialization activities in the Territory. In the event of a public announcement required by Applicable Laws, to the extent practicable under the circumstances, the Party making such announcement shall provide the other Party with a copy of the proposed text of such announcement sufficiently in advance of the scheduled release to afford such other Party a reasonable opportunity to review and comment upon the proposed text. (b) The Parties will coordinate in advance with each other in connection with the filing of this Agreement (including redaction of certain provisions of this Agreement) with the SEC or any stock exchange on which securities issued by a Party or its Affiliate are traded, and each Party will use reasonable efforts to seek confidential treatment for the terms proposed to be redacted; provided that each Party will ultimately retain control over what information to disclose to the SEC or other applicable government body, and provided further that the Parties will use their reasonable efforts to file redacted versions with any governing bodies which are consistent with redacted versions previously filed with any other governing bodies. Other than 31 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 such obligation, neither Party (nor its Affiliates) will be obligated to consult with or obtain approval from the other Party with respect to any filings to the SEC or any other government body governing a stock exchange. (c) Except as expressly permitted in this Agreement or as required by Applicable Laws, neither Party may use the other Party's trademarks, service marks or trade names, or otherwise refer to or identify that other Party in marketing or promotional materials, press releases, statements to news media or other public announcements, without the other Party's prior written consent, which that other Party may grant or withhold in its sole discretion.\"}, {\"id\": \"8.6\", \"title\": \"Publication\", \"level\": 2, \"text\": \"8.6 Publication. At least [***] prior to Distributor or its Affiliates or Sub-distributors publishing, publicly presenting, and/or submitting for written or oral publication a manuscript, presentation, abstract, marketing document or the like that includes Information relating to the Product that has not been previously published, Distributor shall provide to Zogenix's Alliance Manager a draft copy thereof for Zogenix's review (unless Distributor is required by Applicable Laws to publish such Information sooner, in which case Distributor shall provide such draft copy to Zogenix's Alliance Manager as much in advance of such publication as possible). Distributor shall consider in good faith any comments provided by Zogenix during such [***] period, and in the event that Zogenix raises any concerns the matter shall be raised at the JSC; provided that Distributor shall, at Zogenix's reasonable request, cease such proposed publication or remove therefrom any information requested by Zogenix. The contribution of each Party shall be noted in all publications or presentations by acknowledgment or co-authorship, whichever is appropriate.\"}, {\"id\": \"8.7\", \"title\": \"Prior Non-Disclosure Agreements\", \"level\": 2, \"text\": \"8.7 Prior Non-Disclosure Agreements. As of the Effective Date, the terms of this Article 8 shall supersede any prior non-disclosure, secrecy or confidentiality agreement between the Parties (or their Affiliates) dealing with the subject of this Agreement, including the Confidentiality Agreement, but excluding any terms of the Supply Agreement. Any information disclosed under such prior agreements shall be deemed disclosed under this Agreement.\"}, {\"id\": \"8.8\", \"title\": \"Equitable Relief\", \"level\": 2, \"text\": \"8.8 Equitable Relief. Given the nature and value of the Confidential Information and the competitive damage and irreparable harm that would result to a Party upon unauthorized disclosure, use or transfer of its Confidential Information to any Third Party, the Parties agree that monetary damages may not be a sufficient remedy for any breach of this Article 8. If the Receiving Party becomes aware of any breach or threatened breach of this Article 8 by the Receiving Party or a Third Party to whom the Receiving Party disclosed the Disclosing Party's Confidential Information, the Receiving Party promptly shall notify the Disclosing Party and cooperate with the Disclosing Party to regain possession of its Confidential Information and prevent any further breach. In addition to all other remedies, a Party shall be entitled to seek specific performance and injunctive and other equitable relief as a remedy for any breach or threatened breach of this Article 8 without furnishing proof of actual damages or posting a bond. ARTICLE 9. 32 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 INTELLECTUAL PROPERTY OWNERSHIP AND ENFORCEMENT\"}, {\"id\": \"9.1\", \"title\": \"Ownership of Intellectual Property\", \"level\": 2, \"text\": \"9.1 Ownership of Intellectual Property. (a) Zogenix Technology. Zogenix shall retain all right, title and interest in and to the Zogenix Technology. (b) Inventions and Intellectual Property Rights. (i) Ownership. Zogenix shall own the entire right, title and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice solely by or on behalf of Zogenix under or in connection with this Agreement, including in the course of conducting regulatory activities or Commercialization of the Product in the Field in the Territory, whether or not patented or patentable, together with any and all intellectual property rights in any such Inventions, including Patents that claim or disclose any such Inventions (collectively, the \\\"Product Invention\\\"). Distributor shall own the entire right, title and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice solely by Distributor or its Affiliates or Sub-distributors or its other subcontractors in the Territory and under or in connection with this Agreement, including in the course of conducting regulatory activities or Commercialization of the Product in the Field in the Territory, whether or not patented or patentable, together with any and all intellectual property rights in any such Inventions, including Patents that claim or disclose any such Inventions (collectively, the \\\"Distributor Invention\\\"). Zogenix and Distributor shall each own an undivided right, title, and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice jointly by or on behalf of Zogenix under or in connection with this Agreement and by Distributor or its Affiliates or Sub-distributors or its other subcontractors in the Territory and under or in connection with this Agreement (\\\"Joint Invention\\\"). In the event that either Zogenix or Distributor intends to file a patent application containing a Joint Invention, such Party shall promptly notify the other Party of such intention and shall provide a draft of any such patent application to such other Party [***] before filing such patent application with any patent office and the Parties shall negotiate in good faith concerning the terms and conditions of a joint patent agreement. (ii) Disclosure, License. Distributor shall, and shall cause its Affiliates and Sub-distributors and other subcontractors to, promptly disclose any Distributor Inventions to Zogenix in writing promptly following its discovery, development, identification, making, conception or reduction to practice by the Distributor, its Affiliates, Sub-distributors or other subcontractors. Distributor hereby grants Zogenix an irrevocable, perpetual, world-wide, royalty-free, fully paid-up, non-exclusive license with the right to grant sublicenses under such Distributor Inventions and any patents or patent applications claiming or disclosing such Distributor Inventions. In the event that Distributor intends to file a patent application containing Distributor Inventions, Distributor shall promptly notify Zogenix of such intention and shall provide a draft of any such patent application to Zogenix at least [***] before filing such patent application with any patent office. Distributor shall have the sole right to file for patent protection for such Distributor Inventions only if Zogenix does not provide a written objection 33 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 within [***] of being provided with a draft of such patent application. (c) Personnel Obligations. Prior to receiving any Confidential Information or beginning work under this Agreement, Distributor shall ensure that each employee, agent or contractor of Distributor or its Affiliates or Sub-distributors shall be bound in writing by non-disclosure and Invention assignment obligations that are consistent with the obligations of the Parties in Article 8 and this Article 9, including obligations to: (a) promptly report any invention, discovery, process or other intellectual property right; (b) assign to Distributor or Zogenix all of his, her or its right, title and interest in and to any invention, discovery, process or other intellectual property right; (c) cooperate in the preparation, filing, prosecution, maintenance and enforcement of any patent and patent application; (d) perform all acts and sign, execute, acknowledge and deliver any and all documents required for effecting the obligations and purposes of this Agreement; and (e) abide by the obligations of confidentiality and non-use set forth in Article 8. It is understood and agreed that such non-disclosure and invention assignment agreements need not reference or be specific to this Agreement.\"}, {\"id\": \"9.2\", \"title\": \"Zogenix Patent Prosecution and Maintenance\", \"level\": 2, \"text\": \"9.2 Zogenix Patent Prosecution and Maintenance. During the term of this Agreement, Zogenix shall use Commercially Reasonable Efforts to prepare, file, prosecute (including any reissues, re-examinations, post-grant proceedings, requests for patent term extensions, interferences, and defense of oppositions), at Zogenix's sole discretion and cost. If there is any material change in Zogenix Patents specified in Exhibit 1.74, Zogenix shall provide Distributor with updated information concerning the Zogenix Patent in a timely manner.\"}, {\"id\": \"9.3\", \"title\": \"Infringement by Third Parties\", \"level\": 2, \"text\": \"9.3 Infringement by Third Parties. (a) Notice. In the event that either Zogenix or Distributor becomes aware of any infringement or threatened infringement by a Third Party in the Territory of any Zogenix Patents, it shall notify the other Party in writing to that effect. Any such notice shall include evidence to support an allegation of infringement or threatened infringement by such Third Party. (b) Control of Action. Each Party shall share with the other Party all information available to it regarding such alleged or threatened infringement by a Third Party. Zogenix shall have the sole right, but not the obligation, to bring and control any action or proceeding with respect to alleged or threatened infringement by a Third Party in the Territory of any Zogenix Patent at Zogenix's cost and expense. If Zogenix elects to commence a suit to enforce the applicable Zogenix Patent against such infringements, then Distributor shall have the right to join such enforcement action, if permitted by Applicable Law, upon notice to Zogenix and be represented by a counsel of its own choice at its own cost and expense. Zogenix shall keep Distributor reasonably informed of any such actions or proceedings and consider in good faith any comments or requests made by Distributor, and the Parties shall cooperate and consult with each other in strategizing regarding any such action or proceeding, provided that Zogenix shall control and have the right to make all final decisions (regardless of whether or not Distributor is a party to such action or proceeding) regarding all matters in the preparation and conduct of any such action or proceeding. Each Party shall cooperate fully with the other Party with respect to actions or proceedings under this Section 9.3, including being joined as a party 34 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 plaintiff in any such action or proceeding and providing access to relevant documents and other evidence and making its employees available at reasonable business hours, with the costs of such cooperation to be included as shared costs for actions or proceedings brought hereunder. (c) Recoveries. Any monetary recovery resulting from actions or proceedings under this Section 9.3 will be allocated as follows: each of Distributor and Zogenix first will be reimbursed, out of such recovery, for its reasonable and verifiable costs and expenses with respect to such action or proceeding (such reimbursement to be pro-rata based on the Parties' relative costs and expenses if the recovery is not sufficient to reimburse both Parties fully) with any remainder being (i) allocated [***] if[***] or (ii) allocated [***] if [***].\"}, {\"id\": \"9.4\", \"title\": \"Third Party Intellectual Property Rights\", \"level\": 2, \"text\": \"9.4 Third Party Intellectual Property Rights. (a) If either Party becomes aware of a Patent in the Territory owned by a Third Party that it believes will, or may, be infringed by the manufacture, importation, Development or Commercialization of the Product in the Field in the Territory as contemplated by this Agreement, such Party shall notify the other Party of such Patent. The Parties then shall discuss the matter and seek in good faith to agree on whether the Parties should take a license under such Patent, and if so, on what terms; provided, that if the Parties are unable to agree after a reasonable period, [***], of good faith discussions, then Zogenix shall have the right to obtain such a license on such terms as it determines in its sole discretion and at its own cost and expense. Provided, however, in the event that Zogenix elects not to seek or fails to obtain a license under such Patent, Distributor shall have the right to obtain such a license with prior written notice to Zogenix. (b) Each Party shall promptly notify the other Party in writing of any allegation by a Third Party that the activity of either Party pursuant to this Agreement or the Supply Agreement infringes or may infringe the intellectual property rights of such Third Party. Zogenix shall have the sole right to control any defense of any such claim involving alleged infringement of Third Party rights, at Zogenix's sole cost and expense and by counsel of its own choice; provided however that Distributor may participate in the defense, at its own expense, to be represented in any such action by counsel of its own choice. In any event, Zogenix agrees to keep Distributor reasonably informed of all material developments in connection with any such action. Zogenix agrees not to settle such infringement or make any admissions or assert any position in such action in a manner that would materially adversely affect the rights or interest of Distributor, without the prior written consent of Distributor, which shall not be unreasonably withheld, delayed or conditioned. Neither Party shall enter into any settlement or compromise of any action under this Section 9.4 which would in any manner alter, diminish, or be in derogation of the other Party's rights under this Agreement without the prior written consent of such other Party, which shall not be unreasonably withheld, delayed or conditioned.\"}, {\"id\": \"9.5\", \"title\": \"Patent Term Restoration\", \"level\": 2, \"text\": \"9.5 Patent Term Restoration. At the request of Zogenix, the Parties shall cooperate with each other in obtaining patent term restoration, extensions and/or any other extensions of the Zogenix Patents as available under Applicable Laws, subject to Zogenix's rights under Section 9.2. Zogenix shall bear the cost for such patent term restoration and/or any other 35 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 extensions of the Zogenix Patent.\"}, {\"id\": \"9.6\", \"title\": \"Patent Marking\", \"level\": 2, \"text\": \"9.6 Patent Marking. Distributor shall, and shall require its Affiliates and Sub-distributors to, mark all Product sold in the Territory (in a reasonable manner consistent with industry custom and practice and Applicable Law) with appropriate patent numbers or indicia to the extent permitted by Applicable Laws, if such markings impact recoveries of damages or equitable remedies available with respect to infringements of patents.\"}, {\"id\": \"9.7\", \"title\": \"Zogenix Trademarks\", \"level\": 2, \"text\": \"9.7 Zogenix Trademarks. All packaging, promotional materials, package inserts, and labeling for the Product in the Field in the Territory shall bear, free of charge, one or more house Trademarks chosen and owned by Zogenix, including the Zogenix name and logo set forth in Exhibit 9.7 (each, a \\\"Zogenix Trademark\\\"). Zogenix or its Affiliates shall own all right, title, and interest in and to all Zogenix Trademarks, all corresponding trademark applications and registrations thereof, and all common law rights thereto. Zogenix shall, at Zogenix's sole expense, have sole control over the registration, prosecution, maintenance, enforcement and defense of the Zogenix Trademarks. All goodwill of the business associated with or symbolized by the Zogenix Trademarks shall inure to the benefit of Zogenix. Distributor acknowledges Zogenix's exclusive ownership of the Zogenix Trademarks and agrees not to take any action inconsistent with such ownership. Distributor shall provide Zogenix with samples of any advertising and promotional materials in original language that incorporate the Zogenix Trademarks prior to distributing such materials for use. Distributor shall comply with reasonable policies provided by Zogenix from time to time to maintain the goodwill and value of the Zogenix Trademarks. Distributor shall not, and shall cause its Affiliates not to, (i) use, seek to register, or otherwise claim rights in any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that materially dilutes, any of the Zogenix Trademarks, or (ii) knowingly do, cause to be done, or knowingly omit to do any act, the doing, causing or omitting of which endangers, undermines, impairs, destroys or similarly affects, in any material respect, the validity or strength of any of the Zogenix Trademarks (including any registration or pending registration application relating thereto) or the value of the goodwill pertaining to any of the Zogenix Trademarks.\"}, {\"id\": \"9.8\", \"title\": \"Product Trademarks\", \"level\": 2, \"text\": \"9.8 Product Trademarks. (a) Selection and Ownership of Product Trademarks. All packaging, promotional materials, package inserts, and labeling for the Product in the Field in the Territory shall bear one or more Trademarks that pertain specifically to the Product, including the Trademarks in existence as of the Effective Date as set forth in Exhibit 9.8 (each, a \\\"Product Trademark\\\"). If the Product Trademarks in existence as of the Effective Date are not eligible for trademark protection or for use in connection with the Product in the Field in the Territory or if the Parties agree that alternative or additional Trademarks may be beneficial, Distributor may investigate appropriate Trademarks for the Product in the Territory. If the Parties identify and agree on alternative or additional Trademarks for the Product in the Territory, Zogenix shall use Commercially Reasonable Efforts to register such Trademark(s) for the Product in the Field in the Territory. Zogenix or its Affiliates shall own all right, title, and interest in and to all Product 36 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Trademarks, all corresponding trademark applications and registrations thereof, and all common law rights thereto. All goodwill of the business associated with or symbolized by the Product Trademarks shall inure to the benefit of Zogenix. Distributor acknowledges Zogenix's exclusive ownership of the Product Trademarks and agrees not to take any action inconsistent with such ownership. (b) Maintenance and Prosecution of Product Trademarks. Zogenix shall, at Zogenix's sole expense, control the registration, prosecution and maintenance of the Product Trademarks in the Territory; provided, that Zogenix shall keep Distributor reasonably informed of Zogenix's actions with respect thereto and shall consider in good faith any reasonable comments made by Distributor with respect thereto. (c) Use of Product Trademarks. Distributor shall promote, market, sell, offer for sale, import, distribute and otherwise commercialize the Product in the Field in the Territory only under the Product Trademarks. Distributor shall provide Zogenix with samples of any advertising and promotional materials that incorporate the Product Trademarks prior to distributing such materials for use. Distributor shall comply with reasonable policies provided by Zogenix from time to time to maintain the goodwill and value of the Product Trademarks. Distributor shall not, and shall cause its Affiliates not to, (i) use, seek to register, or otherwise claim rights in the Territory in any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that materially dilutes, any of the Product Trademarks, or (ii) knowingly do, cause to be done, or knowingly omit to do any act, the doing, causing or omitting of which endangers, undermines, impairs, destroys or similarly affects, in any material respect, the validity or strength of any of the Product Trademarks (including any registration or pending registration application relating thereto) or the value of the goodwill pertaining to any of the Product Trademarks. (d) Enforcement of Product Trademarks. Zogenix shall have the first right, but not the obligation, at Zogenix's expense, to enforce and defend the Product Trademarks in the Territory, including (i) defending against any alleged, threatened or actual claim by a Third Party that the use of the Product Trademarks in the Territory infringes, dilutes or misappropriates any Trademark of that Third Party or constitutes unfair trade practices, or any other claims that may be brought by a Third Party against a Party in connection with the use of or relating to Product Trademarks in the Territory with respect to the Product and (ii) taking such action as Zogenix deems necessary against a Third Party based on any alleged, threatened or actual infringement, dilution or misappropriation of, or unfair trade practices or any other like offense relating to, the Product Trademarks in the Territory by a Third Party. If Zogenix elects not to enforce or defend the Product Trademarks in any such instance, then Zogenix shall promptly so notify Distributor and Distributor shall have the right, but not the obligation, at its expense, to do so. Each Party shall provide to the other Party all reasonable assistance requested by such first Party in connection with any such action, claim or suit under this Section 9.8(d), including allowing such first Party access to such other Party's documents and to such other Party's personnel who may have possession of relevant information. 37 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (e) Distributor's Housemarks. In addition to the Product Trademarks, Distributor shall have the right to brand the Product in the Territory with those trademarks of Distributor that are associated with Distributor's name or identity and are pre-approved in writing by Zogenix (\\\"Distributor Housemarks\\\"). Distributor shall own all rights in the Distributor Housemarks, and all goodwill in the Distributor Housemarks shall accrue to Distributor. Distributor and its Affiliates and Sub-distributor shall not use any trademarks, other than the Zogenix Trademarks, Product Trademarks and the approved Distributor Housemarks, in connection with the Commercialization of the Product in the Field in the Territory, without the prior written consent of Zogenix.\"}, {\"id\": \"ARTICLE 10\", \"title\": \"REPRESENTATIONS, WARRANTIES AND COVENANTS; LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"ARTICLE 10. REPRESENTATIONS, WARRANTIES AND COVENANTS; LIMITATION OF LIABILITY\"}, {\"id\": \"10.1\", \"title\": \"Mutual Representations, Warranties and Covenants\", \"level\": 2, \"text\": \"10.1 Mutual Representations, Warranties and Covenants. Each Party hereby represents and warrants to the other Party, as of the Effective Date, as follows: (a) Duly Organized. Such Party is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, is qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the conduct of its business or the ownership of its properties requires such qualification and failure to have such would prevent such Party from performing its obligations under this Agreement. (b) Due Authorization; Binding Agreement. The execution, delivery and performance of this Agreement by such Party have been duly authorized by all necessary corporate action. This Agreement is a legal and valid obligation binding on such Party and enforceable in accordance with its terms and does not: (i) to such Party's knowledge and belief, violate any law, rule, regulation, order, writ, judgment, decree, determination or award of any court, governmental body or administrative or other agency having jurisdiction over such Party; nor (ii) conflict with, or constitute a default under, any agreement, instrument or understanding, oral or written, to which such Party is a party or by which it is bound. (c) Consents. Such Party has obtained, or is not required to obtain, the consent, approval, order or authorization of any Third Party, or has completed, or is not required to complete, any registration, qualification, designation, declaration or filing with any Regulatory Authority or governmental authority in connection with the execution and delivery of this Agreement and the performance by such Party of its obligations under this Agreement. (d) No Conflicting Grant of Rights. Such Party has the right to grant the rights contemplated under this Agreement and has not, and will not during the Term, grant any right to any Third Party that would conflict with the rights granted to the other Party hereunder. (e) Debarment. Such Party is not debarred or disqualified under the United 38 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 States Federal Food, Drug and Cosmetic Act or comparable Applicable Laws in the Territory and it does not, and will not during the Term, employ or use the services of any Person who is debarred or disqualified, in connection with activities relating to the Product. In the event that either Party becomes aware of the debarment or disqualification or threatened debarment or disqualification of any Person providing services to such Party, including the Party itself and its Affiliates or Sub-distributors, that directly or indirectly relate to activities under this Agreement, such Party shall immediately notify the other Party and shall cease employing, contracting with, or retaining any such person to perform any services under this Agreement. (f) Comply with Applicable Laws. In the performance of its obligations hereunder, such Party shall comply and shall cause its and its Affiliates' employees and contractors to comply with all Applicable Laws. (g) Anti-Corruption. Such Party shall not, directly or indirectly through Third Parties, pay, promise or offer to pay, or authorize the payment of, any money or give any promise or offer to give, or authorize the giving of anything of value to a Public Official or Entity or other Person for purpose of obtaining or retaining business for or with, or directing business to, any Person, including, without limitation, Zogenix or Distributor. Without any limitation to the foregoing, such Party has not and shall not directly or indirectly promise, offer or provide any corrupt payment, gratuity, emolument, bribe, kickback, illicit gift or hospitality or other illegal or unethical benefit to a Public Official or Entity or any other Person. (h) Accuracy of Materials. All due diligence materials that such Party has provided and will provide to the other Party were and will be to the knowledge of such Party accurate, truthful, and complete at the time such materials are provided to the other Party, and such Party has not and will not intentionally omit any material facts requested by the other Party. (i) Notification for Violation of Applicable Laws. Such Party shall immediately notify the other Party if it has any information or suspicion that there may be a violation of the FCPA or any other Applicable Law in connection with the performance of this Agreement or the sale of the Product in the Territory. (j) No Pubic Officials. No owner, shareholder (direct or beneficial), officer, director, employee, third-party representative, agent, or other individual with any direct or indirect beneficial interest in such Party or its Affiliates or, to its knowledge, in its Sub-distributors or other contractors, or any immediate family relation of any such Person (collectively, \\\"Interested Persons\\\"), is a Public Official or Entity. Such Party shall notify the other Party immediately if during the Term (i) any Interested Person becomes a Public Official or Entity or (ii) any Public Official or Entity acquires a legal or beneficial interest in it or its Affiliate or, to its knowledge, in its Sub-distributors or other subcontractors.\"}, {\"id\": \"10.2\", \"title\": \"Representations, Warranties and Covenants of Distributor\", \"level\": 2, \"text\": \"10.2 Representations, Warranties and Covenants of Distributor. Distributor represents, warrants, and covenants to Zogenix that: (a) in the performance of its obligations hereunder, Distributor shall comply 39 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 and shall cause its and its Affiliates' and Sub-distributors' employees and contractors to comply with Applicable Law and Distributor's compliance policies, complete copies of which will be provided to Zogenix before the launch of the Product in the Territory; (b) during the Term, Distributor agrees that: (i) Zogenix will have the right, upon reasonable prior written notice and during Distributor's regular business hours, to audit Distributor's and its Affiliates' books and records by an independent certified public accounting firm of recognized international standing, and Distributor shall ensure that Zogenix has the right to audit its Sub-distributors' and subcontractors' books and records, to investigation potential violations of any of the representations, warranties or covenants in this Section 10.2, the FCPA or other Applicable Laws or Distributor's compliance policies. Such audit may be made no more than once each Fiscal Year (unless an audit reveals a violation under this Agreement, in which case an additional audit may be conducted within such Fiscal Year); (ii) Distributor will certify to Zogenix annually in writing or otherwise upon Zogenix's written request, under the form set forth in Exhibit 10.2(b) attached hereto, Distributor's compliance with the representations, warranties and covenants in this Section 10.2, the FCPA and other Applicable Laws and Distributor's compliance policies; (iii) Distributor will inform Zogenix promptly of any changes in its business that would change any of its representations, warranties or covenants in this Section 10.2; (iv) Zogenix shall have the right to suspend or terminate the supply of Product under the Supply Agreement and to terminate this Agreement if there is credible evidence that Distributor or its Affiliate or Sub-distributor may have violated any of the representations, warranties or covenants in this Section 10.2 the FCPA or other Applicable Laws or Distributor's compliance policies.\"}, {\"id\": \"10.3\", \"title\": \"Representations and Warranties of Zogenix\", \"level\": 2, \"text\": \"10.3 Representations and Warranties of Zogenix. Zogenix represents, warrants and covenants to Distributor that: (a) Zogenix will inform Distributor promptly of any changes in its business that would change any of its representations, warranties or covenants in this Section 10.3; and (b) as of the Effective Date, Zogenix has not received written notice of any pending or threatened claims or actions alleging that the Development or Commercialization of the Product in the Field infringes or would infringe the Patents of any Third Party in the Territory.\"}, {\"id\": \"10.4\", \"title\": \"Disclaimer\", \"level\": 2, \"text\": \"10.4 Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT AND THE SUPPLY AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, AND 40 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 EACH PARTY EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, VALIDITY AND ENFORCEABILITY OF PATENTS, OR THE PROSPECTS OR LIKELIHOOD OF DEVELOPMENT OR COMMERCIAL SUCCESS OF THE PRODUCT.\"}, {\"id\": \"10.5\", \"title\": \"Limitation of Liability\", \"level\": 2, \"text\": \"10.5 Limitation of Liability. NEITHER PARTY SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS AGREEMENT; provided however, that this Section 10.5 shall not be construed to limit (a) either Party's right to special, incidental or consequential damages for the other Party's breach of Article 8 or (b) either Party's indemnification rights or obligations under Article 11.\"}, {\"id\": \"ARTICLE 11\", \"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"ARTICLE 11. INDEMNIFICATION\"}, {\"id\": \"11.1\", \"title\": \"Indemnification of Zogenix\", \"level\": 2, \"text\": \"11.1 Indemnification of Zogenix. Distributor shall indemnify, defend and hold harmless Zogenix and its Affiliates and their respective directors, officers, employees and agents (the \\\"Zogenix Indemnitees\\\"), from and against any and all losses, liabilities, damages, penalties, fines, costs and expenses (including reasonable attorneys' fees and other expenses of litigation) (\\\"Losses\\\") incurred by any Zogenix Indemnitee resulting from any claims, actions, suits or proceedings brought by a Third Party (\\\"Third Party Claims\\\") to the extent arising from, or occurring as a result of: (a) the registration, use, handling, storage, import, offer for sale, sale or other disposition of the Product in the Territory by or on behalf of Distributor or its Affiliates; (b) the negligence or willful misconduct of any Distributor Indemnitees in connection with Distributor's performance of its obligations or exercise of its rights under this Agreement; or (c) any breach of any representations, warranties or covenants of Distributor in this Agreement, except to the extent such Third Party Claims fall within the scope of the indemnification obligations of Zogenix set forth in Section 11.2 or arise out of the breach by Zogenix of any of the terms of the Supply Agreement.\"}, {\"id\": \"11.2\", \"title\": \"Indemnification of Distributor\", \"level\": 2, \"text\": \"11.2 Indemnification of Distributor. Zogenix shall indemnify, defend and hold harmless Distributor and its Affiliates and their respective directors, officers, employees and agents (the \\\"Distributor Indemnitees\\\"), from and against any and all Losses incurred by any Distributor Indemnitee resulting from any Third Party Claims to the extent arising from, or occurring as a result of: (a) the manufacture, use, handling, storage, import, offer for sale, sale or other disposition of the Product outside the Territory by or on behalf of Zogenix or its Affiliates; (b) the negligence or willful misconduct of any Zogenix Indemnitees in connection with Zogenix's performance of its obligations or exercise of its rights under this Agreement; or (c) any breach of any representations, warranties or covenants of Zogenix in this Agreement, except to the extent such Third Party Claims fall within the scope of the indemnification obligations of Distributor set forth in Section 11.1 or arise out of the breach by Distributor of any of the terms of the Supply Agreement. 41 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"11.3\", \"title\": \"Procedure\", \"level\": 2, \"text\": \"11.3 Procedure. A Party that intends to claim indemnification under this Article 11 (the \\\"Indemnitee\\\") shall promptly notify the indemnifying Party (the \\\"Indemnitor\\\") in writing of any Third Party Claim, in respect of which the Indemnitee intends to claim such indemnification, and the Indemnitor shall have sole control of the defense and/or settlement thereof. The Indemnitee may participate at its expense in the Indemnitor's defense of and settlement negotiations for any Third Party Claim with counsel of the Indemnitee's own selection. The indemnity arrangement in this Article 11 shall not apply to amounts paid in settlement of any action with respect to a Third Party Claim, if such settlement is effected without the consent of the Indemnitor, which consent shall not be withheld or delayed unreasonably. The failure to deliver written notice to the Indemnitor within a reasonable time after the commencement of any action with respect to a Third Party Claim shall only relieve the Indemnitor of its indemnification obligations under this Article 11 if and to the extent the Indemnitor is actually prejudiced thereby. The Indemnitee shall cooperate fully with the Indemnitor and its legal representatives in the investigation of any action with respect to a Third Party Claim covered by this indemnification.\"}, {\"id\": \"11.4\", \"title\": \"Insurance\", \"level\": 2, \"text\": \"11.4 Insurance. Each Party, at its own expense, shall maintain product liability and other appropriate insurance (or self- insure) in an amount consistent with industry standards during the Term. Each Party shall provide a certificate of insurance (or evidence of self-insurance) evidencing such coverage to the other Party upon written request.\"}, {\"id\": \"ARTICLE 12\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 12. TERM AND TERMINATION\"}, {\"id\": \"12.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"12.1 Term. This Agreement shall commence on the Effective Date and shall remain in effect until September 1, 2045, unless earlier terminated by either Party pursuant to this Article 12 (the \\\"Term\\\").\"}, {\"id\": \"12.2\", \"title\": \"Termination\", \"level\": 2, \"text\": \"12.2 Termination. (a) Mutual Agreement. The Parties may terminate this Agreement by mutual written agreement. (b) Distributor Convenience. At any time following the expiration of the Distribution Term (as defined in Section 1.17), the Distributor may terminate this Agreement at will upon [***] prior written notice to Zogenix. (c) Zogenix Convenience. At any time following the expiration of the Distribution Term, Zogenix may terminate this Agreement at will upon [***] prior written notice to Distributor. (d) Material Breach. If either Party believes in good faith that the other is in material breach of its obligations hereunder, then the non-breaching Party may deliver written 42 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 notice of such breach to the other Party, and the allegedly breaching Party shall have [***] from receipt of such notice to dispute the validity of such breach. For all breaches of this Agreement, the allegedly breaching Party shall have [***] from the receipt of the initial notice to cure such breach. If the Party receiving notice of breach fails to cure the breach within such [***] period, then the non-breaching Party may terminate this Agreement in its entirety effective on written notice of termination to the other Party. Notwithstanding the foregoing, (a) if such material breach (other than a payment breach), by its nature, is curable, but is not reasonably curable within the [***] period, then such period shall be extended if the breaching Party provides a written plan for curing such breach to the non-breaching Party and uses Commercially Reasonable Efforts to cure such breach in accordance with such written plan; provided, that no such extension shall exceed [***] without the consent of the non-breaching Party. (e) Diligence. Zogenix shall have the right to terminate this Agreement pursuant to Section 5.1(d). (f) Bankruptcy. A Party shall have the right to terminate this Agreement upon written notice to the other Party upon the bankruptcy, dissolution or winding up of such other Party, or the making or seeking to make or arrange an assignment for the benefit of creditors of such other Party, or the initiation of proceedings in voluntary or involuntary bankruptcy, or the appointment of a receiver or trustee of such other Party's property, that is not discharged within [***]. (g) Commercial Viability. In the event that prior to launch of the Product in the Field in the Territory (i) either Party has a good faith concern that the launch of the Product in the Field in the Territory is not likely to be possible with Commercially Reasonable Efforts, based upon credible evidence, such as any decision by a Regulatory Authority to require significant additional information before granting or as a condition to granting Regulatory Approval, or (ii) Distributor has a good faith concern that the Commercialization of the Product in the Territory will not be commercially viable, such Party may raise such concern for discussion by the JSC. If, within the time periods set forth in Section 3.1(d) or such longer time period as the Parties may mutually agree upon in writing, neither the JSC nor the Executives agree whether to launch or commercialize Product in the Territory, then, notwithstanding anything to the contrary in Section 3.1(d) or Article 13, either Party shall have the right to terminate this Agreement upon at least [***] written notice to the other Party. (h) Third Party Patent. (i) Distributor shall have the right to terminate this Agreement upon written notice to Zogenix if (A) the Parties have discussed an issued Patent under Section 9.4(a), (B) either (1) both Zogenix and Distributor agree not to seek a license under such issued Patent or (2) the applicable Party as determined pursuant to Section 9.4(a) failed to obtain a license under such issued Patent, after good faith efforts to do so, within [***] after the Parties' agreement as to which Party would seek such license, and (C) Distributor reasonably and in good faith believes that the sale, offer for sale or import of the Product in the Territory in the Field infringes such issued Patent in the Territory, such that Distributor is not able to sell the Product in 43 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 the Territory in the Field without infringing such issued Patent. (ii) Zogenix shall have the right to terminate this Agreement upon written notice to Distributor if (A) the Parties have discussed an issued Patent under Section 9.4(a), (B) either (1) both Zogenix and Distributor agree not to seek a license under such issued Patent or (2) the applicable Party as determined pursuant to Section 9.4(a) failed to obtain a license under such issued Patent, after good faith efforts to do so, within [***] after the Parties' agreement as to which Party would seek such license, and (C) Zogenix reasonably and in good faith believes that the manufacture for and sale to Distributor of the Product infringes such issued Patent, such that Zogenix will not be able to conduct (or have conducted on its behalf) such manufacturing for and sale of the Product to Distributor without infringing (or its contract manufacturers infringing) such issued Patent. (i) Change of Control. This Agreement may be terminated by either Party upon [***] written notice to the other Party in the event that the other Party undergoes a Change of Control; provided, however, that such termination notice shall only be effective if delivered within [***] after the later of the occurrence of such Change of Control or the date the Party undergoing the Change of Control delivers written notice thereof to the other Party. (j) Other Zogenix Termination Rights. Zogenix shall have the right to terminate this Agreement immediately upon written notice to Distributor (i) if Distributor or any of its Affiliates or Sub-distributors, directly or indirectly through any Third Party, commences any interference or opposition proceeding with respect to, challenges the validity or enforceability of, or opposes any extension of or the grant of a supplementary protection certificate with respect to, any Zogenix Patent (or any related Patent owned or controlled by Zogenix outside the Territory); (ii) if Zogenix determines that Distributor or its Affiliates or Sub- distributors are, or have caused or shall cause any Zogenix Indemnitee to be, in violation of the FCPA or any other Applicable Laws; or (iii) if Zogenix decides to withdraw the Product from the market in the Territory or otherwise believes that the promotion of the Product in the Field in the Territory presents a substantial risk of harm or injury to consumers which risk is unacceptable according to established principles of medical ethics. (k) Termination of Supply Agreement. Following the execution of the Supply Agreement pursuant to Section 5.2, the Parties agree that this Agreement shall automatically terminate upon termination of the Supply Agreement for any reason. (l) Distributor Safety Concern. This Agreement may be terminated by Distributor upon written notice to Zogenix, in the event that Distributor has a reasonable belief after due inquiry that the promotion of the Product in the Field in the Territory presents a substantial risk of harm or injury to consumers which risk is unacceptable according to established principles of medical ethics. Prior to terminating this Agreement in accordance with this Section 12.2(l), Distributor shall present evidence supporting the basis for such termination to Zogenix and shall consider in good faith all comments provided by Zogenix prior to terminating this Agreement. 44 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"12.3\", \"title\": \"Rights on Termination\", \"level\": 2, \"text\": \"12.3 Rights on Termination. The following will apply upon any termination of this Agreement: 45 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 agreement would include such other standard terms and conditions for license agreements of this type as are mutually agreed to by the Parties. (c) Commercialization Transition. Unless this Agreement is terminated by Zogenix under Sections 12.2(f), (g)(i), (h)(ii), (j)(ii), or (j)(iii), or by Distributor under Sections 12.2(d), (g), or (l), or terminated automatically under Section 12.2(k), Distributor shall continue, to the extent that Distributor continues to have Product inventory, to fulfill orders received from customers for Product in the Territory until up to [***] after the date on which Zogenix notifies Distributor in writing that Zogenix has secured an alternative distributor for the Product in the Territory, but in no event for more for than [***] after the effective date of termination. All Product sold by or on behalf of Distributor or its Affiliates or Sub-distributors after the effective date of termination will be included in calculations under Article 6. Notwithstanding the foregoing, Distributor shall cease such activities upon [***] written notice from Zogenix at any time after the effective date of termination requesting that such activities cease. Within [***] after receipt of such cessation request, Distributor shall provide Zogenix an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory, and Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties. (d) Assignment of Regulatory Filings and Regulatory Approvals. Unless this Agreement is terminated by Zogenix under Section 12.2(c), at Zogenix's option, which shall be exercised by written notice to Distributor, to the extent permitted under Applicable Laws, Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory. (e) Transition. Unless this Agreement is terminated by Zogenix under Section 12.2(c), Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination. Without limiting the foregoing, Distributor shall use Commercially Reasonable Efforts to conduct, in an expeditious manner, any activities to be conducted under this Section 12.3. (f) Third Party Agreements. Unless this Agreement is terminated by Zogenix under Section 12.2(c), at the written request of Zogenix, Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party. In the event such assignment is not requested by Zogenix or is not permitted or agreed by such Third Party, then the rights of such Third Party with respect to the Product will terminate upon termination of Distributor's rights. Distributor shall ensure that each such Third Party (if its contract is not assigned to Zogenix pursuant to this Section 12.3) will transition any remaining Product back to Zogenix in the manner set forth in this Section 12.3 as 46 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 if such Third Party were named herein. Distributor shall include provisions requiring compliance with these provisions in all applicable agreements with Third Parties.\"}, {\"id\": \"12.4\", \"title\": \"Exercise of Right to Terminate\", \"level\": 2, \"text\": \"12.4 Exercise of Right to Terminate. The use by either Party hereto of a termination right provided for under this Agreement shall not give rise, on its own, to the payment of damages or any other form of compensation or relief to the other Party with respect thereto.\"}, {\"id\": \"12.5\", \"title\": \"Damages; Relief\", \"level\": 2, \"text\": \"12.5 Damages; Relief. Subject to Section 12.4 above, termination of this Agreement shall not preclude either Party from claiming any other damages, compensation or relief that it may be entitled to upon such termination.\"}, {\"id\": \"ARTICLE 13\", \"title\": \"DISPUTE RESOLUTION\", \"level\": 1, \"text\": \"ARTICLE 13. DISPUTE RESOLUTION\"}, {\"id\": \"13.1\", \"title\": \"Objective\", \"level\": 2, \"text\": \"13.1 Objective. The Parties recognize that disputes as to matters arising under or relating to this Agreement or either Party's rights or obligations hereunder may arise from time to time. It is the objective of the Parties to establish procedures to facilitate the resolution of such disputes in an expedient manner by mutual cooperation and without resort to litigation. To accomplish this objective, the Parties agree to follow the procedures set forth in this Article 13 to resolve any such dispute if and when it arises.\"}, {\"id\": \"13.2\", \"title\": \"Resolution by Executives\", \"level\": 2, \"text\": \"13.2 Resolution by Executives. Except as otherwise provided in Article 3, if an unresolved dispute as to matters arising under or relating to this Agreement or either Party's rights or obligations hereunder arises, either Party may refer such dispute to the Executives, who shall meet in person or by telephone within [***] after such referral to attempt in good faith to 47 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 resolve such dispute. If such matter cannot be resolved by discussion of such officers within such [***] (as may be extended by mutual written agreement), such dispute shall be resolved in accordance with Section 13.3. The Parties acknowledge that discussions between the Parties to resolve disputes are settlement discussions under applicable rules of evidence and without prejudice to either Party's legal position.\"}, {\"id\": \"13.3\", \"title\": \"Arbitration\", \"level\": 2, \"text\": \"13.3 Arbitration. (a) Any and all disputes that are not resolved pursuant to Section 13.2 shall be finally settled by binding arbitration administered under the Rules of Arbitration of the International Chamber of Commerce by three (3) arbitrators appointed in accordance with said Rules. The arbitration will be conducted in New York, New York. The language to be used in the arbitral proceedings will be English. Judgment on the award may be entered in any court having jurisdiction. (b) The award shall be rendered within [***] of the constitution of the arbitral tribunal, unless the arbitral tribunal determines that the interest of justice requires that such limit be extended. (c) The arbitrators shall award to the prevailing party, if any, as determined by the arbitrators, its reasonable attorneys' fees and costs. (d) The arbitration proceeding will be confidential and the arbitrators shall issue appropriate protective orders to safeguard each Party's Confidential Information. Except as required by Applicable Laws, no Party shall make (or instruct the arbitrators to make) any public announcement with respect to the proceedings or decision of the arbitrators without prior written consent of the other Party. The existence of any dispute submitted to arbitration, and the award, shall be kept in confidence by the Parties and the arbitrators, except as required in connection with the enforcement of such award or as otherwise required by Applicable Laws.\"}, {\"id\": \"ARTICLE 14\", \"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"ARTICLE 14. GENERAL PROVISIONS\"}, {\"id\": \"14.1\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"14.1 Governing Law. This Agreement and all questions regarding its existence, validity, interpretation, breach or performance and any dispute or claim arising out of or in connection with it (whether contractual or non-contractual in nature such as claims in tort, from breach of statute or regulation or otherwise) shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, United States, without reference to its conflicts of law principles to the extent those principles would require applying another jurisdiction's laws. The United Nations Conventions on Contracts for the International Sale of Goods shall not be applicable to this Agreement or the Supply Agreement.\"}, {\"id\": \"14.2\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"14.2 Force Majeure. Neither Party shall be held liable to the other Party nor be 48 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 deemed to have defaulted under or breached this Agreement for failure or delay in performing any obligation under this Agreement (other than failure to make payment when due) when such failure or delay is caused by or results from causes beyond the reasonable control of the affected Party, including embargoes, war, acts of war (whether war be declared or not), insurrections, riots, fire, floods, or other acts of God, or acts, omissions or delays in acting by any governmental authority or the other Party. The affected Party shall notify the other Party of such force majeure circumstances as soon as reasonably practicable, and shall promptly undertake all reasonable efforts necessary to cure such force majeure circumstances. Such excuse from liability shall be effective only to the extent and duration of the event(s) causing the failure or delay in performance and provided that the Party has not caused such event(s) to occur.\"}, {\"id\": \"14.3\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"14.3 Assignment. Except as expressly provided in this Section 14.3, neither this Agreement nor any rights or obligations hereunder may be assigned or otherwise transferred by either Party without the prior written consent of the other Party, which consent shall not be unreasonably withheld; provided, however, that either Party may assign this Agreement and its rights and obligations hereunder without the other Party's consent: (a) in connection with the transfer or sale of all or substantially all of the business of the assigning Party to a Third Party, whether by merger, sale of stock, sale of assets or otherwise; provided that in the event of a transaction (whether this Agreement is actually assigned or is assumed by the acquiring party by operation of law (e.g., in the context of a reverse triangular merger)), unless otherwise agreed with the acquiring party in writing, intellectual property of the acquiring party shall not be included in the intellectual property to which the other Party has access under this Agreement; or (b) to an Affiliate, provided that the assigning Party shall remain liable and responsible to the non\u2011assigning Party hereto for the performance and observance of all such duties and obligations by such Affiliate. For the avoidance of doubt, in the event that either Party assigns this Agreement pursuant to this Section 14.3(a), the other Party shall have the right to terminate this Agreement pursuant to Section 12.2(i). This Agreement shall be binding upon successors and permitted assigns of the Parties. Any assignment not in accordance with this Section 14.3 will be null and void.\"}, {\"id\": \"14.4\", \"title\": \"Severability\", \"level\": 2, \"text\": \"14.4 Severability. If any one or more of the provisions contained in this Agreement is held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby, unless the absence of the invalidated provision(s) adversely affects the substantive rights of the Parties. The Parties shall in such an instance use their best efforts to replace the invalid, illegal or unenforceable provision(s) with valid, legal and enforceable provision(s) which, insofar as practical, implement the purposes of this Agreement.\"}, {\"id\": \"14.5\", \"title\": \"Notices\", \"level\": 2, \"text\": \"14.5 Notices. All notices required or permitted hereunder shall be in writing and sufficient if delivered personally, sent by facsimile (and promptly confirmed by personal delivery, registered or certified mail or overnight courier), sent by internationally- recognized 49 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 overnight courier or sent by registered or certified mail, postage prepaid, return receipt requested, addressed as follows: If to Zogenix, addressed to: Zogenix, Inc. 5959 Horton Street, Suite 500 Emeryville, CA 94608, U.S.A Attention: Chief Executive Officer Facsimile Number: +1 (510) 550-8340 With a copy to (which shall not constitute notice): Latham & Watkins, LLP 12670 High Bluff Drive San Diego, CA 92130, U.S.A Attention: Cheston Larson, Esq. Facsimile Number: +1 (858) 523-5450 If to Distributor, addressed to: Nippon Shinyaku Co., Ltd. 14, Nishinosho-monguchi-cho Kisshoin, Minami-ku Kyoto 601-8550, JAPAN Attention: Alliance Department Facsimile Number: +81-75-321-9019 or to such other address as the Party to whom notice is to be given may have furnished to the other Party in writing in accordance herewith. Any such notice shall be deemed to have been given: (a) when delivered if personally delivered or sent by facsimile on a Business Day; and (b) on the second Business Day after dispatch if sent by internationally-recognized overnight courier.\"}, {\"id\": \"14.6\", \"title\": \"Entire Agreement; Amendments\", \"level\": 2, \"text\": \"14.6 Entire Agreement; Amendments. This Agreement and the Supply Agreement, together with the exhibits hereto and thereto, contain the entire understanding of the Parties with respect to the subject matter hereof and thereof and supersede and cancel all previous express or implied agreements and understandings, negotiations, writings and commitments, either oral or written, in respect to the subject matter hereof and thereof, including the Confidentiality Agreement. This Agreement may be amended, or any term hereof modified, only by a written instrument duly executed by authorized representatives of both Parties, but \\\"written instrument\\\" does not include the text of e-mails or similar electronic transmissions.\"}, {\"id\": \"14.7\", \"title\": \"Headings\", \"level\": 2, \"text\": \"14.7 Headings. The captions to the several Articles and Sections hereof are not a part of this Agreement, but are merely for convenience to assist in locating and reading the several 50 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Sections hereof.\"}, {\"id\": \"14.8\", \"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"14.8 Independent Contractors. It is expressly agreed that Zogenix and Distributor shall be independent contractors and that the relationship between the two Parties shall not constitute a partnership, joint venture or agency. Neither Zogenix nor Distributor shall have the authority to make any statements, representations or commitments of any kind or to take any action that shall be binding on the other Party, without the prior written consent of the other Party.\"}, {\"id\": \"14.9\", \"title\": \"Waiver\", \"level\": 2, \"text\": \"14.9 Waiver. The waiver by either Party hereto of any right hereunder, or the failure of the other Party to perform, or a breach by the other Party, shall not be deemed a waiver of any other right hereunder or of any other breach or failure by such other Party whether of a similar nature or otherwise.\"}, {\"id\": \"14.10\", \"title\": \"Cumulative Remedies\", \"level\": 2, \"text\": \"14.10 Cumulative Remedies. No remedy referred to in this Agreement is intended to be exclusive, but each shall be cumulative and in addition to any other remedy referred to in this Agreement or otherwise available under law.\"}, {\"id\": \"14.11\", \"title\": \"Waiver of Rule of Construction\", \"level\": 2, \"text\": \"14.11 Waiver of Rule of Construction. Each Party has had the opportunity to consult with counsel in connection with the review, drafting and negotiation of this Agreement. Accordingly, the rule of construction that any ambiguity in this Agreement shall be construed against the drafting Party shall not apply.\"}, {\"id\": \"14.12\", \"title\": \"Interpretation\", \"level\": 2, \"text\": \"14.12 Interpretation. All references in this Agreement to an Article or Section shall refer to an Article or Section in or to this Agreement, unless otherwise stated. Any reference to any federal, national, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word \\\"including\\\" and similar words means including without limitation. The words \\\"herein,\\\" \\\"hereof\\\" and \\\"hereunder\\\" and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision. All references to days, months, quarters or years are references to calendar days, calendar months, calendar quarters, or calendar years, unless stated otherwise. References to the singular include the plural.\"}, {\"id\": \"14.13\", \"title\": \"No Third Party Beneficiaries\", \"level\": 2, \"text\": \"14.13 No Third Party Beneficiaries. This Agreement is neither expressly nor impliedly made for the benefit of any Party other than Zogenix and Distributor, except as otherwise provided in this Agreement with respect to Zogenix Indemnitees under Section 11.1 and Distributor Indemnitees under Section 11.2. This Agreement may be terminated, varied or amended in accordance with its terms or with the agreement of Distributor and Zogenix without the consent of the Zogenix Indemnitees or Distributor Indemnitees.\"}, {\"id\": \"14.14\", \"title\": \"English Language\", \"level\": 2, \"text\": \"14.14 English Language. This Agreement is in the English language, and the English language shall control its interpretation. In addition, unless otherwise explicitly stipulated in this Agreement, all notices required or permitted to be given under this Agreement, and all written, electronic, oral or other communications between the Parties regarding this Agreement, shall be in the English language. 51 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}, {\"id\": \"14.15\", \"title\": \"Counterparts\", \"level\": 2, \"text\": \"14.15 Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed to be an original as against any party whose signature appears thereon, all of which together shall constitute but one and the same instrument.\"}, {\"id\": \"14.16\", \"title\": \"Further Actions\", \"level\": 2, \"text\": \"14.16 Further Actions. Each Party will execute, acknowledge and deliver such further instruments, and to do all such other ministerial, administrative or similar acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement. [Signature Page Follows] 52 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 IN WITNESS WHEREOF, the Parties have executed this Distributorship Agreement as of the Effective Date. ZOGENIX, INC. NIPPON SHINYAKU COMPANY, LTD. By: /s/ Stephen J. Farr By: /s/Shigenobu Maekawa Name: Stephen J. Farr Name: Shigenobu Maekawa Title: President and Chief Executive Officer Title: President 53 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 1.70 UNLABELED DRUG PRODUCT [***] [***] [***] [***] [***] [***] [***] US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 1.74 ZOGENIX ZX008 PATENTS AS OF THE EFFECTIVE DATE Patents claiming ZX008 or its use in Japan Docket No Appln. No Filing Date Publn. No Patent No Issue Date [***] ZGNX-135JP [***] [***] [***] [***] 11/30/18 ZGNX-135JP DIV [***] [***] [***] ZGNX-143JP [***] [***] [***] US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 2.3 MATERIAL TERMS OF SUPPLY AGREEMENT The Supply Agreement will include the following terms and conditions: Appointment as Exclusive Supplier. During the Term, Zogenix shall retain and have the sole and exclusive right to supply or have supplied all of Distributors' and its Affiliates' and Sub-distributors' requirements of the Product for sale in the Field in the Territory. Third Party Manufacturer Agreements. The terms of the Supply Agreement shall (a) establish the procedures, terms and conditions for manufacture, quality control, forecasting, ordering, delivery price, payment and appropriate other activities relating to the supply of the Product in the Territory so as to reasonably enable Zogenix to meet its obligations under its agreements with Third Party manufacturers and (b) provide Distributor no remedies for Zogenix's failure to supply the Product in accordance with the Supply Agreement that are in addition to those set forth herein or that are available to Zogenix in its existing agreements with Third Party manufacturers, and (c) set forth such terms and conditions so that the Supply Agreement is otherwise consistent in all material respects with such agreements with Third Party manufacturers. Forecasts and Orders. [***] prior to the anticipated First Commercial Sale, Distributor shall provide Zogenix with a good faith, [***] rolling forecast of its anticipated requirements of the Product, the first [***] of which shall be on a monthly basis and the last [***] of which shall be on a quarterly basis. The first [***] of such forecast shall be binding. Distributor shall submit binding purchase orders consistent with the binding portion of its forecasts. Each purchase order shall have a requested delivery date that is at least [***] after the date of the purchase order. The terms of the Supply Agreement shall also provide for the order and delivery of launch stock for the Product prior to Regulatory Approval to ensure timely launch of the product following Regulatory Approval. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Purchase orders shall be placed in full batch increments as defined in the Supply Agreement. Delivery. All Products shall be shipped Ex Works manufacturing site (Incoterms 2010) to the destination requested by Distributor. Distributor shall be responsible for labeling and packaging Product. Safety Stock. Distributor shall use Commercially Reasonable Efforts to build promptly following Regulatory Approval and thereafter to maintain an inventory of Product (itself and/or with wholesalers) which is not less than the equivalent of the immediate next [***] of anticipated demand for the Product in the Territory. Change Controls. The Parties shall include in the Supply Agreement a reasonable change control procedure to deal with any reasonable changes to the Product specifications and other changes required by Applicable Laws. All Third Party costs incurred by either Party for any such changes in accordance with the agreed-upon change control procedure shall be paid by Distributor if requested by Distributor or if such changes are required by Applicable Laws in the Territory. Second Source. Based on Distributor's forecasts, including its [***] forecasts, the Parties will discuss and determine whether Zogenix will obtain additional capacity to support Distributor's requirements for the Product in the Territory. Any decisions to build or engage additional manufacturing capacity for the Territory will be at Zogenix's sole discretion, and in no event will Zogenix be obligated to supply Product in excess of Distributor's binding forecasts. Product Quality/Complaints. The Supply Agreement will define procedures for resolution of any disputes regarding Product quality and for notification of each Party in the event of a Product complaint or Product recall. The Supply Agreement will contain mutually acceptable provisions regarding release testing of the Product and, if applicable, the transfer of information necessary for Distributor to perform required quality testing, as applicable. Regulatory Audits. Not more than once per Fiscal Year or as otherwise agreed by the Parties, and subject to the terms of the applicable agreement between Zogenix and its Third Party manufacturers, Zogenix shall, at Distributor's request, conduct GMP audits of the Third Party manufacturers and, if applicable, exercise such other audit rights that Zogenix may have under such agreements, and shall disclose to Distributor the results of such audits. Zogenix will use commercially reasonable efforts to cause such Third Party manufacturers to promptly correct any deficiencies or other adverse findings. Representations and Warranties. Zogenix shall provide standard warranties applicable in the pharmaceutical industry, including warranties that all Product manufactured for Distributor: US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 shall be manufactured and tested in accordance with all Applicable Laws, including GMP applicable to the manufacturing, storage, and shipment of the Product, shall not be adulterated or misbranded within the meaning of the United States Food, Drug and Cosmetic Act, 21 U.S.C. Section 301c et. seq., or other Applicable Laws, and the time of delivery to Distributor will meet the Product specifications. Quality Agreement. The Parties shall work together in good faith to enter into a mutually acceptable quality agreement with respect to the manufacture of the Product prior to shipment of any Product to Distributor. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 4.2(a) THE INITIAL VERSION OF THE REGULATORY PLAN US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 8.5(a) PRESS RELEASE US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 9.7 ZOGENIX TRADEMARKS Trademark Country Status Registration number Next renewal date Application number Application date Registration date Class (Zogenix Logo) Japan Pending N/A N/A 2019031449 2/28/2019 N/A 5, 42 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 9.8 PRODUCT TRADEMARKS Trademark Country Status Registration number Next renewal date Application number Application date Registration date Class FINTEPLA Japan Registered 6105099 12/7/2028 2018028557 3/9/2018 12/7/2018 5 (Fintepla Logo) Japan Registered 6093116 10/26/2028 2018028558 3/9/2018 10/26/2018 5 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 10.2(b) FORM OF COMPLIANCE CERTIFICATION Date: __________ To: Zogenix, Inc. and its Affiliates (\\\"Zogenix\\\") Re: Distributorship Agreement dated [ ] (\\\"the Agreement\\\") For and on behalf of [__________________] and our Affiliates (as defined in the Agreement) and employees, we confirm that in respect of our distribution of Zogenix Product within the Territory during the period [insert date] to [insert date]:- there was no offer, or promise to make, authorize or provide (directly or indirectly) a gift, payment or anything of value to a government official, political parties or candidates or private sector employee, in order to influence or reward any action or decision by such person in his or her official or professional capacity, for the purpose of corruptly obtaining or retaining business or securing any improper advantage; all payments, expenses or credits properly paid to or incurred on behalf of Zogenix, were accurately and appropriately recorded and described in accordance with acceptable accounting and recordkeeping procedures, and substantiated by supporting documents and evidence; there were no unauthorized and/or excessive payments of any kind to health care institutions, hospitals, hospital services or departments; and has performed the necessary due diligence to ensure compliance with Applicable Laws (including anti-bribery laws and the U.S. FCPA) and the terms of the Agreement. Please be advised accordingly. Yours faithfully, [____________________] Authorized Representative Name: Title: Signature: Date: US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of Copy of ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.2\", \"level\": 1, \"text\": \"Exhibit 10.2 CERTAIN INFORMATION (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. Zogenix Inc. and Nippon Shinyaku Company Ltd. Distributorship Agreement US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Table of Contents i US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 ii US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 iii US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 List of Exhibits US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 DISTRIBUTORSHIP AGREEMENT This DISTRIBUTORSHIP AGREEMENT (\\\"Agreement\\\") is entered into as of March 18, 2019 (the \\\"Effective Date\\\") by and between ZOGENIX, INC., having a place of business at 5959 Horton Street, Suite 500, Emeryville, California 94608( \\\"Zogenix\\\") and Nippon Shinyaku Company, Ltd., having a place of business at 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan (\\\"Distributor\\\"). Zogenix and Distributor may be referred to individually as a \\\"Party\\\" and collectively as the \\\"Parties\\\". RECITALS WHEREAS, Zogenix is developing its proprietary fenfluramine product, known as Fintepla\u00ae. WHEREAS, Zogenix wishes to commercialize such product through a distributor that will promote, market, sell and distribute such product within the Territory; WHEREAS, Distributor has the ability to promote, market, sell and distribute such product within the Territory for the treatment of Dravet syndrome and Lennox-Gastaut syndrome and any additional indications approved in the Territory, and wishes to be Zogenix's exclusive distributor of such product for such indications within the Territory, and Zogenix is willing to grant to Distributor such exclusive distribution rights on the terms and conditions set forth in this Agreement; and WHEREAS, Zogenix agrees to manufacture (or have manufactured) and sell to Distributor such product for such commercialization activities in the Territory, on the terms and conditions set forth in this Agreement and in a separate supply agreement to be entered into by the Parties. NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Zogenix and Distributor hereby agree as follows:\"}}, {\"id\": \"party:ZOGENIX, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ZOGENIX, INC.\", \"role\": \"Zogenix\", \"address\": \"5959 Horton Street, Suite 500, Emeryville, California 94608\"}}, {\"id\": \"party:Nippon Shinyaku Company, Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Nippon Shinyaku Company, Ltd.\", \"role\": \"Distributor\", \"address\": \"14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan\"}}, {\"id\": \"ARTICLE 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"ARTICLE 1. DEFINITIONS\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Affiliate\\\" of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is c\", \"level\": 2, \"text\": \"1.1 \\\"Affiliate\\\" of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used in this Section 1.1, \\\"control\\\" means (a) to possess, directly or indirectly, the power to direct the management or policies of an entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"1.1 \\\"Affiliate\\\" of a Party means any entity that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with such Party, as the case may be, but for only so long as such control exists. As used in this Section 1.1, \\\"control\\\" means (a) to possess, directly or indirectly, the power to direct the management or policies of an entity, whether through ownership of voting securities, or by contract relating to voting rights or corporate governance; or (b) direct or indirect beneficial ownership of more than fifty percent (50%) (or such lesser percentage which is the maximum allowed to be owned by a foreign corporation in a particular jurisdiction) of the voting share capital or other equity interest in such entity. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\", \"definition_clause\": \"1.1\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Alliance Manager\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.2 \\\"Alliance Manager\\\" has the meaning set forth in Section 3.3.\"}}, {\"id\": \"term:Alliance Manager\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Alliance Manager\", \"text\": \"1.2 \\\"Alliance Manager\\\" has the meaning set forth in Section 3.3.\", \"definition_clause\": \"1.2\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Annual Report\\\" has the meaning set forth in Section 6\", \"level\": 2, \"text\": \"1.3 \\\"Annual Report\\\" has the meaning set forth in Section 6.5(c).\"}}, {\"id\": \"term:Annual Report\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Report\", \"text\": \"1.3 \\\"Annual Report\\\" has the meaning set forth in Section 6.5(c).\", \"definition_clause\": \"1.3\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Applicable Laws\\\" means the applicable provisions of any and all national, supranational, regional, state and local laws\", \"level\": 2, \"text\": \"1.4 \\\"Applicable Laws\\\" means the applicable provisions of any and all national, supranational, regional, state and local laws, treaties, statutes, rules, regulations, administrative codes, industry codes, guidance, ordinances, judgments, decrees, directives, injunctions, orders or permits (including Regulatory Approvals) of or from any court, arbitrator, Regulatory Authority or governmental agency or authority having jurisdiction over or related to the subject item, including the FCPA, export control, embargo, trade sanction and data privacy laws, regulations, rules and licenses, and other laws and regulations pertaining to domestic or international corruption, commercial bribery, fraud, embezzlement or money laundering.\"}}, {\"id\": \"term:Applicable Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicable Laws\", \"text\": \"1.4 \\\"Applicable Laws\\\" means the applicable provisions of any and all national, supranational, regional, state and local laws, treaties, statutes, rules, regulations, administrative codes, industry codes, guidance, ordinances, judgments, decrees, directives, injunctions, orders or permits (including Regulatory Approvals) of or from any court, arbitrator, Regulatory Authority or governmental agency or authority having jurisdiction over or related to the subject item, including the FCPA, export control, embargo, trade sanction and data privacy laws, regulations, rules and licenses, and other laws and regulations pertaining to domestic or international corruption, commercial bribery, fraud, embezzlement or money laundering.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Business Day\\\" means a day other than a Saturday, Sunday, any public holiday, or any bank holiday in the United States o\", \"level\": 2, \"text\": \"1.5 \\\"Business Day\\\" means a day other than a Saturday, Sunday, any public holiday, or any bank holiday in the United States or Japan.\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"1.5 \\\"Business Day\\\" means a day other than a Saturday, Sunday, any public holiday, or any bank holiday in the United States or Japan.\", \"definition_clause\": \"1.5\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Change of Control\\\" means any (a) direct or indirect acquisition of assets of a Party (i) equal to fifty percent (50%) o\", \"level\": 2, \"text\": \"1.6 \\\"Change of Control\\\" means any (a) direct or indirect acquisition of assets of a Party (i) equal to fifty percent (50%) or more of the fair market value of a Party's consolidated assets, or (ii) to which fifty percent (50%) or more of a Party's net revenues or net income on a consolidated basis are attributable, or (iii) representing substantially all of the properties or assets related to a Party's obligations under this Agreement, (b) direct or indirect acquisition by a Person, or group of Persons acting in concert, of fifty percent (50%) or more of the voting equity interests of a Party, (c) tender offer or exchange offer that if consummated would result in any Person, or group of Persons acting in concert, beneficially owning fifty percent (50%) or more of the voting equity interests of a Party, (d) merger, consolidation, other business combination or similar transaction involving a Party, pursuant to which any Person would own fifty percent (50%) or more of the consolidated assets, net revenues or net income of a Party, taken as a whole, or which results in the holders of the voting equity interests of a Party immediately prior to such merger, consolidation, business combination or similar transaction ceasing to hold fifty percent (50%) or more of the combined voting power of the surviving, purchasing or continuing entity immediately after such merger, consolidation, business combination or similar transaction, (e) liquidation or dissolution (or the adoption of a plan of liquidation or dissolution) of a Party, or (f) declaration or payment of an extraordinary dividend (whether in cash or other property) by a Party, where the amount of the dividend or the in specie property which is the subject of the dividend would otherwise come within the application of any of clauses (a)-(e) above, in all cases where such transaction is to be entered into with any Person other than the other Party.\"}}, {\"id\": \"term:Change of Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change of Control\", \"text\": \"1.6 \\\"Change of Control\\\" means any (a) direct or indirect acquisition of assets of a Party (i) equal to fifty percent (50%) or more of the fair market value of a Party's consolidated assets, or (ii) to which fifty percent (50%) or more of a Party's net revenues or net income on a consolidated basis are attributable, or (iii) representing substantially all of the properties or assets related to a Party's obligations under this Agreement, (b) direct or indirect acquisition by a Person, or group of Persons acting in concert, of fifty percent (50%) or more of the voting equity interests of a Party, (c) tender offer or exchange offer that if consummated would result in any Person, or group of Persons acting in concert, beneficially owning fifty percent (50%) or more of the voting equity interests of a Party, (d) merger, consolidation, other business combination or similar transaction involving a Party, pursuant to which any Person would own fifty percent (50%) or more of the consolidated assets, net revenues or net income of a Party, taken as a whole, or which results in the holders of the voting equity interests of a Party immediately prior to such merger, consolidation, business combination or similar transaction ceasing to hold fifty percent (50%) or more of the combined voting power of the surviving, purchasing or continuing entity immediately after such merger, consolidation, business combination or similar transaction, (e) liquidation or dissolution (or the adoption of a plan of liquidation or dissolution) of a Party, or (f) declaration or payment of an extraordinary dividend (whether in cash or other property) by a Party, where the amount of the dividend or the in specie property which is the subject of the dividend would otherwise come within the application of any of clauses (a)-(e) above, in all cases where such transaction is to be entered into with any Person other than the other Party.\", \"definition_clause\": \"1.6\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"CMC\\\" means chemistry, manufacturing and controls\", \"level\": 2, \"text\": \"1.7 \\\"CMC\\\" means chemistry, manufacturing and controls.\"}}, {\"id\": \"term:CMC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CMC\", \"text\": \"1.7 \\\"CMC\\\" means chemistry, manufacturing and controls.\", \"definition_clause\": \"1.7\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Commercialization\\\" means all activities directed to marketing, promoting, advertising, exhibiting, distributing (includ\", \"level\": 2, \"text\": \"1.8 \\\"Commercialization\\\" means all activities directed to marketing, promoting, advertising, exhibiting, distributing (including storage for distribution or inventory), detailing, selling, (and offering for sale or contracting to sell), or otherwise commercially exploiting the Product in the Field in the Territory.\"}}, {\"id\": \"term:Commercialization\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commercialization\", \"text\": \"1.8 \\\"Commercialization\\\" means all activities directed to marketing, promoting, advertising, exhibiting, distributing (including storage for distribution or inventory), detailing, selling, (and offering for sale or contracting to sell), or otherwise commercially exploiting the Product in the Field in the Territory.\", \"definition_clause\": \"1.8\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Commercialization Plan\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.9 \\\"Commercialization Plan\\\" has the meaning set forth in Section 5.1(b). 2 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"term:Commercialization Plan\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commercialization Plan\", \"text\": \"1.9 \\\"Commercialization Plan\\\" has the meaning set forth in Section 5.1(b). 2 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\", \"definition_clause\": \"1.9\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Commercially Reasonable Efforts\\\" means, with respect to a Party's specific obligations under this Agreement, that level\", \"level\": 2, \"text\": \"1.10 \\\"Commercially Reasonable Efforts\\\" means, with respect to a Party's specific obligations under this Agreement, that level of efforts and resources, [***]. Commercially Reasonable Efforts requires that the applicable Party: (i) [***], (ii) [***], and (iii) [***].\"}}, {\"id\": \"term:Commercially Reasonable Efforts\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commercially Reasonable Efforts\", \"text\": \"1.10 \\\"Commercially Reasonable Efforts\\\" means, with respect to a Party's specific obligations under this Agreement, that level of efforts and resources, [***]. Commercially Reasonable Efforts requires that the applicable Party: (i) [***], (ii) [***], and (iii) [***].\", \"definition_clause\": \"1.10\"}}, {\"id\": \"1.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Confidential Information\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.11 \\\"Confidential Information\\\" has the meaning set forth in Section 8.1.\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"1.11 \\\"Confidential Information\\\" has the meaning set forth in Section 8.1.\", \"definition_clause\": \"1.11\"}}, {\"id\": \"1.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Confidentiality Agreement\\\" means that certain Mutual Confidential Disclosure Agreement, dated June 21, 2018, between Zo\", \"level\": 2, \"text\": \"1.12 \\\"Confidentiality Agreement\\\" means that certain Mutual Confidential Disclosure Agreement, dated June 21, 2018, between Zogenix and Distributor.\"}}, {\"id\": \"term:Confidentiality Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidentiality Agreement\", \"text\": \"1.12 \\\"Confidentiality Agreement\\\" means that certain Mutual Confidential Disclosure Agreement, dated June 21, 2018, between Zogenix and Distributor.\", \"definition_clause\": \"1.12\"}}, {\"id\": \"1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Control\\\" (including any variations such as \\\"Controlled\\\" and \\\"Controlling\\\") means, with respect to any Information, Data\", \"level\": 2, \"text\": \"1.13 \\\"Control\\\" (including any variations such as \\\"Controlled\\\" and \\\"Controlling\\\") means, with respect to any Information, Data, Patent or other intellectual property rights, possession by a Party of the ability (whether by ownership or grant of rights, other than pursuant to this Agreement) to grant to the other Party the applicable access or other right under this Agreement without violating the terms of an agreement with a Third Party.\"}}, {\"id\": \"term:Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Control\", \"text\": \"1.13 \\\"Control\\\" (including any variations such as \\\"Controlled\\\" and \\\"Controlling\\\") means, with respect to any Information, Data, Patent or other intellectual property rights, possession by a Party of the ability (whether by ownership or grant of rights, other than pursuant to this Agreement) to grant to the other Party the applicable access or other right under this Agreement without violating the terms of an agreement with a Third Party.\", \"definition_clause\": \"1.13\"}}, {\"id\": \"1.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Data\\\" means any and all scientific, technical or test data pertaining to the Product in the Field that is generated by\", \"level\": 2, \"text\": \"1.14 \\\"Data\\\" means any and all scientific, technical or test data pertaining to the Product in the Field that is generated by or under the authority of Distributor or its Affiliates, Sub-distributors or other subcontractors or by or under the authority of Zogenix or Zogenix ex-Territory Distributors before or during the Term, including research data, clinical pharmacology data, CMC data (including analytical and quality control data and stability data), preclinical data, clinical data and all submissions made in association with an IND or MAA filed in or outside the Territory with respect to the Product in the Field, in each case to the extent such data either (a) is Controlled by Zogenix on the Effective Date or (b) comes within a Party's Control during the Term.\"}}, {\"id\": \"term:Data\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Data\", \"text\": \"1.14 \\\"Data\\\" means any and all scientific, technical or test data pertaining to the Product in the Field that is generated by or under the authority of Distributor or its Affiliates, Sub-distributors or other subcontractors or by or under the authority of Zogenix or Zogenix ex-Territory Distributors before or during the Term, including research data, clinical pharmacology data, CMC data (including analytical and quality control data and stability data), preclinical data, clinical data and all submissions made in association with an IND or MAA filed in or outside the Territory with respect to the Product in the Field, in each case to the extent such data either (a) is Controlled by Zogenix on the Effective Date or (b) comes within a Party's Control during the Term.\", \"definition_clause\": \"1.14\"}}, {\"id\": \"1.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Development\\\" means all activities directed to research, non-clinical and preclinical studies and trials, CMC Data colle\", \"level\": 2, \"text\": \"1.15 \\\"Development\\\" means all activities directed to research, non-clinical and preclinical studies and trials, CMC Data collection, clinical studies and trials, Investigator Initiated Studies, toxicology studies, publication and presentation of study results, preparation and submission to Regulatory Authorities of an MAA concerning the Product, interacting with Regulatory Authorities prior to and following Regulatory Approval of the Product, and Product pricing negotiations and decisions concerning the Product.\"}}, {\"id\": \"term:Development\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Development\", \"text\": \"1.15 \\\"Development\\\" means all activities directed to research, non-clinical and preclinical studies and trials, CMC Data collection, clinical studies and trials, Investigator Initiated Studies, toxicology studies, publication and presentation of study results, preparation and submission to Regulatory Authorities of an MAA concerning the Product, interacting with Regulatory Authorities prior to and following Regulatory Approval of the Product, and Product pricing negotiations and decisions concerning the Product.\", \"definition_clause\": \"1.15\"}}, {\"id\": \"1.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Disclosing Party\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.16 \\\"Disclosing Party\\\" has the meaning set forth in Section 8.1.\"}}, {\"id\": \"term:Disclosing Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disclosing Party\", \"text\": \"1.16 \\\"Disclosing Party\\\" has the meaning set forth in Section 8.1.\", \"definition_clause\": \"1.16\"}}, {\"id\": \"1.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Distribution Term\\\" means the period commencing on the first Regulatory Approval of the Product in the Territory and con\", \"level\": 2, \"text\": \"1.17 \\\"Distribution Term\\\" means the period commencing on the first Regulatory Approval of the Product in the Territory and continuing until [***], or if this Agreement is terminated earlier pursuant to Article 12, the effective date of such termination.\"}}, {\"id\": \"term:Distribution Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distribution Term\", \"text\": \"1.17 \\\"Distribution Term\\\" means the period commencing on the first Regulatory Approval of the Product in the Territory and continuing until [***], or if this Agreement is terminated earlier pursuant to Article 12, the effective date of such termination.\", \"definition_clause\": \"1.17\"}}, {\"id\": \"1.18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Distributor Invention\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.18 \\\"Distributor Invention\\\" has the meaning set forth in Section 9.1(b)(i).\"}}, {\"id\": \"term:Distributor Invention\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor Invention\", \"text\": \"1.18 \\\"Distributor Invention\\\" has the meaning set forth in Section 9.1(b)(i).\", \"definition_clause\": \"1.18\"}}, {\"id\": \"1.19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Executives\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.19 \\\"Executives\\\" has the meaning set forth in Section 3.1(d).\"}}, {\"id\": \"term:Executives\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Executives\", \"text\": \"1.19 \\\"Executives\\\" has the meaning set forth in Section 3.1(d).\", \"definition_clause\": \"1.19\"}}, {\"id\": \"1.20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"FCPA\\\" means the U\", \"level\": 2, \"text\": \"1.20 \\\"FCPA\\\" means the U.S. Foreign Corrupt Practices Act (15 U.S.C. \u00a7 78dd-1 et seq.), as amended.\"}}, {\"id\": \"term:FCPA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FCPA\", \"text\": \"1.20 \\\"FCPA\\\" means the U.S. Foreign Corrupt Practices Act (15 U.S.C. \u00a7 78dd-1 et seq.), as amended.\", \"definition_clause\": \"1.20\"}}, {\"id\": \"1.21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"FDA\\\" means the Food and Drug Administration, or any successor agency thereto\", \"level\": 2, \"text\": \"1.21 \\\"FDA\\\" means the Food and Drug Administration, or any successor agency thereto 3 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 having the administrative authority to regulate the marketing of human pharmaceutical products in the United States.\"}}, {\"id\": \"term:FDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDA\", \"text\": \"1.21 \\\"FDA\\\" means the Food and Drug Administration, or any successor agency thereto 3 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 having the administrative authority to regulate the marketing of human pharmaceutical products in the United States.\", \"definition_clause\": \"1.21\"}}, {\"id\": \"1.22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Field\\\" means the Indications of treatment for the Product in the Territory\", \"level\": 2, \"text\": \"1.22 \\\"Field\\\" means the Indications of treatment for the Product in the Territory.\"}}, {\"id\": \"term:Field\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Field\", \"text\": \"1.22 \\\"Field\\\" means the Indications of treatment for the Product in the Territory.\", \"definition_clause\": \"1.22\"}}, {\"id\": \"1.23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"First Commercial Sale\\\" means the first bona fide, arm's-length sale of the Product in the Field in the Territory follow\", \"level\": 2, \"text\": \"1.23 \\\"First Commercial Sale\\\" means the first bona fide, arm's-length sale of the Product in the Field in the Territory following Regulatory Approval of the Product in the Field in the Territory.\"}}, {\"id\": \"term:First Commercial Sale\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"First Commercial Sale\", \"text\": \"1.23 \\\"First Commercial Sale\\\" means the first bona fide, arm's-length sale of the Product in the Field in the Territory following Regulatory Approval of the Product in the Field in the Territory.\", \"definition_clause\": \"1.23\"}}, {\"id\": \"1.24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Fiscal Quarter\\\" means a period of three (3) consecutive months during a Fiscal Year beginning on and including April 1s\", \"level\": 2, \"text\": \"1.24 \\\"Fiscal Quarter\\\" means a period of three (3) consecutive months during a Fiscal Year beginning on and including April 1st, July 1st or October 1st or January 1st.\"}}, {\"id\": \"term:Fiscal Quarter\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fiscal Quarter\", \"text\": \"1.24 \\\"Fiscal Quarter\\\" means a period of three (3) consecutive months during a Fiscal Year beginning on and including April 1st, July 1st or October 1st or January 1st.\", \"definition_clause\": \"1.24\"}}, {\"id\": \"1.25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Fiscal Year\\\" means a year that starts from April 1st and ends on March 31st\", \"level\": 2, \"text\": \"1.25 \\\"Fiscal Year\\\" means a year that starts from April 1st and ends on March 31st.\"}}, {\"id\": \"term:Fiscal Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fiscal Year\", \"text\": \"1.25 \\\"Fiscal Year\\\" means a year that starts from April 1st and ends on March 31st.\", \"definition_clause\": \"1.25\"}}, {\"id\": \"1.26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Fully-Burdened Manufacturing Cost\\\" means the costs incurred by Zogenix that are directly attributable to and reasonably\", \"level\": 2, \"text\": \"1.26 \\\"Fully-Burdened Manufacturing Cost\\\" means the costs incurred by Zogenix that are directly attributable to and reasonably allocated to the manufacture and delivery of the Product to Distributor. Fully-Burdened Manufacturing Costs shall include the following: [***].\"}}, {\"id\": \"term:Fully-Burdened Manufacturing Cost\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fully-Burdened Manufacturing Cost\", \"text\": \"1.26 \\\"Fully-Burdened Manufacturing Cost\\\" means the costs incurred by Zogenix that are directly attributable to and reasonably allocated to the manufacture and delivery of the Product to Distributor. Fully-Burdened Manufacturing Costs shall include the following: [***].\", \"definition_clause\": \"1.26\"}}, {\"id\": \"1.27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Generic Product\\\" means a pharmaceutical product that (a) [***]; (b) [***]; (c) [***]; and (d) [***]\", \"level\": 2, \"text\": \"1.27 \\\"Generic Product\\\" means a pharmaceutical product that (a) [***]; (b) [***]; (c) [***]; and (d) [***].\"}}, {\"id\": \"term:Generic Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Generic Product\", \"text\": \"1.27 \\\"Generic Product\\\" means a pharmaceutical product that (a) [***]; (b) [***]; (c) [***]; and (d) [***].\", \"definition_clause\": \"1.27\"}}, {\"id\": \"1.28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"IFRS\\\" means international financial reporting standards, as may be amended from time to time\", \"level\": 2, \"text\": \"1.28 \\\"IFRS\\\" means international financial reporting standards, as may be amended from time to time.\"}}, {\"id\": \"term:IFRS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"IFRS\", \"text\": \"1.28 \\\"IFRS\\\" means international financial reporting standards, as may be amended from time to time.\", \"definition_clause\": \"1.28\"}}, {\"id\": \"1.29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"IND\\\" means any Investigational New Drug application, as defined in Title 21 of the Code of Federal Regulations, on file\", \"level\": 2, \"text\": \"1.29 \\\"IND\\\" means any Investigational New Drug application, as defined in Title 21 of the Code of Federal Regulations, on file with the FDA before the commencement of clinical trials of the Product in humans, or any comparable filing with any Regulatory Authority.\"}}, {\"id\": \"term:IND\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"IND\", \"text\": \"1.29 \\\"IND\\\" means any Investigational New Drug application, as defined in Title 21 of the Code of Federal Regulations, on file with the FDA before the commencement of clinical trials of the Product in humans, or any comparable filing with any Regulatory Authority.\", \"definition_clause\": \"1.29\"}}, {\"id\": \"1.30\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Indemnitee\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.30 \\\"Indemnitee\\\" has the meaning set forth in Section 11.3.\"}}, {\"id\": \"term:Indemnitee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnitee\", \"text\": \"1.30 \\\"Indemnitee\\\" has the meaning set forth in Section 11.3.\", \"definition_clause\": \"1.30\"}}, {\"id\": \"1.31\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Indemnitor\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.31 \\\"Indemnitor\\\" has the meaning set forth in Section 11.3.\"}}, {\"id\": \"term:Indemnitor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnitor\", \"text\": \"1.31 \\\"Indemnitor\\\" has the meaning set forth in Section 11.3.\", \"definition_clause\": \"1.31\"}}, {\"id\": \"1.32\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Indication\\\" means the treatment of Dravet syndrome, Lennox-Gastaut syndrome, [***] during the Distribution Term\", \"level\": 2, \"text\": \"1.32 \\\"Indication\\\" means the treatment of Dravet syndrome, Lennox-Gastaut syndrome, [***] during the Distribution Term.\"}}, {\"id\": \"term:Indication\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indication\", \"text\": \"1.32 \\\"Indication\\\" means the treatment of Dravet syndrome, Lennox-Gastaut syndrome, [***] during the Distribution Term.\", \"definition_clause\": \"1.32\"}}, {\"id\": \"1.33\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Indirect Losses\\\" means any damages or other losses involving, but only to the extent of, any loss of profits, diminutio\", \"level\": 2, \"text\": \"1.33 \\\"Indirect Losses\\\" means any damages or other losses involving, but only to the extent of, any loss of profits, diminution in value, or incidental, indirect, consequential, special or punitive damages.\"}}, {\"id\": \"term:Indirect Losses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indirect Losses\", \"text\": \"1.33 \\\"Indirect Losses\\\" means any damages or other losses involving, but only to the extent of, any loss of profits, diminution in value, or incidental, indirect, consequential, special or punitive damages.\", \"definition_clause\": \"1.33\"}}, {\"id\": \"1.34\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Information\\\" means information, ideas, inventions, discoveries, concepts, formulas, practices, procedures, processes, m\", \"level\": 2, \"text\": \"1.34 \\\"Information\\\" means information, ideas, inventions, discoveries, concepts, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets, technology, inventories, machines, techniques, development, designs, drawings, computer programs, skill, experience, documents, apparatus, results, clinical and regulatory strategies, documentation, information and submissions pertaining to, or made in association with, filings with any Regulatory Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and descriptions, patent and legal data, 4 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 market data, financial data or descriptions, specifications and the like, in written, electronic or other form, now known or hereafter developed, whether or not patentable.\"}}, {\"id\": \"term:Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Information\", \"text\": \"1.34 \\\"Information\\\" means information, ideas, inventions, discoveries, concepts, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets, technology, inventories, machines, techniques, development, designs, drawings, computer programs, skill, experience, documents, apparatus, results, clinical and regulatory strategies, documentation, information and submissions pertaining to, or made in association with, filings with any Regulatory Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and descriptions, patent and legal data, 4 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 market data, financial data or descriptions, specifications and the like, in written, electronic or other form, now known or hereafter developed, whether or not patentable.\", \"definition_clause\": \"1.34\"}}, {\"id\": \"1.35\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Invention\\\" means any new and useful process, article of manufacture, composition of matter, formulation or apparatus, o\", \"level\": 2, \"text\": \"1.35 \\\"Invention\\\" means any new and useful process, article of manufacture, composition of matter, formulation or apparatus, or any improvement thereof, discovery or finding, whether or not patentable, as determined in accordance with the patent laws of the United States of America.\"}}, {\"id\": \"term:Invention\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Invention\", \"text\": \"1.35 \\\"Invention\\\" means any new and useful process, article of manufacture, composition of matter, formulation or apparatus, or any improvement thereof, discovery or finding, whether or not patentable, as determined in accordance with the patent laws of the United States of America.\", \"definition_clause\": \"1.35\"}}, {\"id\": \"1.36\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Japan GAAP\\\" means Japan generally accepted accounting principles, as may be amended from time to time\", \"level\": 2, \"text\": \"1.36 \\\"Japan GAAP\\\" means Japan generally accepted accounting principles, as may be amended from time to time.\"}}, {\"id\": \"term:Japan GAAP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Japan GAAP\", \"text\": \"1.36 \\\"Japan GAAP\\\" means Japan generally accepted accounting principles, as may be amended from time to time.\", \"definition_clause\": \"1.36\"}}, {\"id\": \"1.37\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Joint Steering Committee\\\" or \\\"JSC\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.37 \\\"Joint Steering Committee\\\" or \\\"JSC\\\" has the meaning set forth in Section 3.1.\"}}, {\"id\": \"term:Joint Steering Committee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Joint Steering Committee\", \"text\": \"1.37 \\\"Joint Steering Committee\\\" or \\\"JSC\\\" has the meaning set forth in Section 3.1.\", \"definition_clause\": \"1.37\"}}, {\"id\": \"1.38\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Losses\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.38 \\\"Losses\\\" has the meaning set forth in Section 11.1.\"}}, {\"id\": \"term:Losses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Losses\", \"text\": \"1.38 \\\"Losses\\\" has the meaning set forth in Section 11.1.\", \"definition_clause\": \"1.38\"}}, {\"id\": \"1.39\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"MAA\\\" means a marketing authorization application or equivalent application, and all amendments and supplements thereto,\", \"level\": 2, \"text\": \"1.39 \\\"MAA\\\" means a marketing authorization application or equivalent application, and all amendments and supplements thereto, filed with a Regulatory Authority.\"}}, {\"id\": \"term:MAA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MAA\", \"text\": \"1.39 \\\"MAA\\\" means a marketing authorization application or equivalent application, and all amendments and supplements thereto, filed with a Regulatory Authority.\", \"definition_clause\": \"1.39\"}}, {\"id\": \"1.40\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"MAH\\\" means a marketing authorization holder of the Product in the Field in the Territory\", \"level\": 2, \"text\": \"1.40 \\\"MAH\\\" means a marketing authorization holder of the Product in the Field in the Territory.\"}}, {\"id\": \"term:MAH\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MAH\", \"text\": \"1.40 \\\"MAH\\\" means a marketing authorization holder of the Product in the Field in the Territory.\", \"definition_clause\": \"1.40\"}}, {\"id\": \"1.41\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"MHLW\\\" means the Japanese Ministry of Health, Labor and Welfare\", \"level\": 2, \"text\": \"1.41 \\\"MHLW\\\" means the Japanese Ministry of Health, Labor and Welfare.\"}}, {\"id\": \"term:MHLW\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MHLW\", \"text\": \"1.41 \\\"MHLW\\\" means the Japanese Ministry of Health, Labor and Welfare.\", \"definition_clause\": \"1.41\"}}, {\"id\": \"1.42\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Net Price\\\" means, for any Fiscal Year, the unit price of the Product in the Territory in the Field calculated by dividi\", \"level\": 2, \"text\": \"1.42 \\\"Net Price\\\" means, for any Fiscal Year, the unit price of the Product in the Territory in the Field calculated by dividing the aggregate Net Sales for the Product in the Territory in such Fiscal Year by the total number of units of the Product sold by or on behalf of Distributor or its Affiliate or Sub-distributor in the Territory in such Fiscal Year.\"}}, {\"id\": \"term:Net Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Net Price\", \"text\": \"1.42 \\\"Net Price\\\" means, for any Fiscal Year, the unit price of the Product in the Territory in the Field calculated by dividing the aggregate Net Sales for the Product in the Territory in such Fiscal Year by the total number of units of the Product sold by or on behalf of Distributor or its Affiliate or Sub-distributor in the Territory in such Fiscal Year.\", \"definition_clause\": \"1.42\"}}, {\"id\": \"1.43\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Net Sales\\\" means, with respect to any period of time, the gross amounts invoiced for sales or other dispositions of the\", \"level\": 2, \"text\": \"1.43 \\\"Net Sales\\\" means, with respect to any period of time, the gross amounts invoiced for sales or other dispositions of the Product in the Territory by or on behalf of Distributor or its Affiliates or Sub-distributors to Third Parties (other than Sub- distributors) during such period, less the value added taxes levied on or measured by the billing amount for the Product to the extent included in the gross invoiced sales price for the Product or otherwise directly paid or incurred by Distributor or its Affiliates or Sub-distributors, as applicable, with respect to the sale or other disposition of the Product, less the following deductions to the extent actually allowed, paid, incurred or accrued during the applicable period, calculated in accordance with Japan GAAP or IFRS (consistently applied): [***] Net Sales shall be calculated in accordance with Japan GAAP or IFRS, consistently applied in the Territory and shall be consistent with net sales reported in Distributor's audited financial statements. If net sales reported in Distributor's audited financial statements include discounts for products sold in combination or bundled with other products, these discounts will not be included in the calculation of Net Sales of the Product. 5 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Sales of a Product for use in conducting clinical trials of the Product in the Territory in order to obtain Regulatory Approval of the Product in the Territory shall be excluded from Net Sales calculations for all purposes. Upon any sale or other disposition of the Product for any consideration other than exclusively monetary consideration on bona fide arm's-length terms, for purposes of calculating Net Sales under this Agreement, the Product shall be deemed to be sold exclusively for money at the average sales price during the applicable reporting period generally achieved for the Product in the Field in the Territory when the Product is sold alone and not with other products. Distributor and its Affiliates and Sub-distributors shall not sell the Product in combination with or as part of a bundle with other products, or offer packaged arrangements to customers that include the Product, in such a manner as to disproportionately discount the selling price of the Product as compared with the weighted-average discount applied to the other products, as a percent of the respective list prices (or if not available, a good faith estimate thereof) of such products and the Product prior to applying the discount.\"}}, {\"id\": \"term:Net Sales\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Net Sales\", \"text\": \"1.43 \\\"Net Sales\\\" means, with respect to any period of time, the gross amounts invoiced for sales or other dispositions of the Product in the Territory by or on behalf of Distributor or its Affiliates or Sub-distributors to Third Parties (other than Sub- distributors) during such period, less the value added taxes levied on or measured by the billing amount for the Product to the extent included in the gross invoiced sales price for the Product or otherwise directly paid or incurred by Distributor or its Affiliates or Sub-distributors, as applicable, with respect to the sale or other disposition of the Product, less the following deductions to the extent actually allowed, paid, incurred or accrued during the applicable period, calculated in accordance with Japan GAAP or IFRS (consistently applied): [***] Net Sales shall be calculated in accordance with Japan GAAP or IFRS, consistently applied in the Territory and shall be consistent with net sales reported in Distributor's audited financial statements. If net sales reported in Distributor's audited financial statements include discounts for products sold in combination or bundled with other products, these discounts will not be included in the calculation of Net Sales of the Product. 5 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Sales of a Product for use in conducting clinical trials of the Product in the Territory in order to obtain Regulatory Approval of the Product in the Territory shall be excluded from Net Sales calculations for all purposes. Upon any sale or other disposition of the Product for any consideration other than exclusively monetary consideration on bona fide arm's-length terms, for purposes of calculating Net Sales under this Agreement, the Product shall be deemed to be sold exclusively for money at the average sales price during the applicable reporting period generally achieved for the Product in the Field in the Territory when the Product is sold alone and not with other products. Distributor and its Affiliates and Sub-distributors shall not sell the Product in combination with or as part of a bundle with other products, or offer packaged arrangements to customers that include the Product, in such a manner as to disproportionately discount the selling price of the Product as compared with the weighted-average discount applied to the other products, as a percent of the respective list prices (or if not available, a good faith estimate thereof) of such products and the Product prior to applying the discount.\", \"definition_clause\": \"1.43\"}}, {\"id\": \"1.44\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"NHI\\\" means the Japanese national health insurance system, or its successor system\", \"level\": 2, \"text\": \"1.44 \\\"NHI\\\" means the Japanese national health insurance system, or its successor system.\"}}, {\"id\": \"term:NHI\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"NHI\", \"text\": \"1.44 \\\"NHI\\\" means the Japanese national health insurance system, or its successor system.\", \"definition_clause\": \"1.44\"}}, {\"id\": \"1.45\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"NHI Price\\\" means the reimbursement price of the maximum daily dose of Product for purposes of the NHI\", \"level\": 2, \"text\": \"1.45 \\\"NHI Price\\\" means the reimbursement price of the maximum daily dose of Product for purposes of the NHI.\"}}, {\"id\": \"term:NHI Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"NHI Price\", \"text\": \"1.45 \\\"NHI Price\\\" means the reimbursement price of the maximum daily dose of Product for purposes of the NHI.\", \"definition_clause\": \"1.45\"}}, {\"id\": \"1.46\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"NHI Price Listing\\\" means the listing of the NHI Price by Central Social Insurance Medical Council (Chuikyo) of the MHLW\", \"level\": 2, \"text\": \"1.46 \\\"NHI Price Listing\\\" means the listing of the NHI Price by Central Social Insurance Medical Council (Chuikyo) of the MHLW.\"}}, {\"id\": \"term:NHI Price Listing\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"NHI Price Listing\", \"text\": \"1.46 \\\"NHI Price Listing\\\" means the listing of the NHI Price by Central Social Insurance Medical Council (Chuikyo) of the MHLW.\", \"definition_clause\": \"1.46\"}}, {\"id\": \"1.47\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Out-of-Pocket Costs and Expenses\\\" means the costs and expenses incurred by one or both Parties (as applicable) that are\", \"level\": 2, \"text\": \"1.47 \\\"Out-of-Pocket Costs and Expenses\\\" means the costs and expenses incurred by one or both Parties (as applicable) that are directly attributable to and reasonably allocated to a specified project, program or task. Out-of-Pocket Costs and Expenses shall include payments made to third parties such as contract research organizations and investigators and the fully burdened cost of drug product. Out-of-Pocket Costs and Expenses shall not include a Party's employee costs.\"}}, {\"id\": \"term:Out-of-Pocket Costs and Expenses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Out-of-Pocket Costs and Expenses\", \"text\": \"1.47 \\\"Out-of-Pocket Costs and Expenses\\\" means the costs and expenses incurred by one or both Parties (as applicable) that are directly attributable to and reasonably allocated to a specified project, program or task. Out-of-Pocket Costs and Expenses shall include payments made to third parties such as contract research organizations and investigators and the fully burdened cost of drug product. Out-of-Pocket Costs and Expenses shall not include a Party's employee costs.\", \"definition_clause\": \"1.47\"}}, {\"id\": \"1.48\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Patent\\\" means (a) any patent, certificate of invention, application for certificate of invention, priority patent filin\", \"level\": 2, \"text\": \"1.48 \\\"Patent\\\" means (a) any patent, certificate of invention, application for certificate of invention, priority patent filing and patent application, and (b) any renewal, division, continuation (in whole or in part) or request for continued examination of any of such patent, certificate of invention and patent application, and any patent or certificate of invention issuing thereon, and any reissue, reexamination, extension, restoration by any existing or future extension or restoration mechanism, division, renewal, substitution, confirmation, registration, revalidation, revision and addition of or to any of the foregoing.\"}}, {\"id\": \"term:Patent\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Patent\", \"text\": \"1.48 \\\"Patent\\\" means (a) any patent, certificate of invention, application for certificate of invention, priority patent filing and patent application, and (b) any renewal, division, continuation (in whole or in part) or request for continued examination of any of such patent, certificate of invention and patent application, and any patent or certificate of invention issuing thereon, and any reissue, reexamination, extension, restoration by any existing or future extension or restoration mechanism, division, renewal, substitution, confirmation, registration, revalidation, revision and addition of or to any of the foregoing.\", \"definition_clause\": \"1.48\"}}, {\"id\": \"1.49\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Person\\\" means any individual, corporation, partnership, limited liability company, trust or other entity\", \"level\": 2, \"text\": \"1.49 \\\"Person\\\" means any individual, corporation, partnership, limited liability company, trust or other entity.\"}}, {\"id\": \"term:Person\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Person\", \"text\": \"1.49 \\\"Person\\\" means any individual, corporation, partnership, limited liability company, trust or other entity.\", \"definition_clause\": \"1.49\"}}, {\"id\": \"1.50\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Pharmacovigilance Agreement\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.50 \\\"Pharmacovigilance Agreement\\\" has the meaning set forth in Section 4.5. 6 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"term:Pharmacovigilance Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Pharmacovigilance Agreement\", \"text\": \"1.50 \\\"Pharmacovigilance Agreement\\\" has the meaning set forth in Section 4.5. 6 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\", \"definition_clause\": \"1.50\"}}, {\"id\": \"1.51\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PMDA\\\" means the Japanese Pharmaceuticals and Medical Devices Agency, and local counterparts thereto, and any successor\", \"level\": 2, \"text\": \"1.51 \\\"PMDA\\\" means the Japanese Pharmaceuticals and Medical Devices Agency, and local counterparts thereto, and any successor agency(ies) or authority thereto having substantially the same function.\"}}, {\"id\": \"term:PMDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PMDA\", \"text\": \"1.51 \\\"PMDA\\\" means the Japanese Pharmaceuticals and Medical Devices Agency, and local counterparts thereto, and any successor agency(ies) or authority thereto having substantially the same function.\", \"definition_clause\": \"1.51\"}}, {\"id\": \"1.52\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Product\\\" means Zogenix's proprietary fenfluramine product, known as Fintepla\u00ae, or any drug product containing a salt, e\", \"level\": 2, \"text\": \"1.52 \\\"Product\\\" means Zogenix's proprietary fenfluramine product, known as Fintepla\u00ae, or any drug product containing a salt, enantiomer, or polymorph of fenfluramine.\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"1.52 \\\"Product\\\" means Zogenix's proprietary fenfluramine product, known as Fintepla\u00ae, or any drug product containing a salt, enantiomer, or polymorph of fenfluramine.\", \"definition_clause\": \"1.52\"}}, {\"id\": \"1.53\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Product Invention\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.53 \\\"Product Invention\\\" has the meaning set forth in Section 9.1(b)(i).\"}}, {\"id\": \"term:Product Invention\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Invention\", \"text\": \"1.53 \\\"Product Invention\\\" has the meaning set forth in Section 9.1(b)(i).\", \"definition_clause\": \"1.53\"}}, {\"id\": \"1.54\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Product Trademark\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.54 \\\"Product Trademark\\\" has the meaning set forth in Section 9.8(a).\"}}, {\"id\": \"term:Product Trademark\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Trademark\", \"text\": \"1.54 \\\"Product Trademark\\\" has the meaning set forth in Section 9.8(a).\", \"definition_clause\": \"1.54\"}}, {\"id\": \"1.55\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Public Official or Entity\\\" means (a) any officer, employee (including physicians, hospital administrators or other heal\", \"level\": 2, \"text\": \"1.55 \\\"Public Official or Entity\\\" means (a) any officer, employee (including physicians, hospital administrators or other healthcare professionals), agent, representative, department, agency, de facto official, representative, corporate entity, instrumentality or subdivision of any government, military or international organization, including any ministry or department of health or any state-owned or affiliated company or hospital, or (b) any candidate for political office, any political party or any official of a political party.\"}}, {\"id\": \"term:Public Official or Entity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Public Official or Entity\", \"text\": \"1.55 \\\"Public Official or Entity\\\" means (a) any officer, employee (including physicians, hospital administrators or other healthcare professionals), agent, representative, department, agency, de facto official, representative, corporate entity, instrumentality or subdivision of any government, military or international organization, including any ministry or department of health or any state-owned or affiliated company or hospital, or (b) any candidate for political office, any political party or any official of a political party.\", \"definition_clause\": \"1.55\"}}, {\"id\": \"1.56\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Transfer Price\\\" has the meaning set forth in Section 6\", \"level\": 2, \"text\": \"1.56 \\\"Transfer Price\\\" has the meaning set forth in Section 6.5(a).\"}}, {\"id\": \"term:Transfer Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Transfer Price\", \"text\": \"1.56 \\\"Transfer Price\\\" has the meaning set forth in Section 6.5(a).\", \"definition_clause\": \"1.56\"}}, {\"id\": \"1.57\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Receiving Party\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.57 \\\"Receiving Party\\\" has the meaning set forth in Section 8.1.\"}}, {\"id\": \"term:Receiving Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Receiving Party\", \"text\": \"1.57 \\\"Receiving Party\\\" has the meaning set forth in Section 8.1.\", \"definition_clause\": \"1.57\"}}, {\"id\": \"1.58\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Approval\\\" means any and all approvals (except NHI Price Listing), licenses, registrations, or authorizations\", \"level\": 2, \"text\": \"1.58 \\\"Regulatory Approval\\\" means any and all approvals (except NHI Price Listing), licenses, registrations, or authorizations of Regulatory Authorities in the applicable regulatory jurisdiction that are necessary for the manufacture, use, storage, import, transport and/or sale of a pharmaceutical product in such regulatory jurisdiction.\"}}, {\"id\": \"term:Regulatory Approval\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Approval\", \"text\": \"1.58 \\\"Regulatory Approval\\\" means any and all approvals (except NHI Price Listing), licenses, registrations, or authorizations of Regulatory Authorities in the applicable regulatory jurisdiction that are necessary for the manufacture, use, storage, import, transport and/or sale of a pharmaceutical product in such regulatory jurisdiction.\", \"definition_clause\": \"1.58\"}}, {\"id\": \"1.59\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Authority\\\" means any national, regional, state or local regulatory agency, department, bureau, commission, c\", \"level\": 2, \"text\": \"1.59 \\\"Regulatory Authority\\\" means any national, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity whose review and/or approval is necessary for the manufacture, packaging, use, storage, import, export, distribution or promotion of a pharmaceutical product in the applicable regulatory jurisdiction, including the PMDA in the Territory. If governmental approval is required for pricing or reimbursement by national health insurance (or its local equivalent), \\\"Regulatory Authority\\\" shall also include any national, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity whose review and/or approval of pricing or reimbursement is required.\"}}, {\"id\": \"term:Regulatory Authority\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Authority\", \"text\": \"1.59 \\\"Regulatory Authority\\\" means any national, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity whose review and/or approval is necessary for the manufacture, packaging, use, storage, import, export, distribution or promotion of a pharmaceutical product in the applicable regulatory jurisdiction, including the PMDA in the Territory. If governmental approval is required for pricing or reimbursement by national health insurance (or its local equivalent), \\\"Regulatory Authority\\\" shall also include any national, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity whose review and/or approval of pricing or reimbursement is required.\", \"definition_clause\": \"1.59\"}}, {\"id\": \"1.60\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Filings\\\" means all applications, approvals, licenses, notifications, registrations, submissions and authoriz\", \"level\": 2, \"text\": \"1.60 \\\"Regulatory Filings\\\" means all applications, approvals, licenses, notifications, registrations, submissions and authorizations made to or received from a Regulatory Authority in connection with the development, manufacture or commercialization of a pharmaceutical product, including any INDs, MAAs and Regulatory Approvals.\"}}, {\"id\": \"term:Regulatory Filings\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Filings\", \"text\": \"1.60 \\\"Regulatory Filings\\\" means all applications, approvals, licenses, notifications, registrations, submissions and authorizations made to or received from a Regulatory Authority in connection with the development, manufacture or commercialization of a pharmaceutical product, including any INDs, MAAs and Regulatory Approvals.\", \"definition_clause\": \"1.60\"}}, {\"id\": \"1.61\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Plan\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.61 \\\"Regulatory Plan\\\" has the meaning set forth in Section 4.2(a).\"}}, {\"id\": \"term:Regulatory Plan\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Plan\", \"text\": \"1.61 \\\"Regulatory Plan\\\" has the meaning set forth in Section 4.2(a).\", \"definition_clause\": \"1.61\"}}, {\"id\": \"1.62\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"SEC\\\" means the U\", \"level\": 2, \"text\": \"1.62 \\\"SEC\\\" means the U.S. Securities and Exchange Commission or any successor agency. 7 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"term:SEC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SEC\", \"text\": \"1.62 \\\"SEC\\\" means the U.S. Securities and Exchange Commission or any successor agency. 7 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\", \"definition_clause\": \"1.62\"}}, {\"id\": \"1.63\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Sub-distributor\\\" means any Person other than Distributor or its Affiliates that Distributor appoints to market, promote\", \"level\": 2, \"text\": \"1.63 \\\"Sub-distributor\\\" means any Person other than Distributor or its Affiliates that Distributor appoints to market, promote, offer for sale, sell, import or distribute the Product in the Field in the Territory, beyond the mere right to purchase the Product from Distributor or its Affiliates for end use.\"}}, {\"id\": \"term:Sub-distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sub-distributor\", \"text\": \"1.63 \\\"Sub-distributor\\\" means any Person other than Distributor or its Affiliates that Distributor appoints to market, promote, offer for sale, sell, import or distribute the Product in the Field in the Territory, beyond the mere right to purchase the Product from Distributor or its Affiliates for end use.\", \"definition_clause\": \"1.63\"}}, {\"id\": \"1.64\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Supply Agreement\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.64 \\\"Supply Agreement\\\" has the meaning set forth in Section 5.2.\"}}, {\"id\": \"term:Supply Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Supply Agreement\", \"text\": \"1.64 \\\"Supply Agreement\\\" has the meaning set forth in Section 5.2.\", \"definition_clause\": \"1.64\"}}, {\"id\": \"1.65\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Territory\\\" means Japan\", \"level\": 2, \"text\": \"1.65 \\\"Territory\\\" means Japan.\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"1.65 \\\"Territory\\\" means Japan.\", \"definition_clause\": \"1.65\"}}, {\"id\": \"1.66\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party\\\" means any governmental authority or Person other than Zogenix, Distributor and their respective Affiliates\", \"level\": 2, \"text\": \"1.66 \\\"Third Party\\\" means any governmental authority or Person other than Zogenix, Distributor and their respective Affiliates.\"}}, {\"id\": \"term:Third Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party\", \"text\": \"1.66 \\\"Third Party\\\" means any governmental authority or Person other than Zogenix, Distributor and their respective Affiliates.\", \"definition_clause\": \"1.66\"}}, {\"id\": \"1.67\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party Claims\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.67 \\\"Third Party Claims\\\" has the meaning set forth in Section 11.1.\"}}, {\"id\": \"term:Third Party Claims\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party Claims\", \"text\": \"1.67 \\\"Third Party Claims\\\" has the meaning set forth in Section 11.1.\", \"definition_clause\": \"1.67\"}}, {\"id\": \"1.68\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Trademark\\\" means any word, name, symbol, color, designation or device or any combination thereof, including any tradema\", \"level\": 2, \"text\": \"1.68 \\\"Trademark\\\" means any word, name, symbol, color, designation or device or any combination thereof, including any trademark, trade dress, brand mark, service mark, trade name, brand name, logo or business symbol, whether or not registered, as determined in accordance with the trademark laws of the Unites States of America.\"}}, {\"id\": \"term:Trademark\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademark\", \"text\": \"1.68 \\\"Trademark\\\" means any word, name, symbol, color, designation or device or any combination thereof, including any trademark, trade dress, brand mark, service mark, trade name, brand name, logo or business symbol, whether or not registered, as determined in accordance with the trademark laws of the Unites States of America.\", \"definition_clause\": \"1.68\"}}, {\"id\": \"1.69\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"United States\\\" or \\\"U\", \"level\": 2, \"text\": \"1.69 \\\"United States\\\" or \\\"U.S.\\\" means the United States of America, including its territories and possessions and the District of Columbia.\"}}, {\"id\": \"term:United States\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"United States\", \"text\": \"1.69 \\\"United States\\\" or \\\"U.S.\\\" means the United States of America, including its territories and possessions and the District of Columbia.\", \"definition_clause\": \"1.69\"}}, {\"id\": \"1.70\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Unlabeled Drug Product\\\" means [***]\", \"level\": 2, \"text\": \"1.70 \\\"Unlabeled Drug Product\\\" means [***].\"}}, {\"id\": \"term:Unlabeled Drug Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unlabeled Drug Product\", \"text\": \"1.70 \\\"Unlabeled Drug Product\\\" means [***].\", \"definition_clause\": \"1.70\"}}, {\"id\": \"1.71\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Zogenix ex-Territory Distributor\\\" means a licensee, collaborator or distributor engaged by Zogenix or any of its Affili\", \"level\": 2, \"text\": \"1.71 \\\"Zogenix ex-Territory Distributor\\\" means a licensee, collaborator or distributor engaged by Zogenix or any of its Affiliates to market, promote or sell the Product outside the Territory.\"}}, {\"id\": \"term:Zogenix ex-Territory Distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Zogenix ex-Territory Distributor\", \"text\": \"1.71 \\\"Zogenix ex-Territory Distributor\\\" means a licensee, collaborator or distributor engaged by Zogenix or any of its Affiliates to market, promote or sell the Product outside the Territory.\", \"definition_clause\": \"1.71\"}}, {\"id\": \"1.72\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Zogenix Indemnitees\\\" has the meaning set forth in Section 11\", \"level\": 2, \"text\": \"1.72 \\\"Zogenix Indemnitees\\\" has the meaning set forth in Section 11.1.\"}}, {\"id\": \"term:Zogenix Indemnitees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Zogenix Indemnitees\", \"text\": \"1.72 \\\"Zogenix Indemnitees\\\" has the meaning set forth in Section 11.1.\", \"definition_clause\": \"1.72\"}}, {\"id\": \"1.73\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Zogenix Know-How\\\" means all Information and Data that Zogenix Controls as of the Effective Date or during the Term, whi\", \"level\": 2, \"text\": \"1.73 \\\"Zogenix Know-How\\\" means all Information and Data that Zogenix Controls as of the Effective Date or during the Term, which Information is necessary or reasonably useful to file for, obtain or maintain Regulatory Approval or to market, promote, sell, offer for sale or import the Product in the Field in the Territory.\"}}, {\"id\": \"term:Zogenix Know-How\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Zogenix Know-How\", \"text\": \"1.73 \\\"Zogenix Know-How\\\" means all Information and Data that Zogenix Controls as of the Effective Date or during the Term, which Information is necessary or reasonably useful to file for, obtain or maintain Regulatory Approval or to market, promote, sell, offer for sale or import the Product in the Field in the Territory.\", \"definition_clause\": \"1.73\"}}, {\"id\": \"1.74\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Zogenix Patents\\\" means all Patents that Zogenix Controls as of the Effective Date or during the Term, which Patents wou\", \"level\": 2, \"text\": \"1.74 \\\"Zogenix Patents\\\" means all Patents that Zogenix Controls as of the Effective Date or during the Term, which Patents would be infringed, absent a license, by the use, sale, offer for sale or import of the Product in the Field in the Territory, including any Patents issuing from the applications listed in Exhibit 1.74.\"}}, {\"id\": \"term:Zogenix Patents\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Zogenix Patents\", \"text\": \"1.74 \\\"Zogenix Patents\\\" means all Patents that Zogenix Controls as of the Effective Date or during the Term, which Patents would be infringed, absent a license, by the use, sale, offer for sale or import of the Product in the Field in the Territory, including any Patents issuing from the applications listed in Exhibit 1.74.\", \"definition_clause\": \"1.74\"}}, {\"id\": \"1.75\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Zogenix Technology\\\" means the Zogenix Know-How and Zogenix Patents\", \"level\": 2, \"text\": \"1.75 \\\"Zogenix Technology\\\" means the Zogenix Know-How and Zogenix Patents.\"}}, {\"id\": \"term:Zogenix Technology\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Zogenix Technology\", \"text\": \"1.75 \\\"Zogenix Technology\\\" means the Zogenix Know-How and Zogenix Patents.\", \"definition_clause\": \"1.75\"}}, {\"id\": \"1.76\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Zogenix Trademark\\\" has the meaning set forth in Section 9\", \"level\": 2, \"text\": \"1.76 \\\"Zogenix Trademark\\\" has the meaning set forth in Section 9.7. 8 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"term:Zogenix Trademark\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Zogenix Trademark\", \"text\": \"1.76 \\\"Zogenix Trademark\\\" has the meaning set forth in Section 9.7. 8 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\", \"definition_clause\": \"1.76\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GRANT OF RIGHTS\", \"level\": 1, \"text\": \"ARTICLE 2. GRANT OF RIGHTS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Grant of Rights to Distributor\", \"level\": 2, \"text\": \"2.1 Grant of Rights to Distributor. Subject to the terms and conditions of this Agreement, Zogenix hereby appoints Distributor, and Distributor accepts appointment, as the exclusive distributor (even as to Zogenix) of the Product in the Field in the Territory during the Term, and grants to Distributor the exclusive rights to maintain Regulatory Approval of (while Distributor is the MAH Party), package, promote, market, offer for sale, sell, import and distribute the Product in the Field in the Territory during the Term. The Parties agree that the rights granted in this Section 2.1 do not grant any right or license to, and Distributor shall not, supply, sell, offer for sale or otherwise dispose of or provide access to the Product in the Territory unless and until the Product obtains Regulatory Approval in the Field in the Territory.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sub-distribution by Distributor\", \"level\": 2, \"text\": \"2.2 Sub-distribution by Distributor. Distributor shall not have the right to (a) appoint any Sub-distributors for the Product in the Field in the Territory or (b) otherwise subcontract any sales, marketing, distribution or promotional activities with respect to the Product in the Field in the Territory, including to any contract sales organization, in each case, except with the prior written approval of Zogenix. If Zogenix grants such approval, in accordance with this Section 2.2 and Section 4.8, any Sub- distributor agreement shall be in writing and, with the exception of the financial terms, on substantially the same terms as this Agreement, to the extent applicable to the Sub-distributor's activity, and shall provide for the assignment of all Data generated by such Sub-distributors to Distributor, and the right for Distributor to terminate such agreement immediately in the event of any violation by such Sub-distributor of the FCPA or other Applicable Laws. Distributor shall be responsible for the acts or omissions of its Sub-distributors under any Sub-distributors agreement, including any such act or omission that would constitute a breach hereunder. In the event of any such breach by a Sub-distributor of its obligations to comply with the FCPA or other Applicable Laws, Distributor shall immediately terminate the applicable Sub-distributor agreement(s), unless otherwise agreed to by Zogenix in writing. Within [***] after execution thereof, Distributor shall provide Zogenix with a full and complete copy of each Sub- distributor agreement (provided that Distributor may redact any confidential information contained therein that is not relevant to compliance with this Agreement). 9 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Other Rights; Other Limitations\", \"level\": 2, \"text\": \"2.4 No Other Rights; Other Limitations. Except for the rights expressly granted in this Agreement, Zogenix retains all rights under the Zogenix Technology and with respect to the Product, including the exclusive right to manufacture and sell the Product to Distributor, to develop the Product, and to promote, market and sell the Product outside the Territory, and all rights with respect to the Product outside the Field in the Territory. No rights shall be deemed granted by one Party to the other Party under this Agreement by implication, estoppel or otherwise. Distributor agrees not to use any Zogenix Technology except as necessary to file for and maintain Regulatory Approval of, promote, market, sell, offer for sale, distribute and import the Product in the Field in the Territory during the Term in accordance with the terms of this Agreement and the Supply Agreement. Without limiting the foregoing, Distributor agrees that in no event shall Distributor or its Affiliates manufacture or have manufactured the Product, or purchase the Product from any party other than Zogenix pursuant to the Supply Agreement. Without limiting the foregoing, Distributor further acknowledges that it has no right to and agrees that it will not perform any studies of the Product or allow its Affiliate or any Third Party to perform any studies of the Product (including any investigator-initiated studies) except with the prior written approval of Zogenix, which Zogenix may withhold in its sole discretion.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Compete Covenant\", \"level\": 2, \"text\": \"2.5 Non-Compete Covenant. During the Term, without the prior written approval of Zogenix, Distributor shall not, and shall cause its Affiliates not to, either directly or indirectly, file for Regulatory Approval of, promote, market, offer for sale, sell, import or distribute in the Territory any product containing fenfluramine or any salt, enantiomer, or polymorph of fenfluramine, or any product for [***].\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Activities Outside the Territory or Field\", \"level\": 2, \"text\": \"2.6 No Activities Outside the Territory or Field. Distributor shall not, and shall cause its Affiliates and Sub-distributors not to, (a) actively seek customers for the Product outside the Territory or the Field, (b) establish or maintain a branch office, warehouse, or distribution facility for the Product outside the Territory, (c) engage in any advertising or promotional activities relating to the Product directed to customers outside the Territory or directed to any use outside the Field, or (d) solicit orders from any prospective purchaser with its principal place of business located outside the Territory. If Distributor receives any order from a prospective purchaser outside the Territory, Distributor shall not accept any such order but shall immediately refer that order to Zogenix.\"}}, {\"id\": \"ARTICLE 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNANCE\", \"level\": 1, \"text\": \"ARTICLE 3. GOVERNANCE\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Joint Steering Committee\", \"level\": 2, \"text\": \"3.1 Joint Steering Committee. The Parties shall establish a joint steering committee (the \\\"Joint Steering Committee\\\" or \\\"JSC\\\") to oversee the activities of the Parties pursuant to this Agreement. (a) Composition. The JSC will be comprised of [***] members appointed by Distributor and [***] members appointed by Zogenix, which members shall be senior level employees or representatives of each Party with decision-making authority. Each Party will 10 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 notify the other Party of its initial JSC members within [***] after the Effective Date. The Parties, through the JSC, may change the number of JSC members as long as an equal number of members from each of Distributor and Zogenix is maintained. Each Party may change its JSC members at any time by written notice to the other Party, which may be delivered at a scheduled meeting of the JSC. Any member of the JSC may designate a substitute to attend and perform the functions of that member at any meeting of the JSC. Zogenix shall appoint one (1) of its members as chair, whose role shall be to convene and preside at meetings of the JSC, but the chair shall not be entitled to prevent items from being discussed or to cast any tie-breaking vote. Each Party may, with the consent of the other Party, such consent not to be unreasonably withheld or delayed, invite non-member, non-voting representatives of such Party to attend meetings of the JSC. (b) Responsibilities. The JSC shall be responsible for oversight of the Parties' activities under this Agreement with respect to filing for, obtaining and maintaining Regulatory Approval and commercializing (including commercial supply to Distributor and marketing and sales) the Product in the Field in the Territory. Without limiting the foregoing, the JSC shall: (i) review, discuss and approve the Regulatory Plan, including all amendments thereto; (ii) review, discuss and approve the Commercialization Plan, including all amendments thereto; (iii) periodically review, discuss and assess the progress and results of the Parties under the Regulatory Plan and Commercialization Plan to ensure, to the extent reasonably practical, compliance with obligations under this Agreement; (iv) periodically discuss the status of the development and commercialization of the Product in the Field outside the Territory; (v) review Distributor's binding and non-binding forecasts for the Product and monitor the production capacity of Zogenix and its Third Party manufacturers; (vi) periodically review Distributor's and Zogenix's pharmacovigilance policies and procedures; (vii) facilitate the exchange of Data between the Parties; and (viii) perform such other duties as are specifically assigned by the Parties to the JSC in this Agreement. (c) Meetings. The JSC will hold meetings at such frequency as determined by the JSC members, but no less than twice every calendar year. Such meetings may be in person, via videoconference, or via teleconference; provided, that no fewer than two (2) JSC 11 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 meetings each calendar year prior to First Commercial Sale shall be in-person unless the Parties otherwise agree. The location of in-person JSC meetings will alternate between Zogenix's offices and Distributor's offices, unless the Parties otherwise agree. At least [***] prior to each JSC meeting, each Party shall provide written notice to the other Party of agenda items proposed by such Party for discussion or decision at such meeting, together with appropriate information related thereto. Reasonably detailed written minutes will be kept of all JSC meetings and will reflect material decisions made at such meetings. Meeting minutes will be prepared by each Party on an alternating basis and sent to each member of the JSC for review and approval within [***] after a meeting. Minutes will be deemed approved unless a member of the JSC objects to the accuracy of such minutes within [***] of receipt. (d) Decisions. The JSC may make decisions with respect to any subject matter that is within the JSC's responsibilities. Subject to this Section 3.1(d), all decisions of the JSC shall be made by unanimous vote, with Zogenix and Distributor each having, collectively, among its respective members, one (1) vote in all such decisions. If the JSC cannot reach consensus with regard to any matter to be decided by the JSC within [***] after such matter has been brought to the JSC's attention, then such matter shall be referred to the Chief Executive Officer of Zogenix and the Director, Member of the Board of Distributor (the \\\"Executives\\\") for resolution. If the Executives cannot resolve the issue within [***] after the matter has been brought to their attention then: (i) Subject to good faith consideration of the views of Distributor, Zogenix shall have the tie-breaking vote on all matters to be decided by the JSC relating to [***]; provided, however, [***]; and (ii) Subject to good faith consideration of the views of Zogenix and to Section 3.1(d)(iii), Distributor shall have the tie-breaking vote on all matters to be decided by the JSC relating to [***]; provided, however, [***]; and (iii) Subject to good faith consideration of the views of Zogenix and Section 12.2(g), Distributor shall have the tie-breaking vote on the decision of [***], unless otherwise mutually agreed between the Parties; and (iv) Subject to good faith consideration of the views of Distributor, Zogenix shall have the tie-breaking vote on all matters other than the decisions set forth in Section 3.1(d)(ii) and (iii) to be decided by the JSC that may affect commercialization outside the Territory; provided, however, that Zogenix shall not have power to amend or waive compliance with this Agreement or the Commercialization Plan. (e) Discontinuation of JSC Participation. The activities to be performed by the JSC relate solely to governance under this Agreement, and are not intended to be or involve the delivery of services. The JSC will continue to exist until the Parties mutually agreeing to disband the JSC. Once the Parties mutually agree to disband the JSC, the JSC shall have no further obligations under this Agreement and, thereafter, each Party shall designate a contact person for the exchange of information under this Agreement, and decisions of the JSC shall be 12 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 decisions as between the Parties, subject to the decision-making authority under Section 3.1(d) and other terms and conditions of this Agreement.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Expenses\", \"level\": 2, \"text\": \"3.2 Expenses. Each Party shall bear all its own costs, including expenses incurred by the members nominated by it, in connection with its members' JSC representation and meetings.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Alliance Managers\", \"level\": 2, \"text\": \"3.3 Alliance Managers. Promptly after the Effective Date, each Party shall appoint an individual to act as the alliance manager for such Party (the \\\"Alliance Manager\\\"). Each Alliance Manager will be permitted to attend meetings of the JSC as non-voting participants. The Alliance Managers will be the primary contact for the Parties regarding the activities contemplated by this Agreement and shall facilitate all such activities hereunder. Each Party may replace its Alliance Manager with an alternative representative at any time with prior written notice to the other Party. Any Alliance Manager may designate a substitute to temporarily perform the functions of that Alliance Manager.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Scope of Governance\", \"level\": 2, \"text\": \"3.4 Scope of Governance. Notwithstanding the creation of the JSC, each Party shall retain the rights, powers and discretion granted to it hereunder, and the JSC shall not be delegated or vested with rights, powers or discretion unless such delegation or vesting is expressly provided herein or the Parties expressly so agree in writing. The JSC shall not have the power to amend or modify this Agreement, and no decision of the JSC shall be in contravention of any terms and conditions of this Agreement. It is understood and agreed that issues to be formally decided by the JSC are only those specific issues that are expressly provided in this Agreement to be decided by the JSC. In no event shall the JSC have any decision-making authority with respect to matters relating to the Product outside the Territory or outside the Field. For clarity, any decision of an Executive made in resolution of a dispute of the JSC pursuant to Section 3.1(d) shall be treated as decisions of the JSC for purposes of this Agreement. It is understood between the Parties that under no circumstances are the activities to be performed by the JSC intended or allowed to violate any Applicable Laws (including but not limited to any competition and/or antitrust law).\"}}, {\"id\": \"ARTICLE 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEVELOPMENT AND REGULATORY ACTIVITIES\", \"level\": 1, \"text\": \"ARTICLE 4. DEVELOPMENT AND REGULATORY ACTIVITIES\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonclinical and Clinical Studies and CMC Requirements\", \"level\": 2, \"text\": \"4.1 Nonclinical and Clinical Studies and CMC Requirements. Promptly after the Effective Date, the JSC will discuss what nonclinical or clinical Development studies or CMC requirements are required to obtain Regulatory Approval of the Product for the treatment of Dravet syndrome and Lennox-Gastaut syndrome or would otherwise be useful for the Commercialization of the Product in the Field in the Territory, and if Zogenix agrees that such Development activities should be conducted, Zogenix will be responsible for conducting or having conducted all such Development activities. All non-clinical and clinical studies and CMC requirements completed or initiated by Zogenix as of the Effective Date or any such non-clinical and clinical studies and CMC requirements that are described in the initial version of Regulatory Plan, shall be conducted at Zogenix's own cost and expense, except for Distributor's payment 13 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 obligations under Section 6.2 and as otherwise expressly set forth herein. Any additional Territory-specific Development activities not set forth in the initial version of the Regulatory Plan, including those conducted at the suggestion or requirement of the MHLW or at [***] incurred by the Parties while conducting such Territory-specific Development activities. For clarity, Distributor shall have no right to conduct any Development activities for the Product unless otherwise agreed by Zogenix, and Zogenix shall have and retain all rights, in its sole discretion, to conduct any Development activities for the Product in the Territory outside the Field or any Development activities outside the Territory.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Activities\", \"level\": 2, \"text\": \"4.2 Regulatory Activities. (a) Regulatory Plan. All regulatory Development activities with respect to the Product in the Field in the Territory will be conducted in accordance with a comprehensive regulatory plan (as amended in accordance with this Agreement, the \\\"Regulatory Plan\\\") which sets forth [***]. The initial version of the Regulatory Plan prepared by Zogenix and agreed to by Distributor will be attached to this Agreement as Exhibit 4.2(a) [***]. Any changes and updates to the Regulatory Plan must be approved by the JSC, subject to the decision-making procedures set forth in Section 3.1(d). As between the Parties, Zogenix will have the sole right and obligation to conduct (itself or through an Affiliate or Third Party) nonclinical and clinical studies concerning the Product in the Field in or for the Territory. Zogenix shall provide updates to the JSC concerning its progress under the Regulatory Plan and copies of final nonclinical and clinical study reports following completion of such Development studies. The JSC shall discuss such activities, including any updates on the progress and results thereof provided by Zogenix. During the Term, Zogenix shall use Commercially Reasonable Efforts to Develop the Product in the Field in the Territory in accordance with the Regulatory Plan and the terms of this Agreement. (b) Global Clinical Studies for New Indications. In the event that Zogenix intends to conduct a global (including the Territory) clinical trial of the Product for indications other than Dravet syndrome and Lennox-Gastaut syndrome (a \\\"Global Study\\\"), Zogenix will provide a summary of such Global Study to Distributor for review. In the event Distributor agrees to participate in a Global Study, Zogenix (or its designee) will be responsible for conducting such Global Study, including in the Territory, [***]. (c) Conduct of Regulatory Activities. Subject to Section 4.2(d), Zogenix shall be the marketing authorization holder for the Product in the Territory, and Zogenix shall be deemed the MAH Party and Distributor deemed the Non-MAH Party for purposes of this Agreement. Zogenix shall use Commercially Reasonable Efforts to [***]. In addition, Zogenix shall use Commercially Reasonable Effort to ensure [***] shall have the capabilities and obtain the necessary licenses for filing an MAA for the Product in the Territory in advance of the planned MAA submission date in the initial version of Regulatory Plan. (i) Regulatory Approval Activities. Zogenix will be responsible for filing for and obtaining Regulatory Approval of the Product in the Field in the Territory. In connection with such activities, Zogenix shall be responsible for preparing and filing INDs and 14 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 other necessary Regulatory Filings and for communicating with Regulatory Authorities in the Territory, except as otherwise mutually agreed to by the Parties in writing. Zogenix shall be responsible for preparing, filing and obtaining Regulatory Approval of the Product in the Field in the Territory, all in accordance with the Regulatory Plan. Zogenix shall ensure that the Distributor is involved in the planning and conduct of all such activities and the decisions with respect thereto, including discussions with any Regulatory Authority and any decisions regarding the labeling of the Product in the Field in the Territory. Zogenix shall consider in good faith all input provided by the Distributor with respect to such regulatory approval activities. In connection with such activities, Zogenix shall: (i) timely inform the Distributor of any scheduled meetings with Regulatory Authorities in the Territory with respect to the Product in the Field as soon as practicable in order to allow the Distributor time to convey its opinion on the matter and (ii) use all reasonable efforts to ensure that the Distributor is afforded the opportunity to participate in such meetings. Zogenix shall keep the Distributor regularly and fully informed of the preparation, Regulatory Authority review and approval of submissions and communications with Regulatory Authorities with respect to the Product in the Field in the Territory. In particular, Zogenix shall promptly provide the Distributor with copies of all material documents, information and correspondence received from or provided to a Regulatory Authority with respect to the Product in the Field in the Territory and, upon reasonable request, with copies of any other documents, reports and communications from or to any Regulatory Authority relating to the Product in the Field in the Territory, as well as written summaries of all material oral communications with a Regulatory Authority with respect to the Product in the Field in the Territory. (ii) Post-Approval Regulatory Activities. Following the filing of the MAA for the Product in the Territory, Zogenix and Distributor shall collaborate in good faith concerning a pricing negotiation strategy for the Product. Following Regulatory Approval of the Product in the Field in the Territory, Zogenix will be responsible for negotiating and obtaining initial pricing approval for the Product with the applicable Regulatory Authority in accordance with such strategy. The MAH Party shall use Commercially Reasonable Efforts to maintain Regulatory Approval for the Product in the Field in the Territory. The MAH Party shall be responsible for all interactions with Regulatory Authorities with respect to the Product in the Field in the Territory during the Term and maintaining Regulatory Approval of the Product in the Field in the Territory. In connection with such activities, the MAH Party shall: (i) timely inform the Non-MAH Party of any scheduled meetings with Regulatory Authorities in the Territory with respect to the Product in the Field as soon as practicable in order to allow the Non-MAH Party time to convey its opinion on the matter and (ii) use all reasonable efforts to ensure that the Non-MAH Party is afforded the opportunity to participate in such meetings. The MAH Party shall keep the Non-MAH Party regularly and fully informed of the preparation of submissions and communications with Regulatory Authorities with respect to the Product in the Field in the Territory. In particular, the MAH Party shall promptly provide the Non-MAH Party with copies of all material documents, information and correspondence received from or provided to a Regulatory Authority with respect to the Product in the Field in the Territory and, upon reasonable request, with copies of any other documents, reports and communications from or to any Regulatory Authority relating to the Product in the Field in the Territory, as well as written 15 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 summaries of all material oral communications with a Regulatory Authority with respect to the Product in the Field in the Territory. (A) Post-Marketing Surveillance Studies. The MAH Party shall be responsible for conducting any post-marketing surveillance studies, including those required by the MHLW or Applicable Law, that are required to maintain the MAA. The MAH Party shall ensure that Non-MAH Party is involved in the planning and conduct of all such post-approval activities and the decisions with respect thereto, including discussions with any Regulatory Authority and any decisions regarding any post-marketing surveillance studies with respect to, the Product in Field in the Territory. The MAH Party shall consider in good faith all input provided by Zogenix with respect to such regulatory activities. The MAH Party shall be responsible for filing any post-marketing surveillance studies with the MHLW. (B) Post-Approval Clinical Studies. Zogenix shall be responsible for conducting any post- approval clinical study that is requested upon or after approval or otherwise required by the MHLW as a condition of or to maintain the MAA approval. [***] shall bear [***] the total Out-of-Pocket Costs and Expenses incurred by the Parties while conducting any such post-approval clinical study that is for the Territory. Zogenix shall ensure that Distributor is involved in the planning and conduct of all such post-approval clinical studies and the decisions with respect thereto, including discussions with any Regulatory Authority and any decisions regarding any post-approval clinical study with respect to, the Product in Field in the Territory. Zogenix shall consider in good faith all input provided by the Distributor with respect to such post-approval clinical study. The MAH Party shall be responsible for filing any post-approval clinical studies with the MHLW. (C) Risk Management Plan. Zogenix shall be responsible for filing the initial risk management plan, if any, and approving any subsequent changes thereto. The MAH Party shall be responsible for conducting or having conducted any risk management plan requested or required by the MHLW. The Distributor shall support and implement the risk management plan and cooperate with Zogenix, and the Parties shall share and discuss the results and data generated from any risk management plan required by MHLW. The Distributor shall collaborate with Zogenix to ensure global alignment and consistency with the safety specifications, pharmacovigilance planning and risk management commitments and activities. (d) Transfer of Marketing Authorization. Zogenix shall be the marketing authorization holder of the Product in the Territory for the [***] following Regulatory Approval of the Product in the Territory. Thereafter, Zogenix shall transfer the marketing authorization for the Product in the Territory to Distributor within [***] following [***], unless delayed or prohibited by a Regulatory Authority or Applicable Law or otherwise agreed by the Parties. Upon the transfer of the marketing authorization of the Product in the Territory to Distributor, then Distributor shall be deemed the MAH Party for purposes of this Agreement and Zogenix shall be deemed the Non-MAH Party. (e) Ownership of Regulatory Information. The Parties acknowledge and agree that Zogenix shall retain the full unfettered ownership of the Data and drug dossier 16 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 submitted to the PMDA for the Regulatory Approval (including but not limited to safety & efficacy data, clinical data package, drug formulation and method of administration). Notwithstanding the foregoing, if Zogenix asks Distributor to solely conduct any additional Territory-specific Development activities which are urgently required by the MHLW for the MAA in the Territory, Distributor shall retain co-ownership with Zogenix of any Data generated solely by Distributor. Distributor hereby grants Zogenix an irrevocable, perpetual, royalty-free, fully paid-up, exclusive license with the right to grant sublicenses to use such Data solely generated and co-owned by Distributor outside of the Territory and a co-exclusive license in the Territory upon expiration or termination of the Agreement. (f) Regulatory Cooperation. Each Party shall cooperate in good faith with any reasonable requests for assistance from the other Party with respect to obtaining or maintaining Regulatory Approval of the Product in and outside the Territory, including by providing to the other Party all Information in its possession and Control that is requested by, or needed to respond to inquiries of, a Regulatory Authority with respect to the Product.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's Right to Use and Reference\", \"level\": 2, \"text\": \"4.3 Distributor's Right to Use and Reference. Distributor shall have the right to reference and use all Data and Regulatory Filings (including all Regulatory Approvals) for the purpose of fulfilling Distributor's obligations set forth in this Agreement. For clarity, in accordance with Section 4.2(b), [***].\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Zogenix's Right to Use and Reference\", \"level\": 2, \"text\": \"4.4 Zogenix's Right to Use and Reference. In the event that Distributor is responsible for filing for and obtaining Regulatory Approval of the Product in the Field in the Territory or Distributor otherwise is the holder of the Regulatory Approval for the Product in the Territory, Zogenix and its Affiliates and Zogenix ex-Territory Distributors shall have the royalty-free right to reference and use all Data and Regulatory Filings (including all Regulatory Approvals), including all data contained or referenced therein, provided by or to Distributor under this Article 4, such reference and use in connection with filing for, obtaining and maintaining Regulatory Approval and commercializing the Product outside the Territory and in the Territory outside the Field. Distributor shall, on written request by Zogenix, provide, or shall cause its applicable Affiliate to provide, to Zogenix and to any specified Regulatory Authority a letter, in the form reasonably required by Zogenix, acknowledging and confirming that Zogenix and its Affiliates and/or Zogenix ex-Territory Distributors, as applicable, have the rights of reference to any such Regulatory Filing (including any such Regulatory Approval) for all purposes consistent with the Development, Regulatory Approval and commercialization of the Product outside the Territory and in the Territory outside the Field. Distributor shall not, and shall cause its Affiliates not to, transfer or disclose any Regulatory Filings (including any Regulatory Approval) relating to the Product in the Territory to any Third Party without the prior written consent of Zogenix, and in any such permitted transfer Distributor shall require the transferee to acknowledge in writing to Zogenix, Zogenix's (and its Affiliates' and Zogenix ex-Territory Distributors') rights of reference to and right to use all such Regulatory Filings (including Regulatory Approvals) as provided in this Section 4.3.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Adverse Event Reporting\", \"level\": 2, \"text\": \"4.5 Adverse Event Reporting. The MAH Party shall be responsible for the timely 17 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 reporting of all relevant adverse drug reactions/experiences, Product quality, Product complaints and safety data relating to the Product in the Field to the appropriate Regulatory Authorities in the Territory, all in accordance with Applicable Laws and requirements of Regulatory Authorities in the Territory. Zogenix (or its Affiliate, or Zogenix ex-Territory Distributors) shall be responsible for the timely reporting of all relevant adverse drug reactions/experiences, Product quality, Product complaints and safety data relating to the Product to the appropriate Regulatory Authorities outside the Territory. The details of such reporting shall be set forth in a pharmacovigilance agreement (as may be amended, the \\\"Pharmacovigilance Agreement\\\"), which will be agreed to by the Parties prior to the First Commercial Sale in the Territory. The Pharmacovigilance Agreement shall include, without limitation, governance provisions that set forth a process for communication and escalation, where necessary, of safety issues, label changes, and the like. Zogenix shall have the right to share any and all information received from Distributor under this Section 4.5, or the Pharmacovigilance Agreement, with Zogenix's Affiliates and Zogenix ex-Territory Distributors. The Pharmacovigilance Agreement shall identify the responsibilities of each Party regarding the information to be exchanged and the timeframes for such exchange, regulatory reporting, literature review, risk management, and labeling. Prior to executing the Pharmacovigilance Agreement, the Parties agree to work together in good faith to coordinate regarding pharmacovigilance activities with respect to the Product in the Field, including by exchanging Distributor's standard operating procedures and other Information relevant to such pharmacovigilance activities.\"}}, {\"id\": \"4.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Drug Safety and Pharmacovigilance System including Global Safety Database\", \"level\": 2, \"text\": \"4.6 Drug Safety and Pharmacovigilance System including Global Safety Database. Zogenix shall maintain a global system for monitoring and management of the risks associated with the Product. This system will provide signal management as well as the collection, identification, evaluation, and management of individual case safety reports and cumulative reports. As part of this pharmacovigilance system, Zogenix shall maintain the global safety database with respect to the Product, which shall serve as the reference database for all responses to safety queries and aggregate safety reports and be the main source for individual case safety report processing. Each Party shall cooperate, and shall cause its Affiliates, Sub-distributors and Zogenix ex-Territory Distributors, as applicable, to cooperate, in implementing and adhering to a pharmacovigilance mutual alert process with respect to the Product to comply with Applicable Laws, as set forth in the Pharmacovigilance Agreement. Notwithstanding anything to the contrary in this Agreement, Zogenix shall have final decision making authority over all issues that implicate global safety.\"}}, {\"id\": \"4.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Audit\", \"level\": 2, \"text\": \"4.7 Regulatory Audit. Each Party shall notify the other Party within [***] of receipt of any notice of a MHLW audit of any of such Party or its Affiliate or subcontractor with respect to the Product in the Territory. Notwithstanding the foregoing, if a Party is subject to an unannounced audit from the MHLW or receives a notice of an imminent audit from the MHLW, in each case with respect to the Product in the Territory, such Party shall notify the other Party promptly, but in any event within [***]. Such other Party shall have the right to have its or its Affiliates' or its subcontractors' employees or consultants participate in any audits or other inspections to the extent permitted by Applicable Law. To the extent permitted by Applicable Law, the audited Party shall provide the other Party with the copies of any resulting document or 18 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 action pertaining to the Product in the Territory that results from such audit within [***] of their receipt.\"}}, {\"id\": \"4.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Use of Subcontractors\", \"level\": 2, \"text\": \"4.8 Use of Subcontractors. To the extent that Distributor performs any of its regulatory or commercial activities under this Agreement through one or more subcontractors (including a Sub-distributor), if and as permitted under the terms of this Agreement, Distributor shall ensure that (a) none of Zogenix's rights hereunder are diminished or otherwise adversely affected as a result of such subcontracting, (b) the subcontractor assigns to Distributor all Distributor Inventions and all data generated by such subcontractor that, if Controlled by Distributor, would be included in the definition of Data, (c) the subcontractor undertakes in writing obligations of confidentiality and non-use regarding Confidential Information and compliance with the FCPA and other Applicable Laws that are substantially the same as those undertaken by the Parties pursuant to Article 8 and Section 10.2, (d) the subcontractor does not have an adverse history or reputation, (e) the use of the subcontractor will not cause the Zogenix Indemnitees to be in violation of the FCPA or any other Applicable Laws, and (f) the use of the subcontractor will not cause reputational harm to the Zogenix Indemnitees. In the event that Distributor performs any of its regulatory activities hereunder through a subcontractor, Distributor will at all times be fully responsible for the performance and payment of such subcontractor.\"}}, {\"id\": \"4.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recalls\", \"level\": 2, \"text\": \"4.9 Recalls. (a) In the event that the MHLW issues a request or orders a recall or takes similar action in connection with the Product in the Territory, or in the event either Party determines that an event, incident, or circumstance has occurred that may result in the need for a voluntary withdrawal of the Product in the Territory, the Party notified of such recall or desiring such voluntary withdrawal shall, within [***], advise the other Party thereof by telephone (and confirm by electronic mail or facsimile). Regarding any recall order or request from the MHLW, the Parties shall, to the extent practicable, discuss and endeavor to agree upon a plan for recalling the affected Product. Regarding any request for a voluntary withdrawal, the Parties shall discuss and endeavor to agree upon whether to voluntarily withdraw the Product in the Territory, and each Party shall review and consider in good faith all information provided by the other Party in connection with such discussion, including any assessment of safety and whether to withdraw the Product. (b) For all recalls requested or ordered by the MHLW, the MAH Party shall have the sole authority and responsibility to make all decisions with respect to such recall, subject to good faith consideration of the views of the non-MAH Party. For all voluntary withdrawals concerning quality defects, such as compliance, foreign substances, tampering and labeling defects, the MAH Party shall have the sole authority and responsibility to make all decisions with respect to such withdrawal, subject to good faith consideration of the views of non-MAH party. For all voluntary withdrawals concerning efficacy or safety, Zogenix shall have the sole authority and responsibility to make all decisions with respect to such withdrawal, subject to good faith consideration of the views of the Distributor. 19 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (c) Distributor shall be responsible for conducting any such recall or withdrawal, shall use Commercially Reasonable Efforts to minimize the expenses of any such recall or withdrawal and shall keep Zogenix fully informed of all actions taken in conducting such recall or withdrawal. If a recall or withdrawal is due to Zogenix's negligence, willful misconduct or breach of this Agreement, Zogenix shall reimburse Distributor for all of the reasonable costs and expenses actually incurred by Distributor in connection with such recall or withdrawal, including, but not limited to, costs of personnel expenses of Distributor's sales representatives, fees for consultation with the Regulatory Authority in the Territory and travel expenses for consultation, and its actual reasonable Out-of-Pocket Costs and Expenses incurred while retrieving Product already delivered to customers, costs and expenses Distributor is required to pay for notification, shipping and handling charges, and such other costs as may be reasonably related to the recall or withdrawal. If a recall or withdrawal is due to Distributor's negligence, willful misconduct or breach of this Agreement, Distributor shall reimburse Zogenix for all the reasonable costs and expenses described above actually incurred by Zogenix in connection with such recall or withdrawal, including administration of the recall and such other actual costs as may be reasonably related to the recall or withdrawal in the Territory. If a recall or withdrawal results from a cause other than the negligence in the Territory, willful misconduct or breach of this Agreement of or by Distributor or Zogenix, the parties hereto [***]. Prior to any reimbursements pursuant to this Section, the party claiming any reimbursement shall provide the other party with reasonably acceptable documentation of all reimbursable costs and expenses. Neither Party will be liable to the other for Indirect Losses in connection with any recall or withdrawal pursuant to this Section.\"}}, {\"id\": \"4.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Development Expenses\", \"level\": 2, \"text\": \"4.10 Development Expenses. Unless expressly stated otherwise, each Party shall bear its own Out-of-Pocket Costs and Expenses and any employee and overhead expenses incurred while performing its obligations under this Article 4.\"}}, {\"id\": \"ARTICLE 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMMERCIALIZATION; SUPPLY\", \"level\": 1, \"text\": \"ARTICLE 5. COMMERCIALIZATION; SUPPLY: TRADEMARKS\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Commercialization of the Product\", \"level\": 2, \"text\": \"5.1 Commercialization of the Product. (a) Distributor Responsibilities. Distributor shall have the exclusive right to market, promote, sell, offer for sale, import, package and otherwise Commercialize the Product in the Field in the Territory, at its sole cost and expense, in accordance with Applicable Laws and the Commercialization Plan and subject to the terms and conditions of this Agreement. Without limiting the foregoing, Distributor will have the exclusive right and responsibility in the Field in the Territory for the following: (i) designing the Commercialization strategy and tactics for the Product, subject to JSC approval of the Commercialization Plan; (ii) undertaking all promotional activities for the Product; 20 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (iii) establishing and implementing post-marketing surveillance studies for the Product in the Territory as required or recommended by a Regulatory Authority; (iv) receiving, accepting and filling orders for the Product from customers; (v) warehousing and distributing the Product to customers; (vi) controlling invoicing, order processing and collection of accounts receivable for sales of the Product; (vii) recording sales of the Product in the Territory in its books of account for sales; and (viii) providing results of sales of the Product in the Territory for purposes of periodic safety reports and exposure estimates. Distributor shall provide updates regularly to the JSC relating to Commercialization activities for the Product in the Field in the Territory. (b) Commercialization Plan. Distributor shall be responsible for the creation and implementation of an annual plan for the Commercialization of the Product in the Field in the Territory, which shall identify proposed plans to address potential challenges with respect to Commercialization of the Product in the Field in the Territory (the \\\"Commercialization Plan\\\"). The Commercialization Plan shall set forth in reasonable detail the major Commercialization activities planned for the Product in the Territory for the applicable period, including [***]. Distributor shall prepare and submit to the JSC the initial Commercialization Plan no later than [***] after MAA filing for the Product in the Field in the Territory for review and approval by the JSC in accordance with the decision-making procedures set forth in Section 3.1(d). Distributor shall submit subsequent updated Commercialization Plans to the JSC on an annual basis on or before the end of each Fiscal Year for review and approval by the JSC. Through the JSC, Distributor shall regularly consult with and provide updates to Zogenix regarding the Commercialization strategy for and the Commercialization of the Product in the Field in the Territory. (c) Diligence. During the Term, Distributor shall use Commercially Reasonable Efforts to market, promote, sell, offer for sale, import, package, distribute and otherwise commercialize the Product in the Field in the Territory in accordance with the Commercialization Plan and the terms of this Agreement. Without limiting the foregoing, Distributor shall Submit the first purchase order of the Product in the Field in the Territory to Zogenix within [***], achieve First Commercial Sale of the Product in the Field in the Territory as soon as reasonably practicable after the Product is first available for delivery to Distributor in the Territory, and use Commercially Reasonable Efforts to timely accomplish all the activities set forth in the Commercialization Plan. 21 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (d) Distributor's Diligence Failure. (i) After [***] of the First Commercial Sale of the Product in the Territory, if Zogenix reasonably believes that Distributor has failed to achieve or maintain the diligence obligations set forth in Section 5.1(c), Zogenix shall provide written notice thereof to Distributor requesting a detailed written response concerning such failure and Distributor shall provide such detailed written response to Zogenix within [***] of the date of Zogenix's request. Zogenix's notice shall specify in reasonable detail the facts and circumstances constituting Zogenix's reasons for reaching such a determination. Following Zogenix's receipt of Distributor's response, the Parties shall promptly, and in any event within [***], discuss in good faith Distributor's obligations and its proposed actions to cure its failure to achieve its diligence obligations. Where remedy is possible and reasonably acceptable to Zogenix, Distributor shall use its Commercially Reasonable Efforts to start substantive steps within [***] of the date of Zogenix's notice to Distributor. If Distributor (A) fails to provide a detailed written response to Zogenix within [***] of the date of Zogenix's notice to Distributor, or (B) fails to use its Commercially Reasonable Efforts to start substantive steps to remedy such failure [***] of the date of Zogenix's notice to Distributor, Zogenix shall have the right, [***] effective upon written notice thereof by Zogenix to Distributor, to (1) [***] or (2) [***]. (ii) Any failure of Distributor to achieve the diligence obligations set forth in Section 5.1(c) shall not be considered Distributor's diligence failure as described in Section 5.1(d)(i) or a breach of this Agreement to the extent such failure was caused by (A) Zogenix's inability or failure to supply Product in accordance with the terms of the Supply Agreement, (B) any changes to the Regulatory Plan approved by the JSC in accordance with Section 4.2(a), or (C) any changes to the Commercialization Plan approved by the JSC in accordance with Section 5.1(b). (iii) This Section 5.1(d) shall not limit any other remedies or damages that Zogenix may have or seek under this Agreement or Applicable Laws.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply\", \"level\": 2, \"text\": \"5.2 Supply. The Parties acknowledge and agree that Zogenix shall retain all rights to make and have made the Product in and for the Territory. Promptly after the Effective Date, the Parties shall commence negotiating a supply agreement containing reasonable and customary terms for an agreement of such type, governing Zogenix's supply of the Product to Distributor for sale in the Field in the Territory in accordance with the terms of this Agreement (as may be amended, the \\\"Supply Agreement\\\"), and shall use reasonable efforts to enter into the Supply Agreement within [***] after the Effective Date. Zogenix shall supply, or cause to be supplied, Product to Distributor in accordance with the Supply Agreement, and Distributor shall purchase all of its and its Affiliates' and Sub-distributors' requirements for the Product under the Supply Agreement. Distributor shall pay to Zogenix the Transfer Price for Product supplied under the Supply Agreement in accordance with Section 6.5. 22 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademark Rights\", \"level\": 2, \"text\": \"5.3 Trademark Rights. (a) Product Trademarks. Subject to the terms and conditions of this Agreement, Zogenix hereby grants to Distributor an co-exclusive, royalty-free, limited right under the Product Trademarks solely to promote, market, sell, offer for sale, import, package and distribute the Product in Field in the Territory in accordance with the terms of this Agreement. (b) Zogenix Trademarks. Subject to the terms and conditions of this Agreement, Zogenix hereby grants to Distributor a non-exclusive, royalty-free, limited right under the Zogenix Trademarks solely to promote, market, sell, offer for sale, import, package and distribute the Product in Field in the Territory in accordance with the terms of this Agreement.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Commercial Expenses\", \"level\": 2, \"text\": \"5.4 Commercial Expenses. Unless expressly stated otherwise, each Party shall bear its own Out-of-Pocket Costs and Expenses and all employee and overhead expenses incurred while performing its obligations under this Article 5.\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENTS\", \"level\": 1, \"text\": \"ARTICLE 6. PAYMENTS\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upfront Payment\", \"level\": 2, \"text\": \"6.1 Upfront Payment. Distributor shall pay to Zogenix, upon the receipt of the invoice from Zogenix after the Effective Date, a non-refundable, non-creditable upfront payment of Seven Million Five Hundred Thousand U.S. Dollars (US $7,500,000), which upfront payment shall consist of [***] in consideration for the exclusive right to distribute Product in the Territory for the treatment of Dravet syndrome and [***] in consideration for the exclusive right to distribute Product in the Territory for the treatment of Lennox-Gastaut syndrome. Distributor shall pay such payment to Zogenix within [***] of receipt of the invoice.\"}}, {\"id\": \"value:US $7,500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"US $7,500,000\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Funding to Support Development of The Product\", \"level\": 2, \"text\": \"6.2 Funding to Support Development of The Product. Distributor shall pay to Zogenix Twelve Million Five Hundred Thousand U.S. Dollars (US $12,500,000) for support of Zogenix's global nonclinical and clinical Development studies concerning the Product for Dravet syndrome and Lennox-Gastaut syndrome as it relates to Regulatory Approval of the Product in the Territory. For clarity, the Six Million Five Hundred Thousand U.S. Dollar (US $6,500,000) payment is intended to support studies previously conducted by Zogenix and that will be included in the MAA for the Territory. The remaining Six Million U.S. Dollars (US 6,000,000) in payments are intended to support those studies conducted by Zogenix and indicated as being paid for by Zogenix under the initial Regulatory Plan during [***] after the Effective Date, and such payments will be made [***]. The five (5) Development payments pursuant to this Section 6.2 will be made according to the following schedule: (a) Within [***] after the Effective Date, a non-refundable, non-creditable one-time payment of [***]; (b) Within [***] after the Effective Date, a non-refundable, non-creditable 23 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 one-time payment of [***]; (c) On the [***] of the Effective Date, a non-refundable, non-creditable one-time payment of [***]; (d) On the [***] of the Effective Date, a non-refundable, non-creditable one-time payment of [***]; and (e) On the [***] of the Effective Date, a non-refundable, non-creditable one-time payment of [***]. For clarity, each of the foregoing payments to be made by Distributor to Zogenix shall be payable within [***] of receipt of the invoice therefor from Zogenix. In the event that Zogenix terminates the Development the Product in the Territory for both Dravet syndrome and Lennox-Gastaut syndrome prior to the due date for any of the foregoing payments any such payment whose due date is after such termination shall no longer be due and payable to Zogenix.\"}}, {\"id\": \"value:US $12,500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"US $12,500,000\"}}, {\"id\": \"value:US $6,500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"US $6,500,000\"}}, {\"id\": \"value:US 6,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"US 6,000,000\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Milestones\", \"level\": 2, \"text\": \"6.3 Regulatory Milestones. Distributor shall pay to Zogenix the non-refundable, non-creditable milestone payments as set forth in this Section 6.3. Upon the occurrence of each milestone event in this Section 6.3 Zogenix shall issue an invoice to Distributor for the amount of the milestone payment corresponding to such achieved milestone event, and Distributor shall pay to Zogenix such invoiced amount within [***] of its receipt from Zogenix. 24 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Regulatory Milestone Event Milestone Payment [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] Each milestone payment set forth above shall be payable only once for the Product. For clarity, the total regulatory milestone payments set forth in this Section shall not exceed: (a) [***] if [***]; (b) [***] if [***]; and (c) [***].\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sales Milestones\", \"level\": 2, \"text\": \"6.4 Sales Milestones. For each Fiscal Quarter in which aggregate annual Net Sales first reach a threshold indicated in the table below, Distributor shall inform Zogenix within [***] that the aggregated annual Net Sales first reached such threshold. Zogenix shall issue an invoice to Distributor for the applicable milestone payment, and Distributor shall pay such invoice within [***] of its receipt from Zogenix: Annual Net Sales Level Milestone Payment First Fiscal Year in which aggregate annual Net Sales of the Product in the Field in the Territory exceed [***] [***] First Fiscal Year in which aggregate annual Net Sales of the Product in the Field in the Territory exceed [***] [***] First Fiscal Year in which aggregate annual Net Sales of the Products in the Field in the Territory exceed [***] [***] The milestone payments set forth in this Section 6.4 shall be additive, such that if all three (3) 25 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 milestone events are achieved in the same Fiscal Year, Distributor shall pay to Zogenix all three (3) milestone payments.\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply Payments\", \"level\": 2, \"text\": \"6.5 Supply Payments. Amount of Product Supplied per Fiscal Year Net Price Markup For the portion of Product supplied less than or equal to the equivalent of [***] in Net Sales in such Fiscal Year [***] For the portion of Product supplied in excess of the equivalent of [***] in Net Sales and less than or equal to the equivalent of [***] in Net Sales in such Fiscal Year [***] For the portion of Product supplied in excess of the equivalent of [***] in Net Sales and less than or equal to the equivalent of [***] in Net Sales in such Fiscal Year [***] For the portion of Product supplied in excess of the equivalent of [***] in Net Sales in such Fiscal Year [***] The Net Sales equivalent described in the left column of the table above is calculated by determining the total number of units ordered in the applicable Fiscal Year and multiplying such number by the Net Price for such Fiscal Year. Following the expiration of the Distribution Term and during the remaining Term of this Agreement, for all Product supplied by Zogenix to Distributor under purchase orders submitted pursuant to the Supply Agreement in a particular Fiscal Year, Distributor shall pay to Zogenix the Transfer Price per unit of Product supplied shall be equal to the sum of (i) [***] of the Fully-Burdened Manufacturing Cost per unit of Product for such Fiscal Year, and (ii) [***] of aggregate annual Net Sales for such Fiscal Year. (b) Estimates. No later than [***] before the beginning of each Fiscal Year, starting with the Fiscal Year in which the First Commercial Sale is anticipated to occur, the Parties shall discuss in good faith and agree on a reasonable estimate of the Net Price for the Product for such Fiscal Year, which estimate will be based on a reasonable approximation of the aggregate Net Sales of Product to be recognized by Distributor and its Affiliates during such Fiscal Year. The agreed Net Price will be used to calculate the Transfer Price initially invoiced by Zogenix and payable by Distributor for the total number of units of the Product ordered by 26 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 and delivered to Distributor under the Supply Agreement during such Fiscal Year. (c) Reports. Within [***] after the end of each of the first three Fiscal Quarters in a Fiscal Year, starting with the Fiscal Quarter in which the First Commercial Sale occurs, Distributor shall deliver to Zogenix a report setting forth: (i) the total Net Sales of the Product in the Territory during such Fiscal Quarter, (ii) the detailed and total deductions from gross amounts invoiced to arrive at such Net Sales, (iii) the number of units of the Product sold in the Territory during such Fiscal Quarter and (iv) gross amounts invoiced for such sales. Within [***] after the end of each Fiscal Year, starting with the Fiscal Year in which the First Commercial Sale occurs, Distributor shall deliver to Zogenix a report setting forth: (A) the total Net Sales of the Product in the Territory during such Fiscal Year, (B) the detailed and total deductions from gross amounts invoiced to arrive at such Net Sales, (C) the number of units of the Product sold in the Territory during such Fiscal Year, (D) the gross amounts invoiced for such sales, (E) the calculation of actual Net Price for such Fiscal Year, (F) the total amount invoiced by Zogenix and paid by Distributor to Zogenix under the Supply Agreement for the total number of units of the Product ordered by and delivered to Distributor during such Fiscal Year, based on the estimated Net Price for such Fiscal Year, (G) the total amount actually owed to Zogenix for the total number of units of the Product ordered by and delivered to Distributor during such Fiscal Year based on the actual Net Price and (H) the difference between the amounts in clauses (F) and (G) (each such report, an \\\"Annual Report\\\"). (d) True-Up. For each Annual Report, if the amount in clause (G) of such Annual Report exceeds the amount in clause (F), then Distributor shall pay the amount in clause (H) to Zogenix concurrently with its delivery of such Annual Report to Zogenix. Otherwise, if the amount in clause (G) is less than the amount in clause (F), the amount in clause (H) will be credited against the subsequent payment(s) due from Distributor to Zogenix (or if no further payments will be due, paid by Zogenix to Distributor within [***] after Zogenix's receipt of such Annual Report from Distributor). In no event shall the effective Transfer Price for the Product in a Fiscal Year exceed [***] of the aggregate annual Net Sales of the Product in the Field in the Territory for such Fiscal Year.\"}}, {\"id\": \"ARTICLE 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENTS, BOOKS AND RECORDS\", \"level\": 1, \"text\": \"ARTICLE 7. PAYMENTS, BOOKS AND RECORDS\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment Method\", \"level\": 2, \"text\": \"7.1 Payment Method. All amounts specified to be payable under this Agreement are in United States dollars and shall be paid in United States dollars. All payments under this Agreement shall be made by bank wire transfer in immediately available funds to an account designated in writing by the payee Party or by such other means as directed by such Party in writing. Payments hereunder will be considered to be made as of the day on which they are received by the payee Party's designated bank. 27 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Currency Conversion\", \"level\": 2, \"text\": \"7.2 Currency Conversion. For the purpose of calculating any sums due under this Agreement and determining the annual Net Sales levels in Section 6.5, conversion shall be made to U.S. dollars by using the arithmetic mean of the exchange rates for the purchase of United States dollars as published in The Wall Street Journal, Eastern Edition, for each Business Day in the Fiscal Quarter to which such calculations relate.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 2, \"text\": \"7.3 Taxes. Any taxes imposed on Distributor or with respect to Distributor's business operations or activities hereunder, including any value added taxes, consumption, transfer, sales, use or other such taxes relating to the transactions contemplated herein, shall be borne by Distributor, and Distributor shall timely pay, and indemnify and hold harmless, Zogenix from and against all such taxes, including any penalties or interest associated therewith. If Distributor is required by Applicable Law to deduct and withhold taxes from a payment due and payable to Zogenix hereunder (excluding national, state or local taxes based on income to Zogenix), Distributor shall: (a) promptly notify Zogenix of such requirement; (b) make such required deduction and withholding from the corresponding payment; (c) pay to the relevant Governmental Authority the full amount required to be so deducted and withheld; and (d) promptly forward to Zogenix an official receipt or other documentation reasonably acceptable to Zogenix evidencing such payment to such Governmental Authority(ies). The Parties acknowledge and agree that it is their mutual objective and intent to minimize, to the extent feasible under the Applicable Laws, any taxes payable in connection with this Agreement, and shall reasonably cooperate each other in good faith in accordance with Applicable Laws to minimize any Taxes in connection with this Agreement, including provision of any tax forms and other information that may be reasonably necessary in order for the paying Party not to withhold tax or to withhold tax at a reduced rate under an applicable bilateral income tax treaty.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records\", \"level\": 2, \"text\": \"7.4 Records. Distributor shall keep, and require its Affiliate and Sub-distributors to keep, complete, fair and true books of accounts and records for the purpose of (a) determining the amounts payable to Zogenix pursuant to this Agreement and the Supply Agreement and (b) ensuring that Distributor and its Affiliates and Sub-distributors do not otherwise cause any Zogenix Indemnitees to be in violation of the FCPA or other Applicable Laws. Such books and records shall be kept for such period of time required by Applicable Laws, but no less than three (3) years following the end of the Fiscal Year to which they pertain. Such records shall be subject to inspection in accordance with Section 7.5.\"}}, {\"id\": \"7.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Audits\", \"level\": 2, \"text\": \"7.5 Audits. Upon reasonable prior written notice, Distributor shall permit an independent, certified public accountant selected by Zogenix and reasonably acceptable to Distributor, which acceptance will not be unreasonably withheld or delayed, to audit or inspect those books or records of Distributor and its Affiliates and Sub-distributors that relate to Net Sales for the sole purpose of verifying: (a) the payments due hereunder and payments due under the Supply Agreement; (b) the withholding taxes, if any, required by Applicable Laws to be withheld; and (c) Distributor's compliance with Sections 10.1 and 10.2. Such accountant will disclose to Zogenix only the amount and accuracy of payments reported and actually paid or otherwise payable under this Agreement or the Supply Agreement, and will send a copy of the report to Distributor at the same time it is sent to Zogenix. Prompt adjustments (including 28 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 interest under Section 7.6 for underpaid amounts) shall be made by the Parties to reflect the results of such audit. Such inspections may be made no more than once each Fiscal Year (unless an audit or inspection reveals a material inaccuracy in reports made under this Agreement, in which case it may be repeated within such Fiscal Year), and during normal business hours, with reasonable efforts to minimize disruption of Distributor's normal business activities. Inspections conducted under this Section 7.5 shall be at the expense of Zogenix, unless a variation or error producing an underpayment in amounts payable exceeding [***] of the amount paid for a period covered by the inspection is established, in which case all reasonable costs relating to the inspection for such period shall be paid by Distributor. Absent manifest error, the accountant's report will be final and binding on the Parties.\"}}, {\"id\": \"7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Late Payments\", \"level\": 2, \"text\": \"7.6 Late Payments. In the event that any payment due under this Agreement or the Supply Agreement is not made when due, the payment shall accrue interest from the date due at a rate per annum equal to [***] above the U.S. Prime Rate (as set forth in The Wall Street Journal, Eastern U.S. Edition) for the date on which payment was due, calculated daily on the basis of a 365-day year, or similar reputable data source; provided that in no event shall such rate exceed the maximum legal annual interest rate. The payment of such interest shall not limit a Party from exercising any other rights it may have as a consequence of the lateness of any payment.\"}}, {\"id\": \"value:365-day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"365-day\"}}, {\"id\": \"ARTICLE 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"ARTICLE 8. CONFIDENTIALITY\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential Information\", \"level\": 2, \"text\": \"8.1 Confidential Information. Except to the extent expressly authorized by this Agreement or otherwise agreed in writing by the Parties, the Parties agree that during the Term and for [***] thereafter, the receiving Party (the \\\"Receiving Party\\\") shall keep confidential and shall not publish or otherwise disclose or use for any purpose other than as provided for in this Agreement or the Supply Agreement any Information or materials furnished to it or its Affiliates by or on behalf of the other Party (the \\\"Disclosing Party\\\") or its Affiliates pursuant to this Agreement, the Supply Agreement, the Confidentiality Agreement or any other written agreement between the Parties or their Affiliates, in any form (written, oral, photographic, electronic, magnetic, or otherwise), including all information concerning the Product and any other technical or business information of whatever nature (collectively, \\\"Confidential Information\\\" of the Disclosing Party). All Zogenix Technology (including, without limitation, all Product Inventions and Data) shall be deemed the Confidential Information of Zogenix. Distributor Inventions shall be deemed the Confidential Information of Distributor. Joint Inventions shall be deemed the Confidential Information of each of Zogenix and Distributor. Each Party may use the Confidential Information of the other Party only to the extent required to accomplish the purposes of this Agreement or the Supply Agreement (including to exercise its rights or fulfill its obligations under this Agreement or the Supply Agreement). Each Party will use at least the same standard of care as it uses to protect proprietary or confidential information of its own (but in no event less than reasonable care) to ensure that its employees, agents, consultants and other representatives do not disclose or make any unauthorized use of the 29 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Confidential Information of the other Party. Each Party will promptly notify the other upon discovery of any unauthorized use or disclosure of the Confidential Information of the other Party.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exceptions\", \"level\": 2, \"text\": \"8.2 Exceptions. Notwithstanding Section 8.1 above, the obligations of confidentiality and non\u2011use shall not apply to information that the Receiving Party can prove by competent written evidence: (a) is now, or hereafter becomes, through no act or failure to act on the part of the Receiving Party or any of its Affiliates, generally known or available; (b) is known by the Receiving Party or any of its Affiliates, other than under an obligation of confidentiality to the Disclosing Party, at the time of receiving such information; (c) is hereafter lawfully furnished to the Receiving Party or any of its Affiliates by a Third Party, which Third Party did not receive such information directly or indirectly from the Disclosing Party under an obligation of confidence; (d) is independently discovered or developed by the Receiving Party or any of its Affiliates without the use of Confidential Information belonging to the Disclosing Party; or (e) is the subject of a written permission to disclose provided by the Disclosing Party.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Permitted Disclosures\", \"level\": 2, \"text\": \"8.3 Permitted Disclosures. Notwithstanding the provisions of Section 8.1, the Receiving Party may disclose Confidential Information of the Disclosing Party as expressly permitted by this Agreement or if and to the extent such disclosure is reasonably necessary in the following instances: (a) filing or prosecuting Patents as permitted by this Agreement; (b) prosecuting or defending litigation as permitted by this Agreement; (c) complying with applicable court orders, governmental regulations, applicable subpoenas or reasonable requests issued by governmental authorities in relation to compliance with the FCPA and other Applicable Laws; (d) in the case of Zogenix, disclosure under terms of confidentiality no less stringent than under this Agreement to potential or actual Zogenix ex-Territory Distributors; (e) disclosure to its and its Affiliates' contractors, employees and consultants, in each case who need to know such information for filing for, obtaining and maintaining Regulatory Approvals and Commercialization of Product in the Territory in accordance with this Agreement and manufacturing and supplying of Product in accordance with the Supply Agreement (or, in the case of disclosures by Zogenix, who need to know such information for the Development, manufacture and commercialization of the Product outside the Field or Territory), on the condition that any such Third Parties agree to be bound by confidentiality and non-use obligations that are no less stringent than those confidentiality and non-use provisions contained in this Agreement; and (f) disclosure to Third Parties in connection with due diligence or similar investigations by such Third Parties, and disclosure to potential Third Party investors in confidential financing documents, provided, in each case, that any such Third Party agrees to be 30 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 bound by confidentiality and non-use obligations that are no less stringent than those confidentiality and non-use provisions contained in this Agreement. Notwithstanding the foregoing, in the event a Party is required to make a disclosure of the other Party's Confidential Information pursuant to Section 8.3(b) or (c), it will, except where impracticable, give reasonable advance notice to the other Party of such disclosure and use efforts to secure confidential treatment of such information at least as diligent as such Party would use to protect its own confidential information, but in no event less than reasonable efforts. In any event, the Parties agree to take all reasonable action to avoid disclosure of Confidential Information hereunder.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality of this Agreement and its Terms\", \"level\": 2, \"text\": \"8.4 Confidentiality of this Agreement and its Terms. Except as otherwise provided in this Article 8, each Party agrees not to disclose to any Third Party the existence of this Agreement or the terms of this Agreement without the prior written consent of the other Party, except that each Party may disclose the terms of this Agreement that are not otherwise made public as contemplated by Section 8.5 as permitted under Section 8.3.\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Public Announcements\", \"level\": 2, \"text\": \"8.5 Public Announcements. (a) As soon as practicable following the Effective Date, the Parties may each issue a press release in English and/or Japanese, in the form attached hereto as Exhibit 8.5(a), announcing the existence of this Agreement. Except as required by Applicable Laws (including disclosure requirements of the SEC or any stock exchange on which securities issued by a Party or its Affiliates are traded), neither Party shall make any other public announcement concerning this Agreement or the subject matter hereof without the prior written consent of the other, which shall not be unreasonably withheld or delayed; provided that each Party may make any public statement in response to questions by the press, analysts, investors or those attending industry conferences or financial analyst calls, or issue press releases, so long as any such public statement or press release is not inconsistent with prior public disclosures or public statements approved by the other Party pursuant to this Section 8.5 and does not reveal non\u2011public information about the other Party; and provided further that Zogenix may make public statements regarding the results of Development and Commercialization activities in the Territory. In the event of a public announcement required by Applicable Laws, to the extent practicable under the circumstances, the Party making such announcement shall provide the other Party with a copy of the proposed text of such announcement sufficiently in advance of the scheduled release to afford such other Party a reasonable opportunity to review and comment upon the proposed text. (b) The Parties will coordinate in advance with each other in connection with the filing of this Agreement (including redaction of certain provisions of this Agreement) with the SEC or any stock exchange on which securities issued by a Party or its Affiliate are traded, and each Party will use reasonable efforts to seek confidential treatment for the terms proposed to be redacted; provided that each Party will ultimately retain control over what information to disclose to the SEC or other applicable government body, and provided further that the Parties will use their reasonable efforts to file redacted versions with any governing bodies which are consistent with redacted versions previously filed with any other governing bodies. Other than 31 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 such obligation, neither Party (nor its Affiliates) will be obligated to consult with or obtain approval from the other Party with respect to any filings to the SEC or any other government body governing a stock exchange. (c) Except as expressly permitted in this Agreement or as required by Applicable Laws, neither Party may use the other Party's trademarks, service marks or trade names, or otherwise refer to or identify that other Party in marketing or promotional materials, press releases, statements to news media or other public announcements, without the other Party's prior written consent, which that other Party may grant or withhold in its sole discretion.\"}}, {\"id\": \"8.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Publication\", \"level\": 2, \"text\": \"8.6 Publication. At least [***] prior to Distributor or its Affiliates or Sub-distributors publishing, publicly presenting, and/or submitting for written or oral publication a manuscript, presentation, abstract, marketing document or the like that includes Information relating to the Product that has not been previously published, Distributor shall provide to Zogenix's Alliance Manager a draft copy thereof for Zogenix's review (unless Distributor is required by Applicable Laws to publish such Information sooner, in which case Distributor shall provide such draft copy to Zogenix's Alliance Manager as much in advance of such publication as possible). Distributor shall consider in good faith any comments provided by Zogenix during such [***] period, and in the event that Zogenix raises any concerns the matter shall be raised at the JSC; provided that Distributor shall, at Zogenix's reasonable request, cease such proposed publication or remove therefrom any information requested by Zogenix. The contribution of each Party shall be noted in all publications or presentations by acknowledgment or co-authorship, whichever is appropriate.\"}}, {\"id\": \"8.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prior Non-Disclosure Agreements\", \"level\": 2, \"text\": \"8.7 Prior Non-Disclosure Agreements. As of the Effective Date, the terms of this Article 8 shall supersede any prior non-disclosure, secrecy or confidentiality agreement between the Parties (or their Affiliates) dealing with the subject of this Agreement, including the Confidentiality Agreement, but excluding any terms of the Supply Agreement. Any information disclosed under such prior agreements shall be deemed disclosed under this Agreement.\"}}, {\"id\": \"8.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Equitable Relief\", \"level\": 2, \"text\": \"8.8 Equitable Relief. Given the nature and value of the Confidential Information and the competitive damage and irreparable harm that would result to a Party upon unauthorized disclosure, use or transfer of its Confidential Information to any Third Party, the Parties agree that monetary damages may not be a sufficient remedy for any breach of this Article 8. If the Receiving Party becomes aware of any breach or threatened breach of this Article 8 by the Receiving Party or a Third Party to whom the Receiving Party disclosed the Disclosing Party's Confidential Information, the Receiving Party promptly shall notify the Disclosing Party and cooperate with the Disclosing Party to regain possession of its Confidential Information and prevent any further breach. In addition to all other remedies, a Party shall be entitled to seek specific performance and injunctive and other equitable relief as a remedy for any breach or threatened breach of this Article 8 without furnishing proof of actual damages or posting a bond. ARTICLE 9. 32 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 INTELLECTUAL PROPERTY OWNERSHIP AND ENFORCEMENT\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership of Intellectual Property\", \"level\": 2, \"text\": \"9.1 Ownership of Intellectual Property. (a) Zogenix Technology. Zogenix shall retain all right, title and interest in and to the Zogenix Technology. (b) Inventions and Intellectual Property Rights. (i) Ownership. Zogenix shall own the entire right, title and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice solely by or on behalf of Zogenix under or in connection with this Agreement, including in the course of conducting regulatory activities or Commercialization of the Product in the Field in the Territory, whether or not patented or patentable, together with any and all intellectual property rights in any such Inventions, including Patents that claim or disclose any such Inventions (collectively, the \\\"Product Invention\\\"). Distributor shall own the entire right, title and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice solely by Distributor or its Affiliates or Sub-distributors or its other subcontractors in the Territory and under or in connection with this Agreement, including in the course of conducting regulatory activities or Commercialization of the Product in the Field in the Territory, whether or not patented or patentable, together with any and all intellectual property rights in any such Inventions, including Patents that claim or disclose any such Inventions (collectively, the \\\"Distributor Invention\\\"). Zogenix and Distributor shall each own an undivided right, title, and interest in and to any and all Inventions discovered, developed, identified, made, conceived or reduced to practice jointly by or on behalf of Zogenix under or in connection with this Agreement and by Distributor or its Affiliates or Sub-distributors or its other subcontractors in the Territory and under or in connection with this Agreement (\\\"Joint Invention\\\"). In the event that either Zogenix or Distributor intends to file a patent application containing a Joint Invention, such Party shall promptly notify the other Party of such intention and shall provide a draft of any such patent application to such other Party [***] before filing such patent application with any patent office and the Parties shall negotiate in good faith concerning the terms and conditions of a joint patent agreement. (ii) Disclosure, License. Distributor shall, and shall cause its Affiliates and Sub-distributors and other subcontractors to, promptly disclose any Distributor Inventions to Zogenix in writing promptly following its discovery, development, identification, making, conception or reduction to practice by the Distributor, its Affiliates, Sub-distributors or other subcontractors. Distributor hereby grants Zogenix an irrevocable, perpetual, world-wide, royalty-free, fully paid-up, non-exclusive license with the right to grant sublicenses under such Distributor Inventions and any patents or patent applications claiming or disclosing such Distributor Inventions. In the event that Distributor intends to file a patent application containing Distributor Inventions, Distributor shall promptly notify Zogenix of such intention and shall provide a draft of any such patent application to Zogenix at least [***] before filing such patent application with any patent office. Distributor shall have the sole right to file for patent protection for such Distributor Inventions only if Zogenix does not provide a written objection 33 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 within [***] of being provided with a draft of such patent application. (c) Personnel Obligations. Prior to receiving any Confidential Information or beginning work under this Agreement, Distributor shall ensure that each employee, agent or contractor of Distributor or its Affiliates or Sub-distributors shall be bound in writing by non-disclosure and Invention assignment obligations that are consistent with the obligations of the Parties in Article 8 and this Article 9, including obligations to: (a) promptly report any invention, discovery, process or other intellectual property right; (b) assign to Distributor or Zogenix all of his, her or its right, title and interest in and to any invention, discovery, process or other intellectual property right; (c) cooperate in the preparation, filing, prosecution, maintenance and enforcement of any patent and patent application; (d) perform all acts and sign, execute, acknowledge and deliver any and all documents required for effecting the obligations and purposes of this Agreement; and (e) abide by the obligations of confidentiality and non-use set forth in Article 8. It is understood and agreed that such non-disclosure and invention assignment agreements need not reference or be specific to this Agreement.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Zogenix Patent Prosecution and Maintenance\", \"level\": 2, \"text\": \"9.2 Zogenix Patent Prosecution and Maintenance. During the term of this Agreement, Zogenix shall use Commercially Reasonable Efforts to prepare, file, prosecute (including any reissues, re-examinations, post-grant proceedings, requests for patent term extensions, interferences, and defense of oppositions), at Zogenix's sole discretion and cost. If there is any material change in Zogenix Patents specified in Exhibit 1.74, Zogenix shall provide Distributor with updated information concerning the Zogenix Patent in a timely manner.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Infringement by Third Parties\", \"level\": 2, \"text\": \"9.3 Infringement by Third Parties. (a) Notice. In the event that either Zogenix or Distributor becomes aware of any infringement or threatened infringement by a Third Party in the Territory of any Zogenix Patents, it shall notify the other Party in writing to that effect. Any such notice shall include evidence to support an allegation of infringement or threatened infringement by such Third Party. (b) Control of Action. Each Party shall share with the other Party all information available to it regarding such alleged or threatened infringement by a Third Party. Zogenix shall have the sole right, but not the obligation, to bring and control any action or proceeding with respect to alleged or threatened infringement by a Third Party in the Territory of any Zogenix Patent at Zogenix's cost and expense. If Zogenix elects to commence a suit to enforce the applicable Zogenix Patent against such infringements, then Distributor shall have the right to join such enforcement action, if permitted by Applicable Law, upon notice to Zogenix and be represented by a counsel of its own choice at its own cost and expense. Zogenix shall keep Distributor reasonably informed of any such actions or proceedings and consider in good faith any comments or requests made by Distributor, and the Parties shall cooperate and consult with each other in strategizing regarding any such action or proceeding, provided that Zogenix shall control and have the right to make all final decisions (regardless of whether or not Distributor is a party to such action or proceeding) regarding all matters in the preparation and conduct of any such action or proceeding. Each Party shall cooperate fully with the other Party with respect to actions or proceedings under this Section 9.3, including being joined as a party 34 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 plaintiff in any such action or proceeding and providing access to relevant documents and other evidence and making its employees available at reasonable business hours, with the costs of such cooperation to be included as shared costs for actions or proceedings brought hereunder. (c) Recoveries. Any monetary recovery resulting from actions or proceedings under this Section 9.3 will be allocated as follows: each of Distributor and Zogenix first will be reimbursed, out of such recovery, for its reasonable and verifiable costs and expenses with respect to such action or proceeding (such reimbursement to be pro-rata based on the Parties' relative costs and expenses if the recovery is not sufficient to reimburse both Parties fully) with any remainder being (i) allocated [***] if[***] or (ii) allocated [***] if [***].\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third Party Intellectual Property Rights\", \"level\": 2, \"text\": \"9.4 Third Party Intellectual Property Rights. (a) If either Party becomes aware of a Patent in the Territory owned by a Third Party that it believes will, or may, be infringed by the manufacture, importation, Development or Commercialization of the Product in the Field in the Territory as contemplated by this Agreement, such Party shall notify the other Party of such Patent. The Parties then shall discuss the matter and seek in good faith to agree on whether the Parties should take a license under such Patent, and if so, on what terms; provided, that if the Parties are unable to agree after a reasonable period, [***], of good faith discussions, then Zogenix shall have the right to obtain such a license on such terms as it determines in its sole discretion and at its own cost and expense. Provided, however, in the event that Zogenix elects not to seek or fails to obtain a license under such Patent, Distributor shall have the right to obtain such a license with prior written notice to Zogenix. (b) Each Party shall promptly notify the other Party in writing of any allegation by a Third Party that the activity of either Party pursuant to this Agreement or the Supply Agreement infringes or may infringe the intellectual property rights of such Third Party. Zogenix shall have the sole right to control any defense of any such claim involving alleged infringement of Third Party rights, at Zogenix's sole cost and expense and by counsel of its own choice; provided however that Distributor may participate in the defense, at its own expense, to be represented in any such action by counsel of its own choice. In any event, Zogenix agrees to keep Distributor reasonably informed of all material developments in connection with any such action. Zogenix agrees not to settle such infringement or make any admissions or assert any position in such action in a manner that would materially adversely affect the rights or interest of Distributor, without the prior written consent of Distributor, which shall not be unreasonably withheld, delayed or conditioned. Neither Party shall enter into any settlement or compromise of any action under this Section 9.4 which would in any manner alter, diminish, or be in derogation of the other Party's rights under this Agreement without the prior written consent of such other Party, which shall not be unreasonably withheld, delayed or conditioned.\"}}, {\"id\": \"9.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Patent Term Restoration\", \"level\": 2, \"text\": \"9.5 Patent Term Restoration. At the request of Zogenix, the Parties shall cooperate with each other in obtaining patent term restoration, extensions and/or any other extensions of the Zogenix Patents as available under Applicable Laws, subject to Zogenix's rights under Section 9.2. Zogenix shall bear the cost for such patent term restoration and/or any other 35 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 extensions of the Zogenix Patent.\"}}, {\"id\": \"9.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Patent Marking\", \"level\": 2, \"text\": \"9.6 Patent Marking. Distributor shall, and shall require its Affiliates and Sub-distributors to, mark all Product sold in the Territory (in a reasonable manner consistent with industry custom and practice and Applicable Law) with appropriate patent numbers or indicia to the extent permitted by Applicable Laws, if such markings impact recoveries of damages or equitable remedies available with respect to infringements of patents.\"}}, {\"id\": \"9.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Zogenix Trademarks\", \"level\": 2, \"text\": \"9.7 Zogenix Trademarks. All packaging, promotional materials, package inserts, and labeling for the Product in the Field in the Territory shall bear, free of charge, one or more house Trademarks chosen and owned by Zogenix, including the Zogenix name and logo set forth in Exhibit 9.7 (each, a \\\"Zogenix Trademark\\\"). Zogenix or its Affiliates shall own all right, title, and interest in and to all Zogenix Trademarks, all corresponding trademark applications and registrations thereof, and all common law rights thereto. Zogenix shall, at Zogenix's sole expense, have sole control over the registration, prosecution, maintenance, enforcement and defense of the Zogenix Trademarks. All goodwill of the business associated with or symbolized by the Zogenix Trademarks shall inure to the benefit of Zogenix. Distributor acknowledges Zogenix's exclusive ownership of the Zogenix Trademarks and agrees not to take any action inconsistent with such ownership. Distributor shall provide Zogenix with samples of any advertising and promotional materials in original language that incorporate the Zogenix Trademarks prior to distributing such materials for use. Distributor shall comply with reasonable policies provided by Zogenix from time to time to maintain the goodwill and value of the Zogenix Trademarks. Distributor shall not, and shall cause its Affiliates not to, (i) use, seek to register, or otherwise claim rights in any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that materially dilutes, any of the Zogenix Trademarks, or (ii) knowingly do, cause to be done, or knowingly omit to do any act, the doing, causing or omitting of which endangers, undermines, impairs, destroys or similarly affects, in any material respect, the validity or strength of any of the Zogenix Trademarks (including any registration or pending registration application relating thereto) or the value of the goodwill pertaining to any of the Zogenix Trademarks.\"}}, {\"id\": \"9.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Trademarks\", \"level\": 2, \"text\": \"9.8 Product Trademarks. (a) Selection and Ownership of Product Trademarks. All packaging, promotional materials, package inserts, and labeling for the Product in the Field in the Territory shall bear one or more Trademarks that pertain specifically to the Product, including the Trademarks in existence as of the Effective Date as set forth in Exhibit 9.8 (each, a \\\"Product Trademark\\\"). If the Product Trademarks in existence as of the Effective Date are not eligible for trademark protection or for use in connection with the Product in the Field in the Territory or if the Parties agree that alternative or additional Trademarks may be beneficial, Distributor may investigate appropriate Trademarks for the Product in the Territory. If the Parties identify and agree on alternative or additional Trademarks for the Product in the Territory, Zogenix shall use Commercially Reasonable Efforts to register such Trademark(s) for the Product in the Field in the Territory. Zogenix or its Affiliates shall own all right, title, and interest in and to all Product 36 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Trademarks, all corresponding trademark applications and registrations thereof, and all common law rights thereto. All goodwill of the business associated with or symbolized by the Product Trademarks shall inure to the benefit of Zogenix. Distributor acknowledges Zogenix's exclusive ownership of the Product Trademarks and agrees not to take any action inconsistent with such ownership. (b) Maintenance and Prosecution of Product Trademarks. Zogenix shall, at Zogenix's sole expense, control the registration, prosecution and maintenance of the Product Trademarks in the Territory; provided, that Zogenix shall keep Distributor reasonably informed of Zogenix's actions with respect thereto and shall consider in good faith any reasonable comments made by Distributor with respect thereto. (c) Use of Product Trademarks. Distributor shall promote, market, sell, offer for sale, import, distribute and otherwise commercialize the Product in the Field in the Territory only under the Product Trademarks. Distributor shall provide Zogenix with samples of any advertising and promotional materials that incorporate the Product Trademarks prior to distributing such materials for use. Distributor shall comply with reasonable policies provided by Zogenix from time to time to maintain the goodwill and value of the Product Trademarks. Distributor shall not, and shall cause its Affiliates not to, (i) use, seek to register, or otherwise claim rights in the Territory in any Trademark that is confusingly similar to, misleading or deceptive with respect to, or that materially dilutes, any of the Product Trademarks, or (ii) knowingly do, cause to be done, or knowingly omit to do any act, the doing, causing or omitting of which endangers, undermines, impairs, destroys or similarly affects, in any material respect, the validity or strength of any of the Product Trademarks (including any registration or pending registration application relating thereto) or the value of the goodwill pertaining to any of the Product Trademarks. (d) Enforcement of Product Trademarks. Zogenix shall have the first right, but not the obligation, at Zogenix's expense, to enforce and defend the Product Trademarks in the Territory, including (i) defending against any alleged, threatened or actual claim by a Third Party that the use of the Product Trademarks in the Territory infringes, dilutes or misappropriates any Trademark of that Third Party or constitutes unfair trade practices, or any other claims that may be brought by a Third Party against a Party in connection with the use of or relating to Product Trademarks in the Territory with respect to the Product and (ii) taking such action as Zogenix deems necessary against a Third Party based on any alleged, threatened or actual infringement, dilution or misappropriation of, or unfair trade practices or any other like offense relating to, the Product Trademarks in the Territory by a Third Party. If Zogenix elects not to enforce or defend the Product Trademarks in any such instance, then Zogenix shall promptly so notify Distributor and Distributor shall have the right, but not the obligation, at its expense, to do so. Each Party shall provide to the other Party all reasonable assistance requested by such first Party in connection with any such action, claim or suit under this Section 9.8(d), including allowing such first Party access to such other Party's documents and to such other Party's personnel who may have possession of relevant information. 37 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 (e) Distributor's Housemarks. In addition to the Product Trademarks, Distributor shall have the right to brand the Product in the Territory with those trademarks of Distributor that are associated with Distributor's name or identity and are pre-approved in writing by Zogenix (\\\"Distributor Housemarks\\\"). Distributor shall own all rights in the Distributor Housemarks, and all goodwill in the Distributor Housemarks shall accrue to Distributor. Distributor and its Affiliates and Sub-distributor shall not use any trademarks, other than the Zogenix Trademarks, Product Trademarks and the approved Distributor Housemarks, in connection with the Commercialization of the Product in the Field in the Territory, without the prior written consent of Zogenix.\"}}, {\"id\": \"ARTICLE 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS, WARRANTIES AND COVENANTS; LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"ARTICLE 10. REPRESENTATIONS, WARRANTIES AND COVENANTS; LIMITATION OF LIABILITY\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Mutual Representations, Warranties and Covenants\", \"level\": 2, \"text\": \"10.1 Mutual Representations, Warranties and Covenants. Each Party hereby represents and warrants to the other Party, as of the Effective Date, as follows: (a) Duly Organized. Such Party is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, is qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the conduct of its business or the ownership of its properties requires such qualification and failure to have such would prevent such Party from performing its obligations under this Agreement. (b) Due Authorization; Binding Agreement. The execution, delivery and performance of this Agreement by such Party have been duly authorized by all necessary corporate action. This Agreement is a legal and valid obligation binding on such Party and enforceable in accordance with its terms and does not: (i) to such Party's knowledge and belief, violate any law, rule, regulation, order, writ, judgment, decree, determination or award of any court, governmental body or administrative or other agency having jurisdiction over such Party; nor (ii) conflict with, or constitute a default under, any agreement, instrument or understanding, oral or written, to which such Party is a party or by which it is bound. (c) Consents. Such Party has obtained, or is not required to obtain, the consent, approval, order or authorization of any Third Party, or has completed, or is not required to complete, any registration, qualification, designation, declaration or filing with any Regulatory Authority or governmental authority in connection with the execution and delivery of this Agreement and the performance by such Party of its obligations under this Agreement. (d) No Conflicting Grant of Rights. Such Party has the right to grant the rights contemplated under this Agreement and has not, and will not during the Term, grant any right to any Third Party that would conflict with the rights granted to the other Party hereunder. (e) Debarment. Such Party is not debarred or disqualified under the United 38 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 States Federal Food, Drug and Cosmetic Act or comparable Applicable Laws in the Territory and it does not, and will not during the Term, employ or use the services of any Person who is debarred or disqualified, in connection with activities relating to the Product. In the event that either Party becomes aware of the debarment or disqualification or threatened debarment or disqualification of any Person providing services to such Party, including the Party itself and its Affiliates or Sub-distributors, that directly or indirectly relate to activities under this Agreement, such Party shall immediately notify the other Party and shall cease employing, contracting with, or retaining any such person to perform any services under this Agreement. (f) Comply with Applicable Laws. In the performance of its obligations hereunder, such Party shall comply and shall cause its and its Affiliates' employees and contractors to comply with all Applicable Laws. (g) Anti-Corruption. Such Party shall not, directly or indirectly through Third Parties, pay, promise or offer to pay, or authorize the payment of, any money or give any promise or offer to give, or authorize the giving of anything of value to a Public Official or Entity or other Person for purpose of obtaining or retaining business for or with, or directing business to, any Person, including, without limitation, Zogenix or Distributor. Without any limitation to the foregoing, such Party has not and shall not directly or indirectly promise, offer or provide any corrupt payment, gratuity, emolument, bribe, kickback, illicit gift or hospitality or other illegal or unethical benefit to a Public Official or Entity or any other Person. (h) Accuracy of Materials. All due diligence materials that such Party has provided and will provide to the other Party were and will be to the knowledge of such Party accurate, truthful, and complete at the time such materials are provided to the other Party, and such Party has not and will not intentionally omit any material facts requested by the other Party. (i) Notification for Violation of Applicable Laws. Such Party shall immediately notify the other Party if it has any information or suspicion that there may be a violation of the FCPA or any other Applicable Law in connection with the performance of this Agreement or the sale of the Product in the Territory. (j) No Pubic Officials. No owner, shareholder (direct or beneficial), officer, director, employee, third-party representative, agent, or other individual with any direct or indirect beneficial interest in such Party or its Affiliates or, to its knowledge, in its Sub-distributors or other contractors, or any immediate family relation of any such Person (collectively, \\\"Interested Persons\\\"), is a Public Official or Entity. Such Party shall notify the other Party immediately if during the Term (i) any Interested Person becomes a Public Official or Entity or (ii) any Public Official or Entity acquires a legal or beneficial interest in it or its Affiliate or, to its knowledge, in its Sub-distributors or other subcontractors.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations, Warranties and Covenants of Distributor\", \"level\": 2, \"text\": \"10.2 Representations, Warranties and Covenants of Distributor. Distributor represents, warrants, and covenants to Zogenix that: (a) in the performance of its obligations hereunder, Distributor shall comply 39 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 and shall cause its and its Affiliates' and Sub-distributors' employees and contractors to comply with Applicable Law and Distributor's compliance policies, complete copies of which will be provided to Zogenix before the launch of the Product in the Territory; (b) during the Term, Distributor agrees that: (i) Zogenix will have the right, upon reasonable prior written notice and during Distributor's regular business hours, to audit Distributor's and its Affiliates' books and records by an independent certified public accounting firm of recognized international standing, and Distributor shall ensure that Zogenix has the right to audit its Sub-distributors' and subcontractors' books and records, to investigation potential violations of any of the representations, warranties or covenants in this Section 10.2, the FCPA or other Applicable Laws or Distributor's compliance policies. Such audit may be made no more than once each Fiscal Year (unless an audit reveals a violation under this Agreement, in which case an additional audit may be conducted within such Fiscal Year); (ii) Distributor will certify to Zogenix annually in writing or otherwise upon Zogenix's written request, under the form set forth in Exhibit 10.2(b) attached hereto, Distributor's compliance with the representations, warranties and covenants in this Section 10.2, the FCPA and other Applicable Laws and Distributor's compliance policies; (iii) Distributor will inform Zogenix promptly of any changes in its business that would change any of its representations, warranties or covenants in this Section 10.2; (iv) Zogenix shall have the right to suspend or terminate the supply of Product under the Supply Agreement and to terminate this Agreement if there is credible evidence that Distributor or its Affiliate or Sub-distributor may have violated any of the representations, warranties or covenants in this Section 10.2 the FCPA or other Applicable Laws or Distributor's compliance policies.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations and Warranties of Zogenix\", \"level\": 2, \"text\": \"10.3 Representations and Warranties of Zogenix. Zogenix represents, warrants and covenants to Distributor that: (a) Zogenix will inform Distributor promptly of any changes in its business that would change any of its representations, warranties or covenants in this Section 10.3; and (b) as of the Effective Date, Zogenix has not received written notice of any pending or threatened claims or actions alleging that the Development or Commercialization of the Product in the Field infringes or would infringe the Patents of any Third Party in the Territory.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimer\", \"level\": 2, \"text\": \"10.4 Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT AND THE SUPPLY AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR EXTENDS ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, AND 40 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 EACH PARTY EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, VALIDITY AND ENFORCEABILITY OF PATENTS, OR THE PROSPECTS OR LIKELIHOOD OF DEVELOPMENT OR COMMERCIAL SUCCESS OF THE PRODUCT.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation of Liability\", \"level\": 2, \"text\": \"10.5 Limitation of Liability. NEITHER PARTY SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH THIS AGREEMENT; provided however, that this Section 10.5 shall not be construed to limit (a) either Party's right to special, incidental or consequential damages for the other Party's breach of Article 8 or (b) either Party's indemnification rights or obligations under Article 11.\"}}, {\"id\": \"ARTICLE 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"ARTICLE 11. INDEMNIFICATION\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification of Zogenix\", \"level\": 2, \"text\": \"11.1 Indemnification of Zogenix. Distributor shall indemnify, defend and hold harmless Zogenix and its Affiliates and their respective directors, officers, employees and agents (the \\\"Zogenix Indemnitees\\\"), from and against any and all losses, liabilities, damages, penalties, fines, costs and expenses (including reasonable attorneys' fees and other expenses of litigation) (\\\"Losses\\\") incurred by any Zogenix Indemnitee resulting from any claims, actions, suits or proceedings brought by a Third Party (\\\"Third Party Claims\\\") to the extent arising from, or occurring as a result of: (a) the registration, use, handling, storage, import, offer for sale, sale or other disposition of the Product in the Territory by or on behalf of Distributor or its Affiliates; (b) the negligence or willful misconduct of any Distributor Indemnitees in connection with Distributor's performance of its obligations or exercise of its rights under this Agreement; or (c) any breach of any representations, warranties or covenants of Distributor in this Agreement, except to the extent such Third Party Claims fall within the scope of the indemnification obligations of Zogenix set forth in Section 11.2 or arise out of the breach by Zogenix of any of the terms of the Supply Agreement.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification of Distributor\", \"level\": 2, \"text\": \"11.2 Indemnification of Distributor. Zogenix shall indemnify, defend and hold harmless Distributor and its Affiliates and their respective directors, officers, employees and agents (the \\\"Distributor Indemnitees\\\"), from and against any and all Losses incurred by any Distributor Indemnitee resulting from any Third Party Claims to the extent arising from, or occurring as a result of: (a) the manufacture, use, handling, storage, import, offer for sale, sale or other disposition of the Product outside the Territory by or on behalf of Zogenix or its Affiliates; (b) the negligence or willful misconduct of any Zogenix Indemnitees in connection with Zogenix's performance of its obligations or exercise of its rights under this Agreement; or (c) any breach of any representations, warranties or covenants of Zogenix in this Agreement, except to the extent such Third Party Claims fall within the scope of the indemnification obligations of Distributor set forth in Section 11.1 or arise out of the breach by Distributor of any of the terms of the Supply Agreement. 41 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Procedure\", \"level\": 2, \"text\": \"11.3 Procedure. A Party that intends to claim indemnification under this Article 11 (the \\\"Indemnitee\\\") shall promptly notify the indemnifying Party (the \\\"Indemnitor\\\") in writing of any Third Party Claim, in respect of which the Indemnitee intends to claim such indemnification, and the Indemnitor shall have sole control of the defense and/or settlement thereof. The Indemnitee may participate at its expense in the Indemnitor's defense of and settlement negotiations for any Third Party Claim with counsel of the Indemnitee's own selection. The indemnity arrangement in this Article 11 shall not apply to amounts paid in settlement of any action with respect to a Third Party Claim, if such settlement is effected without the consent of the Indemnitor, which consent shall not be withheld or delayed unreasonably. The failure to deliver written notice to the Indemnitor within a reasonable time after the commencement of any action with respect to a Third Party Claim shall only relieve the Indemnitor of its indemnification obligations under this Article 11 if and to the extent the Indemnitor is actually prejudiced thereby. The Indemnitee shall cooperate fully with the Indemnitor and its legal representatives in the investigation of any action with respect to a Third Party Claim covered by this indemnification.\"}}, {\"id\": \"11.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 2, \"text\": \"11.4 Insurance. Each Party, at its own expense, shall maintain product liability and other appropriate insurance (or self- insure) in an amount consistent with industry standards during the Term. Each Party shall provide a certificate of insurance (or evidence of self-insurance) evidencing such coverage to the other Party upon written request.\"}}, {\"id\": \"ARTICLE 12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 12. TERM AND TERMINATION\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"12.1 Term. This Agreement shall commence on the Effective Date and shall remain in effect until September 1, 2045, unless earlier terminated by either Party pursuant to this Article 12 (the \\\"Term\\\").\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination\", \"level\": 2, \"text\": \"12.2 Termination. (a) Mutual Agreement. The Parties may terminate this Agreement by mutual written agreement. (b) Distributor Convenience. At any time following the expiration of the Distribution Term (as defined in Section 1.17), the Distributor may terminate this Agreement at will upon [***] prior written notice to Zogenix. (c) Zogenix Convenience. At any time following the expiration of the Distribution Term, Zogenix may terminate this Agreement at will upon [***] prior written notice to Distributor. (d) Material Breach. If either Party believes in good faith that the other is in material breach of its obligations hereunder, then the non-breaching Party may deliver written 42 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 notice of such breach to the other Party, and the allegedly breaching Party shall have [***] from receipt of such notice to dispute the validity of such breach. For all breaches of this Agreement, the allegedly breaching Party shall have [***] from the receipt of the initial notice to cure such breach. If the Party receiving notice of breach fails to cure the breach within such [***] period, then the non-breaching Party may terminate this Agreement in its entirety effective on written notice of termination to the other Party. Notwithstanding the foregoing, (a) if such material breach (other than a payment breach), by its nature, is curable, but is not reasonably curable within the [***] period, then such period shall be extended if the breaching Party provides a written plan for curing such breach to the non-breaching Party and uses Commercially Reasonable Efforts to cure such breach in accordance with such written plan; provided, that no such extension shall exceed [***] without the consent of the non-breaching Party. (e) Diligence. Zogenix shall have the right to terminate this Agreement pursuant to Section 5.1(d). (f) Bankruptcy. A Party shall have the right to terminate this Agreement upon written notice to the other Party upon the bankruptcy, dissolution or winding up of such other Party, or the making or seeking to make or arrange an assignment for the benefit of creditors of such other Party, or the initiation of proceedings in voluntary or involuntary bankruptcy, or the appointment of a receiver or trustee of such other Party's property, that is not discharged within [***]. (g) Commercial Viability. In the event that prior to launch of the Product in the Field in the Territory (i) either Party has a good faith concern that the launch of the Product in the Field in the Territory is not likely to be possible with Commercially Reasonable Efforts, based upon credible evidence, such as any decision by a Regulatory Authority to require significant additional information before granting or as a condition to granting Regulatory Approval, or (ii) Distributor has a good faith concern that the Commercialization of the Product in the Territory will not be commercially viable, such Party may raise such concern for discussion by the JSC. If, within the time periods set forth in Section 3.1(d) or such longer time period as the Parties may mutually agree upon in writing, neither the JSC nor the Executives agree whether to launch or commercialize Product in the Territory, then, notwithstanding anything to the contrary in Section 3.1(d) or Article 13, either Party shall have the right to terminate this Agreement upon at least [***] written notice to the other Party. (h) Third Party Patent. (i) Distributor shall have the right to terminate this Agreement upon written notice to Zogenix if (A) the Parties have discussed an issued Patent under Section 9.4(a), (B) either (1) both Zogenix and Distributor agree not to seek a license under such issued Patent or (2) the applicable Party as determined pursuant to Section 9.4(a) failed to obtain a license under such issued Patent, after good faith efforts to do so, within [***] after the Parties' agreement as to which Party would seek such license, and (C) Distributor reasonably and in good faith believes that the sale, offer for sale or import of the Product in the Territory in the Field infringes such issued Patent in the Territory, such that Distributor is not able to sell the Product in 43 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 the Territory in the Field without infringing such issued Patent. (ii) Zogenix shall have the right to terminate this Agreement upon written notice to Distributor if (A) the Parties have discussed an issued Patent under Section 9.4(a), (B) either (1) both Zogenix and Distributor agree not to seek a license under such issued Patent or (2) the applicable Party as determined pursuant to Section 9.4(a) failed to obtain a license under such issued Patent, after good faith efforts to do so, within [***] after the Parties' agreement as to which Party would seek such license, and (C) Zogenix reasonably and in good faith believes that the manufacture for and sale to Distributor of the Product infringes such issued Patent, such that Zogenix will not be able to conduct (or have conducted on its behalf) such manufacturing for and sale of the Product to Distributor without infringing (or its contract manufacturers infringing) such issued Patent. (i) Change of Control. This Agreement may be terminated by either Party upon [***] written notice to the other Party in the event that the other Party undergoes a Change of Control; provided, however, that such termination notice shall only be effective if delivered within [***] after the later of the occurrence of such Change of Control or the date the Party undergoing the Change of Control delivers written notice thereof to the other Party. (j) Other Zogenix Termination Rights. Zogenix shall have the right to terminate this Agreement immediately upon written notice to Distributor (i) if Distributor or any of its Affiliates or Sub-distributors, directly or indirectly through any Third Party, commences any interference or opposition proceeding with respect to, challenges the validity or enforceability of, or opposes any extension of or the grant of a supplementary protection certificate with respect to, any Zogenix Patent (or any related Patent owned or controlled by Zogenix outside the Territory); (ii) if Zogenix determines that Distributor or its Affiliates or Sub- distributors are, or have caused or shall cause any Zogenix Indemnitee to be, in violation of the FCPA or any other Applicable Laws; or (iii) if Zogenix decides to withdraw the Product from the market in the Territory or otherwise believes that the promotion of the Product in the Field in the Territory presents a substantial risk of harm or injury to consumers which risk is unacceptable according to established principles of medical ethics. (k) Termination of Supply Agreement. Following the execution of the Supply Agreement pursuant to Section 5.2, the Parties agree that this Agreement shall automatically terminate upon termination of the Supply Agreement for any reason. (l) Distributor Safety Concern. This Agreement may be terminated by Distributor upon written notice to Zogenix, in the event that Distributor has a reasonable belief after due inquiry that the promotion of the Product in the Field in the Territory presents a substantial risk of harm or injury to consumers which risk is unacceptable according to established principles of medical ethics. Prior to terminating this Agreement in accordance with this Section 12.2(l), Distributor shall present evidence supporting the basis for such termination to Zogenix and shall consider in good faith all comments provided by Zogenix prior to terminating this Agreement. 44 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Rights on Termination\", \"level\": 2, \"text\": \"12.3 Rights on Termination. The following will apply upon any termination of this Agreement: 45 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 agreement would include such other standard terms and conditions for license agreements of this type as are mutually agreed to by the Parties. (c) Commercialization Transition. Unless this Agreement is terminated by Zogenix under Sections 12.2(f), (g)(i), (h)(ii), (j)(ii), or (j)(iii), or by Distributor under Sections 12.2(d), (g), or (l), or terminated automatically under Section 12.2(k), Distributor shall continue, to the extent that Distributor continues to have Product inventory, to fulfill orders received from customers for Product in the Territory until up to [***] after the date on which Zogenix notifies Distributor in writing that Zogenix has secured an alternative distributor for the Product in the Territory, but in no event for more for than [***] after the effective date of termination. All Product sold by or on behalf of Distributor or its Affiliates or Sub-distributors after the effective date of termination will be included in calculations under Article 6. Notwithstanding the foregoing, Distributor shall cease such activities upon [***] written notice from Zogenix at any time after the effective date of termination requesting that such activities cease. Within [***] after receipt of such cessation request, Distributor shall provide Zogenix an estimate of the quantity and shelf life of all Product remaining in Distributor's or its Affiliates' or Sub-distributors' inventory, and Zogenix shall have the right to purchase any such quantities of Product from Distributor at a price mutually agreed by the Parties. (d) Assignment of Regulatory Filings and Regulatory Approvals. Unless this Agreement is terminated by Zogenix under Section 12.2(c), at Zogenix's option, which shall be exercised by written notice to Distributor, to the extent permitted under Applicable Laws, Distributor shall assign or cause to be assigned to Zogenix or its designee (or to the extent not so assignable, Distributor shall take all reasonable actions to make available to Zogenix or its designee the benefits of), at Zogenix's cost, all Regulatory Filings and Regulatory Approvals for the Product in the Field in the Territory. (e) Transition. Unless this Agreement is terminated by Zogenix under Section 12.2(c), Distributor shall use Commercially Reasonable Efforts to cooperate with Zogenix and/or its designee to effect a smooth and orderly transition in the registration and Commercialization of the Product in the Field in the Territory during the applicable notice period under Section 12.2 and following the effective date of termination. Without limiting the foregoing, Distributor shall use Commercially Reasonable Efforts to conduct, in an expeditious manner, any activities to be conducted under this Section 12.3. (f) Third Party Agreements. Unless this Agreement is terminated by Zogenix under Section 12.2(c), at the written request of Zogenix, Distributor shall assign to Zogenix any Product-specific Third Party agreements, to the furthest extent possible, provided that such assignment is permitted under the Product-specific agreement or is otherwise agreed by the applicable Third Party. In the event such assignment is not requested by Zogenix or is not permitted or agreed by such Third Party, then the rights of such Third Party with respect to the Product will terminate upon termination of Distributor's rights. Distributor shall ensure that each such Third Party (if its contract is not assigned to Zogenix pursuant to this Section 12.3) will transition any remaining Product back to Zogenix in the manner set forth in this Section 12.3 as 46 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 if such Third Party were named herein. Distributor shall include provisions requiring compliance with these provisions in all applicable agreements with Third Parties.\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exercise of Right to Terminate\", \"level\": 2, \"text\": \"12.4 Exercise of Right to Terminate. The use by either Party hereto of a termination right provided for under this Agreement shall not give rise, on its own, to the payment of damages or any other form of compensation or relief to the other Party with respect thereto.\"}}, {\"id\": \"12.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Damages; Relief\", \"level\": 2, \"text\": \"12.5 Damages; Relief. Subject to Section 12.4 above, termination of this Agreement shall not preclude either Party from claiming any other damages, compensation or relief that it may be entitled to upon such termination.\"}}, {\"id\": \"ARTICLE 13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPUTE RESOLUTION\", \"level\": 1, \"text\": \"ARTICLE 13. DISPUTE RESOLUTION\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Objective\", \"level\": 2, \"text\": \"13.1 Objective. The Parties recognize that disputes as to matters arising under or relating to this Agreement or either Party's rights or obligations hereunder may arise from time to time. It is the objective of the Parties to establish procedures to facilitate the resolution of such disputes in an expedient manner by mutual cooperation and without resort to litigation. To accomplish this objective, the Parties agree to follow the procedures set forth in this Article 13 to resolve any such dispute if and when it arises.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resolution by Executives\", \"level\": 2, \"text\": \"13.2 Resolution by Executives. Except as otherwise provided in Article 3, if an unresolved dispute as to matters arising under or relating to this Agreement or either Party's rights or obligations hereunder arises, either Party may refer such dispute to the Executives, who shall meet in person or by telephone within [***] after such referral to attempt in good faith to 47 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 resolve such dispute. If such matter cannot be resolved by discussion of such officers within such [***] (as may be extended by mutual written agreement), such dispute shall be resolved in accordance with Section 13.3. The Parties acknowledge that discussions between the Parties to resolve disputes are settlement discussions under applicable rules of evidence and without prejudice to either Party's legal position.\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Arbitration\", \"level\": 2, \"text\": \"13.3 Arbitration. (a) Any and all disputes that are not resolved pursuant to Section 13.2 shall be finally settled by binding arbitration administered under the Rules of Arbitration of the International Chamber of Commerce by three (3) arbitrators appointed in accordance with said Rules. The arbitration will be conducted in New York, New York. The language to be used in the arbitral proceedings will be English. Judgment on the award may be entered in any court having jurisdiction. (b) The award shall be rendered within [***] of the constitution of the arbitral tribunal, unless the arbitral tribunal determines that the interest of justice requires that such limit be extended. (c) The arbitrators shall award to the prevailing party, if any, as determined by the arbitrators, its reasonable attorneys' fees and costs. (d) The arbitration proceeding will be confidential and the arbitrators shall issue appropriate protective orders to safeguard each Party's Confidential Information. Except as required by Applicable Laws, no Party shall make (or instruct the arbitrators to make) any public announcement with respect to the proceedings or decision of the arbitrators without prior written consent of the other Party. The existence of any dispute submitted to arbitration, and the award, shall be kept in confidence by the Parties and the arbitrators, except as required in connection with the enforcement of such award or as otherwise required by Applicable Laws.\"}}, {\"id\": \"ARTICLE 14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"ARTICLE 14. GENERAL PROVISIONS\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"14.1 Governing Law. This Agreement and all questions regarding its existence, validity, interpretation, breach or performance and any dispute or claim arising out of or in connection with it (whether contractual or non-contractual in nature such as claims in tort, from breach of statute or regulation or otherwise) shall be governed by, and construed and enforced in accordance with, the laws of the State of New York, United States, without reference to its conflicts of law principles to the extent those principles would require applying another jurisdiction's laws. The United Nations Conventions on Contracts for the International Sale of Goods shall not be applicable to this Agreement or the Supply Agreement.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"14.2 Force Majeure. Neither Party shall be held liable to the other Party nor be 48 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 deemed to have defaulted under or breached this Agreement for failure or delay in performing any obligation under this Agreement (other than failure to make payment when due) when such failure or delay is caused by or results from causes beyond the reasonable control of the affected Party, including embargoes, war, acts of war (whether war be declared or not), insurrections, riots, fire, floods, or other acts of God, or acts, omissions or delays in acting by any governmental authority or the other Party. The affected Party shall notify the other Party of such force majeure circumstances as soon as reasonably practicable, and shall promptly undertake all reasonable efforts necessary to cure such force majeure circumstances. Such excuse from liability shall be effective only to the extent and duration of the event(s) causing the failure or delay in performance and provided that the Party has not caused such event(s) to occur.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"14.3 Assignment. Except as expressly provided in this Section 14.3, neither this Agreement nor any rights or obligations hereunder may be assigned or otherwise transferred by either Party without the prior written consent of the other Party, which consent shall not be unreasonably withheld; provided, however, that either Party may assign this Agreement and its rights and obligations hereunder without the other Party's consent: (a) in connection with the transfer or sale of all or substantially all of the business of the assigning Party to a Third Party, whether by merger, sale of stock, sale of assets or otherwise; provided that in the event of a transaction (whether this Agreement is actually assigned or is assumed by the acquiring party by operation of law (e.g., in the context of a reverse triangular merger)), unless otherwise agreed with the acquiring party in writing, intellectual property of the acquiring party shall not be included in the intellectual property to which the other Party has access under this Agreement; or (b) to an Affiliate, provided that the assigning Party shall remain liable and responsible to the non\u2011assigning Party hereto for the performance and observance of all such duties and obligations by such Affiliate. For the avoidance of doubt, in the event that either Party assigns this Agreement pursuant to this Section 14.3(a), the other Party shall have the right to terminate this Agreement pursuant to Section 12.2(i). This Agreement shall be binding upon successors and permitted assigns of the Parties. Any assignment not in accordance with this Section 14.3 will be null and void.\"}}, {\"id\": \"14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"14.4 Severability. If any one or more of the provisions contained in this Agreement is held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby, unless the absence of the invalidated provision(s) adversely affects the substantive rights of the Parties. The Parties shall in such an instance use their best efforts to replace the invalid, illegal or unenforceable provision(s) with valid, legal and enforceable provision(s) which, insofar as practical, implement the purposes of this Agreement.\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"14.5 Notices. All notices required or permitted hereunder shall be in writing and sufficient if delivered personally, sent by facsimile (and promptly confirmed by personal delivery, registered or certified mail or overnight courier), sent by internationally- recognized 49 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 overnight courier or sent by registered or certified mail, postage prepaid, return receipt requested, addressed as follows: If to Zogenix, addressed to: Zogenix, Inc. 5959 Horton Street, Suite 500 Emeryville, CA 94608, U.S.A Attention: Chief Executive Officer Facsimile Number: +1 (510) 550-8340 With a copy to (which shall not constitute notice): Latham & Watkins, LLP 12670 High Bluff Drive San Diego, CA 92130, U.S.A Attention: Cheston Larson, Esq. Facsimile Number: +1 (858) 523-5450 If to Distributor, addressed to: Nippon Shinyaku Co., Ltd. 14, Nishinosho-monguchi-cho Kisshoin, Minami-ku Kyoto 601-8550, JAPAN Attention: Alliance Department Facsimile Number: +81-75-321-9019 or to such other address as the Party to whom notice is to be given may have furnished to the other Party in writing in accordance herewith. Any such notice shall be deemed to have been given: (a) when delivered if personally delivered or sent by facsimile on a Business Day; and (b) on the second Business Day after dispatch if sent by internationally-recognized overnight courier.\"}}, {\"id\": \"14.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement; Amendments\", \"level\": 2, \"text\": \"14.6 Entire Agreement; Amendments. This Agreement and the Supply Agreement, together with the exhibits hereto and thereto, contain the entire understanding of the Parties with respect to the subject matter hereof and thereof and supersede and cancel all previous express or implied agreements and understandings, negotiations, writings and commitments, either oral or written, in respect to the subject matter hereof and thereof, including the Confidentiality Agreement. This Agreement may be amended, or any term hereof modified, only by a written instrument duly executed by authorized representatives of both Parties, but \\\"written instrument\\\" does not include the text of e-mails or similar electronic transmissions.\"}}, {\"id\": \"14.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Headings\", \"level\": 2, \"text\": \"14.7 Headings. The captions to the several Articles and Sections hereof are not a part of this Agreement, but are merely for convenience to assist in locating and reading the several 50 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Sections hereof.\"}}, {\"id\": \"14.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"14.8 Independent Contractors. It is expressly agreed that Zogenix and Distributor shall be independent contractors and that the relationship between the two Parties shall not constitute a partnership, joint venture or agency. Neither Zogenix nor Distributor shall have the authority to make any statements, representations or commitments of any kind or to take any action that shall be binding on the other Party, without the prior written consent of the other Party.\"}}, {\"id\": \"14.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Waiver\", \"level\": 2, \"text\": \"14.9 Waiver. The waiver by either Party hereto of any right hereunder, or the failure of the other Party to perform, or a breach by the other Party, shall not be deemed a waiver of any other right hereunder or of any other breach or failure by such other Party whether of a similar nature or otherwise.\"}}, {\"id\": \"14.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cumulative Remedies\", \"level\": 2, \"text\": \"14.10 Cumulative Remedies. No remedy referred to in this Agreement is intended to be exclusive, but each shall be cumulative and in addition to any other remedy referred to in this Agreement or otherwise available under law.\"}}, {\"id\": \"14.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Waiver of Rule of Construction\", \"level\": 2, \"text\": \"14.11 Waiver of Rule of Construction. Each Party has had the opportunity to consult with counsel in connection with the review, drafting and negotiation of this Agreement. Accordingly, the rule of construction that any ambiguity in this Agreement shall be construed against the drafting Party shall not apply.\"}}, {\"id\": \"14.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Interpretation\", \"level\": 2, \"text\": \"14.12 Interpretation. All references in this Agreement to an Article or Section shall refer to an Article or Section in or to this Agreement, unless otherwise stated. Any reference to any federal, national, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The word \\\"including\\\" and similar words means including without limitation. The words \\\"herein,\\\" \\\"hereof\\\" and \\\"hereunder\\\" and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision. All references to days, months, quarters or years are references to calendar days, calendar months, calendar quarters, or calendar years, unless stated otherwise. References to the singular include the plural.\"}}, {\"id\": \"14.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Third Party Beneficiaries\", \"level\": 2, \"text\": \"14.13 No Third Party Beneficiaries. This Agreement is neither expressly nor impliedly made for the benefit of any Party other than Zogenix and Distributor, except as otherwise provided in this Agreement with respect to Zogenix Indemnitees under Section 11.1 and Distributor Indemnitees under Section 11.2. This Agreement may be terminated, varied or amended in accordance with its terms or with the agreement of Distributor and Zogenix without the consent of the Zogenix Indemnitees or Distributor Indemnitees.\"}}, {\"id\": \"14.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"English Language\", \"level\": 2, \"text\": \"14.14 English Language. This Agreement is in the English language, and the English language shall control its interpretation. In addition, unless otherwise explicitly stipulated in this Agreement, all notices required or permitted to be given under this Agreement, and all written, electronic, oral or other communications between the Parties regarding this Agreement, shall be in the English language. 51 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"14.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 2, \"text\": \"14.15 Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed to be an original as against any party whose signature appears thereon, all of which together shall constitute but one and the same instrument.\"}}, {\"id\": \"14.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Further Actions\", \"level\": 2, \"text\": \"14.16 Further Actions. Each Party will execute, acknowledge and deliver such further instruments, and to do all such other ministerial, administrative or similar acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement. [Signature Page Follows] 52 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 IN WITNESS WHEREOF, the Parties have executed this Distributorship Agreement as of the Effective Date. ZOGENIX, INC. NIPPON SHINYAKU COMPANY, LTD. By: /s/ Stephen J. Farr By: /s/Shigenobu Maekawa Name: Stephen J. Farr Name: Shigenobu Maekawa Title: President and Chief Executive Officer Title: President 53 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 1.70 UNLABELED DRUG PRODUCT [***] [***] [***] [***] [***] [***] [***] US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 1.74 ZOGENIX ZX008 PATENTS AS OF THE EFFECTIVE DATE Patents claiming ZX008 or its use in Japan Docket No Appln. No Filing Date Publn. No Patent No Issue Date [***] ZGNX-135JP [***] [***] [***] [***] 11/30/18 ZGNX-135JP DIV [***] [***] [***] ZGNX-143JP [***] [***] [***] US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 2.3 MATERIAL TERMS OF SUPPLY AGREEMENT The Supply Agreement will include the following terms and conditions: Appointment as Exclusive Supplier. During the Term, Zogenix shall retain and have the sole and exclusive right to supply or have supplied all of Distributors' and its Affiliates' and Sub-distributors' requirements of the Product for sale in the Field in the Territory. Third Party Manufacturer Agreements. The terms of the Supply Agreement shall (a) establish the procedures, terms and conditions for manufacture, quality control, forecasting, ordering, delivery price, payment and appropriate other activities relating to the supply of the Product in the Territory so as to reasonably enable Zogenix to meet its obligations under its agreements with Third Party manufacturers and (b) provide Distributor no remedies for Zogenix's failure to supply the Product in accordance with the Supply Agreement that are in addition to those set forth herein or that are available to Zogenix in its existing agreements with Third Party manufacturers, and (c) set forth such terms and conditions so that the Supply Agreement is otherwise consistent in all material respects with such agreements with Third Party manufacturers. Forecasts and Orders. [***] prior to the anticipated First Commercial Sale, Distributor shall provide Zogenix with a good faith, [***] rolling forecast of its anticipated requirements of the Product, the first [***] of which shall be on a monthly basis and the last [***] of which shall be on a quarterly basis. The first [***] of such forecast shall be binding. Distributor shall submit binding purchase orders consistent with the binding portion of its forecasts. Each purchase order shall have a requested delivery date that is at least [***] after the date of the purchase order. The terms of the Supply Agreement shall also provide for the order and delivery of launch stock for the Product prior to Regulatory Approval to ensure timely launch of the product following Regulatory Approval. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Purchase orders shall be placed in full batch increments as defined in the Supply Agreement. Delivery. All Products shall be shipped Ex Works manufacturing site (Incoterms 2010) to the destination requested by Distributor. Distributor shall be responsible for labeling and packaging Product. Safety Stock. Distributor shall use Commercially Reasonable Efforts to build promptly following Regulatory Approval and thereafter to maintain an inventory of Product (itself and/or with wholesalers) which is not less than the equivalent of the immediate next [***] of anticipated demand for the Product in the Territory. Change Controls. The Parties shall include in the Supply Agreement a reasonable change control procedure to deal with any reasonable changes to the Product specifications and other changes required by Applicable Laws. All Third Party costs incurred by either Party for any such changes in accordance with the agreed-upon change control procedure shall be paid by Distributor if requested by Distributor or if such changes are required by Applicable Laws in the Territory. Second Source. Based on Distributor's forecasts, including its [***] forecasts, the Parties will discuss and determine whether Zogenix will obtain additional capacity to support Distributor's requirements for the Product in the Territory. Any decisions to build or engage additional manufacturing capacity for the Territory will be at Zogenix's sole discretion, and in no event will Zogenix be obligated to supply Product in excess of Distributor's binding forecasts. Product Quality/Complaints. The Supply Agreement will define procedures for resolution of any disputes regarding Product quality and for notification of each Party in the event of a Product complaint or Product recall. The Supply Agreement will contain mutually acceptable provisions regarding release testing of the Product and, if applicable, the transfer of information necessary for Distributor to perform required quality testing, as applicable. Regulatory Audits. Not more than once per Fiscal Year or as otherwise agreed by the Parties, and subject to the terms of the applicable agreement between Zogenix and its Third Party manufacturers, Zogenix shall, at Distributor's request, conduct GMP audits of the Third Party manufacturers and, if applicable, exercise such other audit rights that Zogenix may have under such agreements, and shall disclose to Distributor the results of such audits. Zogenix will use commercially reasonable efforts to cause such Third Party manufacturers to promptly correct any deficiencies or other adverse findings. Representations and Warranties. Zogenix shall provide standard warranties applicable in the pharmaceutical industry, including warranties that all Product manufactured for Distributor: US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 shall be manufactured and tested in accordance with all Applicable Laws, including GMP applicable to the manufacturing, storage, and shipment of the Product, shall not be adulterated or misbranded within the meaning of the United States Food, Drug and Cosmetic Act, 21 U.S.C. Section 301c et. seq., or other Applicable Laws, and the time of delivery to Distributor will meet the Product specifications. Quality Agreement. The Parties shall work together in good faith to enter into a mutually acceptable quality agreement with respect to the manufacture of the Product prior to shipment of any Product to Distributor. US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 4.2(a) THE INITIAL VERSION OF THE REGULATORY PLAN US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 8.5(a) PRESS RELEASE US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 9.7 ZOGENIX TRADEMARKS Trademark Country Status Registration number Next renewal date Application number Application date Registration date Class (Zogenix Logo) Japan Pending N/A N/A 2019031449 2/28/2019 N/A 5, 42 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 9.8 PRODUCT TRADEMARKS Trademark Country Status Registration number Next renewal date Application number Application date Registration date Class FINTEPLA Japan Registered 6105099 12/7/2028 2018028557 3/9/2018 12/7/2018 5 (Fintepla Logo) Japan Registered 6093116 10/26/2028 2018028558 3/9/2018 10/26/2018 5 US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019 Exhibit 10.2(b) FORM OF COMPLIANCE CERTIFICATION Date: __________ To: Zogenix, Inc. and its Affiliates (\\\"Zogenix\\\") Re: Distributorship Agreement dated [ ] (\\\"the Agreement\\\") For and on behalf of [__________________] and our Affiliates (as defined in the Agreement) and employees, we confirm that in respect of our distribution of Zogenix Product within the Territory during the period [insert date] to [insert date]:- there was no offer, or promise to make, authorize or provide (directly or indirectly) a gift, payment or anything of value to a government official, political parties or candidates or private sector employee, in order to influence or reward any action or decision by such person in his or her official or professional capacity, for the purpose of corruptly obtaining or retaining business or securing any improper advantage; all payments, expenses or credits properly paid to or incurred on behalf of Zogenix, were accurately and appropriately recorded and described in accordance with acceptable accounting and recordkeeping procedures, and substantiated by supporting documents and evidence; there were no unauthorized and/or excessive payments of any kind to health care institutions, hospitals, hospital services or departments; and has performed the necessary due diligence to ensure compliance with Applicable Laws (including anti-bribery laws and the U.S. FCPA) and the terms of the Agreement. Please be advised accordingly. Yours faithfully, [____________________] Authorized Representative Name: Title: Signature: Date: US-DOCS\\\\105216871.19 Source: ZOGENIX, INC., 10-Q, 5/9/2019\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of DIVERSINETCORP_03_01_2012-EX-4-RESELLER AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of DIVERSINETCORP_03_01_2012-EX-4-RESELLER AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"RESELLER AGREEMENT This agreement (\\\"Agreement\\\")\", \"level\": 1, \"text\": \"RESELLER AGREEMENT This agreement (\\\"Agreement\\\") dated as of January 11, 2011 (\\\"Effective Date\\\") is between Diversinet Corp. (\\\"Diversinet\\\"), an Ontario corporation with its principal place of business located at 2235 Sheppard Avenue East, Suite 1700, Toronto, Ontario, Canada M2J 5B5, and 2205925 Ontario Limited, with its principal place of business located at 111 Main Street West, Suite 304, North Bay, Ontario P1B 2T6 (the \\\"Reseller\\\"). Diversinet and the Reseller are hereinafter referred to individually as a \\\"Party\\\" and, collectively, as the \\\"Parties\\\". The Schedules attached hereto shall form an integral part of this Agreement, and all references to this Agreement shall be deemed to include the Schedules. WHEREAS Diversinet is a provider of mobile device security and authentication solutions for the mobile data ecosystem, and is the owner of certain software products, user documentation and services and the related trade-marks; AND WHEREAS Reseller has represented that it is qualified and desires to act as a reseller of certain of Diversinet's products within a certain defined territory, and agrees to use its best efforts to market and sell such products in such territory; NOW THEREFORE, for and in consideration of the mutual promises and commitments contained hereafter and other considerations, the receipt and sufficiency of which is hereby acknowledged, the Parties have entered into this Agreement for the purpose of permitting Reseller to market and sell certain of Diversinet's products pursuant to the terms and conditions set out as follows. 1. Appointment Subject to payment of the Annual Minimum Commitment (\\\"AMC\\\" - defined herein), Diversinet hereby grants to Reseller an exclusive, non- transferable and non-assignable right to market, sell, and sub-license those Diversinet products listed in Schedule 2 (the \\\"Products\\\") within the territory listed in Schedule 3 (the \\\"Territory\\\") to Canadian headquartered companies, and governmental and broader public sector entities located in Canada. Reseller's customers (the \\\"Customers\\\") are defined as those organizations/enterprises that will market and manage the end-users of the Products (the \\\"End-Users\\\"). Reseller acknowledges and agrees that it does not have the right to assign sub-resellers under this Agreement outside of the Territory, except with the prior written consent of Diversinet. Furthermore, if Reseller terminates the AMC in the manner contemplated in Schedule 3, the exclusive license above shall revert to being a non- exclusive license. In either case, Reseller will have the non-exclusive right to contract in the rest of the world, excluding the United States. If Reseller identifies End- Users in the United States, with the prior written consent of Diversinet, Reseller may sell the Products to the End-Users. United Stated revenues will not be counted against the AMC however Reseller will be entitled to the discount rates as indicated in Schedule 3.. In addition, Diversinet hereby grants to Reseller the right to use those Diversinet trademarks and copyrighted materials with respect to the Products solely for the purpose of marketing and distribution of the Products as authorized hereunder. Reseller acknowledges that the use of such trademarks and copyrighted materials does not create in its favour any right, whether of ownership or otherwise, to such trade-marks and copyrighted materials, and that all rights arising from the use thereof by Reseller shall inure to the benefit of Diversinet. Reseller agrees that the rights granted to Reseller in this Section 1 are solely for the purpose of supplying the Products to Reseller, its Customers and End-Users located in the Territory. Any use outside of the rights granted herein shall require an additional license from Diversinet. 2. Ownership and Representations (a) Except as expressly granted herein, Diversinet does not grant any further rights, license or immunity to Reseller, and hereby retains and does not waive any rights it may have with respect to patents, trade-marks, copyrights, moral rights or other intellectual property or proprietary rights enforceable under the laws of any country. Reseller shall not authorize anyone to reverse engineer, decompile, alter, transfer, modify or create a derivative work from any of the Products, nor may Reseller itself engage in so doing. (b) Reseller shall not make any representations or warranties regarding the use or operation of the Products other than those included in any promotional materials provided by Diversinet and any Product documentation provided by Diversinet. 3. Term and Renewal The term of this Agreement shall begin on the Effective Date and continue in effect for a period of five (5) years (the \\\"Initial Term\\\"), unless sooner terminated in accordance with the provisions set out herein. Upon expiration of the Initial Term, this Agreement shall automatically renew for consecutive one (1) year periods, unless terminated by Reseller within sixty (60) days prior to the expiration of the Initial Term or any renewal term, as the case may be (the Initial Term and each renewal term, collectively, the \\\"Term\\\"). Any annual renewal would be subject to the payment, if applicable, of the AMC as agreed to by the parties, however such AMC will not be less than the previous year AMC times 115%, payable in applicable quarterly instalments. 4. Termination (a) Either Party may terminate this Agreement: (i) Upon thirty (30) days' written notice to Reseller if Reseller fails to make any AMC payment when due under this Agreement, or when an audit, as set out in Section 13, by Diversinet reveals any under-payment for any payment due, and it is not paid within the thirty (30) day written notice period; (ii) providing thirty (60) days' written notice to the other Party if the other Party breaches any material term or condition of this Agreement, and fails to cure such breach within the 60 day period; (iii) upon providing thirty (30) days' written notice to Reseller if Reseller terminates the provisions of the Annual Minimum Commitment and fails to meet the sales targets as set out in Schedule 3. (b) This Agreement shall terminate automatically without notice and without further action by Diversinet in the event that: (i) Reseller ceases carrying on its business, or if a petition shall be filed, an order shall be made or an effective resolution is passed for the winding-up, dissolution or liquidation of Reseller. (c) Termination under Subsection 4(a) shall trigger a phase-out period during which Reseller may continue to provide products and services to Customers. Such phase-out period shall be the longer of (i) the remaining term of the agreement between the Reseller and its Customers, and (ii) 18 months. (d) Upon the termination of this Agreement for any reason: (1) all rights granted to Reseller hereunder shall automatically come to an end and revert to Diversinet, including without limitation any right to use, operate and provide customer service or support for the Products; (2) Reseller shall immediately pay to Diversinet all amounts due and outstanding hereunder as of the date of such termination or expiration; and (3) within five (5) days of termination of this Agreement, for whatever reason, Reseller, must: (a) destroy all copies of the Products and any associated Products documentation in its possession or under its direct control; and (b) deliver to Diversinet a written certificate warranting that it has complied with the foregoing obligations. 1. Customer Orders (a) Customer Agreements. The Parties acknowledge and agree that Reseller's Customers will acquire the Products and related services under contract with Reseller, that Diversinet shall not have any contractual interest in Reseller's Customer relationships. Prior to Reseller committing to provide any Products to a Customer, Reseller shall cause Customer to enter into purchase agreement(s) with Reseller with respect to each of the Products purchased by Customer (each, a \\\"Customer Agreement\\\"). Reseller agrees that it shall include terms and conditions in its Customer Agreements that are sufficient to protect Diversinet's interests as reflected in this Agreement, including, but not limited to, those terms set out in Schedule 4 hereto. Such Customer Agreements shall be subject to Diversinet's approval, which approval shall not be unreasonably withheld. Reseller shall use commercially reasonable efforts to ensure that all Customers abide by the terms of the applicable Customer Agreement(s). Furthermore, Reseller shall enforce its Customer Agreements against Customer when requested to do so by Diversinet. For greater clarity, Diversinet expects that the Reseller will include all of the points covered in Section 4 in its end user agreement. When the Reseller receives a customer order they will fax both the end user agreement and the details of the order to Diversinet and if the end user agreement contains all of the points outlined in Section 4 then Diversinet will approve the order and ship the required products to the Reseller. (b) Ordering Process. Reseller shall submit all orders to Diversinet for the applicable Products. Reseller's submission of orders to Diversinet shall comply at all times with Diversinet's reasonable procedures and requirements and are subject to acceptance by Diversinet acting reasonably. Reseller shall be solely responsible for all sales activity culminating in and including the procurement of fully-executed Customer Agreements and purchase orders specifying the Products and Services ordered and the specific number of tokens. 1. Delivery (a) Subject to Reseller's compliance with the terms and procedures set forth in this Agreement, Diversinet shall provide to Reseller or to Customers the Products properly ordered by Reseller and accepted by Diversinet in material compliance with the applicable terms hereof, notwithstanding any inconsistent or additional terms which Reseller includes in any Customer agreement. (b) Unless otherwise agreed to by the Parties, delivery of the Products shall take place via electronic transmission or by courier, and will take place within two (2) Business Days of a written request or purchase order for software and within five (5) Business Days for a standard appliance. Custom built appliances or software are subject to evaluation and delivery date will be communicated after assessment. \\\"Business Day\\\" shall mean 9:00 a.m. to 5:00 p.m. (Eastern Standard Time), Monday through Friday, excluding all statutory holidays observed in the Province of Ontario in Canada. Delivery will be F.O.B. Diversinet's facility. Reseller shall have fifteen (15) calendar days after the later of (i) the delivery of any of the Products by Diversinet; or (ii) any applicable evaluation period; to inspect the Products and ensure their substantial compliance with the corresponding documentation. Unless Reseller notifies Diversinet within such fifteen (15) day period that any of the Products fail to substantially comply with the relevant documentation, such Products shall be deemed accepted. In the event Reseller rejects any of the Products, Reseller shall give Diversinet written notice of rejection, specifying in reasonable detail the basis for such rejection. Diversinet will use commercially reasonable efforts to correct any nonconformance and re-deliver such Products to Reseller. 1. Reseller Covenants (a) Manner of Performance. Reseller shall: (i) use commercially reasonable efforts to market and sell the Products and Services to Customers; (ii) conduct business in a competent and professional manner that reflects favorably at all times on the Products and the goodwill and reputation of Diversinet; (iii) avoid deceptive, misleading, or unethical practices that are or might be detrimental to Diversinet or the Products, or to the public in general; (iv) not make any false or misleading representations with regard to Diversinet or to the Products; (v) not publish or employ, or cooperate in the publication or employment of, any misleading or deceptive advertising material with regard to Diversinet or the Products or related services; (vi) not make any representation, warranties or guarantees to potential Customers or to the trade with respect to the specifications, features or capabilities of the Products that are inconsistent with published statements made by Diversinet; and (vii) comply with all applicable federal, state, region, and local laws and regulations related to the performance of its duties hereunder. (b) Reporting Requirements. Reseller shall, on a monthly basis, communicate to Diversinet information about Customers as reasonably requested by Diversinet including, but not limited to, Customer business, marketing, sales and technical information, installation, service delivery and on-going maintenance information. (c) Technical Expertise. Reseller and its staff shall be conversant with the technical language conventional to the Products and similar technologies in general, and will develop sufficient knowledge of the industry, of the Products and of products competitive with the Products (including specifications, features and benefits) in order to explain in detail to potential Customers and End Users the differences between the Products and competitive products and services. (d) Branding. Reseller may provide its own branding for the Products; however Reseller will include a \\\"powered by Diversinet\\\" tag or such similar identifiers as mutually agreed to by the Parties. Should Reseller require Diversinet to brand the Product, then such work will be done under a separate statement of work to be agreed upon in writing by the Parties. 1. Fees and Billing (a) Rates. For the Diversinet Products sold or distributed by Reseller, Reseller shall pay Diversinet the applicable list price, in U.S. dollars, for such Product, less the applicable discount for each Product, all as set out in Schedule 3. Any reference to any amounts or currency in this Agreement means United States dollars or U.S. dollars. (b) Billing. Diversinet will invoice Reseller for applicable one time Token Fees and the upfront annual Validation and Support Fee upon setting up a master account for each Customer and pre-loading it with MobiSecure tokens. Other fees and charges payable under this Agreement will be invoiced to Reseller according to terms set out in this Agreement or any applicable schedules or attachments hereto. Reseller shall be responsible for payment to Diversinet of all invoiced amounts for Products and services provided by Diversinet at Reseller's request to Reseller, its Customers and/or End-Users. (c) Payment Terms. Invoices are due and payable within 30 calendar days from the invoice date or from when the amount is due, whichever is later. (d) Late Charges and Taxes. All overdue amounts shall bear interest at the rate of 1% per month (12% per annum, simple interest), or the highest rate allowed by applicable law, whichever is less, until paid in full. Interest shall accrue on a daily basis. Fees do not include any sales, transfer, use, property, value added and other taxes, or any customs duties, tariffs or other governmental charges, all of which (if any are due and have been incurred within the Territory) are assumed and payable by Reseller (except for taxes imposed on Diversinet's net income). Providing proof of an exemption from any such duty, tax or charge is the responsibility of Reseller. Diversinet acknowledges and agrees that Reseller shall withhold any applicable non-resident withholding taxes from any amount owing hereunder and remit such taxes to the applicable federal taxing authority without provision for gross-up, if Diversinet becomes a non-resident of Canada or assigns the Agreement to a non-resident of Canada and if Diversinet does not provide Reseller with an appropriate exemption thereto. (e) Network Charges. The Customer or End User shall at all times be responsible for all mobile network data, roaming or airtime charges, SMS related charges, application certification charges or marketing costs and any other fees or levies related to the cellular or wireless network over which the Products are offered and/or provisioned, as well as Customer's own Internet access fees (collectively, the \\\"Network Charges\\\"). None of the fees chargeable hereunder include any Network Charges and Reseller shall ensure that Customer shall indemnify and hold harmless Diversinet and Reseller against any such Network Charges that may be levied against them for the operation of the Products. 1. Training and Consulting (a) Diversinet will arrange for the initial personal technical and sales instruction of up to three (3) Reseller personnel for up to five (5) days in learning the functions, installation, integration, operation and maintenance of the Products. Such instruction shall take place in Diversinet's corporate headquarters and expenses of the Reseller personnel incurred for attending such initial instruction shall be paid by Reseller. There will be no charge for this initial training. Thereafter, Diversinet will make available to Reseller standard Product training courses generally offered by Diversinet at the list price. (a) Upon Reseller's request, Diversinet will provide Reseller with pre-sales consulting and post-sales consulting at the Diversinet's standard rates. Post-sales consulting will be provided under a separate services agreement to be entered into by the Parties, which shall include specific statement(s) of work. (b) Statements of Work (\\\"SOW\\\"). Fees for any future development services shall be as agreed to by the Parties in an SOW. Reimbursable expenses agreed to by Reseller shall be paid by Reseller within thirty (30) days of Diversinet's documented invoice. Diversinet shall offer to perform such work at Diversinet's then standard daily rate (currently at $1,500 per day). Reseller hereby agrees and acknowledges that Diversinet shall own all code, documentation and modifications to the code or documentation, and all copyrights, trade secrets and other intellectual property rights with respect to any such code or documentation. Diversinet hereby agrees and acknowledges that Reseller owns any and all intellectual property rights with respect to any Reseller-specific private label associated with the software. 1. Support (a) Services. Diversinet may provide, upon written agreement between the parties, the server hardware, physical environment, including physical security, HVAC and power for the server hardware, all as required to provide the Products as described in Schedule 2. Diversinet may also provide internet connectivity, by being responsible for network operation and availability from the public Internet up to the termination cables at the network interface card on the server hardware. Diversinet shall use commercially reasonable efforts to maintain connectivity, through the public Internet, between the server hardware and the wireless network operators or other network on which an End User's device operates. Diversinet specifically excludes any responsibility for any connectivity between a network operator and a wireless device, including any SMS, SMTP, or other connectivity. The products, their related service objectives and each Party's related responsibilities in respect thereto are to be more fully described in a separate agreement. (b) Service Term. During the Term, and subject to Reseller's payment of the annual Support Fees, Diversinet will provide support for the Products in accordance with the terms set out in Schedule 5. Furthermore, Diversinet will support the existing Reseller trial including Apple App Store submission until December 31, 2010. Diversinet will support the Reseller certification with Canada Health Infoway, at no additional cost, until December 31, 2010. (c) Standard Support. Reseller's Customers will be responsible for first level support to End-Users. Reseller will be responsible for second level support to its Customer. Diversinet will provide third level support to Reseller. Diversinet will accept electronic mail messages via the Internet using SMTP compliant software (\\\"E Mail\\\") addressed to: support@diversinet.com, from Reseller with questions regarding the functions of the Products, as well as questions about how to make full use of the software (\\\"Support Questions\\\"). If second level support is not being provided by the Reseller, Diversinet may, at its sole discretion, provide additional support to Reseller. In these cases, Diversinet may charge the Reseller for support services or reduce the product price discount provided to Reseller. Reseller's Support Questions must be referred to Diversinet by a single person, designated initially as Primary Technical Support Contact (\\\"Primary Contact\\\") set out in Schedule 1, unless Diversinet is notified in writing of an alternate technical support contact (\\\"Alternate Contact\\\"). The names and e-mail addresses of up to four (4) Alternate Contacts (along with the name of the particular project or department) shall be designated in a list provided by the Primary Contact via E Mail at support@diversinet.com. All Primary Contacts and Alternate Contacts (collectively, \\\"Contacts\\\") must be members of the designated project or department. It is Reseller's responsibility to provide Diversinet with an initial list of Contacts and to keep that list current in order to receive timely service. (d) Updates. During the Term, Diversinet will provide updated versions of the Products (\\\"Updates\\\"). Updates shall be designated by a version number with a higher number to the right of the decimal point (e.g., version 1.4 is an Update to version 1.2), but do not include New Releases or Custom Releases (which are designated with a higher number to the left of the decimal point, or at the end with a letter, respectively). Prior to delivering any Updates, Diversinet may require Reseller to sign a revised schedule if any additional grants or licenses are required for an Update. (e) Internet Access. Diversinet may provide, at no additional cost, access to Diversinet's Internet-based Frequently Asked Questions (FAQ's) archives, a defect 'fix' list, or a private discussion forum available to all Products support customers, which will be moderated by Diversinet's engineers when available. (f) Beta Versions. Diversinet may provide Reseller with access to Beta Test versions of Updates to Products as described in paragraph (d) above. (g) Update Input. Diversinet will give special consideration to Reseller's feature requests for future versions of the Products. 1. ASP Sales The Reseller may sell the Products as an Application Service Provider (\\\"ASP\\\") sales model. Under an ASP model, the Reseller shall provide the Products through computer-based services to End Users over a network. The Reseller shall be responsible for providing, at the Reseller's sole cost and expense, the infrastructure, network, hosting environment, support and/or website. Reseller warrants and guarantees that Diversinet shall have no obligations, representations or guarantees to the End User for sales made by the Reseller under an ASP sale. 2. Confidential Information (a) Reseller agrees that all software, documentation and materials provided with the Products and all information contained therein is owned by Diversinet. The Parties agree that any other information of a confidential or proprietary nature provided by one Party to the other from time to time, whether marked as \\\"Proprietary\\\", \\\"Confidential\\\", \\\"Secret\\\" or any other designation implying confidentiality, is owned by the disclosing Party (all such information hereafter, collectively \\\"Trade Secrets\\\"). Both Parties shall treat the other Party's Trade Secrets with the same care as they treat their own confidential information of a like nature, but in no case shall the receiving Party use less care in handling the Trade Secrets than would be reasonable under the circumstances. The Parties agree not to make the other Party's Trade Secrets available in any form to any third party, or use the other Party's Trade Secrets for any purpose other than as set forth in this Agreement or as authorized by the other Party in writing. The Parties' obligations under this subsection shall survive the termination or expiration of this Agreement. (b) General Exclusions: The Parties' obligations set out in this section shall not apply to any information which is: (i) rightfully in a Party's possession before receipt from the other Party; (ii) independently developed by a Party without reference to the other Party's Trade Secrets; (iii) approved for release by written agreement with the other Party; (iv) rightfully in the public domain; (v) disclosed by requirement of a governmental agency or third party as expressly required by operation of law, regulation or court order. The disclosing Party shall promptly notify the other Party of the pending disclosure to allow the other Party to seek a protective order; or (vi) lawfully disclosed to a Party by a third party without an obligation of confidentiality to the Party. (c) It is expressly agreed that a violation of this section will cause irreparable harm to the owning Party and that a remedy at law would be inadequate. Therefore, in addition to any and all other remedies available at law, the owning Party shall be entitled to seek (without posting of a bond) preliminary, injunctive, emergency or equitable relief in the event of any actual or threatened violation of any or all of the provisions hereof. 3. Audit During the Term and for seven (7) years after the expiration or termination of this Agreement, or such longer period as required by applicable law, Reseller agrees to maintain complete books, records and accounts relevant to the computation of and accounting for the amounts payable under this Agreement. Reseller agrees to allow Diversinet or its agents and representatives the right to examine and audit such books, records and accounts during Reseller's normal business hours for no more than once per calendar quarter upon reasonable notice. If such examination reveals a deficiency in any amounts paid, Reseller agrees to pay any such deficiency forthwith upon demand, plus interest calculated in accordance with Section (Late Charges and Taxes) above and, if in excess of 5%, the cost of the audit incurred by Diversinet. 4. Limited Warranty EACH PARTY DOES NOT WARRANT TO THE OTHER THAT THE MATERIALS IT PROVIDES IN CONNECTION WITH THIS AGREEMENT WILL MEET THE REQUIREMENTS OF THE OTHER PARTY OR ITS CUSTOMERS, OR THAT THEIR OPERATION WILL BE UNINTERRUPTED OR ERROR FREE. Diversinet warrants as follows: (a) Each of the Products operates in substantial accordance with its documentation (\\\"Operation Warranty\\\"). With respect to the Operation Warranty, Reseller's sole remedy, and Diversinet's sole obligation, shall be to cause the Product to operate substantially in accordance with its documentation in a timely manner. All Products shall be virus-checked prior to delivery to Reseller. (b) The services provided under this Agreement shall be performed in a timely and professional manner by personnel (\\\"Personnel\\\") and in all material respects in accordance with the requirements set forth here in Schedule 5 (Service Level Agreement). Personnel shall be appropriately trained in the performance of such services under this Agreement and shall meet those standards generally observed by reputable and competent members of the same industry providing similar services. c) Diversinet shall ensure that there collectively is a sufficient number of employees and personnel assigned and available during the term to provide the services in accordance with the service levels and the standards and other terms and conditions of this Agreement. (d) Diversinet shall exercise professional and good judgement in carrying out and performing its obligations under this Agreement. (e) The Products do not contain any virus, Trojan horse, worm, trapdoor, backdoor, malicious code or other code or device designed to interfere with proper use of the Software or cause harm or injury. (h) As of the Effective Date, to the best of its knowledge, none of the Products infringes upon any third party's patent rights (\\\"Limited Patent Warranty\\\"). EXCEPT AS EXPRESSLY SET FORTH ABOVE, DIVERSINET PROVIDES THE PRODUCTS, DOCUMENTATION AND OTHER RELATED SERVICES (COLLECTIVELY, THE \\\"BUNDLED PRODUCT\\\") TO RESELLER \\\"AS IS\\\" WITHOUT WARRANTY, MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY OTHER WARRANTIES OF PERFORMANCE, AND IMPLIED WARRANTIES OF NON INFRINGEMENT, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, REGARDING THE BUNDLED PRODUCTS, EITHER AS A UNIT, OR AS INDIVIDUAL PARTS. EXCEPT AS ABOVE SET FORTH, DIVERSINET SHALL BEAR NO RISK AS TO THE PERFORMANCE OF THE BUNDLED PRODUCT, AND ALL RISK IS TO BE ALLOCATED BETWEEN RESELLER AND IT CUSTOMERS AND END-USERS, OR ANY OTHERS WHO USE THE BUNDLED PRODUCT (\\\"USERS\\\"). EXCEPT AS ABOVE SET FORTH, SHOULD THE BUNDLED PRODUCT PROVE DEFECTIVE, DIVERSINET SHALL NOT BEAR ANY COST WHATSOEVER FOR ANY SERVICE, REPAIR OR CORRECTION TO ANY PARTY. USERS SHALL BE SOLELY RESPONSIBLE FOR ADEQUATELY PROTECTING DATA USED IN CONNECTION WITH THE BUNDLED PRODUCT. EXCEPT AS ABOVE SET FORTH, DIVERSINET SHALL NOT BE RESPONSIBLE FOR LOST DATA, RERUN TIME, INACCURATE INPUT, WORK DELAYS OR LOST PROFITS, LOSS OF SECURITY FOR PROPRIETARY DATA OR ANY OTHER INJURIES OR DAMAGES RESULTING FROM USE OF THE BUNDLED PRODUCT. Neither Diversinet, nor its subsidiaries, nor their respective directors, officers, employees, agents, assignees, co-developers, servants and contractors, nor the Reseller has any right to make any other representation, warranty or promise of any kind with respect to any of the Products. This Agreement does not, in itself, grant any patent license or patent right of any manner or kind. Reseller will be solely responsible for determining which patent rights it may need to use the Products and for obtaining such licenses, where applicable. So long as the terms of this agreement are respected, Diversinet agrees that it will not bring any suit, claim or demand against Reseller, its Customers or End-Users for breach of Diversinet's patent rights in the Products, if any. 5. Limitation of Liability and Damages (a) EXCEPT TO THE EXTENT DIRECT FORESEEABLE DAMAGES, IN NO EVENT SHALL DIVERSINET BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING WITHOUT LIMITATION ANY COMMERCIAL DAMAGES OR LOSSES) AS A RESULT OF THE USE, SALE OR DISTRIBUTION OF THE BUNDLED PRODUCT, WHETHER BY WAY OF A LEGAL THEORY OF CONTRACT, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY, STRICT LIABILITY, OR ANY OTHER THEORY, EVEN IF DIVERSINET HAS BEEN INFORMED OF THE POSSIBILITY OF SUCH DAMAGES. (b) RESELLER WAIVES ANY RIGHT IT MAY HAVE TO RECEIVE ANY COMPENSATION OR REPARATIONS ON TERMINATION OR EXPIRATION OF THIS AGREEMENT UNDER THE LAW OF THE TERRITORY OR OTHERWISE, OTHER THAN AS EXPRESSLY PROVIDED IN THIS AGREEMENT. THE PARTIES ACKNOWLEDGE THAT THIS SECTION HAS BEEN INCLUDED AS A MATERIAL INDUCEMENT FOR DIVERSINET TO ENTER INTO THIS AGREEMENT AND THAT DIVERSINET WOULD NOT HAVE ENTERED INTO THIS AGREEMENT BUT FOR THE LIMITATIONS OF LIABILITY AS SET FORTH HEREIN. (c) The availability of the MobiSecure\u2122 Strong Authentication service depends on many factors, including Customer's connection to the Internet, End Users' connection to the Internet, the availability of the Internet and the Internet backbone and equipment that, by its nature, is not fault tolerant. Diversinet does not and cannot control the flow of data to or from Diversinet's network and other portions of the Internet. Such flow depends in large part on the performance of Internet services provided or controlled by third parties. At times, actions or inaction of such third parties can impair or disrupt Customers' connections to the Internet (or portions thereof). Although Diversinet will use commercially reasonable efforts to take all actions it deems appropriate to remedy and avoid such events, Diversinet cannot guarantee that such events will not occur. Accordingly, Diversinet shall have no responsibility for any failure to meet the requirements hereunder, with respect to performance issues, including without limitation: (i) caused by factors outside of Diversinet's reasonable control; (ii) that result from any actions or omissions of Customers, End Users or any third parties; (iii) that result from Customers' equipment and/or third party equipment (not within the sole control of Diversinet); (iv) caused by any act or failure to act by Customer or as a result of any Third Party Software. (d) NOTWITHSTANDING THE ABOVE, IN NO EVENT SHALL DIVERSINET'S LIABILITY RELATING TO THIS AGREEMENT (OR THE BUNDLED PRODUCT) EXCEED ONE HUNDRED PERCENT (100%) OF THE AGGREGATE AMOUNT OF THE LICENSE FEES, ROYALTIES AND SUPPORT FEES PAID BY RESELLER IN THE TWELVE (12) MONTH PERIOD PRECEDING THE EVENT OR CIRCUMSTANCE GIVING RISE TO THE ALLEGED LIABILITY ON THE PART OF DIVERSINET. (e) The limitations set forth in Section 15(a), (b), (c), (d) and (e) shall not apply in respect of (i) breach of confidentiality obligations; (ii) breach of privacy provisions as detailed in Schedule 6; (iii) the intellectual property indemnity; (iv) any Abandonment committed by Diversinet; or (v) any willful gross misconduct (including fraud). \\\"Abandonment\\\" means Diversinet's cessation or suspension of, or refusal to perform, its obligations under this Agreement, and such cessation, suspension or refusal (i) was knowingly intended by Diversinet to cause harm to Reseller, and (ii) was not the result of a termination of this Agreement by Diversinet in accordance with Section 4 (Termination). 1. Indemnification (a) Reseller Indemnity. Reseller shall indemnify and hold harmless Diversinet and/or any of its directors, officers, agents, employees, contractors, parent companies, affiliates, and/or subsidiaries (collectively, the \\\"Diversinet Parties\\\") from and against any claim, suit or proceeding by a third party based on or arising out of (i) the acts or omissions of Reseller in connection with its performance or failure to perform any other obligations in this Agreement or any agreement with a Customer, and (ii) any unauthorized representation or any misrepresentation of fact to any third party with respect to one or more of the Diversinet Parties or Products made by Reseller or any director, officer, agent, or employee of Reseller, provided that: (i) Diversinet promptly notifies Reseller in writing of any such claim and Reseller has sole control of any related investigation, defense and settlement negotiations; and (ii) Diversinet fully cooperates with Reseller, at Reseller's expense, in defending or settling such claim. (b) Infringement Indemnity. Diversinet shall diligently defend, indemnify and hold Reseller harmless, at its own expense, any action, loss, cost or expense brought against Reseller to the extent that it is based upon a claim that Reseller's use of the unmodified Products as permitted herein infringes upon a third party's intellectual property rights, and will pay the resulting costs, damages and legal fees finally awarded against Reseller through settlement, judgment, arbitration, mediation or otherwise in such action that are attributable to such claim, provided that: (i) Reseller promptly notifies Diversinet in writing of any such claim under patent law and Diversinet has sole control of any related investigation, defense and settlement negotiations; and (ii) Reseller fully cooperates with Diversinet, at Diversinet's expense, in defending or settling such claim. (c) Should any of the Products become, or in Diversinet's sole opinion is likely to become, the subject of any third party intellectual property infringement claim, Reseller shall permit Diversinet, at Diversinet's sole option and expense, to: (i) procure for Reseller the right to continue to use such Product; or (ii) modify such Product so that it becomes non-infringing; (d) Diversinet shall have no liability for any claim based upon: (i) use of other than a current or the last prior release to the current unaltered version of the Products; or (ii) use, operation or combination of the Products with non-Diversinet programs, data, equipment or documentation in a manner not reasonably contemplated by this Agreement, if such infringement would have been avoided but for such uses, operation, or combination; or (iii) Reseller's or its agent's activities after Diversinet has notified Reseller that such use may result in infringement provided that the Reseller has been provided with access to an updated version that would not be infringing. (e) THE FOREGOING STATES OUT THE ENTIRE LIABILITY OF DIVERSINET, AND THE SOLE AND EXCLUSIVE REMEDY OF RESELLER AND END-USER, WITH RESPECT TO THE INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS BY THE PRODUCTS. 2. Escrow Agreement The Parties agree to execute an escrow agreement, within 90 days of the Effective Date, with a nationally recognized escrow agent with respect to the source code for the Products and name Reseller as a beneficiary. Diversinet will then immediately send a copy of the escrow agreement to Reseller for its counter-signature. Diversinet shall, at least annually, deposit the source code in the escrow account. Costs associated with the escrow agreement shall be borne by Reseller. Reseller will be provided with a copy of any deposit correspondence and escrow agent's acceptance thereof. The escrow agreement shall provide, among other terms, that the source code shall be released to Reseller if any of the following events (collectively the \\\"Release Conditions\\\") occurs: (i) Diversinet ceases to support services at levels as stated in Schedule 5 under this Agreement that is not remedied within sixty (60) days after receipt of written notice of such failure; (ii) Diversinet makes an assignment for the benefit of creditors, or becomes subject to direct control of a trustee, receiver or similar authority, or Diversinet becomes subject to any bankruptcy or insolvency proceeding under federal or state statutes; or (iii) Diversinet suspends or ceases to carry on its business and a receiver, trustee or assignee does not carry on the business. 3. Non-Solicitation During the Term, the Reseller agrees that it shall not induce any person employed by Diversinet to leave Diversinet's employ to become an employee of Reseller or its agents or contractors. 4. Relationship Nothing in this Agreement shall be construed so as to create a joint venture, partnership, employer/employee, franchisor/franchisee or principal/agent relationship between the Parties. Reseller and Diversinet are independent contracting parties. Neither Reseller nor its employees, consultants, contractors or agents have any authority to bind Diversinet by contract or otherwise to any obligation. 5. Choice of Forum This Agreement shall be governed by the laws of the province of Ontario, Canada, without regard to its conflict of laws principles. Any litigation or other dispute resolution between the Parties relating to this Agreement or its construction shall take place in the courts of Toronto, Ontario, Canada. The Parties consent to the personal jurisdiction of, and venue in, the provincial and federal courts therein. The Parties agree that the United Nations Convention on Contracts for the International Sale of Goods shall not apply to this Agreement. No action against Diversinet regardless of form, including negligence, arising out of any claimed breach of this Agreement or transactions under this Agreement may be brought by Reseller more than two years after the cause of action has accrued. 6. Assignment Without the express prior written consent of Diversinet (not to be unreasonably refused), Reseller may not assign this Agreement or its interest herein in whole or in part but Reseller shall continue to be responsible should the assignee fail to perform. Diversinet may assign this Agreement at any time and in such event, this Agreement shall continue in full force and effect as if the assignee were named as the licensor in the first instance but Diversinet shall continue to be responsible should the assignee fail to perform. This Agreement shall be binding upon and inure to the benefit of the successors and permitted assigns of the Parties. 7. Interpretation This Agreement, including all Schedules, attachments and addenda, is the entire agreement constituting the complete and exclusive statement of the terms and conditions between the Parties with respect to the subject matter hereof, and cancels and supersedes all previous negotiations, commitments, writings and agreements that the Parties may have entered into. The Parties acknowledge that they have read this Agreement, understand it and agree to be bound by its terms and conditions. Except for Diversinet's unilateral right to update certain Schedules as specifically set out in such Schedules, any subsequent waiver or modification of this Agreement or any part hereof shall only be effective if in writing and signed by both Parties. No delay or failure to enforce any right under this Agreement shall be considered a waiver of that Party's rights to thereafter enforce each and every right and provision of this Agreement. In addition, headings set out in this Agreement are an organizational aid, not a substantive part of this Agreement, and are not intended to limit or expand the language of each section. Any person signing this Agreement (or any later modifications or addenda) on behalf of Reseller warrants that he or she has the authority to bind Reseller. Time shall be of the essence of this Agreement. 8. Attorney Fees The prevailing Party (as determined by the finder of fact) in any law suit or other dispute resolution to enforce or interpret any part of this Agreement shall be entitled to recover, as a costs of suit, reasonable attorney's fees as determined by the finder of fact (including, but not limited to, costs, expenses and fees on appeal). 9. Severability If any part of this Agreement shall be found invalid or unenforceable by a court of competent jurisdiction, said portion shall be severed from the Agreement, and the remainder shall be interpreted so as to reasonably effect the intention of the Parties. Any limitation of liability, disclaimer of warranties and exclusion of damages set out in this Agreement are expressly intended to exist independently from, and to be severable from, this Agreement. 10. Force Majeure Neither Party shall in any circumstances be liable to the other for any loss of any kind whatsoever including, but not limited to, any damages or abatement of charges whether directly or indirectly caused to or incurred by the other Party by reason of any failure or delay in the performance of its obligations hereunder which is due to circumstances beyond the reasonable control of the affected Party, including, without limitation, acts of God, acts of terrorism, fire, flood, strike, labour disputes, civil, commercial sabotage, statute order or any regulation of any government public or local authority. 11. Compliance with Laws The Products include software (\\\"Software\\\") that is commercial computer software developed at private expense, and in all respects is proprietary data belonging solely to Diversinet or its suppliers. Reseller shall comply with all applicable export and import control and other relevant laws of any applicable jurisdiction. Determination of the applicable law is Reseller's responsibility. Reseller understands that the Products utilize cryptographic products that are highly regulated. 12. Publicity The Parties shall use commercially reasonable efforts to issue a joint press release concerning this Agreement after the execution hereof. Any further use of the other Party's name or logo in any publicity materials is prohibited without such other Party's prior written consent, which consent shall not be unreasonably withheld. 13. Notices Any notice, demand, or communication between the Parties shall be deemed given and received: (i) when personally delivered; (ii) when transmitted by facsimile with proof of transmittal; or (iii) five (5) days after deposit (properly addressed with postage prepaid) with the postal service for registered/certified mail. The addresses and contact information may be changed at any time by giving written notice as allowed under this section. Reseller's address and contact information are as set out in Schedule 1. Address and contact information for Diversinet are as follows: Diversinet Corp. Attention: Chief Financial Officer 2235 Sheppard Avenue East, Suite 1700 Toronto, Ontario, Canada M2J 5B5 Phone: 416-756-2324 Fax: 416-756-7346 14. Survival Any terms or conditions of this Agreement by which obligations of either Party are expressed to be applicable or which extend or may extend beyond termination of this Agreement shall survive the expiration or termination hereof. 15. Language This Agreement shall be interpreted consistent with its English linguistic construction, and all communications between the Parties shall be deemed to be conducted in the English language. Reseller will be responsible, at its own cost and expense, for any language and documentation localization for the Territory. 16. Counterparts This Agreement may be executed in two or more counterparts, by original or facsimile transmission, each of which so executed shall be deemed to be an original and such counterparts together shall constitute one and the same document. IN WITNESS WHEREOF the Parties have signed this Agreement, as of the date first written above, by their duly authorized representatives. 2205925 Ontario Limited DIVERSINET CORP. Signature:__________________________________ Signature:__________________________ Print Name: Dr. Wendy Graham Print Name: Albert Wahbe Title: President Title: CEO\"}, {\"id\": \"Schedule 1\", \"title\": \"Reseller Information\", \"level\": 1, \"text\": \"Schedule 1 Reseller Information # Date Signed_________________________________ Date Signed________________________ Name 2205925 Ontario Limited Street Address 111 Main Street West, Suite 304 City North Bay, ON Country Canada Zip/Postal Code P1B 2T6 Billing Address (if different from above) Shipping Address (if different from above) Telephone Facsimile Person Signing Contract Dr. Wendy Graham E-mail Address drgraham@vianet.ca Primary Technical Support Contact Address and Contact Information for Notice section in the Agreement\"}, {\"id\": \"Schedule 2\", \"title\": \"Products Unless otherwise agreed to by the Parties, the Products shall mean the following: 1. MobiSecure\u00ae Wallet and Vault MobiSecure\u00ae Vault server allows subscribers to securely store and manage their personal data and other information, select the information to be downloaded to their mobile devices and share it with others via email, fax or SMS messaging. The MobiSecure\u00ae Vault server is designed to host and manage a variety of different types of personal information e.g. financial, health, identities and passwords. It provides a framework for administrators to define and customize the information to be hosted and managed and supports a plug-in architecture and web service interfaces to allow for rapid integration with external information, payment and messaging systems. MobiSecure\u00ae Wallet application works in conjunction with the MobiSecure\u00ae vault server. It is designed to run on desktop computers and mobile platforms including Java based phones, RIM Blackberries\u00ae, Microsoft Windows Mobile\u00ae, iPhone, Android and BREW devices. The Wallet application provides offline and online access to personal information. Information is stored in the device for instant and offline access securely using a patented technique. The information is synchronized automatically or upon user's request with the vault server using a secure data synchronization protocol. Users may use the wallet application to access their information instantly when they are traveling, retrieve additional information from the vault server or send their information to others via email, SMS or fax. The wallet application includes an embedded software One-Time-Password (OTP) token to allow for secure and easy access to the vault server using dynamic password based authentication. The MobiSecure\u00ae Wallet SDK and MobiSecure\u00ae Vault API allows customers and third party developers to build secure mobile applications by leveraging Diversinet's Wallet secure container services. Applications features and benefits (utilizing Wallet and Vault) include: Patient Portal The Patient Portal is a set of web pages designed to permit patients to display, add, delete and update information pertaining to their demographics, attending physicians, chronic conditions, allergies, immunizations and messages received from registered doctors and clinical staff. The Physician's Tool This is a windows based application which permits doctors and authorized 'circle of care' workers to access patient records stored in the information repository. These users may add, delete or update the patient records and may also 'Validate' existing records. Validation consists of marking the records as 'Validated' and making them read only from that point to maintain record values that the physician has agreed to by validating the record. The Physician's Tool also can create and display secured messages to the patient which will be protected by the Diversinet MobiSecure\u00ae Health platform. The tool can also display a complete record of messages sent to the patient with associated time and date of acknowledgment from the patient. The administrator users of the tool can also add and delete doctors and other circle of care worker accounts in order to administer the operation of the clinical side of the Diversinet Platform. Message Manager The Message Manager is a tool used to collect and display incoming patient messages to the clinic and answer's to previously sent questions from the clinic. The Message Manager permits the user to prepare reply messages as well as automatically preparing an audit trail of all display and reply activities. Message Generator The Message Generator is an extension of the messaging tool in the Physician's Tool above, used to create user reminder messages based upon reminder criteria and the user records in the repository for recurring action requirements. Examples include recurring tests (i.e. PAP, colonoscopy, recurring blood work supporting medications), reminders about health and lifestyle choices, medication reminders.) 2. MobiSecure\u00ae Strong Authentication MobiSecure\u00ae Strong Authentication is a fully automated, OATH-standards based strong authentication server product. It is available as a fully configured appliance or a packaged software product and is designed to be easy to deploy and easy to use for high-volume Internet or wireless- based strong authentication. Its supported clients operate on mobile phones, personal computers, USB stick and can also be embedded into microchip or smart card technologies. The system supports Over-the-Air and Over-the-Web MobiSecure SoftToken delivery. The same system also supports the MobiSecure Validation Server for ongoing one-time password (OTP) validation for user authentication. MobiSecure Strong Authentication components are: The MobiSecure\u00ae Strong Authentication Platform contains the following components: 1. MobiSecure Provisioning Server 2. MobiSecure Validation Server 3. MobiSecure SMS Server 4. MobiSecure Registration/Administration Server 5. MobiSecure SoftToken Client MobiSecure\u00ae SoftToken: MobiSecure SoftToken is a client-side software token that is available as a Mobile SoftToken or as PCToken. It can be easily delivered, downloaded and embedded into a user's personal computer, PDA or mobile phone. It performs basic functions for managing and generating one-time password values. The client-side software token is easily delivered, downloaded and installed into a user's device. MobiSecure\u00ae SoftToken supports both time based and event based one-time passwords. Event based one-time passwords expire once they are used and are no longer valid. Time based one-time passwords expire once they are used or the valid time period elapses, whichever comes first. MobiSecure\u00ae SoftToken can be embedded into customer client applications using SDK's for mobile platforms and Windows PC. Key features of\", \"level\": 1, \"text\": \"Schedule 2 Products Unless otherwise agreed to by the Parties, the Products shall mean the following: 1. MobiSecure\u00ae Wallet and Vault MobiSecure\u00ae Vault server allows subscribers to securely store and manage their personal data and other information, select the information to be downloaded to their mobile devices and share it with others via email, fax or SMS messaging. The MobiSecure\u00ae Vault server is designed to host and manage a variety of different types of personal information e.g. financial, health, identities and passwords. It provides a framework for administrators to define and customize the information to be hosted and managed and supports a plug-in architecture and web service interfaces to allow for rapid integration with external information, payment and messaging systems. MobiSecure\u00ae Wallet application works in conjunction with the MobiSecure\u00ae vault server. It is designed to run on desktop computers and mobile platforms including Java based phones, RIM Blackberries\u00ae, Microsoft Windows Mobile\u00ae, iPhone, Android and BREW devices. The Wallet application provides offline and online access to personal information. Information is stored in the device for instant and offline access securely using a patented technique. The information is synchronized automatically or upon user's request with the vault server using a secure data synchronization protocol. Users may use the wallet application to access their information instantly when they are traveling, retrieve additional information from the vault server or send their information to others via email, SMS or fax. The wallet application includes an embedded software One-Time-Password (OTP) token to allow for secure and easy access to the vault server using dynamic password based authentication. The MobiSecure\u00ae Wallet SDK and MobiSecure\u00ae Vault API allows customers and third party developers to build secure mobile applications by leveraging Diversinet's Wallet secure container services. Applications features and benefits (utilizing Wallet and Vault) include: Patient Portal The Patient Portal is a set of web pages designed to permit patients to display, add, delete and update information pertaining to their demographics, attending physicians, chronic conditions, allergies, immunizations and messages received from registered doctors and clinical staff. The Physician's Tool This is a windows based application which permits doctors and authorized 'circle of care' workers to access patient records stored in the information repository. These users may add, delete or update the patient records and may also 'Validate' existing records. Validation consists of marking the records as 'Validated' and making them read only from that point to maintain record values that the physician has agreed to by validating the record. The Physician's Tool also can create and display secured messages to the patient which will be protected by the Diversinet MobiSecure\u00ae Health platform. The tool can also display a complete record of messages sent to the patient with associated time and date of acknowledgment from the patient. The administrator users of the tool can also add and delete doctors and other circle of care worker accounts in order to administer the operation of the clinical side of the Diversinet Platform. Message Manager The Message Manager is a tool used to collect and display incoming patient messages to the clinic and answer's to previously sent questions from the clinic. The Message Manager permits the user to prepare reply messages as well as automatically preparing an audit trail of all display and reply activities. Message Generator The Message Generator is an extension of the messaging tool in the Physician's Tool above, used to create user reminder messages based upon reminder criteria and the user records in the repository for recurring action requirements. Examples include recurring tests (i.e. PAP, colonoscopy, recurring blood work supporting medications), reminders about health and lifestyle choices, medication reminders.) 2. MobiSecure\u00ae Strong Authentication MobiSecure\u00ae Strong Authentication is a fully automated, OATH-standards based strong authentication server product. It is available as a fully configured appliance or a packaged software product and is designed to be easy to deploy and easy to use for high-volume Internet or wireless- based strong authentication. Its supported clients operate on mobile phones, personal computers, USB stick and can also be embedded into microchip or smart card technologies. The system supports Over-the-Air and Over-the-Web MobiSecure SoftToken delivery. The same system also supports the MobiSecure Validation Server for ongoing one-time password (OTP) validation for user authentication. MobiSecure Strong Authentication components are: The MobiSecure\u00ae Strong Authentication Platform contains the following components: 1. MobiSecure Provisioning Server 2. MobiSecure Validation Server 3. MobiSecure SMS Server 4. MobiSecure Registration/Administration Server 5. MobiSecure SoftToken Client MobiSecure\u00ae SoftToken: MobiSecure SoftToken is a client-side software token that is available as a Mobile SoftToken or as PCToken. It can be easily delivered, downloaded and embedded into a user's personal computer, PDA or mobile phone. It performs basic functions for managing and generating one-time password values. The client-side software token is easily delivered, downloaded and installed into a user's device. MobiSecure\u00ae SoftToken supports both time based and event based one-time passwords. Event based one-time passwords expire once they are used and are no longer valid. Time based one-time passwords expire once they are used or the valid time period elapses, whichever comes first. MobiSecure\u00ae SoftToken can be embedded into customer client applications using SDK's for mobile platforms and Windows PC. Key features of the MobiSecure\u00ae Strong Authentication Toolkit are listed below: 1. Lightweight library allows for a modular implementation- use only the components you need 2. Client API available in C and Java programming languages for software clients a. Allows organizations to develop their own clients or integrate with existing applications b. DLL provided for rapid development on Microsoft Windows platform 3. Server API a. SPML interface for integrating enterprise applications b. SPML Java client libraries for rapid integration c. Free Radius interface to OTP Validation Server 3. MobiSecure\u00ae SMS Messaging MobiSecure\u00ae SMS Messaging leverages the familiarity and popularity of SMS messaging to create a secure messaging solution that utilizes state of the art AES encryption technology to securely transmit and receive SMS messages. Messages can be both 1-Way (Push) based and 2-Way (Pull or Push-Pull) based between mobile users and backend server applications. Unlike traditional SMS service, MobiSecure\u00ae SMS Messaging subscribers will automatically receive message delivery and read confirmations on their mobile device. The MobiSecure\u00ae SMS Messaging solution offers a fully integrated secure gateway environment. This simplifies and eliminates extensive integration efforts with multiple gateways globally. High-level APIs, allow for the submission of text messages from a third party application or directly from the handset itself.\"}, {\"id\": \"Schedule 3\", \"title\": \"Territory, Sales Targets, Prices and Discount Annual Minimum Commitment (\\\"Annual Minimum Commitment\\\" or \\\"AMC\\\"). During the Term of the Agreement, Reseller shall pay to Diversinet an Annual Minimum Commitment, payable as follows: a) A total of four hundred thousand ($400,000) dollars shall be paid by Reseller to Diversinet as of the Effective Date. b) A total of seven hundred thousand ($700,000) dollars shall be paid by Reseller in quarterly instalments of $175,000 to Diversinet on each of December 1, 2011, March 1, 2012, June 1, 2012 and September 1, 2012. c) A total of one million ($1,000,000) dollars shall be paid by Reseller in quarterly instalments of $250,000 to Diversinet on each of December 1, 2012, March 1, 2013, June 1, 2013 and September 1, 2013. d) A total of one million three hundred thousand ($1,300,000) dollars shall be paid by Reseller in quarterly instalments of $325,000 to Diversinet on each of December 1, 2013, March 1, 2014, June 1, 2014 and September 1, 2014. e) A total of one million six hundred thousand ($1,600,000) dollars shall be paid by Reseller in quarterly instalments of $400,000 to Diversinet on each of December 1, 2014, March 1, 2015, June 1, 2015 and September 1, 2015. AMC Tokens. For each contract year that the AMC applies, Diversinet shall deliver to Reseller the number of End User licenses equal to the contract year AMC divided by twenty-four (24) in satisfaction of the AMC. For the first contract year, the applicable service license fees for the Mihealth pilot production shall be deducted from the AMC. There is no carryover of the AMC from one year to the next. AMC Termination. After the first year and upon 180 days written notice, Reseller may terminate the AMC. Termination of the AMC by Reseller shall eliminate any exclusivity of the Reseller in the Territory. Territory Assuming that the AMC amounts have been paid and the Reseller has not terminated the AMC, Reseller shall have the exclusive right to contract with Canadian head quartered companies and governmental and broader public sector entities located in Canada (the \\\"Territory\\\"). Furthermore, Reseller will have the non-exclusive right to contract in the rest of the world, excluding the United States. Sales Targets After AMC termination, Reseller shall generate at least the following amount of new sales of the Products in each contract year (for the purpose of this Schedule 3, a contract year shall be each 12-month period commencing after the termination by Reseller of the AMC). New sales are defined as the aggregate amount of all Product sales and Support Fees paid by Reseller pursuant to pricing set out below, inclusive of any applicable discounts and exclusive of applicable taxes. If Diversinet materially reduces Reseller's Territory, the Parties shall negotiate and, acting reasonably, adjust Reseller's sales targets. Contract Year 1: $750,000 (quarterly targets at \u00bc of annual amount) Contract Year 2: $1,000,000 (quarterly targets at \u00bc of annual amount) Contract Year 3: $1,250,000 (quarterly targets at \u00bc of annual amount) Contract Year 4 onward: $1,500,000 (quarterly targets at \u00bc of annual amount) Product Prices and Discount: Diversinet maintains a product price list that details the products available and the list price. The product price list is incorporated by reference to this Agreement. The Product List Price is subject to change by Diversinet upon provision of at least thirty (30) days' written notice to Reseller. Reseller shall be entitled to the following discount to the following Diversinet's standard pricing: Discount % For annual revenues < $1m 30% For annual revenues > $1m and <$2m 40% For annual revenues > $2m 50% Product Price List Terms and Conditions \u00ff Price proposals are valid for 30 days and subject to change by Diversinet at its sole discretion \u00ff All prices are expressed in United States dollars \u00ff Prices do not include any applicable taxes \u00ff Prices do not include shipping and additional charges \u00ff Support and maintenance fees are 20% of the server license fee, payable annually in advance after the first year and include: patch, maintenance and major release updates, Diversinet online technical support and email/phone technical product support from Monday- Friday, 9:00a.m.-5:00p.m., excluding statutory holidays \u00ff Optional maintenance and level 2 support and training is available at $1,500 per person day (excluding travel and out-of-expenses) \u00ff Professional services are available at $1,500 per person day (excluding travel and out-of-expenses) SCHEDULE 4\", \"level\": 1, \"text\": \"Schedule 3 Territory, Sales Targets, Prices and Discount Annual Minimum Commitment (\\\"Annual Minimum Commitment\\\" or \\\"AMC\\\"). During the Term of the Agreement, Reseller shall pay to Diversinet an Annual Minimum Commitment, payable as follows: a) A total of four hundred thousand ($400,000) dollars shall be paid by Reseller to Diversinet as of the Effective Date. b) A total of seven hundred thousand ($700,000) dollars shall be paid by Reseller in quarterly instalments of $175,000 to Diversinet on each of December 1, 2011, March 1, 2012, June 1, 2012 and September 1, 2012. c) A total of one million ($1,000,000) dollars shall be paid by Reseller in quarterly instalments of $250,000 to Diversinet on each of December 1, 2012, March 1, 2013, June 1, 2013 and September 1, 2013. d) A total of one million three hundred thousand ($1,300,000) dollars shall be paid by Reseller in quarterly instalments of $325,000 to Diversinet on each of December 1, 2013, March 1, 2014, June 1, 2014 and September 1, 2014. e) A total of one million six hundred thousand ($1,600,000) dollars shall be paid by Reseller in quarterly instalments of $400,000 to Diversinet on each of December 1, 2014, March 1, 2015, June 1, 2015 and September 1, 2015. AMC Tokens. For each contract year that the AMC applies, Diversinet shall deliver to Reseller the number of End User licenses equal to the contract year AMC divided by twenty-four (24) in satisfaction of the AMC. For the first contract year, the applicable service license fees for the Mihealth pilot production shall be deducted from the AMC. There is no carryover of the AMC from one year to the next. AMC Termination. After the first year and upon 180 days written notice, Reseller may terminate the AMC. Termination of the AMC by Reseller shall eliminate any exclusivity of the Reseller in the Territory. Territory Assuming that the AMC amounts have been paid and the Reseller has not terminated the AMC, Reseller shall have the exclusive right to contract with Canadian head quartered companies and governmental and broader public sector entities located in Canada (the \\\"Territory\\\"). Furthermore, Reseller will have the non-exclusive right to contract in the rest of the world, excluding the United States. Sales Targets After AMC termination, Reseller shall generate at least the following amount of new sales of the Products in each contract year (for the purpose of this Schedule 3, a contract year shall be each 12-month period commencing after the termination by Reseller of the AMC). New sales are defined as the aggregate amount of all Product sales and Support Fees paid by Reseller pursuant to pricing set out below, inclusive of any applicable discounts and exclusive of applicable taxes. If Diversinet materially reduces Reseller's Territory, the Parties shall negotiate and, acting reasonably, adjust Reseller's sales targets. Contract Year 1: $750,000 (quarterly targets at \u00bc of annual amount) Contract Year 2: $1,000,000 (quarterly targets at \u00bc of annual amount) Contract Year 3: $1,250,000 (quarterly targets at \u00bc of annual amount) Contract Year 4 onward: $1,500,000 (quarterly targets at \u00bc of annual amount) Product Prices and Discount: Diversinet maintains a product price list that details the products available and the list price. The product price list is incorporated by reference to this Agreement. The Product List Price is subject to change by Diversinet upon provision of at least thirty (30) days' written notice to Reseller. Reseller shall be entitled to the following discount to the following Diversinet's standard pricing: Discount % For annual revenues < $1m 30% For annual revenues > $1m and <$2m 40% For annual revenues > $2m 50% Product Price List Terms and Conditions \u00ff Price proposals are valid for 30 days and subject to change by Diversinet at its sole discretion \u00ff All prices are expressed in United States dollars \u00ff Prices do not include any applicable taxes \u00ff Prices do not include shipping and additional charges \u00ff Support and maintenance fees are 20% of the server license fee, payable annually in advance after the first year and include: patch, maintenance and major release updates, Diversinet online technical support and email/phone technical product support from Monday- Friday, 9:00a.m.-5:00p.m., excluding statutory holidays \u00ff Optional maintenance and level 2 support and training is available at $1,500 per person day (excluding travel and out-of-expenses) \u00ff Professional services are available at $1,500 per person day (excluding travel and out-of-expenses) SCHEDULE 4 CUSTOMER TERMS & CONDITIONS Reseller agrees to include terms and conditions in its Customer agreements that are reflective of the following: (a) the Customer is granted a non-exclusive, non-transferable and non-assignable right to use the Products solely for their intended use; (b) the Customer may not reverse engineer, decompile, alter, transfer, modify or create a derivative work of the Product; (c) no ownership rights to the Products and documentation are transferred to the Customer; (d) the Customer may not use the Products otherwise than as a part of the equipment, hardware or software in which any Product has been incorporated or for which it has been delivered; (e) the Customer may not remove any proprietary, copyrights, trade secret or warning legend from any Products or documentation or copies thereof; (f) the Customer may not furnish the Products or documentation into any country in violation of any export control laws or regulations. The Reseller's agreements with its Customers shall also contain disclaimers of warranties and limitations of liabilities with respect to the Products and documentation at least as restrictive as those set forth in this Agreement. SCHEDULE 5 Service Level Agreement 1. Overview. This Support Plan Schedule (\\\"SLA\\\") details the terms for technical support provided by Diversinet during the term of this Agreement to the Reseller's Technical Support team, provided however, Reseller is current with payment of all fees. The Reseller's Subscribers shall interface with the Reseller Technical Support only. The Reseller Technical Support shall escalate product issues of a certain severity and above to Diversinet Technical Support. This SLA specifically addresses: (i) the service levels definition, measurement and minimum service standard in effect for the product, and (ii) technical support definition, availability and response timeframes. 1.1 Reseller Technical Support Escalation Path Around Product Issues 1.a.1 Subscriber call arrives at the Reseller Level 1 Support: the Reseller Level 1 Support will open a trouble ticket and attempt to resolve the issue. If no resolution, trouble ticket escalates to the Reseller Level 2 Support. 1.a.2 Level 2 Support attempts to resolve the Subscriber trouble ticket utilizing documentation, tools and procedures provided with the product. If Level 2 Support can't resolve the problem, Level 2 shall make a judgment call as to whether this appears to be a Subscriber problem or a Diversinet product related problem. Level 2 will escalate the trouble ticket to the Reseller Engineering Maintenance and Escalations. (EME). 1.a.3 The Reseller's EME will investigate. If this is indeed a Subscriber related problem, EME will be responsible for resolution. If EME determines this is actually a Diversinet Software issue, EME will send the trouble ticket back to Level 2 for dispatch to Diversinet. Level 2 Support will escalate the trouble ticket to Diversinet for resolution. Level 2 Technical Support still owns the Subscriber relationship. Anyone in Reseller Level 2 Technical Support can escalate to Diversinet. 1. Diversinet Support Service Availability. Technical Support Availability. Diversinet Technical Support will be available to accept and respond to problem calls or email from Reseller's Technical Support from 9:00 am - 5:00 pm Eastern Standard Time (US), 5 days a week (Monday through Friday), 52 weeks a year, excluding United States and Canadian national holidays. During such hours, technical support calls or email will be answered immediately by the support staff. Diversinet will provide a phone option to speak directly to a trained technical support representative. Diversinet will make the reasonable commercial effort to answer promptly to calls. 2.1 Diversinet Contact information\"}, {\"id\": \"2.2\", \"title\": \"Reseller Contact information\", \"level\": 2, \"text\": \"2.2 Reseller Contact information\"}, {\"id\": \"2.3\", \"title\": \"Response Time \\\"Response Time\\\" shall mean the time it takes to respond to a request specific to the Severity (defined be\", \"level\": 2, \"text\": \"2.3 Response Time \\\"Response Time\\\" shall mean the time it takes to respond to a request specific to the Severity (defined below) of the incident as described below. In the event the response time is not met the incident shall be escalated as described below. Escalation of Incident: Definitions of Severity levels Severity 1 Problems. Severity 1 Problems generally include any events that have a significant impact on the operations of the system and have an impact on Subscribers' use of the Software, such as: \u00ff Designation Name (if applicable) Direct Tel. No Cell Tel E-Mail Technical Support N/A 416 756 2324 x 300 N/A support@diversinet.com Technical Support & Escalation Manager Charles Blair 416 756 2324 x 234 416 562 1773 cblair@diversinet.com TS VP David Annan 416 756 2324 x 232 416 587 0108 dannan@diversinet.com Designation Name (if applicable) Direct Tel. No Cell Tel E-Mail Technical Support & Escalation Manager TS VP System or application is down or unavailable; transactions can't be processed. \u00ff Any event that significantly disrupts or threatens to disrupt service levels of the Software due to errors in the software, tools or system configuration provided by Diversinet. \u00ff Any online application outage that significantly impacts the online availability and service level of the Software. \u00ff Consistent degradation of performance (response time or function) that significantly impairs the Software. \u00ff Any repeating unresolved incidents that have significant impact on the operations of the Diversinet Based Service or Subscribers' use of the Software. \u00ff Resolution may involve software changes, configuration modifications, operating procedure changes or 'workarounds'. Resolution shall be defined as a situation wherein the system is restored to a state wherein the effective outage is relieved. Severity 2 Problems. Severity 2 Problems generally includes any events (other than Severity 1 Problems) that adversely affect the operation of the Diversinet Based Service or the User Software, such as: \u00ff An error that disables only certain non-essential functions of the User Software and may result in degraded operations, including without limitation, an error that results in computer transactions not processing properly. \u00ff An error/event that disables only non-essential functions of the User Software, but also adversely affects the use of the User Software. \u00ff Resolution may involve software changes, configuration modifications, operating procedure changes or 'workarounds'. Resolution shall be defined as a situation wherein the system is restored to a state wherein the effective outage is relieved. Severity 3 Problems: Severity 3 Problems generally includes minor events that do not have a significant impact or adverse effect on the operation or performance of the Diversinet Based Service or the User Software. Severity 4 Problems: Severity 4 Problems generally are potential Software enhancements or feature requests that Subscribers request of Reseller Technical Support. This is to help Diversinet track Reseller's requests and process them appropriately. Problem Isolation: Diversinet Technical Support will provide best efforts to mitigate all service affecting conditions which may arise. For each S1 - S3 incident Diversinet will produce an Incident Report provided to Reseller. Situations where there are unapproved variations made in the approved design, configuration, network or systems environments are not covered under this SLA. Furthermore, this SLA does not cover problems encountered by end users relating to hand held devices hardware, software and network problems that are outside the control of Diversinet or not supported by Diversinet. Diversinet will inform/publish to Reseller a quarterly list of mobile devices, related software and network operators and telecommunication companies that can support Diversinet software, products and services. Resolution Target: Diversinet will commit to provide a resolution to problems caused by its software, tools or procedures. Every effort will be made to prevent maintenance procedures during Scheduled Maintenance Times from affecting service availability. Table 1: Escalation Tiers and Initial Response Times # Priority Level Technical Support Initial Response (in Hours) Escalation to Manager (in Hours) Escalation to VP (in Hours) S1 1 2 3 S2 2 4 24 S3 4 8 48 S4 Next Business Day\"}, {\"id\": \"SCHEDULE 6\", \"title\": \"PERSONAL INFORMATION Definitions, Interpretation 1) In this Exhibit D:\", \"level\": 1, \"text\": \"SCHEDULE 6 PERSONAL INFORMATION Definitions, Interpretation 1) In this Exhibit D: a) \\\"Agreement\\\" means the License Agreement between Diversinet Corp. (\\\"Licensor\\\") and 2205925 Ontario Limited (\\\"Licensee\\\") with effective date of January 10, 2011; b) \\\"Personal Information\\\" means information that is defined as \\\"personal information\\\" in PIPEDA, including without limitation personal health information, that is held, transmitted or stored on or by the Software licensed to Licensee under the Agreement;\"}, {\"id\": \"c\", \"title\": \"\\\"PIPEDA\\\" means the Personal Information Protection and Electronic Documents Act (Canada); and\", \"level\": 1, \"text\": \"c) \\\"PIPEDA\\\" means the Personal Information Protection and Electronic Documents Act (Canada); and\"}, {\"id\": \"d\", \"title\": \"\\\"Services\\\" means the services provided by Licensor to Licensee under the Agreement including without limitation, the Su\", \"level\": 1, \"text\": \"d) \\\"Services\\\" means the services provided by Licensor to Licensee under the Agreement including without limitation, the Support Services.\"}, {\"id\": \"2\", \"title\": \"Any capitalized term that is not defined in section 1 above has the meaning attributed thereto in the Agreement\", \"level\": 1, \"text\": \"2) Any capitalized term that is not defined in section 1 above has the meaning attributed thereto in the Agreement.\"}, {\"id\": \"3\", \"title\": \"The parties acknowledge and agree that\", \"level\": 1, \"text\": \"3) The parties acknowledge and agree that: a) Licensee represents that it is an organization subject to PIPEDA and Licensor is a third party service provider to the Licensee in connection with the Services; b) Licensee's End Users shall interface with Licensee Technical Support only and in general, Licensor will not require access to Personal Information to provide the Services;\"}, {\"id\": \"c\", \"title\": \"notwithstanding subsection 3(b) above, Licensor may from time to time require access to Personal Information to provide\", \"level\": 1, \"text\": \"c) notwithstanding subsection 3(b) above, Licensor may from time to time require access to Personal Information to provide the Services;\"}, {\"id\": \"d\", \"title\": \"Licensor shall only access Personal Information with the prior written consent of Licensee;\", \"level\": 1, \"text\": \"d) Licensor shall only access Personal Information with the prior written consent of Licensee; e) Licensor shall not download, which for the purposes of this Privacy Exhibit includes copy, hold or otherwise save Personal Information, without the prior written consent of Licensee and for greater certainty, consent to access Personal Information does not constitute consent to download Personal Information; f) where Licensor receives consent to access, access and download or access and otherwise use Personal Information, the terms and conditions of this Privacy Exhibit shall apply to Licensor in relation to those activities; and g) where Confidential Information of the Licensee is also Personal Information, the provisions of this Privacy Exhibit take priority over section 7 of the Agreement in the event of any conflict. Ownership of Personal Information/ Prohibition on Disclosure 4) Nothing in this Privacy Exhibit shall be interpreted or construed to give Licensor any interest in or control of Personal Information and for greater certainty, as between Licensor and Licensee, Licensee owns and controls and shall continue to own and control Personal Information.\"}, {\"id\": \"5\", \"title\": \"Licensor shall not disclose Personal Information\", \"level\": 1, \"text\": \"5) Licensor shall not disclose Personal Information. For clarity, the use of Personal Information by employees, agents and representatives of Licensor in accordance with this Privacy Exhibit does not constitute the disclosure of Personal Information by Licensor to those employees, agents and representatives. Safeguards 6) Notwithstanding any provision to the contrary in the Agreement, Licensor shall not subcontract or assign any of the Services that may require access to or the downloading or other use of Personal Information except with the prior written consent of Licensee or as required to be disclosed by a governmental agency or third party as expressly required by operation of law, regulation or court order.\"}, {\"id\": \"7\", \"title\": \"Licensor shall use security safeguards that meet or exceed industry standards to protect Personal Information against s\", \"level\": 1, \"text\": \"7) Licensor shall use security safeguards that meet or exceed industry standards to protect Personal Information against such risks as loss and unauthorized access, collection, use, disclosure and destruction.\"}, {\"id\": \"8\", \"title\": \"Notwithstanding any provision to the contrary in the Agreement, Licensor shall not, except with the prior written conse\", \"level\": 1, \"text\": \"8) Notwithstanding any provision to the contrary in the Agreement, Licensor shall not, except with the prior written consent of Licensee, access or use Personal Information from outside Canada or transmit Personal Information outside Canada.\"}, {\"id\": \"9\", \"title\": \"Where Licensor downloads Personal Information in accordance with this Privacy Exhibit, Licensor shall prohibit its empl\", \"level\": 1, \"text\": \"9) Where Licensor downloads Personal Information in accordance with this Privacy Exhibit, Licensor shall prohibit its employees, agents and representatives from downloading Personal Information onto any portable device, unless the information is encrypted in accordance with industry standards for strong encryption.\"}, {\"id\": \"10\", \"title\": \"Licensor shall segregate Personal Information from information of any person other than Licensee\", \"level\": 1, \"text\": \"10) Licensor shall segregate Personal Information from information of any person other than Licensee.\"}, {\"id\": \"11\", \"title\": \"Subject to a written direction from Licensee to securely destroy Personal Information, upon the expiry or termination o\", \"level\": 1, \"text\": \"11) Subject to a written direction from Licensee to securely destroy Personal Information, upon the expiry or termination of the Agreement and at any other time at the request of Licensee, Licensor shall promptly return to the Licensee Personal Information that Licensor downloaded in accordance with this Privacy Exhibit. Inspection and Audit 12) In addition to any other rights of inspection, review and audit Licensee may have, Licensee or a person appointed by Licensee may, at any reasonable time, on reasonable notice to Licensor, at Licensee's sole cost and expense, enter any location from or in which Licensor has accessed, used or downloaded Personal Information to inspect, review and audit the equipment, systems (including without limitation security systems), documents, processes and practices that are used in connection with the provision of the Services for the purpose of assessing Licensor's compliance with this Privacy Exhibit. Licensor shall provide all reasonable assistance to Licensee in relation to any such inspection, review and audit.\"}, {\"id\": \"13\", \"title\": \"Licensor shall track the access, downloading and use of Personal Information, in accordance with this Privacy Exhibit,\", \"level\": 1, \"text\": \"13) Licensor shall track the access, downloading and use of Personal Information, in accordance with this Privacy Exhibit, by its employees, agents and representatives and maintain a record of such activities. Within twenty-four hours of a request, Licensor shall provide Licensee with a copy of any or all of the records created and maintained under this section 13. Licensor Employees, Agents, Representatives 14) Licensor shall ensure that it only permits access to Personal Information to those of its employees, agents and representatives who: (a) will need access to Personal Information to deliver the Services; (b) have received training in the protection of Personal Information; and (c) have agreed to comply with the provisions of sections (5), (8), (9), (10) and (12) of this Privacy Exhibit. Notice of Non-Compliance 15) If for any reason Licensor does not comply or anticipates that it shall be unable to comply with a provision of this Privacy Exhibit in any respect, Licensor shall promptly notify Licensee of the particulars of the non-compliance or anticipated non-compliance and of the steps it proposes to take to address or prevent the recurrence of the non-compliance or anticipated non-compliance. Default 16) Notwithstanding anything to the contrary in the Agreement, Licensor acknowledges and agrees that a breach of this Privacy Exhibit by Licensor which remains uncured for a period of sixty (60) days shall constitute a material breach and grounds for the termination on notice of the Agreement by Licensee without cost or liability to Licensee. Without limiting the foregoing, Licensor agrees that in addition to any other rights or remedies Licensee may have for material breach of the Agreement, Licensee has the right to an injunction or other equitable relief in any court of competent jurisdiction enjoining a threatened or actual breach of this Privacy Exhibit by Licensor. No Withholding 17) Licensor shall not, and hereby forever waives any and all right to, refuse to return Personal Information to enforce any alleged payment obligation or in connection with any dispute connected with the Agreement or any other matter between Licensor and Licensee. Survival 18) The obligations of Licensor under this Privacy Exhibit shall survive the termination of the Agreement. #\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of DIVERSINETCORP_03_01_2012-EX-4-RESELLER AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER AGREEMENT This agreement (\\\"Agreement\\\")\", \"level\": 1, \"text\": \"RESELLER AGREEMENT This agreement (\\\"Agreement\\\") dated as of January 11, 2011 (\\\"Effective Date\\\") is between Diversinet Corp. (\\\"Diversinet\\\"), an Ontario corporation with its principal place of business located at 2235 Sheppard Avenue East, Suite 1700, Toronto, Ontario, Canada M2J 5B5, and 2205925 Ontario Limited, with its principal place of business located at 111 Main Street West, Suite 304, North Bay, Ontario P1B 2T6 (the \\\"Reseller\\\"). Diversinet and the Reseller are hereinafter referred to individually as a \\\"Party\\\" and, collectively, as the \\\"Parties\\\". The Schedules attached hereto shall form an integral part of this Agreement, and all references to this Agreement shall be deemed to include the Schedules. WHEREAS Diversinet is a provider of mobile device security and authentication solutions for the mobile data ecosystem, and is the owner of certain software products, user documentation and services and the related trade-marks; AND WHEREAS Reseller has represented that it is qualified and desires to act as a reseller of certain of Diversinet's products within a certain defined territory, and agrees to use its best efforts to market and sell such products in such territory; NOW THEREFORE, for and in consideration of the mutual promises and commitments contained hereafter and other considerations, the receipt and sufficiency of which is hereby acknowledged, the Parties have entered into this Agreement for the purpose of permitting Reseller to market and sell certain of Diversinet's products pursuant to the terms and conditions set out as follows. 1. Appointment Subject to payment of the Annual Minimum Commitment (\\\"AMC\\\" - defined herein), Diversinet hereby grants to Reseller an exclusive, non- transferable and non-assignable right to market, sell, and sub-license those Diversinet products listed in Schedule 2 (the \\\"Products\\\") within the territory listed in Schedule 3 (the \\\"Territory\\\") to Canadian headquartered companies, and governmental and broader public sector entities located in Canada. Reseller's customers (the \\\"Customers\\\") are defined as those organizations/enterprises that will market and manage the end-users of the Products (the \\\"End-Users\\\"). Reseller acknowledges and agrees that it does not have the right to assign sub-resellers under this Agreement outside of the Territory, except with the prior written consent of Diversinet. Furthermore, if Reseller terminates the AMC in the manner contemplated in Schedule 3, the exclusive license above shall revert to being a non- exclusive license. In either case, Reseller will have the non-exclusive right to contract in the rest of the world, excluding the United States. If Reseller identifies End- Users in the United States, with the prior written consent of Diversinet, Reseller may sell the Products to the End-Users. United Stated revenues will not be counted against the AMC however Reseller will be entitled to the discount rates as indicated in Schedule 3.. In addition, Diversinet hereby grants to Reseller the right to use those Diversinet trademarks and copyrighted materials with respect to the Products solely for the purpose of marketing and distribution of the Products as authorized hereunder. Reseller acknowledges that the use of such trademarks and copyrighted materials does not create in its favour any right, whether of ownership or otherwise, to such trade-marks and copyrighted materials, and that all rights arising from the use thereof by Reseller shall inure to the benefit of Diversinet. Reseller agrees that the rights granted to Reseller in this Section 1 are solely for the purpose of supplying the Products to Reseller, its Customers and End-Users located in the Territory. Any use outside of the rights granted herein shall require an additional license from Diversinet. 2. Ownership and Representations (a) Except as expressly granted herein, Diversinet does not grant any further rights, license or immunity to Reseller, and hereby retains and does not waive any rights it may have with respect to patents, trade-marks, copyrights, moral rights or other intellectual property or proprietary rights enforceable under the laws of any country. Reseller shall not authorize anyone to reverse engineer, decompile, alter, transfer, modify or create a derivative work from any of the Products, nor may Reseller itself engage in so doing. (b) Reseller shall not make any representations or warranties regarding the use or operation of the Products other than those included in any promotional materials provided by Diversinet and any Product documentation provided by Diversinet. 3. Term and Renewal The term of this Agreement shall begin on the Effective Date and continue in effect for a period of five (5) years (the \\\"Initial Term\\\"), unless sooner terminated in accordance with the provisions set out herein. Upon expiration of the Initial Term, this Agreement shall automatically renew for consecutive one (1) year periods, unless terminated by Reseller within sixty (60) days prior to the expiration of the Initial Term or any renewal term, as the case may be (the Initial Term and each renewal term, collectively, the \\\"Term\\\"). Any annual renewal would be subject to the payment, if applicable, of the AMC as agreed to by the parties, however such AMC will not be less than the previous year AMC times 115%, payable in applicable quarterly instalments. 4. Termination (a) Either Party may terminate this Agreement: (i) Upon thirty (30) days' written notice to Reseller if Reseller fails to make any AMC payment when due under this Agreement, or when an audit, as set out in Section 13, by Diversinet reveals any under-payment for any payment due, and it is not paid within the thirty (30) day written notice period; (ii) providing thirty (60) days' written notice to the other Party if the other Party breaches any material term or condition of this Agreement, and fails to cure such breach within the 60 day period; (iii) upon providing thirty (30) days' written notice to Reseller if Reseller terminates the provisions of the Annual Minimum Commitment and fails to meet the sales targets as set out in Schedule 3. (b) This Agreement shall terminate automatically without notice and without further action by Diversinet in the event that: (i) Reseller ceases carrying on its business, or if a petition shall be filed, an order shall be made or an effective resolution is passed for the winding-up, dissolution or liquidation of Reseller. (c) Termination under Subsection 4(a) shall trigger a phase-out period during which Reseller may continue to provide products and services to Customers. Such phase-out period shall be the longer of (i) the remaining term of the agreement between the Reseller and its Customers, and (ii) 18 months. (d) Upon the termination of this Agreement for any reason: (1) all rights granted to Reseller hereunder shall automatically come to an end and revert to Diversinet, including without limitation any right to use, operate and provide customer service or support for the Products; (2) Reseller shall immediately pay to Diversinet all amounts due and outstanding hereunder as of the date of such termination or expiration; and (3) within five (5) days of termination of this Agreement, for whatever reason, Reseller, must: (a) destroy all copies of the Products and any associated Products documentation in its possession or under its direct control; and (b) deliver to Diversinet a written certificate warranting that it has complied with the foregoing obligations. 1. Customer Orders (a) Customer Agreements. The Parties acknowledge and agree that Reseller's Customers will acquire the Products and related services under contract with Reseller, that Diversinet shall not have any contractual interest in Reseller's Customer relationships. Prior to Reseller committing to provide any Products to a Customer, Reseller shall cause Customer to enter into purchase agreement(s) with Reseller with respect to each of the Products purchased by Customer (each, a \\\"Customer Agreement\\\"). Reseller agrees that it shall include terms and conditions in its Customer Agreements that are sufficient to protect Diversinet's interests as reflected in this Agreement, including, but not limited to, those terms set out in Schedule 4 hereto. Such Customer Agreements shall be subject to Diversinet's approval, which approval shall not be unreasonably withheld. Reseller shall use commercially reasonable efforts to ensure that all Customers abide by the terms of the applicable Customer Agreement(s). Furthermore, Reseller shall enforce its Customer Agreements against Customer when requested to do so by Diversinet. For greater clarity, Diversinet expects that the Reseller will include all of the points covered in Section 4 in its end user agreement. When the Reseller receives a customer order they will fax both the end user agreement and the details of the order to Diversinet and if the end user agreement contains all of the points outlined in Section 4 then Diversinet will approve the order and ship the required products to the Reseller. (b) Ordering Process. Reseller shall submit all orders to Diversinet for the applicable Products. Reseller's submission of orders to Diversinet shall comply at all times with Diversinet's reasonable procedures and requirements and are subject to acceptance by Diversinet acting reasonably. Reseller shall be solely responsible for all sales activity culminating in and including the procurement of fully-executed Customer Agreements and purchase orders specifying the Products and Services ordered and the specific number of tokens. 1. Delivery (a) Subject to Reseller's compliance with the terms and procedures set forth in this Agreement, Diversinet shall provide to Reseller or to Customers the Products properly ordered by Reseller and accepted by Diversinet in material compliance with the applicable terms hereof, notwithstanding any inconsistent or additional terms which Reseller includes in any Customer agreement. (b) Unless otherwise agreed to by the Parties, delivery of the Products shall take place via electronic transmission or by courier, and will take place within two (2) Business Days of a written request or purchase order for software and within five (5) Business Days for a standard appliance. Custom built appliances or software are subject to evaluation and delivery date will be communicated after assessment. \\\"Business Day\\\" shall mean 9:00 a.m. to 5:00 p.m. (Eastern Standard Time), Monday through Friday, excluding all statutory holidays observed in the Province of Ontario in Canada. Delivery will be F.O.B. Diversinet's facility. Reseller shall have fifteen (15) calendar days after the later of (i) the delivery of any of the Products by Diversinet; or (ii) any applicable evaluation period; to inspect the Products and ensure their substantial compliance with the corresponding documentation. Unless Reseller notifies Diversinet within such fifteen (15) day period that any of the Products fail to substantially comply with the relevant documentation, such Products shall be deemed accepted. In the event Reseller rejects any of the Products, Reseller shall give Diversinet written notice of rejection, specifying in reasonable detail the basis for such rejection. Diversinet will use commercially reasonable efforts to correct any nonconformance and re-deliver such Products to Reseller. 1. Reseller Covenants (a) Manner of Performance. Reseller shall: (i) use commercially reasonable efforts to market and sell the Products and Services to Customers; (ii) conduct business in a competent and professional manner that reflects favorably at all times on the Products and the goodwill and reputation of Diversinet; (iii) avoid deceptive, misleading, or unethical practices that are or might be detrimental to Diversinet or the Products, or to the public in general; (iv) not make any false or misleading representations with regard to Diversinet or to the Products; (v) not publish or employ, or cooperate in the publication or employment of, any misleading or deceptive advertising material with regard to Diversinet or the Products or related services; (vi) not make any representation, warranties or guarantees to potential Customers or to the trade with respect to the specifications, features or capabilities of the Products that are inconsistent with published statements made by Diversinet; and (vii) comply with all applicable federal, state, region, and local laws and regulations related to the performance of its duties hereunder. (b) Reporting Requirements. Reseller shall, on a monthly basis, communicate to Diversinet information about Customers as reasonably requested by Diversinet including, but not limited to, Customer business, marketing, sales and technical information, installation, service delivery and on-going maintenance information. (c) Technical Expertise. Reseller and its staff shall be conversant with the technical language conventional to the Products and similar technologies in general, and will develop sufficient knowledge of the industry, of the Products and of products competitive with the Products (including specifications, features and benefits) in order to explain in detail to potential Customers and End Users the differences between the Products and competitive products and services. (d) Branding. Reseller may provide its own branding for the Products; however Reseller will include a \\\"powered by Diversinet\\\" tag or such similar identifiers as mutually agreed to by the Parties. Should Reseller require Diversinet to brand the Product, then such work will be done under a separate statement of work to be agreed upon in writing by the Parties. 1. Fees and Billing (a) Rates. For the Diversinet Products sold or distributed by Reseller, Reseller shall pay Diversinet the applicable list price, in U.S. dollars, for such Product, less the applicable discount for each Product, all as set out in Schedule 3. Any reference to any amounts or currency in this Agreement means United States dollars or U.S. dollars. (b) Billing. Diversinet will invoice Reseller for applicable one time Token Fees and the upfront annual Validation and Support Fee upon setting up a master account for each Customer and pre-loading it with MobiSecure tokens. Other fees and charges payable under this Agreement will be invoiced to Reseller according to terms set out in this Agreement or any applicable schedules or attachments hereto. Reseller shall be responsible for payment to Diversinet of all invoiced amounts for Products and services provided by Diversinet at Reseller's request to Reseller, its Customers and/or End-Users. (c) Payment Terms. Invoices are due and payable within 30 calendar days from the invoice date or from when the amount is due, whichever is later. (d) Late Charges and Taxes. All overdue amounts shall bear interest at the rate of 1% per month (12% per annum, simple interest), or the highest rate allowed by applicable law, whichever is less, until paid in full. Interest shall accrue on a daily basis. Fees do not include any sales, transfer, use, property, value added and other taxes, or any customs duties, tariffs or other governmental charges, all of which (if any are due and have been incurred within the Territory) are assumed and payable by Reseller (except for taxes imposed on Diversinet's net income). Providing proof of an exemption from any such duty, tax or charge is the responsibility of Reseller. Diversinet acknowledges and agrees that Reseller shall withhold any applicable non-resident withholding taxes from any amount owing hereunder and remit such taxes to the applicable federal taxing authority without provision for gross-up, if Diversinet becomes a non-resident of Canada or assigns the Agreement to a non-resident of Canada and if Diversinet does not provide Reseller with an appropriate exemption thereto. (e) Network Charges. The Customer or End User shall at all times be responsible for all mobile network data, roaming or airtime charges, SMS related charges, application certification charges or marketing costs and any other fees or levies related to the cellular or wireless network over which the Products are offered and/or provisioned, as well as Customer's own Internet access fees (collectively, the \\\"Network Charges\\\"). None of the fees chargeable hereunder include any Network Charges and Reseller shall ensure that Customer shall indemnify and hold harmless Diversinet and Reseller against any such Network Charges that may be levied against them for the operation of the Products. 1. Training and Consulting (a) Diversinet will arrange for the initial personal technical and sales instruction of up to three (3) Reseller personnel for up to five (5) days in learning the functions, installation, integration, operation and maintenance of the Products. Such instruction shall take place in Diversinet's corporate headquarters and expenses of the Reseller personnel incurred for attending such initial instruction shall be paid by Reseller. There will be no charge for this initial training. Thereafter, Diversinet will make available to Reseller standard Product training courses generally offered by Diversinet at the list price. (a) Upon Reseller's request, Diversinet will provide Reseller with pre-sales consulting and post-sales consulting at the Diversinet's standard rates. Post-sales consulting will be provided under a separate services agreement to be entered into by the Parties, which shall include specific statement(s) of work. (b) Statements of Work (\\\"SOW\\\"). Fees for any future development services shall be as agreed to by the Parties in an SOW. Reimbursable expenses agreed to by Reseller shall be paid by Reseller within thirty (30) days of Diversinet's documented invoice. Diversinet shall offer to perform such work at Diversinet's then standard daily rate (currently at $1,500 per day). Reseller hereby agrees and acknowledges that Diversinet shall own all code, documentation and modifications to the code or documentation, and all copyrights, trade secrets and other intellectual property rights with respect to any such code or documentation. Diversinet hereby agrees and acknowledges that Reseller owns any and all intellectual property rights with respect to any Reseller-specific private label associated with the software. 1. Support (a) Services. Diversinet may provide, upon written agreement between the parties, the server hardware, physical environment, including physical security, HVAC and power for the server hardware, all as required to provide the Products as described in Schedule 2. Diversinet may also provide internet connectivity, by being responsible for network operation and availability from the public Internet up to the termination cables at the network interface card on the server hardware. Diversinet shall use commercially reasonable efforts to maintain connectivity, through the public Internet, between the server hardware and the wireless network operators or other network on which an End User's device operates. Diversinet specifically excludes any responsibility for any connectivity between a network operator and a wireless device, including any SMS, SMTP, or other connectivity. The products, their related service objectives and each Party's related responsibilities in respect thereto are to be more fully described in a separate agreement. (b) Service Term. During the Term, and subject to Reseller's payment of the annual Support Fees, Diversinet will provide support for the Products in accordance with the terms set out in Schedule 5. Furthermore, Diversinet will support the existing Reseller trial including Apple App Store submission until December 31, 2010. Diversinet will support the Reseller certification with Canada Health Infoway, at no additional cost, until December 31, 2010. (c) Standard Support. Reseller's Customers will be responsible for first level support to End-Users. Reseller will be responsible for second level support to its Customer. Diversinet will provide third level support to Reseller. Diversinet will accept electronic mail messages via the Internet using SMTP compliant software (\\\"E Mail\\\") addressed to: support@diversinet.com, from Reseller with questions regarding the functions of the Products, as well as questions about how to make full use of the software (\\\"Support Questions\\\"). If second level support is not being provided by the Reseller, Diversinet may, at its sole discretion, provide additional support to Reseller. In these cases, Diversinet may charge the Reseller for support services or reduce the product price discount provided to Reseller. Reseller's Support Questions must be referred to Diversinet by a single person, designated initially as Primary Technical Support Contact (\\\"Primary Contact\\\") set out in Schedule 1, unless Diversinet is notified in writing of an alternate technical support contact (\\\"Alternate Contact\\\"). The names and e-mail addresses of up to four (4) Alternate Contacts (along with the name of the particular project or department) shall be designated in a list provided by the Primary Contact via E Mail at support@diversinet.com. All Primary Contacts and Alternate Contacts (collectively, \\\"Contacts\\\") must be members of the designated project or department. It is Reseller's responsibility to provide Diversinet with an initial list of Contacts and to keep that list current in order to receive timely service. (d) Updates. During the Term, Diversinet will provide updated versions of the Products (\\\"Updates\\\"). Updates shall be designated by a version number with a higher number to the right of the decimal point (e.g., version 1.4 is an Update to version 1.2), but do not include New Releases or Custom Releases (which are designated with a higher number to the left of the decimal point, or at the end with a letter, respectively). Prior to delivering any Updates, Diversinet may require Reseller to sign a revised schedule if any additional grants or licenses are required for an Update. (e) Internet Access. Diversinet may provide, at no additional cost, access to Diversinet's Internet-based Frequently Asked Questions (FAQ's) archives, a defect 'fix' list, or a private discussion forum available to all Products support customers, which will be moderated by Diversinet's engineers when available. (f) Beta Versions. Diversinet may provide Reseller with access to Beta Test versions of Updates to Products as described in paragraph (d) above. (g) Update Input. Diversinet will give special consideration to Reseller's feature requests for future versions of the Products. 1. ASP Sales The Reseller may sell the Products as an Application Service Provider (\\\"ASP\\\") sales model. Under an ASP model, the Reseller shall provide the Products through computer-based services to End Users over a network. The Reseller shall be responsible for providing, at the Reseller's sole cost and expense, the infrastructure, network, hosting environment, support and/or website. Reseller warrants and guarantees that Diversinet shall have no obligations, representations or guarantees to the End User for sales made by the Reseller under an ASP sale. 2. Confidential Information (a) Reseller agrees that all software, documentation and materials provided with the Products and all information contained therein is owned by Diversinet. The Parties agree that any other information of a confidential or proprietary nature provided by one Party to the other from time to time, whether marked as \\\"Proprietary\\\", \\\"Confidential\\\", \\\"Secret\\\" or any other designation implying confidentiality, is owned by the disclosing Party (all such information hereafter, collectively \\\"Trade Secrets\\\"). Both Parties shall treat the other Party's Trade Secrets with the same care as they treat their own confidential information of a like nature, but in no case shall the receiving Party use less care in handling the Trade Secrets than would be reasonable under the circumstances. The Parties agree not to make the other Party's Trade Secrets available in any form to any third party, or use the other Party's Trade Secrets for any purpose other than as set forth in this Agreement or as authorized by the other Party in writing. The Parties' obligations under this subsection shall survive the termination or expiration of this Agreement. (b) General Exclusions: The Parties' obligations set out in this section shall not apply to any information which is: (i) rightfully in a Party's possession before receipt from the other Party; (ii) independently developed by a Party without reference to the other Party's Trade Secrets; (iii) approved for release by written agreement with the other Party; (iv) rightfully in the public domain; (v) disclosed by requirement of a governmental agency or third party as expressly required by operation of law, regulation or court order. The disclosing Party shall promptly notify the other Party of the pending disclosure to allow the other Party to seek a protective order; or (vi) lawfully disclosed to a Party by a third party without an obligation of confidentiality to the Party. (c) It is expressly agreed that a violation of this section will cause irreparable harm to the owning Party and that a remedy at law would be inadequate. Therefore, in addition to any and all other remedies available at law, the owning Party shall be entitled to seek (without posting of a bond) preliminary, injunctive, emergency or equitable relief in the event of any actual or threatened violation of any or all of the provisions hereof. 3. Audit During the Term and for seven (7) years after the expiration or termination of this Agreement, or such longer period as required by applicable law, Reseller agrees to maintain complete books, records and accounts relevant to the computation of and accounting for the amounts payable under this Agreement. Reseller agrees to allow Diversinet or its agents and representatives the right to examine and audit such books, records and accounts during Reseller's normal business hours for no more than once per calendar quarter upon reasonable notice. If such examination reveals a deficiency in any amounts paid, Reseller agrees to pay any such deficiency forthwith upon demand, plus interest calculated in accordance with Section (Late Charges and Taxes) above and, if in excess of 5%, the cost of the audit incurred by Diversinet. 4. Limited Warranty EACH PARTY DOES NOT WARRANT TO THE OTHER THAT THE MATERIALS IT PROVIDES IN CONNECTION WITH THIS AGREEMENT WILL MEET THE REQUIREMENTS OF THE OTHER PARTY OR ITS CUSTOMERS, OR THAT THEIR OPERATION WILL BE UNINTERRUPTED OR ERROR FREE. Diversinet warrants as follows: (a) Each of the Products operates in substantial accordance with its documentation (\\\"Operation Warranty\\\"). With respect to the Operation Warranty, Reseller's sole remedy, and Diversinet's sole obligation, shall be to cause the Product to operate substantially in accordance with its documentation in a timely manner. All Products shall be virus-checked prior to delivery to Reseller. (b) The services provided under this Agreement shall be performed in a timely and professional manner by personnel (\\\"Personnel\\\") and in all material respects in accordance with the requirements set forth here in Schedule 5 (Service Level Agreement). Personnel shall be appropriately trained in the performance of such services under this Agreement and shall meet those standards generally observed by reputable and competent members of the same industry providing similar services. c) Diversinet shall ensure that there collectively is a sufficient number of employees and personnel assigned and available during the term to provide the services in accordance with the service levels and the standards and other terms and conditions of this Agreement. (d) Diversinet shall exercise professional and good judgement in carrying out and performing its obligations under this Agreement. (e) The Products do not contain any virus, Trojan horse, worm, trapdoor, backdoor, malicious code or other code or device designed to interfere with proper use of the Software or cause harm or injury. (h) As of the Effective Date, to the best of its knowledge, none of the Products infringes upon any third party's patent rights (\\\"Limited Patent Warranty\\\"). EXCEPT AS EXPRESSLY SET FORTH ABOVE, DIVERSINET PROVIDES THE PRODUCTS, DOCUMENTATION AND OTHER RELATED SERVICES (COLLECTIVELY, THE \\\"BUNDLED PRODUCT\\\") TO RESELLER \\\"AS IS\\\" WITHOUT WARRANTY, MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY OTHER WARRANTIES OF PERFORMANCE, AND IMPLIED WARRANTIES OF NON INFRINGEMENT, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, REGARDING THE BUNDLED PRODUCTS, EITHER AS A UNIT, OR AS INDIVIDUAL PARTS. EXCEPT AS ABOVE SET FORTH, DIVERSINET SHALL BEAR NO RISK AS TO THE PERFORMANCE OF THE BUNDLED PRODUCT, AND ALL RISK IS TO BE ALLOCATED BETWEEN RESELLER AND IT CUSTOMERS AND END-USERS, OR ANY OTHERS WHO USE THE BUNDLED PRODUCT (\\\"USERS\\\"). EXCEPT AS ABOVE SET FORTH, SHOULD THE BUNDLED PRODUCT PROVE DEFECTIVE, DIVERSINET SHALL NOT BEAR ANY COST WHATSOEVER FOR ANY SERVICE, REPAIR OR CORRECTION TO ANY PARTY. USERS SHALL BE SOLELY RESPONSIBLE FOR ADEQUATELY PROTECTING DATA USED IN CONNECTION WITH THE BUNDLED PRODUCT. EXCEPT AS ABOVE SET FORTH, DIVERSINET SHALL NOT BE RESPONSIBLE FOR LOST DATA, RERUN TIME, INACCURATE INPUT, WORK DELAYS OR LOST PROFITS, LOSS OF SECURITY FOR PROPRIETARY DATA OR ANY OTHER INJURIES OR DAMAGES RESULTING FROM USE OF THE BUNDLED PRODUCT. Neither Diversinet, nor its subsidiaries, nor their respective directors, officers, employees, agents, assignees, co-developers, servants and contractors, nor the Reseller has any right to make any other representation, warranty or promise of any kind with respect to any of the Products. This Agreement does not, in itself, grant any patent license or patent right of any manner or kind. Reseller will be solely responsible for determining which patent rights it may need to use the Products and for obtaining such licenses, where applicable. So long as the terms of this agreement are respected, Diversinet agrees that it will not bring any suit, claim or demand against Reseller, its Customers or End-Users for breach of Diversinet's patent rights in the Products, if any. 5. Limitation of Liability and Damages (a) EXCEPT TO THE EXTENT DIRECT FORESEEABLE DAMAGES, IN NO EVENT SHALL DIVERSINET BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING WITHOUT LIMITATION ANY COMMERCIAL DAMAGES OR LOSSES) AS A RESULT OF THE USE, SALE OR DISTRIBUTION OF THE BUNDLED PRODUCT, WHETHER BY WAY OF A LEGAL THEORY OF CONTRACT, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY, STRICT LIABILITY, OR ANY OTHER THEORY, EVEN IF DIVERSINET HAS BEEN INFORMED OF THE POSSIBILITY OF SUCH DAMAGES. (b) RESELLER WAIVES ANY RIGHT IT MAY HAVE TO RECEIVE ANY COMPENSATION OR REPARATIONS ON TERMINATION OR EXPIRATION OF THIS AGREEMENT UNDER THE LAW OF THE TERRITORY OR OTHERWISE, OTHER THAN AS EXPRESSLY PROVIDED IN THIS AGREEMENT. THE PARTIES ACKNOWLEDGE THAT THIS SECTION HAS BEEN INCLUDED AS A MATERIAL INDUCEMENT FOR DIVERSINET TO ENTER INTO THIS AGREEMENT AND THAT DIVERSINET WOULD NOT HAVE ENTERED INTO THIS AGREEMENT BUT FOR THE LIMITATIONS OF LIABILITY AS SET FORTH HEREIN. (c) The availability of the MobiSecure\u2122 Strong Authentication service depends on many factors, including Customer's connection to the Internet, End Users' connection to the Internet, the availability of the Internet and the Internet backbone and equipment that, by its nature, is not fault tolerant. Diversinet does not and cannot control the flow of data to or from Diversinet's network and other portions of the Internet. Such flow depends in large part on the performance of Internet services provided or controlled by third parties. At times, actions or inaction of such third parties can impair or disrupt Customers' connections to the Internet (or portions thereof). Although Diversinet will use commercially reasonable efforts to take all actions it deems appropriate to remedy and avoid such events, Diversinet cannot guarantee that such events will not occur. Accordingly, Diversinet shall have no responsibility for any failure to meet the requirements hereunder, with respect to performance issues, including without limitation: (i) caused by factors outside of Diversinet's reasonable control; (ii) that result from any actions or omissions of Customers, End Users or any third parties; (iii) that result from Customers' equipment and/or third party equipment (not within the sole control of Diversinet); (iv) caused by any act or failure to act by Customer or as a result of any Third Party Software. (d) NOTWITHSTANDING THE ABOVE, IN NO EVENT SHALL DIVERSINET'S LIABILITY RELATING TO THIS AGREEMENT (OR THE BUNDLED PRODUCT) EXCEED ONE HUNDRED PERCENT (100%) OF THE AGGREGATE AMOUNT OF THE LICENSE FEES, ROYALTIES AND SUPPORT FEES PAID BY RESELLER IN THE TWELVE (12) MONTH PERIOD PRECEDING THE EVENT OR CIRCUMSTANCE GIVING RISE TO THE ALLEGED LIABILITY ON THE PART OF DIVERSINET. (e) The limitations set forth in Section 15(a), (b), (c), (d) and (e) shall not apply in respect of (i) breach of confidentiality obligations; (ii) breach of privacy provisions as detailed in Schedule 6; (iii) the intellectual property indemnity; (iv) any Abandonment committed by Diversinet; or (v) any willful gross misconduct (including fraud). \\\"Abandonment\\\" means Diversinet's cessation or suspension of, or refusal to perform, its obligations under this Agreement, and such cessation, suspension or refusal (i) was knowingly intended by Diversinet to cause harm to Reseller, and (ii) was not the result of a termination of this Agreement by Diversinet in accordance with Section 4 (Termination). 1. Indemnification (a) Reseller Indemnity. Reseller shall indemnify and hold harmless Diversinet and/or any of its directors, officers, agents, employees, contractors, parent companies, affiliates, and/or subsidiaries (collectively, the \\\"Diversinet Parties\\\") from and against any claim, suit or proceeding by a third party based on or arising out of (i) the acts or omissions of Reseller in connection with its performance or failure to perform any other obligations in this Agreement or any agreement with a Customer, and (ii) any unauthorized representation or any misrepresentation of fact to any third party with respect to one or more of the Diversinet Parties or Products made by Reseller or any director, officer, agent, or employee of Reseller, provided that: (i) Diversinet promptly notifies Reseller in writing of any such claim and Reseller has sole control of any related investigation, defense and settlement negotiations; and (ii) Diversinet fully cooperates with Reseller, at Reseller's expense, in defending or settling such claim. (b) Infringement Indemnity. Diversinet shall diligently defend, indemnify and hold Reseller harmless, at its own expense, any action, loss, cost or expense brought against Reseller to the extent that it is based upon a claim that Reseller's use of the unmodified Products as permitted herein infringes upon a third party's intellectual property rights, and will pay the resulting costs, damages and legal fees finally awarded against Reseller through settlement, judgment, arbitration, mediation or otherwise in such action that are attributable to such claim, provided that: (i) Reseller promptly notifies Diversinet in writing of any such claim under patent law and Diversinet has sole control of any related investigation, defense and settlement negotiations; and (ii) Reseller fully cooperates with Diversinet, at Diversinet's expense, in defending or settling such claim. (c) Should any of the Products become, or in Diversinet's sole opinion is likely to become, the subject of any third party intellectual property infringement claim, Reseller shall permit Diversinet, at Diversinet's sole option and expense, to: (i) procure for Reseller the right to continue to use such Product; or (ii) modify such Product so that it becomes non-infringing; (d) Diversinet shall have no liability for any claim based upon: (i) use of other than a current or the last prior release to the current unaltered version of the Products; or (ii) use, operation or combination of the Products with non-Diversinet programs, data, equipment or documentation in a manner not reasonably contemplated by this Agreement, if such infringement would have been avoided but for such uses, operation, or combination; or (iii) Reseller's or its agent's activities after Diversinet has notified Reseller that such use may result in infringement provided that the Reseller has been provided with access to an updated version that would not be infringing. (e) THE FOREGOING STATES OUT THE ENTIRE LIABILITY OF DIVERSINET, AND THE SOLE AND EXCLUSIVE REMEDY OF RESELLER AND END-USER, WITH RESPECT TO THE INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS BY THE PRODUCTS. 2. Escrow Agreement The Parties agree to execute an escrow agreement, within 90 days of the Effective Date, with a nationally recognized escrow agent with respect to the source code for the Products and name Reseller as a beneficiary. Diversinet will then immediately send a copy of the escrow agreement to Reseller for its counter-signature. Diversinet shall, at least annually, deposit the source code in the escrow account. Costs associated with the escrow agreement shall be borne by Reseller. Reseller will be provided with a copy of any deposit correspondence and escrow agent's acceptance thereof. The escrow agreement shall provide, among other terms, that the source code shall be released to Reseller if any of the following events (collectively the \\\"Release Conditions\\\") occurs: (i) Diversinet ceases to support services at levels as stated in Schedule 5 under this Agreement that is not remedied within sixty (60) days after receipt of written notice of such failure; (ii) Diversinet makes an assignment for the benefit of creditors, or becomes subject to direct control of a trustee, receiver or similar authority, or Diversinet becomes subject to any bankruptcy or insolvency proceeding under federal or state statutes; or (iii) Diversinet suspends or ceases to carry on its business and a receiver, trustee or assignee does not carry on the business. 3. Non-Solicitation During the Term, the Reseller agrees that it shall not induce any person employed by Diversinet to leave Diversinet's employ to become an employee of Reseller or its agents or contractors. 4. Relationship Nothing in this Agreement shall be construed so as to create a joint venture, partnership, employer/employee, franchisor/franchisee or principal/agent relationship between the Parties. Reseller and Diversinet are independent contracting parties. Neither Reseller nor its employees, consultants, contractors or agents have any authority to bind Diversinet by contract or otherwise to any obligation. 5. Choice of Forum This Agreement shall be governed by the laws of the province of Ontario, Canada, without regard to its conflict of laws principles. Any litigation or other dispute resolution between the Parties relating to this Agreement or its construction shall take place in the courts of Toronto, Ontario, Canada. The Parties consent to the personal jurisdiction of, and venue in, the provincial and federal courts therein. The Parties agree that the United Nations Convention on Contracts for the International Sale of Goods shall not apply to this Agreement. No action against Diversinet regardless of form, including negligence, arising out of any claimed breach of this Agreement or transactions under this Agreement may be brought by Reseller more than two years after the cause of action has accrued. 6. Assignment Without the express prior written consent of Diversinet (not to be unreasonably refused), Reseller may not assign this Agreement or its interest herein in whole or in part but Reseller shall continue to be responsible should the assignee fail to perform. Diversinet may assign this Agreement at any time and in such event, this Agreement shall continue in full force and effect as if the assignee were named as the licensor in the first instance but Diversinet shall continue to be responsible should the assignee fail to perform. This Agreement shall be binding upon and inure to the benefit of the successors and permitted assigns of the Parties. 7. Interpretation This Agreement, including all Schedules, attachments and addenda, is the entire agreement constituting the complete and exclusive statement of the terms and conditions between the Parties with respect to the subject matter hereof, and cancels and supersedes all previous negotiations, commitments, writings and agreements that the Parties may have entered into. The Parties acknowledge that they have read this Agreement, understand it and agree to be bound by its terms and conditions. Except for Diversinet's unilateral right to update certain Schedules as specifically set out in such Schedules, any subsequent waiver or modification of this Agreement or any part hereof shall only be effective if in writing and signed by both Parties. No delay or failure to enforce any right under this Agreement shall be considered a waiver of that Party's rights to thereafter enforce each and every right and provision of this Agreement. In addition, headings set out in this Agreement are an organizational aid, not a substantive part of this Agreement, and are not intended to limit or expand the language of each section. Any person signing this Agreement (or any later modifications or addenda) on behalf of Reseller warrants that he or she has the authority to bind Reseller. Time shall be of the essence of this Agreement. 8. Attorney Fees The prevailing Party (as determined by the finder of fact) in any law suit or other dispute resolution to enforce or interpret any part of this Agreement shall be entitled to recover, as a costs of suit, reasonable attorney's fees as determined by the finder of fact (including, but not limited to, costs, expenses and fees on appeal). 9. Severability If any part of this Agreement shall be found invalid or unenforceable by a court of competent jurisdiction, said portion shall be severed from the Agreement, and the remainder shall be interpreted so as to reasonably effect the intention of the Parties. Any limitation of liability, disclaimer of warranties and exclusion of damages set out in this Agreement are expressly intended to exist independently from, and to be severable from, this Agreement. 10. Force Majeure Neither Party shall in any circumstances be liable to the other for any loss of any kind whatsoever including, but not limited to, any damages or abatement of charges whether directly or indirectly caused to or incurred by the other Party by reason of any failure or delay in the performance of its obligations hereunder which is due to circumstances beyond the reasonable control of the affected Party, including, without limitation, acts of God, acts of terrorism, fire, flood, strike, labour disputes, civil, commercial sabotage, statute order or any regulation of any government public or local authority. 11. Compliance with Laws The Products include software (\\\"Software\\\") that is commercial computer software developed at private expense, and in all respects is proprietary data belonging solely to Diversinet or its suppliers. Reseller shall comply with all applicable export and import control and other relevant laws of any applicable jurisdiction. Determination of the applicable law is Reseller's responsibility. Reseller understands that the Products utilize cryptographic products that are highly regulated. 12. Publicity The Parties shall use commercially reasonable efforts to issue a joint press release concerning this Agreement after the execution hereof. Any further use of the other Party's name or logo in any publicity materials is prohibited without such other Party's prior written consent, which consent shall not be unreasonably withheld. 13. Notices Any notice, demand, or communication between the Parties shall be deemed given and received: (i) when personally delivered; (ii) when transmitted by facsimile with proof of transmittal; or (iii) five (5) days after deposit (properly addressed with postage prepaid) with the postal service for registered/certified mail. The addresses and contact information may be changed at any time by giving written notice as allowed under this section. Reseller's address and contact information are as set out in Schedule 1. Address and contact information for Diversinet are as follows: Diversinet Corp. Attention: Chief Financial Officer 2235 Sheppard Avenue East, Suite 1700 Toronto, Ontario, Canada M2J 5B5 Phone: 416-756-2324 Fax: 416-756-7346 14. Survival Any terms or conditions of this Agreement by which obligations of either Party are expressed to be applicable or which extend or may extend beyond termination of this Agreement shall survive the expiration or termination hereof. 15. Language This Agreement shall be interpreted consistent with its English linguistic construction, and all communications between the Parties shall be deemed to be conducted in the English language. Reseller will be responsible, at its own cost and expense, for any language and documentation localization for the Territory. 16. Counterparts This Agreement may be executed in two or more counterparts, by original or facsimile transmission, each of which so executed shall be deemed to be an original and such counterparts together shall constitute one and the same document. IN WITNESS WHEREOF the Parties have signed this Agreement, as of the date first written above, by their duly authorized representatives. 2205925 Ontario Limited DIVERSINET CORP. Signature:__________________________________ Signature:__________________________ Print Name: Dr. Wendy Graham Print Name: Albert Wahbe Title: President Title: CEO\"}}, {\"id\": \"Schedule 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller Information\", \"level\": 1, \"text\": \"Schedule 1 Reseller Information # Date Signed_________________________________ Date Signed________________________ Name 2205925 Ontario Limited Street Address 111 Main Street West, Suite 304 City North Bay, ON Country Canada Zip/Postal Code P1B 2T6 Billing Address (if different from above) Shipping Address (if different from above) Telephone Facsimile Person Signing Contract Dr. Wendy Graham E-mail Address drgraham@vianet.ca Primary Technical Support Contact Address and Contact Information for Notice section in the Agreement\"}}, {\"id\": \"Schedule 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Products Unless otherwise agreed to by the Parties, the Products shall mean the following: 1. MobiSecure\u00ae Wallet and Vault MobiSecure\u00ae Vault server allows subscribers to securely store and manage their personal data and other information, select the information to be downloaded to their mobile devices and share it with others via email, fax or SMS messaging. The MobiSecure\u00ae Vault server is designed to host and manage a variety of different types of personal information e.g. financial, health, identities and passwords. It provides a framework for administrators to define and customize the information to be hosted and managed and supports a plug-in architecture and web service interfaces to allow for rapid integration with external information, payment and messaging systems. MobiSecure\u00ae Wallet application works in conjunction with the MobiSecure\u00ae vault server. It is designed to run on desktop computers and mobile platforms including Java based phones, RIM Blackberries\u00ae, Microsoft Windows Mobile\u00ae, iPhone, Android and BREW devices. The Wallet application provides offline and online access to personal information. Information is stored in the device for instant and offline access securely using a patented technique. The information is synchronized automatically or upon user's request with the vault server using a secure data synchronization protocol. Users may use the wallet application to access their information instantly when they are traveling, retrieve additional information from the vault server or send their information to others via email, SMS or fax. The wallet application includes an embedded software One-Time-Password (OTP) token to allow for secure and easy access to the vault server using dynamic password based authentication. The MobiSecure\u00ae Wallet SDK and MobiSecure\u00ae Vault API allows customers and third party developers to build secure mobile applications by leveraging Diversinet's Wallet secure container services. Applications features and benefits (utilizing Wallet and Vault) include: Patient Portal The Patient Portal is a set of web pages designed to permit patients to display, add, delete and update information pertaining to their demographics, attending physicians, chronic conditions, allergies, immunizations and messages received from registered doctors and clinical staff. The Physician's Tool This is a windows based application which permits doctors and authorized 'circle of care' workers to access patient records stored in the information repository. These users may add, delete or update the patient records and may also 'Validate' existing records. Validation consists of marking the records as 'Validated' and making them read only from that point to maintain record values that the physician has agreed to by validating the record. The Physician's Tool also can create and display secured messages to the patient which will be protected by the Diversinet MobiSecure\u00ae Health platform. The tool can also display a complete record of messages sent to the patient with associated time and date of acknowledgment from the patient. The administrator users of the tool can also add and delete doctors and other circle of care worker accounts in order to administer the operation of the clinical side of the Diversinet Platform. Message Manager The Message Manager is a tool used to collect and display incoming patient messages to the clinic and answer's to previously sent questions from the clinic. The Message Manager permits the user to prepare reply messages as well as automatically preparing an audit trail of all display and reply activities. Message Generator The Message Generator is an extension of the messaging tool in the Physician's Tool above, used to create user reminder messages based upon reminder criteria and the user records in the repository for recurring action requirements. Examples include recurring tests (i.e. PAP, colonoscopy, recurring blood work supporting medications), reminders about health and lifestyle choices, medication reminders.) 2. MobiSecure\u00ae Strong Authentication MobiSecure\u00ae Strong Authentication is a fully automated, OATH-standards based strong authentication server product. It is available as a fully configured appliance or a packaged software product and is designed to be easy to deploy and easy to use for high-volume Internet or wireless- based strong authentication. Its supported clients operate on mobile phones, personal computers, USB stick and can also be embedded into microchip or smart card technologies. The system supports Over-the-Air and Over-the-Web MobiSecure SoftToken delivery. The same system also supports the MobiSecure Validation Server for ongoing one-time password (OTP) validation for user authentication. MobiSecure Strong Authentication components are: The MobiSecure\u00ae Strong Authentication Platform contains the following components: 1. MobiSecure Provisioning Server 2. MobiSecure Validation Server 3. MobiSecure SMS Server 4. MobiSecure Registration/Administration Server 5. MobiSecure SoftToken Client MobiSecure\u00ae SoftToken: MobiSecure SoftToken is a client-side software token that is available as a Mobile SoftToken or as PCToken. It can be easily delivered, downloaded and embedded into a user's personal computer, PDA or mobile phone. It performs basic functions for managing and generating one-time password values. The client-side software token is easily delivered, downloaded and installed into a user's device. MobiSecure\u00ae SoftToken supports both time based and event based one-time passwords. Event based one-time passwords expire once they are used and are no longer valid. Time based one-time passwords expire once they are used or the valid time period elapses, whichever comes first. MobiSecure\u00ae SoftToken can be embedded into customer client applications using SDK's for mobile platforms and Windows PC. Key features of\", \"level\": 1, \"text\": \"Schedule 2 Products Unless otherwise agreed to by the Parties, the Products shall mean the following: 1. MobiSecure\u00ae Wallet and Vault MobiSecure\u00ae Vault server allows subscribers to securely store and manage their personal data and other information, select the information to be downloaded to their mobile devices and share it with others via email, fax or SMS messaging. The MobiSecure\u00ae Vault server is designed to host and manage a variety of different types of personal information e.g. financial, health, identities and passwords. It provides a framework for administrators to define and customize the information to be hosted and managed and supports a plug-in architecture and web service interfaces to allow for rapid integration with external information, payment and messaging systems. MobiSecure\u00ae Wallet application works in conjunction with the MobiSecure\u00ae vault server. It is designed to run on desktop computers and mobile platforms including Java based phones, RIM Blackberries\u00ae, Microsoft Windows Mobile\u00ae, iPhone, Android and BREW devices. The Wallet application provides offline and online access to personal information. Information is stored in the device for instant and offline access securely using a patented technique. The information is synchronized automatically or upon user's request with the vault server using a secure data synchronization protocol. Users may use the wallet application to access their information instantly when they are traveling, retrieve additional information from the vault server or send their information to others via email, SMS or fax. The wallet application includes an embedded software One-Time-Password (OTP) token to allow for secure and easy access to the vault server using dynamic password based authentication. The MobiSecure\u00ae Wallet SDK and MobiSecure\u00ae Vault API allows customers and third party developers to build secure mobile applications by leveraging Diversinet's Wallet secure container services. Applications features and benefits (utilizing Wallet and Vault) include: Patient Portal The Patient Portal is a set of web pages designed to permit patients to display, add, delete and update information pertaining to their demographics, attending physicians, chronic conditions, allergies, immunizations and messages received from registered doctors and clinical staff. The Physician's Tool This is a windows based application which permits doctors and authorized 'circle of care' workers to access patient records stored in the information repository. These users may add, delete or update the patient records and may also 'Validate' existing records. Validation consists of marking the records as 'Validated' and making them read only from that point to maintain record values that the physician has agreed to by validating the record. The Physician's Tool also can create and display secured messages to the patient which will be protected by the Diversinet MobiSecure\u00ae Health platform. The tool can also display a complete record of messages sent to the patient with associated time and date of acknowledgment from the patient. The administrator users of the tool can also add and delete doctors and other circle of care worker accounts in order to administer the operation of the clinical side of the Diversinet Platform. Message Manager The Message Manager is a tool used to collect and display incoming patient messages to the clinic and answer's to previously sent questions from the clinic. The Message Manager permits the user to prepare reply messages as well as automatically preparing an audit trail of all display and reply activities. Message Generator The Message Generator is an extension of the messaging tool in the Physician's Tool above, used to create user reminder messages based upon reminder criteria and the user records in the repository for recurring action requirements. Examples include recurring tests (i.e. PAP, colonoscopy, recurring blood work supporting medications), reminders about health and lifestyle choices, medication reminders.) 2. MobiSecure\u00ae Strong Authentication MobiSecure\u00ae Strong Authentication is a fully automated, OATH-standards based strong authentication server product. It is available as a fully configured appliance or a packaged software product and is designed to be easy to deploy and easy to use for high-volume Internet or wireless- based strong authentication. Its supported clients operate on mobile phones, personal computers, USB stick and can also be embedded into microchip or smart card technologies. The system supports Over-the-Air and Over-the-Web MobiSecure SoftToken delivery. The same system also supports the MobiSecure Validation Server for ongoing one-time password (OTP) validation for user authentication. MobiSecure Strong Authentication components are: The MobiSecure\u00ae Strong Authentication Platform contains the following components: 1. MobiSecure Provisioning Server 2. MobiSecure Validation Server 3. MobiSecure SMS Server 4. MobiSecure Registration/Administration Server 5. MobiSecure SoftToken Client MobiSecure\u00ae SoftToken: MobiSecure SoftToken is a client-side software token that is available as a Mobile SoftToken or as PCToken. It can be easily delivered, downloaded and embedded into a user's personal computer, PDA or mobile phone. It performs basic functions for managing and generating one-time password values. The client-side software token is easily delivered, downloaded and installed into a user's device. MobiSecure\u00ae SoftToken supports both time based and event based one-time passwords. Event based one-time passwords expire once they are used and are no longer valid. Time based one-time passwords expire once they are used or the valid time period elapses, whichever comes first. MobiSecure\u00ae SoftToken can be embedded into customer client applications using SDK's for mobile platforms and Windows PC. Key features of the MobiSecure\u00ae Strong Authentication Toolkit are listed below: 1. Lightweight library allows for a modular implementation- use only the components you need 2. Client API available in C and Java programming languages for software clients a. Allows organizations to develop their own clients or integrate with existing applications b. DLL provided for rapid development on Microsoft Windows platform 3. Server API a. SPML interface for integrating enterprise applications b. SPML Java client libraries for rapid integration c. Free Radius interface to OTP Validation Server 3. MobiSecure\u00ae SMS Messaging MobiSecure\u00ae SMS Messaging leverages the familiarity and popularity of SMS messaging to create a secure messaging solution that utilizes state of the art AES encryption technology to securely transmit and receive SMS messages. Messages can be both 1-Way (Push) based and 2-Way (Pull or Push-Pull) based between mobile users and backend server applications. Unlike traditional SMS service, MobiSecure\u00ae SMS Messaging subscribers will automatically receive message delivery and read confirmations on their mobile device. The MobiSecure\u00ae SMS Messaging solution offers a fully integrated secure gateway environment. This simplifies and eliminates extensive integration efforts with multiple gateways globally. High-level APIs, allow for the submission of text messages from a third party application or directly from the handset itself.\"}}, {\"id\": \"Schedule 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Territory, Sales Targets, Prices and Discount Annual Minimum Commitment (\\\"Annual Minimum Commitment\\\" or \\\"AMC\\\"). During the Term of the Agreement, Reseller shall pay to Diversinet an Annual Minimum Commitment, payable as follows: a) A total of four hundred thousand ($400,000) dollars shall be paid by Reseller to Diversinet as of the Effective Date. b) A total of seven hundred thousand ($700,000) dollars shall be paid by Reseller in quarterly instalments of $175,000 to Diversinet on each of December 1, 2011, March 1, 2012, June 1, 2012 and September 1, 2012. c) A total of one million ($1,000,000) dollars shall be paid by Reseller in quarterly instalments of $250,000 to Diversinet on each of December 1, 2012, March 1, 2013, June 1, 2013 and September 1, 2013. d) A total of one million three hundred thousand ($1,300,000) dollars shall be paid by Reseller in quarterly instalments of $325,000 to Diversinet on each of December 1, 2013, March 1, 2014, June 1, 2014 and September 1, 2014. e) A total of one million six hundred thousand ($1,600,000) dollars shall be paid by Reseller in quarterly instalments of $400,000 to Diversinet on each of December 1, 2014, March 1, 2015, June 1, 2015 and September 1, 2015. AMC Tokens. For each contract year that the AMC applies, Diversinet shall deliver to Reseller the number of End User licenses equal to the contract year AMC divided by twenty-four (24) in satisfaction of the AMC. For the first contract year, the applicable service license fees for the Mihealth pilot production shall be deducted from the AMC. There is no carryover of the AMC from one year to the next. AMC Termination. After the first year and upon 180 days written notice, Reseller may terminate the AMC. Termination of the AMC by Reseller shall eliminate any exclusivity of the Reseller in the Territory. Territory Assuming that the AMC amounts have been paid and the Reseller has not terminated the AMC, Reseller shall have the exclusive right to contract with Canadian head quartered companies and governmental and broader public sector entities located in Canada (the \\\"Territory\\\"). Furthermore, Reseller will have the non-exclusive right to contract in the rest of the world, excluding the United States. Sales Targets After AMC termination, Reseller shall generate at least the following amount of new sales of the Products in each contract year (for the purpose of this Schedule 3, a contract year shall be each 12-month period commencing after the termination by Reseller of the AMC). New sales are defined as the aggregate amount of all Product sales and Support Fees paid by Reseller pursuant to pricing set out below, inclusive of any applicable discounts and exclusive of applicable taxes. If Diversinet materially reduces Reseller's Territory, the Parties shall negotiate and, acting reasonably, adjust Reseller's sales targets. Contract Year 1: $750,000 (quarterly targets at \u00bc of annual amount) Contract Year 2: $1,000,000 (quarterly targets at \u00bc of annual amount) Contract Year 3: $1,250,000 (quarterly targets at \u00bc of annual amount) Contract Year 4 onward: $1,500,000 (quarterly targets at \u00bc of annual amount) Product Prices and Discount: Diversinet maintains a product price list that details the products available and the list price. The product price list is incorporated by reference to this Agreement. The Product List Price is subject to change by Diversinet upon provision of at least thirty (30) days' written notice to Reseller. Reseller shall be entitled to the following discount to the following Diversinet's standard pricing: Discount % For annual revenues < $1m 30% For annual revenues > $1m and <$2m 40% For annual revenues > $2m 50% Product Price List Terms and Conditions \u00ff Price proposals are valid for 30 days and subject to change by Diversinet at its sole discretion \u00ff All prices are expressed in United States dollars \u00ff Prices do not include any applicable taxes \u00ff Prices do not include shipping and additional charges \u00ff Support and maintenance fees are 20% of the server license fee, payable annually in advance after the first year and include: patch, maintenance and major release updates, Diversinet online technical support and email/phone technical product support from Monday- Friday, 9:00a.m.-5:00p.m., excluding statutory holidays \u00ff Optional maintenance and level 2 support and training is available at $1,500 per person day (excluding travel and out-of-expenses) \u00ff Professional services are available at $1,500 per person day (excluding travel and out-of-expenses) SCHEDULE 4\", \"level\": 1, \"text\": \"Schedule 3 Territory, Sales Targets, Prices and Discount Annual Minimum Commitment (\\\"Annual Minimum Commitment\\\" or \\\"AMC\\\"). During the Term of the Agreement, Reseller shall pay to Diversinet an Annual Minimum Commitment, payable as follows: a) A total of four hundred thousand ($400,000) dollars shall be paid by Reseller to Diversinet as of the Effective Date. b) A total of seven hundred thousand ($700,000) dollars shall be paid by Reseller in quarterly instalments of $175,000 to Diversinet on each of December 1, 2011, March 1, 2012, June 1, 2012 and September 1, 2012. c) A total of one million ($1,000,000) dollars shall be paid by Reseller in quarterly instalments of $250,000 to Diversinet on each of December 1, 2012, March 1, 2013, June 1, 2013 and September 1, 2013. d) A total of one million three hundred thousand ($1,300,000) dollars shall be paid by Reseller in quarterly instalments of $325,000 to Diversinet on each of December 1, 2013, March 1, 2014, June 1, 2014 and September 1, 2014. e) A total of one million six hundred thousand ($1,600,000) dollars shall be paid by Reseller in quarterly instalments of $400,000 to Diversinet on each of December 1, 2014, March 1, 2015, June 1, 2015 and September 1, 2015. AMC Tokens. For each contract year that the AMC applies, Diversinet shall deliver to Reseller the number of End User licenses equal to the contract year AMC divided by twenty-four (24) in satisfaction of the AMC. For the first contract year, the applicable service license fees for the Mihealth pilot production shall be deducted from the AMC. There is no carryover of the AMC from one year to the next. AMC Termination. After the first year and upon 180 days written notice, Reseller may terminate the AMC. Termination of the AMC by Reseller shall eliminate any exclusivity of the Reseller in the Territory. Territory Assuming that the AMC amounts have been paid and the Reseller has not terminated the AMC, Reseller shall have the exclusive right to contract with Canadian head quartered companies and governmental and broader public sector entities located in Canada (the \\\"Territory\\\"). Furthermore, Reseller will have the non-exclusive right to contract in the rest of the world, excluding the United States. Sales Targets After AMC termination, Reseller shall generate at least the following amount of new sales of the Products in each contract year (for the purpose of this Schedule 3, a contract year shall be each 12-month period commencing after the termination by Reseller of the AMC). New sales are defined as the aggregate amount of all Product sales and Support Fees paid by Reseller pursuant to pricing set out below, inclusive of any applicable discounts and exclusive of applicable taxes. If Diversinet materially reduces Reseller's Territory, the Parties shall negotiate and, acting reasonably, adjust Reseller's sales targets. Contract Year 1: $750,000 (quarterly targets at \u00bc of annual amount) Contract Year 2: $1,000,000 (quarterly targets at \u00bc of annual amount) Contract Year 3: $1,250,000 (quarterly targets at \u00bc of annual amount) Contract Year 4 onward: $1,500,000 (quarterly targets at \u00bc of annual amount) Product Prices and Discount: Diversinet maintains a product price list that details the products available and the list price. The product price list is incorporated by reference to this Agreement. The Product List Price is subject to change by Diversinet upon provision of at least thirty (30) days' written notice to Reseller. Reseller shall be entitled to the following discount to the following Diversinet's standard pricing: Discount % For annual revenues < $1m 30% For annual revenues > $1m and <$2m 40% For annual revenues > $2m 50% Product Price List Terms and Conditions \u00ff Price proposals are valid for 30 days and subject to change by Diversinet at its sole discretion \u00ff All prices are expressed in United States dollars \u00ff Prices do not include any applicable taxes \u00ff Prices do not include shipping and additional charges \u00ff Support and maintenance fees are 20% of the server license fee, payable annually in advance after the first year and include: patch, maintenance and major release updates, Diversinet online technical support and email/phone technical product support from Monday- Friday, 9:00a.m.-5:00p.m., excluding statutory holidays \u00ff Optional maintenance and level 2 support and training is available at $1,500 per person day (excluding travel and out-of-expenses) \u00ff Professional services are available at $1,500 per person day (excluding travel and out-of-expenses) SCHEDULE 4 CUSTOMER TERMS & CONDITIONS Reseller agrees to include terms and conditions in its Customer agreements that are reflective of the following: (a) the Customer is granted a non-exclusive, non-transferable and non-assignable right to use the Products solely for their intended use; (b) the Customer may not reverse engineer, decompile, alter, transfer, modify or create a derivative work of the Product; (c) no ownership rights to the Products and documentation are transferred to the Customer; (d) the Customer may not use the Products otherwise than as a part of the equipment, hardware or software in which any Product has been incorporated or for which it has been delivered; (e) the Customer may not remove any proprietary, copyrights, trade secret or warning legend from any Products or documentation or copies thereof; (f) the Customer may not furnish the Products or documentation into any country in violation of any export control laws or regulations. The Reseller's agreements with its Customers shall also contain disclaimers of warranties and limitations of liabilities with respect to the Products and documentation at least as restrictive as those set forth in this Agreement. SCHEDULE 5 Service Level Agreement 1. Overview. This Support Plan Schedule (\\\"SLA\\\") details the terms for technical support provided by Diversinet during the term of this Agreement to the Reseller's Technical Support team, provided however, Reseller is current with payment of all fees. The Reseller's Subscribers shall interface with the Reseller Technical Support only. The Reseller Technical Support shall escalate product issues of a certain severity and above to Diversinet Technical Support. This SLA specifically addresses: (i) the service levels definition, measurement and minimum service standard in effect for the product, and (ii) technical support definition, availability and response timeframes. 1.1 Reseller Technical Support Escalation Path Around Product Issues 1.a.1 Subscriber call arrives at the Reseller Level 1 Support: the Reseller Level 1 Support will open a trouble ticket and attempt to resolve the issue. If no resolution, trouble ticket escalates to the Reseller Level 2 Support. 1.a.2 Level 2 Support attempts to resolve the Subscriber trouble ticket utilizing documentation, tools and procedures provided with the product. If Level 2 Support can't resolve the problem, Level 2 shall make a judgment call as to whether this appears to be a Subscriber problem or a Diversinet product related problem. Level 2 will escalate the trouble ticket to the Reseller Engineering Maintenance and Escalations. (EME). 1.a.3 The Reseller's EME will investigate. If this is indeed a Subscriber related problem, EME will be responsible for resolution. If EME determines this is actually a Diversinet Software issue, EME will send the trouble ticket back to Level 2 for dispatch to Diversinet. Level 2 Support will escalate the trouble ticket to Diversinet for resolution. Level 2 Technical Support still owns the Subscriber relationship. Anyone in Reseller Level 2 Technical Support can escalate to Diversinet. 1. Diversinet Support Service Availability. Technical Support Availability. Diversinet Technical Support will be available to accept and respond to problem calls or email from Reseller's Technical Support from 9:00 am - 5:00 pm Eastern Standard Time (US), 5 days a week (Monday through Friday), 52 weeks a year, excluding United States and Canadian national holidays. During such hours, technical support calls or email will be answered immediately by the support staff. Diversinet will provide a phone option to speak directly to a trained technical support representative. Diversinet will make the reasonable commercial effort to answer promptly to calls. 2.1 Diversinet Contact information\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller Contact information\", \"level\": 2, \"text\": \"2.2 Reseller Contact information\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Response Time \\\"Response Time\\\" shall mean the time it takes to respond to a request specific to the Severity (defined be\", \"level\": 2, \"text\": \"2.3 Response Time \\\"Response Time\\\" shall mean the time it takes to respond to a request specific to the Severity (defined below) of the incident as described below. In the event the response time is not met the incident shall be escalated as described below. Escalation of Incident: Definitions of Severity levels Severity 1 Problems. Severity 1 Problems generally include any events that have a significant impact on the operations of the system and have an impact on Subscribers' use of the Software, such as: \u00ff Designation Name (if applicable) Direct Tel. No Cell Tel E-Mail Technical Support N/A 416 756 2324 x 300 N/A support@diversinet.com Technical Support & Escalation Manager Charles Blair 416 756 2324 x 234 416 562 1773 cblair@diversinet.com TS VP David Annan 416 756 2324 x 232 416 587 0108 dannan@diversinet.com Designation Name (if applicable) Direct Tel. No Cell Tel E-Mail Technical Support & Escalation Manager TS VP System or application is down or unavailable; transactions can't be processed. \u00ff Any event that significantly disrupts or threatens to disrupt service levels of the Software due to errors in the software, tools or system configuration provided by Diversinet. \u00ff Any online application outage that significantly impacts the online availability and service level of the Software. \u00ff Consistent degradation of performance (response time or function) that significantly impairs the Software. \u00ff Any repeating unresolved incidents that have significant impact on the operations of the Diversinet Based Service or Subscribers' use of the Software. \u00ff Resolution may involve software changes, configuration modifications, operating procedure changes or 'workarounds'. Resolution shall be defined as a situation wherein the system is restored to a state wherein the effective outage is relieved. Severity 2 Problems. Severity 2 Problems generally includes any events (other than Severity 1 Problems) that adversely affect the operation of the Diversinet Based Service or the User Software, such as: \u00ff An error that disables only certain non-essential functions of the User Software and may result in degraded operations, including without limitation, an error that results in computer transactions not processing properly. \u00ff An error/event that disables only non-essential functions of the User Software, but also adversely affects the use of the User Software. \u00ff Resolution may involve software changes, configuration modifications, operating procedure changes or 'workarounds'. Resolution shall be defined as a situation wherein the system is restored to a state wherein the effective outage is relieved. Severity 3 Problems: Severity 3 Problems generally includes minor events that do not have a significant impact or adverse effect on the operation or performance of the Diversinet Based Service or the User Software. Severity 4 Problems: Severity 4 Problems generally are potential Software enhancements or feature requests that Subscribers request of Reseller Technical Support. This is to help Diversinet track Reseller's requests and process them appropriately. Problem Isolation: Diversinet Technical Support will provide best efforts to mitigate all service affecting conditions which may arise. For each S1 - S3 incident Diversinet will produce an Incident Report provided to Reseller. Situations where there are unapproved variations made in the approved design, configuration, network or systems environments are not covered under this SLA. Furthermore, this SLA does not cover problems encountered by end users relating to hand held devices hardware, software and network problems that are outside the control of Diversinet or not supported by Diversinet. Diversinet will inform/publish to Reseller a quarterly list of mobile devices, related software and network operators and telecommunication companies that can support Diversinet software, products and services. Resolution Target: Diversinet will commit to provide a resolution to problems caused by its software, tools or procedures. Every effort will be made to prevent maintenance procedures during Scheduled Maintenance Times from affecting service availability. Table 1: Escalation Tiers and Initial Response Times # Priority Level Technical Support Initial Response (in Hours) Escalation to Manager (in Hours) Escalation to VP (in Hours) S1 1 2 3 S2 2 4 24 S3 4 8 48 S4 Next Business Day\"}}, {\"id\": \"SCHEDULE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PERSONAL INFORMATION Definitions, Interpretation 1) In this Exhibit D:\", \"level\": 1, \"text\": \"SCHEDULE 6 PERSONAL INFORMATION Definitions, Interpretation 1) In this Exhibit D: a) \\\"Agreement\\\" means the License Agreement between Diversinet Corp. (\\\"Licensor\\\") and 2205925 Ontario Limited (\\\"Licensee\\\") with effective date of January 10, 2011; b) \\\"Personal Information\\\" means information that is defined as \\\"personal information\\\" in PIPEDA, including without limitation personal health information, that is held, transmitted or stored on or by the Software licensed to Licensee under the Agreement;\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PIPEDA\\\" means the Personal Information Protection and Electronic Documents Act (Canada); and\", \"level\": 1, \"text\": \"c) \\\"PIPEDA\\\" means the Personal Information Protection and Electronic Documents Act (Canada); and\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Services\\\" means the services provided by Licensor to Licensee under the Agreement including without limitation, the Su\", \"level\": 1, \"text\": \"d) \\\"Services\\\" means the services provided by Licensor to Licensee under the Agreement including without limitation, the Support Services.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any capitalized term that is not defined in section 1 above has the meaning attributed thereto in the Agreement\", \"level\": 1, \"text\": \"2) Any capitalized term that is not defined in section 1 above has the meaning attributed thereto in the Agreement.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties acknowledge and agree that\", \"level\": 1, \"text\": \"3) The parties acknowledge and agree that: a) Licensee represents that it is an organization subject to PIPEDA and Licensor is a third party service provider to the Licensee in connection with the Services; b) Licensee's End Users shall interface with Licensee Technical Support only and in general, Licensor will not require access to Personal Information to provide the Services;\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"notwithstanding subsection 3(b) above, Licensor may from time to time require access to Personal Information to provide\", \"level\": 1, \"text\": \"c) notwithstanding subsection 3(b) above, Licensor may from time to time require access to Personal Information to provide the Services;\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensor shall only access Personal Information with the prior written consent of Licensee;\", \"level\": 1, \"text\": \"d) Licensor shall only access Personal Information with the prior written consent of Licensee; e) Licensor shall not download, which for the purposes of this Privacy Exhibit includes copy, hold or otherwise save Personal Information, without the prior written consent of Licensee and for greater certainty, consent to access Personal Information does not constitute consent to download Personal Information; f) where Licensor receives consent to access, access and download or access and otherwise use Personal Information, the terms and conditions of this Privacy Exhibit shall apply to Licensor in relation to those activities; and g) where Confidential Information of the Licensee is also Personal Information, the provisions of this Privacy Exhibit take priority over section 7 of the Agreement in the event of any conflict. Ownership of Personal Information/ Prohibition on Disclosure 4) Nothing in this Privacy Exhibit shall be interpreted or construed to give Licensor any interest in or control of Personal Information and for greater certainty, as between Licensor and Licensee, Licensee owns and controls and shall continue to own and control Personal Information.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensor shall not disclose Personal Information\", \"level\": 1, \"text\": \"5) Licensor shall not disclose Personal Information. For clarity, the use of Personal Information by employees, agents and representatives of Licensor in accordance with this Privacy Exhibit does not constitute the disclosure of Personal Information by Licensor to those employees, agents and representatives. Safeguards 6) Notwithstanding any provision to the contrary in the Agreement, Licensor shall not subcontract or assign any of the Services that may require access to or the downloading or other use of Personal Information except with the prior written consent of Licensee or as required to be disclosed by a governmental agency or third party as expressly required by operation of law, regulation or court order.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensor shall use security safeguards that meet or exceed industry standards to protect Personal Information against s\", \"level\": 1, \"text\": \"7) Licensor shall use security safeguards that meet or exceed industry standards to protect Personal Information against such risks as loss and unauthorized access, collection, use, disclosure and destruction.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding any provision to the contrary in the Agreement, Licensor shall not, except with the prior written conse\", \"level\": 1, \"text\": \"8) Notwithstanding any provision to the contrary in the Agreement, Licensor shall not, except with the prior written consent of Licensee, access or use Personal Information from outside Canada or transmit Personal Information outside Canada.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Where Licensor downloads Personal Information in accordance with this Privacy Exhibit, Licensor shall prohibit its empl\", \"level\": 1, \"text\": \"9) Where Licensor downloads Personal Information in accordance with this Privacy Exhibit, Licensor shall prohibit its employees, agents and representatives from downloading Personal Information onto any portable device, unless the information is encrypted in accordance with industry standards for strong encryption.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensor shall segregate Personal Information from information of any person other than Licensee\", \"level\": 1, \"text\": \"10) Licensor shall segregate Personal Information from information of any person other than Licensee.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to a written direction from Licensee to securely destroy Personal Information, upon the expiry or termination o\", \"level\": 1, \"text\": \"11) Subject to a written direction from Licensee to securely destroy Personal Information, upon the expiry or termination of the Agreement and at any other time at the request of Licensee, Licensor shall promptly return to the Licensee Personal Information that Licensor downloaded in accordance with this Privacy Exhibit. Inspection and Audit 12) In addition to any other rights of inspection, review and audit Licensee may have, Licensee or a person appointed by Licensee may, at any reasonable time, on reasonable notice to Licensor, at Licensee's sole cost and expense, enter any location from or in which Licensor has accessed, used or downloaded Personal Information to inspect, review and audit the equipment, systems (including without limitation security systems), documents, processes and practices that are used in connection with the provision of the Services for the purpose of assessing Licensor's compliance with this Privacy Exhibit. Licensor shall provide all reasonable assistance to Licensee in relation to any such inspection, review and audit.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensor shall track the access, downloading and use of Personal Information, in accordance with this Privacy Exhibit,\", \"level\": 1, \"text\": \"13) Licensor shall track the access, downloading and use of Personal Information, in accordance with this Privacy Exhibit, by its employees, agents and representatives and maintain a record of such activities. Within twenty-four hours of a request, Licensor shall provide Licensee with a copy of any or all of the records created and maintained under this section 13. Licensor Employees, Agents, Representatives 14) Licensor shall ensure that it only permits access to Personal Information to those of its employees, agents and representatives who: (a) will need access to Personal Information to deliver the Services; (b) have received training in the protection of Personal Information; and (c) have agreed to comply with the provisions of sections (5), (8), (9), (10) and (12) of this Privacy Exhibit. Notice of Non-Compliance 15) If for any reason Licensor does not comply or anticipates that it shall be unable to comply with a provision of this Privacy Exhibit in any respect, Licensor shall promptly notify Licensee of the particulars of the non-compliance or anticipated non-compliance and of the steps it proposes to take to address or prevent the recurrence of the non-compliance or anticipated non-compliance. Default 16) Notwithstanding anything to the contrary in the Agreement, Licensor acknowledges and agrees that a breach of this Privacy Exhibit by Licensor which remains uncured for a period of sixty (60) days shall constitute a material breach and grounds for the termination on notice of the Agreement by Licensee without cost or liability to Licensee. Without limiting the foregoing, Licensor agrees that in addition to any other rights or remedies Licensee may have for material breach of the Agreement, Licensee has the right to an injunction or other equitable relief in any court of competent jurisdiction enjoining a threatened or actual breach of this Privacy Exhibit by Licensor. No Withholding 17) Licensor shall not, and hereby forever waives any and all right to, refuse to return Personal Information to enforce any alleged payment obligation or in connection with any dispute connected with the Agreement or any other matter between Licensor and Licensee. Survival 18) The obligations of Licensor under this Privacy Exhibit shall survive the termination of the Agreement. #\"}}, {\"id\": \"party:Diversinet Corp.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Diversinet Corp.\", \"role\": \"Licensor\", \"address\": \"2235 Sheppard Avenue East, Suite 1700, Toronto, Ontario, Canada M2J 5B5\"}}, {\"id\": \"party:2205925 Ontario Limited\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"2205925 Ontario Limited\", \"role\": \"Reseller\", \"address\": \"111 Main Street West, Suite 304, North Bay, Ontario P1B 2T6\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"the License Agreement between Diversinet Corp. (\\\"Licensor\\\") and 2205925 Ontario Limited (\\\"Licensee\\\") with effective date of January 10, 2011\", \"definition_clause\": \"SCHEDULE 6\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"January 11, 2011\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Diversinet\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Diversinet\", \"text\": \"Diversinet Corp., an Ontario corporation with its principal place of business located at 2235 Sheppard Avenue East, Suite 1700, Toronto, Ontario, Canada M2J 5B5\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Reseller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reseller\", \"text\": \"2205925 Ontario Limited, with its principal place of business located at 111 Main Street West, Suite 304, North Bay, Ontario P1B 2T6\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"Diversinet and the Reseller are hereinafter referred to individually as a \\\"Party\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"Diversinet and the Reseller are hereinafter referred to ... collectively, as the \\\"Parties\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:AMC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AMC\", \"text\": \"Annual Minimum Commitment\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"those Diversinet products listed in Schedule 2\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"Canadian head quartered companies and governmental and broader public sector entities located in Canada\", \"definition_clause\": \"Schedule 3\"}}, {\"id\": \"term:Customers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customers\", \"text\": \"Reseller's customers (the \\\"Customers\\\") are defined as those organizations/enterprises that will market and manage the end-users of the Products\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:End-Users\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End-Users\", \"text\": \"the end-users of the Products\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"a period of five (5) years\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"the Initial Term and each renewal term, collectively\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Customer Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer Agreement\", \"text\": \"purchase agreement(s) with Reseller with respect to each of the Products purchased by Customer\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"\\\"Business Day\\\" shall mean 9:00 a.m. to 5:00 p.m. (Eastern Standard Time), Monday through Friday, excluding all statutory holidays observed in the Province of Ontario in Canada.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Network Charges\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Network Charges\", \"text\": \"all mobile network data, roaming or airtime charges, SMS related charges, application certification charges or marketing costs and any other fees or levies related to the cellular or wireless network over which the Products are offered and/or provisioned, as well as Customer's own Internet access fees\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:SOW\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SOW\", \"text\": \"Statements of Work\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:E Mail\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"E Mail\", \"text\": \"electronic mail messages via the Internet using SMTP compliant software\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Support Questions\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Support Questions\", \"text\": \"questions regarding the functions of the Products, as well as questions about how to make full use of the software\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Primary Contact\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Primary Contact\", \"text\": \"a single person, designated initially as Primary Technical Support Contact\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Alternate Contact\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Alternate Contact\", \"text\": \"an alternate technical support contact\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Contacts\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contacts\", \"text\": \"All Primary Contacts and Alternate Contacts\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Updates\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Updates\", \"text\": \"updated versions of the Products\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:ASP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ASP\", \"text\": \"Application Service Provider\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Trade Secrets\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trade Secrets\", \"text\": \"any other information of a confidential or proprietary nature provided by one Party to the other from time to time, whether marked as \\\"Proprietary\\\", \\\"Confidential\\\", \\\"Secret\\\" or any other designation implying confidentiality, is owned by the disclosing Party\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Operation Warranty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Operation Warranty\", \"text\": \"Each of the Products operates in substantial accordance with its documentation\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Personnel\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Personnel\", \"text\": \"personnel\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Limited Patent Warranty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Limited Patent Warranty\", \"text\": \"none of the Products infringes upon any third party's patent rights\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:BUNDLED PRODUCT\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"BUNDLED PRODUCT\", \"text\": \"THE PRODUCTS, DOCUMENTATION AND OTHER RELATED SERVICES\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:USERS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"USERS\", \"text\": \"ANY OTHERS WHO USE THE BUNDLED PRODUCT\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Abandonment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Abandonment\", \"text\": \"Diversinet's cessation or suspension of, or refusal to perform, its obligations under this Agreement, and such cessation, suspension or refusal (i) was knowingly intended by Diversinet to cause harm to Reseller, and (ii) was not the result of a termination of this Agreement by Diversinet in accordance with Section 4 (Termination).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Diversinet Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Diversinet Parties\", \"text\": \"Diversinet and/or any of its directors, officers, agents, employees, contractors, parent companies, affiliates, and/or subsidiaries\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Release Conditions\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Release Conditions\", \"text\": \"any of the following events\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"software\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Annual Minimum Commitment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Minimum Commitment\", \"text\": \"During the Term of the Agreement, Reseller shall pay to Diversinet an Annual Minimum Commitment\", \"definition_clause\": \"Schedule 3\"}}, {\"id\": \"term:Response Time\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Response Time\", \"text\": \"the time it takes to respond to a request specific to the Severity (defined below) of the incident as described below.\", \"definition_clause\": \"2.3\"}}, {\"id\": \"term:Personal Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Personal Information\", \"text\": \"information that is defined as \\\"personal information\\\" in PIPEDA, including without limitation personal health information, that is held, transmitted or stored on or by the Software licensed to Licensee under the Agreement\", \"definition_clause\": \"SCHEDULE 6\"}}, {\"id\": \"term:PIPEDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PIPEDA\", \"text\": \"the Personal Information Protection and Electronic Documents Act (Canada)\", \"definition_clause\": \"c\"}}, {\"id\": \"term:Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Services\", \"text\": \"the services provided by Licensor to Licensee under the Agreement including without limitation, the Support Services.\", \"definition_clause\": \"d\"}}, {\"id\": \"value:five (5) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) years\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:115%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"115%\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:60 day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 day period\"}}, {\"id\": \"value:18 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"18 months\"}}, {\"id\": \"value:five (5) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"value:two (2) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) Business Days\"}}, {\"id\": \"value:five (5) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) Business Days\"}}, {\"id\": \"value:fifteen (15) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) calendar days\"}}, {\"id\": \"value:fifteen (15) day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) day period\"}}, {\"id\": \"value:30 calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 calendar days\"}}, {\"id\": \"value:1% per month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"1% per month\"}}, {\"id\": \"value:12% per annum\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"12% per annum\"}}, {\"id\": \"value:$1,500 per day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,500 per day\"}}, {\"id\": \"value:seven (7) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) years\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:ONE HUNDRED PERCENT (100%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ONE HUNDRED PERCENT (100%)\"}}, {\"id\": \"value:TWELVE (12) MONTH PERIOD\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"TWELVE (12) MONTH PERIOD\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:two years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two years\"}}, {\"id\": \"value:$400,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$400,000\"}}, {\"id\": \"value:$700,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$700,000\"}}, {\"id\": \"value:$175,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$175,000\"}}, {\"id\": \"value:$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000\"}}, {\"id\": \"value:$250,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$250,000\"}}, {\"id\": \"value:$1,300,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,300,000\"}}, {\"id\": \"value:$325,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$325,000\"}}, {\"id\": \"value:$1,600,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,600,000\"}}, {\"id\": \"value:180 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"180 days\"}}, {\"id\": \"value:12-month period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12-month period\"}}, {\"id\": \"value:$750,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$750,000\"}}, {\"id\": \"value:$1,250,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,250,000\"}}, {\"id\": \"value:$1,500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,500,000\"}}, {\"id\": \"value:$1m\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1m\"}}, {\"id\": \"value:30%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"30%\"}}, {\"id\": \"value:$2m\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2m\"}}, {\"id\": \"value:40%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"40%\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:20%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20%\"}}, {\"id\": \"value:$1,500 per person day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,500 per person day\"}}, {\"id\": \"value:5 days a week\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 days a week\"}}, {\"id\": \"value:52 weeks a year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"52 weeks a year\"}}, {\"id\": \"value:twenty-four hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four hours\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ENTERTAINMENTGAMINGASIAINC_02_15_2005-EX-10.5-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ENTERTAINMENTGAMINGASIAINC_02_15_2005-EX-10.5-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.5\", \"level\": 1, \"text\": \"Exhibit 10.5 DISTRIBUTOR AGREEMENT This Agreement is entered into as of January 21, 2005 (the \\\"Effective Date\\\") by and among VendingData Corporation, a Nevada corporation (\\\"Vendor\\\"), and Technical Casino Supplies Ltd, an English company (\\\"Distributor\\\"). RECITALS WHEREAS, Vendor is the owner of patents, patents pending, trademarks, and other related intellectual property involving a full range of shuffling machine products for the casino industry (collectively, the \\\"Products\\\" and, individually, the \\\"Product\\\"); WHEREAS, Distributor is in the business of distributing products to the casino industry throughout the world and is a subsidiary of Victoria Holdings Ltd; and WHEREAS, Vendor desires to grant to Distributor an exclusive right to market, sell, rent, lease, service and maintain the Products subject to the terms and conditions as set forth herein. NOW, THEREFORE, in consideration of the several and mutual promises, agreements, covenants, understandings, undertakings, representations and warranties hereinafter set forth the receipt and sufficiency of which is hereby acknowledged, the parties to this Agreement agree that the aforementioned recitals are true and correct and by this reference incorporated herein as if fully set forth and the parties further covenant and agree as follows:\"}, {\"id\": \"1\", \"title\": \"TERM\", \"level\": 1, \"text\": \"1. TERM As provided for in this Section 1, the term of this Agreement shall be for a period of five (5) years, beginning on the Effective Date (the \\\"Initial Term\\\"); provided, however, the Initial Term shall be subject to automatic successive renewal terms of three (3) years each (the \\\"Renewal Terms\\\" and together with the Initial Term, the \\\"Term\\\").\"}, {\"id\": \"1.1\", \"title\": \"Termination\", \"level\": 2, \"text\": \"1.1. Termination. This Agreement may be terminated subject to the following clauses:\"}, {\"id\": \"1.1.1\", \"title\": \"By either Vendor or Distributor, upon written notice of termination of this Agreement no later than ninety (90) calenda\", \"level\": 3, \"text\": \"1.1.1. By either Vendor or Distributor, upon written notice of termination of this Agreement no later than ninety (90) calendar days prior to the expiration of the relevant Term, then in effect;\"}, {\"id\": \"1.1.2\", \"title\": \"By Vendor and Distributor, at any time, upon the mutual written agreement of Vendor and Distributor;\", \"level\": 3, \"text\": \"1.1.2. By Vendor and Distributor, at any time, upon the mutual written agreement of Vendor and Distributor;\"}, {\"id\": \"1.1.3\", \"title\": \"By either Vendor or Distributor, following a material or continuing breach of this Agreement (in the case of a breach w\", \"level\": 3, \"text\": \"1.1.3. By either Vendor or Distributor, following a material or continuing breach of this Agreement (in the case of a breach which is capable of remedy) by the other party and the breaching party's failure to cure such breach within ninety (90) days of receiving written notice of such breach, where a breach shall be considered capable of remedy if the party in breach can comply with the provision in question in all respects other than as to the time of the performance (provided that the time of performance is not of the essence); or\"}, {\"id\": \"1.1.4\", \"title\": \"Subject to Section 1\", \"level\": 3, \"text\": \"1.1.4. Subject to Section 1.6, by Vendor (or successor to Vendor), upon written notice to Distributor of a change of control of Vendor and the election by Vendor (or successor to Vendor) to terminate this Agreement, where a \\\"change of control\\\" shall mean a change in ownership of the Vendor such that an unaffiliated third party acquires a majority of the voting power of Vendor;\"}, {\"id\": \"1.1.5\", \"title\": \"Subject to Section 1\", \"level\": 3, \"text\": \"1.1.5. Subject to Section 1.6, with respect to any shuffler line, by Vendor, upon written notice to Distributor of the transfer of ownership of the relevant shuffler line (i.e,, the PokerOne\u2122 Shuffler, the Random Plus\u2122 Shuffler, the Continuous Plus\u2122 Shuffler and other future line of shuffler products offered by Vendor) to an unaffiliated third party and the election by the unaffiliated third party to terminate this Agreement with respect to the relevant shuffler line.\"}, {\"id\": \"1.2\", \"title\": \"No Responsibility\", \"level\": 2, \"text\": \"1.2. No Responsibility. Upon termination of this Agreement in accordance with the terms of this Section 1, the terminating party shall not be responsible for any costs or damages incurred by the other party resulting from the termination, subject to Section 1.6 of this Agreement.\"}, {\"id\": \"1.3\", \"title\": \"Distributor Credit\", \"level\": 2, \"text\": \"1.3. Distributor Credit. Except when this Agreement is terminated due to the uncured breach of Distributor, Distributor shall have within one (1) month of termination of this Agreement the right to return the Products purchased by Distributor to Vendor provided that the Products are unopened upon receipt by Vendor. Distributor will receive a credit for the full price paid by Distributor for the Products. Under such circumstances, Vendor shall have the right to market and sell such returns to other customers that may be interested in acquiring the goods referred to herein.\"}, {\"id\": \"1.4\", \"title\": \"Delivery upon Termination\", \"level\": 2, \"text\": \"1.4. Delivery upon Termination. In the event of termination for whatever reason, Vendor and Distributor agree to complete the delivery of each order of the Product received by Distributor and each unfulfilled order for the Product prior to the termination date.\"}, {\"id\": \"1.5\", \"title\": \"Effect\", \"level\": 2, \"text\": \"1.5. Effect. In the event of the termination of this Agreement for any reason whatsoever, the exclusive distribution right and license granted to Distributor pursuant to this Agreement shall automatically revert to Vendor as Vendor's sole property.\"}, {\"id\": \"1.6\", \"title\": \"Monthly Compensation\", \"level\": 2, \"text\": \"1.6. Monthly Compensation. In the event that this Agreement is terminated pursuant to either Section 1.1.4 or 1.1.5 of this Agreement, this shall not of itself be deemed a breach hereof but Distributor shall have the right to receive monthly compensation from Vendor, or successor to the Vendor, representing the amount of profit to Distributor lost as a result of the termination (the \\\"Monthly Compensation\\\").\"}, {\"id\": \"1.6.1\", \"title\": \"Calculation\", \"level\": 3, \"text\": \"1.6.1. Calculation. The amount of the Monthly Compensation shall be determined by taking average gross profit related to the relevant Products for each of the monthly periods completed since the beginning of this Agreement, where \\\"gross profit\\\" shall mean the difference between the revenue generated by Distributor during the relevant period less any commissions paid by Distributor to third parties and less the Price paid by Distributor to Vendor for the relevant Products (exclusive of any taxes, charges, fees or impositions related to sales or delivery).\"}, {\"id\": \"1.6.2\", \"title\": \"Payment\", \"level\": 3, \"text\": \"1.6.2. Payment. The Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of this Agreement had not occurred, or twenty four (24) calendar months, which ever period is less, where payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period. -2-\"}, {\"id\": \"1.6.3\", \"title\": \"Reservation of Rights\", \"level\": 3, \"text\": \"1.6.3. Reservation of Rights. For the avoidance of doubt, Distributor's right to compensation shall be without prejudice to its rights in respect of any breach by Vendor of this Agreement.\"}, {\"id\": \"2\", \"title\": \"GRANT OF DISTRIBUTION RIGHTS; LICENSE\", \"level\": 1, \"text\": \"2. GRANT OF DISTRIBUTION RIGHTS; LICENSE In consideration for the purchase of the Products by Distributor from Vendor, Vendor grants Distributor the exclusive right to market, sell, rent, lease, service and maintain the Products and all improvements thereon within the Territory (as defined herein) according to the terms and conditions as set forth herein. As part of the exclusive distribution right granted in this Section 2, Vendor hereby grants Distributor the non- exclusive, non-transferable right to use and display Vendor's trademarks, logos, Product photographs and images, Product advertising and promotional copy, including but not limited to the materials contained in Vendor's website, in connection with the promotion, advertising and distribution of the Products.\"}, {\"id\": \"2.1\", \"title\": \"Definition of \\\"Territory\", \"level\": 2, \"text\": \"2.1. Definition of \\\"Territory.\\\" For the purposes of this Agreement, the \\\"Territory\\\" shall mean all countries and territories throughout the world with the exception of the United States of America, the Caribbean and cruise ships based from ports within the United States of America or the Caribbean.\"}, {\"id\": \"2.2\", \"title\": \"Limitations\", \"level\": 2, \"text\": \"2.2. Limitations. Notwithstanding any other provision of this Agreement, the Distributor specifically agrees that any and all marks, logos, images and copy related to the Products are solely the property of Vendor. Distributor agrees not to use in any manner whatsoever the marks, logos, images and copy of Vendor following the expiration or termination of this Agreement, except as may be needed to sell any Products remaining in Distributor's inventory.\"}, {\"id\": \"2.3\", \"title\": \"Design and Specification\", \"level\": 2, \"text\": \"2.3. Design and Specification. In its sole discretion and without any liability to Distributor, Vendor shall have final decision-making power with respect to, from time to time, alter the design or construction of any Products, add new and additional Products and discontinue any Products; provided, however, in the event of any such action on Vendor's part, Vendor shall give reasonable notice to Distributor.\"}, {\"id\": \"2.4\", \"title\": \"Prosecution of the Patent Applications\", \"level\": 2, \"text\": \"2.4. Prosecution of the Patent Applications. Vendor shall retain full and complete control over the prosecution of any patent applications and any related disclaimer proceedings.\"}, {\"id\": \"2.5\", \"title\": \"Ownership of Future Inventions and Improvements\", \"level\": 2, \"text\": \"2.5. Ownership of Future Inventions and Improvements. Any and all future inventions and improvements related to the Products licensed pursuant to this Agreement shall be the property of Vendor.\"}, {\"id\": \"2.6\", \"title\": \"Commission to Vendor For Sales Lead to Distributor\", \"level\": 2, \"text\": \"2.6. Commission to Vendor For Sales Lead to Distributor. Subject to the mutual agreement of Vendor and Distributor, in the event that Vendor provides a new sales lead to Distributor that results in the sale of the Products, Distributor shall pay to Vendor a commission equal to twenty-five percent (25%) of the gross profit for the Products, where gross profit shall mean the difference between the price paid by the customer (where Distributor will determine the customer price for the Products on a case by case basis) and the price paid by Distributor for the Products. Sales leads for rental contracts provided by Vendor to Distributor will be dealt with on a case by case basis by mutual agreement between Vendor and Distributor. Any repeat orders will be dealt with on a case by case basis by mutual agreement between Vendor and Distributor. -3-\"}, {\"id\": \"2.6.1\", \"title\": \"Payment\", \"level\": 3, \"text\": \"2.6.1. Payment. Distributor hereby agrees to provide to Vendor payment of the commission no later than thirty (30) calendar days after the receipt of full payment from the customer.\"}, {\"id\": \"3\", \"title\": \"OBLIGATIONS OF DISTRIBUTOR\", \"level\": 1, \"text\": \"3. OBLIGATIONS OF DISTRIBUTOR In exchange for the exclusive distribution right and license provided in Section 2 of this Agreement, Distributor hereby agrees during the Term to use its best commercial efforts to promote, advertise and distribute the Products throughout the Territory, including, without limitation, the following:\"}, {\"id\": \"3.1\", \"title\": \"Distributor will purchase the Products from Vendor in accordance with the parameters set forth in Sections 5 and 6 of t\", \"level\": 2, \"text\": \"3.1. Distributor will purchase the Products from Vendor in accordance with the parameters set forth in Sections 5 and 6 of this Agreement;\"}, {\"id\": \"3.2\", \"title\": \"Distributor will be responsible for all marketing, selling and servicing efforts for the Products within the Territory;\", \"level\": 2, \"text\": \"3.2. Distributor will be responsible for all marketing, selling and servicing efforts for the Products within the Territory;\"}, {\"id\": \"3.3\", \"title\": \"Distributor shall, in the event of any actual or alleged infringement of the Products comes to the attention of Distrib\", \"level\": 2, \"text\": \"3.3. Distributor shall, in the event of any actual or alleged infringement of the Products comes to the attention of Distributor, promptly notify Vendor, in writing, of the actual or alleged infringement;\"}, {\"id\": \"3.4\", \"title\": \"Distributor shall not obtain, purchase, receive or source any other card shuffling machine from any third party or othe\", \"level\": 2, \"text\": \"3.4. Distributor shall not obtain, purchase, receive or source any other card shuffling machine from any third party or other source under any circumstance other than from Vendor with the exception of all Shuffle Master, Inc. shuffling machines which are held in stock at the Effective Date which Distributor is free to sell, rent purchase or lease until all of the said stock has been depleted.\"}, {\"id\": \"3.5\", \"title\": \"Distributor shall not sell or otherwise transfer any of the rights granted pursuant to this Agreement to any third part\", \"level\": 2, \"text\": \"3.5. Distributor shall not sell or otherwise transfer any of the rights granted pursuant to this Agreement to any third party without the prior written consent of Vendor; provided, however, Distributor may enter into distribution arrangements with regional distributors within the Territory in its efforts to promote, advertise and distribute the Products in accordance with this Agreement;\"}, {\"id\": \"3.6\", \"title\": \"Distributor shall provide written updates to Vendor at the end of each calendar quarter of any distribution arrangement\", \"level\": 2, \"text\": \"3.6. Distributor shall provide written updates to Vendor at the end of each calendar quarter of any distribution arrangements entered into by Distributor as permitted by Section 3.5 of this Agreement, where said notice shall contain the name and location of the regional distributor, and a brief statement on the experience and history of the regional distributor;\"}, {\"id\": \"3.7\", \"title\": \"Distributor shall not make any modifications to the Products without prior written consent of Vendor;\", \"level\": 2, \"text\": \"3.7. Distributor shall not make any modifications to the Products without prior written consent of Vendor;\"}, {\"id\": \"3.8\", \"title\": \"Distributor shall provide to Vendor\", \"level\": 2, \"text\": \"3.8. Distributor shall provide to Vendor: (1) monthly sales figures no later than fifteen (15) calendar days after the end of the relevant monthly period that provides information with respect to sales for each Product; and (2) a non binding three (3) month forecast on a quarterly basis;\"}, {\"id\": \"3.9\", \"title\": \"Distributor shall demonstrate the Products at the following international gaming exhibitions, ICE (London), G2E (Las Ve\", \"level\": 2, \"text\": \"3.9. Distributor shall demonstrate the Products at the following international gaming exhibitions, ICE (London), G2E (Las Vegas), SAGSE (Buenos Aires), EELEX (Moscow) and AGE (Sydney), or any successors or equivalents to the aforementioned exhibitions. Distributor may also demonstrate the products at other gaming exhibitions where Distributor decides to exhibit, subject to there being a good business case to do so; and\"}, {\"id\": \"3.10\", \"title\": \"Distributor shall be responsible for the retention, use and actions of any third parties used to distribute the Product\", \"level\": 2, \"text\": \"3.10. Distributor shall be responsible for the retention, use and actions of any third parties used to distribute the Products, including any claims, liabilities or other damages associated with such third parties. -4-\"}, {\"id\": \"4\", \"title\": \"OBLIGATIONS OF VENDOR\", \"level\": 1, \"text\": \"4. OBLIGATIONS OF VENDOR In exchange for the marketing and selling of the Products provided in Section 3, Vendor hereby agrees:\"}, {\"id\": \"4.1\", \"title\": \"To provide Distributor with the appropriate product brochures, and two (2) fully working and fit for purpose samples of\", \"level\": 2, \"text\": \"4.1. To provide Distributor with the appropriate product brochures, and two (2) fully working and fit for purpose samples of each model of shuffling machine free of charge;\"}, {\"id\": \"4.2\", \"title\": \"To prominently display and advertise that Distributor is the sole and exclusive distributor of Vendor for the Products\", \"level\": 2, \"text\": \"4.2. To prominently display and advertise that Distributor is the sole and exclusive distributor of Vendor for the Products in the Territory;\"}, {\"id\": \"4.3\", \"title\": \"Subject to Section 2\", \"level\": 2, \"text\": \"4.3. Subject to Section 2.6 of this Agreement, not to market, distribute, sell or supply the Products covered by this Agreement to any individual or entity in the Territory directly in response to a request from that person or entity without the prior written consent of Distributor;\"}, {\"id\": \"4.4\", \"title\": \"Subject to Section 4\", \"level\": 2, \"text\": \"4.4. Subject to Section 4.5 of this Agreement, for a period of twenty-four (24) months after the Effective Date, not to develop, manufacture, market, distribute, sell or supply anywhere in the world to any individual or entity a gaming chip-sorting machine for use in a casino; and\"}, {\"id\": \"4.5\", \"title\": \"Notwithstanding Section 4\", \"level\": 2, \"text\": \"4.5. Notwithstanding Section 4.4 of this Agreement, use its best commercial efforts to enter into a separate agreement with Distributor for the manufacture of a gaming chip-sorting machine or the manufacture of components of a gaming chip-sorting machine for use by the casino industry, where a condition of the agreement will be that Vendor will not compete with Distributor in any way in relation to the manufacture, supply, sale and distribution of gaming chip-sorting machines. It is understood that if Vendor and Distributor fail to reach an agreement then the twenty-four (24) month restriction detailed in Section 4.4 above will remain in force.. The obligation detailed under Section 4.4 above will cease immediately if Distributor fails to complete its obligations under Section 5.1 below, where such failure is not a result of any default by Vendor, or if Distributor fails to provide payment for the Products within one hundred and eighty (180) days after the delivery of the same.\"}, {\"id\": \"5\", \"title\": \"PURCHASE; SHIPPING\", \"level\": 1, \"text\": \"5. PURCHASE; SHIPPING\"}, {\"id\": \"5.1\", \"title\": \"Purchase\", \"level\": 2, \"text\": \"5.1. Purchase. In exchange for the exclusive distribution right and license granted to Distributor pursuant to this Agreement, during the Term, Distributor hereby agrees to purchase the Products from Vendor, where such Products are fit for purpose and ready for sale in the Territory, as determined by Distributor, as follows:\"}, {\"id\": \"5.1.1\", \"title\": \"As of the Effective Date, one hundred (100) units of the PokerOne\u2122 Shuffler at a price of Four Thousand Nine Hundred Do\", \"level\": 3, \"text\": \"5.1.1. As of the Effective Date, one hundred (100) units of the PokerOne\u2122 Shuffler at a price of Four Thousand Nine Hundred Dollars ($4,950.00 U.S.) per unit, where Vendor shall ship the units no later than the end of January 2005;\"}, {\"id\": \"5.1.2\", \"title\": \"Upon the delivery of two (2) units of the Random Plus\u2122 Shuffler to Distributor and the expiration of a review period en\", \"level\": 3, \"text\": \"5.1.2. Upon the delivery of two (2) units of the Random Plus\u2122 Shuffler to Distributor and the expiration of a review period ending thirty (30) calendar days after the receipt of delivery by Distributor,, where such review by Distributor determines that the Random Plus\u2122 Shuffler is fit for purpose and ready for commercial sale in the Territory, one hundred (100) units of the Random Plus\u2122 Shuffler at a price of Four Thousand Nine Hundred Fifty Dollars ($4,950.00 U.S.) per unit, where Vendor shall ship the units no later than 30 days after the review period; -5-\"}, {\"id\": \"5.1.3\", \"title\": \"Upon the receipt of any necessary approvals or approval waivers and the expiration of a review period ending thirty (30\", \"level\": 3, \"text\": \"5.1.3. Upon the receipt of any necessary approvals or approval waivers and the expiration of a review period ending thirty (30) calendar days after the receipt of delivery by Distributor of two (2) units of the Continuous Plus\u2122 Shuffler, where such review by Distributor determines that the Continuous Plus\u2122 Shuffler is fit for purpose and ready for commercial sale in the Territory, one hundred (100) units of the Continuous Plus\u2122 Shuffler at a price of Five Thousand Nine Hundred Fifty Dollars ($5,950.00 U.S.);\"}, {\"id\": \"5.1.4\", \"title\": \"Within thirty (30) days of the one (1) year anniversary of the Effective Date, an additional two hundred (200) units of\", \"level\": 3, \"text\": \"5.1.4. Within thirty (30) days of the one (1) year anniversary of the Effective Date, an additional two hundred (200) units of the Products comprising any mix of the shuffler products offered by Vendor; and\"}, {\"id\": \"5.1.5\", \"title\": \"Any additional number of units of the Products as may be submitted by Distributor to Vendor pursuant to a Purchase Orde\", \"level\": 3, \"text\": \"5.1.5. Any additional number of units of the Products as may be submitted by Distributor to Vendor pursuant to a Purchase Order (as defined herein).\"}, {\"id\": \"5.2\", \"title\": \"Purchase Order\", \"level\": 2, \"text\": \"5.2. Purchase Order. Unless otherwise provided for in this Agreement, all orders for the purchase of the Products shall be made through the submission of a purchase order (a \\\"Purchase Order\\\"), where such Purchase Order shall set forth: (1) the relevant monthly period to which the Purchase Order relates; (2) the Products to be ordered; (3) the quantity of the Products ordered; (4) the relevant price for the Products ordered; (5) the requested shipping date and destination of the Products ordered; (6) the Purchase Order number; and (7) the name and authorized signature of Distributor.\"}, {\"id\": \"5.3\", \"title\": \"Shipping\", \"level\": 2, \"text\": \"5.3. Shipping. Unless otherwise provided for in this Agreement, upon the acceptance of a Purchase Order by Vendor, Vendor shall, in the normal course of business, package, crate and insure the Products at its cost (including any applicable export duties and export taxes) and deliver the Products to Distributor F.O.B. Zhongshan City, China. Vendor will advise Distributor immediately of any delay but will use all reasonable means to dispatch the Products within four (4) weeks of an order being received. Vendor shall as soon as practicable inform Distributor of the delivery date for each quantity of Products shipped to Distributor or to an address nominated by Distributor.\"}, {\"id\": \"5.4\", \"title\": \"Partial Shipments; Pro Rata Allocation\", \"level\": 2, \"text\": \"5.4. Partial Shipments; Pro Rata Allocation. Vendor reserves the right to supply against a Purchase Order by making partial shipments of the Products. In the event that Vendor is forced to allocate the distribution of the Products due to limited supply, Distributor shall be treated no less favorably than any other distributor and shall receive its pro rata allocation of the Products.\"}, {\"id\": \"6\", \"title\": \"PRICE; PAYMENT\", \"level\": 1, \"text\": \"6. PRICE; PAYMENT\"}, {\"id\": \"6.1\", \"title\": \"Price Changes\", \"level\": 2, \"text\": \"6.1. Price Changes. The prices stated in Section 5.1 of this Agreement are subject to change. For any price change to take effect ninety (90) days notice must be given in order for the price change to apply; provided, however, the proposed price change must also apply to the Products for sale by Vendor outside the Territory. In the event that there is a price change required by Vendor that does not fall within the ninety (90) day notice period, both parties agree to discuss the nature of the increase in order to reach a mutually acceptable understanding. All the aforementioned price changes will not exceed, on a percentage term basis, any increase in the US retail selling price. -6-\"}, {\"id\": \"6.2\", \"title\": \"Payment\", \"level\": 2, \"text\": \"6.2. Payment. Distributor agrees that all payments to Vendor for the Products shall be made by wire transfer in United States Dollars (U.S.$); provided, further,\"}, {\"id\": \"6.2.1\", \"title\": \"For all Products to be delivered by Vendor directly to Distributor, the Price shall be paid by Distributor to Vendor wi\", \"level\": 3, \"text\": \"6.2.1. For all Products to be delivered by Vendor directly to Distributor, the Price shall be paid by Distributor to Vendor within the earlier of: (1) one hundred eighty (180) calendar days from the date of delivery; or (2) thirty (30) calendar days after the sale or rental of the relevant Products by Distributor; and\"}, {\"id\": \"6.2.2\", \"title\": \"For all Products to be delivered by Vendor directly to a third party purchaser of Distributor (as instructed pursuant t\", \"level\": 3, \"text\": \"6.2.2. For all Products to be delivered by Vendor directly to a third party purchaser of Distributor (as instructed pursuant to the relevant Purchase Order), the Price shall be paid by Distributor to Vendor within forty-five (45) days of Distributor's sale of the Products to the third party purchaser.\"}, {\"id\": \"6.3\", \"title\": \"Notice of Discount Structure and Promotions\", \"level\": 2, \"text\": \"6.3. Notice of Discount Structure and Promotions. Vendor and Distributor each agree to provide the other party with written notice of its intent to offer a discount structure, rebate program or other promotion with respect to the sale of the Products, including the relevant time frame applicable to such discount structure, rebate program or promotion.\"}, {\"id\": \"7\", \"title\": \"MARKETING MATERIALS\", \"level\": 1, \"text\": \"7. MARKETING MATERIALS\"}, {\"id\": \"7.1\", \"title\": \"Development of Marketing Materials\", \"level\": 2, \"text\": \"7.1. Development of Marketing Materials. Vendor and Distributor hereby agree to share marketing materials that are developed by either party for the Products covered by this Agreement, including, without limitation, any information, marketing or promotional materials for the Products, where, upon request, such marketing materials shall be delivered to the other party in hard copy and digital form, if available. Upon receipt of such marketing materials, the party may, in its sole discretion, elect to reject, use or modify such marketing materials.\"}, {\"id\": \"7.2\", \"title\": \"Prior Approval of Product Claims\", \"level\": 2, \"text\": \"7.2. Prior Approval of Product Claims. Distributor hereby agrees to obtain the prior written consent of Vendor prior to the use of any product claims with respect to the Products in its marketing materials.\"}, {\"id\": \"7.3\", \"title\": \"Cost Sharing\", \"level\": 2, \"text\": \"7.3. Cost Sharing. With respect to cost-intensive promotional materials, such as video productions, infomercials and website development and maintenance, Vendor and Distributor hereby agree to share equally in the cost and expenses related to the development and preparation of such promotional materials; provided, however, any and all expenditures related to the development and preparation of such promotional materials shall be approved in advance by Vendor and Distributor.\"}, {\"id\": \"8\", \"title\": \"PRODUCT RETURNS\", \"level\": 1, \"text\": \"8. PRODUCT RETURNS\"}, {\"id\": \"8.1\", \"title\": \"Procedure\", \"level\": 2, \"text\": \"8.1. Procedure. Distributor may return Products to Vendor for credit or full reimbursement, as the case may be, only pursuant to this Section 8.\"}, {\"id\": \"8.2\", \"title\": \"Updated Products\", \"level\": 2, \"text\": \"8.2 Updated Products. Distributor may return to Vendor for credit against future purchases any Products for which a new version or upgrade has been produced and offered for sale; provided, however, the new version or upgrade must be of a material nature whereby the existing Products held by Distributor are considered obsolete. All Products must be returned undamaged, and all shipping charges -7- shall be paid by Distributor. This clause does not apply to any Products that have been in Distributor's inventory for more that one hundred and eighty (180) calendar days.\"}, {\"id\": \"8.3\", \"title\": \"Damaged Products\", \"level\": 2, \"text\": \"8.3. Damaged Products. Promptly upon the receipt of a shipment of Products, Distributor shall inspect the Products for damage or shortage. Within ten (10) calendar days of receipt of the shipment, Distributor shall notify Vendor of any damage or shortage. As soon as commercially practical after receipt of notice, Vendor shall make complete any shipment in short supply. Any Products damaged in shipment shall be returned to Vendor along with documentation of the damage within thirty (30) calendar days of receipt by Distributor, and Vendor will reimburse Distributor for the costs of freight reasonably incurred by Distributor in returning the Products to Vendor. If Vendor finds any Products returned for damage to not be damaged, Distributor shall be subject to a restocking fee equal to fifteen percent (15%) original purchase price of the non-damaged Products.\"}, {\"id\": \"8.4\", \"title\": \"Defective Products\", \"level\": 2, \"text\": \"8.4. Defective Products. Distributor may, no later than one hundred and twenty (120) calendar days after a Product is sold by Distributor to a customer, return to Vendor, at Distributor's expense, any Product received by Distributor from Vendor during the 120-day period prior to such return, which Distributor or its customer believes to be defective. In the event that such Product is defective, i.e., the failure of a Product to operate in accordance with its published specifications, Vendor shall:\"}, {\"id\": \"8.4.1\", \"title\": \"Reimburse Distributor for the costs of freight reasonably incurred by Distributor in returning the Product to Vendor; a\", \"level\": 3, \"text\": \"8.4.1. Reimburse Distributor for the costs of freight reasonably incurred by Distributor in returning the Product to Vendor; and\"}, {\"id\": \"8.4.2\", \"title\": \"Issue Distributor a credit against future purchases in an amount equal to the purchase price paid by Distributor for th\", \"level\": 3, \"text\": \"8.4.2. Issue Distributor a credit against future purchases in an amount equal to the purchase price paid by Distributor for the Product or, as requested by Distributor, full reimbursement for the defective Products.\"}, {\"id\": \"9\", \"title\": \"PRODUCT TESTING AND RESULTS\", \"level\": 1, \"text\": \"9. PRODUCT TESTING AND RESULTS Whereas Vendor has organized and received the results from product testing with respect to the Products, Vendor hereby agrees to make available to Distributor the results of such product testing and grants to Distributor the right to use such results in its promotional materials; provided, however, Distributor may only use such results if Distributor complies with the applicable terms of use as provided by the institution, organization or other person that organized and conducted the relevant product testing. Conversely, in the event that Distributor organizes and receives the results from product testing with respect to the Products, Distributor hereby agrees to make available to Vendor the results of such product testing and grants to Vendor the right to use such results in its promotional materials.\"}, {\"id\": \"10\", \"title\": \"REPRESENTATIONS AND WARRANTIES OF VENDOR\", \"level\": 1, \"text\": \"10. REPRESENTATIONS AND WARRANTIES OF VENDOR Vendor represents and warrants to Distributor as follows:\"}, {\"id\": \"10.1\", \"title\": \"Existence\", \"level\": 2, \"text\": \"10.1. Existence. Vendor is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada.\"}, {\"id\": \"10.2\", \"title\": \"Authorization; Binding Agreement\", \"level\": 2, \"text\": \"10.2. Authorization; Binding Agreement. This Agreement constitutes valid and legally binding obligations of Vendor, enforceable in accordance with its terms, except, in each case, as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws relating to or affecting the enforcement of creditors' rights generally in effect from time to time and by general principles of equity. Vendor has full corporate power and authority to enter into this Agreement. -8-\"}, {\"id\": \"10.3\", \"title\": \"Product Warranty\", \"level\": 2, \"text\": \"10.3. Product Warranty. Vendor warrants to Distributor that the Products shall perform without manufacturing failure and are fit for purpose. Distributor, in cooperation with Vendor will remedy any defect in the Product in accordance with Section 8.\"}, {\"id\": \"10.4\", \"title\": \"Spare Products and Parts\", \"level\": 2, \"text\": \"10.4. Spare Products and Parts. Vendor will provide an initial supply of spare Products and parts as Distributor may reasonably required in accordance with Sections 8 and 10.3 to permit Distributor to offer a six-month warranty on the Products to customers and to enable Distributor to provide a warranty service to customers. The initial spare Products and parts to be provided pursuant to this Section 10.4 shall be at no additional charge to the Distributor; provided, however, any additional Products and parts unrelated to this Section 10.4 shall be purchased by Distributor.\"}, {\"id\": \"10.5\", \"title\": \"Litigation\", \"level\": 2, \"text\": \"10.5. Litigation. Other than as disclosed in Vendor's filings made with the United States Securities and Exchange Commission, including without limitation the legal proceedings involving Shuffle Master, Inc., Vendor is not aware of any action, arbitration, suit, proceeding or investigation pending, or to the knowledge of Vendor, threatened against Vendor, that would have a material adverse effect on its ability to perform the terms of this Agreement.\"}, {\"id\": \"11\", \"title\": \"REPRESENTATIONS AND WARRANTIES OF DISTRIBUTOR\", \"level\": 1, \"text\": \"11. REPRESENTATIONS AND WARRANTIES OF DISTRIBUTOR Distributor represents and warrants to Vendor as follows:\"}, {\"id\": \"11.1\", \"title\": \"Existence\", \"level\": 2, \"text\": \"11.1. Existence. Distributor is a company duly organized, validly existing and in good standing under the laws of England.\"}, {\"id\": \"11.2\", \"title\": \"Authorization; Binding Agreement\", \"level\": 2, \"text\": \"11.2. Authorization; Binding Agreement. This Agreement constitutes valid and legally binding obligations of Distributor, enforceable in accordance with its terms, except, in each case, as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws relating to or affecting the enforcement of creditors' rights generally in effect from time to time and by general principles of equity. Distributor has full corporate power and authority to enter into this Agreement.\"}, {\"id\": \"11.3\", \"title\": \"Litigation\", \"level\": 2, \"text\": \"11.3. Litigation. Other than the legal proceedings involving Shuffle Master Inc, Distributor is not aware of any action, arbitration, suit, proceeding or investigation pending, or to the knowledge of Distributor, threatened against Distributor that would have a material adverse effect on its ability to perform the terms of this Agreement.\"}, {\"id\": \"12\", \"title\": \"LIMITATION OF WARRANTIES\", \"level\": 1, \"text\": \"12. LIMITATION OF WARRANTIES Vendor warrants that all Products are new and that, to its knowledge, all Vendor-supplied promotional materials comply in all respects with all applicable laws, rules and regulations. Although Vendor intends to provide a six-month limited warranty to the end user, Distributor shall make no warranties or representations with respect to the Products on behalf of Vendor. Distributor shall defend, indemnify and hold Vendor harmless from any and all claims, damages, costs or expenses, including attorney fees, incurred by Vendor in relation to any violation by Distributor of the foregoing sentence.\"}, {\"id\": \"13\", \"title\": \"INDEMNIFICATIONS\", \"level\": 1, \"text\": \"13. INDEMNIFICATIONS Each party shall indemnify and hold harmless the other party, its affiliated companies, and its employees, officers, directors, attorneys, and agents and each of them, against any and all claims, liabilities, damages and costs, including reasonable attorneys' fees and settlement amounts, that the foregoing, or any of them, may incur by reason of any material breach of this Agreement. -9- Vendor shall indemnify and hold harmless Distributor, its affiliated companies, and its employees, officers, directors, attorneys, and agents and each of them, against any and all claims, liabilities, damages and costs, including reasonable attorneys' fees and settlement amounts, incurred by any claims of product liability, or any claims arising from any actual or alleged infringement of any patent, copyright, trademark or other intellectual property right by a Product supplied by Vendor pursuant to this Agreement. Each party's responsibilities under this Section 13 shall survive termination of this Agreement.\"}, {\"id\": \"14\", \"title\": \"COVENANT TO PROTECT CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"14. COVENANT TO PROTECT CONFIDENTIAL INFORMATION\"}, {\"id\": \"14.1\", \"title\": \"Definition\", \"level\": 2, \"text\": \"14.1. Definition. \\\"Confidential Information\\\" means any proprietary, non-public information relating to Vendor and the Products, including, without limitation, any and all strategic or business plans, customer lists and information relating to customers, marketing plans and strategies, unique software and databases, lists of material providers of services and products, terms and provisions of existing contracts and agreements, details of negotiations with current partners and business associates, details of business opportunities or projects, information relating to financial statements, employees, manufacturing and servicing methods, equipment, programs, strategies, analyses, profit margins, or other proprietary, non- public information used by Vendor; provided, however, that Confidential Information shall not include any information that: (1) was publicly known and made generally available after disclosure by Vendor; (2) becomes publicly known and made generally available through no wrongful action or inaction of Distributor; (3) is already in the possession of Distributor at the time of disclosure, without confidentiality restrictions, as shown by Distributor's file and records immediately prior to the time of disclosure; (4) is obtained by Distributor without breach of Distributor's obligations of confidentiality; or (5) is independently developed by Distributor without use of or reference to the Confidential Information, as shown by documents and other competent evidence in Distributor's possession.\"}, {\"id\": \"14.2\", \"title\": \"Non-Use and Non-Disclosure\", \"level\": 2, \"text\": \"14.2. Non-Use and Non-Disclosure. Distributor shall not, during the Term or anytime thereafter, without the express prior written consent of Vendor, use, divulge, publish or otherwise disclose to any other person any Confidential Information regarding Vendor, except as provided for in this Agreement or if required to do so pursuant to the order of a court having jurisdiction over the subject matter or a summons, subpoena or order in the nature thereof of any legislative body (including any committee thereof and any litigation or dispute resolution method against Vendor related to or arising out of this Agreement) or any governmental or administrative agency. In the event that Distributor or its directors, officers, employees, consultants or agents are requested or required by legal process to disclose any of the Confidential Information, Distributor shall give prompt notice so that Vendor may seek a protective order or other appropriate relief. In the event that such protective order is not obtained, Distributor shall disclose only that portion of the Confidential Information which its counsel advises that it is legally required to disclose.\"}, {\"id\": \"14.3\", \"title\": \"Maintenance of Confidentiality\", \"level\": 2, \"text\": \"14.3. Maintenance of Confidentiality. Distributor agrees that it shall take all commercially reasonable measures to protect the secrecy of and avoid disclosure and unauthorized use of the Confidential Information. Without limiting the foregoing, Distributor shall take at least those measures that it takes to protect its own most highly confidential information and shall ensure that its employees who have access to Confidential Information have signed a non-use and non-disclosure agreement in content similar to the provisions hereof, prior to any disclosure of Confidential Information to such employees. Distributor shall not make any copies of the Confidential Information unless the same is previously approved in writing by Vendor. -10-\"}, {\"id\": \"14.4\", \"title\": \"Return of Materials\", \"level\": 2, \"text\": \"14.4. Return of Materials. All documents and other tangible objects containing or representing Confidential Information which have been disclosed by Vendor to Distributor, and all copies thereof which are in the possession of Distributor, shall be and remain the property of Vendor and shall be promptly returned to Vendor upon Vendor's written request.\"}, {\"id\": \"14.5\", \"title\": \"Non-Solicitation by Distributor\", \"level\": 2, \"text\": \"14.5. Non-Solicitation by Distributor. Distributor agrees that, without the prior written consent of the Vendor, for a period beginning from the date of this Agreement and ending three (3) years after the termination of this Agreement, neither Distributor nor any of its affiliates or representatives will: (1) employ or solicit to employ any of the employees of Vendor; or (2) encourage of the employees of the Vendor or its subsidiaries to leave the employment of Vendor; provided, however, this Section shall not apply to any such employee who has been terminated by or left the employment of Vendor prior to the Effective Date or, if employed by Vendor as of the Effective Date, any employee who has not been employed by Vendor for at least one (1) year after the end of such employment.\"}, {\"id\": \"14.6\", \"title\": \"Non-Solicitation by Vendor\", \"level\": 2, \"text\": \"14.6. Non-Solicitation by Vendor. Vendor agrees that, without the prior written consent of the Distributor, for a period beginning from the date of this Agreement and ending three (3) years after the termination of this Agreement, neither Vendor nor any of its affiliates or representatives will: (1) employ or solicit to employ any of the employees of Distributor; or (2) encourage of the employees of the Distributor or its subsidiaries to leave the employment of Distributor; provided, however, this Section shall not apply to any such employee who has been terminated by or left the employment of Distributor prior to the Effective Date or, if employed by Distributor as of the Effective Date, any employee who has not been employed by Distributor for at least one (1) year after the end of such employment.\"}, {\"id\": \"14.7\", \"title\": \"Remedies\", \"level\": 2, \"text\": \"14.7. Remedies. Each party agrees that any violation of this Section 14 may cause irreparable injury to the other party, entitling the other party to seek injunctive relief in addition to all legal remedies. Nothing herein contained is intended to waive or diminish any rights the other party may have at law or in equity at any time to protect and defend its legitimate property interests (including its business relationship with third parties), the foregoing provisions being intended to be in addition to and not in derogation or limitation of any other rights the other party may have at law or equity.\"}, {\"id\": \"15\", \"title\": \"OUTSIDE EVENTS\", \"level\": 1, \"text\": \"15. OUTSIDE EVENTS\"}, {\"id\": \"15.1\", \"title\": \"Delay or Non-Performance\", \"level\": 2, \"text\": \"15.1. Delay or Non-Performance. No party shall be liable to the other for delay in performance, or the non-performance, of any of its obligations under this Agreement to the extent that such delay or non-performance is due to any cause beyond the party's control, provided that:\"}, {\"id\": \"15.1.1\", \"title\": \"the party affected shall forthwith notify the other parties thereof; and\", \"level\": 3, \"text\": \"15.1.1. the party affected shall forthwith notify the other parties thereof; and:\"}, {\"id\": \"15.1.2\", \"title\": \"if the circumstances in question prevail for a continuous period in excess of two (2) calendar months, the parties shal\", \"level\": 3, \"text\": \"15.1.2. if the circumstances in question prevail for a continuous period in excess of two (2) calendar months, the parties shall enter into bona fide discussions with a view to alleviating the effects thereof or to agreeing upon such alternative arrangements as may be fair and reasonable in all the circumstances.\"}, {\"id\": \"15.2\", \"title\": \"Vendor Supply Limitation\", \"level\": 2, \"text\": \"15.2 Vendor Supply Limitation. Vendor shall not be responsible or liable for any loss, damage, detention or delay caused by fire, strike, civil or military authority, governmental restrictions or controls, insurrection or riot, railroad, act of terrorism, marine or air embargoes, lockout, tempest, accident, breakdown of machinery, yield problems, delay in delivery of materials by other parties, or any cause which is unavoidable or beyond its reasonable control, nor, in any event, for consequential damages. -11-\"}, {\"id\": \"16\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"16. LIMITATION OF LIABILITY Neither party shall be liable to the other for lost profits or indirect, special consequential or punitive damages of any kind arising in connection with the manufacture, sale and distribution of the products, even if such party has been advised of the possibility of such damages.\"}, {\"id\": \"17\", \"title\": \"FURTHER ASSURANCES\", \"level\": 1, \"text\": \"17. FURTHER ASSURANCES The parties further covenant and agree to do, execute and deliver, or cause to be done, executed and delivered, and covenant and agree to use their best efforts to cause their successors and assigns to do, execute and deliver, or cause to be done, executed and delivered, all such further acts, transfers and assurances, for implementing the intention of the parties under this Agreement, as the parties reasonably shall request. The parties agree to execute any additional instruments or agreements necessary to affect the intent of this Agreement.\"}, {\"id\": \"18\", \"title\": \"RELATIONSHIP OF THE PARTIES\", \"level\": 1, \"text\": \"18. RELATIONSHIP OF THE PARTIES This Agreement shall not create any joint venture or partnership between the parties. Nothing contained in this Agreement shall confer upon either party any proprietary interest in, or subject a party to any liability for or in respect of the business, assets, profits, losses or obligations of the other. Nothing herein contained shall be read or construed so as to make the parties a partnership, nor shall anything contained herein be read or construed in any way to restrict the freedom of either party to conduct any business or activity whatsoever without any accountability to the other party. Neither party shall be considered to be an agent or representative of the other party or have any authority or power to act for or undertake any obligation on behalf of the other party except as expressly authorized by the other party in writing. Any such unauthorized representation or action shall be considered a breach of this Agreement.\"}, {\"id\": \"19\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"19. ENTIRE AGREEMENT This Agreement constitutes the entire agreement between the Parties and supersedes any prior communications, representations or agreements of any kind, whether oral or written; provided, however, notwithstanding this Agreement, that certain Distribution Agreement by and between Vendor and TCS Aces Pty Limited dated September 19, 2004 shall remain in full force and effect.\"}, {\"id\": \"20\", \"title\": \"COUNTERPARTS\", \"level\": 1, \"text\": \"20. COUNTERPARTS This Agreement may be executed in counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument.\"}, {\"id\": \"21\", \"title\": \"MODIFICATION\", \"level\": 1, \"text\": \"21. MODIFICATION This Agreement may not be modified or rescinded except by express written agreement signed by both of the Parties.\"}, {\"id\": \"22\", \"title\": \"CONFLICTS\", \"level\": 1, \"text\": \"22. CONFLICTS If any term included in an invoice, purchase order, packing slip, or bill of lading contradicts or is otherwise at odds with any provision of this Agreement, the provisions of this Agreement shall prevail. -12-\"}, {\"id\": \"23\", \"title\": \"JURISDICTION\", \"level\": 1, \"text\": \"23. JURISDICTION Disputes under this Agreement shall be resolved through arbitration in Ontario, Canada by a single arbitrator to be appointed by agreement of the parties, or in default, by the President of the Law Society/Bar of Canada. The laws of Ontario, Canada shall govern the conduct of the arbitration and any appeal from the decision of the arbitrator.\"}, {\"id\": \"24\", \"title\": \"WAIVER\", \"level\": 1, \"text\": \"24. WAIVER Neither the inspection by Distributor, nor any payment for or acceptance of all or any part of the Products specified in this Agreement, nor any extension of time, nor any possession taken by Distributor or Distributor's employees, shall operate as a waiver of any provision of this Agreement, or any power in this Agreement reserved to Distributor, or any rights or damages provided for in this Agreement, nor shall any waiver of any breach in this Agreement be held to be a waiver of any other or subsequent breach.\"}, {\"id\": \"25\", \"title\": \"ASSIGNMENT OR DELEGATION\", \"level\": 1, \"text\": \"25. ASSIGNMENT OR DELEGATION No assignment by either Party of any rights, including rights to money due or to become due under this Agreement, or delegation of any duties under this Agreement or under any purchase orders subject to this Agreement, shall be binding on the nonassigning Party unless and until a written consent has been obtained from the nonassigning Party.\"}, {\"id\": \"26\", \"title\": \"SEVERABILITY\", \"level\": 1, \"text\": \"26. SEVERABILITY Any term or provision of this Agreement that is invalid or unenforceable in any jurisdiction shall be ineffective only to the extent of such invalidity or unenforceability and only as to such jurisdiction without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of these terms or provisions in any other jurisdiction.\"}, {\"id\": \"27\", \"title\": \"GOVERNING LAW\", \"level\": 1, \"text\": \"27. GOVERNING LAW This Agreement shall be governed by, construed in accordance with the laws of Ontario, Canada. -13-\"}, {\"id\": \"28\", \"title\": \"NOTICES\", \"level\": 1, \"text\": \"28. NOTICES Any notice, request, instruction, or other document required by the terms of this Agreement, or deemed by any of the parties hereto to be desirable, to be given to any other party hereto shall be in writing and shall be given by personal delivery, overnight delivery, facsimile (with confirmation of transmission) or mailed by registered or certified mail, postage prepaid, with return receipt requested, to the addresses of the Parties as follows: If to Distributor: Technical Casino Supplies Ltd Unit 9, Mulberry Business Centre, Quebec May, Rotherhithe, London, SE167LE Telephone: _____-_____-_____ Facsimile: _____-_____-_____ Attn: _____________ With a copy to: _________________ _________________ _________________ Telephone: _____-_____-_____ Facsimile: _____-_____-_____ Attn: ______________, Esq. If to Vendor: VendingData Corporation 6830 Spencer Street Las Vegas, Nevada 89119 Telephone: 702.733.7195 Facsimile: 702.733.7197 Attn: Steven J. Blad, President and CEO With a copy to: Kummer Kaempfer Bonner & Renshaw 3800 Howard Hughes Parkway, Seventh Floor Las Vegas, Nevada 89109 Telephone: 702.792.7000 Facsimile: 702.796.7181 Attn: Michael J. Bonner, Esq. -14- The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, said notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. The Parties acknowledge that they have read this Agreement, understand it, and agree to be bound by its terms. VENDOR: VENDINGDATA CORPORATION, a Nevada corporation By: /s/ Steven J. Blad Its: Steven J. Blad CEO DISTRIBUTOR: TECHNICAL CASINO SUPPLIES LTD, an English company By: /s/ David K. Heap Its: David K. Heap Chief Executive Officer -15-\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ENTERTAINMENTGAMINGASIAINC_02_15_2005-EX-10.5-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.5\", \"level\": 1, \"text\": \"Exhibit 10.5 DISTRIBUTOR AGREEMENT This Agreement is entered into as of January 21, 2005 (the \\\"Effective Date\\\") by and among VendingData Corporation, a Nevada corporation (\\\"Vendor\\\"), and Technical Casino Supplies Ltd, an English company (\\\"Distributor\\\"). RECITALS WHEREAS, Vendor is the owner of patents, patents pending, trademarks, and other related intellectual property involving a full range of shuffling machine products for the casino industry (collectively, the \\\"Products\\\" and, individually, the \\\"Product\\\"); WHEREAS, Distributor is in the business of distributing products to the casino industry throughout the world and is a subsidiary of Victoria Holdings Ltd; and WHEREAS, Vendor desires to grant to Distributor an exclusive right to market, sell, rent, lease, service and maintain the Products subject to the terms and conditions as set forth herein. NOW, THEREFORE, in consideration of the several and mutual promises, agreements, covenants, understandings, undertakings, representations and warranties hereinafter set forth the receipt and sufficiency of which is hereby acknowledged, the parties to this Agreement agree that the aforementioned recitals are true and correct and by this reference incorporated herein as if fully set forth and the parties further covenant and agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 1, \"text\": \"1. TERM As provided for in this Section 1, the term of this Agreement shall be for a period of five (5) years, beginning on the Effective Date (the \\\"Initial Term\\\"); provided, however, the Initial Term shall be subject to automatic successive renewal terms of three (3) years each (the \\\"Renewal Terms\\\" and together with the Initial Term, the \\\"Term\\\").\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination\", \"level\": 2, \"text\": \"1.1. Termination. This Agreement may be terminated subject to the following clauses:\"}}, {\"id\": \"1.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"By either Vendor or Distributor, upon written notice of termination of this Agreement no later than ninety (90) calenda\", \"level\": 3, \"text\": \"1.1.1. By either Vendor or Distributor, upon written notice of termination of this Agreement no later than ninety (90) calendar days prior to the expiration of the relevant Term, then in effect;\"}}, {\"id\": \"1.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"By Vendor and Distributor, at any time, upon the mutual written agreement of Vendor and Distributor;\", \"level\": 3, \"text\": \"1.1.2. By Vendor and Distributor, at any time, upon the mutual written agreement of Vendor and Distributor;\"}}, {\"id\": \"1.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"By either Vendor or Distributor, following a material or continuing breach of this Agreement (in the case of a breach w\", \"level\": 3, \"text\": \"1.1.3. By either Vendor or Distributor, following a material or continuing breach of this Agreement (in the case of a breach which is capable of remedy) by the other party and the breaching party's failure to cure such breach within ninety (90) days of receiving written notice of such breach, where a breach shall be considered capable of remedy if the party in breach can comply with the provision in question in all respects other than as to the time of the performance (provided that the time of performance is not of the essence); or\"}}, {\"id\": \"1.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Section 1\", \"level\": 3, \"text\": \"1.1.4. Subject to Section 1.6, by Vendor (or successor to Vendor), upon written notice to Distributor of a change of control of Vendor and the election by Vendor (or successor to Vendor) to terminate this Agreement, where a \\\"change of control\\\" shall mean a change in ownership of the Vendor such that an unaffiliated third party acquires a majority of the voting power of Vendor;\"}}, {\"id\": \"1.1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Section 1\", \"level\": 3, \"text\": \"1.1.5. Subject to Section 1.6, with respect to any shuffler line, by Vendor, upon written notice to Distributor of the transfer of ownership of the relevant shuffler line (i.e,, the PokerOne\u2122 Shuffler, the Random Plus\u2122 Shuffler, the Continuous Plus\u2122 Shuffler and other future line of shuffler products offered by Vendor) to an unaffiliated third party and the election by the unaffiliated third party to terminate this Agreement with respect to the relevant shuffler line.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Responsibility\", \"level\": 2, \"text\": \"1.2. No Responsibility. Upon termination of this Agreement in accordance with the terms of this Section 1, the terminating party shall not be responsible for any costs or damages incurred by the other party resulting from the termination, subject to Section 1.6 of this Agreement.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor Credit\", \"level\": 2, \"text\": \"1.3. Distributor Credit. Except when this Agreement is terminated due to the uncured breach of Distributor, Distributor shall have within one (1) month of termination of this Agreement the right to return the Products purchased by Distributor to Vendor provided that the Products are unopened upon receipt by Vendor. Distributor will receive a credit for the full price paid by Distributor for the Products. Under such circumstances, Vendor shall have the right to market and sell such returns to other customers that may be interested in acquiring the goods referred to herein.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery upon Termination\", \"level\": 2, \"text\": \"1.4. Delivery upon Termination. In the event of termination for whatever reason, Vendor and Distributor agree to complete the delivery of each order of the Product received by Distributor and each unfulfilled order for the Product prior to the termination date.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effect\", \"level\": 2, \"text\": \"1.5. Effect. In the event of the termination of this Agreement for any reason whatsoever, the exclusive distribution right and license granted to Distributor pursuant to this Agreement shall automatically revert to Vendor as Vendor's sole property.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Monthly Compensation\", \"level\": 2, \"text\": \"1.6. Monthly Compensation. In the event that this Agreement is terminated pursuant to either Section 1.1.4 or 1.1.5 of this Agreement, this shall not of itself be deemed a breach hereof but Distributor shall have the right to receive monthly compensation from Vendor, or successor to the Vendor, representing the amount of profit to Distributor lost as a result of the termination (the \\\"Monthly Compensation\\\").\"}}, {\"id\": \"1.6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Calculation\", \"level\": 3, \"text\": \"1.6.1. Calculation. The amount of the Monthly Compensation shall be determined by taking average gross profit related to the relevant Products for each of the monthly periods completed since the beginning of this Agreement, where \\\"gross profit\\\" shall mean the difference between the revenue generated by Distributor during the relevant period less any commissions paid by Distributor to third parties and less the Price paid by Distributor to Vendor for the relevant Products (exclusive of any taxes, charges, fees or impositions related to sales or delivery).\"}}, {\"id\": \"1.6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment\", \"level\": 3, \"text\": \"1.6.2. Payment. The Monthly Compensation shall be paid for the remaining monthly periods remaining in the Term, as if the termination of this Agreement had not occurred, or twenty four (24) calendar months, which ever period is less, where payment shall be made no later than thirty (30) calendar days after the end of the relevant monthly period. -2-\"}}, {\"id\": \"1.6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reservation of Rights\", \"level\": 3, \"text\": \"1.6.3. Reservation of Rights. For the avoidance of doubt, Distributor's right to compensation shall be without prejudice to its rights in respect of any breach by Vendor of this Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GRANT OF DISTRIBUTION RIGHTS; LICENSE\", \"level\": 1, \"text\": \"2. GRANT OF DISTRIBUTION RIGHTS; LICENSE In consideration for the purchase of the Products by Distributor from Vendor, Vendor grants Distributor the exclusive right to market, sell, rent, lease, service and maintain the Products and all improvements thereon within the Territory (as defined herein) according to the terms and conditions as set forth herein. As part of the exclusive distribution right granted in this Section 2, Vendor hereby grants Distributor the non- exclusive, non-transferable right to use and display Vendor's trademarks, logos, Product photographs and images, Product advertising and promotional copy, including but not limited to the materials contained in Vendor's website, in connection with the promotion, advertising and distribution of the Products.\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definition of \\\"Territory\", \"level\": 2, \"text\": \"2.1. Definition of \\\"Territory.\\\" For the purposes of this Agreement, the \\\"Territory\\\" shall mean all countries and territories throughout the world with the exception of the United States of America, the Caribbean and cruise ships based from ports within the United States of America or the Caribbean.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitations\", \"level\": 2, \"text\": \"2.2. Limitations. Notwithstanding any other provision of this Agreement, the Distributor specifically agrees that any and all marks, logos, images and copy related to the Products are solely the property of Vendor. Distributor agrees not to use in any manner whatsoever the marks, logos, images and copy of Vendor following the expiration or termination of this Agreement, except as may be needed to sell any Products remaining in Distributor's inventory.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Design and Specification\", \"level\": 2, \"text\": \"2.3. Design and Specification. In its sole discretion and without any liability to Distributor, Vendor shall have final decision-making power with respect to, from time to time, alter the design or construction of any Products, add new and additional Products and discontinue any Products; provided, however, in the event of any such action on Vendor's part, Vendor shall give reasonable notice to Distributor.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prosecution of the Patent Applications\", \"level\": 2, \"text\": \"2.4. Prosecution of the Patent Applications. Vendor shall retain full and complete control over the prosecution of any patent applications and any related disclaimer proceedings.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership of Future Inventions and Improvements\", \"level\": 2, \"text\": \"2.5. Ownership of Future Inventions and Improvements. Any and all future inventions and improvements related to the Products licensed pursuant to this Agreement shall be the property of Vendor.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Commission to Vendor For Sales Lead to Distributor\", \"level\": 2, \"text\": \"2.6. Commission to Vendor For Sales Lead to Distributor. Subject to the mutual agreement of Vendor and Distributor, in the event that Vendor provides a new sales lead to Distributor that results in the sale of the Products, Distributor shall pay to Vendor a commission equal to twenty-five percent (25%) of the gross profit for the Products, where gross profit shall mean the difference between the price paid by the customer (where Distributor will determine the customer price for the Products on a case by case basis) and the price paid by Distributor for the Products. Sales leads for rental contracts provided by Vendor to Distributor will be dealt with on a case by case basis by mutual agreement between Vendor and Distributor. Any repeat orders will be dealt with on a case by case basis by mutual agreement between Vendor and Distributor. -3-\"}}, {\"id\": \"2.6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment\", \"level\": 3, \"text\": \"2.6.1. Payment. Distributor hereby agrees to provide to Vendor payment of the commission no later than thirty (30) calendar days after the receipt of full payment from the customer.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OBLIGATIONS OF DISTRIBUTOR\", \"level\": 1, \"text\": \"3. OBLIGATIONS OF DISTRIBUTOR In exchange for the exclusive distribution right and license provided in Section 2 of this Agreement, Distributor hereby agrees during the Term to use its best commercial efforts to promote, advertise and distribute the Products throughout the Territory, including, without limitation, the following:\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will purchase the Products from Vendor in accordance with the parameters set forth in Sections 5 and 6 of t\", \"level\": 2, \"text\": \"3.1. Distributor will purchase the Products from Vendor in accordance with the parameters set forth in Sections 5 and 6 of this Agreement;\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will be responsible for all marketing, selling and servicing efforts for the Products within the Territory;\", \"level\": 2, \"text\": \"3.2. Distributor will be responsible for all marketing, selling and servicing efforts for the Products within the Territory;\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall, in the event of any actual or alleged infringement of the Products comes to the attention of Distrib\", \"level\": 2, \"text\": \"3.3. Distributor shall, in the event of any actual or alleged infringement of the Products comes to the attention of Distributor, promptly notify Vendor, in writing, of the actual or alleged infringement;\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall not obtain, purchase, receive or source any other card shuffling machine from any third party or othe\", \"level\": 2, \"text\": \"3.4. Distributor shall not obtain, purchase, receive or source any other card shuffling machine from any third party or other source under any circumstance other than from Vendor with the exception of all Shuffle Master, Inc. shuffling machines which are held in stock at the Effective Date which Distributor is free to sell, rent purchase or lease until all of the said stock has been depleted.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall not sell or otherwise transfer any of the rights granted pursuant to this Agreement to any third part\", \"level\": 2, \"text\": \"3.5. Distributor shall not sell or otherwise transfer any of the rights granted pursuant to this Agreement to any third party without the prior written consent of Vendor; provided, however, Distributor may enter into distribution arrangements with regional distributors within the Territory in its efforts to promote, advertise and distribute the Products in accordance with this Agreement;\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall provide written updates to Vendor at the end of each calendar quarter of any distribution arrangement\", \"level\": 2, \"text\": \"3.6. Distributor shall provide written updates to Vendor at the end of each calendar quarter of any distribution arrangements entered into by Distributor as permitted by Section 3.5 of this Agreement, where said notice shall contain the name and location of the regional distributor, and a brief statement on the experience and history of the regional distributor;\"}}, {\"id\": \"3.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall not make any modifications to the Products without prior written consent of Vendor;\", \"level\": 2, \"text\": \"3.7. Distributor shall not make any modifications to the Products without prior written consent of Vendor;\"}}, {\"id\": \"3.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall provide to Vendor\", \"level\": 2, \"text\": \"3.8. Distributor shall provide to Vendor: (1) monthly sales figures no later than fifteen (15) calendar days after the end of the relevant monthly period that provides information with respect to sales for each Product; and (2) a non binding three (3) month forecast on a quarterly basis;\"}}, {\"id\": \"3.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall demonstrate the Products at the following international gaming exhibitions, ICE (London), G2E (Las Ve\", \"level\": 2, \"text\": \"3.9. Distributor shall demonstrate the Products at the following international gaming exhibitions, ICE (London), G2E (Las Vegas), SAGSE (Buenos Aires), EELEX (Moscow) and AGE (Sydney), or any successors or equivalents to the aforementioned exhibitions. Distributor may also demonstrate the products at other gaming exhibitions where Distributor decides to exhibit, subject to there being a good business case to do so; and\"}}, {\"id\": \"3.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall be responsible for the retention, use and actions of any third parties used to distribute the Product\", \"level\": 2, \"text\": \"3.10. Distributor shall be responsible for the retention, use and actions of any third parties used to distribute the Products, including any claims, liabilities or other damages associated with such third parties. -4-\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OBLIGATIONS OF VENDOR\", \"level\": 1, \"text\": \"4. OBLIGATIONS OF VENDOR In exchange for the marketing and selling of the Products provided in Section 3, Vendor hereby agrees:\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To provide Distributor with the appropriate product brochures, and two (2) fully working and fit for purpose samples of\", \"level\": 2, \"text\": \"4.1. To provide Distributor with the appropriate product brochures, and two (2) fully working and fit for purpose samples of each model of shuffling machine free of charge;\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To prominently display and advertise that Distributor is the sole and exclusive distributor of Vendor for the Products\", \"level\": 2, \"text\": \"4.2. To prominently display and advertise that Distributor is the sole and exclusive distributor of Vendor for the Products in the Territory;\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Section 2\", \"level\": 2, \"text\": \"4.3. Subject to Section 2.6 of this Agreement, not to market, distribute, sell or supply the Products covered by this Agreement to any individual or entity in the Territory directly in response to a request from that person or entity without the prior written consent of Distributor;\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Section 4\", \"level\": 2, \"text\": \"4.4. Subject to Section 4.5 of this Agreement, for a period of twenty-four (24) months after the Effective Date, not to develop, manufacture, market, distribute, sell or supply anywhere in the world to any individual or entity a gaming chip-sorting machine for use in a casino; and\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding Section 4\", \"level\": 2, \"text\": \"4.5. Notwithstanding Section 4.4 of this Agreement, use its best commercial efforts to enter into a separate agreement with Distributor for the manufacture of a gaming chip-sorting machine or the manufacture of components of a gaming chip-sorting machine for use by the casino industry, where a condition of the agreement will be that Vendor will not compete with Distributor in any way in relation to the manufacture, supply, sale and distribution of gaming chip-sorting machines. It is understood that if Vendor and Distributor fail to reach an agreement then the twenty-four (24) month restriction detailed in Section 4.4 above will remain in force.. The obligation detailed under Section 4.4 above will cease immediately if Distributor fails to complete its obligations under Section 5.1 below, where such failure is not a result of any default by Vendor, or if Distributor fails to provide payment for the Products within one hundred and eighty (180) days after the delivery of the same.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PURCHASE; SHIPPING\", \"level\": 1, \"text\": \"5. PURCHASE; SHIPPING\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase\", \"level\": 2, \"text\": \"5.1. Purchase. In exchange for the exclusive distribution right and license granted to Distributor pursuant to this Agreement, during the Term, Distributor hereby agrees to purchase the Products from Vendor, where such Products are fit for purpose and ready for sale in the Territory, as determined by Distributor, as follows:\"}}, {\"id\": \"5.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As of the Effective Date, one hundred (100) units of the PokerOne\u2122 Shuffler at a price of Four Thousand Nine Hundred Do\", \"level\": 3, \"text\": \"5.1.1. As of the Effective Date, one hundred (100) units of the PokerOne\u2122 Shuffler at a price of Four Thousand Nine Hundred Dollars ($4,950.00 U.S.) per unit, where Vendor shall ship the units no later than the end of January 2005;\"}}, {\"id\": \"5.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon the delivery of two (2) units of the Random Plus\u2122 Shuffler to Distributor and the expiration of a review period en\", \"level\": 3, \"text\": \"5.1.2. Upon the delivery of two (2) units of the Random Plus\u2122 Shuffler to Distributor and the expiration of a review period ending thirty (30) calendar days after the receipt of delivery by Distributor,, where such review by Distributor determines that the Random Plus\u2122 Shuffler is fit for purpose and ready for commercial sale in the Territory, one hundred (100) units of the Random Plus\u2122 Shuffler at a price of Four Thousand Nine Hundred Fifty Dollars ($4,950.00 U.S.) per unit, where Vendor shall ship the units no later than 30 days after the review period; -5-\"}}, {\"id\": \"5.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon the receipt of any necessary approvals or approval waivers and the expiration of a review period ending thirty (30\", \"level\": 3, \"text\": \"5.1.3. Upon the receipt of any necessary approvals or approval waivers and the expiration of a review period ending thirty (30) calendar days after the receipt of delivery by Distributor of two (2) units of the Continuous Plus\u2122 Shuffler, where such review by Distributor determines that the Continuous Plus\u2122 Shuffler is fit for purpose and ready for commercial sale in the Territory, one hundred (100) units of the Continuous Plus\u2122 Shuffler at a price of Five Thousand Nine Hundred Fifty Dollars ($5,950.00 U.S.);\"}}, {\"id\": \"5.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Within thirty (30) days of the one (1) year anniversary of the Effective Date, an additional two hundred (200) units of\", \"level\": 3, \"text\": \"5.1.4. Within thirty (30) days of the one (1) year anniversary of the Effective Date, an additional two hundred (200) units of the Products comprising any mix of the shuffler products offered by Vendor; and\"}}, {\"id\": \"5.1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any additional number of units of the Products as may be submitted by Distributor to Vendor pursuant to a Purchase Orde\", \"level\": 3, \"text\": \"5.1.5. Any additional number of units of the Products as may be submitted by Distributor to Vendor pursuant to a Purchase Order (as defined herein).\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Order\", \"level\": 2, \"text\": \"5.2. Purchase Order. Unless otherwise provided for in this Agreement, all orders for the purchase of the Products shall be made through the submission of a purchase order (a \\\"Purchase Order\\\"), where such Purchase Order shall set forth: (1) the relevant monthly period to which the Purchase Order relates; (2) the Products to be ordered; (3) the quantity of the Products ordered; (4) the relevant price for the Products ordered; (5) the requested shipping date and destination of the Products ordered; (6) the Purchase Order number; and (7) the name and authorized signature of Distributor.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shipping\", \"level\": 2, \"text\": \"5.3. Shipping. Unless otherwise provided for in this Agreement, upon the acceptance of a Purchase Order by Vendor, Vendor shall, in the normal course of business, package, crate and insure the Products at its cost (including any applicable export duties and export taxes) and deliver the Products to Distributor F.O.B. Zhongshan City, China. Vendor will advise Distributor immediately of any delay but will use all reasonable means to dispatch the Products within four (4) weeks of an order being received. Vendor shall as soon as practicable inform Distributor of the delivery date for each quantity of Products shipped to Distributor or to an address nominated by Distributor.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Partial Shipments; Pro Rata Allocation\", \"level\": 2, \"text\": \"5.4. Partial Shipments; Pro Rata Allocation. Vendor reserves the right to supply against a Purchase Order by making partial shipments of the Products. In the event that Vendor is forced to allocate the distribution of the Products due to limited supply, Distributor shall be treated no less favorably than any other distributor and shall receive its pro rata allocation of the Products.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE; PAYMENT\", \"level\": 1, \"text\": \"6. PRICE; PAYMENT\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price Changes\", \"level\": 2, \"text\": \"6.1. Price Changes. The prices stated in Section 5.1 of this Agreement are subject to change. For any price change to take effect ninety (90) days notice must be given in order for the price change to apply; provided, however, the proposed price change must also apply to the Products for sale by Vendor outside the Territory. In the event that there is a price change required by Vendor that does not fall within the ninety (90) day notice period, both parties agree to discuss the nature of the increase in order to reach a mutually acceptable understanding. All the aforementioned price changes will not exceed, on a percentage term basis, any increase in the US retail selling price. -6-\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment\", \"level\": 2, \"text\": \"6.2. Payment. Distributor agrees that all payments to Vendor for the Products shall be made by wire transfer in United States Dollars (U.S.$); provided, further,\"}}, {\"id\": \"6.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For all Products to be delivered by Vendor directly to Distributor, the Price shall be paid by Distributor to Vendor wi\", \"level\": 3, \"text\": \"6.2.1. For all Products to be delivered by Vendor directly to Distributor, the Price shall be paid by Distributor to Vendor within the earlier of: (1) one hundred eighty (180) calendar days from the date of delivery; or (2) thirty (30) calendar days after the sale or rental of the relevant Products by Distributor; and\"}}, {\"id\": \"6.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For all Products to be delivered by Vendor directly to a third party purchaser of Distributor (as instructed pursuant t\", \"level\": 3, \"text\": \"6.2.2. For all Products to be delivered by Vendor directly to a third party purchaser of Distributor (as instructed pursuant to the relevant Purchase Order), the Price shall be paid by Distributor to Vendor within forty-five (45) days of Distributor's sale of the Products to the third party purchaser.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notice of Discount Structure and Promotions\", \"level\": 2, \"text\": \"6.3. Notice of Discount Structure and Promotions. Vendor and Distributor each agree to provide the other party with written notice of its intent to offer a discount structure, rebate program or other promotion with respect to the sale of the Products, including the relevant time frame applicable to such discount structure, rebate program or promotion.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING MATERIALS\", \"level\": 1, \"text\": \"7. MARKETING MATERIALS\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Development of Marketing Materials\", \"level\": 2, \"text\": \"7.1. Development of Marketing Materials. Vendor and Distributor hereby agree to share marketing materials that are developed by either party for the Products covered by this Agreement, including, without limitation, any information, marketing or promotional materials for the Products, where, upon request, such marketing materials shall be delivered to the other party in hard copy and digital form, if available. Upon receipt of such marketing materials, the party may, in its sole discretion, elect to reject, use or modify such marketing materials.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prior Approval of Product Claims\", \"level\": 2, \"text\": \"7.2. Prior Approval of Product Claims. Distributor hereby agrees to obtain the prior written consent of Vendor prior to the use of any product claims with respect to the Products in its marketing materials.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cost Sharing\", \"level\": 2, \"text\": \"7.3. Cost Sharing. With respect to cost-intensive promotional materials, such as video productions, infomercials and website development and maintenance, Vendor and Distributor hereby agree to share equally in the cost and expenses related to the development and preparation of such promotional materials; provided, however, any and all expenditures related to the development and preparation of such promotional materials shall be approved in advance by Vendor and Distributor.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT RETURNS\", \"level\": 1, \"text\": \"8. PRODUCT RETURNS\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Procedure\", \"level\": 2, \"text\": \"8.1. Procedure. Distributor may return Products to Vendor for credit or full reimbursement, as the case may be, only pursuant to this Section 8.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Updated Products\", \"level\": 2, \"text\": \"8.2 Updated Products. Distributor may return to Vendor for credit against future purchases any Products for which a new version or upgrade has been produced and offered for sale; provided, however, the new version or upgrade must be of a material nature whereby the existing Products held by Distributor are considered obsolete. All Products must be returned undamaged, and all shipping charges -7- shall be paid by Distributor. This clause does not apply to any Products that have been in Distributor's inventory for more that one hundred and eighty (180) calendar days.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Damaged Products\", \"level\": 2, \"text\": \"8.3. Damaged Products. Promptly upon the receipt of a shipment of Products, Distributor shall inspect the Products for damage or shortage. Within ten (10) calendar days of receipt of the shipment, Distributor shall notify Vendor of any damage or shortage. As soon as commercially practical after receipt of notice, Vendor shall make complete any shipment in short supply. Any Products damaged in shipment shall be returned to Vendor along with documentation of the damage within thirty (30) calendar days of receipt by Distributor, and Vendor will reimburse Distributor for the costs of freight reasonably incurred by Distributor in returning the Products to Vendor. If Vendor finds any Products returned for damage to not be damaged, Distributor shall be subject to a restocking fee equal to fifteen percent (15%) original purchase price of the non-damaged Products.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Defective Products\", \"level\": 2, \"text\": \"8.4. Defective Products. Distributor may, no later than one hundred and twenty (120) calendar days after a Product is sold by Distributor to a customer, return to Vendor, at Distributor's expense, any Product received by Distributor from Vendor during the 120-day period prior to such return, which Distributor or its customer believes to be defective. In the event that such Product is defective, i.e., the failure of a Product to operate in accordance with its published specifications, Vendor shall:\"}}, {\"id\": \"8.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reimburse Distributor for the costs of freight reasonably incurred by Distributor in returning the Product to Vendor; a\", \"level\": 3, \"text\": \"8.4.1. Reimburse Distributor for the costs of freight reasonably incurred by Distributor in returning the Product to Vendor; and\"}}, {\"id\": \"8.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Issue Distributor a credit against future purchases in an amount equal to the purchase price paid by Distributor for th\", \"level\": 3, \"text\": \"8.4.2. Issue Distributor a credit against future purchases in an amount equal to the purchase price paid by Distributor for the Product or, as requested by Distributor, full reimbursement for the defective Products.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT TESTING AND RESULTS\", \"level\": 1, \"text\": \"9. PRODUCT TESTING AND RESULTS Whereas Vendor has organized and received the results from product testing with respect to the Products, Vendor hereby agrees to make available to Distributor the results of such product testing and grants to Distributor the right to use such results in its promotional materials; provided, however, Distributor may only use such results if Distributor complies with the applicable terms of use as provided by the institution, organization or other person that organized and conducted the relevant product testing. Conversely, in the event that Distributor organizes and receives the results from product testing with respect to the Products, Distributor hereby agrees to make available to Vendor the results of such product testing and grants to Vendor the right to use such results in its promotional materials.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES OF VENDOR\", \"level\": 1, \"text\": \"10. REPRESENTATIONS AND WARRANTIES OF VENDOR Vendor represents and warrants to Distributor as follows:\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Existence\", \"level\": 2, \"text\": \"10.1. Existence. Vendor is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Authorization; Binding Agreement\", \"level\": 2, \"text\": \"10.2. Authorization; Binding Agreement. This Agreement constitutes valid and legally binding obligations of Vendor, enforceable in accordance with its terms, except, in each case, as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws relating to or affecting the enforcement of creditors' rights generally in effect from time to time and by general principles of equity. Vendor has full corporate power and authority to enter into this Agreement. -8-\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Warranty\", \"level\": 2, \"text\": \"10.3. Product Warranty. Vendor warrants to Distributor that the Products shall perform without manufacturing failure and are fit for purpose. Distributor, in cooperation with Vendor will remedy any defect in the Product in accordance with Section 8.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Spare Products and Parts\", \"level\": 2, \"text\": \"10.4. Spare Products and Parts. Vendor will provide an initial supply of spare Products and parts as Distributor may reasonably required in accordance with Sections 8 and 10.3 to permit Distributor to offer a six-month warranty on the Products to customers and to enable Distributor to provide a warranty service to customers. The initial spare Products and parts to be provided pursuant to this Section 10.4 shall be at no additional charge to the Distributor; provided, however, any additional Products and parts unrelated to this Section 10.4 shall be purchased by Distributor.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Litigation\", \"level\": 2, \"text\": \"10.5. Litigation. Other than as disclosed in Vendor's filings made with the United States Securities and Exchange Commission, including without limitation the legal proceedings involving Shuffle Master, Inc., Vendor is not aware of any action, arbitration, suit, proceeding or investigation pending, or to the knowledge of Vendor, threatened against Vendor, that would have a material adverse effect on its ability to perform the terms of this Agreement.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES OF DISTRIBUTOR\", \"level\": 1, \"text\": \"11. REPRESENTATIONS AND WARRANTIES OF DISTRIBUTOR Distributor represents and warrants to Vendor as follows:\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Existence\", \"level\": 2, \"text\": \"11.1. Existence. Distributor is a company duly organized, validly existing and in good standing under the laws of England.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Authorization; Binding Agreement\", \"level\": 2, \"text\": \"11.2. Authorization; Binding Agreement. This Agreement constitutes valid and legally binding obligations of Distributor, enforceable in accordance with its terms, except, in each case, as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or other laws relating to or affecting the enforcement of creditors' rights generally in effect from time to time and by general principles of equity. Distributor has full corporate power and authority to enter into this Agreement.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Litigation\", \"level\": 2, \"text\": \"11.3. Litigation. Other than the legal proceedings involving Shuffle Master Inc, Distributor is not aware of any action, arbitration, suit, proceeding or investigation pending, or to the knowledge of Distributor, threatened against Distributor that would have a material adverse effect on its ability to perform the terms of this Agreement.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF WARRANTIES\", \"level\": 1, \"text\": \"12. LIMITATION OF WARRANTIES Vendor warrants that all Products are new and that, to its knowledge, all Vendor-supplied promotional materials comply in all respects with all applicable laws, rules and regulations. Although Vendor intends to provide a six-month limited warranty to the end user, Distributor shall make no warranties or representations with respect to the Products on behalf of Vendor. Distributor shall defend, indemnify and hold Vendor harmless from any and all claims, damages, costs or expenses, including attorney fees, incurred by Vendor in relation to any violation by Distributor of the foregoing sentence.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATIONS\", \"level\": 1, \"text\": \"13. INDEMNIFICATIONS Each party shall indemnify and hold harmless the other party, its affiliated companies, and its employees, officers, directors, attorneys, and agents and each of them, against any and all claims, liabilities, damages and costs, including reasonable attorneys' fees and settlement amounts, that the foregoing, or any of them, may incur by reason of any material breach of this Agreement. -9- Vendor shall indemnify and hold harmless Distributor, its affiliated companies, and its employees, officers, directors, attorneys, and agents and each of them, against any and all claims, liabilities, damages and costs, including reasonable attorneys' fees and settlement amounts, incurred by any claims of product liability, or any claims arising from any actual or alleged infringement of any patent, copyright, trademark or other intellectual property right by a Product supplied by Vendor pursuant to this Agreement. Each party's responsibilities under this Section 13 shall survive termination of this Agreement.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COVENANT TO PROTECT CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"14. COVENANT TO PROTECT CONFIDENTIAL INFORMATION\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definition\", \"level\": 2, \"text\": \"14.1. Definition. \\\"Confidential Information\\\" means any proprietary, non-public information relating to Vendor and the Products, including, without limitation, any and all strategic or business plans, customer lists and information relating to customers, marketing plans and strategies, unique software and databases, lists of material providers of services and products, terms and provisions of existing contracts and agreements, details of negotiations with current partners and business associates, details of business opportunities or projects, information relating to financial statements, employees, manufacturing and servicing methods, equipment, programs, strategies, analyses, profit margins, or other proprietary, non- public information used by Vendor; provided, however, that Confidential Information shall not include any information that: (1) was publicly known and made generally available after disclosure by Vendor; (2) becomes publicly known and made generally available through no wrongful action or inaction of Distributor; (3) is already in the possession of Distributor at the time of disclosure, without confidentiality restrictions, as shown by Distributor's file and records immediately prior to the time of disclosure; (4) is obtained by Distributor without breach of Distributor's obligations of confidentiality; or (5) is independently developed by Distributor without use of or reference to the Confidential Information, as shown by documents and other competent evidence in Distributor's possession.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Use and Non-Disclosure\", \"level\": 2, \"text\": \"14.2. Non-Use and Non-Disclosure. Distributor shall not, during the Term or anytime thereafter, without the express prior written consent of Vendor, use, divulge, publish or otherwise disclose to any other person any Confidential Information regarding Vendor, except as provided for in this Agreement or if required to do so pursuant to the order of a court having jurisdiction over the subject matter or a summons, subpoena or order in the nature thereof of any legislative body (including any committee thereof and any litigation or dispute resolution method against Vendor related to or arising out of this Agreement) or any governmental or administrative agency. In the event that Distributor or its directors, officers, employees, consultants or agents are requested or required by legal process to disclose any of the Confidential Information, Distributor shall give prompt notice so that Vendor may seek a protective order or other appropriate relief. In the event that such protective order is not obtained, Distributor shall disclose only that portion of the Confidential Information which its counsel advises that it is legally required to disclose.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Maintenance of Confidentiality\", \"level\": 2, \"text\": \"14.3. Maintenance of Confidentiality. Distributor agrees that it shall take all commercially reasonable measures to protect the secrecy of and avoid disclosure and unauthorized use of the Confidential Information. Without limiting the foregoing, Distributor shall take at least those measures that it takes to protect its own most highly confidential information and shall ensure that its employees who have access to Confidential Information have signed a non-use and non-disclosure agreement in content similar to the provisions hereof, prior to any disclosure of Confidential Information to such employees. Distributor shall not make any copies of the Confidential Information unless the same is previously approved in writing by Vendor. -10-\"}}, {\"id\": \"14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Return of Materials\", \"level\": 2, \"text\": \"14.4. Return of Materials. All documents and other tangible objects containing or representing Confidential Information which have been disclosed by Vendor to Distributor, and all copies thereof which are in the possession of Distributor, shall be and remain the property of Vendor and shall be promptly returned to Vendor upon Vendor's written request.\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Solicitation by Distributor\", \"level\": 2, \"text\": \"14.5. Non-Solicitation by Distributor. Distributor agrees that, without the prior written consent of the Vendor, for a period beginning from the date of this Agreement and ending three (3) years after the termination of this Agreement, neither Distributor nor any of its affiliates or representatives will: (1) employ or solicit to employ any of the employees of Vendor; or (2) encourage of the employees of the Vendor or its subsidiaries to leave the employment of Vendor; provided, however, this Section shall not apply to any such employee who has been terminated by or left the employment of Vendor prior to the Effective Date or, if employed by Vendor as of the Effective Date, any employee who has not been employed by Vendor for at least one (1) year after the end of such employment.\"}}, {\"id\": \"14.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Solicitation by Vendor\", \"level\": 2, \"text\": \"14.6. Non-Solicitation by Vendor. Vendor agrees that, without the prior written consent of the Distributor, for a period beginning from the date of this Agreement and ending three (3) years after the termination of this Agreement, neither Vendor nor any of its affiliates or representatives will: (1) employ or solicit to employ any of the employees of Distributor; or (2) encourage of the employees of the Distributor or its subsidiaries to leave the employment of Distributor; provided, however, this Section shall not apply to any such employee who has been terminated by or left the employment of Distributor prior to the Effective Date or, if employed by Distributor as of the Effective Date, any employee who has not been employed by Distributor for at least one (1) year after the end of such employment.\"}}, {\"id\": \"14.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Remedies\", \"level\": 2, \"text\": \"14.7. Remedies. Each party agrees that any violation of this Section 14 may cause irreparable injury to the other party, entitling the other party to seek injunctive relief in addition to all legal remedies. Nothing herein contained is intended to waive or diminish any rights the other party may have at law or in equity at any time to protect and defend its legitimate property interests (including its business relationship with third parties), the foregoing provisions being intended to be in addition to and not in derogation or limitation of any other rights the other party may have at law or equity.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OUTSIDE EVENTS\", \"level\": 1, \"text\": \"15. OUTSIDE EVENTS\"}}, {\"id\": \"15.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delay or Non-Performance\", \"level\": 2, \"text\": \"15.1. Delay or Non-Performance. No party shall be liable to the other for delay in performance, or the non-performance, of any of its obligations under this Agreement to the extent that such delay or non-performance is due to any cause beyond the party's control, provided that:\"}}, {\"id\": \"15.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"the party affected shall forthwith notify the other parties thereof; and\", \"level\": 3, \"text\": \"15.1.1. the party affected shall forthwith notify the other parties thereof; and:\"}}, {\"id\": \"15.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"if the circumstances in question prevail for a continuous period in excess of two (2) calendar months, the parties shal\", \"level\": 3, \"text\": \"15.1.2. if the circumstances in question prevail for a continuous period in excess of two (2) calendar months, the parties shall enter into bona fide discussions with a view to alleviating the effects thereof or to agreeing upon such alternative arrangements as may be fair and reasonable in all the circumstances.\"}}, {\"id\": \"15.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Vendor Supply Limitation\", \"level\": 2, \"text\": \"15.2 Vendor Supply Limitation. Vendor shall not be responsible or liable for any loss, damage, detention or delay caused by fire, strike, civil or military authority, governmental restrictions or controls, insurrection or riot, railroad, act of terrorism, marine or air embargoes, lockout, tempest, accident, breakdown of machinery, yield problems, delay in delivery of materials by other parties, or any cause which is unavoidable or beyond its reasonable control, nor, in any event, for consequential damages. -11-\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"16. LIMITATION OF LIABILITY Neither party shall be liable to the other for lost profits or indirect, special consequential or punitive damages of any kind arising in connection with the manufacture, sale and distribution of the products, even if such party has been advised of the possibility of such damages.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FURTHER ASSURANCES\", \"level\": 1, \"text\": \"17. FURTHER ASSURANCES The parties further covenant and agree to do, execute and deliver, or cause to be done, executed and delivered, and covenant and agree to use their best efforts to cause their successors and assigns to do, execute and deliver, or cause to be done, executed and delivered, all such further acts, transfers and assurances, for implementing the intention of the parties under this Agreement, as the parties reasonably shall request. The parties agree to execute any additional instruments or agreements necessary to affect the intent of this Agreement.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RELATIONSHIP OF THE PARTIES\", \"level\": 1, \"text\": \"18. RELATIONSHIP OF THE PARTIES This Agreement shall not create any joint venture or partnership between the parties. Nothing contained in this Agreement shall confer upon either party any proprietary interest in, or subject a party to any liability for or in respect of the business, assets, profits, losses or obligations of the other. Nothing herein contained shall be read or construed so as to make the parties a partnership, nor shall anything contained herein be read or construed in any way to restrict the freedom of either party to conduct any business or activity whatsoever without any accountability to the other party. Neither party shall be considered to be an agent or representative of the other party or have any authority or power to act for or undertake any obligation on behalf of the other party except as expressly authorized by the other party in writing. Any such unauthorized representation or action shall be considered a breach of this Agreement.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"19. ENTIRE AGREEMENT This Agreement constitutes the entire agreement between the Parties and supersedes any prior communications, representations or agreements of any kind, whether oral or written; provided, however, notwithstanding this Agreement, that certain Distribution Agreement by and between Vendor and TCS Aces Pty Limited dated September 19, 2004 shall remain in full force and effect.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COUNTERPARTS\", \"level\": 1, \"text\": \"20. COUNTERPARTS This Agreement may be executed in counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MODIFICATION\", \"level\": 1, \"text\": \"21. MODIFICATION This Agreement may not be modified or rescinded except by express written agreement signed by both of the Parties.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFLICTS\", \"level\": 1, \"text\": \"22. CONFLICTS If any term included in an invoice, purchase order, packing slip, or bill of lading contradicts or is otherwise at odds with any provision of this Agreement, the provisions of this Agreement shall prevail. -12-\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"JURISDICTION\", \"level\": 1, \"text\": \"23. JURISDICTION Disputes under this Agreement shall be resolved through arbitration in Ontario, Canada by a single arbitrator to be appointed by agreement of the parties, or in default, by the President of the Law Society/Bar of Canada. The laws of Ontario, Canada shall govern the conduct of the arbitration and any appeal from the decision of the arbitrator.\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WAIVER\", \"level\": 1, \"text\": \"24. WAIVER Neither the inspection by Distributor, nor any payment for or acceptance of all or any part of the Products specified in this Agreement, nor any extension of time, nor any possession taken by Distributor or Distributor's employees, shall operate as a waiver of any provision of this Agreement, or any power in this Agreement reserved to Distributor, or any rights or damages provided for in this Agreement, nor shall any waiver of any breach in this Agreement be held to be a waiver of any other or subsequent breach.\"}}, {\"id\": \"25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT OR DELEGATION\", \"level\": 1, \"text\": \"25. ASSIGNMENT OR DELEGATION No assignment by either Party of any rights, including rights to money due or to become due under this Agreement, or delegation of any duties under this Agreement or under any purchase orders subject to this Agreement, shall be binding on the nonassigning Party unless and until a written consent has been obtained from the nonassigning Party.\"}}, {\"id\": \"26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 1, \"text\": \"26. SEVERABILITY Any term or provision of this Agreement that is invalid or unenforceable in any jurisdiction shall be ineffective only to the extent of such invalidity or unenforceability and only as to such jurisdiction without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of these terms or provisions in any other jurisdiction.\"}}, {\"id\": \"27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW\", \"level\": 1, \"text\": \"27. GOVERNING LAW This Agreement shall be governed by, construed in accordance with the laws of Ontario, Canada. -13-\"}}, {\"id\": \"28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 1, \"text\": \"28. NOTICES Any notice, request, instruction, or other document required by the terms of this Agreement, or deemed by any of the parties hereto to be desirable, to be given to any other party hereto shall be in writing and shall be given by personal delivery, overnight delivery, facsimile (with confirmation of transmission) or mailed by registered or certified mail, postage prepaid, with return receipt requested, to the addresses of the Parties as follows: If to Distributor: Technical Casino Supplies Ltd Unit 9, Mulberry Business Centre, Quebec May, Rotherhithe, London, SE167LE Telephone: _____-_____-_____ Facsimile: _____-_____-_____ Attn: _____________ With a copy to: _________________ _________________ _________________ Telephone: _____-_____-_____ Facsimile: _____-_____-_____ Attn: ______________, Esq. If to Vendor: VendingData Corporation 6830 Spencer Street Las Vegas, Nevada 89119 Telephone: 702.733.7195 Facsimile: 702.733.7197 Attn: Steven J. Blad, President and CEO With a copy to: Kummer Kaempfer Bonner & Renshaw 3800 Howard Hughes Parkway, Seventh Floor Las Vegas, Nevada 89109 Telephone: 702.792.7000 Facsimile: 702.796.7181 Attn: Michael J. Bonner, Esq. -14- The persons and addresses set forth above may be changed from time to time by a notice sent as aforesaid. If notice is given by personal delivery or overnight delivery in accordance with the provisions of this Section, said notice shall be conclusively deemed given at the time of such delivery provided a receipt is obtained from the recipient. If notice is given by mail in accordance with the provisions of this Section, such notice shall be conclusively deemed given upon receipt and delivery or refusal. The Parties acknowledge that they have read this Agreement, understand it, and agree to be bound by its terms. VENDOR: VENDINGDATA CORPORATION, a Nevada corporation By: /s/ Steven J. Blad Its: Steven J. Blad CEO DISTRIBUTOR: TECHNICAL CASINO SUPPLIES LTD, an English company By: /s/ David K. Heap Its: David K. Heap Chief Executive Officer -15-\"}}, {\"id\": \"party:VendingData Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"VendingData Corporation\", \"role\": \"Vendor\", \"address\": \"VendingData Corporation 6830 Spencer Street Las Vegas, Nevada 89119\"}}, {\"id\": \"party:Technical Casino Supplies Ltd\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Technical Casino Supplies Ltd\", \"role\": \"Distributor\", \"address\": \"Technical Casino Supplies Ltd Unit 9, Mulberry Business Centre, Quebec May, Rotherhithe, London, SE167LE\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"January 21, 2005\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"a full range of shuffling machine products for the casino industry\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"a full range of shuffling machine products for the casino industry\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"a period of five (5) years, beginning on the Effective Date\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Renewal Terms\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Terms\", \"text\": \"automatic successive renewal terms of three (3) years each\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"together with the Initial Term, the \\\"Term\\\"\", \"definition_clause\": \"1\"}}, {\"id\": \"term:change of control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"change of control\", \"text\": \"a change in ownership of the Vendor such that an unaffiliated third party acquires a majority of the voting power of Vendor\", \"definition_clause\": \"1.1.4\"}}, {\"id\": \"term:Monthly Compensation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Monthly Compensation\", \"text\": \"the amount of profit to Distributor lost as a result of the termination\", \"definition_clause\": \"1.6\"}}, {\"id\": \"term:gross profit\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"gross profit\", \"text\": \"the difference between the revenue generated by Distributor during the relevant period less any commissions paid by Distributor to third parties and less the Price paid by Distributor to Vendor for the relevant Products (exclusive of any taxes, charges, fees or impositions related to sales or delivery)\", \"definition_clause\": \"1.6.1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"all countries and territories throughout the world with the exception of the United States of America, the Caribbean and cruise ships based from ports within the United States of America or the Caribbean\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"a purchase order\", \"definition_clause\": \"5.2\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"any proprietary, non-public information relating to Vendor and the Products, including, without limitation, any and all strategic or business plans, customer lists and information relating to customers, marketing plans and strategies, unique software and databases, lists of material providers of services and products, terms and provisions of existing contracts and agreements, details of negotiations with current partners and business associates, details of business opportunities or projects, information relating to financial statements, employees, manufacturing and servicing methods, equipment, programs, strategies, analyses, profit margins, or other proprietary, non- public information used by Vendor; provided, however, that Confidential Information shall not include any information that: (1) was publicly known and made generally available after disclosure by Vendor; (2) becomes publicly known and made generally available through no wrongful action or inaction of Distributor; (3) is already in the possession of Distributor at the time of disclosure, without confidentiality restrictions, as shown by Distributor's file and records immediately prior to the time of disclosure; (4) is obtained by Distributor without breach of Distributor's obligations of confidentiality; or (5) is independently developed by Distributor without use of or reference to the Confidential Information, as shown by documents and other competent evidence in Distributor's possession.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"value:five (5) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) years\"}}, {\"id\": \"value:three (3) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) years\"}}, {\"id\": \"value:ninety (90) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) calendar days\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:one (1) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) month\"}}, {\"id\": \"value:twenty four (24) calendar months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty four (24) calendar months\"}}, {\"id\": \"value:thirty (30) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) calendar days\"}}, {\"id\": \"value:twenty-five percent (25%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"twenty-five percent (25%)\"}}, {\"id\": \"value:fifteen (15) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) calendar days\"}}, {\"id\": \"value:three (3) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) month\"}}, {\"id\": \"value:twenty-four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) months\"}}, {\"id\": \"value:one hundred and eighty (180) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred and eighty (180) days\"}}, {\"id\": \"value:$4,950.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$4,950.00\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:$5,950.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5,950.00\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:four (4) weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four (4) weeks\"}}, {\"id\": \"value:one hundred eighty (180) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred eighty (180) calendar days\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:ten (10) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) calendar days\"}}, {\"id\": \"value:fifteen percent (15%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifteen percent (15%)\"}}, {\"id\": \"value:one hundred and twenty (120) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred and twenty (120) calendar days\"}}, {\"id\": \"value:120-day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"120-day\"}}, {\"id\": \"value:six-month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six-month\"}}, {\"id\": \"value:two (2) calendar months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) calendar months\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ETELOS,INC_03_09_2004-EX-10.8-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ETELOS,INC_03_09_2004-EX-10.8-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.8\", \"level\": 1, \"text\": \"EXHIBIT 10.8 DISTRIBUTOR AGREEMENT Tripath Technology, Inc. 3900 Freedom Circle Suite # 200 Santa Clara, CA 95054 Tel: (408) 567-3000 Fax: (408) 567-3003 This Agreement is effective 7/1/98 (\\\"Effective Date\\\") between Tripath Technology, Inc. (\\\"Tripath\\\"), and Uniquest Corporation 780 Montague Expressway Suite 406 Santa Jose, CA 95131 Tripath and Distributor intend to establish Distributor as a non-exclusive Distributor for Tripath products in the following designated Territory, subject to the terms and conditions of this Agreement. Korea\"}, {\"id\": \"1\", \"title\": \"Products\", \"level\": 1, \"text\": \"1. Products\"}, {\"id\": \"1.1\", \"title\": \"\\\"Products\\\" means the Tripath semiconductor products identified by Tripath in writing from time to time\", \"level\": 2, \"text\": \"1.1 \\\"Products\\\" means the Tripath semiconductor products identified by Tripath in writing from time to time.\"}, {\"id\": \"1.2\", \"title\": \"Tripath may discontinue manufacture or sale, or otherwise treat as obsolete, any or all of the Products covered by this\", \"level\": 2, \"text\": \"1.2 Tripath may discontinue manufacture or sale, or otherwise treat as obsolete, any or all of the Products covered by this Agreement upon thirty days written notice.\"}, {\"id\": \"2\", \"title\": \"Appointment and Term\", \"level\": 1, \"text\": \"2. Appointment and Term\"}, {\"id\": \"2.1\", \"title\": \"For the term of this Agreement, Tripath appoints Distributor as a non-exclusive distributor for the Products in the Terr\", \"level\": 2, \"text\": \"2.1 For the term of this Agreement, Tripath appoints Distributor as a non-exclusive distributor for the Products in the Territory, subject to Tripath's direct sales activities under Section 4.\"}, {\"id\": \"2.2\", \"title\": \"Distributor will use best efforts to develop the local market and promote the sales of Products within the Territory\", \"level\": 2, \"text\": \"2.2 Distributor will use best efforts to develop the local market and promote the sales of Products within the Territory. Distributor will not sell outside the Territory without Tripath's prior written permission, which will not be unreasonably withheld.\"}, {\"id\": \"2.3\", \"title\": \"After one month's written notice, Tripath may in its discretion amend (i) the Products, and/or (ii) the Territory\", \"level\": 2, \"text\": \"2.3 After one month's written notice, Tripath may in its discretion amend (i) the Products, and/or (ii) the Territory.\"}, {\"id\": \"2.4\", \"title\": \"Tripath reserves the right to appoint other distributors in or out of the Territory who may sell into the Territory\", \"level\": 2, \"text\": \"2.4 Tripath reserves the right to appoint other distributors in or out of the Territory who may sell into the Territory.\"}, {\"id\": \"2.5\", \"title\": \"Distributor's appointment is for a term of one year from the Effective Date, renewable automatically unless terminated u\", \"level\": 2, \"text\": \"2.5 Distributor's appointment is for a term of one year from the Effective Date, renewable automatically unless terminated under Section 18\"}, {\"id\": \"3\", \"title\": \"Distributor Responsibilities\", \"level\": 1, \"text\": \"3. Distributor Responsibilities\"}, {\"id\": \"3.1\", \"title\": \"Distributor will maintain an adequately trained sales organization, capable of fulfilling its obligation under Subsectio\", \"level\": 2, \"text\": \"3.1 Distributor will maintain an adequately trained sales organization, capable of fulfilling its obligation under Subsection 2.2.\"}, {\"id\": \"3.2\", \"title\": \"Tripath will furnish technical and marketing information (such as sales aids and\", \"level\": 2, \"text\": \"3.2 Tripath will furnish technical and marketing information (such as sales aids and Distributor Agreement literature, data sheets, application notes, etc.) for the Products, and Distributor will maintain an organized and well stocked collection of such technical and marketing information for distribution to prospective customers.\"}, {\"id\": \"3.3\", \"title\": \"Distributor will employ sufficient trained personnel (\\\"Application Engineers\\\") to provide technical and marketing suppor\", \"level\": 2, \"text\": \"3.3 Distributor will employ sufficient trained personnel (\\\"Application Engineers\\\") to provide technical and marketing support for Tripath's Products. Distributor and Tripath will cooperate to ensure that the Application Engineers are and remain adequately trained and qualified.\"}, {\"id\": \"3.4\", \"title\": \"Distributor will maintain a reasonable number of Demonstration Products (customer samples), with appropriate technical a\", \"level\": 2, \"text\": \"3.4 Distributor will maintain a reasonable number of Demonstration Products (customer samples), with appropriate technical and marketing literature, available for demonstration by knowledgeable Distributor personnel, provided that Distributor must obtain prior approval by Tripath before any customer receives demonstration Products (customer samples).\"}, {\"id\": \"3.5\", \"title\": \"Distributor has no authorization to make, and will not make, any guarantee or warranty with respect to any Product \u2014 all\", \"level\": 2, \"text\": \"3.5 Distributor has no authorization to make, and will not make, any guarantee or warranty with respect to any Product \u2014 all Product warranties are to be communicated to Customers directly by Tripath in writing. Distributor will make no representations as to quality, performance, capabilities, and the like except as are expressly authorized in writing by Tripath (such as in Tripath's standard, published specifications for a Product).\"}, {\"id\": \"4\", \"title\": \"Other Product Lines\", \"level\": 1, \"text\": \"4. Other Product Lines\"}, {\"id\": \"4.1\", \"title\": \"In appointing Distributor, Tripath is relying to a significant extent on Distributor's undertaking in Subsection 2\", \"level\": 2, \"text\": \"4.1 In appointing Distributor, Tripath is relying to a significant extent on Distributor's undertaking in Subsection 2.2.\"}, {\"id\": \"4.2\", \"title\": \"Distributor will not carry any competitive products without Tripath's consent, which shall not be unreasonable\", \"level\": 2, \"text\": \"4.2 Distributor will not carry any competitive products without Tripath's consent, which shall not be unreasonable.\"}, {\"id\": \"5\", \"title\": \"Tripath Direct Sales Activity\", \"level\": 1, \"text\": \"5. Tripath Direct Sales Activity\"}, {\"id\": \"5.1\", \"title\": \"Tripath may in its sole discretion, immediately upon written notice to Distributor, make direct sales to certain account\", \"level\": 2, \"text\": \"5.1 Tripath may in its sole discretion, immediately upon written notice to Distributor, make direct sales to certain accounts in the Territory (\\\"Direct Sales Accounts\\\"), including accounts to which Distributor has made sales.\"}, {\"id\": \"6\", \"title\": \"Pricing, credits, and allowances\", \"level\": 1, \"text\": \"6. Pricing, credits, and allowances\"}, {\"id\": \"6.1\", \"title\": \"Prices for Products will be as set forth in the then effective distributor price list (\\\"Distributor Price List\\\") which w\", \"level\": 2, \"text\": \"6.1 Prices for Products will be as set forth in the then effective distributor price list (\\\"Distributor Price List\\\") which will be furnished to Distributor from time to time. Any suggested resale prices shown in the Distributor Price List are to be considered as guidelines only.\"}, {\"id\": \"6.2\", \"title\": \"The Distributor Price List may be changed without prior notice, and will be effective as of the effective date indicated\", \"level\": 2, \"text\": \"6.2 The Distributor Price List may be changed without prior notice, and will be effective as of the effective date indicated. The amount and timing of such change will be exclusively at Tripath's discretion.\"}, {\"id\": \"6.3\", \"title\": \"Orders for Products received and acknowledged by Tripath prior to a change in the Price List but shipped after the effec\", \"level\": 2, \"text\": \"6.3 Orders for Products received and acknowledged by Tripath prior to a change in the Price List but shipped after the effective date of such change will be invoiced as follows: (a) in the case of a price decrease, the existing order backlog will be invoiced at the lower price, and (b) in the case of a price increase, the existing order backlog due for delivery within one month of the effective date of such change will be invoiced at the lower price. Outstanding written quotations will be held good for the same two-month period.\"}, {\"id\": \"6.4\", \"title\": \"Distributor's inventory of any Product will be price protected for reductions in the price of such Product as follows\", \"level\": 2, \"text\": \"6.4 Distributor's inventory of any Product will be price protected for reductions in the price of such Product as follows: the lesser of Distributor's (a) entire inventory of the Product, or (b) previous one month's shipments of the Product from Tripath.\"}, {\"id\": \"7\", \"title\": \"Purchase Orders and Payment\", \"level\": 1, \"text\": \"7. Purchase Orders and Payment\"}, {\"id\": \"7.1\", \"title\": \"Distributor will maintain sufficient inventory of Products (but not less than one month's inventory without Tripath's ap\", \"level\": 2, \"text\": \"7.1 Distributor will maintain sufficient inventory of Products (but not less than one month's inventory without Tripath's approval) to provide prompt delivery to Distributor's customers, in furtherance of Distributor's undertaking in Subsection 2.2. -2- Distributor Agreement\"}, {\"id\": \"7.2\", \"title\": \"Distributor will purchase Products for resale to its customers in accordance with Tripath's then effective terms and con\", \"level\": 2, \"text\": \"7.2 Distributor will purchase Products for resale to its customers in accordance with Tripath's then effective terms and conditions of sale set forth in the Tripath sales order acknowledgment (\\\"Sales Order Acknowledgment\\\"), and the pricing terms of the then effective Distributor Price List (including minimum order quantities). The terms and conditions of sale in the Sales Order Acknowledgment may be changed without prior notice, exclusively at Tripath's discretion.\"}, {\"id\": \"7.3\", \"title\": \"No purchase order from Distributor is binding on Tripath until Tripath issues a Sales Order Acknowledgment to Distributo\", \"level\": 2, \"text\": \"7.3 No purchase order from Distributor is binding on Tripath until Tripath issues a Sales Order Acknowledgment to Distributor for such order, or makes a shipment against such order. Tripath will use commercially reasonable efforts to acknowledge Distributor purchase orders promptly.\"}, {\"id\": \"7.4\", \"title\": \"Tripath will invoice Distributor for Products when Tripath ships such Products\", \"level\": 2, \"text\": \"7.4 Tripath will invoice Distributor for Products when Tripath ships such Products.\"}, {\"id\": \"7.5\", \"title\": \"All credits will be handled as separate financial transactions from the original invoice, and will be evidenced by a wri\", \"level\": 2, \"text\": \"7.5 All credits will be handled as separate financial transactions from the original invoice, and will be evidenced by a written credit request submitted to Tripath. Distributor will not reduce any payment to Tripath to account for anticipated or unauthorized credits (except for short shipments and non-receipt of Products), either at the time of the payment of original invoice, or at the time of providing a credit request. Credit requests should be submitted by Distributor within one month after the date of Distributor's invoice for the related transactions.\"}, {\"id\": \"7.6\", \"title\": \"Any credit request will be based on the price shown on the then current Distributor Price List, or the actual net price\", \"level\": 2, \"text\": \"7.6 Any credit request will be based on the price shown on the then current Distributor Price List, or the actual net price paid by Distributor for the Product, whichever is lower.\"}, {\"id\": \"7.7\", \"title\": \"If Tripath notifies Distributor of any discrepancy in a credit request, Distributor has one month to resolve the discrep\", \"level\": 2, \"text\": \"7.7 If Tripath notifies Distributor of any discrepancy in a credit request, Distributor has one month to resolve the discrepancy and pay the amount of the discrepancy.\"}, {\"id\": \"7.8\", \"title\": \"No purchase orders for which a Sales Order Acknowledgment has been issued may be canceled or rescheduled within one mont\", \"level\": 2, \"text\": \"7.8 No purchase orders for which a Sales Order Acknowledgment has been issued may be canceled or rescheduled within one month of the scheduled shipment date without Tripath's approval.\"}, {\"id\": \"8\", \"title\": \"Special Pricing and Other Allowances\", \"level\": 1, \"text\": \"8. Special Pricing and Other Allowances\"}, {\"id\": \"8.1\", \"title\": \"The provisions of this Section 8 will be applicable only to transactions on DPA (distributor price authorization) basis\", \"level\": 2, \"text\": \"8.1 The provisions of this Section 8 will be applicable only to transactions on DPA (distributor price authorization) basis in which Distributor first obtains a DPA confirmation from Tripath.\"}, {\"id\": \"8.2\", \"title\": \"Requests for special pricing and/or allowances will be submitted by Distributor to the appropriate Tripath sales office,\", \"level\": 2, \"text\": \"8.2 Requests for special pricing and/or allowances will be submitted by Distributor to the appropriate Tripath sales office, and must be first approved in writing by that office.\"}, {\"id\": \"8.3\", \"title\": \"Quotes for special pricing are good for one month, and must be backed by a Tripath quote number\", \"level\": 2, \"text\": \"8.3 Quotes for special pricing are good for one month, and must be backed by a Tripath quote number. Distributor will supply supporting documentation showing Products listed by part number, date of transaction, end customer name and address, and the appropriate special pricing details, not later than two weeks after shipment to the associated customer.\"}, {\"id\": \"8.4\", \"title\": \"If Tripath has granted Distributor special pricing on a sale in which Distributor's customer has later returned the Prod\", \"level\": 2, \"text\": \"8.4 If Tripath has granted Distributor special pricing on a sale in which Distributor's customer has later returned the Product to Distributor, Distributor will reimburse Tripath for the amount of the DPA allowance within one month after such return.\"}, {\"id\": \"8.5\", \"title\": \"Any debit memo submitted by Distributor for a DPA allowance will be based on the price shown on the then current Distrib\", \"level\": 2, \"text\": \"8.5 Any debit memo submitted by Distributor for a DPA allowance will be based on the price shown on the then current Distributor Price List, or the actual net price paid by Distributor for the Product, whichever is lower.\"}, {\"id\": \"9\", \"title\": \"Returns\", \"level\": 1, \"text\": \"9. Returns\"}, {\"id\": \"9.1\", \"title\": \"Distributor may return Products only after receiving written authorization from Tripath\", \"level\": 2, \"text\": \"9.1 Distributor may return Products only after receiving written authorization from Tripath. All authorized returns will be shipped by Distributor freight prepaid. Unauthorized returns may be reshipped to Distributor, freight collect. -3- Distributor Agreement\"}, {\"id\": \"9.2\", \"title\": \"Distributor may request stock rotation return of slow moving Products, which will be authorized by Tripath provided that\", \"level\": 2, \"text\": \"9.2 Distributor may request stock rotation return of slow moving Products, which will be authorized by Tripath provided that: (a) the Product is contained in Tripath's then current Distributor Price List, (b) the Product is packaged as it was originally shipped, and (c) a purchase order for equal value accompanies the request for return. Such stock rotation returns will not exceed five percent (5%) of the dollar value of Distributor's previous six (6) months net purchase orders from Tripath.\"}, {\"id\": \"9.3\", \"title\": \"Discontinued Product may be returned only with prior written authorization\", \"level\": 2, \"text\": \"9.3 Discontinued Product may be returned only with prior written authorization.\"}, {\"id\": \"9.4\", \"title\": \"Credit will be allowed for returned Products based on the price actually paid by Distributor, less any prior DPAs, credi\", \"level\": 2, \"text\": \"9.4 Credit will be allowed for returned Products based on the price actually paid by Distributor, less any prior DPAs, credits and other allowances.\"}, {\"id\": \"9.5\", \"title\": \"If, in the reasonable opinion of Tripath, previously authorized returned Products have been used or damaged, a credit or\", \"level\": 2, \"text\": \"9.5 If, in the reasonable opinion of Tripath, previously authorized returned Products have been used or damaged, a credit or replacement may be refused. Distributor will be notified within one month after receipt of Product by Tripath of any such Product Tripath is claiming to be used or damaged.\"}, {\"id\": \"10\", \"title\": \"Limited Warranty\", \"level\": 1, \"text\": \"10. Limited Warranty\"}, {\"id\": \"10.1\", \"title\": \"Tripath provides an end user limited warranty for retail Products, and one-year limited warranty for OEM products\", \"level\": 2, \"text\": \"10.1 Tripath provides an end user limited warranty for retail Products, and one-year limited warranty for OEM products. The terms of the end user limited warranty are set forth in documentation provided with the retail Product.\"}, {\"id\": \"10.2\", \"title\": \"For OEM Products, Tripath warrants that the Products will be free of manufacturing and workmanship defects for one year\", \"level\": 2, \"text\": \"10.2 For OEM Products, Tripath warrants that the Products will be free of manufacturing and workmanship defects for one year from the date of shipment by Distributor to a customer, or eighteen months from the date of shipment to Distributor, whichever is sooner.\"}, {\"id\": \"10.3\", \"title\": \"If any OEM Products prove defective during this one year period as set forth in Section 10\", \"level\": 2, \"text\": \"10.3 If any OEM Products prove defective during this one year period as set forth in Section 10.2, Tripath will, at its option, either (a) repair or replace the Product with a new or reconditioned Product, (b) use reasonable efforts to provide Distributor with a correction of the defect, or (c) refund to Distributor the purchase price paid for the Product. Any Product replaced will become Tripath property.\"}, {\"id\": \"10.4\", \"title\": \"Distributor must return the defective OEM Product pursuant to a return material authorization under Section 9\", \"level\": 2, \"text\": \"10.4 Distributor must return the defective OEM Product pursuant to a return material authorization under Section 9.1 in the original shipping carton (or an equivalent protective carton), and pay the shipping and insurance charges. Distributor assumes the risk of loss or damage during shipment.\"}, {\"id\": \"10.5\", \"title\": \"OEM Products that are defective as set forth in Section 10\", \"level\": 2, \"text\": \"10.5 OEM Products that are defective as set forth in Section 10.2 as a result of improper handling, incorrect installation or other misuse, or as a result of accident, disaster, acts of God or other such events, as determined by Tripath in its reasonable discretion, are not covered by this limited warranty.\"}, {\"id\": \"10.6\", \"title\": \"For OEM Products, Tripath provides only the warranties set forth in this limited one year limited warranty\", \"level\": 2, \"text\": \"10.6 For OEM Products, Tripath provides only the warranties set forth in this limited one year limited warranty. For retail Products, Tripath provides to the end user only the warranties set forth in the applicable end user warranty. Any and all other warranties, either express, implied or statutory, including, without limitation, warranties of fitness for a particular purpose, or of merchantability, are hereby expressly excluded and disclaimed by Tripath.\"}, {\"id\": \"11\", \"title\": \"Reports and Audits\", \"level\": 1, \"text\": \"11. Reports and Audits\"}, {\"id\": \"11.1\", \"title\": \"Distributor will submit reports as may be reasonably requested by Tripath, including, without limitation, monthly report\", \"level\": 2, \"text\": \"11.1 Distributor will submit reports as may be reasonably requested by Tripath, including, without limitation, monthly reports of inventory on hand and sales relating to the Products. Sales data will include, without limitation, Product part number, quantity, resale price, special pricing, distributor invoice number, and customer name. Distributor will submit these reports electronically on a timely basis each month and in no case later than two weeks after the beginning of the month. -4- Distributor Agreement\"}, {\"id\": \"11.2\", \"title\": \"Tripath may have an authorized Tripath representative, at Tripath's cost, audit Distributor's records relating to sales\", \"level\": 2, \"text\": \"11.2 Tripath may have an authorized Tripath representative, at Tripath's cost, audit Distributor's records relating to sales and inventories of Products, including, without limitation, records pertaining to any claims submitted by Distributor for price protection, stock rotation, returned Products, ship from stock and debit, DPA allowances, and credit requests. Upon prior written notice, Distributor will provide reasonable access to such records during normal business hours at Distributor's office. Distributor agrees to maintain all such records for a minimum of three years.\"}, {\"id\": \"12\", \"title\": \"Distributor's Financial Condition\", \"level\": 1, \"text\": \"12. Distributor's Financial Condition\"}, {\"id\": \"12.1\", \"title\": \"Tripath may withhold shipments because of Distributor's general financial condition and/or conditions of Distributor's a\", \"level\": 2, \"text\": \"12.1 Tripath may withhold shipments because of Distributor's general financial condition and/or conditions of Distributor's account with Tripath. Such withholding will be not construed as a breach of this Agreement.\"}, {\"id\": \"12.2\", \"title\": \"Distributor will supply Tripath with credit data sufficient to establish Distributor's credit worthiness\", \"level\": 2, \"text\": \"12.2 Distributor will supply Tripath with credit data sufficient to establish Distributor's credit worthiness.\"}, {\"id\": \"13\", \"title\": \"Advertising and Sales Promotion\", \"level\": 1, \"text\": \"13. Advertising and Sales Promotion\"}, {\"id\": \"13.1\", \"title\": \"Distributor's tradename may be used by Tripath in its advertisements, provided that such use is in proper form\", \"level\": 2, \"text\": \"13.1 Distributor's tradename may be used by Tripath in its advertisements, provided that such use is in proper form.\"}, {\"id\": \"13.2\", \"title\": \"Distributor will be eligible to participate in Tripath distributor cooperative advertising programs designated by Tripat\", \"level\": 2, \"text\": \"13.2 Distributor will be eligible to participate in Tripath distributor cooperative advertising programs designated by Tripath for the Territory. However, prior approval must be obtained in writing from Tripath before any expenditures of funds by Distributor are eligible for reimbursement.\"}, {\"id\": \"14\", \"title\": \"Tripath Trademarks\", \"level\": 1, \"text\": \"14. Tripath Trademarks\"}, {\"id\": \"14.1\", \"title\": \"Tripath grants to Distributor a non-exclusive license to use Tripath's trademarks, trade names and service marks only in\", \"level\": 2, \"text\": \"14.1 Tripath grants to Distributor a non-exclusive license to use Tripath's trademarks, trade names and service marks only in connection with the Products and in the performance of Distributor's obligations under this Agreement. All such uses are subject to Tripath's prior review and consent, which will not be unreasonably withheld or delayed.\"}, {\"id\": \"14.2\", \"title\": \"All use of Tripath trademarks and service marks will be in proper form, giving appropriate attribution to Tripath as the\", \"level\": 2, \"text\": \"14.2 All use of Tripath trademarks and service marks will be in proper form, giving appropriate attribution to Tripath as the owner of the mark. Distributor will not undertake any use of a mark in a manner that might jeopardize Tripath's rights to use or register such mark, or Tripath's rights to prevent unauthorized use. Distributor will promptly notify Tripath of any acts of unfair competition or trade or service mark infringement, and reasonably cooperate with efforts to protect Tripath's rights.\"}, {\"id\": \"14.3\", \"title\": \"All use of Tripath trade marks and service marks by Distributor will inure to the benefit of Tripath, and Distributor wi\", \"level\": 2, \"text\": \"14.3 All use of Tripath trade marks and service marks by Distributor will inure to the benefit of Tripath, and Distributor will reasonably cooperate, at Tripath's expense with Tripath's efforts to register or otherwise secure rights in such marks. Upon termination of this Agreement, Distributor will immediately cease all further use of Tripath's trademarks, trade names or service marks except as may be required in the sale of Products in inventory.\"}, {\"id\": \"15\", \"title\": \"Relationship Between the Parties\", \"level\": 1, \"text\": \"15. Relationship Between the Parties\"}, {\"id\": \"15.1\", \"title\": \"Both Distributor and Tripath are independent contractors, and no agency or other joint relationship is created\", \"level\": 2, \"text\": \"15.1 Both Distributor and Tripath are independent contractors, and no agency or other joint relationship is created.\"}, {\"id\": \"15.2\", \"title\": \"Neither party has any authority to act for and/or to bind the other in any way, or to represent that either is in any wa\", \"level\": 2, \"text\": \"15.2 Neither party has any authority to act for and/or to bind the other in any way, or to represent that either is in any way responsible for the acts of the other.\"}, {\"id\": \"16\", \"title\": \"Confidentiality\", \"level\": 1, \"text\": \"16. Confidentiality\"}, {\"id\": \"16.1\", \"title\": \"Confidential information (\\\"Information\\\") of Tripath and/or Distributor will mean information that the disclosing party d\", \"level\": 2, \"text\": \"16.1 Confidential information (\\\"Information\\\") of Tripath and/or Distributor will mean information that the disclosing party desires to protect against unauthorized use or disclosure, and which is furnished under this Agreement as follows: (a) written or other tangible information clearly marked with a notice, such as -5- Distributor Agreement \\\"CONFIDENTIAL\\\"; and (b) oral information that is identified at the time of disclosure as being confidential. Confidential Information will not include information that: (a) enters the public domain without a breach of this Agreement, (b) is known to the recipient prior to the time of disclosure, or is independently developed by the recipient without using any Information, or (c) is obtained from another source that the receiving party has no reasonable cause to believe is under any obligation of confidentiality with respect to Information.\"}, {\"id\": \"16.2\", \"title\": \"The recipient of Information will treat it as proprietary and confidential, safeguarding the Information at least as car\", \"level\": 2, \"text\": \"16.2 The recipient of Information will treat it as proprietary and confidential, safeguarding the Information at least as carefully as it would its own confidential information, and will use all reasonable efforts to prevent any unauthorized use or disclosure, including restricting access to the Information within its organization and ensuring that its employees comply with this Agreement. A receiving party will not disclose any information to any third party without prior written consent. Either party learning of any unauthorized use or disclosure of any Information will promptly notify the other party, and will reasonably cooperate with efforts to protect such Information.\"}, {\"id\": \"16.3\", \"title\": \"The recipient of information will use it only in the furtherance of the business relationship established by this Agreem\", \"level\": 2, \"text\": \"16.3 The recipient of information will use it only in the furtherance of the business relationship established by this Agreement, and for no other purpose without prior written consent. All Information will remain the property of the disclosing party, and will be returned or destroyed upon written request.\"}, {\"id\": \"16.4\", \"title\": \"The confidentiality obligations in this Agreement will be binding during the Agreement and for a period of three years a\", \"level\": 2, \"text\": \"16.4 The confidentiality obligations in this Agreement will be binding during the Agreement and for a period of three years after any termination or non-renewal of the Agreement.\"}, {\"id\": \"16.5\", \"title\": \"Neither party will disclose the existence or terms of this Agreement without prior written consent\", \"level\": 2, \"text\": \"16.5 Neither party will disclose the existence or terms of this Agreement without prior written consent.\"}, {\"id\": \"17\", \"title\": \"Export Control\", \"level\": 1, \"text\": \"17. Export Control\"}, {\"id\": \"17.1\", \"title\": \"Distributor will not engage in exporting activities within the Territory without the prior written approval of Tripath,\", \"level\": 2, \"text\": \"17.1 Distributor will not engage in exporting activities within the Territory without the prior written approval of Tripath, and the United States Government if such approval is necessary. Nothing in this Subsection is meant to authorize Distributor shipments outside the Territory.\"}, {\"id\": \"17.2\", \"title\": \"Distributor understands that the Products and Tripath confidential information are restricted by the United States Gover\", \"level\": 2, \"text\": \"17.2 Distributor understands that the Products and Tripath confidential information are restricted by the United States Government from export to certain countries, and Distributor agrees that it will not sell or license Products or transfer Tripath confidential information in any way will violate any of the export control laws or regulations of the United States.\"}, {\"id\": \"18\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"18. Term and Termination\"}, {\"id\": \"18.1\", \"title\": \"The terms of this Agreement shall be one year from the effective date and will be automatically renewed on each annivers\", \"level\": 2, \"text\": \"18.1 The terms of this Agreement shall be one year from the effective date and will be automatically renewed on each anniversary of the effective date, for a renewal term of one year unless either party provides written notification of its intention not to renew this Agreement at least one month prior to the expiration of the initial or any renewal terms. Tripath will honor all orders acknowledged prior to the effective date of any such termination by nonrenewable.\"}, {\"id\": \"18.2\", \"title\": \"Tripath or Distributor may terminate this Agreement for any reason with thirty days written notice\", \"level\": 2, \"text\": \"18.2 Tripath or Distributor may terminate this Agreement for any reason with thirty days written notice.\"}, {\"id\": \"18.3\", \"title\": \"Either party may terminate this Agreement immediately if the other party becomes insolvent, or takes any steps to make a\", \"level\": 2, \"text\": \"18.3 Either party may terminate this Agreement immediately if the other party becomes insolvent, or takes any steps to make an arrangement with its creditors, or has a receiver appointed.\"}, {\"id\": \"18.4\", \"title\": \"If Tripath terminates pursuant to Subsection 18\", \"level\": 2, \"text\": \"18.4 If Tripath terminates pursuant to Subsection 18.1 or 18.2, or if Distributor terminates pursuant to Subsection 18.3, Tripath will purchase and Distributor will resell to Tripath Distributor's inventory of Products (excluding -6- Distributor Agreement discontinued and demonstration Products) which Tripath determines to be undamaged and in good condition (including, at Tripath's option on-site inspection). The price for such inventory will be the price actually paid by the Distributor, less any prior credit or allowances.\"}, {\"id\": \"18.6\", \"title\": \"On termination of this Agreement for whatever cause, Distributor will immediately (a) cease to engage in marketing and d\", \"level\": 2, \"text\": \"18.6 On termination of this Agreement for whatever cause, Distributor will immediately (a) cease to engage in marketing and distribution activities as Tripath's official distributor, and (b) cease representing in any manner that it is a distributor of Tripath Products in the Territory.\"}, {\"id\": \"18.7\", \"title\": \"All obligations of Distributor to make payments under this Agreement will survive any termination of this Agreement for\", \"level\": 2, \"text\": \"18.7 All obligations of Distributor to make payments under this Agreement will survive any termination of this Agreement for whatever cause, along with the following provisions: Section 10 (Limited Warranty), Section 11 (Reports and Audits), Section 16 (Confidentiality), Section 17 (Export Control), Section 19 (Intellectual Property Indemnity), and Subsection 21.6 (Governing Law), and Subsection 21.7 (Arbitration).\"}, {\"id\": \"19\", \"title\": \"Intellectual property indemnity\", \"level\": 1, \"text\": \"19. Intellectual property indemnity\"}, {\"id\": \"19.1\", \"title\": \"Indemnification\", \"level\": 2, \"text\": \"19.1 Indemnification. Distributor agrees that Tripath has the right to, and Tripath agrees that it will at its expense, defend or at its option settle any claim, suit, proceeding, or other action brought against Distributor or its customer for infringement of any United States copyright, trademark or other United States intellectual property right related to the Products or their use, subject to the limitations set forth in this Section. Tripath will have sole control of any such action or settlement negotiations (Tripath will not be liable for any costs or expenses incurred without its prior written authorization), and Tripath will pay any final judgment entered against Distributor or its customer based on such infringement. Tripath at its sole option will be relieved of the foregoing obligations unless Distributor or its customer notifies Tripath promptly in writing of such action and gives Tripath full information and assistance to settle and/or defend any such action. If it is adjudicated that a Product infringes, or if the sale or use of a Product is, as a result, enjoined, then Tripath will, at its option and expense either: (i) procure for Distributor and its customers the right to sell or use the Product; or (ii) replace the Product with other suitable Product; or (iii) suitably modify the Product to be noninfringing; or (iv) if none of the foregoing are commercially reasonable, as determined by Tripath, accept return of the affected Products and refund Distributor's aggregate payments for such Products, less a reasonable sum for use and/or damage, if any.\"}, {\"id\": \"19.2\", \"title\": \"Limitation\", \"level\": 2, \"text\": \"19.2 Limitation. Notwithstanding the provisions of Section 19.1, Tripath assumes no liability for, and Distributor agrees to indemnify Tripath to the same extent as Tripath's indemnity under Section 19.1 for: (i) any infringements covering completed equipment or any assembly, circuit, combination, or method in which any of the Products may be used but not covering such Products standing alone; or (ii) any trademark infringements involving any marking or branding not applied by Tripath or involving any marking or branding applied at the request of Distributor; or (iii) any modification of the Products unless such modification was made by Tripath.\"}, {\"id\": \"19.3\", \"title\": \"Entire Liability\", \"level\": 2, \"text\": \"19.3 Entire Liability. The foregoing provisions of this section 19 state the entire liability and obligations of Tripath and the exclusive remedy of Distributor and its customers, with respect to any actual or alleged intellectual property infringement by the Products.\"}, {\"id\": \"20\", \"title\": \"Limitation of Liability\", \"level\": 1, \"text\": \"20. Limitation of Liability\"}, {\"id\": \"20.1\", \"title\": \"Neither Tripath nor Distributor will be liable for any incidental or consequential\", \"level\": 2, \"text\": \"20.1 Neither Tripath nor Distributor will be liable for any incidental or consequential -7- Distributor Agreement damages (including, without limitation, damages for loss of business profits, business interruption, loss of business information, or other pecuniary loss) arising out of this Agreement, even if advised of the possibility of such damages.\"}, {\"id\": \"21\", \"title\": \"General\", \"level\": 1, \"text\": \"21. General\"}, {\"id\": \"21.1\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"21.1 Assignment. This Agreement is not assignable by Distributor without prior written consent of Tripath, which will not be unreasonably withheld. Tripath is free to assign this contract without Distributor's consent.\"}, {\"id\": \"21.2\", \"title\": \"Modifications\", \"level\": 2, \"text\": \"21.2 Modifications. This Agreement may be modified only in writing signed by an officer of each party.\"}, {\"id\": \"21.3\", \"title\": \"Headings\", \"level\": 2, \"text\": \"21.3 Headings. The headings of the several Sections are inserted for convenience of reference only, and are not intended to be part of nor to affect the meaning or interpretation of this Agreement.\"}, {\"id\": \"21.4\", \"title\": \"Notices\", \"level\": 2, \"text\": \"21.4 Notices. All notices under this Agreement will be sent by receipted courier (e.g., U.P.S.).\"}, {\"id\": \"21.5\", \"title\": \"Non-Waiver\", \"level\": 2, \"text\": \"21.5 Non-Waiver. The failure of either party to enforce at any time any of the provisions of this Agreement will not be construed as a waiver of the right of such party to subsequently enforce any such provisions or a waiver of the provision itself.\"}, {\"id\": \"21.6\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"21.6 Governing Law. This Agreement will be governed by the laws of California, without reference to conflicts of laws.\"}, {\"id\": \"21.7\", \"title\": \"Arbitration\", \"level\": 2, \"text\": \"21.7 Arbitration. Any dispute or claim arising out of this Agreement will be referred to and resolved by the International Chamber of Commerce (\\\"ICC\\\") in accordance with the ICC Arbitration Rules. The venue for such arbitration will be Santa Clara County, California, USA. -8- Distributor Agreement This Agreement supersedes all proposals, oral or written, all negotiations, or discussions between or among the parties relating to this Agreement, and all past course of dealing or industry custom. This Agreement takes precedence over the terms of any Tripath or Distributor order or sales documentation, including the Tripath Sales Order Acknowledgment. TRIPATH CORPORATION DISTRIBUTOR By: /s/ EVERETT ROACH By: /s/ CHARLES LIM Name: Everett Roach Name: Charles Lim Title: Vice President, World Wide Sales Title: President Date: 7/1/98 Date: 7/7/98 -9-\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ETELOS,INC_03_09_2004-EX-10.8-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.8\", \"level\": 1, \"text\": \"EXHIBIT 10.8 DISTRIBUTOR AGREEMENT Tripath Technology, Inc. 3900 Freedom Circle Suite # 200 Santa Clara, CA 95054 Tel: (408) 567-3000 Fax: (408) 567-3003 This Agreement is effective 7/1/98 (\\\"Effective Date\\\") between Tripath Technology, Inc. (\\\"Tripath\\\"), and Uniquest Corporation 780 Montague Expressway Suite 406 Santa Jose, CA 95131 Tripath and Distributor intend to establish Distributor as a non-exclusive Distributor for Tripath products in the following designated Territory, subject to the terms and conditions of this Agreement. Korea\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Products\", \"level\": 1, \"text\": \"1. Products\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Products\\\" means the Tripath semiconductor products identified by Tripath in writing from time to time\", \"level\": 2, \"text\": \"1.1 \\\"Products\\\" means the Tripath semiconductor products identified by Tripath in writing from time to time.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath may discontinue manufacture or sale, or otherwise treat as obsolete, any or all of the Products covered by this\", \"level\": 2, \"text\": \"1.2 Tripath may discontinue manufacture or sale, or otherwise treat as obsolete, any or all of the Products covered by this Agreement upon thirty days written notice.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Appointment and Term\", \"level\": 1, \"text\": \"2. Appointment and Term\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For the term of this Agreement, Tripath appoints Distributor as a non-exclusive distributor for the Products in the Terr\", \"level\": 2, \"text\": \"2.1 For the term of this Agreement, Tripath appoints Distributor as a non-exclusive distributor for the Products in the Territory, subject to Tripath's direct sales activities under Section 4.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will use best efforts to develop the local market and promote the sales of Products within the Territory\", \"level\": 2, \"text\": \"2.2 Distributor will use best efforts to develop the local market and promote the sales of Products within the Territory. Distributor will not sell outside the Territory without Tripath's prior written permission, which will not be unreasonably withheld.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"After one month's written notice, Tripath may in its discretion amend (i) the Products, and/or (ii) the Territory\", \"level\": 2, \"text\": \"2.3 After one month's written notice, Tripath may in its discretion amend (i) the Products, and/or (ii) the Territory.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath reserves the right to appoint other distributors in or out of the Territory who may sell into the Territory\", \"level\": 2, \"text\": \"2.4 Tripath reserves the right to appoint other distributors in or out of the Territory who may sell into the Territory.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's appointment is for a term of one year from the Effective Date, renewable automatically unless terminated u\", \"level\": 2, \"text\": \"2.5 Distributor's appointment is for a term of one year from the Effective Date, renewable automatically unless terminated under Section 18\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor Responsibilities\", \"level\": 1, \"text\": \"3. Distributor Responsibilities\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will maintain an adequately trained sales organization, capable of fulfilling its obligation under Subsectio\", \"level\": 2, \"text\": \"3.1 Distributor will maintain an adequately trained sales organization, capable of fulfilling its obligation under Subsection 2.2.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath will furnish technical and marketing information (such as sales aids and\", \"level\": 2, \"text\": \"3.2 Tripath will furnish technical and marketing information (such as sales aids and Distributor Agreement literature, data sheets, application notes, etc.) for the Products, and Distributor will maintain an organized and well stocked collection of such technical and marketing information for distribution to prospective customers.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will employ sufficient trained personnel (\\\"Application Engineers\\\") to provide technical and marketing suppor\", \"level\": 2, \"text\": \"3.3 Distributor will employ sufficient trained personnel (\\\"Application Engineers\\\") to provide technical and marketing support for Tripath's Products. Distributor and Tripath will cooperate to ensure that the Application Engineers are and remain adequately trained and qualified.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will maintain a reasonable number of Demonstration Products (customer samples), with appropriate technical a\", \"level\": 2, \"text\": \"3.4 Distributor will maintain a reasonable number of Demonstration Products (customer samples), with appropriate technical and marketing literature, available for demonstration by knowledgeable Distributor personnel, provided that Distributor must obtain prior approval by Tripath before any customer receives demonstration Products (customer samples).\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor has no authorization to make, and will not make, any guarantee or warranty with respect to any Product \u2014 all\", \"level\": 2, \"text\": \"3.5 Distributor has no authorization to make, and will not make, any guarantee or warranty with respect to any Product \u2014 all Product warranties are to be communicated to Customers directly by Tripath in writing. Distributor will make no representations as to quality, performance, capabilities, and the like except as are expressly authorized in writing by Tripath (such as in Tripath's standard, published specifications for a Product).\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Other Product Lines\", \"level\": 1, \"text\": \"4. Other Product Lines\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In appointing Distributor, Tripath is relying to a significant extent on Distributor's undertaking in Subsection 2\", \"level\": 2, \"text\": \"4.1 In appointing Distributor, Tripath is relying to a significant extent on Distributor's undertaking in Subsection 2.2.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will not carry any competitive products without Tripath's consent, which shall not be unreasonable\", \"level\": 2, \"text\": \"4.2 Distributor will not carry any competitive products without Tripath's consent, which shall not be unreasonable.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath Direct Sales Activity\", \"level\": 1, \"text\": \"5. Tripath Direct Sales Activity\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath may in its sole discretion, immediately upon written notice to Distributor, make direct sales to certain account\", \"level\": 2, \"text\": \"5.1 Tripath may in its sole discretion, immediately upon written notice to Distributor, make direct sales to certain accounts in the Territory (\\\"Direct Sales Accounts\\\"), including accounts to which Distributor has made sales.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Pricing, credits, and allowances\", \"level\": 1, \"text\": \"6. Pricing, credits, and allowances\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices for Products will be as set forth in the then effective distributor price list (\\\"Distributor Price List\\\") which w\", \"level\": 2, \"text\": \"6.1 Prices for Products will be as set forth in the then effective distributor price list (\\\"Distributor Price List\\\") which will be furnished to Distributor from time to time. Any suggested resale prices shown in the Distributor Price List are to be considered as guidelines only.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor Price List may be changed without prior notice, and will be effective as of the effective date indicated\", \"level\": 2, \"text\": \"6.2 The Distributor Price List may be changed without prior notice, and will be effective as of the effective date indicated. The amount and timing of such change will be exclusively at Tripath's discretion.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Orders for Products received and acknowledged by Tripath prior to a change in the Price List but shipped after the effec\", \"level\": 2, \"text\": \"6.3 Orders for Products received and acknowledged by Tripath prior to a change in the Price List but shipped after the effective date of such change will be invoiced as follows: (a) in the case of a price decrease, the existing order backlog will be invoiced at the lower price, and (b) in the case of a price increase, the existing order backlog due for delivery within one month of the effective date of such change will be invoiced at the lower price. Outstanding written quotations will be held good for the same two-month period.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's inventory of any Product will be price protected for reductions in the price of such Product as follows\", \"level\": 2, \"text\": \"6.4 Distributor's inventory of any Product will be price protected for reductions in the price of such Product as follows: the lesser of Distributor's (a) entire inventory of the Product, or (b) previous one month's shipments of the Product from Tripath.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Orders and Payment\", \"level\": 1, \"text\": \"7. Purchase Orders and Payment\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will maintain sufficient inventory of Products (but not less than one month's inventory without Tripath's ap\", \"level\": 2, \"text\": \"7.1 Distributor will maintain sufficient inventory of Products (but not less than one month's inventory without Tripath's approval) to provide prompt delivery to Distributor's customers, in furtherance of Distributor's undertaking in Subsection 2.2. -2- Distributor Agreement\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will purchase Products for resale to its customers in accordance with Tripath's then effective terms and con\", \"level\": 2, \"text\": \"7.2 Distributor will purchase Products for resale to its customers in accordance with Tripath's then effective terms and conditions of sale set forth in the Tripath sales order acknowledgment (\\\"Sales Order Acknowledgment\\\"), and the pricing terms of the then effective Distributor Price List (including minimum order quantities). The terms and conditions of sale in the Sales Order Acknowledgment may be changed without prior notice, exclusively at Tripath's discretion.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No purchase order from Distributor is binding on Tripath until Tripath issues a Sales Order Acknowledgment to Distributo\", \"level\": 2, \"text\": \"7.3 No purchase order from Distributor is binding on Tripath until Tripath issues a Sales Order Acknowledgment to Distributor for such order, or makes a shipment against such order. Tripath will use commercially reasonable efforts to acknowledge Distributor purchase orders promptly.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath will invoice Distributor for Products when Tripath ships such Products\", \"level\": 2, \"text\": \"7.4 Tripath will invoice Distributor for Products when Tripath ships such Products.\"}}, {\"id\": \"7.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All credits will be handled as separate financial transactions from the original invoice, and will be evidenced by a wri\", \"level\": 2, \"text\": \"7.5 All credits will be handled as separate financial transactions from the original invoice, and will be evidenced by a written credit request submitted to Tripath. Distributor will not reduce any payment to Tripath to account for anticipated or unauthorized credits (except for short shipments and non-receipt of Products), either at the time of the payment of original invoice, or at the time of providing a credit request. Credit requests should be submitted by Distributor within one month after the date of Distributor's invoice for the related transactions.\"}}, {\"id\": \"7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any credit request will be based on the price shown on the then current Distributor Price List, or the actual net price\", \"level\": 2, \"text\": \"7.6 Any credit request will be based on the price shown on the then current Distributor Price List, or the actual net price paid by Distributor for the Product, whichever is lower.\"}}, {\"id\": \"7.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Tripath notifies Distributor of any discrepancy in a credit request, Distributor has one month to resolve the discrep\", \"level\": 2, \"text\": \"7.7 If Tripath notifies Distributor of any discrepancy in a credit request, Distributor has one month to resolve the discrepancy and pay the amount of the discrepancy.\"}}, {\"id\": \"7.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No purchase orders for which a Sales Order Acknowledgment has been issued may be canceled or rescheduled within one mont\", \"level\": 2, \"text\": \"7.8 No purchase orders for which a Sales Order Acknowledgment has been issued may be canceled or rescheduled within one month of the scheduled shipment date without Tripath's approval.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Special Pricing and Other Allowances\", \"level\": 1, \"text\": \"8. Special Pricing and Other Allowances\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The provisions of this Section 8 will be applicable only to transactions on DPA (distributor price authorization) basis\", \"level\": 2, \"text\": \"8.1 The provisions of this Section 8 will be applicable only to transactions on DPA (distributor price authorization) basis in which Distributor first obtains a DPA confirmation from Tripath.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Requests for special pricing and/or allowances will be submitted by Distributor to the appropriate Tripath sales office,\", \"level\": 2, \"text\": \"8.2 Requests for special pricing and/or allowances will be submitted by Distributor to the appropriate Tripath sales office, and must be first approved in writing by that office.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Quotes for special pricing are good for one month, and must be backed by a Tripath quote number\", \"level\": 2, \"text\": \"8.3 Quotes for special pricing are good for one month, and must be backed by a Tripath quote number. Distributor will supply supporting documentation showing Products listed by part number, date of transaction, end customer name and address, and the appropriate special pricing details, not later than two weeks after shipment to the associated customer.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Tripath has granted Distributor special pricing on a sale in which Distributor's customer has later returned the Prod\", \"level\": 2, \"text\": \"8.4 If Tripath has granted Distributor special pricing on a sale in which Distributor's customer has later returned the Product to Distributor, Distributor will reimburse Tripath for the amount of the DPA allowance within one month after such return.\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any debit memo submitted by Distributor for a DPA allowance will be based on the price shown on the then current Distrib\", \"level\": 2, \"text\": \"8.5 Any debit memo submitted by Distributor for a DPA allowance will be based on the price shown on the then current Distributor Price List, or the actual net price paid by Distributor for the Product, whichever is lower.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Returns\", \"level\": 1, \"text\": \"9. Returns\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor may return Products only after receiving written authorization from Tripath\", \"level\": 2, \"text\": \"9.1 Distributor may return Products only after receiving written authorization from Tripath. All authorized returns will be shipped by Distributor freight prepaid. Unauthorized returns may be reshipped to Distributor, freight collect. -3- Distributor Agreement\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor may request stock rotation return of slow moving Products, which will be authorized by Tripath provided that\", \"level\": 2, \"text\": \"9.2 Distributor may request stock rotation return of slow moving Products, which will be authorized by Tripath provided that: (a) the Product is contained in Tripath's then current Distributor Price List, (b) the Product is packaged as it was originally shipped, and (c) a purchase order for equal value accompanies the request for return. Such stock rotation returns will not exceed five percent (5%) of the dollar value of Distributor's previous six (6) months net purchase orders from Tripath.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Discontinued Product may be returned only with prior written authorization\", \"level\": 2, \"text\": \"9.3 Discontinued Product may be returned only with prior written authorization.\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Credit will be allowed for returned Products based on the price actually paid by Distributor, less any prior DPAs, credi\", \"level\": 2, \"text\": \"9.4 Credit will be allowed for returned Products based on the price actually paid by Distributor, less any prior DPAs, credits and other allowances.\"}}, {\"id\": \"9.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If, in the reasonable opinion of Tripath, previously authorized returned Products have been used or damaged, a credit or\", \"level\": 2, \"text\": \"9.5 If, in the reasonable opinion of Tripath, previously authorized returned Products have been used or damaged, a credit or replacement may be refused. Distributor will be notified within one month after receipt of Product by Tripath of any such Product Tripath is claiming to be used or damaged.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limited Warranty\", \"level\": 1, \"text\": \"10. Limited Warranty\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath provides an end user limited warranty for retail Products, and one-year limited warranty for OEM products\", \"level\": 2, \"text\": \"10.1 Tripath provides an end user limited warranty for retail Products, and one-year limited warranty for OEM products. The terms of the end user limited warranty are set forth in documentation provided with the retail Product.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For OEM Products, Tripath warrants that the Products will be free of manufacturing and workmanship defects for one year\", \"level\": 2, \"text\": \"10.2 For OEM Products, Tripath warrants that the Products will be free of manufacturing and workmanship defects for one year from the date of shipment by Distributor to a customer, or eighteen months from the date of shipment to Distributor, whichever is sooner.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If any OEM Products prove defective during this one year period as set forth in Section 10\", \"level\": 2, \"text\": \"10.3 If any OEM Products prove defective during this one year period as set forth in Section 10.2, Tripath will, at its option, either (a) repair or replace the Product with a new or reconditioned Product, (b) use reasonable efforts to provide Distributor with a correction of the defect, or (c) refund to Distributor the purchase price paid for the Product. Any Product replaced will become Tripath property.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor must return the defective OEM Product pursuant to a return material authorization under Section 9\", \"level\": 2, \"text\": \"10.4 Distributor must return the defective OEM Product pursuant to a return material authorization under Section 9.1 in the original shipping carton (or an equivalent protective carton), and pay the shipping and insurance charges. Distributor assumes the risk of loss or damage during shipment.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OEM Products that are defective as set forth in Section 10\", \"level\": 2, \"text\": \"10.5 OEM Products that are defective as set forth in Section 10.2 as a result of improper handling, incorrect installation or other misuse, or as a result of accident, disaster, acts of God or other such events, as determined by Tripath in its reasonable discretion, are not covered by this limited warranty.\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For OEM Products, Tripath provides only the warranties set forth in this limited one year limited warranty\", \"level\": 2, \"text\": \"10.6 For OEM Products, Tripath provides only the warranties set forth in this limited one year limited warranty. For retail Products, Tripath provides to the end user only the warranties set forth in the applicable end user warranty. Any and all other warranties, either express, implied or statutory, including, without limitation, warranties of fitness for a particular purpose, or of merchantability, are hereby expressly excluded and disclaimed by Tripath.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reports and Audits\", \"level\": 1, \"text\": \"11. Reports and Audits\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will submit reports as may be reasonably requested by Tripath, including, without limitation, monthly report\", \"level\": 2, \"text\": \"11.1 Distributor will submit reports as may be reasonably requested by Tripath, including, without limitation, monthly reports of inventory on hand and sales relating to the Products. Sales data will include, without limitation, Product part number, quantity, resale price, special pricing, distributor invoice number, and customer name. Distributor will submit these reports electronically on a timely basis each month and in no case later than two weeks after the beginning of the month. -4- Distributor Agreement\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath may have an authorized Tripath representative, at Tripath's cost, audit Distributor's records relating to sales\", \"level\": 2, \"text\": \"11.2 Tripath may have an authorized Tripath representative, at Tripath's cost, audit Distributor's records relating to sales and inventories of Products, including, without limitation, records pertaining to any claims submitted by Distributor for price protection, stock rotation, returned Products, ship from stock and debit, DPA allowances, and credit requests. Upon prior written notice, Distributor will provide reasonable access to such records during normal business hours at Distributor's office. Distributor agrees to maintain all such records for a minimum of three years.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's Financial Condition\", \"level\": 1, \"text\": \"12. Distributor's Financial Condition\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath may withhold shipments because of Distributor's general financial condition and/or conditions of Distributor's a\", \"level\": 2, \"text\": \"12.1 Tripath may withhold shipments because of Distributor's general financial condition and/or conditions of Distributor's account with Tripath. Such withholding will be not construed as a breach of this Agreement.\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will supply Tripath with credit data sufficient to establish Distributor's credit worthiness\", \"level\": 2, \"text\": \"12.2 Distributor will supply Tripath with credit data sufficient to establish Distributor's credit worthiness.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Advertising and Sales Promotion\", \"level\": 1, \"text\": \"13. Advertising and Sales Promotion\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's tradename may be used by Tripath in its advertisements, provided that such use is in proper form\", \"level\": 2, \"text\": \"13.1 Distributor's tradename may be used by Tripath in its advertisements, provided that such use is in proper form.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will be eligible to participate in Tripath distributor cooperative advertising programs designated by Tripat\", \"level\": 2, \"text\": \"13.2 Distributor will be eligible to participate in Tripath distributor cooperative advertising programs designated by Tripath for the Territory. However, prior approval must be obtained in writing from Tripath before any expenditures of funds by Distributor are eligible for reimbursement.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath Trademarks\", \"level\": 1, \"text\": \"14. Tripath Trademarks\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath grants to Distributor a non-exclusive license to use Tripath's trademarks, trade names and service marks only in\", \"level\": 2, \"text\": \"14.1 Tripath grants to Distributor a non-exclusive license to use Tripath's trademarks, trade names and service marks only in connection with the Products and in the performance of Distributor's obligations under this Agreement. All such uses are subject to Tripath's prior review and consent, which will not be unreasonably withheld or delayed.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All use of Tripath trademarks and service marks will be in proper form, giving appropriate attribution to Tripath as the\", \"level\": 2, \"text\": \"14.2 All use of Tripath trademarks and service marks will be in proper form, giving appropriate attribution to Tripath as the owner of the mark. Distributor will not undertake any use of a mark in a manner that might jeopardize Tripath's rights to use or register such mark, or Tripath's rights to prevent unauthorized use. Distributor will promptly notify Tripath of any acts of unfair competition or trade or service mark infringement, and reasonably cooperate with efforts to protect Tripath's rights.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All use of Tripath trade marks and service marks by Distributor will inure to the benefit of Tripath, and Distributor wi\", \"level\": 2, \"text\": \"14.3 All use of Tripath trade marks and service marks by Distributor will inure to the benefit of Tripath, and Distributor will reasonably cooperate, at Tripath's expense with Tripath's efforts to register or otherwise secure rights in such marks. Upon termination of this Agreement, Distributor will immediately cease all further use of Tripath's trademarks, trade names or service marks except as may be required in the sale of Products in inventory.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Relationship Between the Parties\", \"level\": 1, \"text\": \"15. Relationship Between the Parties\"}}, {\"id\": \"15.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Both Distributor and Tripath are independent contractors, and no agency or other joint relationship is created\", \"level\": 2, \"text\": \"15.1 Both Distributor and Tripath are independent contractors, and no agency or other joint relationship is created.\"}}, {\"id\": \"15.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party has any authority to act for and/or to bind the other in any way, or to represent that either is in any wa\", \"level\": 2, \"text\": \"15.2 Neither party has any authority to act for and/or to bind the other in any way, or to represent that either is in any way responsible for the acts of the other.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 1, \"text\": \"16. Confidentiality\"}}, {\"id\": \"16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential information (\\\"Information\\\") of Tripath and/or Distributor will mean information that the disclosing party d\", \"level\": 2, \"text\": \"16.1 Confidential information (\\\"Information\\\") of Tripath and/or Distributor will mean information that the disclosing party desires to protect against unauthorized use or disclosure, and which is furnished under this Agreement as follows: (a) written or other tangible information clearly marked with a notice, such as -5- Distributor Agreement \\\"CONFIDENTIAL\\\"; and (b) oral information that is identified at the time of disclosure as being confidential. Confidential Information will not include information that: (a) enters the public domain without a breach of this Agreement, (b) is known to the recipient prior to the time of disclosure, or is independently developed by the recipient without using any Information, or (c) is obtained from another source that the receiving party has no reasonable cause to believe is under any obligation of confidentiality with respect to Information.\"}}, {\"id\": \"16.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The recipient of Information will treat it as proprietary and confidential, safeguarding the Information at least as car\", \"level\": 2, \"text\": \"16.2 The recipient of Information will treat it as proprietary and confidential, safeguarding the Information at least as carefully as it would its own confidential information, and will use all reasonable efforts to prevent any unauthorized use or disclosure, including restricting access to the Information within its organization and ensuring that its employees comply with this Agreement. A receiving party will not disclose any information to any third party without prior written consent. Either party learning of any unauthorized use or disclosure of any Information will promptly notify the other party, and will reasonably cooperate with efforts to protect such Information.\"}}, {\"id\": \"16.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The recipient of information will use it only in the furtherance of the business relationship established by this Agreem\", \"level\": 2, \"text\": \"16.3 The recipient of information will use it only in the furtherance of the business relationship established by this Agreement, and for no other purpose without prior written consent. All Information will remain the property of the disclosing party, and will be returned or destroyed upon written request.\"}}, {\"id\": \"16.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The confidentiality obligations in this Agreement will be binding during the Agreement and for a period of three years a\", \"level\": 2, \"text\": \"16.4 The confidentiality obligations in this Agreement will be binding during the Agreement and for a period of three years after any termination or non-renewal of the Agreement.\"}}, {\"id\": \"16.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party will disclose the existence or terms of this Agreement without prior written consent\", \"level\": 2, \"text\": \"16.5 Neither party will disclose the existence or terms of this Agreement without prior written consent.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Export Control\", \"level\": 1, \"text\": \"17. Export Control\"}}, {\"id\": \"17.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will not engage in exporting activities within the Territory without the prior written approval of Tripath,\", \"level\": 2, \"text\": \"17.1 Distributor will not engage in exporting activities within the Territory without the prior written approval of Tripath, and the United States Government if such approval is necessary. Nothing in this Subsection is meant to authorize Distributor shipments outside the Territory.\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor understands that the Products and Tripath confidential information are restricted by the United States Gover\", \"level\": 2, \"text\": \"17.2 Distributor understands that the Products and Tripath confidential information are restricted by the United States Government from export to certain countries, and Distributor agrees that it will not sell or license Products or transfer Tripath confidential information in any way will violate any of the export control laws or regulations of the United States.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"18. Term and Termination\"}}, {\"id\": \"18.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The terms of this Agreement shall be one year from the effective date and will be automatically renewed on each annivers\", \"level\": 2, \"text\": \"18.1 The terms of this Agreement shall be one year from the effective date and will be automatically renewed on each anniversary of the effective date, for a renewal term of one year unless either party provides written notification of its intention not to renew this Agreement at least one month prior to the expiration of the initial or any renewal terms. Tripath will honor all orders acknowledged prior to the effective date of any such termination by nonrenewable.\"}}, {\"id\": \"18.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Tripath or Distributor may terminate this Agreement for any reason with thirty days written notice\", \"level\": 2, \"text\": \"18.2 Tripath or Distributor may terminate this Agreement for any reason with thirty days written notice.\"}}, {\"id\": \"18.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Either party may terminate this Agreement immediately if the other party becomes insolvent, or takes any steps to make a\", \"level\": 2, \"text\": \"18.3 Either party may terminate this Agreement immediately if the other party becomes insolvent, or takes any steps to make an arrangement with its creditors, or has a receiver appointed.\"}}, {\"id\": \"18.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Tripath terminates pursuant to Subsection 18\", \"level\": 2, \"text\": \"18.4 If Tripath terminates pursuant to Subsection 18.1 or 18.2, or if Distributor terminates pursuant to Subsection 18.3, Tripath will purchase and Distributor will resell to Tripath Distributor's inventory of Products (excluding -6- Distributor Agreement discontinued and demonstration Products) which Tripath determines to be undamaged and in good condition (including, at Tripath's option on-site inspection). The price for such inventory will be the price actually paid by the Distributor, less any prior credit or allowances.\"}}, {\"id\": \"18.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"On termination of this Agreement for whatever cause, Distributor will immediately (a) cease to engage in marketing and d\", \"level\": 2, \"text\": \"18.6 On termination of this Agreement for whatever cause, Distributor will immediately (a) cease to engage in marketing and distribution activities as Tripath's official distributor, and (b) cease representing in any manner that it is a distributor of Tripath Products in the Territory.\"}}, {\"id\": \"18.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All obligations of Distributor to make payments under this Agreement will survive any termination of this Agreement for\", \"level\": 2, \"text\": \"18.7 All obligations of Distributor to make payments under this Agreement will survive any termination of this Agreement for whatever cause, along with the following provisions: Section 10 (Limited Warranty), Section 11 (Reports and Audits), Section 16 (Confidentiality), Section 17 (Export Control), Section 19 (Intellectual Property Indemnity), and Subsection 21.6 (Governing Law), and Subsection 21.7 (Arbitration).\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Intellectual property indemnity\", \"level\": 1, \"text\": \"19. Intellectual property indemnity\"}}, {\"id\": \"19.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification\", \"level\": 2, \"text\": \"19.1 Indemnification. Distributor agrees that Tripath has the right to, and Tripath agrees that it will at its expense, defend or at its option settle any claim, suit, proceeding, or other action brought against Distributor or its customer for infringement of any United States copyright, trademark or other United States intellectual property right related to the Products or their use, subject to the limitations set forth in this Section. Tripath will have sole control of any such action or settlement negotiations (Tripath will not be liable for any costs or expenses incurred without its prior written authorization), and Tripath will pay any final judgment entered against Distributor or its customer based on such infringement. Tripath at its sole option will be relieved of the foregoing obligations unless Distributor or its customer notifies Tripath promptly in writing of such action and gives Tripath full information and assistance to settle and/or defend any such action. If it is adjudicated that a Product infringes, or if the sale or use of a Product is, as a result, enjoined, then Tripath will, at its option and expense either: (i) procure for Distributor and its customers the right to sell or use the Product; or (ii) replace the Product with other suitable Product; or (iii) suitably modify the Product to be noninfringing; or (iv) if none of the foregoing are commercially reasonable, as determined by Tripath, accept return of the affected Products and refund Distributor's aggregate payments for such Products, less a reasonable sum for use and/or damage, if any.\"}}, {\"id\": \"19.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation\", \"level\": 2, \"text\": \"19.2 Limitation. Notwithstanding the provisions of Section 19.1, Tripath assumes no liability for, and Distributor agrees to indemnify Tripath to the same extent as Tripath's indemnity under Section 19.1 for: (i) any infringements covering completed equipment or any assembly, circuit, combination, or method in which any of the Products may be used but not covering such Products standing alone; or (ii) any trademark infringements involving any marking or branding not applied by Tripath or involving any marking or branding applied at the request of Distributor; or (iii) any modification of the Products unless such modification was made by Tripath.\"}}, {\"id\": \"19.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Liability\", \"level\": 2, \"text\": \"19.3 Entire Liability. The foregoing provisions of this section 19 state the entire liability and obligations of Tripath and the exclusive remedy of Distributor and its customers, with respect to any actual or alleged intellectual property infringement by the Products.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation of Liability\", \"level\": 1, \"text\": \"20. Limitation of Liability\"}}, {\"id\": \"20.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither Tripath nor Distributor will be liable for any incidental or consequential\", \"level\": 2, \"text\": \"20.1 Neither Tripath nor Distributor will be liable for any incidental or consequential -7- Distributor Agreement damages (including, without limitation, damages for loss of business profits, business interruption, loss of business information, or other pecuniary loss) arising out of this Agreement, even if advised of the possibility of such damages.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General\", \"level\": 1, \"text\": \"21. General\"}}, {\"id\": \"21.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"21.1 Assignment. This Agreement is not assignable by Distributor without prior written consent of Tripath, which will not be unreasonably withheld. Tripath is free to assign this contract without Distributor's consent.\"}}, {\"id\": \"21.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Modifications\", \"level\": 2, \"text\": \"21.2 Modifications. This Agreement may be modified only in writing signed by an officer of each party.\"}}, {\"id\": \"21.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Headings\", \"level\": 2, \"text\": \"21.3 Headings. The headings of the several Sections are inserted for convenience of reference only, and are not intended to be part of nor to affect the meaning or interpretation of this Agreement.\"}}, {\"id\": \"21.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"21.4 Notices. All notices under this Agreement will be sent by receipted courier (e.g., U.P.S.).\"}}, {\"id\": \"21.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Waiver\", \"level\": 2, \"text\": \"21.5 Non-Waiver. The failure of either party to enforce at any time any of the provisions of this Agreement will not be construed as a waiver of the right of such party to subsequently enforce any such provisions or a waiver of the provision itself.\"}}, {\"id\": \"21.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"21.6 Governing Law. This Agreement will be governed by the laws of California, without reference to conflicts of laws.\"}}, {\"id\": \"21.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Arbitration\", \"level\": 2, \"text\": \"21.7 Arbitration. Any dispute or claim arising out of this Agreement will be referred to and resolved by the International Chamber of Commerce (\\\"ICC\\\") in accordance with the ICC Arbitration Rules. The venue for such arbitration will be Santa Clara County, California, USA. -8- Distributor Agreement This Agreement supersedes all proposals, oral or written, all negotiations, or discussions between or among the parties relating to this Agreement, and all past course of dealing or industry custom. This Agreement takes precedence over the terms of any Tripath or Distributor order or sales documentation, including the Tripath Sales Order Acknowledgment. TRIPATH CORPORATION DISTRIBUTOR By: /s/ EVERETT ROACH By: /s/ CHARLES LIM Name: Everett Roach Name: Charles Lim Title: Vice President, World Wide Sales Title: President Date: 7/1/98 Date: 7/7/98 -9-\"}}, {\"id\": \"party:Tripath Technology, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Tripath Technology, Inc.\", \"role\": null, \"address\": \"3900 Freedom Circle Suite # 200 Santa Clara, CA 95054\"}}, {\"id\": \"party:Uniquest Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Uniquest Corporation\", \"role\": \"Distributor\", \"address\": \"780 Montague Expressway Suite 406 Santa Jose, CA 95131\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"7/1/98\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"the Tripath semiconductor products identified by Tripath in writing from time to time.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Application Engineers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Application Engineers\", \"text\": \"sufficient trained personnel (...) to provide technical and marketing support for Tripath's Products\", \"definition_clause\": \"3.3\"}}, {\"id\": \"term:Direct Sales Accounts\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Direct Sales Accounts\", \"text\": \"certain accounts in the Territory (...) including accounts to which Distributor has made sales.\", \"definition_clause\": \"5.1\"}}, {\"id\": \"term:Distributor Price List\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor Price List\", \"text\": \"the then effective distributor price list\", \"definition_clause\": \"6.1\"}}, {\"id\": \"term:Sales Order Acknowledgment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sales Order Acknowledgment\", \"text\": \"Tripath's then effective terms and conditions of sale set forth in the Tripath sales order acknowledgment\", \"definition_clause\": \"7.2\"}}, {\"id\": \"term:Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Information\", \"text\": \"information that the disclosing party desires to protect against unauthorized use or disclosure, and which is furnished under this Agreement as follows: (a) written or other tangible information clearly marked with a notice, such as -5- Distributor Agreement \\\"CONFIDENTIAL\\\"; and (b) oral information that is identified at the time of disclosure as being confidential.\", \"definition_clause\": \"16.1\"}}, {\"id\": \"value:thirty days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty days\"}}, {\"id\": \"value:one month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one month\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:two-month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two-month\"}}, {\"id\": \"value:two weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two weeks\"}}, {\"id\": \"value:five percent (5%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"five percent (5%)\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:one-year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one-year\"}}, {\"id\": \"value:eighteen months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"eighteen months\"}}, {\"id\": \"value:three years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three years\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of EUROPEANMICROHOLDINGSINC_03_06_1998-EX-10.6-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of EUROPEANMICROHOLDINGSINC_03_06_1998-EX-10.6-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.6\", \"level\": 1, \"text\": \"EXHIBIT 10.6 EXHIBIT 10.06 WATCHGUARD TECHNOLOGIES, INC. DISTRIBUTOR AGREEMENT This Agreement is made and entered into effective as of November 5, 1997 (the \\\"effective Date), by and between WatchGuard Technologies, Inc., a Delaware corporation (\\\"WGT\\\"), and European Micro (\\\"Distributor\\\"). WGT and Distributor agree as follows:\"}, {\"id\": \"Section 1\", \"title\": \"Definitions\", \"level\": 1, \"text\": \"Section 1. Definitions \\\"Add-On Software Modules\\\" means those computer software programs that (a) provide additional functionality and may be integrated with the existing Hardware and other Software, (b) may be legally exported to the Territory without any export license and (c) WGT elects to include in Exhibit A at a mutually agreed discount percentage. \\\"Distributor Cost\\\" means the purchase price payable by Distributor for each Product at the discount from WGT's then current WatchGuard Price List, as such discount is set forth in Exhibit A. \\\"Documentation\\\" means any and all manuals, user guides, end-user license agreement, limited hardware warranty, on-line help files, on-line menus and other in program printed text regarding the Product prepared by or for WGT in connection with the Product. \\\"Gross Purchases\\\" means the gross purchase price Distributor pays WGT for the Product, excluding any taxes or pass through charges and net of any credits or returns. \\\"Guaranteed Minimum Purchases\\\" means the guaranteed minimum purchase amounts set forth in Exhibit A. \\\"Hardware\\\" means the hardware identified on Exhibit A, together with any Updates to such hardware. WGT reserves the right to add to or delete hardware from Exhibit A and to modify the hardware during the Term. \\\"Product\\\" means the combination of Hardware, Software and Documentation together as part of the same product package (including any Add-On Software Modules and any Updates thereto), in all cases carrying the \\\"WatchGuard\\\" Trademark. \\\"Quarter\\\" means any period of three (3) consecutive calendar months that begins on January 1, April 1, July 1 or October 1, during the Term. \\\"Software\\\" means the computer programs identified on Exhibit A, in object code only, together with any Updates to such programs. WGT reserves the right to add or delete Software from Exhibit A and to modify the Software during the Term. \\\"Term\\\" means the period of time determined in accordance with Section 5. \\\"Territory\\\" means the geographic area described in Exhibit A. \\\"Trademarks\\\" means the trademarks and trade names of WGT identified in Exhibit A. \\\"Update\\\" means any minor modification, minor upgrade or minor enhancement of the Product (excluding any new version of the Product) that WGT publishes and elects to make available to Distributor via BBS, FTP site or other reasonable means. WGT is not obligated to make or release any update.\"}, {\"id\": \"Section 2\", \"title\": \"Relationship of the Parties\", \"level\": 1, \"text\": \"Section 2. Relationship of the Parties\"}, {\"id\": \"2.1\", \"title\": \"Appointment\", \"level\": 2, \"text\": \"2.1 Appointment. Subject to and in accordance with the provisions of this Agreement, WGT hereby appoints Distributor, and Distributor hereby accepts WGT's appointment, as a nonexclusive distributor of the Product to resellers in the Territory during the Term, as long as Distributor makes the Guaranteed Minimum Purchases pursuant to Section 4.\"}, {\"id\": \"2.2\", \"title\": \"License Grant\", \"level\": 2, \"text\": \"2.2 License Grant. Subject to the terms and conditions of this Agreement, WGT grants to Distributor a nontransferable license to do the following in the Territory during the Term: (a) market and distribute the Product to resellers; (b) demonstrate the Product to potential resellers; (c) use the Product internally for the sole purpose of providing this product support specified in paragraph 4.1(c); (d) use and display the Trademarks in connection with marketing and distributing the Product in the Territory pursuant to paragraphs (a) and (b) above.\"}, {\"id\": \"2.3\", \"title\": \"No Exclusivity\", \"level\": 2, \"text\": \"2.3 No Exclusivity. Distributor's appointment and the rights granted hereunder are nonexclusive. WGT may, at its sole option, appoint other distributors of the Product in the Territory at any time during the Term and expressly reserves the right to license the Product directly or indirectly to end-users, third party original equipment manufacturers or other hardware bundlers, value-added resellers or other resellers for sublicense or resale in the Territory.\"}, {\"id\": \"Section 3\", \"title\": \"Compensation\", \"level\": 1, \"text\": \"Section 3. Compensation\"}, {\"id\": \"3.1\", \"title\": \"Support services\", \"level\": 2, \"text\": \"3.1 Support services. As full compensation for the support services described in Exhibit C and provided during the Term, Distributor will pay WGT the Support Fee set forth in Exhibit A. Payment of the Support Fee is due and payable upon execution of this Agreement by wire transfer of immediately payable funds to the bank and account set forth in paragraph 3.4, and then annually by invoice from WGT on the anniversary of the execution of the Agreement. 2\"}, {\"id\": \"3.2\", \"title\": \"Price\", \"level\": 2, \"text\": \"3.2 Price. Distributor will pay WGT for each Product Distributor orders an amount equal to WGT's then current WatchGuard Price List in effect on the date of receipt by WGT of Distributor's order, subject to the applicable discount set forth in Exhibit A. WGT may, from time to time, change its WatchGuard Price List, provided that any such change will not be effective under this Agreement unless and until the expiration of forty-five (45) days after WGT gives Distributor written notices of the change.\"}, {\"id\": \"3.3\", \"title\": \"Guaranteed Minimum Purchases\", \"level\": 2, \"text\": \"3.3 Guaranteed Minimum Purchases. During the Term, Distributor will make Gross Purchases in an amount at least equal to the cumulative Guaranteed Minimum Purchase amounts through committed orders placed pursuant to paragraph 3.5 and calling for shipment on or before the dates set forth in Exhibit A.\"}, {\"id\": \"3.4\", \"title\": \"Invoices\", \"level\": 2, \"text\": \"3.4 Invoices. WGT will issue invoices for the Products ordered by Distributor and all other amounts payable to WGT under this Agreement. Distributor will pay WGT the full amount invoiced within thirty (30) days after the date of WGT's invoice, unless provided otherwise on the applicable invoice, in the lawful money of the United States of America to WGT by wire transfer of immediately available funds to WGT's bank account number 1141139, at the Commerce Bank of Washington, 601 Union Street, Suite 3600, Seattle, WA 98101, ABA routing number 125008013.\"}, {\"id\": \"3.5\", \"title\": \"Orders\", \"level\": 2, \"text\": \"3.5 Orders. Distributor will place orders for the Product from WGT by completing, signing and submitting to WGT a written order for the same, in a form acceptable to WGT, via facsimile, mail or other means. Distributor shall submit such order at least thirty (30) days in advance of the delivery date set forth in each order. All orders will be subject to acceptance by WGT through written acceptance or shipment of the Product subject to the order.\"}, {\"id\": \"Section 4\", \"title\": \"General Obligations of the Parties\", \"level\": 1, \"text\": \"Section 4. General Obligations of the Parties.\"}, {\"id\": \"4.1\", \"title\": \"Obligations of Distributor\", \"level\": 2, \"text\": \"4.1 Obligations of Distributor. Distributor will use its best efforts aggressively to develop sales of the Product in the Territory. In furtherance thereof, Distributor will: (a) keep on hand a reasonable inventory of the Product sufficient to allow for prompt delivery of the Product to resellers; (b) establish a program to market the Product, including, but not limited to, participating regularly in local and regional trade shows, conventions or like events in the Territory, and conducting regular local promotional and other marketing efforts for the Product; (c) provide quality product support to resellers, including, but not limited to, providing appropriate installation and application advice and prompt follow-up service and advice to resellers of the Product upon request; (d) provide a support center to resellers, including, but not limited to, a hotline service to answer reseller questions and to receive and track complaints and any reports of claimed errors in the Product; 3 (e) provide quality product technical and sales training to resellers; (f) respond promptly to sales leads or referrals furnished by WGT or by other distributors or dealers of WGT; (g) have a designated number of employees attend such technical and sales training programs as set forth in Exhibit C; (h) maintain and furnish periodically, as WGT may reasonably request, complete and accurate records of each sale or other distribution of each Product sold or distributed by Distributor (e.g., showing the date of sale, Zip code of the customer, the Product serial number and the applicable Product license key(s)) under this Agreement; (i) promptly advise WGT of each complaint that Distributor may receive or becomes aware of concerning the Product or any portion thereof (including, but not limited to, warranty claims). Distributor will promptly investigate all such complaints and will give immediate attention to and use its best efforts to promptly, courteously and equitably respond to, adjust and settle (without incurring any obligation or liability on behalf of WGT) all complaints received by Distributor from any customer, potential customer or anyone else arising out of or in connection with Distributor's sale of any Product, or the performance of any services. In handling any complaints, Distributor will use its best efforts to maintain and promote good public relations for WGT; (j) secure and maintain, in the name of WGT, any and all registrations, permits, licenses, approvals and other governmental actions required to import, handle, market, sell, demonstrate, use and distribute the Product in the Territory, provide to WGT quarterly progress reports on such action, and provide WGT copies of all registrations, permits, licenses, approvals, certificates, correspondence and other documentation related to such action; (k) hire, train, coordinate and maintain a qualified staff of sufficient size and with a level and mix of capabilities as are reasonably necessary to accomplish the goals contemplated under this Agreement; (l) avoid deceptive, misleading or unethical conduct which are or might be detrimental to WGT or its Product, and refrain from making any representation, warranty or guarantee to any reseller with respect to specifications, features or capabilities of the Product that is inconsistent with the literature distributed by WGT or this Agreement; (m) conduct its business in a manner under its own control, provided that Distributor will at all times comply with all applicable laws and regulations and will not engage in, or permit its employees or agents to engage in, any activities or practices which could reflect negatively upon the reputation or prospects of WGT or the Product or expose WGT to any liability of any nature whatsoever; and\"}, {\"id\": \"4.2\", \"title\": \"Obligations of WGT, WGT will\", \"level\": 2, \"text\": \"4.2 Obligations of WGT, WGT will: 4 (a) provide Distributor with sixty (60) days advance notice in the event that it discontinues production of any Product; (b) provide Distributor with the training and product support services described in Exhibit C; and (c) furnish Distributor with such demonstration Product, promotional literature, data, information and other items as WGT deems appropriate for Distributor's promotion, marketing and sale of the Product. WGT will use such items only for the purpose of performing its obligations under this Agreement.\"}, {\"id\": \"4.3\", \"title\": \"Forecasts\", \"level\": 2, \"text\": \"4.3 Forecasts. Distributor's forecast of Product purchases for the Term is set forth on Exhibit D. At least fifteen (15) days before the beginning of each Quarter during the Term, Distributor will furnish WGT with a rolling revised forecast of Product orders for the remainder of the Term.\"}, {\"id\": \"Section 5\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"Section 5. Term and Termination.\"}, {\"id\": \"5.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"5.1 Term. The Term will commence on the Effective Date of this Agreement and will remain in effect, unless sooner terminated under paragraphs 5.2, 5.3, or 5.4, until the termination date specified in Exhibit A. The Term will automatically renew for successive additional periods of one (1) year each, provided that: (a) Distributor has made all Guaranteed Minimum Purchases and has complied with the marketing requirements under paragraph 4.1(b); (b) the parties have agreed in writing upon the Guaranteed Minimum Purchase amounts and Product price discounts for the next subsequent one (1) year renewal period; (c) neither party provided the other party with notice of such party's intention not to renew this Agreement at least thirty (30) days prior to any year's Expiration Date; and (d) neither party provided the other party with such notice as may be required pursuant to paragraphs 5.2, 5.3 or 5.4.\"}, {\"id\": \"5.2\", \"title\": \"Termination by WGT\", \"level\": 2, \"text\": \"5.2 Termination by WGT. Upon the occurrence of any of the following, WGT may terminate the Term by giving Distributor written notice of such termination for: (a) any failure of Distributor to comply with the marketing requirements under paragraph 4.1(b); (b) any material change in the general management, ownership or control of Distributor, including without limitation the sale, transfer or relinquishment by Distributor of any substantial interest in the ownership of the business to be carried on by Distributor under this Agreement, unless such change is approved in advance and in writing by an officer of WGT; (c) any assignment or attempted assignment of this Agreement by Distributor without the prior written consent of WGT; (d) any solicitation by Distributor for the sale of the Product to resellers located outside the Territory; 5 (e) the insolvency of Distributor, the filing of a petition in bankruptcy by or against Distributor, the appointment of a receiver for Distributor or Distributor's property, the execution of an assignment by Distributor of all or substantially all of its assets for the benefit of its creditors, or the conviction of Distributor or any principal or manager of Distributor for any crime tending to adversely affect the ownership or operation of Distributor's business; (f) any failure by Distributor to perform any of its other obligations under this Agreement where such failure continues for thirty (30) days after written notice thereof by WGT to Distributor; or (g) WGT giving Distributor ninety (90) days' advance written notice of termination at any time after the expiration of the Initial Term.\"}, {\"id\": \"5.3\", \"title\": \"Failure to Make Guaranteed Minimum Purchases\", \"level\": 2, \"text\": \"5.3 Failure to Make Guaranteed Minimum Purchases. Upon any failure by Distributor to make Gross Purchases in sufficient amounts to meet or exceed the applicable cumulative Guaranteed Minimum Purchases, WGT may, at its sole option and effective upon notice to Distributor, terminate this Agreement. Distributor shall pay WGT fifty percent (50%) of the unpaid balance of cumulative Guaranteed Minimum Purchase amounts as liquidated damages. The parties acknowledge and agree that it would be difficult or impossible to calculate WGT's actual damages arising from Distributor's failure to timely pay all of the Guaranteed Minimum Purchases. Therefore, the parties have agreed upon the above payment of liquidated damages in lieu of WGT's claim for actual damages from such breach.\"}, {\"id\": \"5.4\", \"title\": \"Termination by Distributor\", \"level\": 2, \"text\": \"5.4 Termination by Distributor. Upon the occurrence of any of the following, Distributor may terminate the Term by giving WGT written notice of such termination; (a) the insolvency of WGT, the filing of a petition by or against WGT, the appointment of a receiver for WGT or WGT's property, or the execution of an assignment by WGT of all or substantially all of its assets for the benefit of its creditors; (b) any failure by WGT to perform any of its obligations under this Agreement where such failure continues for thirty (30) days after written notice thereof by Distributor to WGT; or (c) for convenience whether or not extended beyond the Initial Term, provided Distributor gives WGT thirty (30) days' advance written notice and, within such thirty (30) day period, Distributor pays to WGT a lump-sum payment equal to fifty (50%) of the unpaid balance of cumulative Guaranteed Minimum Purchase amounts.\"}, {\"id\": \"5.5\", \"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"5.5 Effect of Termination. Any termination pursuant to paragraphs 5.2, 5.3, or 5.4 will be without prejudice to any other right or remedy afforded to either party under this Agreement or any applicable law (e.g., in the case of any breach or default by the other party), and will not affect any rights or obligations which have arisen prior to the date of such termination. In the event of termination, Distributor will: 6 (a) immediately cease to demonstrate, market, sublicense and distribute the Product in the Territory; (b) cease use of all Trademarks of WGT; (c) return to WGT within twenty (20) days following the expiration or termination of the Term, any and all (i) demonstration Product provided to Distributor; (ii) Products not already paid for in full by Distributor; and (iii) promotional literature, data, information and other items received by Distributor under this Agreement; and (d) furnish WGT with such information relating to the marketing, sale or distribution of the Product in the Territory as WGT may reasonably request (including, but not limited to, information as to calls or the status of any negotiations for the sale of the Product, or any sales or service records). Upon the expiration or termination of the Term, the license granted under Section 2 of this Agreement will terminate. Any end-user licenses of the Software granted under the terms of this Agreement will survive the end of the Term in accordance with the terms of the applicable end-user license agreement.\"}, {\"id\": \"6.0\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"6.0 Force Majeure. Neither party will be liable for, or be considered to be in breach of or default under this Agreement on account of, any delay or failure to perform as required by this Agreement (other than for payment under Section 3), as a result of any cause or condition beyond such party's reasonable control.\"}, {\"id\": \"7.0\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"7.0 Entire Agreement. This Agreement is subject to the provisions of WGT's Standard Distributor Terms attached hereto as Exhibit B and by this reference incorporated into and as part of this Agreement. This Agreement is also subject to any additional terms or licenses executed by WGT and Distributor and attached as Exhibits, including any Special Terms and Conditions specified in Exhibit A. This Agreement sets forth the entire agreement, and supersedes any and all prior agreements, among the parties related to the Product. WGT will not be bound by, and specifically objects to, any term, condition, or other provision that is different from or in addition to the provisions of this Agreement (whether or not it would materially alter this Agreement) and that is proffered by Distributor or otherwise appears in any order, receipt, acceptance, confirmation, correspondence, or otherwise, unless WGT specifically agrees to such provision in a written instrument signed by WGT. No 7 modifications of any of the provisions of this Agreement will be valid unless set forth in a written instrument signed by both parties. Any remedy by WGT set forth in this Agreement is in addition to any other remedy afforded to WGT under any other contract, by law, or otherwise. IN WITNESS THEREOF, the parties have executed this Agreement as of the date first above written. Distributor: WatchGuard Technologies, Inc. By: /s/ LAURENCE GILBERT By: /s/ WATCHGUARD ------------------------- ------------------------------ Title: MANAGING DIRECTOR Title: VP/SALES Date Signed: NOVEMBER 5, 1997 Date Signed: NOVEMBER 3, 1997 Address: 20/24 Church Street Required Signature: Altrincham, Cheshire WA14 4DW, ENGLAND By: ------------------------------- Title: Executive Vice-President Sales Date Signed: --------------------- Address: 316 Occidental Avenue South Suite 300 Seattle, Washington 98104 8 FULL SERVICE MASTER DISTRIBUTOR SCHEDULE EXHIBIT A PRODUCTS: Distributor will be entitled to order the following products (which includes hardware and software) at the following discounts of WGT's then current WatchGuard Price List: - ------------------------------------------------------------------------------- DISCOUNT FROM WGT'S PRODUCT THEN CURRENT WATCHGUARD PRICE LIST - ------------------------------------------------------------------------------- WatchGuard Security System 40% plus additional 10% on the remaining undiscounted amount, i.e., 46% - ------------------------------------------------------------------------------ EXCHANGE FEE: $10 per CD SUPPORT FEE: $25,000 per year TERMINATION DATE: September 30, 1997 TRADEMARKS: /bullet/ WatchGuard(TM) /bullet/ WatchGuard(TM) Technologies /bullet/ WatchGuard(TM) SchoolMate /bullet/ Firebox(TM) TERRITORY: /bullet/ Europe SPECIAL TERMS AND CONDITIONS 9 These Special Terms and Conditions are part of the Distributor Agreement between WatchGuard Technologies, Inc. (\\\"WGT\\\") and Distributor (collectively, the \\\"Agreement\\\"). Terms that are defined in the Distributor Agreement will have the same meaning when used in these Special Terms and Conditions. Section A.1 By joint agreement between WGT and Distributor, Distributor may engage in end user sales in the Territory. If it is agreed that Distributor may engage in end user sales, Distributor may distribute, license and sell up to 20% of the Product purchased from WGT directly to end-users in the Territory. Further, Distributor agrees that high end-users satisfaction is a condition of its continued authorization by WGT. To ensure high end-user satisfaction, Distributor shall: (a) provide quality first level support to its end-user customers; (b) promptly report to WGT all suspected and actual problems with any WGT product; (c) assist WGT in tracing WGT Products to particular end users to distribute critical WGT Product information, locate WGT Products for safety reasons, or to be discover unauthorized marketing or infringing acts; (d) avoid deceptive, misleading or unethical conduct which are or might be detrimental to WGT or its WGT product; and (e) refrain from marking any representation, warranty or guarantee to end users with respect to the specifications, features or capabilities of the WGT Product that is inconsistent with the literature distributed by WGT or this Agreement. Section A.2 Distributor is legally organized under the jurisdiction of a country belonging to the European Union. If Distributor is organized under the jurisdiction of the country belonging to the European Union, the following clause is hereby appended to Section 1(c) of the Standard Distributor Terms: \\\"PROVIDED HOWEVER, the foregoing restriction is not intended to preclude Distributor from fulfilling, and Distributor may fulfill, unsolicited orders for Product received from outside the Territory but within the European Union (and Distributor shall provide WGT written notice of any such Sales);\\\" Section A.3 As a Full Service Master Distributor, Distributor agrees to sign up a minimum of 10 new WatchGuard resellers in the Territory within the Initial Term of the Agreement. - -------------------------------------------- --------------------------------- Distributor: WatchGuard Technologies, Inc.: By: /s/ LAURENCE GILBERT By: /s/ WATCHGUARD -------------------------- ----------------------------- Title: MANAGING DIRECTOR Title: SENIOR VICE PRESIDENT/SALES Date Signed: NOVEMBER 5, 1997 Date Signed: NOVEMBER 3, 1997 -------------------------------------------- --------------------------------- 10 STANDARD DISTRIBUTOR TERMS EXHIBIT B These Standard Distributor Terms are part of the Distributor Agreement between WatchGuard Technologies, Inc. (\\\"WGT\\\") and Distributor (collectively, the \\\"Agreement\\\"). Terms that are defined in the Distributor Agreement will have the same meaning when used in these Standard Distributor Terms.\"}, {\"id\": \"1\", \"title\": \"Reservation of Rights\", \"level\": 1, \"text\": \"1. Reservation of Rights. The Software is licensed, not sold, to Distributor. PARAGRAPH 2.2 LICENSE GRANT of the Distributor Agreement sets forth the entirety of Distributor's rights to use, market, distribute, demonstrate and otherwise deal with the Product. All rights in and to the Product not expressly granted to Distributor under this Agreement are hereby expressly reserved to WGT without restriction. Without limiting the generality of the foregoing, Distributor will comply with the following: (a) Distributor will distribute the Product to resellers only pursuant to a reseller agreement that substantially conforms to the term of this Agreement; (b) Distributor will not market, demonstrate or distribute the Product outside the Territory and Distributor will not supply the Product to any reseller that Distributor knows or has reason to know (i) intends to distribute the Product outside the Territory or (ii) intends to use or install the Product outside the Territory; (c) Distributor will market, sell and distribute the Product only in its original, unopened package as received from WGT under the terms of the end-user license agreement and limited hardware warranty, as applicable, originally included in the Product package; (d) Distributor will not modify or make copies of the Product or translate or port the Software into any other computer or human language; (e) Distributor will not disassemble, reverse engineer, decompile or repackage all or any component of the Product or otherwise attempt to discover any portion of the source code or trade secrets related to the Product; (f) Distributor will not remove, alter, distort, cover or modify any notice of copyright, trademark or other proprietary right appearing in or on any item included with the Product or its packaging; and (g) Distributor will not register, attempt to register or assist anyone else to register, directly or indirectly, the Trademarks or any copyright or other proprietary rights associated with the Product in the Territory or elsewhere other than in the name of WGT, without WGT's prior written consent.\"}, {\"id\": \"2\", \"title\": \"Protection Against Unauthorized Use\", \"level\": 1, \"text\": \"2. Protection Against Unauthorized Use. Distributor will promptly notify WGT of any unauthorized use of the Product or the Trademarks which comes to Distributor's attention. In 11 the event of any such unauthorized use by Distributor's employees, agents or representatives, Distributor will use its best efforts to terminate such unauthorized use and to retrieve any copy of the Product in the possession or control of the person or entity engaging in such unauthorized use. Distributor will immediately notify WGT of any legal proceeding initiated by Distributor in connection with such unauthorized use. WGT may, at its option and expense, participate in any proceeding and, in such event, Distributor will provide such authority, information and assistance related to such proceeding as WGT may reasonably request to protect WGT's interests.\"}, {\"id\": \"3\", \"title\": \"Use of Trademarks\", \"level\": 1, \"text\": \"3. Use of Trademarks. WGT reserves all rights in and to the Trademarks and all other trademarks and trade names used by WGT in connection with the Products, but WGT grants to Distributor the nonexclusive right to use and display the Trademarks during the Term to promote and identify the Product in the Territory in connection with this Agreement. Distributor will comply with the trademark guidelines and procedures established by WGT in Distributor's use of the Trademarks including without limitation use of the trademark and copyright symbols as specified by WGT from time to time. When using the Trademarks, Distributor will include a statement acknowledging that the Trademarks are owned by WGT. Distributor hereby acknowledges that the goodwill associated with its use of the Trademarks inures solely and exclusively to WGT and that Distributor does not acquire any rights in the Trademarks as a result of such use. Distributor will not use the Trademarks or any confusingly similar name, marks, logos, designs or artwork as part of Distributor's name, trade name, trademark or artwork without WGT's prior written consent.\"}, {\"id\": \"4\", \"title\": \"Independent Contractor\", \"level\": 1, \"text\": \"4. Independent Contractor. Distributor is an independent contractor, not an employee, agent or franchisee of WGT. Distributor will not represent or hold itself out as an employee, agent or franchisee of WGT. Distributor does not have any authority to, and will not, create or assume any license, warranty or other obligation, express or implied, on behalf of WGT. This Agreement will not be interpreted or construed as creating or evidencing any association, joint venture or partnership between the parties or as imposing any partnership or franchisor obligation or liability on either party.\"}, {\"id\": \"5\", \"title\": \"Delivery\", \"level\": 1, \"text\": \"5. Delivery. WGT will deliver all Products ordered by Distributor F.O.B. carrier at WGT's shipping location as determined by WGT from time to time, on or before the delivery date set forth in each accepted order. Distributor will pay or reimburse WGT for all shipping charges, premiums for freight insurance, inspection fees, duties, import and export fees, assessments, transportation and other costs incurred by WGT to transport the Product to the shipping destination.\"}, {\"id\": \"6\", \"title\": \"Resale\", \"level\": 1, \"text\": \"6. Resale. Distributor represents that all Products acquired under this Agreement are acquired solely for demonstration, licensing or sale (as applicable) and distribution to resellers or end-users in the Territory without intervening use by Distributor. Distributor acknowledges that the prices set forth in this Agreement have been established in reliance upon such representation and that different prices may apply to any Products acquired for any other purpose. Upon WGT's request, Distributor will furnish WGT evidence of such resale (including but not limited to satisfactory evidence of exemption from retail sales, use or similar taxes that may otherwise apply to transactions under this Agreement). 12\"}, {\"id\": \"7\", \"title\": \"Software Update Exchange\", \"level\": 1, \"text\": \"7. Software Update Exchange. Once each Quarter during the Term of this Agreement, Distributor shall have the right to exchange any prior version of the Software then in Distributor's inventory for an equivalent quantity of Software containing Updates, subject to Distributor paying WGT an \\\"Exchange Fee\\\" set forth in Exhibit A, for each copy of the Software exchanged hereunder. WGT will invoice Distributor for and Distributor shall pay all Exchange Fees as provided in Exhibit A. WGT will deliver all such exchanged Software Updates in accordance with paragraph 5. Distributor shall return to WGT the copies of the prior versions of the Software exchanged under this paragraph 7 at Distributor's expense.\"}, {\"id\": \"8\", \"title\": \"Records; Audit\", \"level\": 1, \"text\": \"8. Records; Audit. During the Term and for twenty-four (24) months thereafter, Distributor will keep and maintain accurate accounts and records regarding the Products sold and Product license keys delivered to resellers and end-users under this Agreement. Upon WGT's request, Distributor will provide access to such records for examination, reproduction, and audit by WGT or its representatives. Any such audit will be conducted at such times and in such a manner so as not to unreasonably interfere with Distributor's normal operations. If any such audit discloses that Distributor is deficient in its compliance with the terms and conditions of this Agreement, Distributor will immediately pay to WGT any deficiency, plus interest at the rate of one and one-half percent (1.5%) per month running from the date originally due until the date paid. Acceptance of any payment by WGT will be without prejudice to WGT's rights to an audit under this paragraph 8 or any other rights or remedies afforded to WGT under any other provision of this Agreement or applicable law.\"}, {\"id\": \"9\", \"title\": \"Taxes\", \"level\": 1, \"text\": \"9. Taxes. The Guaranteed Minimum Purchases and other amounts specified in this Agreement do not include sales, use or value added taxes, customs fees, duties or other governmental taxes or charges. Distributor will pay all such taxes and charges. In the event Distributor is required under any applicable law to withhold any taxes or duties from the amounts specified under this Agreement, payment of the amounts specified under this Agreement will be net of such withholding taxes or duties. Distributor will pay the amount of all such withholding taxes and duties and supply WGT with information concerning the amount and type of tax withheld and any certificates concerning payments of such withholding taxes.\"}, {\"id\": \"10\", \"title\": \"Interest\", \"level\": 1, \"text\": \"10. Interest. Any amount not paid when due will be subject to finance charges at the rate of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law; whichever is less, determined and compounded on a daily basis from the date due until the date paid. Payment of such finance charges will not excuse or cure Distributor's breach or default for late payment. If WGT retains a collection agency, attorney or other person or entity to collect overdue payments, all collection costs, including but not limited to reasonable attorney's fees, will be payable by Distributor.\"}, {\"id\": \"11\", \"title\": \"Confidentiality\", \"level\": 1, \"text\": \"11. Confidentiality. Any information received by Distributor in performance of this Agreement relating to the business affairs, customers, markets, finances, methods, Product, technology, trade secrets or proprietary rights of WGT will be treated as confidential and proprietary information of WGT. Distributor will not disclose such information, unless the information is in the public domain at the time of disclosure through no fault of Distributor or WGT consents to the disclosure in writing. Distributor will disclose such information only to its 13 employees whose duties justify their need to know such information and who have agreed to copy with Distributor's confidentiality obligations hereunder.\"}, {\"id\": \"12\", \"title\": \"Ownership\", \"level\": 1, \"text\": \"12. Ownership. The Product involves valuable patent, copyright, trade secret, trade name, trademark and other proprietary rights of WGT. No title to or ownership of such proprietary rights is transferred to Distributor under this Agreement or by use of any trademark, copyright or other proprietary right. WGT reserves all of its copyright, trade secret and other proprietary rights in the Product. Distributor will not infringe, violate or contest and will take appropriate steps and precautions for the protection of, such proprietary rights.\"}, {\"id\": \"13\", \"title\": \"Implementation\", \"level\": 1, \"text\": \"13. Implementation. Distributor will take at WGT's expense, all action during or after the Term that is reasonably requested by WGT for the implementation of the ownership provisions of this Agreement or to evidence, perfect or protect WGT's ownership of this Product and the proprietary rights associated with ownership of the Product (including, without limitation, the execution, acknowledgment and delivery of instruments of conveyance, patent, copyright, trademark or other proprietary rights registration applications or other documents.)\"}, {\"id\": \"14\", \"title\": \"Warranty; Returns\", \"level\": 1, \"text\": \"14. Warranty; Returns. WGT will permit Distributor and end-users purchasing through resellers to return any defective Product in accordance with the limited warranty contained in the applicable end-user license agreement or limited hardware warranty, as applicable, provided that the Distributor and end-user have compiled with the applicable warranty terms and conditions. In order to receive the remedy provided for hereunder, Distributor shall deliver to WGT a sample of the Product which Distributor finds to be defective in workmanship or materials, or damaged in shipment prior to Distributor assuming the risk of loss or damage , along with a written explanation of the alleged defect within thirty (30) days from the later of Distributor's initial receipt of such Product from WGT or from the delivery of such Product to an end-user. In the event WGT verifies a defect reported by Distributor and such defect affects more than one (1) Product, then at WGT's option, Distributor shall either certify destruction of all defective Products or return all Products which it alleges are defective to WGT. Distributor, reseller or the end user will be responsible for transportation charges for such Product units sent to WGT's facilities for service. Provided that WGT is able to verify the presence of the reported defect in such units, transportation charges, via a mode of transportation chosen by WGT, shall be borne by WGT to return the Product units from WGT's location to the Distributor, reseller or the end-user's location. Upon verification of a defect in one or more Products returned in accordance with the foregoing, or upon Distributor's certification that it has destroyed any defective Product in compliance with WGT's instructions, WGT will, at its option, either issue a credit to Distributor in the amount of the purchase price paid or payable for such Product by Distributor or replace the defective Product with an identical (non-defective) Product. Such remedy will be exclusive and in full satisfaction of Distributor's claims hereunder. WGT does not warrant that the Products are free form all bugs, errors, defects, design flaws or omissions. The warranties in this Agreement apply only to the latest version of each Product made available by WGT to Distributor. Such warranties will not apply to any Product which WGT determines has been subject to misuse, neglect, improper installation, repair, alteration or damage by Distributor, reseller or an end-user or any other individual or entity, or modification by any such individual or entity except with the prior express authorization of WGT. WGT's obligations 14 under this paragraph will not apply to the extent arising out of any use or combination of the Product with any other products, goods, services or other items furnished by Distributor or anyone other than WGT, or to any modification or change of the Product not made by WGT. The foregoing warranties and rights may be asserted by Distributor only and not by Distributor's resellers.\"}, {\"id\": \"15\", \"title\": \"Infringement\", \"level\": 1, \"text\": \"15. Infringement. WGT will defend and indemnify Distributor against any judicial proceeding based upon infringement of any U.S. patent or US. copyright by the Product to the extent that such proceeding arises from or in connection with a component of the Product manufactured or developed by WGT and not any third party, provided that Distributor notifies WGT of such proceeding promptly after Distributor receives notice thereof, WGT has control over the defense and settlement of the proceeding, Distributor provides such assistance in the defense and settlement of the proceeding as WGT may reasonably request, and Distributor complies with any settlement or court order made in connection with such proceeding (e.g., as to the future use of any infringing Product). WGT's obligations under this paragraph will not apply to any infringement to the extent arising out of any use or combination of the Product with any other products, goods, services or other items furnished by Distributor or anyone other than WGT or to any modification or change of the Product not made by WGT.\"}, {\"id\": \"16\", \"title\": \"Disclaimer and Release\", \"level\": 1, \"text\": \"16. Disclaimer and Release. THE WARRANTIES OF WGT AND THE REMEDIES OF DISTRIBUTOR SET FORTH IN PARGRAPHS 14 AND 15 ARE EXCLUSIVE AND IN SUBSTITUTION FOR, AND DISTRIBUTOR HEREBY WAIVES, RELEASES AND DISCLAIMS. ALL OTHER WARRANTIES, OBLIGATIONS AND LIABILITIES OF WGT AND ALL OTHER RIGHTS, REMEDIES AND CLAIMS OF DISTRIBUTOR, EXPRESS OR IMPLIED, ARISING BY LAW OR OTHERWISE, WITH RESPECT TO ANY DEFECT, DEFICIENCY OR NONCONFORMITY IN ANY PRODUCT OR OTHER ITEM FURNISHED BY OR ON BEHALF OF WGT UNDER THIS AGREEMENT, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE; IMPLIED WARRANTY ARISING FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USEAGE OF TRADE; ANY OBLIGATION, LIABLITY, RIGHT, REMEDY OR CLAIM IN TORT (INCLUDING NEGLIGENCE, WHETHER ACTIVE, PASSIVE OR IMPUTED), PRODUCT LIABLITY, STRICKT LIABILITY OR OTHER THEORY; AND CLAIM OF INFRINGEMENT.\"}, {\"id\": \"17\", \"title\": \"Representations\", \"level\": 1, \"text\": \"17. Representations. Distributor will be solely responsible for any representations or warranties Distributor may make to any reseller with respect to the Product or any products, goods, services or other items provided by Distributor. Except to the extent inconsistent with paragraph 15, Distributor releases and will defend, indemnify and hold harmless WGT and its officers, directors, employees, agents and representatives from any and all claims, losses, damages, liens, liabilities, costs and expenses (including, but not limited, reasonable attorneys' fees) incurred or asserted by any reseller or otherwise arising out of or in connection with (a) any misrepresentation, negligent or tortious act or omission, or breach of or default under this Agreement by Distributor or by anyone else acting for or on behalf of Distributor in connection with the promotion, distribution or other dealings with respect to the Product; (b) any reseller or end-user's use of the Product or any products or services of 15 Distributor; or (c) any representations and warranties made by Distributor that are inconsistent with or in addition to the warranties made in WGT's end-user license agreement or limited hardware warranty, as applicable, accompanying each copy of the Product.\"}, {\"id\": \"18\", \"title\": \"Limitations of Liability\", \"level\": 1, \"text\": \"18. Limitations of Liability. EXCEPT AS PROVIDED IN PARAGRAPH 15, WGT'S LIABILITY(WHETHER IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE WHETHER ACTIVE, PASSIVE, IMPUTED), PRODUCT LIABILITY, STRICT LIABILITY OR OTHER THEORY) UNDER THIS AGREEMENT OR WITH REGARD TO ANY PRODUCT OR OTHER ITEMS FURNISHED UNDER THIS AGREEMENT WILL IN NO EVENT EXCEED THE COMPENSATION PAID TO WGT CONCERNING SUCH PRODUCT UNDER THIS AGREEMENT.\"}, {\"id\": \"19\", \"title\": \"Consequential Damages\", \"level\": 1, \"text\": \"19. Consequential Damages. IN NO EVENT WILL WGT BE LIABLE, WHETHER IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE (WHETHER ACTIVE, PASSIVE OR IMPUTED), PRODUCT LIABILITY, STRICT LIABILITY OR OTHER THEORY), TO DISTRIBUTOR OR TO ANY RESELLER OF DISTRIBUTOR, END-USER OR OTHER PERSON OR ENTITY FOR COST OF COVER OR FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES (INCLUDING WITHOUT LIMITATION DAMAGES FOR LOSS OF PROFIT, BUSINESS OR DATA) ARISING OUT OF ITS PERFORMANCE OR NONPERFORMANCE OF THIS AGREEMENT OR THE USE OF, INABIILTY TO USE OR RESULTS OF USE OF THE PRODUCT.\"}, {\"id\": \"20\", \"title\": \"Compliance with Laws\", \"level\": 1, \"text\": \"20. Compliance with Laws. In performing this Agreement, Distributor will comply with all applicable laws, regulations and other requirements, now or hereafter in effect, of government authorities having jurisdiction.\"}, {\"id\": \"21\", \"title\": \"Export\", \"level\": 1, \"text\": \"21. Export. Without limiting anything else herein, Distributor will not export or re-export, directly or indirectly, the WGT Product to any country to which export or re-export of such items is prohibited by the U.S. Export Administration Act, regulations of the U.S. Department of Commerce and other export controls of the U.S., as they may be amended without first obtaining an appropriate written authorization from the U.S. Office of Export Licensing or its successor. At the time of execution of this Agreement, Distributor is prohibited from exporting or re-exporting , directly or indirectly, the WGT Product to the following countries: Cuba, Libya, North Korea, Iran, Iraq, Ruwanda, Sudan, Syria and the Federal Republic of Yugoslavia (Serbia and Montenegro). Notwithstanding the foregoing list, Distributor is not relieved from its obligations to comply with the foregoing export control laws, as such laws may be amended from time to time. Distributor shall also comply with all other foreign or local governmental export and import control laws, regulations and rules.\"}, {\"id\": \"22\", \"title\": \"Government Approvals\", \"level\": 1, \"text\": \"22. Government Approvals. Distributor will obtain at its expense all licenses, permits and other governmental approvals; will provide all notices; and will pay all duties, taxes and other charges required for the license, export, re-export and import of the Product distributed by the Distributor; the license of the Software distributed by Distributor; and the implementation of this Agreement. 16\"}, {\"id\": \"23\", \"title\": \"Nonwaiver\", \"level\": 1, \"text\": \"23. Nonwaiver. The failure of either party to insist upon or enforce strict performance of any of the provisions of this Agreement or to exercise any rights or remedies under this Agreement will not be construed as a waiver or relinquishment to any extent of such party's right to assert or rely upon any such provisions, rights or remedies in that or any other instance; rather, the same will be and remain in full force and effect.\"}, {\"id\": \"24\", \"title\": \"Assignment\", \"level\": 1, \"text\": \"24. Assignment. Distributor will not assign all or any part of this Agreement or any of its rights under this Agreement without the prior written consent of WGT. Subject to the foregoing, this Agreement will be fully binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns.\"}, {\"id\": \"25\", \"title\": \"Survival\", \"level\": 1, \"text\": \"25. Survival. Paragraphs 1, 2, 3, 13 through 23 and all accrued obligations to pay, together with all other provisions of this Agreement which may reasonably be interpreted or construed as surviving the expiration or termination of the Term, will survive the expiration or termination of the Term.\"}, {\"id\": \"26\", \"title\": \"Notices\", \"level\": 1, \"text\": \"26. Notices. Any notice or other communication under this Agreement given by either party to the other will be in writing and delivered either (a) in person or by first-class, registered or certified mail or a recognized overnight delivery service, return receipt requested, postage prepaid or (b) by facsimile and then acknowledged as received by return facsimile by the intended recipient. Notices will be deemed received only upon actual receipt. Notices will be directed to the intended recipient at the address specified below its signature on the signature page of this Agreement. Either party may change its address by giving the other party notice of such change in accordance with this paragraph.\"}, {\"id\": \"27\", \"title\": \"No Conflict\", \"level\": 1, \"text\": \"27. No Conflict. Distributor represents and warrants to WGT that Distributor is free to enter into and perform this Agreement without thereby being in breach of or default under the terms of any other contract, commitment or understanding.\"}, {\"id\": \"28\", \"title\": \"Interpretation\", \"level\": 1, \"text\": \"28. Interpretation. The English language of this Agreement will govern any interpretation of or dispute regarding the terms of this Agreement. Paragraph captions are for convenience of reference and do not alter or limit the terms of this Agreement. The parties hereto have expressly required that the present Agreement and its Exhibits be drawn up on the English language. / Les parties aux presentes ont expressement exige que la presente conventions et se Annexes solent redigees en la langue anglaise.\"}, {\"id\": \"29\", \"title\": \"Governing Law; Venue\", \"level\": 1, \"text\": \"29. Governing Law; Venue. This Agreement will be governed by and interpreted in accordance with the local laws of the State of Washington, U.S.A., without regard to its conflicts of law provisions and not including the provisions of the 1980 U.N. Convention in Contracts for the International Sale of Goods. Distributor irrevocably consents, and submits to the jurisdiction of the Federal and State courts of and located in King County, in the State of Washington, U.S.A. Distributor will not commence or prosecute any suit, claim, or proceeding arising under this Agreement other than in the courts identified in the preceding sentence. Any remedy of WGT set forth in this Agreement is in addition to any other remedy afforded to WGT under this Agreement, any other contract, by law or otherwise. 17 SUPPORT SERVICES AND PROCEDURES EXHIBIT C SUPPORT SERVICES: WGT will provide the following training and product support programs to Distributor: A. Training. Promptly after execution of this Agreement, WGT will conduct a one day technical and sales training program for three (3) of Distributor's employees. Such training will be held at Distributor's facilities. Distributor will be responsible for all costs and expenses incurred by Distributor's personnel in attending, receiving or securing training provided by WGT. B. Product Support Services. WGT will provide the following product support services to Distributor for the Term of the Agreement:\"}, {\"id\": \"1\", \"title\": \"Telephone Support\", \"level\": 1, \"text\": \"1. Telephone Support. Reasonable telephone and electronic mail support for the Software will be available in response to a request from Distributor during WGT's normal business hours (6:00 a.m. to 5:00 p.m., Monday through Friday, Pacific Standard Time), excluding holidays that WGT recognizes. Only Distributor's designated, approved personnel will communicate with WGT's customer support specialists.\"}, {\"id\": \"2\", \"title\": \"Submitting a Service Request\", \"level\": 1, \"text\": \"2. Submitting a Service Request. To submit a request for service, Distributor has two service options: (a) over the phone, the Distributor will dial WGT's service number as supplied to Distributor by WGT. When a support specialist answers the phone, Distributor will be prepared to discuss the problem with the support specialist. (b) via electronic mail as supplied to Distributor by WGT, whereby a service request can be submitted to WGT's electronic mail system. In order to submit a service request, either telephonically or electronically, Distributor will employ the following procedures: (a) provide a clear description that fully explains what the problem is, and when the problem occurs; (b) provide a diagnostic trace, sample code or file of the failure symptom that has been recorded on the user's system; and (c) describe the steps taken to resolve the problem. 18\"}, {\"id\": \"3\", \"title\": \"Priority\", \"level\": 1, \"text\": \"3. Priority. WGT will respond to problems with the Software in accordance with the following priority schedule: Priority One (\\\"P-1\\\") is reserved for critical and severe Software problems which cause the Software to fail or act in a manner which causes the Software to be unusable. Priority Two (\\\"P-2\\\") is reserved for Software problems which cause a major component of the Software to become unusable but the overall Software continues to function. Priority Three (\\\"P-3\\\") is reserved for Software problems which cause minimal disruption to normal operations of the Software and can be avoided with a simple work-around process. Priority Four (\\\"P-4\\\") is reserved for all other problems of lesser severity.\"}, {\"id\": \"4\", \"title\": \"Response Time\", \"level\": 1, \"text\": \"4. Response Time: Upon receipt of a service request, a WGT customer support specialist will contact Distributor's designated, approved personnel within the following response times to discuss the problem: \\\"P-1\\\" - respond within two (2) hours (subject to WGT's normal business hours) of receipt of a P-1 problem and use all commercially reasonable and diligent efforts to create a fix or work-around as soon as practicable considering the nature of the problem. \\\"P-2\\\" - respond within four (4) hours (subject to WGT's normal business hours) of receipt of a P-2 problem and use all commercially reasonable and diligent efforts to create a fix or work-around as soon as practicable considering the nature of the problem. \\\"P-3\\\" - respond within twenty-four (24) hours (subject to WGT's normal business hours) of receipt of a P-3 problem and use all commercially reasonable efforts to create a fix or work-around which may be included in the next Update. \\\"P-4\\\" - respond within five (5) business days (subject to WGT's normal business hours) of receipt of a P-4 problem and target a fix in a future Update. WGT will make any corrections available to Distributor via BBS, FTP site or other reasonable means. 19 DISTRIBUTOR'S FORECAST EXHIBIT D Quarter 1: ____________, 19__ through ____________, 19__ $__________ Quarter 2: ____________, 19__ through ____________, 19__ $__________ Quarter 3: ____________, 19__ through ____________, 19__ $__________ Quarter 4: ____________, 19__ through ____________, 19__ $__________ 20\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of EUROPEANMICROHOLDINGSINC_03_06_1998-EX-10.6-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.6\", \"level\": 1, \"text\": \"EXHIBIT 10.6 EXHIBIT 10.06 WATCHGUARD TECHNOLOGIES, INC. DISTRIBUTOR AGREEMENT This Agreement is made and entered into effective as of November 5, 1997 (the \\\"effective Date), by and between WatchGuard Technologies, Inc., a Delaware corporation (\\\"WGT\\\"), and European Micro (\\\"Distributor\\\"). WGT and Distributor agree as follows:\"}}, {\"id\": \"Section 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definitions\", \"level\": 1, \"text\": \"Section 1. Definitions \\\"Add-On Software Modules\\\" means those computer software programs that (a) provide additional functionality and may be integrated with the existing Hardware and other Software, (b) may be legally exported to the Territory without any export license and (c) WGT elects to include in Exhibit A at a mutually agreed discount percentage. \\\"Distributor Cost\\\" means the purchase price payable by Distributor for each Product at the discount from WGT's then current WatchGuard Price List, as such discount is set forth in Exhibit A. \\\"Documentation\\\" means any and all manuals, user guides, end-user license agreement, limited hardware warranty, on-line help files, on-line menus and other in program printed text regarding the Product prepared by or for WGT in connection with the Product. \\\"Gross Purchases\\\" means the gross purchase price Distributor pays WGT for the Product, excluding any taxes or pass through charges and net of any credits or returns. \\\"Guaranteed Minimum Purchases\\\" means the guaranteed minimum purchase amounts set forth in Exhibit A. \\\"Hardware\\\" means the hardware identified on Exhibit A, together with any Updates to such hardware. WGT reserves the right to add to or delete hardware from Exhibit A and to modify the hardware during the Term. \\\"Product\\\" means the combination of Hardware, Software and Documentation together as part of the same product package (including any Add-On Software Modules and any Updates thereto), in all cases carrying the \\\"WatchGuard\\\" Trademark. \\\"Quarter\\\" means any period of three (3) consecutive calendar months that begins on January 1, April 1, July 1 or October 1, during the Term. \\\"Software\\\" means the computer programs identified on Exhibit A, in object code only, together with any Updates to such programs. WGT reserves the right to add or delete Software from Exhibit A and to modify the Software during the Term. \\\"Term\\\" means the period of time determined in accordance with Section 5. \\\"Territory\\\" means the geographic area described in Exhibit A. \\\"Trademarks\\\" means the trademarks and trade names of WGT identified in Exhibit A. \\\"Update\\\" means any minor modification, minor upgrade or minor enhancement of the Product (excluding any new version of the Product) that WGT publishes and elects to make available to Distributor via BBS, FTP site or other reasonable means. WGT is not obligated to make or release any update.\"}}, {\"id\": \"Section 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Relationship of the Parties\", \"level\": 1, \"text\": \"Section 2. Relationship of the Parties\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Appointment\", \"level\": 2, \"text\": \"2.1 Appointment. Subject to and in accordance with the provisions of this Agreement, WGT hereby appoints Distributor, and Distributor hereby accepts WGT's appointment, as a nonexclusive distributor of the Product to resellers in the Territory during the Term, as long as Distributor makes the Guaranteed Minimum Purchases pursuant to Section 4.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"License Grant\", \"level\": 2, \"text\": \"2.2 License Grant. Subject to the terms and conditions of this Agreement, WGT grants to Distributor a nontransferable license to do the following in the Territory during the Term: (a) market and distribute the Product to resellers; (b) demonstrate the Product to potential resellers; (c) use the Product internally for the sole purpose of providing this product support specified in paragraph 4.1(c); (d) use and display the Trademarks in connection with marketing and distributing the Product in the Territory pursuant to paragraphs (a) and (b) above.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Exclusivity\", \"level\": 2, \"text\": \"2.3 No Exclusivity. Distributor's appointment and the rights granted hereunder are nonexclusive. WGT may, at its sole option, appoint other distributors of the Product in the Territory at any time during the Term and expressly reserves the right to license the Product directly or indirectly to end-users, third party original equipment manufacturers or other hardware bundlers, value-added resellers or other resellers for sublicense or resale in the Territory.\"}}, {\"id\": \"Section 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compensation\", \"level\": 1, \"text\": \"Section 3. Compensation\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Support services\", \"level\": 2, \"text\": \"3.1 Support services. As full compensation for the support services described in Exhibit C and provided during the Term, Distributor will pay WGT the Support Fee set forth in Exhibit A. Payment of the Support Fee is due and payable upon execution of this Agreement by wire transfer of immediately payable funds to the bank and account set forth in paragraph 3.4, and then annually by invoice from WGT on the anniversary of the execution of the Agreement. 2\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price\", \"level\": 2, \"text\": \"3.2 Price. Distributor will pay WGT for each Product Distributor orders an amount equal to WGT's then current WatchGuard Price List in effect on the date of receipt by WGT of Distributor's order, subject to the applicable discount set forth in Exhibit A. WGT may, from time to time, change its WatchGuard Price List, provided that any such change will not be effective under this Agreement unless and until the expiration of forty-five (45) days after WGT gives Distributor written notices of the change.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Guaranteed Minimum Purchases\", \"level\": 2, \"text\": \"3.3 Guaranteed Minimum Purchases. During the Term, Distributor will make Gross Purchases in an amount at least equal to the cumulative Guaranteed Minimum Purchase amounts through committed orders placed pursuant to paragraph 3.5 and calling for shipment on or before the dates set forth in Exhibit A.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Invoices\", \"level\": 2, \"text\": \"3.4 Invoices. WGT will issue invoices for the Products ordered by Distributor and all other amounts payable to WGT under this Agreement. Distributor will pay WGT the full amount invoiced within thirty (30) days after the date of WGT's invoice, unless provided otherwise on the applicable invoice, in the lawful money of the United States of America to WGT by wire transfer of immediately available funds to WGT's bank account number 1141139, at the Commerce Bank of Washington, 601 Union Street, Suite 3600, Seattle, WA 98101, ABA routing number 125008013.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Orders\", \"level\": 2, \"text\": \"3.5 Orders. Distributor will place orders for the Product from WGT by completing, signing and submitting to WGT a written order for the same, in a form acceptable to WGT, via facsimile, mail or other means. Distributor shall submit such order at least thirty (30) days in advance of the delivery date set forth in each order. All orders will be subject to acceptance by WGT through written acceptance or shipment of the Product subject to the order.\"}}, {\"id\": \"Section 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General Obligations of the Parties\", \"level\": 1, \"text\": \"Section 4. General Obligations of the Parties.\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Obligations of Distributor\", \"level\": 2, \"text\": \"4.1 Obligations of Distributor. Distributor will use its best efforts aggressively to develop sales of the Product in the Territory. In furtherance thereof, Distributor will: (a) keep on hand a reasonable inventory of the Product sufficient to allow for prompt delivery of the Product to resellers; (b) establish a program to market the Product, including, but not limited to, participating regularly in local and regional trade shows, conventions or like events in the Territory, and conducting regular local promotional and other marketing efforts for the Product; (c) provide quality product support to resellers, including, but not limited to, providing appropriate installation and application advice and prompt follow-up service and advice to resellers of the Product upon request; (d) provide a support center to resellers, including, but not limited to, a hotline service to answer reseller questions and to receive and track complaints and any reports of claimed errors in the Product; 3 (e) provide quality product technical and sales training to resellers; (f) respond promptly to sales leads or referrals furnished by WGT or by other distributors or dealers of WGT; (g) have a designated number of employees attend such technical and sales training programs as set forth in Exhibit C; (h) maintain and furnish periodically, as WGT may reasonably request, complete and accurate records of each sale or other distribution of each Product sold or distributed by Distributor (e.g., showing the date of sale, Zip code of the customer, the Product serial number and the applicable Product license key(s)) under this Agreement; (i) promptly advise WGT of each complaint that Distributor may receive or becomes aware of concerning the Product or any portion thereof (including, but not limited to, warranty claims). Distributor will promptly investigate all such complaints and will give immediate attention to and use its best efforts to promptly, courteously and equitably respond to, adjust and settle (without incurring any obligation or liability on behalf of WGT) all complaints received by Distributor from any customer, potential customer or anyone else arising out of or in connection with Distributor's sale of any Product, or the performance of any services. In handling any complaints, Distributor will use its best efforts to maintain and promote good public relations for WGT; (j) secure and maintain, in the name of WGT, any and all registrations, permits, licenses, approvals and other governmental actions required to import, handle, market, sell, demonstrate, use and distribute the Product in the Territory, provide to WGT quarterly progress reports on such action, and provide WGT copies of all registrations, permits, licenses, approvals, certificates, correspondence and other documentation related to such action; (k) hire, train, coordinate and maintain a qualified staff of sufficient size and with a level and mix of capabilities as are reasonably necessary to accomplish the goals contemplated under this Agreement; (l) avoid deceptive, misleading or unethical conduct which are or might be detrimental to WGT or its Product, and refrain from making any representation, warranty or guarantee to any reseller with respect to specifications, features or capabilities of the Product that is inconsistent with the literature distributed by WGT or this Agreement; (m) conduct its business in a manner under its own control, provided that Distributor will at all times comply with all applicable laws and regulations and will not engage in, or permit its employees or agents to engage in, any activities or practices which could reflect negatively upon the reputation or prospects of WGT or the Product or expose WGT to any liability of any nature whatsoever; and\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Obligations of WGT, WGT will\", \"level\": 2, \"text\": \"4.2 Obligations of WGT, WGT will: 4 (a) provide Distributor with sixty (60) days advance notice in the event that it discontinues production of any Product; (b) provide Distributor with the training and product support services described in Exhibit C; and (c) furnish Distributor with such demonstration Product, promotional literature, data, information and other items as WGT deems appropriate for Distributor's promotion, marketing and sale of the Product. WGT will use such items only for the purpose of performing its obligations under this Agreement.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Forecasts\", \"level\": 2, \"text\": \"4.3 Forecasts. Distributor's forecast of Product purchases for the Term is set forth on Exhibit D. At least fifteen (15) days before the beginning of each Quarter during the Term, Distributor will furnish WGT with a rolling revised forecast of Product orders for the remainder of the Term.\"}}, {\"id\": \"Section 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"Section 5. Term and Termination.\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"5.1 Term. The Term will commence on the Effective Date of this Agreement and will remain in effect, unless sooner terminated under paragraphs 5.2, 5.3, or 5.4, until the termination date specified in Exhibit A. The Term will automatically renew for successive additional periods of one (1) year each, provided that: (a) Distributor has made all Guaranteed Minimum Purchases and has complied with the marketing requirements under paragraph 4.1(b); (b) the parties have agreed in writing upon the Guaranteed Minimum Purchase amounts and Product price discounts for the next subsequent one (1) year renewal period; (c) neither party provided the other party with notice of such party's intention not to renew this Agreement at least thirty (30) days prior to any year's Expiration Date; and (d) neither party provided the other party with such notice as may be required pursuant to paragraphs 5.2, 5.3 or 5.4.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination by WGT\", \"level\": 2, \"text\": \"5.2 Termination by WGT. Upon the occurrence of any of the following, WGT may terminate the Term by giving Distributor written notice of such termination for: (a) any failure of Distributor to comply with the marketing requirements under paragraph 4.1(b); (b) any material change in the general management, ownership or control of Distributor, including without limitation the sale, transfer or relinquishment by Distributor of any substantial interest in the ownership of the business to be carried on by Distributor under this Agreement, unless such change is approved in advance and in writing by an officer of WGT; (c) any assignment or attempted assignment of this Agreement by Distributor without the prior written consent of WGT; (d) any solicitation by Distributor for the sale of the Product to resellers located outside the Territory; 5 (e) the insolvency of Distributor, the filing of a petition in bankruptcy by or against Distributor, the appointment of a receiver for Distributor or Distributor's property, the execution of an assignment by Distributor of all or substantially all of its assets for the benefit of its creditors, or the conviction of Distributor or any principal or manager of Distributor for any crime tending to adversely affect the ownership or operation of Distributor's business; (f) any failure by Distributor to perform any of its other obligations under this Agreement where such failure continues for thirty (30) days after written notice thereof by WGT to Distributor; or (g) WGT giving Distributor ninety (90) days' advance written notice of termination at any time after the expiration of the Initial Term.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Failure to Make Guaranteed Minimum Purchases\", \"level\": 2, \"text\": \"5.3 Failure to Make Guaranteed Minimum Purchases. Upon any failure by Distributor to make Gross Purchases in sufficient amounts to meet or exceed the applicable cumulative Guaranteed Minimum Purchases, WGT may, at its sole option and effective upon notice to Distributor, terminate this Agreement. Distributor shall pay WGT fifty percent (50%) of the unpaid balance of cumulative Guaranteed Minimum Purchase amounts as liquidated damages. The parties acknowledge and agree that it would be difficult or impossible to calculate WGT's actual damages arising from Distributor's failure to timely pay all of the Guaranteed Minimum Purchases. Therefore, the parties have agreed upon the above payment of liquidated damages in lieu of WGT's claim for actual damages from such breach.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination by Distributor\", \"level\": 2, \"text\": \"5.4 Termination by Distributor. Upon the occurrence of any of the following, Distributor may terminate the Term by giving WGT written notice of such termination; (a) the insolvency of WGT, the filing of a petition by or against WGT, the appointment of a receiver for WGT or WGT's property, or the execution of an assignment by WGT of all or substantially all of its assets for the benefit of its creditors; (b) any failure by WGT to perform any of its obligations under this Agreement where such failure continues for thirty (30) days after written notice thereof by Distributor to WGT; or (c) for convenience whether or not extended beyond the Initial Term, provided Distributor gives WGT thirty (30) days' advance written notice and, within such thirty (30) day period, Distributor pays to WGT a lump-sum payment equal to fifty (50%) of the unpaid balance of cumulative Guaranteed Minimum Purchase amounts.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"5.5 Effect of Termination. Any termination pursuant to paragraphs 5.2, 5.3, or 5.4 will be without prejudice to any other right or remedy afforded to either party under this Agreement or any applicable law (e.g., in the case of any breach or default by the other party), and will not affect any rights or obligations which have arisen prior to the date of such termination. In the event of termination, Distributor will: 6 (a) immediately cease to demonstrate, market, sublicense and distribute the Product in the Territory; (b) cease use of all Trademarks of WGT; (c) return to WGT within twenty (20) days following the expiration or termination of the Term, any and all (i) demonstration Product provided to Distributor; (ii) Products not already paid for in full by Distributor; and (iii) promotional literature, data, information and other items received by Distributor under this Agreement; and (d) furnish WGT with such information relating to the marketing, sale or distribution of the Product in the Territory as WGT may reasonably request (including, but not limited to, information as to calls or the status of any negotiations for the sale of the Product, or any sales or service records). Upon the expiration or termination of the Term, the license granted under Section 2 of this Agreement will terminate. Any end-user licenses of the Software granted under the terms of this Agreement will survive the end of the Term in accordance with the terms of the applicable end-user license agreement.\"}}, {\"id\": \"6.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"6.0 Force Majeure. Neither party will be liable for, or be considered to be in breach of or default under this Agreement on account of, any delay or failure to perform as required by this Agreement (other than for payment under Section 3), as a result of any cause or condition beyond such party's reasonable control.\"}}, {\"id\": \"7.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"7.0 Entire Agreement. This Agreement is subject to the provisions of WGT's Standard Distributor Terms attached hereto as Exhibit B and by this reference incorporated into and as part of this Agreement. This Agreement is also subject to any additional terms or licenses executed by WGT and Distributor and attached as Exhibits, including any Special Terms and Conditions specified in Exhibit A. This Agreement sets forth the entire agreement, and supersedes any and all prior agreements, among the parties related to the Product. WGT will not be bound by, and specifically objects to, any term, condition, or other provision that is different from or in addition to the provisions of this Agreement (whether or not it would materially alter this Agreement) and that is proffered by Distributor or otherwise appears in any order, receipt, acceptance, confirmation, correspondence, or otherwise, unless WGT specifically agrees to such provision in a written instrument signed by WGT. No 7 modifications of any of the provisions of this Agreement will be valid unless set forth in a written instrument signed by both parties. Any remedy by WGT set forth in this Agreement is in addition to any other remedy afforded to WGT under any other contract, by law, or otherwise. IN WITNESS THEREOF, the parties have executed this Agreement as of the date first above written. Distributor: WatchGuard Technologies, Inc. By: /s/ LAURENCE GILBERT By: /s/ WATCHGUARD ------------------------- ------------------------------ Title: MANAGING DIRECTOR Title: VP/SALES Date Signed: NOVEMBER 5, 1997 Date Signed: NOVEMBER 3, 1997 Address: 20/24 Church Street Required Signature: Altrincham, Cheshire WA14 4DW, ENGLAND By: ------------------------------- Title: Executive Vice-President Sales Date Signed: --------------------- Address: 316 Occidental Avenue South Suite 300 Seattle, Washington 98104 8 FULL SERVICE MASTER DISTRIBUTOR SCHEDULE EXHIBIT A PRODUCTS: Distributor will be entitled to order the following products (which includes hardware and software) at the following discounts of WGT's then current WatchGuard Price List: - ------------------------------------------------------------------------------- DISCOUNT FROM WGT'S PRODUCT THEN CURRENT WATCHGUARD PRICE LIST - ------------------------------------------------------------------------------- WatchGuard Security System 40% plus additional 10% on the remaining undiscounted amount, i.e., 46% - ------------------------------------------------------------------------------ EXCHANGE FEE: $10 per CD SUPPORT FEE: $25,000 per year TERMINATION DATE: September 30, 1997 TRADEMARKS: /bullet/ WatchGuard(TM) /bullet/ WatchGuard(TM) Technologies /bullet/ WatchGuard(TM) SchoolMate /bullet/ Firebox(TM) TERRITORY: /bullet/ Europe SPECIAL TERMS AND CONDITIONS 9 These Special Terms and Conditions are part of the Distributor Agreement between WatchGuard Technologies, Inc. (\\\"WGT\\\") and Distributor (collectively, the \\\"Agreement\\\"). Terms that are defined in the Distributor Agreement will have the same meaning when used in these Special Terms and Conditions. Section A.1 By joint agreement between WGT and Distributor, Distributor may engage in end user sales in the Territory. If it is agreed that Distributor may engage in end user sales, Distributor may distribute, license and sell up to 20% of the Product purchased from WGT directly to end-users in the Territory. Further, Distributor agrees that high end-users satisfaction is a condition of its continued authorization by WGT. To ensure high end-user satisfaction, Distributor shall: (a) provide quality first level support to its end-user customers; (b) promptly report to WGT all suspected and actual problems with any WGT product; (c) assist WGT in tracing WGT Products to particular end users to distribute critical WGT Product information, locate WGT Products for safety reasons, or to be discover unauthorized marketing or infringing acts; (d) avoid deceptive, misleading or unethical conduct which are or might be detrimental to WGT or its WGT product; and (e) refrain from marking any representation, warranty or guarantee to end users with respect to the specifications, features or capabilities of the WGT Product that is inconsistent with the literature distributed by WGT or this Agreement. Section A.2 Distributor is legally organized under the jurisdiction of a country belonging to the European Union. If Distributor is organized under the jurisdiction of the country belonging to the European Union, the following clause is hereby appended to Section 1(c) of the Standard Distributor Terms: \\\"PROVIDED HOWEVER, the foregoing restriction is not intended to preclude Distributor from fulfilling, and Distributor may fulfill, unsolicited orders for Product received from outside the Territory but within the European Union (and Distributor shall provide WGT written notice of any such Sales);\\\" Section A.3 As a Full Service Master Distributor, Distributor agrees to sign up a minimum of 10 new WatchGuard resellers in the Territory within the Initial Term of the Agreement. - -------------------------------------------- --------------------------------- Distributor: WatchGuard Technologies, Inc.: By: /s/ LAURENCE GILBERT By: /s/ WATCHGUARD -------------------------- ----------------------------- Title: MANAGING DIRECTOR Title: SENIOR VICE PRESIDENT/SALES Date Signed: NOVEMBER 5, 1997 Date Signed: NOVEMBER 3, 1997 -------------------------------------------- --------------------------------- 10 STANDARD DISTRIBUTOR TERMS EXHIBIT B These Standard Distributor Terms are part of the Distributor Agreement between WatchGuard Technologies, Inc. (\\\"WGT\\\") and Distributor (collectively, the \\\"Agreement\\\"). Terms that are defined in the Distributor Agreement will have the same meaning when used in these Standard Distributor Terms.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reservation of Rights\", \"level\": 1, \"text\": \"1. Reservation of Rights. The Software is licensed, not sold, to Distributor. PARAGRAPH 2.2 LICENSE GRANT of the Distributor Agreement sets forth the entirety of Distributor's rights to use, market, distribute, demonstrate and otherwise deal with the Product. All rights in and to the Product not expressly granted to Distributor under this Agreement are hereby expressly reserved to WGT without restriction. Without limiting the generality of the foregoing, Distributor will comply with the following: (a) Distributor will distribute the Product to resellers only pursuant to a reseller agreement that substantially conforms to the term of this Agreement; (b) Distributor will not market, demonstrate or distribute the Product outside the Territory and Distributor will not supply the Product to any reseller that Distributor knows or has reason to know (i) intends to distribute the Product outside the Territory or (ii) intends to use or install the Product outside the Territory; (c) Distributor will market, sell and distribute the Product only in its original, unopened package as received from WGT under the terms of the end-user license agreement and limited hardware warranty, as applicable, originally included in the Product package; (d) Distributor will not modify or make copies of the Product or translate or port the Software into any other computer or human language; (e) Distributor will not disassemble, reverse engineer, decompile or repackage all or any component of the Product or otherwise attempt to discover any portion of the source code or trade secrets related to the Product; (f) Distributor will not remove, alter, distort, cover or modify any notice of copyright, trademark or other proprietary right appearing in or on any item included with the Product or its packaging; and (g) Distributor will not register, attempt to register or assist anyone else to register, directly or indirectly, the Trademarks or any copyright or other proprietary rights associated with the Product in the Territory or elsewhere other than in the name of WGT, without WGT's prior written consent.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Protection Against Unauthorized Use\", \"level\": 1, \"text\": \"2. Protection Against Unauthorized Use. Distributor will promptly notify WGT of any unauthorized use of the Product or the Trademarks which comes to Distributor's attention. In 11 the event of any such unauthorized use by Distributor's employees, agents or representatives, Distributor will use its best efforts to terminate such unauthorized use and to retrieve any copy of the Product in the possession or control of the person or entity engaging in such unauthorized use. Distributor will immediately notify WGT of any legal proceeding initiated by Distributor in connection with such unauthorized use. WGT may, at its option and expense, participate in any proceeding and, in such event, Distributor will provide such authority, information and assistance related to such proceeding as WGT may reasonably request to protect WGT's interests.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Use of Trademarks\", \"level\": 1, \"text\": \"3. Use of Trademarks. WGT reserves all rights in and to the Trademarks and all other trademarks and trade names used by WGT in connection with the Products, but WGT grants to Distributor the nonexclusive right to use and display the Trademarks during the Term to promote and identify the Product in the Territory in connection with this Agreement. Distributor will comply with the trademark guidelines and procedures established by WGT in Distributor's use of the Trademarks including without limitation use of the trademark and copyright symbols as specified by WGT from time to time. When using the Trademarks, Distributor will include a statement acknowledging that the Trademarks are owned by WGT. Distributor hereby acknowledges that the goodwill associated with its use of the Trademarks inures solely and exclusively to WGT and that Distributor does not acquire any rights in the Trademarks as a result of such use. Distributor will not use the Trademarks or any confusingly similar name, marks, logos, designs or artwork as part of Distributor's name, trade name, trademark or artwork without WGT's prior written consent.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractor\", \"level\": 1, \"text\": \"4. Independent Contractor. Distributor is an independent contractor, not an employee, agent or franchisee of WGT. Distributor will not represent or hold itself out as an employee, agent or franchisee of WGT. Distributor does not have any authority to, and will not, create or assume any license, warranty or other obligation, express or implied, on behalf of WGT. This Agreement will not be interpreted or construed as creating or evidencing any association, joint venture or partnership between the parties or as imposing any partnership or franchisor obligation or liability on either party.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery\", \"level\": 1, \"text\": \"5. Delivery. WGT will deliver all Products ordered by Distributor F.O.B. carrier at WGT's shipping location as determined by WGT from time to time, on or before the delivery date set forth in each accepted order. Distributor will pay or reimburse WGT for all shipping charges, premiums for freight insurance, inspection fees, duties, import and export fees, assessments, transportation and other costs incurred by WGT to transport the Product to the shipping destination.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resale\", \"level\": 1, \"text\": \"6. Resale. Distributor represents that all Products acquired under this Agreement are acquired solely for demonstration, licensing or sale (as applicable) and distribution to resellers or end-users in the Territory without intervening use by Distributor. Distributor acknowledges that the prices set forth in this Agreement have been established in reliance upon such representation and that different prices may apply to any Products acquired for any other purpose. Upon WGT's request, Distributor will furnish WGT evidence of such resale (including but not limited to satisfactory evidence of exemption from retail sales, use or similar taxes that may otherwise apply to transactions under this Agreement). 12\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Software Update Exchange\", \"level\": 1, \"text\": \"7. Software Update Exchange. Once each Quarter during the Term of this Agreement, Distributor shall have the right to exchange any prior version of the Software then in Distributor's inventory for an equivalent quantity of Software containing Updates, subject to Distributor paying WGT an \\\"Exchange Fee\\\" set forth in Exhibit A, for each copy of the Software exchanged hereunder. WGT will invoice Distributor for and Distributor shall pay all Exchange Fees as provided in Exhibit A. WGT will deliver all such exchanged Software Updates in accordance with paragraph 5. Distributor shall return to WGT the copies of the prior versions of the Software exchanged under this paragraph 7 at Distributor's expense.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records; Audit\", \"level\": 1, \"text\": \"8. Records; Audit. During the Term and for twenty-four (24) months thereafter, Distributor will keep and maintain accurate accounts and records regarding the Products sold and Product license keys delivered to resellers and end-users under this Agreement. Upon WGT's request, Distributor will provide access to such records for examination, reproduction, and audit by WGT or its representatives. Any such audit will be conducted at such times and in such a manner so as not to unreasonably interfere with Distributor's normal operations. If any such audit discloses that Distributor is deficient in its compliance with the terms and conditions of this Agreement, Distributor will immediately pay to WGT any deficiency, plus interest at the rate of one and one-half percent (1.5%) per month running from the date originally due until the date paid. Acceptance of any payment by WGT will be without prejudice to WGT's rights to an audit under this paragraph 8 or any other rights or remedies afforded to WGT under any other provision of this Agreement or applicable law.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 1, \"text\": \"9. Taxes. The Guaranteed Minimum Purchases and other amounts specified in this Agreement do not include sales, use or value added taxes, customs fees, duties or other governmental taxes or charges. Distributor will pay all such taxes and charges. In the event Distributor is required under any applicable law to withhold any taxes or duties from the amounts specified under this Agreement, payment of the amounts specified under this Agreement will be net of such withholding taxes or duties. Distributor will pay the amount of all such withholding taxes and duties and supply WGT with information concerning the amount and type of tax withheld and any certificates concerning payments of such withholding taxes.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Interest\", \"level\": 1, \"text\": \"10. Interest. Any amount not paid when due will be subject to finance charges at the rate of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law; whichever is less, determined and compounded on a daily basis from the date due until the date paid. Payment of such finance charges will not excuse or cure Distributor's breach or default for late payment. If WGT retains a collection agency, attorney or other person or entity to collect overdue payments, all collection costs, including but not limited to reasonable attorney's fees, will be payable by Distributor.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 1, \"text\": \"11. Confidentiality. Any information received by Distributor in performance of this Agreement relating to the business affairs, customers, markets, finances, methods, Product, technology, trade secrets or proprietary rights of WGT will be treated as confidential and proprietary information of WGT. Distributor will not disclose such information, unless the information is in the public domain at the time of disclosure through no fault of Distributor or WGT consents to the disclosure in writing. Distributor will disclose such information only to its 13 employees whose duties justify their need to know such information and who have agreed to copy with Distributor's confidentiality obligations hereunder.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership\", \"level\": 1, \"text\": \"12. Ownership. The Product involves valuable patent, copyright, trade secret, trade name, trademark and other proprietary rights of WGT. No title to or ownership of such proprietary rights is transferred to Distributor under this Agreement or by use of any trademark, copyright or other proprietary right. WGT reserves all of its copyright, trade secret and other proprietary rights in the Product. Distributor will not infringe, violate or contest and will take appropriate steps and precautions for the protection of, such proprietary rights.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Implementation\", \"level\": 1, \"text\": \"13. Implementation. Distributor will take at WGT's expense, all action during or after the Term that is reasonably requested by WGT for the implementation of the ownership provisions of this Agreement or to evidence, perfect or protect WGT's ownership of this Product and the proprietary rights associated with ownership of the Product (including, without limitation, the execution, acknowledgment and delivery of instruments of conveyance, patent, copyright, trademark or other proprietary rights registration applications or other documents.)\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty; Returns\", \"level\": 1, \"text\": \"14. Warranty; Returns. WGT will permit Distributor and end-users purchasing through resellers to return any defective Product in accordance with the limited warranty contained in the applicable end-user license agreement or limited hardware warranty, as applicable, provided that the Distributor and end-user have compiled with the applicable warranty terms and conditions. In order to receive the remedy provided for hereunder, Distributor shall deliver to WGT a sample of the Product which Distributor finds to be defective in workmanship or materials, or damaged in shipment prior to Distributor assuming the risk of loss or damage , along with a written explanation of the alleged defect within thirty (30) days from the later of Distributor's initial receipt of such Product from WGT or from the delivery of such Product to an end-user. In the event WGT verifies a defect reported by Distributor and such defect affects more than one (1) Product, then at WGT's option, Distributor shall either certify destruction of all defective Products or return all Products which it alleges are defective to WGT. Distributor, reseller or the end user will be responsible for transportation charges for such Product units sent to WGT's facilities for service. Provided that WGT is able to verify the presence of the reported defect in such units, transportation charges, via a mode of transportation chosen by WGT, shall be borne by WGT to return the Product units from WGT's location to the Distributor, reseller or the end-user's location. Upon verification of a defect in one or more Products returned in accordance with the foregoing, or upon Distributor's certification that it has destroyed any defective Product in compliance with WGT's instructions, WGT will, at its option, either issue a credit to Distributor in the amount of the purchase price paid or payable for such Product by Distributor or replace the defective Product with an identical (non-defective) Product. Such remedy will be exclusive and in full satisfaction of Distributor's claims hereunder. WGT does not warrant that the Products are free form all bugs, errors, defects, design flaws or omissions. The warranties in this Agreement apply only to the latest version of each Product made available by WGT to Distributor. Such warranties will not apply to any Product which WGT determines has been subject to misuse, neglect, improper installation, repair, alteration or damage by Distributor, reseller or an end-user or any other individual or entity, or modification by any such individual or entity except with the prior express authorization of WGT. WGT's obligations 14 under this paragraph will not apply to the extent arising out of any use or combination of the Product with any other products, goods, services or other items furnished by Distributor or anyone other than WGT, or to any modification or change of the Product not made by WGT. The foregoing warranties and rights may be asserted by Distributor only and not by Distributor's resellers.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Infringement\", \"level\": 1, \"text\": \"15. Infringement. WGT will defend and indemnify Distributor against any judicial proceeding based upon infringement of any U.S. patent or US. copyright by the Product to the extent that such proceeding arises from or in connection with a component of the Product manufactured or developed by WGT and not any third party, provided that Distributor notifies WGT of such proceeding promptly after Distributor receives notice thereof, WGT has control over the defense and settlement of the proceeding, Distributor provides such assistance in the defense and settlement of the proceeding as WGT may reasonably request, and Distributor complies with any settlement or court order made in connection with such proceeding (e.g., as to the future use of any infringing Product). WGT's obligations under this paragraph will not apply to any infringement to the extent arising out of any use or combination of the Product with any other products, goods, services or other items furnished by Distributor or anyone other than WGT or to any modification or change of the Product not made by WGT.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimer and Release\", \"level\": 1, \"text\": \"16. Disclaimer and Release. THE WARRANTIES OF WGT AND THE REMEDIES OF DISTRIBUTOR SET FORTH IN PARGRAPHS 14 AND 15 ARE EXCLUSIVE AND IN SUBSTITUTION FOR, AND DISTRIBUTOR HEREBY WAIVES, RELEASES AND DISCLAIMS. ALL OTHER WARRANTIES, OBLIGATIONS AND LIABILITIES OF WGT AND ALL OTHER RIGHTS, REMEDIES AND CLAIMS OF DISTRIBUTOR, EXPRESS OR IMPLIED, ARISING BY LAW OR OTHERWISE, WITH RESPECT TO ANY DEFECT, DEFICIENCY OR NONCONFORMITY IN ANY PRODUCT OR OTHER ITEM FURNISHED BY OR ON BEHALF OF WGT UNDER THIS AGREEMENT, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE; IMPLIED WARRANTY ARISING FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USEAGE OF TRADE; ANY OBLIGATION, LIABLITY, RIGHT, REMEDY OR CLAIM IN TORT (INCLUDING NEGLIGENCE, WHETHER ACTIVE, PASSIVE OR IMPUTED), PRODUCT LIABLITY, STRICKT LIABILITY OR OTHER THEORY; AND CLAIM OF INFRINGEMENT.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations\", \"level\": 1, \"text\": \"17. Representations. Distributor will be solely responsible for any representations or warranties Distributor may make to any reseller with respect to the Product or any products, goods, services or other items provided by Distributor. Except to the extent inconsistent with paragraph 15, Distributor releases and will defend, indemnify and hold harmless WGT and its officers, directors, employees, agents and representatives from any and all claims, losses, damages, liens, liabilities, costs and expenses (including, but not limited, reasonable attorneys' fees) incurred or asserted by any reseller or otherwise arising out of or in connection with (a) any misrepresentation, negligent or tortious act or omission, or breach of or default under this Agreement by Distributor or by anyone else acting for or on behalf of Distributor in connection with the promotion, distribution or other dealings with respect to the Product; (b) any reseller or end-user's use of the Product or any products or services of 15 Distributor; or (c) any representations and warranties made by Distributor that are inconsistent with or in addition to the warranties made in WGT's end-user license agreement or limited hardware warranty, as applicable, accompanying each copy of the Product.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitations of Liability\", \"level\": 1, \"text\": \"18. Limitations of Liability. EXCEPT AS PROVIDED IN PARAGRAPH 15, WGT'S LIABILITY(WHETHER IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE WHETHER ACTIVE, PASSIVE, IMPUTED), PRODUCT LIABILITY, STRICT LIABILITY OR OTHER THEORY) UNDER THIS AGREEMENT OR WITH REGARD TO ANY PRODUCT OR OTHER ITEMS FURNISHED UNDER THIS AGREEMENT WILL IN NO EVENT EXCEED THE COMPENSATION PAID TO WGT CONCERNING SUCH PRODUCT UNDER THIS AGREEMENT.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Consequential Damages\", \"level\": 1, \"text\": \"19. Consequential Damages. IN NO EVENT WILL WGT BE LIABLE, WHETHER IN CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE (WHETHER ACTIVE, PASSIVE OR IMPUTED), PRODUCT LIABILITY, STRICT LIABILITY OR OTHER THEORY), TO DISTRIBUTOR OR TO ANY RESELLER OF DISTRIBUTOR, END-USER OR OTHER PERSON OR ENTITY FOR COST OF COVER OR FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES (INCLUDING WITHOUT LIMITATION DAMAGES FOR LOSS OF PROFIT, BUSINESS OR DATA) ARISING OUT OF ITS PERFORMANCE OR NONPERFORMANCE OF THIS AGREEMENT OR THE USE OF, INABIILTY TO USE OR RESULTS OF USE OF THE PRODUCT.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Laws\", \"level\": 1, \"text\": \"20. Compliance with Laws. In performing this Agreement, Distributor will comply with all applicable laws, regulations and other requirements, now or hereafter in effect, of government authorities having jurisdiction.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Export\", \"level\": 1, \"text\": \"21. Export. Without limiting anything else herein, Distributor will not export or re-export, directly or indirectly, the WGT Product to any country to which export or re-export of such items is prohibited by the U.S. Export Administration Act, regulations of the U.S. Department of Commerce and other export controls of the U.S., as they may be amended without first obtaining an appropriate written authorization from the U.S. Office of Export Licensing or its successor. At the time of execution of this Agreement, Distributor is prohibited from exporting or re-exporting , directly or indirectly, the WGT Product to the following countries: Cuba, Libya, North Korea, Iran, Iraq, Ruwanda, Sudan, Syria and the Federal Republic of Yugoslavia (Serbia and Montenegro). Notwithstanding the foregoing list, Distributor is not relieved from its obligations to comply with the foregoing export control laws, as such laws may be amended from time to time. Distributor shall also comply with all other foreign or local governmental export and import control laws, regulations and rules.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Government Approvals\", \"level\": 1, \"text\": \"22. Government Approvals. Distributor will obtain at its expense all licenses, permits and other governmental approvals; will provide all notices; and will pay all duties, taxes and other charges required for the license, export, re-export and import of the Product distributed by the Distributor; the license of the Software distributed by Distributor; and the implementation of this Agreement. 16\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonwaiver\", \"level\": 1, \"text\": \"23. Nonwaiver. The failure of either party to insist upon or enforce strict performance of any of the provisions of this Agreement or to exercise any rights or remedies under this Agreement will not be construed as a waiver or relinquishment to any extent of such party's right to assert or rely upon any such provisions, rights or remedies in that or any other instance; rather, the same will be and remain in full force and effect.\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 1, \"text\": \"24. Assignment. Distributor will not assign all or any part of this Agreement or any of its rights under this Agreement without the prior written consent of WGT. Subject to the foregoing, this Agreement will be fully binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns.\"}}, {\"id\": \"25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Survival\", \"level\": 1, \"text\": \"25. Survival. Paragraphs 1, 2, 3, 13 through 23 and all accrued obligations to pay, together with all other provisions of this Agreement which may reasonably be interpreted or construed as surviving the expiration or termination of the Term, will survive the expiration or termination of the Term.\"}}, {\"id\": \"26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 1, \"text\": \"26. Notices. Any notice or other communication under this Agreement given by either party to the other will be in writing and delivered either (a) in person or by first-class, registered or certified mail or a recognized overnight delivery service, return receipt requested, postage prepaid or (b) by facsimile and then acknowledged as received by return facsimile by the intended recipient. Notices will be deemed received only upon actual receipt. Notices will be directed to the intended recipient at the address specified below its signature on the signature page of this Agreement. Either party may change its address by giving the other party notice of such change in accordance with this paragraph.\"}}, {\"id\": \"27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Conflict\", \"level\": 1, \"text\": \"27. No Conflict. Distributor represents and warrants to WGT that Distributor is free to enter into and perform this Agreement without thereby being in breach of or default under the terms of any other contract, commitment or understanding.\"}}, {\"id\": \"28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Interpretation\", \"level\": 1, \"text\": \"28. Interpretation. The English language of this Agreement will govern any interpretation of or dispute regarding the terms of this Agreement. Paragraph captions are for convenience of reference and do not alter or limit the terms of this Agreement. The parties hereto have expressly required that the present Agreement and its Exhibits be drawn up on the English language. / Les parties aux presentes ont expressement exige que la presente conventions et se Annexes solent redigees en la langue anglaise.\"}}, {\"id\": \"29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law; Venue\", \"level\": 1, \"text\": \"29. Governing Law; Venue. This Agreement will be governed by and interpreted in accordance with the local laws of the State of Washington, U.S.A., without regard to its conflicts of law provisions and not including the provisions of the 1980 U.N. Convention in Contracts for the International Sale of Goods. Distributor irrevocably consents, and submits to the jurisdiction of the Federal and State courts of and located in King County, in the State of Washington, U.S.A. Distributor will not commence or prosecute any suit, claim, or proceeding arising under this Agreement other than in the courts identified in the preceding sentence. Any remedy of WGT set forth in this Agreement is in addition to any other remedy afforded to WGT under this Agreement, any other contract, by law or otherwise. 17 SUPPORT SERVICES AND PROCEDURES EXHIBIT C SUPPORT SERVICES: WGT will provide the following training and product support programs to Distributor: A. Training. Promptly after execution of this Agreement, WGT will conduct a one day technical and sales training program for three (3) of Distributor's employees. Such training will be held at Distributor's facilities. Distributor will be responsible for all costs and expenses incurred by Distributor's personnel in attending, receiving or securing training provided by WGT. B. Product Support Services. WGT will provide the following product support services to Distributor for the Term of the Agreement:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Telephone Support\", \"level\": 1, \"text\": \"1. Telephone Support. Reasonable telephone and electronic mail support for the Software will be available in response to a request from Distributor during WGT's normal business hours (6:00 a.m. to 5:00 p.m., Monday through Friday, Pacific Standard Time), excluding holidays that WGT recognizes. Only Distributor's designated, approved personnel will communicate with WGT's customer support specialists.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Submitting a Service Request\", \"level\": 1, \"text\": \"2. Submitting a Service Request. To submit a request for service, Distributor has two service options: (a) over the phone, the Distributor will dial WGT's service number as supplied to Distributor by WGT. When a support specialist answers the phone, Distributor will be prepared to discuss the problem with the support specialist. (b) via electronic mail as supplied to Distributor by WGT, whereby a service request can be submitted to WGT's electronic mail system. In order to submit a service request, either telephonically or electronically, Distributor will employ the following procedures: (a) provide a clear description that fully explains what the problem is, and when the problem occurs; (b) provide a diagnostic trace, sample code or file of the failure symptom that has been recorded on the user's system; and (c) describe the steps taken to resolve the problem. 18\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Priority\", \"level\": 1, \"text\": \"3. Priority. WGT will respond to problems with the Software in accordance with the following priority schedule: Priority One (\\\"P-1\\\") is reserved for critical and severe Software problems which cause the Software to fail or act in a manner which causes the Software to be unusable. Priority Two (\\\"P-2\\\") is reserved for Software problems which cause a major component of the Software to become unusable but the overall Software continues to function. Priority Three (\\\"P-3\\\") is reserved for Software problems which cause minimal disruption to normal operations of the Software and can be avoided with a simple work-around process. Priority Four (\\\"P-4\\\") is reserved for all other problems of lesser severity.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Response Time\", \"level\": 1, \"text\": \"4. Response Time: Upon receipt of a service request, a WGT customer support specialist will contact Distributor's designated, approved personnel within the following response times to discuss the problem: \\\"P-1\\\" - respond within two (2) hours (subject to WGT's normal business hours) of receipt of a P-1 problem and use all commercially reasonable and diligent efforts to create a fix or work-around as soon as practicable considering the nature of the problem. \\\"P-2\\\" - respond within four (4) hours (subject to WGT's normal business hours) of receipt of a P-2 problem and use all commercially reasonable and diligent efforts to create a fix or work-around as soon as practicable considering the nature of the problem. \\\"P-3\\\" - respond within twenty-four (24) hours (subject to WGT's normal business hours) of receipt of a P-3 problem and use all commercially reasonable efforts to create a fix or work-around which may be included in the next Update. \\\"P-4\\\" - respond within five (5) business days (subject to WGT's normal business hours) of receipt of a P-4 problem and target a fix in a future Update. WGT will make any corrections available to Distributor via BBS, FTP site or other reasonable means. 19 DISTRIBUTOR'S FORECAST EXHIBIT D Quarter 1: ____________, 19__ through ____________, 19__ $__________ Quarter 2: ____________, 19__ through ____________, 19__ $__________ Quarter 3: ____________, 19__ through ____________, 19__ $__________ Quarter 4: ____________, 19__ through ____________, 19__ $__________ 20\"}}, {\"id\": \"party:WatchGuard Technologies, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"WatchGuard Technologies, Inc.\", \"role\": \"WGT\", \"address\": \"316 Occidental Avenue South Suite 300 Seattle, Washington 98104\"}}, {\"id\": \"party:European Micro\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"European Micro\", \"role\": \"Distributor\", \"address\": \"20/24 Church Street Altrincham, Cheshire WA14 4DW, ENGLAND\"}}, {\"id\": \"term:Add-On Software Modules\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Add-On Software Modules\", \"text\": \"\\\"Add-On Software Modules\\\" means those computer software programs that (a) provide additional functionality and may be integrated with the existing Hardware and other Software, (b) may be legally exported to the Territory without any export license and (c) WGT elects to include in Exhibit A at a mutually agreed discount percentage.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Distributor Cost\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor Cost\", \"text\": \"\\\"Distributor Cost\\\" means the purchase price payable by Distributor for each Product at the discount from WGT's then current WatchGuard Price List, as such discount is set forth in Exhibit A.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Documentation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Documentation\", \"text\": \"\\\"Documentation\\\" means any and all manuals, user guides, end-user license agreement, limited hardware warranty, on-line help files, on-line menus and other in program printed text regarding the Product prepared by or for WGT in connection with the Product.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Gross Purchases\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Gross Purchases\", \"text\": \"\\\"Gross Purchases\\\" means the gross purchase price Distributor pays WGT for the Product, excluding any taxes or pass through charges and net of any credits or returns.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Guaranteed Minimum Purchases\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Guaranteed Minimum Purchases\", \"text\": \"\\\"Guaranteed Minimum Purchases\\\" means the guaranteed minimum purchase amounts set forth in Exhibit A.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Hardware\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Hardware\", \"text\": \"\\\"Hardware\\\" means the hardware identified on Exhibit A, together with any Updates to such hardware.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"\\\"Product\\\" means the combination of Hardware, Software and Documentation together as part of the same product package (including any Add-On Software Modules and any Updates thereto), in all cases carrying the \\\"WatchGuard\\\" Trademark.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Quarter\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Quarter\", \"text\": \"\\\"Quarter\\\" means any period of three (3) consecutive calendar months that begins on January 1, April 1, July 1 or October 1, during the Term.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"\\\"Software\\\" means the computer programs identified on Exhibit A, in object code only, together with any Updates to such programs.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"\\\"Term\\\" means the period of time determined in accordance with Section 5.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"\\\"Territory\\\" means the geographic area described in Exhibit A.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"\\\"Trademarks\\\" means the trademarks and trade names of WGT identified in Exhibit A.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"term:Update\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Update\", \"text\": \"\\\"Update\\\" means any minor modification, minor upgrade or minor enhancement of the Product (excluding any new version of the Product) that WGT publishes and elects to make available to Distributor via BBS, FTP site or other reasonable means.\", \"definition_clause\": \"Section 1\"}}, {\"id\": \"value:November 5, 1997\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"November 5, 1997\"}}, {\"id\": \"value:three (3) consecutive calendar months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) consecutive calendar months\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:fifty percent (50%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"value:thirty (30) day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) day period\"}}, {\"id\": \"value:fifty (50%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty (50%)\"}}, {\"id\": \"value:twenty (20) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) days\"}}, {\"id\": \"value:November 3, 1997\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"November 3, 1997\"}}, {\"id\": \"value:40%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"40%\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"10%\"}}, {\"id\": \"value:46%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"46%\"}}, {\"id\": \"value:$10\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$10\"}}, {\"id\": \"value:$25,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$25,000\"}}, {\"id\": \"value:September 30, 1997\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"September 30, 1997\"}}, {\"id\": \"value:20%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20%\"}}, {\"id\": \"value:twenty-four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) months\"}}, {\"id\": \"value:one and one-half percent (1.5%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one and one-half percent (1.5%)\"}}, {\"id\": \"value:one day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one day\"}}, {\"id\": \"value:two (2) hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) hours\"}}, {\"id\": \"value:four (4) hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four (4) hours\"}}, {\"id\": \"value:twenty-four (24) hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) hours\"}}, {\"id\": \"value:five (5) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of EhaveInc_20190515_20-F_EX-4.44_11678816_EX-4.44_License Agreement_ Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of EhaveInc_20190515_20-F_EX-4.44_11678816_EX-4.44_License Agreement_ Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"Exhibit 4.44\", \"title\": \"THIS LICENSE AND RESELLER AGREEMENT dated as of the October 30, 2018 is made BETWEEN: EHAVE, INC., a company incorporated under the laws of the Province of Ontario, Canada (\\\"Ehave\\\"); - and - COMPANION HEALTHCARE TECHNOLOGIES CORP, a company incorporated under the laws of the Province of Ontario (\\\"CHT\\\") RECITALS: A. Ehave has developed a software platform that provides an end-to-end patient management solution to healthcare professionals and provides that platform to users as a service. B. CHT has developed a business model to bring a similar service that Ehave provides using the Ehave Platform for the domain of the animal market including companion animals (i.e. pets). C. The Parties desire to enter into this Agreement to enable CHT to pursue its business model whereby CHT will license and provide services in relation to companion and other animals using the Ehave Companion Solution under the terms and conditions contained herein. NOW THEREFORE, in consideration of the premises and the mutual agreements hereinafter set out herein and of other consideration (the receipt and sufficiency of which are acknowledged by each Party), the Parties covenant and agree as follows: 1. INTERPRETATION (a) Definitions In this Agreement and the schedules annexed hereto, the following terms shall have the respective meanings indicated below: \\\"Acceptance Criteria\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Period\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Procedures\\\" has the meaning ascribed to it in Section 3(d). \\\"Agreement\\\" means this license and reseller agreement and all Schedules, Appendixes and Exhibits attached hereto. \\\"Applicable Laws\\\" means any and all (i) laws, statutes, rules, regulations, by laws, codes, treaties, constitutions and ordinances, including Privacy Legislation (\\\"Laws\\\"), (ii) order, directive, judgment, decree, award or writ of any court (including a court of equity), arbitrator or arbitration panel, or any Governmental Authority or other body exercising adjudicative, regulatory, judicial or quasi-judicial powers, including any stock exchange (\\\"Orders\\\"), and (iii) policies, guidelines, standards, requirements, notices and protocols of any Governmental Authority (\\\"Policies\\\"); which are applicable to or govern CHT, Ehave or the transactions contemplated by this Agreement.\", \"level\": 2, \"text\": \"Exhibit 4.44 THIS LICENSE AND RESELLER AGREEMENT dated as of the October 30, 2018 is made BETWEEN: EHAVE, INC., a company incorporated under the laws of the Province of Ontario, Canada (\\\"Ehave\\\"); - and - COMPANION HEALTHCARE TECHNOLOGIES CORP, a company incorporated under the laws of the Province of Ontario (\\\"CHT\\\") RECITALS: A. Ehave has developed a software platform that provides an end-to-end patient management solution to healthcare professionals and provides that platform to users as a service. B. CHT has developed a business model to bring a similar service that Ehave provides using the Ehave Platform for the domain of the animal market including companion animals (i.e. pets). C. The Parties desire to enter into this Agreement to enable CHT to pursue its business model whereby CHT will license and provide services in relation to companion and other animals using the Ehave Companion Solution under the terms and conditions contained herein. NOW THEREFORE, in consideration of the premises and the mutual agreements hereinafter set out herein and of other consideration (the receipt and sufficiency of which are acknowledged by each Party), the Parties covenant and agree as follows: 1. INTERPRETATION (a) Definitions In this Agreement and the schedules annexed hereto, the following terms shall have the respective meanings indicated below: \\\"Acceptance Criteria\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Period\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Procedures\\\" has the meaning ascribed to it in Section 3(d). \\\"Agreement\\\" means this license and reseller agreement and all Schedules, Appendixes and Exhibits attached hereto. \\\"Applicable Laws\\\" means any and all (i) laws, statutes, rules, regulations, by laws, codes, treaties, constitutions and ordinances, including Privacy Legislation (\\\"Laws\\\"), (ii) order, directive, judgment, decree, award or writ of any court (including a court of equity), arbitrator or arbitration panel, or any Governmental Authority or other body exercising adjudicative, regulatory, judicial or quasi-judicial powers, including any stock exchange (\\\"Orders\\\"), and (iii) policies, guidelines, standards, requirements, notices and protocols of any Governmental Authority (\\\"Policies\\\"); which are applicable to or govern CHT, Ehave or the transactions contemplated by this Agreement. Source: EHAVE, INC., 20-F, 5/15/2019 \\\"Authentication ID\\\" means a security mechanism by which an Authorized User identifies herself or himself to the Ehave Companion Solution and gains access thereto, which security mechanism may include user identification, passwords, digital certificates or any other similar process mechanism for authentication and recognition as determined by Ehave from time to time. \\\"Authorized User\\\" means an individual who an End User has authorized to access and use CHT's services, which includes the use of the Ehave Companion Solution. \\\"Business Day\\\" means any calendar day except for Saturday or Sunday or any statutory holiday observed in the Province of Ontario. \\\"CHT Developments\\\" has the meaning ascribed to it in Section 4(a). \\\"CHT Indemnified Parties\\\" has the meaning ascribed to it on Section 16(a). \\\"CHT Marks\\\" means the names, trademarks, trade names, service marks, designs and logos of CHT. \\\"Claim\\\" has the meaning ascribed to it in Section 16(a). \\\"Competitive Transaction\\\" has the meaning ascribed to it in Section 2(d). \\\"Confidential Information\\\" means this Agreement, the Ehave Companion Solution, End User Data and all ideas, designs, business models, databases, drawings, documents, diagrams, formulas, test data, marketing, financial or personnel data, sales information, customer or supplier information, including information provided by such customers or suppliers, or any other information already furnished and to be furnished or made available by one Party to the other, whether in oral, written, graphic or electronic form including any such information exchanged during informational sessions designated as confidential, including, without limitation, information concerning a Party's actual and potential customers and other Intellectual Property Rights of such Party, provided, however, that Confidential Information shall not include any data or information: (i) that, at the time of disclosure, is in or, after disclosure, becomes part of the public domain, through no act or failure on the part of the receiving Party, whether through breach of this Agreement or otherwise; (ii) that, prior to disclosure by the disclosing Party, was already in the possession of the receiving Party, as evidenced by written records kept by the receiving Party in the ordinary course of its business, or as evidenced by proof of actual prior use by the receiving Party; (iii) independently developed by the receiving Party, by Persons having no direct or indirect access to the disclosing Party's Confidential Information provided that the receiving Party provides clear and convincing evidence of such independent development; (iv) which, subsequent to disclosure, is obtained from a third Person: (A) who is lawfully in possession of such information; (B) who is not in violation of any contractual, legal, or fiduciary obligation to either Party, as applicable, with respect to such information; and (C) who does not prohibit either Party from disclosing such information to others; or (v) is further disclosed with the prior written consent of the disclosing Party, but only to the extent of such consent. \\\"Effective Date\\\" means the date first written above. \\\"Ehave Companion Solution\\\" means the Ehave Platform, as modified, adapted and customized, as provided herein, the specifications of which are set out in Schedule \\\"1\\\". 2. Source: EHAVE, INC., 20-F, 5/15/2019 \\\"Ehave Platform\\\" means the Software, Ehave Server and such devices and peripherals physically located with the Ehave Server, including all computer hardware, software, network elements, and electrical and telecommunications infrastructure located behind the Point of Access. \\\"Ehave Server\\\" means that computer server located at Ehave's premises, or a third party provider of hosting and/or network services, that houses the Software. \\\"End User\\\" means CHT's customers who have entered into a subscription agreement with CHT for CHT services, which services include the use of the Ehave Companion Solution. \\\"End User Data\\\" means collectively any data, files, documentation or other information (including personal information) that an End User or any of its Authorized Users may: (i) upload to the Ehave Companion Solution; and/or (ii) have processed through the use of the Ehave Companion Solution, and includes any data or output resulting from or derived from such use. \\\"Escrow Agent\\\" has the meaning ascribed thereto in Section 12(a). \\\"Escrow Agreement\\\" has the meaning ascribed thereto in Section 12(a). \\\"Field of Use\\\" means indications and outcomes related to any companion and other animals. \\\"Governmental Authority\\\" means any domestic, foreign or supranational government, whether federal, provincial, state, territorial or municipal; and any governmental agency, ministry, department, tribunal, commission, bureau, board or other instrumentality, including international institutions, exercising or purporting to exercise legislative, judicial, regulatory or administrative functions of, or pertaining to, government. \\\"Implementation Plan\\\" has the meaning ascribed to it in Section 3(a). \\\"Intellectual Property\\\" means any property, tangible or intangible, that may be subject to Intellectual Property Rights, including without limitation, ideas, formulae, algorithms, concepts, techniques, processes, procedures, approaches, methodologies, plans, systems, research, information, documentation, data, data compilations, specifications, requirements, designs, diagrams, programs, inventions, technologies, software (including its source code), tools, products knowledge, know-how, including without limitation, trade secrets, and other materials or things. \\\"Intellectual Property Rights\\\" means (a) any and all proprietary rights anywhere in the world provided under (i) patent law; (ii) copyright law, including moral rights; (iii) trademark law; (iv) design patent or industrial design law; (v) semiconductor chip or mask work law; (vi) trade secret law; (vii) privacy law; or (viii) any other statutory provision or common law principle applicable to this Agreement which may provide a right in either (A) Intellectual Property; or (B) the expression or use of Intellectual Property; and (b) any and all applications, registrations, licenses, sub-licenses, franchises, agreements or any other evidence of a right in any of the foregoing. \\\"Objectionable Content\\\" means content that infringes any Applicable Laws or third party rights, and content which is obscene, indecent, pornographic, seditious, defamatory, threatening, liable to incite racial hatred, menacing, blasphemous, misleading, deceptive or in breach of any person's Intellectual Property Rights. \\\"Party\\\" means either Ehave or CHT; and \\\"Parties\\\" means both of them. \\\"Person\\\" means any individual, estate, sole proprietorship, firm, partnership, unincorporated association, unincorporated syndicate, unincorporated organization, limited liability company, corporation, body corporate, trustee, trust, Governmental Authority or other entity or organization and includes any successor to any of the foregoing. 3. Source: EHAVE, INC., 20-F, 5/15/2019 \\\"Point of Access\\\" means Ehave's, or its subcontractor's, border router, which is used to establish connectivity from the Ehave Platform to Ehave's, or its subcontractor's, Internet provider, or the public Internet. \\\"Royalties\\\" means the fees, charges and other amounts to be paid by CHT to Ehave for the rights granted hereunder and which amounts are set out in Schedule \\\"6\\\". \\\"Security Requirements\\\" means those safeguards and controls set out in Schedule \\\"5\\\". \\\"Software\\\" means Ehave's proprietary patient and data management software and any related documentation, as modified for use in the animal (including companion animal) and veterinary industry. \\\"Source Code\\\" means the human-readable form of a computer instruction, including, but not limited to, related system documentation, flow charts, all comments and any procedural code and a description of the procedure for generating object code, all of a level sufficient to enable a programmer reasonably fluent in the programming language in which the Software was written to understand, build, operate, support, maintain and develop modifications, upgrades, updates, adaptations, enhancements, new versions, and other derivative works and improvements of, and to develop computer programs compatible with, the Software. \\\"Specifications\\\" has the meaning ascribed to it in Section 3(a).\\\"Subscription Agreement\\\" has the meaning ascribed to it in Section 5(b). \\\"Term\\\" has the meaning ascribed to it in Section 9. \\\"Territory\\\" means any jurisdiction in the World where the use of the Ehave Companion Solution for the intended purpose herein is permitted under Applicable Law. \\\"Transition out Period\\\" has the meaning ascribed to it in Section 10(f). \\\"Transition-out Services\\\" has the meaning ascribed to it in Section 10(f). \\\"Virus\\\" means a piece of code usually (but not necessarily) disguised as something else that causes some unexpected and, for the victim, usually undesirable, event and which is designed so that it may automatically spread to other computer users; the term 'Virus' will also be deemed to include worms, cancelbots, trojan horses, harmful contaminants (whether self-replicating or not) and nuisance causing or otherwise harmful applets. (b) Headings; Extended Meanings The division of this Agreement into articles, sections, schedules and other subdivisions, and the inclusion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement. The headings in the Agreement are not intended to be full or precise descriptions of the text to which they refer. Unless something in the subject matter or context is inconsistent therewith, references herein to Articles and Sections are to Articles and Sections of this Agreement. The word \\\"including\\\" or \\\"include(s)\\\" means \\\"including without limitation\\\" or \\\"include(s) without limitation\\\". (c) Currency Unless otherwise specified, all references to monetary amounts, including the symbol \\\"$\\\", are in respect of Canadian currency. 4. Source: EHAVE, INC., 20-F, 5/15/2019 (d) Exhibits and Schedules The following Schedules are a part of and are integral to this Agreement: Schedule \\\"1\\\" - Ehave Companion Solution Specifications Schedule \\\"2\\\" - Development and Implementation Plan Schedule \\\"3\\\" - Support Procedures Schedule \\\"4\\\" - Service Level Commitments Schedule \\\"5\\\" - Security Requirements Schedule \\\"6\\\" - Royalties and Early Termination Fee Schedule \\\"7\\\" - Source Code Escrow (e) Entire Agreement This Agreement, together with any other documents to be delivered pursuant hereto, constitutes the entire agreement between the Parties pertaining to the subject matter hereof and supersedes all prior agreements, negotiations, discussions and understandings, written or oral, between the Parties. Except as expressly provided in this Agreement, there are no representations, warranties, conditions other agreements or acknowledgements, whether direct or collateral, express or implied, that form part of or affect this Agreement. The execution of this Agreement has not been induced by, nor do either of the Parties rely upon or regard as material, any representations, warranties, conditions, other agreements or acknowledgements not expressly made in this Agreement or in the other documents to be delivered pursuant hereto. (f) Governing Law: This Agreement shall be governed by, and construed and enforced in accordance with, the laws in force in the Province of Ontario (excluding any conflict of laws rule or principle which might refer such construction to the laws of another jurisdiction). The Parties hereto agree to submit to the exclusive jurisdiction of the courts of the Province of Ontario and waive any objection relating to improper venue or forum non conveniens to the conduct of any proceeding in any such court. (g) Severability: In the event that any provision (or any portion of a provision) of this Agreement shall for any reason be held by a court of competent jurisdiction to be invalid, illegal, or unenforceable for any reason, such invalidity, illegality or unenforceability shall not affect any other provision hereof and this Agreement shall be construed as if such invalid, illegal or unenforceable provision (or portion of a provision) had never been contained herein in regards to that particular jurisdiction. 2. APPOINTMENT AND LICENSE GRANT (a) Exclusive Appointment Ehave hereby appoints CHT, and CHT hereby accepts the appointment, to act as Ehave's reseller of the use of the Ehave Companion Solution within the Field of Use in the Territory for the duration of the Term solely in accordance with the terms and conditions of this Agreement. Subject to Section 2(e), the foregoing appointment is exclusive such that Ehave shall not appoint any other Person to, nor may Ehave itself, sell or resell the use of the Ehave Companion Solution within the Field of Use anywhere in the Territory. 5. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Grant by Ehave Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period, Ehave hereby grants to CHT a non-transferable (except as permitted under Section 20(f)), right to: (i) sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks and services, in accordance with and subject to the provisions of CHT's Subscription Agreement; and (ii) use the Ehave Companion Solution to support its licensed End Users. Subject to Section 2(e), the grant set out in Clause 2(b)(i) is exclusive such that Ehave shall not license any other Person to, nor may Ehave itself, license, sub-license the use of, or provide services similar to, the Ehave Companion Solution within the Field of Use anywhere in the Territory. (c) Restrictions on Use Any rights not granted herein are strictly reserved by Ehave. CHT shall not, and shall not permit others to, reverse engineer, decompile, disassemble or translate any software used by Ehave to provide the Ehave Companion Solution, or otherwise attempt to view, display or print such software, including its Source Code, except as permitted herein. (d) Prohibition on Competitive Solutions For so long as the appointment set out in Section 2(a) is exclusive, CHT shall not enter into an agreement (a \\\"Competitive Transaction\\\") with any other Person related to the license, sub-license, sale, resale or provide service, solutions, goods or products, that are substantially similar to or competitive with the Ehave Companion Solution. For clarity, a Competitive Transaction shall not include an agreement for use, integration or interfacing, or co-marketing, of the Ehave Companion Solution with other services, solutions, devices, goods or products, where such other services, solutions, devices, goods or products do not contain the same or similar functionality of the Ehave Companion Solution, but provides for a complementary solution. (e) Conversion to Non-Exclusive Notwithstanding anything to the contrary contained herein, the exclusive appointment and license set out in Sections 2(a) and 2(b) shall become non-exclusive if: (i) at any time during the Term hereof, CHT breaches Section 2(d) as determined by arbitration in accordance with Section 19(c) or by a final non-appealable judgment of a court of competent jurisdiction; or (ii) at any time after November 1, 2010 CHT fails to achieve annual revenues of $500,000. (f) No Franchise Agreement The Parties to this Agreement are independent contractors and nothing in this Agreement shall be deemed or constructed as creating a joint venture, partnership, agency relationship, or franchise between Ehave and CHT. Neither Party, by virtue of this Agreement, will have any right, power or authority to act or create an obligation, express or implied, on behalf of the other Party. Each Party assumes responsibility for the actions of their personnel under this Agreement and will be solely responsible for their supervision, daily direction and control, wage rates, withholding income taxes, Canada Pension Plan contributions, employment insurance premiums, disability benefits, or the manner and means through which the work under this Agreement will be accomplished. Except as provided otherwise in this Agreement, CHT has the sole discretion to determine CHT's methods of operation, CHT's accounting practices, the types and amounts of insurance CHT carries, CHT's personnel practices, CHT's advertising and promotion, CHT's customers and CHT's service areas and methods. The relationship created hereby between the parties is solely that of supplier and reseller, and licensor and licensee. 6. Source: EHAVE, INC., 20-F, 5/15/2019\"}, {\"id\": \"3\", \"title\": \"DEVELOPMENT AND IMPLEMENTATION OF THE COMPANION SOLUTION (a) Specifications and Implementation Attached hereto as Sched\", \"level\": 1, \"text\": \"3. DEVELOPMENT AND IMPLEMENTATION OF THE COMPANION SOLUTION (a) Specifications and Implementation Attached hereto as Schedule \\\"1\\\" are the business requirements and technical specifications of the Ehave Companion Solution (the \\\"Specifications\\\"). Attached hereto as Schedule \\\"2\\\" is the development and implementation plan (the \\\"Implementation Plan\\\"), which sets out the procedures and obligations of each of the Parties and the key milestones and timelines in relation to the development and implementation of the Ehave Companion Solution. The Parties acknowledge that at the time of execution of this Agreement that the Specifications and Implementation Plan may not have been fully developed, but that the creation of the Specifications and development of the detailed Implementation Plan will be the first step in respect of the development and implementation of the Ehave Companion Solution, in which case, once approved by the Parties in writing, the Specifications and Implementation Plan so developed will be attached hereto and shall replace Schedules \\\"1\\\" and \\\"2\\\" respectively. Once finalized the Specifications and Implementation Plan may not be changed or modified by either Party, except in accordance with the procedures set out in Section 3(c). (b) Obligations Each of Ehave and CHT shall perform, at their own expense (or as otherwise set out in Schedule \\\"6\\\"), their respective obligations and responsibilities set out in the Implementation Plan as necessary to accomplish the development and implementation of the Ehave Companion Solution in accordance with the milestones and timelines set out therein. CHT acknowledges that the development and implementation of the Ehave Companion Solution requires decisions and input from CHT and for CHT to perform its obligations thereunder in a timely manner. In the event that CHT delays in providing such decisions, input or performance of its obligations, the development and implementation of the Ehave Companion Solution shall be correspondingly delayed. Subject to the foregoing, Ehave acknowledges that time is of the essence with respect to its obligations hereunder and that prompt and timely performance of all such obligations, including all development and implementation dates, timetables, project milestones and other requirements in this Agreement is strictly required. Once the implementation of the Ehave Companion Solution is completed, Ehave shall notify CHT of such completion and that the Ehave Companion Solution is ready for testing in accordance with Section 3(d). 7. Source: EHAVE, INC., 20-F, 5/15/2019 (c) Change Control Process Either Party may request additions, deletions or amendments in respect of the development and implementation of the Ehave Companion Solution (\\\"Change\\\"). Changes shall be requested in writing signed by an authorized representative of the Party requesting the Change (\\\"Change Request\\\"). Ehave shall have no obligation to perform, and CHT shall have no obligation to pay for, services related to any proposed modification or change unless both Parties have agreed to the modifications or changes in writing in accordance with the procedures set forth herein. The Change Request shall include a reasonably detailed description of the scope and nature of the requested Change. If CHT desires a Change, Ehave shall evaluate the feasibility of such change as it relates to the proposed Field of Use. As soon as reasonably possible after receipt of CHT's request, Ehave agrees to provide CHT with a written estimate of the cost, if any, of and the timing to implement the requested Changes as well as any additional terms and conditions related to such Changes. The costs, if any, associated with the development of such estimate shall be borne by CHT. Upon CHT's approval in writing of the cost estimate and any additional terms and conditions related to such Changes, including delivery dates and payment terms provided by Ehave, the Parties shall revise the Specifications and Implementation Plan and shall replace the Specifications and Implementation Plan attached hereto as Schedules \\\"1\\\" and \\\"2\\\", and Ehave shall develop and implement the Change as so agreed. Changes shall be subject to acceptance testing by CHT prior to being deployed into production in accordance with procedures described in Section 3(d) or as otherwise agreed by the parties in writing. Ehave shall not refuse to accept a CHT Change request unless it is unable to make the Change requested using commercially reasonable efforts, in which event Ehave will provide an explanation to CHT; or Ehave and CHT fail to agree on the terms and conditions related to the performance of such Change, including the costs, if any. If a mutually acceptable resolution is not reached in respect of a CHT Change request, the Parties may submit the issue to mediation pursuant to Section 19(b). (d) Acceptance The criteria (\\\"Acceptance Criteria\\\") which the Ehave Companion Solution is to meet and the procedures by which such criteria are to be tested (\\\"Acceptance Procedures\\\") shall be set out in the Implementation Plan and shall follow the requirements set out in this Section 3(d). Once notified by Ehave that the Ehave Companion Solution is ready for acceptance testing, CHT shall perform the tests as set out in the Acceptance Procedures. Unless otherwise set out in the Acceptance Procedures, CHT shall have ten (10) Business Days to perform the acceptance tests as set out in the Acceptance Procedures and to provide Ehave written notice of acceptance or non-acceptance of the Ehave Companion Solution (the \\\"Acceptance Period\\\"). CHT shall not refuse to accept the Ehave Companion Solution unless all or one or more portions of the Solution fail to perform, in any material respect, in accordance with the Acceptance Criteria. Any notice of non- acceptance shall describe the material failure of the Ehave Companion Solution in reasonable detail and CHT shall provide Ehave with reasonably detailed documentation and explanations, together with underlying data, to substantiate the failure and to reasonably assist Ehave in its efforts to diagnose and correct the failure. If CHT gives notice to Ehave of non-acceptance of the Ehave Companion Solution then Ehave shall investigate the reported failure in good faith and correct same, and if the engagement is on a fixed fee basis at no additional cost to CHT, within fifteen (15) Business Days unless an extension is granted by CHT. If, within such fifteen (15) Business day period (or extended period, as applicable), Ehave corrects the failure, then Ehave shall give written notice to CHT certifying that the failure has been corrected, and another Acceptance Period of the same duration as the initial Acceptance Period shall begin and shall be governed by the provisions of this Section 3(d) upon delivery of the corrected Ehave Companion Solution to CHT. If the Acceptance Procedures were conducted three (3) times in respect of the initial implementation of the Ehave Companion Solution, and the eHAve Companion Solution failed to pass the Acceptance Criteria on the third (3rd) try, then, at the discretion of either Party, Ehave may continue to fix the problem, or terminate this Agreement in which case, CHT shall promptly return to Ehave all copies of the Ehave Companion Solution, including the Specifications and any other items delivered to CHT by Ehave thereunder and Ehave shall promptly refund to CHT any monies paid by CHT in respect of the initial development and implementation of the Ehave Companion Solution. If the Acceptance Procedures were conducted three (3) times in respect of a Change, and the Change failed to pass the Acceptance Criteria on the third (3rd) try, then, at the discretion of CHT, Ehave may continue to fix the problem, or terminate the performance of the development of the Change, in which case CHT shall promptly return to Ehave all copies of the Change, including the Specifications thereto and Ehave shall promptly refund to CHT any monies paid by CHT in respect of the development and implementation of the Change. 8. Source: EHAVE, INC., 20-F, 5/15/2019 (e) Deployment Once CHT provides Ehave written notice of acceptance, Ehave will deploy the Ehave Companion Solution or Change, as applicable, by putting the Ehave Companion Solution or Change into production in accordance with, and within the timelines set out, in the Implementation Plan or Change Request, as the case may be. (f) Branding The Ehave Companion Solution may, in the sole discretion of CHT, be branded, marketed, advertised, promoted and sublicensed under CHT Marks. For such purpose, CHT hereby grants to Ehave a non-exclusive, royalty-free, revocable, limited license during the Term and Transition-out Period and within the Territory to use, reproduce, publish and display the CHT Marks solely in connection with the operation of the Ehave Companion Solution for and on behalf of CHT and End Users. Ehave agrees that its use of any CHT Marks will comply with CHT's branding guidelines to the extent made available by CHT to Ehave from time to time and will enure to the benefit of CHT. The CHT Marks are proprietary to CHT and nothing in this Agreement constitutes the grant of a general license for their use. Other than as expressly set forth herein, Ehave does not acquire any right, title or interest in or to any CHT Marks or the goodwill associated therewith. CHT reserves any and all rights in and to the CHT Marks not expressly granted herein. 4. CHT DEVELOPMENTS (a) Development From time to time, CHT may request Ehave to develop functionality that is separate from, but interfaces with the Ehave Companion Solution (the \\\"CHT Developments\\\"). Any such development effort shall be subject to a separate services agreement between the Parties which will set out the respective obligations of the Parties regarding the development and deployment of any CHT Developments, including without limitation assignment or transfer of any rights that Ehave may have in such CHT Developments. (b) APIs If CHT desires a third party to develop any CHT Developments, Ehave shall provide to CHT the specifications of the application program interfaces to permit CHT or such other third party to develop the CHT Developments so that it may inter-operate with the Ehave Companion Solution. (c) License If CHT requires Ehave to host the CHT Developments, then CHT hereby grants to Ehave a royalty-free, non-exclusive, non-transferable, limited right and licence during the Term hereof to use the CHT Developments solely for the purpose of enabling its operation for CHT and its End Users' purposes. 5. GENERAL PERFORMANCE OBLIGATIONS (a) Marketing CHT shall, in good faith and at its own expense: (i) market, advertise, promote and re-license the use of the Ehave Companion Solution to End Users located in the Territory consistent with good business practice, provided that CHT shall have full discretion as to where in the Territory it chooses to do so at any time and from time to time; 9. Source: EHAVE, INC., 20-F, 5/15/2019 (ii) develop and execute a marketing plan sufficient to fulfil its obligations under this Agreement; (iii) have sufficient knowledge of the industry and solutions competitive with the Ehave Companion Solution (including specifications, features and benefits) so as to be able to explain in detail to the End Users: A. the material differences between the Ehave Companion Solution and competing solutions; and B. information on standard protocols and features of the Ehave Companion Solution; (iv) market, advertise, promote and provide the Ehave Companion Solution and conduct business in a manner that at all times reflects favourably on the Ehave Companion Solution and, subject to Section 3(f), the good name, goodwill and reputation of Ehave; and (v) maintain books, records and accounts of all transactions and activities covered by this Agreement and permit reasonable examination thereof by Ehave and its representatives in accordance with this Agreement. (b) Provision to End Users CHT shall require each End User to enter into and execute a subscription agreement in a form and substance satisfactory to Ehave and CHT, acting reasonably, and which contains provisions similar to Ehave's collaboration agreement for the use of the Ehave solution (the \\\"Subscription Agreement\\\"). Ehave shall be a third party beneficiary hereunder, but shall not have any obligations to the End User thereunder. (c) End User Data Pursuant to the Subscription Agreement, CHT shall obtain from each End User the right to and hereby grants, effective upon the execution and delivery of such End User's Subscription Agreement, to Ehave: (i) a royalty-free, non-exclusive, non-transferable, limited right and licence during the term of such Subscription Agreement to use, copy, store and display the End User Data solely for the purpose of enabling Ehave to operate the Ehave Companion Solution for such End User and as may be necessary for the purpose of enabling Ehave to provide support services in accordance with this Agreement; and (ii) a royalty-free, non-exclusive, limited, perpetual right and license to use, copy, store and display End User Data on an aggregated and anonymous basis and so as not to permit the identification of any End User or individual for the sole purpose of improving or developing enhancements to the Ehave Companion Solution , provided that Ehave shall not have any right to use, commercialize or exploit such End User Data in any other manner or for any other purpose. Except for the limited license expressly provided in Section 5(c), nothing contained in this Agreement shall be construed as granting to Ehave or any third party any right, title, or interest in or to any End User Data. Without limiting the foregoing, Ehave agrees that it shall not (i) modify, alter or commercially exploit any End User Data; or (ii) distribute or sell, rent, lease, license or otherwise make any End User Data available to any third party (other than the particular End User to whom the End User Data pertains and its Authorized Users). 10. Source: EHAVE, INC., 20-F, 5/15/2019 (d) Authority to Perform Under this Agreement Each Party shall, at its own expense, obtain and maintain required certifications, credentials, licences and permits necessary to conduct business in accordance with this Agreement. CHT shall obtain all necessary licenses, permits, certifications and credentials to conduct its business. (e) End User Support On and after the launch of the Ehave Companion Solution, CHT shall, at its own expense, ensure that an adequate number of trained, capable and qualified technical personnel with sufficient knowledge of the Ehave Companion Solution are available to provide first line support to assist End Users. If CHT's support personnel are unable to resolve any trouble tickets from an End User, CHT may escalate the trouble ticket to Ehave in accordance with the support procedures set out in Schedule \\\"3\\\". On and after the launch of the Ehave Companion Solution, Ehave shall ensure that an adequate number of trained, capable and qualified technical personnel with sufficient knowledge of the Ehave Companion Solution are available to provide support in accordance with the support procedures set out in Schedule \\\"3\\\". (f) Government Approval If, at any time during the Term, any notification, registration or approval is required to give legal effect in any applicable jurisdiction to this Agreement or the transactions contemplated under this Agreement, CHT shall: (i) immediately take whatever steps may be necessary to properly notify, register or obtain approval; (ii) be responsible for any charges incurred in connection with notifying, registering or obtaining this approval; and (iii) keep Ehave currently informed of its efforts regarding this Section 5(f). Ehave is not obligated to provide access to the Ehave Companion Solution in a particular jurisdiction under this Agreement until CHT has provided Ehave with satisfactory evidence that: (i) this approval, notification or registration is not required or that (ii) it has been obtained. At CHT's cost and expense, Ehave shall provide reasonable assistance and cooperation to CHT as CHT may reasonably request in its efforts to obtain or provide any such approval, notification or registration, provided that, CHT shall at all times retain full discretion as to where in the Territory it chooses to market, promote, advertise and/or sublicense the Ehave Companion Solution. (g) Prohibited Acts Notwithstanding anything to the contrary in this Agreement, neither CHT nor CHT personnel shall: (i) make any representations, conditions, warranties, guarantees, indemnities, similar claims or other commitments: A. actually, apparently or ostensibly on behalf of Ehave, or B. to any End User regarding the Ehave Companion Solution, which representations, conditions, warranties, guarantees, indemnities, similar claims or other commitments are additional to or inconsistent with any then-existing representations, conditions, warranties, guarantees, indemnities, similar claims or other commitments in this Agreement or any written or electronic documentation provided by Ehave to CHT; or 11. Source: EHAVE, INC., 20-F, 5/15/2019 (ii) engage in any unfair, competitive, misleading or deceptive practices respecting Ehave, Ehave's Trade-marks or the Ehave Companion Solution, including any product disparagement or \\\"bait-and-switch\\\" practices. 6. EHAVE COMPANION SOLUTION (a) Provision and Access to Ehave Companion Solution Once deployed, Ehave shall operate, support and maintain the Ehave Companion Solution in accordance with the terms of this Agreement, including the Support Procedures set out in Schedule \\\"3\\\", the Service Level Commitments set out in Schedule \\\"4\\\" and the Security Requirements set out in Schedule \\\"5\\\". Access to the Ehave Companion Solution may be through a secure connection with the public Internet. CHT acknowledges and agrees that Ehave is not responsible or liable for any communication over the public Internet. (b) Security Requirements Ehave shall implement and maintain those safeguards and controls set out in Schedule \\\"5\\\" to deter and for the detection, prevention and correction of any unauthorized intrusion, access or use of the Ehave Companion Solution, as well as to protect against any loss, theft or unauthorized access, use, disclosure, copying, or modification of End User Data. CHT acknowledges and agrees, and shall obtain such acknowledgement and agreement from its End Users, that notwithstanding the Security Requirements, such methods and procedures may not prevent unauthorized electronic intruders to access the Ehave Companion Solution through the Internet or through other form of electronic communication. If such unauthorized electronic intruders are able to bypass Ehave's security protocols, firewall and safeguards, such unauthorized electronic intruder may change, delete or otherwise corrupt the contents and data contained in the Ehave Server, including any End User Data. Except for the maintenance of appropriate firewall and safeguards in compliance with the Security Requirements, which are designed to frustrate access from unauthorized electronic intruders, Ehave shall not be liable to CHT or to any of its End users, and hereby disclaims responsibility, with respect to any action, destructive or otherwise, by any unauthorized electronic intruder. (c) Maintenance From time to time, it will be necessary for Ehave to perform maintenance on the Ehave Companion Solution. Such maintenance includes routine maintenance to ensure the continued provision of the Ehave Companion Solution or upgrading, updating or enhancing the Ehave Companion Solution. Ehave shall use its commercially reasonable efforts to perform such maintenance at such times within the designated maintenance windows set forth in Schedule \\\"3\\\" to minimize the impact of any downtime of the Ehave Platform to CHT and its End Users. To the extent Ehave is able, Ehave shall notify CHT at least 48 hours in advance of any scheduled maintenance by sending an email to the designated CHT Service Manager of the scheduled maintenance time and the anticipated duration of such maintenance. (d) Changes to Service Ehave may, at any time, with or without written notice (except in cases where such change may affect the manner in which the Services are delivered, in which case, Ehave shall use reasonable efforts to provide advance written notice, but in any event as soon as reasonably possible thereafter) to CHT (i) make changes to the Ehave Companion Solution that are necessary to comply with applicable safety, security or other statutory requirements or orders from applicable Governmental Authorities; (ii) supplement or make changes to its user documentation and to its rules of operations, access procedures, security and privacy procedures and policies, provided such changes do not materially adversely affect CHT or its End Users; and (iii) change the components, type and location of the Ehave Platform, provided that such changes do not adversely affect the performance, features, functionality or security of the Ehave Companion Solution. 12. Source: EHAVE, INC., 20-F, 5/15/2019 (e) Authentication IDs CHT shall, and shall require its End Users to, control and maintain the security of all Authentication IDs. As between CHT and Ehave, CHT shall be solely responsible for all instructions, commitments and other actions or communications taken under any of CHT's Authentication IDs. CHT shall promptly report to Ehave any errors or irregularities in the Ehave Companion Solution or the Ehave Platform or any unauthorized use of any part thereof that come to CHT's attention and inform Ehave immediately if CHT becomes aware that any Authentication ID becomes known to any third person who is not authorized to possess such password. (f) End User Data CHT acknowledges and agrees that Ehave: (i) will not be responsible for the accuracy, completeness or adequacy of any End User Data or the results generated from any End User Data uploaded to and processed by the Ehave Companion Solution in accordance with the Specifications; (ii) has no control over any End User Data or the results therefrom; (iii) does not purport to monitor End User Data; and (iv) shall not be responsible to back up or maintain any back up of the End User Data or portion thereof. (g) Viruses If Ehave, in its absolute discretion, forms the view that any End User Data or any other information or files uploaded by CHT or any of its End User and their Authorized Users contains or includes a Virus or is reasonably considered Objectionable Content, Ehave may remove such End User Data, information or file from the Ehave Companion Solution and take such other action as Ehave deems necessary to protect the integrity and operation of the Ehave Companion Solution. Any reasonable costs associated with such removal may be charged by Ehave to CHT. Ehave shall notify CHT of its actions under this Section 6(g) as soon as reasonably possible. 7. ROYALTIES AND PAYMENT (a) Royalties The Royalties and payment terms are as set out in Schedule \\\"6\\\". The Royalties do not include applicable taxes. CHT agrees to pay the Royalties and applicable taxes in accordance with the payment terms as set out in Schedule \\\"6\\\". (b) Taxes: CHT shall pay any and all applicable taxes, however designated or incurred, which are payable by it pursuant to Applicable Law as a result of or otherwise in connection with the transactions contemplated in this Agreement including, without limitation, federal, provincial and local, excise, sales, use, goods and services, harmonized, value added and any similar taxes, except for any taxes based on Ehave's net income. (c) Interest on Late Payments: Where CHT fails to pay any amount in accordance with the payment terms set out in Schedule \\\"6\\\", Ehave shall have the right, in addition to any other rights or remedies available to it, to charge, and CHT shall pay, interest on such overdue amounts at the rate of 1% per month calculated daily, compounded monthly (12.68% per annum) both before and after any court judgement in respect of the same from the date such payment was due. 13. Source: EHAVE, INC., 20-F, 5/15/2019\"}, {\"id\": \"8\", \"title\": \"AUDIT RIGHTS (a) Ehave Right to Audit CHT will provide Ehave and its representatives, auditors and inspectors (\\\"Auditor\", \"level\": 1, \"text\": \"8. AUDIT RIGHTS (a) Ehave Right to Audit CHT will provide Ehave and its representatives, auditors and inspectors (\\\"Auditors\\\") upon ten (10) Business Days prior written notice with reasonable access, during business hours, to all facilities, systems and assets used by CHT, to CHT personnel and subcontractors and to all relevant CHT books and records, in each case, to the extent relevant to this Agreement, in order to conduct appropriate audits, examinations and inspections (\\\"Audits\\\") to: (i) verify compliance with the requirements set out in this Agreement; and (ii) verify the Royalty calculations. (b) Principles Regarding Audits CHT shall provide to Ehave and its Auditors any assistance they may reasonably require to conduct such Audits. Audits may be conducted once a calendar year, provided that the foregoing limit shall not apply where an audit discovered an overcharge of 5% or more, in which case, Ehave may conduct another audit sooner. No period shall be audited more than once. Costs incurred by Ehave in connection with any audit or inspection conducted shall be borne by Ehave. Notwithstanding the foregoing, if an Audit reveals that CHT underpaid Ehave for any Royalties hereunder, by more than five percent (5%) of the total Royalties paid during the period being audited, CHT shall promptly reimburse Ehave for all reasonable third party expenses incurred by Ehave in connection with such Audit. In all cases CHT shall promptly pay Ehave in full for any underpayments revealed by an Audit. All information obtained by Ehave and its Auditors during any such Audit shall be kept confidential and shall be considered CHT's Confidential Information. Ehave shall impose confidentiality obligations on its Auditors that are substantially similar to those under Section 13 and shall be responsible for any breach of confidentiality by its Auditors. (c) Records CHT shall keep detailed records and books of account with supporting vouchers, invoices and other documentation showing all expenditures, charges and related calculations of whatsoever nature made by it in the performance of its obligations under this Agreement. CHT shall retain such records for the greater of: (i) three (3) years; or (ii) the period required by Applicable Laws. (d) Security Audit On an annual basis, Ehave shall conduct and provide CHT the results of an audit conducted in accordance with the Statement on Standards for Attestation Engagements (SSAE) No. 18, Service Organization Control (SOC) 2 Report type audit or similar audits in respect of its operations. Ehave shall also provide CHT written notice and detail of any deficiencies that Ehave's auditors (whether internal or external) found through the conduct of such audits and the remediation efforts that Ehave shall undergo to rectify such deficiencies. Ehave shall promptly rectify any deficiencies identified that may materially and adversely impact the Ehave Companion Solution or End User Data, and shall provide CHT with such information as CHT may reasonably request from time to time with respect to its security controls including any remediation efforts undertaken to rectify any deficiencies. 9. TERM This term of this Agreement and the rights and obligations of the Parties hereto shall commence as of the Effective Date and shall continue in perpetuity (the \\\"Term\\\"), unless terminated earlier in accordance with the provisions contained herein. 14. Source: EHAVE, INC., 20-F, 5/15/2019\"}, {\"id\": \"10\", \"title\": \"SUSPENSION AND TERMINATION (a) Suspension of Services\", \"level\": 1, \"text\": \"10. SUSPENSION AND TERMINATION (a) Suspension of Services: Subject to the provisions of this Section, in the event that CHT does not pay the Royalties or any portion thereof, when due, Ehave may immediately suspend CHT's and each of its End Users' right to access and use the Ehave Companion Solution. However, Ehave shall not suspend CHT's or its End Users' right to access and use the Ehave Companion Solution or any End User Data by reason of CHT's good faith withholding of any payment or amount, or in the event of any payment dispute between the parties arising under or concerning this Agreement, in each case, unless and until such dispute is resolved pursuant to Section 19, provided that CHT shall have a period of five (5) Business Days to pay any amount agreed to in settlement or determined by arbitration pursuant to Section 19 to be payable by it. (b) CHT's Right to Terminate: Subject to Sections 10(e) and 10(g), CHT may terminate this Agreement and the rights granted hereunder, in whole or in part, without prejudice to enforcement of any other legal right or remedy (including any express termination right set forth elsewhere in this Agreement), immediately upon giving written notice of such termination if Ehave: (i) breaches any material provision of this Agreement and such breach continues for a period of twenty (20) Business Days after delivery of a written notice by CHT requiring Ehave to correct such failure; or (ii) becomes or is adjudicated insolvent or bankrupt, admits in writing its inability to pay its debts as they mature, or makes an assignment for the benefit of creditors; or Ehave applies for or consents to the appointment of any receiver, trustee or similar officer for it or for all or any substantial part of its property; or such receiver, trustee or similar officer is appointed without the consent of Ehave; or Ehave institutes any bankruptcy, insolvency, reorganization, moratorium, arrangement, readjustment or debt, dissolution, liquidation or similar proceeding relating to it under the laws of any jurisdiction, or any such proceeding is instituted against Ehave and is not dismissed within sixty (60) Business Days; or any judgment, writ, warrant or attachment or execution of similar process is issued or levied against a substantial part of Ehave's property and remains unsatisfied for sixty (60) Business Days. In addition, CHT may terminate this Agreement and the rights granted hereunder, in whole or in part, and without prejudice to enforcement of any other legal right or remedy (including any express termination right set forth elsewhere in this Agreement), at any time without cause, by providing at least thirty (30) Business Days prior written notice to Ehave, but subject to payment of a termination fee equal to an amount set out in Schedule 6. (c) Ehave's Right to Terminate: Subject to Sections 10(e) and 10(g), Ehave may terminate this Agreement and the rights granted hereunder without prejudice to enforcement of any other legal right or remedy, immediately upon giving written notice of such termination if CHT: (i) fails to pay in full any sum owing by it under this Agreement by the due date thereof (other than any sum the payment of which is disputed by CHT in good faith and withheld pending resolution of such dispute in accordance with Section 19) and such failure continues for a period of ten (10) Business Days after delivery of a written notice by Ehave requiring CHT to correct such failure; 15. Source: EHAVE, INC., 20-F, 5/15/2019 (ii) breaches any other material provision of this Agreement and such breach continues for a period of twenty (20) Business Days after delivery of a written notice by Ehave requiring CHT to correct such failure; or (iii) becomes or is adjudicated insolvent or bankrupt, admits in writing its inability to pay its debts as they mature, or makes an assignment for the benefit of creditors; or CHT applies for or consents to the appointment of any receiver, trustee or similar officer for it or for all or any substantial part of its property; or such receiver, trustee or similar officer is appointed without the consent of CHT; or CHT institutes any bankruptcy, insolvency, reorganization, moratorium, arrangement, readjustment or debt, dissolution, liquidation or similar proceeding relating to it under the laws of any jurisdiction, or any such proceeding is instituted against CHT and is not dismissed within sixty (60) Business Days; or any judgment, writ, warrant or attachment or execution of similar process is issued or levied against a substantial part of CHT's property and remains unsatisfied for sixty (60) Business Days. (d) Waiver: The waiver by either Party of a breach or default of any provision of this Agreement by the other Party shall not be effective unless in writing and shall not be construed as a waiver of any succeeding breach of the same or of any other provision. Nor shall any delay or omission on the part of either Party to exercise or avail itself of any right, power or privilege by such Party shall constitute a waiver. (e) Effect of Termination: Upon the termination of this Agreement for any reason, subject to and without limiting the provisions of Section 12: (i) the Parties shall implement the Transition-Out Services pursuant to Section 10(f); (ii) at the end of the Transition-out Period (or earlier upon CHT's request) Ehave shall terminate and invalidate any Authentication IDs associated with CHT and any of its End Users; (iii) Ehave shall, but not earlier than twenty (20) Business Days after the later of termination or expiration of this Agreement or the Transition-out Period, destroy any copies of the End User Data contained in the Ehave Companion Solution and certify in writing to CHT that it has done so; (iv) CHT shall pay to Ehave the full amount of all Royalties payable hereunder as of the date of termination, if any, whether already invoiced or not (including any amounts due as late payment charges), and any other monies owing to Ehave hereunder; and (v) each Party will return to the other Party, or at the other Party's written request, destroy, in a secure manner all Confidential Information of the other Party which is then in its possession or control and certify in writing that it has done so. CHT acknowledges and agrees if any End User fails to download its End User Data from the Ehave Companion Solution in a timely manner (i.e. on or before the later of termination or expiry of this Agreement and the Transition-out Period), it may not have access to such information or such information may be destroyed by Ehave in accordance with the terms of this Section 10(e). Subject to Section 10(f), it is CHT's and each End User's responsibility to download and obtain all the End User Data on or prior to the termination of this Agreement or expiry of the Transition-out Period (whichever is later). Ehave shall have no responsibility for maintaining or providing to CHT or to any of its End Users the End User Data or any portion thereof, or any liability to CHT or any End User for destroying End User Data, in either case, from and after the twentieth (20th) Business Day after the termination or expiration of this Agreement or the Transition-out Period, whichever later. 16. Source: EHAVE, INC., 20-F, 5/15/2019 (f) Transition Assistance: Without limiting the provisions of Section 11, commencing on the delivery of any notice of termination of this Agreement, and continuing through the effective date of termination and for a period of sixty (60) Business Days thereafter (the \\\"Transition-out Period\\\"), Ehave will, to the extent requested by CHT, provide to CHT (or at CHT's request to CHT's End User) such reasonable cooperation, assistance and services to facilitate the orderly wind down, transition and migration and transfer of the End User Data from Ehave to CHT (the \\\"Transition-out Services\\\"). (g) Survival of Covenants: Notwithstanding the termination or expiration of this Agreement for any reason, the covenants set out in this Section 10(g) and in Sections 7(c), 10(e), 10(f), 11, 12, 13, 14(c), 15, 16, 17, 19, 20(a) and those provisions set out in Section 1 as necessary to interpret the foregoing provisions, of this Agreement shall survive any such termination or expiration. 11. OWNERSHIP (a) Ehave's Ownership CHT acknowledges and agrees that, as between CHT and Ehave, Ehave owns all worldwide right, title and interest, including all Intellectual Property Rights, in and to the Ehave Companion Solution, including any developments, enhancements or customizations made as a result of Section 3 and any modifications, enhancements, upgrades, updates or Customization subsequent to the development and implementation in accordance with Section 3, excluding, however, any CHT Developments. CHT does not acquire any rights, title or ownership interests of any kind whatsoever, express or implied, in any of the foregoing other than the licenses granted herein. (b) CHT's Ownership Ehave acknowledges and agrees that, as between Ehave and CHT, CHT owns all worldwide right, title and interest, including all Intellectual Property Rights, in and to the CHT Developments. Ehave does not acquire any rights, title or ownership interests of any kind whatsoever, express or implied, in any of the foregoing other than the licenses granted herein. Further, as between CHT and Ehave, (i) CHT (or its End User) is and will remain the sole and exclusive owner of all right, title, and interest in and to End User Data, including all Intellectual Property Rights therein and/or relating thereto, subject only to the limited license granted in Section 5(c), and (ii) End User Data and CHT Developments are and will be the Confidential Information of CHT. CHT and End Users shall at all times, including in the event of termination of this Agreement and for a period thereafter as set out in Section 10(e), have access to their respective End User Data and the ability to download and/or export their End User Data out of the Ehave Companion Solution. 17. Source: EHAVE, INC., 20-F, 5/15/2019\"}, {\"id\": \"12\", \"title\": \"ESCROW (a) Escrow Agreement (i) Concurrently with execution of this Agreement or, at CHT's option, as soon as practicab\", \"level\": 1, \"text\": \"12. ESCROW (a) Escrow Agreement (i) Concurrently with execution of this Agreement or, at CHT's option, as soon as practicable after the Effective Date but in no event later than CHT's acceptance of and the launch of the Ehave Companion Solution, CHT and Ehave shall enter into a Source Code Escrow Agreement with a reputable software escrow agent mutually acceptable to the Parties (\\\"Escrow Agent\\\"), in or substantially in the form attached hereto as Schedule \\\"7\\\", or otherwise in a form acceptable to the Parties, acting reasonably, and to the Escrow Agent (the \\\"Escrow Agreement\\\"), providing for the release of the Source Code for the Software, as modified pursuant to Section 3 and all necessary programming documentation, utilities and tools used by Ehave to maintain the Software and to compile the source code into object code (excluding third party utilities and tools licensed by Ehave for which Ehave has not been granted the right to sublicense or otherwise make available such utilities and tools to third parties without additional charge, but including such information as necessary for CHT to obtain licenses to and obtain such third party utilities and tools), all in its then-existing form, to CHT, in the certain circumstances expressly stated in Section 12(b). The Escrow Agreement shall provide that the Software, including the Source Code and object code, Specifications and related documentation are and shall be deemed to be \\\"intellectual property\\\" and the rights under the Escrow Agreement and the license granted under Section 12(a)(iii) are deemed to be \\\"rights to use intellectual property\\\" for purposes of section 65.11(7) of the BIA and section 32(6) of the CCAA. (ii) Upon release of the Source Code by the Escrow Agent to CHT pursuant to the terms and conditions of the Escrow Agreement, Ehave hereby warrants that such Source Code and other materials are and will be the then current version of the Software as used by CHT in its provision to End Users of the eEhave Companion Solution under the Subscription Agreements and that Ehave shall throughout the Term keep the Source Code so deposited with the Escrow Agent current by periodically submitting material updates to the Escrow Agent from time to time, as necessary. Save and except for express warranties specified in this Agreement and the Escrow Agreement, Ehave specifically disclaims all other warranties, express or implied, including, without limitation, any warranty of merchantability and fitness for a particular purpose. (iii) In connection with the exercise of CHT's rights under the Escrow Agreement, Ehave hereby grants to CHT a non- exclusive, non-transferable (except as set forth in Section 20(f)), right and license to use and copy the materials deposited with the Escrow Agent, including the Source Code, its Specifications and documentation, and any resulting corrections, repairs, translations, enhancements, and other derivative works and improvements made by CHT, for the sole purposes of providing to CHT the ability to operate, support and maintain, the Ehave Companion Solution for its End Users from time to time, until such time that CHT is able to migrate off the Ehave Companion Solution, but in any event not exceeding twelve months from the date of release of the materials from escrow. CHT may use third parties to perform its foregoing rights, provided that any such third parties are not competitors of Ehave and shall be subject to confidentiality obligations. CHT expressly agrees, however, that CHT shall not exercise any of the foregoing right and license unless and until CHT obtains such Source Code from the Escrow Agent. CHT's obligations with respect to confidentiality and use of the Source Code shall be equivalent to CHT's obligations set forth in Section 13 of this Agreement. Notwithstanding any release of the Source Code pursuant to the provisions hereof, Ehave shall retain sole ownership of and other proprietary rights with respect to the Source Code (including any Source Code relating to any modifications made by CHT to the Source Code, all of which shall be owned by Ehave). CHT shall be responsible for all of the Escrow Agent's fees and charges under the Escrow Agreement. 18. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Release Conditions The parties acknowledge and agree that a \\\"Release Condition\\\" for purposes of the Escrow Agreement shall be deemed to mean any one or more of the following listed events (in addition to any other event specified as a release condition under the Escrow Agreement): (i) Ehave makes a general assignment for the benefit of creditors; (ii) Ehave voluntarily institutes any bankruptcy, insolvency, reorganization, moratorium, arrangement, readjustment or debt, dissolution, liquidation or similar proceeding relating to it under the laws of any jurisdiction, or any such proceeding is instituted against Ehave and is not dismissed within sixty (60) Business Days; or any judgment, writ, warrant or attachment or execution of similar process is issued or levied against a substantial part of Ehave's property and remains unsatisfied for sixty (60) Business Days; or Ehave applies for or consents to the appointment of any receiver, trustee or similar officer for it or for all or any substantial part of its property; or such receiver, trustee or similar officer is appointed without the consent of Ehave; (iii) Ehave consents to the filing of a petition of bankruptcy against it; (iv) a petition of bankruptcy is filed against Ehave which is not discharged within sixty (60) days; (v) Ehave becomes or is adjudicated by a court of competent jurisdiction as being bankrupt or insolvent or admits in writing its inability to pay its debts as they mature; Ehave ceases doing business as a going concern; (vi) Ehave undergoes a change of control or is a party to a merger or amalgamation; (vii) Ehave takes steps to dissolve, liquidate, wind up or otherwise terminate its existence; (viii) Ehave has terminated its provision of or ceased to provide the Ehave Companion Solution or support services for a continuing period of fifteen (15) Business Days or more, except pursuant to the termination of this Agreement by Ehave in accordance with its rights contained hrein. (c) Effect of Bankruptcy All of the Software, including the Source Code and object code, the Specifications and related documentation, and all other escrow deposit materials constitute \\\"intellectual property\\\" and all rights and licenses granted by Ehave to CHT under this Agreement or the Escrow Agreement (which is supplementary to this Agreement) are and shall be deemed to be licenses and \\\"rights to use intellectual property\\\" by CHT for the purposes of and as such terms are used and interpreted under section 65.11(7) of the BIA and section 32(6) of the CCAA. CHT shall have the right to exercise all rights and elections under the BIA and CCAA and all other applicable bankruptcy, insolvency and similar laws with respect to this Agreement, the Escrow Agreement and the subject matter hereof and thereof. Without limiting the generality of the foregoing, if Ehave or its estate becomes subject to any bankruptcy or similar proceeding subject to CHT's rights of election, all rights and licenses granted to CHT under this Agreement and the Escrow Agreement will continue subject to the respective terms and conditions hereof and thereof, and will not be affected, even by Ehave's rejection of this Agreement or the Escrow Agreement. 19. Source: EHAVE, INC., 20-F, 5/15/2019\"}, {\"id\": \"13\", \"title\": \"CONFIDENTIALITY (a) Obligation\", \"level\": 1, \"text\": \"13. CONFIDENTIALITY (a) Obligation: Each Party acknowledges that all Confidential Information consists of confidential and proprietary information of the disclosing Party. Each Party shall, and shall cause its employees, agents and contractors to hold Confidential Information of the other Party in confidence, and shall use the same degree of care by instruction, agreement or otherwise, to maintain the confidentiality of the other Party's Confidential Information that it uses to maintain the confidentiality of its own Confidential Information, but with at least a reasonable degree of care commensurate with the nature and importance of such Confidential Information. Each Party agrees not to make use of Confidential Information other than for the exercise of rights or the performance of obligations under this Agreement (and the Source Code Escrow Agreement), and not to release, disclose, communicate it or make it available to any third person other than employees, agents and contractors of the Party who reasonably need to know it in connection with the exercise of rights or the performance of obligations by such Party under this Agreement (and the Source Code Escrow Agreement) and who are bound by confidentiality and restricted use obligations at least as protective of the Confidential Information as those set forth herein. Each Party agrees to notify the other Party in writing promptly of any loss or unauthorized disclosure or use of such other Party's Confidential Information and cooperate with such other Party to protect the confidentiality and ownership of all Intellectual Property Rights and other rights therein. (b) Subpoena: In the event that any Party receives a request to disclose all or any part of the Confidential Information of the other Party under the terms of a valid and effective subpoena or order issued by a court of competent jurisdiction or by a Governmental Authority, such Party agrees to (i) immediately notify the other Party of the existence, terms and circumstances surrounding such a request; (ii) consult with the other Party on the advisability of taking legally available steps to resist or narrow such request; and (iii) if disclosure of such Confidential Information is required, exercise its commercially reasonable efforts to obtain, and/or assist the other Party to obtain, at the other Party's expense, an order or other reliable assurance that confidential treatment will be accorded to such portion of the disclosed Confidential Information which the other Party so designates. (c) Injunctive Relief: Each Party acknowledges and agrees that any unauthorized use or disclosure by it of any of the other Party's Confidential Information, in whole or part, will cause irreparable damage to the disclosing Party, that monetary damages would be an inadequate remedy and that the amount of such damages would be extremely difficult to measure. The receiving Party agrees that the disclosing Party shall be entitled to seek temporary and permanent injunctive relief to restrain the receiving Party from any unauthorized disclosure or use. Nothing in this Agreement shall be construed as preventing the disclosing Party from pursuing any and all remedies available to it for a breach or threatened breach of a covenant made in this Section 13, including the recovery of monetary damages from the receiving Party. 20. Source: EHAVE, INC., 20-F, 5/15/2019\"}, {\"id\": \"14\", \"title\": \"REPRESENTATIONS, WARRANTIES AND DISCLAIMERS (a) Mutual Representations of the Parties\", \"level\": 1, \"text\": \"14. REPRESENTATIONS, WARRANTIES AND DISCLAIMERS (a) Mutual Representations of the Parties: Each Party represents to the other that: (i) it is a company duly organized, validly existing and in good standing under the laws of its incorporation and it has full power and authority to enter into this Agreement and to perform each and every covenant and agreement herein contained; (ii) this Agreement has been duly authorized, executed and delivered by it and constitutes a valid, binding and legally enforceable agreement of it; (iii) the execution and delivery of this Agreement, and the performance of the covenants and agreements herein contained, are not, in any manner or to any extent, limited or restricted by, and are not in conflict with, any commercial arrangements, obligations, contract, agreement or instrument to which it is either bound or subject; and (iv) the execution and delivery of this Agreement and the performance of its covenants and agreements herein contained shall comply in all respects with all laws and regulations to which it or its business is subject. (b) Additional representations of Ehave: Ehave represents to CHT that Ehave possesses the knowledge, skill and experience necessary for the provision and completion of the Ehave Companion Solution in accordance with the terms of this Agreement. (c) Warranties Ehave warrants that for the duration of the Term, (i) the Ehave Companion Solution will substantially conform to and operate in accordance with, and have the functions and features set out in, the Specifications, and any related documentation provided by Ehave, and any such documentation shall be complete and accurate in all material respects; and the Ehave Companion Solution will not contain any material undocumented feature; (ii) Ehave has implemented and will maintain industry standard protection for the detection, protection and removal of Viruses; (iii) Ehave will perform all services under this Agreement in a timely, professional and workmanlike manner using personnel of required skill, experience and qualifications, and will devote adequate resources to meet its obligations (including the Service Level Commitments and its support obligations) hereunder; (iv) it has or will have all necessary right, power and authority, including all licenses and Intellectual Property Rights required, to provide and operate the Ehave Companion Solution and to grant all rights and licenses granted or required to be granted by it under this Agreement; and (v) Ehave is not aware of any infringement or misappropriation claims by any third party in relation to the Ehave Companion Solution. 21. Source: EHAVE, INC., 20-F, 5/15/2019 (d) Exclusion of Other Warranties: Except as otherwise expressly stated in this Agreement, there are no express or implied warranties or conditions in relation to the Ehave Companion Solution that are the subject matter of this Agreement, including implied warranties or conditions of merchantable quality, fitness for a particular purpose, or non-infringement, or that the Ehave Companion Solution will meet CHT's or any End Users' needs or will be available for use at any particular time or will be error free. Under no circumstances will Ehave be liable for the results of CHT or any of its End Users' misuse of the Ehave Companion Solution, including any use contrary to Applicable Law. 15. INSURANCE (a) Required Insurance: Both Parties shall, at all times during the currency of this Agreement and for a period of one (1) year after the termination or expiration of this Agreement, maintain the following policies of insurance in effect: (i) a comprehensive general liability insurance policy, with minimum coverage of $1,000,000 per occurrence and in the annual aggregate for product liability and completed operations, covering bodily and personal injury, including death, and property damage, including loss of use; and (ii) an information and network technology blended liability insurance policy with an insured limit of at least $1,000,000 in the aggregate. (b) Evidence of Insurance: Upon the execution of this Agreement or at any time at a Party's request during the term of this Agreement, the other Party shall provide the requesting Party with evidence of the aforementioned insurance coverage in the form of a certificate of insurance acceptable to the requesting Party. In the event of any material change or cancellation of the required insurance policies, the applicable Party will provide the other Party with thirty (30) calendar days' prior written notice and will promptly replace such insurance policy in accordance with this Section 15, without lapse in coverage. 16. INDEMNITIES (a) Intellectual Property Indemnity Ehave shall defend at its own expense any claim, proceeding or suit (a \\\"Claim\\\") brought against CHT and/or any of its directors, officers, employees, agents, subcontractors, affiliates and/or End Users (collectively, the \\\"CHT Indemnified Parties\\\") to the extent such Claim alleges that the Ehave Companion Solution furnished hereunder or the use thereof by CHT or its End Users as authorized hereunder or in any Subscription Agreement infringes any copyright, Canadian patent, or registered trademark of a third person, and will indemnify and hold harmless the CHT Indemnified Parties from and against any and all related liabilities, costs, losses, damages and expenses (including reasonable legal fees) arising out of or in connection with or relating to any such Claim, provided that: (i) Ehave is given prompt written notice of the Claim or of any allegations or circumstances known to CHT which could reasonably result in a Claim; (ii) Ehave is given all reasonable information and assistance from CHT, at Ehave's expense, which Ehave may require to defend the Claim; 22. Source: EHAVE, INC., 20-F, 5/15/2019 (iii) Ehave is given sole control of the defence of the Claim, and all negotiations for the settlement or compromise thereof, provided that Ehave shall promptly engage competent counsel and initiate defence in a professional manner and CHT may observe or participate in such proceedings with its own counsel at its own expense; and (iv) the alleged infringement does not result from any non-permitted uses, alterations, modifications or enhancements carried out by CHT, any End User or on its or their behalf by a third person (other than any Ehave personnel or contractors). If such Claim has occurred, or in Ehave's opinion is likely to occur, without limiting Ehave's obligation to defend and indemnify the CHT Indemnified Parties as aforesaid, Ehave may, at its option and expense, either procure for CHT the right to continue using the Ehave Companion Solution in accordance with this Agreement or modify or replace the same so that it becomes non-infringing without loss of functionality, or if none of the foregoing alternatives is reasonably available and at Ehave's discretion, discontinue the use of the Ehave Companion Solution on not less than sixty (60) Business Days' prior written notice to CHT and its End Users. The foregoing states the entire obligations of Ehave with respect to any infringement of Intellectual Property Rights of any third Person. (b) CHT' Indemnity CHT shall defend at its own expense any Claim brought against Ehave, its affiliates, directors, officers, employees and agents, to the extent such Claim: (i) alleges, directly or indirectly, that any End User Data infringes any Canadian copyright, patent or registered trademark of a third person; alleges, directly or indirectly, that the End User Data contains any Objectionable Content; (ii) arises through a breach by CHT of its obligations set out in Section 5(g); or (iii) is in relation to any of its End Users' use of the Ehave Companion Solution, including contrary to Applicable Law, except however to the extent as Ehave has indemnified CHT pursuant to Section 16(a); provided that CHT is given: (i) prompt written notice of the Claim or of any allegations or circumstances known to Ehave which could result in a Claim; (ii) all reasonable information and assistance from Ehave, at CHT's expense, which CHT may require to defend the Claim; and (iii) sole control of the defence of the Claim, and all negotiations for its settlement or compromise thereof. 17. LIMITATION OF LIABILITY (a) Consequential Damages Subject to Section 17(c), in no event shall either Party be liable to the other for any consequential, incidental, exemplary or punitive damages even if advised in advance of the possibility of such damages. Further, subject to Section 17(c), neither Party shall not be liable to the other Party for any lost revenue, lost profit or lost savings. (b) Limitation of Direct Damages Subject to Section 17(c), in no event shall either Party's liability under this Agreement exceed the aggregate of all amounts paid under this Agreement and amounts that have accrued but not yet been paid in the twelve (12) months preceding the event giving rise to the claim. 23. Source: EHAVE, INC., 20-F, 5/15/2019 (c) Exceptions to Limitations Notwithstanding Sections 17(a) and 17(b), neither Party excludes or limits any liability for: (i) personal injury or death to the extent that such injury or death results from the negligence or wilful misconduct of a Party or its employees or subcontractors; (ii) fraud, fraudulent misrepresentation or fraudulent concealment; (iii) the Party's obligations set out in Sections 2(c), 5(b), 5(c), 6(b), 11, 13 or 16; (iv) CHT's payment obligations under Section 7; or (v) willful misconduct or gross negligence. (d) Application of Limitations and Exclusions The limitations and exclusions set out in this Section shall apply whether a claim, demand or action is based in contract, tort (including negligence), or otherwise. 18. FORCE MAJEURE Except for any obligation to make payments, any delay or failure of either Party to perform its obligations under this Agreement or under any Schedule attached hereto shall be excused if, and to the extent, that the delay or failure is caused by an event or occurrence beyond the reasonable control of the Party and without its fault or negligence and that could not have been prevented or avoided by the exercise of reasonable due diligence, such as, by way of example and not by way of limitation, acts of God, action by any Governmental Authority (whether valid or invalid), fires, flood, wind storms, explosions, riots, natural disasters, wars, terrorist acts, sabotage, labour problems (including lock-outs, strikes and slow downs, except for any labour problems of the Party claiming a force majeure event), or court order or injunction; provided that written notice of delay (including anticipated duration of the delay) shall be given by the affected Party to the other Party within two (2) Business Days of the affected Party first becoming aware of such event and the affected Party shall use diligent efforts to end the failure or delay and minimize the effects of such force majeure event. In the event that the force majeure event lasts for fifteen (15) Business Days or longer, either Party shall have the option to terminate this Agreement upon written notice to the other without liability. 19. DISPUTE RESOLUTION (a) Discussions: Each Party agrees to utilize all reasonable efforts to resolve any dispute, whether arising during the term of this Agreement or at any time after the expiration of termination of this Agreement, which touches upon the validity, construction, meaning, performance or effect of this Agreement or the rights and liabilities of the Parties or any matter arising out of or connected with this Agreement, promptly and in an amicable and good faith manner by negotiations between the Parties. 24. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Mediation: Either Party may submit a dispute to mediation by providing written notice to the other Party. In the mediation process, the Parties will try to resolve their differences voluntarily with the aid of a single, impartial mediator, who shall attempt to facilitate negotiations. The mediator shall be selected by agreement of the Parties. If the Parties cannot otherwise agree on a mediator within five (5) Business Days, a single mediator shall be designated by the ADR Institute of Canada, Inc. or any successor organization (\\\"ADR\\\") at the request of a Party. Any mediator so designated must not have a conflict of interest with respect to any Party. The mediation shall be conducted as specified by the mediator and agreed upon by the Parties. The Parties agree to discuss their differences in good faith and to attempt, with the assistance of the mediator, to reach an amicable resolution of the dispute. The mediation shall be treated as a settlement discussion and therefore shall be confidential. The mediator may not testify for either Party in any later proceeding relating to the dispute. No recording or transcript shall be made of the mediation proceedings. Each Party shall bear its own costs and legal fees in the mediation. The Parties shall share the fees and expenses of the mediator equally. (c) Arbitration: Subject to Section 19(d), any dispute that has proceeded through mediation established in Section 19(b) without resolution may be submitted to arbitration. Any arbitration conducted pursuant to this Agreement shall take place in the City of Toronto, Ontario. The costs of the arbitration shall be borne equally by the Parties or as may be specified in the arbitrator's decision. The provisions of the Arbitration Act of Ontario, as amended, except as otherwise provided in this Agreement shall govern the arbitration process. The Parties agree to exclude the appeal provisions of the Arbitration Act, as may be amended from time to time, and in particular, section 45 thereof. The determination arising out of the arbitration process shall be final and binding upon the Parties to the arbitration. (d) Exceptions to Arbitration: The following matters shall be excluded from arbitration under this Agreement: (i) any disputes involving third Persons; (ii) breach of confidentiality by either Party; and (iii) intellectual property claims, whether initiated by third Persons or by one of the Parties to this Agreement. 20. MISCELLANEOUS (a) Notice: Every notice or other communication hereunder shall be deemed to have been duly given and made if in writing and if served by personal delivery upon the Party for whom it is intended, if delivered by registered or certified mail, return receipt requested, or by a national courier service, or if sent by fax (receipt of which is confirmed) to the Person at the address set forth below, or such other address as may be designated in writing hereafter, in the same manner, by such Person: To: Ehave To: CHT 277 Lakeshore Road E 1 Scarsdale Road Suite 203 Oakville, Ontario Toronto, Ontario Canada Canada L6J 6J3 M3B 2R2 Attention: Prateek Dwivedi, President & CEO Attention: Scott Woodrow, CEO Any such notification shall be deemed delivered (a) upon receipt, if delivered personally, (b) on the next Business Day, if sent by national courier service for next Business Day delivery or if sent by fax. Any correctly addressed notice or last known address of the other Party that is relied on herein that is refused, unclaimed, or undeliverable because of an act or omission of the Party to be notified as provided herein shall be deemed effective as of the first date that said notice was refused, unclaimed, or deemed undeliverable by the postal authorities by mail, through messenger or commercial express delivery services. 25. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Modifications: The Parties may modify this Agreement only upon written agreement. (c) Further Assurances: Each Party shall take such action (including, but not limited to, the execution, acknowledgement and delivery of documents) as may reasonably be requested by the other Party for the implementation or continuing performance of this Agreement. (d) Relationship: The Parties are independent contractors and no other relationship is intended. Nothing herein shall be deemed to constitute either Party as an agent, representative or employee of the other Party, or both Parties as joint venturers or partners for any purpose. Neither Party shall act in a manner that expresses or implies a relationship other than that of independent contractor. Each Party shall act solely as an independent contractor and shall not be responsible for the acts or omissions of the other Party. Neither Party will have the authority or right to represent nor obligate the other Party in any way except as expressly authorized by this Agreement. (e) Enurement: This Agreement shall enure to the benefit of and be binding upon each of the Parties hereto and their permitted successors and assigns. (f) No Assignment: Neither this Agreement nor any rights or obligations hereunder shall be assignable by a Party without the prior written consent of the other Party, provided that either Party shall have the right, on notice to but without the other Party's consent, to assign this Agreement and its rights and obligations contained herein, to an affiliate or to a third party who is not a competitor of the other Party in connection with a sale of all or substantially all of the assigning Party's business or assets relating to this Agreement. (g) Counterparts and Facsimile Execution and Delivery: This Agreement may be executed in counterparts, each of which shall be deemed to be an original and both of which together shall constitute one and the same instrument. To evidence its execution of an original counterpart of this Agreement, a Party may send a copy of its original signature on the execution page hereof to the other Party by facsimile transmission or email and such transmission shall constitute delivery of an executed copy of this Agreement to the receiving Party as of the date of receipt thereof by the receiving Party or such other date as may be specified by the sending Party as part of such transmission. (h) Language: It is the Parties desire and agreement that this Agreement and all Exhibits and associated documentation be drafted in English. Les Parties conviennent que la pr\u00e9sente convention et tous les documents s'y rattachant, soient r\u00e9dig\u00e9s en anglais. 26. Source: EHAVE, INC., 20-F, 5/15/2019 IN WITNESS WHEREOF, each Party hereto has caused this Agreement to be duly executed as of the date first written above by an officer authorized in that behalf. EHAVE, INC. COMPANION HEALTHCARE TECHNOLOGIES CORP per: /s/ Prateek Dwivedi per: /s/ Scott Woodrow Name: Prateek Dwivedi Name: Scott Woodrow Title: Chief Executive Officer Title: Chief Executive Officer 27. Source: EHAVE, INC., 20-F, 5/15/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of EhaveInc_20190515_20-F_EX-4.44_11678816_EX-4.44_License Agreement_ Reseller Agreement\", \"nodes\": [{\"id\": \"Exhibit 4.44\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THIS LICENSE AND RESELLER AGREEMENT dated as of the October 30, 2018 is made BETWEEN: EHAVE, INC., a company incorporated under the laws of the Province of Ontario, Canada (\\\"Ehave\\\"); - and - COMPANION HEALTHCARE TECHNOLOGIES CORP, a company incorporated under the laws of the Province of Ontario (\\\"CHT\\\") RECITALS: A. Ehave has developed a software platform that provides an end-to-end patient management solution to healthcare professionals and provides that platform to users as a service. B. CHT has developed a business model to bring a similar service that Ehave provides using the Ehave Platform for the domain of the animal market including companion animals (i.e. pets). C. The Parties desire to enter into this Agreement to enable CHT to pursue its business model whereby CHT will license and provide services in relation to companion and other animals using the Ehave Companion Solution under the terms and conditions contained herein. NOW THEREFORE, in consideration of the premises and the mutual agreements hereinafter set out herein and of other consideration (the receipt and sufficiency of which are acknowledged by each Party), the Parties covenant and agree as follows: 1. INTERPRETATION (a) Definitions In this Agreement and the schedules annexed hereto, the following terms shall have the respective meanings indicated below: \\\"Acceptance Criteria\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Period\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Procedures\\\" has the meaning ascribed to it in Section 3(d). \\\"Agreement\\\" means this license and reseller agreement and all Schedules, Appendixes and Exhibits attached hereto. \\\"Applicable Laws\\\" means any and all (i) laws, statutes, rules, regulations, by laws, codes, treaties, constitutions and ordinances, including Privacy Legislation (\\\"Laws\\\"), (ii) order, directive, judgment, decree, award or writ of any court (including a court of equity), arbitrator or arbitration panel, or any Governmental Authority or other body exercising adjudicative, regulatory, judicial or quasi-judicial powers, including any stock exchange (\\\"Orders\\\"), and (iii) policies, guidelines, standards, requirements, notices and protocols of any Governmental Authority (\\\"Policies\\\"); which are applicable to or govern CHT, Ehave or the transactions contemplated by this Agreement.\", \"level\": 2, \"text\": \"Exhibit 4.44 THIS LICENSE AND RESELLER AGREEMENT dated as of the October 30, 2018 is made BETWEEN: EHAVE, INC., a company incorporated under the laws of the Province of Ontario, Canada (\\\"Ehave\\\"); - and - COMPANION HEALTHCARE TECHNOLOGIES CORP, a company incorporated under the laws of the Province of Ontario (\\\"CHT\\\") RECITALS: A. Ehave has developed a software platform that provides an end-to-end patient management solution to healthcare professionals and provides that platform to users as a service. B. CHT has developed a business model to bring a similar service that Ehave provides using the Ehave Platform for the domain of the animal market including companion animals (i.e. pets). C. The Parties desire to enter into this Agreement to enable CHT to pursue its business model whereby CHT will license and provide services in relation to companion and other animals using the Ehave Companion Solution under the terms and conditions contained herein. NOW THEREFORE, in consideration of the premises and the mutual agreements hereinafter set out herein and of other consideration (the receipt and sufficiency of which are acknowledged by each Party), the Parties covenant and agree as follows: 1. INTERPRETATION (a) Definitions In this Agreement and the schedules annexed hereto, the following terms shall have the respective meanings indicated below: \\\"Acceptance Criteria\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Period\\\" has the meaning ascribed to it in Section 3(d). \\\"Acceptance Procedures\\\" has the meaning ascribed to it in Section 3(d). \\\"Agreement\\\" means this license and reseller agreement and all Schedules, Appendixes and Exhibits attached hereto. \\\"Applicable Laws\\\" means any and all (i) laws, statutes, rules, regulations, by laws, codes, treaties, constitutions and ordinances, including Privacy Legislation (\\\"Laws\\\"), (ii) order, directive, judgment, decree, award or writ of any court (including a court of equity), arbitrator or arbitration panel, or any Governmental Authority or other body exercising adjudicative, regulatory, judicial or quasi-judicial powers, including any stock exchange (\\\"Orders\\\"), and (iii) policies, guidelines, standards, requirements, notices and protocols of any Governmental Authority (\\\"Policies\\\"); which are applicable to or govern CHT, Ehave or the transactions contemplated by this Agreement. Source: EHAVE, INC., 20-F, 5/15/2019 \\\"Authentication ID\\\" means a security mechanism by which an Authorized User identifies herself or himself to the Ehave Companion Solution and gains access thereto, which security mechanism may include user identification, passwords, digital certificates or any other similar process mechanism for authentication and recognition as determined by Ehave from time to time. \\\"Authorized User\\\" means an individual who an End User has authorized to access and use CHT's services, which includes the use of the Ehave Companion Solution. \\\"Business Day\\\" means any calendar day except for Saturday or Sunday or any statutory holiday observed in the Province of Ontario. \\\"CHT Developments\\\" has the meaning ascribed to it in Section 4(a). \\\"CHT Indemnified Parties\\\" has the meaning ascribed to it on Section 16(a). \\\"CHT Marks\\\" means the names, trademarks, trade names, service marks, designs and logos of CHT. \\\"Claim\\\" has the meaning ascribed to it in Section 16(a). \\\"Competitive Transaction\\\" has the meaning ascribed to it in Section 2(d). \\\"Confidential Information\\\" means this Agreement, the Ehave Companion Solution, End User Data and all ideas, designs, business models, databases, drawings, documents, diagrams, formulas, test data, marketing, financial or personnel data, sales information, customer or supplier information, including information provided by such customers or suppliers, or any other information already furnished and to be furnished or made available by one Party to the other, whether in oral, written, graphic or electronic form including any such information exchanged during informational sessions designated as confidential, including, without limitation, information concerning a Party's actual and potential customers and other Intellectual Property Rights of such Party, provided, however, that Confidential Information shall not include any data or information: (i) that, at the time of disclosure, is in or, after disclosure, becomes part of the public domain, through no act or failure on the part of the receiving Party, whether through breach of this Agreement or otherwise; (ii) that, prior to disclosure by the disclosing Party, was already in the possession of the receiving Party, as evidenced by written records kept by the receiving Party in the ordinary course of its business, or as evidenced by proof of actual prior use by the receiving Party; (iii) independently developed by the receiving Party, by Persons having no direct or indirect access to the disclosing Party's Confidential Information provided that the receiving Party provides clear and convincing evidence of such independent development; (iv) which, subsequent to disclosure, is obtained from a third Person: (A) who is lawfully in possession of such information; (B) who is not in violation of any contractual, legal, or fiduciary obligation to either Party, as applicable, with respect to such information; and (C) who does not prohibit either Party from disclosing such information to others; or (v) is further disclosed with the prior written consent of the disclosing Party, but only to the extent of such consent. \\\"Effective Date\\\" means the date first written above. \\\"Ehave Companion Solution\\\" means the Ehave Platform, as modified, adapted and customized, as provided herein, the specifications of which are set out in Schedule \\\"1\\\". 2. Source: EHAVE, INC., 20-F, 5/15/2019 \\\"Ehave Platform\\\" means the Software, Ehave Server and such devices and peripherals physically located with the Ehave Server, including all computer hardware, software, network elements, and electrical and telecommunications infrastructure located behind the Point of Access. \\\"Ehave Server\\\" means that computer server located at Ehave's premises, or a third party provider of hosting and/or network services, that houses the Software. \\\"End User\\\" means CHT's customers who have entered into a subscription agreement with CHT for CHT services, which services include the use of the Ehave Companion Solution. \\\"End User Data\\\" means collectively any data, files, documentation or other information (including personal information) that an End User or any of its Authorized Users may: (i) upload to the Ehave Companion Solution; and/or (ii) have processed through the use of the Ehave Companion Solution, and includes any data or output resulting from or derived from such use. \\\"Escrow Agent\\\" has the meaning ascribed thereto in Section 12(a). \\\"Escrow Agreement\\\" has the meaning ascribed thereto in Section 12(a). \\\"Field of Use\\\" means indications and outcomes related to any companion and other animals. \\\"Governmental Authority\\\" means any domestic, foreign or supranational government, whether federal, provincial, state, territorial or municipal; and any governmental agency, ministry, department, tribunal, commission, bureau, board or other instrumentality, including international institutions, exercising or purporting to exercise legislative, judicial, regulatory or administrative functions of, or pertaining to, government. \\\"Implementation Plan\\\" has the meaning ascribed to it in Section 3(a). \\\"Intellectual Property\\\" means any property, tangible or intangible, that may be subject to Intellectual Property Rights, including without limitation, ideas, formulae, algorithms, concepts, techniques, processes, procedures, approaches, methodologies, plans, systems, research, information, documentation, data, data compilations, specifications, requirements, designs, diagrams, programs, inventions, technologies, software (including its source code), tools, products knowledge, know-how, including without limitation, trade secrets, and other materials or things. \\\"Intellectual Property Rights\\\" means (a) any and all proprietary rights anywhere in the world provided under (i) patent law; (ii) copyright law, including moral rights; (iii) trademark law; (iv) design patent or industrial design law; (v) semiconductor chip or mask work law; (vi) trade secret law; (vii) privacy law; or (viii) any other statutory provision or common law principle applicable to this Agreement which may provide a right in either (A) Intellectual Property; or (B) the expression or use of Intellectual Property; and (b) any and all applications, registrations, licenses, sub-licenses, franchises, agreements or any other evidence of a right in any of the foregoing. \\\"Objectionable Content\\\" means content that infringes any Applicable Laws or third party rights, and content which is obscene, indecent, pornographic, seditious, defamatory, threatening, liable to incite racial hatred, menacing, blasphemous, misleading, deceptive or in breach of any person's Intellectual Property Rights. \\\"Party\\\" means either Ehave or CHT; and \\\"Parties\\\" means both of them. \\\"Person\\\" means any individual, estate, sole proprietorship, firm, partnership, unincorporated association, unincorporated syndicate, unincorporated organization, limited liability company, corporation, body corporate, trustee, trust, Governmental Authority or other entity or organization and includes any successor to any of the foregoing. 3. Source: EHAVE, INC., 20-F, 5/15/2019 \\\"Point of Access\\\" means Ehave's, or its subcontractor's, border router, which is used to establish connectivity from the Ehave Platform to Ehave's, or its subcontractor's, Internet provider, or the public Internet. \\\"Royalties\\\" means the fees, charges and other amounts to be paid by CHT to Ehave for the rights granted hereunder and which amounts are set out in Schedule \\\"6\\\". \\\"Security Requirements\\\" means those safeguards and controls set out in Schedule \\\"5\\\". \\\"Software\\\" means Ehave's proprietary patient and data management software and any related documentation, as modified for use in the animal (including companion animal) and veterinary industry. \\\"Source Code\\\" means the human-readable form of a computer instruction, including, but not limited to, related system documentation, flow charts, all comments and any procedural code and a description of the procedure for generating object code, all of a level sufficient to enable a programmer reasonably fluent in the programming language in which the Software was written to understand, build, operate, support, maintain and develop modifications, upgrades, updates, adaptations, enhancements, new versions, and other derivative works and improvements of, and to develop computer programs compatible with, the Software. \\\"Specifications\\\" has the meaning ascribed to it in Section 3(a).\\\"Subscription Agreement\\\" has the meaning ascribed to it in Section 5(b). \\\"Term\\\" has the meaning ascribed to it in Section 9. \\\"Territory\\\" means any jurisdiction in the World where the use of the Ehave Companion Solution for the intended purpose herein is permitted under Applicable Law. \\\"Transition out Period\\\" has the meaning ascribed to it in Section 10(f). \\\"Transition-out Services\\\" has the meaning ascribed to it in Section 10(f). \\\"Virus\\\" means a piece of code usually (but not necessarily) disguised as something else that causes some unexpected and, for the victim, usually undesirable, event and which is designed so that it may automatically spread to other computer users; the term 'Virus' will also be deemed to include worms, cancelbots, trojan horses, harmful contaminants (whether self-replicating or not) and nuisance causing or otherwise harmful applets. (b) Headings; Extended Meanings The division of this Agreement into articles, sections, schedules and other subdivisions, and the inclusion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement. The headings in the Agreement are not intended to be full or precise descriptions of the text to which they refer. Unless something in the subject matter or context is inconsistent therewith, references herein to Articles and Sections are to Articles and Sections of this Agreement. The word \\\"including\\\" or \\\"include(s)\\\" means \\\"including without limitation\\\" or \\\"include(s) without limitation\\\". (c) Currency Unless otherwise specified, all references to monetary amounts, including the symbol \\\"$\\\", are in respect of Canadian currency. 4. Source: EHAVE, INC., 20-F, 5/15/2019 (d) Exhibits and Schedules The following Schedules are a part of and are integral to this Agreement: Schedule \\\"1\\\" - Ehave Companion Solution Specifications Schedule \\\"2\\\" - Development and Implementation Plan Schedule \\\"3\\\" - Support Procedures Schedule \\\"4\\\" - Service Level Commitments Schedule \\\"5\\\" - Security Requirements Schedule \\\"6\\\" - Royalties and Early Termination Fee Schedule \\\"7\\\" - Source Code Escrow (e) Entire Agreement This Agreement, together with any other documents to be delivered pursuant hereto, constitutes the entire agreement between the Parties pertaining to the subject matter hereof and supersedes all prior agreements, negotiations, discussions and understandings, written or oral, between the Parties. Except as expressly provided in this Agreement, there are no representations, warranties, conditions other agreements or acknowledgements, whether direct or collateral, express or implied, that form part of or affect this Agreement. The execution of this Agreement has not been induced by, nor do either of the Parties rely upon or regard as material, any representations, warranties, conditions, other agreements or acknowledgements not expressly made in this Agreement or in the other documents to be delivered pursuant hereto. (f) Governing Law: This Agreement shall be governed by, and construed and enforced in accordance with, the laws in force in the Province of Ontario (excluding any conflict of laws rule or principle which might refer such construction to the laws of another jurisdiction). The Parties hereto agree to submit to the exclusive jurisdiction of the courts of the Province of Ontario and waive any objection relating to improper venue or forum non conveniens to the conduct of any proceeding in any such court. (g) Severability: In the event that any provision (or any portion of a provision) of this Agreement shall for any reason be held by a court of competent jurisdiction to be invalid, illegal, or unenforceable for any reason, such invalidity, illegality or unenforceability shall not affect any other provision hereof and this Agreement shall be construed as if such invalid, illegal or unenforceable provision (or portion of a provision) had never been contained herein in regards to that particular jurisdiction. 2. APPOINTMENT AND LICENSE GRANT (a) Exclusive Appointment Ehave hereby appoints CHT, and CHT hereby accepts the appointment, to act as Ehave's reseller of the use of the Ehave Companion Solution within the Field of Use in the Territory for the duration of the Term solely in accordance with the terms and conditions of this Agreement. Subject to Section 2(e), the foregoing appointment is exclusive such that Ehave shall not appoint any other Person to, nor may Ehave itself, sell or resell the use of the Ehave Companion Solution within the Field of Use anywhere in the Territory. 5. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Grant by Ehave Subject to the terms and conditions of this Agreement commencing as of the Effective Date and for the duration of the Term and any Transition-out Period, Ehave hereby grants to CHT a non-transferable (except as permitted under Section 20(f)), right to: (i) sub-license the use of the Ehave Companion Solution within the Field of Use in the Territory to End Users and their respective Authorized Users, including in operation or by interfacing with other software, hardware, systems, networks and services, in accordance with and subject to the provisions of CHT's Subscription Agreement; and (ii) use the Ehave Companion Solution to support its licensed End Users. Subject to Section 2(e), the grant set out in Clause 2(b)(i) is exclusive such that Ehave shall not license any other Person to, nor may Ehave itself, license, sub-license the use of, or provide services similar to, the Ehave Companion Solution within the Field of Use anywhere in the Territory. (c) Restrictions on Use Any rights not granted herein are strictly reserved by Ehave. CHT shall not, and shall not permit others to, reverse engineer, decompile, disassemble or translate any software used by Ehave to provide the Ehave Companion Solution, or otherwise attempt to view, display or print such software, including its Source Code, except as permitted herein. (d) Prohibition on Competitive Solutions For so long as the appointment set out in Section 2(a) is exclusive, CHT shall not enter into an agreement (a \\\"Competitive Transaction\\\") with any other Person related to the license, sub-license, sale, resale or provide service, solutions, goods or products, that are substantially similar to or competitive with the Ehave Companion Solution. For clarity, a Competitive Transaction shall not include an agreement for use, integration or interfacing, or co-marketing, of the Ehave Companion Solution with other services, solutions, devices, goods or products, where such other services, solutions, devices, goods or products do not contain the same or similar functionality of the Ehave Companion Solution, but provides for a complementary solution. (e) Conversion to Non-Exclusive Notwithstanding anything to the contrary contained herein, the exclusive appointment and license set out in Sections 2(a) and 2(b) shall become non-exclusive if: (i) at any time during the Term hereof, CHT breaches Section 2(d) as determined by arbitration in accordance with Section 19(c) or by a final non-appealable judgment of a court of competent jurisdiction; or (ii) at any time after November 1, 2010 CHT fails to achieve annual revenues of $500,000. (f) No Franchise Agreement The Parties to this Agreement are independent contractors and nothing in this Agreement shall be deemed or constructed as creating a joint venture, partnership, agency relationship, or franchise between Ehave and CHT. Neither Party, by virtue of this Agreement, will have any right, power or authority to act or create an obligation, express or implied, on behalf of the other Party. Each Party assumes responsibility for the actions of their personnel under this Agreement and will be solely responsible for their supervision, daily direction and control, wage rates, withholding income taxes, Canada Pension Plan contributions, employment insurance premiums, disability benefits, or the manner and means through which the work under this Agreement will be accomplished. Except as provided otherwise in this Agreement, CHT has the sole discretion to determine CHT's methods of operation, CHT's accounting practices, the types and amounts of insurance CHT carries, CHT's personnel practices, CHT's advertising and promotion, CHT's customers and CHT's service areas and methods. The relationship created hereby between the parties is solely that of supplier and reseller, and licensor and licensee. 6. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEVELOPMENT AND IMPLEMENTATION OF THE COMPANION SOLUTION (a) Specifications and Implementation Attached hereto as Sched\", \"level\": 1, \"text\": \"3. DEVELOPMENT AND IMPLEMENTATION OF THE COMPANION SOLUTION (a) Specifications and Implementation Attached hereto as Schedule \\\"1\\\" are the business requirements and technical specifications of the Ehave Companion Solution (the \\\"Specifications\\\"). Attached hereto as Schedule \\\"2\\\" is the development and implementation plan (the \\\"Implementation Plan\\\"), which sets out the procedures and obligations of each of the Parties and the key milestones and timelines in relation to the development and implementation of the Ehave Companion Solution. The Parties acknowledge that at the time of execution of this Agreement that the Specifications and Implementation Plan may not have been fully developed, but that the creation of the Specifications and development of the detailed Implementation Plan will be the first step in respect of the development and implementation of the Ehave Companion Solution, in which case, once approved by the Parties in writing, the Specifications and Implementation Plan so developed will be attached hereto and shall replace Schedules \\\"1\\\" and \\\"2\\\" respectively. Once finalized the Specifications and Implementation Plan may not be changed or modified by either Party, except in accordance with the procedures set out in Section 3(c). (b) Obligations Each of Ehave and CHT shall perform, at their own expense (or as otherwise set out in Schedule \\\"6\\\"), their respective obligations and responsibilities set out in the Implementation Plan as necessary to accomplish the development and implementation of the Ehave Companion Solution in accordance with the milestones and timelines set out therein. CHT acknowledges that the development and implementation of the Ehave Companion Solution requires decisions and input from CHT and for CHT to perform its obligations thereunder in a timely manner. In the event that CHT delays in providing such decisions, input or performance of its obligations, the development and implementation of the Ehave Companion Solution shall be correspondingly delayed. Subject to the foregoing, Ehave acknowledges that time is of the essence with respect to its obligations hereunder and that prompt and timely performance of all such obligations, including all development and implementation dates, timetables, project milestones and other requirements in this Agreement is strictly required. Once the implementation of the Ehave Companion Solution is completed, Ehave shall notify CHT of such completion and that the Ehave Companion Solution is ready for testing in accordance with Section 3(d). 7. Source: EHAVE, INC., 20-F, 5/15/2019 (c) Change Control Process Either Party may request additions, deletions or amendments in respect of the development and implementation of the Ehave Companion Solution (\\\"Change\\\"). Changes shall be requested in writing signed by an authorized representative of the Party requesting the Change (\\\"Change Request\\\"). Ehave shall have no obligation to perform, and CHT shall have no obligation to pay for, services related to any proposed modification or change unless both Parties have agreed to the modifications or changes in writing in accordance with the procedures set forth herein. The Change Request shall include a reasonably detailed description of the scope and nature of the requested Change. If CHT desires a Change, Ehave shall evaluate the feasibility of such change as it relates to the proposed Field of Use. As soon as reasonably possible after receipt of CHT's request, Ehave agrees to provide CHT with a written estimate of the cost, if any, of and the timing to implement the requested Changes as well as any additional terms and conditions related to such Changes. The costs, if any, associated with the development of such estimate shall be borne by CHT. Upon CHT's approval in writing of the cost estimate and any additional terms and conditions related to such Changes, including delivery dates and payment terms provided by Ehave, the Parties shall revise the Specifications and Implementation Plan and shall replace the Specifications and Implementation Plan attached hereto as Schedules \\\"1\\\" and \\\"2\\\", and Ehave shall develop and implement the Change as so agreed. Changes shall be subject to acceptance testing by CHT prior to being deployed into production in accordance with procedures described in Section 3(d) or as otherwise agreed by the parties in writing. Ehave shall not refuse to accept a CHT Change request unless it is unable to make the Change requested using commercially reasonable efforts, in which event Ehave will provide an explanation to CHT; or Ehave and CHT fail to agree on the terms and conditions related to the performance of such Change, including the costs, if any. If a mutually acceptable resolution is not reached in respect of a CHT Change request, the Parties may submit the issue to mediation pursuant to Section 19(b). (d) Acceptance The criteria (\\\"Acceptance Criteria\\\") which the Ehave Companion Solution is to meet and the procedures by which such criteria are to be tested (\\\"Acceptance Procedures\\\") shall be set out in the Implementation Plan and shall follow the requirements set out in this Section 3(d). Once notified by Ehave that the Ehave Companion Solution is ready for acceptance testing, CHT shall perform the tests as set out in the Acceptance Procedures. Unless otherwise set out in the Acceptance Procedures, CHT shall have ten (10) Business Days to perform the acceptance tests as set out in the Acceptance Procedures and to provide Ehave written notice of acceptance or non-acceptance of the Ehave Companion Solution (the \\\"Acceptance Period\\\"). CHT shall not refuse to accept the Ehave Companion Solution unless all or one or more portions of the Solution fail to perform, in any material respect, in accordance with the Acceptance Criteria. Any notice of non- acceptance shall describe the material failure of the Ehave Companion Solution in reasonable detail and CHT shall provide Ehave with reasonably detailed documentation and explanations, together with underlying data, to substantiate the failure and to reasonably assist Ehave in its efforts to diagnose and correct the failure. If CHT gives notice to Ehave of non-acceptance of the Ehave Companion Solution then Ehave shall investigate the reported failure in good faith and correct same, and if the engagement is on a fixed fee basis at no additional cost to CHT, within fifteen (15) Business Days unless an extension is granted by CHT. If, within such fifteen (15) Business day period (or extended period, as applicable), Ehave corrects the failure, then Ehave shall give written notice to CHT certifying that the failure has been corrected, and another Acceptance Period of the same duration as the initial Acceptance Period shall begin and shall be governed by the provisions of this Section 3(d) upon delivery of the corrected Ehave Companion Solution to CHT. If the Acceptance Procedures were conducted three (3) times in respect of the initial implementation of the Ehave Companion Solution, and the eHAve Companion Solution failed to pass the Acceptance Criteria on the third (3rd) try, then, at the discretion of either Party, Ehave may continue to fix the problem, or terminate this Agreement in which case, CHT shall promptly return to Ehave all copies of the Ehave Companion Solution, including the Specifications and any other items delivered to CHT by Ehave thereunder and Ehave shall promptly refund to CHT any monies paid by CHT in respect of the initial development and implementation of the Ehave Companion Solution. If the Acceptance Procedures were conducted three (3) times in respect of a Change, and the Change failed to pass the Acceptance Criteria on the third (3rd) try, then, at the discretion of CHT, Ehave may continue to fix the problem, or terminate the performance of the development of the Change, in which case CHT shall promptly return to Ehave all copies of the Change, including the Specifications thereto and Ehave shall promptly refund to CHT any monies paid by CHT in respect of the development and implementation of the Change. 8. Source: EHAVE, INC., 20-F, 5/15/2019 (e) Deployment Once CHT provides Ehave written notice of acceptance, Ehave will deploy the Ehave Companion Solution or Change, as applicable, by putting the Ehave Companion Solution or Change into production in accordance with, and within the timelines set out, in the Implementation Plan or Change Request, as the case may be. (f) Branding The Ehave Companion Solution may, in the sole discretion of CHT, be branded, marketed, advertised, promoted and sublicensed under CHT Marks. For such purpose, CHT hereby grants to Ehave a non-exclusive, royalty-free, revocable, limited license during the Term and Transition-out Period and within the Territory to use, reproduce, publish and display the CHT Marks solely in connection with the operation of the Ehave Companion Solution for and on behalf of CHT and End Users. Ehave agrees that its use of any CHT Marks will comply with CHT's branding guidelines to the extent made available by CHT to Ehave from time to time and will enure to the benefit of CHT. The CHT Marks are proprietary to CHT and nothing in this Agreement constitutes the grant of a general license for their use. Other than as expressly set forth herein, Ehave does not acquire any right, title or interest in or to any CHT Marks or the goodwill associated therewith. CHT reserves any and all rights in and to the CHT Marks not expressly granted herein. 4. CHT DEVELOPMENTS (a) Development From time to time, CHT may request Ehave to develop functionality that is separate from, but interfaces with the Ehave Companion Solution (the \\\"CHT Developments\\\"). Any such development effort shall be subject to a separate services agreement between the Parties which will set out the respective obligations of the Parties regarding the development and deployment of any CHT Developments, including without limitation assignment or transfer of any rights that Ehave may have in such CHT Developments. (b) APIs If CHT desires a third party to develop any CHT Developments, Ehave shall provide to CHT the specifications of the application program interfaces to permit CHT or such other third party to develop the CHT Developments so that it may inter-operate with the Ehave Companion Solution. (c) License If CHT requires Ehave to host the CHT Developments, then CHT hereby grants to Ehave a royalty-free, non-exclusive, non-transferable, limited right and licence during the Term hereof to use the CHT Developments solely for the purpose of enabling its operation for CHT and its End Users' purposes. 5. GENERAL PERFORMANCE OBLIGATIONS (a) Marketing CHT shall, in good faith and at its own expense: (i) market, advertise, promote and re-license the use of the Ehave Companion Solution to End Users located in the Territory consistent with good business practice, provided that CHT shall have full discretion as to where in the Territory it chooses to do so at any time and from time to time; 9. Source: EHAVE, INC., 20-F, 5/15/2019 (ii) develop and execute a marketing plan sufficient to fulfil its obligations under this Agreement; (iii) have sufficient knowledge of the industry and solutions competitive with the Ehave Companion Solution (including specifications, features and benefits) so as to be able to explain in detail to the End Users: A. the material differences between the Ehave Companion Solution and competing solutions; and B. information on standard protocols and features of the Ehave Companion Solution; (iv) market, advertise, promote and provide the Ehave Companion Solution and conduct business in a manner that at all times reflects favourably on the Ehave Companion Solution and, subject to Section 3(f), the good name, goodwill and reputation of Ehave; and (v) maintain books, records and accounts of all transactions and activities covered by this Agreement and permit reasonable examination thereof by Ehave and its representatives in accordance with this Agreement. (b) Provision to End Users CHT shall require each End User to enter into and execute a subscription agreement in a form and substance satisfactory to Ehave and CHT, acting reasonably, and which contains provisions similar to Ehave's collaboration agreement for the use of the Ehave solution (the \\\"Subscription Agreement\\\"). Ehave shall be a third party beneficiary hereunder, but shall not have any obligations to the End User thereunder. (c) End User Data Pursuant to the Subscription Agreement, CHT shall obtain from each End User the right to and hereby grants, effective upon the execution and delivery of such End User's Subscription Agreement, to Ehave: (i) a royalty-free, non-exclusive, non-transferable, limited right and licence during the term of such Subscription Agreement to use, copy, store and display the End User Data solely for the purpose of enabling Ehave to operate the Ehave Companion Solution for such End User and as may be necessary for the purpose of enabling Ehave to provide support services in accordance with this Agreement; and (ii) a royalty-free, non-exclusive, limited, perpetual right and license to use, copy, store and display End User Data on an aggregated and anonymous basis and so as not to permit the identification of any End User or individual for the sole purpose of improving or developing enhancements to the Ehave Companion Solution , provided that Ehave shall not have any right to use, commercialize or exploit such End User Data in any other manner or for any other purpose. Except for the limited license expressly provided in Section 5(c), nothing contained in this Agreement shall be construed as granting to Ehave or any third party any right, title, or interest in or to any End User Data. Without limiting the foregoing, Ehave agrees that it shall not (i) modify, alter or commercially exploit any End User Data; or (ii) distribute or sell, rent, lease, license or otherwise make any End User Data available to any third party (other than the particular End User to whom the End User Data pertains and its Authorized Users). 10. Source: EHAVE, INC., 20-F, 5/15/2019 (d) Authority to Perform Under this Agreement Each Party shall, at its own expense, obtain and maintain required certifications, credentials, licences and permits necessary to conduct business in accordance with this Agreement. CHT shall obtain all necessary licenses, permits, certifications and credentials to conduct its business. (e) End User Support On and after the launch of the Ehave Companion Solution, CHT shall, at its own expense, ensure that an adequate number of trained, capable and qualified technical personnel with sufficient knowledge of the Ehave Companion Solution are available to provide first line support to assist End Users. If CHT's support personnel are unable to resolve any trouble tickets from an End User, CHT may escalate the trouble ticket to Ehave in accordance with the support procedures set out in Schedule \\\"3\\\". On and after the launch of the Ehave Companion Solution, Ehave shall ensure that an adequate number of trained, capable and qualified technical personnel with sufficient knowledge of the Ehave Companion Solution are available to provide support in accordance with the support procedures set out in Schedule \\\"3\\\". (f) Government Approval If, at any time during the Term, any notification, registration or approval is required to give legal effect in any applicable jurisdiction to this Agreement or the transactions contemplated under this Agreement, CHT shall: (i) immediately take whatever steps may be necessary to properly notify, register or obtain approval; (ii) be responsible for any charges incurred in connection with notifying, registering or obtaining this approval; and (iii) keep Ehave currently informed of its efforts regarding this Section 5(f). Ehave is not obligated to provide access to the Ehave Companion Solution in a particular jurisdiction under this Agreement until CHT has provided Ehave with satisfactory evidence that: (i) this approval, notification or registration is not required or that (ii) it has been obtained. At CHT's cost and expense, Ehave shall provide reasonable assistance and cooperation to CHT as CHT may reasonably request in its efforts to obtain or provide any such approval, notification or registration, provided that, CHT shall at all times retain full discretion as to where in the Territory it chooses to market, promote, advertise and/or sublicense the Ehave Companion Solution. (g) Prohibited Acts Notwithstanding anything to the contrary in this Agreement, neither CHT nor CHT personnel shall: (i) make any representations, conditions, warranties, guarantees, indemnities, similar claims or other commitments: A. actually, apparently or ostensibly on behalf of Ehave, or B. to any End User regarding the Ehave Companion Solution, which representations, conditions, warranties, guarantees, indemnities, similar claims or other commitments are additional to or inconsistent with any then-existing representations, conditions, warranties, guarantees, indemnities, similar claims or other commitments in this Agreement or any written or electronic documentation provided by Ehave to CHT; or 11. Source: EHAVE, INC., 20-F, 5/15/2019 (ii) engage in any unfair, competitive, misleading or deceptive practices respecting Ehave, Ehave's Trade-marks or the Ehave Companion Solution, including any product disparagement or \\\"bait-and-switch\\\" practices. 6. EHAVE COMPANION SOLUTION (a) Provision and Access to Ehave Companion Solution Once deployed, Ehave shall operate, support and maintain the Ehave Companion Solution in accordance with the terms of this Agreement, including the Support Procedures set out in Schedule \\\"3\\\", the Service Level Commitments set out in Schedule \\\"4\\\" and the Security Requirements set out in Schedule \\\"5\\\". Access to the Ehave Companion Solution may be through a secure connection with the public Internet. CHT acknowledges and agrees that Ehave is not responsible or liable for any communication over the public Internet. (b) Security Requirements Ehave shall implement and maintain those safeguards and controls set out in Schedule \\\"5\\\" to deter and for the detection, prevention and correction of any unauthorized intrusion, access or use of the Ehave Companion Solution, as well as to protect against any loss, theft or unauthorized access, use, disclosure, copying, or modification of End User Data. CHT acknowledges and agrees, and shall obtain such acknowledgement and agreement from its End Users, that notwithstanding the Security Requirements, such methods and procedures may not prevent unauthorized electronic intruders to access the Ehave Companion Solution through the Internet or through other form of electronic communication. If such unauthorized electronic intruders are able to bypass Ehave's security protocols, firewall and safeguards, such unauthorized electronic intruder may change, delete or otherwise corrupt the contents and data contained in the Ehave Server, including any End User Data. Except for the maintenance of appropriate firewall and safeguards in compliance with the Security Requirements, which are designed to frustrate access from unauthorized electronic intruders, Ehave shall not be liable to CHT or to any of its End users, and hereby disclaims responsibility, with respect to any action, destructive or otherwise, by any unauthorized electronic intruder. (c) Maintenance From time to time, it will be necessary for Ehave to perform maintenance on the Ehave Companion Solution. Such maintenance includes routine maintenance to ensure the continued provision of the Ehave Companion Solution or upgrading, updating or enhancing the Ehave Companion Solution. Ehave shall use its commercially reasonable efforts to perform such maintenance at such times within the designated maintenance windows set forth in Schedule \\\"3\\\" to minimize the impact of any downtime of the Ehave Platform to CHT and its End Users. To the extent Ehave is able, Ehave shall notify CHT at least 48 hours in advance of any scheduled maintenance by sending an email to the designated CHT Service Manager of the scheduled maintenance time and the anticipated duration of such maintenance. (d) Changes to Service Ehave may, at any time, with or without written notice (except in cases where such change may affect the manner in which the Services are delivered, in which case, Ehave shall use reasonable efforts to provide advance written notice, but in any event as soon as reasonably possible thereafter) to CHT (i) make changes to the Ehave Companion Solution that are necessary to comply with applicable safety, security or other statutory requirements or orders from applicable Governmental Authorities; (ii) supplement or make changes to its user documentation and to its rules of operations, access procedures, security and privacy procedures and policies, provided such changes do not materially adversely affect CHT or its End Users; and (iii) change the components, type and location of the Ehave Platform, provided that such changes do not adversely affect the performance, features, functionality or security of the Ehave Companion Solution. 12. Source: EHAVE, INC., 20-F, 5/15/2019 (e) Authentication IDs CHT shall, and shall require its End Users to, control and maintain the security of all Authentication IDs. As between CHT and Ehave, CHT shall be solely responsible for all instructions, commitments and other actions or communications taken under any of CHT's Authentication IDs. CHT shall promptly report to Ehave any errors or irregularities in the Ehave Companion Solution or the Ehave Platform or any unauthorized use of any part thereof that come to CHT's attention and inform Ehave immediately if CHT becomes aware that any Authentication ID becomes known to any third person who is not authorized to possess such password. (f) End User Data CHT acknowledges and agrees that Ehave: (i) will not be responsible for the accuracy, completeness or adequacy of any End User Data or the results generated from any End User Data uploaded to and processed by the Ehave Companion Solution in accordance with the Specifications; (ii) has no control over any End User Data or the results therefrom; (iii) does not purport to monitor End User Data; and (iv) shall not be responsible to back up or maintain any back up of the End User Data or portion thereof. (g) Viruses If Ehave, in its absolute discretion, forms the view that any End User Data or any other information or files uploaded by CHT or any of its End User and their Authorized Users contains or includes a Virus or is reasonably considered Objectionable Content, Ehave may remove such End User Data, information or file from the Ehave Companion Solution and take such other action as Ehave deems necessary to protect the integrity and operation of the Ehave Companion Solution. Any reasonable costs associated with such removal may be charged by Ehave to CHT. Ehave shall notify CHT of its actions under this Section 6(g) as soon as reasonably possible. 7. ROYALTIES AND PAYMENT (a) Royalties The Royalties and payment terms are as set out in Schedule \\\"6\\\". The Royalties do not include applicable taxes. CHT agrees to pay the Royalties and applicable taxes in accordance with the payment terms as set out in Schedule \\\"6\\\". (b) Taxes: CHT shall pay any and all applicable taxes, however designated or incurred, which are payable by it pursuant to Applicable Law as a result of or otherwise in connection with the transactions contemplated in this Agreement including, without limitation, federal, provincial and local, excise, sales, use, goods and services, harmonized, value added and any similar taxes, except for any taxes based on Ehave's net income. (c) Interest on Late Payments: Where CHT fails to pay any amount in accordance with the payment terms set out in Schedule \\\"6\\\", Ehave shall have the right, in addition to any other rights or remedies available to it, to charge, and CHT shall pay, interest on such overdue amounts at the rate of 1% per month calculated daily, compounded monthly (12.68% per annum) both before and after any court judgement in respect of the same from the date such payment was due. 13. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUDIT RIGHTS (a) Ehave Right to Audit CHT will provide Ehave and its representatives, auditors and inspectors (\\\"Auditor\", \"level\": 1, \"text\": \"8. AUDIT RIGHTS (a) Ehave Right to Audit CHT will provide Ehave and its representatives, auditors and inspectors (\\\"Auditors\\\") upon ten (10) Business Days prior written notice with reasonable access, during business hours, to all facilities, systems and assets used by CHT, to CHT personnel and subcontractors and to all relevant CHT books and records, in each case, to the extent relevant to this Agreement, in order to conduct appropriate audits, examinations and inspections (\\\"Audits\\\") to: (i) verify compliance with the requirements set out in this Agreement; and (ii) verify the Royalty calculations. (b) Principles Regarding Audits CHT shall provide to Ehave and its Auditors any assistance they may reasonably require to conduct such Audits. Audits may be conducted once a calendar year, provided that the foregoing limit shall not apply where an audit discovered an overcharge of 5% or more, in which case, Ehave may conduct another audit sooner. No period shall be audited more than once. Costs incurred by Ehave in connection with any audit or inspection conducted shall be borne by Ehave. Notwithstanding the foregoing, if an Audit reveals that CHT underpaid Ehave for any Royalties hereunder, by more than five percent (5%) of the total Royalties paid during the period being audited, CHT shall promptly reimburse Ehave for all reasonable third party expenses incurred by Ehave in connection with such Audit. In all cases CHT shall promptly pay Ehave in full for any underpayments revealed by an Audit. All information obtained by Ehave and its Auditors during any such Audit shall be kept confidential and shall be considered CHT's Confidential Information. Ehave shall impose confidentiality obligations on its Auditors that are substantially similar to those under Section 13 and shall be responsible for any breach of confidentiality by its Auditors. (c) Records CHT shall keep detailed records and books of account with supporting vouchers, invoices and other documentation showing all expenditures, charges and related calculations of whatsoever nature made by it in the performance of its obligations under this Agreement. CHT shall retain such records for the greater of: (i) three (3) years; or (ii) the period required by Applicable Laws. (d) Security Audit On an annual basis, Ehave shall conduct and provide CHT the results of an audit conducted in accordance with the Statement on Standards for Attestation Engagements (SSAE) No. 18, Service Organization Control (SOC) 2 Report type audit or similar audits in respect of its operations. Ehave shall also provide CHT written notice and detail of any deficiencies that Ehave's auditors (whether internal or external) found through the conduct of such audits and the remediation efforts that Ehave shall undergo to rectify such deficiencies. Ehave shall promptly rectify any deficiencies identified that may materially and adversely impact the Ehave Companion Solution or End User Data, and shall provide CHT with such information as CHT may reasonably request from time to time with respect to its security controls including any remediation efforts undertaken to rectify any deficiencies. 9. TERM This term of this Agreement and the rights and obligations of the Parties hereto shall commence as of the Effective Date and shall continue in perpetuity (the \\\"Term\\\"), unless terminated earlier in accordance with the provisions contained herein. 14. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUSPENSION AND TERMINATION (a) Suspension of Services\", \"level\": 1, \"text\": \"10. SUSPENSION AND TERMINATION (a) Suspension of Services: Subject to the provisions of this Section, in the event that CHT does not pay the Royalties or any portion thereof, when due, Ehave may immediately suspend CHT's and each of its End Users' right to access and use the Ehave Companion Solution. However, Ehave shall not suspend CHT's or its End Users' right to access and use the Ehave Companion Solution or any End User Data by reason of CHT's good faith withholding of any payment or amount, or in the event of any payment dispute between the parties arising under or concerning this Agreement, in each case, unless and until such dispute is resolved pursuant to Section 19, provided that CHT shall have a period of five (5) Business Days to pay any amount agreed to in settlement or determined by arbitration pursuant to Section 19 to be payable by it. (b) CHT's Right to Terminate: Subject to Sections 10(e) and 10(g), CHT may terminate this Agreement and the rights granted hereunder, in whole or in part, without prejudice to enforcement of any other legal right or remedy (including any express termination right set forth elsewhere in this Agreement), immediately upon giving written notice of such termination if Ehave: (i) breaches any material provision of this Agreement and such breach continues for a period of twenty (20) Business Days after delivery of a written notice by CHT requiring Ehave to correct such failure; or (ii) becomes or is adjudicated insolvent or bankrupt, admits in writing its inability to pay its debts as they mature, or makes an assignment for the benefit of creditors; or Ehave applies for or consents to the appointment of any receiver, trustee or similar officer for it or for all or any substantial part of its property; or such receiver, trustee or similar officer is appointed without the consent of Ehave; or Ehave institutes any bankruptcy, insolvency, reorganization, moratorium, arrangement, readjustment or debt, dissolution, liquidation or similar proceeding relating to it under the laws of any jurisdiction, or any such proceeding is instituted against Ehave and is not dismissed within sixty (60) Business Days; or any judgment, writ, warrant or attachment or execution of similar process is issued or levied against a substantial part of Ehave's property and remains unsatisfied for sixty (60) Business Days. In addition, CHT may terminate this Agreement and the rights granted hereunder, in whole or in part, and without prejudice to enforcement of any other legal right or remedy (including any express termination right set forth elsewhere in this Agreement), at any time without cause, by providing at least thirty (30) Business Days prior written notice to Ehave, but subject to payment of a termination fee equal to an amount set out in Schedule 6. (c) Ehave's Right to Terminate: Subject to Sections 10(e) and 10(g), Ehave may terminate this Agreement and the rights granted hereunder without prejudice to enforcement of any other legal right or remedy, immediately upon giving written notice of such termination if CHT: (i) fails to pay in full any sum owing by it under this Agreement by the due date thereof (other than any sum the payment of which is disputed by CHT in good faith and withheld pending resolution of such dispute in accordance with Section 19) and such failure continues for a period of ten (10) Business Days after delivery of a written notice by Ehave requiring CHT to correct such failure; 15. Source: EHAVE, INC., 20-F, 5/15/2019 (ii) breaches any other material provision of this Agreement and such breach continues for a period of twenty (20) Business Days after delivery of a written notice by Ehave requiring CHT to correct such failure; or (iii) becomes or is adjudicated insolvent or bankrupt, admits in writing its inability to pay its debts as they mature, or makes an assignment for the benefit of creditors; or CHT applies for or consents to the appointment of any receiver, trustee or similar officer for it or for all or any substantial part of its property; or such receiver, trustee or similar officer is appointed without the consent of CHT; or CHT institutes any bankruptcy, insolvency, reorganization, moratorium, arrangement, readjustment or debt, dissolution, liquidation or similar proceeding relating to it under the laws of any jurisdiction, or any such proceeding is instituted against CHT and is not dismissed within sixty (60) Business Days; or any judgment, writ, warrant or attachment or execution of similar process is issued or levied against a substantial part of CHT's property and remains unsatisfied for sixty (60) Business Days. (d) Waiver: The waiver by either Party of a breach or default of any provision of this Agreement by the other Party shall not be effective unless in writing and shall not be construed as a waiver of any succeeding breach of the same or of any other provision. Nor shall any delay or omission on the part of either Party to exercise or avail itself of any right, power or privilege by such Party shall constitute a waiver. (e) Effect of Termination: Upon the termination of this Agreement for any reason, subject to and without limiting the provisions of Section 12: (i) the Parties shall implement the Transition-Out Services pursuant to Section 10(f); (ii) at the end of the Transition-out Period (or earlier upon CHT's request) Ehave shall terminate and invalidate any Authentication IDs associated with CHT and any of its End Users; (iii) Ehave shall, but not earlier than twenty (20) Business Days after the later of termination or expiration of this Agreement or the Transition-out Period, destroy any copies of the End User Data contained in the Ehave Companion Solution and certify in writing to CHT that it has done so; (iv) CHT shall pay to Ehave the full amount of all Royalties payable hereunder as of the date of termination, if any, whether already invoiced or not (including any amounts due as late payment charges), and any other monies owing to Ehave hereunder; and (v) each Party will return to the other Party, or at the other Party's written request, destroy, in a secure manner all Confidential Information of the other Party which is then in its possession or control and certify in writing that it has done so. CHT acknowledges and agrees if any End User fails to download its End User Data from the Ehave Companion Solution in a timely manner (i.e. on or before the later of termination or expiry of this Agreement and the Transition-out Period), it may not have access to such information or such information may be destroyed by Ehave in accordance with the terms of this Section 10(e). Subject to Section 10(f), it is CHT's and each End User's responsibility to download and obtain all the End User Data on or prior to the termination of this Agreement or expiry of the Transition-out Period (whichever is later). Ehave shall have no responsibility for maintaining or providing to CHT or to any of its End Users the End User Data or any portion thereof, or any liability to CHT or any End User for destroying End User Data, in either case, from and after the twentieth (20th) Business Day after the termination or expiration of this Agreement or the Transition-out Period, whichever later. 16. Source: EHAVE, INC., 20-F, 5/15/2019 (f) Transition Assistance: Without limiting the provisions of Section 11, commencing on the delivery of any notice of termination of this Agreement, and continuing through the effective date of termination and for a period of sixty (60) Business Days thereafter (the \\\"Transition-out Period\\\"), Ehave will, to the extent requested by CHT, provide to CHT (or at CHT's request to CHT's End User) such reasonable cooperation, assistance and services to facilitate the orderly wind down, transition and migration and transfer of the End User Data from Ehave to CHT (the \\\"Transition-out Services\\\"). (g) Survival of Covenants: Notwithstanding the termination or expiration of this Agreement for any reason, the covenants set out in this Section 10(g) and in Sections 7(c), 10(e), 10(f), 11, 12, 13, 14(c), 15, 16, 17, 19, 20(a) and those provisions set out in Section 1 as necessary to interpret the foregoing provisions, of this Agreement shall survive any such termination or expiration. 11. OWNERSHIP (a) Ehave's Ownership CHT acknowledges and agrees that, as between CHT and Ehave, Ehave owns all worldwide right, title and interest, including all Intellectual Property Rights, in and to the Ehave Companion Solution, including any developments, enhancements or customizations made as a result of Section 3 and any modifications, enhancements, upgrades, updates or Customization subsequent to the development and implementation in accordance with Section 3, excluding, however, any CHT Developments. CHT does not acquire any rights, title or ownership interests of any kind whatsoever, express or implied, in any of the foregoing other than the licenses granted herein. (b) CHT's Ownership Ehave acknowledges and agrees that, as between Ehave and CHT, CHT owns all worldwide right, title and interest, including all Intellectual Property Rights, in and to the CHT Developments. Ehave does not acquire any rights, title or ownership interests of any kind whatsoever, express or implied, in any of the foregoing other than the licenses granted herein. Further, as between CHT and Ehave, (i) CHT (or its End User) is and will remain the sole and exclusive owner of all right, title, and interest in and to End User Data, including all Intellectual Property Rights therein and/or relating thereto, subject only to the limited license granted in Section 5(c), and (ii) End User Data and CHT Developments are and will be the Confidential Information of CHT. CHT and End Users shall at all times, including in the event of termination of this Agreement and for a period thereafter as set out in Section 10(e), have access to their respective End User Data and the ability to download and/or export their End User Data out of the Ehave Companion Solution. 17. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ESCROW (a) Escrow Agreement (i) Concurrently with execution of this Agreement or, at CHT's option, as soon as practicab\", \"level\": 1, \"text\": \"12. ESCROW (a) Escrow Agreement (i) Concurrently with execution of this Agreement or, at CHT's option, as soon as practicable after the Effective Date but in no event later than CHT's acceptance of and the launch of the Ehave Companion Solution, CHT and Ehave shall enter into a Source Code Escrow Agreement with a reputable software escrow agent mutually acceptable to the Parties (\\\"Escrow Agent\\\"), in or substantially in the form attached hereto as Schedule \\\"7\\\", or otherwise in a form acceptable to the Parties, acting reasonably, and to the Escrow Agent (the \\\"Escrow Agreement\\\"), providing for the release of the Source Code for the Software, as modified pursuant to Section 3 and all necessary programming documentation, utilities and tools used by Ehave to maintain the Software and to compile the source code into object code (excluding third party utilities and tools licensed by Ehave for which Ehave has not been granted the right to sublicense or otherwise make available such utilities and tools to third parties without additional charge, but including such information as necessary for CHT to obtain licenses to and obtain such third party utilities and tools), all in its then-existing form, to CHT, in the certain circumstances expressly stated in Section 12(b). The Escrow Agreement shall provide that the Software, including the Source Code and object code, Specifications and related documentation are and shall be deemed to be \\\"intellectual property\\\" and the rights under the Escrow Agreement and the license granted under Section 12(a)(iii) are deemed to be \\\"rights to use intellectual property\\\" for purposes of section 65.11(7) of the BIA and section 32(6) of the CCAA. (ii) Upon release of the Source Code by the Escrow Agent to CHT pursuant to the terms and conditions of the Escrow Agreement, Ehave hereby warrants that such Source Code and other materials are and will be the then current version of the Software as used by CHT in its provision to End Users of the eEhave Companion Solution under the Subscription Agreements and that Ehave shall throughout the Term keep the Source Code so deposited with the Escrow Agent current by periodically submitting material updates to the Escrow Agent from time to time, as necessary. Save and except for express warranties specified in this Agreement and the Escrow Agreement, Ehave specifically disclaims all other warranties, express or implied, including, without limitation, any warranty of merchantability and fitness for a particular purpose. (iii) In connection with the exercise of CHT's rights under the Escrow Agreement, Ehave hereby grants to CHT a non- exclusive, non-transferable (except as set forth in Section 20(f)), right and license to use and copy the materials deposited with the Escrow Agent, including the Source Code, its Specifications and documentation, and any resulting corrections, repairs, translations, enhancements, and other derivative works and improvements made by CHT, for the sole purposes of providing to CHT the ability to operate, support and maintain, the Ehave Companion Solution for its End Users from time to time, until such time that CHT is able to migrate off the Ehave Companion Solution, but in any event not exceeding twelve months from the date of release of the materials from escrow. CHT may use third parties to perform its foregoing rights, provided that any such third parties are not competitors of Ehave and shall be subject to confidentiality obligations. CHT expressly agrees, however, that CHT shall not exercise any of the foregoing right and license unless and until CHT obtains such Source Code from the Escrow Agent. CHT's obligations with respect to confidentiality and use of the Source Code shall be equivalent to CHT's obligations set forth in Section 13 of this Agreement. Notwithstanding any release of the Source Code pursuant to the provisions hereof, Ehave shall retain sole ownership of and other proprietary rights with respect to the Source Code (including any Source Code relating to any modifications made by CHT to the Source Code, all of which shall be owned by Ehave). CHT shall be responsible for all of the Escrow Agent's fees and charges under the Escrow Agreement. 18. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Release Conditions The parties acknowledge and agree that a \\\"Release Condition\\\" for purposes of the Escrow Agreement shall be deemed to mean any one or more of the following listed events (in addition to any other event specified as a release condition under the Escrow Agreement): (i) Ehave makes a general assignment for the benefit of creditors; (ii) Ehave voluntarily institutes any bankruptcy, insolvency, reorganization, moratorium, arrangement, readjustment or debt, dissolution, liquidation or similar proceeding relating to it under the laws of any jurisdiction, or any such proceeding is instituted against Ehave and is not dismissed within sixty (60) Business Days; or any judgment, writ, warrant or attachment or execution of similar process is issued or levied against a substantial part of Ehave's property and remains unsatisfied for sixty (60) Business Days; or Ehave applies for or consents to the appointment of any receiver, trustee or similar officer for it or for all or any substantial part of its property; or such receiver, trustee or similar officer is appointed without the consent of Ehave; (iii) Ehave consents to the filing of a petition of bankruptcy against it; (iv) a petition of bankruptcy is filed against Ehave which is not discharged within sixty (60) days; (v) Ehave becomes or is adjudicated by a court of competent jurisdiction as being bankrupt or insolvent or admits in writing its inability to pay its debts as they mature; Ehave ceases doing business as a going concern; (vi) Ehave undergoes a change of control or is a party to a merger or amalgamation; (vii) Ehave takes steps to dissolve, liquidate, wind up or otherwise terminate its existence; (viii) Ehave has terminated its provision of or ceased to provide the Ehave Companion Solution or support services for a continuing period of fifteen (15) Business Days or more, except pursuant to the termination of this Agreement by Ehave in accordance with its rights contained hrein. (c) Effect of Bankruptcy All of the Software, including the Source Code and object code, the Specifications and related documentation, and all other escrow deposit materials constitute \\\"intellectual property\\\" and all rights and licenses granted by Ehave to CHT under this Agreement or the Escrow Agreement (which is supplementary to this Agreement) are and shall be deemed to be licenses and \\\"rights to use intellectual property\\\" by CHT for the purposes of and as such terms are used and interpreted under section 65.11(7) of the BIA and section 32(6) of the CCAA. CHT shall have the right to exercise all rights and elections under the BIA and CCAA and all other applicable bankruptcy, insolvency and similar laws with respect to this Agreement, the Escrow Agreement and the subject matter hereof and thereof. Without limiting the generality of the foregoing, if Ehave or its estate becomes subject to any bankruptcy or similar proceeding subject to CHT's rights of election, all rights and licenses granted to CHT under this Agreement and the Escrow Agreement will continue subject to the respective terms and conditions hereof and thereof, and will not be affected, even by Ehave's rejection of this Agreement or the Escrow Agreement. 19. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY (a) Obligation\", \"level\": 1, \"text\": \"13. CONFIDENTIALITY (a) Obligation: Each Party acknowledges that all Confidential Information consists of confidential and proprietary information of the disclosing Party. Each Party shall, and shall cause its employees, agents and contractors to hold Confidential Information of the other Party in confidence, and shall use the same degree of care by instruction, agreement or otherwise, to maintain the confidentiality of the other Party's Confidential Information that it uses to maintain the confidentiality of its own Confidential Information, but with at least a reasonable degree of care commensurate with the nature and importance of such Confidential Information. Each Party agrees not to make use of Confidential Information other than for the exercise of rights or the performance of obligations under this Agreement (and the Source Code Escrow Agreement), and not to release, disclose, communicate it or make it available to any third person other than employees, agents and contractors of the Party who reasonably need to know it in connection with the exercise of rights or the performance of obligations by such Party under this Agreement (and the Source Code Escrow Agreement) and who are bound by confidentiality and restricted use obligations at least as protective of the Confidential Information as those set forth herein. Each Party agrees to notify the other Party in writing promptly of any loss or unauthorized disclosure or use of such other Party's Confidential Information and cooperate with such other Party to protect the confidentiality and ownership of all Intellectual Property Rights and other rights therein. (b) Subpoena: In the event that any Party receives a request to disclose all or any part of the Confidential Information of the other Party under the terms of a valid and effective subpoena or order issued by a court of competent jurisdiction or by a Governmental Authority, such Party agrees to (i) immediately notify the other Party of the existence, terms and circumstances surrounding such a request; (ii) consult with the other Party on the advisability of taking legally available steps to resist or narrow such request; and (iii) if disclosure of such Confidential Information is required, exercise its commercially reasonable efforts to obtain, and/or assist the other Party to obtain, at the other Party's expense, an order or other reliable assurance that confidential treatment will be accorded to such portion of the disclosed Confidential Information which the other Party so designates. (c) Injunctive Relief: Each Party acknowledges and agrees that any unauthorized use or disclosure by it of any of the other Party's Confidential Information, in whole or part, will cause irreparable damage to the disclosing Party, that monetary damages would be an inadequate remedy and that the amount of such damages would be extremely difficult to measure. The receiving Party agrees that the disclosing Party shall be entitled to seek temporary and permanent injunctive relief to restrain the receiving Party from any unauthorized disclosure or use. Nothing in this Agreement shall be construed as preventing the disclosing Party from pursuing any and all remedies available to it for a breach or threatened breach of a covenant made in this Section 13, including the recovery of monetary damages from the receiving Party. 20. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS, WARRANTIES AND DISCLAIMERS (a) Mutual Representations of the Parties\", \"level\": 1, \"text\": \"14. REPRESENTATIONS, WARRANTIES AND DISCLAIMERS (a) Mutual Representations of the Parties: Each Party represents to the other that: (i) it is a company duly organized, validly existing and in good standing under the laws of its incorporation and it has full power and authority to enter into this Agreement and to perform each and every covenant and agreement herein contained; (ii) this Agreement has been duly authorized, executed and delivered by it and constitutes a valid, binding and legally enforceable agreement of it; (iii) the execution and delivery of this Agreement, and the performance of the covenants and agreements herein contained, are not, in any manner or to any extent, limited or restricted by, and are not in conflict with, any commercial arrangements, obligations, contract, agreement or instrument to which it is either bound or subject; and (iv) the execution and delivery of this Agreement and the performance of its covenants and agreements herein contained shall comply in all respects with all laws and regulations to which it or its business is subject. (b) Additional representations of Ehave: Ehave represents to CHT that Ehave possesses the knowledge, skill and experience necessary for the provision and completion of the Ehave Companion Solution in accordance with the terms of this Agreement. (c) Warranties Ehave warrants that for the duration of the Term, (i) the Ehave Companion Solution will substantially conform to and operate in accordance with, and have the functions and features set out in, the Specifications, and any related documentation provided by Ehave, and any such documentation shall be complete and accurate in all material respects; and the Ehave Companion Solution will not contain any material undocumented feature; (ii) Ehave has implemented and will maintain industry standard protection for the detection, protection and removal of Viruses; (iii) Ehave will perform all services under this Agreement in a timely, professional and workmanlike manner using personnel of required skill, experience and qualifications, and will devote adequate resources to meet its obligations (including the Service Level Commitments and its support obligations) hereunder; (iv) it has or will have all necessary right, power and authority, including all licenses and Intellectual Property Rights required, to provide and operate the Ehave Companion Solution and to grant all rights and licenses granted or required to be granted by it under this Agreement; and (v) Ehave is not aware of any infringement or misappropriation claims by any third party in relation to the Ehave Companion Solution. 21. Source: EHAVE, INC., 20-F, 5/15/2019 (d) Exclusion of Other Warranties: Except as otherwise expressly stated in this Agreement, there are no express or implied warranties or conditions in relation to the Ehave Companion Solution that are the subject matter of this Agreement, including implied warranties or conditions of merchantable quality, fitness for a particular purpose, or non-infringement, or that the Ehave Companion Solution will meet CHT's or any End Users' needs or will be available for use at any particular time or will be error free. Under no circumstances will Ehave be liable for the results of CHT or any of its End Users' misuse of the Ehave Companion Solution, including any use contrary to Applicable Law. 15. INSURANCE (a) Required Insurance: Both Parties shall, at all times during the currency of this Agreement and for a period of one (1) year after the termination or expiration of this Agreement, maintain the following policies of insurance in effect: (i) a comprehensive general liability insurance policy, with minimum coverage of $1,000,000 per occurrence and in the annual aggregate for product liability and completed operations, covering bodily and personal injury, including death, and property damage, including loss of use; and (ii) an information and network technology blended liability insurance policy with an insured limit of at least $1,000,000 in the aggregate. (b) Evidence of Insurance: Upon the execution of this Agreement or at any time at a Party's request during the term of this Agreement, the other Party shall provide the requesting Party with evidence of the aforementioned insurance coverage in the form of a certificate of insurance acceptable to the requesting Party. In the event of any material change or cancellation of the required insurance policies, the applicable Party will provide the other Party with thirty (30) calendar days' prior written notice and will promptly replace such insurance policy in accordance with this Section 15, without lapse in coverage. 16. INDEMNITIES (a) Intellectual Property Indemnity Ehave shall defend at its own expense any claim, proceeding or suit (a \\\"Claim\\\") brought against CHT and/or any of its directors, officers, employees, agents, subcontractors, affiliates and/or End Users (collectively, the \\\"CHT Indemnified Parties\\\") to the extent such Claim alleges that the Ehave Companion Solution furnished hereunder or the use thereof by CHT or its End Users as authorized hereunder or in any Subscription Agreement infringes any copyright, Canadian patent, or registered trademark of a third person, and will indemnify and hold harmless the CHT Indemnified Parties from and against any and all related liabilities, costs, losses, damages and expenses (including reasonable legal fees) arising out of or in connection with or relating to any such Claim, provided that: (i) Ehave is given prompt written notice of the Claim or of any allegations or circumstances known to CHT which could reasonably result in a Claim; (ii) Ehave is given all reasonable information and assistance from CHT, at Ehave's expense, which Ehave may require to defend the Claim; 22. Source: EHAVE, INC., 20-F, 5/15/2019 (iii) Ehave is given sole control of the defence of the Claim, and all negotiations for the settlement or compromise thereof, provided that Ehave shall promptly engage competent counsel and initiate defence in a professional manner and CHT may observe or participate in such proceedings with its own counsel at its own expense; and (iv) the alleged infringement does not result from any non-permitted uses, alterations, modifications or enhancements carried out by CHT, any End User or on its or their behalf by a third person (other than any Ehave personnel or contractors). If such Claim has occurred, or in Ehave's opinion is likely to occur, without limiting Ehave's obligation to defend and indemnify the CHT Indemnified Parties as aforesaid, Ehave may, at its option and expense, either procure for CHT the right to continue using the Ehave Companion Solution in accordance with this Agreement or modify or replace the same so that it becomes non-infringing without loss of functionality, or if none of the foregoing alternatives is reasonably available and at Ehave's discretion, discontinue the use of the Ehave Companion Solution on not less than sixty (60) Business Days' prior written notice to CHT and its End Users. The foregoing states the entire obligations of Ehave with respect to any infringement of Intellectual Property Rights of any third Person. (b) CHT' Indemnity CHT shall defend at its own expense any Claim brought against Ehave, its affiliates, directors, officers, employees and agents, to the extent such Claim: (i) alleges, directly or indirectly, that any End User Data infringes any Canadian copyright, patent or registered trademark of a third person; alleges, directly or indirectly, that the End User Data contains any Objectionable Content; (ii) arises through a breach by CHT of its obligations set out in Section 5(g); or (iii) is in relation to any of its End Users' use of the Ehave Companion Solution, including contrary to Applicable Law, except however to the extent as Ehave has indemnified CHT pursuant to Section 16(a); provided that CHT is given: (i) prompt written notice of the Claim or of any allegations or circumstances known to Ehave which could result in a Claim; (ii) all reasonable information and assistance from Ehave, at CHT's expense, which CHT may require to defend the Claim; and (iii) sole control of the defence of the Claim, and all negotiations for its settlement or compromise thereof. 17. LIMITATION OF LIABILITY (a) Consequential Damages Subject to Section 17(c), in no event shall either Party be liable to the other for any consequential, incidental, exemplary or punitive damages even if advised in advance of the possibility of such damages. Further, subject to Section 17(c), neither Party shall not be liable to the other Party for any lost revenue, lost profit or lost savings. (b) Limitation of Direct Damages Subject to Section 17(c), in no event shall either Party's liability under this Agreement exceed the aggregate of all amounts paid under this Agreement and amounts that have accrued but not yet been paid in the twelve (12) months preceding the event giving rise to the claim. 23. Source: EHAVE, INC., 20-F, 5/15/2019 (c) Exceptions to Limitations Notwithstanding Sections 17(a) and 17(b), neither Party excludes or limits any liability for: (i) personal injury or death to the extent that such injury or death results from the negligence or wilful misconduct of a Party or its employees or subcontractors; (ii) fraud, fraudulent misrepresentation or fraudulent concealment; (iii) the Party's obligations set out in Sections 2(c), 5(b), 5(c), 6(b), 11, 13 or 16; (iv) CHT's payment obligations under Section 7; or (v) willful misconduct or gross negligence. (d) Application of Limitations and Exclusions The limitations and exclusions set out in this Section shall apply whether a claim, demand or action is based in contract, tort (including negligence), or otherwise. 18. FORCE MAJEURE Except for any obligation to make payments, any delay or failure of either Party to perform its obligations under this Agreement or under any Schedule attached hereto shall be excused if, and to the extent, that the delay or failure is caused by an event or occurrence beyond the reasonable control of the Party and without its fault or negligence and that could not have been prevented or avoided by the exercise of reasonable due diligence, such as, by way of example and not by way of limitation, acts of God, action by any Governmental Authority (whether valid or invalid), fires, flood, wind storms, explosions, riots, natural disasters, wars, terrorist acts, sabotage, labour problems (including lock-outs, strikes and slow downs, except for any labour problems of the Party claiming a force majeure event), or court order or injunction; provided that written notice of delay (including anticipated duration of the delay) shall be given by the affected Party to the other Party within two (2) Business Days of the affected Party first becoming aware of such event and the affected Party shall use diligent efforts to end the failure or delay and minimize the effects of such force majeure event. In the event that the force majeure event lasts for fifteen (15) Business Days or longer, either Party shall have the option to terminate this Agreement upon written notice to the other without liability. 19. DISPUTE RESOLUTION (a) Discussions: Each Party agrees to utilize all reasonable efforts to resolve any dispute, whether arising during the term of this Agreement or at any time after the expiration of termination of this Agreement, which touches upon the validity, construction, meaning, performance or effect of this Agreement or the rights and liabilities of the Parties or any matter arising out of or connected with this Agreement, promptly and in an amicable and good faith manner by negotiations between the Parties. 24. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Mediation: Either Party may submit a dispute to mediation by providing written notice to the other Party. In the mediation process, the Parties will try to resolve their differences voluntarily with the aid of a single, impartial mediator, who shall attempt to facilitate negotiations. The mediator shall be selected by agreement of the Parties. If the Parties cannot otherwise agree on a mediator within five (5) Business Days, a single mediator shall be designated by the ADR Institute of Canada, Inc. or any successor organization (\\\"ADR\\\") at the request of a Party. Any mediator so designated must not have a conflict of interest with respect to any Party. The mediation shall be conducted as specified by the mediator and agreed upon by the Parties. The Parties agree to discuss their differences in good faith and to attempt, with the assistance of the mediator, to reach an amicable resolution of the dispute. The mediation shall be treated as a settlement discussion and therefore shall be confidential. The mediator may not testify for either Party in any later proceeding relating to the dispute. No recording or transcript shall be made of the mediation proceedings. Each Party shall bear its own costs and legal fees in the mediation. The Parties shall share the fees and expenses of the mediator equally. (c) Arbitration: Subject to Section 19(d), any dispute that has proceeded through mediation established in Section 19(b) without resolution may be submitted to arbitration. Any arbitration conducted pursuant to this Agreement shall take place in the City of Toronto, Ontario. The costs of the arbitration shall be borne equally by the Parties or as may be specified in the arbitrator's decision. The provisions of the Arbitration Act of Ontario, as amended, except as otherwise provided in this Agreement shall govern the arbitration process. The Parties agree to exclude the appeal provisions of the Arbitration Act, as may be amended from time to time, and in particular, section 45 thereof. The determination arising out of the arbitration process shall be final and binding upon the Parties to the arbitration. (d) Exceptions to Arbitration: The following matters shall be excluded from arbitration under this Agreement: (i) any disputes involving third Persons; (ii) breach of confidentiality by either Party; and (iii) intellectual property claims, whether initiated by third Persons or by one of the Parties to this Agreement. 20. MISCELLANEOUS (a) Notice: Every notice or other communication hereunder shall be deemed to have been duly given and made if in writing and if served by personal delivery upon the Party for whom it is intended, if delivered by registered or certified mail, return receipt requested, or by a national courier service, or if sent by fax (receipt of which is confirmed) to the Person at the address set forth below, or such other address as may be designated in writing hereafter, in the same manner, by such Person: To: Ehave To: CHT 277 Lakeshore Road E 1 Scarsdale Road Suite 203 Oakville, Ontario Toronto, Ontario Canada Canada L6J 6J3 M3B 2R2 Attention: Prateek Dwivedi, President & CEO Attention: Scott Woodrow, CEO Any such notification shall be deemed delivered (a) upon receipt, if delivered personally, (b) on the next Business Day, if sent by national courier service for next Business Day delivery or if sent by fax. Any correctly addressed notice or last known address of the other Party that is relied on herein that is refused, unclaimed, or undeliverable because of an act or omission of the Party to be notified as provided herein shall be deemed effective as of the first date that said notice was refused, unclaimed, or deemed undeliverable by the postal authorities by mail, through messenger or commercial express delivery services. 25. Source: EHAVE, INC., 20-F, 5/15/2019 (b) Modifications: The Parties may modify this Agreement only upon written agreement. (c) Further Assurances: Each Party shall take such action (including, but not limited to, the execution, acknowledgement and delivery of documents) as may reasonably be requested by the other Party for the implementation or continuing performance of this Agreement. (d) Relationship: The Parties are independent contractors and no other relationship is intended. Nothing herein shall be deemed to constitute either Party as an agent, representative or employee of the other Party, or both Parties as joint venturers or partners for any purpose. Neither Party shall act in a manner that expresses or in a manner that expresses or implies a relationship other than that of independent contractor. Each Party shall act solely as an independent contractor and shall not be responsible for the acts or omissions of the other Party. Neither Party will have the authority or right to represent nor obligate the other Party in any way except as expressly authorized by this Agreement. (e) Enurement: This Agreement shall enure to the benefit of and be binding upon each of the Parties hereto and their permitted successors and assigns. (f) No Assignment: Neither this Agreement nor any rights or obligations hereunder shall be assignable by a Party without the prior written consent of the other Party, provided that either Party shall have the right, on notice to but without the other Party's consent, to assign this Agreement and its rights and obligations contained herein, to an affiliate or to a third party who is not a competitor of the other Party in connection with a sale of all or substantially all of the assigning Party's business or assets relating to this Agreement. (g) Counterparts and Facsimile Execution and Delivery: This Agreement may be executed in counterparts, each of which shall be deemed to be an original and both of which together shall constitute one and the same instrument. To evidence its execution of an original counterpart of this Agreement, a Party may send a copy of its original signature on the execution page hereof to the other Party by facsimile transmission or email and such transmission shall constitute delivery of an executed copy of this Agreement to the receiving Party as of the date of receipt thereof by the receiving Party or such other date as may be specified by the sending Party as part of such transmission. (h) Language: It is the Parties desire and agreement that this Agreement and all Exhibits and associated documentation be drafted in English. Les Parties conviennent que la pr\u00e9sente convention et tous les documents s'y rattachant, soient r\u00e9dig\u00e9s en anglais. 26. Source: EHAVE, INC., 20-F, 5/15/2019 IN WITNESS WHEREOF, each Party hereto has caused this Agreement to be duly executed as of the date first written above by an officer authorized in that behalf. EHAVE, INC. COMPANION HEALTHCARE TECHNOLOGIES CORP per: /s/ Prateek Dwivedi per: /s/ Scott Woodrow Name: Prateek Dwivedi Name: Scott Woodrow Title: Chief Executive Officer Title: Chief Executive Officer 27. Source: EHAVE, INC., 20-F, 5/15/2019\"}}, {\"id\": \"party:EHAVE, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"EHAVE, INC.\", \"role\": \"Chief Executive Officer\", \"address\": \"277 Lakeshore Road E Suite 203 Oakville, Ontario Canada L6J 6J3\"}}, {\"id\": \"party:COMPANION HEALTHCARE TECHNOLOGIES CORP\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"COMPANION HEALTHCARE TECHNOLOGIES CORP\", \"role\": \"Chief Executive Officer\", \"address\": \"1 Scarsdale Road Toronto, Ontario Canada M3B 2R2\"}}, {\"id\": \"term:Acceptance Criteria\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Acceptance Criteria\", \"text\": \"has the meaning ascribed to it in Section 3(d).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Acceptance Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Acceptance Period\", \"text\": \"has the meaning ascribed to it in Section 3(d).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Acceptance Procedures\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Acceptance Procedures\", \"text\": \"has the meaning ascribed to it in Section 3(d).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"means this license and reseller agreement and all Schedules, Appendixes and Exhibits attached hereto.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Applicable Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicable Laws\", \"text\": \"means any and all (i) laws, statutes, rules, regulations, by laws, codes, treaties, constitutions and ordinances, including Privacy Legislation (\\\"Laws\\\"), (ii) order, directive, judgment, decree, award or writ of any court (including a court of equity), arbitrator or arbitration panel, or any Governmental Authority or other body exercising adjudicative, regulatory, judicial or quasi-judicial powers, including any stock exchange (\\\"Orders\\\"), and (iii) policies, guidelines, standards, requirements, notices and protocols of any Governmental Authority (\\\"Policies\\\"); which are applicable to or govern CHT, Ehave or the transactions contemplated by this Agreement.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Authentication ID\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Authentication ID\", \"text\": \"means a security mechanism by which an Authorized User identifies herself or himself to the Ehave Companion Solution and gains access thereto, which security mechanism may include user identification, passwords, digital certificates or any other similar process mechanism for authentication and recognition as determined by Ehave from time to time.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Authorized User\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Authorized User\", \"text\": \"means an individual who an End User has authorized to access and use CHT's services, which includes the use of the Ehave Companion Solution.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"means any calendar day except for Saturday or Sunday or any statutory holiday observed in the Province of Ontario.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:CHT Developments\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CHT Developments\", \"text\": \"has the meaning ascribed to it in Section 4(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:CHT Indemnified Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CHT Indemnified Parties\", \"text\": \"has the meaning ascribed to it on Section 16(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:CHT Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CHT Marks\", \"text\": \"means the names, trademarks, trade names, service marks, designs and logos of CHT.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Claim\", \"text\": \"has the meaning ascribed to it in Section 16(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Competitive Transaction\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Competitive Transaction\", \"text\": \"has the meaning ascribed to it in Section 2(d).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"means this Agreement, the Ehave Companion Solution, End User Data and all ideas, designs, business models, databases, drawings, documents, diagrams, formulas, test data, marketing, financial or personnel data, sales information, customer or supplier information, including information provided by such customers or suppliers, or any other information already furnished and to be furnished or made available by one Party to the other, whether in oral, written, graphic or electronic form including any such information exchanged during informational sessions designated as confidential, including, without limitation, information concerning a Party's actual and potential customers and other Intellectual Property Rights of such Party, provided, however, that Confidential Information shall not include any data or information: (i) that, at the time of disclosure, is in or, after disclosure, becomes part of the public domain, through no act or failure on the part of the receiving Party, whether through breach of this Agreement or otherwise; (ii) that, prior to disclosure by the disclosing Party, was already in the possession of the receiving Party, as evidenced by written records kept by the receiving Party in the ordinary course of its business, or as evidenced by proof of actual prior use by the receiving Party; (iii) independently developed by the receiving Party, by Persons having no direct or indirect access to the disclosing Party's Confidential Information provided that the receiving Party provides clear and convincing evidence of such independent development; (iv) which, subsequent to disclosure, is obtained from a third Person: (A) who is lawfully in possession of such information; (B) who is not in violation of any contractual, legal, or fiduciary obligation to either Party, as applicable, with respect to such information; and (C) who does not prohibit either Party from disclosing such information to others; or (v) is further disclosed with the prior written consent of the disclosing Party, but only to the extent of such consent.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"means the date first written above.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Ehave Companion Solution\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ehave Companion Solution\", \"text\": \"means the Ehave Platform, as modified, adapted and customized, as provided herein, the specifications of which are set out in Schedule \\\"1\\\".\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Ehave Platform\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ehave Platform\", \"text\": \"means the Software, Ehave Server and such devices and peripherals physically located with the Ehave Server, including all computer hardware, software, network elements, and electrical and telecommunications infrastructure located behind the Point of Access.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Ehave Server\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ehave Server\", \"text\": \"means that computer server located at Ehave's premises, or a third party provider of hosting and/or network services, that houses the Software.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:End User\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User\", \"text\": \"means CHT's customers who have entered into a subscription agreement with CHT for CHT services, which services include the use of the Ehave Companion Solution.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:End User Data\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User Data\", \"text\": \"means collectively any data, files, documentation or other information (including personal information) that an End User or any of its Authorized Users may: (i) upload to the Ehave Companion Solution; and/or (ii) have processed through the use of the Ehave Companion Solution, and includes any data or output resulting from or derived from such use.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Escrow Agent\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Escrow Agent\", \"text\": \"has the meaning ascribed thereto in Section 12(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Escrow Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Escrow Agreement\", \"text\": \"has the meaning ascribed thereto in Section 12(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Field of Use\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Field of Use\", \"text\": \"means indications and outcomes related to any companion and other animals.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Governmental Authority\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Governmental Authority\", \"text\": \"means any domestic, foreign or supranational government, whether federal, provincial, state, territorial or municipal; and any governmental agency, ministry, department, tribunal, commission, bureau, board or other instrumentality, including international institutions, exercising or purporting to exercise legislative, judicial, regulatory or administrative functions of, or pertaining to, government.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Implementation Plan\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Implementation Plan\", \"text\": \"has the meaning ascribed to it in Section 3(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property\", \"text\": \"means any property, tangible or intangible, that may be subject to Intellectual Property Rights, including without limitation, ideas, formulae, algorithms, concepts, techniques, processes, procedures, approaches, methodologies, plans, systems, research, information, documentation, data, data compilations, specifications, requirements, designs, diagrams, programs, inventions, technologies, software (including its source code), tools, products knowledge, know-how, including without limitation, trade secrets, and other materials or things.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Intellectual Property Rights\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property Rights\", \"text\": \"means (a) any and all proprietary rights anywhere in the world provided under (i) patent law; (ii) copyright law, including moral rights; (iii) trademark law; (iv) design patent or industrial design law; (v) semiconductor chip or mask work law; (vi) trade secret law; (vii) privacy law; or (viii) any other statutory provision or common law principle applicable to this Agreement which may provide a right in either (A) Intellectual Property; or (B) the expression or use of Intellectual Property; and (b) any and all applications, registrations, licenses, sub-licenses, franchises, agreements or any other evidence of a right in any of the foregoing.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Objectionable Content\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Objectionable Content\", \"text\": \"means content that infringes any Applicable Laws or third party rights, and content which is obscene, indecent, pornographic, seditious, defamatory, threatening, liable to incite racial hatred, menacing, blasphemous, misleading, deceptive or in breach of any person's Intellectual Property Rights.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"means either Ehave or CHT; and \\\"Parties\\\" means both of them.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Person\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Person\", \"text\": \"means any individual, estate, sole proprietorship, firm, partnership, unincorporated association, unincorporated syndicate, unincorporated organization, limited liability company, corporation, body corporate, trustee, trust, Governmental Authority or other entity or organization and includes any successor to any of the foregoing.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Point of Access\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Point of Access\", \"text\": \"means Ehave's, or its subcontractor's, border router, which is used to establish connectivity from the Ehave Platform to Ehave's, or its subcontractor's, Internet provider, or the public Internet.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Royalties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Royalties\", \"text\": \"means the fees, charges and other amounts to be paid by CHT to Ehave for the rights granted hereunder and which amounts are set out in Schedule \\\"6\\\".\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Security Requirements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Security Requirements\", \"text\": \"means those safeguards and controls set out in Schedule \\\"5\\\".\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"means Ehave's proprietary patient and data management software and any related documentation, as modified for use in the animal (including companion animal) and veterinary industry.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Source Code\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Source Code\", \"text\": \"means the human-readable form of a computer instruction, including, but not limited to, related system documentation, flow charts, all comments and any procedural code and a description of the procedure for generating object code, all of a level sufficient to enable a programmer reasonably fluent in the programming language in which the Software was written to understand, build, operate, support, maintain and develop modifications, upgrades, updates, adaptations, enhancements, new versions, and other derivative works and improvements of, and to develop computer programs compatible with, the Software.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Specifications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specifications\", \"text\": \"has the meaning ascribed to it in Section 3(a).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Subscription Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Subscription Agreement\", \"text\": \"has the meaning ascribed to it in Section 5(b).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"has the meaning ascribed to it in Section 9.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"means any jurisdiction in the World where the use of the Ehave Companion Solution for the intended purpose herein is permitted under Applicable Law.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Transition out Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Transition out Period\", \"text\": \"has the meaning ascribed to it in Section 10(f).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Transition-out Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Transition-out Services\", \"text\": \"has the meaning ascribed to it in Section 10(f).\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"term:Virus\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Virus\", \"text\": \"means a piece of code usually (but not necessarily) disguised as something else that causes some unexpected and, for the victim, usually undesirable, event and which is designed so that it may automatically spread to other computer users; the term 'Virus' will also be deemed to include worms, cancelbots, trojan horses, harmful contaminants (whether self-replicating or not) and nuisance causing or otherwise harmful applets.\", \"definition_clause\": \"Exhibit 4.44\"}}, {\"id\": \"value:$500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$500,000\"}}, {\"id\": \"value:ten (10) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) Business Days\"}}, {\"id\": \"value:fifteen (15) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) Business Days\"}}, {\"id\": \"value:1% per month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"1% per month\"}}, {\"id\": \"value:12.68% per annum\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"12.68% per annum\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:five percent (5%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"five percent (5%)\"}}, {\"id\": \"value:three (3) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) years\"}}, {\"id\": \"value:five (5) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) Business Days\"}}, {\"id\": \"value:twenty (20) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) Business Days\"}}, {\"id\": \"value:sixty (60) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) Business Days\"}}, {\"id\": \"value:thirty (30) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) Business Days\"}}, {\"id\": \"value:twelve months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve months\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000\"}}, {\"id\": \"value:thirty (30) calendar days'\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) calendar days'\"}}, {\"id\": \"value:sixty (60) Business Days'\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) Business Days'\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"value:two (2) Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) Business Days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.17\", \"level\": 1, \"text\": \"Exhibit 10.17 Supply Agreement - FUSION CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH \\\"[***]\\\". SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. SUPPLY AGREEMENT (\\\"Supply Agreement\\\") effective as of the date of last signing (\\\"Effective Date\\\") between Centre for Probe Development and Commercialization, a not-for-profit research and services institution with offices located at McMaster University, Nuclear Research Building, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1, (\\\"CPDC\\\"), and FUSION Pharmaceuticals Inc. (\\\"FUSION\\\"), having a place of business at 270 Longwood Road South, Hamilton, Ontario, Canada, L8P 0A6, (together the \\\"Parties\\\" each a \\\"Party\\\"). This document defines the terms and conditions under which CPDC will provide FUSION the Product outlined in this Supply Agreement. This Supply Agreement is conducted under the general provisions of the Master Services Agreement and the Quality Agreement entered into between the PARTIES. Unless explicitly stated within this Supply Agreement should there be discrepancies between the Supply Agreement and the Master Services Agreement, then the Master Services Agreement will be the controlling document. 1. \\\"Products\\\": 1.1 Ac-225 FPI-1434 1.2 [***] 1.3 The specifications for the Products are further defined in Schedule 2. 2. Definitions Accordingly, FUSION hereby engages CPDC, and CPDC hereby accepts such engagement, to supply Products for the Territory in connection with FUSION'S Clinical Trials. The Products shall be manufactured by CPDC at the location in its cGMP facilities in the Nuclear Research Building (NRB) and on the campus of McMaster University in Hamilton, Ontario, Canada, established for this purpose pursuant to Deliverables defined within Supply Agreement. For the avoidance of doubt, it shall be the responsibility of FUSION or its designate to file, obtain and maintain any Investigational New Drug (IND) applications, registrations, listings, authorizations and approvals, as the Regulatory Authority may require to enable use of Product in Clinical Trials, and provide CPDC with all particulars thereof and developments thereunder. Both Parties acknowledge that at the time of signing this Supply Agreement that the CPDC is subject to a supply restriction to the United States of America (the \\\"USA\\\") due to and Import Alert 66-40 (the \\\"Import Alert\\\") issued by the FDA. 3.2 Production Orders. From time to time during the Term set forth in Section 6 of this Supply Agreement, FUSION and CPDC will agree to binding Production Orders for Products, as follows: (a) Based on a template order form for such Production Orders provided by CPDC to FUSION, FUSION shall complete the Production Order in such form [***] no later than (a) the order cut-off period for the third-party isotope providers (\\\"Minimum Lead Time\\\"). \u2022 In the case of [***] the isotope order cut-off is [***] eastern standard time the week prior to isotope delivery Page 2 of 13 CONFIDENTIAL Supply Agreement - FUSION \u2022 In the case of Actinium-225 the isotope order cut-off is [***] eastern standard time the week prior to isotope delivery. (b) CPDC will respond, by email, the acceptance or rejection of each duly completed Production Order within [***] of receipt of such Production Order (an 'Accepted Production Order\\\" or \\\"Rejected Production Order,\\\" respectively). If there is no response to a Production Order within such timeline, it shall be considered an Accepted Production Order. In the case of a Rejected Production Order, [***]. (c) FUSION shall be entitled to make changes to Production Orders (a 'Change Order\\\") to alter the quantity of Units packaged or distributed up to [***] prior to the Date of Manufacturing by providing CPDC with written notice [***]. CPDC will respond, by email, the acceptance or rejection of each Change Order within [***] of receipt of such change (an \\\"Accepted Change Order\\\" or \\\"Rejected Change Order,\\\" respectively). If there is no response to a Change Order within such timeline, it shall be considered an Accepted Change Order. In the case of a Rejected Change Order, [***]. Changes to the number of Units packaged or distributed with less than [***] notice will be subject to the applicable [***] defined in Schedule 1. Notwithstanding the foregoing, CPDC is unable to alter the total quantity of Product produced after the order deadlines imposed by any third-party isotope supplier. (d) Cancelation of a Production Orders: (i) [***] (ii) All cancellations of Production Orders shall be provided to CPDC by FUSION in writing [***]. (e) [***]. 3.3 Shipping: All deliveries of Products shall be Free Carrier shipping point [***]. For greater certainty, [***] shall take ownership of and bear all risk of loss of or damage to the Products at the origin of the shipment. (a) If requested, [***] shall arrange for any insurance desired by [***] on shipments of Product, in amounts that [***] shall determine, and naming [***]. (b) When shipping Product, CPDC shall comply with all applicable laws and regulations, [***]. (c) All costs and responsibility for return shipping of any Products [***] and or re-usable packaging including but not limited to, lead pots, cardboard boxes or foam inserts, and/or other materials shall be borne by [***]. (d) In the event that any Product packaging materials are returned for reuse from clinical trial sites, [***] shall be responsible for transportation, disposal and/or replacement of any damaged, unusable or lost materials, if applicable. 3.4 Inability to Supply. In the event that it becomes apparent to CPDC at any time that it will be unable to fulfill any Production Order, then CPDC shall immediately notify FUSION in writing of CPDC's inability to meet such requirements for Product, along with a specific indication of the amount of such shortfall in manufacture of Product and anticipated timing of delivery. If CPDC is unable to fulfill the Production Order or any portion thereof within [***] of the planned delivery, then either: (a) CPDC will [***]; or Page 3 of 13 CONFIDENTIAL Supply Agreement - FUSION (b) CPDC will [***]. 3.5 Pricing and Payment Terms. Schedule 1 of this Supply Agreement details the pricing and payment terms for the Product. For supply of Product, CPDC shall invoice FUSION [***]. CPDC shall send such invoices to: Address:\"}, {\"id\": \"270\", \"title\": \"Longwood Rd\", \"level\": 1, \"text\": \"270 Longwood Rd. South Hamilton, Ontario L8P 0J6 Canada [***] Supply Agreement - FUSION 4.7 Recalls. FUSION shall notify CPDC promptly if any Product is the subject of a recall or correction (a \\\"Recall\\\"), and FUSION and/or its designee shall have sole responsibility for the handling and disposition of such Recall. [***]. (a) In the event that CPDC disputes FUSION'S determination that the fault is due to CPDC and/or to its employees or agents, the Parties will select a mutually agreeable outside consulting firm which will be instructed to review the applicable information and data and to confirm or dissent from FUSION'S determination. If the consulting firm confirms FUSION'S determination, CPDC will pay the fees of such consulting firm. If the consulting firm dissents from FUSION'S determination, CPDC will not have the obligations set forth herein with respect to the Recall and FUSION will pay the fees of such consulting firm. (b) FUSION and/or its designee shall maintain records of all sales, shipping records of Product and customers in sufficient detail to adequately administer a Recall for the period of time as required by applicable law and regulation. CPDC's Shipping Records of Product will be given to Fusion on request such that Fusion can maintain the records and, if such a request is made, will be delivered within a timeframe to be detailed within Quality Agreement. 4.8 New Regulatory Requirements. Each Party shall promptly notify the other of new regulatory requirements of which it becomes aware which are relevant to the manufacture of any Product under this Agreement and which are required by the Regulatory Authorities, as applicable. The Parties shall confer with each other with respect to the best means to implement and comply with such requirements. Any reasonable costs for modifications or additions to the facility required as a result of new regulatory requirements shall be borne by [***]. 4.9 Records. CPDC shall maintain all records necessary to evidence compliance in all respects with (i) the applicable cGMP regulations, Canadian Environmental Health and Safety (\\\"EHS\\\") regulations, the requirements of the CNSC for handling of radioactive materials and the Canadian and International regulations for the transport of dangerous goods as related to the supply and manufacture of Products; (ii) the Specifications; and (iii) obligations under this Agreement. All such records shall be maintained by CPDC according to that specified within the Quality Agreement. CPDC shall provide to FUSION reasonable access to such records upon request Prior to destruction of any record after such time, CPDC shall give written notice to FUSION. FUSION shall have the right within [***] of receipt of such notice to request that CPDC maintain such records in an off-site storage facility for such longer periods as FUSION requests, provided that FUSION pays all costs associated with such off-site storage. 5. Representations and Warranties 5.1 Mutual Representations and Warranties. Each Party represents and warrants to the other as follows: (a) it is a corporation duly organized and validly existing under the laws of the state, province or country of its incorporation; (b) it has the complete and unrestricted power and right to enter into this Agreement and to perform its obligations hereunder; (c) this Agreement has been duly authorized, executed and delivered by such Party and constitutes a legal, valid and binding obligation of such Party enforceable against such Party in accordance with its terms except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, receivership, moratorium, fraudulent transfer, or other similar laws affecting the rights and remedies of creditors generally and by general principles of equity; Page 6 of 13 CONFIDENTIAL Supply Agreement - FUSION (d) the execution, delivery and performance of this Agreement by such Party do not conflict with any agreement, instrument or understanding, oral or written, to which such Party is a Party or by which such Party may be bound, nor violate any law or regulation of any court, governmental body or administrative or other agency having authority over such Party; (e) all consents, approvals and authorizations from all governmental authorities or other third parties required to be obtained by such Party in connection with the execution and delivery of this Agreement have been obtained; (f) no person or entity has or will have, as a result of the transactions contemplated by this Agreement, any right, interest or valid claim against or upon such Party for any commission, fee or other compensation as a finder or broker because of any act by such Party or its agents, or, with respect to such Party, because of any act by its Affiliates or sublicensees; (g) it has not entered into any agreement with any third Party that is in conflict with the rights granted to the other Party pursuant to this Agreement; and (h) neither it nor its Affiliates has been debarred or is subject to debarment, and such Party will not use in any capacity in connection with this Agreement any person or entity who has been debarred pursuant to Section 306 of the United States Federal Food, Drug and Cosmetic Act. 5.2 CPDC Limited Product Warranty. CPDC hereby provides a limited product warranty, and accordingly does warrant for each Batch, that the Product shipped will (i) conform with the Specifications, (ii) be manufactured, tested, processed, packed and prepared for shipment in accordance with cGMPs, and (iii) be free from defects in material and workmanship for the period from the date of manufacture to the expiry date set out on each Unit of Product packed and prepared for shipment. 5.3 No Implied or Other Warranties. CPDC is manufacturing Batches to meet Specifications and is supplying Products to FUSION'S designees. Except as expressly set out in this Supply Agreement, CPDC and FUSION hereby disclaim all other warranties or conditions, whether express or implied, statutory or otherwise including, but not limited to, any implied warranties or conditions of merchantability or fitness for a particular purpose. 6. Term 6.1 Term. This Supply Agreement shall commence on the Effective Date, and shall continue for a period of [***] unless terminated earlier in accordance with the terms of this Supply Agreement. [***] Import Alert [***], the Parties shall [***]. Negotiating in good faith, the Parties shall agree to a reasonable minimum percentage of Product supply to [***] Import Alert. In addition, the parties will negotiate the different aspects of the territories and related terms which may include, but are not limited to, [***]. [***] Import Alert [***], the Parties shall amend this Supply Agreement to revise the [***] Territories. Negotiating in good faith, the Parties shall agree to a reasonable minimum percentages of Product supply to the each territory, including but not limited to [***] and such amendment shall be closed within [***] of CPDC notifying Fusion [***] Import Alert. 6.2 Term, Renewal. Following the Term, this Supply Agreement shall automatically renew for successive periods of one (1) year (each a \\\"Renewal Term\\\"), unless a Party delivers written notice of non-renewal to the other Party [***] prior to the end of the applicable term. The Term, Initial Renewal Term and Renewal Terms shall be collectively referred to as the \\\"Term\\\". Page 7 of 13 CONFIDENTIAL Supply Agreement - FUSION 10.3 EXPENSES. AS THE PARTIES INTEND COMPLETE INDEMNIFICATION, ALL COSTS AND EXPENSES OF ENFORCING ANY PROVISION OF THIS SECTION 10 SHALL ALSO BE REIMBURSED BY THE INDEMNITOR. 11. LIMITATIONS OF LIABILITY. 11.1 GENERAL. EXCEPT FOR DAMAGES FOR WHICH A PARTY IS RESPONSIBLE PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 10 ABOVE, EACH PARTY SPECIFICALLY DISCLAIMS ALL LIABILITY FOR AND SHALL IN NO EVENT BE LIABLE FOR ANY INCIDENTAL, SPECIAL, INDIRECT OR CONSEQUENTIAL DAMAGES, EXPENSES, LOST PROFITS, LOST SAVINGS, INTERRUPTIONS OF BUSINESS OR OTHER DAMAGES OF ANY KIND OR CHARACTER WHATSOEVER ARISING OUT OF OR RELATED TO THIS AGREEMENT OR RESULTING FROM THE MANUFACTURE, HANDLING. MARKETING, SALE, DISTRIBUTION OR USE OF LICENSED PRODUCT REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, EVEN IF SUCH PARTY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. FUSION SHALL HAVE NO REMEDY, AND CPDC SHALL HAVE NO LIABILITY, OTHER THAN AS EXPRESSLY SET FORTH IN THIS AGREEMENT. EXCEPT FOR DAMAGES FOR WHICH A PARTY IS RESPONSIBLE PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 10 ABOVE, NO ACTION, REGARDLESS OF FORM, ARISING OUT OF OR RELATED TO THIS AGREEMENT MAY BE BROUGHT BY EITHER PARTY MORE THAN [***] AFTER SUCH PARTY HAS KNOWLEDGE OF THE OCCURRENCE THAT GAVE RISE TO THE CAUSE OF SUCH ACTION. 11.2 CPDC MAXIMUM LIABILITY. NOTWITHSTANDING ANY OTHER TERM HEREIN, OR ANY TERM OF THE MASTER SERVICES AGREEMENT. CPDC'S MAXIMUM LIABILITY TO FUSION UNDER THIS SUPPLY AGREEMENT FOR ANY REASON WHATSOEVER, INCLUDING, WILL NOT EXCEED [***]. 12. Non-Solicitation. During the term and for a period of [***] thereafter, neither party shall solicit, induce, encourage or attempt to induce or encourage any employee of the other party with whom such party has had direct contact to terminate his or her employment with such other party or to breach any other obligation to such other party. This section is not meant to encompass general solicitations such as may be found in newspaper advertisements and the like and the interviewing or hiring of any person who responds to a general solicitation 13. FORCE MAJEURE. NEITHER PARTY SHALL BE LIABLE FOR FAILURE TO PERFORM, OR DELAY IN THE PERFORMANCE OF, ITS OBLIGATIONS UNDER THIS AGREEMENT (OTHER THAN PAYMENT OBLIGATIONS) WHEN SUCH FAILURE OR DELAY IS CAUSED BY AN EVENT OF FORCE MAJEURE. FOR PURPOSES OF THIS AGREEMENT, AN EVENT OF FORCE MAJEURE MEANS ANY EVENT OR CIRCUMSTANCE BEYOND THE REASONABLE CONTROL OF THE AFFECTED PARTY. INCLUDING BUT NOT LIMITED TO, WAR, INSURRECTION, RIOT, FIRE, FLOOD OR OTHER UNUSUAL WEATHER CONDITION, EXPLOSION. ACT OF GOD, PERIL OF THE SEA, STRIKE, LOCKOUT OR OTHER INDUSTRIAL DISTURBANCE, SABOTAGE, ACCIDENT, EMBARGO, BREAKAGE OF MACHINERY OR APPARATUS, INJUNCTION, ACT OF GOVERNMENTAL AUTHORITY, COMPLIANCE WITH GOVERNMENTAL ORDER ON NATIONAL DEFENSE REQUIREMENTS, OR INABILITY TO OBTAIN FUEL, POWER, RAW MATERIALS, LABOR OR TRANSPORTATION FACILITIES. IF, DUE TO ANY EVENT OF FORCE MAJEURE, EITHER PARTY SHALL BE UNABLE TO FULFILL ITS OBLIGATIONS UNDER THIS AGREEMENT (OTHER THAN PREVIOUSLY ACCRUED PAYMENT OBLIGATIONS FROM COMPLETED WORK, THE AFFECTED PARTY SHALL IMMEDIATELY NOTIFY THE OTHER PARTY OF SUCH INABILITY AND OF THE PERIOD DURING WHICH SUCH INABILITY IS EXPECTED TO CONTINUE AND SHALL USE COMMERCIALLY REASONABLE EFFORTS TO MITIGATE THE LENGTH AND EFFECT OF SUCH FORCE MAJEURE EVENT. Page 10 of 13 CONFIDENTIAL Supply Agreement - FUSION 14. Compliance with Law. Each Party agrees to comply, and to require its Affiliates and Sublicensees to comply with all applicable international, federal, state and local laws, rules and regulations, including, but not limited to, import/export restrictions, laws, rules and regulations governing use and patent, copyright and trade secret protection, in the performance of its activities as contemplated by this Agreement. 15. Costs and Expenses. Except as otherwise expressly provided in this Agreement, [***] shall bear all costs and expenses associated with the performance of [***] under this Agreement. 16. Notices. Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in person, transmitted by facsimile, e-mail or similar means of recorded electronic communication or sent by registered mail, charges prepaid, addressed to the addresses set out on the signature page hereof. Any such notice or other communication shall be deemed to have been given and received on the day on which it was delivered or transmitted (or, if such day is not a business day, on the next following business day) unless mailed, in which case on the [***] following the date of mailing; provided, however, that if at the time of mailing or within [***] thereafter there is or occurs a labour dispute or other event that might reasonably be expected to disrupt the delivery of documents by mail, any notice or other communication hereunder shall be delivered or transmitted by means of recorded electronic communication as described. 17. Severability. Each provision contained in this Agreement is distinct and severable and a declaration of invalidity or unenforceability of any such provision or part thereof by a court of competent jurisdiction shall not affect the validity or enforceability of any other provision hereof. 18. Headings and References. The descriptive headings of this Agreement are for convenience only and shall be of no force or effect in construing or interpreting any of the provisions of this Agreement. The terms \\\"this Agreement\\\", \\\"hereof, \\\"hereunder\\\" and similar expressions refer to this Agreement and not to any particular Sections, subsection or other portion hereof, and include any agreement supplemental hereto. Unless something in the subject matter or context is inconsistent therewith, references herein to Sections, subsections, paragraphs, subparagraphs and further subdivisions are references to such subdivisions of this Agreement. 19. Number, Gender and Persons. Unless the context otherwise requires, any reference to gender shall include both genders and words importing the singular number shall include the plural and vice-versa. Words importing \\\"persons\\\" include individuals, partnerships, associations, trusts, unincorporated organizations and corporations. 20. Calculation of Time Periods. Where a time period is expressed to begin or end at, on or with a specified day, or to continue to or until a specified day, the time period includes that day. Where a time period is expressed to begin after or to be from a specified day, the time period does not include that day. Where anything is to be done within a time period expressed after, from or before a specified day, the time period does not include that day. If the last day of a time period is not a business day, the time period shall end on the next business day. 21. Definitions. Any definitions contained in this Agreement shall include any necessarily corresponding definitions as the context may require. Any capitalized or otherwise defined term used in this Agreement shall have the meaning ascribed in this Agreement regardless of whether such meaning is ascribed earlier or later in this document than the reference in question. 22. Further Assurances. Each of the Parties hereto shall, at all times and from time to time hereafter, execute, acknowledge, and deliver such other instruments and shall take such other action as may be necessary to carry out their respective obligations under this Agreement. Page 11 of 13 CONFIDENTIAL Supply Agreement - FUSION 23. Waiver. Except as expressly provided in this Agreement, no amendment or waiver of this Agreement or any portion thereof shall be binding unless executed in writing. No waiver of any provision of this Agreement shall constitute a waiver of any other provision, nor shall any waiver of any provision of this Agreement constitute a continuing waiver unless otherwise expressly provided. 24. Counterparts. This Agreement may be executed in any number of counterparts, and/or by facsimile or e-mail transmission of standard PDF files, each of which shall constitute an original and all of which, taken together, shall constitute one and the same instrument. (remainder of page intentionally left blank; signature page follows) Page 12 of 13 CONFIDENTIAL Supply Agreement - FUSION IN WITNESS WHEREOF, the Parties hereto have each caused this Supply Agreement to be duly executed as of the Effective Date. Centre for Probe Development and Commercialization McMaster University Nuclear Research Building, A316 1280 Main Street West Hamilton, Ontario Canada, L8S 4K1 Fusion Pharmaceuticals Inc. 270 Longwood Road South Hamilton, Ontario Canada, L8P 0A6 By By Name Name Title Title Date Date [SIGNATURE PAGE] Page 13 of 13 CONFIDENTIAL Supply Agreement - FUSION SCHEDULE 1: SUPPLY PRICING [***] 4. Production Standby Fee: a fee of $45,000 per month shall apply to [***]. CONFIDENTIAL Page 1 of 2 CONFIDENTIAL\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of FUSIONPHARMACEUTICALSINC_06_05_2020-EX-10.17-Supply Agreement - FUSION\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.17\", \"level\": 1, \"text\": \"Exhibit 10.17 Supply Agreement - FUSION CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH \\\"[***]\\\". SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. SUPPLY AGREEMENT (\\\"Supply Agreement\\\") effective as of the date of last signing (\\\"Effective Date\\\") between Centre for Probe Development and Commercialization, a not-for-profit research and services institution with offices located at McMaster University, Nuclear Research Building, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1, (\\\"CPDC\\\"), and FUSION Pharmaceuticals Inc. (\\\"FUSION\\\"), having a place of business at 270 Longwood Road South, Hamilton, Ontario, Canada, L8P 0A6, (together the \\\"Parties\\\" each a \\\"Party\\\"). This document defines the terms and conditions under which CPDC will provide FUSION the Product outlined in this Supply Agreement. This Supply Agreement is conducted under the general provisions of the Master Services Agreement and the Quality Agreement entered into between the PARTIES. Unless explicitly stated within this Supply Agreement should there be discrepancies between the Supply Agreement and the Master Services Agreement, then the Master Services Agreement will be the controlling document. 1. \\\"Products\\\": 1.1 Ac-225 FPI-1434 1.2 [***] 1.3 The specifications for the Products are further defined in Schedule 2. 2. Definitions Accordingly, FUSION hereby engages CPDC, and CPDC hereby accepts such engagement, to supply Products for the Territory in connection with FUSION'S Clinical Trials. The Products shall be manufactured by CPDC at the location in its cGMP facilities in the Nuclear Research Building (NRB) and on the campus of McMaster University in Hamilton, Ontario, Canada, established for this purpose pursuant to Deliverables defined within Supply Agreement. For the avoidance of doubt, it shall be the responsibility of FUSION or its designate to file, obtain and maintain any Investigational New Drug (IND) applications, registrations, listings, authorizations and approvals, as the Regulatory Authority may require to enable use of Product in Clinical Trials, and provide CPDC with all particulars thereof and developments thereunder. Both Parties acknowledge that at the time of signing this Supply Agreement that the CPDC is subject to a supply restriction to the United States of America (the \\\"USA\\\") due to and Import Alert 66-40 (the \\\"Import Alert\\\") issued by the FDA. 3.2 Production Orders. From time to time during the Term set forth in Section 6 of this Supply Agreement, FUSION and CPDC will agree to binding Production Orders for Products, as follows: (a) Based on a template order form for such Production Orders provided by CPDC to FUSION, FUSION shall complete the Production Order in such form [***] no later than (a) the order cut-off period for the third-party isotope providers (\\\"Minimum Lead Time\\\"). \u2022 In the case of [***] the isotope order cut-off is [***] eastern standard time the week prior to isotope delivery Page 2 of 13 CONFIDENTIAL Supply Agreement - FUSION \u2022 In the case of Actinium-225 the isotope order cut-off is [***] eastern standard time the week prior to isotope delivery. (b) CPDC will respond, by email, the acceptance or rejection of each duly completed Production Order within [***] of receipt of such Production Order (an 'Accepted Production Order\\\" or \\\"Rejected Production Order,\\\" respectively). If there is no response to a Production Order within such timeline, it shall be considered an Accepted Production Order. In the case of a Rejected Production Order, [***]. (c) FUSION shall be entitled to make changes to Production Orders (a 'Change Order\\\") to alter the quantity of Units packaged or distributed up to [***] prior to the Date of Manufacturing by providing CPDC with written notice [***]. CPDC will respond, by email, the acceptance or rejection of each Change Order within [***] of receipt of such change (an \\\"Accepted Change Order\\\" or \\\"Rejected Change Order,\\\" respectively). If there is no response to a Change Order within such timeline, it shall be considered an Accepted Change Order. In the case of a Rejected Change Order, [***]. Changes to the number of Units packaged or distributed with less than [***] notice will be subject to the applicable [***] defined in Schedule 1. Notwithstanding the foregoing, CPDC is unable to alter the total quantity of Product produced after the order deadlines imposed by any third-party isotope supplier. (d) Cancelation of a Production Orders: (i) [***] (ii) All cancellations of Production Orders shall be provided to CPDC by FUSION in writing [***]. (e) [***]. 3.3 Shipping: All deliveries of Products shall be Free Carrier shipping point [***]. For greater certainty, [***] shall take ownership of and bear all risk of loss of or damage to the Products at the origin of the shipment. (a) If requested, [***] shall arrange for any insurance desired by [***] on shipments of Product, in amounts that [***] shall determine, and naming [***]. (b) When shipping Product, CPDC shall comply with all applicable laws and regulations, [***]. (c) All costs and responsibility for return shipping of any Products [***] and or re-usable packaging including but not limited to, lead pots, cardboard boxes or foam inserts, and/or other materials shall be borne by [***]. (d) In the event that any Product packaging materials are returned for reuse from clinical trial sites, [***] shall be responsible for transportation, disposal and/or replacement of any damaged, unusable or lost materials, if applicable. 3.4 Inability to Supply. In the event that it becomes apparent to CPDC at any time that it will be unable to fulfill any Production Order, then CPDC shall immediately notify FUSION in writing of CPDC's inability to meet such requirements for Product, along with a specific indication of the amount of such shortfall in manufacture of Product and anticipated timing of delivery. If CPDC is unable to fulfill the Production Order or any portion thereof within [***] of the planned delivery, then either: (a) CPDC will [***]; or Page 3 of 13 CONFIDENTIAL Supply Agreement - FUSION (b) CPDC will [***]. 3.5 Pricing and Payment Terms. Schedule 1 of this Supply Agreement details the pricing and payment terms for the Product. For supply of Product, CPDC shall invoice FUSION [***]. CPDC shall send such invoices to: Address:\"}}, {\"id\": \"270\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Longwood Rd\", \"level\": 1, \"text\": \"270 Longwood Rd. South Hamilton, Ontario L8P 0J6 Canada [***] Supply Agreement - FUSION 4.7 Recalls. FUSION shall notify CPDC promptly if any Product is the subject of a recall or correction (a \\\"Recall\\\"), and FUSION and/or its designee shall have sole responsibility for the handling and disposition of such Recall. [***]. (a) In the event that CPDC disputes FUSION'S determination that the fault is due to CPDC and/or to its employees or agents, the Parties will select a mutually agreeable outside consulting firm which will be instructed to review the applicable information and data and to confirm or dissent from FUSION'S determination. If the consulting firm confirms FUSION'S determination, CPDC will pay the fees of such consulting firm. If the consulting firm dissents from FUSION'S determination, CPDC will not have the obligations set forth herein with respect to the Recall and FUSION will pay the fees of such consulting firm. (b) FUSION and/or its designee shall maintain records of all sales, shipping records of Product and customers in sufficient detail to adequately administer a Recall for the period of time as required by applicable law and regulation. CPDC's Shipping Records of Product will be given to Fusion on request such that Fusion can maintain the records and, if such a request is made, will be delivered within a timeframe to be detailed within Quality Agreement. 4.8 New Regulatory Requirements. Each Party shall promptly notify the other of new regulatory requirements of which it becomes aware which are relevant to the manufacture of any Product under this Agreement and which are required by the Regulatory Authorities, as applicable. The Parties shall confer with each other with respect to the best means to implement and comply with such requirements. Any reasonable costs for modifications or additions to the facility required as a result of new regulatory requirements shall be borne by [***]. 4.9 Records. CPDC shall maintain all records necessary to evidence compliance in all respects with (i) the applicable cGMP regulations, Canadian Environmental Health and Safety (\\\"EHS\\\") regulations, the requirements of the CNSC for handling of radioactive materials and the Canadian and International regulations for the transport of dangerous goods as related to the supply and manufacture of Products; (ii) the Specifications; and (iii) obligations under this Agreement. All such records shall be maintained by CPDC according to that specified within the Quality Agreement. CPDC shall provide to FUSION reasonable access to such records upon request Prior to destruction of any record after such time, CPDC shall give written notice to FUSION. FUSION shall have the right within [***] of receipt of such notice to request that CPDC maintain such records in an off-site storage facility for such longer periods as FUSION requests, provided that FUSION pays all costs associated with such off-site storage. 5. Representations and Warranties 5.1 Mutual Representations and Warranties. Each Party represents and warrants to the other as follows: (a) it is a corporation duly organized and validly existing under the laws of the state, province or country of its incorporation; (b) it has the complete and unrestricted power and right to enter into this Agreement and to perform its obligations hereunder; (c) this Agreement has been duly authorized, executed and delivered by such Party and constitutes a legal, valid and binding obligation of such Party enforceable against such Party in accordance with its terms except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, receivership, moratorium, fraudulent transfer, or other similar laws affecting the rights and remedies of creditors generally and by general principles of equity; Page 6 of 13 CONFIDENTIAL Supply Agreement - FUSION (d) the execution, delivery and performance of this Agreement by such Party do not conflict with any agreement, instrument or understanding, oral or written, to which such Party is a Party or by which such Party may be bound, nor violate any law or regulation of any court, governmental body or administrative or other agency having authority over such Party; (e) all consents, approvals and authorizations from all governmental authorities or other third parties required to be obtained by such Party in connection with the execution and delivery of this Agreement have been obtained; (f) no person or entity has or will have, as a result of the transactions contemplated by this Agreement, any right, interest or valid claim against or upon such Party for any commission, fee or other compensation as a finder or broker because of any act by such Party or its agents, or, with respect to such Party, because of any act by its Affiliates or sublicensees; (g) it has not entered into any agreement with any third Party that is in conflict with the rights granted to the other Party pursuant to this Agreement; and (h) neither it nor its Affiliates has been debarred or is subject to debarment, and such Party will not use in any capacity in connection with this Agreement any person or entity who has been debarred pursuant to Section 306 of the United States Federal Food, Drug and Cosmetic Act. 5.2 CPDC Limited Product Warranty. CPDC hereby provides a limited product warranty, and accordingly does warrant for each Batch, that the Product shipped will (i) conform with the Specifications, (ii) be manufactured, tested, processed, packed and prepared for shipment in accordance with cGMPs, and (iii) be free from defects in material and workmanship for the period from the date of manufacture to the expiry date set out on each Unit of Product packed and prepared for shipment. 5.3 No Implied or Other Warranties. CPDC is manufacturing Batches to meet Specifications and is supplying Products to FUSION'S designees. Except as expressly set out in this Supply Agreement, CPDC and FUSION hereby disclaim all other warranties or conditions, whether express or implied, statutory or otherwise including, but not limited to, any implied warranties or conditions of merchantability or fitness for a particular purpose. 6. Term 6.1 Term. This Supply Agreement shall commence on the Effective Date, and shall continue for a period of [***] unless terminated earlier in accordance with the terms of this Supply Agreement. [***] Import Alert [***], the Parties shall [***]. Negotiating in good faith, the Parties shall agree to a reasonable minimum percentage of Product supply to [***] Import Alert. In addition, the parties will negotiate the different aspects of the territories and related terms which may include, but are not limited to, [***]. [***] Import Alert [***], the Parties shall amend this Supply Agreement to revise the [***] Territories. Negotiating in good faith, the Parties shall agree to a reasonable minimum percentages of Product supply to the each territory, including but not limited to [***] and such amendment shall be closed within [***] of CPDC notifying Fusion [***] Import Alert. 6.2 Term, Renewal. Following the Term, this Supply Agreement shall automatically renew for successive periods of one (1) year (each a \\\"Renewal Term\\\"), unless a Party delivers written notice of non-renewal to the other Party [***] prior to the end of the applicable term. The Term, Initial Renewal Term and Renewal Terms shall be collectively referred to as the \\\"Term\\\". Page 7 of 13 CONFIDENTIAL Supply Agreement - FUSION 10.3 EXPENSES. AS THE PARTIES INTEND COMPLETE INDEMNIFICATION, ALL COSTS AND EXPENSES OF ENFORCING ANY PROVISION OF THIS SECTION 10 SHALL ALSO BE REIMBURSED BY THE INDEMNITOR. 11. LIMITATIONS OF LIABILITY. 11.1 GENERAL. EXCEPT FOR DAMAGES FOR WHICH A PARTY IS RESPONSIBLE PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 10 ABOVE, EACH PARTY SPECIFICALLY DISCLAIMS ALL LIABILITY FOR AND SHALL IN NO EVENT BE LIABLE FOR ANY INCIDENTAL, SPECIAL, INDIRECT OR CONSEQUENTIAL DAMAGES, EXPENSES, LOST PROFITS, LOST SAVINGS, INTERRUPTIONS OF BUSINESS OR OTHER DAMAGES OF ANY KIND OR CHARACTER WHATSOEVER ARISING OUT OF OR RELATED TO THIS AGREEMENT OR RESULTING FROM THE MANUFACTURE, HANDLING. MARKETING, SALE, DISTRIBUTION OR USE OF LICENSED PRODUCT REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, EVEN IF SUCH PARTY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. FUSION SHALL HAVE NO REMEDY, AND CPDC SHALL HAVE NO LIABILITY, OTHER THAN AS EXPRESSLY SET FORTH IN THIS AGREEMENT. EXCEPT FOR DAMAGES FOR WHICH A PARTY IS RESPONSIBLE PURSUANT TO ITS INDEMNIFICATION OBLIGATIONS SET FORTH IN SECTION 10 ABOVE, NO ACTION, REGARDLESS OF FORM, ARISING OUT OF OR RELATED TO THIS AGREEMENT MAY BE BROUGHT BY EITHER PARTY MORE THAN [***] AFTER SUCH PARTY HAS KNOWLEDGE OF THE OCCURRENCE THAT GAVE RISE TO THE CAUSE OF SUCH ACTION. 11.2 CPDC MAXIMUM LIABILITY. NOTWITHSTANDING ANY OTHER TERM HEREIN, OR ANY TERM OF THE MASTER SERVICES AGREEMENT. CPDC'S MAXIMUM LIABILITY TO FUSION UNDER THIS SUPPLY AGREEMENT FOR ANY REASON WHATSOEVER, INCLUDING, WILL NOT EXCEED [***]. 12. Non-Solicitation. During the term and for a period of [***] thereafter, neither party shall solicit, induce, encourage or attempt to induce or encourage any employee of the other party with whom such party has had direct contact to terminate his or her employment with such other party or to breach any other obligation to such other party. This section is not meant to encompass general solicitations such as may be found in newspaper advertisements and the like and the interviewing or hiring of any person who responds to a general solicitation 13. FORCE MAJEURE. NEITHER PARTY SHALL BE LIABLE FOR FAILURE TO PERFORM, OR DELAY IN THE PERFORMANCE OF, ITS OBLIGATIONS UNDER THIS AGREEMENT (OTHER THAN PAYMENT OBLIGATIONS) WHEN SUCH FAILURE OR DELAY IS CAUSED BY AN EVENT OF FORCE MAJEURE. FOR PURPOSES OF THIS AGREEMENT, AN EVENT OF FORCE MAJEURE MEANS ANY EVENT OR CIRCUMSTANCE BEYOND THE REASONABLE CONTROL OF THE AFFECTED PARTY. INCLUDING BUT NOT LIMITED TO, WAR, INSURRECTION, RIOT, FIRE, FLOOD OR OTHER UNUSUAL WEATHER CONDITION, EXPLOSION. ACT OF GOD, PERIL OF THE SEA, STRIKE, LOCKOUT OR OTHER INDUSTRIAL DISTURBANCE, SABOTAGE, ACCIDENT, EMBARGO, BREAKAGE OF MACHINERY OR APPARATUS, INJUNCTION, ACT OF GOVERNMENTAL AUTHORITY, COMPLIANCE WITH GOVERNMENTAL ORDER ON NATIONAL DEFENSE REQUIREMENTS, OR INABILITY TO OBTAIN FUEL, POWER, RAW MATERIALS, LABOR OR TRANSPORTATION FACILITIES. IF, DUE TO ANY EVENT OF FORCE MAJEURE, EITHER PARTY SHALL BE UNABLE TO FULFILL ITS OBLIGATIONS UNDER THIS AGREEMENT (OTHER THAN PREVIOUSLY ACCRUED PAYMENT OBLIGATIONS FROM COMPLETED WORK, THE AFFECTED PARTY SHALL IMMEDIATELY NOTIFY THE OTHER PARTY OF SUCH INABILITY AND OF THE PERIOD DURING WHICH SUCH INABILITY IS EXPECTED TO CONTINUE AND SHALL USE COMMERCIALLY REASONABLE EFFORTS TO MITIGATE THE LENGTH AND EFFECT OF SUCH FORCE MAJEURE EVENT. Page 10 of 13 CONFIDENTIAL Supply Agreement - FUSION 14. Compliance with Law. Each Party agrees to comply, and to require its Affiliates and Sublicensees to comply with all applicable international, federal, state and local laws, rules and regulations, including, but not limited to, import/export restrictions, laws, rules and regulations governing use and patent, copyright and trade secret protection, in the performance of its activities as contemplated by this Agreement. 15. Costs and Expenses. Except as otherwise expressly provided in this Agreement, [***] shall bear all costs and expenses associated with the performance of [***] under this Agreement. 16. Notices. Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in person, transmitted by facsimile, e-mail or similar means of recorded electronic communication or sent by registered mail, charges prepaid, addressed to the addresses set out on the signature page hereof. Any such notice or other communication shall be deemed to have been given and received on the day on which it was delivered or transmitted (or, if such day is not a business day, on the next following business day) unless mailed, in which case on the [***] following the date of mailing; provided, however, that if at the time of mailing or within [***] thereafter there is or occurs a labour dispute or other event that might reasonably be expected to disrupt the delivery of documents by mail, any notice or other communication hereunder shall be delivered or transmitted by means of recorded electronic communication as described. 17. Severability. Each provision contained in this Agreement is distinct and severable and a declaration of invalidity or unenforceability of any such provision or part thereof by a court of competent jurisdiction shall not affect the validity or enforceability of any other provision hereof. 18. Headings and References. The descriptive headings of this Agreement are for convenience only and shall be of no force or effect in construing or interpreting any of the provisions of this Agreement. The terms \\\"this Agreement\\\", \\\"hereof, \\\"hereunder\\\" and similar expressions refer to this Agreement and not to any particular Sections, subsection or other portion hereof, and include any agreement supplemental hereto. Unless something in the subject matter or context is inconsistent therewith, references herein to Sections, subsections, paragraphs, subparagraphs and further subdivisions are references to such subdivisions of this Agreement. 19. Number, Gender and Persons. Unless the context otherwise requires, any reference to gender shall include both genders and words importing the singular number shall include the plural and vice-versa. Words importing \\\"persons\\\" include individuals, partnerships, associations, trusts, unincorporated organizations and corporations. 20. Calculation of Time Periods. Where a time period is expressed to begin or end at, on or with a specified day, or to continue to or until a specified day, the time period includes that day. Where a time period is expressed to begin after or to be from a specified day, the time period does not include that day. Where anything is to be done within a time period expressed after, from or before a specified day, the time period does not include that day. If the last day of a time period is not a business day, the time period shall end on the next business day. 21. Definitions. Any definitions contained in this Agreement shall include any necessarily corresponding definitions as the context may require. Any capitalized or otherwise defined term used in this Agreement shall have the meaning ascribed in this Agreement regardless of whether such meaning is ascribed earlier or later in this document than the reference in question. 22. Further Assurances. Each of the Parties hereto shall, at all times and from time to time hereafter, execute, acknowledge, and deliver such other instruments and shall take such other action as may be necessary to carry out their respective obligations under this Agreement. Page 11 of 13 CONFIDENTIAL Supply Agreement - FUSION 23. Waiver. Except as expressly provided in this Agreement, no amendment or waiver of this Agreement or any portion thereof shall be binding unless executed in writing. No waiver of any provision of this Agreement shall constitute a waiver of any other provision, nor shall any waiver of any provision of this Agreement constitute a continuing waiver unless otherwise expressly provided. 24. Counterparts. This Agreement may be executed in any number of counterparts, and/or by facsimile or e-mail transmission of standard PDF files, each of which shall constitute an original and all of which, taken together, shall constitute one and the same instrument. (remainder of page intentionally left blank; signature page follows) Page 12 of 13 CONFIDENTIAL Supply Agreement - FUSION IN WITNESS WHEREOF, the Parties hereto have each caused this Supply Agreement to be duly executed as of the Effective Date. Centre for Probe Development and Commercialization McMaster University Nuclear Research Building, A316 1280 Main Street West Hamilton, Ontario Canada, L8S 4K1 Fusion Pharmaceuticals Inc. 270 Longwood Road South Hamilton, Ontario Canada, L8P 0A6 By By Name Name Title Title Date Date [SIGNATURE PAGE] Page 13 of 13 CONFIDENTIAL Supply Agreement - FUSION SCHEDULE 1: SUPPLY PRICING [***] 4. Production Standby Fee: a fee of $45,000 per month shall apply to [***]. CONFIDENTIAL Page 1 of 2 CONFIDENTIAL\"}}, {\"id\": \"party:Centre for Probe Development and Commercialization\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Centre for Probe Development and Commercialization\", \"role\": null, \"address\": \"McMaster University, Nuclear Research Building, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1\"}}, {\"id\": \"party:FUSION Pharmaceuticals Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"FUSION Pharmaceuticals Inc.\", \"role\": null, \"address\": \"270 Longwood Road South, Hamilton, Ontario, Canada, L8P 0A6\"}}, {\"id\": \"term:Supply Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Supply Agreement\", \"text\": \"SUPPLY AGREEMENT (\\\"Supply Agreement\\\") effective as of the date of last signing (\\\"Effective Date\\\") between Centre for Probe Development and Commercialization, a not-for-profit research and services institution with offices located at McMaster University, Nuclear Research Building, 1280 Main Street West, Hamilton, Ontario, Canada, L8S 4K1, (\\\"CPDC\\\"), and FUSION Pharmaceuticals Inc. (\\\"FUSION\\\"), having a place of business at 270 Longwood Road South, Hamilton, Ontario, Canada, L8P 0A6, (together the \\\"Parties\\\" each a \\\"Party\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"effective as of the date of last signing (\\\"Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"1. \\\"Products\\\": 1.1 Ac-225 FPI-1434 1.2 [***] 1.3 The specifications for the Products are further defined in Schedule 2.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:USA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"USA\", \"text\": \"United States of America (the \\\"USA\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Import Alert\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Import Alert\", \"text\": \"Import Alert 66-40 (the \\\"Import Alert\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Minimum Lead Time\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Lead Time\", \"text\": \"the order cut-off period for the third-party isotope providers (\\\"Minimum Lead Time\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Accepted Production Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Accepted Production Order\", \"text\": \"CPDC will respond, by email, the acceptance or rejection of each duly completed Production Order within [***] of receipt of such Production Order (an 'Accepted Production Order\\\" or \\\"Rejected Production Order,\\\" respectively).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Rejected Production Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Rejected Production Order\", \"text\": \"CPDC will respond, by email, the acceptance or rejection of each duly completed Production Order within [***] of receipt of such Production Order (an 'Accepted Production Order\\\" or \\\"Rejected Production Order,\\\" respectively).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Change Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change Order\", \"text\": \"FUSION shall be entitled to make changes to Production Orders (a 'Change Order\\\") to alter the quantity of Units packaged or distributed up to [***] prior to the Date of Manufacturing by providing CPDC with written notice [***].\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Accepted Change Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Accepted Change Order\", \"text\": \"CPDC will respond, by email, the acceptance or rejection of each Change Order within [***] of receipt of such change (an \\\"Accepted Change Order\\\" or \\\"Rejected Change Order,\\\" respectively).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Rejected Change Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Rejected Change Order\", \"text\": \"CPDC will respond, by email, the acceptance or rejection of each Change Order within [***] of receipt of such change (an \\\"Accepted Change Order\\\" or \\\"Rejected Change Order,\\\" respectively).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Recall\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Recall\", \"text\": \"FUSION shall notify CPDC promptly if any Product is the subject of a recall or correction (a \\\"Recall\\\"), and FUSION and/or its designee shall have sole responsibility for the handling and disposition of such Recall.\", \"definition_clause\": \"270\"}}, {\"id\": \"term:EHS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EHS\", \"text\": \"Canadian Environmental Health and Safety (\\\"EHS\\\") regulations\", \"definition_clause\": \"270\"}}, {\"id\": \"term:Renewal Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Term\", \"text\": \"Following the Term, this Supply Agreement shall automatically renew for successive periods of one (1) year (each a \\\"Renewal Term\\\"), unless a Party delivers written notice of non-renewal to the other Party [***] prior to the end of the applicable term.\", \"definition_clause\": \"270\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"The Term, Initial Renewal Term and Renewal Terms shall be collectively referred to as the \\\"Term\\\".\", \"definition_clause\": \"270\"}}, {\"id\": \"term:Event of Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Event of Force Majeure\", \"text\": \"FOR PURPOSES OF THIS AGREEMENT, AN EVENT OF FORCE MAJEURE MEANS ANY EVENT OR CIRCUMSTANCE BEYOND THE REASONABLE CONTROL OF THE AFFECTED PARTY. INCLUDING BUT NOT LIMITED TO, WAR, INSURRECTION, RIOT, FIRE, FLOOD OR OTHER UNUSUAL WEATHER CONDITION, EXPLOSION. ACT OF GOD, PERIL OF THE SEA, STRIKE, LOCKOUT OR OTHER INDUSTRIAL DISTURBANCE, SABOTAGE, ACCIDENT, EMBARGO, BREAKAGE OF MACHINERY OR APPARATUS, INJUNCTION, ACT OF GOVERNMENTAL AUTHORITY, COMPLIANCE WITH GOVERNMENTAL ORDER ON NATIONAL DEFENSE REQUIREMENTS, OR INABILITY TO OBTAIN FUEL, POWER, RAW MATERIALS, LABOR OR TRANSPORTATION FACILITIES.\", \"definition_clause\": \"270\"}}, {\"id\": \"value:$45,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$45,000\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"EXHIBIT 10.43\", \"title\": \"Dated 29/3/18\", \"level\": 2, \"text\": \"EXHIBIT 10.43 Dated 29/3/18 Distributorship agreement between Signature Orthopaedics Pty Ltd And CPM Medical Consultants LLC Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"EXHIBIT 10.43\", \"title\": \"THIS AGREEMENT is dated\", \"level\": 2, \"text\": \"EXHIBIT 10.43 THIS AGREEMENT is dated Parties (1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW (2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080. Background The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement. Agreed terms\"}, {\"id\": \"1\", \"title\": \"Definitions and interpretation\", \"level\": 1, \"text\": \"1. Definitions and interpretation\"}, {\"id\": \"1.1\", \"title\": \"The definitions and rules of interpretation in this clause apply in this agreement\", \"level\": 2, \"text\": \"1.1 The definitions and rules of interpretation in this clause apply in this agreement. Business Day: a day (other than a Saturday, Sunday or public holiday in Australia) when banks in Sydney are open for business. Commencement Date: means the date of this agreement. Control: the ability to direct the affairs of another person, whether by virtue of the ownership of shares, contract or otherwise. Inactive Territories means a country in which the Distributor has not sold or supplied the Product during the Initial Term. Initial Term has the meaning given to it in clause 12.1. Products: As defined in Schedule 1 and includes any other products developed by the Supplier and which the Supplier may permit the Distributor, by express notice in writing, to distribute in the Territory. Term: the term of this agreement, as determined in accordance with clause 11. Territory: means the territory specified in Schedule 2. Trade Marks: the trade mark registrations listed in Schedule 3 and any further trade marks that the Supplier may permit, or procure permission for, the Distributor to use in the Territory in respect of the Products by express notice in writing. GST: goods and services tax chargeable under the Goods and Services Tax Act and any similar replacement or additional tax or such other similar or analogous form of tax under the laws and regulations in the Territory. 1 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 Year: the period of 12 months from the Commencement Date and each consecutive period of 12 months thereafter during the Term.\"}, {\"id\": \"1.2\", \"title\": \"Clause, schedule and paragraph headings shall not affect the interpretation of this agreement\", \"level\": 2, \"text\": \"1.2 Clause, schedule and paragraph headings shall not affect the interpretation of this agreement.\"}, {\"id\": \"1.3\", \"title\": \"A person includes a natural person, corporate or unincorporated body (whether or not having separate legal personality)\", \"level\": 2, \"text\": \"1.3 A person includes a natural person, corporate or unincorporated body (whether or not having separate legal personality).\"}, {\"id\": \"1.4\", \"title\": \"The Schedules form part of this agreement and shall have effect as if set out in full in the body of this agreement\", \"level\": 2, \"text\": \"1.4 The Schedules form part of this agreement and shall have effect as if set out in full in the body of this agreement. Any reference to this agreement includes the Schedules.\"}, {\"id\": \"1.5\", \"title\": \"A reference to a company shall include any company, corporation or other body corporate, wherever and however incorporat\", \"level\": 2, \"text\": \"1.5 A reference to a company shall include any company, corporation or other body corporate, wherever and however incorporated or established.\"}, {\"id\": \"1.6\", \"title\": \"Words in the singular shall include the plural and vice versa\", \"level\": 2, \"text\": \"1.6 Words in the singular shall include the plural and vice versa.\"}, {\"id\": \"1.7\", \"title\": \"A reference to one gender shall include a reference to the other genders\", \"level\": 2, \"text\": \"1.7 A reference to one gender shall include a reference to the other genders.\"}, {\"id\": \"1.8\", \"title\": \"A reference to any party shall include that party's personal representatives, successors or permitted assigns\", \"level\": 2, \"text\": \"1.8 A reference to any party shall include that party's personal representatives, successors or permitted assigns.\"}, {\"id\": \"1.9\", \"title\": \"A reference to a statute, statutory provision or any subordinated legislation made under a statute is a reference to suc\", \"level\": 2, \"text\": \"1.9 A reference to a statute, statutory provision or any subordinated legislation made under a statute is a reference to such statute, provision or subordinated legislation as amended or re-enacted from time to time, whether before or after the date of this agreement and in the case of a reference to a statute is also to all subordinate legislation made under that statute whether before or after the date of this agreement.\"}, {\"id\": \"1.10\", \"title\": \"A reference to writing or written includes faxes and e-mail\", \"level\": 2, \"text\": \"1.10 A reference to writing or written includes faxes and e-mail.\"}, {\"id\": \"1.11\", \"title\": \"Documents in agreed form are documents in the form agreed by the parties and initialled by or on behalf of them for iden\", \"level\": 2, \"text\": \"1.11 Documents in agreed form are documents in the form agreed by the parties and initialled by or on behalf of them for identification.\"}, {\"id\": \"1.12\", \"title\": \"Any reference to a legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court\", \"level\": 2, \"text\": \"1.12 Any reference to a legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than Australia, be deemed to include a reference to what most nearly approximates to the Australian legal term in that jurisdiction.\"}, {\"id\": \"1.13\", \"title\": \"A reference to a document is a reference to that document as varied or novated (in each case, other than in breach of th\", \"level\": 2, \"text\": \"1.13 A reference to a document is a reference to that document as varied or novated (in each case, other than in breach of the provisions of this agreement) at any time.\"}, {\"id\": \"1.14\", \"title\": \"References to clauses and schedules are to the clauses and schedules of this agreement\", \"level\": 2, \"text\": \"1.14 References to clauses and schedules are to the clauses and schedules of this agreement. 2 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"1.15\", \"title\": \"Any phrase introduced by the terms including, include, in particular or any similar expression shall be construed as ill\", \"level\": 2, \"text\": \"1.15 Any phrase introduced by the terms including, include, in particular or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms.\"}, {\"id\": \"2\", \"title\": \"Appointment\", \"level\": 1, \"text\": \"2. Appointment\"}, {\"id\": \"2.1\", \"title\": \"The Supplier appoints the Distributor as its non-exclusive distributor to distribute the Products in the Territory on th\", \"level\": 2, \"text\": \"2.1 The Supplier appoints the Distributor as its non-exclusive distributor to distribute the Products in the Territory on the terms of this agreement.\"}, {\"id\": \"2.2\", \"title\": \"Following the expiry of the Initial Term, the Supplier may amend the Territory to remove any Inactive Territories\", \"level\": 2, \"text\": \"2.2 Following the expiry of the Initial Term, the Supplier may amend the Territory to remove any Inactive Territories.\"}, {\"id\": \"2.3\", \"title\": \"Notwithstanding 2\", \"level\": 2, \"text\": \"2.3 Notwithstanding 2.1 and 2.2, the Supplier may sell or supply the Products to end users within USA at anytime.\"}, {\"id\": \"2.4\", \"title\": \"The Distributor shall not\", \"level\": 2, \"text\": \"2.4 The Distributor shall not: (a) represent itself as an agent of the Supplier for any purpose; or (b) pledge the Supplier's credit; or (c) give any condition or warranty on the Supplier's behalf except for any warranty or guarantee which cannot be excluded under law; or (d) make any representation on the Supplier's behalf; or (e) commit the Supplier to any contracts; or (f) act as the agent or the buying agent, for any person for any goods which are competitive with the Product; or (g) retain any monies of the Supplier except on a trustee or fiduciary basis; or (h) knowingly make any false or misleading statement to any supplier or service provider, or to the Distributor or its business, about the Products or the liability of the Supplier for the cost of any goods or services supplied to the Distributor or its business; or (i) incur any liability or assume any obligation on behalf of the Supplier; or\"}, {\"id\": \"2.5\", \"title\": \"The Distributor shall not without the Supplier's prior written consent make any promises or guarantees about the Product\", \"level\": 2, \"text\": \"2.5 The Distributor shall not without the Supplier's prior written consent make any promises or guarantees about the Products beyond those: (a) agreed between the Distributor and the Supplier; and (b) contained in any promotional material supplied by the Supplier. 3 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"3\", \"title\": \"Distributor's undertakings\", \"level\": 1, \"text\": \"3. Distributor's undertakings The Distributor undertakes and agrees with the Supplier that at all times during the Term it will: (a) use all reasonable endeavours to promote the distribution and sale of the Products; (b) not use any promotional or advertising material for the Products not approved by the Supplier, such approval not be unreasonably withheld; (c) provide Yearly non-binding sales forecasts; (d) establish and maintain documented procedures for identifying the Products with a control number for traceability and copies of those records and procedures must be made available to the Supplier within thirty (30) days of request; (e) provide regular reports on the sales activities within the Territory; (f) employ a sufficient number of suitably qualified personnel to ensure the proper fulfilment of the Distributor's obligations under this agreement; (g) maintain, on its own account, an inventory of the Products at levels which are appropriate and adequate for the Distributor to meet all customer delivery requirements for the Products throughout the Territory; (h) keep full and proper books of account and records clearly showing all enquiries, quotations, transactions and proceedings relating to the Products; (i) allow the Supplier, on reasonable notice, access to its accounts and records relating to the sale or distribution of the Products for inspection but not more than once in each year. For clarity, the Supplier will not be permitted access to any accounts or records which do not directly relate to the sale or distribution of the Products; (j) comply with any reasonable directives or instructions given by the Supplier for any promotional activities, at the suppliers cost, concerning the nature, type, quality, characteristics, fitness for purpose, suitability, use and description of the Products;\"}, {\"id\": \"4\", \"title\": \"Supply of products\", \"level\": 1, \"text\": \"4. Supply of products\"}, {\"id\": \"4.1\", \"title\": \"The parties acknowledge that\", \"level\": 2, \"text\": \"4.1 The parties acknowledge that: (a) the Supplier is the manufacturer of the Products; and 4 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 (b) the Supplier will have no obligation to separately supply the Products, except as otherwise provided for in this Agreement.\"}, {\"id\": \"4.2\", \"title\": \"Supplier's undertakings\", \"level\": 2, \"text\": \"4.2 Supplier's undertakings The Supplier undertakes to: (a) provide information and support that may reasonably be requested by the Distributor to enable it to discharge its duties under this agreement properly and efficiently; and (b) approve or reject any promotional information or material submitted by the Distributor within 28 days of receipt.\"}, {\"id\": \"5\", \"title\": \"Prices and payment\", \"level\": 1, \"text\": \"5. Prices and payment\"}, {\"id\": \"5.1\", \"title\": \"The prices to be paid by the Distributor to the Supplier for the Products are to be the Price, as set out in Schedule 4\", \"level\": 2, \"text\": \"5.1 The prices to be paid by the Distributor to the Supplier for the Products are to be the Price, as set out in Schedule 4.\"}, {\"id\": \"5.2\", \"title\": \"Any and all expenses, costs and charges incurred by the Distributor in the performance of its obligations under this agr\", \"level\": 2, \"text\": \"5.2 Any and all expenses, costs and charges incurred by the Distributor in the performance of its obligations under this agreement will be paid by the Distributor, unless the Supplier has expressly agreed in advance in writing to pay such expenses, costs and charges.\"}, {\"id\": \"5.3\", \"title\": \"The Distributor must pay the full amount invoiced to it by the Supplier in USD$'s within thirty (45) days of the date of\", \"level\": 2, \"text\": \"5.3 The Distributor must pay the full amount invoiced to it by the Supplier in USD$'s within thirty (45) days of the date of invoice.\"}, {\"id\": \"5.4\", \"title\": \"Neither party may withhold payment of any amount due to the other because of any set-off, counter-claim, abatement, or o\", \"level\": 2, \"text\": \"5.4 Neither party may withhold payment of any amount due to the other because of any set-off, counter-claim, abatement, or other similar deduction.\"}, {\"id\": \"6\", \"title\": \"GST and taxes (Only Applicable to Australian companies)\", \"level\": 1, \"text\": \"6. GST and taxes (Only Applicable to Australian companies)\"}, {\"id\": \"6.1\", \"title\": \"All sums payable under this agreement, or otherwise payable by any party to any other party under this agreement are exc\", \"level\": 2, \"text\": \"6.1 All sums payable under this agreement, or otherwise payable by any party to any other party under this agreement are exclusive of any GST chargeable on the supplies for which such sums (or any part of them) are the whole or part of the consideration for GST purposes.\"}, {\"id\": \"6.2\", \"title\": \"Where, under this agreement, any party makes a supply to any other party (Recipient) for GST purposes and GST is or beco\", \"level\": 2, \"text\": \"6.2 Where, under this agreement, any party makes a supply to any other party (Recipient) for GST purposes and GST is or becomes chargeable on that supply for which the supplying party is required to account to the relevant tax authority, the Recipient shall, subject to the receipt of a valid GST invoice, pay the supplying party (in addition to, and at the same time as, any other consideration for that supply) the amount of such GST.\"}, {\"id\": \"6.3\", \"title\": \"Where any party is required by this agreement to reimburse or indemnify any other party for any cost or expense, that fi\", \"level\": 2, \"text\": \"6.3 Where any party is required by this agreement to reimburse or indemnify any other party for any cost or expense, that first party shall reimburse or indemnify the other party for the full amount of the cost or expense, including any GST on that amount, 5 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 except to the extent that the other party is entitled to credit or repayment for that GST from any relevant tax authority.\"}, {\"id\": \"6.4\", \"title\": \"All import taxes, charges, levies, assessments and other fees of any kind imposed on the purchase or import of the Produ\", \"level\": 2, \"text\": \"6.4 All import taxes, charges, levies, assessments and other fees of any kind imposed on the purchase or import of the Products shall be the responsibility of, and for the account of, the Distributor.\"}, {\"id\": \"7\", \"title\": \"Advertising and promotion\", \"level\": 1, \"text\": \"7. Advertising and promotion\"}, {\"id\": \"7.1\", \"title\": \"The Distributor shall\", \"level\": 2, \"text\": \"7.1 The Distributor shall: (a) cooperate with the Supplier in relation to the promotion and advertisement of the Products; (b) not make any written statement as to the quality or manufacture of the Products without the prior written approval of the Supplier; and (c) pays its own costs of advertising the Product except where there is any separate advertising campaign which the Supplier and the Distributor have agreed to fund jointly in any agreed proportion.\"}, {\"id\": \"8\", \"title\": \"Anti-bribery compliance\", \"level\": 1, \"text\": \"8. Anti-bribery compliance\"}, {\"id\": \"8.1\", \"title\": \"The Distributor shall\", \"level\": 2, \"text\": \"8.1 The Distributor shall: (a) comply with all applicable laws, statutes and regulations relating to anti-bribery and anti- corruption; and (b) not engage in any activity, practice or conduct which would constitute an offence.\"}, {\"id\": \"9\", \"title\": \"Trade marks and intellectual property\", \"level\": 1, \"text\": \"9. Trade marks and intellectual property\"}, {\"id\": \"9.1\", \"title\": \"The Supplier hereby grants to the Distributor the non-exclusive right, in the Territory, to use the Trade Marks in the p\", \"level\": 2, \"text\": \"9.1 The Supplier hereby grants to the Distributor the non-exclusive right, in the Territory, to use the Trade Marks in the promotion, advertisement and sale of the Products, subject to, and for the duration of, this agreement.\"}, {\"id\": \"9.2\", \"title\": \"The Distributor may sell and/or distribute the Products using the Trade Marks in conjunction with any trade marks owned\", \"level\": 2, \"text\": \"9.2 The Distributor may sell and/or distribute the Products using the Trade Marks in conjunction with any trade marks owned or licensed by the Distributor.\"}, {\"id\": \"9.3\", \"title\": \"All representations of the Trade Marks that the Distributor intends to use shall be submitted to the Supplier for approv\", \"level\": 2, \"text\": \"9.3 All representations of the Trade Marks that the Distributor intends to use shall be submitted to the Supplier for approval before use.\"}, {\"id\": \"9.4\", \"title\": \"Within limiting this clause 12, the Distributor shall be entitled to add a label to the Products it purchases to show th\", \"level\": 2, \"text\": \"9.4 Within limiting this clause 12, the Distributor shall be entitled to add a label to the Products it purchases to show that the products purchased are being distributed by the Distributor.\"}, {\"id\": \"9.5\", \"title\": \"The Supplier represents and warrants that\", \"level\": 2, \"text\": \"9.5 The Supplier represents and warrants that: 6 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 (a) Trade Marks; and (b) The Products, do not infringe any intellectual property rights of any third parties and the Supplier agrees to indemnify and hold harmless the Distributor against any clauses by a third party for infringement of intellectual property rights in relation to the Products or the Trade marks .\"}, {\"id\": \"9.6\", \"title\": \"The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted unde\", \"level\": 2, \"text\": \"9.6 The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted under this agreement.\"}, {\"id\": \"9.7\", \"title\": \"The Distributor shall not do, or omit to do, anything in its use of the Trade Marks that could adversely affect their va\", \"level\": 2, \"text\": \"9.7 The Distributor shall not do, or omit to do, anything in its use of the Trade Marks that could adversely affect their validity or the goodwill of the Supplier.\"}, {\"id\": \"9.8\", \"title\": \"The Distributor shall immediately enter into any document necessary for the recording, registration or safeguarding of t\", \"level\": 2, \"text\": \"9.8 The Distributor shall immediately enter into any document necessary for the recording, registration or safeguarding of the Supplier's Trade Mark rights with the Supplier for the marketing of the Products under the Trade Marks in a form satisfactory to the Supplier, at the suppliers cost.\"}, {\"id\": \"9.9\", \"title\": \"Each party shall promptly give notice in writing to the other if it becomes aware of\", \"level\": 2, \"text\": \"9.9 Each party shall promptly give notice in writing to the other if it becomes aware of: (a) any infringement or suspected infringement of the Trade Marks or any other intellectual property rights relating to the Products within the Territory; or (b) any claim that any Product or the manufacture, use, sale or other disposal of any Product within the Territory, whether or not under the Trade Marks, infringes the rights of any third party,\"}, {\"id\": \"9.10\", \"title\": \"In respect of any matter that falls within clause 9\", \"level\": 2, \"text\": \"9.10 In respect of any matter that falls within clause 9.9(a): (a) the Supplier shall in its absolute discretion, decide what action to take in respect of the matter (if any); (b) the Supplier shall conduct and have sole control over any consequent action that it deems necessary; and (c) the Supplier shall pay all costs in relation to that action and shall be entitled to all damages and other sums that may be paid or awarded as a result of that action.\"}, {\"id\": \"9.11\", \"title\": \"In respect of any matter that falls within clause 9\", \"level\": 2, \"text\": \"9.11 In respect of any matter that falls within clause 9.9(b): (a) the Supplier and the Distributor shall agree: (i) what steps to take to prevent or terminate the infringement; and (ii) the proportions in which they shall share the cost of those steps and any damages and other sums which may be awarded to or against 7 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 them, being agreed between the parties that the Supplier shall hold Distributor harmless against any damages connected with any material or workmanship defect of the Products; and (b) failing agreement between the parties, either party may take any action as it considers necessary or appropriate, at its own expense, to defend the claim and shall be entitled to and responsible for all damages and other sums that may be recovered or awarded against it as a result of that action.\"}, {\"id\": \"9.12\", \"title\": \"Each party shall, at the request and expense of the other, provide any reasonable assistance to the other (including the\", \"level\": 2, \"text\": \"9.12 Each party shall, at the request and expense of the other, provide any reasonable assistance to the other (including the use of its name in, or being joined as a party to, proceedings) with any action to be taken by the other party under this clause 9, provided that that party is given such indemnity as it may reasonably require against any losses, costs and expenses it may incur as a result of or in connection with providing such assistance.\"}, {\"id\": \"10\", \"title\": \"Product liability and insurance\", \"level\": 1, \"text\": \"10. Product liability and insurance\"}, {\"id\": \"10.1\", \"title\": \"Subject to the Distributor fulfilling all the conditions in this clause 10, the Supplier shall indemnify the Distributor\", \"level\": 2, \"text\": \"10.1 Subject to the Distributor fulfilling all the conditions in this clause 10, the Supplier shall indemnify the Distributor, defend and hold harmless against any liability incurred by the Distributor in respect of damage to property, death or personal injury arising from any fault or defect in the design of the Products and any reasonable costs, claims, demands and expenses, including reasonable attorneys' fees, arising out of or in connection with that liability (Relevant Claim), except to the extent the liability arises as a result of the wilful misconduct of the Distributor. The Supplier shall add the distributor to their current insurance certificate.\"}, {\"id\": \"10.2\", \"title\": \"The Distributor shall, within five days of a matter which may result in a Relevant Claim\", \"level\": 2, \"text\": \"10.2 The Distributor shall, within five days of a matter which may result in a Relevant Claim: (a) give the Supplier written notice of the details of the matter; (b) give the Supplier access to and allow copies to be taken of any materials, records or documents as the Supplier may require to take action under clause 10.2(c); (c) allow the Supplier the exclusive conduct of any proceedings and take any action that the Supplier requires to defend or resist the matter, including using professional advisers nominated by the Supplier; and (d) not admit liability or settle the matter without the Supplier's written consent.\"}, {\"id\": \"10.3\", \"title\": \"During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10\", \"level\": 2, \"text\": \"10.3 During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10 million for any one occurrence for any and all liability (however arising) for a claim that the Products are faulty or defective. The Supplier shall provide a copy of the insurance policy to the Distributor on request. 8 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"10.4\", \"title\": \"The Distributor undertakes to maintain appropriate, up-to-date and accurate records to enable the immediate recall of an\", \"level\": 2, \"text\": \"10.4 The Distributor undertakes to maintain appropriate, up-to-date and accurate records to enable the immediate recall of any Products or batches of Products from the retail or wholesale markets. These records shall include records of deliveries to customers (including batch numbers, delivery date, name and address of customer, telephone number, fax number and e-mail address).\"}, {\"id\": \"10.5\", \"title\": \"The Distributor shall, at the Supplier's cost, give any assistance that the Supplier shall reasonably require to recall,\", \"level\": 2, \"text\": \"10.5 The Distributor shall, at the Supplier's cost, give any assistance that the Supplier shall reasonably require to recall, as a matter of urgency, Products from the retail or wholesale market.\"}, {\"id\": \"11\", \"title\": \"Duration and termination\", \"level\": 1, \"text\": \"11. Duration and termination\"}, {\"id\": \"11.1\", \"title\": \"This agreement begins on the Commencement Date and, subject to clause 11\", \"level\": 2, \"text\": \"11.1 This agreement begins on the Commencement Date and, subject to clause 11.2, shall continue for an initial term of one (1) years (Initial Term) and indefinitely after that until terminated by either party giving at least twelve (12) months' prior written notice to expire on or after the expiry date of the initial term.\"}, {\"id\": \"11.2\", \"title\": \"Without affecting any other rights that it may be entitled to, either party may give notice in writing to the other term\", \"level\": 2, \"text\": \"11.2 Without affecting any other rights that it may be entitled to, either party may give notice in writing to the other terminating this agreement immediately if: (a) the other party fails to pay any amount due under this agreement on the due date for payment and remains in default not less than 14 days after being notified in writing to make such payment; or (b) the other party commits a material breach of any material term of this agreement and (if such breach is remediable) fails to remedy that breach within a period of 14 days of being notified in writing to do so; or (c) the other party repeatedly breaches any of the terms of this agreement in such a manner as to reasonably justify the opinion that its conduct is inconsistent with it having the intention or ability to give effect to the terms of this agreement; or (d) the other party suspends, or threatens to suspend, payment of its debts or is unable to pay its debts as they fall due or admits inability to pay its debts or (being a company) is deemed unable to pay its debts within the meaning of the Corporations Act 2001 (Cth) OR (being a natural person) is deemed either unable to pay its debts or as having no reasonable prospect of so doing, in either case, within the meaning of the Corporations Act 2001 (Cth) OR (being a partnership) has any partner to whom any of the foregoing apply: or (e) the other party commences negotiations with all or any class of its creditors with a view to rescheduling any of its debts, or makes a proposal for or enters into any compromise or arrangement with its creditors other than for the sole purpose of a scheme for a solvent amalgamation of that other party with one or more other companies or the solvent reconstruction of that other party; or 9 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 (f) a petition is filed, a notice is given, a resolution is passed, or an order is made, for or in connection with the winding up of that other party other than for the sole purpose of a scheme for a solvent amalgamation of that other party with one or more other companies or the solvent reconstruction of that other party: or (g) an application is made to court, or an order is made, for the appointment of an administrator or if a notice of intention to appoint an administrator is given or if an administrator is appointed over the other party; or (h) a person becomes entitled to appoint a receiver over the assets of the other party or a receiver is appointed over the assets of the other party; or (i) the other party, being an individual, is the subject of a bankruptcy petition or order; or (j) a creditor or encumbrancer of the other party attaches or takes possession of, or a distress, execution, sequestration or other such process is levied or enforced on or sued against, the whole or any part of its assets and such attachment or process is not discharged within 14 days; or (k) any event occurs, or proceeding is taken, with respect to the other party in any jurisdiction to which it is subject that has an effect equivalent or similar to any of the events mentioned in clause 11.2(d) to clause 11.2(j) (inclusive); or (l) the other party suspends or ceases, or threatens to suspend or cease, to carry on all or a substantial part of its business; or (m) the other party, being an individual, dies or, by reason of illness or incapacity (whether mental or physical), is incapable of managing his or her own affairs or becomes a patient under any mental health legislation. (n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\"}, {\"id\": \"12\", \"title\": \"Effectsof termination\", \"level\": 1, \"text\": \"12. Effectsof termination\"}, {\"id\": \"12.1\", \"title\": \"Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of terminati\", \"level\": 2, \"text\": \"12.1 Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of termination. 10 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"12.2\", \"title\": \"At the Supplier's option, on termination of this agreement\", \"level\": 2, \"text\": \"12.2 At the Supplier's option, on termination of this agreement: (a) the Supplier may buy from the Distributor all or any stocks of Products for the current market value for those Products. The Distributor must deliver such Products to the Supplier within 14 days of receiving the Supplier's notice, and the Supplier must pay for the Products in full within 30 days of their delivery. The Supplier shall be responsible for the costs of packaging, insurance and carriage of the Products; or (b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products; and (c) subject to clause 12.2(b), the Distributor must cease using any intellectual property of the Supplier or of another person that relates to the distributorship and the Distributor must sign any instrument and do any other act that is necessary to achieve this purpose;\"}, {\"id\": \"12.3\", \"title\": \"For the purposes of clause 12\", \"level\": 2, \"text\": \"12.3 For the purposes of clause 12.2(a) the current market value in respect of Products shall be the price that the Products are ordinarily supplied as at the date of termination of this agreement.\"}, {\"id\": \"12.4\", \"title\": \"Subject to clause 12\", \"level\": 2, \"text\": \"12.4 Subject to clause 12.2, all other rights and licences of the Distributor under this agreement shall terminate on the termination date.\"}, {\"id\": \"13\", \"title\": \"Confidentiality\", \"level\": 1, \"text\": \"13. Confidentiality\"}, {\"id\": \"13.1\", \"title\": \"Each party undertakes that it shall not at any time, disclose to any person any confidential information concerning the\", \"level\": 2, \"text\": \"13.1 Each party undertakes that it shall not at any time, disclose to any person any confidential information concerning the business, affairs, customers, clients or suppliers of the other party or of any member of the group of companies to which the other party belongs, except as provided by clause 13.2.\"}, {\"id\": \"13.2\", \"title\": \"Each party may disclose the other party's confidential information\", \"level\": 2, \"text\": \"13.2 Each party may disclose the other party's confidential information: (a) to those of its employees, officers, representatives or advisers who need to know such information for the purpose of carrying out the party's obligations under this agreement. Each party shall ensure that its employees, officers, representatives or advisers to whom it discloses the other party's confidential information comply with this clause 13; and (b) as may be required by law, court order or any governmental or regulatory authority; provided, however, that the other party reserves the right to challenge such disclosure under applicable law. If such party elects to challenge the disclosure, no confidential information shall be disclosed during the pendency of such challenge.\"}, {\"id\": \"13.3\", \"title\": \"No party shall use any other party's confidential information for any purpose other than to perform its obligations unde\", \"level\": 2, \"text\": \"13.3 No party shall use any other party's confidential information for any purpose other than to perform its obligations under this agreement. 11 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"14\", \"title\": \"Entire agreement\", \"level\": 1, \"text\": \"14. Entire agreement\"}, {\"id\": \"14.1\", \"title\": \"This agreement (and any document referred to in it) constitutes the whole agreement between the parties and supersedes a\", \"level\": 2, \"text\": \"14.1 This agreement (and any document referred to in it) constitutes the whole agreement between the parties and supersedes all previous agreements between the parties relating to its subject matter.\"}, {\"id\": \"14.2\", \"title\": \"Each party acknowledges that, in entering into this agreement (and any document referred to in it), it has not relied on\", \"level\": 2, \"text\": \"14.2 Each party acknowledges that, in entering into this agreement (and any document referred to in it), it has not relied on, and shall have no right or remedy in respect of, any statement, representation, assurance or warranty (whether made negligently or innocently) other than as expressly set out in this agreement. Each party agrees that its only liability in respect of those representations and warranties that are set out in this agreement (whether made innocently or negligently) shall be for breach of contract.\"}, {\"id\": \"14.3\", \"title\": \"Nothing in this clause shall limit or exclude any liability for fraud\", \"level\": 2, \"text\": \"14.3 Nothing in this clause shall limit or exclude any liability for fraud.\"}, {\"id\": \"15\", \"title\": \"Variation\", \"level\": 1, \"text\": \"15. Variation No amendment or variation of this agreement shall be effective unless it is in writing and signed by the parties (or their authorised representatives).\"}, {\"id\": \"16\", \"title\": \"Assignment and other dealings prohibited\", \"level\": 1, \"text\": \"16. Assignment and other dealings prohibited\"}, {\"id\": \"16.1\", \"title\": \"The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this a\", \"level\": 2, \"text\": \"16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier. The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent.\"}, {\"id\": \"16.2\", \"title\": \"If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16\", \"level\": 2, \"text\": \"16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: - (a) disclose fully in writing all material facts relating to the dealing (b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\"}, {\"id\": \"16.3\", \"title\": \"Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person\", \"level\": 2, \"text\": \"16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\"}, {\"id\": \"17\", \"title\": \"Freedom to contract\", \"level\": 1, \"text\": \"17. Freedom to contract The parties declare that they each have the right, power and authority and have taken all action necessary to execute and deliver and to exercise their rights and perform their obligations under this agreement. 12 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"18\", \"title\": \"Waiver\", \"level\": 1, \"text\": \"18. Waiver No failure or delay by a party to exercise any right or remedy provided under this agreement or by law shall constitute a waiver of that or any other right or remedy, nor shall it preclude or restrict the further exercise of that or any other right or remedy. No single or partial exercise of such right or remedy shall preclude or restrict the further exercise of that or any other right or remedy.\"}, {\"id\": \"19\", \"title\": \"Severance\", \"level\": 1, \"text\": \"19. Severance\"}, {\"id\": \"19.1\", \"title\": \"If any provision of this agreement (or part of any provision) is found by any court or other authority of competent juri\", \"level\": 2, \"text\": \"19.1 If any provision of this agreement (or part of any provision) is found by any court or other authority of competent jurisdiction to be invalid, illegal or unenforceable, that provision or part-provision shall, to the extent required, be deemed not to form part of this agreement, and the validity and enforceability of the other provisions of this agreement shall not be affected.\"}, {\"id\": \"19.2\", \"title\": \"If a provision of this agreement (or part of any provision) is found illegal, invalid or unenforceable, the provision sh\", \"level\": 2, \"text\": \"19.2 If a provision of this agreement (or part of any provision) is found illegal, invalid or unenforceable, the provision shall apply with the minimum modification necessary to make it legal, valid and enforceable.\"}, {\"id\": \"20\", \"title\": \"Notices\", \"level\": 1, \"text\": \"20. Notices\"}, {\"id\": \"20.1\", \"title\": \"Any notice required to be given under this agreement, shall be in writing and shall be delivered personally, by email, o\", \"level\": 2, \"text\": \"20.1 Any notice required to be given under this agreement, shall be in writing and shall be delivered personally, by email, or sent by pre-paid first class post or recorded delivery or by commercial courier, to each party required to receive the notice at its address as set out at the beginning of this agreement or as otherwise specified by the relevant party by notice in writing to each other party.\"}, {\"id\": \"20.2\", \"title\": \"Any notice shall be deemed to have been duly received\", \"level\": 2, \"text\": \"20.2 Any notice shall be deemed to have been duly received: (a) if delivered personally, when left at the address and for the contact referred to in this clause; or (b) if sent by pre-paid first class post or recorded delivery, at 9.00 am on the second Business Day after posting; or (c) if delivered by commercial courier, on the date and at the time that the courier's delivery receipt is signed; or (d) if delivered by email, on the date and at the time such email is received by the recipient whether such message is opened at that time. Any notice given or received by a lawyer for a party to this agreement is deemed to be given or received with the actual or ostensible authority of the lawyer. The Supplier may at times by notice nominate an address for service of legal proceeding, whether in Australia or in any other place. A nomination binds the 13 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 parties but nothing prevents the Supplier from making further nomination in place of any earlier nomination.\"}, {\"id\": \"20.3\", \"title\": \"A notice given under this agreement shall not be validly given if sent by e-mail\", \"level\": 2, \"text\": \"20.3 A notice given under this agreement shall not be validly given if sent by e-mail.\"}, {\"id\": \"21\", \"title\": \"Third party rights\", \"level\": 1, \"text\": \"21. Third party rights\"}, {\"id\": \"21.1\", \"title\": \"A person who is not a party to this agreement shall not have any rights under or in connection with it by virtue of the\", \"level\": 2, \"text\": \"21.1 A person who is not a party to this agreement shall not have any rights under or in connection with it by virtue of the Contracts\"}, {\"id\": \"21.2\", \"title\": \"The rights of the parties to terminate, rescind or agree any variation, waiver or settlement under this agreement are no\", \"level\": 2, \"text\": \"21.2 The rights of the parties to terminate, rescind or agree any variation, waiver or settlement under this agreement are not subject to the consent of any person that is not a party to this agreement.\"}, {\"id\": \"22\", \"title\": \"No partnership or agency\", \"level\": 1, \"text\": \"22. No partnership or agency Except as expressly provided, nothing in this agreement is intended to, or shall be deemed to, establish any partnership or joint venture between the parties, constitute either party the agent of the other, nor authorise a party to make or enter into any commitments for or on behalf of the other party.\"}, {\"id\": \"23\", \"title\": \"Counterparts\", \"level\": 1, \"text\": \"23. Counterparts This agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute an original of this agreement, but all the counterparts shall together constitute the same agreement.\"}, {\"id\": \"24\", \"title\": \"Governing law and jurisdiction\", \"level\": 1, \"text\": \"24. Governing law and jurisdiction\"}, {\"id\": \"24.1\", \"title\": \"This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (incl\", \"level\": 2, \"text\": \"24.1 This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with Ohio law.\"}, {\"id\": \"24.2\", \"title\": \"The parties irrevocably agree that the courts of Ohio shall have non-exclusive jurisdiction to settle any dispute or cla\", \"level\": 2, \"text\": \"24.2 The parties irrevocably agree that the courts of Ohio shall have non-exclusive jurisdiction to settle any dispute or claim that arises out of or in connection with this agreement or its subject matter or formation (including non- contractual disputes or claims). This agreement has been entered into on the date stated at the beginning of it. 14 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 Schedule 1 AriaTM Hip Stem System RemedyTM Hip Stem system LogicalTM Hip Cup system Signature BiPolar Head Genius Total knee system 15 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"Schedule 2\", \"title\": \"Territory\", \"level\": 1, \"text\": \"Schedule 2 Territory USA. 16 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"Schedule 3\", \"title\": \"The Trade Marks\", \"level\": 1, \"text\": \"Schedule 3 The Trade Marks OriginTM, LogicalTM, AriaTM, RemedyTM, GeniusTM 17 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}, {\"id\": \"Schedule 4\", \"title\": \"Prices\", \"level\": 1, \"text\": \"Schedule 4 Prices Aria Stem $610 Origin Stem $610 Remedy Stem $610 Logical Cup $450 Logical Liner $210 Metal Head $240 Ceramic Head $340 BiPolar Head $250 PS / CR Femoral Component $550 Insert $340 Tibia Tray $440 Patella $70 18 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 SIGNED by Signature Orthopaedics Pty Ltd (ACN 106 702 416) In accordance with section 127 of the Corporations Act: ) ) ) ) ) Director/Secretary Name (please print) Director Name (please print) SIGNED by CPM Medical LLC ) ) ) ) ) Director/Secretary Name (please print) Director Name (please print) 19 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of FuseMedicalInc_20190321_10-K_EX-10.43_11575454_EX-10.43_Distributor Agreement\", \"nodes\": [{\"id\": \"EXHIBIT 10.43\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Dated 29/3/18\", \"level\": 2, \"text\": \"EXHIBIT 10.43 Dated 29/3/18 Distributorship agreement between Signature Orthopaedics Pty Ltd And CPM Medical Consultants LLC Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"EXHIBIT 10.43\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THIS AGREEMENT is dated\", \"level\": 2, \"text\": \"EXHIBIT 10.43 THIS AGREEMENT is dated Parties (1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW (2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080. Background The Supplier wishes to appoint the Distributor as its non-exclusive distributor for the promotion and sale of the Products within the Territory (both as defined below), and the Distributor wishes to promote and sell the Products within the Territory on the terms of this agreement. Agreed terms\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definitions and interpretation\", \"level\": 1, \"text\": \"1. Definitions and interpretation\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The definitions and rules of interpretation in this clause apply in this agreement\", \"level\": 2, \"text\": \"1.1 The definitions and rules of interpretation in this clause apply in this agreement. Business Day: a day (other than a Saturday, Sunday or public holiday in Australia) when banks in Sydney are open for business. Commencement Date: means the date of this agreement. Control: the ability to direct the affairs of another person, whether by virtue of the ownership of shares, contract or otherwise. Inactive Territories means a country in which the Distributor has not sold or supplied the Product during the Initial Term. Initial Term has the meaning given to it in clause 12.1. Products: As defined in Schedule 1 and includes any other products developed by the Supplier and which the Supplier may permit the Distributor, by express notice in writing, to distribute in the Territory. Term: the term of this agreement, as determined in accordance with clause 11. Territory: means the territory specified in Schedule 2. Trade Marks: the trade mark registrations listed in Schedule 3 and any further trade marks that the Supplier may permit, or procure permission for, the Distributor to use in the Territory in respect of the Products by express notice in writing. GST: goods and services tax chargeable under the Goods and Services Tax Act and any similar replacement or additional tax or such other similar or analogous form of tax under the laws and regulations in the Territory. 1 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 Year: the period of 12 months from the Commencement Date and each consecutive period of 12 months thereafter during the Term.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Clause, schedule and paragraph headings shall not affect the interpretation of this agreement\", \"level\": 2, \"text\": \"1.2 Clause, schedule and paragraph headings shall not affect the interpretation of this agreement.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A person includes a natural person, corporate or unincorporated body (whether or not having separate legal personality)\", \"level\": 2, \"text\": \"1.3 A person includes a natural person, corporate or unincorporated body (whether or not having separate legal personality).\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Schedules form part of this agreement and shall have effect as if set out in full in the body of this agreement\", \"level\": 2, \"text\": \"1.4 The Schedules form part of this agreement and shall have effect as if set out in full in the body of this agreement. Any reference to this agreement includes the Schedules.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A reference to a company shall include any company, corporation or other body corporate, wherever and however incorporat\", \"level\": 2, \"text\": \"1.5 A reference to a company shall include any company, corporation or other body corporate, wherever and however incorporated or established.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Words in the singular shall include the plural and vice versa\", \"level\": 2, \"text\": \"1.6 Words in the singular shall include the plural and vice versa.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A reference to one gender shall include a reference to the other genders\", \"level\": 2, \"text\": \"1.7 A reference to one gender shall include a reference to the other genders.\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A reference to any party shall include that party's personal representatives, successors or permitted assigns\", \"level\": 2, \"text\": \"1.8 A reference to any party shall include that party's personal representatives, successors or permitted assigns.\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A reference to a statute, statutory provision or any subordinated legislation made under a statute is a reference to suc\", \"level\": 2, \"text\": \"1.9 A reference to a statute, statutory provision or any subordinated legislation made under a statute is a reference to such statute, provision or subordinated legislation as amended or re-enacted from time to time, whether before or after the date of this agreement and in the case of a reference to a statute is also to all subordinate legislation made under that statute whether before or after the date of this agreement.\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A reference to writing or written includes faxes and e-mail\", \"level\": 2, \"text\": \"1.10 A reference to writing or written includes faxes and e-mail.\"}}, {\"id\": \"1.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Documents in agreed form are documents in the form agreed by the parties and initialled by or on behalf of them for iden\", \"level\": 2, \"text\": \"1.11 Documents in agreed form are documents in the form agreed by the parties and initialled by or on behalf of them for identification.\"}}, {\"id\": \"1.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any reference to a legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court\", \"level\": 2, \"text\": \"1.12 Any reference to a legal term for any action, remedy, method of judicial proceeding, legal document, legal status, court, official or any legal concept or thing shall, in respect of any jurisdiction other than Australia, be deemed to include a reference to what most nearly approximates to the Australian legal term in that jurisdiction.\"}}, {\"id\": \"1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A reference to a document is a reference to that document as varied or novated (in each case, other than in breach of th\", \"level\": 2, \"text\": \"1.13 A reference to a document is a reference to that document as varied or novated (in each case, other than in breach of the provisions of this agreement) at any time.\"}}, {\"id\": \"1.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"References to clauses and schedules are to the clauses and schedules of this agreement\", \"level\": 2, \"text\": \"1.14 References to clauses and schedules are to the clauses and schedules of this agreement. 2 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"1.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any phrase introduced by the terms including, include, in particular or any similar expression shall be construed as ill\", \"level\": 2, \"text\": \"1.15 Any phrase introduced by the terms including, include, in particular or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Appointment\", \"level\": 1, \"text\": \"2. Appointment\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Supplier appoints the Distributor as its non-exclusive distributor to distribute the Products in the Territory on th\", \"level\": 2, \"text\": \"2.1 The Supplier appoints the Distributor as its non-exclusive distributor to distribute the Products in the Territory on the terms of this agreement.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Following the expiry of the Initial Term, the Supplier may amend the Territory to remove any Inactive Territories\", \"level\": 2, \"text\": \"2.2 Following the expiry of the Initial Term, the Supplier may amend the Territory to remove any Inactive Territories.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding 2\", \"level\": 2, \"text\": \"2.3 Notwithstanding 2.1 and 2.2, the Supplier may sell or supply the Products to end users within USA at anytime.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall not\", \"level\": 2, \"text\": \"2.4 The Distributor shall not: (a) represent itself as an agent of the Supplier for any purpose; or (b) pledge the Supplier's credit; or (c) give any condition or warranty on the Supplier's behalf except for any warranty or guarantee which cannot be excluded under law; or (d) make any representation on the Supplier's behalf; or (e) commit the Supplier to any contracts; or (f) act as the agent or the buying agent, for any person for any goods which are competitive with the Product; or (g) retain any monies of the Supplier except on a trustee or fiduciary basis; or (h) knowingly make any false or misleading statement to any supplier or service provider, or to the Distributor or its business, about the Products or the liability of the Supplier for the cost of any goods or services supplied to the Distributor or its business; or (i) incur any liability or assume any obligation on behalf of the Supplier; or\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall not without the Supplier's prior written consent make any promises or guarantees about the Product\", \"level\": 2, \"text\": \"2.5 The Distributor shall not without the Supplier's prior written consent make any promises or guarantees about the Products beyond those: (a) agreed between the Distributor and the Supplier; and (b) contained in any promotional material supplied by the Supplier. 3 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's undertakings\", \"level\": 1, \"text\": \"3. Distributor's undertakings The Distributor undertakes and agrees with the Supplier that at all times during the Term it will: (a) use all reasonable endeavours to promote the distribution and sale of the Products; (b) not use any promotional or advertising material for the Products not approved by the Supplier, such approval not be unreasonably withheld; (c) provide Yearly non-binding sales forecasts; (d) establish and maintain documented procedures for identifying the Products with a control number for traceability and copies of those records and procedures must be made available to the Supplier within thirty (30) days of request; (e) provide regular reports on the sales activities within the Territory; (f) employ a sufficient number of suitably qualified personnel to ensure the proper fulfilment of the Distributor's obligations under this agreement; (g) maintain, on its own account, an inventory of the Products at levels which are appropriate and adequate for the Distributor to meet all customer delivery requirements for the Products throughout the Territory; (h) keep full and proper books of account and records clearly showing all enquiries, quotations, transactions and proceedings relating to the Products; (i) allow the Supplier, on reasonable notice, access to its accounts and records relating to the sale or distribution of the Products for inspection but not more than once in each year. For clarity, the Supplier will not be permitted access to any accounts or records which do not directly relate to the sale or distribution of the Products; (j) comply with any reasonable directives or instructions given by the Supplier for any promotional activities, at the suppliers cost, concerning the nature, type, quality, characteristics, fitness for purpose, suitability, use and description of the Products;\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply of products\", \"level\": 1, \"text\": \"4. Supply of products\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties acknowledge that\", \"level\": 2, \"text\": \"4.1 The parties acknowledge that: (a) the Supplier is the manufacturer of the Products; and 4 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 (b) the Supplier will have no obligation to separately supply the Products, except as otherwise provided for in this Agreement.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supplier's undertakings\", \"level\": 2, \"text\": \"4.2 Supplier's undertakings The Supplier undertakes to: (a) provide information and support that may reasonably be requested by the Distributor to enable it to discharge its duties under this agreement properly and efficiently; and (b) approve or reject any promotional information or material submitted by the Distributor within 28 days of receipt.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices and payment\", \"level\": 1, \"text\": \"5. Prices and payment\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The prices to be paid by the Distributor to the Supplier for the Products are to be the Price, as set out in Schedule 4\", \"level\": 2, \"text\": \"5.1 The prices to be paid by the Distributor to the Supplier for the Products are to be the Price, as set out in Schedule 4.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any and all expenses, costs and charges incurred by the Distributor in the performance of its obligations under this agr\", \"level\": 2, \"text\": \"5.2 Any and all expenses, costs and charges incurred by the Distributor in the performance of its obligations under this agreement will be paid by the Distributor, unless the Supplier has expressly agreed in advance in writing to pay such expenses, costs and charges.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor must pay the full amount invoiced to it by the Supplier in USD$'s within thirty (45) days of the date of\", \"level\": 2, \"text\": \"5.3 The Distributor must pay the full amount invoiced to it by the Supplier in USD$'s within thirty (45) days of the date of invoice.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party may withhold payment of any amount due to the other because of any set-off, counter-claim, abatement, or o\", \"level\": 2, \"text\": \"5.4 Neither party may withhold payment of any amount due to the other because of any set-off, counter-claim, abatement, or other similar deduction.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GST and taxes (Only Applicable to Australian companies)\", \"level\": 1, \"text\": \"6. GST and taxes (Only Applicable to Australian companies)\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All sums payable under this agreement, or otherwise payable by any party to any other party under this agreement are exc\", \"level\": 2, \"text\": \"6.1 All sums payable under this agreement, or otherwise payable by any party to any other party under this agreement are exclusive of any GST chargeable on the supplies for which such sums (or any part of them) are the whole or part of the consideration for GST purposes.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Where, under this agreement, any party makes a supply to any other party (Recipient) for GST purposes and GST is or beco\", \"level\": 2, \"text\": \"6.2 Where, under this agreement, any party makes a supply to any other party (Recipient) for GST purposes and GST is or becomes chargeable on that supply for which the supplying party is required to account to the relevant tax authority, the Recipient shall, subject to the receipt of a valid GST invoice, pay the supplying party (in addition to, and at the same time as, any other consideration for that supply) the amount of such GST.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Where any party is required by this agreement to reimburse or indemnify any other party for any cost or expense, that fi\", \"level\": 2, \"text\": \"6.3 Where any party is required by this agreement to reimburse or indemnify any other party for any cost or expense, that first party shall reimburse or indemnify the other party for the full amount of the cost or expense, including any GST on that amount, 5 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 except to the extent that the other party is entitled to credit or repayment for that GST from any relevant tax authority.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All import taxes, charges, levies, assessments and other fees of any kind imposed on the purchase or import of the Produ\", \"level\": 2, \"text\": \"6.4 All import taxes, charges, levies, assessments and other fees of any kind imposed on the purchase or import of the Products shall be the responsibility of, and for the account of, the Distributor.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Advertising and promotion\", \"level\": 1, \"text\": \"7. Advertising and promotion\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall\", \"level\": 2, \"text\": \"7.1 The Distributor shall: (a) cooperate with the Supplier in relation to the promotion and advertisement of the Products; (b) not make any written statement as to the quality or manufacture of the Products without the prior written approval of the Supplier; and (c) pays its own costs of advertising the Product except where there is any separate advertising campaign which the Supplier and the Distributor have agreed to fund jointly in any agreed proportion.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Anti-bribery compliance\", \"level\": 1, \"text\": \"8. Anti-bribery compliance\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall\", \"level\": 2, \"text\": \"8.1 The Distributor shall: (a) comply with all applicable laws, statutes and regulations relating to anti-bribery and anti- corruption; and (b) not engage in any activity, practice or conduct which would constitute an offence.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trade marks and intellectual property\", \"level\": 1, \"text\": \"9. Trade marks and intellectual property\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Supplier hereby grants to the Distributor the non-exclusive right, in the Territory, to use the Trade Marks in the p\", \"level\": 2, \"text\": \"9.1 The Supplier hereby grants to the Distributor the non-exclusive right, in the Territory, to use the Trade Marks in the promotion, advertisement and sale of the Products, subject to, and for the duration of, this agreement.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor may sell and/or distribute the Products using the Trade Marks in conjunction with any trade marks owned\", \"level\": 2, \"text\": \"9.2 The Distributor may sell and/or distribute the Products using the Trade Marks in conjunction with any trade marks owned or licensed by the Distributor.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All representations of the Trade Marks that the Distributor intends to use shall be submitted to the Supplier for approv\", \"level\": 2, \"text\": \"9.3 All representations of the Trade Marks that the Distributor intends to use shall be submitted to the Supplier for approval before use.\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Within limiting this clause 12, the Distributor shall be entitled to add a label to the Products it purchases to show th\", \"level\": 2, \"text\": \"9.4 Within limiting this clause 12, the Distributor shall be entitled to add a label to the Products it purchases to show that the products purchased are being distributed by the Distributor.\"}}, {\"id\": \"9.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Supplier represents and warrants that\", \"level\": 2, \"text\": \"9.5 The Supplier represents and warrants that: 6 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 (a) Trade Marks; and (b) The Products, do not infringe any intellectual property rights of any third parties and the Supplier agrees to indemnify and hold harmless the Distributor against any clauses by a third party for infringement of intellectual property rights in relation to the Products or the Trade marks .\"}}, {\"id\": \"9.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted unde\", \"level\": 2, \"text\": \"9.6 The Distributor shall not sub-license, transfer or otherwise deal with the rights of use of the Trade Marks granted under this agreement.\"}}, {\"id\": \"9.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall not do, or omit to do, anything in its use of the Trade Marks that could adversely affect their va\", \"level\": 2, \"text\": \"9.7 The Distributor shall not do, or omit to do, anything in its use of the Trade Marks that could adversely affect their validity or the goodwill of the Supplier.\"}}, {\"id\": \"9.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall immediately enter into any document necessary for the recording, registration or safeguarding of t\", \"level\": 2, \"text\": \"9.8 The Distributor shall immediately enter into any document necessary for the recording, registration or safeguarding of the Supplier's Trade Mark rights with the Supplier for the marketing of the Products under the Trade Marks in a form satisfactory to the Supplier, at the suppliers cost.\"}}, {\"id\": \"9.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party shall promptly give notice in writing to the other if it becomes aware of\", \"level\": 2, \"text\": \"9.9 Each party shall promptly give notice in writing to the other if it becomes aware of: (a) any infringement or suspected infringement of the Trade Marks or any other intellectual property rights relating to the Products within the Territory; or (b) any claim that any Product or the manufacture, use, sale or other disposal of any Product within the Territory, whether or not under the Trade Marks, infringes the rights of any third party,\"}}, {\"id\": \"9.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In respect of any matter that falls within clause 9\", \"level\": 2, \"text\": \"9.10 In respect of any matter that falls within clause 9.9(a): (a) the Supplier shall in its absolute discretion, decide what action to take in respect of the matter (if any); (b) the Supplier shall conduct and have sole control over any consequent action that it deems necessary; and (c) the Supplier shall pay all costs in relation to that action and shall be entitled to all damages and other sums that may be paid or awarded as a result of that action.\"}}, {\"id\": \"9.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In respect of any matter that falls within clause 9\", \"level\": 2, \"text\": \"9.11 In respect of any matter that falls within clause 9.9(b): (a) the Supplier and the Distributor shall agree: (i) what steps to take to prevent or terminate the infringement; and (ii) the proportions in which they shall share the cost of those steps and any damages and other sums which may be awarded to or against 7 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 them, being agreed between the parties that the Supplier shall hold Distributor harmless against any damages connected with any material or workmanship defect of the Products; and (b) failing agreement between the parties, either party may take any action as it considers necessary or appropriate, at its own expense, to defend the claim and shall be entitled to and responsible for all damages and other sums that may be recovered or awarded against it as a result of that action.\"}}, {\"id\": \"9.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party shall, at the request and expense of the other, provide any reasonable assistance to the other (including the\", \"level\": 2, \"text\": \"9.12 Each party shall, at the request and expense of the other, provide any reasonable assistance to the other (including the use of its name in, or being joined as a party to, proceedings) with any action to be taken by the other party under this clause 9, provided that that party is given such indemnity as it may reasonably require against any losses, costs and expenses it may incur as a result of or in connection with providing such assistance.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product liability and insurance\", \"level\": 1, \"text\": \"10. Product liability and insurance\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to the Distributor fulfilling all the conditions in this clause 10, the Supplier shall indemnify the Distributor\", \"level\": 2, \"text\": \"10.1 Subject to the Distributor fulfilling all the conditions in this clause 10, the Supplier shall indemnify the Distributor, defend and hold harmless against any liability incurred by the Distributor in respect of damage to property, death or personal injury arising from any fault or defect in the design of the Products and any reasonable costs, claims, demands and expenses, including reasonable attorneys' fees, arising out of or in connection with that liability (Relevant Claim), except to the extent the liability arises as a result of the wilful misconduct of the Distributor. The Supplier shall add the distributor to their current insurance certificate.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall, within five days of a matter which may result in a Relevant Claim\", \"level\": 2, \"text\": \"10.2 The Distributor shall, within five days of a matter which may result in a Relevant Claim: (a) give the Supplier written notice of the details of the matter; (b) give the Supplier access to and allow copies to be taken of any materials, records or documents as the Supplier may require to take action under clause 10.2(c); (c) allow the Supplier the exclusive conduct of any proceedings and take any action that the Supplier requires to defend or resist the matter, including using professional advisers nominated by the Supplier; and (d) not admit liability or settle the matter without the Supplier's written consent.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10\", \"level\": 2, \"text\": \"10.3 During the Term, the Supplier shall maintain product liability insurance with a reputable insurer of no less than AU$10 million for any one occurrence for any and all liability (however arising) for a claim that the Products are faulty or defective. The Supplier shall provide a copy of the insurance policy to the Distributor on request. 8 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor undertakes to maintain appropriate, up-to-date and accurate records to enable the immediate recall of an\", \"level\": 2, \"text\": \"10.4 The Distributor undertakes to maintain appropriate, up-to-date and accurate records to enable the immediate recall of any Products or batches of Products from the retail or wholesale markets. These records shall include records of deliveries to customers (including batch numbers, delivery date, name and address of customer, telephone number, fax number and e-mail address).\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall, at the Supplier's cost, give any assistance that the Supplier shall reasonably require to recall,\", \"level\": 2, \"text\": \"10.5 The Distributor shall, at the Supplier's cost, give any assistance that the Supplier shall reasonably require to recall, as a matter of urgency, Products from the retail or wholesale market.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Duration and termination\", \"level\": 1, \"text\": \"11. Duration and termination\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This agreement begins on the Commencement Date and, subject to clause 11\", \"level\": 2, \"text\": \"11.1 This agreement begins on the Commencement Date and, subject to clause 11.2, shall continue for an initial term of one (1) years (Initial Term) and indefinitely after that until terminated by either party giving at least twelve (12) months' prior written notice to expire on or after the expiry date of the initial term.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Without affecting any other rights that it may be entitled to, either party may give notice in writing to the other term\", \"level\": 2, \"text\": \"11.2 Without affecting any other rights that it may be entitled to, either party may give notice in writing to the other terminating this agreement immediately if: (a) the other party fails to pay any amount due under this agreement on the due date for payment and remains in default not less than 14 days after being notified in writing to make such payment; or (b) the other party commits a material breach of any material term of this agreement and (if such breach is remediable) fails to remedy that breach within a period of 14 days of being notified in writing to do so; or (c) the other party repeatedly breaches any of the terms of this agreement in such a manner as to reasonably justify the opinion that its conduct is inconsistent with it having the intention or ability to give effect to the terms of this agreement; or (d) the other party suspends, or threatens to suspend, payment of its debts or is unable to pay its debts as they fall due or admits inability to pay its debts or (being a company) is deemed unable to pay its debts within the meaning of the Corporations Act 2001 (Cth) OR (being a natural person) is deemed either unable to pay its debts or as having no reasonable prospect of so doing, in either case, within the meaning of the Corporations Act 2001 (Cth) OR (being a partnership) has any partner to whom any of the foregoing apply: or (e) the other party commences negotiations with all or any class of its creditors with a view to rescheduling any of its debts, or makes a proposal for or enters into any compromise or arrangement with its creditors other than for the sole purpose of a scheme for a solvent amalgamation of that other party with one or more other companies or the solvent reconstruction of that other party; or 9 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 (f) a petition is filed, a notice is given, a resolution is passed, or an order is made, for or in connection with the winding up of that other party other than for the sole purpose of a scheme for a solvent amalgamation of that other party with one or more other companies or the solvent reconstruction of that other party: or (g) an application is made to court, or an order is made, for the appointment of an administrator or if a notice of intention to appoint an administrator is given or if an administrator is appointed over the other party; or (h) a person becomes entitled to appoint a receiver over the assets of the other party or a receiver is appointed over the assets of the other party; or (i) the other party, being an individual, is the subject of a bankruptcy petition or order; or (j) a creditor or encumbrancer of the other party attaches or takes possession of, or a distress, execution, sequestration or other such process is levied or enforced on or sued against, the whole or any part of its assets and such attachment or process is not discharged within 14 days; or (k) any event occurs, or proceeding is taken, with respect to the other party in any jurisdiction to which it is subject that has an effect equivalent or similar to any of the events mentioned in clause 11.2(d) to clause 11.2(j) (inclusive); or (l) the other party suspends or ceases, or threatens to suspend or cease, to carry on all or a substantial part of its business; or (m) the other party, being an individual, dies or, by reason of illness or incapacity (whether mental or physical), is incapable of managing his or her own affairs or becomes a patient under any mental health legislation. (n) Without affecting any other rights that it may be entitled to, the Supplier may give notice in writing to the Distributor terminating this agreement immediately if the Distributor purports to assign its rights or obligations under this agreement to an entity that is not (1) affiliated with, (2) related to, or (3) sharing common ownership with the Distributor (a Permitted Assignee).\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effectsof termination\", \"level\": 1, \"text\": \"12. Effectsof termination\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of terminati\", \"level\": 2, \"text\": \"12.1 Termination of this agreement for any reason shall not affect any rights or liabilities accrued at the date of termination. 10 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"At the Supplier's option, on termination of this agreement\", \"level\": 2, \"text\": \"12.2 At the Supplier's option, on termination of this agreement: (a) the Supplier may buy from the Distributor all or any stocks of Products for the current market value for those Products. The Distributor must deliver such Products to the Supplier within 14 days of receiving the Supplier's notice, and the Supplier must pay for the Products in full within 30 days of their delivery. The Supplier shall be responsible for the costs of packaging, insurance and carriage of the Products; or (b) the Distributor may dispose of the balance of the Products in its possession and account to the Supplier for the Price for those Products; and (c) subject to clause 12.2(b), the Distributor must cease using any intellectual property of the Supplier or of another person that relates to the distributorship and the Distributor must sign any instrument and do any other act that is necessary to achieve this purpose;\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For the purposes of clause 12\", \"level\": 2, \"text\": \"12.3 For the purposes of clause 12.2(a) the current market value in respect of Products shall be the price that the Products are ordinarily supplied as at the date of termination of this agreement.\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to clause 12\", \"level\": 2, \"text\": \"12.4 Subject to clause 12.2, all other rights and licences of the Distributor under this agreement shall terminate on the termination date.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 1, \"text\": \"13. Confidentiality\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party undertakes that it shall not at any time, disclose to any person any confidential information concerning the\", \"level\": 2, \"text\": \"13.1 Each party undertakes that it shall not at any time, disclose to any person any confidential information concerning the business, affairs, customers, clients or suppliers of the other party or of any member of the group of companies to which the other party belongs, except as provided by clause 13.2.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party may disclose the other party's confidential information\", \"level\": 2, \"text\": \"13.2 Each party may disclose the other party's confidential information: (a) to those of its employees, officers, representatives or advisers who need to know such information for the purpose of carrying out the party's obligations under this agreement. Each party shall ensure that its employees, officers, representatives or advisers to whom it discloses the other party's confidential information comply with this clause 13; and (b) as may be required by law, court order or any governmental or regulatory authority; provided, however, that the other party reserves the right to challenge such disclosure under applicable law. If such party elects to challenge the disclosure, no confidential information shall be disclosed during the pendency of such challenge.\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No party shall use any other party's confidential information for any purpose other than to perform its obligations unde\", \"level\": 2, \"text\": \"13.3 No party shall use any other party's confidential information for any purpose other than to perform its obligations under this agreement. 11 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire agreement\", \"level\": 1, \"text\": \"14. Entire agreement\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This agreement (and any document referred to in it) constitutes the whole agreement between the parties and supersedes a\", \"level\": 2, \"text\": \"14.1 This agreement (and any document referred to in it) constitutes the whole agreement between the parties and supersedes all previous agreements between the parties relating to its subject matter.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party acknowledges that, in entering into this agreement (and any document referred to in it), it has not relied on\", \"level\": 2, \"text\": \"14.2 Each party acknowledges that, in entering into this agreement (and any document referred to in it), it has not relied on, and shall have no right or remedy in respect of, any statement, representation, assurance or warranty (whether made negligently or innocently) other than as expressly set out in this agreement. Each party agrees that its only liability in respect of those representations and warranties that are set out in this agreement (whether made innocently or negligently) shall be for breach of contract.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing in this clause shall limit or exclude any liability for fraud\", \"level\": 2, \"text\": \"14.3 Nothing in this clause shall limit or exclude any liability for fraud.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Variation\", \"level\": 1, \"text\": \"15. Variation No amendment or variation of this agreement shall be effective unless it is in writing and signed by the parties (or their authorised representatives).\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment and other dealings prohibited\", \"level\": 1, \"text\": \"16. Assignment and other dealings prohibited\"}}, {\"id\": \"16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this a\", \"level\": 2, \"text\": \"16.1 The Distributor shall not assign, transfer, mortgage, charge, declare a trust of or deal in any other manner with this agreement or any of its rights and obligations under or arising out of this agreement, or purport to do any of the same; provided, however, the Distributor may assign or transfer this agreement to a Permitted Assignee without the consent of Supplier. The Distributor shall not sub-contract or delegate in any manner any or all of its obligations under this agreement to any third party or agent.\"}}, {\"id\": \"16.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16\", \"level\": 2, \"text\": \"16.2 If the Distributor seeks the Supplier's consent to any proposed dealing under clause 16.1, the Distributor must: - (a) disclose fully in writing all material facts relating to the dealing (b) comply fully with any conditions or requirements set down by the Supplier which attach to any Suppliers consent that is given.\"}}, {\"id\": \"16.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person\", \"level\": 2, \"text\": \"16.3 Each party that has rights under this agreement is acting on its own behalf and not for the benefit of another person.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Freedom to contract\", \"level\": 1, \"text\": \"17. Freedom to contract The parties declare that they each have the right, power and authority and have taken all action necessary to execute and deliver and to exercise their rights and perform their obligations under this agreement. 12 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Waiver\", \"level\": 1, \"text\": \"18. Waiver No failure or delay by a party to exercise any right or remedy provided under this agreement or by law shall constitute a waiver of that or any other right or remedy, nor shall it preclude or restrict the further exercise of that or any other right or remedy. No single or partial exercise of such right or remedy shall preclude or restrict the further exercise of that or any other right or remedy.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severance\", \"level\": 1, \"text\": \"19. Severance\"}}, {\"id\": \"19.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If any provision of this agreement (or part of any provision) is found by any court or other authority of competent juri\", \"level\": 2, \"text\": \"19.1 If any provision of this agreement (or part of any provision) is found by any court or other authority of competent jurisdiction to be invalid, illegal or unenforceable, that provision or part-provision shall, to the extent required, be deemed not to form part of this agreement, and the validity and enforceability of the other provisions of this agreement shall not be affected.\"}}, {\"id\": \"19.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If a provision of this agreement (or part of any provision) is found illegal, invalid or unenforceable, the provision sh\", \"level\": 2, \"text\": \"19.2 If a provision of this agreement (or part of any provision) is found illegal, invalid or unenforceable, the provision shall apply with the minimum modification necessary to make it legal, valid and enforceable.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 1, \"text\": \"20. Notices\"}}, {\"id\": \"20.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any notice required to be given under this agreement, shall be in writing and shall be delivered personally, by email, o\", \"level\": 2, \"text\": \"20.1 Any notice required to be given under this agreement, shall be in writing and shall be delivered personally, by email, or sent by pre-paid first class post or recorded delivery or by commercial courier, to each party required to receive the notice at its address as set out at the beginning of this agreement or as otherwise specified by the relevant party by notice in writing to each other party.\"}}, {\"id\": \"20.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any notice shall be deemed to have been duly received\", \"level\": 2, \"text\": \"20.2 Any notice shall be deemed to have been duly received: (a) if delivered personally, when left at the address and for the contact referred to in this clause; or (b) if sent by pre-paid first class post or recorded delivery, at 9.00 am on the second Business Day after posting; or (c) if delivered by commercial courier, on the date and at the time that the courier's delivery receipt is signed; or (d) if delivered by email, on the date and at the time such email is received by the recipient whether such message is opened at that time. Any notice given or received by a lawyer for a party to this agreement is deemed to be given or received with the actual or ostensible authority of the lawyer. The Supplier may at times by notice nominate an address for service of legal proceeding, whether in Australia or in any other place. A nomination binds the 13 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 parties but nothing prevents the Supplier from making further nomination in place of any earlier nomination.\"}}, {\"id\": \"20.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A notice given under this agreement shall not be validly given if sent by e-mail\", \"level\": 2, \"text\": \"20.3 A notice given under this agreement shall not be validly given if sent by e-mail.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third party rights\", \"level\": 1, \"text\": \"21. Third party rights\"}}, {\"id\": \"21.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A person who is not a party to this agreement shall not have any rights under or in connection with it by virtue of the\", \"level\": 2, \"text\": \"21.1 A person who is not a party to this agreement shall not have any rights under or in connection with it by virtue of the Contracts\"}}, {\"id\": \"21.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The rights of the parties to terminate, rescind or agree any variation, waiver or settlement under this agreement are no\", \"level\": 2, \"text\": \"21.2 The rights of the parties to terminate, rescind or agree any variation, waiver or settlement under this agreement are not subject to the consent of any person that is not a party to this agreement.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No partnership or agency\", \"level\": 1, \"text\": \"22. No partnership or agency Except as expressly provided, nothing in this agreement is intended to, or shall be deemed to, establish any partnership or joint venture between the parties, constitute either party the agent of the other, nor authorise a party to make or enter into any commitments for or on behalf of the other party.\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 1, \"text\": \"23. Counterparts This agreement may be executed in any number of counterparts, each of which when executed and delivered shall constitute an original of this agreement, but all the counterparts shall together constitute the same agreement.\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing law and jurisdiction\", \"level\": 1, \"text\": \"24. Governing law and jurisdiction\"}}, {\"id\": \"24.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (incl\", \"level\": 2, \"text\": \"24.1 This agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with Ohio law.\"}}, {\"id\": \"24.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties irrevocably agree that the courts of Ohio shall have non-exclusive jurisdiction to settle any dispute or cla\", \"level\": 2, \"text\": \"24.2 The parties irrevocably agree that the courts of Ohio shall have non-exclusive jurisdiction to settle any dispute or claim that arises out of or in connection with this agreement or its subject matter or formation (including non- contractual disputes or claims). This agreement has been entered into on the date stated at the beginning of it. 14 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 Schedule 1 AriaTM Hip Stem System RemedyTM Hip Stem system LogicalTM Hip Cup system Signature BiPolar Head Genius Total knee system 15 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"Schedule 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Territory\", \"level\": 1, \"text\": \"Schedule 2 Territory USA. 16 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"Schedule 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Trade Marks\", \"level\": 1, \"text\": \"Schedule 3 The Trade Marks OriginTM, LogicalTM, AriaTM, RemedyTM, GeniusTM 17 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"Schedule 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices\", \"level\": 1, \"text\": \"Schedule 4 Prices Aria Stem $610 Origin Stem $610 Remedy Stem $610 Logical Cup $450 Logical Liner $210 Metal Head $240 Ceramic Head $340 BiPolar Head $250 PS / CR Femoral Component $550 Insert $340 Tibia Tray $440 Patella $70 18 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019 SIGNED by Signature Orthopaedics Pty Ltd (ACN 106 702 416) In accordance with section 127 of the Corporations Act: ) ) ) ) ) Director/Secretary Name (please print) Director Name (please print) SIGNED by CPM Medical LLC ) ) ) ) ) Director/Secretary Name (please print) Director Name (please print) 19 Source: FUSE MEDICAL, INC., 10-K, 3/21/2019\"}}, {\"id\": \"party:Signature Orthopaedics Pty Ltd\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Signature Orthopaedics Pty Ltd\", \"role\": \"Supplier\", \"address\": \"7 Sirius Road, Lane Cove, NSW\"}}, {\"id\": \"party:CPM Medical Consultants, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"CPM Medical Consultants, LLC\", \"role\": \"Distributor\", \"address\": \"1565N. Central Expressway, Suite 200, Dallas, TX 75080.\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"a day (other than a Saturday, Sunday or public holiday in Australia) when banks in Sydney are open for business.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Commencement Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commencement Date\", \"text\": \"means the date of this agreement.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Control\", \"text\": \"the ability to direct the affairs of another person, whether by virtue of the ownership of shares, contract or otherwise.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Inactive Territories\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Inactive Territories\", \"text\": \"means a country in which the Distributor has not sold or supplied the Product during the Initial Term.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"has the meaning given to it in clause 12.1.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"As defined in Schedule 1 and includes any other products developed by the Supplier and which the Supplier may permit the Distributor, by express notice in writing, to distribute in the Territory.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"the term of this agreement, as determined in accordance with clause 11.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"means the territory specified in Schedule 2.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Trade Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trade Marks\", \"text\": \"the trade mark registrations listed in Schedule 3 and any further trade marks that the Supplier may permit, or procure permission for, the Distributor to use in the Territory in respect of the Products by express notice in writing.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:GST\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"GST\", \"text\": \"goods and services tax chargeable under the Goods and Services Tax Act and any similar replacement or additional tax or such other similar or analogous form of tax under the laws and regulations in the Territory.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Year\", \"text\": \"the period of 12 months from the Commencement Date and each consecutive period of 12 months thereafter during the Term.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 months\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:28 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"28 days\"}}, {\"id\": \"value:thirty (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (45) days\"}}, {\"id\": \"value:five days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five days\"}}, {\"id\": \"value:AU$10 million\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"AU$10 million\"}}, {\"id\": \"value:one (1) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) years\"}}, {\"id\": \"value:twelve (12) months'\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months'\"}}, {\"id\": \"value:14 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"14 days\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:second Business Day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"second Business Day\"}}, {\"id\": \"value:$610\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$610\"}}, {\"id\": \"value:$450\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$450\"}}, {\"id\": \"value:$210\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$210\"}}, {\"id\": \"value:$240\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$240\"}}, {\"id\": \"value:$340\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$340\"}}, {\"id\": \"value:$250\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$250\"}}, {\"id\": \"value:$550\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$550\"}}, {\"id\": \"value:$440\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$440\"}}, {\"id\": \"value:$70\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$70\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.6\", \"level\": 1, \"text\": \"Exhibit 10.6 Goosehead Insurance Agency, LLC Franchise Agreement\"}, {\"id\": \"Exhibit A\", \"title\": \"Declarations Page 1 1.2 The \\\"Approved Location\\\" under this Agreement will be: . 2 4.1 You elect to pay the Initial Franchise Fee in one of the following ways: (check only one): \u2610 In its entirety at the time you enter into this Agreement, in which case the amount of the Initial Franchise Fee shall be: ($ ). \u2610 You shall pay a portion of the Initial Franchise Fee at the time you enter into this Agreement in the amount of ($ ), and shall pay the remaining portion of ($ ), plus interest, according to the terms of the 60-month Promissory Note attached to this Agreement as Exhibit I. 3 4.2 The \\\"Commencement Date\\\" will be: . Initials Franchisee Franchisor\", \"level\": 1, \"text\": \"Exhibit A Declarations Page 1 1.2 The \\\"Approved Location\\\" under this Agreement will be: . 2 4.1 You elect to pay the Initial Franchise Fee in one of the following ways: (check only one): \u2610 In its entirety at the time you enter into this Agreement, in which case the amount of the Initial Franchise Fee shall be: ($ ). \u2610 You shall pay a portion of the Initial Franchise Fee at the time you enter into this Agreement in the amount of ($ ), and shall pay the remaining portion of ($ ), plus interest, according to the terms of the 60-month Promissory Note attached to this Agreement as Exhibit I. 3 4.2 The \\\"Commencement Date\\\" will be: . Initials Franchisee Franchisor Goosehead Insurance Agency, LLC Franchise Agreement TABLE OF CONTENTS Section Title Page# Recitals 2 1 Grant 2 2 Term And Renewal 3 3 Our Duties 4 4 Fees; Sales Reporting 6 5 Franchised Business Commencement 9 6 Operating Principal, Personnel, And Training 11 7 Purchase of Products and Services 13 8 Your Duties 15 9 Proprietary Marks 20 10 Confidential Brand Standards Manuals 23 11 Confidential Information 24 12 Accounting, Financial And Other Records, And Inspections 25 13 Marketing 27 14 Technology 31 15 Insurance 35 16 Transfer Of Interest 38 17 Default And Termination 43 18 Obligations Upon Termination Or Expiration 46 19 Covenants 49 20 Taxes, Permits, And Indebtedness 51 21 Independent Contractor And Indemnification 52 22 Force Majeure 53 23 Approvals And Waivers 54 24 Notices 54 25 Entire Agreement And Amendment 54 26 Severability And Construction 55 27 Applicable Law And Dispute Resolution 55 28 Acknowledgments 57 Exhibits A Declarations Page E ADA Certification B Guarantee, Indemnification, and Acknowledgement F1- 3 Sample Forms of Non-Disclosure and Non- Competition Agreements C List of Principals G Site Selection Addendum D ACH - Authorization Agreement for H Lease Rider Prearranged Payments (Direct Debits) I Promissory Note i Goosehead Insurance Agency, LLC Franchise Agreement THIS FRANCHISE AGREEMENT (the \\\"Agreement\\\") is made and entered into as of the \\\"Effective Date\\\" that we have indicated on the signature page of this Agreement by and between: \u25cf Goosehead Insurance Agency, LLC, a Delaware limited liability company, with its principal place of business at 1500 Solana Blvd., Suite 450, Westlake, Texas 76262 (\\\"we,\\\" \\\"us,\\\" or \\\"our\\\"); and \u25cf a [resident of] [corporation organized in] [limited liability company organized in] the state of and having offices at (\\\"you\\\" or the \\\"Franchisee\\\"). Introduction We have developed our own distinctive and proprietary systems for insurance services, including home insurance, automobile insurance, life insurance, specialty lines, and business insurance (the \\\"System\\\"). Our System includes (among other things): business processes, technologies, trade secrets, customer lists, knowledge, know-how, trade names, service marks, trademarks, logos, emblems, trade dress and other intellectual property; distinctive signage; standards, specifications and sources for services, products, supplies, appearance, operations and management control; safety standards; training and assistance; purchasing programs; and advertising, marketing, promotional and sales programs; all of which we may periodically change, discontinue, improve, modify and further develop. We identify the System by means of our Proprietary Marks. Our proprietary marks include certain trade names (for example, the mark \\\"Goosehead Insurance\\\" and logo), service marks, trademarks, logos, emblems, and indicia of origin, as well as other trade names, service marks, and trademarks that we may periodically specify in writing for use in connection with the System (all of these are referred to as our \\\"Proprietary Marks\\\"). We continue to develop, use, and control the use of our Proprietary Marks in order to identify for the public the source of services and products marketed under those marks and under the System, and to represent the System's high standards of quality, appearance, and service. We are in the business of developing and awarding franchise rights to third party franchisees, such as you, to develop and operate businesses providing insurance services (\\\"Services\\\") to clients under the System and using the Proprietary Marks (\\\"Goosehead Businesses\\\"). You have asked to enter into the business of operating a Goosehead Business under our System and wish to obtain a franchise from us for that purpose, as well as to receive the training and other assistance we provide as described in this Agreement. You also understand and acknowledge the importance of our high standards of quality, appearance, and service and the necessity of operating the business franchised under this Agreement in conformity with our standards and specifications. You will be in the business of operating a Goosehead Business, using the same brand and Proprietary Marks as other independent businesses that operate other Goosehead Businesses under the System. We will not operate your Goosehead Business for you, although we have (and will continue) to set standards for Goosehead Businesses that you will have chosen to adopt as yours by signing this Agreement and by your day-to-day management of your Goosehead Business to our brand standards. Page 1 of 80 Page 2 of 80 Page 3 of 80 Page 4 of 80 Page 5 of 80 Page 6 of 80 changes and net of Agency Fee refunds, for insurance services provided by the Franchised Business; Gross Revenues will not include any Premiums or Policy Fees collected by the Franchised Business on behalf of any insurance carrier. 4.2.4 The term \\\"Minimum Royalty\\\" means a minimum monthly Royalty Fee payment, beginning six (6) months after the Commencement Date, in the following amounts: Number of Months following the Commencement Date Amount of Monthly Minimum Royalty Six (6) to Eighteen (18) Six Hundred Dollars ($600) Nineteen (19) and for the remainder of the term of this Agreement One Thousand Dollars ($1,000) Page 7 of 80 Page 8 of 80 Page 9 of 80 Page 10 of 80 Page 11 of 80 Page 12 of 80 While your Franchised Business will focus principally on the provision of Services, you may also offer certain products at your Franchised Business. This Section 7 addresses those items. 7.1 Products. You agree to buy all products, equipment, furniture, supplies, materials and other products used or offered for sale at the Franchised Business only from suppliers as to whom we have given you our prior written approval (and whom we have not subsequently disapproved). In this regard, the parties further agree: 7.1.1 In determining whether we will approve any particular supplier, we will consider various factors, including: (a) whether the supplier can demonstrate, to our continuing reasonable satisfaction, the ability to meet our then-current standards and specifications for such items; (b) whether the supplier has adequate quality controls and capacity to supply your needs promptly and reliably; (c) whether approval of the supplier would enable the System, in our sole opinion, to take advantage of marketplace efficiencies; and (d) whether the supplier will sign a confidentiality agreement and a license agreement in the form that we may require (which may include a royalty fee for the right to use our Proprietary Marks and any other proprietary rights, recipes, and/or formulae). Page 13 of 80 Page 14 of 80 Page 15 of 80 Page 16 of 80 Page 17 of 80 Page 18 of 80 Page 19 of 80 Page 20 of 80 Page 21 of 80 Page 22 of 80 Page 23 of 80 Page 24 of 80 Page 25 of 80 Page 26 of 80 Page 27 of 80 Page 28 of 80 Page 29 of 80 Page 30 of 80 Page 31 of 80 Page 32 of 80 Page 33 of 80 Page 34 of 80 Page 35 of 80 Page 36 of 80 Page 37 of 80 Page 38 of 80 Page 39 of 80 Page 40 of 80 Page 41 of 80 furniture, fixtures, equipment and the rights under the lease for the Approved Location (if we elect to purchase these assets) will be the fair market value as you and we agree. If we and you (or your appropriate legal representative) cannot agree on the fair market value of such furniture, fixtures, equipment or the rights under the lease for the Approved Location, each party will select an independent appraiser who will each provide a written appraisal of such furniture, fixtures, equipment or rights under the lease for the Approved Location and we may elect to exercise the option granted hereunder by paying to you the average of the two appraisals. We will pay the purchase price to you in twelve (12) equal, monthly installments following the purchase, provided that you are in full compliance with the covenants contained in this Agreement. If, at any time during the twelve (12) months following our purchase of your assets, as described above, you breach any covenant contained in this Agreement (or any other agreement between you and us), our obligation to pay the monthly installments will immediately cease. 16.6.3.3 We may elect to exercise our option to purchase your interest in the Franchised Business by sending written notice of the election to you (or your appropriate legal representative). The election may exclude the purchase of the furniture, fixtures, equipment and rights under the lease for the Approved Location. The closing of the sale will occur within thirty (30) days after we exercise our option to purchase the Franchised Business or such later date as may be necessary to comply with applicable bulk sales or similar laws. At closing, we and you agree to sign and deliver all documents necessary to vest title in the assets purchased by us free and clear of all liens and encumbrances, except any assumed by us and/or to effectuate assignment of the lease for the Approved Location. You (or your appropriate legal representative) must cooperate fully and use your best efforts to acquire the landlord's approval of the assignment of the lease for the Approved Location to us, if necessary. If the lease for the Approved Location cannot be assigned to us, you will agree to sublease the Approved Location to us on all the same terms and conditions as are contained in your lease and will cooperate fully and use your best efforts to acquire the landlord's approval of the sublease, if necessary. We reserve the right to assign our option to purchase the Franchised Business or designate a substitute purchaser of the Franchised Business. 16.7 Consent to Transfer. Our consent to a transfer that is the subject of this Section 16 will not constitute a waiver of any claims that we may have against the transferring party, nor will it be deemed a waiver of our right to demand exact compliance with any of the terms of this Agreement by the transferor or transferee. 16.8 No Transfers to a Non-Franchisee Party to Operate a Similar Business. You agree that neither you nor any Principal of yours will transfer or attempt to transfer any or all of your Franchised Business to a third party who will operate a similar business at the Approved Location but not under the System and the Proprietary Marks, and not under a franchise agreement with us. 16.9 Bankruptcy Issues. If you or any person holding any interest (direct or indirect) in you become a debtor in a proceeding under the U.S. Bankruptcy Code or any similar law in the U.S. or elsewhere, it is the parties' understanding and agreement that any transfer of you, your obligations, and/or rights under this Agreement, any material assets of yours, and/or Page 42 of 80 Page 43 of 80 Page 44 of 80 Page 45 of 80 Upon termination or expiration of this Agreement, all rights granted under this Agreement to you will forthwith terminate, and all of the following will take effect: 18.1 Cease Operation. You agree to: (a) immediately and permanently stop operating the Franchised Business; and (b) never directly or indirectly represent to the public that you are a present or former franchisee of ours. 18.2 Stop Using Marks and Intellectual Property. You agree to immediately and permanently cease to use, in any manner whatsoever, all aspects of the System, including any confidential methods, procedures and techniques associated with the System, the mark \\\"Goosehead Insurance\\\" and any and all other Proprietary Marks, distinctive forms, slogans, signs, symbols, and devices associated with the System, and any and all other intellectual property associated with the System. Without limiting the foregoing, you agree to stop making any further use of any and all signs, marketing materials, displays, stationery, forms, and any other articles that display the Proprietary Marks. 18.3 Cancel Assumed Names. You agree to take such action as may be necessary to cancel any assumed name or equivalent registration which contains the mark \\\"Goosehead Insurance\\\" Page 46 of 80 Page 47 of 80 Page 48 of 80 Page 49 of 80 Page 50 of 80 Page 51 of 80 Page 52 of 80 Page 53 of 80\"}, {\"id\": \"23\", \"title\": \"APPROVALS AND WAIVERS 23\", \"level\": 1, \"text\": \"23 APPROVALS AND WAIVERS 23.1 Request for Approval. Whenever this Agreement requires our prior approval or consent, you agree to make a timely written request to us therefor, and such approval or consent must be obtained in writing. 23.2 No Warranties or Guarantees. You acknowledge and agree that we make no warranties or guarantees upon which you may rely, and that we assume no liability or obligation to you, by providing any waiver, approval, consent, or suggestion to you in connection with this Agreement, or by reason of any neglect, delay, or denial of any request therefor. 23.3 No Waivers. No delay, waiver, omission, or forbearance on our part to exercise any right, option, duty, or power arising out of any breach or default by you or any other franchisee under any of the terms, provisions, covenants, or conditions of this Agreement, and no custom or practice by the parties at variance with the terms of this Agreement, will constitute our waiver of our right to enforce any such right, option, duty, or power as against you, or as to subsequent breach or default by you. If we accept late payments from you or any payments due, that will not be deemed to be our waiver of any earlier or later breach by you of any terms, provisions, covenants, or conditions of this Agreement. No course of dealings or course of conduct will be effective to amend the terms of this Agreement. 24 NOTICES Any and all notices required or permitted under this Agreement must be in writing and must be personally delivered, sent by certified U.S. mail, or by other means which affords the sender evidence of delivery, of rejected delivery, or attempted delivery to the respective parties at the addresses shown on the signature page of this Agreement, unless and until a different address has been designated by written notice to the other party. Any notice by a means that gives the sender evidence of delivery, rejected delivery, or delivery that is not possible because the recipient moved and left no forwarding address will be deemed to have been given at the date and time of receipt, rejected, and/or attempted delivery. The Manual, any changes that we make to the Manual, and/or any other written instructions that we provide relating to operational matters, are not considered to be \\\"notices\\\" for the purpose of the delivery requirements in this Section 24. 25 ENTIRE AGREEMENT AND AMENDMENT 25.1 Entire Agreement. This Agreement and the exhibits referred to in this Agreement constitute the entire, full, and complete Agreement between the parties to this Agreement concerning the subject matter hereof, and supersede all prior agreements. The parties confirm that: (a) they were not induced by any representations other than the words of this Agreement (and the FDD) before deciding whether to sign this Agreement; and (b) they relied only on the words printed in this Agreement in deciding whether to enter into this Agreement. However, nothing in this Section is intended as, nor will it be interpreted to be, a disclaimer by us of any representation made in our Franchise Disclosure Document (\\\"FDD\\\"), including the exhibits and any amendments to the FDD. 25.2 Amendment. Except for those changes that we are permitted to make unilaterally under this Agreement, no amendment, change, or variance from this Agreement will be binding on either party unless mutually agreed to by the parties and executed by their authorized officers or agents in writing. Page 54 of 80 Page 55 of 80 Page 56 of 80 Page 57 of 80 Page 58 of 80 You (on behalf of yourself and your parent, subsidiaries and affiliates and their respective past and present members, officers, directors, members, managers, shareholders, agents and employees, in their corporate and individual capacities) and all guarantors of your obligations under this Agreement (collectively, \\\"Releasors\\\") freely and without any influence forever release and covenant not to sue us, our parent, subsidiaries and affiliates and their respective past and present officers, directors, shareholders, agents and employees, in their corporate and individual capacities (collectively \\\"Releasees\\\"), with respect to any and all claims, demands, liabilities and causes of action of whatever kind or nature, whether known or unknown, vested or contingent, suspected or unsuspected (collectively, \\\"claims\\\"), which any Releasor now owns or holds or may at any time have owned or held, including, without limitation, claims arising under federal, state and local laws, rules and ordinances and claims arising out of, or relating to this Agreement and all other agreements between any Releasor and any Releasee, the sale of any franchise to any Releasor, the development and operation of the Goosehead Businesses and the development and operation of all other businesses operated by any Releasor that are franchised by any Releasee. You expressly agree that fair consideration has been given by us for this General Release and you fully understand that this is a negotiated, complete and final release of all claims. This General Release does not release any claims arising from representations made in our Franchise Disclosure Document and its exhibits or otherwise impair or affect any claims arising after the date of this Agreement. ***** Page 59 of 80 IN WITNESS WHEREOF, the parties hereto have duly signed and delivered this Agreement in duplicate on the day and year first above written. Goosehead Insurance Agency, LLC Franchisor Franchisee Entity By: By: Name: Name: Title: Title: Effective Date: Address for Notices: Address for Notices:\"}, {\"id\": \"1500\", \"title\": \"Solana Blvd\", \"level\": 1, \"text\": \"1500 Solana Blvd., Suite 4500 Westlake, Texas 76262 Fax: Fax: Attn: Attn: Page 60 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT B GUARANTEE, INDEMNIFICATION, AND ACKNOWLEDGMENT In order to induce Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") to sign the Goosehead Insurance Franchise Agreement between Franchisor and (\\\"Franchisee\\\"), dated , 201 (the \\\"Agreement\\\"), each of the undersigned parties, jointly and severally, hereby unconditionally guarantee to Franchisor and its successors and assigns that all of Franchisee's obligations (monetary and otherwise) under the Agreement as well as any other contract between Franchisee and Franchisor (and/or Franchisor's affiliates) will be punctually paid and performed. Each individual signing this Personal Guarantee acknowledges and agrees, jointly and severally, that: \u2022 Upon Franchisor's demand, s/he will immediately make each payment required of Franchisee under the Agreement and/or any other contract with Franchisor and/or its affiliates. \u2022 S/he waives any right to require Franchisor to: (a) proceed against Franchisee for any payment required under the Agreement (and/or any other contract with Franchisor and/or its affiliates); (b) proceed against or exhaust any security from Franchisee; (c) pursue or exhaust any remedy, including any legal or equitable relief, against Franchisee; and/or (d) give notice of demand for payment by Franchisee. \u2022 Without affecting the obligations of the undersigned persons under this Guarantee, Franchisor may, without notice to the undersigned, extend, modify, or release any indebtedness or obligation of Franchisee, or settle, adjust, or compromise any claims against Franchisee. Each of the undersigned persons waive notice of amendment of the Agreement (and any other contract with Franchisor and Franchisor's affiliates) and notice of demand for payment by Franchisee, and agree to be bound by any and all such amendments and changes to the Agreement (and any other contract with Franchisor and Franchisor's affiliates). \u2022 S/he will defend, indemnify and hold Franchisor harmless against any and all losses, damages, liabilities, costs, and expenses (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) resulting from, consisting of, or arising out of or in connection with any failure by Franchisee to perform any obligation of Franchisee under the Agreement (and any other contract with Franchisor and Franchisor's affiliates) and/or any amendment to the Agreement. \u2022 S/he will be personally bound by all of Franchisee's covenants, obligations, and promises in the Agreement. \u2022 S/he agrees to be individually bound by all of Franchisee's covenants, obligations, and promises in the Agreement, which include, but are not limited to, the covenants in the following Sections of the Agreement: Section 9.3 (generally regarding trademarks), Section 11 (generally regarding confidentiality), Section 16 (generally regarding Transfers), Section 18 (generally regarding obligations upon termination or expiration of this Agreement), and Section 19 (generally regarding covenants against competition) of the Agreement. Page 61 of 80 \u25cf S/he understands that: (a) this Guarantee does not grant them any rights under the Agreement (including but not limited to the right to use any of Franchisor's marks such as the \\\"Goosehead Insurance\\\" marks) and/or the system licensed to Franchisee under the Agreement; (b) that they have read, in full, and understand, all of the provisions of the Agreement that are referred to above in this paragraph, and that they intend to fully comply with those provisions of the Agreement as if they were printed here; and (c) that they have had the opportunity to consult with a lawyer of their own choosing in deciding whether to sign this Guarantee. This Guarantee will be interpreted and construed in accordance with Section 27 of the Agreement (including but not limited to the waiver of punitive damages, waiver of jury trial, agreement to bring claims within one year, and agreement not to engage in class or common actions). Among other things, that means that this Guarantee will be interpreted and construed exclusively under the laws of the State of Texas, and that in the event of any conflict of law, Texas law will prevail (without applying Texas conflict of law rules). IN WITNESS WHEREOF, each of the undersigned persons has signed this Guarantee as of the date of the Agreement. (in his/her personal capacity) (in his/her personal capacity) (in his/her personal capacity) Printed Name: Printed Name: Printed Name: Date: Date: Date: Home Address: Home Address: Home Address: Page 62 of 80 GOOSEHEAD INSURANCE AGENCY, LLC] FRANCHISE AGREEMENT EXHIBIT C LIST OF PRINCIPALS Name of Principal Home Address Interest % Initials Franchisee Franchisor Page 63 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT D AUTHORIZATION AGREEMENT FOR ACH PAYMENTS (DIRECT DEBITS FOR ROYALTY, MARKETING CONTRIBUTION, AND OTHER FEES) (Name of Person or Legal Entity) (ID Number) The undersigned depositor (\\\"Depositor\\\" or \\\"Franchisee\\\") hereby authorizes Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") to initiate debit entries and/or credit correction entries to the undersigned's checking and/or savings account(s) indicated below and the depository designated below (\\\"Depository\\\" or \\\"Bank\\\") to debit or credit such account(s) pursuant to our instructions. Depository Branch City State Zip Code Bank Transit/ABA Number Account Number This authorization is to remain in full and force and effect until sixty days after we have received written notification from Franchisee of its termination. Printed Name of Depositor: Signed By: Printed Name: Title: Date: Page 64 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT E ADA CERTIFICATION Goosehead Insurance Agency, LLC (\\\"Franchisor\\\" or \\\"us\\\") and (\\\"Franchisee\\\" or \\\"you\\\") are parties to a franchise agreement dated , 201___ (the \\\"Franchise Agreement\\\") for the operation of a Franchised Business at (the \\\"Franchised Business\\\"). \u2022 In accordance with Section 5.6.2 of the Franchise Agreement, you certify to us that, to the best of your knowledge, the Franchised Business and its adjacent areas comply with all applicable federal, state, and local accessibility laws, statutes, codes, rules, regulations, and standards, including but not limited to the Americans with Disabilities Act. \u2022 You acknowledge that you are an independent contractor and the requirement of this certification by Franchisor does not constitute ownership, control, leasing, or operation of the Franchised Business. \u2022 You acknowledge that we have relied on the information contained in this certification. \u2022 You agree to indemnify us and our officers, directors, members, managers, shareholders, and employees in connection with any and all claims, losses, costs, expenses, liabilities, compliance costs, and damages incurred by the indemnified party(ies) as a result of any matters associated with your compliance with the Americans with Disabilities Act, as well as the costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) related to the same. Acknowledged and Agreed: Franchisee: By: Printed Name: Title: Page 65 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT F-1 SAMPLE FORM OF CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT (to be signed by franchisee with its executive/management personnel) THIS CONFIDENTIALITY AND NON-DISCLOSURE AND AGREEMENT (\\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer, or employee with Franchisee (the \\\"Member\\\"). Background: A. Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\"). B. Franchisor identifies Goosehead Businesses by means of certain trade names, service marks, trademarks, logos, emblems, and indicia of origin (including for example the mark \\\"Goosehead Insurance\\\") and certain other trade names, service marks, and trademarks that Franchisor currently and may in the future designate in writing for use in connection with the System (the \\\"Proprietary Marks\\\").\"}, {\"id\": \"C\", \"title\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to\", \"level\": 1, \"text\": \"C. Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\"}, {\"id\": \"D\", \"title\": \"The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential\", \"level\": 1, \"text\": \"D. The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same confidentiality provisions that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are acknowledged, the parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"Confidential Information\", \"level\": 1, \"text\": \"1. Confidential Information. Member agrees that Member will not, during the term of the Franchise Agreement or thereafter, communicate, divulge, or use for the benefit of any other person, persons, partnership, entity, association, or corporation any confidential information, knowledge, or know-how concerning the methods of operation of the business franchised thereunder which may be communicated to Member or of which Member may be apprised by virtue of your operation under the terms of the Franchise Agreement. Any and all information, knowledge, know-how, and techniques which Franchisor designates as confidential will be deemed confidential for purposes of this Agreement, except information which Franchisee can demonstrate came to its attention before disclosure thereof by Franchisor; or which, at or after the time of disclosure by Franchisor to Franchisee, had become or later becomes a part of the public domain, through publication or communication by others. Page 66 of 80\"}, {\"id\": \"2\", \"title\": \"Injunctive Relief\", \"level\": 1, \"text\": \"2. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement.\"}, {\"id\": \"3\", \"title\": \"Severability\", \"level\": 1, \"text\": \"3. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, will be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court will have the authority to reform and modify that provision in order that the restriction will be the maximum necessary to protect Franchisor's and/or Member's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court will impose the provision with retroactive effect as close as possible to the provision held to be invalid.\"}, {\"id\": \"4\", \"title\": \"Delay\", \"level\": 1, \"text\": \"4. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, will constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement will be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement.\"}, {\"id\": \"5\", \"title\": \"Third-Party Beneficiary\", \"level\": 1, \"text\": \"5. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE MEMBER By: By: Name: Name: Title: Title: Page 67 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT F-2 SAMPLE FORM OF IN-TERM NON-COMPETITION AGREEMENT (to be signed by franchisee with its executive/management personnel) THIS IN-TERM NON-COMPETITION AGREEMENT (\\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer or employee with Franchisee (the \\\"Member\\\"). Background: A. Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\"). B. Franchisor identifies Goosehead Businesses by means of certain trade names, service marks, trademarks, logos, emblems, and indicia of origin (including for example the mark \\\"Goosehead Insurance\\\") and certain other trade names, service marks, and trademarks that Franchisor currently and may in the future designate in writing for use in connection with the System (the \\\"Proprietary Marks\\\").\"}, {\"id\": \"C\", \"title\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to\", \"level\": 1, \"text\": \"C. Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\"}, {\"id\": \"D\", \"title\": \"The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential\", \"level\": 1, \"text\": \"D. The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same non-competition provisions that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are acknowledged, the parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"Covenants Not to Compete\", \"level\": 1, \"text\": \"1. Covenants Not to Compete. (a) Member specifically acknowledges that, pursuant to the Franchise Agreement, and by virtue of his/her position with Franchisee, Member will receive valuable specialized training and confidential information, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of Franchisor and the System. (b) Member covenants and agrees that during the term of the Franchise Agreement, except as otherwise approved in writing by Franchisor, Member will not, either directly or indirectly, for itself, or through, on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity: Page 68 of 80 (i) Solicit, divert or attempt to solicit or divert any business or customer of the Franchised Business or of any Franchised Business using the System to a Competitive Business, by direct or indirect inducement or otherwise, or do or perform, directly or indirectly, any other act injurious or prejudicial to the goodwill associated with Franchisor's Proprietary Marks and the System. (ii) Employ or seek to employ any person who is at that time employed by Franchisor, Franchisee, any other franchisee, master franchisee, developer, or development agent, or otherwise directly or indirectly induce such person to leave his or her employment; or (iii) Either directly or indirectly for him/herself or on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity, own, maintain, operate, engage in, be employed by or accept any compensation or remuneration from, or have any interest in any Competitive Business. (c) As used in this Agreement, the term \\\"Competitive Business\\\" is agreed to mean any property and/or casualty insurance distribution business.\"}, {\"id\": \"2\", \"title\": \"Injunctive Relief\", \"level\": 1, \"text\": \"2. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement.\"}, {\"id\": \"3\", \"title\": \"Severability\", \"level\": 1, \"text\": \"3. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, will be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court will have the authority to reform and modify that provision in order that the restriction will be the maximum necessary to protect Franchisor's and/or Member's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court will impose the provision with retroactive effect as close as possible to the provision held to be invalid.\"}, {\"id\": \"4\", \"title\": \"Delay\", \"level\": 1, \"text\": \"4. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, will constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement will be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement.\"}, {\"id\": \"5\", \"title\": \"Third-Party Beneficiary\", \"level\": 1, \"text\": \"5. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. Page 69 of 80 IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE By: Name: Title: MEMBER By: Name: Title: Page 70 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT F-3 SAMPLE FORM OF POST-TERM NON-COMPETITION AGREEMENT (to be signed by franchisee with its executive/management personnel) THIS POST-TERM NON-COMPETITION AGREEMENT ( \\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer or employee with Franchisee (the \\\"Member\\\"). Background: A. Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\"). B. Franchisor identifies Goosehead Businesses by means of certain trade names, service marks, trademarks, logos, emblems, and indicia of origin (including for example the mark \\\"Goosehead Insurance\\\") and certain other trade names, service marks, and trademarks that Franchisor currently and may in the future designate in writing for use in connection with the System (the \\\"Proprietary Marks\\\").\"}, {\"id\": \"C\", \"title\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to\", \"level\": 1, \"text\": \"C. Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\"}, {\"id\": \"D\", \"title\": \"The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential\", \"level\": 1, \"text\": \"D. The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same non-competition provisions that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are acknowledged, the parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"Covenants Not to Compete\", \"level\": 1, \"text\": \"1. Covenants Not to Compete. Member specifically acknowledges that, pursuant to the Franchise Agreement, and by virtue of his/her position with Franchisee, Member will receive valuable specialized training and confidential information, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of Franchisor and the System. (a) Member covenants and agrees that during the Post-Term Period (defined below), except as otherwise approved in writing by Franchisor, Member will not, either directly or indirectly, for itself, or through, on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity, Member will not own, maintain, operate, engage in, be associated with or accept any compensation or remuneration from, or have any interest in or render services or give Page 71 of 80 advice to any Competitive Business and which business is, or is intended to be, located within the city or county in which the Approved Location is situated. (b) Member covenants and agrees that during the Post-Term Period, Member will not, either directly or indirectly, solicit, divert, or attempt to solicit or divert any actual or potential business or customer of the Franchised Business to any Competitive Business. (c) As used in this Agreement, the term \\\"Competitive Business\\\" is agreed to mean any property and/or casualty insurance distribution business. (d) As used in this Agreement, the term \\\"Post-Term Period\\\" means a continuous uninterrupted period of two (2) years from the date of: (i) a transfer as contemplated under Section 16 of the Franchise Agreement; (ii) expiration or termination of the Franchise Agreement (regardless of the cause for termination); (iii) termination of Member's employment with Franchisee; and/or (iv) a final order of a duly authorized arbitrator, panel of arbitrators, or a court of competent jurisdiction (after all appeals have been taken) with respect to any of the foregoing or with respect to the enforcement of this Agreement; either directly or indirectly (through, on behalf of, or in conjunction with any persons, partnership, corporation or entity). Any period of non-compliance with the requirements of this Section 1, whether such non-compliance takes place after termination, expiration, non-renewal, and/or a transfer, will not be credited toward satisfying the two-year obligation specified above.\"}, {\"id\": \"2\", \"title\": \"Injunctive Relief\", \"level\": 1, \"text\": \"2. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement.\"}, {\"id\": \"3\", \"title\": \"Severability\", \"level\": 1, \"text\": \"3. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, will be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court will have the authority to reform and modify that provision in order that the restriction will be the maximum necessary to protect Franchisor's and/or Member's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court will impose the provision with retroactive effect as close as possible to the provision held to be invalid.\"}, {\"id\": \"4\", \"title\": \"Delay\", \"level\": 1, \"text\": \"4. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, will constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement will be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement.\"}, {\"id\": \"5\", \"title\": \"Third-Party Beneficiary\", \"level\": 1, \"text\": \"5. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. Page 72 of 80 IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE By: Name: Title: MEMBER By: Name: Title: Page 73 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT G SITE SELECTION ADDENDUM Goosehead Insurance Agency, LLC (\\\"Franchisor\\\" or \\\"us\\\" or \\\"we\\\") and (\\\"Franchisee\\\" or \\\"you\\\") have this day of , 201 entered into a Goosehead Insurance Franchise Agreement (\\\"Franchise Agreement\\\") and wish to supplement its terms as set out below in this Site Selection Addendum (the \\\"Addendum\\\"). The parties agree as follows: AGREEMENT\"}, {\"id\": \"1\", \"title\": \"Time to Locate Site\", \"level\": 1, \"text\": \"1. Time to Locate Site: Within ninety (90) days after the date of this Addendum, you agree to acquire or lease/sublease, at your own expense, commercial real estate that is properly zoned for the use of the business that you will conduct under the Franchise Agreement (the \\\"Franchised Business\\\") at a site that we will have approved in writing as provided below. a. Such location must be within the following area: (the \\\"Site Selection Area\\\"). b. The only reason that the Site Selection Area is described is for the purpose of selecting a site for the Franchised Business.\"}, {\"id\": \"c\", \"title\": \"For purposes of this Addendum, the term \\\"Search Period\\\" means ninety (90) days from the date of this Addendum, or the p\", \"level\": 1, \"text\": \"c. For purposes of this Addendum, the term \\\"Search Period\\\" means ninety (90) days from the date of this Addendum, or the period from the date of this Addendum until we have approved of a location for your Franchised Business, whichever event first occurs.\"}, {\"id\": \"d\", \"title\": \"If you do not acquire or lease a site (that we have approved in writing) for the Franchised Business in accordance with\", \"level\": 1, \"text\": \"d. If you do not acquire or lease a site (that we have approved in writing) for the Franchised Business in accordance with this Addendum by not later than ninety (90) days after the date of this Addendum, that will constitute a default under Section 17.2 of the Franchise Agreement and also under this Addendum, and we will have the right to terminate the Franchise Agreement and this Addendum pursuant to the terms of Section 17.2 of the Franchise Agreement.\"}, {\"id\": \"2\", \"title\": \"Site Evaluation Services\", \"level\": 1, \"text\": \"2. Site Evaluation Services: We will provide you with our site selection guidelines, including our minimum standards for a location for the Franchised Business, and such site selection counseling and assistance as we may deem advisable. If we deem on-site evaluation to be necessary and appropriate, we will conduct up to two (2) on-site evaluations at our cost and expense. If we perform any additional on-site evaluations, you must reimburse us, as applicable, for all reasonable expenses that we incur in connection with such on-site evaluation, including, without limitation, the cost of travel, lodging and meals. We will not provide on site evaluation for any proposed site before we have received from you a completed site approval form for the site (prepared as set forth in Section 3 below).\"}, {\"id\": \"3\", \"title\": \"Site Selection Package Submission and Approval\", \"level\": 1, \"text\": \"3. Site Selection Package Submission and Approval: You must submit to us, in the form that we specify: (a) a completed site approval form (in the form that we require); (b) such other information or materials that we may reasonably require; and (c) an option contract, letter of intent, or other evidence satisfactory to us that confirms your favorable prospects for obtaining the site. You acknowledge that time is of the essence. We will have thirty (30) days after receipt of all such information and materials from you to approve or disapprove the proposed site as the location for the Franchised Business. We have the right to approve or disapprove any such site to serve as the Page 74 of 80 Approved Location for the Franchised Business. If we do not approve a proposed site by giving you written notice within the 30-day period, then we will be deemed to have disapproved the site.\"}, {\"id\": \"4\", \"title\": \"Lease Responsibilities\", \"level\": 1, \"text\": \"4. Lease Responsibilities: After we have approved a site and before the expiration of the Search Period, you must execute a lease, which must be coterminous with the Franchise Agreement, or a binding agreement to purchase the site. Our approval of any lease is conditioned upon inclusion in the lease of the Lease Rider attached to the Franchise Agreement as Exhibit H. However, even if we examine the Lease, we are not responsible for review of the Lease for any terms other than those contained in the Lease Rider.\"}, {\"id\": \"5\", \"title\": \"Approved Location\", \"level\": 1, \"text\": \"5. Approved Location: After we have approved the location for the Franchised Business and you have leased or acquired that location, the location will constitute the Approved Location described in Section 1.2 of the Franchise Agreement. The Approved Location will be specified on Exhibit A to the Franchise Agreement, and will become a part the Franchise Agreement. a. You Franchisee hereby acknowledge and agree that our approval of a site does not constitute an assurance, representation, or warranty of any kind, express or implied, as to the suitability of the site for the Franchised Business or for any other purpose. Our approval of the site indicates only that we believe the site complies with our minimum acceptable criteria solely for our own purposes as of the time of the evaluation. The parties each acknowledge that application of criteria that have been effective with respect to other sites and premises may not be predictive of potential for all sites and that, subsequent to our approval of a site, demographic and/or economic factors, such as competition from other similar businesses, included in or excluded from criteria that we used could change, thereby altering the potential of a site. Such factors are unpredictable and are beyond our control. b. We will not be responsible for the failure of a site (even if we have approved that site) to meet your expectations as to revenue or operational criteria.\"}, {\"id\": \"c\", \"title\": \"You acknowledge and agree that your acceptance of a franchise for the operation of the Franchised Business at the site\", \"level\": 1, \"text\": \"c. You acknowledge and agree that your acceptance of a franchise for the operation of the Franchised Business at the site is based on its own independent investigation of the suitability of the site.\"}, {\"id\": \"6\", \"title\": \"Construction\", \"level\": 1, \"text\": \"6. Construction: This Addendum will be considered an integral part of the Franchise Agreement between the parties hereto, and the terms of this Addendum will be controlling with respect to the subject matter hereof. All capitalized terms not otherwise defined herein will have the same meaning as set forth in the Franchise Agreement. Except as modified or supplemented by this Addendum, the terms of the Franchise Agreement are hereby ratified and confirmed. Page 75 of 80 IN WITNESS WHEREOF, each party hereto has caused its duly authorized representative to duly execute and deliver this Addendum on the date first above written. Goosehead Insurance Agency, LLC Franchisor By: Name: Title: Franchisee By: Name: Title: Page 76 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT H LEASE RIDER THIS ADDENDUM (the \\\"Addendum\\\") has been executed as of this day of , 201 , by and between (\\\"Franchisee\\\") and (\\\"Landlord\\\"), as an addendum to the lease, as modified, amended, supplemented, renewed and/or extended from time to time as contemplated herein (\\\"Lease\\\") dated as of , 201 for the premises located at , in the State of (\\\"Premises\\\"). Franchisee has also entered (or will also enter) into a Franchise Agreement (\\\"Franchise Agreement\\\") with Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") for the development and operation of a \\\"Goosehead Insurance\\\" Business at the Premises, and as a condition to obtaining Franchisor's approval of the Lease, the Lease for the Premises must contain the provisions contained in this Addendum. NOW THEREFORE, in consideration of mutual covenants set forth herein, the execution and delivery of the Lease, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Franchisee hereby agree as follows: 1. Landlord agrees to deliver to Franchisor a copy of any notice of default or termination of the Lease at the same time such notice is delivered to Franchisee. Franchisor agrees to deliver to Landlord a copy of any notice of termination under the Franchise Agreement. Franchisee hereby consents to that exchange of information by Landlord and Franchisor. 2. Franchisee hereby assigns to Franchisor, with Landlord's irrevocable and unconditional consent, all of Franchisee's rights, title and interests to and under the Lease upon any termination or non-renewal of the Franchise Agreement, but no such assignment will be effective unless and until: (a) the Franchise Agreement is terminated or expires without renewal; (b) Franchisor has exercised its Option to Purchase under the Franchise Agreement; and (c) Franchisor notifies the Franchisee and Landlord in writing that Franchisor assumes Franchisee's obligations under the Lease. 3. Franchisor will have the right, but not the obligation, to cure any breach of the Lease (within fifteen (15) business days after the expiration of the period in which Franchisee had to cure any such default should Franchisee fail to do so) upon giving written notice of its election to Franchisee and Landlord, and, if so stated in the notice, to also succeed to Franchisee's rights, title and interests thereunder. The Lease may not be modified, amended, supplemented, renewed, extended or assigned by Franchisee without Franchisor's prior written consent. 4. Franchisee and Landlord acknowledge and agree that Franchisor will have no liability or obligation whatsoever under the Lease unless and until Franchisor assumes the Lease in writing pursuant to Section 2 or Section 3, above. 5. If Franchisor assumes the Lease, as provided above, Franchisor may, without Landlord's prior consent, further assign the Lease to another franchisee of Franchisor to operate a \\\"Goosehead Insurance\\\" business at the Premises provided that the proposed franchisee has met all of Franchisor's applicable criteria and requirements and has executed a franchise agreement with Franchisor. Landlord agrees to execute such further documentation to Page 77 of 80 confirm its consent to the assignment permitted under this Addendum as Franchisor may reasonably request. Upon such assignment to a franchisee of Franchisor, Franchisor will be released from any further liability under the terms and conditions of the Lease. 6. Landlord and Franchisee hereby acknowledge that Franchisee has agreed under the Franchise Agreement that Franchisor and its employees or agents will have the right to enter the Premises for certain purposes. Landlord hereby agrees not to interfere with or prevent such entry by Franchisor, its employees or agents. Landlord and Franchisee hereby further acknowledge that if the Franchise Agreement expires (without renewal) or is terminated, Franchisee is obligated to take certain steps under the Franchise Agreement to de-identify the Premises as a \\\"Goosehead Insurance\\\" business (unless Franchisor takes an assignment of the lease, as provided above). Landlord agrees to permit Franchisor, its employees or agent, to enter the Premises and remove signs (both interior and exterior), d\u00e9cor and materials displaying any marks, designs or logos owned by Franchisor, provided that Franchisor will bear the expense of repairing any damage to the Premises as a result thereof. 7. If Landlord is an affiliate or an Owner of Franchisee, Landlord and Franchisee agree that if Landlord proposes to sell the Premises, before the sale of the Premises, upon the request of Franchisor the Lease will be amended to reflect a rental rate and other terms that are the reasonable and customary rental rates and terms prevailing in the community where the \\\"Goosehead Insurance\\\" business is located. 8. Landlord agrees that during and after the term of the Lease, it will not disclose or use Franchisor's Confidential Information (as defined below) for any purpose other than for the purpose of fulfilling Landlord's obligations under the Lease. \\\"Confidential Information\\\" as used herein will mean all non-public information and tangible things, whether written, oral, electronic or in other form, provided or disclosed by or on behalf of Franchisee to Landlord, or otherwise obtained by Landlord, regarding the design and operations of the business located at the Premises, including, without limitation, all information identifying or describing the floor plan and layout, furnishings, equipment, fixtures, wall coverings, flooring materials, shelving, decorations, trade secrets, techniques, trade dress, \\\"look and feel,\\\" design, manner of operation, suppliers, vendors, and all other products, goods, and services used, useful or provided by or for Franchisee on the Premises. Landlord acknowledges that all such Confidential Information belongs exclusively to Franchisor. 9. Landlord agrees that: (a) Franchisor has granted to only one party, the Franchisee, the right to use Franchisor's proprietary trade name, trademarks, service marks logos, insignias, slogans, emblems, symbols, designs and indicia of origin (collectively the \\\"Marks\\\") at the Premises under the terms of the Franchise Agreement; and (b) Franchisor has not granted any rights or privileges to use the Marks to Landlord. 10. Landlord and Franchisee agree that the premises will be used solely for the operation of a \\\"Goosehead Insurance\\\" business. 11. Landlord and Franchisee agree that any default under the lease will also constitute a default under the Franchise Agreement, and any default under the Franchise Agreement will also constitute a default under the lease. 12. Landlord and Franchisee agree that the terms contained herein will supersede any terms to the contrary set forth in the Lease. Page 78 of 80\"}, {\"id\": \"13\", \"title\": \"Franchisor, along with its successors and assigns, is an intended third party beneficiary of the provisions of this Add\", \"level\": 1, \"text\": \"13. Franchisor, along with its successors and assigns, is an intended third party beneficiary of the provisions of this Addendum. 14. Landlord and Franchisee agree that copies of any and all notices required or permitted under this Addendum, or under the Lease, will also be sent to Franchisor at (attention ), or to such other address as Franchisor may specify by giving written notice to Landlord. WITNESS the execution hereof under seal. Landlord: Franchisor* Franchisee: Date: Date: Date: Subscribed and sworn to before me this day of , 201 . Notary Public Subscribed and sworn to before me this day of , 201 . Notary Public Subscribed and sworn to before me this day of , 201 . Notary Public My Commission expires: My Commission expires: My Commission expires: * The Franchisor has signed this lease rider only to acknowledge its terms and not to accept any obligations under the lease. Page 79 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT I PROMISSORY NOTE Page 80 of 80 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF CALIFORNIA In recognition of the requirements of California's Franchise Investment Law and the California Franchise Relations Act, the Goosehead Insurance Agency, LLC Franchise Disclosure Document shall be supplemented as follows: 1. California Corporations Code, Section 31125, requires Franchisor to give Franchisee a disclosure document, approved by the Department of Business Oversight, before a solicitation of a proposed material modification of an existing franchise. 2. THE CALIFORNIA FRANCHISE INVESTMENT LAW REQUIRES THAT A COPY OF ALL PROPOSED AGREEMENTS RELATING TO THE SALE OF THE FRANCHISE BE DELIVERED TOGETHER WITH THE DISCLOSURE DOCUMENT. 3. Item 3 of the Franchise Disclosure Document is modified by adding the following paragraph to the end thereof: Neither Goosehead Insurance Agency, LLC nor any person listed in Item 2 of this Franchise Disclosure Document is subject to any currently effective order of any national securities association or national securities exchange, as defined in the Securities Exchange Act of 1934, 15 U.S.C.A. 78a et seq., suspending or expelling these persons from membership in this association or exchange. 4. Item 17 of the Franchise Disclosure Document is modified by adding the following paragraphs to the end of Item 17: California Business and Professions Code Sections 20000 through 20043 provide rights to Franchisee concerning termination, transfer or non-renewal of a franchise. If the Franchise Agreement contains a provision that is inconsistent with the law, the law will control. The Franchise Agreement provides for termination upon bankruptcy. This provision may not be enforceable under federal bankruptcy law (11 U.S.C.A. Sec. 101 et seq.). The Franchise Agreement contains a covenant not to compete which extends beyond the termination of the franchise. This provision may not be enforceable under California law. Prospective franchisees are encouraged to consult private legal counsel to determine the applicability of California and federal laws (such as Business and Professions Code Section 20040.5, Code of Civil Procedure FDD Exhibit H-1 Section 1281, and the Federal Arbitration Act) to any provisions of a franchise agreement restricting venue to a forum outside the State of California. The Franchise Agreement requires application of the laws of the State of Texas. This provision may not be enforceable under California law. The Franchise Agreement requires Franchisee to sign a general release of claims upon renewal or transfer of the Franchise Agreement. California Corporations Code Section 31512 provides that any condition, stipulation or provision purporting to bind any person acquiring any franchise to waive compliance with any provision of that law or any rule or order thereunder is void. Section 31512 voids a waiver of Franchisee's rights under the Franchise Investment Law (California Corporations Code Section 31000-31516). Business and Professions Code Section 20010 voids a waiver of Franchisee's rights under the Franchise Relations Act (Business and Professions Code Sections 20000-20043). 5. We maintain an Internet website at www.goosehead.com. OUR WEBSITE HAS NOT BEEN REVIEWED OR APPROVED BY THE CALIFORNIA DEPARTMENT OF BUSINESS OVERSIGHT. ANY COMPLAINTS CONCERNING THE CONTENT OF THIS WEBSITE MAY BE DIRECTED TO THE CALIFORNIA DEPARTMENT OF BUSINESS OVERSIGHT AT www.dbo.ca.gov. 6. This Addendum shall be effective only to the extent that jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are met independently of and without reference to this Addendum. This Addendum shall have no effect if the jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are not met. FDD Exhibit H-2 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF CALIFORNIA In recognition of the requirements of California's Franchise Investment Law and the California Franchise Relations Act, the Goosehead Insurance Agency, LLC Franchise Agreement shall be supplemented as follows: 1. Section 17.3 of the Franchise Agreement is amended to read as follows:\"}, {\"id\": \"17.3\", \"title\": \"Termination with Notice and Opportunity to Cure\", \"level\": 2, \"text\": \"17.3 Termination with Notice and Opportunity to Cure. Except as otherwise provided in Sections 17.1 and 17.2 of this Agreement, you will have 60 days after your receipt from us of a written notice of default within which to remedy any default under this Agreement and to provide evidence thereof to us. You may avoid termination by immediately initiating a remedy to cure such default and curing it to our satisfaction within the sixty-day period, and by promptly providing proof thereof to us. If any such default is not cured within the specified time, or such longer period as applicable law may require, this Agreement will terminate without further notice to you, effective immediately upon the expiration of the sixty-day period or such longer period as applicable law may require. You will be in default pursuant to this Section 17.3 for failure substantially to comply with any of the requirements imposed by this Agreement, as it may from time to time reasonably be supplemented by the Manual, or failure to carry out the terms of this Agreement in good faith. Such defaults include, but are not limited to, the following illustrative events: 2. This Amendment shall be effective only to the extent that jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are met independently of and without reference to this Amendment. This Amendment shall have no effect if the jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are not met. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-3 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF ILLINOIS In recognition of the requirements of the Illinois law, the Goosehead Insurance Agency, LLC Franchise Disclosure Document shall be supplemented as follows:\"}, {\"id\": \"1\", \"title\": \"The Risk Factors on the Franchise Disclosure Document cover page of this disclosure document are modified to comply wit\", \"level\": 1, \"text\": \"1. The Risk Factors on the Franchise Disclosure Document cover page of this disclosure document are modified to comply with Section 4 of the Illinois Franchise Disclosure Act, which provides that any provision in a franchise agreement that designates jurisdiction or venue in a forum outside of Illinois is void.\"}, {\"id\": \"2\", \"title\": \"Item 17 of the disclosure document is modified by substituting the following in place of provisions v\", \"level\": 1, \"text\": \"2. Item 17 of the disclosure document is modified by substituting the following in place of provisions v. and w., in the chart: PROVISION SECTION IN FRANCHISE AGREEMENT SUMMARY\"}, {\"id\": \"v\", \"title\": \"Choice of forum Section 25\", \"level\": 1, \"text\": \"v. Choice of forum Section 25.5 Litigation may be brought in Illinois. w. Choice of law Section 25.1 Except to the extent governed by the Lanham Act, Illinois law (including the Illinois Franchise Disclosure Act) will apply to Illinois franchisees. and by adding the following paragraph to the end of the chart: \\\"THE CONDITIONS UNDER WHICH YOUR FRANCHISE CAN BE TERMINATED AND YOUR RIGHTS UPON NON-RENEWAL MAY BE AFFECTED BY ILLINOIS LAW: 815 ILCS 705/19 AND 20.\\\".\"}, {\"id\": \"3\", \"title\": \"This Addendum is effective only to the extent that the jurisdictional requirements of the Illinois law are met independ\", \"level\": 1, \"text\": \"3. This Addendum is effective only to the extent that the jurisdictional requirements of the Illinois law are met independently of and without reference to this Addendum. This Addendum will have no effect if the jurisdictional requirements of the Illinois law are not met. FDD Exhibit H-4 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF ILLINOIS In recognition of the requirements of the Illinois law, the Goosehead Insurance Agency, LLC Franchise Agreement shall be supplemented as follows:\"}, {\"id\": \"1\", \"title\": \"Section 27\", \"level\": 1, \"text\": \"1. Section 27.1 of the Franchise Agreement is deleted in its entirety and the following Section 27.1 is substituted in lieu thereof:\"}, {\"id\": \"27.1\", \"title\": \"This Agreement takes effect when we accept and sign this document\", \"level\": 2, \"text\": \"27.1 This Agreement takes effect when we accept and sign this document. This Agreement will be interpreted and construed exclusively under the laws of the State of Illinois, which laws will prevail in the event of any conflict of law (without regard to, and without giving effect to, the application of Illinois choice-of-law rules); provided, however, that if the covenants in Section 19 of this Agreement would not be enforced as written under Illinois law, then the parties agree that those covenants will instead be interpreted and construed under the laws of the state in which the Franchised Business is located. Nothing in this Section 27.1 is intended by the parties to invoke the application of any franchise, business opportunity, antitrust, implied covenant, unfair competition, fiduciary, and/or other doctrine of law of the State of Illinois (or any other state) that would not otherwise apply without this Section 27.1\"}, {\"id\": \"2\", \"title\": \"Section 27\", \"level\": 1, \"text\": \"2. Section 27.2 of the Franchise Agreement is amended by the addition of the following: Notwithstanding anything to the contrary contained in this Section 27.2, any claims arising under the Illinois Franchise Disclosure Act may be brought in Illinois.\"}, {\"id\": \"3\", \"title\": \"Section 27\", \"level\": 1, \"text\": \"3. Section 27.7 of the Franchise Agreement is deleted in its entirety and the following Section 27.7 is substituted in lieu thereof:\"}, {\"id\": \"27.7\", \"title\": \"Must bring claims within one year\", \"level\": 2, \"text\": \"27.7 Must bring claims within one year. Each party to this agreement agrees that any and all claims and actions arising out of or relating to this agreement, the parties' relationship, and/or your operation of the franchised business, brought by any party hereto against the other, shall be commenced within one (1) year from the occurrence of the facts giving rise to such claim or action, or, it is expressly acknowledged and agreed by all parties, such claim or action shall be irrevocably barred; provided, however, that the time limit for filing claims contained in this Section 27.7 shall not apply FDD Exhibit H-5 to claims or actions arising under the Illinois Franchise Disclosure Act. 4. Section 27 is amended by the addition of the following new Section 27.10 which shall be an integral part of the Franchise Agreement:\"}, {\"id\": \"27.10\", \"title\": \"Nothing contained in this Agreement shall be deemed to waive any right you may have under the Illinois Franchise Disclos\", \"level\": 2, \"text\": \"27.10 Nothing contained in this Agreement shall be deemed to waive any right you may have under the Illinois Franchise Disclosure Act of 1987. If anything in this Agreement is deemed to be contrary to or inconsistent with the Act, the terms of the Act will control.\"}, {\"id\": \"5\", \"title\": \"This Amendment shall be effective only to the extent that the jurisdictional requirements of the Illinois law are met i\", \"level\": 1, \"text\": \"5. This Amendment shall be effective only to the extent that the jurisdictional requirements of the Illinois law are met independently of and without reference to this Amendment. This Amendment shall have no effect if the jurisdictional requirements of the Illinois law are not met. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-6 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF MARYLAND In recognition of the requirements of the Maryland Franchise Registration and Disclosure Law, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC for use in the State of Maryland shall be amended as follows:\"}, {\"id\": \"1\", \"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following lan\", \"level\": 1, \"text\": \"1. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following language: The Franchise Agreement provides for termination upon bankruptcy of the franchisee. This provision may not be enforceable under the U.S. Bankruptcy Code (11 U.S.C. Section 101, et seq.). Any claims arising under the Maryland Franchise Registration and Disclosure Law must be brought within 3 years after the grant of the franchise. Any general release required as a condition of renewal, sale, and/or assignment/transfer shall not apply to any liability under the Maryland Franchise Registration and Disclosure Law.\"}, {\"id\": \"2\", \"title\": \"Exhibit I, \\\"Franchisee Compliance Questionnaire,\\\" shall be amended by the addition of the following at the end of Exhib\", \"level\": 1, \"text\": \"2. Exhibit I, \\\"Franchisee Compliance Questionnaire,\\\" shall be amended by the addition of the following at the end of Exhibit I: The representations under this Franchisee Compliance Questionnaire are not intended, nor shall they act as a release, estoppel or waiver of any liability incurred under the Maryland Franchise Registration and Disclosure Law.\"}, {\"id\": \"3\", \"title\": \"Each provision of this Addendum to the Disclosure Document shall be effective only to the extent, with respect to such\", \"level\": 1, \"text\": \"3. Each provision of this Addendum to the Disclosure Document shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Maryland Franchise Registration and Disclosure Law are met independently without reference to this Addendum. FDD Exhibit H-7 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF MARYLAND In recognition of the requirements of the Maryland Franchise Registration and Disclosure Law, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}, {\"id\": \"1\", \"title\": \"Section 2\", \"level\": 1, \"text\": \"1. Section 2.2.7 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be deleted in its entirety and shall have no force or effect, and the following shall be substituted in lieu thereof:\"}, {\"id\": \"2.2.7\", \"title\": \"You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limit\", \"level\": 3, \"text\": \"2.2.7 You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limited exclusions), which will release all claims against us and our affiliates, and our respective officers, directors, members, managers, agents, and employees. If you are an entity, then your affiliates and your direct and indirect owners (and any other parties that we reasonably request) must also sign and deliver that release to us, excluding only such claims as the Franchisee may have under the Maryland Franchise Registration and Disclosure Law;\"}, {\"id\": \"2\", \"title\": \"Section 16\", \"level\": 1, \"text\": \"2. Section 16.5.1 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be deleted in its entirety and shall have no force or effect, and the following shall be substituted in lieu thereof:\"}, {\"id\": \"16.5.1\", \"title\": \"The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and\", \"level\": 3, \"text\": \"16.5.1 The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and our affiliates, successors, and assigns, and their respective officers, directors, members, managers, shareholders, partners, agents, representatives, servants, and employees in their corporate and individual capacities including, without limitation, claims arising under this Agreement, any other agreement between you and us, and/or our respective affiliates, and federal, state, and local laws and rules, excluding only such claims as the Franchisee may have under the Maryland Franchise Registration and Disclosure Law;\"}, {\"id\": \"3\", \"title\": \"Sections 27\", \"level\": 1, \"text\": \"3. Sections 27.1, 27.2, and 27.7 of the Agreement, under the heading \\\"Applicable and Dispute Resolution,\\\" shall be amended by the addition of the following language: A franchisee may bring a lawsuit in Maryland for claims arising under the Maryland Franchise Registration and Disclosure Law. Any claims arising under the Maryland Franchise Registration and Disclosure Law must be brought within three (3) years after the grant of the franchise. FDD Exhibit H-8\"}, {\"id\": \"4\", \"title\": \"Section 28 of the Agreement, under the heading \\\"Acknowledgments,\\\" shall be supplemented by the following\", \"level\": 1, \"text\": \"4. Section 28 of the Agreement, under the heading \\\"Acknowledgments,\\\" shall be supplemented by the following: The foregoing acknowledgments are not intended to nor shall they act as a release, estoppel or waiver of any liability under the Maryland Franchise Registration and Disclosure Law.\"}, {\"id\": \"5\", \"title\": \"Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisd\", \"level\": 1, \"text\": \"5. Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Maryland Franchise Registration and Disclosure Law are met independently without reference to this Amendment. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-9 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF MICHIGAN THE STATE OF MICHIGAN PROHIBITS CERTAIN UNFAIR PROVISIONS THAT ARE SOMETIMES IN FRANCHISE DOCUMENTS. IF ANY OF THE FOLLOWING PROVISIONS ARE IN THESE FRANCHISE DOCUMENTS, THE PROVISIONS ARE VOID AND CANNOT BE ENFORCED AGAINST YOU: (A) A PROHIBITION ON THE RIGHT OF A FRANCHISEE TO JOIN AN ASSOCIATION OF FRANCHISEES. (B) A REQUIREMENT THAT A FRANCHISEE ASSENT TO A RELEASE, ASSIGNMENT, NOVATION, WAIVER, OR ESTOPPEL WHICH DEPRIVES A FRANCHISEE OF RIGHTS AND PROTECTIONS PROVIDED IN THIS ACT. THIS SHALL NOT PRECLUDE A FRANCHISEE, AFTER ENTERING INTO A FRANCHISE AGREEMENT, FROM SETTLING ANY AND ALL CLAIMS. (C) A PROVISION THAT PERMITS A FRANCHISOR TO TERMINATE A FRANCHISE PRIOR TO THE EXPIRATION OF ITS TERM EXCEPT FOR GOOD CAUSE. GOOD CAUSE SHALL INCLUDE THE FAILURE OF THE FRANCHISEE TO COMPLY WITH ANY LAWFUL PROVISIONS OF THE FRANCHISE AGREEMENT AND TO CURE SUCH FAILURE AFTER BEING GIVEN WRITTEN NOTICE THEREOF AND A REASONABLE OPPORTUNITY, WHICH IN NO EVENT NEED BE MORE THAN 30 DAYS, TO CURE SUCH FAILURE. (D) A PROVISION THAT PERMITS A FRANCHISOR TO REFUSE TO RENEW A FRANCHISE WITHOUT FAIRLY COMPENSATING THE FRANCHISEE BY REPURCHASE OR OTHER MEANS FOR THE FAIR MARKET VALUE, AT THE TIME OF EXPIRATION, OF THE FRANCHISEE'S INVENTORY, SUPPLIES, EQUIPMENT, FIXTURES, AND FURNISHINGS. PERSONALIZED MATERIALS WHICH HAVE NO VALUE TO THE FRANCHISOR AND INVENTORY, SUPPLIES, EQUIPMENT, FIXTURES, AND FURNISHINGS NOT REASONABLY REQUIRED IN THE CONDUCT OF THE FRANCHISED BUSINESS ARE NOT SUBJECT TO COMPENSATION. THIS SUBSECTION APPLIES ONLY IF: (i) THE TERM OF THE FRANCHISE IS LESS THAN 5 YEARS; AND (ii) THE FRANCHISEE IS PROHIBITED BY THE FRANCHISE OR OTHER AGREEMENT FROM CONTINUING TO CONDUCT SUBSTANTIALLY THE SAME BUSINESS UNDER ANOTHER TRADEMARK, SERVICE MARK, TRADE NAME, LOGOTYPE, ADVERTISING, OR OTHER COMMERCIAL SYMBOL IN THE SAME AREA SUBSEQUENT TO THE EXPIRATION OF THE FRANCHISE OR THE FRANCHISEE DOES NOT FDD Exhibit H-10 RECEIVE AT LEAST 6 MONTHS ADVANCE NOTICE OF FRANCHISOR'S INTENT NOT TO RENEW THE FRANCHISE. (E) A PROVISION THAT PERMITS THE FRANCHISOR TO REFUSE TO RENEW A FRANCHISE ON TERMS GENERALLY AVAILABLE TO OTHER FRANCHISEES OF THE SAME CLASS OR TYPE UNDER SIMILAR CIRCUMSTANCES. THIS SECTION DOES NOT REQUIRE A RENEWAL PROVISION. (F) A PROVISION REQUIRING THAT ARBITRATION OR LITIGATION BE CONDUCTED OUTSIDE THIS STATE*. THIS SHALL NOT PRECLUDE THE FRANCHISEE FROM ENTERING INTO AN AGREEMENT, AT THE TIME OF ARBITRATION, TO CONDUCT ARBITRATION AT A LOCATION OUTSIDE THIS STATE. (G) A PROVISION WHICH PERMITS A FRANCHISOR TO REFUSE TO PERMIT A TRANSFER OF OWNERSHIP OF A FRANCHISE, EXCEPT FOR GOOD CAUSE. THIS SUBDIVISION DOES NOT PREVENT A FRANCHISOR FROM EXERCISING A RIGHT OF FIRST REFUSAL TO PURCHASE THE FRANCHISE. GOOD CAUSE SHALL INCLUDE, BUT IS NOT LIMITED TO:\"}, {\"id\": \"525\", \"title\": \"THE FAILURE OF THE PROPOSED FRANCHISEE TO MEET THE FRANCHISOR'S THEN CURRENT REASONABLE QUALIFICATIONS OR STANDARDS\", \"level\": 1, \"text\": \"525 THE FAILURE OF THE PROPOSED FRANCHISEE TO MEET THE FRANCHISOR'S THEN CURRENT REASONABLE QUALIFICATIONS OR STANDARDS.\"}, {\"id\": \"525\", \"title\": \"THE FACT THAT THE PROPOSED TRANSFEREE IS A COMPETITOR OF THE FRANCHISOR OR SUBFRANCHISOR\", \"level\": 1, \"text\": \"525 THE FACT THAT THE PROPOSED TRANSFEREE IS A COMPETITOR OF THE FRANCHISOR OR SUBFRANCHISOR. (iii) THE UNWILLINGNESS OF THE PROPOSED TRANSFEREE TO AGREE IN WRITING TO COMPLY WITH ALL LAWFUL OBLIGATIONS. (iv) THE FAILURE OF THE FRANCHISEE OR PROPOSED TRANSFEREE TO PAY ANY SUMS OWING TO THE FRANCHISOR OR TO CURE ANY DEFAULT IN THE FRANCHISE AGREEMENT EXISTING AT THE TIME OF THE PROPOSED TRANSFER. (H) A PROVISION THAT REQUIRES THE FRANCHISEE TO RESELL TO THE FRANCHISOR ITEMS THAT ARE NOT UNIQUELY IDENTIFIED WITH THE FRANCHISOR. THIS SUBDIVISION DOES NOT PROHIBIT A PROVISION THAT GRANTS TO A FRANCHISOR A RIGHT OF FIRST REFUSAL TO PURCHASE THE ASSETS OF A FRANCHISE ON THE SAME TERMS AND CONDITIONS AS A BONA FIDE THIRD PARTY WILLING AND ABLE TO PURCHASE THOSE ASSETS, NOR DOES THIS SUBDIVISION PROHIBIT A PROVISION THAT GRANTS THE FDD Exhibit H-11 FRANCHISOR THE RIGHT TO ACQUIRE THE ASSETS OF A FRANCHISE FOR THE MARKET OR APPRAISED VALUE OF SUCH ASSETS IF THE FRANCHISEE HAS BREACHED THE LAWFUL PROVISIONS OF THE FRANCHISE AGREEMENT AND HAS FAILED TO CURE THE BREACH IN THE MANNER PROVIDED IN SUBDIVISION I. (I) A PROVISION WHICH PERMITS THE FRANCHISOR TO DIRECTLY OR INDIRECTLY CONVEY, ASSIGN, OR OTHERWISE TRANSFER ITS OBLIGATIONS TO FULFILL CONTRACTUAL OBLIGATIONS TO THE FRANCHISEE UNLESS PROVISION HAS BEEN MADE FOR PROVIDING THE REQUIRED CONTRACTUAL SERVICES. THE FACT THAT THERE IS A NOTICE OF THIS OFFERING ON FILE WITH THE ATTORNEY GENERAL DOES NOT CONSTITUTE APPROVAL, RECOMMENDATION, OR ENDORSEMENT BY THE ATTORNEY GENERAL. * * * * IF THE FRANCHISOR'S MOST RECENT FINANCIAL STATEMENTS ARE UNAUDITED AND SHOW A NET WORTH OF LESS THAN $100,000.00, THE FRANCHISOR MUST, AT THE REQUEST OF THE FRANCHISEE, ARRANGE FOR THE ESCROW OF INITIAL INVESTMENT AND OTHER FUNDS PAID BY THE FRANCHISEE UNTIL THE OBLIGATIONS TO PROVIDE REAL ESTATE, IMPROVEMENTS, EQUIPMENT, INVENTORY, TRAINING, OR OTHER ITEMS INCLUDED IN THE FRANCHISE OFFERING ARE FULFILLED. AT THE OPTION OF THE FRANCHISOR, A SURETY BOND MAY BE PROVIDED IN PLACE OF ESCROW. * * * * THE NAME AND ADDRESS OF THE FRANCHISOR'S AGENT IN THIS STATE AUTHORIZED TO RECEIVE SERVICE OF PROCESS IS: MICHIGAN DEPARTMENT OF COMMERCE, CORPORATION AND SECURITIES BUREAU, 6546 MERCANTILE WAY, P.O. BOX 30222, LANSING, MICHIGAN 48910. * * * * ANY QUESTIONS REGARDING THIS NOTICE SHOULD BE DIRECTED TO: DEPARTMENT OF THE ATTORNEY GENERAL'S OFFICE CONSUMER PROTECTION DIVISION ATTN: FRANCHISE 670 G. MENNEN WILLIAMS BUILDING 525 WEST LANSING LANSING, MICHIGAN 48913 NOTE: NOTWITHSTANDING PARAGRAPH (F) ABOVE, WE INTEND TO, AND YOU AGREE THAT WE AND YOU WILL, ENFORCE FULLY THE PROVISIONS OF THE ARBITRATION SECTION OF OUR AGREEMENTS. WE BELIEVE THAT PARAGRAPH FDD Exhibit H-12 (F) IS UNCONSTITUTIONAL AND CANNOT PRECLUDE US FROM ENFORCING THE ARBITRATION PROVISIONS. FDD Exhibit H-13 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF MINNESOTA In recognition of the requirements of the Minnesota Franchises Law, Minn. Stat. \u00a7\u00a7 80C.01 through 80C.22, and of the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce, Minn. Rules \u00a7\u00a7 2860.0100 through 2860.9930, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC for use in the State of Minnesota shall be amended to include the following:\"}, {\"id\": \"1\", \"title\": \"Item 13 is amended by the addition of the following language\", \"level\": 1, \"text\": \"1. Item 13 is amended by the addition of the following language: The franchisor will protect the franchisee's right to use the trademarks, service marks, trade names, logotypes or other commercial symbols or indemnify the franchisee from any loss, costs or expenses arising out of any claim, suite or demand regarding the use of the name.\"}, {\"id\": \"2\", \"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following par\", \"level\": 1, \"text\": \"2. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following paragraphs: With respect to franchisees governed by Minnesota law, we will comply with Minn. Stat. \u00a7 80C.14, Subds. 3, 4, and 5 which require, except in certain specified cases, that a franchisee be given 90 days' notice of termination (with 60 days to cure) and 180 days' notice of non-renewal of the Franchise Agreement, and that consent to the transfer of the franchise not be unreasonably withheld. Pursuant to Minn. Rule 2860.4400D, any general release of claims that you or a transferor may have against us or our shareholders, directors, employees and agents, including without limitation claims arising under federal, state, and local laws and regulations shall exclude claims you or a transferor may have under the Minnesota Franchise Law and the Rules and Regulations promulgated thereunder by the Commissioner of Commerce. Minn. Stat. \u00a7 80C.21 and Minn. Rule 2860.4400J prohibit us from requiring litigation to be conducted outside Minnesota, requiring waiver of a jury trial, or requiring you to consent to liquidated damages, termination penalties or judgment notes. In addition, nothing in the disclosure document or agreement can abrogate or reduce any of your rights as provided for in Minnesota Statutes, Chapter 80C, or your rights to jury trial, any procedure, forum, or remedies as may be provided for by the laws of the jurisdiction. Minn. Stat. \u00a7 80C.17 prohibits any action from being commenced under the Minnesota Franchises Law more than three years after the cause of action accrues.\"}, {\"id\": \"3\", \"title\": \"Each provision of this addendum shall be effective only to the extent, with respect to such provision, that the jurisdi\", \"level\": 1, \"text\": \"3. Each provision of this addendum shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Minnesota Franchises Law or the Rules and FDD Exhibit H-14 Regulations promulgated thereunder by the Minnesota Commission of Commerce are met independently without reference to this addendum to the disclosure document. FDD Exhibit H-15 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF MINNESOTA In recognition of the requirements of the Minnesota Franchises Law, Minn. Stat. \u00a7\u00a7 80C.01 through 80C.22, and of the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce, Minn. Rules \u00a7\u00a7 2860.0100 through 2860.9930, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}, {\"id\": \"1\", \"title\": \"Section 2\", \"level\": 1, \"text\": \"1. Section 2.2.7 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be deleted in its entirety and shall have no force or effect, and the following paragraph shall be inserted in its place:\"}, {\"id\": \"2.2.7\", \"title\": \"You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limit\", \"level\": 3, \"text\": \"2.2.7 You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limited exclusions), which will release all claims against us and our affiliates, and our respective officers, directors, members, managers, agents, and employees. If you are an entity, then your affiliates and your direct and indirect owners (and any other parties that we reasonably request) must also sign and deliver that release to us, excluding only such claims as Franchisee may have that have arisen under the Minnesota Franchises Law and the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce.\"}, {\"id\": \"2\", \"title\": \"Section 2 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be amended by the addition of the following par\", \"level\": 1, \"text\": \"2. Section 2 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be amended by the addition of the following paragraph: Minnesota law provides franchisees with certain non-renewal rights. In sum, Minn. Stat. \u00a7 80C.14 (subd. 4) currently requires, except in certain specified cases, that a franchisee be given 180 days' notice of non-renewal of the Franchise Agreement.\"}, {\"id\": \"3\", \"title\": \"Section 9 of the Agreement, under the heading \\\"Proprietary Marks,\\\" shall be amended by the addition of the following pa\", \"level\": 1, \"text\": \"3. Section 9 of the Agreement, under the heading \\\"Proprietary Marks,\\\" shall be amended by the addition of the following paragraph: Pursuant to Minnesota Stat. Sec. 80C.12, Subd. 1(g), Franchisor is required to protect any rights Franchise may have to Franchisor's Marks.\"}, {\"id\": \"4\", \"title\": \"Section 16\", \"level\": 1, \"text\": \"4. Section 16.5.1 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be deleted in its entirety and shall have no force or effect, and the following paragraph shall be inserted in its place:\"}, {\"id\": \"16.5.1\", \"title\": \"The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and\", \"level\": 3, \"text\": \"16.5.1 The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and our affiliates, successors, and assigns, and their respective officers, directors, members, managers, shareholders, partners, agents, representatives, servants, and employees in their corporate and individual capacities including, without limitation, claims arising under this Agreement, any other agreement between you and us, and/or our respective affiliates, and federal, state, and local laws and FDD Exhibit H-16 rules, excluding only such claims as Franchisee may have under the Minnesota Franchises Law and the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce.\"}, {\"id\": \"5\", \"title\": \"Section 16 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be amended by the addition of the followin\", \"level\": 1, \"text\": \"5. Section 16 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be amended by the addition of the following paragraph: Minnesota law provides franchisees with certain transfer rights. In sum, Minn. Stat. \u00a780C.14 (subd. 5) currently requires that consent to the transfer of the franchise may not be unreasonably withheld.\"}, {\"id\": \"6\", \"title\": \"Section 17 of the Agreement, under the heading \\\"Default and Termination\\\" shall be amended by the addition of the follow\", \"level\": 1, \"text\": \"6. Section 17 of the Agreement, under the heading \\\"Default and Termination\\\" shall be amended by the addition of the following paragraph: Minnesota law provides franchisees with certain termination rights. In sum, Minn. Stat. \u00a7 80C.14 (subd. 3) currently requires, except in certain specified cases, that a franchisee be given 90 days' notice of termination (with 60 days to cure) of the Franchise Agreement.\"}, {\"id\": \"7\", \"title\": \"Sections 18\", \"level\": 1, \"text\": \"7. Sections 18.8 of the Agreement, under the heading \\\"Obligations Upon Termination or Expiration,\\\" shall be deleted in its entirety and shall have no force or effect; and the following paragraph shall be substituted in its place:\"}, {\"id\": \"18.8\", \"title\": \"Pay Damages\", \"level\": 2, \"text\": \"18.8 Pay Damages. You agree to pay us all damages, costs, and expenses (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) that we incur as a result of your default under this Agreement and/or subsequent to the termination or expiration of this Agreement in seeking injunctive or other relief for the enforcement of any provisions of this Section 18, which will be in addition to amounts due to us under Section 18.11 below.\"}, {\"id\": \"8\", \"title\": \"Sections 27\", \"level\": 1, \"text\": \"8. Sections 27.5 and 27.9 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution,\\\" shall be deleted in their entirety and shall have no force or effect; and the following paragraphs shall be substituted in its place:\"}, {\"id\": \"27.5\", \"title\": \"Injunctions\", \"level\": 2, \"text\": \"27.5 Injunctions. Nothing contained in this Agreement will bar our right to seek injunctive relief in a court of competent jurisdiction against threatened conduct that will cause us loss or damages, under the usual equity rules, including the applicable rules for obtaining restraining orders and preliminary injunctions.\"}, {\"id\": \"27.9\", \"title\": \"Payment of Legal Fees\", \"level\": 2, \"text\": \"27.9 Payment of Legal Fees. You agree to pay us all damages, costs and expenses (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) that we incur after the termination or expiration of the franchise granted under this Agreement in: (a) seeking injunctive or other relief for the enforcement of any provisions of this Agreement (including without limitation Sections 9 and 17 above); and/or (b) successfully defending a claim from you that we misrepresented the terms of this Agreement, fraudulently induced you to sign this Agreement, that the provisions of this Agreement are not FDD Exhibit H-17 fair, were not properly entered into, and/or that the terms of this Agreement (as it may be amended by its terms) do not exclusively govern the parties' relationship.\"}, {\"id\": \"9\", \"title\": \"Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution\\\", shall be amended by the followi\", \"level\": 1, \"text\": \"9. Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution\\\", shall be amended by the following paragraph, which shall be considered an integral part of the Agreement:\"}, {\"id\": \"27.10\", \"title\": \"Minn\", \"level\": 2, \"text\": \"27.10 Minn. Stat. \u00a7 80C.17 prohibits any action from being commenced under the Minnesota Franchises Law more than three years after the cause of action accrues. Minn. Stat. \u00a7 80C.21 and Minn. Rule 2860.4400J prohibit Franchisor from requiring litigation to be conducted outside Minnesota, requiring waiver of a jury trial, or requiring Franchisee to consent to liquidated damages, termination penalties or judgment notes. In addition, nothing in the disclosure document or agreement can abrogate or reduce any of Franchisee's rights as provided for in Minnesota Statutes, Chapter 80C, or Franchisee's rights to jury trial, any procedure, forum, or remedies as may be provided for by the laws of the jurisdiction.\"}, {\"id\": \"10\", \"title\": \"Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisd\", \"level\": 1, \"text\": \"10. Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Minnesota Franchises Law or the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce are met independently without reference to this Amendment. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-18 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF NEW YORK\"}, {\"id\": \"1\", \"title\": \"The following information is added to the cover page of the Franchise Disclosure Document\", \"level\": 1, \"text\": \"1. The following information is added to the cover page of the Franchise Disclosure Document: INFORMATION COMPARING FRANCHISORS IS AVAILABLE. CALL THE STATE ADMINISTRATORS LISTED IN EXHIBIT C OR YOUR PUBLIC LIBRARY FOR SOURCES OF INFORMATION. REGISTRATION OF THIS FRANCHISE BY NEW YORK STATE DOES NOT MEAN THAT NEW YORK STATE RECOMMENDS IT OR HAS VERIFIED THE INFORMATION IN THIS FRANCHISE DISCLOSURE DOCUMENT. IF YOU LEARN THAT ANYTHING IN THE FRANCHISE DISCLOSURE DOCUMENT IS UNTRUE, CONTACT THE FEDERAL TRADE COMMISSION AND NEW YORK STATE DEPARTMENT OF LAW, BUREAU OF INVESTOR PROTECTION AND SECURITIES, 120 BROADWAY, 23RD FLOOR, NEW YORK, NEW YORK 10271. THE FRANCHISOR MAY, IF IT CHOOSES, NEGOTIATE WITH YOU ABOUT ITEMS COVERED IN THE FRANCHISE DISCLOSURE DOCUMENT. HOWEVER, THE FRANCHISOR CANNOT USE THE NEGOTIATING PROCESS TO PREVAIL UPON A PROSPECTIVE FRANCHISEE TO ACCEPT TERMS WHICH ARE LESS FAVORABLE THAN THOSE SET FORTH IN THIS FRANCHISE DISCLOSURE DOCUMENT.\"}, {\"id\": \"2\", \"title\": \"The following is added at the end of Item 3\", \"level\": 1, \"text\": \"2. The following is added at the end of Item 3: Except as provided above, with regard to the franchisor, its predecessor, a person identified in Item 2, or an affiliate offering franchises under the franchisor's principal trademark: A. No such party has an administrative, criminal or civil action pending against that person alleging: a felony, a violation of a franchise, antitrust, or securities law, fraud, embezzlement, fraudulent conversion, misappropriation of property, unfair or deceptive practices, or comparable civil or misdemeanor allegations. B. No such party has pending actions, other than routine litigation incidental to the business, which are significant in the context of the number of franchisees and the size, nature or financial condition of the franchise system or its business operations.\"}, {\"id\": \"C\", \"title\": \"No such party has been convicted of a felony or pleaded nolo contendere to a felony charge or, within the 10 year perio\", \"level\": 1, \"text\": \"C. No such party has been convicted of a felony or pleaded nolo contendere to a felony charge or, within the 10 year period immediately preceding the application for registration, has been convicted of or pleaded nolo contendere to a misdemeanor charge or has been the subject of a civil action alleging: violation of a franchise, antifraud, or securities law; fraud; embezzlement; fraudulent conversion or misappropriation of property; or unfair or deceptive practices or comparable allegations. FDD Exhibit H-19\"}, {\"id\": \"D\", \"title\": \"No such party is subject to a currently effective injunctive or restrictive order or decree relating to the franchise,\", \"level\": 1, \"text\": \"D. No such party is subject to a currently effective injunctive or restrictive order or decree relating to the franchise, or under a Federal, State, or Canadian franchise, securities, antitrust, trade regulation or trade practice law, resulting from a concluded or pending action or proceeding brought by a public agency; or is subject to any currently effective order of any national securities association or national securities exchange, as defined in the Securities and Exchange Act of 1934, suspending or expelling such person from membership in such association or exchange; or is subject to a currently effective injunctive or restrictive order relating to any other business activity as a result of an action brought by a public agency or department, including, without limitation, actions affecting a license as a real estate broker or sales agent.\"}, {\"id\": \"3\", \"title\": \"The following is added to the end of Item 4\", \"level\": 1, \"text\": \"3. The following is added to the end of Item 4: Neither the franchisor, its affiliate, its predecessor, officers, or general partner during the 10-year period immediately before the date of the offering circular: (a) filed as debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code; (b) obtained a discharge of its debts under the bankruptcy code; or (c) was a principal officer of a company or a general partner in a partnership that either filed as a debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code or that obtained a discharge of its debts under the U.S. Bankruptcy Code during or within 1 year after that officer or general partner of the franchisor held this position in the company or partnership.\"}, {\"id\": \"4\", \"title\": \"The following is added to the end of Item 5\", \"level\": 1, \"text\": \"4. The following is added to the end of Item 5: The initial franchise fee constitutes part of our general operating funds and will be used as such in our discretion.\"}, {\"id\": \"5\", \"title\": \"The following is added to the end of the \\\"Summary\\\" sections of Item 17(c), titled \\\"Requirements for franchisee to renew\", \"level\": 1, \"text\": \"5. The following is added to the end of the \\\"Summary\\\" sections of Item 17(c), titled \\\"Requirements for franchisee to renew or extend,\\\" and Item 17(m), entitled \\\"Conditions for franchisor approval of transfer\\\": However, to the extent required by applicable law, all rights you enjoy and any causes of action arising in your favor from the provisions of Article 33 of the General Business Law of the State of New York and the regulations issued thereunder shall remain in force; it being the intent of this proviso that the non-waiver provisions of General Business Law Sections 687.4 and 687.5 be satisfied.\"}, {\"id\": \"6\", \"title\": \"The following language replaces the \\\"Summary\\\" section of Item 17(d), titled \\\"Termination by franchisee\\\"\", \"level\": 1, \"text\": \"6. The following language replaces the \\\"Summary\\\" section of Item 17(d), titled \\\"Termination by franchisee\\\": You may terminate the agreement on any grounds available by law. FDD Exhibit H-20\"}, {\"id\": \"7\", \"title\": \"The following is added to the end of the \\\"Summary\\\" section of Item 17(j), titled \\\"Assignment of contract by franchisor\\\"\", \"level\": 1, \"text\": \"7. The following is added to the end of the \\\"Summary\\\" section of Item 17(j), titled \\\"Assignment of contract by franchisor\\\": However, no assignment will be made except to an assignee who in good faith and judgment of the franchisor, is willing and financially able to assume the franchisor's obligations under the Franchise Agreement.\"}, {\"id\": \"8\", \"title\": \"The following is added to the end of the \\\"Summary\\\" sections of Item 17(v), titled \\\"Choice of forum\\\", and Item 17(w), ti\", \"level\": 1, \"text\": \"8. The following is added to the end of the \\\"Summary\\\" sections of Item 17(v), titled \\\"Choice of forum\\\", and Item 17(w), titled \\\"Choice of law\\\": The foregoing choice of law should not be considered a waiver of any right conferred upon the franchisor or upon the franchisee by Article 33 of the General Business Law of the State of New York. FDD Exhibit H-21 STATEMENT OF DISCLOSURE DOCUMENT ACCURACY THE FRANCHISOR REPRESENTS THAT THIS DISCLOSURE DOCUMENT DOES NOT KNOWINGLY OMIT ANY MATERIAL FACT OR CONTAIN ANY UNTRUE STATEMENT OF A MATERIAL FACT. FDD Exhibit H-22 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF NEW YORK In recognition of the requirements of the New York General Business Law, Article 33, Sections 680 through 695, and of the regulations promulgated thereunder (N.Y. Comp. Code R. & Regs., tit. 13, \u00a7\u00a7 200.1 through 201.16), the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}, {\"id\": \"1\", \"title\": \"Section 2\", \"level\": 1, \"text\": \"1. Section 2.2.6 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be deleted in its entirety, and shall have no force or effect; and the following paragraph shall be substituted in its place:\"}, {\"id\": \"2.2.6\", \"title\": \"You must execute a general release, in a form prescribed by us, of any and all claims against us and our affiliates, and\", \"level\": 3, \"text\": \"2.2.6 You must execute a general release, in a form prescribed by us, of any and all claims against us and our affiliates, and our and our affiliates' respective officers, directors, securities holders, agents, and employees, provided, however, that all rights enjoyed by you and any causes of action arising in your favor from the provisions of New York General Business Law Sections 680-695 and the regulations issued thereunder, shall remain in force; it being the intent of this provision that the non-waiver provisions of N.Y. Gen. Bus. Law Sections 687.4 and 687.5 be satisfied;\"}, {\"id\": \"2\", \"title\": \"Section 13\", \"level\": 1, \"text\": \"2. Section 13.3.3 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be deleted in its entirety, and shall have no force or effect; and the following paragraph shall be substituted in its place:\"}, {\"id\": \"13.3.3\", \"title\": \"That the transferor must execute a general release, in a form satisfactory to us, of any and all claims against us and o\", \"level\": 3, \"text\": \"13.3.3 That the transferor must execute a general release, in a form satisfactory to us, of any and all claims against us and our affiliates, and our respective officers, directors, shareholders, member, agents, and employees, provided, however, that all rights enjoyed by the transferor and any causes of action arising in its favor from the provisions of New York General Business Law Sections 680-695 and the regulations issued thereunder, shall remain in force; it being the intent of this provision that the non-waiver provisions of N.Y. Gen. Bus. Law Sections 687.4 and 687.5 be satisfied;\"}, {\"id\": \"3\", \"title\": \"Section 25\", \"level\": 1, \"text\": \"3. Section 25.6 of the Agreement, under the heading \\\"Applicable Law; Dispute Resolution,\\\" shall be deleted in its entirety, and shall have no force or effect; and the following paragraph shall be substituted in lieu thereof:\"}, {\"id\": \"25.6\", \"title\": \"Nothing contained in this Agreement shall bar our right to seek injunctive relief against threatened conduct that will c\", \"level\": 2, \"text\": \"25.6 Nothing contained in this Agreement shall bar our right to seek injunctive relief against threatened conduct that will cause us loss or damages, under the usual equity rules, including the applicable rules for obtaining restraining orders and preliminary injunctions. FDD Exhibit H-23\"}, {\"id\": \"4\", \"title\": \"Section 25 of the Agreement, under the heading \\\"Applicable Law; Dispute Resolution,\\\" shall be amended by the addition o\", \"level\": 1, \"text\": \"4. Section 25 of the Agreement, under the heading \\\"Applicable Law; Dispute Resolution,\\\" shall be amended by the addition of the following language: Nothing in this Agreement should be considered a waiver of any right conferred upon you by New York General Business Law, Sections 680-695.\"}, {\"id\": \"5\", \"title\": \"There are circumstances in which an offering made by us would not fall within the scope of the New York General Busines\", \"level\": 1, \"text\": \"5. There are circumstances in which an offering made by us would not fall within the scope of the New York General Business Law, Article 33, such as when the offer and acceptance occurred outside the state of New York. However, an offer or sale is deemed made in New York if you are domiciled in or the franchise will be opening in New York. We are required to furnish a New York prospectus to every prospective franchisee who is protected under the New York General Business Law, Article 33. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-24 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF NORTH DAKOTA In recognition of the requirements of the North Dakota Franchise Investment Law, N.D. Cent. Code, \u00a7\u00a7 51 19 01 through 51 19 17, and the policies of the office of the State of North Dakota Securities Commission, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC shall be amended by the addition of the following language: The North Dakota Securities Commissioner has held the following to be unfair, unjust, or inequitable to North Dakota franchisees (Section 51-19-09, N.D.C.C.): A. Restrictive Covenants: Franchise disclosure documents which disclose the existence of covenants restricting competition contrary to Section 9-08-06, N.D.C.C., without further disclosing that such covenants will be subject to this statute. B. Situs of Arbitration Proceedings: Franchise agreements providing that the parties must agree to arbitrate disputes at a location that is remote from the site of the franchisee's business.\"}, {\"id\": \"C\", \"title\": \"Restriction on Forum\", \"level\": 1, \"text\": \"C. Restriction on Forum: Requiring North Dakota franchisees to consent to the jurisdiction of courts outside of North Dakota.\"}, {\"id\": \"D\", \"title\": \"Liquidated Damages and Termination Penalties\", \"level\": 1, \"text\": \"D. Liquidated Damages and Termination Penalties: Requiring North Dakota franchisees to consent to liquidated damages or termination penalties. E. Applicable Laws: Franchise agreements which specify that any claims arising under the North Dakota franchise law will be governed by the laws of a state other than North Dakota. F. Waiver of Trial by Jury: Requiring North Dakota franchisees to consent to the waiver of a trial by jury. G. Waiver of Exemplary and Punitive Damages: Requiring North Dakota franchisees to consent to a waiver of exemplary and punitive damages. H. General Release: Requiring North Dakota franchisees to execute a general release of claims as a condition of renewal or transfer of a franchise.\"}, {\"id\": \"I\", \"title\": \"Limitation on Claims\", \"level\": 1, \"text\": \"I. Limitation on Claims. Requiring North Dakota franchisees to consent to a limitation on when claims may be brought. FDD Exhibit H-25 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF NORTH DAKOTA In recognition of the requirements of the North Dakota Franchise Investment Law, N.D. Cent. Code, \u00a7\u00a7 51 19 01 through 51 19 17, and the policies of the office of the State of North Dakota Securities Commission, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}, {\"id\": \"1\", \"title\": \"The Agreement shall be amended by the addition of the following Section 29\", \"level\": 1, \"text\": \"1. The Agreement shall be amended by the addition of the following Section 29:\"}, {\"id\": \"29\", \"title\": \"The parties acknowledge and agree that they have been advised that the North Dakota Securities Commissioner has determi\", \"level\": 1, \"text\": \"29. The parties acknowledge and agree that they have been advised that the North Dakota Securities Commissioner has determined the following agreement provisions are unfair, unjust or inequitable to North Dakota franchisees: A. Restrictive Covenants: Any provision which discloses the existence of covenants restricting competition contrary to Section 9-08-06, N.D.C.C., without further disclosing that such covenants will be subject to this statute. B. Situs of Arbitration Proceedings: Any provision requiring that the parties must agree to arbitrate disputes at a location that is remote from the site of the Franchisee's business.\"}, {\"id\": \"C\", \"title\": \"Restriction on Forum\", \"level\": 1, \"text\": \"C. Restriction on Forum: Any provision requiring North Dakota franchisees to consent to the jurisdiction of courts outside of North Dakota.\"}, {\"id\": \"D\", \"title\": \"Liquidated Damages and Termination Penalties\", \"level\": 1, \"text\": \"D. Liquidated Damages and Termination Penalties: Any provision requiring North Dakota franchisees to consent to liquidated damages or termination penalties. E. Applicable Laws: Any provision which specifies that any claims arising under the North Dakota franchise law will be governed by the laws of a state other than North Dakota. F. Waiver of Trial by Jury: Any provision requiring North Dakota franchisees to consent to the waiver of a trial by jury. G. Waiver of Exemplary and Punitive Damages: Any provision requiring North Dakota franchisees to consent to a waiver of exemplary and punitive damages. H. General Release: Any provision requiring North Dakota franchisees to execute a general release of claims as a condition of renewal or transfer of a franchise.\"}, {\"id\": \"I\", \"title\": \"Limitation on Claims\", \"level\": 1, \"text\": \"I. Limitation on Claims. Requiring North Dakota franchisees to consent to a limitation on when claims may be brought. [SIGNATURE PAGE FOLLOWS] FDD Exhibit H-26 IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-27 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF RHODE ISLAND In recognition of the requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19 28.1-1 through 19-28.1-34 the Franchise Disclosure Document for Goosehead Insurance Agency, LLC for use in the State of Rhode Island shall be amended to include the following:\"}, {\"id\": \"1\", \"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following\", \"level\": 1, \"text\": \"1. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following: Section 19-28.1-14 of the Rhode Island Franchise Investment Act provides that \\\"A provision in a franchise agreement restricting jurisdiction or venue to a forum outside this state or requiring the application of the laws of another state is void with respect to a claim otherwise enforceable under this Act.\\\"\"}, {\"id\": \"1\", \"title\": \"This addendum to the disclosure document shall be effective only to the extent, with respect to such provision, that th\", \"level\": 1, \"text\": \"1. This addendum to the disclosure document shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19-28.1-1 through 19-28.1-34, are met independently without reference to this addendum to the disclosure document. FDD Exhibit H-28 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF RHODE ISLAND In recognition of the requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19-28.1-1 through 19-28.1-34, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}, {\"id\": \"1\", \"title\": \"Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution,\\\" shall be amended by the additio\", \"level\": 1, \"text\": \"1. Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution,\\\" shall be amended by the addition of the following paragraph: Section 19-28.1-14 of the Rhode Island Franchise Investment Act provides that \\\"A provision in a franchise agreement restricting jurisdiction or venue to a forum outside this state or requiring the application of the laws of another state is void with respect to a claim otherwise enforceable under this Act.\\\"\"}, {\"id\": \"2\", \"title\": \"This amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requireme\", \"level\": 1, \"text\": \"2. This amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19-28.1-1 through 19-28.1-34, are met independently without reference to this amendment. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-29 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF VIRGINIA\"}, {\"id\": \"1\", \"title\": \"Item 17 of the disclosure document is hereby modified by adding the following paragraphs to the end of provision entitl\", \"level\": 1, \"text\": \"1. Item 17 of the disclosure document is hereby modified by adding the following paragraphs to the end of provision entitled \\\"h. 'Cause' defined - non-curable defaults\\\": Under Section 13.1-564 of the Virginia Retail Franchising Act, it is unlawful for a franchisor to cancel a franchise without reasonable cause. If any ground for default or termination stated in the franchise agreement does not constitute 'reasonable cause,' as that term may be defined in the Virginia Retail Franchise Act or the laws of Virginia, that provision may not be enforceable. Under Section 13.1-564 of the Virginia Retail Franchising Act, it is unlawful for a franchisor to use undue influence to induce a franchisee to surrender any right given to him under the franchise. If any provision of the franchise agreement involves the use of undue influence by the franchisor to induce a franchisee to surrender any rights given to him under the franchise, that provision may not be enforceable. FDD Exhibit H-30 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF WASHINGTON In recognition of the requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.180, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC in connection with the offer and sale of franchises for use in the State of Washington shall be amended to include the following:\"}, {\"id\": \"1\", \"title\": \"Item 17(d), \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following\", \"level\": 1, \"text\": \"1. Item 17(d), \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following statement: Franchisees may terminate under any grounds permitted by law.\"}, {\"id\": \"2\", \"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following par\", \"level\": 1, \"text\": \"2. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following paragraphs at the conclusion of the Item: The state of Washington has a statute, RCW 19.100.180, which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise. There may also be court decisions which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise. In any arbitration involving a franchise purchased in Washington, the arbitration site shall be either in the state of Washington, or in a place mutually agreed upon at the time of the arbitration, or as determined by the arbitrator. In the event of a conflict of laws, the provisions of the Washington Franchise Investment Protection Act, Chapter 19.100 RCW shall prevail. A release or waiver of rights executed by a franchisee shall not include rights under the Washington Franchise Investment Protection Act except when executed pursuant to a negotiated settlement after the agreement is in effect and where the parties are represented by independent counsel. Provisions such as those which unreasonably restrict or limit the statute of limitations period for claims under the Act, rights or remedies under the Act such as a right to a jury trial may not be enforceable. Transfer fees are collectable to the extent that they reflect the franchisor's reasonable estimated or actual costs in effecting a transfer.\"}, {\"id\": \"3\", \"title\": \"Each provision of this addendum to the disclosure document shall be effective only to the extent, with respect to such\", \"level\": 1, \"text\": \"3. Each provision of this addendum to the disclosure document shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.180, are met independently without reference to this addendum to the disclosure document. FDD Exhibit H-31 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF WASHINGTON In recognition of the requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.010 through 19.100.940, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement agree as follows:\"}, {\"id\": \"1\", \"title\": \"The state of Washington has a statute, RCW 19\", \"level\": 1, \"text\": \"1. The state of Washington has a statute, RCW 19.100.180, which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise. There may also be court decisions which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise.\"}, {\"id\": \"2\", \"title\": \"In any arbitration involving a franchise purchased in Washington, the arbitration site shall be either in the state of\", \"level\": 1, \"text\": \"2. In any arbitration involving a franchise purchased in Washington, the arbitration site shall be either in the state of Washington, or in a place mutually agreed upon at the time of the arbitration, or as determined by the arbitrator.\"}, {\"id\": \"3\", \"title\": \"In the event of a conflict of laws, the provisions of the Washington Franchise Investment Protection Act, Chapter 19\", \"level\": 1, \"text\": \"3. In the event of a conflict of laws, the provisions of the Washington Franchise Investment Protection Act, Chapter 19.100 RCW shall prevail.\"}, {\"id\": \"4\", \"title\": \"A release or waiver of rights executed by a franchisee shall not include rights under the Washington Franchise Investme\", \"level\": 1, \"text\": \"4. A release or waiver of rights executed by a franchisee shall not include rights under the Washington Franchise Investment Protection Act except when executed pursuant to a negotiated settlement after the agreement is in effect and where the parties are represented by independent counsel. Provisions such as those which unreasonably restrict or limit the statute of limitations period for claims under the Act, rights or remedies under the Act such as a right to a jury trial may not be enforceable.\"}, {\"id\": \"5\", \"title\": \"Transfer fees are collectable to the extent that they reflect the franchisor's reasonable estimated or actual costs in\", \"level\": 1, \"text\": \"5. Transfer fees are collectable to the extent that they reflect the franchisor's reasonable estimated or actual costs in effecting a transfer.\"}, {\"id\": \"6\", \"title\": \"Each provision of this amendment shall be effective only to the extent, with respect to such provision, that the jurisd\", \"level\": 1, \"text\": \"6. Each provision of this amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.010 through 19.100.940, are met independently without reference to this amendment. [SIGNATURE PAGE FOLLOWS] FDD Exhibit H-32 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Washington amendment to the Franchise Agreement on the same date as the Franchise Agreement was executed GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-33\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of GOOSEHEADINSURANCE,INC_04_02_2018-EX-10.6-Franchise Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.6\", \"level\": 1, \"text\": \"Exhibit 10.6 Goosehead Insurance Agency, LLC Franchise Agreement\"}}, {\"id\": \"Exhibit A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Declarations Page 1 1.2 The \\\"Approved Location\\\" under this Agreement will be: . 2 4.1 You elect to pay the Initial Franchise Fee in one of the following ways: (check only one): \u2610 In its entirety at the time you enter into this Agreement, in which case the amount of the Initial Franchise Fee shall be: ($ ). \u2610 You shall pay a portion of the Initial Franchise Fee at the time you enter into this Agreement in the amount of ($ ), and shall pay the remaining portion of ($ ), plus interest, according to the terms of the 60-month Promissory Note attached to this Agreement as Exhibit I. 3 4.2 The \\\"Commencement Date\\\" will be: . Initials Franchisee Franchisor\", \"level\": 1, \"text\": \"Exhibit A Declarations Page 1 1.2 The \\\"Approved Location\\\" under this Agreement will be: . 2 4.1 You elect to pay the Initial Franchise Fee in one of the following ways: (check only one): \u2610 In its entirety at the time you enter into this Agreement, in which case the amount of the Initial Franchise Fee shall be: ($ ). \u2610 You shall pay a portion of the Initial Franchise Fee at the time you enter into this Agreement in the amount of ($ ), and shall pay the remaining portion of ($ ), plus interest, according to the terms of the 60-month Promissory Note attached to this Agreement as Exhibit I. 3 4.2 The \\\"Commencement Date\\\" will be: . Initials Franchisee Franchisor Goosehead Insurance Agency, LLC Franchise Agreement TABLE OF CONTENTS Section Title Page# Recitals 2 1 Grant 2 2 Term And Renewal 3 3 Our Duties 4 4 Fees; Sales Reporting 6 5 Franchised Business Commencement 9 6 Operating Principal, Personnel, And Training 11 7 Purchase of Products and Services 13 8 Your Duties 15 9 Proprietary Marks 20 10 Confidential Brand Standards Manuals 23 11 Confidential Information 24 12 Accounting, Financial And Other Records, And Inspections 25 13 Marketing 27 14 Technology 31 15 Insurance 35 16 Transfer Of Interest 38 17 Default And Termination 43 18 Obligations Upon Termination Or Expiration 46 19 Covenants 49 20 Taxes, Permits, And Indebtedness 51 21 Independent Contractor And Indemnification 52 22 Force Majeure 53 23 Approvals And Waivers 54 24 Notices 54 25 Entire Agreement And Amendment 54 26 Severability And Construction 55 27 Applicable Law And Dispute Resolution 55 28 Acknowledgments 57 Exhibits A Declarations Page E ADA Certification B Guarantee, Indemnification, and Acknowledgement F1- 3 Sample Forms of Non-Disclosure and Non- Competition Agreements C List of Principals G Site Selection Addendum D ACH - Authorization Agreement for H Lease Rider Prearranged Payments (Direct Debits) I Promissory Note i Goosehead Insurance Agency, LLC Franchise Agreement THIS FRANCHISE AGREEMENT (the \\\"Agreement\\\") is made and entered into as of the \\\"Effective Date\\\" that we have indicated on the signature page of this Agreement by and between: \u25cf Goosehead Insurance Agency, LLC, a Delaware limited liability company, with its principal place of business at 1500 Solana Blvd., Suite 450, Westlake, Texas 76262 (\\\"we,\\\" \\\"us,\\\" or \\\"our\\\"); and \u25cf a [resident of] [corporation organized in] [limited liability company organized in] the state of and having offices at (\\\"you\\\" or the \\\"Franchisee\\\"). Introduction We have developed our own distinctive and proprietary systems for insurance services, including home insurance, automobile insurance, life insurance, specialty lines, and business insurance (the \\\"System\\\"). Our System includes (among other things): business processes, technologies, trade secrets, customer lists, knowledge, know-how, trade names, service marks, trademarks, logos, emblems, trade dress and other intellectual property; distinctive signage; standards, specifications and sources for services, products, supplies, appearance, operations and management control; safety standards; training and assistance; purchasing programs; and advertising, marketing, promotional and sales programs; all of which we may periodically change, discontinue, improve, modify and further develop. We identify the System by means of our Proprietary Marks. Our proprietary marks include certain trade names (for example, the mark \\\"Goosehead Insurance\\\" and logo), service marks, trademarks, logos, emblems, and indicia of origin, as well as other trade names, service marks, and trademarks that we may periodically specify in writing for use in connection with the System (all of these are referred to as our \\\"Proprietary Marks\\\"). We continue to develop, use, and control the use of our Proprietary Marks in order to identify for the public the source of services and products marketed under those marks and under the System, and to represent the System's high standards of quality, appearance, and service. We are in the business of developing and awarding franchise rights to third party franchisees, such as you, to develop and operate businesses providing insurance services (\\\"Services\\\") to clients under the System and using the Proprietary Marks (\\\"Goosehead Businesses\\\"). You have asked to enter into the business of operating a Goosehead Business under our System and wish to obtain a franchise from us for that purpose, as well as to receive the training and other assistance we provide as described in this Agreement. You also understand and acknowledge the importance of our high standards of quality, appearance, and service and the necessity of operating the business franchised under this Agreement in conformity with our standards and specifications. You will be in the business of operating a Goosehead Business, using the same brand and Proprietary Marks as other independent businesses that operate other Goosehead Businesses under the System. We will not operate your Goosehead Business for you, although we have (and will continue) to set standards for Goosehead Businesses that you will have chosen to adopt as yours by signing this Agreement and by your day-to-day management of your Goosehead Business to our brand standards. Page 1 of 80 Page 2 of 80 Page 3 of 80 Page 4 of 80 Page 5 of 80 Page 6 of 80 changes and net of Agency Fee refunds, for insurance services provided by the Franchised Business; Gross Revenues will not include any Premiums or Policy Fees collected by the Franchised Business on behalf of any insurance carrier. 4.2.4 The term \\\"Minimum Royalty\\\" means a minimum monthly Royalty Fee payment, beginning six (6) months after the Commencement Date, in the following amounts: Number of Months following the Commencement Date Amount of Monthly Minimum Royalty Six (6) to Eighteen (18) Six Hundred Dollars ($600) Nineteen (19) and for the remainder of the term of this Agreement One Thousand Dollars ($1,000) Page 7 of 80 Page 8 of 80 Page 9 of 80 Page 10 of 80 Page 11 of 80 Page 12 of 80 While your Franchised Business will focus principally on the provision of Services, you may also offer certain products at your Franchised Business. This Section 7 addresses those items. 7.1 Products. You agree to buy all products, equipment, furniture, supplies, materials and other products used or offered for sale at the Franchised Business only from suppliers as to whom we have given you our prior written approval (and whom we have not subsequently disapproved). In this regard, the parties further agree: 7.1.1 In determining whether we will approve any particular supplier, we will consider various factors, including: (a) whether the supplier can demonstrate, to our continuing reasonable satisfaction, the ability to meet our then-current standards and specifications for such items; (b) whether the supplier has adequate quality controls and capacity to supply your needs promptly and reliably; (c) whether approval of the supplier would enable the System, in our sole opinion, to take advantage of marketplace efficiencies; and (d) whether the supplier will sign a confidentiality agreement and a license agreement in the form that we may require (which may include a royalty fee for the right to use our Proprietary Marks and any other proprietary rights, recipes, and/or formulae). Page 13 of 80 Page 14 of 80 Page 15 of 80 Page 16 of 80 Page 17 of 80 Page 18 of 80 Page 19 of 80 Page 20 of 80 Page 21 of 80 Page 22 of 80 Page 23 of 80 Page 24 of 80 Page 25 of 80 Page 26 of 80 Page 27 of 80 Page 28 of 80 Page 29 of 80 Page 30 of 80 Page 31 of 80 Page 32 of 80 Page 33 of 80 Page 34 of 80 Page 35 of 80 Page 36 of 80 Page 37 of 80 Page 38 of 80 Page 39 of 80 Page 40 of 80 Page 41 of 80 furniture, fixtures, equipment and the rights under the lease for the Approved Location (if we elect to purchase these assets) will be the fair market value as you and we agree. If we and you (or your appropriate legal representative) cannot agree on the fair market value of such furniture, fixtures, equipment or the rights under the lease for the Approved Location, each party will select an independent appraiser who will each provide a written appraisal of such furniture, fixtures, equipment or rights under the lease for the Approved Location and we may elect to exercise the option granted hereunder by paying to you the average of the two appraisals. We will pay the purchase price to you in twelve (12) equal, monthly installments following the purchase, provided that you are in full compliance with the covenants contained in this Agreement. If, at any time during the twelve (12) months following our purchase of your assets, as described above, you breach any covenant contained in this Agreement (or any other agreement between you and us), our obligation to pay the monthly installments will immediately cease. 16.6.3.3 We may elect to exercise our option to purchase your interest in the Franchised Business by sending written notice of the election to you (or your appropriate legal representative). The election may exclude the purchase of the furniture, fixtures, equipment and rights under the lease for the Approved Location. The closing of the sale will occur within thirty (30) days after we exercise our option to purchase the Franchised Business or such later date as may be necessary to comply with applicable bulk sales or similar laws. At closing, we and you agree to sign and deliver all documents necessary to vest title in the assets purchased by us free and clear of all liens and encumbrances, except any assumed by us and/or to effectuate assignment of the lease for the Approved Location. You (or your appropriate legal representative) must cooperate fully and use your best efforts to acquire the landlord's approval of the assignment of the lease for the Approved Location to us, if necessary. If the lease for the Approved Location cannot be assigned to us, you will agree to sublease the Approved Location to us on all the same terms and conditions as are contained in your lease and will cooperate fully and use your best efforts to acquire the landlord's approval of the sublease, if necessary. We reserve the right to assign our option to purchase the Franchised Business or designate a substitute purchaser of the Franchised Business. 16.7 Consent to Transfer. Our consent to a transfer that is the subject of this Section 16 will not constitute a waiver of any claims that we may have against the transferring party, nor will it be deemed a waiver of our right to demand exact compliance with any of the terms of this Agreement by the transferor or transferee. 16.8 No Transfers to a Non-Franchisee Party to Operate a Similar Business. You agree that neither you nor any Principal of yours will transfer or attempt to transfer any or all of your Franchised Business to a third party who will operate a similar business at the Approved Location but not under the System and the Proprietary Marks, and not under a franchise agreement with us. 16.9 Bankruptcy Issues. If you or any person holding any interest (direct or indirect) in you become a debtor in a proceeding under the U.S. Bankruptcy Code or any similar law in the U.S. or elsewhere, it is the parties' understanding and agreement that any transfer of you, your obligations, and/or rights under this Agreement, any material assets of yours, and/or Page 42 of 80 Page 43 of 80 Page 44 of 80 Page 45 of 80 Upon termination or expiration of this Agreement, all rights granted under this Agreement to you will forthwith terminate, and all of the following will take effect: 18.1 Cease Operation. You agree to: (a) immediately and permanently stop operating the Franchised Business; and (b) never directly or indirectly represent to the public that you are a present or former franchisee of ours. 18.2 Stop Using Marks and Intellectual Property. You agree to immediately and permanently cease to use, in any manner whatsoever, all aspects of the System, including any confidential methods, procedures and techniques associated with the System, the mark \\\"Goosehead Insurance\\\" and any and all other Proprietary Marks, distinctive forms, slogans, signs, symbols, and devices associated with the System, and any and all other intellectual property associated with the System. Without limiting the foregoing, you agree to stop making any further use of any and all signs, marketing materials, displays, stationery, forms, and any other articles that display the Proprietary Marks. 18.3 Cancel Assumed Names. You agree to take such action as may be necessary to cancel any assumed name or equivalent registration which contains the mark \\\"Goosehead Insurance\\\" Page 46 of 80 Page 47 of 80 Page 48 of 80 Page 49 of 80 Page 50 of 80 Page 51 of 80 Page 52 of 80 Page 53 of 80\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPROVALS AND WAIVERS 23\", \"level\": 1, \"text\": \"23 APPROVALS AND WAIVERS 23.1 Request for Approval. Whenever this Agreement requires our prior approval or consent, you agree to make a timely written request to us therefor, and such approval or consent must be obtained in writing. 23.2 No Warranties or Guarantees. You acknowledge and agree that we make no warranties or guarantees upon which you may rely, and that we assume no liability or obligation to you, by providing any waiver, approval, consent, or suggestion to you in connection with this Agreement, or by reason of any neglect, delay, or denial of any request therefor. 23.3 No Waivers. No delay, waiver, omission, or forbearance on our part to exercise any right, option, duty, or power arising out of any breach or default by you or any other franchisee under any of the terms, provisions, covenants, or conditions of this Agreement, and no custom or practice by the parties at variance with the terms of this Agreement, will constitute our waiver of our right to enforce any such right, option, duty, or power as against you, or as to subsequent breach or default by you. If we accept late payments from you or any payments due, that will not be deemed to be our waiver of any earlier or later breach by you of any terms, provisions, covenants, or conditions of this Agreement. No course of dealings or course of conduct will be effective to amend the terms of this Agreement. 24 NOTICES Any and all notices required or permitted under this Agreement must be in writing and must be personally delivered, sent by certified U.S. mail, or by other means which affords the sender evidence of delivery, of rejected delivery, or attempted delivery to the respective parties at the addresses shown on the signature page of this Agreement, unless and until a different address has been designated by written notice to the other party. Any notice by a means that gives the sender evidence of delivery, rejected delivery, or delivery that is not possible because the recipient moved and left no forwarding address will be deemed to have been given at the date and time of receipt, rejected, and/or attempted delivery. The Manual, any changes that we make to the Manual, and/or any other written instructions that we provide relating to operational matters, are not considered to be \\\"notices\\\" for the purpose of the delivery requirements in this Section 24. 25 ENTIRE AGREEMENT AND AMENDMENT 25.1 Entire Agreement. This Agreement and the exhibits referred to in this Agreement constitute the entire, full, and complete Agreement between the parties to this Agreement concerning the subject matter hereof, and supersede all prior agreements. The parties confirm that: (a) they were not induced by any representations other than the words of this Agreement (and the FDD) before deciding whether to sign this Agreement; and (b) they relied only on the words printed in this Agreement in deciding whether to enter into this Agreement. However, nothing in this Section is intended as, nor will it be interpreted to be, a disclaimer by us of any representation made in our Franchise Disclosure Document (\\\"FDD\\\"), including the exhibits and any amendments to the FDD. 25.2 Amendment. Except for those changes that we are permitted to make unilaterally under this Agreement, no amendment, change, or variance from this Agreement will be binding on either party unless mutually agreed to by the parties and executed by their authorized officers or agents in writing. Page 54 of 80 Page 55 of 80 Page 56 of 80 Page 57 of 80 Page 58 of 80 You (on behalf of yourself and your parent, subsidiaries and affiliates and their respective past and present members, officers, directors, members, managers, shareholders, agents and employees, in their corporate and individual capacities) and all guarantors of your obligations under this Agreement (collectively, \\\"Releasors\\\") freely and without any influence forever release and covenant not to sue us, our parent, subsidiaries and affiliates and their respective past and present officers, directors, shareholders, agents and employees, in their corporate and individual capacities (collectively \\\"Releasees\\\"), with respect to any and all claims, demands, liabilities and causes of action of whatever kind or nature, whether known or unknown, vested or contingent, suspected or unsuspected (collectively, \\\"claims\\\"), which any Releasor now owns or holds or may at any time have owned or held, including, without limitation, claims arising under federal, state and local laws, rules and ordinances and claims arising out of, or relating to this Agreement and all other agreements between any Releasor and any Releasee, the sale of any franchise to any Releasor, the development and operation of the Goosehead Businesses and the development and operation of all other businesses operated by any Releasor that are franchised by any Releasee. You expressly agree that fair consideration has been given by us for this General Release and you fully understand that this is a negotiated, complete and final release of all claims. This General Release does not release any claims arising from representations made in our Franchise Disclosure Document and its exhibits or otherwise impair or affect any claims arising after the date of this Agreement. ***** Page 59 of 80 IN WITNESS WHEREOF, the parties hereto have duly signed and delivered this Agreement in duplicate on the day and year first above written. Goosehead Insurance Agency, LLC Franchisor Franchisee Entity By: By: Name: Name: Title: Title: Effective Date: Address for Notices: Address for Notices:\"}}, {\"id\": \"1500\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Solana Blvd\", \"level\": 1, \"text\": \"1500 Solana Blvd., Suite 4500 Westlake, Texas 76262 Fax: Fax: Attn: Attn: Page 60 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT B GUARANTEE, INDEMNIFICATION, AND ACKNOWLEDGMENT In order to induce Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") to sign the Goosehead Insurance Franchise Agreement between Franchisor and (\\\"Franchisee\\\"), dated , 201 (the \\\"Agreement\\\"), each of the undersigned parties, jointly and severally, hereby unconditionally guarantee to Franchisor and its successors and assigns that all of Franchisee's obligations (monetary and otherwise) under the Agreement as well as any other contract between Franchisee and Franchisor (and/or Franchisor's affiliates) will be punctually paid and performed. Each individual signing this Personal Guarantee acknowledges and agrees, jointly and severally, that: \u2022 Upon Franchisor's demand, s/he will immediately make each payment required of Franchisee under the Agreement and/or any other contract with Franchisor and/or its affiliates. \u2022 S/he waives any right to require Franchisor to: (a) proceed against Franchisee for any payment required under the Agreement (and/or any other contract with Franchisor and/or its affiliates); (b) proceed against or exhaust any security from Franchisee; (c) pursue or exhaust any remedy, including any legal or equitable relief, against Franchisee; and/or (d) give notice of demand for payment by Franchisee. \u2022 Without affecting the obligations of the undersigned persons under this Guarantee, Franchisor may, without notice to the undersigned, extend, modify, or release any indebtedness or obligation of Franchisee, or settle, adjust, or compromise any claims against Franchisee. Each of the undersigned persons waive notice of amendment of the Agreement (and any other contract with Franchisor and Franchisor's affiliates) and notice of demand for payment by Franchisee, and agree to be bound by any and all such amendments and changes to the Agreement (and any other contract with Franchisor and Franchisor's affiliates). \u2022 S/he will defend, indemnify and hold Franchisor harmless against any and all losses, damages, liabilities, costs, and expenses (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) resulting from, consisting of, or arising out of or in connection with any failure by Franchisee to perform any obligation of Franchisee under the Agreement (and any other contract with Franchisor and Franchisor's affiliates) and/or any amendment to the Agreement. \u2022 S/he will be personally bound by all of Franchisee's covenants, obligations, and promises in the Agreement. \u2022 S/he agrees to be individually bound by all of Franchisee's covenants, obligations, and promises in the Agreement, which include, but are not limited to, the covenants in the following Sections of the Agreement: Section 9.3 (generally regarding trademarks), Section 11 (generally regarding confidentiality), Section 16 (generally regarding Transfers), Section 18 (generally regarding obligations upon termination or expiration of this Agreement), and Section 19 (generally regarding covenants against competition) of the Agreement. Page 61 of 80 \u25cf S/he understands that: (a) this Guarantee does not grant them any rights under the Agreement (including but not limited to the right to use any of Franchisor's marks such as the \\\"Goosehead Insurance\\\" marks) and/or the system licensed to Franchisee under the Agreement; (b) that they have read, in full, and understand, all of the provisions of the Agreement that are referred to above in this paragraph, and that they intend to fully comply with those provisions of the Agreement as if they were printed here; and (c) that they have had the opportunity to consult with a lawyer of their own choosing in deciding whether to sign this Guarantee. This Guarantee will be interpreted and construed in accordance with Section 27 of the Agreement (including but not limited to the waiver of punitive damages, waiver of jury trial, agreement to bring claims within one year, and agreement not to engage in class or common actions). Among other things, that means that this Guarantee will be interpreted and construed exclusively under the laws of the State of Texas, and that in the event of any conflict of law, Texas law will prevail (without applying Texas conflict of law rules). IN WITNESS WHEREOF, each of the undersigned persons has signed this Guarantee as of the date of the Agreement. (in his/her personal capacity) (in his/her personal capacity) (in his/her personal capacity) Printed Name: Printed Name: Printed Name: Date: Date: Date: Home Address: Home Address: Home Address: Page 62 of 80 GOOSEHEAD INSURANCE AGENCY, LLC] FRANCHISE AGREEMENT EXHIBIT C LIST OF PRINCIPALS Name of Principal Home Address Interest % Initials Franchisee Franchisor Page 63 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT D AUTHORIZATION AGREEMENT FOR ACH PAYMENTS (DIRECT DEBITS FOR ROYALTY, MARKETING CONTRIBUTION, AND OTHER FEES) (Name of Person or Legal Entity) (ID Number) The undersigned depositor (\\\"Depositor\\\" or \\\"Franchisee\\\") hereby authorizes Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") to initiate debit entries and/or credit correction entries to the undersigned's checking and/or savings account(s) indicated below and the depository designated below (\\\"Depository\\\" or \\\"Bank\\\") to debit or credit such account(s) pursuant to our instructions. Depository Branch City State Zip Code Bank Transit/ABA Number Account Number This authorization is to remain in full and force and effect until sixty days after we have received written notification from Franchisee of its termination. Printed Name of Depositor: Signed By: Printed Name: Title: Date: Page 64 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT E ADA CERTIFICATION Goosehead Insurance Agency, LLC (\\\"Franchisor\\\" or \\\"us\\\") and (\\\"Franchisee\\\" or \\\"you\\\") are parties to a franchise agreement dated , 201___ (the \\\"Franchise Agreement\\\") for the operation of a Franchised Business at (the \\\"Franchised Business\\\"). \u2022 In accordance with Section 5.6.2 of the Franchise Agreement, you certify to us that, to the best of your knowledge, the Franchised Business and its adjacent areas comply with all applicable federal, state, and local accessibility laws, statutes, codes, rules, regulations, and standards, including but not limited to the Americans with Disabilities Act. \u2022 You acknowledge that you are an independent contractor and the requirement of this certification by Franchisor does not constitute ownership, control, leasing, or operation of the Franchised Business. \u2022 You acknowledge that we have relied on the information contained in this certification. \u2022 You agree to indemnify us and our officers, directors, members, managers, shareholders, and employees in connection with any and all claims, losses, costs, expenses, liabilities, compliance costs, and damages incurred by the indemnified party(ies) as a result of any matters associated with your compliance with the Americans with Disabilities Act, as well as the costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) related to the same. Acknowledged and Agreed: Franchisee: By: Printed Name: Title: Page 65 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT F-1 SAMPLE FORM OF CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT (to be signed by franchisee with its executive/management personnel) THIS CONFIDENTIALITY AND NON-DISCLOSURE AND AGREEMENT (\\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer, or employee with Franchisee (the \\\"Member\\\"). Background: A. Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\"). B. Franchisor identifies Goosehead Businesses by means of certain trade names, service marks, trademarks, logos, emblems, and indicia of origin (including for example the mark \\\"Goosehead Insurance\\\") and certain other trade names, service marks, and trademarks that Franchisor currently and may in the future designate in writing for use in connection with the System (the \\\"Proprietary Marks\\\").\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to\", \"level\": 1, \"text\": \"C. Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential\", \"level\": 1, \"text\": \"D. The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same confidentiality provisions that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are acknowledged, the parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential Information\", \"level\": 1, \"text\": \"1. Confidential Information. Member agrees that Member will not, during the term of the Franchise Agreement or thereafter, communicate, divulge, or use for the benefit of any other person, persons, partnership, entity, association, or corporation any confidential information, knowledge, or know-how concerning the methods of operation of the business franchised thereunder which may be communicated to Member or of which Member may be apprised by virtue of your operation under the terms of the Franchise Agreement. Any and all information, knowledge, know-how, and techniques which Franchisor designates as confidential will be deemed confidential for purposes of this Agreement, except information which Franchisee can demonstrate came to its attention before disclosure thereof by Franchisor; or which, at or after the time of disclosure by Franchisor to Franchisee, had become or later becomes a part of the public domain, through publication or communication by others. Page 66 of 80\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Injunctive Relief\", \"level\": 1, \"text\": \"2. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 1, \"text\": \"3. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, will be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court will have the authority to reform and modify that provision in order that the restriction will be the maximum necessary to protect Franchisor's and/or Member's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court will impose the provision with retroactive effect as close as possible to the provision held to be invalid.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delay\", \"level\": 1, \"text\": \"4. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, will constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement will be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third-Party Beneficiary\", \"level\": 1, \"text\": \"5. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE MEMBER By: By: Name: Name: Title: Title: Page 67 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT F-2 SAMPLE FORM OF IN-TERM NON-COMPETITION AGREEMENT (to be signed by franchisee with its executive/management personnel) THIS IN-TERM NON-COMPETITION AGREEMENT (\\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer or employee with Franchisee (the \\\"Member\\\"). Background: A. Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\"). B. Franchisor identifies Goosehead Businesses by means of certain trade names, service marks, trademarks, logos, emblems, and indicia of origin (including for example the mark \\\"Goosehead Insurance\\\") and certain other trade names, service marks, and trademarks that Franchisor currently and may in the future designate in writing for use in connection with the System (the \\\"Proprietary Marks\\\").\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to\", \"level\": 1, \"text\": \"C. Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential\", \"level\": 1, \"text\": \"D. The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same non-competition provisions that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are acknowledged, the parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Covenants Not to Compete\", \"level\": 1, \"text\": \"1. Covenants Not to Compete. (a) Member specifically acknowledges that, pursuant to the Franchise Agreement, and by virtue of his/her position with Franchisee, Member will receive valuable specialized training and confidential information, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of Franchisor and the System. (b) Member covenants and agrees that during the term of the Franchise Agreement, except as otherwise approved in writing by Franchisor, Member will not, either directly or indirectly, for itself, or through, on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity: Page 68 of 80 (i) Solicit, divert or attempt to solicit or divert any business or customer of the Franchised Business or of any Franchised Business using the System to a Competitive Business, by direct or indirect inducement or otherwise, or do or perform, directly or indirectly, any other act injurious or prejudicial to the goodwill associated with Franchisor's Proprietary Marks and the System. (ii) Employ or seek to employ any person who is at that time employed by Franchisor, Franchisee, any other franchisee, master franchisee, developer, or development agent, or otherwise directly or indirectly induce such person to leave his or her employment; or (iii) Either directly or indirectly for him/herself or on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity, own, maintain, operate, engage in, be employed by or accept any compensation or remuneration from, or have any interest in any Competitive Business. (c) As used in this Agreement, the term \\\"Competitive Business\\\" is agreed to mean any property and/or casualty insurance distribution business.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Injunctive Relief\", \"level\": 1, \"text\": \"2. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 1, \"text\": \"3. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, will be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court will have the authority to reform and modify that provision in order that the restriction will be the maximum necessary to protect Franchisor's and/or Member's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court will impose the provision with retroactive effect as close as possible to the provision held to be invalid.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delay\", \"level\": 1, \"text\": \"4. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, will constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement will be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third-Party Beneficiary\", \"level\": 1, \"text\": \"5. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. Page 69 of 80 IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE By: Name: Title: MEMBER By: Name: Title: Page 70 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT F-3 SAMPLE FORM OF POST-TERM NON-COMPETITION AGREEMENT (to be signed by franchisee with its executive/management personnel) THIS POST-TERM NON-COMPETITION AGREEMENT ( \\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer or employee with Franchisee (the \\\"Member\\\"). Background: A. Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\"). B. Franchisor identifies Goosehead Businesses by means of certain trade names, service marks, trademarks, logos, emblems, and indicia of origin (including for example the mark \\\"Goosehead Insurance\\\") and certain other trade names, service marks, and trademarks that Franchisor currently and may in the future designate in writing for use in connection with the System (the \\\"Proprietary Marks\\\").\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to\", \"level\": 1, \"text\": \"C. Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential\", \"level\": 1, \"text\": \"D. The Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same non-competition provisions that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are acknowledged, the parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Covenants Not to Compete\", \"level\": 1, \"text\": \"1. Covenants Not to Compete. Member specifically acknowledges that, pursuant to the Franchise Agreement, and by virtue of his/her position with Franchisee, Member will receive valuable specialized training and confidential information, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of Franchisor and the System. (a) Member covenants and agrees that during the Post-Term Period (defined below), except as otherwise approved in writing by Franchisor, Member will not, either directly or indirectly, for itself, or through, on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity, Member will not own, maintain, operate, engage in, be associated with or accept any compensation or remuneration from, or have any interest in or render services or give Page 71 of 80 advice to any Competitive Business and which business is, or is intended to be, located within the city or county in which the Approved Location is situated. (b) Member covenants and agrees that during the Post-Term Period, Member will not, either directly or indirectly, solicit, divert, or attempt to solicit or divert any actual or potential business or customer of the Franchised Business to any Competitive Business. (c) As used in this Agreement, the term \\\"Competitive Business\\\" is agreed to mean any property and/or casualty insurance distribution business. (d) As used in this Agreement, the term \\\"Post-Term Period\\\" means a continuous uninterrupted period of two (2) years from the date of: (i) a transfer as contemplated under Section 16 of the Franchise Agreement; (ii) expiration or termination of the Franchise Agreement (regardless of the cause for termination); (iii) termination of Member's employment with Franchisee; and/or (iv) a final order of a duly authorized arbitrator, panel of arbitrators, or a court of competent jurisdiction (after all appeals have been taken) with respect to any of the foregoing or with respect to the enforcement of this Agreement; either directly or indirectly (through, on behalf of, or in conjunction with any persons, partnership, corporation or entity). Any period of non-compliance with the requirements of this Section 1, whether such non-compliance takes place after termination, expiration, non-renewal, and/or a transfer, will not be credited toward satisfying the two-year obligation specified above.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Injunctive Relief\", \"level\": 1, \"text\": \"2. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all costs (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 1, \"text\": \"3. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, will be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court will have the authority to reform and modify that provision in order that the restriction will be the maximum necessary to protect Franchisor's and/or Member's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court will impose the provision with retroactive effect as close as possible to the provision held to be invalid.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delay\", \"level\": 1, \"text\": \"4. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, will constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement will be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third-Party Beneficiary\", \"level\": 1, \"text\": \"5. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. Page 72 of 80 IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE By: Name: Title: MEMBER By: Name: Title: Page 73 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT G SITE SELECTION ADDENDUM Goosehead Insurance Agency, LLC (\\\"Franchisor\\\" or \\\"us\\\" or \\\"we\\\") and (\\\"Franchisee\\\" or \\\"you\\\") have this day of , 201 entered into a Goosehead Insurance Franchise Agreement (\\\"Franchise Agreement\\\") and wish to supplement its terms as set out below in this Site Selection Addendum (the \\\"Addendum\\\"). The parties agree as follows: AGREEMENT\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Time to Locate Site\", \"level\": 1, \"text\": \"1. Time to Locate Site: Within ninety (90) days after the date of this Addendum, you agree to acquire or lease/sublease, at your own expense, commercial real estate that is properly zoned for the use of the business that you will conduct under the Franchise Agreement (the \\\"Franchised Business\\\") at a site that we will have approved in writing as provided below. a. Such location must be within the following area: (the \\\"Site Selection Area\\\"). b. The only reason that the Site Selection Area is described is for the purpose of selecting a site for the Franchised Business.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For purposes of this Addendum, the term \\\"Search Period\\\" means ninety (90) days from the date of this Addendum, or the p\", \"level\": 1, \"text\": \"c. For purposes of this Addendum, the term \\\"Search Period\\\" means ninety (90) days from the date of this Addendum, or the period from the date of this Addendum until we have approved of a location for your Franchised Business, whichever event first occurs.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If you do not acquire or lease a site (that we have approved in writing) for the Franchised Business in accordance with\", \"level\": 1, \"text\": \"d. If you do not acquire or lease a site (that we have approved in writing) for the Franchised Business in accordance with this Addendum by not later than ninety (90) days after the date of this Addendum, that will constitute a default under Section 17.2 of the Franchise Agreement and also under this Addendum, and we will have the right to terminate the Franchise Agreement and this Addendum pursuant to the terms of Section 17.2 of the Franchise Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Site Evaluation Services\", \"level\": 1, \"text\": \"2. Site Evaluation Services: We will provide you with our site selection guidelines, including our minimum standards for a location for the Franchised Business, and such site selection counseling and assistance as we may deem advisable. If we deem on-site evaluation to be necessary and appropriate, we will conduct up to two (2) on-site evaluations at our cost and expense. If we perform any additional on-site evaluations, you must reimburse us, as applicable, for all reasonable expenses that we incur in connection with such on-site evaluation, including, without limitation, the cost of travel, lodging and meals. We will not provide on site evaluation for any proposed site before we have received from you a completed site approval form for the site (prepared as set forth in Section 3 below).\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Site Selection Package Submission and Approval\", \"level\": 1, \"text\": \"3. Site Selection Package Submission and Approval: You must submit to us, in the form that we specify: (a) a completed site approval form (in the form that we require); (b) such other information or materials that we may reasonably require; and (c) an option contract, letter of intent, or other evidence satisfactory to us that confirms your favorable prospects for obtaining the site. You acknowledge that time is of the essence. We will have thirty (30) days after receipt of all such information and materials from you to approve or disapprove the proposed site as the location for the Franchised Business. We have the right to approve or disapprove any such site to serve as the Page 74 of 80 Approved Location for the Franchised Business. If we do not approve a proposed site by giving you written notice within the 30-day period, then we will be deemed to have disapproved the site.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Lease Responsibilities\", \"level\": 1, \"text\": \"4. Lease Responsibilities: After we have approved a site and before the expiration of the Search Period, you must execute a lease, which must be coterminous with the Franchise Agreement, or a binding agreement to purchase the site. Our approval of any lease is conditioned upon inclusion in the lease of the Lease Rider attached to the Franchise Agreement as Exhibit H. However, even if we examine the Lease, we are not responsible for review of the Lease for any terms other than those contained in the Lease Rider.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Approved Location\", \"level\": 1, \"text\": \"5. Approved Location: After we have approved the location for the Franchised Business and you have leased or acquired that location, the location will constitute the Approved Location described in Section 1.2 of the Franchise Agreement. The Approved Location will be specified on Exhibit A to the Franchise Agreement, and will become a part the Franchise Agreement. a. You Franchisee hereby acknowledge and agree that our approval of a site does not constitute an assurance, representation, or warranty of any kind, express or implied, as to the suitability of the site for the Franchised Business or for any other purpose. Our approval of the site indicates only that we believe the site complies with our minimum acceptable criteria solely for our own purposes as of the time of the evaluation. The parties each acknowledge that application of criteria that have been effective with respect to other sites and premises may not be predictive of potential for all sites and that, subsequent to our approval of a site, demographic and/or economic factors, such as competition from other similar businesses, included in or excluded from criteria that we used could change, thereby altering the potential of a site. Such factors are unpredictable and are beyond our control. b. We will not be responsible for the failure of a site (even if we have approved that site) to meet your expectations as to revenue or operational criteria.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You acknowledge and agree that your acceptance of a franchise for the operation of the Franchised Business at the site\", \"level\": 1, \"text\": \"c. You acknowledge and agree that your acceptance of a franchise for the operation of the Franchised Business at the site is based on its own independent investigation of the suitability of the site.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Construction\", \"level\": 1, \"text\": \"6. Construction: This Addendum will be considered an integral part of the Franchise Agreement between the parties hereto, and the terms of this Addendum will be controlling with respect to the subject matter hereof. All capitalized terms not otherwise defined herein will have the same meaning as set forth in the Franchise Agreement. Except as modified or supplemented by this Addendum, the terms of the Franchise Agreement are hereby ratified and confirmed. Page 75 of 80 IN WITNESS WHEREOF, each party hereto has caused its duly authorized representative to duly execute and deliver this Addendum on the date first above written. Goosehead Insurance Agency, LLC Franchisor By: Name: Title: Franchisee By: Name: Title: Page 76 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT H LEASE RIDER THIS ADDENDUM (the \\\"Addendum\\\") has been executed as of this day of , 201 , by and between (\\\"Franchisee\\\") and (\\\"Landlord\\\"), as an addendum to the lease, as modified, amended, supplemented, renewed and/or extended from time to time as contemplated herein (\\\"Lease\\\") dated as of , 201 for the premises located at , in the State of (\\\"Premises\\\"). Franchisee has also entered (or will also enter) into a Franchise Agreement (\\\"Franchise Agreement\\\") with Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") for the development and operation of a \\\"Goosehead Insurance\\\" Business at the Premises, and as a condition to obtaining Franchisor's approval of the Lease, the Lease for the Premises must contain the provisions contained in this Addendum. NOW THEREFORE, in consideration of mutual covenants set forth herein, the execution and delivery of the Lease, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Franchisee hereby agree as follows: 1. Landlord agrees to deliver to Franchisor a copy of any notice of default or termination of the Lease at the same time such notice is delivered to Franchisee. Franchisor agrees to deliver to Landlord a copy of any notice of termination under the Franchise Agreement. Franchisee hereby consents to that exchange of information by Landlord and Franchisor. 2. Franchisee hereby assigns to Franchisor, with Landlord's irrevocable and unconditional consent, all of Franchisee's rights, title and interests to and under the Lease upon any termination or non-renewal of the Franchise Agreement, but no such assignment will be effective unless and until: (a) the Franchise Agreement is terminated or expires without renewal; (b) Franchisor has exercised its Option to Purchase under the Franchise Agreement; and (c) Franchisor notifies the Franchisee and Landlord in writing that Franchisor assumes Franchisee's obligations under the Lease. 3. Franchisor will have the right, but not the obligation, to cure any breach of the Lease (within fifteen (15) business days after the expiration of the period in which Franchisee had to cure any such default should Franchisee fail to do so) upon giving written notice of its election to Franchisee and Landlord, and, if so stated in the notice, to also succeed to Franchisee's rights, title and interests thereunder. The Lease may not be modified, amended, supplemented, renewed, extended or assigned by Franchisee without Franchisor's prior written consent. 4. Franchisee and Landlord acknowledge and agree that Franchisor will have no liability or obligation whatsoever under the Lease unless and until Franchisor assumes the Lease in writing pursuant to Section 2 or Section 3, above. 5. If Franchisor assumes the Lease, as provided above, Franchisor may, without Landlord's prior consent, further assign the Lease to another franchisee of Franchisor to operate a \\\"Goosehead Insurance\\\" business at the Premises provided that the proposed franchisee has met all of Franchisor's applicable criteria and requirements and has executed a franchise agreement with Franchisor. Landlord agrees to execute such further documentation to Page 77 of 80 confirm its consent to the assignment permitted under this Addendum as Franchisor may reasonably request. Upon such assignment to a franchisee of Franchisor, Franchisor will be released from any further liability under the terms and conditions of the Lease. 6. Landlord and Franchisee hereby acknowledge that Franchisee has agreed under the Franchise Agreement that Franchisor and its employees or agents will have the right to enter the Premises for certain purposes. Landlord hereby agrees not to interfere with or prevent such entry by Franchisor, its employees or agents. Landlord and Franchisee hereby further acknowledge that if the Franchise Agreement expires (without renewal) or is terminated, Franchisee is obligated to take certain steps under the Franchise Agreement to de-identify the Premises as a \\\"Goosehead Insurance\\\" business (unless Franchisor takes an assignment of the lease, as provided above). Landlord agrees to permit Franchisor, its employees or agent, to enter the Premises and remove signs (both interior and exterior), d\u00e9cor and materials displaying any marks, designs or logos owned by Franchisor, provided that Franchisor will bear the expense of repairing any damage to the Premises as a result thereof. 7. If Landlord is an affiliate or an Owner of Franchisee, Landlord and Franchisee agree that if Landlord proposes to sell the Premises, before the sale of the Premises, upon the request of Franchisor the Lease will be amended to reflect a rental rate and other terms that are the reasonable and customary rental rates and terms prevailing in the community where the \\\"Goosehead Insurance\\\" business is located. 8. Landlord agrees that during and after the term of the Lease, it will not disclose or use Franchisor's Confidential Information (as defined below) for any purpose other than for the purpose of fulfilling Landlord's obligations under the Lease. \\\"Confidential Information\\\" as used herein will mean all non-public information and tangible things, whether written, oral, electronic or in other form, provided or disclosed by or on behalf of Franchisee to Landlord, or otherwise obtained by Landlord, regarding the design and operations of the business located at the Premises, including, without limitation, all information identifying or describing the floor plan and layout, furnishings, equipment, fixtures, wall coverings, flooring materials, shelving, decorations, trade secrets, techniques, trade dress, \\\"look and feel,\\\" design, manner of operation, suppliers, vendors, and all other products, goods, and services used, useful or provided by or for Franchisee on the Premises. Landlord acknowledges that all such Confidential Information belongs exclusively to Franchisor. 9. Landlord agrees that: (a) Franchisor has granted to only one party, the Franchisee, the right to use Franchisor's proprietary trade name, trademarks, service marks logos, insignias, slogans, emblems, symbols, designs and indicia of origin (collectively the \\\"Marks\\\") at the Premises under the terms of the Franchise Agreement; and (b) Franchisor has not granted any rights or privileges to use the Marks to Landlord. 10. Landlord and Franchisee agree that the premises will be used solely for the operation of a \\\"Goosehead Insurance\\\" business. 11. Landlord and Franchisee agree that any default under the lease will also constitute a default under the Franchise Agreement, and any default under the Franchise Agreement will also constitute a default under the lease. 12. Landlord and Franchisee agree that the terms contained herein will supersede any terms to the contrary set forth in the Lease. Page 78 of 80\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Franchisor, along with its successors and assigns, is an intended third party beneficiary of the provisions of this Add\", \"level\": 1, \"text\": \"13. Franchisor, along with its successors and assigns, is an intended third party beneficiary of the provisions of this Addendum. 14. Landlord and Franchisee agree that copies of any and all notices required or permitted under this Addendum, or under the Lease, will also be sent to Franchisor at (attention ), or to such other address as Franchisor may specify by giving written notice to Landlord. WITNESS the execution hereof under seal. Landlord: Franchisor* Franchisee: Date: Date: Date: Subscribed and sworn to before me this day of , 201 . Notary Public Subscribed and sworn to before me this day of , 201 . Notary Public Subscribed and sworn to before me this day of , 201 . Notary Public My Commission expires: My Commission expires: My Commission expires: * The Franchisor has signed this lease rider only to acknowledge its terms and not to accept any obligations under the lease. Page 79 of 80 GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT EXHIBIT I PROMISSORY NOTE Page 80 of 80 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF CALIFORNIA In recognition of the requirements of California's Franchise Investment Law and the California Franchise Relations Act, the Goosehead Insurance Agency, LLC Franchise Disclosure Document shall be supplemented as follows: 1. California Corporations Code, Section 31125, requires Franchisor to give Franchisee a disclosure document, approved by the Department of Business Oversight, before a solicitation of a proposed material modification of an existing franchise. 2. THE CALIFORNIA FRANCHISE INVESTMENT LAW REQUIRES THAT A COPY OF ALL PROPOSED AGREEMENTS RELATING TO THE SALE OF THE FRANCHISE BE DELIVERED TOGETHER WITH THE DISCLOSURE DOCUMENT. 3. Item 3 of the Franchise Disclosure Document is modified by adding the following paragraph to the end thereof: Neither Goosehead Insurance Agency, LLC nor any person listed in Item 2 of this Franchise Disclosure Document is subject to any currently effective order of any national securities association or national securities exchange, as defined in the Securities Exchange Act of 1934, 15 U.S.C.A. 78a et seq., suspending or expelling these persons from membership in this association or exchange. 4. Item 17 of the Franchise Disclosure Document is modified by adding the following paragraphs to the end of Item 17: California Business and Professions Code Sections 20000 through 20043 provide rights to Franchisee concerning termination, transfer or non-renewal of a franchise. If the Franchise Agreement contains a provision that is inconsistent with the law, the law will control. The Franchise Agreement provides for termination upon bankruptcy. This provision may not be enforceable under federal bankruptcy law (11 U.S.C.A. Sec. 101 et seq.). The Franchise Agreement contains a covenant not to compete which extends beyond the termination of the franchise. This provision may not be enforceable under California law. Prospective franchisees are encouraged to consult private legal counsel to determine the applicability of California and federal laws (such as Business and Professions Code Section 20040.5, Code of Civil Procedure FDD Exhibit H-1 Section 1281, and the Federal Arbitration Act) to any provisions of a franchise agreement restricting venue to a forum outside the State of California. The Franchise Agreement requires application of the laws of the State of Texas. This provision may not be enforceable under California law. The Franchise Agreement requires Franchisee to sign a general release of claims upon renewal or transfer of the Franchise Agreement. California Corporations Code Section 31512 provides that any condition, stipulation or provision purporting to bind any person acquiring any franchise to waive compliance with any provision of that law or any rule or order thereunder is void. Section 31512 voids a waiver of Franchisee's rights under the Franchise Investment Law (California Corporations Code Section 31000-31516). Business and Professions Code Section 20010 voids a waiver of Franchisee's rights under the Franchise Relations Act (Business and Professions Code Sections 20000-20043). 5. We maintain an Internet website at www.goosehead.com. OUR WEBSITE HAS NOT BEEN REVIEWED OR APPROVED BY THE CALIFORNIA DEPARTMENT OF BUSINESS OVERSIGHT. ANY COMPLAINTS CONCERNING THE CONTENT OF THIS WEBSITE MAY BE DIRECTED TO THE CALIFORNIA DEPARTMENT OF BUSINESS OVERSIGHT AT www.dbo.ca.gov. 6. This Addendum shall be effective only to the extent that jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are met independently of and without reference to this Addendum. This Addendum shall have no effect if the jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are not met. FDD Exhibit H-2 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF CALIFORNIA In recognition of the requirements of California's Franchise Investment Law and the California Franchise Relations Act, the Goosehead Insurance Agency, LLC Franchise Agreement shall be supplemented as follows: 1. Section 17.3 of the Franchise Agreement is amended to read as follows:\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination with Notice and Opportunity to Cure\", \"level\": 2, \"text\": \"17.3 Termination with Notice and Opportunity to Cure. Except as otherwise provided in Sections 17.1 and 17.2 of this Agreement, you will have 60 days after your receipt from us of a written notice of default within which to remedy any default under this Agreement and to provide evidence thereof to us. You may avoid termination by immediately initiating a remedy to cure such default and curing it to our satisfaction within the sixty-day period, and by promptly providing proof thereof to us. If any such default is not cured within the specified time, or such longer period as applicable law may require, this Agreement will terminate without further notice to you, effective immediately upon the expiration of the sixty-day period or such longer period as applicable law may require. You will be in default pursuant to this Section 17.3 for failure substantially to comply with any of the requirements imposed by this Agreement, as it may from time to time reasonably be supplemented by the Manual, or failure to carry out the terms of this Agreement in good faith. Such defaults include, but are not limited to, the following illustrative events: 2. This Amendment shall be effective only to the extent that jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are met independently of and without reference to this Amendment. This Amendment shall have no effect if the jurisdictional requirements of the California Franchise Investment Law or the California Franchise Relations Act are not met. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-3 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF ILLINOIS In recognition of the requirements of the Illinois law, the Goosehead Insurance Agency, LLC Franchise Disclosure Document shall be supplemented as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Risk Factors on the Franchise Disclosure Document cover page of this disclosure document are modified to comply wit\", \"level\": 1, \"text\": \"1. The Risk Factors on the Franchise Disclosure Document cover page of this disclosure document are modified to comply with Section 4 of the Illinois Franchise Disclosure Act, which provides that any provision in a franchise agreement that designates jurisdiction or venue in a forum outside of Illinois is void.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17 of the disclosure document is modified by substituting the following in place of provisions v\", \"level\": 1, \"text\": \"2. Item 17 of the disclosure document is modified by substituting the following in place of provisions v. and w., in the chart: PROVISION SECTION IN FRANCHISE AGREEMENT SUMMARY\"}}, {\"id\": \"v\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Choice of forum Section 25\", \"level\": 1, \"text\": \"v. Choice of forum Section 25.5 Litigation may be brought in Illinois. w. Choice of law Section 25.1 Except to the extent governed by the Lanham Act, Illinois law (including the Illinois Franchise Disclosure Act) will apply to Illinois franchisees. and by adding the following paragraph to the end of the chart: \\\"THE CONDITIONS UNDER WHICH YOUR FRANCHISE CAN BE TERMINATED AND YOUR RIGHTS UPON NON-RENEWAL MAY BE AFFECTED BY ILLINOIS LAW: 815 ILCS 705/19 AND 20.\\\".\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Addendum is effective only to the extent that the jurisdictional requirements of the Illinois law are met independ\", \"level\": 1, \"text\": \"3. This Addendum is effective only to the extent that the jurisdictional requirements of the Illinois law are met independently of and without reference to this Addendum. This Addendum will have no effect if the jurisdictional requirements of the Illinois law are not met. FDD Exhibit H-4 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF ILLINOIS In recognition of the requirements of the Illinois law, the Goosehead Insurance Agency, LLC Franchise Agreement shall be supplemented as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 27\", \"level\": 1, \"text\": \"1. Section 27.1 of the Franchise Agreement is deleted in its entirety and the following Section 27.1 is substituted in lieu thereof:\"}}, {\"id\": \"27.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement takes effect when we accept and sign this document\", \"level\": 2, \"text\": \"27.1 This Agreement takes effect when we accept and sign this document. This Agreement will be interpreted and construed exclusively under the laws of the State of Illinois, which laws will prevail in the event of any conflict of law (without regard to, and without giving effect to, the application of Illinois choice-of-law rules); provided, however, that if the covenants in Section 19 of this Agreement would not be enforced as written under Illinois law, then the parties agree that those covenants will instead be interpreted and construed under the laws of the state in which the Franchised Business is located. Nothing in this Section 27.1 is intended by the parties to invoke the application of any franchise, business opportunity, antitrust, implied covenant, unfair competition, fiduciary, and/or other doctrine of law of the State of Illinois (or any other state) that would not otherwise apply without this Section 27.1\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 27\", \"level\": 1, \"text\": \"2. Section 27.2 of the Franchise Agreement is amended by the addition of the following: Notwithstanding anything to the contrary contained in this Section 27.2, any claims arising under the Illinois Franchise Disclosure Act may be brought in Illinois.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 27\", \"level\": 1, \"text\": \"3. Section 27.7 of the Franchise Agreement is deleted in its entirety and the following Section 27.7 is substituted in lieu thereof:\"}}, {\"id\": \"27.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Must bring claims within one year\", \"level\": 2, \"text\": \"27.7 Must bring claims within one year. Each party to this agreement agrees that any and all claims and actions arising out of or relating to this agreement, the parties' relationship, and/or your operation of the franchised business, brought by any party hereto against the other, shall be commenced within one (1) year from the occurrence of the facts giving rise to such claim or action, or, it is expressly acknowledged and agreed by all parties, such claim or action shall be irrevocably barred; provided, however, that the time limit for filing claims contained in this Section 27.7 shall not apply FDD Exhibit H-5 to claims or actions arising under the Illinois Franchise Disclosure Act. 4. Section 27 is amended by the addition of the following new Section 27.10 which shall be an integral part of the Franchise Agreement:\"}}, {\"id\": \"27.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing contained in this Agreement shall be deemed to waive any right you may have under the Illinois Franchise Disclos\", \"level\": 2, \"text\": \"27.10 Nothing contained in this Agreement shall be deemed to waive any right you may have under the Illinois Franchise Disclosure Act of 1987. If anything in this Agreement is deemed to be contrary to or inconsistent with the Act, the terms of the Act will control.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Amendment shall be effective only to the extent that the jurisdictional requirements of the Illinois law are met i\", \"level\": 1, \"text\": \"5. This Amendment shall be effective only to the extent that the jurisdictional requirements of the Illinois law are met independently of and without reference to this Amendment. This Amendment shall have no effect if the jurisdictional requirements of the Illinois law are not met. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-6 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF MARYLAND In recognition of the requirements of the Maryland Franchise Registration and Disclosure Law, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC for use in the State of Maryland shall be amended as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following lan\", \"level\": 1, \"text\": \"1. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following language: The Franchise Agreement provides for termination upon bankruptcy of the franchisee. This provision may not be enforceable under the U.S. Bankruptcy Code (11 U.S.C. Section 101, et seq.). Any claims arising under the Maryland Franchise Registration and Disclosure Law must be brought within 3 years after the grant of the franchise. Any general release required as a condition of renewal, sale, and/or assignment/transfer shall not apply to any liability under the Maryland Franchise Registration and Disclosure Law.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit I, \\\"Franchisee Compliance Questionnaire,\\\" shall be amended by the addition of the following at the end of Exhib\", \"level\": 1, \"text\": \"2. Exhibit I, \\\"Franchisee Compliance Questionnaire,\\\" shall be amended by the addition of the following at the end of Exhibit I: The representations under this Franchisee Compliance Questionnaire are not intended, nor shall they act as a release, estoppel or waiver of any liability incurred under the Maryland Franchise Registration and Disclosure Law.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each provision of this Addendum to the Disclosure Document shall be effective only to the extent, with respect to such\", \"level\": 1, \"text\": \"3. Each provision of this Addendum to the Disclosure Document shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Maryland Franchise Registration and Disclosure Law are met independently without reference to this Addendum. FDD Exhibit H-7 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF MARYLAND In recognition of the requirements of the Maryland Franchise Registration and Disclosure Law, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2\", \"level\": 1, \"text\": \"1. Section 2.2.7 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be deleted in its entirety and shall have no force or effect, and the following shall be substituted in lieu thereof:\"}}, {\"id\": \"2.2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limit\", \"level\": 3, \"text\": \"2.2.7 You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limited exclusions), which will release all claims against us and our affiliates, and our respective officers, directors, members, managers, agents, and employees. If you are an entity, then your affiliates and your direct and indirect owners (and any other parties that we reasonably request) must also sign and deliver that release to us, excluding only such claims as the Franchisee may have under the Maryland Franchise Registration and Disclosure Law;\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 16\", \"level\": 1, \"text\": \"2. Section 16.5.1 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be deleted in its entirety and shall have no force or effect, and the following shall be substituted in lieu thereof:\"}}, {\"id\": \"16.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and\", \"level\": 3, \"text\": \"16.5.1 The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and our affiliates, successors, and assigns, and their respective officers, directors, members, managers, shareholders, partners, agents, representatives, servants, and employees in their corporate and individual capacities including, without limitation, claims arising under this Agreement, any other agreement between you and us, and/or our respective affiliates, and federal, state, and local laws and rules, excluding only such claims as the Franchisee may have under the Maryland Franchise Registration and Disclosure Law;\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sections 27\", \"level\": 1, \"text\": \"3. Sections 27.1, 27.2, and 27.7 of the Agreement, under the heading \\\"Applicable and Dispute Resolution,\\\" shall be amended by the addition of the following language: A franchisee may bring a lawsuit in Maryland for claims arising under the Maryland Franchise Registration and Disclosure Law. Any claims arising under the Maryland Franchise Registration and Disclosure Law must be brought within three (3) years after the grant of the franchise. FDD Exhibit H-8\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 28 of the Agreement, under the heading \\\"Acknowledgments,\\\" shall be supplemented by the following\", \"level\": 1, \"text\": \"4. Section 28 of the Agreement, under the heading \\\"Acknowledgments,\\\" shall be supplemented by the following: The foregoing acknowledgments are not intended to nor shall they act as a release, estoppel or waiver of any liability under the Maryland Franchise Registration and Disclosure Law.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisd\", \"level\": 1, \"text\": \"5. Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Maryland Franchise Registration and Disclosure Law are met independently without reference to this Amendment. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-9 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF MICHIGAN THE STATE OF MICHIGAN PROHIBITS CERTAIN UNFAIR PROVISIONS THAT ARE SOMETIMES IN FRANCHISE DOCUMENTS. IF ANY OF THE FOLLOWING PROVISIONS ARE IN THESE FRANCHISE DOCUMENTS, THE PROVISIONS ARE VOID AND CANNOT BE ENFORCED AGAINST YOU: (A) A PROHIBITION ON THE RIGHT OF A FRANCHISEE TO JOIN AN ASSOCIATION OF FRANCHISEES. (B) A REQUIREMENT THAT A FRANCHISEE ASSENT TO A RELEASE, ASSIGNMENT, NOVATION, WAIVER, OR ESTOPPEL WHICH DEPRIVES A FRANCHISEE OF RIGHTS AND PROTECTIONS PROVIDED IN THIS ACT. THIS SHALL NOT PRECLUDE A FRANCHISEE, AFTER ENTERING INTO A FRANCHISE AGREEMENT, FROM SETTLING ANY AND ALL CLAIMS. (C) A PROVISION THAT PERMITS A FRANCHISOR TO TERMINATE A FRANCHISE PRIOR TO THE EXPIRATION OF ITS TERM EXCEPT FOR GOOD CAUSE. GOOD CAUSE SHALL INCLUDE THE FAILURE OF THE FRANCHISEE TO COMPLY WITH ANY LAWFUL PROVISIONS OF THE FRANCHISE AGREEMENT AND TO CURE SUCH FAILURE AFTER BEING GIVEN WRITTEN NOTICE THEREOF AND A REASONABLE OPPORTUNITY, WHICH IN NO EVENT NEED BE MORE THAN 30 DAYS, TO CURE SUCH FAILURE. (D) A PROVISION THAT PERMITS A FRANCHISOR TO REFUSE TO RENEW A FRANCHISE WITHOUT FAIRLY COMPENSATING THE FRANCHISEE BY REPURCHASE OR OTHER MEANS FOR THE FAIR MARKET VALUE, AT THE TIME OF EXPIRATION, OF THE FRANCHISEE'S INVENTORY, SUPPLIES, EQUIPMENT, FIXTURES, AND FURNISHINGS. PERSONALIZED MATERIALS WHICH HAVE NO VALUE TO THE FRANCHISOR AND INVENTORY, SUPPLIES, EQUIPMENT, FIXTURES, AND FURNISHINGS NOT REASONABLY REQUIRED IN THE CONDUCT OF THE FRANCHISED BUSINESS ARE NOT SUBJECT TO COMPENSATION. THIS SUBSECTION APPLIES ONLY IF: (i) THE TERM OF THE FRANCHISE IS LESS THAN 5 YEARS; AND (ii) THE FRANCHISEE IS PROHIBITED BY THE FRANCHISE OR OTHER AGREEMENT FROM CONTINUING TO CONDUCT SUBSTANTIALLY THE SAME BUSINESS UNDER ANOTHER TRADEMARK, SERVICE MARK, TRADE NAME, LOGOTYPE, ADVERTISING, OR OTHER COMMERCIAL SYMBOL IN THE SAME AREA SUBSEQUENT TO THE EXPIRATION OF THE FRANCHISE OR THE FRANCHISEE DOES NOT FDD Exhibit H-10 RECEIVE AT LEAST 6 MONTHS ADVANCE NOTICE OF FRANCHISOR'S INTENT NOT TO RENEW THE FRANCHISE. (E) A PROVISION THAT PERMITS THE FRANCHISOR TO REFUSE TO RENEW A FRANCHISE ON TERMS GENERALLY AVAILABLE TO OTHER FRANCHISEES OF THE SAME CLASS OR TYPE UNDER SIMILAR CIRCUMSTANCES. THIS SECTION DOES NOT REQUIRE A RENEWAL PROVISION. (F) A PROVISION REQUIRING THAT ARBITRATION OR LITIGATION BE CONDUCTED OUTSIDE THIS STATE*. THIS SHALL NOT PRECLUDE THE FRANCHISEE FROM ENTERING INTO AN AGREEMENT, AT THE TIME OF ARBITRATION, TO CONDUCT ARBITRATION AT A LOCATION OUTSIDE THIS STATE. (G) A PROVISION WHICH PERMITS A FRANCHISOR TO REFUSE TO PERMIT A TRANSFER OF OWNERSHIP OF A FRANCHISE, EXCEPT FOR GOOD CAUSE. THIS SUBDIVISION DOES NOT PREVENT A FRANCHISOR FROM EXERCISING A RIGHT OF FIRST REFUSAL TO PURCHASE THE FRANCHISE. GOOD CAUSE SHALL INCLUDE, BUT IS NOT LIMITED TO:\"}}, {\"id\": \"525\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE FAILURE OF THE PROPOSED FRANCHISEE TO MEET THE FRANCHISOR'S THEN CURRENT REASONABLE QUALIFICATIONS OR STANDARDS\", \"level\": 1, \"text\": \"525 THE FAILURE OF THE PROPOSED FRANCHISEE TO MEET THE FRANCHISOR'S THEN CURRENT REASONABLE QUALIFICATIONS OR STANDARDS.\"}}, {\"id\": \"525\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE FACT THAT THE PROPOSED TRANSFEREE IS A COMPETITOR OF THE FRANCHISOR OR SUBFRANCHISOR\", \"level\": 1, \"text\": \"525 THE FACT THAT THE PROPOSED TRANSFEREE IS A COMPETITOR OF THE FRANCHISOR OR SUBFRANCHISOR. (iii) THE UNWILLINGNESS OF THE PROPOSED TRANSFEREE TO AGREE IN WRITING TO COMPLY WITH ALL LAWFUL OBLIGATIONS. (iv) THE FAILURE OF THE FRANCHISEE OR PROPOSED TRANSFEREE TO PAY ANY SUMS OWING TO THE FRANCHISOR OR TO CURE ANY DEFAULT IN THE FRANCHISE AGREEMENT EXISTING AT THE TIME OF THE PROPOSED TRANSFER. (H) A PROVISION THAT REQUIRES THE FRANCHISEE TO RESELL TO THE FRANCHISOR ITEMS THAT ARE NOT UNIQUELY IDENTIFIED WITH THE FRANCHISOR. THIS SUBDIVISION DOES NOT PROHIBIT A PROVISION THAT GRANTS TO A FRANCHISOR A RIGHT OF FIRST REFUSAL TO PURCHASE THE ASSETS OF A FRANCHISE ON THE SAME TERMS AND CONDITIONS AS A BONA FIDE THIRD PARTY WILLING AND ABLE TO PURCHASE THOSE ASSETS, NOR DOES THIS SUBDIVISION PROHIBIT A PROVISION THAT GRANTS THE FDD Exhibit H-11 FRANCHISOR THE RIGHT TO ACQUIRE THE ASSETS OF A FRANCHISE FOR THE MARKET OR APPRAISED VALUE OF SUCH ASSETS IF THE FRANCHISEE HAS BREACHED THE LAWFUL PROVISIONS OF THE FRANCHISE AGREEMENT AND HAS FAILED TO CURE THE BREACH IN THE MANNER PROVIDED IN SUBDIVISION I. (I) A PROVISION WHICH PERMITS THE FRANCHISOR TO DIRECTLY OR INDIRECTLY CONVEY, ASSIGN, OR OTHERWISE TRANSFER ITS OBLIGATIONS TO FULFILL CONTRACTUAL OBLIGATIONS TO THE FRANCHISEE UNLESS PROVISION HAS BEEN MADE FOR PROVIDING THE REQUIRED CONTRACTUAL SERVICES. THE FACT THAT THERE IS A NOTICE OF THIS OFFERING ON FILE WITH THE ATTORNEY GENERAL DOES NOT CONSTITUTE APPROVAL, RECOMMENDATION, OR ENDORSEMENT BY THE ATTORNEY GENERAL. * * * * IF THE FRANCHISOR'S MOST RECENT FINANCIAL STATEMENTS ARE UNAUDITED AND SHOW A NET WORTH OF LESS THAN $100,000.00, THE FRANCHISOR MUST, AT THE REQUEST OF THE FRANCHISEE, ARRANGE FOR THE ESCROW OF INITIAL INVESTMENT AND OTHER FUNDS PAID BY THE FRANCHISEE UNTIL THE OBLIGATIONS TO PROVIDE REAL ESTATE, IMPROVEMENTS, EQUIPMENT, INVENTORY, TRAINING, OR OTHER ITEMS INCLUDED IN THE FRANCHISE OFFERING ARE FULFILLED. AT THE OPTION OF THE FRANCHISOR, A SURETY BOND MAY BE PROVIDED IN PLACE OF ESCROW. * * * * THE NAME AND ADDRESS OF THE FRANCHISOR'S AGENT IN THIS STATE AUTHORIZED TO RECEIVE SERVICE OF PROCESS IS: MICHIGAN DEPARTMENT OF COMMERCE, CORPORATION AND SECURITIES BUREAU, 6546 MERCANTILE WAY, P.O. BOX 30222, LANSING, MICHIGAN 48910. * * * * ANY QUESTIONS REGARDING THIS NOTICE SHOULD BE DIRECTED TO: DEPARTMENT OF THE ATTORNEY GENERAL'S OFFICE CONSUMER PROTECTION DIVISION ATTN: FRANCHISE 670 G. MENNEN WILLIAMS BUILDING 525 WEST LANSING LANSING, MICHIGAN 48913 NOTE: NOTWITHSTANDING PARAGRAPH (F) ABOVE, WE INTEND TO, AND YOU AGREE THAT WE AND YOU WILL, ENFORCE FULLY THE PROVISIONS OF THE ARBITRATION SECTION OF OUR AGREEMENTS. WE BELIEVE THAT PARAGRAPH FDD Exhibit H-12 (F) IS UNCONSTITUTIONAL AND CANNOT PRECLUDE US FROM ENFORCING THE ARBITRATION PROVISIONS. FDD Exhibit H-13 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF MINNESOTA In recognition of the requirements of the Minnesota Franchises Law, Minn. Stat. \u00a7\u00a7 80C.01 through 80C.22, and of the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce, Minn. Rules \u00a7\u00a7 2860.0100 through 2860.9930, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC for use in the State of Minnesota shall be amended to include the following:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 13 is amended by the addition of the following language\", \"level\": 1, \"text\": \"1. Item 13 is amended by the addition of the following language: The franchisor will protect the franchisee's right to use the trademarks, service marks, trade names, logotypes or other commercial symbols or indemnify the franchisee from any loss, costs or expenses arising out of any claim, suite or demand regarding the use of the name.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following par\", \"level\": 1, \"text\": \"2. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following paragraphs: With respect to franchisees governed by Minnesota law, we will comply with Minn. Stat. \u00a7 80C.14, Subds. 3, 4, and 5 which require, except in certain specified cases, that a franchisee be given 90 days' notice of termination (with 60 days to cure) and 180 days' notice of non-renewal of the Franchise Agreement, and that consent to the transfer of the franchise not be unreasonably withheld. Pursuant to Minn. Rule 2860.4400D, any general release of claims that you or a transferor may have against us or our shareholders, directors, employees and agents, including without limitation claims arising under federal, state, and local laws and regulations shall exclude claims you or a transferor may have under the Minnesota Franchise Law and the Rules and Regulations promulgated thereunder by the Commissioner of Commerce. Minn. Stat. \u00a7 80C.21 and Minn. Rule 2860.4400J prohibit us from requiring litigation to be conducted outside Minnesota, requiring waiver of a jury trial, or requiring you to consent to liquidated damages, termination penalties or judgment notes. In addition, nothing in the disclosure document or agreement can abrogate or reduce any of your rights as provided for in Minnesota Statutes, Chapter 80C, or your rights to jury trial, any procedure, forum, or remedies as may be provided for by the laws of the jurisdiction. Minn. Stat. \u00a7 80C.17 prohibits any action from being commenced under the Minnesota Franchises Law more than three years after the cause of action accrues.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each provision of this addendum shall be effective only to the extent, with respect to such provision, that the jurisdi\", \"level\": 1, \"text\": \"3. Each provision of this addendum shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Minnesota Franchises Law or the Rules and FDD Exhibit H-14 Regulations promulgated thereunder by the Minnesota Commission of Commerce are met independently without reference to this addendum to the disclosure document. FDD Exhibit H-15 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF MINNESOTA In recognition of the requirements of the Minnesota Franchises Law, Minn. Stat. \u00a7\u00a7 80C.01 through 80C.22, and of the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce, Minn. Rules \u00a7\u00a7 2860.0100 through 2860.9930, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2\", \"level\": 1, \"text\": \"1. Section 2.2.7 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be deleted in its entirety and shall have no force or effect, and the following paragraph shall be inserted in its place:\"}}, {\"id\": \"2.2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limit\", \"level\": 3, \"text\": \"2.2.7 You agree to sign and deliver to us a release, in a form that we will provide (which will be a mutual release with limited exclusions), which will release all claims against us and our affiliates, and our respective officers, directors, members, managers, agents, and employees. If you are an entity, then your affiliates and your direct and indirect owners (and any other parties that we reasonably request) must also sign and deliver that release to us, excluding only such claims as Franchisee may have that have arisen under the Minnesota Franchises Law and the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be amended by the addition of the following par\", \"level\": 1, \"text\": \"2. Section 2 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be amended by the addition of the following paragraph: Minnesota law provides franchisees with certain non-renewal rights. In sum, Minn. Stat. \u00a7 80C.14 (subd. 4) currently requires, except in certain specified cases, that a franchisee be given 180 days' notice of non-renewal of the Franchise Agreement.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 9 of the Agreement, under the heading \\\"Proprietary Marks,\\\" shall be amended by the addition of the following pa\", \"level\": 1, \"text\": \"3. Section 9 of the Agreement, under the heading \\\"Proprietary Marks,\\\" shall be amended by the addition of the following paragraph: Pursuant to Minnesota Stat. Sec. 80C.12, Subd. 1(g), Franchisor is required to protect any rights Franchise may have to Franchisor's Marks.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 16\", \"level\": 1, \"text\": \"4. Section 16.5.1 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be deleted in its entirety and shall have no force or effect, and the following paragraph shall be inserted in its place:\"}}, {\"id\": \"16.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and\", \"level\": 3, \"text\": \"16.5.1 The transferor must have executed a general release, in a form satisfactory to us, of any and all claims against us and our affiliates, successors, and assigns, and their respective officers, directors, members, managers, shareholders, partners, agents, representatives, servants, and employees in their corporate and individual capacities including, without limitation, claims arising under this Agreement, any other agreement between you and us, and/or our respective affiliates, and federal, state, and local laws and FDD Exhibit H-16 rules, excluding only such claims as Franchisee may have under the Minnesota Franchises Law and the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 16 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be amended by the addition of the followin\", \"level\": 1, \"text\": \"5. Section 16 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be amended by the addition of the following paragraph: Minnesota law provides franchisees with certain transfer rights. In sum, Minn. Stat. \u00a780C.14 (subd. 5) currently requires that consent to the transfer of the franchise may not be unreasonably withheld.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 17 of the Agreement, under the heading \\\"Default and Termination\\\" shall be amended by the addition of the follow\", \"level\": 1, \"text\": \"6. Section 17 of the Agreement, under the heading \\\"Default and Termination\\\" shall be amended by the addition of the following paragraph: Minnesota law provides franchisees with certain termination rights. In sum, Minn. Stat. \u00a7 80C.14 (subd. 3) currently requires, except in certain specified cases, that a franchisee be given 90 days' notice of termination (with 60 days to cure) of the Franchise Agreement.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sections 18\", \"level\": 1, \"text\": \"7. Sections 18.8 of the Agreement, under the heading \\\"Obligations Upon Termination or Expiration,\\\" shall be deleted in its entirety and shall have no force or effect; and the following paragraph shall be substituted in its place:\"}}, {\"id\": \"18.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Pay Damages\", \"level\": 2, \"text\": \"18.8 Pay Damages. You agree to pay us all damages, costs, and expenses (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) that we incur as a result of your default under this Agreement and/or subsequent to the termination or expiration of this Agreement in seeking injunctive or other relief for the enforcement of any provisions of this Section 18, which will be in addition to amounts due to us under Section 18.11 below.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sections 27\", \"level\": 1, \"text\": \"8. Sections 27.5 and 27.9 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution,\\\" shall be deleted in their entirety and shall have no force or effect; and the following paragraphs shall be substituted in its place:\"}}, {\"id\": \"27.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Injunctions\", \"level\": 2, \"text\": \"27.5 Injunctions. Nothing contained in this Agreement will bar our right to seek injunctive relief in a court of competent jurisdiction against threatened conduct that will cause us loss or damages, under the usual equity rules, including the applicable rules for obtaining restraining orders and preliminary injunctions.\"}}, {\"id\": \"27.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment of Legal Fees\", \"level\": 2, \"text\": \"27.9 Payment of Legal Fees. You agree to pay us all damages, costs and expenses (including without limitation reasonable attorneys' fees, court costs, discovery costs, and all other related expenses) that we incur after the termination or expiration of the franchise granted under this Agreement in: (a) seeking injunctive or other relief for the enforcement of any provisions of this Agreement (including without limitation Sections 9 and 17 above); and/or (b) successfully defending a claim from you that we misrepresented the terms of this Agreement, fraudulently induced you to sign this Agreement, that the provisions of this Agreement are not FDD Exhibit H-17 fair, were not properly entered into, and/or that the terms of this Agreement (as it may be amended by its terms) do not exclusively govern the parties' relationship.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution\\\", shall be amended by the followi\", \"level\": 1, \"text\": \"9. Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution\\\", shall be amended by the following paragraph, which shall be considered an integral part of the Agreement:\"}}, {\"id\": \"27.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Minn\", \"level\": 2, \"text\": \"27.10 Minn. Stat. \u00a7 80C.17 prohibits any action from being commenced under the Minnesota Franchises Law more than three years after the cause of action accrues. Minn. Stat. \u00a7 80C.21 and Minn. Rule 2860.4400J prohibit Franchisor from requiring litigation to be conducted outside Minnesota, requiring waiver of a jury trial, or requiring Franchisee to consent to liquidated damages, termination penalties or judgment notes. In addition, nothing in the disclosure document or agreement can abrogate or reduce any of Franchisee's rights as provided for in Minnesota Statutes, Chapter 80C, or Franchisee's rights to jury trial, any procedure, forum, or remedies as may be provided for by the laws of the jurisdiction.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisd\", \"level\": 1, \"text\": \"10. Each provision of this Amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Minnesota Franchises Law or the Rules and Regulations promulgated thereunder by the Minnesota Commissioner of Commerce are met independently without reference to this Amendment. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-18 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF NEW YORK\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following information is added to the cover page of the Franchise Disclosure Document\", \"level\": 1, \"text\": \"1. The following information is added to the cover page of the Franchise Disclosure Document: INFORMATION COMPARING FRANCHISORS IS AVAILABLE. CALL THE STATE ADMINISTRATORS LISTED IN EXHIBIT C OR YOUR PUBLIC LIBRARY FOR SOURCES OF INFORMATION. REGISTRATION OF THIS FRANCHISE BY NEW YORK STATE DOES NOT MEAN THAT NEW YORK STATE RECOMMENDS IT OR HAS VERIFIED THE INFORMATION IN THIS FRANCHISE DISCLOSURE DOCUMENT. IF YOU LEARN THAT ANYTHING IN THE FRANCHISE DISCLOSURE DOCUMENT IS UNTRUE, CONTACT THE FEDERAL TRADE COMMISSION AND NEW YORK STATE DEPARTMENT OF LAW, BUREAU OF INVESTOR PROTECTION AND SECURITIES, 120 BROADWAY, 23RD FLOOR, NEW YORK, NEW YORK 10271. THE FRANCHISOR MAY, IF IT CHOOSES, NEGOTIATE WITH YOU ABOUT ITEMS COVERED IN THE FRANCHISE DISCLOSURE DOCUMENT. HOWEVER, THE FRANCHISOR CANNOT USE THE NEGOTIATING PROCESS TO PREVAIL UPON A PROSPECTIVE FRANCHISEE TO ACCEPT TERMS WHICH ARE LESS FAVORABLE THAN THOSE SET FORTH IN THIS FRANCHISE DISCLOSURE DOCUMENT.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following is added at the end of Item 3\", \"level\": 1, \"text\": \"2. The following is added at the end of Item 3: Except as provided above, with regard to the franchisor, its predecessor, a person identified in Item 2, or an affiliate offering franchises under the franchisor's principal trademark: A. No such party has an administrative, criminal or civil action pending against that person alleging: a felony, a violation of a franchise, antitrust, or securities law, fraud, embezzlement, fraudulent conversion, misappropriation of property, unfair or deceptive practices, or comparable civil or misdemeanor allegations. B. No such party has pending actions, other than routine litigation incidental to the business, which are significant in the context of the number of franchisees and the size, nature or financial condition of the franchise system or its business operations.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No such party has been convicted of a felony or pleaded nolo contendere to a felony charge or, within the 10 year perio\", \"level\": 1, \"text\": \"C. No such party has been convicted of a felony or pleaded nolo contendere to a felony charge or, within the 10 year period immediately preceding the application for registration, has been convicted of or pleaded nolo contendere to a misdemeanor charge or has been the subject of a civil action alleging: violation of a franchise, antifraud, or securities law; fraud; embezzlement; fraudulent conversion or misappropriation of property; or unfair or deceptive practices or comparable allegations. FDD Exhibit H-19\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No such party is subject to a currently effective injunctive or restrictive order or decree relating to the franchise,\", \"level\": 1, \"text\": \"D. No such party is subject to a currently effective injunctive or restrictive order or decree relating to the franchise, or under a Federal, State, or Canadian franchise, securities, antitrust, trade regulation or trade practice law, resulting from a concluded or pending action or proceeding brought by a public agency; or is subject to any currently effective order of any national securities association or national securities exchange, as defined in the Securities and Exchange Act of 1934, suspending or expelling such person from membership in such association or exchange; or is subject to a currently effective injunctive or restrictive order relating to any other business activity as a result of an action brought by a public agency or department, including, without limitation, actions affecting a license as a real estate broker or sales agent.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following is added to the end of Item 4\", \"level\": 1, \"text\": \"3. The following is added to the end of Item 4: Neither the franchisor, its affiliate, its predecessor, officers, or general partner during the 10-year period immediately before the date of the offering circular: (a) filed as debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code; (b) obtained a discharge of its debts under the bankruptcy code; or (c) was a principal officer of a company or a general partner in a partnership that either filed as a debtor (or had filed against it) a petition to start an action under the U.S. Bankruptcy Code or that obtained a discharge of its debts under the U.S. Bankruptcy Code during or within 1 year after that officer or general partner of the franchisor held this position in the company or partnership.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following is added to the end of Item 5\", \"level\": 1, \"text\": \"4. The following is added to the end of Item 5: The initial franchise fee constitutes part of our general operating funds and will be used as such in our discretion.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following is added to the end of the \\\"Summary\\\" sections of Item 17(c), titled \\\"Requirements for franchisee to renew\", \"level\": 1, \"text\": \"5. The following is added to the end of the \\\"Summary\\\" sections of Item 17(c), titled \\\"Requirements for franchisee to renew or extend,\\\" and Item 17(m), entitled \\\"Conditions for franchisor approval of transfer\\\": However, to the extent required by applicable law, all rights you enjoy and any causes of action arising in your favor from the provisions of Article 33 of the General Business Law of the State of New York and the regulations issued thereunder shall remain in force; it being the intent of this proviso that the non-waiver provisions of General Business Law Sections 687.4 and 687.5 be satisfied.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following language replaces the \\\"Summary\\\" section of Item 17(d), titled \\\"Termination by franchisee\\\"\", \"level\": 1, \"text\": \"6. The following language replaces the \\\"Summary\\\" section of Item 17(d), titled \\\"Termination by franchisee\\\": You may terminate the agreement on any grounds available by law. FDD Exhibit H-20\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following is added to the end of the \\\"Summary\\\" section of Item 17(j), titled \\\"Assignment of contract by franchisor\\\"\", \"level\": 1, \"text\": \"7. The following is added to the end of the \\\"Summary\\\" section of Item 17(j), titled \\\"Assignment of contract by franchisor\\\": However, no assignment will be made except to an assignee who in good faith and judgment of the franchisor, is willing and financially able to assume the franchisor's obligations under the Franchise Agreement.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The following is added to the end of the \\\"Summary\\\" sections of Item 17(v), titled \\\"Choice of forum\\\", and Item 17(w), ti\", \"level\": 1, \"text\": \"8. The following is added to the end of the \\\"Summary\\\" sections of Item 17(v), titled \\\"Choice of forum\\\", and Item 17(w), titled \\\"Choice of law\\\": The foregoing choice of law should not be considered a waiver of any right conferred upon the franchisor or upon the franchisee by Article 33 of the General Business Law of the State of New York. FDD Exhibit H-21 STATEMENT OF DISCLOSURE DOCUMENT ACCURACY THE FRANCHISOR REPRESENTS THAT THIS DISCLOSURE DOCUMENT DOES NOT KNOWINGLY OMIT ANY MATERIAL FACT OR CONTAIN ANY UNTRUE STATEMENT OF A MATERIAL FACT. FDD Exhibit H-22 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF NEW YORK In recognition of the requirements of the New York General Business Law, Article 33, Sections 680 through 695, and of the regulations promulgated thereunder (N.Y. Comp. Code R. & Regs., tit. 13, \u00a7\u00a7 200.1 through 201.16), the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2\", \"level\": 1, \"text\": \"1. Section 2.2.6 of the Agreement, under the heading \\\"Term and Renewal,\\\" shall be deleted in its entirety, and shall have no force or effect; and the following paragraph shall be substituted in its place:\"}}, {\"id\": \"2.2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You must execute a general release, in a form prescribed by us, of any and all claims against us and our affiliates, and\", \"level\": 3, \"text\": \"2.2.6 You must execute a general release, in a form prescribed by us, of any and all claims against us and our affiliates, and our and our affiliates' respective officers, directors, securities holders, agents, and employees, provided, however, that all rights enjoyed by you and any causes of action arising in your favor from the provisions of New York General Business Law Sections 680-695 and the regulations issued thereunder, shall remain in force; it being the intent of this provision that the non-waiver provisions of N.Y. Gen. Bus. Law Sections 687.4 and 687.5 be satisfied;\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 13\", \"level\": 1, \"text\": \"2. Section 13.3.3 of the Agreement, under the heading \\\"Transfer of Interest,\\\" shall be deleted in its entirety, and shall have no force or effect; and the following paragraph shall be substituted in its place:\"}}, {\"id\": \"13.3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"That the transferor must execute a general release, in a form satisfactory to us, of any and all claims against us and o\", \"level\": 3, \"text\": \"13.3.3 That the transferor must execute a general release, in a form satisfactory to us, of any and all claims against us and our affiliates, and our respective officers, directors, shareholders, member, agents, and employees, provided, however, that all rights enjoyed by the transferor and any causes of action arising in its favor from the provisions of New York General Business Law Sections 680-695 and the regulations issued thereunder, shall remain in force; it being the intent of this provision that the non-waiver provisions of N.Y. Gen. Bus. Law Sections 687.4 and 687.5 be satisfied;\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 25\", \"level\": 1, \"text\": \"3. Section 25.6 of the Agreement, under the heading \\\"Applicable Law; Dispute Resolution,\\\" shall be deleted in its entirety, and shall have no force or effect; and the following paragraph shall be substituted in lieu thereof:\"}}, {\"id\": \"25.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing contained in this Agreement shall bar our right to seek injunctive relief against threatened conduct that will c\", \"level\": 2, \"text\": \"25.6 Nothing contained in this Agreement shall bar our right to seek injunctive relief against threatened conduct that will cause us loss or damages, under the usual equity rules, including the applicable rules for obtaining restraining orders and preliminary injunctions. FDD Exhibit H-23\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 25 of the Agreement, under the heading \\\"Applicable Law; Dispute Resolution,\\\" shall be amended by the addition o\", \"level\": 1, \"text\": \"4. Section 25 of the Agreement, under the heading \\\"Applicable Law; Dispute Resolution,\\\" shall be amended by the addition of the following language: Nothing in this Agreement should be considered a waiver of any right conferred upon you by New York General Business Law, Sections 680-695.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"There are circumstances in which an offering made by us would not fall within the scope of the New York General Busines\", \"level\": 1, \"text\": \"5. There are circumstances in which an offering made by us would not fall within the scope of the New York General Business Law, Article 33, such as when the offer and acceptance occurred outside the state of New York. However, an offer or sale is deemed made in New York if you are domiciled in or the franchise will be opening in New York. We are required to furnish a New York prospectus to every prospective franchisee who is protected under the New York General Business Law, Article 33. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-24 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF NORTH DAKOTA In recognition of the requirements of the North Dakota Franchise Investment Law, N.D. Cent. Code, \u00a7\u00a7 51 19 01 through 51 19 17, and the policies of the office of the State of North Dakota Securities Commission, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC shall be amended by the addition of the following language: The North Dakota Securities Commissioner has held the following to be unfair, unjust, or inequitable to North Dakota franchisees (Section 51-19-09, N.D.C.C.): A. Restrictive Covenants: Franchise disclosure documents which disclose the existence of covenants restricting competition contrary to Section 9-08-06, N.D.C.C., without further disclosing that such covenants will be subject to this statute. B. Situs of Arbitration Proceedings: Franchise agreements providing that the parties must agree to arbitrate disputes at a location that is remote from the site of the franchisee's business.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Restriction on Forum\", \"level\": 1, \"text\": \"C. Restriction on Forum: Requiring North Dakota franchisees to consent to the jurisdiction of courts outside of North Dakota.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Liquidated Damages and Termination Penalties\", \"level\": 1, \"text\": \"D. Liquidated Damages and Termination Penalties: Requiring North Dakota franchisees to consent to liquidated damages or termination penalties. E. Applicable Laws: Franchise agreements which specify that any claims arising under the North Dakota franchise law will be governed by the laws of a state other than North Dakota. F. Waiver of Trial by Jury: Requiring North Dakota franchisees to consent to the waiver of a trial by jury. G. Waiver of Exemplary and Punitive Damages: Requiring North Dakota franchisees to consent to a waiver of exemplary and punitive damages. H. General Release: Requiring North Dakota franchisees to execute a general release of claims as a condition of renewal or transfer of a franchise.\"}}, {\"id\": \"I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation on Claims\", \"level\": 1, \"text\": \"I. Limitation on Claims. Requiring North Dakota franchisees to consent to a limitation on when claims may be brought. FDD Exhibit H-25 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF NORTH DAKOTA In recognition of the requirements of the North Dakota Franchise Investment Law, N.D. Cent. Code, \u00a7\u00a7 51 19 01 through 51 19 17, and the policies of the office of the State of North Dakota Securities Commission, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Agreement shall be amended by the addition of the following Section 29\", \"level\": 1, \"text\": \"1. The Agreement shall be amended by the addition of the following Section 29:\"}}, {\"id\": \"29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties acknowledge and agree that they have been advised that the North Dakota Securities Commissioner has determi\", \"level\": 1, \"text\": \"29. The parties acknowledge and agree that they have been advised that the North Dakota Securities Commissioner has determined the following agreement provisions are unfair, unjust or inequitable to North Dakota franchisees: A. Restrictive Covenants: Any provision which discloses the existence of covenants restricting competition contrary to Section 9-08-06, N.D.C.C., without further disclosing that such covenants will be subject to this statute. B. Situs of Arbitration Proceedings: Any provision requiring that the parties must agree to arbitrate disputes at a location that is remote from the site of the Franchisee's business.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Restriction on Forum\", \"level\": 1, \"text\": \"C. Restriction on Forum: Any provision requiring North Dakota franchisees to consent to the jurisdiction of courts outside of North Dakota.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Liquidated Damages and Termination Penalties\", \"level\": 1, \"text\": \"D. Liquidated Damages and Termination Penalties: Any provision requiring North Dakota franchisees to consent to liquidated damages or termination penalties. E. Applicable Laws: Any provision which specifies that any claims arising under the North Dakota franchise law will be governed by the laws of a state other than North Dakota. F. Waiver of Trial by Jury: Any provision requiring North Dakota franchisees to consent to the waiver of a trial by jury. G. Waiver of Exemplary and Punitive Damages: Any provision requiring North Dakota franchisees to consent to a waiver of exemplary and punitive damages. H. General Release: Any provision requiring North Dakota franchisees to execute a general release of claims as a condition of renewal or transfer of a franchise.\"}}, {\"id\": \"I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation on Claims\", \"level\": 1, \"text\": \"I. Limitation on Claims. Requiring North Dakota franchisees to consent to a limitation on when claims may be brought. [SIGNATURE PAGE FOLLOWS] FDD Exhibit H-26 IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-27 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF RHODE ISLAND In recognition of the requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19 28.1-1 through 19-28.1-34 the Franchise Disclosure Document for Goosehead Insurance Agency, LLC for use in the State of Rhode Island shall be amended to include the following:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following\", \"level\": 1, \"text\": \"1. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following: Section 19-28.1-14 of the Rhode Island Franchise Investment Act provides that \\\"A provision in a franchise agreement restricting jurisdiction or venue to a forum outside this state or requiring the application of the laws of another state is void with respect to a claim otherwise enforceable under this Act.\\\"\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This addendum to the disclosure document shall be effective only to the extent, with respect to such provision, that th\", \"level\": 1, \"text\": \"1. This addendum to the disclosure document shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19-28.1-1 through 19-28.1-34, are met independently without reference to this addendum to the disclosure document. FDD Exhibit H-28 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF RHODE ISLAND In recognition of the requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19-28.1-1 through 19-28.1-34, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement (the \\\"Agreement\\\") agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution,\\\" shall be amended by the additio\", \"level\": 1, \"text\": \"1. Section 27 of the Agreement, under the heading \\\"Applicable Law and Dispute Resolution,\\\" shall be amended by the addition of the following paragraph: Section 19-28.1-14 of the Rhode Island Franchise Investment Act provides that \\\"A provision in a franchise agreement restricting jurisdiction or venue to a forum outside this state or requiring the application of the laws of another state is void with respect to a claim otherwise enforceable under this Act.\\\"\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requireme\", \"level\": 1, \"text\": \"2. This amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Rhode Island Franchise Investment Act, \u00a7\u00a7 19-28.1-1 through 19-28.1-34, are met independently without reference to this amendment. IN WITNESS WHEREOF, we and you agree to be bound by the terms of this Amendment to be effective as of the Effective Date of the Franchise Agreement. GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-29 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF VIRGINIA\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17 of the disclosure document is hereby modified by adding the following paragraphs to the end of provision entitl\", \"level\": 1, \"text\": \"1. Item 17 of the disclosure document is hereby modified by adding the following paragraphs to the end of provision entitled \\\"h. 'Cause' defined - non-curable defaults\\\": Under Section 13.1-564 of the Virginia Retail Franchising Act, it is unlawful for a franchisor to cancel a franchise without reasonable cause. If any ground for default or termination stated in the franchise agreement does not constitute 'reasonable cause,' as that term may be defined in the Virginia Retail Franchise Act or the laws of Virginia, that provision may not be enforceable. Under Section 13.1-564 of the Virginia Retail Franchising Act, it is unlawful for a franchisor to use undue influence to induce a franchisee to surrender any right given to him under the franchise. If any provision of the franchise agreement involves the use of undue influence by the franchisor to induce a franchisee to surrender any rights given to him under the franchise, that provision may not be enforceable. FDD Exhibit H-30 ADDENDUM TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE DISCLOSURE DOCUMENT FOR THE STATE OF WASHINGTON In recognition of the requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.180, the Franchise Disclosure Document for Goosehead Insurance Agency, LLC in connection with the offer and sale of franchises for use in the State of Washington shall be amended to include the following:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17(d), \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following\", \"level\": 1, \"text\": \"1. Item 17(d), \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following statement: Franchisees may terminate under any grounds permitted by law.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following par\", \"level\": 1, \"text\": \"2. Item 17, \\\"Renewal, Termination, Transfer and Dispute Resolution,\\\" shall be amended by the addition of the following paragraphs at the conclusion of the Item: The state of Washington has a statute, RCW 19.100.180, which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise. There may also be court decisions which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise. In any arbitration involving a franchise purchased in Washington, the arbitration site shall be either in the state of Washington, or in a place mutually agreed upon at the time of the arbitration, or as determined by the arbitrator. In the event of a conflict of laws, the provisions of the Washington Franchise Investment Protection Act, Chapter 19.100 RCW shall prevail. A release or waiver of rights executed by a franchisee shall not include rights under the Washington Franchise Investment Protection Act except when executed pursuant to a negotiated settlement after the agreement is in effect and where the parties are represented by independent counsel. Provisions such as those which unreasonably restrict or limit the statute of limitations period for claims under the Act, rights or remedies under the Act such as a right to a jury trial may not be enforceable. Transfer fees are collectable to the extent that they reflect the franchisor's reasonable estimated or actual costs in effecting a transfer.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each provision of this addendum to the disclosure document shall be effective only to the extent, with respect to such\", \"level\": 1, \"text\": \"3. Each provision of this addendum to the disclosure document shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.180, are met independently without reference to this addendum to the disclosure document. FDD Exhibit H-31 AMENDMENT TO GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISE AGREEMENT FOR THE STATE OF WASHINGTON In recognition of the requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.010 through 19.100.940, the parties to the attached Goosehead Insurance Agency, LLC Franchise Agreement agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The state of Washington has a statute, RCW 19\", \"level\": 1, \"text\": \"1. The state of Washington has a statute, RCW 19.100.180, which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise. There may also be court decisions which may supersede the franchise agreement in your relationship with the franchisor including the areas of termination and renewal of your franchise.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In any arbitration involving a franchise purchased in Washington, the arbitration site shall be either in the state of\", \"level\": 1, \"text\": \"2. In any arbitration involving a franchise purchased in Washington, the arbitration site shall be either in the state of Washington, or in a place mutually agreed upon at the time of the arbitration, or as determined by the arbitrator.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of a conflict of laws, the provisions of the Washington Franchise Investment Protection Act, Chapter 19\", \"level\": 1, \"text\": \"3. In the event of a conflict of laws, the provisions of the Washington Franchise Investment Protection Act, Chapter 19.100 RCW shall prevail.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A release or waiver of rights executed by a franchisee shall not include rights under the Washington Franchise Investme\", \"level\": 1, \"text\": \"4. A release or waiver of rights executed by a franchisee shall not include rights under the Washington Franchise Investment Protection Act except when executed pursuant to a negotiated settlement after the agreement is in effect and where the parties are represented by independent counsel. Provisions such as those which unreasonably restrict or limit the statute of limitations period for claims under the Act, rights or remedies under the Act such as a right to a jury trial may not be enforceable.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer fees are collectable to the extent that they reflect the franchisor's reasonable estimated or actual costs in\", \"level\": 1, \"text\": \"5. Transfer fees are collectable to the extent that they reflect the franchisor's reasonable estimated or actual costs in effecting a transfer.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each provision of this amendment shall be effective only to the extent, with respect to such provision, that the jurisd\", \"level\": 1, \"text\": \"6. Each provision of this amendment shall be effective only to the extent, with respect to such provision, that the jurisdictional requirements of the Washington Franchise Investment Protection Act, Wash. Rev. Code \u00a7\u00a7 19.100.010 through 19.100.940, are met independently without reference to this amendment. [SIGNATURE PAGE FOLLOWS] FDD Exhibit H-32 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Washington amendment to the Franchise Agreement on the same date as the Franchise Agreement was executed GOOSEHEAD INSURANCE AGENCY, LLC FRANCHISEE By: By: Name: P. Ryan Langston Name: Title: Vice President and General Counsel Title: FDD Exhibit H-33\"}}, {\"id\": \"party:Goosehead Insurance Agency, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Goosehead Insurance Agency, LLC\", \"role\": \"Franchisor\", \"address\": \"1500 Solana Blvd., Suite 450, Westlake, Texas 76262\"}}, {\"id\": \"party:Franchisee\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Franchisee\", \"role\": \"Franchisee\", \"address\": null}}, {\"id\": \"party:Landlord\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Landlord\", \"role\": null, \"address\": null}}, {\"id\": \"term:Approved Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Approved Location\", \"text\": \"The \\\"Approved Location\\\" under this Agreement will be: .\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Commencement Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commencement Date\", \"text\": \"The \\\"Commencement Date\\\" will be: .\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS FRANCHISE AGREEMENT (the \\\"Agreement\\\") is made and entered into as of the \\\"Effective Date\\\" that we have indicated on the signature page of this Agreement by and between: \u25cf Goosehead Insurance Agency, LLC, a Delaware limited liability company, with its principal place of business at 1500 Solana Blvd., Suite 450, Westlake, Texas 76262 (\\\"we,\\\" \\\"us,\\\" or \\\"our\\\"); and \u25cf a [resident of] [corporation organized in] [limited liability company organized in] the state of and having offices at (\\\"you\\\" or the \\\"Franchisee\\\").\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System\", \"text\": \"We have developed our own distinctive and proprietary systems for insurance services, including home insurance, automobile insurance, life insurance, specialty lines, and business insurance (the \\\"System\\\").\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Proprietary Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Marks\", \"text\": \"Our proprietary marks include certain trade names (for example, the mark \\\"Goosehead Insurance\\\" and logo), service marks, trademarks, logos, emblems, and indicia of origin, as well as other trade names, service marks, and trademarks that we may periodically specify in writing for use in connection with the System (all of these are referred to as our \\\"Proprietary Marks\\\").\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Services\", \"text\": \"We are in the business of developing and awarding franchise rights to third party franchisees, such as you, to develop and operate businesses providing insurance services (\\\"Services\\\") to clients under the System and using the Proprietary Marks (\\\"Goosehead Businesses\\\").\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Goosehead Businesses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Goosehead Businesses\", \"text\": \"We are in the business of developing and awarding franchise rights to third party franchisees, such as you, to develop and operate businesses providing insurance services (\\\"Services\\\") to clients under the System and using the Proprietary Marks (\\\"Goosehead Businesses\\\").\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Minimum Royalty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Royalty\", \"text\": \"The term \\\"Minimum Royalty\\\" means a minimum monthly Royalty Fee payment, beginning six (6) months after the Commencement Date, in the following amounts: Number of Months following the Commencement Date Amount of Monthly Minimum Royalty Six (6) to Eighteen (18) Six Hundred Dollars ($600) Nineteen (19) and for the remainder of the term of this Agreement One Thousand Dollars ($1,000)\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:FDD\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDD\", \"text\": \"However, nothing in this Section is intended as, nor will it be interpreted to be, a disclaimer by us of any representation made in our Franchise Disclosure Document (\\\"FDD\\\"), including the exhibits and any amendments to the FDD.\", \"definition_clause\": \"23\"}}, {\"id\": \"term:Releasors\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Releasors\", \"text\": \"You (on behalf of yourself and your parent, subsidiaries and affiliates and their respective past and present members, officers, directors, members, managers, shareholders, agents and employees, in their corporate and individual capacities) and all guarantors of your obligations under this Agreement (collectively, \\\"Releasors\\\")\", \"definition_clause\": \"23\"}}, {\"id\": \"term:Releasees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Releasees\", \"text\": \"us, our parent, subsidiaries and affiliates and their respective past and present officers, directors, shareholders, agents and employees, in their corporate and individual capacities (collectively \\\"Releasees\\\")\", \"definition_clause\": \"23\"}}, {\"id\": \"term:claims\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"claims\", \"text\": \"any and all claims, demands, liabilities and causes of action of whatever kind or nature, whether known or unknown, vested or contingent, suspected or unsuspected (collectively, \\\"claims\\\")\", \"definition_clause\": \"23\"}}, {\"id\": \"term:Member\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Member\", \"text\": \"THIS CONFIDENTIALITY AND NON-DISCLOSURE AND AGREEMENT (\\\"Agreement\\\") is made this day of , 201 , by and between (the \\\"Franchisee\\\"), and , who is a Principal, Manager, supervisor, member, partner, Producer, or employee with Franchisee (the \\\"Member\\\").\", \"definition_clause\": \"1500\"}}, {\"id\": \"term:Goosehead Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Goosehead Business\", \"text\": \"Goosehead Insurance Agency, LLC (\\\"Franchisor\\\") owns a format and system (the \\\"System\\\") relating to the establishment and operation of \\\"Goosehead Insurance\\\" businesses providing insurance services, including home insurance, automobile insurance, life insurance, watercraft insurance, and business insurance, operating in structures that bear Franchisor's interior and exterior trade dress, and under its Proprietary Marks, as defined below (each, a \\\"Goosehead Business\\\").\", \"definition_clause\": \"1500\"}}, {\"id\": \"term:Franchise Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchise Agreement\", \"text\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\", \"definition_clause\": \"C\"}}, {\"id\": \"term:Franchised Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchised Business\", \"text\": \"Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Goosehead Business (the \\\"Franchised Business\\\") and to offer and sell products, services, and other ancillary products approved by Franchisor and use the Proprietary Marks in connection therewith under the terms and conditions of the Franchise Agreement.\", \"definition_clause\": \"C\"}}, {\"id\": \"term:Competitive Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Competitive Business\", \"text\": \"As used in this Agreement, the term \\\"Competitive Business\\\" is agreed to mean any property and/or casualty insurance distribution business.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Post-Term Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Post-Term Period\", \"text\": \"As used in this Agreement, the term \\\"Post-Term Period\\\" means a continuous uninterrupted period of two (2) years from the date of: (i) a transfer as contemplated under Section 16 of the Franchise Agreement; (ii) expiration or termination of the Franchise Agreement (regardless of the cause for termination); (iii) termination of Member's employment with Franchisee; and/or (iv) a final order of a duly authorized arbitrator, panel of arbitrators, or a court of competent jurisdiction (after all appeals have been taken) with respect to any of the foregoing or with respect to the enforcement of this Agreement; either directly or indirectly (through, on behalf of, or in conjunction with any persons, partnership, corporation or entity).\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Addendum\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Addendum\", \"text\": \"Goosehead Insurance Agency, LLC (\\\"Franchisor\\\" or \\\"us\\\" or \\\"we\\\") and (\\\"Franchisee\\\" or \\\"you\\\") have this day of , 201 entered into a Goosehead Insurance Franchise Agreement (\\\"Franchise Agreement\\\") and wish to supplement its terms as set out below in this Site Selection Addendum (the \\\"Addendum\\\").\", \"definition_clause\": \"5\"}}, {\"id\": \"term:Site Selection Area\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Site Selection Area\", \"text\": \"Such location must be within the following area: (the \\\"Site Selection Area\\\").\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Search Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Search Period\", \"text\": \"For purposes of this Addendum, the term \\\"Search Period\\\" means ninety (90) days from the date of this Addendum, or the period from the date of this Addendum until we have approved of a location for your Franchised Business, whichever event first occurs.\", \"definition_clause\": \"c\"}}, {\"id\": \"term:Lease\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Lease\", \"text\": \"THIS ADDENDUM (the \\\"Addendum\\\") has been executed as of this day of , 201 , by and between (\\\"Franchisee\\\") and (\\\"Landlord\\\"), as an addendum to the lease, as modified, amended, supplemented, renewed and/or extended from time to time as contemplated herein (\\\"Lease\\\") dated as of , 201 for the premises located at , in the State of (\\\"Premises\\\").\", \"definition_clause\": \"6\"}}, {\"id\": \"term:Premises\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Premises\", \"text\": \"THIS ADDENDUM (the \\\"Addendum\\\") has been executed as of this day of , 201 , by and between (\\\"Franchisee\\\") and (\\\"Landlord\\\"), as an addendum to the lease, as modified, amended, supplemented, renewed and/or extended from time to time as contemplated herein (\\\"Lease\\\") dated as of , 201 for the premises located at , in the State of (\\\"Premises\\\").\", \"definition_clause\": \"6\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"\\\"Confidential Information\\\" as used herein will mean all non-public information and tangible things, whether written, oral, electronic or in other form, provided or disclosed by or on behalf of Franchisee to Landlord, or otherwise obtained by Landlord, regarding the design and operations of the business located at the Premises, including, without limitation, all information identifying or describing the floor plan and layout, furnishings, equipment, fixtures, wall coverings, flooring materials, shelving, decorations, trade secrets, techniques, trade dress, \\\"look and feel,\\\" design, manner of operation, suppliers, vendors, and all other products, goods, and services used, useful or provided by or for Franchisee on the Premises.\", \"definition_clause\": \"6\"}}, {\"id\": \"term:Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marks\", \"text\": \"Franchisor has granted to only one party, the Franchisee, the right to use Franchisor's proprietary trade name, trademarks, service marks logos, insignias, slogans, emblems, symbols, designs and indicia of origin (collectively the \\\"Marks\\\") at the Premises under the terms of the Franchise Agreement\", \"definition_clause\": \"6\"}}, {\"id\": \"value:60-month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60-month\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:$600\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$600\"}}, {\"id\": \"value:$1,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:sixty days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty days\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:30-day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30-day\"}}, {\"id\": \"value:fifteen (15) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) business days\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 days\"}}, {\"id\": \"value:sixty-day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty-day\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:3 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 years\"}}, {\"id\": \"value:30 DAYS\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 DAYS\"}}, {\"id\": \"value:5 YEARS\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 YEARS\"}}, {\"id\": \"value:6 MONTHS\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"6 MONTHS\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:180 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"180 days\"}}, {\"id\": \"value:three years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three years\"}}, {\"id\": \"value:10 year period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 year period\"}}, {\"id\": \"value:10-year period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10-year period\"}}, {\"id\": \"value:1 year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"1 year\"}}, {\"id\": \"value:3 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) years\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"Exhibit 6.1\", \"title\": \"DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\\\"Company\\\"), and XXXXXXXXXXXXXXXXXXXXX (\\\"Distributor\\\"). Company Import the products from Brazil Farm origin (Arte Caf\u00e9 - Prescafe Torrefa\u00e7\u00e3o e Comercio de Cafe, a Brazil company, with an address located at 1 Fazenda Sao Gabriel, Guaxup\u00e9, Cep 37800-000, Minas Gerais, Brazil), and sells the products listed in Section 1.c below (the \\\"Products\\\"). Distributor desires to purchase the Products from Company for resale in the territories or geographic areas as defined in Section 1.b (the \\\"Territory\\\"). Company desires to appoint Distributor as its exclusive distributor of the Products to all Clients that Distributor introduce, and upon confirmed the first order, this client come to be exclusive of Distributor, every new customer introduced by Distributor, must be approved by the company prior to any sale. After official approval from the Company, the customer introduced by Distributor, will appear on an official list in this contract, and will only be met by the Distributor and will follow the rules of this agreement. Distributor desires such appointment subject to the terms and conditions set forth in this Agreement, including any exhibits or schedules attached hereto. Now, Therefore, in consideration of the foregoing, and of the mutual benefit contained herein, the Parties, intending to be legally bound, agree as follows: AGREEMENT OF THE PARTIES 1. APPOINTMENT, ACCEPTANCE & SCOPE. (a) Exclusive Appointment. Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein. Distributor shall limit its activities with respect to the Products to Customers located within the Territory and refrain from selling or otherwise transferring, directly or indirectly, the Products to any person outside the Territory, without the express written consent of Company. Company shall not sell or otherwise supply, directly or indirectly, the Products to any Distributor's Customer's, except by sale through the Distributor. The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.\", \"level\": 2, \"text\": \"Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\\\"Company\\\"), and XXXXXXXXXXXXXXXXXXXXX (\\\"Distributor\\\"). Company Import the products from Brazil Farm origin (Arte Caf\u00e9 - Prescafe Torrefa\u00e7\u00e3o e Comercio de Cafe, a Brazil company, with an address located at 1 Fazenda Sao Gabriel, Guaxup\u00e9, Cep 37800-000, Minas Gerais, Brazil), and sells the products listed in Section 1.c below (the \\\"Products\\\"). Distributor desires to purchase the Products from Company for resale in the territories or geographic areas as defined in Section 1.b (the \\\"Territory\\\"). Company desires to appoint Distributor as its exclusive distributor of the Products to all Clients that Distributor introduce, and upon confirmed the first order, this client come to be exclusive of Distributor, every new customer introduced by Distributor, must be approved by the company prior to any sale. After official approval from the Company, the customer introduced by Distributor, will appear on an official list in this contract, and will only be met by the Distributor and will follow the rules of this agreement. Distributor desires such appointment subject to the terms and conditions set forth in this Agreement, including any exhibits or schedules attached hereto. Now, Therefore, in consideration of the foregoing, and of the mutual benefit contained herein, the Parties, intending to be legally bound, agree as follows: AGREEMENT OF THE PARTIES 1. APPOINTMENT, ACCEPTANCE & SCOPE. (a) Exclusive Appointment. Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein. Distributor shall limit its activities with respect to the Products to Customers located within the Territory and refrain from selling or otherwise transferring, directly or indirectly, the Products to any person outside the Territory, without the express written consent of Company. Company shall not sell or otherwise supply, directly or indirectly, the Products to any Distributor's Customer's, except by sale through the Distributor. The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor. Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (b) Territory. The rights granted Distributor hereunder are granted for the following geographical areas and markets. USA. (c) Products. The Products manufactured and sold by Company to Distributor for distribution hereunder are as follows: \u25cf Arte Caf\u00e9 Especial \u25cf Arte Caf\u00e9 Gourmet \u25cf Arte Caf\u00e9 Laurina \u25cf Arte Caf\u00e9 Organico \u25cf And all another new brand and or kind of coffee. (d) Subagents. Distributor may appoint, with prior approval of the Company, sub-agents, sub-distributors, sub-representatives or other persons to act on Distributor's behalf or to otherwise perform any of Distributor's obligations under this Agreement within the Territory; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement. Any agreement with such sub-agent, sub-distributor, sub-representative or other person shall not extend beyond the term of this Agreement. 2 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (e) Relationship of Parties. Distributor is an independent contractor and is not and shall not be deemed to be an employee, legal representative, dealer, general agent, joint venture or partner of Company for any purpose. Distributor acknowledges that Company has not granted it any authority to make changes to Company's terms and conditions of sale, grant any warranties in excess of those extended by Company or limit its liabilities or remedies less than Company limits its liabilities and remedies, sign quotations, incur obligations (expressed or implied), or in general enter into contracts on behalf of Company or bind Company in any transaction with customers, governmental agencies or third parties. 2. ORDERS, PRICE, TERMS OF SALE & PAYMENT. (a) Communications Pursuant to this Distributor Agreement and Orders. Orders shall be made with Company. Company understands that its timely acceptance of orders from Distributor hereunder is an important element of this Agreement. Company shall have Seven (7) business days after its receipt to accept (or reject for a legitimate business reason) any order submitted by Distributor. All the negotiations between Company and Distributor will be by INCOTERMS Ex-works, in origin farm, in Brazil. So will must be respected the Transite Time to destiny delivery. Should Company fail to timely accept or reject an order from Distributor in accordance with this Section, such order shall be deemed accepted and shall become binding on Company. All orders shall be fulfilled by Company within Seven (7) business days of order acceptance. (b) Prices and Shipment. Company agrees to sell, and Distributor agrees to purchase, the Products in accordance with the Prices and Volume Discount Prices set forth in Schedule A. Such Prices and Volume Discount Prices shall only be subject to increase once per year on each anniversary date of this Agreement, provided (i) Company provides Distributor with at least Ninety (90) days prior written notice of any such increase, and (ii) such increase does not exceed 5% of the preceding year's Prices, except for reasons of force majeure, (Chapter 10), and Volume Discount Prices nor the lowest price charged to others for the same Product. Any such change shall not apply for any order(s) accepted prior to the effective date of the increase. 3 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (c) Company shall package the Products for shipment in accordance with Distributor's instructions. All shipments of Products for Customers in the Territory, and any freight and shipping costs related thereto, will be Distributor's responsibility. All shipments will be prepared and shipped from Company's facility. Distributor will promptly inspect the Products upon receipt at Distributor's facility to determine whether any Products included in the shipment are in short supply, defective, or otherwise not in conformance with this Agreement. Within Seven (7) days of receipt of such Products, Distributor will notify Company of any shortages, defects, non-conformance, and Company will promptly replace such Products free of charge. Title to the Products shall pass to Distributor upon delivery. (d) Terms of Sale. All sales by Company shall be in accordance with the terms and conditions of this Agreement. (e) Payment. Upon Customer's acceptance of any order, Distributor shall submit to Customer via wire transfer at least Twenty-Five Percent (25%) of the total order price. Distributor shall submit to Customer via wire transfer the remaining balance upon receipt Packing List and Bill of landing documents, from origin in Brazil Farm. (f) Resale of the Products. Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS. The Distributor and Company, as applicable, make the following representations, warranties and covenants: (a) Distributor is a company duly organized, validly existing and in good standing in the United States of America (USA) , is qualified to do business and in good standing in each jurisdiction located within the Territory and is and will remain in compliance with all applicable laws and regulations in the conduct of its business and, specifically, in its sale of the Products and provision of any services hereunder. 4 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (b) Company is a corporation, duly organized, validly existing and in good standing in the State of Florida, and is and will remain in compliance with all applicable laws and regulations in the conduct of its business and, specifically, in its sale of the Products. (c) Company warrants and represents that the Products will be free from defects in design, materials and workmanship and conform with any specifications provided. (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement. (g) This Agreement is the binding legal obligation of each Party and is enforceable in accordance with its terms. 4. RESPONSIBILITIES OF DISTRIBUTOR. Distributor agrees that it will diligently perform the services and obligations detailed in this Agreement. The operations of Distributor are under its sole and exclusive control, including without limitation supervision of, and liability for expenses incurred with respect to, employees. The Distributor will use best reasonable efforts to distribute the Products in the Territory. 5. RESPONSIBILITIES OF COMPANY. In addition to any other responsibilities stated in this Agreement, Company will: (a) Provide, at Distributor's reasonable request and without charge, up to 10 hours of training with regard to any characteristics of the Products that Distributor deems reasonably necessary for Distributor and its employees and agents to fulfill the purposes of Distributor's appointment, 5 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (b) provide to Distributor, without charge, reasonable quantities of promotional literature, brochures and commercial and technical information regarding the Products; (c) provide sales support and technical training to Distributor and its personnel as deemed reasonably appropriate by Company. 6. CONFIDENTIAL & PROPRIETARY INFORMATION. (a) As used herein, the term \\\"Proprietary Information\\\" means any information, technical data, or know-how (including, but not limited to, information relating to products, software, services, development, inventions, processes, techniques, customers, pricing, internal procedures, business and marketing plans or strategies, finances, employees and business opportunities) disclosed by one Party (the \\\"Disclosing Party\\\") to the other (the \\\"Recipient Party\\\") either directly or indirectly in any form whatsoever, including, but not limited to, in writing, in machine readable or other tangible form, orally or visually. (b) Unless otherwise expressly authorized by the Disclosing Party, the Recipient Party agrees that it and any of its personnel receiving Proprietary Information under this Agreement shall treat such Proprietary Information in strict confidence with the same degree of care applied to its own Proprietary Information of like importance, which it does not wish to disclose, publish, or disseminate to third parties. (c) In no event will the Recipient Party divulge, in whole or in part, such information to any third party without the prior written consent of the Disclosing Party; provided, further, that any third party must also agree in writing to restrictions comparable to those provided in this Section 6. The Recipient Party may disclose the Proprietary Information to the extent required by a valid order by a court or other governmental body or by applicable law; provided, however, that the Recipient Party will use all reasonable efforts to notify Disclosing Party of the obligation to make such disclosure in advance of the disclosure so that Disclosing Party will have a reasonable opportunity to object to such disclosure. 6 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (d) Notwithstanding any other provisions of this Agreement, each party acknowledges that Proprietary Information shall not include any information that: (i) is already known to the Recipient Party at the time of disclosure, or becomes publicly known through no wrongful act of the Recipient Party's part; (ii) is rightfully received by the Recipient Party from a third party without breach of this Agreement; (iii) is independently developed by the Recipient Party without benefit of information received under this Agreement; (iv) is furnished to a third party by the Disclosing Party without a restriction on the third party's right to disclose it; or (v) is explicitly approved for release by written authorization by the Disclosing Party. (e) It is understood that all Proprietary Information disclosed under this Agreement, is, and shall remain, the property of the Disclosing Party. Upon completion of this Agreement, or upon written notice from the Disclosing Party, the Recipient Party agrees to return all Proprietary Information in its possession. (f) The Recipient Party acknowledges that the Disclosing Party, because of the unique nature of the Proprietary Information, would suffer irreparable harm in the event that the Recipient Party breaches its obligation under this Agreement and that monetary damages would be inadequate to compensate the Disclosing Party for such a breach. The Parties agree that, in such a circumstance, the Disclosing Party shall be entitled, in addition to such monetary relief as may be applicable, to injunctive relief as may be necessary to restrain any continuing or further breach by the Recipient Party, without showing or proving any actual damages sustained by the Disclosing Party. (g) The obligations of the Recipient Party under this Section 6 shall survive termination or nonrenewal of this Agreement for a period of thee (3) years. For the avoidance of doubt, the customer and sub-distributor lists of Distributor shall be deemed to constitute Proprietary Information under this agreement. 7 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}, {\"id\": \"7\", \"title\": \"DURATION & TERMINATION\", \"level\": 1, \"text\": \"7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination. Either Party may terminate this Agreement prior to its expiration upon the occurrence of either of the following: (i) the other Party becomes insolvent, or institutes (or there is instituted against it) proceedings in bankruptcy, insolvency, reorganization or dissolution, makes an assignment for the benefit of creditors or becomes nationalized or has any of its material assets confiscated or expropriated; or (ii) the other Party (in this case, the \\\"breaching Party\\\") fails to perform any of its obligations hereunder and fails to correct such failure within Ninety (90) calendar days after receiving written demand therefore from the non-breaching Party, specifying the failure in sufficient detail for the breaching Party to correct such failure; provided, however, that upon a second breach of the same obligation by such Party, the other Party may forthwith terminate this Agreement upon notice to the breaching Party. 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival. Notwithstanding anything to the contrary set forth herein, no termination of this Agreement shall relieve any Party from any obligations hereunder which are outstanding on, or relate to matters or claims occurring or arising prior to, the date of such termination or which survive such termination by their own terms or nature. 8 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}, {\"id\": \"9\", \"title\": \"INDEMNIFICATION & LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"9. INDEMNIFICATION & LIMITATION OF LIABILITY. (a) Indemnification. Each Party (\\\"Indemnifying Party\\\") shall indemnify, hold harmless and defend the other Party (\\\"Indemnified Party\\\") and its officers, directors, agents, employees, and affiliates, from and against any and all claims, demands, actions, costs, expenses, liabilities, judgments, causes of action, proceedings, suits, losses and damages of any nature, which are threatened or brought against, or are suffered or incurred by, the Indemnified Party or any such person to the extent caused directly by acts or omissions of the Indemnifying Party relating to this Agreement, including without limitation (i) any negligent or tortious conduct, (ii) any breach of any of the representations, warranties, covenants or conditions of the Indemnifying Party contained in this Agreement, (iii) any violation of applicable laws or regulations, (iv) infringement or violation of any patent, copyright, trade secret, or other proprietary interest of any third party, and (v) any breach of any express or implied warranties relating to the Products, including implied warranties of merchantability and fitness for a particular purpose. (b) Limitation of Liability.IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INDIRECT, EXEMPLARY OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT OR PURCHASE OR USE OF THE PRODUCTS. 10. FORCE MAJEURE. Neither Party shall be held liable for any failure to perform that is due to any cause or circumstance beyond the reasonable control of such Party, including without limitation a demand for such Products and other products manufactured by Company which exceeds Company's ability to supply them, earthquakes, fire, accidents, floods, storms, other Acts of God, riots, wars, rebellions, strikes, lockouts or other labor disturbances, national or international emergencies, failure to secure materials or equipment from usual sources of supply, failure of carriers to furnish transportation, government rules, regulations, acts, orders, world financial crisis, restrictions or requirements or any other cause or circumstance beyond the reasonable control of such Party. No such inability to deliver or delay in delivery shall invalidate the remainder of this Agreement. 9 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}, {\"id\": \"11\", \"title\": \"TRADEMARKS\", \"level\": 1, \"text\": \"11. TRADEMARKS. Distributor shall not dispute or contest for any reason whatsoever, directly or indirectly, during the term of this Agreement and thereafter, the validity, ownership or enforceability of any of the trademarks of Company, nor directly or indirectly attempt to acquire or damage the value of the goodwill associated with any of the trademarks of Company, nor counsel, procure or assist any third Party to do any of the foregoing. Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company. Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise. Distributor shall execute any documents or do any acts that may be required to accomplish the intent of this Section. 12. GENERAL PROVISIONS. (a) Amendments. This Agreement may be amended only by a writing signed by each of the Parties, and any such amendment shall be effective only to the extent specifically set forth in such writing. (b) Governing Law. This Agreement is a contract under the laws of the State of Florida and for all purposes shall be governed by and construed in accordance with the substantive laws of the State of Florida, without regard to its principles of conflicts of laws provisions. (c) Disputes. The Parties shall seek to resolve any dispute, controversy or claim arising out of or in connection with this Agreement, including without limitation, any dispute regarding the enforceability of any provision, through good faith negotiations between them within Thirty (30) days of any notice of dispute being served or such longer period of time as may be mutually agreed between the Parties. If the Parties are unable to resolve the dispute within this timeframe, and one or both parties one or both parties desire to pursue the dispute, the complaining party must submit the dispute to binding arbitration in accordance with the rules and regulations of the American Arbitration Association. The Parties will share equally the cost of arbitrating such dispute. The arbitrator(s) shall not be empowered to award punitive or other damages in excess of compensatory damages, and both parties irrevocably waive the right to any such damages. Judgment on the award rendered by the arbitrator(s) may be entered by any court having jurisdiction over the dispute. In the event that the parties cannot agree upon an arbitrator within a Thirty (30) day period, each party shall designate an arbitrator and those two arbitrators shall choose a third arbitrator, with that third arbitrator serving as the sole arbitrator of the dispute. 10 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (d) Assignment. Neither Party shall assign, pledge or otherwise transfer any of its rights, interest or obligations hereunder, whether by operation of law or otherwise, without the prior express written consent of the other Party. (e) Counterparts; Email Execution. This Agreement may be executed in any number of counterparts, and by each of the Parties on separate counterparts, each of which, when so executed, shall be deemed an original, but all of which shall constitute but one and the same instrument. Delivery of an executed counterpart of this Agreement by email shall be equally as effective as delivery of a manually executed counterpart of this Agreement. Any Party delivering an executed counterpart of this Agreement by email shall also deliver a manually executed counterpart of this Agreement, but the failure to deliver a manually executed counterpart shall not affect the validity, enforceability or binding effect of this Agreement. (f) Cumulative Remedies. The rights and remedies of the Parties hereunder are cumulative and not exclusive of any rights or remedies which the Parties would otherwise have. No single or partial exercise of any such right or remedy by a Party, and no discontinuance of steps to enforce any such right or remedy, shall preclude any further exercise thereof or of any other right or remedy of such Party. (g) Entire Agreement. This Agreement contains the entire agreement of the Parties with respect to the transactions contemplated hereby and supersedes all prior written and oral agreements, and all contemporaneous oral agreements, relating to such transactions. (h) Exhibits and Schedules.The exhibits or schedules attached hereto are an integral part hereof and all references herein to this Agreement shall include such exhibits and schedules. 11 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (i) Notices. Unless otherwise specifically provided herein, all notices, consents, requests, demands and other communications required or permitted hereunder: (i) shall be in writing; (ii)) shall be sent by email, certified or registered U.S. mail, or reliable express delivery service (with a copy sent by one of the foregoing means), charges prepaid as applicable, to the appropriate address(es) or number(s) set forth below; and (iii) shall be deemed to have been given on the date of receipt by the addressee, as evidenced by (A) a receipt executed by the addressee (or a responsible person in his or her office), the records of the Person delivering such communication or a notice to the effect that such addressee refused to claim or accept such communication, if sent by messenger, U.S. mail or express delivery service, or (B) a receipt generated by the sender's email showing that such communication was sent to the appropriate number on a specified date, if sent by email. All such communications shall be sent to the addresses for each Party as first set forth above, or to such other addresses or numbers as any Party may inform the others by giving Seven (7) days prior notice. (j) Severability. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability of such provision in any other jurisdiction. (k) Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of each of the Parties and their respective successors and permitted assigns. 12 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 IN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date: Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}, {\"id\": \"SCHEDULE A\", \"title\": \"PRICES AND DISCOUNT VOLUME PRICES Subject to Company's right to increase the price only once per year per the terms and restrictions contained in the Agreement, and Company's right to decrease the price at any time upon notice, the Products shall be sold by Company to Distributor at the following Prices and Volume Discount Prices. Prices are in US Dollars. \u25cf $9 (US) per kilogram Ex-work Incoterms. (Brazil Farm). Distributor will be appropriately credited should Distributor make payment related to an order and later determine that it had achieved a greater discount per the above.\", \"level\": 1, \"text\": \"SCHEDULE A PRICES AND DISCOUNT VOLUME PRICES Subject to Company's right to increase the price only once per year per the terms and restrictions contained in the Agreement, and Company's right to decrease the price at any time upon notice, the Products shall be sold by Company to Distributor at the following Prices and Volume Discount Prices. Prices are in US Dollars. \u25cf $9 (US) per kilogram Ex-work Incoterms. (Brazil Farm). Distributor will be appropriately credited should Distributor make payment related to an order and later determine that it had achieved a greater discount per the above. Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of GentechHoldingsInc_20190808_1-A_EX1A-6 MAT CTRCT_11776814_EX1A-6 MAT CTRCT_Distributor Agreement\", \"nodes\": [{\"id\": \"Exhibit 6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\\\"Company\\\"), and XXXXXXXXXXXXXXXXXXXXX (\\\"Distributor\\\"). Company Import the products from Brazil Farm origin (Arte Caf\u00e9 - Prescafe Torrefa\u00e7\u00e3o e Comercio de Cafe, a Brazil company, with an address located at 1 Fazenda Sao Gabriel, Guaxup\u00e9, Cep 37800-000, Minas Gerais, Brazil), and sells the products listed in Section 1.c below (the \\\"Products\\\"). Distributor desires to purchase the Products from Company for resale in the territories or geographic areas as defined in Section 1.b (the \\\"Territory\\\"). Company desires to appoint Distributor as its exclusive distributor of the Products to all Clients that Distributor introduce, and upon confirmed the first order, this client come to be exclusive of Distributor, every new customer introduced by Distributor, must be approved by the company prior to any sale. After official approval from the Company, the customer introduced by Distributor, will appear on an official list in this contract, and will only be met by the Distributor and will follow the rules of this agreement. Distributor desires such appointment subject to the terms and conditions set forth in this Agreement, including any exhibits or schedules attached hereto. Now, Therefore, in consideration of the foregoing, and of the mutual benefit contained herein, the Parties, intending to be legally bound, agree as follows: AGREEMENT OF THE PARTIES 1. APPOINTMENT, ACCEPTANCE & SCOPE. (a) Exclusive Appointment. Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein. Distributor shall limit its activities with respect to the Products to Customers located within the Territory and refrain from selling or otherwise transferring, directly or indirectly, the Products to any person outside the Territory, without the express written consent of Company. Company shall not sell or otherwise supply, directly or indirectly, the Products to any Distributor's Customer's, except by sale through the Distributor. The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor.\", \"level\": 2, \"text\": \"Exhibit 6.1 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\") is made and effective as of1 August 2019, by and between, B & C General Warehouse Corporation LLC , a USA Limited Liability Company (LLC), with an address located at 7405 SW 11th CT, North Lauderdale, FL, 33068, USA, (\\\"Company\\\"), and XXXXXXXXXXXXXXXXXXXXX (\\\"Distributor\\\"). Company Import the products from Brazil Farm origin (Arte Caf\u00e9 - Prescafe Torrefa\u00e7\u00e3o e Comercio de Cafe, a Brazil company, with an address located at 1 Fazenda Sao Gabriel, Guaxup\u00e9, Cep 37800-000, Minas Gerais, Brazil), and sells the products listed in Section 1.c below (the \\\"Products\\\"). Distributor desires to purchase the Products from Company for resale in the territories or geographic areas as defined in Section 1.b (the \\\"Territory\\\"). Company desires to appoint Distributor as its exclusive distributor of the Products to all Clients that Distributor introduce, and upon confirmed the first order, this client come to be exclusive of Distributor, every new customer introduced by Distributor, must be approved by the company prior to any sale. After official approval from the Company, the customer introduced by Distributor, will appear on an official list in this contract, and will only be met by the Distributor and will follow the rules of this agreement. Distributor desires such appointment subject to the terms and conditions set forth in this Agreement, including any exhibits or schedules attached hereto. Now, Therefore, in consideration of the foregoing, and of the mutual benefit contained herein, the Parties, intending to be legally bound, agree as follows: AGREEMENT OF THE PARTIES 1. APPOINTMENT, ACCEPTANCE & SCOPE. (a) Exclusive Appointment. Subject to the terms and conditions of this Distributor Agreement, Company hereby appoints and grants Distributor the exclusive right to sell and distribute the Products to customers that Distributor introduce and confirmed by Company, (in all territory of United State of America (USA) and to render other services as a distributor for Company as set forth herein. Distributor shall limit its activities with respect to the Products to Customers located within the Territory and refrain from selling or otherwise transferring, directly or indirectly, the Products to any person outside the Territory, without the express written consent of Company. Company shall not sell or otherwise supply, directly or indirectly, the Products to any Distributor's Customer's, except by sale through the Distributor. The Company shall not contact any of Distributor's Customer's for any reason, without the prior written approval of Distributor. Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (b) Territory. The rights granted Distributor hereunder are granted for the following geographical areas and markets. USA. (c) Products. The Products manufactured and sold by Company to Distributor for distribution hereunder are as follows: \u25cf Arte Caf\u00e9 Especial \u25cf Arte Caf\u00e9 Gourmet \u25cf Arte Caf\u00e9 Laurina \u25cf Arte Caf\u00e9 Organico \u25cf And all another new brand and or kind of coffee. (d) Subagents. Distributor may appoint, with prior approval of the Company, sub-agents, sub-distributors, sub-representatives or other persons to act on Distributor's behalf or to otherwise perform any of Distributor's obligations under this Agreement within the Territory; provided that (i) any compensation to such sub-agent, sub-distributor, sub-representative or other person to act on Distributor's behalf or to otherwise perform any of Distributor's obligations shall be solely Distributor's responsibility, and (ii) such appointment does not deprive Company of the essential rights to which it is entitled under this Agreement. Any agreement with such sub-agent, sub-distributor, sub-representative or other person shall not extend beyond the term of this Agreement. 2 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (e) Relationship of Parties. Distributor is an independent contractor and is not and shall not be deemed to be an employee, legal representative, dealer, general agent, joint venture or partner of Company for any purpose. Distributor acknowledges that Company has not granted it any authority to make changes to Company's terms and conditions of sale, grant any warranties in excess of those extended by Company or limit its liabilities or remedies less than Company limits its liabilities and remedies, sign quotations, incur obligations (expressed or implied), or in general enter into contracts on behalf of Company or bind Company in any transaction with customers, governmental agencies or third parties. 2. ORDERS, PRICE, TERMS OF SALE & PAYMENT. (a) Communications Pursuant to this Distributor Agreement and Orders. Orders shall be made with Company. Company understands that its timely acceptance of orders from Distributor hereunder is an important element of this Agreement. Company shall have Seven (7) business days after its receipt to accept (or reject for a legitimate business reason) any order submitted by Distributor. All the negotiations between Company and Distributor will be by INCOTERMS Ex-works, in origin farm, in Brazil. So will must be respected the Transite Time to destiny delivery. Should Company fail to timely accept or reject an order from Distributor in accordance with this Section, such order shall be deemed accepted and shall become binding on Company. All orders shall be fulfilled by Company within Seven (7) business days of order acceptance. (b) Prices and Shipment. Company agrees to sell, and Distributor agrees to purchase, the Products in accordance with the Prices and Volume Discount Prices set forth in Schedule A. Such Prices and Volume Discount Prices shall only be subject to increase once per year on each anniversary date of this Agreement, provided (i) Company provides Distributor with at least Ninety (90) days prior written notice of any such increase, and (ii) such increase does not exceed 5% of the preceding year's Prices, except for reasons of force majeure, (Chapter 10), and Volume Discount Prices nor the lowest price charged to others for the same Product. Any such change shall not apply for any order(s) accepted prior to the effective date of the increase. 3 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (c) Company shall package the Products for shipment in accordance with Distributor's instructions. All shipments of Products for Customers in the Territory, and any freight and shipping costs related thereto, will be Distributor's responsibility. All shipments will be prepared and shipped from Company's facility. Distributor will promptly inspect the Products upon receipt at Distributor's facility to determine whether any Products included in the shipment are in short supply, defective, or otherwise not in conformance with this Agreement. Within Seven (7) days of receipt of such Products, Distributor will notify Company of any shortages, defects, non-conformance, and Company will promptly replace such Products free of charge. Title to the Products shall pass to Distributor upon delivery. (d) Terms of Sale. All sales by Company shall be in accordance with the terms and conditions of this Agreement. (e) Payment. Upon Customer's acceptance of any order, Distributor shall submit to Customer via wire transfer at least Twenty-Five Percent (25%) of the total order price. Distributor shall submit to Customer via wire transfer the remaining balance upon receipt Packing List and Bill of landing documents, from origin in Brazil Farm. (f) Resale of the Products. Distributor shall be free to resell the Products for such prices and upon such terms and conditions as Distributor may see fit in its sole discretion. Company shall have no control over or any liability in connection with the price at which Distributor resells the Products, and Distributor shall hold Company harmless and indemnify and defend Company from and against any liability resulting therefrom. 3. REPRESENTATIONS. The Distributor and Company, as applicable, make the following representations, warranties and covenants: (a) Distributor is a company duly organized, validly existing and in good standing in the United States of America (USA) , is qualified to do business and in good standing in each jurisdiction located within the Territory and is and will remain in compliance with all applicable laws and regulations in the conduct of its business and, specifically, in its sale of the Products and provision of any services hereunder. 4 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (b) Company is a corporation, duly organized, validly existing and in good standing in the State of Florida, and is and will remain in compliance with all applicable laws and regulations in the conduct of its business and, specifically, in its sale of the Products. (c) Company warrants and represents that the Products will be free from defects in design, materials and workmanship and conform with any specifications provided. (d) Company has all rights, power, and authority to enter into this Agreement. (e) Company's execution of this Distributor Agreement, and Company's performance of its obligations and duties hereunder, do not and will not violate any agreement to which Company is a party or by which it is otherwise bound, and (f) Neither Party is subject to any pending or threatened litigation or governmental action that could interfere with its performance of this Agreement. (g) This Agreement is the binding legal obligation of each Party and is enforceable in accordance with its terms. 4. RESPONSIBILITIES OF DISTRIBUTOR. Distributor agrees that it will diligently perform the services and obligations detailed in this Agreement. The operations of Distributor are under its sole and exclusive control, including without limitation supervision of, and liability for expenses incurred with respect to, employees. The Distributor will use best reasonable efforts to distribute the Products in the Territory. 5. RESPONSIBILITIES OF COMPANY. In addition to any other responsibilities stated in this Agreement, Company will: (a) Provide, at Distributor's reasonable request and without charge, up to 10 hours of training with regard to any characteristics of the Products that Distributor deems reasonably necessary for Distributor and its employees and agents to fulfill the purposes of Distributor's appointment, 5 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (b) provide to Distributor, without charge, reasonable quantities of promotional literature, brochures and commercial and technical information regarding the Products; (c) provide sales support and technical training to Distributor and its personnel as deemed reasonably appropriate by Company. 6. CONFIDENTIAL & PROPRIETARY INFORMATION. (a) As used herein, the term \\\"Proprietary Information\\\" means any information, technical data, or know-how (including, but not limited to, information relating to products, software, services, development, inventions, processes, techniques, customers, pricing, internal procedures, business and marketing plans or strategies, finances, employees and business opportunities) disclosed by one Party (the \\\"Disclosing Party\\\") to the other (the \\\"Recipient Party\\\") either directly or indirectly in any form whatsoever, including, but not limited to, in writing, in machine readable or other tangible form, orally or visually. (b) Unless otherwise expressly authorized by the Disclosing Party, the Recipient Party agrees that it and any of its personnel receiving Proprietary Information under this Agreement shall treat such Proprietary Information in strict confidence with the same degree of care applied to its own Proprietary Information of like importance, which it does not wish to disclose, publish, or disseminate to third parties. (c) In no event will the Recipient Party divulge, in whole or in part, such information to any third party without the prior written consent of the Disclosing Party; provided, further, that any third party must also agree in writing to restrictions comparable to those provided in this Section 6. The Recipient Party may disclose the Proprietary Information to the extent required by a valid order by a court or other governmental body or by applicable law; provided, however, that the Recipient Party will use all reasonable efforts to notify Disclosing Party of the obligation to make such disclosure in advance of the disclosure so that Disclosing Party will have a reasonable opportunity to object to such disclosure. 6 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (d) Notwithstanding any other provisions of this Agreement, each party acknowledges that Proprietary Information shall not include any information that: (i) is already known to the Recipient Party at the time of disclosure, or becomes publicly known through no wrongful act of the Recipient Party's part; (ii) is rightfully received by the Recipient Party from a third party without breach of this Agreement; (iii) is independently developed by the Recipient Party without benefit of information received under this Agreement; (iv) is furnished to a third party by the Disclosing Party without a restriction on the third party's right to disclose it; or (v) is explicitly approved for release by written authorization by the Disclosing Party. (e) It is understood that all Proprietary Information disclosed under this Agreement, is, and shall remain, the property of the Disclosing Party. Upon completion of this Agreement, or upon written notice from the Disclosing Party, the Recipient Party agrees to return all Proprietary Information in its possession. (f) The Recipient Party acknowledges that the Disclosing Party, because of the unique nature of the Proprietary Information, would suffer irreparable harm in the event that the Recipient Party breaches its obligation under this Agreement and that monetary damages would be inadequate to compensate the Disclosing Party for such a breach. The Parties agree that, in such a circumstance, the Disclosing Party shall be entitled, in addition to such monetary relief as may be applicable, to injunctive relief as may be necessary to restrain any continuing or further breach by the Recipient Party, without showing or proving any actual damages sustained by the Disclosing Party. (g) The obligations of the Recipient Party under this Section 6 shall survive termination or nonrenewal of this Agreement for a period of thee (3) years. For the avoidance of doubt, the customer and sub-distributor lists of Distributor shall be deemed to constitute Proprietary Information under this agreement. 7 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DURATION & TERMINATION\", \"level\": 1, \"text\": \"7. DURATION & TERMINATION. (a) Effective Date and Duration. This Agreement shall become effective on the date first written above and shall continue in effect for a period of Three (3) years. (b) Distributor Option to Renew. Distributor shall have the option to renew this Agreement for an additional Three (3) year period by providing prior written notice to Company within Ninety (90) days of the end of the initial period of this Agreement. (c) Termination. Either Party may terminate this Agreement prior to its expiration upon the occurrence of either of the following: (i) the other Party becomes insolvent, or institutes (or there is instituted against it) proceedings in bankruptcy, insolvency, reorganization or dissolution, makes an assignment for the benefit of creditors or becomes nationalized or has any of its material assets confiscated or expropriated; or (ii) the other Party (in this case, the \\\"breaching Party\\\") fails to perform any of its obligations hereunder and fails to correct such failure within Ninety (90) calendar days after receiving written demand therefore from the non-breaching Party, specifying the failure in sufficient detail for the breaching Party to correct such failure; provided, however, that upon a second breach of the same obligation by such Party, the other Party may forthwith terminate this Agreement upon notice to the breaching Party. 8. RIGHTS OF PARTIES AT TERMINATION. (a) Obligations After Termination. In the event that this Agreement is terminated or expires on its own terms, Company shall have no further responsibilities to Distributor except that in the event the Agreement terminates for any reason other than a breach hereof by Distributor, Company shall be obligated to process orders accepted by Company prior to the effective date of such termination or expiration or within Ninety (90) days thereafter. (b) Survival. Notwithstanding anything to the contrary set forth herein, no termination of this Agreement shall relieve any Party from any obligations hereunder which are outstanding on, or relate to matters or claims occurring or arising prior to, the date of such termination or which survive such termination by their own terms or nature. 8 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION & LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"9. INDEMNIFICATION & LIMITATION OF LIABILITY. (a) Indemnification. Each Party (\\\"Indemnifying Party\\\") shall indemnify, hold harmless and defend the other Party (\\\"Indemnified Party\\\") and its officers, directors, agents, employees, and affiliates, from and against any and all claims, demands, actions, costs, expenses, liabilities, judgments, causes of action, proceedings, suits, losses and damages of any nature, which are threatened or brought against, or are suffered or incurred by, the Indemnified Party or any such person to the extent caused directly by acts or omissions of the Indemnifying Party relating to this Agreement, including without limitation (i) any negligent or tortious conduct, (ii) any breach of any of the representations, warranties, covenants or conditions of the Indemnifying Party contained in this Agreement, (iii) any violation of applicable laws or regulations, (iv) infringement or violation of any patent, copyright, trade secret, or other proprietary interest of any third party, and (v) any breach of any express or implied warranties relating to the Products, including implied warranties of merchantability and fitness for a particular purpose. (b) Limitation of Liability.IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY SPECIAL, INDIRECT, EXEMPLARY OR CONSEQUENTIAL DAMAGES ARISING OUT OF THIS AGREEMENT OR PURCHASE OR USE OF THE PRODUCTS. 10. FORCE MAJEURE. Neither Party shall be held liable for any failure to perform that is due to any cause or circumstance beyond the reasonable control of such Party, including without limitation a demand for such Products and other products manufactured by Company which exceeds Company's ability to supply them, earthquakes, fire, accidents, floods, storms, other Acts of God, riots, wars, rebellions, strikes, lockouts or other labor disturbances, national or international emergencies, failure to secure materials or equipment from usual sources of supply, failure of carriers to furnish transportation, government rules, regulations, acts, orders, world financial crisis, restrictions or requirements or any other cause or circumstance beyond the reasonable control of such Party. No such inability to deliver or delay in delivery shall invalidate the remainder of this Agreement. 9 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS\", \"level\": 1, \"text\": \"11. TRADEMARKS. Distributor shall not dispute or contest for any reason whatsoever, directly or indirectly, during the term of this Agreement and thereafter, the validity, ownership or enforceability of any of the trademarks of Company, nor directly or indirectly attempt to acquire or damage the value of the goodwill associated with any of the trademarks of Company, nor counsel, procure or assist any third Party to do any of the foregoing. Distributor will not institute any proceedings with respect to the trademarks of Company either in Distributor's own name or on behalf of Company without express written permission of Company. Distributor shall assign to Company, without charge, any rights in the trademarks of Company that may inure to the benefit of Distributor pursuant to this Agreement or otherwise. Distributor shall execute any documents or do any acts that may be required to accomplish the intent of this Section. 12. GENERAL PROVISIONS. (a) Amendments. This Agreement may be amended only by a writing signed by each of the Parties, and any such amendment shall be effective only to the extent specifically set forth in such writing. (b) Governing Law. This Agreement is a contract under the laws of the State of Florida and for all purposes shall be governed by and construed in accordance with the substantive laws of the State of Florida, without regard to its principles of conflicts of laws provisions. (c) Disputes. The Parties shall seek to resolve any dispute, controversy or claim arising out of or in connection with this Agreement, including without limitation, any dispute regarding the enforceability of any provision, through good faith negotiations between them within Thirty (30) days of any notice of dispute being served or such longer period of time as may be mutually agreed between the Parties. If the Parties are unable to resolve the dispute within this timeframe, and one or both parties one or both parties desire to pursue the dispute, the complaining party must submit the dispute to binding arbitration in accordance with the rules and regulations of the American Arbitration Association. The Parties will share equally the cost of arbitrating such dispute. The arbitrator(s) shall not be empowered to award punitive or other damages in excess of compensatory damages, and both parties irrevocably waive the right to any such damages. Judgment on the award rendered by the arbitrator(s) may be entered by any court having jurisdiction over the dispute. In the event that the parties cannot agree upon an arbitrator within a Thirty (30) day period, each party shall designate an arbitrator and those two arbitrators shall choose a third arbitrator, with that third arbitrator serving as the sole arbitrator of the dispute. 10 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (d) Assignment. Neither Party shall assign, pledge or otherwise transfer any of its rights, interest or obligations hereunder, whether by operation of law or otherwise, without the prior express written consent of the other Party. (e) Counterparts; Email Execution. This Agreement may be executed in any number of counterparts, and by each of the Parties on separate counterparts, each of which, when so executed, shall be deemed an original, but all of which shall constitute but one and the same instrument. Delivery of an executed counterpart of this Agreement by email shall be equally as effective as delivery of a manually executed counterpart of this Agreement. Any Party delivering an executed counterpart of this Agreement by email shall also deliver a manually executed counterpart of this Agreement, but the failure to deliver a manually executed counterpart shall not affect the validity, enforceability or binding effect of this Agreement. (f) Cumulative Remedies. The rights and remedies of the Parties hereunder are cumulative and not exclusive of any rights or remedies which the Parties would otherwise have. No single or partial exercise of any such right or remedy by a Party, and no discontinuance of steps to enforce any such right or remedy, shall preclude any further exercise thereof or of any other right or remedy of such Party. (g) Entire Agreement. This Agreement contains the entire agreement of the Parties with respect to the transactions contemplated hereby and supersedes all prior written and oral agreements, and all contemporaneous oral agreements, relating to such transactions. (h) Exhibits and Schedules.The exhibits or schedules attached hereto are an integral part hereof and all references herein to this Agreement shall include such exhibits and schedules. 11 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 (i) Notices. Unless otherwise specifically provided herein, all notices, consents, requests, demands and other communications required or permitted hereunder: (i) shall be in writing; (ii)) shall be sent by email, certified or registered U.S. mail, or reliable express delivery service (with a copy sent by one of the foregoing means), charges prepaid as applicable, to the appropriate address(es) or number(s) set forth below; and (iii) shall be deemed to have been given on the date of receipt by the addressee, as evidenced by (A) a receipt executed by the addressee (or a responsible person in his or her office), the records of the Person delivering such communication or a notice to the effect that such addressee refused to claim or accept such communication, if sent by messenger, U.S. mail or express delivery service, or (B) a receipt generated by the sender's email showing that such communication was sent to the appropriate number on a specified date, if sent by email. All such communications shall be sent to the addresses for each Party as first set forth above, or to such other addresses or numbers as any Party may inform the others by giving Seven (7) days prior notice. (j) Severability. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or affecting the validity or enforceability of such provision in any other jurisdiction. (k) Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of each of the Parties and their respective successors and permitted assigns. 12 Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019 IN WITNESS WHEREOF, this Agreement was signed by the Parties under the hands of their duly authorised officers and made effective as of the date first written above. Luiz Augusto Matavelli Bacetti B & C General Warehouse Corporation LLC Date: 04th, August, 2019. xxxxxxxx xxxxxxxx Date: Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}}, {\"id\": \"SCHEDULE A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICES AND DISCOUNT VOLUME PRICES Subject to Company's right to increase the price only once per year per the terms and restrictions contained in the Agreement, and Company's right to decrease the price at any time upon notice, the Products shall be sold by Company to Distributor at the following Prices and Volume Discount Prices. Prices are in US Dollars. \u25cf $9 (US) per kilogram Ex-work Incoterms. (Brazil Farm). Distributor will be appropriately credited should Distributor make payment related to an order and later determine that it had achieved a greater discount per the above.\", \"level\": 1, \"text\": \"SCHEDULE A PRICES AND DISCOUNT VOLUME PRICES Subject to Company's right to increase the price only once per year per the terms and restrictions contained in the Agreement, and Company's right to decrease the price at any time upon notice, the Products shall be sold by Company to Distributor at the following Prices and Volume Discount Prices. Prices are in US Dollars. \u25cf $9 (US) per kilogram Ex-work Incoterms. (Brazil Farm). Distributor will be appropriately credited should Distributor make payment related to an order and later determine that it had achieved a greater discount per the above. Source: GENTECH HOLDINGS, INC., 1-A, 8/8/2019\"}}, {\"id\": \"party:B & C General Warehouse Corporation LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"B & C General Warehouse Corporation LLC\", \"role\": \"Company\", \"address\": \"7405 SW 11th CT, North Lauderdale, FL, 33068, USA\"}}, {\"id\": \"party:XXXXXXXXXXXXXXXXXXXXX\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"XXXXXXXXXXXXXXXXXXXXX\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS DISTRIBUTOR AGREEMENT (this \\\"Agreement\\\")\", \"definition_clause\": \"Exhibit 6.1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"the products listed in Section 1.c below (the \\\"Products\\\")\", \"definition_clause\": \"Exhibit 6.1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the territories or geographic areas as defined in Section 1.b (the \\\"Territory\\\")\", \"definition_clause\": \"Exhibit 6.1\"}}, {\"id\": \"term:Proprietary Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Information\", \"text\": \"any information, technical data, or know-how (including, but not limited to, information relating to products, software, services, development, inventions, processes, techniques, customers, pricing, internal procedures, business and marketing plans or strategies, finances, employees and business opportunities) disclosed by one Party (the \\\"Disclosing Party\\\") to the other (the \\\"Recipient Party\\\") either directly or indirectly in any form whatsoever, including, but not limited to, in writing, in machine readable or other tangible form, orally or visually\", \"definition_clause\": \"Exhibit 6.1\"}}, {\"id\": \"term:Disclosing Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disclosing Party\", \"text\": \"one Party (the \\\"Disclosing Party\\\")\", \"definition_clause\": \"Exhibit 6.1\"}}, {\"id\": \"term:Recipient Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Recipient Party\", \"text\": \"the other (the \\\"Recipient Party\\\")\", \"definition_clause\": \"Exhibit 6.1\"}}, {\"id\": \"term:breaching Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"breaching Party\", \"text\": \"the other Party (in this case, the \\\"breaching Party\\\")\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Indemnifying Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnifying Party\", \"text\": \"Each Party (\\\"Indemnifying Party\\\")\", \"definition_clause\": \"9\"}}, {\"id\": \"term:Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnified Party\", \"text\": \"the other Party (\\\"Indemnified Party\\\")\", \"definition_clause\": \"9\"}}, {\"id\": \"value:Seven (7) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Seven (7) business days\"}}, {\"id\": \"value:Ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Ninety (90) days\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:Seven (7) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Seven (7) days\"}}, {\"id\": \"value:Twenty-Five Percent (25%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"Twenty-Five Percent (25%)\"}}, {\"id\": \"value:Ninety (90) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Ninety (90) calendar days\"}}, {\"id\": \"value:Thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Thirty (30) days\"}}, {\"id\": \"value:Thirty (30) day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Thirty (30) day period\"}}, {\"id\": \"value:$9 (US)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$9 (US)\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of HEMISPHERX - Sales, Marketing, Distribution, and Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of HEMISPHERX - Sales, Marketing, Distribution, and Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 Sales, Marketing, Distribution, and Supply Agreement {***} WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. (\\\"HEMISPHERX\\\") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\\\" SCIEN\\\"), each a \\\"Party\\\" together, \\\"Parties\\\", and WHEREAS HEMISPHERX owns intellectual proprietary rights relating to Interferon alfa-n3 (human leukocyte derived), and WHEREAS HEMISPHERX desires to have Interferon alfa-n3 (human leukocyte derived) provided to physicians to treat genital warts and other infections and diseases, including MERS, in the GCC (Gulf Cooperation Council) states , as appropriate, prior to regulatory approval in such countries and to have Interferon alfa-n3 (human leukocyte derived) approved by the regulatory authorities in each GCC country (Kingdom of Saudi Arabia, Bahrain, Qatar, Kuwait, United Arab emirates (UAE) and Sultanate of Oman)), and WHEREAS SCIEN has sales, marketing, distribution capabilities in the GCC states, and WHEREAS, AFTER A SUCCESSFUL CLINICAL TRIAL IN MERS, SCIEN affirms it has the ability to supply Interferon alfa-n3 (human leukocyte derived) in the GCC States prior to regulatory approval and simultaneously seek to gain regulatory approval in each of the GCC States. After the clinical trial in MERS has been conducted, in the event it is successful and the Hemispherx manufacturing site requires approved by the GCC / SFDA, the cost of any post-clinical trial inspection of the facility to be the responsibility of Scien or the regulatory authority, and subsequently to market, sell and distribute Interferon alfa-n3 (human leukocyte derived) in the GCC, and WHEREAS, SCIEN desires to supply Interferon alfa-n3 (human leukocyte derived) under special approval from the Saudi Ministry of Health and for other GCC states where applicable, and WHEREAS, HEMISPHERX desires to supply and sell Interferon alfa-n3 (human leukocyte derived)) to SCIEN, and SCIEN is willing to purchase Interferon alfa-n3 (human leukocyte derived) from HEMISPHERX for the purposes described in this agreement. NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows: I. DEFINITIONS \\\"Affiliate\\\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party. \\\"End User\\\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient. \\\"Field\\\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc. \\\"HEMISPHERX Intellectual Property\\\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement. \\\"List Price\\\" means ${***}/Product Unit. \\\"Product\\\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived). {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 1 of 28 \\\"Product Data\\\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory. \\\"Product Unit\\\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived) \\\"Sales Price\\\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit. \\\"Territory\\\" means the GCC States \\\"Transfer Price\\\" means a discounted price of ${***}/ Product Unit. II. LICENSE CONDITION PRECEDENT: THE GRANTING OF ANY AND ALL LICENSES OR PRIVILEGES HEREIN IS SUBJECT THE THE SUCCESSFUL COMPLETION OF A FIVE PERSON MINIMUM CLINICAL TRIAL IN THE KINGDOM OF SAUDI ARABIA TREATING EARLY ONSET PATIENTS INFECTED WITH MERS. A. Subject to the condition above, HEMISPHERX hereby grants SCIEN the exclusive license to sell, market, and distribute Product for use in the Field in the Territory for Direct Access/EAP and Regulatory Agency-Approved (RAA) purposes. B. SCIEN shall not use HEMISPHERX Intellectual Property nor sell nor permit the sale of any products that use the HEMISPHERX Intellectual Property outside the Territory or knowingly sell or have sold any products that use the HEMISPHERX Intellectual Property to any party in or outside the Territory for export or sale outside the Territory, without HEMISPHERX's prior written consent. C. SCIEN will have six 6) months after the date of this Agreement to Purchase at least 50 vials to be used by the MOH in treating patients with MERS. Scien will thereafter, based on the outcome of the initial treatment for MERS by the MOH trial, aggressively promote to all stakeholders in Saudi Arabia and the other GCC states(\\\"First Performance Milestone\\\"). III. COMMERCIAL DEVELOPMENT A. HEMISPHERX has or will provide SCIEN: 1. As an Integral Part of this Agreement and in order for HEMISPHERX to ship Product to SCIEN, the letter with attachments (Exhibit 1) must be signed by an officer of SCIEN. A protocol is also provided (Exhibit 2). 2. All the appropriate information about Products that will assist with the education of physicians about the Product in the Territory. 3. Ongoing scientific and medical support. 4. Product Units in quantities sufficient for SCIEN's Direct Access/EAP and RAA commercial needs in the Territory, subject to availability from HEMISPHERX. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 2 of 28 B. SCIEN will: 1. Within 60 days after this Agreement becomes effective, prepare and provide a Business Plan, to be attached to this Agreement as Exhibit 3, to make aware and educate physicians and patients about Product both prior to and following approval of Product. 2. Assist in determining reimbursable End User pricing of Product and gain reimbursement for Product under Direct Access/EAP program and RAA sales of the Product in the Territory. 3. Assist physicians who desire to administer Product with the required paperwork under any Direct Access/EAP program. 4. Manage the logistics within the Territory from arrival to End User supply. 6. Assist HEMISPHERX to gain regulatory approval of Product in the Field in the Territory 7. Prepare and provide a 3-year post regulatory approval Sales, Marketing, and Distribution Plan including a 3-year minimum sale forecast and a committed-dollar field sales force, product manager and marketing budget to be agreed by both Parties and a non-binding 12 month Product forecast no later than six (6) months prior to the anticipated registration and subsequent launch date for each Product, also to be agreed by both parties, 8. Pay for all the above Sales Marketing and Distribution activities and related expenses. 9. Hold 3 months inventory of the forecasted sales once the product is registered. 10. If needed, assist in recruiting clinical trial sites and principal investigators in the Field in the Territory. 11. Provide HEMISPHERX a monthly written report of SCIEN's efforts and status thereof under this Agreement. IV. SUPPLY A. Subject to the terms and conditions of this Agreement, HEMISPHERX agrees to exclusively supply Product to SCIEN in the Territory with a minimum expiry of 6 months from the date of shipment. B. The price that SCIEN will pay for Product under this Agreement is the Transfer Price, CIF. Taxes, duties, and other expenses to be paid by SCIEN. C. SCIEN shall pay HEMISPHERX for each order of Product within 75 days after receipt of the goods except for the for first purchase order which will be for 50 vials of Interferon alfa-n3 (human leukocyte derived) (\\\"First Order\\\") and paid once the MOH approves the use for Interferon alfa-n3 (human leukocyte derived) on 5 MERS patients. All purchase orders are final. D. SCIEN will ensure all necessary QA testing / approval for use occurs in the Territory and that each Product is stored under the conditions stipulated in a Quality Agreement (QA) to be executed and appended to this Agreement as Exhibit 4. E. Forecasts, Orders, Payment, and Delivery. Direct Access/EAP Distribution Following the signing of this Agreement, SCIEN will start a full and comprehensive market analysis of the potential of each Product for Direct Access/ EAP distribution. This will be from a market potential and willingness to pay point of view and will be completed within 3 months of the signature of this Agreement. A forecast will then be provided for Product for Direct Access/ EAP distribution and this will be added as a supplement to the Business Plan (Exhibit 3). {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 3 of 28 RAA Distribution Six (6) months prior to the estimated regulatory approval for commercial sale of Product in each country in the Territory: 1. SCIEN will provide HEMISPHERX a rolling 12-month forecast of the estimated sales of Product Units, the first 3 months of which will be firm and the second three (3) months of which cannot vary by more than 25% when these become the first three (3) months. This forecast will be updated at 3-month intervals thereafter. 2. In accordance with this forecast, SCIEN agrees to order Product from HEMISPHERX under this Agreement by submitting to HEMISPHERX written purchase orders specifying the quantity, packaging, delivery dates, and delivery location. 3. HEMISPHERX shall manufacture Product as described in the purchase order from SCIEN and HEMISPHERX shall make all shipments to the location specified on SCIEN's purchase order as follows: 4. Hemispherx shall pack, mark and ship Products in accordance with temperature thermometer specifications for the drug product. Hemispherx shall package Products so as to prevent damage or deterioration and shall comply with all applicable temperature and packaging laws. Unless otherwise stipulated, Products shall be packaged, marked, crated and otherwise prepared in accordance with HEMISPHERX's current packaging and crating practices, and good commercial practices. 5. SCIEN will prominently display on all Product that the Product is a product of HEMISPHERX and be so noted and on a visible surface thereof and/or on tags, labels, manuals, and other materials with which Product is sold, the fact that the Product is manufactured and supplied to SCIEN by HEMISPHERX for use and/or sale in the Territory shall be clearly displayed. F. If, for any reason, at any time, HEMISPHERX shall be unable, or should reasonably anticipate being unable to deliver any part or all of the ordered Product in accordance with the terms hereof or the accompanying purchase order, HEMISPHERX shall notify SCIEN of such inability at the earliest possible time (but no later than five (5) workings after HEMISPHERX becomes aware of this their inability to supply Product, whereupon HEMISPHERX and SCIEN will devise a plan to manage the situation. G. HEMISPHERX warrants that the Product (i) shall conform to the specifications set out in the SCIEN purchase order for Product and (ii) shall meet all, if any, reasonably applicable regulatory requirements in the Territory once Product is approved. In the Direct Access/ EAP setting, the Product that HEMISPHERX supplies must confirm with all manufacturing and regulatory requirements (including labelling) for the country in which said Product is intended to be sold. SCIEN's acceptance of the Product shall relieve HEMISPHERX from the obligations arising from this warranty H. SCIEN shall have the right to return and demand replacement of any Product which violates this warranty. I. HEMISPHERX and/or SCIEN shall have the right to cancel, without further obligation to the other party, one or more orders for Product(s) if HEMISPHERX's or SCIEN's business is interrupted because of an event of force majeure beyond the control of HEMISPHERX or SCIEN. J. HEMISPHERX shall permit SCIEN or its agent, at SCIENs' expense, to conduct periodic audits of HEMISPHERX's Quality System and Manufacturing records relating to HEMISPHERX's performance under this Agreement. The audits shall be conducted upon reasonable advance notice during regular business hours at HEMISPHERX's principal office and in such a manner as not to unduly interfere with HEMISPHERX's operations. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 4 of 28 K. SCIEN will provide HEMISPHERX with copies of Product specification sheets, Product inserts, user manuals, user bulletins, and user Product updates and any other customer materials such as brochures, educational materials, web pages or other electronic information relating to SCIEN's efforts to sell, market and distribute Product under this Agreement at least 10 (ten) days prior to the public release or use of such information. V. REPORTS AND PAYMENTS A. Within 30 days following the end of each calendar quarter after execution of the Agreement, SCIEN will provide HEMISPHERX with quarterly reports on the number of Product Units sold and the Sales Price during the preceding three months, key market place issues and successes, regulatory and reimbursement subjects and revisions to the sales and marketing plans. B. Product (s) will be considered sold by SCIEN on the date it is shipped or invoiced to an End User, whichever is earlier. All shipping, taxes, duties and other expenses in the Territory is the responsibility of SCIEN. C. Price Increase: Beginning on the second year anniversary of the signing of this Agreement (\\\"Effective Date\\\") and on each succeeding anniversary of the Effective Date during the term of this agreement and in consideration of a varies of economic factors such as for example, costs of labour, costs of material and costs the price paid by SCIEN for Product(s) shall be renegotiated. Any price increase will need to be justified by HEMISPHERX. Both parties shall, in good faith, attempt to agree upon a reasonable price increase. In the event agreement cannot be reached the Agreement shall terminate. D. All payments hereunder will be made by SCIEN in United States Dollars by wire transfer of immediately available funds to an account designated by HEMISPHERX. The following is wire transfer information: Domestic (U.S.): {***} International: {***} VI. TERM/TERMINATION A. The Term will be 3 years from Effective Date with an automatic 2 year term extensions unless otherwise advised by one of the Parties. B. Termination for breach will include: 1. Failure to purchase Product and distribute to End Users as called for in II D. 2. Failure of SCIEN achieving less than 50% achievement of the minimum Purchases as in III B.7. for two (2) consecutive years, 3. Insolvency, or the filing for protection under either Party's bankruptcy laws. Upon the filing of a petition in bankruptcy, insolvency or reorganization against or by either Party, or either Party becoming subject to a composition for creditors , whether by law or agreement, or either party going into receivership or otherwise becoming insolvent (such party hereinafter referred to as the \\\"insolvent party\\\"), this Agreement may be terminated by the other Party by giving written notice of termination to the insolvent Party, such termination immediately effective upon the giving of such notice of termination. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 5 of 28\"}, {\"id\": \"C\", \"title\": \"Upon the occurrence of a breach or default as to any obligation hereunder by either Party and the failure of the breach\", \"level\": 1, \"text\": \"C. Upon the occurrence of a breach or default as to any obligation hereunder by either Party and the failure of the breaching Party to cure (within thirty (30) days after receiving written notice thereof from the non-breaching Party) such breach or default, this Agreement may be terminated by the non- breaching Party by giving written notice of termination to the breaching Party, such termination being immediately effective upon the giving of such notice of termination. D. In the event this Agreement is terminated by either Party for any reason whatsoever, HEMISPHERX agrees to reasonable efforts to make Product available to SCIEN for a period of three (3) months after the termination date at the same Transfer Price and under the same terms of payment. E. In the event of termination of this Agreement, SCIEN will have the right to complete all contracts for the sale or disposition of Product) under which SCIEN is obligated on the date of termination, provided SCIEN pays the associated Transfer Price and provided all such sales or dispositions are completed within three (3) months after the date of termination. Thereafter, HEMISPHERX shall purchase from the SCIEN all remaining stock of Product that is of merchantable quality at the same price as was paid by SCIEN. VII. ASSIGNMENT Neither this Agreement nor any rights or obligations or licenses hereunder may be assigned, pledged, transferred or encumbered by either party without the express prior written approval of the other party, except that either HEMISPHERX or SCIEN may assign this Agreement to any successor by merger or sale of substantially all of its business or assets to which this Agreement pertains, without any such consent. Any assignment in violation hereof is void. VIII. AUTHORITY SCIEN and HEMISPHERX each warrant and represent that it has the full right and power to make the promises set forth in this Agreement and that there are no outstanding agreements, assignments, or encumbrances inconsistent with the provisions of this Agreement. IX. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION IX, HEMISPHERX MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, REGARDING THE DEVELOPMENT, VIABILITY, COMMERCIAL OR OTHER USEFULNESS OR SUCCESS OF PRODUCT) AND THAT NO WARRANTY OR REPRESENTATION THAT ANYTHING MADE, USED, SOLD OR OTHERWISE PRACTICED OR ANY SERVICE PROVIDED UNDER THIS AGREEMENT WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADE SECRET, OR OTHER PROPRIETARY RIGHT, FOREIGN OR DOMESTIC, OF ANY THIRD PARTY AND MAKES NO WARRANTIES OR REPRESENTATIONS AS TO THE VALIDITY, ENFORCEABILITY OR SCOPE OF ANY HEMISPHERX INTELLECTUAL PROPERTY. X. INDEMNIFICATION AND WARRANTIES A. INDEMNIFICATION SCIEN and HEMISPHERX (each an \\\"Indemnifying Party\\\") shall indemnify, defend and hold harmless and the other Party's subsidiaries or affiliates, their agents, directors, officers, employees and assigns (the \\\"Indemnified Parties\\\") from and against all losses, liabilities, damages, demands and expenses (including reasonable attorneys' fees and expenses) arising out of, as a result of, or in connection with (i) the negligent actions of the Indemnifying Party, its employees or any third party acting on behalf of or under authority of the Indemnifying Party in the performance of this Agreement and/or (ii) the violation of any representation or warranty of Indemnifying Party in this Agreement. Each Party's obligations under this provision shall be subject to the other Party providing reasonable notice of any such claim. Each Party shall defend with competent counsel and pay all costs of defence, including attorneys' fees, and any and all damages and court costs awarded in respect to such claim, action or proceeding regarding the claim of infringement. The Indemnified Parties agree to permit the Indemnifying Party to defend, compromise, or settle any such claim, action or proceeding and further agree to provide all available information, and reasonable assistance to enable the other Indemnifying Party to do so. However, neither party will be liable under this indemnity for any losses, liabilities, damages, demands or expenses arising out of the gross negligence or wilful misconduct of the other party or any of its affiliates, agents, directors, officers, employees or assigns. Limitation of Liability. IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES RESULTING FROM THE LICENSE GRANTED PURSUANT TO THIS AGREEMENT OR THE USE OR COMMERCIAL DEVELOPMENT OF PRODUCT. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 6 of 28 B. WARRANTIES Subject as herein provided HEMISPHERX warrants to SCIEN that: \u00b7 All Product(s) supplied hereunder will comply with the Dossier and with any specification agreed for them in the Quality Agreement; \u00b7 It is not aware of any rights of any third party in the Territory which would or might render the sale of the Product, or the use of any of the Trademarks on or in relation to the Products, unlawful; \u00b7 It is the owner or the permitted licensee of all Intellectual Property Rights and it is not aware of any claims of any third party in the Territory or worldwide related to the fact that the Products infringes any intellectual property of such third party. \u00b7 Nothing in this Agreement shall exclude either party's liability for death or personal injury. Subject to the above WARRANTIES, HEMISPHERX shall indemnify and hold harmless SCIEN and its respective employees from any loss, damage or claim made by a third party in respect of (i) the death or personal injury arising from the manufacture or use of the Products in the Territory or (ii) infringement of third party intellectual property, if and to the extent such loss, damage or claim is caused by any act or omission of HEMISPHERX and is not attributable directly or indirectly to the breach of any of the material terms of this Agreement by SCIEN or by any wilful default or negligent act or omission of SCIEN, its employees or its agents. 1. The indemnity given by HEMISPHERX shall be subject to the following conditions: \u00b7 No indemnity shall be claimed unless notice is given by SCIEN claiming the indemnity to HEMISPHERX together with details of the claim promptly on notice of such claim being received by the SCIEN; \u00b7 No admissions of liability or compromise or offer of settlement of any claim shall be made by SCIEN without the prior written consent of HEMISPHERX; and \u00b7 HEMISPHERX shall have full control over any claim, proceedings or settlement negotiations in respect of which it is providing the indemnity. Subject to clause X.B 1.), SCIEN shall defend and indemnify HEMISPHERX and its Affiliates and hold each of them harmless against all claims, demands, actions, losses, expenses, damages, liabilities, costs (including interest, penalties and reasonable attorneys' fees) and judgements suffered by each of them, which arise out of SCIEN's negligent or wilful acts or omissions or which otherwise arise out of SCIEN's breach of the Agreement. Survivability. The obligations set forth in this Section X. shall survive the termination of this Agreement for the legal periods of limitation provided by US law. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 7 of 28\"}, {\"id\": \"XI\", \"title\": \"CONFIDENTIALITY A\", \"level\": 1, \"text\": \"XI. CONFIDENTIALITY A. SCIEN and HEMISPHERX agree to keep secret and confidential all confidential, proprietary or non-public information (\\\"Confidential Information\\\") of the other Party .This provision shall survive termination or expiration of this Agreement. B. Such Confidential Information will be kept confidential until 5 years after the expiration of termination of this Agreement. Notwithstanding the foregoing , Confidential Information of a Party shall not include information which the other Party can establish by written documentation was (a) to have been publicly known prior to disclosure of such information by the disclosing Party to the other Party, (b) to have become publicly known, without fault on the part of the other Party, subsequent to disclosure of such information by the disclosing Party to the other Party, (c) to have been received by the other Party at any time from a source , other than the disclosing Party, rightfully having possession of and the right to disclose such information, (d) to have been otherwise known by the other Party prior to disclosure of such information by the disclosing Party to the other Party, or (e) to have been independently developed by employees or agents of the other Party without access to or use of such information disclosed by the disclosing Party to the other Party. C. The confidentiality obligations contained in this section XI shall not apply to the extent that the receiving Party (the \\\"Recipient\\\") is required (a) to disclose information by law, order or regulation of a governmental agency or a court of competent jurisdiction , or (b) to disclose information to any governmental agency for purposes of obtaining approval to test or market a Product , provided in either case that the Recipient shall provide written notice thereof to the other Party and sufficient opportunity to object to any such disclosure or to request confidential treatment thereof. XII. PROSECUTION, INFRINGEMENT, AND DEFENSE OF HEMISPHERX INTELLECTUAL PROPERTY A. HEMISPHERX will be responsible for and shall control, at its expense, the preparation, filing, prosecution and maintenance of HEMISPHERX Intellectual Property. B. SCIEN will cooperate in all reasonable ways to establish and protect HEMISPHERX Intellectual Property in the Territory. C. HEMISPHERX, at its expense, will have the right to determine the appropriate course of action to enforce its HEMISPHERX Intellectual Property against infringement or otherwise abate the infringement thereof , to take (or refrain from taking) appropriate action to enforce its HEMISPHERX Intellectual Property, to control any litigation or other enforcement action and to enter into, or permit, the settlement of any such litigation or other enforcement action with respect to its Intellectual Property . D. Each Party shall promptly notify the other Party in writing if any claim, action, demand or other proceeding (a \\\"Claim\\\") is brought against or is threatened to be brought against such Party alleging that the sale of Product violates another party's intellectual property. E. SCIEN will promptly notify HEMISPHERX of any Third party SCIEN knows or believes may be infringing HEMISPHERX Intellectual Property and will, to the greatest extent reasonably possible, provide to HEMISPHERX any information SCIEN has in support of such belief. HEMISPHERX will have the right, but not the obligation, to use such information in an infringement action against such third Party. SCIEN agrees to cooperate with HEMISPHERX in any action for infringement of HEMISPHERX, and HEMISPHERX will reimburse SCIEN for all reasonable costs incurred by it in providing cooperation requested by HEMISPHERX. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 8 of 28 F. HEMISPHERX is and shall remain the sole legal and registered owner for any trademark or trade name of \\\"Interferon alfa-n3 (human leukocyte derived)\\\". The parties shall work together, upon commercial approval in the Territory to secure a trade name in the Territory. G. HEMISPHERX hereby grants to SCIEN and SCIEN hereby accepts the right, privilege and exclusive license to use of \\\"Interferon alfa-n3 (human leukocyte derived)\\\" solely in connection with the terms of the Sales, Marketing, Distribution and Supply Agreement of Product in the Territory for the Term of this Agreement. Should the Agreement expire or terminate, the right to use the trademark shall also terminate. SCIEN shall use \\\"Interferon alfa-n3 (human leukocyte derived)\\\" at all times for the sole purpose of marketing of Product for no other purpose. H. The terms of the intellectual property license hereby granted shall be effective upon the Effective Date of this Agreement and during the term of this Agreement, unless sooner terminated in accordance with the provisions of the Sales, Marketing, Distribution and Supply Agreement between the parties. 1. Good Will. SCIEN recognizes that there exists great value and good will associated with the Intellectual Property of Interferon alfa-n3 (human leukocyte derived)\\\" 2. SCIEN agrees that it will not during the term of this Agreement, or thereafter, attack the title or any rights of HEMISPHERX in and to Interferon alfa-n3 (human leukocyte derived) or attack the validity of the license granted herein by HEMISPHERX and solely owned by HEMISPHERX. I. SCIEN agrees to assist HEMISPHERX to the extent necessary in the procurement of any protection or to protect any of HEMISPHERX's right to Interferon alfa-n3 (human leukocyte derived) and HEMISPHERX, if it so desires, may commence or prosecute any claims or suits in its own name or in the name of SCIEN or join SCIEN as a party thereto. SCIEN shall notify HEMISPHERX in writing of any infringements or imitations by others of \\\"Interferon alfa-n3 (human leukocyte derived) which may come to SCIEN 's attention, and HEMISPHERX shall have the sole right to determine whether or not any action shall be taken on account of any such infringements or imitations. SCIEN shall not institute any suit or take any action on account of any such infringements or imitation without first obtaining the written consent of the HEMISPHERX so to do. J. SCIEN agrees to cooperate fully and in good faith with HEMISPHERX for the purpose of securing and preserving HEMISPHERX's rights. K. It is agreed that nothing contained in this Sales, Marketing, Distribution, and Supply Agreement shall be construed as an assignment or grant to the SCIEN of any rights, title or interest in or to \\\"Interferon alfa-n3 (human leukocyte derived)\\\". L. It is further understood that all rights relating thereto are reserved by HEMISPHERX, except for the license hereunder to SCIEN of the right to use and utilize the name Interferon alfa-n3 (human leukocyte derived) only as specifically and expressly provided in this Agreement. M. In the event of termination of this license for any reason, SCIEN shall within 6months (as described in the Termination clause), cease all use of the \\\"Interferon alfa-n3 (human leukocyte derived)\\\". SCIEN shall not thereafter use any names, mark or trade name similar thereto belonging to HEMISPHERX. Termination of the license under the provisions of this Agreement shall be without prejudice to any rights which HEMISPHERX may otherwise have against SCIEN. N. SCIEN shall, and shall cause its shareholders, officers, directors, and managing personnel to, comply with all laws, rules and government regulations pertaining to its business and shall not violate any laws which would create an adverse effect on \\\"Interferon alfa-n3 (human leukocyte derived)\\\" in the U.S. and/or the Territory. O. Relationship of Parties. SCIEN shall not in any manner or respect be the legal representative or agent of HEMISPHERX and shall not enter into or create any contracts, Agreements, or obligations on the part of HEMISPHERX, either expressed or implied, nor bind HEMISPHERX in any manner or respect whatsoever regarding its intellectual property; it being understood that this Agreement is only a contract for the licensed use of the product names in connection with the terms in this Agreement. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 9 of 28\"}, {\"id\": \"XIII\", \"title\": \"BUYOUT HEMISPHERX will have the option at any time to buy out this Agreement\", \"level\": 1, \"text\": \"XIII. BUYOUT HEMISPHERX will have the option at any time to buy out this Agreement. If exercised within the first two (2) years HEMISPHERX will pay SCIEN three (3) times the Product sales for the preceding 12 months. If exercised after year 3, HEMISPHERX will pay SCIEN two (2) times the Product sales for the preceding 12 months. XIV. MISCELLANEOUS. A. Notices. Notices sent pursuant to this Agreement are valid if in writing and addressed to the parties at the respective addresses given below or at such other addresses as either party shall notify the other in writing and sent by registered or certified mail, postage prepaid and return receipt requested, or by Federal Express or other comparable courier providing proof of delivery, and shall be deemed duly given and received (i) if mailed, on the third business day following the mailing thereof, or (ii) if sent by courier, the date of its receipt (or if not on a business day, the next succeeding business day). If to HEMISPHERX: Thomas K. Equels, President and CEO One Penn Center 1617 JFK Boulevard Suite 500 Philadelphia, PA 19103 United States If to SCIEN: Abdelrhman Mofeed Zhreldin Business Development Manager Scientific Products Pharmaceutical Co. Ltd Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia B. This Agreement and the transactions contemplated herein shall be governed by, and construed in accordance with, the laws of the State of Delaware, USA and disputes, if not resolved by the Parties, will be settled by binding arbitration in and under the rules of arbitration in London, England. C. This Agreement constitutes the entire understanding of the parties with respect to the purchase and sale of Products and supersedes all prior discussions, agreements, and understandings between HEMISPHERX and SCIEN. D. Each party an independent contractor to the other and the relationship between the parties shall not be construed to be that of an employer and employee, or to constitute a partnership, joint venture, or agency of any kind. E. This Agreement may only be amended in a writing signed by both parties hereto. F. If any provision of this Agreement is declared invalid or unenforceable by a court having competent jurisdiction, it is mutually agreed that this Agreement shall endure except for the part declared invalid or unenforceable by order of such court. G. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 10 of 28 H. Prior to their release, the parties must agree on press releases or market communication that utilises the other Party's name. Counterparts; Integration; Effectiveness; Electronic Execution This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. This Agreement shall become effective when it shall have been executed by all parties and upon receipt of all counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by e- mail and/or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. The words \\\"execution,\\\" \\\"signed,\\\" \\\"signature,\\\" and words of like shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper- based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, and any other similar State laws based on the Uniform Electronic Transactions Act. IN WITNESS WHEREOF, the parties have executed this Agreement as of the last date below and in so doing acknowledge that they have a corporate authority to bind their respective organizations to this Agreement. SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD: HEMISPHERX BIOPHARMA, INC: S/ Saleh Al-Abdullah Al-Rasheed S/ Thomas K. Equels Saleh Al-Abdullah Al-Rasheed Thomas K. Equels CEO & Owner President and CEO Date: Date: 3-29-2016 3-31-16 {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 11 of 28\"}, {\"id\": \"Exhibit 1\", \"title\": \"The drug, Interferon Alfa-n3, is intended for investigational use in the countries in which it is distributed prior to receipt of RAA; The drug, Interferon Alfa-n3, meets your specifications as reflected on the attached Certificate of Analysis; The drug, Interferon Alfa-n3, is not in conflict with the laws of the countries in which it is distributed; The investigation will be conducted in accordance with good clinical practices, including review and approval of the study by an independent ethics panel and informed consent of the study subjects; The drug, Interferon Alfa-n3, does not present an imminent hazard to public health, either in the United States, if the drug were to be reimported, or in the countries in which it is distributed; The drug, Interferon Alfa-n3, is labelled in accordance with the laws of the countries in which it is distributed. I have reviewed the attached labels and the current Certificate of Analysis against the specifications and agree with the above statements that these meet the laws of the countries in which the product will be distributed. Signature: __________________________________ Date: ______________________ Printed Name: Saleh Al- Rashid Title: Chairman and CEO Company: Scientific Products Pharmaceutical Co. LTD\", \"level\": 1, \"text\": \"Exhibit 1 The drug, Interferon Alfa-n3, is intended for investigational use in the countries in which it is distributed prior to receipt of RAA; The drug, Interferon Alfa-n3, meets your specifications as reflected on the attached Certificate of Analysis; The drug, Interferon Alfa-n3, is not in conflict with the laws of the countries in which it is distributed; The investigation will be conducted in accordance with good clinical practices, including review and approval of the study by an independent ethics panel and informed consent of the study subjects; The drug, Interferon Alfa-n3, does not present an imminent hazard to public health, either in the United States, if the drug were to be reimported, or in the countries in which it is distributed; The drug, Interferon Alfa-n3, is labelled in accordance with the laws of the countries in which it is distributed. I have reviewed the attached labels and the current Certificate of Analysis against the specifications and agree with the above statements that these meet the laws of the countries in which the product will be distributed. Signature: __________________________________ Date: ______________________ Printed Name: Saleh Al- Rashid Title: Chairman and CEO Company: Scientific Products Pharmaceutical Co. LTD {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 12 of 28 Certificate of Analysis {***} {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 13 of 28 Label information enlarged for ease of read. {***} Enlarged Label: {***} Caution: Limited by Federal (US) Law to Investigational Use. Manufactured For: Hemispherx Biopharma, Inc. Philadelphia, PA 19103 (U.S.A.) Actual Label: {***} {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 14 of 28\"}, {\"id\": \"Exhibit 2\", \"title\": \"Study Protocol Synopsis A Compassionate Use Protocol Using Natural Leukocyte Interferon (Alfa-n3) for Individual Treatment of Symptomatic Patients with Middle East Respiratory Syndrome (MERS) {***}\", \"level\": 1, \"text\": \"Exhibit 2 Study Protocol Synopsis A Compassionate Use Protocol Using Natural Leukocyte Interferon (Alfa-n3) for Individual Treatment of Symptomatic Patients with Middle East Respiratory Syndrome (MERS) {***} {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 15 of 28\"}, {\"id\": \"Exhibit 3\", \"title\": \"Business Plan\", \"level\": 1, \"text\": \"Exhibit 3 Business Plan {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 16 of 28\"}, {\"id\": \"Exhibit 4\", \"title\": \"TECHNICAL / QUALITY AGREEMENT 1. Parties This Quality Agreement is entered by and between Scientific Products Pharmaceutical Co. LTD., a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\\\"SCIEN\\\") and Hemispherx Biopharma, Inc. 783 Jersey Avenue, New Brunswick, New Jersey 08901(HEMISPHERX). 2. Purpose The purpose of this Quality Agreement is to clearly define the quality operating procedures, duties and responsibilities to be employed by SCIEN and HEMISPHERX in the conduct of activities by SCIEN for Hemispherx Biopharma, Inc. The objective of these procedures and this Quality Agreement is assurance that services are conducted in a timely, consistent and uniform manner and in accordance with current laws, directives, regulations and guidelines, as may be applicable to the specific project(s). These requirements may include those defined by the U.S. FDA's regulations At 21CFR314.80 (Post-marketing reporting of adverse drug experiences for drugs), 21CFR312.32 (IND safety reporting) 21CFR600.80 (Post marketing reporting of adverse experiences for biologics) 21CFR Parts 210 and 211 (\\\"current Good Manufacturing Practices\\\" or \\\"cGMPs\\\") with particular interest in 21CFR211.1.42 (Warehousing), 21CFR211.150 (Distribution), 21CFR211.204 (Returned drug) and 21CFR211.208 (Drug product salvaging), ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance and/or others that may be appropriate for the particular project. 3. Scope This Quality Agreement is to be applied to the activities performed by SCIEN, for HEMISPHERX as specifically defined by the Sales, Marketing, Distribution, and Supply Agreement January ___, 2016 (\\\"Agreement\\\") to which this Quality Agreement is an integral Exhibit. In the event of a conflict between the terms of the Agreement and this Quality Agreement, the terms of the Agreement shall control. Unless otherwise stated in these documents, SCIEN shall follow its Standard Operating Procedures (\\\"SOPs\\\") with respect to the activities it shall carry out in accordance with the Agreement. Copies of all relevant SOPs shall be provided to HEMISPHERX for review during audits. 4. Confidentiality The information and procedures contained in this Quality Agreement are confidential and subject to the terms and conditions of the confidentiality provisions as set forth in the Confidential Disclosure Agreement September 22, 2014 (\\\"CDA\\\") executed by HEMISPHERX and SCIEN. 5. Terms This Agreement between HEMISPHERX and SCIEN shall be in effect beginning the last date of execution set forth on the signature page to the Agreement (the \\\"Effective Date\\\") to which this Quality Agreement is Exhibit 2 and remain in effect until HEMISPHERX and SCIEN terminate the Agreement or it is superseded by a revised Quality Agreement executed by both parties. This Quality Agreement should be reviewed periodically by both parties for any needed updating, revisions, amendments, and the like. Regular periodic review of this Quality Agreement should be conducted to ensure it is up-to-date.\", \"level\": 1, \"text\": \"Exhibit 4 TECHNICAL / QUALITY AGREEMENT 1. Parties This Quality Agreement is entered by and between Scientific Products Pharmaceutical Co. LTD., a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\\\"SCIEN\\\") and Hemispherx Biopharma, Inc. 783 Jersey Avenue, New Brunswick, New Jersey 08901(HEMISPHERX). 2. Purpose The purpose of this Quality Agreement is to clearly define the quality operating procedures, duties and responsibilities to be employed by SCIEN and HEMISPHERX in the conduct of activities by SCIEN for Hemispherx Biopharma, Inc. The objective of these procedures and this Quality Agreement is assurance that services are conducted in a timely, consistent and uniform manner and in accordance with current laws, directives, regulations and guidelines, as may be applicable to the specific project(s). These requirements may include those defined by the U.S. FDA's regulations At 21CFR314.80 (Post-marketing reporting of adverse drug experiences for drugs), 21CFR312.32 (IND safety reporting) 21CFR600.80 (Post marketing reporting of adverse experiences for biologics) 21CFR Parts 210 and 211 (\\\"current Good Manufacturing Practices\\\" or \\\"cGMPs\\\") with particular interest in 21CFR211.1.42 (Warehousing), 21CFR211.150 (Distribution), 21CFR211.204 (Returned drug) and 21CFR211.208 (Drug product salvaging), ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance and/or others that may be appropriate for the particular project. 3. Scope This Quality Agreement is to be applied to the activities performed by SCIEN, for HEMISPHERX as specifically defined by the Sales, Marketing, Distribution, and Supply Agreement January ___, 2016 (\\\"Agreement\\\") to which this Quality Agreement is an integral Exhibit. In the event of a conflict between the terms of the Agreement and this Quality Agreement, the terms of the Agreement shall control. Unless otherwise stated in these documents, SCIEN shall follow its Standard Operating Procedures (\\\"SOPs\\\") with respect to the activities it shall carry out in accordance with the Agreement. Copies of all relevant SOPs shall be provided to HEMISPHERX for review during audits. 4. Confidentiality The information and procedures contained in this Quality Agreement are confidential and subject to the terms and conditions of the confidentiality provisions as set forth in the Confidential Disclosure Agreement September 22, 2014 (\\\"CDA\\\") executed by HEMISPHERX and SCIEN. 5. Terms This Agreement between HEMISPHERX and SCIEN shall be in effect beginning the last date of execution set forth on the signature page to the Agreement (the \\\"Effective Date\\\") to which this Quality Agreement is Exhibit 2 and remain in effect until HEMISPHERX and SCIEN terminate the Agreement or it is superseded by a revised Quality Agreement executed by both parties. This Quality Agreement should be reviewed periodically by both parties for any needed updating, revisions, amendments, and the like. Regular periodic review of this Quality Agreement should be conducted to ensure it is up-to-date. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 17 of 28 HEMISPHERX may perform audits for initial qualification of SCIEN as well as periodic audits and \\\"for cause\\\" audits. At mutually agreed upon times, HEMISPHERX may review standard operating and other quality control procedures and records and the records of SCIEN relating to the Agreement. Such routine and general oversight review is to be requested at least twenty (20) business days in advance, limited to two (2) persons, completed within one (1) to two (2) business days and shall be offered to HEMISPHERX one (1) time each calendar year. SCIEN will make every reasonable effort to accommodate the special circumstances that may arise pursuant to \\\"for cause\\\" audits. The following applies to all audits: \u00b7 Prior to an audit HEMISPHERX will communicate to SCIEN the scope of the audit. \u00b7 HEMISPHERX will prepare a written report of the results of the audit and forward a copy to SCIEN. SCIEN will provide a written response to HEMISPHERX's written audit report within twenty (20) business days of receipt of such report setting forth the corrective actions to be taken by SCIEN, if any, and a timeline for such implementation. In the event of an inspection by any governmental or regulatory authority concerning the activities carried out under the Agreement, SCIEN shall notify HEMISPHERX promptly upon learning of such an inspection, shall supply HEMISPHERX with copies of any correspondence or portions of correspondence relating to HEMISPHERX's materials and shall inform HEMISPHERX of the general findings and outcomes of such inspections. SCIEN and HEMISPHERX shall cooperate with each other during any such inspection, investigation or other inquiry, including applying reasonable effort, as might be practical, at allowing, upon reasonable request, a representative of HEMISPHERX to be on site during such inspection, investigation or other inquiry, and providing copies of all documents related to the inspection. Each party acknowledges that it may not direct the manner in which the other party fulfills its obligations to permit inspection by governmental entities 6. Dispute Resolution If a dispute arises between the parties under this Agreement, the parties agree that, prior to either pursuing other available remedies, decision- making individuals from each party will promptly meet, either in person or by telephone, to attempt in good faith to negotiate a resolution of the dispute. If, within sixty days after such meeting, the parties are unable to resolve the dispute (or such longer time as the parties may agree) either party is free to pursue its legal remedies. 7. Definitions Adverse experience: Any adverse event associated with the use of a biological or drug product in humans, whether or not considered product related, including the following: an adverse event occurring in the course of the use of a biological or drug product in professional practice; an adverse event occurring from overdose of the product whether accidental or intentional; an adverse event occurring from abuse of the product; an adverse event occurring from withdrawal of the product; and any failure of expected pharmacological action. Disability: A substantial disruption of a person's ability to conduct normal life functions. Life-threatening adverse experience: Any adverse experience that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse experience as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death. Labeled event: An adverse experience that is listed on the product insert as having been observed in patients who are receiving the drug product. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 18 of 28 Drug Product: A finished dosage form, for example, tablet, capsule, or solution that contains an active ingredient generally, but not necessarily, in association with inactive ingredients Serious adverse experience: Any adverse experience occurring at any dose that results in any of the following outcomes: Death, a life-threatening adverse experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a serious adverse experience when, based upon appropriate medical judgment, they may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition. Unexpected adverse experience: Any adverse experience that is not listed in the current labelling for the biological or drug product. This includes events that may be symptomatically and pathophysiologically related to an event listed in the labelling, but differ from the event because of greater severity or specificity. For example, under this definition, hepatic necrosis would be unexpected (by virtue of greater severity) if the labeling only referred to elevated hepatic enzymes or hepatitis. Similarly, cerebral thromboembolism and cerebral vasculitis would be unexpected (by virtue of greater specificity) if the labeling only listed cerebral vascular accidents. \\\"Unexpected,\\\" as used in this definition, refers to an adverse experience that has not been previously observed (i.e., included in the labeling) rather than from the perspective of such experience not being anticipated from the pharmacological properties of the pharmaceutical product. Call report: A list of all questions, requests for circulars, and physician/patient complaints received by SCIEN's Clinical Support Department is prepared monthly by SCIEN staff and is forwarded to HEMISPHERX RA/QA Department. Audit: A systematic examination of processes, controls and systems, operating procedures, reports, records and/or data to assess SCIEN's compliance with standards, regulatory submissions, SOPs; applicable laws, regulations, directives, standards and guidelines; the terms of this Agreement and other contracts in place defining the services being provided and to verify data integrity. Good Clinical Practices (\\\"GCPs\\\"): Good clinical practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety, and wellbeing of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible. ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance. Good Manufacturing Practices (\\\"GMPs\\\"): The recognized pharmaceutical regulations and requirements of regulatory authorities such as those defined by the U.S. FDA's regulations at 21CFR Parts 210 and 211. Key Contacts: Persons at SCIEN and HEMISPHERX assigned to assure proper communication and follow-up in a timely manner within both parties' organizations. Names, titles and full contact information for Key Contacts shall be appended to this Agreement as Attachment 1 and should be maintained up-to-date during the course of the project. Observation: A statement of fact made during an audit that is substantiated by objective evidence. HEMISPHERX categorizes observations as follows: o Critical: May pose risk to patient or consumer or otherwise compromise the integrity or quality of the material, product, process, or service being provided. Other instances that could be defined as a critical observation include: A practice that poses an immediate safety risk to personnel; Quality System(s) missing or not in compliance with regulations, guidelines, or corporate policies. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 19 of 28 o Major: Does not fully comply with regulations, guidelines or corporate policies and may pose unnecessary risks to the integrity or quality of material, product, process or service being provided. Other instances that could be defined as a major observation include: Likely or probable safety risk to personnel; Quality System(s) weak or needing improvement; repeated Minor deficiencies of a similar nature that indicate a systemic problem and therefore may be classified as Major. o Minor: Does not comply with regulations, guidelines, or corporate policies but does not directly impact the integrity or quality of the material, product, process, or service being provided. o Comment: Compliant with regulations, guidelines and/or corporate policies; however, the auditor comment serves as a recommendation relative to maintaining or improving a specific condition noted. Out-of-Specification / Out-of-Trend (\\\"OOS / \\\"OOT\\\"): A result that is not within the established specifications or trend, whether these are qualitative or quantitative. Standard Operating Procedures (\\\"SOPs\\\"): Procedures in effect at SCIEN that define the processes and controls by and under which activities are to be conducted to assure compliance with the appropriate Code of Federal Regulations. 7. Communications To assure proper communication, notification and follow-up in a timely manner by both parties, \\\"Key\\\" contacts are listed in Attachment 1 of this Agreement. Key contacts shall have access to project managers and technical staff and, upon reasonable notice and as required, facilitate resolution of any issues. Every effort will be made by SCIEN to accommodate timely communications, including face-to-face meetings, with HEMISPHERX. 8. Change of Control SCIEN will maintain and follow change control SOP(s) to ensure that changes to equipment, procedures, processes, etc. occur in a controlled manner and in compliance with requirements e defined by the U.S. FDA's regulations (see Section 2). The implementation of any change that may directly impact the integrity of the activities conducted or data being supplied for HEMISPHERX will require prior written approval of HEMISPHERX. SCIEN and HEMISPHERX will advise the appropriate organization's staff member (See Attachment 1) before implementation of a change, by either party, to equipment, procedures, specifications, processes, clinical protocols, product claims or facilities directly related to HEMISPHERX's specific products and processes. Each party agrees to review the proposed change in a timely manner and, at its discretion, may audit and/or request an alternative or additional change prior to the implementation of the proposed change. The respective party will review the proposed change, determine if it is reasonably practicable to implement the change and can suggest alternative or additional changes prior to the implementation of the proposed change. Change control requirements should be articulated within the specific operation's documentation practices. HEMISPHERX is responsible for assuring changes are in accordance with and/or reported to the investigational, marketing and/or any other filing with regulatory agencies (IND, IMPD, CTA, NDA, MA, etc.) and for informing SCIEN of any changes requested by regulatory agencies. SCIEN agrees to keep HEMISPHERX fully informed of any and all communications with regulatory agencies that may affect the services being provided to HEMISPHERX by SCIEN. This Agreement is not meant to supersede or replace controlled documents typically used to define and record the work to be conducted by SCIEN for HEMISPHERX. Specific requirements of this Agreement and/or any service contracts shall be articulated within SCIEN's current operating procedures and documentation systems. 9. Responsibilities SCIEN is responsible for: 1) case management support services to patients and maintain a 24-hour/365-day a year telephone service for assistance of prescription drug-related medical emergencies to patients 2) the distribution of product, including the shipping, handling and storage and all rules and regulations of every governmental authority having jurisdiction over the shipping, handling, storage, distribution, and dispensing of Product {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 20 of 28\"}, {\"id\": \"3\", \"title\": \"confirming the product labelling requirements in the territory 4) conforming to all labeled specifications concerning t\", \"level\": 1, \"text\": \"3) confirming the product labelling requirements in the territory 4) conforming to all labeled specifications concerning the shipping, handling and storage of Product 5) notifying HEMISPHERX of any unacceptable storage or handling deviation within one (1) business day 6) inspecting all product shipments received by SCIEN from HEMISPHERX and reporting any damage, defect, loss in transit, or other shipping errors to HEMISPHERX within one (1) business days of receipt by SCIEN 7) administering recalls, field alerts, warning letters, quarantines or withdrawals in accordance with HEMISPHERX instructions (See Attachment 2) 8) administering HEMISPHERX's Returned Goods Policy (See Attachment 3) 9) immediately (within 24 hours of becoming aware of event) notifying HEMISPHERX of any serious and unexpected side effects (Adverse Experiences reported to SCIEN, as defined by 21CFR 314.80 and 21CFR 312.32)) 10) providing HEMISPHERX with written Adverse Experience Reports (at the latest day 4 after becoming aware of event) 11) notifying the Regulatory Authorities within the Territory of any reportable adverse experiences 12) notifying the Regulatory Authorities within the Territory of any suspected counterfeiting or tampering except as required different by law 13) obtaining program approval from appropriate regulatory agencies in the Territory 14) keeping HEMISPHERX fully informed of any and all communications with regulatory agencies that may affect the services being provided to HEMISPHERX by SCIEN 15) receiving and processing complaints 16) notifying HEMISPHERX of complaints and actions taken or to be taken to address the complaints 17) the performance of all services provided by SCIEN's subcontractors 18) communicating to HEMISPHERX any events of non-conformance that impact the quality of HEMISPHERX's product. Examples of non-conformances may include, but are not limited to: equipment failure, shipping error or documentation error, labeling error, improper storage, facilities system error, and unplanned study protocol deviations. When a non-conformance event occurs that is specific to HEMISPHERX's product, SCIEN will conduct an investigation and provide copies of all investigation documentation to HEMISPHERX for review and input 19) for initiating, monitoring and completing CAPA tasks related to discrepancies, errors and incidents involving services that are under SCIEN's control HEMISPHERX is responsible for: 1) release of product following review of all manufacturing and quality control testing requirements to confirm the batch has been manufactured according to approved processes and specifications 2) supply all necessary quality documentation with shipments to allow product importation and release 3) ensuring product intended for supply in territory is labelled accordingly 4) assuring changes to the established operations are in accordance with and/or reported to the investigational, marketing and/or any other filing with regulatory agencies (IND, IMPD, CTA, NDA, MA, etc.). 5) informing SCIEN of any changes requested by regulatory agencies 6) assist with/address any Agencies requests relating to manufacture of product 7) providing SCIEN any information that could result in a field alert or recall of a product under a HEMISPHERX NDA or ANDA immediately, but no more than one (1) business day after discovery. HEMISPHERX interprets FDA 21 CFR 314.81, \\\"Other Post- Marketing Reports,\\\" to require a Field Alert Report to be made within three (3) days of an occurrence of an OOS result, whether that result is confirmed or not. The only exception to this would be where the original result was invalidated within the three (3) days. In that case, no field alert would be required 8) making the proper reports to the FDA regarding a field alert or recall {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 21 of 28\"}, {\"id\": \"9\", \"title\": \"making the proper reports to the FDA regarding any serious and unexpected side effects 10) communicating to SCIEN any e\", \"level\": 1, \"text\": \"9) making the proper reports to the FDA regarding any serious and unexpected side effects 10) communicating to SCIEN any events of non-conformance that impact the quality of HEMISPHERX's product. Examples of non- conformances may include, but are not limited to: contamination, calculation or documentation error, labeling error. When a non- conformance event occurs HEMISPHERX will conduct an investigation and inform SCIEN of any appropriate action to be taken 11) for initiating, monitoring and completing CAPA tasks related to discrepancies, errors and incidents involving services that are under HEMISPHERX's control 12) contribute to customer complaint investigations where possible issues due to manufacturing process may have contributed to complaint HEMISPHERX and SCIEN are separately responsible for securing and maintaining all required licenses, permits and certificates applicable to their respective operations and each shall comply with any and all applicable federal, state and local laws, including but not limited to (i) the Federal Food Drug and Cosmetic Act; (ii) the Social Security Act; (iii) HIPAA; (iv) all federal and state health care anti-fraud and abuse laws, and (v) all state privacy, and consumer protection laws, including those relating to the use of medical and prescription information for commercial purposes. 10. Subcontractors SCIEN may enter into agreements between SCIEN and a subcontractor. SCIEN will identify the services performed by each such subcontractor. SCIEN is responsible for the performance of all services provided on behalf HEMISPHERX and the compliance of each subcontractor to the terms of this Agreement. HEMISPHERX will be permitted to conduct periodic audits of the subcontractors to assure compliance to applicable GMP's, GLP's and federal regulations (CFR's). 11. Standard Operating Procedures (SOP's) The following HEMISPHERX SOP's are relevant to this Quality Agreement and interactions between HEMISPHERX and SCIEN and affiliates. A. CLN-009 Handling Adverse Event Reports and Records B. RA-001 Post Marketing Adverse Experience Reporting C. QC-006 Investigation of Out of Specification Results 12. Laboratory Controls-N/A 13. Documentation and Record Maintenance SCIEN shall preserve all records in accordance with any applicable federal, state or local requirements. Raw data, documentation, batch records, source documents, product disposition records and reports (collectively, \\\"Documentation\\\") shall be retained by SCIEN for a minimum period of two (2) years after termination or expiration of the Specialty Distributor Purchase and Service Agreement between HEMISPHERX and SCIEN. SCIEN shall, upon written receipt of a written request from HEMISPHERX, finish such Documentation in a format reasonably acceptable to HEMISPHERX with thirty (30) days of receipt of such request. In this case, the Documentation will be shipped to the Quality Assurance Manager named in this Agreement (see Key Contact List, Attachment 1). It is the responsibility of HEMISPHERX to notify SCIEN of any changes in this contact. During the retention period, documentation shall be available for inspection by HEMISPHERX, its authorized agents and authorized government agencies. 14. Complaints In the event SCIEN is notified of a complaint, SCIEN will receive, investigate and respond to the complaint following its internal procedures. A copy of all complaint investigation documentation will be provided to HEMISPHERX. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 22 of 28\"}, {\"id\": \"15\", \"title\": \"Contact List of Key Personnel\", \"level\": 1, \"text\": \"15. Contact List of Key Personnel. See Attachment 1 IN WITNESS WHEREOF, the parties hereto have executed this Quality Agreement as of the Effective Date. Hemispherx Biopharma Inc. Quality Assurance Signature: _____________________________________________________ Printed Name: Victoria Scott Title: Associate Director Quality and Regulatory Date: _________________________________________________________________________ Management Signature: __________________________________________________________ Printed Name: Wayne Springate Title: Senior Vice President Operations Date: _________________________________________________________________________ SCIEN. Quality Assurance Signature: _____________________________________________________ Printed Name: _________________________________________________________________ Title: _________________________________________________________________________ Date: _________________________________________________________________________ Management Signature: ___________________________________________________________ Printed Name: Abdelrhman Mofeed Zhreldin Title: Business Development Manager Date: _________________________________________________________________________ {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 23 of 28\"}, {\"id\": \"Attachment 1\", \"title\": \"List of Key Contacts SUBJECT HEMISPHERX CONTACT SCIEN CONTACT Regulatory Compliance Requirements Notification of Regulatory Agencies and Regulatory Submissions\", \"level\": 1, \"text\": \"Attachment 1 List of Key Contacts SUBJECT HEMISPHERX CONTACT SCIEN CONTACT Regulatory Compliance Requirements Notification of Regulatory Agencies and Regulatory Submissions Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Regulatory@Hemispherx.net Recall of Marketed Product Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Regulatory@Hemispherx.net Adverse Drug Events David Strayer, MD Medical Director Phone:215-988-0880 Fax: 215-988-1739 Email: SAE@Hemispherx.net Product Complaint Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Field Alert Reports/Biological Product Deviation Reports Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Change Control Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Clinical Study Protocol Changes David Strayer, MD Medical Director Phone:215-988-0880 Fax: 215-988-1739 Email: David.Strayer@Hemispherx.net New or Revised Product Claims David Strayer, MD Medical Director Phone:215-988-0880 Fax: 215-988-1739 Email: David.Strayer@Hemispherx.net Documentation Quality Records Record Retention Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 24 of 28 SUBJECT HEMISPHERX CONTACT Product Testing and Release Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Control of Components, Labelling and Packaging Materials Chris Cavalli VP Quality and Process Development Phone: 732-249-3250 Email:Chris.Cavalli@Hemispherx.net Fax:732-249-6895 Product Storage and Shipping Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Returned Goods Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx. Deviations/Investigations Nonconforming or Rejected Material Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Supplier Qualification Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Quality Audits & Regulatory Inspections Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 25 of 28\"}, {\"id\": \"Attachment 2\", \"title\": \"QA-007-Product Recall\", \"level\": 1, \"text\": \"Attachment 2 QA-007-Product Recall {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 26 of 28\"}, {\"id\": \"Attachment 3\", \"title\": \"HEMISPHERX Return Goods Policy This Return Goods Policy us for all HEMISPHERX product, Interferon alfa-n3 (human leukocyte derived) distributed by SCIEN. The following products are eligible for return and reimbursement: \u00b7 Outdated Product: Product within two (2) months prior or six (6) months past expiration date and noted on product; AND \u00b7 Product in its original container and bearing its original label. OR \u00b7 Product which HEMISPHERX has specified be returned The following products are not eligible for return and reimbursement: \u00b7 Product that is not outdated. \u00b7 Product in which the lot number and/or expiration date is missing, illegible, covered, and/or unreadable on original container. \u00b7 Product that has been damaged due to improper storage handling, fire, flood, or catastrophe. \u00b7 Product that has been sold expressly on a non-returnable basis. \u00b7 Product that is not in its original container and/or not bearing its original label. \u00b7 Product that is in its original container with a prescription label attached. \u00b7 Product that has been repackaged \u00b7 Partial Vials \u00b7 Product obtained illegally or via diverted means \u00b7 Product purchased on the \\\"secondary source\\\" market or from a distributor other than SCIEN. \u00b7 Product that HEMISPHERX determines, in its sole discretion, is otherwise adulterated, misbranded, or counterfeit. HEMISPHERX will only accept returns shipped to SCIEN. All eligible products shall be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes. It is the shipper's responsibility to securely package all return goods to prevent to prevent breakage during transit and otherwise comply with the laws and regulations applicable to the packaging, shipping, and transport of return goods shipments. HEMISPHERX is not responsible for shipments lost and/or damaged in transit. HEMISPHERX recommends that all customers insure return goods shipments. HEMISPHERX will audit the quantities of return goods and final reimbursement will be based on HEMISPHERX count. All products will be reimbursed based on the price paid direct purchasing customers reimbursement will be issued in the form of credit or product replacement to the appropriate party.\", \"level\": 1, \"text\": \"Attachment 3 HEMISPHERX Return Goods Policy This Return Goods Policy us for all HEMISPHERX product, Interferon alfa-n3 (human leukocyte derived) distributed by SCIEN. The following products are eligible for return and reimbursement: \u00b7 Outdated Product: Product within two (2) months prior or six (6) months past expiration date and noted on product; AND \u00b7 Product in its original container and bearing its original label. OR \u00b7 Product which HEMISPHERX has specified be returned The following products are not eligible for return and reimbursement: \u00b7 Product that is not outdated. \u00b7 Product in which the lot number and/or expiration date is missing, illegible, covered, and/or unreadable on original container. \u00b7 Product that has been damaged due to improper storage handling, fire, flood, or catastrophe. \u00b7 Product that has been sold expressly on a non-returnable basis. \u00b7 Product that is not in its original container and/or not bearing its original label. \u00b7 Product that is in its original container with a prescription label attached. \u00b7 Product that has been repackaged \u00b7 Partial Vials \u00b7 Product obtained illegally or via diverted means \u00b7 Product purchased on the \\\"secondary source\\\" market or from a distributor other than SCIEN. \u00b7 Product that HEMISPHERX determines, in its sole discretion, is otherwise adulterated, misbranded, or counterfeit. HEMISPHERX will only accept returns shipped to SCIEN. All eligible products shall be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes. It is the shipper's responsibility to securely package all return goods to prevent to prevent breakage during transit and otherwise comply with the laws and regulations applicable to the packaging, shipping, and transport of return goods shipments. HEMISPHERX is not responsible for shipments lost and/or damaged in transit. HEMISPHERX recommends that all customers insure return goods shipments. HEMISPHERX will audit the quantities of return goods and final reimbursement will be based on HEMISPHERX count. All products will be reimbursed based on the price paid direct purchasing customers reimbursement will be issued in the form of credit or product replacement to the appropriate party. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 27 of 28 To assist in accurate credit memo processing, please include the following information: 1. Purchasers Name and Mailing Address 2. Date and Quantity Return goods shipments which are deemed to be outside of this policy will not be returned to the customer or the third party processor and no reimbursement will be issued by HEMISPHERX. HEMISPHERX return goods policy is subject to change at any time and without prior notices to other parties. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 28 of 28\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of HEMISPHERX - Sales, Marketing, Distribution, and Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 Sales, Marketing, Distribution, and Supply Agreement {***} WHEREAS HEMISPHERX is a biopharmaceutical company with headquarters at One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S. (\\\"HEMISPHERX\\\") and Scientific Products Pharmaceutical Co. LTD is a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\\\" SCIEN\\\"), each a \\\"Party\\\" together, \\\"Parties\\\", and WHEREAS HEMISPHERX owns intellectual proprietary rights relating to Interferon alfa-n3 (human leukocyte derived), and WHEREAS HEMISPHERX desires to have Interferon alfa-n3 (human leukocyte derived) provided to physicians to treat genital warts and other infections and diseases, including MERS, in the GCC (Gulf Cooperation Council) states , as appropriate, prior to regulatory approval in such countries and to have Interferon alfa-n3 (human leukocyte derived) approved by the regulatory authorities in each GCC country (Kingdom of Saudi Arabia, Bahrain, Qatar, Kuwait, United Arab emirates (UAE) and Sultanate of Oman)), and WHEREAS SCIEN has sales, marketing, distribution capabilities in the GCC states, and WHEREAS, AFTER A SUCCESSFUL CLINICAL TRIAL IN MERS, SCIEN affirms it has the ability to supply Interferon alfa-n3 (human leukocyte derived) in the GCC States prior to regulatory approval and simultaneously seek to gain regulatory approval in each of the GCC States. After the clinical trial in MERS has been conducted, in the event it is successful and the Hemispherx manufacturing site requires approved by the GCC / SFDA, the cost of any post-clinical trial inspection of the facility to be the responsibility of Scien or the regulatory authority, and subsequently to market, sell and distribute Interferon alfa-n3 (human leukocyte derived) in the GCC, and WHEREAS, SCIEN desires to supply Interferon alfa-n3 (human leukocyte derived) under special approval from the Saudi Ministry of Health and for other GCC states where applicable, and WHEREAS, HEMISPHERX desires to supply and sell Interferon alfa-n3 (human leukocyte derived)) to SCIEN, and SCIEN is willing to purchase Interferon alfa-n3 (human leukocyte derived) from HEMISPHERX for the purposes described in this agreement. NOW THEREFORE, in consideration of the mutual covenants and agreements made herein, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Parties agree as follows: I. DEFINITIONS \\\"Affiliate\\\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party. \\\"End User\\\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient. \\\"Field\\\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc. \\\"HEMISPHERX Intellectual Property\\\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement. \\\"List Price\\\" means ${***}/Product Unit. \\\"Product\\\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived). {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 1 of 28 \\\"Product Data\\\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory. \\\"Product Unit\\\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived) \\\"Sales Price\\\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit. \\\"Territory\\\" means the GCC States \\\"Transfer Price\\\" means a discounted price of ${***}/ Product Unit. II. LICENSE CONDITION PRECEDENT: THE GRANTING OF ANY AND ALL LICENSES OR PRIVILEGES HEREIN IS SUBJECT THE THE SUCCESSFUL COMPLETION OF A FIVE PERSON MINIMUM CLINICAL TRIAL IN THE KINGDOM OF SAUDI ARABIA TREATING EARLY ONSET PATIENTS INFECTED WITH MERS. A. Subject to the condition above, HEMISPHERX hereby grants SCIEN the exclusive license to sell, market, and distribute Product for use in the Field in the Territory for Direct Access/EAP and Regulatory Agency-Approved (RAA) purposes. B. SCIEN shall not use HEMISPHERX Intellectual Property nor sell nor permit the sale of any products that use the HEMISPHERX Intellectual Property outside the Territory or knowingly sell or have sold any products that use the HEMISPHERX Intellectual Property to any party in or outside the Territory for export or sale outside the Territory, without HEMISPHERX's prior written consent. C. SCIEN will have six 6) months after the date of this Agreement to Purchase at least 50 vials to be used by the MOH in treating patients with MERS. Scien will thereafter, based on the outcome of the initial treatment for MERS by the MOH trial, aggressively promote to all stakeholders in Saudi Arabia and the other GCC states(\\\"First Performance Milestone\\\"). III. COMMERCIAL DEVELOPMENT A. HEMISPHERX has or will provide SCIEN: 1. As an Integral Part of this Agreement and in order for HEMISPHERX to ship Product to SCIEN, the letter with attachments (Exhibit 1) must be signed by an officer of SCIEN. A protocol is also provided (Exhibit 2). 2. All the appropriate information about Products that will assist with the education of physicians about the Product in the Territory. 3. Ongoing scientific and medical support. 4. Product Units in quantities sufficient for SCIEN's Direct Access/EAP and RAA commercial needs in the Territory, subject to availability from HEMISPHERX. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 2 of 28 B. SCIEN will: 1. Within 60 days after this Agreement becomes effective, prepare and provide a Business Plan, to be attached to this Agreement as Exhibit 3, to make aware and educate physicians and patients about Product both prior to and following approval of Product. 2. Assist in determining reimbursable End User pricing of Product and gain reimbursement for Product under Direct Access/EAP program and RAA sales of the Product in the Territory. 3. Assist physicians who desire to administer Product with the required paperwork under any Direct Access/EAP program. 4. Manage the logistics within the Territory from arrival to End User supply. 6. Assist HEMISPHERX to gain regulatory approval of Product in the Field in the Territory 7. Prepare and provide a 3-year post regulatory approval Sales, Marketing, and Distribution Plan including a 3-year minimum sale forecast and a committed-dollar field sales force, product manager and marketing budget to be agreed by both Parties and a non-binding 12 month Product forecast no later than six (6) months prior to the anticipated registration and subsequent launch date for each Product, also to be agreed by both parties, 8. Pay for all the above Sales Marketing and Distribution activities and related expenses. 9. Hold 3 months inventory of the forecasted sales once the product is registered. 10. If needed, assist in recruiting clinical trial sites and principal investigators in the Field in the Territory. 11. Provide HEMISPHERX a monthly written report of SCIEN's efforts and status thereof under this Agreement. IV. SUPPLY A. Subject to the terms and conditions of this Agreement, HEMISPHERX agrees to exclusively supply Product to SCIEN in the Territory with a minimum expiry of 6 months from the date of shipment. B. The price that SCIEN will pay for Product under this Agreement is the Transfer Price, CIF. Taxes, duties, and other expenses to be paid by SCIEN. C. SCIEN shall pay HEMISPHERX for each order of Product within 75 days after receipt of the goods except for the for first purchase order which will be for 50 vials of Interferon alfa-n3 (human leukocyte derived) (\\\"First Order\\\") and paid once the MOH approves the use for Interferon alfa-n3 (human leukocyte derived) on 5 MERS patients. All purchase orders are final. D. SCIEN will ensure all necessary QA testing / approval for use occurs in the Territory and that each Product is stored under the conditions stipulated in a Quality Agreement (QA) to be executed and appended to this Agreement as Exhibit 4. E. Forecasts, Orders, Payment, and Delivery. Direct Access/EAP Distribution Following the signing of this Agreement, SCIEN will start a full and comprehensive market analysis of the potential of each Product for Direct Access/ EAP distribution. This will be from a market potential and willingness to pay point of view and will be completed within 3 months of the signature of this Agreement. A forecast will then be provided for Product for Direct Access/ EAP distribution and this will be added as a supplement to the Business Plan (Exhibit 3). {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 3 of 28 RAA Distribution Six (6) months prior to the estimated regulatory approval for commercial sale of Product in each country in the Territory: 1. SCIEN will provide HEMISPHERX a rolling 12-month forecast of the estimated sales of Product Units, the first 3 months of which will be firm and the second three (3) months of which cannot vary by more than 25% when these become the first three (3) months. This forecast will be updated at 3-month intervals thereafter. 2. In accordance with this forecast, SCIEN agrees to order Product from HEMISPHERX under this Agreement by submitting to HEMISPHERX written purchase orders specifying the quantity, packaging, delivery dates, and delivery location. 3. HEMISPHERX shall manufacture Product as described in the purchase order from SCIEN and HEMISPHERX shall make all shipments to the location specified on SCIEN's purchase order as follows: 4. Hemispherx shall pack, mark and ship Products in accordance with temperature thermometer specifications for the drug product. Hemispherx shall package Products so as to prevent damage or deterioration and shall comply with all applicable temperature and packaging laws. Unless otherwise stipulated, Products shall be packaged, marked, crated and otherwise prepared in accordance with HEMISPHERX's current packaging and crating practices, and good commercial practices. 5. SCIEN will prominently display on all Product that the Product is a product of HEMISPHERX and be so noted and on a visible surface thereof and/or on tags, labels, manuals, and other materials with which Product is sold, the fact that the Product is manufactured and supplied to SCIEN by HEMISPHERX for use and/or sale in the Territory shall be clearly displayed. F. If, for any reason, at any time, HEMISPHERX shall be unable, or should reasonably anticipate being unable to deliver any part or all of the ordered Product in accordance with the terms hereof or the accompanying purchase order, HEMISPHERX shall notify SCIEN of such inability at the earliest possible time (but no later than five (5) workings after HEMISPHERX becomes aware of this their inability to supply Product, whereupon HEMISPHERX and SCIEN will devise a plan to manage the situation. G. HEMISPHERX warrants that the Product (i) shall conform to the specifications set out in the SCIEN purchase order for Product and (ii) shall meet all, if any, reasonably applicable regulatory requirements in the Territory once Product is approved. In the Direct Access/ EAP setting, the Product that HEMISPHERX supplies must confirm with all manufacturing and regulatory requirements (including labelling) for the country in which said Product is intended to be sold. SCIEN's acceptance of the Product shall relieve HEMISPHERX from the obligations arising from this warranty H. SCIEN shall have the right to return and demand replacement of any Product which violates this warranty. I. HEMISPHERX and/or SCIEN shall have the right to cancel, without further obligation to the other party, one or more orders for Product(s) if HEMISPHERX's or SCIEN's business is interrupted because of an event of force majeure beyond the control of HEMISPHERX or SCIEN. J. HEMISPHERX shall permit SCIEN or its agent, at SCIENs' expense, to conduct periodic audits of HEMISPHERX's Quality System and Manufacturing records relating to HEMISPHERX's performance under this Agreement. The audits shall be conducted upon reasonable advance notice during regular business hours at HEMISPHERX's principal office and in such a manner as not to unduly interfere with HEMISPHERX's operations. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 4 of 28 K. SCIEN will provide HEMISPHERX with copies of Product specification sheets, Product inserts, user manuals, user bulletins, and user Product updates and any other customer materials such as brochures, educational materials, web pages or other electronic information relating to SCIEN's efforts to sell, market and distribute Product under this Agreement at least 10 (ten) days prior to the public release or use of such information. V. REPORTS AND PAYMENTS A. Within 30 days following the end of each calendar quarter after execution of the Agreement, SCIEN will provide HEMISPHERX with quarterly reports on the number of Product Units sold and the Sales Price during the preceding three months, key market place issues and successes, regulatory and reimbursement subjects and revisions to the sales and marketing plans. B. Product (s) will be considered sold by SCIEN on the date it is shipped or invoiced to an End User, whichever is earlier. All shipping, taxes, duties and other expenses in the Territory is the responsibility of SCIEN. C. Price Increase: Beginning on the second year anniversary of the signing of this Agreement (\\\"Effective Date\\\") and on each succeeding anniversary of the Effective Date during the term of this agreement and in consideration of a varies of economic factors such as for example, costs of labour, costs of material and costs the price paid by SCIEN for Product(s) shall be renegotiated. Any price increase will need to be justified by HEMISPHERX. Both parties shall, in good faith, attempt to agree upon a reasonable price increase. In the event agreement cannot be reached the Agreement shall terminate. D. All payments hereunder will be made by SCIEN in United States Dollars by wire transfer of immediately available funds to an account designated by HEMISPHERX. The following is wire transfer information: Domestic (U.S.): {***} International: {***} VI. TERM/TERMINATION A. The Term will be 3 years from Effective Date with an automatic 2 year term extensions unless otherwise advised by one of the Parties. B. Termination for breach will include: 1. Failure to purchase Product and distribute to End Users as called for in II D. 2. Failure of SCIEN achieving less than 50% achievement of the minimum Purchases as in III B.7. for two (2) consecutive years, 3. Insolvency, or the filing for protection under either Party's bankruptcy laws. Upon the filing of a petition in bankruptcy, insolvency or reorganization against or by either Party, or either Party becoming subject to a composition for creditors , whether by law or agreement, or either party going into receivership or otherwise becoming insolvent (such party hereinafter referred to as the \\\"insolvent party\\\"), this Agreement may be terminated by the other Party by giving written notice of termination to the insolvent Party, such termination immediately effective upon the giving of such notice of termination. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 5 of 28\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon the occurrence of a breach or default as to any obligation hereunder by either Party and the failure of the breach\", \"level\": 1, \"text\": \"C. Upon the occurrence of a breach or default as to any obligation hereunder by either Party and the failure of the breaching Party to cure (within thirty (30) days after receiving written notice thereof from the non-breaching Party) such breach or default, this Agreement may be terminated by the non- breaching Party by giving written notice of termination to the breaching Party, such termination being immediately effective upon the giving of such notice of termination. D. In the event this Agreement is terminated by either Party for any reason whatsoever, HEMISPHERX agrees to reasonable efforts to make Product available to SCIEN for a period of three (3) months after the termination date at the same Transfer Price and under the same terms of payment. E. In the event of termination of this Agreement, SCIEN will have the right to complete all contracts for the sale or disposition of Product) under which SCIEN is obligated on the date of termination, provided SCIEN pays the associated Transfer Price and provided all such sales or dispositions are completed within three (3) months after the date of termination. Thereafter, HEMISPHERX shall purchase from the SCIEN all remaining stock of Product that is of merchantable quality at the same price as was paid by SCIEN. VII. ASSIGNMENT Neither this Agreement nor any rights or obligations or licenses hereunder may be assigned, pledged, transferred or encumbered by either party without the express prior written approval of the other party, except that either HEMISPHERX or SCIEN may assign this Agreement to any successor by merger or sale of substantially all of its business or assets to which this Agreement pertains, without any such consent. Any assignment in violation hereof is void. VIII. AUTHORITY SCIEN and HEMISPHERX each warrant and represent that it has the full right and power to make the promises set forth in this Agreement and that there are no outstanding agreements, assignments, or encumbrances inconsistent with the provisions of this Agreement. IX. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION IX, HEMISPHERX MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, REGARDING THE DEVELOPMENT, VIABILITY, COMMERCIAL OR OTHER USEFULNESS OR SUCCESS OF PRODUCT) AND THAT NO WARRANTY OR REPRESENTATION THAT ANYTHING MADE, USED, SOLD OR OTHERWISE PRACTICED OR ANY SERVICE PROVIDED UNDER THIS AGREEMENT WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADE SECRET, OR OTHER PROPRIETARY RIGHT, FOREIGN OR DOMESTIC, OF ANY THIRD PARTY AND MAKES NO WARRANTIES OR REPRESENTATIONS AS TO THE VALIDITY, ENFORCEABILITY OR SCOPE OF ANY HEMISPHERX INTELLECTUAL PROPERTY. X. INDEMNIFICATION AND WARRANTIES A. INDEMNIFICATION SCIEN and HEMISPHERX (each an \\\"Indemnifying Party\\\") shall indemnify, defend and hold harmless and the other Party's subsidiaries or affiliates, their agents, directors, officers, employees and assigns (the \\\"Indemnified Parties\\\") from and against all losses, liabilities, damages, demands and expenses (including reasonable attorneys' fees and expenses) arising out of, as a result of, or in connection with (i) the negligent actions of the Indemnifying Party, its employees or any third party acting on behalf of or under authority of the Indemnifying Party in the performance of this Agreement and/or (ii) the violation of any representation or warranty of Indemnifying Party in this Agreement. Each Party's obligations under this provision shall be subject to the other Party providing reasonable notice of any such claim. Each Party shall defend with competent counsel and pay all costs of defence, including attorneys' fees, and any and all damages and court costs awarded in respect to such claim, action or proceeding regarding the claim of infringement. The Indemnified Parties agree to permit the Indemnifying Party to defend, compromise, or settle any such claim, action or proceeding and further agree to provide all available information, and reasonable assistance to enable the other Indemnifying Party to do so. However, neither party will be liable under this indemnity for any losses, liabilities, damages, demands or expenses arising out of the gross negligence or wilful misconduct of the other party or any of its affiliates, agents, directors, officers, employees or assigns. Limitation of Liability. IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES RESULTING FROM THE LICENSE GRANTED PURSUANT TO THIS AGREEMENT OR THE USE OR COMMERCIAL DEVELOPMENT OF PRODUCT. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 6 of 28 B. WARRANTIES Subject as herein provided HEMISPHERX warrants to SCIEN that: \u00b7 All Product(s) supplied hereunder will comply with the Dossier and with any specification agreed for them in the Quality Agreement; \u00b7 It is not aware of any rights of any third party in the Territory which would or might render the sale of the Product, or the use of any of the Trademarks on or in relation to the Products, unlawful; \u00b7 It is the owner or the permitted licensee of all Intellectual Property Rights and it is not aware of any claims of any third party in the Territory or worldwide related to the fact that the Products infringes any intellectual property of such third party. \u00b7 Nothing in this Agreement shall exclude either party's liability for death or personal injury. Subject to the above WARRANTIES, HEMISPHERX shall indemnify and hold harmless SCIEN and its respective employees from any loss, damage or claim made by a third party in respect of (i) the death or personal injury arising from the manufacture or use of the Products in the Territory or (ii) infringement of third party intellectual property, if and to the extent such loss, damage or claim is caused by any act or omission of HEMISPHERX and is not attributable directly or indirectly to the breach of any of the material terms of this Agreement by SCIEN or by any wilful default or negligent act or omission of SCIEN, its employees or its agents. 1. The indemnity given by HEMISPHERX shall be subject to the following conditions: \u00b7 No indemnity shall be claimed unless notice is given by SCIEN claiming the indemnity to HEMISPHERX together with details of the claim promptly on notice of such claim being received by the SCIEN; \u00b7 No admissions of liability or compromise or offer of settlement of any claim shall be made by SCIEN without the prior written consent of HEMISPHERX; and \u00b7 HEMISPHERX shall have full control over any claim, proceedings or settlement negotiations in respect of which it is providing the indemnity. Subject to clause X.B 1.), SCIEN shall defend and indemnify HEMISPHERX and its Affiliates and hold each of them harmless against all claims, demands, actions, losses, expenses, damages, liabilities, costs (including interest, penalties and reasonable attorneys' fees) and judgements suffered by each of them, which arise out of SCIEN's negligent or wilful acts or omissions or which otherwise arise out of SCIEN's breach of the Agreement. Survivability. The obligations set forth in this Section X. shall survive the termination of this Agreement for the legal periods of limitation provided by US law. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 7 of 28\"}}, {\"id\": \"XI\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY A\", \"level\": 1, \"text\": \"XI. CONFIDENTIALITY A. SCIEN and HEMISPHERX agree to keep secret and confidential all confidential, proprietary or non-public information (\\\"Confidential Information\\\") of the other Party .This provision shall survive termination or expiration of this Agreement. B. Such Confidential Information will be kept confidential until 5 years after the expiration of termination of this Agreement. Notwithstanding the foregoing , Confidential Information of a Party shall not include information which the other Party can establish by written documentation was (a) to have been publicly known prior to disclosure of such information by the disclosing Party to the other Party, (b) to have become publicly known, without fault on the part of the other Party, subsequent to disclosure of such information by the disclosing Party to the other Party, (c) to have been received by the other Party at any time from a source , other than the disclosing Party, rightfully having possession of and the right to disclose such information, (d) to have been otherwise known by the other Party prior to disclosure of such information by the disclosing Party to the other Party, or (e) to have been independently developed by employees or agents of the other Party without access to or use of such information disclosed by the disclosing Party to the other Party. C. The confidentiality obligations contained in this section XI shall not apply to the extent that the receiving Party (the \\\"Recipient\\\") is required (a) to disclose information by law, order or regulation of a governmental agency or a court of competent jurisdiction , or (b) to disclose information to any governmental agency for purposes of obtaining approval to test or market a Product , provided in either case that the Recipient shall provide written notice thereof to the other Party and sufficient opportunity to object to any such disclosure or to request confidential treatment thereof. XII. PROSECUTION, INFRINGEMENT, AND DEFENSE OF HEMISPHERX INTELLECTUAL PROPERTY A. HEMISPHERX will be responsible for and shall control, at its expense, the preparation, filing, prosecution and maintenance of HEMISPHERX Intellectual Property. B. SCIEN will cooperate in all reasonable ways to establish and protect HEMISPHERX Intellectual Property in the Territory. C. HEMISPHERX, at its expense, will have the right to determine the appropriate course of action to enforce its HEMISPHERX Intellectual Property against infringement or otherwise abate the infringement thereof , to take (or refrain from taking) appropriate action to enforce its HEMISPHERX Intellectual Property, to control any litigation or other enforcement action and to enter into, or permit, the settlement of any such litigation or other enforcement action with respect to its Intellectual Property . D. Each Party shall promptly notify the other Party in writing if any claim, action, demand or other proceeding (a \\\"Claim\\\") is brought against or is threatened to be brought against such Party alleging that the sale of Product violates another party's intellectual property. E. SCIEN will promptly notify HEMISPHERX of any Third party SCIEN knows or believes may be infringing HEMISPHERX Intellectual Property and will, to the greatest extent reasonably possible, provide to HEMISPHERX any information SCIEN has in support of such belief. HEMISPHERX will have the right, but not the obligation, to use such information in an infringement action against such third Party. SCIEN agrees to cooperate with HEMISPHERX in any action for infringement of HEMISPHERX, and HEMISPHERX will reimburse SCIEN for all reasonable costs incurred by it in providing cooperation requested by HEMISPHERX. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 8 of 28 F. HEMISPHERX is and shall remain the sole legal and registered owner for any trademark or trade name of \\\"Interferon alfa-n3 (human leukocyte derived)\\\". The parties shall work together, upon commercial approval in the Territory to secure a trade name in the Territory. G. HEMISPHERX hereby grants to SCIEN and SCIEN hereby accepts the right, privilege and exclusive license to use of \\\"Interferon alfa-n3 (human leukocyte derived)\\\" solely in connection with the terms of the Sales, Marketing, Distribution and Supply Agreement of Product in the Territory for the Term of this Agreement. Should the Agreement expire or terminate, the right to use the trademark shall also terminate. SCIEN shall use \\\"Interferon alfa-n3 (human leukocyte derived)\\\" at all times for the sole purpose of marketing of Product for no other purpose. H. The terms of the intellectual property license hereby granted shall be effective upon the Effective Date of this Agreement and during the term of this Agreement, unless sooner terminated in accordance with the provisions of the Sales, Marketing, Distribution and Supply Agreement between the parties. 1. Good Will. SCIEN recognizes that there exists great value and good will associated with the Intellectual Property of Interferon alfa-n3 (human leukocyte derived)\\\" 2. SCIEN agrees that it will not during the term of this Agreement, or thereafter, attack the title or any rights of HEMISPHERX in and to Interferon alfa-n3 (human leukocyte derived) or attack the validity of the license granted herein by HEMISPHERX and solely owned by HEMISPHERX. I. SCIEN agrees to assist HEMISPHERX to the extent necessary in the procurement of any protection or to protect any of HEMISPHERX's right to Interferon alfa-n3 (human leukocyte derived) and HEMISPHERX, if it so desires, may commence or prosecute any claims or suits in its own name or in the name of SCIEN or join SCIEN as a party thereto. SCIEN shall notify HEMISPHERX in writing of any infringements or imitations by others of \\\"Interferon alfa-n3 (human leukocyte derived) which may come to SCIEN 's attention, and HEMISPHERX shall have the sole right to determine whether or not any action shall be taken on account of any such infringements or imitations. SCIEN shall not institute any suit or take any action on account of any such infringements or imitation without first obtaining the written consent of the HEMISPHERX so to do. J. SCIEN agrees to cooperate fully and in good faith with HEMISPHERX for the purpose of securing and preserving HEMISPHERX's rights. K. It is agreed that nothing contained in this Sales, Marketing, Distribution, and Supply Agreement shall be construed as an assignment or grant to the SCIEN of any rights, title or interest in or to \\\"Interferon alfa-n3 (human leukocyte derived)\\\". L. It is further understood that all rights relating thereto are reserved by HEMISPHERX, except for the license hereunder to SCIEN of the right to use and utilize the name Interferon alfa-n3 (human leukocyte derived) only as specifically and expressly provided in this Agreement. M. In the event of termination of this license for any reason, SCIEN shall within 6months (as described in the Termination clause), cease all use of the \\\"Interferon alfa-n3 (human leukocyte derived)\\\". SCIEN shall not thereafter use any names, mark or trade name similar thereto belonging to HEMISPHERX. Termination of the license under the provisions of this Agreement shall be without prejudice to any rights which HEMISPHERX may otherwise have against SCIEN. N. SCIEN shall, and shall cause its shareholders, officers, directors, and managing personnel to, comply with all laws, rules and government regulations pertaining to its business and shall not violate any laws which would create an adverse effect on \\\"Interferon alfa-n3 (human leukocyte derived)\\\" in the U.S. and/or the Territory. O. Relationship of Parties. SCIEN shall not in any manner or respect be the legal representative or agent of HEMISPHERX and shall not enter into or create any contracts, Agreements, or obligations on the part of HEMISPHERX, either expressed or implied, nor bind HEMISPHERX in any manner or respect whatsoever regarding its intellectual property; it being understood that this Agreement is only a contract for the licensed use of the product names in connection with the terms in this Agreement. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 9 of 28\"}}, {\"id\": \"XIII\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BUYOUT HEMISPHERX will have the option at any time to buy out this Agreement\", \"level\": 1, \"text\": \"XIII. BUYOUT HEMISPHERX will have the option at any time to buy out this Agreement. If exercised within the first two (2) years HEMISPHERX will pay SCIEN three (3) times the Product sales for the preceding 12 months. If exercised after year 3, HEMISPHERX will pay SCIEN two (2) times the Product sales for the preceding 12 months. XIV. MISCELLANEOUS. A. Notices. Notices sent pursuant to this Agreement are valid if in writing and addressed to the parties at the respective addresses given below or at such other addresses as either party shall notify the other in writing and sent by registered or certified mail, postage prepaid and return receipt requested, or by Federal Express or other comparable courier providing proof of delivery, and shall be deemed duly given and received (i) if mailed, on the third business day following the mailing thereof, or (ii) if sent by courier, the date of its receipt (or if not on a business day, the next succeeding business day). If to HEMISPHERX: Thomas K. Equels, President and CEO One Penn Center 1617 JFK Boulevard Suite 500 Philadelphia, PA 19103 United States If to SCIEN: Abdelrhman Mofeed Zhreldin Business Development Manager Scientific Products Pharmaceutical Co. Ltd Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia B. This Agreement and the transactions contemplated herein shall be governed by, and construed in accordance with, the laws of the State of Delaware, USA and disputes, if not resolved by the Parties, will be settled by binding arbitration in and under the rules of arbitration in London, England. C. This Agreement constitutes the entire understanding of the parties with respect to the purchase and sale of Products and supersedes all prior discussions, agreements, and understandings between HEMISPHERX and SCIEN. D. Each party an independent contractor to the other and the relationship between the parties shall not be construed to be that of an employer and employee, or to constitute a partnership, joint venture, or agency of any kind. E. This Agreement may only be amended in a writing signed by both parties hereto. F. If any provision of this Agreement is declared invalid or unenforceable by a court having competent jurisdiction, it is mutually agreed that this Agreement shall endure except for the part declared invalid or unenforceable by order of such court. G. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 10 of 28 H. Prior to their release, the parties must agree on press releases or market communication that utilises the other Party's name. Counterparts; Integration; Effectiveness; Electronic Execution This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement constitutes the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. This Agreement shall become effective when it shall have been executed by all parties and upon receipt of all counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by e- mail and/or telecopy shall be effective as delivery of a manually executed counterpart of this Agreement. The words \\\"execution,\\\" \\\"signed,\\\" \\\"signature,\\\" and words of like shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper- based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, and any other similar State laws based on the Uniform Electronic Transactions Act. IN WITNESS WHEREOF, the parties have executed this Agreement as of the last date below and in so doing acknowledge that they have a corporate authority to bind their respective organizations to this Agreement. SCIENTIFIC PRODUCTS PHARMACEUTICAL CO. LTD: HEMISPHERX BIOPHARMA, INC: S/ Saleh Al-Abdullah Al-Rasheed S/ Thomas K. Equels Saleh Al-Abdullah Al-Rasheed Thomas K. Equels CEO & Owner President and CEO Date: Date: 3-29-2016 3-31-16 {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 11 of 28\"}}, {\"id\": \"Exhibit 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The drug, Interferon Alfa-n3, is intended for investigational use in the countries in which it is distributed prior to receipt of RAA; The drug, Interferon Alfa-n3, meets your specifications as reflected on the attached Certificate of Analysis; The drug, Interferon Alfa-n3, is not in conflict with the laws of the countries in which it is distributed; The investigation will be conducted in accordance with good clinical practices, including review and approval of the study by an independent ethics panel and informed consent of the study subjects; The drug, Interferon Alfa-n3, does not present an imminent hazard to public health, either in the United States, if the drug were to be reimported, or in the countries in which it is distributed; The drug, Interferon Alfa-n3, is labelled in accordance with the laws of the countries in which it is distributed. I have reviewed the attached labels and the current Certificate of Analysis against the specifications and agree with the above statements that these meet the laws of the countries in which the product will be distributed. Signature: __________________________________ Date: ______________________ Printed Name: Saleh Al- Rashid Title: Chairman and CEO Company: Scientific Products Pharmaceutical Co. LTD\", \"level\": 1, \"text\": \"Exhibit 1 The drug, Interferon Alfa-n3, is intended for investigational use in the countries in which it is distributed prior to receipt of RAA; The drug, Interferon Alfa-n3, meets your specifications as reflected on the attached Certificate of Analysis; The drug, Interferon Alfa-n3, is not in conflict with the laws of the countries in which it is distributed; The investigation will be conducted in accordance with good clinical practices, including review and approval of the study by an independent ethics panel and informed consent of the study subjects; The drug, Interferon Alfa-n3, does not present an imminent hazard to public health, either in the United States, if the drug were to be reimported, or in the countries in which it is distributed; The drug, Interferon Alfa-n3, is labelled in accordance with the laws of the countries in which it is distributed. I have reviewed the attached labels and the current Certificate of Analysis against the specifications and agree with the above statements that these meet the laws of the countries in which the product will be distributed. Signature: __________________________________ Date: ______________________ Printed Name: Saleh Al- Rashid Title: Chairman and CEO Company: Scientific Products Pharmaceutical Co. LTD {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 12 of 28 Certificate of Analysis {***} {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 13 of 28 Label information enlarged for ease of read. {***} Enlarged Label: {***} Caution: Limited by Federal (US) Law to Investigational Use. Manufactured For: Hemispherx Biopharma, Inc. Philadelphia, PA 19103 (U.S.A.) Actual Label: {***} {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 14 of 28\"}}, {\"id\": \"Exhibit 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Study Protocol Synopsis A Compassionate Use Protocol Using Natural Leukocyte Interferon (Alfa-n3) for Individual Treatment of Symptomatic Patients with Middle East Respiratory Syndrome (MERS) {***}\", \"level\": 1, \"text\": \"Exhibit 2 Study Protocol Synopsis A Compassionate Use Protocol Using Natural Leukocyte Interferon (Alfa-n3) for Individual Treatment of Symptomatic Patients with Middle East Respiratory Syndrome (MERS) {***} {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 15 of 28\"}}, {\"id\": \"Exhibit 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Business Plan\", \"level\": 1, \"text\": \"Exhibit 3 Business Plan {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 16 of 28\"}}, {\"id\": \"Exhibit 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TECHNICAL / QUALITY AGREEMENT 1. Parties This Quality Agreement is entered by and between Scientific Products Pharmaceutical Co. LTD., a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\\\"SCIEN\\\") and Hemispherx Biopharma, Inc. 783 Jersey Avenue, New Brunswick, New Jersey 08901(HEMISPHERX). 2. Purpose The purpose of this Quality Agreement is to clearly define the quality operating procedures, duties and responsibilities to be employed by SCIEN and HEMISPHERX in the conduct of activities by SCIEN for Hemispherx Biopharma, Inc. The objective of these procedures and this Quality Agreement is assurance that services are conducted in a timely, consistent and uniform manner and in accordance with current laws, directives, regulations and guidelines, as may be applicable to the specific project(s). These requirements may include those defined by the U.S. FDA's regulations At 21CFR314.80 (Post-marketing reporting of adverse drug experiences for drugs), 21CFR312.32 (IND safety reporting) 21CFR600.80 (Post marketing reporting of adverse experiences for biologics) 21CFR Parts 210 and 211 (\\\"current Good Manufacturing Practices\\\" or \\\"cGMPs\\\") with particular interest in 21CFR211.1.42 (Warehousing), 21CFR211.150 (Distribution), 21CFR211.204 (Returned drug) and 21CFR211.208 (Drug product salvaging), ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance and/or others that may be appropriate for the particular project. 3. Scope This Quality Agreement is to be applied to the activities performed by SCIEN, for HEMISPHERX as specifically defined by the Sales, Marketing, Distribution, and Supply Agreement January ___, 2016 (\\\"Agreement\\\") to which this Quality Agreement is an integral Exhibit. In the event of a conflict between the terms of the Agreement and this Quality Agreement, the terms of the Agreement shall control. Unless otherwise stated in these documents, SCIEN shall follow its Standard Operating Procedures (\\\"SOPs\\\") with respect to the activities it shall carry out in accordance with the Agreement. Copies of all relevant SOPs shall be provided to HEMISPHERX for review during audits. 4. Confidentiality The information and procedures contained in this Quality Agreement are confidential and subject to the terms and conditions of the confidentiality provisions as set forth in the Confidential Disclosure Agreement September 22, 2014 (\\\"CDA\\\") executed by HEMISPHERX and SCIEN. 5. Terms This Agreement between HEMISPHERX and SCIEN shall be in effect beginning the last date of execution set forth on the signature page to the Agreement (the \\\"Effective Date\\\") to which this Quality Agreement is Exhibit 2 and remain in effect until HEMISPHERX and SCIEN terminate the Agreement or it is superseded by a revised Quality Agreement executed by both parties. This Quality Agreement should be reviewed periodically by both parties for any needed updating, revisions, amendments, and the like. Regular periodic review of this Quality Agreement should be conducted to ensure it is up-to-date.\", \"level\": 1, \"text\": \"Exhibit 4 TECHNICAL / QUALITY AGREEMENT 1. Parties This Quality Agreement is entered by and between Scientific Products Pharmaceutical Co. LTD., a pharmaceutical company with its primary offices located at Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia (\\\"SCIEN\\\") and Hemispherx Biopharma, Inc. 783 Jersey Avenue, New Brunswick, New Jersey 08901(HEMISPHERX). 2. Purpose The purpose of this Quality Agreement is to clearly define the quality operating procedures, duties and responsibilities to be employed by SCIEN and HEMISPHERX in the conduct of activities by SCIEN for Hemispherx Biopharma, Inc. The objective of these procedures and this Quality Agreement is assurance that services are conducted in a timely, consistent and uniform manner and in accordance with current laws, directives, regulations and guidelines, as may be applicable to the specific project(s). These requirements may include those defined by the U.S. FDA's regulations At 21CFR314.80 (Post-marketing reporting of adverse drug experiences for drugs), 21CFR312.32 (IND safety reporting) 21CFR600.80 (Post marketing reporting of adverse experiences for biologics) 21CFR Parts 210 and 211 (\\\"current Good Manufacturing Practices\\\" or \\\"cGMPs\\\") with particular interest in 21CFR211.1.42 (Warehousing), 21CFR211.150 (Distribution), 21CFR211.204 (Returned drug) and 21CFR211.208 (Drug product salvaging), ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance and/or others that may be appropriate for the particular project. 3. Scope This Quality Agreement is to be applied to the activities performed by SCIEN, for HEMISPHERX as specifically defined by the Sales, Marketing, Distribution, and Supply Agreement January ___, 2016 (\\\"Agreement\\\") to which this Quality Agreement is an integral Exhibit. In the event of a conflict between the terms of the Agreement and this Quality Agreement, the terms of the Agreement shall control. Unless otherwise stated in these documents, SCIEN shall follow its Standard Operating Procedures (\\\"SOPs\\\") with respect to the activities it shall carry out in accordance with the Agreement. Copies of all relevant SOPs shall be provided to HEMISPHERX for review during audits. 4. Confidentiality The information and procedures contained in this Quality Agreement are confidential and subject to the terms and conditions of the confidentiality provisions as set forth in the Confidential Disclosure Agreement September 22, 2014 (\\\"CDA\\\") executed by HEMISPHERX and SCIEN. 5. Terms This Agreement between HEMISPHERX and SCIEN shall be in effect beginning the last date of execution set forth on the signature page to the Agreement (the \\\"Effective Date\\\") to which this Quality Agreement is Exhibit 2 and remain in effect until HEMISPHERX and SCIEN terminate the Agreement or it is superseded by a revised Quality Agreement executed by both parties. This Quality Agreement should be reviewed periodically by both parties for any needed updating, revisions, amendments, and the like. Regular periodic review of this Quality Agreement should be conducted to ensure it is up-to-date. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 17 of 28 HEMISPHERX may perform audits for initial qualification of SCIEN as well as periodic audits and \\\"for cause\\\" audits. At mutually agreed upon times, HEMISPHERX may review standard operating and other quality control procedures and records and the records of SCIEN relating to the Agreement. Such routine and general oversight review is to be requested at least twenty (20) business days in advance, limited to two (2) persons, completed within one (1) to two (2) business days and shall be offered to HEMISPHERX one (1) time each calendar year. SCIEN will make every reasonable effort to accommodate the special circumstances that may arise pursuant to \\\"for cause\\\" audits. The following applies to all audits: \u00b7 Prior to an audit HEMISPHERX will communicate to SCIEN the scope of the audit. \u00b7 HEMISPHERX will prepare a written report of the results of the audit and forward a copy to SCIEN. SCIEN will provide a written response to HEMISPHERX's written audit report within twenty (20) business days of receipt of such report setting forth the corrective actions to be taken by SCIEN, if any, and a timeline for such implementation. In the event of an inspection by any governmental or regulatory authority concerning the activities carried out under the Agreement, SCIEN shall notify HEMISPHERX promptly upon learning of such an inspection, shall supply HEMISPHERX with copies of any correspondence or portions of correspondence relating to HEMISPHERX's materials and shall inform HEMISPHERX of the general findings and outcomes of such inspections. SCIEN and HEMISPHERX shall cooperate with each other during any such inspection, investigation or other inquiry, including applying reasonable effort, as might be practical, at allowing, upon reasonable request, a representative of HEMISPHERX to be on site during such inspection, investigation or other inquiry, and providing copies of all documents related to the inspection. Each party acknowledges that it may not direct the manner in which the other party fulfills its obligations to permit inspection by governmental entities 6. Dispute Resolution If a dispute arises between the parties under this Agreement, the parties agree that, prior to either pursuing other available remedies, decision- making individuals from each party will promptly meet, either in person or by telephone, to attempt in good faith to negotiate a resolution of the dispute. If, within sixty days after such meeting, the parties are unable to resolve the dispute (or such longer time as the parties may agree) either party is free to pursue its legal remedies. 7. Definitions Adverse experience: Any adverse event associated with the use of a biological or drug product in humans, whether or not considered product related, including the following: an adverse event occurring in the course of the use of a biological or drug product in professional practice; an adverse event occurring from overdose of the product whether accidental or intentional; an adverse event occurring from abuse of the product; an adverse event occurring from withdrawal of the product; and any failure of expected pharmacological action. Disability: A substantial disruption of a person's ability to conduct normal life functions. Life-threatening adverse experience: Any adverse experience that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse experience as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death. Labeled event: An adverse experience that is listed on the product insert as having been observed in patients who are receiving the drug product. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 18 of 28 Drug Product: A finished dosage form, for example, tablet, capsule, or solution that contains an active ingredient generally, but not necessarily, in association with inactive ingredients Serious adverse experience: Any adverse experience occurring at any dose that results in any of the following outcomes: Death, a life-threatening adverse experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a serious adverse experience when, based upon appropriate medical judgment, they may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition. Unexpected adverse experience: Any adverse experience that is not listed in the current labelling for the biological or drug product. This includes events that may be symptomatically and pathophysiologically related to an event listed in the labelling, but differ from the event because of greater severity or specificity. For example, under this definition, hepatic necrosis would be unexpected (by virtue of greater severity) if the labeling only referred to elevated hepatic enzymes or hepatitis. Similarly, cerebral thromboembolism and cerebral vasculitis would be unexpected (by virtue of greater specificity) if the labeling only listed cerebral vascular accidents. \\\"Unexpected,\\\" as used in this definition, refers to an adverse experience that has not been previously observed (i.e., included in the labeling) rather than from the perspective of such experience not being anticipated from the pharmacological properties of the pharmaceutical product. Call report: A list of all questions, requests for circulars, and physician/patient complaints received by SCIEN's Clinical Support Department is prepared monthly by SCIEN staff and is forwarded to HEMISPHERX RA/QA Department. Audit: A systematic examination of processes, controls and systems, operating procedures, reports, records and/or data to assess SCIEN's compliance with standards, regulatory submissions, SOPs; applicable laws, regulations, directives, standards and guidelines; the terms of this Agreement and other contracts in place defining the services being provided and to verify data integrity. Good Clinical Practices (\\\"GCPs\\\"): Good clinical practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety, and wellbeing of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible. ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance. Good Manufacturing Practices (\\\"GMPs\\\"): The recognized pharmaceutical regulations and requirements of regulatory authorities such as those defined by the U.S. FDA's regulations at 21CFR Parts 210 and 211. Key Contacts: Persons at SCIEN and HEMISPHERX assigned to assure proper communication and follow-up in a timely manner within both parties' organizations. Names, titles and full contact information for Key Contacts shall be appended to this Agreement as Attachment 1 and should be maintained up-to-date during the course of the project. Observation: A statement of fact made during an audit that is substantiated by objective evidence. HEMISPHERX categorizes observations as follows: o Critical: May pose risk to patient or consumer or otherwise compromise the integrity or quality of the material, product, process, or service being provided. Other instances that could be defined as a critical observation include: A practice that poses an immediate safety risk to personnel; Quality System(s) missing or not in compliance with regulations, guidelines, or corporate policies. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 19 of 28 o Major: Does not fully comply with regulations, guidelines or corporate policies and may pose unnecessary risks to the integrity or quality of material, product, process or service being provided. Other instances that could be defined as a major observation include: Likely or probable safety risk to personnel; Quality System(s) weak or needing improvement; repeated Minor deficiencies of a similar nature that indicate a systemic problem and therefore may be classified as Major. o Minor: Does not comply with regulations, guidelines, or corporate policies but does not directly impact the integrity or quality of the material, product, process, or service being provided. o Comment: Compliant with regulations, guidelines and/or corporate policies; however, the auditor comment serves as a recommendation relative to maintaining or improving a specific condition noted. Out-of-Specification / Out-of-Trend (\\\"OOS / \\\"OOT\\\"): A result that is not within the established specifications or trend, whether these are qualitative or quantitative. Standard Operating Procedures (\\\"SOPs\\\"): Procedures in effect at SCIEN that define the processes and controls by and under which activities are to be conducted to assure compliance with the appropriate Code of Federal Regulations. 7. Communications To assure proper communication, notification and follow-up in a timely manner by both parties, \\\"Key\\\" contacts are listed in Attachment 1 of this Agreement. Key contacts shall have access to project managers and technical staff and, upon reasonable notice and as required, facilitate resolution of any issues. Every effort will be made by SCIEN to accommodate timely communications, including face-to-face meetings, with HEMISPHERX. 8. Change of Control SCIEN will maintain and follow change control SOP(s) to ensure that changes to equipment, procedures, processes, etc. occur in a controlled manner and in compliance with requirements e defined by the U.S. FDA's regulations (see Section 2). The implementation of any change that may directly impact the integrity of the activities conducted or data being supplied for HEMISPHERX will require prior written approval of HEMISPHERX. SCIEN and HEMISPHERX will advise the appropriate organization's staff member (See Attachment 1) before implementation of a change, by either party, to equipment, procedures, specifications, processes, clinical protocols, product claims or facilities directly related to HEMISPHERX's specific products and processes. Each party agrees to review the proposed change in a timely manner and, at its discretion, may audit and/or request an alternative or additional change prior to the implementation of the proposed change. The respective party will review the proposed change, determine if it is reasonably practicable to implement the change and can suggest alternative or additional changes prior to the implementation of the proposed change. Change control requirements should be articulated within the specific operation's documentation practices. HEMISPHERX is responsible for assuring changes are in accordance with and/or reported to the investigational, marketing and/or any other filing with regulatory agencies (IND, IMPD, CTA, NDA, MA, etc.) and for informing SCIEN of any changes requested by regulatory agencies. SCIEN agrees to keep HEMISPHERX fully informed of any and all communications with regulatory agencies that may affect the services being provided to HEMISPHERX by SCIEN. This Agreement is not meant to supersede or replace controlled documents typically used to define and record the work to be conducted by SCIEN for HEMISPHERX. Specific requirements of this Agreement and/or any service contracts shall be articulated within SCIEN's current operating procedures and documentation systems. 9. Responsibilities SCIEN is responsible for: 1) case management support services to patients and maintain a 24-hour/365-day a year telephone service for assistance of prescription drug-related medical emergencies to patients 2) the distribution of product, including the shipping, handling and storage and all rules and regulations of every governmental authority having jurisdiction over the shipping, handling, storage, distribution, and dispensing of Product {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 20 of 28\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"confirming the product labelling requirements in the territory 4) conforming to all labeled specifications concerning t\", \"level\": 1, \"text\": \"3) confirming the product labelling requirements in the territory 4) conforming to all labeled specifications concerning the shipping, handling and storage of Product 5) notifying HEMISPHERX of any unacceptable storage or handling deviation within one (1) business day 6) inspecting all product shipments received by SCIEN from HEMISPHERX and reporting any damage, defect, loss in transit, or other shipping errors to HEMISPHERX within one (1) business days of receipt by SCIEN 7) administering recalls, field alerts, warning letters, quarantines or withdrawals in accordance with HEMISPHERX instructions (See Attachment 2) 8) administering HEMISPHERX's Returned Goods Policy (See Attachment 3) 9) immediately (within 24 hours of becoming aware of event) notifying HEMISPHERX of any serious and unexpected side effects (Adverse Experiences reported to SCIEN, as defined by 21CFR 314.80 and 21CFR 312.32)) 10) providing HEMISPHERX with written Adverse Experience Reports (at the latest day 4 after becoming aware of event) 11) notifying the Regulatory Authorities within the Territory of any reportable adverse experiences 12) notifying the Regulatory Authorities within the Territory of any suspected counterfeiting or tampering except as required different by law 13) obtaining program approval from appropriate regulatory agencies in the Territory 14) keeping HEMISPHERX fully informed of any and all communications with regulatory agencies that may affect the services being provided to HEMISPHERX by SCIEN 15) receiving and processing complaints 16) notifying HEMISPHERX of complaints and actions taken or to be taken to address the complaints 17) the performance of all services provided by SCIEN's subcontractors 18) communicating to HEMISPHERX any events of non-conformance that impact the quality of HEMISPHERX's product. Examples of non-conformances may include, but are not limited to: equipment failure, shipping error or documentation error, labeling error, improper storage, facilities system error, and unplanned study protocol deviations. When a non-conformance event occurs that is specific to HEMISPHERX's product, SCIEN will conduct an investigation and provide copies of all investigation documentation to HEMISPHERX for review and input 19) for initiating, monitoring and completing CAPA tasks related to discrepancies, errors and incidents involving services that are under SCIEN's control HEMISPHERX is responsible for: 1) release of product following review of all manufacturing and quality control testing requirements to confirm the batch has been manufactured according to approved processes and specifications 2) supply all necessary quality documentation with shipments to allow product importation and release 3) ensuring product intended for supply in territory is labelled accordingly 4) assuring changes to the established operations are in accordance with and/or reported to the investigational, marketing and/or any other filing with regulatory agencies (IND, IMPD, CTA, NDA, MA, etc.). 5) informing SCIEN of any changes requested by regulatory agencies 6) assist with/address any Agencies requests relating to manufacture of product 7) providing SCIEN any information that could result in a field alert or recall of a product under a HEMISPHERX NDA or ANDA immediately, but no more than one (1) business day after discovery. HEMISPHERX interprets FDA 21 CFR 314.81, \\\"Other Post- Marketing Reports,\\\" to require a Field Alert Report to be made within three (3) days of an occurrence of an OOS result, whether that result is confirmed or not. The only exception to this would be where the original result was invalidated within the three (3) days. In that case, no field alert would be required 8) making the proper reports to the FDA regarding a field alert or recall {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 21 of 28\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"making the proper reports to the FDA regarding any serious and unexpected side effects 10) communicating to SCIEN any e\", \"level\": 1, \"text\": \"9) making the proper reports to the FDA regarding any serious and unexpected side effects 10) communicating to SCIEN any events of non-conformance that impact the quality of HEMISPHERX's product. Examples of non- conformances may include, but are not limited to: contamination, calculation or documentation error, labeling error. When a non- conformance event occurs HEMISPHERX will conduct an investigation and inform SCIEN of any appropriate action to be taken 11) for initiating, monitoring and completing CAPA tasks related to discrepancies, errors and incidents involving services that are under HEMISPHERX's control 12) contribute to customer complaint investigations where possible issues due to manufacturing process may have contributed to complaint HEMISPHERX and SCIEN are separately responsible for securing and maintaining all required licenses, permits and certificates applicable to their respective operations and each shall comply with any and all applicable federal, state and local laws, including but not limited to (i) the Federal Food Drug and Cosmetic Act; (ii) the Social Security Act; (iii) HIPAA; (iv) all federal and state health care anti-fraud and abuse laws, and (v) all state privacy, and consumer protection laws, including those relating to the use of medical and prescription information for commercial purposes. 10. Subcontractors SCIEN may enter into agreements between SCIEN and a subcontractor. SCIEN will identify the services performed by each such subcontractor. SCIEN is responsible for the performance of all services provided on behalf HEMISPHERX and the compliance of each subcontractor to the terms of this Agreement. HEMISPHERX will be permitted to conduct periodic audits of the subcontractors to assure compliance to applicable GMP's, GLP's and federal regulations (CFR's). 11. Standard Operating Procedures (SOP's) The following HEMISPHERX SOP's are relevant to this Quality Agreement and interactions between HEMISPHERX and SCIEN and affiliates. A. CLN-009 Handling Adverse Event Reports and Records B. RA-001 Post Marketing Adverse Experience Reporting C. QC-006 Investigation of Out of Specification Results 12. Laboratory Controls-N/A 13. Documentation and Record Maintenance SCIEN shall preserve all records in accordance with any applicable federal, state or local requirements. Raw data, documentation, batch records, source documents, product disposition records and reports (collectively, \\\"Documentation\\\") shall be retained by SCIEN for a minimum period of two (2) years after termination or expiration of the Specialty Distributor Purchase and Service Agreement between HEMISPHERX and SCIEN. SCIEN shall, upon written receipt of a written request from HEMISPHERX, finish such Documentation in a format reasonably acceptable to HEMISPHERX with thirty (30) days of receipt of such request. In this case, the Documentation will be shipped to the Quality Assurance Manager named in this Agreement (see Key Contact List, Attachment 1). It is the responsibility of HEMISPHERX to notify SCIEN of any changes in this contact. During the retention period, documentation shall be available for inspection by HEMISPHERX, its authorized agents and authorized government agencies. 14. Complaints In the event SCIEN is notified of a complaint, SCIEN will receive, investigate and respond to the complaint following its internal procedures. A copy of all complaint investigation documentation will be provided to HEMISPHERX. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 22 of 28\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Contact List of Key Personnel\", \"level\": 1, \"text\": \"15. Contact List of Key Personnel. See Attachment 1 IN WITNESS WHEREOF, the parties hereto have executed this Quality Agreement as of the Effective Date. Hemispherx Biopharma Inc. Quality Assurance Signature: _____________________________________________________ Printed Name: Victoria Scott Title: Associate Director Quality and Regulatory Date: _________________________________________________________________________ Management Signature: __________________________________________________________ Printed Name: Wayne Springate Title: Senior Vice President Operations Date: _________________________________________________________________________ SCIEN. Quality Assurance Signature: _____________________________________________________ Printed Name: _________________________________________________________________ Title: _________________________________________________________________________ Date: _________________________________________________________________________ Management Signature: ___________________________________________________________ Printed Name: Abdelrhman Mofeed Zhreldin Title: Business Development Manager Date: _________________________________________________________________________ {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 23 of 28\"}}, {\"id\": \"Attachment 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"List of Key Contacts SUBJECT HEMISPHERX CONTACT SCIEN CONTACT Regulatory Compliance Requirements Notification of Regulatory Agencies and Regulatory Submissions\", \"level\": 1, \"text\": \"Attachment 1 List of Key Contacts SUBJECT HEMISPHERX CONTACT SCIEN CONTACT Regulatory Compliance Requirements Notification of Regulatory Agencies and Regulatory Submissions Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Regulatory@Hemispherx.net Recall of Marketed Product Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Regulatory@Hemispherx.net Adverse Drug Events David Strayer, MD Medical Director Phone:215-988-0880 Fax: 215-988-1739 Email: SAE@Hemispherx.net Product Complaint Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Field Alert Reports/Biological Product Deviation Reports Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Change Control Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Clinical Study Protocol Changes David Strayer, MD Medical Director Phone:215-988-0880 Fax: 215-988-1739 Email: David.Strayer@Hemispherx.net New or Revised Product Claims David Strayer, MD Medical Director Phone:215-988-0880 Fax: 215-988-1739 Email: David.Strayer@Hemispherx.net Documentation Quality Records Record Retention Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 24 of 28 SUBJECT HEMISPHERX CONTACT Product Testing and Release Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Control of Components, Labelling and Packaging Materials Chris Cavalli VP Quality and Process Development Phone: 732-249-3250 Email:Chris.Cavalli@Hemispherx.net Fax:732-249-6895 Product Storage and Shipping Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Returned Goods Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx. Deviations/Investigations Nonconforming or Rejected Material Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Supplier Qualification Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net Quality Audits & Regulatory Inspections Victoria Scott Associate Director/Quality and Regulatory Phone: 732-249-3250 Fax:732-249-6895 Email:Victoria.Scott@Hemispherx.net {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 25 of 28\"}}, {\"id\": \"Attachment 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"QA-007-Product Recall\", \"level\": 1, \"text\": \"Attachment 2 QA-007-Product Recall {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 26 of 28\"}}, {\"id\": \"Attachment 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"HEMISPHERX Return Goods Policy This Return Goods Policy us for all HEMISPHERX product, Interferon alfa-n3 (human leukocyte derived) distributed by SCIEN. The following products are eligible for return and reimbursement: \u00b7 Outdated Product: Product within two (2) months prior or six (6) months past expiration date and noted on product; AND \u00b7 Product in its original container and bearing its original label. OR \u00b7 Product which HEMISPHERX has specified be returned The following products are not eligible for return and reimbursement: \u00b7 Product that is not outdated. \u00b7 Product in which the lot number and/or expiration date is missing, illegible, covered, and/or unreadable on original container. \u00b7 Product that has been damaged due to improper storage handling, fire, flood, or catastrophe. \u00b7 Product that has been sold expressly on a non-returnable basis. \u00b7 Product that is not in its original container and/or not bearing its original label. \u00b7 Product that is in its original container with a prescription label attached. \u00b7 Product that has been repackaged \u00b7 Partial Vials \u00b7 Product obtained illegally or via diverted means \u00b7 Product purchased on the \\\"secondary source\\\" market or from a distributor other than SCIEN. \u00b7 Product that HEMISPHERX determines, in its sole discretion, is otherwise adulterated, misbranded, or counterfeit. HEMISPHERX will only accept returns shipped to SCIEN. All eligible products shall be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes. It is the shipper's responsibility to securely package all return goods to prevent to prevent breakage during transit and otherwise comply with the laws and regulations applicable to the packaging, shipping, and transport of return goods shipments. HEMISPHERX is not responsible for shipments lost and/or damaged in transit. HEMISPHERX recommends that all customers insure return goods shipments. HEMISPHERX will audit the quantities of return goods and final reimbursement will be based on HEMISPHERX count. All products will be reimbursed based on the price paid direct purchasing customers reimbursement will be issued in the form of credit or product replacement to the appropriate party.\", \"level\": 1, \"text\": \"Attachment 3 HEMISPHERX Return Goods Policy This Return Goods Policy us for all HEMISPHERX product, Interferon alfa-n3 (human leukocyte derived) distributed by SCIEN. The following products are eligible for return and reimbursement: \u00b7 Outdated Product: Product within two (2) months prior or six (6) months past expiration date and noted on product; AND \u00b7 Product in its original container and bearing its original label. OR \u00b7 Product which HEMISPHERX has specified be returned The following products are not eligible for return and reimbursement: \u00b7 Product that is not outdated. \u00b7 Product in which the lot number and/or expiration date is missing, illegible, covered, and/or unreadable on original container. \u00b7 Product that has been damaged due to improper storage handling, fire, flood, or catastrophe. \u00b7 Product that has been sold expressly on a non-returnable basis. \u00b7 Product that is not in its original container and/or not bearing its original label. \u00b7 Product that is in its original container with a prescription label attached. \u00b7 Product that has been repackaged \u00b7 Partial Vials \u00b7 Product obtained illegally or via diverted means \u00b7 Product purchased on the \\\"secondary source\\\" market or from a distributor other than SCIEN. \u00b7 Product that HEMISPHERX determines, in its sole discretion, is otherwise adulterated, misbranded, or counterfeit. HEMISPHERX will only accept returns shipped to SCIEN. All eligible products shall be shipped in a safe, secure, and reliable manner, and in compliance with all applicable federal, state and local laws, regulations and statutes. It is the shipper's responsibility to securely package all return goods to prevent to prevent breakage during transit and otherwise comply with the laws and regulations applicable to the packaging, shipping, and transport of return goods shipments. HEMISPHERX is not responsible for shipments lost and/or damaged in transit. HEMISPHERX recommends that all customers insure return goods shipments. HEMISPHERX will audit the quantities of return goods and final reimbursement will be based on HEMISPHERX count. All products will be reimbursed based on the price paid direct purchasing customers reimbursement will be issued in the form of credit or product replacement to the appropriate party. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 27 of 28 To assist in accurate credit memo processing, please include the following information: 1. Purchasers Name and Mailing Address 2. Date and Quantity Return goods shipments which are deemed to be outside of this policy will not be returned to the customer or the third party processor and no reimbursement will be issued by HEMISPHERX. HEMISPHERX return goods policy is subject to change at any time and without prior notices to other parties. {***} Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Page 28 of 28\"}}, {\"id\": \"party:HEMISPHERX\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"HEMISPHERX BIOPHARMA, INC\", \"role\": null, \"address\": \"One Penn Center, 1617 JFK Boulevard, Suite 500, Philadelphia, PA 19103, U.S.\"}}, {\"id\": \"party:SCIEN\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Scientific Products Pharmaceutical Co. LTD\", \"role\": null, \"address\": \"Tahlia Street, P.O Box 10485, Riyadh 11433 Saudi Arabia\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"\\\"Affiliate\\\" means any corporation or other business entity, which controls, is controlled by, or is under the common control of a Party.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:End_User\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User\", \"text\": \"\\\"End User\\\" means a physician, medical facility or institution, or government agency that purchases Product with the intent of administering it to a patient.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Field\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Field\", \"text\": \"\\\"Field\\\" means refractory/recurrent genital warts, recombinant interferon refractory patients and patients with other infectious diseases, e.g., MERS, influenza, West Nile Virus, and cancer, etc.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:HEMISPHERX_Intellectual_Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"HEMISPHERX Intellectual Property\", \"text\": \"\\\"HEMISPHERX Intellectual Property\\\" means all HEMISPHERX patents, patent applications, know-how, and trademarks owned or controlled by HEMISPHERX up to the termination or expiration of this Agreement.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:List_Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"List Price\", \"text\": \"\\\"List Price\\\" means ${***}/Product Unit.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"\\\"Product\\\" means an injectable formulation of clinical grade Interferon alfa-n3 (human leukocyte derived).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product_Data\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Data\", \"text\": \"\\\"Product Data\\\" means all data possessed by HEMISPHERX relating to the use of Interferon alfa-n3 (human leukocyte derived) to treat patients in the Field and which is needed to obtain regulatory approval in the Territory.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product_Unit\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Unit\", \"text\": \"\\\"Product Unit\\\" means 1 x1ml vial containing 5 million international units (I.U.) of Interferon alfa-n3 (human leukocyte derived)\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Sales_Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sales Price\", \"text\": \"\\\"Sales Price\\\" means the price SCIEN and/or its Affiliates charge an End User for a Product Unit.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"\\\"Territory\\\" means the GCC States\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Transfer_Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Transfer Price\", \"text\": \"\\\"Transfer Price\\\" means a discounted price of ${***}/ Product Unit.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Adverse_experience\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Adverse experience\", \"text\": \"Adverse experience: Any adverse event associated with the use of a biological or drug product in humans, whether or not considered product related, including the following: an adverse event occurring in the course of the use of a biological or drug product in professional practice; an adverse event occurring from overdose of the product whether accidental or intentional; an adverse event occurring from abuse of the product; an adverse event occurring from withdrawal of the product; and any failure of expected pharmacological action.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Disability\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disability\", \"text\": \"Disability: A substantial disruption of a person's ability to conduct normal life functions.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Life-threatening_adverse_experience\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Life-threatening adverse experience\", \"text\": \"Life-threatening adverse experience: Any adverse experience that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse experience as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Labeled_event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Labeled event\", \"text\": \"Labeled event: An adverse experience that is listed on the product insert as having been observed in patients who are receiving the drug product.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Drug_Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Drug Product\", \"text\": \"Drug Product: A finished dosage form, for example, tablet, capsule, or solution that contains an active ingredient generally, but not necessarily, in association with inactive ingredients\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Serious_adverse_experience\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Serious adverse experience\", \"text\": \"Serious adverse experience: Any adverse experience occurring at any dose that results in any of the following outcomes: Death, a life-threatening adverse experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a serious adverse experience when, based upon appropriate medical judgment, they may jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the outcomes listed in this definition.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Unexpected_adverse_experience\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unexpected adverse experience\", \"text\": \"Unexpected adverse experience: Any adverse experience that is not listed in the current labelling for the biological or drug product. This includes events that may be symptomatically and pathophysiologically related to an event listed in the labelling, but differ from the event because of greater severity or specificity.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Call_report\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Call report\", \"text\": \"Call report: A list of all questions, requests for circulars, and physician/patient complaints received by SCIEN's Clinical Support Department is prepared monthly by SCIEN staff and is forwarded to HEMISPHERX RA/QA Department.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Audit\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Audit\", \"text\": \"Audit: A systematic examination of processes, controls and systems, operating procedures, reports, records and/or data to assess SCIEN's compliance with standards, regulatory submissions, SOPs; applicable laws, regulations, directives, standards and guidelines; the terms of this Agreement and other contracts in place defining the services being provided and to verify data integrity.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Good_Clinical_Practices\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Good Clinical Practices\", \"text\": \"Good Clinical Practices (\\\"GCPs\\\"): Good clinical practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety, and wellbeing of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible. ICH Guidance for Industry: E6 Good Clinical Practice Consolidated Guidance.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Good_Manufacturing_Practices\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Good Manufacturing Practices\", \"text\": \"Good Manufacturing Practices (\\\"GMPs\\\"): The recognized pharmaceutical regulations and requirements of regulatory authorities such as those defined by the U.S. FDA's regulations at 21CFR Parts 210 and 211.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Key_Contacts\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Key Contacts\", \"text\": \"Key Contacts: Persons at SCIEN and HEMISPHERX assigned to assure proper communication and follow-up in a timely manner within both parties' organizations. Names, titles and full contact information for Key Contacts shall be appended to this Agreement as Attachment 1 and should be maintained up-to-date during the course of the project.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Observation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Observation\", \"text\": \"Observation: A statement of fact made during an audit that is substantiated by objective evidence. HEMISPHERX categorizes observations as follows:\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Out-of-Specification_/_Out-of-Trend\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Out-of-Specification / Out-of-Trend\", \"text\": \"Out-of-Specification / Out-of-Trend (\\\"OOS / \\\"OOT\\\"): A result that is not within the established specifications or trend, whether these are qualitative or quantitative.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"term:Standard_Operating_Procedures\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Standard Operating Procedures\", \"text\": \"Standard Operating Procedures (\\\"SOPs\\\"): Procedures in effect at SCIEN that define the processes and controls by and under which activities are to be conducted to assure compliance with the appropriate Code of Federal Regulations.\", \"definition_clause\": \"Exhibit 4\"}}, {\"id\": \"value:${***}\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"${***}\"}}, {\"id\": \"value:6_months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six 6) months\"}}, {\"id\": \"value:60_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 days\"}}, {\"id\": \"value:3-year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3-year\"}}, {\"id\": \"value:12_month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 month\"}}, {\"id\": \"value:3_months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 months\"}}, {\"id\": \"value:75_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"75 days\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"25%\"}}, {\"id\": \"value:five_(5)_workings\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) workings\"}}, {\"id\": \"value:10_(ten)_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 (ten) days\"}}, {\"id\": \"value:30_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:3_years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 years\"}}, {\"id\": \"value:2_year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"2 year\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:two_(2)_consecutive_years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) consecutive years\"}}, {\"id\": \"value:thirty_(30)_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:three_(3)_months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) months\"}}, {\"id\": \"value:5_years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 years\"}}, {\"id\": \"value:two_(2)_years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:12_months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 months\"}}, {\"id\": \"value:twenty_(20)_business_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) business days\"}}, {\"id\": \"value:sixty_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty days\"}}, {\"id\": \"value:one_(1)_business_day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) business day\"}}, {\"id\": \"value:24_hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"24 hours\"}}, {\"id\": \"value:day_4\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"day 4\"}}, {\"id\": \"value:three_(3)_days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of HYPERIONSOFTWARECORP_09_28_1994-EX-10.47-EXCLUSIVE DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of HYPERIONSOFTWARECORP_09_28_1994-EX-10.47-EXCLUSIVE DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"1\", \"level\": 1, \"text\": \"1 EXCLUSIVE DISTRIBUTOR AGREEMENT EXCLUSIVE DISTRIBUTOR AGREEMENT (\\\"Agreement\\\") dated as April 15, 1994 by and between IMRS OPERATIONS INC. d/b/a IMRS INC., a Delaware corporation with its principal place of business at 777 Long Ridge Road, Stamford, Connecticut 06902, U.S.A. (hereinafter referred to as \\\"Developer\\\") and Delteq Pte Ltd, a Singapore company (and a subsidiary of Wuthelam Industries (S) Pte LTD) with its principal place of business at 215 Henderson Road, #101-03 Henderson Industrial Park, Singapore 0315 (hereinafter referred to as \\\"Distributor\\\"). WHEREAS, Developer has developed certain computer programs and related documentation more particularly described in Schedule A attached hereto (the \\\"Products\\\") and desires to grant distributor the right to market and distribute the Products in Singapore, Malaysia, Indonesia, Thailand, and Brunei (the \\\"Territory\\\"); and WHEREAS, Distributor is in the business of marketing and distributing computer-related products and desires to have Developer grant to it the right to market and distribute the Products in the Territory. NOW, THEREFORE, in consideration of the mutual promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency whereof are hereby acknowledged, the parties hereto agree as follows:\"}, {\"id\": \"1\", \"title\": \"LICENSE\", \"level\": 1, \"text\": \"1. LICENSE\"}, {\"id\": \"1.1\", \"title\": \"Exclusive Distribution License\", \"level\": 2, \"text\": \"1.1 Exclusive Distribution License. ------------------------------ Upon the terms and subject to the conditions of this Agreement, Developer hereby grants to Distributor an exclusive, non-transferable fight and license to market and distribute the Products in the Territory. Distributor shall distribute the Products to existing and new customers of Distributor located in the Territory (the \\\"End-Users\\\") who enter into an End-User License Agreement (as hereinafter defined). The Products shall be in executable object code form only and Distributor shall have no fight to the source code of such Products. The Products distributed to End-Users shall be in executable object code form only. Distributor shall not itself, nor allow others to modify, translate, decompile, nor create or attempt to create, by reverse engineering or otherwise, the source code from the object code of the Products supplied hereunder, or adapt the Products in any way or for use to create a derivative work. Should Distributor wish to create such a derivative work, Distributor must first seek and obtain express written permission to do so from the Developer and Developer may withold such permission at its sole discretion. Distributor may not, and may not permit End-Users to, use, reproduce, siblicense, distribute or dispose of the Products, in whole or in part, except as expressly permitted under this Agreement. 1 2\"}, {\"id\": \"1.2\", \"title\": \"The Territory\", \"level\": 2, \"text\": \"1.2 The Territory. ------------- Distributor may market and distribute the Products solely within the Territory. Distributor shall not have the right to establish third-party agreements for the license, sale, installation and/or support of the Products in the Territory or elsewhere, without the prior written approval of Developer, which approval may be withheld for any reason.\"}, {\"id\": \"1.3\", \"title\": \"License of the Products to End-Users; Other Responsibilities of -------------------------------------------\", \"level\": 2, \"text\": \"1.3 License of the Products to End-Users; Other Responsibilities of --------------------------------------------------------------- Distributor. - - - ----------- (a) In connection with Distributor's license and distribution of the Products to End-Users, Distributor will have End-Users execute a Software License Agreement in the form attached hereto as Schedule B (the \\\"End-User License Agreement\\\"). Distributor may not negotiate the terms of the End-User License Agreement with any prospective End-User or agree to any conflicting, different or additional terms from those set forth in the End-User License Agreement without Developer's prior written consent. Developer shall have no liability to Distributor in the event any prospective End-User refuses to agree to enter into an End-User License Agreement. (b) Distributor will at all times during the term hereof use all reasonable efforts to promote and increase sales of Products throughout the Territory, and will work diligently to obtain orders for Products. Developer shall, during the term hereof, adopt such policies, strategies, prices, customer license terms and conditions, and decisions which will reasonably support Distributor in promoting and increasing sales of Products throughout the Territory and shall respond to Distributor as soon as reasonably practicable with respect to the foregoing. (c) Distributor will promote the sale of Products throughout the Territory to End-Users by means of personal visits, presentations, seminars, correspondence. Specific marketing and sales programs will be defined jointly by Distributor and Developer. (d) Distributor hereby acknowledges that prompt, courteous and professional service of all End-Users and the fostering and maintenance of good relations with End-Users is of paramount importance to Developer, and Distributor hereby agrees to use reasonable efforts to so serve End-Users and promote such relations with End-Users. Distributor shall call upon End-Users regularly, provide assistance and information to End-Users as requested by End-Users or Developer, serve as liaison between End-Users and Developer, and comply with such policies and procedures as Developer may from time to time communicate to Distributor. (e) Distributor shall take all necessary steps to ensure that it and all of its sales personnel are fully familiar with and can effectively demonstrate the Products, are familiar with the Developer's then-current price list, and applicable Developer policies and procedures. (f) Distributor shall attend such annual sales and consulting meetings for, among other things, training and education as Developer shall reasonably require. Distributor 2 3 shall be responsible for the cost of any travel or lodging for attendance at such meetings required by Developer. (g) All payments by End-Users for Products shall be made directly to Distributor, and Distributor shall so advise Developer of the End-Users to whom sales are made. (h) Distributor will not incur or create any liability on behalf of Developer or in any way pledge or purport to pledge the credit of Developer. (i) Distributor will: (i) work closely with Developer to implement the agreed upon sales strategy and marketing strategy for Developer in the Territory; (ii) prepare any market survey or other marketing or sales report reasonably requested by Developer from time to time; and (iii) inform Developer promptly of any commercial, financial, technical or other information which would be of interest to Developer, including but not limited to foreseeable developments regarding End-Users' needs of which Distributor becomes aware. (j) Distributor will observe all directions and instructions given by Developer in relation to Developer's commercial policy, delivery and payment terms and the distribution of Products, and, in the absence of any such directions or instructions in relation to any particular matter, will act in such manner as Distributor reasonably considers to be most beneficial to the best interests of Developer. (k) Distributor will observe and take all necessary or appropriate steps to observe the standards and technical specifications applicable to Developer's business as may be communicated from time to time by Developer to Distributor. (1) Developer shall be the sole source of all copies of the Products or their components distributed by Distributor under the terms of this Agreement. Furthermore, Developer's and the Product names shall appear on the initial screen in all cases. Distributor may mark all such products and materials with its own names or logos to indicate that the Distributor is a marketer of the Products, provided that any such label or lettering is no larger in size than that used for the name and logo of Developer. (m) Distributor shall allocate a minimum of two (2) dedicated people to sell and support the Products full-time. Distributor shall immediately notify Developer in the event that these people are assigned additional responsibilities that prevent them from remaining dedicated to the Products full-time. 3 4\"}, {\"id\": \"1.4\", \"title\": \"Product Changes\", \"level\": 2, \"text\": \"1.4 Product Changes. --------------- Developer retains the right, in its sole discretion, to upgrade or modify the Products from time to time. In addition, upon ninety (90) days prior written notice to Distributor, Developer may add or delete Products from Schedule A. Upon receipt of any such notice of any upgrade or modification, or upon the expiration of the notice period set forth above for additions or deletions to Schedule A, Distributor shall cease to market and distribute earlier versions of the Products and/or Products deleted from Schedule A.\"}, {\"id\": \"1.5\", \"title\": \"License to Use Trademark and Trade Name\", \"level\": 2, \"text\": \"1.5 License to Use Trademark and Trade Name. --------------------------------------- Any and all trademarks and trade names which Developer uses in connection with the license granted hereunder are and shall remain the exclusive property of Developer. Nothing contained in this Agreement shall be deemed to give Distributor any right, title or interest in any trademark or trade name of Developer relating to the Products. Subject to notice in writing from Developer which modifies or cancels such authorization, during the term of this Agreement, Distributor may use at no charge the trademarks and trade names specified by Developer in writing for normal advertising and promotion of Products. Developer occasionally uses third party trademarks, trade names or screen shots in advertising; Distributor may not use such trademarks, trade names or screen shots in writing for advertising without the prior written permission from the third party developer.\"}, {\"id\": \"2\", \"title\": \"PRICE, PAYMENT AND SHIPMENT\", \"level\": 1, \"text\": \"2. PRICE, PAYMENT AND SHIPMENT. ---------------------------\"}, {\"id\": \"2.1\", \"title\": \"Price\", \"level\": 2, \"text\": \"2.1 Price. ----- Distributor shall adhere to the then current Developer Prices for each Product (collectively, the \\\"Prices\\\"). Developer's current Prices for each Product are set forth in Schedule C. Developer may increase or decrease the Prices for any or all Products upon written notice to Distributor. Distributor must receive, for each instance, express written permission from Developer to sell Product at any price other than such Prices.\"}, {\"id\": \"2.2\", \"title\": \"Orders, Payment and Shipment\", \"level\": 2, \"text\": \"2.2. Orders, Payment and Shipment. ---------------------------- Upon Developer's receipt of a written order from Distributor (each an \\\"Order\\\") together with a copy of an executed End-User License Agreement and Contract Summary Form (Appendix D), Developer will ship to Distributor the designated quantities of the Products. At Distributor's expense, the Products shall be shipped by Developer to Distributor F.O.B. origin, freight pre-paid, with risk of loss to pass to Distributor upon delivery of the Products by Developer to a common carrier. Notwithstanding the above, upon notice to Distributor, Developer may ship the Software directly to Distributor's customer. The terms and conditions of this Agreement shall apply to all Orders submitted to Developer by Distributor. Orders issued by\"}, {\"id\": \"4\", \"title\": \"5\", \"level\": 1, \"text\": \"4 5 Distributor to Developer are solely for the purpose of requesting delivery dates and quantities. All Orders shall be subject to acceptance by Developer; Developer will not unreasonably delay acceptance of any order. Developer shall use reasonable efforts to deliver accepted Orders but shall not be liable for any damages to Distributor or to any third party caused by Developer's delay or error in filling, or failure to fill, any Orders for any reason. Except as otherwise provided herein, all fees and expenses payable hereunder for which Developer issues an invoice to Distributor shall be due and payable thirty (30) days from the date of the invoice. A late payment charge of the lesser of one and one-half percent (1.5%) per month or the highest interest rate allowed by applicable law shall be charged upon all unpaid amounts due hereunder for more than thirty (30) days.\"}, {\"id\": \"2.3\", \"title\": \"Reporting; Royalties\", \"level\": 2, \"text\": \"2.3 Reporting; Royalties. -------------------- Distributor shall submit Monthly Sales and Royalty Reports and make payments to Developer as provided herein. All royalties paid to Developer shall be based upon Developer's list prices in U.S. Dollars, except as otherwise agreed in writing by Developer. Software license fees associated with Software license agreements in which the sales cycle begins on or after May 1, 1994 (hereinafter \\\"New Software license agreements\\\") for Product sites located in the Territory, shall be allocated and distributed as follows: Gross Software Revenue Generated % to Distributor -------------------------------- ---------------- Per Annum July 1- June 30 US$O -- $999,999 40% US$1,O00,000 + 50% On July 1 each year, the gross software revenue generated figure will be reset to zero and the accumulation of software revenues will restart. However, the foregoing allocation of such fees associated with the New Software license agreements involving a headquarter Product or other site licenses situated outside of the Territory may be subject to reduced percentages to Distributor due to royalties owed to other Developer entities, affiliates, or distributors located outside the Territory, who may also have participated in the sale. Each such situation will be evaluated individually and a final decision on the royalty due will be based upon each party's relative contribution and will be made in Developer's sole discretion. The general guidelines for such cases are outlined in Appendix E (Bergamo Rules). Installation, consulting, and training fees associated with the Products are due and payable to the party performing the services.\"}, {\"id\": \"5\", \"title\": \"6\", \"level\": 1, \"text\": \"5 6 License Renewal and Maintenance Fees will be split evenIy with 50% distributed to Developer and 50% distributed to Distributor, also subject to paragraph 4 of this section 2.3. Distributor will submit a monthly report to Developer which accurately identifies the Software license fees, maintenance fees, and any other fees set forth in this Agreement (repons outlined in Schedule D). This report is due at the earliest possible time, but in no event later than ten (10) days following the end of each calendar month Payment by Distributor of the applicable royalty fees to Developer shall accompany the report; provided, however, that Developer shall have the reasonable fight to inspect Distributor's books from time to time during the term hereof and for a one (1) year period after the termination of this Agreement for purposes of verifying the royalties payable to Developer. In addition, Distributor shall report the acquisition of each new license for the Software system to Developer and will provide either an English translation of the End-User License Agreement or a completed contract extract schedule in the form of Exhibit D (Contract Summary Form) within one (1) day of accepting the order.\"}, {\"id\": \"24\", \"title\": \"Inspection and Acceptance\", \"level\": 1, \"text\": \"24 Inspection and Acceptance. ------------------------- Distributor shall inspect all Products immediately upon delivery and shall, within seven (7) calendar days, give written notice to the common cartier and Developer of any claim for damages or shortages. Distributor shall give written notice to Developer within thirty (30) calendar days of delivery in the event that any Product does not conform with the terms of this Agreement. If Distributor fails to give any such notice, the Products shall be deemed accepted for all purposes of this Agreement.\"}, {\"id\": \"2.5\", \"title\": \"Taxes\", \"level\": 2, \"text\": \"2.5 Taxes. ----- In addition to the Prices and other fees payable hereunder, Distributor shall record and pay any federal, state, local or other duties, withholding and excise taxes, now or hereafter applied on the sale, transportation, import, export, licensing or use of the Products including sales tax, value added tax or similar tax. Any taxes imposed by federal, state or any local government or any amount in lieu thereof, including interest and penalties thereon, paid or payable at any time by Developer in connection with Developer's license to Distributor, exclusive of taxes based on Developer's net income, shall be borne by Distributor. Distributor shall co-operate with and assist Developer, as reasonably necessary, to obtain United States tax credits for any duties or taxes described in this Section 2.5 which may be credited to and/or recovered by Developer and applied by Developer to reduce its United States tax liability. In the event Developer obtains any such tax credits, Developer shall notify Distributor of the amount thereof and Distributor shall be entitled to apply such amount against future amounts payable by Distributor to Developer hereunder. 6 7\"}, {\"id\": \"3\", \"title\": \"MAINTENANCE AND SUPPORT\", \"level\": 1, \"text\": \"3. MAINTENANCE AND SUPPORT. -----------------------\"}, {\"id\": \"3.1\", \"title\": \"Distributor Support -------------------\", \"level\": 2, \"text\": \"3.1 Distributor Support ------------------- Distributor shall remain solely responsible for all installation, maintenance, consulting and support services to the End-Users with regard to the Products. Developer agrees to deliver to Distributor together with the first Order delivered to Distributor a copy of the Product to be used solely by Distributor's personnel providing installation, maintenance, consulting or support services to End-Users and shall only be used at Distributor's site. Distributor's failure to maintain the confidentiality of the Products pursuant to the terms of this Agreement shall be deemed a material breach of this Agreement. As mutually agreeable, Developer, Developer's affiliates, or Distributor may each provide local support to the sites of multi-location clients, each on behalf of the other where the provisions of such support will enhance the quality of support provided to the client. Such services will be provided at the local billing rate or such alternative billing rate as shall be agreed between the parties. The party providing the support shall receive all revenues arising therefrom unless otherwise agreed. Furthermore, it is understood that travel expenses, if any, are to be borne by the client utilizing the support services or by the Distributor unless otherwise agreed. For End-Users that have a World Wide Retainer in place, Distributor will provide local support in the Territory as defined in the World Wide Retainer (Schedule F).\"}, {\"id\": \"3.2\", \"title\": \"Audit Rights\", \"level\": 2, \"text\": \"3.2 Audit Rights. ------------ Distributor shall maintain accurate books and records of all End-User License Agreements granted for the Products (which will include at a minimum the location, type and number of products and sites, renewal and payment terms and any special conditions or terms), the End-Users receiving maintenance, and consulting and support services, payable under this Agreement. Upon reasonable notice to Distributor, Distributor shall make such books and records available to Developer, at Distributor's place of business during normal business hours, to audit the payments being made by Distributor hereunder.\"}, {\"id\": \"3.3\", \"title\": \"End-User Training and Developer Consulting Services ---------------------------------------------------\", \"level\": 2, \"text\": \"3.3 End-User Training and Developer Consulting Services --------------------------------------------------- Distributor shall be solely responsible for the training of End-Users. Developer may be available at its then current standard rates to provide training, special enhancements, customization and other special work or services to either Distributor or End-Users. 7 8\"}, {\"id\": \"4\", \"title\": \"CONFIDENTIALITY AND PROPRIETARY RIGHTS\", \"level\": 1, \"text\": \"4. CONFIDENTIALITY AND PROPRIETARY RIGHTS. --------------------------------------\"}, {\"id\": \"4.1\", \"title\": \"Confidentiality\", \"level\": 2, \"text\": \"4.1 Confidentiality. --------------- Distributor acknowledges that in the course of dealings between the parties, Distributor may acquire information about Developer, its business activities and operations, its technical information and trade secrets, including but not limited to the Products, all of which are highly confidential and proprietary to Developer (the \\\"Confidential Information\\\"). Confidential Information shall not include information generally available to or known by the public, or information independently developed outside the scope of this Agreement. Distributor shall hold all such Confidential Information in strict confidence and shall not reveal or use the same except pursuant to a court order or upon written request of Developer. The Confidential Information shall be safeguarded with at least as great a degree of care as Distributor uses to safeguard its own most confidential materials or data relating to its own business, but in no event less than a reasonable degree of care.\"}, {\"id\": \"4.2\", \"title\": \"Proprietary Rights\", \"level\": 2, \"text\": \"4.2 Proprietary Rights. ------------------ Distributor acknowledges and agrees that the Products, and all copies thereof, constitute valuable trade secrets of Developer and/or proprietary and confidential information of Developer and title thereto remains in Developer. Ownership of all applicable copyrights, trade secrets, patents and other intellectual property rights in the Products are and shall remain vested in Developer. All other aspects of the Products, including without limitation, algorithms, models, programs, methods of processing, design and structure of individual programs and their interaction and programming techniques employed therein shall remain the sole and exclusive property of Developer and shall not be sold, revealed, disclosed or otherwise communicated, directly or indirectly, by Distributor to any person, company or entity whatsoever other than as expressly set forth herein. The copyright notice and restricted rights legends contained in the Products shall appear on all tapes, diskettes and other tangible media distributed by Distributor.\"}, {\"id\": \"4.3\", \"title\": \"Specific Remedies\", \"level\": 2, \"text\": \"4.3 Specific Remedies. ----------------- If Distributor commits a breach of any of the provisions of Sections 4.1 or 4.2 above, Developer shall have, in addition to all other fights in law and equity, (a) the right to have such provisions specifically enforced by any court having equity jurisdiction, it being acknowledged and agreed that any such breach will cause irreparable injury to Developer and that money damages will not provide an adequate remedy, and (b) the right to require Distributor to account for and pay to Developer all compensation, profits, monies or other tangible benefits (collectively \\\"Benefits\\\") derived or received as the result of any transactions constituting a breach of any of the provisions of this Article 4, and Distributor hereby agrees to account for and pay such Benefits. 8 9\"}, {\"id\": \"4.4\", \"title\": \"Covenant Not to Compete\", \"level\": 2, \"text\": \"4.4 Covenant Not to Compete. ----------------------- During the term of this Agreement and for a period of two (2) years after the termination hereof for any reason, Distributor will not market, or attempt to market, a computer program which competes in any way with the Products in the areas of consolidation, financial information, financial transaction processing, reporting, data collection, or modeling, including but not limited to the use of personal computers, nor which competes with any modification, alteration or enhancement to the Products which is developed during the term of this Agreement.\"}, {\"id\": \"5\", \"title\": \"LIMITED WARRANTY\", \"level\": 1, \"text\": \"5. LIMITED WARRANTY. ----------------\"}, {\"id\": \"5.1\", \"title\": \"Limited Warranty\", \"level\": 2, \"text\": \"5.1 Limited Warranty. ---------------- For ninety (90) days after delivery of a Product to Distributor, Developer warrants that media upon which the Products are delivered shall be of good quality and workmanship. Upon written notice from Distributor of defective media for a Product, Developer shall use reasonable efforts to promptly provide replacement media.\"}, {\"id\": \"5.2\", \"title\": \"Disclaimer of Warranties\", \"level\": 2, \"text\": \"5.2 Disclaimer of Warranties. ------------------------ EXCEPT FOR THE LIMITED WARRANTY SET FORTH IN SECTION 5.1, THE PRODUCTS ARE PROVIDED \\\"AS IS\\\". DEVELOPER SPECIFICALLY DISCLAIMS ALL WARRANTIES EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT'TO THE PRODUCTS OR DEFECTS IN THE TAPE, DISKETTE OR OTHER TANGIBLE MEDIA AND DOCUMENTATION, OPERATION OF THE PRODUCTS, AND ANY PARTICULAR APPLICATION OR USE OF THE PRODUCTS.\"}, {\"id\": \"6\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"6. LIMITATION OF LIABILITY. ----------------------- IN NO EVENT SHALL DEVELOPER BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE, INCLUDING BUT NOT LIMITED TO SPECIAL, INCIDENTAL, CONSEQUENTIAL OR OTHER INDIRECT DAMAGES UNDER ANY CAUSE OF ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, CLAIMS ARISING FROM MALFUNCTION OR DEFECTS IN THE PRODUCTS. DEVELOPER'S MAXIMUM LIABILITY HEREUNDER IS EXPRESSLY LIMITED TO THE LESSER OF: THE AMOUNT PAID UNDER THIS AGREEMENT BY DISTRIBUTOR TO DEVELOPER WITHIN THE SIX (6) MONTH PERIOD IMMEDIATELY PRECEDING THE CAUSE GIVING RISE TO THE CLAIM; OR FIVE HUNDRED THOUSAND DOLLARS ($5OO,000). 9 10\"}, {\"id\": \"7\", \"title\": \"DISTRIBUTOR OBLIGATIONS\", \"level\": 1, \"text\": \"7. DISTRIBUTOR OBLIGATIONS. -----------------------\"}, {\"id\": \"7.1\", \"title\": \"Marketing Efforts\", \"level\": 2, \"text\": \"7.1 Marketing Efforts. ----------------- Distributor agrees to use its best efforts to promote the sale of the Products in the Territory. Distributor agrees to permit Developer to review all of Distributor's promotion and advertising material for the Products prior to use. Distributor shall not use and shall withdraw and retract any promotion or advertising that Developer finds unsuitable, or is in breach of the terms of this Agreement.\"}, {\"id\": \"7.2\", \"title\": \"Prohibited Practices\", \"level\": 2, \"text\": \"7.2 Prohibited Practices. -------------------- Distributor may not make any contracts or commitments on behalf of Developer nor make any warranties or other representations regarding the Products other than those authorized herein or by Developer in a separate writing.\"}, {\"id\": \"7.3\", \"title\": \"Export Notice\", \"level\": 2, \"text\": \"7.3 Export Notice. ------------- Distributor agrees to provide Developer with reasonable advance notice of each country- to which it intends to export the Products. Prior to exporting to a foreign country for the first time, Distributor shall provide Developer with a reasonable opportunity to file such proprietary rights notices, applications, and other documents as Developer determines to be reasonably necessary to protect in such country the proprietary rights associated with the Products. Distributor agrees at Developer's expense to cooperate with Developer in the protection of such proprietary rights in each country to which it exports the Products.\"}, {\"id\": \"7.4\", \"title\": \"Compliance with Laws\", \"level\": 2, \"text\": \"7.4 Compliance with Laws. -------------------- Distributor agrees to comply with all applicable laws and regulations, both foreign and domestic, in its performance under this Agreement, including, but not limited to, domestic and foreign export/import laws and regulations.\"}, {\"id\": \"8\", \"title\": \"TERMS AND TERMINATION\", \"level\": 1, \"text\": \"8. TERMS AND TERMINATION. ---------------------\"}, {\"id\": \"8.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"8.1 Term. ---- This Agreement shall have an initial term of one (1) year from the date first above written (the \\\"Initial Term\\\"), and shall thereafter automatically renew for successive two (2) year periods (each a \\\"Renewal Term\\\"), unless earlier terminated in accordance with the terms of this Agreement. Developer may cancel this Agreement if the total gross annual software revenue does not meet DeVeloper's revenue forecast for the Distributor, such cancellation to be eftected by written notice delivered to Distributor not later than 30 days after any Developer's Fiscal Year end (June 30). Either party may cancel this Agreement effective on the last day of the Initial Term, or\"}, {\"id\": \"10\", \"title\": \"11\", \"level\": 1, \"text\": \"10 11 any Renewal Term, by serving written notice of such termination on the other party at least ninety (90) days prior to the end of the Initial Term or any Renewal Term as the case may be.\"}, {\"id\": \"8.2\", \"title\": \"Developer Termination\", \"level\": 2, \"text\": \"8.2 Developer Termination. --------------------- This Agreement may be terminated immediately by Developer under any of the following conditions: (a) if one of the parties shall be declared insolvent or bankrupt; (b) if a petition is filed in any court to declare one of the parties bankrupt or for a reorganization under the Bankruptcy Code or any similar statute and such petition is not dismissed in ninety (90) days or if a Trustee in Bankruptcy or a Receiver or similar entity is appointed for one of the parties; (c) if Distributor does not pay Developer within thirty (30) days from the date that any payments are due hereunder; (d) if Distributor breaches the provisions of Sections 4.1 or 4.2 of this Agreement; or (e) if Distributor otherwise materially breaches the terms of this Agreement, and such breach is not cured within thirty (30) days after written notice of such breach is given by Developer.\"}, {\"id\": \"8.3\", \"title\": \"Duties Upon Termination\", \"level\": 2, \"text\": \"8.3 Duties Upon Termination. ----------------------- (a) Provided termination is not a result of a material breach of Sections 4.1 or 4.2, the parties agree to continue their cooperation in order to effect an orderly termination of their relationship. Distributor may continue running the Products solely for purposes of providing maintenance to End-Users granted licenses pursuant to an End-User License Agreement prior to termination. Upon termination, Distributor shall have no fight to order or receive any additional copies of the Products and all of Distributor's rights and licenses granted hereunder shall immediately cease. Within thirty (30) days of termination, Distributor shall return all copies of any promotional materials, marketing literature, written information and reports pertaining to the Products that have been supplied by Developer. (b) Upon termination of this Agreement for any reason, Distributor shall forthwith return all Products, documentation and materials relating thereto to Developer. Termination of this Agreement shall not relieve Distributor of any financial obligations to Developer which remain unsettled at the date of termination, nor of the terms relating to proprietary rights, trade secrets, or non compete restrictions; provided, further, that if this Agreement is terminated for any reason, Developer shall have the option, but not the obligation to\"}, {\"id\": \"11\", \"title\": \"12\", \"level\": 1, \"text\": \"11 12 assume at no cost to Developer, any or all of Distributor's third party agreements (including End-User Agreements) relating to the Products and to receive any and all fees therefrom.\"}, {\"id\": \"8.4\", \"title\": \"Survival --------\", \"level\": 2, \"text\": \"8.4 Survival -------- The provisions of Sections 4, 5 and 9 shall survive the termination of this Agreement.\"}, {\"id\": \"9\", \"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"9. INDEMNIFICATION. ---------------\"}, {\"id\": \"9.1\", \"title\": \"Copyright Indemnification\", \"level\": 2, \"text\": \"9.1 Copyright Indemnification. ------------------------- Developer shall indemnify, defend and hold Distributor harmless from any claims, demands, liabilities or expenses, including reasonable attorneys' fees, directly resulting from any infringement or violation of any copyright with respect to the Product(s), as so awarded by a final judgment against Distributor by a court of competent jurisdiction that the Product(s) infringe any third party's copyright, Developer shall, in its sole discretion: (a) procure for Distributor the right to continue to use, distribute and sell the Product(s) at no additional expense to Distributor; (b) provide Distributor with a non-infringing version of the Product(s) with substantially similar functionality; or (c) notify Distributor that the Product(s) are being withdrawn from the market and Distributor agrees to immediately cease its distribution of such Product(s). If all Products are withdrawn from the market, this Agreement will immediately terminate.\"}, {\"id\": \"9.2\", \"title\": \"Cooperation by Distributor\", \"level\": 2, \"text\": \"9.2 Cooperation by Distributor. -------------------------- Notwithstanding Section 9.1 of this Agreement, Developer is under no obligation to indemnify and hold Distributor harmless unless: (a) Developer shall have been promptly notified of the suit, action, proceeding or claim by Distributor and furnished by Distributor with a copy of each communication, notice or other action relating to said suit, action, proceeding or claim; (b) Developer shall have the right to assume sole authority to conduct the trial or settlement of such suit, action, proceeding or claim or any negotiations related thereto at Developer's expense; and (c) Distributor shall provide reasonable information and assistance requested by Developer in connection with such claim or suit. 12 13\"}, {\"id\": \"9.3\", \"title\": \"Distributor Indemnification\", \"level\": 2, \"text\": \"9.3 Distributor Indemnification. --------------------------- Distributor shall indemnify, defend and hold Developer harmless from any claims, demands, liability or expenses, including reasonable attorneys' fees, incurred by Developer as a result of any claim or proceeding against Developer arising out of or based upon (i) the combination, operation or use of the Products with any hardware, products, programs or data not supplied or approved in writing by Developer, if such infringement would have been avoided but for such combination, operation or use (ii) modification of the Products by Distributor or End- Users(iii) any breach of this Agreement by the Distributor or (iv) any breach by the Distributor of any End User or other agreement to which Developer or Distributor is a party.\"}, {\"id\": \"10\", \"title\": \"GENERAL\", \"level\": 1, \"text\": \"10. GENERAL. -------\"}, {\"id\": \"10.1\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"10.1 Force Majeure. ------------- Neither party shall be liable or deemed to be in default for any delay or failure in performance (other than the payment of money) under this Agreement or interruption of service resulting directly or indirectly from acts of God, or any causes beyond the reasonable control of such party.\"}, {\"id\": \"10.2\", \"title\": \"Jurisdiction and Venue\", \"level\": 2, \"text\": \"10.2 Jurisdiction and Venue. ---------------------- This Agreement shall be governed by and construed in accordance with the laws of the State of Connecticut, U.S.A. without regard to its conflict of taws provision. Jurisdiction for litigation of any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach thereof shall be only in the Federal or the State court with competent jurisdiction located in Stamford, Connecticut.\"}, {\"id\": \"10.3\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"10.3 Entire Agreement. ---------------- This Agreement, including the Schedules attached hereto, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all previous proposals, both oral and written, negotiations, representations, commitments, writings and all other communications between the parties. This Agreement may not be modified except by a writing signed by a duly authorized representative of each of the parties. 13 14\"}, {\"id\": \"10.4\", \"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"10.4 Independent Contractors. ----------------------- It is expressly agreed that Developer and Distributor are acting hereunder as independent contractors and under no circumstances shall any of the employees of one party be deemed the employees of the other for any purpose. This Agreement shall not be construed as authority for either party to act for the other party in any agency or other capacity, or to make commitments of any kind for the account of or on behalf of the other except to the extent and for the purposes provided for herein.\"}, {\"id\": \"10.5\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"10.5 Assignment. ---------- This Agreement is not assignable by either party hereto without the prior written consent of the other, except that this Agreement shall be assignable by Developer to an affiliated entity or upon the sale of the fight to license and sublicense the Products to the purchaser of said right. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and permitted assigns.\"}, {\"id\": \"10.6\", \"title\": \"Severability and Waiver\", \"level\": 2, \"text\": \"10.6 Severability and Waiver. ----------------------- If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid or unenforceable, such determination shall not affect the validity or enforceability of any other part or provision of this Agreement. No waiver by any party of any breach of any provisions hereof shall constitute a waiver unless made in writing signed by the party. IN WITNESS WHEREOF, the parties hereto have executed this Agreement by a duly authorized representative as of the date set forth above. DISTRIBUTOR: DEVELOPER: ----------- --------- DELTEQ SYSTEMS PTE LTD IMRS OPERATIONS INC. d/b/a IMRS INC. By: /s/ S.C. CHEN By: /s/ DAVID M. SAMPLE -------------------- ----------------------- Name: S.C. Chen Name: David M. Sample --------------------- Title: Managing Director Title: Senior Vice President 14\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of HYPERIONSOFTWARECORP_09_28_1994-EX-10.47-EXCLUSIVE DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"1\", \"level\": 1, \"text\": \"1 EXCLUSIVE DISTRIBUTOR AGREEMENT EXCLUSIVE DISTRIBUTOR AGREEMENT (\\\"Agreement\\\") dated as April 15, 1994 by and between IMRS OPERATIONS INC. d/b/a IMRS INC., a Delaware corporation with its principal place of business at 777 Long Ridge Road, Stamford, Connecticut 06902, U.S.A. (hereinafter referred to as \\\"Developer\\\") and Delteq Pte Ltd, a Singapore company (and a subsidiary of Wuthelam Industries (S) Pte LTD) with its principal place of business at 215 Henderson Road, #101-03 Henderson Industrial Park, Singapore 0315 (hereinafter referred to as \\\"Distributor\\\"). WHEREAS, Developer has developed certain computer programs and related documentation more particularly described in Schedule A attached hereto (the \\\"Products\\\") and desires to grant distributor the right to market and distribute the Products in Singapore, Malaysia, Indonesia, Thailand, and Brunei (the \\\"Territory\\\"); and WHEREAS, Distributor is in the business of marketing and distributing computer-related products and desires to have Developer grant to it the right to market and distribute the Products in the Territory. NOW, THEREFORE, in consideration of the mutual promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency whereof are hereby acknowledged, the parties hereto agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSE\", \"level\": 1, \"text\": \"1. LICENSE\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exclusive Distribution License\", \"level\": 2, \"text\": \"1.1 Exclusive Distribution License. ------------------------------ Upon the terms and subject to the conditions of this Agreement, Developer hereby grants to Distributor an exclusive, non-transferable fight and license to market and distribute the Products in the Territory. Distributor shall distribute the Products to existing and new customers of Distributor located in the Territory (the \\\"End-Users\\\") who enter into an End-User License Agreement (as hereinafter defined). The Products shall be in executable object code form only and Distributor shall have no fight to the source code of such Products. The Products distributed to End-Users shall be in executable object code form only. Distributor shall not itself, nor allow others to modify, translate, decompile, nor create or attempt to create, by reverse engineering or otherwise, the source code from the object code of the Products supplied hereunder, or adapt the Products in any way or for use to create a derivative work. Should Distributor wish to create such a derivative work, Distributor must first seek and obtain express written permission to do so from the Developer and Developer may withold such permission at its sole discretion. Distributor may not, and may not permit End-Users to, use, reproduce, siblicense, distribute or dispose of the Products, in whole or in part, except as expressly permitted under this Agreement. 1 2\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Territory\", \"level\": 2, \"text\": \"1.2 The Territory. ------------- Distributor may market and distribute the Products solely within the Territory. Distributor shall not have the right to establish third-party agreements for the license, sale, installation and/or support of the Products in the Territory or elsewhere, without the prior written approval of Developer, which approval may be withheld for any reason.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"License of the Products to End-Users; Other Responsibilities of -------------------------------------------\", \"level\": 2, \"text\": \"1.3 License of the Products to End-Users; Other Responsibilities of --------------------------------------------------------------- Distributor. - - - ----------- (a) In connection with Distributor's license and distribution of the Products to End-Users, Distributor will have End-Users execute a Software License Agreement in the form attached hereto as Schedule B (the \\\"End-User License Agreement\\\"). Distributor may not negotiate the terms of the End-User License Agreement with any prospective End-User or agree to any conflicting, different or additional terms from those set forth in the End-User License Agreement without Developer's prior written consent. Developer shall have no liability to Distributor in the event any prospective End-User refuses to agree to enter into an End-User License Agreement. (b) Distributor will at all times during the term hereof use all reasonable efforts to promote and increase sales of Products throughout the Territory, and will work diligently to obtain orders for Products. Developer shall, during the term hereof, adopt such policies, strategies, prices, customer license terms and conditions, and decisions which will reasonably support Distributor in promoting and increasing sales of Products throughout the Territory and shall respond to Distributor as soon as reasonably practicable with respect to the foregoing. (c) Distributor will promote the sale of Products throughout the Territory to End-Users by means of personal visits, presentations, seminars, correspondence. Specific marketing and sales programs will be defined jointly by Distributor and Developer. (d) Distributor hereby acknowledges that prompt, courteous and professional service of all End-Users and the fostering and maintenance of good relations with End-Users is of paramount importance to Developer, and Distributor hereby agrees to use reasonable efforts to so serve End-Users and promote such relations with End-Users. Distributor shall call upon End-Users regularly, provide assistance and information to End-Users as requested by End-Users or Developer, serve as liaison between End-Users and Developer, and comply with such policies and procedures as Developer may from time to time communicate to Distributor. (e) Distributor shall take all necessary steps to ensure that it and all of its sales personnel are fully familiar with and can effectively demonstrate the Products, are familiar with the Developer's then-current price list, and applicable Developer policies and procedures. (f) Distributor shall attend such annual sales and consulting meetings for, among other things, training and education as Developer shall reasonably require. Distributor 2 3 shall be responsible for the cost of any travel or lodging for attendance at such meetings required by Developer. (g) All payments by End-Users for Products shall be made directly to Distributor, and Distributor shall so advise Developer of the End-Users to whom sales are made. (h) Distributor will not incur or create any liability on behalf of Developer or in any way pledge or purport to pledge the credit of Developer. (i) Distributor will: (i) work closely with Developer to implement the agreed upon sales strategy and marketing strategy for Developer in the Territory; (ii) prepare any market survey or other marketing or sales report reasonably requested by Developer from time to time; and (iii) inform Developer promptly of any commercial, financial, technical or other information which would be of interest to Developer, including but not limited to foreseeable developments regarding End-Users' needs of which Distributor becomes aware. (j) Distributor will observe all directions and instructions given by Developer in relation to Developer's commercial policy, delivery and payment terms and the distribution of Products, and, in the absence of any such directions or instructions in relation to any particular matter, will act in such manner as Distributor reasonably considers to be most beneficial to the best interests of Developer. (k) Distributor will observe and take all necessary or appropriate steps to observe the standards and technical specifications applicable to Developer's business as may be communicated from time to time by Developer to Distributor. (1) Developer shall be the sole source of all copies of the Products or their components distributed by Distributor under the terms of this Agreement. Furthermore, Developer's and the Product names shall appear on the initial screen in all cases. Distributor may mark all such products and materials with its own names or logos to indicate that the Distributor is a marketer of the Products, provided that any such label or lettering is no larger in size than that used for the name and logo of Developer. (m) Distributor shall allocate a minimum of two (2) dedicated people to sell and support the Products full-time. Distributor shall immediately notify Developer in the event that these people are assigned additional responsibilities that prevent them from remaining dedicated to the Products full-time. 3 4\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Changes\", \"level\": 2, \"text\": \"1.4 Product Changes. --------------- Developer retains the right, in its sole discretion, to upgrade or modify the Products from time to time. In addition, upon ninety (90) days prior written notice to Distributor, Developer may add or delete Products from Schedule A. Upon receipt of any such notice of any upgrade or modification, or upon the expiration of the notice period set forth above for additions or deletions to Schedule A, Distributor shall cease to market and distribute earlier versions of the Products and/or Products deleted from Schedule A.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"License to Use Trademark and Trade Name\", \"level\": 2, \"text\": \"1.5 License to Use Trademark and Trade Name. --------------------------------------- Any and all trademarks and trade names which Developer uses in connection with the license granted hereunder are and shall remain the exclusive property of Developer. Nothing contained in this Agreement shall be deemed to give Distributor any right, title or interest in any trademark or trade name of Developer relating to the Products. Subject to notice in writing from Developer which modifies or cancels such authorization, during the term of this Agreement, Distributor may use at no charge the trademarks and trade names specified by Developer in writing for normal advertising and promotion of Products. Developer occasionally uses third party trademarks, trade names or screen shots in advertising; Distributor may not use such trademarks, trade names or screen shots in writing for advertising without the prior written permission from the third party developer.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE, PAYMENT AND SHIPMENT\", \"level\": 1, \"text\": \"2. PRICE, PAYMENT AND SHIPMENT. ---------------------------\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price\", \"level\": 2, \"text\": \"2.1 Price. ----- Distributor shall adhere to the then current Developer Prices for each Product (collectively, the \\\"Prices\\\"). Developer's current Prices for each Product are set forth in Schedule C. Developer may increase or decrease the Prices for any or all Products upon written notice to Distributor. Distributor must receive, for each instance, express written permission from Developer to sell Product at any price other than such Prices.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Orders, Payment and Shipment\", \"level\": 2, \"text\": \"2.2. Orders, Payment and Shipment. ---------------------------- Upon Developer's receipt of a written order from Distributor (each an \\\"Order\\\") together with a copy of an executed End-User License Agreement and Contract Summary Form (Appendix D), Developer will ship to Distributor the designated quantities of the Products. At Distributor's expense, the Products shall be shipped by Developer to Distributor F.O.B. origin, freight pre-paid, with risk of loss to pass to Distributor upon delivery of the Products by Developer to a common carrier. Notwithstanding the above, upon notice to Distributor, Developer may ship the Software directly to Distributor's customer. The terms and conditions of this Agreement shall apply to all Orders submitted to Developer by Distributor. Orders issued by\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"5\", \"level\": 1, \"text\": \"4 5 Distributor to Developer are solely for the purpose of requesting delivery dates and quantities. All Orders shall be subject to acceptance by Developer; Developer will not unreasonably delay acceptance of any order. Developer shall use reasonable efforts to deliver accepted Orders but shall not be liable for any damages to Distributor or to any third party caused by Developer's delay or error in filling, or failure to fill, any Orders for any reason. Except as otherwise provided herein, all fees and expenses payable hereunder for which Developer issues an invoice to Distributor shall be due and payable thirty (30) days from the date of the invoice. A late payment charge of the lesser of one and one-half percent (1.5%) per month or the highest interest rate allowed by applicable law shall be charged upon all unpaid amounts due hereunder for more than thirty (30) days.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reporting; Royalties\", \"level\": 2, \"text\": \"2.3 Reporting; Royalties. -------------------- Distributor shall submit Monthly Sales and Royalty Reports and make payments to Developer as provided herein. All royalties paid to Developer shall be based upon Developer's list prices in U.S. Dollars, except as otherwise agreed in writing by Developer. Software license fees associated with Software license agreements in which the sales cycle begins on or after May 1, 1994 (hereinafter \\\"New Software license agreements\\\") for Product sites located in the Territory, shall be allocated and distributed as follows: Gross Software Revenue Generated % to Distributor -------------------------------- ---------------- Per Annum July 1- June 30 US$O -- $999,999 40% US$1,O00,000 + 50% On July 1 each year, the gross software revenue generated figure will be reset to zero and the accumulation of software revenues will restart. However, the foregoing allocation of such fees associated with the New Software license agreements involving a headquarter Product or other site licenses situated outside of the Territory may be subject to reduced percentages to Distributor due to royalties owed to other Developer entities, affiliates, or distributors located outside the Territory, who may also have participated in the sale. Each such situation will be evaluated individually and a final decision on the royalty due will be based upon each party's relative contribution and will be made in Developer's sole discretion. The general guidelines for such cases are outlined in Appendix E (Bergamo Rules). Installation, consulting, and training fees associated with the Products are due and payable to the party performing the services.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"6\", \"level\": 1, \"text\": \"5 6 License Renewal and Maintenance Fees will be split evenIy with 50% distributed to Developer and 50% distributed to Distributor, also subject to paragraph 4 of this section 2.3. Distributor will submit a monthly report to Developer which accurately identifies the Software license fees, maintenance fees, and any other fees set forth in this Agreement (repons outlined in Schedule D). This report is due at the earliest possible time, but in no event later than ten (10) days following the end of each calendar month Payment by Distributor of the applicable royalty fees to Developer shall accompany the report; provided, however, that Developer shall have the reasonable fight to inspect Distributor's books from time to time during the term hereof and for a one (1) year period after the termination of this Agreement for purposes of verifying the royalties payable to Developer. In addition, Distributor shall report the acquisition of each new license for the Software system to Developer and will provide either an English translation of the End-User License Agreement or a completed contract extract schedule in the form of Exhibit D (Contract Summary Form) within one (1) day of accepting the order.\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Inspection and Acceptance\", \"level\": 1, \"text\": \"24 Inspection and Acceptance. ------------------------- Distributor shall inspect all Products immediately upon delivery and shall, within seven (7) calendar days, give written notice to the common cartier and Developer of any claim for damages or shortages. Distributor shall give written notice to Developer within thirty (30) calendar days of delivery in the event that any Product does not conform with the terms of this Agreement. If Distributor fails to give any such notice, the Products shall be deemed accepted for all purposes of this Agreement.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 2, \"text\": \"2.5 Taxes. ----- In addition to the Prices and other fees payable hereunder, Distributor shall record and pay any federal, state, local or other duties, withholding and excise taxes, now or hereafter applied on the sale, transportation, import, export, licensing or use of the Products including sales tax, value added tax or similar tax. Any taxes imposed by federal, state or any local government or any amount in lieu thereof, including interest and penalties thereon, paid or payable at any time by Developer in connection with Developer's license to Distributor, exclusive of taxes based on Developer's net income, shall be borne by Distributor. Distributor shall co-operate with and assist Developer, as reasonably necessary, to obtain United States tax credits for any duties or taxes described in this Section 2.5 which may be credited to and/or recovered by Developer and applied by Developer to reduce its United States tax liability. In the event Developer obtains any such tax credits, Developer shall notify Distributor of the amount thereof and Distributor shall be entitled to apply such amount against future amounts payable by Distributor to Developer hereunder. 6 7\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MAINTENANCE AND SUPPORT\", \"level\": 1, \"text\": \"3. MAINTENANCE AND SUPPORT. -----------------------\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor Support -------------------\", \"level\": 2, \"text\": \"3.1 Distributor Support ------------------- Distributor shall remain solely responsible for all installation, maintenance, consulting and support services to the End-Users with regard to the Products. Developer agrees to deliver to Distributor together with the first Order delivered to Distributor a copy of the Product to be used solely by Distributor's personnel providing installation, maintenance, consulting or support services to End-Users and shall only be used at Distributor's site. Distributor's failure to maintain the confidentiality of the Products pursuant to the terms of this Agreement shall be deemed a material breach of this Agreement. As mutually agreeable, Developer, Developer's affiliates, or Distributor may each provide local support to the sites of multi-location clients, each on behalf of the other where the provisions of such support will enhance the quality of support provided to the client. Such services will be provided at the local billing rate or such alternative billing rate as shall be agreed between the parties. The party providing the support shall receive all revenues arising therefrom unless otherwise agreed. Furthermore, it is understood that travel expenses, if any, are to be borne by the client utilizing the support services or by the Distributor unless otherwise agreed. For End-Users that have a World Wide Retainer in place, Distributor will provide local support in the Territory as defined in the World Wide Retainer (Schedule F).\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Audit Rights\", \"level\": 2, \"text\": \"3.2 Audit Rights. ------------ Distributor shall maintain accurate books and records of all End-User License Agreements granted for the Products (which will include at a minimum the location, type and number of products and sites, renewal and payment terms and any special conditions or terms), the End-Users receiving maintenance, and consulting and support services, payable under this Agreement. Upon reasonable notice to Distributor, Distributor shall make such books and records available to Developer, at Distributor's place of business during normal business hours, to audit the payments being made by Distributor hereunder.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"End-User Training and Developer Consulting Services ---------------------------------------------------\", \"level\": 2, \"text\": \"3.3 End-User Training and Developer Consulting Services --------------------------------------------------- Distributor shall be solely responsible for the training of End-Users. Developer may be available at its then current standard rates to provide training, special enhancements, customization and other special work or services to either Distributor or End-Users. 7 8\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY AND PROPRIETARY RIGHTS\", \"level\": 1, \"text\": \"4. CONFIDENTIALITY AND PROPRIETARY RIGHTS. --------------------------------------\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 2, \"text\": \"4.1 Confidentiality. --------------- Distributor acknowledges that in the course of dealings between the parties, Distributor may acquire information about Developer, its business activities and operations, its technical information and trade secrets, including but not limited to the Products, all of which are highly confidential and proprietary to Developer (the \\\"Confidential Information\\\"). Confidential Information shall not include information generally available to or known by the public, or information independently developed outside the scope of this Agreement. Distributor shall hold all such Confidential Information in strict confidence and shall not reveal or use the same except pursuant to a court order or upon written request of Developer. The Confidential Information shall be safeguarded with at least as great a degree of care as Distributor uses to safeguard its own most confidential materials or data relating to its own business, but in no event less than a reasonable degree of care.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Proprietary Rights\", \"level\": 2, \"text\": \"4.2 Proprietary Rights. ------------------ Distributor acknowledges and agrees that the Products, and all copies thereof, constitute valuable trade secrets of Developer and/or proprietary and confidential information of Developer and title thereto remains in Developer. Ownership of all applicable copyrights, trade secrets, patents and other intellectual property rights in the Products are and shall remain vested in Developer. All other aspects of the Products, including without limitation, algorithms, models, programs, methods of processing, design and structure of individual programs and their interaction and programming techniques employed therein shall remain the sole and exclusive property of Developer and shall not be sold, revealed, disclosed or otherwise communicated, directly or indirectly, by Distributor to any person, company or entity whatsoever other than as expressly set forth herein. The copyright notice and restricted rights legends contained in the Products shall appear on all tapes, diskettes and other tangible media distributed by Distributor.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Specific Remedies\", \"level\": 2, \"text\": \"4.3 Specific Remedies. ----------------- If Distributor commits a breach of any of the provisions of Sections 4.1 or 4.2 above, Developer shall have, in addition to all other fights in law and equity, (a) the right to have such provisions specifically enforced by any court having equity jurisdiction, it being acknowledged and agreed that any such breach will cause irreparable injury to Developer and that money damages will not provide an adequate remedy, and (b) the right to require Distributor to account for and pay to Developer all compensation, profits, monies or other tangible benefits (collectively \\\"Benefits\\\") derived or received as the result of any transactions constituting a breach of any of the provisions of this Article 4, and Distributor hereby agrees to account for and pay such Benefits. 8 9\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Covenant Not to Compete\", \"level\": 2, \"text\": \"4.4 Covenant Not to Compete. ----------------------- During the term of this Agreement and for a period of two (2) years after the termination hereof for any reason, Distributor will not market, or attempt to market, a computer program which competes in any way with the Products in the areas of consolidation, financial information, financial transaction processing, reporting, data collection, or modeling, including but not limited to the use of personal computers, nor which competes with any modification, alteration or enhancement to the Products which is developed during the term of this Agreement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITED WARRANTY\", \"level\": 1, \"text\": \"5. LIMITED WARRANTY. ----------------\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limited Warranty\", \"level\": 2, \"text\": \"5.1 Limited Warranty. ---------------- For ninety (90) days after delivery of a Product to Distributor, Developer warrants that media upon which the Products are delivered shall be of good quality and workmanship. Upon written notice from Distributor of defective media for a Product, Developer shall use reasonable efforts to promptly provide replacement media.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimer of Warranties\", \"level\": 2, \"text\": \"5.2 Disclaimer of Warranties. ------------------------ EXCEPT FOR THE LIMITED WARRANTY SET FORTH IN SECTION 5.1, THE PRODUCTS ARE PROVIDED \\\"AS IS\\\". DEVELOPER SPECIFICALLY DISCLAIMS ALL WARRANTIES EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT'TO THE PRODUCTS OR DEFECTS IN THE TAPE, DISKETTE OR OTHER TANGIBLE MEDIA AND DOCUMENTATION, OPERATION OF THE PRODUCTS, AND ANY PARTICULAR APPLICATION OR USE OF THE PRODUCTS.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"6. LIMITATION OF LIABILITY. ----------------------- IN NO EVENT SHALL DEVELOPER BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE, INCLUDING BUT NOT LIMITED TO SPECIAL, INCIDENTAL, CONSEQUENTIAL OR OTHER INDIRECT DAMAGES UNDER ANY CAUSE OF ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, CLAIMS ARISING FROM MALFUNCTION OR DEFECTS IN THE PRODUCTS. DEVELOPER'S MAXIMUM LIABILITY HEREUNDER IS EXPRESSLY LIMITED TO THE LESSER OF: THE AMOUNT PAID UNDER THIS AGREEMENT BY DISTRIBUTOR TO DEVELOPER WITHIN THE SIX (6) MONTH PERIOD IMMEDIATELY PRECEDING THE CAUSE GIVING RISE TO THE CLAIM; OR FIVE HUNDRED THOUSAND DOLLARS ($5OO,000). 9 10\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR OBLIGATIONS\", \"level\": 1, \"text\": \"7. DISTRIBUTOR OBLIGATIONS. -----------------------\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Marketing Efforts\", \"level\": 2, \"text\": \"7.1 Marketing Efforts. ----------------- Distributor agrees to use its best efforts to promote the sale of the Products in the Territory. Distributor agrees to permit Developer to review all of Distributor's promotion and advertising material for the Products prior to use. Distributor shall not use and shall withdraw and retract any promotion or advertising that Developer finds unsuitable, or is in breach of the terms of this Agreement.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prohibited Practices\", \"level\": 2, \"text\": \"7.2 Prohibited Practices. -------------------- Distributor may not make any contracts or commitments on behalf of Developer nor make any warranties or other representations regarding the Products other than those authorized herein or by Developer in a separate writing.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Export Notice\", \"level\": 2, \"text\": \"7.3 Export Notice. ------------- Distributor agrees to provide Developer with reasonable advance notice of each country- to which it intends to export the Products. Prior to exporting to a foreign country for the first time, Distributor shall provide Developer with a reasonable opportunity to file such proprietary rights notices, applications, and other documents as Developer determines to be reasonably necessary to protect in such country the proprietary rights associated with the Products. Distributor agrees at Developer's expense to cooperate with Developer in the protection of such proprietary rights in each country to which it exports the Products.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Laws\", \"level\": 2, \"text\": \"7.4 Compliance with Laws. -------------------- Distributor agrees to comply with all applicable laws and regulations, both foreign and domestic, in its performance under this Agreement, including, but not limited to, domestic and foreign export/import laws and regulations.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMS AND TERMINATION\", \"level\": 1, \"text\": \"8. TERMS AND TERMINATION. ---------------------\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"8.1 Term. ---- This Agreement shall have an initial term of one (1) year from the date first above written (the \\\"Initial Term\\\"), and shall thereafter automatically renew for successive two (2) year periods (each a \\\"Renewal Term\\\"), unless earlier terminated in accordance with the terms of this Agreement. Developer may cancel this Agreement if the total gross annual software revenue does not meet DeVeloper's revenue forecast for the Distributor, such cancellation to be eftected by written notice delivered to Distributor not later than 30 days after any Developer's Fiscal Year end (June 30). Either party may cancel this Agreement effective on the last day of the Initial Term, or\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"11\", \"level\": 1, \"text\": \"10 11 any Renewal Term, by serving written notice of such termination on the other party at least ninety (90) days prior to the end of the Initial Term or any Renewal Term as the case may be.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Developer Termination\", \"level\": 2, \"text\": \"8.2 Developer Termination. --------------------- This Agreement may be terminated immediately by Developer under any of the following conditions: (a) if one of the parties shall be declared insolvent or bankrupt; (b) if a petition is filed in any court to declare one of the parties bankrupt or for a reorganization under the Bankruptcy Code or any similar statute and such petition is not dismissed in ninety (90) days or if a Trustee in Bankruptcy or a Receiver or similar entity is appointed for one of the parties; (c) if Distributor does not pay Developer within thirty (30) days from the date that any payments are due hereunder; (d) if Distributor breaches the provisions of Sections 4.1 or 4.2 of this Agreement; or (e) if Distributor otherwise materially breaches the terms of this Agreement, and such breach is not cured within thirty (30) days after written notice of such breach is given by Developer.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Duties Upon Termination\", \"level\": 2, \"text\": \"8.3 Duties Upon Termination. ----------------------- (a) Provided termination is not a result of a material breach of Sections 4.1 or 4.2, the parties agree to continue their cooperation in order to effect an orderly termination of their relationship. Distributor may continue running the Products solely for purposes of providing maintenance to End-Users granted licenses pursuant to an End-User License Agreement prior to termination. Upon termination, Distributor shall have no fight to order or receive any additional copies of the Products and all of Distributor's rights and licenses granted hereunder shall immediately cease. Within thirty (30) days of termination, Distributor shall return all copies of any promotional materials, marketing literature, written information and reports pertaining to the Products that have been supplied by Developer. (b) Upon termination of this Agreement for any reason, Distributor shall forthwith return all Products, documentation and materials relating thereto to Developer. Termination of this Agreement shall not relieve Distributor of any financial obligations to Developer which remain unsettled at the date of termination, nor of the terms relating to proprietary rights, trade secrets, or non compete restrictions; provided, further, that if this Agreement is terminated for any reason, Developer shall have the option, but not the obligation to\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"12\", \"level\": 1, \"text\": \"11 12 assume at no cost to Developer, any or all of Distributor's third party agreements (including End-User Agreements) relating to the Products and to receive any and all fees therefrom.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Survival --------\", \"level\": 2, \"text\": \"8.4 Survival -------- The provisions of Sections 4, 5 and 9 shall survive the termination of this Agreement.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"9. INDEMNIFICATION. ---------------\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Copyright Indemnification\", \"level\": 2, \"text\": \"9.1 Copyright Indemnification. ------------------------- Developer shall indemnify, defend and hold Distributor harmless from any claims, demands, liabilities or expenses, including reasonable attorneys' fees, directly resulting from any infringement or violation of any copyright with respect to the Product(s), as so awarded by a final judgment against Distributor by a court of competent jurisdiction that the Product(s) infringe any third party's copyright, Developer shall, in its sole discretion: (a) procure for Distributor the right to continue to use, distribute and sell the Product(s) at no additional expense to Distributor; (b) provide Distributor with a non-infringing version of the Product(s) with substantially similar functionality; or (c) notify Distributor that the Product(s) are being withdrawn from the market and Distributor agrees to immediately cease its distribution of such Product(s). If all Products are withdrawn from the market, this Agreement will immediately terminate.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cooperation by Distributor\", \"level\": 2, \"text\": \"9.2 Cooperation by Distributor. -------------------------- Notwithstanding Section 9.1 of this Agreement, Developer is under no obligation to indemnify and hold Distributor harmless unless: (a) Developer shall have been promptly notified of the suit, action, proceeding or claim by Distributor and furnished by Distributor with a copy of each communication, notice or other action relating to said suit, action, proceeding or claim; (b) Developer shall have the right to assume sole authority to conduct the trial or settlement of such suit, action, proceeding or claim or any negotiations related thereto at Developer's expense; and (c) Distributor shall provide reasonable information and assistance requested by Developer in connection with such claim or suit. 12 13\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor Indemnification\", \"level\": 2, \"text\": \"9.3 Distributor Indemnification. --------------------------- Distributor shall indemnify, defend and hold Developer harmless from any claims, demands, liability or expenses, including reasonable attorneys' fees, incurred by Developer as a result of any claim or proceeding against Developer arising out of or based upon (i) the combination, operation or use of the Products with any hardware, products, programs or data not supplied or approved in writing by Developer, if such infringement would have been avoided but for such combination, operation or use (ii) modification of the Products by Distributor or End- Users(iii) any breach of this Agreement by the Distributor or (iv) any breach by the Distributor of any End User or other agreement to which Developer or Distributor is a party.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 1, \"text\": \"10. GENERAL. -------\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"10.1 Force Majeure. ------------- Neither party shall be liable or deemed to be in default for any delay or failure in performance (other than the payment of money) under this Agreement or interruption of service resulting directly or indirectly from acts of God, or any causes beyond the reasonable control of such party.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Jurisdiction and Venue\", \"level\": 2, \"text\": \"10.2 Jurisdiction and Venue. ---------------------- This Agreement shall be governed by and construed in accordance with the laws of the State of Connecticut, U.S.A. without regard to its conflict of taws provision. Jurisdiction for litigation of any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach thereof shall be only in the Federal or the State court with competent jurisdiction located in Stamford, Connecticut.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"10.3 Entire Agreement. ---------------- This Agreement, including the Schedules attached hereto, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all previous proposals, both oral and written, negotiations, representations, commitments, writings and all other communications between the parties. This Agreement may not be modified except by a writing signed by a duly authorized representative of each of the parties. 13 14\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"10.4 Independent Contractors. ----------------------- It is expressly agreed that Developer and Distributor are acting hereunder as independent contractors and under no circumstances shall any of the employees of one party be deemed the employees of the other for any purpose. This Agreement shall not be construed as authority for either party to act for the other party in any agency or other capacity, or to make commitments of any kind for the account of or on behalf of the other except to the extent and for the purposes provided for herein.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"10.5 Assignment. ---------- This Agreement is not assignable by either party hereto without the prior written consent of the other, except that this Agreement shall be assignable by Developer to an affiliated entity or upon the sale of the fight to license and sublicense the Products to the purchaser of said right. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and permitted assigns.\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability and Waiver\", \"level\": 2, \"text\": \"10.6 Severability and Waiver. ----------------------- If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid or unenforceable, such determination shall not affect the validity or enforceability of any other part or provision of this Agreement. No waiver by any party of any breach of any provisions hereof shall constitute a waiver unless made in writing signed by the party. IN WITNESS WHEREOF, the parties hereto have executed this Agreement by a duly authorized representative as of the date set forth above. DISTRIBUTOR: DEVELOPER: ----------- --------- DELTEQ SYSTEMS PTE LTD IMRS OPERATIONS INC. d/b/a IMRS INC. By: /s/ S.C. CHEN By: /s/ DAVID M. SAMPLE -------------------- ----------------------- Name: S.C. Chen Name: David M. Sample --------------------- Title: Managing Director Title: Senior Vice President 14\"}}, {\"id\": \"party:Developer\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"IMRS OPERATIONS INC. d/b/a IMRS INC.\", \"role\": \"Developer\", \"address\": \"777 Long Ridge Road, Stamford, Connecticut 06902, U.S.A.\"}}, {\"id\": \"party:Distributor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"DELTEQ SYSTEMS PTE LTD\", \"role\": \"Distributor\", \"address\": \"215 Henderson Road, #101-03 Henderson Industrial Park, Singapore 0315\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"EXCLUSIVE DISTRIBUTOR AGREEMENT (\\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"certain computer programs and related documentation more particularly described in Schedule A attached hereto (the \\\"Products\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"Singapore, Malaysia, Indonesia, Thailand, and Brunei (the \\\"Territory\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:End-Users\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End-Users\", \"text\": \"existing and new customers of Distributor located in the Territory (the \\\"End-Users\\\")\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:End-User License Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End-User License Agreement\", \"text\": \"Software License Agreement in the form attached hereto as Schedule B (the \\\"End-User License Agreement\\\")\", \"definition_clause\": \"1.3\"}}, {\"id\": \"term:Prices\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Prices\", \"text\": \"the then current Developer Prices for each Product (collectively, the \\\"Prices\\\")\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Order\", \"text\": \"a written order from Distributor (each an \\\"Order\\\")\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:New Software license agreements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"New Software license agreements\", \"text\": \"Software license fees associated with Software license agreements in which the sales cycle begins on or after May 1, 1994 (hereinafter \\\"New Software license agreements\\\")\", \"definition_clause\": \"2.3\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"information about Developer, its business activities and operations, its technical information and trade secrets, including but not limited to the Products, all of which are highly confidential and proprietary to Developer (the \\\"Confidential Information\\\")\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:Benefits\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Benefits\", \"text\": \"all compensation, profits, monies or other tangible benefits (collectively \\\"Benefits\\\")\", \"definition_clause\": \"4.3\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"an initial term of one (1) year from the date first above written (the \\\"Initial Term\\\")\", \"definition_clause\": \"8.1\"}}, {\"id\": \"term:Renewal Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Term\", \"text\": \"successive two (2) year periods (each a \\\"Renewal Term\\\")\", \"definition_clause\": \"8.1\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:one and one-half percent (1.5%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one and one-half percent (1.5%)\"}}, {\"id\": \"value:40%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"40%\"}}, {\"id\": \"value:US$1,O00,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"US$1,O00,000\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:one (1) year period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year period\"}}, {\"id\": \"value:one (1) day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) day\"}}, {\"id\": \"value:seven (7) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) calendar days\"}}, {\"id\": \"value:thirty (30) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) calendar days\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:six (6) month period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) month period\"}}, {\"id\": \"value:FIVE HUNDRED THOUSAND DOLLARS ($5OO,000)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"FIVE HUNDRED THOUSAND DOLLARS ($5OO,000)\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:two (2) year periods\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) year periods\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of HealthcareIntegratedTechnologiesInc_20190812_8-K_EX-10.1_11776966_EX-10.1_Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of HealthcareIntegratedTechnologiesInc_20190812_8-K_EX-10.1_11776966_EX-10.1_Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"WALABOT-HOME RESELLER AGREEMENT This Walabot-HOME \", \"level\": 1, \"text\": \"WALABOT-HOME RESELLER AGREEMENT This Walabot-HOME Reseller Agreement (\\\"Agreement\\\") is made and entered into as of this 31 day of July 2019 (\\\"Effective Date\\\") by and between Vayyar Imaging Ltd., having its principal place of business at 3 Avraham Giron St., POB. 325, Yehud 5621717, Israel (\\\"Supplier\\\"), and Inde Living Holdings, Inc., having its principal place of business at 1462 Rudder Lane, Knoxville, TN 37919 (\\\"Reseller\\\"). Vayyar and Reseller shall be referred to individually as \\\"Party\\\" and collectively as \\\"Parties\\\". 1. Definitions. The following capitalized terms shall have the following meanings: \\\"Customer\\\" means a third party who purchases the Products from Reseller within the Territory, for its internal use only (including for the personal use of its End Users), such as nursing homes. \\\"End User\\\" means a third party who is a customer of Customer or is otherwise related to a customer of Customer, and who purchases and/or uses the Products within the Territory, for its personal use only. \\\"End User Agreement\\\" means Supp l i e r ' s s t andard l i cense ag reement s , wh ich a re ava i l ab le a t https://walabot.com/walabot-home, which governs each End User's right to use the Product, as amended by Supplier in its sole discretion from time to time. \\\"MOQ\\\" means the minimum order quantity of Product units during the Initial Term, as set forth in Schedule 1. ***. \\\"Order\\\" means a written purchase order for Products to be purchased by the Reseller. \\\"Products\\\" means the products listed in Schedule 1. \\\"Software\\\" means Supplier's proprietary software components, included as part of the Products, including all improvements, corrections, updates, upgrades and any related documentation and derivatives thereof. \\\"Territory\\\" means the countries and/or territories listed in Schedule 1. Appointment During the Term (defined below) and subject to the terms and conditions of this Agreement (including, but not limited to Section 12.4 hereof), Supplier hereby (i) appoints Reseller, and Reseller accepts the appointment, as a non\u2010 exclusive reseller of the Products in the Territory. In connection with the foregoing appointment, Supplier hereby grants Reseller a non-transferable, revocable, limited right to resell, market, promote, stimulate interest in, and solicit Orders by Customers and/or End Users in the Territory for the Products and to provide services in connection with those activities. Reseller shall be solely responsible for all of its costs and expenses related to the resale of the Products. Notwithstanding anything to the contrary, Supplier reserves any and all rights with respect to the Products not expressly granted in this Agreement. Without limiting the right of the Reseller to receive any and all Paid-For Products (including but not limited to under Section 4.2 hereof), nothing in this Agreement shall entitle the Reseller to any priority of supply in relation to the Products as against any other distributor or customer of the Supplier. \\\"Paid\u2010 For Products\\\" means Products for which Reseller submitted an Order, had that Order accepted by Supplier, and for which Reseller has remitted payment in full to the Supplier under this Agreement. Subject to the terms of Section 13, below, it is hereby clarified that Supplier may, in its sole discretion, sell the Products to any other person or entity, whether within the Territory or otherwise. ***. ***. ***. Obligations of Reseller By fulfilling its obligations under this Agreement, the Reseller shall: (i) comply with all applicable laws and regulations; (ii) use materials and branding solely as determined by the Supplier (subject to the right of the Reseller to make changes to such materials as are described in Section 2.4); (iii) attend training and sales meetings as required by the Supplier, so as to be able to describe, demonstrate, and sell the Products adequately; (iv) make sure that all the End Users are signing the End User Agreement, and in the event that any End User does not comply with these terms, Reseller shall bear all liability associated with said End User; and (v) make no representations or warranties with respect to the Products other than those provided in the Products' documentation; Supplier shall be fully responsible for shipping the Products to the Reseller at the address of the Reseller specified in each Order (or as otherwise communicated by Reseller to Supplier under this Agreement) and will obtain and provide for itself and/or on behalf of Reseller, any and all registrations, licenses, permits, certificates and all other documentation and information required for the exportation, importation, storage, marketing and otherwise resale of the Products in the Territory. For such process, Supplier will allocate the additional cost on a pre-agreed per Product unit additional price basis, which will be subject to an increase (subject to changes in taxes). Reseller agrees to reimburse Supplier for the reasonable out of pocket costs and expenses incurred by Supplier in connection with the shipment and delivery of the Products, and of obtaining the foregoing registrations, licenses, permits, certificated and other documentation, provided that Supplier submits an invoice therefore in reasonable detail (and unless and solely to the extent such reimbursements is prohibited by Section 14.9 or prohibited under other applicable laws). For the avoidance of doubt, in no way will Supplier be subject to any tax (i.e., sales tax) relating to the sale of the Products to Reseller's Customers and/or End Users. 1. 1.1. 1.2. 1.3. 1.9. 2. 2.1. 2.2. 2.3. 2.4. 3. 3.1. 3.2. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019 Diagnostics, Telemetric Data and Analytics. Supplier will retain access to diagnostics, telemetric data and analytics generated by the Product. The data shall be uploaded to Supplier's Firebase server in a timely manner. A server interface will be embedded within the software package provided by the Supplier. Distributor will maintain Supplier's interface to the server and access to such data within the Product; provided that the data and analytics to be received by the Supplier shall, in all cases, not be in violation of any applicable privacy or other law. Orders, Payment and Delivery ***. If Reseller fails to submit Orders with an aggregate value equal to or greater than the MOQ, then Reseller shall pay Supplier a sum equal to the shortfall, within 30 days after the end of the Initial Term. Upon payment of such amount, Seller shall deliver the Products paid for to Reseller in a commercially reasonable timeframe (and in no event any later than 150 days from the date such payment is received in full) to be sold by Reseller in accordance with this Agreement as contemplated by the last sentence of Section 12.4. Reseller shall place its Orders by email, at the email address set out in Schedule 1. Each Order shall detail the total order quantity of the Product and the requested date of delivery (taking into consideration up to 4 months lead time). Within 5 business days following the receipt of each Order, Supplier shall acknowledge receipt of such Order. No Order shall be binding upon Supplier until such written acknowledgment was sent by Supplier to Reseller; provided that Supplier shall confirm or reject such Orders at its discretion. ***. Packaging, Samples and Transportation Immediately upon delivery of the Products at the Reseller's facilities within the Territory (\\\"Arrival Date\\\"), Reseller shall visually inspect the Products and the appropriate documents, and employ good receiving/delivering procedures, verification of the Products to confirm origin, identity, quantity, labeled storage conditions, integrity of the packaging as well as any other inspection, as may be required by applicable laws or regulations. Reseller shall ensure that the Products are delivered with appropriate information and documentation, and shall not make any changes to the Products or to the packaging or labeling thereof, or to the legal documents included in the Products' packages, without Supplier's prior written consent (subject to the right of the Reseller to make changes to such materials as are described in Section 2.4). Reseller shall ensure traceability of the delivered Products. Defective Products; Warranty; Support ***. During the Term Supplier may extend an offer to Reseller for a Returns Discount Program, whereby the Supplier will rebate a percentage of the cost of goods sold in lieu of accepting End-User returns. In the event no Returns Discount Program has been entered into by the Parties, Supplier will not accept Returned Product, except for cases of Defective Products. ***. ***. Intellectual Property Supplier shall retain all its rights and title to and ownership of all intellectual property rights in the Products including, inter alia, all documentation, enhancements, improvements or other modifications made thereof (including those modifications made in connection with Section 3.1 above), and except as expressly provided in this Agreement, Reseller shall have no right, title, or interest in any intellectual property rights in the Products. Nothing in this Section shall limit the rights of the Reseller in or to any modifications made to the Software in accordance with Section 2.3. Reseller shall: (a) not do or omit to do, nor authorize any third party to do or omit to do, any act or omission that would or might invalidate or be inconsistent with any of Supplier's intellectual property rights; (b) promptly notify Supplier of any actual, threatened, or suspected infringement of any of Supplier's intellectual property rights that comes to Reseller's notice; and (c) at Supplier's request and expense, do all such things as may be reasonably required to assist Supplier in taking or resisting any proceedings in relation to any such infringement or claim. Confidential Information. Each Party agrees that it will maintain the confidentiality of all electronic, oral, and written communications from the other Party which should reasonably be regarded in the normal commercial view, as constituting confidential information, trade secrets or proprietary information (\\\"Confidential Information\\\") and use such Confidential Information only as necessary to exercise a Party's rights or perform a Party's obligations under this Agreement. Each Party shall: (i) safeguard and keep secret all Confidential Information, and will not directly or indirectly disclose to any third party the Confidential Information without written permission of the other; and (ii) in performing its obligations hereunder, use at least the same degree of care as it does with respect to its own confidential information of like importance but, in any event, at least reasonable care. Any information related to the Products shall be considered the Supplier's Confidential Information. If either Party becomes legally obliged to make disclosure of the other Party's Confidential Information, that Party shall immediately notify the first Party and reasonably cooperate with the first Party in any efforts to limit or object to the disclosure. 3.3. 4. 4.1. 4.2. 4.3. 4.4. 5. 5.1. 5.2. 6. 6.1. 6.2. 6.3. 6.4. 7. 7.1. 7.2. 8. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019 9.\"}, {\"id\": \"10\", \"title\": \"10\", \"level\": 1, \"text\": \"10. 10.1. 10.2. 11.\"}, {\"id\": \"12\", \"title\": \"12\", \"level\": 1, \"text\": \"12. 12.1. 12.2. 12.3. 12.4.\"}, {\"id\": \"13\", \"title\": \"14\", \"level\": 1, \"text\": \"13. 14. 14.1. 14.2. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019 Except as to the timely payment by Reseller for the Products purchased under this Agreement, no failure or omission to carry out or observe any provision of this Agreement shall give rise to any claim by one Party against the other, or be a breach of this Agreement, if the same is caused by or arises out of circumstances beyond the reasonable control of the other Party, including technical difficulties beyond such Party's reasonable control that delay or prevent manufacture (\\\"Force Majeure\\\"). However, the Parties shall endeavor to avoid, remove, or cure all such conditions as soon as is reasonably feasible. If either Party is prevented or hindered from carrying out its obligations under this Agreement due to a Force Majeure, this Agreement shall be suspended as long as the Force Majeure persists. If such period exceeds 1 month, either Party may terminate this Agreement on giving written notice to the other. No failure or delay on the part of either Party to exercise any right or remedy under this Agreement shall be construed or operate as a waiver thereof, nor shall any single or partial exercise of any right or remedy preclude the further exercise of such right or remedy. If any provision or part of any provision of this Agreement is found to be invalid or unenforceable for any reason, the other provisions of this Agreement shall remain in full force and effect as if the Agreement had been executed without that provision or part. All notices or other communications hereunder shall be in writing and shall be given in person, by courier or by registered mail (provided that written confirmation of receipt is provided) addressed as set forth in the heading of this Agreement or such other address as any Party may designate to the other in accordance with this procedure. All communications delivered in person or by courier service shall be deemed to have been received upon delivery, shall be deemed to have been received on the business day following transmission with confirmed answer back, and all notices and other communications sent by registered mail shall be deemed to have been received within 3 business days after posting. This Agreement shall be governed by the laws of the State of New York and all disputes and controversies arising out of or in connection with the Agreement shall be brought exclusively before the competent courts in New York County, New York; provided however that judgment shall be enforceable in any country and that nothing in this Section shall prevent or restrict either Party from seeking interim relief in any competent jurisdiction as it may deem fit. This Agreement constitutes the entire agreement between the Supplier and the Reseller. All previous or contemporaneous agreements, proposals, understandings, and communications between the Supplier and the Reseller are replaced in their entirety by this Agreement. In entering into this Agreement, neither Party has relied on any warranties, representations, or other matters other than as set out in this Agreement. All conditions, warranties, or other terms implied by statute or common law are excluded to the fullest extent permitted by law. This Agreement may be amended only by a written instrument executed by authorized representatives of the Parties. Each of Reseller and Supplier will, respectively, ensure that it and its employees, agents or affiliates, or by any independent contractors on its behalf or for its benefit, shall comply with the United States' Foreign Corrupt Practices Act of 1977, as amended (15 U.S.C. \u00a7\u00a7 78dd-1 et seq.) and any analogous anti-bribery and anti-corruption law, rule, regulation that may apply to any of the transactions contemplated under this Agreement, including but not limited to in connection with the sale, resale, import, export, transportation, or shipment of the Products. Neither party to this Agreement will make any payment, directly or indirectly, of money or other assets, including but not limited to compensation derived from this Agreement or any Order placed under it, to government or political party officials, officials of international organizations, candidates for public office, or representatives of other businesses or persons acting on behalf of any of the foregoing, that would constitute a violation of any law, rule, or regulation. IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date. Vayyar Imaging Ltd. IndeLiving Holdings, Inc. By: /s/ Raviv Melamed By: /s/ Robert Forrest Chief Executive Officer Chief Executive Officer 14.3. 14.4. 14.5. 14.6. 14.7. 14.8. 14.9. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019\"}, {\"id\": \"Schedule 1\", \"title\": \"Territory, Products, Price, Ordering Address, Notices\", \"level\": 1, \"text\": \"Schedule 1 Territory, Products, Price, Ordering Address, Notices Territory USA Products Walabot HOME hardware device Price $*** per Product unit + $*** for shipment and tax (subject to any tax changes) MOQ *** units Address to which Orders should be sent Supplier's Ordering Email address: logistics@walabot.com Address for Notices to the Supplier Vayyar Ltd. 3 Avraham Giron St., POB. 325, Yehud 5621717, Israel Address for Notices to Reseller Inde Living Holdings, Inc 1462 Rudder Lane Knoxville, TN 37919 Vayyar Wire Transfer Details *** Payment Terms *** Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of HealthcareIntegratedTechnologiesInc_20190812_8-K_EX-10.1_11776966_EX-10.1_Reseller Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WALABOT-HOME RESELLER AGREEMENT This Walabot-HOME \", \"level\": 1, \"text\": \"WALABOT-HOME RESELLER AGREEMENT This Walabot-HOME Reseller Agreement (\\\"Agreement\\\") is made and entered into as of this 31 day of July 2019 (\\\"Effective Date\\\") by and between Vayyar Imaging Ltd., having its principal place of business at 3 Avraham Giron St., POB. 325, Yehud 5621717, Israel (\\\"Supplier\\\"), and Inde Living Holdings, Inc., having its principal place of business at 1462 Rudder Lane, Knoxville, TN 37919 (\\\"Reseller\\\"). Vayyar and Reseller shall be referred to individually as \\\"Party\\\" and collectively as \\\"Parties\\\". 1. Definitions. The following capitalized terms shall have the following meanings: \\\"Customer\\\" means a third party who purchases the Products from Reseller within the Territory, for its internal use only (including for the personal use of its End Users), such as nursing homes. \\\"End User\\\" means a third party who is a customer of Customer or is otherwise related to a customer of Customer, and who purchases and/or uses the Products within the Territory, for its personal use only. \\\"End User Agreement\\\" means Supp l i e r ' s s t andard l i cense ag reement s , wh ich a re ava i l ab le a t https://walabot.com/walabot-home, which governs each End User's right to use the Product, as amended by Supplier in its sole discretion from time to time. \\\"MOQ\\\" means the minimum order quantity of Product units during the Initial Term, as set forth in Schedule 1. ***. \\\"Order\\\" means a written purchase order for Products to be purchased by the Reseller. \\\"Products\\\" means the products listed in Schedule 1. \\\"Software\\\" means Supplier's proprietary software components, included as part of the Products, including all improvements, corrections, updates, upgrades and any related documentation and derivatives thereof. \\\"Territory\\\" means the countries and/or territories listed in Schedule 1. Appointment During the Term (defined below) and subject to the terms and conditions of this Agreement (including, but not limited to Section 12.4 hereof), Supplier hereby (i) appoints Reseller, and Reseller accepts the appointment, as a non\u2010 exclusive reseller of the Products in the Territory. In connection with the foregoing appointment, Supplier hereby grants Reseller a non-transferable, revocable, limited right to resell, market, promote, stimulate interest in, and solicit Orders by Customers and/or End Users in the Territory for the Products and to provide services in connection with those activities. Reseller shall be solely responsible for all of its costs and expenses related to the resale of the Products. Notwithstanding anything to the contrary, Supplier reserves any and all rights with respect to the Products not expressly granted in this Agreement. Without limiting the right of the Reseller to receive any and all Paid-For Products (including but not limited to under Section 4.2 hereof), nothing in this Agreement shall entitle the Reseller to any priority of supply in relation to the Products as against any other distributor or customer of the Supplier. \\\"Paid\u2010 For Products\\\" means Products for which Reseller submitted an Order, had that Order accepted by Supplier, and for which Reseller has remitted payment in full to the Supplier under this Agreement. Subject to the terms of Section 13, below, it is hereby clarified that Supplier may, in its sole discretion, sell the Products to any other person or entity, whether within the Territory or otherwise. ***. ***. ***. Obligations of Reseller By fulfilling its obligations under this Agreement, the Reseller shall: (i) comply with all applicable laws and regulations; (ii) use materials and branding solely as determined by the Supplier (subject to the right of the Reseller to make changes to such materials as are described in Section 2.4); (iii) attend training and sales meetings as required by the Supplier, so as to be able to describe, demonstrate, and sell the Products adequately; (iv) make sure that all the End Users are signing the End User Agreement, and in the event that any End User does not comply with these terms, Reseller shall bear all liability associated with said End User; and (v) make no representations or warranties with respect to the Products other than those provided in the Products' documentation; Supplier shall be fully responsible for shipping the Products to the Reseller at the address of the Reseller specified in each Order (or as otherwise communicated by Reseller to Supplier under this Agreement) and will obtain and provide for itself and/or on behalf of Reseller, any and all registrations, licenses, permits, certificates and all other documentation and information required for the exportation, importation, storage, marketing and otherwise resale of the Products in the Territory. For such process, Supplier will allocate the additional cost on a pre-agreed per Product unit additional price basis, which will be subject to an increase (subject to changes in taxes). Reseller agrees to reimburse Supplier for the reasonable out of pocket costs and expenses incurred by Supplier in connection with the shipment and delivery of the Products, and of obtaining the foregoing registrations, licenses, permits, certificated and other documentation, provided that Supplier submits an invoice therefore in reasonable detail (and unless and solely to the extent such reimbursements is prohibited by Section 14.9 or prohibited under other applicable laws). For the avoidance of doubt, in no way will Supplier be subject to any tax (i.e., sales tax) relating to the sale of the Products to Reseller's Customers and/or End Users. 1. 1.1. 1.2. 1.3. 1.9. 2. 2.1. 2.2. 2.3. 2.4. 3. 3.1. 3.2. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019 Diagnostics, Telemetric Data and Analytics. Supplier will retain access to diagnostics, telemetric data and analytics generated by the Product. The data shall be uploaded to Supplier's Firebase server in a timely manner. A server interface will be embedded within the software package provided by the Supplier. Distributor will maintain Supplier's interface to the server and access to such data within the Product; provided that the data and analytics to be received by the Supplier shall, in all cases, not be in violation of any applicable privacy or other law. Orders, Payment and Delivery ***. If Reseller fails to submit Orders with an aggregate value equal to or greater than the MOQ, then Reseller shall pay Supplier a sum equal to the shortfall, within 30 days after the end of the Initial Term. Upon payment of such amount, Seller shall deliver the Products paid for to Reseller in a commercially reasonable timeframe (and in no event any later than 150 days from the date such payment is received in full) to be sold by Reseller in accordance with this Agreement as contemplated by the last sentence of Section 12.4. Reseller shall place its Orders by email, at the email address set out in Schedule 1. Each Order shall detail the total order quantity of the Product and the requested date of delivery (taking into consideration up to 4 months lead time). Within 5 business days following the receipt of each Order, Supplier shall acknowledge receipt of such Order. No Order shall be binding upon Supplier until such written acknowledgment was sent by Supplier to Reseller; provided that Supplier shall confirm or reject such Orders at its discretion. ***. Packaging, Samples and Transportation Immediately upon delivery of the Products at the Reseller's facilities within the Territory (\\\"Arrival Date\\\"), Reseller shall visually inspect the Products and the appropriate documents, and employ good receiving/delivering procedures, verification of the Products to confirm origin, identity, quantity, labeled storage conditions, integrity of the packaging as well as any other inspection, as may be required by applicable laws or regulations. Reseller shall ensure that the Products are delivered with appropriate information and documentation, and shall not make any changes to the Products or to the packaging or labeling thereof, or to the legal documents included in the Products' packages, without Supplier's prior written consent (subject to the right of the Reseller to make changes to such materials as are described in Section 2.4). Reseller shall ensure traceability of the delivered Products. Defective Products; Warranty; Support ***. During the Term Supplier may extend an offer to Reseller for a Returns Discount Program, whereby the Supplier will rebate a percentage of the cost of goods sold in lieu of accepting End-User returns. In the event no Returns Discount Program has been entered into by the Parties, Supplier will not accept Returned Product, except for cases of Defective Products. ***. ***. Intellectual Property Supplier shall retain all its rights and title to and ownership of all intellectual property rights in the Products including, inter alia, all documentation, enhancements, improvements or other modifications made thereof (including those modifications made in connection with Section 3.1 above), and except as expressly provided in this Agreement, Reseller shall have no right, title, or interest in any intellectual property rights in the Products. Nothing in this Section shall limit the rights of the Reseller in or to any modifications made to the Software in accordance with Section 2.3. Reseller shall: (a) not do or omit to do, nor authorize any third party to do or omit to do, any act or omission that would or might invalidate or be inconsistent with any of Supplier's intellectual property rights; (b) promptly notify Supplier of any actual, threatened, or suspected infringement of any of Supplier's intellectual property rights that comes to Reseller's notice; and (c) at Supplier's request and expense, do all such things as may be reasonably required to assist Supplier in taking or resisting any proceedings in relation to any such infringement or claim. Confidential Information. Each Party agrees that it will maintain the confidentiality of all electronic, oral, and written communications from the other Party which should reasonably be regarded in the normal commercial view, as constituting confidential information, trade secrets or proprietary information (\\\"Confidential Information\\\") and use such Confidential Information only as necessary to exercise a Party's rights or perform a Party's obligations under this Agreement. Each Party shall: (i) safeguard and keep secret all Confidential Information, and will not directly or indirectly disclose to any third party the Confidential Information without written permission of the other; and (ii) in performing its obligations hereunder, use at least the same degree of care as it does with respect to its own confidential information of like importance but, in any event, at least reasonable care. Any information related to the Products shall be considered the Supplier's Confidential Information. If either Party becomes legally obliged to make disclosure of the other Party's Confidential Information, that Party shall immediately notify the first Party and reasonably cooperate with the first Party in any efforts to limit or object to the disclosure. 3.3. 4. 4.1. 4.2. 4.3. 4.4. 5. 5.1. 5.2. 6. 6.1. 6.2. 6.3. 6.4. 7. 7.1. 7.2. 8. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019 9.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"10\", \"level\": 1, \"text\": \"10. 10.1. 10.2. 11.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"12\", \"level\": 1, \"text\": \"12. 12.1. 12.2. 12.3. 12.4.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"14\", \"level\": 1, \"text\": \"13. 14. 14.1. 14.2. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019 Except as to the timely payment by Reseller for the Products purchased under this Agreement, no failure or omission to carry out or observe any provision of this Agreement shall give rise to any claim by one Party against the other, or be a breach of this Agreement, if the same is caused by or arises out of circumstances beyond the reasonable control of the other Party, including technical difficulties beyond such Party's reasonable control that delay or prevent manufacture (\\\"Force Majeure\\\"). However, the Parties shall endeavor to avoid, remove, or cure all such conditions as soon as is reasonably feasible. If either Party is prevented or hindered from carrying out its obligations under this Agreement due to a Force Majeure, this Agreement shall be suspended as long as the Force Majeure persists. If such period exceeds 1 month, either Party may terminate this Agreement on giving written notice to the other. No failure or delay on the part of either Party to exercise any right or remedy under this Agreement shall be construed or operate as a waiver thereof, nor shall any single or partial exercise of any right or remedy preclude the further exercise of such right or remedy. If any provision or part of any provision of this Agreement is found to be invalid or unenforceable for any reason, the other provisions of this Agreement shall remain in full force and effect as if the Agreement had been executed without that provision or part. All notices or other communications hereunder shall be in writing and shall be given in person, by courier or by registered mail (provided that written confirmation of receipt is provided) addressed as set forth in the heading of this Agreement or such other address as any Party may designate to the other in accordance with this procedure. All communications delivered in person or by courier service shall be deemed to have been received upon delivery, shall be deemed to have been received on the business day following transmission with confirmed answer back, and all notices and other communications sent by registered mail shall be deemed to have been received within 3 business days after posting. This Agreement shall be governed by the laws of the State of New York and all disputes and controversies arising out of or in connection with the Agreement shall be brought exclusively before the competent courts in New York County, New York; provided however that judgment shall be enforceable in any country and that nothing in this Section shall prevent or restrict either Party from seeking interim relief in any competent jurisdiction as it may deem fit. This Agreement constitutes the entire agreement between the Supplier and the Reseller. All previous or contemporaneous agreements, proposals, understandings, and communications between the Supplier and the Reseller are replaced in their entirety by this Agreement. In entering into this Agreement, neither Party has relied on any warranties, representations, or other matters other than as set out in this Agreement. All conditions, warranties, or other terms implied by statute or common law are excluded to the fullest extent permitted by law. This Agreement may be amended only by a written instrument executed by authorized representatives of the Parties. Each of Reseller and Supplier will, respectively, ensure that it and its employees, agents or affiliates, or by any independent contractors on its behalf or for its benefit, shall comply with the United States' Foreign Corrupt Practices Act of 1977, as amended (15 U.S.C. \u00a7\u00a7 78dd-1 et seq.) and any analogous anti-bribery and anti-corruption law, rule, regulation that may apply to any of the transactions contemplated under this Agreement, including but not limited to in connection with the sale, resale, import, export, transportation, or shipment of the Products. Neither party to this Agreement will make any payment, directly or indirectly, of money or other assets, including but not limited to compensation derived from this Agreement or any Order placed under it, to government or political party officials, officials of international organizations, candidates for public office, or representatives of other businesses or persons acting on behalf of any of the foregoing, that would constitute a violation of any law, rule, or regulation. IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date. Vayyar Imaging Ltd. IndeLiving Holdings, Inc. By: /s/ Raviv Melamed By: /s/ Robert Forrest Chief Executive Officer Chief Executive Officer 14.3. 14.4. 14.5. 14.6. 14.7. 14.8. 14.9. Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019\"}}, {\"id\": \"Schedule 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Territory, Products, Price, Ordering Address, Notices\", \"level\": 1, \"text\": \"Schedule 1 Territory, Products, Price, Ordering Address, Notices Territory USA Products Walabot HOME hardware device Price $*** per Product unit + $*** for shipment and tax (subject to any tax changes) MOQ *** units Address to which Orders should be sent Supplier's Ordering Email address: logistics@walabot.com Address for Notices to the Supplier Vayyar Ltd. 3 Avraham Giron St., POB. 325, Yehud 5621717, Israel Address for Notices to Reseller Inde Living Holdings, Inc 1462 Rudder Lane Knoxville, TN 37919 Vayyar Wire Transfer Details *** Payment Terms *** Source: HEALTHCARE INTEGRATED TECHNOLOGIES INC., 8-K, 8/12/2019\"}}, {\"id\": \"party:Vayyar Imaging Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Vayyar Imaging Ltd.\", \"role\": \"Supplier\", \"address\": \"3 Avraham Giron St., POB. 325, Yehud 5621717, Israel\"}}, {\"id\": \"party:Inde Living Holdings, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Inde Living Holdings, Inc.\", \"role\": \"Reseller\", \"address\": \"1462 Rudder Lane, Knoxville, TN 37919\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Walabot-HOME Reseller Agreement\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"this 31 day of July 2019\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"Vayyar and Reseller shall be referred to individually as \\\"Party\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"Vayyar and Reseller shall be referred to ... collectively as \\\"Parties\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Customer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer\", \"text\": \"a third party who purchases the Products from Reseller within the Territory, for its internal use only (including for the personal use of its End Users), such as nursing homes.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:End User\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User\", \"text\": \"a third party who is a customer of Customer or is otherwise related to a customer of Customer, and who purchases and/or uses the Products within the Territory, for its personal use only.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:End User Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User Agreement\", \"text\": \"Supplier's standard license agreements, which are available at https://walabot.com/walabot-home, which governs each End User's right to use the Product, as amended by Supplier in its sole discretion from time to time.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:MOQ\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MOQ\", \"text\": \"the minimum order quantity of Product units during the Initial Term, as set forth in Schedule 1.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Order\", \"text\": \"a written purchase order for Products to be purchased by the Reseller.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"the products listed in Schedule 1.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"Supplier's proprietary software components, included as part of the Products, including all improvements, corrections, updates, upgrades and any related documentation and derivatives thereof.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the countries and/or territories listed in Schedule 1.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Paid\u2010 For Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Paid\u2010 For Products\", \"text\": \"Products for which Reseller submitted an Order, had that Order accepted by Supplier, and for which Reseller has remitted payment in full to the Supplier under this Agreement.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Arrival Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Arrival Date\", \"text\": \"delivery of the Products at the Reseller's facilities within the Territory\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"all electronic, oral, and written communications from the other Party which should reasonably be regarded in the normal commercial view, as constituting confidential information, trade secrets or proprietary information\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"circumstances beyond the reasonable control of the other Party, including technical difficulties beyond such Party's reasonable control that delay or prevent manufacture\", \"definition_clause\": \"13\"}}, {\"id\": \"value:31 day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"31 day\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:150 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"150 days\"}}, {\"id\": \"value:5 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 business days\"}}, {\"id\": \"value:3 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 business days\"}}, {\"id\": \"value:$***\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$***\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"FRANCHISE AGREEMENT TABLE OF CONTENTS\"}, {\"id\": \"I\", \"title\": \"INTRODUCTION\", \"level\": 1, \"text\": \"I. INTRODUCTION\"}, {\"id\": \"II\", \"title\": \"AGREEMENT\", \"level\": 1, \"text\": \"II. AGREEMENT\"}, {\"id\": \"1\", \"title\": \"Definitions\", \"level\": 1, \"text\": \"1. Definitions\"}, {\"id\": \"2\", \"title\": \"Franchise Grant; Term\", \"level\": 1, \"text\": \"2. Franchise Grant; Term\"}, {\"id\": \"3\", \"title\": \"Consideration for Franchise Grant\", \"level\": 1, \"text\": \"3. Consideration for Franchise Grant\"}, {\"id\": \"4\", \"title\": \"Management, Control and Corporate Documents of Franchisee\", \"level\": 1, \"text\": \"4. Management, Control and Corporate Documents of Franchisee\"}, {\"id\": \"6\", \"title\": \"Services to Franchisee\", \"level\": 1, \"text\": \"6. Services to Franchisee\"}, {\"id\": \"6.1\", \"title\": \"Services Provided By BKC 6\", \"level\": 2, \"text\": \"6.1 Services Provided By BKC 6.2 Services Not Provided By BKC 6.3 Optional Services\"}, {\"id\": \"7\", \"title\": \"Location 7\", \"level\": 1, \"text\": \"7. Location 7.1 Exclusive Purpose 7.2 Damage to Franchised Restaurant\"}, {\"id\": \"8\", \"title\": \"Training and Staffing\", \"level\": 1, \"text\": \"8. Training and Staffing\"}, {\"id\": \"8.1\", \"title\": \"Pre-Opening Training 8\", \"level\": 2, \"text\": \"8.1 Pre-Opening Training 8.2 New Director of Operations 8.3 Training Program\"}, {\"id\": \"9\", \"title\": \"Royalty and Advertising Contribution\", \"level\": 1, \"text\": \"9. Royalty and Advertising Contribution ii\"}, {\"id\": \"10\", \"title\": \"Accounting Procedures; Right of Audit\", \"level\": 1, \"text\": \"10. Accounting Procedures; Right of Audit.\"}, {\"id\": \"12\", \"title\": \"Unfair Competition\", \"level\": 1, \"text\": \"12. Unfair Competition\"}, {\"id\": \"13\", \"title\": \"Insurance; Indemnification 13\", \"level\": 1, \"text\": \"13. Insurance; Indemnification 13.1 General Liability Insurance 13.2 Workers Compensation, Etc. 13.3 Indemnity\"}, {\"id\": \"14\", \"title\": \"Taxes 14\", \"level\": 1, \"text\": \"14. Taxes 14.1 Payment When Due 14.2 Withholding Taxes 14.3 Election\"}, {\"id\": \"15\", \"title\": \"Disposal 15\", \"level\": 1, \"text\": \"15. Disposal 15.1 Transfer of Interest by Franchisee 15.2 Transfer of Interest by Principals 15.3 Notice of Proposed Transfer 15.4 Right of First Refusal iii\"}, {\"id\": \"15.4.1\", \"title\": \"Notice; Exercise of Option 15\", \"level\": 3, \"text\": \"15.4.1 Notice; Exercise of Option 15.4.2 No Waiver 15.4.3 Unauthorized Transfer Void 15.4.4 Sale; BKC Consent\"}, {\"id\": \"15.5\", \"title\": \"BKC Consent to Transaction 15\", \"level\": 2, \"text\": \"15.5 BKC Consent to Transaction 15.5.1Transfer of Substantially All Assets or Transfer of Stock by Principal 15.5.2 Securities Offerings\"}, {\"id\": \"15.6\", \"title\": \"No Waiver 15\", \"level\": 2, \"text\": \"15.6 No Waiver 15.7 Death or Mental Incapacity of Principal 15.8 Corporate Documents 15.9 Assignment by BKC\"}, {\"id\": \"16\", \"title\": \"The Principals\", \"level\": 1, \"text\": \"16. The Principals\"}, {\"id\": \"16.1\", \"title\": \"Stock Ownership 16\", \"level\": 2, \"text\": \"16.1 Stock Ownership 16.2 Compliance by Principals 16.3 Guaranty\"}, {\"id\": \"17\", \"title\": \"Defaults and Effects of Termination\", \"level\": 1, \"text\": \"17. Defaults and Effects of Termination\"}, {\"id\": \"17.6\", \"title\": \"Dispute Resolution\", \"level\": 2, \"text\": \"17.6 Dispute Resolution\"}, {\"id\": \"18\", \"title\": \"Restrictive Covenant\", \"level\": 1, \"text\": \"18. Restrictive Covenant iv\"}, {\"id\": \"20\", \"title\": \"Entire Agreement\", \"level\": 1, \"text\": \"20. Entire Agreement\"}, {\"id\": \"21\", \"title\": \"independent Advice\", \"level\": 1, \"text\": \"21. independent Advice\"}, {\"id\": \"III\", \"title\": \"SCHEDULE 1\", \"level\": 1, \"text\": \"III. SCHEDULE 1\"}, {\"id\": \"IV\", \"title\": \"SCHEDULE 2\", \"level\": 1, \"text\": \"IV. SCHEDULE 2\"}, {\"id\": \"V\", \"title\": \"EXHIBIT A - Poland Trademarks\", \"level\": 1, \"text\": \"V. EXHIBIT A - Poland Trademarks v FRANCHISE AGREEMENT ------------------- Corporate --------- AGREEMENT dated 199 Between BURGER KING CORPORATION a company incorporated in Florida, United States of America with its principal office and place of business at 17777 Old Cutler Road, Miami, Florida, United States of America (\\\"BKC\\\") AND The party specified as the Franchisee on SCHEDULE 1 attached hereto (the \\\"Franchisee\\\") AND The party or parties specified as the Principals on SCHEDULE 1 attached hereto (collectively, the \\\"Principals\\\" and individually, a \\\"Principal\\\") INTRODUCTION A. BKC has developed a system (the \\\"Burger King System\\\") for the operation of quick service restaurants ( \\\"Burger King Restaurants\\\"). The Burger King System includes proprietary designs for restaurant buildings, equipment and decor, a proprietary service format, standardized product and quality specifications, and such trademarks, service marks and other marks as BKC may authorize for use in connection with the operation of Burger King Restaurants (the \\\"Burger King Marks\\\"). B. The Franchisee possesses knowledge and market information concerning the operation of Burger King Restaurants in the Republic of Poland and the Franchisee recognizes that BKC has not made any representations concerning the level and extent of the awareness of the Burger King Marks or the Burger King System or the likelihood that any such awareness can or will be established in Poland or as to the availability of local sources of supply in Poland or the ability of any supplier to meet standards for approval by BKC. The Franchisee has requested a license to operate a Burger King Restaurant. The Franchisee represents that BKC has not made, and the Franchisee is not relying upon, any representation as to the profits and/or sales volumes which Franchisee might be expected to realize, or costs or levels of costs which Franchisee might be expected to incur, or the prospects of success for Franchisee or Burger King Restaurants in Poland.\"}, {\"id\": \"C\", \"title\": \"The Franchisee acknowledges and represents to BKC that it is entering into this Agreement after having made\", \"level\": 1, \"text\": \"C. The Franchisee acknowledges and represents to BKC that it is entering into this Agreement after having made an independent investigation of BKC and its operations and of market and economic conditions in the Republic of Poland. The Franchisee represents that BKC has not made, and that the Franchisee 1 is not relying upon, any representation as to the profits and/or sales volumes which Franchisee might be expected to realize, or costs or levels of costs which the Franchisee might be expected to incur, or the prospects of success for the Franchisee or Burger King Restaurants in Poland, or the level or extent of the awareness of the Burger King Marks or the Burger King System or brand in Poland or the likelihood that any such awareness can or will be established in Poland, or the availability of local sources of supply in Poland or the ability of any such local sources of supply to meet standards for approval by BKC. The Franchisee further represents and agrees that BKC and persons acting on its behalf have not made, and the Franchisee is not relying upon, any representations or promises that are not contained in this Agreement.\"}, {\"id\": \"D\", \"title\": \"Each of the Principals owns an equity interest in the Franchisee\", \"level\": 1, \"text\": \"D. Each of the Principals owns an equity interest in the Franchisee. AGREEMENT In consideration of the fees and other sums payable by the Franchisee and the mutual covenants herein, the parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"1. DEFINITIONS. For purposes of this Agreement, the following expressions shall have the meanings given to them below:\"}, {\"id\": \"1.1\", \"title\": \"\\\"Affiliate\\\" means any company which is directly or indirectly controlled by BKC, controls BKC, or is controll\", \"level\": 2, \"text\": \"1.1 \\\"Affiliate\\\" means any company which is directly or indirectly controlled by BKC, controls BKC, or is controlled by a company which in turn controls BKC, and \\\"control\\\" for these purposes means de facto control.\"}, {\"id\": \"1.2\", \"title\": \"\\\"Burger King Marks\\\" has the meaning ascribed to it in Paragraph A of the introduction\", \"level\": 2, \"text\": \"1.2 \\\"Burger King Marks\\\" has the meaning ascribed to it in Paragraph A of the introduction.\"}, {\"id\": \"1.3\", \"title\": \"\\\"Burger King System\\\" has the meaning ascribed to it in Paragraph A of the introduction\", \"level\": 2, \"text\": \"1.3 \\\"Burger King System\\\" has the meaning ascribed to it in Paragraph A of the introduction.\"}, {\"id\": \"1.4\", \"title\": \"\\\"Current Image\\\" means the then current, BKC approved physical appearance of new Burger King Restaurants as it\", \"level\": 2, \"text\": \"1.4 \\\"Current Image\\\" means the then current, BKC approved physical appearance of new Burger King Restaurants as it relates to signage, fascia, color schemes, menu boards, lighting, furniture, finishes and other non-structural matters generally.\"}, {\"id\": \"1.5\", \"title\": \"\\\"Franchised Restaurant\\\" means the buildings at the Location and the business carried out at the Location\", \"level\": 2, \"text\": \"1.5 \\\"Franchised Restaurant\\\" means the buildings at the Location and the business carried out at the Location.\"}, {\"id\": \"1.6\", \"title\": \"\\\"Gross Sales\\\" has the meaning ascribed to it in Subparagraph 9\", \"level\": 2, \"text\": \"1.6 \\\"Gross Sales\\\" has the meaning ascribed to it in Subparagraph 9.3.\"}, {\"id\": \"1.7\", \"title\": \"\\\"Location\\\" has the meaning ascribed to it on SCHEDULE 1\", \"level\": 2, \"text\": \"1.7 \\\"Location\\\" has the meaning ascribed to it on SCHEDULE 1. 2\"}, {\"id\": \"1.8\", \"title\": \"\\\"Director of Operations\\\" has the meaning ascribed to it in Subparagraph 4\", \"level\": 2, \"text\": \"1.8 \\\"Director of Operations\\\" has the meaning ascribed to it in Subparagraph 4.1 and on SCHEDULE 1.\"}, {\"id\": \"1.9\", \"title\": \"\\\"Managing Director\\\" has the meaning ascribed to it in Subparagraph 4\", \"level\": 2, \"text\": \"1.9 \\\"Managing Director\\\" has the meaning ascribed to it in Subparagraph 4.3 and on SCHEDULE 1.\"}, {\"id\": \"1.10\", \"title\": \"\\\"MOD Manual\\\" means all volumes of the Manual of Operating Data setting out BKC's standards, specifications and\", \"level\": 2, \"text\": \"1.10 \\\"MOD Manual\\\" means all volumes of the Manual of Operating Data setting out BKC's standards, specifications and procedures of operation, as revised from time to time by BKC including both required and recommended.\"}, {\"id\": \"2\", \"title\": \"FRANCHISE GRANT TERM\", \"level\": 1, \"text\": \"2. FRANCHISE GRANT TERM.\"}, {\"id\": \"2.1\", \"title\": \"GRANT\", \"level\": 2, \"text\": \"2.1 GRANT. In reliance upon the application and information furnished by the Franchisee, and subject to the terms and conditions contained in this Agreement, BKC grants to the Franchisee a license to use the Burger King System and the Burger King Marks in the operation of a Burger King Restaurant at that Location.\"}, {\"id\": \"2.2\", \"title\": \"TERM\", \"level\": 2, \"text\": \"2.2 TERM. The license hereby granted shall commence on the date the Franchised Restaurant opens for business (the \\\"Commencement Date\\\"), and, unless sooner terminated in accordance with the terms and provisions of this Agreement, shall continue for the period of years set forth on SCHEDULE 1 hereto (the \\\"Term\\\").\"}, {\"id\": \"2.3\", \"title\": \"NO RENEWAL RIGHT; NO EXCLUSIVITY\", \"level\": 2, \"text\": \"2.3 NO RENEWAL RIGHT; NO EXCLUSIVITY. The Franchisee acknowledges and agrees that this license is a license for the operation of a Burger King Restaurant at the Location only and that the Franchisee has no right to any exclusive territory or to object to the location of an additional Burger King Restaurant at a site which is in the immediate proximity of the Franchised Restaurant and/or in the same trading area of the Franchised Restaurant Subject to the Restaurant Development Agreement between BKC and International Fast Food Corporation dated March 14, 1997, (the \\\"Development Agreement\\\"), the development and location of additional Burger King Restaurants shall be determined by BKC in its sole business judgment and BKC may develop or franchise additional Burger King Restaurants anywhere, including sites in the immediate proximity of the Franchised Restaurant and/or in the same trading area of the Franchised Restaurant, in its sole business judgment. The Franchisee hereby waives any right it has, may have, or might in the future have, to oppose such development and location, and any claim for compensation from BKC in respect of any and all detriment or los s suffered by it as a result of the development and location of additional Burger King Restaurants in the immediate proximity of the specified Location and/or in the same trading area of the Franchised Restaurant.\"}, {\"id\": \"2.4\", \"title\": \"CONTINUOUS OPERATION\", \"level\": 2, \"text\": \"2.4 CONTINUOUS OPERATION. Franchisee shall continuously operate the Franchised Restaurant at the Location throughout the full term of this Agreement. Except as permitted under this Section 2.4, any failure to do so shall constitute an Event of Default under this Agreement and BKC shall be 3 entitled to alI rights and remedies available under Section 17.2 of this Agreement. Provided, however, that t he Franchisee may temporarily cease operations for a period of time reasonably necessary to comply with the requirement of any competent governmental authority that it repair, clean remodel, or refurbish the Location. The Franchisee may also temporarily cease operations on national holidays and for a period of time reasonably necessary to complete repairs or deal with an act of God, a labor strike, civil unrest, or other emergency situation which would endanger the public or the Franchisee's employees. However, in the event that any temporary closing or discontinuance of operation permitted under this Section 2.4 exceeds 180 days, BKC shall have the right to terminate this Agreement, whereupon all rights granted to Franchisee under this Agreement shall terminate, without liability to BKC.\"}, {\"id\": \"2.5\", \"title\": \"BEST EFFORTS\", \"level\": 2, \"text\": \"2.5 BEST EFFORTS. Franchisee shall use its best efforts to diligently market and promote the Franchised Restaurant.\"}, {\"id\": \"3\", \"title\": \"CONSIDERATION FOR FRANCHISE GRANT\", \"level\": 1, \"text\": \"3. CONSIDERATION FOR FRANCHISE GRANT. At least seven (7) days before the Commencement Date, the Franchisee shall pay to BKC the initial franchise fee described in SCHEDULE 1, which sum shall be fully earned by BKC and non-refundable upon execution of this Agreement.\"}, {\"id\": \"4\", \"title\": \"MANAGEMENT\", \"level\": 1, \"text\": \"4. MANAGEMENT. CONTROL AND CORPORATE DOCUMENTS OF FRANCHISEE.\"}, {\"id\": \"4.1\", \"title\": \"MANAGING DIRECTOR\", \"level\": 2, \"text\": \"4.1 MANAGING DIRECTOR. The Franchisee shall, subject to BKC's approval, appoint an individual as the \\\"Managing Director\\\" who shall be responsible for the overall management of the Franchisee. The Managing Director and Director of Operations may be the same individual.\"}, {\"id\": \"4.2\", \"title\": \"DIRECTOR OF OPERATIONS\", \"level\": 2, \"text\": \"4.2 DIRECTOR OF OPERATIONS. Franchisee shall, subject to BKC's approval, appoint an individual as the \\\"Director of Operations\\\" who shall be trained in the Burger King System. The Director of Operations shall be granted the authority to direct any action necessary to ensure that the day-to-day operation of the Franchised: Restaurant is in compliance with all agreements with BKC relating to the Franchised Restaurant. The Director of Operations shall devote full time and best efforts to the overall supervision of the Franchised Restaurant and any other Burger King Restaurants owned by the Franchisee as to which he/she is designated as the \\\"Director of Operations. \\\"\"}, {\"id\": \"4.3\", \"title\": \"SUBSTITUTE DIRECTOR OF OPERATIONS\", \"level\": 2, \"text\": \"4.3 SUBSTITUTE DIRECTOR OF OPERATIONS. If the position of Director of Operations becomes vacant for any reason, the vacancy shall be filled within ninety (90) days by a new Director of Operations approved by BKC.\"}, {\"id\": \"4.4\", \"title\": \"RESTAURANT MANAGER\", \"level\": 2, \"text\": \"4.4 RESTAURANT MANAGER. At all times during the Term of this Agreement, Franchisee shall employ at least one (1) individual (the \\\"Restaurant Manager\\\") who is responsible for the direct, personal supervision of the Franchise d Restaurant . 4\"}, {\"id\": \"4.5\", \"title\": \"CORPORATE DOCUMENTS\", \"level\": 2, \"text\": \"4.5 CORPORATE DOCUMENTS.\"}, {\"id\": \"4.5.1\", \"title\": \"SINGLE PURPOSE ENTITY\", \"level\": 3, \"text\": \"4.5.1 SINGLE PURPOSE ENTITY. Franchisee's sole business activity shall be the development and operation of Burger King restaurants. The articles of incorporation, bylaws and other governing documents of Franchisee must provide that Franchisee is a single purpose entity formed solely for the purpose of developing and operating Burger King restaurants.\"}, {\"id\": \"4.5.2\", \"title\": \"MANAGING DIRECTOR'S AUTHORITY\", \"level\": 3, \"text\": \"4.5.2 MANAGING DIRECTOR'S AUTHORITY. The articles of incorporation, bylaws and other governing documents of Franchisee must mandate the designation of a Managing Director and describe the Managing Director's authority to bind the Franchisee and to direct any actions necessary to ensure compliance with this Franchise Agreement and any ancillary agreements.\"}, {\"id\": \"4.5.3\", \"title\": \"ISSUANCE AND TRANSFER OF SHARES\", \"level\": 3, \"text\": \"4.5.3 ISSUANCE AND TRANSFER OF SHARES. The articles of incorporation, the bylaws and each stock certificate of Franchisee shall restrict the issuance and the transfer of shares of Franchisee as provided in Paragraph 15.8 below.\"}, {\"id\": \"4.5.4\", \"title\": \"AMENDMENTS\", \"level\": 3, \"text\": \"4.5.4 AMENDMENTS. BKC must be immediately provided with any amendments, shareholder agreements, addenda, revisions or other alterations to the articles of incorporation, bylaws or constitution of Franchisee. No amendment to such governing documents may be made, nor may any resolution be adopted by the board of directors of Franchisee, without the written consent of an authorized officer of BKC, if such amendment or resolution would (1) change the description of the Franchisee's purpose or authorized activities; (2) change the designation of, or the procedures for designating, the Managing Director; (3) change the authority delegated to the Managing Director; or (4) materially alter promises or representations contained in the application approved by BKC.\"}, {\"id\": \"5\", \"title\": \"STANDARDS AND UNIFORMITY\", \"level\": 1, \"text\": \"5. STANDARDS AND UNIFORMITY.\"}, {\"id\": \"5.1\", \"title\": \"STRICT COMPLIANCE\", \"level\": 2, \"text\": \"5.1 STRICT COMPLIANCE. The Franchisee agrees to comply strictly at all times with the Burger King System, which Franchisee acknowledges is a fundamental term of this Agreement and a necessary and reasonable requirement in the interests of the Franchisee and others operating under the Burger King System. In particular, the Franchisee shall at all times comply with the following provisions of this Section 5.\"}, {\"id\": \"5.2\", \"title\": \"THE MOD MANUAL\", \"level\": 2, \"text\": \"5.2 THE MOD MANUAL. The MOD Manual shall be kept at the Franchised Restaurant and all changes or additions shall be inserted upon receipt. The Franchisee agrees that changes in standards, specifications and procedures may become necessary and desirable from time to time and shall comply with such modifications, revisions and additions to the MOD Manual as BKC in the good faith exercise of its judgment believes to be desirable. The information 5 contained in the MOD Manual is confidential and the Franchisee shall use the MOD Manual only in connection with the operation of the Franchised Restaur ant and other licensed Burger King Restaurants\"}, {\"id\": \"5.3\", \"title\": \"BUILDING AND PREMISES\", \"level\": 2, \"text\": \"5.3 BUILDING AND PREMISES.\"}, {\"id\": \"5.3.1\", \"title\": \"INITIAL CONSTRUCTION\", \"level\": 3, \"text\": \"5.3.1 INITIAL CONSTRUCTION. The Franchised Restaurant shall be constructed and the premises initially improved in the manner approved by BKC, and shall be decorated, furnished, and equipped with equipment, furnishings, and fixtures which meet BKC's specifications and Current Image. The appearance of the Franchised Restaurant shall not thereafter be altered except as approved by BKC in writing.\"}, {\"id\": \"5.3.2\", \"title\": \"REPAIR AND MAINTENANCE\", \"level\": 3, \"text\": \"5.3.2 REPAIR AND MAINTENANCE. The Franchisee shall, at its own expense, continuously throughout the Term of this Agreement, maintain the Franchised Restaurant in good condition and repair in accordance with BKC's then current repair and maintenance standards.\"}, {\"id\": \"5.3.3\", \"title\": \"CURRENT IMAGE\", \"level\": 3, \"text\": \"5.3.3 CURRENT IMAGE. During the year immediately following the expiration of one half of the Term of this Agreement (e.g., in the 11th year of a 20 year term), the Franchisee shall remodel, improve and alter the exterior of the Franchised Restaurant to conform with the Current Image in effect during the prior year .\"}, {\"id\": \"5.4\", \"title\": \"SIGNS\", \"level\": 2, \"text\": \"5.4 SIGNS. The Burger King Marks will be displayed only in the manner and at such locations as are authorized by BKC. The Franchisee agrees to maintain and display signs conforming to the Current Image. The Franchisee shall discontinue the use of and destroy such signs as are declared obsolete by BKC.\"}, {\"id\": \"5.5\", \"title\": \"EQUIPMENT\", \"level\": 2, \"text\": \"5.5 EQUIPMENT. Only equipment and equipment layouts approved by BKC shall be used at the Location. All equipment shall be maintained in a condition that meets operational standards specified in the MOD Manual, and as equipment becomes obsolete or inoperable, the Franchisee will replace such items with the types and kinds of equipment as are then approved for use in new Burger King Restaurants at the time of replacement. If BKC determines that additional or substitute equipment is needed in any part of the Location due to a change in menu items or method of preparation and service, or because of health or safety considerations, the Franchisee will install the new equipment within such time as BKC may reasonably specify.\"}, {\"id\": \"5.6\", \"title\": \"VENDING MACHINES, ETC\", \"level\": 2, \"text\": \"5.6 VENDING MACHINES, ETC. No telephone booths, newspaper racks, juke boxes, vending machines, games, rides or any other type of machines shall be installed without the prior written approval of BKC.\"}, {\"id\": \"5.7\", \"title\": \"MENU, SERVICE AND HYGIENE\", \"level\": 2, \"text\": \"5.7 MENU, SERVICE AND HYGIENE. The Franchised Restaurant shall serve all menu items and brands specified by BKC, and shall not serve any items that are not set forth in the MOD Manual or otherwise authorized and approved by BKC in writing. The Franchisee shall adhere to all specifications contained in the MOD 6 Manual or as otherwise prescribed by BKC as to ingredients, storage, handling, method of preparation and service, weight and dimensions of products served, and standards of cleanliness, health, and sanitation. All food, drinks, and other items will be served and sold in packaging that meets BKC's specifications. Only food, paper products, packaging and supplies from sources approved by BKC (which expression includes sources of both product and distribution) shall be used in the Franchised Restaurant.\"}, {\"id\": \"5.8\", \"title\": \"HOURS OF OPERATION\", \"level\": 2, \"text\": \"5.8 HOURS OF OPERATION. Subject to the provisions of Paragraph 2.4 above, or unless otherwise authorized or directed by BKC the entire Franchised Restaurant shall be open for business a minimum of the hours indicated on SCHEDULE 1 daily, seven (7) days a week, except where prohibited by law or government regulation. BKC recognizes that considerations peculiar to the location of the Franchised Restaurant may make it necessary to alter the aforesaid hours of operation, and BKC will not unreasonably withhold its consent to do so.\"}, {\"id\": \"5.9\", \"title\": \"UNIFORMS\", \"level\": 2, \"text\": \"5.9 UNIFORMS. All employees at the Location shall wear uniforms previously approved by BKC as meeting the design, color and specification as are from time to time prescribed by BKC.\"}, {\"id\": \"5.10\", \"title\": \"ADVERTISING AND PROMOTION MATERIALS\", \"level\": 2, \"text\": \"5.10 ADVERTISING AND PROMOTION MATERIALS. Only such advertising or promotional materials, slogans or other items as are authorized by BKC in writing prior to use shall be used, sold, or distributed, and no display or use of the Burger King Marks shall be made without the prior written permission of BKC. All materials on which Burger King Marks are used shall bear such notice of registration or license legend as BKC may specify. The Franchisee agrees to comply with the advertising and promotional standards established from time to time by BKC.\"}, {\"id\": \"5.11\", \"title\": \"INTERFERENCE WITH EMPLOYMENT RELATIONS OF OTHERS\", \"level\": 2, \"text\": \"5.11 INTERFERENCE WITH EMPLOYMENT RELATIONS OF OTHERS. The Franchisee will not attempt, directly or indirectly, to entice or induce any employee of BKC or of an Affiliate of BKC or of another franchisee of BKC to leave such employment, nor to employ such employee within six (6) months after his or her termination of employment with such employer, except with the prior written consent of such employer.\"}, {\"id\": \"5.12\", \"title\": \"IMPROVEMENTS\", \"level\": 2, \"text\": \"5.12 IMPROVEMENTS. The Franchisee shall notify BKC of any potential improvements or new features which it identifies as capable of benefitting the Burger King System. The Franchisee shall not use potential improvements or new features at the Franchised Restaurant unless authorized by BKC in writing and at its sole discretion, but BKC is under no obligation to authorize such use. The Franchisee acknowledges and agrees that all such potential improvements and new features shall become the exclusive property of BKC without payment of any consideration to the Franchisee, and BKC is free to evaluate such potential improvements or new features in its own restaurants and introduce any such improvements or new features into the Burger King System for the benefit of BKC 7 and other franchisees. The Franchisee agrees to execute any additional documents which BKC may deem necessary to effect or perfect the provisions of this Paragraph 5.12.\"}, {\"id\": \"5.13\", \"title\": \"SELF-AUDIt\", \"level\": 2, \"text\": \"5.13 SELF-AUDIt. The Franchisee shall participate in any self-audit scheme which may from time to time form part of the Burger King System.\"}, {\"id\": \"5.14\", \"title\": \"HEALTH PROBLEMS\", \"level\": 2, \"text\": \"5.14 HEALTH PROBLEMS. The Franchisee shall immediately notify BKC of any actual or suspected occurrence of any serious communicable disease or infection at or among staff or customers at the Franchised Restaurant.\"}, {\"id\": \"5.15\", \"title\": \"RIGHT OF ENTRY, INSPECTION AND CLOSURE\", \"level\": 2, \"text\": \"5.15 RIGHT OF ENTRY, INSPECTION AND CLOSURE. BKC shall have the unrestricted right to enter the Franchised Restaurant to conduct such reasonable activities as it deems necessary to ascertain compliance with this Agreement. The inspections may be conducted without prior notice at any time when the Franchisee or any one of its responsible employees or representatives is at the Franchised Restaurant. The inspections shall be performed in a manner which minimizes interference with the operation of the Franchised Restaurant. BKC may require the removal of any items which do not comply with this Agreement at the Franchisee's cost. In the event that BKC identifies, or reasonably suspects the existence of, any significant risk to health or safety in any aspect of the operation at the Location, BKC may require the Franchisee immediately to close the Franchised Restaurant until the hazard as been eliminated. BKC shall specify the grounds for taking such action and such steps if any a it believes are necessary to eliminate the hazard and shall cooperate with the Franchisee to enable the Franchisee to re-open the Franchised Restaurant as soon as possible.\"}, {\"id\": \"5.16\", \"title\": \"SOURCES OF SUPPLY\", \"level\": 2, \"text\": \"5.16 SOURCES OF SUPPLY.\"}, {\"id\": \"5.16.1\", \"title\": \"AUTHORIZED SUPPLIERS\", \"level\": 3, \"text\": \"5.16.1 AUTHORIZED SUPPLIERS. BKC may require that any item required for or used in the operation of the Franchised Restaurant shall be previously approved by BKC in its sole and absolute discretion and that the supplier and distributor of such items also be previously approved by BKC in its sole and absolute discretion. The Franchisee shall in such case purchase only from BKC authorized suppliers and distributors. Should the Franchisee propose an alternative supplier and distributor, BKC shall evaluate such supplier and distributor against its then-current criteria, as established by BKC in its sole discretion, and either approve or disapprove such supplier and distributor. Any supplier and distributor proposed by the Franchisee may be required to sign a suitable confidentiality undertaking before BKC's confidential specifications are disclosed. In approving or disapproving suppliers and distributors, the Franchisee acknowledges and agrees that BKC may devote such resources and time as BKC may reasonably determine is necessary to evaluate any such supplier or distributor in its sole discretion. BKC agrees that it will apply those criteria in good faith toward the Franchisee. If BKC denies the Franchisee's request for approval of a supplier or distributor BKC shall advise the Franchisee of the reasons for its decision. If BKC fails to approve or deny the Franchisee's 8 request for approval of a supplier or distributor within thirty (30) business days then approval shall be deemed to have been given. Approval of any suppler or distributor by BKC is subject to revocation in its sole discretion.\"}, {\"id\": \"5.16.2\", \"title\": \"SELF-SUPPLY\", \"level\": 3, \"text\": \"5.16.2 SELF-SUPPLY. Franchisee may, upon prior written notice to BKC, invest in BKC approved suppliers and/or distributors to the Franchised Restaurant or request approval from BKC to become an approved supplier and/or distributor to the Franchised Restaurant. BKC shall not unreasonably withhold its approval of the Franchisee as a supplier and/or distributor to the Franchised Restaurant and/or other Burger King Restaurants. Franchisee expressly acknowledges and agrees, however, that the Franchisee must meet all of BKC's then current conditions for supplier and/or distribution agreements.\"}, {\"id\": \"5.16.3\", \"title\": \"LIMITS ON BKC RESPONSIBILITY\", \"level\": 3, \"text\": \"5.16.3 LIMITS ON BKC RESPONSIBILITY. BKC shall NOT be responsible for the following: (a) Arranging, assuring, or facilitating the delivery or availability o labor, food, paper, equipment, furniture, fixtures, or any other goods or services in connection with the operation of the Franchised Restaurant. (b) Arranging, assuring, or facilitating the delivery or availability of labor, food, paper, equipment, furniture, fixtures or any other goods or services in connection with the operation of the Franchised Restaurant at a reasonable or at any other particular cost (whether stated as a percentage of sales or otherwise to the Franchised Restaurant or to the Franchisee).\"}, {\"id\": \"5.16.4\", \"title\": \"FRANCHISEE'S RESPONSIBILITIES\", \"level\": 3, \"text\": \"5.16.4 FRANCHISEE'S RESPONSIBILITIES. Franchisee shall be responsible for locating and submitting to BKC for approval, pursuant to Section 5.16.1 above, suppliers and distributors capable of manufacturing and/or delivering all BKC required goods and services to the Franchised Restaurant on a consistent and reliable basis.\"}, {\"id\": \"6\", \"title\": \"SERVICES TO FRANCHISEE\", \"level\": 1, \"text\": \"6. SERVICES TO FRANCHISEE.\"}, {\"id\": \"6.1\", \"title\": \"SERVICES PROVIDED BY BKC\", \"level\": 2, \"text\": \"6.1 SERVICES PROVIDED BY BKC. BKC, its designee or an Affiliate of BKC shall periodically advise and consult with the Franchisee in connection with the operation of the Franchised Restaurant and shall provide to he Franchisee: (a) The MOD Manual, including all revisions and updates thereto, which will be loaned to the Franchisee for the term of this Agreement. The loaned copy of the MOD Manual and other specifications, standard and operating procedures furnished by BKC shall be written in English, and any translation to another language shall be at the Franchisee's responsibility and cost. 9 Franchisee shall translate the MOD Manual into the native language of the employees at the Franchised Restaurant upon request by BKC. The delivery of a copy of the MOD Manual, including all revisions and updates thereto, by BKC to the Franchisee satisfies and fulfills any obligation BKC may be deemed to have to provide the Franchisee with use of the Burger King System or expertise regarding he Burger King System. (b) A representative of BKC who shall make not less than two (2) one day visits to Poland per annum to provide the Franchisee with any requested reasonable operations or marketing guidance and advice. Franchisee shall have the option to participate, at its sole cost and expense, in any additional training pro grams offered by BKC to other franchisees generally. Such training programs shall be at locations designated by BKC. (c) Communication of new developments, techniques and improvements of BKC which BKC deems in its sole discretion to be relevant to the operation of the Franchised Restaurant and which BKC may otherwise make available to all other franchisees in Europe.\"}, {\"id\": \"6.2\", \"title\": \"SERVICES NOT PROVIDED BY BKC\", \"level\": 2, \"text\": \"6.2 SERVICES NOT PROVIDED BY BKC. The Franchisee acknowledges and agrees that compliance by BKC with its obligations under Section 6.1 above shall satisfy all obligations of BKC to provide operational, marketing, and other support to the Franchisee, and that any other support provided by BKC shall be at BKC's sole discretion. The Franchisee further acknowledges and agrees that BKC shall have no obligation with regard to the establishment, development and for maintenance of consumer awareness or recognition of the Burger King Marks, Restaurants or System.\"}, {\"id\": \"6.3\", \"title\": \"OPTIONAL SERVICES\", \"level\": 2, \"text\": \"6.3 OPTIONAL SERVICES. BKC may, but shall under no circumstances be required to, offer the following services and/or assistance to Franchisee, in BKC's sole discretion: (a) If requested by Franchisee, BKC may, at its sole and absolute discretion, provide Franchisee with a pre-opening training program at Franchisee's sole cost and expense at whatever location BKC may designate in its sole discretion. (b) If requested by Franchisee, BKC may, in its sole and absolute discretion, provide Franchisee with pre-opening and opening supervision and assistance by personnel of BKC, its designee or an Affiliate of BKC at Franchisee's sole cost and expense at whatever location BKC may designate in its sole discretion.\"}, {\"id\": \"7\", \"title\": \"LOCATION\", \"level\": 1, \"text\": \"7. LOCATION.\"}, {\"id\": \"7.1\", \"title\": \"EXCLUSIVE PURPOSE\", \"level\": 2, \"text\": \"7.1 EXCLUSIVE PURPOSE. During the term of this Agreement the Location shall be used exclusively for the purpose of operating a Burger King Restaurant. 10\"}, {\"id\": \"7.2\", \"title\": \"DAMAGE TO FRANCHISED RESTAURANT\", \"level\": 2, \"text\": \"7.2 DAMAGE TO FRANCHISED RESTAURANT. In the event of the building being damaged or destroyed by fire or any other peril, or required to be repaired or altered by any competent authority, the Franchisee shall at its own expense repair or reconstruct the building within a reasonable time to reflect the then Current Image of Burger King Restaurants, having first submitted to BKC all plans and specifications related thereto for prior approval. Where the Franchised Restaurant is insured by a person other than the Franchisee, the Franchisee's obligations shall be limited to taking such steps as are reasonably available to the Franchisee to assure that any insurance moneys ar paid out in accordance with this subparagraph. Notwithstanding the foregoing, if (a) the building is leased, (b) the Franchisee is prohibited under the terms of the applicable lease from repairing or reconstructing the building as provided above, and (c) the Franchisee has exhausted its best efforts to convince the landlord to consent to such repair or reconstruction, then the Franchisee shall be released from its obligations under this Paragraph 7.2 and this Agreement shall terminate.\"}, {\"id\": \"8\", \"title\": \"TRAINING AND STAFFING\", \"level\": 1, \"text\": \"8. TRAINING AND STAFFING.\"}, {\"id\": \"8.1\", \"title\": \"PRE-OPENING TRAINING\", \"level\": 2, \"text\": \"8.1 PRE-OPENING TRAINING. Before the Franchised Restaurant opens, the Director of Operations and such members of the Franchisee's staff charged with the responsibility for the day to day operation of the Franchised Restaurant as BKC may determine must have successfully completed BKC's training program at such location in the U.S. or elsewhere as may be designated by BKC. Such members of t e Franchisee's restaurant staff as BKC may determine shall undertake and complete continuing raining programs from time to time as may be directed by BKC in order to implement current operational standards. There shall be no charge for participation in the training programs, but the Franchisee shall be responsible for all travel and living expenses, all compensation of the Franchisee's employee while enrolled in the training program, and any other personal expenses incurred.\"}, {\"id\": \"8.2\", \"title\": \"NEW DIRECTOR OF OPERATIONS\", \"level\": 2, \"text\": \"8.2 NEW DIRECTOR OF OPERATIONS. Any new Director of Operations as BKC may approve shall successfully complete the above program before taking up such position.\"}, {\"id\": \"8.3\", \"title\": \"TRAINING PROGRAM\", \"level\": 2, \"text\": \"8.3 TRAINING PROGRAM. The Franchisee shall implement a training program for Franchised Restaurant employees in accordance with training standards and procedures prescribed by BKC and shall staff the Franchised Restaurant at all times with a sufficient number of trained employees including the minimum number of managers required by BKC who have completed BKC's training program at an accredited location.\"}, {\"id\": \"9\", \"title\": \"ROYALTY AND ADVERTISING CONTRIBUTION\", \"level\": 1, \"text\": \"9. ROYALTY AND ADVERTISING CONTRIBUTION.\"}, {\"id\": \"9.1\", \"title\": \"ROYALTY\", \"level\": 2, \"text\": \"9.1 ROYALTY.\"}, {\"id\": \"9.1.1\", \"title\": \"PAYMENT OF ROYALTY\", \"level\": 3, \"text\": \"9.1.1 PAYMENT OF ROYALTY. Except as otherwise provided in Section 5 3 of the Development Agreement, by the fifteenth (15th) day of each month, the 11 Franchisee shall deliver to BKC a return of Gross Sales for the preceding month and pay to BKC or its designee a royalty for the use of the Burger King Marks an the Burger King System calculated by applying the percentage set forth in SCHEDULE 1 against the Gross Sales for the preceding calendar month. All royalties shall be paid by the Franchisee to BKC or its designee in United States currency into such bank account in the United States of America or elsewhere as BKC shall designate by prior written notice to the Franchisee. Such payments shall be made by such method as BKC may from time to time stipulate including direct debit, in accordance with applicable law. Each conversion from local currency to United States currency shall be at the maximum selling rate of exchange quoted by Citibank, N.A. in New York, New York, U.S.A., or at the maximum selling rate of a nationally recognized bank in the country where the Franchised Restaurant is located, at the sole discretion of BKC, as of the last bank trading day of the month on which the royalty payment is based. The Franchisee will, at its expense, make all necessary and appropriate applications to such governmental authorities as may be requested by BKC or as may be required for transmittal and payment of United States currency to BKC.\"}, {\"id\": \"9.2\", \"title\": \"ADVERTISING AND SALES PROMOTION\", \"level\": 2, \"text\": \"9.2 ADVERTISING AND SALES PROMOTION.\"}, {\"id\": \"9.2.1\", \"title\": \"FRANCHISEE'S ADMINISTRATION OF AD FUND\", \"level\": 3, \"text\": \"9.2.1 FRANCHISEE'S ADMINISTRATION OF AD FUND. Pursuant to the terms of the Ad Fund Agreement dated March 14, 1997 between the Franchisee and BKC, the Franchisee shall expend monthly, in the country where the Franchised Restaurant is located, monies for advertising, sales promotion and public relation services for he benefit of Burger King Restaurants in the country where the Franchised Restaurant is locate, including creative, production, media and clearance costs of advertising and sales promotion materials, and marketing 12 research expenses directly related to the development and evaluation of the effectiveness of advertising and sales promotion. (SUBJECT TO A PENDING REQUEST FOR CONFIDENTIAL TREATMENT)\"}, {\"id\": \"9.2.2\", \"title\": \"BKC'S RIGHT TO ADMINISTER FUNDS\", \"level\": 3, \"text\": \"9.2.2 BKC'S RIGHT TO ADMINISTER FUNDS. Notwithstanding the language in Subparagraph 9.2.1 above, BKC and the Franchisee agrees that, in the event BKC develops company-owned Burger King Restaurants directly or through a subsidiary or joint venture in the country where the Franchised Restaurant is located or franchises Burger King Restaurants in the country where the Franchised Restaurant is located to someone other than the Franchisee, BKC shall have the right to terminate the Ad Fund Agreement pursuant to its terms and require that the Franchisee pay to BKC or its designee by the fifteenth (15th') day of each month, in the currency of the country where the Franchised Restaurant is located an amount equal to the amount calculated by applying the advertising percentage stated in SCHEDULE 1 to the Gross Sales for the preceding calendar month. Any monies received by BKC under this Subparagraph shall be administered by BKC as provided in Subparagraph 9.2.3 below. In the event BKC requires and the Franchisee makes these payments, the direct expenditure obligation of Subparagraph 9.2.1 above will be deemed fully satisfied.\"}, {\"id\": \"9.2.3\", \"title\": \"ADMINISTRATION\", \"level\": 3, \"text\": \"9.2.3 ADMINISTRATION. Any amounts received by BKC pursuant to Subparagraph 9.2.2 above, less administrative expenses and any applicable taxes, will be combined with payments from other Burger King Restaurants to form an ad fund which will be used for (a) market research expenditures directly related to the development and evaluation of the effectiveness of advertising and sales promotions, (b) creative, production and other costs incurred in connection with the development of advertising sales promotions and public relations, both in the market area of the Franchised Restaurant as reasonably defined from time to time by BKC, and on a national basis and (c) various methods of delivering the advertising or promotional message, including without limitation, television, radio, outdoor and print. The allocation of the Advertising Contribution between international, national, regional, and local expenditures shall be made by BKC in its sole business judgment. All general and administrative expenses and overhead associated with the ad fund, including salaries of relevant BKC employees, shall be paid out of the assets of the ad fund. The Franchisee is encouraged to participate in the planning of advertising, sales promotions and public relations for the Franchised Restaurant, but all expenditures for such matters shall be the sole discretion of BKC. In addition to the percentage of Gross Sales, the Franchisee agrees to transfer to BKC or its designee for inclusion in the market fund all advertising or promotional allowances given by suppliers of products which are sold in the Franchised Restaurant uncle a brand name. Such payment to be made to BKC or its designee by the fifteenth (15th) day of the month following receipt of the said allowance. The market fund will be run by BKC directly or by delegation to its designee. 13\"}, {\"id\": \"9.2.4\", \"title\": \"COMPLIANCE WITH LAWS AND POLICIES\", \"level\": 3, \"text\": \"9.2.4 COMPLIANCE WITH LAWS AND POLICIES. The Franchisee agrees to adhere to all applicable statutory regulations and to KC's advertising, sales promotion and public relations standards and all advertisements and other material published, circulated or exhibited shall first be approved by BKC. The Franchisee agree immediately to remove or discontinue the use of any objectionable advertising material upon receiving notice from BKC.\"}, {\"id\": \"9.3\", \"title\": \"GROSS SALES\", \"level\": 2, \"text\": \"9.3 GROSS SALES. The term \\\"Gross Sales\\\" as used in this Agreement includes all sums charged for goods, merchandise, or services sold at or from the Location. The sale of Burger King products away from the Location is not authorized; however, should any such sales be approved in the future, they will be included within the definition of Gross Sales. Gross Sales shall not include any value added tax, turnover tax, or any similar tax collected by the Franchisee from customers based upon sales.\"}, {\"id\": \"9.4\", \"title\": \"INTEREST AND ATTORNEY'S FEES\", \"level\": 2, \"text\": \"9.4 INTEREST AND ATTORNEY'S FEES. The Franchisee shall pay to BKC interest (in U.S. dollars in the United States) upon any sum overdue under this Agreement, calculated at three (3) percent per annum above the prime rate of merest charged by Citibank, N.A., against the overdue sum expressed in U.S. dollars. By way of exception, any overdue sum required to be paid in a currency other than U.S. dollars shall bear merest at three (3) percent per annum above the base lending rate of any nationally recognized bank within the relevant country designated by BKC. Nothing in this paragraph is meant to require the Franchisee to pay interest at a rate greater than that allowed by applicable law and, in the event that this paragraph would have such an effect, the Franchisee shall only be required to pay interest at the maximum rate allowable by law. If an excess amount is inadvertently collected, it shall be applied to reduce the amounts due under Subparagraph 9.1.1 above. The Franchisee shall pay all costs, including reasonable attorney's fees, incurred by BKC in enforcing the tern s of this Agreement.\"}, {\"id\": \"10\", \"title\": \"ACCOUNTING PROCEDURES; RIGHT OF AUDIT\", \"level\": 1, \"text\": \"10. ACCOUNTING PROCEDURES; RIGHT OF AUDIT.\"}, {\"id\": \"10.1\", \"title\": \"ACCOUNTING\", \"level\": 2, \"text\": \"10.1 ACCOUNTING. The Franchisee agrees to keep complete records of the business and shall furnish BKC with monthly and fiscal year-to-date profit and loss statements for the Franchised Restaurant in the format prescribed by BKC. The Franchisee shall also submit to BKC quarterly balance sheets for the Franchisee itself and not merely of the Franchised Restaurant, the first of which shall be for the period ending forty-five (45) days after the expiration of the first calendar quarter after the Franchised Restaurant opens. All profit and loss statements and balance sheets shall be submitted to BKC within fifty-five (45) days after the end of the period covered by the report in a form acceptable to BKC. In addition, the Franchisee shall submit to BKC copies of tax returns relating to the Franchisee's sales at the Franchised Restaurant at the same time the returns are filed, and such other records as BKC may reasonably request from time to time. 14\"}, {\"id\": \"10.2\", \"title\": \"ANNUAL FINANCIAL STATEMENT\", \"level\": 2, \"text\": \"10.2 ANNUAL FINANCIAL STATEMENT. Within ninety (90) days after the close of each fiscal year and at any time on request, the Franchisee shall submit a full disclosure of all shareholders in the Franchisee, and of all persons with an interest in the Franchised Restaurant. ln addition, the Franchisee shall furnish an annual financial statement for the Franchisee and not merely the Franchised Restaurant, which statement shall be certified by a Certified Public Accountant or equivalent.\"}, {\"id\": \"10.3\", \"title\": \"AUDITS\", \"level\": 2, \"text\": \"10.3 AUDITS. The Franchisee agrees that BKC or its representatives, at BKC's expense shall, at all reasonable times, have the right to examine or audit the books and accounts of the Franchisee. The Franchisee shall retain sales records for a period of at least twenty-four (24) months. In the event the reported Gross Sales are less than the actual Gross Sales, the Franchisee shall make an additional payment to BKC in the amount of the discrepancy. In the event that the discrepancy exceeds two percent (2%), th Franchisee shall also reimburse BKC for all costs of the audit including travel, lodging and wages.\"}, {\"id\": \"10.4\", \"title\": \"RELEASE OF FINANCIAL INFORMATION\", \"level\": 2, \"text\": \"10.4 RELEASE OF FINANCIAL INFORMATION. BKC is authorized to release financial and operational information on the Franchised Restaurant as part of any disclosure of information on the Burger King System in the country where the Franchised Restaurant is located or on the Burger King System as a whole. Except as required by law or regulation, BKC shall not specifically identify the Franchised Restaurant to which this information relates.\"}, {\"id\": \"10.5\", \"title\": \"POLLING\", \"level\": 2, \"text\": \"10.5 POLLING.\"}, {\"id\": \"10.5.1\", \"title\": \"POS SYSTEMS\", \"level\": 3, \"text\": \"10.5.1 POS SYSTEMS. The Franchisee shall at all times operate at the Franchised Restaurant POS systems previously approved by BKC as meeting its performance standards and other criteria including compatibility with BKC's polling standards, provided that such POS system operates in accordance with applicable law. BKC shall have the right to call upon the Franchisee to upgrade the POS systems as BKC may deem necessary or desirable in the interest of proper administration of restaurants operating under the Burger King System, and the Franchisee shall comply with such requirement within such reasonable time as may be specified by BKC. Such authorized POS systems shall at all times be used to record and process such information as BKC may from time to time require, and such information shall be maintained in such format and kept available for access by BKC on such POS system for such minimum period as BKC may require. The Franchisee she effect the polling operation at such time or times as may be required by BKC, but BKC may itself initiate polling whenever it deems appropriate. BKC shall have no obligation to provide Franchisee with information, consultation or advice concerning POS systems or accounting or other financial systems for the operation of Franchisee's business.\"}, {\"id\": \"10.5.2\", \"title\": \"AUTHORIZED POLLING\", \"level\": 3, \"text\": \"10.5.2 AUTHORIZED POLLING. The Franchisee shall permit BKC or its duly authorized agents at all times and from time to time to poll any 15 information contained in such POS system. For the purposes of this Agreement the term \\\"poll\\\" or \\\"polling\\\" means any process acceptable to BKC by which information o data may be transmitted from a POS system operated by the Franchisee or its agents into a computer or system operated by BKC, it agents or Affiliates. If for any reason polling is not practicable, BKC may require the Franchisee to download such information into machine readable form compatible with the system operated by BKC, its agents or Affiliates and to derive such information to BKC by such method and within such timescale as BKC may reasonably determine.\"}, {\"id\": \"10.5.3\", \"title\": \"OTHER INFORMATION\", \"level\": 3, \"text\": \"10.5.3 OTHER INFORMATION. The Franchisee shall if requested and as long as polling is not possible provide to BKC such information as BKC may from time to time require regarding product volumes and production.\"}, {\"id\": \"11\", \"title\": \"LIMITATIONS OF FRANCHISE\", \"level\": 1, \"text\": \"11. LIMITATIONS OF FRANCHISE.\"}, {\"id\": \"11.1\", \"title\": \"TRADEMARKS, TRADE NAMES, SERVICE MARKS AND TRADE SECRETS\", \"level\": 2, \"text\": \"11.1 TRADEMARKS, TRADE NAMES, SERVICE MARKS AND TRADE SECRETS.\"}, {\"id\": \"11.1.1\", \"title\": \"REGISTRATION ASSISTANCE BY FRANCHISEE\", \"level\": 3, \"text\": \"11.1.1 REGISTRATION ASSISTANCE BY FRANCHISEE. The Franchisee shall, upon request and at no expense to the Franchisee assist BKC in perfecting and obtaining registration of unregistered Burger King Marks.\"}, {\"id\": \"11.1.2\", \"title\": \"OWNERSHIP\", \"level\": 3, \"text\": \"11.1.2 OWNERSHIP. The Franchisee acknowledges that ownership of all right, title and interest to the Burger King System and the Burger King Marks (registered and unregistered) is and shall remain vested solely in BKC. The Franchisee acknowledges the uniqueness of the Burger King System an that the Franchisee has had no part in its creation or development, no prior knowledge of, and no proprietary or other rights or claims in or to any element of the Burger King System or the Burger King Marks.\"}, {\"id\": \"11.1.3\", \"title\": \"CONFIDENTIALITY OF TRADE SECRETS\", \"level\": 3, \"text\": \"11.1.3 CONFIDENTIALITY OF TRADE SECRETS. The Franchisee agrees that all materials made available to the Franchise and all disclosures made to the Franchisee, and not to the general public, by or at the direction of BKC at any time before or during the term of this Agreement, including the MOD Manual in its entirety and any translations thereof, are to be considered trade secrets of BKC for purpose of this Agreement and shall be kept confidential and used by the Franchisee only in the operation of the Franchised Restaurant and other licensed Burger King Restaurants. The Franchise agrees not to divulge any of the trade secrets to any person other than the Franchisee's employees and then only to the extent necessary for the operation of the Franchised Restaurant, an d not to permit anyone to reproduce, copy or exhibit any portion of the MOD Manual or any other confidential or proprietary information received from BKC, except for translating from English to the language of the country in which the Franchised Restaurant is located, if the Franchisee's employees cannot read and understand English. 16\"}, {\"id\": \"11.1.4\", \"title\": \"REGISTERED USER AGREEMENTS\", \"level\": 3, \"text\": \"11.1.4 REGISTERED USER AGREEMENTS. The Franchisee shall, whenever requested by BKC, enter into one or more Registered User Agreements authorizing and permitting the use of the Burger King Marks as provided in this Agreement and to execute any documents and/or do such things as are requested to assist BKC in connection with registration of any Registered User Agreement. Nothing in any Registered User Agreement shall be construed as giving the Franchisee the right to transfer or sublicense the Franchisee's right to use the Burger King Marks.\"}, {\"id\": \"11.1.5\", \"title\": \"NO IMPAIRMENT OF MARKS\", \"level\": 3, \"text\": \"11.1.5 NO IMPAIRMENT OF MARKS. The Franchisee will not directly or indirectly, at any time during the term of this Agreement or thereafter, do or cause to be done any act or thing disputing, attacking or in any way impairing the validity of and BKC's right, title or interest in the Burger King Marks and the Burger King System.\"}, {\"id\": \"11.1.6\", \"title\": \"ASSIGNMENT OF RIGHTS IN MARKS\", \"level\": 3, \"text\": \"11.1.6 ASSIGNMENT OF RIGHTS IN MARKS. The Franchisee hereby assigns to BKC such rights (if any) as the Franchisee may hereafter acquire in any of the Burger King Marks or the Burger King System and shall execute such documents and do such acts at the cost of BKC as may be necessary to perfect such assignment.\"}, {\"id\": \"11.1.7\", \"title\": \"INFRINGEMENT, ETC\", \"level\": 3, \"text\": \"11.1.7 INFRINGEMENT, ETC. The Franchisee shall immediately notify BKC of all infringements or imitations of the Burger King Marks which come to the Franchisee's attention, and all challenges to the Franchisee's use c f any of the Burger King Marks. BKC will take such action as it in its sole discretion deems appropriate to prevent unauthorized persons from using the Burger King Marks. The Franchisee agrees to cooperate in the prosecution of any action to prevent the infringement, imitation, illegal se or misuse of the Burger King Marks or the Burger King System and agrees to be named as a party in any such action if so requested by BKC. BKC agrees to bear the legal expenses and costs incidental to the Franchisee's participation in such action except for the cost and expenses of the Franchisee's personal legal counsel if the Franchisee elects to be represented by counsel of the Franchisee's own choosing. The Franchisee shall not institute any legal action or other kind of proceeding based upon Burger King Marks or the Burger King System without the prior written approval of BKC.\"}, {\"id\": \"11.1.8\", \"title\": \"REGISTERED MARKS\", \"level\": 3, \"text\": \"11.1.8 REGISTERED MARKS. BKC represents that the marks listed on Exhibit A are registered or applied for, but makes no expressed or implied warranty with respect to the validity of any of the Burger King Marks. The Franchisee accepts that the Franchisee may conduct business utilizing some Burger King Marks which have not been registered and that registration may not be granted for the unregistered marks and that some of the Burger King Marks may be subject to use by third parties unauthorized by BKC.\"}, {\"id\": \"11.1.9\", \"title\": \"FRANCHISEE NAME\", \"level\": 3, \"text\": \"11.1.9 FRANCHISEE NAME. In the adoption of a trade, corporate or partnership name, the Franchisee shall not use any of the Burger King Marks, any variations or abbreviations or any words confusingly similar to any of the Burger King Marks. 17 11.1.10 REGISTRATION OF AGREEMENT. If local law requires the registration or recordation of this Agreement with any local governmental agency, administrative board or banking agency, Franchisee shall request BKC's consent to do so. If BKC grants its consent, Franchise shall effectuate such registration(s) or recordation(s) at its sole cost and expense in strict compliance with local laws as soon as possible.\"}, {\"id\": \"11.2\", \"title\": \"INDEPENDENT CONTRACTOR\", \"level\": 2, \"text\": \"11.2 INDEPENDENT CONTRACTOR.\"}, {\"id\": \"11.2.1\", \"title\": \"NO AGENCY\", \"level\": 3, \"text\": \"11.2.1 NO AGENCY. The franchisee is an independent business entity and is not an agent, partner, joint venture, representative, or employee of BKC, and no express or implied fiduciary relationship exists between the parties. The Franchisee shall not attempt to bind or obligate BKC in any way nor shall the Franchisee represent that the Franchisee has any right to do so. BKC shall have no control over the terms and conditions of employment of the Franchisee's employees.\"}, {\"id\": \"11.2.2\", \"title\": \"PUBLIC NOTICE OF INDEPENDENCE\", \"level\": 3, \"text\": \"11.2.2 PUBLIC NOTICE OF INDEPENDENCE. In all public records and in the Franchisee's relationship with other persons, on stationery, business forms and cheques, the Franchisee shall indicate the independent ownership of the Franchised Restaurant and that the Franchisee is a licensee of BKC. The Franchisee shall exhibit on the Location in such places as may be designated by BKC, a notification that the Franchised Restaurant is operated by an independent operator under license from BKC.\"}, {\"id\": \"12\", \"title\": \"UNFAIR COMPETITION\", \"level\": 1, \"text\": \"12. UNFAIR COMPETITION. The Franchisee agrees, during the term of this Agreement and thereafter, not to directly or indirectly engage in the operation of any restaurant, except as licensed by BKC, which utilizes or duplicates the Burger King System or any part thereof.\"}, {\"id\": \"13\", \"title\": \"INSURANCE, INDEMNIFICATION\", \"level\": 1, \"text\": \"13. INSURANCE, INDEMNIFICATION.\"}, {\"id\": \"13.1\", \"title\": \"GENERAL LIABILITY INSURANCE\", \"level\": 2, \"text\": \"13.1 GENERAL LIABILITY INSURANCE. Franchisee agrees to carry at its expense during the Term of this Agreement Comprehensive General Liability insurance, including Products Liability and Broad Form Contractual Liability, in an amount which is at all times the local equivalent of not less than One Million U.S. Dollars (U.S. $1,000,000.00) per occurrence for bodily injury and Five Hundred Thousand U.S. Dollars (U.S. $500,000.00) per occurrence for property damage, or in such increased amounts as BKC may reasonably request from time to time during the Term of this Agreement. Each policy will name BKC, and its subsidiaries, affiliated and parent companies as an additional insured, and will provide hat the policy cannot be canceled without thirty (30) days prior written notice to BKC, will insure against the liability of BKC for both its and Franchisee's acts or omissions, and will insure the contractual liability of Franchisee under paragraph 13.3 Additionally, Franchisee agrees to carry, at Franchisee's expense, umbrella coverage in an amount which is at all times the equivalent of One Million U.S. Dollars (U.S. $1,000,000) over the basic 18 Comprehensive General Liability insurance per restaurant; except that if Franchisee owns more than ten (10) Burger King Restaurants, the umbrella coverage applicable to all such restaurants need not exceed an mount which is at any time in excess of the equivalent of Ten Million U.S. Dollars (U.S. $10,000,000). The insurance afforded by the policy or policies respecting liability shall not exclude claims, actions or demands brought in the United States or anywhere else outside the country in which the Franchised Restaurant is located and shall not be limited in any way by reason of any insurance which may be maintained by BKC prior to the Commencement Date, Franchisee shall furnish to BKC Certificates of Insurance reflecting that the insurance coverage is in effect pursuant to the terms of this Agreement. All policies shall be renewed, and a renewal Certificate of Insurance mailed to BKC at its main office, or at such other location as may be specified by BKC prior to the expiration date of the policies. This obligation of Franchisee to maintain insurance is separate and distinct from its obligation to indemnify BKC under the provisions of Paragraph 13.3 and shall not be affected by reason of the negligence of or a claim of negligence against BKC.\"}, {\"id\": \"13.2\", \"title\": \"WORKERS COMPENSATION, ETC\", \"level\": 2, \"text\": \"13.2 WORKERS COMPENSATION, ETC. Franchisee agrees to participate in any governmental Worker's Compensation Program, unemployment insurance program, hospitalization program and any other similar program which may be required by the laws of the country where the Franchised Restaurant is located.\"}, {\"id\": \"13.3\", \"title\": \"INDEMNITY\", \"level\": 2, \"text\": \"13.3 INDEMNITY. Franchisee is responsible for all losses or damages and contractual liabilities to third persons arising out of or in connection with possession, ownership or operation of the Franchised Restaurant, and for all claims or demands for damages to property or for injury, illness or death of persons directly or indirectly resulting therefrom. Franchisee agrees to defend, indemnify and save BKC, and its subsidiaries, affiliated and parent companies harmless of, from and with respect to any such claims, demands, losses, obligations, costs, expenses, liabilities, debts or damages, unless they are caused by the gross negligence of BKC itself BKC's right to indemnity under this Agreement shall arise and be valid notwithstanding that joint or concurrent liability may be imposed on BKC by statute, ordinance, regulation or other law. The indemnification of BKC by Franchisee for Franchisee's own negligence, acts or omissions, shall not be limited by the amount of insurance required under Paragraph 13.1, nor upon a claim that BKC is responsible for Franchisee's act or omissions or that Franchisee was acting in the capacity of an agent of BKC. This indemnity obligation shall include, but not be limited to, claims related to the employment of Franchisee's employees. This obligation of Franchisee to indemnify and defend BKC is separate and distinct from its obligation to maintain insurance under the provisions of Paragraph 13.1. BKC shall notify Franchisee of any claims, and Franchisee shall be given the opportunity to assume the defense of the matter, however, BKC shall have the right to participate in the defense of any claim or action against it which is assumed by Franchisee, at BKC's own cost and expense. If Franchisee fails to assume the defense, BKC may defend the action in the manner it deems 19 appropriate, and Franchisee shall pay to BKC all costs, including attorney's fees, incurred by BKC in effecting such defense, in addition to any sum which BKC may pay by reason of any settlement or judgment against BKC. No settlement of any claim against BKC shall be made by Franchisee which is in excess of the amount of insurance referred to in Paragraph 13.1 or which would subject BKC to liability in any amount not covered by such insurance without the prior written consent of BKC. Any final judicial determination of the negligence of BKC in an amount in excess of the policy limits of insurance required under Paragraph 13.1 shall be the responsibility of BKC.\"}, {\"id\": \"14\", \"title\": \"TAXES\", \"level\": 1, \"text\": \"14. TAXES.\"}, {\"id\": \"14.1\", \"title\": \"PAYMENT WHEN DUE\", \"level\": 2, \"text\": \"14.1 PAYMENT WHEN DUE. The Franchisee shall pay when due all taxes levied or assessed by reason of the Franchisee's possession, ownership or operation of the Franchised Restaurant or items loaned to the Franchisee by BKC including any value added tax. In the event of any bona fide dispute as to the liability for a tax assessed against it, the Franchisee may contest the validity or the amount of the tax in accordance with the procedures of the taxing authority, however, the Franchisee shall not permit a tax sale or seizure against the premises or equipment.\"}, {\"id\": \"14.2\", \"title\": \"WITHHOLDING TAXES\", \"level\": 2, \"text\": \"14.2 WITHHOLDING TAXES. lt is understood and agreed by the parties that any and all tax liabilities arising out of this Agreement will be paid by the party owing such taxes. ln the event that BKC incurs withholding tax liability in the country in which the Franchised Restaurant is located as a result of the franchise fee or the royalty payments set forth above, it shall be the responsibility and obligation of the Franchisee to withhold from such franchise fee or royalty payments such withholding taxes as are required by law. The Franchisee shall provide BKC with corresponding receipts from the relevant taxing authorities to evidence such payments or amounts withheld. Taxes, such as income taxes of the Franchisee, which are based on profits from operation of the Franchised Restaurant are the sole responsibility of the Franchisee.\"}, {\"id\": \"14.3\", \"title\": \"ELECTION\", \"level\": 2, \"text\": \"14.3 ELECTION. Where the law permits an election regarding the treatment of any supply or deemed supply under this Agreement for the purposes of any value added or other tax chargeable thereon, the Franchisee shall make or join in any such election as BKC may from time to time require.\"}, {\"id\": \"15\", \"title\": \"DISPOSAL\", \"level\": 1, \"text\": \"15. DISPOSAL.\"}, {\"id\": \"15.1\", \"title\": \"TRANSFER OF LNTEREST BY FRANCHISEE\", \"level\": 2, \"text\": \"15.1 TRANSFER OF LNTEREST BY FRANCHISEE. Except with the prior written consent of an authorized officer of BKC, Franchisee shall not (a) directly or indirectly sell, assign, convey, give away, mortgage, pledge, hypothecate, charge, or otherwise transfer or encumber its rights or obligations under this Agreement, or assign any of Franchisee's rights or delegate any of its duties hereunder; (b) sell, issue, offer, transfer, convey, give away, or otherwise 20 grant or deliver any additional equity interests in the Franchisee, or (c) sell, assign, transfer, convey, or give away substantially all of the assets of the Franchised Restaurant.\"}, {\"id\": \"15.2\", \"title\": \"TRANSFER OF INTEREST BY PRINCIPALS\", \"level\": 2, \"text\": \"15.2 TRANSFER OF INTEREST BY PRINCIPALS. Except with the prior written consent of an authorized officer of BKC, no Principal shall directly or indirectly sell, assign, convey, give away, mortgage, pledge, hypothecate, charge, or otherwise transfer or encumber any legal or beneficial equity interest in Franchisee.\"}, {\"id\": \"15.3\", \"title\": \"NOTICE OF PROPOSED TRANSFER\", \"level\": 2, \"text\": \"15.3 NOTICE OF PROPOSED TRANSFER. Any proposed transferor shall notify BKC in writing of any proposed transfer of an interest referred to in Paragraph 15.1 or 15.2, as applicable, before the proposed transfer is to take place, and shall provide such information and documentation relating to the proposed transfer as BKC may reasonably require.\"}, {\"id\": \"15.4\", \"title\": \"RIGHT OF FIRST REFUSAL\", \"level\": 2, \"text\": \"15.4 RIGHT OF FIRST REFUSAL.\"}, {\"id\": \"15.4.1\", \"title\": \"NOTICE; EXERCISE OF OPTION\", \"level\": 3, \"text\": \"15.4.1 NOTICE; EXERCISE OF OPTION. In the event Franchisee or the Principals wish to accept a bona fide offer from a third party to purchase all or substantially all of the assets constituting the Franchised Restaurant or of the majority of the voting stock of the Franchisee, the proposed transferor(s) shall give BKC written notice setting forth the name and address of the prospective purchaser, the price and terms of the offer together with a franchisee application completed by the prospective purchaser, a copy of the Purchase and Sale Agreement, executed by both the seller and purchaser, and all exhibits, copies of any real estate purchase agreement or agreements, proposed security agreements and related promissory notes, assignment documents, and any other information that BKC may request in order to evaluate the offer. BKC or its designee shall then have the prior option to purchase the interests covered by the offer at the price and upon the same terms of the offer. If the consideration is not money, the purchase price shall be the cash equivalent of the fair market value of the consideration. BKC shall have twenty (20) business days after receipt of the notice of offer and the furnishing of all reasonably requested information within which to notify Franchisee or the owners, as applicable, of BKC's intent to exercise its right hereunder. Silence on the part of BKC shall constitute rejection. If BKC rejects the offer, Franchisee shall have 90 days to sell the Franchised Restaurant upon the terms offered to BKC, subject to the approval of BKC a s required below. If the proposed sale includes assets of Franchisee not related to the operation of franchised Burger King Restaurants, BKC may, at its option, elect to purchase only the assets related to the operation of franchised Burger King Restaurants and an equitable purchase price shall be allocated to each asset included in the proposed sale. A bona fide offer from a third party includes any transfer, conveyance, assignment, consolidation, merger or any other transaction in which legal or beneficial ownership of the franchise granted by this Agreement is vested in other than the Franchisee. 21\"}, {\"id\": \"15.4.2\", \"title\": \"NO WAIVER\", \"level\": 3, \"text\": \"15.4.2 NO WAIVER. The election by BKC not to exercise its right of first refusal as to any offer shall not affect its right of first refusal as to any subsequent offer.\"}, {\"id\": \"15.4.3\", \"title\": \"UNAUTHORIZED TRANSFER VOID\", \"level\": 3, \"text\": \"15.4.3 UNAUTHORIZED TRANSFER VOID. Any sale, attempted sale, assignment, or other transfer of the interests described in Subparagraph 15.4.1 without first giving BKC the right of first refusal described above shall be void and of no force and effect, and shall constitute an Event of Default under Paragraph 17.1(k).\"}, {\"id\": \"15.4.4\", \"title\": \"SALE; BKC CONSENT\", \"level\": 3, \"text\": \"15.4.4 SALE; BKC CONSENT. If BKC does not exercise its option under Subparagraph 15.4.1, Franchisee may conclude the sale to the purchaser who made the offer provided BKC's consent to the assignment or sale be first obtained as provided below.\"}, {\"id\": \"15.5.1\", \"title\": \"TRANSFER OF SUBSTANTIALLY ALL ASSETS OR TRANSFER OF STOCK BY PRINCIPAL\", \"level\": 3, \"text\": \"15.5.1 TRANSFER OF SUBSTANTIALLY ALL ASSETS OR TRANSFER OF STOCK BY PRINCIPAL. Reasonable conditions in connection with (i) a transfer of the Franchisee's rights under this Agreement, the transfer of substantially all of the Franchisee's assets, or the delivery or grant of any additional equity securities, all pursuant to Subparagraph 15.1 above, or (ii) the transfer of the shares of the Franchisee pursuant to Subparagraph 15.2 above, shall include, without limitation, each of the following: (a) All of the Franchisee's accrued monetary obligations to BKC and its Affiliates must be paid at the time of the transfer; (b) The Franchisee must not be in default under this Agreement or any other agreement with BKC or its Affiliates at the time of transfer; (c) The transferee (and, if applicable, all owners of the transferee), must complete BKC's then current franchisee application procedures and meet all of BKC's then current criteria for approval as a BKC franchisee, including financial, character, managerial, credit, operational, and legal standards; (d) The transferee (and, if applicable, all owners of the transferee) must at BKC's option enter into (i) a written agreement, in a form acceptable to BKC, assuming (or guaranteeing) full performance of all obligations of the Franchisee under this Agreement, (ii) a substitute Franchise Agreement, for a term ending on the expiration date of this Agreement, in BKC's 22 then current form, except that royalty and advertising contribution or expenditure rates shall be the same as are provided for in this Agreement, and (iii) such ancillary agreements as BKC may require; (e) The Franchisee (and, if applicable, each owner of the Franchisee) must execute a general release, in a form acceptable to BKC, of any and all claims against BKC, its Affiliates, and their respective officers, directors, agents, and employees; (f) The transferee, its Director of Operations, and its Restaurant Manager must complete, at the transferee's expense, any applicable orientation and training programs required by BKC at the time of transfer; (g) BKC shall approve the terms and conditions of the sale which affect the sufficiency of cash flow from the business after payment of debt service necessary for reinvestment in the business for refurnishing, maintaining, and remodeling the Location; (h) The transferor must pay the transfer fee set forth on SCHEDULE 1 in consideration of BKC's expenses in reviewing the proposed transfer; (i) The transferee must meet with representatives of BKC in Miami, Dade County, Florida, U.S.A., or such other location as may be designated by BKC; (j) The Franchisee shall execute all documents necessary to cancel the entries of the Franchisee as a registered user and shall cooperate with BKC in effecting the cancellation of entries with the relevant registry of the Franchisee as a registered user. (k) The transferee shall, if BKC requests, enter into one or more registered user agreements authorizing and permitting the use of the Burger King Marks referred to in the agreements. (l) The transferor shall be jointly and severally liable with the transferee (and, if applicable, each owner of the transferee) to BKC for future royalty and advertising payments due under this Agreement if and so long as any part of the purchase money consideration remains owing from the transferee to the transferor.\"}, {\"id\": \"15.5.2\", \"title\": \"SECURITIES OFFERINGS\", \"level\": 3, \"text\": \"15.5.2 SECURITIES OFFERINGS. Franchisee represents and agrees that:\"}, {\"id\": \"15.5.2.1\", \"title\": \"COMPLIANCE WITH BKC REQUIREMENTS\", \"level\": 4, \"text\": \"15.5.2.1 COMPLIANCE WITH BKC REQUIREMENTS. In connection with any future offerings of debt or equity securities, Franchisee will comply with all of BKC's then current requirements with respect to such offerings. Without limiting the foregoing, in addition to BKC's then-current requirements 23 applicable to BKC's franchisees and their principals (or owners) generally, the requirements applicable to Franchisee will include the following: immediate written notice to BKC of any proposed securities offering (which notice in any event shall be no later than the time when a proposed letter of intent, memorandum of understanding or similar document is exchanged with any person respecting the underwriting or placement of securities of the Franchisee); submission, before or simultaneously with submission to the U.S. Securities and Exchange Commission (\\\"SEC\\\"), (or similar governmental agency of any other jurisdiction in which securities are offered), of registration statements and/or prospectuses to BKC for review in connection with trademark usage, inclusion of disclaimers, and otherwise; the execution by the principals and by underwriters, if any, of certificates required by BKC, and the execution of the Franchisees and the Principals of an indemnity of BKC, its affiliates, agents, attorneys and employees against any liability arising from or in connection with the offering. Within ten (10) business days after BKC's receipt of a copy of a registration statement filed with the SEC and which BKC wishes to review, BKC shall furnish the Franchisee with its comments, if any, on the prospectus, provided that failure of BKC to comment shall not relieve the Franchisee of its obligations to include in every prospectus such disclaimers as are required by BKC. BKC's then-current general requirements for offerings of equity securities shall also apply to offerings of debt securities by the Franchisee unless and until separate requirements are articulated by BKC for debt and equity securities offerings.\"}, {\"id\": \"15.5.2.2\", \"title\": \"SUBMISSION TO BKC\", \"level\": 4, \"text\": \"15.5.2.2 SUBMISSION TO BKC. Franchisee shall simultaneously file with BKC all reports and other documents that Franchisee may be required to file with the SEC pursuant to the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, or with, any governmental agency pursuant to the laws and regulations of any other jurisdiction in which securities are offered, as and when due.\"}, {\"id\": \"15.5.2.3\", \"title\": \"REGISTRATION RIGHTS\", \"level\": 4, \"text\": \"15.5.2.3 REGISTRATION RIGHTS: SECONDARY OFFERINGS. Franchisee agrees that it will not grant additional registration rights or modify any registration rights previously granted without prior written notice to BKC. The Franchisee further agrees that if it is required to effect a registration pursuant to any registration rights previously granted, then, in connection with any secondary offering of securities pursuant to such registration, it shall comply with BKC's then-current requirements, policies and procedures in connection with such offering and, without limiting the foregoing, shall indemnify BKC from liability arising from or in connection with the Offering, in the same manner as would be required in connection with an offering of securities by the Franchisee.\"}, {\"id\": \"15.5.2.4\", \"title\": \"BKC EXPENSES\", \"level\": 4, \"text\": \"15.5.2.4 BKC EXPENSES. The Franchisee must, in connection with any proposed offering of securities requiring the review or consent of BKC, agree to pay BKC for certain of BKC's internal and external costs in connection with its review of the proposed securities offering. 24\"}, {\"id\": \"15.5.3\", \"title\": \"CERTAIN EXCEPTIONS\", \"level\": 3, \"text\": \"15.5.3 CERTAIN EXCEPTIONS. Notwithstanding any other provision of this agreement, the Franchisee shall not be required to submit to BKC for its review and comment any \\\"S-3\\\" or \\\"S-8\\\" filing by the Franchisee with the SEC, and the Franchisee shall not be required to obtain the prior written consent of BKC in connection with an issuance of securities pursuant to an S-8 filing with the SEC so long as the securities issued pursuant to such filing represent, per offering: (i) through December 31, 1998, less than three (3%) percent of the securities of that class issued and outstanding, and (ii) after December 31, 1998, less than one percent (1%) of the securities of that class issued and outstanding.\"}, {\"id\": \"15.6\", \"title\": \"NO WAIVER\", \"level\": 2, \"text\": \"15.6 NO WAIVER. BKC's consent to a transfer shall not constitute a waiver of any claims it may have against the transferring party, nor shall it be deemed a waiver of BKC's right to demand exact compliance with any of the terms of this Agreement by the transferor or transferee.\"}, {\"id\": \"15.8\", \"title\": \"CORPORATE DOCUMENTS\", \"level\": 2, \"text\": \"15.8 CORPORATE DOCUMENTS. The articles of incorporation, the bylaws and each stock certificate of the Franchisee must at all times provide that the issuance and transfer of shares in the Franchisee are restricted as provided above and may be done only in accordance with the terms and conditions of this Agreement.\"}, {\"id\": \"15.9\", \"title\": \"ASSIGNMENT BY BKC\", \"level\": 2, \"text\": \"15.9 ASSIGNMENT BY BKC. BKC may assign this Agreement to any person or company which acquires its Burger King business in the territory in which the Franchised Restaurant is located or a substantial part thereof, whether by outright acquisition or by way of a master franchise agreement. 25\"}, {\"id\": \"16\", \"title\": \"THE PRINCIPALS\", \"level\": 1, \"text\": \"16. THE PRINCIPALS.\"}, {\"id\": \"16.1\", \"title\": \"STOCK OWNERSHIP\", \"level\": 2, \"text\": \"16.1 STOCK OWNERSHIP. The Principals represent and warrant to BKC that SCHEDULE 2 contains a complete list of their respective shareholdings in the Franchisee on the date of this Agreement and that, unless otherwise stated, the Principals are the beneficial owners of their respective shares.\"}, {\"id\": \"16.2\", \"title\": \"COMPLIANCE BY PRINCIPALS\", \"level\": 2, \"text\": \"16.2 COMPLIANCE BY PRINCIPALS. Each Principal shall comply with the covenants, terms, conditions and acknowledgments contained in the following sections as if it were the party named therein in place of the Franchisee: Section 11 (Limitations of Franchise); Section 12 (Unfair Competition); Section 15 (Disposal); and Section 18 (Restrictive Covenant). Notwithstanding any other provision of this Agreement, including without Imitation Sections 15.1 and 15.5, so long as international Fast Food Corporation, (\\\"IFFC\\\") is a Principal of the Franchisee, BKC will not unreasonably withhold its consent to the sale or issuance of additional equity securities in IFFC provided that IFFC has complied with all reasonable conditions then established by BKC in connection with the proposed sale or issuance of equity securities by IFFC.\"}, {\"id\": \"16.3\", \"title\": \"GUARANTY\", \"level\": 2, \"text\": \"16.3 GUARANTY. Each Principal hereby agrees to jointly, severally, and unconditionally guaranty the payment and performance of all debts, obligations and liabilities of the Franchisee to BKC arising pursuant to this Agreement, or any other agreement with BKC relating directly or indirectly to the Franchised Restaurant (the \\\"BKC Agreements\\\"), together with all costs of collection, compromise or enforcement, including reasonable attorneys' fees, incurred with respect to any such debts, obligations or liabilities or with respect to this or any other guaranty thereof or any bankruptcy proceeding or other similar action affecting the rights of the Franchisee's creditors generally (all of the foregoing being referred to collectively as the \\\"Obligations\\\"). This guaranty by the Principals shall continue in full force and effect until the Franchisee has fully paid and performed all of the Obligations. In connection with the guaranties set forth above (collectively, the \\\"Guaranties\\\"), each of the parties to this Agreement hereby agrees as follows: (a) The Guaranties shall not be impaired by any modification, supplement, extension or amendment of the BKC Agreements or any of the Obligations, nor by any modification, release or other alteration of any of the Obligations hereby guaranteed, nor by any agreements or arrangements whatever with the Franchisee or any one else; (b) The liability of each Principal is primary, direct and unconditional and may be enforced without requiring BKC first to resort to any other right, remedy or security; 26 (c) No Principal shall have any right of subrogation, repayment, reimbursement or indemnity whatsoever, unless and until the Obligations are paid or performed in full and all debts owed by the Franchisee to any Principal are hereby subordinated to the Obligations; (d) If any Principal should at any time die, become incapacitated, become insolvent or make a composition, trust mortgage or general assignment for the benefit of creditors, or if a bankruptcy proceeding or any action under a similar law affecting the rights of creditors generally shall be filed or commenced by, against o r in respect of any Principal, any and all obligations of that Principal shall, at BKC's option, immediately become due and payable without notice, (e) If any payment or transfer to BKC which has been credited against any Obligation, is voided or rescinded or required to be returned by BKC, whether or not in connection with any event or proceeding described in Section 16.3(d), the Guaranties shall continue in effect or be reinstated as though such payment, transfer or recovery had not been made; (f) Except as otherwise provided in this Agreement, each of the Guaranties shall be construed as an absolute, unconditional, continuing and unlimited obligation of each Principal without regard to the regularity, validity or enforceability of any of the Obligations, and without regard to whether any Obligation is limited, modified, voided, released or discharged in any proceeding under any law affecting the rights of creditors generally; (g) Any termination of the Guaranties shall be applicable only to Obligations accruing after the termination or having their inception after the effective date of such termination and shall not affect Obligations having their inception prior to such date; (h) The death or incapacity of any Principal hereunder shall not result in the termination of the Guaranties; (i) Any and all present and future debts and obligations of the Franchisee to any Principal hereunder are hereby waived an id postponed in favor of and subordinated to the full payment and performance of the Obligations; and (j) Each Principal waives to the greatest extent permitted by law: notice of acceptance hereof; presentment and protest of any instrument, and notice thereof; notice of default; notice of foreclosure; notice of any modification, release or other alteration of any of the Obligations or of any security therefor and all other notices to which any Principal might otherwise be entitled. 27\"}, {\"id\": \"17\", \"title\": \"DEFAULT AND EFFECTS OF TERMINATION\", \"level\": 1, \"text\": \"17. DEFAULT AND EFFECTS OF TERMINATION.\"}, {\"id\": \"17.1.1\", \"title\": \"EVENTS OF DEFAULT BY FRANCHISEE\", \"level\": 3, \"text\": \"17.1.1 EVENTS OF DEFAULT BY FRANCHISEE. Franchisee shall be in default under this Agreement upon the occurrence of any of the following events or conditions (individually, an \\\"Event of Default\\\" and collectively, the \\\"Events of Default\\\"): (a) If the Franchisee fails to pay when due any amount owed to BKC under this Agreement, and does not cure such failure within ten (10) days of delivery of written notice of such failure. (b) If the Franchisee fails to operate the Franchised Restaurant in full compliance with the terms of this Agreement and the MOD Manual (including without limitation the provisions regarding product specifications, cleanliness, health, sanitation and the use of the Burger King Marks), and does not cure such failure wh thin ten (10) days of delivery of written notice of such failure. (c) If the Franchisee fails to maintain the Franchised Restaurant in conformance with the Current Image as required by Sections 5.3.1 and 5.3.2 hereof, or to remodel, improve and alter the Franchised Restaurant as required in Section 5.3.3 hereof, and does not cure such failure within ninety (90) days of delivery of written notice of such failure. (d) If the Franchisee challenges the validity or ownership of the Burger King Marks or BKC's ownership rights to the Burger King System. (e) If the Franchisee fails to continuously operate the Franchised Restaurant as required by Section 2.4 of this Agreement. (f) If the Franchisee fails to continuously occupy the Location throughout the term of this Agreement, unless such failure is attributable to a proper exercise of governmental authority. (g) If the Franchisee should at any time become insolvent or make a composition, trust mortgage or general assignment for the benefit of creditors, or if a bankruptcy proceeding, receivership or any action under any similar law affecting the rights of creditors generally shall be filed or commenced by, against or in respect of the Franchisee or any portion of its property. (h) If the Franchisee makes any materially false statement in connection with any report of Gross Sales or in any other financial statement required hereby, other than an obvious and unintentional error. (i) If the Franchisee commits \\\"persistent breaches\\\" of the terms of this Agreement (whether or not material in isolation) after written 28 notice of such breaches has been delivered by BKC, any three breaches occurring within a period of six months shall be deemed to constitute \\\"persistent breaches.\\\" (j) If the Franchisee for any reason other than an improper act or breach by BKC ceases to be entitled to remain registered as a registered user of any of the Burger King Marks. (k) If any events occur which are contrary to Section 15 hereof. (l) If the Franchisee engages in activities prohibited by Section 12 (Unfair Competition) or Section 18 (Restrictive Covenant), or discloses any trade secrets of BKC in violation of Section 11 (Limitations of Franchise). (m) If the Franchisee or any of its affiliates is in breach of any other obligation owed to BKC or any of its Affiliates whether under this or any other agreement. (n) If the Franchisee has knowingly made false or misleading statements in order to obtain execution of this Agreement by BKC. (o) If the Franchisee or any of its officers or directors is convicted of a criminal offense punishable by a term of imprisonment in excess of two (2) years. (p) The Franchisee fails to perform any obligation under this Agreement which is not capable of cure. (q) If the Franchisee fails to perform any other obligation under this Agreement and does not cure such failure within thirty (30) days of written notice of such failure. (r) If any of the above occurs in relation to any Principal.\"}, {\"id\": \"17.2.1\", \"title\": \"EVENT OF BKC DEFAULT\", \"level\": 3, \"text\": \"17.2.1 EVENT OF BKC DEFAULT. BKC shall be in default under this Agreement if BKC fails to perform any of its obligations under this Agreement and does not cure such failure within sixty (60) days of written notice of such failure (an \\\"Event of BKC Default\\\").\"}, {\"id\": \"17.2\", \"title\": \"TERMINATION\", \"level\": 2, \"text\": \"17.2 TERMINATION. Upon the occurrence of an Event of Default, this Agreement shall automatically terminate without any further notice or opportunity to cure under Section 17.1.1 above and BKC shall, subject to the provisions of Subsection 17.6 below, have the right to claim lost royalties and advertising contributions, and shall also have all other rights and remedies available under applicable law. Upon the occurrence of an Event of BKC Default under Section 17.1.2., this Agreement shall automatically terminate without further notice or opportunity to cure and the Franchisee shall have all other 29 rights and remedies available under applicable law. Subject to the provisions of Section 17.6 below, the rights of the parties set forth in this Section 17.2 shall be in addition to any other rights the parties may have under applicable law.\"}, {\"id\": \"17.3\", \"title\": \"EFFECT OF TERMINATION\", \"level\": 2, \"text\": \"17.3 EFFECT OF TERMINATION. Upon expiration or termination for any reason of this Agreement, the Franchisee's right to use the Burger King Marks and the Burger King System shall terminate. The Franchisee shall not thereafter identify itself as a Burger King franchisee or former Burger King franchisee or use, any of BKC's trade secrets, operating procedures, promotional materials, Burger King Marks or any marks confusingly similar. The Franchisee will immediately return to BKC the MOD Manual loaned to the Franchisee including any translations thereof, together with all other materials containing trade secrets, restaurant operating instructions or business practices of BKC. Where applicable, BKC shall be entitled to take all steps necessary for the cancellation of the entries of the Franchisee with the Registrar of Trademarks, or its equivalent authority, as a registered user without opposition or hindrance of the Franchisee. The Franchisee will, at the request and cost of BKC, cooperate in any such steps.\"}, {\"id\": \"17.4\", \"title\": \"POST-TERMINATION OPTION\", \"level\": 2, \"text\": \"17.4 POST-TERMINATION OPTION. The Franchisee grants to BKC or its designee upon termination or expiration of this Agreement, the option to purchase all usable paper goods, containers and printed menus bearing any of the Burger King Marks or trade names at the price paid by the Franchisee and to purchase the Franchisee's restaurant equipment, furniture, fixtures and signs at fair market value.\"}, {\"id\": \"17.5\", \"title\": \"POST-TERMINATION OBLIGATIONS OF FRANCHISEE\", \"level\": 2, \"text\": \"17.5 POST-TERMINATION OBLIGATIONS OF FRANCHISEE.\"}, {\"id\": \"17.5.1\", \"title\": \"OPTIONS TO PURCHASE LOCATION\", \"level\": 3, \"text\": \"17.5.1 OPTIONS TO PURCHASE LOCATION. Upon termination or expiration of this Agreement, if the parties do not enter into a successor Franchise Agreement whereby the Franchisee shall continue to be a franchisee and operate the Franchised Restaurant at the Location, BKC or its designee shall have the option subject to obtaining any necessary governmental consent: (a) To purchase the Location and/or any related equipment at fair market value, if the Franchisee, any of the Principals or an affiliate of the Franchisee owns the Location and/or related equipment. (b) If the Location is leased by the Franchisee, any of the Principals or an affiliate of the Franchisee, subject to obtaining any necessary landlord's consent, to obtain an assignment of the leasehold interest at a price equal to the fair market value of the leasehold interest.\"}, {\"id\": \"17.5.2\", \"title\": \"DEIDENTIFICATION\", \"level\": 3, \"text\": \"17.5.2 DEIDENTIFICATION. If BKC or its designee do not exercise this option the Franchisee agrees to immediately make such removals or changes in 30 signs and the building as BKC shall request so as to effectively distinguish the Location from its former appearance and from any other Burger King Restaurant.\"}, {\"id\": \"17.5.3\", \"title\": \"BKC LIEN\", \"level\": 3, \"text\": \"17.5.3 BKC LIEN. To secure payment of any damages in the event of termination as a result of the Franchisee's default, BKC shall have a lien, on the personal property, machinery, fixtures and equipment owned by the Franchisee at the Location at the time of such default.\"}, {\"id\": \"17.5.4\", \"title\": \"ACCELERATION OF PAYMENTS\", \"level\": 3, \"text\": \"17.5.4 ACCELERATION OF PAYMENTS. All monies owed by Franchisee to BKC shall be immediately due and payable upon term nation.\"}, {\"id\": \"17.6\", \"title\": \"DISPUTE RESOLUTION\", \"level\": 2, \"text\": \"17.6 DISPUTE RESOLUTION. (a) Subject to subparagraph (b) below, all controversies, disputes or claims arising between the Franchisee, the Principals, and their respective shareholders, officers, directors, agents and employees (in their respective capacity) (collectively, the \\\"Franchisee Parties\\\") and BKC arising out of or related to the relationship of the parties hereto, this Agreement or any provision hereof, any related agreement (including any development agreement), the validity of this Agreement or any provision hereof or the operation of the Franchised Restaurant shall be submitted to and settled by arbitration in the City of New York in accordance with the Commercial Arbitration Rules of the American Arbitration Association (\\\"AAA\\\") then obtaining. Such arbitration proceedings shall be conducted before a panel of three (3) arbitrators. The Franchisee Parties shall l appoint one arbitrator, between them, BKC shall each appoint one arbitrator and the two arbitrators so appointed shall appoint a third arbitrator to act as Chair. If said two arbitrators fail to nominate the Chair within thirty (30) days from the date of appointment of the second arbitrator to be appointed, the Chair shall be appointed by the AAA. Unless otherwise provided in this Paragraph, all matters within the scope of the Federal Arbitration Act of the United States of America (9 U.S.C. ss.ss.1 et seq.) shall be governed by it. The arbitrators shall have the right to award or include in their award any relief which they deem proper in the circumstances, including with out limitation, money damages (with interest on unpaid amounts from date due), specific performance, injunctive relief, legal fees and costs, provided that the arbitrators shall not award exemplary or punitive damages. The award and decision of the arbitrators shall be conclusive and binding upon the Franchisee Parties and BKC and judgment upon the award may be entered in any court of competent jurisdiction. The Franchisee Parties and BKC further expressly agree and consent to the jurisdiction of the courts of the State of New York for the purpose of entering judgment upon any such award of the arbitrators. The Franchisee Parties and BKC further agree to be bound by the provisions of any applicable limitation on the period of time in which claims must be brought under applicable law or this Agreement, whichever is less. The parties further agree that in connection with any such arbitration proceeding, they shall submit or file any claim which would constitute a compulsory counterclaim (as defined by Rule 13 of the United States Federal Rules of Civil 31 Procedure) within the same proceeding as the claim to which it relates. Any such claim which is not submitted or filed as described above shall be barred. This provision shall continue in full force and effect subsequent to and notwithstanding expiration or termination of this Agreement. (b) Notwithstanding subparagraph (a) above, BKC shall be entitled to seek the entry of temporary or preliminary injunctions, restraining orders and orders of specific performance enforcing the provisions of this Agreement or any development agreement relating to the use of BKC's Marks or proprietary in \\\"formation by the Franchisee or any Principal upon the termination or expiration of this Agreement or any development agreement. The Franchisee's (or the Principal's) only remedy if an injunction is so entered will be the dissolution of that injunction, if warranted, upon due hearing, all other claims being subject to arbitration under subparagraph (a) above.\"}, {\"id\": \"18\", \"title\": \"RESTRICTIVE COVENANT\", \"level\": 1, \"text\": \"18. RESTRICTIVE COVENANT. Neither the Principals nor the Franchisee shall directly or indirectly (through stock ownership, partnership, trust, joint venture, management contract, or otherwise) (a) have any interest in another \\\"Fast Food Hamburger Restaurant\\\" during the term of this Agreement, or (b) for a period of one ye ar after termination or expiration of this Agreement, have any interest in another Fast Food Hamburger Restaurant business at or within such distance of the Location as is stated SCHEDULE 1. For purposes of this Section, \\\"Fast Food Hamburger Restaurant\\\" shall mean any restaurant which (a) has hamburgers or hamburger based products which account for 50(degree)/o or more of total menu items or total Gross Sales, and (b) does not offer table service as the principal method of ordering or food delivery\"}, {\"id\": \"19\", \"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"19. MISCELLANEOUS: GENERAL CONDITION.\"}, {\"id\": \"19.1\", \"title\": \"INTERPRETATION\", \"level\": 2, \"text\": \"19.1 INTERPRETATION. The Introduction shall be considered a part of this Agreement. Paragraph headings are used only for convenience and do not form part of this Agreement. A covenant on the part of the Franchisee not to do something includes a covenant not to permit others to do it; any right given to BKC includes the right to do it through servants or agents or third party contractors or to do it in conjunction with its servants, agents or third party contractors and includes any necessary rights of access. To the extent of any inconsistency, this Agreement prevails over the MOD Manual. References to the parties shall include their heirs, successors in title and assigns.\"}, {\"id\": \"19.2\", \"title\": \"NON-WAIVER\", \"level\": 2, \"text\": \"19.2 NON-WAIVER. The failure of BKC to exercise any right or option given to it hereunder, or to insist upon strict compliance by the Franchisee or the Principals or any person comprising the Franchisee or the Principals with the terms of this Agreement, shall not constitute a waiver of any terms or conditions of this Agreement with respect to any other or subsequent breach, nor a waiver by BKC of its right at any time thereafter to require exact and strict compliance with all the terms of this Agreement. The rights or remedies set forth in this Agreement are in addition to any other rights or remedies which may be granted by law. 32\"}, {\"id\": \"19.4\", \"title\": \"LICENSES, PERMITS, ETC\", \"level\": 2, \"text\": \"19.4 LICENSES, PERMITS, ETC. The Franchisee shall obtain and maintain all licenses and other permits required by the law of the governing bodies where the Franchised Restaurant is located and shall comply with all local governmental requirements relating to the construction, equipping and operation of the building and the preparation and sale of items in the Franchised Restaurant.\"}, {\"id\": \"19.5\", \"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"19.5 COMPLIANCE WITH LAWS. Notwithstanding anything herein to the contrary, the Franchisee shall operate the Franchised Restaurant in a lawful manner and faithfully comply with the applicable laws, regulations or legitimate administrative requirements of national, regional, and municipal governing bodies or other political subdivisions in which the Franchised Restaurant is located.\"}, {\"id\": \"19.6\", \"title\": \"REMEDIES\", \"level\": 2, \"text\": \"19.6 REMEDIES. If the Franchisee breaches this Agreement, BKC shall be entitled to injunctive relief in addition to all other rights and remedies available under Section 17.2 of this Agreement.\"}, {\"id\": \"19.7\", \"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"19.7 SEVERABILITY. The parties agree that if any provisions of this Agreement may be construed in two ways, one of which would render the provision illegal or otherwise voidable or unenforceable, and the other of which would render the provision valid and enforceable, such provision shall have the meaning which renders it valid and enforceable. The language of all provisions of this Agreement shall be construed according to its fair meaning and not strictly against any party. It is the intent of the parties that the provisions of this Agreement be enforced to the fullest extent and should any court or other public agency determine that any provision herein is not enforceable as written in this Agreement, the provision shall be amended so that it is enforceable to the fullest extent permissible under the laws and public policies of the jurisdiction in which the enforcement is sought. The provisions of this Agreement are severable and this Agreement shall be interpreted and enforced as 33 if all completely invalid or unenforceable provisions were not contained in the Agreement, and partially valid and enforceable provisions shall be enforced to the extent that they are valid and enforceable.\"}, {\"id\": \"19.8\", \"title\": \"NOTICES\", \"level\": 2, \"text\": \"19.8 NOTICES.\"}, {\"id\": \"19.8.1\", \"title\": \"NOTICE TO BKC\", \"level\": 3, \"text\": \"19.8.1 NOTICE TO BKC. All notices to BKC shall be written in English and shall be sent by facsimile and hand delivered in person or by courier or sent by registered airmail, postage fully prepaid, addressed to BKC at 17777 Old Cutler Road, Miami, Florida 33157, U.S.A., Attention: General Counsel, Facsimile number (305) 378-7230, or at such other address as BKC shall from time to time designate in writing.\"}, {\"id\": \"19.8.2\", \"title\": \"NOTICE TO FRANCHISEE/PRINCIPALS\", \"level\": 3, \"text\": \"19.8.2 NOTICE TO FRANCHISEE/PRINCIPALS. All notices to the Franchisee or the Principals shall be written in English and shall be sent by facsimile and hand delivered in person or by courier, or sent by airmail, postage fully prepaid, and shall be addressed to the Franchisee and/or the Principals at the Franchised Restaurant premises, or the Franchisee's last known mailing address if the Franchised Restaurant has ceased operations, with a copy delivered to the Principal's address (but only so long as International Fast Food Corporation is the sole Principal).\"}, {\"id\": \"19.8.3\", \"title\": \"DELIVERY\", \"level\": 3, \"text\": \"19.8.3 DELIVERY. Notices which are sent by mail shall be deemed delivered on the earlier of actual receipt or the tenth (10th) day after being deposited in the mail. Notices sent by hand shall be deemed delivered upon actual receipt.\"}, {\"id\": \"19.9\", \"title\": \"LANGUAGE\", \"level\": 2, \"text\": \"19.9 LANGUAGE. This Agreement is in the English language only, which language shall be controlling in all respects.\"}, {\"id\": \"19.10\", \"title\": \"MODIFICATION\", \"level\": 2, \"text\": \"19.10 MODIFICATION. This Agreement may only be modified or amended by a written document signed by the parties.\"}, {\"id\": \"19.11\", \"title\": \"BINDING EFFECT\", \"level\": 2, \"text\": \"19.11 BINDING EFFECT. This Agreement shall be binding upon the parties, their heirs, executors, personal representatives, successors or assigns.\"}, {\"id\": \"19.12\", \"title\": \"CURRENCY\", \"level\": 2, \"text\": \"19.12 CURRENCY. Unless otherwise provided all payments required under this Agreement shall be made in United States currency in the U.S.A.\"}, {\"id\": \"19.13\", \"title\": \"SURVIVAL\", \"level\": 2, \"text\": \"19.13 SURVIVAL. Any provisions of this Agreement which impose an obligation after termination or expiration of this Agreement shall survive the termination or expiration of this Agreement and remain binding on the parties.\"}, {\"id\": \"19.14\", \"title\": \"AGENCY\", \"level\": 2, \"text\": \"19.14 AGENCY. BKC shall be entitled to entrust the performance of any of its obligations under this Agreement to an Affiliate, and any notice required to be given by BKC shall be validly given if given by an Affiliate. 34\"}, {\"id\": \"20\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"20. ENTIRE AGREEMENT. This Agreement together with any formal Development or Target Reservation Agreement constitutes the entire agreement of the parties and supersedes all prior negotiations, commitments, representations, warranties, and undertaking of the parties (if any) with respect to the subject matter of this Agreement and to the Franchised Restaurant. No term or condition shall be implied into this Agreement in derogation of, or in a manner which is inconsistent with or alters, the express terms set forth in this Agreement.\"}, {\"id\": \"21\", \"title\": \"INDEPENDENT ADVICE\", \"level\": 1, \"text\": \"21. INDEPENDENT ADVICE. THE FRANCHISEE AND EACH PRINCIPAL ACKNOWLEDGE THAT THEY HAVE BEEN ADVISED BY BKC OR ITS AGENTS TO TAKE INDEPENDENT PROFESSIONAL ADVICE ON ALL ASPECTS OF THIS AGREEMENT AND THE BURGER KING BUSINESS AND THAT THEY HAVE TAKEN SUCH INDEPENDENT ADVICE AS THEY DEEM NECESSARY AND HAVE INDEPENDENTLY SATISFIED THEMSELVES ON ALL RELEVANT MATTERS RELATING TO THIS AGREEMENT AND THE OPERATION OF BURGER KING RESTAURANTS BEFORE ENTERING INTO THIS AGREEMENT. The parties have executed this Agreement as of the date indicated on page one. BURGER KING CORPORATION By: /S/ Mark Gerasi ---------------------------------- Vice President Attest: /S/ Kim A. Goodhard ---------------------------------- Assistant Secretary (Corporate Seal) INTERNATIONAL FAST FOOD POLSKA SP ZO.O (the \\\"Franchisee\\\") By: /S/ Mitchell Rubinson ---------------------------------- Name: Mitchell Rubinson -------------------------------- Position: President ---------------------------- 35 THE PRINCIPAL: INTERNATIONAL FAST FOOD CORPORATION By: /S/ Mitchell Rubinson ---------------------------------- Name: Mitchell Rubinson -------------------------------- Position: President ---------------------------- 36\"}, {\"id\": \"SCHEDULE 1\", \"title\": \"TO FRANCHISE AGREEMENT ---------------------------------\", \"level\": 1, \"text\": \"SCHEDULE 1 TO FRANCHISE AGREEMENT --------------------------------- The Franchisee: INTERNATIONAL FAST FOOD POLSKA SP ZO.0 The Principals: INTERNATIONAL FAST FOOD CORPORATION \\\"The Location\\\": means all the land, and any buildings from time to time thereon, known as -------------------------------------- __________________________ and more particularly delineated in the plan attached to the Franchisee's real estate package as finally approved by BKC. Director of Operations (name): ______________________________________ Managing Director (name): ______________________________________ Initial Franchise Fee: U.S. $______________________ Royalty percentage: 5% ------- Advertising percentage: 6% ------- Term: __________ (____) years Hours of Operation: 11:00 a.m. to 11:00 p.m. daily Transfer payment fee: U.S. $10,000 ---------------- Radius of restrictive covenant: Two Kilometers ---------------- Governing Law: State of New York, U.S.A. -------------------------- 37\"}, {\"id\": \"SCHEDULE 2\", \"title\": \"TO FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"SCHEDULE 2 TO FRANCHISE AGREEMENT Shares of the Franchisee owned by the Principals: ================================================================================ | Number of | Class of | % of Class of | % of Total Principal | Shares | Shares | Shares | Shares - -----------------|--------------|-----------|-----------------|----------------- International | | | | Fast Food | | | | 80% Corporation | | | | - -----------------|--------------|-----------|-----------------|----------------- | | | | | | | | - -----------------|--------------|-----------|-----------------|----------------- | | | | | | | | ================================================================================ 38 EXHIBIT \\\"A\\\" TO FRANCHISE AGREEMENT POLAND TRADEMARKS ----------------- Marks registered in Poland: Date of Classes Reg. No. Registration ------- -------- ------------ Burger King Logo 16,29,30,32,42 7441 18 Feb., 1994 Whopper 16,29,30,32,42 7441 18 Feb., 1994 Burger King Wordmark 16,29,30,42 7442 18 Feb., 1994 39\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of INTERNATIONALFASTFOODCORP_04_04_1997-EX-99-FRANCHISE AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"FRANCHISE AGREEMENT TABLE OF CONTENTS\"}}, {\"id\": \"I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTRODUCTION\", \"level\": 1, \"text\": \"I. INTRODUCTION\"}}, {\"id\": \"II\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AGREEMENT\", \"level\": 1, \"text\": \"II. AGREEMENT\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definitions\", \"level\": 1, \"text\": \"1. Definitions\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Franchise Grant; Term\", \"level\": 1, \"text\": \"2. Franchise Grant; Term\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Consideration for Franchise Grant\", \"level\": 1, \"text\": \"3. Consideration for Franchise Grant\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Management, Control and Corporate Documents of Franchisee\", \"level\": 1, \"text\": \"4. Management, Control and Corporate Documents of Franchisee\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Services to Franchisee\", \"level\": 1, \"text\": \"6. Services to Franchisee\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Services Provided By BKC 6\", \"level\": 2, \"text\": \"6.1 Services Provided By BKC 6.2 Services Not Provided By BKC 6.3 Optional Services\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Location 7\", \"level\": 1, \"text\": \"7. Location 7.1 Exclusive Purpose 7.2 Damage to Franchised Restaurant\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Training and Staffing\", \"level\": 1, \"text\": \"8. Training and Staffing\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Pre-Opening Training 8\", \"level\": 2, \"text\": \"8.1 Pre-Opening Training 8.2 New Director of Operations 8.3 Training Program\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Royalty and Advertising Contribution\", \"level\": 1, \"text\": \"9. Royalty and Advertising Contribution ii\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Accounting Procedures; Right of Audit\", \"level\": 1, \"text\": \"10. Accounting Procedures; Right of Audit.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unfair Competition\", \"level\": 1, \"text\": \"12. Unfair Competition\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance; Indemnification 13\", \"level\": 1, \"text\": \"13. Insurance; Indemnification 13.1 General Liability Insurance 13.2 Workers Compensation, Etc. 13.3 Indemnity\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes 14\", \"level\": 1, \"text\": \"14. Taxes 14.1 Payment When Due 14.2 Withholding Taxes 14.3 Election\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disposal 15\", \"level\": 1, \"text\": \"15. Disposal 15.1 Transfer of Interest by Franchisee 15.2 Transfer of Interest by Principals 15.3 Notice of Proposed Transfer 15.4 Right of First Refusal iii\"}}, {\"id\": \"15.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notice; Exercise of Option 15\", \"level\": 3, \"text\": \"15.4.1 Notice; Exercise of Option 15.4.2 No Waiver 15.4.3 Unauthorized Transfer Void 15.4.4 Sale; BKC Consent\"}}, {\"id\": \"15.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BKC Consent to Transaction 15\", \"level\": 2, \"text\": \"15.5 BKC Consent to Transaction 15.5.1Transfer of Substantially All Assets or Transfer of Stock by Principal 15.5.2 Securities Offerings\"}}, {\"id\": \"15.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Waiver 15\", \"level\": 2, \"text\": \"15.6 No Waiver 15.7 Death or Mental Incapacity of Principal 15.8 Corporate Documents 15.9 Assignment by BKC\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Principals\", \"level\": 1, \"text\": \"16. The Principals\"}}, {\"id\": \"16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Stock Ownership 16\", \"level\": 2, \"text\": \"16.1 Stock Ownership 16.2 Compliance by Principals 16.3 Guaranty\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Defaults and Effects of Termination\", \"level\": 1, \"text\": \"17. Defaults and Effects of Termination\"}}, {\"id\": \"17.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Dispute Resolution\", \"level\": 2, \"text\": \"17.6 Dispute Resolution\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Restrictive Covenant\", \"level\": 1, \"text\": \"18. Restrictive Covenant iv\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 1, \"text\": \"20. Entire Agreement\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"independent Advice\", \"level\": 1, \"text\": \"21. independent Advice\"}}, {\"id\": \"III\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SCHEDULE 1\", \"level\": 1, \"text\": \"III. SCHEDULE 1\"}}, {\"id\": \"IV\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SCHEDULE 2\", \"level\": 1, \"text\": \"IV. SCHEDULE 2\"}}, {\"id\": \"V\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT A - Poland Trademarks\", \"level\": 1, \"text\": \"V. EXHIBIT A - Poland Trademarks v FRANCHISE AGREEMENT ------------------- Corporate --------- AGREEMENT dated 199 Between BURGER KING CORPORATION a company incorporated in Florida, United States of America with its principal office and place of business at 17777 Old Cutler Road, Miami, Florida, United States of America (\\\"BKC\\\") AND The party specified as the Franchisee on SCHEDULE 1 attached hereto (the \\\"Franchisee\\\") AND The party or parties specified as the Principals on SCHEDULE 1 attached hereto (collectively, the \\\"Principals\\\" and individually, a \\\"Principal\\\") INTRODUCTION A. BKC has developed a system (the \\\"Burger King System\\\") for the operation of quick service restaurants ( \\\"Burger King Restaurants\\\"). The Burger King System includes proprietary designs for restaurant buildings, equipment and decor, a proprietary service format, standardized product and quality specifications, and such trademarks, service marks and other marks as BKC may authorize for use in connection with the operation of Burger King Restaurants (the \\\"Burger King Marks\\\"). B. The Franchisee possesses knowledge and market information concerning the operation of Burger King Restaurants in the Republic of Poland and the Franchisee recognizes that BKC has not made any representations concerning the level and extent of the awareness of the Burger King Marks or the Burger King System or the likelihood that any such awareness can or will be established in Poland or as to the availability of local sources of supply in Poland or the ability of any supplier to meet standards for approval by BKC. The Franchisee has requested a license to operate a Burger King Restaurant. The Franchisee represents that BKC has not made, and the Franchisee is not relying upon, any representation as to the profits and/or sales volumes which Franchisee might be expected to realize, or costs or levels of costs which Franchisee might be expected to incur, or the prospects of success for Franchisee or Burger King Restaurants in Poland.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Franchisee acknowledges and represents to BKC that it is entering into this Agreement after having made\", \"level\": 1, \"text\": \"C. The Franchisee acknowledges and represents to BKC that it is entering into this Agreement after having made an independent investigation of BKC and its operations and of market and economic conditions in the Republic of Poland. The Franchisee represents that BKC has not made, and that the Franchisee 1 is not relying upon, any representation as to the profits and/or sales volumes which Franchisee might be expected to realize, or costs or levels of costs which the Franchisee might be expected to incur, or the prospects of success for the Franchisee or Burger King Restaurants in Poland, or the level or extent of the awareness of the Burger King Marks or the Burger King System or brand in Poland or the likelihood that any such awareness can or will be established in Poland, or the availability of local sources of supply in Poland or the ability of any such local sources of supply to meet standards for approval by BKC. The Franchisee further represents and agrees that BKC and persons acting on its behalf have not made, and the Franchisee is not relying upon, any representations or promises that are not contained in this Agreement.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each of the Principals owns an equity interest in the Franchisee\", \"level\": 1, \"text\": \"D. Each of the Principals owns an equity interest in the Franchisee. AGREEMENT In consideration of the fees and other sums payable by the Franchisee and the mutual covenants herein, the parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"1. DEFINITIONS. For purposes of this Agreement, the following expressions shall have the meanings given to them below:\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Affiliate\\\" means any company which is directly or indirectly controlled by BKC, controls BKC, or is controll\", \"level\": 2, \"text\": \"1.1 \\\"Affiliate\\\" means any company which is directly or indirectly controlled by BKC, controls BKC, or is controlled by a company which in turn controls BKC, and \\\"control\\\" for these purposes means de facto control.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Burger King Marks\\\" has the meaning ascribed to it in Paragraph A of the introduction\", \"level\": 2, \"text\": \"1.2 \\\"Burger King Marks\\\" has the meaning ascribed to it in Paragraph A of the introduction.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Burger King System\\\" has the meaning ascribed to it in Paragraph A of the introduction\", \"level\": 2, \"text\": \"1.3 \\\"Burger King System\\\" has the meaning ascribed to it in Paragraph A of the introduction.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Current Image\\\" means the then current, BKC approved physical appearance of new Burger King Restaurants as it\", \"level\": 2, \"text\": \"1.4 \\\"Current Image\\\" means the then current, BKC approved physical appearance of new Burger King Restaurants as it relates to signage, fascia, color schemes, menu boards, lighting, furniture, finishes and other non-structural matters generally.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Franchised Restaurant\\\" means the buildings at the Location and the business carried out at the Location\", \"level\": 2, \"text\": \"1.5 \\\"Franchised Restaurant\\\" means the buildings at the Location and the business carried out at the Location.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Gross Sales\\\" has the meaning ascribed to it in Subparagraph 9\", \"level\": 2, \"text\": \"1.6 \\\"Gross Sales\\\" has the meaning ascribed to it in Subparagraph 9.3.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Location\\\" has the meaning ascribed to it on SCHEDULE 1\", \"level\": 2, \"text\": \"1.7 \\\"Location\\\" has the meaning ascribed to it on SCHEDULE 1. 2\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Director of Operations\\\" has the meaning ascribed to it in Subparagraph 4\", \"level\": 2, \"text\": \"1.8 \\\"Director of Operations\\\" has the meaning ascribed to it in Subparagraph 4.1 and on SCHEDULE 1.\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Managing Director\\\" has the meaning ascribed to it in Subparagraph 4\", \"level\": 2, \"text\": \"1.9 \\\"Managing Director\\\" has the meaning ascribed to it in Subparagraph 4.3 and on SCHEDULE 1.\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"MOD Manual\\\" means all volumes of the Manual of Operating Data setting out BKC's standards, specifications and\", \"level\": 2, \"text\": \"1.10 \\\"MOD Manual\\\" means all volumes of the Manual of Operating Data setting out BKC's standards, specifications and procedures of operation, as revised from time to time by BKC including both required and recommended.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FRANCHISE GRANT TERM\", \"level\": 1, \"text\": \"2. FRANCHISE GRANT TERM.\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GRANT\", \"level\": 2, \"text\": \"2.1 GRANT. In reliance upon the application and information furnished by the Franchisee, and subject to the terms and conditions contained in this Agreement, BKC grants to the Franchisee a license to use the Burger King System and the Burger King Marks in the operation of a Burger King Restaurant at that Location.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 2, \"text\": \"2.2 TERM. The license hereby granted shall commence on the date the Franchised Restaurant opens for business (the \\\"Commencement Date\\\"), and, unless sooner terminated in accordance with the terms and provisions of this Agreement, shall continue for the period of years set forth on SCHEDULE 1 hereto (the \\\"Term\\\").\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO RENEWAL RIGHT; NO EXCLUSIVITY\", \"level\": 2, \"text\": \"2.3 NO RENEWAL RIGHT; NO EXCLUSIVITY. The Franchisee acknowledges and agrees that this license is a license for the operation of a Burger King Restaurant at the Location only and that the Franchisee has no right to any exclusive territory or to object to the location of an additional Burger King Restaurant at a site which is in the immediate proximity of the Franchised Restaurant and/or in the same trading area of the Franchised Restaurant Subject to the Restaurant Development Agreement between BKC and International Fast Food Corporation dated March 14, 1997, (the \\\"Development Agreement\\\"), the development and location of additional Burger King Restaurants shall be determined by BKC in its sole business judgment and BKC may develop or franchise additional Burger King Restaurants anywhere, including sites in the immediate proximity of the Franchised Restaurant and/or in the same trading area of the Franchised Restaurant, in its sole business judgment. The Franchisee hereby waives any right it has, may have, or might in the future have, to oppose such development and location, and any claim for compensation from BKC in respect of any and all detriment or los s suffered by it as a result of the development and location of additional Burger King Restaurants in the immediate proximity of the specified Location and/or in the same trading area of the Franchised Restaurant.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONTINUOUS OPERATION\", \"level\": 2, \"text\": \"2.4 CONTINUOUS OPERATION. Franchisee shall continuously operate the Franchised Restaurant at the Location throughout the full term of this Agreement. Except as permitted under this Section 2.4, any failure to do so shall constitute an Event of Default under this Agreement and BKC shall be 3 entitled to alI rights and remedies available under Section 17.2 of this Agreement. Provided, however, that t he Franchisee may temporarily cease operations for a period of time reasonably necessary to comply with the requirement of any competent governmental authority that it repair, clean remodel, or refurbish the Location. The Franchisee may also temporarily cease operations on national holidays and for a period of time reasonably necessary to complete repairs or deal with an act of God, a labor strike, civil unrest, or other emergency situation which would endanger the public or the Franchisee's employees. However, in the event that any temporary closing or discontinuance of operation permitted under this Section 2.4 exceeds 180 days, BKC shall have the right to terminate this Agreement, whereupon all rights granted to Franchisee under this Agreement shall terminate, without liability to BKC.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BEST EFFORTS\", \"level\": 2, \"text\": \"2.5 BEST EFFORTS. Franchisee shall use its best efforts to diligently market and promote the Franchised Restaurant.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONSIDERATION FOR FRANCHISE GRANT\", \"level\": 1, \"text\": \"3. CONSIDERATION FOR FRANCHISE GRANT. At least seven (7) days before the Commencement Date, the Franchisee shall pay to BKC the initial franchise fee described in SCHEDULE 1, which sum shall be fully earned by BKC and non-refundable upon execution of this Agreement.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MANAGEMENT\", \"level\": 1, \"text\": \"4. MANAGEMENT. CONTROL AND CORPORATE DOCUMENTS OF FRANCHISEE.\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MANAGING DIRECTOR\", \"level\": 2, \"text\": \"4.1 MANAGING DIRECTOR. The Franchisee shall, subject to BKC's approval, appoint an individual as the \\\"Managing Director\\\" who shall be responsible for the overall management of the Franchisee. The Managing Director and Director of Operations may be the same individual.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DIRECTOR OF OPERATIONS\", \"level\": 2, \"text\": \"4.2 DIRECTOR OF OPERATIONS. Franchisee shall, subject to BKC's approval, appoint an individual as the \\\"Director of Operations\\\" who shall be trained in the Burger King System. The Director of Operations shall be granted the authority to direct any action necessary to ensure that the day-to-day operation of the Franchised: Restaurant is in compliance with all agreements with BKC relating to the Franchised Restaurant. The Director of Operations shall devote full time and best efforts to the overall supervision of the Franchised Restaurant and any other Burger King Restaurants owned by the Franchisee as to which he/she is designated as the \\\"Director of Operations. \\\"\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUBSTITUTE DIRECTOR OF OPERATIONS\", \"level\": 2, \"text\": \"4.3 SUBSTITUTE DIRECTOR OF OPERATIONS. If the position of Director of Operations becomes vacant for any reason, the vacancy shall be filled within ninety (90) days by a new Director of Operations approved by BKC.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESTAURANT MANAGER\", \"level\": 2, \"text\": \"4.4 RESTAURANT MANAGER. At all times during the Term of this Agreement, Franchisee shall employ at least one (1) individual (the \\\"Restaurant Manager\\\") who is responsible for the direct, personal supervision of the Franchise d Restaurant . 4\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CORPORATE DOCUMENTS\", \"level\": 2, \"text\": \"4.5 CORPORATE DOCUMENTS.\"}}, {\"id\": \"4.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SINGLE PURPOSE ENTITY\", \"level\": 3, \"text\": \"4.5.1 SINGLE PURPOSE ENTITY. Franchisee's sole business activity shall be the development and operation of Burger King restaurants. The articles of incorporation, bylaws and other governing documents of Franchisee must provide that Franchisee is a single purpose entity formed solely for the purpose of developing and operating Burger King restaurants.\"}}, {\"id\": \"4.5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MANAGING DIRECTOR'S AUTHORITY\", \"level\": 3, \"text\": \"4.5.2 MANAGING DIRECTOR'S AUTHORITY. The articles of incorporation, bylaws and other governing documents of Franchisee must mandate the designation of a Managing Director and describe the Managing Director's authority to bind the Franchisee and to direct any actions necessary to ensure compliance with this Franchise Agreement and any ancillary agreements.\"}}, {\"id\": \"4.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ISSUANCE AND TRANSFER OF SHARES\", \"level\": 3, \"text\": \"4.5.3 ISSUANCE AND TRANSFER OF SHARES. The articles of incorporation, the bylaws and each stock certificate of Franchisee shall restrict the issuance and the transfer of shares of Franchisee as provided in Paragraph 15.8 below.\"}}, {\"id\": \"4.5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENTS\", \"level\": 3, \"text\": \"4.5.4 AMENDMENTS. BKC must be immediately provided with any amendments, shareholder agreements, addenda, revisions or other alterations to the articles of incorporation, bylaws or constitution of Franchisee. No amendment to such governing documents may be made, nor may any resolution be adopted by the board of directors of Franchisee, without the written consent of an authorized officer of BKC, if such amendment or resolution would (1) change the description of the Franchisee's purpose or authorized activities; (2) change the designation of, or the procedures for designating, the Managing Director; (3) change the authority delegated to the Managing Director; or (4) materially alter promises or representations contained in the application approved by BKC.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"STANDARDS AND UNIFORMITY\", \"level\": 1, \"text\": \"5. STANDARDS AND UNIFORMITY.\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"STRICT COMPLIANCE\", \"level\": 2, \"text\": \"5.1 STRICT COMPLIANCE. The Franchisee agrees to comply strictly at all times with the Burger King System, which Franchisee acknowledges is a fundamental term of this Agreement and a necessary and reasonable requirement in the interests of the Franchisee and others operating under the Burger King System. In particular, the Franchisee shall at all times comply with the following provisions of this Section 5.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE MOD MANUAL\", \"level\": 2, \"text\": \"5.2 THE MOD MANUAL. The MOD Manual shall be kept at the Franchised Restaurant and all changes or additions shall be inserted upon receipt. The Franchisee agrees that changes in standards, specifications and procedures may become necessary and desirable from time to time and shall comply with such modifications, revisions and additions to the MOD Manual as BKC in the good faith exercise of its judgment believes to be desirable. The information 5 contained in the MOD Manual is confidential and the Franchisee shall use the MOD Manual only in connection with the operation of the Franchised Restaur ant and other licensed Burger King Restaurants\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BUILDING AND PREMISES\", \"level\": 2, \"text\": \"5.3 BUILDING AND PREMISES.\"}}, {\"id\": \"5.3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INITIAL CONSTRUCTION\", \"level\": 3, \"text\": \"5.3.1 INITIAL CONSTRUCTION. The Franchised Restaurant shall be constructed and the premises initially improved in the manner approved by BKC, and shall be decorated, furnished, and equipped with equipment, furnishings, and fixtures which meet BKC's specifications and Current Image. The appearance of the Franchised Restaurant shall not thereafter be altered except as approved by BKC in writing.\"}}, {\"id\": \"5.3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPAIR AND MAINTENANCE\", \"level\": 3, \"text\": \"5.3.2 REPAIR AND MAINTENANCE. The Franchisee shall, at its own expense, continuously throughout the Term of this Agreement, maintain the Franchised Restaurant in good condition and repair in accordance with BKC's then current repair and maintenance standards.\"}}, {\"id\": \"5.3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CURRENT IMAGE\", \"level\": 3, \"text\": \"5.3.3 CURRENT IMAGE. During the year immediately following the expiration of one half of the Term of this Agreement (e.g., in the 11th year of a 20 year term), the Franchisee shall remodel, improve and alter the exterior of the Franchised Restaurant to conform with the Current Image in effect during the prior year .\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SIGNS\", \"level\": 2, \"text\": \"5.4 SIGNS. The Burger King Marks will be displayed only in the manner and at such locations as are authorized by BKC. The Franchisee agrees to maintain and display signs conforming to the Current Image. The Franchisee shall discontinue the use of and destroy such signs as are declared obsolete by BKC.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EQUIPMENT\", \"level\": 2, \"text\": \"5.5 EQUIPMENT. Only equipment and equipment layouts approved by BKC shall be used at the Location. All equipment shall be maintained in a condition that meets operational standards specified in the MOD Manual, and as equipment becomes obsolete or inoperable, the Franchisee will replace such items with the types and kinds of equipment as are then approved for use in new Burger King Restaurants at the time of replacement. If BKC determines that additional or substitute equipment is needed in any part of the Location due to a change in menu items or method of preparation and service, or because of health or safety considerations, the Franchisee will install the new equipment within such time as BKC may reasonably specify.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"VENDING MACHINES, ETC\", \"level\": 2, \"text\": \"5.6 VENDING MACHINES, ETC. No telephone booths, newspaper racks, juke boxes, vending machines, games, rides or any other type of machines shall be installed without the prior written approval of BKC.\"}}, {\"id\": \"5.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MENU, SERVICE AND HYGIENE\", \"level\": 2, \"text\": \"5.7 MENU, SERVICE AND HYGIENE. The Franchised Restaurant shall serve all menu items and brands specified by BKC, and shall not serve any items that are not set forth in the MOD Manual or otherwise authorized and approved by BKC in writing. The Franchisee shall adhere to all specifications contained in the MOD 6 Manual or as otherwise prescribed by BKC as to ingredients, storage, handling, method of preparation and service, weight and dimensions of products served, and standards of cleanliness, health, and sanitation. All food, drinks, and other items will be served and sold in packaging that meets BKC's specifications. Only food, paper products, packaging and supplies from sources approved by BKC (which expression includes sources of both product and distribution) shall be used in the Franchised Restaurant.\"}}, {\"id\": \"5.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"HOURS OF OPERATION\", \"level\": 2, \"text\": \"5.8 HOURS OF OPERATION. Subject to the provisions of Paragraph 2.4 above, or unless otherwise authorized or directed by BKC the entire Franchised Restaurant shall be open for business a minimum of the hours indicated on SCHEDULE 1 daily, seven (7) days a week, except where prohibited by law or government regulation. BKC recognizes that considerations peculiar to the location of the Franchised Restaurant may make it necessary to alter the aforesaid hours of operation, and BKC will not unreasonably withhold its consent to do so.\"}}, {\"id\": \"5.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"UNIFORMS\", \"level\": 2, \"text\": \"5.9 UNIFORMS. All employees at the Location shall wear uniforms previously approved by BKC as meeting the design, color and specification as are from time to time prescribed by BKC.\"}}, {\"id\": \"5.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ADVERTISING AND PROMOTION MATERIALS\", \"level\": 2, \"text\": \"5.10 ADVERTISING AND PROMOTION MATERIALS. Only such advertising or promotional materials, slogans or other items as are authorized by BKC in writing prior to use shall be used, sold, or distributed, and no display or use of the Burger King Marks shall be made without the prior written permission of BKC. All materials on which Burger King Marks are used shall bear such notice of registration or license legend as BKC may specify. The Franchisee agrees to comply with the advertising and promotional standards established from time to time by BKC.\"}}, {\"id\": \"5.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTERFERENCE WITH EMPLOYMENT RELATIONS OF OTHERS\", \"level\": 2, \"text\": \"5.11 INTERFERENCE WITH EMPLOYMENT RELATIONS OF OTHERS. The Franchisee will not attempt, directly or indirectly, to entice or induce any employee of BKC or of an Affiliate of BKC or of another franchisee of BKC to leave such employment, nor to employ such employee within six (6) months after his or her termination of employment with such employer, except with the prior written consent of such employer.\"}}, {\"id\": \"5.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"IMPROVEMENTS\", \"level\": 2, \"text\": \"5.12 IMPROVEMENTS. The Franchisee shall notify BKC of any potential improvements or new features which it identifies as capable of benefitting the Burger King System. The Franchisee shall not use potential improvements or new features at the Franchised Restaurant unless authorized by BKC in writing and at its sole discretion, but BKC is under no obligation to authorize such use. The Franchisee acknowledges and agrees that all such potential improvements and new features shall become the exclusive property of BKC without payment of any consideration to the Franchisee, and BKC is free to evaluate such potential improvements or new features in its own restaurants and introduce any such improvements or new features into the Burger King System for the benefit of BKC 7 and other franchisees. The Franchisee agrees to execute any additional documents which BKC may deem necessary to effect or perfect the provisions of this Paragraph 5.12.\"}}, {\"id\": \"5.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SELF-AUDIt\", \"level\": 2, \"text\": \"5.13 SELF-AUDIt. The Franchisee shall participate in any self-audit scheme which may from time to time form part of the Burger King System.\"}}, {\"id\": \"5.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"HEALTH PROBLEMS\", \"level\": 2, \"text\": \"5.14 HEALTH PROBLEMS. The Franchisee shall immediately notify BKC of any actual or suspected occurrence of any serious communicable disease or infection at or among staff or customers at the Franchised Restaurant.\"}}, {\"id\": \"5.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RIGHT OF ENTRY, INSPECTION AND CLOSURE\", \"level\": 2, \"text\": \"5.15 RIGHT OF ENTRY, INSPECTION AND CLOSURE. BKC shall have the unrestricted right to enter the Franchised Restaurant to conduct such reasonable activities as it deems necessary to ascertain compliance with this Agreement. The inspections may be conducted without prior notice at any time when the Franchisee or any one of its responsible employees or representatives is at the Franchised Restaurant. The inspections shall be performed in a manner which minimizes interference with the operation of the Franchised Restaurant. BKC may require the removal of any items which do not comply with this Agreement at the Franchisee's cost. In the event that BKC identifies, or reasonably suspects the existence of, any significant risk to health or safety in any aspect of the operation at the Location, BKC may require the Franchisee immediately to close the Franchised Restaurant until the hazard as been eliminated. BKC shall specify the grounds for taking such action and such steps if any a it believes are necessary to eliminate the hazard and shall cooperate with the Franchisee to enable the Franchisee to re-open the Franchised Restaurant as soon as possible.\"}}, {\"id\": \"5.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SOURCES OF SUPPLY\", \"level\": 2, \"text\": \"5.16 SOURCES OF SUPPLY.\"}}, {\"id\": \"5.16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUTHORIZED SUPPLIERS\", \"level\": 3, \"text\": \"5.16.1 AUTHORIZED SUPPLIERS. BKC may require that any item required for or used in the operation of the Franchised Restaurant shall be previously approved by BKC in its sole and absolute discretion and that the supplier and distributor of such items also be previously approved by BKC in its sole and absolute discretion. The Franchisee shall in such case purchase only from BKC authorized suppliers and distributors. Should the Franchisee propose an alternative supplier and distributor, BKC shall evaluate such supplier and distributor against its then-current criteria, as established by BKC in its sole discretion, and either approve or disapprove such supplier and distributor. Any supplier and distributor proposed by the Franchisee may be required to sign a suitable confidentiality undertaking before BKC's confidential specifications are disclosed. In approving or disapproving suppliers and distributors, the Franchisee acknowledges and agrees that BKC may devote such resources and time as BKC may reasonably determine is necessary to evaluate any such supplier or distributor in its sole discretion. BKC agrees that it will apply those criteria in good faith toward the Franchisee. If BKC denies the Franchisee's request for approval of a supplier or distributor BKC shall advise the Franchisee of the reasons for its decision. If BKC fails to approve or deny the Franchisee's 8 request for approval of a supplier or distributor within thirty (30) business days then approval shall be deemed to have been given. Approval of any suppler or distributor by BKC is subject to revocation in its sole discretion.\"}}, {\"id\": \"5.16.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SELF-SUPPLY\", \"level\": 3, \"text\": \"5.16.2 SELF-SUPPLY. Franchisee may, upon prior written notice to BKC, invest in BKC approved suppliers and/or distributors to the Franchised Restaurant or request approval from BKC to become an approved supplier and/or distributor to the Franchised Restaurant. BKC shall not unreasonably withhold its approval of the Franchisee as a supplier and/or distributor to the Franchised Restaurant and/or other Burger King Restaurants. Franchisee expressly acknowledges and agrees, however, that the Franchisee must meet all of BKC's then current conditions for supplier and/or distribution agreements.\"}}, {\"id\": \"5.16.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITS ON BKC RESPONSIBILITY\", \"level\": 3, \"text\": \"5.16.3 LIMITS ON BKC RESPONSIBILITY. BKC shall NOT be responsible for the following: (a) Arranging, assuring, or facilitating the delivery or availability o labor, food, paper, equipment, furniture, fixtures, or any other goods or services in connection with the operation of the Franchised Restaurant. (b) Arranging, assuring, or facilitating the delivery or availability of labor, food, paper, equipment, furniture, fixtures or any other goods or services in connection with the operation of the Franchised Restaurant at a reasonable or at any other particular cost (whether stated as a percentage of sales or otherwise to the Franchised Restaurant or to the Franchisee).\"}}, {\"id\": \"5.16.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FRANCHISEE'S RESPONSIBILITIES\", \"level\": 3, \"text\": \"5.16.4 FRANCHISEE'S RESPONSIBILITIES. Franchisee shall be responsible for locating and submitting to BKC for approval, pursuant to Section 5.16.1 above, suppliers and distributors capable of manufacturing and/or delivering all BKC required goods and services to the Franchised Restaurant on a consistent and reliable basis.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SERVICES TO FRANCHISEE\", \"level\": 1, \"text\": \"6. SERVICES TO FRANCHISEE.\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SERVICES PROVIDED BY BKC\", \"level\": 2, \"text\": \"6.1 SERVICES PROVIDED BY BKC. BKC, its designee or an Affiliate of BKC shall periodically advise and consult with the Franchisee in connection with the operation of the Franchised Restaurant and shall provide to he Franchisee: (a) The MOD Manual, including all revisions and updates thereto, which will be loaned to the Franchisee for the term of this Agreement. The loaned copy of the MOD Manual and other specifications, standard and operating procedures furnished by BKC shall be written in English, and any translation to another language shall be at the Franchisee's responsibility and cost. 9 Franchisee shall translate the MOD Manual into the native language of the employees at the Franchised Restaurant upon request by BKC. The delivery of a copy of the MOD Manual, including all revisions and updates thereto, by BKC to the Franchisee satisfies and fulfills any obligation BKC may be deemed to have to provide the Franchisee with use of the Burger King System or expertise regarding he Burger King System. (b) A representative of BKC who shall make not less than two (2) one day visits to Poland per annum to provide the Franchisee with any requested reasonable operations or marketing guidance and advice. Franchisee shall have the option to participate, at its sole cost and expense, in any additional training pro grams offered by BKC to other franchisees generally. Such training programs shall be at locations designated by BKC. (c) Communication of new developments, techniques and improvements of BKC which BKC deems in its sole discretion to be relevant to the operation of the Franchised Restaurant and which BKC may otherwise make available to all other franchisees in Europe.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SERVICES NOT PROVIDED BY BKC\", \"level\": 2, \"text\": \"6.2 SERVICES NOT PROVIDED BY BKC. The Franchisee acknowledges and agrees that compliance by BKC with its obligations under Section 6.1 above shall satisfy all obligations of BKC to provide operational, marketing, and other support to the Franchisee, and that any other support provided by BKC shall be at BKC's sole discretion. The Franchisee further acknowledges and agrees that BKC shall have no obligation with regard to the establishment, development and for maintenance of consumer awareness or recognition of the Burger King Marks, Restaurants or System.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OPTIONAL SERVICES\", \"level\": 2, \"text\": \"6.3 OPTIONAL SERVICES. BKC may, but shall under no circumstances be required to, offer the following services and/or assistance to Franchisee, in BKC's sole discretion: (a) If requested by Franchisee, BKC may, at its sole and absolute discretion, provide Franchisee with a pre-opening training program at Franchisee's sole cost and expense at whatever location BKC may designate in its sole discretion. (b) If requested by Franchisee, BKC may, in its sole and absolute discretion, provide Franchisee with pre-opening and opening supervision and assistance by personnel of BKC, its designee or an Affiliate of BKC at Franchisee's sole cost and expense at whatever location BKC may designate in its sole discretion.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LOCATION\", \"level\": 1, \"text\": \"7. LOCATION.\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVE PURPOSE\", \"level\": 2, \"text\": \"7.1 EXCLUSIVE PURPOSE. During the term of this Agreement the Location shall be used exclusively for the purpose of operating a Burger King Restaurant. 10\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DAMAGE TO FRANCHISED RESTAURANT\", \"level\": 2, \"text\": \"7.2 DAMAGE TO FRANCHISED RESTAURANT. In the event of the building being damaged or destroyed by fire or any other peril, or required to be repaired or altered by any competent authority, the Franchisee shall at its own expense repair or reconstruct the building within a reasonable time to reflect the then Current Image of Burger King Restaurants, having first submitted to BKC all plans and specifications related thereto for prior approval. Where the Franchised Restaurant is insured by a person other than the Franchisee, the Franchisee's obligations shall be limited to taking such steps as are reasonably available to the Franchisee to assure that any insurance moneys ar paid out in accordance with this subparagraph. Notwithstanding the foregoing, if (a) the building is leased, (b) the Franchisee is prohibited under the terms of the applicable lease from repairing or reconstructing the building as provided above, and (c) the Franchisee has exhausted its best efforts to convince the landlord to consent to such repair or reconstruction, then the Franchisee shall be released from its obligations under this Paragraph 7.2 and this Agreement shall terminate.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRAINING AND STAFFING\", \"level\": 1, \"text\": \"8. TRAINING AND STAFFING.\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRE-OPENING TRAINING\", \"level\": 2, \"text\": \"8.1 PRE-OPENING TRAINING. Before the Franchised Restaurant opens, the Director of Operations and such members of the Franchisee's staff charged with the responsibility for the day to day operation of the Franchised Restaurant as BKC may determine must have successfully completed BKC's training program at such location in the U.S. or elsewhere as may be designated by BKC. Such members of t e Franchisee's restaurant staff as BKC may determine shall undertake and complete continuing raining programs from time to time as may be directed by BKC in order to implement current operational standards. There shall be no charge for participation in the training programs, but the Franchisee shall be responsible for all travel and living expenses, all compensation of the Franchisee's employee while enrolled in the training program, and any other personal expenses incurred.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NEW DIRECTOR OF OPERATIONS\", \"level\": 2, \"text\": \"8.2 NEW DIRECTOR OF OPERATIONS. Any new Director of Operations as BKC may approve shall successfully complete the above program before taking up such position.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRAINING PROGRAM\", \"level\": 2, \"text\": \"8.3 TRAINING PROGRAM. The Franchisee shall implement a training program for Franchised Restaurant employees in accordance with training standards and procedures prescribed by BKC and shall staff the Franchised Restaurant at all times with a sufficient number of trained employees including the minimum number of managers required by BKC who have completed BKC's training program at an accredited location.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ROYALTY AND ADVERTISING CONTRIBUTION\", \"level\": 1, \"text\": \"9. ROYALTY AND ADVERTISING CONTRIBUTION.\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ROYALTY\", \"level\": 2, \"text\": \"9.1 ROYALTY.\"}}, {\"id\": \"9.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT OF ROYALTY\", \"level\": 3, \"text\": \"9.1.1 PAYMENT OF ROYALTY. Except as otherwise provided in Section 5 3 of the Development Agreement, by the fifteenth (15th) day of each month, the 11 Franchisee shall deliver to BKC a return of Gross Sales for the preceding month and pay to BKC or its designee a royalty for the use of the Burger King Marks an the Burger King System calculated by applying the percentage set forth in SCHEDULE 1 against the Gross Sales for the preceding calendar month. All royalties shall be paid by the Franchisee to BKC or its designee in United States currency into such bank account in the United States of America or elsewhere as BKC shall designate by prior written notice to the Franchisee. Such payments shall be made by such method as BKC may from time to time stipulate including direct debit, in accordance with applicable law. Each conversion from local currency to United States currency shall be at the maximum selling rate of exchange quoted by Citibank, N.A. in New York, New York, U.S.A., or at the maximum selling rate of a nationally recognized bank in the country where the Franchised Restaurant is located, at the sole discretion of BKC, as of the last bank trading day of the month on which the royalty payment is based. The Franchisee will, at its expense, make all necessary and appropriate applications to such governmental authorities as may be requested by BKC or as may be required for transmittal and payment of United States currency to BKC.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ADVERTISING AND SALES PROMOTION\", \"level\": 2, \"text\": \"9.2 ADVERTISING AND SALES PROMOTION.\"}}, {\"id\": \"9.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FRANCHISEE'S ADMINISTRATION OF AD FUND\", \"level\": 3, \"text\": \"9.2.1 FRANCHISEE'S ADMINISTRATION OF AD FUND. Pursuant to the terms of the Ad Fund Agreement dated March 14, 1997 between the Franchisee and BKC, the Franchisee shall expend monthly, in the country where the Franchised Restaurant is located, monies for advertising, sales promotion and public relation services for he benefit of Burger King Restaurants in the country where the Franchised Restaurant is locate, including creative, production, media and clearance costs of advertising and sales promotion materials, and marketing 12 research expenses directly related to the development and evaluation of the effectiveness of advertising and sales promotion. (SUBJECT TO A PENDING REQUEST FOR CONFIDENTIAL TREATMENT)\"}}, {\"id\": \"9.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BKC'S RIGHT TO ADMINISTER FUNDS\", \"level\": 3, \"text\": \"9.2.2 BKC'S RIGHT TO ADMINISTER FUNDS. Notwithstanding the language in Subparagraph 9.2.1 above, BKC and the Franchisee agrees that, in the event BKC develops company-owned Burger King Restaurants directly or through a subsidiary or joint venture in the country where the Franchised Restaurant is located or franchises Burger King Restaurants in the country where the Franchised Restaurant is located to someone other than the Franchisee, BKC shall have the right to terminate the Ad Fund Agreement pursuant to its terms and require that the Franchisee pay to BKC or its designee by the fifteenth (15th') day of each month, in the currency of the country where the Franchised Restaurant is located an amount equal to the amount calculated by applying the advertising percentage stated in SCHEDULE 1 to the Gross Sales for the preceding calendar month. Any monies received by BKC under this Subparagraph shall be administered by BKC as provided in Subparagraph 9.2.3 below. In the event BKC requires and the Franchisee makes these payments, the direct expenditure obligation of Subparagraph 9.2.1 above will be deemed fully satisfied.\"}}, {\"id\": \"9.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ADMINISTRATION\", \"level\": 3, \"text\": \"9.2.3 ADMINISTRATION. Any amounts received by BKC pursuant to Subparagraph 9.2.2 above, less administrative expenses and any applicable taxes, will be combined with payments from other Burger King Restaurants to form an ad fund which will be used for (a) market research expenditures directly related to the development and evaluation of the effectiveness of advertising and sales promotions, (b) creative, production and other costs incurred in connection with the development of advertising sales promotions and public relations, both in the market area of the Franchised Restaurant as reasonably defined from time to time by BKC, and on a national basis and (c) various methods of delivering the advertising or promotional message, including without limitation, television, radio, outdoor and print. The allocation of the Advertising Contribution between international, national, regional, and local expenditures shall be made by BKC in its sole business judgment. All general and administrative expenses and overhead associated with the ad fund, including salaries of relevant BKC employees, shall be paid out of the assets of the ad fund. The Franchisee is encouraged to participate in the planning of advertising, sales promotions and public relations for the Franchised Restaurant, but all expenditures for such matters shall be the sole discretion of BKC. In addition to the percentage of Gross Sales, the Franchisee agrees to transfer to BKC or its designee for inclusion in the market fund all advertising or promotional allowances given by suppliers of products which are sold in the Franchised Restaurant uncle a brand name. Such payment to be made to BKC or its designee by the fifteenth (15th) day of the month following receipt of the said allowance. The market fund will be run by BKC directly or by delegation to its designee. 13\"}}, {\"id\": \"9.2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH LAWS AND POLICIES\", \"level\": 3, \"text\": \"9.2.4 COMPLIANCE WITH LAWS AND POLICIES. The Franchisee agrees to adhere to all applicable statutory regulations and to KC's advertising, sales promotion and public relations standards and all advertisements and other material published, circulated or exhibited shall first be approved by BKC. The Franchisee agree immediately to remove or discontinue the use of any objectionable advertising material upon receiving notice from BKC.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GROSS SALES\", \"level\": 2, \"text\": \"9.3 GROSS SALES. The term \\\"Gross Sales\\\" as used in this Agreement includes all sums charged for goods, merchandise, or services sold at or from the Location. The sale of Burger King products away from the Location is not authorized; however, should any such sales be approved in the future, they will be included within the definition of Gross Sales. Gross Sales shall not include any value added tax, turnover tax, or any similar tax collected by the Franchisee from customers based upon sales.\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTEREST AND ATTORNEY'S FEES\", \"level\": 2, \"text\": \"9.4 INTEREST AND ATTORNEY'S FEES. The Franchisee shall pay to BKC interest (in U.S. dollars in the United States) upon any sum overdue under this Agreement, calculated at three (3) percent per annum above the prime rate of merest charged by Citibank, N.A., against the overdue sum expressed in U.S. dollars. By way of exception, any overdue sum required to be paid in a currency other than U.S. dollars shall bear merest at three (3) percent per annum above the base lending rate of any nationally recognized bank within the relevant country designated by BKC. Nothing in this paragraph is meant to require the Franchisee to pay interest at a rate greater than that allowed by applicable law and, in the event that this paragraph would have such an effect, the Franchisee shall only be required to pay interest at the maximum rate allowable by law. If an excess amount is inadvertently collected, it shall be applied to reduce the amounts due under Subparagraph 9.1.1 above. The Franchisee shall pay all costs, including reasonable attorney's fees, incurred by BKC in enforcing the tern s of this Agreement.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACCOUNTING PROCEDURES; RIGHT OF AUDIT\", \"level\": 1, \"text\": \"10. ACCOUNTING PROCEDURES; RIGHT OF AUDIT.\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACCOUNTING\", \"level\": 2, \"text\": \"10.1 ACCOUNTING. The Franchisee agrees to keep complete records of the business and shall furnish BKC with monthly and fiscal year-to-date profit and loss statements for the Franchised Restaurant in the format prescribed by BKC. The Franchisee shall also submit to BKC quarterly balance sheets for the Franchisee itself and not merely of the Franchised Restaurant, the first of which shall be for the period ending forty-five (45) days after the expiration of the first calendar quarter after the Franchised Restaurant opens. All profit and loss statements and balance sheets shall be submitted to BKC within fifty-five (45) days after the end of the period covered by the report in a form acceptable to BKC. In addition, the Franchisee shall submit to BKC copies of tax returns relating to the Franchisee's sales at the Franchised Restaurant at the same time the returns are filed, and such other records as BKC may reasonably request from time to time. 14\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ANNUAL FINANCIAL STATEMENT\", \"level\": 2, \"text\": \"10.2 ANNUAL FINANCIAL STATEMENT. Within ninety (90) days after the close of each fiscal year and at any time on request, the Franchisee shall submit a full disclosure of all shareholders in the Franchisee, and of all persons with an interest in the Franchised Restaurant. ln addition, the Franchisee shall furnish an annual financial statement for the Franchisee and not merely the Franchised Restaurant, which statement shall be certified by a Certified Public Accountant or equivalent.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUDITS\", \"level\": 2, \"text\": \"10.3 AUDITS. The Franchisee agrees that BKC or its representatives, at BKC's expense shall, at all reasonable times, have the right to examine or audit the books and accounts of the Franchisee. The Franchisee shall retain sales records for a period of at least twenty-four (24) months. In the event the reported Gross Sales are less than the actual Gross Sales, the Franchisee shall make an additional payment to BKC in the amount of the discrepancy. In the event that the discrepancy exceeds two percent (2%), th Franchisee shall also reimburse BKC for all costs of the audit including travel, lodging and wages.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RELEASE OF FINANCIAL INFORMATION\", \"level\": 2, \"text\": \"10.4 RELEASE OF FINANCIAL INFORMATION. BKC is authorized to release financial and operational information on the Franchised Restaurant as part of any disclosure of information on the Burger King System in the country where the Franchised Restaurant is located or on the Burger King System as a whole. Except as required by law or regulation, BKC shall not specifically identify the Franchised Restaurant to which this information relates.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"POLLING\", \"level\": 2, \"text\": \"10.5 POLLING.\"}}, {\"id\": \"10.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"POS SYSTEMS\", \"level\": 3, \"text\": \"10.5.1 POS SYSTEMS. The Franchisee shall at all times operate at the Franchised Restaurant POS systems previously approved by BKC as meeting its performance standards and other criteria including compatibility with BKC's polling standards, provided that such POS system operates in accordance with applicable law. BKC shall have the right to call upon the Franchisee to upgrade the POS systems as BKC may deem necessary or desirable in the interest of proper administration of restaurants operating under the Burger King System, and the Franchisee shall comply with such requirement within such reasonable time as may be specified by BKC. Such authorized POS systems shall at all times be used to record and process such information as BKC may from time to time require, and such information shall be maintained in such format and kept available for access by BKC on such POS system for such minimum period as BKC may require. The Franchisee she effect the polling operation at such time or times as may be required by BKC, but BKC may itself initiate polling whenever it deems appropriate. BKC shall have no obligation to provide Franchisee with information, consultation or advice concerning POS systems or accounting or other financial systems for the operation of Franchisee's business.\"}}, {\"id\": \"10.5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUTHORIZED POLLING\", \"level\": 3, \"text\": \"10.5.2 AUTHORIZED POLLING. The Franchisee shall permit BKC or its duly authorized agents at all times and from time to time to poll any 15 information contained in such POS system. For the purposes of this Agreement the term \\\"poll\\\" or \\\"polling\\\" means any process acceptable to BKC by which information o data may be transmitted from a POS system operated by the Franchisee or its agents into a computer or system operated by BKC, it agents or Affiliates. If for any reason polling is not practicable, BKC may require the Franchisee to download such information into machine readable form compatible with the system operated by BKC, its agents or Affiliates and to derive such information to BKC by such method and within such timescale as BKC may reasonably determine.\"}}, {\"id\": \"10.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OTHER INFORMATION\", \"level\": 3, \"text\": \"10.5.3 OTHER INFORMATION. The Franchisee shall if requested and as long as polling is not possible provide to BKC such information as BKC may from time to time require regarding product volumes and production.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATIONS OF FRANCHISE\", \"level\": 1, \"text\": \"11. LIMITATIONS OF FRANCHISE.\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS, TRADE NAMES, SERVICE MARKS AND TRADE SECRETS\", \"level\": 2, \"text\": \"11.1 TRADEMARKS, TRADE NAMES, SERVICE MARKS AND TRADE SECRETS.\"}}, {\"id\": \"11.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REGISTRATION ASSISTANCE BY FRANCHISEE\", \"level\": 3, \"text\": \"11.1.1 REGISTRATION ASSISTANCE BY FRANCHISEE. The Franchisee shall, upon request and at no expense to the Franchisee assist BKC in perfecting and obtaining registration of unregistered Burger King Marks.\"}}, {\"id\": \"11.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OWNERSHIP\", \"level\": 3, \"text\": \"11.1.2 OWNERSHIP. The Franchisee acknowledges that ownership of all right, title and interest to the Burger King System and the Burger King Marks (registered and unregistered) is and shall remain vested solely in BKC. The Franchisee acknowledges the uniqueness of the Burger King System an that the Franchisee has had no part in its creation or development, no prior knowledge of, and no proprietary or other rights or claims in or to any element of the Burger King System or the Burger King Marks.\"}}, {\"id\": \"11.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY OF TRADE SECRETS\", \"level\": 3, \"text\": \"11.1.3 CONFIDENTIALITY OF TRADE SECRETS. The Franchisee agrees that all materials made available to the Franchise and all disclosures made to the Franchisee, and not to the general public, by or at the direction of BKC at any time before or during the term of this Agreement, including the MOD Manual in its entirety and any translations thereof, are to be considered trade secrets of BKC for purpose of this Agreement and shall be kept confidential and used by the Franchisee only in the operation of the Franchised Restaurant and other licensed Burger King Restaurants. The Franchise agrees not to divulge any of the trade secrets to any person other than the Franchisee's employees and then only to the extent necessary for the operation of the Franchised Restaurant, an d not to permit anyone to reproduce, copy or exhibit any portion of the MOD Manual or any other confidential or proprietary information received from BKC, except for translating from English to the language of the country in which the Franchised Restaurant is located, if the Franchisee's employees cannot read and understand English. 16\"}}, {\"id\": \"11.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REGISTERED USER AGREEMENTS\", \"level\": 3, \"text\": \"11.1.4 REGISTERED USER AGREEMENTS. The Franchisee shall, whenever requested by BKC, enter into one or more Registered User Agreements authorizing and permitting the use of the Burger King Marks as provided in this Agreement and to execute any documents and/or do such things as are requested to assist BKC in connection with registration of any Registered User Agreement. Nothing in any Registered User Agreement shall be construed as giving the Franchisee the right to transfer or sublicense the Franchisee's right to use the Burger King Marks.\"}}, {\"id\": \"11.1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO IMPAIRMENT OF MARKS\", \"level\": 3, \"text\": \"11.1.5 NO IMPAIRMENT OF MARKS. The Franchisee will not directly or indirectly, at any time during the term of this Agreement or thereafter, do or cause to be done any act or thing disputing, attacking or in any way impairing the validity of and BKC's right, title or interest in the Burger King Marks and the Burger King System.\"}}, {\"id\": \"11.1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT OF RIGHTS IN MARKS\", \"level\": 3, \"text\": \"11.1.6 ASSIGNMENT OF RIGHTS IN MARKS. The Franchisee hereby assigns to BKC such rights (if any) as the Franchisee may hereafter acquire in any of the Burger King Marks or the Burger King System and shall execute such documents and do such acts at the cost of BKC as may be necessary to perfect such assignment.\"}}, {\"id\": \"11.1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INFRINGEMENT, ETC\", \"level\": 3, \"text\": \"11.1.7 INFRINGEMENT, ETC. The Franchisee shall immediately notify BKC of all infringements or imitations of the Burger King Marks which come to the Franchisee's attention, and all challenges to the Franchisee's use c f any of the Burger King Marks. BKC will take such action as it in its sole discretion deems appropriate to prevent unauthorized persons from using the Burger King Marks. The Franchisee agrees to cooperate in the prosecution of any action to prevent the infringement, imitation, illegal se or misuse of the Burger King Marks or the Burger King System and agrees to be named as a party in any such action if so requested by BKC. BKC agrees to bear the legal expenses and costs incidental to the Franchisee's participation in such action except for the cost and expenses of the Franchisee's personal legal counsel if the Franchisee elects to be represented by counsel of the Franchisee's own choosing. The Franchisee shall not institute any legal action or other kind of proceeding based upon Burger King Marks or the Burger King System without the prior written approval of BKC.\"}}, {\"id\": \"11.1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REGISTERED MARKS\", \"level\": 3, \"text\": \"11.1.8 REGISTERED MARKS. BKC represents that the marks listed on Exhibit A are registered or applied for, but makes no expressed or implied warranty with respect to the validity of any of the Burger King Marks. The Franchisee accepts that the Franchisee may conduct business utilizing some Burger King Marks which have not been registered and that registration may not be granted for the unregistered marks and that some of the Burger King Marks may be subject to use by third parties unauthorized by BKC.\"}}, {\"id\": \"11.1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FRANCHISEE NAME\", \"level\": 3, \"text\": \"11.1.9 FRANCHISEE NAME. In the adoption of a trade, corporate or partnership name, the Franchisee shall not use any of the Burger King Marks, any variations or abbreviations or any words confusingly similar to any of the Burger King Marks. 17 11.1.10 REGISTRATION OF AGREEMENT. If local law requires the registration or recordation of this Agreement with any local governmental agency, administrative board or banking agency, Franchisee shall request BKC's consent to do so. If BKC grants its consent, Franchise shall effectuate such registration(s) or recordation(s) at its sole cost and expense in strict compliance with local laws as soon as possible.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEPENDENT CONTRACTOR\", \"level\": 2, \"text\": \"11.2 INDEPENDENT CONTRACTOR.\"}}, {\"id\": \"11.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO AGENCY\", \"level\": 3, \"text\": \"11.2.1 NO AGENCY. The franchisee is an independent business entity and is not an agent, partner, joint venture, representative, or employee of BKC, and no express or implied fiduciary relationship exists between the parties. The Franchisee shall not attempt to bind or obligate BKC in any way nor shall the Franchisee represent that the Franchisee has any right to do so. BKC shall have no control over the terms and conditions of employment of the Franchisee's employees.\"}}, {\"id\": \"11.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PUBLIC NOTICE OF INDEPENDENCE\", \"level\": 3, \"text\": \"11.2.2 PUBLIC NOTICE OF INDEPENDENCE. In all public records and in the Franchisee's relationship with other persons, on stationery, business forms and cheques, the Franchisee shall indicate the independent ownership of the Franchised Restaurant and that the Franchisee is a licensee of BKC. The Franchisee shall exhibit on the Location in such places as may be designated by BKC, a notification that the Franchised Restaurant is operated by an independent operator under license from BKC.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"UNFAIR COMPETITION\", \"level\": 1, \"text\": \"12. UNFAIR COMPETITION. The Franchisee agrees, during the term of this Agreement and thereafter, not to directly or indirectly engage in the operation of any restaurant, except as licensed by BKC, which utilizes or duplicates the Burger King System or any part thereof.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSURANCE, INDEMNIFICATION\", \"level\": 1, \"text\": \"13. INSURANCE, INDEMNIFICATION.\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL LIABILITY INSURANCE\", \"level\": 2, \"text\": \"13.1 GENERAL LIABILITY INSURANCE. Franchisee agrees to carry at its expense during the Term of this Agreement Comprehensive General Liability insurance, including Products Liability and Broad Form Contractual Liability, in an amount which is at all times the local equivalent of not less than One Million U.S. Dollars (U.S. $1,000,000.00) per occurrence for bodily injury and Five Hundred Thousand U.S. Dollars (U.S. $500,000.00) per occurrence for property damage, or in such increased amounts as BKC may reasonably request from time to time during the Term of this Agreement. Each policy will name BKC, and its subsidiaries, affiliated and parent companies as an additional insured, and will provide hat the policy cannot be canceled without thirty (30) days prior written notice to BKC, will insure against the liability of BKC for both its and Franchisee's acts or omissions, and will insure the contractual liability of Franchisee under paragraph 13.3 Additionally, Franchisee agrees to carry, at Franchisee's expense, umbrella coverage in an amount which is at all times the equivalent of One Million U.S. Dollars (U.S. $1,000,000) over the basic 18 Comprehensive General Liability insurance per restaurant; except that if Franchisee owns more than ten (10) Burger King Restaurants, the umbrella coverage applicable to all such restaurants need not exceed an mount which is at any time in excess of the equivalent of Ten Million U.S. Dollars (U.S. $10,000,000). The insurance afforded by the policy or policies respecting liability shall not exclude claims, actions or demands brought in the United States or anywhere else outside the country in which the Franchised Restaurant is located and shall not be limited in any way by reason of any insurance which may be maintained by BKC prior to the Commencement Date, Franchisee shall furnish to BKC Certificates of Insurance reflecting that the insurance coverage is in effect pursuant to the terms of this Agreement. All policies shall be renewed, and a renewal Certificate of Insurance mailed to BKC at its main office, or at such other location as may be specified by BKC prior to the expiration date of the policies. This obligation of Franchisee to maintain insurance is separate and distinct from its obligation to indemnify BKC under the provisions of Paragraph 13.3 and shall not be affected by reason of the negligence of or a claim of negligence against BKC.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WORKERS COMPENSATION, ETC\", \"level\": 2, \"text\": \"13.2 WORKERS COMPENSATION, ETC. Franchisee agrees to participate in any governmental Worker's Compensation Program, unemployment insurance program, hospitalization program and any other similar program which may be required by the laws of the country where the Franchised Restaurant is located.\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNITY\", \"level\": 2, \"text\": \"13.3 INDEMNITY. Franchisee is responsible for all losses or damages and contractual liabilities to third persons arising out of or in connection with possession, ownership or operation of the Franchised Restaurant, and for all claims or demands for damages to property or for injury, illness or death of persons directly or indirectly resulting therefrom. Franchisee agrees to defend, indemnify and save BKC, and its subsidiaries, affiliated and parent companies harmless of, from and with respect to any such claims, demands, losses, obligations, costs, expenses, liabilities, debts or damages, unless they are caused by the gross negligence of BKC itself BKC's right to indemnity under this Agreement shall arise and be valid notwithstanding that joint or concurrent liability may be imposed on BKC by statute, ordinance, regulation or other law. The indemnification of BKC by Franchisee for Franchisee's own negligence, acts or omissions, shall not be limited by the amount of insurance required under Paragraph 13.1, nor upon a claim that BKC is responsible for Franchisee's act or omissions or that Franchisee was acting in the capacity of an agent of BKC. This indemnity obligation shall include, but not be limited to, claims related to the employment of Franchisee's employees. This obligation of Franchisee to indemnify and defend BKC is separate and distinct from its obligation to maintain insurance under the provisions of Paragraph 13.1. BKC shall notify Franchisee of any claims, and Franchisee shall be given the opportunity to assume the defense of the matter, however, BKC shall have the right to participate in the defense of any claim or action against it which is assumed by Franchisee, at BKC's own cost and expense. If Franchisee fails to assume the defense, BKC may defend the action in the manner it deems 19 appropriate, and Franchisee shall pay to BKC all costs, including attorney's fees, incurred by BKC in effecting such defense, in addition to any sum which BKC may pay by reason of any settlement or judgment against BKC. No settlement of any claim against BKC shall be made by Franchisee which is in excess of the amount of insurance referred to in Paragraph 13.1 or which would subject BKC to liability in any amount not covered by such insurance without the prior written consent of BKC. Any final judicial determination of the negligence of BKC in an amount in excess of the policy limits of insurance required under Paragraph 13.1 shall be the responsibility of BKC.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TAXES\", \"level\": 1, \"text\": \"14. TAXES.\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT WHEN DUE\", \"level\": 2, \"text\": \"14.1 PAYMENT WHEN DUE. The Franchisee shall pay when due all taxes levied or assessed by reason of the Franchisee's possession, ownership or operation of the Franchised Restaurant or items loaned to the Franchisee by BKC including any value added tax. In the event of any bona fide dispute as to the liability for a tax assessed against it, the Franchisee may contest the validity or the amount of the tax in accordance with the procedures of the taxing authority, however, the Franchisee shall not permit a tax sale or seizure against the premises or equipment.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WITHHOLDING TAXES\", \"level\": 2, \"text\": \"14.2 WITHHOLDING TAXES. lt is understood and agreed by the parties that any and all tax liabilities arising out of this Agreement will be paid by the party owing such taxes. ln the event that BKC incurs withholding tax liability in the country in which the Franchised Restaurant is located as a result of the franchise fee or the royalty payments set forth above, it shall be the responsibility and obligation of the Franchisee to withhold from such franchise fee or royalty payments such withholding taxes as are required by law. The Franchisee shall provide BKC with corresponding receipts from the relevant taxing authorities to evidence such payments or amounts withheld. Taxes, such as income taxes of the Franchisee, which are based on profits from operation of the Franchised Restaurant are the sole responsibility of the Franchisee.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ELECTION\", \"level\": 2, \"text\": \"14.3 ELECTION. Where the law permits an election regarding the treatment of any supply or deemed supply under this Agreement for the purposes of any value added or other tax chargeable thereon, the Franchisee shall make or join in any such election as BKC may from time to time require.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPOSAL\", \"level\": 1, \"text\": \"15. DISPOSAL.\"}}, {\"id\": \"15.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRANSFER OF LNTEREST BY FRANCHISEE\", \"level\": 2, \"text\": \"15.1 TRANSFER OF LNTEREST BY FRANCHISEE. Except with the prior written consent of an authorized officer of BKC, Franchisee shall not (a) directly or indirectly sell, assign, convey, give away, mortgage, pledge, hypothecate, charge, or otherwise transfer or encumber its rights or obligations under this Agreement, or assign any of Franchisee's rights or delegate any of its duties hereunder; (b) sell, issue, offer, transfer, convey, give away, or otherwise 20 grant or deliver any additional equity interests in the Franchisee, or (c) sell, assign, transfer, convey, or give away substantially all of the assets of the Franchised Restaurant.\"}}, {\"id\": \"15.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRANSFER OF INTEREST BY PRINCIPALS\", \"level\": 2, \"text\": \"15.2 TRANSFER OF INTEREST BY PRINCIPALS. Except with the prior written consent of an authorized officer of BKC, no Principal shall directly or indirectly sell, assign, convey, give away, mortgage, pledge, hypothecate, charge, or otherwise transfer or encumber any legal or beneficial equity interest in Franchisee.\"}}, {\"id\": \"15.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICE OF PROPOSED TRANSFER\", \"level\": 2, \"text\": \"15.3 NOTICE OF PROPOSED TRANSFER. Any proposed transferor shall notify BKC in writing of any proposed transfer of an interest referred to in Paragraph 15.1 or 15.2, as applicable, before the proposed transfer is to take place, and shall provide such information and documentation relating to the proposed transfer as BKC may reasonably require.\"}}, {\"id\": \"15.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RIGHT OF FIRST REFUSAL\", \"level\": 2, \"text\": \"15.4 RIGHT OF FIRST REFUSAL.\"}}, {\"id\": \"15.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICE; EXERCISE OF OPTION\", \"level\": 3, \"text\": \"15.4.1 NOTICE; EXERCISE OF OPTION. In the event Franchisee or the Principals wish to accept a bona fide offer from a third party to purchase all or substantially all of the assets constituting the Franchised Restaurant or of the majority of the voting stock of the Franchisee, the proposed transferor(s) shall give BKC written notice setting forth the name and address of the prospective purchaser, the price and terms of the offer together with a franchisee application completed by the prospective purchaser, a copy of the Purchase and Sale Agreement, executed by both the seller and purchaser, and all exhibits, copies of any real estate purchase agreement or agreements, proposed security agreements and related promissory notes, assignment documents, and any other information that BKC may request in order to evaluate the offer. BKC or its designee shall then have the prior option to purchase the interests covered by the offer at the price and upon the same terms of the offer. If the consideration is not money, the purchase price shall be the cash equivalent of the fair market value of the consideration. BKC shall have twenty (20) business days after receipt of the notice of offer and the furnishing of all reasonably requested information within which to notify Franchisee or the owners, as applicable, of BKC's intent to exercise its right hereunder. Silence on the part of BKC shall constitute rejection. If BKC rejects the offer, Franchisee shall have 90 days to sell the Franchised Restaurant upon the terms offered to BKC, subject to the approval of BKC a s required below. If the proposed sale includes assets of Franchisee not related to the operation of franchised Burger King Restaurants, BKC may, at its option, elect to purchase only the assets related to the operation of franchised Burger King Restaurants and an equitable purchase price shall be allocated to each asset included in the proposed sale. A bona fide offer from a third party includes any transfer, conveyance, assignment, consolidation, merger or any other transaction in which legal or beneficial ownership of the franchise granted by this Agreement is vested in other than the Franchisee. 21\"}}, {\"id\": \"15.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO WAIVER\", \"level\": 3, \"text\": \"15.4.2 NO WAIVER. The election by BKC not to exercise its right of first refusal as to any offer shall not affect its right of first refusal as to any subsequent offer.\"}}, {\"id\": \"15.4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"UNAUTHORIZED TRANSFER VOID\", \"level\": 3, \"text\": \"15.4.3 UNAUTHORIZED TRANSFER VOID. Any sale, attempted sale, assignment, or other transfer of the interests described in Subparagraph 15.4.1 without first giving BKC the right of first refusal described above shall be void and of no force and effect, and shall constitute an Event of Default under Paragraph 17.1(k).\"}}, {\"id\": \"15.4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SALE; BKC CONSENT\", \"level\": 3, \"text\": \"15.4.4 SALE; BKC CONSENT. If BKC does not exercise its option under Subparagraph 15.4.1, Franchisee may conclude the sale to the purchaser who made the offer provided BKC's consent to the assignment or sale be first obtained as provided below.\"}}, {\"id\": \"15.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRANSFER OF SUBSTANTIALLY ALL ASSETS OR TRANSFER OF STOCK BY PRINCIPAL\", \"level\": 3, \"text\": \"15.5.1 TRANSFER OF SUBSTANTIALLY ALL ASSETS OR TRANSFER OF STOCK BY PRINCIPAL. Reasonable conditions in connection with (i) a transfer of the Franchisee's rights under this Agreement, the transfer of substantially all of the Franchisee's assets, or the delivery or grant of any additional equity securities, all pursuant to Subparagraph 15.1 above, or (ii) the transfer of the shares of the Franchisee pursuant to Subparagraph 15.2 above, shall include, without limitation, each of the following: (a) All of the Franchisee's accrued monetary obligations to BKC and its Affiliates must be paid at the time of the transfer; (b) The Franchisee must not be in default under this Agreement or any other agreement with BKC or its Affiliates at the time of transfer; (c) The transferee (and, if applicable, all owners of the transferee), must complete BKC's then current franchisee application procedures and meet all of BKC's then current criteria for approval as a BKC franchisee, including financial, character, managerial, credit, operational, and legal standards; (d) The transferee (and, if applicable, all owners of the transferee) must at BKC's option enter into (i) a written agreement, in a form acceptable to BKC, assuming (or guaranteeing) full performance of all obligations of the Franchisee under this Agreement, (ii) a substitute Franchise Agreement, for a term ending on the expiration date of this Agreement, in BKC's 22 then current form, except that royalty and advertising contribution or expenditure rates shall be the same as are provided for in this Agreement, and (iii) such ancillary agreements as BKC may require; (e) The Franchisee (and, if applicable, each owner of the Franchisee) must execute a general release, in a form acceptable to BKC, of any and all claims against BKC, its Affiliates, and their respective officers, directors, agents, and employees; (f) The transferee, its Director of Operations, and its Restaurant Manager must complete, at the transferee's expense, any applicable orientation and training programs required by BKC at the time of transfer; (g) BKC shall approve the terms and conditions of the sale which affect the sufficiency of cash flow from the business after payment of debt service necessary for reinvestment in the business for refurnishing, maintaining, and remodeling the Location; (h) The transferor must pay the transfer fee set forth on SCHEDULE 1 in consideration of BKC's expenses in reviewing the proposed transfer; (i) The transferee must meet with representatives of BKC in Miami, Dade County, Florida, U.S.A., or such other location as may be designated by BKC; (j) The Franchisee shall execute all documents necessary to cancel the entries of the Franchisee as a registered user and shall cooperate with BKC in effecting the cancellation of entries with the relevant registry of the Franchisee as a registered user. (k) The transferee shall, if BKC requests, enter into one or more registered user agreements authorizing and permitting the use of the Burger King Marks referred to in the agreements. (l) The transferor shall be jointly and severally liable with the transferee (and, if applicable, each owner of the transferee) to BKC for future royalty and advertising payments due under this Agreement if and so long as any part of the purchase money consideration remains owing from the transferee to the transferor.\"}}, {\"id\": \"15.5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SECURITIES OFFERINGS\", \"level\": 3, \"text\": \"15.5.2 SECURITIES OFFERINGS. Franchisee represents and agrees that:\"}}, {\"id\": \"15.5.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH BKC REQUIREMENTS\", \"level\": 4, \"text\": \"15.5.2.1 COMPLIANCE WITH BKC REQUIREMENTS. In connection with any future offerings of debt or equity securities, Franchisee will comply with all of BKC's then current requirements with respect to such offerings. Without limiting the foregoing, in addition to BKC's then-current requirements 23 applicable to BKC's franchisees and their principals (or owners) generally, the requirements applicable to Franchisee will include the following: immediate written notice to BKC of any proposed securities offering (which notice in any event shall be no later than the time when a proposed letter of intent, memorandum of understanding or similar document is exchanged with any person respecting the underwriting or placement of securities of the Franchisee); submission, before or simultaneously with submission to the U.S. Securities and Exchange Commission (\\\"SEC\\\"), (or similar governmental agency of any other jurisdiction in which securities are offered), of registration statements and/or prospectuses to BKC for review in connection with trademark usage, inclusion of disclaimers, and otherwise; the execution by the principals and by underwriters, if any, of certificates required by BKC, and the execution of the Franchisees and the Principals of an indemnity of BKC, its affiliates, agents, attorneys and employees against any liability arising from or in connection with the offering. Within ten (10) business days after BKC's receipt of a copy of a registration statement filed with the SEC and which BKC wishes to review, BKC shall furnish the Franchisee with its comments, if any, on the prospectus, provided that failure of BKC to comment shall not relieve the Franchisee of its obligations to include in every prospectus such disclaimers as are required by BKC. BKC's then-current general requirements for offerings of equity securities shall also apply to offerings of debt securities by the Franchisee unless and until separate requirements are articulated by BKC for debt and equity securities offerings.\"}}, {\"id\": \"15.5.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUBMISSION TO BKC\", \"level\": 4, \"text\": \"15.5.2.2 SUBMISSION TO BKC. Franchisee shall simultaneously file with BKC all reports and other documents that Franchisee may be required to file with the SEC pursuant to the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, or with, any governmental agency pursuant to the laws and regulations of any other jurisdiction in which securities are offered, as and when due.\"}}, {\"id\": \"15.5.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REGISTRATION RIGHTS\", \"level\": 4, \"text\": \"15.5.2.3 REGISTRATION RIGHTS: SECONDARY OFFERINGS. Franchisee agrees that it will not grant additional registration rights or modify any registration rights previously granted without prior written notice to BKC. The Franchisee further agrees that if it is required to effect a registration pursuant to any registration rights previously granted, then, in connection with any secondary offering of securities pursuant to such registration, it shall comply with BKC's then-current requirements, policies and procedures in connection with such offering and, without limiting the foregoing, shall indemnify BKC from liability arising from or in connection with the Offering, in the same manner as would be required in connection with an offering of securities by the Franchisee.\"}}, {\"id\": \"15.5.2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BKC EXPENSES\", \"level\": 4, \"text\": \"15.5.2.4 BKC EXPENSES. The Franchisee must, in connection with any proposed offering of securities requiring the review or consent of BKC, agree to pay BKC for certain of BKC's internal and external costs in connection with its review of the proposed securities offering. 24\"}}, {\"id\": \"15.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CERTAIN EXCEPTIONS\", \"level\": 3, \"text\": \"15.5.3 CERTAIN EXCEPTIONS. Notwithstanding any other provision of this agreement, the Franchisee shall not be required to submit to BKC for its review and comment any \\\"S-3\\\" or \\\"S-8\\\" filing by the Franchisee with the SEC, and the Franchisee shall not be required to obtain the prior written consent of BKC in connection with an issuance of securities pursuant to an S-8 filing with the SEC so long as the securities issued pursuant to such filing represent, per offering: (i) through December 31, 1998, less than three (3%) percent of the securities of that class issued and outstanding, and (ii) after December 31, 1998, less than one percent (1%) of the securities of that class issued and outstanding.\"}}, {\"id\": \"15.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO WAIVER\", \"level\": 2, \"text\": \"15.6 NO WAIVER. BKC's consent to a transfer shall not constitute a waiver of any claims it may have against the transferring party, nor shall it be deemed a waiver of BKC's right to demand exact compliance with any of the terms of this Agreement by the transferor or transferee.\"}}, {\"id\": \"15.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CORPORATE DOCUMENTS\", \"level\": 2, \"text\": \"15.8 CORPORATE DOCUMENTS. The articles of incorporation, the bylaws and each stock certificate of the Franchisee must at all times provide that the issuance and transfer of shares in the Franchisee are restricted as provided above and may be done only in accordance with the terms and conditions of this Agreement.\"}}, {\"id\": \"15.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT BY BKC\", \"level\": 2, \"text\": \"15.9 ASSIGNMENT BY BKC. BKC may assign this Agreement to any person or company which acquires its Burger King business in the territory in which the Franchised Restaurant is located or a substantial part thereof, whether by outright acquisition or by way of a master franchise agreement. 25\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE PRINCIPALS\", \"level\": 1, \"text\": \"16. THE PRINCIPALS.\"}}, {\"id\": \"16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"STOCK OWNERSHIP\", \"level\": 2, \"text\": \"16.1 STOCK OWNERSHIP. The Principals represent and warrant to BKC that SCHEDULE 2 contains a complete list of their respective shareholdings in the Franchisee on the date of this Agreement and that, unless otherwise stated, the Principals are the beneficial owners of their respective shares.\"}}, {\"id\": \"16.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE BY PRINCIPALS\", \"level\": 2, \"text\": \"16.2 COMPLIANCE BY PRINCIPALS. Each Principal shall comply with the covenants, terms, conditions and acknowledgments contained in the following sections as if it were the party named therein in place of the Franchisee: Section 11 (Limitations of Franchise); Section 12 (Unfair Competition); Section 15 (Disposal); and Section 18 (Restrictive Covenant). Notwithstanding any other provision of this Agreement, including without Imitation Sections 15.1 and 15.5, so long as international Fast Food Corporation, (\\\"IFFC\\\") is a Principal of the Franchisee, BKC will not unreasonably withhold its consent to the sale or issuance of additional equity securities in IFFC provided that IFFC has complied with all reasonable conditions then established by BKC in connection with the proposed sale or issuance of equity securities by IFFC.\"}}, {\"id\": \"16.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GUARANTY\", \"level\": 2, \"text\": \"16.3 GUARANTY. Each Principal hereby agrees to jointly, severally, and unconditionally guaranty the payment and performance of all debts, obligations and liabilities of the Franchisee to BKC arising pursuant to this Agreement, or any other agreement with BKC relating directly or indirectly to the Franchised Restaurant (the \\\"BKC Agreements\\\"), together with all costs of collection, compromise or enforcement, including reasonable attorneys' fees, incurred with respect to any such debts, obligations or liabilities or with respect to this or any other guaranty thereof or any bankruptcy proceeding or other similar action affecting the rights of the Franchisee's creditors generally (all of the foregoing being referred to collectively as the \\\"Obligations\\\"). This guaranty by the Principals shall continue in full force and effect until the Franchisee has fully paid and performed all of the Obligations. In connection with the guaranties set forth above (collectively, the \\\"Guaranties\\\"), each of the parties to this Agreement hereby agrees as follows: (a) The Guaranties shall not be impaired by any modification, supplement, extension or amendment of the BKC Agreements or any of the Obligations, nor by any modification, release or other alteration of any of the Obligations hereby guaranteed, nor by any agreements or arrangements whatever with the Franchisee or any one else; (b) The liability of each Principal is primary, direct and unconditional and may be enforced without requiring BKC first to resort to any other right, remedy or security; 26 (c) No Principal shall have any right of subrogation, repayment, reimbursement or indemnity whatsoever, unless and until the Obligations are paid or performed in full and all debts owed by the Franchisee to any Principal are hereby subordinated to the Obligations; (d) If any Principal should at any time die, become incapacitated, become insolvent or make a composition, trust mortgage or general assignment for the benefit of creditors, or if a bankruptcy proceeding or any action under a similar law affecting the rights of creditors generally shall be filed or commenced by, against o r in respect of any Principal, any and all obligations of that Principal shall, at BKC's option, immediately become due and payable without notice, (e) If any payment or transfer to BKC which has been credited against any Obligation, is voided or rescinded or required to be returned by BKC, whether or not in connection with any event or proceeding described in Section 16.3(d), the Guaranties shall continue in effect or be reinstated as though such payment, transfer or recovery had not been made; (f) Except as otherwise provided in this Agreement, each of the Guaranties shall be construed as an absolute, unconditional, continuing and unlimited obligation of each Principal without regard to the regularity, validity or enforceability of any of the Obligations, and without regard to whether any Obligation is limited, modified, voided, released or discharged in any proceeding under any law affecting the rights of creditors generally; (g) Any termination of the Guaranties shall be applicable only to Obligations accruing after the termination or having their inception after the effective date of such termination and shall not affect Obligations having their inception prior to such date; (h) The death or incapacity of any Principal hereunder shall not result in the termination of the Guaranties; (i) Any and all present and future debts and obligations of the Franchisee to any Principal hereunder are hereby waived an id postponed in favor of and subordinated to the full payment and performance of the Obligations; and (j) Each Principal waives to the greatest extent permitted by law: notice of acceptance hereof; presentment and protest of any instrument, and notice thereof; notice of default; notice of foreclosure; notice of any modification, release or other alteration of any of the Obligations or of any security therefor and all other notices to which any Principal might otherwise be entitled. 27\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFAULT AND EFFECTS OF TERMINATION\", \"level\": 1, \"text\": \"17. DEFAULT AND EFFECTS OF TERMINATION.\"}}, {\"id\": \"17.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EVENTS OF DEFAULT BY FRANCHISEE\", \"level\": 3, \"text\": \"17.1.1 EVENTS OF DEFAULT BY FRANCHISEE. Franchisee shall be in default under this Agreement upon the occurrence of any of the following events or conditions (individually, an \\\"Event of Default\\\" and collectively, the \\\"Events of Default\\\"): (a) If the Franchisee fails to pay when due any amount owed to BKC under this Agreement, and does not cure such failure within ten (10) days of delivery of written notice of such failure. (b) If the Franchisee fails to operate the Franchised Restaurant in full compliance with the terms of this Agreement and the MOD Manual (including without limitation the provisions regarding product specifications, cleanliness, health, sanitation and the use of the Burger King Marks), and does not cure such failure wh thin ten (10) days of delivery of written notice of such failure. (c) If the Franchisee fails to maintain the Franchised Restaurant in conformance with the Current Image as required by Sections 5.3.1 and 5.3.2 hereof, or to remodel, improve and alter the Franchised Restaurant as required in Section 5.3.3 hereof, and does not cure such failure within ninety (90) days of delivery of written notice of such failure. (d) If the Franchisee challenges the validity or ownership of the Burger King Marks or BKC's ownership rights to the Burger King System. (e) If the Franchisee fails to continuously operate the Franchised Restaurant as required by Section 2.4 of this Agreement. (f) If the Franchisee fails to continuously occupy the Location throughout the term of this Agreement, unless such failure is attributable to a proper exercise of governmental authority. (g) If the Franchisee should at any time become insolvent or make a composition, trust mortgage or general assignment for the benefit of creditors, or if a bankruptcy proceeding, receivership or any action under any similar law affecting the rights of creditors generally shall be filed or commenced by, against or in respect of the Franchisee or any portion of its property. (h) If the Franchisee makes any materially false statement in connection with any report of Gross Sales or in any other financial statement required hereby, other than an obvious and unintentional error. (i) If the Franchisee commits \\\"persistent breaches\\\" of the terms of this Agreement (whether or not material in isolation) after written 28 notice of such breaches has been delivered by BKC, any three breaches occurring within a period of six months shall be deemed to constitute \\\"persistent breaches.\\\" (j) If the Franchisee for any reason other than an improper act or breach by BKC ceases to be entitled to remain registered as a registered user of any of the Burger King Marks. (k) If any events occur which are contrary to Section 15 hereof. (l) If the Franchisee engages in activities prohibited by Section 12 (Unfair Competition) or Section 18 (Restrictive Covenant), or discloses any trade secrets of BKC in violation of Section 11 (Limitations of Franchise). (m) If the Franchisee or any of its affiliates is in breach of any other obligation owed to BKC or any of its Affiliates whether under this or any other agreement. (n) If the Franchisee has knowingly made false or misleading statements in order to obtain execution of this Agreement by BKC. (o) If the Franchisee or any of its officers or directors is convicted of a criminal offense punishable by a term of imprisonment in excess of two (2) years. (p) The Franchisee fails to perform any obligation under this Agreement which is not capable of cure. (q) If the Franchisee fails to perform any other obligation under this Agreement and does not cure such failure within thirty (30) days of written notice of such failure. (r) If any of the above occurs in relation to any Principal.\"}}, {\"id\": \"17.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EVENT OF BKC DEFAULT\", \"level\": 3, \"text\": \"17.2.1 EVENT OF BKC DEFAULT. BKC shall be in default under this Agreement if BKC fails to perform any of its obligations under this Agreement and does not cure such failure within sixty (60) days of written notice of such failure (an \\\"Event of BKC Default\\\").\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION\", \"level\": 2, \"text\": \"17.2 TERMINATION. Upon the occurrence of an Event of Default, this Agreement shall automatically terminate without any further notice or opportunity to cure under Section 17.1.1 above and BKC shall, subject to the provisions of Subsection 17.6 below, have the right to claim lost royalties and advertising contributions, and shall also have all other rights and remedies available under applicable law. Upon the occurrence of an Event of BKC Default under Section 17.1.2., this Agreement shall automatically terminate without further notice or opportunity to cure and the Franchisee shall have all other 29 rights and remedies available under applicable law. Subject to the provisions of Section 17.6 below, the rights of the parties set forth in this Section 17.2 shall be in addition to any other rights the parties may have under applicable law.\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECT OF TERMINATION\", \"level\": 2, \"text\": \"17.3 EFFECT OF TERMINATION. Upon expiration or termination for any reason of this Agreement, the Franchisee's right to use the Burger King Marks and the Burger King System shall terminate. The Franchisee shall not thereafter identify itself as a Burger King franchisee or former Burger King franchisee or use, any of BKC's trade secrets, operating procedures, promotional materials, Burger King Marks or any marks confusingly similar. The Franchisee will immediately return to BKC the MOD Manual loaned to the Franchisee including any translations thereof, together with all other materials containing trade secrets, restaurant operating instructions or business practices of BKC. Where applicable, BKC shall be entitled to take all steps necessary for the cancellation of the entries of the Franchisee with the Registrar of Trademarks, or its equivalent authority, as a registered user without opposition or hindrance of the Franchisee. The Franchisee will, at the request and cost of BKC, cooperate in any such steps.\"}}, {\"id\": \"17.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"POST-TERMINATION OPTION\", \"level\": 2, \"text\": \"17.4 POST-TERMINATION OPTION. The Franchisee grants to BKC or its designee upon termination or expiration of this Agreement, the option to purchase all usable paper goods, containers and printed menus bearing any of the Burger King Marks or trade names at the price paid by the Franchisee and to purchase the Franchisee's restaurant equipment, furniture, fixtures and signs at fair market value.\"}}, {\"id\": \"17.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"POST-TERMINATION OBLIGATIONS OF FRANCHISEE\", \"level\": 2, \"text\": \"17.5 POST-TERMINATION OBLIGATIONS OF FRANCHISEE.\"}}, {\"id\": \"17.5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OPTIONS TO PURCHASE LOCATION\", \"level\": 3, \"text\": \"17.5.1 OPTIONS TO PURCHASE LOCATION. Upon termination or expiration of this Agreement, if the parties do not enter into a successor Franchise Agreement whereby the Franchisee shall continue to be a franchisee and operate the Franchised Restaurant at the Location, BKC or its designee shall have the option subject to obtaining any necessary governmental consent: (a) To purchase the Location and/or any related equipment at fair market value, if the Franchisee, any of the Principals or an affiliate of the Franchisee owns the Location and/or related equipment. (b) If the Location is leased by the Franchisee, any of the Principals or an affiliate of the Franchisee, subject to obtaining any necessary landlord's consent, to obtain an assignment of the leasehold interest at a price equal to the fair market value of the leasehold interest.\"}}, {\"id\": \"17.5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEIDENTIFICATION\", \"level\": 3, \"text\": \"17.5.2 DEIDENTIFICATION. If BKC or its designee do not exercise this option the Franchisee agrees to immediately make such removals or changes in 30 signs and the building as BKC shall request so as to effectively distinguish the Location from its former appearance and from any other Burger King Restaurant.\"}}, {\"id\": \"17.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BKC LIEN\", \"level\": 3, \"text\": \"17.5.3 BKC LIEN. To secure payment of any damages in the event of termination as a result of the Franchisee's default, BKC shall have a lien, on the personal property, machinery, fixtures and equipment owned by the Franchisee at the Location at the time of such default.\"}}, {\"id\": \"17.5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ACCELERATION OF PAYMENTS\", \"level\": 3, \"text\": \"17.5.4 ACCELERATION OF PAYMENTS. All monies owed by Franchisee to BKC shall be immediately due and payable upon term nation.\"}}, {\"id\": \"17.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPUTE RESOLUTION\", \"level\": 2, \"text\": \"17.6 DISPUTE RESOLUTION. (a) Subject to subparagraph (b) below, all controversies, disputes or claims arising between the Franchisee, the Principals, and their respective shareholders, officers, directors, agents and employees (in their respective capacity) (collectively, the \\\"Franchisee Parties\\\") and BKC arising out of or related to the relationship of the parties hereto, this Agreement or any provision hereof, any related agreement (including any development agreement), the validity of this Agreement or any provision hereof or the operation of the Franchised Restaurant shall be submitted to and settled by arbitration in the City of New York in accordance with the Commercial Arbitration Rules of the American Arbitration Association (\\\"AAA\\\") then obtaining. Such arbitration proceedings shall be conducted before a panel of three (3) arbitrators. The Franchisee Parties shall l appoint one arbitrator, between them, BKC shall each appoint one arbitrator and the two arbitrators so appointed shall appoint a third arbitrator to act as Chair. If said two arbitrators fail to nominate the Chair within thirty (30) days from the date of appointment of the second arbitrator to be appointed, the Chair shall be appointed by the AAA. Unless otherwise provided in this Paragraph, all matters within the scope of the Federal Arbitration Act of the United States of America (9 U.S.C. ss.ss.1 et seq.) shall be governed by it. The arbitrators shall have the right to award or include in their award any relief which they deem proper in the circumstances, including with out limitation, money damages (with interest on unpaid amounts from date due), specific performance, injunctive relief, legal fees and costs, provided that the arbitrators shall not award exemplary or punitive damages. The award and decision of the arbitrators shall be conclusive and binding upon the Franchisee Parties and BKC and judgment upon the award may be entered in any court of competent jurisdiction. The Franchisee Parties and BKC further expressly agree and consent to the jurisdiction of the courts of the State of New York for the purpose of entering judgment upon any such award of the arbitrators. The Franchisee Parties and BKC further agree to be bound by the provisions of any applicable limitation on the period of time in which claims must be brought under applicable law or this Agreement, whichever is less. The parties further agree that in connection with any such arbitration proceeding, they shall submit or file any claim which would constitute a compulsory counterclaim (as defined by Rule 13 of the United States Federal Rules of Civil 31 Procedure) within the same proceeding as the claim to which it relates. Any such claim which is not submitted or filed as described above shall be barred. This provision shall continue in full force and effect subsequent to and notwithstanding expiration or termination of this Agreement. (b) Notwithstanding subparagraph (a) above, BKC shall be entitled to seek the entry of temporary or preliminary injunctions, restraining orders and orders of specific performance enforcing the provisions of this Agreement or any development agreement relating to the use of BKC's Marks or proprietary in \\\"formation by the Franchisee or any Principal upon the termination or expiration of this Agreement or any development agreement. The Franchisee's (or the Principal's) only remedy if an injunction is so entered will be the dissolution of that injunction, if warranted, upon due hearing, all other claims being subject to arbitration under subparagraph (a) above.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESTRICTIVE COVENANT\", \"level\": 1, \"text\": \"18. RESTRICTIVE COVENANT. Neither the Principals nor the Franchisee shall directly or indirectly (through stock ownership, partnership, trust, joint venture, management contract, or otherwise) (a) have any interest in another \\\"Fast Food Hamburger Restaurant\\\" during the term of this Agreement, or (b) for a period of one ye ar after termination or expiration of this Agreement, have any interest in another Fast Food Hamburger Restaurant business at or within such distance of the Location as is stated SCHEDULE 1. For purposes of this Section, \\\"Fast Food Hamburger Restaurant\\\" shall mean any restaurant which (a) has hamburgers or hamburger based products which account for 50(degree)/o or more of total menu items or total Gross Sales, and (b) does not offer table service as the principal method of ordering or food delivery\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"19. MISCELLANEOUS: GENERAL CONDITION.\"}}, {\"id\": \"19.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTERPRETATION\", \"level\": 2, \"text\": \"19.1 INTERPRETATION. The Introduction shall be considered a part of this Agreement. Paragraph headings are used only for convenience and do not form part of this Agreement. A covenant on the part of the Franchisee not to do something includes a covenant not to permit others to do it; any right given to BKC includes the right to do it through servants or agents or third party contractors or to do it in conjunction with its servants, agents or third party contractors and includes any necessary rights of access. To the extent of any inconsistency, this Agreement prevails over the MOD Manual. References to the parties shall include their heirs, successors in title and assigns.\"}}, {\"id\": \"19.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NON-WAIVER\", \"level\": 2, \"text\": \"19.2 NON-WAIVER. The failure of BKC to exercise any right or option given to it hereunder, or to insist upon strict compliance by the Franchisee or the Principals or any person comprising the Franchisee or the Principals with the terms of this Agreement, shall not constitute a waiver of any terms or conditions of this Agreement with respect to any other or subsequent breach, nor a waiver by BKC of its right at any time thereafter to require exact and strict compliance with all the terms of this Agreement. The rights or remedies set forth in this Agreement are in addition to any other rights or remedies which may be granted by law. 32\"}}, {\"id\": \"19.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSES, PERMITS, ETC\", \"level\": 2, \"text\": \"19.4 LICENSES, PERMITS, ETC. The Franchisee shall obtain and maintain all licenses and other permits required by the law of the governing bodies where the Franchised Restaurant is located and shall comply with all local governmental requirements relating to the construction, equipping and operation of the building and the preparation and sale of items in the Franchised Restaurant.\"}}, {\"id\": \"19.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"19.5 COMPLIANCE WITH LAWS. Notwithstanding anything herein to the contrary, the Franchisee shall operate the Franchised Restaurant in a lawful manner and faithfully comply with the applicable laws, regulations or legitimate administrative requirements of national, regional, and municipal governing bodies or other political subdivisions in which the Franchised Restaurant is located.\"}}, {\"id\": \"19.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REMEDIES\", \"level\": 2, \"text\": \"19.6 REMEDIES. If the Franchisee breaches this Agreement, BKC shall be entitled to injunctive relief in addition to all other rights and remedies available under Section 17.2 of this Agreement.\"}}, {\"id\": \"19.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"19.7 SEVERABILITY. The parties agree that if any provisions of this Agreement may be construed in two ways, one of which would render the provision illegal or otherwise voidable or unenforceable, and the other of which would render the provision valid and enforceable, such provision shall have the meaning which renders it valid and enforceable. The language of all provisions of this Agreement shall be construed according to its fair meaning and not strictly against any party. It is the intent of the parties that the provisions of this Agreement be enforced to the fullest extent and should any court or other public agency determine that any provision herein is not enforceable as written in this Agreement, the provision shall be amended so that it is enforceable to the fullest extent permissible under the laws and public policies of the jurisdiction in which the enforcement is sought. The provisions of this Agreement are severable and this Agreement shall be interpreted and enforced as 33 if all completely invalid or unenforceable provisions were not contained in the Agreement, and partially valid and enforceable provisions shall be enforced to the extent that they are valid and enforceable.\"}}, {\"id\": \"19.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 2, \"text\": \"19.8 NOTICES.\"}}, {\"id\": \"19.8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICE TO BKC\", \"level\": 3, \"text\": \"19.8.1 NOTICE TO BKC. All notices to BKC shall be written in English and shall be sent by facsimile and hand delivered in person or by courier or sent by registered airmail, postage fully prepaid, addressed to BKC at 17777 Old Cutler Road, Miami, Florida 33157, U.S.A., Attention: General Counsel, Facsimile number (305) 378-7230, or at such other address as BKC shall from time to time designate in writing.\"}}, {\"id\": \"19.8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICE TO FRANCHISEE/PRINCIPALS\", \"level\": 3, \"text\": \"19.8.2 NOTICE TO FRANCHISEE/PRINCIPALS. All notices to the Franchisee or the Principals shall be written in English and shall be sent by facsimile and hand delivered in person or by courier, or sent by airmail, postage fully prepaid, and shall be addressed to the Franchisee and/or the Principals at the Franchised Restaurant premises, or the Franchisee's last known mailing address if the Franchised Restaurant has ceased operations, with a copy delivered to the Principal's address (but only so long as International Fast Food Corporation is the sole Principal).\"}}, {\"id\": \"19.8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DELIVERY\", \"level\": 3, \"text\": \"19.8.3 DELIVERY. Notices which are sent by mail shall be deemed delivered on the earlier of actual receipt or the tenth (10th) day after being deposited in the mail. Notices sent by hand shall be deemed delivered upon actual receipt.\"}}, {\"id\": \"19.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LANGUAGE\", \"level\": 2, \"text\": \"19.9 LANGUAGE. This Agreement is in the English language only, which language shall be controlling in all respects.\"}}, {\"id\": \"19.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MODIFICATION\", \"level\": 2, \"text\": \"19.10 MODIFICATION. This Agreement may only be modified or amended by a written document signed by the parties.\"}}, {\"id\": \"19.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BINDING EFFECT\", \"level\": 2, \"text\": \"19.11 BINDING EFFECT. This Agreement shall be binding upon the parties, their heirs, executors, personal representatives, successors or assigns.\"}}, {\"id\": \"19.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CURRENCY\", \"level\": 2, \"text\": \"19.12 CURRENCY. Unless otherwise provided all payments required under this Agreement shall be made in United States currency in the U.S.A.\"}}, {\"id\": \"19.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SURVIVAL\", \"level\": 2, \"text\": \"19.13 SURVIVAL. Any provisions of this Agreement which impose an obligation after termination or expiration of this Agreement shall survive the termination or expiration of this Agreement and remain binding on the parties.\"}}, {\"id\": \"19.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AGENCY\", \"level\": 2, \"text\": \"19.14 AGENCY. BKC shall be entitled to entrust the performance of any of its obligations under this Agreement to an Affiliate, and any notice required to be given by BKC shall be validly given if given by an Affiliate. 34\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"20. ENTIRE AGREEMENT. This Agreement together with any formal Development or Target Reservation Agreement constitutes the entire agreement of the parties and supersedes all prior negotiations, commitments, representations, warranties, and undertaking of the parties (if any) with respect to the subject matter of this Agreement and to the Franchised Restaurant. No term or condition shall be implied into this Agreement in derogation of, or in a manner which is inconsistent with or alters, the express terms set forth in this Agreement.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEPENDENT ADVICE\", \"level\": 1, \"text\": \"21. INDEPENDENT ADVICE. THE FRANCHISEE AND EACH PRINCIPAL ACKNOWLEDGE THAT THEY HAVE BEEN ADVISED BY BKC OR ITS AGENTS TO TAKE INDEPENDENT PROFESSIONAL ADVICE ON ALL ASPECTS OF THIS AGREEMENT AND THE BURGER KING BUSINESS AND THAT THEY HAVE TAKEN SUCH INDEPENDENT ADVICE AS THEY DEEM NECESSARY AND HAVE INDEPENDENTLY SATISFIED THEMSELVES ON ALL RELEVANT MATTERS RELATING TO THIS AGREEMENT AND THE OPERATION OF BURGER KING RESTAURANTS BEFORE ENTERING INTO THIS AGREEMENT. The parties have executed this Agreement as of the date indicated on page one. BURGER KING CORPORATION By: /S/ Mark Gerasi ---------------------------------- Vice President Attest: /S/ Kim A. Goodhard ---------------------------------- Assistant Secretary (Corporate Seal) INTERNATIONAL FAST FOOD POLSKA SP ZO.O (the \\\"Franchisee\\\") By: /S/ Mitchell Rubinson ---------------------------------- Name: Mitchell Rubinson -------------------------------- Position: President ---------------------------- 35 THE PRINCIPAL: INTERNATIONAL FAST FOOD CORPORATION By: /S/ Mitchell Rubinson ---------------------------------- Name: Mitchell Rubinson -------------------------------- Position: President ---------------------------- 36\"}}, {\"id\": \"SCHEDULE 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TO FRANCHISE AGREEMENT ---------------------------------\", \"level\": 1, \"text\": \"SCHEDULE 1 TO FRANCHISE AGREEMENT --------------------------------- The Franchisee: INTERNATIONAL FAST FOOD POLSKA SP ZO.0 The Principals: INTERNATIONAL FAST FOOD CORPORATION \\\"The Location\\\": means all the land, and any buildings from time to time thereon, known as -------------------------------------- __________________________ and more particularly delineated in the plan attached to the Franchisee's real estate package as finally approved by BKC. Director of Operations (name): ______________________________________ Managing Director (name): ______________________________________ Initial Franchise Fee: U.S. $______________________ Royalty percentage: 5% ------- Advertising percentage: 6% ------- Term: __________ (____) years Hours of Operation: 11:00 a.m. to 11:00 p.m. daily Transfer payment fee: U.S. $10,000 ---------------- Radius of restrictive covenant: Two Kilometers ---------------- Governing Law: State of New York, U.S.A. -------------------------- 37\"}}, {\"id\": \"SCHEDULE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TO FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"SCHEDULE 2 TO FRANCHISE AGREEMENT Shares of the Franchisee owned by the Principals: ================================================================================ | Number of | Class of | % of Class of | % of Total Principal | Shares | Shares | Shares | Shares - -----------------|--------------|-----------|-----------------|----------------- International | | | | Fast Food | | | | 80% Corporation | | | | - -----------------|--------------|-----------|-----------------|----------------- | | | | | | | | - -----------------|--------------|-----------|-----------------|----------------- | | | | | | | | ================================================================================ 38 EXHIBIT \\\"A\\\" TO FRANCHISE AGREEMENT POLAND TRADEMARKS ----------------- Marks registered in Poland: Date of Classes Reg. No. Registration ------- -------- ------------ Burger King Logo 16,29,30,32,42 7441 18 Feb., 1994 Whopper 16,29,30,32,42 7441 18 Feb., 1994 Burger King Wordmark 16,29,30,42 7442 18 Feb., 1994 39\"}}, {\"id\": \"party:BURGER KING CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"BURGER KING CORPORATION\", \"role\": \"Franchisor\", \"address\": \"17777 Old Cutler Road, Miami, Florida, United States of America\"}}, {\"id\": \"party:INTERNATIONAL FAST FOOD POLSKA SP ZO.0\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"INTERNATIONAL FAST FOOD POLSKA SP ZO.0\", \"role\": \"Franchisee\", \"address\": null}}, {\"id\": \"party:INTERNATIONAL FAST FOOD CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"INTERNATIONAL FAST FOOD CORPORATION\", \"role\": \"Principal\", \"address\": null}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"\\\"Affiliate\\\" means any company which is directly or indirectly controlled by BKC, controls BKC, or is controlled by a company which in turn controls BKC, and \\\"control\\\" for these purposes means de facto control.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Burger King Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Burger King Marks\", \"text\": \"\\\"Burger King Marks\\\" has the meaning ascribed to it in Paragraph A of the introduction.\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:Burger King System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Burger King System\", \"text\": \"\\\"Burger King System\\\" has the meaning ascribed to it in Paragraph A of the introduction.\", \"definition_clause\": \"1.3\"}}, {\"id\": \"term:Current Image\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Current Image\", \"text\": \"\\\"Current Image\\\" means the then current, BKC approved physical appearance of new Burger King Restaurants as it relates to signage, fascia, color schemes, menu boards, lighting, furniture, finishes and other non-structural matters generally.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"term:Franchised Restaurant\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchised Restaurant\", \"text\": \"\\\"Franchised Restaurant\\\" means the buildings at the Location and the business carried out at the Location.\", \"definition_clause\": \"1.5\"}}, {\"id\": \"term:Gross Sales\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Gross Sales\", \"text\": \"The term \\\"Gross Sales\\\" as used in this Agreement includes all sums charged for goods, merchandise, or services sold at or from the Location. The sale of Burger King products away from the Location is not authorized; however, should any such sales be approved in the future, they will be included within the definition of Gross Sales. Gross Sales shall not include any value added tax, turnover tax, or any similar tax collected by the Franchisee from customers based upon sales.\", \"definition_clause\": \"9.3\"}}, {\"id\": \"term:Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Location\", \"text\": \"\\\"Location\\\" has the meaning ascribed to it on SCHEDULE 1.\", \"definition_clause\": \"1.7\"}}, {\"id\": \"term:Director of Operations\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Director of Operations\", \"text\": \"\\\"Director of Operations\\\" has the meaning ascribed to it in Subparagraph 4.1 and on SCHEDULE 1.\", \"definition_clause\": \"1.8\"}}, {\"id\": \"term:Managing Director\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Managing Director\", \"text\": \"\\\"Managing Director\\\" has the meaning ascribed to it in Subparagraph 4.3 and on SCHEDULE 1.\", \"definition_clause\": \"1.9\"}}, {\"id\": \"term:MOD Manual\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MOD Manual\", \"text\": \"\\\"MOD Manual\\\" means all volumes of the Manual of Operating Data setting out BKC's standards, specifications and procedures of operation, as revised from time to time by BKC including both required and recommended.\", \"definition_clause\": \"1.10\"}}, {\"id\": \"term:Commencement Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commencement Date\", \"text\": \"The license hereby granted shall commence on the date the Franchised Restaurant opens for business (the \\\"Commencement Date\\\")\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"unless sooner terminated in accordance with the terms and provisions of this Agreement, shall continue for the period of years set forth on SCHEDULE 1 hereto (the \\\"Term\\\").\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:Development Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Development Agreement\", \"text\": \"Subject to the Restaurant Development Agreement between BKC and International Fast Food Corporation dated March 14, 1997, (the \\\"Development Agreement\\\"), the development and location of additional Burger King Restaurants shall be determined by BKC in its sole business judgment\", \"definition_clause\": \"2.3\"}}, {\"id\": \"term:Restaurant Manager\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Restaurant Manager\", \"text\": \"At all times during the Term of this Agreement, Franchisee shall employ at least one (1) individual (the \\\"Restaurant Manager\\\") who is responsible for the direct, personal supervision of the Franchise d Restaurant .\", \"definition_clause\": \"4.4\"}}, {\"id\": \"term:BKC Agreements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"BKC Agreements\", \"text\": \"Each Principal hereby agrees to jointly, severally, and unconditionally guaranty the payment and performance of all debts, obligations and liabilities of the Franchisee to BKC arising pursuant to this Agreement, or any other agreement with BKC relating directly or indirectly to the Franchised Restaurant (the \\\"BKC Agreements\\\")\", \"definition_clause\": \"16.3\"}}, {\"id\": \"term:Obligations\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Obligations\", \"text\": \"together with all costs of collection, compromise or enforcement, including reasonable attorneys' fees, incurred with respect to any such debts, obligations or liabilities or with respect to this or any other guaranty thereof or any bankruptcy proceeding or other similar action affecting the rights of the Franchisee's creditors generally (all of the foregoing being referred to collectively as the \\\"Obligations\\\").\", \"definition_clause\": \"16.3\"}}, {\"id\": \"term:Guaranties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Guaranties\", \"text\": \"In connection with the guaranties set forth above (collectively, the \\\"Guaranties\\\"), each of the parties to this Agreement hereby agrees as follows:\", \"definition_clause\": \"16.3\"}}, {\"id\": \"term:Event of Default\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Event of Default\", \"text\": \"Franchisee shall be in default under this Agreement upon the occurrence of any of the following events or conditions (individually, an \\\"Event of Default\\\" and collectively, the \\\"Events of Default\\\"):\", \"definition_clause\": \"17.1.1\"}}, {\"id\": \"term:Event of BKC Default\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Event of BKC Default\", \"text\": \"BKC shall be in default under this Agreement if BKC fails to perform any of its obligations under this Agreement and does not cure such failure within sixty (60) days of written notice of such failure (an \\\"Event of BKC Default\\\").\", \"definition_clause\": \"17.2.1\"}}, {\"id\": \"term:Franchisee Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchisee Parties\", \"text\": \"all controversies, disputes or claims arising between the Franchisee, the Principals, and their respective shareholders, officers, directors, agents and employees (in their respective capacity) (collectively, the \\\"Franchisee Parties\\\") and BKC arising out of or related to the relationship of the parties hereto\", \"definition_clause\": \"17.6\"}}, {\"id\": \"term:AAA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AAA\", \"text\": \"shall be submitted to and settled by arbitration in the City of New York in accordance with the Commercial Arbitration Rules of the American Arbitration Association (\\\"AAA\\\") then obtaining.\", \"definition_clause\": \"17.6\"}}, {\"id\": \"term:Fast Food Hamburger Restaurant\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fast Food Hamburger Restaurant\", \"text\": \"For purposes of this Section, \\\"Fast Food Hamburger Restaurant\\\" shall mean any restaurant which (a) has hamburgers or hamburger based products which account for 50(degree)/o or more of total menu items or total Gross Sales, and (b) does not offer table service as the principal method of ordering or food delivery\", \"definition_clause\": \"18\"}}, {\"id\": \"term:SEC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SEC\", \"text\": \"submission, before or simultaneously with submission to the U.S. Securities and Exchange Commission (\\\"SEC\\\")\", \"definition_clause\": \"15.5.2.1\"}}, {\"id\": \"value:180 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"180 days\"}}, {\"id\": \"value:seven (7) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) days\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:thirty (30) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) business days\"}}, {\"id\": \"value:three (3) percent\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"three (3) percent\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:twenty-four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) months\"}}, {\"id\": \"value:two percent (2%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"two percent (2%)\"}}, {\"id\": \"value:U.S. $1,000,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"U.S. $1,000,000.00\"}}, {\"id\": \"value:U.S. $500,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"U.S. $500,000.00\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:U.S. $1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"U.S. $1,000,000\"}}, {\"id\": \"value:U.S. $10,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"U.S. $10,000,000\"}}, {\"id\": \"value:twenty (20) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) business days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:ten (10) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) business days\"}}, {\"id\": \"value:three (3%) percent\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"three (3%) percent\"}}, {\"id\": \"value:one percent (1%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one percent (1%)\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:50(degree)/o\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50(degree)/o\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:6%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"6%\"}}, {\"id\": \"value:U.S. $10,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"U.S. $10,000\"}}, {\"id\": \"value:80%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"80%\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of INTERSECTENT,INC_05_11_2020-EX-10.1-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of INTERSECTENT,INC_05_11_2020-EX-10.1-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.1\", \"title\": \"[*] Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.\", \"level\": 2, \"text\": \"Exhibit 10.1 [*] Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (this \\\"Agreement\\\") is made this, 20t h day of January, 2020 (the \\\"Effective Date\\\"), by and between HOVIONE INTER AG, together with its subsidiaries and affiliates, and organized and existing under the laws of Switzerland and having its registered office at Pilatusstrasse 23, CH-6003, Luzern, Switzerland (hereafter referred to as \\\"HOVIONE\\\"), and INTERSECT ENT, Inc. together with its subsidiaries and affiliates, and organized and existing under the laws of Delaware and having its registered office at 1555 Adams Drive, Menlo Park, CA 94025 (hereafter referred to as \\\"INTERSECT\\\"). HOVIONE and INTERSECT are each sometimes referred to herein as a \\\"Party\\\" and together as the \\\"Parties.\\\" WHEREAS, HOVIONE has developed and manufacturers the active pharmaceutical ingredient(s) identified in Exhibit A hereto (the \\\"API\\\"); and WHEREAS, INTERSECT develops and markets Finished Product based on the API, as defined herein; and WHEREAS, INTERSECT desires to acquire API from HOVIONE to incorporate into the Finished Product; and WHEREAS, HOVIONE is willing to supply such API for INTERSECT's use, on the terms and conditions set forth in this Agreement.\"}, {\"id\": \"10\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"10. Term and Termination. 10.1. Term.\"}, {\"id\": \"13\", \"title\": \"Force Majeure\", \"level\": 1, \"text\": \"13. Force Majeure. Any delay in the performance of any of the duties or obligations of either party hereto (except for the payment of money) caused by an event outside the affected party's reasonable control shall not be considered a breach of this Agreement and the time required for performance shall be extended for a period equal to the period of such delay. Such events shall include, but will not be limited to, acts of God, acts of a public enemy, acts of terrorism, insurrections, riots, injunctions, embargoes, fires, explosions, floods, or other unforeseeable causes beyond the reasonable control and without the fault or negligence of the Party so affected. The Party so affected shall give prompt written notice to the other party of such event. The suspension of performance shall be of no greater scope and no longer duration than is reasonably required and the nonperforming Party shall use its commercially reasonable efforts to remedy its inability to perform; provided, however, that in the event the suspension of performance continues for sixty (60) days after the date of the occurrence, and such failure to perform would constitute a material breach of this Agreement in the absence of such force majeure event, the no affected Party may terminate this Agreement immediately by written notice to the affected Party. 14. General Provisions. 14.1. Assignment. Neither this Agreement nor any interest herein may be assigned, in whole or in part, by either party without the prior written consent of the other, which consent shall not be unreasonably withheld or delayed, except that either party may assign its rights and obligations under this Agreement: (a) to an affiliate, division or subsidiary of such party; and/or (b) to any third party that acquires all or substantially all of the stock or assets of such party, whether by asset sale, stock sale, merger or otherwise, and, in any such event such assignee shall assume the transferring party's obligations hereunder. However, notwithstanding any such assignment, in the case of an assignment to an affiliate, division or subsidiary, the transferring party shall remain liable under this Agreement (in addition to the transferee) unless such liability is specifically waived in writing by the other party hereto. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the Parties hereto, and their respective successors and permitted assigns. (a) Buyout. In the case that either company is acquired by, or merges with, another company which has reason to not wish to continue the relationship, that company may make a contract buyout payment [*] for the [*], with a [*] buyout payment amount of [*]. 14.2. Notice. Any notice or request required or permitted to be given under or in connection with this Agreement shall be deemed to have been sufficiently given if in writing and sent by: (a) personal delivery against a signed receipt therefore, (b) certified mail, return receipt requested, first class postage prepaid, (c) nationally recognized overnight delivery service (signature required), (d) confirmed facsimile transmission, or (e) electronic mail (with any notices to send by facsimile transmission or electronic mail to also be sent by one of the other methods set forth in this Section), addressed as follows: If to HOVIONE, then to: Hovione FarmaCiencia SA Attention: General Counsel Estrada do Paco do Lumiar Campus do Lumiar, Edificio R 1649-038 Lisboa, Portugal With a copy, sent as provided herein, to: gc@hovione.com If to INTERSECT, then to: 1555 Adams Dr., Menlo Park, CA 94025 Attn: Chief Operations Officer email: purchasing@intersectent.com 8 IN WITNESS WHEREOF, the parties have executed the Agreement as of the date first above written. HOVIONE INTER AG: By: /s/ Frederic Kahn Name: Frederic Kahn Its: VP Marketing and Sales 10 INTERSECT ENT, INC.: By: /s/ Thomas A. West Name: Thomas A. West Its: CEO 11\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of INTERSECTENT,INC_05_11_2020-EX-10.1-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*] Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.\", \"level\": 2, \"text\": \"Exhibit 10.1 [*] Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (this \\\"Agreement\\\") is made this, 20t h day of January, 2020 (the \\\"Effective Date\\\"), by and between HOVIONE INTER AG, together with its subsidiaries and affiliates, and organized and existing under the laws of Switzerland and having its registered office at Pilatusstrasse 23, CH-6003, Luzern, Switzerland (hereafter referred to as \\\"HOVIONE\\\"), and INTERSECT ENT, Inc. together with its subsidiaries and affiliates, and organized and existing under the laws of Delaware and having its registered office at 1555 Adams Drive, Menlo Park, CA 94025 (hereafter referred to as \\\"INTERSECT\\\"). HOVIONE and INTERSECT are each sometimes referred to herein as a \\\"Party\\\" and together as the \\\"Parties.\\\" WHEREAS, HOVIONE has developed and manufacturers the active pharmaceutical ingredient(s) identified in Exhibit A hereto (the \\\"API\\\"); and WHEREAS, INTERSECT develops and markets Finished Product based on the API, as defined herein; and WHEREAS, INTERSECT desires to acquire API from HOVIONE to incorporate into the Finished Product; and WHEREAS, HOVIONE is willing to supply such API for INTERSECT's use, on the terms and conditions set forth in this Agreement.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"10. Term and Termination. 10.1. Term.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 1, \"text\": \"13. Force Majeure. Any delay in the performance of any of the duties or obligations of either party hereto (except for the payment of money) caused by an event outside the affected party's reasonable control shall not be considered a breach of this Agreement and the time required for performance shall be extended for a period equal to the period of such delay. Such events shall include, but will not be limited to, acts of God, acts of a public enemy, acts of terrorism, insurrections, riots, injunctions, embargoes, fires, explosions, floods, or other unforeseeable causes beyond the reasonable control and without the fault or negligence of the Party so affected. The Party so affected shall give prompt written notice to the other party of such event. The suspension of performance shall be of no greater scope and no longer duration than is reasonably required and the nonperforming Party shall use its commercially reasonable efforts to remedy its inability to perform; provided, however, that in the event the suspension of performance continues for sixty (60) days after the date of the occurrence, and such failure to perform would constitute a material breach of this Agreement in the absence of such force majeure event, the no affected Party may terminate this Agreement immediately by written notice to the affected Party. 14. General Provisions. 14.1. Assignment. Neither this Agreement nor any interest herein may be assigned, in whole or in part, by either party without the prior written consent of the other, which consent shall not be unreasonably withheld or delayed, except that either party may assign its rights and obligations under this Agreement: (a) to an affiliate, division or subsidiary of such party; and/or (b) to any third party that acquires all or substantially all of the stock or assets of such party, whether by asset sale, stock sale, merger or otherwise, and, in any such event such assignee shall assume the transferring party's obligations hereunder. However, notwithstanding any such assignment, in the case of an assignment to an affiliate, division or subsidiary, the transferring party shall remain liable under this Agreement (in addition to the transferee) unless such liability is specifically waived in writing by the other party hereto. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the Parties hereto, and their respective successors and permitted assigns. (a) Buyout. In the case that either company is acquired by, or merges with, another company which has reason to not wish to continue the relationship, that company may make a contract buyout payment [*] for the [*], with a [*] buyout payment amount of [*]. 14.2. Notice. Any notice or request required or permitted to be given under or in connection with this Agreement shall be deemed to have been sufficiently given if in writing and sent by: (a) personal delivery against a signed receipt therefore, (b) certified mail, return receipt requested, first class postage prepaid, (c) nationally recognized overnight delivery service (signature required), (d) confirmed facsimile transmission, or (e) electronic mail (with any notices to send by facsimile transmission or electronic mail to also be sent by one of the other methods set forth in this Section), addressed as follows: If to HOVIONE, then to: Hovione FarmaCiencia SA Attention: General Counsel Estrada do Paco do Lumiar Campus do Lumiar, Edificio R 1649-038 Lisboa, Portugal With a copy, sent as provided herein, to: gc@hovione.com If to INTERSECT, then to: 1555 Adams Dr., Menlo Park, CA 94025 Attn: Chief Operations Officer email: purchasing@intersectent.com 8 IN WITNESS WHEREOF, the parties have executed the Agreement as of the date first above written. HOVIONE INTER AG: By: /s/ Frederic Kahn Name: Frederic Kahn Its: VP Marketing and Sales 10 INTERSECT ENT, INC.: By: /s/ Thomas A. West Name: Thomas A. West Its: CEO 11\"}}, {\"id\": \"party:HOVIONE INTER AG\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"HOVIONE INTER AG\", \"role\": \"Supplier\", \"address\": \"Pilatusstrasse 23, CH-6003, Luzern, Switzerland\"}}, {\"id\": \"party:INTERSECT ENT, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"INTERSECT ENT, Inc.\", \"role\": \"Buyer\", \"address\": \"1555 Adams Drive, Menlo Park, CA 94025\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS SUPPLY AGREEMENT (this \\\"Agreement\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"20t h day of January, 2020 (the \\\"Effective Date\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:HOVIONE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"HOVIONE\", \"text\": \"HOVIONE INTER AG, together with its subsidiaries and affiliates, and organized and existing under the laws of Switzerland and having its registered office at Pilatusstrasse 23, CH-6003, Luzern, Switzerland (hereafter referred to as \\\"HOVIONE\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:INTERSECT\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"INTERSECT\", \"text\": \"INTERSECT ENT, Inc. together with its subsidiaries and affiliates, and organized and existing under the laws of Delaware and having its registered office at 1555 Adams Drive, Menlo Park, CA 94025 (hereafter referred to as \\\"INTERSECT\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"HOVIONE and INTERSECT are each sometimes referred to herein as a \\\"Party\\\"\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"HOVIONE and INTERSECT are each sometimes referred to herein as a \\\"Party\\\" and together as the \\\"Parties.\\\"\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"term:API\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"API\", \"text\": \"the active pharmaceutical ingredient(s) identified in Exhibit A hereto (the \\\"API\\\")\", \"definition_clause\": \"Exhibit 10.1\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Source: IMINE CORP, S-1, 7/25/2018\", \"level\": 1, \"text\": \"Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 IN WITNESS WHEREOF, THE PARTIES HERETO HAVE EXECUTED THIS AGREEMENT AS OF THE DATE FIRST WRITTEN ABOVE. Sunwai Technology iMine Corporation /s/ Sei-Peng Tu /s/ Daniel Tsai By: Sei-Peng Tu By: Daniel Tsai Title: President Title: Chief Executive Officer 9 Source: IMINE CORP, S-1, 7/25/2018\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ImineCorp_20180725_S-1_EX-10.5_11275970_EX-10.5_Distributor Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Source: IMINE CORP, S-1, 7/25/2018\", \"level\": 1, \"text\": \"Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 Source: IMINE CORP, S-1, 7/25/2018 IN WITNESS WHEREOF, THE PARTIES HERETO HAVE EXECUTED THIS AGREEMENT AS OF THE DATE FIRST WRITTEN ABOVE. Sunwai Technology iMine Corporation /s/ Sei-Peng Tu /s/ Daniel Tsai By: Sei-Peng Tu By: Daniel Tsai Title: President Title: Chief Executive Officer 9 Source: IMINE CORP, S-1, 7/25/2018\"}}, {\"id\": \"party:Sunwai Technology\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Sunwai Technology\", \"role\": null, \"address\": null}}, {\"id\": \"party:iMine Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"iMine Corporation\", \"role\": null, \"address\": null}}, {\"id\": \"party:IMINE CORP\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"IMINE CORP\", \"role\": null, \"address\": null}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of InnerscopeHearingTechnologiesInc_20181109_8-K_EX-10.6_11419704_EX-10.6_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of InnerscopeHearingTechnologiesInc_20181109_8-K_EX-10.6_11419704_EX-10.6_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.6\", \"title\": \"ATTACHMENT A ERCHONIA CORPORATION EXCLUSIVE DISTRIBUTOR AGREEMENT\", \"level\": 2, \"text\": \"Exhibit 10.6 ATTACHMENT A ERCHONIA CORPORATION EXCLUSIVE DISTRIBUTOR AGREEMENT This agreement (\\\"Agreement\\\") is made by and between Erchonia Corporation. (\\\"Erchonia\\\") whose address is 650 Atlantis Rd., Melbourne, Florida, USA, 32904 and InnerScope Hearing Technologies Inc, (\\\"Distributor\\\") whose address is 2151 Professional Drive, Second Floor, Roseville, California, USA, 95661 hereafter referred to collectively as the (\\\"Parties\\\"). Recitals A. Erchonia is engaged in, among other things, the business of developing and promoting low level lasers. Erchonia desires to retain Distributor to promote, distribute and sell such equipment listed in Schedule A (the \\\"Products\\\"). B. Distributor is engaged in the business of, among other things, selling medical products and services, specifically for the treatment of hearing disorders. C. Distributor desires to obtain the exclusive right to distribute the Products pursuant to the terms set for in this Agreement. D. The parties agree that these recitals shall be considered a term of this Agreement. NOW, THEREFORE, the parties agree:\"}, {\"id\": \"1\", \"title\": \"Grant of License\", \"level\": 1, \"text\": \"1. Grant of License. a. Subject to the terms set forth in this agreement, Erchonia grants Distributor the exclusive, non- transferable right and license to promote, distribute and sell the Products identified in Exhibit A to those type of customer specified in Exhibit B and only within the Territory specified in Exhibit B. Distributor shall only distribute or sell the Products to customers who are licensed health care professionals and meet the other requirements set forth in Exhibit B. b. Erchonia retains the right, in its sole discretion, to add, delete, upgrade, or modify the Products from time to time. Upon receipt of notice of such change, Distributor shall cease to market and distribute earlier versions of the Products and/or Products deleted from Schedule A. Distributor will deliver, at Erchonia's expense, all recalled, discontinued or products otherwise rendered unmarketable (under the terms of this paragraph) to Erchonia. Erchonia will fully reimburse Distributor for all costs related to the cost of materials and products returned to Erchonia\"}, {\"id\": \"2\", \"title\": \"Obligations of Distributor\", \"level\": 1, \"text\": \"2. Obligations of Distributor. a. Distributor shall use its best efforts to market, promote and sell the Products to the authorized customers in the Filed of Use and in the Territory during the term of this agreement. b. Distributor agrees that during the term of this agreement it meet the minimum performance goals set forth in Exhibit C to this agreement. Failure to meet these minimum performance goals for any period, shall, at Erchonia's option (i) be considered a breach of this agreement for which Erchonia shall have all the rights and remedies provided for herein upon a breach of this agreement, including termination of this agreement, or (ii) shall give Erchonia to terminate or limit the exclusivity provisions of this agreement\"}, {\"id\": \"c\", \"title\": \"Upon Erchonia's reasonable request, Distributor shall consult with Erchonia regarding Distributor's marketing and promo\", \"level\": 1, \"text\": \"c. Upon Erchonia's reasonable request, Distributor shall consult with Erchonia regarding Distributor's marketing and promotion efforts in the Territory and Field of Use and shall cooperate with Erchonia's reasonable requests regarding Distributor's marketing and promotional efforts.\"}, {\"id\": \"d\", \"title\": \"Distributor shall maintain appropriate records concerning the sales of the Products\", \"level\": 1, \"text\": \"d. Distributor shall maintain appropriate records concerning the sales of the Products. Such records shall include at a minimum the name, address and telephone number of each customer, the date of sale, a listing of the Products sold to each customer. Upon Erchonia's request, Distributor shall provide Erchonia with regular periodic reports including the information described in this paragraph. All such information shall be available for inspection by Erchonia, upon reasonable notice. Distributor shall also maintain such other records related to sales of the Products as Erchonia may reasonably request. e. Distributor shall pay for all products purchased in a timely manner. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 f. Distributor shall not, and may not permit any other person, including customers, to reproduce, distribute, sell or dispose of the Products, in whole or in part, except as expressly permitted under this Agreement. g. Distributor will at all times be and represent itself to be an independent distributor, not an agent or employee of Erchonia. h. Distributor may not make any contracts or commitments on behalf of Erchonia nor make any warranties or other representations regarding the Products other than those authorized herein.\"}, {\"id\": \"i\", \"title\": \"Distributor must adhere to and comply with any use recommendations or restrictions for the Products as indicated or rec\", \"level\": 1, \"text\": \"i. Distributor must adhere to and comply with any use recommendations or restrictions for the Products as indicated or recommended by Erchonia. Distributor shall not make any statements, representations, or recommendations inconsistent with any use restriction or limitation. j. Distributor shall not sell or export the Products outside the United States without prior written consent of Erchonia. To the extent sales of the Products outside the United States are permitted, Distributor will be solely responsible to comply with all applicable import and export laws and regulations. k. Distributor shall promptly notify Erchonia of any complaint about negative, unwanted, deleterious, or other side effects due to the use of the Products, including the complainant's name, contact information, and date of complaint.\"}, {\"id\": \"l\", \"title\": \"During the term of this agreement Distributor shall at all time act in responsible and professional manner\", \"level\": 1, \"text\": \"l. During the term of this agreement Distributor shall at all time act in responsible and professional manner. Distributor shall not do anything which is contrary to or which in Erchonia's reasonable business judgment is harmful to its honor, goodwill or reputation.\"}, {\"id\": \"m\", \"title\": \"Distributor shall at all times comply with all applicable laws and regulations\", \"level\": 1, \"text\": \"m. Distributor shall at all times comply with all applicable laws and regulations.\"}, {\"id\": \"3\", \"title\": \"Restriction on Promotion of Competing Products\", \"level\": 1, \"text\": \"3. Restriction on Promotion of Competing Products. During the term of this agreement, Distributor shall not market, sell advertise or promote the sale or use of any product or device which is competitive with or substantially similar to the Products, without the prior express written consent of Erchonia, nor shall they assist any third party in doing so. Notwithstanding the foregoing, to the extent Distributor or Distributor's customer is a licensed health care professional or licensed health care practitioner, nothing in this paragraph shall prevent or limit Distributor or Distributor's customer from exercising their independent medical judgment with regard to the treatment of any patient.\"}, {\"id\": \"4\", \"title\": \"Orders, Payment, and Shipment\", \"level\": 1, \"text\": \"4. Orders, Payment, and Shipment. a. Erchonia agrees to provide Products to Distributor pursuant to orders placed by Distributor in the form of individual purchase orders issued by Distributor to Erchonia. Such purchase orders shall set forth the quantity of each product ordered, the required delivery date, and the point of delivery. The price for the Products shall be as designated in Schedule A. Erchonia may revise its prices from time to time and deliver a written 90 day notice of the reasonable price revision to Distributor; provided that Erchonia agrees that the prices listed in Exhibit A shall not be increased during the first 90 days of this agreement. b. Erchonia shall submit invoices to Distributor after or concurrent with shipment of Products to Distributor at the delivery address. Distributor shall pay half (1/2) of the purchase price prior to shipment and the remaining balance 30 days after shipment of the Products. Payments received after the 30 day calendar period will be subject to a late fee of 1.5% of the invoice amount. All payments shall be made in U.S. Dollars.\"}, {\"id\": \"c\", \"title\": \"Distributor is responsible for all shipping costs and applicable sales taxes\", \"level\": 1, \"text\": \"c. Distributor is responsible for all shipping costs and applicable sales taxes. Distributor is also responsible for all customs and duties applicable to any sales of the Products outside the United States, to the extent such sales are authorized or permitted.\"}, {\"id\": \"5\", \"title\": \"Expenses and Taxes\", \"level\": 1, \"text\": \"5. Expenses and Taxes. a. Distributor is responsible for any out-of-pocket expenses incurred including but not limited to Products for demonstration, Products for treatment, sales and promotional material, seminar costs including room rental, and travel-related expenses. b. Distributor is responsible for all federal, state and local taxes attributable to compensation received Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 pursuant to this Agreement, including sales, income, social security, and unemployment.\"}, {\"id\": \"6\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"6. Term and Termination. a. Unless terminated earlier as provided in this agreement, this Agreement shall have an initial term of three (3) years. This agreement shall automatically renew for a period of three (3) years and upon the parties mutual agreement on new minimum performance goals for the renewal period. b. Either party may terminate this Agreement in the event of a material breach by the other party, provided the breaching party is first given reasonably detailed, written notice of the breach. If the breach is not cured within ten days of such notice, the Agreement will terminate immediately.\"}, {\"id\": \"c\", \"title\": \"This Agreement may be terminated immediately by Erchonia under any of the following conditions\", \"level\": 1, \"text\": \"c. This Agreement may be terminated immediately by Erchonia under any of the following conditions: (a) if the Distributor is declared insolvent or bankrupt; (b) if a petition is filed in any court to declare Distributor bankrupt or for reorganization under the Bankruptcy Law or any similar statute and such petition is not dismissed within 30 days.\"}, {\"id\": \"d\", \"title\": \"Upon termination of this Agreement by either party, Distributor shall immediately cease using the Trademarks (defined b\", \"level\": 1, \"text\": \"d. Upon termination of this Agreement by either party, Distributor shall immediately cease using the Trademarks (defined below) and discontinue all representations that it is an authorized distributor of the Products or is in anyway affiliated with Erchonia. e. Except upon termination due to Distributors breach of this agreement, Erchonia will complete delivery of all purchase orders accepted by it prior to termination of this agreement; provided that Distributor shall remain liable for full payment of all such orders. f. The provisions of paragraphs 2 (c) (reporting), 7 (Confidentiality), 8 (Protection of Intellectual Property, 10 (Warranty; Limitation of Liability), 11 (Indemnification), 12 (General Provisions) shall survive termination of this agreement.\"}, {\"id\": \"7\", \"title\": \"Confidentiality\", \"level\": 1, \"text\": \"7. Confidentiality. a. In connection with this Agreement, the Distributor will have disclosed to it or otherwise have access to information that is confidential and proprietary to Erchonia. Such information includes but is not limited to Product designs, methods and processes, know-how, business or marketing strategies, Product plans, plans for research and development, development tools, financial information, production costs and information, and supplier and customer lists and information and medical research conducted in pursuit of intended medical applications of the product. b. Distributor will not copy, reproduce, disclose, disseminate or provide any confidential information to any third party, without the prior written consent of Erchonia. In addition, Distributor agrees that it will use such confidential information only for the purpose of carrying out its obligations under this agreement. Upon termination of this agreement for any reason, Distributor will return all such confidential information and any copies of it to Erchonia and will remove and delete any such confidential information for any computers, computer systems or other electronic, magnetic or optical media in its possession or control.\"}, {\"id\": \"c\", \"title\": \"Notwithstanding the above, the following materials will not be deemed confidential\", \"level\": 1, \"text\": \"c. Notwithstanding the above, the following materials will not be deemed confidential:\"}, {\"id\": \"i\", \"title\": \"Information which was in the public domain at the time of disclosure\", \"level\": 1, \"text\": \"i. Information which was in the public domain at the time of disclosure\"}, {\"id\": \"ii\", \"title\": \"Information which was published or otherwise became part of the public domain after disclosure to the Distributor throu\", \"level\": 1, \"text\": \"ii. Information which was published or otherwise became part of the public domain after disclosure to the Distributor through no fault of the Distributor; and\"}, {\"id\": \"iii\", \"title\": \"Information which was received from a third party who did not acquire it, directly or indirectly, from Erchonia under a\", \"level\": 1, \"text\": \"iii. Information which was received from a third party who did not acquire it, directly or indirectly, from Erchonia under an obligation of confidence except where required by law.\"}, {\"id\": \"8\", \"title\": \"Protection of Intellectual Property\", \"level\": 1, \"text\": \"8. Protection of Intellectual Property. a. Ownership of all applicable copyrights, trade secrets, patents and other intellectual property rights in the Products are and shall at all times remain vested in Erchonia, its licensors or assigns. b. Distributor shall promptly inform Erchonia of any suggested modifications or improvements to the Products and shall, upon Erchonia's request and at Erchonia's expense, execute any documents necessary or appropriate to assign or confirm that all intellectual property rights in any modification Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 or improvement related to the Products are fully vested in Erchonia.\"}, {\"id\": \"c\", \"title\": \"Distributor shall not modify nor create or attempt to create, by reverse engineering or otherwise, the Products supplie\", \"level\": 1, \"text\": \"c. Distributor shall not modify nor create or attempt to create, by reverse engineering or otherwise, the Products supplied hereunder, or adapt the Products in any way for other uses without Erchonia's prior written consent\"}, {\"id\": \"d\", \"title\": \"Several of the Products may be protected by one or more U\", \"level\": 1, \"text\": \"d. Several of the Products may be protected by one or more U.S. or international patents. Distributor shall take reasonable steps to ensure that all patent markings and/or notices for or related to the Products are properly placed on the Products, and on any advertising or marketing materials for the Products, and it shall not remove any such markings, notices or labels from any of the Products or related materials or related advertising or marketing materials.\"}, {\"id\": \"9\", \"title\": \"Use of Erchonia Trademarks\", \"level\": 1, \"text\": \"9. Use of Erchonia Trademarks. a. All trademarks, including service marks, trade names and trade address that Erchonia uses in connection with the license granted hereunder (the \\\"Trademarks\\\") are and remain the exclusive property of Erchonia. Nothing contained in this Agreement shall be deemed to give Distributor any right, title or interest in any Trademark. The Trademarks include but are not limited to: the names \\\"Erchonia\\\", \\\"Erchonia Medical\\\", the phrase \\\"Erchonia, Designs Into the Future\\\", the Erchonia logo, packaging design, and Product design. b. During the term of this Agreement, Erchonia grants Distributor a non-exclusive, non-transferable license to use the Trademarks for advertising and promotion of Products. Distributor shall use the Trademarks according to quality standards defined by Erchonia which shall be reasonable and shall be no greater than the standards used by Erchonia for its own advertising and promotion.\"}, {\"id\": \"c\", \"title\": \"Upon Erchonia's request, the Distributor shall at its expense deliver to Erchonia representative samples of labels, adv\", \"level\": 1, \"text\": \"c. Upon Erchonia's request, the Distributor shall at its expense deliver to Erchonia representative samples of labels, advertisements, catalogs, spec sheets, and the like, containing the Trademarks, and to inspect all of Distributors websites, social media accounts and any online information posted by Distributor, to ensure that such Trademarks are used only in a manner complaint with the quality standards. Should such material fail to meet the standards set by Erchonia, as determined by Erchonia in its sole discretion, Distributor shall not use and shall withdraw and retract any promotion or advertising that Erchonia finds unsuitable and will at its expense destroy such materials or make them compliant.\"}, {\"id\": \"d\", \"title\": \"All goodwill associated with such trademark use by Distributor inures to the benefit of Erchonia\", \"level\": 1, \"text\": \"d. All goodwill associated with such trademark use by Distributor inures to the benefit of Erchonia.\"}, {\"id\": \"10\", \"title\": \"Warranty; Limitation of Liability\", \"level\": 1, \"text\": \"10. Warranty; Limitation of Liability. a. Distributor Warranty. Distributor represents that it has requisite knowledge and experience to provide the products and services contracted for herein. b. Erchonia Warranty and Warranty Limitations: Other than the written warranty accompanying the Products, Erchonia DISCLAIMS ALL OTHER REPRESENTATIONS AND WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF THIRD PARTY INTELLECTUAL PROPERTY RIGHTS.\"}, {\"id\": \"c\", \"title\": \"IN NO EVENT SHALL Erchonia BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE, INCLUDING BUT NOT LIMITED T\", \"level\": 1, \"text\": \"c. IN NO EVENT SHALL Erchonia BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE, INCLUDING BUT NOT LIMITED TO SPECIAL, INCIDENTAL, CONSEQUENTIAL OR OTHER INDIRECT DAMAGES UNDER ANY CAUSE OF ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, CLAIMS ARISING FROM MALFUNCTION OR DEFECTS IN THE PRODUCTS.\"}, {\"id\": \"11\", \"title\": \"Indemnification\", \"level\": 1, \"text\": \"11. Indemnification. a. Erchonia shall indemnify, defend and hold Distributor harmless from any claims, demands, liabilities or expenses, including reasonable attorneys' fees, incurred by Distributor as a result of any claim or proceeding against Distributor arising out of or based upon: (i) a claim that the Products infringe upon any U.S. patent, trademark, copyright or other intellectual property rights of any third party, (ii) the products fail to comply with applicable federal law or regulation. b. Distributor shall promptly notify Erchonia of any suit or claim by a third party relating to the Products or use of the Products and Distributor shall promptly furnished Erchonia with a copy of each Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 communication, notice or other action relating to said claim. Erchonia shall have the right to assume sole authority to conduct the trial or settlement of such claim or any negotiations related to any claim for which Erchonia is obligated to indemnify Distributor at Erchonia expense; and Distributor shall provide reasonable information and assistance requested by Erchonia in connection with such claim or suit.\"}, {\"id\": \"c\", \"title\": \"Distributor shall indemnify, defend and hold Erchonia harmless from any claims, demands, liabilities or expenses, inclu\", \"level\": 1, \"text\": \"c. Distributor shall indemnify, defend and hold Erchonia harmless from any claims, demands, liabilities or expenses, including reasonable attorneys' fees, incurred by Erchonia as a result of any claim or proceeding against Erchonia arising out of or based upon (i) the combination, operation or use of the Products with any hardware, products, programs or data not supplied or approved in writing by Erchonia, if such infringement would have been avoided but for such combination, operation or use; (ii) the modification of the Products by Distributor or its Customers; (iii) any breach of this agreement by Distributor; or (iv) any negligent, grossly negligent, or willful or reckless acts by Distributor, or any of its officers, employees, agents or representatives.\"}, {\"id\": \"12\", \"title\": \"General Provisions\", \"level\": 1, \"text\": \"12. General Provisions: a. Assignment. Distributor may not assign to any person any duties or obligations arising under this Agreement without Erchonia's prior written consent (which consent may be withheld in Erchonia's sole discretion). Notwithstanding the foregoing, the Distributor may engage individuals, at the sole expense and responsibility of the Distributor, to assist the Distributor in performing any of the Distributor's duties or obligations arising under this Agreement. Erchonia may not assign any duties or obligations arising under this Agreement, except to a successor who acquires substantially all of the assets of Erchonia. b. Arbitration. The parties intend to negotiate in good faith and resolve any dispute arising under this Agreement. In the event the parties are unable to resolve any such dispute to binding arbitration for settlement in accordance with the rules of the American Arbitration Association, the arbitrator will determine the manner in which the parties are to pay the costs of such arbitration, including reasonable attorneys' fees\"}, {\"id\": \"c\", \"title\": \"Notices\", \"level\": 1, \"text\": \"c. Notices. All notices and communications required under this Agreement will be in writing and will be delivered in person, faxed or mailed, postage prepaid, by overnight express carrier, to the address of the parties listed at the beginning of this Agreement, or to any other address as such party designates in a written notice to the other party. All notices sent pursuant to the terms of this section will be deemed received on the date of delivery if personally delivered or faxed, or if sent by overnight express carrier, on the next business day immediately following the day sent\"}, {\"id\": \"d\", \"title\": \"Severability\", \"level\": 1, \"text\": \"d. Severability. The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of any other provisions hereof. e. Governing Law. This Agreement shall be governed in all respects by the laws of the United States and the State of Florida, except for conflict of laws provisions. The parties agree that for any dispute, controversy or claim arising out of or in connection with this Agreement, venue and personal jurisdiction shall be in the federal or state court with competent jurisdiction located in Brevard Country, Florida. f. Entire Agreement. This Agreement constitutes and expresses the entire agreement and understanding between the parties hereto with respect to the subject matter, all revisions discussions, promises, representation, and understanding relative thereto, if any, being herein merged. Dated: . Erchonia Medical Corporation. By _____________________ Its _____________________ Distributor: ________________________ InnerScope Hearing Technologies, Inc. By _______________________ Its _______________________ Exhibits Exhibit A - Products and Pricing Exhibit B - Territory and Field of Use Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018\"}, {\"id\": \"Exhibit C\", \"title\": \"- Minimum Performance Goals Rev. IMS 8/29/2018 3:38 PM\", \"level\": 1, \"text\": \"Exhibit C - Minimum Performance Goals Rev. IMS 8/29/2018 3:38 PM Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018\"}, {\"id\": \"SCHEDULE A\", \"title\": \"ERCHONIA CORPORATION Products and Pricing Erchonia 3LT Laser - Hearing Products Version (product may be renamed) All prices are per unit sold excluding freight, duty, and taxes. Prices will remain in effect for the period of the initial 5 year term. Wholesale Price Item To Be determined when successful research project is complete. The parties agree to cooperate in developing a private label version of the above products on the terms the parties may agree. The private label products shall be versions of the above products labeled and packaged to bear the Distributor's name or the Distributor's trade name. In addition, customized packaging for the private label products may also be developed on the terms agreed to by the parties. Pricing for the private labeled products may be modified due to any increased costs of production or packaging for the private labeled products. In addition, Erchonia may require reasonable minimum purchasing requirements for each run of private labeled products.\", \"level\": 1, \"text\": \"SCHEDULE A ERCHONIA CORPORATION Products and Pricing Erchonia 3LT Laser - Hearing Products Version (product may be renamed) All prices are per unit sold excluding freight, duty, and taxes. Prices will remain in effect for the period of the initial 5 year term. Wholesale Price Item To Be determined when successful research project is complete. The parties agree to cooperate in developing a private label version of the above products on the terms the parties may agree. The private label products shall be versions of the above products labeled and packaged to bear the Distributor's name or the Distributor's trade name. In addition, customized packaging for the private label products may also be developed on the terms agreed to by the parties. Pricing for the private labeled products may be modified due to any increased costs of production or packaging for the private labeled products. In addition, Erchonia may require reasonable minimum purchasing requirements for each run of private labeled products. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 EXHIBIT B Licensed Territory Worldwide Field of Use The products will be sold only for the use in the treatment of hearing disorders. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 Exhibit C Minimum Performance Goals Minimum Performance won't be determined until FDA 50k market clearance is obtained. At that time parties will operate in good faith to set performance goals. Note: Performance goals to begin 120 days after receipt of FDA market clearance. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of InnerscopeHearingTechnologiesInc_20181109_8-K_EX-10.6_11419704_EX-10.6_Distributor Agreement\", \"nodes\": [{\"id\": \"Exhibit 10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ATTACHMENT A ERCHONIA CORPORATION EXCLUSIVE DISTRIBUTOR AGREEMENT\", \"level\": 2, \"text\": \"Exhibit 10.6 ATTACHMENT A ERCHONIA CORPORATION EXCLUSIVE DISTRIBUTOR AGREEMENT This agreement (\\\"Agreement\\\") is made by and between Erchonia Corporation. (\\\"Erchonia\\\") whose address is 650 Atlantis Rd., Melbourne, Florida, USA, 32904 and InnerScope Hearing Technologies Inc, (\\\"Distributor\\\") whose address is 2151 Professional Drive, Second Floor, Roseville, California, USA, 95661 hereafter referred to collectively as the (\\\"Parties\\\"). Recitals A. Erchonia is engaged in, among other things, the business of developing and promoting low level lasers. Erchonia desires to retain Distributor to promote, distribute and sell such equipment listed in Schedule A (the \\\"Products\\\"). B. Distributor is engaged in the business of, among other things, selling medical products and services, specifically for the treatment of hearing disorders. C. Distributor desires to obtain the exclusive right to distribute the Products pursuant to the terms set for in this Agreement. D. The parties agree that these recitals shall be considered a term of this Agreement. NOW, THEREFORE, the parties agree:\"}}, {\"id\": \"party:Erchonia Corporation.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Erchonia Corporation.\", \"role\": \"Erchonia\", \"address\": \"650 Atlantis Rd., Melbourne, Florida, USA, 32904\"}}, {\"id\": \"party:InnerScope Hearing Technologies Inc\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"InnerScope Hearing Technologies Inc,\", \"role\": \"Distributor\", \"address\": \"2151 Professional Drive, Second Floor, Roseville, California, USA, 95661\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This agreement\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"Erchonia Corporation. (\\\"Erchonia\\\") whose address is 650 Atlantis Rd., Melbourne, Florida, USA, 32904 and InnerScope Hearing Technologies Inc, (\\\"Distributor\\\") whose address is 2151 Professional Drive, Second Floor, Roseville, California, USA, 95661 hereafter referred to collectively as the (\\\"Parties\\\")\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"such equipment listed in Schedule A\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Grant of License\", \"level\": 1, \"text\": \"1. Grant of License. a. Subject to the terms set forth in this agreement, Erchonia grants Distributor the exclusive, non- transferable right and license to promote, distribute and sell the Products identified in Exhibit A to those type of customer specified in Exhibit B and only within the Territory specified in Exhibit B. Distributor shall only distribute or sell the Products to customers who are licensed health care professionals and meet the other requirements set forth in Exhibit B. b. Erchonia retains the right, in its sole discretion, to add, delete, upgrade, or modify the Products from time to time. Upon receipt of notice of such change, Distributor shall cease to market and distribute earlier versions of the Products and/or Products deleted from Schedule A. Distributor will deliver, at Erchonia's expense, all recalled, discontinued or products otherwise rendered unmarketable (under the terms of this paragraph) to Erchonia. Erchonia will fully reimburse Distributor for all costs related to the cost of materials and products returned to Erchonia\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Obligations of Distributor\", \"level\": 1, \"text\": \"2. Obligations of Distributor. a. Distributor shall use its best efforts to market, promote and sell the Products to the authorized customers in the Filed of Use and in the Territory during the term of this agreement. b. Distributor agrees that during the term of this agreement it meet the minimum performance goals set forth in Exhibit C to this agreement. Failure to meet these minimum performance goals for any period, shall, at Erchonia's option (i) be considered a breach of this agreement for which Erchonia shall have all the rights and remedies provided for herein upon a breach of this agreement, including termination of this agreement, or (ii) shall give Erchonia to terminate or limit the exclusivity provisions of this agreement\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon Erchonia's reasonable request, Distributor shall consult with Erchonia regarding Distributor's marketing and promo\", \"level\": 1, \"text\": \"c. Upon Erchonia's reasonable request, Distributor shall consult with Erchonia regarding Distributor's marketing and promotion efforts in the Territory and Field of Use and shall cooperate with Erchonia's reasonable requests regarding Distributor's marketing and promotional efforts.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall maintain appropriate records concerning the sales of the Products\", \"level\": 1, \"text\": \"d. Distributor shall maintain appropriate records concerning the sales of the Products. Such records shall include at a minimum the name, address and telephone number of each customer, the date of sale, a listing of the Products sold to each customer. Upon Erchonia's request, Distributor shall provide Erchonia with regular periodic reports including the information described in this paragraph. All such information shall be available for inspection by Erchonia, upon reasonable notice. Distributor shall also maintain such other records related to sales of the Products as Erchonia may reasonably request. e. Distributor shall pay for all products purchased in a timely manner. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 f. Distributor shall not, and may not permit any other person, including customers, to reproduce, distribute, sell or dispose of the Products, in whole or in part, except as expressly permitted under this Agreement. g. Distributor will at all times be and represent itself to be an independent distributor, not an agent or employee of Erchonia. h. Distributor may not make any contracts or commitments on behalf of Erchonia nor make any warranties or other representations regarding the Products other than those authorized herein.\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor must adhere to and comply with any use recommendations or restrictions for the Products as indicated or rec\", \"level\": 1, \"text\": \"i. Distributor must adhere to and comply with any use recommendations or restrictions for the Products as indicated or recommended by Erchonia. Distributor shall not make any statements, representations, or recommendations inconsistent with any use restriction or limitation. j. Distributor shall not sell or export the Products outside the United States without prior written consent of Erchonia. To the extent sales of the Products outside the United States are permitted, Distributor will be solely responsible to comply with all applicable import and export laws and regulations. k. Distributor shall promptly notify Erchonia of any complaint about negative, unwanted, deleterious, or other side effects due to the use of the Products, including the complainant's name, contact information, and date of complaint.\"}}, {\"id\": \"l\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the term of this agreement Distributor shall at all time act in responsible and professional manner\", \"level\": 1, \"text\": \"l. During the term of this agreement Distributor shall at all time act in responsible and professional manner. Distributor shall not do anything which is contrary to or which in Erchonia's reasonable business judgment is harmful to its honor, goodwill or reputation.\"}}, {\"id\": \"m\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall at all times comply with all applicable laws and regulations\", \"level\": 1, \"text\": \"m. Distributor shall at all times comply with all applicable laws and regulations.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Restriction on Promotion of Competing Products\", \"level\": 1, \"text\": \"3. Restriction on Promotion of Competing Products. During the term of this agreement, Distributor shall not market, sell advertise or promote the sale or use of any product or device which is competitive with or substantially similar to the Products, without the prior express written consent of Erchonia, nor shall they assist any third party in doing so. Notwithstanding the foregoing, to the extent Distributor or Distributor's customer is a licensed health care professional or licensed health care practitioner, nothing in this paragraph shall prevent or limit Distributor or Distributor's customer from exercising their independent medical judgment with regard to the treatment of any patient.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Orders, Payment, and Shipment\", \"level\": 1, \"text\": \"4. Orders, Payment, and Shipment. a. Erchonia agrees to provide Products to Distributor pursuant to orders placed by Distributor in the form of individual purchase orders issued by Distributor to Erchonia. Such purchase orders shall set forth the quantity of each product ordered, the required delivery date, and the point of delivery. The price for the Products shall be as designated in Schedule A. Erchonia may revise its prices from time to time and deliver a written 90 day notice of the reasonable price revision to Distributor; provided that Erchonia agrees that the prices listed in Exhibit A shall not be increased during the first 90 days of this agreement. b. Erchonia shall submit invoices to Distributor after or concurrent with shipment of Products to Distributor at the delivery address. Distributor shall pay half (1/2) of the purchase price prior to shipment and the remaining balance 30 days after shipment of the Products. Payments received after the 30 day calendar period will be subject to a late fee of 1.5% of the invoice amount. All payments shall be made in U.S. Dollars.\"}}, {\"id\": \"value:90 day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 day\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:30 day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 day\"}}, {\"id\": \"value:1.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"1.5%\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor is responsible for all shipping costs and applicable sales taxes\", \"level\": 1, \"text\": \"c. Distributor is responsible for all shipping costs and applicable sales taxes. Distributor is also responsible for all customs and duties applicable to any sales of the Products outside the United States, to the extent such sales are authorized or permitted.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Expenses and Taxes\", \"level\": 1, \"text\": \"5. Expenses and Taxes. a. Distributor is responsible for any out-of-pocket expenses incurred including but not limited to Products for demonstration, Products for treatment, sales and promotional material, seminar costs including room rental, and travel-related expenses. b. Distributor is responsible for all federal, state and local taxes attributable to compensation received Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 pursuant to this Agreement, including sales, income, social security, and unemployment.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"6. Term and Termination. a. Unless terminated earlier as provided in this agreement, this Agreement shall have an initial term of three (3) years. This agreement shall automatically renew for a period of three (3) years and upon the parties mutual agreement on new minimum performance goals for the renewal period. b. Either party may terminate this Agreement in the event of a material breach by the other party, provided the breaching party is first given reasonably detailed, written notice of the breach. If the breach is not cured within ten days of such notice, the Agreement will terminate immediately.\"}}, {\"id\": \"value:three (3) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) years\"}}, {\"id\": \"value:ten days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten days\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement may be terminated immediately by Erchonia under any of the following conditions\", \"level\": 1, \"text\": \"c. This Agreement may be terminated immediately by Erchonia under any of the following conditions: (a) if the Distributor is declared insolvent or bankrupt; (b) if a petition is filed in any court to declare Distributor bankrupt or for reorganization under the Bankruptcy Law or any similar statute and such petition is not dismissed within 30 days.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon termination of this Agreement by either party, Distributor shall immediately cease using the Trademarks (defined b\", \"level\": 1, \"text\": \"d. Upon termination of this Agreement by either party, Distributor shall immediately cease using the Trademarks (defined below) and discontinue all representations that it is an authorized distributor of the Products or is in anyway affiliated with Erchonia. e. Except upon termination due to Distributors breach of this agreement, Erchonia will complete delivery of all purchase orders accepted by it prior to termination of this agreement; provided that Distributor shall remain liable for full payment of all such orders. f. The provisions of paragraphs 2 (c) (reporting), 7 (Confidentiality), 8 (Protection of Intellectual Property, 10 (Warranty; Limitation of Liability), 11 (Indemnification), 12 (General Provisions) shall survive termination of this agreement.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 1, \"text\": \"7. Confidentiality. a. In connection with this Agreement, the Distributor will have disclosed to it or otherwise have access to information that is confidential and proprietary to Erchonia. Such information includes but is not limited to Product designs, methods and processes, know-how, business or marketing strategies, Product plans, plans for research and development, development tools, financial information, production costs and information, and supplier and customer lists and information and medical research conducted in pursuit of intended medical applications of the product. b. Distributor will not copy, reproduce, disclose, disseminate or provide any confidential information to any third party, without the prior written consent of Erchonia. In addition, Distributor agrees that it will use such confidential information only for the purpose of carrying out its obligations under this agreement. Upon termination of this agreement for any reason, Distributor will return all such confidential information and any copies of it to Erchonia and will remove and delete any such confidential information for any computers, computer systems or other electronic, magnetic or optical media in its possession or control.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding the above, the following materials will not be deemed confidential\", \"level\": 1, \"text\": \"c. Notwithstanding the above, the following materials will not be deemed confidential:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Information which was in the public domain at the time of disclosure\", \"level\": 1, \"text\": \"i. Information which was in the public domain at the time of disclosure\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Information which was published or otherwise became part of the public domain after disclosure to the Distributor throu\", \"level\": 1, \"text\": \"ii. Information which was published or otherwise became part of the public domain after disclosure to the Distributor through no fault of the Distributor; and\"}}, {\"id\": \"iii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Information which was received from a third party who did not acquire it, directly or indirectly, from Erchonia under a\", \"level\": 1, \"text\": \"iii. Information which was received from a third party who did not acquire it, directly or indirectly, from Erchonia under an obligation of confidence except where required by law.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Protection of Intellectual Property\", \"level\": 1, \"text\": \"8. Protection of Intellectual Property. a. Ownership of all applicable copyrights, trade secrets, patents and other intellectual property rights in the Products are and shall at all times remain vested in Erchonia, its licensors or assigns. b. Distributor shall promptly inform Erchonia of any suggested modifications or improvements to the Products and shall, upon Erchonia's request and at Erchonia's expense, execute any documents necessary or appropriate to assign or confirm that all intellectual property rights in any modification Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 or improvement related to the Products are fully vested in Erchonia.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall not modify nor create or attempt to create, by reverse engineering or otherwise, the Products supplie\", \"level\": 1, \"text\": \"c. Distributor shall not modify nor create or attempt to create, by reverse engineering or otherwise, the Products supplied hereunder, or adapt the Products in any way for other uses without Erchonia's prior written consent\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Several of the Products may be protected by one or more U\", \"level\": 1, \"text\": \"d. Several of the Products may be protected by one or more U.S. or international patents. Distributor shall take reasonable steps to ensure that all patent markings and/or notices for or related to the Products are properly placed on the Products, and on any advertising or marketing materials for the Products, and it shall not remove any such markings, notices or labels from any of the Products or related materials or related advertising or marketing materials.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Use of Erchonia Trademarks\", \"level\": 1, \"text\": \"9. Use of Erchonia Trademarks. a. All trademarks, including service marks, trade names and trade address that Erchonia uses in connection with the license granted hereunder (the \\\"Trademarks\\\") are and remain the exclusive property of Erchonia. Nothing contained in this Agreement shall be deemed to give Distributor any right, title or interest in any Trademark. The Trademarks include but are not limited to: the names \\\"Erchonia\\\", \\\"Erchonia Medical\\\", the phrase \\\"Erchonia, Designs Into the Future\\\", the Erchonia logo, packaging design, and Product design. b. During the term of this Agreement, Erchonia grants Distributor a non-exclusive, non-transferable license to use the Trademarks for advertising and promotion of Products. Distributor shall use the Trademarks according to quality standards defined by Erchonia which shall be reasonable and shall be no greater than the standards used by Erchonia for its own advertising and promotion.\"}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"All trademarks, including service marks, trade names and trade address that Erchonia uses in connection with the license granted hereunder\", \"definition_clause\": \"9\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon Erchonia's request, the Distributor shall at its expense deliver to Erchonia representative samples of labels, adv\", \"level\": 1, \"text\": \"c. Upon Erchonia's request, the Distributor shall at its expense deliver to Erchonia representative samples of labels, advertisements, catalogs, spec sheets, and the like, containing the Trademarks, and to inspect all of Distributors websites, social media accounts and any online information posted by Distributor, to ensure that such Trademarks are used only in a manner complaint with the quality standards. Should such material fail to meet the standards set by Erchonia, as determined by Erchonia in its sole discretion, Distributor shall not use and shall withdraw and retract any promotion or advertising that Erchonia finds unsuitable and will at its expense destroy such materials or make them compliant.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All goodwill associated with such trademark use by Distributor inures to the benefit of Erchonia\", \"level\": 1, \"text\": \"d. All goodwill associated with such trademark use by Distributor inures to the benefit of Erchonia.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty; Limitation of Liability\", \"level\": 1, \"text\": \"10. Warranty; Limitation of Liability. a. Distributor Warranty. Distributor represents that it has requisite knowledge and experience to provide the products and services contracted for herein. b. Erchonia Warranty and Warranty Limitations: Other than the written warranty accompanying the Products, Erchonia DISCLAIMS ALL OTHER REPRESENTATIONS AND WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF THIRD PARTY INTELLECTUAL PROPERTY RIGHTS.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"IN NO EVENT SHALL Erchonia BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE, INCLUDING BUT NOT LIMITED T\", \"level\": 1, \"text\": \"c. IN NO EVENT SHALL Erchonia BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COMMERCIAL DAMAGE, INCLUDING BUT NOT LIMITED TO SPECIAL, INCIDENTAL, CONSEQUENTIAL OR OTHER INDIRECT DAMAGES UNDER ANY CAUSE OF ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT, INCLUDING, WITHOUT LIMITATION, CLAIMS ARISING FROM MALFUNCTION OR DEFECTS IN THE PRODUCTS.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification\", \"level\": 1, \"text\": \"11. Indemnification. a. Erchonia shall indemnify, defend and hold Distributor harmless from any claims, demands, liabilities or expenses, including reasonable attorneys' fees, incurred by Distributor as a result of any claim or proceeding against Distributor arising out of or based upon: (i) a claim that the Products infringe upon any U.S. patent, trademark, copyright or other intellectual property rights of any third party, (ii) the products fail to comply with applicable federal law or regulation. b. Distributor shall promptly notify Erchonia of any suit or claim by a third party relating to the Products or use of the Products and Distributor shall promptly furnished Erchonia with a copy of each Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 communication, notice or other action relating to said claim. Erchonia shall have the right to assume sole authority to conduct the trial or settlement of such claim or any negotiations related to any claim for which Erchonia is obligated to indemnify Distributor at Erchonia expense; and Distributor shall provide reasonable information and assistance requested by Erchonia in connection with such claim or suit.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall indemnify, defend and hold Erchonia harmless from any claims, demands, liabilities or expenses, inclu\", \"level\": 1, \"text\": \"c. Distributor shall indemnify, defend and hold Erchonia harmless from any claims, demands, liabilities or expenses, including reasonable attorneys' fees, incurred by Erchonia as a result of any claim or proceeding against Erchonia arising out of or based upon (i) the combination, operation or use of the Products with any hardware, products, programs or data not supplied or approved in writing by Erchonia, if such infringement would have been avoided but for such combination, operation or use; (ii) the modification of the Products by Distributor or its Customers; (iii) any breach of this agreement by Distributor; or (iv) any negligent, grossly negligent, or willful or reckless acts by Distributor, or any of its officers, employees, agents or representatives.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General Provisions\", \"level\": 1, \"text\": \"12. General Provisions: a. Assignment. Distributor may not assign to any person any duties or obligations arising under this Agreement without Erchonia's prior written consent (which consent may be withheld in Erchonia's sole discretion). Notwithstanding the foregoing, the Distributor may engage individuals, at the sole expense and responsibility of the Distributor, to assist the Distributor in performing any of the Distributor's duties or obligations arising under this Agreement. Erchonia may not assign any duties or obligations arising under this Agreement, except to a successor who acquires substantially all of the assets of Erchonia. b. Arbitration. The parties intend to negotiate in good faith and resolve any dispute arising under this Agreement. In the event the parties are unable to resolve any such dispute to binding arbitration for settlement in accordance with the rules of the American Arbitration Association, the arbitrator will determine the manner in which the parties are to pay the costs of such arbitration, including reasonable attorneys' fees\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 1, \"text\": \"c. Notices. All notices and communications required under this Agreement will be in writing and will be delivered in person, faxed or mailed, postage prepaid, by overnight express carrier, to the address of the parties listed at the beginning of this Agreement, or to any other address as such party designates in a written notice to the other party. All notices sent pursuant to the terms of this section will be deemed received on the date of delivery if personally delivered or faxed, or if sent by overnight express carrier, on the next business day immediately following the day sent\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 1, \"text\": \"d. Severability. The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of any other provisions hereof. e. Governing Law. This Agreement shall be governed in all respects by the laws of the United States and the State of Florida, except for conflict of laws provisions. The parties agree that for any dispute, controversy or claim arising out of or in connection with this Agreement, venue and personal jurisdiction shall be in the federal or state court with competent jurisdiction located in Brevard Country, Florida. f. Entire Agreement. This Agreement constitutes and expresses the entire agreement and understanding between the parties hereto with respect to the subject matter, all revisions discussions, promises, representation, and understanding relative thereto, if any, being herein merged. Dated: . Erchonia Medical Corporation. By _____________________ Its _____________________ Distributor: ________________________ InnerScope Hearing Technologies, Inc. By _______________________ Its _______________________ Exhibits Exhibit A - Products and Pricing Exhibit B - Territory and Field of Use Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018\"}}, {\"id\": \"Exhibit C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- Minimum Performance Goals Rev. IMS 8/29/2018 3:38 PM\", \"level\": 1, \"text\": \"Exhibit C - Minimum Performance Goals Rev. IMS 8/29/2018 3:38 PM Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018\"}}, {\"id\": \"SCHEDULE A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ERCHONIA CORPORATION Products and Pricing Erchonia 3LT Laser - Hearing Products Version (product may be renamed) All prices are per unit sold excluding freight, duty, and taxes. Prices will remain in effect for the period of the initial 5 year term. Wholesale Price Item To Be determined when successful research project is complete. The parties agree to cooperate in developing a private label version of the above products on the terms the parties may agree. The private label products shall be versions of the above products labeled and packaged to bear the Distributor's name or the Distributor's trade name. In addition, customized packaging for the private label products may also be developed on the terms agreed to by the parties. Pricing for the private labeled products may be modified due to any increased costs of production or packaging for the private labeled products. In addition, Erchonia may require reasonable minimum purchasing requirements for each run of private labeled products.\", \"level\": 1, \"text\": \"SCHEDULE A ERCHONIA CORPORATION Products and Pricing Erchonia 3LT Laser - Hearing Products Version (product may be renamed) All prices are per unit sold excluding freight, duty, and taxes. Prices will remain in effect for the period of the initial 5 year term. Wholesale Price Item To Be determined when successful research project is complete. The parties agree to cooperate in developing a private label version of the above products on the terms the parties may agree. The private label products shall be versions of the above products labeled and packaged to bear the Distributor's name or the Distributor's trade name. In addition, customized packaging for the private label products may also be developed on the terms agreed to by the parties. Pricing for the private labeled products may be modified due to any increased costs of production or packaging for the private labeled products. In addition, Erchonia may require reasonable minimum purchasing requirements for each run of private labeled products. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 EXHIBIT B Licensed Territory Worldwide Field of Use The products will be sold only for the use in the treatment of hearing disorders. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018 Exhibit C Minimum Performance Goals Minimum Performance won't be determined until FDA 50k market clearance is obtained. At that time parties will operate in good faith to set performance goals. Note: Performance goals to begin 120 days after receipt of FDA market clearance. Source: INNERSCOPE HEARING TECHNOLOGIES, INC., 8-K, 11/9/2018\"}}, {\"id\": \"value:5 year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 year\"}}, {\"id\": \"value:120 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"120 days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of IpassInc_20181203_8-K_EX-99.1_11445874_EX-99.1_Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of IpassInc_20181203_8-K_EX-99.1_11445874_EX-99.1_Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"Exhibit 99.1\", \"title\": \"[***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.\", \"level\": 2, \"text\": \"Exhibit 99.1 [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. CHANNEL PARTNER RESELLER AGREEMENT THIS CHANNEL PARTNER RESELLER AGREEMENT (\\\"Agreement\\\") is entered into and agreed upon as of the Effective Date by and between IPASS INC., having a principal place of business at 3800 Bridge Parkway, Redwood Shores, CA 94065 (\\\"iPass\\\"), and Pareteum Corporation, having a principal business address at 100 Park Avenue, Suite 1600, New York City, New York 10017 (\\\"Channel Partner\\\"). Capitalized terms used in this Agreement shall be defined as set forth herein. This Agreement is comprised of the Terms and Conditions together with all Exhibits attached hereto. The undersigned represent and warrant that they are authorized as representatives of the party on whose behalf they are signing this Agreement and that they have read and agree to adhere to the Terms and Conditions as well as the exhibits attached hereto and incorporated herein by reference. IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date. Channel Partner: iPass Inc.: By: /s/ Victor A. Bozzo By: /s/ Christine Gardner Victor A. Bozzo Christine Gardner Printed Name Printed Name Chief Executive Officer VP Finance Title Title 4/24/2018 04/25/2018 Date Date Source: IPASS INC, 8-K, 12/3/2018 Page 2 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 3 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 4 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 5 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 6 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 7 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 8 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 9 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"12.10\", \"title\": \"Channel Partner represents that\", \"level\": 2, \"text\": \"12.10 Channel Partner represents that: (i) it is duly authorized to provide personal data to iPass; (ii) iPass, its affiliates and its subcontractors can process such data, and (iii) iPass may disclose such data to any affiliate and subcontractor for the purpose of: (a) providing Licensed Software and Services under the Agreement; (b) administering the Agreement; and/or (c) providing marketing and/or product information to Channel Partner through any medium including email. The Parties further agree that iPass may use End User emails to directly contact End Users for service support and updates. This is limited to providing assistance with service sign up, credential retrieval, troubleshooting network connectivity or application use, informational updates about hotspot additions/changes or planned outages (maintenance). 12.11 This Agreement constitutes the entire agreement between the parties concerning the parties with regard to the Licensed Software and Services provided hereunder. All purchase orders, prior agreements, proposals, representations and other understandings whether oral or written, are superseded in their entirety by this Agreement and any applicable order forms. A purchase order may not be used as an order form, and any pre-printed terms on any Channel Partner generated purchase order shall not apply. No alteration or modification of the Agreement will be valid unless made in writing and signed by the parties. In the event of a conflict between the Agreement and any terms and conditions in any other order form, the terms of this Agreement will control unless otherwise expressly stated. The person signing this Agreement represents that he/she is duly authorized to bind the company to the terms and conditions herein. 12.12 Without limiting any of the terms and conditions contained herein, Channel Partner will make available to iPass certain services in exchange for the fees and subject at all times to the terms and conditions referenced in Exhibit G, as same may be updated and amended from time to time. Page 10 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT A\", \"title\": \"DEFINITIONS \\\"Access Point\\\" means Internet access points to which a User connects via the Client Software. \\\"Affiliate\\\" means any entity which is controlled by, controls or is under common control with Channel Partner. For the purposes of this definition, control shall mean ownership of at least fifty percent (50%) of the outstanding voting equity interest. Channel Partner may appoint an Affiliate to perform resale services hereunder with written consent of iPass and in accordance with any iPass mandated contractual commitments and contractual documents. \\\"Agreement\\\" means this Channel Partner Reseller Agreement, including the Exhibits attached hereto, and orders placed pursuant to this Agreement. For clarity, each order constitutes a separate and distinct order for iPass Software and/or Services, and thus each order constitutes a separate contractual commitment. Each order incorporates the terms and conditions set forth herein. \\\"Business Entity\\\" means a corporation, partnership, or enterprise that acquires Services from Channel Partner for use by its employees and contractors. A Business Entity is not authorized to resell the Services to any third parties. 11. \\\"Business Entity Minimum Monthly Commitment\\\" means, for each Business Entity, a minimum monthly commitment of at least 250 Users, by Channel Partner for each Business Entity. iPass shall invoice Channel Partner on a monthly basis, the agreed upon price for the Services as set forth herein. If Channel Partner's total invoiced amount for the Services, for each Business Entity is less than the amount for the number of Users for the Business Entity's Minimum Monthly Commitment, iPass will invoice and Channel Partner will pay to iPass, the shortfall difference between the actual amount paid by Channel Partner to iPass and the amount for the number of Users for the Business Entity Minimum Monthly Commitment. \\\"Business Entity Term\\\" means, for each Business Entity, a period beginning at the beginning of the Business Entity Implementation Period and ending no less than twelve (12) months following the expiration of the Business Entity Implementation Period, as indicated in the order placed by Channel Partner for such Business Entity. Every Business Entity Term automatically renews for a period of no less than 12 months, unless otherwise agreed to in writing between the parties. \\\"Certified iPass Engineer\\\" means an employee of Channel Partner who has attended one RoamServer training session and successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, and Competitive Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Certified Help Desk Agent\\\" means an employee of Channel Partner who has attended one RoamServer training session, one Help Desk training session, and one Broadband Support training session. \\\"Certified Trained Sales Personnel\\\" means an employee of Channel Partner who has successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, Competitive Training, and Sales Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Client Software\\\" means the machine executable version(s) of the client software code, including any Updates thereto, that iPass provides Channel Partner hereunder to enable Channel Partner's End Users to use the Service. The Client Software currently consists of iPass' Open Mobile software as well as the iPassConnect software. \\\"Confidential Information\\\" means information maintained in confidence by a party, and which is marked as such, or information whether written or oral that by its nature would be to a reasonable person under the circumstances understood to be confidential or proprietary information of a party including but not limited to iPass' Software, Documentation, and the parties' product development and marketing plans, business methods and non-public financial and personnel dat \\\"Device\\\" means any machine, computer, smartphone or similar User apparatus on which Channel Partner or a Business Entity has installed the Client Software. \\\"Documentation\\\" means the standard published technical user manuals provided by iPass.\", \"level\": 1, \"text\": \"EXHIBIT A DEFINITIONS \\\"Access Point\\\" means Internet access points to which a User connects via the Client Software. \\\"Affiliate\\\" means any entity which is controlled by, controls or is under common control with Channel Partner. For the purposes of this definition, control shall mean ownership of at least fifty percent (50%) of the outstanding voting equity interest. Channel Partner may appoint an Affiliate to perform resale services hereunder with written consent of iPass and in accordance with any iPass mandated contractual commitments and contractual documents. \\\"Agreement\\\" means this Channel Partner Reseller Agreement, including the Exhibits attached hereto, and orders placed pursuant to this Agreement. For clarity, each order constitutes a separate and distinct order for iPass Software and/or Services, and thus each order constitutes a separate contractual commitment. Each order incorporates the terms and conditions set forth herein. \\\"Business Entity\\\" means a corporation, partnership, or enterprise that acquires Services from Channel Partner for use by its employees and contractors. A Business Entity is not authorized to resell the Services to any third parties. 11. \\\"Business Entity Minimum Monthly Commitment\\\" means, for each Business Entity, a minimum monthly commitment of at least 250 Users, by Channel Partner for each Business Entity. iPass shall invoice Channel Partner on a monthly basis, the agreed upon price for the Services as set forth herein. If Channel Partner's total invoiced amount for the Services, for each Business Entity is less than the amount for the number of Users for the Business Entity's Minimum Monthly Commitment, iPass will invoice and Channel Partner will pay to iPass, the shortfall difference between the actual amount paid by Channel Partner to iPass and the amount for the number of Users for the Business Entity Minimum Monthly Commitment. \\\"Business Entity Term\\\" means, for each Business Entity, a period beginning at the beginning of the Business Entity Implementation Period and ending no less than twelve (12) months following the expiration of the Business Entity Implementation Period, as indicated in the order placed by Channel Partner for such Business Entity. Every Business Entity Term automatically renews for a period of no less than 12 months, unless otherwise agreed to in writing between the parties. \\\"Certified iPass Engineer\\\" means an employee of Channel Partner who has attended one RoamServer training session and successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, and Competitive Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Certified Help Desk Agent\\\" means an employee of Channel Partner who has attended one RoamServer training session, one Help Desk training session, and one Broadband Support training session. \\\"Certified Trained Sales Personnel\\\" means an employee of Channel Partner who has successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, Competitive Training, and Sales Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Client Software\\\" means the machine executable version(s) of the client software code, including any Updates thereto, that iPass provides Channel Partner hereunder to enable Channel Partner's End Users to use the Service. The Client Software currently consists of iPass' Open Mobile software as well as the iPassConnect software. \\\"Confidential Information\\\" means information maintained in confidence by a party, and which is marked as such, or information whether written or oral that by its nature would be to a reasonable person under the circumstances understood to be confidential or proprietary information of a party including but not limited to iPass' Software, Documentation, and the parties' product development and marketing plans, business methods and non-public financial and personnel dat \\\"Device\\\" means any machine, computer, smartphone or similar User apparatus on which Channel Partner or a Business Entity has installed the Client Software. \\\"Documentation\\\" means the standard published technical user manuals provided by iPass. Page 11 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 \\\"Effective Date\\\" means the date of last signature on this Agreement. \\\"Enabled Devices\\\" mean any device with the Channel Partner's app (iOS, Android, PC or Mac) which is enabled by Channel Partner to access the iPass services and also registered and enabled, by the Channel Partner to access Channel Partner's services. \\\"End Users\\\" or \\\"User\\\" means is any person who has an eligible subscriber ID that allows them to access the iPass Services and iPass Network. \\\"End User Agreement\\\" means a written agreement between Channel Partner and a Business Entity or an End User, containing terms and conditions at least as protective of iPass and its suppliers as the terms and conditions set forth in Exhibit E. \\\"iPass Hosted Authentication Service\\\" means a hosted, managed authentication service available within the iPass Portal and hosted by iPass. \\\"iPass Portal\\\" means the secure website accessible through http://www.ipass.com/ where Channel Partner may obtain information about iPass Services, including invoice, billing, ordering and account information, and submit technical support requests. \\\"iPass Web Content\\\" means the information and other materials/content provided to Channel Partner to use in developing Channel Partner's web site(s) or web pages to explain, promote and support the Service. \\\"Licensed Software\\\" \\\"Software\\\" means the Client Software and the Server Software and any Updates to the Client Software and the Server Software (if any). \\\"Mobile Network\\\" or \\\"iPass Network\\\" means iPass' multi-technology mobile access network which includes mobile broadband, Wi-Fi and Ethernet services. The iPass Network is subject to change by iPass upon notice to Partner, on condition that such changes do not materially degrade the network. The iPass Network does not include certain Wi-Fi services that are subject to supplier enforced restrictions. In addition, if any country is subject to a US embargo or other export restriction, it will not be deemed included in the foregoing list, the iPass Network will not be available from such country, and Customer agrees not to use the Licensed Software or the iPass Network in such country.. \\\"Services\\\" means the services and software provided by iPass as more fully described in Exhibit B attached hereto which allow access to the iPass Network. \\\"Term\\\" means the duration of the Agreement. \\\"Update\\\" means any bug fixes, patches or software updates for error corrections which iPass makes available to Channel Partner under this Agreement. Page 12 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT B\", \"title\": \"IPASS SERVICES iPass Services - includes the following services: iPass Mobile Services are delivered to End Users through a cloud-based platform (the \\\"Platform\\\") comprising software elements on the mobile device and available over the Internet. iPass\u00b4 Platform gives control over the definition and management of mobility services configured to a carrier's specific needs. This architecture gives an End User choice in access services and serves as a bridge to future functionality through use of extensible web services standards, while keeping the operational and financial burden on carriers low by not requiring them to purchase, deploy and manage on-premises infrastructure. iPass\u00b4 Platform is designed to provide Customer with reliability, flexibility, network security, policy enforcement, consolidated billing and scalability. The technology consists of the following principal components: i. Foundation Services. Provide the basic capabilities needed for a cloud-based platform, including the ability to manage users (add, remove, or change rights), authenticate users to access the platform, authorize access to particular functions, or track and audit use of the platform. ii. Operational Services. Are built on top of the iPass Foundation Services platform, enabling Customer to operate the various iPass\u00b4 market- facing offers, including user profile/configuration management, network directory management, account management, order management, usage management, support, billing and training. iii. Presentation Services. Impact how information is presented to users of the Platform, usually through a web based portal. Presentation Services include web presentation, data validation, access control (controlling who can see and enter what), and web analytics. iv. Client Services. Provide the core update functionality within the Platform, with the ability to update the iPass Client Software, configuration files, and network registries associated with it, and to receive the data that the client collects. v. Curation Services. Ability of iPass platform to collect information about Open Networks and be able to decode the hotspot information and automate steps to connect to that Network. vi. High-Availability and Scalable Authentication Architecture. iPass\u00b4 relationships with network service providers enables iPass to provide connectivity through multiple networks in over 100 countries on the Platform. As a result, the cloud-based Platform reduces the risk of service interruptions associated with depending on only one service provider. Furthermore, iPass\u00b4 geographically distributed transaction centers act as a unified and fault-tolerant system that provides scalable and highly-available user authentication and quality management information collection. Each point in the authentication process is designed with built-in redundancy and fail-over capabilities.\", \"level\": 1, \"text\": \"EXHIBIT B IPASS SERVICES iPass Services - includes the following services: iPass Mobile Services are delivered to End Users through a cloud-based platform (the \\\"Platform\\\") comprising software elements on the mobile device and available over the Internet. iPass\u00b4 Platform gives control over the definition and management of mobility services configured to a carrier's specific needs. This architecture gives an End User choice in access services and serves as a bridge to future functionality through use of extensible web services standards, while keeping the operational and financial burden on carriers low by not requiring them to purchase, deploy and manage on-premises infrastructure. iPass\u00b4 Platform is designed to provide Customer with reliability, flexibility, network security, policy enforcement, consolidated billing and scalability. The technology consists of the following principal components: i. Foundation Services. Provide the basic capabilities needed for a cloud-based platform, including the ability to manage users (add, remove, or change rights), authenticate users to access the platform, authorize access to particular functions, or track and audit use of the platform. ii. Operational Services. Are built on top of the iPass Foundation Services platform, enabling Customer to operate the various iPass\u00b4 market- facing offers, including user profile/configuration management, network directory management, account management, order management, usage management, support, billing and training. iii. Presentation Services. Impact how information is presented to users of the Platform, usually through a web based portal. Presentation Services include web presentation, data validation, access control (controlling who can see and enter what), and web analytics. iv. Client Services. Provide the core update functionality within the Platform, with the ability to update the iPass Client Software, configuration files, and network registries associated with it, and to receive the data that the client collects. v. Curation Services. Ability of iPass platform to collect information about Open Networks and be able to decode the hotspot information and automate steps to connect to that Network. vi. High-Availability and Scalable Authentication Architecture. iPass\u00b4 relationships with network service providers enables iPass to provide connectivity through multiple networks in over 100 countries on the Platform. As a result, the cloud-based Platform reduces the risk of service interruptions associated with depending on only one service provider. Furthermore, iPass\u00b4 geographically distributed transaction centers act as a unified and fault-tolerant system that provides scalable and highly-available user authentication and quality management information collection. Each point in the authentication process is designed with built-in redundancy and fail-over capabilities. Page 13 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT C\", \"title\": \"SERVICE FEES 1. Pricing. For each Business Entity where UTLD Pricing is elected, Channel Partner shall pay the fees based on the elected Business Entity User Base Package designated by Channel Partner for each order. The fees include the (i) use of the Mobility Management Services; (ii) unlimited iPass network access (except for certain premium in-flight Wi-Fi Services); and (iii) iPass Hosted Authentication Service. Additionally, no Business Entity Start Up Service Fees will be applied to new Business Entities electing the ULTD Pricing option. The fees for ULTD Pricing are defined in Table 1 below. The prices in Table 1 represent the transfer pricing from iPass to Channel Partner for ULTD Pricing. No further discounts are applied to this pricing. TABLE 1\", \"level\": 1, \"text\": \"EXHIBIT C SERVICE FEES 1. Pricing. For each Business Entity where UTLD Pricing is elected, Channel Partner shall pay the fees based on the elected Business Entity User Base Package designated by Channel Partner for each order. The fees include the (i) use of the Mobility Management Services; (ii) unlimited iPass network access (except for certain premium in-flight Wi-Fi Services); and (iii) iPass Hosted Authentication Service. Additionally, no Business Entity Start Up Service Fees will be applied to new Business Entities electing the ULTD Pricing option. The fees for ULTD Pricing are defined in Table 1 below. The prices in Table 1 represent the transfer pricing from iPass to Channel Partner for ULTD Pricing. No further discounts are applied to this pricing. TABLE 1 Business Entity Committed Users Monthly Fee/User Minimum Monthly Fee [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]\"}, {\"id\": \"2\", \"title\": \"Channel Partner shall be charged a maximum rate of [***] per User (\\\"Special Pricing\\\") for all Business Entities signed\", \"level\": 1, \"text\": \"2. Channel Partner shall be charged a maximum rate of [***] per User (\\\"Special Pricing\\\") for all Business Entities signed up by Channel Partner during the first three (3) full calendar months following the Effective Date (\\\"Introductory Period\\\"). The \\\"Special Pricing\\\" is contingent on a minimum order size of [***] users. Following twelve months after the month, during the Introductory Period, a Business Entity was signed, each Business Entity will be charged according to Table 1 above. By way of example and for clarity: For a Business Entity order placed in the first month following the Effective Date and with [***] Users, Channel Partner would be invoiced at [***] per User per month from the first month following the Business Entity order and twelve (12) months thereafter. After the first twelve months, and thereafter, Channel Partner will be charged for [***] Users at the rate of [***] per User per month, pursuant to Table 1 above. Page 14 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT D\", \"title\": \"CUSTOMIZED SERVICES AND SUPPORT 1. SOFTWARE INSTALLATION SUPPORT . iPass personnel will work remotely with Channel Partner to assist the Channel Partner in the installation of the Server Software on Channel Partner's systems. iPass will provide the services indicated in Table 1 below in order to assist Channel Partner with implementation of Service for use by Channel Partner and End Users. Table 1-Start Up Services Service Access to iPass' expanding global network \u00a8 Automatic Phonebook updates \u00a8 Automatic Open Mobile updates \u00a8 RoamServer software updates \u00a8 Monthly Statement and Call Detail Records (CDRs) \u00a8 Help desk and deployment materials \u00a8 Monitoring for authentication failures \u00a8 Customized Open Mobile Client Software 1 Authentication realms (domains) 1 Technical Training Curriculum 1 Web-based session Sales and Marketing Training Curriculum 1 Web-based session Participation in open web conference training sessions scheduled by iPass \u00a8 Seats per year in open regional training scheduled by iPass 4 Access to self-paced training materials on iPass training portal \u00a8 2. TECHNICAL SUPPORT 2.1 Definitions. Any capitalized terms used herein and not defined below are defined in the Agreement. (a) \\\"First Level Technical Support\\\" means taking End User calls, getting complete information from End Users regarding problems experienced by such End Users, testing the End User name and password, eliminating common End User errors, checking the network status page and escalating unresolved issues with written documentation detailing steps taken prior to escalation. (b) \\\"Second Level Technical Support\\\" means providing assistance to First Level Technical Support help desk for issues that cannot be resolved through First Level Technical Support. (c) \\\"Third Level Technical Support\\\" means providing technical assistance to Channel Partner's authorized Second Level Technical Support personnel for technical issues that cannot be resolved by Second Level Technical Support. 2.2 First Level Technical Support and Second Level Technical Support. Channel Partner or Business Entity will be responsible for providing its End Users First Level Technical Support. Channel Partner will be responsible for providing End Users Second Level Technical Support. Second Level Technical Support personnel who have received training regarding the Service and the Software from iPass pursuant to Section 2 of the Agreement will be authorized to contact the applicable Third Level Technical Support centers at iPass to resolve any problems that cannot be resolved by First Level Technical Support or Second Level Technical Support. Channel Partner may change its authorized contacts for Third Level Technical Support at any time upon written notice to iPass so long as any new authorized contacts have completed the requisite iPass training. 2.3 Third Level Technical Support. iPass will provide Channel Partner with Third Level Technical Support in accordance with iPass standard procedures. iPass will only be obligated to provide Third Level Technical Support for the Software if Channel Partner has installed all Updates released by iPass which fix errors in the Software in accordance with Section 2.4 below. Channel Partner must have its password and id available in order to access and submit a request, absent which iPass will have no obligation to provide Channel Partner with Third Level Technical Support.\", \"level\": 1, \"text\": \"EXHIBIT D CUSTOMIZED SERVICES AND SUPPORT 1. SOFTWARE INSTALLATION SUPPORT . iPass personnel will work remotely with Channel Partner to assist the Channel Partner in the installation of the Server Software on Channel Partner's systems. iPass will provide the services indicated in Table 1 below in order to assist Channel Partner with implementation of Service for use by Channel Partner and End Users. Table 1-Start Up Services Service Access to iPass' expanding global network \u00a8 Automatic Phonebook updates \u00a8 Automatic Open Mobile updates \u00a8 RoamServer software updates \u00a8 Monthly Statement and Call Detail Records (CDRs) \u00a8 Help desk and deployment materials \u00a8 Monitoring for authentication failures \u00a8 Customized Open Mobile Client Software 1 Authentication realms (domains) 1 Technical Training Curriculum 1 Web-based session Sales and Marketing Training Curriculum 1 Web-based session Participation in open web conference training sessions scheduled by iPass \u00a8 Seats per year in open regional training scheduled by iPass 4 Access to self-paced training materials on iPass training portal \u00a8 2. TECHNICAL SUPPORT 2.1 Definitions. Any capitalized terms used herein and not defined below are defined in the Agreement. (a) \\\"First Level Technical Support\\\" means taking End User calls, getting complete information from End Users regarding problems experienced by such End Users, testing the End User name and password, eliminating common End User errors, checking the network status page and escalating unresolved issues with written documentation detailing steps taken prior to escalation. (b) \\\"Second Level Technical Support\\\" means providing assistance to First Level Technical Support help desk for issues that cannot be resolved through First Level Technical Support. (c) \\\"Third Level Technical Support\\\" means providing technical assistance to Channel Partner's authorized Second Level Technical Support personnel for technical issues that cannot be resolved by Second Level Technical Support. 2.2 First Level Technical Support and Second Level Technical Support. Channel Partner or Business Entity will be responsible for providing its End Users First Level Technical Support. Channel Partner will be responsible for providing End Users Second Level Technical Support. Second Level Technical Support personnel who have received training regarding the Service and the Software from iPass pursuant to Section 2 of the Agreement will be authorized to contact the applicable Third Level Technical Support centers at iPass to resolve any problems that cannot be resolved by First Level Technical Support or Second Level Technical Support. Channel Partner may change its authorized contacts for Third Level Technical Support at any time upon written notice to iPass so long as any new authorized contacts have completed the requisite iPass training. 2.3 Third Level Technical Support. iPass will provide Channel Partner with Third Level Technical Support in accordance with iPass standard procedures. iPass will only be obligated to provide Third Level Technical Support for the Software if Channel Partner has installed all Updates released by iPass which fix errors in the Software in accordance with Section 2.4 below. Channel Partner must have its password and id available in order to access and submit a request, absent which iPass will have no obligation to provide Channel Partner with Third Level Technical Support. Page 15 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 16 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"c\", \"title\": \"Ticket Requirements At a minimum all Severity One and Severity Two problem reports shall contain the following in order\", \"level\": 1, \"text\": \"c. Ticket Requirements At a minimum all Severity One and Severity Two problem reports shall contain the following in order to expedite investigation and verification of the problem: (i) Username and Description of observed behavior. (ii) Debug Logs if available. (iii) Steps to reproduce. (iv) Operating environment (Operating system, language, software version, profile number and hardware, as applicable.) (v) Dates / times of transaction failures. (vi) Name of network attempted. iPass may request additional information for verification of a reported problem as necessary. d. Customer Care Hotline For Severity One issues, iPass recommends that opening a web-based support request be followed by a phone call to iPass at one of the following Severity One Customer Care numbers: Inside the United States: +1-877-464-7277 Outside the United States: +1 650-232-4300 Dialing within Europe: +44 20 7010 8344 Phone numbers are available 24 hours a day, 7 seven days a week. Please note that in order to safeguard customers against unauthorized service activity, iPass will require that callers authenticate their credentials via the web based ticketing system prior to any action by iPass. All change requests MUST be in writing. In order to ensure that tickets are handled in order of receipt, by priority, calls of a nature which are not Severity One will be ticketed and placed in queue to be handled in order of receipt, by severity. 4.4 Service Levels (a) Support Request Response - For each Severity Level, iPass shall provide the following response Service Levels: For Channel Partner Helpdesk Support Requests submitted in accordance with the process defined herein. Problem Severity Response Service Level Severity One Targeted Response Time: Issues will receive a response from iPass within fifteen (15) minutes (1 hour on weekends and local public holidays) after submitting a Severity One support case followed by a phone call to iPass. Please note Severity One issues reported via a support case only will be responded to within 1 hour. Severity Two Targeted Response Time: Issues will receive a response from iPass within 8 hours of receipt of the request (except weekends and local public holidays.) Severity Three Targeted Response Time: Issues will receive a response from iPass within 12 hours of receipt of the request (except weekends and local public holidays.) (b) Problem Verification. iPass and Channel Partner will make reasonable efforts to verify any reported problem as soon as it is reported as well as any follow-up information that may be required. (c) Update Intervals. iPass will make reasonable efforts to keep Channel Partner's Second Level Technical Support personnel informed of the latest status on any problem submitted. In the event Channel Partner's Second Level Technical Support personnel requires more frequent updates, then these will be discussed and mutually agreed upon and will depend on the severity and complexity of the problem. Page 17 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 (d) Severity Reclassification. To ensure that severe problems receive highest priority, iPass may modify a ticket submitted as Severity One issue if it clearly does not meet the criteria for Severity One. 4.5 iPass Support Escalation Process (a) When to Escalate an Issue (i) If iPass fails to respond within the prescribed service level response time, the Channel Partner Help Desk is encouraged to escalate the issue to the Escalation Contact in the respective time zone (see escalation contacts below.) (ii) If the iPass Customer Care Representative and the Channel Partner Help Desk cannot agree on an action plan to resolve an issue (Severity One, Two or Three), then the iPass Customer Care Representative and the Channel Partner Help Desk are encouraged to escalate the issue to the Director of Customer Care. (iii) Once a plan has been agreed, iPass will work to resolve the issue. If the Channel Partner Help Desk is not satisfied with the progress that is being made to resolve an issue, they are encouraged to contact the Director of Customer Care. (b) How to Escalate an Issue (i) All escalations should be in writing (to the e-mail address listed below) or by phone followed up with a summary from Channel Partner 's Help Desk. (ii) Written documentation should outline the original issue and progress to date. It should also include impact to the customer and reason for the escalation. (c) Response to Escalation (i) The Director of Customer Care will respond upon receipt to any escalations. (ii) Escalations will take priority over any issue of the same severity level. Customer Care Escalation Contact Location/Time Zone London, UK (GMT) Regional Contact Richard Sabbarton email rsabbarton@ipass.com Office Phone +44 20 7010 8319 Location/Time Zone Redwood Shores, US (PST) Regional Contact Saritha Padubidri email spadubid@ipass.com Office Phone + 1 650 232 4127 Location/Time Zone Bangalore, IN (IST) Regional Contact Sujith Varijakshan email svarijakshan@ipass.com Office Phone +91 80 41380976 ESCALATION Manager - Director of Support Escalation Manager Alan Ridgewell email aridgewell@ipass.com Office Phone +44 20 7010 8304 Page 18 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT E\", \"title\": \"MINIMUM END USER TERMS Channel Partner when used herein has the same meaning as in the Agreement. Channel Partner should change the word \\\"Channel Partner\\\" herein to its name when drafting End User agreements. \\\"You\\\" referred to herein refers to the End User(s). iPass as referenced herein shall mean iPass Inc. Capitalized terms used herein shall have the same meaning ascribed to them in the Agreement. 1. By its very nature, the Internet contains offensive and/or harmful material, in some cases under descriptions that have been mislabeled or are otherwise deceptive. Neither Channel Partner, iPass nor their suppliers shall be responsible for any damages suffered by any person as a result of obtaining Internet access. Access to the Internet is provided solely on an \\\"AS IS\\\" basis. Neither Channel Partner, iPass, nor its suppliers warrant, nor do they assume responsibility for, any consequences suffered by any person as a result of Internet access including, without limitation, those suffered as a result of accessing Internet information and content, such as, by way of example only, the possibility of contracting computer viruses, accessing information with offensive, inaccurate or inappropriate content. Channel Partner, iPass and its suppliers exercise no control whatsoever over the content of the information passing through their systems. 2. You agree to be bound by the usage policies of iPass including, by way of example, its Privacy Policy. You acknowledge and agree that iPass may disclose your usage data to Channel Partner and other third parties as detailed in iPass' Privacy Policy (see http:www.ipass.com). You accept that certain uses of your data are necessary to enable provision of the Services to you and accordingly that if you withdraw your consent for iPass to use your data as is detailed in its Privacy Policy the supply of the Service to you may have to be terminated. You acknowledge and agree that all End Users must exercise their own due diligence before relying on any information available on the Internet, and must determine that they have all necessary rights to copy, publish or otherwise distribute any such information available on the Internet under copyright and other applicable laws. 3. NOTWITHSTANDING ANYTHING ELSE IN THIS AGREEMENT, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, SERVICES ARE PROVIDED ON AN \\\"AS IS\\\" AND \\\"AS AVAILABLE\\\" BASIS, AND CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DISCLAIM AND MAKE NO REPRESENTATIONS OR WARRANTIES AND THERE ARE NO CONDITIONS OF ANY KIND, EITHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF NON-INTERFERENCE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ARISING FROM COURSE OF DEALING OR USAGE OF TRADE. YOU ASSUME ALL RESPONSIBILITY AND RISK FOR USE OF SERVICES. ANY STATEMENTS MADE IN ANY PACKAGING, MANUALS, WRITTEN OR ELECTRONIC DOCUMENTS, OR BY ANY CHANNEL PARTNER OR IPASS EMPLOYEES, REPRESENTATIVES, OR AGENTS, ARE PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND NOT AS REPRESENTATIONS OR WARRANTIES OF ANY KIND. CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DO NOT WARRANT THAT SERVICES WILL BE UNINTERRUPTED, ERROR FREE, OR FREE FROM SERVICE DEGRADATION, OR THAT ANY INFORMATION, SOFTWARE, OR OTHER MATERIAL ACCESSIBLE ON THE SERVICES ARE FREE FROM VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING, INTERFERING, OR DESTRUCTIVE PROPERTIES. CHANNEL PARTNER, IPASS AND THEIR SUUPLIERS CANNOT AND DO NOT GUARANTEE THE SECURITY OR INTEGRITY OF DATA TRANSMISSION OR STORAGE, OR THAT VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE DETECTED OR REMEDIATED BY SERVICES. SERVICES ARE ONLY AVAILABLE WITHIN THE COVERAGE AREA OF THE IPASS NETWORK, WHICH IS SUBJECT TO CHANGE. YOU ACKNOWLEDGE THAT SERVICES MAY BE TEMPORARILY UNAVAILABLE FOR MAINTENANCE, EQUIPMENT MODIFICATIONS, OR UPGRADES, AND FOR OTHER REASONS WITHIN AND WITHOUT THE DIRECT CONTROL OF IPASS. 4. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL CHANNEL PARTNER, IPASS OR ITS SUPPLIERS BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR FOR INTERRUPTED COMMUNICATIONS, LOST DATA OR LOST PROFITS, ARISING OUT OF OR IN CONNECTION WITH THE SERVICE.\", \"level\": 1, \"text\": \"EXHIBIT E MINIMUM END USER TERMS Channel Partner when used herein has the same meaning as in the Agreement. Channel Partner should change the word \\\"Channel Partner\\\" herein to its name when drafting End User agreements. \\\"You\\\" referred to herein refers to the End User(s). iPass as referenced herein shall mean iPass Inc. Capitalized terms used herein shall have the same meaning ascribed to them in the Agreement. 1. By its very nature, the Internet contains offensive and/or harmful material, in some cases under descriptions that have been mislabeled or are otherwise deceptive. Neither Channel Partner, iPass nor their suppliers shall be responsible for any damages suffered by any person as a result of obtaining Internet access. Access to the Internet is provided solely on an \\\"AS IS\\\" basis. Neither Channel Partner, iPass, nor its suppliers warrant, nor do they assume responsibility for, any consequences suffered by any person as a result of Internet access including, without limitation, those suffered as a result of accessing Internet information and content, such as, by way of example only, the possibility of contracting computer viruses, accessing information with offensive, inaccurate or inappropriate content. Channel Partner, iPass and its suppliers exercise no control whatsoever over the content of the information passing through their systems. 2. You agree to be bound by the usage policies of iPass including, by way of example, its Privacy Policy. You acknowledge and agree that iPass may disclose your usage data to Channel Partner and other third parties as detailed in iPass' Privacy Policy (see http:www.ipass.com). You accept that certain uses of your data are necessary to enable provision of the Services to you and accordingly that if you withdraw your consent for iPass to use your data as is detailed in its Privacy Policy the supply of the Service to you may have to be terminated. You acknowledge and agree that all End Users must exercise their own due diligence before relying on any information available on the Internet, and must determine that they have all necessary rights to copy, publish or otherwise distribute any such information available on the Internet under copyright and other applicable laws. 3. NOTWITHSTANDING ANYTHING ELSE IN THIS AGREEMENT, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, SERVICES ARE PROVIDED ON AN \\\"AS IS\\\" AND \\\"AS AVAILABLE\\\" BASIS, AND CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DISCLAIM AND MAKE NO REPRESENTATIONS OR WARRANTIES AND THERE ARE NO CONDITIONS OF ANY KIND, EITHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF NON-INTERFERENCE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ARISING FROM COURSE OF DEALING OR USAGE OF TRADE. YOU ASSUME ALL RESPONSIBILITY AND RISK FOR USE OF SERVICES. ANY STATEMENTS MADE IN ANY PACKAGING, MANUALS, WRITTEN OR ELECTRONIC DOCUMENTS, OR BY ANY CHANNEL PARTNER OR IPASS EMPLOYEES, REPRESENTATIVES, OR AGENTS, ARE PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND NOT AS REPRESENTATIONS OR WARRANTIES OF ANY KIND. CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DO NOT WARRANT THAT SERVICES WILL BE UNINTERRUPTED, ERROR FREE, OR FREE FROM SERVICE DEGRADATION, OR THAT ANY INFORMATION, SOFTWARE, OR OTHER MATERIAL ACCESSIBLE ON THE SERVICES ARE FREE FROM VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING, INTERFERING, OR DESTRUCTIVE PROPERTIES. CHANNEL PARTNER, IPASS AND THEIR SUUPLIERS CANNOT AND DO NOT GUARANTEE THE SECURITY OR INTEGRITY OF DATA TRANSMISSION OR STORAGE, OR THAT VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE DETECTED OR REMEDIATED BY SERVICES. SERVICES ARE ONLY AVAILABLE WITHIN THE COVERAGE AREA OF THE IPASS NETWORK, WHICH IS SUBJECT TO CHANGE. YOU ACKNOWLEDGE THAT SERVICES MAY BE TEMPORARILY UNAVAILABLE FOR MAINTENANCE, EQUIPMENT MODIFICATIONS, OR UPGRADES, AND FOR OTHER REASONS WITHIN AND WITHOUT THE DIRECT CONTROL OF IPASS. 4. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL CHANNEL PARTNER, IPASS OR ITS SUPPLIERS BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR FOR INTERRUPTED COMMUNICATIONS, LOST DATA OR LOST PROFITS, ARISING OUT OF OR IN CONNECTION WITH THE SERVICE. Page 19 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"5\", \"title\": \"You may not use the Services to take any actions or make any statements that, by way of example only\", \"level\": 1, \"text\": \"5. You may not use the Services to take any actions or make any statements that, by way of example only: (a) infringe on any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy; (b) violate any applicable law, statute, ordinance or regulation (including without limitation those regarding export control); (c) are defamatory, trade libelous or unlawfully threatening; (d) are pornographic or obscene; (e) violate any laws regarding unfair competition, antidiscrimination or false advertising, (f) result in the distribution of viruses, Trojan horses, worms, time bombs, cancelbots, chain letters or other similar harmful or deleterious programming routines, or (g) result in the unauthorized entry to any other machine accessible via the network. You may not use the Services to distribute any bulk unsolicited emails or otherwise cause an excessive or disproportionate load on Channel Partner's, iPass' or their suppliers' infrastructure. Any access to other networks connected to Channel Partner's, iPass' and its suppliers' networks must comply with the rules appropriate for such networks. Violation of the foregoing may result in termination of access. Given the current regulatory and technical environment you should not have an expectation of privacy in your online activities 6. iPass and its suppliers shall be deemed to be third-party beneficiaries of this agreement, with the right to enforce the terms of this agreement. You agree that this Agreement is expressly for the benefit of Channel Partner, iPass and its suppliers and may be enforced by them. 7. You may not resell or redistribute any of the Services to any third parties. 8. Subject to the terms and conditions of this agreement, Channel Partner grants to you a royalty-free, non-exclusive, non-transferable, limited license right exercisable solely during the term of this agreement to: (1) reproduce, exactly as provided by Channel Partner, object code copies of the Client Software, as needed for distribution to your End Users the iPass Software; and to install and use the iPass Licensed Software. You acknowledge that the Licensed Software contains the valuable information of iPass and its suppliers, and agree not to cause or permit the modification, reverse engineering, translation, disassembly, or decompilation of, or otherwise to attempt to derive the source code of such Licensed Software, whether in whole or in part (except to the extent permitted by applicable law). You will not obfuscate, alter or remove any copyright, trademark or other proprietary notice or legend on or in the Licensed Software and associated Documentation and will include all such markings in all copies of such materials. 9. The Services may be suspended or terminated if you breach these terms. Any breach of these terms by your End Users shall be deemed a breach by you. 10. This Agreement shall terminate upon termination of the agreement between Channel Partner and iPass. Page 20 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT F\", \"title\": \"IPASS MARKS\", \"level\": 1, \"text\": \"EXHIBIT F IPASS MARKS iPass\u00ae iPass Open Mobile\u2122 iPass Open Mobile Exchange\u2122 iPass OMX\u2122 iPass ULTD Page 21 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}, {\"id\": \"EXHIBIT G\", \"title\": \"PARATEUM SERVICES Subject to the terms and conditions below, Channel Partner (Pareteum Corporation) will provide on a non-exclusive basis the following services to iPass for resale to iPass' customers: Managed Services Platform and Global Cloud Mobility Platform (collectively, the \\\"Pareteum Services\\\"). Channel Partner (Pareteum Corporation) and iPass shall mutually agree upon the terms and conditions (which will include, without limitation, the scope and geography where the Pareteum Services may be resold, fees and support service and related user terms) upon the earlier to occur of: (i) iPass' first proposed resale of the Pareteum Services to one of its customers; or (ii) within ninety (90) days from the Effective Date. Once the parties have mutually agreed upon the foregoing terms and conditions, the parties will amend this Exhibit G to reflect the terms by which iPass may resell the Pareteum Services.\", \"level\": 1, \"text\": \"EXHIBIT G PARATEUM SERVICES Subject to the terms and conditions below, Channel Partner (Pareteum Corporation) will provide on a non-exclusive basis the following services to iPass for resale to iPass' customers: Managed Services Platform and Global Cloud Mobility Platform (collectively, the \\\"Pareteum Services\\\"). Channel Partner (Pareteum Corporation) and iPass shall mutually agree upon the terms and conditions (which will include, without limitation, the scope and geography where the Pareteum Services may be resold, fees and support service and related user terms) upon the earlier to occur of: (i) iPass' first proposed resale of the Pareteum Services to one of its customers; or (ii) within ninety (90) days from the Effective Date. Once the parties have mutually agreed upon the foregoing terms and conditions, the parties will amend this Exhibit G to reflect the terms by which iPass may resell the Pareteum Services. Page 22 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of IpassInc_20181203_8-K_EX-99.1_11445874_EX-99.1_Reseller Agreement\", \"nodes\": [{\"id\": \"Exhibit 99.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.\", \"level\": 2, \"text\": \"Exhibit 99.1 [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. CHANNEL PARTNER RESELLER AGREEMENT THIS CHANNEL PARTNER RESELLER AGREEMENT (\\\"Agreement\\\") is entered into and agreed upon as of the Effective Date by and between IPASS INC., having a principal place of business at 3800 Bridge Parkway, Redwood Shores, CA 94065 (\\\"iPass\\\"), and Pareteum Corporation, having a principal business address at 100 Park Avenue, Suite 1600, New York City, New York 10017 (\\\"Channel Partner\\\"). Capitalized terms used in this Agreement shall be defined as set forth herein. This Agreement is comprised of the Terms and Conditions together with all Exhibits attached hereto. The undersigned represent and warrant that they are authorized as representatives of the party on whose behalf they are signing this Agreement and that they have read and agree to adhere to the Terms and Conditions as well as the exhibits attached hereto and incorporated herein by reference. IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date. Channel Partner: iPass Inc.: By: /s/ Victor A. Bozzo By: /s/ Christine Gardner Victor A. Bozzo Christine Gardner Printed Name Printed Name Chief Executive Officer VP Finance Title Title 4/24/2018 04/25/2018 Date Date Source: IPASS INC, 8-K, 12/3/2018 Page 2 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 3 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 4 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 5 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 6 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 7 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 8 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 9 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"12.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Channel Partner represents that\", \"level\": 2, \"text\": \"12.10 Channel Partner represents that: (i) it is duly authorized to provide personal data to iPass; (ii) iPass, its affiliates and its subcontractors can process such data, and (iii) iPass may disclose such data to any affiliate and subcontractor for the purpose of: (a) providing Licensed Software and Services under the Agreement; (b) administering the Agreement; and/or (c) providing marketing and/or product information to Channel Partner through any medium including email. The Parties further agree that iPass may use End User emails to directly contact End Users for service support and updates. This is limited to providing assistance with service sign up, credential retrieval, troubleshooting network connectivity or application use, informational updates about hotspot additions/changes or planned outages (maintenance). 12.11 This Agreement constitutes the entire agreement between the parties concerning the parties with regard to the Licensed Software and Services provided hereunder. All purchase orders, prior agreements, proposals, representations and other understandings whether oral or written, are superseded in their entirety by this Agreement and any applicable order forms. A purchase order may not be used as an order form, and any pre-printed terms on any Channel Partner generated purchase order shall not apply. No alteration or modification of the Agreement will be valid unless made in writing and signed by the parties. In the event of a conflict between the Agreement and any terms and conditions in any other order form, the terms of this Agreement will control unless otherwise expressly stated. The person signing this Agreement represents that he/she is duly authorized to bind the company to the terms and conditions herein. 12.12 Without limiting any of the terms and conditions contained herein, Channel Partner will make available to iPass certain services in exchange for the fees and subject at all times to the terms and conditions referenced in Exhibit G, as same may be updated and amended from time to time. Page 10 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS \\\"Access Point\\\" means Internet access points to which a User connects via the Client Software. \\\"Affiliate\\\" means any entity which is controlled by, controls or is under common control with Channel Partner. For the purposes of this definition, control shall mean ownership of at least fifty percent (50%) of the outstanding voting equity interest. Channel Partner may appoint an Affiliate to perform resale services hereunder with written consent of iPass and in accordance with any iPass mandated contractual commitments and contractual documents. \\\"Agreement\\\" means this Channel Partner Reseller Agreement, including the Exhibits attached hereto, and orders placed pursuant to this Agreement. For clarity, each order constitutes a separate and distinct order for iPass Software and/or Services, and thus each order constitutes a separate contractual commitment. Each order incorporates the terms and conditions set forth herein. \\\"Business Entity\\\" means a corporation, partnership, or enterprise that acquires Services from Channel Partner for use by its employees and contractors. A Business Entity is not authorized to resell the Services to any third parties. 11. \\\"Business Entity Minimum Monthly Commitment\\\" means, for each Business Entity, a minimum monthly commitment of at least 250 Users, by Channel Partner for each Business Entity. iPass shall invoice Channel Partner on a monthly basis, the agreed upon price for the Services as set forth herein. If Channel Partner's total invoiced amount for the Services, for each Business Entity is less than the amount for the number of Users for the Business Entity's Minimum Monthly Commitment, iPass will invoice and Channel Partner will pay to iPass, the shortfall difference between the actual amount paid by Channel Partner to iPass and the amount for the number of Users for the Business Entity Minimum Monthly Commitment. \\\"Business Entity Term\\\" means, for each Business Entity, a period beginning at the beginning of the Business Entity Implementation Period and ending no less than twelve (12) months following the expiration of the Business Entity Implementation Period, as indicated in the order placed by Channel Partner for such Business Entity. Every Business Entity Term automatically renews for a period of no less than 12 months, unless otherwise agreed to in writing between the parties. \\\"Certified iPass Engineer\\\" means an employee of Channel Partner who has attended one RoamServer training session and successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, and Competitive Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Certified Help Desk Agent\\\" means an employee of Channel Partner who has attended one RoamServer training session, one Help Desk training session, and one Broadband Support training session. \\\"Certified Trained Sales Personnel\\\" means an employee of Channel Partner who has successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, Competitive Training, and Sales Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Client Software\\\" means the machine executable version(s) of the client software code, including any Updates thereto, that iPass provides Channel Partner hereunder to enable Channel Partner's End Users to use the Service. The Client Software currently consists of iPass' Open Mobile software as well as the iPassConnect software. \\\"Confidential Information\\\" means information maintained in confidence by a party, and which is marked as such, or information whether written or oral that by its nature would be to a reasonable person under the circumstances understood to be confidential or proprietary information of a party including but not limited to iPass' Software, Documentation, and the parties' product development and marketing plans, business methods and non-public financial and personnel dat \\\"Device\\\" means any machine, computer, smartphone or similar User apparatus on which Channel Partner or a Business Entity has installed the Client Software. \\\"Documentation\\\" means the standard published technical user manuals provided by iPass.\", \"level\": 1, \"text\": \"EXHIBIT A DEFINITIONS \\\"Access Point\\\" means Internet access points to which a User connects via the Client Software. \\\"Affiliate\\\" means any entity which is controlled by, controls or is under common control with Channel Partner. For the purposes of this definition, control shall mean ownership of at least fifty percent (50%) of the outstanding voting equity interest. Channel Partner may appoint an Affiliate to perform resale services hereunder with written consent of iPass and in accordance with any iPass mandated contractual commitments and contractual documents. \\\"Agreement\\\" means this Channel Partner Reseller Agreement, including the Exhibits attached hereto, and orders placed pursuant to this Agreement. For clarity, each order constitutes a separate and distinct order for iPass Software and/or Services, and thus each order constitutes a separate contractual commitment. Each order incorporates the terms and conditions set forth herein. \\\"Business Entity\\\" means a corporation, partnership, or enterprise that acquires Services from Channel Partner for use by its employees and contractors. A Business Entity is not authorized to resell the Services to any third parties. 11. \\\"Business Entity Minimum Monthly Commitment\\\" means, for each Business Entity, a minimum monthly commitment of at least 250 Users, by Channel Partner for each Business Entity. iPass shall invoice Channel Partner on a monthly basis, the agreed upon price for the Services as set forth herein. If Channel Partner's total invoiced amount for the Services, for each Business Entity is less than the amount for the number of Users for the Business Entity's Minimum Monthly Commitment, iPass will invoice and Channel Partner will pay to iPass, the shortfall difference between the actual amount paid by Channel Partner to iPass and the amount for the number of Users for the Business Entity Minimum Monthly Commitment. \\\"Business Entity Term\\\" means, for each Business Entity, a period beginning at the beginning of the Business Entity Implementation Period and ending no less than twelve (12) months following the expiration of the Business Entity Implementation Period, as indicated in the order placed by Channel Partner for such Business Entity. Every Business Entity Term automatically renews for a period of no less than 12 months, unless otherwise agreed to in writing between the parties. \\\"Certified iPass Engineer\\\" means an employee of Channel Partner who has attended one RoamServer training session and successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, and Competitive Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Certified Help Desk Agent\\\" means an employee of Channel Partner who has attended one RoamServer training session, one Help Desk training session, and one Broadband Support training session. \\\"Certified Trained Sales Personnel\\\" means an employee of Channel Partner who has successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, Competitive Training, and Sales Training. Successful completion means achieving a passing result on the on-line tests after each module. \\\"Client Software\\\" means the machine executable version(s) of the client software code, including any Updates thereto, that iPass provides Channel Partner hereunder to enable Channel Partner's End Users to use the Service. The Client Software currently consists of iPass' Open Mobile software as well as the iPassConnect software. \\\"Confidential Information\\\" means information maintained in confidence by a party, and which is marked as such, or information whether written or oral that by its nature would be to a reasonable person under the circumstances understood to be confidential or proprietary information of a party including but not limited to iPass' Software, Documentation, and the parties' product development and marketing plans, business methods and non-public financial and personnel dat \\\"Device\\\" means any machine, computer, smartphone or similar User apparatus on which Channel Partner or a Business Entity has installed the Client Software. \\\"Documentation\\\" means the standard published technical user manuals provided by iPass. Page 11 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 \\\"Effective Date\\\" means the date of last signature on this Agreement. \\\"Enabled Devices\\\" mean any device with the Channel Partner's app (iOS, Android, PC or Mac) which is enabled by Channel Partner to access the iPass services and also registered and enabled, by the Channel Partner to access Channel Partner's services. \\\"End Users\\\" or \\\"User\\\" means is any person who has an eligible subscriber ID that allows them to access the iPass Services and iPass Network. \\\"End User Agreement\\\" means a written agreement between Channel Partner and a Business Entity or an End User, containing terms and conditions at least as protective of iPass and its suppliers as the terms and conditions set forth in Exhibit E. \\\"iPass Hosted Authentication Service\\\" means a hosted, managed authentication service available within the iPass Portal and hosted by iPass. \\\"iPass Portal\\\" means the secure website accessible through http://www.ipass.com/ where Channel Partner may obtain information about iPass Services, including invoice, billing, ordering and account information, and submit technical support requests. \\\"iPass Web Content\\\" means the information and other materials/content provided to Channel Partner to use in developing Channel Partner's web site(s) or web pages to explain, promote and support the Service. \\\"Licensed Software\\\" \\\"Software\\\" means the Client Software and the Server Software and any Updates to the Client Software and the Server Software (if any). \\\"Mobile Network\\\" or \\\"iPass Network\\\" means iPass' multi-technology mobile access network which includes mobile broadband, Wi-Fi and Ethernet services. The iPass Network is subject to change by iPass upon notice to Partner, on condition that such changes do not materially degrade the network. The iPass Network does not include certain Wi-Fi services that are subject to supplier enforced restrictions. In addition, if any country is subject to a US embargo or other export restriction, it will not be deemed included in the foregoing list, the iPass Network will not be available from such country, and Customer agrees not to use the Licensed Software or the iPass Network in such country.. \\\"Services\\\" means the services and software provided by iPass as more fully described in Exhibit B attached hereto which allow access to the iPass Network. \\\"Term\\\" means the duration of the Agreement. \\\"Update\\\" means any bug fixes, patches or software updates for error corrections which iPass makes available to Channel Partner under this Agreement. Page 12 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"IPASS SERVICES iPass Services - includes the following services: iPass Mobile Services are delivered to End Users through a cloud-based platform (the \\\"Platform\\\") comprising software elements on the mobile device and available over the Internet. iPass\u00b4 Platform gives control over the definition and management of mobility services configured to a carrier's specific needs. This architecture gives an End User choice in access services and serves as a bridge to future functionality through use of extensible web services standards, while keeping the operational and financial burden on carriers low by not requiring them to purchase, deploy and manage on-premises infrastructure. iPass\u00b4 Platform is designed to provide Customer with reliability, flexibility, network security, policy enforcement, consolidated billing and scalability. The technology consists of the following principal components: i. Foundation Services. Provide the basic capabilities needed for a cloud-based platform, including the ability to manage users (add, remove, or change rights), authenticate users to access the platform, authorize access to particular functions, or track and audit use of the platform. ii. Operational Services. Are built on top of the iPass Foundation Services platform, enabling Customer to operate the various iPass\u00b4 market- facing offers, including user profile/configuration management, network directory management, account management, order management, usage management, support, billing and training. iii. Presentation Services. Impact how information is presented to users of the Platform, usually through a web based portal. Presentation Services include web presentation, data validation, access control (controlling who can see and enter what), and web analytics. iv. Client Services. Provide the core update functionality within the Platform, with the ability to update the iPass Client Software, configuration files, and network registries associated with it, and to receive the data that the client collects. v. Curation Services. Ability of iPass platform to collect information about Open Networks and be able to decode the hotspot information and automate steps to connect to that Network. vi. High-Availability and Scalable Authentication Architecture. iPass\u00b4 relationships with network service providers enables iPass to provide connectivity through multiple networks in over 100 countries on the Platform. As a result, the cloud-based Platform reduces the risk of service interruptions associated with depending on only one service provider. Furthermore, iPass\u00b4 geographically distributed transaction centers act as a unified and fault-tolerant system that provides scalable and highly-available user authentication and quality management information collection. Each point in the authentication process is designed with built-in redundancy and fail-over capabilities.\", \"level\": 1, \"text\": \"EXHIBIT B IPASS SERVICES iPass Services - includes the following services: iPass Mobile Services are delivered to End Users through a cloud-based platform (the \\\"Platform\\\") comprising software elements on the mobile device and available over the Internet. iPass\u00b4 Platform gives control over the definition and management of mobility services configured to a carrier's specific needs. This architecture gives an End User choice in access services and serves as a bridge to future functionality through use of extensible web services standards, while keeping the operational and financial burden on carriers low by not requiring them to purchase, deploy and manage on-premises infrastructure. iPass\u00b4 Platform is designed to provide Customer with reliability, flexibility, network security, policy enforcement, consolidated billing and scalability. The technology consists of the following principal components: i. Foundation Services. Provide the basic capabilities needed for a cloud-based platform, including the ability to manage users (add, remove, or change rights), authenticate users to access the platform, authorize access to particular functions, or track and audit use of the platform. ii. Operational Services. Are built on top of the iPass Foundation Services platform, enabling Customer to operate the various iPass\u00b4 market- facing offers, including user profile/configuration management, network directory management, account management, order management, usage management, support, billing and training. iii. Presentation Services. Impact how information is presented to users of the Platform, usually through a web based portal. Presentation Services include web presentation, data validation, access control (controlling who can see and enter what), and web analytics. iv. Client Services. Provide the core update functionality within the Platform, with the ability to update the iPass Client Software, configuration files, and network registries associated with it, and to receive the data that the client collects. v. Curation Services. Ability of iPass platform to collect information about Open Networks and be able to decode the hotspot information and automate steps to connect to that Network. vi. High-Availability and Scalable Authentication Architecture. iPass\u00b4 relationships with network service providers enables iPass to provide connectivity through multiple networks in over 100 countries on the Platform. As a result, the cloud-based Platform reduces the risk of service interruptions associated with depending on only one service provider. Furthermore, iPass\u00b4 geographically distributed transaction centers act as a unified and fault-tolerant system that provides scalable and highly-available user authentication and quality management information collection. Each point in the authentication process is designed with built-in redundancy and fail-over capabilities. Page 13 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SERVICE FEES 1. Pricing. For each Business Entity where UTLD Pricing is elected, Channel Partner shall pay the fees based on the elected Business Entity User Base Package designated by Channel Partner for each order. The fees include the (i) use of the Mobility Management Services; (ii) unlimited iPass network access (except for certain premium in-flight Wi-Fi Services); and (iii) iPass Hosted Authentication Service. Additionally, no Business Entity Start Up Service Fees will be applied to new Business Entities electing the ULTD Pricing option. The fees for ULTD Pricing are defined in Table 1 below. The prices in Table 1 represent the transfer pricing from iPass to Channel Partner for ULTD Pricing. No further discounts are applied to this pricing. TABLE 1\", \"level\": 1, \"text\": \"EXHIBIT C SERVICE FEES 1. Pricing. For each Business Entity where UTLD Pricing is elected, Channel Partner shall pay the fees based on the elected Business Entity User Base Package designated by Channel Partner for each order. The fees include the (i) use of the Mobility Management Services; (ii) unlimited iPass network access (except for certain premium in-flight Wi-Fi Services); and (iii) iPass Hosted Authentication Service. Additionally, no Business Entity Start Up Service Fees will be applied to new Business Entities electing the ULTD Pricing option. The fees for ULTD Pricing are defined in Table 1 below. The prices in Table 1 represent the transfer pricing from iPass to Channel Partner for ULTD Pricing. No further discounts are applied to this pricing. TABLE 1 Business Entity Committed Users Monthly Fee/User Minimum Monthly Fee [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***]\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Channel Partner shall be charged a maximum rate of [***] per User (\\\"Special Pricing\\\") for all Business Entities signed\", \"level\": 1, \"text\": \"2. Channel Partner shall be charged a maximum rate of [***] per User (\\\"Special Pricing\\\") for all Business Entities signed up by Channel Partner during the first three (3) full calendar months following the Effective Date (\\\"Introductory Period\\\"). The \\\"Special Pricing\\\" is contingent on a minimum order size of [***] users. Following twelve months after the month, during the Introductory Period, a Business Entity was signed, each Business Entity will be charged according to Table 1 above. By way of example and for clarity: For a Business Entity order placed in the first month following the Effective Date and with [***] Users, Channel Partner would be invoiced at [***] per User per month from the first month following the Business Entity order and twelve (12) months thereafter. After the first twelve months, and thereafter, Channel Partner will be charged for [***] Users at the rate of [***] per User per month, pursuant to Table 1 above. Page 14 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CUSTOMIZED SERVICES AND SUPPORT 1. SOFTWARE INSTALLATION SUPPORT . iPass personnel will work remotely with Channel Partner to assist the Channel Partner in the installation of the Server Software on Channel Partner's systems. iPass will provide the services indicated in Table 1 below in order to assist Channel Partner with implementation of Service for use by Channel Partner and End Users. Table 1-Start Up Services Service Access to iPass' expanding global network \u00a8 Automatic Phonebook updates \u00a8 Automatic Open Mobile updates \u00a8 RoamServer software updates \u00a8 Monthly Statement and Call Detail Records (CDRs) \u00a8 Help desk and deployment materials \u00a8 Monitoring for authentication failures \u00a8 Customized Open Mobile Client Software 1 Authentication realms (domains) 1 Technical Training Curriculum 1 Web-based session Sales and Marketing Training Curriculum 1 Web-based session Participation in open web conference training sessions scheduled by iPass \u00a8 Seats per year in open regional training scheduled by iPass 4 Access to self-paced training materials on iPass training portal \u00a8 2. TECHNICAL SUPPORT 2.1 Definitions. Any capitalized terms used herein and not defined below are defined in the Agreement. (a) \\\"First Level Technical Support\\\" means taking End User calls, getting complete information from End Users regarding problems experienced by such End Users, testing the End User name and password, eliminating common End User errors, checking the network status page and escalating unresolved issues with written documentation detailing steps taken prior to escalation. (b) \\\"Second Level Technical Support\\\" means providing assistance to First Level Technical Support help desk for issues that cannot be resolved through First Level Technical Support. (c) \\\"Third Level Technical Support\\\" means providing technical assistance to Channel Partner's authorized Second Level Technical Support personnel for technical issues that cannot be resolved by Second Level Technical Support. 2.2 First Level Technical Support and Second Level Technical Support. Channel Partner or Business Entity will be responsible for providing its End Users First Level Technical Support. Channel Partner will be responsible for providing End Users Second Level Technical Support. Second Level Technical Support personnel who have received training regarding the Service and the Software from iPass pursuant to Section 2 of the Agreement will be authorized to contact the applicable Third Level Technical Support centers at iPass to resolve any problems that cannot be resolved by First Level Technical Support or Second Level Technical Support. Channel Partner may change its authorized contacts for Third Level Technical Support at any time upon written notice to iPass so long as any new authorized contacts have completed the requisite iPass training. 2.3 Third Level Technical Support. iPass will provide Channel Partner with Third Level Technical Support in accordance with iPass standard procedures. iPass will only be obligated to provide Third Level Technical Support for the Software if Channel Partner has installed all Updates released by iPass which fix errors in the Software in accordance with Section 2.4 below. Channel Partner must have its password and id available in order to access and submit a request, absent which iPass will have no obligation to provide Channel Partner with Third Level Technical Support.\", \"level\": 1, \"text\": \"EXHIBIT D CUSTOMIZED SERVICES AND SUPPORT 1. SOFTWARE INSTALLATION SUPPORT . iPass personnel will work remotely with Channel Partner to assist the Channel Partner in the installation of the Server Software on Channel Partner's systems. iPass will provide the services indicated in Table 1 below in order to assist Channel Partner with implementation of Service for use by Channel Partner and End Users. Table 1-Start Up Services Service Access to iPass' expanding global network \u00a8 Automatic Phonebook updates \u00a8 Automatic Open Mobile updates \u00a8 RoamServer software updates \u00a8 Monthly Statement and Call Detail Records (CDRs) \u00a8 Help desk and deployment materials \u00a8 Monitoring for authentication failures \u00a8 Customized Open Mobile Client Software 1 Authentication realms (domains) 1 Technical Training Curriculum 1 Web-based session Sales and Marketing Training Curriculum 1 Web-based session Participation in open web conference training sessions scheduled by iPass \u00a8 Seats per year in open regional training scheduled by iPass 4 Access to self-paced training materials on iPass training portal \u00a8 2. TECHNICAL SUPPORT 2.1 Definitions. Any capitalized terms used herein and not defined below are defined in the Agreement. (a) \\\"First Level Technical Support\\\" means taking End User calls, getting complete information from End Users regarding problems experienced by such End Users, testing the End User name and password, eliminating common End User errors, checking the network status page and escalating unresolved issues with written documentation detailing steps taken prior to escalation. (b) \\\"Second Level Technical Support\\\" means providing assistance to First Level Technical Support help desk for issues that cannot be resolved through First Level Technical Support. (c) \\\"Third Level Technical Support\\\" means providing technical assistance to Channel Partner's authorized Second Level Technical Support personnel for technical issues that cannot be resolved by Second Level Technical Support. 2.2 First Level Technical Support and Second Level Technical Support. Channel Partner or Business Entity will be responsible for providing its End Users First Level Technical Support. Channel Partner will be responsible for providing End Users Second Level Technical Support. Second Level Technical Support personnel who have received training regarding the Service and the Software from iPass pursuant to Section 2 of the Agreement will be authorized to contact the applicable Third Level Technical Support centers at iPass to resolve any problems that cannot be resolved by First Level Technical Support or Second Level Technical Support. Channel Partner may change its authorized contacts for Third Level Technical Support at any time upon written notice to iPass so long as any new authorized contacts have completed the requisite iPass training. 2.3 Third Level Technical Support. iPass will provide Channel Partner with Third Level Technical Support in accordance with iPass standard procedures. iPass will only be obligated to provide Third Level Technical Support for the Software if Channel Partner has installed all Updates released by iPass which fix errors in the Software in accordance with Section 2.4 below. Channel Partner must have its password and id available in order to access and submit a request, absent which iPass will have no obligation to provide Channel Partner with Third Level Technical Support. Page 15 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 Page 16 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ticket Requirements At a minimum all Severity One and Severity Two problem reports shall contain the following in order\", \"level\": 1, \"text\": \"c. Ticket Requirements At a minimum all Severity One and Severity Two problem reports shall contain the following in order to expedite investigation and verification of the problem: (i) Username and Description of observed behavior. (ii) Debug Logs if available. (iii) Steps to reproduce. (iv) Operating environment (Operating system, language, software version, profile number and hardware, as applicable.) (v) Dates / times of transaction failures. (vi) Name of network attempted. iPass may request additional information for verification of a reported problem as necessary. d. Customer Care Hotline For Severity One issues, iPass recommends that opening a web-based support request be followed by a phone call to iPass at one of the following Severity One Customer Care numbers: Inside the United States: +1-877-464-7277 Outside the United States: +1 650-232-4300 Dialing within Europe: +44 20 7010 8344 Phone numbers are available 24 hours a day, 7 seven days a week. Please note that in order to safeguard customers against unauthorized service activity, iPass will require that callers authenticate their credentials via the web based ticketing system prior to any action by iPass. All change requests MUST be in writing. In order to ensure that tickets are handled in order of receipt, by priority, calls of a nature which are not Severity One will be ticketed and placed in queue to be handled in order of receipt, by severity. 4.4 Service Levels (a) Support Request Response - For each Severity Level, iPass shall provide the following response Service Levels: For Channel Partner Helpdesk Support Requests submitted in accordance with the process defined herein. Problem Severity Response Service Level Severity One Targeted Response Time: Issues will receive a response from iPass within fifteen (15) minutes (1 hour on weekends and local public holidays) after submitting a Severity One support case followed by a phone call to iPass. Please note Severity One issues reported via a support case only will be responded to within 1 hour. Severity Two Targeted Response Time: Issues will receive a response from iPass within 8 hours of receipt of the request (except weekends and local public holidays.) Severity Three Targeted Response Time: Issues will receive a response from iPass within 12 hours of receipt of the request (except weekends and local public holidays.) (b) Problem Verification. iPass and Channel Partner will make reasonable efforts to verify any reported problem as soon as it is reported as well as any follow-up information that may be required. (c) Update Intervals. iPass will make reasonable efforts to keep Channel Partner's Second Level Technical Support personnel informed of the latest status on any problem submitted. In the event Channel Partner's Second Level Technical Support personnel requires more frequent updates, then these will be discussed and mutually agreed upon and will depend on the severity and complexity of the problem. Page 17 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018 (d) Severity Reclassification. To ensure that severe problems receive highest priority, iPass may modify a ticket submitted as Severity One issue if it clearly does not meet the criteria for Severity One. 4.5 iPass Support Escalation Process (a) When to Escalate an Issue (i) If iPass fails to respond within the prescribed service level response time, the Channel Partner Help Desk is encouraged to escalate the issue to the Escalation Contact in the respective time zone (see escalation contacts below.) (ii) If the iPass Customer Care Representative and the Channel Partner Help Desk cannot agree on an action plan to resolve an issue (Severity One, Two or Three), then the iPass Customer Care Representative and the Channel Partner Help Desk are encouraged to escalate the issue to the Director of Customer Care. (iii) Once a plan has been agreed, iPass will work to resolve the issue. If the Channel Partner Help Desk is not satisfied with the progress that is being made to resolve an issue, they are encouraged to contact the Director of Customer Care. (b) How to Escalate an Issue (i) All escalations should be in writing (to the e-mail address listed below) or by phone followed up with a summary from Channel Partner 's Help Desk. (ii) Written documentation should outline the original issue and progress to date. It should also include impact to the customer and reason for the escalation. (c) Response to Escalation (i) The Director of Customer Care will respond upon receipt to any escalations. (ii) Escalations will take priority over any issue of the same severity level. Customer Care Escalation Contact Location/Time Zone London, UK (GMT) Regional Contact Richard Sabbarton email rsabbarton@ipass.com Office Phone +44 20 7010 8319 Location/Time Zone Redwood Shores, US (PST) Regional Contact Saritha Padubidri email spadubid@ipass.com Office Phone + 1 650 232 4127 Location/Time Zone Bangalore, IN (IST) Regional Contact Sujith Varijakshan email svarijakshan@ipass.com Office Phone +91 80 41380976 ESCALATION Manager - Director of Support Escalation Manager Alan Ridgewell email aridgewell@ipass.com Office Phone +44 20 7010 8304 Page 18 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT E\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MINIMUM END USER TERMS Channel Partner when used herein has the same meaning as in the Agreement. Channel Partner should change the word \\\"Channel Partner\\\" herein to its name when drafting End User agreements. \\\"You\\\" referred to herein refers to the End User(s). iPass as referenced herein shall mean iPass Inc. Capitalized terms used herein shall have the same meaning ascribed to them in the Agreement. 1. By its very nature, the Internet contains offensive and/or harmful material, in some cases under descriptions that have been mislabeled or are otherwise deceptive. Neither Channel Partner, iPass nor their suppliers shall be responsible for any damages suffered by any person as a result of obtaining Internet access. Access to the Internet is provided solely on an \\\"AS IS\\\" basis. Neither Channel Partner, iPass, nor its suppliers warrant, nor do they assume responsibility for, any consequences suffered by any person as a result of Internet access including, without limitation, those suffered as a result of accessing Internet information and content, such as, by way of example only, the possibility of contracting computer viruses, accessing information with offensive, inaccurate or inappropriate content. Channel Partner, iPass and its suppliers exercise no control whatsoever over the content of the information passing through their systems. 2. You agree to be bound by the usage policies of iPass including, by way of example, its Privacy Policy. You acknowledge and agree that iPass may disclose your usage data to Channel Partner and other third parties as detailed in iPass' Privacy Policy (see http:www.ipass.com). You accept that certain uses of your data are necessary to enable provision of the Services to you and accordingly that if you withdraw your consent for iPass to use your data as is detailed in its Privacy Policy the supply of the Service to you may have to be terminated. You acknowledge and agree that all End Users must exercise their own due diligence before relying on any information available on the Internet, and must determine that they have all necessary rights to copy, publish or otherwise distribute any such information available on the Internet under copyright and other applicable laws. 3. NOTWITHSTANDING ANYTHING ELSE IN THIS AGREEMENT, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, SERVICES ARE PROVIDED ON AN \\\"AS IS\\\" AND \\\"AS AVAILABLE\\\" BASIS, AND CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DISCLAIM AND MAKE NO REPRESENTATIONS OR WARRANTIES AND THERE ARE NO CONDITIONS OF ANY KIND, EITHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF NON-INTERFERENCE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ARISING FROM COURSE OF DEALING OR USAGE OF TRADE. YOU ASSUME ALL RESPONSIBILITY AND RISK FOR USE OF SERVICES. ANY STATEMENTS MADE IN ANY PACKAGING, MANUALS, WRITTEN OR ELECTRONIC DOCUMENTS, OR BY ANY CHANNEL PARTNER OR IPASS EMPLOYEES, REPRESENTATIVES, OR AGENTS, ARE PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND NOT AS REPRESENTATIONS OR WARRANTIES OF ANY KIND. CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DO NOT WARRANT THAT SERVICES WILL BE UNINTERRUPTED, ERROR FREE, OR FREE FROM SERVICE DEGRADATION, OR THAT ANY INFORMATION, SOFTWARE, OR OTHER MATERIAL ACCESSIBLE ON THE SERVICES ARE FREE FROM VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING, INTERFERING, OR DESTRUCTIVE PROPERTIES. CHANNEL PARTNER, IPASS AND THEIR SUUPLIERS CANNOT AND DO NOT GUARANTEE THE SECURITY OR INTEGRITY OF DATA TRANSMISSION OR STORAGE, OR THAT VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE DETECTED OR REMEDIATED BY SERVICES. SERVICES ARE ONLY AVAILABLE WITHIN THE COVERAGE AREA OF THE IPASS NETWORK, WHICH IS SUBJECT TO CHANGE. YOU ACKNOWLEDGE THAT SERVICES MAY BE TEMPORARILY UNAVAILABLE FOR MAINTENANCE, EQUIPMENT MODIFICATIONS, OR UPGRADES, AND FOR OTHER REASONS WITHIN AND WITHOUT THE DIRECT CONTROL OF IPASS. 4. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL CHANNEL PARTNER, IPASS OR ITS SUPPLIERS BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR FOR INTERRUPTED COMMUNICATIONS, LOST DATA OR LOST PROFITS, ARISING OUT OF OR IN CONNECTION WITH THE SERVICE.\", \"level\": 1, \"text\": \"EXHIBIT E MINIMUM END USER TERMS Channel Partner when used herein has the same meaning as in the Agreement. Channel Partner should change the word \\\"Channel Partner\\\" herein to its name when drafting End User agreements. \\\"You\\\" referred to herein refers to the End User(s). iPass as referenced herein shall mean iPass Inc. Capitalized terms used herein shall have the same meaning ascribed to them in the Agreement. 1. By its very nature, the Internet contains offensive and/or harmful material, in some cases under descriptions that have been mislabeled or are otherwise deceptive. Neither Channel Partner, iPass nor their suppliers shall be responsible for any damages suffered by any person as a result of obtaining Internet access. Access to the Internet is provided solely on an \\\"AS IS\\\" basis. Neither Channel Partner, iPass, nor its suppliers warrant, nor do they assume responsibility for, any consequences suffered by any person as a result of Internet access including, without limitation, those suffered as a result of accessing Internet information and content, such as, by way of example only, the possibility of contracting computer viruses, accessing information with offensive, inaccurate or inappropriate content. Channel Partner, iPass and its suppliers exercise no control whatsoever over the content of the information passing through their systems. 2. You agree to be bound by the usage policies of iPass including, by way of example, its Privacy Policy. You acknowledge and agree that iPass may disclose your usage data to Channel Partner and other third parties as detailed in iPass' Privacy Policy (see http:www.ipass.com). You accept that certain uses of your data are necessary to enable provision of the Services to you and accordingly that if you withdraw your consent for iPass to use your data as is detailed in its Privacy Policy the supply of the Service to you may have to be terminated. You acknowledge and agree that all End Users must exercise their own due diligence before relying on any information available on the Internet, and must determine that they have all necessary rights to copy, publish or otherwise distribute any such information available on the Internet under copyright and other applicable laws. 3. NOTWITHSTANDING ANYTHING ELSE IN THIS AGREEMENT, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, SERVICES ARE PROVIDED ON AN \\\"AS IS\\\" AND \\\"AS AVAILABLE\\\" BASIS, AND CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DISCLAIM AND MAKE NO REPRESENTATIONS OR WARRANTIES AND THERE ARE NO CONDITIONS OF ANY KIND, EITHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF NON-INTERFERENCE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ARISING FROM COURSE OF DEALING OR USAGE OF TRADE. YOU ASSUME ALL RESPONSIBILITY AND RISK FOR USE OF SERVICES. ANY STATEMENTS MADE IN ANY PACKAGING, MANUALS, WRITTEN OR ELECTRONIC DOCUMENTS, OR BY ANY CHANNEL PARTNER OR IPASS EMPLOYEES, REPRESENTATIVES, OR AGENTS, ARE PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND NOT AS REPRESENTATIONS OR WARRANTIES OF ANY KIND. CHANNEL PARTNER, IPASS AND THEIR SUPPLIERS DO NOT WARRANT THAT SERVICES WILL BE UNINTERRUPTED, ERROR FREE, OR FREE FROM SERVICE DEGRADATION, OR THAT ANY INFORMATION, SOFTWARE, OR OTHER MATERIAL ACCESSIBLE ON THE SERVICES ARE FREE FROM VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING, INTERFERING, OR DESTRUCTIVE PROPERTIES. CHANNEL PARTNER, IPASS AND THEIR SUUPLIERS CANNOT AND DO NOT GUARANTEE THE SECURITY OR INTEGRITY OF DATA TRANSMISSION OR STORAGE, OR THAT VIRUSES, WORMS, TROJAN HORSES, OR OTHER CODE THAT MANIFESTS CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE DETECTED OR REMEDIATED BY SERVICES. SERVICES ARE ONLY AVAILABLE WITHIN THE COVERAGE AREA OF THE IPASS NETWORK, WHICH IS SUBJECT TO CHANGE. YOU ACKNOWLEDGE THAT SERVICES MAY BE TEMPORARILY UNAVAILABLE FOR MAINTENANCE, EQUIPMENT MODIFICATIONS, OR UPGRADES, AND FOR OTHER REASONS WITHIN AND WITHOUT THE DIRECT CONTROL OF IPASS. 4. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL CHANNEL PARTNER, IPASS OR ITS SUPPLIERS BE LIABLE FOR ANY SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, OR FOR INTERRUPTED COMMUNICATIONS, LOST DATA OR LOST PROFITS, ARISING OUT OF OR IN CONNECTION WITH THE SERVICE. Page 19 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You may not use the Services to take any actions or make any statements that, by way of example only\", \"level\": 1, \"text\": \"5. You may not use the Services to take any actions or make any statements that, by way of example only: (a) infringe on any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy; (b) violate any applicable law, statute, ordinance or regulation (including without limitation those regarding export control); (c) are defamatory, trade libelous or unlawfully threatening; (d) are pornographic or obscene; (e) violate any laws regarding unfair competition, antidiscrimination or false advertising, (f) result in the distribution of viruses, Trojan horses, worms, time bombs, cancelbots, chain letters or other similar harmful or deleterious programming routines, or (g) result in the unauthorized entry to any other machine accessible via the network. You may not use the Services to distribute any bulk unsolicited emails or otherwise cause an excessive or disproportionate load on Channel Partner's, iPass' or their suppliers' infrastructure. Any access to other networks connected to Channel Partner's, iPass' and its suppliers' networks must comply with the rules appropriate for such networks. Violation of the foregoing may result in termination of access. Given the current regulatory and technical environment you should not have an expectation of privacy in your online activities 6. iPass and its suppliers shall be deemed to be third-party beneficiaries of this agreement, with the right to enforce the terms of this agreement. You agree that this Agreement is expressly for the benefit of Channel Partner, iPass and its suppliers and may be enforced by them. 7. You may not resell or redistribute any of the Services to any third parties. 8. Subject to the terms and conditions of this agreement, Channel Partner grants to you a royalty-free, non-exclusive, non-transferable, limited license right exercisable solely during the term of this agreement to: (1) reproduce, exactly as provided by Channel Partner, object code copies of the Client Software, as needed for distribution to your End Users the iPass Software; and to install and use the iPass Licensed Software. You acknowledge that the Licensed Software contains the valuable information of iPass and its suppliers, and agree not to cause or permit the modification, reverse engineering, translation, disassembly, or decompilation of, or otherwise to attempt to derive the source code of such Licensed Software, whether in whole or in part (except to the extent permitted by applicable law). You will not obfuscate, alter or remove any copyright, trademark or other proprietary notice or legend on or in the Licensed Software and associated Documentation and will include all such markings in all copies of such materials. 9. The Services may be suspended or terminated if you breach these terms. Any breach of these terms by your End Users shall be deemed a breach by you. 10. This Agreement shall terminate upon termination of the agreement between Channel Partner and iPass. Page 20 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT F\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"IPASS MARKS\", \"level\": 1, \"text\": \"EXHIBIT F IPASS MARKS iPass\u00ae iPass Open Mobile\u2122 iPass Open Mobile Exchange\u2122 iPass OMX\u2122 iPass ULTD Page 21 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"EXHIBIT G\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PARATEUM SERVICES Subject to the terms and conditions below, Channel Partner (Pareteum Corporation) will provide on a non-exclusive basis the following services to iPass for resale to iPass' customers: Managed Services Platform and Global Cloud Mobility Platform (collectively, the \\\"Pareteum Services\\\"). Channel Partner (Pareteum Corporation) and iPass shall mutually agree upon the terms and conditions (which will include, without limitation, the scope and geography where the Pareteum Services may be resold, fees and support service and related user terms) upon the earlier to occur of: (i) iPass' first proposed resale of the Pareteum Services to one of its customers; or (ii) within ninety (90) days from the Effective Date. Once the parties have mutually agreed upon the foregoing terms and conditions, the parties will amend this Exhibit G to reflect the terms by which iPass may resell the Pareteum Services.\", \"level\": 1, \"text\": \"EXHIBIT G PARATEUM SERVICES Subject to the terms and conditions below, Channel Partner (Pareteum Corporation) will provide on a non-exclusive basis the following services to iPass for resale to iPass' customers: Managed Services Platform and Global Cloud Mobility Platform (collectively, the \\\"Pareteum Services\\\"). Channel Partner (Pareteum Corporation) and iPass shall mutually agree upon the terms and conditions (which will include, without limitation, the scope and geography where the Pareteum Services may be resold, fees and support service and related user terms) upon the earlier to occur of: (i) iPass' first proposed resale of the Pareteum Services to one of its customers; or (ii) within ninety (90) days from the Effective Date. Once the parties have mutually agreed upon the foregoing terms and conditions, the parties will amend this Exhibit G to reflect the terms by which iPass may resell the Pareteum Services. Page 22 of 22 iPass Channel Partner Reseller Agreement 04.18.2018 iPass Confidential [***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b- 2 of the Securities Exchange Act of 1934, as amended. Source: IPASS INC, 8-K, 12/3/2018\"}}, {\"id\": \"party:iPass\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"IPASS INC.\", \"role\": \"iPass\", \"address\": \"3800 Bridge Parkway, Redwood Shores, CA 94065\"}}, {\"id\": \"party:Channel Partner\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Pareteum Corporation\", \"role\": \"Channel Partner\", \"address\": \"100 Park Avenue, Suite 1600, New York City, New York 10017\"}}, {\"id\": \"term:Access Point\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Access Point\", \"text\": \"\\\"Access Point\\\" means Internet access points to which a User connects via the Client Software.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"\\\"Affiliate\\\" means any entity which is controlled by, controls or is under common control with Channel Partner. For the purposes of this definition, control shall mean ownership of at least fifty percent (50%) of the outstanding voting equity interest. Channel Partner may appoint an Affiliate to perform resale services hereunder with written consent of iPass and in accordance with any iPass mandated contractual commitments and contractual documents.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"\\\"Agreement\\\" means this Channel Partner Reseller Agreement, including the Exhibits attached hereto, and orders placed pursuant to this Agreement. For clarity, each order constitutes a separate and distinct order for iPass Software and/or Services, and thus each order constitutes a separate contractual commitment. Each order incorporates the terms and conditions set forth herein.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Business Entity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Entity\", \"text\": \"\\\"Business Entity\\\" means a corporation, partnership, or enterprise that acquires Services from Channel Partner for use by its employees and contractors. A Business Entity is not authorized to resell the Services to any third parties.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Business Entity Minimum Monthly Commitment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Entity Minimum Monthly Commitment\", \"text\": \"\\\"Business Entity Minimum Monthly Commitment\\\" means, for each Business Entity, a minimum monthly commitment of at least 250 Users, by Channel Partner for each Business Entity. iPass shall invoice Channel Partner on a monthly basis, the agreed upon price for the Services as set forth herein. If Channel Partner's total invoiced amount for the Services, for each Business Entity is less than the amount for the number of Users for the Business Entity's Minimum Monthly Commitment, iPass will invoice and Channel Partner will pay to iPass, the shortfall difference between the actual amount paid by Channel Partner to iPass and the amount for the number of Users for the Business Entity Minimum Monthly Commitment.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Business Entity Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Entity Term\", \"text\": \"\\\"Business Entity Term\\\" means, for each Business Entity, a period beginning at the beginning of the Business Entity Implementation Period and ending no less than twelve (12) months following the expiration of the Business Entity Implementation Period, as indicated in the order placed by Channel Partner for such Business Entity. Every Business Entity Term automatically renews for a period of no less than 12 months, unless otherwise agreed to in writing between the parties.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Certified iPass Engineer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Certified iPass Engineer\", \"text\": \"\\\"Certified iPass Engineer\\\" means an employee of Channel Partner who has attended one RoamServer training session and successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, and Competitive Training. Successful completion means achieving a passing result on the on-line tests after each module.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Certified Help Desk Agent\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Certified Help Desk Agent\", \"text\": \"\\\"Certified Help Desk Agent\\\" means an employee of Channel Partner who has attended one RoamServer training session, one Help Desk training session, and one Broadband Support training session.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Certified Trained Sales Personnel\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Certified Trained Sales Personnel\", \"text\": \"\\\"Certified Trained Sales Personnel\\\" means an employee of Channel Partner who has successfully completed the following on-line training modules: iPass Orientation, Product Training, Technology Training, Competitive Training, and Sales Training. Successful completion means achieving a passing result on the on-line tests after each module.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Client Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Client Software\", \"text\": \"\\\"Client Software\\\" means the machine executable version(s) of the client software code, including any Updates thereto, that iPass provides Channel Partner hereunder to enable Channel Partner's End Users to use the Service. The Client Software currently consists of iPass' Open Mobile software as well as the iPassConnect software.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"\\\"Confidential Information\\\" means information maintained in confidence by a party, and which is marked as such, or information whether written or oral that by its nature would be to a reasonable person under the circumstances understood to be confidential or proprietary information of a party including but not limited to iPass' Software, Documentation, and the parties' product development and marketing plans, business methods and non-public financial and personnel dat\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Device\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Device\", \"text\": \"\\\"Device\\\" means any machine, computer, smartphone or similar User apparatus on which Channel Partner or a Business Entity has installed the Client Software.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Documentation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Documentation\", \"text\": \"\\\"Documentation\\\" means the standard published technical user manuals provided by iPass.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"\\\"Effective Date\\\" means the date of last signature on this Agreement.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Enabled Devices\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Enabled Devices\", \"text\": \"\\\"Enabled Devices\\\" mean any device with the Channel Partner's app (iOS, Android, PC or Mac) which is enabled by Channel Partner to access the iPass services and also registered and enabled, by the Channel Partner to access Channel Partner's services.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:End Users\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End Users\", \"text\": \"\\\"End Users\\\" or \\\"User\\\" means is any person who has an eligible subscriber ID that allows them to access the iPass Services and iPass Network.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:End User Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User Agreement\", \"text\": \"\\\"End User Agreement\\\" means a written agreement between Channel Partner and a Business Entity or an End User, containing terms and conditions at least as protective of iPass and its suppliers as the terms and conditions set forth in Exhibit E.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:iPass Hosted Authentication Service\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"iPass Hosted Authentication Service\", \"text\": \"\\\"iPass Hosted Authentication Service\\\" means a hosted, managed authentication service available within the iPass Portal and hosted by iPass.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:iPass Portal\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"iPass Portal\", \"text\": \"\\\"iPass Portal\\\" means the secure website accessible through http://www.ipass.com/ where Channel Partner may obtain information about iPass Services, including invoice, billing, ordering and account information, and submit technical support requests.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:iPass Web Content\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"iPass Web Content\", \"text\": \"\\\"iPass Web Content\\\" means the information and other materials/content provided to Channel Partner to use in developing Channel Partner's web site(s) or web pages to explain, promote and support the Service.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Licensed Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Licensed Software\", \"text\": \"\\\"Licensed Software\\\" \\\"Software\\\" means the Client Software and the Server Software and any Updates to the Client Software and the Server Software (if any).\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Mobile Network\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Mobile Network\", \"text\": \"\\\"Mobile Network\\\" or \\\"iPass Network\\\" means iPass' multi-technology mobile access network which includes mobile broadband, Wi-Fi and Ethernet services. The iPass Network is subject to change by iPass upon notice to Partner, on condition that such changes do not materially degrade the network. The iPass Network does not include certain Wi-Fi services that are subject to supplier enforced restrictions. In addition, if any country is subject to a US embargo or other export restriction, it will not be deemed included in the foregoing list, the iPass Network will not be available from such country, and Customer agrees not to use the Licensed Software or the iPass Network in such country..\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Services\", \"text\": \"\\\"Services\\\" means the services and software provided by iPass as more fully described in Exhibit B attached hereto which allow access to the iPass Network.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"\\\"Term\\\" means the duration of the Agreement.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Update\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Update\", \"text\": \"\\\"Update\\\" means any bug fixes, patches or software updates for error corrections which iPass makes available to Channel Partner under this Agreement.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:First Level Technical Support\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"First Level Technical Support\", \"text\": \"\\\"First Level Technical Support\\\" means taking End User calls, getting complete information from End Users regarding problems experienced by such End Users, testing the End User name and password, eliminating common End User errors, checking the network status page and escalating unresolved issues with written documentation detailing steps taken prior to escalation.\", \"definition_clause\": \"EXHIBIT D\"}}, {\"id\": \"term:Second Level Technical Support\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Second Level Technical Support\", \"text\": \"\\\"Second Level Technical Support\\\" means providing assistance to First Level Technical Support help desk for issues that cannot be resolved through First Level Technical Support.\", \"definition_clause\": \"EXHIBIT D\"}}, {\"id\": \"term:Third Level Technical Support\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Level Technical Support\", \"text\": \"\\\"Third Level Technical Support\\\" means providing technical assistance to Channel Partner's authorized Second Level Technical Support personnel for technical issues that cannot be resolved by Second Level Technical Support.\", \"definition_clause\": \"EXHIBIT D\"}}, {\"id\": \"value:fifty percent (50%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 months\"}}, {\"id\": \"value:three (3) full calendar months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) full calendar months\"}}, {\"id\": \"value:twelve months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve months\"}}, {\"id\": \"value:7 seven days a week\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"7 seven days\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.15\", \"level\": 1, \"text\": \"Exhibit 10.15 THE JOINT CORP. FRANCHISE AGREEMENT i ii iii THE JOINT CORP. FRANCHISE AGREEMENT This Franchise Agreement (this or the \\\"Agreement\\\") is being entered into effective as of the _____ day of _______________, 20__ (the \\\"Agreement Date\\\"). The parties to this Agreement are The Joint Corp., a Delaware corporation (\\\"we,\\\" \\\"us,\\\" the \\\"Company,\\\" or \\\"The Joint Corp.\\\"); _________________________________________, as Franchise Owner (\\\"you,\\\" \\\"Franchise Owner,\\\" or \\\"Franchisee\\\"), and, if you are a partnership, corporation, or limited liability company, your \\\"Principal Owners\\\" (defined below). 1. INTRODUCTION. This Agreement has been written in an informal style in order to make it more easily readable and to be sure that you become thoroughly familiar with all of the important rights and obligations the Agreement covers before you sign it. This Agreement includes several exhibits, all of which are legally binding and are an integral part of the complete Franchise Agreement. In this Agreement, we refer to The Joint Corp. as \\\"we,\\\" \\\"us,\\\" or the \\\"Company.\\\" We refer to you as \\\"you,\\\" \\\"Franchise Owner\\\" or \\\"Franchisee.\\\" If you are a corporation, partnership or limited liability company, you will notice certain provisions that are applicable to those principal shareholders, partners or members on whose business skill, financial capability and personal character we are relying in entering into this Agreement. Those individuals will be referred to in this Agreement as \\\"Principal Owners.\\\" Through the expenditure of considerable time, effort and money, we and our affiliates have devised a system for the establishment and operation of The Joint Corp. business model, a chiropractic location that specializes in affordable, convenient, and accessible chiropractic care. It is our mission \\\"to improve your quality of life through affordable Chiropractic care.\\\" Our atmosphere is fun and upbeat, and no appointments are necessary (all of these characteristics are referred to in this Agreement as the \\\"System\\\"). This business model includes a location model offering all of our franchised services and products (individually, a \\\"Location\\\" and collectively, the \\\"Locations\\\"). We identify the System by the use of certain trademarks, service marks and other commercial symbols, including the marks \\\"The Joint\u2026A Chiropractic Place\u00ae\\\", \\\"The Joint\u2026The Chiropractic Place\u2122\\\" and certain associated designs, artwork and logos, which we may change or add to from time to time (the \\\"Marks\\\"). THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 1 From time to time we grant to persons who meet our qualifications, franchises to own and operate a The Joint Corp. Location franchise business that will manage clinics that specialize in providing chiropractic services and products to the general public through licensed chiropractic professionals (\\\"Clinic(s)\\\"). This Agreement is being presented to you because of the desire you have expressed to obtain the right to develop, own, and be franchised to operate a The Joint Corp. Location (we will refer to your The Joint Corp. franchise as the \\\"Franchise\\\" or the \\\"Franchised Business\\\"). You may purchase and operate your Franchise as a new, start-up Location (a \\\"Start-up Location\\\"), or may convert an existing chiropractic practice to a The Joint Corp. Location (a \\\"Conversion Location\\\"). In signing this Agreement, you acknowledge that you have conducted an independent investigation of The Joint Corp. Franchised Business, and recognize that, like any other business, the nature of it may evolve and change over time, that an investment in a The Joint Corp. Franchised Business involves business risks, and that the success of this business venture is primarily dependent on your business abilities and efforts. We expressly disclaim making, and you acknowledge that you have not received or relied on, any guarantee, express or implied, as to the revenues, profits, or likelihood of success of The Joint Corp. Franchise venture contemplated by this Agreement. You acknowledge that there have been no representations by us or our affiliates or our or their respective officers, directors, members, employees, or agents that are inconsistent with the statements made in our current Franchise Disclosure Document concerning the Franchised Business, or the provisions of this Agreement. You further represent to us, as an inducement to our entering into this Agreement with you, that there have been no misrepresentations to us in your application for the rights granted by this Agreement, or in the financial information provided by you and your Principal Owners. 2. GRANT OF FRANCHISE. 2.1 Term; Reference to Exhibit 1. You have applied for a franchise to own and operate a The Joint Corp. Location, and we have approved your application in reliance on all of the representations you made in that application. As a result, and subject to the provisions of this Agreement, we grant to you a Franchise to operate a The Joint Corp. Location offering all products, services, and proprietary programs of ours, in accordance with all elements of the System, that we may require for The Joint Corp. Locations. You must operate the Franchise at a mutually agreeable site (the \\\"Premises\\\") to be identified after the signing of this Agreement, and to use the System and the Marks in the operation of that Franchise, for a term of 10 years (the \\\"Initial Term\\\"). The Initial Term will begin on the Agreement Date. (For convenience, the expiration date of the Initial Term is listed on Exhibit 1.) Termination or expiration of this Agreement will constitute a termination or expiration of your Franchise. (All references to the \\\"term\\\" of this Agreement refer to the period from the Agreement Date to the date on which this Agreement actually terminates or expires.) THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 2\"}, {\"id\": \"2.2\", \"title\": \"Full Term Performance\", \"level\": 2, \"text\": \"2.2 Full Term Performance. You specifically agree to be obligated to operate the Franchise, perform the obligations of this Agreement, and continuously exert your best efforts to promote and enhance the business of the Franchise for the full term of this Agreement. 2.3 Management Agreement with Professional Corporation - Non-Licensed Franchisees. If you are not a licensed chiropractor, prior to commencing operations of the Franchised Business, you must enter into a management agreement (\\\"Management Agreement\\\") with a chiropractic professional corporation (or a professional limited liability company, if permitted in the state in which the Clinic is located) (a \\\"PC\\\") whereby you will provide to the PC management and administrative services and support consistent with the System and as outlined in our form of Management Agreement, a copy of which is included as an Exhibit to our Disclosure Document, to support the PC's chiropractic practice and its delivery of chiropractic services and related products to chiropractic patients, consistent with all applicable laws and regulations. The PC shall employ and control the chiropractors and other chiropractic personnel that will provide the actual chiropractic services required to be delivered at and through the Clinic. You shall not provide any actual chiropractic services, nor shall you supervise, direct, control or suggest to, the PC or its chiropractors or employees the manner in which the PC provides or may provide chiropractic services to its patients. You acknowledge and agree that we will not provide any chiropractic services, nor will we supervise, direct, control or suggest to, the PC or its chiropractors or employees the manner in which the PC provide chiropractic services to its patients. Due to various federal and state laws regarding the practice of chiropractic medicine, and the ownership and operation of chiropractic practices and health care businesses that provide chiropractic services, you understand and acknowledge that that you, as non-chiropractor Location franchisee, shall not engage in any practices that are, or may appear to be, the practice of chiropractic medicine. You acknowledge that the PC must offer all chiropractic services in accordance with the Management Agreement and the System. You must use our standard form of Management Agreement, however, you may negotiate the monetary terms and, with our written consent, certain other terms of the relationship with the PC. We will not unreasonably withhold our approval to requested changes in the Management Agreement. You must obtain our written approval of the final Management Agreement prior to your execution. We must approve the PC candidate. You shall ensure that the PC offers all chiropractic services in accordance with the Management Agreement and the System. If you are not able to find a suitable chiropractor to create, own and staff the PC, we will attempt to help you find a suitable PC. You must have a Management Agreement in effect with a PC at all times during the operation of the Franchised Business and during the Initial Term of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 3 If you are a licensed chiropractor, or part of a PC owned by licensed chiropractors, you do not need to execute a Management Agreement. However, you are still responsible for compliance with all laws application to the operation of a chiropractic Clinic and your Location franchise. 2.4 Waiver of Management Agreement. In certain states, it may be permissible under the existing laws that may be applicable to chiropractic professionals and/or practices, such as chiropractic clinics, for a non-chiropractor to both own and operate a Clinic and a Location Franchise, including hiring chiropractic and other professional personnel and providing chiropractic services to patients at the Clinic. If you determine that the laws that would apply to a Clinic in your state would permit you to do so, you may request that we waive certain of the requirements of the Franchise Agreement related to separating the operation of the chiropractic aspects of the Clinic from the management aspects. In particular, you (i) would not enter into a Management Agreement with a PC that, as a separate entity, would otherwise operate the Clinic and provide all chiropractic services, and (ii) you would not be restricted from hiring and supervising chiropractic professionals. Any waiver, or any modification of our standards, would be subject to compliance with all applicable laws and regulations. If we agree to do a waiver, you must enter into an Amendment to Waive Management Agreement (\\\"Waiver Agreement\\\"), a copy of which is attached as an exhibit to our Disclosure Document. Under the Waiver Agreement, you will agree that, instead of entering into the Management Agreement with a separate PC, you will (a) operate the Clinic, including performing all responsibilities and obligations of the \\\"PC\\\" under the Management Agreement, and (b) manage the Clinic as required in this Agreement and by performing all the responsibilities and obligations of the \\\"Company\\\" under the Management Agreement. You are responsible for operating in full compliance with all laws that apply to a Clinic, and you must make your own determination as to your legal compliance obligations. Additionally, the laws applicable to your Clinic may change, and if there are any chiropractic regulations or other laws that would render your operation of the Clinic through a single entity (or otherwise) in violation of any medical regulations, you must immediately advise us of such change and of the your proposed corrective action to comply with chiropractic regulations, including (if applicable) entering into a Management Agreement with a PC. Similarly, if we discover any such laws, upon providing you notice of such laws, you agree to make such changes as are necessary to comply with medical regulations, including (if applicable) entering into a Management Agreement with a PC. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 4\"}, {\"id\": \"2.5\", \"title\": \"Selection of Premises; No Protected Territory; Reservation of Rights\", \"level\": 2, \"text\": \"2.5 Selection of Premises; No Protected Territory; Reservation of Rights. You and we will mutually select the location of the Premises upon or after the signing of this Agreement. You acknowledge that the Franchise granted by this Agreement gives you the right to operate your Franchise only at the Premises. Although we will not seek to operate or grant others the right to operate a The Joint Corp. Location within the same general area as the Premises, we make no guarantee of any protected territory. Except as otherwise provided in this Paragraph 2.5, we retain all rights with respect to The Joint Corp. Location franchises, the Marks and the System, including (by way of example only and not as a limitation): (a) the right to operate or grant others the right to operate The Joint Corp. Location franchises in any location on terms and conditions we deem appropriate; and (b) the right to operate or offer other healthcare-related companies or franchises or enter into other lines of business offering similar or dissimilar products or services under trademarks or service marks other than the Marks, in any location. 2.6 Renewal of Franchise. (a) Franchise Owner's Right to Renew. Subject to the provisions of subparagraph 2.6(b) below, and if you have substantially complied with all provisions of this Agreement and all other agreements between us, on expiration of the Initial Term, if you refurbish and decorate the Premises, replace fixtures, furnishings, wall decor, furniture, equipment, and signs and otherwise modify the Franchise in compliance with specifications and standards then applicable under new or renewal franchises for The Joint Corp. Location franchises, you will have the right to renew the Franchise for one (1) additional term of ten (10) years (the \\\"Renewal Term\\\"). (b) Notice of Deficiencies and Other Requirements. At least one (1) year before the expiration of the Initial Term, we agree to give you written notice of any deficiencies in your operation or in the historical performance of the Franchise that could cause us not to renew the Franchise. If we will permit renewal, our notice will state what actions, if any, you must take to correct the deficiencies in your operation of the Franchise or of the Premises, and will specify the time period in which those deficiencies must be corrected or other requirements satisfied. Renewal of the Franchise will be conditioned on your continued compliance with all the terms and conditions of this Agreement up to the date of expiration. If we send a notice of non-renewal, it will state the reasons for our refusal to renew. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 5 (c) Renewal Agreement; Releases. Should you choose to renew the Franchise, you must provide us with written notice of that intent no earlier than two (2) years and no later than one (1) year before the expiration of the Initial Term. To renew the Franchise, the Company, you and your Principal Owners must execute the form of Franchise Agreement and any ancillary agreements we are then customarily using in the grant or renewal of franchises for the operation of The Joint Corp. Location Franchises (with appropriate modifications to reflect the fact that the agreement relates to the grant of a renewal franchise), except that no initial franchise fee will be payable upon renewal of the Franchise. However, you must pay to us a renewal fee equal to 25% of our then-current initial franchise fee for Start-up Locations. You and your Principal Owners and your and their spouses must also execute general releases, in a form satisfactory to us, of any and all claims against us and our affiliates, and our and their respective owners, officers, directors, employees, and agents. 2.7 Personal Guaranty by Principal Owners; Reference to Exhibit 2. Each of the Principal Owners and their spouses (where applicable), will be required to execute a personal guaranty (the \\\"Guaranty\\\"), guaranteeing the Franchise's liabilities and obligations to the Company. A copy of the Guaranty is incorporated herein as Exhibit 2. 3. DEVELOPMENT AND OPENING OF THE FRANCHISE 3.1 Site Approval; Lease or Purchase of Premises; Opening Timeline; Reference to Exhibit 3. (a) You will use your best efforts to locate and select a proposed site for the Premises that is acceptable to us as suitable for the operation of the Franchise, which must be reviewed and approved by us within six (6) months of the Agreement Date. Our review and approval process may take up to thirty (30) days, so we recommend you submit your proposed site to us within one hundred fifty (150) days of the Agreement Date. You must submit to us, in the form we specify, a description of the site and such other information or materials as we may reasonably require. We will not unreasonably withhold approval of a site that meets our standards for general location and neighborhood, traffic patterns, parking size, layout and other physical characteristics, for The Joint Corp. Location franchises. Our approval of a site shall not constitute, nor be deemed, a judgment as to the likelihood of success of a The Joint Corp. Location at such location, or a judgment as to the relative desirability of such location in comparison to other locations. If you fail to identify a mutually-agreeable site within the aforementioned six (6) month period, we may terminate this Agreement. (b) Once we have approved the proposed site of the Premises for your Franchise, you must obtain lawful possession of the Premises through lease or purchase within thirty (30) days of our approval of the Premises. You agree that you will not execute a lease without our advance written approval of the lease terms. The lease for the Premises must include the Addendum to Lease, attached hereto as Exhibit 3, permitting us to take possession of the Premises under certain conditions if this Agreement is terminated or if you violate the terms of the lease. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 6 (c) Unless we agree otherwise, you must open your franchise for business no later than nine (9) months from the Effective Date of this Agreement. 3.2 Prototype and Construction Plans and Specifications. We will furnish to you prototype plans and specifications for your Location, reflecting our requirements for design, decoration, furnishings, furniture, layout, equipment, fixtures and signs for The Joint Corp. Locations, which may be in the form of actual plans for an existing or proposed Location with which we are involved. Using an architect we designate or approve, it will then be your responsibility to have the plans and specifications modified to comply with all ordinances, building codes, permit requirements, and lease requirements and restrictions applicable to the Premises. You must submit final construction plans and specifications to us for our approval before you begin construction at the Premises, and must construct the Franchise location in accordance with those approved plans and specifications. 3.3 Development of the Franchise. You agree at your own expense to do the following by the Opening Deadline defined in Exhibit 1: (1) secure all financing required to fully develop the Franchise; (2) obtain all required building, utility, sign, health, sanitation and business permits and licenses and any other required permits and licenses; (3) construct the Franchise location according to the approved construction plans and specifications; (4) decorate the Franchise location in compliance with the approved plans and specifications; (5) purchase and install all required equipment, furniture, furnishings and signs; (6) cause the training requirements of Section 4 to be completed; (7) purchase an opening inventory of products and other supplies and materials; (8) provide proof, in a form satisfactory to us, that your operation of the Franchise at the Franchise location does not violate any applicable state or local zoning or land use laws, ordinances, or regulations, or any restrictive covenants that apply to such location; (9) provide proof, in a form satisfactory to us, that you (and/or your General Manager, as defined in Section 4.1, if any) are legally authorized and have all licenses necessary to perform all of the services to be offered by your Franchise, and that your organizational structure is consistent with all legal requirements; (10) provide proof, in a format satisfactory to us, that you have obtained all required insurance policies, and have name us, as an additional insurance under all such policies; (11) submit to us a completed copy of the grand opening checklist we provide to you; (12) do any other acts necessary to open the Franchise for business; (13) obtain our approval to open the Franchise for business; and (14) open the Franchise for business. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 7\"}, {\"id\": \"3.4\", \"title\": \"Computer System\", \"level\": 2, \"text\": \"3.4 Computer System. (a) General Requirements. You agree to use in the development and operation of the Franchise the computer terminals/billing systems and operating software (\\\"Computer System\\\") that we specify from time to time. You acknowledge that we may modify such specifications and the components of the Computer System from time to time. As part of the Computer System, we may require you to obtain specified computer hardware and/or software, including without limitation a license to use proprietary software developed by us or others. Our modification of such specifications for the components of the Computer System may require you to incur costs to purchase, lease and/or obtain by license new or modified computer hardware and/or software, and to obtain service and support for the Computer System during the term of this Agreement. You acknowledge that we cannot estimate the future costs of the Computer System (or additions or modifications thereto), and that the cost to you of obtaining the Computer System (or additions or modifications thereto), including software, may not be fully amortizable over the remaining term of this Agreement. Nonetheless, you agree to incur such costs in connection with obtaining the computer hardware and software comprising the Computer System (or additions or modifications thereto). Within sixty (60) days after you receive notice from us, you agree to obtain the components of the Computer System that we designate and require. You further acknowledge and agree that we and our affiliates have the right to charge a reasonable systems fee for software or systems installation services; modifications and enhancements specifically made for us or our affiliates that are licensed to you; and other maintenance and support Computer System-related services that we or our affiliates furnish to you. You will have sole responsibility for: (1) the acquisition, operation, maintenance, and upgrading of your Computer System; (2) the manner in which your Computer System interfaces with our computer system and those of third parties; and (3) any and all consequences that may arise if your Computer System is not properly operated, maintained, and upgraded. (b) Software. As a franchisee of The Joint Corp., we will provide to you The Joint Corp.'s proprietary office management software (the \\\"Joint Software\\\"), which you will be required to install onto the Computer System and use in the daily operation of the Franchise. In addition, we may, at any time and from time to time, contract with one or more software providers, business service providers, or other third parties (individually, a \\\"Service Provider\\\") to develop, license, or otherwise provide to or for the use and benefit of you and other The Joint Corp. Franchises certain software, software applications, and software maintenance and support services related to the Computer System that you must or may use in accordance with our instructions with respect to your Computer System. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 8 9\"}, {\"id\": \"4.2\", \"title\": \"Training\", \"level\": 2, \"text\": \"4.2 Training. You acknowledge that it is very important to the operation of the Franchise that you and your employees receive appropriate training. To that end, you agree as follows: (a) No later than thirty (30) days before the Franchise opens for business, you must attend our initial training program for your Franchise (the \\\"Initial Training\\\") at the time and place we designate. You (if you are an individual) or at least one of your Principal Owners (if you are a legal entity) must complete the Initial Training to our satisfaction. If you employ a General Manager other than yourself or one of your Principal Owners, that General Manager must also complete the Initial Training to our satisfaction. Other employees may complete the Initial Training at your sole discretion and expense, provided you first obtain our approval and subject to availability of facilities and materials. The Initial Training may include classroom instruction and Franchise operation training, and will be furnished at our training facility in Scottsdale, Arizona, a The Joint Corp. Franchise location we designate, your Franchise location, and/or at another location we designate. Our Initial Training programs may be different for each employee depending on their responsibilities at the Franchise. There will be no tuition charge for the persons whom we require to attend any Initial Training program or for any additional personnel of your choosing. All persons who attend our Initial Training must attend and complete the Initial Training to our satisfaction. If we, in our sole discretion, determine that any General Manager or employee whom we require to attend any Initial Training program is unable to satisfactorily complete such program, then you must not hire that person, and must hire a substitute General Manager or employee (as the case may be), who must enroll in the Initial Training program within fifteen (15) days thereafter, and complete the Initial Training to our satisfaction. (b) You agree to have your General Manager (if any) and/or other employees who attend our Initial Training complete additional training programs at places and times as we may request from time to time during the term of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 10 (c) In addition to providing the Initial Training described above, we reserve the right to offer and hold such additional ongoing training programs and franchise owners meetings regarding such topics and at such times and locations as we may deem necessary or appropriate. We also reserve the right to make any of these training programs mandatory for you and/or designated owners, employees, and/or representatives of yours. We reserve the right to charge you a daily attendance fee in an amount to be set by us for each attendee of yours who attends any mandatory or optional training program or owners meeting. If we offer any such mandatory training programs, then you or your designated personnel must attend a minimum of seventy-five percent (75%) of the programs offered on an annual basis. In addition to any other remedies we may have, if you fail to attend any required training, we reserve the right to charge you a non-attendance fee of up to $400 per day for each day of mandatory training programs or meetings you miss or fail to attend. (d) You agree to pay all wages and compensation owed to, and travel, lodging, meal, transportation, and personal expenses incurred by, all of your personnel who attend our Initial Training and/or any mandatory or optional training we provide. (e) We may require your employees to take and pass an online computer training course. While there is no cost to take such training, we may require all employees and staff to pass such training to our satisfaction before they may begin working at your Franchise location. (f) The Franchise's General Manager (if any) and other employees shall obtain all certifications and licenses required by law in order to perform their responsibilities and duties for the Franchise. 5. GUIDANCE; OPERATIONS MANUAL. 5.1 Guidance and Assistance. During the term of this Agreement, we may from time to time furnish you guidance and assistance with respect to: (1) specifications, standards, and operating procedures used by The Joint Corp. Location franchises; (2) purchasing approved equipment, furniture, furnishings, signs, materials and supplies; (3) development and implementation of local advertising and promotional programs; (4) general operating and management procedures; (5) establishing and conducting employee training programs for your Franchise; and (6) changes in any of the above that occur from time to time. This guidance and assistance may, in our discretion, be furnished in the form of bulletins, written reports and recommendations, operations manuals and other written materials (the \\\"Operations Manual\\\"), and/or telephone consultations and/or personal consultations at our offices or your Franchise. If you request\u2014and if we agree to provide\u2014any additional, special on-premises training of your personnel or other assistance in operating your Franchise, then you agree to pay a daily training fee in an amount to be set by us, and all expenses we incur in providing such training or assistance, including any wages or compensation owed to, and travel, lodging, transportation, and living expenses incurred by, our Company personnel. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 11\"}, {\"id\": \"5.2\", \"title\": \"Operations Manual\", \"level\": 2, \"text\": \"5.2 Operations Manual. The Operations Manual we lend to you will contain mandatory and suggested specifications, standards, and operating procedures that we prescribe from time to time for your Franchise, as well as information relative to other obligations you have in the operation of the Franchise. The Operations Manual may be composed of or include audio recordings, video recordings, computer disks, compact disks, and/or other written or intangible materials. We may make all or part of the Manual available to you through various means, including the Internet. A previously delivered Operations Manual may be superseded from time to time with replacement materials to reflect changes in the specifications, standards, operating procedures and other obligations in operating the Franchise. You must keep your copy of the Operations Manual current, and if you and we have a dispute over the contents of the Manual, then our master copy of the Manual will control. You agree that you will not at any time copy any part of the Operations Manual, permit it to be copied, disclose it to anyone not having a need to know its contents for purposes of operating your Franchise, or remove it from the Franchise location without our permission. If your copy of the Operations Manual is lost, destroyed, or significantly damaged, then you must obtain a replacement copy for us at our then-applicable charge. 5.3 Modifications to System. We will continually be reviewing and analyzing developments in the healthcare, and chiropractic industries, as well as developments in fields related to small-business management, and based upon our evaluation of this information, may make changes in the System, including but not limited to, adding new components to services offered and equipment used by The Joint Corp. Location franchises. Moreover, changes in laws regulating the services offered by The Joint Corp. franchises may (a) require us to restructure our franchise program, (b) require your General Manager (if any) and employees to obtain additional licenses or certifications, (c) require you to retain or establish relationships with additional professionals and specialists in the chiropractic and/or healthcare industries, and/or (d) require you to modify your ownership or organizational structure. You agree, at our request, to modify the operation of the Franchise to comply with all such changes, and to be solely responsible for all related costs. 5.4 Advisory Councils. You agree to participate in, and, if required, become a member of any advisory councils or similar organizations we form or organize for The Joint Corp. Location franchises. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 12 THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 13 14 15\"}, {\"id\": \"6.9\", \"title\": \"Electronic Funds Transfer\", \"level\": 2, \"text\": \"6.9 Electronic Funds Transfer. We have the right to require you to participate in an electronic funds transfer program under which Royalty Fees, Advertising Fees, and any other amounts payable to us or our affiliates are deducted or paid electronically from your bank account (the \\\"Account\\\"). In the event you are required to authorize us to initiate debit entries, you agree to make the funds available in the Account for withdrawal by electronic transfer no later than the payment due date. The amount actually transferred from the Account to pay Royalty Fees and Advertising Fees will be based on the Franchise's gross revenues as reported in the Franchise's practice management software. If you have not properly input the Franchise's gross revenues for any reporting period, then we will be authorized to debit the Account in an amount equal to one hundred twenty percent (120%) of the Royalty Fee, Advertising Fee, and other amounts transferred from the Account for the last reporting period for which a report of the Franchise's gross revenues was provided to us. If at any time we determine that you have under-reported the Franchise's gross revenues or underpaid any Royalty Fee or Advertising Fee due us under this Agreement, then we will be authorized to initiate immediately a debit to the Account in the appropriate amount, plus applicable interest, in accordance with the foregoing procedure. Any overpayment will be credited, without interest, against the Royalty Fee, Advertising Fee, and other amounts we otherwise would debit from your account during the following reporting period. Our use of electronic funds transfers as a method of collecting Royalty Fees and Advertising Fees due us does not constitute a waiver of any of your obligations to provide us with weekly reports as provided in Section 12, nor shall it be deemed a waiver of any of the rights and remedies available to us under this Agreement. 6.10 Application of Payments. When we receive a payment from you, we have the right in our sole discretion to apply it as we see fit to any past due indebtedness of yours due to us or our affiliates, whether for Royalty Fees, Advertising Fees, purchases, interest, or for any other reason, regardless of how you may designate a particular payment should be applied. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 16\"}, {\"id\": \"6.11\", \"title\": \"Modification of Payments\", \"level\": 2, \"text\": \"6.11 Modification of Payments. If, by operation of law or otherwise, any fees contemplated by this Agreement cannot be based upon gross revenues, then you and we agree to negotiate in good faith an alternative fee arrangement. If you and we are unable to reach an agreement on an alternative fee arrangement, then the Company reserves the right to terminate this Agreement upon notice to you, in which case all of the post-termination obligations set forth in Section 16 shall apply. 6.12 Non-Compliance Charge. In addition to our other rights and remedies, we may charge you a non-compliance charge in an amount up to five hundred dollars ($500) per violation by you of any term or condition of this Agreement, including, without limitation, failure to pay (or to have adequate amounts available for electronic transfer of) amounts owed to Franchisor or Franchisor's affiliates or failure to timely provide required reports, or failure to obtain prior approval from Franchisor whenever Franchisor approval is required (i.e., advertising). 7. MARKS. 7.1 Ownership and Goodwill of Marks. You acknowledge that your right to use the Marks is derived solely from this Agreement, and is limited to your operation of the Franchise pursuant to and in compliance with this Agreement and all applicable standards, specifications, and operating procedures we prescribe from time to time during the term of the Franchise. You understand and acknowledge that our right to regulate the use of the Marks includes, without limitation, any use of the Marks in any form of electronic media, such as Websites (as defined herein) or web pages, or as a domain name or electronic media identifier. If you make any unauthorized use of the Marks, it will constitute a breach of this Agreement and an infringement of our rights in and to the Marks. You acknowledge and agree that all your usage of the Marks and any goodwill established by your use will inure exclusively to our benefit and the benefit of our affiliates, and that this Agreement does not confer any goodwill or other interests in the Marks on you (other than the right to operate the Franchise in compliance with this Agreement). All provisions of this Agreement applicable to the Marks will apply to any additional trademarks, service marks, commercial symbols, designs, artwork, or logos we may authorize and/or license you to use during the term of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 17\"}, {\"id\": \"7.2\", \"title\": \"Limitations on Franchise Owner's Use of Marks\", \"level\": 2, \"text\": \"7.2 Limitations on Franchise Owner's Use of Marks. You agree to use the Marks as the sole trade identification of the Franchise, except that you will display at the Franchise location a notice, in the form we prescribe, stating that you are the independent owner of the Franchise pursuant to a Franchise Agreement with us. You agree not to use any Mark as part of any corporate or trade name or with any prefix, suffix, or other modifying words, terms, designs, or symbols (other than logos and additional trade and service marks licensed to you under this Agreement), or in any modified form. You also shall not use any Mark or any commercial symbol similar to the Marks in connection with the performance or sale of any unauthorized services or products, or in any other manner we have not expressly authorized in writing. You agree to display the Marks in the manner we prescribe at the Franchise and in connection with advertising and marketing materials, and to use, along with the Marks, any notices of trade and service mark registrations we specify. You further agree to obtain any fictitious or assumed name registrations as may be required under applicable law. 7.3 Notification of Infringements and Claims. You agree to immediately notify us in writing of any apparent infringement of or challenge to your use of any Mark, or claim by any person of any rights in any Mark or similar trade name, trademark, or service mark of which you become aware. You agree not to communicate with anyone except us and our counsel in connection with any such infringement, challenge, or claim. We have the right to exclusively control any litigation or other proceeding arising out of any actual or alleged infringement, challenge, or claim relating to any Mark. You agree to sign any documents, render any assistance, and do any acts that our attorneys say is necessary or advisable in order to protect and maintain our interests in any litigation or proceeding related to the Marks, or to otherwise protect and maintain our interests in the Marks. 7.4 Discontinuance of Use of Marks. If it becomes advisable at any time in our sole judgment for the Franchise to modify or discontinue the use of any Mark, or use one or more additional or substitute trade or service marks, including the Marks used as the name of the Franchise, then you agree, at your sole expense, to comply with our directions to modify or otherwise discontinue the use of the Mark, or use one or more additional or substitute trade or service marks, within a reasonable time after our notice to you. 7.5 Indemnification of Franchise Owner. We agree to indemnify you against, and reimburse you for, all damages for which you are held liable in any trademark infringement proceeding arising out of your use of any Mark pursuant to and in compliance with this Agreement, and for all costs you reasonably incur in the defense of any such claim in which you are named as a party, so long as you have timely notified us of the claim, and have otherwise complied with this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 18\"}, {\"id\": \"8\", \"title\": \"RELATIONSHIP OF THE PARTIES; INDEMNIFICATION\", \"level\": 1, \"text\": \"8. RELATIONSHIP OF THE PARTIES; INDEMNIFICATION. 8.1 Independent Contractor; No Fiduciary Relationship. This Agreement does not create a fiduciary relationship between you and us. You and we are independent contractors, and nothing in this Agreement is intended to make either party a general or special agent, joint venture, partner, or employee of the other for any purpose whatsoever. You agree to conspicuously identify yourself in all your dealings with customers, suppliers, public officials, Franchise personnel, and others as the owner of the Franchise pursuant to a Franchise Agreement with us, and to place any other notices of independent ownership on your forms, business cards, stationery, advertising, and other materials as we may require from time to time. 8.2 No Liability, No Warranties. We have not authorized or empowered you to use the Marks except as provided by this Agreement, and you agree not to employ any of the Marks in signing any contract, check, purchase agreement, negotiable instrument or legal obligation, application for any license or permit, or in a manner that may result in liability to us for any indebtedness or obligation of yours. Except as expressly authorized by this Agreement, neither you nor we will make any express or implied agreements, warranties, guarantees or representations, or incur any debt, in the name of or on behalf of the other, or represent that your and our relationship is other than that of franchisor and franchisee. 8.3 Indemnification. We will not assume any liability or be deemed liable for any agreements, representations, or warranties you make that are not expressly authorized under this Agreement, nor will we be obligated for any damages to you or any person or property directly or indirectly arising out of the operation of the business you conduct pursuant to this Agreement, whether or not caused by your negligent or willful action or failure to act. We will have no liability for any sales, use, excise, income, gross receipts, property, or other taxes levied against you or your assets, or on us, in connection with the business you conduct, or any payments you make to us pursuant to this Agreement (except for our own income taxes). We will not assume any liability or be deemed liable for any agreements you enter with any third-parties, whether or not they are an approved or required vendor. You agree to indemnify, defend, and hold us, our affiliates and our and their respective owners, directors, officers, employees, agents, successors, and assigns (individually, an \\\"Indemnified Party,\\\" and collectively, the \\\"Indemnified Parties\\\"), harmless against, and to reimburse such Indemnified Parties for, all such obligations, damages, and taxes for which any Indemnified Party may be held liable, and for all costs the Indemnified Party reasonably may incur in the defense of any such claim brought against the Indemnified Party, or in any such action in which the Indemnified Party may be named as a party, including without limitation actual and consequential damages; reasonable attorneys', accountants', and/or expert witness fees; cost of investigation and proof of facts; court costs; other litigation expenses; and travel and living expenses. Each Indemnified Party has the right to defend any such claim against the Indemnified Party. You further agree to hold us harmless and indemnify and defend us for all costs, expenses, and/or losses we incur in enforcing the provisions of this Agreement, defending our actions taken relating to this Agreement, or resulting from your breach of this Agreement, including without limitation reasonable arbitrator's and attorneys' fees (including those for appeal), unless, after legal proceedings are completed, you are found to have fulfilled and complied with all of the terms of this Agreement. Your indemnification obligations described above will continue in full force and effect after, and notwithstanding, the expiration or termination of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 19\"}, {\"id\": \"9\", \"title\": \"CONFIDENTIAL INFORMATION; NON-COMPETITION\", \"level\": 1, \"text\": \"9. CONFIDENTIAL INFORMATION; NON-COMPETITION. 9.1 Types of Confidential Information. We possess certain unique confidential and proprietary information and trade secrets consisting of the following categories of information, methods, techniques, products, and knowledge developed by us, including but not limited to: (1) services and products offered and sold at The Joint Corp. franchises; (2) knowledge of sales and profit performance of any one or more The Joint Corp. franchises; (3) knowledge of sources of products sold at The Joint Corp. franchises, advertising and promotional programs, and image and decor; (4) the Joint Software; (5) methods, techniques, formats, specifications, procedures, information, systems, and knowledge of, and experience in, the development, operation, and franchising of The Joint Corp. franchises; and (6) the selection and methods of training employees. We will disclose much of the above- described information to you in advising you about site selection, providing our Initial Training, the Operations Manual, the Joint Software, and providing guidance and assistance to you under this Agreement. In addition, in the course of the operation of your Franchise, you or your employees may develop ideas, concepts, methods, or techniques of improvement relating to the Franchise that you disclose to us, and that we may then authorize you to use in the operation of your Franchise, and may use or authorize others to use in other The Joint Corp. franchises owned or franchised by us or our affiliates. Any such information disclosed to or developed by you will be referred to in this Agreement as \\\"Confidential Information\\\". THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 20\"}, {\"id\": \"9.2\", \"title\": \"Non-Disclosure Agreement\", \"level\": 2, \"text\": \"9.2 Non-Disclosure Agreement. You agree that your relationship with us does not vest in you any interest in the Confidential Information, other than the right to use it in the development and operation of the Franchise, and that the use or duplication of the Confidential Information in any other business would constitute an unfair method of competition. You acknowledge and agree that the Confidential Information belongs to us, may contain trade secrets belonging to us, and is disclosed to you or authorized for your use solely on the condition that you agree, and you therefore do agree, that you (1) will not use the Confidential Information in any other business or capacity; (2) will maintain the absolute confidentiality of the Confidential Information during and after the term of this Agreement; (3) will not make unauthorized copies of any portion of the Confidential Information disclosed in written form or another form that may be copied or duplicated; and (4) will adopt and implement all reasonable procedures we may prescribe from time to time to prevent unauthorized use or disclosure of the Confidential Information, including without limitation restrictions on disclosure to your employees, and the use of non-disclosure and non-competition agreements we may prescribe or approve for your shareholders, partners, members, officers, directors, employees, independent contractors, or agents who may have access to the Confidential Information. 9.3 Non-Competition Agreement. You agree that we would be unable to protect the Confidential Information against unauthorized use or disclosure, and would be unable to encourage a free exchange of ideas and information among The Joint Corp. franchises, if franchise owners of The Joint Corp. franchises were permitted to hold interests in any competitive businesses (as described below). Therefore, during the term of this Agreement, neither you, nor any Principal Owner, nor any member of your immediate family or of the immediate family of any Principal Owner, shall perform services for, or have any direct or indirect interest as a disclosed or beneficial owner, investor, partner, director, officer, employee, manager, consultant, representative, or agent in, any business that offers products or services the same as or similar to those offered or sold at The Joint Corp. Location franchises. The ownership of one percent (1%) or less of a publicly traded company will not be deemed to be prohibited by this Paragraph. Upon expiration or termination of this Agreement for any reason, you agree not to engage in a competitive business for a period of two (2) years after the termination or expiration and within twenty-five (25) miles of your Franchise Premises or any other The Joint Corp. Location franchise location. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 21\"}, {\"id\": \"10\", \"title\": \"THE JOINT CORP\", \"level\": 1, \"text\": \"10. THE JOINT CORP. FRANCHISE OPERATING STANDARDS. 10.1 Condition and Appearance of the Franchise. You agree that: (a) neither the Franchise nor the Premises will be used for any purpose other than the operation of the Franchise in compliance with this Agreement; (b) you will maintain the condition and appearance of the Franchise; its equipment, furniture, furnishings, and signs; and the Premises in accordance with our standards and consistent with the image of a The Joint Corp. Location franchise as an efficiently operated business offering high quality services, and observing the highest standards of cleanliness, sanitation, efficient, courteous service and pleasant ambiance, and in that connection will take, without limitation, the following actions during the term of this Agreement: (1) thorough cleaning, repainting and redecorating of the interior and exterior of the Premises at reasonable intervals; (2) interior and exterior repair of the Premises; and (3) repair or replacement of damaged, worn out or obsolete equipment, furniture, furnishings and signs; (c) you will not make any material alterations to the Premises or the appearance of the Franchise, as originally developed, without our advance written approval. If you do so, we have the right, at our option and at your expense, to rectify alterations we have not previously approved; (d) you will promptly replace or add new equipment when we reasonably specify in order to meet changing standards or new methods of service; (e) you will expend at least Six Thousand and No/100 Dollars ($6,000.00) every four (4) years in remodeling, expansion, redecorating and/or refurnishing of the Premises and the Franchise, if deemed necessary by us (any changes to the decoration or furnishing of the Premises must be approved by us); (f) on notice from us, you will engage in remodeling, expansion, redecorating and/or refurnishing of the Premises and the Franchise to reflect changes in the operations of The Joint Corp. franchises that we prescribe and require of new franchisees, provided that (1) no material changes will be required unless there are at least two (2) years remaining on the Initial Term of the Franchise (any changes to the decoration or furnishing of the Premises must be approved by us); and (2) we have required the proposed change in at least twenty-five percent (25%) of all similarly situated Company and affiliate-owned The Joint Corp. Locations, and have undertaken a plan to make the proposed change in the balance of such Company and affiliate-owned Locations (any expenditures incurred pursuant to this Paragraph 10.1(f) shall apply to the requirement in Paragraph 10.1(e)); THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 22 (g) you will place or display at the Premises (interior and exterior) only those signs, emblems, designs, artwork, lettering, logos, and display and advertising materials that we from time to time approve; and (h) if at any time in our reasonable judgment, the general state of repair, appearance, or cleanliness of the premises of the Franchise or its fixtures, equipment, furniture, or signs do not meet our standards, then we shall have the right to notify you specifying the action you must take to correct the deficiency. If you do not initiate action to correct such deficiencies within (ten) 10 days after receipt of our notice, and then continue in good faith and with due diligence, a bona fide program to complete any required maintenance or refurbishing, then we shall have the right, in addition to all other remedies available to us at law or under this Agreement, to enter the Premises or the Franchise and perform any required maintenance or refurbishing on your behalf, and you agree to reimburse us on demand. 10.2 Franchise Services and Products. You agree that (a) the Franchise will offer for sale all services and products that we from time to time specify for Locations, (b) the Franchise will offer and sell approved services and products only in the manner we have prescribed; (c) you will not offer for sale or sell at the Franchise, the Premises, or any other location any services or products we have not approved; (d) all products will be offered at retail prices, and you will not offer or sell any products at wholesale prices; (e) you will not use the Premises for any purpose other than the operation of the Franchise; and (f) you will discontinue selling and offering for sale any services or products that we at any time decide (in our sole discretion) to disapprove in writing. In the event that you use, sell or distribute unauthorized products or services, and do not cease the use, sale, or distribution of unauthorized services or products within ten (10) days after written notice is given to you, we reserve the right to terminate this agreement and/or charge you a fee of One Hundred and No/100 Dollars ($100.00) for each day that you fail to comply with our demand to cease the use, sale or distribution of unauthorized products or services, which is a reasonable estimate of the damages we would incur from your continued use, sale or distribution of unauthorized products or services, and not a penalty. You agree to maintain an inventory of approved products sufficient in quantity and variety to realize the full potential of the Franchise. We may, from time to time, conduct market research and testing to determine consumer trends and the saleability of new services and products. You agree to cooperate by participating in our market research programs, test marketing new services and products in the Franchise, and providing us with timely reports and other relevant information regarding such market research. In connection with any such test marketing, you agree to offer a reasonable quantity of the products or services being tested, and effectively promote and make a reasonable effort to sell them. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 23\"}, {\"id\": \"10.3\", \"title\": \"Approved Products, Distributors and Suppliers\", \"level\": 2, \"text\": \"10.3 Approved Products, Distributors and Suppliers. We have developed or may develop various unique products or services that may be prepared according to our formulations. We have approved, and will continue to periodically approve, specifications for suppliers and distributors (which may include us and/or our affiliates) for products or services required to be purchased by, or offered and sold at, The Joint Corp. Location franchises, that meet our standards and requirements, including without limitation standards and requirements relating to product quality, prices, consistency, reliability, and customer relations. You understand and acknowledge we will not be liable to you or anyone else for any damages or claims arising out of or resulting from the acts or omissions any supplier and distributor of products or services, whether or not such supplier or distributor is an approved or required supplier or distributor of products or services. You agree that the Franchise will: (1) purchase any required products or services in such quantities as we designate; (2) utilize such formats, formulae, and packaging for products or services as we prescribe; and (3) purchase all designated products and services only from distributors and other suppliers we have approved. In the event we designate a required supplier or distributor during the term of this Agreement, or any subsequent franchise agreement, you must begin to use such required supplier or distributor with thirty (30) days of the date we notify you that you must use such supplier or distributor, unless we designate a longer period for you to switch or convert over to such supplier or distributor. Your failure or refusal to do so shall constitute a breach of this Agreement. We may approve a single distributor or other supplier (collectively \\\"supplier\\\") for any product, and may approve a supplier only as to certain products. We may concentrate purchases with one or more suppliers to obtain lower prices or the best advertising support or services for any group of The Joint Corp. Locations franchised or operated by us. Approval of a supplier may be conditioned on requirements relating to the frequency of delivery, concentration of purchases, standards of service (including prompt attention to complaints), or other criteria, and may be temporary, pending our continued evaluation of the supplier from time to time. If you would like to purchase any items from any unapproved supplier, then you must submit to us a written request for approval of the proposed supplier. We have the right to inspect the proposed supplier's facilities, and require that product samples from the proposed supplier be delivered, at our option, either directly to us, or to any independent, certified laboratory that we may designate, for testing. We may charge you a supplier evaluation fee (not to exceed the reasonable cost of the inspection and the actual cost of the test) to make the evaluation. We reserve the right to periodically re-inspect the facilities and products of any approved supplier, and revoke our approval if the supplier does not continue to meet any of our criteria. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 24 We and/or our affiliates may be an approved supplier of certain products or services to be purchased by you for use and/or sale by the Franchise. We and our affiliates reserve the right to charge any licensed manufacturer engaged by us or our affiliates a royalty to manufacture products for us or our affiliates, or to receive commissions or rebates from vendors that supply goods or services to you. We or our affiliates may also derive income from our sale of products or services to you, and may sell these items at prices exceeding our or their costs in order to make a profit on the sale. 10.4 Hours of Operation. You agree to keep the Franchise open for business at such times and during such hours as we may prescribe from time to time. 10.5 Specifications, Standards and Procedures. You agree to comply with all mandatory specifications, standards, and operating procedures relating to the appearance, function, cleanliness, sanitation and operation of the Franchise. Any mandatory specifications, standards, and operating procedures that we prescribe from time to time in the Operations Manual, or otherwise communicate to you in writing, will constitute provisions of this Agreement as if fully set forth in this Agreement. All references to \\\"this Agreement\\\" include all such mandatory specifications, standards, and operating procedures. 10.6 Compliance with Laws and Good Business Practices. You agree to secure and maintain in force in your name all required licenses, permits and certificates relating to the operation of the Franchise. You also agree to operate the Franchise in full compliance with all applicable laws, ordinances, and regulations, including without limitation all government regulations relating to worker's compensation insurance, unemployment insurance, and withholding and payment of federal and state income taxes, social security taxes, and sales taxes. All advertising you employ must be completely factual, in good taste (in our judgment), and conform to the highest standards of ethical advertising and all legal requirements. You agree that in all dealings with us and any of our affiliates, other franchisees, your customers, your suppliers, and public officials, you will adhere to the highest standards of honesty, integrity, fair dealing and ethical conduct. You further agree to refrain from any business or advertising practice that may be harmful to the business of the Company, the Franchise, and/or the goodwill associated with the Marks and other The Joint Corp. franchises. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 25 You must notify us in writing within 5 days of (1) the commencement of any action, suit, or proceeding, and/or of the issuance of any order, writ, injunction, award, or decree of any court, agency, or other governmental unit, that may adversely affect your and/or the Franchise's operation, financial condition, or reputation; and/or (2) your receipt or knowledge any notice of violation of any law, ordinance, or regulation relating to health or safety. 10.7 Management and Personnel of the Franchise. Unless we approve your employment of a General Manager to operate the Franchise as provided in Paragraph 4.1, you must actively participate in the actual, on-site, day-to-day operation of the Franchise, and devote as much of your time as is reasonably necessary for the efficient operation of the Franchise. If you are other than an individual, then at least one (1) Principal Owner, director, officer, or other employee of you whom we approve must comply with the this requirement. If we agree that you may employ a General Manager, then the General Manager must fulfill this requirement. Any General Manager shall each obtain all licenses and certifications required by law before assuming his or her responsibilities at the Franchise. You will ensure that your employees and independent contractors of the Franchise have any licenses as may be required by law, and hold or are pursuing any licenses, certifications, and/or degrees required by law or by us in the Operations Manual, as updated from time to time. You will be exclusively responsible for the terms of your employees' and independent contractors' employment and compensation, and for the proper training of your employees and independent contractors in the operation of the Franchise. You must establish any training programs for your employees and/or independent contractors that we may prescribe in writing from time to time. You must require all employees and independent contractors to maintain a neat and clean appearance, and conform to the standards of dress that we specify in the Operations Manual, as updated from time to time. Each of your employees and independent contractors must sign a written agreement, in a form approved by us, to maintain confidential our Confidential Information, proprietary information, and trade secrets as described in Paragraph 9.1, and to abide by the covenants not to compete described in Paragraph 9.3. You must forward to us a copy of each such signed agreement. All of your employees and independent contractors must render prompt, efficient and courteous service to all customers of the Franchise. You agree not to recruit or hire, either directly or indirectly, any employee (or a former employee, for sixty (60) days after his or her employment has ended) of any The Joint Corp. Location franchise operated by us, our affiliates, or another The Joint Corp. franchise owner without first obtaining the written consent of us, our affiliate, or the franchise owner that currently employs (or previously employed) such employee. If you violate this provision, in addition to any other right or remedy we may have, you agree to pay the employee's current or former employer twice the employee's annual salary, plus all costs and attorneys' fees incurred as a result of the violation. This amount is set at twice the employee's annual salary because it is a reasonable estimation of the damages that would occur from such a breach, and it will almost certainly be impossible to calculate precisely the actual damages from such a breach. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 26\"}, {\"id\": \"10.8\", \"title\": \"Insurance\", \"level\": 2, \"text\": \"10.8 Insurance. Before you open the Franchise and during any Term of this Agreement, you must maintain in force, under policies of insurance written on an occurrence basis issued by carriers with an A.M. Best rating of A-VIII or better approved by us, and in such amounts as we may determine from time to time: (1) comprehensive public, professional, product, medical malpractice and motor vehicle liability insurance against claims for bodily and personal injury, death and property damage caused by or occurring in conjunction with the operation of the Franchise or otherwise in conjunction with your conduct of the Franchise Business pursuant to this Agreement, under one or more policies of insurance containing minimum liability coverage amounts as set forth in the Operations Manual; (2) general casualty insurance, including theft, cash theft, fire and extended coverage, vandalism and malicious mischief insurance, for the replacement value of the Franchise and its contents, and any other assets of the Franchise; (3) worker's compensation and employer's liability insurance as required by law, with limits equal to or in excess of those required by statute; (4) business interruption insurance for a period adequate to reestablish normal business operations, but in any event not less than six (6) months; (5) any other insurance required by applicable law, rule, regulation, ordinance or licensing requirements; and (6) umbrella liability coverage with limits of not less than $1,000,000/$3,000,000 or such other amounts that we may establish in the Operations Manual. You must purchase such insurance coverage(s) only from our approved or designated supplier(s). We may periodically increase or decrease the amounts of coverage required under these insurance policies, and/or require different or additional kinds of insurance, including excess liability insurance, to reflect inflation, identification of new risks, changes in law or standards of liability, higher damage awards, or other relevant changes in circumstances. Each insurance policy must name us (and, if we so request, our members, directors, employees, agents, and affiliates) as additional insureds, and must provide us with thirty (30) days' advance written notice of any material modification, cancellation, or expiration of the policy. Deductibles must be in reasonable amounts, and are subject to review and written approval by us. You must provide us with copies of policies evidencing the existence of such insurance concurrently with execution of this Agreement and prior to each subsequent renewal date of each insurance policy, along with certificates evidencing such insurance. You are responsible for any and all claims, losses or damages, including to third persons, originating from, in connection with, or caused by your failure to name us as an additional insured on each insurance policy. You agree to defend, indemnify and hold us harmless of, from, and with respect to any such claims, loss or damage arising out of your failure to name us as additional insured, which indemnity shall survive the termination or expiration and non-renewal of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 27 Prior to the expiration of the term of each insurance policy, you must furnish us with a copy of a renewal or replacement insurance policy and appropriate certificates of insurance. If you at any time fail or refuse to maintain any insurance coverage required by us or to furnish satisfactory evidence thereof, then we, at our option and in addition to our other rights and remedies under this Agreement, may, but need not, obtain such insurance coverage on your behalf, and you shall reimburse us on demand for any costs or premiums paid or incurred by us, including any administrative fees or surcharges that we may incur. If you fail to pay us within ten (10) days of our demand for reimbursement, we reserve the right to debit your account the amounts owed to us for any premiums paid on your behalf for such insurance coverage along with any other costs, surcharges expenses and fees we incur to obtain such coverage on your behalf or on behalf of your franchise. We reserve the right to require you to provide us with an application for insurance (in a form acceptable to our required supplier for insurance) for any medical professional that has been offered a position to work in a Franchise location so that we may, if you fail to do so, procure any necessary insurance coverage for such medical professional. Notwithstanding the existence of such insurance, you are and will be responsible for all loss or damage and contractual liability to third persons originating from or in connection with the operation of the Franchise, and for all claims or demands for damages to property or for injury, illness or death of persons directly or indirectly resulting therefrom; and you agree to defend, indemnify and hold us harmless of, from, and with respect to any such claims, loss or damage, which indemnity shall survive the termination or expiration and non-renewal of this Agreement. In addition to the requirements of the foregoing paragraphs of this Paragraph 10.8, you must maintain any and all insurance coverage in such amounts and under such terms and conditions as may be required in connection with your lease or purchase of the Premises. Your obligation to maintain insurance coverage as described in this Agreement will not be reduced in any manner by reason of any separate insurance we maintain on our own behalf, nor will our maintenance of that insurance relieve you of any obligations under Section 7 of this Agreement. 10.9 Credit Cards and Other Methods of Payment. You must at all times have arrangements in existence with Visa, Master Card, American Express, Discover and any other credit and debit card issuers or sponsors, check verification services, and electronic fund transfer systems that we designate from time to time, in order that the Franchise may accept customers' credit and debit cards, checks, and other methods of payment. We may require you to obtain such services through us or our affiliates. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 28 29 The Ad Fund will be accounted for separately from other funds of the Company, and will not be used to defray any of our general operating expenses, except for any reasonable salaries, administrative costs, and overhead we may incur in activities reasonably related to the administration of the Ad Fund and its advertising programs (including without limitation conducting market research, preparing advertising and marketing materials, and collecting and accounting for contributions to the Ad Fund). We may spend in any fiscal year an amount greater or less than the total contributions to the Ad Fund in that year. We may cause the Ad Fund to borrow from us or other lenders to cover deficits of the Ad Fund, or to invest any surplus for future use by the Ad Fund. You authorize us to collect for remission to the Ad Fund any advertising monies or credits offered by any supplier to you based upon purchases you make. We will prepare an annual statement of monies collected and costs incurred by the Ad Fund and will make it available to you on written request. You understand and acknowledge that the Ad Fund will be intended to maximize recognition of the Marks and patronage of The Joint Corp. Location franchises. Although we will endeavor to use the Ad Fund to develop advertising and marketing materials, and to place advertising in a manner that will benefit all The Joint Corp. Location franchises, we undertake no obligation to ensure that expenditures by the Ad Fund in or affecting any geographic area are proportionate or equivalent to contributions to the Ad Fund by The Joint Corp. Location franchises operating in that geographic area, or that any The Joint Corp. Location franchise will benefit directly or in proportion to its contribution to the Ad Fund from the development of advertising and marketing materials or the placement of advertising. Except as expressly provided in this Paragraph, we assume no direct or indirect liability or obligation to you with respect to the maintenance, direction, or administration of the Ad Fund. We will have the right to terminate the Ad Fund by giving you thirty (30) days' advance written notice. All unspent monies on date of termination will be divided between the Company and the contributing The Joint Corp. Location franchisees in proportion to our and their respective contributions. At any time thereafter, we will have the right to reinstate the Ad Fund under the same terms and conditions as described in this Section (including the rights to terminate and reinstate the Ad Fund) by giving you thirty (30) days' advance written notice of reinstatement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 30 31 (a) Before establishing any Website or Other Form of Advertising Media, you will submit to us a sample of such Website or Other Form of Advertising Media format and information in the form and manner we may require. (b) You will not establish or use any Website or Other Forms of Advertising Media without our prior written approval. (c) In addition to any other applicable requirements, you must comply with our standards and specifications for Website or Other Forms of Advertising Media as we prescribe in the Operations Manual or otherwise in writing, including any specifications relating to the use of organic and paid search engine optimization, keyword and landing page management. If we require, you will establish a website as part of our corporate website and/or establish electronic links to our corporate website. (d) If you propose any material revision to Website or Other Forms of Advertising Media or any of the information contained therein, you will submit each such revision to us for our prior written approval. 12. ACCOUNTING, REPORTS AND FINANCIAL STATEMENTS. You agree to maintain, at your own expense, the Joint Software and accounting software, to act as a bookkeeping, accounting, and record keeping system for the Franchise. The Joint Software includes the capability of being polled by our central computer system, which you agree to permit. With respect to the operation and financial condition of the Franchise, we will pull from the Joint Software (if available), or require you to provide from your accounting software in a form we designate, or in accordance with General Acceptably Accounting Principles (\\\"GAAP\\\"), as the case may be, the following: (1) by Tuesday of each week, an electronic report of the Franchise's gross revenues for the preceding week ending on, and including, Sunday, and any other data, information, and supporting records that we may require; (2) by the thirtieth (30 t h) day of each month, a profit and loss statement for the preceding calendar month, and a year-to-date profit and loss statement and balance sheet; (3) within ninety (90) days after the end of your fiscal year, a fiscal year-end balance sheet, and an annual profit and loss statement for that fiscal year, reflecting all year- end adjustments; and (4) such other reports as we require from time to time (collectively, the \\\"Reports\\\"). You agree to input all Franchise transactions into the Joint Software and your accounting software in a timely manner to ensure that all Reports are accurate. If it is determined that any information was omitted from the Joint Software or your accounting software was input inaccurately, or you have failed to provide us any required Reports, we may charge a non-refundable accounting fee of One Hundred and No/100 Dollars ($100.00), payable in a lump sum by the fifth (5th) day of the month following the month during which the inaccurate report was submitted or for any late Reports. You agree to maintain and furnish upon our request complete copies of federal and state income tax returns you file with the Internal Revenue Service and state tax departments, reflecting revenues and income of the Franchise or the corporation, partnership, or limited liability company that holds the Franchise. We reserve the right to require you to have audited or reviewed financial statements prepared by a certified public accountant on an annual basis. You agree to retain hard copies of all records for a minimum of four (4) years. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 32\"}, {\"id\": \"13\", \"title\": \"INSPECTIONS AND AUDITS\", \"level\": 1, \"text\": \"13. INSPECTIONS AND AUDITS. 13.1 Company's Right to Inspect the Franchise. To determine whether you and the Franchise are complying with this Agreement and the specifications, standards, and operating procedures we prescribe for the operation of the Franchise, we or our agents have the right, at any reasonable time and without advance notice to you, to: (1) inspect the Premises; (2) observe the operations of the Franchise for such consecutive or intermittent periods as we deem necessary; (3) interview personnel of the Franchise; (4) interview customers of the Franchise; and (5) inspect and copy any books, records and documents relating to the operation of the Franchise. You agree to fully cooperate with us in connection with any of those inspections, observations and interviews. You agree to present to your customers any evaluation forms we periodically prescribe, and agree to participate in, and/or request that your customers participate in, any surveys performed by or on our behalf. Based on the results of any such inspections and audits and your other reports, we may provide to you such guidance and assistance in operating your Franchise as we deem appropriate. 13.2 Company's Right to Audit. We have the right at any time during business hours, and without advance notice to you, to inspect and audit, or cause to be inspected and audited, the business records, bookkeeping and accounting records, sales and income tax records and returns and other records of the Franchise, and the books and records of any corporation, limited liability company, or partnership that holds the Franchise. You agree to fully cooperate with our representatives and any independent accountants we may hire to conduct any inspection or audit. If the inspection or audit is necessary because of your failure to furnish any reports, supporting records, other information or financial statements as required by this Agreement, or to furnish such reports, records, information, or financial statements on a timely basis, or if an understatement of gross revenues for any period is determined by an audit or inspection to be greater than two percent (2%), then you agree to pay us all monies owed, plus interest of one and one-half percent (1.5%) per month, and reimburse us for the cost of such inspection or audit, including without limitation any attorneys' fees and/or accountants' fees we may incur, and the travel expenses, room and board, and applicable per diem charges for our employees or contractors. The above remedies are in addition to all our other remedies and rights under this Agreement or under applicable law. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 33\"}, {\"id\": \"14\", \"title\": \"TRANSFER REQUIREMENTS\", \"level\": 1, \"text\": \"14. TRANSFER REQUIREMENTS. 14.1 Organization. If you are a corporation, partnership or limited liability company (or if this Agreement is assigned to a corporation, partnership or limited liability company with our approval), you represent and warrant to us that you are and will continue to be throughout the term of this Agreement, duly organized and validly existing in good standing under the laws of the state of your incorporation, registration or organization, that you are qualified to do business and will continue to be qualified to do business throughout the term of this Agreement in all states in which you are required to qualify, that you have the authority to execute, deliver and carry out all of the terms of this Agreement, and that during the term of this Agreement the only business you (i.e., the corporate, partnership or limited liability entity) will conduct will be the development, ownership and operation of the Franchise. 14.2 Interests in Franchise Owner; Reference to Exhibit 4. You and each Principal Owner represent, warrant and agree that all \\\"Interests\\\" in Franchise Owner are owned in the amount and manner described in Exhibit 4. No Interests in Franchise Owner will, during the term of this Agreement, be \\\"public\\\" securities (i.e., securities that require, for their issuance, registration with any state or federal authority). (An \\\"Interest\\\" is defined to mean any shares, membership interests, or partnership interests of Franchise Owner and any other equitable or legal right in any of Franchise Owner's stock, revenues, profits, rights or assets. When referring to Franchise Owner's rights or assets, an \\\"Interest\\\" means this Agreement, Franchise Owner's rights under and interest in this Agreement, any The Joint Corp. franchise, or the revenues, profits or assets of any The Joint Corp. franchise.) You and each Principal Owner also represent, warrant, and agree that no Principal Owner's Interest has been given as security for any obligation (i.e., no one has a lien on or security interest in a Principal Owner's Interest), and that no change will be made in the ownership of an Interest other than as expressly permitted by this Agreement or as we may otherwise approve in writing. You and each Principal Owner agree to furnish us with such evidence as we may request from time to time to assure ourselves that the Interests of Franchise Owner and each of your Principal Owners remain as permitted by this Agreement, including a list of all persons or entities owning any Interest, as defined above. If you have transferred your Interests in violation of this Agreement you shall be considered in breach of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 34\"}, {\"id\": \"14.3\", \"title\": \"Transfer by Company\", \"level\": 2, \"text\": \"14.3 Transfer by Company. This Agreement is fully transferable by us and will inure to the benefit of any person or entity to whom it is transferred, or to any other legal successor to our interests in this Agreement. 14.4 No Transfer Without Approval. You understand and acknowledge that the rights and duties created by this Agreement are personal to you and that we have entered into this Agreement in reliance on the individual or collective character, skill, aptitude, attitude, business ability, and financial capacity of you and your Principal Owners. Accordingly, neither this Agreement nor any part of your interest in it, nor any Interest (as defined in Paragraph 14.2) of Franchise Owner or a Principal Owner, may be transferred (see definition below) without our advance written approval if such transfer will result in the Principal Owner(s) set forth in Exhibit 4 holding less than a seventy-five percent (75%) Interest in Franchise Owner. Any Transfer that is made without our approval will constitute a breach of this Agreement and convey no rights to or interests in this Agreement, you, the Franchise, or any other The Joint Corp. franchise. As used in this Agreement the term \\\"Transfer\\\" means any voluntary, involuntary, direct or indirect assignment, sale, gift, exchange, grant of a security interest, or occurrence of any other event which would or might change the ownership of any Interest, and includes, without limitation: (1) the Transfer of ownership of capital stock, partnership interest or other ownership interest (including the granting of options (such as stock options or any option which give anyone ownership rights now or in the future); (2) merger or consolidation, or issuance of additional securities representing an ownership interest in Franchise Owner; (3) sale of common stock of Franchise Owner sold pursuant to a private placement or registered public offering; (4) Transfer of an Interest in a divorce proceeding or otherwise by operation of law; or (5) Transfer of an Interest by will, declaration of or transfer in trust, or under the laws of intestate succession. We will not unreasonably withhold consent to a Transfer of an Interest by a Principal Owner to a member of his or her immediate family or to your key employees, so long as all Principal Owners together retain a \\\"controlling Interest\\\" (i.e., the minimum ownership percentage listed in Exhibit 4), although we reserve the right to impose reasonable conditions on the Transfer as a requirement for our consent. Interests owned by persons other than the Principal Owners (\\\"minority owners\\\") may be Transferred without our advance consent unless the Transfer would give that transferee and any person or group of persons affiliated or having a common interest with the transferee more than a collective twenty-five percent (25%) Interest in Franchise Owner, in which case our advance written approval for the Transfer must be obtained. Your formal partnership, corporation or other formation documents and all stock certificates, partnership units or other evidence of ownership must recite or bear a legend reflecting the transfer restrictions of this Paragraph 14.4. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 35\"}, {\"id\": \"14.5\", \"title\": \"Conditions for Approval of Transfer\", \"level\": 2, \"text\": \"14.5 Conditions for Approval of Transfer. If you and your Principal Owners are in full compliance with this Agreement, we will not unreasonably withhold our approval of a Transfer that meets all the applicable requirements of this Section 14. The person or entity to whom you wish to make the Transfer, or its principal owners (\\\"Proposed New Owner\\\"), must be individuals of good moral character and otherwise meet our then-applicable standards for The Joint Corp. Location franchisees. If you propose to Transfer this Agreement, the Franchise or its assets, or any Interest, or if any of your Principal Owners proposes to Transfer a controlling Interest in you or make a Transfer that is one of a series of Transfers which taken together would constitute the Transfer of a controlling Interest in you, then all of the following conditions must be met before or at the time of the Transfer: (a) the Proposed New Owner must have sufficient business experience, aptitude, and financial resources to operate the Franchise; (b) you must pay any amounts owed for purchases from us and our affiliates, and any other amounts owed to us or our affiliates which are unpaid; (c) the Proposed New Owner's directors and such other personnel as we may designate must have successfully completed our Initial Training program, and shall be legally authorized and have all licenses necessary to perform the services offered by the Franchise. The Proposed New Owner shall be responsible for any wages and compensation owed to, and the travel and living expenses (including all transportation costs, room, board and meals) incurred by, the attendees who attend the Initial Training program; (d) if your lease for the Premises requires it, the lessor must have consented to the assignment of the lease of the Premises to the Proposed New Owner; (e) you (or the Proposed New Owner) must pay us a Transfer fee equal to seventy-five percent (75%) of the then current initial franchise fee we charge to new Start-up Location franchisees, and must reimburse us for any reasonable expenses incurred by us in investigating and processing any Proposed New Owner where the Transfer is not consummated for any reason; (f) you and your Principal Owners and your and their spouses must execute a general release (in a form satisfactory to us) of any and all claims you and/or they may have against us, our affiliates, and our and our affiliates' respective officers, directors, employees, and agents; THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 36 (g) we must approve the material terms and conditions of the proposed Transfer, including without limitation that the price and terms of payment are not so burdensome as to adversely affect the operation of the Franchise; (h) the Franchise and the Premises shall have been placed in an attractive, neat and sanitary condition; (i) you and your Principal Owners must enter into an agreement with us providing that all obligations of the Proposed New Owner to make installment payments of the purchase price (and any interest on it) to you or your Principal Owners will be subordinate to the obligations of the Proposed New Owner to pay any amounts payable under this Agreement or any new Franchise Agreement that we may require the Proposed New Owner to sign in connection with the Transfer; (j) you and your Principal Owners must enter into a non-competition agreement wherein you agree not to engage in a competitive business for a period of two (2) years after the Transfer and within twenty-five (25) miles of your Franchise Premises or any other The Joint Corp. Location franchise location; (k) the Franchise shall have been determined by us to contain all equipment and fixtures in good working condition, as were required at the initial opening of the Franchise. The Proposed New Owner shall have agreed, in writing, to make such reasonable capital expenditures to remodel, equip, modernize and redecorate the interior and exterior of the premises in accordance with our then existing plans and specifications for a The Joint Corp. Location franchise, and shall have agreed to pay our expenses for plan preparation or review, and site inspection; (l) upon receiving our consent for the Transfer or sale of the Franchise, the Proposed New Owner shall agree to assume all of your obligations under this Agreement in a form acceptable to us, or, at our option, shall agree to execute a new Franchise Agreement with us in the form then being used by us. We may, at our option, require that you guarantee the performance, and obligations of the Proposed New Owner; and (m) you must have properly offered us the opportunity to exercise our right of first refusal as described below, and we must have then declined to exercise it. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 37\"}, {\"id\": \"14.6\", \"title\": \"Right of First Refusal\", \"level\": 2, \"text\": \"14.6 Right of First Refusal. If you or any of your Principal Owners wishes to Transfer any Interest, we will have a right of first refusal to purchase that Interest as follows. The party proposing the Transfer (the \\\"transferor\\\") must obtain a bona fide, executed written offer (accompanied by a \\\"good faith\\\" earnest money deposit of at least five percent (5%) of the proposed purchase price) from a responsible and fully disclosed purchaser, and must submit an exact copy of the offer to us. You also agree to provide us with any other information we need to evaluate the offer, if we request it within five (5) days of receipt of the offer. We have the right, exercisable by delivering written notice to the transferor within fifteen (15) days from the date of last delivery to us of the offer and any other documents we have requested, to purchase the Interest for the price and on the terms and conditions contained in the offer, except that we may substitute cash for any form of payment proposed in the offer, and will not be obligated to pay any \\\"finder's\\\" or broker's fees that are a part of the proposed Transfer. We also will not be required to pay any amount for any claimed value of intangible benefits, for example, possible tax benefits that may result by structuring and/or closing the proposed Transfer in a particular manner or for any consideration payable other than the bona fide purchase price for the Interest proposed to be transferred. (In fact, we may in our sole and absolute discretion withhold consent to any proposed Transfer if the offer directly or indirectly requires payment of any consideration other than the bona fide purchase price for the Interest proposed to be transferred.) Our credit will be deemed equal to the credit of any other proposed purchaser, and we will have at least sixty (60) days to prepare for closing. We will be entitled to all customary representations and warranties given purchasers in connection with such sales. If the proposed Transfer includes assets not related to the operation of the Franchise, we may purchase only the assets related to the operation of the Franchise or may also purchase the other assets. (An equitable purchase price will be allocated to each asset included in the Transfer.) If we do not exercise our right of first refusal, the transferor may complete the sale to the Proposed New Owner pursuant to and on the terms of the offer, as long as we have approved the Transfer as provided in this Section 14. You must immediately notify us of any changes in the terms of an offer. Any material change in the terms of an offer before closing will make it a new offer, revoking any previous approval or previously made election to purchase and giving us a new right of first refusal effective as of the day we receive formal notice of a material change in the terms. If the sale to the Proposed New Owner is not completed within one hundred twenty (120) days after we have approved the Transfer, our approval of the proposed Transfer will expire. Any later proposal to complete that proposed Transfer will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal. We will not exercise a right of first refusal with respect to a proposed Transfer of less than a controlling interest to a member of a Principal Owner's immediate family or to your key employees. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 38\"}, {\"id\": \"14.7\", \"title\": \"Death and Disability\", \"level\": 2, \"text\": \"14.7 Death and Disability. Upon the death or permanent disability of you or a Principal Owner, the executor, administrator, conservator or other personal representative of the deceased or disabled person must Transfer the deceased or disabled person's Interest within a reasonable time, not to exceed forty-five (45) days from the date of death or permanent disability, to a person we have approved. Such Transfers, including without limitation transfers by a will or inheritance, will be subject to all the terms and conditions for assignments and Transfers contained in this Agreement. Failure to so dispose of an Interest within the forty-five (45) day period of time will constitute grounds for termination of this Agreement. 14.8 Effect of Consent to Transfer. Our consent to a proposed Transfer pursuant to this Section 14 will not constitute a waiver of any claims we may have against you or any Principal Owner, nor will it be deemed a waiver of our right to demand exact compliance with any of the terms or conditions of this Agreement by the Proposed New Owner. 14.9 Consent Not Unreasonably Delayed. If all the conditions are met to transfer the FA or any interest therein, we will not unreasonably delay granting our consent to the transfer. 15. TERMINATION OF THE FRANCHISE. We have the right to terminate this Agreement effective upon delivery of notice of termination to you, if: (1) you do not develop or open the Franchise as provided in this Agreement; (2) you abandon, surrender, transfer control of, lose the right to occupy the Premises of, or do not actively operate, the Franchise, or your lease for or purchase of the location of the Franchise is terminated for any reason; (3) you or your Principal Owners assign or Transfer this Agreement, any Interest, the Franchise, or assets of the Franchise without complying with the provisions of Section 14; (4) you are adjudged a bankrupt, become insolvent or make a general assignment for the benefit of creditors; (5) you use, sell, distribute or give away any unauthorized services or products, and do not cease the use, sale, or distribution of unauthorized services or products within ten (10) days after written notice is given to you; (6) you fail to maintain a valid license to practice and/or fail to maintain compliance with state and federal regulations and do not cure the failure within twenty (20) days after written notice is given to you; (7) you or any of your Principal Owners are convicted of or plead no contest to a felony or are convicted or plead no contest to any crime or offense that is likely to adversely affect the reputation of the Company, the Franchise, and/or the goodwill associated with the Marks; (8) you are involved in any action that is likely to adversely affect the reputation of the Company, the Franchise, and/or the goodwill associated with the Marks; (9) you or any of your employees violate any health or safety law, ordinance or regulation, or operate the Franchise in a manner that presents a health or safety hazard to your customers or the public; (10) you do not pay when due any monies owed to us or our affiliates, and do not make such payment within ten (10) days after written notice is given to you; (11) you fail to meet the minimum local advertising expenditures required in Section 11.2, and to provide the required proof of your expenditures; (12) you or any of your Principal Owners fail to comply with any other provision of this Agreement or any mandatory specification, standard, or operating procedure or you fail to make changes required to comply with applicable state or federal laws within twenty (20) days after written notice of such failure to comply is given to you; (13) you fail to procure or maintain any and all insurance coverage that we require, or otherwise fail to name us as an additional insured on any such insurance policies and failure to do so within ten (10) days after written notice is given to you; or (13) you or any of your Principal Owners fail on three (3) or more separate occasions within any twelve (12) consecutive month period to submit when due any financial statements, reports or other data, information, or supporting records; pay when due any amounts due under this Agreement; or otherwise fail to comply with this Agreement, whether or not such failures to comply are corrected after notice is given to you or your Principal Owners. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 39 In addition, if, in the opinion of our legal counsel, any provision of this Agreement is contrary to law, then you and we agree to negotiate in good faith an amendment that would make this Agreement conform to the applicable legal requirements. If you and we are unable to reach such an agreement, or if fundamental changes to this Agreement are required to make it conform to the legal requirements, then we reserve the right to terminate this Agreement upon notice to you, in which case all of the post-termination obligations set forth in Section 16 shall apply. In the event that we terminate this Agreement under this Section or other applicable provisions of this Agreement, we shall be entitled, in those states in which such termination fees are enforceable, to receive from you a termination fee in the amount equal to one-half (1/2) of our then- current initial franchise fee for new The Joint Corp. Location franchises (the \\\"Termination Fee\\\"). The Termination Fee shall be payable by you in addition to any damages payable to us, including loss of future revenues, resulting from your improper or wrongful breach or other termination of this Agreement. We shall be entitled to recover all costs, including attorneys' fees, incurred in connection with the termination and collection of the Termination Fee. If you continue to operate the Franchise after termination of this Agreement, in addition to any other right or remedy we may have (including the Termination Fee), you agree to pay to us the amount of One Thousand and No/100 Dollars ($1,000.00) per day that you operate the Franchise in violation of this Agreement, plus all costs and attorneys' fees incurred as a result of the violation. This amount is set at $1,000 per day because it is a reasonable estimation of the damages that would occur from such a breach, and it will almost certainly be impossible to calculate precisely the actual damages from such a breach. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 40\"}, {\"id\": \"16\", \"title\": \"RIGHTS AND OBLIGATIONS OF COMPANY AND FRANCHISE OWNER UPON TERMINATION OR EXPIRATION OF THE FRANCHISE\", \"level\": 1, \"text\": \"16. RIGHTS AND OBLIGATIONS OF COMPANY AND FRANCHISE OWNER UPON TERMINATION OR EXPIRATION OF THE FRANCHISE. 16.1 Payment of Amounts Owed to Company. You agree to pay us within five (5) days after the effective date of termination or expiration of the Franchise, or any later date that the amounts due to us are determined, all amounts owed to us or our affiliates which are then unpaid. 16.2 Marks. You agree that after the termination or expiration of the Franchise you will: (a) not directly or indirectly at any time identify any business with which you are associated as a current or former The Joint Corp. franchise or franchisee; (b) not use any Mark or any colorable imitation of any Mark in any manner or for any purpose, or use for any purpose any trademark or other commercial symbol that suggests or indicates an association with us; (c) return to us or destroy (whichever we specify) all customer lists, forms and materials containing any Mark or otherwise relating to a The Joint Corp. franchise; (d) remove all Marks affixed to uniforms or, at our direction, cease to use those uniforms; and (e) take any action that may be required to cancel all fictitious or assumed name or equivalent registrations relating to your use of any Mark. 16.3 De-Identification. If you retain possession of the Premises, you agree to completely remove or modify, at your sole expense, any part of the interior and exterior decor that we deem necessary to disassociate the Premises with the image of a The Joint Corp. franchise, including any signage bearing the Marks. If you do not take the actions we request within thirty (30) days after notice from us, we have the right to enter the Premises and make the required changes at your expense, and you agree to reimburse us for those expenses on demand. 16.4 Confidential Information. You agree that on termination or expiration of the Franchise you will immediately cease to use any of the Confidential Information, and agree not to use it in any business or for any other purpose. You further agree to immediately return to us all copies of the Operations Manual and any written Confidential Information or other confidential materials that we have loaned or provided to you. Upon THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 41\"}, {\"id\": \"16.5\", \"title\": \"Joint Software\", \"level\": 2, \"text\": \"16.5 Joint Software. You agree that on termination or expiration of the Franchise, you will immediately cease to use the Joint Software and will uninstall it from all computer systems owned by the Franchise. 16.6 Company's Option to Purchase the Franchise. Upon the termination or expiration of the Franchise, we will have the option, but not the obligation, exercisable for thirty (30) days upon written notice to you, to purchase at fair market value all of the assets of the Franchise, including all approved equipment, fixtures, furniture and signs and all supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise. If you and we cannot agree on the fair market value of the assets of the Franchise within a reasonable time, such value shall be determined by an average of the appraisals of two (2) independent appraisers, one of whom will be selected by you and one of whom will be selected by us. If the appraisals differ by more than ten percent (10%), then you and we will mutually agree on a value, or if you and we cannot agree, our appraisers will select a third appraiser whose determination of market value will be final. We shall not assume any liabilities, debts or obligations of the Franchise in connection with any such transfer, and you will indemnify us from any and all claims made against us arising out of any such transfer of the assets of the Franchise. All parties will comply with all applicable laws in connection with any such transfer, and you agree to cooperate with us in complying with all such requirements. The closing shall occur within thirty (30) days after we exercise our option to purchase the assets or such later date as may be necessary to comply with applicable bulk sales or similar laws. At the closing, you and we both agree to execute and deliver all documents necessary to vest title in the purchased assets and/or real property in us free and clear of all liens and encumbrances, except those assumed by us and/or to effectuate the lease of the Franchise Premises. You also agree to provide us with all information necessary to close the transaction. We reserve the right to assign our option to purchase the Franchise or designate a substitute purchaser for the Franchise. By signing this Agreement, you irrevocably appoint us as your lawful attorney-in-fact with respect to the matters contemplated by this Paragraph 16.6, with full power and authority to execute and deliver in your name all documents required to be provided by you under this Paragraph in the event you do not provide them in a timely and proper manner. You also agree to ratify and confirm all of our acts as your lawful attorney-in-fact, and indemnify and hold us harmless from all claims, liabilities, losses or damages suffered by us in so doing. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 42 43 If any lawful requirement or court order of any jurisdiction (1) requires a greater advance notice of the termination or non-renewal of this Agreement than is required under this Agreement, or the taking of some other action which is not required by this Agreement, or (2) makes any provision of this Agreement or any specification, standard, or operating procedure we prescribed invalid or unenforceable, then the advance notice and/or other action required or revision of the specification, standard, or operating procedure will be substituted for the comparable provisions of this Agreement in order to make the modified provisions enforceable to the greatest extent possible. You agree to be bound by the modification to the greatest extent lawfully permitted. 17.2 Unilateral Waiver of Obligations. Either you or we may, by written notice, unilaterally waive or reduce any obligation or restriction of the other under this Agreement. The waiver or reduction may be revoked at any time for any reason on ten (10) days' written notice. 17.3 Written Consents from Company. Whenever this Agreement requires our advance approval or consent, you agree to make a timely written request for it. Our approval or consent will not be valid unless it is in writing. 17.4 Lien. To secure your performance under this Agreement and indebtedness for all sums due us or our affiliates, we shall have a lien upon, and you hereby grant us a security interest in, the following collateral and any and all additions, accessions, and substitutions to or for it and the proceeds from all of the same: (a) all inventory now owned or after-acquired by you and the Franchise, including but not limited to all inventory and supplies transferred to or acquired by you in connection with this Agreement; (b) all accounts of you and/or the Franchise now existing or subsequently arising, together with all interest in you and/or the Franchise, now existing or subsequently arising, together with all chattel paper, documents, and instruments relating to such accounts; (c) all contract rights of you and/or the Franchise, now existing or subsequently arising; and (d) all general intangibles of you and/or the Franchise, now owned or existing, or after-acquired or subsequently arising. You agree to execute such financing statements, instruments, and other documents, in a form satisfactory to us, that we deem necessary so that we may establish and maintain a valid security interest in and to these assets. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 44\"}, {\"id\": \"17.5\", \"title\": \"No Guarantees\", \"level\": 2, \"text\": \"17.5 No Guarantees. If in connection with this Agreement we provide to you any waiver, approval, consent, or suggestion, or if we neglect or delay our response or deny any request for any of those, then we will not be deemed to have made any warranties or guarantees upon which you may rely, and will not assume any liability or obligation to you. 17.6 No Waiver. If at any time we do not exercise a right or power available to us under this Agreement or do not insist on your strict compliance with the terms of the Agreement, or if there develops a custom or practice that is at variance with the terms of this Agreement, then we will not be deemed to have waived our right to demand exact compliance with any of the terms of this Agreement at a later time. Similarly, our waiver of any particular breach or series of breaches under this Agreement, or of any similar term in any other agreement between us and any other The Joint Corp. franchisee will not affect our rights with respect to any later breach. It will also not be deemed to be a waiver of any breach of this Agreement for us to accept payments that are due to us under this Agreement. 17.7 Cumulative Remedies. The rights and remedies specifically granted to either you or us by this Agreement will not be deemed to prohibit either you or us from exercising any other right or remedy provided under this Agreement, or permitted by law or equity. 17.8 Specific Performance; Injunctive Relief. Provided we give you the appropriate notice, we will be entitled, without being required to post a bond, to the entry of temporary and permanent injunctions and orders of specific performance to (1) enforce the provisions of this Agreement relating to your use of the Marks and non-disclosure and non-competition obligations under this Agreement; (2) prohibit any act or omission by you or your employees that constitutes a violation of any applicable law, ordinance, or regulation; constitutes a danger to the public; or may impair the goodwill associated with the Marks or The Joint Corp. franchises; or (3) prevent any other irreparable harm to our interests. If we obtain an injunction or order of specific performance, then you shall pay us an amount equal to the total of our costs of obtaining it, including without limitation reasonable attorneys' and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, and any damages we incur as a result of the breach of any such provision. You further agree to waive any claims for damage in the event there is a later determination that an injunction or specific performance order was issued improperly. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 45\"}, {\"id\": \"17.9\", \"title\": \"Arbitration\", \"level\": 2, \"text\": \"17.9 Arbitration. Except insofar as we elect to enforce this Agreement or to seek temporary or permanent injunctive relief as provided above, all controversies, disputes or claims arising between us, our affiliates, and our and their respective owners, officers, directors, agents, and employees (in their representative capacity) and you (and your Principal Owners and guarantors) arising out of or related to: (1) this Agreement, any provision thereof, or any related agreement (except for any lease or sublease with us or any of our affiliates); (2) the relationship of the parties hereto; (3) the validity of this Agreement or any related agreement, or any provision thereof; or (4) any specification, standard or operating procedure relating to the establishment or operation of the Franchise, shall be submitted for arbitration to be administered by the office of the American Arbitration Association. Such arbitration proceedings shall be conducted in Maricopa County, Arizona, and, except as otherwise provided in this Agreement, shall be conducted in accordance with then current commercial arbitration rules of the American Arbitration Association. The arbitrator shall have the right to award or include in his award any relief that he or she deems proper in the circumstances, including without limitation, money damages (with interest on unpaid amounts from date due), specific performance, injunctive relief, attorneys' fees, and costs. The award and decision of the arbitrator shall be conclusive and binding on all parties to this agreement, and judgment on the award may be entered in any court of competent jurisdiction, and each such party waives any right to contest the validity or enforceability of such award. The provisions of this Paragraph are intended to benefit and limit third-party non-signatories, and will continue in full force and effect subsequent to, and notwithstanding expiration or termination of, this Agreement. You and we agree that any such arbitration shall be conducted on an individual, not a class-wide basis, and shall not be consolidated with any other arbitration proceeding. 17.10 Waiver of Punitive Damages and Jury Trial; Limitations of Actions. Except with respect to your obligations to indemnify us and claims that we may bring under Sections 7, 9, 15, or 16 of this Agreement, and except for claims arising from your non-payment or underpayment of any amounts owed to us or our affiliates, (1) any and all claims arising out of or related to this Agreement or the relationship between you and us shall be barred, by express agreement of the parties, unless an action or proceeding is commenced within two (2) years from the date the cause of action accrues; and (2) you and we hereby waive to the fullest extent permitted by law, any right to or claim for any punitive or exemplary damages against the other, and agree that, except to the extent provided to the contrary in this Agreement, in the event of a dispute between you and us, each party will be limited to the recovery of any actual damages sustained by it. You and we irrevocably waive trial by jury in any action, proceeding or counterclaim, whether at law or in equity, brought by either you or us. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 46 47\"}, {\"id\": \"17.15\", \"title\": \"Joint and Several Liability\", \"level\": 2, \"text\": \"17.15 Joint and Several Liability. If two (2) or more persons are the Franchise Owner under this Agreement, their obligation and liability to us shall be joint and several. 17.16 Multiple Originals. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other parties hereto. This Agreement, once executed by a party, may be delivered to the other parties hereto by facsimile transmission or other electronic means of a copy of this Agreement bearing the signature of the party so delivering this Agreement. 17.17 Timing Is Important. Time is of the essence of this Agreement. \\\"Time is of the essence\\\" is a legal term that emphasizes the strictness of time limits. In this case, it means it will be a material breach of this Agreement to fail to perform any obligation within the time required or permitted by this Agreement. 17.18 Independent Provisions. The provisions of this Agreement are deemed to be severable. In other words, the parties agree that each provision of this Agreement will be construed as independent of any other provision of this Agreement. 18. NOTICES AND PAYMENTS. All written notices, reports and payments permitted or required under this Agreement or by the Operations Manual will be deemed delivered: (a) at the time delivered by hand; (b) one (1) business day after transmission by telecopy, facsimile or other electronic system; (c) one (1) business day after being placed in the hands of a reputable commercial courier service for next business day delivery; or (d) three (3) business days after placed in the U.S. mail by Registered or Certified Mail, Return Receipt Requested, postage prepaid; and addressed to the party to be notified or paid at its most current principal business address of which the notifying party has been advised, or to any other place designated by either party. Any required notice, payment or report which we do not actually receive during regular business hours on the date due (or postmarked by postal authorities at least two (2) days before it is due) will be deemed delinquent. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 48\"}, {\"id\": \"19\", \"title\": \"INDEPENDENT PROFESSIONAL JUDGMENT OF YOU AND YOUR GENERAL MANAGER\", \"level\": 1, \"text\": \"19. INDEPENDENT PROFESSIONAL JUDGMENT OF YOU AND YOUR GENERAL MANAGER. You and we acknowledge and agree that the specifications, standards and operating procedures related to the services offered by the Franchise are not intended to limit or replace your or your General Manager's (if any) professional judgment in supervising and performing the services offered by your Franchise. The specifications, standards, and operating procedures represent only the minimum standards, and you and your General Manager (if any) are solely responsible for ensuring that the Franchise performs services in accordance with all applicable requirements and standards of care. Nothing in this Agreement shall obligate you or your General Manager (if any) to perform any act that is contrary to your or your General Manager's (if any) professional judgment; provided, however, that you must notify us immediately upon your determination that any specification, standard or operating procedure is contrary to your or your General Manager's (if any) professional judgment. 20. ENTIRE AGREEMENT. This Agreement, together with the introduction and exhibits to it, constitutes the entire agreement between us, and there are no other oral or written understandings or agreements between us concerning the subject matter of this Agreement. This Agreement may be modified only by written agreement signed by both you and us, except that we may modify the Operations Manual at any time as provided herein. However, nothing in this Agreement or any addendum shall have the effect of disclaiming any of the representations made in the Franchise Disclosure Document or any of its exhibits. IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the Agreement Date. \\\"COMPANY\\\" THE JOINT CORP., a Delaware corporation \\\"FRANCHISE OWNER\\\" ___________________, a_________________ By: By: Name: Chad Everts Name: Title: V.P. Franchise Development Title: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 49\"}, {\"id\": \"EXHIBIT 1\", \"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT 1 TO THE JOINT CORP. FRANCHISE AGREEMENT FRANCHISE AGREEMENT EXPIRATION DATE PROJECTED FRANCHISING OPENING SCHEDULE 1-1 Expiration Date. Unless sooner terminated in accordance with the provisions of this Agreement, this Agreement will expire on _______________________________________. 1-2 Franchising Opening Schedule. In signing the foregoing Agreement to which this Exhibit 1 is attached, you acknowledge that: You have purchased the Franchise to which the Agreement corresponds as a The Joint Corp. Location Franchise. You will establish this Franchise as a Start-up Location. 2. You must open the Franchise mentioned above within a certain time period specified by us, the length of which depends upon the number of Franchises you have purchased and the number of these Franchises that you have developed and opened for business before developing and opening the Franchise to which the Agreement corresponds. 3. You must open the Franchise to which this Agreement corresponds within the following time period (the \\\"Opening Deadline\\\"), subject to the requirements of Paragraphs 3.3 and 3.6, and any other applicable provision of the Agreement: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 1 - Expiration Date and Opening Schedule FRANCHISE AGREEMENT 1\"}, {\"id\": \"EXHIBIT 2\", \"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT OWNER'S GUARANTY AND ASSUMPTION OF OBLIGATIONS In consideration of, and as an inducement to, the execution of the Franchise Agreement, dated as of this _____ day of ____________________, 20__ (the \\\"Agreement\\\"), by and between The Joint Corp. (\\\"us\\\") and (the \\\"Franchise Owner\\\"), each of the undersigned owners of the Franchise Owner and their respective spouses (\\\"you,\\\" for purposes of this Guaranty only), hereby personally and unconditionally agree to perform and keep during the terms of the Agreement, each and every covenant, obligation, payment, agreement, and undertaking on the part of Franchise Owner contained and set forth in the Agreement. Each of you agree that all provisions of the Agreement relating to the obligations of Franchise Owners, including, without limitation, the covenants of confidentiality and non-competition and other covenants set forth in the Agreement, shall be binding on you. Each of you waives (1) protest and notice of default, demand for payment or nonperformance of any obligations guaranteed by this Guaranty; (2) any right you may have to require that an action be brought against Franchise Owner or any other person as a condition of your liability; (3) all right to payment or reimbursement from, or subrogation against, the Franchise Owner which you may have arising out of your guaranty of the Franchise Owner's obligations; and (4) any and all other notices and legal or equitable defenses to which you may be entitled in your capacity as guarantor. Each of you consents and agrees that (1) your direct and immediate liability under this Guaranty shall be joint and several; (2) you will make any payment or render any performance required under the Agreement on demand if Franchise Owner fails or refuses to do so when required; (3) your liability will not be contingent or conditioned on our pursuit of any remedies against Franchise Owner or any other person; (4) your liability will not be diminished, relieved or otherwise affected by any extension of time, credit or other indulgence which we may from time to time grant to Franchise Owner or to any other person, including without limitation, the acceptance of any partial payment or performance, or the compromise or release of any claims; and (5) this Guaranty will continue and be irrevocable during the term of the Agreement and afterward for so long as the Franchise Owner has any obligations under the Agreement. If we are required to enforce this Guaranty in a judicial or arbitration proceeding, and prevail in such proceeding, we will be entitled to reimbursement of our costs and expenses, including, but not limited to, reasonable accountants', attorneys', attorneys' assistants', arbitrators' and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, whether incurred prior to, in preparation for or in contemplation of the filing of any such proceeding. If we are required to engage legal counsel in connection with any failure by you to comply with this Guaranty, you agree to reimburse us for any of the above-listed costs and expenses incurred by us. [Remainder of Page Left Intentionally Blank - Signature Page Follows] THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 2 - Owner's Guaranty and Assumption of Obligations FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT 2 TO THE JOINT CORP. FRANCHISE AGREEMENT OWNER'S GUARANTY AND ASSUMPTION OF OBLIGATIONS In consideration of, and as an inducement to, the execution of the Franchise Agreement, dated as of this _____ day of ____________________, 20__ (the \\\"Agreement\\\"), by and between The Joint Corp. (\\\"us\\\") and (the \\\"Franchise Owner\\\"), each of the undersigned owners of the Franchise Owner and their respective spouses (\\\"you,\\\" for purposes of this Guaranty only), hereby personally and unconditionally agree to perform and keep during the terms of the Agreement, each and every covenant, obligation, payment, agreement, and undertaking on the part of Franchise Owner contained and set forth in the Agreement. Each of you agree that all provisions of the Agreement relating to the obligations of Franchise Owners, including, without limitation, the covenants of confidentiality and non-competition and other covenants set forth in the Agreement, shall be binding on you. Each of you waives (1) protest and notice of default, demand for payment or nonperformance of any obligations guaranteed by this Guaranty; (2) any right you may have to require that an action be brought against Franchise Owner or any other person as a condition of your liability; (3) all right to payment or reimbursement from, or subrogation against, the Franchise Owner which you may have arising out of your guaranty of the Franchise Owner's obligations; and (4) any and all other notices and legal or equitable defenses to which you may be entitled in your capacity as guarantor. Each of you consents and agrees that (1) your direct and immediate liability under this Guaranty shall be joint and several; (2) you will make any payment or render any performance required under the Agreement on demand if Franchise Owner fails or refuses to do so when required; (3) your liability will not be contingent or conditioned on our pursuit of any remedies against Franchise Owner or any other person; (4) your liability will not be diminished, relieved or otherwise affected by any extension of time, credit or other indulgence which we may from time to time grant to Franchise Owner or to any other person, including without limitation, the acceptance of any partial payment or performance, or the compromise or release of any claims; and (5) this Guaranty will continue and be irrevocable during the term of the Agreement and afterward for so long as the Franchise Owner has any obligations under the Agreement. If we are required to enforce this Guaranty in a judicial or arbitration proceeding, and prevail in such proceeding, we will be entitled to reimbursement of our costs and expenses, including, but not limited to, reasonable accountants', attorneys', attorneys' assistants', arbitrators' and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, whether incurred prior to, in preparation for or in contemplation of the filing of any such proceeding. If we are required to engage legal counsel in connection with any failure by you to comply with this Guaranty, you agree to reimburse us for any of the above-listed costs and expenses incurred by us. [Remainder of Page Left Intentionally Blank - Signature Page Follows] THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 2 - Owner's Guaranty and Assumption of Obligations FRANCHISE AGREEMENT 1 This Guaranty is now executed as of the Agreement Date. OWNER: OWNER'S SPOUSE: Name: Name: OWNER: OWNER'S SPOUSE: Name: Name: OWNER: OWNER'S SPOUSE: Name: Name: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 2 - Owner's Guaranty and Assumption of Obligations FRANCHISE AGREEMENT 2\"}, {\"id\": \"EXHIBIT 3\", \"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT 3 TO THE JOINT CORP. FRANCHISE AGREEMENT ADDENDUM TO LEASE AGREEMENT This Addendum to Lease Agreement (this \\\"Addendum\\\"), is entered into effective on this ______ day of _______________, 20___, (the \\\"Effective Date\\\") by and between __________________, a ________________________ (the \\\"Lessor\\\"), and __________________, a ________________________ (the \\\"Lessee\\\") (each a \\\"Party\\\" and collectively, the \\\"Parties\\\"). RECITALS WHEREAS, the Parties hereto have entered into a certain Lease Agreement, dated on the ______ day of _______________, 20___ (the \\\"Agreement\\\"), and pertaining to the premises located at _____________________________ (the \\\"Premises\\\"); WHEREAS, Lessor acknowledges that Lessee intends to operate The Joint franchise from the Premises pursuant to a Franchise Agreement (the \\\"Franchise Agreement\\\") with The Joint Corp. (\\\"Franchisor\\\") under the name The Joint or other name designated by Franchisor (\\\"Franchised Business\\\"); and WHEREAS, the Parties now desire to amend the Lease Agreement in accordance with the terms and conditions contained herein. NOW, THEREFORE, in consideration of the mutual covenants and agreements herein set forth and each act done and to be done pursuant hereto, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, do hereby represent, warrant, covenant and agree as follows: 1. Remodeling and Decor. The above recitals are hereby incorporated by reference. Lessor agrees that Lessee shall have the right to remodel, equip, paint and decorate the interior of the Premises and to display the proprietary marks and signs on the interior and exterior of the Premises as Lessee is reasonably required to do pursuant to the Franchise Agreement and any successor Franchise Agreement under which Lessee may operate a Franchised Business on the Premises. 2. Assignment. Lessee shall have the right to assign all of its right, title and interest in and to the Lease Agreement to Franchisor or its parent, subsidiary, or affiliate, (including another franchisee) at any time during the term of the Lease, including any extensions or renewals thereof, without first obtaining Lessor's consent, pursuant to the terms of the Collateral Assignment of Lease attached hereto as Exhibit A. However, no assignment shall be effective until such time as Franchisor or its designated affiliate gives Lessor written notice of its acceptance of the assignment, and nothing contained herein or in any other document shall constitute Franchisor or its designated subsidiary or affiliate a party to the Lease Agreement, or guarantor thereof, and shall not create any liability or obligation of Franchisor or its parent unless and until the Lease Agreement is assigned to, and accepted in writing by, Franchisor or its parent, subsidiary or affiliate. In the event of any assignment, Lessee shall remain liable under the terms of the Lease. Franchisor shall have the right to reassign the Lease to another franchisee without the Landlord's consent in accordance with Section 4(a). THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 1\"}, {\"id\": \"3\", \"title\": \"Default and Notice\", \"level\": 1, \"text\": \"3. Default and Notice. (a) In the event there is a default or violation by Lessee under the terms of the Lease Agreement, Lessor shall give Lessee and Franchisor written notice of the default or violation within ten (10) days after Lessor receives knowledge of its occurrence. If Lessor gives Lessee a default notice, Lessor shall contemporaneously give Franchisor a copy of the notice. Franchisor shall have the right, but not the obligation, to cure the default. Franchisor will notify Lessor whether it intends to cure the default and take an automatic assignment of Lessee's interest as provided in Paragraph 4(a). Franchisor will have an additional fifteen (15) days from the expiration of Lessee's cure period in which it may exercise the option to cure, but is not obligated to cure the default or violation. (b) All notices to Franchisor shall be sent by registered or certified mail, postage prepaid, to the following address: The Joint Corp. 16767 N. Perimeter Dr., Suite 240 Scottsdale, AZ 85260 Attention: Chad Everts E-mail: ceverts@thejoint.com Franchisor may change its address for receiving notices by giving Lessor written notice of the new address. Lessor agrees that it will notify both Lessee and Franchisor of any change in Lessor's mailing address to which notices should be sent. (c) Following Franchisor's approval of the Lease Agreement, Lessee agrees not to terminate, or in any way alter or amend the same during the Initial Term of the Franchise Agreement or any Interim Period thereof without Franchisor's prior written consent, and any attempted termination, alteration or amendment shall be null and void and have no effect as to Franchisor's interests thereunder; and a clause to the effect shall be included in the Lease. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 2\"}, {\"id\": \"4\", \"title\": \"Termination or Expiration\", \"level\": 1, \"text\": \"4. Termination or Expiration. (a) Upon Lessee's default and failure to cure the default within the applicable cure period, if any, under either the Lease Agreement or the Franchise Agreement, Franchisor will, at its option, have the right, but not the obligation, to take an automatic assignment of Lessee's interest in the Lease Agreement and at any time thereafter to re-assign the Lease Agreement to a new franchisee without Lessor's consent and to be fully released from any and all liability to Lessor upon the reassignment, provided the franchisee agrees to assume Lessee's obligations and the Lease Agreement. Upon notice from Franchisor to Lessor requesting an automatic assignment, Lessor will, at the cost of Franchisor, take appropriate actions to secure the leased premises including but not limited changing the locks and granting Franchisor sole rights to the Premises. (b) Upon the expiration or termination of either the Lease Agreement or the Franchise Agreement (attached), Lessor will cooperate with and assist Franchisor in securing possession of the Premises and if Franchisor does not elect to take an assignment of the Lessee's interest, Lessor will allow Franchisor to enter the Premises, without being guilty of trespass and without incurring any liability to Lessor, to remove all signs, awnings, and all other items identifying the Premises as a Franchised Business and to make other modifications (such as repainting) as are reasonably necessary to protect The Joint marks and system, and to distinguish the Premises from a Franchised Business. In the event Franchisor exercises its option to purchase assets of Lessee or has rights to those through the terms and conditions any agreement between Lessee and Franchisor, Lessor shall permit Franchisor to remove all the assets being purchased by Franchisor. 5. Consideration; No Liability. (a) Lessor hereby acknowledges that the provisions of this Addendum are required pursuant to the Franchise Agreement under which Lessee plans to operate its business and Lessee would not lease the Premises without this Addendum. Lessor also hereby consents to the Collateral Assignment of Lease from Lessee to Franchisor as evidenced by Exhibit A. (b) Lessor further acknowledges that Lessee is not an agent or employee of Franchisor and Lessee has no authority or power to act for, or to create any liability on behalf of, or to in any way bind Franchisor or any affiliate of Franchisor, and that Lessor has entered into this Addendum with full understanding that it creates no duties, obligations or liabilities of or against Franchisor or any affiliate of Franchisor. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 3\"}, {\"id\": \"6\", \"title\": \"Sales Reports\", \"level\": 1, \"text\": \"6. Sales Reports. If requested by Franchisor, Lessor will provide Franchisor with whatever information Lessor has regarding Lessee's sales from its Franchised Business. 7. Amendments. No amendment or variation of the terms of the Lease or this Addendum shall be valid unless made in writing and signed by the Parties hereto. 8. Reaffirmation of Lease. Except as amended or modified herein, all of the terms, conditions and covenants of the Lease Agreement shall remain in full force and effect and are incorporated herein by reference and made a part of this Addendum as though copied herein in full. 9. Beneficiary. Lessor and Lessee expressly agree that Franchisor is a third party beneficiary of this Addendum. [Remainder of Page Left Intentionally Blank - Signature Page Follows] THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 4 IN WITNESS WHEREOF, the Parties have duly executed this Addendum as of the Effective Date. LESSOR: LESSEE: _____________________________, _____________________________, a _____________________________ a _____________________________ By: By: Name: Name: Its: Its: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 5\"}, {\"id\": \"EXHIBIT A\", \"title\": \"COLLATERAL ASSIGNMENT OF LEASE This COLLATERAL ASSIGNMENT OF LEASE (this \\\"Assignment\\\") is entered into effective as of the ___ day of _____, 20___ (the \\\"Effective Date\\\"), the undersigned, __________________________________, (\\\"Assignor\\\") hereby assigns, transfers and sets over unto The Joint Corp., a Delaware Corporation (\\\"Assignee\\\") all of Assignor's right, title and interest as tenant, in, to and under that certain lease, a copy of w h i c h i s a t t a c h e d h e r e t o a s Exhib i t 1 ( t h e \\\" L e a s e A g r e e m e n t \\\" ) w i t h r e s p e c t t o t h e p r e m i s e s l o c a t e d a t _______________________________________________________________ (the \\\"Premises\\\"). This Assignment is for collateral purposes only and except as specified herein, Assignee shall have no liability or obligation of any kind whatsoever arising from or in connection with this Assignment unless Assignee shall take possession of the Premises demised by the Lease Agreement pursuant to the terms hereof and shall assume the obligations of Assignor thereunder. Assignor represents and warrants to Assignee that it has full power and authority to so assign the Lease Agreement and its interest therein and that Assignor has not previously, and is not obligated to, assign or transfer any of its interest in the Lease Agreement nor the Premises demised thereby. Upon a default by Assignor under the Lease Agreement or under that certain franchise agreement for The Joint between Assignee and Assignor (\\\"Franchise Agreement\\\"), or in the event of a default by Assignor under any document or instrument securing the Franchise Agreement, Assignee shall have the right and is hereby empowered to take possession of the Premises, expel Assignor therefrom, and, in the event, Assignor shall have no further right, title or interest in the Lease Agreement. Assignor agrees it will not suffer or permit any surrender, termination, amendment or modification of the Lease Agreement without the prior written consent of Assignee. Through the Initial Term of the Franchise Agreement and any Renewal Period thereof (as defined in the Franchise Agreement), Assignor agrees that it shall elect and exercise all options to extend the term of or renew the Lease Agreement not less than thirty (30) days before the last day that said option must be exercised, unless Assignee otherwise agrees in writing. Upon failure of Assignee to otherwise agree in writing, and upon failure of Assignor to so elect to extend or renew the Lease Agreement as stated herein, Assignor hereby irrevocably appoints Assignee as its true and lawful attorney-in-fact, which appointment is coupled with an interest, to exercise the extension or renewal options in the name, place and stead of Assignor for the sole purpose of effecting the extension or renewal. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT A COLLATERAL ASSIGNMENT OF LEASE This COLLATERAL ASSIGNMENT OF LEASE (this \\\"Assignment\\\") is entered into effective as of the ___ day of _____, 20___ (the \\\"Effective Date\\\"), the undersigned, __________________________________, (\\\"Assignor\\\") hereby assigns, transfers and sets over unto The Joint Corp., a Delaware Corporation (\\\"Assignee\\\") all of Assignor's right, title and interest as tenant, in, to and under that certain lease, a copy of w h i c h i s a t t a c h e d h e r e t o a s Exhib i t 1 ( t h e \\\" L e a s e A g r e e m e n t \\\" ) w i t h r e s p e c t t o t h e p r e m i s e s l o c a t e d a t _______________________________________________________________ (the \\\"Premises\\\"). This Assignment is for collateral purposes only and except as specified herein, Assignee shall have no liability or obligation of any kind whatsoever arising from or in connection with this Assignment unless Assignee shall take possession of the Premises demised by the Lease Agreement pursuant to the terms hereof and shall assume the obligations of Assignor thereunder. Assignor represents and warrants to Assignee that it has full power and authority to so assign the Lease Agreement and its interest therein and that Assignor has not previously, and is not obligated to, assign or transfer any of its interest in the Lease Agreement nor the Premises demised thereby. Upon a default by Assignor under the Lease Agreement or under that certain franchise agreement for The Joint between Assignee and Assignor (\\\"Franchise Agreement\\\"), or in the event of a default by Assignor under any document or instrument securing the Franchise Agreement, Assignee shall have the right and is hereby empowered to take possession of the Premises, expel Assignor therefrom, and, in the event, Assignor shall have no further right, title or interest in the Lease Agreement. Assignor agrees it will not suffer or permit any surrender, termination, amendment or modification of the Lease Agreement without the prior written consent of Assignee. Through the Initial Term of the Franchise Agreement and any Renewal Period thereof (as defined in the Franchise Agreement), Assignor agrees that it shall elect and exercise all options to extend the term of or renew the Lease Agreement not less than thirty (30) days before the last day that said option must be exercised, unless Assignee otherwise agrees in writing. Upon failure of Assignee to otherwise agree in writing, and upon failure of Assignor to so elect to extend or renew the Lease Agreement as stated herein, Assignor hereby irrevocably appoints Assignee as its true and lawful attorney-in-fact, which appointment is coupled with an interest, to exercise the extension or renewal options in the name, place and stead of Assignor for the sole purpose of effecting the extension or renewal. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 6 IN WITNESS WHEREOF, Assignor and Assignee have duly executed this Collateral Assignment of Lease as of the Effective Date. ASSIGNOR: ASSIGNEE: , THE JOINT CORP., a__________________________ a Delaware corporation By: By: Name: Name: Chad Everts Its: Its: VP Franchise Development THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 7\"}, {\"id\": \"EXHIBIT 4\", \"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT OWNERSHIP INTERESTS IN FRANCHISE OWNER 4-1. Full name and address of the owners of, and a description of the type of, all currently held Interests in Franchise Owner: 4-2. Minimum individual and aggregate Principal Owner ownership percentage required at all times during the term of this Agreement: 4-2.1 During the term of this Agreement, the Principal Owners together must have a \\\"controlling interest\\\" of no less than seventy-five percent (75%) of the equity, voting control and profits in the Franchise Owner. 4-2.2 Unless otherwise permitted, the required minimum \\\"ownership interest\\\" of each Principal Owner during the term of this Agreement is:\", \"level\": 1, \"text\": \"EXHIBIT 4 TO THE JOINT CORP. FRANCHISE AGREEMENT OWNERSHIP INTERESTS IN FRANCHISE OWNER 4-1. Full name and address of the owners of, and a description of the type of, all currently held Interests in Franchise Owner: 4-2. Minimum individual and aggregate Principal Owner ownership percentage required at all times during the term of this Agreement: 4-2.1 During the term of this Agreement, the Principal Owners together must have a \\\"controlling interest\\\" of no less than seventy-five percent (75%) of the equity, voting control and profits in the Franchise Owner. 4-2.2 Unless otherwise permitted, the required minimum \\\"ownership interest\\\" of each Principal Owner during the term of this Agreement is: Name Ownership Percentage THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 4 - Ownership Interests in Franchise Owner FRANCHISE AGREEMENT 1\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of JOINTCORP_09_19_2014-EX-10.15-FRANCHISE AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.15\", \"level\": 1, \"text\": \"Exhibit 10.15 THE JOINT CORP. FRANCHISE AGREEMENT i ii iii THE JOINT CORP. FRANCHISE AGREEMENT This Franchise Agreement (this or the \\\"Agreement\\\") is being entered into effective as of the _____ day of _______________, 20__ (the \\\"Agreement Date\\\"). The parties to this Agreement are The Joint Corp., a Delaware corporation (\\\"we,\\\" \\\"us,\\\" the \\\"Company,\\\" or \\\"The Joint Corp.\\\"); _________________________________________, as Franchise Owner (\\\"you,\\\" \\\"Franchise Owner,\\\" or \\\"Franchisee\\\"), and, if you are a partnership, corporation, or limited liability company, your \\\"Principal Owners\\\" (defined below). 1. INTRODUCTION. This Agreement has been written in an informal style in order to make it more easily readable and to be sure that you become thoroughly familiar with all of the important rights and obligations the Agreement covers before you sign it. This Agreement includes several exhibits, all of which are legally binding and are an integral part of the complete Franchise Agreement. In this Agreement, we refer to The Joint Corp. as \\\"we,\\\" \\\"us,\\\" or the \\\"Company.\\\" We refer to you as \\\"you,\\\" \\\"Franchise Owner\\\" or \\\"Franchisee.\\\" If you are a corporation, partnership or limited liability company, you will notice certain provisions that are applicable to those principal shareholders, partners or members on whose business skill, financial capability and personal character we are relying in entering into this Agreement. Those individuals will be referred to in this Agreement as \\\"Principal Owners.\\\" Through the expenditure of considerable time, effort and money, we and our affiliates have devised a system for the establishment and operation of The Joint Corp. business model, a chiropractic location that specializes in affordable, convenient, and accessible chiropractic care. It is our mission \\\"to improve your quality of life through affordable Chiropractic care.\\\" Our atmosphere is fun and upbeat, and no appointments are necessary (all of these characteristics are referred to in this Agreement as the \\\"System\\\"). This business model includes a location model offering all of our franchised services and products (individually, a \\\"Location\\\" and collectively, the \\\"Locations\\\"). We identify the System by the use of certain trademarks, service marks and other commercial symbols, including the marks \\\"The Joint\u2026A Chiropractic Place\u00ae\\\", \\\"The Joint\u2026The Chiropractic Place\u2122\\\" and certain associated designs, artwork and logos, which we may change or add to from time to time (the \\\"Marks\\\"). THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 1 From time to time we grant to persons who meet our qualifications, franchises to own and operate a The Joint Corp. Location franchise business that will manage clinics that specialize in providing chiropractic services and products to the general public through licensed chiropractic professionals (\\\"Clinic(s)\\\"). This Agreement is being presented to you because of the desire you have expressed to obtain the right to develop, own, and be franchised to operate a The Joint Corp. Location (we will refer to your The Joint Corp. franchise as the \\\"Franchise\\\" or the \\\"Franchised Business\\\"). You may purchase and operate your Franchise as a new, start-up Location (a \\\"Start-up Location\\\"), or may convert an existing chiropractic practice to a The Joint Corp. Location (a \\\"Conversion Location\\\"). In signing this Agreement, you acknowledge that you have conducted an independent investigation of The Joint Corp. Franchised Business, and recognize that, like any other business, the nature of it may evolve and change over time, that an investment in a The Joint Corp. Franchised Business involves business risks, and that the success of this business venture is primarily dependent on your business abilities and efforts. We expressly disclaim making, and you acknowledge that you have not received or relied on, any guarantee, express or implied, as to the revenues, profits, or likelihood of success of The Joint Corp. Franchise venture contemplated by this Agreement. You acknowledge that there have been no representations by us or our affiliates or our or their respective officers, directors, members, employees, or agents that are inconsistent with the statements made in our current Franchise Disclosure Document concerning the Franchised Business, or the provisions of this Agreement. You further represent to us, as an inducement to our entering into this Agreement with you, that there have been no misrepresentations to us in your application for the rights granted by this Agreement, or in the financial information provided by you and your Principal Owners. 2. GRANT OF FRANCHISE. 2.1 Term; Reference to Exhibit 1. You have applied for a franchise to own and operate a The Joint Corp. Location, and we have approved your application in reliance on all of the representations you made in that application. As a result, and subject to the provisions of this Agreement, we grant to you a Franchise to operate a The Joint Corp. Location offering all products, services, and proprietary programs of ours, in accordance with all elements of the System, that we may require for The Joint Corp. Locations. You must operate the Franchise at a mutually agreeable site (the \\\"Premises\\\") to be identified after the signing of this Agreement, and to use the System and the Marks in the operation of that Franchise, for a term of 10 years (the \\\"Initial Term\\\"). The Initial Term will begin on the Agreement Date. (For convenience, the expiration date of the Initial Term is listed on Exhibit 1.) Termination or expiration of this Agreement will constitute a termination or expiration of your Franchise. (All references to the \\\"term\\\" of this Agreement refer to the period from the Agreement Date to the date on which this Agreement actually terminates or expires.) THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 2\"}}, {\"id\": \"party:The Joint Corp.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"The Joint Corp., a Delaware corporation\", \"role\": \"Franchisor\", \"address\": \"16767 N. Perimeter Dr., Suite 240 Scottsdale, AZ 85260\"}}, {\"id\": \"party:Franchise Owner\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Franchise Owner\", \"role\": \"Franchisee\", \"address\": null}}, {\"id\": \"party:Principal Owners\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Principal Owners\", \"role\": \"Guarantor\", \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Franchise Agreement (this or the \\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Agreement Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement Date\", \"text\": \"the _____ day of _______________, 20__ (the \\\"Agreement Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Principal Owners\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Principal Owners\", \"text\": \"if you are a partnership, corporation, or limited liability company, your \\\"Principal Owners\\\" (defined below). ... those principal shareholders, partners or members on whose business skill, financial capability and personal character we are relying in entering into this Agreement. Those individuals will be referred to in this Agreement as \\\"Principal Owners.\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System\", \"text\": \"Through the expenditure of considerable time, effort and money, we and our affiliates have devised a system for the establishment and operation of The Joint Corp. business model, a chiropractic location that specializes in affordable, convenient, and accessible chiropractic care. It is our mission \\\"to improve your quality of life through affordable Chiropractic care.\\\" Our atmosphere is fun and upbeat, and no appointments are necessary (all of these characteristics are referred to in this Agreement as the \\\"System\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Location\", \"text\": \"This business model includes a location model offering all of our franchised services and products (individually, a \\\"Location\\\" and collectively, the \\\"Locations\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marks\", \"text\": \"We identify the System by the use of certain trademarks, service marks and other commercial symbols, including the marks \\\"The Joint\u2026A Chiropractic Place\u00ae\\\", \\\"The Joint\u2026The Chiropractic Place\u2122\\\" and certain associated designs, artwork and logos, which we may change or add to from time to time (the \\\"Marks\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Clinic(s)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Clinic(s)\", \"text\": \"franchises to own and operate a The Joint Corp. Location franchise business that will manage clinics that specialize in providing chiropractic services and products to the general public through licensed chiropractic professionals (\\\"Clinic(s)\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchise\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchise\", \"text\": \"(we will refer to your The Joint Corp. franchise as the \\\"Franchise\\\" or the \\\"Franchised Business\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchised Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchised Business\", \"text\": \"(we will refer to your The Joint Corp. franchise as the \\\"Franchise\\\" or the \\\"Franchised Business\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Start-up Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Start-up Location\", \"text\": \"You may purchase and operate your Franchise as a new, start-up Location (a \\\"Start-up Location\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Conversion Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Conversion Location\", \"text\": \"may convert an existing chiropractic practice to a The Joint Corp. Location (a \\\"Conversion Location\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Premises\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Premises\", \"text\": \"You must operate the Franchise at a mutually agreeable site (the \\\"Premises\\\") to be identified after the signing of this Agreement\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"for a term of 10 years (the \\\"Initial Term\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"value:10 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 years\"}}, {\"id\": \"term:term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"term\", \"text\": \"(All references to the \\\"term\\\" of this Agreement refer to the period from the Agreement Date to the date on which this Agreement actually terminates or expires.)\", \"definition_clause\": \"para_1\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Full Term Performance\", \"level\": 2, \"text\": \"2.2 Full Term Performance. You specifically agree to be obligated to operate the Franchise, perform the obligations of this Agreement, and continuously exert your best efforts to promote and enhance the business of the Franchise for the full term of this Agreement. 2.3 Management Agreement with Professional Corporation - Non-Licensed Franchisees. If you are not a licensed chiropractor, prior to commencing operations of the Franchised Business, you must enter into a management agreement (\\\"Management Agreement\\\") with a chiropractic professional corporation (or a professional limited liability company, if permitted in the state in which the Clinic is located) (a \\\"PC\\\") whereby you will provide to the PC management and administrative services and support consistent with the System and as outlined in our form of Management Agreement, a copy of which is included as an Exhibit to our Disclosure Document, to support the PC's chiropractic practice and its delivery of chiropractic services and related products to chiropractic patients, consistent with all applicable laws and regulations. The PC shall employ and control the chiropractors and other chiropractic personnel that will provide the actual chiropractic services required to be delivered at and through the Clinic. You shall not provide any actual chiropractic services, nor shall you supervise, direct, control or suggest to, the PC or its chiropractors or employees the manner in which the PC provides or may provide chiropractic services to its patients. You acknowledge and agree that we will not provide any chiropractic services, nor will we supervise, direct, control or suggest to, the PC or its chiropractors or employees the manner in which the PC provide chiropractic services to its patients. Due to various federal and state laws regarding the practice of chiropractic medicine, and the ownership and operation of chiropractic practices and health care businesses that provide chiropractic services, you understand and acknowledge that that you, as non-chiropractor Location franchisee, shall not engage in any practices that are, or may appear to be, the practice of chiropractic medicine. You acknowledge that the PC must offer all chiropractic services in accordance with the Management Agreement and the System. You must use our standard form of Management Agreement, however, you may negotiate the monetary terms and, with our written consent, certain other terms of the relationship with the PC. We will not unreasonably withhold our approval to requested changes in the Management Agreement. You must obtain our written approval of the final Management Agreement prior to your execution. We must approve the PC candidate. You shall ensure that the PC offers all chiropractic services in accordance with the Management Agreement and the System. If you are not able to find a suitable chiropractor to create, own and staff the PC, we will attempt to help you find a suitable PC. You must have a Management Agreement in effect with a PC at all times during the operation of the Franchised Business and during the Initial Term of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 3 If you are a licensed chiropractor, or part of a PC owned by licensed chiropractors, you do not need to execute a Management Agreement. However, you are still responsible for compliance with all laws application to the operation of a chiropractic Clinic and your Location franchise. 2.4 Waiver of Management Agreement. In certain states, it may be permissible under the existing laws that may be applicable to chiropractic professionals and/or practices, such as chiropractic clinics, for a non-chiropractor to both own and operate a Clinic and a Location Franchise, including hiring chiropractic and other professional personnel and providing chiropractic services to patients at the Clinic. If you determine that the laws that would apply to a Clinic in your state would permit you to do so, you may request that we waive certain of the requirements of the Franchise Agreement related to separating the operation of the chiropractic aspects of the Clinic from the management aspects. In particular, you (i) would not enter into a Management Agreement with a PC that, as a separate entity, would otherwise operate the Clinic and provide all chiropractic services, and (ii) you would not be restricted from hiring and supervising chiropractic professionals. Any waiver, or any modification of our standards, would be subject to compliance with all applicable laws and regulations. If we agree to do a waiver, you must enter into an Amendment to Waive Management Agreement (\\\"Waiver Agreement\\\"), a copy of which is attached as an exhibit to our Disclosure Document. Under the Waiver Agreement, you will agree that, instead of entering into the Management Agreement with a separate PC, you will (a) operate the Clinic, including performing all responsibilities and obligations of the \\\"PC\\\" under the Management Agreement, and (b) manage the Clinic as required in this Agreement and by performing all the responsibilities and obligations of the \\\"Company\\\" under the Management Agreement. You are responsible for operating in full compliance with all laws that apply to a Clinic, and you must make your own determination as to your legal compliance obligations. Additionally, the laws applicable to your Clinic may change, and if there are any chiropractic regulations or other laws that would render your operation of the Clinic through a single entity (or otherwise) in violation of any medical regulations, you must immediately advise us of such change and of the your proposed corrective action to comply with chiropractic regulations, including (if applicable) entering into a Management Agreement with a PC. Similarly, if we discover any such laws, upon providing you notice of such laws, you agree to make such changes as are necessary to comply with medical regulations, including (if applicable) entering into a Management Agreement with a PC. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 4\"}}, {\"id\": \"term:Management Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Management Agreement\", \"text\": \"you must enter into a management agreement (\\\"Management Agreement\\\") with a chiropractic professional corporation (or a professional limited liability company, if permitted in the state in which the Clinic is located) (a \\\"PC\\\") whereby you will provide to the PC management and administrative services and support consistent with the System and as outlined in our form of Management Agreement\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:PC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PC\", \"text\": \"a chiropractic professional corporation (or a professional limited liability company, if permitted in the state in which the Clinic is located) (a \\\"PC\\\")\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:Waiver Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Waiver Agreement\", \"text\": \"If we agree to do a waiver, you must enter into an Amendment to Waive Management Agreement (\\\"Waiver Agreement\\\")\", \"definition_clause\": \"2.2\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Selection of Premises; No Protected Territory; Reservation of Rights\", \"level\": 2, \"text\": \"2.5 Selection of Premises; No Protected Territory; Reservation of Rights. You and we will mutually select the location of the Premises upon or after the signing of this Agreement. You acknowledge that the Franchise granted by this Agreement gives you the right to operate your Franchise only at the Premises. Although we will not seek to operate or grant others the right to operate a The Joint Corp. Location within the same general area as the Premises, we make no guarantee of any protected territory. Except as otherwise provided in this Paragraph 2.5, we retain all rights with respect to The Joint Corp. Location franchises, the Marks and the System, including (by way of example only and not as a limitation): (a) the right to operate or grant others the right to operate The Joint Corp. Location franchises in any location on terms and conditions we deem appropriate; and (b) the right to operate or offer other healthcare-related companies or franchises or enter into other lines of business offering similar or dissimilar products or services under trademarks or service marks other than the Marks, in any location. 2.6 Renewal of Franchise. (a) Franchise Owner's Right to Renew. Subject to the provisions of subparagraph 2.6(b) below, and if you have substantially complied with all provisions of this Agreement and all other agreements between us, on expiration of the Initial Term, if you refurbish and decorate the Premises, replace fixtures, furnishings, wall decor, furniture, equipment, and signs and otherwise modify the Franchise in compliance with specifications and standards then applicable under new or renewal franchises for The Joint Corp. Location franchises, you will have the right to renew the Franchise for one (1) additional term of ten (10) years (the \\\"Renewal Term\\\"). (b) Notice of Deficiencies and Other Requirements. At least one (1) year before the expiration of the Initial Term, we agree to give you written notice of any deficiencies in your operation or in the historical performance of the Franchise that could cause us not to renew the Franchise. If we will permit renewal, our notice will state what actions, if any, you must take to correct the deficiencies in your operation of the Franchise or of the Premises, and will specify the time period in which those deficiencies must be corrected or other requirements satisfied. Renewal of the Franchise will be conditioned on your continued compliance with all the terms and conditions of this Agreement up to the date of expiration. If we send a notice of non-renewal, it will state the reasons for our refusal to renew. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 5 (c) Renewal Agreement; Releases. Should you choose to renew the Franchise, you must provide us with written notice of that intent no earlier than two (2) years and no later than one (1) year before the expiration of the Initial Term. To renew the Franchise, the Company, you and your Principal Owners must execute the form of Franchise Agreement and any ancillary agreements we are then customarily using in the grant or renewal of franchises for the operation of The Joint Corp. Location Franchises (with appropriate modifications to reflect the fact that the agreement relates to the grant of a renewal franchise), except that no initial franchise fee will be payable upon renewal of the Franchise. However, you must pay to us a renewal fee equal to 25% of our then-current initial franchise fee for Start-up Locations. You and your Principal Owners and your and their spouses must also execute general releases, in a form satisfactory to us, of any and all claims against us and our affiliates, and our and their respective owners, officers, directors, employees, and agents. 2.7 Personal Guaranty by Principal Owners; Reference to Exhibit 2. Each of the Principal Owners and their spouses (where applicable), will be required to execute a personal guaranty (the \\\"Guaranty\\\"), guaranteeing the Franchise's liabilities and obligations to the Company. A copy of the Guaranty is incorporated herein as Exhibit 2. 3. DEVELOPMENT AND OPENING OF THE FRANCHISE 3.1 Site Approval; Lease or Purchase of Premises; Opening Timeline; Reference to Exhibit 3. (a) You will use your best efforts to locate and select a proposed site for the Premises that is acceptable to us as suitable for the operation of the Franchise, which must be reviewed and approved by us within six (6) months of the Agreement Date. Our review and approval process may take up to thirty (30) days, so we recommend you submit your proposed site to us within one hundred fifty (150) days of the Agreement Date. You must submit to us, in the form we specify, a description of the site and such other information or materials as we may reasonably require. We will not unreasonably withhold approval of a site that meets our standards for general location and neighborhood, traffic patterns, parking size, layout and other physical characteristics, for The Joint Corp. Location franchises. Our approval of a site shall not constitute, nor be deemed, a judgment as to the likelihood of success of a The Joint Corp. Location at such location, or a judgment as to the relative desirability of such location in comparison to other locations. If you fail to identify a mutually-agreeable site within the aforementioned six (6) month period, we may terminate this Agreement. (b) Once we have approved the proposed site of the Premises for your Franchise, you must obtain lawful possession of the Premises through lease or purchase within thirty (30) days of our approval of the Premises. You agree that you will not execute a lease without our advance written approval of the lease terms. The lease for the Premises must include the Addendum to Lease, attached hereto as Exhibit 3, permitting us to take possession of the Premises under certain conditions if this Agreement is terminated or if you violate the terms of the lease. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 6 (c) Unless we agree otherwise, you must open your franchise for business no later than nine (9) months from the Effective Date of this Agreement. 3.2 Prototype and Construction Plans and Specifications. We will furnish to you prototype plans and specifications for your Location, reflecting our requirements for design, decoration, furnishings, furniture, layout, equipment, fixtures and signs for The Joint Corp. Locations, which may be in the form of actual plans for an existing or proposed Location with which we are involved. Using an architect we designate or approve, it will then be your responsibility to have the plans and specifications modified to comply with all ordinances, building codes, permit requirements, and lease requirements and restrictions applicable to the Premises. You must submit final construction plans and specifications to us for our approval before you begin construction at the Premises, and must construct the Franchise location in accordance with those approved plans and specifications. 3.3 Development of the Franchise. You agree at your own expense to do the following by the Opening Deadline defined in Exhibit 1: (1) secure all financing required to fully develop the Franchise; (2) obtain all required building, utility, sign, health, sanitation and business permits and licenses and any other required permits and licenses; (3) construct the Franchise location according to the approved construction plans and specifications; (4) decorate the Franchise location in compliance with the approved plans and specifications; (5) purchase and install all required equipment, furniture, furnishings and signs; (6) cause the training requirements of Section 4 to be completed; (7) purchase an opening inventory of products and other supplies and materials; (8) provide proof, in a form satisfactory to us, that your operation of the Franchise at the Franchise location does not violate any applicable state or local zoning or land use laws, ordinances, or regulations, or any restrictive covenants that apply to such location; (9) provide proof, in a form satisfactory to us, that you (and/or your General Manager, as defined in Section 4.1, if any) are legally authorized and have all licenses necessary to perform all of the services to be offered by your Franchise, and that your organizational structure is consistent with all legal requirements; (10) provide proof, in a format satisfactory to us, that you have obtained all required insurance policies, and have name us, as an additional insurance under all such policies; (11) submit to us a completed copy of the grand opening checklist we provide to you; (12) do any other acts necessary to open the Franchise for business; (13) obtain our approval to open the Franchise for business; and (14) open the Franchise for business. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 7\"}}, {\"id\": \"term:Renewal Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Term\", \"text\": \"you will have the right to renew the Franchise for one (1) additional term of ten (10) years (the \\\"Renewal Term\\\")\", \"definition_clause\": \"2.5\"}}, {\"id\": \"value:one (1) additional term of ten (10) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) additional term of ten (10) years\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"25%\"}}, {\"id\": \"term:Guaranty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Guaranty\", \"text\": \"Each of the Principal Owners and their spouses (where applicable), will be required to execute a personal guaranty (the \\\"Guaranty\\\"), guaranteeing the Franchise's liabilities and obligations to the Company.\", \"definition_clause\": \"2.5\"}}, {\"id\": \"value:six (6) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:one hundred fifty (150) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred fifty (150) days\"}}, {\"id\": \"value:six (6) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) month\"}}, {\"id\": \"value:nine (9) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"nine (9) months\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Computer System\", \"level\": 2, \"text\": \"3.4 Computer System. (a) General Requirements. You agree to use in the development and operation of the Franchise the computer terminals/billing systems and operating software (\\\"Computer System\\\") that we specify from time to time. You acknowledge that we may modify such specifications and the components of the Computer System from time to time. As part of the Computer System, we may require you to obtain specified computer hardware and/or software, including without limitation a license to use proprietary software developed by us or others. Our modification of such specifications for the components of the Computer System may require you to incur costs to purchase, lease and/or obtain by license new or modified computer hardware and/or software, and to obtain service and support for the Computer System during the term of this Agreement. You acknowledge that we cannot estimate the future costs of the Computer System (or additions or modifications thereto), and that the cost to you of obtaining the Computer System (or additions or modifications thereto), including software, may not be fully amortizable over the remaining term of this Agreement. Nonetheless, you agree to incur such costs in connection with obtaining the computer hardware and software comprising the Computer System (or additions or modifications thereto). Within sixty (60) days after you receive notice from us, you agree to obtain the components of the Computer System that we designate and require. You further acknowledge and agree that we and our affiliates have the right to charge a reasonable systems fee for software or systems installation services; modifications and enhancements specifically made for us or our affiliates that are licensed to you; and other maintenance and support Computer System-related services that we or our affiliates furnish to you. You will have sole responsibility for: (1) the acquisition, operation, maintenance, and upgrading of your Computer System; (2) the manner in which your Computer System interfaces with our computer system and those of third parties; and (3) any and all consequences that may arise if your Computer System is not properly operated, maintained, and upgraded. (b) Software. As a franchisee of The Joint Corp., we will provide to you The Joint Corp.'s proprietary office management software (the \\\"Joint Software\\\"), which you will be required to install onto the Computer System and use in the daily operation of the Franchise. In addition, we may, at any time and from time to time, contract with one or more software providers, business service providers, or other third parties (individually, a \\\"Service Provider\\\") to develop, license, or otherwise provide to or for the use and benefit of you and other The Joint Corp. Franchises certain software, software applications, and software maintenance and support services related to the Computer System that you must or may use in accordance with our instructions with respect to your Computer System. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 8 9\"}}, {\"id\": \"term:Computer System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Computer System\", \"text\": \"You agree to use in the development and operation of the Franchise the computer terminals/billing systems and operating software (\\\"Computer System\\\") that we specify from time to time.\", \"definition_clause\": \"3.4\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"term:Joint Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Joint Software\", \"text\": \"As a franchisee of The Joint Corp., we will provide to you The Joint Corp.'s proprietary office management software (the \\\"Joint Software\\\")\", \"definition_clause\": \"3.4\"}}, {\"id\": \"term:Service Provider\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Service Provider\", \"text\": \"we may, at any time and from time to time, contract with one or more software providers, business service providers, or other third parties (individually, a \\\"Service Provider\\\") to develop, license, or otherwise provide to or for the use and benefit of you and other The Joint Corp. Franchises certain software, software applications, and software maintenance and support services related to the Computer System\", \"definition_clause\": \"3.4\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Training\", \"level\": 2, \"text\": \"4.2 Training. You acknowledge that it is very important to the operation of the Franchise that you and your employees receive appropriate training. To that end, you agree as follows: (a) No later than thirty (30) days before the Franchise opens for business, you must attend our initial training program for your Franchise (the \\\"Initial Training\\\") at the time and place we designate. You (if you are an individual) or at least one of your Principal Owners (if you are a legal entity) must complete the Initial Training to our satisfaction. If you employ a General Manager other than yourself or one of your Principal Owners, that General Manager must also complete the Initial Training to our satisfaction. Other employees may complete the Initial Training at your sole discretion and expense, provided you first obtain our approval and subject to availability of facilities and materials. The Initial Training may include classroom instruction and Franchise operation training, and will be furnished at our training facility in Scottsdale, Arizona, a The Joint Corp. Franchise location we designate, your Franchise location, and/or at another location we designate. Our Initial Training programs may be different for each employee depending on their responsibilities at the Franchise. There will be no tuition charge for the persons whom we require to attend any Initial Training program or for any additional personnel of your choosing. All persons who attend our Initial Training must attend and complete the Initial Training to our satisfaction. If we, in our sole discretion, determine that any General Manager or employee whom we require to attend any Initial Training program is unable to satisfactorily complete such program, then you must not hire that person, and must hire a substitute General Manager or employee (as the case may be), who must enroll in the Initial Training program within fifteen (15) days thereafter, and complete the Initial Training to our satisfaction. (b) You agree to have your General Manager (if any) and/or other employees who attend our Initial Training complete additional training programs at places and times as we may request from time to time during the term of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 10 (c) In addition to providing the Initial Training described above, we reserve the right to offer and hold such additional ongoing training programs and franchise owners meetings regarding such topics and at such times and locations as we may deem necessary or appropriate. We also reserve the right to make any of these training programs mandatory for you and/or designated owners, employees, and/or representatives of yours. We reserve the right to charge you a daily attendance fee in an amount to be set by us for each attendee of yours who attends any mandatory or optional training program or owners meeting. If we offer any such mandatory training programs, then you or your designated personnel must attend a minimum of seventy-five percent (75%) of the programs offered on an annual basis. In addition to any other remedies we may have, if you fail to attend any required training, we reserve the right to charge you a non-attendance fee of up to $400 per day for each day of mandatory training programs or meetings you miss or fail to attend. (d) You agree to pay all wages and compensation owed to, and travel, lodging, meal, transportation, and personal expenses incurred by, all of your personnel who attend our Initial Training and/or any mandatory or optional training we provide. (e) We may require your employees to take and pass an online computer training course. While there is no cost to take such training, we may require all employees and staff to pass such training to our satisfaction before they may begin working at your Franchise location. (f) The Franchise's General Manager (if any) and other employees shall obtain all certifications and licenses required by law in order to perform their responsibilities and duties for the Franchise. 5. GUIDANCE; OPERATIONS MANUAL. 5.1 Guidance and Assistance. During the term of this Agreement, we may from time to time furnish you guidance and assistance with respect to: (1) specifications, standards, and operating procedures used by The Joint Corp. Location franchises; (2) purchasing approved equipment, furniture, furnishings, signs, materials and supplies; (3) development and implementation of local advertising and promotional programs; (4) general operating and management procedures; (5) establishing and conducting employee training programs for your Franchise; and (6) changes in any of the above that occur from time to time. This guidance and assistance may, in our discretion, be furnished in the form of bulletins, written reports and recommendations, operations manuals and other written materials (the \\\"Operations Manual\\\"), and/or telephone consultations and/or personal consultations at our offices or your Franchise. If you request\u2014and if we agree to provide\u2014any additional, special on-premises training of your personnel or other assistance in operating your Franchise, then you agree to pay a daily training fee in an amount to be set by us, and all expenses we incur in providing such training or assistance, including any wages or compensation owed to, and travel, lodging, transportation, and living expenses incurred by, our Company personnel. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 11\"}}, {\"id\": \"term:Initial Training\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Training\", \"text\": \"you must attend our initial training program for your Franchise (the \\\"Initial Training\\\") at the time and place we designate.\", \"definition_clause\": \"4.2\"}}, {\"id\": \"value:thirty (30) days_4.2_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:seventy-five percent (75%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"seventy-five percent (75%)\"}}, {\"id\": \"value:$400\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$400\"}}, {\"id\": \"term:Operations Manual\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Operations Manual\", \"text\": \"This guidance and assistance may, in our discretion, be furnished in the form of bulletins, written reports and recommendations, operations manuals and other written materials (the \\\"Operations Manual\\\")\", \"definition_clause\": \"4.2\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Operations Manual\", \"level\": 2, \"text\": \"5.2 Operations Manual. The Operations Manual we lend to you will contain mandatory and suggested specifications, standards, and operating procedures that we prescribe from time to time for your Franchise, as well as information relative to other obligations you have in the operation of the Franchise. The Operations Manual may be composed of or include audio recordings, video recordings, computer disks, compact disks, and/or other written or intangible materials. We may make all or part of the Manual available to you through various means, including the Internet. A previously delivered Operations Manual may be superseded from time to time with replacement materials to reflect changes in the specifications, standards, operating procedures and other obligations in operating the Franchise. You must keep your copy of the Operations Manual current, and if you and we have a dispute over the contents of the Manual, then our master copy of the Manual will control. You agree that you will not at any time copy any part of the Operations Manual, permit it to be copied, disclose it to anyone not having a need to know its contents for purposes of operating your Franchise, or remove it from the Franchise location without our permission. If your copy of the Operations Manual is lost, destroyed, or significantly damaged, then you must obtain a replacement copy for us at our then-applicable charge. 5.3 Modifications to System. We will continually be reviewing and analyzing developments in the healthcare, and chiropractic industries, as well as developments in fields related to small-business management, and based upon our evaluation of this information, may make changes in the System, including but not limited to, adding new components to services offered and equipment used by The Joint Corp. Location franchises. Moreover, changes in laws regulating the services offered by The Joint Corp. franchises may (a) require us to restructure our franchise program, (b) require your General Manager (if any) and employees to obtain additional licenses or certifications, (c) require you to retain or establish relationships with additional professionals and specialists in the chiropractic and/or healthcare industries, and/or (d) require you to modify your ownership or organizational structure. You agree, at our request, to modify the operation of the Franchise to comply with all such changes, and to be solely responsible for all related costs. 5.4 Advisory Councils. You agree to participate in, and, if required, become a member of any advisory councils or similar organizations we form or organize for The Joint Corp. Location franchises. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 12 THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 13 14 15\"}}, {\"id\": \"6.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Electronic Funds Transfer\", \"level\": 2, \"text\": \"6.9 Electronic Funds Transfer. We have the right to require you to participate in an electronic funds transfer program under which Royalty Fees, Advertising Fees, and any other amounts payable to us or our affiliates are deducted or paid electronically from your bank account (the \\\"Account\\\"). In the event you are required to authorize us to initiate debit entries, you agree to make the funds available in the Account for withdrawal by electronic transfer no later than the payment due date. The amount actually transferred from the Account to pay Royalty Fees and Advertising Fees will be based on the Franchise's gross revenues as reported in the Franchise's practice management software. If you have not properly input the Franchise's gross revenues for any reporting period, then we will be authorized to debit the Account in an amount equal to one hundred twenty percent (120%) of the Royalty Fee, Advertising Fee, and other amounts transferred from the Account for the last reporting period for which a report of the Franchise's gross revenues was provided to us. If at any time we determine that you have under-reported the Franchise's gross revenues or underpaid any Royalty Fee or Advertising Fee due us under this Agreement, then we will be authorized to initiate immediately a debit to the Account in the appropriate amount, plus applicable interest, in accordance with the foregoing procedure. Any overpayment will be credited, without interest, against the Royalty Fee, Advertising Fee, and other amounts we otherwise would debit from your account during the following reporting period. Our use of electronic funds transfers as a method of collecting Royalty Fees and Advertising Fees due us does not constitute a waiver of any of your obligations to provide us with weekly reports as provided in Section 12, nor shall it be deemed a waiver of any of the rights and remedies available to us under this Agreement. 6.10 Application of Payments. When we receive a payment from you, we have the right in our sole discretion to apply it as we see fit to any past due indebtedness of yours due to us or our affiliates, whether for Royalty Fees, Advertising Fees, purchases, interest, or for any other reason, regardless of how you may designate a particular payment should be applied. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 16\"}}, {\"id\": \"term:Account\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Account\", \"text\": \"We have the right to require you to participate in an electronic funds transfer program under which Royalty Fees, Advertising Fees, and any other amounts payable to us or our affiliates are deducted or paid electronically from your bank account (the \\\"Account\\\").\", \"definition_clause\": \"6.9\"}}, {\"id\": \"value:one hundred twenty percent (120%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one hundred twenty percent (120%)\"}}, {\"id\": \"6.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Modification of Payments\", \"level\": 2, \"text\": \"6.11 Modification of Payments. If, by operation of law or otherwise, any fees contemplated by this Agreement cannot be based upon gross revenues, then you and we agree to negotiate in good faith an alternative fee arrangement. If you and we are unable to reach an agreement on an alternative fee arrangement, then the Company reserves the right to terminate this Agreement upon notice to you, in which case all of the post-termination obligations set forth in Section 16 shall apply. 6.12 Non-Compliance Charge. In addition to our other rights and remedies, we may charge you a non-compliance charge in an amount up to five hundred dollars ($500) per violation by you of any term or condition of this Agreement, including, without limitation, failure to pay (or to have adequate amounts available for electronic transfer of) amounts owed to Franchisor or Franchisor's affiliates or failure to timely provide required reports, or failure to obtain prior approval from Franchisor whenever Franchisor approval is required (i.e., advertising). 7. MARKS. 7.1 Ownership and Goodwill of Marks. You acknowledge that your right to use the Marks is derived solely from this Agreement, and is limited to your operation of the Franchise pursuant to and in compliance with this Agreement and all applicable standards, specifications, and operating procedures we prescribe from time to time during the term of the Franchise. You understand and acknowledge that our right to regulate the use of the Marks includes, without limitation, any use of the Marks in any form of electronic media, such as Websites (as defined herein) or web pages, or as a domain name or electronic media identifier. If you make any unauthorized use of the Marks, it will constitute a breach of this Agreement and an infringement of our rights in and to the Marks. You acknowledge and agree that all your usage of the Marks and any goodwill established by your use will inure exclusively to our benefit and the benefit of our affiliates, and that this Agreement does not confer any goodwill or other interests in the Marks on you (other than the right to operate the Franchise in compliance with this Agreement). All provisions of this Agreement applicable to the Marks will apply to any additional trademarks, service marks, commercial symbols, designs, artwork, or logos we may authorize and/or license you to use during the term of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 17\"}}, {\"id\": \"value:five hundred dollars ($500)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"five hundred dollars ($500)\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitations on Franchise Owner's Use of Marks\", \"level\": 2, \"text\": \"7.2 Limitations on Franchise Owner's Use of Marks. You agree to use the Marks as the sole trade identification of the Franchise, except that you will display at the Franchise location a notice, in the form we prescribe, stating that you are the independent owner of the Franchise pursuant to a Franchise Agreement with us. You agree not to use any Mark as part of any corporate or trade name or with any prefix, suffix, or other modifying words, terms, designs, or symbols (other than logos and additional trade and service marks licensed to you under this Agreement), or in any modified form. You also shall not use any Mark or any commercial symbol similar to the Marks in connection with the performance or sale of any unauthorized services or products, or in any other manner we have not expressly authorized in writing. You agree to display the Marks in the manner we prescribe at the Franchise and in connection with advertising and marketing materials, and to use, along with the Marks, any notices of trade and service mark registrations we specify. You further agree to obtain any fictitious or assumed name registrations as may be required under applicable law. 7.3 Notification of Infringements and Claims. You agree to immediately notify us in writing of any apparent infringement of or challenge to your use of any Mark, or claim by any person of any rights in any Mark or similar trade name, trademark, or service mark of which you become aware. You agree not to communicate with anyone except us and our counsel in connection with any such infringement, challenge, or claim. We have the right to exclusively control any litigation or other proceeding arising out of any actual or alleged infringement, challenge, or claim relating to any Mark. You agree to sign any documents, render any assistance, and do any acts that our attorneys say is necessary or advisable in order to protect and maintain our interests in any litigation or proceeding related to the Marks, or to otherwise protect and maintain our interests in the Marks. 7.4 Discontinuance of Use of Marks. If it becomes advisable at any time in our sole judgment for the Franchise to modify or discontinue the use of any Mark, or use one or more additional or substitute trade or service marks, including the Marks used as the name of the Franchise, then you agree, at your sole expense, to comply with our directions to modify or otherwise discontinue the use of the Mark, or use one or more additional or substitute trade or service marks, within a reasonable time after our notice to you. 7.5 Indemnification of Franchise Owner. We agree to indemnify you against, and reimburse you for, all damages for which you are held liable in any trademark infringement proceeding arising out of your use of any Mark pursuant to and in compliance with this Agreement, and for all costs you reasonably incur in the defense of any such claim in which you are named as a party, so long as you have timely notified us of the claim, and have otherwise complied with this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 18\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RELATIONSHIP OF THE PARTIES; INDEMNIFICATION\", \"level\": 1, \"text\": \"8. RELATIONSHIP OF THE PARTIES; INDEMNIFICATION. 8.1 Independent Contractor; No Fiduciary Relationship. This Agreement does not create a fiduciary relationship between you and us. You and we are independent contractors, and nothing in this Agreement is intended to make either party a general or special agent, joint venture, partner, or employee of the other for any purpose whatsoever. You agree to conspicuously identify yourself in all your dealings with customers, suppliers, public officials, Franchise personnel, and others as the owner of the Franchise pursuant to a Franchise Agreement with us, and to place any other notices of independent ownership on your forms, business cards, stationery, advertising, and other materials as we may require from time to time. 8.2 No Liability, No Warranties. We have not authorized or empowered you to use the Marks except as provided by this Agreement, and you agree not to employ any of the Marks in signing any contract, check, purchase agreement, negotiable instrument or legal obligation, application for any license or permit, or in a manner that may result in liability to us for any indebtedness or obligation of yours. Except as expressly authorized by this Agreement, neither you nor we will make any express or implied agreements, warranties, guarantees or representations, or incur any debt, in the name of or on behalf of the other, or represent that your and our relationship is other than that of franchisor and franchisee. 8.3 Indemnification. We will not assume any liability or be deemed liable for any agreements, representations, or warranties you make that are not expressly authorized under this Agreement, nor will we be obligated for any damages to you or any person or property directly or indirectly arising out of the operation of the business you conduct pursuant to this Agreement, whether or not caused by your negligent or willful action or failure to act. We will have no liability for any sales, use, excise, income, gross receipts, property, or other taxes levied against you or your assets, or on us, in connection with the business you conduct, or any payments you make to us pursuant to this Agreement (except for our own income taxes). We will not assume any liability or be deemed liable for any agreements you enter with any third-parties, whether or not they are an approved or required vendor. You agree to indemnify, defend, and hold us, our affiliates and our and their respective owners, directors, officers, employees, agents, successors, and assigns (individually, an \\\"Indemnified Party,\\\" and collectively, the \\\"Indemnified Parties\\\"), harmless against, and to reimburse such Indemnified Parties for, all such obligations, damages, and taxes for which any Indemnified Party may be held liable, and for all costs the Indemnified Party reasonably may incur in the defense of any such claim brought against the Indemnified Party, or in any such action in which the Indemnified Party may be named as a party, including without limitation actual and consequential damages; reasonable attorneys', accountants', and/or expert witness fees; cost of investigation and proof of facts; court costs; other litigation expenses; and travel and living expenses. Each Indemnified Party has the right to defend any such claim against the Indemnified Party. You further agree to hold us harmless and indemnify and defend us for all costs, expenses, and/or losses we incur in enforcing the provisions of this Agreement, defending our actions taken relating to this Agreement, or resulting from your breach of this Agreement, including without limitation reasonable arbitrator's and attorneys' fees (including those for appeal), unless, after legal proceedings are completed, you are found to have fulfilled and complied with all of the terms of this Agreement. Your indemnification obligations described above will continue in full force and effect after, and notwithstanding, the expiration or termination of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 19\"}}, {\"id\": \"term:Indemnified Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnified Parties\", \"text\": \"us, our affiliates and our and their respective owners, directors, officers, employees, agents, successors, and assigns (individually, an \\\"Indemnified Party,\\\" and collectively, the \\\"Indemnified Parties\\\")\", \"definition_clause\": \"8\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION; NON-COMPETITION\", \"level\": 1, \"text\": \"9. CONFIDENTIAL INFORMATION; NON-COMPETITION. 9.1 Types of Confidential Information. We possess certain unique confidential and proprietary information and trade secrets consisting of the following categories of information, methods, techniques, products, and knowledge developed by us, including but not limited to: (1) services and products offered and sold at The Joint Corp. franchises; (2) knowledge of sales and profit performance of any one or more The Joint Corp. franchises; (3) knowledge of sources of products sold at The Joint Corp. franchises, advertising and promotional programs, and image and decor; (4) the Joint Software; (5) methods, techniques, formats, specifications, procedures, information, systems, and knowledge of, and experience in, the development, operation, and franchising of The Joint Corp. franchises; and (6) the selection and methods of training employees. We will disclose much of the above- described information to you in advising you about site selection, providing our Initial Training, the Operations Manual, the Joint Software, and providing guidance and assistance to you under this Agreement. In addition, in the course of the operation of your Franchise, you or your employees may develop ideas, concepts, methods, or techniques of improvement relating to the Franchise that you disclose to us, and that we may then authorize you to use in the operation of your Franchise, and may use or authorize others to use in other The Joint Corp. franchises owned or franchised by us or our affiliates. Any such information disclosed to or developed by you will be referred to in this Agreement as \\\"Confidential Information\\\". THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 20\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"We possess certain unique confidential and proprietary information and trade secrets consisting of the following categories of information, methods, techniques, products, and knowledge developed by us... Any such information disclosed to or developed by you will be referred to in this Agreement as \\\"Confidential Information\\\".\", \"definition_clause\": \"9\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Disclosure Agreement\", \"level\": 2, \"text\": \"9.2 Non-Disclosure Agreement. You agree that your relationship with us does not vest in you any interest in the Confidential Information, other than the right to use it in the development and operation of the Franchise, and that the use or duplication of the Confidential Information in any other business would constitute an unfair method of competition. You acknowledge and agree that the Confidential Information belongs to us, may contain trade secrets belonging to us, and is disclosed to you or authorized for your use solely on the condition that you agree, and you therefore do agree, that you (1) will not use the Confidential Information in any other business or capacity; (2) will maintain the absolute confidentiality of the Confidential Information during and after the term of this Agreement; (3) will not make unauthorized copies of any portion of the Confidential Information disclosed in written form or another form that may be copied or duplicated; and (4) will adopt and implement all reasonable procedures we may prescribe from time to time to prevent unauthorized use or disclosure of the Confidential Information, including without limitation restrictions on disclosure to your employees, and the use of non-disclosure and non-competition agreements we may prescribe or approve for your shareholders, partners, members, officers, directors, employees, independent contractors, or agents who may have access to the Confidential Information. 9.3 Non-Competition Agreement. You agree that we would be unable to protect the Confidential Information against unauthorized use or disclosure, and would be unable to encourage a free exchange of ideas and information among The Joint Corp. franchises, if franchise owners of The Joint Corp. franchises were permitted to hold interests in any competitive businesses (as described below). Therefore, during the term of this Agreement, neither you, nor any Principal Owner, nor any member of your immediate family or of the immediate family of any Principal Owner, shall perform services for, or have any direct or indirect interest as a disclosed or beneficial owner, investor, partner, director, officer, employee, manager, consultant, representative, or agent in, any business that offers products or services the same as or similar to those offered or sold at The Joint Corp. Location franchises. The ownership of one percent (1%) or less of a publicly traded company will not be deemed to be prohibited by this Paragraph. Upon expiration or termination of this Agreement for any reason, you agree not to engage in a competitive business for a period of two (2) years after the termination or expiration and within twenty-five (25) miles of your Franchise Premises or any other The Joint Corp. Location franchise location. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 21\"}}, {\"id\": \"value:one percent (1%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one percent (1%)\"}}, {\"id\": \"value:two (2) years_9.2_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:twenty-five (25) miles\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Distance\", \"text\": \"twenty-five (25) miles\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE JOINT CORP\", \"level\": 1, \"text\": \"10. THE JOINT CORP. FRANCHISE OPERATING STANDARDS. 10.1 Condition and Appearance of the Franchise. You agree that: (a) neither the Franchise nor the Premises will be used for any purpose other than the operation of the Franchise in compliance with this Agreement; (b) you will maintain the condition and appearance of the Franchise; its equipment, furniture, furnishings, and signs; and the Premises in accordance with our standards and consistent with the image of a The Joint Corp. Location franchise as an efficiently operated business offering high quality services, and observing the highest standards of cleanliness, sanitation, efficient, courteous service and pleasant ambiance, and in that connection will take, without limitation, the following actions during the term of this Agreement: (1) thorough cleaning, repainting and redecorating of the interior and exterior of the Premises at reasonable intervals; (2) interior and exterior repair of the Premises; and (3) repair or replacement of damaged, worn out or obsolete equipment, furniture, furnishings and signs; (c) you will not make any material alterations to the Premises or the appearance of the Franchise, as originally developed, without our advance written approval. If you do so, we have the right, at our option and at your expense, to rectify alterations we have not previously approved; (d) you will promptly replace or add new equipment when we reasonably specify in order to meet changing standards or new methods of service; (e) you will expend at least Six Thousand and No/100 Dollars ($6,000.00) every four (4) years in remodeling, expansion, redecorating and/or refurnishing of the Premises and the Franchise, if deemed necessary by us (any changes to the decoration or furnishing of the Premises must be approved by us); (f) on notice from us, you will engage in remodeling, expansion, redecorating and/or refurnishing of the Premises and the Franchise to reflect changes in the operations of The Joint Corp. franchises that we prescribe and require of new franchisees, provided that (1) no material changes will be required unless there are at least two (2) years remaining on the Initial Term of the Franchise (any changes to the decoration or furnishing of the Premises must be approved by us); and (2) we have required the proposed change in at least twenty-five percent (25%) of all similarly situated Company and affiliate-owned The Joint Corp. Locations, and have undertaken a plan to make the proposed change in the balance of such Company and affiliate-owned Locations (any expenditures incurred pursuant to this Paragraph 10.1(f) shall apply to the requirement in Paragraph 10.1(e)); THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 22 (g) you will place or display at the Premises (interior and exterior) only those signs, emblems, designs, artwork, lettering, logos, and display and advertising materials that we from time to time approve; and (h) if at any time in our reasonable judgment, the general state of repair, appearance, or cleanliness of the premises of the Franchise or its fixtures, equipment, furniture, or signs do not meet our standards, then we shall have the right to notify you specifying the action you must take to correct the deficiency. If you do not initiate action to correct such deficiencies within (ten) 10 days after receipt of our notice, and then continue in good faith and with due diligence, a bona fide program to complete any required maintenance or refurbishing, then we shall have the right, in addition to all other remedies available to us at law or under this Agreement, to enter the Premises or the Franchise and perform any required maintenance or refurbishing on your behalf, and you agree to reimburse us on demand. 10.2 Franchise Services and Products. You agree that (a) the Franchise will offer for sale all services and products that we from time to time specify for Locations, (b) the Franchise will offer and sell approved services and products only in the manner we have prescribed; (c) you will not offer for sale or sell at the Franchise, the Premises, or any other location any services or products we have not approved; (d) all products will be offered at retail prices, and you will not offer or sell any products at wholesale prices; (e) you will not use the Premises for any purpose other than the operation of the Franchise; and (f) you will discontinue selling and offering for sale any services or products that we at any time decide (in our sole discretion) to disapprove in writing. In the event that you use, sell or distribute unauthorized products or services, and do not cease the use, sale, or distribution of unauthorized services or products within ten (10) days after written notice is given to you, we reserve the right to terminate this agreement and/or charge you a fee of One Hundred and No/100 Dollars ($100.00) for each day that you fail to comply with our demand to cease the use, sale or distribution of unauthorized products or services, which is a reasonable estimate of the damages we would incur from your continued use, sale or distribution of unauthorized products or services, and not a penalty. You agree to maintain an inventory of approved products sufficient in quantity and variety to realize the full potential of the Franchise. We may, from time to time, conduct market research and testing to determine consumer trends and the saleability of new services and products. You agree to cooperate by participating in our market research programs, test marketing new services and products in the Franchise, and providing us with timely reports and other relevant information regarding such market research. In connection with any such test marketing, you agree to offer a reasonable quantity of the products or services being tested, and effectively promote and make a reasonable effort to sell them. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 23\"}}, {\"id\": \"value:$6,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$6,000.00\"}}, {\"id\": \"value:four (4) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four (4) years\"}}, {\"id\": \"value:two (2) years_10_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:twenty-five percent (25%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"twenty-five percent (25%)\"}}, {\"id\": \"value:10 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 days\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:$100.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$100.00\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Approved Products, Distributors and Suppliers\", \"level\": 2, \"text\": \"10.3 Approved Products, Distributors and Suppliers. We have developed or may develop various unique products or services that may be prepared according to our formulations. We have approved, and will continue to periodically approve, specifications for suppliers and distributors (which may include us and/or our affiliates) for products or services required to be purchased by, or offered and sold at, The Joint Corp. Location franchises, that meet our standards and requirements, including without limitation standards and requirements relating to product quality, prices, consistency, reliability, and customer relations. You understand and acknowledge we will not be liable to you or anyone else for any damages or claims arising out of or resulting from the acts or omissions any supplier and distributor of products or services, whether or not such supplier or distributor is an approved or required supplier or distributor of products or services. You agree that the Franchise will: (1) purchase any required products or services in such quantities as we designate; (2) utilize such formats, formulae, and packaging for products or services as we prescribe; and (3) purchase all designated products and services only from distributors and other suppliers we have approved. In the event we designate a required supplier or distributor during the term of this Agreement, or any subsequent franchise agreement, you must begin to use such required supplier or distributor with thirty (30) days of the date we notify you that you must use such supplier or distributor, unless we designate a longer period for you to switch or convert over to such supplier or distributor. Your failure or refusal to do so shall constitute a breach of this Agreement. We may approve a single distributor or other supplier (collectively \\\"supplier\\\") for any product, and may approve a supplier only as to certain products. We may concentrate purchases with one or more suppliers to obtain lower prices or the best advertising support or services for any group of The Joint Corp. Locations franchised or operated by us. Approval of a supplier may be conditioned on requirements relating to the frequency of delivery, concentration of purchases, standards of service (including prompt attention to complaints), or other criteria, and may be temporary, pending our continued evaluation of the supplier from time to time. If you would like to purchase any items from any unapproved supplier, then you must submit to us a written request for approval of the proposed supplier. We have the right to inspect the proposed supplier's facilities, and require that product samples from the proposed supplier be delivered, at our option, either directly to us, or to any independent, certified laboratory that we may designate, for testing. We may charge you a supplier evaluation fee (not to exceed the reasonable cost of the inspection and the actual cost of the test) to make the evaluation. We reserve the right to periodically re-inspect the facilities and products of any approved supplier, and revoke our approval if the supplier does not continue to meet any of our criteria. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 24 We and/or our affiliates may be an approved supplier of certain products or services to be purchased by you for use and/or sale by the Franchise. We and our affiliates reserve the right to charge any licensed manufacturer engaged by us or our affiliates a royalty to manufacture products for us or our affiliates, or to receive commissions or rebates from vendors that supply goods or services to you. We or our affiliates may also derive income from our sale of products or services to you, and may sell these items at prices exceeding our or their costs in order to make a profit on the sale. 10.4 Hours of Operation. You agree to keep the Franchise open for business at such times and during such hours as we may prescribe from time to time. 10.5 Specifications, Standards and Procedures. You agree to comply with all mandatory specifications, standards, and operating procedures relating to the appearance, function, cleanliness, sanitation and operation of the Franchise. Any mandatory specifications, standards, and operating procedures that we prescribe from time to time in the Operations Manual, or otherwise communicate to you in writing, will constitute provisions of this Agreement as if fully set forth in this Agreement. All references to \\\"this Agreement\\\" include all such mandatory specifications, standards, and operating procedures. 10.6 Compliance with Laws and Good Business Practices. You agree to secure and maintain in force in your name all required licenses, permits and certificates relating to the operation of the Franchise. You also agree to operate the Franchise in full compliance with all applicable laws, ordinances, and regulations, including without limitation all government regulations relating to worker's compensation insurance, unemployment insurance, and withholding and payment of federal and state income taxes, social security taxes, and sales taxes. All advertising you employ must be completely factual, in good taste (in our judgment), and conform to the highest standards of ethical advertising and all legal requirements. You agree that in all dealings with us and any of our affiliates, other franchisees, your customers, your suppliers, and public officials, you will adhere to the highest standards of honesty, integrity, fair dealing and ethical conduct. You further agree to refrain from any business or advertising practice that may be harmful to the business of the Company, the Franchise, and/or the goodwill associated with the Marks and other The Joint Corp. franchises. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 25 You must notify us in writing within 5 days of (1) the commencement of any action, suit, or proceeding, and/or of the issuance of any order, writ, injunction, award, or decree of any court, agency, or other governmental unit, that may adversely affect your and/or the Franchise's operation, financial condition, or reputation; and/or (2) your receipt or knowledge any notice of violation of any law, ordinance, or regulation relating to health or safety. 10.7 Management and Personnel of the Franchise. Unless we approve your employment of a General Manager to operate the Franchise as provided in Paragraph 4.1, you must actively participate in the actual, on-site, day-to-day operation of the Franchise, and devote as much of your time as is reasonably necessary for the efficient operation of the Franchise. If you are other than an individual, then at least one (1) Principal Owner, director, officer, or other employee of you whom we approve must comply with the this requirement. If we agree that you may employ a General Manager, then the General Manager must fulfill this requirement. Any General Manager shall each obtain all licenses and certifications required by law before assuming his or her responsibilities at the Franchise. You will ensure that your employees and independent contractors of the Franchise have any licenses as may be required by law, and hold or are pursuing any licenses, certifications, and/or degrees required by law or by us in the Operations Manual, as updated from time to time. You will be exclusively responsible for the terms of your employees' and independent contractors' employment and compensation, and for the proper training of your employees and independent contractors in the operation of the Franchise. You must establish any training programs for your employees and/or independent contractors that we may prescribe in writing from time to time. You must require all employees and independent contractors to maintain a neat and clean appearance, and conform to the standards of dress that we specify in the Operations Manual, as updated from time to time. Each of your employees and independent contractors must sign a written agreement, in a form approved by us, to maintain confidential our Confidential Information, proprietary information, and trade secrets as described in Paragraph 9.1, and to abide by the covenants not to compete described in Paragraph 9.3. You must forward to us a copy of each such signed agreement. All of your employees and independent contractors must render prompt, efficient and courteous service to all customers of the Franchise. You agree not to recruit or hire, either directly or indirectly, any employee (or a former employee, for sixty (60) days after his or her employment has ended) of any The Joint Corp. Location franchise operated by us, our affiliates, or another The Joint Corp. franchise owner without first obtaining the written consent of us, our affiliate, or the franchise owner that currently employs (or previously employed) such employee. If you violate this provision, in addition to any other right or remedy we may have, you agree to pay the employee's current or former employer twice the employee's annual salary, plus all costs and attorneys' fees incurred as a result of the violation. This amount is set at twice the employee's annual salary because it is a reasonable estimation of the damages that would occur from such a breach, and it will almost certainly be impossible to calculate precisely the actual damages from such a breach. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 26\"}}, {\"id\": \"value:thirty (30) days_10.3_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:5 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 days\"}}, {\"id\": \"value:sixty (60) days_10.3_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"10.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 2, \"text\": \"10.8 Insurance. Before you open the Franchise and during any Term of this Agreement, you must maintain in force, under policies of insurance written on an occurrence basis issued by carriers with an A.M. Best rating of A-VIII or better approved by us, and in such amounts as we may determine from time to time: (1) comprehensive public, professional, product, medical malpractice and motor vehicle liability insurance against claims for bodily and personal injury, death and property damage caused by or occurring in conjunction with the operation of the Franchise or otherwise in conjunction with your conduct of the Franchise Business pursuant to this Agreement, under one or more policies of insurance containing minimum liability coverage amounts as set forth in the Operations Manual; (2) general casualty insurance, including theft, cash theft, fire and extended coverage, vandalism and malicious mischief insurance, for the replacement value of the Franchise and its contents, and any other assets of the Franchise; (3) worker's compensation and employer's liability insurance as required by law, with limits equal to or in excess of those required by statute; (4) business interruption insurance for a period adequate to reestablish normal business operations, but in any event not less than six (6) months; (5) any other insurance required by applicable law, rule, regulation, ordinance or licensing requirements; and (6) umbrella liability coverage with limits of not less than $1,000,000/$3,000,000 or such other amounts that we may establish in the Operations Manual. You must purchase such insurance coverage(s) only from our approved or designated supplier(s). We may periodically increase or decrease the amounts of coverage required under these insurance policies, and/or require different or additional kinds of insurance, including excess liability insurance, to reflect inflation, identification of new risks, changes in law or standards of liability, higher damage awards, or other relevant changes in circumstances. Each insurance policy must name us (and, if we so request, our members, directors, employees, agents, and affiliates) as additional insureds, and must provide us with thirty (30) days' advance written notice of any material modification, cancellation, or expiration of the policy. Deductibles must be in reasonable amounts, and are subject to review and written approval by us. You must provide us with copies of policies evidencing the existence of such insurance concurrently with execution of this Agreement and prior to each subsequent renewal date of each insurance policy, along with certificates evidencing such insurance. You are responsible for any and all claims, losses or damages, including to third persons, originating from, in connection with, or caused by your failure to name us as an additional insured on each insurance policy. You agree to defend, indemnify and hold us harmless of, from, and with respect to any such claims, loss or damage arising out of your failure to name us as additional insured, which indemnity shall survive the termination or expiration and non-renewal of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 27 Prior to the expiration of the term of each insurance policy, you must furnish us with a copy of a renewal or replacement insurance policy and appropriate certificates of insurance. If you at any time fail or refuse to maintain any insurance coverage required by us or to furnish satisfactory evidence thereof, then we, at our option and in addition to our other rights and remedies under this Agreement, may, but need not, obtain such insurance coverage on your behalf, and you shall reimburse us on demand for any costs or premiums paid or incurred by us, including any administrative fees or surcharges that we may incur. If you fail to pay us within ten (10) days of our demand for reimbursement, we reserve the right to debit your account the amounts owed to us for any premiums paid on your behalf for such insurance coverage along with any other costs, surcharges expenses and fees we incur to obtain such coverage on your behalf or on behalf of your franchise. We reserve the right to require you to provide us with an application for insurance (in a form acceptable to our required supplier for insurance) for any medical professional that has been offered a position to work in a Franchise location so that we may, if you fail to do so, procure any necessary insurance coverage for such medical professional. Notwithstanding the existence of such insurance, you are and will be responsible for all loss or damage and contractual liability to third persons originating from or in connection with the operation of the Franchise, and for all claims or demands for damages to property or for injury, illness or death of persons directly or indirectly resulting therefrom; and you agree to defend, indemnify and hold us harmless of, from, and with respect to any such claims, loss or damage, which indemnity shall survive the termination or expiration and non-renewal of this Agreement. In addition to the requirements of the foregoing paragraphs of this Paragraph 10.8, you must maintain any and all insurance coverage in such amounts and under such terms and conditions as may be required in connection with your lease or purchase of the Premises. Your obligation to maintain insurance coverage as described in this Agreement will not be reduced in any manner by reason of any separate insurance we maintain on our own behalf, nor will our maintenance of that insurance relieve you of any obligations under Section 7 of this Agreement. 10.9 Credit Cards and Other Methods of Payment. You must at all times have arrangements in existence with Visa, Master Card, American Express, Discover and any other credit and debit card issuers or sponsors, check verification services, and electronic fund transfer systems that we designate from time to time, in order that the Franchise may accept customers' credit and debit cards, checks, and other methods of payment. We may require you to obtain such services through us or our affiliates. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 28 29 The Ad Fund will be accounted for separately from other funds of the Company, and will not be used to defray any of our general operating expenses, except for any reasonable salaries, administrative costs, and overhead we may incur in activities reasonably related to the administration of the Ad Fund and its advertising programs (including without limitation conducting market research, preparing advertising and marketing materials, and collecting and accounting for contributions to the Ad Fund). We may spend in any fiscal year an amount greater or less than the total contributions to the Ad Fund in that year. We may cause the Ad Fund to borrow from us or other lenders to cover deficits of the Ad Fund, or to invest any surplus for future use by the Ad Fund. You authorize us to collect for remission to the Ad Fund any advertising monies or credits offered by any supplier to you based upon purchases you make. We will prepare an annual statement of monies collected and costs incurred by the Ad Fund and will make it available to you on written request. You understand and acknowledge that the Ad Fund will be intended to maximize recognition of the Marks and patronage of The Joint Corp. Location franchises. Although we will endeavor to use the Ad Fund to develop advertising and marketing materials, and to place advertising in a manner that will benefit all The Joint Corp. Location franchises, we undertake no obligation to ensure that expenditures by the Ad Fund in or affecting any geographic area are proportionate or equivalent to contributions to the Ad Fund by The Joint Corp. Location franchises operating in that geographic area, or that any The Joint Corp. Location franchise will benefit directly or in proportion to its contribution to the Ad Fund from the development of advertising and marketing materials or the placement of advertising. Except as expressly provided in this Paragraph, we assume no direct or indirect liability or obligation to you with respect to the maintenance, direction, or administration of the Ad Fund. We will have the right to terminate the Ad Fund by giving you thirty (30) days' advance written notice. All unspent monies on date of termination will be divided between the Company and the contributing The Joint Corp. Location franchisees in proportion to our and their respective contributions. At any time thereafter, we will have the right to reinstate the Ad Fund under the same terms and conditions as described in this Section (including the rights to terminate and reinstate the Ad Fund) by giving you thirty (30) days' advance written notice of reinstatement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 30 31 (a) Before establishing any Website or Other Form of Advertising Media, you will submit to us a sample of such Website or Other Form of Advertising Media format and information in the form and manner we may require. (b) You will not establish or use any Website or Other Forms of Advertising Media without our prior written approval. (c) In addition to any other applicable requirements, you must comply with our standards and specifications for Website or Other Forms of Advertising Media as we prescribe in the Operations Manual or otherwise in writing, including any specifications relating to the use of organic and paid search engine optimization, keyword and landing page management. If we require, you will establish a website as part of our corporate website and/or establish electronic links to our corporate website. (d) If you propose any material revision to Website or Other Forms of Advertising Media or any of the information contained therein, you will submit each such revision to us for our prior written approval. 12. ACCOUNTING, REPORTS AND FINANCIAL STATEMENTS. You agree to maintain, at your own expense, the Joint Software and accounting software, to act as a bookkeeping, accounting, and record keeping system for the Franchise. The Joint Software includes the capability of being polled by our central computer system, which you agree to permit. With respect to the operation and financial condition of the Franchise, we will pull from the Joint Software (if available), or require you to provide from your accounting software in a form we designate, or in accordance with General Acceptably Accounting Principles (\\\"GAAP\\\"), as the case may be, the following: (1) by Tuesday of each week, an electronic report of the Franchise's gross revenues for the preceding week ending on, and including, Sunday, and any other data, information, and supporting records that we may require; (2) by the thirtieth (30 t h) day of each month, a profit and loss statement for the preceding calendar month, and a year-to-date profit and loss statement and balance sheet; (3) within ninety (90) days after the end of your fiscal year, a fiscal year-end balance sheet, and an annual profit and loss statement for that fiscal year, reflecting all year- end adjustments; and (4) such other reports as we require from time to time (collectively, the \\\"Reports\\\"). You agree to input all Franchise transactions into the Joint Software and your accounting software in a timely manner to ensure that all Reports are accurate. If it is determined that any information was omitted from the Joint Software or your accounting software was input inaccurately, or you have failed to provide us any required Reports, we may charge a non-refundable accounting fee of One Hundred and No/100 Dollars ($100.00), payable in a lump sum by the fifth (5th) day of the month following the month during which the inaccurate report was submitted or for any late Reports. You agree to maintain and furnish upon our request complete copies of federal and state income tax returns you file with the Internal Revenue Service and state tax departments, reflecting revenues and income of the Franchise or the corporation, partnership, or limited liability company that holds the Franchise. We reserve the right to require you to have audited or reviewed financial statements prepared by a certified public accountant on an annual basis. You agree to retain hard copies of all records for a minimum of four (4) years. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 32\"}}, {\"id\": \"value:six (6) months_10.8_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:$1,000,000/$3,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000/$3,000,000\"}}, {\"id\": \"value:thirty (30) days_10.8_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:ten (10) days_10.8_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"term:Reports\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reports\", \"text\": \"such other reports as we require from time to time (collectively, the \\\"Reports\\\")\", \"definition_clause\": \"10.8\"}}, {\"id\": \"value:thirtieth (30 t h) day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirtieth (30 t h) day\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:$100.00_10.8_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$100.00\"}}, {\"id\": \"value:four (4) years_10.8_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four (4) years\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSPECTIONS AND AUDITS\", \"level\": 1, \"text\": \"13. INSPECTIONS AND AUDITS. 13.1 Company's Right to Inspect the Franchise. To determine whether you and the Franchise are complying with this Agreement and the specifications, standards, and operating procedures we prescribe for the operation of the Franchise, we or our agents have the right, at any reasonable time and without advance notice to you, to: (1) inspect the Premises; (2) observe the operations of the Franchise for such consecutive or intermittent periods as we deem necessary; (3) interview personnel of the Franchise; (4) interview customers of the Franchise; and (5) inspect and copy any books, records and documents relating to the operation of the Franchise. You agree to fully cooperate with us in connection with any of those inspections, observations and interviews. You agree to present to your customers any evaluation forms we periodically prescribe, and agree to participate in, and/or request that your customers participate in, any surveys performed by or on our behalf. Based on the results of any such inspections and audits and your other reports, we may provide to you such guidance and assistance in operating your Franchise as we deem appropriate. 13.2 Company's Right to Audit. We have the right at any time during business hours, and without advance notice to you, to inspect and audit, or cause to be inspected and audited, the business records, bookkeeping and accounting records, sales and income tax records and returns and other records of the Franchise, and the books and records of any corporation, limited liability company, or partnership that holds the Franchise. You agree to fully cooperate with our representatives and any independent accountants we may hire to conduct any inspection or audit. If the inspection or audit is necessary because of your failure to furnish any reports, supporting records, other information or financial statements as required by this Agreement, or to furnish such reports, records, information, or financial statements on a timely basis, or if an understatement of gross revenues for any period is determined by an audit or inspection to be greater than two percent (2%), then you agree to pay us all monies owed, plus interest of one and one-half percent (1.5%) per month, and reimburse us for the cost of such inspection or audit, including without limitation any attorneys' fees and/or accountants' fees we may incur, and the travel expenses, room and board, and applicable per diem charges for our employees or contractors. The above remedies are in addition to all our other remedies and rights under this Agreement or under applicable law. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 33\"}}, {\"id\": \"value:two percent (2%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"two percent (2%)\"}}, {\"id\": \"value:one and one-half percent (1.5%) per month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one and one-half percent (1.5%) per month\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRANSFER REQUIREMENTS\", \"level\": 1, \"text\": \"14. TRANSFER REQUIREMENTS. 14.1 Organization. If you are a corporation, partnership or limited liability company (or if this Agreement is assigned to a corporation, partnership or limited liability company with our approval), you represent and warrant to us that you are and will continue to be throughout the term of this Agreement, duly organized and validly existing in good standing under the laws of the state of your incorporation, registration or organization, that you are qualified to do business and will continue to be qualified to do business throughout the term of this Agreement in all states in which you are required to qualify, that you have the authority to execute, deliver and carry out all of the terms of this Agreement, and that during the term of this Agreement the only business you (i.e., the corporate, partnership or limited liability entity) will conduct will be the development, ownership and operation of the Franchise. 14.2 Interests in Franchise Owner; Reference to Exhibit 4. You and each Principal Owner represent, warrant and agree that all \\\"Interests\\\" in Franchise Owner are owned in the amount and manner described in Exhibit 4. No Interests in Franchise Owner will, during the term of this Agreement, be \\\"public\\\" securities (i.e., securities that require, for their issuance, registration with any state or federal authority). (An \\\"Interest\\\" is defined to mean any shares, membership interests, or partnership interests of Franchise Owner and any other equitable or legal right in any of Franchise Owner's stock, revenues, profits, rights or assets. When referring to Franchise Owner's rights or assets, an \\\"Interest\\\" means this Agreement, Franchise Owner's rights under and interest in this Agreement, any The Joint Corp. franchise, or the revenues, profits or assets of any The Joint Corp. franchise.) You and each Principal Owner also represent, warrant, and agree that no Principal Owner's Interest has been given as security for any obligation (i.e., no one has a lien on or security interest in a Principal Owner's Interest), and that no change will be made in the ownership of an Interest other than as expressly permitted by this Agreement or as we may otherwise approve in writing. You and each Principal Owner agree to furnish us with such evidence as we may request from time to time to assure ourselves that the Interests of Franchise Owner and each of your Principal Owners remain as permitted by this Agreement, including a list of all persons or entities owning any Interest, as defined above. If you have transferred your Interests in violation of this Agreement you shall be considered in breach of this Agreement. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 34\"}}, {\"id\": \"term:Interest\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Interest\", \"text\": \"(An \\\"Interest\\\" is defined to mean any shares, membership interests, or partnership interests of Franchise Owner and any other equitable or legal right in any of Franchise Owner's stock, revenues, profits, rights or assets. When referring to Franchise Owner's rights or assets, an \\\"Interest\\\" means this Agreement, Franchise Owner's rights under and interest in this Agreement, any The Joint Corp. franchise, or the revenues, profits or assets of any The Joint Corp. franchise.)\", \"definition_clause\": \"14\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer by Company\", \"level\": 2, \"text\": \"14.3 Transfer by Company. This Agreement is fully transferable by us and will inure to the benefit of any person or entity to whom it is transferred, or to any other legal successor to our interests in this Agreement. 14.4 No Transfer Without Approval. You understand and acknowledge that the rights and duties created by this Agreement are personal to you and that we have entered into this Agreement in reliance on the individual or collective character, skill, aptitude, attitude, business ability, and financial capacity of you and your Principal Owners. Accordingly, neither this Agreement nor any part of your interest in it, nor any Interest (as defined in Paragraph 14.2) of Franchise Owner or a Principal Owner, may be transferred (see definition below) without our advance written approval if such transfer will result in the Principal Owner(s) set forth in Exhibit 4 holding less than a seventy-five percent (75%) Interest in Franchise Owner. Any Transfer that is made without our approval will constitute a breach of this Agreement and convey no rights to or interests in this Agreement, you, the Franchise, or any other The Joint Corp. franchise. As used in this Agreement the term \\\"Transfer\\\" means any voluntary, involuntary, direct or indirect assignment, sale, gift, exchange, grant of a security interest, or occurrence of any other event which would or might change the ownership of any Interest, and includes, without limitation: (1) the Transfer of ownership of capital stock, partnership interest or other ownership interest (including the granting of options (such as stock options or any option which give anyone ownership rights now or in the future); (2) merger or consolidation, or issuance of additional securities representing an ownership interest in Franchise Owner; (3) sale of common stock of Franchise Owner sold pursuant to a private placement or registered public offering; (4) Transfer of an Interest in a divorce proceeding or otherwise by operation of law; or (5) Transfer of an Interest by will, declaration of or transfer in trust, or under the laws of intestate succession. We will not unreasonably withhold consent to a Transfer of an Interest by a Principal Owner to a member of his or her immediate family or to your key employees, so long as all Principal Owners together retain a \\\"controlling Interest\\\" (i.e., the minimum ownership percentage listed in Exhibit 4), although we reserve the right to impose reasonable conditions on the Transfer as a requirement for our consent. Interests owned by persons other than the Principal Owners (\\\"minority owners\\\") may be Transferred without our advance consent unless the Transfer would give that transferee and any person or group of persons affiliated or having a common interest with the transferee more than a collective twenty-five percent (25%) Interest in Franchise Owner, in which case our advance written approval for the Transfer must be obtained. Your formal partnership, corporation or other formation documents and all stock certificates, partnership units or other evidence of ownership must recite or bear a legend reflecting the transfer restrictions of this Paragraph 14.4. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 35\"}}, {\"id\": \"value:seventy-five percent (75%)_14.3_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"seventy-five percent (75%)\"}}, {\"id\": \"term:Transfer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Transfer\", \"text\": \"As used in this Agreement the term \\\"Transfer\\\" means any voluntary, involuntary, direct or indirect assignment, sale, gift, exchange, grant of a security interest, or occurrence of any other event which would or might change the ownership of any Interest, and includes, without limitation: (1) the Transfer of ownership of capital stock, partnership interest or other ownership interest (including the granting of options (such as stock options or any option which give anyone ownership rights now or in the future); (2) merger or consolidation, or issuance of additional securities representing an ownership interest in Franchise Owner; (3) sale of common stock of Franchise Owner sold pursuant to a private placement or registered public offering; (4) Transfer of an Interest in a divorce proceeding or otherwise by operation of law; or (5) Transfer of an Interest by will, declaration of or transfer in trust, or under the laws of intestate succession.\", \"definition_clause\": \"14.3\"}}, {\"id\": \"value:twenty-five percent (25%)_14.3_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"twenty-five percent (25%)\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Conditions for Approval of Transfer\", \"level\": 2, \"text\": \"14.5 Conditions for Approval of Transfer. If you and your Principal Owners are in full compliance with this Agreement, we will not unreasonably withhold our approval of a Transfer that meets all the applicable requirements of this Section 14. The person or entity to whom you wish to make the Transfer, or its principal owners (\\\"Proposed New Owner\\\"), must be individuals of good moral character and otherwise meet our then-applicable standards for The Joint Corp. Location franchisees. If you propose to Transfer this Agreement, the Franchise or its assets, or any Interest, or if any of your Principal Owners proposes to Transfer a controlling Interest in you or make a Transfer that is one of a series of Transfers which taken together would constitute the Transfer of a controlling Interest in you, then all of the following conditions must be met before or at the time of the Transfer: (a) the Proposed New Owner must have sufficient business experience, aptitude, and financial resources to operate the Franchise; (b) you must pay any amounts owed for purchases from us and our affiliates, and any other amounts owed to us or our affiliates which are unpaid; (c) the Proposed New Owner's directors and such other personnel as we may designate must have successfully completed our Initial Training program, and shall be legally authorized and have all licenses necessary to perform the services offered by the Franchise. The Proposed New Owner shall be responsible for any wages and compensation owed to, and the travel and living expenses (including all transportation costs, room, board and meals) incurred by, the attendees who attend the Initial Training program; (d) if your lease for the Premises requires it, the lessor must have consented to the assignment of the lease of the Premises to the Proposed New Owner; (e) you (or the Proposed New Owner) must pay us a Transfer fee equal to seventy-five percent (75%) of the then current initial franchise fee we charge to new Start-up Location franchisees, and must reimburse us for any reasonable expenses incurred by us in investigating and processing any Proposed New Owner where the Transfer is not consummated for any reason; (f) you and your Principal Owners and your and their spouses must execute a general release (in a form satisfactory to us) of any and all claims you and/or they may have against us, our affiliates, and our and our affiliates' respective officers, directors, employees, and agents; THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 36 (g) we must approve the material terms and conditions of the proposed Transfer, including without limitation that the price and terms of payment are not so burdensome as to adversely affect the operation of the Franchise; (h) the Franchise and the Premises shall have been placed in an attractive, neat and sanitary condition; (i) you and your Principal Owners must enter into an agreement with us providing that all obligations of the Proposed New Owner to make installment payments of the purchase price (and any interest on it) to you or your Principal Owners will be subordinate to the obligations of the Proposed New Owner to pay any amounts payable under this Agreement or any new Franchise Agreement that we may require the Proposed New Owner to sign in connection with the Transfer; (j) you and your Principal Owners must enter into a non-competition agreement wherein you agree not to engage in a competitive business for a period of two (2) years after the Transfer and within twenty-five (25) miles of your Franchise Premises or any other The Joint Corp. Location franchise location; (k) the Franchise shall have been determined by us to contain all equipment and fixtures in good working condition, as were required at the initial opening of the Franchise. The Proposed New Owner shall have agreed, in writing, to make such reasonable capital expenditures to remodel, equip, modernize and redecorate the interior and exterior of the premises in accordance with our then existing plans and specifications for a The Joint Corp. Location franchise, and shall have agreed to pay our expenses for plan preparation or review, and site inspection; (l) upon receiving our consent for the Transfer or sale of the Franchise, the Proposed New Owner shall agree to assume all of your obligations under this Agreement in a form acceptable to us, or, at our option, shall agree to execute a new Franchise Agreement with us in the form then being used by us. We may, at our option, require that you guarantee the performance, and obligations of the Proposed New Owner; and (m) you must have properly offered us the opportunity to exercise our right of first refusal as described below, and we must have then declined to exercise it. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 37\"}}, {\"id\": \"term:Proposed New Owner\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proposed New Owner\", \"text\": \"The person or entity to whom you wish to make the Transfer, or its principal owners (\\\"Proposed New Owner\\\"), must be individuals of good moral character and otherwise meet our then-applicable standards for The Joint Corp. Location franchisees.\", \"definition_clause\": \"14.5\"}}, {\"id\": \"value:seventy-five percent (75%)_14.5_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"seventy-five percent (75%)\"}}, {\"id\": \"value:two (2) years_14.5_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:twenty-five (25) miles_14.5_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Distance\", \"text\": \"twenty-five (25) miles\"}}, {\"id\": \"14.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Right of First Refusal\", \"level\": 2, \"text\": \"14.6 Right of First Refusal. If you or any of your Principal Owners wishes to Transfer any Interest, we will have a right of first refusal to purchase that Interest as follows. The party proposing the Transfer (the \\\"transferor\\\") must obtain a bona fide, executed written offer (accompanied by a \\\"good faith\\\" earnest money deposit of at least five percent (5%) of the proposed purchase price) from a responsible and fully disclosed purchaser, and must submit an exact copy of the offer to us. You also agree to provide us with any other information we need to evaluate the offer, if we request it within five (5) days of receipt of the offer. We have the right, exercisable by delivering written notice to the transferor within fifteen (15) days from the date of last delivery to us of the offer and any other documents we have requested, to purchase the Interest for the price and on the terms and conditions contained in the offer, except that we may substitute cash for any form of payment proposed in the offer, and will not be obligated to pay any \\\"finder's\\\" or broker's fees that are a part of the proposed Transfer. We also will not be required to pay any amount for any claimed value of intangible benefits, for example, possible tax benefits that may result by structuring and/or closing the proposed Transfer in a particular manner or for any consideration payable other than the bona fide purchase price for the Interest proposed to be transferred. (In fact, we may in our sole and absolute discretion withhold consent to any proposed Transfer if the offer directly or indirectly requires payment of any consideration other than the bona fide purchase price for the Interest proposed to be transferred.) Our credit will be deemed equal to the credit of any other proposed purchaser, and we will have at least sixty (60) days to prepare for closing. We will be entitled to all customary representations and warranties given purchasers in connection with such sales. If the proposed Transfer includes assets not related to the operation of the Franchise, we may purchase only the assets related to the operation of the Franchise or may also purchase the other assets. (An equitable purchase price will be allocated to each asset included in the Transfer.) If we do not exercise our right of first refusal, the transferor may complete the sale to the Proposed New Owner pursuant to and on the terms of the offer, as long as we have approved the Transfer as provided in this Section 14. You must immediately notify us of any changes in the terms of an offer. Any material change in the terms of an offer before closing will make it a new offer, revoking any previous approval or previously made election to purchase and giving us a new right of first refusal effective as of the day we receive formal notice of a material change in the terms. If the sale to the Proposed New Owner is not completed within one hundred twenty (120) days after we have approved the Transfer, our approval of the proposed Transfer will expire. Any later proposal to complete that proposed Transfer will be deemed a new offer, giving us a new right of approval and right of first refusal effective as of the day we receive formal notice of the new (or continuing) proposal. We will not exercise a right of first refusal with respect to a proposed Transfer of less than a controlling interest to a member of a Principal Owner's immediate family or to your key employees. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 38\"}}, {\"id\": \"term:transferor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"transferor\", \"text\": \"The party proposing the Transfer (the \\\"transferor\\\") must obtain a bona fide, executed written offer (accompanied by a \\\"good faith\\\" earnest money deposit of at least five percent (5%) of the proposed purchase price) from a responsible and fully disclosed purchaser, and must submit an exact copy of the offer to us.\", \"definition_clause\": \"14.6\"}}, {\"id\": \"value:five percent (5%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"five percent (5%)\"}}, {\"id\": \"value:five (5) days_14.6_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"value:fifteen (15) days_14.6_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:sixty (60) days_14.6_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:one hundred twenty (120) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred twenty (120) days\"}}, {\"id\": \"14.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Death and Disability\", \"level\": 2, \"text\": \"14.7 Death and Disability. Upon the death or permanent disability of you or a Principal Owner, the executor, administrator, conservator or other personal representative of the deceased or disabled person must Transfer the deceased or disabled person's Interest within a reasonable time, not to exceed forty-five (45) days from the date of death or permanent disability, to a person we have approved. Such Transfers, including without limitation transfers by a will or inheritance, will be subject to all the terms and conditions for assignments and Transfers contained in this Agreement. Failure to so dispose of an Interest within the forty-five (45) day period of time will constitute grounds for termination of this Agreement. 14.8 Effect of Consent to Transfer. Our consent to a proposed Transfer pursuant to this Section 14 will not constitute a waiver of any claims we may have against you or any Principal Owner, nor will it be deemed a waiver of our right to demand exact compliance with any of the terms or conditions of this Agreement by the Proposed New Owner. 14.9 Consent Not Unreasonably Delayed. If all the conditions are met to transfer the FA or any interest therein, we will not unreasonably delay granting our consent to the transfer. 15. TERMINATION OF THE FRANCHISE. We have the right to terminate this Agreement effective upon delivery of notice of termination to you, if: (1) you do not develop or open the Franchise as provided in this Agreement; (2) you abandon, surrender, transfer control of, lose the right to occupy the Premises of, or do not actively operate, the Franchise, or your lease for or purchase of the location of the Franchise is terminated for any reason; (3) you or your Principal Owners assign or Transfer this Agreement, any Interest, the Franchise, or assets of the Franchise without complying with the provisions of Section 14; (4) you are adjudged a bankrupt, become insolvent or make a general assignment for the benefit of creditors; (5) you use, sell, distribute or give away any unauthorized services or products, and do not cease the use, sale, or distribution of unauthorized services or products within ten (10) days after written notice is given to you; (6) you fail to maintain a valid license to practice and/or fail to maintain compliance with state and federal regulations and do not cure the failure within twenty (20) days after written notice is given to you; (7) you or any of your Principal Owners are convicted of or plead no contest to a felony or are convicted or plead no contest to any crime or offense that is likely to adversely affect the reputation of the Company, the Franchise, and/or the goodwill associated with the Marks; (8) you are involved in any action that is likely to adversely affect the reputation of the Company, the Franchise, and/or the goodwill associated with the Marks; (9) you or any of your employees violate any health or safety law, ordinance or regulation, or operate the Franchise in a manner that presents a health or safety hazard to your customers or the public; (10) you do not pay when due any monies owed to us or our affiliates, and do not make such payment within ten (10) days after written notice is given to you; (11) you fail to meet the minimum local advertising expenditures required in Section 11.2, and to provide the required proof of your expenditures; (12) you or any of your Principal Owners fail to comply with any other provision of this Agreement or any mandatory specification, standard, or operating procedure or you fail to make changes required to comply with applicable state or federal laws within twenty (20) days after written notice of such failure to comply is given to you; (13) you fail to procure or maintain any and all insurance coverage that we require, or otherwise fail to name us as an additional insured on any such insurance policies and failure to do so within ten (10) days after written notice is given to you; or (13) you or any of your Principal Owners fail on three (3) or more separate occasions within any twelve (12) consecutive month period to submit when due any financial statements, reports or other data, information, or supporting records; pay when due any amounts due under this Agreement; or otherwise fail to comply with this Agreement, whether or not such failures to comply are corrected after notice is given to you or your Principal Owners. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 39 In addition, if, in the opinion of our legal counsel, any provision of this Agreement is contrary to law, then you and we agree to negotiate in good faith an amendment that would make this Agreement conform to the applicable legal requirements. If you and we are unable to reach such an agreement, or if fundamental changes to this Agreement are required to make it conform to the legal requirements, then we reserve the right to terminate this Agreement upon notice to you, in which case all of the post-termination obligations set forth in Section 16 shall apply. In the event that we terminate this Agreement under this Section or other applicable provisions of this Agreement, we shall be entitled, in those states in which such termination fees are enforceable, to receive from you a termination fee in the amount equal to one-half (1/2) of our then- current initial franchise fee for new The Joint Corp. Location franchises (the \\\"Termination Fee\\\"). The Termination Fee shall be payable by you in addition to any damages payable to us, including loss of future revenues, resulting from your improper or wrongful breach or other termination of this Agreement. We shall be entitled to recover all costs, including attorneys' fees, incurred in connection with the termination and collection of the Termination Fee. If you continue to operate the Franchise after termination of this Agreement, in addition to any other right or remedy we may have (including the Termination Fee), you agree to pay to us the amount of One Thousand and No/100 Dollars ($1,000.00) per day that you operate the Franchise in violation of this Agreement, plus all costs and attorneys' fees incurred as a result of the violation. This amount is set at $1,000 per day because it is a reasonable estimation of the damages that would occur from such a breach, and it will almost certainly be impossible to calculate precisely the actual damages from such a breach. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 40\"}}, {\"id\": \"value:forty-five (45) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45) days\"}}, {\"id\": \"value:ten (10) days_14.7_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:twenty (20) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) days\"}}, {\"id\": \"value:twelve (12) consecutive month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) consecutive month\"}}, {\"id\": \"term:Termination Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Termination Fee\", \"text\": \"In the event that we terminate this Agreement under this Section or other applicable provisions of this Agreement, we shall be entitled, in those states in which such termination fees are enforceable, to receive from you a termination fee in the amount equal to one-half (1/2) of our then- current initial franchise fee for new The Joint Corp. Location franchises (the \\\"Termination Fee\\\").\", \"definition_clause\": \"14.7\"}}, {\"id\": \"value:$1,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"One Thousand and No/100 Dollars ($1,000.00)\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RIGHTS AND OBLIGATIONS OF COMPANY AND FRANCHISE OWNER UPON TERMINATION OR EXPIRATION OF THE FRANCHISE\", \"level\": 1, \"text\": \"16. RIGHTS AND OBLIGATIONS OF COMPANY AND FRANCHISE OWNER UPON TERMINATION OR EXPIRATION OF THE FRANCHISE. 16.1 Payment of Amounts Owed to Company. You agree to pay us within five (5) days after the effective date of termination or expiration of the Franchise, or any later date that the amounts due to us are determined, all amounts owed to us or our affiliates which are then unpaid. 16.2 Marks. You agree that after the termination or expiration of the Franchise you will: (a) not directly or indirectly at any time identify any business with which you are associated as a current or former The Joint Corp. franchise or franchisee; (b) not use any Mark or any colorable imitation of any Mark in any manner or for any purpose, or use for any purpose any trademark or other commercial symbol that suggests or indicates an association with us; (c) return to us or destroy (whichever we specify) all customer lists, forms and materials containing any Mark or otherwise relating to a The Joint Corp. franchise; (d) remove all Marks affixed to uniforms or, at our direction, cease to use those uniforms; and (e) take any action that may be required to cancel all fictitious or assumed name or equivalent registrations relating to your use of any Mark. 16.3 De-Identification. If you retain possession of the Premises, you agree to completely remove or modify, at your sole expense, any part of the interior and exterior decor that we deem necessary to disassociate the Premises with the image of a The Joint Corp. franchise, including any signage bearing the Marks. If you do not take the actions we request within thirty (30) days after notice from us, we have the right to enter the Premises and make the required changes at your expense, and you agree to reimburse us for those expenses on demand. 16.4 Confidential Information. You agree that on termination or expiration of the Franchise you will immediately cease to use any of the Confidential Information, and agree not to use it in any business or for any other purpose. You further agree to immediately return to us all copies of the Operations Manual and any written Confidential Information or other confidential materials that we have loaned or provided to you. Upon THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 41\"}}, {\"id\": \"value:five (5) days_16_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"value:thirty (30) days_16_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"16.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Joint Software\", \"level\": 2, \"text\": \"16.5 Joint Software. You agree that on termination or expiration of the Franchise, you will immediately cease to use the Joint Software and will uninstall it from all computer systems owned by the Franchise. 16.6 Company's Option to Purchase the Franchise. Upon the termination or expiration of the Franchise, we will have the option, but not the obligation, exercisable for thirty (30) days upon written notice to you, to purchase at fair market value all of the assets of the Franchise, including all approved equipment, fixtures, furniture and signs and all supplies, materials, and other items imprinted with any Mark, and to take an assignment of the lease for the Premises and any other lease or concession agreement necessary for the operation of the Franchise. If you and we cannot agree on the fair market value of the assets of the Franchise within a reasonable time, such value shall be determined by an average of the appraisals of two (2) independent appraisers, one of whom will be selected by you and one of whom will be selected by us. If the appraisals differ by more than ten percent (10%), then you and we will mutually agree on a value, or if you and we cannot agree, our appraisers will select a third appraiser whose determination of market value will be final. We shall not assume any liabilities, debts or obligations of the Franchise in connection with any such transfer, and you will indemnify us from any and all claims made against us arising out of any such transfer of the assets of the Franchise. All parties will comply with all applicable laws in connection with any such transfer, and you agree to cooperate with us in complying with all such requirements. The closing shall occur within thirty (30) days after we exercise our option to purchase the assets or such later date as may be necessary to comply with applicable bulk sales or similar laws. At the closing, you and we both agree to execute and deliver all documents necessary to vest title in the purchased assets and/or real property in us free and clear of all liens and encumbrances, except those assumed by us and/or to effectuate the lease of the Franchise Premises. You also agree to provide us with all information necessary to close the transaction. We reserve the right to assign our option to purchase the Franchise or designate a substitute purchaser for the Franchise. By signing this Agreement, you irrevocably appoint us as your lawful attorney-in-fact with respect to the matters contemplated by this Paragraph 16.6, with full power and authority to execute and deliver in your name all documents required to be provided by you under this Paragraph in the event you do not provide them in a timely and proper manner. You also agree to ratify and confirm all of our acts as your lawful attorney-in-fact, and indemnify and hold us harmless from all claims, liabilities, losses or damages suffered by us in so doing. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 42 43 If any lawful requirement or court order of any jurisdiction (1) requires a greater advance notice of the termination or non-renewal of this Agreement than is required under this Agreement, or the taking of some other action which is not required by this Agreement, or (2) makes any provision of this Agreement or any specification, standard, or operating procedure we prescribed invalid or unenforceable, then the advance notice and/or other action required or revision of the specification, standard, or operating procedure will be substituted for the comparable provisions of this Agreement in order to make the modified provisions enforceable to the greatest extent possible. You agree to be bound by the modification to the greatest extent lawfully permitted. 17.2 Unilateral Waiver of Obligations. Either you or we may, by written notice, unilaterally waive or reduce any obligation or restriction of the other under this Agreement. The waiver or reduction may be revoked at any time for any reason on ten (10) days' written notice. 17.3 Written Consents from Company. Whenever this Agreement requires our advance approval or consent, you agree to make a timely written request for it. Our approval or consent will not be valid unless it is in writing. 17.4 Lien. To secure your performance under this Agreement and indebtedness for all sums due us or our affiliates, we shall have a lien upon, and you hereby grant us a security interest in, the following collateral and any and all additions, accessions, and substitutions to or for it and the proceeds from all of the same: (a) all inventory now owned or after-acquired by you and the Franchise, including but not limited to all inventory and supplies transferred to or acquired by you in connection with this Agreement; (b) all accounts of you and/or the Franchise now existing or subsequently arising, together with all interest in you and/or the Franchise, now existing or subsequently arising, together with all chattel paper, documents, and instruments relating to such accounts; (c) all contract rights of you and/or the Franchise, now existing or subsequently arising; and (d) all general intangibles of you and/or the Franchise, now owned or existing, or after-acquired or subsequently arising. You agree to execute such financing statements, instruments, and other documents, in a form satisfactory to us, that we deem necessary so that we may establish and maintain a valid security interest in and to these assets. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 44\"}}, {\"id\": \"value:thirty (30) days_16.5_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:ten percent (10%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ten percent (10%)\"}}, {\"id\": \"value:thirty (30) days_16.5_2\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:ten (10) days_16.5_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days'\"}}, {\"id\": \"17.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Guarantees\", \"level\": 2, \"text\": \"17.5 No Guarantees. If in connection with this Agreement we provide to you any waiver, approval, consent, or suggestion, or if we neglect or delay our response or deny any request for any of those, then we will not be deemed to have made any warranties or guarantees upon which you may rely, and will not assume any liability or obligation to you. 17.6 No Waiver. If at any time we do not exercise a right or power available to us under this Agreement or do not insist on your strict compliance with the terms of the Agreement, or if there develops a custom or practice that is at variance with the terms of this Agreement, then we will not be deemed to have waived our right to demand exact compliance with any of the terms of this Agreement at a later time. Similarly, our waiver of any particular breach or series of breaches under this Agreement, or of any similar term in any other agreement between us and any other The Joint Corp. franchisee will not affect our rights with respect to any later breach. It will also not be deemed to be a waiver of any breach of this Agreement for us to accept payments that are due to us under this Agreement. 17.7 Cumulative Remedies. The rights and remedies specifically granted to either you or us by this Agreement will not be deemed to prohibit either you or us from exercising any other right or remedy provided under this Agreement, or permitted by law or equity. 17.8 Specific Performance; Injunctive Relief. Provided we give you the appropriate notice, we will be entitled, without being required to post a bond, to the entry of temporary and permanent injunctions and orders of specific performance to (1) enforce the provisions of this Agreement relating to your use of the Marks and non-disclosure and non-competition obligations under this Agreement; (2) prohibit any act or omission by you or your employees that constitutes a violation of any applicable law, ordinance, or regulation; constitutes a danger to the public; or may impair the goodwill associated with the Marks or The Joint Corp. franchises; or (3) prevent any other irreparable harm to our interests. If we obtain an injunction or order of specific performance, then you shall pay us an amount equal to the total of our costs of obtaining it, including without limitation reasonable attorneys' and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, and any damages we incur as a result of the breach of any such provision. You further agree to waive any claims for damage in the event there is a later determination that an injunction or specific performance order was issued improperly. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 45\"}}, {\"id\": \"17.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Arbitration\", \"level\": 2, \"text\": \"17.9 Arbitration. Except insofar as we elect to enforce this Agreement or to seek temporary or permanent injunctive relief as provided above, all controversies, disputes or claims arising between us, our affiliates, and our and their respective owners, officers, directors, agents, and employees (in their representative capacity) and you (and your Principal Owners and guarantors) arising out of or related to: (1) this Agreement, any provision thereof, or any related agreement (except for any lease or sublease with us or any of our affiliates); (2) the relationship of the parties hereto; (3) the validity of this Agreement or any related agreement, or any provision thereof; or (4) any specification, standard or operating procedure relating to the establishment or operation of the Franchise, shall be submitted for arbitration to be administered by the office of the American Arbitration Association. Such arbitration proceedings shall be conducted in Maricopa County, Arizona, and, except as otherwise provided in this Agreement, shall be conducted in accordance with then current commercial arbitration rules of the American Arbitration Association. The arbitrator shall have the right to award or include in his award any relief that he or she deems proper in the circumstances, including without limitation, money damages (with interest on unpaid amounts from date due), specific performance, injunctive relief, attorneys' fees, and costs. The award and decision of the arbitrator shall be conclusive and binding on all parties to this agreement, and judgment on the award may be entered in any court of competent jurisdiction, and each such party waives any right to contest the validity or enforceability of such award. The provisions of this Paragraph are intended to benefit and limit third-party non-signatories, and will continue in full force and effect subsequent to, and notwithstanding expiration or termination of, this Agreement. You and we agree that any such arbitration shall be conducted on an individual, not a class-wide basis, and shall not be consolidated with any other arbitration proceeding. 17.10 Waiver of Punitive Damages and Jury Trial; Limitations of Actions. Except with respect to your obligations to indemnify us and claims that we may bring under Sections 7, 9, 15, or 16 of this Agreement, and except for claims arising from your non-payment or underpayment of any amounts owed to us or our affiliates, (1) any and all claims arising out of or related to this Agreement or the relationship between you and us shall be barred, by express agreement of the parties, unless an action or proceeding is commenced within two (2) years from the date the cause of action accrues; and (2) you and we hereby waive to the fullest extent permitted by law, any right to or claim for any punitive or exemplary damages against the other, and agree that, except to the extent provided to the contrary in this Agreement, in the event of a dispute between you and us, each party will be limited to the recovery of any actual damages sustained by it. You and we irrevocably waive trial by jury in any action, proceeding or counterclaim, whether at law or in equity, brought by either you or us. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 46 47\"}}, {\"id\": \"value:two (2) years_17.9_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"17.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Joint and Several Liability\", \"level\": 2, \"text\": \"17.15 Joint and Several Liability. If two (2) or more persons are the Franchise Owner under this Agreement, their obligation and liability to us shall be joint and several. 17.16 Multiple Originals. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other parties hereto. This Agreement, once executed by a party, may be delivered to the other parties hereto by facsimile transmission or other electronic means of a copy of this Agreement bearing the signature of the party so delivering this Agreement. 17.17 Timing Is Important. Time is of the essence of this Agreement. \\\"Time is of the essence\\\" is a legal term that emphasizes the strictness of time limits. In this case, it means it will be a material breach of this Agreement to fail to perform any obligation within the time required or permitted by this Agreement. 17.18 Independent Provisions. The provisions of this Agreement are deemed to be severable. In other words, the parties agree that each provision of this Agreement will be construed as independent of any other provision of this Agreement. 18. NOTICES AND PAYMENTS. All written notices, reports and payments permitted or required under this Agreement or by the Operations Manual will be deemed delivered: (a) at the time delivered by hand; (b) one (1) business day after transmission by telecopy, facsimile or other electronic system; (c) one (1) business day after being placed in the hands of a reputable commercial courier service for next business day delivery; or (d) three (3) business days after placed in the U.S. mail by Registered or Certified Mail, Return Receipt Requested, postage prepaid; and addressed to the party to be notified or paid at its most current principal business address of which the notifying party has been advised, or to any other place designated by either party. Any required notice, payment or report which we do not actually receive during regular business hours on the date due (or postmarked by postal authorities at least two (2) days before it is due) will be deemed delinquent. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 48\"}}, {\"id\": \"value:one (1) business day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) business day\"}}, {\"id\": \"value:three (3) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) business days\"}}, {\"id\": \"value:two (2) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) days\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEPENDENT PROFESSIONAL JUDGMENT OF YOU AND YOUR GENERAL MANAGER\", \"level\": 1, \"text\": \"19. INDEPENDENT PROFESSIONAL JUDGMENT OF YOU AND YOUR GENERAL MANAGER. You and we acknowledge and agree that the specifications, standards and operating procedures related to the services offered by the Franchise are not intended to limit or replace your or your General Manager's (if any) professional judgment in supervising and performing the services offered by your Franchise. The specifications, standards, and operating procedures represent only the minimum standards, and you and your General Manager (if any) are solely responsible for ensuring that the Franchise performs services in accordance with all applicable requirements and standards of care. Nothing in this Agreement shall obligate you or your General Manager (if any) to perform any act that is contrary to your or your General Manager's (if any) professional judgment; provided, however, that you must notify us immediately upon your determination that any specification, standard or operating procedure is contrary to your or your General Manager's (if any) professional judgment. 20. ENTIRE AGREEMENT. This Agreement, together with the introduction and exhibits to it, constitutes the entire agreement between us, and there are no other oral or written understandings or agreements between us concerning the subject matter of this Agreement. This Agreement may be modified only by written agreement signed by both you and us, except that we may modify the Operations Manual at any time as provided herein. However, nothing in this Agreement or any addendum shall have the effect of disclaiming any of the representations made in the Franchise Disclosure Document or any of its exhibits. IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the Agreement Date. \\\"COMPANY\\\" THE JOINT CORP., a Delaware corporation \\\"FRANCHISE OWNER\\\" ___________________, a_________________ By: By: Name: Chad Everts Name: Title: V.P. Franchise Development Title: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 FRANCHISE AGREEMENT 49\"}}, {\"id\": \"EXHIBIT 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT 1 TO THE JOINT CORP. FRANCHISE AGREEMENT FRANCHISE AGREEMENT EXPIRATION DATE PROJECTED FRANCHISING OPENING SCHEDULE 1-1 Expiration Date. Unless sooner terminated in accordance with the provisions of this Agreement, this Agreement will expire on _______________________________________. 1-2 Franchising Opening Schedule. In signing the foregoing Agreement to which this Exhibit 1 is attached, you acknowledge that: You have purchased the Franchise to which the Agreement corresponds as a The Joint Corp. Location Franchise. You will establish this Franchise as a Start-up Location. 2. You must open the Franchise mentioned above within a certain time period specified by us, the length of which depends upon the number of Franchises you have purchased and the number of these Franchises that you have developed and opened for business before developing and opening the Franchise to which the Agreement corresponds. 3. You must open the Franchise to which this Agreement corresponds within the following time period (the \\\"Opening Deadline\\\"), subject to the requirements of Paragraphs 3.3 and 3.6, and any other applicable provision of the Agreement: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 1 - Expiration Date and Opening Schedule FRANCHISE AGREEMENT 1\"}}, {\"id\": \"term:Opening Deadline\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Opening Deadline\", \"text\": \"You must open the Franchise to which this Agreement corresponds within the following time period (the \\\"Opening Deadline\\\")\", \"definition_clause\": \"EXHIBIT 1\"}}, {\"id\": \"EXHIBIT 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT OWNER'S GUARANTY AND ASSUMPTION OF OBLIGATIONS In consideration of, and as an inducement to, the execution of the Franchise Agreement, dated as of this _____ day of ____________________, 20__ (the \\\"Agreement\\\"), by and between The Joint Corp. (\\\"us\\\") and (the \\\"Franchise Owner\\\"), each of the undersigned owners of the Franchise Owner and their respective spouses (\\\"you,\\\" for purposes of this Guaranty only), hereby personally and unconditionally agree to perform and keep during the terms of the Agreement, each and every covenant, obligation, payment, agreement, and undertaking on the part of Franchise Owner contained and set forth in the Agreement. Each of you agree that all provisions of the Agreement relating to the obligations of Franchise Owners, including, without limitation, the covenants of confidentiality and non-competition and other covenants set forth in the Agreement, shall be binding on you. Each of you waives (1) protest and notice of default, demand for payment or nonperformance of any obligations guaranteed by this Guaranty; (2) any right you may have to require that an action be brought against Franchise Owner or any other person as a condition of your liability; (3) all right to payment or reimbursement from, or subrogation against, the Franchise Owner which you may have arising out of your guaranty of the Franchise Owner's obligations; and (4) any and all other notices and legal or equitable defenses to which you may be entitled in your capacity as guarantor. Each of you consents and agrees that (1) your direct and immediate liability under this Guaranty shall be joint and several; (2) you will make any payment or render any performance required under the Agreement on demand if Franchise Owner fails or refuses to do so when required; (3) your liability will not be contingent or conditioned on our pursuit of any remedies against Franchise Owner or any other person; (4) your liability will not be diminished, relieved or otherwise affected by any extension of time, credit or other indulgence which we may from time to time grant to Franchise Owner or to any other person, including without limitation, the acceptance of any partial payment or performance, or the compromise or release of any claims; and (5) this Guaranty will continue and be irrevocable during the term of the Agreement and afterward for so long as the Franchise Owner has any obligations under the Agreement. If we are required to enforce this Guaranty in a judicial or arbitration proceeding, and prevail in such proceeding, we will be entitled to reimbursement of our costs and expenses, including, but not limited to, reasonable accountants', attorneys', attorneys' assistants', arbitrators' and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, whether incurred prior to, in preparation for or in contemplation of the filing of any such proceeding. If we are required to engage legal counsel in connection with any failure by you to comply with this Guaranty, you agree to reimburse us for any of the above-listed costs and expenses incurred by us. [Remainder of Page Left Intentionally Blank - Signature Page Follows] THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 2 - Owner's Guaranty and Assumption of Obligations FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT 2 TO THE JOINT CORP. FRANCHISE AGREEMENT OWNER'S GUARANTY AND ASSUMPTION OF OBLIGATIONS In consideration of, and as an inducement to, the execution of the Franchise Agreement, dated as of this _____ day of ____________________, 20__ (the \\\"Agreement\\\"), by and between The Joint Corp. (\\\"us\\\") and (the \\\"Franchise Owner\\\"), each of the undersigned owners of the Franchise Owner and their respective spouses (\\\"you,\\\" for purposes of this Guaranty only), hereby personally and unconditionally agree to perform and keep during the terms of the Agreement, each and every covenant, obligation, payment, agreement, and undertaking on the part of Franchise Owner contained and set forth in the Agreement. Each of you agree that all provisions of the Agreement relating to the obligations of Franchise Owners, including, without limitation, the covenants of confidentiality and non-competition and other covenants set forth in the Agreement, shall be binding on you. Each of you waives (1) protest and notice of default, demand for payment or nonperformance of any obligations guaranteed by this Guaranty; (2) any right you may have to require that an action be brought against Franchise Owner or any other person as a condition of your liability; (3) all right to payment or reimbursement from, or subrogation against, the Franchise Owner which you may have arising out of your guaranty of the Franchise Owner's obligations; and (4) any and all other notices and legal or equitable defenses to which you may be entitled in your capacity as guarantor. Each of you consents and agrees that (1) your direct and immediate liability under this Guaranty shall be joint and several; (2) you will make any payment or render any performance required under the Agreement on demand if Franchise Owner fails or refuses to do so when required; (3) your liability will not be contingent or conditioned on our pursuit of any remedies against Franchise Owner or any other person; (4) your liability will not be diminished, relieved or otherwise affected by any extension of time, credit or other indulgence which we may from time to time grant to Franchise Owner or to any other person, including without limitation, the acceptance of any partial payment or performance, or the compromise or release of any claims; and (5) this Guaranty will continue and be irrevocable during the term of the Agreement and afterward for so long as the Franchise Owner has any obligations under the Agreement. If we are required to enforce this Guaranty in a judicial or arbitration proceeding, and prevail in such proceeding, we will be entitled to reimbursement of our costs and expenses, including, but not limited to, reasonable accountants', attorneys', attorneys' assistants', arbitrators' and expert witness fees, costs of investigation and proof of facts, court costs, other litigation expenses and travel and living expenses, whether incurred prior to, in preparation for or in contemplation of the filing of any such proceeding. If we are required to engage legal counsel in connection with any failure by you to comply with this Guaranty, you agree to reimburse us for any of the above-listed costs and expenses incurred by us. [Remainder of Page Left Intentionally Blank - Signature Page Follows] THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 2 - Owner's Guaranty and Assumption of Obligations FRANCHISE AGREEMENT 1 This Guaranty is now executed as of the Agreement Date. OWNER: OWNER'S SPOUSE: Name: Name: OWNER: OWNER'S SPOUSE: Name: Name: OWNER: OWNER'S SPOUSE: Name: Name: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 2 - Owner's Guaranty and Assumption of Obligations FRANCHISE AGREEMENT 2\"}}, {\"id\": \"EXHIBIT 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT 3 TO THE JOINT CORP. FRANCHISE AGREEMENT ADDENDUM TO LEASE AGREEMENT This Addendum to Lease Agreement (this \\\"Addendum\\\"), is entered into effective on this ______ day of _______________, 20___, (the \\\"Effective Date\\\") by and between __________________, a ________________________ (the \\\"Lessor\\\"), and __________________, a ________________________ (the \\\"Lessee\\\") (each a \\\"Party\\\" and collectively, the \\\"Parties\\\"). RECITALS WHEREAS, the Parties hereto have entered into a certain Lease Agreement, dated on the ______ day of _______________, 20___ (the \\\"Agreement\\\"), and pertaining to the premises located at _____________________________ (the \\\"Premises\\\"); WHEREAS, Lessor acknowledges that Lessee intends to operate The Joint franchise from the Premises pursuant to a Franchise Agreement (the \\\"Franchise Agreement\\\") with The Joint Corp. (\\\"Franchisor\\\") under the name The Joint or other name designated by Franchisor (\\\"Franchised Business\\\"); and WHEREAS, the Parties now desire to amend the Lease Agreement in accordance with the terms and conditions contained herein. NOW, THEREFORE, in consideration of the mutual covenants and agreements herein set forth and each act done and to be done pursuant hereto, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, do hereby represent, warrant, covenant and agree as follows: 1. Remodeling and Decor. The above recitals are hereby incorporated by reference. Lessor agrees that Lessee shall have the right to remodel, equip, paint and decorate the interior of the Premises and to display the proprietary marks and signs on the interior and exterior of the Premises as Lessee is reasonably required to do pursuant to the Franchise Agreement and any successor Franchise Agreement under which Lessee may operate a Franchised Business on the Premises. 2. Assignment. Lessee shall have the right to assign all of its right, title and interest in and to the Lease Agreement to Franchisor or its parent, subsidiary, or affiliate, (including another franchisee) at any time during the term of the Lease, including any extensions or renewals thereof, without first obtaining Lessor's consent, pursuant to the terms of the Collateral Assignment of Lease attached hereto as Exhibit A. However, no assignment shall be effective until such time as Franchisor or its designated affiliate gives Lessor written notice of its acceptance of the assignment, and nothing contained herein or in any other document shall constitute Franchisor or its designated subsidiary or affiliate a party to the Lease Agreement, or guarantor thereof, and shall not create any liability or obligation of Franchisor or its parent unless and until the Lease Agreement is assigned to, and accepted in writing by, Franchisor or its parent, subsidiary or affiliate. In the event of any assignment, Lessee shall remain liable under the terms of the Lease. Franchisor shall have the right to reassign the Lease to another franchisee without the Landlord's consent in accordance with Section 4(a). THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 1\"}}, {\"id\": \"party:Lessor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Lessor\", \"role\": \"Lessor\", \"address\": null}}, {\"id\": \"party:Lessee\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Lessee\", \"role\": \"Lessee\", \"address\": null}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Default and Notice\", \"level\": 1, \"text\": \"3. Default and Notice. (a) In the event there is a default or violation by Lessee under the terms of the Lease Agreement, Lessor shall give Lessee and Franchisor written notice of the default or violation within ten (10) days after Lessor receives knowledge of its occurrence. If Lessor gives Lessee a default notice, Lessor shall contemporaneously give Franchisor a copy of the notice. Franchisor shall have the right, but not the obligation, to cure the default. Franchisor will notify Lessor whether it intends to cure the default and take an automatic assignment of Lessee's interest as provided in Paragraph 4(a). Franchisor will have an additional fifteen (15) days from the expiration of Lessee's cure period in which it may exercise the option to cure, but is not obligated to cure the default or violation. (b) All notices to Franchisor shall be sent by registered or certified mail, postage prepaid, to the following address: The Joint Corp. 16767 N. Perimeter Dr., Suite 240 Scottsdale, AZ 85260 Attention: Chad Everts E-mail: ceverts@thejoint.com Franchisor may change its address for receiving notices by giving Lessor written notice of the new address. Lessor agrees that it will notify both Lessee and Franchisor of any change in Lessor's mailing address to which notices should be sent. (c) Following Franchisor's approval of the Lease Agreement, Lessee agrees not to terminate, or in any way alter or amend the same during the Initial Term of the Franchise Agreement or any Interim Period thereof without Franchisor's prior written consent, and any attempted termination, alteration or amendment shall be null and void and have no effect as to Franchisor's interests thereunder; and a clause to the effect shall be included in the Lease. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 2\"}}, {\"id\": \"value:ten (10) days_3_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:fifteen (15) days_3_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination or Expiration\", \"level\": 1, \"text\": \"4. Termination or Expiration. (a) Upon Lessee's default and failure to cure the default within the applicable cure period, if any, under either the Lease Agreement or the Franchise Agreement, Franchisor will, at its option, have the right, but not the obligation, to take an automatic assignment of Lessee's interest in the Lease Agreement and at any time thereafter to re-assign the Lease Agreement to a new franchisee without Lessor's consent and to be fully released from any and all liability to Lessor upon the reassignment, provided the franchisee agrees to assume Lessee's obligations and the Lease Agreement. Upon notice from Franchisor to Lessor requesting an automatic assignment, Lessor will, at the cost of Franchisor, take appropriate actions to secure the leased premises including but not limited changing the locks and granting Franchisor sole rights to the Premises. (b) Upon the expiration or termination of either the Lease Agreement or the Franchise Agreement (attached), Lessor will cooperate with and assist Franchisor in securing possession of the Premises and if Franchisor does not elect to take an assignment of the Lessee's interest, Lessor will allow Franchisor to enter the Premises, without being guilty of trespass and without incurring any liability to Lessor, to remove all signs, awnings, and all other items identifying the Premises as a Franchised Business and to make other modifications (such as repainting) as are reasonably necessary to protect The Joint marks and system, and to distinguish the Premises from a Franchised Business. In the event Franchisor exercises its option to purchase assets of Lessee or has rights to those through the terms and conditions any agreement between Lessee and Franchisor, Lessor shall permit Franchisor to remove all the assets being purchased by Franchisor. 5. Consideration; No Liability. (a) Lessor hereby acknowledges that the provisions of this Addendum are required pursuant to the Franchise Agreement under which Lessee plans to operate its business and Lessee would not lease the Premises without this Addendum. Lessor also hereby consents to the Collateral Assignment of Lease from Lessee to Franchisor as evidenced by Exhibit A. (b) Lessor further acknowledges that Lessee is not an agent or employee of Franchisor and Lessee has no authority or power to act for, or to create any liability on behalf of, or to in any way bind Franchisor or any affiliate of Franchisor, and that Lessor has entered into this Addendum with full understanding that it creates no duties, obligations or liabilities of or against Franchisor or any affiliate of Franchisor. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 3\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sales Reports\", \"level\": 1, \"text\": \"6. Sales Reports. If requested by Franchisor, Lessor will provide Franchisor with whatever information Lessor has regarding Lessee's sales from its Franchised Business. 7. Amendments. No amendment or variation of the terms of the Lease or this Addendum shall be valid unless made in writing and signed by the Parties hereto. 8. Reaffirmation of Lease. Except as amended or modified herein, all of the terms, conditions and covenants of the Lease Agreement shall remain in full force and effect and are incorporated herein by reference and made a part of this Addendum as though copied herein in full. 9. Beneficiary. Lessor and Lessee expressly agree that Franchisor is a third party beneficiary of this Addendum. [Remainder of Page Left Intentionally Blank - Signature Page Follows] THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 4 IN WITNESS WHEREOF, the Parties have duly executed this Addendum as of the Effective Date. LESSOR: LESSEE: _____________________________, _____________________________, a _____________________________ a _____________________________ By: By: Name: Name: Its: Its: THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 5\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COLLATERAL ASSIGNMENT OF LEASE This COLLATERAL ASSIGNMENT OF LEASE (this \\\"Assignment\\\") is entered into effective as of the ___ day of _____, 20___ (the \\\"Effective Date\\\"), the undersigned, __________________________________, (\\\"Assignor\\\") hereby assigns, transfers and sets over unto The Joint Corp., a Delaware Corporation (\\\"Assignee\\\") all of Assignor's right, title and interest as tenant, in, to and under that certain lease, a copy of w h i c h i s a t t a c h e d h e r e t o a s Exhib i t 1 ( t h e \\\" L e a s e A g r e e m e n t \\\" ) w i t h r e s p e c t t o t h e p r e m i s e s l o c a t e d a t _______________________________________________________________ (the \\\"Premises\\\"). This Assignment is for collateral purposes only and except as specified herein, Assignee shall have no liability or obligation of any kind whatsoever arising from or in connection with this Assignment unless Assignee shall take possession of the Premises demised by the Lease Agreement pursuant to the terms hereof and shall assume the obligations of Assignor thereunder. Assignor represents and warrants to Assignee that it has full power and authority to so assign the Lease Agreement and its interest therein and that Assignor has not previously, and is not obligated to, assign or transfer any of its interest in the Lease Agreement nor the Premises demised thereby. Upon a default by Assignor under the Lease Agreement or under that certain franchise agreement for The Joint between Assignee and Assignor (\\\"Franchise Agreement\\\"), or in the event of a default by Assignor under any document or instrument securing the Franchise Agreement, Assignee shall have the right and is hereby empowered to take possession of the Premises, expel Assignor therefrom, and, in the event, Assignor shall have no further right, title or interest in the Lease Agreement. Assignor agrees it will not suffer or permit any surrender, termination, amendment or modification of the Lease Agreement without the prior written consent of Assignee. Through the Initial Term of the Franchise Agreement and any Renewal Period thereof (as defined in the Franchise Agreement), Assignor agrees that it shall elect and exercise all options to extend the term of or renew the Lease Agreement not less than thirty (30) days before the last day that said option must be exercised, unless Assignee otherwise agrees in writing. Upon failure of Assignee to otherwise agree in writing, and upon failure of Assignor to so elect to extend or renew the Lease Agreement as stated herein, Assignor hereby irrevocably appoints Assignee as its true and lawful attorney-in-fact, which appointment is coupled with an interest, to exercise the extension or renewal options in the name, place and stead of Assignor for the sole purpose of effecting the extension or renewal. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT\", \"level\": 1, \"text\": \"EXHIBIT A COLLATERAL ASSIGNMENT OF LEASE This COLLATERAL ASSIGNMENT OF LEASE (this \\\"Assignment\\\") is entered into effective as of the ___ day of _____, 20___ (the \\\"Effective Date\\\"), the undersigned, __________________________________, (\\\"Assignor\\\") hereby assigns, transfers and sets over unto The Joint Corp., a Delaware Corporation (\\\"Assignee\\\") all of Assignor's right, title and interest as tenant, in, to and under that certain lease, a copy of w h i c h i s a t t a c h e d h e r e t o a s Exhib i t 1 ( t h e \\\" L e a s e A g r e e m e n t \\\" ) w i t h r e s p e c t t o t h e p r e m i s e s l o c a t e d a t _______________________________________________________________ (the \\\"Premises\\\"). This Assignment is for collateral purposes only and except as specified herein, Assignee shall have no liability or obligation of any kind whatsoever arising from or in connection with this Assignment unless Assignee shall take possession of the Premises demised by the Lease Agreement pursuant to the terms hereof and shall assume the obligations of Assignor thereunder. Assignor represents and warrants to Assignee that it has full power and authority to so assign the Lease Agreement and its interest therein and that Assignor has not previously, and is not obligated to, assign or transfer any of its interest in the Lease Agreement nor the Premises demised thereby. Upon a default by Assignor under the Lease Agreement or under that certain franchise agreement for The Joint between Assignee and Assignor (\\\"Franchise Agreement\\\"), or in the event of a default by Assignor under any document or instrument securing the Franchise Agreement, Assignee shall have the right and is hereby empowered to take possession of the Premises, expel Assignor therefrom, and, in the event, Assignor shall have no further right, title or interest in the Lease Agreement. Assignor agrees it will not suffer or permit any surrender, termination, amendment or modification of the Lease Agreement without the prior written consent of Assignee. Through the Initial Term of the Franchise Agreement and any Renewal Period thereof (as defined in the Franchise Agreement), Assignor agrees that it shall elect and exercise all options to extend the term of or renew the Lease Agreement not less than thirty (30) days before the last day that said option must be exercised, unless Assignee otherwise agrees in writing. Upon failure of Assignee to otherwise agree in writing, and upon failure of Assignor to so elect to extend or renew the Lease Agreement as stated herein, Assignor hereby irrevocably appoints Assignee as its true and lawful attorney-in-fact, which appointment is coupled with an interest, to exercise the extension or renewal options in the name, place and stead of Assignor for the sole purpose of effecting the extension or renewal. THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 6 IN WITNESS WHEREOF, Assignor and Assignee have duly executed this Collateral Assignment of Lease as of the Effective Date. ASSIGNOR: ASSIGNEE: , THE JOINT CORP., a__________________________ a Delaware corporation By: By: Name: Name: Chad Everts Its: Its: VP Franchise Development THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 3 - Addendum to Lease Agreement FRANCHISE AGREEMENT 7\"}}, {\"id\": \"value:thirty (30) days_EXHIBIT A_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"EXHIBIT 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TO THE JOINT CORP. FRANCHISE AGREEMENT OWNERSHIP INTERESTS IN FRANCHISE OWNER 4-1. Full name and address of the owners of, and a description of the type of, all currently held Interests in Franchise Owner: 4-2. Minimum individual and aggregate Principal Owner ownership percentage required at all times during the term of this Agreement: 4-2.1 During the term of this Agreement, the Principal Owners together must have a \\\"controlling interest\\\" of no less than seventy-five percent (75%) of the equity, voting control and profits in the Franchise Owner. 4-2.2 Unless otherwise permitted, the required minimum \\\"ownership interest\\\" of each Principal Owner during the term of this Agreement is:\", \"level\": 1, \"text\": \"EXHIBIT 4 TO THE JOINT CORP. FRANCHISE AGREEMENT OWNERSHIP INTERESTS IN FRANCHISE OWNER 4-1. Full name and address of the owners of, and a description of the type of, all currently held Interests in Franchise Owner: 4-2. Minimum individual and aggregate Principal Owner ownership percentage required at all times during the term of this Agreement: 4-2.1 During the term of this Agreement, the Principal Owners together must have a \\\"controlling interest\\\" of no less than seventy-five percent (75%) of the equity, voting control and profits in the Franchise Owner. 4-2.2 Unless otherwise permitted, the required minimum \\\"ownership interest\\\" of each Principal Owner during the term of this Agreement is: Name Ownership Percentage THE JOINT\u2026THE CHIROPRACTIC PLACE\u2122 Exhibit 4 - Ownership Interests in Franchise Owner FRANCHISE AGREEMENT 1\"}}, {\"id\": \"value:seventy-five percent (75%)_EXHIBIT 4_1\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"seventy-five percent (75%)\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of LEGACYTECHNOLOGYHOLDINGS,INC_12_09_2005-EX-10.2-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of LEGACYTECHNOLOGYHOLDINGS,INC_12_09_2005-EX-10.2-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.2\", \"level\": 1, \"text\": \"EXHIBIT 10.2 DISTRIBUTOR AGREEMENT EXHIBIT 10.2 EXCLUSIVE DISTRIBUTOR AGREEMENT THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") shall be effective as of _Dec. 8, 2005 (hereinafter \\\"Effective Date\\\"), by and between LifeUSA/ Envision Health, Inc., a corporation (hereinafter collectively \\\"ENVISION\\\"), and Sierra Mountain Minerals, Inc., a Canadian company (hereinafter \\\"SIERRA\\\"), is made with reference to the following facts: Recitals A. SIERRA is the manufacture and producer of a joint health product called \\\"SierraSil\\\" (hereinafter \\\"the Product\\\") for human use. B. ENVISION is the manufacturer of certain nutritional supplements and is desirous of becoming an exclusive distributor for the Product in any blend with Krill Oil (hereinafter \\\"the Finished Product\\\") in all distribution channels in the Territory on the terms and conditions set forth herein.\"}, {\"id\": \"C\", \"title\": \"SIERRA is desirous of having ENVISION act as its exclusive distributor for the Product in any blend wit\", \"level\": 1, \"text\": \"C. SIERRA is desirous of having ENVISION act as its exclusive distributor for the Product in any blend with Krill Oil in all distribution channels in the Territory on the terms and conditions set forth herein. NOW, THEREFORE, it is hereby agreed as follows:\"}, {\"id\": \"1\", \"title\": \"Incorporation of Recitals\", \"level\": 1, \"text\": \"1. Incorporation of Recitals. The Recitals set forth in Paragraphs A through C, above, are incorporated herein as though set forth in full.\"}, {\"id\": \"2\", \"title\": \"Appointment\", \"level\": 1, \"text\": \"2. Appointment. SIERRA hereby appoints ENVISION as its exclusive distributor for the Product in any blend with Krill Oil within the Territory subject to ENVISION fulfilling the terms and conditions of the best efforts marketing requirements set forth herein in Sections 4, 5, and 9. SIERRA shall cease making sales to any customer or distributor who, during the term of this Agreement, violates ENVISION's exclusivity.\"}, {\"id\": \"3\", \"title\": \"Territory\", \"level\": 1, \"text\": \"3. Territory. The Territory shall be the entire world.\"}, {\"id\": \"4\", \"title\": \"Prices and Terms\", \"level\": 1, \"text\": \"4. Prices and Terms. The price for the Product as set forth in Section 9 herein, sold by SIERRA to ENVISION, shall be subject to change due to changes in manufacturing costs and so as to maximize profits; any changes in price for the Product shall not be applicable to previously accepted orders and shall be made with at least ninety (90) days advance notice in writing and in good faith by conference of the parties. ENVISION shall not resell the Product alone. Terms of payment will be 1/3 upon placement of order and 2/3 balance net thirty (30) days or as mutually agreed upon in writing between the parties. Delivery will be F.O.B. ENVISION shall be responsible for all costs of shipping from SIERRA to ENVISION.\"}, {\"id\": \"5\", \"title\": \"Product Support\", \"level\": 1, \"text\": \"5. Product Support. ENVISION will use its best efforts to market and sell the Finished Product throughout the Territory. The parties also agree that: o If SIERRA customers are interested in purchasing the Product in any blend with Krill Oil, SIERRA will refer them to ENVISION. o ENVISION will be responsible for all costs associated with developing and manufacturing the Finished Product.\"}, {\"id\": \"6\", \"title\": \"Sales Disclosures\", \"level\": 1, \"text\": \"6. Sales Disclosures. ENVISION will provide SIERRA with demand projections for the Product and SIERRA will produce enough Product to meet such demand projections. ENVISION will inform SIERRA of committed sales and SIERRA will increase or scale up its production of the Product accordingly. SIERRA will not unreasonably withhold the Product, but shall not be liable for unfulfilled or partially fulfilled orders given just cause for such action.\"}, {\"id\": \"7\", \"title\": \"Term\", \"level\": 1, \"text\": \"7. Term. The term of this Agreement shall be two (2) years from the Effective Date with automatic annual renewals thereafter provided either party does not provide sixty (60) days notice of termination prior to the renewal date or the Agreement is not otherwise terminated as set forth in Section 8.\"}, {\"id\": \"8\", \"title\": \"Termination\", \"level\": 1, \"text\": \"8. Termination. (a) Upon the occurrence of a material breach or default as to any obligation, term or provision contained herein by either party and the failure of the breaching party to promptly pursue (within thirty (30) days after receiving written notice thereof from the non-breaching party) a reasonable remedy designed to cure (in the reasonable judgment of the non-breaching party) such material breach or default, this Agreement may be terminated by the non-breaching party by giving written notice of termination to the breaching party, such termination being immediately effective upon the giving of such notice of termination. (b) Upon the occurrence of bankruptcy of the other party, breach of confidentiality, government legislative interference, or force majeure extending beyond sixty (60) days, either party may immediately terminate the Agreement.\"}, {\"id\": \"9\", \"title\": \"Purchase Requirements\", \"level\": 1, \"text\": \"9. Purchase Requirements. During the term of this Agreement, ENVISION will exclusively purchase the Product from SIERRA. The parties mutually agree to the Purchase Price of: Product Purchase Price ----------------------------------------------- A. SierraSil Per Sierra Sil's wholesale price list.\"}, {\"id\": \"10\", \"title\": \"Intellectual Property\", \"level\": 1, \"text\": \"10. Intellectual Property. SIERRA is responsible for all Patent costs for the Product. SIERRA warrants it owns pending patents for the Product in the U.S. and internationally. SIERRA hereby grants ENVISION an exclusive, royalty-free sub-license of the Product's future patents, and patent applications to distribute, sell and market the Finished Product. SIERRA hereby agrees to indemnify, defend and hold ENVISION harmless from any claims that the Product infringes upon any other patent.\"}, {\"id\": \"11\", \"title\": \"Trademarks SIERRA is the owner of the trademark&sbsp; \\\"SierraSil\\\"\", \"level\": 1, \"text\": \"11. Trademarks SIERRA is the owner of the trademark&sbsp; \\\"SierraSil\\\". This Agreement grants ENVISION a non-exclusive and non-royalty bearing license to use the mark \\\"SierraSil\\\". SIERRA shall at all times be the owner of the trademark and ENVISION shall acquire no rights thereto. Upon termination, ENVISION shall have eighteen (18) months to exhaust any inventories, packaging and advertising materials bearing the \\\"SierraSil\\\" trademark and SIERRA shall have first option to buy back any inventory at ENVISION's net purchase price.\"}, {\"id\": \"12\", \"title\": \"Independent Contractor Status\", \"level\": 1, \"text\": \"12. Independent Contractor Status. The parties acknowledge that ENVISION is an independent contractor and shall not be deemed to be an employee, agent, or joint venturer of SIERRA for any purpose, including federal tax purposes.\"}, {\"id\": \"13\", \"title\": \"Warranty\", \"level\": 1, \"text\": \"13. Warranty. SIERRA warrants that the Product shall be free from defects in material and workmanship for the reasonable shelf life of the Product. In the event of any breach of this warranty or in the event any user of Product makes a claim that the Product was the cause of personal injury or property damage (product liability claim), SIERRA shall indemnify, defend and hold ENVISION harmless from any liability occasioned by a breach of warranty or a product liability claim. SIERRA warrants that it carries general liability insurance of not less than $2 million per occurrence and product liability insurance of not less than $5 million per occurrence and that, upon the execution of this Agreement, it will name ENVISION as an additional insured on such policies. SIERRA further warrants that the Product will not be adulterated or misbranded within the meaning of any federal, state, or local law or regulation or other applicable law. SIERRA agrees to promptly notify ENVISION of any problem, anomaly, defect or condition which would reasonably cause ENVISION's concern relative to stability, reliability, form, fit, function or quality of the Product. ENVISION warrants that the Finished Product will not be adulterated or misbranded within the meaning of any federal, state, or local law or regulation or other applicable law. In the event of any breach of this warranty or in the event any user of the Finished Product makes a claim that the Finished Product was the cause of personal injury or property damage (product liability claim), ENVISION shall indemnify, defend, and hold SIERRA harmless from any liability occasioned by a breach of warranty or a product liability claim. ENVISION warrants that it carries general liability insurance of $1 million per occurrence and product liability insurance of not less than $2 million per occurrence and that, upon execution of this Agreement, it will name SIERRA as an additional insured on such policies.\"}, {\"id\": \"14\", \"title\": \"Confidential Information\", \"level\": 1, \"text\": \"14. Confidential Information. The parties acknowledge that, during the term of this Agreement, each may receive certain Proprietary Information of the other. Proprietary Information includes, without limitation, formula, scientific studies, processes, plans, formulations, technical information, new product information, methods of product delivery, test procedures, product samples, specifications, scientific, clinical, commercial and other information or data, customer lists, customer contacts, and other distributors within the Territory which are considered confidential in nature whether communicated in writing or orally. The parties agree that each will treat such information as confidential. Neither party shall have the right to disclose the Proprietary Information to any third party without the express written consent of the disclosing party. Neither party may use the proprietary information except in furtherance of the goals of this Agreement and is further prohibited from utilizing the Proprietary Information directly nor indirectly to engage in any business activity which is competitive with the other.\"}, {\"id\": \"15\", \"title\": \"Force Majeure\", \"level\": 1, \"text\": \"15. Force Majeure. In no event shall any party be responsible for its failure to fulfill any of its obligations under this Agreement when such failure is due to fires, floods, riots, strikes, freight embargoes, acts of God or insurrection. In the event of a force majeure, the party affected thereby shall give immediate written notice to the other. If the event of force majeure continues for longer than sixty (60) days, the party not so affected shall have the right to terminate this Agreement.\"}, {\"id\": \"16\", \"title\": \"Non-Waiver of Default\", \"level\": 1, \"text\": \"16. Non-Waiver of Default. The failure of either party at any time to require the performance by a party of any provision of this Agreement shall in no way affect the right to require performance at any time after such failure. The waiver of either party of a breach of any provision of this Agreement shall not be taken to be a waiver of any succeeding breach of the provision or as a waiver of the provision itself.\"}, {\"id\": \"17\", \"title\": \"Attorney's Fees\", \"level\": 1, \"text\": \"17. Attorney's Fees. In the event either party is required to institute litigation to enforce any provision of this Agreement, the prevailing party in such litigation shall be entitled to recover all costs including without limitation, reasonable attorney's fees and expenses incurred in connection with such enforcement and collection.\"}, {\"id\": \"18\", \"title\": \"Venue\", \"level\": 1, \"text\": \"18. Venue. This Agreement is deemed to have been entered into in the State of Colorado, and its interpretation, construction, and the remedies for its enforcement or breach are to be applied pursuant to and in accordance with the laws of the State of Colorado.\"}, {\"id\": \"19\", \"title\": \"Notices\", \"level\": 1, \"text\": \"19. Notices. Any and all notices or other communication required or permitted to be given pursuant to this Agreement shall be in writing and shall be construed as properly given if mailed first class, postage prepaid to the address specified herein. Either party may designate, in writing, a change of address or other place to which notices may be sent. If to SIERRA: If to LIFEUSA/ENVISION: Mr. Michael Bentley Mr. Michael Schuett Sierra Mountain Minerals Inc. Envision Health, Inc. 1501 West Broadway, Suite 500 2475 Broadway, Suite 202 Vancouver BC V6J4Z6 Boulder, CO 80304 Canada\"}, {\"id\": \"20\", \"title\": \"Amendment\", \"level\": 1, \"text\": \"20. Amendment. This Agreement shall not be modified or amended except by a written agreement executed by both parties.\"}, {\"id\": \"21\", \"title\": \"Entire Agreement\", \"level\": 1, \"text\": \"21. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter thereof and supersedes all prior agreements, whether written or oral.\"}, {\"id\": \"22\", \"title\": \"Assignment\", \"level\": 1, \"text\": \"22. Assignment. The parties shall have the right to assign all, or part, of its rights under this Agreement to any wholly owned subsidiary or affiliate without the consent of the other Party. Any other assignment by the parties, requires the prior written consent of the other Party. ACKNOWLEDGEMENTS Each party acknowledges that he or she has had an adequate opportunity to read and study this Agreement. The understanding of the aforesaid articles causes no difficulty whatsoever and each party has retained a copy of this agreement immediately after the signing of it by all parties. IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date and year first written above. SIERRA MOUNTAIN MINERALS LIFEUSA/ENVISION HEALTH By: /s/ Michael Bentley By: /s/ Michael Schuett ----------------------- ------------------------- Michael Bentley Michael Schuett December 8, 2005 December 7, 2005 ----------------------- ------------------------------ Date Date\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of LEGACYTECHNOLOGYHOLDINGS,INC_12_09_2005-EX-10.2-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.2\", \"level\": 1, \"text\": \"EXHIBIT 10.2 DISTRIBUTOR AGREEMENT EXHIBIT 10.2 EXCLUSIVE DISTRIBUTOR AGREEMENT THIS EXCLUSIVE DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") shall be effective as of _Dec. 8, 2005 (hereinafter \\\"Effective Date\\\"), by and between LifeUSA/ Envision Health, Inc., a corporation (hereinafter collectively \\\"ENVISION\\\"), and Sierra Mountain Minerals, Inc., a Canadian company (hereinafter \\\"SIERRA\\\"), is made with reference to the following facts: Recitals A. SIERRA is the manufacture and producer of a joint health product called \\\"SierraSil\\\" (hereinafter \\\"the Product\\\") for human use. B. ENVISION is the manufacturer of certain nutritional supplements and is desirous of becoming an exclusive distributor for the Product in any blend with Krill Oil (hereinafter \\\"the Finished Product\\\") in all distribution channels in the Territory on the terms and conditions set forth herein.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SIERRA is desirous of having ENVISION act as its exclusive distributor for the Product in any blend wit\", \"level\": 1, \"text\": \"C. SIERRA is desirous of having ENVISION act as its exclusive distributor for the Product in any blend with Krill Oil in all distribution channels in the Territory on the terms and conditions set forth herein. NOW, THEREFORE, it is hereby agreed as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Incorporation of Recitals\", \"level\": 1, \"text\": \"1. Incorporation of Recitals. The Recitals set forth in Paragraphs A through C, above, are incorporated herein as though set forth in full.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Appointment\", \"level\": 1, \"text\": \"2. Appointment. SIERRA hereby appoints ENVISION as its exclusive distributor for the Product in any blend with Krill Oil within the Territory subject to ENVISION fulfilling the terms and conditions of the best efforts marketing requirements set forth herein in Sections 4, 5, and 9. SIERRA shall cease making sales to any customer or distributor who, during the term of this Agreement, violates ENVISION's exclusivity.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Territory\", \"level\": 1, \"text\": \"3. Territory. The Territory shall be the entire world.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices and Terms\", \"level\": 1, \"text\": \"4. Prices and Terms. The price for the Product as set forth in Section 9 herein, sold by SIERRA to ENVISION, shall be subject to change due to changes in manufacturing costs and so as to maximize profits; any changes in price for the Product shall not be applicable to previously accepted orders and shall be made with at least ninety (90) days advance notice in writing and in good faith by conference of the parties. ENVISION shall not resell the Product alone. Terms of payment will be 1/3 upon placement of order and 2/3 balance net thirty (30) days or as mutually agreed upon in writing between the parties. Delivery will be F.O.B. ENVISION shall be responsible for all costs of shipping from SIERRA to ENVISION.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Support\", \"level\": 1, \"text\": \"5. Product Support. ENVISION will use its best efforts to market and sell the Finished Product throughout the Territory. The parties also agree that: o If SIERRA customers are interested in purchasing the Product in any blend with Krill Oil, SIERRA will refer them to ENVISION. o ENVISION will be responsible for all costs associated with developing and manufacturing the Finished Product.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sales Disclosures\", \"level\": 1, \"text\": \"6. Sales Disclosures. ENVISION will provide SIERRA with demand projections for the Product and SIERRA will produce enough Product to meet such demand projections. ENVISION will inform SIERRA of committed sales and SIERRA will increase or scale up its production of the Product accordingly. SIERRA will not unreasonably withhold the Product, but shall not be liable for unfulfilled or partially fulfilled orders given just cause for such action.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 1, \"text\": \"7. Term. The term of this Agreement shall be two (2) years from the Effective Date with automatic annual renewals thereafter provided either party does not provide sixty (60) days notice of termination prior to the renewal date or the Agreement is not otherwise terminated as set forth in Section 8.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination\", \"level\": 1, \"text\": \"8. Termination. (a) Upon the occurrence of a material breach or default as to any obligation, term or provision contained herein by either party and the failure of the breaching party to promptly pursue (within thirty (30) days after receiving written notice thereof from the non-breaching party) a reasonable remedy designed to cure (in the reasonable judgment of the non-breaching party) such material breach or default, this Agreement may be terminated by the non-breaching party by giving written notice of termination to the breaching party, such termination being immediately effective upon the giving of such notice of termination. (b) Upon the occurrence of bankruptcy of the other party, breach of confidentiality, government legislative interference, or force majeure extending beyond sixty (60) days, either party may immediately terminate the Agreement.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Requirements\", \"level\": 1, \"text\": \"9. Purchase Requirements. During the term of this Agreement, ENVISION will exclusively purchase the Product from SIERRA. The parties mutually agree to the Purchase Price of: Product Purchase Price ----------------------------------------------- A. SierraSil Per Sierra Sil's wholesale price list.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Intellectual Property\", \"level\": 1, \"text\": \"10. Intellectual Property. SIERRA is responsible for all Patent costs for the Product. SIERRA warrants it owns pending patents for the Product in the U.S. and internationally. SIERRA hereby grants ENVISION an exclusive, royalty-free sub-license of the Product's future patents, and patent applications to distribute, sell and market the Finished Product. SIERRA hereby agrees to indemnify, defend and hold ENVISION harmless from any claims that the Product infringes upon any other patent.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademarks SIERRA is the owner of the trademark&sbsp; \\\"SierraSil\\\"\", \"level\": 1, \"text\": \"11. Trademarks SIERRA is the owner of the trademark&sbsp; \\\"SierraSil\\\". This Agreement grants ENVISION a non-exclusive and non-royalty bearing license to use the mark \\\"SierraSil\\\". SIERRA shall at all times be the owner of the trademark and ENVISION shall acquire no rights thereto. Upon termination, ENVISION shall have eighteen (18) months to exhaust any inventories, packaging and advertising materials bearing the \\\"SierraSil\\\" trademark and SIERRA shall have first option to buy back any inventory at ENVISION's net purchase price.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractor Status\", \"level\": 1, \"text\": \"12. Independent Contractor Status. The parties acknowledge that ENVISION is an independent contractor and shall not be deemed to be an employee, agent, or joint venturer of SIERRA for any purpose, including federal tax purposes.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty\", \"level\": 1, \"text\": \"13. Warranty. SIERRA warrants that the Product shall be free from defects in material and workmanship for the reasonable shelf life of the Product. In the event of any breach of this warranty or in the event any user of Product makes a claim that the Product was the cause of personal injury or property damage (product liability claim), SIERRA shall indemnify, defend and hold ENVISION harmless from any liability occasioned by a breach of warranty or a product liability claim. SIERRA warrants that it carries general liability insurance of not less than $2 million per occurrence and product liability insurance of not less than $5 million per occurrence and that, upon the execution of this Agreement, it will name ENVISION as an additional insured on such policies. SIERRA further warrants that the Product will not be adulterated or misbranded within the meaning of any federal, state, or local law or regulation or other applicable law. SIERRA agrees to promptly notify ENVISION of any problem, anomaly, defect or condition which would reasonably cause ENVISION's concern relative to stability, reliability, form, fit, function or quality of the Product. ENVISION warrants that the Finished Product will not be adulterated or misbranded within the meaning of any federal, state, or local law or regulation or other applicable law. In the event of any breach of this warranty or in the event any user of the Finished Product makes a claim that the Finished Product was the cause of personal injury or property damage (product liability claim), ENVISION shall indemnify, defend, and hold SIERRA harmless from any liability occasioned by a breach of warranty or a product liability claim. ENVISION warrants that it carries general liability insurance of $1 million per occurrence and product liability insurance of not less than $2 million per occurrence and that, upon execution of this Agreement, it will name SIERRA as an additional insured on such policies.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential Information\", \"level\": 1, \"text\": \"14. Confidential Information. The parties acknowledge that, during the term of this Agreement, each may receive certain Proprietary Information of the other. Proprietary Information includes, without limitation, formula, scientific studies, processes, plans, formulations, technical information, new product information, methods of product delivery, test procedures, product samples, specifications, scientific, clinical, commercial and other information or data, customer lists, customer contacts, and other distributors within the Territory which are considered confidential in nature whether communicated in writing or orally. The parties agree that each will treat such information as confidential. Neither party shall have the right to disclose the Proprietary Information to any third party without the express written consent of the disclosing party. Neither party may use the proprietary information except in furtherance of the goals of this Agreement and is further prohibited from utilizing the Proprietary Information directly nor indirectly to engage in any business activity which is competitive with the other.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 1, \"text\": \"15. Force Majeure. In no event shall any party be responsible for its failure to fulfill any of its obligations under this Agreement when such failure is due to fires, floods, riots, strikes, freight embargoes, acts of God or insurrection. In the event of a force majeure, the party affected thereby shall give immediate written notice to the other. If the event of force majeure continues for longer than sixty (60) days, the party not so affected shall have the right to terminate this Agreement.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Waiver of Default\", \"level\": 1, \"text\": \"16. Non-Waiver of Default. The failure of either party at any time to require the performance by a party of any provision of this Agreement shall in no way affect the right to require performance at any time after such failure. The waiver of either party of a breach of any provision of this Agreement shall not be taken to be a waiver of any succeeding breach of the provision or as a waiver of the provision itself.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Attorney's Fees\", \"level\": 1, \"text\": \"17. Attorney's Fees. In the event either party is required to institute litigation to enforce any provision of this Agreement, the prevailing party in such litigation shall be entitled to recover all costs including without limitation, reasonable attorney's fees and expenses incurred in connection with such enforcement and collection.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Venue\", \"level\": 1, \"text\": \"18. Venue. This Agreement is deemed to have been entered into in the State of Colorado, and its interpretation, construction, and the remedies for its enforcement or breach are to be applied pursuant to and in accordance with the laws of the State of Colorado.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 1, \"text\": \"19. Notices. Any and all notices or other communication required or permitted to be given pursuant to this Agreement shall be in writing and shall be construed as properly given if mailed first class, postage prepaid to the address specified herein. Either party may designate, in writing, a change of address or other place to which notices may be sent. If to SIERRA: If to LIFEUSA/ENVISION: Mr. Michael Bentley Mr. Michael Schuett Sierra Mountain Minerals Inc. Envision Health, Inc. 1501 West Broadway, Suite 500 2475 Broadway, Suite 202 Vancouver BC V6J4Z6 Boulder, CO 80304 Canada\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Amendment\", \"level\": 1, \"text\": \"20. Amendment. This Agreement shall not be modified or amended except by a written agreement executed by both parties.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 1, \"text\": \"21. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter thereof and supersedes all prior agreements, whether written or oral.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 1, \"text\": \"22. Assignment. The parties shall have the right to assign all, or part, of its rights under this Agreement to any wholly owned subsidiary or affiliate without the consent of the other Party. Any other assignment by the parties, requires the prior written consent of the other Party. ACKNOWLEDGEMENTS Each party acknowledges that he or she has had an adequate opportunity to read and study this Agreement. The understanding of the aforesaid articles causes no difficulty whatsoever and each party has retained a copy of this agreement immediately after the signing of it by all parties. IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date and year first written above. SIERRA MOUNTAIN MINERALS LIFEUSA/ENVISION HEALTH By: /s/ Michael Bentley By: /s/ Michael Schuett ----------------------- ------------------------- Michael Bentley Michael Schuett December 8, 2005 December 7, 2005 ----------------------- ------------------------------ Date Date\"}}, {\"id\": \"party:LifeUSA/ Envision Health, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"LifeUSA/ Envision Health, Inc.\", \"role\": \"Distributor\", \"address\": \"2475 Broadway, Suite 202, Boulder, CO 80304\"}}, {\"id\": \"party:Sierra Mountain Minerals, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Sierra Mountain Minerals, Inc.\", \"role\": \"Producer\", \"address\": \"1501 West Broadway, Suite 500, Vancouver BC V6J4Z6, Canada\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS EXCLUSIVE DISTRIBUTOR AGREEMENT\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"_Dec. 8, 2005\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:ENVISION\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"ENVISION\", \"text\": \"LifeUSA/ Envision Health, Inc., a corporation\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:SIERRA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SIERRA\", \"text\": \"Sierra Mountain Minerals, Inc., a Canadian company\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"a joint health product called \\\"SierraSil\\\" for human use\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Finished Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Finished Product\", \"text\": \"the Product in any blend with Krill Oil\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the entire world\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Proprietary Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Information\", \"text\": \"includes, without limitation, formula, scientific studies, processes, plans, formulations, technical information, new product information, methods of product delivery, test procedures, product samples, specifications, scientific, clinical, commercial and other information or data, customer lists, customer contacts, and other distributors within the Territory which are considered confidential in nature whether communicated in writing or orally\", \"definition_clause\": \"14\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:eighteen (18) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"eighteen (18) months\"}}, {\"id\": \"value:$2 million\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2 million\"}}, {\"id\": \"value:$5 million\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5 million\"}}, {\"id\": \"value:$1 million\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1 million\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.6\", \"level\": 1, \"text\": \"EXHIBIT 10.6 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") is made by and between Electric City Corp., a Delaware corporation (\\\"Company\\\") and Electric City of Illinois LLC (\\\"Distributor\\\") this 7th day of September, 1999. RECITALS A. The Company's Business. The Company is presently engaged in the business of selling an energy efficiency device, which is referred to as an \\\"Energy Saver\\\" which may be improved or otherwise changed from its present composition (the \\\"Products\\\"). The Company may engage in the business of selling other products or other devices other than the Products, which will be considered Products if Distributor exercises its options pursuant to Section 7 hereof. B. Representations. As an inducement to the Company to enter into this Agreement, the Distributor has represented that it has or will have the facilities, personnel, and financial capability to promote the sale and use of Products. As an inducement to Distributor to enter into this Agreement the Company has represented that it has the facilities, personnel and financial capability to have the Products produced and supplied as needed pursuant to the terms hereof.\"}, {\"id\": \"C\", \"title\": \"The Distributor's Objectives\", \"level\": 1, \"text\": \"C. The Distributor's Objectives. The Distributor desires to become a distributor for the Company and to develop demand for and sell and distribute Products solely for the use within the State of Illinois, including but not limited to public and private entities, institutions, corporations, public schools, park districts, corrections facilities, airports, government housing authorities and other government agencies and facilities (the \\\"Market\\\").\"}, {\"id\": \"D\", \"title\": \"The Company's Appointment\", \"level\": 1, \"text\": \"D. The Company's Appointment. The Company appoints the Distributor as an exclusive distributor of Products in the Market, subject to the terms and conditions of this Agreement.\"}, {\"id\": \"1\", \"title\": \"ESTABLISHMENT OF DISTRIBUTORSHIP\", \"level\": 1, \"text\": \"1. ESTABLISHMENT OF DISTRIBUTORSHIP\"}, {\"id\": \"1.1\", \"title\": \"Grant and Acceptance\", \"level\": 2, \"text\": \"1.1 Grant and Acceptance. Company hereby appoints Distributor as Company's exclusive distributor within the Market and grants to Distributor the exclusive right to sell and distribute Products within the Market, and Distributor hereby accepts such appointment and such grant, in accordance with the terms and conditions of this Agreement. Distributor acknowledges that customers of other distributors of the Products may have sites, locations or operations in the Market, which will use the Products. Distributor will sell any and all Products required by such customers in the Market to those customers. Distributor also acknowledges that if its customers have sites, locations or operations outside the Market, in the market of another exclusive distributor of the Products, those customers will be required to purchase products from the applicable exclusive distributor in that market; otherwise, Distributor shall be free to sell to its customers in any market which does not have another exclusive distributor.\"}, {\"id\": \"1.2\", \"title\": \"License\", \"level\": 2, \"text\": \"1.2 License. The Company hereby grants the Distributor the right to do business and use the name \\\"Electric City of Illinois\\\" or a similar variation thereof (collectively the \\\"Names\\\") for use under this Agreement. Distributor may file with the appropriate state and local authorities assumed name certificates as required. Copies of all documents relating to the use of the Names shall be forwarded to the Company. Upon termination of this Agreement Distributor shall have no further right to the Names and said License to use the Names shall terminate. Distributor shall have no right to sublicense the Names or to do business under any other names without the Company's prior approval in writing. The parties acknowledge that the terms herein consist of there terms for Illinois. At the request of either party, a new agreement reflecting the terms and conditions of this Agreement, may be executed for each state or entity representing each state.\"}, {\"id\": \"1.3\", \"title\": \"Term\", \"level\": 2, \"text\": \"1.3 Term. The term of this Agreement shall be ten (10) years (the \\\"Term\\\") which shall commence on the date upon which the Company delivers to Distributor the last Sample, as defined hereinafter. If Distributor complies with all of the terms of this Agreement, the Agreement shall be renewable on an annual basis for one (1) year terms for up to another ten (10) years on the same terms and conditions as set forth herein. All renewals of this Agreement shall be on the same terms and conditions as are set forth herein.\"}, {\"id\": \"1.4\", \"title\": \"Company's Obligation\", \"level\": 2, \"text\": \"1.4 Company's Obligation. Company shall sell and deliver as provided in Section 2.3 of this Agreement to Distributor on the price terms set forth in this Agreement or as amended from time to time such quantity of Products as Distributor from time to time orders from Company. Company shall promote and advertise the Products generally, at its own expense, and shall furnish Distributor copies at all advertisement and promotional materials.\"}, {\"id\": \"1.5\", \"title\": \"The Distributor's Obligation\", \"level\": 2, \"text\": \"1.5 The Distributor's Obligation. The Distributor, at its own expense, shall promote the distribution, sales, and use of Products in the Market.\"}, {\"id\": \"1.6\", \"title\": \"Distributor's Terms and Minimum Expectations\", \"level\": 2, \"text\": \"1.6 Distributor's Terms and Minimum Expectations. In order to maintain the exclusive rights to sell, lease, distribute and service Products in the Market, the Distributor must use all commercially reasonably efforts to purchase for sale to subdistributors the following minimum quantities of the Products from the Company: On the commencement of the Term Distributor will issue to the Company an irrevocable letter of credit (\\\"LC\\\") in the amount of Five Hundred Thousand Dollars ($500,000), the form of which is attached hereto as Exhibit A and incorporated herein by reference. The LC shall have a two (2) month term, and shall be renewed for five (5) consecutive bimonthly periods. A minimum of a $250,000.00 purchase order must be received by Company by the first of each month for a total (12) month period. The Company may draw funds from the LC to pay for Distributor's purchases, which are not paid according to the terms in Section 2.7. Prices for the EnergySaver units are Page -2- provided by the Company as Exhibit C. The Company will be entitled to draw against the LC pursuant to the terms of the LC. (A) 375 units in the first Product Year (1999) (B) 750 units in the next succeeding Product Year; (2000) (C) 937 units in the next succeeding Product Year; (2001) (D) 1,171 units in the next succeeding Product Year; (2002) (E) 1,463 units in the next succeeding Product Year; (2003) (F) 1,828 units in the next succeeding Product Year; (2004) (G) 2,285 units in the next succeeding Product Year; (2005) (H) 2,856 unit each in the lat three years of the initial Term of this Agreement and any renewals thereof. For purposes of this Agreement, a Product Year shall be the twelve (12) month period following the commencement of the initial Term of this Agreement and each twelve (12) months thereafter. Distributor's expected sales shall include the purchase of the Samples as defined hereinafter. Sales in excess of the expected sales which are actually made in a Product Year may be applied to meet the expectations for the next Product Year. Any such carry-over from one year to the next Product Year may not be considered in determining whether there is a carry-over from that next Product Year. Thus, by way of example and not limitation, if there was an expectation of 50 in year one and 200 for year two and 60 units are sold in year one and 195 units are sold in year two, the expectation for year two will have been met, but there will be no carry-over to year three. If the Distributor shall fail to purchase the minimum number of units in any year, the Distributor's exclusive rights to sell and distribute the Product in the Market, may at Company's sole option, be reevaluated. Company agrees that Distributor shall not be liable or subject to reevaluation for failure to meet expectations due to any occurrence beyond Distributor's reasonable control, including, but not limited to, Acts of God, fires, floods, wars, sabotage, accidents in shipping, labor disturbances, weather conditions, governmental regulation, lack of Company performance, delay by Company, failure of Company to honor warranties or otherwise materially support the Products. The aggregate units to be sold on an annual basis described above are for the Illinois distributorship on an aggregate basis.\"}, {\"id\": \"1.7\", \"title\": \"Relationship of Parties\", \"level\": 2, \"text\": \"1.7 Relationship of Parties. The relationship between the Company and the Distributor Page -3- is that of vendor and vendee. This Agreement does not create the relationship of principal and agent between the Company and the Distributor for any purpose whatsoever. This Agreement shall not be construed as constituting the Distributor and the Company as partners, joint venturers, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or omission of the other party. Neither party is granted any express or implied right of authority by the other party to assume or to create any obligation or responsibility on behalf of or in the name of the other party, or to bind the other party in any manner or thing whatsoever.\"}, {\"id\": \"2\", \"title\": \"PURCHASE OF PRODUCTS\", \"level\": 1, \"text\": \"2. PURCHASE OF PRODUCTS\"}, {\"id\": \"2.1\", \"title\": \"Orders\", \"level\": 2, \"text\": \"2.1 Orders. The Distributor shall order Products from the Company on a purchase order form mutually acceptable to the Company and Distributor and which is consistent with Exhibit B hereto, and which incorporates the terms and provisions of this Distributor Agreement. The Distributor shall not order or purchase Products from any source other than the Company. All orders shall be subject to acceptance and confirmation by the Company. Distributor may cancel an order that is properly cancelled by Distributor's customer, unless the Company has commenced production which is in any way customized for that customer. The Distributor shall annually provide the Company with a non-binding forecast of orders for Products for the succeeding 12-month period.\"}, {\"id\": \"2.2\", \"title\": \"Shipment\", \"level\": 2, \"text\": \"2.2 Shipment. The Company and the Distributor shall jointly determine shipment dates. The Company shall use commercially reasonable efforts to ship promptly all orders for Products received from the Distributor. In addition to any other remedy which this Agreement provides to Distributor against Company, if Company fails to deliver or delays in delivering Products as were ordered by Distributor within 45 days after their required delivery date, and if as a result of such failure or delay Distributor loses its customer's orders for those Products, the number of units which Distributor ordered but were not timely delivered to Distributor or to Distributor's customer will be credited against Distributor's minimum expectation as specified on Section 1.6 of this Agreement. The Company may refuse to accept a purchase order on the grounds that it cannot meet the delivery schedule therein, and if as a result of such failure or delay Distributor loses its customer's orders for those Products, the number of units which Distributor ordered but were not timely delivered to Distributor or to Distributor's customer will be credited against Distributor's minimum. Distributor shall make reasonable efforts to notify the Company of the proposed delivery schedule before accepting a customer order and shall give the Company written notice of any customer purchase orders which imposes liability for late shipment and neither the Distributor nor the Company shall have a liability for consequential or liquidated damages pertaining to late delivery unless Company specifically acknowledges and agrees in writing to the same. The Distributor agrees that the Company shall not be liable for its failure to perform due to any occurrence beyond the Company's reasonable control, including, but not limited to, acts of God, fires, Page -4- floods, wars, sabotage, accidents in shipping beyond the Company's control, labor strikes other than strikes against the Company itself, weather conditions or foreign or domestic government regulation or authority which directly affects Company's ability to deliver Product.\"}, {\"id\": \"2.3\", \"title\": \"Delivery\", \"level\": 2, \"text\": \"2.3 Delivery. Other than \\\"drop ship\\\" deliveries, all deliveries made pursuant to this Agreement shall be FOB the Company's facilities located within the continental United States by a carrier authorized by the Distributor.\"}, {\"id\": \"2.4\", \"title\": \"Prices\", \"level\": 2, \"text\": \"2.4. Prices. (A) Prices For Basic Units. The prices for Products in the first Product Year are supplied by Company as Exhibit C. (B) Inflation Price Adjustment. The prices set forth in Section 2.4(a) shall be subject to adjustment annually on the first day of each Product Year beginning in the calendar year 2000 and on the first day of each succeeding Product Year for the remainder of the Term and all renewals of this Agreement in proportion to the increase or decrease in the Consumer Price Index (CPI) as compared to the CPI as it existed on the first day of the Term of this Agreement. The Company also reserves the right to increase or decrease the price per unit based on Company wide changes in unit prices to all distributors of the Company, provided however, that any price changes, other than those based on the CPI, shall be uniformly applied to all distributors of the Products and shall reasonably applied to all distributors of the Products and shall reasonably reflect Company's costs of manufacturing the Products and/or market demand for the Products, provided further than any increase in price based upon market demand shall not be so great as to deprive Distributor of its normal and customary profit margin. The Company agrees to exercise this right in good faith, and consider all circumstances of the Distributor and the Company. The CPI referred to herein in issued by the Bureau of Labor Statistics of the U.S. Department of Labor. Should the Bureau of Labor Statistics discontinue publication of the CPI, the parties shall accept comparable statistics on the purchasing power of the consumer dollar as published at the time of said discontinuation by responsible periodical or recognized authority to be chosen by the parties.\"}, {\"id\": \"2.5\", \"title\": \"Resale Prices\", \"level\": 2, \"text\": \"2.5. Resale Prices. The Distributor may resell Products at such price, as the Distributor, in its sole discretion, shall determine. While the Company has the right to suggest a range of manufacturer's suggested retail prices for the Products, the distributor is not obligated to set retail prices within the Company's suggested range of retail prices.\"}, {\"id\": \"2.6\", \"title\": \"Product Returns\", \"level\": 2, \"text\": \"2.6 Product Returns. Page -5- (A) Non-defective Products. Unless the Company has first authorized or permitted the return of any non-defective Products and except as otherwise permitted or required herein, the Company shall not be obligated to accept the return from the Distributor of any non-defective Products, nor to make any exchanges therefor, nor to credit the Distributor therefor. If Company does not give Annual Notice pursuant to Section 3.1 hereof, Distributor may, within 90 days of modification, improvement or alteration, return the Products to the Company. The Company shall not have any obligation with respect to Products after 365 days following delivery to Distributor, except as provided herein. (B) Defective Products. In the event of any damages or other defect in a Product which is discovered by Distributor within 365 days of satisfactory installation of a Product at Distributor's or a subdistributor's customer, the Distributor shall promptly report the same to the Company and reasonably demonstrate the defect to the Company. If the Distributor reasonably demonstrates that the Company is responsible for such damage or defect, the Company shall promptly deliver and install at the Company's expense, additional or substitute Products to the subdistributor's customer without additional cost or charge to the Distributor or the customer for material, labor, shipping, insurance or any other charge.\"}, {\"id\": \"2.7\", \"title\": \"Payment Terms\", \"level\": 2, \"text\": \"2.7 Payment Terms. Distributor shall pay Company within thirty (30) days of Distributor's or, as the case may be, the end-user's receipt of Products.\"}, {\"id\": \"2.8\", \"title\": \"Company Cooperation\", \"level\": 2, \"text\": \"2.8 Company Cooperation. The Company shall cooperate with the Distributor in obtaining all necessary permits and approvals to permit the use of the Products. The Company shall bear responsibility for any permits needed to manufacture the Products and Distributor shall bear responsibility for any permits needed to distribute the Products.\"}, {\"id\": \"3\", \"title\": \"PRODUCTS AND WARRANTY\", \"level\": 1, \"text\": \"3. PRODUCTS AND WARRANTY\"}, {\"id\": \"3.1\", \"title\": \"Product Improvements by the Company\", \"level\": 2, \"text\": \"3.1 Product Improvements by the Company. At the Company's sole discretion, and at any time, the Company may give the Distributor at least 90 days advance notice (\\\"Annual Notice\\\") of any modification, improvement or alteration of Products (\\\"New Products\\\") and development of new models of Products (collectively with \\\"New Products\\\", \\\"Improved Products\\\"). Except for the Improved Products for which the Distributor receives the Annual Notice, the Company shall sell Improved Products to Distributor only with the consent of the Distributor. Any Improved Products shall be subject to the provisions of this Agreement. Old Products will remain available unless Page -6- Improved Products perform at the same or better levels and are offered at reasonably similar prices or at prices increases, which reasonably reflect improvements in performance.\"}, {\"id\": \"3.2\", \"title\": \"Product Improvements by the Distributor\", \"level\": 2, \"text\": \"3.2 Product Improvements by the Distributor. The Distributor shall disclose to the Company any modifications to Products requested by end-users or other proposals for Product improvement from end-users or the Distributor, but shall have no right to make modifications without Distributor's consent.\"}, {\"id\": \"3.3\", \"title\": \"Warranty\", \"level\": 2, \"text\": \"3.3 Warranty. Company shall at all times make reasonable efforts to maintain quality control and to deliver Products to Distributor which, when received by Distributor, or, as the case may be, the end-user, are properly and adequately packaged and contained, fully assembled (except for miscellaneous components which may be shipped separately to prevent damage in transit), fully functional and otherwise in conformance with the warranties set forth herein. Company warrants that the Products will be designed, manufactured, constructed, assembled and packaged in a workmanlike manner and that such Products shall be fully functional and fit for their intended purposes. Company further warrants that the Products sold hereunder shall be free from defects in design, materials and workmanship for a period of twenty-four (24) months after delivery to Distributor's end-user. The Company shall not be liable for defective Products, except as provided in this Agreement. The Distributor at all times shall comply with all requirements of the Magnuson-Moss Warranty-Federal Trade Commission Improvement Act and similar federal and state laws and regulations.\"}, {\"id\": \"3.4\", \"title\": \"Warranty Work\", \"level\": 2, \"text\": \"3.4 Warranty Work. If, within the twenty-four (24) month warranty period set forth above, Company received from Distributor or any of Distributor's end-user's a notice which may be oral notice confirmed in writing) that any of the Products sold hereunder do not meet the Warranties specified above, Company shall thereupon correct each such defect by providing the necessary repairs, and/or replacement parts, or if necessary, Products. Company shall promptly respond to any timely notice of defect. Unless otherwise expressly agreed to in writing by Distributor or Distributor's and-user, Company shall bear the reasonable expense of all labor, materials and shipping expended or used in connection with the correction of any defects in the Products occasioned by the non-conformance of the Product with Company's warranty as set forth herein. Company shall be entitled to dispute whether a Product is defective. In the event that Company is unable or unwilling to promptly perform any warranty work without reasonable cause and following full and fair opportunity to do so, or in the event of the necessity for emergency repairs of a defective Product for which there is no reasonable possibility of performance by Company, Distributor may perform such warranty work or hire a third party to perform such warranty work and the reasonable cost thereof shall be paid by Company. Page -7-\"}, {\"id\": \"3.5\", \"title\": \"Service of Products in Territory\", \"level\": 2, \"text\": \"3.5 Service of Products in Territory. Within thirty (30) days after the execution of this Agreement, the Company and the Distributor shall mutually agree upon a reasonable schedule of charges for after market parts and services provided by the Company or the Distributor so that such charges do not adversely affect the marketability of the Products.\"}, {\"id\": \"3.6\", \"title\": \"Non-Disclosure of Confidential Information\", \"level\": 2, \"text\": \"3.6. Non-Disclosure of Confidential Information. None of the parties hereto nor their associated or affiliated or affiliated companies shall during the term of this Agreement or thereafter disclose any confidential information obtained or acquired by them in connection with the Products and the business of the other, including, without limitation, trade secrets, business techniques, technical information, customer and potential customer lists, marketing data and information, prices, improvements to the Products in various stages of development, processes, or other confidential information relating to the Products or the business of the Distributor, except that either party shall be permitted to disclose (x) all or portions of such confidential information on a strictly need-to-know basis to the extent required by an order of a court of competent jurisdiction or by the order or demand of a regulatory body having jurisdiction over one or both parties and (y) any of such confidential information that is the sole property of the party making the disclosure and does not include any information owned by the other party. The Distributor shall not disclose this agreement except upon consent of Company. Confidential information shall not include information which: (A) Is or becomes generally available to the party who desires to disclose such information (or its associated or affiliated companies) (a \\\"Disclosing Party\\\") other than as a result of a breach of this Agreement or some other unlawful means; (B) Becomes available to the Disclosing Party on a non-confidential basis from a third party who is under no confidentiality or nondisclosure obligation with respect to such information; or (C) Was known to the Disclosing Party on a non-confidential basis prior to the disclosure thereof to such disclosing Party by a party to this Agreement.\"}, {\"id\": \"4\", \"title\": \"DURATION AND TERMINATION\", \"level\": 1, \"text\": \"4. DURATION AND TERMINATION\"}, {\"id\": \"4.1\", \"title\": \"Duration\", \"level\": 2, \"text\": \"4.1 Duration. Unless earlier terminated otherwise provided therein, this Agreement, subject to the commencement date established in Section 1.3, shall be effective immediately. Distributor shall submit written reports to the Company each quarter during the first year of the Term, commencing ninety (90) days after execution of this Agreement, describing its efforts, the potential customers it has approached and the status of its efforts.\"}, {\"id\": \"4.2\", \"title\": \"Termination for Cause\", \"level\": 2, \"text\": \"4.2 Termination for Cause. Either party may terminate this Agreement upon 30 days Page -8- prior written notice to the other upon the occurrence of any of the following events: (A) the Distributor's failure to make full and prompt payment to the Company of all sums due and owing to it; (b) either party's default in the performance of any of the material, terms, conditions, obligations, undertakings, covenants or liabilities set forth herein and such default is not cured within a commercially reasonable time after the defaulting party has been notified of the default by the other party and (c) as otherwise expressly provided herein. In the event either party (a) becomes adjudicated insolvent, (b) discontinues its business, (c) has voluntary of involuntary bankruptcy proceedings instituted against it, or (d) makes an assignment for the benefit of creditors, the other party shall be entitled to terminate this Agreement effective immediately upon written notice.\"}, {\"id\": \"4.3\", \"title\": \"Accrued Obligations\", \"level\": 2, \"text\": \"4.3 Accrued Obligations. In the event that either Distributor or Company fails to comply with the terms of this Agreement, both Distributor and Company acknowledge and agree that in addition to any claim for damages either party may have arising from the default of the other, they shall have the right to seek equitable relief by way of a temporary restraining order, preliminary injunction, permanent injunction and such other equitable relief as may be appropriate. In the event a party seeks the equitable relief of a temporary restraining order, preliminary injunction, permanent injunction, mandatory injunction or specific performance both parties acknowledge that they shall not be required to demonstrate the absence of an adequate remedy at law, and neither party shall be required to post bond as a precondition to obtaining a temporary restraining order or preliminary injunction. The termination of this Agreement shall not relieve either party hereto from obligations which have occurred pursuant to the provisions of this Agreement prior to its termination, nor shall it release either party hereto from any obligations which have been incurred as a result of operations conducted under this Agreement.\"}, {\"id\": \"4.4\", \"title\": \"Repurchase of Products\", \"level\": 2, \"text\": \"4.4 Repurchase of Products. Upon the expiration or termination of this Agreement, pursuant to Section 4.1 or 4.2 hereof, the Company may, at its option to be exercised within 30 days of the date of the termination of this Agreement, and in its sole discretion, repurchase any Products in the possession of the Distributor at the net invoice price paid by the Distributor to the Company less any applicable special allowances, discounts, shipping or allowances for cooperative advertising. If Company terminates the Agreement without cause and for reasons other than Distributor's failure to meet its minimum expectations; it shall repurchase from Distributor any unopened Product, and shall bear all shipping, handling and related costs notwithstanding any other remedies to which Distributor may be entitled. On demand and tender of the repurchase price, the Distributor shall be obligated to deliver such Products to the Company. The Company reserves the right to reject any Products that are not factory sealed and in new and unused condition. Repurchased Products shall be shipped at the Company's expense, and the Company may offset any indebtedness of the Distributor to the Company against the repurchase price of such Products. Following expiration or termination of this Agreement, the Distributor may continue to sell any Products in the Market which are in its inventory Page -9- and which the Company has not repurchased.\"}, {\"id\": \"5\", \"title\": \"REPRESENTATIONS AND WARRANTIES AND OTHER MATTERS\", \"level\": 1, \"text\": \"5. REPRESENTATIONS AND WARRANTIES AND OTHER MATTERS\"}, {\"id\": \"5.1\", \"title\": \"Representations and Warranties of Company\", \"level\": 2, \"text\": \"5.1 Representations and Warranties of Company. (A) The Company represents that, to the best of its knowledge, Products are in compliance with all laws, and that the Products will not be hazardous or dangerous when used for their intended purpose. Products do not cause harmful emissions or other environmental hazards and Products do not violate or infringe any patents, copyrights, trademarks or other rights of nay third party(ies). Company further represents and warrants that its Products will perform as advertised and promoted by the Company, and will be approved or certified by Underwriters Laboratory. (B) The Company will make available to Distributor comprehensive technical support for the first Product Year. Distributor will have direct access to (a) the Company's engineering consultants and (b) the patent holder's technicians. Company's representatives will make themselves available three days per month in the first Product Year to consult with and train Distributor. All costs and expenses associated with the services provided to Distributor hereunder, including travel, lodging, engineering consultants' fees and employee time will be paid by Distributor. (C) Company will timely furnish all of Distributor's requirements for Products within the Market, provided it is given adequate notice of Distributor's requirements and a full and fair opportunity to fulfill the same.\"}, {\"id\": \"5.2\", \"title\": \"Representations and Warranties of Distributor\", \"level\": 2, \"text\": \"5.2 Representations and Warranties of Distributor. (A) Distributor shall be entirely responsible for learning, understanding and training about the Products, the costs of advertising and promoting the Products in the Market through the Term of this Agreement. Distributor shall not issue, print or disseminate any information about the Products in the first Product Year without the express written consent of the Company. (B) Distributor will not engage the services of any engineering or consulting firm without the express written consent of the Company.\"}, {\"id\": \"5.3\", \"title\": \"Indemnification\", \"level\": 2, \"text\": \"5.3 Indemnification. Company and Distributor agree to indemnify, defend and hold each other harmless from any and all suits, claims, obligations, liabilities, damages, losses and the like (including attorneys' fees and costs) relating to or arising out of: (A) any breach of any material representations, warranties, covenants, obligations, agreements or duties in connection with this Agreement; (b) any negligence or fault; (c) any violation by either of them of the patent, copyright, trademark or other Page -10- intellectual property rights of third parties. In addition, Company agrees to indemnify, defend and hold harmless Distributor from and against all suits, claims, obligations, liabilities, damages, losses and the like (including attorneys' fees and costs) arising out of or related to Company's manufacture or design of the Products, provided that Distributor is not at fault in connection with the same, and Distributor agrees to indemnify, defend and hold harmless Company from and against all suits, claims, obligations, liabilities, damages, losses and the like (including a attorneys' fees and costs) arising out of or related to Distributor's sales, marketing practices or unauthorized Product alteration (provided that Company is not at fault in connection with same).\"}, {\"id\": \"5.4\", \"title\": \"Product Liability Insurance\", \"level\": 2, \"text\": \"5.4 Product Liability Insurance. Company will carry a reasonable amount of product liability insurance through a reasonably acceptable products liability insurance company and will name the Distributor as an additional insured under that policy. Company will make reasonable efforts to procure a policy, which is non-cancelable, except upon thirty (30) days, advance notice to the Distributor.\"}, {\"id\": \"5.5\", \"title\": \"No License\", \"level\": 2, \"text\": \"5.5 No License. The Distributor acknowledges and agrees the except as provided by Section 1.2 of this Agreement, this Agreement will not be construed as granting by implication, estopped or otherwise any license or other right of use with respect to any present or future patent, copyright, trademark, trade name or other proprietary right owned by or licensed to the Company or any of its affiliates.\"}, {\"id\": \"5.6\", \"title\": \"No Action to Invalidate\", \"level\": 2, \"text\": \"5.6 No Action to Invalidate. During the Term of this Agreement and for three years thereafter, the Distributor (on behalf of itself and each of its affiliates) agrees not to commence, or provide any information to or otherwise assist any person or entity in connection with, any suit, action or proceeding contesting the ownership, validity or enforceability of any patent, copyright, trademark, trade name or other propriety right owned by or licensed to the Company, whether currently existing or hereinafter invented, developed or acquired unless required to by court order. The Distributor agrees to inform the Company promptly and cooperate with the Company in the event the Distributor obtains knowledge of any such suit, action or proceeding which has been initiated or is contemplated by any other person or entity.\"}, {\"id\": \"5.7\", \"title\": \"Nonsolicitation\", \"level\": 2, \"text\": \"5.7 Nonsolicitation. (A) During the Term of this Agreement and for a period of twelve (12) months thereafter, the Distributor (on behalf of itself, each of its affiliates and each of their respective representatives) agrees that it will not directly or indirectly solicit or hire any executive, managerial or technical employee of the Company or any of its affiliates. (B) Distributor further agrees that it will not interfere with or otherwise disrupt the business relations between the Company or nay of its affiliates and any of their current or prospective customers, suppliers or distributors, during the Page -11- Term of the Agreement and for a period of eighteen (18) months thereafter, nor will Distributor solicit any customer or potential customer of Company to purchase a competitive product during that period.\"}, {\"id\": \"5.8\", \"title\": \"Nonpublic Information\", \"level\": 2, \"text\": \"5.8. Nonpublic Information. The Distributor acknowledges that is it aware that the securities laws prohibit any person who has material, non-public information concerning the Company or the matters which are the subject of this Agreement from purchasing or selling securities of the Company (or options, warrants and rights relating thereto) and from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities.\"}, {\"id\": \"6\", \"title\": \"INTERPRETATION AND ENFORCEMENT\", \"level\": 1, \"text\": \"6. INTERPRETATION AND ENFORCEMENT\"}, {\"id\": \"6.1\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"6.1 Assignment. No assignment of this Agreement or any right accruing hereunder shall be made by the Distributor in whole or in part, without the prior written consent of the Company, which consent shall not be unreasonably withheld. As a condition to obtaining such consent, the Assignee of Distributor's interest hereunder shall first agree in writing in form and substance satisfactory to the Company, that is shall assume and be liable for the performance of all obligations imposes by this Agreement on Distributor, whether such obligations have then accrued are owing, or are yet to be performed, and shall demonstrate that is has the economic, and with approval of the assignment, the legal capability to perform all of the obligations of Distributor hereunder. Company may assign its interest in this agreement to any person or entity which has authority to fulfill Company's obligations hereunder and which has the economic ability to perform its obligations hereunder. Upon the assignment of a party's interest and rights in this Agreement the assigning party shall be relieved of all further obligations imposed by this Agreement. 6.2 Nonwaiver of Rights. Failure of either party to enforce any of the provisions of this Agreement or any rights with respect thereto or failure to exercise any election provided for herein shall in no way be a waiver of such provisions, rights or elections or in any way affect the validity of this Agreement. The failure of either party to exercise any of said provisions, rights or elections shall not preclude or prejudice such party from later enforcing or exercising the same or any other provisions, rights or elections which is may have under this Agreement.\"}, {\"id\": \"6.3\", \"title\": \"Invalid Provisions\", \"level\": 2, \"text\": \"6.3 Invalid Provisions. If any terms, provision, covenant, or condition of this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable, the remainder of the provisions shall remain in full force and effect and shall in no way be affected, impaired or invalidated.\"}, {\"id\": \"6.4\", \"title\": \"Notices\", \"level\": 2, \"text\": \"6.4 Notices. Any notice or other communication required or permitted hereunder shall be in writing and shall be delivered personally, telegraphed, telexed, or sent by facsimile transmission or sent by certified, registered or express mail, postage prepaid. Any such notice shall be deemed given when so delivered personally, Page -12- telegraphed, telexed or sent by facsimile transmission or, if mailed, two (2) business days after the date of deposit in the United States mail, by certified mail return receipt requested, as follows: If to the Distributor to: Electric City of Illinois L.L.C. 8628 Oketo Avenue Bridgeview, IL 60455 Facsimile No. (708) 598-4671 Attn: Jim Stumpe With a copy to: Thomas V. McCauley 200 W. Adams, Suite 2500 Chicago, IL 60606 Facsimile No. (312) 346-9316 If to Company to: Electric City Corp. 1280 Lanmeier Rd. Elk Grove Village, IL 60007 Attn: Joseph Marino, President With a copy to: Kwaitt & Ruben, Ltd. 211 Waukegan Road Suite 300 Northfield, Illinois 60093 Attn: Philip E. Ruben, Esq.\"}, {\"id\": \"6.5\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"6.5 Entire Agreement. This Agreement, together with all exhibits attached hereto which are hereby incorporated by reference, supersedes any and all other agreements, either oral or written, between the parties hereto with respect to the subject matter hereof and contains of the covenants and agreements between the parties with respect to said matter. This Agreement may not be altered, amended or modified, except by written instrument signed by the parties hereto.\"}, {\"id\": \"6.6\", \"title\": \"Sample Products\", \"level\": 2, \"text\": \"6.6 Sample Products. Company will, during the Term of this Agreement (and any renewal term), provide Distributor, at Distributor's cost pursuant to the terms of this Agreement, with five (5) sample units (the \\\"Sample\\\" or \\\"Samples\\\") for use by Distributor in promoting sales. Distributor shall use the Samples for purposes of permitting potential customers to use the Products in the field. The Samples purchased by Distributor hereunder shall count toward the minimum expectations under this Agreement.\"}, {\"id\": \"6.7\", \"title\": \"Time of the Essence\", \"level\": 2, \"text\": \"6.7 Time of the Essence. Time is of the essence of this Agreement. Page -13-\"}, {\"id\": \"6.8\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"6.8 Force Majeure. Neither party to this Agreement shall be liable to the other party, nor shall be subject to injunctive relief by the other party if that party's performance of its duties or obligations under this Agreement is the consequence of Force Majeure as defined in Section 2.2 hereunder.\"}, {\"id\": \"6.9\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"6.9 Governing Law. This Agreement is to be construed according to the laws of the State of Illinois.\"}, {\"id\": \"7\", \"title\": \"NEW PRODUCTS\", \"level\": 1, \"text\": \"7. NEW PRODUCTS\"}, {\"id\": \"7.1\", \"title\": \"Right of Option\", \"level\": 2, \"text\": \"7.1 Right of Option. Should Company introduce other products or devices as contemplated by recital paragraph \\\"A\\\", Distributor shall have the option of becoming Company's exclusive distributor of such other Products or devices within the Market.\"}, {\"id\": \"7.2\", \"title\": \"Exercise of Option\", \"level\": 2, \"text\": \"7.2 Exercise of Option. Distributor shall exercise its option to become exclusive Distributor of other Products or devices by serving written notification on Company of its election to become exclusive distributor within thirty (30) days upon which Company informed Distributor in writing of Company's intention to introduce other Products or devices. If Distributor does not exercise its option as herein provided, Company may distribute the other Products or devices within the Market itself or through other distributors.\"}, {\"id\": \"7.3\", \"title\": \"Other Agreements\", \"level\": 2, \"text\": \"7.3 Other Agreements. The terms pursuant to which such other Products or devices shall be sold by Company to Distributor shall be determined by a separate agreement, but such agreement shall be essentially on the same terms and conditions as herein provided, understanding that such terms as price, quotas, and length of the term of the agreement shall be reasonably adjusted to reflect the nature of the other Product or device which is the subject of the agreement. In witness whereof the parties have executed this Agreement as of the date first abovementioned. Electric City Corp. Electric City of Illinois L.L.C. By: /s/Joseph Marino By: Jim Stump ------------------- ------------------------------- President Page -14-\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of LIMEENERGYCO_09_09_1999-EX-10-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.6\", \"level\": 1, \"text\": \"EXHIBIT 10.6 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") is made by and between Electric City Corp., a Delaware corporation (\\\"Company\\\") and Electric City of Illinois LLC (\\\"Distributor\\\") this 7th day of September, 1999. RECITALS A. The Company's Business. The Company is presently engaged in the business of selling an energy efficiency device, which is referred to as an \\\"Energy Saver\\\" which may be improved or otherwise changed from its present composition (the \\\"Products\\\"). The Company may engage in the business of selling other products or other devices other than the Products, which will be considered Products if Distributor exercises its options pursuant to Section 7 hereof. B. Representations. As an inducement to the Company to enter into this Agreement, the Distributor has represented that it has or will have the facilities, personnel, and financial capability to promote the sale and use of Products. As an inducement to Distributor to enter into this Agreement the Company has represented that it has the facilities, personnel and financial capability to have the Products produced and supplied as needed pursuant to the terms hereof.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor's Objectives\", \"level\": 1, \"text\": \"C. The Distributor's Objectives. The Distributor desires to become a distributor for the Company and to develop demand for and sell and distribute Products solely for the use within the State of Illinois, including but not limited to public and private entities, institutions, corporations, public schools, park districts, corrections facilities, airports, government housing authorities and other government agencies and facilities (the \\\"Market\\\").\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Company's Appointment\", \"level\": 1, \"text\": \"D. The Company's Appointment. The Company appoints the Distributor as an exclusive distributor of Products in the Market, subject to the terms and conditions of this Agreement.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ESTABLISHMENT OF DISTRIBUTORSHIP\", \"level\": 1, \"text\": \"1. ESTABLISHMENT OF DISTRIBUTORSHIP\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Grant and Acceptance\", \"level\": 2, \"text\": \"1.1 Grant and Acceptance. Company hereby appoints Distributor as Company's exclusive distributor within the Market and grants to Distributor the exclusive right to sell and distribute Products within the Market, and Distributor hereby accepts such appointment and such grant, in accordance with the terms and conditions of this Agreement. Distributor acknowledges that customers of other distributors of the Products may have sites, locations or operations in the Market, which will use the Products. Distributor will sell any and all Products required by such customers in the Market to those customers. Distributor also acknowledges that if its customers have sites, locations or operations outside the Market, in the market of another exclusive distributor of the Products, those customers will be required to purchase products from the applicable exclusive distributor in that market; otherwise, Distributor shall be free to sell to its customers in any market which does not have another exclusive distributor.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"License\", \"level\": 2, \"text\": \"1.2 License. The Company hereby grants the Distributor the right to do business and use the name \\\"Electric City of Illinois\\\" or a similar variation thereof (collectively the \\\"Names\\\") for use under this Agreement. Distributor may file with the appropriate state and local authorities assumed name certificates as required. Copies of all documents relating to the use of the Names shall be forwarded to the Company. Upon termination of this Agreement Distributor shall have no further right to the Names and said License to use the Names shall terminate. Distributor shall have no right to sublicense the Names or to do business under any other names without the Company's prior approval in writing. The parties acknowledge that the terms herein consist of there terms for Illinois. At the request of either party, a new agreement reflecting the terms and conditions of this Agreement, may be executed for each state or entity representing each state.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"1.3 Term. The term of this Agreement shall be ten (10) years (the \\\"Term\\\") which shall commence on the date upon which the Company delivers to Distributor the last Sample, as defined hereinafter. If Distributor complies with all of the terms of this Agreement, the Agreement shall be renewable on an annual basis for one (1) year terms for up to another ten (10) years on the same terms and conditions as set forth herein. All renewals of this Agreement shall be on the same terms and conditions as are set forth herein.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company's Obligation\", \"level\": 2, \"text\": \"1.4 Company's Obligation. Company shall sell and deliver as provided in Section 2.3 of this Agreement to Distributor on the price terms set forth in this Agreement or as amended from time to time such quantity of Products as Distributor from time to time orders from Company. Company shall promote and advertise the Products generally, at its own expense, and shall furnish Distributor copies at all advertisement and promotional materials.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor's Obligation\", \"level\": 2, \"text\": \"1.5 The Distributor's Obligation. The Distributor, at its own expense, shall promote the distribution, sales, and use of Products in the Market.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor's Terms and Minimum Expectations\", \"level\": 2, \"text\": \"1.6 Distributor's Terms and Minimum Expectations. In order to maintain the exclusive rights to sell, lease, distribute and service Products in the Market, the Distributor must use all commercially reasonably efforts to purchase for sale to subdistributors the following minimum quantities of the Products from the Company: On the commencement of the Term Distributor will issue to the Company an irrevocable letter of credit (\\\"LC\\\") in the amount of Five Hundred Thousand Dollars ($500,000), the form of which is attached hereto as Exhibit A and incorporated herein by reference. The LC shall have a two (2) month term, and shall be renewed for five (5) consecutive bimonthly periods. A minimum of a $250,000.00 purchase order must be received by Company by the first of each month for a total (12) month period. The Company may draw funds from the LC to pay for Distributor's purchases, which are not paid according to the terms in Section 2.7. Prices for the EnergySaver units are Page -2- provided by the Company as Exhibit C. The Company will be entitled to draw against the LC pursuant to the terms of the LC. (A) 375 units in the first Product Year (1999) (B) 750 units in the next succeeding Product Year; (2000) (C) 937 units in the next succeeding Product Year; (2001) (D) 1,171 units in the next succeeding Product Year; (2002) (E) 1,463 units in the next succeeding Product Year; (2003) (F) 1,828 units in the next succeeding Product Year; (2004) (G) 2,285 units in the next succeeding Product Year; (2005) (H) 2,856 unit each in the lat three years of the initial Term of this Agreement and any renewals thereof. For purposes of this Agreement, a Product Year shall be the twelve (12) month period following the commencement of the initial Term of this Agreement and each twelve (12) months thereafter. Distributor's expected sales shall include the purchase of the Samples as defined hereinafter. Sales in excess of the expected sales which are actually made in a Product Year may be applied to meet the expectations for the next Product Year. Any such carry-over from one year to the next Product Year may not be considered in determining whether there is a carry-over from that next Product Year. Thus, by way of example and not limitation, if there was an expectation of 50 in year one and 200 for year two and 60 units are sold in year one and 195 units are sold in year two, the expectation for year two will have been met, but there will be no carry-over to year three. If the Distributor shall fail to purchase the minimum number of units in any year, the Distributor's exclusive rights to sell and distribute the Product in the Market, may at Company's sole option, be reevaluated. Company agrees that Distributor shall not be liable or subject to reevaluation for failure to meet expectations due to any occurrence beyond Distributor's reasonable control, including, but not limited to, Acts of God, fires, floods, wars, sabotage, accidents in shipping, labor disturbances, weather conditions, governmental regulation, lack of Company performance, delay by Company, failure of Company to honor warranties or otherwise materially support the Products. The aggregate units to be sold on an annual basis described above are for the Illinois distributorship on an aggregate basis.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Relationship of Parties\", \"level\": 2, \"text\": \"1.7 Relationship of Parties. The relationship between the Company and the Distributor Page -3- is that of vendor and vendee. This Agreement does not create the relationship of principal and agent between the Company and the Distributor for any purpose whatsoever. This Agreement shall not be construed as constituting the Distributor and the Company as partners, joint venturers, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or omission of the other party. Neither party is granted any express or implied right of authority by the other party to assume or to create any obligation or responsibility on behalf of or in the name of the other party, or to bind the other party in any manner or thing whatsoever.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PURCHASE OF PRODUCTS\", \"level\": 1, \"text\": \"2. PURCHASE OF PRODUCTS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Orders\", \"level\": 2, \"text\": \"2.1 Orders. The Distributor shall order Products from the Company on a purchase order form mutually acceptable to the Company and Distributor and which is consistent with Exhibit B hereto, and which incorporates the terms and provisions of this Distributor Agreement. The Distributor shall not order or purchase Products from any source other than the Company. All orders shall be subject to acceptance and confirmation by the Company. Distributor may cancel an order that is properly cancelled by Distributor's customer, unless the Company has commenced production which is in any way customized for that customer. The Distributor shall annually provide the Company with a non-binding forecast of orders for Products for the succeeding 12-month period.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shipment\", \"level\": 2, \"text\": \"2.2 Shipment. The Company and the Distributor shall jointly determine shipment dates. The Company shall use commercially reasonable efforts to ship promptly all orders for Products received from the Distributor. In addition to any other remedy which this Agreement provides to Distributor against Company, if Company fails to deliver or delays in delivering Products as were ordered by Distributor within 45 days after their required delivery date, and if as a result of such failure or delay Distributor loses its customer's orders for those Products, the number of units which Distributor ordered but were not timely delivered to Distributor or to Distributor's customer will be credited against Distributor's minimum expectation as specified on Section 1.6 of this Agreement. The Company may refuse to accept a purchase order on the grounds that it cannot meet the delivery schedule therein, and if as a result of such failure or delay Distributor loses its customer's orders for those Products, the number of units which Distributor ordered but were not timely delivered to Distributor or to Distributor's customer will be credited against Distributor's minimum. Distributor shall make reasonable efforts to notify the Company of the proposed delivery schedule before accepting a customer order and shall give the Company written notice of any customer purchase orders which imposes liability for late shipment and neither the Distributor nor the Company shall have a liability for consequential or liquidated damages pertaining to late delivery unless Company specifically acknowledges and agrees in writing to the same. The Distributor agrees that the Company shall not be liable for its failure to perform due to any occurrence beyond the Company's reasonable control, including, but not limited to, acts of God, fires, Page -4- floods, wars, sabotage, accidents in shipping beyond the Company's control, labor strikes other than strikes against the Company itself, weather conditions or foreign or domestic government regulation or authority which directly affects Company's ability to deliver Product.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery\", \"level\": 2, \"text\": \"2.3 Delivery. Other than \\\"drop ship\\\" deliveries, all deliveries made pursuant to this Agreement shall be FOB the Company's facilities located within the continental United States by a carrier authorized by the Distributor.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices\", \"level\": 2, \"text\": \"2.4. Prices. (A) Prices For Basic Units. The prices for Products in the first Product Year are supplied by Company as Exhibit C. (B) Inflation Price Adjustment. The prices set forth in Section 2.4(a) shall be subject to adjustment annually on the first day of each Product Year beginning in the calendar year 2000 and on the first day of each succeeding Product Year for the remainder of the Term and all renewals of this Agreement in proportion to the increase or decrease in the Consumer Price Index (CPI) as compared to the CPI as it existed on the first day of the Term of this Agreement. The Company also reserves the right to increase or decrease the price per unit based on Company wide changes in unit prices to all distributors of the Company, provided however, that any price changes, other than those based on the CPI, shall be uniformly applied to all distributors of the Products and shall reasonably applied to all distributors of the Products and shall reasonably reflect Company's costs of manufacturing the Products and/or market demand for the Products, provided further than any increase in price based upon market demand shall not be so great as to deprive Distributor of its normal and customary profit margin. The Company agrees to exercise this right in good faith, and consider all circumstances of the Distributor and the Company. The CPI referred to herein in issued by the Bureau of Labor Statistics of the U.S. Department of Labor. Should the Bureau of Labor Statistics discontinue publication of the CPI, the parties shall accept comparable statistics on the purchasing power of the consumer dollar as published at the time of said discontinuation by responsible periodical or recognized authority to be chosen by the parties.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resale Prices\", \"level\": 2, \"text\": \"2.5. Resale Prices. The Distributor may resell Products at such price, as the Distributor, in its sole discretion, shall determine. While the Company has the right to suggest a range of manufacturer's suggested retail prices for the Products, the distributor is not obligated to set retail prices within the Company's suggested range of retail prices.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Returns\", \"level\": 2, \"text\": \"2.6 Product Returns. Page -5- (A) Non-defective Products. Unless the Company has first authorized or permitted the return of any non-defective Products and except as otherwise permitted or required herein, the Company shall not be obligated to accept the return from the Distributor of any non-defective Products, nor to make any exchanges therefor, nor to credit the Distributor therefor. If Company does not give Annual Notice pursuant to Section 3.1 hereof, Distributor may, within 90 days of modification, improvement or alteration, return the Products to the Company. The Company shall not have any obligation with respect to Products after 365 days following delivery to Distributor, except as provided herein. (B) Defective Products. In the event of any damages or other defect in a Product which is discovered by Distributor within 365 days of satisfactory installation of a Product at Distributor's or a subdistributor's customer, the Distributor shall promptly report the same to the Company and reasonably demonstrate the defect to the Company. If the Distributor reasonably demonstrates that the Company is responsible for such damage or defect, the Company shall promptly deliver and install at the Company's expense, additional or substitute Products to the subdistributor's customer without additional cost or charge to the Distributor or the customer for material, labor, shipping, insurance or any other charge.\"}}, {\"id\": \"2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment Terms\", \"level\": 2, \"text\": \"2.7 Payment Terms. Distributor shall pay Company within thirty (30) days of Distributor's or, as the case may be, the end-user's receipt of Products.\"}}, {\"id\": \"2.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company Cooperation\", \"level\": 2, \"text\": \"2.8 Company Cooperation. The Company shall cooperate with the Distributor in obtaining all necessary permits and approvals to permit the use of the Products. The Company shall bear responsibility for any permits needed to manufacture the Products and Distributor shall bear responsibility for any permits needed to distribute the Products.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCTS AND WARRANTY\", \"level\": 1, \"text\": \"3. PRODUCTS AND WARRANTY\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Improvements by the Company\", \"level\": 2, \"text\": \"3.1 Product Improvements by the Company. At the Company's sole discretion, and at any time, the Company may give the Distributor at least 90 days advance notice (\\\"Annual Notice\\\") of any modification, improvement or alteration of Products (\\\"New Products\\\") and development of new models of Products (collectively with \\\"New Products\\\", \\\"Improved Products\\\"). Except for the Improved Products for which the Distributor receives the Annual Notice, the Company shall sell Improved Products to Distributor only with the consent of the Distributor. Any Improved Products shall be subject to the provisions of this Agreement. Old Products will remain available unless Page -6- Improved Products perform at the same or better levels and are offered at reasonably similar prices or at prices increases, which reasonably reflect improvements in performance.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Improvements by the Distributor\", \"level\": 2, \"text\": \"3.2 Product Improvements by the Distributor. The Distributor shall disclose to the Company any modifications to Products requested by end-users or other proposals for Product improvement from end-users or the Distributor, but shall have no right to make modifications without Distributor's consent.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty\", \"level\": 2, \"text\": \"3.3 Warranty. Company shall at all times make reasonable efforts to maintain quality control and to deliver Products to Distributor which, when received by Distributor, or, as the case may be, the end-user, are properly and adequately packaged and contained, fully assembled (except for miscellaneous components which may be shipped separately to prevent damage in transit), fully functional and otherwise in conformance with the warranties set forth herein. Company warrants that the Products will be designed, manufactured, constructed, assembled and packaged in a workmanlike manner and that such Products shall be fully functional and fit for their intended purposes. Company further warrants that the Products sold hereunder shall be free from defects in design, materials and workmanship for a period of twenty-four (24) months after delivery to Distributor's end-user. The Company shall not be liable for defective Products, except as provided in this Agreement. The Distributor at all times shall comply with all requirements of the Magnuson-Moss Warranty-Federal Trade Commission Improvement Act and similar federal and state laws and regulations.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty Work\", \"level\": 2, \"text\": \"3.4 Warranty Work. If, within the twenty-four (24) month warranty period set forth above, Company received from Distributor or any of Distributor's end-user's a notice which may be oral notice confirmed in writing) that any of the Products sold hereunder do not meet the Warranties specified above, Company shall thereupon correct each such defect by providing the necessary repairs, and/or replacement parts, or if necessary, Products. Company shall promptly respond to any timely notice of defect. Unless otherwise expressly agreed to in writing by Distributor or Distributor's and-user, Company shall bear the reasonable expense of all labor, materials and shipping expended or used in connection with the correction of any defects in the Products occasioned by the non-conformance of the Product with Company's warranty as set forth herein. Company shall be entitled to dispute whether a Product is defective. In the event that Company is unable or unwilling to promptly perform any warranty work without reasonable cause and following full and fair opportunity to do so, or in the event of the necessity for emergency repairs of a defective Product for which there is no reasonable possibility of performance by Company, Distributor may perform such warranty work or hire a third party to perform such warranty work and the reasonable cost thereof shall be paid by Company. Page -7-\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Service of Products in Territory\", \"level\": 2, \"text\": \"3.5 Service of Products in Territory. Within thirty (30) days after the execution of this Agreement, the Company and the Distributor shall mutually agree upon a reasonable schedule of charges for after market parts and services provided by the Company or the Distributor so that such charges do not adversely affect the marketability of the Products.\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Disclosure of Confidential Information\", \"level\": 2, \"text\": \"3.6. Non-Disclosure of Confidential Information. None of the parties hereto nor their associated or affiliated or affiliated companies shall during the term of this Agreement or thereafter disclose any confidential information obtained or acquired by them in connection with the Products and the business of the other, including, without limitation, trade secrets, business techniques, technical information, customer and potential customer lists, marketing data and information, prices, improvements to the Products in various stages of development, processes, or other confidential information relating to the Products or the business of the Distributor, except that either party shall be permitted to disclose (x) all or portions of such confidential information on a strictly need-to-know basis to the extent required by an order of a court of competent jurisdiction or by the order or demand of a regulatory body having jurisdiction over one or both parties and (y) any of such confidential information that is the sole property of the party making the disclosure and does not include any information owned by the other party. The Distributor shall not disclose this agreement except upon consent of Company. Confidential information shall not include information which: (A) Is or becomes generally available to the party who desires to disclose such information (or its associated or affiliated companies) (a \\\"Disclosing Party\\\") other than as a result of a breach of this Agreement or some other unlawful means; (B) Becomes available to the Disclosing Party on a non-confidential basis from a third party who is under no confidentiality or nondisclosure obligation with respect to such information; or (C) Was known to the Disclosing Party on a non-confidential basis prior to the disclosure thereof to such disclosing Party by a party to this Agreement.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DURATION AND TERMINATION\", \"level\": 1, \"text\": \"4. DURATION AND TERMINATION\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Duration\", \"level\": 2, \"text\": \"4.1 Duration. Unless earlier terminated otherwise provided therein, this Agreement, subject to the commencement date established in Section 1.3, shall be effective immediately. Distributor shall submit written reports to the Company each quarter during the first year of the Term, commencing ninety (90) days after execution of this Agreement, describing its efforts, the potential customers it has approached and the status of its efforts.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for Cause\", \"level\": 2, \"text\": \"4.2 Termination for Cause. Either party may terminate this Agreement upon 30 days Page -8- prior written notice to the other upon the occurrence of any of the following events: (A) the Distributor's failure to make full and prompt payment to the Company of all sums due and owing to it; (b) either party's default in the performance of any of the material, terms, conditions, obligations, undertakings, covenants or liabilities set forth herein and such default is not cured within a commercially reasonable time after the defaulting party has been notified of the default by the other party and (c) as otherwise expressly provided herein. In the event either party (a) becomes adjudicated insolvent, (b) discontinues its business, (c) has voluntary of involuntary bankruptcy proceedings instituted against it, or (d) makes an assignment for the benefit of creditors, the other party shall be entitled to terminate this Agreement effective immediately upon written notice.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Accrued Obligations\", \"level\": 2, \"text\": \"4.3 Accrued Obligations. In the event that either Distributor or Company fails to comply with the terms of this Agreement, both Distributor and Company acknowledge and agree that in addition to any claim for damages either party may have arising from the default of the other, they shall have the right to seek equitable relief by way of a temporary restraining order, preliminary injunction, permanent injunction and such other equitable relief as may be appropriate. In the event a party seeks the equitable relief of a temporary restraining order, preliminary injunction, permanent injunction, mandatory injunction or specific performance both parties acknowledge that they shall not be required to demonstrate the absence of an adequate remedy at law, and neither party shall be required to post bond as a precondition to obtaining a temporary restraining order or preliminary injunction. The termination of this Agreement shall not relieve either party hereto from obligations which have occurred pursuant to the provisions of this Agreement prior to its termination, nor shall it release either party hereto from any obligations which have been incurred as a result of operations conducted under this Agreement.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Repurchase of Products\", \"level\": 2, \"text\": \"4.4 Repurchase of Products. Upon the expiration or termination of this Agreement, pursuant to Section 4.1 or 4.2 hereof, the Company may, at its option to be exercised within 30 days of the date of the termination of this Agreement, and in its sole discretion, repurchase any Products in the possession of the Distributor at the net invoice price paid by the Distributor to the Company less any applicable special allowances, discounts, shipping or allowances for cooperative advertising. If Company terminates the Agreement without cause and for reasons other than Distributor's failure to meet its minimum expectations; it shall repurchase from Distributor any unopened Product, and shall bear all shipping, handling and related costs notwithstanding any other remedies to which Distributor may be entitled. On demand and tender of the repurchase price, the Distributor shall be obligated to deliver such Products to the Company. The Company reserves the right to reject any Products that are not factory sealed and in new and unused condition. Repurchased Products shall be shipped at the Company's expense, and the Company may offset any indebtedness of the Distributor to the Company against the repurchase price of such Products. Following expiration or termination of this Agreement, the Distributor may continue to sell any Products in the Market which are in its inventory Page -9- and which the Company has not repurchased.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES AND OTHER MATTERS\", \"level\": 1, \"text\": \"5. REPRESENTATIONS AND WARRANTIES AND OTHER MATTERS\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations and Warranties of Company\", \"level\": 2, \"text\": \"5.1 Representations and Warranties of Company. (A) The Company represents that, to the best of its knowledge, Products are in compliance with all laws, and that the Products will not be hazardous or dangerous when used for their intended purpose. Products do not cause harmful emissions or other environmental hazards and Products do not violate or infringe any patents, copyrights, trademarks or other rights of nay third party(ies). Company further represents and warrants that its Products will perform as advertised and promoted by the Company, and will be approved or certified by Underwriters Laboratory. (B) The Company will make available to Distributor comprehensive technical support for the first Product Year. Distributor will have direct access to (a) the Company's engineering consultants and (b) the patent holder's technicians. Company's representatives will make themselves available three days per month in the first Product Year to consult with and train Distributor. All costs and expenses associated with the services provided to Distributor hereunder, including travel, lodging, engineering consultants' fees and employee time will be paid by Distributor. (C) Company will timely furnish all of Distributor's requirements for Products within the Market, provided it is given adequate notice of Distributor's requirements and a full and fair opportunity to fulfill the same.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations and Warranties of Distributor\", \"level\": 2, \"text\": \"5.2 Representations and Warranties of Distributor. (A) Distributor shall be entirely responsible for learning, understanding and training about the Products, the costs of advertising and promoting the Products in the Market through the Term of this Agreement. Distributor shall not issue, print or disseminate any information about the Products in the first Product Year without the express written consent of the Company. (B) Distributor will not engage the services of any engineering or consulting firm without the express written consent of the Company.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification\", \"level\": 2, \"text\": \"5.3 Indemnification. Company and Distributor agree to indemnify, defend and hold each other harmless from any and all suits, claims, obligations, liabilities, damages, losses and the like (including attorneys' fees and costs) relating to or arising out of: (A) any breach of any material representations, warranties, covenants, obligations, agreements or duties in connection with this Agreement; (b) any negligence or fault; (c) any violation by either of them of the patent, copyright, trademark or other Page -10- intellectual property rights of third parties. In addition, Company agrees to indemnify, defend and hold harmless Distributor from and against all suits, claims, obligations, liabilities, damages, losses and the like (including attorneys' fees and costs) arising out of or related to Company's manufacture or design of the Products, provided that Distributor is not at fault in connection with the same, and Distributor agrees to indemnify, defend and hold harmless Company from and against all suits, claims, obligations, liabilities, damages, losses and the like (including a attorneys' fees and costs) arising out of or related to Distributor's sales, marketing practices or unauthorized Product alteration (provided that Company is not at fault in connection with same).\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Liability Insurance\", \"level\": 2, \"text\": \"5.4 Product Liability Insurance. Company will carry a reasonable amount of product liability insurance through a reasonably acceptable products liability insurance company and will name the Distributor as an additional insured under that policy. Company will make reasonable efforts to procure a policy, which is non-cancelable, except upon thirty (30) days, advance notice to the Distributor.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No License\", \"level\": 2, \"text\": \"5.5 No License. The Distributor acknowledges and agrees the except as provided by Section 1.2 of this Agreement, this Agreement will not be construed as granting by implication, estopped or otherwise any license or other right of use with respect to any present or future patent, copyright, trademark, trade name or other proprietary right owned by or licensed to the Company or any of its affiliates.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Action to Invalidate\", \"level\": 2, \"text\": \"5.6 No Action to Invalidate. During the Term of this Agreement and for three years thereafter, the Distributor (on behalf of itself and each of its affiliates) agrees not to commence, or provide any information to or otherwise assist any person or entity in connection with, any suit, action or proceeding contesting the ownership, validity or enforceability of any patent, copyright, trademark, trade name or other propriety right owned by or licensed to the Company, whether currently existing or hereinafter invented, developed or acquired unless required to by court order. The Distributor agrees to inform the Company promptly and cooperate with the Company in the event the Distributor obtains knowledge of any such suit, action or proceeding which has been initiated or is contemplated by any other person or entity.\"}}, {\"id\": \"5.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonsolicitation\", \"level\": 2, \"text\": \"5.7 Nonsolicitation. (A) During the Term of this Agreement and for a period of twelve (12) months thereafter, the Distributor (on behalf of itself, each of its affiliates and each of their respective representatives) agrees that it will not directly or indirectly solicit or hire any executive, managerial or technical employee of the Company or any of its affiliates. (B) Distributor further agrees that it will not interfere with or otherwise disrupt the business relations between the Company or nay of its affiliates and any of their current or prospective customers, suppliers or distributors, during the Page -11- Term of the Agreement and for a period of eighteen (18) months thereafter, nor will Distributor solicit any customer or potential customer of Company to purchase a competitive product during that period.\"}}, {\"id\": \"5.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonpublic Information\", \"level\": 2, \"text\": \"5.8. Nonpublic Information. The Distributor acknowledges that is it aware that the securities laws prohibit any person who has material, non-public information concerning the Company or the matters which are the subject of this Agreement from purchasing or selling securities of the Company (or options, warrants and rights relating thereto) and from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTERPRETATION AND ENFORCEMENT\", \"level\": 1, \"text\": \"6. INTERPRETATION AND ENFORCEMENT\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"6.1 Assignment. No assignment of this Agreement or any right accruing hereunder shall be made by the Distributor in whole or in part, without the prior written consent of the Company, which consent shall not be unreasonably withheld. As a condition to obtaining such consent, the Assignee of Distributor's interest hereunder shall first agree in writing in form and substance satisfactory to the Company, that is shall assume and be liable for the performance of all obligations imposes by this Agreement on Distributor, whether such obligations have then accrued are owing, or are yet to be performed, and shall demonstrate that is has the economic, and with approval of the assignment, the legal capability to perform all of the obligations of Distributor hereunder. Company may assign its interest in this agreement to any person or entity which has authority to fulfill Company's obligations hereunder and which has the economic ability to perform its obligations hereunder. Upon the assignment of a party's interest and rights in this Agreement the assigning party shall be relieved of all further obligations imposed by this Agreement. 6.2 Nonwaiver of Rights. Failure of either party to enforce any of the provisions of this Agreement or any rights with respect thereto or failure to exercise any election provided for herein shall in no way be a waiver of such provisions, rights or elections or in any way affect the validity of this Agreement. The failure of either party to exercise any of said provisions, rights or elections shall not preclude or prejudice such party from later enforcing or exercising the same or any other provisions, rights or elections which is may have under this Agreement.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Invalid Provisions\", \"level\": 2, \"text\": \"6.3 Invalid Provisions. If any terms, provision, covenant, or condition of this Agreement is held by a court of competent jurisdiction to be invalid, void, or unenforceable, the remainder of the provisions shall remain in full force and effect and shall in no way be affected, impaired or invalidated.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"6.4 Notices. Any notice or other communication required or permitted hereunder shall be in writing and shall be delivered personally, telegraphed, telexed, or sent by facsimile transmission or sent by certified, registered or express mail, postage prepaid. Any such notice shall be deemed given when so delivered personally, Page -12- telegraphed, telexed or sent by facsimile transmission or, if mailed, two (2) business days after the date of deposit in the United States mail, by certified mail return receipt requested, as follows: If to the Distributor to: Electric City of Illinois L.L.C. 8628 Oketo Avenue Bridgeview, IL 60455 Facsimile No. (708) 598-4671 Attn: Jim Stumpe With a copy to: Thomas V. McCauley 200 W. Adams, Suite 2500 Chicago, IL 60606 Facsimile No. (312) 346-9316 If to Company to: Electric City Corp. 1280 Lanmeier Rd. Elk Grove Village, IL 60007 Attn: Joseph Marino, President With a copy to: Kwaitt & Ruben, Ltd. 211 Waukegan Road Suite 300 Northfield, Illinois 60093 Attn: Philip E. Ruben, Esq.\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"6.5 Entire Agreement. This Agreement, together with all exhibits attached hereto which are hereby incorporated by reference, supersedes any and all other agreements, either oral or written, between the parties hereto with respect to the subject matter hereof and contains of the covenants and agreements between the parties with respect to said matter. This Agreement may not be altered, amended or modified, except by written instrument signed by the parties hereto.\"}}, {\"id\": \"6.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sample Products\", \"level\": 2, \"text\": \"6.6 Sample Products. Company will, during the Term of this Agreement (and any renewal term), provide Distributor, at Distributor's cost pursuant to the terms of this Agreement, with five (5) sample units (the \\\"Sample\\\" or \\\"Samples\\\") for use by Distributor in promoting sales. Distributor shall use the Samples for purposes of permitting potential customers to use the Products in the field. The Samples purchased by Distributor hereunder shall count toward the minimum expectations under this Agreement.\"}}, {\"id\": \"6.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Time of the Essence\", \"level\": 2, \"text\": \"6.7 Time of the Essence. Time is of the essence of this Agreement. Page -13-\"}}, {\"id\": \"6.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"6.8 Force Majeure. Neither party to this Agreement shall be liable to the other party, nor shall be subject to injunctive relief by the other party if that party's performance of its duties or obligations under this Agreement is the consequence of Force Majeure as defined in Section 2.2 hereunder.\"}}, {\"id\": \"6.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"6.9 Governing Law. This Agreement is to be construed according to the laws of the State of Illinois.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NEW PRODUCTS\", \"level\": 1, \"text\": \"7. NEW PRODUCTS\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Right of Option\", \"level\": 2, \"text\": \"7.1 Right of Option. Should Company introduce other products or devices as contemplated by recital paragraph \\\"A\\\", Distributor shall have the option of becoming Company's exclusive distributor of such other Products or devices within the Market.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exercise of Option\", \"level\": 2, \"text\": \"7.2 Exercise of Option. Distributor shall exercise its option to become exclusive Distributor of other Products or devices by serving written notification on Company of its election to become exclusive distributor within thirty (30) days upon which Company informed Distributor in writing of Company's intention to introduce other Products or devices. If Distributor does not exercise its option as herein provided, Company may distribute the other Products or devices within the Market itself or through other distributors.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Other Agreements\", \"level\": 2, \"text\": \"7.3 Other Agreements. The terms pursuant to which such other Products or devices shall be sold by Company to Distributor shall be determined by a separate agreement, but such agreement shall be essentially on the same terms and conditions as herein provided, understanding that such terms as price, quotas, and length of the term of the agreement shall be reasonably adjusted to reflect the nature of the other Product or device which is the subject of the agreement. In witness whereof the parties have executed this Agreement as of the date first abovementioned. Electric City Corp. Electric City of Illinois L.L.C. By: /s/Joseph Marino By: Jim Stump ------------------- ------------------------------- President Page -14-\"}}, {\"id\": \"party:Electric City Corp.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Electric City Corp.\", \"role\": \"Company\", \"address\": \"1280 Lanmeier Rd., Elk Grove Village, IL 60007\"}}, {\"id\": \"party:Electric City of Illinois LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Electric City of Illinois LLC\", \"role\": \"Distributor\", \"address\": \"8628 Oketo Avenue, Bridgeview, IL 60455\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Company\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company\", \"text\": \"Electric City Corp., a Delaware corporation (\\\"Company\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor\", \"text\": \"Electric City of Illinois LLC (\\\"Distributor\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"an energy efficiency device, which is referred to as an \\\"Energy Saver\\\" which may be improved or otherwise changed from its present composition (the \\\"Products\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Market\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Market\", \"text\": \"the State of Illinois, including but not limited to public and private entities, institutions, corporations, public schools, park districts, corrections facilities, airports, government housing authorities and other government agencies and facilities (the \\\"Market\\\")\", \"definition_clause\": \"C\"}}, {\"id\": \"term:Names\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Names\", \"text\": \"the right to do business and use the name \\\"Electric City of Illinois\\\" or a similar variation thereof (collectively the \\\"Names\\\")\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"The term of this Agreement shall be ten (10) years (the \\\"Term\\\")\", \"definition_clause\": \"1.3\"}}, {\"id\": \"term:LC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"LC\", \"text\": \"an irrevocable letter of credit (\\\"LC\\\")\", \"definition_clause\": \"1.6\"}}, {\"id\": \"term:Product Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Year\", \"text\": \"For purposes of this Agreement, a Product Year shall be the twelve (12) month period following the commencement of the initial Term of this Agreement and each twelve (12) months thereafter.\", \"definition_clause\": \"1.6\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"any occurrence beyond the Company's reasonable control, including, but not limited to, acts of God, fires, Page -4- floods, wars, sabotage, accidents in shipping beyond the Company's control, labor strikes other than strikes against the Company itself, weather conditions or foreign or domestic government regulation or authority which directly affects Company's ability to deliver Product.\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:Annual Notice\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Notice\", \"text\": \"at least 90 days advance notice (\\\"Annual Notice\\\")\", \"definition_clause\": \"3.1\"}}, {\"id\": \"term:New Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"New Products\", \"text\": \"any modification, improvement or alteration of Products (\\\"New Products\\\")\", \"definition_clause\": \"3.1\"}}, {\"id\": \"term:Improved Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Improved Products\", \"text\": \"development of new models of Products (collectively with \\\"New Products\\\", \\\"Improved Products\\\")\", \"definition_clause\": \"3.1\"}}, {\"id\": \"term:Disclosing Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disclosing Party\", \"text\": \"the party who desires to disclose such information (or its associated or affiliated companies) (a \\\"Disclosing Party\\\")\", \"definition_clause\": \"3.6\"}}, {\"id\": \"term:Sample\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sample\", \"text\": \"five (5) sample units (the \\\"Sample\\\" or \\\"Samples\\\")\", \"definition_clause\": \"6.6\"}}, {\"id\": \"value:ten (10) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) years\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:$500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$500,000\"}}, {\"id\": \"value:two (2) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) month\"}}, {\"id\": \"value:$250,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$250,000.00\"}}, {\"id\": \"value:(12) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"(12) month\"}}, {\"id\": \"value:twelve (12) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) month\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"value:12-month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12-month\"}}, {\"id\": \"value:45 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"45 days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:365 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"365 days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:twenty-four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) months\"}}, {\"id\": \"value:twenty-four (24) month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) month\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:three days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three days\"}}, {\"id\": \"value:three years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three years\"}}, {\"id\": \"value:eighteen (18) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"eighteen (18) months\"}}, {\"id\": \"value:two (2) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of LOYALTYPOINTINC_11_16_2004-EX-10.2-RESELLER AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of LOYALTYPOINTINC_11_16_2004-EX-10.2-RESELLER AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.2\", \"level\": 1, \"text\": \"EXHIBIT 10.2 [LOGO AMERICAN EXPRESS] INCENTIVE SERVICES -------------------------------------------------------------------------------- RESELLER INFORMATION Company Name: Schoolpop, Inc. Address:3885 Crestwood Parkway, Suite 550 City: Duluth State: GA Zip: 30096 Contact Name: Paul Robinson Phone: 770-638-5101 Fax: 770-638-5101 TAX ID #: E mail Add: probinson@Schoolpop.com AMERICAN EXPRESS INCENTIVE SERVICES STORED VALUE PRODUCTS RESELLER AGREEMENT This Distribution Agreement (the \\\"Agreement\\\") is entered into by and between American Express Incentive Services, L.L.C., a Missouri limited liability company (\\\"AEIS\\\"), and its Reseller, Schoolpop, Inc., a Delaware corporation (\\\"Schoolpop\\\"). This Agreement is effective as of August 1, 2004, (the \\\"Effective Date\\\") and shall terminate on July 31, 2009, (the \\\"Termination Date\\\") unless earlier terminated or extended as provided for herein. The following points outline this agreement:\"}, {\"id\": \"1\", \"title\": \"PURPOSE\", \"level\": 1, \"text\": \"1. PURPOSE Under and subject to the terms of this Agreement: a. AEIS will provide Schoolpop for resale the following stored value cards: Encompass(R) Select, Persona(R) Select, Fill It Up(R), and Be My Guest(R), and any other stored value products developed by AEIS and mutually agreed upon by both parties, (\\\"Cards\\\"). The Cards shall be sold only to those of Schoolpop's clients and prospective clients (the \\\"Clients\\\"), in the United States who are nonprofit organizations, (\\\"NPO Marketplace\\\"), which are defined as organizations that are (i) a school, (ii) an organization formed as not-for-profit under its charter documents, or (iii) an organization related to (i) or (ii) such as a participating school's Parent Teacher Organization or other similarly related organization. b. Period One shall mean the Effective Date through the date that Schoolpop has met all of the Security Requirements as such term is defined herein and has received approval from AEIS to assume all Card inventory, distribution and fulfillment responsibilities as currently managed by AEIS. Period Two shall commence with the end of Period One through the Termination Date.\"}, {\"id\": \"2\", \"title\": \"EXCLUSIVITY\", \"level\": 1, \"text\": \"2. EXCLUSIVITY a. Schoolpop shall have the exclusive right to resell Cards in the NPO Marketplace. Notwithstanding the foregoing, Schoolpop shall fund from AEIS a minimum of $52,000,000 of Cards (the \\\"Guaranteed Minimum\\\") in each Contract Year in order to maintain the exclusive right to sell Cards in the NPO Marketplace. A Contract Year shall be the period of August 1 through July 31 of the succeeding year. In any Contract Year in which Schoolpop fails to fund the Guaranteed Minimum, AEIS shall have the right, in its sole discretion, to (a) terminate the Agreement or (b) revoke the exclusivity. b. In consideration of the exclusivity referred to above, Schoolpop shall pay AEIS a marketing rights fee (\\\"Marketing Rights Fee\\\"), of $1,250,000. The Marketing Rights Fee shall be paid in five (5) equal installments of $250,000 on March 15th of each year with the first such payment being due on March 15, 2005 and with the final payment due on March 15, 2009.\"}, {\"id\": \"c\", \"title\": \"Schoolpop shall also pay AEIS a fee of $250,000, (the \\\"Encompass(R) Select Fee\\\") as considerati\", \"level\": 1, \"text\": \"c. Schoolpop shall also pay AEIS a fee of $250,000, (the \\\"Encompass(R) Select Fee\\\") as consideration for the right to sell the Encompass(R) Select Card through December 31, 2004. The Encompass(R) Select Fee shall be payable concurrently with the execution of this Agreement.\"}, {\"id\": \"d\", \"title\": \"Schoolpop understands and agrees that this Agreement does not grant Schoolpop any exclusive rig\", \"level\": 1, \"text\": \"d. Schoolpop understands and agrees that this Agreement does not grant Schoolpop any exclusive right to market the Cards or any other AEIS products and services outside of the NPO Marketplace. AEIS, on its own behalf, reserves the right to market its Cards and other products and services directly as 1 well as through additional firms on terms and conditions that it selects in its sole discretion, provided that no such sales shall take place within the NPO Marketplace.\"}, {\"id\": \"3\", \"title\": \"INVENTORY AND FORECASTING\", \"level\": 1, \"text\": \"3. INVENTORY AND FORECASTING a. Schoolpop shall secure a physical location for maintaining, distributing, and fulfilling Card inventory no later than August 1, 2004 which location shall be subject to such security requirements (the \\\"Security Requirements\\\") as shall be required by AEIS or American Express Travel Related Services, Inc. all as further set forth in the Trust Agreement attached hereto as Exhibit 1. b. Schoolpop shall effectively manage its Card inventory and Ordering schedule such that all Cards are resold and distributed to the Client with the following Card expiration lives (the \\\"Card Life\\\") intact:\"}, {\"id\": \"i\", \"title\": \"Persona(R) Select - nine (9) months ii\", \"level\": 1, \"text\": \"i. Persona(R) Select - nine (9) months ii. Encompass(R) Select, Be My Guest(R), Fill It Up(R) - three (3) months The Card life of any Cards other than Cards specifically indicated in b(i). and b(ii) above (\\\"New Cards\\\"), shall be mutually agreed upon in writing.\"}, {\"id\": \"c\", \"title\": \"During Period One, Card expiration shall be determined by the date Schoolpop places an Order (t\", \"level\": 1, \"text\": \"c. During Period One, Card expiration shall be determined by the date Schoolpop places an Order (the \\\"Order\\\") and provides full payment and clearance of funding. During Period Two, Card Life shall be determined by the date Schoolpop places an Order.\"}, {\"id\": \"d\", \"title\": \"Should any Card expire or lose Card Life prior to distribution, Schoolpop shall assume all loss\", \"level\": 1, \"text\": \"d. Should any Card expire or lose Card Life prior to distribution, Schoolpop shall assume all loss associated with the Card funding, if applicable, and shall pay AEIS a $2.00 per Card destruction fee. Schoolpop shall not return such Cards to AEIS, and shall follow the destruction process as detailed in the Trust Agreement. e. Card Life shall be unaffected by the termination of this Agreement. f. From the Effective Date through September 30, 2004, Schoolpop may order non-standard Encompass(R) Select denominations (other than 25, 50, 75, and 100 Points) up to a maximum of 200 Points. Such non-standard Encompass(R) Select denominations require eight (8) weeks to fulfill and must be ordered in boxes of 100 Cards of like denominations. Schoolpop shall discontinue reselling Encompass(R) Select Cards on December 31, 2004 and shall effectively manage and forecast Encompass(R) Select Card needs to deplete such inventory as of December 31, 2004. In the event that any unsold Encompass(R) Select Cards remain in inventory by Schoolpop on December 31, 2004, Schoolpop shall provide to AEIS, no later than January 5, 2005, the Encompass(R) Select Card numbers, the respective expiration dates and denominations of the Cards. AEIS shall invoice Schoolpop for the applicable Card destruction fees which shall be payable by Schoolpop within thirty days (30) of receipt of invoice. Such Card list shall be submitted on a disk/CD and shall be sent via a form of shipment where signature is required upon delivery. g. Effective with Period Two, Schoolpop shall provide to AEIS a twelve (12) month sold Card forecast and Card inventory forecast (hereinafter defined). In addition, Schoolpop shall provide AEIS with a monthly forecast, no later than the third business day of each month, of the number of Cards to be sold to its clients, (\\\"Sold Card Forecast\\\") as well as the number of Cards to be stocked in inventory, (\\\"Card Inventory Forecast\\\"), (collectively referred to as the \\\"Forecasts\\\") for the month, ninety-days out. For example, Schoolpop shall provide AEIS with the Card Inventory Forecast and Sold Card Forecast in August for the month of November. The Forecasts will be relied on, (\\\"Locked\\\") at the time they are reported. h. Changes to the Forecasts within the Locked period are expected. However, any changes to Locked Forecasts will not impact any applicable penalties as detailed below in subsections (i) and (j). AEIS will place reliance on the Forecasts provided by Schoolpop to align resources and ensure adequate production, fulfillment and customer service capabilities. Schoolpop shall provide AEIS with any changes to the Locked Forecasts on a monthly basis including any respective changes to either Forecast for the remaining twelve (12) month period.\"}, {\"id\": \"i\", \"title\": \"In any consecutive three (3) month period in which the difference between the Card Inventory Fo\", \"level\": 1, \"text\": \"i. In any consecutive three (3) month period in which the difference between the Card Inventory Forecast less the actual Card Order volume for that period is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, (\\\"Card Inventory Penalty\\\") of sixteen and one-half cents ($0.165) per Card for such difference as detailed in Examples 1 and 2 below. --------------------------------------------------------------------------------------------- EXAMPLE 1 --------------- --------------------- ------------------ ------------------ ----------------- FORECAST PERIOD ACTUAL VOLUME FORECASTED VOLUME DIFFERENCE --------------- --------------------- ------------------ ------------------ ----------------- MONTH 1 10/1/04-10/31/04 8,000 10,000 (2,000) 20% --------------- --------------------- ------------------ ------------------ ----------------- MONTH 2 11/1/04-11/30/04 8,500 10,000 (1,500) 15% --------------- --------------------- ------------------ ------------------ ----------------- MONTH 3 12/01/04-12/31/04 8750 10,000 (1,250) 12.5% ------------------------------------------------------- ------------------------------------- PENALTY 4,750 X $0.165 = $783.75 --------------------------------------------------------------------------------------------- 2 --------------------------------------------------------------------------------------------- EXAMPLE 2 --------------- --------------------- ----------------- ------------------- ----------------- MONTH 1 12/1/04-12/31/04 10,500 11,000 (500) 4.5% --------------- --------------------- ----------------- ------------------- ----------------- MONTH 2 1/1/05-1/31/05 10,000 13,000 (3,000) 23% --------------- --------------------- ----------------- ------------------- ----------------- MONTH 3 02/01/05-02/28/05 12,000 12,500 (500) 4% ------------------------------------------------------- ------------------------------------- PENALTY NO PENALTY ------------------------------------------------------- ------------------------------------- j. In any given month where the difference between the Sold Card Forecast less the actual Card activation volume, (\\\"Cards in Force\\\") is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, the (\\\"Customer Service Penalty\\\") which shall be calculated by converting Cards in Force into call volume minutes as follows:\"}, {\"id\": \"i\", \"title\": \"Cards in Force times the call to card ratio times the average handle time equals the t\", \"level\": 1, \"text\": \"i. Cards in Force times the call to card ratio times the average handle time equals the total call volume minutes. AEIS will calculate the respective product's average year-to-date call to Card ratio and the average year-to-date handle time monthly to calculate the call volume minutes. For purposes of example, the year-to-date through August 2004, Encompass(R) Select average call to Card ratio is 2.43 and the average handle time is 4.0 minutes. &sbsp; ii. Actual call volume minutes under 90% of the Card Sold Forecast will be charged at 90% of Locked Rolling Forecast at the standard rate of $0.50 per minute. Schoolpop's Customer Service Penalty shall be calculated at the difference between actual call volume minutes and 90% of Card Sold Forecast call volume minutes.\"}, {\"id\": \"iii\", \"title\": \"The Customer Service Penalty shall be calculated based upon the a) call volume minutes p\", \"level\": 1, \"text\": \"iii. The Customer Service Penalty shall be calculated based upon the a) call volume minutes plus b) Cards in Force as detailed in the example below:\"}, {\"id\": \"l\", \"title\": \"Schoolpop shall pay AEIS all incurred penalties within thirty (30) days of receipt of invoice f\", \"level\": 1, \"text\": \"l. Schoolpop shall pay AEIS all incurred penalties within thirty (30) days of receipt of invoice for such penalties by AEIS.\"}, {\"id\": \"m\", \"title\": \"At any given time during this Agreement, Schoolpop's inactive Card inventory shall be limited t\", \"level\": 1, \"text\": \"m. At any given time during this Agreement, Schoolpop's inactive Card inventory shall be limited to $3,000,000 in Card value as determined by the Point denomination on each Card. This limit &sbsp; shall consist of a maximum Card value of $1,500,000 in Encompass(R) Select Cards and $1,500,000 Card value in any other product (s). Effective January 1, 2005, after which Encompass(R) Select shall no longer be available to Schoolpop, the maximum inactive Card value shall not exceed $3,000,000 in any combination of products at any given time. In the event that Schoolpop exceeds either of these limits, AEIS shall cease fulfilling Orders from Schoolpop until such time that Schoolpop's inventory returns to an acceptable level based on the established maximums. n. Any New Cards shall be excluded from the forecasting and penalty provisions of this Section 3 for the three (3) month period commencing on the date of the first order of such New Cards.\"}, {\"id\": \"4\", \"title\": \"CARD ISSUANCE\", \"level\": 1, \"text\": \"4. CARD ISSUANCE a. Schoolpop agrees that it will review all requests for each Program requested by the Client and will use reasonable and customary business practices to qualify and recommend Clients proposed for a Program. Schoolpop shall take commercially reasonable efforts to ensure all information requested for a Client is true, accurate and correct. b. AEIS may, from time to time, provide Schoolpop with commercially reasonable qualification standards for Clients. Schoolpop shall not knowingly submit an Order to AEIS on behalf of any Client that does not meet any such standards. Schoolpop agrees that it will sell Cards only to Clients and only for use in connection with a bona fide fund raising program. Schoolpop will not knowingly sell Cards to any Client who does not meet any AEIS qualification standard(s) or to any 3 Client or potential Client that Schoolpop has reason to believe would be unsatisfactory to AEIS.\"}, {\"id\": \"c\", \"title\": \"AEIS reserves the right at any time, with or without cause, with reasonable written notice to S\", \"level\": 1, \"text\": \"c. AEIS reserves the right at any time, with or without cause, with reasonable written notice to Schoolpop, to cancel or decline any Client's participation in the Program.\"}, {\"id\": \"d\", \"title\": \"AEIS may, at its sole discretion, decline to provide Cards to Clients\", \"level\": 1, \"text\": \"d. AEIS may, at its sole discretion, decline to provide Cards to Clients. e. Cards are intended for use in the United States and must be designated for receipt of shipment within the United States. f. AEIS' designated vendor will be responsible for shipping Cards in accordance with Schoolpop's instructions. g. AEIS's designated vendor will ship the Cards as follows:\"}, {\"id\": \"i\", \"title\": \"During Period One, AEIS' designated vendor will use reasonable commercial efforts to s\", \"level\": 1, \"text\": \"i. During Period One, AEIS' designated vendor will use reasonable commercial efforts to ship the Cards as detailed below, following receipt and clearance by AEIS of Card Funding.\"}, {\"id\": \"ii\", \"title\": \"During Period Two, AEIS' designated vendor will use reasonable commercial efforts to sh\", \"level\": 1, \"text\": \"ii. During Period Two, AEIS' designated vendor will use reasonable commercial efforts to ship the Cards as detailed below, following receipt of Card Order placed by Schoolpop. The initial Order of (a) standard non-branded Cards within 5 business days after set-up; subsequent Orders, (b) of less than 5,000 Cards per day within three (3) to five (5) business days of receipt of Order; (c) forecasted Orders of 5,000 or more Cards per day within eight (8) to thirteen (13) business days of receipt of Order; and (d) non-forecasted Orders of 5,000 or more Cards per day within twenty (20) to thirty (30) business days of receipt of Order. All shipment timelines are subject to change without notice due to seasonal or unforecasted production volume and AEIS shall work with its Card production vendor and use reasonable commercial efforts to secure the most favorable shipment date commitment and shall notify Schoolpop accordingly. h. One point is worth one (1) U.S. Dollar ($1.00 USD) (\\\"Point\\\").\"}, {\"id\": \"i\", \"title\": \"AEIS shall ship Cards in bulk shipment via its designated vendor to Schoolpop, F\", \"level\": 1, \"text\": \"i. AEIS shall ship Cards in bulk shipment via its designated vendor to Schoolpop, F.O.B. Atlanta, Georgia. Schoolpop shall distribute to each Cardholder the Cardholder agreement as provided with each Card and which includes instructions on \\\"How to Use the Card\\\". Should Schoolpop or its Client distribute Cards without such Cardholder agreement, Schoolpop shall indemnify and hold harmless AEIS, its parents, subsidiaries and their respective affiliates, officers, directors, employees and agents, against any and all Loss, hereinafter defined, that AEIS may incur or be subjected to as a result of such action, including, without limitation, any claims brought by any entity including but not limited to governmental entities and Cardholders. j. Purchases made with a Card having insufficient Points will be deemed a deniable transaction. The correct way to handle the purchase is described in the Cardholder agreement. If there is a purchase made on a Card where there are insufficient Points on the Card, the negative amount will be the responsibility of the person whose signature appears on the Card, as described in the Cardholder agreement. k. CARDS LOST OR STOLEN IN TRANSIT IN THE INITIAL SHIPMENT FROM AEIS WILL BE THE RESPONSIBILITY OF AEIS. The full risk of loss for ordered Cards shall pass to Schoolpop immediately upon their delivery to Schoolpop by AEIS and AEIS shall not reimburse Schoolpop or Client for any delivered Card that is lost, stolen, misappropriated, or that otherwise disappears or is fraudulently or inappropriately used (together referred to as \\\"Loss\\\"). Schoolpop shall remain solely liable for any Loss caused by the negligence or willful misconduct of its employees, agents or representatives after the shipment has been received by Schoolpop. AEIS will not reimburse Schoolpop or its Client or be responsible for any Loss in connection with or after delivery of Cards to Schoolpop, its Clients or the Cardholder whether they are shipped to Schoolpop, its Client, or to either of their pre-designated delivery agents. Only Cardholders are eligible to receive replacements from AEIS and replacements are given only in accordance with the agreement between the Cardholder and AEIS. Cards are usually shipped in packaging with AEIS' designated vendor as the return address. Notwithstanding the foregoing, AEIS shall bear no risk of Loss and of non-receipt of Cards by the intended Cardholder in the event that AEIS is instructed to use another address as the return address, the address provided to AEIS for Schoolpop or the Client was incorrect, the request for the Card was unauthorized, and/or any information received by AEIS with regard to the processing of the Order was fraudulent or incorrect.\"}, {\"id\": \"l\", \"title\": \"All agreements entered into between Schoolpop and its Clients, shall contain a provision substa\", \"level\": 1, \"text\": \"l. All agreements entered into between Schoolpop and its Clients, shall contain a provision substantially similar to the preceding Section 3 (k). 4\"}, {\"id\": \"m\", \"title\": \"During the term hereof, Schoolpop shall maintain at all times the following information with re\", \"level\": 1, \"text\": \"m. During the term hereof, Schoolpop shall maintain at all times the following information with respect to Card resale and distribution to Client:\"}, {\"id\": \"i\", \"title\": \"For each box of Cards, or partial thereof, sent from AEIS's designated vendor to Schoo\", \"level\": 1, \"text\": \"i. For each box of Cards, or partial thereof, sent from AEIS's designated vendor to Schoolpop, the UPS(TM) Tracking number appearing on the shipping label of the box and the respective Card numbers for the Cards contained in the box (AEIS's shipping vendor shall include a list of Card numbers within each box.), and\"}, {\"id\": \"ii\", \"title\": \"The Client name and delivery date of each box of Cards or partial thereof, sent from Sc\", \"level\": 1, \"text\": \"ii. The Client name and delivery date of each box of Cards or partial thereof, sent from Schoolpop via their designated shipping vendor, to the Client, including proof of signature and tracking number for the box, specific to Schoolpop's shipping vendor. n. Schoolpop shall comply with all applicable Federal, State and local laws concerning the use of Cards, including anti-money laundering and anti-terrorism laws, and currency control regulations. Schoolpop warrants it shall take measures to track information about its Clients which shall meet compliance requirements related to the above stated laws, track all Card shipment(s) to each such Client, and maintain appropriate records for its Clients for a period of seven (7) years after termination of the Agreement and to provide such records and other information to AEIS upon reasonable request and subject to applicable law. Schoolpop shall further inform in writing all of its Clients of their requirement to comply with all applicable laws concerning the use of Cards, including those laws stated in the previous sentence. School shall inform its Clients of the requirement to maintain records with respect to the Cards and Cardholders, and to verify the identity of Cardholders as required by law, to maintain records of the information used to verify each Cardholder's identity, to retain such records for at least seven (7) years following the date of distribution, including &sbsp; name, home address, Card number, and other identifying information, and the name, title and phone number of the individual responsible for maintaining such records, and to provide such records and other information to AEIS upon reasonable request and subject to applicable law. Schoolpop and Schoolpop's Clients shall establish and maintain an anti-money laundering program with an assigned compliance officer and compliance program. Details of such shall be provided to AEIS upon request. Schoolpop and Schoolpop's Clients shall not accept cash, coin or currency in exchange for Cards. Schoolpop shall indemnify and hold harmless AEIS its parents, subsidiaries and their respective affiliates, officers, directors, employees and agents, against any and all Loss that AEIS may incur or be subjected to as a result of or arising out of Schoolpop's failure to comply with such laws and regulations, including, without limitation, any Loss resulting from any claims brought by any entity including but not limited to governmental entities, unless due to the acts or omissions of AEIS. AEIS reserves the right, at its sole discretion, to monitor and enforce Schoolpop's compliance with all applicable laws and regulations, including but not limited to those contained in this Section 3 (n). Schoolpop shall monitor and use reasonable commercial efforts to enforce its Clients' compliance with all applicable laws and regulations including, but not limited to those contained in this Section 3 (n). All agreements entered into between Schoolpop and its Clients shall contain a provision substantially similar to this Section 3 (n). o. Schoolpop agrees that it will indemnify and hold AEIS harmless for any claims or losses resulting from its failure to comply with the requirements of Sections 4 (k), (m-n), unless due to the acts or omissions of AEIS. p. AEIS will not hold Schoolpop responsible for or seek to collect from Schoolpop any Loss caused by or resulting from any Cardholder's fraud, misuse, or negative balance transactions involving the Cards except to the extent such Loss was caused by Schoolpop's breach of a representation, warranty, or covenant of this Agreement or if Schoolpop (or Schoolpop's employees, agents or representatives) participated in or had knowledge of any deceptive, fraudulent or other illegal activity. q. Schoolpop acknowledges that Points must be used prior to the expiration date of the Cards. No refund will be made with respect to Points remaining on Cards at the time of expiration to Schoolpop, its Clients or the Cardholders, subject to applicable law. Schoolpop further acknowledges the Cardholder Agreement contains such notice to Cardholders.\"}, {\"id\": \"5\", \"title\": \"PAYMENT INSTRUCTIONS\", \"level\": 1, \"text\": \"5. PAYMENT INSTRUCTIONS a. Effective Period One, Schoolpop shall provide full payment of Card funding via wire transfer for Orders placed through the end of Period One. AEIS shall fulfill such Orders upon receipt and clearance of funds. b. Effective Period Two, Schoolpop shall provide the full payment of Card funding via ACH Debit at the time Schoolpop requests activation of Cards. AEIS shall activate the Cards by loading the appropriate number of Points onto the Cards as determined by the denomination, and at which time the Cards shall be ready for use by Cardholders within two (2) business days. 5\"}, {\"id\": \"c\", \"title\": \"Schoolpop shall pay AEIS $25\", \"level\": 1, \"text\": \"c. Schoolpop shall pay AEIS $25.00 each time a wire transfer is used for amounts under $5,000.\"}, {\"id\": \"d\", \"title\": \"The Schoolpop account number as detailed on Exhibit 3, attached hereto, must be on each form of\", \"level\": 1, \"text\": \"d. The Schoolpop account number as detailed on Exhibit 3, attached hereto, must be on each form of payment along with the amount of funding to be applied to each account number. Failure to provide AEIS with this account number and funding detail may result in a delay in Funding. e. Schoolpop shall pay AEIS $15.00 for each returned ACH Debit payment. f. All instruments bearing funds for Cards should be made payable to American Express Incentive Services, L.L.C. AEIS' required payment method is in U.S. currency. AEIS reserves the right to decline payment made in any other currency. g. The following instructions should be used for Electronic Settlements to AEIS: American Express Incentive Services c/o Bank of America Dallas, TX Routing/ABA #111000012 Account #375-100-6936 Reference: XXXX (Client Name and Account #) All invoices for Schoolpop should be sent to the following address: Schoolpop, Inc. Attn: Paul Robinson Address: 3885 Crestwood Parkway, Suite 550 City, State, Zip: Duluth, GA 30096 Phone #: 770-638-5101 Fax #: 770-678-3334 Email address: probinson@Schoolpop.com Schoolpop agrees to notify AEIS promptly in the event the address or contact for invoice submission changes.\"}, {\"id\": \"6\", \"title\": \"ORDERING INSTRUCTIONS\", \"level\": 1, \"text\": \"6. ORDERING INSTRUCTIONS a. Effective Period One, Schoolpop's designated contact shall place Orders by submitting data in an electronic document via email to AEIS. b. Schoolpop will be assigned a user name and password that will be used for identification when placing Orders using easyorder(TM). Schoolpop authorizes AEIS to accept and process Orders from anyone using Schoolpop's password. AEIS will have no obligation or responsibility for verifying the identity of anyone using Schoolpop's password. Schoolpop shall have the responsibility of safeguarding Schoolpop's password and should not reveal its password to anyone. AEIS will not ask Schoolpop in an unsolicited telephone call or email for its password. In addition, Schoolpop should take precautions when using a computer that is not its own or in a public setting. If Schoolpop suspects that someone else may have had access to its password, Schoolpop shall notify AEIS immediately.\"}, {\"id\": \"c\", \"title\": \"Effective with Period Two, the following ordering terms and conditions apply\", \"level\": 1, \"text\": \"c. Effective with Period Two, the following ordering terms and conditions apply:\"}, {\"id\": \"i\", \"title\": \"Schoolpop shall order Cards in increments of 100 per box and shall not place Orders fo\", \"level\": 1, \"text\": \"i. Schoolpop shall order Cards in increments of 100 per box and shall not place Orders for any partial box (es) of 100, nor request any partial activation of any box (es).\"}, {\"id\": \"ii\", \"title\": \"Cards within each box shall be of the same product and Point value\", \"level\": 1, \"text\": \"ii. Cards within each box shall be of the same product and Point value. AEIS shall not mix products and/or Point values within any single box.\"}, {\"id\": \"iii\", \"title\": \"Upon receipt of Cards, Schoolpop shall confirm receipt of such Cards as detailed in the\", \"level\": 1, \"text\": \"iii. Upon receipt of Cards, Schoolpop shall confirm receipt of such Cards as detailed in the Trust Agreement.\"}, {\"id\": \"iv\", \"title\": \"AEIS shall use commercially reasonable efforts to activate each full box of Cards withi\", \"level\": 1, \"text\": \"iv. AEIS shall use commercially reasonable efforts to activate each full box of Cards within two (2) &sbsp; business days upon receipt of the UPS(TM) Tracking number (used by AEIS's designated shipping vendor) for the box of Cards from Schoolpop along with the receipt and clearance of Card funding for the box of Cards.\"}, {\"id\": \"v\", \"title\": \"Once activated, all Cards become the property of Schoolpop, excluding all Marks as det\", \"level\": 1, \"text\": \"v. Once activated, all Cards become the property of Schoolpop, excluding all Marks as detailed in Section 8, and further defined within the Trust Agreement.\"}, {\"id\": \"vi\", \"title\": \"Activation terms for New Cards shall follow the process established for existing Cards\", \"level\": 1, \"text\": \"vi. Activation terms for New Cards shall follow the process established for existing Cards. 6\"}, {\"id\": \"7\", \"title\": \"PROGRAM COMMUNICATIONS\", \"level\": 1, \"text\": \"7. PROGRAM COMMUNICATIONS a. All rights to the name, logo, service marks and/or trademarks (the \\\"Marks\\\"), trade names, tag lines, or any other proprietary designation (\\\"Proprietary Designation\\\") of AEIS remains the sole property of AEIS. Certain use of the Marks and Proprietary Designation of American Express Travel Related Services Company and Maritz Inc. has been granted to AEIS under license agreements. It is understood that the Marks may be necessary to enhance the impact and clarity of Program communications. All use of Marks and Proprietary Designations of AEIS, American Express and Maritz Inc. requires prior written approval from AEIS and use of the Marks shall follow and be subject to requirements issued by AEIS and attached hereto as Exhibit 4 and 4.A and 4.B, including any such Marks used by Schoolpop's Clients. b. Camera-ready artwork is available from AEIS for inclusion of the AEIS logo or to display a picture of a Card in Program communications. Requests for camera-ready artwork should be directed to the address below.\"}, {\"id\": \"c\", \"title\": \"Schoolpop shall inform AEIS in writing, and obtain prior written consent (which consent shall n\", \"level\": 1, \"text\": \"c. Schoolpop shall inform AEIS in writing, and obtain prior written consent (which consent shall not be unreasonably withheld), for any and all television, radio, newspaper, magazine, Internet, Intranet, or other advertising, promotional or marketing campaign or strategy using the Marks or when referring directly to American Express Travel Related Services Company, Maritz Inc. or AEIS or any American Express merchant.\"}, {\"id\": \"d\", \"title\": \"Schoolpop is solely responsible for ensuring that any names and/or logos, designs, pictures or\", \"level\": 1, \"text\": \"d. Schoolpop is solely responsible for ensuring that any names and/or logos, designs, pictures or other intellectual property, which are provided by Schoolpop to be used in the Program (including collateral material), does not infringe or violate the intellectual property rights of any other party and shall indemnify AEIS from any and all claims made by any third party respecting such infringement. e. Schoolpop shall discontinue its use and shall notify its Clients to discontinue use of the Marks, including all American Express merchant marks, and all associated promotions, including but not limited to Client promotions, upon termination of this Agreement. f. Schoolpop, at its option, may request that AEIS include in the shipment of Cards, Program specific collateral materials. Program specific collateral materials are subject to review and approval by AEIS and additional charges may apply. g. AEIS retains the right to immediately terminate this Agreement should Schoolpop distribute any promotional materials or communications that are not approved by AEIS and/or do not meet AEIS' branding guidelines, including American Express merchant marks. h. Schoolpop shall send all materials for review to: Branding and Product Communications Specialist American Express Incentive Services, L.L.C. 1309 N. Highway Drive Fenton, MO 63099 Tel: 636-226-2071 Fax: 636-226-2002 AEIS shall review all submissions within seven (7) business days.\"}, {\"id\": \"8\", \"title\": \"JOINT MARKETING AND COMMUNICATIONS\", \"level\": 1, \"text\": \"8. JOINT MARKETING AND COMMUNICATIONS a. AEIS shall provide standard Card plastic design and standard Card carrier design including pre-printed paper and electronic copy, and standard Card envelope design for all Card packaging (collectively \\\"Card Packaging\\\"). In the event Schoolpop or its Clients request any non-standard Card plastic design or Card Packaging, AEIS and Schoolpop shall mutually agree upon such materials. AEIS shall provide to Schoolpop pricing for non-standard materials b. AEIS shall provide standard promotional materials, and communication to provide market exposure for Cards. In the event Schoolpop or its Clients request any non-standard promotional or communication materials, AEIS and Schoolpop shall mutually agree upon such materials. AEIS shall provide to Schoolpop pricing for non-standard materials, which may or may not include Cardholder website customization.\"}, {\"id\": \"c\", \"title\": \"AEIS and Schoolpop shall mutually develop, market, and implement two (2) new Cards for Program\", \"level\": 1, \"text\": \"c. AEIS and Schoolpop shall mutually develop, market, and implement two (2) new Cards for Program use no later than October 1, 2004 as follows:\"}, {\"id\": \"i\", \"title\": \"A category Card, where AEIS shall put forth a commercially reasonable effort to secure\", \"level\": 1, \"text\": \"i. A category Card, where AEIS shall put forth a commercially reasonable effort to secure contracts with a select group of merchants to participate in the Card program as identified on Exhibit 5, attached hereto, and to make changes to such categories and/or merchants. 7\"}, {\"id\": \"ii\", \"title\": \"A grocery Card, where AEIS shall put forth a commercially reasonable effort to secure c\", \"level\": 1, \"text\": \"ii. A grocery Card, where AEIS shall put forth a commercially reasonable effort to secure contracts with a select group of merchants leveraging Schoolpop's existing relationships with grocery store companies, as identified on Exhibit 5.A, attached hereto, and to add other merchants as mutually agreed upon by both parties.\"}, {\"id\": \"iii\", \"title\": \"AEIS shall communicate and maintain participating merchants in the category and grocery\", \"level\": 1, \"text\": \"iii. AEIS shall communicate and maintain participating merchants in the category and grocery Cards through the Card website, an Interactive Voice Response fax-back service listing of current merchants, and through a merchant listing that shall accompany each Card.\"}, {\"id\": \"iv\", \"title\": \"AEIS and Schoolpop mutually agree to pursue additional Card products, as market conditi\", \"level\": 1, \"text\": \"iv. AEIS and Schoolpop mutually agree to pursue additional Card products, as market conditions warrant, for use in the NPO marketplace and shall document such products in a separate Agreement.\"}, {\"id\": \"d\", \"title\": \"The parties agree that the minimum number required for the category Card shall be not less than\", \"level\": 1, \"text\": \"d. The parties agree that the minimum number required for the category Card shall be not less than 70% of the consumer categories contained within Exhibit 5; and the grocery Card not less than 70% national coverage to launch each respectively. The parties shall mutually agree upon any New Card minimum numbers required for each&sbsp;New Card launch.\"}, {\"id\": \"9\", \"title\": \"PROGRAM TERMS\", \"level\": 1, \"text\": \"9. PROGRAM TERMS a. From the Effective Date through September 30, 2004, Schoolpop may order non-standard Encompass(R) Select denominations (other than 25, 50, 75, and 100 Points) up to a maximum of 200 Points. Such non-standard Encompass(R) Select denominations require eight (8) weeks to fulfill and must be ordered in boxes of 100 Cards of like denominations. Schoolpop shall be limited to $26,500,000 in total Encompass(R) Select sales through December 31, 2004. Such limit may be increased in the event Persona Select actual sales exceed its forecasted sales for the period ending December 31, 2004. The limit increase shall be calculated on three-to-one ratio of Encompass Select sales to Persona Select Sales. Schoolpop shall discontinue reselling Encompass(R) Select Cards on December 31, 2004 and shall effectively manage and forecast Encompass(R) Select Card needs to deplete such inventory as of December 31, 2004. In the event that any unsold Encompass Select Cards remain in inventory by Schoolpop on December 31, 2004, Schoolpop shall provide to AEIS, no later than January 5, 2005, the Encompass(R) Select Card numbers, the respective expiration dates and denominations of the Cards. Such Card list shall be provided to AEIS by Schoolpop via disk/CD and sent via a form of shipment where signature is required upon delivery. AEIS shall invoice Schoolpop for applicable destruction fees of $2.00 per Card which shall be payable by Schoolpop within thirty (30) days upon receipt of invoice. b. Cards shall not be used to purchase gift certificates and/or gift cards at participating merchants.\"}, {\"id\": \"c\", \"title\": \"Schoolpop acknowledges it will be listed as a current Client of AEIS\", \"level\": 1, \"text\": \"c. Schoolpop acknowledges it will be listed as a current Client of AEIS. Schoolpop agrees to be used as a reference to current and future AEIS Clients with prior approval from Schoolpop.\"}, {\"id\": \"d\", \"title\": \"Schoolpop agrees to an annual review to take place forty-five (45 days) prior to each contract\", \"level\": 1, \"text\": \"d. Schoolpop agrees to an annual review to take place forty-five (45 days) prior to each contract anniversary, on or about June 15th of each contract year. This review will include, but is not limited to, a review of volume performance, economics of the products, and branding. e. Schoolpop agrees to product and program training as required by AEIS. f. The parties agree to jointly develop a Cardholder appeasement &bbsp; program. Such appeasement program shall require Schoolpop develop a process with its Clients to mutually resolve Cardholder appeasement issues prior to raising them with any third party(ies). g. AEIS may from time to time provide Schoolpop with certain reasonable terms and provisions to be included in the agreements to be entered into between Schoolpop and its Clients and Schoolpop agrees that any such terms and provisions shall be included in such agreements.\"}, {\"id\": \"10\", \"title\": \"PROGRAM SERVICING\", \"level\": 1, \"text\": \"10. PROGRAM SERVICING a. AEIS will provide:\"}, {\"id\": \"i\", \"title\": \"24-hour customer service representation, via a 24x7 English speaking toll-free telepho\", \"level\": 1, \"text\": \"i. 24-hour customer service representation, via a 24x7 English speaking toll-free telephone number, for Program Cardholders who have questions concerning a Card. The toll-free numbers as of the drafting of this Agreement are: Persona(R) Select 800-259-9526 Encompass(R) Select 888-210-9821 Fill It Up(R) 800-575-7365 Be My Guest(R) 877-243-5082 8\"}, {\"id\": \"ii\", \"title\": \"Cardholders with the ability to obtain point balance information through the following\", \"level\": 1, \"text\": \"ii. Cardholders with the ability to obtain point balance information through the following Cardholder Web sites: www.personaselect.com Persona(R) Select www.encompass-select.com Encompass(R) Select www.rewardearner.com/fillitup Fill It Up(R) www.rewardearner.com/bmg Be My Guest(R)\"}, {\"id\": \"iii\", \"title\": \"Merchant Management - includes the management of the authorization network, merchant set\", \"level\": 1, \"text\": \"iii. Merchant Management - includes the management of the authorization network, merchant settlement and dispute handling, and\"}, {\"id\": \"iv\", \"title\": \"AEIS will provide reasonable assistance to Schoolpop in managing the Program as needed\", \"level\": 1, \"text\": \"iv. AEIS will provide reasonable assistance to Schoolpop in managing the Program as needed and requested by Schoolpop. Additional charges may apply.\"}, {\"id\": \"v\", \"title\": \"AEIS and Schoolpop shall mutually agree upon a Client and/or Cardholder appeasement pr\", \"level\": 1, \"text\": \"v. AEIS and Schoolpop shall mutually agree upon a Client and/or Cardholder appeasement process and the respective financial responsibility. b. AEIS reserves the right to change program servicing from time to time.\"}, {\"id\": \"11\", \"title\": \"REPRESENTATIONS AND WARRANTIES\", \"level\": 1, \"text\": \"11. REPRESENTATIONS AND WARRANTIES a. Schoolpop and AEIS each represents and warrants that participation in the Program shall at all times conform to the highest standards of business ethics and practices and at no time will they permit any act to be done by their employees or representatives that will damage the name, reputation or goodwill of the other party or its affiliated companies. b. Schoolpop and AEIS each further represents and warrants that its participation in the Program is and will remain during the term of this Agreement in compliance with all laws, rules and regulations applicable to it.\"}, {\"id\": \"c\", \"title\": \"Schoolpop and AEIS each further represents and warrants that they are authorized to enter into\", \"level\": 1, \"text\": \"c. Schoolpop and AEIS each further represents and warrants that they are authorized to enter into this Agreement and that this Agreement does not violate any other agreement to which it is a party.\"}, {\"id\": \"12\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"12. CONFIDENTIALITY a. The terms, procedures, any applicable criteria for success and results of this Agreement and all information furnished by and between the parties in connection with this Agreement shall be confidential and shall not be disclosed by either party without the express written consent of the other party; provided that Schoolpop shall have the right to disclose such information as may be required to comply with applicable SEC regulations. b. Both parties acknowledge that they may have access to or receive confidential information, data, and materials about the other party, their Clients and Cardholders, and their entities, including, without limitation, marketing philosophies and objectives, pricing information, business materials and data, processes, customer lists, product information, financial data, competitive advantages and disadvantages, and other confidential information received (\\\"Confidential Information\\\"), and that disclosure or misuses of such Confidential Information, would be irreparably damaging to the other party. Accordingly, both parties agree to receive and hold in confidence all Confidential Information considered proprietary or confidential by the other party, and &sbsp; agree not to disclose or use such information in any manner except for uses contemplated by this Agreement unless permitted in writing in advance by the other party (except for information disclosed to Cardholders in accordance with the Cardholder Agreement). Both parties also agree to bind their employees, and subcontractors to compliance with this paragraph and to take all other reasonable action to ensure protection of the Confidential Information.\"}, {\"id\": \"c\", \"title\": \"Such Confidential Information is subject to the terms and conditions of this Agreement, if (a)\", \"level\": 1, \"text\": \"c. Such Confidential Information is subject to the terms and conditions of this Agreement, if (a) such Confidential Information is either Party's marketing philosophies and objectives, financial and pricing information, Client lists, business processes or competitive advantages and disadvantages; (b) such Confidential Information is disclosed verbally and is verbally identified as proprietary or confidential at the time of disclosure, and there exists a written record that such Confidential Information was disclosed and identified verbally as proprietary or confidential; or (c) such Confidential Information is in written, graphic or electronic form when disclosed and the media that contains such Confidential Information is clearly marked \\\"confidential\\\" or \\\"proprietary\\\", or something substantially similar. Notwithstanding the foregoing, Confidential Information shall not include (d) information that is publicly known, already known by, or in the possession of the non-disclosing party, or (e) is independently developed by the non-disclosing party without use or reference to the other party's Confidential Information, or (f) is rightly 9 obtained by the non-disclosing party from a source other than the disclosing party without such restrictions.\"}, {\"id\": \"d\", \"title\": \"Each party agrees that during the term of this Agreement and thereafter (a) it will use Confide\", \"level\": 1, \"text\": \"d. Each party agrees that during the term of this Agreement and thereafter (a) it will use Confidential Information belonging to the other party solely for purposes outlined in this Agreement, (subject to the terms and conditions thereof), (b) it will not disclose Confidential Information belonging to the other Party to any third party other than the receiving Party's employees, affiliates, agents, permitted vendors, subcontractors and/or professional advisors on a need-to-know basis who are advised of the confidential nature of the Confidential Information and under a similar confidentiality agreement, and (c) each Party will treat the Confidential Information of the other Party with the same care that the receiving party normally affords its own proprietary and confidential information. If any such employee, affiliate, agent, subcontractor or professional advisor discloses or uses the Confidential Information in a manner not permitted under this Agreement, the party disclosing the Confidential Information to such employee, affiliate, agent, subcontractor or professional advisor will be liable therefore. If either party is required by law to disclose Confidential Information, it may be disclosed, provided that, unless prohibited, sufficient prior notice is given to the non-disclosing party to afford it an opportunity to take whatever steps it deems necessary to protect the confidential nature of the Confidential Information. In the event a party is required to disclose the other party's Confidential Information in connection with any judicial proceeding or government investigation, a notification of such requirement shall promptly occur allowing a reasonable time for the appropriate party to seek a protective Order from the appropriate court or government agency. Thereafter, Confidential Information may be disclosed to the extent required by law, subject to any applicable protective Order. e. Upon request of the other party, each party will promptly return to the other any or all Confidential Information of the other then in its possession or under its control provided, however, that each party may retain one copy of all such Confidential Information solely for its own internal records, such Confidential Information to remain subject to the restrictions on use and disclosure contained in this Agreement f. Authorized users, (\\\"Authorized Users\\\") include Schoolpop, its affiliates and its Client's personnel involved in administering the Program and eligible Cardholders of a Schoolpop Program. Schoolpop acknowledges that it will likely receive private information (\\\"PI\\\") from Authorized Users that will be subject to various privacy laws and regulations in the various States in which the Authorized Users and the parties hereto reside. Furthermore, Schoolpop, and/or its Client, will likely be providing such PI to AEIS for identification of such Authorized Users. Schoolpop shall, and shall cause its Client to, (a) comply with all applicable privacy laws and regulations, (b) shall provide to AEIS evidence of such compliance upon request, (c) and shall obtain such permissions, clearances, or other allowances as shall be necessary for AEIS to use such PI as contemplated hereunder. Schoolpop shall, and shall cause its Client to, (d) cooperate with AEIS with respect to complying and avoiding any claims based on PI rights of others including without limitation Schoolpop and/or its Client communicating to AEIS all necessary acts and safeguards required of AEIS in handling PI, (e) providing such notices and information to Authorized Users as required, (f) identifying all PI as PI at the time of its transmission to AEIS, (g) segregating any PI required to be handled differently as necessary to ensure its proper treatment including without limitation not providing PI to AEIS and, if applicable, (h) PI that has been \\\"opted out\\\" of Schoolpop's or its Client's permission for use hereunder. Schoolpop and its Client shall respectively bear the cost of compliance with all privacy laws and regulations. Schoolpop will, at its sole cost and expense, defend, indemnify and hold harmless AEIS and each of its respective officers, directors, employees, agents, contractors, affiliates, service providers and insurers (collectively, \\\"AEIS Indemnified Parties\\\") from and against any and all loss or liability, claims, demands, damages, losses and expenses including, without limitation, reasonable attorneys, accountants and expert witness fees, costs and expenses that the AEIS Indemnified Parties, or any one or more of them, may sustain or incur as a result of a claim of violation of any law or regulation or personal right directed to protecting the PI rights of individuals or the use, misuse, collection, loss of privacy or confidentiality, or other mishandling or improper or illegal act with respect to such PI including without limitation governmental enforcement action as well as civil claims involved with any such Schoolpop Program. Excluded from the obligation to defend and indemnify shall be any claims or damages attributable &bbsp; solely to the negligence or intentional misconduct of any AEIS Indemnified Party, and solely as to that AEIS Indemnified Party to which such negligence or intentional misconduct is attributable. The obligations under this Section 12 shall survive the termination, cancellation, and expiration of this Agreement. 10\"}, {\"id\": \"13\", \"title\": \"INSURANCE\", \"level\": 1, \"text\": \"13. INSURANCE a. Schoolpop shall, during the term of this Agreement, at its own cost and expense, procure with sound and reputable insurers, the following insurance coverage's: (i) Workers' Compensation Insurance in an amount not less than the statutory limits for the state(s), country or province in where the services are to be performed; (ii) Employer's Liability Insurance not less than (a) $100,000 per occurrence, and not less than $100,000 aggregate limit of liability per policy year for disease, including death at any time resulting therefrom, not caused by accident or (b) such amount as required by law, whichever is higher; (iii) Comprehensive General Liability Insurance, including blanket extended coverage against all hazards, including personal injury and death resulting therefrom, for not less than $1,000,000 per occurrence, and not less than $2,000,000 aggregate; (iv) Automobile Liability insurance against liability arising from the maintenance or use of all owned, non-owned and hired automobiles and trucks used to provide services, with (a) a minimum limit of liability for bodily injury of $1,000,000 in the aggregate, and with a minimum limit of liability for property damage of $500,000 per accident, or (b) amount as required by law, whichever is higher; and (v) fidelity or crime policy of not less than $3,000,000 in the aggregate against misappropriation and/or destruction of Cards. b. Schoolpop's insurance shall be deemed primary. Schoolpop shall provide AEIS with certificates of insurance evidencing the coverage's required hereunder within fifteen (15) days after execution of this Agreement. Each policy required hereunder shall provide that AEIS shall receive thirty (30) days advance written notice in the event of a cancellation or material change in such policy. Each policy of insurance which Schoolpop is required to possess under this Agreement shall name AEIS, and its Directors, Officers, and Employees, as additional insured in the insurance policy limits herein required. In the event that any service under this Agreement is to be rendered by persons other than Schoolpop's employees, Schoolpop shall furnish AEIS with evidence of insurance for such persons subject to the same terms and conditions as set forth above and applicable to Schoolpop prior to commencement of service by such person(s).\"}, {\"id\": \"14\", \"title\": \"GENERAL TERMS & CONDITIONS\", \"level\": 1, \"text\": \"14. GENERAL TERMS & CONDITIONS a. This Agreement along with the Trust Agreement constitute the entire Agreement between the parties hereto and supersedes all prior communications and agreements between the parties with respect to the subject matter hereof. Except for changes in AEIS product rules and other procedural or operational changes in terms initiated by AEIS as described herein, this Agreement may not be modified or otherwise amended except by a further writing executed by both parties hereto, which writing makes specific reference to this Agreement. b. No right or interest in this Agreement shall be assigned by Schoolpop without prior written permission of AEIS, which shall not be unreasonably withheld.\"}, {\"id\": \"c\", \"title\": \"This Agreement shall be deemed to have been made and executed in the State of Missouri and any\", \"level\": 1, \"text\": \"c. This Agreement shall be deemed to have been made and executed in the State of Missouri and any dispute arising thereunder shall be resolved in accordance with the laws of the State of Missouri, without reference to its rules governing conflicts of law.\"}, {\"id\": \"d\", \"title\": \"Either party may terminate this Agreement with written notice to the other party as follows\", \"level\": 1, \"text\": \"d. Either party may terminate this Agreement with written notice to the other party as follows:\"}, {\"id\": \"i\", \"title\": \"Should either party (1) admit in writing its inability to pay its debts generally as t\", \"level\": 1, \"text\": \"i. Should either party (1) admit in writing its inability to pay its debts generally as they become due; (2) make a general assignment for the benefit of creditors; (3) institute proceedings to be adjudicated a voluntary bankrupt; (4) consent to the filing of a petition or bankruptcy against it; (5) be adjudicated by a court of competent jurisdiction as being bankrupt or insolvent; (6) seek reorganization under any bankruptcy act; (7) consent to the filing of a petition seeking such reorganization; or (8) have a decree entered against it by a court of competent jurisdiction appointing a receiver, liquidator, trustee, or assignee in bankruptcy or in insolvency covering all or substantially all of such party's property or providing for the liquidation of such party's property or business affairs; then, in any such event, the other party, at its option and without prior notice, may terminate this Agreement effective immediately; or\"}, {\"id\": \"ii\", \"title\": \"Upon the occurrence of a breach by the other party, which breach has not been cured wit\", \"level\": 1, \"text\": \"ii. Upon the occurrence of a breach by the other party, which breach has not been cured within (30) days after the date of written notice to the breaching party by the non-breaching party; or\"}, {\"id\": \"iii\", \"title\": \"For non-payment of any amounts due hereunder\", \"level\": 1, \"text\": \"iii. For non-payment of any amounts due hereunder. In the event this Agreement is terminated for any reason prior to May 31, 2009, all unpaid Marketing Rights Fees incurred to the termination date, will be fully due and payable by Schoolpop to AEIS. Upon termination, each party will return to the other or destroy, and provide written certification of destruction of, all information furnished by such other party hereunder, prior to termination and follow necessary termination instructions detailed in the Trust Agreement. All Cards ordered by Schoolpop and supplied by AEIS shall be governed by the terms and conditions of this Agreement and the Trust Agreement. 11 e. Notwithstanding anything contained herein to the contrary, the cumulative liability of the parties to one another for any claims, liabilities, losses, damages or expenses, direct or indirect, arising out of or related to this Agreement shall not exceed the lesser of $50,000 or (not including other funding amounts such as the Point value of Cards) or the amount paid by Schoolpop to AEIS for the immediately preceding twelve (12) months provided, however, that in no event shall this limitation of liability apply to any claims, liabilities, losses, damages, or expenses, direct or indirect, arising out of or related to this Agreement brought by the actions of Schoolpop pursuant to paragraphs 4(e), 4(i), 4(k), 4(p), 5(a), 5(b), 6(b), 7(a), 7(d), 14(d.iii), 9(f) and Sections 2, 3 11, 12, and 13, and Exhibit 1 of this Agreement. In no event shall either party be liable to the other, under any theory, for lost profits, exemplary, punitive, special incidental, indirect, or consequential damages. f. In the event that either party breaches or violates any covenant or agreement contained in this Agreement, or in the event of any breach or violation (or alleged breach or violation) of any covenants or agreement made by LoyaltyPoint with any Client or other third party, the breaching party shall indemnify and hold harmless the other party, its affiliates, parent company(ies), officers, directors, employees, and agents against and in respect of any and all costs, expenses, deficiencies, litigation, proceedings, taxes, levies, assessments, attorneys' fees, damages or judgments of any kind or nature whatsoever, related to, arising from, or associated with such breach or violation (or alleged breach of violation). The non-breaching party shall give the breaching party prompt notice of the non-breaching party's intention to make a claim for indemnification hereunder. the breaching party shall have the opportunity to defend the underlying claims, suit or proceeding by competent counsel of its own choosing, provided that non-breaching party has approved such counsel, which approval shall not be unreasonably withheld. The non-breaching party shall cooperate in the defense of such claim, suit or proceeding. The obligations under this Section 14 shall survive the termination, cancellation, and expiration of this Agreement. g. Any notice required or permitted under this Agreement will be effective if in writing and delivered personally, sent by certified U.S. Mail, return receipt requested, postage prepared, sent by a national overnight delivery service (such as Federal Express), or sent by telefax, in each instance addressed and delivered personally or sent for delivery as provided on the signature page of this Agreement. Any notice shall be deemed given (a) if personally delivered when received by the intended recipient, (b) if sent by telefax, when sent and receipt is confirmed, provided that the recipient is sent another copy by one of the other means of notice specified in this section, or (c) if sent by certified mail or overnight delivery, on the earlier of the date of receipt by the intended recipient or three (3) days after the date on which the notice is sent. h. Upon termination of this Agreement, Schoolpop shall have the right to continue to sell any Cards in its possession for a period of three (3) months following the effective date of termination, subject to compliance with the applicable terms and conditions set forth herein, provided however, that termination of the Agreement is not due to a breach of representation or warranty of the Agreement by Schoolpop in which case Schoolpop shall discontinue selling Cards immediately upon termination. [Signature Pages Attached] 12 Signed for and on behalf of SCHOOLPOP INC. Name: Paul Robinson -------------------------------------------- Title: Chief Executive Officer Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- Name: Sheree Herr -------------------------------------------- Title: VP, Legal Management Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- 13 EXHIBIT 1 TRUST AGREEMENT - FULL LIABILITY AGREEMENT between American Express Incentive Services, L.L.C. organized under the laws of the State of Missouri, USA, with an office at 1309 North Highway Drive, Fenton, MO 63099, USA (\\\"AEIS\\\") And Schoolpop, Inc., a Delaware corporation, with an office at 3100 Five Forks Trickum Road, Suite 410, Liliburn, GA 30047 USA (\\\"Seller\\\").\"}, {\"id\": \"1\", \"title\": \"AEIS and Seller have entered into an American Express Stored Value Products reseller Agreement of even d\", \"level\": 1, \"text\": \"1. AEIS and Seller have entered into an American Express Stored Value Products reseller Agreement of even date herewith pursuant to which Seller is authorized to resell certain Cards as such term is defined therein. As such, AEIS hereby appoints Seller as trustee and agent to sell incentive cards issued by AEIS including Persona Select(R), Be My Guest(R), Fill It Up(R), Encompass Select(R), and any other incentive Card offered by AEIS (hereinafter collectively referred to as \\\"Cards\\\") in standard denominations of 25 Points, 50 Points and 100 Points according to the specific terms in the Reseller Agreement Effective August 1, 2004, and any amendments thereto.\"}, {\"id\": \"2\", \"title\": \"In consideration of its entitlement to the charges referred to in paragraph (g) below, Seller accepts ap\", \"level\": 1, \"text\": \"2. In consideration of its entitlement to the charges referred to in paragraph (g) below, Seller accepts appointment as such trustee and agent and agrees: a. To receive and hold in trust for AEIS, any Cards which are delivered to Seller until paid for by Seller. AEIS or their representatives or vendors may deliver Cards to any employee or representative of Seller and such employees and representatives are hereby authorized to accept such Cards on behalf of Seller. b. To acknowledge Seller's receipt of such Cards in writing to: (i) confirm and inform AEIS of the physical inventory of each Card delivery, and (ii) provide written confirmation of each Card delivery to an AEIS authorized representative by returning a completed Acknowledgement of Receipt form attached hereto as Schedule I and following the directions included thereon within 24 hours of receipt of each Card delivery received by or on behalf of Seller.\"}, {\"id\": \"c\", \"title\": \"To retain Cards in trust for AEIS in an \\\"inactive\\\" status as sent by AEIS until paid in full by\", \"level\": 1, \"text\": \"c. To retain Cards in trust for AEIS in an \\\"inactive\\\" status as sent by AEIS until paid in full by Seller to AEIS. Inactive Cards do not have points loaded on the Cards and are not ready for sale to or use by any consumer.\"}, {\"id\": \"d\", \"title\": \"To prepay for each box of Cards to be sold by Seller\", \"level\": 1, \"text\": \"d. To prepay for each box of Cards to be sold by Seller. Upon clearance of funds for each box of Cards, AEIS shall activate the box of Cards at which time such box of Cards shall become property of Seller. Following such activation, each Card shall generally be ready for use at an appropriate establishment within two (2) business days. e. To sell the Cards in accordance with the written instructions of AEIS. f. To deliver to AEIS or their representatives any unsold Cards upon demand by AEIS. g. To collect any charges for the sale of Cards as may be established by Seller. h. To safeguard all Cards received by Seller at all times, including inactive and active Cards and when the Cards are in transit, as a prudent financial or commercial institution should safeguard a like amount of its own cash. All Cards kept on Seller's premises, both active and inactive, shall be kept locked in Seller's safe which safe must be satisfactory to AEIS. AEIS and/or their appointed representatives of AEIS or American Express Travel Related Services Inc. as solely determined by AEIS, shall be entitled to inspect and approve Seller's safekeeping facilities at any time during normal business hours.\"}, {\"id\": \"i\", \"title\": \"To notify AEIS at destination indicated on the Acknowledgement of Receipt Form, as soon as poss\", \"level\": 1, \"text\": \"i. To notify AEIS at destination indicated on the Acknowledgement of Receipt Form, as soon as possible upon any loss of the Cards due to theft, burglary, fire or other cause. All notifications of loss must include the Card number for all lost Card stock. In the event an entire shipment was lost, the Card tracking number must also be provided. AEIS reserves the right to hold Seller liable for any loss, as to which Seller might not otherwise have been liable for under subparagraph 2(k) below, if Seller has unreasonably delayed reporting the loss to AEIS, and such delay has disadvantaged AEIS or prejudiced AEIS' ability to mitigate or eliminate its damages. 14 j. To maintain accurate records of all Cards sold or held in inventory, including Card numbers, shipment tracking numbers, account numbers, and the Acknowledgement Receipt form, etc. k. To be responsible for any loss of any Cards received in accordance with subsection (a) above prior to the time such Cards are paid for by Seller, whether such loss occurs by theft, burglary, hold-up, fire, dishonesty of employees, mysterious disappearance, or any other cause irrespective of such cause. In the case of loss of Cards, Seller shall pay AEIS from time to time upon demand the amount of any Cards so reported as lost and later used at any merchant or other location or otherwise appear for sale for any reason whatsoever. Seller shall be fully liable for the amounts paid by AEIS and/or their affiliates with respect to such Cards together with any additional reasonable costs incurred by AEIS and/or their affiliates arising out of such Cards. Such liability shall survive termination of this Agreement.\"}, {\"id\": \"l\", \"title\": \"Not to sell Cards on credit or post-paid method of any kind to any individual, company, or enti\", \"level\": 1, \"text\": \"l. Not to sell Cards on credit or post-paid method of any kind to any individual, company, or entity whatsoever nor to utilize the Cards for the benefit of Seller, Seller's owners, officers, employees, representatives or any third party.\"}, {\"id\": \"m\", \"title\": \"To increase Seller's inventory of Cards by following AEIS' process\", \"level\": 1, \"text\": \"m. To increase Seller's inventory of Cards by following AEIS' process. n. To destroy Cards for purposes of past expiration or reason other than termination that causes Seller to remove from inventory. Such Cards must be completely destroyed by cremating or shredding to the point where such Cards cannot be reconstructed in any way or Card numbers cannot be read in any way. Such destruction must be evidenced by execution of AEIS' Destruction Certificate, which is attached hereto as Schedule II. The Destruction Certificate shall be executed by Seller through two authorized signatures and shall particularly describe the Cards by (1) Card product name, (2) Card number, (3) denomination, (4) shipment tracking number, and (5) quantity by product and denomination, and account number. Seller shall pay AEIS associated destruction fees for such Card destruction as detailed within the Destruction Certificate. In the event any Cards certified as destroyed by Seller are later used at any establishment or other location or otherwise appear for sale for any reason whatsoever, Seller shall be fully liable for the amounts paid by AEIS and/or their affiliates with respect to such Cards together with any additional costs incurred by AEIS and/or their affiliates arising out of such Cards. In no event shall Seller throw away discard expired or spoiled or otherwise unwanted Cards in any other manner than described in this Section 2(n). Such liability shall survive termination of this Agreement. o. To pass to a security audit as performed by AEIS and/or their appointed representatives of AEIS or American Express Travel Related Services Inc. at a time and frequency solely determined by AEIS during the term of this Agreement. This Agreement shall be terminated by AEIS at AEIS' choice immediately upon Seller receiving a non-passing status of such security audit. AEIS may chose to allow Seller to conform to non-passing elements of security audit within a time so specified by AEIS in writing to Seller. Seller shall choose to make necessary changes to conform to the security audit or terminate the Agreement as so indicated in Section 4 below.\"}, {\"id\": \"3\", \"title\": \"This Agreement (a) may not be assigned by Seller without the written consent of AEIS, except to an entit\", \"level\": 1, \"text\": \"3. This Agreement (a) may not be assigned by Seller without the written consent of AEIS, except to an entity controlling, controlled by or under common control with Seller, provided, however, Schoolpop shall remain liable for the obligations contained herein including the attachments and Exhibits thereto, and (b) may be modified only by an agreement in writing signed on behalf of AEIS by an executive officer. No other employees of AEIS have authority to modify or waive any term of this Agreement. This Agreement may be assigned by AEIS to any parent, subsidiary, affiliated or associate corporation without Seller's consent and shall, whether or not so assigned, inure to the benefit of any AEIS parent, subsidiary, associate or affiliate thereof which pays or becomes liable upon any Cards delivered to Seller under this Agreement.\"}, {\"id\": \"4\", \"title\": \"This Agreement shall remain in force until terminated by either party by notice given in accordance with\", \"level\": 1, \"text\": \"4. This Agreement shall remain in force until terminated by either party by notice given in accordance with paragraph 8, below and in accordance with Section 14(h) of the Agreement. a. Notices so given shall, unless otherwise specified therein, be effective upon receipt whereupon both parties shall cooperate in an effective wrap up of all outstanding issues and transition of inventory and other termination responsibilities as determined by AEIS. b. Upon such termination, Seller shall forthwith remit to AEIS or their agents all unsold Cards and shall safeguard such Cards during transit to AEIS in such a manner as detailed in Section 2(h) herein. 15\"}, {\"id\": \"5\", \"title\": \"The rights of AEIS hereunder shall not be prejudiced or restricted by\", \"level\": 1, \"text\": \"5. The rights of AEIS hereunder shall not be prejudiced or restricted by any time given or forbearance extended to Seller in the enforcement of its rights and no waiver by AEIS of their rights in respect of any breach hereof by Seller shall be deemed to operate as a waiver in respect of any subsequent breach hereof.\"}, {\"id\": \"6\", \"title\": \"It is agreed between the parties that if any provision of this Agreement is held to be invalid, the rema\", \"level\": 1, \"text\": \"6. It is agreed between the parties that if any provision of this Agreement is held to be invalid, the remainder of this Agreement shall continue in full force and effect and shall be binding and effective on the parties thereto.\"}, {\"id\": \"7\", \"title\": \"This Agreement shall be subject to and governed by the laws of the State of Missouri, USA\", \"level\": 1, \"text\": \"7. This Agreement shall be subject to and governed by the laws of the State of Missouri, USA.\"}, {\"id\": \"8\", \"title\": \"All notices hereunder&sbsp;shall be mailed or faxed to the other party as follows\", \"level\": 1, \"text\": \"8. All notices hereunder&sbsp;shall be mailed or faxed to the other party as follows: Notices to Seller shall be addressed or faxed to it at the address or fax number set forth on the first page hereof. Notices to AEIS shall be addressed or faxed as to: American Express Incentive Services, L.L.C. with a copy to: General Counsel's Office 1309 North Highway Drive American Express Fenton, MO 63099 200 Vesey Street Attn: Legal Management New York, N.Y. 10285-4908 Fax: (636) 226-2009 Attn: Marcy Wilkov Fax: (212) 640-0360 [Signature Pages Attached] 16 Signed for and on behalf of SCHOOLPOP INC. Name: Paul Robinson -------------------------------------------- Title: Chief Executive Officer Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- Name: Sheree Herr -------------------------------------------- Title: VP, Legal Management Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- 17 EXHIBIT 1.A ACKNOWLEDGEMENT OF RECEIPT FORM Schoolpop Inc., a for-profit company incorporated under the laws of the state of Delaware, USA with an office at 3885 Crestwood Parkway, Suite 550, Duluth, GA 30096 USA (hereinafter referred to as \\\"Seller\\\"). Seller, named above, as trustee and agent of AEIS, acknowledges receipt of the Cards listed on page 2 of the Acknowledgement of Receipt Form hereof (\\\"Cards\\\") and agrees: (1) to hold the Cards IN TRUST for AEIS pursuant to the terms of the Trust Agreement; (2) to sell the Cards only in accordance with written instructions from AEIS; (3) to collect such charges for the sale of Cards as Seller may establish from time to time; (4) to safeguard the Cards as a prudent person would safeguard a like amount of his own cash; (5) to notify AEIS promptly, at the address listed on page 2 of the Acknowledgement of Receipt Form hereof, of any loss of Cards due to theft, burglary, fire or any other cause. (6) (A) to be responsible for any loss of Cards unless the Cards were safeguarded in accordance with Section 2.h of the Trust Agreement and the loss occurred without Seller's fault. (B) to be absolutely responsible without regard to Seller's fault for any loss of Cards due to failure to safeguard the Cards in accordance with Section 2(h) of the Trust Agreement or due to the dishonesty of Seller's employees or agents or due to a disappearance which Seller cannot explain. (7) to pay AEIS upon demand for any Cards so lost which have been presented to any establishment or retailer in exchange for service(s) or product(s) so reported by Seller as lost and later used at any establishment or other location or otherwise appear for sale for any reason whatsoever, Seller shall be fully liable for an amount of money equal to the face value of amounts paid by AEIS and/or their affiliates with respect to such Cards together with any additional costs incurred by AEIS and/or their affiliates arising out of such Cards. and (8) that the terms hereof shall not relieve Seller of any obligation or liability under any other agreement relating to the sale of Cards existing between Seller and AEIS, its parent, subsidiaries or affiliates. WARNING: Except in the event of termination of the Agreement Do Not Return Any of the Cards Listed on page 2 of the Acknowledgement of Receipt Form. If it is necessary to reduce Seller's inventory of Cards, including spoiled or expired Cards, destroy such Cards by cremating or shedding and evidence their destruction by a Destruction Certificate attached to the Agreement as Exhibit 1.C, applicable destruction fees shall apply. The Destruction Certificate shall be (i) on the Seller's letterhead, (ii) executed by Seller through two authorized signatures and (iii) shall particularly describe the Cards by (a) name of Card product, (b) Card number, (c) denomination, (d) shipment tracking number, and (e) quantity by product, denomination and account number. Schoolpop shall forward the original Destruction Certificate to AEIS and Schoolpop shall confirm receipt by AEIS. If this procedure is not practical, contact AEIS Client Service Support for specific instructions regarding disposition. AMERICAN EXPRESS INCENTIVE SERVICES, L.L.C., is the designated servicing agent for the following Cards: Persona(R) Select, Be My Guest(R), Fill It Up(R), Encompass(R) Select, and any other pre-denominated incentive card offered by AEIS. 18 ACKNOWLEDGEMENT OF RECEIPT FORM - PAGE 2 Schoolpop, Inc., a for-profit company incorporated under the laws of the state of Georgia, USA with an office at 3885 Crestwood Parkway, Suite 550, Duluth, GA 30096 USA (hereinafter referred to as \\\"Seller\\\") ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- DATE RECEIVED UPS TRACKING PRODUCT ACCOUNT # DENOMINATION BEGINNING CARD ENDING CARD NUMBER NUMBER NUMBER ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- Fax completed Acknowledgement of Receipt Form to Gregg Baum, 636.226.2004, or by certified mail to 1309 North Highway Drive, Fenton, MO 63099, attention: Gregg Baum. 19 EXHIBIT 1.B AMERICAN EXPRESS INCENTIVE SERVICES, L.L.C. 1309 N. HIGHWAY DRIVE FENTON, MO 63099 Seller, named above, as trustee and agent of CERTIFICATE OF INVENTORY DESTRUCTION FOR ANONYOMOUS CARDS ONLY MUST BE RECEIVED BY AEIS AT LEAST 15 DAYS PRIOR TO VALID THROUGH DATE ON CARD. CLIENT NAME: SCHOOLPOP, INC. DATE OF ORIGINATING ORDER:______________ CLIENT ADDRESS: 3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH, GA 30096 USA CLIENT ACCOUNT #:______________ DESTROYING WHOLE OR PART OF AN ORDER____________\"}, {\"id\": \"1\", \"title\": \"The undersigned hereby certifies that\", \"level\": 1, \"text\": \"1. The undersigned hereby certifies that: [X] Each of the cards described on the attached Schedule A (the \\\"Cards\\\") has been destroyed; [X] Destruction of the Cards was necessary because _______________________________________________ [X] The Cards were destroyed by this Method:_____________________________________________________ [X] At the time of destruction, Schoolpop Inc. was the unconditional trustee of each of the Cards and was holding in trust for AEIS, and none of the Cards described herein have been assigned, transferred, or issued to any person, firm, or corporation.\"}, {\"id\": \"2\", \"title\": \"Schoolpop, Inc\", \"level\": 1, \"text\": \"2. Schoolpop, Inc., on behalf of itself and its successors and assigns, agrees that should any charge(s) be incurred with respect to any of the Cards, Schoolpop, Inc. will, upon request of American Express Incentive Services, LLC (\\\"AEIS\\\"), pay AEIS the full amount of such charge(s) and Schoolpop Inc. shall indemnify AEIS, its officers, and members, and hold each of them harmless from and against any and all claims, actions and suits, whether groundless or otherwise, and from and against any and all liabilities, losses, damages, costs, charges and any other expenses (including but not limited to attorneys' fees and expenses) of every nature and character by reason of the cancellation and destruction of the Cards or the making of any payment or costs incurred as a result of any use of the Cards described herein. SCHOOLPOP INC. By: ----------------------------------- Return this original Destruction Certificate and completed Certificate of Name: Inventory Destruction to AEIS at the --------------------------------- above address via certified mail or &bbsp; other tracked shipment method. Title: -------------------------------- Date: --------------------------------- WITNESS WITNESS Name: --------------------------------- --------------------------------------- Title: -------------------------------- --------------------------------------- Date: --------------------------------- --------------------------------------- (Signature) (Signature) 20\"}, {\"id\": \"EXHIBIT 1.C\", \"title\": \"CERTIFICATION OF INVENTORY DESTRUCTION FOR SCHOOLPOP, INC.\", \"level\": 2, \"text\": \"EXHIBIT 1.C CERTIFICATION OF INVENTORY DESTRUCTION FOR SCHOOLPOP, INC. If the number of Cards destroyed requires more rows, use multiple pages of this form or type the denomination and Card numbers into a spreadsheet and attach the printed spreadsheet to this form. ----------------------- --------------------------------------------- ---------------------- DENOMINATION CARD # CARD STATUS (active or inactive) ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- Total number of ACTIVE Cards:________________________________ Total number of INACTIVE Cards:______________________________ Total number of CARDS________________________________________ Destruction Date:____________________________________________ Aggregate total denomination of Cards:_______________________ Client Authorized Signature:_________________________________ Printed Name:________________________________________________ Title:_______________________________________________________ 21 EXHIBIT 2 SCHOOLPOP CARD PRICING The following pricing is effective with the Effective date of this Agreement through the term of the Agreement and is subject to change as detailed in the Agreement. Off-face point value based on volume mix: Persona Select 8% Encompass Select 2% Fill It Up 4% Be My Guest 4% Category Card 3% (Contingent upon achieving a four and one-half percent (4.5%) weighted average commission via the contracted merchant.) Grocery Card 3% (Contingent upon achieving a four percent (4%) weighted average commission via the contracted merchant.) 22 EXHIBIT 3 SCHOOLPOP ACCOUNT NUMBERS\"}, {\"id\": \"1\", \"title\": \"Effective with Period One, the following account numbers shall be used by Schoolpop when placing Orders\", \"level\": 1, \"text\": \"1. Effective with Period One, the following account numbers shall be used by Schoolpop when placing Orders for Cards. ----------------------------------- ----------------------------------------- --------------------------- PRODUCT DENOMINATION ACCOUNT NUMBER ----------------------------------- ----------------------------------------- --------------------------- Persona(R) Select 25, 50, and 100 Points 8531 ----------------------------------- ----------------------------------------- --------------------------- Encompass(R) Select 25, 50, and 100 Points 8536 ----------------------------------- ----------------------------------------- --------------------------- Fill It Up(R) 25, and 50 Points 8533 ----------------------------------- ----------------------------------------- ---------------------------\"}, {\"id\": \"2\", \"title\": \"Effective with Period Two, the following account numbers are to be used by Schoolpop\", \"level\": 1, \"text\": \"2. Effective with Period Two, the following account numbers are to be used by Schoolpop. ----------------------------------- ------------------------------------------ -------------------------- PRODUCT DENOMINATION ACCOUNT NUMBER ----------------------------------- ------------------------------------------ -------------------------- Persona(R) Select 25 Points 8684 ----------------------------------- ------------------------------------------ -------------------------- Persona(R) Select 50 Points 8685 ----------------------------------- ------------------------------------------ -------------------------- Persona(R) Select 100 Points 8686 ----------------------------------- ------------------------------------------ -------------------------- ----------------------------------- ------------------------------------------ -------------------------- Encompass(R) Select* 25 Points 8705 ----------------------------------- ------------------------------------------ -------------------------- Encompass(R) Select 50 Points 8687 ----------------------------------- ------------------------------------------ -------------------------- Encompass(R) Select 100 Points 8801 ----------------------------------- ------------------------------------------ -------------------------- ----------------------------------- ------------------------------------------ -------------------------- Fill It Up(R) 25 Points 8681 ----------------------------------- ------------------------------------------ -------------------------- Fill It Up(R) 50 Points 8683 ----------------------------------- ------------------------------------------ -------------------------- ----------------------------------- ------------------------------------------ -------------------------- Be My Guest(R) 25 Points 12095 ----------------------------------- ------------------------------------------ -------------------------- Be My Guest(R) 50 Points 12098 ----------------------------------- ------------------------------------------ --------------------------\"}, {\"id\": \"3\", \"title\": \"Account numbers and effective dates for any products and/or denominations in addition to the account num\", \"level\": 1, \"text\": \"3. Account numbers and effective dates for any products and/or denominations in addition to the account numbers detailed above will be provided to Schoolpop by AEIS upon completion of setup of such products and/or denominations. *Encompass(R) Select account numbers shall not be submitted with Orders effective December 31, 2004. 23 EXHIBIT 4 BRANDING QUICK REFERENCE GUIDE\"}, {\"id\": \"1\", \"title\": \"All communication pieces/media referencing Gift Cheques, all AEIS Card products, American Express Incent\", \"level\": 1, \"text\": \"1. All communication pieces/media referencing Gift Cheques, all AEIS Card products, American Express Incentive Services, AEIS, American Express, and/or any American Express merchant must be submitted for approval. Please allow five (5) to seven (7) business days for the branding review. Typical turnaround is three (3) to five (5) days, however, unusual circumstances may cause a delay in the typical turnaround. You will be notified of any delay.\"}, {\"id\": \"2\", \"title\": \"Types of communications that require approval\", \"level\": 1, \"text\": \"2. Types of communications that require approval: Web sites, audio/visual productions, printed materials (brochures, fact sheets, direct mailings, newsletters, point of purchase displays), news releases, etc.\"}, {\"id\": \"3\", \"title\": \"Our agreement with our parent company, American Express, is that they retain the authority to review eve\", \"level\": 1, \"text\": \"3. Our agreement with our parent company, American Express, is that they retain the authority to review every communication piece containing references to the sources in the first bullet above. These approvals are forwarded by AEIS to: The American Express Advertising Review Board (\\\"ARB\\\") who will review the following: Communications from an advertising perspective How the product is being communicated Card images General Counsel's Office (\\\"GCO\\\") who will review the following: Communications from a legal perspective Sweepstakes rules Charitable mentions Copyright infringements\"}, {\"id\": \"4\", \"title\": \"Product marks should be represented as follows\", \"level\": 1, \"text\": \"4. Product marks should be represented as follows: Persona(R) Select Encompass(R) Select Fill It Up(R) Be My Guest(R)\"}, {\"id\": \"5\", \"title\": \"Since American Express is not a bank and not affiliated with a bank, terminology implying as much should\", \"level\": 1, \"text\": \"5. Since American Express is not a bank and not affiliated with a bank, terminology implying as much should not be used. Please refer to the following examples: --------------------------------------------------------- --------------------------------------------------------------- DO NOT USE REPLACE WITH --------------------------------------------------------- --------------------------------------------------------------- American Express Gift Card; American Express Incentive Services gift card; American Express Reward Card; American Express Incentive Services reward card; Gift/Reward Card from American Express American Express branded reward card; Reward card with the American Express brand --------------------------------------------------------- --------------------------------------------------------------- Statement Transaction Summary --------------------------------------------------------- --------------------------------------------------------------- Deposit; Credit Load; add; fill --------------------------------------------------------- --------------------------------------------------------------- Available funds/points; Balance Remaining funds/points Point balance --------------------------------------------------------- --------------------------------------------------------------- Account Card --------------------------------------------------------- --------------------------------------------------------------- Merchants Establishments --------------------------------------------------------- --------------------------------------------------------------- Similar to a debit card; A prepaid Card; Debit/Credit Card &sbsp; Stored-value Card; Reward Card --------------------------------------------------------- ---------------------------------------------------------------\"}, {\"id\": \"6\", \"title\": \"The AEIS or American Express logos (Blue Box) are not to be used on Client pieces, as it implies that AE\", \"level\": 1, \"text\": \"6. The AEIS or American Express logos (Blue Box) are not to be used on Client pieces, as it implies that AEIS and/or American Express are more involved in the program than providing the reward product. The words \\\"new\\\" and \\\"introducing\\\" are limited to the first six months of use. 24\"}, {\"id\": \"7\", \"title\": \"Development of Cards or communication materials associated with the following industries (including show\", \"level\": 1, \"text\": \"7. Development of Cards or communication materials associated with the following industries (including showing images related to these industries, e.g. pictures of guns, cigarettes, etc.) must be reviewed on a case-by-case basis. Alcohol Tobacco Gambling Firearms Under no circumstances may any advertising appear in the following media: Howard Stern Rush Limbaugh Don Imus\"}, {\"id\": \"8\", \"title\": \"Development of Cards with company names or logos from adult entertainment or pornography industries is s\", \"level\": 1, \"text\": \"8. Development of Cards with company names or logos from adult entertainment or pornography industries is strictly prohibited.\"}, {\"id\": \"9\", \"title\": \"Use the correct service Mark or registered Mark the first mention of the name on each page\", \"level\": 1, \"text\": \"9. Use the correct service Mark or registered Mark the first mention of the name on each page.\"}, {\"id\": \"10\", \"title\": \"AEIS and American Express will treat communications sent through the branding process as confidential\", \"level\": 1, \"text\": \"10. AEIS and American Express will treat communications sent through the branding process as confidential.\"}, {\"id\": \"11\", \"title\": \"This Quick Reference Guide is not all-inclusive\", \"level\": 1, \"text\": \"11. This Quick Reference Guide is not all-inclusive. All communications are subject to the sole approval of American Express. 25 EXHIBIT 4.A BRANDING APPROVAL PROCESS OVERVIEW GET READY You have the idea for the piece We send you a low-resolution card or Gift Cheque image, if needed, for placement purposes only (FPO) You develop the layout GET SET You send us the layout and copy We will review it in AEIS Branding and send to American Express Review Units You should allow a five (5) day turnaround* We will return any revisions with the high-resolution image, if needed GO! You produce and distribute the piece You send us three (3) copies of the final printed piece to keep on file You (and we) celebrate your success! * Standard turnaround is three to five business days, however, if unusual circumstances occur, the turnaround may take longer. Should this occur, we will notify you of any delay. 26 EXHIBIT 4.B AEIS MERCHANT APPROVAL GUIDELINES AND PROCESS INTRODUCTION / OVERVIEW The AEIS Communications Group requires review of any new or revised materials, which include any mention of Merchant Partners -- in order to ensure proper merchant guidelines. This includes ALL advertising, promotional and marketing materials in any medium (INCLUDING: COMMUNICATIONS, ADVERTISING, SALES PROMOTION COLLATERAL, DIRECT MAIL, PRESS RELEASES, VIDEOS, WEB SITES, PROMOTIONAL ITEMS, SALES PRESENTATIONS AND SIMILAR MATERIALS.) Copy and layout should be submitted as early as possible. Due to the type of communications piece, approval could take anywhere from 3 to 10 business days. MERCHANT SUPPORTING DOCUMENTATION FOR APPROVAL GUIDELINES Consumer applications are typically more involved. Generally, consumer programs are targeted to a wider audience; therefore, the implications are greater for the merchant. For this reason, the merchants mandate that AEIS seek individual approvals from each and every merchant. Any standard applications using customized collateral should be reviewed by AEIS for content and accuracy. Even in the cases where standard program materials are to be used, AEIS will need to internally review any customized announcements and/or teasers. More than likely, these pieces feature only merchant names or merchant lists in print and can typically be approved within 24-48 hours. Pieces using only select groups of merchants, photos or logos will generally require a higher level of approval and depending on the merchants used, may require approval from the merchant as well. The approval timeline will range from three to ten (3-10) business days for existing/ongoing. Once, layout and copy are approved by AEIS Communications Group, Merchant Partnerships, Operations and American Express, any ongoing and additional changes must also be approved. IMAGES, LOGOS, PRODUCT PATENT, AND REGISTERED/SERVICE MARKS IMAGES AND LOGOS The following are examples of merchant image and logo usage, which require merchant approval through Merchant Partnerships: o Any communication or collateral, whether standard or customized, containing merchant images or logos must be reviewed by Merchant Partnerships o Any new design work of merchant logos and images not previously approved o Use of standard merchant logos in any color other than the original color o Unique positioning of merchant images - surrounding merchants, etc. o \\\"Direct mail\\\" pieces, which include merchant references when only \\\"select\\\" merchants are referenced. o Unusual type of creative print work such as posters o Borders around logos and busy backgrounds o Any copy or tag-lines not previously approved o Under no circumstances are press release photos to be used on or in association with any form of communication relating to incentive card programs unless approved by Merchant Partnerships' contact. o Images and/or logos are not to be altered (cropped, inset, or overlaid) unless approved by Merchant Partnerships' contact. o All images used in magazine format must be obtain merchant copy write information next to the image MERCHANT PARTNERSHIPS RESERVES THE RIGHT TO REMOVE IMAGES AT ANY TIME THAT MAY BE DEEMED INAPPROPRIATE REPRESENTATION OF THE MERCHANT (THIS INCLUDES OUTDATED OR SEASONAL IMAGES AND LOGOS). ALL QUESTIONS REGARDING MERCHANT COMMUNICATION APPROVAL SHOULD BE SUBMITTED TO ANN FINK AT ANN.FINK@AEIS.COM, 636-226-2043. 27 EXHIBIT 5 CATEGORY CARD TARGET ACQUISITIONS ---------------------------------------------------------------------------------------------- PRIMARY CARD MARKETING CATEGORIES TARGET MERCHANTS ---------------------------------------------------------------------------------------------- CONSUMER CATEGORIES: ---------------------------------------------------------------------------------------------- Entertainment - Electronics & Misc Electronics Best Buy ---------------------------------------------------------------------------------------------- Apparel & Services Apparel TJ Maxx, Marshalls ---------------------------------------------------------------------------------------------- Household Furnishings & Equipment - Major and Small Best Buy Major and Small Appliance & Misc Appliances household equipment ---------------------------------------------------------------------------------------------- Telephone Services Phones and Accessories Best Buy ---------------------------------------------------------------------------------------------- Household Furnishings & Equipment - Home furnishings and textiles and Furniture decorations Home Goods ---------------------------------------------------------------------------------------------- Restaurants Restaurants Darden (Red Lobster, Olive Garden, etc.) ---------------------------------------------------------------------------------------------- Gifts - combined from all categories Gifts Fossil Crabtree & Evelyn* Barnes & Nobles ---------------------------------------------------------------------------------------------- Entertainment - Tickets & Admissions Entertainment Regal Theatres, Hollywood Video, Ticketsnow.com ---------------------------------------------------------------------------------------------- Gasoline & Motor Oil Auto Accessories Autozone/TBD ---------------------------------------------------------------------------------------------- Entertainment - Toys Gifts Toys R Us ---------------------------------------------------------------------------------------------- Personal Care Products & Drugs Drugs Walgreens ---------------------------------------------------------------------------------------------- ALTERNATE CATEGORIES: ---------------------------------------------------------------------------------------------- Office Supplies Office Supplies Staples ---------------------------------------------------------------------------------------------- Sporting Goods Sporting Goods Sports Authority ---------------------------------------------------------------------------------------------- Entertainment Pet Supplies Petsmart ---------------------------------------------------------------------------------------------- 28 EXHIBIT 5.A GROCERY CARD TARGET ACQUISITIONS Longs HEB Piggly Wiggly Save Mart ShopKo Safeway Staters 29\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of LOYALTYPOINTINC_11_16_2004-EX-10.2-RESELLER AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.2\", \"level\": 1, \"text\": \"EXHIBIT 10.2 [LOGO AMERICAN EXPRESS] INCENTIVE SERVICES -------------------------------------------------------------------------------- RESELLER INFORMATION Company Name: Schoolpop, Inc. Address:3885 Crestwood Parkway, Suite 550 City: Duluth State: GA Zip: 30096 Contact Name: Paul Robinson Phone: 770-638-5101 Fax: 770-638-5101 TAX ID #: E mail Add: probinson@Schoolpop.com AMERICAN EXPRESS INCENTIVE SERVICES STORED VALUE PRODUCTS RESELLER AGREEMENT This Distribution Agreement (the \\\"Agreement\\\") is entered into by and between American Express Incentive Services, L.L.C., a Missouri limited liability company (\\\"AEIS\\\"), and its Reseller, Schoolpop, Inc., a Delaware corporation (\\\"Schoolpop\\\"). This Agreement is effective as of August 1, 2004, (the \\\"Effective Date\\\") and shall terminate on July 31, 2009, (the \\\"Termination Date\\\") unless earlier terminated or extended as provided for herein. The following points outline this agreement:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PURPOSE\", \"level\": 1, \"text\": \"1. PURPOSE Under and subject to the terms of this Agreement: a. AEIS will provide Schoolpop for resale the following stored value cards: Encompass(R) Select, Persona(R) Select, Fill It Up(R), and Be My Guest(R), and any other stored value products developed by AEIS and mutually agreed upon by both parties, (\\\"Cards\\\"). The Cards shall be sold only to those of Schoolpop's clients and prospective clients (the \\\"Clients\\\"), in the United States who are nonprofit organizations, (\\\"NPO Marketplace\\\"), which are defined as organizations that are (i) a school, (ii) an organization formed as not-for-profit under its charter documents, or (iii) an organization related to (i) or (ii) such as a participating school's Parent Teacher Organization or other similarly related organization. b. Period One shall mean the Effective Date through the date that Schoolpop has met all of the Security Requirements as such term is defined herein and has received approval from AEIS to assume all Card inventory, distribution and fulfillment responsibilities as currently managed by AEIS. Period Two shall commence with the end of Period One through the Termination Date.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVITY\", \"level\": 1, \"text\": \"2. EXCLUSIVITY a. Schoolpop shall have the exclusive right to resell Cards in the NPO Marketplace. Notwithstanding the foregoing, Schoolpop shall fund from AEIS a minimum of $52,000,000 of Cards (the \\\"Guaranteed Minimum\\\") in each Contract Year in order to maintain the exclusive right to sell Cards in the NPO Marketplace. A Contract Year shall be the period of August 1 through July 31 of the succeeding year. In any Contract Year in which Schoolpop fails to fund the Guaranteed Minimum, AEIS shall have the right, in its sole discretion, to (a) terminate the Agreement or (b) revoke the exclusivity. b. In consideration of the exclusivity referred to above, Schoolpop shall pay AEIS a marketing rights fee (\\\"Marketing Rights Fee\\\"), of $1,250,000. The Marketing Rights Fee shall be paid in five (5) equal installments of $250,000 on March 15th of each year with the first such payment being due on March 15, 2005 and with the final payment due on March 15, 2009.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop shall also pay AEIS a fee of $250,000, (the \\\"Encompass(R) Select Fee\\\") as considerati\", \"level\": 1, \"text\": \"c. Schoolpop shall also pay AEIS a fee of $250,000, (the \\\"Encompass(R) Select Fee\\\") as consideration for the right to sell the Encompass(R) Select Card through December 31, 2004. The Encompass(R) Select Fee shall be payable concurrently with the execution of this Agreement.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop understands and agrees that this Agreement does not grant Schoolpop any exclusive rig\", \"level\": 1, \"text\": \"d. Schoolpop understands and agrees that this Agreement does not grant Schoolpop any exclusive right to market the Cards or any other AEIS products and services outside of the NPO Marketplace. AEIS, on its own behalf, reserves the right to market its Cards and other products and services directly as 1 well as through additional firms on terms and conditions that it selects in its sole discretion, provided that no such sales shall take place within the NPO Marketplace.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INVENTORY AND FORECASTING\", \"level\": 1, \"text\": \"3. INVENTORY AND FORECASTING a. Schoolpop shall secure a physical location for maintaining, distributing, and fulfilling Card inventory no later than August 1, 2004 which location shall be subject to such security requirements (the \\\"Security Requirements\\\") as shall be required by AEIS or American Express Travel Related Services, Inc. all as further set forth in the Trust Agreement attached hereto as Exhibit 1. b. Schoolpop shall effectively manage its Card inventory and Ordering schedule such that all Cards are resold and distributed to the Client with the following Card expiration lives (the \\\"Card Life\\\") intact:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Persona(R) Select - nine (9) months ii\", \"level\": 1, \"text\": \"i. Persona(R) Select - nine (9) months ii. Encompass(R) Select, Be My Guest(R), Fill It Up(R) - three (3) months The Card life of any Cards other than Cards specifically indicated in b(i). and b(ii) above (\\\"New Cards\\\"), shall be mutually agreed upon in writing.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During Period One, Card expiration shall be determined by the date Schoolpop places an Order (t\", \"level\": 1, \"text\": \"c. During Period One, Card expiration shall be determined by the date Schoolpop places an Order (the \\\"Order\\\") and provides full payment and clearance of funding. During Period Two, Card Life shall be determined by the date Schoolpop places an Order.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Should any Card expire or lose Card Life prior to distribution, Schoolpop shall assume all loss\", \"level\": 1, \"text\": \"d. Should any Card expire or lose Card Life prior to distribution, Schoolpop shall assume all loss associated with the Card funding, if applicable, and shall pay AEIS a $2.00 per Card destruction fee. Schoolpop shall not return such Cards to AEIS, and shall follow the destruction process as detailed in the Trust Agreement. e. Card Life shall be unaffected by the termination of this Agreement. f. From the Effective Date through September 30, 2004, Schoolpop may order non-standard Encompass(R) Select denominations (other than 25, 50, 75, and 100 Points) up to a maximum of 200 Points. Such non-standard Encompass(R) Select denominations require eight (8) weeks to fulfill and must be ordered in boxes of 100 Cards of like denominations. Schoolpop shall discontinue reselling Encompass(R) Select Cards on December 31, 2004 and shall effectively manage and forecast Encompass(R) Select Card needs to deplete such inventory as of December 31, 2004. In the event that any unsold Encompass(R) Select Cards remain in inventory by Schoolpop on December 31, 2004, Schoolpop shall provide to AEIS, no later than January 5, 2005, the Encompass(R) Select Card numbers, the respective expiration dates and denominations of the Cards. AEIS shall invoice Schoolpop for the applicable Card destruction fees which shall be payable by Schoolpop within thirty days (30) of receipt of invoice. Such Card list shall be submitted on a disk/CD and shall be sent via a form of shipment where signature is required upon delivery. g. Effective with Period Two, Schoolpop shall provide to AEIS a twelve (12) month sold Card forecast and Card inventory forecast (hereinafter defined). In addition, Schoolpop shall provide AEIS with a monthly forecast, no later than the third business day of each month, of the number of Cards to be sold to its clients, (\\\"Sold Card Forecast\\\") as well as the number of Cards to be stocked in inventory, (\\\"Card Inventory Forecast\\\"), (collectively referred to as the \\\"Forecasts\\\") for the month, ninety-days out. For example, Schoolpop shall provide AEIS with the Card Inventory Forecast and Sold Card Forecast in August for the month of November. The Forecasts will be relied on, (\\\"Locked\\\") at the time they are reported. h. Changes to the Forecasts within the Locked period are expected. However, any changes to Locked Forecasts will not impact any applicable penalties as detailed below in subsections (i) and (j). AEIS will place reliance on the Forecasts provided by Schoolpop to align resources and ensure adequate production, fulfillment and customer service capabilities. Schoolpop shall provide AEIS with any changes to the Locked Forecasts on a monthly basis including any respective changes to either Forecast for the remaining twelve (12) month period.\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In any consecutive three (3) month period in which the difference between the Card Inventory Fo\", \"level\": 1, \"text\": \"i. In any consecutive three (3) month period in which the difference between the Card Inventory Forecast less the actual Card Order volume for that period is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, (\\\"Card Inventory Penalty\\\") of sixteen and one-half cents ($0.165) per Card for such difference as detailed in Examples 1 and 2 below. --------------------------------------------------------------------------------------------- EXAMPLE 1 --------------- --------------------- ------------------ ------------------ ----------------- FORECAST PERIOD ACTUAL VOLUME FORECASTED VOLUME DIFFERENCE --------------- --------------------- ------------------ ------------------ ----------------- MONTH 1 10/1/04-10/31/04 8,000 10,000 (2,000) 20% --------------- --------------------- ------------------ ------------------ ----------------- MONTH 2 11/1/04-11/30/04 8,500 10,000 (1,500) 15% --------------- --------------------- ------------------ ------------------ ----------------- MONTH 3 12/01/04-12/31/04 8750 10,000 (1,250) 12.5% ------------------------------------------------------- ------------------------------------- PENALTY 4,750 X $0.165 = $783.75 --------------------------------------------------------------------------------------------- 2 --------------------------------------------------------------------------------------------- EXAMPLE 2 --------------- --------------------- ----------------- ------------------- ----------------- MONTH 1 12/1/04-12/31/04 10,500 11,000 (500) 4.5% --------------- --------------------- ----------------- ------------------- ----------------- MONTH 2 1/1/05-1/31/05 10,000 13,000 (3,000) 23% --------------- --------------------- ----------------- ------------------- ----------------- MONTH 3 02/01/05-02/28/05 12,000 12,500 (500) 4% ------------------------------------------------------- ------------------------------------- PENALTY NO PENALTY ------------------------------------------------------- ------------------------------------- j. In any given month where the difference between the Sold Card Forecast less the actual Card activation volume, (\\\"Cards in Force\\\") is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, the (\\\"Customer Service Penalty\\\") which shall be calculated by converting Cards in Force into call volume minutes as follows:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cards in Force times the call to card ratio times the average handle time equals the t\", \"level\": 1, \"text\": \"i. Cards in Force times the call to card ratio times the average handle time equals the total call volume minutes. AEIS will calculate the respective product's average year-to-date call to Card ratio and the average year-to-date handle time monthly to calculate the call volume minutes. For purposes of example, the year-to-date through August 2004, Encompass(R) Select average call to Card ratio is 2.43 and the average handle time is 4.0 minutes. &sbsp; ii. Actual call volume minutes under 90% of the Card Sold Forecast will be charged at 90% of Locked Rolling Forecast at the standard rate of $0.50 per minute. Schoolpop's Customer Service Penalty shall be calculated at the difference between actual call volume minutes and 90% of Card Sold Forecast call volume minutes.\"}}, {\"id\": \"iii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Customer Service Penalty shall be calculated based upon the a) call volume minutes p\", \"level\": 1, \"text\": \"iii. The Customer Service Penalty shall be calculated based upon the a) call volume minutes plus b) Cards in Force as detailed in the example below:\"}}, {\"id\": \"l\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop shall pay AEIS all incurred penalties within thirty (30) days of receipt of invoice f\", \"level\": 1, \"text\": \"l. Schoolpop shall pay AEIS all incurred penalties within thirty (30) days of receipt of invoice for such penalties by AEIS.\"}}, {\"id\": \"m\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"At any given time during this Agreement, Schoolpop's inactive Card inventory shall be limited t\", \"level\": 1, \"text\": \"m. At any given time during this Agreement, Schoolpop's inactive Card inventory shall be limited to $3,000,000 in Card value as determined by the Point denomination on each Card. This limit &sbsp; shall consist of a maximum Card value of $1,500,000 in Encompass(R) Select Cards and $1,500,000 Card value in any other product (s). Effective January 1, 2005, after which Encompass(R) Select shall no longer be available to Schoolpop, the maximum inactive Card value shall not exceed $3,000,000 in any combination of products at any given time. In the event that Schoolpop exceeds either of these limits, AEIS shall cease fulfilling Orders from Schoolpop until such time that Schoolpop's inventory returns to an acceptable level based on the established maximums. n. Any New Cards shall be excluded from the forecasting and penalty provisions of this Section 3 for the three (3) month period commencing on the date of the first order of such New Cards.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CARD ISSUANCE\", \"level\": 1, \"text\": \"4. CARD ISSUANCE a. Schoolpop agrees that it will review all requests for each Program requested by the Client and will use reasonable and customary business practices to qualify and recommend Clients proposed for a Program. Schoolpop shall take commercially reasonable efforts to ensure all information requested for a Client is true, accurate and correct. b. AEIS may, from time to time, provide Schoolpop with commercially reasonable qualification standards for Clients. Schoolpop shall not knowingly submit an Order to AEIS on behalf of any Client that does not meet any such standards. Schoolpop agrees that it will sell Cards only to Clients and only for use in connection with a bona fide fund raising program. Schoolpop will not knowingly sell Cards to any Client who does not meet any AEIS qualification standard(s) or to any 3 Client or potential Client that Schoolpop has reason to believe would be unsatisfactory to AEIS.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS reserves the right at any time, with or without cause, with reasonable written notice to S\", \"level\": 1, \"text\": \"c. AEIS reserves the right at any time, with or without cause, with reasonable written notice to Schoolpop, to cancel or decline any Client's participation in the Program.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS may, at its sole discretion, decline to provide Cards to Clients\", \"level\": 1, \"text\": \"d. AEIS may, at its sole discretion, decline to provide Cards to Clients. e. Cards are intended for use in the United States and must be designated for receipt of shipment within the United States. f. AEIS' designated vendor will be responsible for shipping Cards in accordance with Schoolpop's instructions. g. AEIS's designated vendor will ship the Cards as follows:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During Period One, AEIS' designated vendor will use reasonable commercial efforts to s\", \"level\": 1, \"text\": \"i. During Period One, AEIS' designated vendor will use reasonable commercial efforts to ship the Cards as detailed below, following receipt and clearance by AEIS of Card Funding.\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During Period Two, AEIS' designated vendor will use reasonable commercial efforts to sh\", \"level\": 1, \"text\": \"ii. During Period Two, AEIS' designated vendor will use reasonable commercial efforts to ship the Cards as detailed below, following receipt of Card Order placed by Schoolpop. The initial Order of (a) standard non-branded Cards within 5 business days after set-up; subsequent Orders, (b) of less than 5,000 Cards per day within three (3) to five (5) business days of receipt of Order; (c) forecasted Orders of 5,000 or more Cards per day within eight (8) to thirteen (13) business days of receipt of Order; and (d) non-forecasted Orders of 5,000 or more Cards per day within twenty (20) to thirty (30) business days of receipt of Order. All shipment timelines are subject to change without notice due to seasonal or unforecasted production volume and AEIS shall work with its Card production vendor and use reasonable commercial efforts to secure the most favorable shipment date commitment and shall notify Schoolpop accordingly. h. One point is worth one (1) U.S. Dollar ($1.00 USD) (\\\"Point\\\").\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS shall ship Cards in bulk shipment via its designated vendor to Schoolpop, F\", \"level\": 1, \"text\": \"i. AEIS shall ship Cards in bulk shipment via its designated vendor to Schoolpop, F.O.B. Atlanta, Georgia. Schoolpop shall distribute to each Cardholder the Cardholder agreement as provided with each Card and which includes instructions on \\\"How to Use the Card\\\". Should Schoolpop or its Client distribute Cards without such Cardholder agreement, Schoolpop shall indemnify and hold harmless AEIS, its parents, subsidiaries and their respective affiliates, officers, directors, employees and agents, against any and all Loss, hereinafter defined, that AEIS may incur or be subjected to as a result of such action, including, without limitation, any claims brought by any entity including but not limited to governmental entities and Cardholders. j. Purchases made with a Card having insufficient Points will be deemed a deniable transaction. The correct way to handle the purchase is described in the Cardholder agreement. If there is a purchase made on a Card where there are insufficient Points on the Card, the negative amount will be the responsibility of the person whose signature appears on the Card, as described in the Cardholder agreement. k. CARDS LOST OR STOLEN IN TRANSIT IN THE INITIAL SHIPMENT FROM AEIS WILL BE THE RESPONSIBILITY OF AEIS. The full risk of loss for ordered Cards shall pass to Schoolpop immediately upon their delivery to Schoolpop by AEIS and AEIS shall not reimburse Schoolpop or Client for any delivered Card that is lost, stolen, misappropriated, or that otherwise disappears or is fraudulently or inappropriately used (together referred to as \\\"Loss\\\"). Schoolpop shall remain solely liable for any Loss caused by the negligence or willful misconduct of its employees, agents or representatives after the shipment has been received by Schoolpop. AEIS will not reimburse Schoolpop or its Client or be responsible for any Loss in connection with or after delivery of Cards to Schoolpop, its Clients or the Cardholder whether they are shipped to Schoolpop, its Client, or to either of their pre-designated delivery agents. Only Cardholders are eligible to receive replacements from AEIS and replacements are given only in accordance with the agreement between the Cardholder and AEIS. Cards are usually shipped in packaging with AEIS' designated vendor as the return address. Notwithstanding the foregoing, AEIS shall bear no risk of Loss and of non-receipt of Cards by the intended Cardholder in the event that AEIS is instructed to use another address as the return address, the address provided to AEIS for Schoolpop or the Client was incorrect, the request for the Card was unauthorized, and/or any information received by AEIS with regard to the processing of the Order was fraudulent or incorrect.\"}}, {\"id\": \"l\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All agreements entered into between Schoolpop and its Clients, shall contain a provision substa\", \"level\": 1, \"text\": \"l. All agreements entered into between Schoolpop and its Clients, shall contain a provision substantially similar to the preceding Section 3 (k). 4\"}}, {\"id\": \"m\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the term hereof, Schoolpop shall maintain at all times the following information with re\", \"level\": 1, \"text\": \"m. During the term hereof, Schoolpop shall maintain at all times the following information with respect to Card resale and distribution to Client:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For each box of Cards, or partial thereof, sent from AEIS's designated vendor to Schoo\", \"level\": 1, \"text\": \"i. For each box of Cards, or partial thereof, sent from AEIS's designated vendor to Schoolpop, the UPS(TM) Tracking number appearing on the shipping label of the box and the respective Card numbers for the Cards contained in the box (AEIS's shipping vendor shall include a list of Card numbers within each box.), and\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Client name and delivery date of each box of Cards or partial thereof, sent from Sc\", \"level\": 1, \"text\": \"ii. The Client name and delivery date of each box of Cards or partial thereof, sent from Schoolpop via their designated shipping vendor, to the Client, including proof of signature and tracking number for the box, specific to Schoolpop's shipping vendor. n. Schoolpop shall comply with all applicable Federal, State and local laws concerning the use of Cards, including anti-money laundering and anti-terrorism laws, and currency control regulations. Schoolpop warrants it shall take measures to track information about its Clients which shall meet compliance requirements related to the above stated laws, track all Card shipment(s) to each such Client, and maintain appropriate records for its Clients for a period of seven (7) years after termination of the Agreement and to provide such records and other information to AEIS upon reasonable request and subject to applicable law. Schoolpop shall further inform in writing all of its Clients of their requirement to comply with all applicable laws concerning the use of Cards, including those laws stated in the previous sentence. School shall inform its Clients of the requirement to maintain records with respect to the Cards and Cardholders, and to verify the identity of Cardholders as required by law, to maintain records of the information used to verify each Cardholder's identity, to retain such records for at least seven (7) years following the date of distribution, including &sbsp; name, home address, Card number, and other identifying information, and the name, title and phone number of the individual responsible for maintaining such records, and to provide such records and other information to AEIS upon reasonable request and subject to applicable law. Schoolpop and Schoolpop's Clients shall establish and maintain an anti-money laundering program with an assigned compliance officer and compliance program. Details of such shall be provided to AEIS upon request. Schoolpop and Schoolpop's Clients shall not accept cash, coin or currency in exchange for Cards. Schoolpop shall indemnify and hold harmless AEIS its parents, subsidiaries and their respective affiliates, officers, directors, employees and agents, against any and all Loss that AEIS may incur or be subjected to as a result of or arising out of Schoolpop's failure to comply with such laws and regulations, including, without limitation, any Loss resulting from any claims brought by any entity including but not limited to governmental entities, unless due to the acts or omissions of AEIS. AEIS reserves the right, at its sole discretion, to monitor and enforce Schoolpop's compliance with all applicable laws and regulations, including but not limited to those contained in this Section 3 (n). Schoolpop shall monitor and use reasonable commercial efforts to enforce its Clients' compliance with all applicable laws and regulations including, but not to limited to those contained in this Section 3 (n). All agreements entered into between Schoolpop and its Clients shall contain a provision substantially similar to this Section 3 (n). o. Schoolpop agrees that it will indemnify and hold AEIS harmless for any claims or losses resulting from its failure to comply with the requirements of Sections 4 (k), (m-n), unless due to the acts or omissions of AEIS. p. AEIS will not hold Schoolpop responsible for or seek to collect from Schoolpop any Loss caused by or resulting from any Cardholder's fraud, misuse, or negative balance transactions involving the Cards except to the extent such Loss was caused by Schoolpop's breach of a representation, warranty, or covenant of this Agreement or if Schoolpop (or Schoolpop's employees, agents or representatives) participated in or had knowledge of any deceptive, fraudulent or other illegal activity. q. Schoolpop acknowledges that Points must be used prior to the expiration date of the Cards. No refund will be made with respect to Points remaining on Cards at the time of expiration to Schoolpop, its Clients or the Cardholders, subject to applicable law. Schoolpop further acknowledges the Cardholder Agreement contains such notice to Cardholders.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT INSTRUCTIONS\", \"level\": 1, \"text\": \"5. PAYMENT INSTRUCTIONS a. Effective Period One, Schoolpop shall provide full payment of Card funding via wire transfer for Orders placed through the end of Period One. AEIS shall fulfill such Orders upon receipt and clearance of funds. b. Effective Period Two, Schoolpop shall provide the full payment of Card funding via ACH Debit at the time Schoolpop requests activation of Cards. AEIS shall activate the Cards by loading the appropriate number of Points onto the Cards as determined by the denomination, and at which time the Cards shall be ready for use by Cardholders within two (2) business days. 5\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop shall pay AEIS $25\", \"level\": 1, \"text\": \"c. Schoolpop shall pay AEIS $25.00 each time a wire transfer is used for amounts under $5,000.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Schoolpop account number as detailed on Exhibit 3, attached hereto, must be on each form of\", \"level\": 1, \"text\": \"d. The Schoolpop account number as detailed on Exhibit 3, attached hereto, must be on each form of payment along with the amount of funding to be applied to each account number. Failure to provide AEIS with this account number and funding detail may result in a delay in Funding. e. Schoolpop shall pay AEIS $15.00 for each returned ACH Debit payment. f. All instruments bearing funds for Cards should be made payable to American Express Incentive Services, L.L.C. AEIS' required payment method is in U.S. currency. AEIS reserves the right to decline payment made in any other currency. g. The following instructions should be used for Electronic Settlements to AEIS: American Express Incentive Services c/o Bank of America Dallas, TX Routing/ABA #111000012 Account #375-100-6936 Reference: XXXX (Client Name and Account #) All invoices for Schoolpop should be sent to the following address: Schoolpop, Inc. Attn: Paul Robinson Address: 3885 Crestwood Parkway, Suite 550 City, State, Zip: Duluth, GA 30096 Phone #: 770-638-5101 Fax #: 770-678-3334 Email address: probinson@Schoolpop.com Schoolpop agrees to notify AEIS promptly in the event the address or contact for invoice submission changes.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDERING INSTRUCTIONS\", \"level\": 1, \"text\": \"6. ORDERING INSTRUCTIONS a. Effective Period One, Schoolpop's designated contact shall place Orders by submitting data in an electronic document via email to AEIS. b. Schoolpop will be assigned a user name and password that will be used for identification when placing Orders using easyorder(TM). Schoolpop authorizes AEIS to accept and process Orders from anyone using Schoolpop's password. AEIS will have no obligation or responsibility for verifying the identity of anyone using Schoolpop's password. Schoolpop shall have the responsibility of safeguarding Schoolpop's password and should not reveal its password to anyone. AEIS will not ask Schoolpop in an unsolicited telephone call or email for its password. In addition, Schoolpop should take precautions when using a computer that is not its own or in a public setting. If Schoolpop suspects that someone else may have had access to its password, Schoolpop shall notify AEIS immediately.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effective with Period Two, the following ordering terms and conditions apply\", \"level\": 1, \"text\": \"c. Effective with Period Two, the following ordering terms and conditions apply:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop shall order Cards in increments of 100 per box and shall not place Orders fo\", \"level\": 1, \"text\": \"i. Schoolpop shall order Cards in increments of 100 per box and shall not place Orders for any partial box (es) of 100, nor request any partial activation of any box (es).\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cards within each box shall be of the same product and Point value\", \"level\": 1, \"text\": \"ii. Cards within each box shall be of the same product and Point value. AEIS shall not mix products and/or Point values within any single box.\"}}, {\"id\": \"iii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon receipt of Cards, Schoolpop shall confirm receipt of such Cards as detailed in the\", \"level\": 1, \"text\": \"iii. Upon receipt of Cards, Schoolpop shall confirm receipt of such Cards as detailed in the Trust Agreement.\"}}, {\"id\": \"iv\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS shall use commercially reasonable efforts to activate each full box of Cards withi\", \"level\": 1, \"text\": \"iv. AEIS shall use commercially reasonable efforts to activate each full box of Cards within two (2) &sbsp; business days upon receipt of the UPS(TM) Tracking number (used by AEIS's designated shipping vendor) for the box of Cards from Schoolpop along with the receipt and clearance of Card funding for the box of Cards.\"}}, {\"id\": \"v\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Once activated, all Cards become the property of Schoolpop, excluding all Marks as det\", \"level\": 1, \"text\": \"v. Once activated, all Cards become the property of Schoolpop, excluding all Marks as detailed in Section 8, and further defined within the Trust Agreement.\"}}, {\"id\": \"vi\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Activation terms for New Cards shall follow the process established for existing Cards\", \"level\": 1, \"text\": \"vi. Activation terms for New Cards shall follow the process established for existing Cards. 6\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROGRAM COMMUNICATIONS\", \"level\": 1, \"text\": \"7. PROGRAM COMMUNICATIONS a. All rights to the name, logo, service marks and/or trademarks (the \\\"Marks\\\"), trade names, tag lines, or any other proprietary designation (\\\"Proprietary Designation\\\") of AEIS remains the sole property of AEIS. Certain use of the Marks and Proprietary Designation of American Express Travel Related Services Company and Maritz Inc. has been granted to AEIS under license agreements. It is understood that the Marks may be necessary to enhance the impact and clarity of Program communications. All use of Marks and Proprietary Designations of AEIS, American Express and Maritz Inc. requires prior written approval from AEIS and use of the Marks shall follow and be subject to requirements issued by AEIS and attached hereto as Exhibit 4 and 4.A and 4.B, including any such Marks used by Schoolpop's Clients. b. Camera-ready artwork is available from AEIS for inclusion of the AEIS logo or to display a picture of a Card in Program communications. Requests for camera-ready artwork should be directed to the address below.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop shall inform AEIS in writing, and obtain prior written consent (which consent shall n\", \"level\": 1, \"text\": \"c. Schoolpop shall inform AEIS in writing, and obtain prior written consent (which consent shall not be unreasonably withheld), for any and all television, radio, newspaper, magazine, Internet, Intranet, or other advertising, promotional or marketing campaign or strategy using the Marks or when referring directly to American Express Travel Related Services Company, Maritz Inc. or AEIS or any American Express merchant.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop is solely responsible for ensuring that any names and/or logos, designs, pictures or\", \"level\": 1, \"text\": \"d. Schoolpop is solely responsible for ensuring that any names and/or logos, designs, pictures or other intellectual property, which are provided by Schoolpop to be used in the Program (including collateral material), does not infringe or violate the intellectual property rights of any other party and shall indemnify AEIS from any and all claims made by any third party respecting such infringement. e. Schoolpop shall discontinue its use and shall notify its Clients to discontinue use of the Marks, including all American Express merchant marks, and all associated promotions, including but not limited to Client promotions, upon termination of this Agreement. f. Schoolpop, at its option, may request that AEIS include in the shipment of Cards, Program specific collateral materials. Program specific collateral materials are subject to review and approval by AEIS and additional charges may apply. g. AEIS retains the right to immediately terminate this Agreement should Schoolpop distribute any promotional materials or communications that are not approved by AEIS and/or do not meet AEIS' branding guidelines, including American Express merchant marks. h. Schoolpop shall send all materials for review to: Branding and Product Communications Specialist American Express Incentive Services, L.L.C. 1309 N. Highway Drive Fenton, MO 63099 Tel: 636-226-2071 Fax: 636-226-2002 AEIS shall review all submissions within seven (7) business days.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"JOINT MARKETING AND COMMUNICATIONS\", \"level\": 1, \"text\": \"8. JOINT MARKETING AND COMMUNICATIONS a. AEIS shall provide standard Card plastic design and standard Card carrier design including pre-printed paper and electronic copy, and standard Card envelope design for all Card packaging (collectively \\\"Card Packaging\\\"). In the event Schoolpop or its Clients request any non-standard Card plastic design or Card Packaging, AEIS and Schoolpop shall mutually agree upon such materials. AEIS shall provide to Schoolpop pricing for non-standard materials b. AEIS shall provide standard promotional materials, and communication to provide market exposure for Cards. In the event Schoolpop or its Clients request any non-standard promotional or communication materials, AEIS and Schoolpop shall mutually agree upon such materials. AEIS shall provide to Schoolpop pricing for non-standard materials, which may or may not include Cardholder website customization.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS and Schoolpop shall mutually develop, market, and implement two (2) new Cards for Program\", \"level\": 1, \"text\": \"c. AEIS and Schoolpop shall mutually develop, market, and implement two (2) new Cards for Program use no later than October 1, 2004 as follows:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A category Card, where AEIS shall put forth a commercially reasonable effort to secure\", \"level\": 1, \"text\": \"i. A category Card, where AEIS shall put forth a commercially reasonable effort to secure contracts with a select group of merchants to participate in the Card program as identified on Exhibit 5, attached hereto, and to make changes to such categories and/or merchants. 7\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A grocery Card, where AEIS shall put forth a commercially reasonable effort to secure c\", \"level\": 1, \"text\": \"ii. A grocery Card, where AEIS shall put forth a commercially reasonable effort to secure contracts with a select group of merchants leveraging Schoolpop's existing relationships with grocery store companies, as identified on Exhibit 5.A, attached hereto, and to add other merchants as mutually agreed upon by both parties.\"}}, {\"id\": \"iii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS shall communicate and maintain participating merchants in the category and grocery\", \"level\": 1, \"text\": \"iii. AEIS shall communicate and maintain participating merchants in the category and grocery Cards through the Card website, an Interactive Voice Response fax-back service listing of current merchants, and through a merchant listing that shall accompany each Card.\"}}, {\"id\": \"iv\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS and Schoolpop mutually agree to pursue additional Card products, as market conditi\", \"level\": 1, \"text\": \"iv. AEIS and Schoolpop mutually agree to pursue additional Card products, as market conditions warrant, for use in the NPO marketplace and shall document such products in a separate Agreement.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties agree that the minimum number required for the category Card shall be not less than\", \"level\": 1, \"text\": \"d. The parties agree that the minimum number required for the category Card shall be not less than 70% of the consumer categories contained within Exhibit 5; and the grocery Card not less than 70% national coverage to launch each respectively. The parties shall mutually agree upon any New Card minimum numbers required for each&sbsp;New Card launch.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROGRAM TERMS\", \"level\": 1, \"text\": \"9. PROGRAM TERMS a. From the Effective Date through September 30, 2004, Schoolpop may order non-standard Encompass(R) Select denominations (other than 25, 50, 75, and 100 Points) up to a maximum of 200 Points. Such non-standard Encompass(R) Select denominations require eight (8) weeks to fulfill and must be ordered in boxes of 100 Cards of like denominations. Schoolpop shall be limited to $26,500,000 in total Encompass(R) Select sales through December 31, 2004. Such limit may be increased in the event Persona Select actual sales exceed its forecasted sales for the period ending December 31, 2004. The limit increase shall be calculated on three-to-one ratio of Encompass Select sales to Persona Select Sales. Schoolpop shall discontinue reselling Encompass(R) Select Cards on December 31, 2004 and shall effectively manage and forecast Encompass(R) Select Card needs to deplete such inventory as of December 31, 2004. In the event that any unsold Encompass Select Cards remain in inventory by Schoolpop on December 31, 2004, Schoolpop shall provide to AEIS, no later than January 5, 2005, the Encompass(R) Select Card numbers, the respective expiration dates and denominations of the Cards. Such Card list shall be provided to AEIS by Schoolpop via disk/CD and sent via a form of shipment where signature is required upon delivery. AEIS shall invoice Schoolpop for applicable destruction fees of $2.00 per Card which shall be payable by Schoolpop within thirty (30) days upon receipt of invoice. b. Cards shall not be used to purchase gift certificates and/or gift cards at participating merchants.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop acknowledges it will be listed as a current Client of AEIS\", \"level\": 1, \"text\": \"c. Schoolpop acknowledges it will be listed as a current Client of AEIS. Schoolpop agrees to be used as a reference to current and future AEIS Clients with prior approval from Schoolpop.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop agrees to an annual review to take place forty-five (45 days) prior to each contract\", \"level\": 1, \"text\": \"d. Schoolpop agrees to an annual review to take place forty-five (45 days) prior to each contract anniversary, on or about June 15th of each contract year. This review will include, but is not limited to, a review of volume performance, economics of the products, and branding. e. Schoolpop agrees to product and program training as required by AEIS. f. The parties agree to jointly develop a Cardholder appeasement &bbsp; program. Such appeasement program shall require Schoolpop develop a process with its Clients to mutually resolve Cardholder appeasement issues prior to raising them with any third party(ies). g. AEIS may from time to time provide Schoolpop with certain reasonable terms and provisions to be included in the agreements to be entered into between Schoolpop and its Clients and Schoolpop agrees that any such terms and provisions shall be included in such agreements.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROGRAM SERVICING\", \"level\": 1, \"text\": \"10. PROGRAM SERVICING a. AEIS will provide:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"24-hour customer service representation, via a 24x7 English speaking toll-free telepho\", \"level\": 1, \"text\": \"i. 24-hour customer service representation, via a 24x7 English speaking toll-free telephone number, for Program Cardholders who have questions concerning a Card. The toll-free numbers as of the drafting of this Agreement are: Persona(R) Select 800-259-9526 Encompass(R) Select 888-210-9821 Fill It Up(R) 800-575-7365 Be My Guest(R) 877-243-5082 8\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cardholders with the ability to obtain point balance information through the following\", \"level\": 1, \"text\": \"ii. Cardholders with the ability to obtain point balance information through the following Cardholder Web sites: www.personaselect.com Persona(R) Select www.encompass-select.com Encompass(R) Select www.rewardearner.com/fillitup Fill It Up(R) www.rewardearner.com/bmg Be My Guest(R)\"}}, {\"id\": \"iii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Merchant Management - includes the management of the authorization network, merchant set\", \"level\": 1, \"text\": \"iii. Merchant Management - includes the management of the authorization network, merchant settlement and dispute handling, and\"}}, {\"id\": \"iv\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS will provide reasonable assistance to Schoolpop in managing the Program as needed\", \"level\": 1, \"text\": \"iv. AEIS will provide reasonable assistance to Schoolpop in managing the Program as needed and requested by Schoolpop. Additional charges may apply.\"}}, {\"id\": \"v\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS and Schoolpop shall mutually agree upon a Client and/or Cardholder appeasement pr\", \"level\": 1, \"text\": \"v. AEIS and Schoolpop shall mutually agree upon a Client and/or Cardholder appeasement process and the respective financial responsibility. b. AEIS reserves the right to change program servicing from time to time.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES\", \"level\": 1, \"text\": \"11. REPRESENTATIONS AND WARRANTIES a. Schoolpop and AEIS each represents and warrants that participation in the Program shall at all times conform to the highest standards of business ethics and practices and at no time will they permit any act to be done by their employees or representatives that will damage the name, reputation or goodwill of the other party or its affiliated companies. b. Schoolpop and AEIS each further represents and warrants that its participation in the Program is and will remain during the term of this Agreement in compliance with all laws, rules and regulations applicable to it.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop and AEIS each further represents and warrants that they are authorized to enter into\", \"level\": 1, \"text\": \"c. Schoolpop and AEIS each further represents and warrants that they are authorized to enter into this Agreement and that this Agreement does not violate any other agreement to which it is a party.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"12. CONFIDENTIALITY a. The terms, procedures, any applicable criteria for success and results of this Agreement and all information furnished by and between the parties in connection with this Agreement shall be confidential and shall not be disclosed by either party without the express written consent of the other party; provided that Schoolpop shall have the right to disclose such information as may be required to comply with applicable SEC regulations. b. Both parties acknowledge that they may have access to or receive confidential information, data, and materials about the other party, their Clients and Cardholders, and their entities, including, without limitation, marketing philosophies and objectives, pricing information, business materials and data, processes, customer lists, product information, financial data, competitive advantages and disadvantages, and other confidential information received (\\\"Confidential Information\\\"), and that disclosure or misuses of such Confidential Information, would be irreparably damaging to the other party. Accordingly, both parties agree to receive and hold in confidence all Confidential Information considered proprietary or confidential by the other party, and &sbsp; agree not to disclose or use such information in any manner except for uses contemplated by this Agreement unless permitted in writing in advance by the other party (except for information disclosed to Cardholders in accordance with the Cardholder Agreement). Both parties also agree to bind their employees, and subcontractors to compliance with this paragraph and to take all other reasonable action to ensure protection of the Confidential Information.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Such Confidential Information is subject to the terms and conditions of this Agreement, if (a)\", \"level\": 1, \"text\": \"c. Such Confidential Information is subject to the terms and conditions of this Agreement, if (a) such Confidential Information is either Party's marketing philosophies and objectives, financial and pricing information, Client lists, business processes or competitive advantages and disadvantages; (b) such Confidential Information is disclosed verbally and is verbally identified as proprietary or confidential at the time of disclosure, and there exists a written record that such Confidential Information was disclosed and identified verbally as proprietary or confidential; or (c) such Confidential Information is in written, graphic or electronic form when disclosed and the media that contains such Confidential Information is clearly marked \\\"confidential\\\" or \\\"proprietary\\\", or something substantially similar. Notwithstanding the foregoing, Confidential Information shall not include (d) information that is publicly known, already known by, or in the possession of the non-disclosing party, or (e) is independently developed by the non-disclosing party without use or reference to the other party's Confidential Information, or (f) is rightly 9 obtained by the non-disclosing party from a source other than the disclosing party without such restrictions.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party agrees that during the term of this Agreement and thereafter (a) it will use Confide\", \"level\": 1, \"text\": \"d. Each party agrees that during the term of this Agreement and thereafter (a) it will use Confidential Information belonging to the other party solely for purposes outlined in this Agreement, (subject to the terms and conditions thereof), (b) it will not disclose Confidential Information belonging to the other Party to any third party other than the receiving Party's employees, affiliates, agents, permitted vendors, subcontractors and/or professional advisors on a need-to-know basis who are advised of the confidential nature of the Confidential Information and under a similar confidentiality agreement, and (c) each Party will treat the Confidential Information of the other Party with the same care that the receiving party normally affords its own proprietary and confidential information. If any such employee, affiliate, agent, subcontractor or professional advisor discloses or uses the Confidential Information in a manner not permitted under this Agreement, the party disclosing the Confidential Information to such employee, affiliate, agent, subcontractor or professional advisor will be liable therefore. If either party is required by law to disclose Confidential Information, it may be disclosed, provided that, unless prohibited, sufficient prior notice is given to the non-disclosing party to afford it an opportunity to take whatever steps it deems necessary to protect the confidential nature of the Confidential Information. In the event a party is required to disclose the other party's Confidential Information in connection with any judicial proceeding or government investigation, a notification of such requirement shall promptly occur allowing a reasonable time for the appropriate party to seek a protective Order from the appropriate court or government agency. Thereafter, Confidential Information may be disclosed to the extent required by law, subject to any applicable protective Order. e. Upon request of the other party, each party will promptly return to the other any or all Confidential Information of the other then in its possession or under its control provided, however, that each party may retain one copy of all such Confidential Information solely for its own internal records, such Confidential Information to remain subject to the restrictions on use and disclosure contained in this Agreement f. Authorized users, (\\\"Authorized Users\\\") include Schoolpop, its affiliates and its Client's personnel involved in administering the Program and eligible Cardholders of a Schoolpop Program. Schoolpop acknowledges that it will likely receive private information (\\\"PI\\\") from Authorized Users that will be subject to various privacy laws and regulations in the various States in which the Authorized Users and the parties hereto reside. Furthermore, Schoolpop, and/or its Client, will likely be providing such PI to AEIS for identification of such Authorized Users. Schoolpop shall, and shall cause its Client to, (a) comply with all applicable privacy laws and regulations, (b) shall provide to AEIS evidence of such compliance upon request, (c) and shall obtain such permissions, clearances, or other allowances as shall be necessary for AEIS to use such PI as contemplated hereunder. Schoolpop shall, and shall cause its Client to, (d) cooperate with AEIS with respect to complying and avoiding any claims based on PI rights of others including without limitation Schoolpop and/or its Client communicating to AEIS all necessary acts and safeguards required of AEIS in handling PI, (e) providing such notices and information to Authorized Users as required, (f) identifying all PI as PI at the time of its transmission to AEIS, (g) segregating any PI required to be handled differently as necessary to ensure its proper treatment including without limitation not providing PI to AEIS and, if applicable, (h) PI that has been \\\"opted out\\\" of Schoolpop's or its Client's permission for use hereunder. Schoolpop and its Client shall respectively bear the cost of compliance with all privacy laws and regulations. Schoolpop will, at its sole cost and expense, defend, indemnify and hold harmless AEIS and each of its respective officers, directors, employees, agents, contractors, affiliates, service providers and insurers (collectively, \\\"AEIS Indemnified Parties\\\") from and against any and all loss or liability, claims, demands, damages, losses and expenses including, without limitation, reasonable attorneys, accountants and expert witness fees, costs and expenses that the AEIS Indemnified Parties, or any one or more of them, may sustain or incur as a result of a claim of violation of any law or regulation or personal right directed to protecting the PI rights of individuals or the use, misuse, collection, loss of privacy or confidentiality, or other mishandling or improper or illegal act with respect to such PI including without limitation governmental enforcement action as well as civil claims involved with any such Schoolpop Program. Excluded from the obligation to defend and indemnify shall be any claims or damages attributable &bbsp; solely to the negligence or intentional misconduct of any AEIS Indemnitied Party, and solely as to that AEIS Indemnified Party to which such negligence or intentional misconduct is attributable. The obligations under this Section 12 shall survive the termination, cancellation, and expiration of this Agreement. 10\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSURANCE\", \"level\": 1, \"text\": \"13. INSURANCE a. Schoolpop shall, during the term of this Agreement, at its own cost and expense, procure with sound and reputable insurers, the following insurance coverage's: (i) Workers' Compensation Insurance in an amount not less than the statutory limits for the state(s), country or province in where the services are to be performed; (ii) Employer's Liability Insurance not less than (a) $100,000 per occurrence, and not less than $100,000 aggregate limit of liability per policy year for disease, including death at any time resulting therefrom, not caused by accident or (b) such amount as required by law, whichever is higher; (iii) Comprehensive General Liability Insurance, including blanket extended coverage against all hazards, including personal injury and death resulting therefrom, for not less than $1,000,000 per occurrence, and not less than $2,000,000 aggregate; (iv) Automobile Liability insurance against liability arising from the maintenance or use of all owned, non-owned and hired automobiles and trucks used to provide services, with (a) a minimum limit of liability for bodily injury of $1,000,000 in the aggregate, and with a minimum limit of liability for property damage of $500,000 per accident, or (b) amount as required by law, whichever is higher; and (v) fidelity or crime policy of not less than $3,000,000 in the aggregate against misappropriation and/or destruction of Cards. b. Schoolpop's insurance shall be deemed primary. Schoolpop shall provide AEIS with certificates of insurance evidencing the coverage's required hereunder within fifteen (15) days after execution of this Agreement. Each policy required hereunder shall provide that AEIS shall receive thirty (30) days advance written notice in the event of a cancellation or material change in such policy. Each policy of insurance which Schoolpop is required to possess under this Agreement shall name AEIS, and its Directors, Officers, and Employees, as additional insured in the insurance policy limits herein required. In the event that any service under this Agreement is to be rendered by persons other than Schoolpop's employees, Schoolpop shall furnish AEIS with evidence of insurance for such persons subject to the same terms and conditions as set forth above and applicable to Schoolpop prior to commencement of service by such person(s).\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL TERMS & CONDITIONS\", \"level\": 1, \"text\": \"14. GENERAL TERMS & CONDITIONS a. This Agreement along with the Trust Agreement constitute the entire Agreement between the parties hereto and supersedes all prior communications and agreements between the parties with respect to the subject matter hereof. Except for changes in AEIS product rules and other procedural or operational changes in terms initiated by AEIS as described herein, this Agreement may not be modified or otherwise amended except by a further writing executed by both parties hereto, which writing makes specific reference to this Agreement. b. No right or interest in this Agreement shall be assigned by Schoolpop without prior written permission of AEIS, which shall not be unreasonably withheld.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement shall be deemed to have been made and executed in the State of Missouri and any\", \"level\": 1, \"text\": \"c. This Agreement shall be deemed to have been made and executed in the State of Missouri and any dispute arising thereunder shall be resolved in accordance with the laws of the State of Missouri, without reference to its rules governing conflicts of law.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Either party may terminate this Agreement with written notice to the other party as follows\", \"level\": 1, \"text\": \"d. Either party may terminate this Agreement with written notice to the other party as follows:\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Should either party (1) admit in writing its inability to pay its debts generally as t\", \"level\": 1, \"text\": \"i. Should either party (1) admit in writing its inability to pay its debts generally as they become due; (2) make a general assignment for the benefit of creditors; (3) institute proceedings to be adjudicated a voluntary bankrupt; (4) consent to the filing of a petition or bankruptcy against it; (5) be adjudicated by a court of competent jurisdiction as being bankrupt or insolvent; (6) seek reorganization under any bankruptcy act; (7) consent to the filing of a petition seeking such reorganization; or (8) have a decree entered against it by a court of competent jurisdiction appointing a receiver, liquidator, trustee, or assignee in bankruptcy or in insolvency covering all or substantially all of such party's property or providing for the liquidation of such party's property or business affairs; then, in any such event, the other party, at its option and without prior notice, may terminate this Agreement effective immediately; or\"}}, {\"id\": \"ii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon the occurrence of a breach by the other party, which breach has not been cured wit\", \"level\": 1, \"text\": \"ii. Upon the occurrence of a breach by the other party, which breach has not been cured within (30) days after the date of written notice to the breaching party by the non-breaching party; or\"}}, {\"id\": \"iii\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For non-payment of any amounts due hereunder\", \"level\": 1, \"text\": \"iii. For non-payment of any amounts due hereunder. In the event this Agreement is terminated for any reason prior to May 31, 2009, all unpaid Marketing Rights Fees incurred to the termination date, will be fully due and payable by Schoolpop to AEIS. Upon termination, each party will return to the other or destroy, and provide written certification of destruction of, all information furnished by such other party hereunder, prior to termination and follow necessary termination instructions detailed in the Trust Agreement. All Cards ordered by Schoolpop and supplied by AEIS shall be governed by the terms and conditions of this Agreement and the Trust Agreement. 11 e. Notwithstanding anything contained herein to the contrary, the cumulative liability of the parties to one another for any claims, liabilities, losses, damages or expenses, direct or indirect, arising out of or related to this Agreement shall not exceed the lesser of $50,000 or (not including other funding amounts such as the Point value of Cards) or the amount paid by Schoolpop to AEIS for the immediately preceding twelve (12) months provided, however, that in no event shall this limitation of liability apply to any claims, liabilities, losses, damages, or expenses, direct or indirect, arising out of or related to this Agreement brought by the actions of Schoolpop pursuant to paragraphs 4(e), 4(i), 4(k), 4(p), 5(a), 5(b), 6(b), 7(a), 7(d), 14(d.iii), 9(f) and Sections 2, 3 11, 12, and 13, and Exhibit 1 of this Agreement. In no event shall either party be liable to the other, under any theory, for lost profits, exemplary, punitive, special incidental, indirect, or consequential damages. f. In the event that either party breaches or violates any covenant or agreement contained in this Agreement, or in the event of any breach or violation (or alleged breach or violation) of any covenants or agreement made by LoyaltyPoint with any Client or other third party, the breaching party shall indemnify and hold harmless the other party, its affiliates, parent company(ies), officers, directors, employees, and agents against and in respect of any and all costs, expenses, deficiencies, litigation, proceedings, taxes, levies, assessments, attorneys' fees, damages or judgments of any kind or nature whatsoever, related to, arising from, or associated with such breach or violation (or alleged breach of violation). The non-breaching party shall give the breaching party prompt notice of the non-breaching party's intention to make a claim for indemnification hereunder. the breaching party shall have the opportunity to defend the underlying claims, suit or proceeding by competent counsel of its own choosing, provided that non-breaching party has approved such counsel, which approval shall not be unreasonably withheld. The non-breaching party shall cooperate in the defense of such claim, suit or proceeding. The obligations under this Section 14 shall survive the termination, cancellation, and expiration of this Agreement. g. Any notice required or permitted under this Agreement will be effective if in writing and delivered personally, sent by certified U.S. Mail, return receipt requested, postage prepared, sent by a national overnight delivery service (such as Federal Express), or sent by telefax, in each instance addressed and delivered personally or sent for delivery as provided on the signature page of this Agreement. Any notice shall be deemed given (a) if personally delivered when received by the intended recipient, (b) if sent by telefax, when sent and receipt is confirmed, provided that the recipient is sent another copy by one of the other means of notice specified in this section, or (c) if sent by certified mail or overnight delivery, on the earlier of the date of receipt by the intended recipient or three (3) days after the date on which the notice is sent. h. Upon termination of this Agreement, Schoolpop shall have the right to continue to sell any Cards in its possession for a period of three (3) months following the effective date of termination, subject to compliance with the applicable terms and conditions set forth herein, provided however, that termination of the Agreement is not due to a breach of representation or warranty of the Agreement by Schoolpop in which case Schoolpop shall discontinue selling Cards immediately upon termination. [Signature Pages Attached] 12 Signed for and on behalf of SCHOOLPOP INC. Name: Paul Robinson -------------------------------------------- Title: Chief Executive Officer Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- Name: Sheree Herr -------------------------------------------- Title: VP, Legal Management Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- 13 EXHIBIT 1 TRUST AGREEMENT - FULL LIABILITY AGREEMENT between American Express Incentive Services, L.L.C. organized under the laws of the State of Missouri, USA, with an office at 1309 North Highway Drive, Fenton, MO 63099, USA (\\\"AEIS\\\") And Schoolpop, Inc., a Delaware corporation, with an office at 3100 Five Forks Trickum Road, Suite 410, Liliburn, GA 30047 USA (\\\"Seller\\\").\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS and Seller have entered into an American Express Stored Value Products reseller Agreement of even d\", \"level\": 1, \"text\": \"1. AEIS and Seller have entered into an American Express Stored Value Products reseller Agreement of even date herewith pursuant to which Seller is authorized to resell certain Cards as such term is defined therein. As such, AEIS hereby appoints Seller as trustee and agent to sell incentive cards issued by AEIS including Persona Select(R), Be My Guest(R), Fill It Up(R), Encompass Select(R), and any other incentive Card offered by AEIS (hereinafter collectively referred to as \\\"Cards\\\") in standard denominations of 25 Points, 50 Points and 100 Points according to the specific terms in the Reseller Agreement Effective August 1, 2004, and any amendments thereto.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In consideration of its entitlement to the charges referred to in paragraph (g) below, Seller accepts ap\", \"level\": 1, \"text\": \"2. In consideration of its entitlement to the charges referred to in paragraph (g) below, Seller accepts appointment as such trustee and agent and agrees: a. To receive and hold in trust for AEIS, any Cards which are delivered to Seller until paid for by Seller. AEIS or their representatives or vendors may deliver Cards to any employee or representative of Seller and such employees and representatives are hereby authorized to accept such Cards on behalf of Seller. b. To acknowledge Seller's receipt of such Cards in writing to: (i) confirm and inform AEIS of the physical inventory of each Card delivery, and (ii) provide written confirmation of each Card delivery to an AEIS authorized representative by returning a completed Acknowledgement of Receipt form attached hereto as Schedule I and following the directions included thereon within 24 hours of receipt of each Card delivery received by or on behalf of Seller.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To retain Cards in trust for AEIS in an \\\"inactive\\\" status as sent by AEIS until paid in full by\", \"level\": 1, \"text\": \"c. To retain Cards in trust for AEIS in an \\\"inactive\\\" status as sent by AEIS until paid in full by Seller to AEIS. Inactive Cards do not have points loaded on the Cards and are not ready for sale to or use by any consumer.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To prepay for each box of Cards to be sold by Seller\", \"level\": 1, \"text\": \"d. To prepay for each box of Cards to be sold by Seller. Upon clearance of funds for each box of Cards, AEIS shall activate the box of Cards at which time such box of Cards shall become property of Seller. Following such activation, each Card shall generally be ready for use at an appropriate establishment within two (2) business days. e. To sell the Cards in accordance with the written instructions of AEIS. f. To deliver to AEIS or their representatives any unsold Cards upon demand by AEIS. g. To collect any charges for the sale of Cards as may be established by Seller. h. To safeguard all Cards received by Seller at all times, including inactive and active Cards and when the Cards are in transit, as a prudent financial or commercial institution should safeguard a like amount of its own cash. All Cards kept on Seller's premises, both active and inactive, shall be kept locked in Seller's safe which safe must be satisfactory to AEIS. AEIS and/or their appointed representatives of AEIS or American Express Travel Related Services Inc. as solely determined by AEIS, shall be entitled to inspect and approve Seller's safekeeping facilities at any time during normal business hours.\"}}, {\"id\": \"i\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To notify AEIS at destination indicated on the Acknowledgement of Receipt Form, as soon as poss\", \"level\": 1, \"text\": \"i. To notify AEIS at destination indicated on the Acknowledgement of Receipt Form, as soon as possible upon any loss of the Cards due to theft, burglary, fire or other cause. All notifications of loss must include the Card number for all lost Card stock. In the event an entire shipment was lost, the Card tracking number must also be provided. AEIS reserves the right to hold Seller liable for any loss, as to which Seller might not otherwise have been liable for under subparagraph 2(k) below, if Seller has unreasonably delayed reporting the loss to AEIS, and such delay has disadvantaged AEIS or prejudiced AEIS' ability to mitigate or eliminate its damages. 14 j. To maintain accurate records of all Cards sold or held in inventory, including Card numbers, shipment tracking numbers, account numbers, and the Acknowledgement Receipt form, etc. k. To be responsible for any loss of any Cards received in accordance with subsection (a) above prior to the time such Cards are paid for by Seller, whether such loss occurs by theft, burglary, hold-up, fire, dishonesty of employees, mysterious disappearance, or any other cause irrespective of such cause. In the case of loss of Cards, Seller shall pay AEIS from time to time upon demand the amount of any Cards so reported as lost and later used at any merchant or other location or otherwise appear for sale for any reason whatsoever. Seller shall be fully liable for the amounts paid by AEIS and/or their affiliates with respect to such Cards together with any additional reasonable costs incurred by AEIS and/or their affiliates arising out of such Cards. Such liability shall survive termination of this Agreement.\"}}, {\"id\": \"l\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Not to sell Cards on credit or post-paid method of any kind to any individual, company, or enti\", \"level\": 1, \"text\": \"l. Not to sell Cards on credit or post-paid method of any kind to any individual, company, or entity whatsoever nor to utilize the Cards for the benefit of Seller, Seller's owners, officers, employees, representatives or any third party.\"}}, {\"id\": \"m\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To increase Seller's inventory of Cards by following AEIS' process\", \"level\": 1, \"text\": \"m. To increase Seller's inventory of Cards by following AEIS' process. n. To destroy Cards for purposes of past expiration or reason other than termination that causes Seller to remove from inventory. Such Cards must be completely destroyed by cremating or shredding to the point where such Cards cannot be reconstructed in any way or Card numbers cannot be read in any way. Such destruction must be evidenced by execution of AEIS' Destruction Certificate, which is attached hereto as Schedule II. The Destruction Certificate shall be executed by Seller through two authorized signatures and shall particularly describe the Cards by (1) Card product name, (2) Card number, (3) denomination, (4) shipment tracking number, and (5) quantity by product and denomination, and account number. Seller shall pay AEIS associated destruction fees for such Card destruction as detailed within the Destruction Certificate. In the event any Cards certified as destroyed by Seller are later used at any establishment or other location or otherwise appear for sale for any reason whatsoever, Seller shall be fully liable for the amounts paid by AEIS and/or their affiliates with respect to such Cards together with any additional costs incurred by AEIS and/or their affiliates arising out of such Cards. In no event shall Seller throw away discard expired or spoiled or otherwise unwanted Cards in any other manner than described in this Section 2(n). Such liability shall survive termination of this Agreement. o. To pass to a security audit as performed by AEIS and/or their appointed representatives of AEIS or American Express Travel Related Services Inc. at a time and frequency solely determined by AEIS during the term of this Agreement. This Agreement shall be terminated by AEIS at AEIS' choice immediately upon Seller receiving a non-passing status of such security audit. AEIS may chose to allow Seller to conform to non-passing elements of security audit within a time so specified by AEIS in writing to Seller. Seller shall choose to make necessary changes to conform to the security audit or terminate the Agreement as so indicated in Section 4 below.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement (a) may not be assigned by Seller without the written consent of AEIS, except to an entit\", \"level\": 1, \"text\": \"3. This Agreement (a) may not be assigned by Seller without the written consent of AEIS, except to an entity controlling, controlled by or under common control with Seller, provided, however, Schoolpop shall remain liable for the obligations contained herein including the attachments and Exhibits thereto, and (b) may be modified only by an agreement in writing signed on behalf of AEIS by an executive officer. No other employees of AEIS have authority to modify or waive any term of this Agreement. This Agreement may be assigned by AEIS to any parent, subsidiary, affiliated or associate corporation without Seller's consent and shall, whether or not so assigned, inure to the benefit of any AEIS parent, subsidiary, associate or affiliate thereof which pays or becomes liable upon any Cards delivered to Seller under this Agreement.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement shall remain in force until terminated by either party by notice given in accordance with\", \"level\": 1, \"text\": \"4. This Agreement shall remain in force until terminated by either party by notice given in accordance with paragraph 8, below and in accordance with Section 14(h) of the Agreement. a. Notices so given shall, unless otherwise specified therein, be effective upon receipt whereupon both parties shall cooperate in an effective wrap up of all outstanding issues and transition of inventory and other termination responsibilities as determined by AEIS. b. Upon such termination, Seller shall forthwith remit to AEIS or their agents all unsold Cards and shall safeguard such Cards during transit to AEIS in such a manner as detailed in Section 2(h) herein. 15\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The rights of AEIS hereunder shall not be prejudiced or restricted by\", \"level\": 1, \"text\": \"5. The rights of AEIS hereunder shall not be prejudiced or restricted by any time given or forbearance extended to Seller in the enforcement of its rights and no waiver by AEIS of their rights in respect of any breach hereof by Seller shall be deemed to operate as a waiver in respect of any subsequent breach hereof.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"It is agreed between the parties that if any provision of this Agreement is held to be invalid, the rema\", \"level\": 1, \"text\": \"6. It is agreed between the parties that if any provision of this Agreement is held to be invalid, the remainder of this Agreement shall continue in full force and effect and shall be binding and effective on the parties thereto.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement shall be subject to and governed by the laws of the State of Missouri, USA\", \"level\": 1, \"text\": \"7. This Agreement shall be subject to and governed by the laws of the State of Missouri, USA.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All notices hereunder&sbsp;shall be mailed or faxed to the other party as follows\", \"level\": 1, \"text\": \"8. All notices hereunder&sbsp;shall be mailed or faxed to the other party as follows: Notices to Seller shall be addressed or faxed to it at the address or fax number set forth on the first page hereof. Notices to AEIS shall be addressed or faxed as to: American Express Incentive Services, L.L.C. with a copy to: General Counsel's Office 1309 North Highway Drive American Express Fenton, MO 63099 200 Vesey Street Attn: Legal Management New York, N.Y. 10285-4908 Fax: (636) 226-2009 Attn: Marcy Wilkov Fax: (212) 640-0360 [Signature Pages Attached] 16 Signed for and on behalf of SCHOOLPOP INC. Name: Paul Robinson -------------------------------------------- Title: Chief Executive Officer Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- Name: Sheree Herr -------------------------------------------- Title: VP, Legal Management Its duly authorized agent in the presence of: Witness -------------------------------------------- Printed name -------------------------------------------- 17 EXHIBIT 1.A ACKNOWLEDGEMENT OF RECEIPT FORM Schoolpop Inc., a for-profit company incorporated under the laws of the state of Delaware, USA with an office at 3885 Crestwood Parkway, Suite 550, Duluth, GA 30096 USA (hereinafter referred to as \\\"Seller\\\"). Seller, named above, as trustee and agent of AEIS, acknowledges receipt of the Cards listed on page 2 of the Acknowledgement of Receipt Form hereof (\\\"Cards\\\") and agrees: (1) to hold the Cards IN TRUST for AEIS pursuant to the terms of the Trust Agreement; (2) to sell the Cards only in accordance with written instructions from AEIS; (3) to collect such charges for the sale of Cards as Seller may establish from time to time; (4) to safeguard the Cards as a prudent person would safeguard a like amount of his own cash; (5) to notify AEIS promptly, at the address listed on page 2 of the Acknowledgement of Receipt Form hereof, of any loss of Cards due to theft, burglary, fire or any other cause. (6) (A) to be responsible for any loss of Cards unless the Cards were safeguarded in accordance with Section 2.h of the Trust Agreement and the loss occurred without Seller's fault. (B) to be absolutely responsible without regard to Seller's fault for any loss of Cards due to failure to safeguard the Cards in accordance with Section 2(h) of the Trust Agreement or due to the dishonesty of Seller's employees or agents or due to a disappearance which Seller cannot explain. (7) to pay AEIS upon demand for any Cards so lost which have been presented to any establishment or retailer in exchange for service(s) or product(s) so reported by Seller as lost and later used at any establishment or other location or otherwise appear for sale for any reason whatsoever, Seller shall be fully liable for an amount of money equal to the face value of amounts paid by AEIS and/or their affiliates with respect to such Cards together with any additional costs incurred by AEIS and/or their affiliates arising out of such Cards. and (8) that the terms hereof shall not relieve Seller of any obligation or liability under any other agreement relating to the sale of Cards existing between Seller and AEIS, its parent, subsidiaries or affiliates. WARNING: Except in the event of termination of the Agreement Do Not Return Any of the Cards Listed on page 2 of the Acknowledgement of Receipt Form. If it is necessary to reduce Seller's inventory of Cards, including spoiled or expired Cards, destroy such Cards by cremating or shedding and evidence their destruction by a Destruction Certificate attached to the Agreement as Exhibit 1.C, applicable destruction fees shall apply. The Destruction Certificate shall be (i) on the Seller's letterhead, (ii) executed by Seller through two authorized signatures and (iii) shall particularly describe the Cards by (a) name of Card product, (b) Card number, (c) denomination, (d) shipment tracking number, and (e) quantity by product, denomination and account number. Schoolpop shall forward the original Destruction Certificate to AEIS and Schoolpop shall confirm receipt by AEIS. If this procedure is not practical, contact AEIS Client Service Support for specific instructions regarding disposition. AMERICAN EXPRESS INCENTIVE SERVICES, L.L.C., is the designated servicing agent for the following Cards: Persona(R) Select, Be My Guest(R), Fill It Up(R), Encompass(R) Select, and any other pre-denominated incentive card offered by AEIS. 18 ACKNOWLEDGEMENT OF RECEIPT FORM - PAGE 2 Schoolpop, Inc., a for-profit company incorporated under the laws of the state of Georgia, USA with an office at 3885 Crestwood Parkway, Suite 550, Duluth, GA 30096 USA (hereinafter referred to as \\\"Seller\\\") ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- DATE RECEIVED UPS TRACKING PRODUCT ACCOUNT # DENOMINATION BEGINNING CARD ENDING CARD NUMBER NUMBER NUMBER ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- ------------------ --------------- -------------- --------------- ------------------- --------------------- ----------------- Fax completed Acknowledgement of Receipt Form to Gregg Baum, 636.226.2004, or by certified mail to 1309 North Highway Drive, Fenton, MO 63099, attention: Gregg Baum. 19 EXHIBIT 1.B AMERICAN EXPRESS INCENTIVE SERVICES, L.L.C. 1309 N. HIGHWAY DRIVE FENTON, MO 63099 Seller, named above, as trustee and agent of CERTIFICATE OF INVENTORY DESTRUCTION FOR ANONYOMOUS CARDS ONLY MUST BE RECEIVED BY AEIS AT LEAST 15 DAYS PRIOR TO VALID THROUGH DATE ON CARD. CLIENT NAME: SCHOOLPOP, INC. DATE OF ORIGINATING ORDER:______________ CLIENT ADDRESS: 3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH, GA 30096 USA CLIENT ACCOUNT #:______________ DESTROYING WHOLE OR PART OF AN ORDER____________\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The undersigned hereby certifies that\", \"level\": 1, \"text\": \"1. The undersigned hereby certifies that: [X] Each of the cards described on the attached Schedule A (the \\\"Cards\\\") has been destroyed; [X] Destruction of the Cards was necessary because _______________________________________________ [X] The Cards were destroyed by this Method:_____________________________________________________ [X] At the time of destruction, Schoolpop Inc. was the unconditional trustee of each of the Cards and was holding in trust for AEIS, and none of the Cards described herein have been assigned, transferred, or issued to any person, firm, or corporation.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Schoolpop, Inc\", \"level\": 1, \"text\": \"2. Schoolpop, Inc., on behalf of itself and its successors and assigns, agrees that should any charge(s) be incurred with respect to any of the Cards, Schoolpop, Inc. will, upon request of American Express Incentive Services, LLC (\\\"AEIS\\\"), pay AEIS the full amount of such charge(s) and Schoolpop Inc. shall indemnify AEIS, its officers, and members, and hold each of them harmless from and against any and all claims, actions and suits, whether groundless or otherwise, and from and against any and all liabilities, losses, damages, costs, charges and any other expenses (including but not limited to attorneys' fees and expenses) of every nature and character by reason of the cancellation and destruction of the Cards or the making of any payment or costs incurred as a result of any use of the Cards described herein. SCHOOLPOP INC. By: ----------------------------------- Return this original Destruction Certificate and completed Certificate of Name: Inventory Destruction to AEIS at the --------------------------------- above address via certified mail or &bbsp; other tracked shipment method. Title: -------------------------------- Date: --------------------------------- WITNESS WITNESS Name: --------------------------------- --------------------------------------- Title: -------------------------------- --------------------------------------- Date: --------------------------------- --------------------------------------- (Signature) (Signature) 20\"}}, {\"id\": \"EXHIBIT 1.C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CERTIFICATION OF INVENTORY DESTRUCTION FOR SCHOOLPOP, INC.\", \"level\": 2, \"text\": \"EXHIBIT 1.C CERTIFICATION OF INVENTORY DESTRUCTION FOR SCHOOLPOP, INC. If the number of Cards destroyed requires more rows, use multiple pages of this form or type the denomination and Card numbers into a spreadsheet and attach the printed spreadsheet to this form. ----------------------- --------------------------------------------- ---------------------- DENOMINATION CARD # CARD STATUS (active or inactive) ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- ----------------------- --------------------------------------------- ---------------------- Total number of ACTIVE Cards:________________________________ Total number of INACTIVE Cards:______________________________ Total number of CARDS________________________________________ Destruction Date:____________________________________________ Aggregate total denomination of Cards:_______________________ Client Authorized Signature:_________________________________ Printed Name:________________________________________________ Title:_______________________________________________________ 21 EXHIBIT 2 SCHOOLPOP CARD PRICING The following pricing is effective with the Effective date of this Agreement through the term of the Agreement and is subject to change as detailed in the Agreement. Off-face point value based on volume mix: Persona Select 8% Encompass Select 2% Fill It Up 4% Be My Guest 4% Category Card 3% (Contingent upon achieving a four and one-half percent (4.5%) weighted average commission via the contracted merchant.) Grocery Card 3% (Contingent upon achieving a four percent (4%) weighted average commission via the contracted merchant.) 22 EXHIBIT 3 SCHOOLPOP ACCOUNT NUMBERS\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effective with Period One, the following account numbers shall be used by Schoolpop when placing Orders\", \"level\": 1, \"text\": \"1. Effective with Period One, the following account numbers shall be used by Schoolpop when placing Orders for Cards. ----------------------------------- ----------------------------------------- --------------------------- PRODUCT DENOMINATION ACCOUNT NUMBER ----------------------------------- ----------------------------------------- --------------------------- Persona(R) Select 25, 50, and 100 Points 8531 ----------------------------------- ----------------------------------------- --------------------------- Encompass(R) Select 25, 50, and 100 Points 8536 ----------------------------------- ----------------------------------------- --------------------------- Fill It Up(R) 25, and 50 Points 8533 ----------------------------------- ----------------------------------------- ---------------------------\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effective with Period Two, the following account numbers are to be used by Schoolpop\", \"level\": 1, \"text\": \"2. Effective with Period Two, the following account numbers are to be used by Schoolpop. ----------------------------------- ------------------------------------------ -------------------------- PRODUCT DENOMINATION ACCOUNT NUMBER ----------------------------------- ------------------------------------------ -------------------------- Persona(R) Select 25 Points 8684 ----------------------------------- ------------------------------------------ -------------------------- Persona(R) Select 50 Points 8685 ----------------------------------- ------------------------------------------ -------------------------- Persona(R) Select 100 Points 8686 ----------------------------------- ------------------------------------------ -------------------------- ----------------------------------- ------------------------------------------ -------------------------- Encompass(R) Select* 25 Points 8705 ----------------------------------- ------------------------------------------ -------------------------- Encompass(R) Select 50 Points 8687 ----------------------------------- ------------------------------------------ -------------------------- Encompass(R) Select 100 Points 8801 ----------------------------------- ------------------------------------------ -------------------------- ----------------------------------- ------------------------------------------ -------------------------- Fill It Up(R) 25 Points 8681 ----------------------------------- ------------------------------------------ -------------------------- Fill It Up(R) 50 Points 8683 ----------------------------------- ------------------------------------------ -------------------------- ----------------------------------- ------------------------------------------ -------------------------- Be My Guest(R) 25 Points 12095 ----------------------------------- ------------------------------------------ -------------------------- Be My Guest(R) 50 Points 12098 ----------------------------------- ------------------------------------------ --------------------------\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Account numbers and effective dates for any products and/or denominations in addition to the account num\", \"level\": 1, \"text\": \"3. Account numbers and effective dates for any products and/or denominations in addition to the account numbers detailed above will be provided to Schoolpop by AEIS upon completion of setup of such products and/or denominations. *Encompass(R) Select account numbers shall not be submitted with Orders effective December 31, 2004. 23 EXHIBIT 4 BRANDING QUICK REFERENCE GUIDE\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All communication pieces/media referencing Gift Cheques, all AEIS Card products, American Express Incent\", \"level\": 1, \"text\": \"1. All communication pieces/media referencing Gift Cheques, all AEIS Card products, American Express Incentive Services, AEIS, American Express, and/or any American Express merchant must be submitted for approval. Please allow five (5) to seven (7) business days for the branding review. Typical turnaround is three (3) to five (5) days, however, unusual circumstances may cause a delay in the typical turnaround. You will be notified of any delay.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Types of communications that require approval\", \"level\": 1, \"text\": \"2. Types of communications that require approval: Web sites, audio/visual productions, printed materials (brochures, fact sheets, direct mailings, newsletters, point of purchase displays), news releases, etc.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Our agreement with our parent company, American Express, is that they retain the authority to review eve\", \"level\": 1, \"text\": \"3. Our agreement with our parent company, American Express, is that they retain the authority to review every communication piece containing references to the sources in the first bullet above. These approvals are forwarded by AEIS to: The American Express Advertising Review Board (\\\"ARB\\\") who will review the following: Communications from an advertising perspective How the product is being communicated Card images General Counsel's Office (\\\"GCO\\\") who will review the following: Communications from a legal perspective Sweepstakes rules Charitable mentions Copyright infringements\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product marks should be represented as follows\", \"level\": 1, \"text\": \"4. Product marks should be represented as follows: Persona(R) Select Encompass(R) Select Fill It Up(R) Be My Guest(R)\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Since American Express is not a bank and not affiliated with a bank, terminology implying as much should\", \"level\": 1, \"text\": \"5. Since American Express is not a bank and not affiliated with a bank, terminology implying as much should not be used. Please refer to the following examples: --------------------------------------------------------- --------------------------------------------------------------- DO NOT USE REPLACE WITH --------------------------------------------------------- --------------------------------------------------------------- American Express Gift Card; American Express Incentive Services gift card; American Express Reward Card; American Express Incentive Services reward card; Gift/Reward Card from American Express American Express branded reward card; Reward card with the American Express brand --------------------------------------------------------- --------------------------------------------------------------- Statement Transaction Summary --------------------------------------------------------- --------------------------------------------------------------- Deposit; Credit Load; add; fill --------------------------------------------------------- --------------------------------------------------------------- Available funds/points; Balance Remaining funds/points Point balance --------------------------------------------------------- --------------------------------------------------------------- Account Card --------------------------------------------------------- --------------------------------------------------------------- Merchants Establishments --------------------------------------------------------- --------------------------------------------------------------- Similar to a debit card; A prepaid Card; Debit/Credit Card &sbsp; Stored-value Card; Reward Card --------------------------------------------------------- ---------------------------------------------------------------\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The AEIS or American Express logos (Blue Box) are not to be used on Client pieces, as it implies that AE\", \"level\": 1, \"text\": \"6. The AEIS or American Express logos (Blue Box) are not to be used on Client pieces, as it implies that AEIS and/or American Express are more involved in the program than providing the reward product. The words \\\"new\\\" and \\\"introducing\\\" are limited to the first six months of use. 24\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Development of Cards or communication materials associated with the following industries (including show\", \"level\": 1, \"text\": \"7. Development of Cards or communication materials associated with the following industries (including showing images related to these industries, e.g. pictures of guns, cigarettes, etc.) must be reviewed on a case-by-case basis. Alcohol Tobacco Gambling Firearms Under no circumstances may any advertising appear in the following media: Howard Stern Rush Limbaugh Don Imus\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Development of Cards with company names or logos from adult entertainment or pornography industries is s\", \"level\": 1, \"text\": \"8. Development of Cards with company names or logos from adult entertainment or pornography industries is strictly prohibited.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Use the correct service Mark or registered Mark the first mention of the name on each page\", \"level\": 1, \"text\": \"9. Use the correct service Mark or registered Mark the first mention of the name on each page.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AEIS and American Express will treat communications sent through the branding process as confidential\", \"level\": 1, \"text\": \"10. AEIS and American Express will treat communications sent through the branding process as confidential.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Quick Reference Guide is not all-inclusive\", \"level\": 1, \"text\": \"11. This Quick Reference Guide is not all-inclusive. All communications are subject to the sole approval of American Express. 25 EXHIBIT 4.A BRANDING APPROVAL PROCESS OVERVIEW GET READY You have the idea for the piece We send you a low-resolution card or Gift Cheque image, if needed, for placement purposes only (FPO) You develop the layout GET SET You send us the layout and copy We will review it in AEIS Branding and send to American Express Review Units You should allow a five (5) day turnaround* We will return any revisions with the high-resolution image, if needed GO! You produce and distribute the piece You send us three (3) copies of the final printed piece to keep on file You (and we) celebrate your success! * Standard turnaround is three to five business days, however, if unusual circumstances occur, the turnaround may take longer. Should this occur, we will notify you of any delay. 26 EXHIBIT 4.B AEIS MERCHANT APPROVAL GUIDELINES AND PROCESS INTRODUCTION / OVERVIEW The AEIS Communications Group requires review of any new or revised materials, which include any mention of Merchant Partners -- in order to ensure proper merchant guidelines. This includes ALL advertising, promotional and marketing materials in any medium (INCLUDING: COMMUNICATIONS, ADVERTISING, SALES PROMOTION COLLATERAL, DIRECT MAIL, PRESS RELEASES, VIDEOS, WEB SITES, PROMOTIONAL ITEMS, SALES PRESENTATIONS AND SIMILAR MATERIALS.) Copy and layout should be submitted as early as possible. Due to the type of communications piece, approval could take anywhere from 3 to 10 business days. MERCHANT SUPPORTING DOCUMENTATION FOR APPROVAL GUIDELINES Consumer applications are typically more involved. Generally, consumer programs are targeted to a wider audience; therefore, the implications are greater for the merchant. For this reason, the merchants mandate that AEIS seek individual approvals from each and every merchant. Any standard applications using customized collateral should be reviewed by AEIS for content and accuracy. Even in the cases where standard program materials are to be used, AEIS will need to internally review any customized announcements and/or teasers. More than likely, these pieces feature only merchant names or merchant lists in print and can typically be approved within 24-48 hours. Pieces using only select groups of merchants, photos or logos will generally require a higher level of approval and depending on the merchants used, may require approval from the merchant as well. The approval timeline will range from three to ten (3-10) business days for existing/ongoing. Once, layout and copy are approved by AEIS Communications Group, Merchant Partnerships, Operations and American Express, any ongoing and additional changes must also be approved. IMAGES, LOGOS, PRODUCT PATENT, AND REGISTERED/SERVICE MARKS IMAGES AND LOGOS The following are examples of merchant image and logo usage, which require merchant approval through Merchant Partnerships: o Any communication or collateral, whether standard or customized, containing merchant images or logos must be reviewed by Merchant Partnerships o Any new design work of merchant logos and images not previously approved o Use of standard merchant logos in any color other than the original color o Unique positioning of merchant images - surrounding merchants, etc. o \\\"Direct mail\\\" pieces, which include merchant references when only \\\"select\\\" merchants are referenced. o Unusual type of creative print work such as posters o Borders around logos and busy backgrounds o Any copy or tag-lines not previously approved o Under no circumstances are press release photos to be used on or in association with any form of communication relating to incentive card programs unless approved by Merchant Partnerships' contact. o Images and/or logos are not to be altered (cropped, inset, or overlaid) unless approved by Merchant Partnerships' contact. o All images used in magazine format must be obtain merchant copy write information next to the image MERCHANT PARTNERSHIPS RESERVES THE RIGHT TO REMOVE IMAGES AT ANY TIME THAT MAY BE DEEMED INAPPROPRIATE REPRESENTATION OF THE MERCHANT (THIS INCLUDES OUTDATED OR SEASONAL IMAGES AND LOGOS). ALL QUESTIONS REGARDING MERCHANT COMMUNICATION APPROVAL SHOULD BE SUBMITTED TO ANN FINK AT ANN.FINK@AEIS.COM, 636-226-2043. 27 EXHIBIT 5 CATEGORY CARD TARGET ACQUISITIONS ---------------------------------------------------------------------------------------------- PRIMARY CARD MARKETING CATEGORIES TARGET MERCHANTS ---------------------------------------------------------------------------------------------- CONSUMER CATEGORIES: ---------------------------------------------------------------------------------------------- Entertainment - Electronics & Misc Electronics Best Buy ---------------------------------------------------------------------------------------------- Apparel & Services Apparel TJ Maxx, Marshalls ---------------------------------------------------------------------------------------------- Household Furnishings & Equipment - Major and Small Best Buy Major and Small Appliance & Misc Appliances household equipment ---------------------------------------------------------------------------------------------- Telephone Services Phones and Accessories Best Buy ---------------------------------------------------------------------------------------------- Household Furnishings & Equipment - Home furnishings and textiles and Furniture decorations Home Goods ---------------------------------------------------------------------------------------------- Restaurants Restaurants Darden (Red Lobster, Olive Garden, etc.) ---------------------------------------------------------------------------------------------- Gifts - combined from all categories Gifts Fossil Crabtree & Evelyn* Barnes & Nobles ---------------------------------------------------------------------------------------------- Entertainment - Tickets & Admissions Entertainment Regal Theatres, Hollywood Video, Ticketsnow.com ---------------------------------------------------------------------------------------------- Gasoline & Motor Oil Auto Accessories Autozone/TBD ---------------------------------------------------------------------------------------------- Entertainment - Toys Gifts Toys R Us ---------------------------------------------------------------------------------------------- Personal Care Products & Drugs Drugs Walgreens ---------------------------------------------------------------------------------------------- ALTERNATE CATEGORIES: ---------------------------------------------------------------------------------------------- Office Supplies Office Supplies Staples ---------------------------------------------------------------------------------------------- Sporting Goods Sporting Goods Sports Authority ---------------------------------------------------------------------------------------------- Entertainment Pet Supplies Petsmart ---------------------------------------------------------------------------------------------- 28 EXHIBIT 5.A GROCERY CARD TARGET ACQUISITIONS Longs HEB Piggly Wiggly Save Mart ShopKo Safeway Staters 29\"}}, {\"id\": \"party:American Express Incentive Services, L.L.C.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"American Express Incentive Services, L.L.C.\", \"role\": \"AEIS\", \"address\": \"1309 North Highway Drive, Fenton, MO 63099, USA\"}}, {\"id\": \"party:Schoolpop, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Schoolpop, Inc.\", \"role\": \"Schoolpop\", \"address\": \"3885 Crestwood Parkway, Suite 550, Duluth, GA 30096\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Distribution Agreement (the \\\"Agreement\\\") is entered into by and between American Express Incentive Services, L.L.C., a Missouri limited liability company (\\\"AEIS\\\"), and its Reseller, Schoolpop, Inc., a Delaware corporation (\\\"Schoolpop\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:AEIS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AEIS\", \"text\": \"American Express Incentive Services, L.L.C., a Missouri limited liability company (\\\"AEIS\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Schoolpop\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Schoolpop\", \"text\": \"its Reseller, Schoolpop, Inc., a Delaware corporation (\\\"Schoolpop\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"This Agreement is effective as of August 1, 2004, (the \\\"Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Termination Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Termination Date\", \"text\": \"and shall terminate on July 31, 2009, (the \\\"Termination Date\\\") unless earlier terminated or extended as provided for herein.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Cards\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cards\", \"text\": \"Encompass(R) Select, Persona(R) Select, Fill It Up(R), and Be My Guest(R), and any other stored value products developed by AEIS and mutually agreed upon by both parties, (\\\"Cards\\\").\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Clients\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Clients\", \"text\": \"The Cards shall be sold only to those of Schoolpop's clients and prospective clients (the \\\"Clients\\\"), in the United States who are nonprofit organizations, (\\\"NPO Marketplace\\\"), which are defined as organizations that are (i) a school, (ii) an organization formed as not-for-profit under its charter documents, or (iii) an organization related to (i) or (ii) such as a participating school's Parent Teacher Organization or other similarly related organization.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:NPO Marketplace\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"NPO Marketplace\", \"text\": \"The Cards shall be sold only to those of Schoolpop's clients and prospective clients (the \\\"Clients\\\"), in the United States who are nonprofit organizations, (\\\"NPO Marketplace\\\"), which are defined as organizations that are (i) a school, (ii) an organization formed as not-for-profit under its charter documents, or (iii) an organization related to (i) or (ii) such as a participating school's Parent Teacher Organization or other similarly related organization.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Period One\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Period One\", \"text\": \"Period One shall mean the Effective Date through the date that Schoolpop has met all of the Security Requirements as such term is defined herein and has received approval from AEIS to assume all Card inventory, distribution and fulfillment responsibilities as currently managed by AEIS.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Period Two\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Period Two\", \"text\": \"Period Two shall commence with the end of Period One through the Termination Date.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Guaranteed Minimum\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Guaranteed Minimum\", \"text\": \"Notwithstanding the foregoing, Schoolpop shall fund from AEIS a minimum of $52,000,000 of Cards (the \\\"Guaranteed Minimum\\\") in each Contract Year in order to maintain the exclusive right to sell Cards in the NPO Marketplace.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Contract Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract Year\", \"text\": \"A Contract Year shall be the period of August 1 through July 31 of the succeeding year.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Marketing Rights Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marketing Rights Fee\", \"text\": \"In consideration of the exclusivity referred to above, Schoolpop shall pay AEIS a marketing rights fee (\\\"Marketing Rights Fee\\\"), of $1,250,000.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Encompass(R) Select Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Encompass(R) Select Fee\", \"text\": \"Schoolpop shall also pay AEIS a fee of $250,000, (the \\\"Encompass(R) Select Fee\\\") as consideration for the right to sell the Encompass(R) Select Card through December 31, 2004.\", \"definition_clause\": \"c\"}}, {\"id\": \"term:Security Requirements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Security Requirements\", \"text\": \"Schoolpop shall secure a physical location for maintaining, distributing, and fulfilling Card inventory no later than August 1, 2004 which location shall be subject to such security requirements (the \\\"Security Requirements\\\") as shall be required by AEIS or American Express Travel Related Services, Inc. all as further set forth in the Trust Agreement attached hereto as Exhibit 1.\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Card Life\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Card Life\", \"text\": \"Schoolpop shall effectively manage its Card inventory and Ordering schedule such that all Cards are resold and distributed to the Client with the following Card expiration lives (the \\\"Card Life\\\") intact:\", \"definition_clause\": \"3\"}}, {\"id\": \"term:New Cards\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"New Cards\", \"text\": \"The Card life of any Cards other than Cards specifically indicated in b(i). and b(ii) above (\\\"New Cards\\\"), shall be mutually agreed upon in writing.\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Order\", \"text\": \"During Period One, Card expiration shall be determined by the date Schoolpop places an Order (the \\\"Order\\\") and provides full payment and clearance of funding.\", \"definition_clause\": \"c\"}}, {\"id\": \"term:Sold Card Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sold Card Forecast\", \"text\": \"In addition, Schoolpop shall provide AEIS with a monthly forecast, no later than the third business day of each month, of the number of Cards to be sold to its clients, (\\\"Sold Card Forecast\\\") as well as the number of Cards to be stocked in inventory, (\\\"Card Inventory Forecast\\\"), (collectively referred to as the \\\"Forecasts\\\") for the month, ninety-days out.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:Card Inventory Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Card Inventory Forecast\", \"text\": \"In addition, Schoolpop shall provide AEIS with a monthly forecast, no later than the third business day of each month, of the number of Cards to be sold to its clients, (\\\"Sold Card Forecast\\\") as well as the number of Cards to be stocked in inventory, (\\\"Card Inventory Forecast\\\"), (collectively referred to as the \\\"Forecasts\\\") for the month, ninety-days out.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:Forecasts\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Forecasts\", \"text\": \"(\\\"Card Inventory Forecast\\\"), (collectively referred to as the \\\"Forecasts\\\") for the month, ninety-days out.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:Locked\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Locked\", \"text\": \"The Forecasts will be relied on, (\\\"Locked\\\") at the time they are reported.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:Card Inventory Penalty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Card Inventory Penalty\", \"text\": \"In any consecutive three (3) month period in which the difference between the Card Inventory Forecast less the actual Card Order volume for that period is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, (\\\"Card Inventory Penalty\\\") of sixteen and one-half cents ($0.165) per Card for such difference as detailed in Examples 1 and 2 below.\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Cards in Force\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cards in Force\", \"text\": \"In any given month where the difference between the Sold Card Forecast less the actual Card activation volume, (\\\"Cards in Force\\\") is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, the (\\\"Customer Service Penalty\\\") which shall be calculated by converting Cards in Force into call volume minutes as follows:\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Customer Service Penalty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer Service Penalty\", \"text\": \"In any given month where the difference between the Sold Card Forecast less the actual Card activation volume, (\\\"Cards in Force\\\") is a shortage of ten percent or greater (10%+), AEIS reserves the right to assess a penalty, the (\\\"Customer Service Penalty\\\") which shall be calculated by converting Cards in Force into call volume minutes as follows:\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Point\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Point\", \"text\": \"One point is worth one (1) U.S. Dollar ($1.00 USD) (\\\"Point\\\").\", \"definition_clause\": \"ii\"}}, {\"id\": \"term:Loss\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Loss\", \"text\": \"The full risk of loss for ordered Cards shall pass to Schoolpop immediately upon their delivery to Schoolpop by AEIS and AEIS shall not reimburse Schoolpop or Client for any delivered Card that is lost, stolen, misappropriated, or that otherwise disappears or is fraudulently or inappropriately used (together referred to as \\\"Loss\\\").\", \"definition_clause\": \"i\"}}, {\"id\": \"term:Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marks\", \"text\": \"All rights to the name, logo, service marks and/or trademarks (the \\\"Marks\\\"), trade names, tag lines, or any other proprietary designation (\\\"Proprietary Designation\\\") of AEIS remains the sole property of AEIS.\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Proprietary Designation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Designation\", \"text\": \"All rights to the name, logo, service marks and/or trademarks (the \\\"Marks\\\"), trade names, tag lines, or any other proprietary designation (\\\"Proprietary Designation\\\") of AEIS remains the sole property of AEIS.\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Card Packaging\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Card Packaging\", \"text\": \"AEIS shall provide standard Card plastic design and standard Card carrier design including pre-printed paper and electronic copy, and standard Card envelope design for all Card packaging (collectively \\\"Card Packaging\\\").\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"Both parties acknowledge that they may have access to or receive confidential information, data, and materials about the other party, their Clients and Cardholders, and their entities, including, without limitation, marketing philosophies and objectives, pricing information, business materials and data, processes, customer lists, product information, financial data, competitive advantages and disadvantages, and other confidential information received (\\\"Confidential Information\\\"), and that disclosure or misuses of such Confidential Information, would be irreparably damaging to the other party.\", \"definition_clause\": \"12\"}}, {\"id\": \"term:Authorized Users\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Authorized Users\", \"text\": \"Authorized users, (\\\"Authorized Users\\\") include Schoolpop, its affiliates and its Client's personnel involved in administering the Program and eligible Cardholders of a Schoolpop Program.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:PI\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PI\", \"text\": \"Schoolpop acknowledges that it will likely receive private information (\\\"PI\\\") from Authorized Users that will be subject to various privacy laws and regulations in the various States in which the Authorized Users and the parties hereto reside.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:AEIS Indemnified Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AEIS Indemnified Parties\", \"text\": \"Schoolpop will, at its sole cost and expense, defend, indemnify and hold harmless AEIS and each of its respective officers, directors, employees, agents, contractors, affiliates, service providers and insurers (collectively, \\\"AEIS Indemnified Parties\\\") from and against any and all loss or liability, claims, demands, damages, losses and expenses including, without limitation, reasonable attorneys, accountants and expert witness fees, costs and expenses that the AEIS Indemnified Parties, or any one or more of them, may sustain or incur as a result of a claim of violation of any law or regulation or personal right directed to protecting the PI rights of individuals or the use, misuse, collection, loss of privacy or confidentiality, or other mishandling or improper or illegal act with respect to such PI including without limitation governmental enforcement action as well as civil claims involved with any such Schoolpop Program.\", \"definition_clause\": \"d\"}}, {\"id\": \"term:Seller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Seller\", \"text\": \"And Schoolpop, Inc., a Delaware corporation, with an office at 3100 Five Forks Trickum Road, Suite 410, Liliburn, GA 30047 USA (\\\"Seller\\\").\", \"definition_clause\": \"14\"}}, {\"id\": \"value:$52,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$52,000,000\"}}, {\"id\": \"value:$1,250,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,250,000\"}}, {\"id\": \"value:$250,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$250,000\"}}, {\"id\": \"value:9 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"nine (9) months\"}}, {\"id\": \"value:3 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) months\"}}, {\"id\": \"value:$2.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2.00\"}}, {\"id\": \"value:8 weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"eight (8) weeks\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty days (30)\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) month\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety-days\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ten percent\"}}, {\"id\": \"value:$0.165\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$0.165\"}}, {\"id\": \"value:$783.75\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$783.75\"}}, {\"id\": \"value:20%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20%\"}}, {\"id\": \"value:15%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"15%\"}}, {\"id\": \"value:12.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"12.5%\"}}, {\"id\": \"value:4.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"4.5%\"}}, {\"id\": \"value:23%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"23%\"}}, {\"id\": \"value:4%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"4%\"}}, {\"id\": \"value:90%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"90%\"}}, {\"id\": \"value:$0.50\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$0.50\"}}, {\"id\": \"value:$3,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$3,000,000\"}}, {\"id\": \"value:$1,500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,500,000\"}}, {\"id\": \"value:7 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) years\"}}, {\"id\": \"value:5 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 business days\"}}, {\"id\": \"value:3 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) business days\"}}, {\"id\": \"value:8 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"eight (8) business days\"}}, {\"id\": \"value:13 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirteen (13) business days\"}}, {\"id\": \"value:20 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) business days\"}}, {\"id\": \"value:30 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) business days\"}}, {\"id\": \"value:$1.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1.00\"}}, {\"id\": \"value:2 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) business days\"}}, {\"id\": \"value:$25.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$25.00\"}}, {\"id\": \"value:$5,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5,000\"}}, {\"id\": \"value:$15.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$15.00\"}}, {\"id\": \"value:70%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"70%\"}}, {\"id\": \"value:$26,500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$26,500,000\"}}, {\"id\": \"value:45 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty-five (45 days)\"}}, {\"id\": \"value:$100,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$100,000\"}}, {\"id\": \"value:$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000\"}}, {\"id\": \"value:$2,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2,000,000\"}}, {\"id\": \"value:$500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$500,000\"}}, {\"id\": \"value:15 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:$50,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$50,000\"}}, {\"id\": \"value:3 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) days\"}}, {\"id\": \"value:8%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"8%\"}}, {\"id\": \"value:2%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"2%\"}}, {\"id\": \"value:3%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"3%\"}}, {\"id\": \"value:7 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven (7) business days\"}}, {\"id\": \"value:6 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six months\"}}, {\"id\": \"value:10 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of LUCIDINC_04_15_2011-EX-10.9-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of LUCIDINC_04_15_2011-EX-10.9-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"EXHIBIT 10.9\", \"title\": \"DISTRIBUTOR AGREEMENT This Distributor Agreement (the 'Agreement') dated [*] is between Lucid Inc., a New York corporation, having a principal place of business at 2320 Brighton Henrietta T/L Road, Rochester NY 14623 And [*] ('Distributor') For good and valuable consideration, the parties hereby agree: 1. Appointment A) Lucid appoints the Distributor and the Distributor accepts appointment as an exclusive authorized Lucid Distributor. The Distributor will be entitled to purchase certain Lucid products and resell them to End User customers within the following market segments:- hospital and medical research centres, including but not limited to dermatology, pathology, plastic surgery and mohs surgery departments, clinical research centres, small animal research facilities, cosmetic and cosmeceutical companies. B) The relationship of the parties under this Agreement is that of independent contractors and nothing contained herein shall be construed as creating any partnership, joint venture or agency relationship between the Distributor and Lucid. Under no circumstances shall any employees of one party be deemed the employees of the other for any purpose. The Distributor shall not have the authority to assume or create any obligation, or make any representation of any kind on behalf of Lucid. 2. Term A) The initial term of this Agreement shall be three (3) calendar years from the Agreement date. After the initial term, unless terminated, this Agreement will automatically renew for periods of one (1) calendar year each. 3. Products A) Lucid agrees to sell the following products to the Distributor: - VivaScope in-vivo Confocal Microscope Model VS1500 VivaScope ex-vivo Confocal Microscope Model VS2500 VivaSCOPE in-vivo Confocal Microscope Model VS3000 B) Further products manufactured by Lucid will be discussed with the Distributor and by agreement will be added to this Agreement.\", \"level\": 2, \"text\": \"EXHIBIT 10.9 DISTRIBUTOR AGREEMENT This Distributor Agreement (the 'Agreement') dated [*] is between Lucid Inc., a New York corporation, having a principal place of business at 2320 Brighton Henrietta T/L Road, Rochester NY 14623 And [*] ('Distributor') For good and valuable consideration, the parties hereby agree: 1. Appointment A) Lucid appoints the Distributor and the Distributor accepts appointment as an exclusive authorized Lucid Distributor. The Distributor will be entitled to purchase certain Lucid products and resell them to End User customers within the following market segments:- hospital and medical research centres, including but not limited to dermatology, pathology, plastic surgery and mohs surgery departments, clinical research centres, small animal research facilities, cosmetic and cosmeceutical companies. B) The relationship of the parties under this Agreement is that of independent contractors and nothing contained herein shall be construed as creating any partnership, joint venture or agency relationship between the Distributor and Lucid. Under no circumstances shall any employees of one party be deemed the employees of the other for any purpose. The Distributor shall not have the authority to assume or create any obligation, or make any representation of any kind on behalf of Lucid. 2. Term A) The initial term of this Agreement shall be three (3) calendar years from the Agreement date. After the initial term, unless terminated, this Agreement will automatically renew for periods of one (1) calendar year each. 3. Products A) Lucid agrees to sell the following products to the Distributor: - VivaScope in-vivo Confocal Microscope Model VS1500 VivaScope ex-vivo Confocal Microscope Model VS2500 VivaSCOPE in-vivo Confocal Microscope Model VS3000 B) Further products manufactured by Lucid will be discussed with the Distributor and by agreement will be added to this Agreement.\"}, {\"id\": \"4\", \"title\": \"Territory A) The Distributor is appointed as an exclusive Distributor within the following territories\", \"level\": 1, \"text\": \"4. Territory A) The Distributor is appointed as an exclusive Distributor within the following territories: [*]. B) The Distributor agrees to act as a Distributor for Lucid within the above Territories and not to solicit any sales of the Product(s) outside the above Territories. 5. Duties of The Distributor A) The Distributor will use his best efforts to actively promote and sell the Product to all relevant End Users within all relevant market segments within the Territory. B) The Distributor agrees to undertake detailed sales demonstrations of the Product(s) to potential End Users within all relevant market segments within the Territory. C) The Distributor agrees to allow the End User to undertake sales evaluations (trials) of the product(s), using the Distributor's own Demonstration Equipment as necessary. D) The Distributor agrees to promote the Product(s) at all relevant trade shows, seminars and exhibitions held within the Territory. Lucid may, at it's discretion, and in co-ordination with the Distributor when Lucid deems it necessary, at its own expense and in its own name, engage in advertising activities of or hold or participate in exhibitions of the Product in the Territory. E) The Distributors will not develop, manufacture or sell any equipment or service, which in any way can be considered to be competitive to the equipment or service offered by Lucid to the Distributor as Product. Lucid reserves the right to inform the Distributor from time to time of specific products and companies that Lucid considers to be competitive. A competitive product includes, but is not limited to, any product that would infringe any claim of any Lucid owned or licensed patent issued or pending worldwide, whether or not corresponding patent claims are in force in the Distributors territory or the sale of which would restrict sale of Lucid product. F) The Distributor will provide to the End User, full installation and customer training of the Product(s).\"}, {\"id\": \"6\", \"title\": \"Personnel A) The Distributor will employ as a minimum one full-time Lucid dedicated Product Manager sales professio\", \"level\": 1, \"text\": \"6. Personnel A) The Distributor will employ as a minimum one full-time Lucid dedicated Product Manager sales professional, giving one hundred per cent of their time to the promotion and sale of Lucid products. 7. Demonstration Equipment A) The Distributor agrees to purchase demonstration products as new products are released subject to special pricing. The Distributor agrees to use the demonstration equipment for the duties as noted in 5 A, B, C, D as above and not to re-sell this demonstration equipment to End Users. 8. Training A) The Distributor agrees to have all sales professionals employed on Lucid products undergo sales training at an agreed location and to a level approved by Lucid. B) The Distributor agrees to allow Lucid to accompany the Distributor sales professionals during sales calls within the Territory as required. C) The Distributor agrees to allow Lucid to participate in sales meetings for training purposes, held within the Distributor's facility. 9. Information A) The Distributor will supply to Lucid, on a monthly basis, a detailed listing of all sales prospects within the Territory. A sales prospect is considered by Lucid to be any End User who has expressed an interest in purchasing Lucid products. B) The Distributor agrees to supply to Lucid on a monthly basis a detailed sales forecast, highlighting potential order dates of product. C) The Distributor agrees to supply to Lucid, from time to time, with any competitive data emanating from the Territory. D) The Distributor agrees to supply Lucid, on an annual basis, with a detailed sales plan for the Product(s), broken down by sales for each individual country within the Territory. Any country or part of the territory that does not meet the sales expectations as forecasted by the Distributor will be subject to review by Lucid and may subsequently be removed from the Territory. The first sales plan will be presented to Lucid within three (3) months of the signing of this agreement and annual sales plans will be due on November 30 each year. E) The distributor agrees to keep Lucid informed of details of forthcoming and installed units together with customer details including customer name, address and email details at a level sufficient to fulfil all requirements of US Government Export Administration Regulations and Lucid quality audits. 10. Sub-Distribution The Distributor shall not be entitled to engage sub-distributors or any other third party as his sub-agent for sales of the Product, without having obtained Lucid's prior written approval. Such approval shall not be unreasonably withheld. 11. Intellectual Property A) Lucid is the sole owner of all trademark symbols and logos under which the products will be sold. Lucid agrees that the Distributor may use the appropriate trademarks to promote the sale of products in the Territory. Such use is only with Lucid's permission and must be related to the sale of Lucid products. The Distributor acquires no rights to Lucid trademarks by selling Lucid products. The Distributor may not use Lucid trademarks, symbols or logos as part of its business or corporate names. B) The Distributor will assist Lucid in protecting Lucid's patents, copyright, trademarks and logos. The Distributor will inform Lucid of any known or suspected violations of Lucid's patents, copyright, trademarks, symbols and logos. If Lucid requests, the Distributor will assist in protecting such intellectual property from infringement. 12. Duties of Lucid A) Lucid will supply to the Distributor, free of any charge, reasonable quantities of Product datasheets. B) Lucid will supply to the Distributor, free of charge, images of skin in vivo. Lucid will make every reasonable effort to supply images of skin to the Distributor, which are required by the Distributor for a particular End User application. C) Lucid will make available free of charge to the Distributor the services of at least one suitable sales professional. D) Lucid will make available free of charge to the Distributor the services of at least one Clinical Research Engineer. This person will normally reside at Lucid's USA Headquarters but may from time to time assist the Distributor within the Territory. E) Lucid will make its facility in the USA available, from time to time, to the Distributor and the Distributor's sales force for sales training purposes. Lucid will also offer this service to the Distributor for the introduction of potential End Users from the Territory. 13. Prices, Terms & Conditions of Sale A) The Distributor may purchase Products from Lucid at the price published by Lucid, from time to time, in the International Distributor price list (attached). Lucid agrees to allow the Distributor a discount of thirty (30) per cent against the published International Distributor price list. B) All orders from the Distributor to Lucid will be subject to Lucid's standard terms and conditions of sale. C) All prices are quoted by Lucid in US Dollars and are sold Ex Works, becoming the Distributor's property when despatched from the Lucid facility. 14. Minimum Purchase Obligation The Distributor agrees to purchase from Lucid minimum agreed quantity of product in the first, second and third years of the Agreement, excluding demonstration product. These quantities to be agreed by both parties in the initial detailed sales plan noted in clause 9D and amended with further agreement in subsequent annual sales plans 15. PAYMENT TERMS The Distributor agrees to abide by Lucid's standard payment terms, which are as follows; One Hundred (100) per cent of order value by sixty ( 90 ) day irrevocable letter of credit when order is placed on Lucid. 16. TERMINATION A) Either party may terminate this agreement by giving written Notice to the other party if: i) The other party fails to perform or satisfy any of the conditions, covenants or obligations of this Agreement. ii) The other party files or has filed against it, a petition seeking relief under any bankruptcy, insolvency, reorganisation, moratorium, liquidation or similar law affecting creditors' rights B) In addition, Lucid may terminate this agreement by giving the Distributor Written Notice if there is any change of control, ownership or management of the Distributor.\"}, {\"id\": \"C\", \"title\": \"Either party may terminate this agreement by providing Ninety days Written Notice\", \"level\": 1, \"text\": \"C) Either party may terminate this agreement by providing Ninety days Written Notice. 17. EFFECT OF TERMINATION A) Upon the termination of this Agreement: 1. The Distributor shall terminate any registration it has made as a Lucid Distributor. 2. Distributor will immediately return any samples, sales literature, promotional materials and other documents supplied to the Distributor free of charge from Lucid. 3. Any right to use Lucid patents, copyrights, trademarks, symbols and logos shall immediately cease. B) If this Agreement is terminated Lucid shall not be liable for any incidental, indirect; special punitive of consequential damages of any kind, including any perceived or real market development costs. 18. Incident and Traceability Reporting A) DISTRIBUTOR will IMMEDIATELY report via telephone communication to Lucid any incidents that involve the use of PRODUCTS sold by the DISTRIBUTOR to end users that affect patient safety or well-being (an \\\"INCIDENT\\\"). Such oral incident reporting will be followed immediately by a written incident report that documents the detailed conditions that resulted in the INCIDENT and Distributor shall thereafter co-operate with Lucid in the investigation of any and all conditions that led to, or resulted from the INCIDENT. B) DISTRIBUTOR will routinely, but not less than annually, report in writing to Lucid, documenting the end users to which PRODUCTS have been sold, including the address, telephone number and name of a person who is the primary emergency contact. Lucid will use this information in the event of Lucid issuing a product recall of the PRODUCT for safety or other reasons. If such an event occurs, and upon Lucid's request, the DISTRIBUTOR will immediately provide Lucid with the names, addresses, telephone numbers and emergency contact personnel of any end user sites not previously reported to Lucid. 19. LIMITATION OF LIABILITY A) Lucid does not guarantee delivery of Product by any particular date. If Lucid accepts Distributor's order and fails to deliver ordered products, Distributors sole remedy will be limited to refund of money paid to Lucid for any undelivered products. B) Lucid will not have any liability or responsibility to Distributor or any other person or entity for any consequential, indirect, special, punitive or incidental damages or lost profits, whether foreseeable or unforeseeable, based on claims of Distributor or Distributor's customers (including but not limited to, claims for loss of data, goodwill, profits, use of money or use of product, interruption in use or availability of data stoppage or other work or impairment or assets) arising out of breach or failure of express or implied warranty, breach of contract, misrepresentation, negligence, strict liability in tort or otherwise, except only in the case of death or personal injury where and to the extent that applicable law requires such liability. In no event will the aggregate liability incurred by Lucid in any action or proceeding exceed the total amount actually paid to Lucid by Distributor for the purchase of the products that actually caused the damage or loss. 20. Governing Law A) This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York, USA without regard to conflict of laws principles. 21. NOTICE A) All notices required herein (\\\"NOTICE\\\") shall be given in English language. Notices must be sent postage pre-paid, and (a) delivered personally against written receipt (b) transmitted via facsimile or (c) sent by nationally recognised overnight courier service, or (d) sent via first class certified mail, return receipt requested, to the address listed above. Any change of addresser fax number must be designated in writing and served in accordance with this Section. Notice shall be effective (a) upon receipt if personally delivered (b) upon confirmation of transmission if sent via facsimile and (c) two (2) business days after deposit with the courier or an official depository of the US Post Office, if sent via recognised overnight courier of via Certified Mail, as the case may be. 22 ENTIRE AGREEMENT: A) This Agreement, including the Price List attached hereto, as amended from time to time, constitutes the entire understanding between the parties with respect to the subject matter of this Agreement and supersedes and replaces all previous proposals, both oral and written, negotiations, representations, commitments, writings, contracts, agreements and all other communications between the two parties. Signatures on the next page IN WITNESS WHEREOF, the parties have duly executed this Agreement on the date first above written. LUCID Inc. [*] By By Marcy K. Davis-McHugh [*] TITLE TITLE: Corporate Vice President DATE [*] DATE: [*] SIGNATURE SIGNATURE\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of LUCIDINC_04_15_2011-EX-10.9-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"EXHIBIT 10.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREEMENT This Distributor Agreement (the 'Agreement') dated [*] is between Lucid Inc., a New York corporation, having a principal place of business at 2320 Brighton Henrietta T/L Road, Rochester NY 14623 And [*] ('Distributor') For good and valuable consideration, the parties hereby agree: 1. Appointment A) Lucid appoints the Distributor and the Distributor accepts appointment as an exclusive authorized Lucid Distributor. The Distributor will be entitled to purchase certain Lucid products and resell them to End User customers within the following market segments:- hospital and medical research centres, including but not limited to dermatology, pathology, plastic surgery and mohs surgery departments, clinical research centres, small animal research facilities, cosmetic and cosmeceutical companies. B) The relationship of the parties under this Agreement is that of independent contractors and nothing contained herein shall be construed as creating any partnership, joint venture or agency relationship between the Distributor and Lucid. Under no circumstances shall any employees of one party be deemed the employees of the other for any purpose. The Distributor shall not have the authority to assume or create any obligation, or make any representation of any kind on behalf of Lucid. 2. Term A) The initial term of this Agreement shall be three (3) calendar years from the Agreement date. After the initial term, unless terminated, this Agreement will automatically renew for periods of one (1) calendar year each. 3. Products A) Lucid agrees to sell the following products to the Distributor: - VivaScope in-vivo Confocal Microscope Model VS1500 VivaScope ex-vivo Confocal Microscope Model VS2500 VivaSCOPE in-vivo Confocal Microscope Model VS3000 B) Further products manufactured by Lucid will be discussed with the Distributor and by agreement will be added to this Agreement.\", \"level\": 2, \"text\": \"EXHIBIT 10.9 DISTRIBUTOR AGREEMENT This Distributor Agreement (the 'Agreement') dated [*] is between Lucid Inc., a New York corporation, having a principal place of business at 2320 Brighton Henrietta T/L Road, Rochester NY 14623 And [*] ('Distributor') For good and valuable consideration, the parties hereby agree: 1. Appointment A) Lucid appoints the Distributor and the Distributor accepts appointment as an exclusive authorized Lucid Distributor. The Distributor will be entitled to purchase certain Lucid products and resell them to End User customers within the following market segments:- hospital and medical research centres, including but not limited to dermatology, pathology, plastic surgery and mohs surgery departments, clinical research centres, small animal research facilities, cosmetic and cosmeceutical companies. B) The relationship of the parties under this Agreement is that of independent contractors and nothing contained herein shall be construed as creating any partnership, joint venture or agency relationship between the Distributor and Lucid. Under no circumstances shall any employees of one party be deemed the employees of the other for any purpose. The Distributor shall not have the authority to assume or create any obligation, or make any representation of any kind on behalf of Lucid. 2. Term A) The initial term of this Agreement shall be three (3) calendar years from the Agreement date. After the initial term, unless terminated, this Agreement will automatically renew for periods of one (1) calendar year each. 3. Products A) Lucid agrees to sell the following products to the Distributor: - VivaScope in-vivo Confocal Microscope Model VS1500 VivaScope ex-vivo Confocal Microscope Model VS2500 VivaSCOPE in-vivo Confocal Microscope Model VS3000 B) Further products manufactured by Lucid will be discussed with the Distributor and by agreement will be added to this Agreement.\"}}, {\"id\": \"party:Lucid Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Lucid Inc.\", \"role\": null, \"address\": \"2320 Brighton Henrietta T/L Road, Rochester NY 14623\"}}, {\"id\": \"party:Distributor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Distributor\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Distributor Agreement (the 'Agreement')\", \"definition_clause\": \"EXHIBIT 10.9\"}}, {\"id\": \"term:Distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor\", \"text\": \"[*] ('Distributor')\", \"definition_clause\": \"EXHIBIT 10.9\"}}, {\"id\": \"value:three (3) calendar years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) calendar years\"}}, {\"id\": \"value:one (1) calendar year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) calendar year\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Territory A) The Distributor is appointed as an exclusive Distributor within the following territories\", \"level\": 1, \"text\": \"4. Territory A) The Distributor is appointed as an exclusive Distributor within the following territories: [*]. B) The Distributor agrees to act as a Distributor for Lucid within the above Territories and not to solicit any sales of the Product(s) outside the above Territories. 5. Duties of The Distributor A) The Distributor will use his best efforts to actively promote and sell the Product to all relevant End Users within all relevant market segments within the Territory. B) The Distributor agrees to undertake detailed sales demonstrations of the Product(s) to potential End Users within all relevant market segments within the Territory. C) The Distributor agrees to allow the End User to undertake sales evaluations (trials) of the product(s), using the Distributor's own Demonstration Equipment as necessary. D) The Distributor agrees to promote the Product(s) at all relevant trade shows, seminars and exhibitions held within the Territory. Lucid may, at it's discretion, and in co-ordination with the Distributor when Lucid deems it necessary, at its own expense and in its own name, engage in advertising activities of or hold or participate in exhibitions of the Product in the Territory. E) The Distributors will not develop, manufacture or sell any equipment or service, which in any way can be considered to be competitive to the equipment or service offered by Lucid to the Distributor as Product. Lucid reserves the right to inform the Distributor from time to time of specific products and companies that Lucid considers to be competitive. A competitive product includes, but is not limited to, any product that would infringe any claim of any Lucid owned or licensed patent issued or pending worldwide, whether or not corresponding patent claims are in force in the Distributors territory or the sale of which would restrict sale of Lucid product. F) The Distributor will provide to the End User, full installation and customer training of the Product(s).\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Personnel A) The Distributor will employ as a minimum one full-time Lucid dedicated Product Manager sales professio\", \"level\": 1, \"text\": \"6. Personnel A) The Distributor will employ as a minimum one full-time Lucid dedicated Product Manager sales professional, giving one hundred per cent of their time to the promotion and sale of Lucid products. 7. Demonstration Equipment A) The Distributor agrees to purchase demonstration products as new products are released subject to special pricing. The Distributor agrees to use the demonstration equipment for the duties as noted in 5 A, B, C, D as above and not to re-sell this demonstration equipment to End Users. 8. Training A) The Distributor agrees to have all sales professionals employed on Lucid products undergo sales training at an agreed location and to a level approved by Lucid. B) The Distributor agrees to allow Lucid to accompany the Distributor sales professionals during sales calls within the Territory as required. C) The Distributor agrees to allow Lucid to participate in sales meetings for training purposes, held within the Distributor's facility. 9. Information A) The Distributor will supply to Lucid, on a monthly basis, a detailed listing of all sales prospects within the Territory. A sales prospect is considered by Lucid to be any End User who has expressed an interest in purchasing Lucid products. B) The Distributor agrees to supply to Lucid on a monthly basis a detailed sales forecast, highlighting potential order dates of product. C) The Distributor agrees to supply to Lucid, from time to time, with any competitive data emanating from the Territory. D) The Distributor agrees to supply Lucid, on an annual basis, with a detailed sales plan for the Product(s), broken down by sales for each individual country within the Territory. Any country or part of the territory that does not meet the sales expectations as forecasted by the Distributor will be subject to review by Lucid and may subsequently be removed from the Territory. The first sales plan will be presented to Lucid within three (3) months of the signing of this agreement and annual sales plans will be due on November 30 each year. E) The distributor agrees to keep Lucid informed of details of forthcoming and installed units together with customer details including customer name, address and email details at a level sufficient to fulfil all requirements of US Government Export Administration Regulations and Lucid quality audits. 10. Sub-Distribution The Distributor shall not be entitled to engage sub-distributors or any other third party as his sub-agent for sales of the Product, without having obtained Lucid's prior written approval. Such approval shall not be unreasonably withheld. 11. Intellectual Property A) Lucid is the sole owner of all trademark symbols and logos under which the products will be sold. Lucid agrees that the Distributor may use the appropriate trademarks to promote the sale of products in the Territory. Such use is only with Lucid's permission and must be related to the sale of Lucid products. The Distributor acquires no rights to Lucid trademarks by selling Lucid products. The Distributor may not use Lucid trademarks, symbols or logos as part of its business or corporate names. B) The Distributor will assist Lucid in protecting Lucid's patents, copyright, trademarks and logos. The Distributor will inform Lucid of any known or suspected violations of Lucid's patents, copyright, trademarks, symbols and logos. If Lucid requests, the Distributor will assist in protecting such intellectual property from infringement. 12. Duties of Lucid A) Lucid will supply to the Distributor, free of any charge, reasonable quantities of Product datasheets. B) Lucid will supply to the Distributor, free of charge, images of skin in vivo. Lucid will make every reasonable effort to supply images of skin to the Distributor, which are required by the Distributor for a particular End User application. C) Lucid will make available free of charge to the Distributor the services of at least one suitable sales professional. D) Lucid will make available free of charge to the Distributor the services of at least one Clinical Research Engineer. This person will normally reside at Lucid's USA Headquarters but may from time to time assist the Distributor within the Territory. E) Lucid will make its facility in the USA available, from time to time, to the Distributor and the Distributor's sales force for sales training purposes. Lucid will also offer this service to the Distributor for the introduction of potential End Users from the Territory. 13. Prices, Terms & Conditions of Sale A) The Distributor may purchase Products from Lucid at the price published by Lucid, from time to time, in the International Distributor price list (attached). Lucid agrees to allow the Distributor a discount of thirty (30) per cent against the published International Distributor price list. B) All orders from the Distributor to Lucid will be subject to Lucid's standard terms and conditions of sale. C) All prices are quoted by Lucid in US Dollars and are sold Ex Works, becoming the Distributor's property when despatched from the Lucid facility. 14. Minimum Purchase Obligation The Distributor agrees to purchase from Lucid minimum agreed quantity of product in the first, second and third years of the Agreement, excluding demonstration product. These quantities to be agreed by both parties in the initial detailed sales plan noted in clause 9D and amended with further agreement in subsequent annual sales plans 15. PAYMENT TERMS The Distributor agrees to abide by Lucid's standard payment terms, which are as follows; One Hundred (100) per cent of order value by sixty ( 90 ) day irrevocable letter of credit when order is placed on Lucid. 16. TERMINATION A) Either party may terminate this agreement by giving written Notice to the other party if: i) The other party fails to perform or satisfy any of the conditions, covenants or obligations of this Agreement. ii) The other party files or has filed against it, a petition seeking relief under any bankruptcy, insolvency, reorganisation, moratorium, liquidation or similar law affecting creditors' rights B) In addition, Lucid may terminate this agreement by giving the Distributor Written Notice if there is any change of control, ownership or management of the Distributor.\"}}, {\"id\": \"value:one hundred per cent\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one hundred per cent\"}}, {\"id\": \"value:three (3) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) months\"}}, {\"id\": \"value:thirty (30) per cent\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"thirty (30) per cent\"}}, {\"id\": \"value:One Hundred (100) per cent\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"One Hundred (100) per cent\"}}, {\"id\": \"value:sixty ( 90 ) day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty ( 90 ) day\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Either party may terminate this agreement by providing Ninety days Written Notice\", \"level\": 1, \"text\": \"C) Either party may terminate this agreement by providing Ninety days Written Notice. 17. EFFECT OF TERMINATION A) Upon the termination of this Agreement: 1. The Distributor shall terminate any registration it has made as a Lucid Distributor. 2. Distributor will immediately return any samples, sales literature, promotional materials and other documents supplied to the Distributor free of charge from Lucid. 3. Any right to use Lucid patents, copyrights, trademarks, symbols and logos shall immediately cease. B) If this Agreement is terminated Lucid shall not be liable for any incidental, indirect; special punitive of consequential damages of any kind, including any perceived or real market development costs. 18. Incident and Traceability Reporting A) DISTRIBUTOR will IMMEDIATELY report via telephone communication to Lucid any incidents that involve the use of PRODUCTS sold by the DISTRIBUTOR to end users that affect patient safety or well-being (an \\\"INCIDENT\\\"). Such oral incident reporting will be followed immediately by a written incident report that documents the detailed conditions that resulted in the INCIDENT and Distributor shall thereafter co-operate with Lucid in the investigation of any and all conditions that led to, or resulted from the INCIDENT. B) DISTRIBUTOR will routinely, but not less than annually, report in writing to Lucid, documenting the end users to which PRODUCTS have been sold, including the address, telephone number and name of a person who is the primary emergency contact. Lucid will use this information in the event of Lucid issuing a product recall of the PRODUCT for safety or other reasons. If such an event occurs, and upon Lucid's request, the DISTRIBUTOR will immediately provide Lucid with the names, addresses, telephone numbers and emergency contact personnel of any end user sites not previously reported to Lucid. 19. LIMITATION OF LIABILITY A) Lucid does not guarantee delivery of Product by any particular date. If Lucid accepts Distributor's order and fails to deliver ordered products, Distributors sole remedy will be limited to refund of money paid to Lucid for any undelivered products. B) Lucid will not have any liability or responsibility to Distributor or any other person or entity for any consequential, indirect, special, punitive or incidental damages or lost profits, whether foreseeable or unforeseeable, based on claims of Distributor or Distributor's customers (including but not limited to, claims for loss of data, goodwill, profits, use of money or use of product, interruption in use or availability of data stoppage or other work or impairment or assets) arising out of breach or failure of express or implied warranty, breach of contract, misrepresentation, negligence, strict liability in tort or otherwise, except only in the case of death or personal injury where and to the extent that applicable law requires such liability. In no event will the aggregate liability incurred by Lucid in any action or proceeding exceed the total amount actually paid to Lucid by Distributor for the purchase of the products that actually caused the damage or loss. 20. Governing Law A) This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York, USA without regard to conflict of laws principles. 21. NOTICE A) All notices required herein (\\\"NOTICE\\\") shall be given in English language. Notices must be sent postage pre-paid, and (a) delivered personally against written receipt (b) transmitted via facsimile or (c) sent by nationally recognised overnight courier service, or (d) sent via first class certified mail, return receipt requested, to the address listed above. Any change of addresser fax number must be designated in writing and served in accordance with this Section. Notice shall be effective (a) upon receipt if personally delivered (b) upon confirmation of transmission if sent via facsimile and (c) two (2) business days after deposit with the courier or an official depository of the US Post Office, if sent via recognised overnight courier of via Certified Mail, as the case may be. 22 ENTIRE AGREEMENT: A) This Agreement, including the Price List attached hereto, as amended from time to time, constitutes the entire understanding between the parties with respect to the subject matter of this Agreement and supersedes and replaces all previous proposals, both oral and written, negotiations, representations, commitments, writings, contracts, agreements and all other communications between the two parties. Signatures on the next page IN WITNESS WHEREOF, the parties have duly executed this Agreement on the date first above written. LUCID Inc. [*] By By Marcy K. Davis-McHugh [*] TITLE TITLE: Corporate Vice President DATE [*] DATE: [*] SIGNATURE SIGNATURE\"}}, {\"id\": \"value:Ninety days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Ninety days\"}}, {\"id\": \"term:INCIDENT\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"INCIDENT\", \"text\": \"any incidents that involve the use of PRODUCTS sold by the DISTRIBUTOR to end users that affect patient safety or well-being (an \\\"INCIDENT\\\")\", \"definition_clause\": \"C\"}}, {\"id\": \"term:NOTICE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"NOTICE\", \"text\": \"All notices required herein (\\\"NOTICE\\\")\", \"definition_clause\": \"C\"}}, {\"id\": \"value:two (2) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of LohaCompanyltd_20191209_F-1_EX-10.16_11917878_EX-10.16_Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of LohaCompanyltd_20191209_F-1_EX-10.16_11917878_EX-10.16_Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"1\", \"level\": 1, \"text\": \"1 Source: LOHA CO. LTD., F-1, 12/9/2019\"}, {\"id\": \"3\", \"title\": \"GOODS AND COUNTRY OF ORIGIN\", \"level\": 1, \"text\": \"3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \\\"KEEP AWAY FROM MOISTURE\\\",\\\"HANDLE WITH CARE\\\" \\\"THIS SIDE UP\\\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT: 2 Source: LOHA CO. LTD., F-1, 12/9/2019\"}, {\"id\": \"9\", \"title\": \"PORT OF DESTINATION\", \"level\": 1, \"text\": \"9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer's agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made. 3 Source: LOHA CO. LTD., F-1, 12/9/2019\"}, {\"id\": \"12.2\", \"title\": \"(1) Invoice in 3 originals indicating contract number and L/C number\", \"level\": 2, \"text\": \"12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers. 4 Source: LOHA CO. LTD., F-1, 12/9/2019\"}, {\"id\": \"17\", \"title\": \"FORCE MAJEURE\", \"level\": 1, \"text\": \"17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited. 5 Source: LOHA CO. LTD., F-1, 12/9/2019\"}, {\"id\": \"21\", \"title\": \"Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Na\", \"level\": 1, \"text\": \"21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6 Source: LOHA CO. LTD., F-1, 12/9/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of LohaCompanyltd_20191209_F-1_EX-10.16_11917878_EX-10.16_Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"1\", \"level\": 1, \"text\": \"1 Source: LOHA CO. LTD., F-1, 12/9/2019\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOODS AND COUNTRY OF ORIGIN\", \"level\": 1, \"text\": \"3. GOODS AND COUNTRY OF ORIGIN: 4. Specific order: The products quantity, unit price, specifications, delivery time and transportation, specific content shall be subject to the purchase order issued by entrusted party which is commissioned the buyer. 5. PACKING: To be packed in new strong wooden case(s) /carton(s), suitable for long distance transportation and for the change of climate, well protected against rough handling, moisture, rain, corrosion, shocks, rust, and freezing. The seller shall be liable for any damage and loss of the commodity, expenses incurred on account of improper packing, and any damage attributable to inadequate or improper protective measures taken by the seller in regard to the packing. One full set of technical All wooden material of shipping package must be treated as the requirements of Entry-Exit Inspection and Quarantine Bureau of China, by the agent whom is certified by the government where the goods is exported. And the goods must be marked with the IPPC stamps, which are certified by the government agent of Botanical-Inspection and Quarantine Bureau. 6. SHIPPING MARK: The Sellers shall mark on each package with fadeless paint the package number, gross weight, net weight, measurements and the wordings: \\\"KEEP AWAY FROM MOISTURE\\\",\\\"HANDLE WITH CARE\\\" \\\"THIS SIDE UP\\\" etc. and the shipping mark on each package with fadeless paint. 7. DATE OF SHIPMENT: According to specific order by YICHANGTAI or LEHEYUAN. 8. PORT OF SHIPMENT: 2 Source: LOHA CO. LTD., F-1, 12/9/2019\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PORT OF DESTINATION\", \"level\": 1, \"text\": \"9. PORT OF DESTINATION: SHENZHEN, GUANGDONG, CHINA 10. INSURANCE: To be covered by the Seller for 110% invoice value against All Risks and War Risk. 11. PAYMENT: Under Letter of Credit or T/T: Under the Letter of Credit: The Buyer shall open an irrevocable letter of credit with the bank within 30 days after signing the contract, in favor of the Seller, for 100% value of the total contract value. The letter of credit should state that partial shipments are allowed. The Buyer's agent agrees to pay for the goods in accordance with the actual amount of the goods shipped. 80% of the system value being shipped will be paid against the documents stipulated in Clause 12.1. The remaining 20% of the system value being shipped will be paid against the documents stipulated in Clause 12.2. The Letter of Credit shall be valid until 90 days after the latest shipment is effected. Under the T/T The trustee of the buyer remitted the goods to the seller by telegraphic transfer in batches as agreed upon after signing each order. 12. DOCUMENTS: 12.1 (1) Invoice in 5 originals indicating contract number and Shipping Mark (in case of more than one shipping mark, the invoice shall be issued separately). (2) One certificate of origin of the goods. (3) Four original copies of the packing list. (4) Certificate of Quality and Quantity in 1 original issued by the agriculture products base. (5) One copy of insurance coverage (6) Copy of cable/letter to the transportation department of Buyer advising of particulars as to shipment immediately after shipment is made. 3 Source: LOHA CO. LTD., F-1, 12/9/2019\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"(1) Invoice in 3 originals indicating contract number and L/C number\", \"level\": 2, \"text\": \"12.2 (1) Invoice in 3 originals indicating contract number and L/C number. (2) Final acceptance certificate signed by the Buyer and the Seller. 13. SHIPMENT: CIP The seller shall contract on usual terms at his own expenses for the carriage of the goods to the agreed point at the named place of destination and bear all risks and expenses until the goods have been delivered to the port of destination. The Sellers shall ship the goods within the shipment time from the port of shipment to the port of destination. Transshipment is allowed. Partial Shipment is allowed. In case the goods are to be dispatched by parcel post/sea-freight, the Sellers shall, 3 days before the time of delivery, inform the Buyers by cable/letter of the estimated date of delivery, Contract No., commodity, invoiced value, etc. The sellers shall, immediately after dispatch of the goods, advise the Buyers by cable/letter of the Contract No., commodity, invoiced value and date of dispatch for the Buyers. 14. SHIPPING ADVICE: The seller shall within 72 hours after the shipment of the goods, advise the shipping department of buyer by fax or E-mail of Contract No., goods name, quantity, value, number of packages, gross weight, measurements and the estimated arrival time of the goods at the destination. 15. GUARANTEE OF QUALITY: The Sellers guarantee that the commodity hereof is complies in all respects with the quality and specification stipulated in this Contract. 16. CLAIMS: Within 7 days after the arrival of the goods at destination, should the quality, specification, or quantity be found not in conformity with the stipulations of the Contract except those claims for which the insurance company or the owners of the vessel are liable, the Buyers, on the strength of the Inspection Certificate issued by the China Commodity Inspection Bureau, have the right to claim for replacement with new goods, or for compensation, and all the expenses (such as inspection charges, freight for returning the goods and for sending the replacement, insurance premium, storage and loading and unloading charges etc.) shall be borne by the Sellers. The Certificate so issued shall be accepted as the base of a claim. The Sellers, in accordance with the Buyers' claim, shall be responsible for the immediate elimination of the defect(s), complete or partial replacement of the commodity or shall devaluate the commodity according to the state of defect(s). Where necessary, the Buyers shall be at liberty to eliminate the defect(s) themselves at the Sellers' expenses. If the Sellers fail to answer the Buyers within one weeks after receipt of the aforesaid claim, the claim shall be reckoned as having been accepted by the Sellers. 4 Source: LOHA CO. LTD., F-1, 12/9/2019\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE\", \"level\": 1, \"text\": \"17. FORCE MAJEURE: The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit. The Sellers shall advise the Buyers immediately of the occurrence mentioned above and within fourteen days thereafter, the Sellers shall send by airmail to the Buyers a certificate of the accident issued by the competent government authorities, Chamber of Commerce or registered notary public of the place where the accident occurs as evidence thereof. Under such circumstances the Sellers, however, are still under the obligation to take all necessary measures to hasten the delivery of the goods. In case the accident lasts for more than 10 weeks, the Buyers shall have the right to cancel the Contract. 18. LATE DELIVERY AND PENALTY: Should the Sellers fail to make delivery on time as stipulated in the Contract, with exception of Force Majeure causes specified in Clause 17 of this Contract, the Buyers shall agree to postpone the delivery on condition that the Sellers agree to pay a penalty which shall be deducted by the paying bank from the payment. The penalty, however, shall not exceed 5% of the total value of the goods involved in the late delivery. The rate of penalty is charged at 0.5% for every seven days, odd days less than seven days should be counted as seven days. In case the Sellers fail to make delivery ten weeks later than the time of shipment stipulated in the Contract, the Buyers have the right to cancel the contract and the Sellers, in spite of the cancellation, shall still pay the aforesaid penalty to the Buyers without delay, the seller should refund the money received and pay the 30% of the total goods price of the penalty 19. ARBITRATION: All disputes in connection with this Contract or the execution thereof shall be settled friendly through negotiations. In case no settlement can be reached, the case may then be submitted for arbitration to the Foreign Economic and Trade Arbitration Committee of the China Beijing Council for the Promotion of International Trade in accordance with its Provisional Rules of Procedures by the said Arbitration Committee. The Arbitration shall take place in Beijing and the decision of the Arbitration Committee shall be final and binding upon both parties; neither party shall seek recourse to a law court nor other authorities to appeal for revision of the decision. Arbitration fee shall be borne by the losing party. 20. This final price is the confidential information. Dissemination, distribution or duplication of this price is strictly prohibited. 5 Source: LOHA CO. LTD., F-1, 12/9/2019\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Na\", \"level\": 1, \"text\": \"21. Law application It will be governed by the law of the People's Republic of China ,otherwise it is governed by United Nations Convention on Contract for the International Sale of Goods. 22. <> The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce. 23. The Contract is valid for 5 years, beginning from and ended on . This Contract is made out in three originals in both Chinese and English, each language being legally of the equal effect. Conflicts between these two languages arising there from, if any, shall be subject to Chinese version. One copy for the Sellers, two copies for the Buyers. The Contract becomes effective after signed by both parties. THE BUYER: THE SELLER: SIGNATURE: SIGNATURE: 6 Source: LOHA CO. LTD., F-1, 12/9/2019\"}}, {\"id\": \"party:THE BUYER\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"THE BUYER\", \"role\": \"Buyer\", \"address\": null}}, {\"id\": \"party:THE SELLER\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"THE SELLER\", \"role\": \"Seller\", \"address\": null}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"The Sellers shall not be held responsible for the delay in shipment or non-delivery, of the goods due to Force Majeure, which might occur during the process of manufacturing or in the course of loading or transit.\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Incoterms 2000\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Incoterms 2000\", \"text\": \"The terms in the contract are based on (INCOTERMS 2000) of the International Chamber of Commerce.\", \"definition_clause\": \"21\"}}, {\"id\": \"value:110%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"110%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:100%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"100%\"}}, {\"id\": \"value:80%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"80%\"}}, {\"id\": \"value:20%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20%\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:3 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 days\"}}, {\"id\": \"value:72 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"72 hours\"}}, {\"id\": \"value:7 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"7 days\"}}, {\"id\": \"value:one weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one weeks\"}}, {\"id\": \"value:fourteen days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fourteen days\"}}, {\"id\": \"value:10 weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 weeks\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:0.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"0.5%\"}}, {\"id\": \"value:every seven days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"every seven days\"}}, {\"id\": \"value:seven days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seven days\"}}, {\"id\": \"value:ten weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten weeks\"}}, {\"id\": \"value:30%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"30%\"}}, {\"id\": \"value:5 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 years\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of MEDIWOUNDLTD_01_15_2014-EX-10.6-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of MEDIWOUNDLTD_01_15_2014-EX-10.6-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.6\", \"title\": \"MediWound Ltd. and Challenge Bioproducts Corporation Ltd. Supply Agreement \u2014 As amended on February 28, 2010\", \"level\": 2, \"text\": \"Exhibit 10.6 MediWound Ltd. and Challenge Bioproducts Corporation Ltd. Supply Agreement \u2014 As amended on February 28, 2010 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. SUPPLY AGREEMENT This Supply Agreement (\\\"Agreement\\\") was made and entered into as of the 11 day of January, 2001 by and between MediWound Ltd., a corporation organized and existing under the laws of Israel (hereinafter referred to as \\\"MediWound\\\") and Challenge Bioproducts Corporation Ltd., a corporation organized and existing under the laws of the Republic of China (hereinafter referred to as \\\"CBC\\\") and amended by the parties on February 28, 2010 (\\\"Amendment Effective Date\\\"). WITNESSETH: THAT Whereas MediWound and CBC have originally entered into this Agreement on the date stated above (copy of which shall be attached hereto as Exhibit A); and Whereas, the parties hereto have agreed to amend and add certain terms and conditions to this Agreement as of the Amendment Effective Date, all as set forth and marked herein; and Whereas, CBC has invented and developed methods, processes and equipment to manufacture, and produce Bromelain SP (as such term is defined below), specially processed for transformation into a Bromelain-based pharmaceutical product derived from pineapple stems, known as Debridase (the \\\"Product\\\"); and Whereas, subject to the going into effect of a License Agreement dated September 27, 2000 between MediWound and Mark Klein (respectively, the \\\"Klein Agreement\\\" and \\\"Klein\\\") as amended on June 19, 2007, MediWound shall have an exclusive license under patents and other intellectual property, to develop, use, manufacture, market and sell the Product for burn treatment in humans; and Whereas, MediWound desires to utilize Bromelain SP in the development and commercialization of the Product and to subsequently purchase Bromelain SP in bulk form to make and have made Product and pharmaceutical preparations thereof; and Whereas, CBC is willing to supply Bromelain SP to MediWound for such purpose on the terms and conditions set forth hereunder. NOW THEREFORE IN CONSIDERATION OF THE MUTUAL PROMISES AND COVENANTS SET FORTH HEREIN IT IS HEREBY AGREED AS FOLLOWS: *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 2 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 3 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 4 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 5 of price shall be considered by MediWound at CBC's written request without the limit of no more often than once every [***] months. 4.2.3 MediWound shall make payment for each Bromelain SP batch that was supplied by CBC on a [***] days basis as of the date of delivery of the applicable batch at MediWound, provided that MediWound has provided CBC with an Acceptance Batch Notice for such purchased batch pursuant to Section 6.4. Payment for each purchase batch shall be effected by MediWound by swift to a bank account designated by CBC, or by other requested method as agreed between the parties. MediWound shall make down payment of USD[***]/kg for the [***]% of the amount of Annual Forecast before Dec.31 of the respective year for the insurance of components and materials and maintenance of manufacture and supply capacity of the requested [***]% of the next calendar year's Annual Forecast. The down payment will be then deducted respectively as every shipment is made to MediWound and listed in CBC's Invoice to MediWound. 4.2.4 Payment shall be made directly to CBC for payment for each order of Bromelain SP or, at CBC's written request, to Golden Life International Co., Ltd. on CBC's behalf, for payments other than any order of Bromelain SP (\\\"Payee\\\"); provided however, that any such payment to the Payee shall be considered as valid payment to CBC (as if made directly to CBC) in accordance with this Agreement, and that so long as such payment is made in accordance with CBC's said request, CBC shall have no claims or demands against MediWound for non-payment or in any other respect whatsoever in this regard. CBC solely shall be responsible to ensure that payment by MediWound to the Payee pursuant to CBC's request does not violate any applicable laws and regulations. Any tax implications due to payment to the Payee in accordance with CBC's request shall be borne by CBC. For avoidance of doubt, it is clarified that the Payee shall not be considered as a third party beneficiary under this Agreement and shall not have any rights to enforce payment or any other rights of CBC under this Agreement. 4.2.5 Invoices shall only be issued upon delivery of the Bromelain SP batch which shall take place only after CBC's quality control department has completed its testing and authorized delivery to MediWound, and MediWound's quality control department has provided CBC with an Acceptance Sample Notice for that batch and that the batch itself can be delivered. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 6\"}, {\"id\": \"4.2.6\", \"title\": \"The consideration to be paid pursuant to this Agreement is final and inclusive of all taxes and/or duties, of whatsoever\", \"level\": 3, \"text\": \"4.2.6 The consideration to be paid pursuant to this Agreement is final and inclusive of all taxes and/or duties, of whatsoever nature. If applicable laws require the withholding of taxes, MediWound will deduct the taxes from the related payment otherwise due to CBC, and such taxes shall be paid to the proper taxing authority. For avoidance of doubt, payments will be made only after receiving exemption from tax deduction approval from the tax authority in Israel. Delay in payment as a result of not receiving such exemption will not constitute late payment or breach hereunder. 5. Manufacture of Bromelain SP 5.1 Without derogating from CBC's representations and warranties herein, CBC and MediWound shall work together in order to enable the CBC facility to accomplish all required standards, related to the manufacturing, packaging and delivering of Bromelain SP in accordance with the Specifications, GACP (Good Agricultural and Collection Practice) and cGMP (Current Good Manufacturing Practice) standards, ISO 22000 and all other applicable laws and regulations. For such purpose, and without derogating from other terms herein, CBC shall permit MediWound, and/or a consultant on MediWound's behalf, to access and inspect the CBC facility and advise MediWound and/or CBC on such actions to be taken for accomplishing such compliance. Such mutual regulatory preparations shall begin no later than the finalization of MediWound's current phase III clinical trial. CBC warrants and represents that all Bromelain SP shall be manufactured and supplied in compliance with the Specifications, quality control methods and test methods, all applicable SOP's and all applicable laws, and in accordance with GACP, cGMP, including the relevant guidelines, policies, codes, requirements, regulations, approvals and/or standards from time to time promulgated or issued by any relevant governmental and/or regulatory authority which relate to the manufacture of the Bromelain SP to be used for the production of a pharmaceutical agent as the Product. CBC warrants further that CBC has, and will for the duration of this Agreement retain, all applicable regulatory approvals required for the carrying out of its obligations hereunder, including without limitation the manufacturing, packaging and supply of the Bromelain SP. 5.2 All manufacturing, packaging and labeling activities done at CBC will be performed according to the pre-approved batch records. If CBC wishes to make changes to the Specifications, the production and/or packaging batch records, the SOPs related to the Bromelain SP, or the design of the manufacturing process or any other change during production which would effect the quality of the *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 7 Bromelain SP or of the Product and/or otherwise would effect the Bromelain SP in any way or which might effect the regulatory approvals of the Product, then CBC shall (i) notify MediWound in writing at least 6 months in advance regarding such proposed changes, and (ii) represent that such change will not adversely effect the quality of the Bromelain SP or of the Product in any way, and (iii) not make such changes without MediWound's prior written approval, and (iv) will assure that such change will not delay or in any way effect any open orders for Bromelain SP. 5.3 MediWound shall participate and support the upgrade of the Facility and the generation of documentation for submission to the relevant Regulatory Authorities, all as may be determined to be necessary and appropriate, by independent regulatory consultants, designated by mutual consent. Such participation and support shall be in the form of an investment made by MediWound in the CBC facility, not to exceed $[***] (US Dollars [***]). 5.4 CBC undertakes to keep all records reasonably required by MediWound relating to the manufacture, quality control and testing of Bromelain SP. Such records shall include, but not be limited to, all records required by applicable laws and regulations, of the territories in which the Product is marketed and sold. MediWound (itself or through anyone on its behalf) or any relevant regulatory authority shall have the right to audit any such records and/or the relevant facilities of CBC (or any facilities of any CBC third party or subcontractor involved in the manufacture, quality control and/or supply of the Bromelain SP) with reasonable prior notice, during regular business hours, including the right to ask CBC to provide any relevant documents. CBC shall inform MediWound of any announced regulatory inspections that directly involve the Bromelain SP or the Product within 48 hours of the notification to CBC of such an inspection. 5.5 During the term of this Agreement, CBC shall make available to MediWound any and all information and data which it generates or which comes into its possession relating to any improvements in the manufacture and supply of the Bromelain SP. CBC shall, throughout the term of this Agreement, assist MediWound in all respects with regard to regulatory submission including but not limited to providing any information, data or documents in its possession. If any regulatory agency requests any changes to the Specifications or the manufacturing process, (including but not limited to any changes as a result of an audit performed) CBC shall (i) inform MediWound in advance and in writing of the changes needed to be made, and (ii) promptly advise MediWound as to any lead-time changes or other terms which may result therefrom, and (iii) make such changes, in coordination with MediWound as soon as possible. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 8 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 9 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 10\"}, {\"id\": \"6.2\", \"title\": \"MediWound shall furnish CBC with a non-binding forecast of its anticipated annual requirements of Bromeline SP by no lat\", \"level\": 2, \"text\": \"6.2 MediWound shall furnish CBC with a non-binding forecast of its anticipated annual requirements of Bromeline SP by no later than November 1 of each year (\\\"Annual Forecast\\\"), for the next calendar year. Notwithstanding the foregoing, the first forecast for the calendar year that commenced on January 1, 2001, was furnished by MediWound to CBC by March 15, 2001. MediWound undertakes to order at least [***]% of the Annual Forecast per each year. CBC shall maintain, at all times, manufacture and supply capacity of at least [***]% of the Annual Forecast and shall maintain, in coordination with MediWound, inventory of Bromelain SP at its premises of (i) at least [***]% of the applicable Annual Forecast; and (ii) all Bromelain SP components and materials (\\\"the BSP Components and Materials\\\") needed for the manufacture and supply of the Bromelain SP such that CBC can guarantee continuous supply of the Bromelain SP in accordance with MediWound's complete Annual Forecasts. In addition, the inventory of the BSP Components and Materials shall not be less than needed to manufacture [***] months stock of Bromelain SP (compared to the open purchase orders and the applicable Annual Forecast) or longer (respectively) for BSP Components and Materials having a lead time of more than [***] months. CBC shall provide MediWound with quarterly inventory and production reports for Bromelain SP and BSP Components and Materials. Purchase orders issued by MediWound to CBC for quantities within the [***]% of the Annual Forecast shall be binding upon CBC and shall be deemed accepted upon delivery of the purchase order to CBC. Such purchase orders shall be supplied on the date specified in the applicable purchase order provided that the lead time in any purchase order shall be at least [***] days as of the purchase order's date. Purchase orders issued by MediWound to CBC during a certain year for quantities exceeding [***]% of the applicable Annual Forecast shall be binding upon CBC, except that with respect to any amounts exceeding [***]% of the applicable Annual Forecast, CBC's obligation to provide such exceeding quantities shall be based on best efforts and CBC shall have an extended lead time for delivery as shall be agreed upon by the parties on a case by case basis. CBC shall confirm in writing, within 5 days of its acceptance of such exceeding purchase order, and shall state the anticipated delivery date for the exceeding amounts. Without derogating from CBC's obligations under this Agreement, in the event that CBC is unable to supply all the Bromelain SP covered under any purchase order on the dates specified in the applicable supply plans, CBC shall promptly notify MediWound in writing in a separate notice to MediWound of such delay or noncompliance. In such event, and without prejudice to any other remedies *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 11 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 12 batch to MediWound within [***] days of rejection, free of cost (including transportation, duty, handling and insurance costs). For clarification purposes, MediWound's Acceptance Batch Notice in accordance with this section above shall in no event derogate from CBC's responsibilities hereunder. 6.5 If there is a dispute between the parties as to whether any Bromelain SP sample or batch complies with the sample or batch Specifications respectively and/or with the quality requirements set forth herein and/or under the law, then, without derogating from MediWound's remedies under this Agreement or at law, such dispute shall be resolved by mutual investigation of the parties which shall be conducted in good faith. If the parties are still unable to resolve such dispute, an independent, mutually agreed third party shall be retained as a consultant to review batch records and related documentation. Such consultant's determination in respect of the conformity of a sample or batch shall be binding upon the parties. The non-prevailing party shall bear the costs of consultant's services as well as for the production of the batch and corrective actions. If appropriate, pursuant to such investigation and/or consultant's determination, CBC shall replace the non-complying Bromelain SP within 30 (thirty) days thereafter, free of cost (including transportation, duty, handling and insurance costs). 6.6 CBC, at its own cost, shall obtain and shall cause to remain in effect, such licenses, permits, approval and consents as may be required for its performance hereunder, including, without limitation, export of Bromelain SP from the Republic of China. 7. Liability and Indemnity 7.1 CBC shall defend and assume responsibility for any suit, claim or other action by a third party alleging that MediWound's use of Bromelain SP infringes any patents or other rights of such third party. 7.2 MediWound shall be solely responsible for the commercialization of the Product, e.g. the completion of development, final formulation, the conduct of clinical trials (as necessary), labeling and packaging, as well as the due preparation and submission of all documentation required for the prosecution of registration and Approval of the Product in each of the countries in the Territory. MediWound shall assume all liabilities arising from the development, commercialization, use, offer for sale, sale or supply by, through or on behalf of MediWound or its Affiliates, of the Product (and related materials). 7A. Insurance In order to provide insurance coverage for CBC responsibilities, obligations and undertakings as set out under this Agreement and/or as required under any law with *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 13 respect to the manufacturing of Bromelain SP, CBC undertakes, at its sole cost and expense, to take out and maintain an \\\"All risk\\\" insurance against loss of and destruction or damage to the Facility (including fire, theft and vandalism, etc.), third party liability insurance, product liability insurance for the Bromelain SP and employers liability insurance. Without prejudice to the above, CBC shall maintain, or shall cause to be maintained with respect to itself and each of its Affiliates, such types and levels of insurance (including, without limitation, third party and product liability insurance), as are customary in the pharmaceutical or manufacturing industry to provide coverage for their activities contemplated hereby. Upon request of MediWound, CBC shall keep MediWound informed of the general parameters of its liability insurance program and any proposed substantive changes therein. Upon request, CBC shall furnish MediWound certification of insurance (and/or true copies of policies) showing the above coverage, signed by an authorized agent of the insurance company, certifying that liability assumed under this Agreement is fully insured without exception, and providing for at least thirty (30) days prior written notice. 7B. Limitation of Consequential Damages EXCEPT FOR BREACH OF CONFIDENTIALITY OBLIGATION HEREUNDER, AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING WITHOUT LIMITATION LOSS OF USE, DATA OR LOST PROFITS, EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, WHETHER UNDER THIS AGREEMENT, IN TORT OR OTHERWISE. 8. Confidentiality 8.1 CBC and MediWound undertake to each other to keep, and shall procure that their respective Affiliates, employees, directors, officers, consultants and contractors (including those of any Affiliate) shall keep, confidential all information received from each other during or in anticipation of this Agreement however obtained and in whatever form (the \\\"Confidential Information\\\"). For clarification purposes, any information, materials and know-how related to the Product and/or provided by MediWound in connection with this Agreement including any related intellectual property rights, shall be owned solely by MediWound and shall constitute MediWound's Confidential Information which may be used by CBC solely for the purpose of manufacturing and supply of Bromelain SP to MediWound. Confidential Information shall not include the following: *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 14 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 15 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 16 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 17 MediWound Ltd. 42 Hayarkon St., 81227 Yavne Israel Tel: +972 8 932 4010 Fax: +972 8 932 4011 E-Mail: [***] 14.3 CBC's address for service of notices and other documents shall be:- Challenge Bioproducts Corporation, Ltd. 17 Tou-Kong 12 Rd., Tou-Liu City, Yun-Lin Hsien, Taiwan, R.O.C., (\\\"CBC\\\") Facsimile: +55-5572-045 E-Mail: [***] 15. Governing Law and Disputes 15.1 This Agreement is made under and subject to the provision of the substantive laws of the State of New York, without giving effect to its conflict of law rules. 15.2 Any disputes relating to this Agreement of whatever nature that cannot be resolved by negotiation between the parties shall be referred for final resolution to arbitration in New York City by 3 (three) Arbitrators under the Rules of the American Arbitration Association. The arbitration proceedings shall be conducted in English. The decision of the arbitrators shall be final and binding upon the parties and their legal successors. The arbitrators may at their discretion, provide for discovery by the parties not to exceed 4 (four) months from the date of notice of arbitration and the arbitrators shall notify the parties of their decision in writing within 30 (thirty) days of the completion of the final hearing. The arbitrators may at their discretion award costs and expenses in respect of the arbitration. 15.3 The parties submit to the exclusive jurisdiction of the courts of the State of New York. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 18 IN WITNESS WHEREOF, the parties, each by its duly authorized signatory, have caused this Agreement to be executed as of the date first above- mentioned. /s/ Gal Cohen /s/ Ching-Kuan Lin MediWound Ltd. Challenge Bioproducts Corporation Ltd. By: Gal Cohen By: Ching-Kuan Lin Its: Chief Executive Officer Its: President MediWound Ltd. Challenge Bioproducts Co., Ltd. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 19 List of Exhibits Exhibit 1.13 - Current Bromelain SP Specifications Exhibit 4.2 - Price list per annual quantity Exhibit A - a copy of this Supply Agreement as originally signed on 11/1/2001 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 20\"}, {\"id\": \"Exhibit 1.13\", \"title\": \"\u2014 Current Bromelain SP Specifications [***]\", \"level\": 2, \"text\": \"Exhibit 1.13 \u2014 Current Bromelain SP Specifications [***] *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.\"}, {\"id\": \"Exhibit 4.2\", \"title\": \"\u2014 Price list per annual quantity\", \"level\": 2, \"text\": \"Exhibit 4.2 \u2014 Price list per annual quantity MediWound Ltd. 42 Hayarkon Street, Yavne, Israel Tel: 972-8-9324010 www.mediwound.com Supply Agreement as amended on Feb 28 2010. Exhibit 4.2 \u2014 Price list per annual quantity The price of [***]Kg of released BSP below an annual ordered quantity of [***] Kg shall be USD[***]/Kg [***]. The price of [***]Kg of released BSP above an annual ordered quantity of [***] Kg shall be between USD[***]/Kg [***], as jointly agreed and set between CBC and MW, once the forecasted annual ordered quantity exceeds [***] Kg of released BSP. Challenge Bioproducts Corporation Ltd: Date: 2011.10.12 Signature: /s/ Ching-Kuan Lin MediWound Ltd. Date: Signature: /s/ Gal Cohen Chief Executive Officer MediWound, Ltd. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. th\"}, {\"id\": \"Exhibit A\", \"title\": \"- a copy of this Supply Agreement as originally signed on 11/1/2001 [Omitted: Agreement no longer in effect]\", \"level\": 1, \"text\": \"Exhibit A - a copy of this Supply Agreement as originally signed on 11/1/2001 [Omitted: Agreement no longer in effect] *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 1\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of MEDIWOUNDLTD_01_15_2014-EX-10.6-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MediWound Ltd. and Challenge Bioproducts Corporation Ltd. Supply Agreement \u2014 As amended on February 28, 2010\", \"level\": 2, \"text\": \"Exhibit 10.6 MediWound Ltd. and Challenge Bioproducts Corporation Ltd. Supply Agreement \u2014 As amended on February 28, 2010 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. SUPPLY AGREEMENT This Supply Agreement (\\\"Agreement\\\") was made and entered into as of the 11 day of January, 2001 by and between MediWound Ltd., a corporation organized and existing under the laws of Israel (hereinafter referred to as \\\"MediWound\\\") and Challenge Bioproducts Corporation Ltd., a corporation organized and existing under the laws of the Republic of China (hereinafter referred to as \\\"CBC\\\") and amended by the parties on February 28, 2010 (\\\"Amendment Effective Date\\\"). WITNESSETH: THAT Whereas MediWound and CBC have originally entered into this Agreement on the date stated above (copy of which shall be attached hereto as Exhibit A); and Whereas, the parties hereto have agreed to amend and add certain terms and conditions to this Agreement as of the Amendment Effective Date, all as set forth and marked herein; and Whereas, CBC has invented and developed methods, processes and equipment to manufacture, and produce Bromelain SP (as such term is defined below), specially processed for transformation into a Bromelain-based pharmaceutical product derived from pineapple stems, known as Debridase (the \\\"Product\\\"); and Whereas, subject to the going into effect of a License Agreement dated September 27, 2000 between MediWound and Mark Klein (respectively, the \\\"Klein Agreement\\\" and \\\"Klein\\\") as amended on June 19, 2007, MediWound shall have an exclusive license under patents and other intellectual property, to develop, use, manufacture, market and sell the Product for burn treatment in humans; and Whereas, MediWound desires to utilize Bromelain SP in the development and commercialization of the Product and to subsequently purchase Bromelain SP in bulk form to make and have made Product and pharmaceutical preparations thereof; and Whereas, CBC is willing to supply Bromelain SP to MediWound for such purpose on the terms and conditions set forth hereunder. NOW THEREFORE IN CONSIDERATION OF THE MUTUAL PROMISES AND COVENANTS SET FORTH HEREIN IT IS HEREBY AGREED AS FOLLOWS: *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 2 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 3 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 4 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 5 of price shall be considered by MediWound at CBC's written request without the limit of no more often than once every [***] months. 4.2.3 MediWound shall make payment for each Bromelain SP batch that was supplied by CBC on a [***] days basis as of the date of delivery of the applicable batch at MediWound, provided that MediWound has provided CBC with an Acceptance Batch Notice for such purchased batch pursuant to Section 6.4. Payment for each purchase batch shall be effected by MediWound by swift to a bank account designated by CBC, or by other requested method as agreed between the parties. MediWound shall make down payment of USD[***]/kg for the [***]% of the amount of Annual Forecast before Dec.31 of the respective year for the insurance of components and materials and maintenance of manufacture and supply capacity of the requested [***]% of the next calendar year's Annual Forecast. The down payment will be then deducted respectively as every shipment is made to MediWound and listed in CBC's Invoice to MediWound. 4.2.4 Payment shall be made directly to CBC for payment for each order of Bromelain SP or, at CBC's written request, to Golden Life International Co., Ltd. on CBC's behalf, for payments other than any order of Bromelain SP (\\\"Payee\\\"); provided however, that any such payment to the Payee shall be considered as valid payment to CBC (as if made directly to CBC) in accordance with this Agreement, and that so long as such payment is made in accordance with CBC's said request, CBC shall have no claims or demands against MediWound for non-payment or in any other respect whatsoever in this regard. CBC solely shall be responsible to ensure that payment by MediWound to the Payee pursuant to CBC's request does not violate any applicable laws and regulations. Any tax implications due to payment to the Payee in accordance with CBC's request shall be borne by CBC. For avoidance of doubt, it is clarified that the Payee shall not be considered as a third party beneficiary under this Agreement and shall not have any rights to enforce payment or any other rights of CBC under this Agreement. 4.2.5 Invoices shall only be issued upon delivery of the Bromelain SP batch which shall take place only after CBC's quality control department has completed its testing and authorized delivery to MediWound, and MediWound's quality control department has provided CBC with an Acceptance Sample Notice for that batch and that the batch itself can be delivered. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 6\"}}, {\"id\": \"4.2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The consideration to be paid pursuant to this Agreement is final and inclusive of all taxes and/or duties, of whatsoever\", \"level\": 3, \"text\": \"4.2.6 The consideration to be paid pursuant to this Agreement is final and inclusive of all taxes and/or duties, of whatsoever nature. If applicable laws require the withholding of taxes, MediWound will deduct the taxes from the related payment otherwise due to CBC, and such taxes shall be paid to the proper taxing authority. For avoidance of doubt, payments will be made only after receiving exemption from tax deduction approval from the tax authority in Israel. Delay in payment as a result of not receiving such exemption will not constitute late payment or breach hereunder. 5. Manufacture of Bromelain SP 5.1 Without derogating from CBC's representations and warranties herein, CBC and MediWound shall work together in order to enable the CBC facility to accomplish all required standards, related to the manufacturing, packaging and delivering of Bromelain SP in accordance with the Specifications, GACP (Good Agricultural and Collection Practice) and cGMP (Current Good Manufacturing Practice) standards, ISO 22000 and all other applicable laws and regulations. For such purpose, and without derogating from other terms herein, CBC shall permit MediWound, and/or a consultant on MediWound's behalf, to access and inspect the CBC facility and advise MediWound and/or CBC on such actions to be taken for accomplishing such compliance. Such mutual regulatory preparations shall begin no later than the finalization of MediWound's current phase III clinical trial. CBC warrants and represents that all Bromelain SP shall be manufactured and supplied in compliance with the Specifications, quality control methods and test methods, all applicable SOP's and all applicable laws, and in accordance with GACP, cGMP, including the relevant guidelines, policies, codes, requirements, regulations, approvals and/or standards from time to time promulgated or issued by any relevant governmental and/or regulatory authority which relate to the manufacture of the Bromelain SP to be used for the production of a pharmaceutical agent as the Product. CBC warrants further that CBC has, and will for the duration of this Agreement retain, all applicable regulatory approvals required for the carrying out of its obligations hereunder, including without limitation the manufacturing, packaging and supply of the Bromelain SP. 5.2 All manufacturing, packaging and labeling activities done at CBC will be performed according to the pre-approved batch records. If CBC wishes to make changes to the Specifications, the production and/or packaging batch records, the SOPs related to the Bromelain SP, or the design of the manufacturing process or any other change during production which would effect the quality of the *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 7 Bromelain SP or of the Product and/or otherwise would effect the Bromelain SP in any way or which might effect the regulatory approvals of the Product, then CBC shall (i) notify MediWound in writing at least 6 months in advance regarding such proposed changes, and (ii) represent that such change will not adversely effect the quality of the Bromelain SP or of the Product in any way, and (iii) not make such changes without MediWound's prior written approval, and (iv) will assure that such change will not delay or in any way effect any open orders for Bromelain SP. 5.3 MediWound shall participate and support the upgrade of the Facility and the generation of documentation for submission to the relevant Regulatory Authorities, all as may be determined to be necessary and appropriate, by independent regulatory consultants, designated by mutual consent. Such participation and support shall be in the form of an investment made by MediWound in the CBC facility, not to exceed $[***] (US Dollars [***]). 5.4 CBC undertakes to keep all records reasonably required by MediWound relating to the manufacture, quality control and testing of Bromelain SP. Such records shall include, but not be limited to, all records required by applicable laws and regulations, of the territories in which the Product is marketed and sold. MediWound (itself or through anyone on its behalf) or any relevant regulatory authority shall have the right to audit any such records and/or the relevant facilities of CBC (or any facilities of any CBC third party or subcontractor involved in the manufacture, quality control and/or supply of the Bromelain SP) with reasonable prior notice, during regular business hours, including the right to ask CBC to provide any relevant documents. CBC shall inform MediWound of any announced regulatory inspections that directly involve the Bromelain SP or the Product within 48 hours of the notification to CBC of such an inspection. 5.5 During the term of this Agreement, CBC shall make available to MediWound any and all information and data which it generates or which comes into its possession relating to any improvements in the manufacture and supply of the Bromelain SP. CBC shall, throughout the term of this Agreement, assist MediWound in all respects with regard to regulatory submission including but not limited to providing any information, data or documents in its possession. If any regulatory agency requests any changes to the Specifications or the manufacturing process, (including but not limited to any changes as a result of an audit performed) CBC shall (i) inform MediWound in advance and in writing of the changes needed to be made, and (ii) promptly advise MediWound as to any lead-time changes or other terms which may result therefrom, and (iii) make such changes, in coordination with MediWound as soon as possible. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 8 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 9 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 10\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MediWound shall furnish CBC with a non-binding forecast of its anticipated annual requirements of Bromeline SP by no lat\", \"level\": 2, \"text\": \"6.2 MediWound shall furnish CBC with a non-binding forecast of its anticipated annual requirements of Bromeline SP by no later than November 1 of each year (\\\"Annual Forecast\\\"), for the next calendar year. Notwithstanding the foregoing, the first forecast for the calendar year that commenced on January 1, 2001, was furnished by MediWound to CBC by March 15, 2001. MediWound undertakes to order at least [***]% of the Annual Forecast per each year. CBC shall maintain, at all times, manufacture and supply capacity of at least [***]% of the Annual Forecast and shall maintain, in coordination with MediWound, inventory of Bromelain SP at its premises of (i) at least [***]% of the applicable Annual Forecast; and (ii) all Bromelain SP components and materials (\\\"the BSP Components and Materials\\\") needed for the manufacture and supply of the Bromelain SP such that CBC can guarantee continuous supply of the Bromelain SP in accordance with MediWound's complete Annual Forecasts. In addition, the inventory of the BSP Components and Materials shall not be less than needed to manufacture [***] months stock of Bromelain SP (compared to the open purchase orders and the applicable Annual Forecast) or longer (respectively) for BSP Components and Materials having a lead time of more than [***] months. CBC shall provide MediWound with quarterly inventory and production reports for Bromelain SP and BSP Components and Materials. Purchase orders issued by MediWound to CBC for quantities within the [***]% of the Annual Forecast shall be binding upon CBC and shall be deemed accepted upon delivery of the purchase order to CBC. Such purchase orders shall be supplied on the date specified in the applicable purchase order provided that the lead time in any purchase order shall be at least [***] days as of the purchase order's date. Purchase orders issued by MediWound to CBC during a certain year for quantities exceeding [***]% of the applicable Annual Forecast shall be binding upon CBC, except that with respect to any amounts exceeding [***]% of the applicable Annual Forecast, CBC's obligation to provide such exceeding quantities shall be based on best efforts and CBC shall have an extended lead time for delivery as shall be agreed upon by the parties on a case by case basis. CBC shall confirm in writing, within 5 days of its acceptance of such exceeding purchase order, and shall state the anticipated delivery date for the exceeding amounts. Without derogating from CBC's obligations under this Agreement, in the event that CBC is unable to supply all the Bromelain SP covered under any purchase order on the dates specified in the applicable supply plans, CBC shall promptly notify MediWound in writing in a separate notice to MediWound of such delay or noncompliance. In such event, and without prejudice to any other remedies *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 11 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 12 batch to MediWound within [***] days of rejection, free of cost (including transportation, duty, handling and insurance costs). For clarification purposes, MediWound's Acceptance Batch Notice in accordance with this section above shall in no event derogate from CBC's responsibilities hereunder. 6.5 If there is a dispute between the parties as to whether any Bromelain SP sample or batch complies with the sample or batch Specifications respectively and/or with the quality requirements set forth herein and/or under the law, then, without derogating from MediWound's remedies under this Agreement or at law, such dispute shall be resolved by mutual investigation of the parties which shall be conducted in good faith. If the parties are still unable to resolve such dispute, an independent, mutually agreed third party shall be retained as a consultant to review batch records and related documentation. Such consultant's determination in respect of the conformity of a sample or batch shall be binding upon the parties. The non-prevailing party shall bear the costs of consultant's services as well as for the production of the batch and corrective actions. If appropriate, pursuant to such investigation and/or consultant's determination, CBC shall replace the non-complying Bromelain SP within 30 (thirty) days thereafter, free of cost (including transportation, duty, handling and insurance costs). 6.6 CBC, at its own cost, shall obtain and shall cause to remain in effect, such licenses, permits, approval and consents as may be required for its performance hereunder, including, without limitation, export of Bromelain SP from the Republic of China. 7. Liability and Indemnity 7.1 CBC shall defend and assume responsibility for any suit, claim or other action by a third party alleging that MediWound's use of Bromelain SP infringes any patents or other rights of such third party. 7.2 MediWound shall be solely responsible for the commercialization of the Product, e.g. the completion of development, final formulation, the conduct of clinical trials (as necessary), labeling and packaging, as well as the due preparation and submission of all documentation required for the prosecution of registration and Approval of the Product in each of the countries in the Territory. MediWound shall assume all liabilities arising from the development, commercialization, use, offer for sale, sale or supply by, through or on behalf of MediWound or its Affiliates, of the Product (and related materials). 7A. Insurance In order to provide insurance coverage for CBC responsibilities, obligations and undertakings as set out under this Agreement and/or as required under any law with *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 13 respect to the manufacturing of Bromelain SP, CBC undertakes, at its sole cost and expense, to take out and maintain an \\\"All risk\\\" insurance against loss of and destruction or damage to the Facility (including fire, theft and vandalism, etc.), third party liability insurance, product liability insurance for the Bromelain SP and employers liability insurance. Without prejudice to the above, CBC shall maintain, or shall cause to be maintained with respect to itself and each of its Affiliates, such types and levels of insurance (including, without limitation, third party and product liability insurance), as are customary in the pharmaceutical or manufacturing industry to provide coverage for their activities contemplated hereby. Upon request of MediWound, CBC shall keep MediWound informed of the general parameters of its liability insurance program and any proposed substantive changes therein. Upon request, CBC shall furnish MediWound certification of insurance (and/or true copies of policies) showing the above coverage, signed by an authorized agent of the insurance company, certifying that liability assumed under this Agreement is fully insured without exception, and providing for at least thirty (30) days prior written notice. 7B. Limitation of Consequential Damages EXCEPT FOR BREACH OF CONFIDENTIALITY OBLIGATION HEREUNDER, AND TO THE EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR SPECIAL, PUNITIVE, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, INCLUDING WITHOUT LIMITATION LOSS OF USE, DATA OR LOST PROFITS, EVEN IF IT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, WHETHER UNDER THIS AGREEMENT, IN TORT OR OTHERWISE. 8. Confidentiality 8.1 CBC and MediWound undertake to each other to keep, and shall procure that their respective Affiliates, employees, directors, officers, consultants and contractors (including those of any Affiliate) shall keep, confidential all information received from each other during or in anticipation of this Agreement however obtained and in whatever form (the \\\"Confidential Information\\\"). For clarification purposes, any information, materials and know-how related to the Product and/or provided by MediWound in connection with this Agreement including any related intellectual property rights, shall be owned solely by MediWound and shall constitute MediWound's Confidential Information which may be used by CBC solely for the purpose of manufacturing and supply of Bromelain SP to MediWound. Confidential Information shall not include the following: *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 14 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 15 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 16 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 17 MediWound Ltd. 42 Hayarkon St., 81227 Yavne Israel Tel: +972 8 932 4010 Fax: +972 8 932 4011 E-Mail: [***] 14.3 CBC's address for service of notices and other documents shall be:- Challenge Bioproducts Corporation, Ltd. 17 Tou-Kong 12 Rd., Tou-Liu City, Yun-Lin Hsien, Taiwan, R.O.C., (\\\"CBC\\\") Facsimile: +55-5572-045 E-Mail: [***] 15. Governing Law and Disputes 15.1 This Agreement is made under and subject to the provision of the substantive laws of the State of New York, without giving effect to its conflict of law rules. 15.2 Any disputes relating to this Agreement of whatever nature that cannot be resolved by negotiation between the parties shall be referred for final resolution to arbitration in New York City by 3 (three) Arbitrators under the Rules of the American Arbitration Association. The arbitration proceedings shall be conducted in English. The decision of the arbitrators shall be final and binding upon the parties and their legal successors. The arbitrators may at their discretion, provide for discovery by the parties not to exceed 4 (four) months from the date of notice of arbitration and the arbitrators shall notify the parties of their decision in writing within 30 (thirty) days of the completion of the final hearing. The arbitrators may at their discretion award costs and expenses in respect of the arbitration. 15.3 The parties submit to the exclusive jurisdiction of the courts of the State of New York. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 18 IN WITNESS WHEREOF, the parties, each by its duly authorized signatory, have caused this Agreement to be executed as of the date first above- mentioned. /s/ Gal Cohen /s/ Ching-Kuan Lin MediWound Ltd. Challenge Bioproducts Corporation Ltd. By: Gal Cohen By: Ching-Kuan Lin Its: Chief Executive Officer Its: President MediWound Ltd. Challenge Bioproducts Co., Ltd. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 19 List of Exhibits Exhibit 1.13 - Current Bromelain SP Specifications Exhibit 4.2 - Price list per annual quantity Exhibit A - a copy of this Supply Agreement as originally signed on 11/1/2001 *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 20\"}}, {\"id\": \"Exhibit 1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\u2014 Current Bromelain SP Specifications [***]\", \"level\": 2, \"text\": \"Exhibit 1.13 \u2014 Current Bromelain SP Specifications [***] *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.\"}}, {\"id\": \"Exhibit 4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\u2014 Price list per annual quantity\", \"level\": 2, \"text\": \"Exhibit 4.2 \u2014 Price list per annual quantity MediWound Ltd. 42 Hayarkon Street, Yavne, Israel Tel: 972-8-9324010 www.mediwound.com Supply Agreement as amended on Feb 28 2010. Exhibit 4.2 \u2014 Price list per annual quantity The price of [***]Kg of released BSP below an annual ordered quantity of [***] Kg shall be USD[***]/Kg [***]. The price of [***]Kg of released BSP above an annual ordered quantity of [***] Kg shall be between USD[***]/Kg [***], as jointly agreed and set between CBC and MW, once the forecasted annual ordered quantity exceeds [***] Kg of released BSP. Challenge Bioproducts Corporation Ltd: Date: 2011.10.12 Signature: /s/ Ching-Kuan Lin MediWound Ltd. Date: Signature: /s/ Gal Cohen Chief Executive Officer MediWound, Ltd. *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. th\"}}, {\"id\": \"Exhibit A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- a copy of this Supply Agreement as originally signed on 11/1/2001 [Omitted: Agreement no longer in effect]\", \"level\": 1, \"text\": \"Exhibit A - a copy of this Supply Agreement as originally signed on 11/1/2001 [Omitted: Agreement no longer in effect] *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. 1\"}}, {\"id\": \"party:MediWound Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"MediWound Ltd.\", \"role\": \"MediWound\", \"address\": \"42 Hayarkon St., 81227 Yavne Israel\"}}, {\"id\": \"party:Challenge Bioproducts Corporation Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Challenge Bioproducts Corporation Ltd.\", \"role\": \"CBC\", \"address\": \"17 Tou-Kong 12 Rd., Tou-Liu City, Yun-Lin Hsien, Taiwan, R.O.C.\"}}, {\"id\": \"party:Mark Klein\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Mark Klein\", \"role\": \"Klein\", \"address\": \"\"}}, {\"id\": \"party:Golden Life International Co., Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Golden Life International Co., Ltd.\", \"role\": \"Payee\", \"address\": \"\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Supply Agreement\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Amendment Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment Effective Date\", \"text\": \"February 28, 2010\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"a Bromelain-based pharmaceutical product derived from pineapple stems, known as Debridase\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Klein Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Klein Agreement\", \"text\": \"a License Agreement dated September 27, 2000 between MediWound and Mark Klein\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Payee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Payee\", \"text\": \"Golden Life International Co., Ltd. on CBC's behalf, for payments other than any order of Bromelain SP\", \"definition_clause\": \"Exhibit 10.6\"}}, {\"id\": \"term:Annual Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Forecast\", \"text\": \"a non-binding forecast of its anticipated annual requirements of Bromeline SP by no later than November 1 of each year\", \"definition_clause\": \"6.2\"}}, {\"id\": \"term:the BSP Components and Materials\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"the BSP Components and Materials\", \"text\": \"all Bromelain SP components and materials\", \"definition_clause\": \"6.2\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"all information received from each other during or in anticipation of this Agreement however obtained and in whatever form\", \"definition_clause\": \"6.2\"}}, {\"id\": \"value:[***] months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[***] months\"}}, {\"id\": \"value:[***] days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[***] days\"}}, {\"id\": \"value:USD[***]/kg\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"USD[***]/kg\"}}, {\"id\": \"value:[***]%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"[***]%\"}}, {\"id\": \"value:6 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"6 months\"}}, {\"id\": \"value:$[***]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$[***]\"}}, {\"id\": \"value:US Dollars [***]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"US Dollars [***]\"}}, {\"id\": \"value:48 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"48 hours\"}}, {\"id\": \"value:5 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 days\"}}, {\"id\": \"value:30 (thirty) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 (thirty) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:4 (four) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"4 (four) months\"}}, {\"id\": \"value:USD[***]/Kg\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"USD[***]/Kg\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of MTITECHNOLOGYCORP_11_16_2004-EX-10.102-Reseller Agreement Premier Addendum\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of MTITECHNOLOGYCORP_11_16_2004-EX-10.102-Reseller Agreement Premier Addendum.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.102\", \"level\": 1, \"text\": \"EXHIBIT 10.102 [McDATA LOGO] RESELLER AGREEMENT AGREEMENT NUMBER: 200-04-634-00 McDATA CORPORATION (\\\"McDATA) \\\"RESELLER\\\" MTI TECHNOLOGY CORPORATION\"}, {\"id\": \"380\", \"title\": \"INTERLOCKEN CRESCENT ADDRESS\", \"level\": 1, \"text\": \"380 INTERLOCKEN CRESCENT ADDRESS: 14661 FRANKLIN AVE BROOMFIELD, CO 80021 ADDRESS: TUSTIN, CA 92780 ADDRESS: THE EFFECTIVE DATE OF THIS RESELLER AGREEMENT SHALL BE: Sept 29, 2004 The following documents are incorporated herein by reference: Reseller Agreement Premier Addendum This Agreement, and all Addendums and attachments hereto, identified above, and Channel Notification Documents as issued by McDATA from time to time constitute the entire agreement between McDATA and Reseller with respect to the subject matter hereof, and supersedes all prior and contemporaneous oral or written representations or agreements between the parties regarding the subject matter of this Agreement. ACCEPTED AND AGREED TO BY: ACCEPTED AND AGREED TO BY: McDATA CORPORATION(McDATA) RESELLER MTI TECHNOLOGY CORPORATION SIGNED: /s/ Bruce Chumley SIGNED: /s/ Ron Umagat --------------------------- ---------------------------------- NAME: Bruce Chumley NAME: Ron Umagat TITLE: VP Channel Sales TITLE: VP of Operations DATE: 9/29/04 DATE: 9/24/04 This Reseller Agreement (the \\\"Agreement\\\") is entered into by and between McDATA and Reseller.\"}, {\"id\": \"1\", \"title\": \"SCOPE\", \"level\": 1, \"text\": \"1. SCOPE This Agreement establishes the terms and conditions under which Reseller will purchase, market, sell, license or incorporate for resale the McDATA Products and End User Customer Services in the Territory and the non-exclusive terms under which McDATA will provide the Products and End-User Customer Services (as defined below).\"}, {\"id\": \"2\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS\"}, {\"id\": \"2.1\", \"title\": \"\\\"CHANNEL NOTIFICATION DOCUMENT(S)\\\" means McDATA's standard form, incorporated herein by reference, for notifying Reselle\", \"level\": 2, \"text\": \"2.1 \\\"CHANNEL NOTIFICATION DOCUMENT(S)\\\" means McDATA's standard form, incorporated herein by reference, for notifying Resellers of price changes, new product announcements, discontinued/obsolete product announcements, engineering change notifications, product information, marketing and sales Incentive programs, and any other business matters affecting pricing, products and services.\"}, {\"id\": \"2.2\", \"title\": \"\\\"END USER CUSTOMER SERVICES\\\" means the collective reference to warranty and post warranty (maintenance) services, includ\", \"level\": 2, \"text\": \"2.2 \\\"END USER CUSTOMER SERVICES\\\" means the collective reference to warranty and post warranty (maintenance) services, including standard and enhanced warranty services, made available by McDATA and provided directly to End User Customers.\"}, {\"id\": \"2.3\", \"title\": \"\\\"PRODUCT(S)\\\" means McDATA hardware, Software, and related features, conversions, and options, as listed in the Addendum\", \"level\": 2, \"text\": \"2.3 \\\"PRODUCT(S)\\\" means McDATA hardware, Software, and related features, conversions, and options, as listed in the Addendum and further provided through Channel Notification Documents.\"}, {\"id\": \"2.4\", \"title\": \"\\\"SOFTWARE\\\" means the computer software, In machine executable object code format only, that is delivered and licensed by\", \"level\": 2, \"text\": \"2.4 \\\"SOFTWARE\\\" means the computer software, In machine executable object code format only, that is delivered and licensed by McDATA with the Product.\"}, {\"id\": \"2.5\", \"title\": \"\\\"TERRITORY\\\" means the area designated on the first page of the incorporated Addendum to this Agreement in which Reseller\", \"level\": 2, \"text\": \"2.5 \\\"TERRITORY\\\" means the area designated on the first page of the incorporated Addendum to this Agreement in which Reseller may, on a non-exclusive basis, market and sell the Products and End User Customer Services.\"}, {\"id\": \"3\", \"title\": \"APPOINTMENT/TERRITORY\", \"level\": 1, \"text\": \"3. APPOINTMENT/TERRITORY\"}, {\"id\": \"3.1\", \"title\": \"Subject to the terms and conditions of this Agreement, McDATA hereby authorizes and appoints Reseller and Reseller accep\", \"level\": 2, \"text\": \"3.1 Subject to the terms and conditions of this Agreement, McDATA hereby authorizes and appoints Reseller and Reseller accepts the appointment, as a non-exclusive reseller to purchase Products from McDATA and to market, sell, or incorporate for resale McDATA Products to End User Customers in the Territory.\"}, {\"id\": \"3.2\", \"title\": \"Reseller's authorization from McDATA to resell McDATA Products is limited to the Territory shown on the first page of th\", \"level\": 2, \"text\": \"3.2 Reseller's authorization from McDATA to resell McDATA Products is limited to the Territory shown on the first page of this Agreement. Additional sales locations must be pre-approved by McDATA. Reseller may request that additional Reseller sales locations are added to this Agreement. Upon Reseller's request, McDATA will provide Reseller with the criteria and process for applying for authorization of additional sales locations. Reseller agrees that any additional McDATA authorized sales locations will be governed by the terms and conditions of this Agreement.\"}, {\"id\": \"3.3\", \"title\": \"McDATA reserves the right to revise the list of Products and End User Services at any time during the term of this Agree\", \"level\": 2, \"text\": \"3.3 McDATA reserves the right to revise the list of Products and End User Services at any time during the term of this Agreement. McDATA will notify Reseller of such revisions through a Channel Notification Document(s).\"}, {\"id\": \"4\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"4. TERM AND TERMINATION\"}, {\"id\": \"4.1\", \"title\": \"TERMINATION WITHOUT CAUSE\", \"level\": 2, \"text\": \"4.1 TERMINATION WITHOUT CAUSE. Either party may terminate this Agreement without cause upon sixty (60) days prior written notice to the other party.\"}, {\"id\": \"4.2\", \"title\": \"TERMINATION FOR BREACH\", \"level\": 2, \"text\": \"4.2 TERMINATION FOR BREACH. In addition to any other rights or remedies that may be available at law or in equity, either party may terminate this Agreement if the other party is in material breach of this Agreement and has not cured the breach within thirty (30) days of receiving written notice specifying the breach. If the breach is not cured within the thirty (30) day period, termination will become effective on the thirty-first (31st) day following the written notice.\"}, {\"id\": \"4.3\", \"title\": \"TERMINATION FOR INSOLVENCY\", \"level\": 2, \"text\": \"4.3 TERMINATION FOR INSOLVENCY. Either party, upon written notice to the other party, may elect to immediately terminate this Agreement upon the occurrence of any of the following events: (i) a receiver is appointed for either party or its property; (ii) either party makes, or attempts to make, an assignment for the benefit of its creditors; (iii) any proceedings are commenced by or for either party under any bankruptcy, insolvency, or debtor's relief law and such proceedings are not set aside within thirty days following their filing; and/or (iv) either party liquidates or dissolves or makes a good faith attempt to liquidate or dissolve.\"}, {\"id\": \"4.4\", \"title\": \"EFFECT OF TERMINATION\", \"level\": 2, \"text\": \"4.4 EFFECT OF TERMINATION. Termination of this Agreement shall not limit either party from pursuing any other remedies available to it, Inducing injunctive relief. The termination of this Agreement simultaneously terminates all programs and incentives McDATA offered to Reseller through Channel Notification Documents and voids any unused program account balances. Upon cancellation, termination or expiration of this McDATA Corporation Standard Terms OF Reseller Agreement JUNE 2004 2 Agreement, Reseller agrees to immediately pay all monies due to McDATA under this Agreement. The parties' rights and obligations under Sections 8,9 and 10 hereof shall survive termination of this Agreement.\"}, {\"id\": \"5\", \"title\": \"RESELLER OBLIGATIONS/RESPONSIBILITIES\", \"level\": 1, \"text\": \"5. RESELLER OBLIGATIONS/RESPONSIBILITIES\"}, {\"id\": \"5.1\", \"title\": \"SALES\", \"level\": 2, \"text\": \"5.1 SALES. Reseller agrees to actively market, promote, demonstrate, sell and provide the Products and End User Customer Services only within the Territory during the term of this Agreement\"}, {\"id\": \"5.2\", \"title\": \"REPORTS\", \"level\": 2, \"text\": \"5.2 REPORTS. For warranty purposes, McDATA may require Reseller to provide McDATA with a written report containing, without limitation, the following information: End User Customer name, Reseller's authorization or location Number, End User Customer information, Product serial numbers, number of units, and level of warranty. McDATA will notify Reseller of reporting requirements, including content and format, in a Channel Notification Document.\"}, {\"id\": \"5.3\", \"title\": \"EDUCATIONAL REQUIREMENTS\", \"level\": 2, \"text\": \"5.3 EDUCATIONAL REQUIREMENTS. Reseller agrees to participate in McDATA-speciflad educational courses for purposes of training Reseller's personnel. Educational course requirements will be provided in a Channel Notification Document and must be satisfied by Reseller to maintain its status as a McDATA authorized Reseller McDATA will provide to Reseller without tuition fee, at a McDATA designated training site, the required educational courses identified on the Addendum.\"}, {\"id\": \"5.4\", \"title\": \"END USER CUSTOMER TERMS AND CONDITIONS\", \"level\": 2, \"text\": \"5.4 END USER CUSTOMER TERMS AND CONDITIONS. Reseller will ensure that the terms of its executed agreements with End User Customers am not in conflict with this Agreement\"}, {\"id\": \"5.5\", \"title\": \"POINT OF SALE (POS) REPORTS\", \"level\": 2, \"text\": \"5.5 POINT OF SALE (POS) REPORTS. Beginning on the first month after the Effective Date, in order to qualify for certain McDATA channel partner program benefits, Reseller will provide McDATA with a written monthly point of sale report (\\\"POS Report\\\") listing the Products that Reseller has sold, by model and serial number, together with the names and addresses of all End User Customers. Detailed POS requirements will be communicated through Channel Notification Documents.\"}, {\"id\": \"5.6\", \"title\": \"FINANCIAL STATEMENTS\", \"level\": 2, \"text\": \"5.6 FINANCIAL STATEMENTS. Reseller agrees to provide McDATA with its and its ultimate parent company's most recent financial statements prior to the Effective Date of the Agreement.\"}, {\"id\": \"6\", \"title\": \"McDATA OBLIGATIONS/RESPONSIBILITIES\", \"level\": 1, \"text\": \"6. McDATA OBLIGATIONS/RESPONSIBILITIES\"}, {\"id\": \"6.1\", \"title\": \"END USER CUSTOMER SERVICES\", \"level\": 2, \"text\": \"6.1 END USER CUSTOMER SERVICES McDATA will make available, for End User Customers, warranty, enhanced warranty, and post warranty services according to the terms and conditions of the applicable manufacturer's warranty and McDATA's then-current maintenance policies, McDATA, or an authorized McDATA service provider, will provide technical support and repairs during the warranty and post warranty periods to End User Customers. McDATA reserves the right to revise its technical support program. McDATA will notify Reseller of changes to McDATA's warranty and technical support and repairs policy through Channel Notification Document(s).\"}, {\"id\": \"6.2\", \"title\": \"PRODUCT DISCONTINUATION\", \"level\": 2, \"text\": \"6.2 PRODUCT DISCONTINUATION. McDATA reserves the right to discontinue Products. McDATA will notify Reseller of any Product discontinuance through Channel Notification Document(s).\"}, {\"id\": \"6.3\", \"title\": \"PRODUCT AND SERVICE ANNOUNCEMENTS\", \"level\": 2, \"text\": \"6.3 PRODUCT AND SERVICE ANNOUNCEMENTS. McDATA will notify Reseller of changes and innovations in performance, serviceability, uses and applications of Products and End User Services through Channel Notification Document(s).\"}, {\"id\": \"7\", \"title\": \"END USER CUSTOMER SOFTWARE LICENSE\", \"level\": 1, \"text\": \"7. END USER CUSTOMER SOFTWARE LICENSE Product(s) that embody or include Software will be delivered with a shrink-wrap or click-through software license which shall govern End User Customer's use of the Software. McDATA or its suppliers retain title in and to the Software and all intellectual property rights, and no title to the Software or intellectual property rights is transferred to the End User Customers. Such Software is proprietary to, trade secret of, and copyrighted by McDATA or its suppliers.\"}, {\"id\": \"8\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"8. CONFIDENTIALITY\"}, {\"id\": \"8.1\", \"title\": \"As used herein, \\\"CONFIDENTIAL INFORMATION\\\" will mean any and all technical or business information, including third part\", \"level\": 2, \"text\": \"8.1 As used herein, \\\"CONFIDENTIAL INFORMATION\\\" will mean any and all technical or business information, including third party information, furnished or disclosed, in whatever form or medium (regardless of whether tangible, Intangible, visual or oral), by one party to the other, including but not limited to information regarding patents and patent applications, trade secrets, works of authorship, software programs, software source documents, software architecture, algorithms, formulae, ideas, techniques, know-how, processes, inventions, apparatuses, equipment, models, information related to current, future and proposed products and services, research, experimental work, development, design details, specifications and engineering information, financial information, procurement, purchasing and manufacturing requirements, potential and actual customer lists, investors, employees, business and contractual relationships, business forecasts, sales and merchandising information, marketing plans; information regarding third parties; and any physical manifestations of Confidential Information (such as notes, reports, memoranda, etc.). McDATA Corporation Standard Terms of Reseller Agreement June 2004 3\"}, {\"id\": \"8.2\", \"title\": \"Information will not be deemed Confidential Information hereunder if the receiving party can demonstrate that such Infor\", \"level\": 2, \"text\": \"8.2 Information will not be deemed Confidential Information hereunder if the receiving party can demonstrate that such Information: (a) is already known to the receiving party prior to disclosure; (b) is independently developed by the receiving party without the use of the disclosing party's Confidential Information; (c) is or becomes publicly available through no fault of the receiving party; or (d) is obtained by the receiving party from a third party other than one having an obligation to the disclosing party with respect to the Confidential Information disclosed. A party may disclose Confidential Information pursuant to the requirements of a governmental agency or by operation of law, provided that such party gives the other party reasonable prior written notice sufficient to allow the other party time to contest such disclosure.\"}, {\"id\": \"8.3\", \"title\": \"Each party agrees that for a period of three (3) years following the disclosure of Confidential Information, it (a) will\", \"level\": 2, \"text\": \"8.3 Each party agrees that for a period of three (3) years following the disclosure of Confidential Information, it (a) will not use, directly or indirectly, or reproduce the Confidential Information of the other party for any purpose except in accordance with the terms of the Agreement, (b) will not disclose the Confidential Information of the other party to any third parties except as expressly permitted in this Agreement, and (c) will take all reasonable security measures to maintain the confidentiality of all Confidential Information of the other party in its possession or control, which will in no event be less than the measures it uses to maintain the confidentiality of its own information of similar importance.\"}, {\"id\": \"8.4\", \"title\": \"Upon the termination or expiration of this Agreement, or upon any request of a party, all Confidential Information, toge\", \"level\": 2, \"text\": \"8.4 Upon the termination or expiration of this Agreement, or upon any request of a party, all Confidential Information, together with any copies of same as may be authorized herein, will (at the election of the disclosing party) either be returned to the disclosing party or certified destroyed by the receiving party. Notwithstanding the termination or expiration of this Agreement, each party agrees the requirements regarding use, confidentiality and non-disclosure set forth herein will survive the termination or expiration of this Agreement for a period of three (3) years from the date of the disclosure of the Confidential Information.\"}, {\"id\": \"8.5\", \"title\": \"Each party acknowledges that its breach of this Section will cause irreparable damage and hereby agrees that the other p\", \"level\": 2, \"text\": \"8.5 Each party acknowledges that its breach of this Section will cause irreparable damage and hereby agrees that the other party shall be entitled to seek injunctive relief under this Agreement, as well as such further relief as may be granted by a court of competent jurisdiction.\"}, {\"id\": \"9\", \"title\": \"TRADEMARKS\", \"level\": 1, \"text\": \"9. TRADEMARKS. Subject to McDATA's prior written approval, McDATA grants Reseller a limited, nonexclusive, non-transferable, revocable license to use McDATA's Trademarks (defined as McDATA's name or any abbreviation thereof, its acronym, logotype or any other trademarks or trade names of McDATA) for the sole purpose of marketing and selling Products and End User Customer Services in the Territory during the term of this Agreement Reseller agrees to comply with McDATA's Logo Usage Guide, which is found at McDATA's web site, www.mcdata.com. By using McDATA's Trademarks, Reseller does not acquire any proprietary rights to such Trademarks, and Reseller agrees not to obtain or attempt to obtain, by any method, any rights, title or interest in or to any of the Trademarks. Additional provisions relating to the proper usage of the Trademarks are sat forth in Channel Notification Documents.\"}, {\"id\": \"10\", \"title\": \"LIMITATION OF LIABILITY AND DISCLAIMER OF WARRANTY\", \"level\": 1, \"text\": \"10. LIMITATION OF LIABILITY AND DISCLAIMER OF WARRANTY\"}, {\"id\": \"10.1\", \"title\": \"EXCEPT FOR A BREACH OF SECTION 8 (CONFIDENTIALITY), IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INDIRECT, PUNITIVE,\", \"level\": 2, \"text\": \"10.1 EXCEPT FOR A BREACH OF SECTION 8 (CONFIDENTIALITY), IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INDIRECT, PUNITIVE, SPECIAL, INCIDENTAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES, NOR FOR ANY DAMAGES RELATING TO LOST DATA, LOST PROFITS, ADVERTISING OR PROMOTIONAL COSTS, TERMINATION OF EMPLOYEES, SALARIES OF EMPLOYEES OR SEVERANCE PAYMENTS, CREATION OF CUSTOMER BASE, OR FUTURE EXPECTATIONS OR OTHER ECONOMIC ADVANTAGE, HOWSOEVER ARISING AND REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, WARRANTY OR TORT (INCLUDING NEGLIGENCE) OR UNDER ANY OTHER THEORY OF LIABILITY IN LAW OR IN EQUITY, EVEN IF SUCH PARTY HAS BEEN PREVIOUSLY ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.\"}, {\"id\": \"10.2\", \"title\": \"Notwithstanding any provision herein to the contrary, McDATA's entire liability in any given instance from any cause wha\", \"level\": 2, \"text\": \"10.2 Notwithstanding any provision herein to the contrary, McDATA's entire liability in any given instance from any cause whatsoever, and regardless of the form of action, whether in contract, warranty or tort (including negligence) or any other theory of liability in law or in equity, will in no event exceed the lease, of (i) the purchase price for the specific Product that is the subject matter of or is directly relative the cause of action; or (ii) Five Hundred Thousand Dollars ($500,000).\"}, {\"id\": \"10.3\", \"title\": \"The foregoing limitations will not apply (i) to claims by either party for personal injury or damage to personal propert\", \"level\": 2, \"text\": \"10.3 The foregoing limitations will not apply (i) to claims by either party for personal injury or damage to personal property, or (ii) claims by McDATA for negligent or misuse or unauthorized use by Reseller of any of McDATA's proprietary rights, including Trademarks and Software.\"}, {\"id\": \"10.4\", \"title\": \"THE WARRANTIES, IF ANY, PROVIDED IN THIS AGREEMENT (INCLUDING THE APPENDICES AND CHANNEL NOTIFICATION DOCUMENTS) OR AS P\", \"level\": 2, \"text\": \"10.4 THE WARRANTIES, IF ANY, PROVIDED IN THIS AGREEMENT (INCLUDING THE APPENDICES AND CHANNEL NOTIFICATION DOCUMENTS) OR AS PROVIDED WITH THE PRODUCTS ARE GIVEN IN LIEU OF ALL OTHER McDATA Corporation Standard Terms of Reseller Agreement June 2004 4 WARRANTIES, WHETHER EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE, ALL OF WHICH ARE HEREBY EXPRESSLY DISCLAIMED AND EXCLUDED.\"}, {\"id\": \"11\", \"title\": \"MARKETING\", \"level\": 1, \"text\": \"11. MARKETING McDATA and Reseller may publicly refer to the existence, but not the content, of this Agreement and may reference their business relationship by creating a hyper-link from one party's web site to the other party's web site. Reseller grants McDATA a license to use Reseller's trademarks and corporate logos solely for such marketing and reference purposes. Copies of each party's logo and authorized trademark(s) can be obtained from their respective marketing departments and may not be altered or changed by either party, its employees or agents, without prior written permission from an authorized representative of the other.\"}, {\"id\": \"12\", \"title\": \"GENERAL\", \"level\": 1, \"text\": \"12. GENERAL\"}, {\"id\": \"12.1\", \"title\": \"NO AMENDMENT OR WAIVER\", \"level\": 2, \"text\": \"12.1 NO AMENDMENT OR WAIVER. No provision of this Agreement will be deemed waived, amended or modified by either party, unless such waiver, amendment or modification is made in writing and signed by authorized representatives of both parties. No waiver of rights under this Agreement by either party shall constitute a subsequent waiver of&sbsp;such rights or any other rights under this Agreement. Notwithstanding the foregoing, the parties agree to the use of Channel Notification Documents as set forth in this Agreement.\"}, {\"id\": \"12.2\", \"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"12.2 SEVERABILITY. If any provision of this Agreement is held to be invalid or unenforceable by a proper authority having jurisdiction over this Agreement, the remaining provisions of this Agreement will remain in full force and effect.\"}, {\"id\": \"12.3\", \"title\": \"NO AGENCY CREATED\", \"level\": 2, \"text\": \"12.3 NO AGENCY CREATED. Nothing in this Agreement shall be construed to create a partnership, joint venture, or agency relationship between the parties. Neither party is granted the tight or authority to assume or create any obligation or responsibility, express or implied, on behalf of, or in the name of the other party, or to bind such other party in any manner to anything whatsoever.\"}, {\"id\": \"12.4\", \"title\": \"NO THIRD PARTY BENEFICIARIES\", \"level\": 2, \"text\": \"12.4 NO THIRD PARTY BENEFICIARIES. The parties agree that there shall be no third party beneficiaries to this Agreement, including but not limited to Reseller's End User Customers.\"}, {\"id\": \"12.5\", \"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"12.5 ASSIGNMENT. Neither party will assign this Agreement or any rights hereunder without the prior written consent of the other party, which consent will not be unreasonably withheld. Notwithstanding the foregoing sentence, McDATA may assign this Agreement to any entity controlled by, controlling, or under common control with McDATA or to any successor by merger, divestiture, consolidation or reorganization, or to any purchasers of all or substantially all of the assets of the business of McDATA without consent of Reseller.\"}, {\"id\": \"12.6\", \"title\": \"GOVERNING LAWS\", \"level\": 2, \"text\": \"12.6 GOVERNING LAWS. This Agreement shall be governed by and construed in accordance with the laws of the State of Colorado excluding its choice of law provisions. The United Nations Convention on Contracts for the International Sale of Goods (CISG) is specifically excluded and shall not be applicable to any transaction contemplated herein.\"}, {\"id\": \"12.7\", \"title\": \"DISPUTE RESOLUTION PROCESS\", \"level\": 2, \"text\": \"12.7 DISPUTE RESOLUTION PROCESS. In case of any dispute between the parties relating to this Agreement, such dispute shall be finally resolved in Denver, Colorado (USA) by arbitration under the Commercial Rules of Arbitration of the American Arbitration Association, using three arbitrators, one selected by each of McDATA and Reseller and the third selected in accordance with such Rules. The arbitrators will decide the issues presented to them applying the substantive laws of the Sate of Colorado (USA). The award of the arbitrators may be granted notwithstanding the absence of any party and such award shall be in writing and shall be final and binding upon the parties and shall not be appealed from or contested in any court or tribunal. Any award rendered hereunder may be entered for enforcement, if necessary, in any court of competent jurisdiction.\"}, {\"id\": \"12.8\", \"title\": \"INJUNCTIVE RELIEF\", \"level\": 2, \"text\": \"12.8 INJUNCTIVE RELIEF. Notwithstanding the above provisions relating to arbitration, the parties agree that in respect of any violation of any provision of this Agreement, including without limitation violation of any proprietary or confidential information, for which an award of damages is an inadequate remedy to project the injured party, the injured party is entitled to seek injunctive relief, including a preliminary injunction, in a court of competent jurisdiction, in addition to any other relief available to it under the arbitration procedures specified above in Section 12.7.\"}, {\"id\": \"12.9\", \"title\": \"OFFICIAL LANGUAGE\", \"level\": 2, \"text\": \"12.9 OFFICIAL LANGUAGE. The official language of this Agreement and all transactions conducted under this Agreement is English.\"}, {\"id\": \"12.10\", \"title\": \"FORCE MAJEURE\", \"level\": 2, \"text\": \"12.10 FORCE MAJEURE. Neither party will be liable for any failure or delay in its performance under this Agreement due to any cause beyond its reasonable control, including but not limited to acts of God, war, riot, embargoes, acts of civil or military authorities, fire, floods, accidents, strikes, delays by suppliers or shortages of transportation, facilities, fuel, energy, labor, or materials. McDATA Corporation Standard Terms of Reseller Agreement June 2004 5\"}, {\"id\": \"12.11\", \"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"12.11 COMPLIANCE WITH LAWS. McDATA and Reseller each agree to comply with all applicable laws and each understand and agree that the continuing rights and obligations of the parties hereunder are specifically conditioned upon compliance with such laws. These laws include, without limitation, the following: (i) the U.S. anti-boycott regulations, (ii) the U.S. Foreign Corrupt Practices Act (\\\"FCPA\\\"), (iii) the export control laws of the United States of America, (iv) the prevailing regulations which may be issued from time to time by the U.S. Department of Commerce and the Office of Munitions Control and the U.S. Department of State, and (v) any export or import laws of the agencies of the Territory or of any countries into or through which the Products purchased under this Agreement may be transported.\"}, {\"id\": \"12.12\", \"title\": \"NOTICES\", \"level\": 2, \"text\": \"12.12 NOTICES. Notices required hereunder will be in writing and will be deemed given when transmitted by facsimile (provided such facsimile is subsequently confirmed in writing within five (5) days of the facsimile date) or deposited with an express delivery service with guaranteed third-day delivery, prepaid, addressed as follows: NOTICES TO: McDATA CORPORATION: McDATA Corporation 380 Interlocken Crescent Broomfield, CO 80021 Attn: VP of Sales With a copy to: VP and General Counsel Fax:720-558-3235 NOTICES TO: RESELLER MTI Technology Corp 14661 Franklin Ave Tustin,CA 92780 Attn: CFO Fax : 714-481-4136\"}, {\"id\": \"12.13\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 2, \"text\": \"12.13 ENTIRE AGREEMENT. This Agreement, together with any and all attachments hereto and applicable Appendices, Addendums and Channel Notification Documents as issued from time to time by McDATA constitutes the entire agreement between McDATA and Reseller with respect to the subject matter hereof, and supersedes all prior and contemporaneous oral or written representations or agreements between the parties regarding the subject matter of this Agreement.\"}, {\"id\": \"12.14\", \"title\": \"COUNTERPARTS\", \"level\": 2, \"text\": \"12.14 COUNTERPARTS. This Agreement may be executed in counterparts or by facsimile, each of which shall be an original, and all of which together shall constitute one and the same instrument.\"}, {\"id\": \"12.15\", \"title\": \"NUCLEAR, AVIATION OR LIFE SUPPORT APPLICATION\", \"level\": 2, \"text\": \"12.15 NUCLEAR, AVIATION OR LIFE SUPPORT APPLICATION. McDATA specifically disclaims liability for use of McDATA Software in connection with the design, construction, maintenance, and/or operation of any (i) nuclear facility, (ii) aircraft, aircraft communication or aircraft ground support system, or (iii) life support system by Reseller or its End User Customers. Such use is entirely at the user's risk. McDATA shall not be liable to Reseller or its End User Customers, in whole or in part, for any claims arising out of such use. Reseller agrees to defend, indemnify, and hold McDATA harmless from and against any and all claims arising out of use of the Software in such applications by Reseller or its End User Customers. McDATA Corporation Standard Terms of Reseller Agreement June 2004 6 PREMIER RESELLER ADDENDUM RESELLER AGREEMENT This addendum applies to a Reseller that will purchase, market, sell license or incorporate Product to any commercial non-United States government entity, instrumentality or agency. TERRITORY: NORTH AMERICA\"}, {\"id\": \"1\", \"title\": \"SCOPE\", \"level\": 1, \"text\": \"1. SCOPE\"}, {\"id\": \"1.1\", \"title\": \"Sales to the US Government are not authorized under this Agreement\", \"level\": 2, \"text\": \"1.1 Sales to the US Government are not authorized under this Agreement.\"}, {\"id\": \"1.2\", \"title\": \"Reseller is authorized to procure McDATA Products and End User Customer Services through the source defined in Paragraph\", \"level\": 2, \"text\": \"1.2 Reseller is authorized to procure McDATA Products and End User Customer Services through the source defined in Paragraph 2.3, \\\"Product Provider.\\\" Reseller procurement of Product and End User Customer Services from sources other than the Product Provider is a material breach of this Agreement and may result in termination of this Agreement. In the event Reseller procures Product or End User Customer Services from sources other than its Product Provider, such procurements will not be included in any McDATA marketing and promotional programs made available to Reseller by McDATA. McDATA, at its sole discretion, may change this policy through a Channel Notification Document.\"}, {\"id\": \"2\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS\"}, {\"id\": \"2.1\", \"title\": \"\\\"DISTRIBUTOR\\\" means a business entity which is authorized by McDATA through a fully executed distributor agreement to ma\", \"level\": 2, \"text\": \"2.1 \\\"DISTRIBUTOR\\\" means a business entity which is authorized by McDATA through a fully executed distributor agreement to market and sell, or incorporate for resale, the McDATA Products and End User Customer Services to McDATA authorized Resellers in its Territory.\"}, {\"id\": \"2.2\", \"title\": \"\\\"END USER CUSTOMER\\\" means any entity which, for its own use and not for resale, (i) purchase McDATA-manufactured Product\", \"level\": 2, \"text\": \"2.2 \\\"END USER CUSTOMER\\\" means any entity which, for its own use and not for resale, (i) purchase McDATA-manufactured Products; and/or (ii) licenses Software associated therewith from McDATA; and/or (iii) receives End User Customer Services from McDATA.\"}, {\"id\": \"2.3\", \"title\": \"\\\"PRODUCT PROVIDER\\\" means either a McDATA-authorized OEM and/or Distributor who provides Product(s) to the Reseller, as s\", \"level\": 2, \"text\": \"2.3 \\\"PRODUCT PROVIDER\\\" means either a McDATA-authorized OEM and/or Distributor who provides Product(s) to the Reseller, as set forth in Appendix 1.\"}, {\"id\": \"2.4\", \"title\": \"\\\"RESELLER\\\" means a business entity which is authorized by McDATA through a fully executed Reseller Agreement to (i) mark\", \"level\": 2, \"text\": \"2.4 \\\"RESELLER\\\" means a business entity which is authorized by McDATA through a fully executed Reseller Agreement to (i) market and resell Products; (ii) purchase McDATA-manufactured Products from a Product Provider, without the intention of purchasing such Products for its own use; and/or (iii) resell End User Customer Services from McDATA.\"}, {\"id\": \"3\", \"title\": \"TERM\", \"level\": 1, \"text\": \"3. TERM The initial term of this Agreement shall be for a period of one (1) year from the Effective Date unless sooner terminated pursuant to the termination provisions herein. Thereafter, this Agreement automatically renews for successive terms of one (1) year.\"}, {\"id\": \"4\", \"title\": \"RESELLER OBLIGATIONS/RESPONSIBILITIES\", \"level\": 1, \"text\": \"4. RESELLER OBLIGATIONS/RESPONSIBILITIES For enhanced warranty and post warranty services, Reseller shall refer to McDATA's Product Offerings on its website. McDATA will notify Reseller of changes to the Product Offerings through its Channel Notification Documents.\"}, {\"id\": \"5\", \"title\": \"END USER CUSTOMER SOFTWARE LICENSE\", \"level\": 1, \"text\": \"5. END USER CUSTOMER SOFTWARE LICENSE Product(s) that embody or include Software will be delivered with a shrink-wrap or click-through software license which shall govern End User Customer's use of the Software. Such Software is proprietary to, trade secret of, and copyrighted by McDATA or its suppliers. McDATA or its suppliers retain title in and to the Software and all intellectual property rights, and no title to the Software or intellectual property rights is transferred to the End User Customers.\"}, {\"id\": \"6\", \"title\": \"MARKETING\", \"level\": 1, \"text\": \"6. MARKETING Reseller agrees not to publish or advertise any price below Manufacturer's Suggested List Price on its web site or by means of any online communications or any other mass communications, including without limitation, catalogues, fax blasts, direct mail pieces, or e-mail blasts.\"}, {\"id\": \"7\", \"title\": \"GOVERNMENT FLOWDOWN PROVISIONS\", \"level\": 1, \"text\": \"7. GOVERNMENT FLOWDOWN PROVISIONS. Reseller agrees that flowdown provisions, including, but not limited to United States Government Federal Acquisition Regulations (\\\"FARs\\\"), Defense FARs or NASA FARs, shall not apply to McDATA and McDATA does not accept such provisions notwithstanding the existence of such provisions. In addition, McDATA is not responsible for fulfilling any contract obligations under any schedule contracts including those obligations under the United States Government General Service Administration (\\\"GSA\\\") contract and the California Multiple Award Schedule (\\\"CMAS\\\") contract. McDATA Corporation Standard Terms of Reseller Agreement June 2004 7 APPENDIX I RESELLER AGREEMENT PREMIER PARTNER PRODUCTS, PRODUCT PROVIDER AND REVENUE TARGETS PRODUCTS: Reseller is eligible to sell the McDATA Products listed below. McDATA will provide Product information including pricing, availability, features, accessories, services and support in the Channel Notification Documents. McDATA will update the Product listing from time-to-time through the Channel Notification Documents. - Fibre Channel Directors - Switches - Software - Fabricenter(TM) Cabinet\"}, {\"id\": \"004\", \"title\": \"ANNUALIZED REVENUE TARGET\", \"level\": 1, \"text\": \"004 ANNUALIZED REVENUE TARGET: $500,000 The 2004 Annualized Revenue Target to qualify as a Premier Reseller is $500,000. Reseller is eligible for Premier Reseller program benefits and responsible for the obligations as defined in the Channel Notification Documents. INITIAL EDUCATION REQUIREMENTS: Reseller must successfully complete both Sales and Technical Foundation training, for each McDATA authorized sales location, as follows, within ninety (90) days of the effective date of this Agreement. Sales: All Sales Reps/sales location McDATA Solution (web-based) Technical: 3 individuals Certified Professional Accelerated Track (CPAT) McDATA will waive the charges associated with the above listed required technical courses for three (3) individuals at Reseller's organization. McDATA may, at its sole discretion, provide additional education incentives to Reseller based upon sales performance. These incentives, if made available, will be communicated via Channel Notification Documents. McDATA Corporation Reseller Agreement Premier Partner Addendum June 2004 8 PRODUCT PROVIDER: Reseller will purchase Products directly from one of the Distributors listed on the next page below. Terms and conditions for purchase of Products from the Distributor are as agreed between Distributor and Reseller. Reseller may elect a new distributor annually by notifying McDATA thirty (30) days prior to renewal of the Agreement. If McDATA does not receive notice of a new distributor election and the Agreement is renewed, Reseller agrees that it will continue to purchase Products through the currently designated distributor. Under limited circumstances as approved by McDATA in writing, Reseller may purchase from another Product Provider as directed by McDATA. This may include a) critical customer need where Product is not available from Product Provider in the time frame required by End User, but available through another Authorized McDATA Product Provider or b) repeated, documented dissatisfaction with specified Product Provider during the term of the Agreement. PLEASE INDICATE WHICH ONE OF THE FOLLOWING DISTRIBUTORS YOU CHOOSE TO BUY FROM FOR THE FIRST YEAR OF YOUR AGREEMENT WITH McDATA: [ ] AVNET East Coast Sates - Elsa Neves Phone: 877-286-3879 X5815 Fax: 480-794-9324 Email: elsa.neves@avnet.com West Coast Sates - Jan Johnson Phone: 877-967-3664 Fax: 480-794-9324 Email: jan.johnson@avnet.com [ ] ARROW ESS Cindie Snell Phone: 303-824-3651 Fax: 303-824.3646 Email: csnell@arrow.com [ ] BELL MICROPRODUCTS,INC Lyle Freemen Phone: 952-345-7942 1941 Ringwood Ave Email: lfreerman@bellmicro.com San Jose, California 95131 -1721 [ ] MOCA Adrienne Hargrove Phone: 1 -800-786-3425 5230 Pacific Concourse Dr, 4th Flr, Fax: Los Angeles, CA 80045 Email: [X] TIDAL WIRE Cherie Vallone Phone: 781-332-1104 Email: cvallone@tidalwire.com McDATA reserves the right to change the Premier Partner criteria each January or upon sixty (60) days advanced notice through a Channel Notification Document. If Reseller fails to comply with any of the above requirements, McDATA reserves the right to change the Reseller Designation and Reseller will become eligible for only those programs applicable to the new Reseller Designation. McDATA Corporation Reseller Agreement Premier Partner Addendum June 2004 9\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of MTITECHNOLOGYCORP_11_16_2004-EX-10.102-Reseller Agreement Premier Addendum\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.102\", \"level\": 1, \"text\": \"EXHIBIT 10.102 [McDATA LOGO] RESELLER AGREEMENT AGREEMENT NUMBER: 200-04-634-00 McDATA CORPORATION (\\\"McDATA) \\\"RESELLER\\\" MTI TECHNOLOGY CORPORATION\"}}, {\"id\": \"380\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTERLOCKEN CRESCENT ADDRESS\", \"level\": 1, \"text\": \"380 INTERLOCKEN CRESCENT ADDRESS: 14661 FRANKLIN AVE BROOMFIELD, CO 80021 ADDRESS: TUSTIN, CA 92780 ADDRESS: THE EFFECTIVE DATE OF THIS RESELLER AGREEMENT SHALL BE: Sept 29, 2004 The following documents are incorporated herein by reference: Reseller Agreement Premier Addendum This Agreement, and all Addendums and attachments hereto, identified above, and Channel Notification Documents as issued by McDATA from time to time constitute the entire agreement between McDATA and Reseller with respect to the subject matter hereof, and supersedes all prior and contemporaneous oral or written representations or agreements between the parties regarding the subject matter of this Agreement. ACCEPTED AND AGREED TO BY: ACCEPTED AND AGREED TO BY: McDATA CORPORATION(McDATA) RESELLER MTI TECHNOLOGY CORPORATION SIGNED: /s/ Bruce Chumley SIGNED: /s/ Ron Umagat --------------------------- ---------------------------------- NAME: Bruce Chumley NAME: Ron Umagat TITLE: VP Channel Sales TITLE: VP of Operations DATE: 9/29/04 DATE: 9/24/04 This Reseller Agreement (the \\\"Agreement\\\") is entered into by and between McDATA and Reseller.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SCOPE\", \"level\": 1, \"text\": \"1. SCOPE This Agreement establishes the terms and conditions under which Reseller will purchase, market, sell, license or incorporate for resale the McDATA Products and End User Customer Services in the Territory and the non-exclusive terms under which McDATA will provide the Products and End-User Customer Services (as defined below).\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"CHANNEL NOTIFICATION DOCUMENT(S)\\\" means McDATA's standard form, incorporated herein by reference, for notifying Reselle\", \"level\": 2, \"text\": \"2.1 \\\"CHANNEL NOTIFICATION DOCUMENT(S)\\\" means McDATA's standard form, incorporated herein by reference, for notifying Resellers of price changes, new product announcements, discontinued/obsolete product announcements, engineering change notifications, product information, marketing and sales Incentive programs, and any other business matters affecting pricing, products and services.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"END USER CUSTOMER SERVICES\\\" means the collective reference to warranty and post warranty (maintenance) services, includ\", \"level\": 2, \"text\": \"2.2 \\\"END USER CUSTOMER SERVICES\\\" means the collective reference to warranty and post warranty (maintenance) services, including standard and enhanced warranty services, made available by McDATA and provided directly to End User Customers.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PRODUCT(S)\\\" means McDATA hardware, Software, and related features, conversions, and options, as listed in the Addendum\", \"level\": 2, \"text\": \"2.3 \\\"PRODUCT(S)\\\" means McDATA hardware, Software, and related features, conversions, and options, as listed in the Addendum and further provided through Channel Notification Documents.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"SOFTWARE\\\" means the computer software, In machine executable object code format only, that is delivered and licensed by\", \"level\": 2, \"text\": \"2.4 \\\"SOFTWARE\\\" means the computer software, In machine executable object code format only, that is delivered and licensed by McDATA with the Product.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"TERRITORY\\\" means the area designated on the first page of the incorporated Addendum to this Agreement in which Reseller\", \"level\": 2, \"text\": \"2.5 \\\"TERRITORY\\\" means the area designated on the first page of the incorporated Addendum to this Agreement in which Reseller may, on a non-exclusive basis, market and sell the Products and End User Customer Services.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT/TERRITORY\", \"level\": 1, \"text\": \"3. APPOINTMENT/TERRITORY\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to the terms and conditions of this Agreement, McDATA hereby authorizes and appoints Reseller and Reseller accep\", \"level\": 2, \"text\": \"3.1 Subject to the terms and conditions of this Agreement, McDATA hereby authorizes and appoints Reseller and Reseller accepts the appointment, as a non-exclusive reseller to purchase Products from McDATA and to market, sell, or incorporate for resale McDATA Products to End User Customers in the Territory.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller's authorization from McDATA to resell McDATA Products is limited to the Territory shown on the first page of th\", \"level\": 2, \"text\": \"3.2 Reseller's authorization from McDATA to resell McDATA Products is limited to the Territory shown on the first page of this Agreement. Additional sales locations must be pre-approved by McDATA. Reseller may request that additional Reseller sales locations are added to this Agreement. Upon Reseller's request, McDATA will provide Reseller with the criteria and process for applying for authorization of additional sales locations. Reseller agrees that any additional McDATA authorized sales locations will be governed by the terms and conditions of this Agreement.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"McDATA reserves the right to revise the list of Products and End User Services at any time during the term of this Agree\", \"level\": 2, \"text\": \"3.3 McDATA reserves the right to revise the list of Products and End User Services at any time during the term of this Agreement. McDATA will notify Reseller of such revisions through a Channel Notification Document(s).\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"4. TERM AND TERMINATION\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION WITHOUT CAUSE\", \"level\": 2, \"text\": \"4.1 TERMINATION WITHOUT CAUSE. Either party may terminate this Agreement without cause upon sixty (60) days prior written notice to the other party.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION FOR BREACH\", \"level\": 2, \"text\": \"4.2 TERMINATION FOR BREACH. In addition to any other rights or remedies that may be available at law or in equity, either party may terminate this Agreement if the other party is in material breach of this Agreement and has not cured the breach within thirty (30) days of receiving written notice specifying the breach. If the breach is not cured within the thirty (30) day period, termination will become effective on the thirty-first (31st) day following the written notice.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION FOR INSOLVENCY\", \"level\": 2, \"text\": \"4.3 TERMINATION FOR INSOLVENCY. Either party, upon written notice to the other party, may elect to immediately terminate this Agreement upon the occurrence of any of the following events: (i) a receiver is appointed for either party or its property; (ii) either party makes, or attempts to make, an assignment for the benefit of its creditors; (iii) any proceedings are commenced by or for either party under any bankruptcy, insolvency, or debtor's relief law and such proceedings are not set aside within thirty days following their filing; and/or (iv) either party liquidates or dissolves or makes a good faith attempt to liquidate or dissolve.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECT OF TERMINATION\", \"level\": 2, \"text\": \"4.4 EFFECT OF TERMINATION. Termination of this Agreement shall not limit either party from pursuing any other remedies available to it, Inducing injunctive relief. The termination of this Agreement simultaneously terminates all programs and incentives McDATA offered to Reseller through Channel Notification Documents and voids any unused program account balances. Upon cancellation, termination or expiration of this McDATA Corporation Standard Terms OF Reseller Agreement JUNE 2004 2 Agreement, Reseller agrees to immediately pay all monies due to McDATA under this Agreement. The parties' rights and obligations under Sections 8,9 and 10 hereof shall survive termination of this Agreement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER OBLIGATIONS/RESPONSIBILITIES\", \"level\": 1, \"text\": \"5. RESELLER OBLIGATIONS/RESPONSIBILITIES\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SALES\", \"level\": 2, \"text\": \"5.1 SALES. Reseller agrees to actively market, promote, demonstrate, sell and provide the Products and End User Customer Services only within the Territory during the term of this Agreement\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPORTS\", \"level\": 2, \"text\": \"5.2 REPORTS. For warranty purposes, McDATA may require Reseller to provide McDATA with a written report containing, without limitation, the following information: End User Customer name, Reseller's authorization or location Number, End User Customer information, Product serial numbers, number of units, and level of warranty. McDATA will notify Reseller of reporting requirements, including content and format, in a Channel Notification Document.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EDUCATIONAL REQUIREMENTS\", \"level\": 2, \"text\": \"5.3 EDUCATIONAL REQUIREMENTS. Reseller agrees to participate in McDATA-speciflad educational courses for purposes of training Reseller's personnel. Educational course requirements will be provided in a Channel Notification Document and must be satisfied by Reseller to maintain its status as a McDATA authorized Reseller McDATA will provide to Reseller without tuition fee, at a McDATA designated training site, the required educational courses identified on the Addendum.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"END USER CUSTOMER TERMS AND CONDITIONS\", \"level\": 2, \"text\": \"5.4 END USER CUSTOMER TERMS AND CONDITIONS. Reseller will ensure that the terms of its executed agreements with End User Customers am not in conflict with this Agreement\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"POINT OF SALE (POS) REPORTS\", \"level\": 2, \"text\": \"5.5 POINT OF SALE (POS) REPORTS. Beginning on the first month after the Effective Date, in order to qualify for certain McDATA channel partner program benefits, Reseller will provide McDATA with a written monthly point of sale report (\\\"POS Report\\\") listing the Products that Reseller has sold, by model and serial number, together with the names and addresses of all End User Customers. Detailed POS requirements will be communicated through Channel Notification Documents.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FINANCIAL STATEMENTS\", \"level\": 2, \"text\": \"5.6 FINANCIAL STATEMENTS. Reseller agrees to provide McDATA with its and its ultimate parent company's most recent financial statements prior to the Effective Date of the Agreement.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"McDATA OBLIGATIONS/RESPONSIBILITIES\", \"level\": 1, \"text\": \"6. McDATA OBLIGATIONS/RESPONSIBILITIES\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"END USER CUSTOMER SERVICES\", \"level\": 2, \"text\": \"6.1 END USER CUSTOMER SERVICES McDATA will make available, for End User Customers, warranty, enhanced warranty, and post warranty services according to the terms and conditions of the applicable manufacturer's warranty and McDATA's then-current maintenance policies, McDATA, or an authorized McDATA service provider, will provide technical support and repairs during the warranty and post warranty periods to End User Customers. McDATA reserves the right to revise its technical support program. McDATA will notify Reseller of changes to McDATA's warranty and technical support and repairs policy through Channel Notification Document(s).\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT DISCONTINUATION\", \"level\": 2, \"text\": \"6.2 PRODUCT DISCONTINUATION. McDATA reserves the right to discontinue Products. McDATA will notify Reseller of any Product discontinuance through Channel Notification Document(s).\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT AND SERVICE ANNOUNCEMENTS\", \"level\": 2, \"text\": \"6.3 PRODUCT AND SERVICE ANNOUNCEMENTS. McDATA will notify Reseller of changes and innovations in performance, serviceability, uses and applications of Products and End User Services through Channel Notification Document(s).\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"END USER CUSTOMER SOFTWARE LICENSE\", \"level\": 1, \"text\": \"7. END USER CUSTOMER SOFTWARE LICENSE Product(s) that embody or include Software will be delivered with a shrink-wrap or click-through software license which shall govern End User Customer's use of the Software. McDATA or its suppliers retain title in and to the Software and all intellectual property rights, and no title to the Software or intellectual property rights is transferred to the End User Customers. Such Software is proprietary to, trade secret of, and copyrighted by McDATA or its suppliers.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"8. CONFIDENTIALITY\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As used herein, \\\"CONFIDENTIAL INFORMATION\\\" will mean any and all technical or business information, including third part\", \"level\": 2, \"text\": \"8.1 As used herein, \\\"CONFIDENTIAL INFORMATION\\\" will mean any and all technical or business information, including third party information, furnished or disclosed, in whatever form or medium (regardless of whether tangible, Intangible, visual or oral), by one party to the other, including but not limited to information regarding patents and patent applications, trade secrets, works of authorship, software programs, software source documents, software architecture, algorithms, formulae, ideas, techniques, know-how, processes, inventions, apparatuses, equipment, models, information related to current, future and proposed products and services, research, experimental work, development, design details, specifications and engineering information, financial information, procurement, purchasing and manufacturing requirements, potential and actual customer lists, investors, employees, business and contractual relationships, business forecasts, sales and merchandising information, marketing plans; information regarding third parties; and any physical manifestations of Confidential Information (such as notes, reports, memoranda, etc.). McDATA Corporation Standard Terms of Reseller Agreement June 2004 3\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Information will not be deemed Confidential Information hereunder if the receiving party can demonstrate that such Infor\", \"level\": 2, \"text\": \"8.2 Information will not be deemed Confidential Information hereunder if the receiving party can demonstrate that such Information: (a) is already known to the receiving party prior to disclosure; (b) is independently developed by the receiving party without the use of the disclosing party's Confidential Information; (c) is or becomes publicly available through no fault of the receiving party; or (d) is obtained by the receiving party from a third party other than one having an obligation to the disclosing party with respect to the Confidential Information disclosed. A party may disclose Confidential Information pursuant to the requirements of a governmental agency or by operation of law, provided that such party gives the other party reasonable prior written notice sufficient to allow the other party time to contest such disclosure.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party agrees that for a period of three (3) years following the disclosure of Confidential Information, it (a) will\", \"level\": 2, \"text\": \"8.3 Each party agrees that for a period of three (3) years following the disclosure of Confidential Information, it (a) will not use, directly or indirectly, or reproduce the Confidential Information of the other party for any purpose except in accordance with the terms of the Agreement, (b) will not disclose the Confidential Information of the other party to any third parties except as expressly permitted in this Agreement, and (c) will take all reasonable security measures to maintain the confidentiality of all Confidential Information of the other party in its possession or control, which will in no event be less than the measures it uses to maintain the confidentiality of its own information of similar importance.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon the termination or expiration of this Agreement, or upon any request of a party, all Confidential Information, toge\", \"level\": 2, \"text\": \"8.4 Upon the termination or expiration of this Agreement, or upon any request of a party, all Confidential Information, together with any copies of same as may be authorized herein, will (at the election of the disclosing party) either be returned to the disclosing party or certified destroyed by the receiving party. Notwithstanding the termination or expiration of this Agreement, each party agrees the requirements regarding use, confidentiality and non-disclosure set forth herein will survive the termination or expiration of this Agreement for a period of three (3) years from the date of the disclosure of the Confidential Information.\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party acknowledges that its breach of this Section will cause irreparable damage and hereby agrees that the other p\", \"level\": 2, \"text\": \"8.5 Each party acknowledges that its breach of this Section will cause irreparable damage and hereby agrees that the other party shall be entitled to seek injunctive relief under this Agreement, as well as such further relief as may be granted by a court of competent jurisdiction.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS\", \"level\": 1, \"text\": \"9. TRADEMARKS. Subject to McDATA's prior written approval, McDATA grants Reseller a limited, nonexclusive, non-transferable, revocable license to use McDATA's Trademarks (defined as McDATA's name or any abbreviation thereof, its acronym, logotype or any other trademarks or trade names of McDATA) for the sole purpose of marketing and selling Products and End User Customer Services in the Territory during the term of this Agreement Reseller agrees to comply with McDATA's Logo Usage Guide, which is found at McDATA's web site, www.mcdata.com. By using McDATA's Trademarks, Reseller does not acquire any proprietary rights to such Trademarks, and Reseller agrees not to obtain or attempt to obtain, by any method, any rights, title or interest in or to any of the Trademarks. Additional provisions relating to the proper usage of the Trademarks are sat forth in Channel Notification Documents.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY AND DISCLAIMER OF WARRANTY\", \"level\": 1, \"text\": \"10. LIMITATION OF LIABILITY AND DISCLAIMER OF WARRANTY\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCEPT FOR A BREACH OF SECTION 8 (CONFIDENTIALITY), IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INDIRECT, PUNITIVE,\", \"level\": 2, \"text\": \"10.1 EXCEPT FOR A BREACH OF SECTION 8 (CONFIDENTIALITY), IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INDIRECT, PUNITIVE, SPECIAL, INCIDENTAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES, NOR FOR ANY DAMAGES RELATING TO LOST DATA, LOST PROFITS, ADVERTISING OR PROMOTIONAL COSTS, TERMINATION OF EMPLOYEES, SALARIES OF EMPLOYEES OR SEVERANCE PAYMENTS, CREATION OF CUSTOMER BASE, OR FUTURE EXPECTATIONS OR OTHER ECONOMIC ADVANTAGE, HOWSOEVER ARISING AND REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, WARRANTY OR TORT (INCLUDING NEGLIGENCE) OR UNDER ANY OTHER THEORY OF LIABILITY IN LAW OR IN EQUITY, EVEN IF SUCH PARTY HAS BEEN PREVIOUSLY ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding any provision herein to the contrary, McDATA's entire liability in any given instance from any cause wha\", \"level\": 2, \"text\": \"10.2 Notwithstanding any provision herein to the contrary, McDATA's entire liability in any given instance from any cause whatsoever, and regardless of the form of action, whether in contract, warranty or tort (including negligence) or any other theory of liability in law or in equity, will in no event exceed the lease, of (i) the purchase price for the specific Product that is the subject matter of or is directly relative the cause of action; or (ii) Five Hundred Thousand Dollars ($500,000).\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The foregoing limitations will not apply (i) to claims by either party for personal injury or damage to personal propert\", \"level\": 2, \"text\": \"10.3 The foregoing limitations will not apply (i) to claims by either party for personal injury or damage to personal property, or (ii) claims by McDATA for negligent or misuse or unauthorized use by Reseller of any of McDATA's proprietary rights, including Trademarks and Software.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE WARRANTIES, IF ANY, PROVIDED IN THIS AGREEMENT (INCLUDING THE APPENDICES AND CHANNEL NOTIFICATION DOCUMENTS) OR AS P\", \"level\": 2, \"text\": \"10.4 THE WARRANTIES, IF ANY, PROVIDED IN THIS AGREEMENT (INCLUDING THE APPENDICES AND CHANNEL NOTIFICATION DOCUMENTS) OR AS PROVIDED WITH THE PRODUCTS ARE GIVEN IN LIEU OF ALL OTHER McDATA Corporation Standard Terms of Reseller Agreement June 2004 4 WARRANTIES, WHETHER EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE, ALL OF WHICH ARE HEREBY EXPRESSLY DISCLAIMED AND EXCLUDED.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING\", \"level\": 1, \"text\": \"11. MARKETING McDATA and Reseller may publicly refer to the existence, but not the content, of this Agreement and may reference their business relationship by creating a hyper-link from one party's web site to the other party's web site. Reseller grants McDATA a license to use Reseller's trademarks and corporate logos solely for such marketing and reference purposes. Copies of each party's logo and authorized trademark(s) can be obtained from their respective marketing departments and may not be altered or changed by either party, its employees or agents, without prior written permission from an authorized representative of the other.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 1, \"text\": \"12. GENERAL\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO AMENDMENT OR WAIVER\", \"level\": 2, \"text\": \"12.1 NO AMENDMENT OR WAIVER. No provision of this Agreement will be deemed waived, amended or modified by either party, unless such waiver, amendment or modification is made in writing and signed by authorized representatives of both parties. No waiver of rights under this Agreement by either party shall constitute a subsequent waiver of&sbsp;such rights or any other rights under this Agreement. Notwithstanding the foregoing, the parties agree to the use of Channel Notification Documents as set forth in this Agreement.\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"12.2 SEVERABILITY. If any provision of this Agreement is held to be invalid or unenforceable by a proper authority having jurisdiction over this Agreement, the remaining provisions of this Agreement will remain in full force and effect.\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO AGENCY CREATED\", \"level\": 2, \"text\": \"12.3 NO AGENCY CREATED. Nothing in this Agreement shall be construed to create a partnership, joint venture, or agency relationship between the parties. Neither party is granted the tight or authority to assume or create any obligation or responsibility, express or implied, on behalf of, or in the name of the other party, or to bind such other party in any manner to anything whatsoever.\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO THIRD PARTY BENEFICIARIES\", \"level\": 2, \"text\": \"12.4 NO THIRD PARTY BENEFICIARIES. The parties agree that there shall be no third party beneficiaries to this Agreement, including but not limited to Reseller's End User Customers.\"}}, {\"id\": \"12.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"12.5 ASSIGNMENT. Neither party will assign this Agreement or any rights hereunder without the prior written consent of the other party, which consent will not be unreasonably withheld. Notwithstanding the foregoing sentence, McDATA may assign this Agreement to any entity controlled by, controlling, or under common control with McDATA or to any successor by merger, divestiture, consolidation or reorganization, or to any purchasers of all or substantially all of the assets of the business of McDATA without consent of Reseller.\"}}, {\"id\": \"12.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAWS\", \"level\": 2, \"text\": \"12.6 GOVERNING LAWS. This Agreement shall be governed by and construed in accordance with the laws of the State of Colorado excluding its choice of law provisions. The United Nations Convention on Contracts for the International Sale of Goods (CISG) is specifically excluded and shall not be applicable to any transaction contemplated herein.\"}}, {\"id\": \"12.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPUTE RESOLUTION PROCESS\", \"level\": 2, \"text\": \"12.7 DISPUTE RESOLUTION PROCESS. In case of any dispute between the parties relating to this Agreement, such dispute shall be finally resolved in Denver, Colorado (USA) by arbitration under the Commercial Rules of Arbitration of the American Arbitration Association, using three arbitrators, one selected by each of McDATA and Reseller and the third selected in accordance with such Rules. The arbitrators will decide the issues presented to them applying the substantive laws of the Sate of Colorado (USA). The award of the arbitrators may be granted notwithstanding the absence of any party and such award shall be in writing and shall be final and binding upon the parties and shall not be appealed from or contested in any court or tribunal. Any award rendered hereunder may be entered for enforcement, if necessary, in any court of competent jurisdiction.\"}}, {\"id\": \"12.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INJUNCTIVE RELIEF\", \"level\": 2, \"text\": \"12.8 INJUNCTIVE RELIEF. Notwithstanding the above provisions relating to arbitration, the parties agree that in respect of any violation of any provision of this Agreement, including without limitation violation of any proprietary or confidential information, for which an award of damages is an inadequate remedy to project the injured party, the injured party is entitled to seek injunctive relief, including a preliminary injunction, in a court of competent jurisdiction, in addition to any other relief available to it under the arbitration procedures specified above in Section 12.7.\"}}, {\"id\": \"12.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OFFICIAL LANGUAGE\", \"level\": 2, \"text\": \"12.9 OFFICIAL LANGUAGE. The official language of this Agreement and all transactions conducted under this Agreement is English.\"}}, {\"id\": \"12.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE\", \"level\": 2, \"text\": \"12.10 FORCE MAJEURE. Neither party will be liable for any failure or delay in its performance under this Agreement due to any cause beyond its reasonable control, including but not limited to acts of God, war, riot, embargoes, acts of civil or military authorities, fire, floods, accidents, strikes, delays by suppliers or shortages of transportation, facilities, fuel, energy, labor, or materials. McDATA Corporation Standard Terms of Reseller Agreement June 2004 5\"}}, {\"id\": \"12.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"12.11 COMPLIANCE WITH LAWS. McDATA and Reseller each agree to comply with all applicable laws and each understand and agree that the continuing rights and obligations of the parties hereunder are specifically conditioned upon compliance with such laws. These laws include, without limitation, the following: (i) the U.S. anti-boycott regulations, (ii) the U.S. Foreign Corrupt Practices Act (\\\"FCPA\\\"), (iii) the export control laws of the United States of America, (iv) the prevailing regulations which may be issued from time to time by the U.S. Department of Commerce and the Office of Munitions Control and the U.S. Department of State, and (v) any export or import laws of the agencies of the Territory or of any countries into or through which the Products purchased under this Agreement may be transported.\"}}, {\"id\": \"12.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 2, \"text\": \"12.12 NOTICES. Notices required hereunder will be in writing and will be deemed given when transmitted by facsimile (provided such facsimile is subsequently confirmed in writing within five (5) days of the facsimile date) or deposited with an express delivery service with guaranteed third-day delivery, prepaid, addressed as follows: NOTICES TO: McDATA CORPORATION: McDATA Corporation 380 Interlocken Crescent Broomfield, CO 80021 Attn: VP of Sales With a copy to: VP and General Counsel Fax:720-558-3235 NOTICES TO: RESELLER MTI Technology Corp 14661 Franklin Ave Tustin,CA 92780 Attn: CFO Fax : 714-481-4136\"}}, {\"id\": \"12.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 2, \"text\": \"12.13 ENTIRE AGREEMENT. This Agreement, together with any and all attachments hereto and applicable Appendices, Addendums and Channel Notification Documents as issued from time to time by McDATA constitutes the entire agreement between McDATA and Reseller with respect to the subject matter hereof, and supersedes all prior and contemporaneous oral or written representations or agreements between the parties regarding the subject matter of this Agreement.\"}}, {\"id\": \"12.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COUNTERPARTS\", \"level\": 2, \"text\": \"12.14 COUNTERPARTS. This Agreement may be executed in counterparts or by facsimile, each of which shall be an original, and all of which together shall constitute one and the same instrument.\"}}, {\"id\": \"12.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NUCLEAR, AVIATION OR LIFE SUPPORT APPLICATION\", \"level\": 2, \"text\": \"12.15 NUCLEAR, AVIATION OR LIFE SUPPORT APPLICATION. McDATA specifically disclaims liability for use of McDATA Software in connection with the design, construction, maintenance, and/or operation of any (i) nuclear facility, (ii) aircraft, aircraft communication or aircraft ground support system, or (iii) life support system by Reseller or its End User Customers. Such use is entirely at the user's risk. McDATA shall not be liable to Reseller or its End User Customers, in whole or in part, for any claims arising out of such use. Reseller agrees to defend, indemnify, and hold McDATA harmless from and against any and all claims arising out of use of the Software in such applications by Reseller or its End User Customers. McDATA Corporation Standard Terms of Reseller Agreement June 2004 6 PREMIER RESELLER ADDENDUM RESELLER AGREEMENT This addendum applies to a Reseller that will purchase, market, sell license or incorporate Product to any commercial non-United States government entity, instrumentality or agency. TERRITORY: NORTH AMERICA\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SCOPE\", \"level\": 1, \"text\": \"1. SCOPE\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sales to the US Government are not authorized under this Agreement\", \"level\": 2, \"text\": \"1.1 Sales to the US Government are not authorized under this Agreement.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller is authorized to procure McDATA Products and End User Customer Services through the source defined in Paragraph\", \"level\": 2, \"text\": \"1.2 Reseller is authorized to procure McDATA Products and End User Customer Services through the source defined in Paragraph 2.3, \\\"Product Provider.\\\" Reseller procurement of Product and End User Customer Services from sources other than the Product Provider is a material breach of this Agreement and may result in termination of this Agreement. In the event Reseller procures Product or End User Customer Services from sources other than its Product Provider, such procurements will not be included in any McDATA marketing and promotional programs made available to Reseller by McDATA. McDATA, at its sole discretion, may change this policy through a Channel Notification Document.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"DISTRIBUTOR\\\" means a business entity which is authorized by McDATA through a fully executed distributor agreement to ma\", \"level\": 2, \"text\": \"2.1 \\\"DISTRIBUTOR\\\" means a business entity which is authorized by McDATA through a fully executed distributor agreement to market and sell, or incorporate for resale, the McDATA Products and End User Customer Services to McDATA authorized Resellers in its Territory.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"END USER CUSTOMER\\\" means any entity which, for its own use and not for resale, (i) purchase McDATA-manufactured Product\", \"level\": 2, \"text\": \"2.2 \\\"END USER CUSTOMER\\\" means any entity which, for its own use and not for resale, (i) purchase McDATA-manufactured Products; and/or (ii) licenses Software associated therewith from McDATA; and/or (iii) receives End User Customer Services from McDATA.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PRODUCT PROVIDER\\\" means either a McDATA-authorized OEM and/or Distributor who provides Product(s) to the Reseller, as s\", \"level\": 2, \"text\": \"2.3 \\\"PRODUCT PROVIDER\\\" means either a McDATA-authorized OEM and/or Distributor who provides Product(s) to the Reseller, as set forth in Appendix 1.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"RESELLER\\\" means a business entity which is authorized by McDATA through a fully executed Reseller Agreement to (i) mark\", \"level\": 2, \"text\": \"2.4 \\\"RESELLER\\\" means a business entity which is authorized by McDATA through a fully executed Reseller Agreement to (i) market and resell Products; (ii) purchase McDATA-manufactured Products from a Product Provider, without the intention of purchasing such Products for its own use; and/or (iii) resell End User Customer Services from McDATA.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 1, \"text\": \"3. TERM The initial term of this Agreement shall be for a period of one (1) year from the Effective Date unless sooner terminated pursuant to the termination provisions herein. Thereafter, this Agreement automatically renews for successive terms of one (1) year.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER OBLIGATIONS/RESPONSIBILITIES\", \"level\": 1, \"text\": \"4. RESELLER OBLIGATIONS/RESPONSIBILITIES For enhanced warranty and post warranty services, Reseller shall refer to McDATA's Product Offerings on its website. McDATA will notify Reseller of changes to the Product Offerings through its Channel Notification Documents.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"END USER CUSTOMER SOFTWARE LICENSE\", \"level\": 1, \"text\": \"5. END USER CUSTOMER SOFTWARE LICENSE Product(s) that embody or include Software will be delivered with a shrink-wrap or click-through software license which shall govern End User Customer's use of the Software. Such Software is proprietary to, trade secret of, and copyrighted by McDATA or its suppliers. McDATA or its suppliers retain title in and to the Software and all intellectual property rights, and no title to the Software or intellectual property rights is transferred to the End User Customers.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING\", \"level\": 1, \"text\": \"6. MARKETING Reseller agrees not to publish or advertise any price below Manufacturer's Suggested List Price on its web site or by means of any online communications or any other mass communications, including without limitation, catalogues, fax blasts, direct mail pieces, or e-mail blasts.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNMENT FLOWDOWN PROVISIONS\", \"level\": 1, \"text\": \"7. GOVERNMENT FLOWDOWN PROVISIONS. Reseller agrees that flowdown provisions, including, but not limited to United States Government Federal Acquisition Regulations (\\\"FARs\\\"), Defense FARs or NASA FARs, shall not apply to McDATA and McDATA does not accept such provisions notwithstanding the existence of such provisions. In addition, McDATA is not responsible for fulfilling any contract obligations under any schedule contracts including those obligations under the United States Government General Service Administration (\\\"GSA\\\") contract and the California Multiple Award Schedule (\\\"CMAS\\\") contract. McDATA Corporation Standard Terms of Reseller Agreement June 2004 7 APPENDIX I RESELLER AGREEMENT PREMIER PARTNER PRODUCTS, PRODUCT PROVIDER AND REVENUE TARGETS PRODUCTS: Reseller is eligible to sell the McDATA Products listed below. McDATA will provide Product information including pricing, availability, features, accessories, services and support in the Channel Notification Documents. McDATA will update the Product listing from time-to-time through the Channel Notification Documents. - Fibre Channel Directors - Switches - Software - Fabricenter(TM) Cabinet\"}}, {\"id\": \"004\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ANNUALIZED REVENUE TARGET\", \"level\": 1, \"text\": \"004 ANNUALIZED REVENUE TARGET: $500,000 The 2004 Annualized Revenue Target to qualify as a Premier Reseller is $500,000. Reseller is eligible for Premier Reseller program benefits and responsible for the obligations as defined in the Channel Notification Documents. INITIAL EDUCATION REQUIREMENTS: Reseller must successfully complete both Sales and Technical Foundation training, for each McDATA authorized sales location, as follows, within ninety (90) days of the effective date of this Agreement. Sales: All Sales Reps/sales location McDATA Solution (web-based) Technical: 3 individuals Certified Professional Accelerated Track (CPAT) McDATA will waive the charges associated with the above listed required technical courses for three (3) individuals at Reseller's organization. McDATA may, at its sole discretion, provide additional education incentives to Reseller based upon sales performance. These incentives, if made available, will be communicated via Channel Notification Documents. McDATA Corporation Reseller Agreement Premier Partner Addendum June 2004 8 PRODUCT PROVIDER: Reseller will purchase Products directly from one of the Distributors listed on the next page below. Terms and conditions for purchase of Products from the Distributor are as agreed between Distributor and Reseller. Reseller may elect a new distributor annually by notifying McDATA thirty (30) days prior to renewal of the Agreement. If McDATA does not receive notice of a new distributor election and the Agreement is renewed, Reseller agrees that it will continue to purchase Products through the currently designated distributor. Under limited circumstances as approved by McDATA in writing, Reseller may purchase from another Product Provider as directed by McDATA. This may include a) critical customer need where Product is not available from Product Provider in the time frame required by End User, but available through another Authorized McDATA Product Provider or b) repeated, documented dissatisfaction with specified Product Provider during the term of the Agreement. PLEASE INDICATE WHICH ONE OF THE FOLLOWING DISTRIBUTORS YOU CHOOSE TO BUY FROM FOR THE FIRST YEAR OF YOUR AGREEMENT WITH McDATA: [ ] AVNET East Coast Sates - Elsa Neves Phone: 877-286-3879 X5815 Fax: 480-794-9324 Email: elsa.neves@avnet.com West Coast Sates - Jan Johnson Phone: 877-967-3664 Fax: 480-794-9324 Email: jan.johnson@avnet.com [ ] ARROW ESS Cindie Snell Phone: 303-824-3651 Fax: 303-824.3646 Email: csnell@arrow.com [ ] BELL MICROPRODUCTS,INC Lyle Freemen Phone: 952-345-7942 1941 Ringwood Ave Email: lfreerman@bellmicro.com San Jose, California 95131 -1721 [ ] MOCA Adrienne Hargrove Phone: 1 -800-786-3425 5230 Pacific Concourse Dr, 4th Flr, Fax: Los Angeles, CA 80045 Email: [X] TIDAL WIRE Cherie Vallone Phone: 781-332-1104 Email: cvallone@tidalwire.com McDATA reserves the right to change the Premier Partner criteria each January or upon sixty (60) days advanced notice through a Channel Notification Document. If Reseller fails to comply with any of the above requirements, McDATA reserves the right to change the Reseller Designation and Reseller will become eligible for only those programs applicable to the new Reseller Designation. McDATA Corporation Reseller Agreement Premier Partner Addendum June 2004 9\"}}, {\"id\": \"party:McDATA CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"McDATA CORPORATION\", \"role\": null, \"address\": \"380 Interlocken Crescent Broomfield, CO 80021\"}}, {\"id\": \"party:MTI TECHNOLOGY CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"MTI TECHNOLOGY CORPORATION\", \"role\": \"RESELLER\", \"address\": \"14661 Franklin Ave Tustin, CA 92780\"}}, {\"id\": \"party:AVNET\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"AVNET\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"party:ARROW ESS\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ARROW ESS\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"party:BELL MICROPRODUCTS,INC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"BELL MICROPRODUCTS,INC\", \"role\": \"Distributor\", \"address\": \"1941 Ringwood Ave San Jose, California 95131 -1721\"}}, {\"id\": \"party:MOCA\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"MOCA\", \"role\": \"Distributor\", \"address\": \"5230 Pacific Concourse Dr, 4th Flr, Los Angeles, CA 80045\"}}, {\"id\": \"party:TIDAL WIRE\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"TIDAL WIRE\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"term:CHANNEL NOTIFICATION DOCUMENT(S)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CHANNEL NOTIFICATION DOCUMENT(S)\", \"text\": \"McDATA's standard form, incorporated herein by reference, for notifying Resellers of price changes, new product announcements, discontinued/obsolete product announcements, engineering change notifications, product information, marketing and sales Incentive programs, and any other business matters affecting pricing, products and services.\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:END USER CUSTOMER SERVICES\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"END USER CUSTOMER SERVICES\", \"text\": \"the collective reference to warranty and post warranty (maintenance) services, including standard and enhanced warranty services, made available by McDATA and provided directly to End User Customers.\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:PRODUCT(S)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PRODUCT(S)\", \"text\": \"McDATA hardware, Software, and related features, conversions, and options, as listed in the Addendum and further provided through Channel Notification Documents.\", \"definition_clause\": \"2.3\"}}, {\"id\": \"term:SOFTWARE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SOFTWARE\", \"text\": \"the computer software, In machine executable object code format only, that is delivered and licensed by McDATA with the Product.\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:TERRITORY\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TERRITORY\", \"text\": \"the area designated on the first page of the incorporated Addendum to this Agreement in which Reseller may, on a non-exclusive basis, market and sell the Products and End User Customer Services.\", \"definition_clause\": \"2.5\"}}, {\"id\": \"term:CONFIDENTIAL INFORMATION\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CONFIDENTIAL INFORMATION\", \"text\": \"any and all technical or business information, including third party information, furnished or disclosed, in whatever form or medium (regardless of whether tangible, Intangible, visual or oral), by one party to the other, including but not limited to information regarding patents and patent applications, trade secrets, works of authorship, software programs, software source documents, software architecture, algorithms, formulae, ideas, techniques, know-how, processes, inventions, apparatuses, equipment, models, information related to current, future and proposed products and services, research, experimental work, development, design details, specifications and engineering information, financial information, procurement, purchasing and manufacturing requirements, potential and actual customer lists, investors, employees, business and contractual relationships, business forecasts, sales and merchandising information, marketing plans; information regarding third parties; and any physical manifestations of Confidential Information (such as notes, reports, memoranda, etc.).\", \"definition_clause\": \"8.1\"}}, {\"id\": \"term:DISTRIBUTOR\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"DISTRIBUTOR\", \"text\": \"a business entity which is authorized by McDATA through a fully executed distributor agreement to market and sell, or incorporate for resale, the McDATA Products and End User Customer Services to McDATA authorized Resellers in its Territory.\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:END USER CUSTOMER\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"END USER CUSTOMER\", \"text\": \"any entity which, for its own use and not for resale, (i) purchase McDATA-manufactured Products; and/or (ii) licenses Software associated therewith from McDATA; and/or (iii) receives End User Customer Services from McDATA.\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:PRODUCT PROVIDER\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PRODUCT PROVIDER\", \"text\": \"either a McDATA-authorized OEM and/or Distributor who provides Product(s) to the Reseller, as set forth in Appendix 1.\", \"definition_clause\": \"2.3\"}}, {\"id\": \"term:RESELLER\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"RESELLER\", \"text\": \"a business entity which is authorized by McDATA through a fully executed Reseller Agreement to (i) market and resell Products; (ii) purchase McDATA-manufactured Products from a Product Provider, without the intention of purchasing such Products for its own use; and/or (iii) resell End User Customer Services from McDATA.\", \"definition_clause\": \"2.4\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 days\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:$500,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$500,000\"}}, {\"id\": \"value:5 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NANOPHASETECHNOLOGIESCORP_11_01_2005-EX-99.1-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NANOPHASETECHNOLOGIESCORP_11_01_2005-EX-99.1-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"a) For all referrals under Section 6.1, except whe\", \"level\": 1, \"text\": \"a) For all referrals under Section 6.1, except where NTC has evidence that it referral the customer (including its affiliates) to ALFA AESAR to purchase a prior sample of the Product in question, or where NTC has made sales to the customer (including its affiliates) referred to NTC by ALFA AESAR within a period of twelve (12) months before ALFA AESAR's referral under Section 6.1, NTC shall pay ALFA AESAR a commission at the rate of [***] on the Net Sales made to each such customer so referred to NTC under Section 6.1. NTC shall pay ALFA AESAR on a monthly basis for all such commissions for a period of three (3) years from the date of such referred customer's first order of Products or Custom Services from NTC. *** CONFIDENTIAL TREATMENT REQUESTED\u2014This confidential portion has been omitted from this document and filed separately with the Commission. 4\"}, {\"id\": \"13.2\", \"title\": \"Termination of this Agreement shall not affect the rights or obligations of the parties accrued as of the date of termin\", \"level\": 2, \"text\": \"13.2 Termination of this Agreement shall not affect the rights or obligations of the parties accrued as of the date of termination. The provisions of Sections 6, 9, 10, 15 will survive termination of the Agreement. 13.3 Upon termination of this Agreement for any reason, ALFA AESAR may i) return its current inventory of Products for reimbursement by NTC or ii) keep its current inventory of Products and continue to sell such Products pursuant to the terms hereof until depletion of inventory. Upon termination of this Agreement, NTC shall promptly refund to ALFA AESAR all outstanding credits accrued on ALFA AESAR's account. 14. Insurance. Each party agrees to maintain and provide the other with evidence of insurance coverage for comprehensive general liability in an amount no less than $2,000,000.00 U.S. dollars. 15. Confidentiality. The parties agree as follows; \\\"Confidential Information\\\" shall mean trade secret, technical, commercial, or financial information and all other nonpublic proprietary or confidential information. Each party receiving Confidential Information from the other party agrees to maintain in confidence and not divulge such Confidential Information, in whole or in part, to any third party, including subsidiaries or affiliates, licensees or clients anywhere, and not make use of such Confidential Information other than in relation to its performance under this Agreement. This obligation shall not apply to: (i) Confidential Information which at the time of disclosure by the disclosing party is in the public domain; or (ii) Confidential Information which, after disclosure by the disclosing party, becomes part of the public domain by publication or otherwise, other than by an unauthorized act or omission by the receiving party; (iii) Confidential Information which receiving party can show by contemporary written records was in its possession at the time of the disclosure and which was not acquired, directly or indirectly from disclosing party; or (iv) Confidential Information which receiving party rightfully receives from a third party and which was not acquired, directly or indirectly, from the disclosing party; (v) information which is developed independently without reference to the Confidential Information of the other party; or (v) Confidential Information which, if disclosed in written or other tangible form, is not marked \\\"Confidential\\\", or if disclosed orally is not summarized in a writing identifying the Confidential Information and submitted to the receiving party within thirty (30) days of the oral disclosure; or (vi) Confidential Information which is compelled by law to be disclosed by the receiving party, provided that the receiving party shall use its best efforts to give the disclosing party ten (10) days prior written notice of any such compelled disclosure. Each party agrees that it shall restrict its disclosures of the disclosing party's Confidential Information within its own organization to those persons having a need to know it for the purposes of performance under this Agreement and that such persons shall be advised of the obligations of confidentiality set forth herein and shall be obligated in like fashion. Upon request on termination or expiration of this Agreement, the receiving party shall promptly return to the disclosing party all Confidential Information and shall retain no copies except that one copy may be retained for purposes of determining such receiving party's compliance with the terms of this paragraph. 16. Disputes and Arbitration. The parties shall first seek to resolve any dispute by negotiations between their senior executives. When a party believes there is a dispute under this Agreement, that party will give the other party written notice of the dispute. Failing settlement of the dispute within 60 days of notice, either party may initiate binding arbitration proceeding; by 9 written notice to the other party, provided however, no dispute arising from any actual or threatened breach of any provisions in Sections 10 or 15 of this Agreement shall be subject to Arbitration. However, any other claims or disputes arising hereunder, including the construction or application of this Agreement, shall be settled by arbitration before a single arbitrator in accordance with the Rules for Commercial Arbitration of the American Arbitration Association (\\\"AAA\\\") then in force. The place of arbitration shall be the location of the party hereto against whom the claim is made. If the parties cannot agree on an arbitrator within 10 days after demand by either of them, then the arbitrator shall be selected pursuant to the AAA's Commercial Arbitration rules. The decision of the arbitrator shall be final and binding upon the parties and may be submitted to any court of competent jurisdiction for entry of a judgment thereon in accord with the Federal Arbitration Act or the Uniform Arbitration Act. The expense of the arbitration shall be shared equally by both parties. Each party shall bear its own \\\"other\\\" costs, i.e. fees and costs of its own lawyers and witnesses. 17. Notices. Any notice required or permitted to be given hereunder shall be deemed to have been duly given if delivered by hand, overnight courier delivery or mailed, certified and registered mail, with postage prepaid to the addresses first set forth above or at such other addresses as either party may designate in writing to the other, and if to ALFA AESAR with a copy to Johnson Matthey, 435 Devon Park, Suite 600. Wayne PA 19087, Attention: Vice President & General Counsel. This section is not intended to govern the day-to-day business communications necessary between the parties in performing their duties, in due course, under the terms of this Agreement. 18. Severability. The provisions of this agreement shall be severable, and if any provision of this Agreement is held to be invalid or unenforceable, it shall be construed to have the broadest interpretation which would render it valid and enforceable. Invalidity or unenforceability of one provision shall not affect any other provision of this Agreement. 19. Entire Agreement. This Agreement contains the entire agreement with respect to the subject matter hereof, and there are no other agreements or understandings, express or implied, written or oral, as to the subject matter hereof. This Agreement may not be amended or altered except by a written instrument signed by both parties, expressly stating that it is intended as an amendment hereto. No purchase order or other written order or acknowledgment issued by either party shall serve to vary the terms and conditions of this Agreement, or otherwise alter the obligations of the parties provided herein. 20. Waiver. The waiver by either party of any breach or failure to enforce any of the terms and conditions of this Agreement at any time shall not in any way affect, limit or waive either party's rights thereafter to enforce and compel strict compliance with every term and condition of this Agreement. 21. Counterparts. This Agreement may be executed in one or more counterpart copies, each of which shall be deemed an original and all of which shall together be deemed to constitute one agreement. 22. Governing Law. This Agreement shall be governed by and interpreted under and in accordance with the laws of the State of Delaware without regard to principles of conflicts of laws. 10\"}, {\"id\": \"23\", \"title\": \"Public Announcements\", \"level\": 1, \"text\": \"23. Public Announcements. Upon execution and at any time during the term of this Agreement, the parties shall cooperate in preparing a joint press release announcing this Agreement and the availability of NTC Products in Research Quantities through ALFA AESAR, provided that no such joint press release shall be issued without both parties' prior approval. 24. Headings. The headings in this Agreement are for convenience only and do not in any way limit or amplify the terms or conditions of this Agreement. IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first set forth above. NANOPHASE TECHNOLOGIES CORPORATION JOHNSON MATTHEY CATALOG COMPANY, INC. By: /s/ W. Ian Roberts By: /s/ Barry Singelais W. Ian Roberts Barry Singelais V.P. U.S. & International Sales General Manager Dated: October 14, 2005 Dated: October 24, 2005 11\"}, {\"id\": \"Schedule A\", \"title\": \"List of Products to be offered by ALFA AESAR. Quantities and NTC pricing to ALFA AESAR are included. All prices are USD, FOB Romeoville IL, net 30. Product Specification Nanopowders: Name\", \"level\": 1, \"text\": \"Schedule A List of Products to be offered by ALFA AESAR. Quantities and NTC pricing to ALFA AESAR are included. All prices are USD, FOB Romeoville IL, net 30. Product Specification Nanopowders: Name Product Code Quantity Price/kg NanoTek\u00ae Aluminum Oxide 0115 [***] $[***] NanoDur\u2122 Aluminum Oxide 0119 [***] $[***] NanoTek\u00ae Antimony Tin Oxide 2400 [***] $[***] NanoArc\u00ae Bismuth Oxide EXP 0250 [***] $[***] NanoArc\u00ae Copper Oxide EXP 0502 [***] $[***] NanoTek\u00ae Indium Tin Oxide 0600 [***] $[***] NanoArc\u00ae Cosmetic Iron Oxide EXP 0807 [***] $[***] NanoArc\u00ae Magnetic Iron Oxide EXP 0806 [***] $[***] NanoTek\u00ae Tin Oxide 1400 [***] $[***] NanoGard\u00ae Zinc Oxide 1700 [***] $[***] NanoTek\u00ae Zinc Oxide 1701 [***] $[***] NanoTek\u00ae Zinc Oxide C1 1716 [***] $[***] NanoTek\u00ae Zinc Oxide C2 EXP 1726 [***] $[***] Nanoparticle dispersions: Name Product Code Quantity Price/kg NanoDur\u2122 X1121W, 50wt% EXP 0187 [***] $[***] NanoDur\u2122 X1130PMA, 50wt% EXP 0151 [***] $[***] NanoShield\u00ae ZN-2000, 50wt% EXP 1754 [***] $[***] NanoShield\u00ae ZN-3010, 50wt% EXP 1769 [***] $[***] NanoTek\u00ae Z1102PMA, 50wt% EXP 1707 [***] $[***] NanoTek\u00ae AL-6081, 23wt% EXP 0180 [***] $[***] NanoTek\u00ae AL-6051, 23 wt% EXP 0142 [***] $[***] NanoTek\u00ae CE-6042, 18wt% 0311 [***] $[***] NanoTek\u00ae CE-6080, 20wt% 0315 [***] $[***] NanoTek\u00ae CE-6082, 18wt% 0314 [***] $[***] NanoTek\u00ae CE-6086, 18wt% EXP 0333 [***] $[***] *** CONFIDENTIAL TREATMENT REQUESTED\u2014This confidential portion has been omitted from this document and filed separately with the Commission. 12\"}, {\"id\": \"Schedule B\", \"title\": \"NANOPHASE TECHNOLOGIES CORPORATION STANDARD TERMS AND CONDITIONS 1. General Terms: As used in these Terms and Conditions, the terms (a) \\\"Seller\\\" shall mean Nanophase Technologies Corporation and (b) \\\"Buyer\\\" shall mean the party ordering shipment of Seller's products under the Order. These Terms and Conditions, including the provisions on the face hereof, constitute the exclusive contract between the parties for the products provided by Seller (\\\"Order\\\" or \\\"Agreement\\\"). Seller will be deemed to have accepted this Order when Seller returns an acknowledged copy of this Order, or, at Seller's option, when Seller begins substantial performance under this Order. Buyer accepts this Order by acknowledging a copy of this Order, by confirming this Order by its purchase order, purchase requisition or confirmation, or by accepting for shipment the products hereunder. Notwithstanding the manner in which Buyer accepts, Buyer's acceptance is limited exclusively to the acceptance of Seller's terms and conditions set forth in this Order only. Seller hereby rejects any proposal by Buyer for additional or different terms in connection with the products or services provided. Buyer may acknowledge this Order by purchase order, but any and all terms, conditions and provisions contained in said purchase order, acknowledgment form or other communications with respect to the transaction contemplated by this Order, or subsequent to the date hereof, are agreed to be superfluous and without any force and effect. This Order, which includes all terms and conditions hereof, is intended to be the exclusive and final statement of the terms and understandings relative to the subject matter hereof, merging herein and superseding all negotiations and prior written or oral agreements between the parties as to the subject matter of the purchase of the products hereunder. There are no promises, representations or understandings made in connection with this Order or contemporaneous with the execution hereof, except as set forth herein. 2. Prices and Taxes: All prices are set forth on the face of this Order. Seller is entitled to defer shipment of products in the event all amounts due it under this or any other Agreement are not paid in full. All payments shall be made to Seller at its offices. The failure to make prompt payment shall be a material breach of this Agreement. The price of the products specified in this Order does not include federal taxes, state or local sales taxes, value added taxes, use taxes or occupational taxes. Unless prohibited by law, Buyer is responsible for and shall pay all applicable sales, use, occupational, excise, value added or other similar taxes applicable to the manufacture, sale, price, shipment or use of the products provided by Seller. 3. Delivery and Risk of Loss: All sales are FOB Seller's premises in Burr Ridge or Romeoville, Illinois. Seller shall have no liability or responsibility for the late or non-shipment of products hereunder. Title to, risk of loss, destruction of or damage to the products shall be Seller's until delivery of the products to a carrier at the Seller's premises in Burr Ridge, Illinois. Thereafter, Buyer shall be fully responsible for and assume all ownership, risk of loss, destruction of or damage to the products. Loss or damage to the products after title and risk of loss have passed to Seller will not release or excuse Buyer from its obligations under this Order to Seller, including the obligation to make full payment. 4. Short Shipments/Damage Claims: Seller will endeavor to ship all Orders complete or as complete as reasonably possible. Seller will, however, ship incomplete orders upon written authorization by Buyer. In that event, Seller shall have no liability for short, incomplete or delayed orders. All damage claims shall be made within fourteen (14) days of delivery and shall be in writing. 5. Rejection and Revocation of Acceptance: Any rejection or revocation of acceptance by Buyer (a) must be made within thirty (30) days of the products being made available for shipment to Buyer, (b) any attempted rejection or revocation of acceptance made thereafter shall be null and void, and (c) any rejection or revocation of acceptance shall comply with Seller's return protocol.\", \"level\": 1, \"text\": \"Schedule B NANOPHASE TECHNOLOGIES CORPORATION STANDARD TERMS AND CONDITIONS 1. General Terms: As used in these Terms and Conditions, the terms (a) \\\"Seller\\\" shall mean Nanophase Technologies Corporation and (b) \\\"Buyer\\\" shall mean the party ordering shipment of Seller's products under the Order. These Terms and Conditions, including the provisions on the face hereof, constitute the exclusive contract between the parties for the products provided by Seller (\\\"Order\\\" or \\\"Agreement\\\"). Seller will be deemed to have accepted this Order when Seller returns an acknowledged copy of this Order, or, at Seller's option, when Seller begins substantial performance under this Order. Buyer accepts this Order by acknowledging a copy of this Order, by confirming this Order by its purchase order, purchase requisition or confirmation, or by accepting for shipment the products hereunder. Notwithstanding the manner in which Buyer accepts, Buyer's acceptance is limited exclusively to the acceptance of Seller's terms and conditions set forth in this Order only. Seller hereby rejects any proposal by Buyer for additional or different terms in connection with the products or services provided. Buyer may acknowledge this Order by purchase order, but any and all terms, conditions and provisions contained in said purchase order, acknowledgment form or other communications with respect to the transaction contemplated by this Order, or subsequent to the date hereof, are agreed to be superfluous and without any force and effect. This Order, which includes all terms and conditions hereof, is intended to be the exclusive and final statement of the terms and understandings relative to the subject matter hereof, merging herein and superseding all negotiations and prior written or oral agreements between the parties as to the subject matter of the purchase of the products hereunder. There are no promises, representations or understandings made in connection with this Order or contemporaneous with the execution hereof, except as set forth herein. 2. Prices and Taxes: All prices are set forth on the face of this Order. Seller is entitled to defer shipment of products in the event all amounts due it under this or any other Agreement are not paid in full. All payments shall be made to Seller at its offices. The failure to make prompt payment shall be a material breach of this Agreement. The price of the products specified in this Order does not include federal taxes, state or local sales taxes, value added taxes, use taxes or occupational taxes. Unless prohibited by law, Buyer is responsible for and shall pay all applicable sales, use, occupational, excise, value added or other similar taxes applicable to the manufacture, sale, price, shipment or use of the products provided by Seller. 3. Delivery and Risk of Loss: All sales are FOB Seller's premises in Burr Ridge or Romeoville, Illinois. Seller shall have no liability or responsibility for the late or non-shipment of products hereunder. Title to, risk of loss, destruction of or damage to the products shall be Seller's until delivery of the products to a carrier at the Seller's premises in Burr Ridge, Illinois. Thereafter, Buyer shall be fully responsible for and assume all ownership, risk of loss, destruction of or damage to the products. Loss or damage to the products after title and risk of loss have passed to Seller will not release or excuse Buyer from its obligations under this Order to Seller, including the obligation to make full payment. 4. Short Shipments/Damage Claims: Seller will endeavor to ship all Orders complete or as complete as reasonably possible. Seller will, however, ship incomplete orders upon written authorization by Buyer. In that event, Seller shall have no liability for short, incomplete or delayed orders. All damage claims shall be made within fourteen (14) days of delivery and shall be in writing. 5. Rejection and Revocation of Acceptance: Any rejection or revocation of acceptance by Buyer (a) must be made within thirty (30) days of the products being made available for shipment to Buyer, (b) any attempted rejection or revocation of acceptance made thereafter shall be null and void, and (c) any rejection or revocation of acceptance shall comply with Seller's return protocol.\"}, {\"id\": \"6\", \"title\": \"Compliance with Governing Laws\", \"level\": 1, \"text\": \"6. Compliance with Governing Laws: Buyer warrants that its performance hereunder, including the use of the products hereunder, shall comply with all applicable state, federal and foreign law, regulations, environmental regulations, statutes or requirements, including, but not limited to, FDA approvals or any other approvals or certifications required by law 7. Assignment and Modification: The rights and obligations of the parties under this Agreement shall not be assignable unless consent to the assignment is in writing and signed by the parties. This Order shall not be modified, altered or amended in any respect except by a writing signed by the parties. Any variation, modification, or addition to the terms set forth in this Order shall be considered a material modification and shall not be considered part of this Agreement. 8. Limited Warranty and Disclaimer of All Other Warranties: EXCEPT FOR THE EXPRESS WARRANTY, IF ANY, THAT THE PRODUCTS COMPLY WITH THE SPECIFICATIONS IDENTIFIED IN WRITING ON THE FACE OF OR ACCOMPANYING THIS ORDER, SELLER MAKES NO EXPRESS OR IMPLIED WARRANTIES IN THIS ORDER OR OTHERWISE. TO THE FULLEST EXTENT PERMITTED BY LAW, SELLER DISCLAIMS ALL WARRANTIES, WRITTEN, EXPRESS OR IMPLIED, INCLUDING ALL WARRANTIES OF MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE. SELLER EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY TO BUYER FOR ANY CONSEQUENTIAL DAMAGES, DAMAGES FOR LOSS OF USE, LOSS OF PROFITS, INCOME, OR REVENUE, LOSS OF TIME OR INCONVENIENCE, LOSS OR DAMAGE TO ASSOCIATED EQUIPMENT, COST OF SUBSTITUTED OR REPLACEMENT EQUIPMENT, LOSS TO FACILITIES, LOSS OF CAPITAL, LOSS OF SERVICES OR ANY OTHER INCIDENTAL, CONSEQUENTIAL OR SPECIAL DAMAGE ARISING OUT OF THIS ORDER OR THE OPERATION, FUNCTION OR CHARACTERISTICS OF THE PRODUCTS PURCHASED HEREUNDER OR OTHERWISE PROVIDED BY SELLER. IN THE EVENT THAT PRODUCTS DO NOT SATISFY SPECIFICATIONS, THEY WILL BE REPLACED, AT SELLER'S OPTION, WITH PRODUCTS THAT DO SATISFY THE SPECIFICATIONS AT SELLER'S SOLE EXPENSE. SAID REPLACEMENT IS THE SOLE AND EXCLUSIVE REMEDY OF BUYER. 9. Limitation of Liability: To the fullest extent permitted by law, the parties waive and relinquish any claims, demands, causes of action or recoveries for punitive damages, exemplary damages, or statutory damages. Seller shall not be liable for indirect, special, incidental or consequential damages arising under this Agreement or otherwise with respect to the sale of the products, including any lost revenues or profits, consequential and/or incidental damages, business interruption or damage to business reputation, regardless of the theory upon which any claim may be based, including any statutory causes of action or claims. In no event will Seller's entire liability to Buyer, including any liability in the event the exclusive remedy set forth in this Agreement fails of its essential purpose, exceed the purchase price actually paid by Buyer for the products hereunder, or any defective portion thereof, whichever is the lesser amount. 10. Force Majeure: Seller shall have no liability or obligation to Buyer of any kind, including but not limited to any obligation to ship products, arising from any delay or failure to perform all or any part of this Order as a result of causes, conduct or occurrences beyond Seller's reasonable control, including, but not limited to, commercial impracticability, fire, flood, act of war, civil disorder or disobedience, act of public enemies, terrorist acts, terrorism generally affecting commerce, problems associated with transportation (including car or truck shortages), acts or failure to act of any state, federal or foreign governmental or regulatory authorities, labor disputes or strikes. 11. Relationship: The relationship between Seller and Buyer shall be that of independent contractors. Seller, its agents and employees, shall under no circumstances be deemed the employees, distributors, franchisees, agents or representatives of Buyer.\"}, {\"id\": \"12\", \"title\": \"Default\", \"level\": 1, \"text\": \"12. Default: The failure of Buyer to perform any obligations hereunder, including without limitation, the payment of the purchase price for products and all other amounts due hereunder, the failure to materially perform other agreements between Buyer and Seller, or Buyer's bankruptcy or insolvency, shall constitute a default under this Agreement and shall, in addition to any other remedies, afford Seller all of the remedies of a secured party under the Uniform Commercial Code of the State of Illinois. In the event of default, Seller may, in addition to pursuing any of the remedies provided by law, equity or as set forth in this Agreement, refuse to make available for shipment products under this or any other agreement relating to the products, and may also cancel this Order and any pending orders without liability to Buyer. It is expressly understood that Seller's remedies are cumulative to the fullest extent permitted by law. 13. Attorneys' Fees: In the event it becomes necessary for Seller to enforce the terms and conditions of this Order by litigation or otherwise, or to defend itself in any Controversy (as defined herein), litigation, claim, demand or cause of action arising out of or as a result of this Order or the products or services provided hereunder, and if Seller is the substantially prevailing party in said Controversy, litigation, claim, demand or cause of action, then Seller shall be entitled to recover, in addition to any other relief granted or damages assessed, its reasonable attorneys' fees, expert witness fees, costs, and all expenses of litigation. 14. Waiver: No claim or right arising out of a breach of this Order can be discharged in whole or in part by a waiver or renunciation of the claim or right unless the waiver or renunciation is supported by consideration and is in writing signed by the aggrieved party. 15. Severability: If any term, covenant, warranty or condition of this Order, or the application thereof to any person or circumstance shall, to any extent, be held or deemed invalid or unenforceable, the remainder of this Order or the application of such term, covenant or provision, to persons or circumstances other than those to which it is held invalid or unenforceable, shall not be affected thereby, and each remaining term, covenant or provision of this Order shall be deemed valid and enforced to the fullest extent permitted by law. 16. Indemnification: To the fullest extent permitted by law, Buyer shall defend, indemnify and hold Seller harmless from any and all claims, demands, subrogation claims by Buyer's insurers, causes of action, liabilities, fines, regulatory actions, seizures of product, losses, costs, expenses (including, but not limited to attorneys' fees, expert witness expenses and litigation expenses) (hereinafter \\\"Claim\\\"), arising from or in connection with any Claim asserted against Seller for any damage, injury, death, loss, property damage, environmental liability, or any other Claim, whether in tort, contract, or otherwise, relating to this Order, the business relationship between the parties or the goods provided hereunder. Notwithstanding the foregoing, Buyer has no indemnity obligation to Seller with respect to any Claims that result solely from the negligence of Seller and this indemnity provision does not purport to indemnify Seller solely for its own negligence, but rather for the negligence or conduct, whether sole or concurrent, of Buyer. Buyer, for itself and its insurers, expressly waives any and all limitations or liability caps, if any, on Buyer's contribution liability to Seller, and any and all statutory or common law lien rights or Claims against Seller arising from any applicable workers compensation or disability acts, which Buyer might or could assert against Seller or Seller's insurers in the event of the personal injury or death of Buyer's employees, representatives or servants. Without limiting the foregoing, Buyer, for itself and its insurers, also waives any liens, claims or other rights it may have as a result of being subrogated to any rights of its employees, representatives or servants. 17. Insurance: Buyer shall obtain comprehensive general liability coverage, including contractual liability coverage, naming Seller as an additional named insured, in amounts sufficient to fully protect Seller under this Agreement from loss, damage or casualty caused by Buyer or incurred by Seller under this Agreement. 18. Governing Law and Forum Selection: This agreement shall be governed by and subject to the internal laws (exclusive of the conflicts of law provisions) and decisions of the courts of the State of Illinois. The parties consent to the exclusive jurisdiction of the federal court in Chicago, Illinois or the state court located in DuPage County, Illinois with respect to all litigation, claims, causes of action, demands, Controversies (as defined herein) or disputes among the parties. The only exception to this forum selection provision is a claim by Seller seeking the replevin of the products in the event the courts specified in this provision will not or cannot assert jurisdiction. All counterclaims, if any, in connection with the replevin claim, shall be subject to this forum selection provision.\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NANOPHASETECHNOLOGIESCORP_11_01_2005-EX-99.1-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"a) For all referrals under Section 6.1, except whe\", \"level\": 1, \"text\": \"a) For all referrals under Section 6.1, except where NTC has evidence that it referral the customer (including its affiliates) to ALFA AESAR to purchase a prior sample of the Product in question, or where NTC has made sales to the customer (including its affiliates) referred to NTC by ALFA AESAR within a period of twelve (12) months before ALFA AESAR's referral under Section 6.1, NTC shall pay ALFA AESAR a commission at the rate of [***] on the Net Sales made to each such customer so referred to NTC under Section 6.1. NTC shall pay ALFA AESAR on a monthly basis for all such commissions for a period of three (3) years from the date of such referred customer's first order of Products or Custom Services from NTC. *** CONFIDENTIAL TREATMENT REQUESTED\u2014This confidential portion has been omitted from this document and filed separately with the Commission. 4\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination of this Agreement shall not affect the rights or obligations of the parties accrued as of the date of termin\", \"level\": 2, \"text\": \"13.2 Termination of this Agreement shall not affect the rights or obligations of the parties accrued as of the date of termination. The provisions of Sections 6, 9, 10, 15 will survive termination of the Agreement. 13.3 Upon termination of this Agreement for any reason, ALFA AESAR may i) return its current inventory of Products for reimbursement by NTC or ii) keep its current inventory of Products and continue to sell such Products pursuant to the terms hereof until depletion of inventory. Upon termination of this Agreement, NTC shall promptly refund to ALFA AESAR all outstanding credits accrued on ALFA AESAR's account. 14. Insurance. Each party agrees to maintain and provide the other with evidence of insurance coverage for comprehensive general liability in an amount no less than $2,000,000.00 U.S. dollars. 15. Confidentiality. The parties agree as follows; \\\"Confidential Information\\\" shall mean trade secret, technical, commercial, or financial information and all other nonpublic proprietary or confidential information. Each party receiving Confidential Information from the other party agrees to maintain in confidence and not divulge such Confidential Information, in whole or in part, to any third party, including subsidiaries or affiliates, licensees or clients anywhere, and not make use of such Confidential Information other than in relation to its performance under this Agreement. This obligation shall not apply to: (i) Confidential Information which at the time of disclosure by the disclosing party is in the public domain; or (ii) Confidential Information which, after disclosure by the disclosing party, becomes part of the public domain by publication or otherwise, other than by an unauthorized act or omission by the receiving party; (iii) Confidential Information which receiving party can show by contemporary written records was in its possession at the time of the disclosure and which was not acquired, directly or indirectly from disclosing party; or (iv) Confidential Information which receiving party rightfully receives from a third party and which was not acquired, directly or indirectly, from the disclosing party; (v) information which is developed independently without reference to the Confidential Information of the other party; or (vi) Confidential Information which, if disclosed in written or other tangible form, is not marked \\\"Confidential\\\", or if disclosed orally is not summarized in a writing identifying the Confidential Information and submitted to the receiving party within thirty (30) days of the oral disclosure; or (vi) Confidential Information which is compelled by law to be disclosed by the receiving party, provided that the receiving party shall use its best efforts to give the disclosing party ten (10) days prior written notice of any such compelled disclosure. Each party agrees that it shall restrict its disclosures of the disclosing party's Confidential Information within its own organization to those persons having a need to know it for the purposes of performance under this Agreement and that such persons shall be advised of the obligations of confidentiality set forth herein and shall be obligated in like fashion. Upon request on termination or expiration of this Agreement, the receiving party shall promptly return to the disclosing party all Confidential Information and shall retain no copies except that one copy may be retained for purposes of determining such receiving party's compliance with the terms of this paragraph. 16. Disputes and Arbitration. The parties shall first seek to resolve any dispute by negotiations between their senior executives. When a party believes there is a dispute under this Agreement, that party will give the other party written notice of the dispute. Failing settlement of the dispute within 60 days of notice, either party may initiate binding arbitration proceeding; by 9 written notice to the other party, provided however, no dispute arising from any actual or threatened breach of any provisions in Sections 10 or 15 of this Agreement shall be subject to Arbitration. However, any other claims or disputes arising hereunder, including the construction or application of this Agreement, shall be settled by arbitration before a single arbitrator in accordance with the Rules for Commercial Arbitration of the American Arbitration Association (\\\"AAA\\\") then in force. The place of arbitration shall be the location of the party hereto against whom the claim is made. If the parties cannot agree on an arbitrator within 10 days after demand by either of them, then the arbitrator shall be selected pursuant to the AAA's Commercial Arbitration rules. The decision of the arbitrator shall be final and binding upon the parties and may be submitted to any court of competent jurisdiction for entry of a judgment thereon in accord with the Federal Arbitration Act or the Uniform Arbitration Act. The expense of the arbitration shall be shared equally by both parties. Each party shall bear its own \\\"other\\\" costs, i.e. fees and costs of its own lawyers and witnesses. 17. Notices. Any notice required or permitted to be given hereunder shall be deemed to have been duly given if delivered by hand, overnight courier delivery or mailed, certified and registered mail, with postage prepaid to the addresses first set forth above or at such other addresses as either party may designate in writing to the other, and if to ALFA AESAR with a copy to Johnson Matthey, 435 Devon Park, Suite 600. Wayne PA 19087, Attention: Vice President & General Counsel. This section is not intended to govern the day-to-day business communications necessary between the parties in performing their duties, in due course, under the terms of this Agreement. 18. Severability. The provisions of this agreement shall be severable, and if any provision of this Agreement is held to be invalid or unenforceable, it shall be construed to have the broadest interpretation which would render it valid and enforceable. Invalidity or unenforceability of one provision shall not affect any other provision of this Agreement. 19. Entire Agreement. This Agreement contains the entire agreement with respect to the subject matter hereof, and there are no other agreements or understandings, express or implied, written or oral, as to the subject matter hereof. This Agreement may not be amended or altered except by a written instrument signed by both parties, expressly stating that it is intended as an amendment hereto. No purchase order or other written order or acknowledgment issued by either party shall serve to vary the terms and conditions of this Agreement, or otherwise alter the obligations of the parties provided herein. 20. Waiver. The waiver by either party of any breach or failure to enforce any of the terms and conditions of this Agreement at any time shall not in any way affect, limit or waive either party's rights thereafter to enforce and compel strict compliance with every term and condition of this Agreement. 21. Counterparts. This Agreement may be executed in one or more counterpart copies, each of which shall be deemed an original and all of which shall together be deemed to constitute one agreement. 22. Governing Law. This Agreement shall be governed by and interpreted under and in accordance with the laws of the State of Delaware without regard to principles of conflicts of laws. 10\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Public Announcements\", \"level\": 1, \"text\": \"23. Public Announcements. Upon execution and at any time during the term of this Agreement, the parties shall cooperate in preparing a joint press release announcing this Agreement and the availability of NTC Products in Research Quantities through ALFA AESAR, provided that no such joint press release shall be issued without both parties' prior approval. 24. Headings. The headings in this Agreement are for convenience only and do not in any way limit or amplify the terms or conditions of this Agreement. IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date first set forth above. NANOPHASE TECHNOLOGIES CORPORATION JOHNSON MATTHEY CATALOG COMPANY, INC. By: /s/ W. Ian Roberts By: /s/ Barry Singelais W. Ian Roberts Barry Singelais V.P. U.S. & International Sales General Manager Dated: October 14, 2005 Dated: October 24, 2005 11\"}}, {\"id\": \"Schedule A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"List of Products to be offered by ALFA AESAR. Quantities and NTC pricing to ALFA AESAR are included. All prices are USD, FOB Romeoville IL, net 30. Product Specification Nanopowders: Name\", \"level\": 1, \"text\": \"Schedule A List of Products to be offered by ALFA AESAR. Quantities and NTC pricing to ALFA AESAR are included. All prices are USD, FOB Romeoville IL, net 30. Product Specification Nanopowders: Name Product Code Quantity Price/kg NanoTek\u00ae Aluminum Oxide 0115 [***] $[***] NanoDur\u2122 Aluminum Oxide 0119 [***] $[***] NanoTek\u00ae Antimony Tin Oxide 2400 [***] $[***] NanoArc\u00ae Bismuth Oxide EXP 0250 [***] $[***] NanoArc\u00ae Copper Oxide EXP 0502 [***] $[***] NanoTek\u00ae Indium Tin Oxide 0600 [***] $[***] NanoArc\u00ae Cosmetic Iron Oxide EXP 0807 [***] $[***] NanoArc\u00ae Magnetic Iron Oxide EXP 0806 [***] $[***] NanoTek\u00ae Tin Oxide 1400 [***] $[***] NanoGard\u00ae Zinc Oxide 1700 [***] $[***] NanoTek\u00ae Zinc Oxide 1701 [***] $[***] NanoTek\u00ae Zinc Oxide C1 1716 [***] $[***] NanoTek\u00ae Zinc Oxide C2 EXP 1726 [***] $[***] Nanoparticle dispersions: Name Product Code Quantity Price/kg NanoDur\u2122 X1121W, 50wt% EXP 0187 [***] $[***] NanoDur\u2122 X1130PMA, 50wt% EXP 0151 [***] $[***] NanoShield\u00ae ZN-2000, 50wt% EXP 1754 [***] $[***] NanoShield\u00ae ZN-3010, 50wt% EXP 1769 [***] $[***] NanoTek\u00ae Z1102PMA, 50wt% EXP 1707 [***] $[***] NanoTek\u00ae AL-6081, 23wt% EXP 0180 [***] $[***] NanoTek\u00ae AL-6051, 23 wt% EXP 0142 [***] $[***] NanoTek\u00ae CE-6042, 18wt% 0311 [***] $[***] NanoTek\u00ae CE-6080, 20wt% 0315 [***] $[***] NanoTek\u00ae CE-6082, 18wt% 0314 [***] $[***] NanoTek\u00ae CE-6086, 18wt% EXP 0333 [***] $[***] *** CONFIDENTIAL TREATMENT REQUESTED\u2014This confidential portion has been omitted from this document and filed separately with the Commission. 12\"}}, {\"id\": \"Schedule B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NANOPHASE TECHNOLOGIES CORPORATION STANDARD TERMS AND CONDITIONS 1. General Terms: As used in these Terms and Conditions, the terms (a) \\\"Seller\\\" shall mean Nanophase Technologies Corporation and (b) \\\"Buyer\\\" shall mean the party ordering shipment of Seller's products under the Order. These Terms and Conditions, including the provisions on the face hereof, constitute the exclusive contract between the parties for the products provided by Seller (\\\"Order\\\" or \\\"Agreement\\\"). Seller will be deemed to have accepted this Order when Seller returns an acknowledged copy of this Order, or, at Seller's option, when Seller begins substantial performance under this Order. Buyer accepts this Order by acknowledging a copy of this Order, by confirming this Order by its purchase order, purchase requisition or confirmation, or by accepting for shipment the products hereunder. Notwithstanding the manner in which Buyer accepts, Buyer's acceptance is limited exclusively to the acceptance of Seller's terms and conditions set forth in this Order only. Seller hereby rejects any proposal by Buyer for additional or different terms in connection with the products or services provided. Buyer may acknowledge this Order by purchase order, but any and all terms, conditions and provisions contained in said purchase order, acknowledgment form or other communications with respect to the transaction contemplated by this Order, or subsequent to the date hereof, are agreed to be superfluous and without any force and effect. This Order, which includes all terms and conditions hereof, is intended to be the exclusive and final statement of the terms and understandings relative to the subject matter hereof, merging herein and superseding all negotiations and prior written or oral agreements between the parties as to the subject matter of the purchase of the products hereunder. There are no promises, representations or understandings made in connection with this Order or contemporaneous with the execution hereof, except as set forth herein. 2. Prices and Taxes: All prices are set forth on the face of this Order. Seller is entitled to defer shipment of products in the event all amounts due it under this or any other Agreement are not paid in full. All payments shall be made to Seller at its offices. The failure to make prompt payment shall be a material breach of this Agreement. The price of the products specified in this Order does not include federal taxes, state or local sales taxes, value added taxes, use taxes or occupational taxes. Unless prohibited by law, Buyer is responsible for and shall pay all applicable sales, use, occupational, excise, value added or other similar taxes applicable to the manufacture, sale, price, shipment or use of the products provided by Seller. 3. Delivery and Risk of Loss: All sales are FOB Seller's premises in Burr Ridge or Romeoville, Illinois. Seller shall have no liability or responsibility for the late or non-shipment of products hereunder. Title to, risk of loss, destruction of or damage to the products shall be Seller's until delivery of the products to a carrier at the Seller's premises in Burr Ridge, Illinois. Thereafter, Buyer shall be fully responsible for and assume all ownership, risk of loss, destruction of or damage to the products. Loss or damage to the products after title and risk of loss have passed to Seller will not release or excuse Buyer from its obligations under this Order to Seller, including the obligation to make full payment. 4. Short Shipments/Damage Claims: Seller will endeavor to ship all Orders complete or as complete as reasonably possible. Seller will, however, ship incomplete orders upon written authorization by Buyer. In that event, Seller shall have no liability for short, incomplete or delayed orders. All damage claims shall be made within fourteen (14) days of delivery and shall be in writing. 5. Rejection and Revocation of Acceptance: Any rejection or revocation of acceptance by Buyer (a) must be made within thirty (30) days of the products being made available for shipment to Buyer, (b) any attempted rejection or revocation of acceptance made thereafter shall be null and void, and (c) any rejection or revocation of acceptance shall comply with Seller's return protocol.\", \"level\": 1, \"text\": \"Schedule B NANOPHASE TECHNOLOGIES CORPORATION STANDARD TERMS AND CONDITIONS 1. General Terms: As used in these Terms and Conditions, the terms (a) \\\"Seller\\\" shall mean Nanophase Technologies Corporation and (b) \\\"Buyer\\\" shall mean the party ordering shipment of Seller's products under the Order. These Terms and Conditions, including the provisions on the face hereof, constitute the exclusive contract between the parties for the products provided by Seller (\\\"Order\\\" or \\\"Agreement\\\"). Seller will be deemed to have accepted this Order when Seller returns an acknowledged copy of this Order, or, at Seller's option, when Seller begins substantial performance under this Order. Buyer accepts this Order by acknowledging a copy of this Order, by confirming this Order by its purchase order, purchase requisition or confirmation, or by accepting for shipment the products hereunder. Notwithstanding the manner in which Buyer accepts, Buyer's acceptance is limited exclusively to the acceptance of Seller's terms and conditions set forth in this Order only. Seller hereby rejects any proposal by Buyer for additional or different terms in connection with the products or services provided. Buyer may acknowledge this Order by purchase order, but any and all terms, conditions and provisions contained in said purchase order, acknowledgment form or other communications with respect to the transaction contemplated by this Order, or subsequent to the date hereof, are agreed to be superfluous and without any force and effect. This Order, which includes all terms and conditions hereof, is intended to be the exclusive and final statement of the terms and understandings relative to the subject matter hereof, merging herein and superseding all negotiations and prior written or oral agreements between the parties as to the subject matter of the purchase of the products hereunder. There are no promises, representations or understandings made in connection with this Order or contemporaneous with the execution hereof, except as set forth herein. 2. Prices and Taxes: All prices are set forth on the face of this Order. Seller is entitled to defer shipment of products in the event all amounts due it under this or any other Agreement are not paid in full. All payments shall be made to Seller at its offices. The failure to make prompt payment shall be a material breach of this Agreement. The price of the products specified in this Order does not include federal taxes, state or local sales taxes, value added taxes, use taxes or occupational taxes. Unless prohibited by law, Buyer is responsible for and shall pay all applicable sales, use, occupational, excise, value added or other similar taxes applicable to the manufacture, sale, price, shipment or use of the products provided by Seller. 3. Delivery and Risk of Loss: All sales are FOB Seller's premises in Burr Ridge or Romeoville, Illinois. Seller shall have no liability or responsibility for the late or non-shipment of products hereunder. Title to, risk of loss, destruction of or damage to the products shall be Seller's until delivery of the products to a carrier at the Seller's premises in Burr Ridge, Illinois. Thereafter, Buyer shall be fully responsible for and assume all ownership, risk of loss, destruction of or damage to the products. Loss or damage to the products after title and risk of loss have passed to Seller will not release or excuse Buyer from its obligations under this Order to Seller, including the obligation to make full payment. 4. Short Shipments/Damage Claims: Seller will endeavor to ship all Orders complete or as complete as reasonably possible. Seller will, however, ship incomplete orders upon written authorization by Buyer. In that event, Seller shall have no liability for short, incomplete or delayed orders. All damage claims shall be made within fourteen (14) days of delivery and shall be in writing. 5. Rejection and Revocation of Acceptance: Any rejection or revocation of acceptance by Buyer (a) must be made within thirty (30) days of the products being made available for shipment to Buyer, (b) any attempted rejection or revocation of acceptance made thereafter shall be null and void, and (c) any rejection or revocation of acceptance shall comply with Seller's return protocol.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Governing Laws\", \"level\": 1, \"text\": \"6. Compliance with Governing Laws: Buyer warrants that its performance hereunder, including the use of the products hereunder, shall comply with all applicable state, federal and foreign law, regulations, environmental regulations, statutes or requirements, including, but not limited to, FDA approvals or any other approvals or certifications required by law 7. Assignment and Modification: The rights and obligations of the parties under this Agreement shall not be assignable unless consent to the assignment is in writing and signed by the parties. This Order shall not be modified, altered or amended in any respect except by a writing signed by the parties. Any variation, modification, or addition to the terms set forth in this Order shall be considered a material modification and shall not be considered part of this Agreement. 8. Limited Warranty and Disclaimer of All Other Warranties: EXCEPT FOR THE EXPRESS WARRANTY, IF ANY, THAT THE PRODUCTS COMPLY WITH THE SPECIFICATIONS IDENTIFIED IN WRITING ON THE FACE OF OR ACCOMPANYING THIS ORDER, SELLER MAKES NO EXPRESS OR IMPLIED WARRANTIES IN THIS ORDER OR OTHERWISE. TO THE FULLEST EXTENT PERMITTED BY LAW, SELLER DISCLAIMS ALL WARRANTIES, WRITTEN, EXPRESS OR IMPLIED, INCLUDING ALL WARRANTIES OF MERCHANTABILITY AND/OR FITNESS FOR A PARTICULAR PURPOSE. SELLER EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY TO BUYER FOR ANY CONSEQUENTIAL DAMAGES, DAMAGES FOR LOSS OF USE, LOSS OF PROFITS, INCOME, OR REVENUE, LOSS OF TIME OR INCONVENIENCE, LOSS OR DAMAGE TO ASSOCIATED EQUIPMENT, COST OF SUBSTITUTED OR REPLACEMENT EQUIPMENT, LOSS TO FACILITIES, LOSS OF CAPITAL, LOSS OF SERVICES OR ANY OTHER INCIDENTAL, CONSEQUENTIAL OR SPECIAL DAMAGE ARISING OUT OF THIS ORDER OR THE OPERATION, FUNCTION OR CHARACTERISTICS OF THE PRODUCTS PURCHASED HEREUNDER OR OTHERWISE PROVIDED BY SELLER. IN THE EVENT THAT PRODUCTS DO NOT SATISFY SPECIFICATIONS, THEY WILL BE REPLACED, AT SELLER'S OPTION, WITH PRODUCTS THAT DO SATISFY THE SPECIFICATIONS AT SELLER'S SOLE EXPENSE. SAID REPLACEMENT IS THE SOLE AND EXCLUSIVE REMEDY OF BUYER. 9. Limitation of Liability: To the fullest extent permitted by law, the parties waive and relinquish any claims, demands, causes of action or recoveries for punitive damages, exemplary damages, or statutory damages. Seller shall not be liable for indirect, special, incidental or consequential damages arising under this Agreement or otherwise with respect to the sale of the products, including any lost revenues or profits, consequential and/or incidental damages, business interruption or damage to business reputation, regardless of the theory upon which any claim may be based, including any statutory causes of action or claims. In no event will Seller's entire liability to Buyer, including any liability in the event the exclusive remedy set forth in this Agreement fails of its essential purpose, exceed the purchase price actually paid by Buyer for the products hereunder, or any defective portion thereof, whichever is the lesser amount. 10. Force Majeure: Seller shall have no liability or obligation to Buyer of any kind, including but not limited to any obligation to ship products, arising from any delay or failure to perform all or any part of this Order as a result of causes, conduct or occurrences beyond Seller's reasonable control, including, but not limited to, commercial impracticability, fire, flood, act of war, civil disorder or disobedience, act of public enemies, terrorist acts, terrorism generally affecting commerce, problems associated with transportation (including car or truck shortages), acts or failure to act of any state, federal or foreign governmental or regulatory authorities, labor disputes or strikes. 11. Relationship: The relationship between Seller and Buyer shall be that of independent contractors. Seller, its agents and employees, shall under no circumstances be deemed the employees, distributors, franchisees, agents or representatives of Buyer.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Default\", \"level\": 1, \"text\": \"12. Default: The failure of Buyer to perform any obligations hereunder, including without limitation, the payment of the purchase price for products and all other amounts due hereunder, the failure to materially perform other agreements between Buyer and Seller, or Buyer's bankruptcy or insolvency, shall constitute a default under this Agreement and shall, in addition to any other remedies, afford Seller all of the remedies of a secured party under the Uniform Commercial Code of the State of Illinois. In the event of default, Seller may, in addition to pursuing any of the remedies provided by law, equity or as set forth in this Agreement, refuse to make available for shipment products under this or any other agreement relating to the products, and may also cancel this Order and any pending orders without liability to Buyer. It is expressly understood that Seller's remedies are cumulative to the fullest extent permitted by law. 13. Attorneys' Fees: In the event it becomes necessary for Seller to enforce the terms and conditions of this Order by litigation or otherwise, or to defend itself in any Controversy (as defined herein), litigation, claim, demand or cause of action arising out of or as a result of this Order or the products or services provided hereunder, and if Seller is the substantially prevailing party in said Controversy, litigation, claim, demand or cause of action, then Seller shall be entitled to recover, in addition to any other relief granted or damages assessed, its reasonable attorneys' fees, expert witness fees, costs, and all expenses of litigation. 14. Waiver: No claim or right arising out of a breach of this Order can be discharged in whole or in part by a waiver or renunciation of the claim or right unless the waiver or renunciation is supported by consideration and is in writing signed by the aggrieved party. 15. Severability: If any term, covenant, warranty or condition of this Order, or the application thereof to any person or circumstance shall, to any extent, be held or deemed invalid or unenforceable, the remainder of this Order or the application of such term, covenant or provision, to persons or circumstances other than those to which it is held invalid or unenforceable, shall not be affected thereby, and each remaining term, covenant or provision of this Order shall be deemed valid and enforced to the fullest extent permitted by law. 16. Indemnification: To the fullest extent permitted by law, Buyer shall defend, indemnify and hold Seller harmless from any and all claims, demands, subrogation claims by Buyer's insurers, causes of action, liabilities, fines, regulatory actions, seizures of product, losses, costs, expenses (including, but not limited to attorneys' fees, expert witness expenses and litigation expenses) (hereinafter \\\"Claim\\\"), arising from or in connection with any Claim asserted against Seller for any damage, injury, death, loss, property damage, environmental liability, or any other Claim, whether in tort, contract, or otherwise, relating to this Order, the business relationship between the parties or the goods provided hereunder. Notwithstanding the foregoing, Buyer has no indemnity obligation to Seller with respect to any Claims that result solely from the negligence of Seller and this indemnity provision does not purport to indemnify Seller solely for its own negligence, but rather for the negligence or conduct, whether sole or concurrent, of Buyer. Buyer, for itself and its insurers, expressly waives any and all limitations or liability caps, if any, on Buyer's contribution liability to Seller, and any and all statutory or common law lien rights or Claims against Seller arising from any applicable workers compensation or disability acts, which Buyer might or could assert against Seller or Seller's insurers in the event of the personal injury or death of Buyer's employees, representatives or servants. Without limiting the foregoing, Buyer, for itself and its insurers, also waives any liens, claims or other rights it may have as a result of being subrogated to any rights of its employees, representatives or servants. 17. Insurance: Buyer shall obtain comprehensive general liability coverage, including contractual liability coverage, naming Seller as an additional named insured, in amounts sufficient to fully protect Seller under this Agreement from loss, damage or casualty caused by Buyer or incurred by Seller under this Agreement. 18. Governing Law and Forum Selection: This agreement shall be governed by and subject to the internal laws (exclusive of the conflicts of law provisions) and decisions of the courts of the State of Illinois. The parties consent to the exclusive jurisdiction of the federal court in Chicago, Illinois or the state court located in DuPage County, Illinois with respect to all litigation, claims, causes of action, demands, Controversies (as defined herein) or disputes among the parties. The only exception to this forum selection provision is a claim by Seller seeking the replevin of the products in the event the courts specified in this provision will not or cannot assert jurisdiction. All counterclaims, if any, in connection with the replevin claim, shall be subject to this forum selection provision.\"}}, {\"id\": \"party:NANOPHASE TECHNOLOGIES CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NANOPHASE TECHNOLOGIES CORPORATION\", \"role\": \"Seller\", \"address\": null}}, {\"id\": \"party:JOHNSON MATTHEY CATALOG COMPANY, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"JOHNSON MATTHEY CATALOG COMPANY, INC.\", \"role\": \"Buyer\", \"address\": \"435 Devon Park, Suite 600. Wayne PA 19087\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"trade secret, technical, commercial, or financial information and all other nonpublic proprietary or confidential information\", \"definition_clause\": \"13.2\"}}, {\"id\": \"term:Seller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Seller\", \"text\": \"Nanophase Technologies Corporation\", \"definition_clause\": \"Schedule B\"}}, {\"id\": \"term:Buyer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Buyer\", \"text\": \"the party ordering shipment of Seller's products under the Order\", \"definition_clause\": \"Schedule B\"}}, {\"id\": \"term:Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Order\", \"text\": \"the exclusive contract between the parties for the products provided by Seller\", \"definition_clause\": \"Schedule B\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"the exclusive contract between the parties for the products provided by Seller\", \"definition_clause\": \"Schedule B\"}}, {\"id\": \"term:Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Claim\", \"text\": \"any and all claims, demands, subrogation claims by Buyer's insurers, causes of action, liabilities, fines, regulatory actions, seizures of product, losses, costs, expenses (including, but not limited to attorneys' fees, expert witness expenses and litigation expenses)\", \"definition_clause\": \"12\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 months\"}}, {\"id\": \"value:3 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 years\"}}, {\"id\": \"value:$2,000,000.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2,000,000.00\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:10 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 days\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 days\"}}, {\"id\": \"value:50wt%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50wt%\"}}, {\"id\": \"value:23wt%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"23wt%\"}}, {\"id\": \"value:18wt%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"18wt%\"}}, {\"id\": \"value:20wt%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20wt%\"}}, {\"id\": \"value:14 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"14 days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NEOMEDIATECHNOLOGIESINC_12_15_2005-EX-16.1-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NEOMEDIATECHNOLOGIESINC_12_15_2005-EX-16.1-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 16.1\", \"level\": 1, \"text\": \"Exhibit 16.1 AUTOMOTIVE REFINISH DISTRIBUTOR AGREEMENT (P.R.China) THIS AGREEMENT, made as of the 1st day of December, (the \\\"Effective Date\\\") by and between: PPG Paints Trading (Shanghai) Co Ltd hereinafter referred to as (\\\"PPG Shanghai\\\") Address : Suite 2512, 5th Floor No. 2 Xin Kang Building, 28 Jia Feng Road Wai Gao Qiao Free Trade Zone Shanghai, P. R. China Tel. : (86-21) 6291 3500 Fax : (86-21) 6291 2100 Business liscence no. : 0537762 Legal representative : Viktoras R. Sekmakas and NeoMedia Micro Paint Repair hereinafter referred to as (\\\"DISTRIBUTOR\\\") Address : 2201 Second Street, Suite 600 Ft. Myers, Florida, 33901 Tel. : 239-337-3434 Fax : 239-337-3668 Business licence no. : 2648151 Legal representative : Charles T. Jensen WITNESSETH: WHEREAS: A. PPG SHANGHAI desires DISTRIBUTOR to market and sell PPG's \\\"Deltron\\\" and \\\"ACS\\\" brand products, as hereinafter defined in Section 2 (the \\\"Products\\\"), to the repair chain shops in P.R.China as listed on Appendix 4 (the \\\"Territory\\\"); B. DISTRIBUTOR has the means to market Products in the Territory. As soon as Distributor's China subsidary, NeoMeida Micro Paint Repair China, a Wholley Foreign Owned Enterprise (\\\"WFOE\\\") registered under the Chinese laws and regulations, will be established, this title of Distributor will be automatically switched to the WFOE.\"}, {\"id\": \"C\", \"title\": \"PPG SHANGHAI desires to appoint DISTRIBUTOR as a PPG SHANGHAI distributor in the Territory and DISTRIBUT\", \"level\": 1, \"text\": \"C. PPG SHANGHAI desires to appoint DISTRIBUTOR as a PPG SHANGHAI distributor in the Territory and DISTRIBUTOR desires to be such distributor; and\"}, {\"id\": \"D\", \"title\": \"Accordingly, PPG SHANGHAI and DISTRIBUTOR have reached an agreement as hereinafter set forth\", \"level\": 1, \"text\": \"D. Accordingly, PPG SHANGHAI and DISTRIBUTOR have reached an agreement as hereinafter set forth. In consideration of the mutual covenants and agreements herein contained, the parties hereto, intending to be legally bound hereby, covenant and agree as follows:\"}, {\"id\": \"1\", \"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT\"}, {\"id\": \"1.1\", \"title\": \"PPG SHANGHAI does hereby appoint DISTRIBUTOR to distribute in the Territory the Products (as defined in paragra\", \"level\": 2, \"text\": \"1.1 PPG SHANGHAI does hereby appoint DISTRIBUTOR to distribute in the Territory the Products (as defined in paragraph 2, below) upon the terms and conditions hereinafter set forth. DISTRIBUTOR does hereby accept such appointment.\"}, {\"id\": \"1.2\", \"title\": \"It is agreed that such appointment is nonexclusive and PPG SHANGHAI may, without obligation to pay DISTRIBUTOR\", \"level\": 2, \"text\": \"1.2 It is agreed that such appointment is nonexclusive and PPG SHANGHAI may, without obligation to pay DISTRIBUTOR any commission or other compensation, make direct sales of Products to other customers in the Territory and/or appoint additional distributors of Products in the Territory. During the term of this Agreement, DISTRIBUTOR shall have the exclusive right for selling the Products to Beijing Sino-US Jinche Yingang Auto Technological Services Limited (the \\\"Auto Center\\\"). PPG Shanghai or any of its direct or indirect affiliates shall not sell any of its products directly to the Auto Center or to any of the Auto Center's affiliates in China or throughout the world, unless PPG Shanghai obtains Distributor's written approval. It is understood and agreed that as used herein the term \\\"PPG\\\" shall mean PPG Industries Inc. and/or one or more affiliated companies of PPG Industries Inc. as the context may require.\"}, {\"id\": \"1.3\", \"title\": \"Notwithstanding anything to the contrary in this Section 1, PPG SHANGHAI may also sell Products to any person o\", \"level\": 2, \"text\": \"1.3 Notwithstanding anything to the contrary in this Section 1, PPG SHANGHAI may also sell Products to any person or entity located outside the Territory without being obligated to consider whether such Products may be resold in the Territory. DISTRIBUTOR shall not be entitled to any commission or other compensation in such event.\"}, {\"id\": \"1.4\", \"title\": \"Deleted\", \"level\": 2, \"text\": \"1.4 Deleted.\"}, {\"id\": \"1.5\", \"title\": \"DISTRIBUTOR warrants that it will not handle any counterfeit, passing-off products or products other than those\", \"level\": 2, \"text\": \"1.5 DISTRIBUTOR warrants that it will not handle any counterfeit, passing-off products or products other than those purchased directly from PPG SHANGHAI.\"}, {\"id\": \"1.6\", \"title\": \"DISTRIBUTOR warrants and represents that it is a corporation duly organized, validly existing, and in good stan\", \"level\": 2, \"text\": \"1.6 DISTRIBUTOR warrants and represents that it is a corporation duly organized, validly existing, and in good standing under the applicable laws, that it has full legal right, power, and authority to enter into this Agreement and to consummate or cause to be consummated all of the transactions contemplated hereby, and that the execution, delivery, and/or performance of this Agreement do not or will not conflict with or result in a breach of any provision of any articles of incorporation or by-laws, or any written undertaking to which it is a party or by which it, or any of its assets, may be bound or affected, or result in a violation of any law, regulation, order, or award of any authority or body having jurisdiction over the assets and operations of it.\"}, {\"id\": \"2\", \"title\": \"PRODUCTS\", \"level\": 1, \"text\": \"2. PRODUCTS\"}, {\"id\": \"2.1\", \"title\": \"The Products and subject matter of this Agreement shall be the products listed below manufactured and sold by PPG SHANGH\", \"level\": 2, \"text\": \"2.1 The Products and subject matter of this Agreement shall be the products listed below manufactured and sold by PPG SHANGHAI or affiliated companies of PPG SHANGHAI. Additional Products may be added to or deleted from the list at the sole discretion of PPG SHANGHAI: (a) Global Deltron Refinish Products. (b) ACS Products. (c) Ancilliaries confirmed in writing for distribution by PPG SHANGHAI. (d) Mixing equipment and related accessories as approved and supplied by PPG SHANGHAI. (e) Any other products as PPG SHANGHAI may launch from time to time, at its absolute discretion.\"}, {\"id\": \"2.2\", \"title\": \"Specific product codes for above category a, b, c, d, and e shall reference PPG SHANGHAI Price List in effect a\", \"level\": 2, \"text\": \"2.2 Specific product codes for above category a, b, c, d, and e shall reference PPG SHANGHAI Price List in effect as of January 1, 2005 on Appendix 5.\"}, {\"id\": \"3\", \"title\": \"REPRESENTATIONS AND WARRANTIES BY DISTRIBUTOR\", \"level\": 1, \"text\": \"3. REPRESENTATIONS AND WARRANTIES BY DISTRIBUTOR DISTRIBUTOR represents and warrants to PPG SHANGHAI that(pound)(0) (a) it is a business entity duly incorporated and registered and validly existing under the relevant PRC laws and regulations; (b) it has been issued a valid business licence in its name by the relevant local branch of the State Administration of Industry and Commerce, and that business licence shall be valid within the duration of this Agreement; (c) it is permitted to distribute chemical products pursuant to this Agreement under its approved business scope; (d) it has a Dangerous Goods Business Permit Licence issued by the appropriate local government; (e) it has the qualification of a general taxpayer and is able to issue value added tax invoices; (f) it shall comply with all the relevant laws, regulations and permits, which have jurisdiction over its business, in relation to the sale of Products,\"}, {\"id\": \"4\", \"title\": \"DISTRIBUTOR'S RESPONSIBILITY\", \"level\": 1, \"text\": \"4. DISTRIBUTOR'S RESPONSIBILITY\"}, {\"id\": \"4.1\", \"title\": \"DISTRIBUTOR shall promote the sale of the Products in the Territory\", \"level\": 2, \"text\": \"4.1 DISTRIBUTOR shall promote the sale of the Products in the Territory. DISTRIBUTOR will conduct its operations in the Territory through offices or agencies to be maintained by DISTRIBUTOR at its sole cost and expense.\"}, {\"id\": \"4.2\", \"title\": \"If DISTRIBUTOR sells or distributes the Products outside the Territory, whether directly or indirectly through\", \"level\": 2, \"text\": \"4.2 If DISTRIBUTOR sells or distributes the Products outside the Territory, whether directly or indirectly through DISTRIBUTOR's cooperation or in conjunction with other third parties, or to customers outside the Territory without the prior knowledge and consent of PPG SHANGHAI, PPG SHANGHAI shall have the right to terminate with immediate effect this Agreement and any existing incentive arrangements between PPG SHANGHAI and DISTRIBUTOR, whether entered into before or after the commencement of the Agreement.\"}, {\"id\": \"4.3\", \"title\": \"DISTRIBUTOR agrees to satisfy the annual and quarterly sale targets for the Products set forth in Appendix 3 he\", \"level\": 2, \"text\": \"4.3 DISTRIBUTOR agrees to satisfy the annual and quarterly sale targets for the Products set forth in Appendix 3 herein as mutually agreed to by the parties hereof.\"}, {\"id\": \"4.4\", \"title\": \"DISTRIBUTOR and PPG Shanghai shall be responsible for providing technical support and after sale services to th\", \"level\": 2, \"text\": \"4.4 DISTRIBUTOR and PPG Shanghai shall be responsible for providing technical support and after sale services to the Territory. PPG Shanghai's responsibility under this Section 4.4 is defined in Section 8.\"}, {\"id\": \"5\", \"title\": \"PRICES AND TERMS\", \"level\": 1, \"text\": \"5. PRICES AND TERMS\"}, {\"id\": \"5.1\", \"title\": \"PPG SHANGHAI agrees that PPG SHANGHAI will sell and DISTRIBUTOR agrees to buy the Products at the prices agreed\", \"level\": 2, \"text\": \"5.1 PPG SHANGHAI agrees that PPG SHANGHAI will sell and DISTRIBUTOR agrees to buy the Products at the prices agreed to by the parties from time to time and subject to the terms and conditions stated herein. The prices in effect as of the Effective Date of the Agreement are set forth on Appendix 5. The prices for the Products must be agreed upon by PPG SHANGHAI at the time of PPG SHANGHAI's written acceptance of an order hereunder. Unless otherwise agreed by PPG SHANGHAI in writing, DISTRIBUTOR shall prepay all the invoiced amount in the currency and manner as indicated by PPG Shanghai. DISTRIBUTOR shall be deemed to complete its payment obligation upon full payment of the invoiced sum, and such amount has been allocated into the account as directed by PPG SHANGHAI. PPG SHANGHAI shall only have the obligation to deliver the Products upon full and due payment.\"}, {\"id\": \"5.2\", \"title\": \"PPG SHANGHAI reserves the right to adjust its selling prices based on local market situation\", \"level\": 2, \"text\": \"5.2 PPG SHANGHAI reserves the right to adjust its selling prices based on local market situation.\"}, {\"id\": \"5.3\", \"title\": \"PPG SHANGHAI shall bear the cost of transportation from overseas to its own warehouse, insurance and export / i\", \"level\": 2, \"text\": \"5.3 PPG SHANGHAI shall bear the cost of transportation from overseas to its own warehouse, insurance and export / import duty for any Products to be sold to Distributor hereunder. DISTRIBUTOR shall pick up the ordered Products from PPG SHANGHAI by its own transport agency to its own places at its own expenses.\"}, {\"id\": \"6\", \"title\": \"INTENT\", \"level\": 1, \"text\": \"6. INTENT It is the intent of this Agreement, and PPG SHANGHAI and DISTRIBUTOR agree, that: (a) no consignment shipments shall be made to DISTRIBUTOR; (b) DISTRIBUTOR is not authorized to sell the Products in any area outside the Territory or to establish or operate a \\\"permanent establishment\\\" in any country on behalf of PPG SHANGHAI; (c) DISTRIBUTOR shall take no action which would cause PPG SHANGHAI to be classified or to be considered as doing business in any country under the laws of any country, or which would cause PPG SHANGHAI to become subject to the income tax, excess profits tax, corporation receipts tax, or any other tax of any country; (d) DISTRIBUTOR has no authority to conclude contracts on behalf of or in the name of PPG SHANGHAI; (e) DISTRIBUTOR shall hold PPG SHANGHAI harmless from any taxes or other liability of any type, kind or nature, assessed against PPG SHANGHAI because of DISTRIBUTOR taking any action prohibited by subparagraphs (b), (c) and (d) above; (f) DISTRIBUTOR distributes the Products solely as an independent contractor and is not a franchisee, employee, partner or agent of PPG SHANGHAI and agrees not to represent the relationship as otherwise; (g) No fee or other mandatory consideration has been paid by DISTRIBUTOR to PPG SHANGHAI for issuance of this Agreement.\"}, {\"id\": \"8\", \"title\": \"PPG SHANGHAI'S RESPONSIBILITIES\", \"level\": 1, \"text\": \"8. PPG SHANGHAI'S RESPONSIBILITIES (a) PPG SHANGHAI shall use reasonable commercial efforts to support DISTRIBUTOR in its sale and marketing. PPG SHANGHAI shall provide its assistance in sale by providing DISTRIBUTOR with its usual and newly developed sale materials, samples and sale items from time to time through its sale/technical representatives. (b) Upon request by DISTRIBUTOR, PPG SHANGHAI shall provide DISTRIBUTOR with extra support by generally providing the relevant technique and other manner of consultation in relation to sale and use of Products. (c) In pursuance to the reasonable request of DISTRIBUTOR, PPG SHANGHAI shall arrange training for DISTRIBUTOR in accordance with the product training generally provided by PPG SHANGHAI at its Training Centers or other pre-agreed venues. (d) PPG SHANGHAI shall use reasonable commercial efforts to provide forthwith DISTRIBUTOR with the quantity of Products ordered by it and accepted by PPG SHANGHAI. The supplying responsibility of PPG SHANGHAI shall be subject to the stock of the ordered products at the time when DISTRIBUTOR's order is made with PPG SHANGHAI. (e) PPG SHANGHAI shall provide DISTRIBUTOR Quarterly and Annual Rebate as listed in Appendix 3 if agreed targets are achieved on time.\"}, {\"id\": \"9\", \"title\": \"DISTRIBUTOR'S RESPONSIBILITIES\", \"level\": 1, \"text\": \"9. DISTRIBUTOR'S RESPONSIBILITIES DISTRIBUTOR agrees that DISTRIBUTOR shall, use all reasonable efforts , do the following: (a) provide its customers with services regarding the Products, including the safety and toxicological aspects of Products handling and ensure that delivery to customers is made of technical information provided by PPG SHANGHAI regarding Products, including the safety precautions and toxicological aspects of Products handling; (b) maintain an adequate supply of Products to expedite customer deliveries and give prompt and efficient service to its customers in the Territory; (c) maintain knowledge of the market in the Territory and regularly communicate such knowledge to PPG SHANGHAI; (d) be responsible that the labels for the Products meet all governmental and all applicable laws of the Territory regulatory requirements and comply with all applicable laws of the Territory; (e) provide to its customers, Product technical support and training and ensure its customers maintain technical support and training to end-users. (f) plan and develop promotional and advertising strategies to enhance PPG SHANGHAI's image and sales value in the region. (g) Achieve agreed and signed sales target (Appendix 3).\"}, {\"id\": \"10\", \"title\": \"PPG SHANGHAI TRADEMARKS\", \"level\": 1, \"text\": \"10. PPG SHANGHAI TRADEMARKS\"}, {\"id\": \"10.1\", \"title\": \"PPG SHANGHAI represents that it has rights and interests in the trademarks used on the Products, including, wit\", \"level\": 2, \"text\": \"10.1 PPG SHANGHAI represents that it has rights and interests in the trademarks used on the Products, including, without limitation, the PPG logo listed on Appendix 2 hereto which shall herein be collectively referred to as the \\\"PPG Trademarks.\\\" PPG SHANGHAI hereby grants to DISTRIBUTOR during the Term, subject to the terms and conditions hereinafter specified, a limited, nonexclusive, nonassignable and nontransferable right to use the PPG Trademarks in the Territory for or in connection with its advertisement, promotion, sale and distribution of Products. In connection with any use of the PPG Trademarks, DISTRIBUTOR shall prominently indicate that DISTRIBUTOR is an independent distributor for PPG SHANGHAI. DISTRIBUTOR's use shall be subject to PPG SHANGHAI's approval and shall be limited to labels and advertisements of the Products in the Territory and shall be at the expense of DISTRIBUTOR. DISTRIBUTOR agrees to submit proposed uses of the PPG Trademarks on labels to the Director of Automotive Refinish (Asia Pacific region), or such other person as PPG SHANGHAI may designate from time to time, for review and approval. DISTRIBUTOR agrees that if it uses the PPG Trademarks on its labels and in its advertisements, it shall only be in the form approved in writing by PPG SHANGHAI. PPG SHANGHAI agrees that it will not unreasonably withhold approval of any labels or advertising material submitted to it by DISTRIBUTOR for approval and use pursuant to the provisions hereof. DISTRIBUTOR will not seek to obtain any registration of any of the PPG Trademarks. Upon termination of this Agreement, DISTRIBUTOR shall forthwith cease all further use of the PPG Trademarks and shall destroy all unused labels and advertisements containing the PPG Trademarks. Thereafter, DISTRIBUTOR shall not use any PPG Trademarks or trade or corporate names similar thereto.\"}, {\"id\": \"10.2\", \"title\": \"DISTRIBUTOR acknowledges PPG SHANGHAI's exclusive right and interests in relation to the PPG Trademarks and fur\", \"level\": 2, \"text\": \"10.2 DISTRIBUTOR acknowledges PPG SHANGHAI's exclusive right and interests in relation to the PPG Trademarks and further acknowledges that all copyrights, patent, utility model rights and all other industrial property rights of whatever kind used in or in connection with the Products are the sole and exclusive property of PPG SHANGHAI or PPG and that DISTRIBUTOR will not, whether during the Term of this appointment or after its expiry or termination, knowingly do or cause to be done any act or thing directly or indirectly, contest or in any way impair or attempting to impair PPG SHANGHAI or PPG's rights, titles or interests in the PPG Trademarks.\"}, {\"id\": \"10.3\", \"title\": \"DISTRIBUTOR shall not apply for registration of the PPG Trademarks in the People's Republic of China or in any\", \"level\": 2, \"text\": \"10.3 DISTRIBUTOR shall not apply for registration of the PPG Trademarks in the People's Republic of China or in any other countries.\"}, {\"id\": \"11\", \"title\": \"WARRANTY AND LIMITATION\", \"level\": 1, \"text\": \"11. WARRANTY AND LIMITATION\"}, {\"id\": \"11.1\", \"title\": \"PPG SHANGHAI warrants only its title to the Products and that the &bbsp; Products will be as set forth in the war\", \"level\": 2, \"text\": \"11.1 PPG SHANGHAI warrants only its title to the Products and that the &bbsp; Products will be as set forth in the warranty statement, if any, on the Products' labeling or in the absence of any such warranty statement that the Products will conform to PPG SHANGHAI's standard warranty when they are taken from PPG SHANGHAI's warehouse by DISTRIUTOR or its transport agent. DISTRIBUTOR is not authorized to make warranties or representations on behalf of PPG SHANGHAI and shall make no such warranties or representations. THESE ARE THE ONLY REPRESENTATIONS OR WARRANTIES THAT PPG SHANGHAI MAKES, AND ALL OTHER EXPRESS OR IMPLIED WARRANTIES UNDER STATUTE OR ARISING OTHERWISE IN LAW FROM A COURSE OF DEALING OR USAGE OF TRADE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTIBILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, ARE DISCLAIMED BY PPG SHANGHAI. In the event that the Product fails to conform to the warranties herein given, DISTRIBUTOR's exclusive remedy and PPG SHANGHAI's sole responsibility is, at PPG SHANGHAI's option, limited to the replacement of such nonconforming Product at PPG SHANGHAI's expense or the refund of the purchase price attributable to a specific delivery as to which a claim is made. For the avoidance of doubt, PPG SHANGHAI hereby declares and represents that PPG SHANGHAI is not responsible for any damage to the Products after they have been taken away from PPG SHANGHAI's warehouse and caused by DISTRIBUTOR or its transport agent.\"}, {\"id\": \"11.2\", \"title\": \"It is PPG SHANGHAI's responsibility to ensure that mis-delivery of Product is kept to the minimum\", \"level\": 2, \"text\": \"11.2 It is PPG SHANGHAI's responsibility to ensure that mis-delivery of Product is kept to the minimum. DISTRIBUTOR shall inspect the Products within 48 hours upon delivery. In case of discrepancy found in Products delivered, DISTRIBUTOR shall report to PPG SHANGHAI in writing, detailing all the discrepancies within 48 hours after delivery. PPG SHANGHAI will not accept any claims for discrepancy in delivery beyond the 48 hours period. If Products are found damaged upon delivery, DISTRIBUTOR or its customers who directly receive the delivery shall report to PPG SHANGHAI in writing within 48 hours. The necessary and sufficient evidence (and photos) required for insurance claim must be submitted altogether. None of the damaged Products shall be disposed of until the claim is settled by the insurance company or PPG SHANGHAI.\"}, {\"id\": \"11.3\", \"title\": \"DISTRIBUTOR assumes all responsibility, risk and liability arising from (i) the unloading, discharge, storage,\", \"level\": 2, \"text\": \"11.3 DISTRIBUTOR assumes all responsibility, risk and liability arising from (i) the unloading, discharge, storage, handling and use of the Products, including use thereof alone or in combination with other substances; (ii) the improper functioning or failure of unloading, discharge, transportation or storage systems equipment used by DISTRIBUTOR, whether furnished or recommended by PPG SHANGHAI or not; and (iii) the failure to comply with laws, rules and regulations governing unloading, discharge, storage, handling and use of the Products.\"}, {\"id\": \"12\", \"title\": \"FORCE MAJEURE\", \"level\": 1, \"text\": \"12. FORCE MAJEURE PPG SHANGHAI's failure or inability to make, or DISTRIBUTOR's failure or inability to take, any delivery or deliveries when due, or the failure or inability of either party to effect timely performance of any other obligation required of it hereunder, if caused by \\\"force majeure\\\" as hereinafter defined, shall not constitute a default hereunder or subject the party affected by force majeure to any liability to the other; provided, however, that the party so affected shall promptly notify the other of the existence thereof and of its expected duration and the estimated effect thereof upon its ability to perform its obligations hereunder. Such party shall promptly notify the other party when such force majeure circumstance has ceased to affect its ability to perform its obligations hereunder. The quantity to be delivered hereunder shall be reduced to the extent of the deliveries omitted for such cause or causes, unless both parties agree that the total quantity to be delivered hereunder shall remain unchanged. For so long as its ability to perform hereunder is affected by such force majeure circumstance, PPG SHANGHAI may, at its option, elect to allocate its total production of Product among its various requirements therefor (e.g., manufacturing and sales) in such manner as PPG SHANGHAI deems practicable and which, in the opinion of PPG SHANGHAI, is fair and reasonable. During the time that PPG SHANGHAI is unable to make deliveries or otherwise perform, it shall not be obligated to procure, or to use its best efforts to procure, any quantity of Product sold hereunder from any alternate producer or supplier. As used herein, the term \\\"force majeure\\\" shall mean and include any act of God, nature or the public enemy, accident, explosion, operation malfunction or interruption, fire, storm, earthquake, flood, drought, perils of the sea, strikes, lockouts, labor disputes, riots, sabotage, embargo, war (whether or not declared and whether or not the United States of America is a participant), federal, state or municipal legal restriction or limitation or compliance therewith, inability to obtain export licenses, failure or delay of transportation, shortage of, or inability to obtain, raw materials, supplies, equipment, fuel, power, labor, or other operational necessity, interruption, or curtailment of power supply, or any other circumstance of a similar or different nature beyond the reasonable control of the party affected thereby. In this connection, a party shall not be required to resolve labor disputes or disputes with suppliers of raw materials, supplies, equipment, fuel or power, except in accordance with such party's business judgment as to its best interest.\"}, {\"id\": \"13\", \"title\": \"PRODUCT HANDLING\", \"level\": 1, \"text\": \"13. PRODUCT HANDLING DISTRIBUTOR acknowledges that it has experience and expertise in handling and storing the Products, and that DISTRIBUTOR has the obligation to handle, store and distribute the Products safely and properly.\"}, {\"id\": \"14\", \"title\": \"PRODUCT SAFETY\", \"level\": 1, \"text\": \"14. PRODUCT SAFETY PPG SHANGHAI and DISTRIBUTOR recognize the importance of product safety considerations and the need to protect persons and property against unsafe conditions that could occur from the improper use, transportation, storage, handling, distribution or disposal of the Products sold hereunder. PPG SHANGHAI and DISTRIBUTOR will follow PPG's Responsible Care(R) Distributor Guidelines as set forth in the attached Appendix I (Responsible Care(R) is a registered trademark in the United States of the American Chemistry Council ). Accordingly, PPG SHANGHAI will furnish certain information to DISTRIBUTOR regarding product safety and handling aspects of the Products, and DISTRIBUTOR, in addition to its independent responsibility to obtain and implement a product safety program regarding the Products, will implement and conform to PPG SHANGHAI's product safety recommendations and Responsible Care(R) Distributor Guidelines, DISTRIBUTOR will also provide its customers, employees and other third parties foreseeably exposed to the Products with appropriate warnings, advice and other material regarding the Products, including all product safety and handling material provided by PPG SHANGHAI, and will ensure that the Products are used, stored, handled, distributed, transported and disposed of in a manner consistent with all of the above recommendations.\"}, {\"id\": \"15\", \"title\": \"PRODUCT DISCONTINUANCE\", \"level\": 1, \"text\": \"15. PRODUCT DISCONTINUANCE DISTRIBUTOR acknowledges that it has express notice that PPG or PPG SHANGHAI may at any time discontinue the production and/or sale of any of the Products. If PPG or PPG SHANGHAI does discontinue the production and/or sale of any of the Products, this Agreement shall automatically terminate with respect to such discontinued Product, and DISTRIBUTOR shall not be entitled to claim or receive from PPG or PPG SHANGHAI any compensation, reimbursement or damages of any nature as a result (direct or indirect) of PPG or PPG SHANGHAI's discontinuance of the production and/or sale of the affected Product.\"}, {\"id\": \"16\", \"title\": \"LIMITATION OF DAMAGES\", \"level\": 1, \"text\": \"16. LIMITATION OF DAMAGES Notwithstanding the provisions of any law, rule, or regulation to the contrary, on the termination of this Agreement for any cause whatsoever, DISTRIBUTOR shall not be entitled to claim or receive from PPG SHANGHAI any compensation, reimbursement, or damages on account of any expenditure or commitment of any kind in connection with its business or on account of goodwill or on account of loss of prospective profits or otherwise. In no event shall PPG SHANGHAI be liable for consequential damages.\"}, {\"id\": \"17\", \"title\": \"BUSINESS CONDUCT\", \"level\": 1, \"text\": \"17. BUSINESS CONDUCT\"}, {\"id\": \"17.1\", \"title\": \"In the performance of its responsibilities pursuant to this Agreement, DISTRIBUTOR agrees to make every effort\", \"level\": 2, \"text\": \"17.1 In the performance of its responsibilities pursuant to this Agreement, DISTRIBUTOR agrees to make every effort to operate as a good, responsible and ethical corporate entity in the Territory and will comply with the laws of the Territory, the applicable laws of the United States of America and the countries of origin of the Products. DISTRIBUTOR further agrees that it will not, in connection with this Agreement or its performance hereunder, directly or indirectly offer, pay, promise to pay or authorize the payment of any money or thing of value to any employee of a customer or to any government official or to any person, (a) to improperly or unlawfully influence any act or decision of such customer employee or governmental official, including a decision to fail to perform his/her official functions, or (b) to induce such customer employee or government official to use his/her influence with the customer or the government (or instrumentality thereof), respectively, to affect or influence any act or decision of such customer or government (or instrumentality), in order to assist PPG SHANGHAI or DISTRIBUTOR in obtaining or retaining business or directing business to any other party. As used in this Section, the term \\\"government official\\\" means any officer or employee of any government or any department, agency, instrumentality or wholly-owned corporation thereof, or any person acting in an official capacity for or on behalf of any such government or department, agency, instrumentality or wholly-owned corporation thereof, or any candidate for political office.\"}, {\"id\": \"17.2\", \"title\": \"DISTRIBUTOR agrees to notify PPG SHANGHAI immediately of any solicitation, demand or other request for anything\", \"level\": 2, \"text\": \"17.2 DISTRIBUTOR agrees to notify PPG SHANGHAI immediately of any solicitation, demand or other request for anything of value, by or on behalf of any employee of a customer, government official or employee of any government which is directed to itself or to PPG SHANGHAI related to the sale and/or service of the Products.\"}, {\"id\": \"17.3\", \"title\": \"DISTRIBUTOR agrees to require any sub-distributor or other person which it hires or engages to assist in the pe\", \"level\": 2, \"text\": \"17.3 DISTRIBUTOR agrees to require any sub-distributor or other person which it hires or engages to assist in the performance of this Agreement to comply with the provisions of this Section 17.\"}, {\"id\": \"18\", \"title\": \"TERM OF AGREEMENT\", \"level\": 1, \"text\": \"18. TERM OF AGREEMENT\"}, {\"id\": \"18.1\", \"title\": \"The term of this Agreement (the \\\"Term\\\") shall commence on the date first above written and shall terminate on 3\", \"level\": 2, \"text\": \"18.1 The term of this Agreement (the \\\"Term\\\") shall commence on the date first above written and shall terminate on 31 December 2006, unless sooner terminated in accordance with the provisions hereof.\"}, {\"id\": \"18.2\", \"title\": \"The parties hereof intend to form a long-term relationship\", \"level\": 2, \"text\": \"18.2 The parties hereof intend to form a long-term relationship. To this end, if both parties wish to renew this Agreement, the parties shall agree on such intention in writing at least thirty(30) days before the expiry of the current Term of the Agreement. The parties shall agree on the terms and conditions of the renewal, and enter into a new agreement within sixty(60) days from the expiry of this Agreement. During this sixty(60) days period, both parties shall continue to perform their respective obligation under the same terms and conditions of this Agreement.\"}, {\"id\": \"18.3\", \"title\": \"In the event that there is no written notice issued by either party to show the intention to renew this Agreeme\", \"level\": 2, \"text\": \"18.3 In the event that there is no written notice issued by either party to show the intention to renew this Agreement in the said thirty(30) days before the expiry of the current Term of the Agreement, the Agreement shall terminate at the end of the said thirty(30) days. In the event that such a notice of intention to renew is issued, but the parties are not able to enter into a new agreement within that sixty(60) days from the expiry of this Agreement, this Agreement shall terminate at the end of the said sixty(60) days.\"}, {\"id\": \"19\", \"title\": \"DEFAULT AND TERMINATION\", \"level\": 1, \"text\": \"19. DEFAULT AND TERMINATION\"}, {\"id\": \"19.1\", \"title\": \"If either party be in default with respect to any of the terms or conditions of this Agreement, including, with\", \"level\": 2, \"text\": \"19.1 If either party be in default with respect to any of the terms or conditions of this Agreement, including, without limitation, DISTRIBUTOR's failure to pay any invoice of PPG SHANGHAI in accordance with its terms, and if it fails to correct such default or failure within ten (10) business days following written notice thereof from the other, the party serving such notice may, without prejudice to any other right or remedy, defer further performance hereunder until such default be remedied or terminate this Agreement by written notice to the other, and the same shall terminate immediately upon the giving of such notice.\"}, {\"id\": \"19.2\", \"title\": \"PPG SHANGHAI shall have the right to terminate this Agreement and/or suspend its performance hereunder immediat\", \"level\": 2, \"text\": \"19.2 PPG SHANGHAI shall have the right to terminate this Agreement and/or suspend its performance hereunder immediately upon giving notice to DISTRIBUTOR, which termination shall be effective upon receipt of notice, if any one of the following occurs: (i) DISTRIBUTOR engages in fraudulent conduct in its dealings with PPG SHANGHAI or the Products; (ii) DISTRIBUTOR, or any principal owner of DISTRIBUTOR, is convicted of a crime which, in PPG SHANGHAI's reasonable judgment, may adversely affect the goodwill or interest of DISTRIBUTOR or of PPG SHANGHAI; (iii) DISTRIBUTOR becomes insolvent, assigns or attempts to assign its business assets for the benefit of creditors, institutes or has instituted against it proceedings in bankruptcy, or dissolves or liquidates the business of DISTRIBUTOR; or (iv) the business licence of DISTRIBUTOR is cancelled by the State Administration of Industry and Commerce.\"}, {\"id\": \"20\", \"title\": \"DISPUTE RESOLUTION\", \"level\": 1, \"text\": \"20. DISPUTE RESOLUTION\"}, {\"id\": \"20.1\", \"title\": \"All disputes, controversies and claims arising from or incidental to this Agreement shall be resolved by both p\", \"level\": 2, \"text\": \"20.1 All disputes, controversies and claims arising from or incidental to this Agreement shall be resolved by both parties through friendly consultation. If no resolution can be reached within thirty (30) days following the date on which one party informed the other party his intention to refer the disputes, controversies and claims for arbitration, such disputes, controversies and claims shall be referred to the China International Economic and Trade Arbitration Committee (\\\"Arbitration Committee\\\") for a final and binding arbitration in pursuance to the arbitration rules which is effective on the date hereof.\"}, {\"id\": \"20.2\", \"title\": \"The venue of arbitration shall be in Shanghai or Beijing, China (to be decided by PPG SHANGHAI)\", \"level\": 2, \"text\": \"20.2 The venue of arbitration shall be in Shanghai or Beijing, China (to be decided by PPG SHANGHAI).\"}, {\"id\": \"20.3\", \"title\": \"The arbitration shall be conducted in English and Chinese\", \"level\": 2, \"text\": \"20.3 The arbitration shall be conducted in English and Chinese.\"}, {\"id\": \"20.4\", \"title\": \"There shall be three arbitrators\", \"level\": 2, \"text\": \"20.4 There shall be three arbitrators. Each of PPG SHANGHAI and DISTRIBUTOR shall select one; the chief arbitrator shall be selected by the first two arbitrators, provided that where the first two arbitrators are not able to agree on the appointment of the chief arbitrator within ten (10) days of the later of their appointments, the chief arbitrator shall be selected by the chairman of the Arbitration Committee.\"}, {\"id\": \"20.5\", \"title\": \"The chief arbitrator shall not be a PRC national or a national of the United States\", \"level\": 2, \"text\": \"20.5 The chief arbitrator shall not be a PRC national or a national of the United States.\"}, {\"id\": \"20.6\", \"title\": \"The arbitration award shall be final and binding on both parties\", \"level\": 2, \"text\": \"20.6 The arbitration award shall be final and binding on both parties. Each party agree to be bound by the arbitration award. The arbitration fees and enforcement costs (including witness fees and reasonable legal fees) shall be borne by the losing party unless provided otherwise in the arbitration award.\"}, {\"id\": \"20.7\", \"title\": \"During the occurrence of the dispute and the arbitration, other than the issues in dispute, each party shall co\", \"level\": 2, \"text\": \"20.7 During the occurrence of the dispute and the arbitration, other than the issues in dispute, each party shall continuously exercise its undisturbed rights and discharge its undisturbed obligations under this agreement.\"}, {\"id\": \"21\", \"title\": \"GOVERNING LAW\", \"level\": 1, \"text\": \"21. GOVERNING LAW The validity, construction, and performance of this Agreement shall be governed by and interpreted in accordance with the laws of the People's Republic of China.\"}, {\"id\": \"22\", \"title\": \"LANGUAGE AND COUNTERPART\", \"level\": 1, \"text\": \"22. LANGUAGE AND COUNTERPART This Agreement shall be executed in two (2) counterparts of the Chinese language text.\"}, {\"id\": \"23\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"23. ENTIRE AGREEMENT This writing, including all documents attached to and/or referenced herein, constitutes the entire agreement between PPG SHANGHAI and DISTRIBUTOR regarding the subject matter hereof, terminating and superseding any prior agreements relating to the subject matter hereof, and there are no understandings, representations, or warranties of any kind except as expressly set forth herein. No modification, amendment or change in this Agreement or addition hereto shall be effective or binding on either of the parties hereto unless set forth in a writing which specifically references this Agreement and is executed by the respective duly authorized representatives of PPG SHANGHAI and DISTRIBUTOR and, if required, upon approval by competent governmental authorities, and no modifications shall be effected by any DISTRIBUTOR purchase order forms or other documents containing terms or conditions at variance with or in addition to those in this Agreement. IN WITNESS WHEREOF, PPG SHANGHAI and DISTRIBUTOR have executed this Distributor Agreement effective the day, month, and year first above written. Witness: PPG Paints Trading (Shanghai) Co., Ltd. /s/ Ju dian By: /s/ Yuen Kit Yeg, Pauline ---------------------------- ------------------------------ Name: Yuen Kit Yeg, Pauline ---------------------------- Title: General Manager --------------------------- Witness: [DISTRIBUTOR] /s/ Paul Grzebielucha By /s/ Charles T. Jensen ---------------------------- ------------------------------- Name: Charles T. Jensen ---------------------------- Title: CEO ---------------------------\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NEOMEDIATECHNOLOGIESINC_12_15_2005-EX-16.1-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 16.1\", \"level\": 1, \"text\": \"Exhibit 16.1 AUTOMOTIVE REFINISH DISTRIBUTOR AGREEMENT (P.R.China) THIS AGREEMENT, made as of the 1st day of December, (the \\\"Effective Date\\\") by and between: PPG Paints Trading (Shanghai) Co Ltd hereinafter referred to as (\\\"PPG Shanghai\\\") Address : Suite 2512, 5th Floor No. 2 Xin Kang Building, 28 Jia Feng Road Wai Gao Qiao Free Trade Zone Shanghai, P. R. China Tel. : (86-21) 6291 3500 Fax : (86-21) 6291 2100 Business liscence no. : 0537762 Legal representative : Viktoras R. Sekmakas and NeoMedia Micro Paint Repair hereinafter referred to as (\\\"DISTRIBUTOR\\\") Address : 2201 Second Street, Suite 600 Ft. Myers, Florida, 33901 Tel. : 239-337-3434 Fax : 239-337-3668 Business licence no. : 2648151 Legal representative : Charles T. Jensen WITNESSETH: WHEREAS: A. PPG SHANGHAI desires DISTRIBUTOR to market and sell PPG's \\\"Deltron\\\" and \\\"ACS\\\" brand products, as hereinafter defined in Section 2 (the \\\"Products\\\"), to the repair chain shops in P.R.China as listed on Appendix 4 (the \\\"Territory\\\"); B. DISTRIBUTOR has the means to market Products in the Territory. As soon as Distributor's China subsidary, NeoMeida Micro Paint Repair China, a Wholley Foreign Owned Enterprise (\\\"WFOE\\\") registered under the Chinese laws and regulations, will be established, this title of Distributor will be automatically switched to the WFOE.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI desires to appoint DISTRIBUTOR as a PPG SHANGHAI distributor in the Territory and DISTRIBUT\", \"level\": 1, \"text\": \"C. PPG SHANGHAI desires to appoint DISTRIBUTOR as a PPG SHANGHAI distributor in the Territory and DISTRIBUTOR desires to be such distributor; and\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Accordingly, PPG SHANGHAI and DISTRIBUTOR have reached an agreement as hereinafter set forth\", \"level\": 1, \"text\": \"D. Accordingly, PPG SHANGHAI and DISTRIBUTOR have reached an agreement as hereinafter set forth. In consideration of the mutual covenants and agreements herein contained, the parties hereto, intending to be legally bound hereby, covenant and agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI does hereby appoint DISTRIBUTOR to distribute in the Territory the Products (as defined in paragra\", \"level\": 2, \"text\": \"1.1 PPG SHANGHAI does hereby appoint DISTRIBUTOR to distribute in the Territory the Products (as defined in paragraph 2, below) upon the terms and conditions hereinafter set forth. DISTRIBUTOR does hereby accept such appointment.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"It is agreed that such appointment is nonexclusive and PPG SHANGHAI may, without obligation to pay DISTRIBUTOR\", \"level\": 2, \"text\": \"1.2 It is agreed that such appointment is nonexclusive and PPG SHANGHAI may, without obligation to pay DISTRIBUTOR any commission or other compensation, make direct sales of Products to other customers in the Territory and/or appoint additional distributors of Products in the Territory. During the term of this Agreement, DISTRIBUTOR shall have the exclusive right for selling the Products to Beijing Sino-US Jinche Yingang Auto Technological Services Limited (the \\\"Auto Center\\\"). PPG Shanghai or any of its direct or indirect affiliates shall not sell any of its products directly to the Auto Center or to any of the Auto Center's affiliates in China or throughout the world, unless PPG Shanghai obtains Distributor's written approval. It is understood and agreed that as used herein the term \\\"PPG\\\" shall mean PPG Industries Inc. and/or one or more affiliated companies of PPG Industries Inc. as the context may require.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding anything to the contrary in this Section 1, PPG SHANGHAI may also sell Products to any person o\", \"level\": 2, \"text\": \"1.3 Notwithstanding anything to the contrary in this Section 1, PPG SHANGHAI may also sell Products to any person or entity located outside the Territory without being obligated to consider whether such Products may be resold in the Territory. DISTRIBUTOR shall not be entitled to any commission or other compensation in such event.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Deleted\", \"level\": 2, \"text\": \"1.4 Deleted.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR warrants that it will not handle any counterfeit, passing-off products or products other than those\", \"level\": 2, \"text\": \"1.5 DISTRIBUTOR warrants that it will not handle any counterfeit, passing-off products or products other than those purchased directly from PPG SHANGHAI.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR warrants and represents that it is a corporation duly organized, validly existing, and in good stan\", \"level\": 2, \"text\": \"1.6 DISTRIBUTOR warrants and represents that it is a corporation duly organized, validly existing, and in good standing under the applicable laws, that it has full legal right, power, and authority to enter into this Agreement and to consummate or cause to be consummated all of the transactions contemplated hereby, and that the execution, delivery, and/or performance of this Agreement do not or will not conflict with or result in a breach of any provision of any articles of incorporation or by-laws, or any written undertaking to which it is a party or by which it, or any of its assets, may be bound or affected, or result in a violation of any law, regulation, order, or award of any authority or body having jurisdiction over the assets and operations of it.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCTS\", \"level\": 1, \"text\": \"2. PRODUCTS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Products and subject matter of this Agreement shall be the products listed below manufactured and sold by PPG SHANGH\", \"level\": 2, \"text\": \"2.1 The Products and subject matter of this Agreement shall be the products listed below manufactured and sold by PPG SHANGHAI or affiliated companies of PPG SHANGHAI. Additional Products may be added to or deleted from the list at the sole discretion of PPG SHANGHAI: (a) Global Deltron Refinish Products. (b) ACS Products. (c) Ancilliaries confirmed in writing for distribution by PPG SHANGHAI. (d) Mixing equipment and related accessories as approved and supplied by PPG SHANGHAI. (e) Any other products as PPG SHANGHAI may launch from time to time, at its absolute discretion.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Specific product codes for above category a, b, c, d, and e shall reference PPG SHANGHAI Price List in effect a\", \"level\": 2, \"text\": \"2.2 Specific product codes for above category a, b, c, d, and e shall reference PPG SHANGHAI Price List in effect as of January 1, 2005 on Appendix 5.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES BY DISTRIBUTOR\", \"level\": 1, \"text\": \"3. REPRESENTATIONS AND WARRANTIES BY DISTRIBUTOR DISTRIBUTOR represents and warrants to PPG SHANGHAI that(pound)(0) (a) it is a business entity duly incorporated and registered and validly existing under the relevant PRC laws and regulations; (b) it has been issued a valid business licence in its name by the relevant local branch of the State Administration of Industry and Commerce, and that business licence shall be valid within the duration of this Agreement; (c) it is permitted to distribute chemical products pursuant to this Agreement under its approved business scope; (d) it has a Dangerous Goods Business Permit Licence issued by the appropriate local government; (e) it has the qualification of a general taxpayer and is able to issue value added tax invoices; (f) it shall comply with all the relevant laws, regulations and permits, which have jurisdiction over its business, in relation to the sale of Products,\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR'S RESPONSIBILITY\", \"level\": 1, \"text\": \"4. DISTRIBUTOR'S RESPONSIBILITY\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR shall promote the sale of the Products in the Territory\", \"level\": 2, \"text\": \"4.1 DISTRIBUTOR shall promote the sale of the Products in the Territory. DISTRIBUTOR will conduct its operations in the Territory through offices or agencies to be maintained by DISTRIBUTOR at its sole cost and expense.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If DISTRIBUTOR sells or distributes the Products outside the Territory, whether directly or indirectly through\", \"level\": 2, \"text\": \"4.2 If DISTRIBUTOR sells or distributes the Products outside the Territory, whether directly or indirectly through DISTRIBUTOR's cooperation or in conjunction with other third parties, or to customers outside the Territory without the prior knowledge and consent of PPG SHANGHAI, PPG SHANGHAI shall have the right to terminate with immediate effect this Agreement and any existing incentive arrangements between PPG SHANGHAI and DISTRIBUTOR, whether entered into before or after the commencement of the Agreement.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR agrees to satisfy the annual and quarterly sale targets for the Products set forth in Appendix 3 he\", \"level\": 2, \"text\": \"4.3 DISTRIBUTOR agrees to satisfy the annual and quarterly sale targets for the Products set forth in Appendix 3 herein as mutually agreed to by the parties hereof.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR and PPG Shanghai shall be responsible for providing technical support and after sale services to th\", \"level\": 2, \"text\": \"4.4 DISTRIBUTOR and PPG Shanghai shall be responsible for providing technical support and after sale services to the Territory. PPG Shanghai's responsibility under this Section 4.4 is defined in Section 8.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICES AND TERMS\", \"level\": 1, \"text\": \"5. PRICES AND TERMS\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI agrees that PPG SHANGHAI will sell and DISTRIBUTOR agrees to buy the Products at the prices agreed\", \"level\": 2, \"text\": \"5.1 PPG SHANGHAI agrees that PPG SHANGHAI will sell and DISTRIBUTOR agrees to buy the Products at the prices agreed to by the parties from time to time and subject to the terms and conditions stated herein. The prices in effect as of the Effective Date of the Agreement are set forth on Appendix 5. The prices for the Products must be agreed upon by PPG SHANGHAI at the time of PPG SHANGHAI's written acceptance of an order hereunder. Unless otherwise agreed by PPG SHANGHAI in writing, DISTRIBUTOR shall prepay all the invoiced amount in the currency and manner as indicated by PPG Shanghai. DISTRIBUTOR shall be deemed to complete its payment obligation upon full payment of the invoiced sum, and such amount has been allocated into the account as directed by PPG SHANGHAI. PPG SHANGHAI shall only have the obligation to deliver the Products upon full and due payment.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI reserves the right to adjust its selling prices based on local market situation\", \"level\": 2, \"text\": \"5.2 PPG SHANGHAI reserves the right to adjust its selling prices based on local market situation.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI shall bear the cost of transportation from overseas to its own warehouse, insurance and export / i\", \"level\": 2, \"text\": \"5.3 PPG SHANGHAI shall bear the cost of transportation from overseas to its own warehouse, insurance and export / import duty for any Products to be sold to Distributor hereunder. DISTRIBUTOR shall pick up the ordered Products from PPG SHANGHAI by its own transport agency to its own places at its own expenses.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTENT\", \"level\": 1, \"text\": \"6. INTENT It is the intent of this Agreement, and PPG SHANGHAI and DISTRIBUTOR agree, that: (a) no consignment shipments shall be made to DISTRIBUTOR; (b) DISTRIBUTOR is not authorized to sell the Products in any area outside the Territory or to establish or operate a \\\"permanent establishment\\\" in any country on behalf of PPG SHANGHAI; (c) DISTRIBUTOR shall take no action which would cause PPG SHANGHAI to be classified or to be considered as doing business in any country under the laws of any country, or which would cause PPG SHANGHAI to become subject to the income tax, excess profits tax, corporation receipts tax, or any other tax of any country; (d) DISTRIBUTOR has no authority to conclude contracts on behalf of or in the name of PPG SHANGHAI; (e) DISTRIBUTOR shall hold PPG SHANGHAI harmless from any taxes or other liability of any type, kind or nature, assessed against PPG SHANGHAI because of DISTRIBUTOR taking any action prohibited by subparagraphs (b), (c) and (d) above; (f) DISTRIBUTOR distributes the Products solely as an independent contractor and is not a franchisee, employee, partner or agent of PPG SHANGHAI and agrees not to represent the relationship as otherwise; (g) No fee or other mandatory consideration has been paid by DISTRIBUTOR to PPG SHANGHAI for issuance of this Agreement.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI'S RESPONSIBILITIES\", \"level\": 1, \"text\": \"8. PPG SHANGHAI'S RESPONSIBILITIES (a) PPG SHANGHAI shall use reasonable commercial efforts to support DISTRIBUTOR in its sale and marketing. PPG SHANGHAI shall provide its assistance in sale by providing DISTRIBUTOR with its usual and newly developed sale materials, samples and sale items from time to time through its sale/technical representatives. (b) Upon request by DISTRIBUTOR, PPG SHANGHAI shall provide DISTRIBUTOR with extra support by generally providing the relevant technique and other manner of consultation in relation to sale and use of Products. (c) In pursuance to the reasonable request of DISTRIBUTOR, PPG SHANGHAI shall arrange training for DISTRIBUTOR in accordance with the product training generally provided by PPG SHANGHAI at its Training Centers or other pre-agreed venues. (d) PPG SHANGHAI shall use reasonable commercial efforts to provide forthwith DISTRIBUTOR with the quantity of Products ordered by it and accepted by PPG SHANGHAI. The supplying responsibility of PPG SHANGHAI shall be subject to the stock of the ordered products at the time when DISTRIBUTOR's order is made with PPG SHANGHAI. (e) PPG SHANGHAI shall provide DISTRIBUTOR Quarterly and Annual Rebate as listed in Appendix 3 if agreed targets are achieved on time.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR'S RESPONSIBILITIES\", \"level\": 1, \"text\": \"9. DISTRIBUTOR'S RESPONSIBILITIES DISTRIBUTOR agrees that DISTRIBUTOR shall, use all reasonable efforts , do the following: (a) provide its customers with services regarding the Products, including the safety and toxicological aspects of Products handling and ensure that delivery to customers is made of technical information provided by PPG SHANGHAI regarding Products, including the safety precautions and toxicological aspects of Products handling; (b) maintain an adequate supply of Products to expedite customer deliveries and give prompt and efficient service to its customers in the Territory; (c) maintain knowledge of the market in the Territory and regularly communicate such knowledge to PPG SHANGHAI; (d) be responsible that the labels for the Products meet all governmental and all applicable laws of the Territory regulatory requirements and comply with all applicable laws of the Territory; (e) provide to its customers, Product technical support and training and ensure its customers maintain technical support and training to end-users. (f) plan and develop promotional and advertising strategies to enhance PPG SHANGHAI's image and sales value in the region. (g) Achieve agreed and signed sales target (Appendix 3).\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI TRADEMARKS\", \"level\": 1, \"text\": \"10. PPG SHANGHAI TRADEMARKS\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI represents that it has rights and interests in the trademarks used on the Products, including, wit\", \"level\": 2, \"text\": \"10.1 PPG SHANGHAI represents that it has rights and interests in the trademarks used on the Products, including, without limitation, the PPG logo listed on Appendix 2 hereto which shall herein be collectively referred to as the \\\"PPG Trademarks.\\\" PPG SHANGHAI hereby grants to DISTRIBUTOR during the Term, subject to the terms and conditions hereinafter specified, a limited, nonexclusive, nonassignable and nontransferable right to use the PPG Trademarks in the Territory for or in connection with its advertisement, promotion, sale and distribution of Products. In connection with any use of the PPG Trademarks, DISTRIBUTOR shall prominently indicate that DISTRIBUTOR is an independent distributor for PPG SHANGHAI. DISTRIBUTOR's use shall be subject to PPG SHANGHAI's approval and shall be limited to labels and advertisements of the Products in the Territory and shall be at the expense of DISTRIBUTOR. DISTRIBUTOR agrees to submit proposed uses of the PPG Trademarks on labels to the Director of Automotive Refinish (Asia Pacific region), or such other person as PPG SHANGHAI may designate from time to time, for review and approval. DISTRIBUTOR agrees that if it uses the PPG Trademarks on its labels and in its advertisements, it shall only be in the form approved in writing by PPG SHANGHAI. PPG SHANGHAI agrees that it will not unreasonably withhold approval of any labels or advertising material submitted to it by DISTRIBUTOR for approval and use pursuant to the provisions hereof. DISTRIBUTOR will not seek to obtain any registration of any of the PPG Trademarks. Upon termination of this Agreement, DISTRIBUTOR shall forthwith cease all further use of the PPG Trademarks and shall destroy all unused labels and advertisements containing the PPG Trademarks. Thereafter, DISTRIBUTOR shall not use any PPG Trademarks or trade or corporate names similar thereto.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR acknowledges PPG SHANGHAI's exclusive right and interests in relation to the PPG Trademarks and fur\", \"level\": 2, \"text\": \"10.2 DISTRIBUTOR acknowledges PPG SHANGHAI's exclusive right and interests in relation to the PPG Trademarks and further acknowledges that all copyrights, patent, utility model rights and all other industrial property rights of whatever kind used in or in connection with the Products are the sole and exclusive property of PPG SHANGHAI or PPG and that DISTRIBUTOR will not, whether during the Term of this appointment or after its expiry or termination, knowingly do or cause to be done any act or thing directly or indirectly, contest or in any way impair or attempting to impair PPG SHANGHAI or PPG's rights, titles or interests in the PPG Trademarks.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR shall not apply for registration of the PPG Trademarks in the People's Republic of China or in any\", \"level\": 2, \"text\": \"10.3 DISTRIBUTOR shall not apply for registration of the PPG Trademarks in the People's Republic of China or in any other countries.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY AND LIMITATION\", \"level\": 1, \"text\": \"11. WARRANTY AND LIMITATION\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI warrants only its title to the Products and that the &bbsp; Products will be as set forth in the war\", \"level\": 2, \"text\": \"11.1 PPG SHANGHAI warrants only its title to the Products and that the &bbsp; Products will be as set forth in the warranty statement, if any, on the Products' labeling or in the absence of any such warranty statement that the Products will conform to PPG SHANGHAI's standard warranty when they are taken from PPG SHANGHAI's warehouse by DISTRIUTOR or its transport agent. DISTRIBUTOR is not authorized to make warranties or representations on behalf of PPG SHANGHAI and shall make no such warranties or representations. THESE ARE THE ONLY REPRESENTATIONS OR WARRANTIES THAT PPG SHANGHAI MAKES, AND ALL OTHER EXPRESS OR IMPLIED WARRANTIES UNDER STATUTE OR ARISING OTHERWISE IN LAW FROM A COURSE OF DEALING OR USAGE OF TRADE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF MERCHANTIBILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, ARE DISCLAIMED BY PPG SHANGHAI. In the event that the Product fails to conform to the warranties herein given, DISTRIBUTOR's exclusive remedy and PPG SHANGHAI's sole responsibility is, at PPG SHANGHAI's option, limited to the replacement of such nonconforming Product at PPG SHANGHAI's expense or the refund of the purchase price attributable to a specific delivery as to which a claim is made. For the avoidance of doubt, PPG SHANGHAI hereby declares and represents that PPG SHANGHAI is not responsible for any damage to the Products after they have been taken away from PPG SHANGHAI's warehouse and caused by DISTRIBUTOR or its transport agent.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"It is PPG SHANGHAI's responsibility to ensure that mis-delivery of Product is kept to the minimum\", \"level\": 2, \"text\": \"11.2 It is PPG SHANGHAI's responsibility to ensure that mis-delivery of Product is kept to the minimum. DISTRIBUTOR shall inspect the Products within 48 hours upon delivery. In case of discrepancy found in Products delivered, DISTRIBUTOR shall report to PPG SHANGHAI in writing, detailing all the discrepancies within 48 hours after delivery. PPG SHANGHAI will not accept any claims for discrepancy in delivery beyond the 48 hours period. If Products are found damaged upon delivery, DISTRIBUTOR or its customers who directly receive the delivery shall report to PPG SHANGHAI in writing within 48 hours. The necessary and sufficient evidence (and photos) required for insurance claim must be submitted altogether. None of the damaged Products shall be disposed of until the claim is settled by the insurance company or PPG SHANGHAI.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR assumes all responsibility, risk and liability arising from (i) the unloading, discharge, storage,\", \"level\": 2, \"text\": \"11.3 DISTRIBUTOR assumes all responsibility, risk and liability arising from (i) the unloading, discharge, storage, handling and use of the Products, including use thereof alone or in combination with other substances; (ii) the improper functioning or failure of unloading, discharge, transportation or storage systems equipment used by DISTRIBUTOR, whether furnished or recommended by PPG SHANGHAI or not; and (iii) the failure to comply with laws, rules and regulations governing unloading, discharge, storage, handling and use of the Products.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE\", \"level\": 1, \"text\": \"12. FORCE MAJEURE PPG SHANGHAI's failure or inability to make, or DISTRIBUTOR's failure or inability to take, any delivery or deliveries when due, or the failure or inability of either party to effect timely performance of any other obligation required of it hereunder, if caused by \\\"force majeure\\\" as hereinafter defined, shall not constitute a default hereunder or subject the party affected by force majeure to any liability to the other; provided, however, that the party so affected shall promptly notify the other of the existence thereof and of its expected duration and the estimated effect thereof upon its ability to perform its obligations hereunder. Such party shall promptly notify the other party when such force majeure circumstance has ceased to affect its ability to perform its obligations hereunder. The quantity to be delivered hereunder shall be reduced to the extent of the deliveries omitted for such cause or causes, unless both parties agree that the total quantity to be delivered hereunder shall remain unchanged. For so long as its ability to perform hereunder is affected by such force majeure circumstance, PPG SHANGHAI may, at its option, elect to allocate its total production of Product among its various requirements therefor (e.g., manufacturing and sales) in such manner as PPG SHANGHAI deems practicable and which, in the opinion of PPG SHANGHAI, is fair and reasonable. During the time that PPG SHANGHAI is unable to make deliveries or otherwise perform, it shall not be obligated to procure, or to use its best efforts to procure, any quantity of Product sold hereunder from any alternate producer or supplier. As used herein, the term \\\"force majeure\\\" shall mean and include any act of God, nature or the public enemy, accident, explosion, operation malfunction or interruption, fire, storm, earthquake, flood, drought, perils of the sea, strikes, lockouts, labor disputes, riots, sabotage, embargo, war (whether or not declared and whether or not the United States of America is a participant), federal, state or municipal legal restriction or limitation or compliance therewith, inability to obtain export licenses, failure or delay of transportation, shortage of, or inability to obtain, raw materials, supplies, equipment, fuel, power, labor, or other operational necessity, interruption, or curtailment of power supply, or any other circumstance of a similar or different nature beyond the reasonable control of the party affected thereby. In this connection, a party shall not be required to resolve labor disputes or disputes with suppliers of raw materials, supplies, equipment, fuel or power, except in accordance with such party's business judgment as to its best interest.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT HANDLING\", \"level\": 1, \"text\": \"13. PRODUCT HANDLING DISTRIBUTOR acknowledges that it has experience and expertise in handling and storing the Products, and that DISTRIBUTOR has the obligation to handle, store and distribute the Products safely and properly.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT SAFETY\", \"level\": 1, \"text\": \"14. PRODUCT SAFETY PPG SHANGHAI and DISTRIBUTOR recognize the importance of product safety considerations and the need to protect persons and property against unsafe conditions that could occur from the improper use, transportation, storage, handling, distribution or disposal of the Products sold hereunder. PPG SHANGHAI and DISTRIBUTOR will follow PPG's Responsible Care(R) Distributor Guidelines as set forth in the attached Appendix I (Responsible Care(R) is a registered trademark in the United States of the American Chemistry Council ). Accordingly, PPG SHANGHAI will furnish certain information to DISTRIBUTOR regarding product safety and handling aspects of the Products, and DISTRIBUTOR, in addition to its independent responsibility to obtain and implement a product safety program regarding the Products, will implement and conform to PPG SHANGHAI's product safety recommendations and Responsible Care(R) Distributor Guidelines, DISTRIBUTOR will also provide its customers, employees and other third parties foreseeably exposed to the Products with appropriate warnings, advice and other material regarding the Products, including all product safety and handling material provided by PPG SHANGHAI, and will ensure that the Products are used, stored, handled, distributed, transported and disposed of in a manner consistent with all of the above recommendations.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT DISCONTINUANCE\", \"level\": 1, \"text\": \"15. PRODUCT DISCONTINUANCE DISTRIBUTOR acknowledges that it has express notice that PPG or PPG SHANGHAI may at any time discontinue the production and/or sale of any of the Products. If PPG or PPG SHANGHAI does discontinue the production and/or sale of any of the Products, this Agreement shall automatically terminate with respect to such discontinued Product, and DISTRIBUTOR shall not be entitled to claim or receive from PPG or PPG SHANGHAI any compensation, reimbursement or damages of any nature as a result (direct or indirect) of PPG or PPG SHANGHAI's discontinuance of the production and/or sale of the affected Product.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF DAMAGES\", \"level\": 1, \"text\": \"16. LIMITATION OF DAMAGES Notwithstanding the provisions of any law, rule, or regulation to the contrary, on the termination of this Agreement for any cause whatsoever, DISTRIBUTOR shall not be entitled to claim or receive from PPG SHANGHAI any compensation, reimbursement, or damages on account of any expenditure or commitment of any kind in connection with its business or on account of goodwill or on account of loss of prospective profits or otherwise. In no event shall PPG SHANGHAI be liable for consequential damages.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BUSINESS CONDUCT\", \"level\": 1, \"text\": \"17. BUSINESS CONDUCT\"}}, {\"id\": \"17.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the performance of its responsibilities pursuant to this Agreement, DISTRIBUTOR agrees to make every effort\", \"level\": 2, \"text\": \"17.1 In the performance of its responsibilities pursuant to this Agreement, DISTRIBUTOR agrees to make every effort to operate as a good, responsible and ethical corporate entity in the Territory and will comply with the laws of the Territory, the applicable laws of the United States of America and the countries of origin of the Products. DISTRIBUTOR further agrees that it will not, in connection with this Agreement or its performance hereunder, directly or indirectly offer, pay, promise to pay or authorize the payment of any money or thing of value to any employee of a customer or to any government official or to any person, (a) to improperly or unlawfully influence any act or decision of such customer employee or governmental official, including a decision to fail to perform his/her official functions, or (b) to induce such customer employee or government official to use his/her influence with the customer or the government (or instrumentality thereof), respectively, to affect or influence any act or decision of such customer or government (or instrumentality), in order to assist PPG SHANGHAI or DISTRIBUTOR in obtaining or retaining business or directing business to any other party. As used in this Section, the term \\\"government official\\\" means any officer or employee of any government or any department, agency, instrumentality or wholly-owned corporation thereof, or any person acting in an official capacity for or on behalf of any such government or department, agency, instrumentality or wholly-owned corporation thereof, or any candidate for political office.\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR agrees to notify PPG SHANGHAI immediately of any solicitation, demand or other request for anything\", \"level\": 2, \"text\": \"17.2 DISTRIBUTOR agrees to notify PPG SHANGHAI immediately of any solicitation, demand or other request for anything of value, by or on behalf of any employee of a customer, government official or employee of any government which is directed to itself or to PPG SHANGHAI related to the sale and/or service of the Products.\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR agrees to require any sub-distributor or other person which it hires or engages to assist in the pe\", \"level\": 2, \"text\": \"17.3 DISTRIBUTOR agrees to require any sub-distributor or other person which it hires or engages to assist in the performance of this Agreement to comply with the provisions of this Section 17.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM OF AGREEMENT\", \"level\": 1, \"text\": \"18. TERM OF AGREEMENT\"}}, {\"id\": \"18.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The term of this Agreement (the \\\"Term\\\") shall commence on the date first above written and shall terminate on 3\", \"level\": 2, \"text\": \"18.1 The term of this Agreement (the \\\"Term\\\") shall commence on the date first above written and shall terminate on 31 December 2006, unless sooner terminated in accordance with the provisions hereof.\"}}, {\"id\": \"18.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties hereof intend to form a long-term relationship\", \"level\": 2, \"text\": \"18.2 The parties hereof intend to form a long-term relationship. To this end, if both parties wish to renew this Agreement, the parties shall agree on such intention in writing at least thirty(30) days before the expiry of the current Term of the Agreement. The parties shall agree on the terms and conditions of the renewal, and enter into a new agreement within sixty(60) days from the expiry of this Agreement. During this sixty(60) days period, both parties shall continue to perform their respective obligation under the same terms and conditions of this Agreement.\"}}, {\"id\": \"18.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event that there is no written notice issued by either party to show the intention to renew this Agreeme\", \"level\": 2, \"text\": \"18.3 In the event that there is no written notice issued by either party to show the intention to renew this Agreement in the said thirty(30) days before the expiry of the current Term of the Agreement, the Agreement shall terminate at the end of the said thirty(30) days. In the event that such a notice of intention to renew is issued, but the parties are not able to enter into a new agreement within that sixty(60) days from the expiry of this Agreement, this Agreement shall terminate at the end of the said sixty(60) days.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFAULT AND TERMINATION\", \"level\": 1, \"text\": \"19. DEFAULT AND TERMINATION\"}}, {\"id\": \"19.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If either party be in default with respect to any of the terms or conditions of this Agreement, including, with\", \"level\": 2, \"text\": \"19.1 If either party be in default with respect to any of the terms or conditions of this Agreement, including, without limitation, DISTRIBUTOR's failure to pay any invoice of PPG SHANGHAI in accordance with its terms, and if it fails to correct such default or failure within ten (10) business days following written notice thereof from the other, the party serving such notice may, without prejudice to any other right or remedy, defer further performance hereunder until such default be remedied or terminate this Agreement by written notice to the other, and the same shall terminate immediately upon the giving of such notice.\"}}, {\"id\": \"19.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PPG SHANGHAI shall have the right to terminate this Agreement and/or suspend its performance hereunder immediat\", \"level\": 2, \"text\": \"19.2 PPG SHANGHAI shall have the right to terminate this Agreement and/or suspend its performance hereunder immediately upon giving notice to DISTRIBUTOR, which termination shall be effective upon receipt of notice, if any one of the following occurs: (i) DISTRIBUTOR engages in fraudulent conduct in its dealings with PPG SHANGHAI or the Products; (ii) DISTRIBUTOR, or any principal owner of DISTRIBUTOR, is convicted of a crime which, in PPG SHANGHAI's reasonable judgment, may adversely affect the goodwill or interest of DISTRIBUTOR or of PPG SHANGHAI; (iii) DISTRIBUTOR becomes insolvent, assigns or attempts to assign its business assets for the benefit of creditors, institutes or has instituted against it proceedings in bankruptcy, or dissolves or liquidates the business of DISTRIBUTOR; or (iv) the business licence of DISTRIBUTOR is cancelled by the State Administration of Industry and Commerce.\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPUTE RESOLUTION\", \"level\": 1, \"text\": \"20. DISPUTE RESOLUTION\"}}, {\"id\": \"20.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All disputes, controversies and claims arising from or incidental to this Agreement shall be resolved by both p\", \"level\": 2, \"text\": \"20.1 All disputes, controversies and claims arising from or incidental to this Agreement shall be resolved by both parties through friendly consultation. If no resolution can be reached within thirty (30) days following the date on which one party informed the other party his intention to refer the disputes, controversies and claims for arbitration, such disputes, controversies and claims shall be referred to the China International Economic and Trade Arbitration Committee (\\\"Arbitration Committee\\\") for a final and binding arbitration in pursuance to the arbitration rules which is effective on the date hereof.\"}}, {\"id\": \"20.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The venue of arbitration shall be in Shanghai or Beijing, China (to be decided by PPG SHANGHAI)\", \"level\": 2, \"text\": \"20.2 The venue of arbitration shall be in Shanghai or Beijing, China (to be decided by PPG SHANGHAI).\"}}, {\"id\": \"20.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The arbitration shall be conducted in English and Chinese\", \"level\": 2, \"text\": \"20.3 The arbitration shall be conducted in English and Chinese.\"}}, {\"id\": \"20.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"There shall be three arbitrators\", \"level\": 2, \"text\": \"20.4 There shall be three arbitrators. Each of PPG SHANGHAI and DISTRIBUTOR shall select one; the chief arbitrator shall be selected by the first two arbitrators, provided that where the first two arbitrators are not able to agree on the appointment of the chief arbitrator within ten (10) days of the later of their appointments, the chief arbitrator shall be selected by the chairman of the Arbitration Committee.\"}}, {\"id\": \"20.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The chief arbitrator shall not be a PRC national or a national of the United States\", \"level\": 2, \"text\": \"20.5 The chief arbitrator shall not be a PRC national or a national of the United States.\"}}, {\"id\": \"20.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The arbitration award shall be final and binding on both parties\", \"level\": 2, \"text\": \"20.6 The arbitration award shall be final and binding on both parties. Each party agree to be bound by the arbitration award. The arbitration fees and enforcement costs (including witness fees and reasonable legal fees) shall be borne by the losing party unless provided otherwise in the arbitration award.\"}}, {\"id\": \"20.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the occurrence of the dispute and the arbitration, other than the issues in dispute, each party shall co\", \"level\": 2, \"text\": \"20.7 During the occurrence of the dispute and the arbitration, other than the issues in dispute, each party shall continuously exercise its undisturbed rights and discharge its undisturbed obligations under this agreement.\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW\", \"level\": 1, \"text\": \"21. GOVERNING LAW The validity, construction, and performance of this Agreement shall be governed by and interpreted in accordance with the laws of the People's Republic of China.\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LANGUAGE AND COUNTERPART\", \"level\": 1, \"text\": \"22. LANGUAGE AND COUNTERPART This Agreement shall be executed in two (2) counterparts of the Chinese language text.\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"23. ENTIRE AGREEMENT This writing, including all documents attached to and/or referenced herein, constitutes the entire agreement between PPG SHANGHAI and DISTRIBUTOR regarding the subject matter hereof, terminating and superseding any prior agreements relating to the subject matter hereof, and there are no understandings, representations, or warranties of any kind except as expressly set forth herein. No modification, amendment or change in this Agreement or addition hereto shall be effective or binding on either of the parties hereto unless set forth in a writing which specifically references this Agreement and is executed by the respective duly authorized representatives of PPG SHANGHAI and DISTRIBUTOR and, if required, upon approval by competent governmental authorities, and no modifications shall be effected by any DISTRIBUTOR purchase order forms or other documents containing terms or conditions at variance with or in addition to those in this Agreement. IN WITNESS WHEREOF, PPG SHANGHAI and DISTRIBUTOR have executed this Distributor Agreement effective the day, month, and year first above written. Witness: PPG Paints Trading (Shanghai) Co., Ltd. /s/ Ju dian By: /s/ Yuen Kit Yeg, Pauline ---------------------------- ------------------------------ Name: Yuen Kit Yeg, Pauline ---------------------------- Title: General Manager --------------------------- Witness: [DISTRIBUTOR] /s/ Paul Grzebielucha By /s/ Charles T. Jensen ---------------------------- ------------------------------- Name: Charles T. Jensen ---------------------------- Title: CEO ---------------------------\"}}, {\"id\": \"party:PPG Paints Trading (Shanghai) Co Ltd\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PPG Paints Trading (Shanghai) Co Ltd\", \"role\": \"PPG Shanghai\", \"address\": \"Suite 2512, 5th Floor No. 2 Xin Kang Building, 28 Jia Feng Road Wai Gao Qiao Free Trade Zone Shanghai, P. R. China\"}}, {\"id\": \"party:NeoMedia Micro Paint Repair\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NeoMedia Micro Paint Repair\", \"role\": \"DISTRIBUTOR\", \"address\": \"2201 Second Street, Suite 600 Ft. Myers, Florida, 33901\"}}, {\"id\": \"party:NeoMeida Micro Paint Repair China\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NeoMeida Micro Paint Repair China\", \"role\": \"WFOE\", \"address\": null}}, {\"id\": \"party:Beijing Sino-US Jinche Yingang Auto Technological Services Limited\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Beijing Sino-US Jinche Yingang Auto Technological Services Limited\", \"role\": \"Auto Center\", \"address\": null}}, {\"id\": \"party:PPG Industries Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PPG Industries Inc.\", \"role\": \"PPG\", \"address\": null}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the 1st day of December\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"PPG's \\\"Deltron\\\" and \\\"ACS\\\" brand products, as hereinafter defined in Section 2\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the repair chain shops in P.R.China as listed on Appendix 4\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:WFOE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"WFOE\", \"text\": \"Distributor's China subsidary, NeoMeida Micro Paint Repair China, a Wholley Foreign Owned Enterprise\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Auto Center\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Auto Center\", \"text\": \"Beijing Sino-US Jinche Yingang Auto Technological Services Limited\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:PPG\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PPG\", \"text\": \"PPG Industries Inc. and/or one or more affiliated companies of PPG Industries Inc. as the context may require\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:PPG Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PPG Trademarks\", \"text\": \"the trademarks used on the Products, including, without limitation, the PPG logo listed on Appendix 2 hereto\", \"definition_clause\": \"10.1\"}}, {\"id\": \"term:force majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"force majeure\", \"text\": \"any act of God, nature or the public enemy, accident, explosion, operation malfunction or interruption, fire, storm, earthquake, flood, drought, perils of the sea, strikes, lockouts, labor disputes, riots, sabotage, embargo, war (whether or not declared and whether or not the United States of America is a participant), federal, state or municipal legal restriction or limitation or compliance therewith, inability to obtain export licenses, failure or delay of transportation, shortage of, or inability to obtain, raw materials, supplies, equipment, fuel, power, labor, or other operational necessity, interruption, or curtailment of power supply, or any other circumstance of a similar or different nature beyond the reasonable control of the party affected thereby\", \"definition_clause\": \"12\"}}, {\"id\": \"term:government official\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"government official\", \"text\": \"any officer or employee of any government or any department, agency, instrumentality or wholly-owned corporation thereof, or any person acting in an official capacity for or on behalf of any such government or department, agency, instrumentality or wholly-owned corporation thereof, or any candidate for political office\", \"definition_clause\": \"17.1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"The term of this Agreement (...) shall commence on the date first above written and shall terminate on 31 December 2006, unless sooner terminated in accordance with the provisions hereof\", \"definition_clause\": \"18.1\"}}, {\"id\": \"term:Arbitration Committee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Arbitration Committee\", \"text\": \"the China International Economic and Trade Arbitration Committee\", \"definition_clause\": \"20.1\"}}, {\"id\": \"value:48 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"48 hours\"}}, {\"id\": \"value:thirty(30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty(30) days\"}}, {\"id\": \"value:sixty(60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty(60) days\"}}, {\"id\": \"value:ten (10) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) business days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"21\", \"level\": 1, \"text\": \"21\"}, {\"id\": \"EXHIBIT C\", \"title\": \"FORM OF SUBLICENSE\", \"level\": 1, \"text\": \"EXHIBIT C FORM OF SUBLICENSE [Form follows.] 22\"}, {\"id\": \"EXHIBIT D\", \"title\": \"FORM OF AGREEMENT FOR TRIAL\", \"level\": 1, \"text\": \"EXHIBIT D FORM OF AGREEMENT FOR TRIAL [Form follows.] 23 FIRST AMENDMENT TO DISTRIBUTOR AGREEMENT THIS FIRST AMENDMENT TO DISTRIBUTOR AGREEMENT (this \\\"Amendment\\\") is made and entered into as of the 1st day of January, 1999, by and between Peregrine/Bridge Transfer Corporation, a Delaware corporation (\\\"Licensor\\\"), and NEON Systems, Inc., a Delaware corporation (\\\"Licensee\\\"). RECITALS: Licensor and Licensee are parties to that certain Distributor Agreement dated as of January 1, 1996 (the \\\"Distributor Agreement\\\"). Licensor and Licensee desire to amend the Distributor Agreement as set forth herein. NOW, THEREFORE, for and consideration of the mutual covenants of the parties set forth herein, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follow:\"}, {\"id\": \"1\", \"title\": \"AMENDMENT OF DEFINITIONS\", \"level\": 1, \"text\": \"1. AMENDMENT OF DEFINITIONS. Article 1 of the Distributor Agreement is hereby amended to add thereto the following:\"}, {\"id\": \"1.11\", \"title\": \"\\\"Annual Royalty Advance Requirement\\\" shall mean (i) $1,000,000 in respect of Licensee's fiscal year beginning\", \"level\": 2, \"text\": \"1.11 \\\"Annual Royalty Advance Requirement\\\" shall mean (i) $1,000,000 in respect of Licensee's fiscal year beginning April 1, 1999, (ii) $2,000,000 in respect of Licensee's fiscal year beginning April 1, 2000, (iii) $3,000,000 in respect of Licensee's fiscal year beginning April 1, 2001, (iv) $4,000,000 in respect of Licensee's fiscal year beginning April 1, 2002 and (v) $5,000,000 in respect of Licensee's fiscal year beginning April 1, 2003. In the event that the term hereof extends beyond Licensee's fiscal year beginning April 1, 2003, the amount of the Annual Royalty Advance shall increase by $1,000,000 for each such fiscal year thereafter.\"}, {\"id\": \"1.12\", \"title\": \"\\\"Royalty Advance\\\" shall have the meaning provided therefor in Section 3\", \"level\": 2, \"text\": \"1.12 \\\"Royalty Advance\\\" shall have the meaning provided therefor in Section 3.2 hereof.\"}, {\"id\": \"1.13\", \"title\": \"\\\"Specified Royalty Percentage\\\" shall mean fifty percent (50%) for the period from and including January 1, 199\", \"level\": 2, \"text\": \"1.13 \\\"Specified Royalty Percentage\\\" shall mean fifty percent (50%) for the period from and including January 1, 1999 through and including March 31, 1994. Thereafter, the term \\\"Specified Royalty Percentage\\\" shall mean (i) fifty percent (50%) from and after the first day of each quarter of each fiscal year of Licensee commencing with Licensee's fiscal year beginning April 1, 1999) until such time, if any, during such quarter that the aggregate amount of all Royalty Advances outstanding as of the first day of such quarter (including the Royalty Advance payable on such first day) has been credited against royalties earned hereunder (a \\\"Satisfaction Date\\\"), and (ii) forty percent (40%) from and after a Satisfaction Date through and including the last day of the fiscal quarter in which such Satisfaction Date occurs.\"}, {\"id\": \"2\", \"title\": \"AMENDMENT OF SECTIONS 3\", \"level\": 1, \"text\": \"2. AMENDMENT OF SECTIONS 3.1 AND 3.2. Sections 3.1 and 3.2 of the Distributor Agreement are hereby amended to read in their entirety as follows:\"}, {\"id\": \"Section 3.1\", \"title\": \"ROYALTIES TO LICENSOR\", \"level\": 2, \"text\": \"Section 3.1 ROYALTIES TO LICENSOR. (a) Licensee shall pay to Licensor for each Licensed Product licensed to a Redistributor or a Customer a royalty equal to the Specified Royalty Percentage of all revenues received (without deduction for value added tax, if any, but excluding any revenues for maintenance and support or upgrade services, which revenues are covered in paragraph (b) below) by Licensee under the Redistributor Agreement or Sublicense applicable to such Licensed Product. (b) Licensee shall pay to Licensor for maintenance and support and upgrade services provided under the applicable Sublicense or other written maintenance and support agreement with or approved by Licensee for each of the Licensed Products a royalty equal to the Specified Royalty Percentage of all revenues received (without deduction for value added tax, if any) by Licensee from a Redistributor or Customer relating to maintenance and support services or services for Upgrades or upgrades of systems for such Licensed Products.\"}, {\"id\": \"Section 3.2\", \"title\": \"TERMS OF PAYMENT\", \"level\": 2, \"text\": \"Section 3.2 TERMS OF PAYMENT. The royalties payable to Licensor pursuant to Section 3.1 shall be payable in accordance with the provisions of this Section 3.2. On or before the first day of each fiscal quarter of each fiscal year during the term hereof, commencing with the Licensee's fiscal year which begins on April 1, 1999, Licensee shall pay to Licensor, as an advance (a \\\"Royalty Advance\\\") of royalties anticipated to be paid hereunder during such fiscal year, an amount equal to twenty-five percent (25%) of the Annual Royalty Advance Requirement for such fiscal year. The aggregate amount of Royalty Advances outstanding from time to time shall be credited against royalties payable hereunder pursuant to Section 3.1 as and when such royalties are recognized as earned in accordance with generally accepted accounting principles. Royalty Advances made hereunder shall be made in respect of royalties that may become payable in respect of any and all Licensed Products and shall not be deemed made in respect 2 of any particular Licensed Product. With respect to any royalty payments due hereunder from Licensee to Licensor in excess of the amount of Royalty Advances made by Licensee from time to time hereunder, such payments shall be payable on the later of (i) sixty (60) days after the date of the applicable invoice to a Redistributor or Customer, as the case may be, or (ii) five (5) business days following Licensee's receipt of payment from a Redistributor or Customer, as the case may be. Any royalty payment that is not paid when due will bear interest from the date such amount is due until the date payment is made at a rate equal to ten percent (10%) per annum. All royalty payments due to Licensor under this Agreement shall be paid in U.S. Dollars. Upon the expiration or any termination of this Agreement, Licensor shall repay to Licensee the aggregate amount of all Royalty Advances then outstanding.\"}, {\"id\": \"3\", \"title\": \"AMENDMENT OF TERM\", \"level\": 1, \"text\": \"3. AMENDMENT OF TERM. Section 14.1 of the Distributor Agreement is hereby amended to read in its entirety as follows:\"}, {\"id\": \"Section 14.1\", \"title\": \"TERM\", \"level\": 2, \"text\": \"Section 14.1 TERM. This Agreement shall be effective through and including March 31, 2004. Upon the expiration of such term, this Agreement will renew automatically for successive terms of one (1) year each unless either party to this Agreement delivers written notice of termination to the other party to this Agreement at least sixty (60) days prior to the end of the original or any renewal term. 4. AMENDMENT OF TERMINATION PROVISIONS. The provisions of Section 14.2 are amended by deleting in its entirety subsection (b) thereof and by amending Section 14.2(a)(2) to read in its entirety as follows: (2) Immediately upon written notice if the other party defaults in the performance of any obligation under this Agreement, including failure to promptly pay any amount due hereunder, and fails to cure such default within thirty (30) days after delivery of written notice specifying the default (with any termination as a result of Licensee's failure to pay amounts due under this Agreement resulting in acceleration of Licensee's obligation to pay all sums accrued and payable to Licensor under this Agreement as of the date of such termination).\"}, {\"id\": \"5\", \"title\": \"AMENDMENT OF NATURE OF DISTRIBUTORSHIP\", \"level\": 1, \"text\": \"5. AMENDMENT OF NATURE OF DISTRIBUTORSHIP. Licensor and Licensee do hereby agree that this Amendment shall effect a change in the nature of the distributorship granted to Licensee pursuant to the Distributor Agreement from a non-exclusive to an exclusive distributorship (provided, however, that with respect to Licensor's Partitioned Database Facility product, Licensor also may license such product to International Business Machines Corporation for sublicensing and distribution). Any and all references in the Distributor Agreement to the rights granted to Licensee as non-exclusive rights are hereby amended to provide that such rights are 3 exclusive rights (including without limitation such references in Sections 2.1 (Use of Master Copy), 2.2 (Sublicensing) and 2.8 (Trademarks and Copyright).).\"}, {\"id\": \"6\", \"title\": \"AMENDMENT OF SECTION 13\", \"level\": 1, \"text\": \"6. AMENDMENT OF SECTION 13.1. The Distributor Agreement is hereby amended by adding the following sentence to the end of Section 13.1: Notwithstanding the foregoing, the foregoing limitation on liability shall not be applicable in respect of any liability of Licensor to Licensee resulting from any misrepresentation in, or breach of, the terms of Section 6.2 hereof or in respect of Licensor's obligation to repay Royalty Advances pursuant to Section 3.2 hereof.\"}, {\"id\": \"7\", \"title\": \"CHANGE OF ADDRESSES FOR NOTICE\", \"level\": 1, \"text\": \"7. CHANGE OF ADDRESSES FOR NOTICE. Section 15.2 of the Distributor Agreement is hereby amended by changing the address for notice to each of Licensor and Licensee to the following:\"}, {\"id\": \"14100\", \"title\": \"Southwest Freeway, Suite 500 Sugar Land, Texas 77478 Attn\", \"level\": 1, \"text\": \"14100 Southwest Freeway, Suite 500 Sugar Land, Texas 77478 Attn: President\"}, {\"id\": \"8\", \"title\": \"ADDITION OF RIGHT OF FIRST REFUSAL\", \"level\": 1, \"text\": \"8. ADDITION OF RIGHT OF FIRST REFUSAL. The Distributor Agreement is hereby amended by adding thereto a new Section 15.11 and a new Section 15.12, which shall read in their entirety as follows: Section 15.11 Right of First Refusal. If, at any time or from time to time during the term hereof, Licensor or any stockholder in Licensor shall have received a bona fide offer from any person or entity to sell, transfer or otherwise convey all or any stock in, or assets of, Licensor which Licensor or such stockholder, as the case may be (the \\\"Offeree\\\"), desires to accept, the Offeree shall first give written notice (the \\\"Offering Notice\\\") to Licensee of the financial and other terms and conditions (the \\\"Terms and Conditions\\\") of such offer. Licensee shall have the right and a first opportunity to purchase, lease or otherwise acquire, as the case may be, all or the applicable portion of such stock or assets (as specified in the applicable Offering Notice) on the Terms and Conditions set forth in the Offering Notice, such right to be exercised by notice in writing to the Offeree within ninety (90) days after the giving of the Offering Notice. If Licensee shall have exercised such right, the closing shall be held at the corporate offices of Licensee on the closing date specified in the Offering Notice or the date that is ninety (90) days after the date of Licensee's notice of its exercise of such right, whichever is later. If either party shall default under this Section, the other party shall be entitled to specific performance. If Licensee shall fail to give notice of the exercise of its right of first 4 refusal under this Section within such ninety (90) day period, or if Licensee shall notify the Offeree within such ninety (90) day period that Licensee has waived such right, then the Offeree shall have the right to sell, transfer or convey all or the applicable portion of the stock in, or assets of, Licensor (as specified in the Offering Notice) pursuant to the terms of the specific offer described in the applicable Offering Notice, but not otherwise. If such sale, transfer or conveyance is not consummated in accordance with the offer and the Terms and Conditions specified in the applicable Offering Notice, the rights of Licensee to an Offering Notice shall be reinstated. No exercise or waiver by Licensee of any of its rights hereunder shall modify, abridge, impair or affect any of Licensee's rights under any of the other terms or provisions of this Agreement. Any sale, transfer or other conveyance of all or any part of the stock in, or assets of, Licensor in violation of this Section shall be null and void. Skunkware, Inc., a Delaware corporation and the sole stockholder of Licensor (\\\"Skunkware\\\"), is joining in this Agreement for the purpose of agreeing to the terms of this Section and Section 15.12.\"}, {\"id\": \"Section 15.12\", \"title\": \"OPTION TO PURCHASE\", \"level\": 2, \"text\": \"Section 15.12 OPTION TO PURCHASE. Skunkware and Licensor hereby grant to Licensee the exclusive and irrevocable right and option to purchase (the \\\"Option\\\"), at Licensee's election, either (i) all of the assets of Licensor or (ii) all of the issued and outstanding stock of Licensor. Such option shall be exercisable during a period (the \\\"Option Period\\\") commencing on and including the earlier of (i) the date upon which Licensee shall have paid to Licensor, in any single fiscal year of Licensee, royalty payments hereunder in the aggregate amount of $10,000,000 or (ii) January 1, 2002, and ending upon the expiration or sooner termination of this Agreement. Licensee's exercise of the Option is at its sole discretion. Licensee may exercise the Option by written notice to Licensor and Skunkware at any time during the Option Period. Upon any such exercise of the Option, Licensee and Licensor or Skunkware (as the case may be) shall proceed to diligently and in good faith negotiate and execute a definitive purchase and sale agreement for Licensor's acquisition of all of the assets of, or outstanding capital stock in, Licensor, as the case may be. In the event that Licensee and Licensor or Skunkware, as the case may be, are unable to agree on any terms or conditions for such acquisition, the same shall be submitted to arbitration in accordance with the rules and procedures of the American Arbitration Association, with the arbitrator(s) to be experienced in the mainframe software industry. Notwithstanding the foregoing provision for arbitration concerning the terms of any purchase and sale agreement, and without limiting any other 5 conditions that may be included in any such purchase and sale agreement, Licensee shall have no obligation to consummate the acquisition of the assets of, or stock in, Licensor pursuant to its exercise of the Option if Licensee's board of directors should determine, in its sole discretion, that such acquisition would not be accretive to the value of Licensee. The definitive purchase and sale agreement shall provide that License may pay the purchase price thereunder in cash, in shares of its Common Stock or in some combination thereof. So long as the Option shall be in existence (whether or not exercisable), Skunkware and Licensor agree that Licensor will conduct its business in the ordinary course and will not, without the prior written consent of Licensee, merge or consolidated with any other entity, sell all or substantially all of its assets, grant or permit to exist any lien or encumbrance on any material portion of its assets, issue any securities to any person other than Skunkware or engage in any other transaction or enter into any other agreement other than in the ordinary course of business. Skunkware further agrees that, so long as the Option shall be in existence (whether or not exercisable), it shall be and remain the sole Stockholder Licensor, and Licensor shall not issue to any other person or entity any stock, warrants or similar rights to acquire equity interests in Licensor.\"}, {\"id\": \"9\", \"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"9. MISCELLANEOUS. (a) Capitalized terms used in this Amendment that are not defined herein shall have the meanings provided therefor in the Distributor Agreement. (b) The captions used for the Sections in this Amendment are inserted only as a matter of convenience and for reference and in no way define, limit or describe the scope or the intent of this Amendment or any Section hereof. (c) This Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which, taken together, shall be construed as a single instrument. (d) In the event any provision of this Amendment is declared or adjudged to be unenforceable or unlawful by any court, then such unenforceable or unlawful provision shall be excised herefrom, and the remainder of this Amendment, together with all rights and remedies granted thereby, shall continue and remain in full force and effect. 6 (e) The Distributor Agreement, as amended by this Amendment, constitutes the entire agreement between the parties hereto with respect to the matters covered hereby and thereby. All prior negotiations, representations and agreements with respect thereto not incorporated in this Amendment or the Distributor Agreement are hereby canceled. As modified hereby, the Distributor Agreement shall continue in full force and effect and be binding upon the parties hereto and their respective successors and permitted assigns. References to the Distributor Agreement after the date hereof shall mean the Distributor Agreement as amended pursuant to this Amendment. The amendments to the Distributor Agreement effected by this Amendment shall be effective from and after the date hereof. (f) This Amendment shall be governed by and construed under the law governing the Distributor Agreement. [The remainder of this page is intentionally left blank.] 7 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first set forth above. PEREGRINE/BRIDGE TRANSFER CORPORATION By: /s/ Joe Backer ---------------------------- Name: Joe Backer -------------------------- Title: CEO ------------------------- NEON SYSTEMS, INC. By: /s/ John S. Reiland ---------------------------- Name: John S. Reiland -------------------------- Title: CFO ------------------------- 8 JOINDER OF SKUNKWARE, INC. Skunkware, Inc., a Delaware corporation, hereby joins in that certain Distributor Agreement dated as of January 1, 1996, between Peregrine/Bridge Transfer Corporation (\\\"PBTC\\\") and NEON Systems, Inc. (\\\"NEON\\\"), as amended by the First Amendment to Distributor Agreement dated as of November 19, 1998 by and between PBTC and NEON, such joinder being for purposes of acknowledging and agreeing to be bound by the terms of the Right of First Refusal set forth in Section 15.11 of the Distributor Agreement and the Option to Purchase set forth in Section 15.12 of the Distributor Agreement. Skunkware hereby represents and warrants to NEON that Skunkware is the sole stockholder of PBTC. Skunkware further agrees that its agreements set forth herein shall be binding on its successors and assigns and inure to the benefit of NEON's successors and assigns. Skunkware's address for any notice to it under the terms of the Distributor Agreement is as follows: Skunkware, Inc., 14100 Southwest Freeway, Suite 500, Sugar Land, Texas 77478, Attn: President. Executed as of the 1st day of January, 1999. SKUNKWARE, INC. By: /s/ Joe Backer ------------------------- Name: Joe Backer ----------------------- Title: CEO ---------------------- 66049:53214:DALLAS:277267.9 9\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_Amendment\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"21\", \"level\": 1, \"text\": \"21\"}}, {\"id\": \"EXHIBIT C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORM OF SUBLICENSE\", \"level\": 1, \"text\": \"EXHIBIT C FORM OF SUBLICENSE [Form follows.] 22\"}}, {\"id\": \"EXHIBIT D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORM OF AGREEMENT FOR TRIAL\", \"level\": 1, \"text\": \"EXHIBIT D FORM OF AGREEMENT FOR TRIAL [Form follows.] 23 FIRST AMENDMENT TO DISTRIBUTOR AGREEMENT THIS FIRST AMENDMENT TO DISTRIBUTOR AGREEMENT (this \\\"Amendment\\\") is made and entered into as of the 1st day of January, 1999, by and between Peregrine/Bridge Transfer Corporation, a Delaware corporation (\\\"Licensor\\\"), and NEON Systems, Inc., a Delaware corporation (\\\"Licensee\\\"). RECITALS: Licensor and Licensee are parties to that certain Distributor Agreement dated as of January 1, 1996 (the \\\"Distributor Agreement\\\"). Licensor and Licensee desire to amend the Distributor Agreement as set forth herein. NOW, THEREFORE, for and consideration of the mutual covenants of the parties set forth herein, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follow:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT OF DEFINITIONS\", \"level\": 1, \"text\": \"1. AMENDMENT OF DEFINITIONS. Article 1 of the Distributor Agreement is hereby amended to add thereto the following:\"}}, {\"id\": \"1.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Annual Royalty Advance Requirement\\\" shall mean (i) $1,000,000 in respect of Licensee's fiscal year beginning\", \"level\": 2, \"text\": \"1.11 \\\"Annual Royalty Advance Requirement\\\" shall mean (i) $1,000,000 in respect of Licensee's fiscal year beginning April 1, 1999, (ii) $2,000,000 in respect of Licensee's fiscal year beginning April 1, 2000, (iii) $3,000,000 in respect of Licensee's fiscal year beginning April 1, 2001, (iv) $4,000,000 in respect of Licensee's fiscal year beginning April 1, 2002 and (v) $5,000,000 in respect of Licensee's fiscal year beginning April 1, 2003. In the event that the term hereof extends beyond Licensee's fiscal year beginning April 1, 2003, the amount of the Annual Royalty Advance shall increase by $1,000,000 for each such fiscal year thereafter.\"}}, {\"id\": \"1.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Royalty Advance\\\" shall have the meaning provided therefor in Section 3\", \"level\": 2, \"text\": \"1.12 \\\"Royalty Advance\\\" shall have the meaning provided therefor in Section 3.2 hereof.\"}}, {\"id\": \"1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Specified Royalty Percentage\\\" shall mean fifty percent (50%) for the period from and including January 1, 199\", \"level\": 2, \"text\": \"1.13 \\\"Specified Royalty Percentage\\\" shall mean fifty percent (50%) for the period from and including January 1, 1999 through and including March 31, 1994. Thereafter, the term \\\"Specified Royalty Percentage\\\" shall mean (i) fifty percent (50%) from and after the first day of each quarter of each fiscal year of Licensee commencing with Licensee's fiscal year beginning April 1, 1999) until such time, if any, during such quarter that the aggregate amount of all Royalty Advances outstanding as of the first day of such quarter (including the Royalty Advance payable on such first day) has been credited against royalties earned hereunder (a \\\"Satisfaction Date\\\"), and (ii) forty percent (40%) from and after a Satisfaction Date through and including the last day of the fiscal quarter in which such Satisfaction Date occurs.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT OF SECTIONS 3\", \"level\": 1, \"text\": \"2. AMENDMENT OF SECTIONS 3.1 AND 3.2. Sections 3.1 and 3.2 of the Distributor Agreement are hereby amended to read in their entirety as follows:\"}}, {\"id\": \"Section 3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ROYALTIES TO LICENSOR\", \"level\": 2, \"text\": \"Section 3.1 ROYALTIES TO LICENSOR. (a) Licensee shall pay to Licensor for each Licensed Product licensed to a Redistributor or a Customer a royalty equal to the Specified Royalty Percentage of all revenues received (without deduction for value added tax, if any, but excluding any revenues for maintenance and support or upgrade services, which revenues are covered in paragraph (b) below) by Licensee under the Redistributor Agreement or Sublicense applicable to such Licensed Product. (b) Licensee shall pay to Licensor for maintenance and support and upgrade services provided under the applicable Sublicense or other written maintenance and support agreement with or approved by Licensee for each of the Licensed Products a royalty equal to the Specified Royalty Percentage of all revenues received (without deduction for value added tax, if any) by Licensee from a Redistributor or Customer relating to maintenance and support services or services for Upgrades or upgrades of systems for such Licensed Products.\"}}, {\"id\": \"Section 3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMS OF PAYMENT\", \"level\": 2, \"text\": \"Section 3.2 TERMS OF PAYMENT. The royalties payable to Licensor pursuant to Section 3.1 shall be payable in accordance with the provisions of this Section 3.2. On or before the first day of each fiscal quarter of each fiscal year during the term hereof, commencing with the Licensee's fiscal year which begins on April 1, 1999, Licensee shall pay to Licensor, as an advance (a \\\"Royalty Advance\\\") of royalties anticipated to be paid hereunder during such fiscal year, an amount equal to twenty-five percent (25%) of the Annual Royalty Advance Requirement for such fiscal year. The aggregate amount of Royalty Advances outstanding from time to time shall be credited against royalties payable hereunder pursuant to Section 3.1 as and when such royalties are recognized as earned in accordance with generally accepted accounting principles. Royalty Advances made hereunder shall be made in respect of royalties that may become payable in respect of any and all Licensed Products and shall not be deemed made in respect 2 of any particular Licensed Product. With respect to any royalty payments due hereunder from Licensee to Licensor in excess of the amount of Royalty Advances made by Licensee from time to time hereunder, such payments shall be payable on the later of (i) sixty (60) days after the date of the applicable invoice to a Redistributor or Customer, as the case may be, or (ii) five (5) business days following Licensee's receipt of payment from a Redistributor or Customer, as the case may be. Any royalty payment that is not paid when due will bear interest from the date such amount is due until the date payment is made at a rate equal to ten percent (10%) per annum. All royalty payments due to Licensor under this Agreement shall be paid in U.S. Dollars. Upon the expiration or any termination of this Agreement, Licensor shall repay to Licensee the aggregate amount of all Royalty Advances then outstanding.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT OF TERM\", \"level\": 1, \"text\": \"3. AMENDMENT OF TERM. Section 14.1 of the Distributor Agreement is hereby amended to read in its entirety as follows:\"}}, {\"id\": \"Section 14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 2, \"text\": \"Section 14.1 TERM. This Agreement shall be effective through and including March 31, 2004. Upon the expiration of such term, this Agreement will renew automatically for successive terms of one (1) year each unless either party to this Agreement delivers written notice of termination to the other party to this Agreement at least sixty (60) days prior to the end of the original or any renewal term. 4. AMENDMENT OF TERMINATION PROVISIONS. The provisions of Section 14.2 are amended by deleting in its entirety subsection (b) thereof and by amending Section 14.2(a)(2) to read in its entirety as follows: (2) Immediately upon written notice if the other party defaults in the performance of any obligation under this Agreement, including failure to promptly pay any amount due hereunder, and fails to cure such default within thirty (30) days after delivery of written notice specifying the default (with any termination as a result of Licensee's failure to pay amounts due under this Agreement resulting in acceleration of Licensee's obligation to pay all sums accrued and payable to Licensor under this Agreement as of the date of such termination).\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT OF NATURE OF DISTRIBUTORSHIP\", \"level\": 1, \"text\": \"5. AMENDMENT OF NATURE OF DISTRIBUTORSHIP. Licensor and Licensee do hereby agree that this Amendment shall effect a change in the nature of the distributorship granted to Licensee pursuant to the Distributor Agreement from a non-exclusive to an exclusive distributorship (provided, however, that with respect to Licensor's Partitioned Database Facility product, Licensor also may license such product to International Business Machines Corporation for sublicensing and distribution). Any and all references in the Distributor Agreement to the rights granted to Licensee as non-exclusive rights are hereby amended to provide that such rights are 3 exclusive rights (including without limitation such references in Sections 2.1 (Use of Master Copy), 2.2 (Sublicensing) and 2.8 (Trademarks and Copyright)).\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT OF SECTION 13\", \"level\": 1, \"text\": \"6. AMENDMENT OF SECTION 13.1. The Distributor Agreement is hereby amended by adding the following sentence to the end of Section 13.1: Notwithstanding the foregoing, the foregoing limitation on liability shall not be applicable in respect of any liability of Licensor to Licensee resulting from any misrepresentation in, or breach of, the terms of Section 6.2 hereof or in respect of Licensor's obligation to repay Royalty Advances pursuant to Section 3.2 hereof.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CHANGE OF ADDRESSES FOR NOTICE\", \"level\": 1, \"text\": \"7. CHANGE OF ADDRESSES FOR NOTICE. Section 15.2 of the Distributor Agreement is hereby amended by changing the address for notice to each of Licensor and Licensee to the following:\"}}, {\"id\": \"14100\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Southwest Freeway, Suite 500 Sugar Land, Texas 77478 Attn\", \"level\": 1, \"text\": \"14100 Southwest Freeway, Suite 500 Sugar Land, Texas 77478 Attn: President\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ADDITION OF RIGHT OF FIRST REFUSAL\", \"level\": 1, \"text\": \"8. ADDITION OF RIGHT OF FIRST REFUSAL. The Distributor Agreement is hereby amended by adding thereto a new Section 15.11 and a new Section 15.12, which shall read in their entirety as follows: Section 15.11 Right of First Refusal. If, at any time or from time to time during the term hereof, Licensor or any stockholder in Licensor shall have received a bona fide offer from any person or entity to sell, transfer or otherwise convey all or any stock in, or assets of, Licensor which Licensor or such stockholder, as the case may be (the \\\"Offeree\\\"), desires to accept, the Offeree shall first give written notice (the \\\"Offering Notice\\\") to Licensee of the financial and other terms and conditions (the \\\"Terms and Conditions\\\") of such offer. Licensee shall have the right and a first opportunity to purchase, lease or otherwise acquire, as the case may be, all or the applicable portion of such stock or assets (as specified in the applicable Offering Notice) on the Terms and Conditions set forth in the Offering Notice, such right to be exercised by notice in writing to the Offeree within ninety (90) days after the giving of the Offering Notice. If Licensee shall have exercised such right, the closing shall be held at the corporate offices of Licensee on the closing date specified in the Offering Notice or the date that is ninety (90) days after the date of Licensee's notice of its exercise of such right, whichever is later. If either party shall default under this Section, the other party shall be entitled to specific performance. If Licensee shall fail to give notice of the exercise of its right of first 4 refusal under this Section within such ninety (90) day period, or if Licensee shall notify the Offeree within such ninety (90) day period that Licensee has waived such right, then the Offeree shall have the right to sell, transfer or convey all or the applicable portion of the stock in, or assets of, Licensor (as specified in the Offering Notice) pursuant to the terms of the specific offer described in the applicable Offering Notice, but not otherwise. If such sale, transfer or conveyance is not consummated in accordance with the offer and the Terms and Conditions specified in the applicable Offering Notice, the rights of Licensee to an Offering Notice shall be reinstated. No exercise or waiver by Licensee of any of its rights hereunder shall modify, abridge, impair or affect any of Licensee's rights under any of the other terms or provisions of this Agreement. Any sale, transfer or other conveyance of all or any part of the stock in, or assets of, Licensor in violation of this Section shall be null and void. Skunkware, Inc., a Delaware corporation and the sole stockholder of Licensor (\\\"Skunkware\\\"), is joining in this Agreement for the purpose of agreeing to the terms of this Section and Section 15.12.\"}}, {\"id\": \"Section 15.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OPTION TO PURCHASE\", \"level\": 2, \"text\": \"Section 15.12 OPTION TO PURCHASE. Skunkware and Licensor hereby grant to Licensee the exclusive and irrevocable right and option to purchase (the \\\"Option\\\"), at Licensee's election, either (i) all of the assets of Licensor or (ii) all of the issued and outstanding stock of Licensor. Such option shall be exercisable during a period (the \\\"Option Period\\\") commencing on and including the earlier of (i) the date upon which Licensee shall have paid to Licensor, in any single fiscal year of Licensee, royalty payments hereunder in the aggregate amount of $10,000,000 or (ii) January 1, 2002, and ending upon the expiration or sooner termination of this Agreement. Licensee's exercise of the Option is at its sole discretion. Licensee may exercise the Option by written notice to Licensor and Skunkware at any time during the Option Period. Upon any such exercise of the Option, Licensee and Licensor or Skunkware (as the case may be) shall proceed to diligently and in good faith negotiate and execute a definitive purchase and sale agreement for Licensor's acquisition of all of the assets of, or outstanding capital stock in, Licensor, as the case may be. In the event that Licensee and Licensor or Skunkware, as the case may be, are unable to agree on any terms or conditions for such acquisition, the same shall be submitted to arbitration in accordance with the rules and procedures of the American Arbitration Association, with the arbitrator(s) to be experienced in the mainframe software industry. Notwithstanding the foregoing provision for arbitration concerning the terms of any purchase and sale agreement, and without limiting any other 5 conditions that may be included in any such purchase and sale agreement, Licensee shall have no obligation to consummate the acquisition of the assets of, or stock in, Licensor pursuant to its exercise of the Option if Licensee's board of directors should determine, in its sole discretion, that such acquisition would not be accretive to the value of Licensee. The definitive purchase and sale agreement shall provide that License may pay the purchase price thereunder in cash, in shares of its Common Stock or in some combination thereof. So long as the Option shall be in existence (whether or not exercisable), Skunkware and Licensor agree that Licensor will conduct its business in the ordinary course and will not, without the prior written consent of Licensee, merge or consolidated with any other entity, sell all or substantially all of its assets, grant or permit to exist any lien or encumbrance on any material portion of its assets, issue any securities to any person other than Skunkware or engage in any other transaction or enter into any other agreement other than in the ordinary course of business. Skunkware further agrees that, so long as the Option shall be in existence (whether or not exercisable), it shall be and remain the sole Stockholder Licensor, and Licensor shall not issue to any other person or entity any stock, warrants or similar rights to acquire equity interests in Licensor.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"9. MISCELLANEOUS. (a) Capitalized terms used in this Amendment that are not defined herein shall have the meanings provided therefor in the Distributor Agreement. (b) The captions used for the Sections in this Amendment are inserted only as a matter of convenience and for reference and in no way define, limit or describe the scope or the intent of this Amendment or any Section hereof. (c) This Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which, taken together, shall be construed as a single instrument. (d) In the event any provision of this Amendment is declared or adjudged to be unenforceable or unlawful by any court, then such unenforceable or unlawful provision shall be excised herefrom, and the remainder of this Amendment, together with all rights and remedies granted thereby, shall continue and remain in full force and effect. 6 (e) The Distributor Agreement, as amended by this Amendment, constitutes the entire agreement between the parties hereto with respect to the matters covered hereby and thereby. All prior negotiations, representations and agreements with respect thereto not incorporated in this Amendment or the Distributor Agreement are hereby canceled. As modified hereby, the Distributor Agreement shall continue in full force and effect and be binding upon the parties hereto and their respective successors and permitted assigns. References to the Distributor Agreement after the date hereof shall mean the Distributor Agreement as amended pursuant to this Amendment. The amendments to the Distributor Agreement effected by this Amendment shall be effective from and after the date hereof. (f) This Amendment shall be governed by and construed under the law governing the Distributor Agreement. [The remainder of this page is intentionally left blank.] 7 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first set forth above. PEREGRINE/BRIDGE TRANSFER CORPORATION By: /s/ Joe Backer ---------------------------- Name: Joe Backer -------------------------- Title: CEO ------------------------- NEON SYSTEMS, INC. By: /s/ John S. Reiland ---------------------------- Name: John S. Reiland -------------------------- Title: CFO ------------------------- 8 JOINDER OF SKUNKWARE, INC. Skunkware, Inc., a Delaware corporation, hereby joins in that certain Distributor Agreement dated as of January 1, 1996, between Peregrine/Bridge Transfer Corporation (\\\"PBTC\\\") and NEON Systems, Inc. (\\\"NEON\\\"), as amended by the First Amendment to Distributor Agreement dated as of November 19, 1998 by and between PBTC and NEON, such joinder being for purposes of acknowledging and agreeing to be bound by the terms of the Right of First Refusal set forth in Section 15.11 of the Distributor Agreement and the Option to Purchase set forth in Section 15.12 of the Distributor Agreement. Skunkware hereby represents and warrants to NEON that Skunkware is the sole stockholder of PBTC. Skunkware further agrees that its agreements set forth herein shall be binding on its successors and assigns and inure to the benefit of NEON's successors and assigns. Skunkware's address for any notice to it under the terms of the Distributor Agreement is as follows: Skunkware, Inc., 14100 Southwest Freeway, Suite 500, Sugar Land, Texas 77478, Attn: President. Executed as of the 1st day of January, 1999. SKUNKWARE, INC. By: /s/ Joe Backer ------------------------- Name: Joe Backer ----------------------- Title: CEO ---------------------- 66049:53214:DALLAS:277267.9 9\"}}, {\"id\": \"party:Peregrine/Bridge Transfer Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Peregrine/Bridge Transfer Corporation\", \"role\": \"Licensor\", \"address\": null}}, {\"id\": \"party:NEON Systems, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NEON Systems, Inc.\", \"role\": \"Licensee\", \"address\": null}}, {\"id\": \"party:International Business Machines Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"International Business Machines Corporation\", \"role\": null, \"address\": null}}, {\"id\": \"party:Skunkware, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Skunkware, Inc.\", \"role\": \"Skunkware\", \"address\": \"14100 Southwest Freeway, Suite 500, Sugar Land, Texas 77478, Attn: President.\"}}, {\"id\": \"term:Annual Royalty Advance Requirement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Royalty Advance Requirement\", \"text\": \"\\\"Annual Royalty Advance Requirement\\\" shall mean (i) $1,000,000 in respect of Licensee's fiscal year beginning April 1, 1999, (ii) $2,000,000 in respect of Licensee's fiscal year beginning April 1, 2000, (iii) $3,000,000 in respect of Licensee's fiscal year beginning April 1, 2001, (iv) $4,000,000 in respect of Licensee's fiscal year beginning April 1, 2002 and (v) $5,000,000 in respect of Licensee's fiscal year beginning April 1, 2003. In the event that the term hereof extends beyond Licensee's fiscal year beginning April 1, 2003, the amount of the Annual Royalty Advance shall increase by $1,000,000 for each such fiscal year thereafter.\", \"definition_clause\": \"1.11\"}}, {\"id\": \"term:Royalty Advance\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Royalty Advance\", \"text\": \"\\\"Royalty Advance\\\" shall have the meaning provided therefor in Section 3.2 hereof.\", \"definition_clause\": \"1.12\"}}, {\"id\": \"term:Specified Royalty Percentage\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specified Royalty Percentage\", \"text\": \"\\\"Specified Royalty Percentage\\\" shall mean fifty percent (50%) for the period from and including January 1, 1999 through and including March 31, 1994. Thereafter, the term \\\"Specified Royalty Percentage\\\" shall mean (i) fifty percent (50%) from and after the first day of each quarter of each fiscal year of Licensee commencing with Licensee's fiscal year beginning April 1, 1999) until such time, if any, during such quarter that the aggregate amount of all Royalty Advances outstanding as of the first day of such quarter (including the Royalty Advance payable on such first day) has been credited against royalties earned hereunder (a \\\"Satisfaction Date\\\"), and (ii) forty percent (40%) from and after a Satisfaction Date through and including the last day of the fiscal quarter in which such Satisfaction Date occurs.\", \"definition_clause\": \"1.13\"}}, {\"id\": \"value:$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000\"}}, {\"id\": \"value:$2,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2,000,000\"}}, {\"id\": \"value:$3,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$3,000,000\"}}, {\"id\": \"value:$4,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$4,000,000\"}}, {\"id\": \"value:$5,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5,000,000\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:40%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"40%\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"25%\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:5 business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) business days\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"10%\"}}, {\"id\": \"value:$10,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$10,000,000\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_New\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_New.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 1, \"text\": \"DISTRIBUTOR AGREEMENT by and between PEREGRINE/BRIDGE TRANSFER CORPORATION and NEON SYSTEMS, INC. TABLE OF CONTENTS EXHIBITS\"}, {\"id\": \"Exhibit A\", \"title\": \"List of Products Exhibit B The Territory Exhibit C Sublicense Agreement Exhibit D Agreement for Trial\", \"level\": 1, \"text\": \"Exhibit A List of Products Exhibit B The Territory Exhibit C Sublicense Agreement Exhibit D Agreement for Trial i DISTRIBUTOR AGREEMENT DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") is made as of the 1st day of January, 1996 by and between Peregrine/Bridge Transfer Corporation, a Delaware corporation (the \\\"Licensor\\\"), and Neon Systems, Inc., a Delaware corporation (the \\\"Licensee\\\"). WHEREAS, Licensor is engaged in the development, support and licensing of certain computer software products, including without limitation the computer software products fisted in EXHIBIT A to this Agreement; and WHEREAS, Licensee desires to obtain from Licensor, and Licensor desires to grant to Licensee, the right to market and sublicense the Licensed Products (as defined herein) in accordance with the terms and conditions set forth in this Agreement; NOW THEREFORE, in consideration of the foregoing and the mutual covenants set forth in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows.\"}, {\"id\": \"ARTICLE 1\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"ARTICLE 1 DEFINITIONS\"}, {\"id\": \"1.1\", \"title\": \"\\\"Customer\\\" means a person or entity that has acquired, or has indicated its interest in acquiring from Licensee, or\", \"level\": 2, \"text\": \"1.1 \\\"Customer\\\" means a person or entity that has acquired, or has indicated its interest in acquiring from Licensee, or from a Redistributor if so specified herein, a non-exclusive and nontransferable Sublicense to use one (1) or more of the Licensed Products.\"}, {\"id\": \"1.2\", \"title\": \"\\\"Documentation\\\" means all visually readable materials published or made available by Licensor during the term of th\", \"level\": 2, \"text\": \"1.2 \\\"Documentation\\\" means all visually readable materials published or made available by Licensor during the term of this Agreement for use by Customers in connection with the Licensed Products.\"}, {\"id\": \"1.3\", \"title\": \"\\\"Emergency Fix\\\" means a temporary correction of a problem in a Licensed Product reported by Licensee to Licensor th\", \"level\": 2, \"text\": \"1.3 \\\"Emergency Fix\\\" means a temporary correction of a problem in a Licensed Product reported by Licensee to Licensor that may take the form of a written instruction or magnetic or optical media.\"}, {\"id\": \"1.4\", \"title\": \"\\\"Licensed Product\\\" means any copy, or part thereof, of object code of the software products listed on EXHIBIT A att\", \"level\": 2, \"text\": \"1.4 \\\"Licensed Product\\\" means any copy, or part thereof, of object code of the software products listed on EXHIBIT A attached to this Agreement, as well as any Upgrades or other material distributed to Licensee by Licensor in connection with such software products.\"}, {\"id\": \"1.5\", \"title\": \"\\\"Master Copy\\\" means the initial object code copy of each Licensed Product and of any subsequent Upgrades or other d\", \"level\": 2, \"text\": \"1.5 \\\"Master Copy\\\" means the initial object code copy of each Licensed Product and of any subsequent Upgrades or other derivations distributed to Licensee by Licensor under this Agreement. 1\"}, {\"id\": \"1.6\", \"title\": \"\\\"Redistributor\\\" means any individual or entity that is granted a license by Licensee to copy and sublicense one or\", \"level\": 2, \"text\": \"1.6 \\\"Redistributor\\\" means any individual or entity that is granted a license by Licensee to copy and sublicense one or more Licensed Products to Customers.\"}, {\"id\": \"1.7\", \"title\": \"\\\"Sublicense\\\" means the sublicense agreement to be entered into by Customers, the form of which is attached hereto a\", \"level\": 2, \"text\": \"1.7 \\\"Sublicense\\\" means the sublicense agreement to be entered into by Customers, the form of which is attached hereto as EXHIBIT C, or such form as otherwise may be approved by Licensor pursuant to this Agreement.\"}, {\"id\": \"1.8\", \"title\": \"\\\"Sublicense Copy\\\" means an object code copy of the Licensed Product that Licensee licenses from Licensor and invent\", \"level\": 2, \"text\": \"1.8 \\\"Sublicense Copy\\\" means an object code copy of the Licensed Product that Licensee licenses from Licensor and inventories for sublicensing to Redistributors and Customers.\"}, {\"id\": \"1.9\", \"title\": \"\\\"Territory\\\" means that geographic area specified in EXHIBIT B attached to this Agreement\", \"level\": 2, \"text\": \"1.9 \\\"Territory\\\" means that geographic area specified in EXHIBIT B attached to this Agreement.\"}, {\"id\": \"1.10\", \"title\": \"\\\"Upgrade\\\" means any revision, adaptation or new version of a Licensed Product which enhances a Licensed Product and\", \"level\": 2, \"text\": \"1.10 \\\"Upgrade\\\" means any revision, adaptation or new version of a Licensed Product which enhances a Licensed Product and which is offered by Licensor to registered users of that Licensed Product as an \\\"upgrade.\\\"\"}, {\"id\": \"ARTICLE 2\", \"title\": \"LICENSE GRANT\", \"level\": 1, \"text\": \"ARTICLE 2 LICENSE GRANT\"}, {\"id\": \"Section 2.1\", \"title\": \"USE OF MASTER COPY\", \"level\": 2, \"text\": \"Section 2.1 USE OF MASTER COPY. Licensor hereby grants to Licensee a non- exclusive, worldwide right to use and reproduce the Master Copy of each Licensed Product and the related Documentation during the term of this Agreement for testing, demonstration to Redistributors. and Customers, support and maintenance, if any, back-up and archive purposes.\"}, {\"id\": \"Section 2.2\", \"title\": \"SUBLICENSING\", \"level\": 2, \"text\": \"Section 2.2 SUBLICENSING. Licensor hereby grants to Licensee an exclusive in the Territory to (1) make Sublicense Copies and copies of the Documentation to meet the demand of Redistributors and Customers and (2) market and sublicense Sublicense Copies and copies of the Documentation, together with any copies of promotional and other materials which Licensor may produce or obtain from time to time to assist Licensee in marketing and sublicensing the Licensed Products during the term of this Agreement by any one or more of the following means: (a) TO A REDISTRIBUTOR: To a Redistributor pursuant to a Redistributor Agreement containing substantially the same terms and conditions as are set forth in this Agreement (subject to Section 2.5) and a Sublicense with each Customer of Redistributor in accordance with subsection 2.2(b); or (b) TO CUSTOMERS: Pursuant to a Sublicense signed by the Customer.\"}, {\"id\": \"Section 2.3\", \"title\": \"AGREEMENTS FOR TRIAL\", \"level\": 2, \"text\": \"Section 2.3 AGREEMENTS FOR TRIAL. Licensee may make available the Licensed Products or Documentation to any Redistributor or Customer who wishes to test the Licensed Products on a trial basis so long as such Redistributor or Customer has entered into an Agreement For Trial with Licensee in the form attached to this Agreement as EXHIBIT D. 2\"}, {\"id\": \"Section 2.4\", \"title\": \"MAINTENANCE AND SUPPORT AGREEMENTS\", \"level\": 2, \"text\": \"Section 2.4 MAINTENANCE AND SUPPORT AGREEMENTS. Licensee may make available to Customers maintenance, support and upgrade services only under the terms contained in the Sublicense or other written maintenance and support agreement pertaining to such services.\"}, {\"id\": \"Section 2.5\", \"title\": \"REVIEW OF ARRANGEMENTS\", \"level\": 2, \"text\": \"Section 2.5 REVIEW OF ARRANGEMENTS. Licensee shall not enter into any agreement referred to in this Article 2 with any Redistributor or Customer until each such agreement has been submitted to and approved by Licensor. Within five (5) business days after its receipt of any such agreement, Licensor shall notify Licensee whether it approves or disapproves of the agreement and, if it disapproves of the agreement, Licensor shall provide written notice of the reasons therefor, including any changes that would require to approve of the agreement. If Licensor fails to notify Licensee of its approval or disapproval of any such agreement within such period of time, the agreement shall be deemed to be approved by Licensor.\"}, {\"id\": \"Section 2.6\", \"title\": \"TERMS OF AGREEMENTS\", \"level\": 2, \"text\": \"Section 2.6 TERMS OF AGREEMENTS. Licensee shall ensure that the terms of any Redistributor Agreement and, to the extent a Sublicense must be modified to comply with applicable law, any Sublicense executed in connection with the Licensed Products do not: (a) Diminish or limit any of the rights of Licensor in the Licensed Products or Documentation; (b) Diminish or limit the enforceability of the proprietary rights of Licensor in and to the Licensed Products or Documentation; (c) Convey any rights of ownership in the Licensed Products or Documentation to any individual or entity other than Licensor, except for the license rights granted in accordance with the terms of this Agreement; (d) Permit the use or duplication of the Licensed Products or Documentation, except as specifically provided in this Agreement or in the Sublicense; or (e) Permit disclosure of proprietary information regarding the Licensed Products or Documentation.\"}, {\"id\": \"Section 2.7\", \"title\": \"NATURE OF GRANT\", \"level\": 2, \"text\": \"Section 2.7 NATURE OF GRANT. Licensee shall not have any rights of ownership or other proprietary rights in the Licensed Products or any Documentation by virtue of this Agreement, except for the license grants set forth herein.\"}, {\"id\": \"Section 2.8\", \"title\": \"TRADEMARKS AND COPYRIGHT\", \"level\": 2, \"text\": \"Section 2.8 TRADEMARKS AND COPYRIGHT. Licensor hereby grants to Licensee a non-exclusive right to use the trademarks, service marks, trade names, copyrights, logos and designations (collectively, the \\\"Marks\\\") relating to the Licensed Products or the Documentation during the term of this Agreement in the marketing by Licensee of the Licensed Products, provided that such Marks clearly indicate Licensor as the owner of the Marks whenever the Licensed Product or Documentation is first mentioned in any written material referencing the Licensed Product and the proper symbol is used in a superscript following the Marks. Licensor promptly shall provide 3 a list of all Marks held by Licensor that relate to the Licensed Products. Upon reasonable written request by Licensor, Licensee shall provide Licensor with samples of any use of the Marks of Licensor relating to the Licensed Products, including any documentation and object code copies of the Licensed Products that Licensee sublicenses to Redistributors and Customers.\"}, {\"id\": \"ARTICLE 3\", \"title\": \"PRICING AND PAYMENT\", \"level\": 1, \"text\": \"ARTICLE 3 PRICING AND PAYMENT\"}, {\"id\": \"Section 3.1\", \"title\": \"FEES TO LICENSOR\", \"level\": 2, \"text\": \"Section 3.1 FEES TO LICENSOR. (a) Licensee shall pay to Licensor for each Licensed Product licensed to a Redistributor or a Customer a licensee fee equal to 50% of all revenues received (without deduction for value added tax, if any, but excluding any revenues for maintenance and support or upgrade services, which revenues are covered in paragraph (b) below) by Licensee under the Redistributor Agreement or Sublicense applicable to such Licensed Product. (b) Licensee shall pay to Licensor for maintenance and support and upgrade services provided under the applicable Sublicense or other written maintenance and support agreement with or approved by Licensee for each of the Licensed Products a fee equal to 50% of all revenues received (without deduction for value added tax, if any) by Licensee from a Redistributor or Customer relating to maintenance and support services or services for Upgrades or upgrades of systems for such Licensed Product.\"}, {\"id\": \"Section 3.2\", \"title\": \"TERMS OF PAYMENT\", \"level\": 2, \"text\": \"Section 3.2 TERMS OF PAYMENT. All fees due to Licensor under this Agreement shall be paid in U.S. Dollars. Fees due to Licensor from invoices rendered by Licensee during the first year of the term hereof will be payable one hundred and twenty (120) days after the date of the Licensee's invoice to a Redistributor or Customer, as the case may be. Fees due to Licensor from invoices rendered on or after the first day of the thirteenth (13th) month through and including the last day of the eighteenth (18th) month of the term hereof will be payable ninety (90) days after the date of such invoice. Fees due to Licensor from invoices rendered thereafter will be payable sixty (60) days after the date of such invoice. Any amount that is not paid when due will bear simple interest from the date such amount is due until the date payment is made at a rate equal to 10% per annum.\"}, {\"id\": \"ARTICLE 4\", \"title\": \"ORDER, DELIVERY AND ACCEPTANCE\", \"level\": 1, \"text\": \"ARTICLE 4 ORDER, DELIVERY AND ACCEPTANCE\"}, {\"id\": \"Section 4.1\", \"title\": \"ORDER AND DELIVERY\", \"level\": 2, \"text\": \"Section 4.1 ORDER AND DELIVERY. Licensee shall deliver to Licensor product orders (or other documents of similar purpose and effect) in writing that are signed by an authorized representative of Licensee and that list the quantity, product name, number, version, license fee and 4 proposed delivery date for such order. Licensor shall ship Licensed Products and Documentation in accordance with Licensee's product orders received and accepted by Licensor. Licensor shall ship Licensed Products and Documentation F.O.B. Licensor's place of business. Licensee shall be responsible for all customs fees and other costs and expenses arising in connection with the transactions contemplated by this Agreement, including costs and expenses related to packing and shipping the Licensed Products and Documentation and any freight and insurance charges, and Licensor may require Licensee to pay for such costs and expenses in advance of shipment of any Licensed Products or Documentation. Licensor shall not be liable to Licensee for delays in shipments due to causes beyond Licensor's reasonable control. Licensor reserves the right to reject any product order, to cancel any product orders placed by Licensee and accepted by Licensor and to refuse or delay shipment thereof if Licensee fails to make any payments as provided in this Agreement or otherwise continues to fail to comply with the terms and conditions of this Agreement for thirty (30) days after delivery of written notice of such failure.\"}, {\"id\": \"Section 4.2\", \"title\": \"TIME FOR ACCEPTANCE\", \"level\": 2, \"text\": \"Section 4.2 TIME FOR ACCEPTANCE. Licensee shall accept or reject the Licensed Products or Documentation within a ten (10) day evaluation period after receipt of such Licensed Product and the related Documentation by Licensee. If Licensee fails to give Licensor written notice of its rejection of such Licensed Products or Documentation within such ten (10) day evaluation period or Licensee ships such Licensed Products or Documentation to a Redistributor or Customer, then such Licensed Products and Documentation will be deemed to be accepted by Licensee.\"}, {\"id\": \"Section 4.3\", \"title\": \"REJECTION\", \"level\": 2, \"text\": \"Section 4.3 REJECTION. If Licensee rejects any Licensed Product in accordance with Section 4.2 because such Licensed Product fails to conform to the Documentation relating to such Licensed Product, Licensee shall notify Licensor promptly in writing to that effect and return all copies of such Licensed Product to Licensor with a certification by an authorized representative of Licensee that all copies have been returned to Licensor or have been destroyed and Licensor shall refund to Licensee the amount paid by Licensee to Licensor for such Licensed Products.\"}, {\"id\": \"ARTICLE 5\", \"title\": \"REPRESENTATIONS AND WARRANTIES OF LICENSEE\", \"level\": 1, \"text\": \"ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF LICENSEE\"}, {\"id\": \"Section 5.1\", \"title\": \"AUTHORITY\", \"level\": 2, \"text\": \"Section 5.1 AUTHORITY. Licensee represents and warrants that it is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and that it is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required by applicable law, except where the failure to be so qualified would not have a material adverse effect on Licensee or the assets of Licensee. Licensee represents and warrants that it has all requisite power and authority to execute this Agreement and to consummate the transactions contemplated hereby and that this Agreement has been duly executed and delivered by Licensee and constitutes a valid and binding obligation of Licensee enforceable in accordance with its terms. 5\"}, {\"id\": \"Section 5.2\", \"title\": \"ABILITY TO PERFORM\", \"level\": 2, \"text\": \"Section 5.2 ABILITY TO PERFORM. Licensee represents and warrants that it has sufficient facilities, resources and personnel to adequately perform its obligations under this Agreement and that no existing arrangement, contractual or otherwise, will cause Licensee to breach the terms of this Agreement or prevent Licensee from fulfilling its obligations under this Agreement.\"}, {\"id\": \"ARTICLE 6\", \"title\": \"REPRESENTATIONS AND WARRANTIES OF LICENSOR\", \"level\": 1, \"text\": \"ARTICLE 6 REPRESENTATIONS AND WARRANTIES OF LICENSOR\"}, {\"id\": \"Section 6.1\", \"title\": \"AUTHORITY\", \"level\": 2, \"text\": \"Section 6.1 AUTHORITY. Licensor represents and warrants that it is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and that it is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required by applicable law, except where the failure to be so qualified would not have a material adverse effect on Licensor or the assets of Licensor. Licensor represents and warrants that it has all requisite power and authority to execute this Agreement and to consummate the transactions contemplated hereby and that this Agreement has been duly executed and delivered by Licensor and constitutes a valid and binding obligation of Licensor enforceable in accordance with its terms.\"}, {\"id\": \"Section 6.2\", \"title\": \"TITLE TO LICENSED PRODUCTS\", \"level\": 2, \"text\": \"Section 6.2 TITLE TO LICENSED PRODUCTS. Licensor represents and warrants that it possesses all right, title and interest in and to the Licensed Products and the Documentation and that the use of each of the Licensed Products and the Documentation by Licensee, a Redistributor or a Customer will not in any way constitute an infringement or other violation of any copyright, trade secret, trademark, patent or other intellectual property fights or any proprietary information or nondisclosure or other rights of any third party. Licensor represents and warrants that no existing arrangement, contractual or otherwise, will cause Licensor to breach the terms of this Agreement or prevent Licensor from fulfilling its obligations under this Agreement.\"}, {\"id\": \"ARTICLE 7\", \"title\": \"COVENANTS OF LICENSEE\", \"level\": 1, \"text\": \"ARTICLE 7 COVENANTS OF LICENSEE\"}, {\"id\": \"Section 7.1\", \"title\": \"DUTIES OF LICENSEE\", \"level\": 2, \"text\": \"Section 7.1 DUTIES OF LICENSEE. Licensee shall be solely responsible for the proper advertising, demonstration, shipment, export and collection of payment relating to the Licensed Products and Documentation in the Territory. The duties of Licensee include without limitation the following: (a) Advertising the Licensed Product in appropriate media, contacting and developing Customers and prospective Redistributors by telephone and otherwise, providing information concerning Licensed Products to Customers and prospective Redistributors and advising such Customers and prospective Redistributors on the selection and use of the Licensed Products. 6 (b) Complying with Licensee's warranty obligations as set forth in its agreements with Redistributors and Customers. (c) Sending at Licensee's expense qualified and appropriate personnel of Licensee to participate in training sessions, which shall be conducted by Licensor from time to time without charge to Licensee for the benefit of Licensee and Licensee's personnel. (d) Obligating each Redistributor to keep complete and accurate records of such Redistributor's Customers, leads to prospective Customers, the number and type of Licensed Products licensed by such Redistributor and such related operating and financial data as Licensor reasonably may request from time to time for the sole purpose of monitoring the Licensed Products.\"}, {\"id\": \"Section 7.2\", \"title\": \"DOCUMENTATION\", \"level\": 2, \"text\": \"Section 7.2 DOCUMENTATION. Licensee shall represent accurately and completely the Licensed Products to Customers as to quality, function, purpose and compatibility in accordance with the Documentation whenever the Licensed Products are referenced, demonstrated or advertised. Licensee shall obtain prior written approval from Licensor for all materials other than the Documentation to be used by Licensee in connection with trials, demonstrations and agreements relating to the Licensed Products, and such approval shall not be unreasonably withheld or delayed by Licensor. Licensee shall give Licensor and any licensors of Licensor appropriate credit for the authorship of the Licensed Products and Documentation at any seminar, trade show or other presentation of the Licensed Products.\"}, {\"id\": \"Section 7.3\", \"title\": \"EXPORTING AND SHIPMENT\", \"level\": 2, \"text\": \"Section 7.3 EXPORTING AND SHIPMENT. Licensee shall obtain prior written approval from Licensor and any required export licenses from the United States Department of Commerce, Office of Export Administration or other applicable domestic or foreign governmental agency before exporting any Licensed Product or Documentation from the United States. Licensee agrees and covenants to comply fully with all applicable laws, rules and regulations, and to adopt such policies and procedures in connection with, the exporting of the Licensed Products and Documentation as may be required thereby. Each party to this Agreement shall cooperate fully with the other party to this Agreement and any governmental authorities by giving consents or information or providing or executing such documents as reasonably may be required to comply fully with such laws, rules or regulations existing now or in the future.\"}, {\"id\": \"Section 7.4\", \"title\": \"TAXES AND TARIFFS\", \"level\": 2, \"text\": \"Section 7.4 TAXES AND TARIFFS. (a) Licensee shall pay any and all taxes (other than taxes on Licensor's net income), tariffs, import and export duties or other fees imposed or assessed in connection with the transactions contemplated by this Agreement, including the delivery of Licensed Products and Documentation to Licensee and the shipment of Licensed Products from Licensee to a Redistributor or Customer. 7 (b) in the event that Licensee is required by law to withhold any form of tax, tariff or duty from any amount payable to Licensor under this Agreement, then Licensee shall provide Licensor with copies of all documentation required in connection with such withholdings and shall provide to Licensor all assistance requested by Licensor in applying for relief from such withholding obligations and in substantiating corresponding tax, duty or tariff credits or deductions which may be available to Licensor with respect to such withholding under applicable law.\"}, {\"id\": \"Section 7.5\", \"title\": \"BOOKS AND RECORDS\", \"level\": 2, \"text\": \"Section 7.5 BOOKS AND RECORDS. Licensee shall keep proper records and books of account concerning the reproduction and sublicensing of the Licensed Products that are adequate to determine the amount of fees owed to Licensor and Licensee shall preserve such records and books in a safe place for a period of five (5) years following termination of this Agreement.\"}, {\"id\": \"Section 7.6\", \"title\": \"MONTHLY REPORT\", \"level\": 2, \"text\": \"Section 7.6 MONTHLY REPORT. On or prior to the fifteenth (15th) day of each calendar month Licensee shall deliver to Licensor a written report certified as true and correct by an authorized office of Licensee stating (a) each Agreement for Trial entered into by Licensee during the previous calendar month, together with the expected revenues, if any, to Licensee under each such agreement, (b) each Sublicense entered into by Licensee during the previous calendar month, together with the expected revenues to Licensee for each such Sublicense, (c) each Redistributor Agreement entered into by Licensee during the previous calendar month, together with the expected revenues to Licensee for each such agreement, and (d) a list of invoices, together with the dollar amounts thereof, sent by Licensee to each Redistributor and Customer during the previous calendar month.\"}, {\"id\": \"Section 7.7\", \"title\": \"FINANCIAL STATEMENTS\", \"level\": 2, \"text\": \"Section 7.7 FINANCIAL STATEMENTS. Licensee shall provide (but shall not be obligated to do so more frequently than twice annually) to Licensor financial statements, credit ratings or other evidence of Licensee's financial condition promptly upon written request of Licensor.\"}, {\"id\": \"Section 7.8\", \"title\": \"REPLACEMENTS\", \"level\": 2, \"text\": \"Section 7.8 REPLACEMENTS. Licensee shall honor any proper refund or replacement requests received for the Licensed Products from Redistributors pursuant to the applicable Redistributor Agreement or from Customers pursuant to a Sublicense. Upon receipt of any such properly returned Licensed Products, Licensor shall refund to Licensee the amount paid by Licensee to Licensor for such Licensed Products. Licensee shall instruct Redistributors and Customers to direct all refund requests directly to Licensee rather than Licensor.\"}, {\"id\": \"Section 7.9\", \"title\": \"MODIFICATIONS\", \"level\": 2, \"text\": \"Section 7.9 MODIFICATIONS. Licensee shall not make any modifications to or derivations of the Licensed Products without the prior written consent of Licensor, except in the case of an Emergency Fix. Licensee shall not reverse engineer or otherwise attempt to reproduce the source code of any Licensed Product. In the event that Licensee makes any modification, alteration or enhancement to the Licensed Product or Documentation (including but not limited to an Emergency Fix), such modification, alteration or enhancement, including all intellectual property rights thereto, will be and remain the sole and exclusive property of Licensor. Any suggestions or changes desired by Licensee to the Licensed Product or Documentation shall be made by 8 Licensee in writing to Licensor and, if incorporated into the Licensed Product or Documentation, shall be the property of Licensor.\"}, {\"id\": \"Section 7.10\", \"title\": \"COPYRIGHT AND OTHER PROPRIETARY NOTICES\", \"level\": 2, \"text\": \"Section 7.10 COPYRIGHT AND OTHER PROPRIETARY NOTICES. Licensee shall ensure that the copyright, trademark and any other proprietary notices of Licensor or other legends contained in or on any copies of the Licensed Products or Documentation remain in or on the original Licensed Product or Documentation and any copies of such product or documentation reproduced by Licensee. The existence of any copyright, trademark or other proprietary notices in or on the Licensed Product or Documentation shall not be construed as a publication of the Licensed Product or Documentation.\"}, {\"id\": \"Section 7.11\", \"title\": \"NO ENCUMBRANCES\", \"level\": 2, \"text\": \"Section 7.11 NO ENCUMBRANCES. Licensee shall not engage in the lease, transfer, rental or loan of the Licensed Products or Documentation and Licensee shall not allow the Licensed Products or Documentation to become encumbered by any means.\"}, {\"id\": \"Section 7.12\", \"title\": \"NO INCONSISTENT WARRANTIES\", \"level\": 2, \"text\": \"Section 7.12 NO INCONSISTENT WARRANTIES. Licensee shall not, and shall obligate Redistributors not to, make or pass on to Customers any warranty or representation on behalf of Licensor inconsistent with or in addition to the limited warranty contained in the Sublicense.\"}, {\"id\": \"Section 7.13\", \"title\": \"DISPUTES BETWEEN LICENSEE AND CUSTOMERS\", \"level\": 2, \"text\": \"Section 7.13 DISPUTES BETWEEN LICENSEE AND CUSTOMERS. Licensee shall notify Licensor promptly concerning any threatened legal proceedings between Licensee on the one hand and a Redistributor or a Customer on the other hand and of any legal notices served on, or legal actions commenced against, Licensee regarding the Licensed Products or Documentation which might affect Licensor. Licensee shall not institute proceedings or enter into a compromise with any third party with whom it is in dispute concerning the Licensed Products or Documentation without the prior written consent of a duly authorized officer of Licensor, which consent shall not be unreasonably withheld or delayed by Licensor.\"}, {\"id\": \"Section 7.14\", \"title\": \"TRANSLATION\", \"level\": 2, \"text\": \"Section 7.14 TRANSLATION. Licensee shall not translate any portion of the Licensed Products, including any Documentation, into any other language without the prior written permission of Licensor.\"}, {\"id\": \"Section 7.15\", \"title\": \"INTELLECTUAL PROPERTY REGISTRATION\", \"level\": 2, \"text\": \"Section 7.15 INTELLECTUAL PROPERTY REGISTRATION. Without the prior written consent of Licensor, Licensee shall not register, apply for registration or in any other way attempt to obtain any intellectual property rights relating to any Licensed Product, any Documentation or any part thereof or take any action that materially and adversely affects such rights held by Licensor.\"}, {\"id\": \"ARTICLE 8\", \"title\": \"COVENANTS OF LICENSOR\", \"level\": 1, \"text\": \"ARTICLE 8 COVENANTS OF LICENSOR\"}, {\"id\": \"Section 8.1\", \"title\": \"Licensor shall be solely responsible for delivering to Licensee a Master Copy of each Licensed Product and Documentation\", \"level\": 2, \"text\": \"Section 8.1 Licensor shall be solely responsible for delivering to Licensee a Master Copy of each Licensed Product and Documentation and for the maintenance and support of the 9 Sublicense Copies and Documentation used by any Redistributors and Customers. The duties of Licensor include the following: (a) Delivering a Master Copy of each Licensed Product and Documentation, including any Upgrades as they become available, to permit Licensee to (1) make Sublicense Copies and copies of the Documentation to meet the demand of Redistributors and Customers and (2) market and license Sublicense Copies and copies of the Documentation, together with the copies of promotional and other materials which Licensor may produce from time to time in order to assist Licensee in marketing and sublicensing the Licensed Products during the term of this Agreement. (b) Employing a sufficient number of skilled technicians experienced in the computing industry and familiar with the Licensed Products and Documentation to provide adequate technical support and assistance to all Redistributors and Customers. (c) Providing competent instruction to Redistributors and Customers regarding the use and installation of the Licensed Products. (d) Providing information, including by means of telephone support, to Redistributors and Customers as to the proper procedures and persons to contact to enable the proper installation and operation of the Licensed Products and providing responsive answers to questions and problems regarding the use and operation of the Licensed Products. (e) Providing technical assistance in supporting the Licensed Products and correcting any errors in the Licensed Products on an ongoing basis. (f) Delivering to Licensee sample copies of all Licensor's marketing and licensing materials relating to the Licensed Products in use in the United States of America for copying and distribution in the Territory at Licensee's expense.\"}, {\"id\": \"Section 8.2\", \"title\": \"REGISTRATION FOR TRADEMARKS AND COPYRIGHTS\", \"level\": 2, \"text\": \"Section 8.2 REGISTRATION FOR TRADEMARKS AND COPYRIGHTS. Licensor shall use its best efforts to register in its name all Marks relating to the Licensed Products in the Territory and Licensor shall bear all costs of such registration and the maintenance and enforcement of all such rights and shall notify Licensee from time to time of all successful and unsuccessful registrations.\"}, {\"id\": \"ARTICLE 9\", \"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"ARTICLE 9 INDEMNIFICATION\"}, {\"id\": \"Section 9.1\", \"title\": \"INDEMNIFICATION OF LICENSOR\", \"level\": 2, \"text\": \"Section 9.1 INDEMNIFICATION OF LICENSOR. Licensee hereby agrees to defend and indemnify Licensor and Licensor's officers, directors, employees, stockholders, agents and representatives 10 against, and agrees to hold them harmless from, any loss, liability, claim, damage or expense (including reasonable legal fees and expenses incurred therein or in enforcing the indemnity), as incurred, for or on account of or arising from or in connection with or otherwise with respect to any breach of any representation, warranty or covenant of Licensee contained in this Agreement or any document delivered in connection herewith.\"}, {\"id\": \"Section 9.2\", \"title\": \"INDEMNIFICATION OF LICENSEE\", \"level\": 2, \"text\": \"Section 9.2 INDEMNIFICATION OF LICENSEE. Licensor hereby agrees to defend and indemnify Licensee and Licensee's officers, directors, employees, stockholders, agents and representatives against, and agrees to hold them harmless from, any loss, liability, claim, damage or expense (including reasonable legal fees and expenses incurred therein or in enforcing the indemnity), as incurred, for or on account of or arising from or in connection with or otherwise with respect to any breach of any representation, warranty or covenant of Licensor contained in this Agreement or any document delivered in connection herewith.\"}, {\"id\": \"Section 9.3\", \"title\": \"INDEMNIFICATION PROCEDURE\", \"level\": 2, \"text\": \"Section 9.3 INDEMNIFICATION PROCEDURE. Promptly after acquiring knowledge of any loss, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claim against Licensor or Licensee, or as to which Licensor or Licensee may be liable, a party entitled hereunder to be indemnified shall give written notice thereof to the party obligated hereunder to provide indemnification. The indemnifying party at its own expense promptly shall defend, contest or otherwise protect against any damage, loss, deficiency, liability, claim, encumbrance, penalty, cost, expense, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claim made by a third party against which such indemnifying party has agreed to indemnify any indemnified party, and each indemnifying party shall receive from the indemnified party all necessary and reasonable cooperation in said defense, including without limitation the services of employees of the indemnified party who are familiar with the transactions out of which any such damage, loss, deficiency, liability, claim, encumbrance, penalty, cost, expense, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claim may have arisen. The indemnified party shall have the right to control the defense of any such third party proceeding unless it is relieved of its liability hereunder with respect to such defense by the indemnified party. The indemnified party shall have the right to employ separate counsel in any such action and to participate in the defense thereof, but the fees and expenses of such counsel shall not be at the expense of the indemnifying party if the indemnifying party has assumed the defense of the action with counsel reasonably satisfactory to the indemnified party; provided that the fees and expenses of the indemnified party's counsel shall be at the expense of the indemnifying party if (i) the employment of such counsel has been specifically authorized in writing by the indemnifying party or (ii) such indemnified party shall have been advised by counsel hat there is a conflict of interest or issue conflict involved in the representation by counsel employed by the indemnifying party in the defense of such action on behalf of the indemnified party or that there may be one or more legal defenses available to such indemnified party which are not available to the indemnifying party (in which case the indemnifying party shall not have the fight to assume the defense of such action on behalf of such indemnified party, it being understood, however, that the indemnifying party shall not be liable, in connection with any one such action or separate but substantially similar or related actions in the same Jurisdiction arising out of the same general allegations or circumstances, for the 11 reasonable fees and expenses of more than one separate firm of attorneys for the indemnified party, which firm shall be designated in writing by the indemnified party). The indemnifying party shall have the right, at its option and unless so relieved, to compromise, at its own expense by its own counsel, any such matter involving the asserted liability to a third party of the indemnified party. In the event that the indemnifying party shall undertake to compromise any such asserted liability, the indemnifying party shall notify the indemnified party promptly of its intention to do so. In the event that an indemnifying party after written notice from an indemnified party fails to take timely action to defend any such damage, loss, deficiency, liability, claimed encumbrance, penalty, cost, expense, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claimed the indemnified party shall have the right to defend the same by counsel of its own choosing but at the cost and expense of the indemnifying party. In the event that the indemnified party defends such an asserted liability, it shall not compromise any such asserted liability without the written consent of the indemnifying party, such consent not to be unreasonably withheld or delayed.\"}, {\"id\": \"Section 9.4\", \"title\": \"FURTHER REMEDIES FOR INFRINGEMENT\", \"level\": 2, \"text\": \"Section 9.4 FURTHER REMEDIES FOR INFRINGEMENT. If Licensee is prevented from its normal use of any Licensed Product or Documentation by injunction or court order arising from, relating to or in connection with any alleged or actual infringement on the intellectual property rights of a third party relating to any Licensed Product or Documentation, then Licensor at its option and in addition to the other remedies contained in this Agreement and at no expense, loss or damage to Licensee shall (a) replace such Licensed Product or Documentation free of any such infringement, (b) modify such Licensed Product or Documentation so that it is free of any such infringement or (c) procure for the benefit of Licensee, whether by license or other release of claim of infringement, the fight to make Sublicense Copies and copies of the Documentation to meet the demand of Redistributors and Customers and to market and sublicense Sublicense Copies and copies of the Documentation.\"}, {\"id\": \"ARTICLE 10\", \"title\": \"AGREEMENT NOT TO COMPETE, CONFIDENTIALITY\", \"level\": 1, \"text\": \"ARTICLE 10 AGREEMENT NOT TO COMPETE, CONFIDENTIALITY\"}, {\"id\": \"Section 10.1\", \"title\": \"NONCOMPETITION\", \"level\": 2, \"text\": \"Section 10.1 NONCOMPETITION. Each of Licensor and Licensee understands and acknowledges that Licensor shall be entitled to protect and preserve the going concern value of Licensor's business to the extent permitted by law and that Licensor would not have entered into this Agreement absent the provisions of this Section 10.1 and, therefore, each of Licensor and Licensee agrees that during the term of this Agreement Licensee shall not engage in, represent in any way or be connected with directly or indirectly any business competing with the Licensed Products.\"}, {\"id\": \"Section 10.2\", \"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 2, \"text\": \"Section 10.2 CONFIDENTIAL INFORMATION. Licensee understands and agrees that the Licensed Products and any related information marked \\\"Confidential\\\" constitute valuable intellectual property and trade secrets of Licensor and embody substantial creative efforts and confidential information, ideas and expressions belonging to Licensor. Licensor understands and agrees that 12 any reports supplied pursuant to this Agreement by Licensee to Licensor relating to the Licensed Products contain proprietary information of Licensee. The Licensed Products and related information and such reports are referred to collectively in this Agreement as the \\\"Confidential Information.\\\" Each party to this Agreement shall observe at all times complete confidentiality with regard to the Confidential Information of the other party to this Agreement held by such party and shall not permit or authorize access to or disclosure of any such Confidential Information to any other person or entity other than such party's employees and consultants who have executed confidentiality agreements with terms substantially similar to this Agreement. This Section 10.2 will not apply to any Confidential Information that is required to be disclosed by applicable law or any Confidential Information that becomes (a) public other than by virtue of a breach of this Section 10.2 or (b) available to such party from another source (other than any independent contractor engaged by such party to audit pursuant to this Agreement the records of the other party hereto) that is not subject to a confidentiality agreement with the other party hereto of which such party at that time is aware.\"}, {\"id\": \"Section 10.3\", \"title\": \"UNAUTHORIZED USE\", \"level\": 2, \"text\": \"Section 10.3 UNAUTHORIZED USE. Each party to this Agreement shall notify the other party to this Agreement promptly in writing of the existence of any circumstances surrounding any unauthorized knowledge, possession or use of the Confidential Information by any person or entity other than the parties to this Agreement and each of their authorized employees and consultants.\"}, {\"id\": \"Section 10.4\", \"title\": \"REMEDY\", \"level\": 2, \"text\": \"Section 10.4 REMEDY. Notwithstanding any other provision of this Agreement, each of the parties to this Agreement understands and agrees that the remedy of indemnity payments pursuant to this Agreement and other remedies at law would be inadequate in the case of any breach of the covenants contained in this Article 10 and each party to this Agreement agrees that the other party to this Agreement shall be entitled to equitable relief, including the remedy of specific performance, without posting of bond or other security, with respect to any breach or attempted breach of such covenants.\"}, {\"id\": \"ARTICLE 11\", \"title\": \"AUDITS\", \"level\": 1, \"text\": \"ARTICLE 11 AUDITS\"}, {\"id\": \"Section 11.1\", \"title\": \"AUDITS\", \"level\": 2, \"text\": \"Section 11.1 AUDITS. During the term of this Agreement and the five (5) year period immediately following termination of this Agreement, Licensor will have the right, at its own expense, to audit and examine Licensees records concerning either (a) the reproduction and sublicensing of the Licensed Products and the resulting fees due to Licensor or (b) compliance by Licensee with its obligations as to confidentiality under this Agreement. During the term of this Agreement and the five (5) year period immediately following termination of this Agreement, Licensee will have the right, at its own expense, to audit and examine Licensor's records concerning compliance by Licensor with its obligations as to confidentiality under this Agreement. Any such audit shall be conducted during normal business hours, upon at least three business days prior written notification to the party to be audited stating the purpose of the audit 13 and in such a manner so as to not unreasonably interfere with such party's business operations. The auditing party shall keep any and all information derived from any audits confidential. Such information is deemed to be \\\"Confidential Information\\\" within the meaning of Article 10. In relation to such information, the parties to this Agreement are subject to the obligations and remedies set forth in Article 10. The auditing party shall not use such information for any purpose other than the purpose of the audit as stated in such party's written notification for such audit. If an audit of Licensee's records and books of account reveals that Licensee has underpaid the fees due under this Agreement to Licensor for the period under audit, Licensee shall pay to Licensor promptly the amount of the underpayment. If the amount of underpayment for the period under audit exceeds five percent (5%) of the total amount owed during such period, Licensee shall reimburse Licensor for all costs and expenses incurred by Licensor in connection with performing the audit.\"}, {\"id\": \"ARTICLE 12\", \"title\": \"LIMITED WARRANTIES\", \"level\": 1, \"text\": \"ARTICLE 12 LIMITED WARRANTIES\"}, {\"id\": \"Section 12.1\", \"title\": \"NO DEFECTS\", \"level\": 2, \"text\": \"Section 12.1 NO DEFECTS. For twelve (12) months after delivery of the Master Copy of each Licensed Product to Licensee, Licensor warrants that the media in which the Licensed Products are stored shall be free from defects in materials and workmanship, assuming normal use. Licensee may return any defective media to Licensor for replacement free of charge during such twelve (12) month period.\"}, {\"id\": \"Section 12.2\", \"title\": \"PERFORMANCE\", \"level\": 2, \"text\": \"Section 12.2 PERFORMANCE. For twelve (12) months after delivery of any Licensed Product to a Customer, whether Customer receives such Licensed Product from Licensee or a Redistributor, Licensor warrants that each Licensed Product will perform as described in the applicable Documentation. If Licensee or any Redistributor or Customer discovers any errors or discrepancies in the Licensed Products from the Documentation during the twelve (12) month warranty period, Licensee shall notify Licensor promptly in writing of such error or discrepancy in sufficient detail to enable Licensor to recreate the error or discrepancy. If the error or discrepancy is found by Licensee prior to the expiration of the ten (10) day evaluation period set forth in Section 4.2, such evaluation period shall be extended ten (10) days from the date of receipt by Licensee of the corrected Licensed Product from Licensor.\"}, {\"id\": \"Section 12.3\", \"title\": \"DUTIES UNDER WARRANTY\", \"level\": 2, \"text\": \"Section 12.3 DUTIES UNDER WARRANTY. If Licensee or any Redistributor or Customer discovers any error in any Licensed Product or discrepancy in any Licensed Product from the Documentation that results in a material loss of performance in the Licensed Product within the twelve (12) month warranty period, then Licensor shall provide Licensee with the correction or method of resolving such error or discrepancy provided that Licensor shall not be responsible for any error or discrepancy caused by failure to use the Licensed Products as specified in the Documentation or any modifications made to any Licensed Product by or on behalf of a party other than Licensor. If such error or discrepancy is not resolved within thirty (30) days after Licensee's 14 written notice to Licensor, then Licensee as its sole remedy may (a) extend the correction period to a date which is agreeable to Licensor and Licensee or (b) return all copies of the Licensed Products to Licensor with a certification by an authorized representative of Licensee that all copies have been returned to Licensor or have been destroyed and that Licensee has not retained any copies thereof and Licensor shall refund to Licensee the amount paid by Licensee to Licensor for such Licensed Products. Licensee shall pay for all services rendered by Licensor in connection with the Licensed Products or Documentation that are not covered or at that time are no longer covered by the warranty described in this Agreement.\"}, {\"id\": \"Section 12.4\", \"title\": \"EXCLUSIVE REMEDIES\", \"level\": 2, \"text\": \"Section 12.4 EXCLUSIVE REMEDIES. THE REMEDIES SPECIFIED ABOVE SHALL BE THE SOLE AND EXCLUSIVE REMEDIES OF LICENSEE REGARDING THE LICENSED PRODUCTS. LICENSOR SPECIFICALLY DISCLAIMS ANY AND ALL OTHER WARRANTIES OF ANY KIND, EXPRESS, RAPLIED OR STATUTORY, INCLUDING ANY WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. LICENSOR SPECIFICALLY MAKES NO REPRESENTATIONS REGARDING THE SUITABILITY OF THE LICENSED PRODUCTS FOR THE REQUIREMENTS OF ANY REDISTRIBUTOR. OR CUSTOMER CONCERNING CAPACITY, INTERCONNECTIVITY, EXPANDABILITY OR PERFORMANCE.\"}, {\"id\": \"ARTICLE 13\", \"title\": \"LIABILITY\", \"level\": 1, \"text\": \"ARTICLE 13 LIABILITY\"}, {\"id\": \"Section 13.1\", \"title\": \"LIMIT OF LIABILITY\", \"level\": 2, \"text\": \"Section 13.1 LIMIT OF LIABILITY. Licensor's total liability to Licensee under any provision of this Agreement shall be limited to the amount actually paid by Licensee to Licensor for the Licensed Product giving rise to the liability. The existence of claims or suits against more than one Licensed Product shall not enlarge or extend the limit. The parties to this Agreement acknowledge that each of them relied upon the inclusion of this limitation in consideration of entering into this Agreement. IN NO EVENT SHALL A PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTY TO THIS AGREEMENT FOR ANY SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM THE USE, OR INABILITY TO USE, THE LICENSED PRODUCTS OR ARISING OUT OF THIS AGREEMENT, INCLUDING BUT NOT LMTED TO LOSS OF PROFIT OR OTHER MONETARY LOSS, LOSS OR INTERRUPTION OF DATA OR CONTUTER TIME, ALTERATION OR ERRONEOUS TRANSNUSSION OF DATA OR PROGRAM ERRORS, EVEN IF SUCH PARTY IS ADVISED IN ADVANCE OF THE POSSIBILITY OF SUCH DAMAGES. 15\"}, {\"id\": \"ARTICLE 14\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 14 TERM AND TERMINATION\"}, {\"id\": \"Section 14.1\", \"title\": \"TERM\", \"level\": 2, \"text\": \"Section 14.1 TERM. This Agreement shall be effective until the earlier of (a) its termination in accordance with the provisions of this Article 14 or (b) the date that is two (2) years after the date of this Agreement; provided, however, that this Agreement will renew automatically for successive terms of one (1) year each unless a party to this Agreement delivers written notice of termination to the other party to this Agreement at least sixty (60) days prior to the end of the original or any renewal term or the parties to this Agreement do not agree in writing to the Quota Amount referred to in subsection 14.2(b)(1) for any one (1) year renewal term at least sixty (60) days prior to the commencement of such term.\"}, {\"id\": \"Section 14.2\", \"title\": \"TERMINATION\", \"level\": 2, \"text\": \"Section 14.2 TERMINATION. (a) Either party to this Agreement may terminate this Agreement: (1) Immediately upon written notice if the other party to this Agreement becomes insolvent, is the subject of a petition in bankruptcy that is not resolved within thirty (30) days, admits in writing its inability to pay its debts, makes an assignment for the benefit of creditors, ceases doing business or attempts an unauthorized assignment of this Agreement; or (2) Immediately upon written notice if the other party to this Agreement performance of any obligation under this Agreement, including failure to promptly pay any amount due hereunder, and fails to cure such default within thirty (30) days after delivery of written notice specifying the default (with any termination as a result of Licensee's failure to pay amounts due under this Agreement resulting in the acceleration of Licensee's obligation to pay all sums due to Licensor under this Agreement). (b) Licensor may terminate this Agreement: (1) Upon ninety (90) days prior written notice if Licensee does not enter into Sublicenses and other agreements relating to the Licensed Products with Redistributors and Customers that result in fees payable to Licensor hereunder in an aggregate amount equal to or greater than the Quota Amount for any year during the term hereof. As used herein, the term \\\"Quota Amount\\\" means $50,000 for each of the first and second years of the original term of this Agreement and an amount agreed to in writing by the parties hereto in respect of any subsequent one year renewal term (provided that such amount equals or exceeds $50,000). If Licensor fails to deliver notice of termination pursuant to this subsection 14.2(b)(1) within six (6) months after the end of the term to which such termination relates, Licensor will be deemed to have waived such termination right in respect of such term (but not in respect of subsequent terms); or (2) Upon thirty (30) days prior written notice if Licensee enters into an agreement or other arrangement relating to the merger of Licensee with another entity, the acquisition of the majority of Licensee's issued and outstanding capital stock or the acquisition of substantially all of the assets of Licensee.\"}, {\"id\": \"Section 14.3\", \"title\": \"DUTIES UPON TERMINATION\", \"level\": 2, \"text\": \"Section 14.3 DUTIES UPON TERMINATION. Upon the termination or expiration of the term of this Agreement, the parties shall have the following rights and obligations: (a) Within five (5) days of written demand by Licensor to Licensee, Licensee shall return or destroy all copies of the Licensed Products and any materials associated with the Licensed Products in Licensee's possession or control, except that Licensee may retain sufficient copies of the Master Copy of each Licensed Product in object code form to enable Licensee to meet its maintenance and support obligations to its Customers, if any. (b) Licensee immediately shall cease any use, reproduction, sublicensing or distribution of the Licensed Products or the Documentation. 16 (c) Within five (5) days of Licensor's written request, Licensee shall certify in a writing reasonably acceptable to Licensor that except as set forth in this Agreement all copies of the Licensed Products and related material have been delivered to Licensor, destroyed or rendered unusable. (d) Licensee shall not use any Licensed Product or Documentation as part of any other product that Licensee may use, sublicense or distribute and Licensee shall cease any use of the Marks associated with the Licensed Products or Documentation. (e) All valid Redistributor Agreements and Sublicenses by and between Licensee and any Redistributors and Customers will remain and continue in full force and effect for the remainder of their respective terms, and at Licensor's option Licensee shall assign to Licensor its rights in such agreements with respect to the Licensed Products or Documentation; provided that if Licensor fails to provide reasonable support to any Redistributor or Customer, Licensee may support such Redistributor or Customer without payment of fees to Licensor. (f) Licensee promptly shall account for and pay to Licensor all amounts due and owing pursuant to the terms of this Agreement and provide Licensor with all outstanding reports due under this Agreement. (g) Licensee immediately shall cease holding itself out as having any connection with any Licensed Product or Licensor, unless Licensee at that time has a connection with Licensor by reason other than this Agreement. (h) Licensee shall report to Licensor in reasonable detail the status of all negotiations with prospective Redistributors and Customers or leads to prospective Redistributors and Customers and all services which Licensee is obligated to provide to any Redistributors or Customers.\"}, {\"id\": \"Section 14.4\", \"title\": \"RIGHTS NOT EXHAUSTIVE\", \"level\": 2, \"text\": \"Section 14.4 RIGHTS NOT EXHAUSTIVE. The fights and remedies of Licensor included in this Article 14 shall not be exclusive and are in addition to any other rights and remedies provided by law or equity.\"}, {\"id\": \"Section 14.5\", \"title\": \"SURVIVAL\", \"level\": 2, \"text\": \"Section 14.5 SURVIVAL. The provisions of Articles 9, 10 and 11, Section 7.5 and this Section 14.5 and all obligations of Licensee to pay any amounts to Licensor under this Agreement will survive the termination of this Agreement. 17\"}, {\"id\": \"ARTICLE 15\", \"title\": \"GENERAL\", \"level\": 1, \"text\": \"ARTICLE 15 GENERAL\"}, {\"id\": \"Section 15.1\", \"title\": \"NATURE OF RELATIONSHIP\", \"level\": 2, \"text\": \"Section 15.1 NATURE OF RELATIONSHIP. The relationship existing between Licensee and Licensor is one of an independent contractor, and this Agreement shall not be construed as creating a partnership, joint venture, agency relationship or as granting a franchise under federal or any state law. Each of Licensee and its officers, employees or other representatives shall not enter into or attempt to enter into any obligation on behalf of Licensor. Licensee shall not make any representations to any Redistributors or Customers with respect to the Licensed Products and Documentation, including without limitation representations as to any warranty, covenant or other terms or conditions relating to licensing of the Licensed Products, unless such representations are made (a) in strict accordance with this Agreement or (b) with the prior written consent of Licensor.\"}, {\"id\": \"Section 15.2\", \"title\": \"NOTICES\", \"level\": 2, \"text\": \"Section 15.2 NOTICES. All notices and other communications hereunder shall be in writing and shall be deemed delivered (i) when delivered if delivered personally or by overnight courier or telecopier with proof of delivery or (ii) three (3) days after such communication is deposited in the United States mail with postage prepaid, if delivered, if mailed by registered or certified mail (return receipt requested) to the parties to this Agreement at the following addresses (or at such other address for a party as shall be specified by like notice): (a) if to Licensor, to Peregrine/Bridge Transfer Corporation 14141 Southwest Freeway, Suite 6200 Sugar Land, Texas 77478 Attn: President and (b) if to Licensee, to Neon Systems, Inc. 14141 Southwest Freeway, Suite 6200 Sugar Land, Texas 77478 Attn: President 18\"}, {\"id\": \"Section 15.3\", \"title\": \"INTERPRETATION\", \"level\": 2, \"text\": \"Section 15.3 INTERPRETATION. When a reference is made in this Agreement to an Article, Section, subsection or Exhibit, such reference shall be to an Article, Section, subsection or Exhibit of this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words \\\"include,\\\" \\\"includes\\\" or \\\"including\\\" are used in this Agreement, such term shall be deemed to be followed by the words \\\"without limitation.\\\" All accounting terms not defined in this Agreement shall have the meanings determined by generally accepted accounting principles.\"}, {\"id\": \"Section 15.4\", \"title\": \"COUNTERPARTS This Agreement may be executed in two or more counterparts, all of which shall be considered one and the s\", \"level\": 2, \"text\": \"Section 15.4 COUNTERPARTS This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become effective when two or more counterparts have been signed by each of the parties to this Agreement and delivered to the other parties to this Agreement, it being understood that all such parties need not sign the same counterpart. For purposes hereof, delivery shall be deemed effective upon exchange of signed copies of this Agreement by facsimile, provided that originally signed counterparts of this Agreement are transmitted promptly to the other parties hereto.\"}, {\"id\": \"Section 15.5\", \"title\": \"ENTIRE AGREEMENT, THIRD PARTY BENEFICIARIES\", \"level\": 2, \"text\": \"Section 15.5 ENTIRE AGREEMENT, THIRD PARTY BENEFICIARIES. This Agreement (including the documents and instruments referred to herein) (a) constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, between the parties hereto with respect to the subject matter hereof and (b) is not intended to confer upon any person (including any Redistributor or Customer) other than the parties hereto any rights or remedies hereunder, except as provided in Article 9.\"}, {\"id\": \"Section 15.6\", \"title\": \"GOVERNING LAW\", \"level\": 2, \"text\": \"Section 15.6 GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE SIATE OF TEXAS.\"}, {\"id\": \"Section 15.7\", \"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"Section 15.7 ASSIGNMENT. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto without the prior written consent of the other party to this Agreement; provided, however, that Licensor may assign this Agreement to a subsidiary or entity controlling, controlled by or under common control with Licensor. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be to this Agreement and their respective successors and permitted assigns.\"}, {\"id\": \"Section 15.8\", \"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"Section 15.8 SEVERABILITY. If any provision of this Agreement, or any portion of any provision hereof, shall be deemed invalid or unenforceable pursuant to a final determination of any court of competent jurisdiction or as a result of future legislative action, such determination or action shall be construed so as not to affect the validity or enforceability hereof and shall not affect the validity or effect of any other portion hereof\"}, {\"id\": \"Section 15.9\", \"title\": \"AMENDMENT\", \"level\": 2, \"text\": \"Section 15.9 AMENDMENT. This Agreement may be amended only by a written instrument duly signed by each of the parties hereto. 19\"}, {\"id\": \"Section 15.10\", \"title\": \"WAIVER\", \"level\": 2, \"text\": \"Section 15.10 WAIVER. Any of the terms, covenants, representations, warranties or conditions of this Agreement may be waived only by a written instrument signed by the party to this Agreement waiving compliance. No waiver by any party to this Agreement of any condition or breach of any term, covenant, representation or warranty contained in this Agreement, whether by conduct or otherwise, in any one or more instances, shall be construed as a further or continuing waiver of any such condition or breach or a waiver of any other condition or of the breach of any other term, covenant, representation or warranty set forth in this Agreement. IN WITNESS WBEREOF, the parties hereto have executed this Agreement as of the date first above written. LICENSOR: PEREGRINE/BRIDGE TRANSFER By: /s/ Charles E Noell ---------------------------------- Name: Charles E Noell -------------------------------- Title: General Partner ------------------------------- LICENSEE: NEON SYSTEMS, INC. By: /s/ F. Joseph Backer ---------------------------------- Name: F. Joseph Backer -------------------------------- Title: CEO ------------------------------- 20\"}, {\"id\": \"EXHIBIT B\", \"title\": \"THE TERRITORY\", \"level\": 1, \"text\": \"EXHIBIT B THE TERRITORY The Territory included is worldwide.\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NEONSYSTEMSINC_03_01_1999-EX-10.5-DISTRIBUTOR AGREEMENT_New\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 1, \"text\": \"DISTRIBUTOR AGREEMENT by and between PEREGRINE/BRIDGE TRANSFER CORPORATION and NEON SYSTEMS, INC. TABLE OF CONTENTS EXHIBITS\"}}, {\"id\": \"Exhibit A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"List of Products Exhibit B The Territory Exhibit C Sublicense Agreement Exhibit D Agreement for Trial\", \"level\": 1, \"text\": \"Exhibit A List of Products Exhibit B The Territory Exhibit C Sublicense Agreement Exhibit D Agreement for Trial i DISTRIBUTOR AGREEMENT DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") is made as of the 1st day of January, 1996 by and between Peregrine/Bridge Transfer Corporation, a Delaware corporation (the \\\"Licensor\\\"), and Neon Systems, Inc., a Delaware corporation (the \\\"Licensee\\\"). WHEREAS, Licensor is engaged in the development, support and licensing of certain computer software products, including without limitation the computer software products fisted in EXHIBIT A to this Agreement; and WHEREAS, Licensee desires to obtain from Licensor, and Licensor desires to grant to Licensee, the right to market and sublicense the Licensed Products (as defined herein) in accordance with the terms and conditions set forth in this Agreement; NOW THEREFORE, in consideration of the foregoing and the mutual covenants set forth in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows.\"}}, {\"id\": \"ARTICLE 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"ARTICLE 1 DEFINITIONS\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Customer\\\" means a person or entity that has acquired, or has indicated its interest in acquiring from Licensee, or\", \"level\": 2, \"text\": \"1.1 \\\"Customer\\\" means a person or entity that has acquired, or has indicated its interest in acquiring from Licensee, or from a Redistributor if so specified herein, a non-exclusive and nontransferable Sublicense to use one (1) or more of the Licensed Products.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Documentation\\\" means all visually readable materials published or made available by Licensor during the term of th\", \"level\": 2, \"text\": \"1.2 \\\"Documentation\\\" means all visually readable materials published or made available by Licensor during the term of this Agreement for use by Customers in connection with the Licensed Products.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Emergency Fix\\\" means a temporary correction of a problem in a Licensed Product reported by Licensee to Licensor th\", \"level\": 2, \"text\": \"1.3 \\\"Emergency Fix\\\" means a temporary correction of a problem in a Licensed Product reported by Licensee to Licensor that may take the form of a written instruction or magnetic or optical media.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Licensed Product\\\" means any copy, or part thereof, of object code of the software products listed on EXHIBIT A att\", \"level\": 2, \"text\": \"1.4 \\\"Licensed Product\\\" means any copy, or part thereof, of object code of the software products listed on EXHIBIT A attached to this Agreement, as well as any Upgrades or other material distributed to Licensee by Licensor in connection with such software products.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Master Copy\\\" means the initial object code copy of each Licensed Product and of any subsequent Upgrades or other d\", \"level\": 2, \"text\": \"1.5 \\\"Master Copy\\\" means the initial object code copy of each Licensed Product and of any subsequent Upgrades or other derivations distributed to Licensee by Licensor under this Agreement. 1\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Redistributor\\\" means any individual or entity that is granted a license by Licensee to copy and sublicense one or\", \"level\": 2, \"text\": \"1.6 \\\"Redistributor\\\" means any individual or entity that is granted a license by Licensee to copy and sublicense one or more Licensed Products to Customers.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Sublicense\\\" means the sublicense agreement to be entered into by Customers, the form of which is attached hereto a\", \"level\": 2, \"text\": \"1.7 \\\"Sublicense\\\" means the sublicense agreement to be entered into by Customers, the form of which is attached hereto as EXHIBIT C, or such form as otherwise may be approved by Licensor pursuant to this Agreement.\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Sublicense Copy\\\" means an object code copy of the Licensed Product that Licensee licenses from Licensor and invent\", \"level\": 2, \"text\": \"1.8 \\\"Sublicense Copy\\\" means an object code copy of the Licensed Product that Licensee licenses from Licensor and inventories for sublicensing to Redistributors and Customers.\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Territory\\\" means that geographic area specified in EXHIBIT B attached to this Agreement\", \"level\": 2, \"text\": \"1.9 \\\"Territory\\\" means that geographic area specified in EXHIBIT B attached to this Agreement.\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Upgrade\\\" means any revision, adaptation or new version of a Licensed Product which enhances a Licensed Product and\", \"level\": 2, \"text\": \"1.10 \\\"Upgrade\\\" means any revision, adaptation or new version of a Licensed Product which enhances a Licensed Product and which is offered by Licensor to registered users of that Licensed Product as an \\\"upgrade.\\\"\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSE GRANT\", \"level\": 1, \"text\": \"ARTICLE 2 LICENSE GRANT\"}}, {\"id\": \"Section 2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"USE OF MASTER COPY\", \"level\": 2, \"text\": \"Section 2.1 USE OF MASTER COPY. Licensor hereby grants to Licensee a non- exclusive, worldwide right to use and reproduce the Master Copy of each Licensed Product and the related Documentation during the term of this Agreement for testing, demonstration to Redistributors. and Customers, support and maintenance, if any, back-up and archive purposes.\"}}, {\"id\": \"Section 2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUBLICENSING\", \"level\": 2, \"text\": \"Section 2.2 SUBLICENSING. Licensor hereby grants to Licensee an exclusive in the Territory to (1) make Sublicense Copies and copies of the Documentation to meet the demand of Redistributors and Customers and (2) market and sublicense Sublicense Copies and copies of the Documentation, together with any copies of promotional and other materials which Licensor may produce or obtain from time to time to assist Licensee in marketing and sublicensing the Licensed Products during the term of this Agreement by any one or more of the following means: (a) TO A REDISTRIBUTOR: To a Redistributor pursuant to a Redistributor Agreement containing substantially the same terms and conditions as are set forth in this Agreement (subject to Section 2.5) and a Sublicense with each Customer of Redistributor in accordance with subsection 2.2(b); or (b) TO CUSTOMERS: Pursuant to a Sublicense signed by the Customer.\"}}, {\"id\": \"Section 2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AGREEMENTS FOR TRIAL\", \"level\": 2, \"text\": \"Section 2.3 AGREEMENTS FOR TRIAL. Licensee may make available the Licensed Products or Documentation to any Redistributor or Customer who wishes to test the Licensed Products on a trial basis so long as such Redistributor or Customer has entered into an Agreement For Trial with Licensee in the form attached to this Agreement as EXHIBIT D. 2\"}}, {\"id\": \"Section 2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MAINTENANCE AND SUPPORT AGREEMENTS\", \"level\": 2, \"text\": \"Section 2.4 MAINTENANCE AND SUPPORT AGREEMENTS. Licensee may make available to Customers maintenance, support and upgrade services only under the terms contained in the Sublicense or other written maintenance and support agreement pertaining to such services.\"}}, {\"id\": \"Section 2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REVIEW OF ARRANGEMENTS\", \"level\": 2, \"text\": \"Section 2.5 REVIEW OF ARRANGEMENTS. Licensee shall not enter into any agreement referred to in this Article 2 with any Redistributor or Customer until each such agreement has been submitted to and approved by Licensor. Within five (5) business days after its receipt of any such agreement, Licensor shall notify Licensee whether it approves or disapproves of the agreement and, if it disapproves of the agreement, Licensor shall provide written notice of the reasons therefor, including any changes that would require to approve of the agreement. If Licensor fails to notify Licensee of its approval or disapproval of any such agreement within such period of time, the agreement shall be deemed to be approved by Licensor.\"}}, {\"id\": \"Section 2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMS OF AGREEMENTS\", \"level\": 2, \"text\": \"Section 2.6 TERMS OF AGREEMENTS. Licensee shall ensure that the terms of any Redistributor Agreement and, to the extent a Sublicense must be modified to comply with applicable law, any Sublicense executed in connection with the Licensed Products do not: (a) Diminish or limit any of the rights of Licensor in the Licensed Products or Documentation; (b) Diminish or limit the enforceability of the proprietary rights of Licensor in and to the Licensed Products or Documentation; (c) Convey any rights of ownership in the Licensed Products or Documentation to any individual or entity other than Licensor, except for the license rights granted in accordance with the terms of this Agreement; (d) Permit the use or duplication of the Licensed Products or Documentation, except as specifically provided in this Agreement or in the Sublicense; or (e) Permit disclosure of proprietary information regarding the Licensed Products or Documentation.\"}}, {\"id\": \"Section 2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NATURE OF GRANT\", \"level\": 2, \"text\": \"Section 2.7 NATURE OF GRANT. Licensee shall not have any rights of ownership or other proprietary rights in the Licensed Products or any Documentation by virtue of this Agreement, except for the license grants set forth herein.\"}}, {\"id\": \"Section 2.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS AND COPYRIGHT\", \"level\": 2, \"text\": \"Section 2.8 TRADEMARKS AND COPYRIGHT. Licensor hereby grants to Licensee a non-exclusive right to use the trademarks, service marks, trade names, copyrights, logos and designations (collectively, the \\\"Marks\\\") relating to the Licensed Products or the Documentation during the term of this Agreement in the marketing by Licensee of the Licensed Products, provided that such Marks clearly indicate Licensor as the owner of the Marks whenever the Licensed Product or Documentation is first mentioned in any written material referencing the Licensed Product and the proper symbol is used in a superscript following the Marks. Licensor promptly shall provide 3 a list of all Marks held by Licensor that relate to the Licensed Products. Upon reasonable written request by Licensor, Licensee shall provide Licensor with samples of any use of the Marks of Licensor relating to the Licensed Products, including any documentation and object code copies of the Licensed Products that Licensee sublicenses to Redistributors and Customers.\"}}, {\"id\": \"ARTICLE 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICING AND PAYMENT\", \"level\": 1, \"text\": \"ARTICLE 3 PRICING AND PAYMENT\"}}, {\"id\": \"Section 3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FEES TO LICENSOR\", \"level\": 2, \"text\": \"Section 3.1 FEES TO LICENSOR. (a) Licensee shall pay to Licensor for each Licensed Product licensed to a Redistributor or a Customer a licensee fee equal to 50% of all revenues received (without deduction for value added tax, if any, but excluding any revenues for maintenance and support or upgrade services, which revenues are covered in paragraph (b) below) by Licensee under the Redistributor Agreement or Sublicense applicable to such Licensed Product. (b) Licensee shall pay to Licensor for maintenance and support and upgrade services provided under the applicable Sublicense or other written maintenance and support agreement with or approved by Licensee for each of the Licensed Products a fee equal to 50% of all revenues received (without deduction for value added tax, if any) by Licensee from a Redistributor or Customer relating to maintenance and support services or services for Upgrades or upgrades of systems for such Licensed Product.\"}}, {\"id\": \"Section 3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMS OF PAYMENT\", \"level\": 2, \"text\": \"Section 3.2 TERMS OF PAYMENT. All fees due to Licensor under this Agreement shall be paid in U.S. Dollars. Fees due to Licensor from invoices rendered by Licensee during the first year of the term hereof will be payable one hundred and twenty (120) days after the date of the Licensee's invoice to a Redistributor or Customer, as the case may be. Fees due to Licensor from invoices rendered on or after the first day of the thirteenth (13th) month through and including the last day of the eighteenth (18th) month of the term hereof will be payable ninety (90) days after the date of such invoice. Fees due to Licensor from invoices rendered thereafter will be payable sixty (60) days after the date of such invoice. Any amount that is not paid when due will bear simple interest from the date such amount is due until the date payment is made at a rate equal to 10% per annum.\"}}, {\"id\": \"ARTICLE 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDER, DELIVERY AND ACCEPTANCE\", \"level\": 1, \"text\": \"ARTICLE 4 ORDER, DELIVERY AND ACCEPTANCE\"}}, {\"id\": \"Section 4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDER AND DELIVERY\", \"level\": 2, \"text\": \"Section 4.1 ORDER AND DELIVERY. Licensee shall deliver to Licensor product orders (or other documents of similar purpose and effect) in writing that are signed by an authorized representative of Licensee and that list the quantity, product name, number, version, license fee and 4 proposed delivery date for such order. Licensor shall ship Licensed Products and Documentation in accordance with Licensee's product orders received and accepted by Licensor. Licensor shall ship Licensed Products and Documentation F.O.B. Licensor's place of business. Licensee shall be responsible for all customs fees and other costs and expenses arising in connection with the transactions contemplated by this Agreement, including costs and expenses related to packing and shipping the Licensed Products and Documentation and any freight and insurance charges, and Licensor may require Licensee to pay for such costs and expenses in advance of shipment of any Licensed Products or Documentation. Licensor shall not be liable to Licensee for delays in shipments due to causes beyond Licensor's reasonable control. Licensor reserves the right to reject any product order, to cancel any product orders placed by Licensee and accepted by Licensor and to refuse or delay shipment thereof if Licensee fails to make any payments as provided in this Agreement or otherwise continues to fail to comply with the terms and conditions of this Agreement for thirty (30) days after delivery of written notice of such failure.\"}}, {\"id\": \"Section 4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TIME FOR ACCEPTANCE\", \"level\": 2, \"text\": \"Section 4.2 TIME FOR ACCEPTANCE. Licensee shall accept or reject the Licensed Products or Documentation within a ten (10) day evaluation period after receipt of such Licensed Product and the related Documentation by Licensee. If Licensee fails to give Licensor written notice of its rejection of such Licensed Products or Documentation within such ten (10) day evaluation period or Licensee ships such Licensed Products or Documentation to a Redistributor or Customer, then such Licensed Products and Documentation will be deemed to be accepted by Licensee.\"}}, {\"id\": \"Section 4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REJECTION\", \"level\": 2, \"text\": \"Section 4.3 REJECTION. If Licensee rejects any Licensed Product in accordance with Section 4.2 because such Licensed Product fails to conform to the Documentation relating to such Licensed Product, Licensee shall notify Licensor promptly in writing to that effect and return all copies of such Licensed Product to Licensor with a certification by an authorized representative of Licensee that all copies have been returned to Licensor or have been destroyed and Licensor shall refund to Licensee the amount paid by Licensee to Licensor for such Licensed Products.\"}}, {\"id\": \"ARTICLE 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES OF LICENSEE\", \"level\": 1, \"text\": \"ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF LICENSEE\"}}, {\"id\": \"Section 5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUTHORITY\", \"level\": 2, \"text\": \"Section 5.1 AUTHORITY. Licensee represents and warrants that it is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and that it is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required by applicable law, except where the failure to be so qualified would not have a material adverse effect on Licensee or the assets of Licensee. Licensee represents and warrants that it has all requisite power and authority to execute this Agreement and to consummate the transactions contemplated hereby and that this Agreement has been duly executed and delivered by Licensee and constitutes a valid and binding obligation of Licensee enforceable in accordance with its terms. 5\"}}, {\"id\": \"Section 5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ABILITY TO PERFORM\", \"level\": 2, \"text\": \"Section 5.2 ABILITY TO PERFORM. Licensee represents and warrants that it has sufficient facilities, resources and personnel to adequately perform its obligations under this Agreement and that no existing arrangement, contractual or otherwise, will cause Licensee to breach the terms of this Agreement or prevent Licensee from fulfilling its obligations under this Agreement.\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS AND WARRANTIES OF LICENSOR\", \"level\": 1, \"text\": \"ARTICLE 6 REPRESENTATIONS AND WARRANTIES OF LICENSOR\"}}, {\"id\": \"Section 6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUTHORITY\", \"level\": 2, \"text\": \"Section 6.1 AUTHORITY. Licensor represents and warrants that it is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and that it is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required by applicable law, except where the failure to be so qualified would not have a material adverse effect on Licensor or the assets of Licensor. Licensor represents and warrants that it has all requisite power and authority to execute this Agreement and to consummate the transactions contemplated hereby and that this Agreement has been duly executed and delivered by Licensor and constitutes a valid and binding obligation of Licensor enforceable in accordance with its terms.\"}}, {\"id\": \"Section 6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TITLE TO LICENSED PRODUCTS\", \"level\": 2, \"text\": \"Section 6.2 TITLE TO LICENSED PRODUCTS. Licensor represents and warrants that it possesses all right, title and interest in and to the Licensed Products and the Documentation and that the use of each of the Licensed Products and the Documentation by Licensee, a Redistributor or a Customer will not in any way constitute an infringement or other violation of any copyright, trade secret, trademark, patent or other intellectual property fights or any proprietary information or nondisclosure or other rights of any third party. Licensor represents and warrants that no existing arrangement, contractual or otherwise, will cause Licensor to breach the terms of this Agreement or prevent Licensor from fulfilling its obligations under this Agreement.\"}}, {\"id\": \"ARTICLE 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COVENANTS OF LICENSEE\", \"level\": 1, \"text\": \"ARTICLE 7 COVENANTS OF LICENSEE\"}}, {\"id\": \"Section 7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DUTIES OF LICENSEE\", \"level\": 2, \"text\": \"Section 7.1 DUTIES OF LICENSEE. Licensee shall be solely responsible for the proper advertising, demonstration, shipment, export and collection of payment relating to the Licensed Products and Documentation in the Territory. The duties of Licensee include without limitation the following: (a) Advertising the Licensed Product in appropriate media, contacting and developing Customers and prospective Redistributors by telephone and otherwise, providing information concerning Licensed Products to Customers and prospective Redistributors and advising such Customers and prospective Redistributors on the selection and use of the Licensed Products. 6 (b) Complying with Licensee's warranty obligations as set forth in its agreements with Redistributors and Customers. (c) Sending at Licensee's expense qualified and appropriate personnel of Licensee to participate in training sessions, which shall be conducted by Licensor from time to time without charge to Licensee for the benefit of Licensee and Licensee's personnel. (d) Obligating each Redistributor to keep complete and accurate records of such Redistributor's Customers, leads to prospective Customers, the number and type of Licensed Products licensed by such Redistributor and such related operating and financial data as Licensor reasonably may request from time to time for the sole purpose of monitoring the Licensed Products.\"}}, {\"id\": \"Section 7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DOCUMENTATION\", \"level\": 2, \"text\": \"Section 7.2 DOCUMENTATION. Licensee shall represent accurately and completely the Licensed Products to Customers as to quality, function, purpose and compatibility in accordance with the Documentation whenever the Licensed Products are referenced, demonstrated or advertised. Licensee shall obtain prior written approval from Licensor for all materials other than the Documentation to be used by Licensee in connection with trials, demonstrations and agreements relating to the Licensed Products, and such approval shall not be unreasonably withheld or delayed by Licensor. Licensee shall give Licensor and any licensors of Licensor appropriate credit for the authorship of the Licensed Products and Documentation at any seminar, trade show or other presentation of the Licensed Products.\"}}, {\"id\": \"Section 7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXPORTING AND SHIPMENT\", \"level\": 2, \"text\": \"Section 7.3 EXPORTING AND SHIPMENT. Licensee shall obtain prior written approval from Licensor and any required export licenses from the United States Department of Commerce, Office of Export Administration or other applicable domestic or foreign governmental agency before exporting any Licensed Product or Documentation from the United States. Licensee agrees and covenants to comply fully with all applicable laws, rules and regulations, and to adopt such policies and procedures in connection with, the exporting of the Licensed Products and Documentation as may be required thereby. Each party to this Agreement shall cooperate fully with the other party to this Agreement and any governmental authorities by giving consents or information or providing or executing such documents as reasonably may be required to comply fully with such laws, rules or regulations existing now or in the future.\"}}, {\"id\": \"Section 7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TAXES AND TARIFFS\", \"level\": 2, \"text\": \"Section 7.4 TAXES AND TARIFFS. (a) Licensee shall pay any and all taxes (other than taxes on Licensor's net income), tariffs, import and export duties or other fees imposed or assessed in connection with the transactions contemplated by this Agreement, including the delivery of Licensed Products and Documentation to Licensee and the shipment of Licensed Products from Licensee to a Redistributor or Customer. 7 (b) in the event that Licensee is required by law to withhold any form of tax, tariff or duty from any amount payable to Licensor under this Agreement, then Licensee shall provide Licensor with copies of all documentation required in connection with such withholdings and shall provide to Licensor all assistance requested by Licensor in applying for relief from such withholding obligations and in substantiating corresponding tax, duty or tariff credits or deductions which may be available to Licensor with respect to such withholding under applicable law.\"}}, {\"id\": \"Section 7.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BOOKS AND RECORDS\", \"level\": 2, \"text\": \"Section 7.5 BOOKS AND RECORDS. Licensee shall keep proper records and books of account concerning the reproduction and sublicensing of the Licensed Products that are adequate to determine the amount of fees owed to Licensor and Licensee shall preserve such records and books in a safe place for a period of five (5) years following termination of this Agreement.\"}}, {\"id\": \"Section 7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MONTHLY REPORT\", \"level\": 2, \"text\": \"Section 7.6 MONTHLY REPORT. On or prior to the fifteenth (15th) day of each calendar month Licensee shall deliver to Licensor a written report certified as true and correct by an authorized office of Licensee stating (a) each Agreement for Trial entered into by Licensee during the previous calendar month, together with the expected revenues, if any, to Licensee under each such agreement, (b) each Sublicense entered into by Licensee during the previous calendar month, together with the expected revenues to Licensee for each such Sublicense, (c) each Redistributor Agreement entered into by Licensee during the previous calendar month, together with the expected revenues to Licensee for each such agreement, and (d) a list of invoices, together with the dollar amounts thereof, sent by Licensee to each Redistributor and Customer during the previous calendar month.\"}}, {\"id\": \"Section 7.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FINANCIAL STATEMENTS\", \"level\": 2, \"text\": \"Section 7.7 FINANCIAL STATEMENTS. Licensee shall provide (but shall not be obligated to do so more frequently than twice annually) to Licensor financial statements, credit ratings or other evidence of Licensee's financial condition promptly upon written request of Licensor.\"}}, {\"id\": \"Section 7.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPLACEMENTS\", \"level\": 2, \"text\": \"Section 7.8 REPLACEMENTS. Licensee shall honor any proper refund or replacement requests received for the Licensed Products from Redistributors pursuant to the applicable Redistributor Agreement or from Customers pursuant to a Sublicense. Upon receipt of any such properly returned Licensed Products, Licensor shall refund to Licensee the amount paid by Licensee to Licensor for such Licensed Products. Licensee shall instruct Redistributors and Customers to direct all refund requests directly to Licensee rather than Licensor.\"}}, {\"id\": \"Section 7.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MODIFICATIONS\", \"level\": 2, \"text\": \"Section 7.9 MODIFICATIONS. Licensee shall not make any modifications to or derivations of the Licensed Products without the prior written consent of Licensor, except in the case of an Emergency Fix. Licensee shall not reverse engineer or otherwise attempt to reproduce the source code of any Licensed Product. In the event that Licensee makes any modification, alteration or enhancement to the Licensed Product or Documentation (including but not limited to an Emergency Fix), such modification, alteration or enhancement, including all intellectual property rights thereto, will be and remain the sole and exclusive property of Licensor. Any suggestions or changes desired by Licensee to the Licensed Product or Documentation shall be made by 8 Licensee in writing to Licensor and, if incorporated into the Licensed Product or Documentation, shall be the property of Licensor.\"}}, {\"id\": \"Section 7.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COPYRIGHT AND OTHER PROPRIETARY NOTICES\", \"level\": 2, \"text\": \"Section 7.10 COPYRIGHT AND OTHER PROPRIETARY NOTICES. Licensee shall ensure that the copyright, trademark and any other proprietary notices of Licensor or other legends contained in or on any copies of the Licensed Products or Documentation remain in or on the original Licensed Product or Documentation and any copies of such product or documentation reproduced by Licensee. The existence of any copyright, trademark or other proprietary notices in or on the Licensed Product or Documentation shall not be construed as a publication of the Licensed Product or Documentation.\"}}, {\"id\": \"Section 7.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO ENCUMBRANCES\", \"level\": 2, \"text\": \"Section 7.11 NO ENCUMBRANCES. Licensee shall not engage in the lease, transfer, rental or loan of the Licensed Products or Documentation and Licensee shall not allow the Licensed Products or Documentation to become encumbered by any means.\"}}, {\"id\": \"Section 7.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO INCONSISTENT WARRANTIES\", \"level\": 2, \"text\": \"Section 7.12 NO INCONSISTENT WARRANTIES. Licensee shall not, and shall obligate Redistributors not to, make or pass on to Customers any warranty or representation on behalf of Licensor inconsistent with or in addition to the limited warranty contained in the Sublicense.\"}}, {\"id\": \"Section 7.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPUTES BETWEEN LICENSEE AND CUSTOMERS\", \"level\": 2, \"text\": \"Section 7.13 DISPUTES BETWEEN LICENSEE AND CUSTOMERS. Licensee shall notify Licensor promptly concerning any threatened legal proceedings between Licensee on the one hand and a Redistributor or a Customer on the other hand and of any legal notices served on, or legal actions commenced against, Licensee regarding the Licensed Products or Documentation which might affect Licensor. Licensee shall not institute proceedings or enter into a compromise with any third party with whom it is in dispute concerning the Licensed Products or Documentation without the prior written consent of a duly authorized officer of Licensor, which consent shall not be unreasonably withheld or delayed by Licensor.\"}}, {\"id\": \"Section 7.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRANSLATION\", \"level\": 2, \"text\": \"Section 7.14 TRANSLATION. Licensee shall not translate any portion of the Licensed Products, including any Documentation, into any other language without the prior written permission of Licensor.\"}}, {\"id\": \"Section 7.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY REGISTRATION\", \"level\": 2, \"text\": \"Section 7.15 INTELLECTUAL PROPERTY REGISTRATION. Without the prior written consent of Licensor, Licensee shall not register, apply for registration or in any other way attempt to obtain any intellectual property rights relating to any Licensed Product, any Documentation or any part thereof or take any action that materially and adversely affects such rights held by Licensor.\"}}, {\"id\": \"ARTICLE 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COVENANTS OF LICENSOR\", \"level\": 1, \"text\": \"ARTICLE 8 COVENANTS OF LICENSOR\"}}, {\"id\": \"Section 8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensor shall be solely responsible for delivering to Licensee a Master Copy of each Licensed Product and Documentation\", \"level\": 2, \"text\": \"Section 8.1 Licensor shall be solely responsible for delivering to Licensee a Master Copy of each Licensed Product and Documentation and for the maintenance and support of the 9 Sublicense Copies and Documentation used by any Redistributors and Customers. The duties of Licensor include the following: (a) Delivering a Master Copy of each Licensed Product and Documentation, including any Upgrades as they become available, to permit Licensee to (1) make Sublicense Copies and copies of the Documentation to meet the demand of Redistributors and Customers and (2) market and license Sublicense Copies and copies of the Documentation, together with the copies of promotional and other materials which Licensor may produce from time to time in order to assist Licensee in marketing and sublicensing the Licensed Products during the term of this Agreement. (b) Employing a sufficient number of skilled technicians experienced in the computing industry and familiar with the Licensed Products and Documentation to provide adequate technical support and assistance to all Redistributors and Customers. (c) Providing competent instruction to Redistributors and Customers regarding the use and installation of the Licensed Products. (d) Providing information, including by means of telephone support, to Redistributors and Customers as to the proper procedures and persons to contact to enable the proper installation and operation of the Licensed Products and providing responsive answers to questions and problems regarding the use and operation of the Licensed Products. (e) Providing technical assistance in supporting the Licensed Products and correcting any errors in the Licensed Products on an ongoing basis. (f) Delivering to Licensee sample copies of all Licensor's marketing and licensing materials relating to the Licensed Products in use in the United States of America for copying and distribution in the Territory at Licensee's expense.\"}}, {\"id\": \"Section 8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REGISTRATION FOR TRADEMARKS AND COPYRIGHTS\", \"level\": 2, \"text\": \"Section 8.2 REGISTRATION FOR TRADEMARKS AND COPYRIGHTS. Licensor shall use its best efforts to register in its name all Marks relating to the Licensed Products in the Territory and Licensor shall bear all costs of such registration and the maintenance and enforcement of all such rights and shall notify Licensee from time to time of all successful and unsuccessful registrations.\"}}, {\"id\": \"ARTICLE 9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"ARTICLE 9 INDEMNIFICATION\"}}, {\"id\": \"Section 9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION OF LICENSOR\", \"level\": 2, \"text\": \"Section 9.1 INDEMNIFICATION OF LICENSOR. Licensee hereby agrees to defend and indemnify Licensor and Licensor's officers, directors, employees, stockholders, agents and representatives 10 against, and agrees to hold them harmless from, any loss, liability, claim, damage or expense (including reasonable legal fees and expenses incurred therein or in enforcing the indemnity), as incurred, for or on account of or arising from or in connection with or otherwise with respect to any breach of any representation, warranty or covenant of Licensee contained in this Agreement or any document delivered in connection herewith.\"}}, {\"id\": \"Section 9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION OF LICENSEE\", \"level\": 2, \"text\": \"Section 9.2 INDEMNIFICATION OF LICENSEE. Licensor hereby agrees to defend and indemnify Licensee and Licensee's officers, directors, employees, stockholders, agents and representatives against, and agrees to hold them harmless from, any loss, liability, claim, damage or expense (including reasonable legal fees and expenses incurred therein or in enforcing the indemnity), as incurred, for or on account of or arising from or in connection with or otherwise with respect to any breach of any representation, warranty or covenant of Licensor contained in this Agreement or any document delivered in connection herewith.\"}}, {\"id\": \"Section 9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION PROCEDURE\", \"level\": 2, \"text\": \"Section 9.3 INDEMNIFICATION PROCEDURE. Promptly after acquiring knowledge of any loss, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claim against Licensor or Licensee, or as to which Licensor or Licensee may be liable, a party entitled hereunder to be indemnified shall give written notice thereof to the party obligated hereunder to provide indemnification. The indemnifying party at its own expense promptly shall defend, contest or otherwise protect against any damage, loss, deficiency, liability, claim, encumbrance, penalty, cost, expense, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claim made by a third party against which such indemnifying party has agreed to indemnify any indemnified party, and each indemnifying party shall receive from the indemnified party all necessary and reasonable cooperation in said defense, including without limitation the services of employees of the indemnified party who are familiar with the transactions out of which any such damage, loss, deficiency, liability, claim, encumbrance, penalty, cost, expense, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claim may have arisen. The indemnified party shall have the right to control the defense of any such third party proceeding unless it is relieved of its liability hereunder with respect to such defense by the indemnified party. The indemnified party shall have the right to employ separate counsel in any such action and to participate in the defense thereof, but the fees and expenses of such counsel shall not be at the expense of the indemnifying party if the indemnifying party has assumed the defense of the action with counsel reasonably satisfactory to the indemnified party; provided that the fees and expenses of the indemnified party's counsel shall be at the expense of the indemnifying party if (i) the employment of such counsel has been specifically authorized in writing by the indemnifying party or (ii) such indemnified party shall have been advised by counsel hat there is a conflict of interest or issue conflict involved in the representation by counsel employed by the indemnifying party in the defense of such action on behalf of the indemnified party or that there may be one or more legal defenses available to such indemnified party which are not available to the indemnifying party (in which case the indemnifying party shall not have the fight to assume the defense of such action on behalf of such indemnified party, it being understood, however, that the indemnifying party shall not be liable, in connection with any one such action or separate but substantially similar or related actions in the same Jurisdiction arising out of the same general allegations or circumstances, for the 11 reasonable fees and expenses of more than one separate firm of attorneys for the indemnified party, which firm shall be designated in writing by the indemnified party). The indemnifying party shall have the right, at its option and unless so relieved, to compromise, at its own expense by its own counsel, any such matter involving the asserted liability to a third party of the indemnified party. In the event that the indemnifying party shall undertake to compromise any such asserted liability, the indemnifying party shall notify the indemnified party promptly of its intention to do so. In the event that an indemnifying party after written notice from an indemnified party fails to take timely action to defend any such damage, loss, deficiency, liability, claimed encumbrance, penalty, cost, expense, action, suit, investigation, proceeding, demand, assessment, audit, judgment or claimed the indemnified party shall have the right to defend the same by counsel of its own choosing but at the cost and expense of the indemnifying party. In the event that the indemnified party defends such an asserted liability, it shall not compromise any such asserted liability without the written consent of the indemnifying party, such consent not to be unreasonably withheld or delayed.\"}}, {\"id\": \"Section 9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FURTHER REMEDIES FOR INFRINGEMENT\", \"level\": 2, \"text\": \"Section 9.4 FURTHER REMEDIES FOR INFRINGEMENT. If Licensee is prevented from its normal use of any Licensed Product or Documentation by injunction or court order arising from, relating to or in connection with any alleged or actual infringement on the intellectual property rights of a third party relating to any Licensed Product or Documentation, then Licensor at its option and in addition to the other remedies contained in this Agreement and at no expense, loss or damage to Licensee shall (a) replace such Licensed Product or Documentation free of any such infringement, (b) modify such Licensed Product or Documentation so that it is free of any such infringement or (c) procure for the benefit of Licensee, whether by license or other release of claim of infringement, the fight to make Sublicense Copies and copies of the Documentation to meet the demand of Redistributors and Customers and to market and sublicense Sublicense Copies and copies of the Documentation.\"}}, {\"id\": \"ARTICLE 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AGREEMENT NOT TO COMPETE, CONFIDENTIALITY\", \"level\": 1, \"text\": \"ARTICLE 10 AGREEMENT NOT TO COMPETE, CONFIDENTIALITY\"}}, {\"id\": \"Section 10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NONCOMPETITION\", \"level\": 2, \"text\": \"Section 10.1 NONCOMPETITION. Each of Licensor and Licensee understands and acknowledges that Licensor shall be entitled to protect and preserve the going concern value of Licensor's business to the extent permitted by law and that Licensor would not have entered into this Agreement absent the provisions of this Section 10.1 and, therefore, each of Licensor and Licensee agrees that during the term of this Agreement Licensee shall not engage in, represent in any way or be connected with directly or indirectly any business competing with the Licensed Products.\"}}, {\"id\": \"Section 10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 2, \"text\": \"Section 10.2 CONFIDENTIAL INFORMATION. Licensee understands and agrees that the Licensed Products and any related information marked \\\"Confidential\\\" constitute valuable intellectual property and trade secrets of Licensor and embody substantial creative efforts and confidential information, ideas and expressions belonging to Licensor. Licensor understands and agrees that 12 any reports supplied pursuant to this Agreement by Licensee to Licensor relating to the Licensed Products contain proprietary information of Licensee. The Licensed Products and related information and such reports are referred to collectively in this Agreement as the \\\"Confidential Information.\\\" Each party to this Agreement shall observe at all times complete confidentiality with regard to the Confidential Information of the other party to this Agreement held by such party and shall not permit or authorize access to or disclosure of any such Confidential Information to any other person or entity other than such party's employees and consultants who have executed confidentiality agreements with terms substantially similar to this Agreement. This Section 10.2 will not apply to any Confidential Information that is required to be disclosed by applicable law or any Confidential Information that becomes (a) public other than by virtue of a breach of this Section 10.2 or (b) available to such party from another source (other than any independent contractor engaged by such party to audit pursuant to this Agreement the records of the other party hereto) that is not subject to a confidentiality agreement with the other party hereto of which such party at that time is aware.\"}}, {\"id\": \"Section 10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"UNAUTHORIZED USE\", \"level\": 2, \"text\": \"Section 10.3 UNAUTHORIZED USE. Each party to this Agreement shall notify the other party to this Agreement promptly in writing of the existence of any circumstances surrounding any unauthorized knowledge, possession or use of the Confidential Information by any person or entity other than the parties to this Agreement and each of their authorized employees and consultants.\"}}, {\"id\": \"Section 10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REMEDY\", \"level\": 2, \"text\": \"Section 10.4 REMEDY. Notwithstanding any other provision of this Agreement, each of the parties to this Agreement understands and agrees that the remedy of indemnity payments pursuant to this Agreement and other remedies at law would be inadequate in the case of any breach of the covenants contained in this Article 10 and each party to this Agreement agrees that the other party to this Agreement shall be entitled to equitable relief, including the remedy of specific performance, without posting of bond or other security, with respect to any breach or attempted breach of such covenants.\"}}, {\"id\": \"ARTICLE 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUDITS\", \"level\": 1, \"text\": \"ARTICLE 11 AUDITS\"}}, {\"id\": \"Section 11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AUDITS\", \"level\": 2, \"text\": \"Section 11.1 AUDITS. During the term of this Agreement and the five (5) year period immediately following termination of this Agreement, Licensor will have the right, at its own expense, to audit and examine Licensees records concerning either (a) the reproduction and sublicensing of the Licensed Products and the resulting fees due to Licensor or (b) compliance by Licensee with its obligations as to confidentiality under this Agreement. During the term of this Agreement and the five (5) year period immediately following termination of this Agreement, Licensee will have the right, at its own expense, to audit and examine Licensor's records concerning compliance by Licensor with its obligations as to confidentiality under this Agreement. Any such audit shall be conducted during normal business hours, upon at least three business days prior written notification to the party to be audited stating the purpose of the audit 13 and in such a manner so as to not unreasonably interfere with such party's business operations. The auditing party shall keep any and all information derived from any audits confidential. Such information is deemed to be \\\"Confidential Information\\\" within the meaning of Article 10. In relation to such information, the parties to this Agreement are subject to the obligations and remedies set forth in Article 10. The auditing party shall not use such information for any purpose other than the purpose of the audit as stated in such party's written notification for such audit. If an audit of Licensee's records and books of account reveals that Licensee has underpaid the fees due under this Agreement to Licensor for the period under audit, Licensee shall pay to Licensor promptly the amount of the underpayment. If the amount of underpayment for the period under audit exceeds five percent (5%) of the total amount owed during such period, Licensee shall reimburse Licensor for all costs and expenses incurred by Licensor in connection with performing the audit.\"}}, {\"id\": \"ARTICLE 12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITED WARRANTIES\", \"level\": 1, \"text\": \"ARTICLE 12 LIMITED WARRANTIES\"}}, {\"id\": \"Section 12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO DEFECTS\", \"level\": 2, \"text\": \"Section 12.1 NO DEFECTS. For twelve (12) months after delivery of the Master Copy of each Licensed Product to Licensee, Licensor warrants that the media in which the Licensed Products are stored shall be free from defects in materials and workmanship, assuming normal use. Licensee may return any defective media to Licensor for replacement free of charge during such twelve (12) month period.\"}}, {\"id\": \"Section 12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PERFORMANCE\", \"level\": 2, \"text\": \"Section 12.2 PERFORMANCE. For twelve (12) months after delivery of any Licensed Product to a Customer, whether Customer receives such Licensed Product from Licensee or a Redistributor, Licensor warrants that each Licensed Product will perform as described in the applicable Documentation. If Licensee or any Redistributor or Customer discovers any errors or discrepancies in the Licensed Products from the Documentation during the twelve (12) month warranty period, Licensee shall notify Licensor promptly in writing of such error or discrepancy in sufficient detail to enable Licensor to recreate the error or discrepancy. If the error or discrepancy is found by Licensee prior to the expiration of the ten (10) day evaluation period set forth in Section 4.2, such evaluation period shall be extended ten (10) days from the date of receipt by Licensee of the corrected Licensed Product from Licensor.\"}}, {\"id\": \"Section 12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DUTIES UNDER WARRANTY\", \"level\": 2, \"text\": \"Section 12.3 DUTIES UNDER WARRANTY. If Licensee or any Redistributor or Customer discovers any error in any Licensed Product or discrepancy in any Licensed Product from the Documentation that results in a material loss of performance in the Licensed Product within the twelve (12) month warranty period, then Licensor shall provide Licensee with the correction or method of resolving such error or discrepancy provided that Licensor shall not be responsible for any error or discrepancy caused by failure to use the Licensed Products as specified in the Documentation or any modifications made to any Licensed Product by or on behalf of a party other than Licensor. If such error or discrepancy is not resolved within thirty (30) days after Licensee's 14 written notice to Licensor, then Licensee as its sole remedy may (a) extend the correction period to a date which is agreeable to Licensor and Licensee or (b) return all copies of the Licensed Products to Licensor with a certification by an authorized representative of Licensee that all copies have been returned to Licensor or have been destroyed and that Licensee has not retained any copies thereof and Licensor shall refund to Licensee the amount paid by Licensee to Licensor for such Licensed Products. Licensee shall pay for all services rendered by Licensor in connection with the Licensed Products or Documentation that are not covered or at that time are no longer covered by the warranty described in this Agreement.\"}}, {\"id\": \"Section 12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVE REMEDIES\", \"level\": 2, \"text\": \"Section 12.4 EXCLUSIVE REMEDIES. THE REMEDIES SPECIFIED ABOVE SHALL BE THE SOLE AND EXCLUSIVE REMEDIES OF LICENSEE REGARDING THE LICENSED PRODUCTS. LICENSOR SPECIFICALLY DISCLAIMS ANY AND ALL OTHER WARRANTIES OF ANY KIND, EXPRESS, RAPLIED OR STATUTORY, INCLUDING ANY WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. LICENSOR SPECIFICALLY MAKES NO REPRESENTATIONS REGARDING THE SUITABILITY OF THE LICENSED PRODUCTS FOR THE REQUIREMENTS OF ANY REDISTRIBUTOR. OR CUSTOMER CONCERNING CAPACITY, INTERCONNECTIVITY, EXPANDABILITY OR PERFORMANCE.\"}}, {\"id\": \"ARTICLE 13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIABILITY\", \"level\": 1, \"text\": \"ARTICLE 13 LIABILITY\"}}, {\"id\": \"Section 13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMIT OF LIABILITY\", \"level\": 2, \"text\": \"Section 13.1 LIMIT OF LIABILITY. Licensor's total liability to Licensee under any provision of this Agreement shall be limited to the amount actually paid by Licensee to Licensor for the Licensed Product giving rise to the liability. The existence of claims or suits against more than one Licensed Product shall not enlarge or extend the limit. The parties to this Agreement acknowledge that each of them relied upon the inclusion of this limitation in consideration of entering into this Agreement. IN NO EVENT SHALL A PARTY TO THIS AGREEMENT BE LIABLE TO THE OTHER PARTY TO THIS AGREEMENT FOR ANY SPECIAL, INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM THE USE, OR INABILITY TO USE, THE LICENSED PRODUCTS OR ARISING OUT OF THIS AGREEMENT, INCLUDING BUT NOT LMTED TO LOSS OF PROFIT OR OTHER MONETARY LOSS, LOSS OR INTERRUPTION OF DATA OR CONTUTER TIME, ALTERATION OR ERRONEOUS TRANSNUSSION OF DATA OR PROGRAM ERRORS, EVEN IF SUCH PARTY IS ADVISED IN ADVANCE OF THE POSSIBILITY OF SUCH DAMAGES. 15\"}}, {\"id\": \"ARTICLE 14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 14 TERM AND TERMINATION\"}}, {\"id\": \"Section 14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 2, \"text\": \"Section 14.1 TERM. This Agreement shall be effective until the earlier of (a) its termination in accordance with the provisions of this Article 14 or (b) the date that is two (2) years after the date of this Agreement; provided, however, that this Agreement will renew automatically for successive terms of one (1) year each unless a party to this Agreement delivers written notice of termination to the other party to this Agreement at least sixty (60) days prior to the end of the original or any renewal term or the parties to this Agreement do not agree in writing to the Quota Amount referred to in subsection 14.2(b)(1) for any one (1) year renewal term at least sixty (60) days prior to the commencement of such term.\"}}, {\"id\": \"Section 14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION\", \"level\": 2, \"text\": \"Section 14.2 TERMINATION. (a) Either party to this Agreement may terminate this Agreement: (1) Immediately upon written notice if the other party to this Agreement becomes insolvent, is the subject of a petition in bankruptcy that is not resolved within thirty (30) days, admits in writing its inability to pay its debts, makes an assignment for the benefit of creditors, ceases doing business or attempts an unauthorized assignment of this Agreement; or (2) Immediately upon written notice if the other party to this Agreement performance of any obligation under this Agreement, including failure to promptly pay any amount due hereunder, and fails to cure such default within thirty (30) days after delivery of written notice specifying the default (with any termination as a result of Licensee's failure to pay amounts due under this Agreement resulting in the acceleration of Licensee's obligation to pay all sums due to Licensor under this Agreement). (b) Licensor may terminate this Agreement: (1) Upon ninety (90) days prior written notice if Licensee does not enter into Sublicenses and other agreements relating to the Licensed Products with Redistributors and Customers that result in fees payable to Licensor hereunder in an aggregate amount equal to or greater than the Quota Amount for any year during the term hereof. As used herein, the term \\\"Quota Amount\\\" means $50,000 for each of the first and second years of the original term of this Agreement and an amount agreed to in writing by the parties hereto in respect of any subsequent one year renewal term (provided that such amount equals or exceeds $50,000). If Licensor fails to deliver notice of termination pursuant to this subsection 14.2(b)(1) within six (6) months after the end of the term to which such termination relates, Licensor will be deemed to have waived such termination right in respect of such term (but not in respect of subsequent terms); or (2) Upon thirty (30) days prior written notice if Licensee enters into an agreement or other arrangement relating to the merger of Licensee with another entity, the acquisition of the majority of Licensee's issued and outstanding capital stock or the acquisition of substantially all of the assets of Licensee.\"}}, {\"id\": \"Section 14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DUTIES UPON TERMINATION\", \"level\": 2, \"text\": \"Section 14.3 DUTIES UPON TERMINATION. Upon the termination or expiration of the term of this Agreement, the parties shall have the following rights and obligations: (a) Within five (5) days of written demand by Licensor to Licensee, Licensee shall return or destroy all copies of the Licensed Products and any materials associated with the Licensed Products in Licensee's possession or control, except that Licensee may retain sufficient copies of the Master Copy of each Licensed Product in object code form to enable Licensee to meet its maintenance and support obligations to its Customers, if any. (b) Licensee immediately shall cease any use, reproduction, sublicensing or distribution of the Licensed Products or the Documentation. 16 (c) Within five (5) days of Licensor's written request, Licensee shall certify in a writing reasonably acceptable to Licensor that except as set forth in this Agreement all copies of the Licensed Products and related material have been delivered to Licensor, destroyed or rendered unusable. (d) Licensee shall not use any Licensed Product or Documentation as part of any other product that Licensee may use, sublicense or distribute and Licensee shall cease any use of the Marks associated with the Licensed Products or Documentation. (e) All valid Redistributor Agreements and Sublicenses by and between Licensee and any Redistributors and Customers will remain and continue in full force and effect for the remainder of their respective terms, and at Licensor's option Licensee shall assign to Licensor its rights in such agreements with respect to the Licensed Products or Documentation; provided that if Licensor fails to provide reasonable support to any Redistributor or Customer, Licensee may support such Redistributor or Customer without payment of fees to Licensor. (f) Licensee promptly shall account for and pay to Licensor all amounts due and owing pursuant to the terms of this Agreement and provide Licensor with all outstanding reports due under this Agreement. (g) Licensee immediately shall cease holding itself out as having any connection with any Licensed Product or Licensor, unless Licensee at that time has a connection with Licensor by reason other than this Agreement. (h) Licensee shall report to Licensor in reasonable detail the status of all negotiations with prospective Redistributors and Customers or leads to prospective Redistributors and Customers and all services which Licensee is obligated to provide to any Redistributors or Customers.\"}}, {\"id\": \"Section 14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RIGHTS NOT EXHAUSTIVE\", \"level\": 2, \"text\": \"Section 14.4 RIGHTS NOT EXHAUSTIVE. The fights and remedies of Licensor included in this Article 14 shall not be exclusive and are in addition to any other rights and remedies provided by law or equity.\"}}, {\"id\": \"Section 14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SURVIVAL\", \"level\": 2, \"text\": \"Section 14.5 SURVIVAL. The provisions of Articles 9, 10 and 11, Section 7.5 and this Section 14.5 and all obligations of Licensee to pay any amounts to Licensor under this Agreement will survive the termination of this Agreement. 17\"}}, {\"id\": \"ARTICLE 15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 1, \"text\": \"ARTICLE 15 GENERAL\"}}, {\"id\": \"Section 15.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NATURE OF RELATIONSHIP\", \"level\": 2, \"text\": \"Section 15.1 NATURE OF RELATIONSHIP. The relationship existing between Licensee and Licensor is one of an independent contractor, and this Agreement shall not be construed as creating a partnership, joint venture, agency relationship or as granting a franchise under federal or any state law. Each of Licensee and its officers, employees or other representatives shall not enter into or attempt to enter into any obligation on behalf of Licensor. Licensee shall not make any representations to any Redistributors or Customers with respect to the Licensed Products and Documentation, including without limitation representations as to any warranty, covenant or other terms or conditions relating to licensing of the Licensed Products, unless such representations are made (a) in strict accordance with this Agreement or (b) with the prior written consent of Licensor.\"}}, {\"id\": \"Section 15.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 2, \"text\": \"Section 15.2 NOTICES. All notices and other communications hereunder shall be in writing and shall be deemed delivered (i) when delivered if delivered personally or by overnight courier or telecopier with proof of delivery or (ii) three (3) days after such communication is deposited in the United States mail with postage prepaid, if delivered, if mailed by registered or certified mail (return receipt requested) to the parties to this Agreement at the following addresses (or at such other address for a party as shall be specified by like notice): (a) if to Licensor, to Peregrine/Bridge Transfer Corporation 14141 Southwest Freeway, Suite 6200 Sugar Land, Texas 77478 Attn: President and (b) if to Licensee, to Neon Systems, Inc. 14141 Southwest Freeway, Suite 6200 Sugar Land, Texas 77478 Attn: President 18\"}}, {\"id\": \"Section 15.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTERPRETATION\", \"level\": 2, \"text\": \"Section 15.3 INTERPRETATION. When a reference is made in this Agreement to an Article, Section, subsection or Exhibit, such reference shall be to an Article, Section, subsection or Exhibit of this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the words \\\"include,\\\" \\\"includes\\\" or \\\"including\\\" are used in this Agreement, such term shall be deemed to be followed by the words \\\"without limitation.\\\" All accounting terms not defined in this Agreement shall have the meanings determined by generally accepted accounting principles.\"}}, {\"id\": \"Section 15.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COUNTERPARTS This Agreement may be executed in two or more counterparts, all of which shall be considered one and the s\", \"level\": 2, \"text\": \"Section 15.4 COUNTERPARTS This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same agreement and shall become effective when two or more counterparts have been signed by each of the parties to this Agreement and delivered to the other parties to this Agreement, it being understood that all such parties need not sign the same counterpart. For purposes hereof, delivery shall be deemed effective upon exchange of signed copies of this Agreement by facsimile, provided that originally signed counterparts of this Agreement are transmitted promptly to the other parties hereto.\"}}, {\"id\": \"Section 15.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT, THIRD PARTY BENEFICIARIES\", \"level\": 2, \"text\": \"Section 15.5 ENTIRE AGREEMENT, THIRD PARTY BENEFICIARIES. This Agreement (including the documents and instruments referred to herein) (a) constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, between the parties hereto with respect to the subject matter hereof and (b) is not intended to confer upon any person (including any Redistributor or Customer) other than the parties hereto any rights or remedies hereunder, except as provided in Article 9.\"}}, {\"id\": \"Section 15.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW\", \"level\": 2, \"text\": \"Section 15.6 GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE SIATE OF TEXAS.\"}}, {\"id\": \"Section 15.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"Section 15.7 ASSIGNMENT. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the parties hereto without the prior written consent of the other party to this Agreement; provided, however, that Licensor may assign this Agreement to a subsidiary or entity controlling, controlled by or under common control with Licensor. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be to this Agreement and their respective successors and permitted assigns.\"}}, {\"id\": \"Section 15.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"Section 15.8 SEVERABILITY. If any provision of this Agreement, or any portion of any provision hereof, shall be deemed invalid or unenforceable pursuant to a final determination of any court of competent jurisdiction or as a result of future legislative action, such determination or action shall be construed so as not to affect the validity or enforceability hereof and shall not affect the validity or effect of any other portion hereof\"}}, {\"id\": \"Section 15.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AMENDMENT\", \"level\": 2, \"text\": \"Section 15.9 AMENDMENT. This Agreement may be amended only by a written instrument duly signed by each of the parties hereto. 19\"}}, {\"id\": \"Section 15.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WAIVER\", \"level\": 2, \"text\": \"Section 15.10 WAIVER. Any of the terms, covenants, representations, warranties or conditions of this Agreement may be waived only by a written instrument signed by the party to this Agreement waiving compliance. No waiver by any party to this Agreement of any condition or breach of any term, covenant, representation or warranty contained in this Agreement, whether by conduct or otherwise, in any one or more instances, shall be construed as a further or continuing waiver of any such condition or breach or a waiver of any other condition or of the breach of any other term, covenant, representation or warranty set forth in this Agreement. IN WITNESS WBEREOF, the parties hereto have executed this Agreement as of the date first above written. LICENSOR: PEREGRINE/BRIDGE TRANSFER By: /s/ Charles E Noell ---------------------------------- Name: Charles E Noell -------------------------------- Title: General Partner ------------------------------- LICENSEE: NEON SYSTEMS, INC. By: /s/ F. Joseph Backer ---------------------------------- Name: F. Joseph Backer -------------------------------- Title: CEO ------------------------------- 20\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE TERRITORY\", \"level\": 1, \"text\": \"EXHIBIT B THE TERRITORY The Territory included is worldwide.\"}}, {\"id\": \"party:PEREGRINE/BRIDGE TRANSFER CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PEREGRINE/BRIDGE TRANSFER CORPORATION\", \"role\": \"Licensor\", \"address\": \"Peregrine/Bridge Transfer Corporation 14141 Southwest Freeway, Suite 6200 Sugar Land, Texas 77478\"}}, {\"id\": \"party:NEON SYSTEMS, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NEON SYSTEMS, INC.\", \"role\": \"Licensee\", \"address\": \"Neon Systems, Inc. 14141 Southwest Freeway, Suite 6200 Sugar Land, Texas 77478\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"DISTRIBUTOR AGREEMENT (the \\\"Agreement\\\") is made as of the 1st day of January, 1996 by and between Peregrine/Bridge Transfer Corporation, a Delaware corporation (the \\\"Licensor\\\"), and Neon Systems, Inc., a Delaware corporation (the \\\"Licensee\\\").\", \"definition_clause\": \"Exhibit A\"}}, {\"id\": \"term:Customer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer\", \"text\": \"\\\"Customer\\\" means a person or entity that has acquired, or has indicated its interest in acquiring from Licensee, or from a Redistributor if so specified herein, a non-exclusive and nontransferable Sublicense to use one (1) or more of the Licensed Products.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Documentation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Documentation\", \"text\": \"\\\"Documentation\\\" means all visually readable materials published or made available by Licensor during the term of this Agreement for use by Customers in connection with the Licensed Products.\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:Emergency Fix\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Emergency Fix\", \"text\": \"\\\"Emergency Fix\\\" means a temporary correction of a problem in a Licensed Product reported by Licensee to Licensor that may take the form of a written instruction or magnetic or optical media.\", \"definition_clause\": \"1.3\"}}, {\"id\": \"term:Licensed Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Licensed Product\", \"text\": \"\\\"Licensed Product\\\" means any copy, or part thereof, of object code of the software products listed on EXHIBIT A attached to this Agreement, as well as any Upgrades or other material distributed to Licensee by Licensor in connection with such software products.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"term:Master Copy\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Master Copy\", \"text\": \"\\\"Master Copy\\\" means the initial object code copy of each Licensed Product and of any subsequent Upgrades or other derivations distributed to Licensee by Licensor under this Agreement.\", \"definition_clause\": \"1.5\"}}, {\"id\": \"term:Redistributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Redistributor\", \"text\": \"\\\"Redistributor\\\" means any individual or entity that is granted a license by Licensee to copy and sublicense one or more Licensed Products to Customers.\", \"definition_clause\": \"1.6\"}}, {\"id\": \"term:Sublicense\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sublicense\", \"text\": \"\\\"Sublicense\\\" means the sublicense agreement to be entered into by Customers, the form of which is attached hereto as EXHIBIT C, or such form as otherwise may be approved by Licensor pursuant to this Agreement.\", \"definition_clause\": \"1.7\"}}, {\"id\": \"term:Sublicense Copy\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sublicense Copy\", \"text\": \"\\\"Sublicense Copy\\\" means an object code copy of the Licensed Product that Licensee licenses from Licensor and inventories for sublicensing to Redistributors and Customers.\", \"definition_clause\": \"1.8\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"\\\"Territory\\\" means that geographic area specified in EXHIBIT B attached to this Agreement.\", \"definition_clause\": \"1.9\"}}, {\"id\": \"term:Upgrade\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Upgrade\", \"text\": \"\\\"Upgrade\\\" means any revision, adaptation or new version of a Licensed Product which enhances a Licensed Product and which is offered by Licensor to registered users of that Licensed Product as an \\\"upgrade.\\\"\", \"definition_clause\": \"1.10\"}}, {\"id\": \"term:Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marks\", \"text\": \"the trademarks, service marks, trade names, copyrights, logos and designations (collectively, the \\\"Marks\\\") relating to the Licensed Products or the Documentation\", \"definition_clause\": \"Section 2.8\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"The Licensed Products and any related information marked \\\"Confidential\\\" constitute valuable intellectual property and trade secrets of Licensor and embody substantial creative efforts and confidential information, ideas and expressions belonging to Licensor. Licensor understands and agrees that 12 any reports supplied pursuant to this Agreement by Licensee to Licensor relating to the Licensed Products contain proprietary information of Licensee. The Licensed Products and related information and such reports are referred to collectively in this Agreement as the \\\"Confidential Information.\\\"\", \"definition_clause\": \"Section 10.2\"}}, {\"id\": \"term:Quota Amount\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Quota Amount\", \"text\": \"the term \\\"Quota Amount\\\" means $50,000 for each of the first and second years of the original term of this Agreement and an amount agreed to in writing by the parties hereto in respect of any subsequent one year renewal term (provided that such amount equals or exceeds $50,000).\", \"definition_clause\": \"Section 14.2\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:120 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"120 days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 days\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"10%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:10 day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 day\"}}, {\"id\": \"value:five (5) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) business days\"}}, {\"id\": \"value:fifteenth (15th) day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteenth (15th) day\"}}, {\"id\": \"value:three business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three business days\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:$50,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$50,000\"}}, {\"id\": \"value:five (5) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"value:three (3) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16- AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16- AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"This Amendment is entered into effective October 1\", \"level\": 1, \"text\": \"This Amendment is entered into effective October 1,1996 (\\\"Amendment Date\\\") by and between NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc., and Ingram Micro (\\\"Distributor\\\") acting on behalf of itself and its affiliates. NETGEAR and Distributor having previously entered into a Distributor Agreement (\\\"Agreement\\\") with an Effective Date of March 1,1996, now mutually agree to amend that Agreement as follows:\"}, {\"id\": \"1\", \"title\": \"Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to\", \"level\": 1, \"text\": \"1. Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to be the United States and [*].\"}, {\"id\": \"2\", \"title\": \"During the initial one year period beginning on the Amendment Date, Distributor shall be the only distri\", \"level\": 1, \"text\": \"2. During the initial one year period beginning on the Amendment Date, Distributor shall be the only distributor appointed by NETGEAR in [*], subject to Distributor conducting mutually agreed to marketing activities as described in the Marketing Plan for [*] to be developed and agreed to by and between the parties and which shall be attached to and made a part of this Agreement as Exhibit 4a. For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers. The foregoing notwithstanding, during the [*] and any subsequent period, NETGEAR reserves the right to sell or license Products in [*] to customers other than distributors such as, but not limited to resellers who procure Products at centralized locations for resale to end-use customers solely through their wholly or majority owned retail outlets, both store-front and catalog. Following the [*], for any extension or renewal term, Distributor's appointment as Distributor shall be non-exclusive and NETGEAR may appoint other distributors in [*] at its sole discretion.\"}, {\"id\": \"3\", \"title\": \"The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the origi\", \"level\": 1, \"text\": \"3. The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the original Agreement. All other terms of the original Agreement shall remain unchanged. IN WITNESS WHEREOF, the parties have executed this Amendment to be effective as of the date first written above. NETGEAR: DISTRIBUTOR: NETGEAR, INC. INGRAM MICRO By: /s/ Lloyd Cainey By: /s/ Michael Terrell --------------- ------------------- Name: /s/ Lloyd Cainey Name: Michael Terrell Title: Exec VP Enterprise Business Group Title: Vice President Purchasing Date: 4/30/97 Date: 2/21/97 Ingram Amendment 1 111296 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. [INGRAM MICRO LOGO] AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT THIS AMENDMENT (the \\\"Amendment\\\") is entered into this 15th day of July 1998, by and between INGRAM MICRO INC. (\\\"Ingram\\\") and NETGEAR, INC. (\\\"Vendor\\\"). The parties have agreed to amend their Distribution Agreement (\\\"Agreement\\\") dated October 1,1996.\"}, {\"id\": \"1\", \"title\": \"Section 2, TERRITORY, is amended to be United States, [*]\", \"level\": 1, \"text\": \"1. Section 2, TERRITORY, is amended to be United States, [*].\"}, {\"id\": \"2\", \"title\": \"This Amendment shall remain in effect for the current term and any renewal term of the Agreement\", \"level\": 1, \"text\": \"2. This Amendment shall remain in effect for the current term and any renewal term of the Agreement. Notwithstanding the foregoing, all other provisions of the Agreement remain unchanged. The undersigned has read this Amendment, agrees hereto, and is an authorized representative of its respective party. INGRAM MICRO INC. NETGEAR, INC. 1600 East St. Andrew Place 4401 Great America Parkway Santa Ana, CA 92705 P.O. Box 58185 Santa Clara, CA 95052-8185 By: /S/ AC Mann By: /s/ PATRICK Lo ---------------- -------------------- Name: AC Mann Name: PATRICK Lo Title: VP Purchasing Title: V. P. Netgear, Inc. 1 Confidential Doc Rev 2/97 7/15/98\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16- AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Amendment is entered into effective October 1\", \"level\": 1, \"text\": \"This Amendment is entered into effective October 1,1996 (\\\"Amendment Date\\\") by and between NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc., and Ingram Micro (\\\"Distributor\\\") acting on behalf of itself and its affiliates. NETGEAR and Distributor having previously entered into a Distributor Agreement (\\\"Agreement\\\") with an Effective Date of March 1,1996, now mutually agree to amend that Agreement as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to\", \"level\": 1, \"text\": \"1. Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to be the United States and [*].\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the initial one year period beginning on the Amendment Date, Distributor shall be the only distri\", \"level\": 1, \"text\": \"2. During the initial one year period beginning on the Amendment Date, Distributor shall be the only distributor appointed by NETGEAR in [*], subject to Distributor conducting mutually agreed to marketing activities as described in the Marketing Plan for [*] to be developed and agreed to by and between the parties and which shall be attached to and made a part of this Agreement as Exhibit 4a. For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers. The foregoing notwithstanding, during the [*] and any subsequent period, NETGEAR reserves the right to sell or license Products in [*] to customers other than distributors such as, but not limited to resellers who procure Products at centralized locations for resale to end-use customers solely through their wholly or majority owned retail outlets, both store-front and catalog. Following the [*], for any extension or renewal term, Distributor's appointment as Distributor shall be non-exclusive and NETGEAR may appoint other distributors in [*] at its sole discretion.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the origi\", \"level\": 1, \"text\": \"3. The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the original Agreement. All other terms of the original Agreement shall remain unchanged. IN WITNESS WHEREOF, the parties have executed this Amendment to be effective as of the date first written above. NETGEAR: DISTRIBUTOR: NETGEAR, INC. INGRAM MICRO By: /s/ Lloyd Cainey By: /s/ Michael Terrell --------------- ------------------- Name: /s/ Lloyd Cainey Name: Michael Terrell Title: Exec VP Enterprise Business Group Title: Vice President Purchasing Date: 4/30/97 Date: 2/21/97 Ingram Amendment 1 111296 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. [INGRAM MICRO LOGO] AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT THIS AMENDMENT (the \\\"Amendment\\\") is entered into this 15th day of July 1998, by and between INGRAM MICRO INC. (\\\"Ingram\\\") and NETGEAR, INC. (\\\"Vendor\\\"). The parties have agreed to amend their Distribution Agreement (\\\"Agreement\\\") dated October 1,1996.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2, TERRITORY, is amended to be United States, [*]\", \"level\": 1, \"text\": \"1. Section 2, TERRITORY, is amended to be United States, [*].\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Amendment shall remain in effect for the current term and any renewal term of the Agreement\", \"level\": 1, \"text\": \"2. This Amendment shall remain in effect for the current term and any renewal term of the Agreement. Notwithstanding the foregoing, all other provisions of the Agreement remain unchanged. The undersigned has read this Amendment, agrees hereto, and is an authorized representative of its respective party. INGRAM MICRO INC. NETGEAR, INC. 1600 East St. Andrew Place 4401 Great America Parkway Santa Ana, CA 92705 P.O. Box 58185 Santa Clara, CA 95052-8185 By: /S/ AC Mann By: /s/ PATRICK Lo ---------------- -------------------- Name: AC Mann Name: PATRICK Lo Title: VP Purchasing Title: V. P. Netgear, Inc. 1 Confidential Doc Rev 2/97 7/15/98\"}}, {\"id\": \"party:NETGEAR, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc.\", \"role\": \"Vendor\", \"address\": \"4401 Great America Parkway P.O. Box 58185 Santa Clara, CA 95052-8185\"}}, {\"id\": \"party:INGRAM MICRO INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Ingram Micro (\\\"Distributor\\\")\", \"role\": \"Distributor\", \"address\": \"1600 East St. Andrew Place Santa Ana, CA 92705\"}}, {\"id\": \"term:Amendment Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment Date\", \"text\": \"October 1,1996\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"a Distributor Agreement (\\\"Agreement\\\") with an Effective Date of March 1,1996\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"distributor\", \"text\": \"a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Amendment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment\", \"text\": \"THIS AMENDMENT (the \\\"Amendment\\\") is entered into this 15th day of July 1998\", \"definition_clause\": \"3\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16-AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16-AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"term under the Agreement will not be effective unl\", \"level\": 1, \"text\": \"term under the Agreement will not be effective unless mutually agreed to in writing and signed by authorized representatives of both parties. Neither party shall be bound by typographical or clerical errors. G. Neither party is liable for its failure or delay to perform its obligations under the Agreement due to strikes, wars, revolutions, acts of terrorism, fires, floods, explosions, earthquakes, shortages in labor, components or materials, government regulations, or other causes beyond its control. H. This Agreement may not be assigned by either party without prior written permission from the other party, which permission shall not be unreasonably withheld or delayed. Any attempt by either party to assign any right, or delegate any duty or obligation which arises under the Agreement without such permission will be voidable.\"}, {\"id\": \"19\", \"title\": \"ENTIRE AGREEMENT, GOVERNING LAW\", \"level\": 1, \"text\": \"19. ENTIRE AGREEMENT, GOVERNING LAW This Agreement, including its attachment and order acknowledgments under the Agreement, constitutes the entire agreement between Distributor and NETGEAR with respect to the purchase, resale and distribution of the Products and is governed by the laws of the State of California except that body of law dealing with conflicts of law. INGRAM NETGEAR Distributor Agreement 11 083096 * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 1 DISCOUNT SCHEDULE The initial Discount offered Distributor for purchase or license of NETGEAR Products included on the NETGEAR Price List in effect on the Effective Date of this Agreement is [*] off of the then current NETGEAR list price. Distributor agrees that the foregoing Discount is only applicable to Products included on the NETGEAR Price List on the Effective Date of this Agreement. NETGEAR reserves the right to add Products to the Price List at its sole discretion and any such additional Products shall be offered to Distributor at discounts to be determined at that time. INGRAM NETGEAR Distributor Agreement 12 083096 EXHIBIT 2 DISTRIBUTOR'S ROUTING GUIDE INGRAM NETGEAR Distributor Agreement 13 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 3\"}, {\"id\": \"CMD\", \"title\": \"NAMED ACCOUNTS [*]\", \"level\": 1, \"text\": \"CMD NAMED ACCOUNTS [*] INGRAM NETGEAR Distributor Agreement 14 092696 EXHIBIT 4 MARKETING PLAN INGRAM NETGEAR Distributor Agreement 15 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR This Amendment is entered into effective October 1,1996 (\\\"Amendment Date\\\") by and between NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc., and Ingram Micro (\\\"Distributor\\\") acting on behalf of itself and its affiliates. NETGEAR and Distributor having previously entered into a Distributor Agreement (\\\"Agreement\\\") with an Effective Date of March 1,1996, now mutually agree to amend that Agreement as follows:\"}, {\"id\": \"1\", \"title\": \"Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to\", \"level\": 1, \"text\": \"1. Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to be the United States and [*].\"}, {\"id\": \"2\", \"title\": \"During the initial one year period beginning on the Amendment Date, Distributor shall be the only distri\", \"level\": 1, \"text\": \"2. During the initial one year period beginning on the Amendment Date, Distributor shall be the only distributor appointed by NETGEAR in [*], subject to Distributor conducting mutually agreed to marketing activities as described in the Marketing Plan for [*] to be developed and agreed to by and between the parties and which shall be attached to and made a part of this Agreement as Exhibit 4a. For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers. The foregoing notwithstanding, during the [*] and any subsequent period, NETGEAR reserves the right to sell or license Products in [*] to customers other than distributors such as, but not limited to resellers who procure Products at centralized locations for resale to end-use customers solely through their wholly or majority owned retail outlets, both store-front and catalog. Following the [*], for any extension or renewal term, Distributor's appointment as Distributor shall be non-exclusive and NETGEAR may appoint other distributors in [*] at its sole discretion.\"}, {\"id\": \"3\", \"title\": \"The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the origi\", \"level\": 1, \"text\": \"3. The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the original Agreement. All other terms of the original Agreement shall remain unchanged. IN WITNESS WHEREOF, the parties have executed this Amendment to be effective as of the date first written above. NETGEAR: DISTRIBUTOR: NETGEAR, INC. INGRAM MICRO By: /s/ Lloyd Cainey By: /s/ Michael Terrell --------------- ------------------- Name: /s/ Lloyd Cainey Name: Michael Terrell Title: Exec VP Enterprise Business Group Title: Vice President Purchasing Date: 4/30/97 Date: 2/21/97 Ingram Amendment 1 111296 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. [INGRAM MICRO LOGO] AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT THIS AMENDMENT (the \\\"Amendment\\\") is entered into this 15th day of July 1998, by and between INGRAM MICRO INC. (\\\"Ingram\\\") and NETGEAR, INC. (\\\"Vendor\\\"). The parties have agreed to amend their Distribution Agreement (\\\"Agreement\\\") dated October 1,1996.\"}, {\"id\": \"1\", \"title\": \"Section 2, TERRITORY, is amended to be United States, [*]\", \"level\": 1, \"text\": \"1. Section 2, TERRITORY, is amended to be United States, [*].\"}, {\"id\": \"2\", \"title\": \"This Amendment shall remain in effect for the current term and any renewal term of the Agreement\", \"level\": 1, \"text\": \"2. This Amendment shall remain in effect for the current term and any renewal term of the Agreement. Notwithstanding the foregoing, all other provisions of the Agreement remain unchanged. The undersigned has read this Amendment, agrees hereto, and is an authorized representative of its respective party. INGRAM MICRO INC. NETGEAR, INC. 1600 East St. Andrew Place 4401 Great America Parkway Santa Ana, CA 92705 P.O. Box 58185 Santa Clara, CA 95052-8185 By: /S/ AC Mann By: /s/ PATRICK Lo ---------------- -------------------- Name: AC Mann Name: PATRICK Lo Title: VP Purchasing Title: V. P. Netgear, Inc. 1 Confidential Doc Rev 2/97 7/15/98\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16-AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"term under the Agreement will not be effective unl\", \"level\": 1, \"text\": \"term under the Agreement will not be effective unless mutually agreed to in writing and signed by authorized representatives of both parties. Neither party shall be bound by typographical or clerical errors. G. Neither party is liable for its failure or delay to perform its obligations under the Agreement due to strikes, wars, revolutions, acts of terrorism, fires, floods, explosions, earthquakes, shortages in labor, components or materials, government regulations, or other causes beyond its control. H. This Agreement may not be assigned by either party without prior written permission from the other party, which permission shall not be unreasonably withheld or delayed. Any attempt by either party to assign any right, or delegate any duty or obligation which arises under the Agreement without such permission will be voidable.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT, GOVERNING LAW\", \"level\": 1, \"text\": \"19. ENTIRE AGREEMENT, GOVERNING LAW This Agreement, including its attachment and order acknowledgments under the Agreement, constitutes the entire agreement between Distributor and NETGEAR with respect to the purchase, resale and distribution of the Products and is governed by the laws of the State of California except that body of law dealing with conflicts of law. INGRAM NETGEAR Distributor Agreement 11 083096 * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 1 DISCOUNT SCHEDULE The initial Discount offered Distributor for purchase or license of NETGEAR Products included on the NETGEAR Price List in effect on the Effective Date of this Agreement is [*] off of the then current NETGEAR list price. Distributor agrees that the foregoing Discount is only applicable to Products included on the NETGEAR Price List on the Effective Date of this Agreement. NETGEAR reserves the right to add Products to the Price List at its sole discretion and any such additional Products shall be offered to Distributor at discounts to be determined at that time. INGRAM NETGEAR Distributor Agreement 12 083096 EXHIBIT 2 DISTRIBUTOR'S ROUTING GUIDE INGRAM NETGEAR Distributor Agreement 13 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 3\"}}, {\"id\": \"CMD\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NAMED ACCOUNTS [*]\", \"level\": 1, \"text\": \"CMD NAMED ACCOUNTS [*] INGRAM NETGEAR Distributor Agreement 14 092696 EXHIBIT 4 MARKETING PLAN INGRAM NETGEAR Distributor Agreement 15 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR This Amendment is entered into effective October 1,1996 (\\\"Amendment Date\\\") by and between NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc., and Ingram Micro (\\\"Distributor\\\") acting on behalf of itself and its affiliates. NETGEAR and Distributor having previously entered into a Distributor Agreement (\\\"Agreement\\\") with an Effective Date of March 1,1996, now mutually agree to amend that Agreement as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to\", \"level\": 1, \"text\": \"1. Subject to the terms of this Amendment, the Territory listed in Section 2 of the Agreement is amended to be the United States and [*].\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the initial one year period beginning on the Amendment Date, Distributor shall be the only distri\", \"level\": 1, \"text\": \"2. During the initial one year period beginning on the Amendment Date, Distributor shall be the only distributor appointed by NETGEAR in [*], subject to Distributor conducting mutually agreed to marketing activities as described in the Marketing Plan for [*] to be developed and agreed to by and between the parties and which shall be attached to and made a part of this Agreement as Exhibit 4a. For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers. The foregoing notwithstanding, during the [*] and any subsequent period, NETGEAR reserves the right to sell or license Products in [*] to customers other than distributors such as, but not limited to resellers who procure Products at centralized locations for resale to end-use customers solely through their wholly or majority owned retail outlets, both store-front and catalog. Following the [*], for any extension or renewal term, Distributor's appointment as Distributor shall be non-exclusive and NETGEAR may appoint other distributors in [*] at its sole discretion.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the origi\", \"level\": 1, \"text\": \"3. The terms and conditions of this Amendment, shall amend and supersede any conflicting terms of the original Agreement. All other terms of the original Agreement shall remain unchanged. IN WITNESS WHEREOF, the parties have executed this Amendment to be effective as of the date first written above. NETGEAR: DISTRIBUTOR: NETGEAR, INC. INGRAM MICRO By: /s/ Lloyd Cainey By: /s/ Michael Terrell --------------- ------------------- Name: /s/ Lloyd Cainey Name: Michael Terrell Title: Exec VP Enterprise Business Group Title: Vice President Purchasing Date: 4/30/97 Date: 2/21/97 Ingram Amendment 1 111296 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. [INGRAM MICRO LOGO] AMENDMENT #2 TO THE DISTRIBUTION AGREEMENT THIS AMENDMENT (the \\\"Amendment\\\") is entered into this 15th day of July 1998, by and between INGRAM MICRO INC. (\\\"Ingram\\\") and NETGEAR, INC. (\\\"Vendor\\\"). The parties have agreed to amend their Distribution Agreement (\\\"Agreement\\\") dated October 1,1996.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 2, TERRITORY, is amended to be United States, [*]\", \"level\": 1, \"text\": \"1. Section 2, TERRITORY, is amended to be United States, [*].\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Amendment shall remain in effect for the current term and any renewal term of the Agreement\", \"level\": 1, \"text\": \"2. This Amendment shall remain in effect for the current term and any renewal term of the Agreement. Notwithstanding the foregoing, all other provisions of the Agreement remain unchanged. The undersigned has read this Amendment, agrees hereto, and is an authorized representative of its respective party. INGRAM MICRO INC. NETGEAR, INC. 1600 East St. Andrew Place 4401 Great America Parkway Santa Ana, CA 92705 P.O. Box 58185 Santa Clara, CA 95052-8185 By: /S/ AC Mann By: /s/ PATRICK Lo ---------------- -------------------- Name: AC Mann Name: PATRICK Lo Title: VP Purchasing Title: V. P. Netgear, Inc. 1 Confidential Doc Rev 2/97 7/15/98\"}}, {\"id\": \"party:NETGEAR\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NETGEAR, Inc.\", \"role\": \"NETGEAR\"}}, {\"id\": \"party:Distributor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Ingram Micro\", \"role\": \"Distributor\"}}, {\"id\": \"party:Ingram\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"INGRAM MICRO INC.\", \"role\": \"Ingram\", \"address\": \"1600 East St. Andrew Place Santa Ana, CA 92705\"}}, {\"id\": \"party:Vendor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NETGEAR, INC.\", \"role\": \"Vendor\", \"address\": \"4401 Great America Parkway P.O. Box 58185 Santa Clara, CA 95052-8185\"}}, {\"id\": \"term:Amendment Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment Date\", \"text\": \"This Amendment is entered into effective October 1,1996 (\\\"Amendment Date\\\")\", \"definition_clause\": \"CMD\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"NETGEAR and Distributor having previously entered into a Distributor Agreement (\\\"Agreement\\\") with an Effective Date of March 1,1996\", \"definition_clause\": \"CMD\"}}, {\"id\": \"term:distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"distributor\", \"text\": \"For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Amendment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment\", \"text\": \"THIS AMENDMENT (the \\\"Amendment\\\") is entered into this 15th day of July 1998, by and between INGRAM MICRO INC. (\\\"Ingram\\\") and NETGEAR, INC. (\\\"Vendor\\\").\", \"definition_clause\": \"3\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"CONFIDENTIAL TREATMENT REQUEST * Portions denoted \", \"level\": 1, \"text\": \"CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 10.16 DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR NETGEAR Agreement Number: N115 Effective Date: March 1, 1996 Term: 1 Year Ingram Micro, a corporation organized under the laws of the State of California, having a place of business located at 1600 E. St. Andrew Place, Santa Ana, California, USA, (\\\"Distributor\\\") and NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc., organized under the laws of the State of Delaware, having a place of business at 4401 Great America Parkway, Santa Clara, California, USA, agree that the following terms govern the purchase, sale, and licensing of Products (as defined below) between the parties. NOTICES: All notices given under the Agreement are to be in writing and may be sent by mail, telefax, courier service or otherwise delivered to the party to be notified at the following address, or to such other address as may have been substituted by written notice: To Distributor: To NETGEAR: 1600 E. ST. ANDREWS PL. 4401 Great America Parkway P.O. BOX 25125 P.O. Box 58185 SANTA ANA, CA 92799-5125 Santa Clara, CA 95052-8185 (???) Patricia Dutra-Gerard DISTRIBUTOR AND NETGEAR ACKNOWLEDGE THAT EACH HAS READ THIS AGREEMENT TOGETHER WITH THE ATTACHED EXHIBIT, UNDERSTANDS IT AND AGREES TO BE BOUND BY ITS TERMS AND CONDITIONS. AGREED: AGREED: Distributor NETGEAR, Inc. By: /s/ Sanat K. Dutta By: /s/ Joe Booker ---------------------- ----------------------- (authorized signature) (authorized signature) Name: Sanat K. Dutta Name: Joe Booker --------------- ---------------- (type or print) (type or print) Title: Executive vice President Title: Vice President & General Manager Commercial Business Unit Date: October 16, 1996 Date: November 5, 1996 Ingram NETGEAR Distributor Agreement 083096\"}, {\"id\": \"1\", \"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT Subject to Distributor's performance of its obligations under this Agreement, Distributor is appointed as a NETGEAR Distributor and may purchase certain equipment (\\\"Hardware\\\") and licenses for software including revisions and updates (\\\"Software\\\"), as are listed in NETGEAR's then-current price list (the \\\"Price List\\\") for resale within the Territory (as defined below). During the initial one (1) year term of this Agreement. Distributor shall be the only distributor appointed by NETGEAR in the Territory, subject to Distributor conducting mutually agreed to marketing activities as described in the Marketing Plan to be developed and agreed to by and between the parties and which shall be attached to and made a part of this Agreement as Exhibit 4. For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers. The foregoing notwithstanding, during the initial one (1) year term and any subsequent period. NETGEAR reserves the right to sell or license Products in the Territory to customers other than distributors such as, but not limited to resellers who procure Products at centralized locations for resale to end-use customers solely through their wholly or majority owned retail outlets, both store-front and catalog. Following the initial one (1) year term, for any extension or renewal term, Distributor's appointment as Distributor shall be non-exclusive and NETGEAR may appoint other distributors in the Territory at its sole discretion.\"}, {\"id\": \"2\", \"title\": \"TERRITORY\", \"level\": 1, \"text\": \"2. TERRITORY Except as may be otherwise provided by law, Distributor may not distribute or re-export any Products outside of the Territory identified herein as the United States without the specific written consent of NETGEAR. In the event that Distributor wishes to expand the scope of the Territory and is able to adequately sell and support Products within the additional region, then upon the approval of NETGEAR, the parties may choose by written agreement to modify the Territory.\"}, {\"id\": \"3\", \"title\": \"ORDERS\", \"level\": 1, \"text\": \"3. ORDERS A. Distributor may purchase Products by placing orders under this Agreement which are accepted by NETGEAR. No order will be effective until accepted by delivery of NETGEAR's order acknowledgment. Distributor agrees that each order placed with NETGEAR for Products shall be governed by this Agreement, regardless of any additional or conflicting term in Distributor's order. Unless otherwise specifically stated in the Order, all Orders accepted by NETGEAR shall be deemed to be for immediate release. Orders may be sent by telefax or other electronic media approved by NETGEAR and must specify: (a) Distributor's Purchase Order number, (b) Product and/or Service number and description for each item ordered; (c) Desired quantities; (d) Purchase price for each Product or Service ordered; (e) Tax status, including exemption certificate number if tax exempt; (f) Preferred shipping method; and (g) Exact \\\"Bill to\\\" and \\\"Ship to\\\" address. B. MINIMUM/STANDARD LOT SIZES. Products must be ordered in the minimum and/or standard lot size quantities specified in the Price Schedule. Orders for less than minimum or non-standard lot size quantities of any Product may, at NETGEAR's discretion, be rejected.\"}, {\"id\": \"4\", \"title\": \"PRICES, PRICE LIST, TAXES AND PAYMENT\", \"level\": 1, \"text\": \"4. PRICES, PRICE LIST, TAXES AND PAYMENT INGRAM NETGEAR Distributor Agreement 2 083096 A. PRICES. Prices for Produce are those set out in NETGEAR's Price List, less the applicable discount specified in Exhibit 1. All Product prices are F.O.B. NETGEAR's point of shipment, except as specified in Section 5 D. B. CHANGES. NETGEAR may modify the Price List at any time, including changes to the Products or their corresponding list prices, but NETGEAR will provide Distributor with written notice thirty days in advance of the effective date of any price increase or Product deletion. Price decreases will apply to the corresponding Products that art shipped by NETGEAR on or after the effective date of the list price decrease.\"}, {\"id\": \"C\", \"title\": \"INVENTORY PRICE PROTECTION\", \"level\": 1, \"text\": \"C. INVENTORY PRICE PROTECTION. In the event of a list price decrease on any of the Products, Distributor may apply for a credit on those units of Product: a) which were shipped by NETGEAR to Distributor no more than [*] prior to the effective date of the list price decrease and remain unsold in Distributor's inventory or are being returned under open RMA's or are in the inventories of certain mutually agreed to Distributor retail accounts (\\\"CMD Named Accounts\\\") as listed in Exhibit 3 to this Agreement on the effective date of the list price decrease or b) which were in transit between NETGEAR and Distributor on the effective date of the list price decrease. The amount of the credit on any unit shall be equal to [*]. The foregoing notwithstanding, in the event any of the Products were acquired under special competitive pricing arrangements, the credit on such Products shall be [*]. In order to receive a credit, Distributor a) must submit to NETGEAR within [*] of the effective date of the list price decrease, a report of inventory eligible for the price credit and must have submitted its regular monthly inventory report on time, according to Section 11, in each of the [*] prior to the effective date of the list price decrease. Upon verification by NETGEAR of the eligible units and credit amounts, NETGEAR will issue a credit to the Distributor's account.\"}, {\"id\": \"D\", \"title\": \"TAXES AND OTHER LEVIES\", \"level\": 1, \"text\": \"D. TAXES AND OTHER LEVIES. Prices are exclusive of any tax, value-added tax, fee, duty or governmental charge, however designated (except for NETGEAR's franchise taxes or for taxes on NETGEAR's net income) which may be levied or based on the Products, their sale, importation, use, or possession, or on this Agreement. All such taxes or duties shall be for the account of Distributor and any such taxes or duties required to be paid or collected by NETGEAR shall be paid by Distributor to NETGEAR unless Distributor provides NETGEAR with a valid certificate of exemption acceptable to the appropriate taxing or governmental authority. E. PAYMENT. Except as may be specifically authorized in writing by NETGEAR, and subject to NETGEAR's continuing approval of Distributor's credit status and financial condition, Distributor will pay NETGEAR for all Products ordered by Distributor within [*] of the date the corresponding invoice is issued by NETGEAR. The foregoing notwithstanding, the parties agree that payment for the initial order placed by Distributor under this Agreement shall be due and payable within [*] of the date the corresponding invoice is issued by NETGEAR. NETGEAR, in its sole discretion, reserves the right to specify, and to change from time to time, Distributor's credit line and payment terms. All payments are to be made in U.S. dollars. Payment for shipments made outside of the United States shall be made by wire transfer in accordance with wire transfer procedures provided by NETGEAR. If at any time Distributor is delinquent in the payment of any invoice, exceeds the credit line established by NETGEAR, or is otherwise in breach of the Agreement, NETGEAR may, in its discretion, withhold shipment (including partial shipments) of any order or may require Distributor to pay cash on delivery for further shipments. Payment not received by NETGEAR when due may be subject to a late payment INGRAM NETGEAR Distributor Agreement 3 083096 service charge provided NETGEAR has provided 10 days written notice to Distributor of Distributor's failure to pay. The foregoing notwithstanding, Distributor shall not be deemed in default under this provision if Distributor withholds payment of amounts legitimately in dispute on any invoice provided that (1) Distributor promptly pays the undisputed portion of the invoice in accordance with the terms of this Agreement; (2) Distributor provides NETGEAR with written notice of the disputed amount within 10 days of receipt of the invoice; and (3) Distributor works in good faith with NETGEAR to resolve any dispute within a reasonable time period.\"}, {\"id\": \"5\", \"title\": \"SHIPMENT, CANCELLATION, RETURNS, TITLE, RISK OF LOSS, SECURITY INTEREST\", \"level\": 1, \"text\": \"5. SHIPMENT, CANCELLATION, RETURNS, TITLE, RISK OF LOSS, SECURITY INTEREST A. SHIPMENT. Unless otherwise instructed by Distributor, NETGEAR will ship Products ordered by Distributor using the method and carrier specified in Distributor's then current Routing Guide, as may be amended from time to time by written notice from Distributor. The version of the Routing Guide which is in force on the Effective Date of this Agreement is attached to and made a part of this Agreement as Exhibit 2. Distributor is responsible for all freight, handling, insurance and other transportation charges, and agrees to pay all such charges if separately identified on NETGEAR's invoice. NETGEAR will ship freight collect, uninsured, if so instructed by Distributor's order. B. CANCELLATION AND RESCHEDULING. Distributor may not cancel or reschedule any order, in whole or in part, less than five business days prior to the corresponding shipment date specified in NETGEAR's order acknowledgment.\"}, {\"id\": \"C\", \"title\": \"RETURNS\", \"level\": 1, \"text\": \"C. RETURNS. Products received by Distributor as a result of an error by NETGEAR in shipment may be returned for credit. Such credit will include an amount equal to the purchase price of the Product shipped in error as well as the cost of return freight paid by Distributor to return the Product to NETGEAR. Products with defects covered by the warranty may be returned for remedy under the warranty. Prior to returning any Product, whether for exchange or warranty or non-warranty action, Distributor must obtain a Return Materials Authorization (RMA) number from NETGEAR. Distributor should return the Product to NETGEAR, with shipping charges prepaid. NETGEAR will not accept collect shipments. Any Product returned to NETGEAR, which is not returned in accordance with the terms of this Agreement, may be refused.\"}, {\"id\": \"D\", \"title\": \"TITLE, RISK OF LOSS, SECURITY INTEREST\", \"level\": 1, \"text\": \"D. TITLE, RISK OF LOSS, SECURITY INTEREST. For all shipments to locations within the United States, title to the Hardware passes to Distributor when presented by NETGEAR or its agent to the carrier, from which point Distributor is responsible for risk of all loss, damage to, or theft of all Products. For shipments to locations outside of the United States, (i) risk of loss of all Products passes from NETGEAR to Distributor upon arrival at the point of entry in the destination country specified in Distributor's order.\"}, {\"id\": \"6\", \"title\": \"SOFTWARE LICENSES\", \"level\": 1, \"text\": \"6. SOFTWARE LICENSES A. INTERNAL USE BY DISTRIBUTOR. Distributor may purchase for its internal use licenses to Software and accompanying documentation by placing orders under this Agreement. Distributor's right to use the Software is subject to the \\\"shrink-wrap\\\" license agreement with the Software and in its accompanying documentation shipped by NETGEAR to Distributor. B. DISTRIBUTION OF SOFTWARE LICENSES TO END-USERS. Distributor may procure and distribute Software and accompanying documentation by placing orders under this Agreement. The terms of the licenses for such Software to which end-users are subject are included as a \\\"shrink-wrap\\\" license agreement with the Software and in its accompanying documentation when shipped by NETGEAR (the INGRAM NETGEAR Distributor Agreement 4 083096 \\\"License Agreement\\\"). Distributor agrees that for each Software product it procures under this Agreement, Distributor will (i) assure the deliver the License Agreement to its customers, and (ii) use reasonable efforts to inform its resale customers of the requirement to deliver the License Agreement to their end-user customers in the form supplied by NETGEAR with the Products.\"}, {\"id\": \"C\", \"title\": \"LIMITATIONS\", \"level\": 1, \"text\": \"C. LIMITATIONS. Distributor may not, nor authorize its resale customers or the end-user to translate, decompile, disassemble, use for any competitive analysis, or reverse engineer the Software or its documentation, in any way, except for the event where the end-user locates Products within the European Union, in which case the Software Directive enacted by the Council of European Communities Directive dated 14 May 1991 will apply to the examination of the Software to facilitate interoperability; in such event Distributor agrees to notify, and cause its end-user to notify NETGEAR of any such intended examination of the Software and procure from NETGEAR its support and assistance. Distributor agrees to not translate, nor allow end-users to translate any portion of the Software or associated documentation into any other format or foreign language without the prior written consent of NETGEAR. In no event will Distributor grant the U.S. Government rights in any Software greater than those set out in subparagraphs (a) through (d) of the Commercial Computer Software- Restricted Rights clause at FAR 52,227-19 and the limitations for civilian agencies set out the License Agreement; and subparagraph (c)(l)(ii) of the Rights in Technical Data and Computer Software clause at DFARS 252.227-7013 for agencies of the Department of Defense.\"}, {\"id\": \"7\", \"title\": \"WARRANTIES\", \"level\": 1, \"text\": \"7. WARRANTIES A. WARRANTY PERIOD. The warranty period for each Product is specified in the Price List that is in effect on the date NETGEAR receives Distributor's order, and shall apply regardless of any extended warranty period which Distributor may choose to provide to its customers. NETGEAR reserves the right to change a warranty period for a specific Product but only for orders placed after the effective date of such change, provided that the minimum warranty period for all Products is ninety days, except for those Products specifically identified in the Price List as provided \\\" AS IS\\\" with no warranties. B. HARDWARE WARRANTY. NETGEAR warrants to end-user that each item of Hardware will be free from defects in workmanship and materials for its respective warranty period which begins on the date of purchase by the end user. Should a Product fail within this warranty period, Distributor shall replace such defective Product from Distributor's inventory and accept return of the failed Product from Distributor's customer. At intervals to be mutually agreed upon between NETGEAR and Distributor. Distributor shall contact NETGEAR to receive a Return Material Authorization number for the collected failed Product. Upon receipt of the failed Product, NETGEAR shall issue a credit to Distributor for Distributor's purchase price of the replacement Product issued, less any prior credits or allowances. End-users' exclusive remedy is to receive replacement Product from reseller and NETGEAR's sole obligation and liability under this warranty is to issue an off-setting credit to reseller for Product returned by reseller on behalf of its end-user because of defects in workmanship or material.\"}, {\"id\": \"C\", \"title\": \"SOFTWARE WARRANTY\", \"level\": 1, \"text\": \"C. SOFTWARE WARRANTY. NETGEAR warrants to the end-user that each item of Software, as delivered or updated by NETGEAR and properly installed and operated on the Hardware or other equipment it is originally licensed for, will function substantially as described in its then-current user documentation during its respective warranty period. If any item of Software fails to so perform during its warranty period, as the sole remedy NETGEAR of NETGEAR's supplier will at its discretion provide a suitable fix, patch or workaround for the problem which may be included in a future revision of the Software. For specific Software which is distributed by NETGEAR as a licensee of third parties, additional warranty terms offered by such third parties to end-users may apply. INGRAM NETGEAR Distributor Agreement 5 083096\"}, {\"id\": \"D\", \"title\": \"DISTRIBUTOR'S INTERNAL USE WARRANTY\", \"level\": 1, \"text\": \"D. DISTRIBUTOR'S INTERNAL USE WARRANTY. For Products ordered under this Agreement for Distributor's internal use, NETGEAR provides Distributor the same warranties as described above for end-users. E. LIMITATIONS. NETGEAR does not warrant that any item of Software is error-free or that its use will be uninterrupted. NETGEAR is not obligated to remedy any Software defect which cannot be reproduced with the latest revision of the Software. These warranties do not apply to any Product which has been (i) altered, except by NETGEAR or in accordance with its instructions, or (ii) used in conjunction with another vendor's product resulting in the defect, or (iii) damaged by improper environment, abuse, misuse, accident or negligence. Replacement parts furnished under this warranty may be refurbished or contain refurbished components. THE FOREGOING WARRANTIES AND LIMITATIONS ARE EXCLUSIVE REMEDIES AND ARE IN LIEU OF ALL OTHER WARRANTIES EXPRESS OR IMPLIED, INCLUDING WITHOUT ANY LIMITATION WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. ANY PRODUCT THAT MAY BE FURNISHED BY NETGEAR WHICH IS NOT LISTED IN THE PRICE LIST, OR WHICH IS IDENTIFIED IN THE PRICE LIST AS AN \\\"AS IS\\\" PRODUCT, IS FURNISHED \\\"AS IS\\\" WITH NO WARRANTIES OF ANY KIND.\"}, {\"id\": \"8\", \"title\": \"PRODUCT RETURNS\", \"level\": 1, \"text\": \"8. PRODUCT RETURNS Prior to returning any Product, whether for exchange or warranty or non-warranty action, Distributor must obtain a Return Materials Authorization (RMA) number from NETGEAR. Distributor should return the product to NETGEAR, [*]. NETGEAR will not accept collect shipments. Any Product returned to NETGEAR, which is not returned in accordance with the terms of this Agreement, may be rejected.\"}, {\"id\": \"9\", \"title\": \"PRODUCT EXCHANGE PRIVILEGES\", \"level\": 1, \"text\": \"9. PRODUCT EXCHANGE PRIVILEGES A. Distributor may return previously purchased Products for replacement by an equal or greater value of different Products, under the following conditions: a) Distributor may return Products only within the [*] period following [*] of each year. b) The total value of the returned Products shall not exceed [*] of the Net Shipments invoiced by NETGEAR for all Products, [*], during the [*] immediately preceding each of the above dates.\"}, {\"id\": \"c\", \"title\": \"The replacement Products are not identical to the returned Products\", \"level\": 1, \"text\": \"c) The replacement Products are not identical to the returned Products. Distributor shall be invoiced for the replacement Products at prices in effect at the time of return, and credited for the value of the returned products at the prices actually paid by the Distributor less any prior credits.\"}, {\"id\": \"d\", \"title\": \"The returned Products have not been in the Distributor's inventory for more than [*] after shipment from NETGEAR\", \"level\": 1, \"text\": \"d) The returned Products have not been in the Distributor's inventory for more than [*] after shipment from NETGEAR. e) The returned Products are in their original shipping containers and have not been altered, damaged or used.\"}, {\"id\": \"10\", \"title\": \"DISTRIBUTOR'S RESPONSIBILITIES\", \"level\": 1, \"text\": \"10. DISTRIBUTOR'S RESPONSIBILITIES INGRAM NETGEAR Distributor Agreement 6 083096 A. PROMOTION AND SALE. Distributor shall sell or license Products only to resale customers which will in-turn resell or transfer the licenses to those Products to end use customers. Distributor may not sell or license Products directly to end use customers without the express written consent of NETGEAR. Distributor agrees to use commercially reasonable efforts to maximize sales of NETGEAR Products. B. SUPPORT. Distributor shall be the sole point of contact for its resale customers and their end-use customers in all support situations. Distributor shall provide first level support for its customers, NETGEAR shall provide second and third level support to Distributor in order to resolve end user technical problems.\"}, {\"id\": \"C\", \"title\": \"TRAINING\", \"level\": 1, \"text\": \"C. TRAINING. Distributor agrees to maintain, and to adequately and thoroughly train on an on-going basis, a sufficient staff of qualified sales, marketing, technical and support personnel familiar with the applications, features, benefits, operation and configuration of the Products so as to effectively promote and support the Products and to assure end-user satisfaction. NETGEAR agrees to provide assistance to Distributor to allow Distributor to comply with the foregoing training responsibility.\"}, {\"id\": \"D\", \"title\": \"RESTRICTION ON APPOINTMENT OF ADDITIONAL DISTRIBUTORS\", \"level\": 1, \"text\": \"D. RESTRICTION ON APPOINTMENT OF ADDITIONAL DISTRIBUTORS. NETGEAR's agreement not to appoint additional distributors of NETGEAR Products in the Territory during the [*] of this Agreement is predicated upon Distributor performing the mutually agreed upon activities included in the Marketing Plan attached as Exhibit 4. In the event Distributor fails to perform the activities included in the Marketing plan in [*], NETGEAR may appoint additional distributors in the Territory and the provisions of this Agreement appointing Distributor as the only NETGEAR distributor in the Territory shall be deemed deleted.\"}, {\"id\": \"11\", \"title\": \"REPORTS\", \"level\": 1, \"text\": \"11. REPORTS A. Each month Distributor shall submit a Point of Sale (POS) shipments report covering the preceding month, broken out by Product. The report may be submitted via BBS and shall include, at a minimum, Distributor's reseller's name, address, part number, quantity shipped and unit cost. B. Each month Distributor shall prepare and forward to NETGEAR a weekly report showing Distributor's inventory of the Products purchased and licensed from NETGEAR as of the end of the previous calendar month. The report may be submitted via BBS and shall include, at a minimum the part number and the number of units and purchase value of the inventory remaining by Product.\"}, {\"id\": \"C\", \"title\": \"From time to time, but not more than twice per year, NETGEAR may request access to information about the Distribu\", \"level\": 1, \"text\": \"C. From time to time, but not more than twice per year, NETGEAR may request access to information about the Distributor's business reasonably required to insure that Distributor is in compliance with the terms of this Agreement and the Distributor will grant the right for a NETGEAR representative to visit the Distributor's place of business during normal business hours at a mutually agreed upon time to examine such information.\"}, {\"id\": \"12\", \"title\": \"PROPRIETARY RIGHTS AND INFORMATION\", \"level\": 1, \"text\": \"12. PROPRIETARY RIGHTS AND INFORMATION A. USE OF PROPRIETARY INFORMATION. \\\"Proprietary information includes, without limitation, diagnostics, the Software, all documentation for Software, other user manuals, as well as electronically and visually transmitted printed materials and information disclosed by Distributor or NETGEAR, such as new product information, financial or technical data, information reported under section II above or other information or data that is marked with a proprietary or confidential legend. Each party agrees to hold the Proprietary Information of the other in confidence and to use the Proprietary Information only for the purposes expressly permitted under this Agreement, and to disclose Proprietary Information only to its employees and contractors as authorized in this Agreement and then only on a need-to-know basis. Each party agrees to maintain adequate internal procedures, including appropriate agreements with employees and authorized third parties, to protect the confidentiality of the INGRAM NETGEAR Distributor Agreement 7 083096 Proprietary Information as required by this Agreement. Each party is entitled to appropriate injunctive relief in the event of any unauthorized disclosure or use of its Proprietary Information by the other party. B. LIMITATIONS. Proprietary Information does not include information which (i) is rightfully in the receiving party's possession in a complete and tangible form before it is received from the disclosing party, (ii) is or becomes a matter of public knowledge through no fault of the receiving party, (iii) is rightfully furnished to the receiving party by a third party without restriction on disclosure or use, or (iv) is independently developed by the receiving party without use of or reference to the disclosing party's Proprietary Information.\"}, {\"id\": \"D\", \"title\": \"RESERVATION OF RIGHTS\", \"level\": 1, \"text\": \"D. RESERVATION OF RIGHTS. NETGEAR, on behalf of itself and its suppliers, reserves all proprietary rights in and to (i) all designs, engineering details, and other data pertaining to the Products, (ii) all original works, computer programs, fixes, updates (but not Distributor's or 'end-users' developed programs), discoveries, inventions, patents, know-how and techniques arising out of work done wholly or in part by NETGEAR or its subcontractors in connection with the Agreement, and (iii) any and all products developed as a result of such work. The performance by NETGEAR of professional Services shall not be deemed a work-for-hire but shall instead be subject to this section. E. ADMINISTRATIVE PROCEDURES. Distributor and end-users are each responsible for the security of their own proprietary and confidential information and for maintaining adequate procedures apart from the Products to reconstruct lost or altered files, data or programs.\"}, {\"id\": \"13\", \"title\": \"TRADEMARKS AND TRADE NAMES\", \"level\": 1, \"text\": \"13. TRADEMARKS AND TRADE NAMES A. USE OF TRADEMARKS. In the advertising and promotion of the Products, Distributor agrees to use NETGEAR's and certain of Bay Networks' trade names, logos and trademarks (the \\\"Trademarks\\\") as reasonably instructed by NETGEAR during the term of the Agreement. Solely for this purpose, NETGEAR and Bay Networks grant Distributor a non-exclusive, royalty-free, limited right to use the Trademarks. Distributor will not make or permit the removal or modification of any Trademarks or tags, proprietary notices, labels, or other identifying marks placed by Bay Networks, NETGEAR or their agents on the Products or associated literature. B. RIGHTS TO TRADEMARKS. Distributor acknowledges that Bay Networks is the exclusive owner of the Trademarks and the use of the Trademarks by Distributor does not convey to Distributor any right, title or interest in or to the Trademarks. Distributor has no claim or right in the Trademarks, service marks, or trade names owned, used or claimed now or in the future by NETGEAR. Distributor agrees that it will not register, nor attempt to register any Trademark or any mark confusingly similar to any Trademark in any jurisdiction unless expressly approved in writing by Bay Networks in advance.\"}, {\"id\": \"C\", \"title\": \"NOTIFICATION\", \"level\": 1, \"text\": \"C. NOTIFICATION. In order to assure proper use and protection of Trademarks, Distributor agrees to inform NETGEAR in writing if Distributor purchases, or is offered for purchase, any Products with a Trademark or other mark of NETGEAR from a source other than NETGEAR, its subsidiaries, or an authorized NETGEAR Distributor.\"}, {\"id\": \"14\", \"title\": \"CLAIMS OF INFRINGEMENT\", \"level\": 1, \"text\": \"14. CLAIMS OF INFRINGEMENT A. INDEMNIFICATION. NETGEAR agrees to defend at its own expense any action brought against Distributor to the extent that it is based on a claim that any Product infringes a United States or Territory patent, copyright, trade mark, trade secret or other valid intellectual property right, and will pay any costs and damages finally awarded against Distributor in any such actions which are attributable to any such claim. NETGEAR shall have no liability for any settlement or compromise made without its prior written consent. NETGEAR shall, at its option and expense, (1) procure the right to continue using the Product. INGRAM NETGEAR Distributor Agreement 8 083096 (2) replace or modify the Product so that it becomes non-infringing or, if (1) or (2) are not reasonably or economically possible. (3) Distributor may return the Product to NETGEAR for a refund of an amount equal to the depreciated value of the equipment, or an amount equal to the Distributor's actual purchase price paid without any depreciation minus any prior credits or allowances if the returned Products are in their original shipping containers and have not been altered, damaged or used. B. LIMITATIONS. NETGEAR has no liability to Distributor under this section entitled CLAIMS OF INFRINGEMENT with respect to any claim which is based upon or results from (i) the combination of any Product with any equipment, device, firmware or software not furnished by NETGEAR, or (ii) any modification of any Product by a party other than NETGEAR. (iii) Distributor's failure to install or have installed changes, revisions or updates as instructed by NETGEAR, or (iv) NETGEAR's compliance with Distributor's or end-user's specifications, designs or instructions.\"}, {\"id\": \"15\", \"title\": \"TERM OF AGREEMENT AND TERMINATION\", \"level\": 1, \"text\": \"15. TERM OF AGREEMENT AND TERMINATION A. TERM. This Agreement will be in effect for one year from the Effective Date and will automatically renew for successive one (1) year periods unless terminated as provided below. B. TERMINATION. This Agreement may be canceled at any time without cause, by either party upon ninety (90) days written notice to the other party. Either party may terminate this Agreement immediately if (i) the other party becomes insolvent, files or has filed against it a petition in bankruptcy, or ceases doing business; or (ii) the other party fails to cure a material breach of the Agreement within thirty (30) days after receipt of written notice of such breach from the party not in default. Upon termination of the Agreement by NETGEAR for Distributor's breach, NETGEAR may cancel all of Distributor's unfulfilled orders without further obligation. This Agreement may be terminated at any time without cause by either party upon ninety (90) days written notice to the other party.\"}, {\"id\": \"C\", \"title\": \"EFFECT OF TERMINATION\", \"level\": 1, \"text\": \"C. EFFECT OF TERMINATION. Except as otherwise specifically stated in the Agreement, neither party will be liable to the other for damages in any form by reason of the expiration or earlier termination of the Agreement.\"}, {\"id\": \"D\", \"title\": \"CONTINUING EFFECT\", \"level\": 1, \"text\": \"D. CONTINUING EFFECT. Any expiration or earlier termination of the Agreement does not modify or alter any of the obligations of the parties which accrued prior to such expiration or termination. The sections of the Agreement which address taxes; duty; fee; payment; security interest; proprietary rights and information; warranties; foreign reshipment; remedies; limitations; termination and governing law survive any expiration or termination of the Agreement. The section entitled SOFTWARE LICENSES also survives any expiration or termination provided Distributor and end-users continues to comply with the provisions of the applicable software license terms. Except as expressly agreed in writing between the parties, no party is liable to the other for any dollar amounts, costs or damages by reason of the expiration or earlier termination of the Agreement.\"}, {\"id\": \"16\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"16. LIMITATION OF LIABILITY A. NETGEAR agrees to indemnify Distributor against any claim arising out of or resulting from the Products or the Agreement, provided that any such claim (i) is attributable to bodily injury, death, or to injury to or destruction of physical property (other than the Products), and (ii) is caused by the negligent act or omission of NETGEAR or a material defect in the Product. This obligation on the part of NETGEAR is subject to Distributor's obligation to (a) give NETGEAR prompt written notice of any such claim, (b) grant NETGEAR control of the defense and settlement of such claim, and (c) assist fully in the defense provided that NETGEAR reimburses Distributor's out-of pocket costs. NETGEAR has no liability for any settlement or compromise made without its prior written consent. Under no circumstances INGRAM NETGEAR Distributor AGREEMENT 9 083096 is NETGEAR liable for any third-party claims except for those described in this section and in the section entitled CLAIMS OF INFRINGEMENT. B. NETGEAR, at its expense, agrees to maintain insurance coverage to protect against its liabilities under the Agreement in an amount no less than is reasonable or required by applicable statute. This insurance will include (a) worker's compensation insurance, (b) comprehensive general liability insurance, including coverage for product liability, bodily injury and property damage, and (c) automobile liability insurance. Upon Distributor's written request, NETGEAR will furnish the applicable certificate of insurance. IN NO EVENT WILL EITHER PARTY OR THEIR RESPECTIVE PARENT CORPORATIONS OR SUPPLIERS BE LIABLE FOR (1) THE COST OF SUBSTITUTE PROCUREMENT, SPECIAL, INDIRECT, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, OR (2) ANY DAMAGES RESULTING FROM INACCURATE OR LOST DATA OR LOSS OF USE OR PROFITS ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, THE FURNISHING OF SERVICES, OR THE USE OR PERFORMANCE OF PRODUCTS, EVEN IF INFORMED OF SUCH DAMAGES. EXCEPT FOR DAMAGES ARISING UNDER SECTIONS 14.A AND 16.A, IN NO EVENT WILL NETGEAR's OR BAY NETWORKS' TOTAL LIABILITY FOR ANY DAMAGES IN ANY ACTION BASED ON OR ARISING OUT OF OR IN CONNECTION WITH THE AGREEMENT EXCEED THE [*] TO NETGEAR PURSUANT TO THE AGREEMENT. EXCEPT FOR DAMAGES ARISING FROM BREACH OF SECTIONS 6.C AND 12,13 OR 17, IN NO EVENT WELL DISTRIBUTOR's TOTAL LIABILITY FOR ANY DAMAGES IN ANY ACTION BASED ON OR ARISING OUT OF OR IN CONNECTION WITH THE AGREEMENT EXCEED THE [*] TO NETGEAR PURSUANT TO THE AGREEMENT.\"}, {\"id\": \"17\", \"title\": \"FOREIGN RESHIPMENT\", \"level\": 1, \"text\": \"17. FOREIGN RESHIPMENT This Agreement is made subject to all laws, regulations, orders or other restrictions on the export from the United States of Products and accompanying documentation, or of other technical data and information about such Products, which may be imposed from time to time. Distributor agrees not to export, directly or indirectly, any such Products or information to any country for which an export license or other governmental approval is required at the time of export without first obtaining such license or approval. Distributor is solely responsible, at its own expense, for obtaining all necessary import and re-export permits and certificates and for the payment of any and all taxes and duties imposed upon the movement and delivery of Products.\"}, {\"id\": \"18\", \"title\": \"GENERAL\", \"level\": 1, \"text\": \"18. GENERAL A. The relationship of NETGEAR and Distributor is that of independent contractors. There is no relationship of agency, partnership, joint venture, employment or franchise between the parties. Neither party has the authority to bind the other or to incur any obligation on the other's behalf or to represent itself as the other's agent or in any way which might result in confusion as to the fact that the parties are separate and distinct entities. B. If any provision of this Agreement is held to be invalid or unenforceable, the remainder of the provisions shall remain in full force and effect.\"}, {\"id\": \"C\", \"title\": \"NETGEAR and Distributor agree to comply with the provisions of all applicable federal, state, county and local la\", \"level\": 1, \"text\": \"C. NETGEAR and Distributor agree to comply with the provisions of all applicable federal, state, county and local laws, ordinances, regulations and codes, domestic and foreign. INGRAM NETGEAR Distributor Agreement 10 083096\"}, {\"id\": \"D\", \"title\": \"NETGEAR reserves the right to change the discount schedule, policy or program, whether referred to in the Agreeme\", \"level\": 1, \"text\": \"D. NETGEAR reserves the right to change the discount schedule, policy or program, whether referred to in the Agreement or set forth in an Exhibit to the Agreement. For changes which, in NETGEAR's opinion, may adversely affect Distributor, NETGEAR will provide thirty (30) days notice, or such longer period as NETGEAR deems appropriate, prior to the effective date of such change. E. Distributor will keep suitable records to demonstrate compliance with this Agreement. NETGEAR or its representative, at NETGEAR's cost may review these records during normal business hours for the sole purpose of determining Distributor's compliance with this Agreement. F. Any waiver, amendment or modification of any right, remedy or other term under the Agreement will not be effective unless mutually agreed to in writing and signed by authorized representatives of both parties. Neither party shall be bound by typographical or clerical errors. G. Neither party is liable for its failure or delay to perform its obligations under the Agreement due to strikes, wars, revolutions, acts of terrorism, fires, floods, explosions, earthquakes, shortages in labor, components or materials, government regulations, or other causes beyond its control. H. This Agreement may not be assigned by either party without prior written permission from the other party, which permission shall not be unreasonably withheld or delayed. Any attempt by either party to assign any right, or delegate any duty or obligation which arises under the Agreement without such permission will be voidable.\"}, {\"id\": \"19\", \"title\": \"ENTIRE AGREEMENT, GOVERNING LAW\", \"level\": 1, \"text\": \"19. ENTIRE AGREEMENT, GOVERNING LAW This Agreement, including its attachment and order acknowledgments under the Agreement, constitutes the entire agreement between Distributor and NETGEAR with respect to the purchase, resale and distribution of the Products and is governed by the laws of the State of California except that body of law dealing with conflicts of law. INGRAM NETGEAR Distributor Agreement 11 083096 * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 1 DISCOUNT SCHEDULE The initial Discount offered Distributor for purchase or license of NETGEAR Products included on the NETGEAR Price List in effect on the Effective Date of this Agreement is [*] off of the then current NETGEAR list price. Distributor agrees that the foregoing Discount is only applicable to Products included on the NETGEAR Price List on the Effective Date of this Agreement. NETGEAR reserves the right to add Products to the Price List at its sole discretion and any such additional Products shall be offered to Distributor at discounts to be determined at that time. INGRAM NETGEAR Distributor Agreement 12 083096 EXHIBIT 2 DISTRIBUTOR'S ROUTING GUIDE INGRAM NETGEAR Distributor Agreement 13 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 3\"}, {\"id\": \"CMD\", \"title\": \"NAMED ACCOUNTS [*]\", \"level\": 1, \"text\": \"CMD NAMED ACCOUNTS [*] INGRAM NETGEAR Distributor Agreement 14 092696 EXHIBIT 4 MARKETING PLAN INGRAM NETGEAR Distributor Agreement 15 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of NETGEAR,INC_04_21_2003-EX-10.16-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL TREATMENT REQUEST * Portions denoted \", \"level\": 1, \"text\": \"CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 10.16 DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR NETGEAR Agreement Number: N115 Effective Date: March 1, 1996 Term: 1 Year Ingram Micro, a corporation organized under the laws of the State of California, having a place of business located at 1600 E. St. Andrew Place, Santa Ana, California, USA, (\\\"Distributor\\\") and NETGEAR, Inc. (\\\"NETGEAR\\\"), a wholly owned subsidiary of Bay Networks, Inc., organized under the laws of the State of Delaware, having a place of business at 4401 Great America Parkway, Santa Clara, California, USA, agree that the following terms govern the purchase, sale, and licensing of Products (as defined below) between the parties. NOTICES: All notices given under the Agreement are to be in writing and may be sent by mail, telefax, courier service or otherwise delivered to the party to be notified at the following address, or to such other address as may have been substituted by written notice: To Distributor: To NETGEAR: 1600 E. ST. ANDREWS PL. 4401 Great America Parkway P.O. BOX 25125 P.O. Box 58185 SANTA ANA, CA 92799-5125 Santa Clara, CA 95052-8185 (???) Patricia Dutra-Gerard DISTRIBUTOR AND NETGEAR ACKNOWLEDGE THAT EACH HAS READ THIS AGREEMENT TOGETHER WITH THE ATTACHED EXHIBIT, UNDERSTANDS IT AND AGREES TO BE BOUND BY ITS TERMS AND CONDITIONS. AGREED: AGREED: Distributor NETGEAR, Inc. By: /s/ Sanat K. Dutta By: /s/ Joe Booker ---------------------- ----------------------- (authorized signature) (authorized signature) Name: Sanat K. Dutta Name: Joe Booker --------------- ---------------- (type or print) (type or print) Title: Executive vice President Title: Vice President & General Manager Commercial Business Unit Date: October 16, 1996 Date: November 5, 1996 Ingram NETGEAR Distributor Agreement 083096\"}}, {\"id\": \"party:Ingram Micro\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Ingram Micro\", \"role\": \"Distributor\", \"address\": \"1600 E. St. Andrew Place, Santa Ana, California, USA\"}}, {\"id\": \"party:NETGEAR, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"NETGEAR, Inc.\", \"role\": \"NETGEAR\", \"address\": \"4401 Great America Parkway, Santa Clara, California, USA\"}}, {\"id\": \"party:Bay Networks, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Bay Networks, Inc.\", \"role\": null, \"address\": null}}, {\"id\": \"value:1 Year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"1 Year\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT Subject to Distributor's performance of its obligations under this Agreement, Distributor is appointed as a NETGEAR Distributor and may purchase certain equipment (\\\"Hardware\\\") and licenses for software including revisions and updates (\\\"Software\\\"), as are listed in NETGEAR's then-current price list (the \\\"Price List\\\") for resale within the Territory (as defined below). During the initial one (1) year term of this Agreement. Distributor shall be the only distributor appointed by NETGEAR in the Territory, subject to Distributor conducting mutually agreed to marketing activities as described in the Marketing Plan to be developed and agreed to by and between the parties and which shall be attached to and made a part of this Agreement as Exhibit 4. For the purposes of this provision, distributor shall mean a company acquiring products directly from NETGEAR for resale or license to dealers or other second tier resellers which in turn resell or license the products to end use customers. The foregoing notwithstanding, during the initial one (1) year term and any subsequent period. NETGEAR reserves the right to sell or license Products in the Territory to customers other than distributors such as, but not limited to resellers who procure Products at centralized locations for resale to end-use customers solely through their wholly or majority owned retail outlets, both store-front and catalog. Following the initial one (1) year term, for any extension or renewal term, Distributor's appointment as Distributor shall be non-exclusive and NETGEAR may appoint other distributors in the Territory at its sole discretion.\"}}, {\"id\": \"term:Hardware\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Hardware\", \"text\": \"certain equipment\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"licenses for software including revisions and updates\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Price List\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Price List\", \"text\": \"NETGEAR's then-current price list\", \"definition_clause\": \"1\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERRITORY\", \"level\": 1, \"text\": \"2. TERRITORY Except as may be otherwise provided by law, Distributor may not distribute or re-export any Products outside of the Territory identified herein as the United States without the specific written consent of NETGEAR. In the event that Distributor wishes to expand the scope of the Territory and is able to adequately sell and support Products within the additional region, then upon the approval of NETGEAR, the parties may choose by written agreement to modify the Territory.\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the United States\", \"definition_clause\": \"2\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDERS\", \"level\": 1, \"text\": \"3. ORDERS A. Distributor may purchase Products by placing orders under this Agreement which are accepted by NETGEAR. No order will be effective until accepted by delivery of NETGEAR's order acknowledgment. Distributor agrees that each order placed with NETGEAR for Products shall be governed by this Agreement, regardless of any additional or conflicting term in Distributor's order. Unless otherwise specifically stated in the Order, all Orders accepted by NETGEAR shall be deemed to be for immediate release. Orders may be sent by telefax or other electronic media approved by NETGEAR and must specify: (a) Distributor's Purchase Order number, (b) Product and/or Service number and description for each item ordered; (c) Desired quantities; (d) Purchase price for each Product or Service ordered; (e) Tax status, including exemption certificate number if tax exempt; (f) Preferred shipping method; and (g) Exact \\\"Bill to\\\" and \\\"Ship to\\\" address. B. MINIMUM/STANDARD LOT SIZES. Products must be ordered in the minimum and/or standard lot size quantities specified in the Price Schedule. Orders for less than minimum or non-standard lot size quantities of any Product may, at NETGEAR's discretion, be rejected.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICES, PRICE LIST, TAXES AND PAYMENT\", \"level\": 1, \"text\": \"4. PRICES, PRICE LIST, TAXES AND PAYMENT INGRAM NETGEAR Distributor Agreement 2 083096 A. PRICES. Prices for Produce are those set out in NETGEAR's Price List, less the applicable discount specified in Exhibit 1. All Product prices are F.O.B. NETGEAR's point of shipment, except as specified in Section 5 D. B. CHANGES. NETGEAR may modify the Price List at any time, including changes to the Products or their corresponding list prices, but NETGEAR will provide Distributor with written notice thirty days in advance of the effective date of any price increase or Product deletion. Price decreases will apply to the corresponding Products that art shipped by NETGEAR on or after the effective date of the list price decrease.\"}}, {\"id\": \"value:thirty days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty days\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INVENTORY PRICE PROTECTION\", \"level\": 1, \"text\": \"C. INVENTORY PRICE PROTECTION. In the event of a list price decrease on any of the Products, Distributor may apply for a credit on those units of Product: a) which were shipped by NETGEAR to Distributor no more than [*] prior to the effective date of the list price decrease and remain unsold in Distributor's inventory or are being returned under open RMA's or are in the inventories of certain mutually agreed to Distributor retail accounts (\\\"CMD Named Accounts\\\") as listed in Exhibit 3 to this Agreement on the effective date of the list price decrease or b) which were in transit between NETGEAR and Distributor on the effective date of the list price decrease. The amount of the credit on any unit shall be equal to [*]. The foregoing notwithstanding, in the event any of the Products were acquired under special competitive pricing arrangements, the credit on such Products shall be [*]. In order to receive a credit, Distributor a) must submit to NETGEAR within [*] of the effective date of the list price decrease, a report of inventory eligible for the price credit and must have submitted its regular monthly inventory report on time, according to Section 11, in each of the [*] prior to the effective date of the list price decrease. Upon verification by NETGEAR of the eligible units and credit amounts, NETGEAR will issue a credit to the Distributor's account.\"}}, {\"id\": \"term:CMD Named Accounts\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CMD Named Accounts\", \"text\": \"certain mutually agreed to Distributor retail accounts\", \"definition_clause\": \"C\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TAXES AND OTHER LEVIES\", \"level\": 1, \"text\": \"D. TAXES AND OTHER LEVIES. Prices are exclusive of any tax, value-added tax, fee, duty or governmental charge, however designated (except for NETGEAR's franchise taxes or for taxes on NETGEAR's net income) which may be levied or based on the Products, their sale, importation, use, or possession, or on this Agreement. All such taxes or duties shall be for the account of Distributor and any such taxes or duties required to be paid or collected by NETGEAR shall be paid by Distributor to NETGEAR unless Distributor provides NETGEAR with a valid certificate of exemption acceptable to the appropriate taxing or governmental authority. E. PAYMENT. Except as may be specifically authorized in writing by NETGEAR, and subject to NETGEAR's continuing approval of Distributor's credit status and financial condition, Distributor will pay NETGEAR for all Products ordered by Distributor within [*] of the date the corresponding invoice is issued by NETGEAR. The foregoing notwithstanding, the parties agree that payment for the initial order placed by Distributor under this Agreement shall be due and payable within [*] of the date the corresponding invoice is issued by NETGEAR. NETGEAR, in its sole discretion, reserves the right to specify, and to change from time to time, Distributor's credit line and payment terms. All payments are to be made in U.S. dollars. Payment for shipments made outside of the United States shall be made by wire transfer in accordance with wire transfer procedures provided by NETGEAR. If at any time Distributor is delinquent in the payment of any invoice, exceeds the credit line established by NETGEAR, or is otherwise in breach of the Agreement, NETGEAR may, in its discretion, withhold shipment (including partial shipments) of any order or may require Distributor to pay cash on delivery for further shipments. Payment not received by NETGEAR when due may be subject to a late payment INGRAM NETGEAR Distributor Agreement 3 083096 service charge provided NETGEAR has provided 10 days written notice to Distributor of Distributor's failure to pay. The foregoing notwithstanding, Distributor shall not be deemed in default under this provision if Distributor withholds payment of amounts legitimately in dispute on any invoice provided that (1) Distributor promptly pays the undisputed portion of the invoice in accordance with the terms of this Agreement; (2) Distributor provides NETGEAR with written notice of the disputed amount within 10 days of receipt of the invoice; and (3) Distributor works in good faith with NETGEAR to resolve any dispute within a reasonable time period.\"}}, {\"id\": \"value:10 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"10 days\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SHIPMENT, CANCELLATION, RETURNS, TITLE, RISK OF LOSS, SECURITY INTEREST\", \"level\": 1, \"text\": \"5. SHIPMENT, CANCELLATION, RETURNS, TITLE, RISK OF LOSS, SECURITY INTEREST A. SHIPMENT. Unless otherwise instructed by Distributor, NETGEAR will ship Products ordered by Distributor using the method and carrier specified in Distributor's then current Routing Guide, as may be amended from time to time by written notice from Distributor. The version of the Routing Guide which is in force on the Effective Date of this Agreement is attached to and made a part of this Agreement as Exhibit 2. Distributor is responsible for all freight, handling, insurance and other transportation charges, and agrees to pay all such charges if separately identified on NETGEAR's invoice. NETGEAR will ship freight collect, uninsured, if so instructed by Distributor's order. B. CANCELLATION AND RESCHEDULING. Distributor may not cancel or reschedule any order, in whole or in part, less than five business days prior to the corresponding shipment date specified in NETGEAR's order acknowledgment.\"}}, {\"id\": \"value:five business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five business days\"}}, {\"id\": \"C_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RETURNS\", \"level\": 1, \"text\": \"C. RETURNS. Products received by Distributor as a result of an error by NETGEAR in shipment may be returned for credit. Such credit will include an amount equal to the purchase price of the Product shipped in error as well as the cost of return freight paid by Distributor to return the Product to NETGEAR. Products with defects covered by the warranty may be returned for remedy under the warranty. Prior to returning any Product, whether for exchange or warranty or non-warranty action, Distributor must obtain a Return Materials Authorization (RMA) number from NETGEAR. Distributor should return the Product to NETGEAR, with shipping charges prepaid. NETGEAR will not accept collect shipments. Any Product returned to NETGEAR, which is not returned in accordance with the terms of this Agreement, may be refused.\"}}, {\"id\": \"D_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TITLE, RISK OF LOSS, SECURITY INTEREST\", \"level\": 1, \"text\": \"D. TITLE, RISK OF LOSS, SECURITY INTEREST. For all shipments to locations within the United States, title to the Hardware passes to Distributor when presented by NETGEAR or its agent to the carrier, from which point Distributor is responsible for risk of all loss, damage to, or theft of all Products. For shipments to locations outside of the United States, (i) risk of loss of all Products passes from NETGEAR to Distributor upon arrival at the point of entry in the destination country specified in Distributor's order.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SOFTWARE LICENSES\", \"level\": 1, \"text\": \"6. SOFTWARE LICENSES A. INTERNAL USE BY DISTRIBUTOR. Distributor may purchase for its internal use licenses to Software and accompanying documentation by placing orders under this Agreement. Distributor's right to use the Software is subject to the \\\"shrink-wrap\\\" license agreement with the Software and in its accompanying documentation shipped by NETGEAR to Distributor. B. DISTRIBUTION OF SOFTWARE LICENSES TO END-USERS. Distributor may procure and distribute Software and accompanying documentation by placing orders under this Agreement. The terms of the licenses for such Software to which end-users are subject are included as a \\\"shrink-wrap\\\" license agreement with the Software and in its accompanying documentation when shipped by NETGEAR (the INGRAM NETGEAR Distributor Agreement 4 083096 \\\"License Agreement\\\"). Distributor agrees that for each Software product it procures under this Agreement, Distributor will (i) assure the deliver the License Agreement to its customers, and (ii) use reasonable efforts to inform its resale customers of the requirement to deliver the License Agreement to their end-user customers in the form supplied by NETGEAR with the Products.\"}}, {\"id\": \"term:License Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"License Agreement\", \"text\": \"a \\\"shrink-wrap\\\" license agreement with the Software and in its accompanying documentation when shipped by NETGEAR\", \"definition_clause\": \"6\"}}, {\"id\": \"C_2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATIONS\", \"level\": 1, \"text\": \"C. LIMITATIONS. Distributor may not, nor authorize its resale customers or the end-user to translate, decompile, disassemble, use for any competitive analysis, or reverse engineer the Software or its documentation, in any way, except for the event where the end-user locates Products within the European Union, in which case the Software Directive enacted by the Council of European Communities Directive dated 14 May 1991 will apply to the examination of the Software to facilitate interoperability; in such event Distributor agrees to notify, and cause its end-user to notify NETGEAR of any such intended examination of the Software and procure from NETGEAR its support and assistance. Distributor agrees to not translate, nor allow end-users to translate any portion of the Software or associated documentation into any other format or foreign language without the prior written consent of NETGEAR. In no event will Distributor grant the U.S. Government rights in any Software greater than those set out in subparagraphs (a) through (d) of the Commercial Computer Software- Restricted Rights clause at FAR 52,227-19 and the limitations for civilian agencies set out the License Agreement; and subparagraph (c)(l)(ii) of the Rights in Technical Data and Computer Software clause at DFARS 252.227-7013 for agencies of the Department of Defense.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTIES\", \"level\": 1, \"text\": \"7. WARRANTIES A. WARRANTY PERIOD. The warranty period for each Product is specified in the Price List that is in effect on the date NETGEAR receives Distributor's order, and shall apply regardless of any extended warranty period which Distributor may choose to provide to its customers. NETGEAR reserves the right to change a warranty period for a specific Product but only for orders placed after the effective date of such change, provided that the minimum warranty period for all Products is ninety days, except for those Products specifically identified in the Price List as provided \\\" AS IS\\\" with no warranties. B. HARDWARE WARRANTY. NETGEAR warrants to end-user that each item of Hardware will be free from defects in workmanship and materials for its respective warranty period which begins on the date of purchase by the end user. Should a Product fail within this warranty period, Distributor shall replace such defective Product from Distributor's inventory and accept return of the failed Product from Distributor's customer. At intervals to be mutually agreed upon between NETGEAR and Distributor. Distributor shall contact NETGEAR to receive a Return Material Authorization number for the collected failed Product. Upon receipt of the failed Product, NETGEAR shall issue a credit to Distributor for Distributor's purchase price of the replacement Product issued, less any prior credits or allowances. End-users' exclusive remedy is to receive replacement Product from reseller and NETGEAR's sole obligation and liability under this warranty is to issue an off-setting credit to reseller for Product returned by reseller on behalf of its end-user because of defects in workmanship or material.\"}}, {\"id\": \"value:ninety days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety days\"}}, {\"id\": \"C_3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SOFTWARE WARRANTY\", \"level\": 1, \"text\": \"C. SOFTWARE WARRANTY. NETGEAR warrants to the end-user that each item of Software, as delivered or updated by NETGEAR and properly installed and operated on the Hardware or other equipment it is originally licensed for, will function substantially as described in its then-current user documentation during its respective warranty period. If any item of Software fails to so perform during its warranty period, as the sole remedy NETGEAR of NETGEAR's supplier will at its discretion provide a suitable fix, patch or workaround for the problem which may be included in a future revision of the Software. For specific Software which is distributed by NETGEAR as a licensee of third parties, additional warranty terms offered by such third parties to end-users may apply. INGRAM NETGEAR Distributor Agreement 5 083096\"}}, {\"id\": \"D_2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR'S INTERNAL USE WARRANTY\", \"level\": 1, \"text\": \"D. DISTRIBUTOR'S INTERNAL USE WARRANTY. For Products ordered under this Agreement for Distributor's internal use, NETGEAR provides Distributor the same warranties as described above for end-users. E. LIMITATIONS. NETGEAR does not warrant that any item of Software is error-free or that its use will be uninterrupted. NETGEAR is not obligated to remedy any Software defect which cannot be reproduced with the latest revision of the Software. These warranties do not apply to any Product which has been (i) altered, except by NETGEAR or in accordance with its instructions, or (ii) used in conjunction with another vendor's product resulting in the defect, or (iii) damaged by improper environment, abuse, misuse, accident or negligence. Replacement parts furnished under this warranty may be refurbished or contain refurbished components. THE FOREGOING WARRANTIES AND LIMITATIONS ARE EXCLUSIVE REMEDIES AND ARE IN LIEU OF ALL OTHER WARRANTIES EXPRESS OR IMPLIED, INCLUDING WITHOUT ANY LIMITATION WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. ANY PRODUCT THAT MAY BE FURNISHED BY NETGEAR WHICH IS NOT LISTED IN THE PRICE LIST, OR WHICH IS IDENTIFIED IN THE PRICE LIST AS AN \\\"AS IS\\\" PRODUCT, IS FURNISHED \\\"AS IS\\\" WITH NO WARRANTIES OF ANY KIND.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT RETURNS\", \"level\": 1, \"text\": \"8. PRODUCT RETURNS Prior to returning any Product, whether for exchange or warranty or non-warranty action, Distributor must obtain a Return Materials Authorization (RMA) number from NETGEAR. Distributor should return the product to NETGEAR, [*]. NETGEAR will not accept collect shipments. Any Product returned to NETGEAR, which is not returned in accordance with the terms of this Agreement, may be rejected.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT EXCHANGE PRIVILEGES\", \"level\": 1, \"text\": \"9. PRODUCT EXCHANGE PRIVILEGES A. Distributor may return previously purchased Products for replacement by an equal or greater value of different Products, under the following conditions: a) Distributor may return Products only within the [*] period following [*] of each year. b) The total value of the returned Products shall not exceed [*] of the Net Shipments invoiced by NETGEAR for all Products, [*], during the [*] immediately preceding each of the above dates.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The replacement Products are not identical to the returned Products\", \"level\": 1, \"text\": \"c) The replacement Products are not identical to the returned Products. Distributor shall be invoiced for the replacement Products at prices in effect at the time of return, and credited for the value of the returned products at the prices actually paid by the Distributor less any prior credits.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The returned Products have not been in the Distributor's inventory for more than [*] after shipment from NETGEAR\", \"level\": 1, \"text\": \"d) The returned Products have not been in the Distributor's inventory for more than [*] after shipment from NETGEAR. e) The returned Products are in their original shipping containers and have not been altered, damaged or used.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR'S RESPONSIBILITIES\", \"level\": 1, \"text\": \"10. DISTRIBUTOR'S RESPONSIBILITIES INGRAM NETGEAR Distributor Agreement 6 083096 A. PROMOTION AND SALE. Distributor shall sell or license Products only to resale customers which will in-turn resell or transfer the licenses to those Products to end use customers. Distributor may not sell or license Products directly to end use customers without the express written consent of NETGEAR. Distributor agrees to use commercially reasonable efforts to maximize sales of NETGEAR Products. B. SUPPORT. Distributor shall be the sole point of contact for its resale customers and their end-use customers in all support situations. Distributor shall provide first level support for its customers, NETGEAR shall provide second and third level support to Distributor in order to resolve end user technical problems.\"}}, {\"id\": \"C_4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRAINING\", \"level\": 1, \"text\": \"C. TRAINING. Distributor agrees to maintain, and to adequately and thoroughly train on an on-going basis, a sufficient staff of qualified sales, marketing, technical and support personnel familiar with the applications, features, benefits, operation and configuration of the Products so as to effectively promote and support the Products and to assure end-user satisfaction. NETGEAR agrees to provide assistance to Distributor to allow Distributor to comply with the foregoing training responsibility.\"}}, {\"id\": \"D_3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESTRICTION ON APPOINTMENT OF ADDITIONAL DISTRIBUTORS\", \"level\": 1, \"text\": \"D. RESTRICTION ON APPOINTMENT OF ADDITIONAL DISTRIBUTORS. NETGEAR's agreement not to appoint additional distributors of NETGEAR Products in the Territory during the [*] of this Agreement is predicated upon Distributor performing the mutually agreed upon activities included in the Marketing Plan attached as Exhibit 4. In the event Distributor fails to perform the activities included in the Marketing plan in [*], NETGEAR may appoint additional distributors in the Territory and the provisions of this Agreement appointing Distributor as the only NETGEAR distributor in the Territory shall be deemed deleted.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPORTS\", \"level\": 1, \"text\": \"11. REPORTS A. Each month Distributor shall submit a Point of Sale (POS) shipments report covering the preceding month, broken out by Product. The report may be submitted via BBS and shall include, at a minimum, Distributor's reseller's name, address, part number, quantity shipped and unit cost. B. Each month Distributor shall prepare and forward to NETGEAR a weekly report showing Distributor's inventory of the Products purchased and licensed from NETGEAR as of the end of the previous calendar month. The report may be submitted via BBS and shall include, at a minimum the part number and the number of units and purchase value of the inventory remaining by Product.\"}}, {\"id\": \"C_5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"From time to time, but not more than twice per year, NETGEAR may request access to information about the Distribu\", \"level\": 1, \"text\": \"C. From time to time, but not more than twice per year, NETGEAR may request access to information about the Distributor's business reasonably required to insure that Distributor is in compliance with the terms of this Agreement and the Distributor will grant the right for a NETGEAR representative to visit the Distributor's place of business during normal business hours at a mutually agreed upon time to examine such information.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROPRIETARY RIGHTS AND INFORMATION\", \"level\": 1, \"text\": \"12. PROPRIETARY RIGHTS AND INFORMATION A. USE OF PROPRIETARY INFORMATION. \\\"Proprietary information includes, without limitation, diagnostics, the Software, all documentation for Software, other user manuals, as well as electronically and visually transmitted printed materials and information disclosed by Distributor or NETGEAR, such as new product information, financial or technical data, information reported under section II above or other information or data that is marked with a proprietary or confidential legend. Each party agrees to hold the Proprietary Information of the other in confidence and to use the Proprietary Information only for the purposes expressly permitted under this Agreement, and to disclose Proprietary Information only to its employees and contractors as authorized in this Agreement and then only on a need-to-know basis. Each party agrees to maintain adequate internal procedures, including appropriate agreements with employees and authorized third parties, to protect the confidentiality of the INGRAM NETGEAR Distributor Agreement 7 083096 Proprietary Information as required by this Agreement. Each party is entitled to appropriate injunctive relief in the event of any unauthorized disclosure or use of its Proprietary Information by the other party. B. LIMITATIONS. Proprietary Information does not include information which (i) is rightfully in the receiving party's possession in a complete and tangible form before it is received from the disclosing party, (ii) is or becomes a matter of public knowledge through no fault of the receiving party, (iii) is rightfully furnished to the receiving party by a third party without restriction on disclosure or use, or (iv) is independently developed by the receiving party without use of or reference to the disclosing party's Proprietary Information.\"}}, {\"id\": \"term:Proprietary information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary information\", \"text\": \"includes, without limitation, diagnostics, the Software, all documentation for Software, other user manuals, as well as electronically and visually transmitted printed materials and information disclosed by Distributor or NETGEAR, such as new product information, financial or technical data, information reported under section II above or other information or data that is marked with a proprietary or confidential legend\", \"definition_clause\": \"12\"}}, {\"id\": \"D_4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESERVATION OF RIGHTS\", \"level\": 1, \"text\": \"D. RESERVATION OF RIGHTS. NETGEAR, on behalf of itself and its suppliers, reserves all proprietary rights in and to (i) all designs, engineering details, and other data pertaining to the Products, (ii) all original works, computer programs, fixes, updates (but not Distributor's or 'end-users' developed programs), discoveries, inventions, patents, know-how and techniques arising out of work done wholly or in part by NETGEAR or its subcontractors in connection with the Agreement, and (iii) any and all products developed as a result of such work. The performance by NETGEAR of professional Services shall not be deemed a work-for-hire but shall instead be subject to this section. E. ADMINISTRATIVE PROCEDURES. Distributor and end-users are each responsible for the security of their own proprietary and confidential information and for maintaining adequate procedures apart from the Products to reconstruct lost or altered files, data or programs.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS AND TRADE NAMES\", \"level\": 1, \"text\": \"13. TRADEMARKS AND TRADE NAMES A. USE OF TRADEMARKS. In the advertising and promotion of the Products, Distributor agrees to use NETGEAR's and certain of Bay Networks' trade names, logos and trademarks (the \\\"Trademarks\\\") as reasonably instructed by NETGEAR during the term of the Agreement. Solely for this purpose, NETGEAR and Bay Networks grant Distributor a non-exclusive, royalty-free, limited right to use the Trademarks. Distributor will not make or permit the removal or modification of any Trademarks or tags, proprietary notices, labels, or other identifying marks placed by Bay Networks, NETGEAR or their agents on the Products or associated literature. B. RIGHTS TO TRADEMARKS. Distributor acknowledges that Bay Networks is the exclusive owner of the Trademarks and the use of the Trademarks by Distributor does not convey to Distributor any right, title or interest in or to the Trademarks. Distributor has no claim or right in the Trademarks, service marks, or trade names owned, used or claimed now or in the future by NETGEAR. Distributor agrees that it will not register, nor attempt to register any Trademark or any mark confusingly similar to any Trademark in any jurisdiction unless expressly approved in writing by Bay Networks in advance.\"}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"NETGEAR's and certain of Bay Networks' trade names, logos and trademarks\", \"definition_clause\": \"13\"}}, {\"id\": \"C_6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTIFICATION\", \"level\": 1, \"text\": \"C. NOTIFICATION. In order to assure proper use and protection of Trademarks, Distributor agrees to inform NETGEAR in writing if Distributor purchases, or is offered for purchase, any Products with a Trademark or other mark of NETGEAR from a source other than NETGEAR, its subsidiaries, or an authorized NETGEAR Distributor.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CLAIMS OF INFRINGEMENT\", \"level\": 1, \"text\": \"14. CLAIMS OF INFRINGEMENT A. INDEMNIFICATION. NETGEAR agrees to defend at its own expense any action brought against Distributor to the extent that it is based on a claim that any Product infringes a United States or Territory patent, copyright, trade mark, trade secret or other valid intellectual property right, and will pay any costs and damages finally awarded against Distributor in any such actions which are attributable to any such claim. NETGEAR shall have no liability for any settlement or compromise made without its prior written consent. NETGEAR shall, at its option and expense, (1) procure the right to continue using the Product. INGRAM NETGEAR Distributor Agreement 8 083096 (2) replace or modify the Product so that it becomes non-infringing or, if (1) or (2) are not reasonably or economically possible. (3) Distributor may return the Product to NETGEAR for a refund of an amount equal to the depreciated value of the equipment, or an amount equal to the Distributor's actual purchase price paid without any depreciation minus any prior credits or allowances if the returned Products are in their original shipping containers and have not been altered, damaged or used. B. LIMITATIONS. NETGEAR has no liability to Distributor under this section entitled CLAIMS OF INFRINGEMENT with respect to any claim which is based upon or results from (i) the combination of any Product with any equipment, device, firmware or software not furnished by NETGEAR, or (ii) any modification of any Product by a party other than NETGEAR. (iii) Distributor's failure to install or have installed changes, revisions or updates as instructed by NETGEAR, or (iv) NETGEAR's compliance with Distributor's or end-user's specifications, designs or instructions.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM OF AGREEMENT AND TERMINATION\", \"level\": 1, \"text\": \"15. TERM OF AGREEMENT AND TERMINATION A. TERM. This Agreement will be in effect for one year from the Effective Date and will automatically renew for successive one (1) year periods unless terminated as provided below. B. TERMINATION. This Agreement may be canceled at any time without cause, by either party upon ninety (90) days written notice to the other party. Either party may terminate this Agreement immediately if (i) the other party becomes insolvent, files or has filed against it a petition in bankruptcy, or ceases doing business; or (ii) the other party fails to cure a material breach of the Agreement within thirty (30) days after receipt of written notice of such breach from the party not in default. Upon termination of the Agreement by NETGEAR for Distributor's breach, NETGEAR may cancel all of Distributor's unfulfilled orders without further obligation. This Agreement may be terminated at any time without cause by either party upon ninety (90) days written notice to the other party.\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"C_7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECT OF TERMINATION\", \"level\": 1, \"text\": \"C. EFFECT OF TERMINATION. Except as otherwise specifically stated in the Agreement, neither party will be liable to the other for damages in any form by reason of the expiration or earlier termination of the Agreement.\"}}, {\"id\": \"D_5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONTINUING EFFECT\", \"level\": 1, \"text\": \"D. CONTINUING EFFECT. Any expiration or earlier termination of the Agreement does not modify or alter any of the obligations of the parties which accrued prior to such expiration or termination. The sections of the Agreement which address taxes; duty; fee; payment; security interest; proprietary rights and information; warranties; foreign reshipment; remedies; limitations; termination and governing law survive any expiration or termination of the Agreement. The section entitled SOFTWARE LICENSES also survives any expiration or termination provided Distributor and end-users continues to comply with the provisions of the applicable software license terms. Except as expressly agreed in writing between the parties, no party is liable to the other for any dollar amounts, costs or damages by reason of the expiration or earlier termination of the Agreement.\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"16. LIMITATION OF LIABILITY A. NETGEAR agrees to indemnify Distributor against any claim arising out of or resulting from the Products or the Agreement, provided that any such claim (i) is attributable to bodily injury, death, or to injury to or destruction of physical property (other than the Products), and (ii) is caused by the negligent act or omission of NETGEAR or a material defect in the Product. This obligation on the part of NETGEAR is subject to Distributor's obligation to (a) give NETGEAR prompt written notice of any such claim, (b) grant NETGEAR control of the defense and settlement of such claim, and (c) assist fully in the defense provided that NETGEAR reimburses Distributor's out-of pocket costs. NETGEAR has no liability for any settlement or compromise made without its prior written consent. Under no circumstances INGRAM NETGEAR Distributor AGREEMENT 9 083096 is NETGEAR liable for any third-party claims except for those described in this section and in the section entitled CLAIMS OF INFRINGEMENT. B. NETGEAR, at its expense, agrees to maintain insurance coverage to protect against its liabilities under the Agreement in an amount no less than is reasonable or required by applicable statute. This insurance will include (a) worker's compensation insurance, (b) comprehensive general liability insurance, including coverage for product liability, bodily injury and property damage, and (c) automobile liability insurance. Upon Distributor's written request, NETGEAR will furnish the applicable certificate of insurance. IN NO EVENT WILL EITHER PARTY OR THEIR RESPECTIVE PARENT CORPORATIONS OR SUPPLIERS BE LIABLE FOR (1) THE COST OF SUBSTITUTE PROCUREMENT, SPECIAL, INDIRECT, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, OR (2) ANY DAMAGES RESULTING FROM INACCURATE OR LOST DATA OR LOSS OF USE OR PROFITS ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, THE FURNISHING OF SERVICES, OR THE USE OR PERFORMANCE OF PRODUCTS, EVEN IF INFORMED OF SUCH DAMAGES. EXCEPT FOR DAMAGES ARISING UNDER SECTIONS 14.A AND 16.A, IN NO EVENT WILL NETGEAR's OR BAY NETWORKS' TOTAL LIABILITY FOR ANY DAMAGES IN ANY ACTION BASED ON OR ARISING OUT OF OR IN CONNECTION WITH THE AGREEMENT EXCEED THE [*] TO NETGEAR PURSUANT TO THE AGREEMENT. EXCEPT FOR DAMAGES ARISING FROM BREACH OF SECTIONS 6.C AND 12,13 OR 17, IN NO EVENT WELL DISTRIBUTOR's TOTAL LIABILITY FOR ANY DAMAGES IN ANY ACTION BASED ON OR ARISING OUT OF OR IN CONNECTION WITH THE AGREEMENT EXCEED THE [*] TO NETGEAR PURSUANT TO THE AGREEMENT.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FOREIGN RESHIPMENT\", \"level\": 1, \"text\": \"17. FOREIGN RESHIPMENT This Agreement is made subject to all laws, regulations, orders or other restrictions on the export from the United States of Products and accompanying documentation, or of other technical data and information about such Products, which may be imposed from time to time. Distributor agrees not to export, directly or indirectly, any such Products or information to any country for which an export license or other governmental approval is required at the time of export without first obtaining such license or approval. Distributor is solely responsible, at its own expense, for obtaining all necessary import and re-export permits and certificates and for the payment of any and all taxes and duties imposed upon the movement and delivery of Products.\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 1, \"text\": \"18. GENERAL A. The relationship of NETGEAR and Distributor is that of independent contractors. There is no relationship of agency, partnership, joint venture, employment or franchise between the parties. Neither party has the authority to bind the other or to incur any obligation on the other's behalf or to represent itself as the other's agent or in any way which might result in confusion as to the fact that the parties are separate and distinct entities. B. If any provision of this Agreement is held to be invalid or unenforceable, the remainder of the provisions shall remain in full force and effect.\"}}, {\"id\": \"C_8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NETGEAR and Distributor agree to comply with the provisions of all applicable federal, state, county and local la\", \"level\": 1, \"text\": \"C. NETGEAR and Distributor agree to comply with the provisions of all applicable federal, state, county and local laws, ordinances, regulations and codes, domestic and foreign. INGRAM NETGEAR Distributor Agreement 10 083096\"}}, {\"id\": \"D_6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NETGEAR reserves the right to change the discount schedule, policy or program, whether referred to in the Agreeme\", \"level\": 1, \"text\": \"D. NETGEAR reserves the right to change the discount schedule, policy or program, whether referred to in the Agreement or set forth in an Exhibit to the Agreement. For changes which, in NETGEAR's opinion, may adversely affect Distributor, NETGEAR will provide thirty (30) days notice, or such longer period as NETGEAR deems appropriate, prior to the effective date of such change. E. Distributor will keep suitable records to demonstrate compliance with this Agreement. NETGEAR or its representative, at NETGEAR's cost may review these records during normal business hours for the sole purpose of determining Distributor's compliance with this Agreement. F. Any waiver, amendment or modification of any right, remedy or other term under the Agreement will not be effective unless mutually agreed to in writing and signed by authorized representatives of both parties. Neither party shall be bound by typographical or clerical errors. G. Neither party is liable for its failure or delay to perform its obligations under the Agreement due to strikes, wars, revolutions, acts of terrorism, fires, floods, explosions, earthquakes, shortages in labor, components or materials, government regulations, or other causes beyond its control. H. This Agreement may not be assigned by either party without prior written permission from the other party, which permission shall not be unreasonably withheld or delayed. Any attempt by either party to assign any right, or delegate any duty or obligation which arises under the Agreement without such permission will be voidable.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT, GOVERNING LAW\", \"level\": 1, \"text\": \"19. ENTIRE AGREEMENT, GOVERNING LAW This Agreement, including its attachment and order acknowledgments under the Agreement, constitutes the entire agreement between Distributor and NETGEAR with respect to the purchase, resale and distribution of the Products and is governed by the laws of the State of California except that body of law dealing with conflicts of law. INGRAM NETGEAR Distributor Agreement 11 083096 * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 1 DISCOUNT SCHEDULE The initial Discount offered Distributor for purchase or license of NETGEAR Products included on the NETGEAR Price List in effect on the Effective Date of this Agreement is [*] off of the then current NETGEAR list price. Distributor agrees that the foregoing Discount is only applicable to Products included on the NETGEAR Price List on the Effective Date of this Agreement. NETGEAR reserves the right to add Products to the Price List at its sole discretion and any such additional Products shall be offered to Distributor at discounts to be determined at that time. INGRAM NETGEAR Distributor Agreement 12 083096 EXHIBIT 2 DISTRIBUTOR'S ROUTING GUIDE INGRAM NETGEAR Distributor Agreement 13 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. EXHIBIT 3\"}}, {\"id\": \"CMD\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NAMED ACCOUNTS [*]\", \"level\": 1, \"text\": \"CMD NAMED ACCOUNTS [*] INGRAM NETGEAR Distributor Agreement 14 092696 EXHIBIT 4 MARKETING PLAN INGRAM NETGEAR Distributor Agreement 15 083096 CONFIDENTIAL TREATMENT REQUEST * Portions denoted with an asterisk have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. AMENDMENT TO THE DISTRIBUTOR AGREEMENT BETWEEN INGRAM MICRO AND NETGEAR\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of OMINTO,INC_03_29_2004-EX-10-RESELLER AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of OMINTO,INC_03_29_2004-EX-10-RESELLER AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"EXHIBIT 10.25\", \"title\": \"RESELLER AGREEMENT\", \"level\": 2, \"text\": \"EXHIBIT 10.25 RESELLER AGREEMENT THIS AGREEMENT (the \\\"AGREEMENT\\\") entered into as of the 19 day of March, 2004 (the \\\"EFFECTIVE DATE\\\") provides the terms and conditions under which MediaNet Group Technologies, Inc., a Nevada corporation having an address at 5100 W. Copans Road Suite 710 Margate, FL 33063 USA (\\\"MEDIANET GROUP TECHNOLOGIES\\\"), authorizes International Direct Response, Inc., a Pennsylvania Corporation, having an address at 1125 Lancaster Avenue, Berwyn, PA 19312(\\\"RESELLER\\\") to be its true and lawful representative and agent for the purpose of reselling licenses of the MediaNet Group Technologies Portals (\\\"PORTALS\\\") and other MediaNet Group Technologies products and services in accordance with the terms and conditions contained in this Agreement. This Agreement, together with the other agreements and schedules referenced in it, contains the complete terms and conditions between the parties. MEDIANET GROUP TECHNOLOGIES AND RESELLER AGREE AS FOLLOWS:\"}, {\"id\": \"1\", \"title\": \"LICENSE\", \"level\": 1, \"text\": \"1. LICENSE Reseller is hereunder licensed to market MediaNet Group Technologies' Brand-A-Port portals (\\\"PORTALS\\\") and to resell MediaNet Group Technologies products and services for compensation in accordance with the annexed \\\"RESELLING SCHEDULE.\\\" Under the terms and conditions as outlined in this Agreement.\"}, {\"id\": \"2\", \"title\": \"RESELLING\", \"level\": 1, \"text\": \"2. RESELLING The Reseller intends to market the Portals to companies and various businesses and individuals (\\\"BUYERS\\\") who may include corporations, small businesses, religious organizations, network marketing, franchise, business opportunities, chains, charities, organizations and other companies that would have a use for individual and multiple portals. The purpose of this Agreement is to define the scope of compensation for the marketing of Portals to these potential customers. During the Term of this Agreement, Reseller shall have the right to market Brand-A-Port Portals, both through the existing Brand-A-Port Portal under the License and independently to Buyers for resale, subject to approval by MediaNet Group Technologies.\"}, {\"id\": \"3\", \"title\": \"COMPENSATION\", \"level\": 1, \"text\": \"3. COMPENSATION MediaNet Group Technologies shall pay Reseller a fee in accordance with the annexed Fee Schedule. MediaNet Group Technologies will remit payment as directed by Reseller in the time frames noted on the Compensation Schedule attached hereto.\"}, {\"id\": \"4\", \"title\": \"PUBLICITY AND ADVERTISING\", \"level\": 1, \"text\": \"4. PUBLICITY AND ADVERTISING Subject to Section 7, Reseller and MediaNet Group Technologies agree that broad publicity with respect to the relationship developed by this Agreement, and the advantages of such relationship, will be permitted and actively encouraged and supported by both parties. This publicity initiative will include, but is not limited to, a press releases issued by Reseller and MediaNet Group Technologies, publicizing the strategic alliance between the parties, on site promotion and email campaigns. In this regard, Reseller and MediaNet Group Technologies shall agree on the form, content of the press release prior to its release. MediaNet Group Technologies must approve any advertising prior to issuance and placement.\"}, {\"id\": \"5\", \"title\": \"PROPRIETARY RIGHTS\", \"level\": 1, \"text\": \"5. PROPRIETARY RIGHTS\"}, {\"id\": \"5.1\", \"title\": \"OWNERSHIP\", \"level\": 2, \"text\": \"5.1 OWNERSHIP. RESELLER understands and agrees that MediaNet Group Technologies is the exclusive holder of and shall retain, all right, title and interest in and to the Portal, Content and Engine and the All Pages, including without limitation all intellectual Property therein site (EXCLUDING PROPRIETARY PAGES PROVIDED BY RESELLER OR BUYERS). Reseller Agreement Initials ______ _______ 1\"}, {\"id\": \"5.2\", \"title\": \"INTELLECTUAL PROPERTY\", \"level\": 2, \"text\": \"5.2 INTELLECTUAL PROPERTY. Nothing herein shall grant a party any right, title or interest in the other party's Intellectual Property, except as explicitly set forth herein. At no time during or after the Term of this Agreement shall a party challenge or assist others to challenge the other party's Intellectual Property or the registration thereof or attempt to register any trademarks, marks or trade names confusingly similar to those or the other party.\"}, {\"id\": \"5.3\", \"title\": \"INTELLECTUAL PROPERTY WARRANTY\", \"level\": 2, \"text\": \"5.3 INTELLECTUAL PROPERTY WARRANTY. The MediaNet Group Technologies BrandAPort Service and the operation of the site(s) and co-branded site(s) as currently operated by MediaNet Group Technologies, Inc. is designed to provide a link taking the end-user to it's originating website. Other than claims arising out of the use of the BrandAPort services, MediaNet Group Technologies shall not be responsible for unauthorized use of the Co-branded sites by Reseller, users of Reseller's or Buyers' Sites.\"}, {\"id\": \"6\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"6. CONFIDENTIALITY\"}, {\"id\": \"6.1\", \"title\": \"CONFIDENTIALITY INFORMATION\", \"level\": 2, \"text\": \"6.1 CONFIDENTIALITY INFORMATION. Each party (the \\\"RECEIVING PARTY\\\") acknowledges that by reason of its relationship to the other party (the \\\"DISCLOSING PARTY\\\") hereunder, the Receiving Party will have access to certain information and materials, including the terms of this Agreement, concerning the Disclosing Party's business, plans, technology, products and services that are confidential and of substantial value to the Disclosing Party, which value would be impaired if such information were disclosed to third parties (\\\"CONFIDENTIAL INFORMATION\\\"). The Receiving Party agrees that it shall not use in any way for its own account or the account of any third party, nor disclose to any third party, any such Confidential Information revealed to it by the Disclosing Party. The Receiving Party shall take every reasonable precaution to protect the confidentiality of Confidential Information. Upon request by the Receiving Party, the Disclosing Party shall advise whether or not it considers any particular information to be Confidential Information. The Receiving Party shall not publish any technical description of the Disclosing Party's Confidential Information beyond any descriptions published by the Disclosing party. In the event of expiration or termination of this Agreement, there shall be no use or disclosure by the Receiving Party of any Confidential Information of the Disclosing Party, and the Receiving Party shall not develop any software, devices, components or assemblies utilizing the Disclosing Party's Intellectual Property. Both parties agree that the terms and conditions of this Agreement are confidential and shall not be disclosed to any third party, unless disclosure is compelled by final, non-appealable order of a court of competent jurisdiction.\"}, {\"id\": \"6.2\", \"title\": \"EXCLUSIONS\", \"level\": 2, \"text\": \"6.2 EXCLUSIONS. Confidential Information does not include information permitted to be disclosed under section 5 and any information that the Receiving Party can demonstrate by written records: (a) was known to the Receiving Party prior to its disclosure hereunder by the disclosing party; (b) is independently developed by the Receiving Party; (c) is or becomes publicly known through no wrongful act of the Receiving Party; (d) has been rightfully received from a third party whom the Receiving party has reasonable grounds to believe is authorized to make such disclosure without restriction; (e) has been approved for public release by the Disclosing Party's prior written authorization, or (f) must be produced or disclosed pursuant to applicable law, regulation or court order, provided that the receiving party provides prompt advance notice thereof to enable the disclosing party to seek a protective order or otherwise prevent such disclosure. In addition, Reseller and MediaNet Group Technologies may disclose the existence and terms of this Agreement in connection with a potential acquisition of substantially the entire business of the other party, or a private or public offering of securities of either party. Reseller Agreement Initials ______ _______ &sbsp; 2\"}, {\"id\": \"7\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"7. LIMITATION OF LIABILITY NEITHER RESELLER NOR MEDIANET GROUP TECHNOLOGIES MAKES ANY WARRANTY WHATSOEVER WITH REGARD TO THE FEATURES, FUNCTIONS, PERFORMANCE, QUALITY OR OTHER CHARACTERISTICS OF THE SERVICE EACH COMPANY PROVIDES. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO EACH OTHER OR ANY OTHER ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL OR INDIRECT DAMAGES, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY, AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. RESELLER SHALL NOT BE LIABLE TO MEDIANET GROUP TECHNOLOGIES OR ANY OTHER PARTY FOR ANY DAMAGES ARISING FROM THIRD PARTY UNAUTHORIZED ACCESS OR USE OF THE MEDIANET GROUP TECHNOLOGIES SERVICE OR ANY IMAGES OBTAINED BY USING THE MEDIANET GROUP TECHNOLOGIES SERVICE. MEDIANET GROUP TECHNOLOGIES SHALL NOT BE LIABLE TO RESELLER OR ANY OTHER PARTY FOR ANY DAMAGES ARISING FROM THIRD PARTY UNAUTHORIZED ACCESS OR USE OF THE MEDIANET GROUP TECHNOLOGIES SERVICE OR ANY IMAGES OBTAINED BY USING THE MEDIANET GROUP TECHNOLOGIES SERVICES.\"}, {\"id\": \"8\", \"title\": \"DISCLAIMERS\", \"level\": 1, \"text\": \"8. DISCLAIMERS MEDIANET GROUP TECHNOLOGIES DISCLAIMERS. MEDIANET GROUP TECHNOLOGIES MAKES NO OTHER WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, REGARDING THE MEDIANET GROUP TECHNOLOGIES, PICTUREJUDGE OR BRANDAPORT SERVICE, AND MEDIANET GROUP TECHNOLOGIES SPECIFICALLY DISCLAIMS ANY IMPLIED WARRANTIES OF NON-INFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE. MEDIANET GROUP TECHNOLOGIES DOES NOT WARRANT THAT THE OPERATION OF THE MEDIANET GROUP TECHNOLOGIES SERVICE WILL BE UNINTERRUPTED OR ERROR-FREE. FURTHERMORE, MEDIANET GROUP TECHNOLOGIES DOES NOT MAKE ANY REPRESENTATIONS REGARDING THE USE OF THE RESULTS OF THE USE OF THE MEDIANET GROUP TECHNOLOGIES SITE IN TERMS OF THEIR CORRECTNESS, ACCURACY, RELIABILITY OR OTHERWISE.\"}, {\"id\": \"9\", \"title\": \"TERMS AND TERMINATION\", \"level\": 1, \"text\": \"9. TERMS AND TERMINATION\"}, {\"id\": \"9.1\", \"title\": \"TERM\", \"level\": 2, \"text\": \"9.1 TERM. The term of this Agreement shall commence on the Effective Date and continue for a period of 1 year after the Effective Date, unless earlier terminated as set forth herein (the \\\"TERM\\\"). This Agreement shall renew for successive 1-year periods, after the initial 1 Year Term, if agreed by both parties in writing within 30 days of license expiration. Either party may terminate the Agreement on 60-days written notice during a renewed term. However, in no event shall termination of this Agreement by MediaNet Group Technologies relieve it of the obligation to remit payment to Reseller for sales or Portals, Hosting Services or other products and services to or through Buyers contracted by Reseller prior to such termination. The obligation to remit payment cease 30 days after termination of this Agreement.\"}, {\"id\": \"9.2\", \"title\": \"TERMINATION FOR BREACH OR INSOLVENCY\", \"level\": 2, \"text\": \"9.2 TERMINATION FOR BREACH OR INSOLVENCY. A party shall have the right to terminate this Agreement on written notice if (a) the other party ceases to do business in the ordinary course or is insolvent (i.e., unable to pay its debts in the ordinary course as they come due), or is declared bankrupt, or is the subject of any liquidation or insolvency proceeding which is not dismissed within 90 days, or makes any assignment for the benefit of creditors, or (b) the other party breaches any material term of this Agreement, including timely payments, and fails to cure such breach within 30 days after written notice thereof (collectively referred to here in as \\\"TERMINATING EVENTS\\\"). In the event of a Terminating Event, involving Reseller, other than for an event involving fraud or dishonesty by Reseller, MediaNet Group Technologies shall be entitled to offset payments due under this Agreement against its costs incurred as a result of the Terminating Event, but shall remain obligated to remit all payments due under this agreement as a direct result of the activities of Reseller prior to the effective date of termination. Reseller Agreement Initials ______ _______ &sbsp; 3\"}, {\"id\": \"10\", \"title\": \"EFFECT OF TERMINATION\", \"level\": 1, \"text\": \"10. EFFECT OF TERMINATION Upon the expiration or termination of this Agreement:\"}, {\"id\": \"10.1\", \"title\": \"Each party shall, within 30 days of such expiration or termination return to other party or destroy all Confidentia\", \"level\": 2, \"text\": \"10.1 Each party shall, within 30 days of such expiration or termination return to other party or destroy all Confidential Information and all other material received from such other party.\"}, {\"id\": \"10.2\", \"title\": \"All rights granted by Reseller hereunder to MediaNet Group Technologies shall terminate\", \"level\": 2, \"text\": \"10.2 All rights granted by Reseller hereunder to MediaNet Group Technologies shall terminate. All rights granted by MediaNet Group Technologies hereunder to Reseller shall terminate, subject to the continuing obligation of MediaNet Group Technologies to remit payment pursuant to the provisions of Section 8.\"}, {\"id\": \"10.3\", \"title\": \"Sections 5, 6, 7, 9\", \"level\": 2, \"text\": \"10.3 Sections 5, 6, 7, 9.2 10, 11, 12 and 13 shall survive the expiration or termination of this Agreement for any reason.\"}, {\"id\": \"11\", \"title\": \"REMEDIES\", \"level\": 1, \"text\": \"11. REMEDIES\"}, {\"id\": \"11.1\", \"title\": \"INDEMNIFICATION\", \"level\": 2, \"text\": \"11.1 INDEMNIFICATION. Reseller and MediaNet Group Technologies shall indemnify and hold harmless each other, and their respective directors, officers, employees, and agents, from and against all claims, losses, damages and expenses (including reasonable attorney's fees) resulting from the breach of any agreement, representation or warranty set forth herein; provided the indemnified party provides the indemnifying party with (i) prompt written notice of such claim or action, (ii) sole control and authority over the defense or settlement of such claim or action and (iii) proper and full information and reasonable assistance to defend and/or settle any such claim or action.\"}, {\"id\": \"11.2\", \"title\": \"INJUNCTIVE RELIEF\", \"level\": 2, \"text\": \"11.2 INJUNCTIVE RELIEF. The parties acknowledge that the breach or threatened breach of this Agreement by Reseller would cause irreparable harm to MediaNet Group Technologies, the extent of which would be difficult to ascertain. Accordingly, each party agrees that, in addition to any other remedies to which MediaNet Group Technologies may be legally entitled, MediaNet Group Technologies may seek immediate injunctive relief in the event of a breach or threatened breach of such sections by the Reseller or any of Resellers employees or subcontractors.\"}, {\"id\": \"12\", \"title\": \"RESELLER PORTAL\", \"level\": 1, \"text\": \"12. RESELLER PORTAL If applicable, MediaNet Group Technologies shall produce a Branded Portal for Licensee under terms as outlined in a Portal Agreement attached hereto.\"}, {\"id\": \"13\", \"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"13. MISCELLANEOUS\"}, {\"id\": \"13.1\", \"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"13.1 ASSIGNMENT. This Agreement will be binding upon and inure to the benefits of the parties hereto and their permitted successors and assigns. Reseller may nat assign or otherwise transfer this Agreement without MediaNet Group Technologies's prior written consent except to a successor.\"}, {\"id\": \"13.2\", \"title\": \"WAIVER AND AMENDMENT\", \"level\": 2, \"text\": \"13.2 WAIVER AND AMENDMENT. No modifications, amendment or waiver of any provision of this Agreement shall be effective unless in writing and signed by the party to be charged. No failure or delay by either party in exercising any right, power, or remedy under this Agreement shall operate as a waiver of any such right, power or remedy.\"}, {\"id\": \"13.3\", \"title\": \"GOVERNING LAW\", \"level\": 2, \"text\": \"13.3 GOVERNING LAW. The laws of the State of Florida shall govern this Agreement, without reference to conflicts of law provisions.\"}, {\"id\": \"13.4\", \"title\": \"NOTICES, ETC\", \"level\": 2, \"text\": \"13.4 NOTICES, ETC. Any notice required or permitted by this Agreement shall be deemed given if delivered by registered mail, postage prepaid, addressed to the other party at the address shown at the beginning of this Agreement or at such other address for which such party gives notice hereunder. Delivery shall be deemed effective 3 days after deposit with postal Reseller Agreement Initials ______ _______ 4 authorities. Email, facsimile or other form of transmission pursuant to which MediaNet Group Technologies receives actual notice of the accounts into which the funds are to be wired may give notices of the accounts into which payment is to be wired shall be effective and MediaNet Group Technologies shall be entitled to rely upon them as if they were sent in accordance with the notice provisions of this paragraph.\"}, {\"id\": \"13.5\", \"title\": \"INDEPENDENT CONTRACTORS\", \"level\": 2, \"text\": \"13.5 INDEPENDENT CONTRACTORS. The parties are independent contractors with respect to each other. Each party is not and shall not be deemed to be an employees, agent, joint venture Reseller or legal representative of the other for any purpose and shall not have any right, power, or authority to create any obligation or responsibility on behalf of the other.\"}, {\"id\": \"13.6\", \"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"13.6 SEVERABILITY. If any provision of this Agreement shall be held by a court of competent jurisdiction to be contrary to law, such provision shall be changed and interpreted so as to best accomplish the objectives of the original provision to the fullest extent allowed by law and the remaining provisions of this Agreement shall remain in full force and effect.\"}, {\"id\": \"13.7\", \"title\": \"COMPLETE UNDERSTANDING\", \"level\": 2, \"text\": \"13.7 COMPLETE UNDERSTANDING. This Agreement constitutes the final, complete and exclusive agreement between the parties with respect to the subject matter hereof, and supersedes any prior or contemporaneous agreement, either written or oral.\"}, {\"id\": \"13.8\", \"title\": \"FORCE MAJEUR\", \"level\": 2, \"text\": \"13.8 FORCE MAJEUR. Except with respect to obligations to make payments hereunder, neither party shall be deemed in default hereunder, nor shall it hold the other party responsible for, any cessation, interruption or delay in the performance of its obligations hereunder due to causes beyond its reasonable control including, but not limited to: earthquake, flood, fire, storm or other natural disaster, act of God, labor controversy or threat thereof, civil disturbance or commotion, disruption of the public markets, war or armed conflict or the inability to obtain sufficient material, supplies, labor, transportation, power or other essential commodity or service required in the conduct of its business, including internet access, or any change in or the adoption of any law, ordinance, rule, regulation, order, judgment or decree.\"}, {\"id\": \"13.9\", \"title\": \"CONTENT\", \"level\": 2, \"text\": \"13.9 CONTENT. It is agreed that MediaNet Group Technologies shall have complete control of content on the Portals with the exception of the customized pages and links on contracted portals, and these pages and links are subject to MediaNet Group Technologies's approval.\"}, {\"id\": \"13.10\", \"title\": \"NO DISPARAGEMENT\", \"level\": 2, \"text\": \"13.10 NO DISPARAGEMENT. Each party agrees that, during the Term of this Agreement and for a period of five (5) years thereafter, neither will make written or oral comments regarding the other that are negative, disparaging, tend to bring the other into disrepute or call into question the business acumen, character, honesty or integrity of the other. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed effective as of the day and year last set forth below. MEDIANET GROUP TECHNOLOGIES, INC. LEGAL NAME: Michael Guyer /s/ Martin A.Berns /s/ Michael Guyer --------------------------------- ------------------------------------ Signature Signature By: Martin A. Berns By: Michael Guyer Title: Chief Executive Officer Title: VP & Director of Marketing Name of Master Reseller (if applicable):____________ Approved by:_______________ Reseller Agreement Initials ______ _______ 5 LICENSE RESELLING SCHEDULE Resellers are licensed to market the Brand-A-Port applications and receive commission on all product sales plus residual income on hosting/maintenance fees as outlined on the Compensation Schedule attached hereto. THE PLAN The MediaNet Group Technologies Reseller Plan is free to join. Under the plan, resellers market and promote MediaNet Group Technologies's software product range to their existing customer base and the general Internet community. By referring a customer to the MediaNet Group Technologies web site, the reseller receives a commission for customer's purchase of the MediaNet Group Technologies Brand-A-Port software. MARKETING AND PROMOTION Resellers are expected to actively market and promote MediaNet Group Technologies Software to their existing customer base and visitors to their web site. Promotion by newsletters and e-mail to customers is encouraged, but we do not encourage spam e-mail and hence specifically ask resellers not to promote MediaNet Group Technologies Software or Applications via unsolicited e-mail. RESELLER LINK Customers are identified as coming from a particular reseller by placing a link(s) on their web site, which contains a cookie (i.e.. small packet of code) which identifies the reseller. On acceptance into the program, MediaNet Group Technologies issues the reseller with the cookie and instructions on how to insert the cookie into their web site. WHAT PRODUCTS ARE AVAILABLE FOR RESALE? Products which can be resold, include: Brand-A-Port Gold (Generic Portal), Brand-A-Port Platinum Portal and Branded PictureJudge applications. MediaNet Group Technologies may offer additional products from time to time. COMMISSION MediaNet Group Technologies tracks the customer sales coming from the reseller and at the end of every calendar month issues a check for 20% commission to the reseller on product sales and 10% the total amount of hosting/maintenance sales made. Commissions are only paid each month if the amount owing exceeds $100 US. MediaNet Group Technologies reserves the right to change the level of commission with out notice. Commission is not paid on MediaNet Group Technologies's free-ware programs. (pricing and products subject to change without notice). CUSTOMER CONTACT Once a customer has come from the reseller to the MediaNet Group Technologies web site, MediaNet Group Technologies deals with the customer directly, issuing the software from the MediaNet Group Technologies server and billing the customer. MediaNet Group Technologies handles all technical support and refund issues. REFUNDS If a refund is issued to a customer who came from a reseller, the reseller's account is adjusted accordingly. TERMINATION The Reseller Agreement can be terminated at any time at the discretion of either party. Reseller Agreement Initials ______ _______ 6 COMPENSATION SCHEDULE This Compensation Schedule is attached hereto and made a part thereof that certain Reseller Agreement of even date: Reseller shall be entitled to receive compensation in the following manner: COMPENSATION: BSP REWARDS PROGRAM: MediaNet shall, upon collection, remit to Member Provider _1_% of the net Rewards earned by Members through and provided directly by it, and _1_% of the net Member Rewards received and collected that is earned through Merchants, Companies, Organizations, Groups and individuals that have been contracted through Member Provider. BRAND-A-PORT OR BSP PORTAL SALES: MediaNet shall remit to Member Provider 20% of the price of each Portal sold directly by it. BSP MONTHLY HOSTING FEES: In addition, MediaNet shall remit to Member Provider an amount equal to 10% of the hosting fees paid by Buyers who purchase portals or host websites with MediaNet as a direct result of the activities of Member Provider, whether those activities are sold through the portal or independent of it. PAYMENT OF COMPENSATION (SUBJECT TO RECEIPT OF GOOD, VALID FUNDS) PORTAL SALES: MediaNet shall remit all sums due to Member Provider within 30 days of receipt of cleared funds. MONTHLY HOSTING FEES: In addition, MediaNet shall remit hosting fees to Member Provider in monthly installments on or before the 15th business day of each month. All sums received by MediaNet through the last business day of the preceding month shall be included in the calculation of the amount to be remitted. BSP REWARDS MEMBER PURCHASES VOLUME: Amounts due for purchases of products or services shall be calculated as of funds received by the last day of each month and remitted on or before the 15th day of the following month. RECORDS MediaNet shall maintain books and records and shall provide for online confirmation of sales and payments. MediaNet shall permit Member Provider or its designees reasonable access during normal business hours and, upon request, to verify funds and payments due pursuant to this Agreement. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed effective as of the day and year last set forth below. Reseller Agreement Initials ______ _______ 7 RESELLER DISTRIBUTOR PRICING STRUCTURE & DETAILS GOLD PORTAL Includes the following available options: o Complete Basic Portal o Web-based Admin Panel to turn on and turn off individual applications and features o Branded Header o Branded Frames o Reseller Program o Email o MediaNet Group Technologies Photo Sharing o MediaNet Group Technologies Travel Agency Retail $495 License Wholesale $395 Monthly Hosting/Maintenance/Updates Retail $39 Wholesale $35 (quarterly maintenance fee due in advance) PLATINUM PORTAL Includes at your option: o Full Featured Customizable Portal with web based administration panel o Branded Header o Branded Photo Sharing o Branded Travel Agency o Branded Frames o Email o Branded Picture Judge o Reseller program Retail $1295 License Wholesale $1035 Monthly Hosting/Maintenance/Updates Retail $99 Wholesale $89 (quarterly maintenance fee due in advance) BRANDED PICTUREJUDGE(SM) INTERACTIVE PHOTO RATING GAME Includes at your option: o Branded PictureJudge photo rating game o Customized phot catagories o Reseller Program Retail $795 License Wholesale $635 Monthly Hosting/Maintenance/Updates Retail $69 Wholesale $63 (quarterly maintenance fee due in advance) Reseller Agreement Initials ______ _______ 8 PROCEDURE FOR REGISTERING PROSPECTIVE CLIENTS, MEMBER PROVIDERS/ MERCHANTS/MERCHANT MEMBER PROVIDERS This Addendum is attached hereto and made a part hereof that certain Reseller or Master Reseller Agreement between the parties: MEDIANET GROUP (MNG) HAS DEVELOPED A SET OF CRITERIA DESIGNED TO AVOID ANY POTENTIAL PROSPECT REGISTRATION DISPUTES AND TO ASSURE OUR RESELLERS FULL COMMISSION ON SALES MADE BY THEM. TO INSURE THIS GOAL, WE HAVE CREATED CRITERIA THAT MUST BE FOLLOWED FOR REGISTRATION OF THE COMPANIES (PROSPECTS) INTRODUCED TO THE BSP REWARDS PROGRAM.\"}, {\"id\": \"1\", \"title\": \"Resellers must send us an E-mail with the company name, contact and title that you wish to register with the Company\", \"level\": 1, \"text\": \"1. Resellers must send us an E-mail with the company name, contact and title that you wish to register with the Company. Said contact must have the authority to make the decision relative to the Brand-A-Port and/or BSP programs.\"}, {\"id\": \"2\", \"title\": \"MNG will send an e-mail to the Reseller approving or disapproving the registration of the prospective client dependent\", \"level\": 1, \"text\": \"2. MNG will send an e-mail to the Reseller approving or disapproving the registration of the prospective client dependent upon whether or not there has been prior contact by the company, registration of the prospect by another Reseller or other factors as determined by the MNG.\"}, {\"id\": \"3\", \"title\": \"Upon approval by MNG, the Reseller will have 30 days to initiate and complete a proposal to said prospect\", \"level\": 1, \"text\": \"3. Upon approval by MNG, the Reseller will have 30 days to initiate and complete a proposal to said prospect. The proposal must be approved by MNG and receipt confirmed by the prospect.\"}, {\"id\": \"4\", \"title\": \"The Reseller will then have 5 months to bring the registered prospect to contract\", \"level\": 1, \"text\": \"4. The Reseller will then have 5 months to bring the registered prospect to contract. If a contract is not consummated in the allotted time-frame, the prospect shall then revert back to MNG. Reseller may then re-register the prospect subject to the above criteria and/or other criteria in effect at the time. The above criteria points are firm unless a special situation is approved by MNG in writing. WE BELIEVE THAT EACH REPRESENTATIVE AND RESELLER WILL SEE THE BENEFITS OF THIS PROGRAM AND THE PROTECTION IT AFFORDS THEM. APPROVED AND ACCEPTED BY THE SIGNATORY PARTIES BELOW THIS __ OF ________, 200__. MediaNet Group Technologies, Inc. ________________________ Accepted by: __________________________ Accepted by:__________________ Chief Executive Officer Title: Reseller Agreement Initials ______ _______ 9\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of OMINTO,INC_03_29_2004-EX-10-RESELLER AGREEMENT\", \"nodes\": [{\"id\": \"EXHIBIT 10.25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER AGREEMENT\", \"level\": 2, \"text\": \"EXHIBIT 10.25 RESELLER AGREEMENT THIS AGREEMENT (the \\\"AGREEMENT\\\") entered into as of the 19 day of March, 2004 (the \\\"EFFECTIVE DATE\\\") provides the terms and conditions under which MediaNet Group Technologies, Inc., a Nevada corporation having an address at 5100 W. Copans Road Suite 710 Margate, FL 33063 USA (\\\"MEDIANET GROUP TECHNOLOGIES\\\"), authorizes International Direct Response, Inc., a Pennsylvania Corporation, having an address at 1125 Lancaster Avenue, Berwyn, PA 19312(\\\"RESELLER\\\") to be its true and lawful representative and agent for the purpose of reselling licenses of the MediaNet Group Technologies Portals (\\\"PORTALS\\\") and other MediaNet Group Technologies products and services in accordance with the terms and conditions contained in this Agreement. This Agreement, together with the other agreements and schedules referenced in it, contains the complete terms and conditions between the parties. MEDIANET GROUP TECHNOLOGIES AND RESELLER AGREE AS FOLLOWS:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSE\", \"level\": 1, \"text\": \"1. LICENSE Reseller is hereunder licensed to market MediaNet Group Technologies' Brand-A-Port portals (\\\"PORTALS\\\") and to resell MediaNet Group Technologies products and services for compensation in accordance with the annexed \\\"RESELLING SCHEDULE.\\\" Under the terms and conditions as outlined in this Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLING\", \"level\": 1, \"text\": \"2. RESELLING The Reseller intends to market the Portals to companies and various businesses and individuals (\\\"BUYERS\\\") who may include corporations, small businesses, religious organizations, network marketing, franchise, business opportunities, chains, charities, organizations and other companies that would have a use for individual and multiple portals. The purpose of this Agreement is to define the scope of compensation for the marketing of Portals to these potential customers. During the Term of this Agreement, Reseller shall have the right to market Brand-A-Port Portals, both through the existing Brand-A-Port Portal under the License and independently to Buyers for resale, subject to approval by MediaNet Group Technologies.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPENSATION\", \"level\": 1, \"text\": \"3. COMPENSATION MediaNet Group Technologies shall pay Reseller a fee in accordance with the annexed Fee Schedule. MediaNet Group Technologies will remit payment as directed by Reseller in the time frames noted on the Compensation Schedule attached hereto.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PUBLICITY AND ADVERTISING\", \"level\": 1, \"text\": \"4. PUBLICITY AND ADVERTISING Subject to Section 7, Reseller and MediaNet Group Technologies agree that broad publicity with respect to the relationship developed by this Agreement, and the advantages of such relationship, will be permitted and actively encouraged and supported by both parties. This publicity initiative will include, but is not limited to, a press releases issued by Reseller and MediaNet Group Technologies, publicizing the strategic alliance between the parties, on site promotion and email campaigns. In this regard, Reseller and MediaNet Group Technologies shall agree on the form, content of the press release prior to its release. MediaNet Group Technologies must approve any advertising prior to issuance and placement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROPRIETARY RIGHTS\", \"level\": 1, \"text\": \"5. PROPRIETARY RIGHTS\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OWNERSHIP\", \"level\": 2, \"text\": \"5.1 OWNERSHIP. RESELLER understands and agrees that MediaNet Group Technologies is the exclusive holder of and shall retain, all right, title and interest in and to the Portal, Content and Engine and the All Pages, including without limitation all intellectual Property therein site (EXCLUDING PROPRIETARY PAGES PROVIDED BY RESELLER OR BUYERS). Reseller Agreement Initials ______ _______ 1\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY\", \"level\": 2, \"text\": \"5.2 INTELLECTUAL PROPERTY. Nothing herein shall grant a party any right, title or interest in the other party's Intellectual Property, except as explicitly set forth herein. At no time during or after the Term of this Agreement shall a party challenge or assist others to challenge the other party's Intellectual Property or the registration thereof or attempt to register any trademarks, marks or trade names confusingly similar to those or the other party.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY WARRANTY\", \"level\": 2, \"text\": \"5.3 INTELLECTUAL PROPERTY WARRANTY. The MediaNet Group Technologies BrandAPort Service and the operation of the site(s) and co-branded site(s) as currently operated by MediaNet Group Technologies, Inc. is designed to provide a link taking the end-user to it's originating website. Other than claims arising out of the use of the BrandAPort services, MediaNet Group Technologies shall not be responsible for unauthorized use of the Co-branded sites by Reseller, users of Reseller's or Buyers' Sites.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"6. CONFIDENTIALITY\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY INFORMATION\", \"level\": 2, \"text\": \"6.1 CONFIDENTIALITY INFORMATION. Each party (the \\\"RECEIVING PARTY\\\") acknowledges that by reason of its relationship to the other party (the \\\"DISCLOSING PARTY\\\") hereunder, the Receiving Party will have access to certain information and materials, including the terms of this Agreement, concerning the Disclosing Party's business, plans, technology, products and services that are confidential and of substantial value to the Disclosing Party, which value would be impaired if such information were disclosed to third parties (\\\"CONFIDENTIAL INFORMATION\\\"). The Receiving Party agrees that it shall not use in any way for its own account or the account of any third party, nor disclose to any third party, any such Confidential Information revealed to it by the Disclosing Party. The Receiving Party shall take every reasonable precaution to protect the confidentiality of Confidential Information. Upon request by the Receiving Party, the Disclosing Party shall advise whether or not it considers any particular information to be Confidential Information. The Receiving Party shall not publish any technical description of the Disclosing Party's Confidential Information beyond any descriptions published by the Disclosing party. In the event of expiration or termination of this Agreement, there shall be no use or disclosure by the Receiving Party of any Confidential Information of the Disclosing Party, and the Receiving Party shall not develop any software, devices, components or assemblies utilizing the Disclosing Party's Intellectual Property. Both parties agree that the terms and conditions of this Agreement are confidential and shall not be disclosed to any third party, unless disclosure is compelled by final, non-appealable order of a court of competent jurisdiction.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIONS\", \"level\": 2, \"text\": \"6.2 EXCLUSIONS. Confidential Information does not include information permitted to be disclosed under section 5 and any information that the Receiving Party can demonstrate by written records: (a) was known to the Receiving Party prior to its disclosure hereunder by the disclosing party; (b) is independently developed by the Receiving Party; (c) is or becomes publicly known through no wrongful act of the Receiving Party; (d) has been rightfully received from a third party whom the Receiving party has reasonable grounds to believe is authorized to make such disclosure without restriction; (e) has been approved for public release by the Disclosing Party's prior written authorization, or (f) must be produced or disclosed pursuant to applicable law, regulation or court order, provided that the receiving party provides prompt advance notice thereof to enable the disclosing party to seek a protective order or otherwise prevent such disclosure. In addition, Reseller and MediaNet Group Technologies may disclose the existence and terms of this Agreement in connection with a potential acquisition of substantially the entire business of the other party, or a private or public offering of securities of either party. Reseller Agreement Initials ______ _______ &sbsp; 2\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"7. LIMITATION OF LIABILITY NEITHER RESELLER NOR MEDIANET GROUP TECHNOLOGIES MAKES ANY WARRANTY WHATSOEVER WITH REGARD TO THE FEATURES, FUNCTIONS, PERFORMANCE, QUALITY OR OTHER CHARACTERISTICS OF THE SERVICE EACH COMPANY PROVIDES. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO EACH OTHER OR ANY OTHER ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL OR INDIRECT DAMAGES, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY, AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. RESELLER SHALL NOT BE LIABLE TO MEDIANET GROUP TECHNOLOGIES OR ANY OTHER PARTY FOR ANY DAMAGES ARISING FROM THIRD PARTY UNAUTHORIZED ACCESS OR USE OF THE MEDIANET GROUP TECHNOLOGIES SERVICE OR ANY IMAGES OBTAINED BY USING THE MEDIANET GROUP TECHNOLOGIES SERVICE. MEDIANET GROUP TECHNOLOGIES SHALL NOT BE LIABLE TO RESELLER OR ANY OTHER PARTY FOR ANY DAMAGES ARISING FROM THIRD PARTY UNAUTHORIZED ACCESS OR USE OF THE MEDIANET GROUP TECHNOLOGIES SERVICE OR ANY IMAGES OBTAINED BY USING THE MEDIANET GROUP TECHNOLOGIES SERVICES.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISCLAIMERS\", \"level\": 1, \"text\": \"8. DISCLAIMERS MEDIANET GROUP TECHNOLOGIES DISCLAIMERS. MEDIANET GROUP TECHNOLOGIES MAKES NO OTHER WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, REGARDING THE MEDIANET GROUP TECHNOLOGIES, PICTUREJUDGE OR BRANDAPORT SERVICE, AND MEDIANET GROUP TECHNOLOGIES SPECIFICALLY DISCLAIMS ANY IMPLIED WARRANTIES OF NON-INFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE. MEDIANET GROUP TECHNOLOGIES DOES NOT WARRANT THAT THE OPERATION OF THE MEDIANET GROUP TECHNOLOGIES SERVICE WILL BE UNINTERRUPTED OR ERROR-FREE. FURTHERMORE, MEDIANET GROUP TECHNOLOGIES DOES NOT MAKE ANY REPRESENTATIONS REGARDING THE USE OF THE RESULTS OF THE USE OF THE MEDIANET GROUP TECHNOLOGIES SITE IN TERMS OF THEIR CORRECTNESS, ACCURACY, RELIABILITY OR OTHERWISE.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMS AND TERMINATION\", \"level\": 1, \"text\": \"9. TERMS AND TERMINATION\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 2, \"text\": \"9.1 TERM. The term of this Agreement shall commence on the Effective Date and continue for a period of 1 year after the Effective Date, unless earlier terminated as set forth herein (the \\\"TERM\\\"). This Agreement shall renew for successive 1-year periods, after the initial 1 Year Term, if agreed by both parties in writing within 30 days of license expiration. Either party may terminate the Agreement on 60-days written notice during a renewed term. However, in no event shall termination of this Agreement by MediaNet Group Technologies relieve it of the obligation to remit payment to Reseller for sales or Portals, Hosting Services or other products and services to or through Buyers contracted by Reseller prior to such termination. The obligation to remit payment cease 30 days after termination of this Agreement.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION FOR BREACH OR INSOLVENCY\", \"level\": 2, \"text\": \"9.2 TERMINATION FOR BREACH OR INSOLVENCY. A party shall have the right to terminate this Agreement on written notice if (a) the other party ceases to do business in the ordinary course or is insolvent (i.e., unable to pay its debts in the ordinary course as they come due), or is declared bankrupt, or is the subject of any liquidation or insolvency proceeding which is not dismissed within 90 days, or makes any assignment for the benefit of creditors, or (b) the other party breaches any material term of this Agreement, including timely payments, and fails to cure such breach within 30 days after written notice thereof (collectively referred to here in as \\\"TERMINATING EVENTS\\\"). In the event of a Terminating Event, involving Reseller, other than for an event involving fraud or dishonesty by Reseller, MediaNet Group Technologies shall be entitled to offset payments due under this Agreement against its costs incurred as a result of the Terminating Event, but shall remain obligated to remit all payments due under this agreement as a direct result of the activities of Reseller prior to the effective date of termination. Reseller Agreement Initials ______ _______ &sbsp; 3\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECT OF TERMINATION\", \"level\": 1, \"text\": \"10. EFFECT OF TERMINATION Upon the expiration or termination of this Agreement:\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party shall, within 30 days of such expiration or termination return to other party or destroy all Confidentia\", \"level\": 2, \"text\": \"10.1 Each party shall, within 30 days of such expiration or termination return to other party or destroy all Confidential Information and all other material received from such other party.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All rights granted by Reseller hereunder to MediaNet Group Technologies shall terminate\", \"level\": 2, \"text\": \"10.2 All rights granted by Reseller hereunder to MediaNet Group Technologies shall terminate. All rights granted by MediaNet Group Technologies hereunder to Reseller shall terminate, subject to the continuing obligation of MediaNet Group Technologies to remit payment pursuant to the provisions of Section 8.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sections 5, 6, 7, 9\", \"level\": 2, \"text\": \"10.3 Sections 5, 6, 7, 9.2 10, 11, 12 and 13 shall survive the expiration or termination of this Agreement for any reason.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REMEDIES\", \"level\": 1, \"text\": \"11. REMEDIES\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 2, \"text\": \"11.1 INDEMNIFICATION. Reseller and MediaNet Group Technologies shall indemnify and hold harmless each other, and their respective directors, officers, employees, and agents, from and against all claims, losses, damages and expenses (including reasonable attorney's fees) resulting from the breach of any agreement, representation or warranty set forth herein; provided the indemnified party provides the indemnifying party with (i) prompt written notice of such claim or action, (ii) sole control and authority over the defense or settlement of such claim or action and (iii) proper and full information and reasonable assistance to defend and/or settle any such claim or action.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INJUNCTIVE RELIEF\", \"level\": 2, \"text\": \"11.2 INJUNCTIVE RELIEF. The parties acknowledge that the breach or threatened breach of this Agreement by Reseller would cause irreparable harm to MediaNet Group Technologies, the extent of which would be difficult to ascertain. Accordingly, each party agrees that, in addition to any other remedies to which MediaNet Group Technologies may be legally entitled, MediaNet Group Technologies may seek immediate injunctive relief in the event of a breach or threatened breach of such sections by the Reseller or any of Resellers employees or subcontractors.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER PORTAL\", \"level\": 1, \"text\": \"12. RESELLER PORTAL If applicable, MediaNet Group Technologies shall produce a Branded Portal for Licensee under terms as outlined in a Portal Agreement attached hereto.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"13. MISCELLANEOUS\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"13.1 ASSIGNMENT. This Agreement will be binding upon and inure to the benefits of the parties hereto and their permitted successors and assigns. Reseller may nat assign or otherwise transfer this Agreement without MediaNet Group Technologies's prior written consent except to a successor.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WAIVER AND AMENDMENT\", \"level\": 2, \"text\": \"13.2 WAIVER AND AMENDMENT. No modifications, amendment or waiver of any provision of this Agreement shall be effective unless in writing and signed by the party to be charged. No failure or delay by either party in exercising any right, power, or remedy under this Agreement shall operate as a waiver of any such right, power or remedy.\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW\", \"level\": 2, \"text\": \"13.3 GOVERNING LAW. The laws of the State of Florida shall govern this Agreement, without reference to conflicts of law provisions.\"}}, {\"id\": \"13.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES, ETC\", \"level\": 2, \"text\": \"13.4 NOTICES, ETC. Any notice required or permitted by this Agreement shall be deemed given if delivered by registered mail, postage prepaid, addressed to the other party at the address shown at the beginning of this Agreement or at such other address for which such party gives notice hereunder. Delivery shall be deemed effective 3 days after deposit with postal Reseller Agreement Initials ______ _______ 4 authorities. Email, facsimile or other form of transmission pursuant to which MediaNet Group Technologies receives actual notice of the accounts into which the funds are to be wired may give notices of the accounts into which payment is to be wired shall be effective and MediaNet Group Technologies shall be entitled to rely upon them as if they were sent in accordance with the notice provisions of this paragraph.\"}}, {\"id\": \"13.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEPENDENT CONTRACTORS\", \"level\": 2, \"text\": \"13.5 INDEPENDENT CONTRACTORS. The parties are independent contractors with respect to each other. Each party is not and shall not be deemed to be an employees, agent, joint venture Reseller or legal representative of the other for any purpose and shall not have any right, power, or authority to create any obligation or responsibility on behalf of the other.\"}}, {\"id\": \"13.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"13.6 SEVERABILITY. If any provision of this Agreement shall be held by a court of competent jurisdiction to be contrary to law, such provision shall be changed and interpreted so as to best accomplish the objectives of the original provision to the fullest extent allowed by law and the remaining provisions of this Agreement shall remain in full force and effect.\"}}, {\"id\": \"13.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLETE UNDERSTANDING\", \"level\": 2, \"text\": \"13.7 COMPLETE UNDERSTANDING. This Agreement constitutes the final, complete and exclusive agreement between the parties with respect to the subject matter hereof, and supersedes any prior or contemporaneous agreement, either written or oral.\"}}, {\"id\": \"13.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEUR\", \"level\": 2, \"text\": \"13.8 FORCE MAJEUR. Except with respect to obligations to make payments hereunder, neither party shall be deemed in default hereunder, nor shall it hold the other party responsible for, any cessation, interruption or delay in the performance of its obligations hereunder due to causes beyond its reasonable control including, but not limited to: earthquake, flood, fire, storm or other natural disaster, act of God, labor controversy or threat thereof, civil disturbance or commotion, disruption of the public markets, war or armed conflict or the inability to obtain sufficient material, supplies, labor, transportation, power or other essential commodity or service required in the conduct of its business, including internet access, or any change in or the adoption of any law, ordinance, rule, regulation, order, judgment or decree.\"}}, {\"id\": \"13.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONTENT\", \"level\": 2, \"text\": \"13.9 CONTENT. It is agreed that MediaNet Group Technologies shall have complete control of content on the Portals with the exception of the customized pages and links on contracted portals, and these pages and links are subject to MediaNet Group Technologies's approval.\"}}, {\"id\": \"13.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NO DISPARAGEMENT\", \"level\": 2, \"text\": \"13.10 NO DISPARAGEMENT. Each party agrees that, during the Term of this Agreement and for a period of five (5) years thereafter, neither will make written or oral comments regarding the other that are negative, disparaging, tend to bring the other into disrepute or call into question the business acumen, character, honesty or integrity of the other. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed effective as of the day and year last set forth below. MEDIANET GROUP TECHNOLOGIES, INC. LEGAL NAME: Michael Guyer /s/ Martin A.Berns /s/ Michael Guyer --------------------------------- ------------------------------------ Signature Signature By: Martin A. Berns By: Michael Guyer Title: Chief Executive Officer Title: VP & Director of Marketing Name of Master Reseller (if applicable):____________ Approved by:_______________ Reseller Agreement Initials ______ _______ 5 LICENSE RESELLING SCHEDULE Resellers are licensed to market the Brand-A-Port applications and receive commission on all product sales plus residual income on hosting/maintenance fees as outlined on the Compensation Schedule attached hereto. THE PLAN The MediaNet Group Technologies Reseller Plan is free to join. Under the plan, resellers market and promote MediaNet Group Technologies's software product range to their existing customer base and the general Internet community. By referring a customer to the MediaNet Group Technologies web site, the reseller receives a commission for customer's purchase of the MediaNet Group Technologies Brand-A-Port software. MARKETING AND PROMOTION Resellers are expected to actively market and promote MediaNet Group Technologies Software to their existing customer base and visitors to their web site. Promotion by newsletters and e-mail to customers is encouraged, but we do not encourage spam e-mail and hence specifically ask resellers not to promote MediaNet Group Technologies Software or Applications via unsolicited e-mail. RESELLER LINK Customers are identified as coming from a particular reseller by placing a link(s) on their web site, which contains a cookie (i.e.. small packet of code) which identifies the reseller. On acceptance into the program, MediaNet Group Technologies issues the reseller with the cookie and instructions on how to insert the cookie into their web site. WHAT PRODUCTS ARE AVAILABLE FOR RESALE? Products which can be resold, include: Brand-A-Port Gold (Generic Portal), Brand-A-Port Platinum Portal and Branded PictureJudge applications. MediaNet Group Technologies may offer additional products from time to time. COMMISSION MediaNet Group Technologies tracks the customer sales coming from the reseller and at the end of every calendar month issues a check for 20% commission to the reseller on product sales and 10% the total amount of hosting/maintenance sales made. Commissions are only paid each month if the amount owing exceeds $100 US. MediaNet Group Technologies reserves the right to change the level of commission with out notice. Commission is not paid on MediaNet Group Technologies's free-ware programs. (pricing and products subject to change without notice). CUSTOMER CONTACT Once a customer has come from the reseller to the MediaNet Group Technologies web site, MediaNet Group Technologies deals with the customer directly, issuing the software from the MediaNet Group Technologies server and billing the customer. MediaNet Group Technologies handles all technical support and refund issues. REFUNDS If a refund is issued to a customer who came from a reseller, the reseller's account is adjusted accordingly. TERMINATION The Reseller Agreement can be terminated at any time at the discretion of either party. Reseller Agreement Initials ______ _______ 6 COMPENSATION SCHEDULE This Compensation Schedule is attached hereto and made a part thereof that certain Reseller Agreement of even date: Reseller shall be entitled to receive compensation in the following manner: COMPENSATION: BSP REWARDS PROGRAM: MediaNet shall, upon collection, remit to Member Provider _1_% of the net Rewards earned by Members through and provided directly by it, and _1_% of the net Member Rewards received and collected that is earned through Merchants, Companies, Organizations, Groups and individuals that have been contracted through Member Provider. BRAND-A-PORT OR BSP PORTAL SALES: MediaNet shall remit to Member Provider 20% of the price of each Portal sold directly by it. BSP MONTHLY HOSTING FEES: In addition, MediaNet shall remit to Member Provider an amount equal to 10% of the hosting fees paid by Buyers who purchase portals or host websites with MediaNet as a direct result of the activities of Member Provider, whether those activities are sold through the portal or independent of it. PAYMENT OF COMPENSATION (SUBJECT TO RECEIPT OF GOOD, VALID FUNDS) PORTAL SALES: MediaNet shall remit all sums due to Member Provider within 30 days of receipt of cleared funds. MONTHLY HOSTING FEES: In addition, MediaNet shall remit hosting fees to Member Provider in monthly installments on or before the 15th business day of each month. All sums received by MediaNet through the last business day of the preceding month shall be included in the calculation of the amount to be remitted. BSP REWARDS MEMBER PURCHASES VOLUME: Amounts due for purchases of products or services shall be calculated as of funds received by the last day of each month and remitted on or before the 15th day of the following month. RECORDS MediaNet shall maintain books and records and shall provide for online confirmation of sales and payments. MediaNet shall permit Member Provider or its designees reasonable access during normal business hours and, upon request, to verify funds and payments due pursuant to this Agreement. IN WITNESS WHEREOF, the parties have caused this Agreement to be executed effective as of the day and year last set forth below. Reseller Agreement Initials ______ _______ 7 RESELLER DISTRIBUTOR PRICING STRUCTURE & DETAILS GOLD PORTAL Includes the following available options: o Complete Basic Portal o Web-based Admin Panel to turn on and turn off individual applications and features o Branded Header o Branded Frames o Reseller Program o Email o MediaNet Group Technologies Photo Sharing o MediaNet Group Technologies Travel Agency Retail $495 License Wholesale $395 Monthly Hosting/Maintenance/Updates Retail $39 Wholesale $35 (quarterly maintenance fee due in advance) PLATINUM PORTAL Includes at your option: o Full Featured Customizable Portal with web based administration panel o Branded Header o Branded Photo Sharing o Branded Travel Agency o Branded Frames o Email o Branded Picture Judge o Reseller program Retail $1295 License Wholesale $1035 Monthly Hosting/Maintenance/Updates Retail $99 Wholesale $89 (quarterly maintenance fee due in advance) BRANDED PICTUREJUDGE(SM) INTERACTIVE PHOTO RATING GAME Includes at your option: o Branded PictureJudge photo rating game o Customized phot catagories o Reseller Program Retail $795 License Wholesale $635 Monthly Hosting/Maintenance/Updates Retail $69 Wholesale $63 (quarterly maintenance fee due in advance) Reseller Agreement Initials ______ _______ 8 PROCEDURE FOR REGISTERING PROSPECTIVE CLIENTS, MEMBER PROVIDERS/ MERCHANTS/MERCHANT MEMBER PROVIDERS This Addendum is attached hereto and made a part hereof that certain Reseller or Master Reseller Agreement between the parties: MEDIANET GROUP (MNG) HAS DEVELOPED A SET OF CRITERIA DESIGNED TO AVOID ANY POTENTIAL PROSPECT REGISTRATION DISPUTES AND TO ASSURE OUR RESELLERS FULL COMMISSION ON SALES MADE BY THEM. TO INSURE THIS GOAL, WE HAVE CREATED CRITERIA THAT MUST BE FOLLOWED FOR REGISTRATION OF THE COMPANIES (PROSPECTS) INTRODUCED TO THE BSP REWARDS PROGRAM.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resellers must send us an E-mail with the company name, contact and title that you wish to register with the Company\", \"level\": 1, \"text\": \"1. Resellers must send us an E-mail with the company name, contact and title that you wish to register with the Company. Said contact must have the authority to make the decision relative to the Brand-A-Port and/or BSP programs.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MNG will send an e-mail to the Reseller approving or disapproving the registration of the prospective client dependent\", \"level\": 1, \"text\": \"2. MNG will send an e-mail to the Reseller approving or disapproving the registration of the prospective client dependent upon whether or not there has been prior contact by the company, registration of the prospect by another Reseller or other factors as determined by the MNG.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon approval by MNG, the Reseller will have 30 days to initiate and complete a proposal to said prospect\", \"level\": 1, \"text\": \"3. Upon approval by MNG, the Reseller will have 30 days to initiate and complete a proposal to said prospect. The proposal must be approved by MNG and receipt confirmed by the prospect.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Reseller will then have 5 months to bring the registered prospect to contract\", \"level\": 1, \"text\": \"4. The Reseller will then have 5 months to bring the registered prospect to contract. If a contract is not consummated in the allotted time-frame, the prospect shall then revert back to MNG. Reseller may then re-register the prospect subject to the above criteria and/or other criteria in effect at the time. The above criteria points are firm unless a special situation is approved by MNG in writing. WE BELIEVE THAT EACH REPRESENTATIVE AND RESELLER WILL SEE THE BENEFITS OF THIS PROGRAM AND THE PROTECTION IT AFFORDS THEM. APPROVED AND ACCEPTED BY THE SIGNATORY PARTIES BELOW THIS __ OF ________, 200__. MediaNet Group Technologies, Inc. ________________________ Accepted by: __________________________ Accepted by:__________________ Chief Executive Officer Title: Reseller Agreement Initials ______ _______ 9\"}}, {\"id\": \"party:MediaNet Group Technologies, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"MediaNet Group Technologies, Inc.\", \"role\": \"MEDIANET GROUP TECHNOLOGIES\", \"address\": \"5100 W. Copans Road Suite 710 Margate, FL 33063 USA\"}}, {\"id\": \"party:International Direct Response, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"International Direct Response, Inc.\", \"role\": \"RESELLER\", \"address\": \"1125 Lancaster Avenue, Berwyn, PA 19312\"}}, {\"id\": \"term:AGREEMENT\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AGREEMENT\", \"text\": \"THIS AGREEMENT\", \"definition_clause\": \"EXHIBIT 10.25\"}}, {\"id\": \"term:EFFECTIVE DATE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EFFECTIVE DATE\", \"text\": \"the 19 day of March, 2004\", \"definition_clause\": \"EXHIBIT 10.25\"}}, {\"id\": \"term:PORTALS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PORTALS\", \"text\": \"the MediaNet Group Technologies Portals\", \"definition_clause\": \"EXHIBIT 10.25\"}}, {\"id\": \"term:BUYERS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"BUYERS\", \"text\": \"companies and various businesses and individuals\", \"definition_clause\": \"2\"}}, {\"id\": \"term:RECEIVING PARTY\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"RECEIVING PARTY\", \"text\": \"Each party\", \"definition_clause\": \"6.1\"}}, {\"id\": \"term:DISCLOSING PARTY\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"DISCLOSING PARTY\", \"text\": \"the other party\", \"definition_clause\": \"6.1\"}}, {\"id\": \"term:CONFIDENTIAL INFORMATION\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CONFIDENTIAL INFORMATION\", \"text\": \"certain information and materials, including the terms of this Agreement, concerning the Disclosing Party's business, plans, technology, products and services that are confidential and of substantial value to the Disclosing Party, which value would be impaired if such information were disclosed to third parties\", \"definition_clause\": \"6.1\"}}, {\"id\": \"term:TERM\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TERM\", \"text\": \"The term of this Agreement shall commence on the Effective Date and continue for a period of 1 year after the Effective Date, unless earlier terminated as set forth herein\", \"definition_clause\": \"9.1\"}}, {\"id\": \"term:TERMINATING EVENTS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TERMINATING EVENTS\", \"text\": \"(a) the other party ceases to do business in the ordinary course or is insolvent (i.e., unable to pay its debts in the ordinary course as they come due), or is declared bankrupt, or is the subject of any liquidation or insolvency proceeding which is not dismissed within 90 days, or makes any assignment for the benefit of creditors, or (b) the other party breaches any material term of this Agreement, including timely payments, and fails to cure such breach within 30 days after written notice thereof\", \"definition_clause\": \"9.2\"}}, {\"id\": \"term:MNG\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MNG\", \"text\": \"MEDIANET GROUP\", \"definition_clause\": \"13.10\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:60-days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60-days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"90 days\"}}, {\"id\": \"value:3 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 days\"}}, {\"id\": \"value:20%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20%\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"10%\"}}, {\"id\": \"value:$100\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$100\"}}, {\"id\": \"value:$495\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$495\"}}, {\"id\": \"value:$395\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$395\"}}, {\"id\": \"value:$39\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$39\"}}, {\"id\": \"value:$35\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$35\"}}, {\"id\": \"value:$1295\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1295\"}}, {\"id\": \"value:$1035\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1035\"}}, {\"id\": \"value:$99\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$99\"}}, {\"id\": \"value:$89\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$89\"}}, {\"id\": \"value:$795\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$795\"}}, {\"id\": \"value:$635\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$635\"}}, {\"id\": \"value:$69\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$69\"}}, {\"id\": \"value:$63\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$63\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of OPTIMIZEDTRANSPORTATIONMANAGEMENT,INC_07_26_2000-EX-6.6-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of OPTIMIZEDTRANSPORTATIONMANAGEMENT,INC_07_26_2000-EX-6.6-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 1, \"text\": \"DISTRIBUTOR AGREEMENT\"}, {\"id\": \"1\", \"title\": \"CERTIFICATION AND IDENTIFICATION\", \"level\": 1, \"text\": \"1. CERTIFICATION AND IDENTIFICATION: COMWARE TECHNICAL SERVICES OF 17922 SKY PARK CIRCLE, SUITE E, IRVINE, CALIFORNIA 92614-6414 (COMWARE) certifies that the Products furnished under this agreement by INTERNATIONAL TEST SYSTEMS, INC. OF 4703 SHAVANO OAK, SUITE 102, SAN ANTONIO, TEXAS 78249 (ITS) will be incorporated by COMWARE as a part of COMWARE'S systems which COMWARE sells or leases to unaffiliated third parties in the regular course of COMWARE'S business and that COMWARE'S own contribution to these systems reflect a verifiable value added. COMWARE also represents that it is an experienced user of computer equipment and software sufficiently like the Products, as defined below, and that it needs only minor support in the incorporation of the Products into its lines of business.\"}, {\"id\": \"2\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS: INITIAL DISTRIBUTION PERIOD: April 15, 2000 through October 15, 2000 (6 Months from the Effective Date) PRODUCTS: The CircuiTest 2000S In-Circuit Test System The CircuiTest 2100 Scanner Expansion EXCLUSIVE TERRITORIES: The 48 Contiguous United States EFFECTIVE DATE: The earlier of the date Comware orders and pays for a minimum of $22,710 worth of Products, in any combination, or April 15, 2000.\"}, {\"id\": \"3\", \"title\": \"EXCLUSIVE RIGHTS\", \"level\": 1, \"text\": \"3. EXCLUSIVE RIGHTS: Upon the effective date of this agreement COMWARE shall have the exclusive right to purchase, at the DISCOUNTS described below, and resell Products to potential customers during the Initial Distribution Period, based on the following terms and conditions: (a) COMWARE must purchase no less than $22,710.00 worth of Products, in any combination, by April 15, 2000. This initial order shall be evidenced by valid purchase order from COMWARE to be received by ITS no later than 5:00PM April 1, 2000, with payment to be received by ITS no later than April 15, 2000. In the event either of these dates are not met, this Agreement will automatically and immediately terminate and neither of the parties hereto will have any further obligations, one to the other. (b) Future Purchase Orders and delivery will approximate the 15 day delivery schedule (but not the dates), although payment will be made by COMWARE to ITS no later than thirty (30) days after receipt of invoice from ITS. (c) Provided COMWARE purchases the initial products as in (a) above, COMWARE shall have the right to purchase additional Products up to a total of $45,420.00 at the following discounts: 1 INITIAL DISCOUNTS: PRODUCT IDENTIFICATION SUGGESTED RETAIL PRICE DISCOUNT PRICE TO COMWARE ------------------------------------------------------------------------------------------------- CircuiTest 2000S $5,995.00 45% $3,297.25 CircuiTest 2100 Scanner $2,995.00 56% $1,317.80 (INTERNATIONAL TEST SYSTEMS RESERVES THE RIGHT TO CHANGE THE RETAIL PRICE AT ANY TIME, WITH NOTICE TO COMWARE.) (d) In the event COMWARE purchases products in excess of $45,420.00 during the Initial Distribution Period, COMWARE shall have the right to purchase additional Products at the following discounts: SUBSEQUENT DISCOUNTS: PRODUCT IDENTIFICATION SUGGESTED RETAIL PRICE DISCOUNT PRICE TO COMWARE ------------------------------------------------------------------------------------------------- CircuiTest 2000S $5,995.00 50% $2,997.50 CircuiTest 2100 Scanner $2,995.00 60% $1,198.00 (INTERNATIONAL TEST SYSTEMS RESERVES THE RIGHT TO CHANGE THE RETAIL PRICE AT ANY TIME, WITH NOTICE TO COMWARE.)\"}, {\"id\": \"4\", \"title\": \"RENEWAL PERIOD\", \"level\": 1, \"text\": \"4. RENEWAL PERIOD: Provided that COMWARE purchases a minimum of $45,420.00 worth of Products, in any combination, during the Initial Distribution Period, this Agreement will automatically renew for an additional 6 months (the Renewal Period). In the event COMWARE purchases an amount less than $45,420.00, than this Agreement will automatically terminate.\"}, {\"id\": \"5\", \"title\": \"MINIMUM ORDERS TO MAINTAIN AGREEMENT\", \"level\": 1, \"text\": \"5. MINIMUM ORDERS TO MAINTAIN AGREEMENT: COMWARE must purchase order a minimum of $4,200 worth of Products per month during the Renewal Period TO maintain the terms and conditions of this Agreement. In the event COMWARE does not meet these minimum purchase requirements, this Agreement will automatically and immediately terminate and neither of the parties hereto will have any further obligations, one to the other.\"}, {\"id\": \"6\", \"title\": \"OBLIGATIONS OF COMWARE\", \"level\": 1, \"text\": \"6. OBLIGATIONS OF COMWARE: o Use best efforts to market and sell the Products to customers. o Provide marketing feedback to ITS. o Train customers on and demonstrate ITS products. o COMWARE reserves the right to develop and sell value-added services that support the sales of ITS systems. o COMWARE reserves the right to develop their own marketing materials, brochures, and advertisements for ITS' products at no cost to ITS. o Communicate with and respond to ITS AND ITS inquires. o Assist ITS in customer feedback. 2\"}, {\"id\": \"7\", \"title\": \"OBLIGATIONS OF ITS\", \"level\": 1, \"text\": \"7. OBLIGATIONS OF ITS: o ITS will deliver working systems no later than 30 days after a hard copy purchase order is received from COMWARE. o ITS will provide free technical support to customers who have purchased ITS systems for a period of 30 days. After the 30 day free technical support period, ITS reserves the right to charge a reasonable fee for additional support. o ITS will be solely responsible for the production of brochures describing the products, and will provide COMWARE with ample space for placement of business card/label and provide COMWARE with as many brochures as it may from time to time reasonably require, free of charge. o In event of cancellation of a purchase order, or re-scheduling of any item on a purchase order beyond the discount period, COMWARE may be liable for bill back or adjustment of discounts based upon actual quantities of items delivered within the discount period. o COMWARE will not be penalized for delays in delivery caused by ITS, or any agent of ITS. o ITS will use its best efforts to provide a swift and complete resolution of any product-related problems, whether or not such problems are covered under the terms of the WARRANTY. In the event that one of COMWARE'S customers has a problem that is beyond the scope of COMWARE'S capabilities, ITS will address the problem without delay in the best interest of customer service.\"}, {\"id\": \"8\", \"title\": \"WARRANTY\", \"level\": 1, \"text\": \"8. WARRANTY: ITS Products are warranted free from defects of material or workmanship for 3 years after shipment from the manufacturer. Equipment purchased from ITS, which becomes defective within that time period will be repaired by ITS at its headquarters in San Antonio, Texas at no cost to COMWARE beyond cost of shipping the equipment to ITS. ITS will bear the cost of returning the item to COMWARE by UPS, REGULAR DELIVERY. priority shipping costs will be borne by COMWARE. This warranty is contingent upon proper use and installation of the Products and does not cover equipment which has been modified without ITS' consent or which has been subjected to unusual physical or electrical stress or on which the original identification marks have been removed or altered.\"}, {\"id\": \"9\", \"title\": \"DOCUMENTATION AND SUPPORT\", \"level\": 1, \"text\": \"9. DOCUMENTATION AND SUPPORT: ITS will supply with each of the Products ordered one set of user and technical documentation and one set of software in reproducible form. COMWARE may purchase additional copies of the documentation and software disks at then prevailing prices. COMWARE will receive minimal assistance and support from ITS consistent with the certifications in Section 1. 3 TERMINATION: except as specifically described elsewhere in this agreement, either ITS or COMWARE shall have the right to terminate this Agreement with 30 days written notice from the other party, for any reason whatsoever.\"}, {\"id\": \"11\", \"title\": \"GOVERNMENT SALES\", \"level\": 1, \"text\": \"11. GOVERNMENT SALES: COMWARE reserves the right to incorporate, as extension of this Agreement, additional terms and conditions as may be required for sale of Products to the US Government. These terms and conditions will be expressly quoted in attachments to subject purchase orders. ITS reserves the right to reject such purchase orders only under those conditions where these terms and conditions are in conflict with stated policy or corporate condition of ITS at the time the purchase orders are received.\"}, {\"id\": \"12\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"12. ENTIRE AGREEMENT: This Agreement supersedes all prior agreements and understandings between the parties relating to the subject matter and is intended by the parties as the complete and exclusive statement of the terms of the Agreement. No modification, addition to or waiver of the terms and conditions of this Agreement shall be effective unless in writing and signed by the party against whom the same is sought to be enforced.\"}, {\"id\": \"13\", \"title\": \"GOVERNED BY THE STATE OF TEXAS\", \"level\": 1, \"text\": \"13. GOVERNED BY THE STATE OF TEXAS: This Agreement shall be interpreted and governed by the laws of the State of Texas. Comware agrees to submit to the jurisdiction of the State of Texas, Bexar County, USA. INTERNATIONAL TEST SYSTEMS, INC. COMWARE TECHNICAL SERVICES BY BY ------------------------------- --------------------------------- PRINTED PRINTED -------------------------- ---------------------------- TITLE TITLE ---------------------------- ------------------------------ DATE DATE ----------------------------- ------------------------------- 4\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of OPTIMIZEDTRANSPORTATIONMANAGEMENT,INC_07_26_2000-EX-6.6-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 1, \"text\": \"DISTRIBUTOR AGREEMENT\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CERTIFICATION AND IDENTIFICATION\", \"level\": 1, \"text\": \"1. CERTIFICATION AND IDENTIFICATION: COMWARE TECHNICAL SERVICES OF 17922 SKY PARK CIRCLE, SUITE E, IRVINE, CALIFORNIA 92614-6414 (COMWARE) certifies that the Products furnished under this agreement by INTERNATIONAL TEST SYSTEMS, INC. OF 4703 SHAVANO OAK, SUITE 102, SAN ANTONIO, TEXAS 78249 (ITS) will be incorporated by COMWARE as a part of COMWARE'S systems which COMWARE sells or leases to unaffiliated third parties in the regular course of COMWARE'S business and that COMWARE'S own contribution to these systems reflect a verifiable value added. COMWARE also represents that it is an experienced user of computer equipment and software sufficiently like the Products, as defined below, and that it needs only minor support in the incorporation of the Products into its lines of business.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"2. DEFINITIONS: INITIAL DISTRIBUTION PERIOD: April 15, 2000 through October 15, 2000 (6 Months from the Effective Date) PRODUCTS: The CircuiTest 2000S In-Circuit Test System The CircuiTest 2100 Scanner Expansion EXCLUSIVE TERRITORIES: The 48 Contiguous United States EFFECTIVE DATE: The earlier of the date Comware orders and pays for a minimum of $22,710 worth of Products, in any combination, or April 15, 2000.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVE RIGHTS\", \"level\": 1, \"text\": \"3. EXCLUSIVE RIGHTS: Upon the effective date of this agreement COMWARE shall have the exclusive right to purchase, at the DISCOUNTS described below, and resell Products to potential customers during the Initial Distribution Period, based on the following terms and conditions: (a) COMWARE must purchase no less than $22,710.00 worth of Products, in any combination, by April 15, 2000. This initial order shall be evidenced by valid purchase order from COMWARE to be received by ITS no later than 5:00PM April 1, 2000, with payment to be received by ITS no later than April 15, 2000. In the event either of these dates are not met, this Agreement will automatically and immediately terminate and neither of the parties hereto will have any further obligations, one to the other. (b) Future Purchase Orders and delivery will approximate the 15 day delivery schedule (but not the dates), although payment will be made by COMWARE to ITS no later than thirty (30) days after receipt of invoice from ITS. (c) Provided COMWARE purchases the initial products as in (a) above, COMWARE shall have the right to purchase additional Products up to a total of $45,420.00 at the following discounts: 1 INITIAL DISCOUNTS: PRODUCT IDENTIFICATION SUGGESTED RETAIL PRICE DISCOUNT PRICE TO COMWARE ------------------------------------------------------------------------------------------------- CircuiTest 2000S $5,995.00 45% $3,297.25 CircuiTest 2100 Scanner $2,995.00 56% $1,317.80 (INTERNATIONAL TEST SYSTEMS RESERVES THE RIGHT TO CHANGE THE RETAIL PRICE AT ANY TIME, WITH NOTICE TO COMWARE.) (d) In the event COMWARE purchases products in excess of $45,420.00 during the Initial Distribution Period, COMWARE shall have the right to purchase additional Products at the following discounts: SUBSEQUENT DISCOUNTS: PRODUCT IDENTIFICATION SUGGESTED RETAIL PRICE DISCOUNT PRICE TO COMWARE ------------------------------------------------------------------------------------------------- CircuiTest 2000S $5,995.00 50% $2,997.50 CircuiTest 2100 Scanner $2,995.00 60% $1,198.00 (INTERNATIONAL TEST SYSTEMS RESERVES THE RIGHT TO CHANGE THE RETAIL PRICE AT ANY TIME, WITH NOTICE TO COMWARE.)\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RENEWAL PERIOD\", \"level\": 1, \"text\": \"4. RENEWAL PERIOD: Provided that COMWARE purchases a minimum of $45,420.00 worth of Products, in any combination, during the Initial Distribution Period, this Agreement will automatically renew for an additional 6 months (the Renewal Period). In the event COMWARE purchases an amount less than $45,420.00, than this Agreement will automatically terminate.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MINIMUM ORDERS TO MAINTAIN AGREEMENT\", \"level\": 1, \"text\": \"5. MINIMUM ORDERS TO MAINTAIN AGREEMENT: COMWARE must purchase order a minimum of $4,200 worth of Products per month during the Renewal Period TO maintain the terms and conditions of this Agreement. In the event COMWARE does not meet these minimum purchase requirements, this Agreement will automatically and immediately terminate and neither of the parties hereto will have any further obligations, one to the other.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OBLIGATIONS OF COMWARE\", \"level\": 1, \"text\": \"6. OBLIGATIONS OF COMWARE: o Use best efforts to market and sell the Products to customers. o Provide marketing feedback to ITS. o Train customers on and demonstrate ITS products. o COMWARE reserves the right to develop and sell value-added services that support the sales of ITS systems. o COMWARE reserves the right to develop their own marketing materials, brochures, and advertisements for ITS' products at no cost to ITS. o Communicate with and respond to ITS AND ITS inquires. o Assist ITS in customer feedback. 2\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OBLIGATIONS OF ITS\", \"level\": 1, \"text\": \"7. OBLIGATIONS OF ITS: o ITS will deliver working systems no later than 30 days after a hard copy purchase order is received from COMWARE. o ITS will provide free technical support to customers who have purchased ITS systems for a period of 30 days. After the 30 day free technical support period, ITS reserves the right to charge a reasonable fee for additional support. o ITS will be solely responsible for the production of brochures describing the products, and will provide COMWARE with ample space for placement of business card/label and provide COMWARE with as many brochures as it may from time to time reasonably require, free of charge. o In event of cancellation of a purchase order, or re-scheduling of any item on a purchase order beyond the discount period, COMWARE may be liable for bill back or adjustment of discounts based upon actual quantities of items delivered within the discount period. o COMWARE will not be penalized for delays in delivery caused by ITS, or any agent of ITS. o ITS will use its best efforts to provide a swift and complete resolution of any product-related problems, whether or not such problems are covered under the terms of the WARRANTY. In the event that one of COMWARE'S customers has a problem that is beyond the scope of COMWARE'S capabilities, ITS will address the problem without delay in the best interest of customer service.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY\", \"level\": 1, \"text\": \"8. WARRANTY: ITS Products are warranted free from defects of material or workmanship for 3 years after shipment from the manufacturer. Equipment purchased from ITS, which becomes defective within that time period will be repaired by ITS at its headquarters in San Antonio, Texas at no cost to COMWARE beyond cost of shipping the equipment to ITS. ITS will bear the cost of returning the item to COMWARE by UPS, REGULAR DELIVERY. priority shipping costs will be borne by COMWARE. This warranty is contingent upon proper use and installation of the Products and does not cover equipment which has been modified without ITS' consent or which has been subjected to unusual physical or electrical stress or on which the original identification marks have been removed or altered.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DOCUMENTATION AND SUPPORT\", \"level\": 1, \"text\": \"9. DOCUMENTATION AND SUPPORT: ITS will supply with each of the Products ordered one set of user and technical documentation and one set of software in reproducible form. COMWARE may purchase additional copies of the documentation and software disks at then prevailing prices. COMWARE will receive minimal assistance and support from ITS consistent with the certifications in Section 1. 3 TERMINATION: except as specifically described elsewhere in this agreement, either ITS or COMWARE shall have the right to terminate this Agreement with 30 days written notice from the other party, for any reason whatsoever.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNMENT SALES\", \"level\": 1, \"text\": \"11. GOVERNMENT SALES: COMWARE reserves the right to incorporate, as extension of this Agreement, additional terms and conditions as may be required for sale of Products to the US Government. These terms and conditions will be expressly quoted in attachments to subject purchase orders. ITS reserves the right to reject such purchase orders only under those conditions where these terms and conditions are in conflict with stated policy or corporate condition of ITS at the time the purchase orders are received.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 1, \"text\": \"12. ENTIRE AGREEMENT: This Agreement supersedes all prior agreements and understandings between the parties relating to the subject matter and is intended by the parties as the complete and exclusive statement of the terms of the Agreement. No modification, addition to or waiver of the terms and conditions of this Agreement shall be effective unless in writing and signed by the party against whom the same is sought to be enforced.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNED BY THE STATE OF TEXAS\", \"level\": 1, \"text\": \"13. GOVERNED BY THE STATE OF TEXAS: This Agreement shall be interpreted and governed by the laws of the State of Texas. Comware agrees to submit to the jurisdiction of the State of Texas, Bexar County, USA. INTERNATIONAL TEST SYSTEMS, INC. COMWARE TECHNICAL SERVICES BY BY ------------------------------- --------------------------------- PRINTED PRINTED -------------------------- ---------------------------- TITLE TITLE ---------------------------- ------------------------------ DATE DATE ----------------------------- ------------------------------- 4\"}}, {\"id\": \"party:COMWARE TECHNICAL SERVICES\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"COMWARE TECHNICAL SERVICES\", \"role\": null, \"address\": \"17922 SKY PARK CIRCLE, SUITE E, IRVINE, CALIFORNIA 92614-6414\"}}, {\"id\": \"party:INTERNATIONAL TEST SYSTEMS, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"INTERNATIONAL TEST SYSTEMS, INC.\", \"role\": null, \"address\": \"4703 SHAVANO OAK, SUITE 102, SAN ANTONIO, TEXAS 78249\"}}, {\"id\": \"term:INITIAL DISTRIBUTION PERIOD\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"INITIAL DISTRIBUTION PERIOD\", \"text\": \"April 15, 2000 through October 15, 2000 (6 Months from the Effective Date)\", \"definition_clause\": \"2\"}}, {\"id\": \"term:PRODUCTS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PRODUCTS\", \"text\": \"The CircuiTest 2000S In-Circuit Test System The CircuiTest 2100 Scanner Expansion\", \"definition_clause\": \"2\"}}, {\"id\": \"term:EXCLUSIVE TERRITORIES\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EXCLUSIVE TERRITORIES\", \"text\": \"The 48 Contiguous United States\", \"definition_clause\": \"2\"}}, {\"id\": \"term:EFFECTIVE DATE\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EFFECTIVE DATE\", \"text\": \"The earlier of the date Comware orders and pays for a minimum of $22,710 worth of Products, in any combination, or April 15, 2000.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Renewal Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Period\", \"text\": \"an additional 6 months (the Renewal Period)\", \"definition_clause\": \"4\"}}, {\"id\": \"value:$22,710\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$22,710\"}}, {\"id\": \"value:$22,710.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$22,710.00\"}}, {\"id\": \"value:15 day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"15 day\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:$45,420.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$45,420.00\"}}, {\"id\": \"value:$5,995.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5,995.00\"}}, {\"id\": \"value:45%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"45%\"}}, {\"id\": \"value:$3,297.25\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$3,297.25\"}}, {\"id\": \"value:$2,995.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2,995.00\"}}, {\"id\": \"value:56%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"56%\"}}, {\"id\": \"value:$1,317.80\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,317.80\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:$2,997.50\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2,997.50\"}}, {\"id\": \"value:60%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"60%\"}}, {\"id\": \"value:$1,198.00\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,198.00\"}}, {\"id\": \"value:$4,200\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$4,200\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of PROFOUNDMEDICALCORP_08_29_2019-EX-4.5-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of PROFOUNDMEDICALCORP_08_29_2019-EX-4.5-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 4.5\", \"title\": \"SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\", \"level\": 2, \"text\": \"Exhibit 4.5 SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. THIS AGREEMENT is made July 31, 2017 BETWEEN: PROFOUND MEDICAL INC., a company incorporated under the laws of the province of Ontario and having its registered address at 2400 Skymark, Unit 6, Mississauga, Ontario L4W 5K5, Canada (hereinafter referred to as \\\"Customer\\\") - and - PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., a company incorporated under the laws of the Netherlands with its principal place of business at Veenpluis 4-6 5684 PC Best, the Netherlands (hereinafter referred to as \\\"Philips\\\") Customer and Philips hereinafter also collectively referred to as the \\\"Parties\\\" and individually as a \\\"Party\\\". WHEREAS: A. Pursuant to the Asset and Share Purchase Agreement (the \\\"Purchase Agreement\\\") entered into on June 30, 2017 by Customer, Koninklijke Philips NV (\\\"Philips NV\\\") N.V. and Customer agreed to execute and deliver (or cause to be executed and delivered) certain ancillary agreements one of which is this Agreement; B. Prior to the consummation of the transactions contemplated by the Purchase Agreement, Philips manufactured the Product in-house and did not outsource the manufacturing to an independent facility, and as a result, Philips has intimate knowledge of the manufacturing process and requirements for the Product; C. Customer originally desired to take over responsibility for the manufacture of the Product immediately upon closing of the transactions contemplated by the Purchase Agreement; D. As Philips historically manufactured the Product in-house, to enable Customer to prepare for and realize the transition of the manufacturing of the Product to Customer's organization, Customer requires the assistance of Philips to continue manufacturing the Product until such time as the manufacturing process can be transitioned to Customer hereunder; E. Until such time as the manufacturing of the Product can be transitioned to Customer in accordance with the terms of this Agreement, Philips agrees to supply, as a contract manufacturer to Customer, on a temporary basis for the Term (as defined herein), the Product, and Customer wishes to buy such Products from Philips under this Agreement; F. Customer acknowledges and agrees that it assumes all obligations and liabilities as the legal manufacturer of the Product as from the Effective Date, on the terms and conditions set out in this Agreement. NOW IT IS HEREBY AGREED as follows: 1. DEFINITIONS The following terms used in this Agreement shall have the meaning set forth below: \\\"Affiliate\\\" means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified Person. As used in this definition, \\\"control\\\", \\\"controlled by\\\" and \\\"under common control with\\\" means possession, directly or indirectly, of power to direct or cause the direction of management or policies of such Person (whether through ownership of securities or other partnership or ownership interests, as trustee, personal representative or executive or by contract, credit agreement or otherwise), provided that in any event, any Person which owns directly, indirectly or beneficially 50% or more of the securities having voting power for the election of directors or other governing body of a corporation or 50% or more of the partnership interests or other ownership interests of any other Person will be deemed to control such Person. \\\"Agreement\\\" means this Supply Agreement including any and all of its Schedules as attached hereto and as may be amended or supplemented from time to time in accordance with the provisions hereof. \\\"Business Day\\\" means any day other than a Saturday, Sunday or statutory holiday, in the Province of Ontario or the Netherlands. \\\"Claim\\\" means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other, whether at Law, in equity or otherwise. \\\"Confidential Information\\\" means any information, provided in whatever form (including in written, electronic or oral form) or medium, which relates to either Party's or its Affiliates' business, products (hardware and software), technology, business plans, product plans, customers, customer information, specifications, designs, costs, prices, business opportunities, Know How, trade secrets, inventions, techniques, processes, algorithms, software programs, schematics and any other business or technical information disclosed by the Disclosing Party to the Receiving Party in connection with this Agreement. \\\"Confirmation\\\" has the meaning ascribed thereto in clause 4.4. \\\"Contract Year\\\" means the twelve (12) month period beginning on the Effective Date, and each subsequent twelve (12) month period during the Term. - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - (c) the other Party materially breaches any of its obligations under the Agreement, and the breaching failures to cure such breach within [Redacted - Commercial Sensitive - Termination Timing] after it receives written notice from the non-breaching Party to cure same; (d) [Redacted - Commercially Sensitive - Termination Timing] (e) conviction of, or commission by, the other Party or any principal officer, shareholder, employee or any partner of the other Party of any crime or immoral act which may adversely affect the goodwill or reputation of Customer or Philips; 12.4 If Philips causes the Agreement to be terminated, directly or indirectly, then Philips undertakes to sell all Products which have been ordered by Customer but not yet delivered at the date of termination upon the terms and conditions of this Agreement. 12.5 On termination or expiry of this Agreement, each Party shall promptly: (a) return to the other Party all equipment, materials and property belonging to the other Party that the other Party had supplied to the other Party (or its Affiliates) in connection with the supply and purchase of the Products under this Agreement; (b) cooperate with the other Party to arrange for the sale and purchase of the materials, parts and components as referred to in clause 3.4; (c) return to the other Party all documents and materials (and any copies) containing the other party's Confidential Information; (d) erase all the other party's Confidential Information from its computer systems (to the extent possible); and (e) on request, certify in writing to the other Party that it has complied with the requirements of this clause. On termination or expiry of this Agreement Philips shall facilitate an orderly transition of suppliers from Philips to Customer in accordance with the requirements outlined in Section 5.4 (Material Supplier Contracts) of the Purchase Agreement, including using commercially reasonable best efforts to assist Customer to enter into supply agreements directly with the counterparties to the Material Supplier Contracts (as defined in the Purchase Agreement) on terms that are satisfactory to the Customer, acting reasonably. - 15 - - 16 - - 17 -\"}, {\"id\": \"14.2\", \"title\": \"Each Party may disclose the other Party's Confidential Information to its and its Affiliates' employees, officers, lawye\", \"level\": 2, \"text\": \"14.2 Each Party may disclose the other Party's Confidential Information to its and its Affiliates' employees, officers, lawyers, accountants, professional advisers, consultants and sub-contractors (collectively, \\\"Representatives\\\") or financing sources (both debt and equity) or any prospective acquirer of a Party (or substantially all of the assets related to the Products)(collectively, \\\"Other Recipients\\\") on a strict need to know basis, provided that such Representatives and Other Recipients are subject to confidentiality obligations and/or agreements at least as stringent as the confidentiality restrictions imposed by this clause 14 on the Receiving Party. 14.3 The confidentiality obligations set out in this clause 14 shall not apply to any information (but only to the extent that such information) and the definition of \\\"Confidential Information\\\" shall not be deemed to include any information that: (a) is generally available from public sources or in the public domain through no fault or breach of the Receiving Party or any of its Representatives; (b) becomes available to the Receiving Party (or any of its Affiliates) unless the Receiving Party (or such Affiliate) is aware that such source was bound by a confidentiality agreement with the Disclosing Party or any or its Representatives or otherwise under a contractual, legal, fiduciary or other obligation of confidentiality with respect such information; (c) developed independently by the Receiving Party or any of its Affiliates without use of or reliance on the Disclosing Party's (or any of its Affiliates') Confidential Information as demonstrated by written records; or (d) was known or in the possession of the Receiving Party (or any of its Affiliates) prior to its disclosure by the Disclosing Party unless the Receiving Party (or such Affiliate) is aware that the source of such information was bound by a confidentiality undertaking to the Disclosing Party (or its Affiliates) or any or its Representatives or otherwise under a contractual, legal, fiduciary or other obligation of confidentiality with respect to such information. - 18 - - 19 - (b) the existence of a Force Majeure event that has caused a breach of this Agreement shall not prevent a Party from asserting and acting upon a breach of this Agreement that has not been caused by a Force Majeure event; (c) If a Party is not or is not expected to be able to perform any material obligation under this Agreement due to a Force Majeure event for a period of [Redacted - Commercial Sensitive - Time Period] or more, the other Party may terminate this Agreement without liability. (d) Notwithstanding the foregoing, Customer may cancel without liability any affected Purchase Orders if the Force Majeure event would result in a delay in delivery of more than [Redacted - Commercial Sensitive - Time Period]. For the purposes of this clause 15, \\\"Force Majeure\\\" means any prevention, delay, stoppage or interruption in the performance of any obligation or the occurrence of any event due to an act of God, the occurrence of enemy or hostile actions, sabotage, war, blockades, terrorist attacks, insurrections, riots, epidemics, nuclear and radiation activity or fall-out, civil disturbances, explosions, fire or other casualty, failure of energy sources, any industry-wide material shortage and changes in governmental or regulatory action or legislation or regulation, third party labour disputes or strikes or any other similar causes beyond the control of the Party seeking relief from its obligations as a result of such event, but not including, for clarity, any financial inability of Philips or any of its Affiliates or the failure of any subcontractor to perform obligations owed to Philips unless when those are caused by Force Majeure. 16. EXPORT CONTROL 16.1 Customer understands that certain transactions of Philips are subject to export control Laws and regulations, such as but not limited to the UN, EU and the USA export control Laws and regulations, (\\\"Export Regulations\\\") which prohibit export or diversion of certain products and technology to certain countries. Any and all obligations of Philips to export, re-export or transfer Products as well as any technical assistance, training, investments, financial assistance, financing and brokering will be subject in all respects to such Export Regulations and will from time to time govern the license and Delivery of Products and technology abroad by persons subject to the jurisdiction of the relevant authorities responsible for such Export Regulations. If the Delivery of Products, services and/or documentation is subject to the granting of an export or import license by certain governmental authorities or otherwise restricted or prohibited due to export/import control regulations, Philips may suspend its obligations and Customer's and/or end-user's rights until such license is granted or for the duration of such restrictions or prohibitions. Furthermore, Philips may even terminate the relevant order in all cases without incurring any liability towards Customer or end-user. 16.2 Philips undertakes to provide Customer on request and in a timely fashion, with the following information in relation to the Products: (a) The country of origin of items to be supplied; and - 20 - - 21 -\"}, {\"id\": \"17.3\", \"title\": \"Complaints and Adverse Events Philips and Customer shall fully comply with the terms of the Quality Agreement regarding\", \"level\": 2, \"text\": \"17.3 Complaints and Adverse Events Philips and Customer shall fully comply with the terms of the Quality Agreement regarding their respective obligations and responsibilities with respect to any complaints or adverse events regarding the Product and other activities related to this Agreement. 17.4 Records Philips shall maintain, and provide Customer reasonable access to, all records, both during and after the termination or expiration of this Agreement, in accordance with the Quality Agreement. The cost of any off-site storage of such records after the Term of this Agreement shall be borne by Customer and invoiced on a calendar quarter basis. After the Term, Customer may elect to have such records delivered to it upon reimbursing Philips for its reasonable costs of such transfer. 17.5 Testing, Documentation, and Quality Assurance Philips shall maintain, and provide Customer reasonable access to, accurate and complete production records with respect to the manufacture of the Product in accordance with the Quality Agreement. The Parties agree to execute, and shall comply with their respective obligations and duties set forth in, the Quality Agreement. To the extent that there is any conflict between the terms of this Agreement and the Quality Agreement, the terms of this Agreement shall govern. 17.6 Cooperation as to Adverse Events, Product Inquiries and Recalls Each Party shall provide to each other in a timely manner all information which the other party reasonably requests regarding the Product in order to enable the other party to comply with all applicable Laws. Without limiting the foregoing, each Party will cooperate fully with the other party in connection with any recall efforts and mandatory problem reporting to Governmental Authorities as more fully detailed in the Quality Agreement. - 22 -\"}, {\"id\": \"18\", \"title\": \"MISCELLANEOUS 18\", \"level\": 1, \"text\": \"18. MISCELLANEOUS 18.1 Entire Agreement This Agreement, together with the Quality Agreement and the Purchase Order, contains the entire agreement between the Parties relating to the subject matter of this Agreement, to the exclusion of any terms implied by applicable Law which may be excluded by contract, and supersedes any previous written or oral agreement between the Parties in relation to the matters dealt with in this Agreement. Each Party acknowledges that it has not been induced to enter into this Agreement by any representation, warranty or undertaking not expressly set out in this Agreement. 18.2 Severability If any provision in this Agreement is held to be illegal, invalid or unenforceable, in whole or in part, under any applicable Law, then: (a) such provision or part shall to that extent be deemed not to form part of this Agreement but the legality, validity or enforceability of the remainder of this Agreement shall not be affected; (b) the Parties shall use reasonable efforts to agree a replacement provision that is legal, valid and enforceable to achieve so far as possible the intended effect of the illegal, invalid or unenforceable provision. 18.3 Notices Any notice or other communication required or permitted to be given to any Party hereunder shall be in writing and shall be given to such Party at such Party's address set forth below, or such other address as such Party may hereafter specify by notice in writing to the other Party. Any such notice or other communication shall be addressed as aforesaid and given by: (a) delivered personally; (b) sent by an internationally recognized overnight courier service such as Federal Express; or (c) e-mail transmission, Philips' details: PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. Address: PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. P.O. Box 10.000 5680 DA Best, The Netherlands - 23 - Attention: [Redacted - Personal Information], Operations Manager MR Best Email: [Redacted - Personal Information] With copy to: Legal Department PMSN BV Veenpluis 4-6 5684 PC Best Building QX2 Email: The Company's details: PROFOUND MEDICAL INC. Address: Profound Medical Inc. 2400 Skymark Avenue, Unit #6 Mississauga, ON, L4W 5K5, Canada Attention: Arun Menawat E-mail: [Redacted - Personal Information] With copy to: Torys LLP Suite 3000, P.O. Box 270 79 Wellington Street West TD Centre Toronto, ON M5K 1N2 Attention: Cheryl Reicin Any notice or other communication will be deemed to have been duly given: (A) on the date of service if served personally; (B) on the Business Day after delivery to an international overnight courier service, provided receipt of delivery has been confirmed; or (C) on the date of transmission if sent via e-mail transmission, provided confirmation of receipt is obtained promptly after completion of transmission and provided that transmission via e-mail is followed promptly by delivery via one of the methods in Clause 18.3(a) or (b) above. 18.4 Assignment This Agreement will be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns. This Agreement may not be assigned by either Party, in whole or in part, to any Third Party without the prior written consent of the other Party, except that either Party may assign this Agreement as a whole, and all of its rights and obligations hereunder, without the consent of the other Party, but upon written notice to the other Party (a) to an Affiliate, or (b) in case of a transfer of all, or substantially all, stock or assets of such Party or the relevant business activity through which such Party acts in this Agreement to a Third Party or to any partnership or other venture in which such business activity is to participate. Except as provided above, without prior written consent of the other Party, any assignment or pledge of rights under this Agreement by a Party to a Third Party shall have no effect vis-\u00e0-vis such Third Party. - 24 - - 25 -\"}, {\"id\": \"18.11\", \"title\": \"Costs Except as otherwise provided in this Agreement, all costs which a Party has incurred or shall incur in preparing,\", \"level\": 2, \"text\": \"18.11 Costs Except as otherwise provided in this Agreement, all costs which a Party has incurred or shall incur in preparing, concluding or performing this Agreement are for that Party's own account. 18.12 Insurance Philips shall fully comply with the terms of the Quality Agreement regarding its obligations and responsibilities with respect to maintaining the required level of insurance. 18.13 Further Assurances Each Party shall at its own costs and expenses from time to time execute such documents and perform such acts and things as the other Party may reasonably require to give the other Party the full benefit of this Agreement. - 26 - IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly authorized representatives of the parties as of the dates set forth below. PHILIPS MEDICAL SYSTEMS PROFOUND MEDICAL INC. NEDERLAND B.V. By: /s/ Iwald Mons By: /s/ Arun Menawat Name: Iwald Mons Name: Arun Menawat Title: M&A Project Leader Title: Chief Executive Officer Date: July 31, 2017 Date: July 31, 2017 [Redacted - Commercially Sensitive - Schedules concerning Product specifications, details, pricing, lead times, production plan and transition details]\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of PROFOUNDMEDICALCORP_08_29_2019-EX-4.5-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\", \"level\": 2, \"text\": \"Exhibit 4.5 SUPPLY AGREEMENT between PROFOUND MEDICAL INC. and PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. THIS AGREEMENT is made July 31, 2017 BETWEEN: PROFOUND MEDICAL INC., a company incorporated under the laws of the province of Ontario and having its registered address at 2400 Skymark, Unit 6, Mississauga, Ontario L4W 5K5, Canada (hereinafter referred to as \\\"Customer\\\") - and - PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., a company incorporated under the laws of the Netherlands with its principal place of business at Veenpluis 4-6 5684 PC Best, the Netherlands (hereinafter referred to as \\\"Philips\\\") Customer and Philips hereinafter also collectively referred to as the \\\"Parties\\\" and individually as a \\\"Party\\\". WHEREAS: A. Pursuant to the Asset and Share Purchase Agreement (the \\\"Purchase Agreement\\\") entered into on June 30, 2017 by Customer, Koninklijke Philips NV (\\\"Philips NV\\\") N.V. and Customer agreed to execute and deliver (or cause to be executed and delivered) certain ancillary agreements one of which is this Agreement; B. Prior to the consummation of the transactions contemplated by the Purchase Agreement, Philips manufactured the Product in-house and did not outsource the manufacturing to an independent facility, and as a result, Philips has intimate knowledge of the manufacturing process and requirements for the Product; C. Customer originally desired to take over responsibility for the manufacture of the Product immediately upon closing of the transactions contemplated by the Purchase Agreement; D. As Philips historically manufactured the Product in-house, to enable Customer to prepare for and realize the transition of the manufacturing of the Product to Customer's organization, Customer requires the assistance of Philips to continue manufacturing the Product until such time as the manufacturing process can be transitioned to Customer hereunder; E. Until such time as the manufacturing of the Product can be transitioned to Customer in accordance with the terms of this Agreement, Philips agrees to supply, as a contract manufacturer to Customer, on a temporary basis for the Term (as defined herein), the Product, and Customer wishes to buy such Products from Philips under this Agreement; F. Customer acknowledges and agrees that it assumes all obligations and liabilities as the legal manufacturer of the Product as from the Effective Date, on the terms and conditions set out in this Agreement. NOW IT IS HEREBY AGREED as follows: 1. DEFINITIONS The following terms used in this Agreement shall have the meaning set forth below: \\\"Affiliate\\\" means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified Person. As used in this definition, \\\"control\\\", \\\"controlled by\\\" and \\\"under common control with\\\" means possession, directly or indirectly, of power to direct or cause the direction of management or policies of such Person (whether through ownership of securities or other partnership or ownership interests, as trustee, personal representative or executive or by contract, credit agreement or otherwise), provided that in any event, any Person which owns directly, indirectly or beneficially 50% or more of the securities having voting power for the election of directors or other governing body of a corporation or 50% or more of the partnership interests or other ownership interests of any other Person will be deemed to control such Person. \\\"Agreement\\\" means this Supply Agreement including any and all of its Schedules as attached hereto and as may be amended or supplemented from time to time in accordance with the provisions hereof. \\\"Business Day\\\" means any day other than a Saturday, Sunday or statutory holiday, in the Province of Ontario or the Netherlands. \\\"Claim\\\" means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other, whether at Law, in equity or otherwise. \\\"Confidential Information\\\" means any information, provided in whatever form (including in written, electronic or oral form) or medium, which relates to either Party's or its Affiliates' business, products (hardware and software), technology, business plans, product plans, customers, customer information, specifications, designs, costs, prices, business opportunities, Know How, trade secrets, inventions, techniques, processes, algorithms, software programs, schematics and any other business or technical information disclosed by the Disclosing Party to the Receiving Party in connection with this Agreement. \\\"Confirmation\\\" has the meaning ascribed thereto in clause 4.4. \\\"Contract Year\\\" means the twelve (12) month period beginning on the Effective Date, and each subsequent twelve (12) month period during the Term. - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - (c) the other Party materially breaches any of its obligations under the Agreement, and the breaching failures to cure such breach within [Redacted - Commercial Sensitive - Termination Timing] after it receives written notice from the non-breaching Party to cure same; (d) [Redacted - Commercially Sensitive - Termination Timing] (e) conviction of, or commission by, the other Party or any principal officer, shareholder, employee or any partner of the other Party of any crime or immoral act which may adversely affect the goodwill or reputation of Customer or Philips; 12.4 If Philips causes the Agreement to be terminated, directly or indirectly, then Philips undertakes to sell all Products which have been ordered by Customer but not yet delivered at the date of termination upon the terms and conditions of this Agreement. 12.5 On termination or expiry of this Agreement, each Party shall promptly: (a) return to the other Party all equipment, materials and property belonging to the other Party that the other Party had supplied to the other Party (or its Affiliates) in connection with the supply and purchase of the Products under this Agreement; (b) cooperate with the other Party to arrange for the sale and purchase of the materials, parts and components as referred to in clause 3.4; (c) return to the other Party all documents and materials (and any copies) containing the other party's Confidential Information; (d) erase all the other party's Confidential Information from its computer systems (to the extent possible); and (e) on request, certify in writing to the other Party that it has complied with the requirements of this clause. On termination or expiry of this Agreement Philips shall facilitate an orderly transition of suppliers from Philips to Customer in accordance with the requirements outlined in Section 5.4 (Material Supplier Contracts) of the Purchase Agreement, including using commercially reasonable best efforts to assist Customer to enter into supply agreements directly with the counterparties to the Material Supplier Contracts (as defined in the Purchase Agreement) on terms that are satisfactory to the Customer, acting reasonably. - 15 - - 16 - - 17 -\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each Party may disclose the other Party's Confidential Information to its and its Affiliates' employees, officers, lawye\", \"level\": 2, \"text\": \"14.2 Each Party may disclose the other Party's Confidential Information to its and its Affiliates' employees, officers, lawyers, accountants, professional advisers, consultants and sub-contractors (collectively, \\\"Representatives\\\") or financing sources (both debt and equity) or any prospective acquirer of a Party (or substantially all of the assets related to the Products)(collectively, \\\"Other Recipients\\\") on a strict need to know basis, provided that such Representatives and Other Recipients are subject to confidentiality obligations and/or agreements at least as stringent as the confidentiality restrictions imposed by this clause 14 on the Receiving Party. 14.3 The confidentiality obligations set out in this clause 14 shall not apply to any information (but only to the extent that such information) and the definition of \\\"Confidential Information\\\" shall not be deemed to include any information that: (a) is generally available from public sources or in the public domain through no fault or breach of the Receiving Party or any of its Representatives; (b) becomes available to the Receiving Party (or any of its Affiliates) unless the Receiving Party (or such Affiliate) is aware that such source was bound by a confidentiality agreement with the Disclosing Party or any or its Representatives or otherwise under a contractual, legal, fiduciary or other obligation of confidentiality with respect such information; (c) developed independently by the Receiving Party or any of its Affiliates without use of or reliance on the Disclosing Party's (or any of its Affiliates') Confidential Information as demonstrated by written records; or (d) was known or in the possession of the Receiving Party (or any of its Affiliates) prior to its disclosure by the Disclosing Party unless the Receiving Party (or such Affiliate) is aware that the source of such information was bound by a confidentiality undertaking to the Disclosing Party (or its Affiliates) or any or its Representatives or otherwise under a contractual, legal, fiduciary or other obligation of confidentiality with respect to such information. - 18 - - 19 - (b) the existence of a Force Majeure event that has caused a breach of this Agreement shall not prevent a Party from asserting and acting upon a breach of this Agreement that has not been caused by a Force Majeure event; (c) If a Party is not or is not expected to be able to perform any material obligation under this Agreement due to a Force Majeure event for a period of [Redacted - Commercial Sensitive - Time Period] or more, the other Party may terminate this Agreement without liability. (d) Notwithstanding the foregoing, Customer may cancel without liability any affected Purchase Orders if the Force Majeure event would result in a delay in delivery of more than [Redacted - Commercial Sensitive - Time Period]. For the purposes of this clause 15, \\\"Force Majeure\\\" means any prevention, delay, stoppage or interruption in the performance of any obligation or the occurrence of any event due to an act of God, the occurrence of enemy or hostile actions, sabotage, war, blockades, terrorist attacks, insurrections, riots, epidemics, nuclear and radiation activity or fall-out, civil disturbances, explosions, fire or other casualty, failure of energy sources, any industry-wide material shortage and changes in governmental or regulatory action or legislation or regulation, third party labour disputes or strikes or any other similar causes beyond the control of the Party seeking relief from its obligations as a result of such event, but not including, for clarity, any financial inability of Philips or any of its Affiliates or the failure of any subcontractor to perform obligations owed to Philips unless when those are caused by Force Majeure. 16. EXPORT CONTROL 16.1 Customer understands that certain transactions of Philips are subject to export control Laws and regulations, such as but not limited to the UN, EU and the USA export control Laws and regulations, (\\\"Export Regulations\\\") which prohibit export or diversion of certain products and technology to certain countries. Any and all obligations of Philips to export, re-export or transfer Products as well as any technical assistance, training, investments, financial assistance, financing and brokering will be subject in all respects to such Export Regulations and will from time to time govern the license and Delivery of Products and technology abroad by persons subject to the jurisdiction of the relevant authorities responsible for such Export Regulations. If the Delivery of Products, services and/or documentation is subject to the granting of an export or import license by certain governmental authorities or otherwise restricted or prohibited due to export/import control regulations, Philips may suspend its obligations and Customer's and/or end-user's rights until such license is granted or for the duration of such restrictions or prohibitions. Furthermore, Philips may even terminate the relevant order in all cases without incurring any liability towards Customer or end-user. 16.2 Philips undertakes to provide Customer on request and in a timely fashion, with the following information in relation to the Products: (a) The country of origin of items to be supplied; and - 20 - - 21 -\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Complaints and Adverse Events Philips and Customer shall fully comply with the terms of the Quality Agreement regarding\", \"level\": 2, \"text\": \"17.3 Complaints and Adverse Events Philips and Customer shall fully comply with the terms of the Quality Agreement regarding their respective obligations and responsibilities with respect to any complaints or adverse events regarding the Product and other activities related to this Agreement. 17.4 Records Philips shall maintain, and provide Customer reasonable access to, all records, both during and after the termination or expiration of this Agreement, in accordance with the Quality Agreement. The cost of any off-site storage of such records after the Term of this Agreement shall be borne by Customer and invoiced on a calendar quarter basis. After the Term, Customer may elect to have such records delivered to it upon reimbursing Philips for its reasonable costs of such transfer. 17.5 Testing, Documentation, and Quality Assurance Philips shall maintain, and provide Customer reasonable access to, accurate and complete production records with respect to the manufacture of the Product in accordance with the Quality Agreement. The Parties agree to execute, and shall comply with their respective obligations and duties set forth in, the Quality Agreement. To the extent that there is any conflict between the terms of this Agreement and the Quality Agreement, the terms of this Agreement shall govern. 17.6 Cooperation as to Adverse Events, Product Inquiries and Recalls Each Party shall provide to each other in a timely manner all information which the other party reasonably requests regarding the Product in order to enable the other party to comply with all applicable Laws. Without limiting the foregoing, each Party will cooperate fully with the other party in connection with any recall efforts and mandatory problem reporting to Governmental Authorities as more fully detailed in the Quality Agreement. - 22 -\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS 18\", \"level\": 1, \"text\": \"18. MISCELLANEOUS 18.1 Entire Agreement This Agreement, together with the Quality Agreement and the Purchase Order, contains the entire agreement between the Parties relating to the subject matter of this Agreement, to the exclusion of any terms implied by applicable Law which may be excluded by contract, and supersedes any previous written or oral agreement between the Parties in relation to the matters dealt with in this Agreement. Each Party acknowledges that it has not been induced to enter into this Agreement by any representation, warranty or undertaking not expressly set out in this Agreement. 18.2 Severability If any provision in this Agreement is held to be illegal, invalid or unenforceable, in whole or in part, under any applicable Law, then: (a) such provision or part shall to that extent be deemed not to form part of this Agreement but the legality, validity or enforceability of the remainder of this Agreement shall not be affected; (b) the Parties shall use reasonable efforts to agree a replacement provision that is legal, valid and enforceable to achieve so far as possible the intended effect of the illegal, invalid or unenforceable provision. 18.3 Notices Any notice or other communication required or permitted to be given to any Party hereunder shall be in writing and shall be given to such Party at such Party's address set forth below, or such other address as such Party may hereafter specify by notice in writing to the other Party. Any such notice or other communication shall be addressed as aforesaid and given by: (a) delivered personally; (b) sent by an internationally recognized overnight courier service such as Federal Express; or (c) e-mail transmission, Philips' details: PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. Address: PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. P.O. Box 10.000 5680 DA Best, The Netherlands - 23 - Attention: [Redacted - Personal Information], Operations Manager MR Best Email: [Redacted - Personal Information] With copy to: Legal Department PMSN BV Veenpluis 4-6 5684 PC Best Building QX2 Email: The Company's details: PROFOUND MEDICAL INC. Address: Profound Medical Inc. 2400 Skymark Avenue, Unit #6 Mississauga, ON, L4W 5K5, Canada Attention: Arun Menawat E-mail: [Redacted - Personal Information] With copy to: Torys LLP Suite 3000, P.O. Box 270 79 Wellington Street West TD Centre Toronto, ON M5K 1N2 Attention: Cheryl Reicin Any notice or other communication will be deemed to have been duly given: (A) on the date of service if served personally; (B) on the Business Day after delivery to an international overnight courier service, provided receipt of delivery has been confirmed; or (C) on the date of transmission if sent via e-mail transmission, provided confirmation of receipt is obtained promptly after completion of transmission and provided that transmission via e-mail is followed promptly by delivery via one of the methods in Clause 18.3(a) or (b) above. 18.4 Assignment This Agreement will be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns. This Agreement may not be assigned by either Party, in whole or in part, to any Third Party without the prior written consent of the other Party, except that either Party may assign this Agreement as a whole, and all of its rights and obligations hereunder, without the consent of the other Party, but upon written notice to the other Party (a) to an Affiliate, or (b) in case of a transfer of all, or substantially all, stock or assets of such Party or the relevant business activity through which such Party acts in this Agreement to a Third Party or to any partnership or other venture in which such business activity is to participate. Except as provided above, without prior written consent of the other Party, any assignment or pledge of rights under this Agreement by a Party to a Third Party shall have no effect vis-\u00e0-vis such Third Party. - 24 - - 25 -\"}}, {\"id\": \"18.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Costs Except as otherwise provided in this Agreement, all costs which a Party has incurred or shall incur in preparing,\", \"level\": 2, \"text\": \"18.11 Costs Except as otherwise provided in this Agreement, all costs which a Party has incurred or shall incur in preparing, concluding or performing this Agreement are for that Party's own account. 18.12 Insurance Philips shall fully comply with the terms of the Quality Agreement regarding its obligations and responsibilities with respect to maintaining the required level of insurance. 18.13 Further Assurances Each Party shall at its own costs and expenses from time to time execute such documents and perform such acts and things as the other Party may reasonably require to give the other Party the full benefit of this Agreement. - 26 - IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly authorized representatives of the parties as of the dates set forth below. PHILIPS MEDICAL SYSTEMS PROFOUND MEDICAL INC. NEDERLAND B.V. By: /s/ Iwald Mons By: /s/ Arun Menawat Name: Iwald Mons Name: Arun Menawat Title: M&A Project Leader Title: Chief Executive Officer Date: July 31, 2017 Date: July 31, 2017 [Redacted - Commercially Sensitive - Schedules concerning Product specifications, details, pricing, lead times, production plan and transition details]\"}}, {\"id\": \"party:PROFOUND MEDICAL INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PROFOUND MEDICAL INC.\", \"role\": \"Customer\", \"address\": \"2400 Skymark, Unit 6, Mississauga, Ontario L4W 5K5, Canada\"}}, {\"id\": \"party:PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.\", \"role\": \"Philips\", \"address\": \"Veenpluis 4-6 5684 PC Best, the Netherlands\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the specified Person. As used in this definition, \\\"control\\\", \\\"controlled by\\\" and \\\"under common control with\\\" means possession, directly or indirectly, of power to direct or cause the direction of management or policies of such Person (whether through ownership of securities or other partnership or ownership interests, as trustee, personal representative or executive or by contract, credit agreement or otherwise), provided that in any event, any Person which owns directly, indirectly or beneficially 50% or more of the securities having voting power for the election of directors or other governing body of a corporation or 50% or more of the partnership interests or other ownership interests of any other Person will be deemed to control such Person.\", \"definition_clause\": \"Exhibit 4.5\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"means this Supply Agreement including any and all of its Schedules as attached hereto and as may be amended or supplemented from time to time in accordance with the provisions hereof.\", \"definition_clause\": \"Exhibit 4.5\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"means any day other than a Saturday, Sunday or statutory holiday, in the Province of Ontario or the Netherlands.\", \"definition_clause\": \"Exhibit 4.5\"}}, {\"id\": \"term:Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Claim\", \"text\": \"means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or other, whether at Law, in equity or otherwise.\", \"definition_clause\": \"Exhibit 4.5\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"means any information, provided in whatever form (including in written, electronic or oral form) or medium, which relates to either Party's or its Affiliates' business, products (hardware and software), technology, business plans, product plans, customers, customer information, specifications, designs, costs, prices, business opportunities, Know How, trade secrets, inventions, techniques, processes, algorithms, software programs, schematics and any other business or technical information disclosed by the Disclosing Party to the Receiving Party in connection with this Agreement.\", \"definition_clause\": \"Exhibit 4.5\"}}, {\"id\": \"term:Contract Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract Year\", \"text\": \"means the twelve (12) month period beginning on the Effective Date, and each subsequent twelve (12) month period during the Term.\", \"definition_clause\": \"Exhibit 4.5\"}}, {\"id\": \"term:Representatives\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Representatives\", \"text\": \"its and its Affiliates' employees, officers, lawyers, accountants, professional advisers, consultants and sub-contractors\", \"definition_clause\": \"14.2\"}}, {\"id\": \"term:Other Recipients\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Other Recipients\", \"text\": \"financing sources (both debt and equity) or any prospective acquirer of a Party (or substantially all of the assets related to the Products)\", \"definition_clause\": \"14.2\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"means any prevention, delay, stoppage or interruption in the performance of any obligation or the occurrence of any event due to an act of God, the occurrence of enemy or hostile actions, sabotage, war, blockades, terrorist attacks, insurrections, riots, epidemics, nuclear and radiation activity or fall-out, civil disturbances, explosions, fire or other casualty, failure of energy sources, any industry-wide material shortage and changes in governmental or regulatory action or legislation or regulation, third party labour disputes or strikes or any other similar causes beyond the control of the Party seeking relief from its obligations as a result of such event, but not including, for clarity, any financial inability of Philips or any of its Affiliates or the failure of any subcontractor to perform obligations owed to Philips unless when those are caused by Force Majeure.\", \"definition_clause\": \"14.2\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement3\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement3.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"APPENDIX C SAMPLE OF NON-DISCLOSURE AND NON-COMPET\", \"level\": 1, \"text\": \"APPENDIX C SAMPLE OF NON-DISCLOSURE AND NON-COMPETITION AGREEMENT (BETWEEN FRANCHISEE AND ITS PERSONNEL) THIS SAMPLE OF NON-DISCLOSURE AND NON-COMPETITION AGREEMENT ( \\\"Agreement\\\") is made this _____ day of _________, 20___, by and between ___________________________ (the \\\"Franchisee\\\"), and ___________________________, who is an officer, director, or employee of Franchisee (the \\\"Member\\\"). RECITALS: WHEREAS, __________________ (\\\"Franchisor\\\") has developed a distinctive set of specifications and operating procedures (collectively, the \\\"System\\\") for the operation of \\\"Pizza Fusion\\\" restaurant businesses (\\\"Franchised Businesses\\\"). WHEREAS, Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Franchised Business under the terms and conditions of the Franchise Agreement; WHEREAS, the Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same confidentiality and non-competition agreement that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties agree as follows: 1. Confidential Information. Member shall not, during the term of the Franchise Agreement or thereafter, communicate, divulge or use, for any purpose other than the operation of the Franchised Business, any confidential information, knowledge, trade secrets or know-how which may be communicated to Member or which Member may learn by virtue of Member's relationship with Franchisee. All information, knowledge and know-how relating to Franchisor, its business plans, Franchised Businesses, or the System (\\\"Confidential Information\\\") is deemed confidential, except for information that Member can demonstrate came to Member's attention by lawful means prior to disclosure to Member; or which, at the time of the disclosure to Member, had become a part of the public domain. 2. Covenants Not to Compete. (a) Member specifically acknowledges that, pursuant to the Franchise Agreement, and by virtue of its position with Franchisee, Member will receive valuable specialized training and Confidential Information, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of Franchisor and the System. (b) Member covenants and agrees that during the term of the Franchise Agreement, except as otherwise approved in writing by Franchisor, Member shall not, either directly or indirectly, for itself, or through, on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity: (i) Own, manage, engage in, be employed by, advise, make loans to, consult for, rent or lease to, or have any other interest in business that (directly or indirectly) operates, or grants franchises or licenses to operate, a restaurant featuring pizza and related food specialties or that offers products or services substantially similar to those then offered by Pizza Fusions Restaurants (\\\"Competitive Business\\\"); C - 1 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015 (ii) Divert or attempt to divert any business or customer, or potential business or customer, to any Competitive Business; or (iii) Induce any person to leave his or her employment with Franchisee or Franchisor. (c) Member covenants and agrees that during the Post-Term Period (defined below), except as otherwise approved in writing by Franchisor, Member shall not, either directly or indirectly, own, manage, engage in, be employed by, advise, make loans to, consult for, or have any other interest in any Competitive Business that is, or intends to operate, within a three (3) mile radius of the premises of your Franchised Business or within a three (3) mile radius of any Franchised Business then-operating or under construction to operate under the System. (d) As used in this Agreement, the term \\\"Post-Term Period\\\" shall mean a continuous uninterrupted period of two (2) years from the date of: (a) a transfer permitted under Section 14 of the Franchise Agreement; (b) expiration or termination of the Franchise Agreement (regardless of the cause for termination); (c) termination of Member's employment with Franchisee; and/or (d) a final order of a duly authorized arbitrator, panel of arbitrators, or a court of competent jurisdiction (after all appeals have been taken) with respect to any of the foregoing or with respect to the enforcement of this Agreement; either directly or indirectly (through, on behalf of, or in conjunction with any persons, partnership, corporation or entity). 3. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all court costs and reasonable attorney's fees incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement. 4. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, shall be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court shall have the authority to reform and modify that provision in order that the restriction shall be the maximum necessary to protect Franchisor's and/or Franchisee's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court shall impose the provision with retroactive effect as close as possible to the provision held to be invalid. 5. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, shall constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement shall be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement. 6. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. C - 2 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015 IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE MEMBER By: By: Name: Name: Title: Title: C - 3 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement3\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPENDIX C SAMPLE OF NON-DISCLOSURE AND NON-COMPET\", \"level\": 1, \"text\": \"APPENDIX C SAMPLE OF NON-DISCLOSURE AND NON-COMPETITION AGREEMENT (BETWEEN FRANCHISEE AND ITS PERSONNEL) THIS SAMPLE OF NON-DISCLOSURE AND NON-COMPETITION AGREEMENT ( \\\"Agreement\\\") is made this _____ day of _________, 20___, by and between ___________________________ (the \\\"Franchisee\\\"), and ___________________________, who is an officer, director, or employee of Franchisee (the \\\"Member\\\"). RECITALS: WHEREAS, __________________ (\\\"Franchisor\\\") has developed a distinctive set of specifications and operating procedures (collectively, the \\\"System\\\") for the operation of \\\"Pizza Fusion\\\" restaurant businesses (\\\"Franchised Businesses\\\"). WHEREAS, Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Franchised Business under the terms and conditions of the Franchise Agreement; WHEREAS, the Member, by virtue of his or her position with Franchisee, will gain access to certain of Franchisor's Confidential Information, as defined herein, and must therefore be bound by the same confidentiality and non-competition agreement that Franchisee is bound by. IN CONSIDERATION of these premises, the conditions stated herein, and for other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties agree as follows: 1. Confidential Information. Member shall not, during the term of the Franchise Agreement or thereafter, communicate, divulge or use, for any purpose other than the operation of the Franchised Business, any confidential information, knowledge, trade secrets or know-how which may be communicated to Member or which Member may learn by virtue of Member's relationship with Franchisee. All information, knowledge and know-how relating to Franchisor, its business plans, Franchised Businesses, or the System (\\\"Confidential Information\\\") is deemed confidential, except for information that Member can demonstrate came to Member's attention by lawful means prior to disclosure to Member; or which, at the time of the disclosure to Member, had become a part of the public domain. 2. Covenants Not to Compete. (a) Member specifically acknowledges that, pursuant to the Franchise Agreement, and by virtue of its position with Franchisee, Member will receive valuable specialized training and Confidential Information, including, without limitation, information regarding the operational, sales, promotional, and marketing methods and techniques of Franchisor and the System. (b) Member covenants and agrees that during the term of the Franchise Agreement, except as otherwise approved in writing by Franchisor, Member shall not, either directly or indirectly, for itself, or through, on behalf of, or in conjunction with any person, persons, partnership, corporation, or entity: (i) Own, manage, engage in, be employed by, advise, make loans to, consult for, rent or lease to, or have any other interest in business that (directly or indirectly) operates, or grants franchises or licenses to operate, a restaurant featuring pizza and related food specialties or that offers products or services substantially similar to those then offered by Pizza Fusions Restaurants (\\\"Competitive Business\\\"); C - 1 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015 (ii) Divert or attempt to divert any business or customer, or potential business or customer, to any Competitive Business; or (iii) Induce any person to leave his or her employment with Franchisee or Franchisor. (c) Member covenants and agrees that during the Post-Term Period (defined below), except as otherwise approved in writing by Franchisor, Member shall not, either directly or indirectly, own, manage, engage in, be employed by, advise, make loans to, consult for, or have any other interest in any Competitive Business that is, or intends to operate, within a three (3) mile radius of the premises of your Franchised Business or within a three (3) mile radius of any Franchised Business then-operating or under construction to operate under the System. (d) As used in this Agreement, the term \\\"Post-Term Period\\\" shall mean a continuous uninterrupted period of two (2) years from the date of: (a) a transfer permitted under Section 14 of the Franchise Agreement; (b) expiration or termination of the Franchise Agreement (regardless of the cause for termination); (c) termination of Member's employment with Franchisee; and/or (d) a final order of a duly authorized arbitrator, panel of arbitrators, or a court of competent jurisdiction (after all appeals have been taken) with respect to any of the foregoing or with respect to the enforcement of this Agreement; either directly or indirectly (through, on behalf of, or in conjunction with any persons, partnership, corporation or entity). 3. Injunctive Relief. Member acknowledges that any failure to comply with the requirements of this Agreement will cause Franchisor irreparable injury, and Member agrees to pay all court costs and reasonable attorney's fees incurred by Franchisor in obtaining specific performance of, or an injunction against violation of, the requirements of this Agreement. 4. Severability. All agreements and covenants contained herein are severable. If any of them, or any part or parts of them, shall be held invalid by any court of competent jurisdiction for any reason, then the Member agrees that the court shall have the authority to reform and modify that provision in order that the restriction shall be the maximum necessary to protect Franchisor's and/or Franchisee's legitimate business needs as permitted by applicable law and public policy. In so doing, the Member agrees that the court shall impose the provision with retroactive effect as close as possible to the provision held to be invalid. 5. Delay. No delay or failure by the Franchisor or Franchisee to exercise any right under this Agreement, and no partial or single exercise of that right, shall constitute a waiver of that or any other right provided herein, and no waiver of any violation of any terms and provisions of this Agreement shall be construed as a waiver of any succeeding violation of the same or any other provision of this Agreement. 6. Third-Party Beneficiary. Member hereby acknowledges and agrees that Franchisor is an intended third-party beneficiary of this Agreement with the right to enforce it, independently or jointly with Franchisee. C - 2 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015 IN WITNESS WHEREOF, the Franchisee and the Member attest that each has read and understands the terms of this Agreement, and voluntarily signed this Agreement on the date first written above. FRANCHISEE MEMBER By: By: Name: Name: Title: Title: C - 3 Source: PF HOSPITALITY GROUP INC., 10-12G, 9/23/2015\"}}, {\"id\": \"party:Franchisee\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Franchisee\", \"role\": \"Franchisee\"}}, {\"id\": \"party:Member\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Member\", \"role\": \"Member\"}}, {\"id\": \"party:Franchisor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Franchisor\", \"role\": \"Franchisor\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS SAMPLE OF NON-DISCLOSURE AND NON-COMPETITION AGREEMENT ( \\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchisee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchisee\", \"text\": \"___________________________ (the \\\"Franchisee\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Member\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Member\", \"text\": \"___________________________, who is an officer, director, or employee of Franchisee (the \\\"Member\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchisor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchisor\", \"text\": \"WHEREAS, __________________ (\\\"Franchisor\\\") has developed a distinctive set of specifications and operating procedures (collectively, the \\\"System\\\") for the operation of \\\"Pizza Fusion\\\" restaurant businesses (\\\"Franchised Businesses\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System\", \"text\": \"a distinctive set of specifications and operating procedures (collectively, the \\\"System\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchised Businesses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchised Businesses\", \"text\": \"the operation of \\\"Pizza Fusion\\\" restaurant businesses (\\\"Franchised Businesses\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchise Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchise Agreement\", \"text\": \"WHEREAS, Franchisor and Franchisee have executed a Franchise Agreement (\\\"Franchise Agreement\\\") granting Franchisee the right to operate a Franchised Business under the terms and conditions of the Franchise Agreement;\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"All information, knowledge and know-how relating to Franchisor, its business plans, Franchised Businesses, or the System (\\\"Confidential Information\\\") is deemed confidential, except for information that Member can demonstrate came to Member's attention by lawful means prior to disclosure to Member; or which, at the time of the disclosure to Member, had become a part of the public domain.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Competitive Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Competitive Business\", \"text\": \"a restaurant featuring pizza and related food specialties or that offers products or services substantially similar to those then offered by Pizza Fusions Restaurants (\\\"Competitive Business\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Post-Term Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Post-Term Period\", \"text\": \"As used in this Agreement, the term \\\"Post-Term Period\\\" shall mean a continuous uninterrupted period of two (2) years from the date of: (a) a transfer permitted under Section 14 of the Franchise Agreement; (b) expiration or termination of the Franchise Agreement (regardless of the cause for termination); (c) termination of Member's employment with Franchisee; and/or (d) a final order of a duly authorized arbitrator, panel of arbitrators, or a court of competent jurisdiction (after all appeals have been taken) with respect to any of the foregoing or with respect to the enforcement of this Agreement; either directly or indirectly (through, on behalf of, or in conjunction with any persons, partnership, corporation or entity).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of PrecheckHealthServicesInc_20200320_8-K_EX-99.2_12070169_EX-99.2_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of PrecheckHealthServicesInc_20200320_8-K_EX-99.2_12070169_EX-99.2_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"EXHIBIT 99.2\", \"title\": \"Page 1 of 3 DISTRIBUTOR AGREEMENT Agreement made this 19t h day of March, 2020 Between: Co-Diagnostics, Inc. (herein referred to as \\\"Principal\\\") And PreCheck Health Services, Inc. (herein referred to as \\\"Distributor\\\"). In consideration of the mutual terms, conditions and covenants hereinafter set forth, Principal and Distributor acknowledge and agree to the following descriptions and conditions: DESCRIPTION OF PRINCIPAL The Principal is a company located in Utah, United States and is in the business of research and development of reagents. The Principal markets and sells it products globally through direct sales and distributors. DESCRIPTION OF DISTRIBUTOR The Distributor is a company operating or planning to operate in the United States of America, Latin America, Europe and Russia. The Distributor represents that the Distributor or a subsidiary of the Distributor is or will be fully licensed and registered in the Territory and will provide professional distribution services for the products of the Principal. CONDITIONS: 1. The Principal appoints the Distributor as a non-exclusive distributor, to sell Principal's qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box\u2122 instrument (the \\\"Products\\\"). The Products are described on Exhibit A to this Agreement. 2. The Principal grants Distributor non- exclusive rights to sell these products within the countries of Romania (the \\\"Territory\\\"), which may be amended by mutual written agreement.\", \"level\": 2, \"text\": \"EXHIBIT 99.2 Page 1 of 3 DISTRIBUTOR AGREEMENT Agreement made this 19t h day of March, 2020 Between: Co-Diagnostics, Inc. (herein referred to as \\\"Principal\\\") And PreCheck Health Services, Inc. (herein referred to as \\\"Distributor\\\"). In consideration of the mutual terms, conditions and covenants hereinafter set forth, Principal and Distributor acknowledge and agree to the following descriptions and conditions: DESCRIPTION OF PRINCIPAL The Principal is a company located in Utah, United States and is in the business of research and development of reagents. The Principal markets and sells it products globally through direct sales and distributors. DESCRIPTION OF DISTRIBUTOR The Distributor is a company operating or planning to operate in the United States of America, Latin America, Europe and Russia. The Distributor represents that the Distributor or a subsidiary of the Distributor is or will be fully licensed and registered in the Territory and will provide professional distribution services for the products of the Principal. CONDITIONS: 1. The Principal appoints the Distributor as a non-exclusive distributor, to sell Principal's qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box\u2122 instrument (the \\\"Products\\\"). The Products are described on Exhibit A to this Agreement. 2. The Principal grants Distributor non- exclusive rights to sell these products within the countries of Romania (the \\\"Territory\\\"), which may be amended by mutual written agreement. Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020\"}, {\"id\": \"3\", \"title\": \"The Distributor accepts the appointment and shall use its commercially reasonable efforts to promote, market and sell t\", \"level\": 1, \"text\": \"3. The Distributor accepts the appointment and shall use its commercially reasonable efforts to promote, market and sell the Products within the Territory, devote such time and attention as may be reasonably necessary and abide by the Principal's policies. 4. The Principal shall maintain the right to contact and market its products to potential customers in the Territory; but agrees to pass on all sales leads and orders to the Distributor. 5. The parties agree that the list of Products and/or prices may be amended from time to time. The Principal may unilaterally remove Products from the catalog or change prices. Additions to the Products shall be by mutual agreement. However, in the event the Distributor rejects a new product addition to the product list, the Principal shall then retain the right to market and distribute the new product that is rejected by the Distributor. 6. Unless accepted by the Principal, the Distributor agrees that during the term of this Agreement, the Distributor, either directly or indirectly, shall handle no products that are competitive with the Products within the Territory. 7. The Distributor shall obtain at its own expense, all necessary licenses and permits to allow the Distributor to conduct business as contemplated herein. The Distributor represents and warrants that the Distributor shall conduct business in strict conformity with all local, state and federal laws, rules and regulations. 8. The Principal agrees that the Distributor may employ or engage representatives or sub-distributors in furtherance of this Agreement and the Distributor agrees that the Distributor shall be solely responsible for the payment of wages or commissions to those representatives and sub-distributors, and that under no circumstances shall Distributor's representatives be deemed employees of Principal for any purpose whatsoever. 9. Principal will grant Distributor a discount based on the Products and Prices. The proposed discount is expected to be \u00a8%. Discount may vary depending on product volume ordered or promotions. 10. This Agreement shall be in effect until March 18. 2021, unless sooner terminated by either party upon (30) days written notice, without cause. 11. In the event of termination, the Distributor shall be entitled to receive all orders accepted by the Principal prior to the date of termination and may sell the ordered Products in the Territory. Payment to be made upon shipment. Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020\"}, {\"id\": \"12\", \"title\": \"In the event of termination, neither party, their heirs nor successors shall issue any challenge whatsoever to contest\", \"level\": 1, \"text\": \"12. In the event of termination, neither party, their heirs nor successors shall issue any challenge whatsoever to contest the termination. 13. The Distributor is an independent contractor and nothing contained in this agreement shall be deemed or interpreted to constitute the Distributor as a partner or employee of the Principal, nor shall either party have any authority to bind the other in any respect, it being understood and agreed that all orders submitted by the Distributor are subject to acceptance by Principal in its sole discretion. 14. It is agreed between the parties that there are no other agreements or understandings between them relating to the subject matter of this Agreement. This Agreement supersedes all prior agreements, oral or written, between the parties and is intended as a complete and exclusive statement of the agreement between the parties. No change or modification of this Agreement shall be valid unless the same be in writing and signed by the parties. 15. This Agreement shall not be assigned by the Distributor without the prior written consent of the Principal. 16. Official communication from Distributor or the Principal shall be in written form or by email, acknowledged by the recipient. 17. This Agreement shall be construed in accordance with and governed by the laws of the State of Texas without regard to principles of conflicts of laws. 18. Each of Principal and Distributor represents that it has the right to enter into this Agreement and that this Agreement does not violate any agreement to which it is a party. Principal represents that it owns or has rights to the intellectual property embodied in the Products. Intending to be legally bound, the parties hereto have caused this Agreement to be executed as of the date first above written. BY /s/ Cameron Gundry BY /s/ Justin Anderson Cameron Gundry, Dir. of Commercialization Justin Anderson, CEO Co-Diagnostics, Inc. PreCheck Health Services, Inc. (Principal) (Distributor) Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020 .EXHIBIT A LIST OF PRODUCTS Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020 Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020 Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of PrecheckHealthServicesInc_20200320_8-K_EX-99.2_12070169_EX-99.2_Distributor Agreement\", \"nodes\": [{\"id\": \"EXHIBIT 99.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Page 1 of 3 DISTRIBUTOR AGREEMENT Agreement made this 19t h day of March, 2020 Between: Co-Diagnostics, Inc. (herein referred to as \\\"Principal\\\") And PreCheck Health Services, Inc. (herein referred to as \\\"Distributor\\\"). In consideration of the mutual terms, conditions and covenants hereinafter set forth, Principal and Distributor acknowledge and agree to the following descriptions and conditions: DESCRIPTION OF PRINCIPAL The Principal is a company located in Utah, United States and is in the business of research and development of reagents. The Principal markets and sells it products globally through direct sales and distributors. DESCRIPTION OF DISTRIBUTOR The Distributor is a company operating or planning to operate in the United States of America, Latin America, Europe and Russia. The Distributor represents that the Distributor or a subsidiary of the Distributor is or will be fully licensed and registered in the Territory and will provide professional distribution services for the products of the Principal. CONDITIONS: 1. The Principal appoints the Distributor as a non-exclusive distributor, to sell Principal's qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box\u2122 instrument (the \\\"Products\\\"). The Products are described on Exhibit A to this Agreement. 2. The Principal grants Distributor non- exclusive rights to sell these products within the countries of Romania (the \\\"Territory\\\"), which may be amended by mutual written agreement.\", \"level\": 2, \"text\": \"EXHIBIT 99.2 Page 1 of 3 DISTRIBUTOR AGREEMENT Agreement made this 19t h day of March, 2020 Between: Co-Diagnostics, Inc. (herein referred to as \\\"Principal\\\") And PreCheck Health Services, Inc. (herein referred to as \\\"Distributor\\\"). In consideration of the mutual terms, conditions and covenants hereinafter set forth, Principal and Distributor acknowledge and agree to the following descriptions and conditions: DESCRIPTION OF PRINCIPAL The Principal is a company located in Utah, United States and is in the business of research and development of reagents. The Principal markets and sells it products globally through direct sales and distributors. DESCRIPTION OF DISTRIBUTOR The Distributor is a company operating or planning to operate in the United States of America, Latin America, Europe and Russia. The Distributor represents that the Distributor or a subsidiary of the Distributor is or will be fully licensed and registered in the Territory and will provide professional distribution services for the products of the Principal. CONDITIONS: 1. The Principal appoints the Distributor as a non-exclusive distributor, to sell Principal's qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box\u2122 instrument (the \\\"Products\\\"). The Products are described on Exhibit A to this Agreement. 2. The Principal grants Distributor non- exclusive rights to sell these products within the countries of Romania (the \\\"Territory\\\"), which may be amended by mutual written agreement. Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Distributor accepts the appointment and shall use its commercially reasonable efforts to promote, market and sell t\", \"level\": 1, \"text\": \"3. The Distributor accepts the appointment and shall use its commercially reasonable efforts to promote, market and sell the Products within the Territory, devote such time and attention as may be reasonably necessary and abide by the Principal's policies. 4. The Principal shall maintain the right to contact and market its products to potential customers in the Territory; but agrees to pass on all sales leads and orders to the Distributor. 5. The parties agree that the list of Products and/or prices may be amended from time to time. The Principal may unilaterally remove Products from the catalog or change prices. Additions to the Products shall be by mutual agreement. However, in the event the Distributor rejects a new product addition to the product list, the Principal shall then retain the right to market and distribute the new product that is rejected by the Distributor. 6. Unless accepted by the Principal, the Distributor agrees that during the term of this Agreement, the Distributor, either directly or indirectly, shall handle no products that are competitive with the Products within the Territory. 7. The Distributor shall obtain at its own expense, all necessary licenses and permits to allow the Distributor to conduct business as contemplated herein. The Distributor represents and warrants that the Distributor shall conduct business in strict conformity with all local, state and federal laws, rules and regulations. 8. The Principal agrees that the Distributor may employ or engage representatives or sub-distributors in furtherance of this Agreement and the Distributor agrees that the Distributor shall be solely responsible for the payment of wages or commissions to those representatives and sub-distributors, and that under no circumstances shall Distributor's representatives be deemed employees of Principal for any purpose whatsoever. 9. Principal will grant Distributor a discount based on the Products and Prices. The proposed discount is expected to be \u00a8%. Discount may vary depending on product volume ordered or promotions. 10. This Agreement shall be in effect until March 18. 2021, unless sooner terminated by either party upon (30) days written notice, without cause. 11. In the event of termination, the Distributor shall be entitled to receive all orders accepted by the Principal prior to the date of termination and may sell the ordered Products in the Territory. Payment to be made upon shipment. Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of termination, neither party, their heirs nor successors shall issue any challenge whatsoever to contest\", \"level\": 1, \"text\": \"12. In the event of termination, neither party, their heirs nor successors shall issue any challenge whatsoever to contest the termination. 13. The Distributor is an independent contractor and nothing contained in this agreement shall be deemed or interpreted to constitute the Distributor as a partner or employee of the Principal, nor shall either party have any authority to bind the other in any respect, it being understood and agreed that all orders submitted by the Distributor are subject to acceptance by Principal in its sole discretion. 14. It is agreed between the parties that there are no other agreements or understandings between them relating to the subject matter of this Agreement. This Agreement supersedes all prior agreements, oral or written, between the parties and is intended as a complete and exclusive statement of the agreement between the parties. No change or modification of this Agreement shall be valid unless the same be in writing and signed by the parties. 15. This Agreement shall not be assigned by the Distributor without the prior written consent of the Principal. 16. Official communication from Distributor or the Principal shall be in written form or by email, acknowledged by the recipient. 17. This Agreement shall be construed in accordance with and governed by the laws of the State of Texas without regard to principles of conflicts of laws. 18. Each of Principal and Distributor represents that it has the right to enter into this Agreement and that this Agreement does not violate any agreement to which it is a party. Principal represents that it owns or has rights to the intellectual property embodied in the Products. Intending to be legally bound, the parties hereto have caused this Agreement to be executed as of the date first above written. BY /s/ Cameron Gundry BY /s/ Justin Anderson Cameron Gundry, Dir. of Commercialization Justin Anderson, CEO Co-Diagnostics, Inc. PreCheck Health Services, Inc. (Principal) (Distributor) Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020 .EXHIBIT A LIST OF PRODUCTS Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020 Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020 Source: PRECHECK HEALTH SERVICES, INC., 8-K, 3/20/2020\"}}, {\"id\": \"party:Co-Diagnostics, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Co-Diagnostics, Inc.\", \"role\": \"Principal\", \"address\": \"Utah, United States\"}}, {\"id\": \"party:PreCheck Health Services, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PreCheck Health Services, Inc.\", \"role\": \"Distributor\", \"address\": \"United States of America, Latin America, Europe and Russia\"}}, {\"id\": \"term:Principal\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Principal\", \"text\": \"Co-Diagnostics, Inc. (herein referred to as \\\"Principal\\\")\", \"definition_clause\": \"EXHIBIT 99.2\"}}, {\"id\": \"term:Distributor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor\", \"text\": \"PreCheck Health Services, Inc. (herein referred to as \\\"Distributor\\\")\", \"definition_clause\": \"EXHIBIT 99.2\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"Principal's qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box\u2122 instrument (the \\\"Products\\\")\", \"definition_clause\": \"EXHIBIT 99.2\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"the countries of Romania (the \\\"Territory\\\")\", \"definition_clause\": \"EXHIBIT 99.2\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"(30) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.18\", \"level\": 1, \"text\": \"Exhibit 10.18 MASTER SUPPLY AGREEMENT MASTER SUPPLY AGREEMENT (the \\\"Agreement\\\") dated November 1, 2019 (the \\\"Effective Date\\\") between REYNOLDS CONSUMER PRODUCTS LLC, a Delaware limited liability company with its headquarters at 1900 West Field Court, Lake Forest, IL 60045 (\\\"Seller\\\"), and PACTIV LLC, a Delaware limited liability company with its headquarters at 1900 West Field Court, Lake Forest, IL 60045 (\\\"Buyer\\\"). Seller and Buyer are referred to individually at times as a \\\"Party\\\" and collectively at times as the \\\"Parties\\\". BACKGROUND A. Seller sells various types of products used in the consumer and food service markets. B. Buyer sells various types of products, including certain products of the type made by Seller, to its customers.\"}, {\"id\": \"C\", \"title\": \"The Parties are entering into this Agreement to establish the terms and conditions under which Seller may agree to sell\", \"level\": 1, \"text\": \"C. The Parties are entering into this Agreement to establish the terms and conditions under which Seller may agree to sell specific products to Buyer, and Buyer may agree to purchase specific products from Seller for later resale by Buyer to its business customers. AGREEMENT\"}, {\"id\": \"1\", \"title\": \"Term\", \"level\": 1, \"text\": \"1. Term. The \\\"Term\\\" of this Agreement will commence on the Effective Date and will end on the earlier of: (a) the first anniversary of the expiration date of the last Purchase Schedule (as defined in this next Section); (b) a termination date elected by a Party in a written notice delivered to the other Party any time after the expiration of the last Purchase Schedule; or (c) a termination date elected by a Party in a written notice delivered to the other Party as provided in Subsection 11(d) of this Agreement. The rights and obligations of the Parties under this Agreement will survive the expiration or earlier termination of this Agreement with respect to any (i) products purchased and sold under this Agreement during the Term and products sold after the Term for orders accepted during the Term; (ii) Confidential Information (as defined in Section 10 of this Agreement) disclosed or received by a Party during the Term; (iii) breach of this Agreement by a Party; (iv) any other statement, decision, act or omission of a Party concerning or related to this Agreement; (v) any Dispute (as defined in Section 11 of this Agreement) between the Parties concerning or related to this Agreement; (vi) products and other materials manufactured or maintained by Seller in inventory for sale to Buyer that Buyer is obligated to purchase under a Purchase Schedule; and (vii) any provision that expressly states that it will survive the expiration or earlier termination of this Agreement.\"}, {\"id\": \"2\", \"title\": \"Scope\", \"level\": 1, \"text\": \"2. Scope. This Agreement will apply to all products sold by Seller to Buyer, and all products purchased by Buyer from Seller, during the Term unless the Parties expressly agree that this Agreement will not apply to a particular type of transaction in a separate written document signed by an officer of each Party. This Agreement will not require Seller to sell any type or quantity of a product to Buyer, nor will this Agreement required Buyer to purchase any type or quantity of a product from Seller, except as expressly provided by the Parties in a Purchase Schedule. The phrase \\\"Purchase Schedule\\\" will mean a written supplement to this Agreement signed by an officer of each Party which references this Agreement and which identities, among other terms and conditions, the specific types and quantities of products that will be purchased and sold by the Parties on terms and conditions in the schedule, the specifications for the identified products, the duration of the commitment period during which the Parties will be obligated to purchase and sell the identified products on the terms and conditions in the schedule, the prices of the identified products, any mechanisms for adjusting the prices of the identified products over the commitment period, and the facilities at which the identified products will be manufactured, stored and delivered by Seller. The Parties may add terms and conditions to, and amend the terms and conditions of, this Agreement in a Purchase Schedule, but any additional and amended terms and conditions in a Purchase Schedule supplementing and modifying this Agreement will only apply the specific products identified in that Purchase Schedule for its duration. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}, {\"id\": \"3\", \"title\": \"Standard Operating Procedures\", \"level\": 1, \"text\": \"3. Standard Operating Procedures. Over approximately the past eight years, the Parties have been supplying select Products to one another for use in the operation of their respective businesses within the United States of America, Canada and Mexico. The Parties developed and been following certain standard operating procedures in connecting with, among other topics, forecasting, production planning, ordering, delivering and resolving claims on the Products supplied to one another (the \\\"Current SOPs\\\"). The Parties will be updating their respective business systems over the next six months, and the updates to these business systems will require the Parties to modify the Current SOPs. Once the Parties have completed the updates to the business systems and agreed on the necessary modifications to the Current SOPs, the Parties will sign a written amendment to this Agreement appending the updated standard operating procedures (the \\\"Updated SOPs\\\"). Until the Parties have signed a written amendment appending the Updated SOPs, the parties will continue to follow the Current SOPs. The Parties will comply with the applicable SOPs in connection with the purchase and sale of products identified in a Purchase Schedule. The Parties may add terms and conditions to, and amend the terms and conditions of, the SOP in a Purchase Schedule, but any additional and amended terms and conditions in a Purchase Schedule supplementing and modifying the SOP will only apply the specific products identified in that Purchase Schedule for its duration.\"}, {\"id\": \"4\", \"title\": \"Order and Priority of Interpretation\", \"level\": 1, \"text\": \"4. Order and Priority of Interpretation. In the event of any conflict, inconsistency or ambiguity between two or more provisions in this Agreement, including the provisions in its Exhibits and Purchase Schedules, the provisions in the documents will govern, supersede and control over one another in the following order of priority: (1st) a Purchase Schedule with regards to the purchase and sale of the specific products identified in that Purchase Schedule for its duration; (2nd) the SOP; (3rd) any Exhibit to this Agreement but only with regards to specific subject matter of the Exhibit; and (4t h) the main body of this Agreement prior to the signature page.\"}, {\"id\": \"5\", \"title\": \"General Representations, Warranties and Covenants\", \"level\": 1, \"text\": \"5. General Representations, Warranties and Covenants. A Party represents, warrant and covenants on the Effective Date and at all times during the Term that: a. The Party is formed, registered, licensed and operating its business in compliance with the laws of the United States of America, its states and territories, and any districts, municipalities and other political subdivisions of the foregoing (\\\"Applicable Laws\\\"). b. The Party is operating its business in compliance with a commercially reasonable code of ethics adopted by such Party. c. The Party may enter into and perform its obligations under this Agreement without being in conflict with, or in breach of, any other agreement of the Party. d. The Party is solvent, is capable of paying its debts as and when they become due and is paying its debts as and when due. e. The Party is not the subject of a criminal investigation nor a defendant in any criminal indictment, petition, complaint or proceeding that carries a potential sentence involving incarceration in excess of one year for any director or executive officer of the Party involved in the alleged criminal misconduct or a fine in excess of $100,000 USD. A Party will promptly notify the other Party of any change in circumstance during the Term in which the Party is no longer in compliance with the foregoing general representations, warranties and covenants. An incident of actual, alleged or suspected non-compliance by a Party with a warranty under this Section being investigated, contested or corrected in good faith by the Party and which, regardless of outcome, will have no material adverse effect on the Party or its performance under this Agreement or on the other Party, will not be considered a breach of this clause. An incident of actual, alleged or suspected non-compliance by a Party of this Section or any other Section of this Agreement will be grounds for the other Party to demand adequate assurances of performance as provided by Section 2-609 of the Illinois Uniform Commercial Code. A Party will have ten (10) days to provide adequate assurances of performance to the other Party in a form acceptable to the other Party in its good faith discretion. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}, {\"id\": \"6\", \"title\": \"Specific Product Warranties\", \"level\": 1, \"text\": \"6. Specific Product Warranties. Seller represents and warrants to Buyer that each product sold under this Agreement will at the time of delivery to Buyer: a. Be in new, undamaged and unadulterated condition free of any defects in design, materials and manufacture. Seller is not making any representation or warranty under this clause with regards to the design of a product to the extent the design constitutes, incorporates or otherwise embodies intellectual property that Buyer has represented and warranted to Seller is owned by Buyer and which Buyer has licensed to Seller to manufacture the product for Buyer. b. Have been manufactured and stored by Seller at a plant (and, if applicable under a Purchase Schedule, a warehouse) of Seller approved in the applicable Purchase Schedule prior to its delivery to Buyer. c. Has been manufactured, packaged, labelled, sold and delivered by Seller, and may be sold by Buyer in interstate commerce, in compliance with Applicable Laws, including without limitation with food safety regulations issued by the United States Food and Drug Administration that are applicable to the product. Seller will not be in breach of this warranty because an Applicable Law prohibits, restricts or imposes a charge on a product in a district, municipality or other political subdivision of the United States of America or its states or territories. d. Comply with the written specifications for the product identified in the applicable Purchase Schedule. e. Be fit for the purpose of packaging, selling or use in consuming food subject to qualifications and instructions on the use of the product in the written specifications for the product identified in the applicable Purchase Schedule. f. Be conveyed by Seller to Buyer with good and marketable title free and clear of all liens, encumbrances and claims arising by, through or under Seller. g. Not infringe on any patent, trademark, copyright, trade secret or other the intellectual property of any third-party registered or otherwise recognized and enforceable under Applicable Law. Seller is not making any representation or warranty under this clause with regards to the design of a product to the extent the design constitutes, incorporates or otherwise embodies intellectual property that Buyer has represented and warranted to Seller is owned by Buyer and which Buyer has licensed to Seller to manufacture the product for Buyer. h. Comply with any additional representations and warranties of Seller regarding the product in the applicable Purchase Schedule. If a Buyer receives a product that fails to conform to these representations and warranties, the sole remedies of Buyer for the breach of warranty will be to: (1) reject and return the non-conforming product to Seller for a refund or credit, or a replacement conforming product, in the manner and time period provided in the SOP; (2) obtain reimbursement from Seller for actual, reasonable, substantiated out-of-pocket expenses incurred by Buyer in the recovery, return or disposal of a non-conforming product that is the subject of a mandatory product recall required under Applicable Laws or a voluntary withdrawal declared by Seller or approved by Seller (such approval not to be unreasonably withheld, conditioned or delayed); and (3) obtain indemnification from Seller for any Indemnified Claim arising from or related to the non-conforming product as provided in Section 7. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}, {\"id\": \"7\", \"title\": \"Indemnification\", \"level\": 1, \"text\": \"7. Indemnification. a. A claim that a Party (referred to at times in this Section as an \\\"Indemnifying Party\\\") is required to defend and indemnify the other Party (referred to at times in this Section as an \\\"Indemnified Party\\\") under this Agreement is referred to at times in this Section as an \\\"Indemnified Claim\\\". Defense and indemnification under this Section will include, without limitation, (1) paying or reimbursing the actual, reasonable, substantiated out-of-pocket expenses incurred in connection with the investigation, defense and settlement of any civil, criminal or administrative action, suit, arbitration, mediation, hearing, audit, investigation or other proceeding threatened or commenced against an Indemnified Party on an Indemnified Claim (e.g., fees and expenses of attorneys, accountants, auditors, investigators, consulting experts, testifying experts and other consultants; fees and expenses of an arbitrator or mediator; filing fees and costs imposed by any court, administrative agency or other tribunal; etc.), and (2) satisfying any judgment, award, order, lien, levy, fine, penalty or other sanction imposed against an Indemnified Party on an Indemnified Claim. b. Seller will defend and indemnify Buyer against: (1) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged breach of this Agreement by Seller, including, without limitation, any product supplied by Seller which fails to conform to the representations and warranties in this Agreement; (2) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged negligence or other legally culpable misconduct of Seller in the design, manufacture, storage, sale or delivery of any product sold by Seller under this Agreement or in the performance of other obligation of Seller under this Agreement; (3) any third-party claim for actual or alleged infringement of a product sold by Seller under this Agreement or its design, manufacture, storage, packaging, sale or delivery by Seller under this Agreement or in the performance of any other obligation of Seller under this Agreement (except to the extent that the infringement is based on intellectual property that that Buyer has represented and warranted to Seller that Buyer owns and that Buyer has licensed to Seller and that Seller has used in compliance with the license terms in supplying the product); (4) the threat or imposition of any fine, penalty or other sanction by a governmental authority on Buyer to the extent caused by any actual or alleged violation by Seller of Applicable Law; or (5) any other matter that Seller has agreed to defend and indemnify Buyer against under a Purchase Schedule. c. Buyer will defend and indemnify Seller against: (1) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged breach of this Agreement by Buyer; (2) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged negligence or other legally culpable misconduct of Buyer in the purchase, storage, repackaging, resale or delivery of any product purchased from Seller under this Agreement or in the performance of other obligation of Buyer under this Agreement; (3) any third-party claim for actual or alleged infringement of a product sold by Seller under this Agreement or its design, manufacture, storage, sale or delivery by Seller under this Agreement or in the performance of any other obligation of Seller under this Agreement to the extent based on intellectual property that that Buyer has represented and warranted to Seller that Buyer owns and that Buyer has licensed to Seller and that Seller has used in compliance with the license term in supplying the product; (4) the threat or imposition of any fine, penalty or other sanction by governmental authority on Seller to the extent caused by any actual or alleged violation by Buyer of Applicable Law; or (5) any other matter that Buyer has agreed to defend and indemnify Seller against under a Purchase Schedule. d. As a condition of receiving defense and indemnification under this Section for an Indemnified Claim, the Indemnified Party must: (1) notify and tender the defense of an Indemnified Claim to the Indemnifying Party promptly after the Indemnified Party learns of the Indemnified Claim; and Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 (2) provide information and cooperation reasonably requested by the Indemnifying Party in the investigation, defense, settlement and satisfaction of the Indemnified Claim. An Indemnifying Party will reimburse the Indemnified Party of any reasonable, actual, substantiated out-of-pocket expense incurred in providing the requested information or cooperation. e. If the Indemnifying Party accepts the tender of defense of an Indemnified Claim, with or without reservation, the Indemnifying Party will: (1) promptly notify the Indemnified Party of the acceptance of the tender of defense of the Indemnified Claim. (2) control the investigation, defense, settlement and satisfaction of the Indemnified Claim, including, without limitation, the selection of licensed, qualified and reputable attorneys and expert witnesses and all decisions over settlement and litigation strategy. The Indemnifying Party must act in good faith in exercising control over the investigation, defense, settlement and satisfaction of the Indemnified Claim. (3) Provide information reasonably requested by the Indemnified Party regarding the investigation, defense, settlement and satisfaction of the Indemnified Claim f. An Indemnifying Party, acting in good faith, may settle an Indemnified Claim for which it is responsible under this Agreement involving infringement on the intellectual property of a third-party by: (1) obtaining a license from the third-party allowing the required use of its intellectual property; (2) modifying a product, equipment or process in a manner which avoids infringing on the intellectual property of the third-party; or (3) voluntarily withdrawing the infringing product from the market and either refunding the amount paid by the Indemnified Party for the infringing product or replacing the infringing product with a non-infringing product. g. The Parties may disagree on whether a claim is an Indemnified Claim under this Agreement, which Party should be considered the Indemnifying Party and Indemnified Party for an Indemnified Claim or whether each Party is partially liable for an Indemnified Claim and how liability for such an Indemnified Claim should be allocated between them. In these and other circumstances in which an actual or potential conflict of interest exists or arises between the Parties with regards to an alleged or agreed upon Indemnified Claim that would preclude their joint representation by a single defense counsel, the Parties will endeavor in good faith to attempt to resolve the conflict. If the Parties are able to resolve the actual or potential conflict of interest, the Parties will memorialize the agreed upon resolution in a written joint defense agreement signed by officers of each Party and their joint defense counsel. If the Parties are unable to resolve the actual or potential conflict of interest, each Party may independently and separately investigate, defend, settle and satisfy the claim subject to their right to pursue payment or reimbursement for costs incurred in doing so from the other Party as provided in this Agreement.\"}, {\"id\": \"8\", \"title\": \"Insurance\", \"level\": 1, \"text\": \"8. Insurance. During the Term of this Agreement, each Party will maintain the following minimum types and amounts of insurance coverage during the Term of this Agreement: a. Commercial General Liability Insurance. Occurrence based coverage with a combined single limit of at least $10,000,000 per occurrence and in the aggregate for premises and operations; products and completed operations; contractual liability coverage for indemnities of a Party contained within this Agreement; broad form property damage (including completed operations); explosion, collapse and underground hazards; and personal injury. Requires additional insured endorsement and waiver of subrogation endorsement. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 b. Automobile Liability Insurance. Occurrence based coverage with a combined single limit of at least $10,000,000 per occurrence and in the aggregate for owned, non-owned, and hired automotive equipment of the Party. Requires additional insured endorsement and waiver of subrogation endorsement. c. Workers' Compensation Liability Insurance. Occurrence based coverage providing benefits in the minimal amount required by Applicable Law for workplace and work related injuries and illnesses to the employees of a Party, including, without limitation, Workers Compensation Acts of applicable U.S. States, the U.S. Longshoremen's and Harbor Workers Compensation Act and the U.S. Jones Act. Requires alternate employer endorsement and waiver of subrogation endorsement. d. Employers' Liability Insurance. Occurrence based coverage with a limit of at least $10,000,000 per occurrence or any greater limits set by Applicable Law workplace and work related injuries and illnesses to the employees of a Party. Requires waiver of alternate employer endorsement. e. Property Insurance. Coverage providing \\\"all risk\\\" property insurance at the replacement value of the machinery, equipment, fixtures, tools, materials and other property of the Party. \\\"All risk\\\" coverage will include, by way of example and not limitation, loss or damage resulting from earthquakes, floods, wind, fire or other natural or weather-related phenomenon. Requires waiver of subrogation endorsement. All insurers of a Party on such policies must have at all times an A.M. Best financial rating of at least \\\"A-Minus VII\\\". An insuring Party may satisfy the required minimum amounts of insurance through a primary policy and one or more excess policies. All insurance of an insuring Party must be \\\"primary and non-contributory\\\" with respect to any insurance that the other Party may maintain, but only with respect to the negligence or other legal liability of the insuring Party. An insuring Party must deliver the following written evidence of the required insurance coverage to the other Party (Attention: Risk Management), or its designated insurance monitoring service, within ten (10) of written request and at least thirty (30) days in advance of the expiration of a then current policy term (if a declaration or endorsement is not available from an insurer at the time requested or required, an insuring Party will provide them as soon as the declaration or endorsement is available from the insurer): i. Certificate of insurance confirming that the required insurance coverage and minimal limits are met for the extended, renewed or replacement policy term. ii. Declaration pages of insurance policy (or a copy of the binder until the declaration pages are available) confirming that the required insurance coverage and minimal limits are met for the extended, renewed or replacement policy term. iii. Copies of additional insured endorsements required for applicable policies in the name and for the benefit of: \\\"[NAME OF OTHER PARTY], its parent, subsidiaries and affiliates; any lessors of the foregoing and any mortgagees, deed of trust beneficiaries and secured creditors of such lessors; and any successors and assignees of all of the foregoing.\\\" iv. Copies of alternate employer endorsements and waiver of subrogation endorsements required for applicable policies in the name and for the benefit of: \\\"\\\"[NAME OF OTHER PARTY], its parent, subsidiaries and affiliates; any lessors of the foregoing and any mortgagees, deed of trust beneficiaries and secured creditors of such lessors; and any successors and assignees of all of the foregoing.\\\" Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 A Party may maintain any level of deductible on required insurance coverage allowed by Applicable Law. A Party may also self-insure any of the required insurance coverage, in whole or in part, if allowed by Applicable Law during any period that the Party maintains a tangible net worth in excess of $100 million USD and maintains a professionally managed and adequately reserved for and funded self-insurance program.\"}, {\"id\": \"9\", \"title\": \"Limitations on Liability\", \"level\": 1, \"text\": \"9. Limitations on Liability. a. Disclaimer of Representations and Warranties. Each Party: (1) disclaims all representations and warranties regarding its products, performance, supplied information or business, whether oral or written, express or implied, arising by operation of law or otherwise, including, without limitation, the implied warranty of merchantability and the implied warranty of fitness for a particular purpose, other than those express representations and warranties of the Party in this Agreement; (2) acknowledges that the Party has not relied on, and will not rely on, any representations and warranties of the other Party regarding its products, performance, supplied information or business, whether oral or written, express or implied, arising by operation of law or otherwise, other than those express representations and warranties of the other Party in this Agreement; and (3) waives any claim that the Party may have based, in whole or in part, on any representations and warranties of the other Party regarding its products, performance, supplied information or business, whether oral or written, express or implied, arising by operation of law or otherwise, other than those express representations and warranties of the other Party in this Agreement. Notwithstanding the foregoing, Buyer is entitled to rely on (i) the descriptive information in transaction documents issued by either Party in the ordinary course of business during the Term identifying the ordered Products (e.g., the type and quantity of ordered products and scheduled date and location for delivery) and (ii) FDA guaranty letters and other similar written assurances in Seller's standard forms certifying that a product complies with Applicable Laws issued by Seller to Buyers and other U.S. customers in the ordinance course of business during the Term. b. Exclusion of Indirect Damages; Waiver of Claim for Insured Damage or Loss. A Party that breaches this Agreement will only be liable to the other Party for direct damages arising from the breach. Each Party waives any right to recover consequential, incidental, indirect, exemplary, punitive or any other types of indirect damages from the other Party for a breach of this Agreement. Notwithstanding the preceding sentences, this Subsection will not limit the liability of a Party for any amount or type of damages for: (1) the defense and indemnification of an Indemnified Claim on which the Party is the Indemnifying Party; (2) infringement by the Party on the intellectual property of the other Party; (3) the unauthorized disclosure or use by the Party of the Confidential Information of the other Party; (4) payment or reimbursement of any amount expressly required to be paid or reimbursed by the Party under a provision of this Agreement; or (5) the intentional misconduct of the Party in violation of Applicable Laws. c. Force Majeure. A Party will not be considered in breach of this Agreement or liable to the other Party for any interruption or delay in performance under this Agreement to the extent caused by an event outside of the ability of the performing Party to foresee and avoid with the exercise of commercially reasonable efforts (such an event is referred to at times as an event of \\\"Force Majeure\\\"). Examples of events of Force Majeure include, without limitation: natural disasters; war; acts of terrorism; government action; accident; strikes, slowdowns and other labor disputes; shortages in or inability to obtain material, equipment, transportation or labor; any breach, negligence, criminal misconduct or other act or omission of any third-party; fire or other insured or uninsured casualty. A Party whose performance is interrupted or delayed by an event of Force Majeure will be excused from the interruption or delay in performance during the event of Force Majeure and for a commercially reasonable period of additional time after the event of Force Majeure that the Party needs to recover from the event of Force Majeure and restore performance. Notwithstanding the foregoing, a Party will only be excused for an interruption or delay in performance under this Subsection for an event of Force Majeure only if the Party (1) promptly notifies the other Party of the event of Force Majeure and provides information reasonably requested by the other Party regarding the event of Force Majeure, the efforts undertaken by the Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 Party to foresee and avoid interruption or delay in its performance before the occurrence of the event, to mitigate interruption or delay in performance during the event, and to recover from and restore performance following the event; and (2) the Party exercises commercially reasonable efforts to mitigate, recover from and restore performance following the event of Force Majeure. During, and while recovering from and restoring performance following, an event of Force Majeure, Seller will act in good faith in allocating its available manufacturing capacity to supply products to Buyer under this Agreement and any products to other customers of Seller. If an event of Force Majeure interrupts or delays Seller from supplying a product to Buyer under this Agreement in the quantities and timetable required by Buyer, Buyer may cancel any unfilled orders for the product with Seller and procure the required quantities of the product from one or more other sources until Seller has recovered from and restored its ability to perform following the event of Force Majeure. If the interruption or delay in the supply of a product to Buyer under this Agreement caused by an event of Force Majeure has exceeded, or is reasonably likely to exceed, thirty (30) days, Buyer may enter into longer term supply agreements or make other arrangements to procure the required quantities of the product from one or more other sources for a duration and on terms acceptable to Buyer in its good faith discretion. In such a circumstance, Buyer will not have to resume purchasing the product from Seller under this Agreement until Seller has recovered from and restored its ability to perform following the event of Force Majeure and the longer term agreements or other arrangements have expired or Buyer is able to end them without liability. This Subsection will not excuse nor extend a deadline by which a Party must pay an amount owed under this Agreement or Applicable Law or by which a Party must exercise any right or remedy under this Agreement or Applicable Law.\"}, {\"id\": \"10\", \"title\": \"Confidential Information and Other Intellectual Property\", \"level\": 1, \"text\": \"10. Confidential Information and Other Intellectual Property. a. The Parties anticipate exchanging Confidential Information (as defined in in the next Subsection) over the Term of this Agreement for the purpose of negotiating and entering into Purchase Schedules and amendments to this Agreement, transacting business with one in accordance with this Agreement and exercising their rights and performing their obligations under this Agreement (collectively referred to as the \\\"Authorized Purpose\\\"). b. The phrase \\\"Confidential Information\\\" means information meeting all of the following criteria: 1) The information is a trade secret or other non-public, proprietary information owned by a Party or its direct and indirect subsidiaries under Applicable Law (this Party is referred to at times in this Section as the \\\"Disclosing Party\\\"); and 2) The other Party (referred to at times in this Section as the \\\"Receiving Party\\\") requests such information from the Disclosing Party for the Authorized Purpose during the Term (i.e., neither Party wants unsolicited Confidential Information from the other Party); and 3) The Disclosing Party discloses such requested information to the Receiving Party during the Term either labelled as \\\"Confidential\\\" or words of similar intent, or describes the disclosed information in reasonable detail in a written notice to the Receiving Party delivered, either at the time of disclosure or within five (5) days of disclosure. If a Disclosing Party neglects to label or deliver timely written notice to the Receiving Party identifying the disclosed information as confidential in nature, the disclosed information will only be treated as Confidential Information under this Agreement if the Disclosing Party is able to demonstrate by clear and convincing evidence that the Receiving Party knew that the disclosed information was a trade secret or other non-public, proprietary information of the Disclosing Party at the time of disclosure. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 The criteria in Clause (2) and Clause (3) will not apply to Confidential Information of a Disclosing Party observed or heard by a Receiving Party in a plant, warehouse, facility or system of the Disclosing Party. The existence and terms of this Agreement, and the existence, nature and extent of the business relationship between the Parties, will be considered the Confidential Information of each Party. c. The phrase \\\"Confidential Information\\\" also means the Know-How of a Disclosing Party and its direct and indirect subsidiaries that a Receiving Party and its direct and indirect subsidiaries learned of, acquired or otherwise used prior to the Effective Date. The phrase \\\"Know-How\\\" means trade secret and other confidential, proprietary information of a Party or its Affiliate concerning the manufacture, storage, packaging, marketing, sale and delivery of its products. Examples of Know-How may be in the form of drawings, equipment specifications, formulae, formulations, guidelines, manuals, methods, plans, policies, procedures, processes, properties and applications of raw materials and products, tools, dies and molds. A Receiving Party and its direct and indirect subsidiaries may continue to use the Know- How of the Disclosing Party and its direct and indirect subsidiaries in the possession of the Receiving Party and its direct and indirect subsidiaries as of the Effective Date for the Authorized Purpose and in connection with the operation of the business of the Receiving Party and its direct and indirect subsidiaries. Nothing in this Subsection or any other provisions of this Agreement will obligate a Party to disclose or license the use of its Know-How of any kind and in any form arising, discovered, acquired or developed after the Effective Date to the other Party. d. The phrase \\\"Confidential Information\\\" does not include, and there will not be any duties of confidentiality or other restrictions under this Agreement for, the following types of information: (1) Information which is or becomes available as part of the public domain through any means other than as a result of a breach of this Agreement by the Receiving Party; or (2) Information, other than Know-How received prior the Effective Date, which is known to the Receiving Party before the disclosure of the same information by the Disclosing Party; or (3) Information which is or becomes available to the Receiving Party from a third-party who is not under any duty to preserve the confidentiality of such information; or (4) Information which is furnished by the Disclosing Party to a third-party without imposing any duty on the third-party to preserve the confidentiality of such information; or (5) Information which is independently developed by the Receiving Party without the use of or reliance on any trade secret or other non-public, proprietary information provided by the Disclosing Party as Confidential Information under this Agreement or under any prior agreement between the Parties; or (6) Information that ceases to be a trade secret or other non-public, proprietary information of the Disclosing Party under applicable law through any means other than those enumerated above that does not involve nor result from a breach of this Agreement by the Receiving Party. e. A Party may request and disclose Confidential Information in any form or medium. Confidential Information may include, without limitation, information concerning the assets, liabilities, financing, financial statements, ownership, goods, services, customers, suppliers, marketing, manufacturing, equipment, software, technology, supply chain, business strategies, plans, models, policies, methods, processes, formulae, specifications, drawings, schematics, software and technical know-how of a Disclosing Party. A Receiving Party will take all commercially reasonable actions required to safeguard the Confidential Information of a Disclosing Party in the possession of such Receiving Party against the unauthorized disclosure or use of the Confidential Information by other persons. A Receiving Party will promptly notify the Disclosing Party if the Receiving Party learns of any unauthorized disclosure or use of the Confidential Information of the Disclosing Party by any Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 person. A Receiving Party will cooperate in good faith with the Disclosing Party to prevent any unauthorized disclosure or use of the Confidential Information of the Disclosing Party by any person. f. A Receiving Party will not disclose nor use the Confidential Information of a Disclosing Party except as follows: (1) A Receiving Party may disclose Confidential Information of a Disclosing Party on a \\\"need to know\\\" basis to the Representatives of the Receiving Party who require such information for the Authorized Purpose and in order for the Receiving Party and its Affiliates to comply with Applicable Laws, accounting standards and securities exchange requirements. Before making such a disclosure, the Receiving Party will advise the Representatives of the confidential nature of the information being shared and ensure that duties and restrictions are, or have been, imposed on the Representatives receiving the Confidential Information similar to those imposed on the Receiving Party under this Agreement. A Receiving Party will be liable for any breach of this Agreement by its Representatives. An \\\"Affiliate\\\" of a Party means a legal entity that owns and controls, or is owned and controlled by, or is under common ownership and control with, a Party (other than the other Party or any of its direct and indirect subsidiaries), with ownership and control of a legal entity being determined by the ownership of the majority voting interest in the legal entity. A \\\"Representative\\\" means the Affiliates of a Party and the directors, officers, managers, employees, accountants, attorneys, auditors and other agents and consultants of a Party and its Affiliates. (2) A Receiving Party may disclose Confidential Information of a Disclosing Party to a court, governmental entity or any other person in order for the Receiving Party and its Affiliates to comply with Applicable Laws, accounting standards and securities exchange requirements. If legally permissible and reasonably possible, a Receiving Party will notify the Disclosing Party prior to disclosing its Confidential Information pursuant to this Section and cooperate in good faith with any lawful efforts by the Disclosing Party to avoid or limit the disclosure of its Confidential Information. A Receiving Party will not be obligated to incur any liability, expense or risk in extending such cooperation to a Disclosing Party. Based on legal advice of its attorney, a Receiving Party may disclose the Confidential Information of the Disclosing Party by any deadline established under an Applicable Law, accounting standard and securities exchange requirement. (3) A Receiving Party may disclose and use the Confidential Information of a Disclosing Party to enforce or interpret this Agreement or any other agreement with the Disclosing Party in any arbitration, court or other legal proceeding. A Receiving Party may disclose and use this Confidential Information of a Disclosing Party to defend the Receiving Party or its Affiliates or their respective Representatives in any arbitration, court or other legal proceeding. In either circumstance, the Receiving Party will ensure that a protective order, agreement or other mechanism is in place to preserve the confidentiality of the Confidential Information. (4) A Receiving Party and its Representatives may disclose and use the Confidential Information for any other purpose consented to by a Disclosing Party in a written notice signed by an officer of the Disclosing Party delivered to the Receiving Party. g. In disclosing its Confidential Information to a Receiving Party, a Disclosing Party represents, warrants and covenants to the Receiving Party that: (1) The Disclosing Party owns and has the right to disclose and authorize the use of Confidential Information as provided in this Agreement. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 (2) The Receiving Party and its Representatives may use the Confidential Information of the Disclosing Party for the Authorized Purpose and other limited purposes provided in this Agreement. (3) The Disclosing Party will indemnify, defend and hold harmless the Receiving Party and its Representatives against any claim of a third-party that the disclosure and use of the Confidential Information of the Disclosing Party as provided in this Agreement infringes on a patent, trademark, copyright, trade secret or other intellectual property of the third-party registered in or otherwise recognized and enforceable under Applicable Laws. Except for the limited representations and warranties in this Section, a Disclosing Party disclaims all other representations and warranties of any kind related to its Confidential Information, whether express, implied or arising by operation of law, including the disclaimer, without limitation, of any representation and warranties concerning merchantability, fitness for a particular purpose, truth, accuracy or completeness. h. The rights and obligations of the Parties under this Section with regards to disclosed Confidential Information will continue: (1) Until the earlier of (i) sixty (60) months from the date of disclosure to a Receiving Party or (ii) the date such information ceases to be considered Confidential Information under this Agreement, for Confidential Information that is not a trade secret of a Disclosing Party under Applicable Law; and (2) Until Confidential Information that is a trade secret of a Disclosing Party under Applicable Law ceases to be a trade secret of the Disclosing Party under Applicable Law. i. A Receiving Party will return or destroy all forms of Confidential Information of the Disclosing Party in the custody of the Receiving Party and its Representatives within ten (10) days of receipt of a written request from the Disclosing Party and after the expiration or earlier termination of this Agreement. This will include, without limitation, all copies, records, documents and other information representing, comprising, containing, referencing or created based on Confidential Information of the Disclosing Party. Notwithstanding the foregoing, a Receiving Party and its Representatives may retain copies of Confidential Information of the Disclosing Party which (x) the Receiving Party and its Representatives are required to retain to comply with Applicable Laws, accounting standards and security exchange requirements (but only for the duration and in the manner so required for this limited purpose); or (y) have been archived in electronic form by the Receiving Party and its Representatives and which would be unduly burdensome for the Receiving Party and its Representatives to have to search for and delete the Confidential Information of the Disclosing Party. j. Except for the limited right to disclose and use Confidential Information of a Disclosing Party for the Authorized Purpose and other purposes provided in the this Section and except for any license of intellectual property granted by a Disclosing Party to the Receiving Party in a Purchase Schedule, this Agreement does not grant a Receiving Party or its Representatives any right, title, interest or ownership in the Confidential Information of the Disclosing Party nor in any patent, trademark, copyright or other intellectual property of the Disclosing Party. As between the Parties during the Term, to be effective, the grant of any right, title, interest and ownership in and to any Confidential Information of Party or in an patents, trademarks, copyrights and other intellectual property of the Party must be in writing and signed by the chief executive officers of the Parties. During the Term, a Party will not develop intellectual property for, on behalf of, or in collaboration with, the other Party unless the Parties have entered into a Purchase Schedule or other separate written agreement signed by an officer of each Party. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}, {\"id\": \"11\", \"title\": \"Dispute Resolution\", \"level\": 1, \"text\": \"11. Dispute Resolution. a. Negotiation. If a Party believes that the other Party has breached this Agreement or if there is a dispute between the Parties over the interpretation of this Agreement (a \\\"Dispute\\\"), the Parties will endeavor to resolve the Dispute through good faith negotiation for a period of thirty (30) days after a Party notifies the other Party of the Dispute and before either Party requests mediation or files litigation to resolve the Dispute. b. Mediation. If the Parties have been unable to resolve a Dispute through good faith negotiation as provided in the prior Subsection, a Party may request that the Parties attempt to resolve the Dispute through mediation by notifying the other Party with a copy to JAMS. The Parties will attempt to select a mutually acceptable JAMS mediator within ten (10) days of the notice requesting mediation. The mediation will be held in Lake County or Cook County, Illinois within thirty (30) days of the notice requesting mediation before a JAMS mediator and in compliance with JAMS mediation guidelines. Each party will bear its own costs in preparing for and participating in the mediation and one-half of the fees and expenses charged by JAMS for conducting the mediation. c. Litigation. If the Parties have been unable to resolve a Dispute through mediation as provided in the prior Subsection, a Party may file litigation against the other Party in a court of competent jurisdiction in the United States of America. With respect to litigation involving only the Parties or their Affiliates, the Parties irrevocably consent to the exclusive personal jurisdiction and venue of the U.S. federal and Illinois state courts of competent subject matter jurisdiction located in Lake County, Illinois or Cook County, Illinois and their respective higher courts of appeal for the limited purpose of resolving a Dispute, and the Parties waive, to the fullest extent permitted by law, any defense of inconvenient forum. The Parties waive any right to trial by jury as to any Disputes resolved through litigation. Notwithstanding the foregoing, a Party may file litigation to resolve a Dispute without undergoing either negotiation or mediation as provided in the prior Subsections for any Dispute involving: (i) infringement on intellectual property; (ii) the unauthorized use or disclosure of Confidential Information; or (iii) a request for a temporary restraining order, a preliminary or permanent injunction or any other type of equitable relief. d. Remedies. Except as expressly limited in the preceding Subsections and the other provisions in this Agreement, a Party may immediately exercise any rights and remedies available to the Party under Applicable Law upon a breach of this Agreement by the other Party. A Party will not suspend performance under or terminate this Agreement or any accepted purchase order for a product being purchased and sold under this Agreement unless: (1) the other Party is in material breach of this Agreement and has either refused to cure the material breach or has failed to cure the material breach within thirty (30) day of its receipt of written notice of the failure; and (2) the Parties have been unable to resolve the Dispute related to the material breach through negotiation or mediation, or the breaching Party has refused or failed to attempt to resolve the Dispute through negotiation or mediation, as provided in this Section. Notwithstanding the foregoing, a Party may suspend performance or terminate this Agreement or any accepted purchase order for a product being purchase and sold under this Agreement immediately on written notice to the other Party, and without providing the other Party an opportunity to cure the material breach or attempting to resolve a Dispute over the material breach by negotiation or mediation as provided in this Section, for a material breach by the other Party involving substantial harm to the reputation, goodwill and business of the non-breaching Party that cannot reasonably be avoided or fully redressed by providing the other Party an opportunity to cure the material breach. e. Late Fees and Collection Costs. If Buyer fails to pay Seller an amount owed under this Agreement by the invoice due date, then Buyer will owe Seller: (i) the delinquent amount; and (ii) a late payment fee equal to two percent (2%) of the delinquent amount for each full or partial calendar month past the invoice due date that the delinquent amount remains unpaid. In addition, if Seller has to file Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 litigation to collect the amount owed and Seller prevails in the litigation, Buyer will reimburse Seller for actual, reasonable, substantiated out-of-pocket expenses incurred by Seller in collecting the delinquent amount and accrued late payment fees on the delinquent amount. Under no circumstance will the late payment fee payable to Seller exceed the amount that a creditor may lawfully impose on a debtor on a delinquent amount under Applicable Law.\"}, {\"id\": \"12\", \"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"12. Miscellaneous. a. Entire Agreement. This Agreement, including its appended Exhibits and Purchase Schedules entered into during the Term, constitutes the entire agreement between the Parties with respect to the sale of products by Seller to Buyer and the purchase of products by Buyer from Seller. This Agreement supersedes all prior and simultaneous representations, discussions, negotiations, letters, proposals, agreements and understandings, whether written or oral, with respect to this subject matter. This Agreement will not be binding on either Party unless and until signed by the chief executive officers of each Party. No handwritten or other addition, deletion or other modification to the printed portions of this Agreement will be binding upon either Party to this Agreement. b. Amendments. A Party may not amend nor supplement the terms and conditions in this Agreement through the inclusion of additional or different terms and conditions in any quotation, purchase order, invoice, bill of lading, letter, email or other document or communication. This Section does not prevent the reliance on the descriptive information in transaction documents identifying the ordered Products (e.g., the type and quantity of ordered products and scheduled date and location for delivery). No amendment of this Agreement will be valid or effective unless made in writing and signed and exchanged by the chief executive officers of the Parties. A Party may approve or reject a request for an amendment in its sole and absolute discretion. c. Waiver. The failure of either party to insist in any one or more instances upon strict performance of any of the provisions of this Agreement or to take advantage of any of its rights shall not operate as a continuing waiver of such rights. No right or obligation under this Agreement will be considered to have been waived by a Party unless such waiver is in writing and is signed by an officer of the waiving Party and delivered to the other Party. No consent to or waiver of a breach by either Party will constitute a consent to, waiver of, or excuse for any other, different, or subsequent breach by such Party. d. Governing Law. This Agreement and all claims or causes of action arising out of or related to this Agreement shall be governed in all respects, including as to validity, interpretation and effect, by the laws of the State of Illinois and the United States of America, without giving effect to its principles or rules of conflict of laws. The United Nations Convention on Contracts for the International Sale of Goods will not govern or otherwise be applicable to this Agreement. e. Severability. If any term of provision of this Agreement, or the application thereof shall be found invalid, void or unenforceable by any government or governmental organization having jurisdiction over the subject matter, the remaining provisions, and any application thereof, shall nevertheless continue in full force and effect. f. Assignment. This Agreement, its rights and obligations, is not assignable or transferable by either Party, in whole or in part, except with the prior written consent of the other Party, which consent will not be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, either Party may transfer and assign this Agreement to any of its affiliates or in connection with any merger, consolidation or sale of assets without the other Party's prior consent provided (a) that any such assignment will not result in the assigning Party being released or discharged from any liability under this Agreement, and (b) the purchaser/assignee will expressly assume all obligations of the assigning Party under this Agreement. The assigning Party will provide the other Party with written Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 notice of such assignment prior to or promptly following the effective date of such assignment. A change of control shall be deemed an assignment requiring consent hereunder provided that any transfer or assignment that results in Seller's and Buyer's current common parent, Reynolds Group Holdings Limited, ceasing to control either party shall not require consent of the other party. The restrictions in this Section will not preclude a Party for authorizing an Affiliate to purchase or sell a product on behalf of a Party under this Agreement. Subject to the foregoing, all of the terms, conditions and provisions of this Agreement shall be binding upon and shall inure to the benefit of the successors and assignees of the respective Parties. g. Third Party Beneficiaries. Except as otherwise provided in a Purchase Schedule, there are no intended third-party beneficiaries of this Agreement. h. Good Faith and Cooperation. Except where this Agreement states that a Party may expressly exercise a right or render a decision in its \\\"sole and absolute discretion\\\", a Party will exercise its rights under this Agreement in its good faith business judgment. A Party will perform its obligations under this Agreement in a commercially reasonable manner consistent with industry practices and in compliance with Applicable Law. A Party will promptly take such actions, provide such information and sign such documents as the other Party may reasonably request to obtain the benefits and exercise the rights granted, and to perform the obligations imposed, under this Agreement. i. Notices. Any notice required or permitted to be provided by a Party under this Agreement will be made to the notice address of the receiving Party set forth below or to an alternate notice address later designated by the receiving Party in accordance with this Subsection. Notices will be effective upon actual receipt by the receiving Party. An emailed notice will be effective against a receiving Party only if the Receiving Party acknowledge receipt of the emailed notice in a return notice to the notifying Party. A receiving Party agrees to acknowledge receipt of an email notice in good faith promptly following receipt. A Party may change its address for notice by giving notice to the other party Pursuant to this Subsection. Address for notice to Buyer: Pactiv LLC 1900 West Field Court Lake Forest, IL 60045 Attn: John McGrath, Chief Executive Officer Email: jmcgrath@pactiv.com For any notice concerning default or termination, with a copy to: Pactiv LLC 1900 West Field Court Lake Forest, IL 60045 Attn: Steven R. Karl, General Counsel Email: skarl@pactiv.com Address for notices to Seller: Reynolds Consumer Products LLC 1900 W. Field Court Lake Forest, IL 60045 Attention: Lance Mitchell, Chief Executive Officer Email: Lance.Mitchell@@ReynoldsBrands.com Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 For any notice concerning default or termination, with a copy to: Reynolds Consumer Products LLC 1900 W. Field Court Lake Forest, IL 60045 Attention: David Watson, General Counsel Email: David.Watson@ReynoldsBrands.com j. Independent Contractors. The relationship of the Parties established by this Agreement is that of independent contractors, and nothing contained in this Agreement shall be construed to: (a) give either Party the power to direct and control the day-to-day activities of the other Party, (b) establish the Parties as partners, joint ventures, co-owners or otherwise as participants in a joint or common undertaking, or (c) allow a Party to bind the other Party in any manner or otherwise create or assume any obligation on behalf of the other Party for any purpose whatsoever. A Party will not be considered an agent of the other Party. k. Non-Exclusive Supply Relationship. Except as may be provided in a Purchase Schedule, the Agreement is not evidence of, nor does it create, any form of exclusive supply relationship between the Parties concerning the purchase and sale of products. Except as may be provided in a Purchase Schedule and for the types and quantities of products in an accepted purchase order, nothing in the Agreement obligates a Party to sell or purchase any specified volume, market share or other minimum level of products during the Term. l. Construction. Unless the context otherwise requires, the following rules of construction will be applied to in the interpretation of the Agreement: (1) Headings are for convenience only and do not affect interpretation; (2) Singular includes the plural and vice-versa; (3) Gender includes all genders; (4) If a word or phrase is defined, its other grammatical forms have a corresponding meaning; (5) The meaning of general words is not limited by specific examples introduced by \\\"includes\\\", \\\"including\\\" or \\\"for example\\\" or similar expressions; (6) The word \\\"person\\\" includes an individual, corporation, company, trust, partnership, limited partnership, unincorporated body, joint venture, consortium or other legal entity; (7) A reference in any Purchase Schedule or Exhibit to an Article, Section, Subsection or Clause is a reference to an Article, Section, Subsection or Clause in that Purchase Schedule or Exhibit unless otherwise identified; (8) Reference to a Purchase Schedule or Exhibit is a reference to a Schedule, Exhibit described, appended or otherwise identified in this Agreement; (9) A reference to conduct includes, without limitation, an omission, statement or undertaking, whether or not in writing; (10) A reference to a third-party is a reference to a person who is not a Party to this Agreement; (11) Where a period of time is specified for the performance of any act and dates from a given day or the day of an act or event, the period shall be exclusive of that date; and (12) the Parties agree that the Agreement is the product of negotiation between sophisticated parties and individuals, all of whom were or have been given the opportunity to be represented by counsel, and each of whom had an opportunity to participate in, and did participate in, negotiation of the terms hereof. Accordingly, the Parties acknowledge and agree that the Agreement is not a contract of adhesion and that ambiguities in the Agreement, if any, shall not be construed strictly or in favor of or against either Party, but rather shall be given a fair and reasonable construction. m. Execution. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against the Party whose signature appears thereon, but all of which taken together shall constitute but one and the same instrument. Acceptance of this Agreement may be made by e-mail, mail or other commercially reasonable means showing the signatures of the chief executive officers of the Parties. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 In witness whereof, Seller and Buyer have executed this Master Supply Agreement as of the Effective Date. REYNOLDS CONSUMER PRODUCTS LLC, as Seller By: //s// Lance Mitchell Lance Mitchell Chief Executive Officer PACTIV LLC, as Buyer By: //s// John McGrath John McGrath Chief Executive Officer Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ReynoldsConsumerProductsInc_20191115_S-1_EX-10.18_11896469_EX-10.18_Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.18\", \"level\": 1, \"text\": \"Exhibit 10.18 MASTER SUPPLY AGREEMENT MASTER SUPPLY AGREEMENT (the \\\"Agreement\\\") dated November 1, 2019 (the \\\"Effective Date\\\") between REYNOLDS CONSUMER PRODUCTS LLC, a Delaware limited liability company with its headquarters at 1900 West Field Court, Lake Forest, IL 60045 (\\\"Seller\\\"), and PACTIV LLC, a Delaware limited liability company with its headquarters at 1900 West Field Court, Lake Forest, IL 60045 (\\\"Buyer\\\"). Seller and Buyer are referred to individually at times as a \\\"Party\\\" and collectively at times as the \\\"Parties\\\". BACKGROUND A. Seller sells various types of products used in the consumer and food service markets. B. Buyer sells various types of products, including certain products of the type made by Seller, to its customers.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Parties are entering into this Agreement to establish the terms and conditions under which Seller may agree to sell\", \"level\": 1, \"text\": \"C. The Parties are entering into this Agreement to establish the terms and conditions under which Seller may agree to sell specific products to Buyer, and Buyer may agree to purchase specific products from Seller for later resale by Buyer to its business customers. AGREEMENT\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 1, \"text\": \"1. Term. The \\\"Term\\\" of this Agreement will commence on the Effective Date and will end on the earlier of: (a) the first anniversary of the expiration date of the last Purchase Schedule (as defined in this next Section); (b) a termination date elected by a Party in a written notice delivered to the other Party any time after the expiration of the last Purchase Schedule; or (c) a termination date elected by a Party in a written notice delivered to the other Party as provided in Subsection 11(d) of this Agreement. The rights and obligations of the Parties under this Agreement will survive the expiration or earlier termination of this Agreement with respect to any (i) products purchased and sold under this Agreement during the Term and products sold after the Term for orders accepted during the Term; (ii) Confidential Information (as defined in Section 10 of this Agreement) disclosed or received by a Party during the Term; (iii) breach of this Agreement by a Party; (iv) any other statement, decision, act or omission of a Party concerning or related to this Agreement; (v) any Dispute (as defined in Section 11 of this Agreement) between the Parties concerning or related to this Agreement; (vi) products and other materials manufactured or maintained by Seller in inventory for sale to Buyer that Buyer is obligated to purchase under a Purchase Schedule; and (vii) any provision that expressly states that it will survive the expiration or earlier termination of this Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Scope\", \"level\": 1, \"text\": \"2. Scope. This Agreement will apply to all products sold by Seller to Buyer, and all products purchased by Buyer from Seller, during the Term unless the Parties expressly agree that this Agreement will not apply to a particular type of transaction in a separate written document signed by an officer of each Party. This Agreement will not require Seller to sell any type or quantity of a product to Buyer, nor will this Agreement required Buyer to purchase any type or quantity of a product from Seller, except as expressly provided by the Parties in a Purchase Schedule. The phrase \\\"Purchase Schedule\\\" will mean a written supplement to this Agreement signed by an officer of each Party which references this Agreement and which identities, among other terms and conditions, the specific types and quantities of products that will be purchased and sold by the Parties on terms and conditions in the schedule, the specifications for the identified products, the duration of the commitment period during which the Parties will be obligated to purchase and sell the identified products on the terms and conditions in the schedule, the prices of the identified products, any mechanisms for adjusting the prices of the identified products over the commitment period, and the facilities at which the identified products will be manufactured, stored and delivered by Seller. The Parties may add terms and conditions to, and amend the terms and conditions of, this Agreement in a Purchase Schedule, but any additional and amended terms and conditions in a Purchase Schedule supplementing and modifying this Agreement will only apply the specific products identified in that Purchase Schedule for its duration. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Standard Operating Procedures\", \"level\": 1, \"text\": \"3. Standard Operating Procedures. Over approximately the past eight years, the Parties have been supplying select Products to one another for use in the operation of their respective businesses within the United States of America, Canada and Mexico. The Parties developed and been following certain standard operating procedures in connecting with, among other topics, forecasting, production planning, ordering, delivering and resolving claims on the Products supplied to one another (the \\\"Current SOPs\\\"). The Parties will be updating their respective business systems over the next six months, and the updates to these business systems will require the Parties to modify the Current SOPs. Once the Parties have completed the updates to the business systems and agreed on the necessary modifications to the Current SOPs, the Parties will sign a written amendment to this Agreement appending the updated standard operating procedures (the \\\"Updated SOPs\\\"). Until the Parties have signed a written amendment appending the Updated SOPs, the parties will continue to follow the Current SOPs. The Parties will comply with the applicable SOPs in connection with the purchase and sale of products identified in a Purchase Schedule. The Parties may add terms and conditions to, and amend the terms and conditions of, the SOP in a Purchase Schedule, but any additional and amended terms and conditions in a Purchase Schedule supplementing and modifying the SOP will only apply the specific products identified in that Purchase Schedule for its duration.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Order and Priority of Interpretation\", \"level\": 1, \"text\": \"4. Order and Priority of Interpretation. In the event of any conflict, inconsistency or ambiguity between two or more provisions in this Agreement, including the provisions in its Exhibits and Purchase Schedules, the provisions in the documents will govern, supersede and control over one another in the following order of priority: (1st) a Purchase Schedule with regards to the purchase and sale of the specific products identified in that Purchase Schedule for its duration; (2nd) the SOP; (3rd) any Exhibit to this Agreement but only with regards to specific subject matter of the Exhibit; and (4t h) the main body of this Agreement prior to the signature page.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General Representations, Warranties and Covenants\", \"level\": 1, \"text\": \"5. General Representations, Warranties and Covenants. A Party represents, warrant and covenants on the Effective Date and at all times during the Term that: a. The Party is formed, registered, licensed and operating its business in compliance with the laws of the United States of America, its states and territories, and any districts, municipalities and other political subdivisions of the foregoing (\\\"Applicable Laws\\\"). b. The Party is operating its business in compliance with a commercially reasonable code of ethics adopted by such Party. c. The Party may enter into and perform its obligations under this Agreement without being in conflict with, or in breach of, any other agreement of the Party. d. The Party is solvent, is capable of paying its debts as and when they become due and is paying its debts as and when due. e. The Party is not the subject of a criminal investigation nor a defendant in any criminal indictment, petition, complaint or proceeding that carries a potential sentence involving incarceration in excess of one year for any director or executive officer of the Party involved in the alleged criminal misconduct or a fine in excess of $100,000 USD. A Party will promptly notify the other Party of any change in circumstance during the Term in which the Party is no longer in compliance with the foregoing general representations, warranties and covenants. An incident of actual, alleged or suspected non-compliance by a Party with a warranty under this Section being investigated, contested or corrected in good faith by the Party and which, regardless of outcome, will have no material adverse effect on the Party or its performance under this Agreement or on the other Party, will not be considered a breach of this clause. An incident of actual, alleged or suspected non-compliance by a Party of this Section or any other Section of this Agreement will be grounds for the other Party to demand adequate assurances of performance as provided by Section 2-609 of the Illinois Uniform Commercial Code. A Party will have ten (10) days to provide adequate assurances of performance to the other Party in a form acceptable to the other Party in its good faith discretion. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Specific Product Warranties\", \"level\": 1, \"text\": \"6. Specific Product Warranties. Seller represents and warrants to Buyer that each product sold under this Agreement will at the time of delivery to Buyer: a. Be in new, undamaged and unadulterated condition free of any defects in design, materials and manufacture. Seller is not making any representation or warranty under this clause with regards to the design of a product to the extent the design constitutes, incorporates or otherwise embodies intellectual property that Buyer has represented and warranted to Seller is owned by Buyer and which Buyer has licensed to Seller to manufacture the product for Buyer. b. Have been manufactured and stored by Seller at a plant (and, if applicable under a Purchase Schedule, a warehouse) of Seller approved in the applicable Purchase Schedule prior to its delivery to Buyer. c. Has been manufactured, packaged, labelled, sold and delivered by Seller, and may be sold by Buyer in interstate commerce, in compliance with Applicable Laws, including without limitation with food safety regulations issued by the United States Food and Drug Administration that are applicable to the product. Seller will not be in breach of this warranty because an Applicable Law prohibits, restricts or imposes a charge on a product in a district, municipality or other political subdivision of the United States of America or its states or territories. d. Comply with the written specifications for the product identified in the applicable Purchase Schedule. e. Be fit for the purpose of packaging, selling or use in consuming food subject to qualifications and instructions on the use of the product in the written specifications for the product identified in the applicable Purchase Schedule. f. Be conveyed by Seller to Buyer with good and marketable title free and clear of all liens, encumbrances and claims arising by, through or under Seller. g. Not infringe on any patent, trademark, copyright, trade secret or other the intellectual property of any third-party registered or otherwise recognized and enforceable under Applicable Law. Seller is not making any representation or warranty under this clause with regards to the design of a product to the extent the design constitutes, incorporates or otherwise embodies intellectual property that Buyer has represented and warranted to Seller is owned by Buyer and which Buyer has licensed to Seller to manufacture the product for Buyer. h. Comply with any additional representations and warranties of Seller regarding the product in the applicable Purchase Schedule. If a Buyer receives a product that fails to conform to these representations and warranties, the sole remedies of Buyer for the breach of warranty will be to: (1) reject and return the non-conforming product to Seller for a refund or credit, or a replacement conforming product, in the manner and time period provided in the SOP; (2) obtain reimbursement from Seller for actual, reasonable, substantiated out-of-pocket expenses incurred by Buyer in the recovery, return or disposal of a non-conforming product that is the subject of a mandatory product recall required under Applicable Laws or a voluntary withdrawal declared by Seller or approved by Seller (such approval not to be unreasonably withheld, conditioned or delayed); and (3) obtain indemnification from Seller for any Indemnified Claim arising from or related to the non-conforming product as provided in Section 7. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification\", \"level\": 1, \"text\": \"7. Indemnification. a. A claim that a Party (referred to at times in this Section as an \\\"Indemnifying Party\\\") is required to defend and indemnify the other Party (referred to at times in this Section as an \\\"Indemnified Party\\\") under this Agreement is referred to at times in this Section as an \\\"Indemnified Claim\\\". Defense and indemnification under this Section will include, without limitation, (1) paying or reimbursing the actual, reasonable, substantiated out-of-pocket expenses incurred in connection with the investigation, defense and settlement of any civil, criminal or administrative action, suit, arbitration, mediation, hearing, audit, investigation or other proceeding threatened or commenced against an Indemnified Party on an Indemnified Claim (e.g., fees and expenses of attorneys, accountants, auditors, investigators, consulting experts, testifying experts and other consultants; fees and expenses of an arbitrator or mediator; filing fees and costs imposed by any court, administrative agency or other tribunal; etc.), and (2) satisfying any judgment, award, order, lien, levy, fine, penalty or other sanction imposed against an Indemnified Party on an Indemnified Claim. b. Seller will defend and indemnify Buyer against: (1) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged breach of this Agreement by Seller, including, without limitation, any product supplied by Seller which fails to conform to the representations and warranties in this Agreement; (2) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged negligence or other legally culpable misconduct of Seller in the design, manufacture, storage, sale or delivery of any product sold by Seller under this Agreement or in the performance of other obligation of Seller under this Agreement; (3) any third-party claim for actual or alleged infringement of a product sold by Seller under this Agreement or its design, manufacture, storage, packaging, sale or delivery by Seller under this Agreement or in the performance of any other obligation of Seller under this Agreement (except to the extent that the infringement is based on intellectual property that that Buyer has represented and warranted to Seller that Buyer owns and that Buyer has licensed to Seller and that Seller has used in compliance with the license terms in supplying the product); (4) the threat or imposition of any fine, penalty or other sanction by a governmental authority on Buyer to the extent caused by any actual or alleged violation by Seller of Applicable Law; or (5) any other matter that Seller has agreed to defend and indemnify Buyer against under a Purchase Schedule. c. Buyer will defend and indemnify Seller against: (1) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged breach of this Agreement by Buyer; (2) any third-party claim for personal injury, damage to tangible property or other loss to the extent caused by any actual or alleged negligence or other legally culpable misconduct of Buyer in the purchase, storage, repackaging, resale or delivery of any product purchased from Seller under this Agreement or in the performance of other obligation of Buyer under this Agreement; (3) any third-party claim for actual or alleged infringement of a product sold by Seller under this Agreement or its design, manufacture, storage, sale or delivery by Seller under this Agreement or in the performance of any other obligation of Seller under this Agreement to the extent based on intellectual property that that Buyer has represented and warranted to Seller that Buyer owns and that Buyer has licensed to Seller and that Seller has used in compliance with the license term in supplying the product; (4) the threat or imposition of any fine, penalty or other sanction by governmental authority on Seller to the extent caused by any actual or alleged violation by Buyer of Applicable Law; or (5) any other matter that Buyer has agreed to defend and indemnify Seller against under a Purchase Schedule. d. As a condition of receiving defense and indemnification under this Section for an Indemnified Claim, the Indemnified Party must: (1) notify and tender the defense of an Indemnified Claim to the Indemnifying Party promptly after the Indemnified Party learns of the Indemnified Claim; and Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 (2) provide information and cooperation reasonably requested by the Indemnifying Party in the investigation, defense, settlement and satisfaction of the Indemnified Claim. An Indemnifying Party will reimburse the Indemnified Party of any reasonable, actual, substantiated out-of-pocket expense incurred in providing the requested information or cooperation. e. If the Indemnifying Party accepts the tender of defense of an Indemnified Claim, with or without reservation, the Indemnifying Party will: (1) promptly notify the Indemnified Party of the acceptance of the tender of defense of the Indemnified Claim. (2) control the investigation, defense, settlement and satisfaction of the Indemnified Claim, including, without limitation, the selection of licensed, qualified and reputable attorneys and expert witnesses and all decisions over settlement and litigation strategy. The Indemnifying Party must act in good faith in exercising control over the investigation, defense, settlement and satisfaction of the Indemnified Claim. (3) Provide information reasonably requested by the Indemnified Party regarding the investigation, defense, settlement and satisfaction of the Indemnified Claim f. An Indemnifying Party, acting in good faith, may settle an Indemnified Claim for which it is responsible under this Agreement involving infringement on the intellectual property of a third-party by: (1) obtaining a license from the third-party allowing the required use of its intellectual property; (2) modifying a product, equipment or process in a manner which avoids infringing on the intellectual property of the third-party; or (3) voluntarily withdrawing the infringing product from the market and either refunding the amount paid by the Indemnified Party for the infringing product or replacing the infringing product with a non-infringing product. g. The Parties may disagree on whether a claim is an Indemnified Claim under this Agreement, which Party should be considered the Indemnifying Party and Indemnified Party for an Indemnified Claim or whether each Party is partially liable for an Indemnified Claim and how liability for such an Indemnified Claim should be allocated between them. In these and other circumstances in which an actual or potential conflict of interest exists or arises between the Parties with regards to an alleged or agreed upon Indemnified Claim that would preclude their joint representation by a single defense counsel, the Parties will endeavor in good faith to attempt to resolve the conflict. If the Parties are able to resolve the actual or potential conflict of interest, the Parties will memorialize the agreed upon resolution in a written joint defense agreement signed by officers of each Party and their joint defense counsel. If the Parties are unable to resolve the actual or potential conflict of interest, each Party may independently and separately investigate, defend, settle and satisfy the claim subject to their right to pursue payment or reimbursement for costs incurred in doing so from the other Party as provided in this Agreement.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 1, \"text\": \"8. Insurance. During the Term of this Agreement, each Party will maintain the following minimum types and amounts of insurance coverage during the Term of this Agreement: a. Commercial General Liability Insurance. Occurrence based coverage with a combined single limit of at least $10,000,000 per occurrence and in the aggregate for premises and operations; products and completed operations; contractual liability coverage for indemnities of a Party contained within this Agreement; broad form property damage (including completed operations); explosion, collapse and underground hazards; and personal injury. Requires additional insured endorsement and waiver of subrogation endorsement. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 b. Automobile Liability Insurance. Occurrence based coverage with a combined single limit of at least $10,000,000 per occurrence and in the aggregate for owned, non-owned, and hired automotive equipment of the Party. Requires additional insured endorsement and waiver of subrogation endorsement. c. Workers' Compensation Liability Insurance. Occurrence based coverage providing benefits in the minimal amount required by Applicable Law for workplace and work related injuries and illnesses to the employees of a Party, including, without limitation, Workers Compensation Acts of applicable U.S. States, the U.S. Longshoremen's and Harbor Workers Compensation Act and the U.S. Jones Act. Requires alternate employer endorsement and waiver of subrogation endorsement. d. Employers' Liability Insurance. Occurrence based coverage with a limit of at least $10,000,000 per occurrence or any greater limits set by Applicable Law workplace and work related injuries and illnesses to the employees of a Party. Requires waiver of alternate employer endorsement. e. Property Insurance. Coverage providing \\\"all risk\\\" property insurance at the replacement value of the machinery, equipment, fixtures, tools, materials and other property of the Party. \\\"All risk\\\" coverage will include, by way of example and not limitation, loss or damage resulting from earthquakes, floods, wind, fire or other natural or weather-related phenomenon. Requires waiver of subrogation endorsement. All insurers of a Party on such policies must have at all times an A.M. Best financial rating of at least \\\"A-Minus VII\\\". An insuring Party may satisfy the required minimum amounts of insurance through a primary policy and one or more excess policies. All insurance of an insuring Party must be \\\"primary and non-contributory\\\" with respect to any insurance that the other Party may maintain, but only with respect to the negligence or other legal liability of the insuring Party. An insuring Party must deliver the following written evidence of the required insurance coverage to the other Party (Attention: Risk Management), or its designated insurance monitoring service, within ten (10) of written request and at least thirty (30) days in advance of the expiration of a then current policy term (if a declaration or endorsement is not available from an insurer at the time requested or required, an insuring Party will provide them as soon as the declaration or endorsement is available from the insurer): i. Certificate of insurance confirming that the required insurance coverage and minimal limits are met for the extended, renewed or replacement policy term. ii. Declaration pages of insurance policy (or a copy of the binder until the declaration pages are available) confirming that the required insurance coverage and minimal limits are met for the extended, renewed or replacement policy term. iii. Copies of additional insured endorsements required for applicable policies in the name and for the benefit of: \\\"[NAME OF OTHER PARTY], its parent, subsidiaries and affiliates; any lessors of the foregoing and any mortgagees, deed of trust beneficiaries and secured creditors of such lessors; and any successors and assignees of all of the foregoing.\\\" iv. Copies of alternate employer endorsements and waiver of subrogation endorsements required for applicable policies in the name and for the benefit of: \\\"\\\"[NAME OF OTHER PARTY], its parent, subsidiaries and affiliates; any lessors of the foregoing and any mortgagees, deed of trust beneficiaries and secured creditors of such lessors; and any successors and assignees of all of the foregoing.\\\" Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 A Party may maintain any level of deductible on required insurance coverage allowed by Applicable Law. A Party may also self-insure any of the required insurance coverage, in whole or in part, if allowed by Applicable Law during any period that the Party maintains a tangible net worth in excess of $100 million USD and maintains a professionally managed and adequately reserved for and funded self-insurance program.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitations on Liability\", \"level\": 1, \"text\": \"9. Limitations on Liability. a. Disclaimer of Representations and Warranties. Each Party: (1) disclaims all representations and warranties regarding its products, performance, supplied information or business, whether oral or written, express or implied, arising by operation of law or otherwise, including, without limitation, the implied warranty of merchantability and the implied warranty of fitness for a particular purpose, other than those express representations and warranties of the Party in this Agreement; (2) acknowledges that the Party has not relied on, and will not rely on, any representations and warranties of the other Party regarding its products, performance, supplied information or business, whether oral or written, express or implied, arising by operation of law or otherwise, other than those express representations and warranties of the other Party in this Agreement; and (3) waives any claim that the Party may have based, in whole or in part, on any representations and warranties of the other Party regarding its products, performance, supplied information or business, whether oral or written, express or implied, arising by operation of law or otherwise, other than those express representations and warranties of the other Party in this Agreement. Notwithstanding the foregoing, Buyer is entitled to rely on (i) the descriptive information in transaction documents issued by either Party in the ordinary course of business during the Term identifying the ordered Products (e.g., the type and quantity of ordered products and scheduled date and location for delivery) and (ii) FDA guaranty letters and other similar written assurances in Seller's standard forms certifying that a product complies with Applicable Laws issued by Seller to Buyers and other U.S. customers in the ordinance course of business during the Term. b. Exclusion of Indirect Damages; Waiver of Claim for Insured Damage or Loss. A Party that breaches this Agreement will only be liable to the other Party for direct damages arising from the breach. Each Party waives any right to recover consequential, incidental, indirect, exemplary, punitive or any other types of indirect damages from the other Party for a breach of this Agreement. Notwithstanding the preceding sentences, this Subsection will not limit the liability of a Party for any amount or type of damages for: (1) the defense and indemnification of an Indemnified Claim on which the Party is the Indemnifying Party; (2) infringement by the Party on the intellectual property of the other Party; (3) the unauthorized disclosure or use by the Party of the Confidential Information of the other Party; (4) payment or reimbursement of any amount expressly required to be paid or reimbursed by the Party under a provision of this Agreement; or (5) the intentional misconduct of the Party in violation of Applicable Laws. c. Force Majeure. A Party will not be considered in breach of this Agreement or liable to the other Party for any interruption or delay in performance under this Agreement to the extent caused by an event outside of the ability of the performing Party to foresee and avoid with the exercise of commercially reasonable efforts (such an event is referred to at times as an event of \\\"Force Majeure\\\"). Examples of events of Force Majeure include, without limitation: natural disasters; war; acts of terrorism; government action; accident; strikes, slowdowns and other labor disputes; shortages in or inability to obtain material, equipment, transportation or labor; any breach, negligence, criminal misconduct or other act or omission of any third-party; fire or other insured or uninsured casualty. A Party whose performance is interrupted or delayed by an event of Force Majeure will be excused from the interruption or delay in performance during the event of Force Majeure and for a commercially reasonable period of additional time after the event of Force Majeure that the Party needs to recover from the event of Force Majeure and restore performance. Notwithstanding the foregoing, a Party will only be excused for an interruption or delay in performance under this Subsection for an event of Force Majeure only if the Party (1) promptly notifies the other Party of the event of Force Majeure and provides information reasonably requested by the other Party regarding the event of Force Majeure, the efforts undertaken by the Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 Party to foresee and avoid interruption or delay in its performance before the occurrence of the event, to mitigate interruption or delay in performance during the event, and to recover from and restore performance following the event; and (2) the Party exercises commercially reasonable efforts to mitigate, recover from and restore performance following the event of Force Majeure. During, and while recovering from and restoring performance following, an event of Force Majeure, Seller will act in good faith in allocating its available manufacturing capacity to supply products to Buyer under this Agreement and any products to other customers of Seller. If an event of Force Majeure interrupts or delays Seller from supplying a product to Buyer under this Agreement in the quantities and timetable required by Buyer, Buyer may cancel any unfilled orders for the product with Seller and procure the required quantities of the product from one or more other sources until Seller has recovered from and restored its ability to perform following the event of Force Majeure. If the interruption or delay in the supply of a product to Buyer under this Agreement caused by an event of Force Majeure has exceeded, or is reasonably likely to exceed, thirty (30) days, Buyer may enter into longer term supply agreements or make other arrangements to procure the required quantities of the product from one or more other sources for a duration and on terms acceptable to Buyer in its good faith discretion. In such a circumstance, Buyer will not have to resume purchasing the product from Seller under this Agreement until Seller has recovered from and restored its ability to perform following the event of Force Majeure and the longer term agreements or other arrangements have expired or Buyer is able to end them without liability. This Subsection will not excuse nor extend a deadline by which a Party must pay an amount owed under this Agreement or Applicable Law or by which a Party must exercise any right or remedy under this Agreement or Applicable Law.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential Information and Other Intellectual Property\", \"level\": 1, \"text\": \"10. Confidential Information and Other Intellectual Property. a. The Parties anticipate exchanging Confidential Information (as defined in in the next Subsection) over the Term of this Agreement for the purpose of negotiating and entering into Purchase Schedules and amendments to this Agreement, transacting business with one in accordance with this Agreement and exercising their rights and performing their obligations under this Agreement (collectively referred to as the \\\"Authorized Purpose\\\"). b. The phrase \\\"Confidential Information\\\" means information meeting all of the following criteria: 1) The information is a trade secret or other non-public, proprietary information owned by a Party or its direct and indirect subsidiaries under Applicable Law (this Party is referred to at times in this Section as the \\\"Disclosing Party\\\"); and 2) The other Party (referred to at times in this Section as the \\\"Receiving Party\\\") requests such information from the Disclosing Party for the Authorized Purpose during the Term (i.e., neither Party wants unsolicited Confidential Information from the other Party); and 3) The Disclosing Party discloses such requested information to the Receiving Party during the Term either labelled as \\\"Confidential\\\" or words of similar intent, or describes the disclosed information in reasonable detail in a written notice to the Receiving Party delivered, either at the time of disclosure or within five (5) days of disclosure. If a Disclosing Party neglects to label or deliver timely written notice to the Receiving Party identifying the disclosed information as confidential in nature, the disclosed information will only be treated as Confidential Information under this Agreement if the Disclosing Party is able to demonstrate by clear and convincing evidence that the Receiving Party knew that the disclosed information was a trade secret or other non-public, proprietary information of the Disclosing Party at the time of disclosure. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 The criteria in Clause (2) and Clause (3) will not apply to Confidential Information of a Disclosing Party observed or heard by a Receiving Party in a plant, warehouse, facility or system of the Disclosing Party. The existence and terms of this Agreement, and the existence, nature and extent of the business relationship between the Parties, will be considered the Confidential Information of each Party. c. The phrase \\\"Confidential Information\\\" also means the Know-How of a Disclosing Party and its direct and indirect subsidiaries that a Receiving Party and its direct and indirect subsidiaries learned of, acquired or otherwise used prior to the Effective Date. The phrase \\\"Know-How\\\" means trade secret and other confidential, proprietary information of a Party or its Affiliate concerning the manufacture, storage, packaging, marketing, sale and delivery of its products. Examples of Know-How may be in the form of drawings, equipment specifications, formulae, formulations, guidelines, manuals, methods, plans, policies, procedures, processes, properties and applications of raw materials and products, tools, dies and molds. A Receiving Party and its direct and indirect subsidiaries may continue to use the Know- How of the Disclosing Party and its direct and indirect subsidiaries in the possession of the Receiving Party and its direct and indirect subsidiaries as of the Effective Date for the Authorized Purpose and in connection with the operation of the business of the Receiving Party and its direct and indirect subsidiaries. Nothing in this Subsection or any other provisions of this Agreement will obligate a Party to disclose or license the use of its Know-How of any kind and in any form arising, discovered, acquired or developed after the Effective Date to the other Party. d. The phrase \\\"Confidential Information\\\" does not include, and there will not be any duties of confidentiality or other restrictions under this Agreement for, the following types of information: (1) Information which is or becomes available as part of the public domain through any means other than as a result of a breach of this Agreement by the Receiving Party; or (2) Information, other than Know-How received prior the Effective Date, which is known to the Receiving Party before the disclosure of the same information by the Disclosing Party; or (3) Information which is or becomes available to the Receiving Party from a third-party who is not under any duty to preserve the confidentiality of such information; or (4) Information which is furnished by the Disclosing Party to a third-party without imposing any duty on the third-party to preserve the confidentiality of such information; or (5) Information which is independently developed by the Receiving Party without the use of or reliance on any trade secret or other non-public, proprietary information provided by the Disclosing Party as Confidential Information under this Agreement or under any prior agreement between the Parties; or (6) Information that ceases to be a trade secret or other non-public, proprietary information of the Disclosing Party under applicable law through any means other than those enumerated above that does not involve nor result from a breach of this Agreement by the Receiving Party. e. A Party may request and disclose Confidential Information in any form or medium. Confidential Information may include, without limitation, information concerning the assets, liabilities, financing, financial statements, ownership, goods, services, customers, suppliers, marketing, manufacturing, equipment, software, technology, supply chain, business strategies, plans, models, policies, methods, processes, formulae, specifications, drawings, schematics, software and technical know-how of a Disclosing Party. A Receiving Party will take all commercially reasonable actions required to safeguard the Confidential Information of a Disclosing Party in the possession of such Receiving Party against the unauthorized disclosure or use of the Confidential Information by other persons. A Receiving Party will promptly notify the Disclosing Party if the Receiving Party learns of any unauthorized disclosure or use of the Confidential Information of the Disclosing Party by any Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 person. A Receiving Party will cooperate in good faith with the Disclosing Party to prevent any unauthorized disclosure or use of the Confidential Information of the Disclosing Party by any person. f. A Receiving Party will not disclose nor use the Confidential Information of a Disclosing Party except as follows: (1) A Receiving Party may disclose Confidential Information of a Disclosing Party on a \\\"need to know\\\" basis to the Representatives of the Receiving Party who require such information for the Authorized Purpose and in order for the Receiving Party and its Affiliates to comply with Applicable Laws, accounting standards and securities exchange requirements. Before making such a disclosure, the Receiving Party will advise the Representatives of the confidential nature of the information being shared and ensure that duties and restrictions are, or have been, imposed on the Representatives receiving the Confidential Information similar to those imposed on the Receiving Party under this Agreement. A Receiving Party will be liable for any breach of this Agreement by its Representatives. An \\\"Affiliate\\\" of a Party means a legal entity that owns and controls, or is owned and controlled by, or is under common ownership and control with, a Party (other than the other Party or any of its direct and indirect subsidiaries), with ownership and control of a legal entity being determined by the ownership of the majority voting interest in the legal entity. A \\\"Representative\\\" means the Affiliates of a Party and the directors, officers, managers, employees, accountants, attorneys, auditors and other agents and consultants of a Party and its Affiliates. (2) A Receiving Party may disclose Confidential Information of a Disclosing Party to a court, governmental entity or any other person in order for the Receiving Party and its Affiliates to comply with Applicable Laws, accounting standards and securities exchange requirements. If legally permissible and reasonably possible, a Receiving Party will notify the Disclosing Party prior to disclosing its Confidential Information pursuant to this Section and cooperate in good faith with any lawful efforts by the Disclosing Party to avoid or limit the disclosure of its Confidential Information. A Receiving Party will not be obligated to incur any liability, expense or risk in extending such cooperation to a Disclosing Party. Based on legal advice of its attorney, a Receiving Party may disclose the Confidential Information of the Disclosing Party by any deadline established under an Applicable Law, accounting standard and securities exchange requirement. (3) A Receiving Party may disclose and use the Confidential Information of a Disclosing Party to enforce or interpret this Agreement or any other agreement with the Disclosing Party in any arbitration, court or other legal proceeding. A Receiving Party may disclose and use this Confidential Information of a Disclosing Party to defend the Receiving Party or its Affiliates or their respective Representatives in any arbitration, court or other legal proceeding. In either circumstance, the Receiving Party will ensure that a protective order, agreement or other mechanism is in place to preserve the confidentiality of the Confidential Information. (4) A Receiving Party and its Representatives may disclose and use the Confidential Information for any other purpose consented to by a Disclosing Party in a written notice signed by an officer of the Disclosing Party delivered to the Receiving Party. g. In disclosing its Confidential Information to a Receiving Party, a Disclosing Party represents, warrants and covenants to the Receiving Party that: (1) The Disclosing Party owns and has the right to disclose and authorize the use of Confidential Information as provided in this Agreement. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 (2) The Receiving Party and its Representatives may use the Confidential Information of the Disclosing Party for the Authorized Purpose and other limited purposes provided in this Agreement. (3) The Disclosing Party will indemnify, defend and hold harmless the Receiving Party and its Representatives against any claim of a third-party that the disclosure and use of the Confidential Information of the Disclosing Party as provided in this Agreement infringes on a patent, trademark, copyright, trade secret or other intellectual property of the third-party registered in or otherwise recognized and enforceable under Applicable Laws. Except for the limited representations and warranties in this Section, a Disclosing Party disclaims all other representations and warranties of any kind related to its Confidential Information, whether express, implied or arising by operation of law, including the disclaimer, without limitation, of any representation and warranties concerning merchantability, fitness for a particular purpose, truth, accuracy or completeness. h. The rights and obligations of the Parties under this Section with regards to disclosed Confidential Information will continue: (1) Until the earlier of (i) sixty (60) months from the date of disclosure to a Receiving Party or (ii) the date such information ceases to be considered Confidential Information under this Agreement, for Confidential Information that is not a trade secret of a Disclosing Party under Applicable Law; and (2) Until Confidential Information that is a trade secret of a Disclosing Party under Applicable Law ceases to be a trade secret of the Disclosing Party under Applicable Law. i. A Receiving Party will return or destroy all forms of Confidential Information of the Disclosing Party in the custody of the Receiving Party and its Representatives within ten (10) days of receipt of a written request from the Disclosing Party and after the expiration or earlier termination of this Agreement. This will include, without limitation, all copies, records, documents and other information representing, comprising, containing, referencing or created based on Confidential Information of the Disclosing Party. Notwithstanding the foregoing, a Receiving Party and its Representatives may retain copies of Confidential Information of the Disclosing Party which (x) the Receiving Party and its Representatives are required to retain to comply with Applicable Laws, accounting standards and security exchange requirements (but only for the duration and in the manner so required for this limited purpose); or (y) have been archived in electronic form by the Receiving Party and its Representatives and which would be unduly burdensome for the Receiving Party and its Representatives to have to search for and delete the Confidential Information of the Disclosing Party. j. Except for the limited right to disclose and use Confidential Information of a Disclosing Party for the Authorized Purpose and other purposes provided in the this Section and except for any license of intellectual property granted by a Disclosing Party to the Receiving Party in a Purchase Schedule, this Agreement does not grant a Receiving Party or its Representatives any right, title, interest or ownership in the Confidential Information of the Disclosing Party nor in any patent, trademark, copyright or other intellectual property of the Disclosing Party. As between the Parties during the Term, to be effective, the grant of any right, title, interest and ownership in and to any Confidential Information of Party or in an patents, trademarks, copyrights and other intellectual property of the Party must be in writing and signed by the chief executive officers of the Parties. During the Term, a Party will not develop intellectual property for, on behalf of, or in collaboration with, the other Party unless the Parties have entered into a Purchase Schedule or other separate written agreement signed by an officer of each Party. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Dispute Resolution\", \"level\": 1, \"text\": \"11. Dispute Resolution. a. Negotiation. If a Party believes that the other Party has breached this Agreement or if there is a dispute between the Parties over the interpretation of this Agreement (a \\\"Dispute\\\"), the Parties will endeavor to resolve the Dispute through good faith negotiation for a period of thirty (30) days after a Party notifies the other Party of the Dispute and before either Party requests mediation or files litigation to resolve the Dispute. b. Mediation. If the Parties have been unable to resolve a Dispute through good faith negotiation as provided in the prior Subsection, a Party may request that the Parties attempt to resolve the Dispute through mediation by notifying the other Party with a copy to JAMS. The Parties will attempt to select a mutually acceptable JAMS mediator within ten (10) days of the notice requesting mediation. The mediation will be held in Lake County or Cook County, Illinois within thirty (30) days of the notice requesting mediation before a JAMS mediator and in compliance with JAMS mediation guidelines. Each party will bear its own costs in preparing for and participating in the mediation and one-half of the fees and expenses charged by JAMS for conducting the mediation. c. Litigation. If the Parties have been unable to resolve a Dispute through mediation as provided in the prior Subsection, a Party may file litigation against the other Party in a court of competent jurisdiction in the United States of America. With respect to litigation involving only the Parties or their Affiliates, the Parties irrevocably consent to the exclusive personal jurisdiction and venue of the U.S. federal and Illinois state courts of competent subject matter jurisdiction located in Lake County, Illinois or Cook County, Illinois and their respective higher courts of appeal for the limited purpose of resolving a Dispute, and the Parties waive, to the fullest extent permitted by law, any defense of inconvenient forum. The Parties waive any right to trial by jury as to any Disputes resolved through litigation. Notwithstanding the foregoing, a Party may file litigation to resolve a Dispute without undergoing either negotiation or mediation as provided in the prior Subsections for any Dispute involving: (i) infringement on intellectual property; (ii) the unauthorized use or disclosure of Confidential Information; or (iii) a request for a temporary restraining order, a preliminary or permanent injunction or any other type of equitable relief. d. Remedies. Except as expressly limited in the preceding Subsections and the other provisions in this Agreement, a Party may immediately exercise any rights and remedies available to the Party under Applicable Law upon a breach of this Agreement by the other Party. A Party will not suspend performance under or terminate this Agreement or any accepted purchase order for a product being purchased and sold under this Agreement unless: (1) the other Party is in material breach of this Agreement and has either refused to cure the material breach or has failed to cure the material breach within thirty (30) day of its receipt of written notice of the failure; and (2) the Parties have been unable to resolve the Dispute related to the material breach through negotiation or mediation, or the breaching Party has refused or failed to attempt to resolve the Dispute through negotiation or mediation, as provided in this Section. Notwithstanding the foregoing, a Party may suspend performance or terminate this Agreement or any accepted purchase order for a product being purchase and sold under this Agreement immediately on written notice to the other Party, and without providing the other Party an opportunity to cure the material breach or attempting to resolve a Dispute over the material breach by negotiation or mediation as provided in this Section, for a material breach by the other Party involving substantial harm to the reputation, goodwill and business of the non-breaching Party that cannot reasonably be avoided or fully redressed by providing the other Party an opportunity to cure the material breach. e. Late Fees and Collection Costs. If Buyer fails to pay Seller an amount owed under this Agreement by the invoice due date, then Buyer will owe Seller: (i) the delinquent amount; and (ii) a late payment fee equal to two percent (2%) of the delinquent amount for each full or partial calendar month past the invoice due date that the delinquent amount remains unpaid. In addition, if Seller has to file Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 litigation to collect the amount owed and Seller prevails in the litigation, Buyer will reimburse Seller for actual, reasonable, substantiated out-of-pocket expenses incurred by Seller in collecting the delinquent amount and accrued late payment fees on the delinquent amount. Under no circumstance will the late payment fee payable to Seller exceed the amount that a creditor may lawfully impose on a debtor on a delinquent amount under Applicable Law.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Miscellaneous\", \"level\": 1, \"text\": \"12. Miscellaneous. a. Entire Agreement. This Agreement, including its appended Exhibits and Purchase Schedules entered into during the Term, constitutes the entire agreement between the Parties with respect to the sale of products by Seller to Buyer and the purchase of products by Buyer from Seller. This Agreement supersedes all prior and simultaneous representations, discussions, negotiations, letters, proposals, agreements and understandings, whether written or oral, with respect to this subject matter. This Agreement will not be binding on either Party unless and until signed by the chief executive officers of each Party. No handwritten or other addition, deletion or other modification to the printed portions of this Agreement will be binding upon either Party to this Agreement. b. Amendments. A Party may not amend nor supplement the terms and conditions in this Agreement through the inclusion of additional or different terms and conditions in any quotation, purchase order, invoice, bill of lading, letter, email or other document or communication. This Section does not prevent the reliance on the descriptive information in transaction documents identifying the ordered Products (e.g., the type and quantity of ordered products and scheduled date and location for delivery). No amendment of this Agreement will be valid or effective unless made in writing and signed and exchanged by the chief executive officers of the Parties. A Party may approve or reject a request for an amendment in its sole and absolute discretion. c. Waiver. The failure of either party to insist in any one or more instances upon strict performance of any of the provisions of this Agreement or to take advantage of any of its rights shall not operate as a continuing waiver of such rights. No right or obligation under this Agreement will be considered to have been waived by a Party unless such waiver is in writing and is signed by an officer of the waiving Party and delivered to the other Party. No consent to or waiver of a breach by either Party will constitute a consent to, waiver of, or excuse for any other, different, or subsequent breach by such Party. d. Governing Law. This Agreement and all claims or causes of action arising out of or related to this Agreement shall be governed in all respects, including as to validity, interpretation and effect, by the laws of the State of Illinois and the United States of America, without giving effect to its principles or rules of conflict of laws. The United Nations Convention on Contracts for the International Sale of Goods will not govern or otherwise be applicable to this Agreement. e. Severability. If any term of provision of this Agreement, or the application thereof shall be found invalid, void or unenforceable by any government or governmental organization having jurisdiction over the subject matter, the remaining provisions, and any application thereof, shall nevertheless continue in full force and effect. f. Assignment. This Agreement, its rights and obligations, is not assignable or transferable by either Party, in whole or in part, except with the prior written consent of the other Party, which consent will not be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, either Party may transfer and assign this Agreement to any of its affiliates or in connection with any merger, consolidation or sale of assets without the other Party's prior consent provided (a) that any such assignment will not result in the assigning Party being released or discharged from any liability under this Agreement, and (b) the purchaser/assignee will expressly assume all obligations of the assigning Party under this Agreement. The assigning Party will provide the other Party with written Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 notice of such assignment prior to or promptly following the effective date of such assignment. A change of control shall be deemed an assignment requiring consent hereunder provided that any transfer or assignment that results in Seller's and Buyer's current common parent, Reynolds Group Holdings Limited, ceasing to control either party shall not require consent of the other party. The restrictions in this Section will not preclude a Party for authorizing an Affiliate to purchase or sell a product on behalf of a Party under this Agreement. Subject to the foregoing, all of the terms, conditions and provisions of this Agreement shall be binding upon and shall inure to the benefit of the successors and assignees of the respective Parties. g. Third Party Beneficiaries. Except as otherwise provided in a Purchase Schedule, there are no intended third-party beneficiaries of this Agreement. h. Good Faith and Cooperation. Except where this Agreement states that a Party may expressly exercise a right or render a decision in its \\\"sole and absolute discretion\\\", a Party will exercise its rights under this Agreement in its good faith business judgment. A Party will perform its obligations under this Agreement in a commercially reasonable manner consistent with industry practices and in compliance with Applicable Law. A Party will promptly take such actions, provide such information and sign such documents as the other Party may reasonably request to obtain the benefits and exercise the rights granted, and to perform the obligations imposed, under this Agreement. i. Notices. Any notice required or permitted to be provided by a Party under this Agreement will be made to the notice address of the receiving Party set forth below or to an alternate notice address later designated by the receiving Party in accordance with this Subsection. Notices will be effective upon actual receipt by the receiving Party. An emailed notice will be effective against a receiving Party only if the Receiving Party acknowledge receipt of the emailed notice in a return notice to the notifying Party. A receiving Party agrees to acknowledge receipt of an email notice in good faith promptly following receipt. A Party may change its address for notice by giving notice to the other party Pursuant to this Subsection. Address for notice to Buyer: Pactiv LLC 1900 West Field Court Lake Forest, IL 60045 Attn: John McGrath, Chief Executive Officer Email: jmcgrath@pactiv.com For any notice concerning default or termination, with a copy to: Pactiv LLC 1900 West Field Court Lake Forest, IL 60045 Attn: Steven R. Karl, General Counsel Email: skarl@pactiv.com Address for notices to Seller: Reynolds Consumer Products LLC 1900 W. Field Court Lake Forest, IL 60045 Attention: Lance Mitchell, Chief Executive Officer Email: Lance.Mitchell@@ReynoldsBrands.com Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 For any notice concerning default or termination, with a copy to: Reynolds Consumer Products LLC 1900 W. Field Court Lake Forest, IL 60045 Attention: David Watson, General Counsel Email: David.Watson@ReynoldsBrands.com j. Independent Contractors. The relationship of the Parties established by this Agreement is that of independent contractors, and nothing contained in this Agreement shall be construed to: (a) give either Party the power to direct and control the day-to-day activities of the other Party, (b) establish the Parties as partners, joint ventures, co-owners or otherwise as participants in a joint or common undertaking, or (c) allow a Party to bind the other Party in any manner or otherwise create or assume any obligation on behalf of the other Party for any purpose whatsoever. A Party will not be considered an agent of the other Party. k. Non-Exclusive Supply Relationship. Except as may be provided in a Purchase Schedule, the Agreement is not evidence of, nor does it create, any form of exclusive supply relationship between the Parties concerning the purchase and sale of products. Except as may be provided in a Purchase Schedule and for the types and quantities of products in an accepted purchase order, nothing in the Agreement obligates a Party to sell or purchase any specified volume, market share or other minimum level of products during the Term. l. Construction. Unless the context otherwise requires, the following rules of construction will be applied to in the interpretation of the Agreement: (1) Headings are for convenience only and do not affect interpretation; (2) Singular includes the plural and vice-versa; (3) Gender includes all genders; (4) If a word or phrase is defined, its other grammatical forms have a corresponding meaning; (5) The meaning of general words is not limited by specific examples introduced by \\\"includes\\\", \\\"including\\\" or \\\"for example\\\" or similar expressions; (6) The word \\\"person\\\" includes an individual, corporation, company, trust, partnership, limited partnership, unincorporated body, joint venture, consortium or other legal entity; (7) A reference in any Purchase Schedule or Exhibit to an Article, Section, Subsection or Clause is a reference to an Article, Section, Subsection or Clause in that Purchase Schedule or Exhibit unless otherwise identified; (8) Reference to a Purchase Schedule or Exhibit is a reference to a Schedule, Exhibit described, appended or otherwise identified in this Agreement; (9) A reference to conduct includes, without limitation, an omission, statement or undertaking, whether or not in writing; (10) A reference to a third-party is a reference to a person who is not a Party to this Agreement; (11) Where a period of time is specified for the performance of any act and dates from a given day or the day of an act or event, the period shall be exclusive of that date; and (12) the Parties agree that the Agreement is the product of negotiation between sophisticated parties and individuals, all of whom were or have been given the opportunity to be represented by counsel, and each of whom had an opportunity to participate in, and did participate in, negotiation of the terms hereof. Accordingly, the Parties acknowledge and agree that the Agreement is not a contract of adhesion and that ambiguities in the Agreement, if any, shall not be construed strictly or in favor of or against either Party, but rather shall be given a fair and reasonable construction. m. Execution. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against the Party whose signature appears thereon, but all of which taken together shall constitute but one and the same instrument. Acceptance of this Agreement may be made by e-mail, mail or other commercially reasonable means showing the signatures of the chief executive officers of the Parties. Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019 In witness whereof, Seller and Buyer have executed this Master Supply Agreement as of the Effective Date. REYNOLDS CONSUMER PRODUCTS LLC, as Seller By: //s// Lance Mitchell Lance Mitchell Chief Executive Officer PACTIV LLC, as Buyer By: //s// John McGrath John McGrath Chief Executive Officer Source: REYNOLDS CONSUMER PRODUCTS INC., S-1, 11/15/2019\"}}, {\"id\": \"party:REYNOLDS CONSUMER PRODUCTS LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"REYNOLDS CONSUMER PRODUCTS LLC\", \"role\": \"Seller\", \"address\": \"1900 West Field Court, Lake Forest, IL 60045\"}}, {\"id\": \"party:PACTIV LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PACTIV LLC\", \"role\": \"Buyer\", \"address\": \"1900 West Field Court, Lake Forest, IL 60045\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"MASTER SUPPLY AGREEMENT (the \\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"November 1, 2019 (the \\\"Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"Seller and Buyer are referred to individually at times as a \\\"Party\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"and collectively at times as the \\\"Parties\\\".\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"The \\\"Term\\\" of this Agreement will commence on the Effective Date and will end on the earlier of: (a) the first anniversary of the expiration date of the last Purchase Schedule (as defined in this next Section); (b) a termination date elected by a Party in a written notice delivered to the other Party any time after the expiration of the last Purchase Schedule; or (c) a termination date elected by a Party in a written notice delivered to the other Party as provided in Subsection 11(d) of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Purchase Schedule\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Schedule\", \"text\": \"The phrase \\\"Purchase Schedule\\\" will mean a written supplement to this Agreement signed by an officer of each Party which references this Agreement and which identities, among other terms and conditions, the specific types and quantities of products that will be purchased and sold by the Parties on terms and conditions in the schedule, the specifications for the identified products, the duration of the commitment period during which the Parties will be obligated to purchase and sell the identified products on the terms and conditions in the schedule, the prices of the identified products, any mechanisms for adjusting the prices of the identified products over the commitment period, and the facilities at which the identified products will be manufactured, stored and delivered by Seller.\", \"definition_clause\": \"2\"}}, {\"id\": \"term:Current SOPs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Current SOPs\", \"text\": \"The Parties developed and been following certain standard operating procedures in connecting with, among other topics, forecasting, production planning, ordering, delivering and resolving claims on the Products supplied to one another (the \\\"Current SOPs\\\").\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Updated SOPs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Updated SOPs\", \"text\": \"Once the Parties have completed the updates to the business systems and agreed on the necessary modifications to the Current SOPs, the Parties will sign a written amendment to this Agreement appending the updated standard operating procedures (the \\\"Updated SOPs\\\").\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Applicable Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicable Laws\", \"text\": \"The Party is formed, registered, licensed and operating its business in compliance with the laws of the United States of America, its states and territories, and any districts, municipalities and other political subdivisions of the foregoing (\\\"Applicable Laws\\\").\", \"definition_clause\": \"5\"}}, {\"id\": \"term:Indemnifying Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnifying Party\", \"text\": \"A claim that a Party (referred to at times in this Section as an \\\"Indemnifying Party\\\") is required to defend and indemnify the other Party (referred to at times in this Section as an \\\"Indemnified Party\\\") under this Agreement is referred to at times in this Section as an \\\"Indemnified Claim\\\".\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnified Party\", \"text\": \"A claim that a Party (referred to at times in this Section as an \\\"Indemnifying Party\\\") is required to defend and indemnify the other Party (referred to at times in this Section as an \\\"Indemnified Party\\\") under this Agreement is referred to at times in this Section as an \\\"Indemnified Claim\\\".\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Indemnified Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnified Claim\", \"text\": \"A claim that a Party (referred to at times in this Section as an \\\"Indemnifying Party\\\") is required to defend and indemnify the other Party (referred to at times in this Section as an \\\"Indemnified Party\\\") under this Agreement is referred to at times in this Section as an \\\"Indemnified Claim\\\".\", \"definition_clause\": \"7\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"A Party will not be considered in breach of this Agreement or liable to the other Party for any interruption or delay in performance under this Agreement to the extent caused by an event outside of the ability of the performing Party to foresee and avoid with the exercise of commercially reasonable efforts (such an event is referred to at times as an event of \\\"Force Majeure\\\").\", \"definition_clause\": \"9\"}}, {\"id\": \"term:Authorized Purpose\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Authorized Purpose\", \"text\": \"The Parties anticipate exchanging Confidential Information (as defined in in the next Subsection) over the Term of this Agreement for the purpose of negotiating and entering into Purchase Schedules and amendments to this Agreement, transacting business with one in accordance with this Agreement and exercising their rights and performing their obligations under this Agreement (collectively referred to as the \\\"Authorized Purpose\\\").\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"The phrase \\\"Confidential Information\\\" means information meeting all of the following criteria: 1) The information is a trade secret or other non-public, proprietary information owned by a Party or its direct and indirect subsidiaries under Applicable Law (this Party is referred to at times in this Section as the \\\"Disclosing Party\\\"); and 2) The other Party (referred to at times in this Section as the \\\"Receiving Party\\\") requests such information from the Disclosing Party for the Authorized Purpose during the Term (i.e., neither Party wants unsolicited Confidential Information from the other Party); and 3) The Disclosing Party discloses such requested information to the Receiving Party during the Term either labelled as \\\"Confidential\\\" or words of similar intent, or describes the disclosed information in reasonable detail in a written notice to the Receiving Party delivered, either at the time of disclosure or within five (5) days of disclosure.\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Disclosing Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disclosing Party\", \"text\": \"(this Party is referred to at times in this Section as the \\\"Disclosing Party\\\")\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Receiving Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Receiving Party\", \"text\": \"(referred to at times in this Section as the \\\"Receiving Party\\\")\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Know-How\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Know-How\", \"text\": \"The phrase \\\"Know-How\\\" means trade secret and other confidential, proprietary information of a Party or its Affiliate concerning the manufacture, storage, packaging, marketing, sale and delivery of its products.\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"An \\\"Affiliate\\\" of a Party means a legal entity that owns and controls, or is owned and controlled by, or is under common ownership and control with, a Party (other than the other Party or any of its direct and indirect subsidiaries), with ownership and control of a legal entity being determined by the ownership of the majority voting interest in the legal entity.\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Representative\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Representative\", \"text\": \"A \\\"Representative\\\" means the Affiliates of a Party and the directors, officers, managers, employees, accountants, attorneys, auditors and other agents and consultants of a Party and its Affiliates.\", \"definition_clause\": \"10\"}}, {\"id\": \"term:Dispute\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Dispute\", \"text\": \"If a Party believes that the other Party has breached this Agreement or if there is a dispute between the Parties over the interpretation of this Agreement (a \\\"Dispute\\\")\", \"definition_clause\": \"11\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:$100,000 USD\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$100,000 USD\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:$10,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$10,000,000\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:$100 million USD\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$100 million USD\"}}, {\"id\": \"value:five (5) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"value:two percent (2%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"two percent (2%)\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of RgcResourcesInc_20151216_8-K_EX-10.3_9372751_EX-10.3_Franchise Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of RgcResourcesInc_20151216_8-K_EX-10.3_9372751_EX-10.3_Franchise Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.3\", \"level\": 1, \"text\": \"Exhibit 10.3 GAS FRANCHISE AGREEMENT THIS AGREEMENT (\\\"Agreement\\\"), made and entered into this 17th day of November, 2015, by and between the TOWN OF VINTON, VIRGINIA, a Virginia municipal corporation (\\\"Grantor\\\"), and ROANOKE GAS COMPANY, a Virginia corporation (\\\"Grantee\\\"). WHEREAS, Grantor has reviewed the proposal for a Gas Franchise of Grantee; and WHEREAS, Grantor, at a duly authorized and regular meeting of its Town Council, did vote to grant a renewal of the Gas Franchise to Grantee pursuant to provisions of the State Code and Town Charter. NOW, THEREFORE, in consideration of said grant of renewal of the Gas Franchise, the parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"GRANT\", \"level\": 1, \"text\": \"1. GRANT. Grantor hereby grants to Grantee and Grantee hereby accepts a franchise to construct, reconstruct, operate, maintain, repair, and extend a Gas Distribution System within Grantor's Territorial Limits in accordance with the terms and conditions set forth below (\\\"Franchise\\\"). The Franchise is granted pursuant to Grantor's Franchise Ordinance (Ordinance No. 967), adopted November 17, 2015, (\\\"Ordinance\\\"), which is incorporated by reference herein, including any applicable definitions.\"}, {\"id\": \"2\", \"title\": \"TERM\", \"level\": 1, \"text\": \"2. TERM. The term of the Franchise shall be twenty (20) years, commencing on January 1, 2016.\"}, {\"id\": \"3\", \"title\": \"FRANCHISE FEE\", \"level\": 1, \"text\": \"3. FRANCHISE FEE. (a) Grantee shall pay to Grantor a Franchise Fee which shall be calculated pursuant to this Section. It is understood that Grantee has or will enter into franchise agreements with the City of Roanoke (\\\"Roanoke\\\") and the City of Salem (\\\"Salem\\\") and the Town of Vinton (\\\"Vinton\\\") (Grantor, Roanoke and Salem being hereinafter sometimes collectively referred to as the \\\"localities\\\" and singularly as a \\\"locality\\\") with fee provisions identical to this one, and that the total annual Franchise Fee to be paid to the three localities in aggregate is $98,196 for calendar year 2016 (\\\"base year total annual Franchise Fee\\\"). Grantor's Franchise Fee shall be a percentage share of the base year total annual Franchise Fee, which shall be determined on a pro rata basis according to its percentage share of the total dollar value of Grantee's gas sales occurring within the localities during the calendar year. For each calendar year of the Franchise, each locality's percentage share shall be determined by the following formula: total dollar value of Grantee's gas sales within Locality's percentage share = the Territorial Limits of the locality total dollar value of Grantee's gas sales in the three localities For calendar year 2016, the Franchise Fee shall be paid to Grantor on or before March 31, 2017. 1 Source: RGC RESOURCES INC, 8-K, 12/16/2015 (b) For each succeeding calendar year during the term of this Franchise, the total annual Franchise Fee paid by Grantee to the localities shall be the base year total annual Franchise Fee increased by three (3) percent compounded annually over the term of the Franchise. For each calendar year during the term of this Franchise, Grantor's percentage share shall be determined pursuant to this Section, and paid to Grantor on or before March 31 of the succeeding calendar year.\"}, {\"id\": \"4\", \"title\": \"BUSINESS OFFICE\", \"level\": 1, \"text\": \"4. BUSINESS OFFICE. Grantee shall during the term of this Franchise maintain at least one business office within the Territorial Limits of Grantor. Such office shall be open at least forty (40) hours per week for the conduct of business between Grantee and its customers.\"}, {\"id\": \"5\", \"title\": \"NONDISCRIMINATION\", \"level\": 1, \"text\": \"5. NONDISCRIMINATION. Grantee shall not discriminate on the basis of race, religion, color, sex, national origin, age, disability, or any other basis prohibited by state law relating to discrimination in employment, except where there is a bona fide occupational qualification reasonably necessary to the normal operation of the Grantee.\"}, {\"id\": \"6\", \"title\": \"NOTICE\", \"level\": 1, \"text\": \"6. NOTICE. All notices required under this Agreement or the Ordinance shall be in writing and shall be deemed validly given, unless otherwise required, when sent by certified mail, return receipt requested, or by a nationally recognized overnight courier, addressed as follows (or any other address the party to be notified may have designated to the sender by like notice): Grantor: Grantee: Town of Vinton Roanoke Gas Company Attention: Town Manager Attention: President 311 S. Pollard Street 519 Kimball Avenue, N.E. Vinton, Virginia 24179 P.O. Box 13007 Roanoke, Virginia 24030 The parties may, by notice given under this Section, designate such other addresses as they may deem appropriate for the receipt of notices under this Agreement.\"}, {\"id\": \"7\", \"title\": \"EFFECTIVE DATE\", \"level\": 1, \"text\": \"7. EFFECTIVE DATE. The effective date of the Franchise will be January 1, 2016. SIGNATURES APPEAR ON FOLLOWING PAGES 2 Source: RGC RESOURCES INC, 8-K, 12/16/2015 IN WITNESS WHEREOF, the parties hereto have signed this Agreement by their authorized representatives. WITNESS: ROANOKE GAS COMPANY /s/ Diane L. Conner By /s/ John S. D'Orazio John S. D'Orazio, President and CEO Diane L. Conner, Assistant to CEO 12/14/2015 Printed Name and Title WITNESS: TOWN OF VINTON, VIRGINIA /s/ Susan N. Johnson By /s/ Christopher S. Lawrence Christopher S. Lawrence, Town Manager Susan N. Johnson, Town Clerk Printed Name and Title 3 Source: RGC RESOURCES INC, 8-K, 12/16/2015\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of RgcResourcesInc_20151216_8-K_EX-10.3_9372751_EX-10.3_Franchise Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.3\", \"level\": 1, \"text\": \"Exhibit 10.3 GAS FRANCHISE AGREEMENT THIS AGREEMENT (\\\"Agreement\\\"), made and entered into this 17th day of November, 2015, by and between the TOWN OF VINTON, VIRGINIA, a Virginia municipal corporation (\\\"Grantor\\\"), and ROANOKE GAS COMPANY, a Virginia corporation (\\\"Grantee\\\"). WHEREAS, Grantor has reviewed the proposal for a Gas Franchise of Grantee; and WHEREAS, Grantor, at a duly authorized and regular meeting of its Town Council, did vote to grant a renewal of the Gas Franchise to Grantee pursuant to provisions of the State Code and Town Charter. NOW, THEREFORE, in consideration of said grant of renewal of the Gas Franchise, the parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GRANT\", \"level\": 1, \"text\": \"1. GRANT. Grantor hereby grants to Grantee and Grantee hereby accepts a franchise to construct, reconstruct, operate, maintain, repair, and extend a Gas Distribution System within Grantor's Territorial Limits in accordance with the terms and conditions set forth below (\\\"Franchise\\\"). The Franchise is granted pursuant to Grantor's Franchise Ordinance (Ordinance No. 967), adopted November 17, 2015, (\\\"Ordinance\\\"), which is incorporated by reference herein, including any applicable definitions.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 1, \"text\": \"2. TERM. The term of the Franchise shall be twenty (20) years, commencing on January 1, 2016.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FRANCHISE FEE\", \"level\": 1, \"text\": \"3. FRANCHISE FEE. (a) Grantee shall pay to Grantor a Franchise Fee which shall be calculated pursuant to this Section. It is understood that Grantee has or will enter into franchise agreements with the City of Roanoke (\\\"Roanoke\\\") and the City of Salem (\\\"Salem\\\") and the Town of Vinton (\\\"Vinton\\\") (Grantor, Roanoke and Salem being hereinafter sometimes collectively referred to as the \\\"localities\\\" and singularly as a \\\"locality\\\") with fee provisions identical to this one, and that the total annual Franchise Fee to be paid to the three localities in aggregate is $98,196 for calendar year 2016 (\\\"base year total annual Franchise Fee\\\"). Grantor's Franchise Fee shall be a percentage share of the base year total annual Franchise Fee, which shall be determined on a pro rata basis according to its percentage share of the total dollar value of Grantee's gas sales occurring within the localities during the calendar year. For each calendar year of the Franchise, each locality's percentage share shall be determined by the following formula: total dollar value of Grantee's gas sales within Locality's percentage share = the Territorial Limits of the locality total dollar value of Grantee's gas sales in the three localities For calendar year 2016, the Franchise Fee shall be paid to Grantor on or before March 31, 2017. 1 Source: RGC RESOURCES INC, 8-K, 12/16/2015 (b) For each succeeding calendar year during the term of this Franchise, the total annual Franchise Fee paid by Grantee to the localities shall be the base year total annual Franchise Fee increased by three (3) percent compounded annually over the term of the Franchise. For each calendar year during the term of this Franchise, Grantor's percentage share shall be determined pursuant to this Section, and paid to Grantor on or before March 31 of the succeeding calendar year.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"BUSINESS OFFICE\", \"level\": 1, \"text\": \"4. BUSINESS OFFICE. Grantee shall during the term of this Franchise maintain at least one business office within the Territorial Limits of Grantor. Such office shall be open at least forty (40) hours per week for the conduct of business between Grantee and its customers.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NONDISCRIMINATION\", \"level\": 1, \"text\": \"5. NONDISCRIMINATION. Grantee shall not discriminate on the basis of race, religion, color, sex, national origin, age, disability, or any other basis prohibited by state law relating to discrimination in employment, except where there is a bona fide occupational qualification reasonably necessary to the normal operation of the Grantee.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICE\", \"level\": 1, \"text\": \"6. NOTICE. All notices required under this Agreement or the Ordinance shall be in writing and shall be deemed validly given, unless otherwise required, when sent by certified mail, return receipt requested, or by a nationally recognized overnight courier, addressed as follows (or any other address the party to be notified may have designated to the sender by like notice): Grantor: Grantee: Town of Vinton Roanoke Gas Company Attention: Town Manager Attention: President 311 S. Pollard Street 519 Kimball Avenue, N.E. Vinton, Virginia 24179 P.O. Box 13007 Roanoke, Virginia 24030 The parties may, by notice given under this Section, designate such other addresses as they may deem appropriate for the receipt of notices under this Agreement.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EFFECTIVE DATE\", \"level\": 1, \"text\": \"7. EFFECTIVE DATE. The effective date of the Franchise will be January 1, 2016. SIGNATURES APPEAR ON FOLLOWING PAGES 2 Source: RGC RESOURCES INC, 8-K, 12/16/2015 IN WITNESS WHEREOF, the parties hereto have signed this Agreement by their authorized representatives. WITNESS: ROANOKE GAS COMPANY /s/ Diane L. Conner By /s/ John S. D'Orazio John S. D'Orazio, President and CEO Diane L. Conner, Assistant to CEO 12/14/2015 Printed Name and Title WITNESS: TOWN OF VINTON, VIRGINIA /s/ Susan N. Johnson By /s/ Christopher S. Lawrence Christopher S. Lawrence, Town Manager Susan N. Johnson, Town Clerk Printed Name and Title 3 Source: RGC RESOURCES INC, 8-K, 12/16/2015\"}}, {\"id\": \"party:TOWN OF VINTON, VIRGINIA\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"TOWN OF VINTON, VIRGINIA\", \"role\": \"Grantor\", \"address\": \"311 S. Pollard Street Vinton, Virginia 24179\"}}, {\"id\": \"party:ROANOKE GAS COMPANY\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ROANOKE GAS COMPANY\", \"role\": \"Grantee\", \"address\": \"519 Kimball Avenue, N.E. P.O. Box 13007 Roanoke, Virginia 24030\"}}, {\"id\": \"party:City of Roanoke\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"City of Roanoke\", \"role\": \"locality\", \"address\": null}}, {\"id\": \"party:City of Salem\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"City of Salem\", \"role\": \"locality\", \"address\": null}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS AGREEMENT (\\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Grantor\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Grantor\", \"text\": \"the TOWN OF VINTON, VIRGINIA, a Virginia municipal corporation (\\\"Grantor\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Grantee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Grantee\", \"text\": \"ROANOKE GAS COMPANY, a Virginia corporation (\\\"Grantee\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchise\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchise\", \"text\": \"a franchise to construct, reconstruct, operate, maintain, repair, and extend a Gas Distribution System within Grantor's Territorial Limits in accordance with the terms and conditions set forth below (\\\"Franchise\\\")\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Ordinance\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ordinance\", \"text\": \"Grantor's Franchise Ordinance (Ordinance No. 967), adopted November 17, 2015, (\\\"Ordinance\\\")\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Roanoke\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Roanoke\", \"text\": \"the City of Roanoke (\\\"Roanoke\\\")\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Salem\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Salem\", \"text\": \"the City of Salem (\\\"Salem\\\")\", \"definition_clause\": \"3\"}}, {\"id\": \"term:Vinton\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Vinton\", \"text\": \"the Town of Vinton (\\\"Vinton\\\")\", \"definition_clause\": \"3\"}}, {\"id\": \"term:localities\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"localities\", \"text\": \"(Grantor, Roanoke and Salem being hereinafter sometimes collectively referred to as the \\\"localities\\\"\", \"definition_clause\": \"3\"}}, {\"id\": \"term:locality\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"locality\", \"text\": \"singularly as a \\\"locality\\\")\", \"definition_clause\": \"3\"}}, {\"id\": \"term:base year total annual Franchise Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"base year total annual Franchise Fee\", \"text\": \"the total annual Franchise Fee to be paid to the three localities in aggregate is $98,196 for calendar year 2016 (\\\"base year total annual Franchise Fee\\\")\", \"definition_clause\": \"3\"}}, {\"id\": \"value:twenty (20) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) years\"}}, {\"id\": \"value:$98,196\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$98,196\"}}, {\"id\": \"value:three (3) percent\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"three (3) percent\"}}, {\"id\": \"value:forty (40) hours per week\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"forty (40) hours per week\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of SEASPINEHOLDINGSCORP_10_10_2018-EX-10.1-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of SEASPINEHOLDINGSCORP_10_10_2018-EX-10.1-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (\\\"Agreement\\\") is entered into as of this 15th day of May, 2013 (the \\\"Effective Date\\\") by and between Integra LifeSciences Corporation (\\\"Integra\\\"), a Delaware corporation with offices at 311 Enterprise Drive, Plainsboro, New Jersey 08536, and PcoMed, LLC (\\\"PcoMed\\\"), a Colorado limited liability company with offices at 105 S. Sunset Street, Longmont, Colorado 80501. RECITALS: WHEREAS, Integra is a medical device company that is developing and commercializing implantable spinal medical devices and procedures in the field of spinal surgery; WHEREAS, PcoMed has experience and expertise in the surface modification of medical device materials; WHEREAS, Integra desires to engage PcoMed to apply certain of its surface technologies onto Integra's implantable spinal medical devices for preclinical, clinical and commercial use and distribution by Integra; and WHEREAS, PcoMed is willing to apply such surface technologies onto Integra's implantable spinal medical devices and to grant Integra certain exclusive rights to use and commercialize those devices; and NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties hereto agree as follows: 1. DEFINITIONS. As used in this Agreement, the following initially capitalized terms, whether used in the singular or plural form, shall have the meanings set forth in this Section 1.\"}, {\"id\": \"1.1\", \"title\": \"\\\"Affiliate\\\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is\", \"level\": 2, \"text\": \"1.1. \\\"Affiliate\\\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes of this Section 1.1, the term \\\"control\\\" (with a correlative meaning for \\\"controlled by\\\") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the subject corporation, person or entity, whether through the ownership of voting securities, by contract or otherwise.\"}, {\"id\": \"1.2\", \"title\": \"\\\"*** Run\\\" means a single production run of PcoMed's *** to apply the PcoMed Surface Modification Technology to Integra\", \"level\": 2, \"text\": \"1.2. \\\"*** Run\\\" means a single production run of PcoMed's *** to apply the PcoMed Surface Modification Technology to Integra Products.\"}, {\"id\": \"1.3\", \"title\": \"\\\"*** Run Fee\\\" means the fee for a single *** Run\", \"level\": 2, \"text\": \"1.3. \\\"*** Run Fee\\\" means the fee for a single *** Run. The *** Run Fee is exclusive of potential fees for any surface preparation requirements currently performed prior to PcoMed's receipt of Integra Product.\"}, {\"id\": \"1.4\", \"title\": \"\\\"Confidential Disclosure Agreements\\\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by\", \"level\": 2, \"text\": \"1.4. \\\"Confidential Disclosure Agreements\\\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by certain Integra Affiliates and PcoMed. 1 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"1.5\", \"title\": \"\\\"Confidential Information\\\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whet\", \"level\": 2, \"text\": \"1.5. \\\"Confidential Information\\\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whether developed by the disclosing party or by others, any confidential, non-public, proprietary information of Integra or PcoMed that is designated by the disclosing party as confidential or secret or that should reasonably be assumed by the receiving party to be confidential or secret. Confidential Information includes, without limitation: (i) specifications, know-how, trade secrets, designs, technical information, drawings, sketches, engineering drawings, work of authorship, software, prototypes, samples, models, business information, marketing information, current products and services, future products and services, proposed products and services, inventions, discoveries, devices, apparatus, equipment, algorithms, business methods, plans, assays, methods, procedures, processes, formulae, protocols, techniques, data, research and development data, experimental work, clinical data, engineering data, manufacturing data, technical or non-technical information, ideas, media, and unpublished patent applications; (ii) personnel and financial information, product cost information, contractual relationships, operational and procedural manuals; (iii) information or data regarding product research and development, including technical, engineering, or production data, test data, or results, information concerning a disclosing party's efforts to acquire, protect, and license proprietary rights, (iv) a disclosing party's price, cost and fee data, pricing and billing policies, forecasts, plans, procurement requirements, and strategies for all aspects of the disclosing party's operations, marketing, and sales, whether or not in effect; and (v) data relating to the type, quality, specifications, and price of the disclosing party's products and/or services received or provided by any customer or vendor.\"}, {\"id\": \"1.6\", \"title\": \"\\\"Derive\\\" and cognates thereof means to develop, make, invent, discover, create, synthesize, conceive, reduce to practic\", \"level\": 2, \"text\": \"1.6. \\\"Derive\\\" and cognates thereof means to develop, make, invent, discover, create, synthesize, conceive, reduce to practice, design or result from, to be based upon or to otherwise generate (whether directly or indirectly, or in whole or in part).\"}, {\"id\": \"1.7\", \"title\": \"\\\"FDA\\\" means the United States Food and Drug Administration, or any successor thereto, having the administrative authori\", \"level\": 2, \"text\": \"1.7. \\\"FDA\\\" means the United States Food and Drug Administration, or any successor thereto, having the administrative authority to regulate the marketing of pharmaceutical products, biological therapeutic product, delivery systems, and medical devices in the United States.\"}, {\"id\": \"1.8\", \"title\": \"\\\"Field\\\" means spinal interbody and/or intervertebral surgical methods and procedures, including without limitation, int\", \"level\": 2, \"text\": \"1.8. \\\"Field\\\" means spinal interbody and/or intervertebral surgical methods and procedures, including without limitation, interbody and/or intervertebral fusion and/or spacer procedures and interbody and/or intervertebral spinal arthroplasty procedures.\"}, {\"id\": \"1.9\", \"title\": \"\\\"First Product Order\\\" means the first purchase order issued by Integra to PcoMed for the production of salable Treated\", \"level\": 2, \"text\": \"1.9. \\\"First Product Order\\\" means the first purchase order issued by Integra to PcoMed for the production of salable Treated Integra Product or Partially Treated Integra Product.\"}, {\"id\": \"1.10\", \"title\": \"\\\"Integra Customers\\\" means Third Parties who purchase Treated Integra Products and Partially Treated Integra Products fr\", \"level\": 2, \"text\": \"1.10. \\\"Integra Customers\\\" means Third Parties who purchase Treated Integra Products and Partially Treated Integra Products from Integra or its Affiliates and does not include any Integra Affiliates.\\\"Integra Products\\\" means any implantable spinal surgery interbody and/or intervertebral medical device designed and/or manufactured by or for Integra. 2\"}, {\"id\": \"1.11\", \"title\": \"\\\"Integra Regulatory Data\\\" means Integra information associated with regulatory procedures relating to Treated Integra P\", \"level\": 2, \"text\": \"1.11. \\\"Integra Regulatory Data\\\" means Integra information associated with regulatory procedures relating to Treated Integra Product and/or Partially Treated Integra Product, including bench and animal data, submission data and methodologies, responses of Regulatory Authorities to submissions, information pertaining to such submissions, and additional data generated as required for US Marketing Clearance, EU Marketing Clearance or commercial launch of any Treated Integra Product or Partially Treated Integra Product.\"}, {\"id\": \"1.12\", \"title\": \"\\\"Integra Technology\\\" means any technology owned, licensed or controlled by Integra and/or any Integra Affiliates includ\", \"level\": 2, \"text\": \"1.12. \\\"Integra Technology\\\" means any technology owned, licensed or controlled by Integra and/or any Integra Affiliates including but not limited to SeaSpine and Theken Spine as of the Effective Date and all technology Derived solely by Integra and/or Integra Affiliates during or after the Term, including but not limited to the devices described in U. S. Patent Numbers 7,799,083 and 8,097,036 together with any improvements, enhancements, or extensions of or to any of the foregoing, and Intellectual Property Rights therein, but excluding any technology or information relating to or derived from PcoMed Technology. The Integra Technology shall include all proprietary ideas in any form and embodied in any media, technical information, ideas, discoveries, knowledge, know-how, skill, experience, concepts, data, processes, procedures, methods, techniques, protocols, formulae, trade secrets, Inventions (whether or not patentable), media, research tools, compositions, software, hardware, instruments, documents, works of authorship, formulations, and other physical, chemical or biological materials and information, including, without limitation, clinical and regulatory strategies, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, manufacturing, patent, marketing and legal data or descriptions, apparatus, prototypes, devices, chemical formulations, compound compositions of matter, product samples, assays and similar information and Inventions.\"}, {\"id\": \"1.13\", \"title\": \"\\\"Intellectual Property Rights\\\" means any and all intellectual property and industrial design rights, whether protected,\", \"level\": 2, \"text\": \"1.13. \\\"Intellectual Property Rights\\\" means any and all intellectual property and industrial design rights, whether protected, created or arising under the laws of the United States or any other foreign jurisdiction, including the following: (i) patent rights; (ii) copyrights, mask work rights, database rights and design rights, whether or not registered, published or unpublished, and registrations and applications for registration thereof, and all rights therein whether provided by international treaties or conventions or otherwise; (iii) trade secrets and Inventions; (iv) moral rights; and (v) other applications and registrations related to any of the rights set forth in the foregoing clauses (i) through (iv); provided, however, that as used in this Agreement, the term \\\"Intellectual Property\\\" expressly excludes rights in trademarks, trade names, service marks, service names, design marks, logos, slogans, trade dress, or similar rights with respect to indicators of origin, whether registered or unregistered, as well as rights in internet domain names, uniform resource locators and e-mail addresses.\"}, {\"id\": \"1.14\", \"title\": \"\\\"Inventions\\\" means conceptions, ideas, innovations, discoveries, inventions, processes, machines, formulae, formulation\", \"level\": 2, \"text\": \"1.14. \\\"Inventions\\\" means conceptions, ideas, innovations, discoveries, inventions, processes, machines, formulae, formulations, biological materials, molecules, compounds, compositions, improvements, enhancements, modifications, technological developments, know-how, show-how, methods, techniques, systems, designs, production system, plans, source code, object code and documentation pertaining thereto, including, without limitation, functional specifications, object libraries, design documentation, technical documentation, statements of principles of operations, schematics, programmers' guides, and other documentation, data, programs and information and works of authorship, whether or not patentable, copyrightable or susceptible to any other form of legal protection.\"}, {\"id\": \"1.15\", \"title\": \"\\\"Minimum Payment\\\" means the amounts set forth on Attachment B as payable by Integra to PcoMed in each Minimum Payment P\", \"level\": 2, \"text\": \"1.15. \\\"Minimum Payment\\\" means the amounts set forth on Attachment B as payable by Integra to PcoMed in each Minimum Payment Period.\"}, {\"id\": \"1.16\", \"title\": \"\\\"Minimum Payment Period\\\" has the meaning set forth on attached Attachment B\", \"level\": 2, \"text\": \"1.16. \\\"Minimum Payment Period\\\" has the meaning set forth on attached Attachment B. 3 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"1.17\", \"title\": \"\\\"Net Sales\\\" means the gross amount of all revenues invoiced and received by Integra and its Affiliates from Integra Cus\", \"level\": 2, \"text\": \"1.17. \\\"Net Sales\\\" means the gross amount of all revenues invoiced and received by Integra and its Affiliates from Integra Customers from the Sale of Treated Integra Products and Partially Treated Integra Products, less the following deductions (to the extent otherwise then or previously included in the gross amounts invoiced and in respect of which no previous deduction was taken): (i) amounts taken or accrued for sales, distributor or other commissions allowed, discounts allowed dealers, trade and/or quantity and cash discounts; (ii) refunds, rebates, chargebacks, replacements or credits and allowances actually allowed or granted to purchasers on account of contractual obligations, rejections, returns, or billing errors and for uncollectible amounts (except to the extent later collected) on Sales; (iii) sales, use and/or other excise taxes, import and/or export duties paid, tariffs, and any other governmental tax or charge (except income taxes) imposed on or at the time of production, importation, use, or sale of the Treated Integra Product or Partially Treated Integra Product, including any value added taxes, and taxes on medical devices; (iv) shipping insurance costs and prepaid transportation and/or freight charges. Net Sales shall exclude any amounts Integra or its Affiliates receive for Treated Integra Product or Partially Treated Integra Product that are used for clinical trials required or reasonably deemed to be desirable for Regulatory Approval or additional product indications in any country.\"}, {\"id\": \"1.18\", \"title\": \"\\\"Non-Treated Integra Product\\\" means an Integra Product that does not utilize or embody, in whole or in part, the PcoMed\", \"level\": 2, \"text\": \"1.18. \\\"Non-Treated Integra Product\\\" means an Integra Product that does not utilize or embody, in whole or in part, the PcoMed Surface Modification Technology.\"}, {\"id\": \"1.19\", \"title\": \"\\\"Notice of Initial Acceptance of First Product Order\\\" means Integra's acceptance of the Treated Integra Product or Part\", \"level\": 2, \"text\": \"1.19. \\\"Notice of Initial Acceptance of First Product Order\\\" means Integra's acceptance of the Treated Integra Product or Partially Treated Integra Product pursuant to the First Product Order. Such acceptance shall be issued in the form of Attachment C by Integra within ten (10) business days of receipt by Integra or its Affiliates of product (and related quality and testing documentation) meeting specifications mutually agreed upon by Integra and PcoMed.\"}, {\"id\": \"1.20\", \"title\": \"\\\"Partially Treated Integra Product\\\" means an Integra Product that (i) utilizes or embodies, in whole or in part, the Pc\", \"level\": 2, \"text\": \"1.20. \\\"Partially Treated Integra Product\\\" means an Integra Product that (i) utilizes or embodies, in whole or in part, the PcoMed Surface Modification Technology and (ii) a portion of which (not including radiographic or radiopaque markers) is formed from a material other than PEEK or PAEK and does not utilize or embody the PcoMed Surface Modification Technology.\"}, {\"id\": \"1.21\", \"title\": \"\\\"PcoMed Regulatory Data\\\" means PcoMed information associated with regulatory procedures relating to the PcoMed Surface\", \"level\": 2, \"text\": \"1.21. \\\"PcoMed Regulatory Data\\\" means PcoMed information associated with regulatory procedures relating to the PcoMed Surface Modification Technology, including bench and animal data, submission data and methodologies, responses of Regulatory Authorities to submissions, information pertaining to such submissions, and additional data generated as required for US Marketing Clearance, EU Marketing Clearance or commercial launch of a product using or embodying the Surface Modification Technology.\"}, {\"id\": \"1.22\", \"title\": \"\\\"PcoMed Surface Modification Technology\\\" means a proprietary PcoMed osteoconductive commercially pure titanium *** mole\", \"level\": 2, \"text\": \"1.22. \\\"PcoMed Surface Modification Technology\\\" means a proprietary PcoMed osteoconductive commercially pure titanium *** molecular surface modification of PEEK (polyetheretherkeytone), PEKK (polyetherkeytonekeytone), and/or PAEK (polyaryletherkeytone) materials as illustrated in Attachment A.\"}, {\"id\": \"1.23\", \"title\": \"\\\"PcoMed Technology\\\" means any technology owned, licensed or controlled by PcoMed as of the Effective Date, including th\", \"level\": 2, \"text\": \"1.23. \\\"PcoMed Technology\\\" means any technology owned, licensed or controlled by PcoMed as of the Effective Date, including the (i) PcoMed Surface Modification Technology and (ii) coating, surface, application, surface modification and pretreatment technology and knowhow, and all technology Derived by PcoMed during or after the Term, together with any improvements, enhancements, or extensions of or to any of the foregoing, and Intellectual Property Rights therein, but excluding any technology or information relating solely to or Derived solely from Integra Technology. The PcoMed Technology includes all proprietary ideas in any form and embodied in any media, technical information, ideas, discoveries, knowledge, know-how, skill, experience, 4 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. concepts, data, processes, procedures, methods, techniques, protocols, formulae, trade secrets, Inventions (whether or not patentable), media, research tools, compositions, software, hardware, instruments, documents, works of authorship, formulations, and other physical, chemical or biological materials and information, including, without limitation, clinical and regulatory strategies, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, manufacturing, patent, marketing and legal data or descriptions, apparatus, prototypes, devices, chemical formulations, compound compositions of matter, product samples, assays and similar information and Inventions.\"}, {\"id\": \"1.24\", \"title\": \"\\\"Regulatory Approval\\\" means, with respect to a country in the Territory, all approvals, licenses, registrations, or aut\", \"level\": 2, \"text\": \"1.24. \\\"Regulatory Approval\\\" means, with respect to a country in the Territory, all approvals, licenses, registrations, or authorizations by an applicable Regulatory Authority necessary to import, commercialize, transport, store, market and sell Treated Integra Product and/or Partially Treated Integra Product in such country, including labeling, pricing, or reimbursement approvals.\"}, {\"id\": \"1.25\", \"title\": \"\\\"Regulatory Authority\\\" means the FDA in the United States, and the equivalent regulatory authority or governmental enti\", \"level\": 2, \"text\": \"1.25. \\\"Regulatory Authority\\\" means the FDA in the United States, and the equivalent regulatory authority or governmental entity having the responsibility, jurisdiction, and authority to approve the to importation, commercialization, transport, storage, marketing and sale of the Treated Integra Product or Partially Treated Integra Product in any country or jurisdiction outside of the United States.\"}, {\"id\": \"1.26\", \"title\": \"\\\"Sale\\\" or \\\"Sales\\\" or \\\"Sell\\\" or \\\"Sold\\\" means the transfer or disposition by Integra or its Affiliates of a Treated Integ\", \"level\": 2, \"text\": \"1.26. \\\"Sale\\\" or \\\"Sales\\\" or \\\"Sell\\\" or \\\"Sold\\\" means the transfer or disposition by Integra or its Affiliates of a Treated Integra Product or a Partially Treated Integra Product for value to Integra Customers in the Territory\"}, {\"id\": \"1.27\", \"title\": \"\\\"Territory\\\" means worldwide, during the thirty six (36) month period following Notice of Initial Acceptance of First Pr\", \"level\": 2, \"text\": \"1.27. \\\"Territory\\\" means worldwide, during the thirty six (36) month period following Notice of Initial Acceptance of First Product Order. Thereafter, \\\"Territory\\\" may exclude the People's Republic of China (\\\"PRC\\\"), to the extent that Integra has had no sales of Treated Integra Products in that country. In the event that Integra has had no such sales, PcoMed shall give sixty (60) days advance written notice of PcoMed's intent to utilize a third party to market the PcoMed Surface Modification Technology in the PRC .\"}, {\"id\": \"1.28\", \"title\": \"\\\"Third Party\\\" means any entity or person other than (i) Integra and its Affiliates, or (ii) PcoMed and its Affiliates\", \"level\": 2, \"text\": \"1.28. \\\"Third Party\\\" means any entity or person other than (i) Integra and its Affiliates, or (ii) PcoMed and its Affiliates.\"}, {\"id\": \"1.29\", \"title\": \"\\\"Treated Integra Product\\\" means an Integra Product that utilizes or embodies, in whole or part, the PcoMed Surface Modi\", \"level\": 2, \"text\": \"1.29. \\\"Treated Integra Product\\\" means an Integra Product that utilizes or embodies, in whole or part, the PcoMed Surface Modification Technology, excluding Partially Treated Integra Product.\"}, {\"id\": \"1.30\", \"title\": \"\\\"US Marketing Clearance\\\" means Regulatory Approval of a Treated Integra Product or Partially Treated Integra Product fo\", \"level\": 2, \"text\": \"1.30. \\\"US Marketing Clearance\\\" means Regulatory Approval of a Treated Integra Product or Partially Treated Integra Product for use in the Field in the United States. 2. CONSIDERATION.\"}, {\"id\": \"2.1\", \"title\": \"Milestone Payments\", \"level\": 2, \"text\": \"2.1. Milestone Payments. (a) First Payment. Integra shall pay PcoMed $*** ( *** US dollars) upon full execution of this Agreement. (b) Second Payment. Integra shall pay PcoMed $*** ( *** US dollars) within 30 days after Notice of Initial Acceptance of First Product Order. Integra shall place the First Product Order within sixty (60) days of the Effective Date of this Agreement. 5 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"2.2\", \"title\": \"Fees\", \"level\": 2, \"text\": \"2.2. Fees. (a) Treated Integra Products. Subject to Section 2.2(c), for so long as the Agreement has not been converted to a non-exclusive arrangement under the provisions of Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Treated Integra Product Sold by Integra or its Affiliates. Subject to Section 2.2(c), for so long as Integra's Rights under the Agreement have been converted to a non-exclusive arrangement under the provisions of Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Treated Integra Product Sold by Integra or its Affiliates. The Fee rate payable shall be determined based on whether this Agreement is exclusive or non-exclusive at the time of Integra's Sale of the Treated Integra Product, not at the time of PcoMed's production of the Treated Integra Product. (b) Partially Treated Integra Products. Subject to Section 2.2(c), for so long as Agreement has not been converted to a non-exclusive arrangement pursuant to Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Partially Treated Integra Product Sold by Integra or its Affiliates. Subject to Section 2.2(c), for so long as Integra's rights under the Agreement have been converted to a non-exclusive arrangement under the provisions of Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Partially Treated Integra Product Sold by Integra or its Affiliates. The Fee rate payable shall be determined based on whether this Agreement is exclusive or non-exclusive at the time of Integra's Sale of Partially Treated Integra Product, not at the time of PcoMed's production of the Partially Treated Integra Product. (c) Fee Adjustment. The Fees may be subject to reduction according to the provisions of Sections 8.5 and 10.1. If it becomes necessary for Integra to settle a Third Party patent infringement suit covered by Section 10.1 (i), solely because of any action or omission of PcoMed or because of Third Party claims against PcoMed Surface Modification Technology and/or such settlement involves obtaining a license from a Third Party, in order to make, have made, import, export, use, offer for Sale, or Sell a Treated Integra Product or a Partially Treated Integra Product in the Field, then Integra may offset, dollar for dollar, against Fees up to *** percent (***%) of Integra's reasonable, out-of-pocket expenses, costs, fees (including reasonable attorneys' fees), and other consideration related to the investigation, negotiation and settlement paid by Integra to such Third Party to obtain such settlement or license with respect to the PcoMed Surface Modification Technology. The parties agree that, to the extent Fees are reduced pursuant to this Agreement, for purposes of determining the contribution toward the Minimum Payments, the Fee shall be counted as if it had not been reduced. (d) Payment. All Fees shall be due and payable quarterly as provided in Section 6.1.\"}, {\"id\": \"2.3\", \"title\": \"*** Run Fees\", \"level\": 2, \"text\": \"2.3. *** Run Fees. (a) For Distribution. Integra shall pay PcoMed a flat *** Run Fee of $*** (*** US dollars) for each *** Run in which a maximum of one hundred (100) Non-Treated Integra Product are converted by PcoMed to Treated Integra Product or Partially Treated Integra Product. PcoMed and Integra will make commercially reasonable efforts to increase the *** Run capacity. Changes to the *** Run Fee based on increased capacity will be determined upon completion of the appropriate process validations. (b) For Regulatory Purposes. PcoMed will not charge *** Run Fees for reasonable quantities, not to exceed *** units or four *** Runs, of Treated Integra Products or Partially Treated Integra Product and test samples required to complete US Marketing Clearance and/or EU Marketing Clearance testing and validations. 6 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. (c) Payment. *** Run Fees shall be due and payable within thirty (30) days of each *** Run.\"}, {\"id\": \"2.4\", \"title\": \"Minimum Payments\", \"level\": 2, \"text\": \"2.4. Minimum Payments. Integra shall use commercially reasonable efforts to Sell Treated Integra Products and Partially Treated Integra Products that generate payments to PcoMed of no less than the Minimum Payments applicable to each Minimum Payment Period. The Minimum Payment applicable to each Minimum Payment Period shall be due annually on or before 45 days after the last day of each Minimum Payment Period. The Minimum Payment may be satisfied either by payments of the Fees paid pursuant to Sections 2.2 and 2.3, or by the sum of Fees paid and an additional elective cash payment from Integra to PcoMed. It shall remain in Integra's sole discretion whether or not to satisfy the Minimum Payment for any Minimum Payment Period by making an additional elective cash payment. In the event that Integra fails to satisfy the Minimum Payment for any Minimum Payment Period, PcoMed may, at its sole election, give notice, as set forth in Section 3.2, for conversion of Integra's exclusive arrangement under Section 3.1 to a non-exclusive arrangement. PcoMed's conversion right is PcoMed's sole and exclusive remedy for Integra's failure to satisfy the Minimum Payment for any Minimum Payment Period. Integra shall have no liability at any time to PcoMed for Integra's failure to pay the Minimum Payment. 3. GRANT OF EXCLUSIVITY COMMERCIALIZATION\"}, {\"id\": \"3.1\", \"title\": \"Grant of Exclusive Rights\", \"level\": 2, \"text\": \"3.1. Grant of Exclusive Rights. Subject to the terms and conditions of this Agreement, PcoMed hereby grants to Integra and its Affiliates a sole and exclusive worldwide right to sell and commercialize Integra Products treated by PcoMed, with the PcoMed Surface Modification Technology (the \\\"Right\\\") for use in the Field in the Territory, including the right to conduct research and development in support of any of the foregoing. Nothing herein grants any rights to Integra (i) to manufacture any products using the PcoMed Surface Modification Technology or (ii) to sell or commercialize any products utilizing the PcoMed Surface Modification Technology other than the Integra Products for use in the Field in the Territory. Neither PcoMed nor its Affiliates shall sell or offer for sale, or grant rights under the PcoMed Surface Modification Technology to any Third Party in the Field in the Territory for products that utilize or embody the PcoMed Surface Modification Technology. Except as expressly stated in the preceding sentence, PcoMed shall not be subject to any restriction under this Agreement with regard to the PcoMed Surface Modification Technology. Without limiting the foregoing or Section 8.3 below, the exclusive nature of the Rights shall not in any way limit PcoMed from making, having made, using, selling or offering for sale products and/or services that do not utilize or embody the PcoMed Surface Modification Technology.\"}, {\"id\": \"3.3\", \"title\": \"Exclusive Coating\", \"level\": 2, \"text\": \"3.3. Exclusive Coating. Integra (i) shall not apply or have applied any other coating to any Integra Products treated with the PcoMed Surface Modification Technology, unless that coating is for the sole purpose of identification or sterilization and (ii) shall not process the PcoMed Surface Modification Technology in any way that will adversely affect its integrity or performance. 7 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"4\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"4. TERM AND TERMINATION.\"}, {\"id\": \"4.1\", \"title\": \"Initial Term\", \"level\": 2, \"text\": \"4.1. Initial Term. The initial term of this Agreement (the \\\"Initial Term\\\") shall commence on the Effective Date and shall end on the date that payment is due for Minimum Payment Period 7, pursuant to Section 2.4 hereof and as set forth in Attachment B hereof, unless earlier terminated as provided herein.\"}, {\"id\": \"4.2\", \"title\": \"Right to Renew\", \"level\": 2, \"text\": \"4.2. Right to Renew. Thereafter, this Agreement may be renewed for such periods of time and under such terms and conditions as are mutually agreed to in writing and pursuant to Section 12.7.\"}, {\"id\": \"4.3\", \"title\": \"Termination for Cause\", \"level\": 2, \"text\": \"4.3. Termination for Cause. Without limiting the other rights to terminate set forth in this Agreement, this Agreement may be terminated by either party as follows: (a) Material Breach. In the event that a party materially defaults under or materially breaches any of the provisions of this Agreement, the other party shall have the right to terminate this Agreement upon 60 days' prior written notice, unless such material default or breach is cured during such 60-day period (or in the event any breach is incapable of being cured in such time period, the other party presents a plan to attempt cure of such breach and prevent similar breaches, which plan is reasonably acceptable to the terminating party), in which event this Agreement shall continue in full force and effect. (b) Bankruptcy. If a party institutes for its protection or is made a defendant in any proceeding under bankruptcy, insolvency, reorganization or receivership law, or such party is placed in receivership, makes an assignment for benefit of creditors or is unable to meet its debts in the regular course of business, the other party may elect to terminate this Agreement immediately by written notice to the first party without prejudice to any right or remedy the other party may have, including damages for breach.\"}, {\"id\": \"4.4\", \"title\": \"Effects of Termination\", \"level\": 2, \"text\": \"4.4. Effects of Termination. (a) Obligations Accruing Prior to Termination. Expiration or termination of this Agreement shall not relieve the Parties of any obligation accruing prior to such expiration or termination. (b) Termination of Rights. Subject to Section 4.-4(c), upon expiration or termination of this Agreement, the Rights and all rights of either party hereunder shall immediately cease and terminate. (c) Transition. After early termination of this Agreement (other than a termination based on a breach of Sections 5 or 8 by Integra) and continuing for a period of eighteen (18) months thereafter, Integra and its Affiliates may Sell any Treated Integra Product and Partially Treated Integra Product in its inventory in the Field, and may, with respect to all components which, prior to the effective date of termination, were ordered or manufactured with the anticipation of being included as Treated Integra Product or Partially Treated Integra Product, complete their manufacture and sell them as though they had been inventory on the effective date of termination, subject to payment of all amounts payable to PcoMed for such Sales under this Agreement. (d) Survival. The following provisions of this Agreement and all defined terms shall survive termination of this Agreement for any reason: Sections 2.1, 2.2, 2.3, 4.4(c), 5, 6, 7, 8, 9, 10 and 12. 8\"}, {\"id\": \"5\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"5. CONFIDENTIALITY.\"}, {\"id\": \"5.1\", \"title\": \"Confidential Information\", \"level\": 2, \"text\": \"5.1. Confidential Information. Except to the extent expressly authorized by this Agreement or otherwise agreed to in writing by the parties, each party agrees that, for the term of this Agreement and for 20 years thereafter, it shall keep confidential and shall not publish or otherwise disclose and shall not use for any purpose other than as provided for in this Agreement any Confidential Information furnished to it by the other party pursuant to this Agreement, except that the foregoing shall not apply to any information for which the receiving party can demonstrate that such information: (i) was already known to the receiving party, other than under an obligation of confidentiality, at the time of disclosure by the other party; (ii) was generally available to the public or otherwise part of the public domain at the time of its disclosure to the receiving party; (iii) later became part of the public domain through no act or omission of the receiving party; (iv) was disclosed to the receiving party by a Third Party who had no obligation to the disclosing party not to disclose such information to others; (iv) was independently developed by a person having no knowledge of or access to the disclosing party's Confidential Information; or (v) is an Authorized Disclosure under Section 5.3 below.\"}, {\"id\": \"5.2\", \"title\": \"Ownership of Confidential Information\", \"level\": 2, \"text\": \"5.2. Ownership of Confidential Information. Confidential Information relating to the PcoMed Technology is PcoMed's Confidential Information. Confidential Information relating to the Integra Technology is Integra's Confidential Information. PcoMed's Confidential Information and Integra's Confidential Information will include all Confidential Information as such term is defined in Section 1.6.\"}, {\"id\": \"5.3\", \"title\": \"Authorized Disclosure\", \"level\": 2, \"text\": \"5.3. Authorized Disclosure. (a) Authorized Disclosure. Except as expressly agreed to in writing by Integra or as permitted by this Agreement, PcoMed shall keep Integra Technology and all Integra Confidential Information confidential. Except as expressly agreed to in writing by PcoMed or as permitted by this Agreement, Integra shall keep PcoMed Technology and all PcoMed Confidential Information confidential. Each party may disclose the other party's Confidential Information to the extent such disclosure is reasonably necessary for the following reasons: (i) regulatory filings, including filings with the U.S. Securities Exchange Commission and Regulatory Authorities; (ii) prosecuting or defending litigation provided the Confidential Information is under seal or protective order; and (iii) complying with applicable governmental regulations and legal requirements. (b) Notice of Disclosure. Notwithstanding the foregoing, in the event a party is required to make a disclosure of the other party's Confidential Information pursuant to this Section it will, except where impracticable, give reasonable advance notice to the other party of such disclosure and use best efforts to secure confidential treatment of such information. In any event, the parties agree to take all reasonable actions to avoid any unauthorized use or disclosure of Confidential Information hereunder.\"}, {\"id\": \"5.4\", \"title\": \"Employees; Agents\", \"level\": 2, \"text\": \"5.4. Employees; Agents. Each party shall ensure that each of its Affiliates and each employee, director, officer, consultant, or other agent of it or of its Affiliates (collectively \\\"Agents\\\"), who has access to Confidential Information of the other party is bound to obligations of confidentiality and non-use substantially similar in scope to those set forth herein Each party agrees that any disclosure or distribution of the other party's Confidential Information within its own organization shall be made only as is reasonably necessary to carry out the intent of this Agreement.\"}, {\"id\": \"5.5\", \"title\": \"Regulatory Submissions of Integra Regulatory Data\", \"level\": 2, \"text\": \"5.5. Regulatory Submissions of Integra Regulatory Data. During the Term, Integra shall provide all Integra Regulatory Data directly to the relevant Regulatory Authority within the required timeframes. PcoMed is expressly not authorized to disclose Integra Confidential Information directly to 9 any Regulatory Authority unless such disclosure is authorized in writing by Integra, except in the following circumstances: (a) where PcoMed is required by regulation or other legal requirement to disclose such information; (b) as part of a complaint filing concerning a Treated Integra Product or a Partially Treated Integra Product; (c) as part of an FDA audit response; or (d) as otherwise required or permitted by this Agreement.\"}, {\"id\": \"5.6\", \"title\": \"Regulatory Submissions of PcoMed Regulatory Data\", \"level\": 2, \"text\": \"5.6. Regulatory Submissions of PcoMed Regulatory Data. PcoMed shall provide all PcoMed Regulatory Data directly to the relevant Regulatory Authority within the required timeframes. Integra is expressly not authorized to disclose PcoMed Confidential Information directly to any Regulatory Authority unless such disclosure is authorized in writing by PcoMed, except in the following circumstances: (a) where Integra is required by regulation or other legal requirement to disclose such information, (b) as part of a complaint filing concerning a Treated Integra Product or a Partially Treated Integra Product; (c) as part of an FDA audit response; or (d) as otherwise required or permitted by this Agreement\"}, {\"id\": \"5.7\", \"title\": \"Injunctive Relief\", \"level\": 2, \"text\": \"5.7. Injunctive Relief. The parties expressly acknowledge and agree that any breach or threatened breach of this Section 5 may cause immediate and irreparable harm to the owner of the Confidential Information which may not be adequately compensated by damages. Each party therefore agrees that in the event of such breach or threatened breach and in addition to any remedies available at law, the party that owns the Confidential Information shall have the right to seek equitable and injunctive relief, in connection with such a breach or threatened breach, without posting bond.\"}, {\"id\": \"5.8\", \"title\": \"Terms of Agreement Confidential\", \"level\": 2, \"text\": \"5.8. Terms of Agreement Confidential. The parties agree that the terms of this Agreement are confidential and shall not be disclosed by either party to any Third Party (except to a party's professional advisors) without advance written permission of the other party, subject to the following: (i) either party may make any filings of this Agreement required by law or regulation in any country so long as such party uses its reasonable efforts to obtain confidential treatment for portions of this Agreement as available, consults with the other party, and permits the other party to participate, to the extent practicable, in seeking a protective order or other confidential treatment; (ii) either party may disclose the terms of this Agreement to a Third Party (and its professional advisors) when such disclosure is reasonably necessary in connection with (A) the grant of a license or sublicense to such Third Party, (B) prosecuting or defending litigation, (C) an actual or potential merger, 10 acquisition, placement, investment, or other such transaction with such Third Party, or (D) the sale of securities to or other financing from such Third Party or a financing underwritten by such Third Party, in which case disclosure may be made to any person or entity to whom such Third Party sells such securities (and its professional advisers); (iii) advance written permission for disclosure will not be required when a party is ordered to disclose information concerning the Agreement by a competent tribunal or such disclosures are required by law, regulation, or stock exchange rules, except that such party shall make all reasonable efforts to limit any disclosure as may be required in the course of legal proceedings by entry of an appropriate protective and confidentiality order, and shall provide the other party with as much advance notice of such circumstances as is reasonably practical.\"}, {\"id\": \"5.9\", \"title\": \"Return of Materials\", \"level\": 2, \"text\": \"5.9. Return of Materials. Any materials or documents which have been furnished by a disclosing party to a receiving party will be promptly returned, accompanied by all copies thereof, or certified as destroyed upon request by the disclosing party following termination of this Agreement, except that a party may retain one copy solely for reference to comply with regulatory or other legal requirements, subject to the obligations of confidentiality herein. 6. PAYMENT AND ACCOUNTING.\"}, {\"id\": \"6.1\", \"title\": \"Payment Terms and Reports\", \"level\": 2, \"text\": \"6.1. Payment Terms and Reports. Payments due under Section 2.2 shall be payable to PcoMed by Integra on a quarterly basis within 45 days following the end of each calendar quarter. Each such payment shall be accompanied by a statement setting forth in reasonable detail (i) the number and type of Treated Integra Product and Partially Treated Integra Product sold and the Net Sales applicable thereto, (ii) a breakdown of all the components of Net Sales for the determination of payments due under Sections 2.2 (the numbers may be and type of products may be stated in the aggregate and not by customer and are not required to be detailed by geographic area unless Fee rates are different in different geographic areas). Treated Integra Product and/or Partially Treated Integra Product shall be considered as being sold for the purpose of the calculation of payments due under Sections 2.2 when the payments for the Treated Integra Product and/or Partially Treated Integra Product are received by Integra or its Affiliates from a Third Party. All payments to be made under this Agreement shall be paid in United States dollars. Net Sales of Treated Integra Product and/or Partially Treated Integra Product and fees in currencies other than United States dollars shall be first determined in the currency of the country in which they are earned and shall be converted (for the purpose of calculation only) in accordance with generally accepted accounting principles for financial reporting in the United States.\"}, {\"id\": \"6.2\", \"title\": \"Records and Audits\", \"level\": 2, \"text\": \"6.2. Records and Audits. Integra shall keep and maintain accurate records and documentation pertaining to Net Sales of Treated Integra Product in sufficient detail to permit PcoMed to calculate payments due hereunder. Integra shall retain such records and documentation for a period that is consistent with its Records Retention Policy. Such records and documentation will be available for inspection during such period by an independent certified public accountant selected by PcoMed and reasonably acceptable to Integra, solely for the purpose of verifying the payments made by Integra under this Agreement. Said accountant shall enter into a confidentiality agreement with Integra and shall not disclose to PcoMed any information except that which is necessary to determine whether PcoMed has received all amounts due to it from Integra. Such inspections shall be made no more than once each calendar year during ordinary business hours and on reasonable prior notice and shall be at PcoMed's sole cost and expense. PcoMed shall report the results of any such audit to Integra within 60 days of completion and provide a copy of such audit 11 to Integra. The results of any such audit shall be the Confidential Information of Integra. To the extent that such audit reveals any underpayments by Integra, Integra shall pay to PcoMed the amount of shortfall within 60 days from the date on which the parties actually agreed on the amount of the shortfall, or, in the event the parties do not reach agreement on the shortfall, the date a court issues a judgment finally resolving the matter.\"}, {\"id\": \"6.3\", \"title\": \"Taxes\", \"level\": 2, \"text\": \"6.3. Taxes. PcoMed shall pay any and all taxes levied on account of payments it receives under this Agreement. Integra shall pay, or cause to be paid, any and all taxes required to be paid or withheld on any Sales, supply or other transfers for value of Treated Integra Product and/or Partially Treated Integra Product (other than taxes imposed on the income or revenues of PcoMed). All amounts due hereunder shall be without deduction of exchange, collection or other charges, provided that if Integra is required to withhold and pay on behalf of PcoMed any income or other similar tax with respect to the amounts payable under this Agreement, Integra shall deduct such tax payments from and offset against any said payments prior to remittance to PcoMed; and further provided that in regard to any tax so deducted, Integra shall give to PcoMed such assistance as may reasonably be necessary to enable PcoMed to claim exemption therefrom and credit therefor, and in each case shall furnish PcoMed proper evidence of the taxes paid on PcoMed's behalf, provided that Integra shall not be required to incur any out-of-pocket expenses or costs. 7. REPRESENTATIONS AND WARRANTIES\"}, {\"id\": \"7.1\", \"title\": \"Mutual Representations and Warranties\", \"level\": 2, \"text\": \"7.1. Mutual Representations and Warranties. Each party represents and warrants as to itself the following: (a) Corporate Power. Such party is duly organized and validly existing under the laws of the state of its organization and has full corporate power and authority to enter into this Agreement and to carry out the provisions hereof. (b) Due Authorization. Such party is duly authorized to execute and deliver this Agreement and to perform its obligations hereunder. The person executing this Agreement on such party's behalf has been duly authorized to do so by all requisite corporate action. (c) Binding Agreement. The execution, delivery and performance of this Agreement by such party does not conflict with any agreement, instrument or understanding, oral or written, to which it is a party or by which it may be bound, nor, to the party's knowledge, does it violate any material law or regulation of any court, governmental body or administrative or other agency having jurisdiction over it.\"}, {\"id\": \"7.2\", \"title\": \"PcoMed's Representations and Warranties\", \"level\": 2, \"text\": \"7.2. PcoMed's Representations and Warranties. PcoMed hereby represents and warrants to Integra as follows: (a) Sole Owner; No Prior Grant. Except as disclosed to Integra, PcoMed is the sole holder of all legal and equitable right, title and interest in and to the PcoMed Technology. PcoMed has not assigned any of its right, title or interest in or to the Inventions disclosed in the PcoMed Surface Modification Technology. PcoMed has not granted to a Third Party any license under the PcoMed Surface Modification Technology that is inconsistent with, or otherwise restricts, the rights granted to Integra hereunder. PcoMed currently holds valid and effective assignments of all inventors' rights to all the inventions covered by the PcoMed Surface Modification Technology. No Third Party has any right, title or interest in or to the PcoMed Surface Modification Technology. No unnamed inventor has any valid claim to any rights to the inventions contained in the PcoMed Surface Modification Technology and all named inventors are properly named as such. (b) No Asserted Infringement. To PcoMed's knowledge after diligent investigation, (i) the PcoMed Surface Modification Technology does not include any trade secret, confidential information, or know-how of such Third Party that has been misappropriated or improperly used or disclosed, or (ii) the application of the PcoMed Surface Modification Technology to Integra Products or the offer, Sale and use of Treated Integra Products or Partially Treated Integra Products will not infringe a Third Party's patent rights because of the PcoMed Surface Modification Technology being applied thereto or practiced thereby. 12 (c) No Litigation. There is no suit, arbitration or legal, administrative or other proceeding or governmental investigation pending or, to PcoMed's knowledge, threatened against (i) PcoMed's consummation of the transactions described herein, or (ii) PcoMed respecting the PcoMed Surface Modification Technology. To PcoMed's knowledge, there are no claims, judgments or settlements involving PcoMed and relating to the PcoMed Surface Modification Technology or the manufacture, use or Sale of any products using the PcoMed Surface Modification Technology, and no pending claims, litigation or proceedings against PcoMed relating to the PcoMed Surface Modification Technology, PcoMed Technology or the manufacture, use or Sale of products using the PcoMed Surface Modification Technology. (d) No Approvals. No approval or consent of any person, court or governmental agency is required in connection with PcoMed's execution and delivery of this Agreement and the performance of its obligations hereunder. There are no outstanding liens, encumbrances, Third Party rights, agreements or understandings of any kind, either written or oral, express of implied, regarding the the PcoMed Technology that are inconsistent or conflict with any provision of this Agreement. (e) Non-Compete. The Settlement Agreement and Mutual Release between *** and *** does not contain a covenant-non-compete applicable to *** and, to the best of PcoMed's current knowledge, *** is not subject to any covenant-non-compete that would prevent is employment with PcoMed.\"}, {\"id\": \"7.3\", \"title\": \"Integra's Representations and Warranties\", \"level\": 2, \"text\": \"7.3. Integra's Representations and Warranties. Integra hereby represents and warrants to PcoMed as follows: (a) Sole Owner; No Prior Grant. Integra is the sole holder of all legal and equitable right, title and interest in and to the Integra Technology. Integra has not assigned any of its right, title or interest in or to the Inventions disclosed in the Integra Technology. Integra has not granted to a Third Party any license under the Integra Technology that is inconsistent with, or otherwise restricts, this Agreement. Integra currently holds valid and effective assignments of all inventors' rights to all the inventions covered by the Integra Technology. No Third Party has any right, title or interest in or to the Integra Technology. No unnamed inventor has any valid claim to any rights to the inventions contained in the Integra Technology and all named inventors are properly named as such. (b) No Asserted Infringement. To Integra's knowledge after diligent investigation, (i) the Integra Technology does not include any trade secret, confidential information, or know-how of such Third Party that has been misappropriated or improperly used or disclosed and, (ii) to the best of Integra's knowledge, the Sale of Treated Integra Products or Partially Treated Integra Products will not infringe any currently known Third Party patent rights. (c) No Litigation. There is no suit, arbitration or legal, administrative or other proceeding or governmental investigation pending or, to Integra's knowledge, threatened against (i) Integra's consummation of the transactions described herein, or (ii) Integra respecting the Integra Technology. To Integra's knowledge, there are no claims, judgments or settlements involving Integra and relating to the Integra Technology or the manufacture, use or Sale of any products using the Integra Technology, and no pending claims, litigation or proceedings against Integra relating to the Integra Technology or the manufacture, use or Sale of products using the Integra Technology. (d) No Approvals. No approval or consent of any person, court or governmental agency is required in connection with Integra's execution and delivery of this Agreement and the performance of its obligations hereunder. There are no outstanding liens, encumbrances, Third Party rights, agreements or understandings of any kind, either written or oral, express of implied, regarding the the Integra Technology that are inconsistent or conflict with any provision of this Agreement. 13 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"8\", \"title\": \"INTELLECTUAL PROPERTY OWNERSHIP; PROSECUTION, ENFORCEMENT\", \"level\": 1, \"text\": \"8. INTELLECTUAL PROPERTY OWNERSHIP; PROSECUTION, ENFORCEMENT.\"}, {\"id\": \"8.1\", \"title\": \"Ownership\", \"level\": 2, \"text\": \"8.1. Ownership. All PcoMed Technology shall remain the property of PcoMed, and all Integra Technology shall remain the property of Integra. Any Invention that is neither PcoMed Technology nor Integra Technology but that is Derived during the Term jointly by the parties relating to this Agreement shall be the property of (i) PcoMed if it relates primarily to the PcoMed Technology and (ii) Integra if it relates primarily to the Integra Products; provided that the parties may agree that an Invention that is Derived during the Term jointly may become the property of both parties, including Inventions or methods related to the surface preparation of Integra Products. Except with regard to the foregoing joint Inventions or methods, each party hereby assigns to the other, by way of present and future assignment, all of the right, title and interest (including all Intellectual Property Rights therein) that it has or may have in any such Invention that is jointly Derived and that is subject to ownership by the other party.\"}, {\"id\": \"8.2\", \"title\": \"Inventions\", \"level\": 2, \"text\": \"8.2. Inventions. All Inventions and Intellectual Property Rights that relate primarily to the PcoMed Technology Derived during the Term of this Agreement shall remain as the sole and exclusive property of PcoMed.\"}, {\"id\": \"8.3\", \"title\": \"Reservation of Rights\", \"level\": 2, \"text\": \"8.3. Reservation of Rights. Nothing in this Agreement shall be construed as granting to any party any right, title or interest in or to or under any Intellectual Property Rights or Inventions of the other party, other than as expressly agreed by the parties in writing in this Agreement. All rights not specifically granted herein are reserved to the applicable party, which may at all times fully and freely exercise the same except as otherwise restricted herein.\"}, {\"id\": \"8.4\", \"title\": \"Filing, Prosecution, and Maintenance of PcoMed Surface Modification Technology\", \"level\": 2, \"text\": \"8.4. Filing, Prosecution, and Maintenance of PcoMed Surface Modification Technology. PcoMed shall at all times, at its sole election and expense, have the exclusive and sole right to file patent applications covering the PcoMed Surface Modification Technology in its own name. If PcoMed elects to file patent applications covering the PcoMed Surface Modification Technology, PcoMed shall be responsible for diligently prosecuting and maintaining, at its sole expense, such patent applications and patents issuing thereon. PcoMed shall retain patent counsel of its choosing in connection with the performance of its obligations under this Section. PcoMed shall keep Integra reasonably informed of its patent prosecution activities with respect to the PcoMed Surface Modification Technology.\"}, {\"id\": \"8.5\", \"title\": \"Enforcement against Third Parties\", \"level\": 2, \"text\": \"8.5. Enforcement against Third Parties. (a) Notice. If either party learns of the actual, suspected, threatened or likely infringement or misappropriation of any of the PcoMed Surface Modification Technology, or any of the Integra Technology, then that party shall give written notice thereof to the other party and shall provide the other party with any evidence of such infringement or misappropriation in its possession. (b) Infringement Not Relating Solely to PcoMed Surface Modification Technology. (i) Integra shall have the sole right, but shall be under no obligation, to take any action to enforce any suspected or actual infringement, misappropriation or other unauthorized use of Intellectual Property Rights relating to Treated Integra Products or Partially Treated Integra Products where such infringement, misappropriation or other unauthorized use does not relate exclusively to the PcoMed Technology. If Integra does not have standing without PcoMed joining the action, PcoMed shall join the action at Integra's expense. 14 (c) Infringement Relating Exclusively to PcoMed Surface Modification Technology. (i) PcoMed shall have the first and primary right, but shall be under no obligation, to take any action to enforce any suspected or actual infringement, misappropriation or other unauthorized use of Intellectual Property Rights relating to Treated Integra Products or Partially Treated Integra Products to the extent that such infringement, misappropriation or other unauthorized use relates exclusively to the PcoMed Surface Modification Technology. (ii) PcoMed shall notify Integra of its intent to take any such action. If Integra desires PcoMed to take any such action, Integra shall notify PcoMed of such desire in writing and PcoMed shall have ninety (90) days in which to notify Integra whether it decides to take any action, if it has not already so notified Integra. (iii) Integra may elect to join as a party in PcoMed's action at Integra's expense; provided, however, that if PcoMed does not have standing without Integra joining the action, Integra shall join the action at PcoMed's expense. (iv) If PcoMed does not notify Integra of its desire to take action within ninety (90) days after written request by Integra to do so, or PcoMed agrees to take action and fails to resolve or bring suit to enforce any suspected or actual infringement, misappropriation or other unauthorized use within six months thereafter, then Integra may, but shall be under no obligation to, and at its own cost, require PcoMed to take such enforcement action as Integra deems necessary. If PcoMed takes any such enforcement action, Integra shall reimburse PcoMed for all of its reasonable expenses, costs, and fees, including reasonable attorney fees, incurred in connection therewith, except as provided in Section 8.5(d)(i). Any such reimbursement shall be deducted from the Fees payable by Integra pursuant to Section 2.2 hereof. (d) Disagreements; Procedures. (i) Whichever party takes or controls an enforcement action under this Section 8.4 shall be entitled to reimburse itself first out of any sums recovered in such suit or in settlement thereof for all costs and expenses, including reasonable attorneys' fees, involved in the prosecution of such action. Any amount remaining after this reimbursement shall be used to reimburse the other party for all costs and expenses, including reasonable attorney's fees, if any, involved in its participation in such action. Any amounts thereafter remaining shall be split in proportion to the damages from the suspected or actual infringement, misappropriation or other unauthorized use reasonably attributable to the PcoMed Surface Modification Technology versus the damages from the suspected or actual infringement, misappropriation or other unauthorized use reasonably not attributable to the PcoMed Surface Modification Technology. Any and all of Integra's reasonable expenses, costs and fees (including reasonable attorneys' fees) incurred by Integra in the investigation, commencement, pursuit, enforcement, defense and settlement of any infringement related exclusively to the PcoMed Surface Modification Technology that are not reimbursed as provided above, shall be fully creditable, dollar for dollar, against the Minimum Payments or Fees that would otherwise be due and owing hereunder. 15 (ii) In the event that a declaratory judgment action alleging invalidity or noninfringement of any of the PcoMed Surface Modification Technology shall be brought against Integra as a result of any enforcement action taken by Integra, Integra shall be responsible for defending such action; provided, however, that within thirty (30) days after commencement of such action, PcoMed shall have the right to intervene and take over the sole defense of the action at its own expense. In the event that a declaratory judgment action alleging invalidity or noninfringement of any of the Integra Technology shall be brought against PcoMed as a result of any enforcement action taken by PcoMed, PcoMed shall be responsible for defending such action; provided, however, that within thirty (30) days after commencement of such action, Integra shall have the right to intervene and take over the sole defense of the action at its own expense. Notwithstanding the foregoing, in the event that a declaratory judgment action is brought against one or both of the parties alleging invalidity or noninfringement of PcoMed Technology and Integra Technology, PcoMed and Integra shall each have the right to participate in the defense of the action at its own expense. 9. LIMITATION OF LIABILITY.\"}, {\"id\": \"9.1\", \"title\": \"Limitation of Liability\", \"level\": 2, \"text\": \"9.1. Limitation of Liability. NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS SECTION IS INTENDED TO LIMIT OR RESTRICT THE DAMAGES AVAILABLE FOR BREACHES OF SECTION 3.1 (GRANT OF RIGHTS), SECTION 5 (CONFIDENTIALITY PROVISIONS), OR SECTIONS 8.1 AND 8.2 (OWNERSHIP AND LICENSE). 10. INDEMNIFICATION.\"}, {\"id\": \"10.1\", \"title\": \"PcoMed's Indemnification\", \"level\": 2, \"text\": \"10.1. PcoMed's Indemnification. PcoMed shall indemnify and defend Integra and its Affiliates, and the directors, officers, members, employees, counsel , agents and representatives of Integra and its Affiliates, and the successors and assigns of any of the foregoing (the \\\"Integra Indemnitees\\\"), and hold the Integra Indemnitees harmless from and against any and all claims, demands, actions, liabilities, damages, losses, judgments, costs or expenses (including interest and penalties and reasonable attorneys' fees and professional fees and expenses of litigation) (collectively, \\\"Claims\\\") arising out of, in connection with, or resulting from any and all claims incurred by or asserted against Integra Indemnitees for (i) infringement of any patent or other proprietary rights arising solely from or occurring as a result of the manufacture, sale, offer to sell, importation and/or use of PcoMed Surface Modification Technology; (ii) any and all breaches of the representations and warranties of this Agreement by PcoMed; and (iii) product defects or liability associated with the PcoMed Surface Modification Technology. Integra may offset all costs and expenses covered under (i) above against the Fees as provided in Section 2.2 (c) as its sole and exclusive remedy for the recovery of such costs and expenses.\"}, {\"id\": \"10.2\", \"title\": \"Integra's Indemnification\", \"level\": 2, \"text\": \"10.2. Integra's Indemnification. Integra shall indemnify and defend PcoMed and its Affiliates, and the directors, officers, members, employees, counsel , agents and representatives of PcoMed and its Affiliates, and the successors and assigns of any of the foregoing (the \\\"PcoMed 16 Indemnitees\\\"), and hold the PcoMed Indemnitees harmless from and against any and all claims, demands, actions, liabilities, damages, losses, judgments, costs or expenses (including interest and penalties and reasonable attorneys' fees and professional fees and expenses of litigation) (collectively, \\\"Claims\\\") asserted by third parties and arising out of, in connection with, or resulting from any and all claims incurred by or asserted against PcoMed for (i) infringement of any patent or other proprietary rights arising from or occurring as a result of the manufacture, sale, offer to sell, importation and/or use of Integra Technology; (ii) any and all breaches of the representations and warranties of this Agreement by Integra; and (iii) any product defects or liability associated with any Integra Products except that arising solely from the PcoMed Surface Modification Technology. 11. USE OF NAMES.\"}, {\"id\": \"11.1\", \"title\": \"Names and Trademarks\", \"level\": 2, \"text\": \"11.1. Names and Trademarks. Each party agrees not to use or reference the name of the other party, or the other party's logos or trademarks in any advertising, sales promotion, press release or other communication relating to this Agreement without obtaining such party's prior written consent. Notwithstanding the foregoing, a party may use or reference such information to the extent reasonably necessary for (i) regulatory filings, including filings with the U.S. Securities Exchange Commission and Regulatory Authorities, (ii) prosecuting or defending litigation, or (iii) complying with applicable governmental regulations and legal requirements. Notwithstanding the foregoing, Integra shall have the right to indicate that the Treated Integra Products and Partially Treated Integra Products were partly manufactured by PcoMed. 12. MISCELLANEOUS.\"}, {\"id\": \"12.1\", \"title\": \"Notices\", \"level\": 2, \"text\": \"12.1. Notices. Any notice, request, instruction or other document required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given (i) if mailed with the United States Postal Service by prepaid, first class, certified mail, return receipt requested, at the time of receipt by the intended recipient, (ii) if sent by Federal Express, Airborne, or other overnight carrier, signature of delivery required, at the time of receipt by the intended recipient, (iii) if sent by facsimile transmission, when so sent and when receipt has been acknowledged by appropriate telephone or facsimile receipt, or (iv) if hand-delivered, at the time of receipt by the intended recipient, addressed as follows: (a) For Integra: Brian Larkin, President, Global Spine and Orthobiologics Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536 Patricia Jacobson, Corporate Counsel Integra LifeSciences Corporation 2302 La Mirada Drive Vista, CA 92081 General Counsel Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536 17 (b) For PcoMed: Steve Jacobs CEO PcoMed, LLC. 105 S. Sunset St. Suite O Longmont, CO 80501 With required copy to: Alan Keeffe Sherman & Howard LLC 675 Snapdragon Way Suite 350 Steamboat Springs, CO 80477\"}, {\"id\": \"12.2\", \"title\": \"Compliance with Laws\", \"level\": 2, \"text\": \"12.2. Compliance with Laws. Each party shall comply with all applicable federal, state and local laws and regulations in connection with its activities pursuant to this Agreement.\"}, {\"id\": \"12.3\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"12.3. Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the State of New Jersey.\"}, {\"id\": \"12.4\", \"title\": \"Dispute Resolution\", \"level\": 2, \"text\": \"12.4. Dispute Resolution. In the event of any controversy or claim relating to, arising out of or in any way connected to any provision of this Agreement (a \\\"Dispute\\\"), either Party may, by notice to the other Party, have such dispute referred to their respective senior officials designated below or their successors, for attempted resolution by good faith negotiations within 30 days after such notice is received. Any Dispute that is not resolved through such negotiations may be referred to binding arbitration in Denver, Colorado with the Judicial Arbiter Group as part of a 3 person panel, with costs borne separately by each party, to be conducted in accordance with the rules of the American Arbitration Association. (a) For Integra: Brian Larkin President, Global Spine and Orthobiologics Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536 (b) For PcoMed: Steven Jacobs CEO PcoMed, LLC. 105 S. Sunset St. Suite O Longmont, CO 80501 18\"}, {\"id\": \"12.5\", \"title\": \"No Waiver\", \"level\": 2, \"text\": \"12.5. No Waiver. Failure of any party to enforce a right under this Agreement shall not act as a waiver of that right or the ability to assert that right unless such party has signed an express written waiver as to a particular matter for a particular period of time.\"}, {\"id\": \"12.6\", \"title\": \"Severability\", \"level\": 2, \"text\": \"12.6. Severability. If any provision of this Agreement shall be found by a court of competent jurisdiction to be void, invalid or unenforceable, the provision shall be considered severed from this Agreement and shall not affect the validity or enforceability of the remainder of this Agreement. The parties shall make a good faith effort to replace any invalid or unenforceable provision with a valid and enforceable one such that the objectives contemplated by the parties when entering this Agreement may be realized.\"}, {\"id\": \"12.7\", \"title\": \"Modification\", \"level\": 2, \"text\": \"12.7. Modification. No change, modification, addition or amendment to this Agreement is valid or enforceable unless in writing and signed and dated by the authorized officers of the parties to this Agreement.\"}, {\"id\": \"12.8\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"12.8. Entire Agreement. This Agreement and the Attachments attached hereto constitute the entire agreement between the parties and replace and supersede as of the Effective Date any and all prior agreements and understandings, whether oral or written, between the parties with respect to the subject matter hereof, except any prior Confidential Disclosure Agreement(s).\"}, {\"id\": \"12.9\", \"title\": \"Successors\", \"level\": 2, \"text\": \"12.9. Successors. Except as otherwise expressly provided in this Agreement, this Agreement shall be binding upon, inures to the benefit of, and is enforceable by, the parties and their respective heirs, legal representatives, successors and permitted assigns.\"}, {\"id\": \"12.10\", \"title\": \"Construction\", \"level\": 2, \"text\": \"12.10. Construction. This Agreement has been prepared, examined, negotiated and revised by each party and their respective attorneys, and no implication shall be drawn and no provision shall be construed against any party to this Agreement by virtue of the purported identity of the drafter of this Agreement or any portion thereof.\"}, {\"id\": \"12.11\", \"title\": \"Counterparts\", \"level\": 2, \"text\": \"12.11. Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which shall constitute one and the same instrument.\"}, {\"id\": \"12.12\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"12.12. Assignment. This Agreement shall be binding upon and shall inure to the benefit of PcoMed and Integra, and their successors and assigns. Neither party shall assign their respective rights under this Agreement without the prior written consent of the other party. Notwithstanding the foregoing, no such consent shall be required for either party to assign this Agreement (i) to an Affiliate provided the party to this Agreement continues to be liable for all obligations hereunder, or (ii) in connection with a merger or sale of all or substantially all of the assets of such party to which this Agreement relates, provided in the case of (ii) the successor or assignee assumes all liabilities hereunder.\"}, {\"id\": \"12.13\", \"title\": \"Further Assurances\", \"level\": 2, \"text\": \"12.13. Further Assurances. Each party shall do, execute, acknowledge and deliver, and cause to be done, executed, acknowledged or delivered, all such further acts, transfers, conveyances, assignments or assurances as may be reasonably required to consummate the transactions contemplated by this Agreement.\"}, {\"id\": \"12.14\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"12.14. Force Majeure. Except for obligations to make payments payable under this Agreement, each party shall be excused from the performance of its obligations under this Agreement to the extent that such performance is prevented by force majeure and the nonperforming party promptly provides the other party with written notice of the event of force majeure and its effect. Such excuse shall be continued so long as the condition constituting force 19 majeure continues and the nonperforming party takes reasonable efforts to remove or circumvent the interference caused by the condition. For purposes of this Agreement, force majeure shall include an act of God, war, civil commotion, terrorist act, labor strike or lock-out other than at a party's facility, epidemic, failure or default of public utilities or common carriers, destruction of production facilities or materials by fire, earthquake, storm or like catastrophe, and failure of plant or machinery (provided that such failure could not have been prevented by the exercise of skill, diligence, and prudence that would be reasonably and ordinarily expected from a skilled and experienced person engaged in the same type of undertaking under the same or similar circumstances).\"}, {\"id\": \"12.15\", \"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"12.15. Independent Contractors. Each party shall act solely as an independent contractor, and nothing in this Agreement shall be construed to give either party the power or authority to act for, bind or commit the other party in any way. Nothing herein shall be construed to create the relationship of partnership, principal and agent or joint venture between the parties. IN WITNESS WHEREOF, the parties have caused their duly authorized representatives to execute this Agreement as of the Effective Date. INTEGRA LIFESCIENCES CORPORATION PCOMED, LLC By: /s/ Brian Larkin By: /s/ Steve Jacobs Name: Brian Larkin Name: Steve Jacobs Title: President Title: CEO Date: May 29, 2013 Date: May 15, 2013 20\"}, {\"id\": \"ATTACHMENT A\", \"title\": \"PcoMed Surface Modification Technology\", \"level\": 1, \"text\": \"ATTACHMENT A PcoMed Surface Modification Technology *** i *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"ATTACHMENT A\", \"title\": \"PcoMed Surface Modification Technology (continued)\", \"level\": 1, \"text\": \"ATTACHMENT A PcoMed Surface Modification Technology (continued) *** ii *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}, {\"id\": \"Attachment B\", \"title\": \"Minimum Payments\", \"level\": 1, \"text\": \"Attachment B Minimum Payments PERIOD MINIMUM PAYMENT Minimum Payment Period 1 $ *** Minimum Payment Period 2 $ *** Minimum Payment Period 3 $ *** Minimum Payment Period 4 $ *** Minimum Payment Period 5 $ *** Minimum Payment Period 6 $ *** Minimum Payment Period 7 $ *** For this purpose: \\\"Minimum Payment Period 1\\\" means the one-year period commencing on the date set forth in the Notice of Initial Acceptance of First Product Order. \\\"Minimum Payment Period 2\\\" means the one-year period commencing on the first day after Minimum Payment Period 1. \\\"Minimum Payment Period 3\\\" means the one-year period commencing on the first day after Minimum Payment Period 2. \\\"Minimum Payment Period 4\\\" means the one-year period commencing on the first day after Minimum Payment Period 3. \\\"Minimum Payment Period 5\\\" means the one-year period commencing on the first day after Minimum Payment Period 4. \\\"Minimum Payment Period 6\\\" means the one-year period commencing on the first day after Minimum Payment Period 5. \\\"Minimum Payment Period 7\\\" means the one-year period commencing on the first day after Minimum Payment Period 6. *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. ATTACHMENT C NOTICE OF INITIAL ACCEPTANCE OF FIRST PRODUCT ORDER This Notice references the Agreement executed effective as of , 2013, by and between Integra LifeSciences Corporation (\\\"Integra\\\") and PcoMed, LLC (\\\"PcoMed\\\") (\\\"Agreement\\\"). In accordance with Section 12.1 (Notices) and pursuant to Section 4.1 of the Agreement, notice is hereby given that the date of Integra's acceptance of the First Product Order (as defined in the Agreement and as approved by the applicable Regulatory Authority for sale) is designated as the day of , 20 . This Notice of Initial Acceptance of the First Product Order is issued by Integra LifeSciences Corporation on this day of , 20 . By: Name: Title:\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of SEASPINEHOLDINGSCORP_10_10_2018-EX-10.1-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETED ASTERISKS [***], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (\\\"Agreement\\\") is entered into as of this 15th day of May, 2013 (the \\\"Effective Date\\\") by and between Integra LifeSciences Corporation (\\\"Integra\\\"), a Delaware corporation with offices at 311 Enterprise Drive, Plainsboro, New Jersey 08536, and PcoMed, LLC (\\\"PcoMed\\\"), a Colorado limited liability company with offices at 105 S. Sunset Street, Longmont, Colorado 80501. RECITALS: WHEREAS, Integra is a medical device company that is developing and commercializing implantable spinal medical devices and procedures in the field of spinal surgery; WHEREAS, PcoMed has experience and expertise in the surface modification of medical device materials; WHEREAS, Integra desires to engage PcoMed to apply certain of its surface technologies onto Integra's implantable spinal medical devices for preclinical, clinical and commercial use and distribution by Integra; and WHEREAS, PcoMed is willing to apply such surface technologies onto Integra's implantable spinal medical devices and to grant Integra certain exclusive rights to use and commercialize those devices; and NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, the parties hereto agree as follows: 1. DEFINITIONS. As used in this Agreement, the following initially capitalized terms, whether used in the singular or plural form, shall have the meanings set forth in this Section 1.\"}}, {\"id\": \"party:Integra LifeSciences Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Integra LifeSciences Corporation (\\\"Integra\\\")\", \"role\": null, \"address\": \"311 Enterprise Drive, Plainsboro, New Jersey 08536\"}}, {\"id\": \"party:PcoMed, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PcoMed, LLC (\\\"PcoMed\\\")\", \"role\": null, \"address\": \"105 S. Sunset Street, Longmont, Colorado 80501\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS SUPPLY AGREEMENT (\\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"this 15th day of May, 2013 (the \\\"Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Affiliate\\\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is\", \"level\": 2, \"text\": \"1.1. \\\"Affiliate\\\" means any corporation, limited liability company, person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes of this Section 1.1, the term \\\"control\\\" (with a correlative meaning for \\\"controlled by\\\") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the subject corporation, person or entity, whether through the ownership of voting securities, by contract or otherwise.\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"any corporation, limited liability company, person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to this Agreement. For purposes of this Section 1.1, the term \\\"control\\\" (with a correlative meaning for \\\"controlled by\\\") means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the subject corporation, person or entity, whether through the ownership of voting securities, by contract or otherwise.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"*** Run\\\" means a single production run of PcoMed's *** to apply the PcoMed Surface Modification Technology to Integra\", \"level\": 2, \"text\": \"1.2. \\\"*** Run\\\" means a single production run of PcoMed's *** to apply the PcoMed Surface Modification Technology to Integra Products.\"}}, {\"id\": \"term:*** Run\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"*** Run\", \"text\": \"a single production run of PcoMed's *** to apply the PcoMed Surface Modification Technology to Integra Products.\", \"definition_clause\": \"1.2\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"*** Run Fee\\\" means the fee for a single *** Run\", \"level\": 2, \"text\": \"1.3. \\\"*** Run Fee\\\" means the fee for a single *** Run. The *** Run Fee is exclusive of potential fees for any surface preparation requirements currently performed prior to PcoMed's receipt of Integra Product.\"}}, {\"id\": \"term:*** Run Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"*** Run Fee\", \"text\": \"the fee for a single *** Run. The *** Run Fee is exclusive of potential fees for any surface preparation requirements currently performed prior to PcoMed's receipt of Integra Product.\", \"definition_clause\": \"1.3\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Confidential Disclosure Agreements\\\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by\", \"level\": 2, \"text\": \"1.4. \\\"Confidential Disclosure Agreements\\\" means all Mutual Non-Disclosure Agreements previously or hereafter entered into by certain Integra Affiliates and PcoMed. 1 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"term:Confidential Disclosure Agreements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Disclosure Agreements\", \"text\": \"all Mutual Non-Disclosure Agreements previously or hereafter entered into by certain Integra Affiliates and PcoMed.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Confidential Information\\\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whet\", \"level\": 2, \"text\": \"1.5. \\\"Confidential Information\\\" means, whether disclosed in oral, written, graphic, electronic form, or other form, and whether developed by the disclosing party or by others, any confidential, non-public, proprietary information of Integra or PcoMed that is designated by the disclosing party as confidential or secret or that should reasonably be assumed by the receiving party to be confidential or secret. Confidential Information includes, without limitation: (i) specifications, know-how, trade secrets, designs, technical information, drawings, sketches, engineering drawings, work of authorship, software, prototypes, samples, models, business information, marketing information, current products and services, future products and services, proposed products and services, inventions, discoveries, devices, apparatus, equipment, algorithms, business methods, plans, assays, methods, procedures, processes, formulae, protocols, techniques, data, research and development data, experimental work, clinical data, engineering data, manufacturing data, technical or non-technical information, ideas, media, and unpublished patent applications; (ii) personnel and financial information, product cost information, contractual relationships, operational and procedural manuals; (iii) information or data regarding product research and development, including technical, engineering, or production data, test data, or results, information concerning a disclosing party's efforts to acquire, protect, and license proprietary rights, (iv) a disclosing party's price, cost and fee data, pricing and billing policies, forecasts, plans, procurement requirements, and strategies for all aspects of the disclosing party's operations, marketing, and sales, whether or not in effect; and (v) data relating to the type, quality, specifications, and price of the disclosing party's products and/or services received or provided by any customer or vendor.\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"whether disclosed in oral, written, graphic, electronic form, or other form, and whether developed by the disclosing party or by others, any confidential, non-public, proprietary information of Integra or PcoMed that is designated by the disclosing party as confidential or secret or that should reasonably be assumed by the receiving party to be confidential or secret. Confidential Information includes, without limitation: (i) specifications, know-how, trade secrets, designs, technical information, drawings, sketches, engineering drawings, work of authorship, software, prototypes, samples, models, business information, marketing information, current products and services, future products and services, proposed products and services, inventions, discoveries, devices, apparatus, equipment, algorithms, business methods, plans, assays, methods, procedures, processes, formulae, protocols, techniques, data, research and development data, experimental work, clinical data, engineering data, manufacturing data, technical or non-technical information, ideas, media, and unpublished patent applications; (ii) personnel and financial information, product cost information, contractual relationships, operational and procedural manuals; (iii) information or data regarding product research and development, including technical, engineering, or production data, test data, or results, information concerning a disclosing party's efforts to acquire, protect, and license proprietary rights, (iv) a disclosing party's price, cost and fee data, pricing and billing policies, forecasts, plans, procurement requirements, and strategies for all aspects of the disclosing party's operations, marketing, and sales, whether or not in effect; and (v) data relating to the type, quality, specifications, and price of the disclosing party's products and/or services received or provided by any customer or vendor.\", \"definition_clause\": \"1.5\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Derive\\\" and cognates thereof means to develop, make, invent, discover, create, synthesize, conceive, reduce to practic\", \"level\": 2, \"text\": \"1.6. \\\"Derive\\\" and cognates thereof means to develop, make, invent, discover, create, synthesize, conceive, reduce to practice, design or result from, to be based upon or to otherwise generate (whether directly or indirectly, or in whole or in part).\"}}, {\"id\": \"term:Derive\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Derive\", \"text\": \"to develop, make, invent, discover, create, synthesize, conceive, reduce to practice, design or result from, to be based upon or to otherwise generate (whether directly or indirectly, or in whole or in part).\", \"definition_clause\": \"1.6\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"FDA\\\" means the United States Food and Drug Administration, or any successor thereto, having the administrative authori\", \"level\": 2, \"text\": \"1.7. \\\"FDA\\\" means the United States Food and Drug Administration, or any successor thereto, having the administrative authority to regulate the marketing of pharmaceutical products, biological therapeutic product, delivery systems, and medical devices in the United States.\"}}, {\"id\": \"term:FDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDA\", \"text\": \"the United States Food and Drug Administration, or any successor thereto, having the administrative authority to regulate the marketing of pharmaceutical products, biological therapeutic product, delivery systems, and medical devices in the United States.\", \"definition_clause\": \"1.7\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Field\\\" means spinal interbody and/or intervertebral surgical methods and procedures, including without limitation, int\", \"level\": 2, \"text\": \"1.8. \\\"Field\\\" means spinal interbody and/or intervertebral surgical methods and procedures, including without limitation, interbody and/or intervertebral fusion and/or spacer procedures and interbody and/or intervertebral spinal arthroplasty procedures.\"}}, {\"id\": \"term:Field\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Field\", \"text\": \"spinal interbody and/or intervertebral surgical methods and procedures, including without limitation, interbody and/or intervertebral fusion and/or spacer procedures and interbody and/or intervertebral spinal arthroplasty procedures.\", \"definition_clause\": \"1.8\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"First Product Order\\\" means the first purchase order issued by Integra to PcoMed for the production of salable Treated\", \"level\": 2, \"text\": \"1.9. \\\"First Product Order\\\" means the first purchase order issued by Integra to PcoMed for the production of salable Treated Integra Product or Partially Treated Integra Product.\"}}, {\"id\": \"term:First Product Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"First Product Order\", \"text\": \"the first purchase order issued by Integra to PcoMed for the production of salable Treated Integra Product or Partially Treated Integra Product.\", \"definition_clause\": \"1.9\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Integra Customers\\\" means Third Parties who purchase Treated Integra Products and Partially Treated Integra Products fr\", \"level\": 2, \"text\": \"1.10. \\\"Integra Customers\\\" means Third Parties who purchase Treated Integra Products and Partially Treated Integra Products from Integra or its Affiliates and does not include any Integra Affiliates.\\\"Integra Products\\\" means any implantable spinal surgery interbody and/or intervertebral medical device designed and/or manufactured by or for Integra. 2\"}}, {\"id\": \"term:Integra Customers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Integra Customers\", \"text\": \"Third Parties who purchase Treated Integra Products and Partially Treated Integra Products from Integra or its Affiliates and does not include any Integra Affiliates.\", \"definition_clause\": \"1.10\"}}, {\"id\": \"term:Integra Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Integra Products\", \"text\": \"any implantable spinal surgery interbody and/or intervertebral medical device designed and/or manufactured by or for Integra.\", \"definition_clause\": \"1.10\"}}, {\"id\": \"1.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Integra Regulatory Data\\\" means Integra information associated with regulatory procedures relating to Treated Integra P\", \"level\": 2, \"text\": \"1.11. \\\"Integra Regulatory Data\\\" means Integra information associated with regulatory procedures relating to Treated Integra Product and/or Partially Treated Integra Product, including bench and animal data, submission data and methodologies, responses of Regulatory Authorities to submissions, information pertaining to such submissions, and additional data generated as required for US Marketing Clearance, EU Marketing Clearance or commercial launch of any Treated Integra Product or Partially Treated Integra Product.\"}}, {\"id\": \"term:Integra Regulatory Data\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Integra Regulatory Data\", \"text\": \"Integra information associated with regulatory procedures relating to Treated Integra Product and/or Partially Treated Integra Product, including bench and animal data, submission data and methodologies, responses of Regulatory Authorities to submissions, information pertaining to such submissions, and additional data generated as required for US Marketing Clearance, EU Marketing Clearance or commercial launch of any Treated Integra Product or Partially Treated Integra Product.\", \"definition_clause\": \"1.11\"}}, {\"id\": \"1.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Integra Technology\\\" means any technology owned, licensed or controlled by Integra and/or any Integra Affiliates includ\", \"level\": 2, \"text\": \"1.12. \\\"Integra Technology\\\" means any technology owned, licensed or controlled by Integra and/or any Integra Affiliates including but not limited to SeaSpine and Theken Spine as of the Effective Date and all technology Derived solely by Integra and/or Integra Affiliates during or after the Term, including but not limited to the devices described in U. S. Patent Numbers 7,799,083 and 8,097,036 together with any improvements, enhancements, or extensions of or to any of the foregoing, and Intellectual Property Rights therein, but excluding any technology or information relating to or derived from PcoMed Technology. The Integra Technology shall include all proprietary ideas in any form and embodied in any media, technical information, ideas, discoveries, knowledge, know-how, skill, experience, concepts, data, processes, procedures, methods, techniques, protocols, formulae, trade secrets, Inventions (whether or not patentable), media, research tools, compositions, software, hardware, instruments, documents, works of authorship, formulations, and other physical, chemical or biological materials and information, including, without limitation, clinical and regulatory strategies, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, manufacturing, patent, marketing and legal data or descriptions, apparatus, prototypes, devices, chemical formulations, compound compositions of matter, product samples, assays and similar information and Inventions.\"}}, {\"id\": \"term:Integra Technology\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Integra Technology\", \"text\": \"any technology owned, licensed or controlled by Integra and/or any Integra Affiliates including but not limited to SeaSpine and Theken Spine as of the Effective Date and all technology Derived solely by Integra and/or Integra Affiliates during or after the Term, including but not limited to the devices described in U. S. Patent Numbers 7,799,083 and 8,097,036 together with any improvements, enhancements, or extensions of or to any of the foregoing, and Intellectual Property Rights therein, but excluding any technology or information relating to or derived from PcoMed Technology. The Integra Technology shall include all proprietary ideas in any form and embodied in any media, technical information, ideas, discoveries, knowledge, know-how, skill, experience, concepts, data, processes, procedures, methods, techniques, protocols, formulae, trade secrets, Inventions (whether or not patentable), media, research tools, compositions, software, hardware, instruments, documents, works of authorship, formulations, and other physical, chemical or biological materials and information, including, without limitation, clinical and regulatory strategies, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, manufacturing, patent, marketing and legal data or descriptions, apparatus, prototypes, devices, chemical formulations, compound compositions of matter, product samples, assays and similar information and Inventions.\", \"definition_clause\": \"1.12\"}}, {\"id\": \"1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Intellectual Property Rights\\\" means any and all intellectual property and industrial design rights, whether protected,\", \"level\": 2, \"text\": \"1.13. \\\"Intellectual Property Rights\\\" means any and all intellectual property and industrial design rights, whether protected, created or arising under the laws of the United States or any other foreign jurisdiction, including the following: (i) patent rights; (ii) copyrights, mask work rights, database rights and design rights, whether or not registered, published or unpublished, and registrations and applications for registration thereof, and all rights therein whether provided by international treaties or conventions or otherwise; (iii) trade secrets and Inventions; (iv) moral rights; and (v) other applications and registrations related to any of the rights set forth in the foregoing clauses (i) through (iv); provided, however, that as used in this Agreement, the term \\\"Intellectual Property\\\" expressly excludes rights in trademarks, trade names, service marks, service names, design marks, logos, slogans, trade dress, or similar rights with respect to indicators of origin, whether registered or unregistered, as well as rights in internet domain names, uniform resource locators and e-mail addresses.\"}}, {\"id\": \"term:Intellectual Property Rights\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property Rights\", \"text\": \"any and all intellectual property and industrial design rights, whether protected, created or arising under the laws of the United States or any other foreign jurisdiction, including the following: (i) patent rights; (ii) copyrights, mask work rights, database rights and design rights, whether or not registered, published or unpublished, and registrations and applications for registration thereof, and all rights therein whether provided by international treaties or conventions or otherwise; (iii) trade secrets and Inventions; (iv) moral rights; and (v) other applications and registrations related to any of the rights set forth in the foregoing clauses (i) through (iv); provided, however, that as used in this Agreement, the term \\\"Intellectual Property\\\" expressly excludes rights in trademarks, trade names, service marks, service names, design marks, logos, slogans, trade dress, or similar rights with respect to indicators of origin, whether registered or unregistered, as well as rights in internet domain names, uniform resource locators and e-mail addresses.\", \"definition_clause\": \"1.13\"}}, {\"id\": \"1.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Inventions\\\" means conceptions, ideas, innovations, discoveries, inventions, processes, machines, formulae, formulation\", \"level\": 2, \"text\": \"1.14. \\\"Inventions\\\" means conceptions, ideas, innovations, discoveries, inventions, processes, machines, formulae, formulations, biological materials, molecules, compounds, compositions, improvements, enhancements, modifications, technological developments, know-how, show-how, methods, techniques, systems, designs, production system, plans, source code, object code and documentation pertaining thereto, including, without limitation, functional specifications, object libraries, design documentation, technical documentation, statements of principles of operations, schematics, programmers' guides, and other documentation, data, programs and information and works of authorship, whether or not patentable, copyrightable or susceptible to any other form of legal protection.\"}}, {\"id\": \"term:Inventions\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Inventions\", \"text\": \"conceptions, ideas, innovations, discoveries, inventions, processes, machines, formulae, formulations, biological materials, molecules, compounds, compositions, improvements, enhancements, modifications, technological developments, know-how, show-how, methods, techniques, systems, designs, production system, plans, source code, object code and documentation pertaining thereto, including, without limitation, functional specifications, object libraries, design documentation, technical documentation, statements of principles of operations, schematics, programmers' guides, and other documentation, data, programs and information and works of authorship, whether or not patentable, copyrightable or susceptible to any other form of legal protection.\", \"definition_clause\": \"1.14\"}}, {\"id\": \"1.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Minimum Payment\\\" means the amounts set forth on Attachment B as payable by Integra to PcoMed in each Minimum Payment P\", \"level\": 2, \"text\": \"1.15. \\\"Minimum Payment\\\" means the amounts set forth on Attachment B as payable by Integra to PcoMed in each Minimum Payment Period.\"}}, {\"id\": \"term:Minimum Payment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment\", \"text\": \"the amounts set forth on Attachment B as payable by Integra to PcoMed in each Minimum Payment Period.\", \"definition_clause\": \"1.15\"}}, {\"id\": \"1.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Minimum Payment Period\\\" has the meaning set forth on attached Attachment B\", \"level\": 2, \"text\": \"1.16. \\\"Minimum Payment Period\\\" has the meaning set forth on attached Attachment B. 3 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"term:Minimum Payment Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period\", \"text\": \"has the meaning set forth on attached Attachment B.\", \"definition_clause\": \"1.16\"}}, {\"id\": \"1.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Net Sales\\\" means the gross amount of all revenues invoiced and received by Integra and its Affiliates from Integra Cus\", \"level\": 2, \"text\": \"1.17. \\\"Net Sales\\\" means the gross amount of all revenues invoiced and received by Integra and its Affiliates from Integra Customers from the Sale of Treated Integra Products and Partially Treated Integra Products, less the following deductions (to the extent otherwise then or previously included in the gross amounts invoiced and in respect of which no previous deduction was taken): (i) amounts taken or accrued for sales, distributor or other commissions allowed, discounts allowed dealers, trade and/or quantity and cash discounts; (ii) refunds, rebates, chargebacks, replacements or credits and allowances actually allowed or granted to purchasers on account of contractual obligations, rejections, returns, or billing errors and for uncollectible amounts (except to the extent later collected) on Sales; (iii) sales, use and/or other excise taxes, import and/or export duties paid, tariffs, and any other governmental tax or charge (except income taxes) imposed on or at the time of production, importation, use, or sale of the Treated Integra Product or Partially Treated Integra Product, including any value added taxes, and taxes on medical devices; (iv) shipping insurance costs and prepaid transportation and/or freight charges. Net Sales shall exclude any amounts Integra or its Affiliates receive for Treated Integra Product or Partially Treated Integra Product that are used for clinical trials required or reasonably deemed to be desirable for Regulatory Approval or additional product indications in any country.\"}}, {\"id\": \"term:Net Sales\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Net Sales\", \"text\": \"the gross amount of all revenues invoiced and received by Integra and its Affiliates from Integra Customers from the Sale of Treated Integra Products and Partially Treated Integra Products, less the following deductions (to the extent otherwise then or previously included in the gross amounts invoiced and in respect of which no previous deduction was taken): (i) amounts taken or accrued for sales, distributor or other commissions allowed, discounts allowed dealers, trade and/or quantity and cash discounts; (ii) refunds, rebates, chargebacks, replacements or credits and allowances actually allowed or granted to purchasers on account of contractual obligations, rejections, returns, or billing errors and for uncollectible amounts (except to the extent later collected) on Sales; (iii) sales, use and/or other excise taxes, import and/or export duties paid, tariffs, and any other governmental tax or charge (except income taxes) imposed on or at the time of production, importation, use, or sale of the Treated Integra Product or Partially Treated Integra Product, including any value added taxes, and taxes on medical devices; (iv) shipping insurance costs and prepaid transportation and/or freight charges. Net Sales shall exclude any amounts Integra or its Affiliates receive for Treated Integra Product or Partially Treated Integra Product that are used for clinical trials required or reasonably deemed to be desirable for Regulatory Approval or additional product indications in any country.\", \"definition_clause\": \"1.17\"}}, {\"id\": \"1.18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Non-Treated Integra Product\\\" means an Integra Product that does not utilize or embody, in whole or in part, the PcoMed\", \"level\": 2, \"text\": \"1.18. \\\"Non-Treated Integra Product\\\" means an Integra Product that does not utilize or embody, in whole or in part, the PcoMed Surface Modification Technology.\"}}, {\"id\": \"term:Non-Treated Integra Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Non-Treated Integra Product\", \"text\": \"an Integra Product that does not utilize or embody, in whole or in part, the PcoMed Surface Modification Technology.\", \"definition_clause\": \"1.18\"}}, {\"id\": \"1.19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Notice of Initial Acceptance of First Product Order\\\" means Integra's acceptance of the Treated Integra Product or Part\", \"level\": 2, \"text\": \"1.19. \\\"Notice of Initial Acceptance of First Product Order\\\" means Integra's acceptance of the Treated Integra Product or Partially Treated Integra Product pursuant to the First Product Order. Such acceptance shall be issued in the form of Attachment C by Integra within ten (10) business days of receipt by Integra or its Affiliates of product (and related quality and testing documentation) meeting specifications mutually agreed upon by Integra and PcoMed.\"}}, {\"id\": \"term:Notice of Initial Acceptance of First Product Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Notice of Initial Acceptance of First Product Order\", \"text\": \"Integra's acceptance of the Treated Integra Product or Partially Treated Integra Product pursuant to the First Product Order. Such acceptance shall be issued in the form of Attachment C by Integra within ten (10) business days of receipt by Integra or its Affiliates of product (and related quality and testing documentation) meeting specifications mutually agreed upon by Integra and PcoMed.\", \"definition_clause\": \"1.19\"}}, {\"id\": \"value:10 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) business days\"}}, {\"id\": \"1.20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Partially Treated Integra Product\\\" means an Integra Product that (i) utilizes or embodies, in whole or in part, the Pc\", \"level\": 2, \"text\": \"1.20. \\\"Partially Treated Integra Product\\\" means an Integra Product that (i) utilizes or embodies, in whole or in part, the PcoMed Surface Modification Technology and (ii) a portion of which (not including radiographic or radiopaque markers) is formed from a material other than PEEK or PAEK and does not utilize or embody the PcoMed Surface Modification Technology.\"}}, {\"id\": \"term:Partially Treated Integra Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Partially Treated Integra Product\", \"text\": \"an Integra Product that (i) utilizes or embodies, in whole or in part, the PcoMed Surface Modification Technology and (ii) a portion of which (not including radiographic or radiopaque markers) is formed from a material other than PEEK or PAEK and does not utilize or embody the PcoMed Surface Modification Technology.\", \"definition_clause\": \"1.20\"}}, {\"id\": \"1.21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PcoMed Regulatory Data\\\" means PcoMed information associated with regulatory procedures relating to the PcoMed Surface\", \"level\": 2, \"text\": \"1.21. \\\"PcoMed Regulatory Data\\\" means PcoMed information associated with regulatory procedures relating to the PcoMed Surface Modification Technology, including bench and animal data, submission data and methodologies, responses of Regulatory Authorities to submissions, information pertaining to such submissions, and additional data generated as required for US Marketing Clearance, EU Marketing Clearance or commercial launch of a product using or embodying the Surface Modification Technology.\"}}, {\"id\": \"term:PcoMed Regulatory Data\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PcoMed Regulatory Data\", \"text\": \"PcoMed information associated with regulatory procedures relating to the PcoMed Surface Modification Technology, including bench and animal data, submission data and methodologies, responses of Regulatory Authorities to submissions, information pertaining to such submissions, and additional data generated as required for US Marketing Clearance, EU Marketing Clearance or commercial launch of a product using or embodying the Surface Modification Technology.\", \"definition_clause\": \"1.21\"}}, {\"id\": \"1.22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PcoMed Surface Modification Technology\\\" means a proprietary PcoMed osteoconductive commercially pure titanium *** mole\", \"level\": 2, \"text\": \"1.22. \\\"PcoMed Surface Modification Technology\\\" means a proprietary PcoMed osteoconductive commercially pure titanium *** molecular surface modification of PEEK (polyetheretherkeytone), PEKK (polyetherkeytonekeytone), and/or PAEK (polyaryletherkeytone) materials as illustrated in Attachment A.\"}}, {\"id\": \"term:PcoMed Surface Modification Technology\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PcoMed Surface Modification Technology\", \"text\": \"a proprietary PcoMed osteoconductive commercially pure titanium *** molecular surface modification of PEEK (polyetheretherkeytone), PEKK (polyetherkeytonekeytone), and/or PAEK (polyaryletherkeytone) materials as illustrated in Attachment A.\", \"definition_clause\": \"1.22\"}}, {\"id\": \"1.23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"PcoMed Technology\\\" means any technology owned, licensed or controlled by PcoMed as of the Effective Date, including th\", \"level\": 2, \"text\": \"1.23. \\\"PcoMed Technology\\\" means any technology owned, licensed or controlled by PcoMed as of the Effective Date, including the (i) PcoMed Surface Modification Technology and (ii) coating, surface, application, surface modification and pretreatment technology and knowhow, and all technology Derived by PcoMed during or after the Term, together with any improvements, enhancements, or extensions of or to any of the foregoing, and Intellectual Property Rights therein, but excluding any technology or information relating solely to or Derived solely from Integra Technology. The PcoMed Technology includes all proprietary ideas in any form and embodied in any media, technical information, ideas, discoveries, knowledge, know-how, skill, experience, 4 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. concepts, data, processes, procedures, methods, techniques, protocols, formulae, trade secrets, Inventions (whether or not patentable), media, research tools, compositions, software, hardware, instruments, documents, works of authorship, formulations, and other physical, chemical or biological materials and information, including, without limitation, clinical and regulatory strategies, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, manufacturing, patent, marketing and legal data or descriptions, apparatus, prototypes, devices, chemical formulations, compound compositions of matter, product samples, assays and similar information and Inventions.\"}}, {\"id\": \"term:PcoMed Technology\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PcoMed Technology\", \"text\": \"any technology owned, licensed or controlled by PcoMed as of the Effective Date, including the (i) PcoMed Surface Modification Technology and (ii) coating, surface, application, surface modification and pretreatment technology and knowhow, and all technology Derived by PcoMed during or after the Term, together with any improvements, enhancements, or extensions of or to any of the foregoing, and Intellectual Property Rights therein, but excluding any technology or information relating solely to or Derived solely from Integra Technology. The PcoMed Technology includes all proprietary ideas in any form and embodied in any media, technical information, ideas, discoveries, knowledge, know-how, skill, experience, 4 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. concepts, data, processes, procedures, methods, techniques, protocols, formulae, trade secrets, Inventions (whether or not patentable), media, research tools, compositions, software, hardware, instruments, documents, works of authorship, formulations, and other physical, chemical or biological materials and information, including, without limitation, clinical and regulatory strategies, test data (including pharmacological, toxicological and clinical test data), analytical and quality control data, manufacturing, patent, marketing and legal data or descriptions, apparatus, prototypes, devices, chemical formulations, compound compositions of matter, product samples, assays and similar information and Inventions.\", \"definition_clause\": \"1.23\"}}, {\"id\": \"1.24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Approval\\\" means, with respect to a country in the Territory, all approvals, licenses, registrations, or aut\", \"level\": 2, \"text\": \"1.24. \\\"Regulatory Approval\\\" means, with respect to a country in the Territory, all approvals, licenses, registrations, or authorizations by an applicable Regulatory Authority necessary to import, commercialize, transport, store, market and sell Treated Integra Product and/or Partially Treated Integra Product in such country, including labeling, pricing, or reimbursement approvals.\"}}, {\"id\": \"term:Regulatory Approval\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Approval\", \"text\": \"with respect to a country in the Territory, all approvals, licenses, registrations, or authorizations by an applicable Regulatory Authority necessary to import, commercialize, transport, store, market and sell Treated Integra Product and/or Partially Treated Integra Product in such country, including labeling, pricing, or reimbursement approvals.\", \"definition_clause\": \"1.24\"}}, {\"id\": \"1.25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Authority\\\" means the FDA in the United States, and the equivalent regulatory authority or governmental enti\", \"level\": 2, \"text\": \"1.25. \\\"Regulatory Authority\\\" means the FDA in the United States, and the equivalent regulatory authority or governmental entity having the responsibility, jurisdiction, and authority to approve the to importation, commercialization, transport, storage, marketing and sale of the Treated Integra Product or Partially Treated Integra Product in any country or jurisdiction outside of the United States.\"}}, {\"id\": \"term:Regulatory Authority\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Authority\", \"text\": \"the FDA in the United States, and the equivalent regulatory authority or governmental entity having the responsibility, jurisdiction, and authority to approve the to importation, commercialization, transport, storage, marketing and sale of the Treated Integra Product or Partially Treated Integra Product in any country or jurisdiction outside of the United States.\", \"definition_clause\": \"1.25\"}}, {\"id\": \"1.26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Sale\\\" or \\\"Sales\\\" or \\\"Sell\\\" or \\\"Sold\\\" means the transfer or disposition by Integra or its Affiliates of a Treated Integ\", \"level\": 2, \"text\": \"1.26. \\\"Sale\\\" or \\\"Sales\\\" or \\\"Sell\\\" or \\\"Sold\\\" means the transfer or disposition by Integra or its Affiliates of a Treated Integra Product or a Partially Treated Integra Product for value to Integra Customers in the Territory\"}}, {\"id\": \"term:Sale\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sale\", \"text\": \"the transfer or disposition by Integra or its Affiliates of a Treated Integra Product or a Partially Treated Integra Product for value to Integra Customers in the Territory\", \"definition_clause\": \"1.26\"}}, {\"id\": \"1.27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Territory\\\" means worldwide, during the thirty six (36) month period following Notice of Initial Acceptance of First Pr\", \"level\": 2, \"text\": \"1.27. \\\"Territory\\\" means worldwide, during the thirty six (36) month period following Notice of Initial Acceptance of First Product Order. Thereafter, \\\"Territory\\\" may exclude the People's Republic of China (\\\"PRC\\\"), to the extent that Integra has had no sales of Treated Integra Products in that country. In the event that Integra has had no such sales, PcoMed shall give sixty (60) days advance written notice of PcoMed's intent to utilize a third party to market the PcoMed Surface Modification Technology in the PRC .\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"worldwide, during the thirty six (36) month period following Notice of Initial Acceptance of First Product Order. Thereafter, \\\"Territory\\\" may exclude the People's Republic of China (\\\"PRC\\\"), to the extent that Integra has had no sales of Treated Integra Products in that country. In the event that Integra has had no such sales, PcoMed shall give sixty (60) days advance written notice of PcoMed's intent to utilize a third party to market the PcoMed Surface Modification Technology in the PRC .\", \"definition_clause\": \"1.27\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"1.28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party\\\" means any entity or person other than (i) Integra and its Affiliates, or (ii) PcoMed and its Affiliates\", \"level\": 2, \"text\": \"1.28. \\\"Third Party\\\" means any entity or person other than (i) Integra and its Affiliates, or (ii) PcoMed and its Affiliates.\"}}, {\"id\": \"term:Third Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party\", \"text\": \"any entity or person other than (i) Integra and its Affiliates, or (ii) PcoMed and its Affiliates.\", \"definition_clause\": \"1.28\"}}, {\"id\": \"1.29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Treated Integra Product\\\" means an Integra Product that utilizes or embodies, in whole or part, the PcoMed Surface Modi\", \"level\": 2, \"text\": \"1.29. \\\"Treated Integra Product\\\" means an Integra Product that utilizes or embodies, in whole or part, the PcoMed Surface Modification Technology, excluding Partially Treated Integra Product.\"}}, {\"id\": \"term:Treated Integra Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Treated Integra Product\", \"text\": \"an Integra Product that utilizes or embodies, in whole or part, the PcoMed Surface Modification Technology, excluding Partially Treated Integra Product.\", \"definition_clause\": \"1.29\"}}, {\"id\": \"1.30\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"US Marketing Clearance\\\" means Regulatory Approval of a Treated Integra Product or Partially Treated Integra Product fo\", \"level\": 2, \"text\": \"1.30. \\\"US Marketing Clearance\\\" means Regulatory Approval of a Treated Integra Product or Partially Treated Integra Product for use in the Field in the United States. 2. CONSIDERATION.\"}}, {\"id\": \"term:US Marketing Clearance\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"US Marketing Clearance\", \"text\": \"Regulatory Approval of a Treated Integra Product or Partially Treated Integra Product for use in the Field in the United States.\", \"definition_clause\": \"1.30\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Milestone Payments\", \"level\": 2, \"text\": \"2.1. Milestone Payments. (a) First Payment. Integra shall pay PcoMed $*** ( *** US dollars) upon full execution of this Agreement. (b) Second Payment. Integra shall pay PcoMed $*** ( *** US dollars) within 30 days after Notice of Initial Acceptance of First Product Order. Integra shall place the First Product Order within sixty (60) days of the Effective Date of this Agreement. 5 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"value:$***\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$***\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Fees\", \"level\": 2, \"text\": \"2.2. Fees. (a) Treated Integra Products. Subject to Section 2.2(c), for so long as the Agreement has not been converted to a non-exclusive arrangement under the provisions of Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Treated Integra Product Sold by Integra or its Affiliates. Subject to Section 2.2(c), for so long as Integra's Rights under the Agreement have been converted to a non-exclusive arrangement under the provisions of Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Treated Integra Product Sold by Integra or its Affiliates. The Fee rate payable shall be determined based on whether this Agreement is exclusive or non-exclusive at the time of Integra's Sale of the Treated Integra Product, not at the time of PcoMed's production of the Treated Integra Product. (b) Partially Treated Integra Products. Subject to Section 2.2(c), for so long as Agreement has not been converted to a non-exclusive arrangement pursuant to Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Partially Treated Integra Product Sold by Integra or its Affiliates. Subject to Section 2.2(c), for so long as Integra's rights under the Agreement have been converted to a non-exclusive arrangement under the provisions of Section 3.2, Integra shall pay PcoMed a Fee of ***% of Net Sales of all Partially Treated Integra Product Sold by Integra or its Affiliates. The Fee rate payable shall be determined based on whether this Agreement is exclusive or non-exclusive at the time of Integra's Sale of Partially Treated Integra Product, not at the time of PcoMed's production of the Partially Treated Integra Product. (c) Fee Adjustment. The Fees may be subject to reduction according to the provisions of Sections 8.5 and 10.1. If it becomes necessary for Integra to settle a Third Party patent infringement suit covered by Section 10.1 (i), solely because of any action or omission of PcoMed or because of Third Party claims against PcoMed Surface Modification Technology and/or such settlement involves obtaining a license from a Third Party, in order to make, have made, import, export, use, offer for Sale, or Sell a Treated Integra Product or a Partially Treated Integra Product in the Field, then Integra may offset, dollar for dollar, against Fees up to *** percent (***%) of Integra's reasonable, out-of-pocket expenses, costs, fees (including reasonable attorneys' fees), and other consideration related to the investigation, negotiation and settlement paid by Integra to such Third Party to obtain such settlement or license with respect to the PcoMed Surface Modification Technology. The parties agree that, to the extent Fees are reduced pursuant to this Agreement, for purposes of determining the contribution toward the Minimum Payments, the Fee shall be counted as if it had not been reduced. (d) Payment. All Fees shall be due and payable quarterly as provided in Section 6.1.\"}}, {\"id\": \"value:***%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"***%\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"*** Run Fees\", \"level\": 2, \"text\": \"2.3. *** Run Fees. (a) For Distribution. Integra shall pay PcoMed a flat *** Run Fee of $*** (*** US dollars) for each *** Run in which a maximum of one hundred (100) Non-Treated Integra Product are converted by PcoMed to Treated Integra Product or Partially Treated Integra Product. PcoMed and Integra will make commercially reasonable efforts to increase the *** Run capacity. Changes to the *** Run Fee based on increased capacity will be determined upon completion of the appropriate process validations. (b) For Regulatory Purposes. PcoMed will not charge *** Run Fees for reasonable quantities, not to exceed *** units or four *** Runs, of Treated Integra Products or Partially Treated Integra Product and test samples required to complete US Marketing Clearance and/or EU Marketing Clearance testing and validations. 6 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. (c) Payment. *** Run Fees shall be due and payable within thirty (30) days of each *** Run.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Minimum Payments\", \"level\": 2, \"text\": \"2.4. Minimum Payments. Integra shall use commercially reasonable efforts to Sell Treated Integra Products and Partially Treated Integra Products that generate payments to PcoMed of no less than the Minimum Payments applicable to each Minimum Payment Period. The Minimum Payment applicable to each Minimum Payment Period shall be due annually on or before 45 days after the last day of each Minimum Payment Period. The Minimum Payment may be satisfied either by payments of the Fees paid pursuant to Sections 2.2 and 2.3, or by the sum of Fees paid and an additional elective cash payment from Integra to PcoMed. It shall remain in Integra's sole discretion whether or not to satisfy the Minimum Payment for any Minimum Payment Period by making an additional elective cash payment. In the event that Integra fails to satisfy the Minimum Payment for any Minimum Payment Period, PcoMed may, at its sole election, give notice, as set forth in Section 3.2, for conversion of Integra's exclusive arrangement under Section 3.1 to a non-exclusive arrangement. PcoMed's conversion right is PcoMed's sole and exclusive remedy for Integra's failure to satisfy the Minimum Payment for any Minimum Payment Period. Integra shall have no liability at any time to PcoMed for Integra's failure to pay the Minimum Payment. 3. GRANT OF EXCLUSIVITY COMMERCIALIZATION\"}}, {\"id\": \"value:45 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"45 days\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Grant of Exclusive Rights\", \"level\": 2, \"text\": \"3.1. Grant of Exclusive Rights. Subject to the terms and conditions of this Agreement, PcoMed hereby grants to Integra and its Affiliates a sole and exclusive worldwide right to sell and commercialize Integra Products treated by PcoMed, with the PcoMed Surface Modification Technology (the \\\"Right\\\") for use in the Field in the Territory, including the right to conduct research and development in support of any of the foregoing. Nothing herein grants any rights to Integra (i) to manufacture any products using the PcoMed Surface Modification Technology or (ii) to sell or commercialize any products utilizing the PcoMed Surface Modification Technology other than the Integra Products for use in the Field in the Territory. Neither PcoMed nor its Affiliates shall sell or offer for sale, or grant rights under the PcoMed Surface Modification Technology to any Third Party in the Field in the Territory for products that utilize or embody the PcoMed Surface Modification Technology. Except as expressly stated in the preceding sentence, PcoMed shall not be subject to any restriction under this Agreement with regard to the PcoMed Surface Modification Technology. Without limiting the foregoing or Section 8.3 below, the exclusive nature of the Rights shall not in any way limit PcoMed from making, having made, using, selling or offering for sale products and/or services that do not utilize or embody the PcoMed Surface Modification Technology.\"}}, {\"id\": \"term:Right\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Right\", \"text\": \"a sole and exclusive worldwide right to sell and commercialize Integra Products treated by PcoMed, with the PcoMed Surface Modification Technology\", \"definition_clause\": \"3.1\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exclusive Coating\", \"level\": 2, \"text\": \"3.3. Exclusive Coating. Integra (i) shall not apply or have applied any other coating to any Integra Products treated with the PcoMed Surface Modification Technology, unless that coating is for the sole purpose of identification or sterilization and (ii) shall not process the PcoMed Surface Modification Technology in any way that will adversely affect its integrity or performance. 7 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"4. TERM AND TERMINATION.\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Initial Term\", \"level\": 2, \"text\": \"4.1. Initial Term. The initial term of this Agreement (the \\\"Initial Term\\\") shall commence on the Effective Date and shall end on the date that payment is due for Minimum Payment Period 7, pursuant to Section 2.4 hereof and as set forth in Attachment B hereof, unless earlier terminated as provided herein.\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"The initial term of this Agreement\", \"definition_clause\": \"4.1\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Right to Renew\", \"level\": 2, \"text\": \"4.2. Right to Renew. Thereafter, this Agreement may be renewed for such periods of time and under such terms and conditions as are mutually agreed to in writing and pursuant to Section 12.7.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for Cause\", \"level\": 2, \"text\": \"4.3. Termination for Cause. Without limiting the other rights to terminate set forth in this Agreement, this Agreement may be terminated by either party as follows: (a) Material Breach. In the event that a party materially defaults under or materially breaches any of the provisions of this Agreement, the other party shall have the right to terminate this Agreement upon 60 days' prior written notice, unless such material default or breach is cured during such 60-day period (or in the event any breach is incapable of being cured in such time period, the other party presents a plan to attempt cure of such breach and prevent similar breaches, which plan is reasonably acceptable to the terminating party), in which event this Agreement shall continue in full force and effect. (b) Bankruptcy. If a party institutes for its protection or is made a defendant in any proceeding under bankruptcy, insolvency, reorganization or receivership law, or such party is placed in receivership, makes an assignment for benefit of creditors or is unable to meet its debts in the regular course of business, the other party may elect to terminate this Agreement immediately by written notice to the first party without prejudice to any right or remedy the other party may have, including damages for breach.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effects of Termination\", \"level\": 2, \"text\": \"4.4. Effects of Termination. (a) Obligations Accruing Prior to Termination. Expiration or termination of this Agreement shall not relieve the Parties of any obligation accruing prior to such expiration or termination. (b) Termination of Rights. Subject to Section 4.-4(c), upon expiration or termination of this Agreement, the Rights and all rights of either party hereunder shall immediately cease and terminate. (c) Transition. After early termination of this Agreement (other than a termination based on a breach of Sections 5 or 8 by Integra) and continuing for a period of eighteen (18) months thereafter, Integra and its Affiliates may Sell any Treated Integra Product and Partially Treated Integra Product in its inventory in the Field, and may, with respect to all components which, prior to the effective date of termination, were ordered or manufactured with the anticipation of being included as Treated Integra Product or Partially Treated Integra Product, complete their manufacture and sell them as though they had been inventory on the effective date of termination, subject to payment of all amounts payable to PcoMed for such Sales under this Agreement. (d) Survival. The following provisions of this Agreement and all defined terms shall survive termination of this Agreement for any reason: Sections 2.1, 2.2, 2.3, 4.4(c), 5, 6, 7, 8, 9, 10 and 12. 8\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"5. CONFIDENTIALITY.\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidential Information\", \"level\": 2, \"text\": \"5.1. Confidential Information. Except to the extent expressly authorized by this Agreement or otherwise agreed to in writing by the parties, each party agrees that, for the term of this Agreement and for 20 years thereafter, it shall keep confidential and shall not publish or otherwise disclose and shall not use for any purpose other than as provided for in this Agreement any Confidential Information furnished to it by the other party pursuant to this Agreement, except that the foregoing shall not apply to any information for which the receiving party can demonstrate that such information: (i) was already known to the receiving party, other than under an obligation of confidentiality, at the time of disclosure by the other party; (ii) was generally available to the public or otherwise part of the public domain at the time of its disclosure to the receiving party; (iii) later became part of the public domain through no act or omission of the receiving party; (iv) was disclosed to the receiving party by a Third Party who had no obligation to the disclosing party not to disclose such information to others; (iv) was independently developed by a person having no knowledge of or access to the disclosing party's Confidential Information; or (v) is an Authorized Disclosure under Section 5.3 below.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership of Confidential Information\", \"level\": 2, \"text\": \"5.2. Ownership of Confidential Information. Confidential Information relating to the PcoMed Technology is PcoMed's Confidential Information. Confidential Information relating to the Integra Technology is Integra's Confidential Information. PcoMed's Confidential Information and Integra's Confidential Information will include all Confidential Information as such term is defined in Section 1.6.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Authorized Disclosure\", \"level\": 2, \"text\": \"5.3. Authorized Disclosure. (a) Authorized Disclosure. Except as expressly agreed to in writing by Integra or as permitted by this Agreement, PcoMed shall keep Integra Technology and all Integra Confidential Information confidential. Except as expressly agreed to in writing by PcoMed or as permitted by this Agreement, Integra shall keep PcoMed Technology and all PcoMed Confidential Information confidential. Each party may disclose the other party's Confidential Information to the extent such disclosure is reasonably necessary for the following reasons: (i) regulatory filings, including filings with the U.S. Securities Exchange Commission and Regulatory Authorities; (ii) prosecuting or defending litigation provided the Confidential Information is under seal or protective order; and (iii) complying with applicable governmental regulations and legal requirements. (b) Notice of Disclosure. Notwithstanding the foregoing, in the event a party is required to make a disclosure of the other party's Confidential Information pursuant to this Section it will, except where impracticable, give reasonable advance notice to the other party of such disclosure and use best efforts to secure confidential treatment of such information. In any event, the parties agree to take all reasonable actions to avoid any unauthorized use or disclosure of Confidential Information hereunder.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Employees; Agents\", \"level\": 2, \"text\": \"5.4. Employees; Agents. Each party shall ensure that each of its Affiliates and each employee, director, officer, consultant, or other agent of it or of its Affiliates (collectively \\\"Agents\\\"), who has access to Confidential Information of the other party is bound to obligations of confidentiality and non-use substantially similar in scope to those set forth herein Each party agrees that any disclosure or distribution of the other party's Confidential Information within its own organization shall be made only as is reasonably necessary to carry out the intent of this Agreement.\"}}, {\"id\": \"term:Agents\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agents\", \"text\": \"each employee, director, officer, consultant, or other agent of it or of its Affiliates\", \"definition_clause\": \"5.4\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Submissions of Integra Regulatory Data\", \"level\": 2, \"text\": \"5.5. Regulatory Submissions of Integra Regulatory Data. During the Term, Integra shall provide all Integra Regulatory Data directly to the relevant Regulatory Authority within the required timeframes. PcoMed is expressly not authorized to disclose Integra Confidential Information directly to 9 any Regulatory Authority unless such disclosure is authorized in writing by Integra, except in the following circumstances: (a) where PcoMed is required by regulation or other legal requirement to disclose such information; (b) as part of a complaint filing concerning a Treated Integra Product or a Partially Treated Integra Product; (c) as part of an FDA audit response; or (d) as otherwise required or permitted by this Agreement.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Submissions of PcoMed Regulatory Data\", \"level\": 2, \"text\": \"5.6. Regulatory Submissions of PcoMed Regulatory Data. PcoMed shall provide all PcoMed Regulatory Data directly to the relevant Regulatory Authority within the required timeframes. Integra is expressly not authorized to disclose PcoMed Confidential Information directly to any Regulatory Authority unless such disclosure is authorized in writing by PcoMed, except in the following circumstances: (a) where Integra is required by regulation or other legal requirement to disclose such information, (b) as part of a complaint filing concerning a Treated Integra Product or a Partially Treated Integra Product; (c) as part of an FDA audit response; or (d) as otherwise required or permitted by this Agreement\"}}, {\"id\": \"5.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Injunctive Relief\", \"level\": 2, \"text\": \"5.7. Injunctive Relief. The parties expressly acknowledge and agree that any breach or threatened breach of this Section 5 may cause immediate and irreparable harm to the owner of the Confidential Information which may not be adequately compensated by damages. Each party therefore agrees that in the event of such breach or threatened breach and in addition to any remedies available at law, the party that owns the Confidential Information shall have the right to seek equitable and injunctive relief, in connection with such a breach or threatened breach, without posting bond.\"}}, {\"id\": \"5.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Terms of Agreement Confidential\", \"level\": 2, \"text\": \"5.8. Terms of Agreement Confidential. The parties agree that the terms of this Agreement are confidential and shall not be disclosed by either party to any Third Party (except to a party's professional advisors) without advance written permission of the other party, subject to the following: (i) either party may make any filings of this Agreement required by law or regulation in any country so long as such party uses its reasonable efforts to obtain confidential treatment for portions of this Agreement as available, consults with the other party, and permits the other party to participate, to the extent practicable, in seeking a protective order or other confidential treatment; (ii) either party may disclose the terms of this Agreement to a Third Party (and its professional advisors) when such disclosure is reasonably necessary in connection with (A) the grant of a license or sublicense to such Third Party, (B) prosecuting or defending litigation, (C) an actual or potential merger, 10 acquisition, placement, investment, or other such transaction with such Third Party, or (D) the sale of securities to or other financing from such Third Party or a financing underwritten by such Third Party, in which case disclosure may be made to any person or entity to whom such Third Party sells such securities (and its professional advisers); (iii) advance written permission for disclosure will not be required when a party is ordered to disclose information concerning the Agreement by a competent tribunal or such disclosures are required by law, regulation, or stock exchange rules, except that such party shall make all reasonable efforts to limit any disclosure as may be required in the course of legal proceedings by entry of an appropriate protective and confidentiality order, and shall provide the other party with as much advance notice of such circumstances as is reasonably practical.\"}}, {\"id\": \"5.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Return of Materials\", \"level\": 2, \"text\": \"5.9. Return of Materials. Any materials or documents which have been furnished by a disclosing party to a receiving party will be promptly returned, accompanied by all copies thereof, or certified as destroyed upon request by the disclosing party following termination of this Agreement, except that a party may retain one copy solely for reference to comply with regulatory or other legal requirements, subject to the obligations of confidentiality herein. 6. PAYMENT AND ACCOUNTING.\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment Terms and Reports\", \"level\": 2, \"text\": \"6.1. Payment Terms and Reports. Payments due under Section 2.2 shall be payable to PcoMed by Integra on a quarterly basis within 45 days following the end of each calendar quarter. Each such payment shall be accompanied by a statement setting forth in reasonable detail (i) the number and type of Treated Integra Product and Partially Treated Integra Product sold and the Net Sales applicable thereto, (ii) a breakdown of all the components of Net Sales for the determination of payments due under Sections 2.2 (the numbers may be and type of products may be stated in the aggregate and not by customer and are not required to be detailed by geographic area unless Fee rates are different in different geographic areas). Treated Integra Product and/or Partially Treated Integra Product shall be considered as being sold for the purpose of the calculation of payments due under Sections 2.2 when the payments for the Treated Integra Product and/or Partially Treated Integra Product are received by Integra or its Affiliates from a Third Party. All payments to be made under this Agreement shall be paid in United States dollars. Net Sales of Treated Integra Product and/or Partially Treated Integra Product and fees in currencies other than United States dollars shall be first determined in the currency of the country in which they are earned and shall be converted (for the purpose of calculation only) in accordance with generally accepted accounting principles for financial reporting in the United States.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records and Audits\", \"level\": 2, \"text\": \"6.2. Records and Audits. Integra shall keep and maintain accurate records and documentation pertaining to Net Sales of Treated Integra Product in sufficient detail to permit PcoMed to calculate payments due hereunder. Integra shall retain such records and documentation for a period that is consistent with its Records Retention Policy. Such records and documentation will be available for inspection during such period by an independent certified public accountant selected by PcoMed and reasonably acceptable to Integra, solely for the purpose of verifying the payments made by Integra under this Agreement. Said accountant shall enter into a confidentiality agreement with Integra and shall not disclose to PcoMed any information except that which is necessary to determine whether PcoMed has received all amounts due to it from Integra. Such inspections shall be made no more than once each calendar year during ordinary business hours and on reasonable prior notice and shall be at PcoMed's sole cost and expense. PcoMed shall report the results of any such audit to Integra within 60 days of completion and provide a copy of such audit 11 to Integra. The results of any such audit shall be the Confidential Information of Integra. To the extent that such audit reveals any underpayments by Integra, Integra shall pay to PcoMed the amount of shortfall within 60 days from the date on which the parties actually agreed on the amount of the shortfall, or, in the event the parties do not reach agreement on the shortfall, the date a court issues a judgment finally resolving the matter.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 2, \"text\": \"6.3. Taxes. PcoMed shall pay any and all taxes levied on account of payments it receives under this Agreement. Integra shall pay, or cause to be paid, any and all taxes required to be paid or withheld on any Sales, supply or other transfers for value of Treated Integra Product and/or Partially Treated Integra Product (other than taxes imposed on the income or revenues of PcoMed). All amounts due hereunder shall be without deduction of exchange, collection or other charges, provided that if Integra is required to withhold and pay on behalf of PcoMed any income or other similar tax with respect to the amounts payable under this Agreement, Integra shall deduct such tax payments from and offset against any said payments prior to remittance to PcoMed; and further provided that in regard to any tax so deducted, Integra shall give to PcoMed such assistance as may reasonably be necessary to enable PcoMed to claim exemption therefrom and credit therefor, and in each case shall furnish PcoMed proper evidence of the taxes paid on PcoMed's behalf, provided that Integra shall not be required to incur any out-of-pocket expenses or costs. 7. REPRESENTATIONS AND WARRANTIES\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Mutual Representations and Warranties\", \"level\": 2, \"text\": \"7.1. Mutual Representations and Warranties. Each party represents and warrants as to itself the following: (a) Corporate Power. Such party is duly organized and validly existing under the laws of the state of its organization and has full corporate power and authority to enter into this Agreement and to carry out the provisions hereof. (b) Due Authorization. Such party is duly authorized to execute and deliver this Agreement and to perform its obligations hereunder. The person executing this Agreement on such party's behalf has been duly authorized to do so by all requisite corporate action. (c) Binding Agreement. The execution, delivery and performance of this Agreement by such party does not conflict with any agreement, instrument or understanding, oral or written, to which it is a party or by which it may be bound, nor, to the party's knowledge, does it violate any material law or regulation of any court, governmental body or administrative or other agency having jurisdiction over it.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PcoMed's Representations and Warranties\", \"level\": 2, \"text\": \"7.2. PcoMed's Representations and Warranties. PcoMed hereby represents and warrants to Integra as follows: (a) Sole Owner; No Prior Grant. Except as disclosed to Integra, PcoMed is the sole holder of all legal and equitable right, title and interest in and to the PcoMed Technology. PcoMed has not assigned any of its right, title or interest in or to the Inventions disclosed in the PcoMed Surface Modification Technology. PcoMed has not granted to a Third Party any license under the PcoMed Surface Modification Technology that is inconsistent with, or otherwise restricts, the rights granted to Integra hereunder. PcoMed currently holds valid and effective assignments of all inventors' rights to all the inventions covered by the PcoMed Surface Modification Technology. No Third Party has any right, title or interest in or to the PcoMed Surface Modification Technology. No unnamed inventor has any valid claim to any rights to the inventions contained in the PcoMed Surface Modification Technology and all named inventors are properly named as such. (b) No Asserted Infringement. To PcoMed's knowledge after diligent investigation, (i) the PcoMed Surface Modification Technology does not include any trade secret, confidential information, or know-how of such Third Party that has been misappropriated or improperly used or disclosed, or (ii) the application of the PcoMed Surface Modification Technology to Integra Products or the offer, Sale and use of Treated Integra Products or Partially Treated Integra Products will not infringe a Third Party's patent rights because of the PcoMed Surface Modification Technology being applied thereto or practiced thereby. 12 (c) No Litigation. There is no suit, arbitration or legal, administrative or other proceeding or governmental investigation pending or, to PcoMed's knowledge, threatened against (i) PcoMed's consummation of the transactions described herein, or (ii) PcoMed respecting the PcoMed Surface Modification Technology. To PcoMed's knowledge, there are no claims, judgments or settlements involving PcoMed and relating to the PcoMed Surface Modification Technology or the manufacture, use or Sale of any products using the PcoMed Surface Modification Technology, and no pending claims, litigation or proceedings against PcoMed relating to the PcoMed Surface Modification Technology, PcoMed Technology or the manufacture, use or Sale of products using the PcoMed Surface Modification Technology. (d) No Approvals. No approval or consent of any person, court or governmental agency is required in connection with PcoMed's execution and delivery of this Agreement and the performance of its obligations hereunder. There are no outstanding liens, encumbrances, Third Party rights, agreements or understandings of any kind, either written or oral, express of implied, regarding the the PcoMed Technology that are inconsistent or conflict with any provision of this Agreement. (e) Non-Compete. The Settlement Agreement and Mutual Release between *** and *** does not contain a covenant-non-compete applicable to *** and, to the best of PcoMed's current knowledge, *** is not subject to any covenant-non-compete that would prevent is employment with PcoMed.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Integra's Representations and Warranties\", \"level\": 2, \"text\": \"7.3. Integra's Representations and Warranties. Integra hereby represents and warrants to PcoMed as follows: (a) Sole Owner; No Prior Grant. Integra is the sole holder of all legal and equitable right, title and interest in and to the Integra Technology. Integra has not assigned any of its right, title or interest in or to the Inventions disclosed in the Integra Technology. Integra has not granted to a Third Party any license under the Integra Technology that is inconsistent with, or otherwise restricts, this Agreement. Integra currently holds valid and effective assignments of all inventors' rights to all the inventions covered by the Integra Technology. No Third Party has any right, title or interest in or to the Integra Technology. No unnamed inventor has any valid claim to any rights to the inventions contained in the Integra Technology and all named inventors are properly named as such. (b) No Asserted Infringement. To Integra's knowledge after diligent investigation, (i) the Integra Technology does not include any trade secret, confidential information, or know-how of such Third Party that has been misappropriated or improperly used or disclosed and, (ii) to the best of Integra's knowledge, the Sale of Treated Integra Products or Partially Treated Integra Products will not infringe any currently known Third Party patent rights. (c) No Litigation. There is no suit, arbitration or legal, administrative or other proceeding or governmental investigation pending or, to Integra's knowledge, threatened against (i) Integra's consummation of the transactions described herein, or (ii) Integra respecting the Integra Technology. To Integra's knowledge, there are no claims, judgments or settlements involving Integra and relating to the Integra Technology or the manufacture, use or Sale of any products using the Integra Technology, and no pending claims, litigation or proceedings against Integra relating to the Integra Technology or the manufacture, use or Sale of products using the Integra Technology. (d) No Approvals. No approval or consent of any person, court or governmental agency is required in connection with Integra's execution and delivery of this Agreement and the performance of its obligations hereunder. There are no outstanding liens, encumbrances, Third Party rights, agreements or understandings of any kind, either written or oral, express of implied, regarding the the Integra Technology that are inconsistent or conflict with any provision of this Agreement. 13 *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY OWNERSHIP; PROSECUTION, ENFORCEMENT\", \"level\": 1, \"text\": \"8. INTELLECTUAL PROPERTY OWNERSHIP; PROSECUTION, ENFORCEMENT.\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership\", \"level\": 2, \"text\": \"8.1. Ownership. All PcoMed Technology shall remain the property of PcoMed, and all Integra Technology shall remain the property of Integra. Any Invention that is neither PcoMed Technology nor Integra Technology but that is Derived during the Term jointly by the parties relating to this Agreement shall be the property of (i) PcoMed if it relates primarily to the PcoMed Technology and (ii) Integra if it relates primarily to the Integra Products; provided that the parties may agree that an Invention that is Derived during the Term jointly may become the property of both parties, including Inventions or methods related to the surface preparation of Integra Products. Except with regard to the foregoing joint Inventions or methods, each party hereby assigns to the other, by way of present and future assignment, all of the right, title and interest (including all Intellectual Property Rights therein) that it has or may have in any such Invention that is jointly Derived and that is subject to ownership by the other party.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Inventions\", \"level\": 2, \"text\": \"8.2. Inventions. All Inventions and Intellectual Property Rights that relate primarily to the PcoMed Technology Derived during the Term of this Agreement shall remain as the sole and exclusive property of PcoMed.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reservation of Rights\", \"level\": 2, \"text\": \"8.3. Reservation of Rights. Nothing in this Agreement shall be construed as granting to any party any right, title or interest in or to or under any Intellectual Property Rights or Inventions of the other party, other than as expressly agreed by the parties in writing in this Agreement. All rights not specifically granted herein are reserved to the applicable party, which may at all times fully and freely exercise the same except as otherwise restricted herein.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Filing, Prosecution, and Maintenance of PcoMed Surface Modification Technology\", \"level\": 2, \"text\": \"8.4. Filing, Prosecution, and Maintenance of PcoMed Surface Modification Technology. PcoMed shall at all times, at its sole election and expense, have the exclusive and sole right to file patent applications covering the PcoMed Surface Modification Technology in its own name. If PcoMed elects to file patent applications covering the PcoMed Surface Modification Technology, PcoMed shall be responsible for diligently prosecuting and maintaining, at its sole expense, such patent applications and patents issuing thereon. PcoMed shall retain patent counsel of its choosing in connection with the performance of its obligations under this Section. PcoMed shall keep Integra reasonably informed of its patent prosecution activities with respect to the PcoMed Surface Modification Technology.\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Enforcement against Third Parties\", \"level\": 2, \"text\": \"8.5. Enforcement against Third Parties. (a) Notice. If either party learns of the actual, suspected, threatened or likely infringement or misappropriation of any of the PcoMed Surface Modification Technology, or any of the Integra Technology, then that party shall give written notice thereof to the other party and shall provide the other party with any evidence of such infringement or misappropriation in its possession. (b) Infringement Not Relating Solely to PcoMed Surface Modification Technology. (i) Integra shall have the sole right, but shall be under no obligation, to take any action to enforce any suspected or actual infringement, misappropriation or other unauthorized use of Intellectual Property Rights relating to Treated Integra Products or Partially Treated Integra Products where such infringement, misappropriation or other unauthorized use does not relate exclusively to the PcoMed Technology. If Integra does not have standing without PcoMed joining the action, PcoMed shall join the action at Integra's expense. 14 (c) Infringement Relating Exclusively to PcoMed Surface Modification Technology. (i) PcoMed shall have the first and primary right, but shall be under no obligation, to take any action to enforce any suspected or actual infringement, misappropriation or other unauthorized use of Intellectual Property Rights relating to Treated Integra Products or Partially Treated Integra Products to the extent that such infringement, misappropriation or other unauthorized use relates exclusively to the PcoMed Surface Modification Technology. (ii) PcoMed shall notify Integra of its intent to take any such action. If Integra desires PcoMed to take any such action, Integra shall notify PcoMed of such desire in writing and PcoMed shall have ninety (90) days in which to notify Integra whether it decides to take any action, if it has not already so notified Integra. (iii) Integra may elect to join as a party in PcoMed's action at Integra's expense; provided, however, that if PcoMed does not have standing without Integra joining the action, Integra shall join the action at PcoMed's expense. (iv) If PcoMed does not notify Integra of its desire to take action within ninety (90) days after written request by Integra to do so, or PcoMed agrees to take action and fails to resolve or bring suit to enforce any suspected or actual infringement, misappropriation or other unauthorized use within six months thereafter, then Integra may, but shall be under no obligation to, and at its own cost, require PcoMed to take such enforcement action as Integra deems necessary. If PcoMed takes any such enforcement action, Integra shall reimburse PcoMed for all of its reasonable expenses, costs, and fees, including reasonable attorney fees, incurred in connection therewith, except as provided in Section 8.5(d)(i). Any such reimbursement shall be deducted from the Fees payable by Integra pursuant to Section 2.2 hereof. (d) Disagreements; Procedures. (i) Whichever party takes or controls an enforcement action under this Section 8.4 shall be entitled to reimburse itself first out of any sums recovered in such suit or in settlement thereof for all costs and expenses, including reasonable attorneys' fees, involved in the prosecution of such action. Any amount remaining after this reimbursement shall be used to reimburse the other party for all costs and expenses, including reasonable attorney's fees, if any, involved in its participation in such action. Any amounts thereafter remaining shall be split in proportion to the damages from the suspected or actual infringement, misappropriation or other unauthorized use reasonably attributable to the PcoMed Surface Modification Technology versus the damages from the suspected or actual infringement, misappropriation or other unauthorized use reasonably not attributable to the PcoMed Surface Modification Technology. Any and all of Integra's reasonable expenses, costs and fees (including reasonable attorneys' fees) incurred by Integra in the investigation, commencement, pursuit, enforcement, defense and settlement of any infringement related exclusively to the PcoMed Surface Modification Technology that are not reimbursed as provided above, shall be fully creditable, dollar for dollar, against the Minimum Payments or Fees that would otherwise be due and owing hereunder. 15 (ii) In the event that a declaratory judgment action alleging invalidity or noninfringement of any of the PcoMed Surface Modification Technology shall be brought against Integra as a result of any enforcement action taken by Integra, Integra shall be responsible for defending such action; provided, however, that within thirty (30) days after commencement of such action, PcoMed shall have the right to intervene and take over the sole defense of the action at its own expense. In the event that a declaratory judgment action alleging invalidity or noninfringement of any of the Integra Technology shall be brought against PcoMed as a result of any enforcement action taken by PcoMed, PcoMed shall be responsible for defending such action; provided, however, that within thirty (30) days after commencement of such action, Integra shall have the right to intervene and take over the sole defense of the action at its own expense. Notwithstanding the foregoing, in the event that a declaratory judgment action is brought against one or both of the parties alleging invalidity or noninfringement of PcoMed Technology and Integra Technology, PcoMed and Integra shall each have the right to participate in the defense of the action at its own expense. 9. LIMITATION OF LIABILITY.\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation of Liability\", \"level\": 2, \"text\": \"9.1. Limitation of Liability. NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, OR INDIRECT DAMAGES ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. NOTWITHSTANDING THE FOREGOING, NOTHING IN THIS SECTION IS INTENDED TO LIMIT OR RESTRICT THE DAMAGES AVAILABLE FOR BREACHES OF SECTION 3.1 (GRANT OF RIGHTS), SECTION 5 (CONFIDENTIALITY PROVISIONS), OR SECTIONS 8.1 AND 8.2 (OWNERSHIP AND LICENSE). 10. INDEMNIFICATION.\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PcoMed's Indemnification\", \"level\": 2, \"text\": \"10.1. PcoMed's Indemnification. PcoMed shall indemnify and defend Integra and its Affiliates, and the directors, officers, members, employees, counsel , agents and representatives of Integra and its Affiliates, and the successors and assigns of any of the foregoing (the \\\"Integra Indemnitees\\\"), and hold the Integra Indemnitees harmless from and against any and all claims, demands, actions, liabilities, damages, losses, judgments, costs or expenses (including interest and penalties and reasonable attorneys' fees and professional fees and expenses of litigation) (collectively, \\\"Claims\\\") arising out of, in connection with, or resulting from any and all claims incurred by or asserted against Integra Indemnitees for (i) infringement of any patent or other proprietary rights arising solely from or occurring as a result of the manufacture, sale, offer to sell, importation and/or use of PcoMed Surface Modification Technology; (ii) any and all breaches of the representations and warranties of this Agreement by PcoMed; and (iii) product defects or liability associated with the PcoMed Surface Modification Technology. Integra may offset all costs and expenses covered under (i) above against the Fees as provided in Section 2.2 (c) as its sole and exclusive remedy for the recovery of such costs and expenses.\"}}, {\"id\": \"term:Integra Indemnitees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Integra Indemnitees\", \"text\": \"Integra and its Affiliates, and the directors, officers, members, employees, counsel , agents and representatives of Integra and its Affiliates, and the successors and assigns of any of the foregoing\", \"definition_clause\": \"10.1\"}}, {\"id\": \"term:Claims\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Claims\", \"text\": \"any and all claims, demands, actions, liabilities, damages, losses, judgments, costs or expenses (including interest and penalties and reasonable attorneys' fees and professional fees and expenses of litigation)\", \"definition_clause\": \"10.1\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Integra's Indemnification\", \"level\": 2, \"text\": \"10.2. Integra's Indemnification. Integra shall indemnify and defend PcoMed and its Affiliates, and the directors, officers, members, employees, counsel , agents and representatives of PcoMed and its Affiliates, and the successors and assigns of any of the foregoing (the \\\"PcoMed 16 Indemnitees\\\"), and hold the PcoMed Indemnitees harmless from and against any and all claims, demands, actions, liabilities, damages, losses, judgments, costs or expenses (including interest and penalties and reasonable attorneys' fees and professional fees and expenses of litigation) (collectively, \\\"Claims\\\") asserted by third parties and arising out of, in connection with, or resulting from any and all claims incurred by or asserted against PcoMed for (i) infringement of any patent or other proprietary rights arising from or occurring as a result of the manufacture, sale, offer to sell, importation and/or use of Integra Technology; (ii) any and all breaches of the representations and warranties of this Agreement by Integra; and (iii) any product defects or liability associated with any Integra Products except that arising solely from the PcoMed Surface Modification Technology. 11. USE OF NAMES.\"}}, {\"id\": \"term:PcoMed Indemnitees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PcoMed Indemnitees\", \"text\": \"PcoMed and its Affiliates, and the directors, officers, members, employees, counsel , agents and representatives of PcoMed and its Affiliates, and the successors and assigns of any of the foregoing\", \"definition_clause\": \"10.2\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Names and Trademarks\", \"level\": 2, \"text\": \"11.1. Names and Trademarks. Each party agrees not to use or reference the name of the other party, or the other party's logos or trademarks in any advertising, sales promotion, press release or other communication relating to this Agreement without obtaining such party's prior written consent. Notwithstanding the foregoing, a party may use or reference such information to the extent reasonably necessary for (i) regulatory filings, including filings with the U.S. Securities Exchange Commission and Regulatory Authorities, (ii) prosecuting or defending litigation, or (iii) complying with applicable governmental regulations and legal requirements. Notwithstanding the foregoing, Integra shall have the right to indicate that the Treated Integra Products and Partially Treated Integra Products were partly manufactured by PcoMed. 12. MISCELLANEOUS.\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"12.1. Notices. Any notice, request, instruction or other document required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been given (i) if mailed with the United States Postal Service by prepaid, first class, certified mail, return receipt requested, at the time of receipt by the intended recipient, (ii) if sent by Federal Express, Airborne, or other overnight carrier, signature of delivery required, at the time of receipt by the intended recipient, (iii) if sent by facsimile transmission, when so sent and when receipt has been acknowledged by appropriate telephone or facsimile receipt, or (iv) if hand-delivered, at the time of receipt by the intended recipient, addressed as follows: (a) For Integra: Brian Larkin, President, Global Spine and Orthobiologics Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536 Patricia Jacobson, Corporate Counsel Integra LifeSciences Corporation 2302 La Mirada Drive Vista, CA 92081 General Counsel Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536 17 (b) For PcoMed: Steve Jacobs CEO PcoMed, LLC. 105 S. Sunset St. Suite O Longmont, CO 80501 With required copy to: Alan Keeffe Sherman & Howard LLC 675 Snapdragon Way Suite 350 Steamboat Springs, CO 80477\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Laws\", \"level\": 2, \"text\": \"12.2. Compliance with Laws. Each party shall comply with all applicable federal, state and local laws and regulations in connection with its activities pursuant to this Agreement.\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"12.3. Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the State of New Jersey.\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Dispute Resolution\", \"level\": 2, \"text\": \"12.4. Dispute Resolution. In the event of any controversy or claim relating to, arising out of or in any way connected to any provision of this Agreement (a \\\"Dispute\\\"), either Party may, by notice to the other Party, have such dispute referred to their respective senior officials designated below or their successors, for attempted resolution by good faith negotiations within 30 days after such notice is received. Any Dispute that is not resolved through such negotiations may be referred to binding arbitration in Denver, Colorado with the Judicial Arbiter Group as part of a 3 person panel, with costs borne separately by each party, to be conducted in accordance with the rules of the American Arbitration Association. (a) For Integra: Brian Larkin President, Global Spine and Orthobiologics Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536 (b) For PcoMed: Steven Jacobs CEO PcoMed, LLC. 105 S. Sunset St. Suite O Longmont, CO 80501 18\"}}, {\"id\": \"term:Dispute\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Dispute\", \"text\": \"any controversy or claim relating to, arising out of or in any way connected to any provision of this Agreement\", \"definition_clause\": \"12.4\"}}, {\"id\": \"12.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Waiver\", \"level\": 2, \"text\": \"12.5. No Waiver. Failure of any party to enforce a right under this Agreement shall not act as a waiver of that right or the ability to assert that right unless such party has signed an express written waiver as to a particular matter for a particular period of time.\"}}, {\"id\": \"12.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"12.6. Severability. If any provision of this Agreement shall be found by a court of competent jurisdiction to be void, invalid or unenforceable, the provision shall be considered severed from this Agreement and shall not affect the validity or enforceability of the remainder of this Agreement. The parties shall make a good faith effort to replace any invalid or unenforceable provision with a valid and enforceable one such that the objectives contemplated by the parties when entering this Agreement may be realized.\"}}, {\"id\": \"12.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Modification\", \"level\": 2, \"text\": \"12.7. Modification. No change, modification, addition or amendment to this Agreement is valid or enforceable unless in writing and signed and dated by the authorized officers of the parties to this Agreement.\"}}, {\"id\": \"12.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"12.8. Entire Agreement. This Agreement and the Attachments attached hereto constitute the entire agreement between the parties and replace and supersede as of the Effective Date any and all prior agreements and understandings, whether oral or written, between the parties with respect to the subject matter hereof, except any prior Confidential Disclosure Agreement(s).\"}}, {\"id\": \"12.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Successors\", \"level\": 2, \"text\": \"12.9. Successors. Except as otherwise expressly provided in this Agreement, this Agreement shall be binding upon, inures to the benefit of, and is enforceable by, the parties and their respective heirs, legal representatives, successors and permitted assigns.\"}}, {\"id\": \"12.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Construction\", \"level\": 2, \"text\": \"12.10. Construction. This Agreement has been prepared, examined, negotiated and revised by each party and their respective attorneys, and no implication shall be drawn and no provision shall be construed against any party to this Agreement by virtue of the purported identity of the drafter of this Agreement or any portion thereof.\"}}, {\"id\": \"12.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 2, \"text\": \"12.11. Counterparts. This Agreement may be executed simultaneously in one or more counterparts, each of which shall constitute one and the same instrument.\"}}, {\"id\": \"12.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"12.12. Assignment. This Agreement shall be binding upon and shall inure to the benefit of PcoMed and Integra, and their successors and assigns. Neither party shall assign their respective rights under this Agreement without the prior written consent of the other party. Notwithstanding the foregoing, no such consent shall be required for either party to assign this Agreement (i) to an Affiliate provided the party to this Agreement continues to be liable for all obligations hereunder, or (ii) in connection with a merger or sale of all or substantially all of the assets of such party to which this Agreement relates, provided in the case of (ii) the successor or assignee assumes all liabilities hereunder.\"}}, {\"id\": \"12.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Further Assurances\", \"level\": 2, \"text\": \"12.13. Further Assurances. Each party shall do, execute, acknowledge and deliver, and cause to be done, executed, acknowledged or delivered, all such further acts, transfers, conveyances, assignments or assurances as may be reasonably required to consummate the transactions contemplated by this Agreement.\"}}, {\"id\": \"12.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"12.14. Force Majeure. Except for obligations to make payments payable under this Agreement, each party shall be excused from the performance of its obligations under this Agreement to the extent that such performance is prevented by force majeure and the nonperforming party promptly provides the other party with written notice of the event of force majeure and its effect. Such excuse shall be continued so long as the condition constituting force 19 majeure continues and the nonperforming party takes reasonable efforts to remove or circumvent the interference caused by the condition. For purposes of this Agreement, force majeure shall include an act of God, war, civil commotion, terrorist act, labor strike or lock-out other than at a party's facility, epidemic, failure or default of public utilities or common carriers, destruction of production facilities or materials by fire, earthquake, storm or like catastrophe, and failure of plant or machinery (provided that such failure could not have been prevented by the exercise of skill, diligence, and prudence that would be reasonably and ordinarily expected from a skilled and experienced person engaged in the same type of undertaking under the same or similar circumstances).\"}}, {\"id\": \"12.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractors\", \"level\": 2, \"text\": \"12.15. Independent Contractors. Each party shall act solely as an independent contractor, and nothing in this Agreement shall be construed to give either party the power or authority to act for, bind or commit the other party in any way. Nothing herein shall be construed to create the relationship of partnership, principal and agent or joint venture between the parties. IN WITNESS WHEREOF, the parties have caused their duly authorized representatives to execute this Agreement as of the Effective Date. INTEGRA LIFESCIENCES CORPORATION PCOMED, LLC By: /s/ Brian Larkin By: /s/ Steve Jacobs Name: Brian Larkin Name: Steve Jacobs Title: President Title: CEO Date: May 29, 2013 Date: May 15, 2013 20\"}}, {\"id\": \"ATTACHMENT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PcoMed Surface Modification Technology\", \"level\": 1, \"text\": \"ATTACHMENT A PcoMed Surface Modification Technology *** i *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"ATTACHMENT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PcoMed Surface Modification Technology (continued)\", \"level\": 1, \"text\": \"ATTACHMENT A PcoMed Surface Modification Technology (continued) *** ii *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission.\"}}, {\"id\": \"Attachment B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Minimum Payments\", \"level\": 1, \"text\": \"Attachment B Minimum Payments PERIOD MINIMUM PAYMENT Minimum Payment Period 1 $ *** Minimum Payment Period 2 $ *** Minimum Payment Period 3 $ *** Minimum Payment Period 4 $ *** Minimum Payment Period 5 $ *** Minimum Payment Period 6 $ *** Minimum Payment Period 7 $ *** For this purpose: \\\"Minimum Payment Period 1\\\" means the one-year period commencing on the date set forth in the Notice of Initial Acceptance of First Product Order. \\\"Minimum Payment Period 2\\\" means the one-year period commencing on the first day after Minimum Payment Period 1. \\\"Minimum Payment Period 3\\\" means the one-year period commencing on the first day after Minimum Payment Period 2. \\\"Minimum Payment Period 4\\\" means the one-year period commencing on the first day after Minimum Payment Period 3. \\\"Minimum Payment Period 5\\\" means the one-year period commencing on the first day after Minimum Payment Period 4. \\\"Minimum Payment Period 6\\\" means the one-year period commencing on the first day after Minimum Payment Period 5. \\\"Minimum Payment Period 7\\\" means the one-year period commencing on the first day after Minimum Payment Period 6. *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. ATTACHMENT C NOTICE OF INITIAL ACCEPTANCE OF FIRST PRODUCT ORDER This Notice references the Agreement executed effective as of , 2013, by and between Integra LifeSciences Corporation (\\\"Integra\\\") and PcoMed, LLC (\\\"PcoMed\\\") (\\\"Agreement\\\"). In accordance with Section 12.1 (Notices) and pursuant to Section 4.1 of the Agreement, notice is hereby given that the date of Integra's acceptance of the First Product Order (as defined in the Agreement and as approved by the applicable Regulatory Authority for sale) is designated as the day of , 20 . This Notice of Initial Acceptance of the First Product Order is issued by Integra LifeSciences Corporation on this day of , 20 . By: Name: Title:\"}}, {\"id\": \"term:Minimum Payment Period 1\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 1\", \"text\": \"the one-year period commencing on the date set forth in the Notice of Initial Acceptance of First Product Order.\", \"definition_clause\": \"Attachment B\"}}, {\"id\": \"term:Minimum Payment Period 2\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 2\", \"text\": \"the one-year period commencing on the first day after Minimum Payment Period 1.\", \"definition_clause\": \"Attachment B\"}}, {\"id\": \"term:Minimum Payment Period 3\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 3\", \"text\": \"the one-year period commencing on the first day after Minimum Payment Period 2.\", \"definition_clause\": \"Attachment B\"}}, {\"id\": \"term:Minimum Payment Period 4\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 4\", \"text\": \"the one-year period commencing on the first day after Minimum Payment Period 3.\", \"definition_clause\": \"Attachment B\"}}, {\"id\": \"term:Minimum Payment Period 5\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 5\", \"text\": \"the one-year period commencing on the first day after Minimum Payment Period 4.\", \"definition_clause\": \"Attachment B\"}}, {\"id\": \"term:Minimum Payment Period 6\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 6\", \"text\": \"the one-year period commencing on the first day after Minimum Payment Period 5.\", \"definition_clause\": \"Attachment B\"}}, {\"id\": \"term:Minimum Payment Period 7\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Payment Period 7\", \"text\": \"the one-year period commencing on the first day after Minimum Payment Period 6.\", \"definition_clause\": \"Attachment B\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of SalesforcecomInc_20171122_10-Q_EX-10.1_10961535_EX-10.1_Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of SalesforcecomInc_20171122_10-Q_EX-10.1_10961535_EX-10.1_Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 FORM OF SUB-RESELLER AGREEMENT Signature Page Reseller Full Legal Name Salesforce.org, a nonprofit public benefit corporation having its principal place of business at 50 Fremont Street, Suite 300, San Francisco, California 94105 This Form of Sub-Reseller Agreement (this \\\"Sub-Reseller Agreement\\\") is made and entered in by and between salesforce.com, inc., a Delaware corporation having its principal place of business at The Landmark @ One Market, Suite 300, San Francisco, California 94105 (\\\"SFDC\\\" or \\\"Salesforce\\\") and the Reseller named above and amends that certain Reseller Agreement between Salesforce and Reseller dated as of August 1, 2015, as previously amended (the \\\"Agreement\\\"). This Sub-Reseller Agreement is effective as of the later of the dates beneath the Parties' signatures below (\\\"Sub-Reseller Effective Date\\\"), provided, however, that the dates of the Parties' signatures are not separated by a period of time greater than ten (10) business days. If such period is greater than ten (10) business days then this Sub-Reseller Agreement shall be deemed null and void and to be of no effect. Capitalized terms not defined herein shall have the meanings given to them in the Agreement. The Parties, by their respective authorized signatories, have duly executed this Sub-Reseller Agreement as of the Sub-Reseller Effective Date. Salesforce.com, Inc. Reseller By: By: Name: Name: Title: Title: Date: Date: Source: SALESFORCE.COM, INC., 10-Q, 11/22/2017 Exhibit 10.1 Sub-Reseller Agreement Terms & Conditions\"}, {\"id\": \"1\", \"title\": \"Resale Rights\", \"level\": 1, \"text\": \"1. Resale Rights. SFDC hereby appoints SUB-RESELLER (\\\"Sub-Reseller\\\") as a sub-reseller to whom Reseller may resell Services in accordance with Section 2(ii) of the Agreement, provided that Sub-Reseller may only resell such Services to Customer. Reseller must ensure that Sub-Reseller complies with the terms of the Agreement applicable to Reseller as if Sub- Reseller were an original party to the Agreement and any breach by Sub-Reseller of the Agreement will be deemed a breach by Reseller. Sub-Reseller is not be a third-party beneficiary of the Agreement.\"}, {\"id\": \"2\", \"title\": \"Effect of Sub-Reseller Agreement\", \"level\": 1, \"text\": \"2. Effect of Sub-Reseller Agreement. Subject to the above modifications, the Agreement remains in full force and effect.\"}, {\"id\": \"3\", \"title\": \"Entire Agreement\", \"level\": 1, \"text\": \"3. Entire Agreement. The terms and conditions herein contained constitute the entire agreement between the Parties with respect to the subject matter of this Sub-Reseller Agreement and supersede any previous and contemporaneous agreements and understandings, whether oral or written, between the Parties hereto with respect to the subject matter hereof.\"}, {\"id\": \"4\", \"title\": \"Counterparts\", \"level\": 1, \"text\": \"4. Counterparts. This Sub-Reseller Agreement may be executed in one or more counterparts, including facsimiles or scanned copies sent via email or otherwise, each of which will be deemed to be a duplicate original, but all of which, taken together, will be deemed to constitute a single instrument. Source: SALESFORCE.COM, INC., 10-Q, 11/22/2017\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of SalesforcecomInc_20171122_10-Q_EX-10.1_10961535_EX-10.1_Reseller Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 FORM OF SUB-RESELLER AGREEMENT Signature Page Reseller Full Legal Name Salesforce.org, a nonprofit public benefit corporation having its principal place of business at 50 Fremont Street, Suite 300, San Francisco, California 94105 This Form of Sub-Reseller Agreement (this \\\"Sub-Reseller Agreement\\\") is made and entered in by and between salesforce.com, inc., a Delaware corporation having its principal place of business at The Landmark @ One Market, Suite 300, San Francisco, California 94105 (\\\"SFDC\\\" or \\\"Salesforce\\\") and the Reseller named above and amends that certain Reseller Agreement between Salesforce and Reseller dated as of August 1, 2015, as previously amended (the \\\"Agreement\\\"). This Sub-Reseller Agreement is effective as of the later of the dates beneath the Parties' signatures below (\\\"Sub-Reseller Effective Date\\\"), provided, however, that the dates of the Parties' signatures are not separated by a period of time greater than ten (10) business days. If such period is greater than ten (10) business days then this Sub-Reseller Agreement shall be deemed null and void and to be of no effect. Capitalized terms not defined herein shall have the meanings given to them in the Agreement. The Parties, by their respective authorized signatories, have duly executed this Sub-Reseller Agreement as of the Sub-Reseller Effective Date. Salesforce.com, Inc. Reseller By: By: Name: Name: Title: Title: Date: Date: Source: SALESFORCE.COM, INC., 10-Q, 11/22/2017 Exhibit 10.1 Sub-Reseller Agreement Terms & Conditions\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resale Rights\", \"level\": 1, \"text\": \"1. Resale Rights. SFDC hereby appoints SUB-RESELLER (\\\"Sub-Reseller\\\") as a sub-reseller to whom Reseller may resell Services in accordance with Section 2(ii) of the Agreement, provided that Sub-Reseller may only resell such Services to Customer. Reseller must ensure that Sub-Reseller complies with the terms of the Agreement applicable to Reseller as if Sub- Reseller were an original party to the Agreement and any breach by Sub-Reseller of the Agreement will be deemed a breach by Reseller. Sub-Reseller is not be a third-party beneficiary of the Agreement.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effect of Sub-Reseller Agreement\", \"level\": 1, \"text\": \"2. Effect of Sub-Reseller Agreement. Subject to the above modifications, the Agreement remains in full force and effect.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 1, \"text\": \"3. Entire Agreement. The terms and conditions herein contained constitute the entire agreement between the Parties with respect to the subject matter of this Sub-Reseller Agreement and supersede any previous and contemporaneous agreements and understandings, whether oral or written, between the Parties hereto with respect to the subject matter hereof.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 1, \"text\": \"4. Counterparts. This Sub-Reseller Agreement may be executed in one or more counterparts, including facsimiles or scanned copies sent via email or otherwise, each of which will be deemed to be a duplicate original, but all of which, taken together, will be deemed to constitute a single instrument. Source: SALESFORCE.COM, INC., 10-Q, 11/22/2017\"}}, {\"id\": \"party:Salesforce.org\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Salesforce.org\", \"role\": \"Reseller\", \"address\": \"50 Fremont Street, Suite 300, San Francisco, California 94105\"}}, {\"id\": \"party:salesforce.com, inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"salesforce.com, inc.\", \"role\": null, \"address\": \"The Landmark @ One Market, Suite 300, San Francisco, California 94105\"}}, {\"id\": \"term:Sub-Reseller Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sub-Reseller Agreement\", \"text\": \"This Form of Sub-Reseller Agreement (this \\\"Sub-Reseller Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:SFDC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SFDC\", \"text\": \"salesforce.com, inc., a Delaware corporation having its principal place of business at The Landmark @ One Market, Suite 300, San Francisco, California 94105 (\\\"SFDC\\\" or \\\"Salesforce\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Salesforce\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Salesforce\", \"text\": \"salesforce.com, inc., a Delaware corporation having its principal place of business at The Landmark @ One Market, Suite 300, San Francisco, California 94105 (\\\"SFDC\\\" or \\\"Salesforce\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"that certain Reseller Agreement between Salesforce and Reseller dated as of August 1, 2015, as previously amended (the \\\"Agreement\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Sub-Reseller Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sub-Reseller Effective Date\", \"text\": \"the later of the dates beneath the Parties' signatures below (\\\"Sub-Reseller Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Sub-Reseller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sub-Reseller\", \"text\": \"SFDC hereby appoints SUB-RESELLER (\\\"Sub-Reseller\\\") as a sub-reseller\", \"definition_clause\": \"1\"}}, {\"id\": \"value:ten (10) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) business days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ScansourceInc_20190509_10-Q_EX-10.2_11661422_EX-10.2_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ScansourceInc_20190509_10-Q_EX-10.2_11661422_EX-10.2_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.2\", \"level\": 1, \"text\": \"Exhibit 10.2 IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****]. ZEBRA\u00ae PARTNERCONNECT PROGRAM ADDENDUM TO ZEBRA\u00ae PARTNERCONNECT DISTRIBUTOR AGREEMENT THIS ADDENDUM (\\\"Addendum\\\") is made on the 4th day of February 2019 (\\\"Effective Date\\\") between the following parties: Zebra Technologies International, LLC, with an office at 3 Overlook Point, Lincolnshire IL 60069 (\\\"Zebra\\\"); Zebra Technologies do Brasil - Com\u00e9rcio de Produtos de Inform\u00e5tica Ltda., a company incorporated and organized under the laws of Brazil, with offices at Av. Magalh\u00e4es de Castro, 4800, sala 72-A, Cidade Jardim, CEP 05676-120, S\u00e4o Paulo, sp (\\\"Zebra Brazil\\\") Xplore Technologies Corporation of America, a company with its principal place of business at 8601 RR 2222, Building 2, Suite #100, Austin, Texas 78730, U.S.A. (\\\"Xplore\\\"); (collectively \\\"Zebra\\\") AND ScanSource, Inc., a company incorporated in South Carolina, with its registered office at 6 Logue Court, Greenville, South Carolina 29615 (\\\"ScanSource\\\"). ScanSource Latin America, Inc. a ScanSource Affiliate incorporated in Florida, whose registered business address is 1935 NW 87 Avenue, Miami, Florida 33172 (\\\"ScanSource Latin America\\\") ScanSource Brazil Distribuidora de Technologias, Ltda., a ScanSource Affiliate incorporated and organized under the laws of Brazil, with offices in the City of S\u00e4o Jos\u00e9 dos Pinhais, State of Paran\u00e5, at Avenida Rui Barbosa, 2529, Modulos 11 and 12, Bairro Jardim Ip\u00e9, CEP: 83055-320, enrolled with the Taxpayer Register (CNPJ/MF) under No. 05.607.657/0001-35 (\\\"ScanSource Brazil\\\") SCANSOURCE DE MEXICO S. DE R.L. DE C.V., a ScanSource Affiliate incorporated in Mexico, whose registered business address is Calle 4 No. 298, Colonia Franccionamiento Industrial Alce Blanco, Naucalpan de Juarez, Estado de M\u00e9xico 53370 (\\\"ScanSource Mexico\\\") (Collectively \\\"Distributor') \\\"Zebra\\\" and the \\\"Distributor\\\" are referred to collectively as 'Parties\\\" and individually as a \\\"Party\\\". WHEREAS: (A) On February 12, 2014 the Parties entered into an agreement that was renamed, as of April 11, 2016, to: PartnerConnectTM EVM Distribution Agreement, (as amended) (\\\"Distribution Agreement\\\"), which relates to Zebra Enterprise Visibility and Mobility ('EVM\\\") products and services, and which, as acknowledged by the Parties by entering into this Amendment, is in full force and effect and valid as when this Amendment is executed; (B) Distributor purchases Products from Zebra under the Distributor Agreement; (C)\u200b Zebra has recently completed the acquisition of Xplore, which transaction closed on August 14, 2018; (D) Zebra has expanded its products portfolio by adding the product families listed in Exhibit A, that as of the Effective Date hereof are branded Xplore or Motion Computing, thereto (\\\"Xplore Products\\\"); (E) Xplore, now a Zebra Affiliate, is the seller of Xplore Products; Source: SCANSOURCE, INC., 10-Q, 5/9/2019 (F) Xplore wishes to sell Xplore Products to Distributor and Distributor wishes to purchase such products from Xplore pursuant to the terms and conditions of the Distributor Agreement by entering into this Addendum; and (G) The Parties desire to amend the Distributor Agreement by adding Xplore Products and authorizing Distributor to purchase such products from Xplore for further resale to members of the Zebra PartnerConnect Program in the Market or Territory. THEREFORE, in consideration of the mutual covenants and promises, and subject to the terms and conditions of the Distributor Agreement, the Parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the c\", \"level\": 1, \"text\": \"1. Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the context requires otherwise.\"}, {\"id\": \"2\", \"title\": \"This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be\", \"level\": 1, \"text\": \"2. This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be made part of this Addendum to the extent that the amendments do not conflict therewith, unless otherwise agreed in writing by the Parties.\"}, {\"id\": \"3\", \"title\": \"Commencing on the Effective Date hereof, Xplore Products will be considered for all intents and purposes of the Distrib\", \"level\": 1, \"text\": \"3. Commencing on the Effective Date hereof, Xplore Products will be considered for all intents and purposes of the Distributor Agreement as Products and the purchase and sale thereof will be conducted in accordance with, and be subject to the terms and conditions of the Distributor Agreement, unless otherwise set out in this section: a. The actual sale of Xplore Products (or any part thereof) is subject to Zebra obtaining the relevant regulatory approvals for the sale of Xplore Products in and into the Market or Territory (or any portion thereof) and shall commence only upon the attainment of such approvals. b. Zebra Consolidated Global Limited Warranty posted at www.zebra.com/partnerconnect-tc or any equivalent website thereof, will not apply to Xplore Products which shall carry the warranty posted at: https://support.xploretech.com/us/support/warranty-specifications/.\"}, {\"id\": \"c\", \"title\": \"Certain operational aspects relating to the purchase of Xplore Products, will be governed by the terms and conditions o\", \"level\": 1, \"text\": \"c. Certain operational aspects relating to the purchase of Xplore Products, will be governed by the terms and conditions of Exhibit B, attached to this Addendum and incorporated therein by this reference. The terms of the Distribution Agreement will apply to all areas not covered by Exhibit B.\"}, {\"id\": \"4\", \"title\": \"By signing this Addendum, Xplore hereby agrees to be bound by the terms of the Distributor Agreement as a party thereto\", \"level\": 1, \"text\": \"4. By signing this Addendum, Xplore hereby agrees to be bound by the terms of the Distributor Agreement as a party thereto for the sole purpose of selling Xplore Products to Distributor. With the exception of the sale of Xplore Products, Xplore does not assume any obligations (prior, current or future) of Zebra under the Distributor Agreement.\"}, {\"id\": \"5\", \"title\": \"In the event of a conflict between the Distributor Agreement with this Addendum, the terms of this Addendum shall take\", \"level\": 1, \"text\": \"5. In the event of a conflict between the Distributor Agreement with this Addendum, the terms of this Addendum shall take precedence.\"}, {\"id\": \"6\", \"title\": \"Signature Counterparts\", \"level\": 1, \"text\": \"6. Signature Counterparts. This Addendum and any additional amendments of addenda to the Distribution Agreement may be executed in two or more of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. A facsimile copy or Computer image, such as a PDF or tiff image, of a signature shall be treated as and shall have the same effect as an original signature. In addition, a true and correct facsimile copy or computer image of this Addendum and any additional amendments of addenda thereto shall be treated as and shall have the same effect as an original signed copy of this document.\"}, {\"id\": \"7\", \"title\": \"Term and Termination\", \"level\": 1, \"text\": \"7. Term and Termination. This Addendum may be terminated at any time by either Party in accordance with the termination provisions of the Distribution Agreement. The Addendum shall not have an Initial Period.\"}, {\"id\": \"8\", \"title\": \"Governing Law and Dispute Resolution\", \"level\": 1, \"text\": \"8. Governing Law and Dispute Resolution. The terms of the Governing Law and Dispute Resolution provisions of the Distribution Agreement will apply to this Addendum. Source: SCANSOURCE, INC., 10-Q, 5/9/2019 IN WITNESS HEREOF, the Parties have executed this Addendum on the dates specified herein. ZEBRA TECHNOLOGIES INTERNATIONAL, LLC SCANSOURCE, INC. By: /s/ Alex Castaneda By: /s/ Brenda McCurry Name: Alex Castaneda Name: Brenda McCurry Title: VP NA Territory and Channel Sales Title: Vice President, Supplier Services Date: May 7, 2019 Date: 1/29/2019 ZEBRA TECHNOLOGIES DO BRASIL- COM\u00c9RCIO DE PRODUTOS DESCANSOURCE LATIN AMERICA, INC. By: By: /s/ Marcelo Hirsch Name: Vanderlei Ferreira Name: Marcelo Hirsch Title: Director Title: Managing Director Date: May 8, 2019 Date: 2/7/2019 XPLORE TECHNOLOGIES CORPORATION OF AMERICA SCANSOURCE DE MEXICO S. DE R.L. DE C.V. By: /s/ Alex Castaneda By: /s/ Victor Perez Name: Alex Castaneda Name: Victor Perez Title: VP NA Territory and Channel Sales Title: Country Manager Date: May 7, 2019 Date: 26/2/19 SCANSOURCE BRASIL DISTRIBUIDORA DE TECHNOLOGIAS LTDA. By: /s/ Paulo Roberto Ferreira Name: Paulo Roberto Ferreira Title: Executive Director Date: 22/02/19 Source: SCANSOURCE, INC., 10-Q, 5/9/2019 EXHIBIT A Xplore Products and Distributor Upfront Discounts off List Price therefore [*****] [*****] [*****] L10 [*****] [*****] R12 [*****] [*****] F5 [*****] [*****] C5 [*****] [*****] B10 [*****] [*****] D10 [*****] [*****] Bobcat [*****] [*****] XC6 [*****] [*****] M60 [*****] [*****] Accessories & Services [*****] [*****]\"}, {\"id\": \"EXHIBIT B\", \"title\": \"Operational Terms for Purchase of Xplore Products\", \"level\": 1, \"text\": \"EXHIBIT B Operational Terms for Purchase of Xplore Products\"}, {\"id\": \"ARTICLE I\", \"title\": \"PURCHASE ORDERS AND STOCK ON HAND\", \"level\": 1, \"text\": \"ARTICLE I. PURCHASE ORDERS AND STOCK ON HAND\"}, {\"id\": \"1\", \"title\": \"Issuance and Acceptance of Purchase Order\", \"level\": 1, \"text\": \"1. Issuance and Acceptance of Purchase Order. To order the Xplore Products, Distributor shall place a purchase order via sending an email to xpldistributors@zebra.com. Each purchase order shall specify the bill-to address, ship-to address, quantity and description of each Xplore Product ordered, the unit price for each Xplore Product, the requested ship date, the preferred means of delivery, and tax-exempt certifications, if any. Orders received without this information or which contain any discrepancy may be returned to Distributor for completion or revision as applicable. Each purchase order placed by Distributor, as well as each invoice sent by Xplore, shall be governed by the terms of this Addendum and the Distribution Agreement and any additional or different terms within the purchase order or invoice shall have no effect. Each purchase order for the Xplore Products shall be subject to Xplore's acceptance and, upon acceptance, Xplore shall confirm the purchase order and the Estimated Shipping Date with Distributor. Notwithstanding such acceptance, Xplore reserves the right where necessary to amend the Orders including without limitation part numbers, special pricing and Estimated Shipping Date, and may at its sole discretion require an amended Order from Distributor incorporating such changes. For the purposes of this Exhibit B, \\\"Estimated Shipping Date\\\" shall mean the estimated shipping date of an accepted purchase order.\"}, {\"id\": \"2\", \"title\": \"Purchase Order Rescheduling, Cancellation and Modification\", \"level\": 1, \"text\": \"2. Purchase Order Rescheduling, Cancellation and Modification. Distributor has the right to cancel, reschedule or modify all or any portion of a purchase order that has been accepted by Xplore at no cost to Distributor only if such cancellation or modification request is made within [*****] business days of PO acceptance or rescheduling request is made at least [*****] business days prior to the most current Estimated Shipping Date for that purchase order. Distributor has the right to change the destination of all or any portion of a purchase order that has been accepted by Xplore at no cost to Distributor only if such change in destination request is made at least [*****] business days prior to the most current Estimated Shipping Date for that purchase order. Except as set forth above, purchase orders are non-changeable and non- cancellable by Distributor, once accepted by Xplore. Certain purchase orders, determined at Xplore's sole discretion, and generally of large volume and/or extended lead times, may be subject to alternative rescheduling, cancellation, and modification rights. Should such purchase orders be subject to alternative rights, Xplore shall inform Distributor of alternative rights prior to order acceptance. Distributor will then have [*****] business days to accept, or reject, the alternative terms of Xplore for that certain purchase order. If Distributor rejects such alternative terms, the purchase order will not be accepted by Xplore.\"}, {\"id\": \"3\", \"title\": \"Product Allocation\", \"level\": 1, \"text\": \"3. Product Allocation. If for any reason, Xplore's production is not on schedule, Xplore may, at its sole and absolute discretion, allocate available inventory to Distributor and make shipments in accordance with Zebra's then current processes. Source: SCANSOURCE, INC., 10-Q, 5/9/2019\"}, {\"id\": \"4\", \"title\": \"Stock on Hand\", \"level\": 1, \"text\": \"4. Stock on Hand. Distributor shall use commercially reasonable efforts to maintain thirty (30) days of stock in Distributor's inventory to support sales. Xplore acknowledges that from time to time, Distributor's inventory levels may fall below the thirty (30) days goal that is agreed upon by both Parties. If inventory levels fall below the thirty (30) day goal for more than sixty (60) consecutive days, Xplore, upon written notice to Distributor, shall replenish the stock to an amount agreed by both Parties.\"}, {\"id\": \"5\", \"title\": \"Product Return and Stock Rotation\", \"level\": 1, \"text\": \"5. Product Return and Stock Rotation. The terms of Section 3 of Schedule 2 of the Distribution Agreement will apply to Xplore Products, provided however that stock rotation allowance for Xplore Products will be based on the net dollar value of Distributor's purchases in each calendar quarter of Xplore Products and such allowance will be calculated separate and apart from all other Products purchased by Distributor during such period.\"}, {\"id\": \"ARTICLE II\", \"title\": \"DELIVERY OF PRODUCTS\", \"level\": 1, \"text\": \"ARTICLE II. DELIVERY OF PRODUCTS\"}, {\"id\": \"1\", \"title\": \"Shipping Terms\", \"level\": 1, \"text\": \"1. Shipping Terms. Notwithstanding anything to the contrary contained in the Distribution Agreement, and unless notified by Xplore otherwise, shipping terms for Xplore Products will be Delivery Duty Paid (DDP) INCOTERMS\u00ae 2010, whereby Distributor's price, includes all costs of delivery, insurance, import and / or export duties and tariffs. Such prices are exclusive of all federal, state, municipal or other government excise, sales, use, occupational or like taxes in force, and any such taxes shall be assumed and paid for by Distributor in addition to its payment for the Xplore Products. Title and risk of loss to Xplore Products shall pass to Distributor upon delivery to Distributor, as indicated in the Proof of Delivery (PoD) documents. [*****]\"}, {\"id\": \"1\", \"title\": \"At Distributor's request, Xplore may deliver Xplore Products directly to Program Members or their respective End Users\", \"level\": 1, \"text\": \"1. At Distributor's request, Xplore may deliver Xplore Products directly to Program Members or their respective End Users on behalf of Distributor, and in such instances title and risk of loss will pass to Distributor upon delivery to the applicable recipients, as indicated on the PoD documents. Some exclusions may apply, including countries not served by Xplore shipping and importing methods, and/or countries where Xplore Products, are not certified for resale and/or use.\"}, {\"id\": \"1\", \"title\": \"Proof of Delivery (\\\"POD\\\")\", \"level\": 1, \"text\": \"1. Proof of Delivery (\\\"POD\\\"). Xplore shall provide to Distributor, at no charge, a means for confirming proof of delivery for Xplore Product shipments when requested by Distributor. Xplore shall provide packing slips for all shipments. Source: SCANSOURCE, INC., 10-Q, 5/9/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ScansourceInc_20190509_10-Q_EX-10.2_11661422_EX-10.2_Distributor Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.2\", \"level\": 1, \"text\": \"Exhibit 10.2 IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****]. ZEBRA\u00ae PARTNERCONNECT PROGRAM ADDENDUM TO ZEBRA\u00ae PARTNERCONNECT DISTRIBUTOR AGREEMENT THIS ADDENDUM (\\\"Addendum\\\") is made on the 4th day of February 2019 (\\\"Effective Date\\\") between the following parties: Zebra Technologies International, LLC, with an office at 3 Overlook Point, Lincolnshire IL 60069 (\\\"Zebra\\\"); Zebra Technologies do Brasil - Com\u00e9rcio de Produtos de Inform\u00e5tica Ltda., a company incorporated and organized under the laws of Brazil, with offices at Av. Magalh\u00e4es de Castro, 4800, sala 72-A, Cidade Jardim, CEP 05676-120, S\u00e4o Paulo, sp (\\\"Zebra Brazil\\\") Xplore Technologies Corporation of America, a company with its principal place of business at 8601 RR 2222, Building 2, Suite #100, Austin, Texas 78730, U.S.A. (\\\"Xplore\\\"); (collectively \\\"Zebra\\\") AND ScanSource, Inc., a company incorporated in South Carolina, with its registered office at 6 Logue Court, Greenville, South Carolina 29615 (\\\"ScanSource\\\"). ScanSource Latin America, Inc. a ScanSource Affiliate incorporated in Florida, whose registered business address is 1935 NW 87 Avenue, Miami, Florida 33172 (\\\"ScanSource Latin America\\\") ScanSource Brazil Distribuidora de Technologias, Ltda., a ScanSource Affiliate incorporated and organized under the laws of Brazil, with offices in the City of S\u00e4o Jos\u00e9 dos Pinhais, State of Paran\u00e5, at Avenida Rui Barbosa, 2529, Modulos 11 and 12, Bairro Jardim Ip\u00e9, CEP: 83055-320, enrolled with the Taxpayer Register (CNPJ/MF) under No. 05.607.657/0001-35 (\\\"ScanSource Brazil\\\") SCANSOURCE DE MEXICO S. DE R.L. DE C.V., a ScanSource Affiliate incorporated in Mexico, whose registered business address is Calle 4 No. 298, Colonia Franccionamiento Industrial Alce Blanco, Naucalpan de Juarez, Estado de M\u00e9xico 53370 (\\\"ScanSource Mexico\\\") (Collectively \\\"Distributor') \\\"Zebra\\\" and the \\\"Distributor\\\" are referred to collectively as 'Parties\\\" and individually as a \\\"Party\\\". WHEREAS: (A) On February 12, 2014 the Parties entered into an agreement that was renamed, as of April 11, 2016, to: PartnerConnectTM EVM Distribution Agreement, (as amended) (\\\"Distribution Agreement\\\"), which relates to Zebra Enterprise Visibility and Mobility ('EVM\\\") products and services, and which, as acknowledged by the Parties by entering into this Amendment, is in full force and effect and valid as when this Amendment is executed; (B) Distributor purchases Products from Zebra under the Distributor Agreement; (C)\u200b Zebra has recently completed the acquisition of Xplore, which transaction closed on August 14, 2018; (D) Zebra has expanded its products portfolio by adding the product families listed in Exhibit A, that as of the Effective Date hereof are branded Xplore or Motion Computing, thereto (\\\"Xplore Products\\\"); (E) Xplore, now a Zebra Affiliate, is the seller of Xplore Products; Source: SCANSOURCE, INC., 10-Q, 5/9/2019 (F) Xplore wishes to sell Xplore Products to Distributor and Distributor wishes to purchase such products from Xplore pursuant to the terms and conditions of the Distributor Agreement by entering into this Addendum; and (G) The Parties desire to amend the Distributor Agreement by adding Xplore Products and authorizing Distributor to purchase such products from Xplore for further resale to members of the Zebra PartnerConnect Program in the Market or Territory. THEREFORE, in consideration of the mutual covenants and promises, and subject to the terms and conditions of the Distributor Agreement, the Parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the c\", \"level\": 1, \"text\": \"1. Expressions used in this Addendum shall have the same meanings given to them in the Distributor Agreement, unless the context requires otherwise.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be\", \"level\": 1, \"text\": \"2. This Addendum automatically incorporates any future amendments to the Distributor Agreement and such amendments will be made part of this Addendum to the extent that the amendments do not conflict therewith, unless otherwise agreed in writing by the Parties.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Commencing on the Effective Date hereof, Xplore Products will be considered for all intents and purposes of the Distrib\", \"level\": 1, \"text\": \"3. Commencing on the Effective Date hereof, Xplore Products will be considered for all intents and purposes of the Distributor Agreement as Products and the purchase and sale thereof will be conducted in accordance with, and be subject to the terms and conditions of the Distributor Agreement, unless otherwise set out in this section: a. The actual sale of Xplore Products (or any part thereof) is subject to Zebra obtaining the relevant regulatory approvals for the sale of Xplore Products in and into the Market or Territory (or any portion thereof) and shall commence only upon the attainment of such approvals. b. Zebra Consolidated Global Limited Warranty posted at www.zebra.com/partnerconnect-tc or any equivalent website thereof, will not apply to Xplore Products which shall carry the warranty posted at: https://support.xploretech.com/us/support/warranty-specifications/.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Certain operational aspects relating to the purchase of Xplore Products, will be governed by the terms and conditions o\", \"level\": 1, \"text\": \"c. Certain operational aspects relating to the purchase of Xplore Products, will be governed by the terms and conditions of Exhibit B, attached to this Addendum and incorporated therein by this reference. The terms of the Distribution Agreement will apply to all areas not covered by Exhibit B.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"By signing this Addendum, Xplore hereby agrees to be bound by the terms of the Distributor Agreement as a party thereto\", \"level\": 1, \"text\": \"4. By signing this Addendum, Xplore hereby agrees to be bound by the terms of the Distributor Agreement as a party thereto for the sole purpose of selling Xplore Products to Distributor. With the exception of the sale of Xplore Products, Xplore does not assume any obligations (prior, current or future) of Zebra under the Distributor Agreement.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of a conflict between the Distributor Agreement with this Addendum, the terms of this Addendum shall take\", \"level\": 1, \"text\": \"5. In the event of a conflict between the Distributor Agreement with this Addendum, the terms of this Addendum shall take precedence.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Signature Counterparts\", \"level\": 1, \"text\": \"6. Signature Counterparts. This Addendum and any additional amendments of addenda to the Distribution Agreement may be executed in two or more of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. A facsimile copy or Computer image, such as a PDF or tiff image, of a signature shall be treated as and shall have the same effect as an original signature. In addition, a true and correct facsimile copy or computer image of this Addendum and any additional amendments of addenda thereto shall be treated as and shall have the same effect as an original signed copy of this document.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term and Termination\", \"level\": 1, \"text\": \"7. Term and Termination. This Addendum may be terminated at any time by either Party in accordance with the termination provisions of the Distribution Agreement. The Addendum shall not have an Initial Period.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law and Dispute Resolution\", \"level\": 1, \"text\": \"8. Governing Law and Dispute Resolution. The terms of the Governing Law and Dispute Resolution provisions of the Distribution Agreement will apply to this Addendum. Source: SCANSOURCE, INC., 10-Q, 5/9/2019 IN WITNESS HEREOF, the Parties have executed this Addendum on the dates specified herein. ZEBRA TECHNOLOGIES INTERNATIONAL, LLC SCANSOURCE, INC. By: /s/ Alex Castaneda By: /s/ Brenda McCurry Name: Alex Castaneda Name: Brenda McCurry Title: VP NA Territory and Channel Sales Title: Vice President, Supplier Services Date: May 7, 2019 Date: 1/29/2019 ZEBRA TECHNOLOGIES DO BRASIL- COM\u00c9RCIO DE PRODUTOS DESCANSOURCE LATIN AMERICA, INC. By: By: /s/ Marcelo Hirsch Name: Vanderlei Ferreira Name: Marcelo Hirsch Title: Director Title: Managing Director Date: May 8, 2019 Date: 2/7/2019 XPLORE TECHNOLOGIES CORPORATION OF AMERICA SCANSOURCE DE MEXICO S. DE R.L. DE C.V. By: /s/ Alex Castaneda By: /s/ Victor Perez Name: Alex Castaneda Name: Victor Perez Title: VP NA Territory and Channel Sales Title: Country Manager Date: May 7, 2019 Date: 26/2/19 SCANSOURCE BRASIL DISTRIBUIDORA DE TECHNOLOGIAS LTDA. By: /s/ Paulo Roberto Ferreira Name: Paulo Roberto Ferreira Title: Executive Director Date: 22/02/19 Source: SCANSOURCE, INC., 10-Q, 5/9/2019 EXHIBIT A Xplore Products and Distributor Upfront Discounts off List Price therefore [*****] [*****] [*****] L10 [*****] [*****] R12 [*****] [*****] F5 [*****] [*****] C5 [*****] [*****] B10 [*****] [*****] D10 [*****] [*****] Bobcat [*****] [*****] XC6 [*****] [*****] M60 [*****] [*****] Accessories & Services [*****] [*****]\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Operational Terms for Purchase of Xplore Products\", \"level\": 1, \"text\": \"EXHIBIT B Operational Terms for Purchase of Xplore Products\"}}, {\"id\": \"ARTICLE I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PURCHASE ORDERS AND STOCK ON HAND\", \"level\": 1, \"text\": \"ARTICLE I. PURCHASE ORDERS AND STOCK ON HAND\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Issuance and Acceptance of Purchase Order\", \"level\": 1, \"text\": \"1. Issuance and Acceptance of Purchase Order. To order the Xplore Products, Distributor shall place a purchase order via sending an email to xpldistributors@zebra.com. Each purchase order shall specify the bill-to address, ship-to address, quantity and description of each Xplore Product ordered, the unit price for each Xplore Product, the requested ship date, the preferred means of delivery, and tax-exempt certifications, if any. Orders received without this information or which contain any discrepancy may be returned to Distributor for completion or revision as applicable. Each purchase order placed by Distributor, as well as each invoice sent by Xplore, shall be governed by the terms of this Addendum and the Distribution Agreement and any additional or different terms within the purchase order or invoice shall have no effect. Each purchase order for the Xplore Products shall be subject to Xplore's acceptance and, upon acceptance, Xplore shall confirm the purchase order and the Estimated Shipping Date with Distributor. Notwithstanding such acceptance, Xplore reserves the right where necessary to amend the Orders including without limitation part numbers, special pricing and Estimated Shipping Date, and may at its sole discretion require an amended Order from Distributor incorporating such changes. For the purposes of this Exhibit B, \\\"Estimated Shipping Date\\\" shall mean the estimated shipping date of an accepted purchase order.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Order Rescheduling, Cancellation and Modification\", \"level\": 1, \"text\": \"2. Purchase Order Rescheduling, Cancellation and Modification. Distributor has the right to cancel, reschedule or modify all or any portion of a purchase order that has been accepted by Xplore at no cost to Distributor only if such cancellation or modification request is made within [*****] business days of PO acceptance or rescheduling request is made at least [*****] business days prior to the most current Estimated Shipping Date for that purchase order. Distributor has the right to change the destination of all or any portion of a purchase order that has been accepted by Xplore at no cost to Distributor only if such change in destination request is made at least [*****] business days prior to the most current Estimated Shipping Date for that purchase order. Except as set forth above, purchase orders are non-changeable and non- cancellable by Distributor, once accepted by Xplore. Certain purchase orders, determined at Xplore's sole discretion, and generally of large volume and/or extended lead times, may be subject to alternative rescheduling, cancellation, and modification rights. Should such purchase orders be subject to alternative rights, Xplore shall inform Distributor of alternative rights prior to order acceptance. Distributor will then have [*****] business days to accept, or reject, the alternative terms of Xplore for that certain purchase order. If Distributor rejects such alternative terms, the purchase order will not be accepted by Xplore.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Allocation\", \"level\": 1, \"text\": \"3. Product Allocation. If for any reason, Xplore's production is not on schedule, Xplore may, at its sole and absolute discretion, allocate available inventory to Distributor and make shipments in accordance with Zebra's then current processes. Source: SCANSOURCE, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Stock on Hand\", \"level\": 1, \"text\": \"4. Stock on Hand. Distributor shall use commercially reasonable efforts to maintain thirty (30) days of stock in Distributor's inventory to support sales. Xplore acknowledges that from time to time, Distributor's inventory levels may fall below the thirty (30) days goal that is agreed upon by both Parties. If inventory levels fall below the thirty (30) day goal for more than sixty (60) consecutive days, Xplore, upon written notice to Distributor, shall replenish the stock to an amount agreed by both Parties.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Return and Stock Rotation\", \"level\": 1, \"text\": \"5. Product Return and Stock Rotation. The terms of Section 3 of Schedule 2 of the Distribution Agreement will apply to Xplore Products, provided however that stock rotation allowance for Xplore Products will be based on the net dollar value of Distributor's purchases in each calendar quarter of Xplore Products and such allowance will be calculated separate and apart from all other Products purchased by Distributor during such period.\"}}, {\"id\": \"ARTICLE II\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DELIVERY OF PRODUCTS\", \"level\": 1, \"text\": \"ARTICLE II. DELIVERY OF PRODUCTS\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shipping Terms\", \"level\": 1, \"text\": \"1. Shipping Terms. Notwithstanding anything to the contrary contained in the Distribution Agreement, and unless notified by Xplore otherwise, shipping terms for Xplore Products will be Delivery Duty Paid (DDP) INCOTERMS\u00ae 2010, whereby Distributor's price, includes all costs of delivery, insurance, import and / or export duties and tariffs. Such prices are exclusive of all federal, state, municipal or other government excise, sales, use, occupational or like taxes in force, and any such taxes shall be assumed and paid for by Distributor in addition to its payment for the Xplore Products. Title and risk of loss to Xplore Products shall pass to Distributor upon delivery to Distributor, as indicated in the Proof of Delivery (PoD) documents. [*****]\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"At Distributor's request, Xplore may deliver Xplore Products directly to Program Members or their respective End Users\", \"level\": 1, \"text\": \"1. At Distributor's request, Xplore may deliver Xplore Products directly to Program Members or their respective End Users on behalf of Distributor, and in such instances title and risk of loss will pass to Distributor upon delivery to the applicable recipients, as indicated on the PoD documents. Some exclusions may apply, including countries not served by Xplore shipping and importing methods, and/or countries where Xplore Products, are not certified for resale and/or use.\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Proof of Delivery (\\\"POD\\\")\", \"level\": 1, \"text\": \"1. Proof of Delivery (\\\"POD\\\"). Xplore shall provide to Distributor, at no charge, a means for confirming proof of delivery for Xplore Product shipments when requested by Distributor. Xplore shall provide packing slips for all shipments. Source: SCANSOURCE, INC., 10-Q, 5/9/2019\"}}, {\"id\": \"term:CONFIDENTIAL INFORMATION\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CONFIDENTIAL INFORMATION\", \"text\": \"CERTAIN IDENTIFIED INFORMATION\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Addendum\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Addendum\", \"text\": \"THIS ADDENDUM\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the 4th day of February 2019\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Distribution Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distribution Agreement\", \"text\": \"PartnerConnectTM EVM Distribution Agreement, (as amended)\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:EVM\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EVM\", \"text\": \"Zebra Enterprise Visibility and Mobility\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Xplore Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Xplore Products\", \"text\": \"the product families listed in Exhibit A, that as of the Effective Date hereof are branded Xplore or Motion Computing, thereto\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"\\\"Zebra\\\" and the \\\"Distributor\\\" are referred to collectively as 'Parties\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"\\\"Zebra\\\" and the \\\"Distributor\\\" are referred to ... individually as a \\\"Party\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Estimated Shipping Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Estimated Shipping Date\", \"text\": \"the estimated shipping date of an accepted purchase order\", \"definition_clause\": \"1\"}}, {\"id\": \"term:POD\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"POD\", \"text\": \"Proof of Delivery\", \"definition_clause\": \"1\"}}, {\"id\": \"party:Zebra Technologies International, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Zebra Technologies International, LLC\", \"role\": \"Zebra\", \"address\": \"3 Overlook Point, Lincolnshire IL 60069\"}}, {\"id\": \"party:Zebra Technologies do Brasil - Com\u00e9rcio de Produtos de Inform\u00e5tica Ltda.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Zebra Technologies do Brasil - Com\u00e9rcio de Produtos de Inform\u00e5tica Ltda.\", \"role\": \"Zebra Brazil\", \"address\": \"Av. Magalh\u00e4es de Castro, 4800, sala 72-A, Cidade Jardim, CEP 05676-120, S\u00e4o Paulo, sp\"}}, {\"id\": \"party:Xplore Technologies Corporation of America\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Xplore Technologies Corporation of America\", \"role\": \"Xplore\", \"address\": \"8601 RR 2222, Building 2, Suite #100, Austin, Texas 78730, U.S.A.\"}}, {\"id\": \"party:Zebra\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Zebra\", \"role\": \"Zebra\", \"address\": null}}, {\"id\": \"party:ScanSource, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ScanSource, Inc.\", \"role\": \"ScanSource\", \"address\": \"6 Logue Court, Greenville, South Carolina 29615\"}}, {\"id\": \"party:ScanSource Latin America, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ScanSource Latin America, Inc.\", \"role\": \"ScanSource Latin America\", \"address\": \"1935 NW 87 Avenue, Miami, Florida 33172\"}}, {\"id\": \"party:ScanSource Brazil Distribuidora de Technologias, Ltda.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ScanSource Brazil Distribuidora de Technologias, Ltda.\", \"role\": \"ScanSource Brazil\", \"address\": \"City of S\u00e4o Jos\u00e9 dos Pinhais, State of Paran\u00e5, at Avenida Rui Barbosa, 2529, Modulos 11 and 12, Bairro Jardim Ip\u00e9, CEP: 83055-320, enrolled with the Taxpayer Register (CNPJ/MF) under No. 05.607.657/0001-35\"}}, {\"id\": \"party:SCANSOURCE DE MEXICO S. DE R.L. DE C.V.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"SCANSOURCE DE MEXICO S. DE R.L. DE C.V.\", \"role\": \"ScanSource Mexico\", \"address\": \"Calle 4 No. 298, Colonia Franccionamiento Industrial Alce Blanco, Naucalpan de Juarez, Estado de M\u00e9xico 53370\"}}, {\"id\": \"party:Distributor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Distributor\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:sixty (60) consecutive days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) consecutive days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement1\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement1.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.38\", \"level\": 1, \"text\": \"Exhibit 10.38 IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****]. CISCO SYSTEMS, INC. NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT This Nonexclusive Value Added Distributor Agreement (\\\"Agreement\\\"), between ScanSource, Inc., a South Carolina corporation, with its principal place of business at 6 Logue Court, Greenville, South Carolina, 29615 (\\\"Distributor\\\"), and Cisco Systems, Inc., a California corporation with its principal place of business at 170 West Tasman Drive, San Jose, California 95134 - 1706, (\\\"Cisco\\\") is entered into as of the date last written below (\\\"the Effective Date\\\"). This Agreement consists of this signature page and the following attachments, each of which is incorporated into this Agreement by reference:\"}, {\"id\": \"1\", \"title\": \"Nonexclusive Value Added Distributor Agreement Terms and Conditions 2\", \"level\": 1, \"text\": \"1. Nonexclusive Value Added Distributor Agreement Terms and Conditions 2. EXHIBIT A: Territory 3. EXHIBIT B: Value Added Distributor Support Exhibit 3.1 Appendix 1: Cisco Problem Prioritization and Escalation Guideline 4. EXHIBIT C: Software License Agreement 5. EXHIBIT D: Distributor Freight Policy 6. EXHIBIT E: Affiliate List 7. EXHIBIT F: Software Transfer and Relicensing Policy 8. EXHIBIT G: End of Life Policy This Agreement is the complete agreement between the parties hereto concerning the subject matter of this Agreement and replaces any prior or contemporaneous oral or written communications between the parties. In the event of conflict between the terms of this Agreement and the terms of an Exhibit hereto, the terms of the Exhibit shall govern. There are no conditions, understandings, agreements, representations or warranties, express or implied, which are not specified herein. This Agreement may only be modified by a written document executed by the parties hereto. IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed. Each party warrants and represents that its respective signatories whose signatures appear below have been and are on the date of signature duly authorized to execute this Agreement. ScanSource,Inc. (\\\"Distributor\\\") Cisco Systems, Inc. (\\\"Cisco\\\") By: /s/ Jeffrey E. Yelton By: /s/ Frank A. Calderon Name: Jeffrey E. Yelton Name: Frank A . Calderon Title: VP Merchandising Title: VP, WW Sales Finance Date: 1/19/07 Date: January 22, 2007 Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT TERMS AND CONDITIONS\"}, {\"id\": \"1.0\", \"title\": \"DEFINITIONS\", \"level\": 2, \"text\": \"1.0 DEFINITIONS. Affiliate(s) are the entities listed on Exhibit E to this Agreement that are either business units of Distributor (and therefore wholly-owned and a part of Distributor) or are wholly-owned subsidiaries of Distributor, but in either case, only for so long as ownership remains as defined in this provision. Cisco Quarter shall mean Cisco's fiscal quarters (August 1-October 31; November 1-January 31; February 1-April 30; and May 1-July 31). Documentation shall mean user manuals, training materials, Product descriptions and specifications, technical manuals, license agreements, supporting materials and other printed information relating to any Product, whether distributed in print, in electronic form, or in CD-ROM or video format. End User is the final purchaser or licensee who has acquired Products for its own internal use and not for resale, remarketing or redistribution. An entity that performs stocking, sparing or warehousing activities for third parties or procures Cisco Products, Services or Software for delivery to third parties is not an End User. Global Price List means a complete listing of those Cisco products, services, including products and services which Cisco may make available to Distributor at its sole discretion, and associated prices. Hardware is the tangible product made available to Distributor. Major Release or New Release means a release of Software which is designated by Cisco as a change in the ones digit in the Software version number [(x).x.x]. Non-Genuine Products are any and all products: (i) to which a Mark or other Cisco trademark or service mark has been affixed without Cisco's consent; (ii) that have not been manufactured by Cisco or Cisco Technologies, Inc. (\\\"CTI\\\") or by a licensed manufacturer of either Cisco or CTI in accordance with the applicable license; or (iii) are produced with the intent to counterfeit or imitate a genuine Cisco Product Obsolete Product shall mean any Product that is removed from the then-current Value Added Distributor Price List. Purchase Order is a written or electronic order from Distributor to Cisco for Hardware, Software or Services to be purchased, licensed or provided under this Agreement. Product means, individually or collectively as appropriate, Hardware, licensed Software, Documentation, developed products, supplies, accessories, and goods to the foregoing, listed on the then-current published Global Price List. Reseller means an authorized reseller of Distributor that meets Cisco's then-current requirements for resellers, including, without limitation, the requirements set out in Section 26.0 of this Agreement. In the event Cisco enters into authorization agreements whereby Cisco authorizes particular resellers to purchase Products or Services from Distributor and to resell Products or Services to End User, then \\\"Reseller\\\" shall mean a reseller that is a party to such an authorization agreement. Services means Cisco's SmartNet family of packaged service offerings, as well as such other service offerings as Cisco makes available for purchase by Distributor on Cisco's Wholesale or Global Price List. Software is the machine readable (object code) version of the computer programs listed from time to time on the Wholesale or Global Price List and made available by Cisco for license by Distributor, and any copies or Updates thereof. Cisco reserves the right, during the term of this Agreement, to license and distribute items of Software from time to time. Such items of Software may be licensed under additional or different policies and license terms, which will be made available to Distributor. Notwithstanding the use of the term \\\"purchase\\\" to refer to any item of Software comprising or included within a Product, Cisco and Distributor agree that all Software provided by Cisco to Distributor under this Agreement is licensed by Cisco to Distributor rather than purchased by Distributor from Cisco. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 Territory is comprised of those regions or countries listed in Exhibit A. Unauthorized Cisco Product means any genuine Cisco Product or Cisco Service that Distributor purchases or acquires from any party other than Cisco and/or an Approved Source. Unauthorized Cisco Products do not include Non-Genuine Products. Update means a bug fix, error correction, patch or workaround for the Software which is provided by Cisco to Distributor in response to Distributor's request, or at Cisco's option, which Cisco chooses to provide to Distributor. Value Added Distributor Price List shall mean a portion of the Global Price List containing Products which Cisco makes available to Distributor for stocking and the prices at which Cisco will sell such Products to Distributor.\"}, {\"id\": \"2.0\", \"title\": \"SCOPE\", \"level\": 2, \"text\": \"2.0 SCOPE. This Agreement and the attached Exhibits set forth the terms and conditions for Distributor's purchase of Hardware and license of Software, and redistribution of Products, during the term of this Agreement. Affiliates of Distributor listed on Exhibit E may purchase Products, solely for redistribution, from Cisco under this Agreement. Distributor hereby guarantees the performance by such Affiliates of the financial and other contractual obligations set forth in this Agreement and represents and warrants that it is empowered to enter into this Agreement on behalf of such Affiliates, and to bind (and does so bind) such Affiliates to the terms and conditions of this Agreement. Cisco may require certain of the listed Affiliates to execute an agreement with Cisco or an affiliate of Cisco such that the legal relationship shall be between Cisco or Cisco's affiliate and Distributor's Affiliate. Any breach by Distributor or by an Affiliate of (i) this Agreement, or (ii) any other agreement between Cisco and Distributor or an Affiliate of either party, shall entitle Cisco to terminate this Agreement and/or any such agreement with Affiliate and/or any other Affiliate pursuant to Section 18. The limit of liability set forth in this Agreement shall be deemed an aggregate limit of liability, not per Affiliate, regardless of whether an Affiliate or Affiliates has executed a separate agreement with Cisco or a Cisco Affiliate permitting such Affiliate to purchase under the terms of this Agreement. In addition, any reporting requirements hereunder shall be performed solely by Distributor. All reporting information related to Distributor or any Affiliate(s) shall be aggregated and submitted as part of a single report, as required herein.\"}, {\"id\": \"3.0\", \"title\": \"APPOINTMENT OF DISTRIBUTOR\", \"level\": 2, \"text\": \"3.0 APPOINTMENT OF DISTRIBUTOR. 3.1 By this Agreement, Cisco makes, and Distributor accepts, the appointment of Distributor as an authorized, non-exclusive distributor of Products and Services to Resellers located in the Territory. Distributor agrees to use its best efforts to distribute Product solely to Resellers located in the Territory. Those Resellers may resell Product only to End Users who intend to use the Product in the Territory. All Resellers to which Distributor distributes Product must meet Cisco's then-current guidelines for Resellers, as amended from time to time.\"}, {\"id\": \"3.2\", \"title\": \"Distributor is authorized to resell only those Products and Services which are listed on the Value Added Distributor Pri\", \"level\": 2, \"text\": \"3.2 Distributor is authorized to resell only those Products and Services which are listed on the Value Added Distributor Price List. Notwithstanding the foregoing, Cisco may, in its discretion, make available for purchase and resale by Distributor, but not for stocking by Distributor, certain other products and/or services which are listed on the Global Price List. Upon such products or services being made available to Distributor, such products and services will be deemed to be Products and Services as defined herein.\"}, {\"id\": \"3.3\", \"title\": \"Products Requirements\", \"level\": 2, \"text\": \"3.3 Products Requirements. For new Products or Services added to the Global or Value Added Distributor Price List, including products or services which become available to Cisco as a result of an acquisition by Cisco of another entity, Cisco may impose certification, installation, or training requirements on Distributor prior to allowing Distributor to purchase, resell, or provide support for such Products or Services.\"}, {\"id\": \"3.4\", \"title\": \"Distributor agrees not to solicit orders for Products or Services, or to engage salespeople or establish warehouses or o\", \"level\": 2, \"text\": \"3.4 Distributor agrees not to solicit orders for Products or Services, or to engage salespeople or establish warehouses or other distribution centers for the redistribution of Products or Services, outside the Territory, except to the extent advertising is placed in a particular advertising medium (except catalogs) which is distributed both inside and outside of the Territory. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}, {\"id\": \"3.5\", \"title\": \"Unauthorized Cisco Products\", \"level\": 2, \"text\": \"3.5 Unauthorized Cisco Products. Distributor acknowledges that the purchase and Resale of Non-Genuine or Unauthorized Cisco Products are not within the scope of this Agreement and Integrator is not entitled to the rights granted herein with respect to the resale of such Non-Genuine or Unauthorized Cisco Products. For all Unauthorized Cisco Products, Cisco reserves the right to withhold any warranty or Cisco Support on such products, unless such products pass a Cisco equipment inspection and Cisco receives payment for the applicable equipment inspection and/or software license fees, as required in the then\u200b current Software Transfer and Licensing Policy. A printed copy of the Software Transfe and Licensing Policy, in effect on the Effective Date of this Agreement and available at http://www.cisco.com/warp/public/csc/refurb_equipment/swpolicy.html, shall accompany this agreement. This policy is subject to change without notice. If Cisco determines that Reseller has Resold and/or redistributed Unauthorized Cisco Products purchased from Unauthorized Sources, then Cisco may, at Cisco's sole discretion: (a) audit Reseller's purchase and resale records of Cisco Product and relevant records pursuant to Section 17.0 (Reports and Records) and/or (b) invoice Reseller for all reasonable costs incurred by Cisco in its performance of the Audit and/or (c) suspend all Product shipments to Reseller.\"}, {\"id\": \"4.0\", \"title\": \"ORDERS\", \"level\": 2, \"text\": \"4.0 ORDERS. 4.1 Upon and subject to credit approval by Cisco at the time of Cisco's receipt of any Purchase Order, Distributor shall purchase or license Products or Services by issuing a Purchase Order, signed, if requested by Cisco, or (in the case of electronic transmission) sent by its authorized representative, indicating specific Products and Services, Cisco Product numbers, quantity, unit price, total purchase price, shipping instructions, requested shipping dates, bill-to and ship-to addresses, tax exempt certifications, if applicable and contract reference, if any. No contingency contained on any Purchase Order shall be binding upon Cisco. The terms of this Agreement shall apply, regardless of any additional or conflicting terms on any Purchase Order or other correspondence or documentation submitted by Distributor to Cisco, and any such additional or conflicting terms are deemed rejected by Cisco.\"}, {\"id\": \"4.2\", \"title\": \"Cisco shall use commercially reasonable efforts to provide order acknowledgement information within [*****] business day\", \"level\": 2, \"text\": \"4.2 Cisco shall use commercially reasonable efforts to provide order acknowledgement information within [*****] business days for all Purchase Orders placed on Cisco.com or within [*****] business days of Purchase Orders faxed or hand delivered to Cisco. Cisco Customer Service will review and accept or decline all Purchase Orders for the Cisco entity that will supply the Products or Services, and no other person is authorized to accept Purchase Orders on behalf of Cisco. Cisco Customer Service may accept a Purchase Order even if some of the information required by Section 4.1 above is missing or incomplete. In relation to Services, Cisco will confirm acceptance of a Purchase Order for Services by issuing a list of Products covered by such Services (the \\\"Equipment List\\\").\"}, {\"id\": \"4.3\", \"title\": \"Distributor may defer Product shipment for up to [*****] from the original shipping date scheduled by Cisco, provided wr\", \"level\": 2, \"text\": \"4.3 Distributor may defer Product shipment for up to [*****] from the original shipping date scheduled by Cisco, provided written or electronic notice (issued, in either case, by an authorized representative of Distributor) is received by Cisco at least [*****] days before the originally scheduled shipping date. Cancelled Purchase Orders, rescheduled shipments or Product configuration changes requested by Distributor less than [*****] days before the original scheduled shipping date shall be subject to (a) acceptance by Cisco, and (b) a charge of [*****] of the total invoice amount relating to the affected Products. Cisco reserves the right to reschedule shipment in cases of configuration changes requested by Distributor within [*****] days of scheduled shipment. No cancellation shall be accepted by Cisco where Products are purchased with implementation Services, including design, customization or installation Services, except as may be set forth in the agreement or Statement of Work under which the Services are to be rendered.\"}, {\"id\": \"5.0\", \"title\": \"SHIPPING AND DELIVERY 5\", \"level\": 2, \"text\": \"5.0 SHIPPING AND DELIVERY 5.1 Scheduled shipping dates will be assigned by Cisco as close as practicable to the Distributor's requested date based on Cisco's then-current lead times for the Products. Cisco will communicate scheduled shipping dates in the order acknowledgement or on Cisco.com. Cisco will ship Product in compliance with Distributor Freight Policy set forth in Exhibit D. If no guidance is contained on Exhibit D for any particular shipment, Cisco shall select the carrier.\"}, {\"id\": \"5.2\", \"title\": \"For shipments to the United States, shipping terms are [*****], which shall appear on Cisco's order acknowledgement or b\", \"level\": 2, \"text\": \"5.2 For shipments to the United States, shipping terms are [*****], which shall appear on Cisco's order acknowledgement or be accessible via Cisco.com. Title and risk of loss shall pass from Cisco to Distributor [*****]. For orders placed and/or shipments to destinations outside of the United States but within the Territory (\\\"International Orders\\\"), Distributor may need to contract with, and/or order from, a Cisco affiliate. Different shipping terms may apply to International Orders, as Cisco shall specify at the time and as shall be recorded in Distributor's agreement with such Cisco affiliate or otherwise set out on Cisco.com.\"}, {\"id\": \"5.3\", \"title\": \"CISCO SHALL NOT BE LIABLE FOR LOSS, DAMAGE OR PENALTY FOR DELAY IN DELIVERY OR FOR FAILURE TO GIVE NOTICE OF ANY DELAY\", \"level\": 2, \"text\": \"5.3 CISCO SHALL NOT BE LIABLE FOR LOSS, DAMAGE OR PENALTY FOR DELAY IN DELIVERY OR FOR FAILURE TO GIVE NOTICE OF ANY DELAY. EXCEPT IN ACCORDANCE WITH THE APPLICABLE DELIVERY TERMS SET FORTH IN THIS AGREEMENT, CISCO SHALL NOT HAVE ANY Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 LIABILITY IN CONNECTION WITH SHIPMENT, NOR SHALL THE CARRIER BE DEEMED TO BE AN AGENT OF CISCO.\"}, {\"id\": \"6.0\", \"title\": \"PAYMENT\", \"level\": 2, \"text\": \"6.0 PAYMENT. 6.1 Prices for Products shall be those specified in Cisco's then-current Global or Value Added Distributor Price List. [*****] As provided in sub- section 3.2, in its discretion, Cisco may choose to make products or services which are on the Global Price List but not on the Value Added Distributor Price List available to Distributor. The prices for such products or services will be provided by Cisco to Distributor at the time Cisco makes such products available.\"}, {\"id\": \"6.2\", \"title\": \"Upon and subject to credit approval by Cisco, payment terms shall be [*****] days from shipping date\", \"level\": 2, \"text\": \"6.2 Upon and subject to credit approval by Cisco, payment terms shall be [*****] days from shipping date. All payments shall be made in the currency in which the Price List is quoted for the applicable Purchase Order [*****].\"}, {\"id\": \"6.3\", \"title\": \"The purchase price does not include any federal, state or local taxes, or sales, use, excise, ad valorem, value-add, wit\", \"level\": 2, \"text\": \"6.3 The purchase price does not include any federal, state or local taxes, or sales, use, excise, ad valorem, value-add, withholding or other taxes or duties that may be applicable to the purchase of Products. When Cisco has the legal obligation to collect such taxes, the appropriate amount shall be added to Distributor's invoice and paid by Distributor, unless Distributor provides Cisco with a valid tax exemption certificate prior to issuance of a purchase order. Such certificate must be in a form authorized by the appropriate taxing authority.\"}, {\"id\": \"6.4\", \"title\": \"Distributor is free to determine its minimum resale prices unilaterally\", \"level\": 2, \"text\": \"6.4 Distributor is free to determine its minimum resale prices unilaterally. Distributor understands that neither Cisco nor any employee or representative of Cisco may give any special treatment (favorable or unfavorable) to Distributor as a result of Distributor's selection of minimum resale prices. No employee or representative of Cisco or anyone else has any authority to determine what Distributor's minimum resale prices for the Products must be, or to limit Distributor's pricing discretion with respect to the Products and Services.\"}, {\"id\": \"6.5\", \"title\": \"In the event any provisions of this Agreement or any other agreement between Distributor and Cisco require that Cisco gr\", \"level\": 2, \"text\": \"6.5 In the event any provisions of this Agreement or any other agreement between Distributor and Cisco require that Cisco grant credits to Distributor's account, Cisco will grant such credit to Distributor's account. [*****]. Cisco will only consider debit memos initially received from Distributor during the time period associated with such request, as set forth herein. All debit memos Distributor submits to Cisco will be submitted using any method identified in 25.8, or as otherwise agreed between the parties.\"}, {\"id\": \"6.6\", \"title\": \"Except as stated in Sections 7 (Price Protection), 12 (Inventory Balance), 13 (Return of Obsolete Product), 18 (Term and\", \"level\": 2, \"text\": \"6.6 Except as stated in Sections 7 (Price Protection), 12 (Inventory Balance), 13 (Return of Obsolete Product), 18 (Term and Termination) or as otherwise stated herein, for all price adjustment related credits requested by the Distributor to be granted by Cisco, the\"}, {\"id\": \"6.7\", \"title\": \"Distributor must make the initial credit request to Cisco, in writing, within [*****] of the underlying point of sale tr\", \"level\": 2, \"text\": \"6.7 Distributor must make the initial credit request to Cisco, in writing, within [*****] of the underlying point of sale transaction. Any initial credit requests submitted by the Distributor to Cisco greater than [*****] after the underlying point of sale transaction will not be honored by Cisco and Cisco will not grant such credit to Distributor.\"}, {\"id\": \"7.0\", \"title\": \"PRICE PROTECTION\", \"level\": 2, \"text\": \"7.0 PRICE PROTECTION. 7.1 Definition: For purposes of this Section 7.0, Products \\\"In-Transit\\\" shall be defined as all Products with a particular Cisco part number shipped by Cisco to Distributor in the [*****] day period prior to the date on which Cisco announces a general price decrease for Products with such part number, excluding those Products which Distributor has received into its inventory during such [*****] day period.\"}, {\"id\": \"7.2\", \"title\": \"In the event Cisco puts into effect a general price decrease for any Product from the Value Added Distributor Price List\", \"level\": 2, \"text\": \"7.2 In the event Cisco puts into effect a general price decrease for any Product from the Value Added Distributor Price List, Cisco will provide to Distributor a price credit on any such Product on order, In Transit or in Distributor's inventory as of the effective date of the price decrease, provided that the price credit for such Product in inventory or In Transit shall not exceed the dollar value of shipments of that Product (measured by the appropriate Cisco product number) to Distributor over the preceding [*****]. Cisco will credit Distributor's account with an amount equal to the number of units of such Product in Distributor's inventory and In Transit on the effective date of a price decrease multiplied by the difference between the net price paid and the new net price. Distributor will have [*****] from the effective date of the price change to exercise protection under this program by issuing a request for credit memo with supporting documentation to Cisco. Claims for price protection submitted more than [*****] from the effective date of a price decrease will be rejected. Notwithstanding the foregoing, Product on order will receive an automatic retroactive price credit. The only inventoried Product covered under this price protection clause is Product which has been identified by Distributor to Cisco in the daily inventory reports required in sub-sub-section 17.2.2, excluding any Third-Party Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 Sourced Product. Cisco will use commercially reasonable efforts to notify Distributor within [*****] of all such pricing changes.\"}, {\"id\": \"8.0\", \"title\": \"RESERVED\", \"level\": 2, \"text\": \"8.0 RESERVED\"}, {\"id\": \"9.0\", \"title\": \"PROPRIETARY RIGHTS AND SOFTWARE LICENSING\", \"level\": 2, \"text\": \"9.0 PROPRIETARY RIGHTS AND SOFTWARE LICENSING. 9.1 Distributor's use of Software is governed by the terms contained in Exhibit C (End User License Agreement (\\\"EULA\\\")). For purposes of this Agreement, all references to \\\"Customer\\\" or \\\"You\\\" therein shall refer to Distributor.\"}, {\"id\": \"9.2\", \"title\": \"Distributor shall notify Cisco promptly of any breach or suspected breach of the EULA and further agrees that it will, a\", \"level\": 2, \"text\": \"9.2 Distributor shall notify Cisco promptly of any breach or suspected breach of the EULA and further agrees that it will, at Cisco's request, assist Cisco in efforts to preserve Cisco's intellectual property rights including pursuing an action against any breaching third parties.\"}, {\"id\": \"10\", \"title\": \"WARRANTY\", \"level\": 1, \"text\": \"10. WARRANTY. 10.1 C i s c o P r o d u c t s a r e p r o v i d e d w i t h w r i t t e n l i m i t e d w a r r a n t i e s , a s s e t f o r t h a t t h e f o l l o w i n g U R L : http://www.cisco.com/warp/public/cc/serv/mkt/sup/tsssv/wnty/. Distributor will pass through to Resellers all written limited warranties provided by Cisco with Products purchased by Distributor and Distributor shall contractually require (in whatever manner Distributor deems appropriate) each such Reseller to provide such warranty and other terms to any End User to which the Reseller redistributes the Product.\"}, {\"id\": \"10.2\", \"title\": \"In addition to the written limited warranty provided by Cisco with its Products, such warranty statement shall apply to\", \"level\": 2, \"text\": \"10.2 In addition to the written limited warranty provided by Cisco with its Products, such warranty statement shall apply to Distributor during the period between when it receives a Product and when it resells or redistributes such Product,\"}, {\"id\": \"10.3\", \"title\": \"Notwithstanding any other provision hereof, Cisco's sole and exclusive warranty and obligation with respect to the Produ\", \"level\": 2, \"text\": \"10.3 Notwithstanding any other provision hereof, Cisco's sole and exclusive warranty and obligation with respect to the Products sold hereunder are set forth in Cisco's Limited Warranty Statement delivered with the Product. Distributor SHALL NOT MAKE ANY WARRANTY COMMITMENT, WHETHER WRITTEN OR ORAL, ON CISCO'S BEHALF. Distributor shall indemnify Cisco against any warranties made in addition to Cisco's standard warranty and for any misrepresentation of Cisco's reputation or Cisco's Products.\"}, {\"id\": \"10.4\", \"title\": \"DISCLAIMER OF WARRANTY\", \"level\": 2, \"text\": \"10.4 DISCLAIMER OF WARRANTY. EXCEPT AS EXPRESSLY PROVIDED IN THIS SECTION 10.0, CISCO HEREBY DISCLAIMS AND DISTRIBUTOR WAIVES ALL REPRESENTATIONS, CONDITIONS AND WARRANTIES (WHETHER EXPRESS, IMPLIED, OR STATUTORY), INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OR CONDITION (A) OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, SATISFACTORY QUALITY, QUIET ENJOYMENT, ACCURACY, OR SYSTEM INTEGRATION, OR (B) ARISING FROM ANY COURSE OF DEALING, COURSE OF PERFORMANCE, OR USAGE IN THE INDUSTRY. TO THE EXTENT AN IMPLIED WARRANTY CANNOT BE DISCLAIMED, SUCH WARRANTY IS LIMITED IN DURATION TO THE APPLICABLE EXPRESS WARRANTY PERIOD. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS SECTION 10, CISCO MAKES NO REPRESENTATION OR WARRANTY AS TO OWNERSHIP OF INTELLECTUAL PROPERTY OR OF PROPRIETARY RIGHTS, OR AS TO INFRINGEMENT OR MISAPPROPRIATION THEREOF. DISTRIBUTOR'S SOLE AND EXCLUSIVE REMEDIES IN THE EVENT OF ANY SUCH INFRINGEMENT, MISAPPROPRIATION OR ANY CLAIM THEREOF SHALL BE AS SET FORTH IN SECTION 15 OF THIS AGREEMENT (\\\"PATENT AND COPYRIGHT INFRINGEMENT\\\").\"}, {\"id\": \"11.0\", \"title\": \"TRADEMARKS\", \"level\": 2, \"text\": \"11.0 TRADEMARKS. 11.1 Cisco grants to Distributor the right to use the name, logo, trademarks, and other marks of Cisco (collectively, the \\\"Marks\\\") for all proper purposes in the sale of Cisco Products and Services to End Users and the performance of Distributor's duties hereunder only so long as this Agreement is in effect. Distributor's use of such Marks shall be in accordance with Cisco's policies including, but not limited to trademark usage and advertising policies, and be subject to Cisco's written approval. Distributor further agrees not to affix any Marks to products other than genuine Products. Distributor shall have no claim or right in the Marks, including but not limited to trademarks, service marks, or trade names owned, used or claimed now or which Cisco has authority to grant Distributor the right to use in the future. Distributor agrees that upon notice from Cisco it will immediately terminate its use of a particular Mark.\"}, {\"id\": \"11.2\", \"title\": \"Distributor shall not acquire, use, promote or Resell Non-Genuine Products\", \"level\": 2, \"text\": \"11.2 Distributor shall not acquire, use, promote or Resell Non-Genuine Products. Additionally, Distributor shall Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 notify Cisco promptly of the existence, or suspected existence, of Non\u200b Genuine Products in possession of or promoted by third parties, and further agrees that it will, at Cisco's request, assist Cisco to diligently pursue any action against any third party in possession of or promoting Non- Genuine Products.\"}, {\"id\": \"11.3\", \"title\": \"If Distributor acquires, uses, promotes or Resells Non-Genuine Products, Cisco may take one or more of the following act\", \"level\": 2, \"text\": \"11.3 If Distributor acquires, uses, promotes or Resells Non-Genuine Products, Cisco may take one or more of the following actions, at Cisco's discretion: (i) invoice Distributor, and the latter further agrees to pay within [*****] of receipt of the invoice, for all reasonable costs associated with any Audit and/or any investigation carried out by Cisco or its independent accountants or investigators, that disclosed a material breach by Distributor of this Section, and/or (ii) require Distributor, [*****] of Cisco's request, to recall and destroy all Non-Genuine Products that Distributor has sold to Resellers and replace such products with legitimate, equivalent Products at Distributor's expense, (iii) require Distributor, within [*****] of receiving Cisco's written request, to provide Cisco with all details related to Distributor's acquisition of all Non-Genuine Products, including without limitation, its suppliers, shipping details and all buyers to whom Distributor resold Non-Genuine Products, and (iv) terminate this Agreement by notice with immediate effect.\"}, {\"id\": \"12.0\", \"title\": \"INVENTORY BALANCE\", \"level\": 2, \"text\": \"12.0 INVENTORY BALANCE. For a [*****] period, beginning on the effective date of this agreement, Distributor has the option to return to Cisco, for credit, up to [*****] of the dollar value of Product listed on the Value Added Distributor Price List and shipped to Distributor in the preceding Cisco Quarter, net of credits issued by Cisco to Distributor. [*****] Cisco shall credit Distributor's account in the amount of the price paid by Distributor for returned Products, less any price protection credits issued to Distributor related to the Product returned (the \\\"Return Credit\\\"). Each of the following requirements must be met by Distributor:\"}, {\"id\": \"12.1\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"12.1 [*****]\"}, {\"id\": \"12.2\", \"title\": \"Distributor may submit the inventory balance claim between the first and [*****] calendar days of the following months\", \"level\": 2, \"text\": \"12.2 Distributor may submit the inventory balance claim between the first and [*****] calendar days of the following months: February, May, August, and November.\"}, {\"id\": \"12.3\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"12.3 [*****]\"}, {\"id\": \"12.4\", \"title\": \"Distributor shall bear all shipping and handling charges to the Cisco designated United States site for Product returned\", \"level\": 2, \"text\": \"12.4 Distributor shall bear all shipping and handling charges to the Cisco designated United States site for Product returned for credit;\"}, {\"id\": \"12.5\", \"title\": \"Distributor shall obtain an RMA number prior to returning any Product to Cisco\", \"level\": 2, \"text\": \"12.5 Distributor shall obtain an RMA number prior to returning any Product to Cisco. Distributor shall follow Cisco's then-current RMA process; and\"}, {\"id\": \"12.6\", \"title\": \"Distributor reports must be provided to Cisco in accordance with the requirements of sub- section 17\", \"level\": 2, \"text\": \"12.6 Distributor reports must be provided to Cisco in accordance with the requirements of sub- section 17.2. [*****]\"}, {\"id\": \"13.0\", \"title\": \"RETURN OF OBSOLETE PRODUCT 13\", \"level\": 2, \"text\": \"13.0 RETURN OF OBSOLETE PRODUCT 13.1 Cisco will use commercially reasonable efforts to notify Distributor, including by electronic posting, when a Product becomes an Obsolete Product.\"}, {\"id\": \"13.2\", \"title\": \"Provided Distributor provides required reports to Cisco in accordance with Section 17\", \"level\": 2, \"text\": \"13.2 Provided Distributor provides required reports to Cisco in accordance with Section 17.0 of this Agreement, Distributor shall have the right to return Obsolete Product for full credit under Cisco's then-current RMA Process. [*****]\"}, {\"id\": \"13.3\", \"title\": \"Distributor must notify Cisco of the quantity of Obsolete Product to be returned to Cisco within [*****] of notification\", \"level\": 2, \"text\": \"13.3 Distributor must notify Cisco of the quantity of Obsolete Product to be returned to Cisco within [*****] of notification of obsolescence by Cisco. Such right to return is contingent upon return by Distributor of Obsolete Product within [*****] of such notification by Cisco. Such Product must be in new and unused condition and in factory sealed boxes.\"}, {\"id\": \"13.4\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"13.4 [*****]\"}, {\"id\": \"14.0\", \"title\": \"RESERVED\", \"level\": 2, \"text\": \"14.0 RESERVED\"}, {\"id\": \"15.0\", \"title\": \"PATENT AND COPYRIGHT INFRINGEMENT\", \"level\": 2, \"text\": \"15.0 PATENT AND COPYRIGHT INFRINGEMENT. 15.1 Cisco will have the obligation and right to defend any claim, action, suit or proceeding (\\\"IPR Claim\\\") brought Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 against Distributor, its officers, directors, employees and agents (\\\"Named Parties\\\") so far as it is based on a claim that any Product supplied under this Agreement infringes Third Party IPR (as defined below). Cisco will indemnify Named Parties and hold harmless against any final judgment entered in respect of such an IPR Claim by a court of competent jurisdiction and against any settlements arising out of such an IPR Claim. Cisco's obligations to defend the IPR Claim and indemnify Distributor are conditional upon:\"}, {\"id\": \"15.1.1\", \"title\": \"Distributor notifying Cisco promptly in writing of the IPR Claim or threat thereof; Distributor granting Cisco full and\", \"level\": 3, \"text\": \"15.1.1 Distributor notifying Cisco promptly in writing of the IPR Claim or threat thereof; Distributor granting Cisco full and exclusive authority for the conduct of the defense and settlement of the 15.1.2 IPR Claim and any subsequent appeal; and 15.1.3 Distributor providing Cisco all information and assistance reasonably requested by Cisco in connection with the conduct of the defense and settlement of the IPR Claim and any subsequent appeal.\"}, {\"id\": \"15.2\", \"title\": \"For the purposes of this Agreement, Third Party IPR means a United States copyright existing as at the Effective Date, a\", \"level\": 2, \"text\": \"15.2 For the purposes of this Agreement, Third Party IPR means a United States copyright existing as at the Effective Date, a United States patent issued as at the Effective Date, a trademark registered in the United States as at the Effective Date, trade dress existing in the United States as at the Effective Date, or a claim that a Product is manufactured by means of misappropriation of a third party's trade secrets.\"}, {\"id\": \"15.3\", \"title\": \"If an IPR Claim has been made, or in Cisco's opinion is likely to be made, Distributor agrees to permit Cisco, at its op\", \"level\": 2, \"text\": \"15.3 If an IPR Claim has been made, or in Cisco's opinion is likely to be made, Distributor agrees to permit Cisco, at its option and expense, either to: (a) procure for Distributor the right to continue using the Product; (b) replace or modify the Product so that it becomes non-infringing; or (c) immediately terminate both parties' respective rights and obligations under this Agreement with regard to the Product, in which case Distributor will return the Product to Cisco and Cisco will refund to Distributor the price originally paid by Distributor to Cisco for the Product, [*****].\"}, {\"id\": \"15.4\", \"title\": \"Notwithstanding the foregoing, Cisco has no liability for, and Distributor will defend and indemnify Cisco against, any\", \"level\": 2, \"text\": \"15.4 Notwithstanding the foregoing, Cisco has no liability for, and Distributor will defend and indemnify Cisco against, any IPR Claim arising from:\"}, {\"id\": \"15.5\", \"title\": \"This Section states the entire obligation of Cisco and its suppliers, and the exclusive remedy of Distributor, in respec\", \"level\": 2, \"text\": \"15.5 This Section states the entire obligation of Cisco and its suppliers, and the exclusive remedy of Distributor, in respect of any infringement or alleged infringement of any intellectual property rights or proprietary rights. THIS INDEMNITY OBLIGATION AND REMEDY ARE GIVEN TO Distributor SOLELY FOR ITS BENEFIT AND IN LIEU OF, AND CISCO DISCLAIMS, ALL WARRANTIES, CONDITIONS AND OTHER TERMS OF NON-INFRINGEMENT OR TITLE WITH RESPECT TO ANY PRODUCT.\"}, {\"id\": \"15.6\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"15.6 [*****].\"}, {\"id\": \"16.0\", \"title\": \"SUPPORT\", \"level\": 2, \"text\": \"16.0 SUPPORT. Support shall be provided in accordance with Exhibit B. Distributor acknowledges that Cisco will not be responsible for warranty service and support except as specifically provided in Exhibit B or a Cisco support program (e.g., SmartNet).\"}, {\"id\": \"17.0\", \"title\": \"REPORTS AND RECORDS\", \"level\": 2, \"text\": \"17.0 REPORTS AND RECORDS. 17.1 With regard to both Distributor and Affiliates' activity, Distributor shall keep full, true, and accurate records and accounts, in accordance with generally-accepted accounting principles, of each Product or Service purchased and deployed, Resold, or distributed by serial number, including information regarding compliance with Cisco marketing and sales programs, Software usage, and export or transfer. Distributor shall make these records available for audit by Cisco upon [*****] prior written notice, during regular business hours, at Distributor's principal place of business or such other of Distributor's locations where Distributor may maintain relevant records. [*****]. All reporting and related obligations in this Section 17 apply to not only data regarding Distributor's activities, but also Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 the activities of the Affiliates. All such information shall be compiled into one report unless otherwise directed herein. The report(s) shall identify the specific Distributor entity involved in the subject transaction.\"}, {\"id\": \"17.2\", \"title\": \"Reporting\", \"level\": 2, \"text\": \"17.2 Reporting. [*****]\"}, {\"id\": \"17.3\", \"title\": \"Distributor agrees to use commercially reasonable efforts, commensurate with the manner in which Distributor treats any\", \"level\": 2, \"text\": \"17.3 Distributor agrees to use commercially reasonable efforts, commensurate with the manner in which Distributor treats any of its other leading vendors, in order to facilitate Cisco's ability to obtain daily sales information from Distributor via EDI.\"}, {\"id\": \"17.4\", \"title\": \"ECCN Numbers\", \"level\": 2, \"text\": \"17.4 ECCN Numbers. Upon request by Distributor, Cisco agrees to make available to Distributor the Export Control Classification Number (ECCN) for each of Cisco's Product and information as to whether or not any of such Products are classified under the U.S. Munitions license.\"}, {\"id\": \"17.5\", \"title\": \"Unauthorized Cisco Product\", \"level\": 2, \"text\": \"17.5 Unauthorized Cisco Product. Distributor will not purchase Products for resale to any Reseller from any person or entity other than Cisco, provided that Distributor may accept returned Product from Resellers if Distributor initially sold the Product to be returned to such Reseller. [*****]\"}, {\"id\": \"18.0\", \"title\": \"TERM AND TERMINATION\", \"level\": 2, \"text\": \"18.0 TERM AND TERMINATION. 18.1 This Agreement shall commence on the Effective Date and continue thereafter for a period of two (2) years, unless extended by written agreement of both parties or sooner terminated as set forth below. Without prejudice to either party's right to terminate this Agreement as set forth in sub\u200b sections 18.2 to 18.5 below, Cisco may, by written notice to Distributor, given at least thirty (30) days prior to the end of the then-current term of the Agreement, extend the term of the Agreement for the period set forth in such notice, up to a maximum of one (1) year beyond the then- current expiration date. Any extension shall be on the same terms and conditions then in force, except as may be mutually agreed in writing by the parties. In the event the Agreement expires and Cisco intends to not renew the Agreement, Cisco will provide written notice of same to Distributor. Notwithstanding Cisco's right to extend the term of this Agreement, each party acknowledges that this Agreement shall always be interpreted as being limited in duration to a definite term and that the other party has made no commitments whatsoever regarding the duration or renewal of this Agreement beyond those expressly stated herein.\"}, {\"id\": \"18.3\", \"title\": \"A party may terminate this Agreement immediately through written notice if (i) the other party ceases to carry on busine\", \"level\": 2, \"text\": \"18.3 A party may terminate this Agreement immediately through written notice if (i) the other party ceases to carry on business as a going concern; or (ii) the other party becomes or may become the object of the institution of voluntary or involuntary proceedings in bankruptcy or liquidation; or (iii) a receiver or similar officer is appointed with respect to the whole or a substantial part of the other party's assets; or (iv) an event similar to any of the foregoing occurs under applicable law.\"}, {\"id\": \"18.4\", \"title\": \"Cisco may terminate this Agreement upon [*****] days' written notice, in the event it becomes known that (i) Distributor\", \"level\": 2, \"text\": \"18.4 Cisco may terminate this Agreement upon [*****] days' written notice, in the event it becomes known that (i) Distributor or an Affiliate or Distributor's direct or indirect parent has acquired or intends to acquire a controlling interest in a third party that is a competitor of Cisco, or (ii) Distributor or its direct or indirect parent is to be acquired by a third party, or (iii) a controlling interest in Distributor or its direct or indirect parent is to be transferred to a third party.\"}, {\"id\": \"18.5\", \"title\": \"Upon termination or expiration of this Agreement, (a) Cisco reserves the right to cease all further delivery of Product\", \"level\": 2, \"text\": \"18.5 Upon termination or expiration of this Agreement, (a) Cisco reserves the right to cease all further delivery of Product or Services due against any existing Purchase Orders unless Distributor agrees to pay for such deliveries in advance by certified or cashier's check, (b) all outstanding invoices immediately become due and payable by certified or cashier's check, and (c) all rights and licenses of Distributor hereunder shall terminate, subject to the terms of the following sentence. Except for a termination of this Agreement resulting from Distributor's breach of Section 9.0 (Proprietary Rights and Software Licensing) or Section 19.0(Confidential Information), upon termination or expiration of this Agreement, Distributor may continue to use, in accordance with the terms and conditions of this Agreement, Products shipped to it by Cisco prior to the date of termination or expiration.\"}, {\"id\": \"18.6\", \"title\": \"Upon termination or expiration of this Agreement, Distributor shall immediately return to Cisco all Confidential Informa\", \"level\": 2, \"text\": \"18.6 Upon termination or expiration of this Agreement, Distributor shall immediately return to Cisco all Confidential Information (including all copies thereof) then in Distributor's possession, custody or control; provided, that except for a termination resulting from Distributor's breach of Section 9.0 (Proprietary Rights and Software Licensing) or Section 19.0 (Confidential Information), Distributor may retain a sufficient amount of such Confidential Information and material Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 to support its installed base of Products.\"}, {\"id\": \"18.7\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"18.7 [*****].\"}, {\"id\": \"18.8\", \"title\": \"In the event of termination by Cisco for convenience, termination by Distributor for Cisco's material breach, or expirat\", \"level\": 2, \"text\": \"18.8 In the event of termination by Cisco for convenience, termination by Distributor for Cisco's material breach, or expiration of this Agreement where Cisco has provided Distributor with written notice from an authorized representative of its intention not to renew the Agreement, Cisco agrees to repurchase all Product in Distributor's inventory within [*****] days following the effective date of termination or expiration. Within [*****] days following the effective date of termination or expiration, Distributor shall return to Cisco all Product held in inventory as of the effective date of termination. Distributor shall receive credit for any Product so returned in an amount equal to the original purchase price thereof, less any credits or discounts which have been previously paid or applied to Distributor. Such credits shall be first applied to any uncontested amounts due Cisco. Any remaining balance shall be payable to Distributor as soon as commercially practicable. Cisco shall have the option to select the method of return and shall bear all freight costs associated with returns of Product by Distributor under this Section 18.8.\"}, {\"id\": \"18.9\", \"title\": \"In the event of termination by Cisco for Distributor's material breach, or termination by Distributor for convenience, C\", \"level\": 2, \"text\": \"18.9 In the event of termination by Cisco for Distributor's material breach, or termination by Distributor for convenience, Cisco may, at its option, allow Distributor to return unsold Product, but Cisco is in no way obligated to do so. In the case of authorized return of Product by Cisco under Section 18.9, Distributor will bear all freight costs associated with return of Product to Cisco.\"}, {\"id\": \"18.10\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"18.10 [*****] Distributor shall obtain an RMA number prior to returning any Product to Cisco. Distributor shall follow Cisco's then-current RMA process.\"}, {\"id\": \"18.11\", \"title\": \"DISTRIBUTOR AGREES THAT, IN THE EVENT OF ANY TERMINATION OF THIS AGREEMENT, IT SHALL HAVE NO RIGHTS TO DAMAGES OR INDEMN\", \"level\": 2, \"text\": \"18.11 DISTRIBUTOR AGREES THAT, IN THE EVENT OF ANY TERMINATION OF THIS AGREEMENT, IT SHALL HAVE NO RIGHTS TO DAMAGES OR INDEMNIFICATION OF ANY NATURE, SPECIFICALLY INCLUDING COMMERCIAL SEVERANCE PAY, WHETHER BY WAY OF LOSS OF FUTURE PROFITS, EXPENDITURES FOR PROMOTION OF ANY PRODUCT, OR OTHER COMMITMENTS IN CONNECTION WITH THE BUSINESS AND GOOD WILL OF DISTRIBUTOR. DISTRIBUTOR EXPRESSLY WAIVES AND RENOUNCES ANY CLAIM TO COMPENSATION OR INDEMNITIES FOR ANY TERMINATION OF A BUSINESS RELATIONSHIP. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH HEREIN, THIS SECTION SHALL IN NO WAY BE INTERPRETED TO RELEASE EITHER CISCO OR DISTRIBUTOR FROM ANY PAYMENTS OR FINANCIAL OBLIGATION MADE PRIOR TO TERMINATION.\"}, {\"id\": \"19.0\", \"title\": \"CONFIDENTIALITY\", \"level\": 2, \"text\": \"19.0 CONFIDENTIALITY. Distributor acknowledges that, in the course of selling Products and Services and performing its duties under this Agreement, Distributor, its Resellers, and End Users to which Distributor provides access to Cisco technical data (including without limitation Products, Services, and technical data made available on Cisco Connection Online pursuant to Exhibit C), may obtain information relating to Products, Services, or to Cisco, which is of a confidential and proprietary nature (\\\"Proprietary Information\\\"). Such Proprietary Information includes, but is not limited to, trade secrets, know-how, inventions, techniques, processes, programs, schematics, software source documents, data, Customer lists, financial information and sales and marketing plans. Cisco owns and intends to maintain its ownership of all such Proprietary Information. [*****] Distributor shall appropriately bind each of its employees to whom such disclosure is made, to hold the Proprietary Information in strict confidence and not to disclose such information to any person other than as is necessary in the course of its employment by Distributor and will indemnify Cisco for all damages suffered by Cisco in the event of wrongful disclosure of such Proprietary Information. Neither party shall disclose, advertise, or publish either the existence, the subject matter, any discussions relating to, or any of the terms and conditions, of this Agreement (or any summary of any of the forgoing) to any third party without the prior written consent of the other party. Any press release, publication, advertisement or public disclosure regarding this Agreement is subject to both the prior review and the written approval of both parties. Cisco acknowledges that, under this Agreement, Distributor may provide Point of Sale (\\\"POS\\\") reports, financial information, sales and marketing plans, Distributor network design information and Distributor lists, of a proprietary and confidential nature (\\\"Distributor Confidential Information\\\"). Such Distributor information, excluding POS reports and Distributor lists, shall be used by Cisco only in connection with this Agreement. [*****] Cisco further agrees to immediately return to Distributor, at Distributor's request, all Distributor Confidential Information in Cisco's possession, custody, or control upon termination of this Agreement at any time and for any reason, except for POS reports or Distributor Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 lists that Cisco may use for internal business or end user support purposes or government-related purposes.\"}, {\"id\": \"20.0\", \"title\": \"EXPORT RESTRICTIONS\", \"level\": 2, \"text\": \"20.0 EXPORT RESTRICTIONS. Certain of the Products supplied by Cisco under the Agreement are subject to export controls under the laws and regulations of the United States (U.S.) and elsewhere. Distributor shall comply with such laws and regulations governing use, export, re-export, and transfer of Products and will obtain all required U.S. and local authorizations, permits, or licenses.\"}, {\"id\": \"21.0\", \"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"21.0 COMPLIANCE WITH LAWS. 21.1 Distributor shall obtain all licenses, permits and approvals required by any government, including any recycling or take-back programs applicable to packaging or Products, and shall comply with all applicable laws, rules, regulations, policies and procedures and any requirements applicable to the importation, exportation, use, sale, loan, purchase, and distribution of Products under telecommunications, consumer rights related, environmental, labor, tax, and any other laws and regulations, of any government or other competent authority where the Products are to be sold, used or deployed (collectively \\\"Applicable Laws\\\").\"}, {\"id\": \"21.2\", \"title\": \"Distributor will indemnify and hold harmless Cisco for any claim arising from or relating to Distributor's violation or\", \"level\": 2, \"text\": \"21.2 Distributor will indemnify and hold harmless Cisco for any claim arising from or relating to Distributor's violation or alleged violation of any Applicable Laws.\"}, {\"id\": \"21.3\", \"title\": \"Distributor hereby represents and warrants that\", \"level\": 2, \"text\": \"21.3 Distributor hereby represents and warrants that: (a) it shall comply with all Applicable Laws; (b) this Agreement and each of its terms are in full conformance and in compliance with such laws; and (c) it shall not take any action or permit or authorize any action which will render Cisco liable for a violation of the U.S. Foreign Corrupt Practices Act, which prohibits the offering, giving or promising to offer or give, directly or indirectly, money or anything of value to any official of a government, political party or instrumentality thereof in order to assist it or Cisco in obtaining or retaining business and (i) it will not violate or cause Cisco to violate such Act in connection with the sale or distribution of Cisco Products or Services; and (ii) if Distributor is a non-governmental entity, it will notify Cisco in writing if any of its owners, partners, principals, officers, and employees are or become during the term of this Agreement officials, officers or representatives of any government, political party or candidate for political office outside the United States and are responsible for a decision regarding obtaining or retaining business for Cisco Products by such government. Cisco strives to maintain the highest standards of business integrity and, accordingly, if Distributor has any cause for concern regarding any business practices these should be reported to Cisco at [EMAIL ADDRESS] or by Fax to [FAX NUMBER].\"}, {\"id\": \"21.4\", \"title\": \"Distributor shall use its best efforts to regularly and continuously inform Cisco of any requirements under any Applicab\", \"level\": 2, \"text\": \"21.4 Distributor shall use its best efforts to regularly and continuously inform Cisco of any requirements under any Applicable Laws that directly or indirectly affect this Agreement, the sale, use and distribution of Products, or Cisco's trade name, trademarks or other commercial, industrial or intellectual property interests, including, but not limited to, certification or type approval of the Products from the proper authorities in the Territory.\"}, {\"id\": \"22.0\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"22.0 LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING ELSE IN THIS AGREEMENT TO THE CONTRARY, AND EXCEPT FOR LIABILITY ARISING OUT OF DISTRIBUTOR'S BREACH OF SECTION 9 (PROPRIETARY RIGHTS AND SOFTWARE LICENSING) OR EXHIBIT C (SOFTWARE LICENSE AGREEMENT), OR AMOUNTS DUE FOR PRODUCTS AND SERVICES PURCHASED WITH RESPECT TO THE PAYMENT OF WHICH NO BONA FIDE DISPUTE EXISTS, ALL LIABILITY OF EACH PARTY, INCLUDING EACH PARTY'S AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS AND SUPPLIERS COLLECTIVELY, FOR CLAIMS ARISING UNDER THIS AGREEMENT OR OTHERWISE HOWSOEVER ARISING SHALL BE LIMITED SEPARATELY FOR PRODUCTS AND SERVICES PURCHASES TO THE GREATER OF I) [*****] OR (ll)THE MONEY PAID TO CISCO FOR PRODUCTS OR FOR SERVICES, SEPARATELY AND AS APPLICABLE, UNDER THIS AGREEMENT DURING THE [*****] PERIOD PRECEDING THE EVENT OR CIRCUMSTANCES FIRST GIVING RISE TO SUCH LIABILITY. THESE LIMITATIONS OF LIABILITY FOR PRODUCT AND SERVICES ARE CUMULATIVE AND NOT PER-INCIDENT (I.E., THE EXISTENCE OF TWO OR MORE CLAIMS WILL NOT ENLARGE THIS LIMIT).\"}, {\"id\": \"23.0\", \"title\": \"CONSEQUENTIAL DAMAGES WAIVER\", \"level\": 2, \"text\": \"23.0 CONSEQUENTIAL DAMAGES WAIVER. EXCEPT FOR LIABILITY ARISING OUT OF OR IN CONNECTION WITH DISTRIBUTOR'S BREACH OF SECTION 9 (PROPRIETARY RIGHTS AND SOFTWARE LICENSING) OR EXHIBIT C (SOFTWARE LICENSE AGREEMENT), IN NO EVENT SHALL EITHER PARTY, ITS RESPECTIVE AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR SUPPLIERS BE LIABLE FOR ANY SPECIAL, INCIDENTAL, Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 INDIRECT OR CONSEQUENTIAL DAMAGES, OR LOST REVENUE, LOST PROFITS, OR LOST OR DAMAGED DATA, WHETHER ARISING IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, EVEN IF SUCH PARTY HAS BEEN INFORMED OF THE POSSIBILITY THEREOF.\"}, {\"id\": \"24.0\", \"title\": \"GENERAL INDEMNIFICATION Each party shall defend, indemnify and hold harmless the other, and their respective officers, d\", \"level\": 2, \"text\": \"24.0 GENERAL INDEMNIFICATION Each party shall defend, indemnify and hold harmless the other, and their respective officers, directors, employees, and agents from and against any and all claims, losses, liabilities, damages, and expenses (including, without limitation, reasonable attorneys' fees), including without limitation, those based on contract or tort, arising out of or in connection with a claim, suit or proceeding brought by a third party based upon bodily injury (including death) or damage to tangible personal property (not including lost or damaged data) arising from the negligent or intentional acts or omissions of the indemnifying party or its subcontractors, or the officers, directors, employees, agents, successors and assigns of any of them. In the event that the indemnified party's or a third party's negligent or intentional acts or omissions contributed to cause the injury or damage for which a claim of indemnity is being asserted against the indemnifying party hereunder, the damages and expenses (including, without limitation, reasonable attorneys' fees) shall be allocated or reallocated, as the case may be, between the indemnified party, the indemnifying party and any other party bearing responsibility in such proportion as appropriately reflects the relative fault of such parties, or their subcontractors, or the officers, directors, employees, agents, successors and assigns of any of them, and the liability of the indemnifying party shall be proportionately reduced. The foregoing indemnification obligations are conditioned upon the indemnified party promptly notifying the indemnifying party in writing of the claim, suit or proceeding for which the indemnifying party is obligated under this Section 24, cooperating with, assisting and providing information to, the indemnifying party as reasonably required, and granting the indemnifying party the exclusive right to defend or settle such claim, suit or proceeding.\"}, {\"id\": \"25.0\", \"title\": \"INSURANCE (a) Each party shall be responsible for maintaining Worker's Compensation insurance in the statutory amounts r\", \"level\": 2, \"text\": \"25.0 INSURANCE (a) Each party shall be responsible for maintaining Worker's Compensation insurance in the statutory amounts required by the applicable state laws. (b) Each party shall maintain Commercial General Liability insurance with bodily injury and property damage limits of $[*****] per occurrence and $[*****] aggregate. Such insurance shall (a) provide for contractual liability coverage, (b) provide for cross liability coverage, and (c) name the other party and its subcontractors, as well as the directors, officers, employees, agents, successors and assigns of all of them, as additional insureds, but only to the extent of liabilities falling within the indemnity obligations of the other party pursuant to the terms of Section 24 in this Agreement.\"}, {\"id\": \"26.0\", \"title\": \"REQUIREMENTS FOR RESELLERS 26\", \"level\": 2, \"text\": \"26.0 REQUIREMENTS FOR RESELLERS 26.1 [*****]\"}, {\"id\": \"26.2\", \"title\": \"[*****]\", \"level\": 2, \"text\": \"26.2 [*****]\"}, {\"id\": \"27.0\", \"title\": \"GENERAL PROVISIONS\", \"level\": 2, \"text\": \"27.0 GENERAL PROVISIONS. 27.1 Choice of Law. The validity, interpretation, and performance of this Agreement shall be controlled by and construed under the laws of the State of New York, United States of America, as if performed wholly within the state and without giving effect to the principles of conflicts of law, and the state and federal courts of California shall have jurisdiction over any claim arising under this Agreement. The parties specifically disclaim the UN Convention on Contracts for the International Sale of Goods. Notwithstanding the foregoing, either party may seek interim injunctive relief in any court of appropriate jurisdiction with respect to any alleged breach of such party's intellectual property or proprietary rights.\"}, {\"id\": \"27.2\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"27.2 Force Majeure. Except for the obligation to pay monies due and owing, neither party shall be liable for any delay or failure in performance due to events outside the defaulting party's reasonable control, including without limitation acts of God, earthquakes, labor disputes, industry wide shortages of supplies, actions of governmental entities, riots, war, acts of terrorism, fire, epidemics, or delays of common carriers or other circumstances beyond its reasonable control. The obligations and rights of the defaulting party shall be extended for a period equal to the period during which such event prevented such party's performance.\"}, {\"id\": \"27.3\", \"title\": \"No Waiver\", \"level\": 2, \"text\": \"27.3 No Waiver. The waiver by either party of any right provided under this Agreement shall Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 not constitute a subsequent or continuing waiver of such right or of any other right under this Agreement.\"}, {\"id\": \"27.4\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"27.4 Assignment. Distributor may not assign or delegate its rights or obligations under this Agreement (other than (i) the right to receive any amount due, which shall be freely assignable, or (ii) to Distributor's parent or majority-owned subsidiary company of sufficient net worth to meet any potential liability under this Agreement) without the prior written consent of Cisco, such consent not to be unreasonably withheld or delayed, provided that any such assignment shall not relieve Distributor of any obligation to pay monies that were owed Cisco prior to the date of the assignment.\"}, {\"id\": \"27.5\", \"title\": \"Severability\", \"level\": 2, \"text\": \"27.5 Severability. In the event that one or more terms of this Agreement becomes or is declared to be illegal or otherwise unenforceable by any court of competent jurisdiction, each such term shall be null and void and shall be deemed deleted from this Agreement. All remaining terms of this Agreement shall remain in full force and effect. Notwithstanding the foregoing, if this paragraph is invoked and, as a result, the value of this Agreement is materially impaired for either party, as determined by such party in its sole discretion, then the affected party may terminate this Agreement by written notice with immediate effect to the other.\"}, {\"id\": \"27.6\", \"title\": \"Attorneys' Fees\", \"level\": 2, \"text\": \"27.6 Attorneys' Fees. In any suit or proceeding relating to this Agreement the prevailing party will have the right to recover from the other its costs and reasonable fees and expenses of attorneys incurred in connection with the suit or proceeding, including costs, fees and expenses upon appeal, separately from and in addition to any other amount included in such judgment. This provision is intended to be severable from the other provisions of this Agreement, and shall survive expiration or termination and shall not be merged into any such judgment\"}, {\"id\": \"27.7\", \"title\": \"No Agency\", \"level\": 2, \"text\": \"27.7 No Agency. This Agreement does not create any agency, partnership, joint venture, or franchise relationship. No employee of either party shall be or become, or shall be deemed to be or become, an employee of the other party by virtue of the existence or implementation of this Agreement. Each party hereto is an independent contractor. Neither party has the right or authority to, and shall not, assume or create any obligation of any nature whatsoever on behalf of the other party or bind the other party in any respect whatsoever.\"}, {\"id\": \"27.8\", \"title\": \"Notices\", \"level\": 2, \"text\": \"27.8 Notices. All notices required or permitted under this Agreement will be in writing and will be deemed given one (1) day after deposit with a commercial express courier specifying next day delivery (or two (2) days for international courier packages specifying 2-day delivery), with written verification of receipt. All communications will be sent to the addresses set forth on the cover sheet of this Agreement or such other address as may be designated by a party by giving written notice to the other party pursuant to this paragraph. Notwithstanding the foregoing, notices regarding general changes in product status, pricing, policies, financial transactions or programs may also be made by posting on Cisco.com or delivery by e-mail or fax, as applicable. Cisco shall use commercially reasonable efforts to provide Distributor [*****] notice when introducing new Programs or Product or modifying Product pricing. Any notice regarding discontinuation of Product shall be pursuant to Cisco's then-current End of Life Policy, as found at http://www.cisco.com/en/US/products/products end-of-life policy.html. A current copy of this policy, as of the Effective Date of this Agreement, is attached hereto as Exhibit G. [*****].\"}, {\"id\": \"27.9\", \"title\": \"Non-exclusive Market and Purchase Rights\", \"level\": 2, \"text\": \"27.9 Non-exclusive Market and Purchase Rights. It is expressly understood and agreed that this Agreement does not grant to Cisco or Distributor an exclusive right to purchase or sell Products and shall not prevent either party from developing or acquiring or selling competing Products of other vendors or customers.\"}, {\"id\": \"27.11\", \"title\": \"Counterparts\", \"level\": 2, \"text\": \"27.11 Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed an original and together which shall constitute one and the same instrument. A validly executed counterpart that is delivered by Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 one party to the other via electronic transmission (a \\\"Counterpart Image\\\") shall be valid and binding to the same extent as one delivered physically, provided that the valid signature is clearly visible in the Counterpart Image. In the event that a party delivers a Counterpart Image in place of an originally-executed counterpart, such party shall retain the originally-executed counterpart in its files for at least the duration of the Term hereof.\"}, {\"id\": \"27.12\", \"title\": \"Headings\", \"level\": 2, \"text\": \"27.12 Headings. Headings of sections have been added solely for convenience of reference and shall not be deemed part of this Agreement. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}, {\"id\": \"EXHIBIT A\", \"title\": \"TERRITORY\", \"level\": 1, \"text\": \"EXHIBIT A TERRITORY Territory: The United States, excluding its territories. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}, {\"id\": \"EXHIBIT B\", \"title\": \"VALUE ADDED DISTRIBUTOR SUPPORT EXHIBIT\", \"level\": 1, \"text\": \"EXHIBIT B VALUE ADDED DISTRIBUTOR SUPPORT EXHIBIT\"}, {\"id\": \"1.0\", \"title\": \"DEFINITIONS\", \"level\": 2, \"text\": \"1.0 DEFINITIONS. Capitalized terms used in this Exhibit B have the meanings assigned to those terms in Section 1.0 of the Nonexclusive Value Added Distributor Agreement Terms and Conditions. Additional capitalized terms and the definitions assigned to those terms in this Exhibit B follow: CCO means Cisco Connection Online, Cisco's online information web server. Customer means End Users and Resellers. Standard Business Hours means 6:00 AM to 6:00 PM Pacific Standard Time Monday through Friday, excluding Cisco-observed holidays, in the U.S. and Canada and outside the U.S. and Canada, means 8:00 AM to 6:00 PM Australia's Eastern Standard Time and Central European Time, Monday through Friday, excluding local Cisco-observed holidays. TAC means Cisco's Technical Assistance Center.\"}, {\"id\": \"2.0\", \"title\": \"CISCO RIGHTS AND OBLIGATIONS\", \"level\": 2, \"text\": \"2.0 CISCO RIGHTS AND OBLIGATIONS. For Products purchased under the Agreement, Cisco provides the services described below. [*****]\"}, {\"id\": \"2.1\", \"title\": \"CCO Access\", \"level\": 2, \"text\": \"2.1 CCO Access. Cisco will provide DISTRIBUTOR with partner-level access to CCO.\"}, {\"id\": \"2.2\", \"title\": \"Technical Support\", \"level\": 2, \"text\": \"2.2 Technical Support. [*****].\"}, {\"id\": \"2.3\", \"title\": \"Updates\", \"level\": 2, \"text\": \"2.3 Updates. [*****].\"}, {\"id\": \"2.4\", \"title\": \"Hardware Support\", \"level\": 2, \"text\": \"2.4 Hardware Support. 2.4.1 Return for Replacement. During the Cisco warranty period, DISTRIBUTOR may return failed Product to Cisco for replacement. Cisco will use commercially reasonable efforts to ship a replacement within [*****] days after receipt of the failed Product from DISTRIBUTOR. After the end of the warranty period, parts will be charged at Cisco's then-current rates.\"}, {\"id\": \"2.4.2\", \"title\": \"DISTRIBUTOR may request advance replacement delivery of replacement parts (Cisco will send the part upon DISTRIBUTOR's r\", \"level\": 3, \"text\": \"2.4.2 DISTRIBUTOR may request advance replacement delivery of replacement parts (Cisco will send the part upon DISTRIBUTOR's receipt of an RMA number) at Cisco's then-current Advance Replacement charge.\"}, {\"id\": \"2.4.3\", \"title\": \"Product used for replacement may be new or equivalent to new, at Cisco's discretion\", \"level\": 3, \"text\": \"2.4.3 Product used for replacement may be new or equivalent to new, at Cisco's discretion.\"}, {\"id\": \"2.5\", \"title\": \"Cisco Brand Services Option\", \"level\": 2, \"text\": \"2.5 Cisco Brand Services Option. Cisco will make available for purchase by DISTRIBUTOR, all appropriate Cisco Brand support Products for Distributor's internal use and for resale to Resellers. This option to resell Cisco brand services whereby services are delivered directly by Cisco to the End User is available in accordance with Cisco's then-current packaged service resale program. Availability of Cisco brand services is subject to geographic limitations. Information on w h e r e s u c h s e r v i c e s a r e a v a i l a b l e f o r r e s a l e , a s w e l l a s t h e p r o c e s s f o r r e s e l l i n g C i s c o b r a n d s e r v i c e s i s l o c a t e d a t \\\"http://www.cisco.com/warp/cproreg/45/index.html\\\".\"}, {\"id\": \"3.0\", \"title\": \"DISTRIBUTOR RIGHTS AND OBLIGATIONS\", \"level\": 2, \"text\": \"3.0 DISTRIBUTOR RIGHTS AND OBLIGATIONS. 3.1 Prioritization and Escalation Guideline. DISTRIBUTOR will escalate problems to Cisco pursuant to the Escalation and Prioritization Guideline (Appendix A).\"}, {\"id\": \"3.2\", \"title\": \"Spare Parts\", \"level\": 2, \"text\": \"3.2 Spare Parts. DISTRIBUTOR shall maintain sufficient spare parts inventory to support its Customer base for a one-month period under normal circumstances. DISTRIBUTOR shall maintain adequate manpower and facilities to assure prompt handling of inquiries, orders and shipments for Products.\"}, {\"id\": \"3.3\", \"title\": \"Warranty Service\", \"level\": 2, \"text\": \"3.3 Warranty Service. DISTRIBUTOR shall provide to its Resellers, [*****] all warranty service for a minimum Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 of the warranty period set forth in the published Product warranty provided with the original Product. Such warranty shall commence upon shipment to the End User. Warranty service will consist of Software and Hardware replacement service as follows:\"}, {\"id\": \"3.3.1\", \"title\": \"Software Service\", \"level\": 3, \"text\": \"3.3.1 Software Service. DISTRIBUTOR will use reasonable efforts to provide work\u200b around solutions or implement a Cisco-provided patch. DISTRIBUTOR will use reasonable effort to make latest release of all Cisco Software available to its resellers.\"}, {\"id\": \"3.3.2\", \"title\": \"Hardware Advance Replacement\", \"level\": 3, \"text\": \"3.3.2 Hardware Advance Replacement. DISTRIBUTOR will ship replacement parts and/or Product to its Resellers in accordance with Cisco's then- current published Product warranty applicable to the particular Product.\"}, {\"id\": \"3.4\", \"title\": \"Returns Coordination\", \"level\": 2, \"text\": \"3.4 Returns Coordination. DISTRIBUTOR will comply with the following: 3.4.1 DISTRIBUTOR shall coordinate the return of all failed parts and/or Product, freight and insurance prepaid, to the Cisco repair center specified by Cisco.\"}, {\"id\": \"3.4.2\", \"title\": \"DISTRIBUTOR shall comply with the following RMA procedure\", \"level\": 3, \"text\": \"3.4.2 DISTRIBUTOR shall comply with the following RMA procedure: 3.4.2.1 DISTRIBUTOR will ensure all Products are properly packaged prior to being shipped, and will include a written description of the failure and specification of any changes or alterations made to the Product. Product returned to Cisco will conform in quantity and serial number to the RMA request.\"}, {\"id\": \"3.4.2.2\", \"title\": \"DISTRIBUTOR shall tag each Product returned with the RMA transaction number and a brief description of the problem\", \"level\": 4, \"text\": \"3.4.2.2 DISTRIBUTOR shall tag each Product returned with the RMA transaction number and a brief description of the problem.\"}, {\"id\": \"3.4.2.3\", \"title\": \"Cisco will not accept any Product returned which is not accompanied by an RMA number\", \"level\": 4, \"text\": \"3.4.2.3 Cisco will not accept any Product returned which is not accompanied by an RMA number.\"}, {\"id\": \"3.4.3\", \"title\": \"Title and risk of loss to failed Product and parts transfers to Cisco upon delivery to the Cisco repair center specified\", \"level\": 3, \"text\": \"3.4.3 Title and risk of loss to failed Product and parts transfers to Cisco upon delivery to the Cisco repair center specified by Cisco.\"}, {\"id\": \"3.5\", \"title\": \"Reseller Support\", \"level\": 2, \"text\": \"3.5 Reseller Support. DISTRIBUTOR will ensure Reseller has all appropriate support as follows: 3.5.1 DISTRIBUTOR shall provide competent technical support staff to support the Product so as to ensure that the Reseller is able to provide the necessary support to the End User Reseller.\"}, {\"id\": \"3.5.2\", \"title\": \"Reseller Frontline Support\", \"level\": 3, \"text\": \"3.5.2 Reseller Frontline Support. DISTRIBUTOR will use best efforts to ensure that its Resellers provide high quality front-line support.\"}, {\"id\": \"3.5.3\", \"title\": \"[*****] Cisco is not responsible for any claims arising from failure by Distributor's Resellers to provide this support\", \"level\": 3, \"text\": \"3.5.3 [*****] Cisco is not responsible for any claims arising from failure by Distributor's Resellers to provide this support.\"}, {\"id\": \"3.5.4\", \"title\": \"Resale of Cisco Brand Services\", \"level\": 3, \"text\": \"3.5.4 Resale of Cisco Brand Services. Where available, DISTRIBUTOR will offer for purchase by its Resellers, all appropriate Cisco brand support products through its normal products availability process.\"}, {\"id\": \"4.0\", \"title\": \"SERVICES NOT COVERED UNDER THIS EXHIBIT\", \"level\": 2, \"text\": \"4.0 SERVICES NOT COVERED UNDER THIS EXHIBIT. 4.1 New Releases or Major Releases for Software.\"}, {\"id\": \"4.2\", \"title\": \"Customization of existing Software for non-standard applications\", \"level\": 2, \"text\": \"4.2 Customization of existing Software for non-standard applications.\"}, {\"id\": \"4.3\", \"title\": \"Support or replacement of Product that is altered, modified, mishandled, destroyed or damaged by natural causes or damag\", \"level\": 2, \"text\": \"4.3 Support or replacement of Product that is altered, modified, mishandled, destroyed or damaged by natural causes or damaged during unauthorized use.\"}, {\"id\": \"4.4\", \"title\": \"Software problems resulting from third party equipment or causes beyond Cisco's control\", \"level\": 2, \"text\": \"4.4 Software problems resulting from third party equipment or causes beyond Cisco's control.\"}, {\"id\": \"4.5\", \"title\": \"Any hardware upgrade of Product required to accept Updates\", \"level\": 2, \"text\": \"4.5 Any hardware upgrade of Product required to accept Updates.\"}, {\"id\": \"5.0\", \"title\": \"TERMINATION\", \"level\": 2, \"text\": \"5.0 TERMINATION. Upon expiration or termination of the Agreement, (a) all rights and licenses of DISTRIBUTOR under this Support Exhibit shall terminate, (b) DISTRIBUTOR shall immediately discontinue all representations that DISTRIBUTOR Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 provides maintenance services for Cisco Product, and (c) DISTRIBUTOR access to CCO shall terminate.\"}, {\"id\": \"6.0\", \"title\": \"SOFTWARE LICENSE\", \"level\": 2, \"text\": \"6.0 SOFTWARE LICENSE. DISTRIBUTOR acknowledges that it may receive Software as a result of services provided under this Agreement. DISTRIBUTOR agrees that it is licensed to distribute such Software only on Product covered under the services and subject to the terms and conditions of this Agreement and the Software license granted with the original acquisition. Except as otherwise specified in this Exhibit, DISTRIBUTOR shall not copy, in whole or in part, Software or documentation; modify the Software, reverse compile or reverse assemble all or any portion of the Software; or rent, lease, distribute, sell, or create derivative works of the Software. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 APPENDIX 1 CISCO PROBLEM PRIORITIZATION AND ESCALATION GUIDELINE To ensure that all problems are reported in a standard format, Cisco has established the following problem priority definitions. These definitions will assist Cisco in allocating the appropriate resources to resolve problems. Distributor must assign a priority to all problems submitted to Cisco. [*****] Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}, {\"id\": \"EXHIBIT D\", \"title\": \"SCANSOURCE FREIGHT POLICY\", \"level\": 1, \"text\": \"EXHIBIT D SCANSOURCE FREIGHT POLICY TO: All SUPPLIERS SUBJECT: ROUTING INSTRUCTIONS In order to mm1m1ze inbound transportation cost, and to maximize control over transit time, tracing, and expediting, this routing guide has been issued. These instructions supercede all previous shipping instructions and are to be retained for ready reference. For shipments of Catalyst Telecom and Paracon products: Contact: Melinda Hamilton, Receiving Supervisor Phone: (800) 854-9570 ext. 8187 Fax: (901) 369-7876 Email: melinda.hamilton@partnerservicesinc.com Ship to address: ScanSource, Inc. 4020 Quest Way, Ste. 114 Memphis, TN. 38115 Receiving hours: 7:00 am - 2:00 pm For shipments of ScanSource and ScanSource Security products: Contact: Deborah Lucas, Receiving Manager Phone: (800) 854-9570 ext. 8111 Fax: (901) 367-0666 Email: deborah.lucas@partnerservicesinc.com Ship to address: ScanSource, Inc. 4100 Quest Way Memphis, TN. 38115 Receiving hours 7:00 am - 12:00 pm (noon) Note: A packing slip/manifest must be included with each shipment. It should include: a) A listing of products and quantities shipped b) Purchase order number (this must also show on the bill of lading) c) Date shipped d) Name of carrier e) Tracking or pro number Please comply with the following instructions when transportation is our responsibility: 1. All freight charges assigned to ScanSource must be shipped \\\"freight collect\\\". For UPS shipments ship \\\"bill recipient\\\". Please consolidate all of one day's shipments on one bill of lading. Exceptions will be charged back. Cisco may accomplish this by leveraging an order grouping process and setting up internal tools accordingly. OG will only be available for LTL or TL carriers. In order to support OG, ScanSource must include a LTL and TL carriers in their routing config in SRC tool. If combined shipments do not meet the minimum requirement to ship LTL or TL (i.e. number pieces, min weight) then no grouping will be done. 2. Do not insure shipments or declare value for carriage. 3. Each bill of lading must display the total number of cartons in the shipment, i.e. 24 cartons on 1 pallet. Bill of lading must be filled out completely. Please accurately describe products with the appropriate NMFC code. If you do not have the NMFC information available, ask the carrier to identify it for you. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}, {\"id\": \"4\", \"title\": \"Indicate our purchase order number and number of boxes on all containers and shipping documents\", \"level\": 1, \"text\": \"4. Indicate our purchase order number and number of boxes on all containers and shipping documents. 5. All pallets must be standard 40\\\" wide X 48\\\" long four way pallets. Primary fork entry from the 40\\\" end. 6. Banding must be plastic, no metal. 7. Stack height on pallets is 48\\\" maximum. All freight bills are audited, and any premium transportation charges incurred because these instructions have not been followed will be charged to Cisco. The charges will be based on the actual premium paid. ScanSource agrees to provide Cisco with advance notice in the event such a charge becomes necessary. Cisco will have the opportunity to validate any such charge prior to actually incurring same. If pickup service, via the carrier shown below, is not available in your area or if you have any other questions concerning this guide, please contact the ScanSource Traffic Department at (901) 362-0421, Bob Balsano. Your cooperation in following this program is appreciated. STANDARD SURFACE TRANSPORTATION\"}, {\"id\": \"I\", \"title\": \"Shipments, not individual cartons, weighing less than 250 lbs\", \"level\": 1, \"text\": \"I. Shipments, not individual cartons, weighing less than 250 lbs. and meeting the weight and size restrictions, must be shipped by United Parcel Service. II. Approved motor carriers for all LTL shipments from the States shown below are listed. CARRIER SERVICING FedEx Freight East Toll free number for pickups (800) 874-4723 -Alabama -Arkansas -Georgia -Illinois -Indiana -Kentucky -Louisiana -Minnesota -Mississippi -Missouri -New Jersey -North Carolina -Oklahoma -South Carolina -Tennessee -Texas -Virginia -West Virginia -Wisconsin Con-way: Arizona California Colorado Oregon Washington ALL REMAINING STATES Yellow Freight Toll free (800) 610-6500 PREMIUM ROUTINGS Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 ScanSource Purchasing or Traffic Department must authorize use of premium freight (air, special truck, truckload) in advance. All premium shipments must state the total number of cartons in the shipment and the correct dimension of each carton. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 EXHIBIT E AFFILIATE LIST The following entities are either business units of Distributor or are wholly-owned subsidiaries of Distributor. For the purposes of this Agreement, and as set forth in Section 1 (\\\"Definitions\\\"), all such entities listed below shall be referred to herein as \\\"Affiliate(s).\\\"\"}, {\"id\": \"1\", \"title\": \"ScanSource, Inc\", \"level\": 1, \"text\": \"1. ScanSource, Inc. 2. ScanSource, Inc. d/b/a Catalyst Telecom 3. ScanSource, Inc. d/b/a Paracon 4. ScanSource Security Distribution, Inc. 5. T2 Supply, Inc. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 EXHIBIT F Software Transfer and Relicensing Policy September 15, 2000 This document sets forth Cisco's policy with respect to the transferability of any Cisco software (\\\"Software\\\"). A transfer occurs when: (1) the original or authorized subsequent licensee tries to convey or reassign its right to use the Software to another entity, or (2) the original lessor of Cisco used hardware (including bundled Software) (\\\"Hardware\\\") tries to reassign the original lessee's right to use the Software to another lessee, or the lessor tries to convey or reassign its right to lease the Hardware and Software bundle to another lessor. A rental would be treated the same as the lease situation as described in item 2 above. This policy applies to all Software whether Standalone or Embedded. Standalone Software is Software which is not required to operate the Hardware upon which it resides (i.e., ICSG software such as call center, unified messaging, network management software). Embedded Software is Software which is incorporated into the Hardware and is required for its operation (i.e., operating system software, certain features of IOS). Policy: Cisco's policy is that Software, whether Standalone or Embedded, is not transferable, except where a listed exception below applies, and except, of course, where Cisco's contract expressly allows it. Any other transfers will require the payment of a new license fee (see Global Price List). For products where there is no separate line item for the Software (i.e. the prices for both the Hardware and Software are bundled), and therefore, a fee cannot be determined, an exception will be made to allow for the transfer without the customer being required to obtain a new license (the customer may be required to pay an inspection fee), if (A) Software to be transferred (i) will be under a support contract provided by either Cisco or a Cisco\u200b\u2010 authorized support partner or (ii) is still supported by Cisco; or (B) approval from the theatre Sales Controller has been obtained. Use of the Software will be governed by either the original license terms and conditions in place between Cisco and the original Software licensee or by the new license between Cisco and the new user. Cisco may withhold its consent to any transfer not conforming to this policy. License Fee: The License Fee is generally the same amount as the fee charged for a new license or a portion of the fee of a new license, unless otherwise noted on the Global Price List. It is the obligation of the transferor to obtain Cisco's consent and/or a new license before the transfer occurs. Exceptions: Provided the conditions of transfer are met as set forth below, the follow exceptions apply to the prohibition against transfer without written approval and payment of the applicable fee. These exceptions may be overridden by express terms in an applicable licensing agreement governing the transferability of Special License Software (Special License Software is the term now used in our templates to refer to ICSG Product) Affiliate: An entity may transfer its right to use a certain piece of Software to its Affiliate. An Affiliate is another entity where at least 50.1% of its voting power is owned or controlled by the transferring entity or where as least 50.1% of the transferring entity's voting power is owned or controlled by the transferee. Merger or Acquisition: An entity may transfer its right to use a certain piece of Software to the purchaser of all or substantially all of the capital stock of the transferor or all or substantially all of the assets of that portion of the transferor's business to which those licenses pertain. Lease: In a leasing situation where the original lessee/customer would like to buy out the equipment from the leasing company during or at the end of the lease term, the original lessee/customer may retain the license without paying a new License Fee, provided leasing company gives Cisco prior written notice. Also, if the original lessee/customer defaults under the lease and the leasing company takes the equipment back before the end of the lease term, the leasing company may transfer the license to the another lessee for the remainder of the original lease term, without paying Cisco a License Fee, upon 30 days' prior written notice to Cisco, or as soon as practicable if the equipment is re-leased before such 30- day period. If the new lease term is in Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 excess of the original lease term, the leasing company is expected to pay Cisco a new License Fee on or before the expiration date of the original lease term. [NOTE: In the situation where a leasing company leases Cisco equipment to Customer A for a specified term and at the end of the lease term, the leasing company desires to lease the same equipment to Customer B, leasing company may not transfer the license without obtaining a new license from Cisco.)]. Outsource: Customer desires to outsource the operation, support and maintenance of its network to a third party (e.g. EDS) (\\\"Third-Party Service Provider\\\"), for the benefit of that customer. As part of the outsourcing, customer transfers all of its rights, title and interest to the assets, including certain Cisco products and software licenses, to the Third-Party Service Provider. Customer may transfer the license to the Third-Party Service Provider solely for the purposes of providing services to Customer upon 30 days' prior written notice to Cisco. All notices should be sent to sw-license@cisco.com or as indicated in the agreement between Cisco and the customer or transferor, if any. Conditions of Transfer: Transfers, in any event, shall only be allowed under the following conditions: \u25e6 The parties involved in the transfer are not in breach of the agreement governing the use of the Software or any other agreement with Cisco; \u25e6 Any additional services or charges incurred by Cisco as the result of any transfer shall be borne by the transferor and transferee; and \u25e6 The parties involved in the transfer shall provide written prior notice of a permitted transfer to Cisco and the transferee shall, in a writing to Cisco, (i) assume all of the obligations of the transferor, and (ii) agree that transferee's use of the Software shall be governed by the terms of the then-current license agreement between Cisco and transferor or, at Cisco's sole discretion, by the terms of Cisco's then-current standard license agreement. Questions? Any questions or comments regarding this policy should be sent to sw-license@cisco.com. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 EXHIBIT G Cisco End of Life Policy Products reach the end of their Product Life Cycle for a number of reasons. These reasons may be due to market demands, technology innovation and development driving changes in the product, or the products simply mature over time and are replaced by functionally richer technology. While this is an established part of the overall product life cycle, Cisco Systems recognizes that end-of-life milestones often prompt companies to review the way in which such end-of-sale and end-of-life milestones impact the Cisco products in their networks. With that in mind, we have set out below Cisco's end-of-life policy to help customers better manage their end-of-life transition and to understand the role that Cisco can play in helping to migrate to alternative Cisco platforms and technology. The End of Life Policy only applies to End of Life and End of Sale announcements made in all Theaters on or after November 30, 2002 for all Cisco product lines. The Policy does not apply to product that is already subject to an End of Life and/or End of Sale announcement. The general policy guidelines are:\"}, {\"id\": \"1\", \"title\": \"As a general rule, Cisco will provide 6 months' notice of the affected product's end-of-sale date and/or the last day w\", \"level\": 1, \"text\": \"1. As a general rule, Cisco will provide 6 months' notice of the affected product's end-of-sale date and/or the last day when the affected product can be ordered. This notice will appear on Cisco.com site (http://www.cisco.com/en/US/products/prod_end_of_life.html) and we encourage you to visit this site regularly as it contains useful information regarding Cisco's end-of-life program. Sign up to receive notification here: http://www.cisco.com/pcgi-bin/Support/FieldNoticeTool/field-notice\"}, {\"id\": \"2\", \"title\": \"Access to Cisco's Technical Assistance Center (TAC) will be available 24 hours a day, seven days a week for a period of\", \"level\": 1, \"text\": \"2. Access to Cisco's Technical Assistance Center (TAC) will be available 24 hours a day, seven days a week for a period of 5 years from the end-of-sale date for hardware and operating system software issues and for a period of 3 years from the end-of-sale date for application software issues.\"}, {\"id\": \"3\", \"title\": \"Spares or replacement parts for hardware will be available for a period of 5 years from the end-of\u200b sale date\", \"level\": 1, \"text\": \"3. Spares or replacement parts for hardware will be available for a period of 5 years from the end-of\u200b sale date. We will provide spares and replacement parts in accordance with our Return Materials Authorization (RMA) process.\"}, {\"id\": \"4\", \"title\": \"Software support will be as follows\", \"level\": 1, \"text\": \"4. Software support will be as follows a. For the first year following the end-of-sale date, we will provide bug fixes, maintenance releases, workarounds, or patches for critical bugs reported via the TAC or Cisco.com Web site. b. After the first year and for Operating System SW -where available- we will provide bug fixes, maintenance releases, workarounds or patches for a period of 4 years for operating system software. Bear in mind that it may be necessary to use software upgrade release to correct a reported problem.\"}, {\"id\": \"c\", \"title\": \"After the first year and for Application SW -where available - we will provide bug fixes, maintenance releases, workaro\", \"level\": 1, \"text\": \"c. After the first year and for Application SW -where available - we will provide bug fixes, maintenance releases, workarounds or patches for a period of 2 years for application software. Bear in mind that it may be necessary to use software upgrade release to correct a reported problem.\"}, {\"id\": \"5\", \"title\": \"You will need to ensure that you have a current and fully paid support contract with Cisco\", \"level\": 1, \"text\": \"5. You will need to ensure that you have a current and fully paid support contract with Cisco. Please contact your Support Account Manager regarding fees payable during the end-of-life period so that we can support you right through the end-of-life transition period.\"}, {\"id\": \"6\", \"title\": \"Below are guidelines that should be followed to ensure that you receive effective support for the affected products wit\", \"level\": 1, \"text\": \"6. Below are guidelines that should be followed to ensure that you receive effective support for the affected products within your network: a. For hardware or software that is not covered under a service contract, customers may add the product(s) to a current contract or purchase a new contract until 12 months after the end-of-sale date. b. Service contracts that have not been renewed or have lapsed after 12 months of end-of\u200b sale date are not re-newable.\"}, {\"id\": \"c\", \"title\": \"Renewal of your service contract will generally be available until the last year of support, but will not extend\", \"level\": 1, \"text\": \"c. Renewal of your service contract will generally be available until the last year of support, but will not extend Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 beyond the last date of support. The end-of-life milestones and Cisco commitments are presented in Table 1. Table 1. Standard Guideline for End-of-Life Milestones Milestone - 6 mos Day 0 1 Year 2 Year 3 Year 4 year 5 Year End-of-sale date End-of-Sale Notice Period Operating System Software Maintenance Support See 4(a) See 4(b) above Add or attach new service contracts Renew service contracts - for HW & Operating System SW Hardware Repair or Replacement Customer Service and Support of HW & Operating System SW (TAC access & support) Application Software maintenance support See 4(a) See 4(c) above Renew service contracts - for Application SW Here is an explanation of some of the terms that we have used in this notice: End of Product Life Cycle: A process that guides the final business operations associated with the product life cycle. The end-of-life process consists of a series of technical and business milestones and activities that, once completed, make a product obsolete. Once obsolete, the product is not sold, manufactured, improved, repaired, maintained, or supported. End-of-sale date: The last date to order the product through Cisco point-of-sale mechanisms. The product is no longer for sale. Hardware: The physical product and its physical components. Operating System Software: Cisco operating system software that runs on Cisco hardware Application software: Cisco software that requires the presence of some non-Cisco operating system software. Software Maintenance support: The time period that Cisco may release any software maintenance releases or bug fixes to the software product. After this date, Cisco Engineering will no longer develop, repair, maintain, or test the product software. Source: SCANSOURCE, INC., 10-K, 8/22/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement1\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.38\", \"level\": 1, \"text\": \"Exhibit 10.38 IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****]. CISCO SYSTEMS, INC. NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT This Nonexclusive Value Added Distributor Agreement (\\\"Agreement\\\"), between ScanSource, Inc., a South Carolina corporation, with its principal place of business at 6 Logue Court, Greenville, South Carolina, 29615 (\\\"Distributor\\\"), and Cisco Systems, Inc., a California corporation with its principal place of business at 170 West Tasman Drive, San Jose, California 95134 - 1706, (\\\"Cisco\\\") is entered into as of the date last written below (\\\"the Effective Date\\\"). This Agreement consists of this signature page and the following attachments, each of which is incorporated into this Agreement by reference:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonexclusive Value Added Distributor Agreement Terms and Conditions 2\", \"level\": 1, \"text\": \"1. Nonexclusive Value Added Distributor Agreement Terms and Conditions 2. EXHIBIT A: Territory 3. EXHIBIT B: Value Added Distributor Support Exhibit 3.1 Appendix 1: Cisco Problem Prioritization and Escalation Guideline 4. EXHIBIT C: Software License Agreement 5. EXHIBIT D: Distributor Freight Policy 6. EXHIBIT E: Affiliate List 7. EXHIBIT F: Software Transfer and Relicensing Policy 8. EXHIBIT G: End of Life Policy This Agreement is the complete agreement between the parties hereto concerning the subject matter of this Agreement and replaces any prior or contemporaneous oral or written communications between the parties. In the event of conflict between the terms of this Agreement and the terms of an Exhibit hereto, the terms of the Exhibit shall govern. There are no conditions, understandings, agreements, representations or warranties, express or implied, which are not specified herein. This Agreement may only be modified by a written document executed by the parties hereto. IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed. Each party warrants and represents that its respective signatories whose signatures appear below have been and are on the date of signature duly authorized to execute this Agreement. ScanSource,Inc. (\\\"Distributor\\\") Cisco Systems, Inc. (\\\"Cisco\\\") By: /s/ Jeffrey E. Yelton By: /s/ Frank A. Calderon Name: Jeffrey E. Yelton Name: Frank A . Calderon Title: VP Merchandising Title: VP, WW Sales Finance Date: 1/19/07 Date: January 22, 2007 Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT TERMS AND CONDITIONS\"}}, {\"id\": \"1.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 2, \"text\": \"1.0 DEFINITIONS. Affiliate(s) are the entities listed on Exhibit E to this Agreement that are either business units of Distributor (and therefore wholly-owned and a part of Distributor) or are wholly-owned subsidiaries of Distributor, but in either case, only for so long as ownership remains as defined in this provision. Cisco Quarter shall mean Cisco's fiscal quarters (August 1-October 31; November 1-January 31; February 1-April 30; and May 1-July 31). Documentation shall mean user manuals, training materials, Product descriptions and specifications, technical manuals, license agreements, supporting materials and other printed information relating to any Product, whether distributed in print, in electronic form, or in CD-ROM or video format. End User is the final purchaser or licensee who has acquired Products for its own internal use and not for resale, remarketing or redistribution. An entity that performs stocking, sparing or warehousing activities for third parties or procures Cisco Products, Services or Software for delivery to third parties is not an End User. Global Price List means a complete listing of those Cisco products, services, including products and services which Cisco may make available to Distributor at its sole discretion, and associated prices. Hardware is the tangible product made available to Distributor. Major Release or New Release means a release of Software which is designated by Cisco as a change in the ones digit in the Software version number [(x).x.x]. Non-Genuine Products are any and all products: (i) to which a Mark or other Cisco trademark or service mark has been affixed without Cisco's consent; (ii) that have not been manufactured by Cisco or Cisco Technologies, Inc. (\\\"CTI\\\") or by a licensed manufacturer of either Cisco or CTI in accordance with the applicable license; or (iii) are produced with the intent to counterfeit or imitate a genuine Cisco Product Obsolete Product shall mean any Product that is removed from the then-current Value Added Distributor Price List. Purchase Order is a written or electronic order from Distributor to Cisco for Hardware, Software or Services to be purchased, licensed or provided under this Agreement. Product means, individually or collectively as appropriate, Hardware, licensed Software, Documentation, developed products, supplies, accessories, and goods to the foregoing, listed on the then-current published Global Price List. Reseller means an authorized reseller of Distributor that meets Cisco's then-current requirements for resellers, including, without limitation, the requirements set out in Section 26.0 of this Agreement. In the event Cisco enters into authorization agreements whereby Cisco authorizes particular resellers to purchase Products or Services from Distributor and to resell Products or Services to End User, then \\\"Reseller\\\" shall mean a reseller that is a party to such an authorization agreement. Services means Cisco's SmartNet family of packaged service offerings, as well as such other service offerings as Cisco makes available for purchase by Distributor on Cisco's Wholesale or Global Price List. Software is the machine readable (object code) version of the computer programs listed from time to time on the Wholesale or Global Price List and made available by Cisco for license by Distributor, and any copies or Updates thereof. Cisco reserves the right, during the term of this Agreement, to license and distribute items of Software from time to time. Such items of Software may be licensed under additional or different policies and license terms, which will be made available to Distributor. Notwithstanding the use of the term \\\"purchase\\\" to refer to any item of Software comprising or included within a Product, Cisco and Distributor agree that all Software provided by Cisco to Distributor under this Agreement is licensed by Cisco to Distributor rather than purchased by Distributor from Cisco. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 Territory is comprised of those regions or countries listed in Exhibit A. Unauthorized Cisco Product means any genuine Cisco Product or Cisco Service that Distributor purchases or acquires from any party other than Cisco and/or an Approved Source. Unauthorized Cisco Products do not include Non-Genuine Products. Update means a bug fix, error correction, patch or workaround for the Software which is provided by Cisco to Distributor in response to Distributor's request, or at Cisco's option, which Cisco chooses to provide to Distributor. Value Added Distributor Price List shall mean a portion of the Global Price List containing Products which Cisco makes available to Distributor for stocking and the prices at which Cisco will sell such Products to Distributor.\"}}, {\"id\": \"2.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SCOPE\", \"level\": 2, \"text\": \"2.0 SCOPE. This Agreement and the attached Exhibits set forth the terms and conditions for Distributor's purchase of Hardware and license of Software, and redistribution of Products, during the term of this Agreement. Affiliates of Distributor listed on Exhibit E may purchase Products, solely for redistribution, from Cisco under this Agreement. Distributor hereby guarantees the performance by such Affiliates of the financial and other contractual obligations set forth in this Agreement and represents and warrants that it is empowered to enter into this Agreement on behalf of such Affiliates, and to bind (and does so bind) such Affiliates to the terms and conditions of this Agreement. Cisco may require certain of the listed Affiliates to execute an agreement with Cisco or an affiliate of Cisco such that the legal relationship shall be between Cisco or Cisco's affiliate and Distributor's Affiliate. Any breach by Distributor or by an Affiliate of (i) this Agreement, or (ii) any other agreement between Cisco and Distributor or an Affiliate of either party, shall entitle Cisco to terminate this Agreement and/or any such agreement with Affiliate and/or any other Affiliate pursuant to Section 18. The limit of liability set forth in this Agreement shall be deemed an aggregate limit of liability, not per Affiliate, regardless of whether an Affiliate or Affiliates has executed a separate agreement with Cisco or a Cisco Affiliate permitting such Affiliate to purchase under the terms of this Agreement. In addition, any reporting requirements hereunder shall be performed solely by Distributor. All reporting information related to Distributor or any Affiliate(s) shall be aggregated and submitted as part of a single report, as required herein.\"}}, {\"id\": \"3.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT OF DISTRIBUTOR\", \"level\": 2, \"text\": \"3.0 APPOINTMENT OF DISTRIBUTOR. 3.1 By this Agreement, Cisco makes, and Distributor accepts, the appointment of Distributor as an authorized, non-exclusive distributor of Products and Services to Resellers located in the Territory. Distributor agrees to use its best efforts to distribute Product solely to Resellers located in the Territory. Those Resellers may resell Product only to End Users who intend to use the Product in the Territory. All Resellers to which Distributor distributes Product must meet Cisco's then-current guidelines for Resellers, as amended from time to time.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor is authorized to resell only those Products and Services which are listed on the Value Added Distributor Pri\", \"level\": 2, \"text\": \"3.2 Distributor is authorized to resell only those Products and Services which are listed on the Value Added Distributor Price List. Notwithstanding the foregoing, Cisco may, in its discretion, make available for purchase and resale by Distributor, but not for stocking by Distributor, certain other products and/or services which are listed on the Global Price List. Upon such products or services being made available to Distributor, such products and services will be deemed to be Products and Services as defined herein.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Products Requirements\", \"level\": 2, \"text\": \"3.3 Products Requirements. For new Products or Services added to the Global or Value Added Distributor Price List, including products or services which become available to Cisco as a result of an acquisition by Cisco of another entity, Cisco may impose certification, installation, or training requirements on Distributor prior to allowing Distributor to purchase, resell, or provide support for such Products or Services.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees not to solicit orders for Products or Services, or to engage salespeople or establish warehouses or o\", \"level\": 2, \"text\": \"3.4 Distributor agrees not to solicit orders for Products or Services, or to engage salespeople or establish warehouses or other distribution centers for the redistribution of Products or Services, outside the Territory, except to the extent advertising is placed in a particular advertising medium (except catalogs) which is distributed both inside and outside of the Territory. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unauthorized Cisco Products\", \"level\": 2, \"text\": \"3.5 Unauthorized Cisco Products. Distributor acknowledges that the purchase and Resale of Non-Genuine or Unauthorized Cisco Products are not within the scope of this Agreement and Integrator is not entitled to the rights granted herein with respect to the resale of such Non-Genuine or Unauthorized Cisco Products. For all Unauthorized Cisco Products, Cisco reserves the right to withhold any warranty or Cisco Support on such products, unless such products pass a Cisco equipment inspection and Cisco receives payment for the applicable equipment inspection and/or software license fees, as required in the then\u200b current Software Transfer and Licensing Policy. A printed copy of the Software Transfe and Licensing Policy, in effect on the Effective Date of this Agreement and available at http://www.cisco.com/warp/public/csc/refurb_equipment/swpolicy.html, shall accompany this agreement. This policy is subject to change without notice. If Cisco determines that Reseller has Resold and/or redistributed Unauthorized Cisco Products purchased from Unauthorized Sources, then Cisco may, at Cisco's sole discretion: (a) audit Reseller's purchase and resale records of Cisco Product and relevant records pursuant to Section 17.0 (Reports and Records) and/or (b) invoice Reseller for all reasonable costs incurred by Cisco in its performance of the Audit and/or (c) suspend all Product shipments to Reseller.\"}}, {\"id\": \"4.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDERS\", \"level\": 2, \"text\": \"4.0 ORDERS. 4.1 Upon and subject to credit approval by Cisco at the time of Cisco's receipt of any Purchase Order, Distributor shall purchase or license Products or Services by issuing a Purchase Order, signed, if requested by Cisco, or (in the case of electronic transmission) sent by its authorized representative, indicating specific Products and Services, Cisco Product numbers, quantity, unit price, total purchase price, shipping instructions, requested shipping dates, bill-to and ship-to addresses, tax exempt certifications, if applicable and contract reference, if any. No contingency contained on any Purchase Order shall be binding upon Cisco. The terms of this Agreement shall apply, regardless of any additional or conflicting terms on any Purchase Order or other correspondence or documentation submitted by Distributor to Cisco, and any such additional or conflicting terms are deemed rejected by Cisco.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cisco shall use commercially reasonable efforts to provide order acknowledgement information within [*****] business day\", \"level\": 2, \"text\": \"4.2 Cisco shall use commercially reasonable efforts to provide order acknowledgement information within [*****] business days for all Purchase Orders placed on Cisco.com or within [*****] business days of Purchase Orders faxed or hand delivered to Cisco. Cisco Customer Service will review and accept or decline all Purchase Orders for the Cisco entity that will supply the Products or Services, and no other person is authorized to accept Purchase Orders on behalf of Cisco. Cisco Customer Service may accept a Purchase Order even if some of the information required by Section 4.1 above is missing or incomplete. In relation to Services, Cisco will confirm acceptance of a Purchase Order for Services by issuing a list of Products covered by such Services (the \\\"Equipment List\\\").\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor may defer Product shipment for up to [*****] from the original shipping date scheduled by Cisco, provided wr\", \"level\": 2, \"text\": \"4.3 Distributor may defer Product shipment for up to [*****] from the original shipping date scheduled by Cisco, provided written or electronic notice (issued, in either case, by an authorized representative of Distributor) is received by Cisco at least [*****] days before the originally scheduled shipping date. Cancelled Purchase Orders, rescheduled shipments or Product configuration changes requested by Distributor less than [*****] days before the original scheduled shipping date shall be subject to (a) acceptance by Cisco, and (b) a charge of [*****] of the total invoice amount relating to the affected Products. Cisco reserves the right to reschedule shipment in cases of configuration changes requested by Distributor within [*****] days of scheduled shipment. No cancellation shall be accepted by Cisco where Products are purchased with implementation Services, including design, customization or installation Services, except as may be set forth in the agreement or Statement of Work under which the Services are to be rendered.\"}}, {\"id\": \"5.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SHIPPING AND DELIVERY 5\", \"level\": 2, \"text\": \"5.0 SHIPPING AND DELIVERY 5.1 Scheduled shipping dates will be assigned by Cisco as close as practicable to the Distributor's requested date based on Cisco's then-current lead times for the Products. Cisco will communicate scheduled shipping dates in the order acknowledgement or on Cisco.com. Cisco will ship Product in compliance with Distributor Freight Policy set forth in Exhibit D. If no guidance is contained on Exhibit D for any particular shipment, Cisco shall select the carrier.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For shipments to the United States, shipping terms are [*****], which shall appear on Cisco's order acknowledgement or b\", \"level\": 2, \"text\": \"5.2 For shipments to the United States, shipping terms are [*****], which shall appear on Cisco's order acknowledgement or be accessible via Cisco.com. Title and risk of loss shall pass from Cisco to Distributor [*****]. For orders placed and/or shipments to destinations outside of the United States but within the Territory (\\\"International Orders\\\"), Distributor may need to contract with, and/or order from, a Cisco affiliate. Different shipping terms may apply to International Orders, as Cisco shall specify at the time and as shall be recorded in Distributor's agreement with such Cisco affiliate or otherwise set out on Cisco.com.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CISCO SHALL NOT BE LIABLE FOR LOSS, DAMAGE OR PENALTY FOR DELAY IN DELIVERY OR FOR FAILURE TO GIVE NOTICE OF ANY DELAY\", \"level\": 2, \"text\": \"5.3 CISCO SHALL NOT BE LIABLE FOR LOSS, DAMAGE OR PENALTY FOR DELAY IN DELIVERY OR FOR FAILURE TO GIVE NOTICE OF ANY DELAY. EXCEPT IN ACCORDANCE WITH THE APPLICABLE DELIVERY TERMS SET FORTH IN THIS AGREEMENT, CISCO SHALL NOT HAVE ANY Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 LIABILITY IN CONNECTION WITH SHIPMENT, NOR SHALL THE CARRIER BE DEEMED TO BE AN AGENT OF CISCO.\"}}, {\"id\": \"6.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT\", \"level\": 2, \"text\": \"6.0 PAYMENT. 6.1 Prices for Products shall be those specified in Cisco's then-current Global or Value Added Distributor Price List. [*****] As provided in sub- section 3.2, in its discretion, Cisco may choose to make products or services which are on the Global Price List but not on the Value Added Distributor Price List available to Distributor. The prices for such products or services will be provided by Cisco to Distributor at the time Cisco makes such products available.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon and subject to credit approval by Cisco, payment terms shall be [*****] days from shipping date\", \"level\": 2, \"text\": \"6.2 Upon and subject to credit approval by Cisco, payment terms shall be [*****] days from shipping date. All payments shall be made in the currency in which the Price List is quoted for the applicable Purchase Order [*****].\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The purchase price does not include any federal, state or local taxes, or sales, use, excise, ad valorem, value-add, wit\", \"level\": 2, \"text\": \"6.3 The purchase price does not include any federal, state or local taxes, or sales, use, excise, ad valorem, value-add, withholding or other taxes or duties that may be applicable to the purchase of Products. When Cisco has the legal obligation to collect such taxes, the appropriate amount shall be added to Distributor's invoice and paid by Distributor, unless Distributor provides Cisco with a valid tax exemption certificate prior to issuance of a purchase order. Such certificate must be in a form authorized by the appropriate taxing authority.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor is free to determine its minimum resale prices unilaterally\", \"level\": 2, \"text\": \"6.4 Distributor is free to determine its minimum resale prices unilaterally. Distributor understands that neither Cisco nor any employee or representative of Cisco may give any special treatment (favorable or unfavorable) to Distributor as a result of Distributor's selection of minimum resale prices. No employee or representative of Cisco or anyone else has any authority to determine what Distributor's minimum resale prices for the Products must be, or to limit Distributor's pricing discretion with respect to the Products and Services.\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event any provisions of this Agreement or any other agreement between Distributor and Cisco require that Cisco gr\", \"level\": 2, \"text\": \"6.5 In the event any provisions of this Agreement or any other agreement between Distributor and Cisco require that Cisco grant credits to Distributor's account, Cisco will grant such credit to Distributor's account. [*****]. Cisco will only consider debit memos initially received from Distributor during the time period associated with such request, as set forth herein. All debit memos Distributor submits to Cisco will be submitted using any method identified in 25.8, or as otherwise agreed between the parties.\"}}, {\"id\": \"6.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Except as stated in Sections 7 (Price Protection), 12 (Inventory Balance), 13 (Return of Obsolete Product), 18 (Term and\", \"level\": 2, \"text\": \"6.6 Except as stated in Sections 7 (Price Protection), 12 (Inventory Balance), 13 (Return of Obsolete Product), 18 (Term and Termination) or as otherwise stated herein, for all price adjustment related credits requested by the Distributor to be granted by Cisco, the\"}}, {\"id\": \"6.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor must make the initial credit request to Cisco, in writing, within [*****] of the underlying point of sale tr\", \"level\": 2, \"text\": \"6.7 Distributor must make the initial credit request to Cisco, in writing, within [*****] of the underlying point of sale transaction. Any initial credit requests submitted by the Distributor to Cisco greater than [*****] after the underlying point of sale transaction will not be honored by Cisco and Cisco will not grant such credit to Distributor.\"}}, {\"id\": \"7.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE PROTECTION\", \"level\": 2, \"text\": \"7.0 PRICE PROTECTION. 7.1 Definition: For purposes of this Section 7.0, Products \\\"In-Transit\\\" shall be defined as all Products with a particular Cisco part number shipped by Cisco to Distributor in the [*****] day period prior to the date on which Cisco announces a general price decrease for Products with such part number, excluding those Products which Distributor has received into its inventory during such [*****] day period.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event Cisco puts into effect a general price decrease for any Product from the Value Added Distributor Price List\", \"level\": 2, \"text\": \"7.2 In the event Cisco puts into effect a general price decrease for any Product from the Value Added Distributor Price List, Cisco will provide to Distributor a price credit on any such Product on order, In Transit or in Distributor's inventory as of the effective date of the price decrease, provided that the price credit for such Product in inventory or In Transit shall not exceed the dollar value of shipments of that Product (measured by the appropriate Cisco product number) to Distributor over the preceding [*****]. Cisco will credit Distributor's account with an amount equal to the number of units of such Product in Distributor's inventory and In Transit on the effective date of a price decrease multiplied by the difference between the net price paid and the new net price. Distributor will have [*****] from the effective date of the price change to exercise protection under this program by issuing a request for credit memo with supporting documentation to Cisco. Claims for price protection submitted more than [*****] from the effective date of a price decrease will be rejected. Notwithstanding the foregoing, Product on order will receive an automatic retroactive price credit. The only inventoried Product covered under this price protection clause is Product which has been identified by Distributor to Cisco in the daily inventory reports required in sub-sub-section 17.2.2, excluding any Third-Party Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 Sourced Product. Cisco will use commercially reasonable efforts to notify Distributor within [*****] of all such pricing changes.\"}}, {\"id\": \"8.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESERVED\", \"level\": 2, \"text\": \"8.0 RESERVED\"}}, {\"id\": \"9.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROPRIETARY RIGHTS AND SOFTWARE LICENSING\", \"level\": 2, \"text\": \"9.0 PROPRIETARY RIGHTS AND SOFTWARE LICENSING. 9.1 Distributor's use of Software is governed by the terms contained in Exhibit C (End User License Agreement (\\\"EULA\\\")). For purposes of this Agreement, all references to \\\"Customer\\\" or \\\"You\\\" therein shall refer to Distributor.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall notify Cisco promptly of any breach or suspected breach of the EULA and further agrees that it will, a\", \"level\": 2, \"text\": \"9.2 Distributor shall notify Cisco promptly of any breach or suspected breach of the EULA and further agrees that it will, at Cisco's request, assist Cisco in efforts to preserve Cisco's intellectual property rights including pursuing an action against any breaching third parties.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY\", \"level\": 1, \"text\": \"10. WARRANTY. 10.1 C i s c o P r o d u c t s a r e p r o v i d e d w i t h w r i t t e n l i m i t e d w a r r a n t i e s , a s s e t f o r t h a t t h e f o l l o w i n g U R L : http://www.cisco.com/warp/public/cc/serv/mkt/sup/tsssv/wnty/. Distributor will pass through to Resellers all written limited warranties provided by Cisco with Products purchased by Distributor and Distributor shall contractually require (in whatever manner Distributor deems appropriate) each such Reseller to provide such warranty and other terms to any End User to which the Reseller redistributes the Product.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In addition to the written limited warranty provided by Cisco with its Products, such warranty statement shall apply to\", \"level\": 2, \"text\": \"10.2 In addition to the written limited warranty provided by Cisco with its Products, such warranty statement shall apply to Distributor during the period between when it receives a Product and when it resells or redistributes such Product,\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding any other provision hereof, Cisco's sole and exclusive warranty and obligation with respect to the Produ\", \"level\": 2, \"text\": \"10.3 Notwithstanding any other provision hereof, Cisco's sole and exclusive warranty and obligation with respect to the Products sold hereunder are set forth in Cisco's Limited Warranty Statement delivered with the Product. Distributor SHALL NOT MAKE ANY WARRANTY COMMITMENT, WHETHER WRITTEN OR ORAL, ON CISCO'S BEHALF. Distributor shall indemnify Cisco against any warranties made in addition to Cisco's standard warranty and for any misrepresentation of Cisco's reputation or Cisco's Products.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISCLAIMER OF WARRANTY\", \"level\": 2, \"text\": \"10.4 DISCLAIMER OF WARRANTY. EXCEPT AS EXPRESSLY PROVIDED IN THIS SECTION 10.0, CISCO HEREBY DISCLAIMS AND DISTRIBUTOR WAIVES ALL REPRESENTATIONS, CONDITIONS AND WARRANTIES (WHETHER EXPRESS, IMPLIED, OR STATUTORY), INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OR CONDITION (A) OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, SATISFACTORY QUALITY, QUIET ENJOYMENT, ACCURACY, OR SYSTEM INTEGRATION, OR (B) ARISING FROM ANY COURSE OF DEALING, COURSE OF PERFORMANCE, OR USAGE IN THE INDUSTRY. TO THE EXTENT AN IMPLIED WARRANTY CANNOT BE DISCLAIMED, SUCH WARRANTY IS LIMITED IN DURATION TO THE APPLICABLE EXPRESS WARRANTY PERIOD. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS SECTION 10, CISCO MAKES NO REPRESENTATION OR WARRANTY AS TO OWNERSHIP OF INTELLECTUAL PROPERTY OR OF PROPRIETARY RIGHTS, OR AS TO INFRINGEMENT OR MISAPPROPRIATION THEREOF. DISTRIBUTOR'S SOLE AND EXCLUSIVE REMEDIES IN THE EVENT OF ANY SUCH INFRINGEMENT, MISAPPROPRIATION OR ANY CLAIM THEREOF SHALL BE AS SET FORTH IN SECTION 15 OF THIS AGREEMENT (\\\"PATENT AND COPYRIGHT INFRINGEMENT\\\").\"}}, {\"id\": \"11.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TRADEMARKS\", \"level\": 2, \"text\": \"11.0 TRADEMARKS. 11.1 Cisco grants to Distributor the right to use the name, logo, trademarks, and other marks of Cisco (collectively, the \\\"Marks\\\") for all proper purposes in the sale of Cisco Products and Services to End Users and the performance of Distributor's duties hereunder only so long as this Agreement is in effect. Distributor's use of such Marks shall be in accordance with Cisco's policies including, but not limited to trademark usage and advertising policies, and be subject to Cisco's written approval. Distributor further agrees not to affix any Marks to products other than genuine Products. Distributor shall have no claim or right in the Marks, including but not limited to trademarks, service marks, or trade names owned, used or claimed now or which Cisco has authority to grant Distributor the right to use in the future. Distributor agrees that upon notice from Cisco it will immediately terminate its use of a particular Mark.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall not acquire, use, promote or Resell Non-Genuine Products\", \"level\": 2, \"text\": \"11.2 Distributor shall not acquire, use, promote or Resell Non-Genuine Products. Additionally, Distributor shall Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 notify Cisco promptly of the existence, or suspected existence, of Non\u200b Genuine Products in possession of or promoted by third parties, and further agrees that it will, at Cisco's request, assist Cisco to diligently pursue any action against any third party in possession of or promoting Non- Genuine Products.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Distributor acquires, uses, promotes or Resells Non-Genuine Products, Cisco may take one or more of the following act\", \"level\": 2, \"text\": \"11.3 If Distributor acquires, uses, promotes or Resells Non-Genuine Products, Cisco may take one or more of the following actions, at Cisco's discretion: (i) invoice Distributor, and the latter further agrees to pay within [*****] of receipt of the invoice, for all reasonable costs associated with any Audit and/or any investigation carried out by Cisco or its independent accountants or investigators, that disclosed a material breach by Distributor of this Section, and/or (ii) require Distributor, [*****] of Cisco's request, to recall and destroy all Non-Genuine Products that Distributor has sold to Resellers and replace such products with legitimate, equivalent Products at Distributor's expense, (iii) require Distributor, within [*****] of receiving Cisco's written request, to provide Cisco with all details related to Distributor's acquisition of all Non-Genuine Products, including without limitation, its suppliers, shipping details and all buyers to whom Distributor resold Non-Genuine Products, and (iv) terminate this Agreement by notice with immediate effect.\"}}, {\"id\": \"12.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INVENTORY BALANCE\", \"level\": 2, \"text\": \"12.0 INVENTORY BALANCE. For a [*****] period, beginning on the effective date of this agreement, Distributor has the option to return to Cisco, for credit, up to [*****] of the dollar value of Product listed on the Value Added Distributor Price List and shipped to Distributor in the preceding Cisco Quarter, net of credits issued by Cisco to Distributor. [*****] Cisco shall credit Distributor's account in the amount of the price paid by Distributor for returned Products, less any price protection credits issued to Distributor related to the Product returned (the \\\"Return Credit\\\"). Each of the following requirements must be met by Distributor:\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"12.1 [*****]\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor may submit the inventory balance claim between the first and [*****] calendar days of the following months\", \"level\": 2, \"text\": \"12.2 Distributor may submit the inventory balance claim between the first and [*****] calendar days of the following months: February, May, August, and November.\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"12.3 [*****]\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall bear all shipping and handling charges to the Cisco designated United States site for Product returned\", \"level\": 2, \"text\": \"12.4 Distributor shall bear all shipping and handling charges to the Cisco designated United States site for Product returned for credit;\"}}, {\"id\": \"12.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall obtain an RMA number prior to returning any Product to Cisco\", \"level\": 2, \"text\": \"12.5 Distributor shall obtain an RMA number prior to returning any Product to Cisco. Distributor shall follow Cisco's then-current RMA process; and\"}}, {\"id\": \"12.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor reports must be provided to Cisco in accordance with the requirements of sub- section 17\", \"level\": 2, \"text\": \"12.6 Distributor reports must be provided to Cisco in accordance with the requirements of sub- section 17.2. [*****]\"}}, {\"id\": \"13.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RETURN OF OBSOLETE PRODUCT 13\", \"level\": 2, \"text\": \"13.0 RETURN OF OBSOLETE PRODUCT 13.1 Cisco will use commercially reasonable efforts to notify Distributor, including by electronic posting, when a Product becomes an Obsolete Product.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Provided Distributor provides required reports to Cisco in accordance with Section 17\", \"level\": 2, \"text\": \"13.2 Provided Distributor provides required reports to Cisco in accordance with Section 17.0 of this Agreement, Distributor shall have the right to return Obsolete Product for full credit under Cisco's then-current RMA Process. [*****]\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor must notify Cisco of the quantity of Obsolete Product to be returned to Cisco within [*****] of notification\", \"level\": 2, \"text\": \"13.3 Distributor must notify Cisco of the quantity of Obsolete Product to be returned to Cisco within [*****] of notification of obsolescence by Cisco. Such right to return is contingent upon return by Distributor of Obsolete Product within [*****] of such notification by Cisco. Such Product must be in new and unused condition and in factory sealed boxes.\"}}, {\"id\": \"13.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"13.4 [*****]\"}}, {\"id\": \"14.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESERVED\", \"level\": 2, \"text\": \"14.0 RESERVED\"}}, {\"id\": \"15.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PATENT AND COPYRIGHT INFRINGEMENT\", \"level\": 2, \"text\": \"15.0 PATENT AND COPYRIGHT INFRINGEMENT. 15.1 Cisco will have the obligation and right to defend any claim, action, suit or proceeding (\\\"IPR Claim\\\") brought Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 against Distributor, its officers, directors, employees and agents (\\\"Named Parties\\\") so far as it is based on a claim that any Product supplied under this Agreement infringes Third Party IPR (as defined below). Cisco will indemnify Named Parties and hold harmless against any final judgment entered in respect of such an IPR Claim by a court of competent jurisdiction and against any settlements arising out of such an IPR Claim. Cisco's obligations to defend the IPR Claim and indemnify Distributor are conditional upon:\"}}, {\"id\": \"15.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor notifying Cisco promptly in writing of the IPR Claim or threat thereof; Distributor granting Cisco full and\", \"level\": 3, \"text\": \"15.1.1 Distributor notifying Cisco promptly in writing of the IPR Claim or threat thereof; Distributor granting Cisco full and exclusive authority for the conduct of the defense and settlement of the 15.1.2 IPR Claim and any subsequent appeal; and 15.1.3 Distributor providing Cisco all information and assistance reasonably requested by Cisco in connection with the conduct of the defense and settlement of the IPR Claim and any subsequent appeal.\"}}, {\"id\": \"15.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For the purposes of this Agreement, Third Party IPR means a United States copyright existing as at the Effective Date, a\", \"level\": 2, \"text\": \"15.2 For the purposes of this Agreement, Third Party IPR means a United States copyright existing as at the Effective Date, a United States patent issued as at the Effective Date, a trademark registered in the United States as at the Effective Date, trade dress existing in the United States as at the Effective Date, or a claim that a Product is manufactured by means of misappropriation of a third party's trade secrets.\"}}, {\"id\": \"15.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If an IPR Claim has been made, or in Cisco's opinion is likely to be made, Distributor agrees to permit Cisco, at its op\", \"level\": 2, \"text\": \"15.3 If an IPR Claim has been made, or in Cisco's opinion is likely to be made, Distributor agrees to permit Cisco, at its option and expense, either to: (a) procure for Distributor the right to continue using the Product; (b) replace or modify the Product so that it becomes non-infringing; or (c) immediately terminate both parties' respective rights and obligations under this Agreement with regard to the Product, in which case Distributor will return the Product to Cisco and Cisco will refund to Distributor the price originally paid by Distributor to Cisco for the Product, [*****].\"}}, {\"id\": \"15.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding the foregoing, Cisco has no liability for, and Distributor will defend and indemnify Cisco against, any\", \"level\": 2, \"text\": \"15.4 Notwithstanding the foregoing, Cisco has no liability for, and Distributor will defend and indemnify Cisco against, any IPR Claim arising from:\"}}, {\"id\": \"15.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Section states the entire obligation of Cisco and its suppliers, and the exclusive remedy of Distributor, in respec\", \"level\": 2, \"text\": \"15.5 This Section states the entire obligation of Cisco and its suppliers, and the exclusive remedy of Distributor, in respect of any infringement or alleged infringement of any intellectual property rights or proprietary rights. THIS INDEMNITY OBLIGATION AND REMEDY ARE GIVEN TO Distributor SOLELY FOR ITS BENEFIT AND IN LIEU OF, AND CISCO DISCLAIMS, ALL WARRANTIES, CONDITIONS AND OTHER TERMS OF NON-INFRINGEMENT OR TITLE WITH RESPECT TO ANY PRODUCT.\"}}, {\"id\": \"15.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"15.6 [*****].\"}}, {\"id\": \"16.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPORT\", \"level\": 2, \"text\": \"16.0 SUPPORT. Support shall be provided in accordance with Exhibit B. Distributor acknowledges that Cisco will not be responsible for warranty service and support except as specifically provided in Exhibit B or a Cisco support program (e.g., SmartNet).\"}}, {\"id\": \"17.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPORTS AND RECORDS\", \"level\": 2, \"text\": \"17.0 REPORTS AND RECORDS. 17.1 With regard to both Distributor and Affiliates' activity, Distributor shall keep full, true, and accurate records and accounts, in accordance with generally-accepted accounting principles, of each Product or Service purchased and deployed, Resold, or distributed by serial number, including information regarding compliance with Cisco marketing and sales programs, Software usage, and export or transfer. Distributor shall make these records available for audit by Cisco upon [*****] prior written notice, during regular business hours, at Distributor's principal place of business or such other of Distributor's locations where Distributor may maintain relevant records. [*****]. All reporting and related obligations in this Section 17 apply to not only data regarding Distributor's activities, but also Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 the activities of the Affiliates. All such information shall be compiled into one report unless otherwise directed herein. The report(s) shall identify the specific Distributor entity involved in the subject transaction.\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reporting\", \"level\": 2, \"text\": \"17.2 Reporting. [*****]\"}}, {\"id\": \"17.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor agrees to use commercially reasonable efforts, commensurate with the manner in which Distributor treats any\", \"level\": 2, \"text\": \"17.3 Distributor agrees to use commercially reasonable efforts, commensurate with the manner in which Distributor treats any of its other leading vendors, in order to facilitate Cisco's ability to obtain daily sales information from Distributor via EDI.\"}}, {\"id\": \"17.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ECCN Numbers\", \"level\": 2, \"text\": \"17.4 ECCN Numbers. Upon request by Distributor, Cisco agrees to make available to Distributor the Export Control Classification Number (ECCN) for each of Cisco's Product and information as to whether or not any of such Products are classified under the U.S. Munitions license.\"}}, {\"id\": \"17.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unauthorized Cisco Product\", \"level\": 2, \"text\": \"17.5 Unauthorized Cisco Product. Distributor will not purchase Products for resale to any Reseller from any person or entity other than Cisco, provided that Distributor may accept returned Product from Resellers if Distributor initially sold the Product to be returned to such Reseller. [*****]\"}}, {\"id\": \"18.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 2, \"text\": \"18.0 TERM AND TERMINATION. 18.1 This Agreement shall commence on the Effective Date and continue thereafter for a period of two (2) years, unless extended by written agreement of both parties or sooner terminated as set forth below. Without prejudice to either party's right to terminate this Agreement as set forth in sub\u200b sections 18.2 to 18.5 below, Cisco may, by written notice to Distributor, given at least thirty (30) days prior to the end of the then-current term of the Agreement, extend the term of the Agreement for the period set forth in such notice, up to a maximum of one (1) year beyond the then- current expiration date. Any extension shall be on the same terms and conditions then in force, except as may be mutually agreed in writing by the parties. In the event the Agreement expires and Cisco intends to not renew the Agreement, Cisco will provide written notice of same to Distributor. Notwithstanding Cisco's right to extend the term of this Agreement, each party acknowledges that this Agreement shall always be interpreted as being limited in duration to a definite term and that the other party has made no commitments whatsoever regarding the duration or renewal of this Agreement beyond those expressly stated herein.\"}}, {\"id\": \"18.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"A party may terminate this Agreement immediately through written notice if (i) the other party ceases to carry on busine\", \"level\": 2, \"text\": \"18.3 A party may terminate this Agreement immediately through written notice if (i) the other party ceases to carry on business as a going concern; or (ii) the other party becomes or may become the object of the institution of voluntary or involuntary proceedings in bankruptcy or liquidation; or (iii) a receiver or similar officer is appointed with respect to the whole or a substantial part of the other party's assets; or (iv) an event similar to any of the foregoing occurs under applicable law.\"}}, {\"id\": \"18.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cisco may terminate this Agreement upon [*****] days' written notice, in the event it becomes known that (i) Distributor\", \"level\": 2, \"text\": \"18.4 Cisco may terminate this Agreement upon [*****] days' written notice, in the event it becomes known that (i) Distributor or an Affiliate or Distributor's direct or indirect parent has acquired or intends to acquire a controlling interest in a third party that is a competitor of Cisco, or (ii) Distributor or its direct or indirect parent is to be acquired by a third party, or (iii) a controlling interest in Distributor or its direct or indirect parent is to be transferred to a third party.\"}}, {\"id\": \"18.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon termination or expiration of this Agreement, (a) Cisco reserves the right to cease all further delivery of Product\", \"level\": 2, \"text\": \"18.5 Upon termination or expiration of this Agreement, (a) Cisco reserves the right to cease all further delivery of Product or Services due against any existing Purchase Orders unless Distributor agrees to pay for such deliveries in advance by certified or cashier's check, (b) all outstanding invoices immediately become due and payable by certified or cashier's check, and (c) all rights and licenses of Distributor hereunder shall terminate, subject to the terms of the following sentence. Except for a termination of this Agreement resulting from Distributor's breach of Section 9.0 (Proprietary Rights and Software Licensing) or Section 19.0(Confidential Information), upon termination or expiration of this Agreement, Distributor may continue to use, in accordance with the terms and conditions of this Agreement, Products shipped to it by Cisco prior to the date of termination or expiration.\"}}, {\"id\": \"18.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon termination or expiration of this Agreement, Distributor shall immediately return to Cisco all Confidential Informa\", \"level\": 2, \"text\": \"18.6 Upon termination or expiration of this Agreement, Distributor shall immediately return to Cisco all Confidential Information (including all copies thereof) then in Distributor's possession, custody or control; provided, that except for a termination resulting from Distributor's breach of Section 9.0 (Proprietary Rights and Software Licensing) or Section 19.0 (Confidential Information), Distributor may retain a sufficient amount of such Confidential Information and material Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 to support its installed base of Products.\"}}, {\"id\": \"18.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"18.7 [*****].\"}}, {\"id\": \"18.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of termination by Cisco for convenience, termination by Distributor for Cisco's material breach, or expirat\", \"level\": 2, \"text\": \"18.8 In the event of termination by Cisco for convenience, termination by Distributor for Cisco's material breach, or expiration of this Agreement where Cisco has provided Distributor with written notice from an authorized representative of its intention not to renew the Agreement, Cisco agrees to repurchase all Product in Distributor's inventory within [*****] days following the effective date of termination or expiration. Within [*****] days following the effective date of termination or expiration, Distributor shall return to Cisco all Product held in inventory as of the effective date of termination. Distributor shall receive credit for any Product so returned in an amount equal to the original purchase price thereof, less any credits or discounts which have been previously paid or applied to Distributor. Such credits shall be first applied to any uncontested amounts due Cisco. Any remaining balance shall be payable to Distributor as soon as commercially practicable. Cisco shall have the option to select the method of return and shall bear all freight costs associated with returns of Product by Distributor under this Section 18.8.\"}}, {\"id\": \"18.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In the event of termination by Cisco for Distributor's material breach, or termination by Distributor for convenience, C\", \"level\": 2, \"text\": \"18.9 In the event of termination by Cisco for Distributor's material breach, or termination by Distributor for convenience, Cisco may, at its option, allow Distributor to return unsold Product, but Cisco is in no way obligated to do so. In the case of authorized return of Product by Cisco under Section 18.9, Distributor will bear all freight costs associated with return of Product to Cisco.\"}}, {\"id\": \"18.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"18.10 [*****] Distributor shall obtain an RMA number prior to returning any Product to Cisco. Distributor shall follow Cisco's then-current RMA process.\"}}, {\"id\": \"18.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREES THAT, IN THE EVENT OF ANY TERMINATION OF THIS AGREEMENT, IT SHALL HAVE NO RIGHTS TO DAMAGES OR INDEMN\", \"level\": 2, \"text\": \"18.11 DISTRIBUTOR AGREES THAT, IN THE EVENT OF ANY TERMINATION OF THIS AGREEMENT, IT SHALL HAVE NO RIGHTS TO DAMAGES OR INDEMNIFICATION OF ANY NATURE, SPECIFICALLY INCLUDING COMMERCIAL SEVERANCE PAY, WHETHER BY WAY OF LOSS OF FUTURE PROFITS, EXPENDITURES FOR PROMOTION OF ANY PRODUCT, OR OTHER COMMITMENTS IN CONNECTION WITH THE BUSINESS AND GOOD WILL OF DISTRIBUTOR. DISTRIBUTOR EXPRESSLY WAIVES AND RENOUNCES ANY CLAIM TO COMPENSATION OR INDEMNITIES FOR ANY TERMINATION OF A BUSINESS RELATIONSHIP. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH HEREIN, THIS SECTION SHALL IN NO WAY BE INTERPRETED TO RELEASE EITHER CISCO OR DISTRIBUTOR FROM ANY PAYMENTS OR FINANCIAL OBLIGATION MADE PRIOR TO TERMINATION.\"}}, {\"id\": \"19.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 2, \"text\": \"19.0 CONFIDENTIALITY. Distributor acknowledges that, in the course of selling Products and Services and performing its duties under this Agreement, Distributor, its Resellers, and End Users to which Distributor provides access to Cisco technical data (including without limitation Products, Services, and technical data made available on Cisco Connection Online pursuant to Exhibit C), may obtain information relating to Products, Services, or to Cisco, which is of a confidential and proprietary nature (\\\"Proprietary Information\\\"). Such Proprietary Information includes, but is not limited to, trade secrets, know-how, inventions, techniques, processes, programs, schematics, software source documents, data, Customer lists, financial information and sales and marketing plans. Cisco owns and intends to maintain its ownership of all such Proprietary Information. [*****] Distributor shall appropriately bind each of its employees to whom such disclosure is made, to hold the Proprietary Information in strict confidence and not to disclose such information to any person other than as is necessary in the course of its employment by Distributor and will indemnify Cisco for all damages suffered by Cisco in the event of wrongful disclosure of such Proprietary Information. Neither party shall disclose, advertise, or publish either the existence, the subject matter, any discussions relating to, or any of the terms and conditions, of this Agreement (or any summary of any of the forgoing) to any third party without the prior written consent of the other party. Any press release, publication, advertisement or public disclosure regarding this Agreement is subject to both the prior review and the written approval of both parties. Cisco acknowledges that, under this Agreement, Distributor may provide Point of Sale (\\\"POS\\\") reports, financial information, sales and marketing plans, Distributor network design information and Distributor lists, of a proprietary and confidential nature (\\\"Distributor Confidential Information\\\"). Such Distributor information, excluding POS reports and Distributor lists, shall be used by Cisco only in connection with this Agreement. [*****] Cisco further agrees to immediately return to Distributor, at Distributor's request, all Distributor Confidential Information in Cisco's possession, custody, or control upon termination of this Agreement at any time and for any reason, except for POS reports or Distributor Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 lists that Cisco may use for internal business or end user support purposes or government-related purposes.\"}}, {\"id\": \"20.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXPORT RESTRICTIONS\", \"level\": 2, \"text\": \"20.0 EXPORT RESTRICTIONS. Certain of the Products supplied by Cisco under the Agreement are subject to export controls under the laws and regulations of the United States (U.S.) and elsewhere. Distributor shall comply with such laws and regulations governing use, export, re-export, and transfer of Products and will obtain all required U.S. and local authorizations, permits, or licenses.\"}}, {\"id\": \"21.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"21.0 COMPLIANCE WITH LAWS. 21.1 Distributor shall obtain all licenses, permits and approvals required by any government, including any recycling or take-back programs applicable to packaging or Products, and shall comply with all applicable laws, rules, regulations, policies and procedures and any requirements applicable to the importation, exportation, use, sale, loan, purchase, and distribution of Products under telecommunications, consumer rights related, environmental, labor, tax, and any other laws and regulations, of any government or other competent authority where the Products are to be sold, used or deployed (collectively \\\"Applicable Laws\\\").\"}}, {\"id\": \"21.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will indemnify and hold harmless Cisco for any claim arising from or relating to Distributor's violation or\", \"level\": 2, \"text\": \"21.2 Distributor will indemnify and hold harmless Cisco for any claim arising from or relating to Distributor's violation or alleged violation of any Applicable Laws.\"}}, {\"id\": \"21.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor hereby represents and warrants that\", \"level\": 2, \"text\": \"21.3 Distributor hereby represents and warrants that: (a) it shall comply with all Applicable Laws; (b) this Agreement and each of its terms are in full conformance and in compliance with such laws; and (c) it shall not take any action or permit or authorize any action which will render Cisco liable for a violation of the U.S. Foreign Corrupt Practices Act, which prohibits the offering, giving or promising to offer or give, directly or indirectly, money or anything of value to any official of a government, political party or instrumentality thereof in order to assist it or Cisco in obtaining or retaining business and (i) it will not violate or cause Cisco to violate such Act in connection with the sale or distribution of Cisco Products or Services; and (ii) if Distributor is a non-governmental entity, it will notify Cisco in writing if any of its owners, partners, principals, officers, and employees are or become during the term of this Agreement officials, officers or representatives of any government, political party or candidate for political office outside the United States and are responsible for a decision regarding obtaining or retaining business for Cisco Products by such government. Cisco strives to maintain the highest standards of business integrity and, accordingly, if Distributor has any cause for concern regarding any business practices these should be reported to Cisco at [EMAIL ADDRESS] or by Fax to [FAX NUMBER].\"}}, {\"id\": \"21.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall use its best efforts to regularly and continuously inform Cisco of any requirements under any Applicab\", \"level\": 2, \"text\": \"21.4 Distributor shall use its best efforts to regularly and continuously inform Cisco of any requirements under any Applicable Laws that directly or indirectly affect this Agreement, the sale, use and distribution of Products, or Cisco's trade name, trademarks or other commercial, industrial or intellectual property interests, including, but not limited to, certification or type approval of the Products from the proper authorities in the Territory.\"}}, {\"id\": \"22.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"22.0 LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING ELSE IN THIS AGREEMENT TO THE CONTRARY, AND EXCEPT FOR LIABILITY ARISING OUT OF DISTRIBUTOR'S BREACH OF SECTION 9 (PROPRIETARY RIGHTS AND SOFTWARE LICENSING) OR EXHIBIT C (SOFTWARE LICENSE AGREEMENT), OR AMOUNTS DUE FOR PRODUCTS AND SERVICES PURCHASED WITH RESPECT TO THE PAYMENT OF WHICH NO BONA FIDE DISPUTE EXISTS, ALL LIABILITY OF EACH PARTY, INCLUDING EACH PARTY'S AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS AND SUPPLIERS COLLECTIVELY, FOR CLAIMS ARISING UNDER THIS AGREEMENT OR OTHERWISE HOWSOEVER ARISING SHALL BE LIMITED SEPARATELY FOR PRODUCTS AND SERVICES PURCHASES TO THE GREATER OF I) [*****] OR (ll)THE MONEY PAID TO CISCO FOR PRODUCTS OR FOR SERVICES, SEPARATELY AND AS APPLICABLE, UNDER THIS AGREEMENT DURING THE [*****] PERIOD PRECEDING THE EVENT OR CIRCUMSTANCES FIRST GIVING RISE TO SUCH LIABILITY. THESE LIMITATIONS OF LIABILITY FOR PRODUCT AND SERVICES ARE CUMULATIVE AND NOT PER-INCIDENT (I.E., THE EXISTENCE OF TWO OR MORE CLAIMS WILL NOT ENLARGE THIS LIMIT).\"}}, {\"id\": \"23.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONSEQUENTIAL DAMAGES WAIVER\", \"level\": 2, \"text\": \"23.0 CONSEQUENTIAL DAMAGES WAIVER. EXCEPT FOR LIABILITY ARISING OUT OF OR IN CONNECTION WITH DISTRIBUTOR'S BREACH OF SECTION 9 (PROPRIETARY RIGHTS AND SOFTWARE LICENSING) OR EXHIBIT C (SOFTWARE LICENSE AGREEMENT), IN NO EVENT SHALL EITHER PARTY, ITS RESPECTIVE AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR SUPPLIERS BE LIABLE FOR ANY SPECIAL, INCIDENTAL, Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 INDIRECT OR CONSEQUENTIAL DAMAGES, OR LOST REVENUE, LOST PROFITS, OR LOST OR DAMAGED DATA, WHETHER ARISING IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, EVEN IF SUCH PARTY HAS BEEN INFORMED OF THE POSSIBILITY THEREOF.\"}}, {\"id\": \"24.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL INDEMNIFICATION Each party shall defend, indemnify and hold harmless the other, and their respective officers, d\", \"level\": 2, \"text\": \"24.0 GENERAL INDEMNIFICATION Each party shall defend, indemnify and hold harmless the other, and their respective officers, directors, employees, and agents from and against any and all claims, losses, liabilities, damages, and expenses (including, without limitation, reasonable attorneys' fees), including without limitation, those based on contract or tort, arising out of or in connection with a claim, suit or proceeding brought by a third party based upon bodily injury (including death) or damage to tangible personal property (not including lost or damaged data) arising from the negligent or intentional acts or omissions of the indemnifying party or its subcontractors, or the officers, directors, employees, agents, successors and assigns of any of them. In the event that the indemnified party's or a third party's negligent or intentional acts or omissions contributed to cause the injury or damage for which a claim of indemnity is being asserted against the indemnifying party hereunder, the damages and expenses (including, without limitation, reasonable attorneys' fees) shall be allocated or reallocated, as the case may be, between the indemnified party, the indemnifying party and any other party bearing responsibility in such proportion as appropriately reflects the relative fault of such parties, or their subcontractors, or the officers, directors, employees, agents, successors and assigns of any of them, and the liability of the indemnifying party shall be proportionately reduced. The foregoing indemnification obligations are conditioned upon the indemnified party promptly notifying the indemnifying party in writing of the claim, suit or proceeding for which the indemnifying party is obligated under this Section 24, cooperating with, assisting and providing information to, the indemnifying party as reasonably required, and granting the indemnifying party the exclusive right to defend or settle such claim, suit or proceeding.\"}}, {\"id\": \"25.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSURANCE (a) Each party shall be responsible for maintaining Worker's Compensation insurance in the statutory amounts r\", \"level\": 2, \"text\": \"25.0 INSURANCE (a) Each party shall be responsible for maintaining Worker's Compensation insurance in the statutory amounts required by the applicable state laws. (b) Each party shall maintain Commercial General Liability insurance with bodily injury and property damage limits of $[*****] per occurrence and $[*****] aggregate. Such insurance shall (a) provide for contractual liability coverage, (b) provide for cross liability coverage, and (c) name the other party and its subcontractors, as well as the directors, officers, employees, agents, successors and assigns of all of them, as additional insureds, but only to the extent of liabilities falling within the indemnity obligations of the other party pursuant to the terms of Section 24 in this Agreement.\"}}, {\"id\": \"26.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REQUIREMENTS FOR RESELLERS 26\", \"level\": 2, \"text\": \"26.0 REQUIREMENTS FOR RESELLERS 26.1 [*****]\"}}, {\"id\": \"26.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 2, \"text\": \"26.2 [*****]\"}}, {\"id\": \"27.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS\", \"level\": 2, \"text\": \"27.0 GENERAL PROVISIONS. 27.1 Choice of Law. The validity, interpretation, and performance of this Agreement shall be controlled by and construed under the laws of the State of New York, United States of America, as if performed wholly within the state and without giving effect to the principles of conflicts of law, and the state and federal courts of California shall have jurisdiction over any claim arising under this Agreement. The parties specifically disclaim the UN Convention on Contracts for the International Sale of Goods. Notwithstanding the foregoing, either party may seek interim injunctive relief in any court of appropriate jurisdiction with respect to any alleged breach of such party's intellectual property or proprietary rights.\"}}, {\"id\": \"27.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"27.2 Force Majeure. Except for the obligation to pay monies due and owing, neither party shall be liable for any delay or failure in performance due to events outside the defaulting party's reasonable control, including without limitation acts of God, earthquakes, labor disputes, industry wide shortages of supplies, actions of governmental entities, riots, war, acts of terrorism, fire, epidemics, or delays of common carriers or other circumstances beyond its reasonable control. The obligations and rights of the defaulting party shall be extended for a period equal to the period during which such event prevented such party's performance.\"}}, {\"id\": \"27.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Waiver\", \"level\": 2, \"text\": \"27.3 No Waiver. The waiver by either party of any right provided under this Agreement shall Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 not constitute a subsequent or continuing waiver of such right or of any other right under this Agreement.\"}}, {\"id\": \"27.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"27.4 Assignment. Distributor may not assign or delegate its rights or obligations under this Agreement (other than (i) the right to receive any amount due, which shall be freely assignable, or (ii) to Distributor's parent or majority-owned subsidiary company of sufficient net worth to meet any potential liability under this Agreement) without the prior written consent of Cisco, such consent not to be unreasonably withheld or delayed, provided that any such assignment shall not relieve Distributor of any obligation to pay monies that were owed Cisco prior to the date of the assignment.\"}}, {\"id\": \"27.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"27.5 Severability. In the event that one or more terms of this Agreement becomes or is declared to be illegal or otherwise unenforceable by any court of competent jurisdiction, each such term shall be null and void and shall be deemed deleted from this Agreement. All remaining terms of this Agreement shall remain in full force and effect. Notwithstanding the foregoing, if this paragraph is invoked and, as a result, the value of this Agreement is materially impaired for either party, as determined by such party in its sole discretion, then the affected party may terminate this Agreement by written notice with immediate effect to the other.\"}}, {\"id\": \"27.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Attorneys' Fees\", \"level\": 2, \"text\": \"27.6 Attorneys' Fees. In any suit or proceeding relating to this Agreement the prevailing party will have the right to recover from the other its costs and reasonable fees and expenses of attorneys incurred in connection with the suit or proceeding, including costs, fees and expenses upon appeal, separately from and in addition to any other amount included in such judgment. This provision is intended to be severable from the other provisions of this Agreement, and shall survive expiration or termination and shall not be merged into any such judgment\"}}, {\"id\": \"27.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Agency\", \"level\": 2, \"text\": \"27.7 No Agency. This Agreement does not create any agency, partnership, joint venture, or franchise relationship. No employee of either party shall be or become, or shall be deemed to be or become, an employee of the other party by virtue of the existence or implementation of this Agreement. Each party hereto is an independent contractor. Neither party has the right or authority to, and shall not, assume or create any obligation of any nature whatsoever on behalf of the other party or bind the other party in any respect whatsoever.\"}}, {\"id\": \"27.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"27.8 Notices. All notices required or permitted under this Agreement will be in writing and will be deemed given one (1) day after deposit with a commercial express courier specifying next day delivery (or two (2) days for international courier packages specifying 2-day delivery), with written verification of receipt. All communications will be sent to the addresses set forth on the cover sheet of this Agreement or such other address as may be designated by a party by giving written notice to the other party pursuant to this paragraph. Notwithstanding the foregoing, notices regarding general changes in product status, pricing, policies, financial transactions or programs may also be made by posting on Cisco.com or delivery by e-mail or fax, as applicable. Cisco shall use commercially reasonable efforts to provide Distributor [*****] notice when introducing new Programs or Product or modifying Product pricing. Any notice regarding discontinuation of Product shall be pursuant to Cisco's then-current End of Life Policy, as found at http://www.cisco.com/en/US/products/products end-of-life policy.html. A current copy of this policy, as of the Effective Date of this Agreement, is attached hereto as Exhibit G. [*****].\"}}, {\"id\": \"27.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-exclusive Market and Purchase Rights\", \"level\": 2, \"text\": \"27.9 Non-exclusive Market and Purchase Rights. It is expressly understood and agreed that this Agreement does not grant to Cisco or Distributor an exclusive right to purchase or sell Products and shall not prevent either party from developing or acquiring or selling competing Products of other vendors or customers.\"}}, {\"id\": \"27.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 2, \"text\": \"27.11 Counterparts. This Agreement may be executed in two counterparts, each of which shall be deemed an original and together which shall constitute one and the same instrument. A validly executed counterpart that is delivered by Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 one party to the other via electronic transmission (a \\\"Counterpart Image\\\") shall be valid and binding to the same extent as one delivered physically, provided that the valid signature is clearly visible in the Counterpart Image. In the event that a party delivers a Counterpart Image in place of an originally-executed counterpart, such party shall retain the originally-executed counterpart in its files for at least the duration of the Term hereof.\"}}, {\"id\": \"27.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Headings\", \"level\": 2, \"text\": \"27.12 Headings. Headings of sections have been added solely for convenience of reference and shall not be deemed part of this Agreement. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERRITORY\", \"level\": 1, \"text\": \"EXHIBIT A TERRITORY Territory: The United States, excluding its territories. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"VALUE ADDED DISTRIBUTOR SUPPORT EXHIBIT\", \"level\": 1, \"text\": \"EXHIBIT B VALUE ADDED DISTRIBUTOR SUPPORT EXHIBIT\"}}, {\"id\": \"1.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 2, \"text\": \"1.0 DEFINITIONS. Capitalized terms used in this Exhibit B have the meanings assigned to those terms in Section 1.0 of the Nonexclusive Value Added Distributor Agreement Terms and Conditions. Additional capitalized terms and the definitions assigned to those terms in this Exhibit B follow: CCO means Cisco Connection Online, Cisco's online information web server. Customer means End Users and Resellers. Standard Business Hours means 6:00 AM to 6:00 PM Pacific Standard Time Monday through Friday, excluding Cisco-observed holidays, in the U.S. and Canada and outside the U.S. and Canada, means 8:00 AM to 6:00 PM Australia's Eastern Standard Time and Central European Time, Monday through Friday, excluding local Cisco-observed holidays. TAC means Cisco's Technical Assistance Center.\"}}, {\"id\": \"2.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CISCO RIGHTS AND OBLIGATIONS\", \"level\": 2, \"text\": \"2.0 CISCO RIGHTS AND OBLIGATIONS. For Products purchased under the Agreement, Cisco provides the services described below. [*****]\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CCO Access\", \"level\": 2, \"text\": \"2.1 CCO Access. Cisco will provide DISTRIBUTOR with partner-level access to CCO.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Technical Support\", \"level\": 2, \"text\": \"2.2 Technical Support. [*****].\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Updates\", \"level\": 2, \"text\": \"2.3 Updates. [*****].\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Hardware Support\", \"level\": 2, \"text\": \"2.4 Hardware Support. 2.4.1 Return for Replacement. During the Cisco warranty period, DISTRIBUTOR may return failed Product to Cisco for replacement. Cisco will use commercially reasonable efforts to ship a replacement within [*****] days after receipt of the failed Product from DISTRIBUTOR. After the end of the warranty period, parts will be charged at Cisco's then-current rates.\"}}, {\"id\": \"2.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR may request advance replacement delivery of replacement parts (Cisco will send the part upon DISTRIBUTOR's r\", \"level\": 3, \"text\": \"2.4.2 DISTRIBUTOR may request advance replacement delivery of replacement parts (Cisco will send the part upon DISTRIBUTOR's receipt of an RMA number) at Cisco's then-current Advance Replacement charge.\"}}, {\"id\": \"2.4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product used for replacement may be new or equivalent to new, at Cisco's discretion\", \"level\": 3, \"text\": \"2.4.3 Product used for replacement may be new or equivalent to new, at Cisco's discretion.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cisco Brand Services Option\", \"level\": 2, \"text\": \"2.5 Cisco Brand Services Option. Cisco will make available for purchase by DISTRIBUTOR, all appropriate Cisco Brand support Products for Distributor's internal use and for resale to Resellers. This option to resell Cisco brand services whereby services are delivered directly by Cisco to the End User is available in accordance with Cisco's then-current packaged service resale program. Availability of Cisco brand services is subject to geographic limitations. Information on w h e r e s u c h s e r v i c e s a r e a v a i l a b l e f o r r e s a l e , a s w e l l a s t h e p r o c e s s f o r r e s e l l i n g C i s c o b r a n d s e r v i c e s i s l o c a t e d a t \\\"http://www.cisco.com/warp/cproreg/45/index.html\\\".\"}}, {\"id\": \"3.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR RIGHTS AND OBLIGATIONS\", \"level\": 2, \"text\": \"3.0 DISTRIBUTOR RIGHTS AND OBLIGATIONS. 3.1 Prioritization and Escalation Guideline. DISTRIBUTOR will escalate problems to Cisco pursuant to the Escalation and Prioritization Guideline (Appendix A).\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Spare Parts\", \"level\": 2, \"text\": \"3.2 Spare Parts. DISTRIBUTOR shall maintain sufficient spare parts inventory to support its Customer base for a one-month period under normal circumstances. DISTRIBUTOR shall maintain adequate manpower and facilities to assure prompt handling of inquiries, orders and shipments for Products.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty Service\", \"level\": 2, \"text\": \"3.3 Warranty Service. DISTRIBUTOR shall provide to its Resellers, [*****] all warranty service for a minimum Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 of the warranty period set forth in the published Product warranty provided with the original Product. Such warranty shall commence upon shipment to the End User. Warranty service will consist of Software and Hardware replacement service as follows:\"}}, {\"id\": \"3.3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Software Service\", \"level\": 3, \"text\": \"3.3.1 Software Service. DISTRIBUTOR will use reasonable efforts to provide work\u200b around solutions or implement a Cisco-provided patch. DISTRIBUTOR will use reasonable effort to make latest release of all Cisco Software available to its resellers.\"}}, {\"id\": \"3.3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Hardware Advance Replacement\", \"level\": 3, \"text\": \"3.3.2 Hardware Advance Replacement. DISTRIBUTOR will ship replacement parts and/or Product to its Resellers in accordance with Cisco's then- current published Product warranty applicable to the particular Product.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Returns Coordination\", \"level\": 2, \"text\": \"3.4 Returns Coordination. DISTRIBUTOR will comply with the following: 3.4.1 DISTRIBUTOR shall coordinate the return of all failed parts and/or Product, freight and insurance prepaid, to the Cisco repair center specified by Cisco.\"}}, {\"id\": \"3.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR shall comply with the following RMA procedure\", \"level\": 3, \"text\": \"3.4.2 DISTRIBUTOR shall comply with the following RMA procedure: 3.4.2.1 DISTRIBUTOR will ensure all Products are properly packaged prior to being shipped, and will include a written description of the failure and specification of any changes or alterations made to the Product. Product returned to Cisco will conform in quantity and serial number to the RMA request.\"}}, {\"id\": \"3.4.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR shall tag each Product returned with the RMA transaction number and a brief description of the problem\", \"level\": 4, \"text\": \"3.4.2.2 DISTRIBUTOR shall tag each Product returned with the RMA transaction number and a brief description of the problem.\"}}, {\"id\": \"3.4.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cisco will not accept any Product returned which is not accompanied by an RMA number\", \"level\": 4, \"text\": \"3.4.2.3 Cisco will not accept any Product returned which is not accompanied by an RMA number.\"}}, {\"id\": \"3.4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Title and risk of loss to failed Product and parts transfers to Cisco upon delivery to the Cisco repair center specified\", \"level\": 3, \"text\": \"3.4.3 Title and risk of loss to failed Product and parts transfers to Cisco upon delivery to the Cisco repair center specified by Cisco.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller Support\", \"level\": 2, \"text\": \"3.5 Reseller Support. DISTRIBUTOR will ensure Reseller has all appropriate support as follows: 3.5.1 DISTRIBUTOR shall provide competent technical support staff to support the Product so as to ensure that the Reseller is able to provide the necessary support to the End User Reseller.\"}}, {\"id\": \"3.5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller Frontline Support\", \"level\": 3, \"text\": \"3.5.2 Reseller Frontline Support. DISTRIBUTOR will use best efforts to ensure that its Resellers provide high quality front-line support.\"}}, {\"id\": \"3.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****] Cisco is not responsible for any claims arising from failure by Distributor's Resellers to provide this support\", \"level\": 3, \"text\": \"3.5.3 [*****] Cisco is not responsible for any claims arising from failure by Distributor's Resellers to provide this support.\"}}, {\"id\": \"3.5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resale of Cisco Brand Services\", \"level\": 3, \"text\": \"3.5.4 Resale of Cisco Brand Services. Where available, DISTRIBUTOR will offer for purchase by its Resellers, all appropriate Cisco brand support products through its normal products availability process.\"}}, {\"id\": \"4.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SERVICES NOT COVERED UNDER THIS EXHIBIT\", \"level\": 2, \"text\": \"4.0 SERVICES NOT COVERED UNDER THIS EXHIBIT. 4.1 New Releases or Major Releases for Software.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Customization of existing Software for non-standard applications\", \"level\": 2, \"text\": \"4.2 Customization of existing Software for non-standard applications.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Support or replacement of Product that is altered, modified, mishandled, destroyed or damaged by natural causes or damag\", \"level\": 2, \"text\": \"4.3 Support or replacement of Product that is altered, modified, mishandled, destroyed or damaged by natural causes or damaged during unauthorized use.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Software problems resulting from third party equipment or causes beyond Cisco's control\", \"level\": 2, \"text\": \"4.4 Software problems resulting from third party equipment or causes beyond Cisco's control.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any hardware upgrade of Product required to accept Updates\", \"level\": 2, \"text\": \"4.5 Any hardware upgrade of Product required to accept Updates.\"}}, {\"id\": \"5.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION\", \"level\": 2, \"text\": \"5.0 TERMINATION. Upon expiration or termination of the Agreement, (a) all rights and licenses of DISTRIBUTOR under this Support Exhibit shall terminate, (b) DISTRIBUTOR shall immediately discontinue all representations that DISTRIBUTOR Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 provides maintenance services for Cisco Product, and (c) DISTRIBUTOR access to CCO shall terminate.\"}}, {\"id\": \"6.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SOFTWARE LICENSE\", \"level\": 2, \"text\": \"6.0 SOFTWARE LICENSE. DISTRIBUTOR acknowledges that it may receive Software as a result of services provided under this Agreement. DISTRIBUTOR agrees that it is licensed to distribute such Software only on Product covered under the services and subject to the terms and conditions of this Agreement and the Software license granted with the original acquisition. Except as otherwise specified in this Exhibit, DISTRIBUTOR shall not copy, in whole or in part, Software or documentation; modify the Software, reverse compile or reverse assemble all or any portion of the Software; or rent, lease, distribute, sell, or create derivative works of the Software. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 APPENDIX 1 CISCO PROBLEM PRIORITIZATION AND ESCALATION GUIDELINE To ensure that all problems are reported in a standard format, Cisco has established the following problem priority definitions. These definitions will assist Cisco in allocating the appropriate resources to resolve problems. Distributor must assign a priority to all problems submitted to Cisco. [*****] Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}}, {\"id\": \"EXHIBIT D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SCANSOURCE FREIGHT POLICY\", \"level\": 1, \"text\": \"EXHIBIT D SCANSOURCE FREIGHT POLICY TO: All SUPPLIERS SUBJECT: ROUTING INSTRUCTIONS In order to mm1m1ze inbound transportation cost, and to maximize control over transit time, tracing, and expediting, this routing guide has been issued. These instructions supercede all previous shipping instructions and are to be retained for ready reference. For shipments of Catalyst Telecom and Paracon products: Contact: Melinda Hamilton, Receiving Supervisor Phone: (800) 854-9570 ext. 8187 Fax: (901) 369-7876 Email: melinda.hamilton@partnerservicesinc.com Ship to address: ScanSource, Inc. 4020 Quest Way, Ste. 114 Memphis, TN. 38115 Receiving hours: 7:00 am - 2:00 pm For shipments of ScanSource and ScanSource Security products: Contact: Deborah Lucas, Receiving Manager Phone: (800) 854-9570 ext. 8111 Fax: (901) 367-0666 Email: deborah.lucas@partnerservicesinc.com Ship to address: ScanSource, Inc. 4100 Quest Way Memphis, TN. 38115 Receiving hours 7:00 am - 12:00 pm (noon) Note: A packing slip/manifest must be included with each shipment. It should include: a) A listing of products and quantities shipped b) Purchase order number (this must also show on the bill of lading) c) Date shipped d) Name of carrier e) Tracking or pro number Please comply with the following instructions when transportation is our responsibility: 1. All freight charges assigned to ScanSource must be shipped \\\"freight collect\\\". For UPS shipments ship \\\"bill recipient\\\". Please consolidate all of one day's shipments on one bill of lading. Exceptions will be charged back. Cisco may accomplish this by leveraging an order grouping process and setting up internal tools accordingly. OG will only be available for LTL or TL carriers. In order to support OG, ScanSource must include a LTL and TL carriers in their routing config in SRC tool. If combined shipments do not meet the minimum requirement to ship LTL or TL (i.e. number pieces, min weight) then no grouping will be done. 2. Do not insure shipments or declare value for carriage. 3. Each bill of lading must display the total number of cartons in the shipment, i.e. 24 cartons on 1 pallet. Bill of lading must be filled out completely. Please accurately describe products with the appropriate NMFC code. If you do not have the NMFC information available, ask the carrier to identify it for you. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indicate our purchase order number and number of boxes on all containers and shipping documents\", \"level\": 1, \"text\": \"4. Indicate our purchase order number and number of boxes on all containers and shipping documents. 5. All pallets must be standard 40\\\" wide X 48\\\" long four way pallets. Primary fork entry from the 40\\\" end. 6. Banding must be plastic, no metal. 7. Stack height on pallets is 48\\\" maximum. All freight bills are audited, and any premium transportation charges incurred because these instructions have not been followed will be charged to Cisco. The charges will be based on the actual premium paid. ScanSource agrees to provide Cisco with advance notice in the event such a charge becomes necessary. Cisco will have the opportunity to validate any such charge prior to actually incurring same. If pickup service, via the carrier shown below, is not available in your area or if you have any other questions concerning this guide, please contact the ScanSource Traffic Department at (901) 362-0421, Bob Balsano. Your cooperation in following this program is appreciated. STANDARD SURFACE TRANSPORTATION\"}}, {\"id\": \"I\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shipments, not individual cartons, weighing less than 250 lbs\", \"level\": 1, \"text\": \"I. Shipments, not individual cartons, weighing less than 250 lbs. and meeting the weight and size restrictions, must be shipped by United Parcel Service. II. Approved motor carriers for all LTL shipments from the States shown below are listed. CARRIER SERVICING FedEx Freight East Toll free number for pickups (800) 874-4723 -Alabama -Arkansas -Georgia -Illinois -Indiana -Kentucky -Louisiana -Minnesota -Mississippi -Missouri -New Jersey -North Carolina -Oklahoma -South Carolina -Tennessee -Texas -Virginia -West Virginia -Wisconsin Con-way: Arizona California Colorado Oregon Washington ALL REMAINING STATES Yellow Freight Toll free (800) 610-6500 PREMIUM ROUTINGS Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 ScanSource Purchasing or Traffic Department must authorize use of premium freight (air, special truck, truckload) in advance. All premium shipments must state the total number of cartons in the shipment and the correct dimension of each carton. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 EXHIBIT E AFFILIATE LIST The following entities are either business units of Distributor or are wholly-owned subsidiaries of Distributor. For the purposes of this Agreement, and as set forth in Section 1 (\\\"Definitions\\\"), all such entities listed below shall be referred to herein as \\\"Affiliate(s).\\\"\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ScanSource, Inc\", \"level\": 1, \"text\": \"1. ScanSource, Inc. 2. ScanSource, Inc. d/b/a Catalyst Telecom 3. ScanSource, Inc. d/b/a Paracon 4. ScanSource Security Distribution, Inc. 5. T2 Supply, Inc. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 EXHIBIT F Software Transfer and Relicensing Policy September 15, 2000 This document sets forth Cisco's policy with respect to the transferability of any Cisco software (\\\"Software\\\"). A transfer occurs when: (1) the original or authorized subsequent licensee tries to convey or reassign its right to use the Software to another entity, or (2) the original lessor of Cisco used hardware (including bundled Software) (\\\"Hardware\\\") tries to reassign the original lessee's right to use the Software to another lessee, or the lessor tries to convey or reassign its right to lease the Hardware and Software bundle to another lessor. A rental would be treated the same as the lease situation as described in item 2 above. This policy applies to all Software whether Standalone or Embedded. Standalone Software is Software which is not required to operate the Hardware upon which it resides (i.e., ICSG software such as call center, unified messaging, network management software). Embedded Software is Software which is incorporated into the Hardware and is required for its operation (i.e., operating system software, certain features of IOS). Policy: Cisco's policy is that Software, whether Standalone or Embedded, is not transferable, except where a listed exception below applies, and except, of course, where Cisco's contract expressly allows it. Any other transfers will require the payment of a new license fee (see Global Price List). For products where there is no separate line item for the Software (i.e. the prices for both the Hardware and Software are bundled), and therefore, a fee cannot be determined, an exception will be made to allow for the transfer without the customer being required to obtain a new license (the customer may be required to pay an inspection fee), if (A) Software to be transferred (i) will be under a support contract provided by either Cisco or a Cisco\u200b\u2010 authorized support partner or (ii) is still supported by Cisco; or (B) approval from the theatre Sales Controller has been obtained. Use of the Software will be governed by either the original license terms and conditions in place between Cisco and the original Software licensee or by the new license between Cisco and the new user. Cisco may withhold its consent to any transfer not conforming to this policy. License Fee: The License Fee is generally the same amount as the fee charged for a new license or a portion of the fee of a new license, unless otherwise noted on the Global Price List. It is the obligation of the transferor to obtain Cisco's consent and/or a new license before the transfer occurs. Exceptions: Provided the conditions of transfer are met as set forth below, the follow exceptions apply to the prohibition against transfer without written approval and payment of the applicable fee. These exceptions may be overridden by express terms in an applicable licensing agreement governing the transferability of Special License Software (Special License Software is the term now used in our templates to refer to ICSG Product) Affiliate: An entity may transfer its right to use a certain piece of Software to its Affiliate. An Affiliate is another entity where at least 50.1% of its voting power is owned or controlled by the transferring entity or where as least 50.1% of the transferring entity's voting power is owned or controlled by the transferee. Merger or Acquisition: An entity may transfer its right to use a certain piece of Software to the purchaser of all or substantially all of the capital stock of the transferor or all or substantially all of the assets of that portion of the transferor's business to which those licenses pertain. Lease: In a leasing situation where the original lessee/customer would like to buy out the equipment from the leasing company during or at the end of the lease term, the original lessee/customer may retain the license without paying a new License Fee, provided leasing company gives Cisco prior written notice. Also, if the original lessee/customer defaults under the lease and the leasing company takes the equipment back before the end of the lease term, the leasing company may transfer the license to the another lessee for the remainder of the original lease term, without paying Cisco a License Fee, upon 30 days' prior written notice to Cisco, or as soon as practicable if the equipment is re-leased before such 30- day period. If the new lease term is in Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 excess of the original lease term, the leasing company is expected to pay Cisco a new License Fee on or before the expiration date of the original lease term. [NOTE: In the situation where a leasing company leases Cisco equipment to Customer A for a specified term and at the end of the lease term, the leasing company desires to lease the same equipment to Customer B, leasing company may not transfer the license without obtaining a new license from Cisco.)]. Outsource: Customer desires to outsource the operation, support and maintenance of its network to a third party (e.g. EDS) (\\\"Third-Party Service Provider\\\"), for the benefit of that customer. As part of the outsourcing, customer transfers all of its rights, title and interest to the assets, including certain Cisco products and software licenses, to the Third-Party Service Provider. Customer may transfer the license to the Third-Party Service Provider solely for the purposes of providing services to Customer upon 30 days' prior written notice to Cisco. All notices should be sent to sw-license@cisco.com or as indicated in the agreement between Cisco and the customer or transferor, if any. Conditions of Transfer: Transfers, in any event, shall only be allowed under the following conditions: \u25e6 The parties involved in the transfer are not in breach of the agreement governing the use of the Software or any other agreement with Cisco; \u25e6 Any additional services or charges incurred by Cisco as the result of any transfer shall be borne by the transferor and transferee; and \u25e6 The parties involved in the transfer shall provide written prior notice of a permitted transfer to Cisco and the transferee shall, in a writing to Cisco, (i) assume all of the obligations of the transferor, and (ii) agree that transferee's use of the Software shall be governed by the terms of the then-current license agreement between Cisco and transferor or, at Cisco's sole discretion, by the terms of Cisco's then-current standard license agreement. Questions? Any questions or comments regarding this policy should be sent to sw-license@cisco.com. Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 EXHIBIT G Cisco End of Life Policy Products reach the end of their Product Life Cycle for a number of reasons. These reasons may be due to market demands, technology innovation and development driving changes in the product, or the products simply mature over time and are replaced by functionally richer technology. While this is an established part of the overall product life cycle, Cisco Systems recognizes that end-of-life milestones often prompt companies to review the way in which such end-of-sale and end-of-life milestones impact the Cisco products in their networks. With that in mind, we have set out below Cisco's end-of-life policy to help customers better manage their end-of-life transition and to understand the role that Cisco can play in helping to migrate to alternative Cisco platforms and technology. The End of Life Policy only applies to End of Life and End of Sale announcements made in all Theaters on or after November 30, 2002 for all Cisco product lines. The Policy does not apply to product that is already subject to an End of Life and/or End of Sale announcement. The general policy guidelines are:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As a general rule, Cisco will provide 6 months' notice of the affected product's end-of-sale date and/or the last day w\", \"level\": 1, \"text\": \"1. As a general rule, Cisco will provide 6 months' notice of the affected product's end-of-sale date and/or the last day when the affected product can be ordered. This notice will appear on Cisco.com site (http://www.cisco.com/en/US/products/prod_end_of_life.html) and we encourage you to visit this site regularly as it contains useful information regarding Cisco's end-of-life program. Sign up to receive notification here: http://www.cisco.com/pcgi-bin/Support/FieldNoticeTool/field-notice\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Access to Cisco's Technical Assistance Center (TAC) will be available 24 hours a day, seven days a week for a period of\", \"level\": 1, \"text\": \"2. Access to Cisco's Technical Assistance Center (TAC) will be available 24 hours a day, seven days a week for a period of 5 years from the end-of-sale date for hardware and operating system software issues and for a period of 3 years from the end-of-sale date for application software issues.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Spares or replacement parts for hardware will be available for a period of 5 years from the end-of\u200b sale date\", \"level\": 1, \"text\": \"3. Spares or replacement parts for hardware will be available for a period of 5 years from the end-of\u200b sale date. We will provide spares and replacement parts in accordance with our Return Materials Authorization (RMA) process.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Software support will be as follows\", \"level\": 1, \"text\": \"4. Software support will be as follows a. For the first year following the end-of-sale date, we will provide bug fixes, maintenance releases, workarounds, or patches for critical bugs reported via the TAC or Cisco.com Web site. b. After the first year and for Operating System SW -where available- we will provide bug fixes, maintenance releases, workarounds or patches for a period of 4 years for operating system software. Bear in mind that it may be necessary to use software upgrade release to correct a reported problem.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"After the first year and for Application SW -where available - we will provide bug fixes, maintenance releases, workaro\", \"level\": 1, \"text\": \"c. After the first year and for Application SW -where available - we will provide bug fixes, maintenance releases, workarounds or patches for a period of 2 years for application software. Bear in mind that it may be necessary to use software upgrade release to correct a reported problem.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"You will need to ensure that you have a current and fully paid support contract with Cisco\", \"level\": 1, \"text\": \"5. You will need to ensure that you have a current and fully paid support contract with Cisco. Please contact your Support Account Manager regarding fees payable during the end-of-life period so that we can support you right through the end-of-life transition period.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Below are guidelines that should be followed to ensure that you receive effective support for the affected products wit\", \"level\": 1, \"text\": \"6. Below are guidelines that should be followed to ensure that you receive effective support for the affected products within your network: a. For hardware or software that is not covered under a service contract, customers may add the product(s) to a current contract or purchase a new contract until 12 months after the end-of-sale date. b. Service contracts that have not been renewed or have lapsed after 12 months of end-of\u200b sale date are not re-newable.\"}}, {\"id\": \"c\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Renewal of your service contract will generally be available until the last year of support, but will not extend\", \"level\": 1, \"text\": \"c. Renewal of your service contract will generally be available until the last year of support, but will not extend Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 beyond the last date of support. The end-of-life milestones and Cisco commitments are presented in Table 1. Table 1. Standard Guideline for End-of-Life Milestones Milestone - 6 mos Day 0 1 Year 2 Year 3 Year 4 year 5 Year End-of-sale date End-of-Sale Notice Period Operating System Software Maintenance Support See 4(a) See 4(b) above Add or attach new service contracts Renew service contracts - for HW & Operating System SW Hardware Repair or Replacement Customer Service and Support of HW & Operating System SW (TAC access & support) Application Software maintenance support See 4(a) See 4(c) above Renew service contracts - for Application SW Here is an explanation of some of the terms that we have used in this notice: End of Product Life Cycle: A process that guides the final business operations associated with the product life cycle. The end-of-life process consists of a series of technical and business milestones and activities that, once completed, make a product obsolete. Once obsolete, the product is not sold, manufactured, improved, repaired, maintained, or supported. End-of-sale date: The last date to order the product through Cisco point-of-sale mechanisms. The product is no longer for sale. Hardware: The physical product and its physical components. Operating System Software: Cisco operating system software that runs on Cisco hardware Application software: Cisco software that requires the presence of some non-Cisco operating system software. Software Maintenance support: The time period that Cisco may release any software maintenance releases or bug fixes to the software product. After this date, Cisco Engineering will no longer develop, repair, maintain, or test the product software. Source: SCANSOURCE, INC., 10-K, 8/22/2019\"}}, {\"id\": \"party:ScanSource, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ScanSource, Inc.\", \"role\": \"Distributor\", \"address\": \"6 Logue Court, Greenville, South Carolina, 29615\"}}, {\"id\": \"party:Cisco Systems, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Cisco Systems, Inc.\", \"role\": \"Cisco\", \"address\": \"170 West Tasman Drive, San Jose, California 95134 - 1706\"}}, {\"id\": \"term:CONFIDENTIAL INFORMATION\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CONFIDENTIAL INFORMATION\", \"text\": \"CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Nonexclusive Value Added Distributor Agreement (\\\"Agreement\\\"), between ScanSource, Inc., a South Carolina corporation, with its principal place of business at 6 Logue Court, Greenville, South Carolina, 29615 (\\\"Distributor\\\"), and Cisco Systems, Inc., a California corporation with its principal place of business at 170 West Tasman Drive, San Jose, California 95134 - 1706, (\\\"Cisco\\\") is entered into as of the date last written below (\\\"the Effective Date\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Affiliate(s)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate(s)\", \"text\": \"Affiliate(s) are the entities listed on Exhibit E to this Agreement that are either business units of Distributor (and therefore wholly-owned and a part of Distributor) or are wholly-owned subsidiaries of Distributor, but in either case, only for so long as ownership remains as defined in this provision.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Cisco Quarter\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cisco Quarter\", \"text\": \"Cisco Quarter shall mean Cisco's fiscal quarters (August 1-October 31; November 1-January 31; February 1-April 30; and May 1-July 31).\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Documentation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Documentation\", \"text\": \"Documentation shall mean user manuals, training materials, Product descriptions and specifications, technical manuals, license agreements, supporting materials and other printed information relating to any Product, whether distributed in print, in electronic form, or in CD-ROM or video format.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:End User\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User\", \"text\": \"End User is the final purchaser or licensee who has acquired Products for its own internal use and not for resale, remarketing or redistribution.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Global Price List\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Global Price List\", \"text\": \"Global Price List means a complete listing of those Cisco products, services, including products and services which Cisco may make available to Distributor at its sole discretion, and associated prices.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Hardware\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Hardware\", \"text\": \"Hardware is the tangible product made available to Distributor.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Major Release or New Release\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Major Release or New Release\", \"text\": \"Major Release or New Release means a release of Software which is designated by Cisco as a change in the ones digit in the Software version number [(x).x.x].\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Non-Genuine Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Non-Genuine Products\", \"text\": \"Non-Genuine Products are any and all products: (i) to which a Mark or other Cisco trademark or service mark has been affixed without Cisco's consent; (ii) that have not been manufactured by Cisco or Cisco Technologies, Inc. (\\\"CTI\\\") or by a licensed manufacturer of either Cisco or CTI in accordance with the applicable license; or (iii) are produced with the intent to counterfeit or imitate a genuine Cisco Product\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Obsolete Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Obsolete Product\", \"text\": \"Obsolete Product shall mean any Product that is removed from the then-current Value Added Distributor Price List.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"Purchase Order is a written or electronic order from Distributor to Cisco for Hardware, Software or Services to be purchased, licensed or provided under this Agreement.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"Product means, individually or collectively as appropriate, Hardware, licensed Software, Documentation, developed products, supplies, accessories, and goods to the foregoing, listed on the then-current published Global Price List.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Reseller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reseller\", \"text\": \"Reseller means an authorized reseller of Distributor that meets Cisco's then-current requirements for resellers, including, without limitation, the requirements set out in Section 26.0 of this Agreement.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Services\", \"text\": \"Services means Cisco's SmartNet family of packaged service offerings, as well as such other service offerings as Cisco makes available for purchase by Distributor on Cisco's Wholesale or Global Price List.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"Software is the machine readable (object code) version of the computer programs listed from time to time on the Wholesale or Global Price List and made available by Cisco for license by Distributor, and any copies or Updates thereof.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"Territory is comprised of those regions or countries listed in Exhibit A.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Unauthorized Cisco Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unauthorized Cisco Product\", \"text\": \"Unauthorized Cisco Product means any genuine Cisco Product or Cisco Service that Distributor purchases or acquires from any party other than Cisco and/or an Approved Source.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Update\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Update\", \"text\": \"Update means a bug fix, error correction, patch or workaround for the Software which is provided by Cisco to Distributor in response to Distributor's request, or at Cisco's option, which Cisco chooses to provide to Distributor.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Value Added Distributor Price List\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Value Added Distributor Price List\", \"text\": \"Value Added Distributor Price List shall mean a portion of the Global Price List containing Products which Cisco makes available to Distributor for stocking and the prices at which Cisco will sell such Products to Distributor.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:In-Transit\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"In-Transit\", \"text\": \"For purposes of this Section 7.0, Products \\\"In-Transit\\\" shall be defined as all Products with a particular Cisco part number shipped by Cisco to Distributor in the [*****] day period prior to the date on which Cisco announces a general price decrease for Products with such part number, excluding those Products which Distributor has received into its inventory during such [*****] day period.\", \"definition_clause\": \"7.0\"}}, {\"id\": \"term:IPR Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"IPR Claim\", \"text\": \"Cisco will have the obligation and right to defend any claim, action, suit or proceeding (\\\"IPR Claim\\\") brought Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 against Distributor, its officers, directors, employees and agents (\\\"Named Parties\\\") so far as it is based on a claim that any Product supplied under this Agreement infringes Third Party IPR (as defined below).\", \"definition_clause\": \"15.0\"}}, {\"id\": \"term:Third Party IPR\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party IPR\", \"text\": \"For the purposes of this Agreement, Third Party IPR means a United States copyright existing as at the Effective Date, a United States patent issued as at the Effective Date, a trademark registered in the United States as at the Effective Date, trade dress existing in the United States as at the Effective Date, or a claim that a Product is manufactured by means of misappropriation of a third party's trade secrets.\", \"definition_clause\": \"15.2\"}}, {\"id\": \"term:Proprietary Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Information\", \"text\": \"Distributor acknowledges that, in the course of selling Products and Services and performing its duties under this Agreement, Distributor, its Resellers, and End Users to which Distributor provides access to Cisco technical data (including without limitation Products, Services, and technical data made available on Cisco Connection Online pursuant to Exhibit C), may obtain information relating to Products, Services, or to Cisco, which is of a confidential and proprietary nature (\\\"Proprietary Information\\\").\", \"definition_clause\": \"19.0\"}}, {\"id\": \"term:Distributor Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor Confidential Information\", \"text\": \"Cisco acknowledges that, under this Agreement, Distributor may provide Point of Sale (\\\"POS\\\") reports, financial information, sales and marketing plans, Distributor network design information and Distributor lists, of a proprietary and confidential nature (\\\"Distributor Confidential Information\\\").\", \"definition_clause\": \"19.0\"}}, {\"id\": \"term:CCO\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CCO\", \"text\": \"CCO means Cisco Connection Online, Cisco's online information web server.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Customer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer\", \"text\": \"Customer means End Users and Resellers.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:Standard Business Hours\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Standard Business Hours\", \"text\": \"Standard Business Hours means 6:00 AM to 6:00 PM Pacific Standard Time Monday through Friday, excluding Cisco-observed holidays, in the U.S. and Canada and outside the U.S. and Canada, means 8:00 AM to 6:00 PM Australia's Eastern Standard Time and Central European Time, Monday through Friday, excluding local Cisco-observed holidays.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"term:TAC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TAC\", \"text\": \"TAC means Cisco's Technical Assistance Center.\", \"definition_clause\": \"1.0\"}}, {\"id\": \"value:[*****] days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[*****] days\"}}, {\"id\": \"value:[*****]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"[*****]\"}}, {\"id\": \"value:[*****] day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[*****] day period\"}}, {\"id\": \"value:[*****] of the dollar value\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"[*****]\"}}, {\"id\": \"value:[*****] calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"[*****] calendar days\"}}, {\"id\": \"value:two (2) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:$[*****]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$[*****]\"}}, {\"id\": \"value:one (1) day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) day\"}}, {\"id\": \"value:two (2) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) days\"}}, {\"id\": \"value:one-month period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one-month period\"}}, {\"id\": \"value:50.1%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50.1%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:6 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"6 months\"}}, {\"id\": \"value:5 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 years\"}}, {\"id\": \"value:3 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3 years\"}}, {\"id\": \"value:first year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"first year\"}}, {\"id\": \"value:4 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"4 years\"}}, {\"id\": \"value:2 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"2 years\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12 months\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement2\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement2.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.38\", \"level\": 1, \"text\": \"Exhibit 10.38 EXHIBIT C Software License Agreement [v.08.05.03] PLEASE READ THIS SOFTWARE LICENSE AGREEMENT CAREFULLY BEFORE DOWNLOADING, INSTALLING OR USING CISCO OR CISCO- SUPPLIED SOFTWARE. BY DOWNLOADING OR INSTALLING THE SOFTWARE, OR USING THE EQUIPMENT THAT CONTAINS THIS SOFTWARE, YOU ARE BINDING THE BUSINESS ENTITY THAT YOU REPRESENT (\\\"CUSTOMER\\\") TO THIS AGREEMENT. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, THEN (A) DO NOT DOWNLOAD, INSTALL OR USE THE SOFTWARE, AND (B) YOU MAY RETURN THE SOFTWARE FOR A FULL REFUND, OR, IF THE SOFTWARE IS SUPPLIED AS PART OF ANOTHER PRODUCT, YOU MAY RETURN THE ENTIRE PRODUCT FOR A FULL REFUND. YOUR RIGHT TO RETURN AND REFUND EXPIRES 30 DAYS AFTER PURCHASE FROM CISCO OR AN AUTHORIZED CISCO RESELLER, AND APPLIES ONLY IF CUSTOMER IS THE ORIGINAL END USER PURCHASER. The following terms of this Software License Agreement (\\\"Agreement') govern Customer's access and use of the Software, except to the extent (a) there is a separate signed agreement between Customer and Cisco governing Customer's use of the Software or (b) the Software includes a separate \\\"click-accept\\\" license agreement as part of the installation and/or download process. To the extent of a conflict between the provisions of the foregoing documents, the order of precedence shall be (1) the signed agreement, (2) the click-accept agreement, and (3) this Software License Agreement. License. Subject to the terms and conditions of this Agreement, Cisco Systems, Inc. or its subsidiary licensing the Software instead of Cisco Systems, Inc. (\\\"Cisco\\\"), grants to Customer a nonexclusive and nontransferable license to use for Customer's internal business purposes the Software and the Documentation for which Customer has paid the required license fees. \\\"Documentation\\\" means written information (whether contained in user or technical manuals, training materials, specifications or otherwise) regarding the Software and made available by Cisco in any manner (including on CD-Rom, or on-line). Customer's license to use the Software shall be limited to, and Customer shall not use the Software in excess of, a single hardware chassis or card or that number of agent(s), concurrent users, sessions, IP addresses, port(s), seat(s), server(s) or site(s), as set forth in the applicable Purchase Order which has been accepted by Cisco and for which Customer has paid to Cisco the required license fee. Unless otherwise expressly provided in the Documentation, Customer shall use the Software solely as embedded in, for execution on, or (where the applicable documentation permits installation on non-Cisco equipment) for communication with Cisco equipment owned or leased by Customer. NOTE: For evaluation or beta copies for which Cisco does not charge a license fee, the above requirement to pay license fees does not apply. General Limitations. Except as otherwise expressly provided under this Agreement, Customer shall have no right, and Customer specifically agrees not to: (i) transfer, assign or sublicense its license rights to any other person or entity, or use the Software on unauthorized or secondhand Cisco equipment, and Customer acknowledges that any attempted transfer, assignment, sublicense or use shall be void; (ii) make error corrections to or otherwise modify or adapt the Software or create derivative works based upon the Software, or permit third parties to do the same; (iii) decompile, decrypt, reverse engineer, disassemble or otherwise reduce the Software to human- readable form; or (iv) use or permit the Software to be used to perform services for third parties without the express written authorization of Cisco. To the extent required by law, and at Customer's written request, Cisco shall provide Customer with the interface information needed to achieve interoperability between the Software and another independently created program, on payment of Cisco's Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 applicable fee, if any. Customer shall observe strict obligations of confidentiality with respect to such information. Software, Upgrades and Additional Copies. For purposes of this Agreement, \\\"Software\\\" shall include (and the terms and conditions of this Agreement shall apply to) computer programs, including firmware, as provided to Customer by Cisco or an authorized Cisco reseller, and any upgrades, updates, bug fixes or modified versions thereto (collectively, \\\"Upgrades\\\") or backup copies of the Software licensed or provided to Customer by Cisco or an authorized Cisco reseller. NOTWITHSTANDING ANY OTHER PROVISION OF THIS AGREEMENT: (1) CUSTOMER HAS NO LICENSE OR RIGHT TO USE ANY ADDITIONAL COPIES OR UPGRADES UNLESS CUSTOMER, AT THE TIME OF ACQUIRING SUCH COPY OR UPGRADE, ALREADY HOLDS A VALID LICENSE TO THE ORIGINAL SOFTWARE AND HAS PAID THE APPLICABLE FEE FOR THE UPGRADE; (2) USE OF UPGRADES IS LIMITED TO CISCO EQUIPMENT FOR WHICH CUSTOMER IS THE ORIGINAL END USER PURCHASER OR LESSEE OR WHO OTHERWISE HOLDS A VALID LICENSE TO USE THE SOFTWARE WHICH IS BEING UPGRADED; AND (3) THE MAKING AND USE OF ADDITIONAL COPIES IS LIMITED TO NECESSARY BACKUP PURPOSES ONLY. Proprietary Notices. Customer agrees to maintain and reproduce all copyright and other proprietary notices on all copies, in any form, of the Software in the same form and manner that such copyright and other proprietary notices are included on the Software. Except as expressly authorized in this Agreement, Customer shall not make any copies or duplicates of any Software without the prior written permission of Cisco. Protection of Information. Customer agrees that aspects of the Software and associated Documentation, including the specific design and structure of individual programs, are trade secrets and/or copyrighted materials of Cisco, its suppliers or licensors. Customer shall not disclose, provide, or otherwise make available such trade secrets or copyrighted material in any form to any third party without the prior written consent of Cisco. Customer shall implement reasonable security measures to protect such trade secrets and copyrighted materials. Title to Software and Documentation shall remain solely with Cisco, its suppliers or licensors. Term and Termination. This Agreement and the license granted herein shall remain effective until terminated. Customer may terminate this Agreement and the license at any time by destroying all copies of Software including any Documentation. Customer's rights under this Agreement will terminate immediately without notice from Cisco if Customer fails to comply with any provision of this Agreement. Upon termination, Customer shall destroy all copies of Software and Documentation in its possession or control. Customer Records. Customer grants to Cisco and its independent accountants the right to examine Customer's books, records and accounts during Customer's normal business hours to verify compliance with this Agreement. In the event such audit discloses non-compliance with this Agreement, Customer shall promptly pay to Cisco the appropriate license fees. Export. Software, including technical data, may be subject to U.S. export control laws, including the U.S. Export Administration Act and its associated regulations, and may be subject to export or import regulations in other countries. Customer agrees to comply strictly with all such regulations and acknowledges that it has the responsibility to obtain licenses to export, re-export, or import Software. Limited Warranty Cisco warrants that commencing from the date of shipment to Customer (but in case of resale by an authorized Cisco reseller, commencing not more than ninety (90) days after original shipment by Cisco), and continuing for a period of the longer of (a) ninety (90) days or (b) the software warranty period (if any) set forth in the warranty card accompanying the Product (if any): (a) the media on which the Software is furnished will be free of defects in materials and workmanship under normal use; and (b) the Software substantially conforms to its published specifications. The date of shipment of a Product by Cisco is set forth on the packaging material in which the Product is shipped. Except for the foregoing, the Software is provided AS IS. This limited warranty extends only to the Customer who is the original licensee. Customer's sole and exclusive remedy and the entire liability of Cisco and its suppliers and licensors under this limited warranty will be, at Cisco's option, repair, replacement, Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 or refund of the Software if reported (or, upon request, returned) to Cisco or the party supplying the Software to Customer, if different than Cisco. In no event does Cisco warrant that the Software is error free or that Customer will be able to operate the Software without problems or interruptions. In addition, due to the continual development of new techniques for intruding upon and attacking networks, Cisco does not warrant that the Software or any equipment, system or network on which the Software is used will be free of vulnerability to intrusion or attack. Restrictions. This warranty does not apply if the Software, Product or any other equipment upon which the Software is authorized to be used (a) has been altered, except by Cisco, (b) has not been installed, operated, repaired, or maintained in accordance with instructions supplied by Cisco, (c) has been subjected to abnormal physical or electrical stress, misuse, negligence, or accident; or (d) is licensed, for beta, evaluation, testing or demonstration purposes for which Cisco does not charge a purchase price or license fee. DISCLAIMER OF WARRANTY. EXCEPT AS SPECIFIED IN THIS WARRANTY, ALL EXPRESS OR IMPLIED CONDITIONS, REPRESENTATIONS, AND WARRANTIES INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OR CONDITION OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, SATISFACTORY QUALITY OR ARISING FROM A COURSE OF DEALING, LAW, USAGE, OR TRADE PRACTICE, ARE HEREBY EXCLUDED TO THE EXTENT ALLOWED BY APPLICABLE LAW AND ARE EXPRESSLY DISCLAIMED BY CISCO, ITS SUPPLIERS AND LICENSORS. TO THE EXTENT AN IMPLIED WARRANTY CANNOT BE EXCLUDED, SUCH WARRANTY IS LIMITED IN DURATION TO THE WARRANTY PERIOD. BECAUSE SOME STATES OR JURISDICTIONS DO NOT ALLOW LIMITATIONS ON HOW LONG AN IMPLIED WARRANTY LASTS, THE ABOVE LIMITATION MAY NOT APPLY. THIS WARRANTY GIVES CUSTOMER SPECIFIC LEGAL RIGHTS, AND CUSTOMER MAY ALSO HAVE OTHER RIGHTS WHICH VARY FROM JURISDICTION TO JURISDICTION. This disclaimer and exclusion shall apply even if the express warranty set forth above fails of its essential purpose. General Terms Applicable to the Limited Warranty Statement and Software License Disclaimer of Liabilities. IN NO EVENT WILL CISCO OR ITS SUPPLIERS BE LIABLE FOR ANY LOST REVENUE, PROFIT, OR LOST OR DAMAGED DATA, OR FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, OR PUNITIVE DAMAGES HOWEVER CAUSED AND REGARDLESS OF THE THEORY OF LIABILITY OR WHETHER ARISING OUT OF THE USE OF OR INABILITY TO USE SOFTWARE OR OTHERWISE AND EVEN IF CISCO OR ITS SUPPLIERS OR LICENSORS HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. In no event shall Cisco's or its suppliers' or licensors' liability to Customer, whether in contract, tort (including negligence), or otherwise, exceed the price paid by Customer for the Software that gave rise to the claim or if the Software is part of another Product, the price paid for such other Product. The foregoing limitations shall apply even if the above\u200b stated warranty fails of its essential purpose. BECAUSE SOME STATES OR JURISDICTIONS DO NOT ALLOW LIMITATION OR EXCLUSION OF CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU. The Warranty and the Software License shall be governed by and construed in accordance with the laws of the State of California, without reference to principles of conflict of laws. The United Nations Convention on the International Sale of Goods shall not apply. If any portion hereof is found to be void or unenforceable, the remaining provisions of the Agreement shall remain in full force and effect. Except as expressly provided herein, this Agreement constitutes the entire agreement between the parties with respect to the license of the Software and supersedes any conflicting or additional terms contained in any purchase order or elsewhere all of which terms are excluded. Source: SCANSOURCE, INC., 10-K, 8/22/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ScansourceInc_20190822_10-K_EX-10.38_11793958_EX-10.38_Distributor Agreement2\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.38\", \"level\": 1, \"text\": \"Exhibit 10.38 EXHIBIT C Software License Agreement [v.08.05.03] PLEASE READ THIS SOFTWARE LICENSE AGREEMENT CAREFULLY BEFORE DOWNLOADING, INSTALLING OR USING CISCO OR CISCO- SUPPLIED SOFTWARE. BY DOWNLOADING OR INSTALLING THE SOFTWARE, OR USING THE EQUIPMENT THAT CONTAINS THIS SOFTWARE, YOU ARE BINDING THE BUSINESS ENTITY THAT YOU REPRESENT (\\\"CUSTOMER\\\") TO THIS AGREEMENT. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, THEN (A) DO NOT DOWNLOAD, INSTALL OR USE THE SOFTWARE, AND (B) YOU MAY RETURN THE SOFTWARE FOR A FULL REFUND, OR, IF THE SOFTWARE IS SUPPLIED AS PART OF ANOTHER PRODUCT, YOU MAY RETURN THE ENTIRE PRODUCT FOR A FULL REFUND. YOUR RIGHT TO RETURN AND REFUND EXPIRES 30 DAYS AFTER PURCHASE FROM CISCO OR AN AUTHORIZED CISCO RESELLER, AND APPLIES ONLY IF CUSTOMER IS THE ORIGINAL END USER PURCHASER. The following terms of this Software License Agreement (\\\"Agreement') govern Customer's access and use of the Software, except to the extent (a) there is a separate signed agreement between Customer and Cisco governing Customer's use of the Software or (b) the Software includes a separate \\\"click-accept\\\" license agreement as part of the installation and/or download process. To the extent of a conflict between the provisions of the foregoing documents, the order of precedence shall be (1) the signed agreement, (2) the click-accept agreement, and (3) this Software License Agreement. License. Subject to the terms and conditions of this Agreement, Cisco Systems, Inc. or its subsidiary licensing the Software instead of Cisco Systems, Inc. (\\\"Cisco\\\"), grants to Customer a nonexclusive and nontransferable license to use for Customer's internal business purposes the Software and the Documentation for which Customer has paid the required license fees. \\\"Documentation\\\" means written information (whether contained in user or technical manuals, training materials, specifications or otherwise) regarding the Software and made available by Cisco in any manner (including on CD-Rom, or on-line). Customer's license to use the Software shall be limited to, and Customer shall not use the Software in excess of, a single hardware chassis or card or that number of agent(s), concurrent users, sessions, IP addresses, port(s), seat(s), server(s) or site(s), as set forth in the applicable Purchase Order which has been accepted by Cisco and for which Customer has paid to Cisco the required license fee. Unless otherwise expressly provided in the Documentation, Customer shall use the Software solely as embedded in, for execution on, or (where the applicable documentation permits installation on non-Cisco equipment) for communication with Cisco equipment owned or leased by Customer. NOTE: For evaluation or beta copies for which Cisco does not charge a license fee, the above requirement to pay license fees does not apply. General Limitations. Except as otherwise expressly provided under this Agreement, Customer shall have no right, and Customer specifically agrees not to: (i) transfer, assign or sublicense its license rights to any other person or entity, or use the Software on unauthorized or secondhand Cisco equipment, and Customer acknowledges that any attempted transfer, assignment, sublicense or use shall be void; (ii) make error corrections to or otherwise modify or adapt the Software or create derivative works based upon the Software, or permit third parties to do the same; (iii) decompile, decrypt, reverse engineer, disassemble or otherwise reduce the Software to human- readable form; or (iv) use or permit the Software to be used to perform services for third parties without the express written authorization of Cisco. To the extent required by law, and at Customer's written request, Cisco shall provide Customer with the interface information needed to achieve interoperability between the Software and another independently created program, on payment of Cisco's Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 applicable fee, if any. Customer shall observe strict obligations of confidentiality with respect to such information. Software, Upgrades and Additional Copies. For purposes of this Agreement, \\\"Software\\\" shall include (and the terms and conditions of this Agreement shall apply to) computer programs, including firmware, as provided to Customer by Cisco or an authorized Cisco reseller, and any upgrades, updates, bug fixes or modified versions thereto (collectively, \\\"Upgrades\\\") or backup copies of the Software licensed or provided to Customer by Cisco or an authorized Cisco reseller. NOTWITHSTANDING ANY OTHER PROVISION OF THIS AGREEMENT: (1) CUSTOMER HAS NO LICENSE OR RIGHT TO USE ANY ADDITIONAL COPIES OR UPGRADES UNLESS CUSTOMER, AT THE TIME OF ACQUIRING SUCH COPY OR UPGRADE, ALREADY HOLDS A VALID LICENSE TO THE ORIGINAL SOFTWARE AND HAS PAID THE APPLICABLE FEE FOR THE UPGRADE; (2) USE OF UPGRADES IS LIMITED TO CISCO EQUIPMENT FOR WHICH CUSTOMER IS THE ORIGINAL END USER PURCHASER OR LESSEE OR WHO OTHERWISE HOLDS A VALID LICENSE TO USE THE SOFTWARE WHICH IS BEING UPGRADED; AND (3) THE MAKING AND USE OF ADDITIONAL COPIES IS LIMITED TO NECESSARY BACKUP PURPOSES ONLY. Proprietary Notices. Customer agrees to maintain and reproduce all copyright and other proprietary notices on all copies, in any form, of the Software in the same form and manner that such copyright and other proprietary notices are included on the Software. Except as expressly authorized in this Agreement, Customer shall not make any copies or duplicates of any Software without the prior written permission of Cisco. Protection of Information. Customer agrees that aspects of the Software and associated Documentation, including the specific design and structure of individual programs, are trade secrets and/or copyrighted materials of Cisco, its suppliers or licensors. Customer shall not disclose, provide, or otherwise make available such trade secrets or copyrighted material in any form to any third party without the prior written consent of Cisco. Customer shall implement reasonable security measures to protect such trade secrets and copyrighted materials. Title to Software and Documentation shall remain solely with Cisco, its suppliers or licensors. Term and Termination. This Agreement and the license granted herein shall remain effective until terminated. Customer may terminate this Agreement and the license at any time by destroying all copies of Software including any Documentation. Customer's rights under this Agreement will terminate immediately without notice from Cisco if Customer fails to comply with any provision of this Agreement. Upon termination, Customer shall destroy all copies of Software and Documentation in its possession or control. Customer Records. Customer grants to Cisco and its independent accountants the right to examine Customer's books, records and accounts during Customer's normal business hours to verify compliance with this Agreement. In the event such audit discloses non-compliance with this Agreement, Customer shall promptly pay to Cisco the appropriate license fees. Export. Software, including technical data, may be subject to U.S. export control laws, including the U.S. Export Administration Act and its associated regulations, and may be subject to export or import regulations in other countries. Customer agrees to comply strictly with all such regulations and acknowledges that it has the responsibility to obtain licenses to export, re-export, or import Software. Limited Warranty Cisco warrants that commencing from the date of shipment to Customer (but in case of resale by an authorized Cisco reseller, commencing not more than ninety (90) days after original shipment by Cisco), and continuing for a period of the longer of (a) ninety (90) days or (b) the software warranty period (if any) set forth in the warranty card accompanying the Product (if any): (a) the media on which the Software is furnished will be free of defects in materials and workmanship under normal use; and (b) the Software substantially conforms to its published specifications. The date of shipment of a Product by Cisco is set forth on the packaging material in which the Product is shipped. Except for the foregoing, the Software is provided AS IS. This limited warranty extends only to the Customer who is the original licensee. Customer's sole and exclusive remedy and the entire liability of Cisco and its suppliers and licensors under this limited warranty will be, at Cisco's option, repair, replacement, Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.38 or refund of the Software if reported (or, upon request, returned) to Cisco or the party supplying the Software to Customer, if different than Cisco. In no event does Cisco warrant that the Software is error free or that Customer will be able to operate the Software without problems or interruptions. In addition, due to the continual development of new techniques for intruding upon and attacking networks, Cisco does not warrant that the Software or any equipment, system or network on which the Software is used will be free of vulnerability to intrusion or attack. Restrictions. This warranty does not apply if the Software, Product or any other equipment upon which the Software is authorized to be used (a) has been altered, except by Cisco, (b) has not been installed, operated, repaired, or maintained in accordance with instructions supplied by Cisco, (c) has been subjected to abnormal physical or electrical stress, misuse, negligence, or accident; or (d) is licensed, for beta, evaluation, testing or demonstration purposes for which Cisco does not charge a purchase price or license fee. DISCLAIMER OF WARRANTY. EXCEPT AS SPECIFIED IN THIS WARRANTY, ALL EXPRESS OR IMPLIED CONDITIONS, REPRESENTATIONS, AND WARRANTIES INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OR CONDITION OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, SATISFACTORY QUALITY OR ARISING FROM A COURSE OF DEALING, LAW, USAGE, OR TRADE PRACTICE, ARE HEREBY EXCLUDED TO THE EXTENT ALLOWED BY APPLICABLE LAW AND ARE EXPRESSLY DISCLAIMED BY CISCO, ITS SUPPLIERS AND LICENSORS. TO THE EXTENT AN IMPLIED WARRANTY CANNOT BE EXCLUDED, SUCH WARRANTY IS LIMITED IN DURATION TO THE WARRANTY PERIOD. BECAUSE SOME STATES OR JURISDICTIONS DO NOT ALLOW LIMITATIONS ON HOW LONG AN IMPLIED WARRANTY LASTS, THE ABOVE LIMITATION MAY NOT APPLY. THIS WARRANTY GIVES CUSTOMER SPECIFIC LEGAL RIGHTS, AND CUSTOMER MAY ALSO HAVE OTHER RIGHTS WHICH VARY FROM JURISDICTION TO JURISDICTION. This disclaimer and exclusion shall apply even if the express warranty set forth above fails of its essential purpose. General Terms Applicable to the Limited Warranty Statement and Software License Disclaimer of Liabilities. IN NO EVENT WILL CISCO OR ITS SUPPLIERS BE LIABLE FOR ANY LOST REVENUE, PROFIT, OR LOST OR DAMAGED DATA, OR FOR SPECIAL, INDIRECT, CONSEQUENTIAL, INCIDENTAL, OR PUNITIVE DAMAGES HOWEVER CAUSED AND REGARDLESS OF THE THEORY OF LIABILITY OR WHETHER ARISING OUT OF THE USE OF OR INABILITY TO USE SOFTWARE OR OTHERWISE AND EVEN IF CISCO OR ITS SUPPLIERS OR LICENSORS HAVE BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. In no event shall Cisco's or its suppliers' or licensors' liability to Customer, whether in contract, tort (including negligence), or otherwise, exceed the price paid by Customer for the Software that gave rise to the claim or if the Software is part of another Product, the price paid for such other Product. The foregoing limitations shall apply even if the above\u200b stated warranty fails of its essential purpose. BECAUSE SOME STATES OR JURISDICTIONS DO NOT ALLOW LIMITATION OR EXCLUSION OF CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU. The Warranty and the Software License shall be governed by and construed in accordance with the laws of the State of California, without reference to principles of conflict of laws. The United Nations Convention on the International Sale of Goods shall not apply. If any portion hereof is found to be void or unenforceable, the remaining provisions of the Agreement shall remain in full force and effect. Except as expressly provided herein, this Agreement constitutes the entire agreement between the parties with respect to the license of the Software and supersedes any conflicting or additional terms contained in any purchase order or elsewhere all of which terms are excluded. Source: SCANSOURCE, INC., 10-K, 8/22/2019\"}}, {\"id\": \"party:the business entity that you represent\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"the business entity that you represent\", \"role\": \"CUSTOMER\", \"address\": null}}, {\"id\": \"party:Cisco Systems, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Cisco Systems, Inc.\", \"role\": \"Cisco\", \"address\": null}}, {\"id\": \"term:CUSTOMER\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CUSTOMER\", \"text\": \"THE BUSINESS ENTITY THAT YOU REPRESENT (\\\"CUSTOMER\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"The following terms of this Software License Agreement (\\\"Agreement')\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Cisco\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cisco\", \"text\": \"Cisco Systems, Inc. or its subsidiary licensing the Software instead of Cisco Systems, Inc. (\\\"Cisco\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Documentation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Documentation\", \"text\": \"\\\"Documentation\\\" means written information (whether contained in user or technical manuals, training materials, specifications or otherwise) regarding the Software and made available by Cisco in any manner (including on CD-Rom, or on-line).\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Software\", \"text\": \"For purposes of this Agreement, \\\"Software\\\" shall include (and the terms and conditions of this Agreement shall apply to) computer programs, including firmware, as provided to Customer by Cisco or an authorized Cisco reseller, and any upgrades, updates, bug fixes or modified versions thereto (collectively, \\\"Upgrades\\\") or backup copies of the Software licensed or provided to Customer by Cisco or an authorized Cisco reseller.\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Upgrades\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Upgrades\", \"text\": \"any upgrades, updates, bug fixes or modified versions thereto (collectively, \\\"Upgrades\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"value:30 DAYS\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 DAYS\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of ScansourceInc_20190822_10-K_EX-10.39_11793959_EX-10.39_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of ScansourceInc_20190822_10-K_EX-10.39_11793959_EX-10.39_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.39\", \"level\": 1, \"text\": \"Exhibit 10.39 IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****]. AMENDMENT NO. 3 TO THE NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT This Amendment No. 3 (\\\"Amendment No. 3\\\") to the Nonexclusive Value Added Distributor Agreement, as amended (\\\"Agreement''), by and between Cisco Systems, Inc. (\\\"Cisco\\\"), a California corporation having Its principal place of business at 170 West Tasman Drive, San Jose, CA, 95134, and ScanSource, Inc. (\\\"Distributor\\\"), a South Carolina corporation with a place of business at 6 Logue Court, Greenville, South Carolina, 29615, is effective as of the date last signed below (\\\"Amendment Effective Date\\\"). All capitalized terms contained herein shall have the same meaning as the terms defined in the Agreement unless specifically modified in this Amendment. WHEREAS, Cisco and Distributor have previously entered into the Agreement dated January 22, 2007, and WHEREAS, Cisco and Distributor wish to renew and update certain terms and conditions in the Agreement regarding payment; and, NOW WHEREFORE, the parties agree to further amend the Agreement as follows:\"}, {\"id\": \"1\", \"title\": \"The Term of the Agreement is hereby extended to January 20, 2012 unless sooner terminated as provided for in the Agreem\", \"level\": 1, \"text\": \"1. The Term of the Agreement is hereby extended to January 20, 2012 unless sooner terminated as provided for in the Agreement. If the Agreement expired prior to the Amendment Effective Date, any orders received and Products and Services purchased between the date of expiration and the Amendment Effective Date shall be in all respects deemed made under the Agreement as in effect prior to this Amendment. The parties further agree that if Distributor places Purchase Orders after the expiration of the Agreement, and Cisco accepts such Purchase Orders, then any such Purchase Orders shall be governed by the terms and conditions of the Agreement; provided, however that acceptance by Cisco of any Purchase Order placed after the Agreement has expired will not be considered as an extension of the term of the Agreement nor a renewal thereof. Notwithstanding Cisco's right to extend the term of the Agreement, each party acknowledges that the Agreement shall always be interpreted as being limited in duration to a definite term and that the other party has made no commitments whatsoever regarding the renewal of the Agreement beyond those expressly agreed in writing.\"}, {\"id\": \"2\", \"title\": \"Section 6\", \"level\": 1, \"text\": \"2. Section 6.0 (\\\"Payment\\\") of the Agreement is modified by adding the following new Section 6.7: 6.7 [*****]\"}, {\"id\": \"3\", \"title\": \"Section 12 (\\\"Inventory Balance\\\") is deleted in its entirety and hereby replaced with the following\", \"level\": 1, \"text\": \"3. Section 12 (\\\"Inventory Balance\\\") is deleted in its entirety and hereby replaced with the following:\"}, {\"id\": \"12.0\", \"title\": \"INVENTORY BALANCE\", \"level\": 2, \"text\": \"12.0 INVENTORY BALANCE\"}, {\"id\": \"12.1\", \"title\": \"Distributor shall have the option to return to Cisco, for credit, up [*****] of the dollar value of Products from the Wh\", \"level\": 2, \"text\": \"12.1 Distributor shall have the option to return to Cisco, for credit, up [*****] of the dollar value of Products from the Wholesale Price List (or, if no Wholesale Price Lists exists for Distributor's Territory, then the applicable price list) shipped to Distributor, net of credits, less returns to Cisco, in the preceding [*****] period (the \\\"Balancing Cap\\\") of the preceding Cisco fiscal quarter. The above-referenced cap shall be determined based on all Product purchases made under this Agreement. The responsibility to manage the Balancing Cap shall rest solely upon Distributor. Distributor shall be entitled to return Product once per quarter, provided such returns do not exceed the Balancing Cap. \\\"Dead on Arrival\\\" and Obsolete Products returned pursuant to Section 13 of this Agreement shall be excluded from calculation of the Balancing Cap. Cisco shall credit Distributor's account in the amount of the price paid by Distributor therefore, less any price protection credits issued to Distributor related to the Product returned (the \\\"Return Credit\\\").\"}, {\"id\": \"12.2\", \"title\": \"For all returns made pursuant to this Section 12, the following requirements must be met by Distributor\", \"level\": 2, \"text\": \"12.2 For all returns made pursuant to this Section 12, the following requirements must be met by Distributor:\"}, {\"id\": \"12.2.1\", \"title\": \"[*****]\", \"level\": 3, \"text\": \"12.2.1 [*****]\"}, {\"id\": \"12.2.2\", \"title\": \"[*****]\", \"level\": 3, \"text\": \"12.2.2 [*****] Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.39\"}, {\"id\": \"12.2.3\", \"title\": \"Distributor shall bear all shipping and handling charges to the Cisco designated site set forth ln Cisco's published Ret\", \"level\": 3, \"text\": \"12.2.3 Distributor shall bear all shipping and handling charges to the Cisco designated site set forth ln Cisco's published Return Materials Authorization (\\\"RMA\\\") Policy for Product returned for credit;\"}, {\"id\": \"12.2.4\", \"title\": \"Distributor shall obtain an RMA number prior to returning any Product to Cisco\", \"level\": 3, \"text\": \"12.2.4 Distributor shall obtain an RMA number prior to returning any Product to Cisco. Distributor shall follow Cisco's then-current RMA process; and\"}, {\"id\": \"12.2.5\", \"title\": \"Distributor reports must be provided to Cisco In accordance with the terms of this Agreement\", \"level\": 3, \"text\": \"12.2.5 Distributor reports must be provided to Cisco In accordance with the terms of this Agreement.\"}, {\"id\": \"4.0\", \"title\": \"Section 21\", \"level\": 2, \"text\": \"4.0 Section 21.0 (\\\"Compliance with Laws\\\") is hereby deleted in its entirety and replaced with the following:\"}, {\"id\": \"21.0\", \"title\": \"COMPLIANCE WITH LAWS, INCLUDING ANTI-CORRUPTIONLAWS\", \"level\": 2, \"text\": \"21.0 COMPLIANCE WITH LAWS, INCLUDING ANTI-CORRUPTIONLAWS\"}, {\"id\": \"21.1\", \"title\": \"In connection with the sale or distribution of Cisco Products or Services, or otherwise in carrying out its obligations\", \"level\": 2, \"text\": \"21.1 In connection with the sale or distribution of Cisco Products or Services, or otherwise in carrying out its obligations under this Agreement, Distributor represents and warrants the following: (a) Distributor will comply with all country, federal, state and local laws, ordinances, codes, regulations, rules, policies and procedures, Including, without limitation, all anti-corruption laws, Including, the U.S. Foreign Corrupt Practices Act (Applicable Laws). Distributor can find more information about the Foreign Corrupt Practices Act at the following URL: http://www.usdoj.gov/criminal/fraud/docs/dojdocb.html, o r b y contacting publicsectorcompllance@cisco.com. (b) Distributor shall not take any action or permit or authorize any action in violation of the Applicable Laws; (c) Distributor will not use money or other consideration paid by Cisco (and Distributor will not use its own money on Cisco's behalf) for any unlawful purposes, including any purposes violating Applicable Laws, such as direct or indirect payments, for the purpose of assisting Cisco in obtaining or retaining business, to any of the following: (i) Government officials (including any person holding an executive, legislative, judicial or administrative office, whether elected or appointed, or of any public international organization, such as the United Nations or World Bank, or any person acting in any official capacity for or on behalf of such government, public enterprise or state-owned business); (ii) Political parties or party officials; (iii) Candidates for political office; or (iii) Any person, while knowing that all or a portion of such money or thing of value will be offered, given or promised, directly or indirectly to any of the above identified persons or organizations. (d) Distributor remains responsible for undertaking appropriate and reasonable measures to ensure that its own relevant subcontractors, consultants, agents or representatives who interact with government\u200b affiliated organizations comply with applicable anti-corruption laws; (e) Distributor's key personnel who directly support Cisco's account have or will have completed training (provided by Distributor, Cisco Cisco's on-line anti-corruption training is available in numerous languages and is free of charge for up to five of Distributor's personnel at http://corpedia.com/clients/cisco/pre_reg.asp?lid-300446001., or another third party) on compliance with applicable anti-corruption laws within the past 12 months (from the date when this Agreement becomes effective); (f) Distributor's record-keeping obligations, set forth In the \\\"Audit\\\" provision herein, shall apply equally to Distributor's representations and warranties In this section, Cisco's audit rights, as set forth herein, and Distributor's compliance with the Applicable Laws; (g) In no event shall Cisco be obligated under this Agreement to take any action or omit to take any action that Cisco believes, in good faith, would cause it to be In violation of any laws of the Territory(ies) identified in this Agreement or the Applicable Laws; (h) Distributor Is unaware of any of Its directors, officers or employees serving as government officials or employees (at any level of government); (i) The directors, officers and employees of Distributor's business are not employees of Cisco (Including any of Its affiliated companies); Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.39 (j) Neither Distributor nor, to Distributor's knowledge, any of its directors or officers have been formally charged with, convicted of, or plead guilty to, any offense involving fraud or corruption; (k) Distributor, its directors and officers have not been listed by any government or public agency (such as the United Nations or World Bank) as debarred, suspended, or proposed for suspension or debarment or otherwise ineligible for government procurement programs; (l) Distributor has not offered to pay, nor has Distributor paid, nor will Distributor pay, any political contributions to any person or entity on behalf of Cisco; (m) If Distributor is a non-governmental entity, it will notify Cisco In writing lf any of its owners, partners, principals, officers, or employees are or become, during the term of this Agreement, officials, officers or representatives of any government, political party or candidate for political office outside the United States and are responsible for a decision regarding obtaining or retaining business for Cisco Products or Services by such government. Distributor will also promptly inform Cisco if any other portion of the statements set forth in subsections (g) through (k) above changes. (n) Notwithstanding any other provision in this Agreement, Cisco may terminate this Agreement immediately upon written notice if Distributor breaches any of the representations and warranties set forth in this section. (o) Distributor can report to Cisco any concerns it may have regarding any business practices by emailing ethics@cisco.com, or by calling Cisco's Helpline toll free number In North America 1- 877-571-1700 or worldwide number (reverse calling charges to Cisco) 001-770-776-5611. Contact ethics@cisco.com for other Cisco) 001-770-776-5611. Contact ethics@cisco.com for other available regional hotline numbers; (p) Distributor has read Cisco's \\\"Compliance with Global Anticorruption Laws by Cisco' Partners\\\", published at http://www.cisco.com/legal/anti corruption.html.\"}, {\"id\": \"5.0\", \"title\": \"All capitalized terms not defined in this Amendment No\", \"level\": 2, \"text\": \"5.0 All capitalized terms not defined in this Amendment No. 3 shall have the meaning assigned to them in the Agreement. In the event of conflict between the terms of this Amendment No. 3 and the Agreement, the terms of this Amendment No. 3 shall prevail. All other terms and conditions of the Agreement remain unchanged. IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 3 to be duly executed as of the Effective Date. Cisco Systems, Inc. ScanSource, Inc. BY: /s/ S.K. Vereschagin BY: /s/ Jeffry E. Yelton (Authorized Signature) (Authorized Signature) NAME: S.K. Vereschagin NAME: Jeff Yelton TITLE: Director, Finance TITLE: President POS/Barocoding DATE: 8/4/10 DATE: 7-29-10 Source: SCANSOURCE, INC., 10-K, 8/22/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of ScansourceInc_20190822_10-K_EX-10.39_11793959_EX-10.39_Distributor Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.39\", \"level\": 1, \"text\": \"Exhibit 10.39 IN ACCORDANCE WITH ITEM 601(b) OF REGULATION S-K, CERTAIN IDENTIFIED INFORMATION (THE \\\"CONFIDENTIAL INFORMATION\\\") HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*****]. AMENDMENT NO. 3 TO THE NONEXCLUSIVE VALUE ADDED DISTRIBUTOR AGREEMENT This Amendment No. 3 (\\\"Amendment No. 3\\\") to the Nonexclusive Value Added Distributor Agreement, as amended (\\\"Agreement''), by and between Cisco Systems, Inc. (\\\"Cisco\\\"), a California corporation having Its principal place of business at 170 West Tasman Drive, San Jose, CA, 95134, and ScanSource, Inc. (\\\"Distributor\\\"), a South Carolina corporation with a place of business at 6 Logue Court, Greenville, South Carolina, 29615, is effective as of the date last signed below (\\\"Amendment Effective Date\\\"). All capitalized terms contained herein shall have the same meaning as the terms defined in the Agreement unless specifically modified in this Amendment. WHEREAS, Cisco and Distributor have previously entered into the Agreement dated January 22, 2007, and WHEREAS, Cisco and Distributor wish to renew and update certain terms and conditions in the Agreement regarding payment; and, NOW WHEREFORE, the parties agree to further amend the Agreement as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Term of the Agreement is hereby extended to January 20, 2012 unless sooner terminated as provided for in the Agreem\", \"level\": 1, \"text\": \"1. The Term of the Agreement is hereby extended to January 20, 2012 unless sooner terminated as provided for in the Agreement. If the Agreement expired prior to the Amendment Effective Date, any orders received and Products and Services purchased between the date of expiration and the Amendment Effective Date shall be in all respects deemed made under the Agreement as in effect prior to this Amendment. The parties further agree that if Distributor places Purchase Orders after the expiration of the Agreement, and Cisco accepts such Purchase Orders, then any such Purchase Orders shall be governed by the terms and conditions of the Agreement; provided, however that acceptance by Cisco of any Purchase Order placed after the Agreement has expired will not be considered as an extension of the term of the Agreement nor a renewal thereof. Notwithstanding Cisco's right to extend the term of the Agreement, each party acknowledges that the Agreement shall always be interpreted as being limited in duration to a definite term and that the other party has made no commitments whatsoever regarding the renewal of the Agreement beyond those expressly agreed in writing.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 6\", \"level\": 1, \"text\": \"2. Section 6.0 (\\\"Payment\\\") of the Agreement is modified by adding the following new Section 6.7: 6.7 [*****]\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 12 (\\\"Inventory Balance\\\") is deleted in its entirety and hereby replaced with the following\", \"level\": 1, \"text\": \"3. Section 12 (\\\"Inventory Balance\\\") is deleted in its entirety and hereby replaced with the following:\"}}, {\"id\": \"12.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INVENTORY BALANCE\", \"level\": 2, \"text\": \"12.0 INVENTORY BALANCE\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall have the option to return to Cisco, for credit, up [*****] of the dollar value of Products from the Wh\", \"level\": 2, \"text\": \"12.1 Distributor shall have the option to return to Cisco, for credit, up [*****] of the dollar value of Products from the Wholesale Price List (or, if no Wholesale Price Lists exists for Distributor's Territory, then the applicable price list) shipped to Distributor, net of credits, less returns to Cisco, in the preceding [*****] period (the \\\"Balancing Cap\\\") of the preceding Cisco fiscal quarter. The above-referenced cap shall be determined based on all Product purchases made under this Agreement. The responsibility to manage the Balancing Cap shall rest solely upon Distributor. Distributor shall be entitled to return Product once per quarter, provided such returns do not exceed the Balancing Cap. \\\"Dead on Arrival\\\" and Obsolete Products returned pursuant to Section 13 of this Agreement shall be excluded from calculation of the Balancing Cap. Cisco shall credit Distributor's account in the amount of the price paid by Distributor therefore, less any price protection credits issued to Distributor related to the Product returned (the \\\"Return Credit\\\").\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"For all returns made pursuant to this Section 12, the following requirements must be met by Distributor\", \"level\": 2, \"text\": \"12.2 For all returns made pursuant to this Section 12, the following requirements must be met by Distributor:\"}}, {\"id\": \"12.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 3, \"text\": \"12.2.1 [*****]\"}}, {\"id\": \"12.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[*****]\", \"level\": 3, \"text\": \"12.2.2 [*****] Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.39\"}}, {\"id\": \"12.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall bear all shipping and handling charges to the Cisco designated site set forth ln Cisco's published Ret\", \"level\": 3, \"text\": \"12.2.3 Distributor shall bear all shipping and handling charges to the Cisco designated site set forth ln Cisco's published Return Materials Authorization (\\\"RMA\\\") Policy for Product returned for credit;\"}}, {\"id\": \"12.2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor shall obtain an RMA number prior to returning any Product to Cisco\", \"level\": 3, \"text\": \"12.2.4 Distributor shall obtain an RMA number prior to returning any Product to Cisco. Distributor shall follow Cisco's then-current RMA process; and\"}}, {\"id\": \"12.2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor reports must be provided to Cisco In accordance with the terms of this Agreement\", \"level\": 3, \"text\": \"12.2.5 Distributor reports must be provided to Cisco In accordance with the terms of this Agreement.\"}}, {\"id\": \"4.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Section 21\", \"level\": 2, \"text\": \"4.0 Section 21.0 (\\\"Compliance with Laws\\\") is hereby deleted in its entirety and replaced with the following:\"}}, {\"id\": \"21.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH LAWS, INCLUDING ANTI-CORRUPTIONLAWS\", \"level\": 2, \"text\": \"21.0 COMPLIANCE WITH LAWS, INCLUDING ANTI-CORRUPTIONLAWS\"}}, {\"id\": \"21.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In connection with the sale or distribution of Cisco Products or Services, or otherwise in carrying out its obligations\", \"level\": 2, \"text\": \"21.1 In connection with the sale or distribution of Cisco Products or Services, or otherwise in carrying out its obligations under this Agreement, Distributor represents and warrants the following: (a) Distributor will comply with all country, federal, state and local laws, ordinances, codes, regulations, rules, policies and procedures, Including, without limitation, all anti-corruption laws, Including, the U.S. Foreign Corrupt Practices Act (Applicable Laws). Distributor can find more information about the Foreign Corrupt Practices Act at the following URL: http://www.usdoj.gov/criminal/fraud/docs/dojdocb.html, o r b y contacting publicsectorcompllance@cisco.com. (b) Distributor shall not take any action or permit or authorize any action in violation of the Applicable Laws; (c) Distributor will not use money or other consideration paid by Cisco (and Distributor will not use its own money on Cisco's behalf) for any unlawful purposes, including any purposes violating Applicable Laws, such as direct or indirect payments, for the purpose of assisting Cisco in obtaining or retaining business, to any of the following: (i) Government officials (including any person holding an executive, legislative, judicial or administrative office, whether elected or appointed, or of any public international organization, such as the United Nations or World Bank, or any person acting in any official capacity for or on behalf of such government, public enterprise or state-owned business); (ii) Political parties or party officials; (iii) Candidates for political office; or (iv) Any person, while knowing that all or a portion of such money or thing of value will be offered, given or promised, directly or indirectly to any of the above identified persons or organizations. (d) Distributor remains responsible for undertaking appropriate and reasonable measures to ensure that its own relevant subcontractors, consultants, agents or representatives who interact with government\u200b affiliated organizations comply with applicable anti-corruption laws; (e) Distributor's key personnel who directly support Cisco's account have or will have completed training (provided by Distributor, Cisco Cisco's on-line anti-corruption training is available in numerous languages and is free of charge for up to five of Distributor's personnel at http://corpedia.com/clients/cisco/pre_reg.asp?lid-300446001., or another third party) on compliance with applicable anti-corruption laws within the past 12 months (from the date when this Agreement becomes effective); (f) Distributor's record-keeping obligations, set forth In the \\\"Audit\\\" provision herein, shall apply equally to Distributor's representations and warranties In this section, Cisco's audit rights, as set forth herein, and Distributor's compliance with the Applicable Laws; (g) In no event shall Cisco be obligated under this Agreement to take any action or omit to take any action that Cisco believes, in good faith, would cause it to be In violation of any laws of the Territory(ies) identified in this Agreement or the Applicable Laws; (h) Distributor Is unaware of any of Its directors, officers or employees serving as government officials or employees (at any level of government); (i) The directors, officers and employees of Distributor's business are not employees of Cisco (Including any of Its affiliated companies); Source: SCANSOURCE, INC., 10-K, 8/22/2019 Exhibit 10.39 (j) Neither Distributor nor, to Distributor's knowledge, any of its directors or officers have been formally charged with, convicted of, or plead guilty to, any offense involving fraud or corruption; (k) Distributor, its directors and officers have not been listed by any government or public agency (such as the United Nations or World Bank) as debarred, suspended, or proposed for suspension or debarment or otherwise ineligible for government procurement programs; (l) Distributor has not offered to pay, nor has Distributor paid, nor will Distributor pay, any political contributions to any person or entity on behalf of Cisco; (m) If Distributor is a non-governmental entity, it will notify Cisco In writing lf any of its owners, partners, principals, officers, or employees are or become, during the term of this Agreement, officials, officers or representatives of any government, political party or candidate for political office outside the United States and are responsible for a decision regarding obtaining or retaining business for Cisco Products or Services by such government. Distributor will also promptly inform Cisco if any other portion of the statements set forth in subsections (g) through (k) above changes. (n) Notwithstanding any other provision in this Agreement, Cisco may terminate this Agreement immediately upon written notice if Distributor breaches any of the representations and warranties set forth in this section. (o) Distributor can report to Cisco any concerns it may have regarding any business practices by emailing ethics@cisco.com, or by calling Cisco's Helpline toll free number In North America 1- 877-571-1700 or worldwide number (reverse calling charges to Cisco) 001-770-776-5611. Contact ethics@cisco.com for other Cisco) 001-770-776-5611. Contact ethics@cisco.com for other available regional hotline numbers; (p) Distributor has read Cisco's \\\"Compliance with Global Anticorruption Laws by Cisco' Partners\\\", published at http://www.cisco.com/legal/anti corruption.html.\"}}, {\"id\": \"5.0\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All capitalized terms not defined in this Amendment No\", \"level\": 2, \"text\": \"5.0 All capitalized terms not defined in this Amendment No. 3 shall have the meaning assigned to them in the Agreement. In the event of conflict between the terms of this Amendment No. 3 and the Agreement, the terms of this Amendment No. 3 shall prevail. All other terms and conditions of the Agreement remain unchanged. IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 3 to be duly executed as of the Effective Date. Cisco Systems, Inc. ScanSource, Inc. BY: /s/ S.K. Vereschagin BY: /s/ Jeffry E. Yelton (Authorized Signature) (Authorized Signature) NAME: S.K. Vereschagin NAME: Jeff Yelton TITLE: Director, Finance TITLE: President POS/Barocoding DATE: 8/4/10 DATE: 7-29-10 Source: SCANSOURCE, INC., 10-K, 8/22/2019\"}}, {\"id\": \"party:Cisco Systems, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Cisco Systems, Inc.\", \"role\": \"Cisco\", \"address\": \"170 West Tasman Drive, San Jose, CA, 95134\"}}, {\"id\": \"party:ScanSource, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"ScanSource, Inc.\", \"role\": \"Distributor\", \"address\": \"6 Logue Court, Greenville, South Carolina, 29615\"}}, {\"id\": \"term:CONFIDENTIAL INFORMATION\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CONFIDENTIAL INFORMATION\", \"text\": \"CERTAIN IDENTIFIED INFORMATION\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Amendment No. 3\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment No. 3\", \"text\": \"This Amendment No. 3 to the Nonexclusive Value Added Distributor Agreement, as amended\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"the Nonexclusive Value Added Distributor Agreement, as amended\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Amendment Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Amendment Effective Date\", \"text\": \"the date last signed below\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Balancing Cap\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Balancing Cap\", \"text\": \"[*****] of the dollar value of Products from the Wholesale Price List (or, if no Wholesale Price Lists exists for Distributor's Territory, then the applicable price list) shipped to Distributor, net of credits, less returns to Cisco, in the preceding [*****] period\", \"definition_clause\": \"12.1\"}}, {\"id\": \"term:Return Credit\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Return Credit\", \"text\": \"the price paid by Distributor therefore, less any price protection credits issued to Distributor related to the Product returned\", \"definition_clause\": \"12.1\"}}, {\"id\": \"term:RMA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"RMA\", \"text\": \"Return Materials Authorization\", \"definition_clause\": \"12.2.3\"}}, {\"id\": \"term:Applicable Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicable Laws\", \"text\": \"all country, federal, state and local laws, ordinances, codes, regulations, rules, policies and procedures, Including, without limitation, all anti-corruption laws, Including, the U.S. Foreign Corrupt Practices Act\", \"definition_clause\": \"21.1\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of SimplicityEsportsGamingCompany_20181130_8-K_EX-10.1_11444071_EX-10.1_Franchise Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of SimplicityEsportsGamingCompany_20181130_8-K_EX-10.1_11444071_EX-10.1_Franchise Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30\", \"level\": 1, \"text\": \"Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 (c) Franchisee or the third party franchisee, as the case may be, shall be entitled to receive the revenue generated from each of the Smaaash Centres. If third party franchisees are operating the Smaaash Centres, then the Franchisee shall be entitled to receive, (i) 5% (five percent) of the capital expenditure as agreed among the parties for the particular Smaaash Centre as sign -on fees or upfront advance, and (ii) 5% (five percent) fee or commission of the revenue generated by such third party franchisees from the Smaash Centres on an annual basis. 1.5 Operation of Smaaash Centres. Franchisee or third party sub -franchisees shall be under an obligation to set up at least 6 (six) Smaaash Centres during the first Contract Year or any other time period as may be provided by Franchisor. The Smaaash Centres shall be established and operated in the Territory using the assumed trade name 'Smaaash'or any other trade name that the Franchisor may designate. Franchisee shall maintain good customer relations in accordance with prudent and reasonable business practices. Franchisee shall perform its obligations hereunder without using subcontractors, sub-distributors, independent sales representatives, agents, Franchisee's affiliates or other non-employees (\\\"Third Parties\\\") to perform the obligations of Franchisee under this Agreement except to the contrary specifically stated in this Agreement or unless they have been approved, in writing, in advance, by Franchisor, such approval not to be unreasonably withheld. 2. Term The term of this Agreement shall commence as of the Effective Date and shall continue until terminated as hereinafter provided (the \\\"Term\\\"). Each calendar year during the Term is sometimes hereinafter referred to as a \\\"Contract Year.\\\" 3. Grant of License in the Trademarks 3.1 License. Subject to the terms of this Agreement (including all obligations to first obtain Franchisor's written approval), Franchisor hereby grants to Franchisee the right to use the Trademarks (the details of which are set out in Exhibit A to this Agreement) (including sub-licensing this right to third party franchisees with the approval of Franchisor), on a royalty-free basis, for the purpose of operating and promoting the Smaaash Centres in the Territory. Franchisee is, in particular entitled to: (a) offer, market and/or distribute any products and services in connection with the Smaaash Centres under the Trademarks; and Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}, {\"id\": \"8.2\", \"title\": \"Termination by Franchisor with Notice\", \"level\": 2, \"text\": \"8.2 Termination by Franchisor with Notice. Franchisor may terminate this Agreement upon thirty (30) days written notice to Franchisee upon the occurrence of any of the following: (a) Franchisee fails to make any payment required under or in connection with this Agreement; (b) Franchisee ceases to operate or otherwise abandon the Smaaash Centres without the consent of Franchisor, or otherwise forfeit the right to do or transact business in the Territory; (c) Franchisee fails to use its best efforts to market and promote Smaaash Centres and the services and products offered by Smaaash Centres within the Territory and such failure is not cured within thirty (30) days of Franchisor's notification to Franchisee of such failure. 8.3 Termination for Cause. This Agreement may be terminated by either party for \\\"Cause\\\" without the need of providing a notice period prior to such termination becoming effective. \\\"Cause\\\" shall exist if circumstances occur which, taking into consideration the substance and purpose of this Agreement, would make it unreasonable for one or both of the parties to continue the contractual relationship and the other party fails to cure the cause (assuming that such cause is susceptible to cure) within thirty (30) days after the date of receipt of a corresponding written notice (\\\"Remedy Notice\\\"). If such cause by its nature is not curable, then no such Remedy Notice is required. Without limiting the generality of the foregoing, a party may terminate this Agreement for \\\"Cause\\\"if: (a) the other party to this Agreement is in breach of one or more of its material obligations; or (b) the other party to this Agreement becomes insolvent, generally cannot pay its obligations when due or otherwise suffers a substantial deterioration of its financial situation, or if insolvency/bankruptcy proceedings are initiated against such party or such party initiates any dissolution or liquidation of its business and/or assets. 8.4 Effects of Termination. (a) Upon the termination of this Agreement, any indebtedness of Franchisee to Franchisor shall become immediately due and payable. Franchisee shall immediately cease to operate the Smaaash Centres and shall not thereafter, directly or indirectly, represent to the public or hold itself out as a franchisee of Franchisor. Franchisor shall have the right to suspend the performance of any of their obligations under this Agreement. Franchisor shall have the right to provide the rights and license granted herein to Franchisee to any other third party entity that Franchisor may deem fit. (b) All benefits which may accrue by reason of the activities of Franchisee hereunder shall be deemed transferred automatically to Franchisor, and all licenses and other rights granted to Franchisee hereunder shall immediately cease. Unless otherwise agreed by Franchisor in writing, Franchisee shall immediately discontinue the advertising and marketing of Smaaash Centres and the products and services offered by Smaaash Centres. (c) Each of the parties shall continue to maintain in confidence any and all confidential information received from the other party. At Franchisor's election, Franchisor may purchase from Franchisee any materials used by Franchisee for the advertising, marketing, promotion, publicizing or other exploitation of Smaaash Centres and the products and services offered by the Smaaash Centres, including all Promotional Materials, Franchisor Property, or any other materials which contain any of the Trademarks. (d) The termination of this Agreement for any reason shall not affect obligations accrued prior to the effective date of such termination of this Agreement or any obligations which, either expressly or from the context of this Agreement, are intended to survive the termination of this Agreement. 9. Notices and Other Communications All reports, approvals, requests, demands, notices and other communications (collectively \\\"Communications\\\") required or permitted by this Agreement shall be in writing and signed by a duly authorized officer of or such other individual designated in writing by a party. Communications will be duly given if delivered personally, if mailed (by registered mail, return receipt requested) or if delivered by nationally-recognized courier or mail service which requires the addressee to acknowledge, in writing, the receipt thereof, to the party concerned at the following addresses (or at any other address as a party may specify by notice in writing to the other): If to Franchisor: Smaaash Entertainment Private Limited Trade View, Level 2 Kamala Mills Lower Parel, Mumbai 400013, India Attention: Mr. Vishwanath Kotian If to Franchisee: 1345 Avenue of the Americas, 11th floor New York, NY 101015, USA Attention: Mr. Suhel Kanuga Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}, {\"id\": \"10.10\", \"title\": \"Amendment\", \"level\": 2, \"text\": \"10.10 Amendment. This Agreement shall, from the Effective Date, bind the parties to the terms herein and cannot be amended without the consent of the parties. Further, this Agreement cannot be terminated by any party except in accordance with Clause 8 of this Agreement. 10.11 Assignment. The Franchisor shall be entitled to assign, transfer, encumber or dispose of any of its rights and or obligations under this Agreement, including to an affiliate, without the prior written consent of the Franchisee. The Franchisee shall not be entitled to assign, transfer, encumber or dispose of any of its rights and or obligations under this Agreement, including to an affiliate, without the prior written consent of the Franchisor. 10.12 Expenses. The Franchisee shall bear all the costs and expenses in relation to the execution of this Agreement and the consummation of all the transactions hereunder. 10.13 Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The delivery of signed counterparts by facsimile transmission or electronic mail in \\\"portable document format\\\" (\\\".pdf\\\") shall be as effective as signing and delivering the document in person. Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement the day and year first above written. SMAAASH ENTERTAINMENT PRIVATE LIMITED By: /s/ Shripal Morakhia Name: Shripal Morakhia Title: I-AM CAPITAL ACQUISITION COMPANY By: /s/ F. Jacob Cherian Name: F. Jacob Cherian Title: Chief Executive Officer (exhibits follow) Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}, {\"id\": \"Exhibit A\", \"title\": \"Trademarks Separately annexed\", \"level\": 1, \"text\": \"Exhibit A Trademarks Separately annexed Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of SimplicityEsportsGamingCompany_20181130_8-K_EX-10.1_11444071_EX-10.1_Franchise Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30\", \"level\": 1, \"text\": \"Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 (c) Franchisee or the third party franchisee, as the case may be, shall be entitled to receive the revenue generated from each of the Smaaash Centres. If third party franchisees are operating the Smaaash Centres, then the Franchisee shall be entitled to receive, (i) 5% (five percent) of the capital expenditure as agreed among the parties for the particular Smaaash Centre as sign -on fees or upfront advance, and (ii) 5% (five percent) fee or commission of the revenue generated by such third party franchisees from the Smaash Centres on an annual basis. 1.5 Operation of Smaaash Centres. Franchisee or third party sub -franchisees shall be under an obligation to set up at least 6 (six) Smaaash Centres during the first Contract Year or any other time period as may be provided by Franchisor. The Smaaash Centres shall be established and operated in the Territory using the assumed trade name 'Smaaash'or any other trade name that the Franchisor may designate. Franchisee shall maintain good customer relations in accordance with prudent and reasonable business practices. Franchisee shall perform its obligations hereunder without using subcontractors, sub-distributors, independent sales representatives, agents, Franchisee's affiliates or other non-employees (\\\"Third Parties\\\") to perform the obligations of Franchisee under this Agreement except to the contrary specifically stated in this Agreement or unless they have been approved, in writing, in advance, by Franchisor, such approval not to be unreasonably withheld. 2. Term The term of this Agreement shall commence as of the Effective Date and shall continue until terminated as hereinafter provided (the \\\"Term\\\"). Each calendar year during the Term is sometimes hereinafter referred to as a \\\"Contract Year.\\\" 3. Grant of License in the Trademarks 3.1 License. Subject to the terms of this Agreement (including all obligations to first obtain Franchisor's written approval), Franchisor hereby grants to Franchisee the right to use the Trademarks (the details of which are set out in Exhibit A to this Agreement) (including sub-licensing this right to third party franchisees with the approval of Franchisor), on a royalty-free basis, for the purpose of operating and promoting the Smaaash Centres in the Territory. Franchisee is, in particular entitled to: (a) offer, market and/or distribute any products and services in connection with the Smaaash Centres under the Trademarks; and Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination by Franchisor with Notice\", \"level\": 2, \"text\": \"8.2 Termination by Franchisor with Notice. Franchisor may terminate this Agreement upon thirty (30) days written notice to Franchisee upon the occurrence of any of the following: (a) Franchisee fails to make any payment required under or in connection with this Agreement; (b) Franchisee ceases to operate or otherwise abandon the Smaaash Centres without the consent of Franchisor, or otherwise forfeit the right to do or transact business in the Territory; (c) Franchisee fails to use its best efforts to market and promote Smaaash Centres and the services and products offered by Smaaash Centres within the Territory and such failure is not cured within thirty (30) days of Franchisor's notification to Franchisee of such failure. 8.3 Termination for Cause. This Agreement may be terminated by either party for \\\"Cause\\\" without the need of providing a notice period prior to such termination becoming effective. \\\"Cause\\\" shall exist if circumstances occur which, taking into consideration the substance and purpose of this Agreement, would make it unreasonable for one or both of the parties to continue the contractual relationship and the other party fails to cure the cause (assuming that such cause is susceptible to cure) within thirty (30) days after the date of receipt of a corresponding written notice (\\\"Remedy Notice\\\"). If such cause by its nature is not curable, then no such Remedy Notice is required. Without limiting the generality of the foregoing, a party may terminate this Agreement for \\\"Cause\\\"if: (a) the other party to this Agreement is in breach of one or more of its material obligations; or (b) the other party to this Agreement becomes insolvent, generally cannot pay its obligations when due or otherwise suffers a substantial deterioration of its financial situation, or if insolvency/bankruptcy proceedings are initiated against such party or such party initiates any dissolution or liquidation of its business and/or assets. 8.4 Effects of Termination. (a) Upon the termination of this Agreement, any indebtedness of Franchisee to Franchisor shall become immediately due and payable. Franchisee shall immediately cease to operate the Smaaash Centres and shall not thereafter, directly or indirectly, represent to the public or hold itself out as a franchisee of Franchisor. Franchisor shall have the right to suspend the performance of any of their obligations under this Agreement. Franchisor shall have the right to provide the rights and license granted herein to Franchisee to any other third party entity that Franchisor may deem fit. (b) All benefits which may accrue by reason of the activities of Franchisee hereunder shall be deemed transferred automatically to Franchisor, and all licenses and other rights granted to Franchisee hereunder shall immediately cease. Unless otherwise agreed by Franchisor in writing, Franchisee shall immediately discontinue the advertising and marketing of Smaaash Centres and the products and services offered by Smaaash Centres. (c) Each of the parties shall continue to maintain in confidence any and all confidential information received from the other party. At Franchisor's election, Franchisor may purchase from Franchisee any materials used by Franchisee for the advertising, marketing, promotion, publicizing or other exploitation of Smaaash Centres and the products and services offered by the Smaaash Centres, including all Promotional Materials, Franchisor Property, or any other materials which contain any of the Trademarks. (d) The termination of this Agreement for any reason shall not affect obligations accrued prior to the effective date of such termination of this Agreement or any obligations which, either expressly or from the context of this Agreement, are intended to survive the termination of this Agreement. 9. Notices and Other Communications All reports, approvals, requests, demands, notices and other communications (collectively \\\"Communications\\\") required or permitted by this Agreement shall be in writing and signed by a duly authorized officer of or such other individual designated in writing by a party. Communications will be duly given if delivered personally, if mailed (by registered mail, return receipt requested) or if delivered by nationally-recognized courier or mail service which requires the addressee to acknowledge, in writing, the receipt thereof, to the party concerned at the following addresses (or at any other address as a party may specify by notice in writing to the other): If to Franchisor: Smaaash Entertainment Private Limited Trade View, Level 2 Kamala Mills Lower Parel, Mumbai 400013, India Attention: Mr. Vishwanath Kotian If to Franchisee: 1345 Avenue of the Americas, 11th floor New York, NY 101015, USA Attention: Mr. Suhel Kanuga Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}}, {\"id\": \"10.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Amendment\", \"level\": 2, \"text\": \"10.10 Amendment. This Agreement shall, from the Effective Date, bind the parties to the terms herein and cannot be amended without the consent of the parties. Further, this Agreement cannot be terminated by any party except in accordance with Clause 8 of this Agreement. 10.11 Assignment. The Franchisor shall be entitled to assign, transfer, encumber or dispose of any of its rights and or obligations under this Agreement, including to an affiliate, without the prior written consent of the Franchisee. The Franchisee shall not be entitled to assign, transfer, encumber or dispose of any of its rights and or obligations under this Agreement, including to an affiliate, without the prior written consent of the Franchisor. 10.12 Expenses. The Franchisee shall bear all the costs and expenses in relation to the execution of this Agreement and the consummation of all the transactions hereunder. 10.13 Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The delivery of signed counterparts by facsimile transmission or electronic mail in \\\"portable document format\\\" (\\\".pdf\\\") shall be as effective as signing and delivering the document in person. Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement the day and year first above written. SMAAASH ENTERTAINMENT PRIVATE LIMITED By: /s/ Shripal Morakhia Name: Shripal Morakhia Title: I-AM CAPITAL ACQUISITION COMPANY By: /s/ F. Jacob Cherian Name: F. Jacob Cherian Title: Chief Executive Officer (exhibits follow) Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}}, {\"id\": \"Exhibit A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademarks Separately annexed\", \"level\": 1, \"text\": \"Exhibit A Trademarks Separately annexed Source: SIMPLICITY ESPORTS & GAMING CO, 8-K, 11/30/2018\"}}, {\"id\": \"party:SMAAASH ENTERTAINMENT PRIVATE LIMITED\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"SMAAASH ENTERTAINMENT PRIVATE LIMITED\", \"role\": \"Franchisor\", \"address\": \"Smaaash Entertainment Private Limited Trade View, Level 2 Kamala Mills Lower Parel, Mumbai 400013, India\"}}, {\"id\": \"party:I-AM CAPITAL ACQUISITION COMPANY\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"I-AM CAPITAL ACQUISITION COMPANY\", \"role\": \"Franchisee\", \"address\": \"1345 Avenue of the Americas, 11th floor New York, NY 101015, USA\"}}, {\"id\": \"value:5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"5%\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"term:Third Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Parties\", \"text\": \"subcontractors, sub-distributors, independent sales representatives, agents, Franchisee's affiliates or other non-employees\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"The term of this Agreement shall commence as of the Effective Date and shall continue until terminated as hereinafter provided\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Contract Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract Year\", \"text\": \"Each calendar year during the Term\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Cause\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cause\", \"text\": \"\\\"Cause\\\" shall exist if circumstances occur which, taking into consideration the substance and purpose of this Agreement, would make it unreasonable for one or both of the parties to continue the contractual relationship and the other party fails to cure the cause (assuming that such cause is susceptible to cure) within thirty (30) days after the date of receipt of a corresponding written notice (\\\"Remedy Notice\\\").\", \"definition_clause\": \"8.2\"}}, {\"id\": \"term:Remedy Notice\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Remedy Notice\", \"text\": \"a corresponding written notice\", \"definition_clause\": \"8.2\"}}, {\"id\": \"term:Communications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Communications\", \"text\": \"All reports, approvals, requests, demands, notices and other communications\", \"definition_clause\": \"8.2\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of SmartRxSystemsInc_20180914_1-A_EX1A-6 MAT CTRCT_11351705_EX1A-6 MAT CTRCT_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of SmartRxSystemsInc_20180914_1-A_EX1A-6 MAT CTRCT_11351705_EX1A-6 MAT CTRCT_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"Exhibit 6.7\", \"title\": \"EXCLUSIVE DISTRIBUTOR AGREEMENT This Distributor Agreement (\\\"Agreement\\\") is made and entered into this 17t h day of May, 2017 by and between SMART RX SYSTEMS, INC., a Florida corporation, with its principal place of business at Red Bug Lake Road, Suite 256, Winter Springs, Florida 32708, U.S.A. (\\\"Company\\\") and A3 DEVELOPMENT GROUP, LLC, a Texas limited liability company, with its principal place of business at 17521 Highway 69 South, Suite 120, Tyler, Texas 75703 (\\\"Distributor\\\"). 1. DEFINITIONS: Background IP or \\\"Background Technology\\\" means existing Intellectual Property not generated in the course of the Company's Business and owned by Smart RX Systems, Inc. Business means the Business to be conducted by the parties as described in Section 2 of this Agreement. Code means the Internal Revenue Code of 1986, as amended. All references herein to sections of the Code shall include any corresponding provision or provisions of succeeding law. Company Marks shall mean those trademarks, service marks, logos and trade names specified in Exhibit A used by Company in its commercial activities related to the Products. Confidential Information means all proprietary information of Company or a third party disclosed on or after the date hereof by Company to Distributor in any form (written, oral, photographic, electronic, magnetic, or otherwise) which is designated as confidential or proprietary, including, without limitation: technical data; methods; computer programs and related materials; product specifications; documentation; processes; inventions; products under development; sales; marketing; business and financial information; pro formas and projections; customer lists; internal memoranda; and correspondence. Customers shall have the meaning as set forth in Section 2.5. Intellectual Property means any Invention, Patent, trade secret, technical know-how, trademark, or work for which copyright protection is available under Title 17 of the United States Code. Invention means an invention patentable under Title 35 of the United States Code, or any patent on such an invention. Kiosk Location means each Pharmacy where the Pharmacy Kiosk is installed and operational. Medications means the inventory contained within each Kiosk Location.\", \"level\": 2, \"text\": \"Exhibit 6.7 EXCLUSIVE DISTRIBUTOR AGREEMENT This Distributor Agreement (\\\"Agreement\\\") is made and entered into this 17t h day of May, 2017 by and between SMART RX SYSTEMS, INC., a Florida corporation, with its principal place of business at Red Bug Lake Road, Suite 256, Winter Springs, Florida 32708, U.S.A. (\\\"Company\\\") and A3 DEVELOPMENT GROUP, LLC, a Texas limited liability company, with its principal place of business at 17521 Highway 69 South, Suite 120, Tyler, Texas 75703 (\\\"Distributor\\\"). 1. DEFINITIONS: Background IP or \\\"Background Technology\\\" means existing Intellectual Property not generated in the course of the Company's Business and owned by Smart RX Systems, Inc. Business means the Business to be conducted by the parties as described in Section 2 of this Agreement. Code means the Internal Revenue Code of 1986, as amended. All references herein to sections of the Code shall include any corresponding provision or provisions of succeeding law. Company Marks shall mean those trademarks, service marks, logos and trade names specified in Exhibit A used by Company in its commercial activities related to the Products. Confidential Information means all proprietary information of Company or a third party disclosed on or after the date hereof by Company to Distributor in any form (written, oral, photographic, electronic, magnetic, or otherwise) which is designated as confidential or proprietary, including, without limitation: technical data; methods; computer programs and related materials; product specifications; documentation; processes; inventions; products under development; sales; marketing; business and financial information; pro formas and projections; customer lists; internal memoranda; and correspondence. Customers shall have the meaning as set forth in Section 2.5. Intellectual Property means any Invention, Patent, trade secret, technical know-how, trademark, or work for which copyright protection is available under Title 17 of the United States Code. Invention means an invention patentable under Title 35 of the United States Code, or any patent on such an invention. Kiosk Location means each Pharmacy where the Pharmacy Kiosk is installed and operational. Medications means the inventory contained within each Kiosk Location. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 1 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 2 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}, {\"id\": \"2.5\", \"title\": \"Distributor Responsibilities\", \"level\": 2, \"text\": \"2.5 Distributor Responsibilities. The primary responsibilities of the Distributor shall be as follows: (i) Marketing the Smart Pharm Assist Kiosk\u2122 to Physicians, Physician group practices, Urgent Care Center, Freestanding Emergency Rooms, other retail convenience stores, other medical facilities, retailers (such as grocery stores (Brookshires), variety stores, (i.e., Family Dollar), medical office building owners, and other similar business in the Territory (collectively, \\\"Customers\\\"); and Smart Rx Reserves the right to market directly to Retailers nationally. (ii) Entering into pharmacy management services agreements (\\\"PMAs\\\") with Customers in the Territory (similar in form as set forth on Exhibit B); (iii) Arranging to have Smart Pharm Assist Kiosk\u2122 supplied to Customers in the Territory under various contractual arrangements with Customers, including lease agreements, joint ventures, license agreements, jointly owned entities or other such ventures, between Customers in the Territory (and may also include contractual relationships with the manufacturer of Smart Pharm Assist Kiosk\u2122 and the Distributor); (iv) Except as otherwise provided by the applicable law, the debts, obligations and liabilities of both the Distributor and the Company, whether arising in contract, tort or otherwise, shall be solely the debts, obligations and liabilities of the party incurring such and neither Distributor, nor Company shall be obligated for any such debt, obligation or liability of the other party; (v) devotion of such time, energy, and skill on a regular and consistent basis as is necessary to distribute, promote the sale of, and sell the Products through all channels of distribution in the Territory in conformity with the Company's established marketing policies and programs; (vi) accurate representation and statement of Company policies to all potential and present customers; (vii) disclosure of any problems concerning Customers to the Company; (viii) Distributor has the sole right to bring in additional dealers under this Agreement. All new dealers will be compensated by A3 Development Group, LLC. 3. SERVICES PROVIDED BY COMPANY: 3.1 Purchasing of medications, vials, labels and other items for Customers in the Territory needed to supply prescription and over the counter (OTC) medications to be dispensed via the Smart Pharm Assist Kiosk\u2122. 3.2 Management and training services to be rendered to all employees of the Pharmacy. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 3 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 4 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 5 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 6 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 7 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 8 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 9 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 (i) It (1) has the power and authority and the legal right to enter into this Agreement and perform its obligations hereunder and (2) has taken all necessary action on its part required to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder. (ii) This Agreement has been duly executed and delivered on its behalf and constitutes a legal, valid, and binding obligation of such Party and is enforceable against it in accordance with its terms subject to the effects of bankruptcy, insolvency, or other laws of general application affecting the enforcement of creditor rights and judicial principles affecting the availability of specific performance and general principles of equity, whether enforceability is considered a proceeding at law or equity. (iii) It is not aware of any pending or threatened litigation (and has not received any communication) that alleges that its activities related to this Agreement have violated, or that by conducting the activities as contemplated herein it would violate, any person's intellectual property rights. (iv) All necessary consents, approvals, and authorizations of all regulatory and governmental authorities or other persons required to be obtained by it in connection with the execution and delivery of this Agreement and the performance of its obligations hereunder have been obtained. (v) The execution and delivery of this Agreement and the performance of its obligations hereunder (1) do not conflict with or violate any requirement of applicable law or regulation or any provision of its articles of incorporation, bylaws, limited partnership agreement, or any similar instrument, as applicable, in any material way, and (2) do not conflict with, violate, or breach or constitute a default or require any consent under, any contractual obligation or court or administrative order by which it is bound. (vi) It is duly organized and in good standing under the laws of its respective state of organization, and has full power and authority and the legal right to own and operate its property and assets and to carry on its business as it is now being conducted and as it is contemplated to be conducted by this Agreement. (vii) In the event of any dispute, any deadlock among both parties, or any claim, question, or disagreement arising from or relating to this Agreement or the interpretation, performance or breach thereof, the Parties shall use their best efforts to settle the dispute, claim, question, or disagreement. To this effect, they shall consult and negotiate with each other in good faith and, recognizing their mutual interests, attempt to reach a just and equitable solution satisfactory to the parties. (viii) If any dispute, any deadlock among the Parties, or any claim, question, or disagreement arises out of or relates to this Agreement, or to the interpretation, performance, or breach thereof, and if the dispute or deadlock is not resolved through negotiation, all such disputes, deadlocks, claims, questions, or differences shall be finally resolved by arbitration in Orlando, Florida. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 10 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 11 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 12 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 13 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}, {\"id\": \"18\", \"title\": \"ATTORNEYS' FEES\", \"level\": 1, \"text\": \"18. ATTORNEYS' FEES: If either party employs attorneys to enforce any rights arising out of or related to this Distributor Agreement, the party prevailing shall be entitled to recover reasonable attorneys' fees and costs from the other party. 19. BINDING EFFECT: Subject to the limitations hereinbefore expressed, this Distributor Agreement will inure to the benefit of and shall be binding upon the parties, their successors, administrators, heirs, and assigns. 20. NATURE OF RELATIONSHIP: Nothing in this Agreement shall be construed as creating a joint venture, partnership, agency, employer/employee, or similar relationship between the Parties, or as authorizing either Party to act as the agent of the other. The Distributor's relationship to the Company is that of an independent contractor. 21. NO IMPLIED WAIVER: The failure of either Party to insist on strict performance of any covenant or obligation under this Agreement, regardless of the length of time for which such failure continues, shall not be deemed a waiver of such Party's right to demand strict compliance in the future. No consent or waiver, express or implied, to or of any breach or default in the performance of any obligation under this Agreement shall constitute a consent or waiver to or of any other breach or default in the performance of the same or any other obligation. 22. COUNTERPARTS/ELECTRONIC SIGNATURES: This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument. For purposes of this Agreement, use of a facsimile, e-mail, or other electronic medium shall have the same force and effect as an original signature. 23. SEVERABILITY: Whenever possible, each provision of this Agreement, will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal, or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed, and enforced in such jurisdiction as if such invalid, illegal, or unenforceable provisions had never been contained herein. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 14 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}, {\"id\": \"24\", \"title\": \"HEADINGS\", \"level\": 1, \"text\": \"24. HEADINGS: Headings used in this Agreement are provided for convenience only and shall not be used to construe meaning or intent. IN WITNESS HEREOF, the parties have hereunto set their hands and seals as of the date stated at the beginning of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original for all purposes, and together shall constitute one and the same document. Telecopied signatures shall be relied on as original signatures in all respects. COMPANY: DISTRIBUTOR: SMART RX SYSTEMS, INC., A3 DEVELOPMENT GROUP, LLC, a Florida corporation a Texas limited liability company By: /s/ Sandeep Mathow By: /s/ Tracy W. Gunter Name: Sandeep Mathow Name: Tracy W. Gunter Title: Founder & CEO Title: Partner EXCLUSIVE DISTRIBUTOR AGREEMENT Page 15 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}, {\"id\": \"Exhibit A\", \"title\": \"Company Marks trademarks, service marks, logos and trade names\", \"level\": 1, \"text\": \"Exhibit A Company Marks trademarks, service marks, logos and trade names EXCLUSIVE DISTRIBUTOR AGREEMENT Page 16 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}, {\"id\": \"Exhibit B\", \"title\": \"Example Pharmacy Management Services Agreements\", \"level\": 1, \"text\": \"Exhibit B Example Pharmacy Management Services Agreements EXCLUSIVE DISTRIBUTOR AGREEMENT Page 17 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}, {\"id\": \"Exhibit C\", \"title\": \"Sales and Marketing Plans\", \"level\": 1, \"text\": \"Exhibit C Sales and Marketing Plans EXCLUSIVE DISTRIBUTOR AGREEMENT Page 18 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of SmartRxSystemsInc_20180914_1-A_EX1A-6 MAT CTRCT_11351705_EX1A-6 MAT CTRCT_Distributor Agreement\", \"nodes\": [{\"id\": \"Exhibit 6.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSIVE DISTRIBUTOR AGREEMENT This Distributor Agreement (\\\"Agreement\\\") is made and entered into this 17t h day of May, 2017 by and between SMART RX SYSTEMS, INC., a Florida corporation, with its principal place of business at Red Bug Lake Road, Suite 256, Winter Springs, Florida 32708, U.S.A. (\\\"Company\\\") and A3 DEVELOPMENT GROUP, LLC, a Texas limited liability company, with its principal place of business at 17521 Highway 69 South, Suite 120, Tyler, Texas 75703 (\\\"Distributor\\\"). 1. DEFINITIONS: Background IP or \\\"Background Technology\\\" means existing Intellectual Property not generated in the course of the Company's Business and owned by Smart RX Systems, Inc. Business means the Business to be conducted by the parties as described in Section 2 of this Agreement. Code means the Internal Revenue Code of 1986, as amended. All references herein to sections of the Code shall include any corresponding provision or provisions of succeeding law. Company Marks shall mean those trademarks, service marks, logos and trade names specified in Exhibit A used by Company in its commercial activities related to the Products. Confidential Information means all proprietary information of Company or a third party disclosed on or after the date hereof by Company to Distributor in any form (written, oral, photographic, electronic, magnetic, or otherwise) which is designated as confidential or proprietary, including, without limitation: technical data; methods; computer programs and related materials; product specifications; documentation; processes; inventions; products under development; sales; marketing; business and financial information; pro formas and projections; customer lists; internal memoranda; and correspondence. Customers shall have the meaning as set forth in Section 2.5. Intellectual Property means any Invention, Patent, trade secret, technical know-how, trademark, or work for which copyright protection is available under Title 17 of the United States Code. Invention means an invention patentable under Title 35 of the United States Code, or any patent on such an invention. Kiosk Location means each Pharmacy where the Pharmacy Kiosk is installed and operational. Medications means the inventory contained within each Kiosk Location.\", \"level\": 2, \"text\": \"Exhibit 6.7 EXCLUSIVE DISTRIBUTOR AGREEMENT This Distributor Agreement (\\\"Agreement\\\") is made and entered into this 17t h day of May, 2017 by and between SMART RX SYSTEMS, INC., a Florida corporation, with its principal place of business at Red Bug Lake Road, Suite 256, Winter Springs, Florida 32708, U.S.A. (\\\"Company\\\") and A3 DEVELOPMENT GROUP, LLC, a Texas limited liability company, with its principal place of business at 17521 Highway 69 South, Suite 120, Tyler, Texas 75703 (\\\"Distributor\\\"). 1. DEFINITIONS: Background IP or \\\"Background Technology\\\" means existing Intellectual Property not generated in the course of the Company's Business and owned by Smart RX Systems, Inc. Business means the Business to be conducted by the parties as described in Section 2 of this Agreement. Code means the Internal Revenue Code of 1986, as amended. All references herein to sections of the Code shall include any corresponding provision or provisions of succeeding law. Company Marks shall mean those trademarks, service marks, logos and trade names specified in Exhibit A used by Company in its commercial activities related to the Products. Confidential Information means all proprietary information of Company or a third party disclosed on or after the date hereof by Company to Distributor in any form (written, oral, photographic, electronic, magnetic, or otherwise) which is designated as confidential or proprietary, including, without limitation: technical data; methods; computer programs and related materials; product specifications; documentation; processes; inventions; products under development; sales; marketing; business and financial information; pro formas and projections; customer lists; internal memoranda; and correspondence. Customers shall have the meaning as set forth in Section 2.5. Intellectual Property means any Invention, Patent, trade secret, technical know-how, trademark, or work for which copyright protection is available under Title 17 of the United States Code. Invention means an invention patentable under Title 35 of the United States Code, or any patent on such an invention. Kiosk Location means each Pharmacy where the Pharmacy Kiosk is installed and operational. Medications means the inventory contained within each Kiosk Location. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 1 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 2 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}, {\"id\": \"party:SMART RX SYSTEMS, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"SMART RX SYSTEMS, INC.\", \"role\": \"Company\", \"address\": \"Red Bug Lake Road, Suite 256, Winter Springs, Florida 32708, U.S.A.\"}}, {\"id\": \"party:A3 DEVELOPMENT GROUP, LLC\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"A3 DEVELOPMENT GROUP, LLC\", \"role\": \"Distributor\", \"address\": \"17521 Highway 69 South, Suite 120, Tyler, Texas 75703\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Distributor Agreement\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Background IP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Background IP\", \"text\": \"existing Intellectual Property not generated in the course of the Company's Business and owned by Smart RX Systems, Inc.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business\", \"text\": \"the Business to be conducted by the parties as described in Section 2 of this Agreement.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Code\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Code\", \"text\": \"the Internal Revenue Code of 1986, as amended.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Company Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Company Marks\", \"text\": \"those trademarks, service marks, logos and trade names specified in Exhibit A used by Company in its commercial activities related to the Products.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"all proprietary information of Company or a third party disclosed on or after the date hereof by Company to Distributor in any form (written, oral, photographic, electronic, magnetic, or otherwise) which is designated as confidential or proprietary, including, without limitation: technical data; methods; computer programs and related materials; product specifications; documentation; processes; inventions; products under development; sales; marketing; business and financial information; pro formas and projections; customer lists; internal memoranda; and correspondence.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property\", \"text\": \"any Invention, Patent, trade secret, technical know-how, trademark, or work for which copyright protection is available under Title 17 of the United States Code.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Invention\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Invention\", \"text\": \"an invention patentable under Title 35 of the United States Code, or any patent on such an invention.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Kiosk Location\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Kiosk Location\", \"text\": \"each Pharmacy where the Pharmacy Kiosk is installed and operational.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"term:Medications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Medications\", \"text\": \"the inventory contained within each Kiosk Location.\", \"definition_clause\": \"Exhibit 6.7\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor Responsibilities\", \"level\": 2, \"text\": \"2.5 Distributor Responsibilities. The primary responsibilities of the Distributor shall be as follows: (i) Marketing the Smart Pharm Assist Kiosk\u2122 to Physicians, Physician group practices, Urgent Care Center, Freestanding Emergency Rooms, other retail convenience stores, other medical facilities, retailers (such as grocery stores (Brookshires), variety stores, (i.e., Family Dollar), medical office building owners, and other similar business in the Territory (collectively, \\\"Customers\\\"); and Smart Rx Reserves the right to market directly to Retailers nationally. (ii) Entering into pharmacy management services agreements (\\\"PMAs\\\") with Customers in the Territory (similar in form as set forth on Exhibit B); (iii) Arranging to have Smart Pharm Assist Kiosk\u2122 supplied to Customers in the Territory under various contractual arrangements with Customers, including lease agreements, joint ventures, license agreements, jointly owned entities or other such ventures, between Customers in the Territory (and may also include contractual relationships with the manufacturer of Smart Pharm Assist Kiosk\u2122 and the Distributor); (iv) Except as otherwise provided by the applicable law, the debts, obligations and liabilities of both the Distributor and the Company, whether arising in contract, tort or otherwise, shall be solely the debts, obligations and liabilities of the party incurring such and neither Distributor, nor Company shall be obligated for any such debt, obligation or liability of the other party; (v) devotion of such time, energy, and skill on a regular and consistent basis as is necessary to distribute, promote the sale of, and sell the Products through all channels of distribution in the Territory in conformity with the Company's established marketing policies and programs; (vi) accurate representation and statement of Company policies to all potential and present customers; (vii) disclosure of any problems concerning Customers to the Company; (viii) Distributor has the sole right to bring in additional dealers under this Agreement. All new dealers will be compensated by A3 Development Group, LLC. 3. SERVICES PROVIDED BY COMPANY: 3.1 Purchasing of medications, vials, labels and other items for Customers in the Territory needed to supply prescription and over the counter (OTC) medications to be dispensed via the Smart Pharm Assist Kiosk\u2122. 3.2 Management and training services to be rendered to all employees of the Pharmacy. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 3 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 4 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 5 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 6 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 7 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 8 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 9 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 (i) It (1) has the power and authority and the legal right to enter into this Agreement and perform its obligations hereunder and (2) has taken all necessary action on its part required to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder. (ii) This Agreement has been duly executed and delivered on its behalf and constitutes a legal, valid, and binding obligation of such Party and is enforceable against it in accordance with its terms subject to the effects of bankruptcy, insolvency, or other laws of general application affecting the enforcement of creditor rights and judicial principles affecting the availability of specific performance and general principles of equity, whether enforceability is considered a proceeding at law or equity. (iii) It is not aware of any pending or threatened litigation (and has not received any communication) that alleges that its activities related to this Agreement have violated, or that by conducting the activities as contemplated herein it would violate, any person's intellectual property rights. (iv) All necessary consents, approvals, and authorizations of all regulatory and governmental authorities or other persons required to be obtained by it in connection with the execution and delivery of this Agreement and the performance of its obligations hereunder have been obtained. (v) The execution and delivery of this Agreement and the performance of its obligations hereunder (1) do not conflict with or violate any requirement of applicable law or regulation or any provision of its articles of incorporation, bylaws, limited partnership agreement, or any similar instrument, as applicable, in any material way, and (2) do not conflict with, violate, or breach or constitute a default or require any consent under, any contractual obligation or court or administrative order by which it is bound. (vi) It is duly organized and in good standing under the laws of its respective state of organization, and has full power and authority and the legal right to own and operate its property and assets and to carry on its business as it is now being conducted and as it is contemplated to be conducted by this Agreement. (vii) In the event of any dispute, any deadlock among both parties, or any claim, question, or disagreement arising from or relating to this Agreement or the interpretation, performance or breach thereof, the Parties shall use their best efforts to settle the dispute, claim, question, or disagreement. To this effect, they shall consult and negotiate with each other in good faith and, recognizing their mutual interests, attempt to reach a just and equitable solution satisfactory to the parties. (viii) If any dispute, any deadlock among the Parties, or any claim, question, or disagreement arises out of or relates to this Agreement, or to the interpretation, performance, or breach thereof, and if the dispute or deadlock is not resolved through negotiation, all such disputes, deadlocks, claims, questions, or differences shall be finally resolved by arbitration in Orlando, Florida. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 10 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 11 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 12 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018 EXCLUSIVE DISTRIBUTOR AGREEMENT Page 13 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}, {\"id\": \"term:Customers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customers\", \"text\": \"Physicians, Physician group practices, Urgent Care Center, Freestanding Emergency Rooms, other retail convenience stores, other medical facilities, retailers (such as grocery stores (Brookshires), variety stores, (i.e., Family Dollar), medical office building owners, and other similar business in the Territory\", \"definition_clause\": \"2.5\"}}, {\"id\": \"term:PMAs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"PMAs\", \"text\": \"pharmacy management services agreements\", \"definition_clause\": \"2.5\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ATTORNEYS' FEES\", \"level\": 1, \"text\": \"18. ATTORNEYS' FEES: If either party employs attorneys to enforce any rights arising out of or related to this Distributor Agreement, the party prevailing shall be entitled to recover reasonable attorneys' fees and costs from the other party. 19. BINDING EFFECT: Subject to the limitations hereinbefore expressed, this Distributor Agreement will inure to the benefit of and shall be binding upon the parties, their successors, administrators, heirs, and assigns. 20. NATURE OF RELATIONSHIP: Nothing in this Agreement shall be construed as creating a joint venture, partnership, agency, employer/employee, or similar relationship between the Parties, or as authorizing either Party to act as the agent of the other. The Distributor's relationship to the Company is that of an independent contractor. 21. NO IMPLIED WAIVER: The failure of either Party to insist on strict performance of any covenant or obligation under this Agreement, regardless of the length of time for which such failure continues, shall not be deemed a waiver of such Party's right to demand strict compliance in the future. No consent or waiver, express or implied, to or of any breach or default in the performance of any obligation under this Agreement shall constitute a consent or waiver to or of any other breach or default in the performance of the same or any other obligation. 22. COUNTERPARTS/ELECTRONIC SIGNATURES: This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same instrument. For purposes of this Agreement, use of a facsimile, e-mail, or other electronic medium shall have the same force and effect as an original signature. 23. SEVERABILITY: Whenever possible, each provision of this Agreement, will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal, or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed, and enforced in such jurisdiction as if such invalid, illegal, or unenforceable provisions had never been contained herein. EXCLUSIVE DISTRIBUTOR AGREEMENT Page 14 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"HEADINGS\", \"level\": 1, \"text\": \"24. HEADINGS: Headings used in this Agreement are provided for convenience only and shall not be used to construe meaning or intent. IN WITNESS HEREOF, the parties have hereunto set their hands and seals as of the date stated at the beginning of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original for all purposes, and together shall constitute one and the same document. Telecopied signatures shall be relied on as original signatures in all respects. COMPANY: DISTRIBUTOR: SMART RX SYSTEMS, INC., A3 DEVELOPMENT GROUP, LLC, a Florida corporation a Texas limited liability company By: /s/ Sandeep Mathow By: /s/ Tracy W. Gunter Name: Sandeep Mathow Name: Tracy W. Gunter Title: Founder & CEO Title: Partner EXCLUSIVE DISTRIBUTOR AGREEMENT Page 15 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}, {\"id\": \"Exhibit A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Company Marks trademarks, service marks, logos and trade names\", \"level\": 1, \"text\": \"Exhibit A Company Marks trademarks, service marks, logos and trade names EXCLUSIVE DISTRIBUTOR AGREEMENT Page 16 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}, {\"id\": \"Exhibit B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Example Pharmacy Management Services Agreements\", \"level\": 1, \"text\": \"Exhibit B Example Pharmacy Management Services Agreements EXCLUSIVE DISTRIBUTOR AGREEMENT Page 17 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}, {\"id\": \"Exhibit C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sales and Marketing Plans\", \"level\": 1, \"text\": \"Exhibit C Sales and Marketing Plans EXCLUSIVE DISTRIBUTOR AGREEMENT Page 18 of 18 Source: SMART RX SYSTEMS INC, 1-A, 9/14/2018\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 KIOSK CONCEPTS, INC. MASTER FRANCHISE AGREEMENT THE GRILLED CHEESE TRUCK, INC. MASTER FRANCHISEE DATE OF AGREEMENT Source: SOUPMAN, INC., 8-K, 8/14/2015 i Source: SOUPMAN, INC., 8-K, 8/14/2015 ii Source: SOUPMAN, INC., 8-K, 8/14/2015 iii Source: SOUPMAN, INC., 8-K, 8/14/2015 iv Source: SOUPMAN, INC., 8-K, 8/14/2015 KIOSK CONCEPTS, INC. MASTER FRANCHISE AGREEMENT AGREEMENT made as of the _____ day of __________________, 2015 (the \\\"Effective Date\\\") by and between Kiosk Concepts, Inc., a New York corporation having its principal place of business at 1110 South Avenue, Staten Island, New York 10314 (\\\"we\\\", \\\"us\\\" or \\\"our\\\"), and The Grilled Cheese Truck, Inc., a Nevada corporation having its principal address at 151 North Nob Hill Road, Suite 321, Fort Lauderdale, FL 33324 (\\\"you\\\" or \\\"your\\\"), with reference to the following facts: A. We are in the business of franchising outlets that sell proprietary gourmet soups, chilis, stews, desserts, wraps and non-proprietary products like salads, sandwiches, specialty coffees, soft drinks and other beverages under the name and trademark \\\"The Original Soupman\\\", together with any trademarks, trade names, service marks, slogans and logos which may be authorized in writing by us from time to time (collectively the \\\"Proprietary Marks\\\"). We have developed and used, and continue to use and control, the Proprietary Marks so as to impart to the public superior standards of quality and service. B. You desire us to grant you a license to use the methods, procedures and products developed by us and our parent (the \\\"System\\\") to operate an independent business (the \\\"Franchised Business\\\") that sells and services The Original Soupman franchises (\\\"Unit Franchises\\\") to qualified individuals and business entities (\\\"Unit Franchisees\\\") who will sell proprietary gourmet soups, chilis, stews, desserts, wraps and non- proprietary products like salads, sandwiches, specialty coffees, soft drinks and other beverages in the territory described in Section 1 of this Agreement, and you agree that your operation of the Franchised Business shall be governed by the terms, covenants and conditions contained in this Agreement. Our System includes a method of offering and selling Unit Franchises, management methods, marketing programs, financial reporting, Unit Franchisee performance reporting, and providing services to Unit Franchisees, all of which we may modify and/or update from time to time during the term of this Agreement. C. You represent and warrant to us, as an inducement to our execution of this Agreement, that all statements made by you and all materials provided to us by you in connection with the grant of this franchise to you are true, accurate and complete and that you have made no misrepresentations or material omissions in connection with obtaining this franchise. We grant this franchise in reliance upon each and all of your representations. NOW, THEREFORE, IT IS AGREED: 1. GRANT OF FRANCHISE 1.1 Rights Granted to You We grant to you, upon the terms and conditions contained in this Agreement, the exclusive right to establish and operate a Franchised Business and a license to use the methods, procedures and products developed by us in the business of selling and servicing Unit Franchises in the territory described on Attachment A attached to this Agreement and incorporated into this Agreement by reference (the \\\"Master Territory\\\"). You shall operate the Franchised Business at or from a location of your choice within the Master Territory upon the terms and conditions set forth in this Agreement. The Proprietary Marks, any Internet domain names, URLs, copyrights, toll-free \\\"1-800\\\", \\\"1-888\\\" and \\\"1- 877\\\" telephone numbers or other like toll-free telephone numbers which may be utilized by us or our affiliates, and their mnemonics, and other identifying marks constituting a part of the System, now or in the future, shall be used by you only in connection with the operation of the Franchised Business. The rights granted herein include the limited right to sublicense the use of the Proprietary Marks to Unit Franchisees in the Master Territory. Source: SOUPMAN, INC., 8-K, 8/14/2015 2 Source: SOUPMAN, INC., 8-K, 8/14/2015 3 Source: SOUPMAN, INC., 8-K, 8/14/2015 4 Source: SOUPMAN, INC., 8-K, 8/14/2015 5 Source: SOUPMAN, INC., 8-K, 8/14/2015 6 Source: SOUPMAN, INC., 8-K, 8/14/2015 7 Source: SOUPMAN, INC., 8-K, 8/14/2015 (f) We shall be permitted to sell branded products to national accounts without any money due to you or your parent company. Once you have units open and operating in the trade area where a National Account is located, we will remit to you 25% of the profits derived from the sales in that specific trade area. (g) We will continue to collect the royalties from franchisees and service existing franchisee in the Master Territory. 5.1 Sale of Unit Franchises; Minimum Development Quota You shall have the right and obligation to market and sell independent Unit Franchises to qualified Unit Franchisees who shall operate a The Original Soupman business as granted in the Unit Franchise Agreement. The rights granted to you hereunder do not include the right to sub-franchise others to sell franchises. You may not grant any such right to a Unit Franchisee, and Unit Franchisees shall not have the right to sub-franchise or sell Unit Franchises. You shall commence operation of the Franchised Business no later than the \\\"Commencement Date\\\" set forth on Attachment A hereto. 5.1.1 In addition to The Original Soupman business you must own and continuously operate, you must sell and have open the minimum number of The Original Soupman businesses as set forth on Attachment E hereto (the \\\"Minimum Development Quota\\\") by the dates set forth on such Attachment. We will not grant other franchises nor establish our own Unit Franchises within the Master Territory during the term of this Agreement unless you do not meet the Minimum Development Quota. If you do not meet the Minimum Development Quota, we may cancel your exclusive right to market and sell Unit Franchises in your Master Territory and may sell additional Master Franchises within your Master Territory, or we may begin operations of our own in your Master Territory, or we may terminate this Agreement. 5.1.2 You shall prepare and present to each applicant for the purchase of a Unit Franchise (an \\\"Applicant\\\") a Franchise Disclosure Document and all other related documents in accordance with the requirements of all federal and state regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises in the Master Territory (a \\\"Unit Franchise Disclosure Document\\\"). You may not present a Unit Franchise Disclosure Document to any Applicant until such Unit Franchise Disclosure Document has been submitted to and approved by us or our counsel in accordance with Section 13 of this Agreement and, if applicable, the Unit Franchise Disclosure Document has been registered with the appropriate state authority. You agree to make any changes to the Unit Franchise Disclosure Document (including its exhibits) as may be requested by us or our counsel. We shall have no responsibility whatsoever for the accuracy or legal compliance of your Unit Franchise Disclosure Document or your compliance with the requirements of any regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises. You acknowledge and understand that you are solely and exclusively responsible for complying with all federal and state franchise registration and disclosure laws and the payment of all franchise registration and filing fees . To prepare your Unit Franchise Disclosure Document and comply with applicable franchise registration and disclosure laws as just discussed, you may require the services of a franchise attorney, who would be retained at your expense. 5.1.3 You must charge your Unit Franchisees the initial franchise fee, royalty fee, National Advertising Fund Contribution and any other continuing fees that we designate or require, within the limits established by all regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises and the requirements imposed by this Agreement. Any deviations from these amounts must be pre- approved by us. 8 Source: SOUPMAN, INC., 8-K, 8/14/2015 9 Source: SOUPMAN, INC., 8-K, 8/14/2015 10 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"5.5.3\", \"title\": \"As it relates to the operation of your Franchised Business\", \"level\": 3, \"text\": \"5.5.3 As it relates to the operation of your Franchised Business: worker's compensation and employer's liability insurance in statutory amounts, unemployment insurance and state disability insurance as required by governing law for your employees; 5.5.4 As it relates to the Unit Franchisees' operation in the Master Territory, and if you elect to obtain such coverage: general liability insurance, which insurance is in addition to any general liability insurance the Unit Franchisees are required to maintain under their Unit Franchise Agreements. You shall also maintain such additional insurance as is necessary to comply with all legal requirements concerning insurance. We may periodically increase the amounts of coverage required under such insurance policies and require different or additional kinds of insurance at any time including excess liability insurance to reflect inflation, identification of new risks, changes in law or standards of liability, higher damage awards, or other relevant changes in circumstances. The insurance policies required herein shall: (a) name us as an additional named insured and contain a waiver of all subrogation rights against us, our affiliates, and our and their successors and assigns; (b) provide for thirty (30) days' prior written notice to us of any material modification, cancellation, or expiration of such policy; (c) provide that the coverage applies separately to each insured against whom a claim is brought as though a separate policy had been issued to each insured; (d) contain no provision which in any way limits or reduces coverage for you in the event of a claim by any one or more of the parties indemnified under this Agreement; (e) be primary to and without right of contribution from any other insurance purchased by the parties indemnified under this Agreement; and (f) extend to and provide indemnity for all obligations assumed by you hereunder and all other items for which you are required to indemnify us under this Agreement. You shall provide us with evidence of the insurance required hereunder not later than ten (10) days before you begin operating as a Master Franchisee, and with a complete copy of each insurance policy no more than thirty (30) days after delivery of the original proof of insurance. Thereafter, prior to the expiration of the term of each insurance policy, you shall furnish us with a copy of each renewal or replacement insurance policy to be maintained by you for the immediately following term and evidence of the payment of the premium therefor. Should you, for any reason, fail to procure or maintain the insurance required by this Agreement, as such requirements may be revised from time to time by us in writing, we shall have the right and authority (without, however, any obligation to do so) immediately to procure such insurance and to charge same to you, which charges shall be payable by you immediately upon notice together with a ten percent (10%) administrative fee. The foregoing remedies shall be in addition to any other remedies we may have at law or in equity. The maintenance of sufficient insurance coverage shall be your responsibility. Your obligations to maintain insurance coverage as herein described shall not be affected in any manner by reason of any separate insurance maintained by us nor shall the maintenance of such insurance relieve you of any indemnification obligations under this Agreement. 5.6 Computer Hardware and Software 5.6.1 You shall, in accordance with any specifications that we may prescribe and from any suppliers we may designate (which may include us or an affiliate), purchase, lease or license all computer hardware and software designated by us for the Franchised Business, whether in this Agreement, the Manuals or otherwise during the term of this Agreement. You shall likewise procure and install printers and other computer-related accessories or peripheral equipment as we may require. You shall at all times have a high speed internet connection for your computer system. All computer hardware and software specified by us shall be purchased, leased or licensed by you and your sole expense. You shall utilize all software programs that we may specify in connection with the operation of the Franchised Business. We reserve the right to develop proprietary software programs and, if we elect to do so, you shall execute our standard form of software license agreement for such proprietary software programs upon demand by us, and shall input and maintain in your computer system all software programs, data and information as we prescribe. You shall purchase, lease or license all software programs and materials whenever we elect to use new or upgraded programs and materials, either from us or from an approved distributor, if any, and, if from an approved distributor, upon terms determined by such distributor. During the term of this Agreement, you shall maintain and update all computer hardware and software as required by us. 11 Source: SOUPMAN, INC., 8-K, 8/14/2015 12 Source: SOUPMAN, INC., 8-K, 8/14/2015 13 Source: SOUPMAN, INC., 8-K, 8/14/2015 You shall at all times during the term of this Agreement maintain your office and all fixtures, furnishing, signs and equipment located therein in good order and condition, and in conformity with the System image as may be prescribed by us from time to time. You shall, within a reasonable time specified by us, make all necessary reasonable additions, alterations, repairs and replacements to your office as required by us to conform to our quality standards, but no others without our prior written consent, including, without limitation, periodic repainting or replacement of signs, furnishings, or equipment. No other business venture shall operate out of the premises utilized by you for your Franchised Business without our prior written consent. 5.14 Solicitation Advertising You shall conduct advertising to solicit Applicants for the purchase of Unit Franchisees in the Master Territory (\\\"Solicitation Advertising\\\"). You shall expend not less than $5,000 each month on such Solicitation Advertising. To protect the Proprietary Marks and our goodwill in the industry, you must submit samples of all proposed Solicitation Advertising materials to us at least fifteen (15) days before any use of the same. If we do not disapprove the proposed Solicitation Advertising materials within fifteen (15) days after receipt of the same, you may use the proposed Solicitation Advertising materials as submitted to us; provided, however, that if such Solicitation Advertising is required to be submitted to a government agency, you shall so submit such materials to the applicable government agency and shall not use such materials until the materials are approved or disapproved or if the use of the materials otherwise become permissible under law, such as if notice of disapproval is not received from a governmental agency within a stated period of time prescribed by law. We may, at any time after you begin to use the Solicitation Advertising materials, prohibit further use of the same, effective upon your receipt of written notice from us to do so. 5.15 Policies and Procedures You shall not have the right to establish policies and/or procedures pertaining to the operation of the Franchised Business to protect the Proprietary Marks and our goodwill in the industry outside of the policies and/or procedures that we designate. You and all Unit Franchisees subject to the license granted under this Agreement shall be bound by our policies and/or procedures upon receipt of the same. 5.16 Changes to the System You acknowledge and agree that the System must continue to evolve in order to reflect the changing market and to meet new and changing customer demands and that, accordingly, variations and additions to the System may be required from time to time in order to preserve and enhance the public image of the System and to insure the continuing operation efficiency of Unit Franchisees generally. Accordingly, you acknowledge and agree that we may from time to time change the System, including, without limitation, the adoption and use of new or modified trademarks, products, services, equipment and furnishings and new techniques and methodologies relating to the preparation, sale, promotion and marketing of services and supplies. You shall promptly accept, implement, use and display all such additions, modifications and changes at your sole cost and expense, and you shall ensure that all Unit Franchisees in your Master Territory promptly accept, implement, use and display all such additions, modifications and changes. You further acknowledge and agree that we may inspect your Franchised Business and any Unit Franchise in the Master Territory to verify that your Franchised Business and/or such Unit Franchise is operating in compliance with our System, as it may be modified from time to time. 14 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"5.17\", \"title\": \"Developments are Our Property You acknowledge and agree that, in consideration for the right to use the System and our\", \"level\": 2, \"text\": \"5.17 Developments are Our Property You acknowledge and agree that, in consideration for the right to use the System and our expertise in the field, if you, any of your employees or any Unit Franchisees in the Master Territory develop any new concept, process or improvement in the operation or promotion of the Franchised Business, you will promptly notify us and provide us with all necessary information concerning same, without any compensation to you, your employee or Unit Franchisee. You acknowledge and agree that any such concept, process or improvement shall become our property and we may utilize or disclose such information to other master franchisees and unit franchisees as we determine to be appropriate. 5.18 Financial Statements and Updated Unit Franchise Disclosure Document You shall, at your sole cost and expense, prepare and submit to us within one hundred twenty (120) days after each fiscal year end, a complete, audited financial statement for the preceding fiscal year prepared by an independent certified public accountant in accordance with generally accepted accounting principles. Each audited financial statement shall include a balance sheet and a profit and loss statement. If you own, directly or beneficially, a controlling financial interest in any other business, the financial statements required to be submitted by you must reflect your financial condition and your other business operations on a consolidated basis. You understand and acknowledge that the Federal Trade Commission's disclosure requirements for franchising (16 CFR Part 436) require you to include audited financial statements each year after your fiscal year end. You further understand and acknowledge that, as with your initial Unit Franchise Disclosure Document, all annual updates to your Unit Franchise Disclosure Document shall be submitted to us or our counsel for review within one hundred twenty (120) days after each fiscal year end. Notwithstanding the foregoing, we reserve the right to inspect or examine your accounts, books, records and tax returns, at any reasonable time, with or without prior notice to you. 5.19 Our Website We or one or more of our designees may establish a website or series of websites for the System to advertise, market and promote The Original Soupman businesses and the products and services they offer, the Unit Franchise and/or master franchise opportunity, and/or for any other purposes that we determine are appropriate for The Original Soupman businesses (collectively, the \\\"System Website\\\"). If we include information about your Franchised Business on the System Website, you agree to give us the information and materials that we periodically request concerning the Franchised Business and otherwise participate in the System Website in the manner that we periodically specify. By posting or submitting to us information or materials for the System Website, you are representing to us that the information and materials are accurate and not misleading and do not infringe upon any third party's rights. We shall own all intellectual property and other rights in the System Website and all information it contains, including the domain name or uniform resource locator (\\\"URL\\\") for the System Website, the log of \\\"hits\\\" by visitors, and any personal or business data that visitors (including you and your personnel) supply. We may implement and periodically modify System standards relating to the System Website and, at our option, may discontinue the System Website, or any services offered through the System Website, at any time. All advertising, marketing and promotional materials that you develop for your Franchised Business must contain notices of the URL of the System Website in the manner that we periodically designate. You may not develop, maintain or authorize any other website, other online presence or other electronic medium that mentions or describes the Franchised Business, the System or displays any of the Marks without our prior approval. We do not restrict the use of internet or web page advertising within or outside of your Master Territory, but the advertising content must be approved by us before it is used. 15 Source: SOUPMAN, INC., 8-K, 8/14/2015 Nothing in the Franchise Agreement shall limit our right to maintain websites other than the System Website or to offer and sell products and services under the Marks from the System Website, another website or otherwise over the Internet without payment or obligation of any kind to you. You are strictly prohibited from establishing your own website related to the Proprietary Marks or our System without our prior written consent, which we do not have to provide. You are also prohibited from promoting your Franchised Business on social and networking websites, including Facebook, LinkedIn, MySpace Twitter and/or other social media sites or platforms, without our prior written consent. We will control all social media initiatives. You must comply with our System standards regarding the use of social media in the operation of your Franchised Business, including prohibitions on your and your employees posting or blogging comments about the Franchised Business or the System, other than on a website established or authorized by us (\\\"social media\\\" includes personal blogs, common social networks like Facebook and MySpace, professional networks like LinkedIn, live-blogging tools like Twitter, virtual worlds, file, audio and video-sharing sites, and other similar social networking or media sites or tools). We will provide access to branded social media pages/handles/assets, and you must update these regularly. We reserve the right to conduct collective/national campaigns via local social media on your behalf. We alone will be, and at all times will remain, the sole owner of the copyrights to all material which appears on any System Website we establish and maintain, including any and all material you may furnish to us as provided above. 5.20 Our Intranet 5.20.1 We may, at our sole discretion and option, establish and maintain a private method of communication for use only by employees and master franchisees of ours, as well as Unit Franchisees in the System (an \\\"Intranet\\\"), through which we, master franchisees, our employees and Unit Franchisees may communicate with each other, and through which we may disseminate the Manuals, updates thereto and other confidential information. We shall have sole discretion and control over all aspects of the Intranet, including the content and functionality thereof. We will have no obligation to maintain the Intranet indefinitely, and may dismantle it at any time without liability to you. 5.20.2 If we establish an Intranet, you shall have the privilege to use the Intranet, subject to your strict compliance with the standards and specifications, protocols and restrictions that we may establish from time to time. Such standards and specifications, protocols and restrictions may relate to, among other things, (a) the use of abusive, slanderous or otherwise offensive language in electronic communications; (b) communications between or among master franchisees that endorse or encourage breach of any master franchisee's agreement with us; (c) confidential treatment of materials that we transmit via the Intranet; (e) password protocols and other security precautions; (f) grounds and procedures for our suspending or revoking a master franchisee's access to the Intranet; and (g) a privacy policy governing our access to and use of electronic communications that master franchisees post to the Intranet. We may establish similar standards and protocols related to Unit Franchises. You acknowledge that, as administrator of the Intranet, we can technically access and shall be entitled to view any communication that any person posts on the Intranet. You further acknowledge that the Intranet facility and all communications that are posted to it will become our property, free of any claims of privacy or privilege that you or any other person may assert. 16 Source: SOUPMAN, INC., 8-K, 8/14/2015 17 Source: SOUPMAN, INC., 8-K, 8/14/2015 18 Source: SOUPMAN, INC., 8-K, 8/14/2015 19 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"8\", \"title\": \"MANUALS AND CONFIDENTIAL INFORMATION 8\", \"level\": 1, \"text\": \"8. MANUALS AND CONFIDENTIAL INFORMATION 8.1 Use of Manuals We shall provide the Manuals to you, on loan, for the term of this Agreement and any renewals hereof. You shall operate the Franchised Business in accordance with the standards, methods, policies, and procedures specified in the Manuals to ensure compliance with quality standards to protect the Proprietary Marks and our goodwill in the industry. You shall treat the Manuals, any other manuals created for or approved for use in the operation of the Franchised Business, and the information contained therein as confidential, and shall maintain such information as secret and confidential. You shall not at any time copy, duplicate, record, or otherwise reproduce the foregoing materials, in whole or in part, or otherwise make the same available to any unauthorized person. The Manuals shall at all times remain our sole property and shall be kept in a secure place at your office. You shall ensure that your copy of the Manuals is kept current at all times, and in the event of any dispute as to the contents of the Manuals, the terms of the master copy of the Manuals maintained by us shall be controlling. If you require or request additional copies of any of the Manuals, you agree to pay our then-current fee for each replacement volume of the Manuals required or requested. 8.2 Confidentiality of Information You shall not, during the term of this Agreement or thereafter, communicate, divulge, or use for the benefit of anyone else, any confidential information, knowledge, or know-how concerning the methods of operation of the Franchised Business which may be communicated to you, or of which you may be apprised, by virtue of your operation under the terms of this Agreement. You shall divulge such confidential information only to such of your employees as must have access to it in order to perform their employment responsibilities. Any and all matters, information, knowledge, know-how, techniques and other data which we designate as confidential shall be deemed confidential for purposes of this Agreement. 8.3 Irreparable Injury from Disclosure of Confidential Information You acknowledge that failure to comply with the requirements of this Section 8 will result in irreparable injury to us for which no adequate remedy at law may be available, and you consent to the issuance of, and agree to pay all court costs and reasonable attorneys' fees incurred by us in obtaining, without the posting of any bond, an ex parte or other order for injunctive or other legal or equitable relief with respect to the requirements of this Section 8. 8.4 Confidentiality Covenants from Individuals Associated with You You shall require any employee who may have access to any confidential information of ours to execute covenants that they will maintain the confidentiality of information they receive in connection with their association with you. Such covenants shall be in a form satisfactory to us, including, without limitation, specific identification of us as a third party beneficiary of such covenants with the independent right to enforce them. 21 Source: SOUPMAN, INC., 8-K, 8/14/2015 22 Source: SOUPMAN, INC., 8-K, 8/14/2015 23 Source: SOUPMAN, INC., 8-K, 8/14/2015 24 Source: SOUPMAN, INC., 8-K, 8/14/2015 In each of the foregoing cases, we (and any of our affiliates) will have all remedies allowed at law, including termination of your rights (and/or those of any person/company affiliated with you) and our (and/or our affiliates') obligations. No right or remedy which we may have (including termination) is exclusive of any other right or remedy provided under law or equity and we may pursue any rights and/or remedies available. 10.5 Our Right to Discontinue Services to You If you are in breach of any obligation under this Agreement, and we deliver to you a notice of termination as provided herein, we have the right to suspend our performance of any of our obligations under this Agreement including, without limitation, the sale or supply of any services or products for which we are an approved supplier to you and/or suspension of your webpage and/or listing on the System Website, until such time as you correct the breach. 10.6 Termination of this Agreement by You You shall have no right to terminate this Agreement. 10.7 Without Prejudice The termination of this Agreement shall be without prejudice to any remedy or cause of action which we may have against you for the recovery of any monies due us or any equipment or other property of ours, or any other right of ours to recover damages for any breach hereof. 10.8 Amendment Pursuant to Applicable Law Notwithstanding anything to the contrary contained in this Article, if any valid, applicable law or regulation of a competent governmental authority having jurisdiction over this franchise and the parties hereto shall limit our rights of termination under this Agreement or shall require longer notice periods than those set forth above, this Agreement is deemed amended to satisfy the minimum notice periods or restrictions upon such termination required by such laws and regulations; provided, however, that such constructive amendment shall not be deemed a concession by us that the grounds for termination set forth in this Agreement do not constitute \\\"good cause\\\" for termination within the meaning ascribed to that term by any applicable law or regulation. We shall not be precluded from contesting the validity, enforceability or application of such laws or regulations in any action, hearing or proceeding relating to this Agreement or the termination of this Agreement. 25 Source: SOUPMAN, INC., 8-K, 8/14/2015 26 Source: SOUPMAN, INC., 8-K, 8/14/2015 27 Source: SOUPMAN, INC., 8-K, 8/14/2015 28 Source: SOUPMAN, INC., 8-K, 8/14/2015 29 Source: SOUPMAN, INC., 8-K, 8/14/2015 30 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"14.2\", \"title\": \"Public Notice of Independent Status You shall conspicuously identify yourself and the Franchised Business in all deali\", \"level\": 2, \"text\": \"14.2 Public Notice of Independent Status You shall conspicuously identify yourself and the Franchised Business in all dealings with your customers, contractors, suppliers, public officials, and others, as an independent master franchisee of ours, and shall place such notice of independent ownership in your Franchised Business and on all forms. We shall have the right to specify the language of any such notice. 14.3 Independent Contractor You acknowledge and agree that you are not authorized to make any contract, agreement, warranty, or representation on our behalf, or to incur any debt or other obligations in our name; and that we shall in no event assume liability for, or be deemed liable under this Agreement as a result of, any such action; nor shall we be liable by reason of any act or omission of yours in your conduct of the Franchised Business or for any claim or judgment arising therefrom against you or us. 14.4 Indemnification You shall indemnify and hold harmless to the fullest extent by law us, our affiliates and our respective directors, officers, employees, shareholders, and agents, (collectively the \\\"Indemnitees\\\") from any and all losses and expenses (as hereinafter defined) incurred in connection with any litigation or other form of adjudicatory procedure, claim, demand, investigation, or formal or informal inquiry (regardless of whether same is reduced to judgment) or any settlement thereof which arises directly or indirectly from, as a result of, or in connection with your operation of the Franchised Business including, but not limited to, claims arising as a result of the maintenance and operation of vehicles (collectively an \\\"event\\\"), and regardless of whether same resulted from any strict or vicarious liability imposed by law on the Indemnitees; provided, however, that this indemnity shall not apply to any liability arising from the gross negligence of the Indemnitees (except to the extent that joint liability is involved, in which event the indemnification provided herein shall extend to any finding of comparative negligence or contributory negligence attributable to you). For the purpose of this Section 14.4, the term \\\"losses and expenses\\\" shall be deemed to include compensatory, exemplary, or punitive damages; fines and penalties; attorneys' fees; experts' fees; court costs; costs associated with investigating and defending against claims; settlement amounts; judgments; compensation for damages to our reputation and goodwill; and all other costs associated with any of the foregoing losses and expenses. You shall give us prompt notice of any event of which you are aware for which indemnification is required and, at your expense and risk, we may elect to assume (but under no circumstance are obligated to undertake) the defense and/or settlement thereof, provided that we will seek your advice and counsel. Any assumption of ours shall not modify your indemnification obligation. We may, in our sole judgment, take such actions as we deem necessary and appropriate to investigate, defend, or settle any event or take other remedial or corrective actions with respect thereto as may be, in our sole judgment, necessary for the protection of the Indemnitees or the System. You shall defend us and each of our affiliates, officers, directors, shareholders, agents, and employees named in any lawsuit based on such loss or expenses and shall pay all costs and reasonable attorneys' fees associated with such defense. If we wish to retain our own counsel to defend any such action, you shall reimburse us for all reasonable costs and legal fees incurred by us for such defense. Said reimbursement shall be made to us in a timely manner upon demand as such fees are incurred by us and billed to you. 31 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"15\", \"title\": \"APPROVALS, WAIVERS AND NOTICES 15\", \"level\": 1, \"text\": \"15. APPROVALS, WAIVERS AND NOTICES 15.1 Obtaining Approvals Whenever this Agreement requires our prior approval or consent, you shall make a timely written request to us therefor, and such approval or consent must be obtained in writing. We make no warranties or guarantees upon which you may rely, and assume no liability or obligation to you by providing any waiver, approval, consent, or suggestion to you in connection with this Agreement, or by reason of any neglect, delay, or denial of any request therefor. 15.2 No Waiver No delay, waiver, omission, or forbearance on our part to exercise any right, option, duty, or power arising out of any breach or default by you, or by any other franchisee, of any of the terms, provisions, or covenants thereof, and no custom or practice by the parties at variance with the terms of this Agreement, shall constitute our waiver to enforce any such right, option, or power as against you, or as to a subsequent breach or default by you. Subsequent acceptance by us of any payments due to us under this Agreement shall not be deemed to be our waiver of any preceding or succeeding breach by you of any terms, covenants, or conditions of this Agreement. 15.3 Notices All notices or demands shall be in writing and shall be served in person, by Express Mail, by certified mail; by private overnight delivery; or by facsimile. Service shall be deemed conclusively made (a) at the time of service, if personally served; (b) twenty-four (24) hours (exclusive of weekends and national holidays) after deposit in the United States mail, properly addressed and postage prepaid, if served by Express Mail; (c) upon the earlier of actual receipt or three (3) calendar days after deposit in the United States mail, properly addressed and postage prepaid, return receipt requested, if served by certified mail; (d) twenty-four (24) hours after delivery by the party giving the notice, statement or demand if by private overnight delivery; and (e) at the time of transmission by facsimile, if such transmission occurs prior to 5:00 p.m. on a business day and a copy of such notice is mailed within twenty-four (24) hours after the transmission. Notices and demands shall be given to the respective parties at the following addresses, unless and until a different address has been designated by written notice to the other party: To Franchisor: Kiosk Concepts, Inc. 1110 South Avenue Staten Island, New York 10314 Attention: President Fax: With a copy to: Harold L. Kestenbaum, Esq. 90 Merrick Avenue, Suite 601 East Meadow, New York 11554 Fax: (516) 745-0293 To Master Franchisee: The Grilled Cheese Truck, Inc. 151 North Nob Hill Road, Suite 321 Fort Lauderdale, FL. 33324 Fax: 32 Source: SOUPMAN, INC., 8-K, 8/14/2015 With a copy to: Martin J. Brill, Esq. Levene, Neale, Bender, Yoo & Brill, LLP 10250 Constellation Blvd., Suite 1700 Los Angeles, CA 90067 Fax: (310 229-1244 Either party may change its address for the purpose of receiving notices, demands and other communications as herein provided by a written notice given in the manner aforesaid to the other party. 16. ENTIRE AGREEMENT; SEVERABILITY AND CONSTRUCTION 16.1 Entire Agreement This Agreement, any attachments hereto, and any ancillary agreements between you and us or any affiliate which are executed contemporaneously with this Agreement, constitute the entire and complete Agreement between us (and, if applicable, any affiliate) and you concerning the subject matter thereof, and supersede all prior agreements. You acknowledge that you are entering into this Agreement, and any ancillary agreements executed contemporaneously herewith, as a result of your own independent investigation of the business franchised hereby and not as a result of any representation made by us or persons associated with us, or other franchisees, which are contrary to the terms herein set forth or which are contrary to the terms of any Franchise Disclosure Document or other similar document required or permitted to be given to you pursuant to applicable law. Except for those permitted under this Agreement to be made unilaterally by us, no amendment, change, or variation from this Agreement shall be binding on either party unless mutually agreed to by the parties and executed by their authorized officers or agents in writing. Nothing in this Section 16.1 is intended to disclaim, or require you to waive reliance on, any representation made in the Franchise Disclosure Document (the \\\"FDD\\\") that we have provided to you, except with respect to specific contract terms and conditions set forth in the FDD that you have voluntarily waived during the course of franchise-sale negotiations. 16.2 Severability and Construction Except as expressly provided to the contrary herein, each section, paragraph, part, term, and provision of this Agreement shall be considered severable; and if, for any reason, any section, paragraph, part, term, provision, and/or covenant herein is determined to be invalid and contrary to, or in conflict with, any existing or future law or regulation by a court or agency having valid jurisdiction, such shall not impair the operation of, or have any other effect upon, such other portions, sections, paragraphs, parts, terms, provisions, and/or covenants of this Agreement as may remain otherwise intelligible; and the latter shall continue to be given full force and effect and bind the parties hereto; and the invalid portions, sections, paragraphs, parts, terms, provisions, and/or covenants shall be deemed not to be a part of this Agreement. Neither this Agreement or any uncertainty or ambiguity in this Agreement shall be construed or resolved against the drafter of this Agreement, whether under any rule of construction or otherwise. On the contrary, this Agreement has been review by all parties and shall be construed and interpreted according to the ordinary meaning of the words used to fairly accomplish the purposes and intentions of all parties to this Agreement. We and you intend that if any provision of this Agreement is susceptible to two or more constructions, one of which would render the provision enforceable and the other or others of which would render the provision unenforceable, the provision shall be given the meaning that renders it enforceable. 33 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 IN WITNESS WHEREOF, the parties have executed this Agreement on the date first shown above. KIOSK CONCEPTS, INC.: By: Witness Name: Title: MASTER FRANCHISEE : THE GRILLED CHEESE TRUCK, INC. By: Witness Name: Title: 40 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"SCHEDULE OF\", \"title\": \"PRINCIPALS (Not Applicable) ANY OTHER PERSON NOT LISTED IN THIS AGREEMENT WHO IS A SPOUSE, PARTNER, AN OFFICER, DIRECTOR, SHAREHOLDER, GENERAL PARTNER OR MEMBER OF MASTER FRANCHISEE: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship:\", \"level\": 1, \"text\": \"SCHEDULE OF PRINCIPALS (Not Applicable) ANY OTHER PERSON NOT LISTED IN THIS AGREEMENT WHO IS A SPOUSE, PARTNER, AN OFFICER, DIRECTOR, SHAREHOLDER, GENERAL PARTNER OR MEMBER OF MASTER FRANCHISEE: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Source: SOUPMAN, INC., 8-K, 8/14/2015\"}, {\"id\": \"Attachment A\", \"title\": \"to Master Franchise Agreement MASTER TERRITORY AND COMMENCEMENT DATE MASTER TERRITORY: North America COMMENCEMENT DATE: Upon approval of the State of New York. KIOSK CONCEPTS, INC. MASTER FRANCHISEE THE GRILLED CHEESE TRUCK, INC. By: By: Name: Name: Title: Title:\", \"level\": 1, \"text\": \"Attachment A to Master Franchise Agreement MASTER TERRITORY AND COMMENCEMENT DATE MASTER TERRITORY: North America COMMENCEMENT DATE: Upon approval of the State of New York. KIOSK CONCEPTS, INC. MASTER FRANCHISEE THE GRILLED CHEESE TRUCK, INC. By: By: Name: Name: Title: Title: Source: SOUPMAN, INC., 8-K, 8/14/2015\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.1\", \"level\": 1, \"text\": \"Exhibit 10.1 KIOSK CONCEPTS, INC. MASTER FRANCHISE AGREEMENT THE GRILLED CHEESE TRUCK, INC. MASTER FRANCHISEE DATE OF AGREEMENT Source: SOUPMAN, INC., 8-K, 8/14/2015 i Source: SOUPMAN, INC., 8-K, 8/14/2015 ii Source: SOUPMAN, INC., 8-K, 8/14/2015 iii Source: SOUPMAN, INC., 8-K, 8/14/2015 iv Source: SOUPMAN, INC., 8-K, 8/14/2015 KIOSK CONCEPTS, INC. MASTER FRANCHISE AGREEMENT AGREEMENT made as of the _____ day of __________________, 2015 (the \\\"Effective Date\\\") by and between Kiosk Concepts, Inc., a New York corporation having its principal place of business at 1110 South Avenue, Staten Island, New York 10314 (\\\"we\\\", \\\"us\\\" or \\\"our\\\"), and The Grilled Cheese Truck, Inc., a Nevada corporation having its principal address at 151 North Nob Hill Road, Suite 321, Fort Lauderdale, FL 33324 (\\\"you\\\" or \\\"your\\\"), with reference to the following facts: A. We are in the business of franchising outlets that sell proprietary gourmet soups, chilis, stews, desserts, wraps and non-proprietary products like salads, sandwiches, specialty coffees, soft drinks and other beverages under the name and trademark \\\"The Original Soupman\\\", together with any trademarks, trade names, service marks, slogans and logos which may be authorized in writing by us from time to time (collectively the \\\"Proprietary Marks\\\"). We have developed and used, and continue to use and control, the Proprietary Marks so as to impart to the public superior standards of quality and service. B. You desire us to grant you a license to use the methods, procedures and products developed by us and our parent (the \\\"System\\\") to operate an independent business (the \\\"Franchised Business\\\") that sells and services The Original Soupman franchises (\\\"Unit Franchises\\\") to qualified individuals and business entities (\\\"Unit Franchisees\\\") who will sell proprietary gourmet soups, chilis, stews, desserts, wraps and non- proprietary products like salads, sandwiches, specialty coffees, soft drinks and other beverages in the territory described in Section 1 of this Agreement, and you agree that your operation of the Franchised Business shall be governed by the terms, covenants and conditions contained in this Agreement. Our System includes a method of offering and selling Unit Franchises, management methods, marketing programs, financial reporting, Unit Franchisee performance reporting, and providing services to Unit Franchisees, all of which we may modify and/or update from time to time during the term of this Agreement. C. You represent and warrant to us, as an inducement to our execution of this Agreement, that all statements made by you and all materials provided to us by you in connection with the grant of this franchise to you are true, accurate and complete and that you have made no misrepresentations or material omissions in connection with obtaining this franchise. We grant this franchise in reliance upon each and all of your representations. NOW, THEREFORE, IT IS AGREED: 1. GRANT OF FRANCHISE 1.1 Rights Granted to You We grant to you, upon the terms and conditions contained in this Agreement, the exclusive right to establish and operate a Franchised Business and a license to use the methods, procedures and products developed by us in the business of selling and servicing Unit Franchises in the territory described on Attachment A attached to this Agreement and incorporated into this Agreement by reference (the \\\"Master Territory\\\"). You shall operate the Franchised Business at or from a location of your choice within the Master Territory upon the terms and conditions set forth in this Agreement. The Proprietary Marks, any Internet domain names, URLs, copyrights, toll-free \\\"1-800\\\", \\\"1-888\\\" and \\\"1- 877\\\" telephone numbers or other like toll-free telephone numbers which may be utilized by us or our affiliates, and their mnemonics, and other identifying marks constituting a part of the System, now or in the future, shall be used by you only in connection with the operation of the Franchised Business. The rights granted herein include the limited right to sublicense the use of the Proprietary Marks to Unit Franchisees in the Master Territory. Source: SOUPMAN, INC., 8-K, 8/14/2015 2 Source: SOUPMAN, INC., 8-K, 8/14/2015 3 Source: SOUPMAN, INC., 8-K, 8/14/2015 4 Source: SOUPMAN, INC., 8-K, 8/14/2015 5 Source: SOUPMAN, INC., 8-K, 8/14/2015 6 Source: SOUPMAN, INC., 8-K, 8/14/2015 7 Source: SOUPMAN, INC., 8-K, 8/14/2015 (f) We shall be permitted to sell branded products to national accounts without any money due to you or your parent company. Once you have units open and operating in the trade area where a National Account is located, we will remit to you 25% of the profits derived from the sales in that specific trade area. (g) We will continue to collect the royalties from franchisees and service existing franchisee in the Master Territory. 5.1 Sale of Unit Franchises; Minimum Development Quota You shall have the right and obligation to market and sell independent Unit Franchises to qualified Unit Franchisees who shall operate a The Original Soupman business as granted in the Unit Franchise Agreement. The rights granted to you hereunder do not include the right to sub-franchise others to sell franchises. You may not grant any such right to a Unit Franchisee, and Unit Franchisees shall not have the right to sub-franchise or sell Unit Franchises. You shall commence operation of the Franchised Business no later than the \\\"Commencement Date\\\" set forth on Attachment A hereto. 5.1.1 In addition to The Original Soupman business you must own and continuously operate, you must sell and have open the minimum number of The Original Soupman businesses as set forth on Attachment E hereto (the \\\"Minimum Development Quota\\\") by the dates set forth on such Attachment. We will not grant other franchises nor establish our own Unit Franchises within the Master Territory during the term of this Agreement unless you do not meet the Minimum Development Quota. If you do not meet the Minimum Development Quota, we may cancel your exclusive right to market and sell Unit Franchises in your Master Territory and may sell additional Master Franchises within your Master Territory, or we may begin operations of our own in your Master Territory, or we may terminate this Agreement. 5.1.2 You shall prepare and present to each applicant for the purchase of a Unit Franchise (an \\\"Applicant\\\") a Franchise Disclosure Document and all other related documents in accordance with the requirements of all federal and state regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises in the Master Territory (a \\\"Unit Franchise Disclosure Document\\\"). You may not present a Unit Franchise Disclosure Document to any Applicant until such Unit Franchise Disclosure Document has been submitted to and approved by us or our counsel in accordance with Section 13 of this Agreement and, if applicable, the Unit Franchise Disclosure Document has been registered with the appropriate state authority. You agree to make any changes to the Unit Franchise Disclosure Document (including its exhibits) as may be requested by us or our counsel. We shall have no responsibility whatsoever for the accuracy or legal compliance of your Unit Franchise Disclosure Document or your compliance with the requirements of any regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises. You acknowledge and understand that you are solely and exclusively responsible for complying with all federal and state franchise registration and disclosure laws and the payment of all franchise registration and filing fees . To prepare your Unit Franchise Disclosure Document and comply with applicable franchise registration and disclosure laws as just discussed, you may require the services of a franchise attorney, who would be retained at your expense. 5.1.3 You must charge your Unit Franchisees the initial franchise fee, royalty fee, National Advertising Fund Contribution and any other continuing fees that we designate or require, within the limits established by all regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises and the requirements imposed by this Agreement. Any deviations from these amounts must be pre- approved by us. 8 Source: SOUPMAN, INC., 8-K, 8/14/2015 9 Source: SOUPMAN, INC., 8-K, 8/14/2015 10 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"5.5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As it relates to the operation of your Franchised Business\", \"level\": 3, \"text\": \"5.5.3 As it relates to the operation of your Franchised Business: worker's compensation and employer's liability insurance in statutory amounts, unemployment insurance and state disability insurance as required by governing law for your employees; 5.5.4 As it relates to the Unit Franchisees' operation in the Master Territory, and if you elect to obtain such coverage: general liability insurance, which insurance is in addition to any general liability insurance the Unit Franchisees are required to maintain under their Unit Franchise Agreements. You shall also maintain such additional insurance as is necessary to comply with all legal requirements concerning insurance. We may periodically increase the amounts of coverage required under such insurance policies and require different or additional kinds of insurance at any time including excess liability insurance to reflect inflation, identification of new risks, changes in law or standards of liability, higher damage awards, or other relevant changes in circumstances. The insurance policies required herein shall: (a) name us as an additional named insured and contain a waiver of all subrogation rights against us, our affiliates, and our and their successors and assigns; (b) provide for thirty (30) days' prior written notice to us of any material modification, cancellation, or expiration of such policy; (c) provide that the coverage applies separately to each insured against whom a claim is brought as though a separate policy had been issued to each insured; (d) contain no provision which in any way limits or reduces coverage for you in the event of a claim by any one or more of the parties indemnified under this Agreement; (e) be primary to and without right of contribution from any other insurance purchased by the parties indemnified under this Agreement; and (f) extend to and provide indemnity for all obligations assumed by you hereunder and all other items for which you are required to indemnify us under this Agreement. You shall provide us with evidence of the insurance required hereunder not later than ten (10) days before you begin operating as a Master Franchisee, and with a complete copy of each insurance policy no more than thirty (30) days after delivery of the original proof of insurance. Thereafter, prior to the expiration of the term of each insurance policy, you shall furnish us with a copy of each renewal or replacement insurance policy to be maintained by you for the immediately following term and evidence of the payment of the premium therefor. Should you, for any reason, fail to procure or maintain the insurance required by this Agreement, as such requirements may be revised from time to time by us in writing, we shall have the right and authority (without, however, any obligation to do so) immediately to procure such insurance and to charge same to you, which charges shall be payable by you immediately upon notice together with a ten percent (10%) administrative fee. The foregoing remedies shall be in addition to any other remedies we may have at law or in equity. The maintenance of sufficient insurance coverage shall be your responsibility. Your obligations to maintain insurance coverage as herein described shall not be affected in any manner by reason of any separate insurance maintained by us nor shall the maintenance of such insurance relieve you of any indemnification obligations under this Agreement. 5.6 Computer Hardware and Software 5.6.1 You shall, in accordance with any specifications that we may prescribe and from any suppliers we may designate (which may include us or an affiliate), purchase, lease or license all computer hardware and software designated by us for the Franchised Business, whether in this Agreement, the Manuals or otherwise during the term of this Agreement. You shall likewise procure and install printers and other computer-related accessories or peripheral equipment as we may require. You shall at all times have a high speed internet connection for your computer system. All computer hardware and software specified by us shall be purchased, leased or licensed by you and your sole expense. You shall utilize all software programs that we may specify in connection with the operation of the Franchised Business. We reserve the right to develop proprietary software programs and, if we elect to do so, you shall execute our standard form of software license agreement for such proprietary software programs upon demand by us, and shall input and maintain in your computer system all software programs, data and information as we prescribe. You shall purchase, lease or license all software programs and materials whenever we elect to use new or upgraded programs and materials, either from us or from an approved distributor, if any, and, if from an approved distributor, upon terms determined by such distributor. During the term of this Agreement, you shall maintain and update all computer hardware and software as required by us. 11 Source: SOUPMAN, INC., 8-K, 8/14/2015 12 Source: SOUPMAN, INC., 8-K, 8/14/2015 13 Source: SOUPMAN, INC., 8-K, 8/14/2015 You shall at all times during the term of this Agreement maintain your office and all fixtures, furnishing, signs and equipment located therein in good order and condition, and in conformity with the System image as may be prescribed by us from time to time. You shall, within a reasonable time specified by us, make all necessary reasonable additions, alterations, repairs and replacements to your office as required by us to conform to our quality standards, but no others without our prior written consent, including, without limitation, periodic repainting or replacement of signs, furnishings, or equipment. No other business venture shall operate out of the premises utilized by you for your Franchised Business without our prior written consent. 5.14 Solicitation Advertising You shall conduct advertising to solicit Applicants for the purchase of Unit Franchisees in the Master Territory (\\\"Solicitation Advertising\\\"). You shall expend not less than $5,000 each month on such Solicitation Advertising. To protect the Proprietary Marks and our goodwill in the industry, you must submit samples of all proposed Solicitation Advertising materials to us at least fifteen (15) days before any use of the same. If we do not disapprove the proposed Solicitation Advertising materials within fifteen (15) days after receipt of the same, you may use the proposed Solicitation Advertising materials as submitted to us; provided, however, that if such Solicitation Advertising is required to be submitted to a government agency, you shall so submit such materials to the applicable government agency and shall not use such materials until the materials are approved or disapproved or if the use of the materials otherwise become permissible under law, such as if notice of disapproval is not received from a governmental agency within a stated period of time prescribed by law. We may, at any time after you begin to use the Solicitation Advertising materials, prohibit further use of the same, effective upon your receipt of written notice from us to do so. 5.15 Policies and Procedures You shall not have the right to establish policies and/or procedures pertaining to the operation of the Franchised Business to protect the Proprietary Marks and our goodwill in the industry outside of the policies and/or procedures that we designate. You and all Unit Franchisees subject to the license granted under this Agreement shall be bound by our policies and/or procedures upon receipt of the same. 5.16 Changes to the System You acknowledge and agree that the System must continue to evolve in order to reflect the changing market and to meet new and changing customer demands and that, accordingly, variations and additions to the System may be required from time to time in order to preserve and enhance the public image of the System and to insure the continuing operation efficiency of Unit Franchisees generally. Accordingly, you acknowledge and agree that we may from time to time change the System, including, without limitation, the adoption and use of new or modified trademarks, products, services, equipment and furnishings and new techniques and methodologies relating to the preparation, sale, promotion and marketing of services and supplies. You shall promptly accept, implement, use and display all such additions, modifications and changes at your sole cost and expense, and you shall ensure that all Unit Franchisees in your Master Territory promptly accept, implement, use and display all such additions, modifications and changes. You further acknowledge and agree that we may inspect your Franchised Business and any Unit Franchise in the Master Territory to verify that your Franchised Business and/or such Unit Franchise is operating in compliance with our System, as it may be modified from time to time. 14 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"5.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Developments are Our Property You acknowledge and agree that, in consideration for the right to use the System and our\", \"level\": 2, \"text\": \"5.17 Developments are Our Property You acknowledge and agree that, in consideration for the right to use the System and our expertise in the field, if you, any of your employees or any Unit Franchisees in the Master Territory develop any new concept, process or improvement in the operation or promotion of the Franchised Business, you will promptly notify us and provide us with all necessary information concerning same, without any compensation to you, your employee or Unit Franchisee. You acknowledge and agree that any such concept, process or improvement shall become our property and we may utilize or disclose such information to other master franchisees and unit franchisees as we determine to be appropriate. 5.18 Financial Statements and Updated Unit Franchise Disclosure Document You shall, at your sole cost and expense, prepare and submit to us within one hundred twenty (120) days after each fiscal year end, a complete, audited financial statement for the preceding fiscal year prepared by an independent certified public accountant in accordance with generally accepted accounting principles. Each audited financial statement shall include a balance sheet and a profit and loss statement. If you own, directly or beneficially, a controlling financial interest in any other business, the financial statements required to be submitted by you must reflect your financial condition and your other business operations on a consolidated basis. You understand and acknowledge that the Federal Trade Commission's disclosure requirements for franchising (16 CFR Part 436) require you to include audited financial statements each year after your fiscal year end. You further understand and acknowledge that, as with your initial Unit Franchise Disclosure Document, all annual updates to your Unit Franchise Disclosure Document shall be submitted to us or our counsel for review within one hundred twenty (120) days after each fiscal year end. Notwithstanding the foregoing, we reserve the right to inspect or examine your accounts, books, records and tax returns, at any reasonable time, with or without prior notice to you. 5.19 Our Website We or one or more of our designees may establish a website or series of websites for the System to advertise, market and promote The Original Soupman businesses and the products and services they offer, the Unit Franchise and/or master franchise opportunity, and/or for any other purposes that we determine are appropriate for The Original Soupman businesses (collectively, the \\\"System Website\\\"). If we include information about your Franchised Business on the System Website, you agree to give us the information and materials that we periodically request concerning the Franchised Business and otherwise participate in the System Website in the manner that we periodically specify. By posting or submitting to us information or materials for the System Website, you are representing to us that the information and materials are accurate and not misleading and do not infringe upon any third party's rights. We shall own all intellectual property and other rights in the System Website and all information it contains, including the domain name or uniform resource locator (\\\"URL\\\") for the System Website, the log of \\\"hits\\\" by visitors, and any personal or business data that visitors (including you and your personnel) supply. We may implement and periodically modify System standards relating to the System Website and, at our option, may discontinue the System Website, or any services offered through the System Website, at any time. All advertising, marketing and promotional materials that you develop for your Franchised Business must contain notices of the URL of the System Website in the manner that we periodically designate. You may not develop, maintain or authorize any other website, other online presence or other electronic medium that mentions or describes the Franchised Business, the System or displays any of the Marks without our prior approval. We do not restrict the use of internet or web page advertising within or outside of your Master Territory, but the advertising content must be approved by us before it is used. 15 Source: SOUPMAN, INC., 8-K, 8/14/2015 Nothing in the Franchise Agreement shall limit our right to maintain websites other than the System Website or to offer and sell products and services under the Marks from the System Website, another website or otherwise over the Internet without payment or obligation of any kind to you. You are strictly prohibited from establishing your own website related to the Proprietary Marks or our System without our prior written consent, which we do not have to provide. You are also prohibited from promoting your Franchised Business on social and networking websites, including Facebook, LinkedIn, MySpace Twitter and/or other social media sites or platforms, without our prior written consent. We will control all social media initiatives. You must comply with our System standards regarding the use of social media in the operation of your Franchised Business, including prohibitions on your and your employees posting or blogging comments about the Franchised Business or the System, other than on a website established or authorized by us (\\\"social media\\\" includes personal blogs, common social networks like Facebook and MySpace, professional networks like LinkedIn, live-blogging tools like Twitter, virtual worlds, file, audio and video-sharing sites, and other similar social networking or media sites or tools). We will provide access to branded social media pages/handles/assets, and you must update these regularly. We reserve the right to conduct collective/national campaigns via local social media on your behalf. We alone will be, and at all times will remain, the sole owner of the copyrights to all material which appears on any System Website we establish and maintain, including any and all material you may furnish to us as provided above. 5.20 Our Intranet 5.20.1 We may, at our sole discretion and option, establish and maintain a private method of communication for use only by employees and master franchisees of ours, as well as Unit Franchisees in the System (an \\\"Intranet\\\"), through which we, master franchisees, our employees and Unit Franchisees may communicate with each other, and through which we may disseminate the Manuals, updates thereto and other confidential information. We shall have sole discretion and control over all aspects of the Intranet, including the content and functionality thereof. We will have no obligation to maintain the Intranet indefinitely, and may dismantle it at any time without liability to you. 5.20.2 If we establish an Intranet, you shall have the privilege to use the Intranet, subject to your strict compliance with the standards and specifications, protocols and restrictions that we may establish from time to time. Such standards and specifications, protocols and restrictions may relate to, among other things, (a) the use of abusive, slanderous or otherwise offensive language in electronic communications; (b) communications between or among master franchisees that endorse or encourage breach of any master franchisee's agreement with us; (c) confidential treatment of materials that we transmit via the Intranet; (e) password protocols and other security precautions; (f) grounds and procedures for our suspending or revoking a master franchisee's access to the Intranet; and (g) a privacy policy governing our access to and use of electronic communications that master franchisees post to the Intranet. We may establish similar standards and protocols related to Unit Franchises. You acknowledge that, as administrator of the Intranet, we can technically access and shall be entitled to view any communication that any person posts on the Intranet. You further acknowledge that the Intranet facility and all communications that are posted to it will become our property, free of any claims of privacy or privilege that you or any other person may assert. 16 Source: SOUPMAN, INC., 8-K, 8/14/2015 17 Source: SOUPMAN, INC., 8-K, 8/14/2015 18 Source: SOUPMAN, INC., 8-K, 8/14/2015 19 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MANUALS AND CONFIDENTIAL INFORMATION 8\", \"level\": 1, \"text\": \"8. MANUALS AND CONFIDENTIAL INFORMATION 8.1 Use of Manuals We shall provide the Manuals to you, on loan, for the term of this Agreement and any renewals hereof. You shall operate the Franchised Business in accordance with the standards, methods, policies, and procedures specified in the Manuals to ensure compliance with quality standards to protect the Proprietary Marks and our goodwill in the industry. You shall treat the Manuals, any other manuals created for or approved for use in the operation of the Franchised Business, and the information contained therein as confidential, and shall maintain such information as secret and confidential. You shall not at any time copy, duplicate, record, or otherwise reproduce the foregoing materials, in whole or in part, or otherwise make the same available to any unauthorized person. The Manuals shall at all times remain our sole property and shall be kept in a secure place at your office. You shall ensure that your copy of the Manuals is kept current at all times, and in the event of any dispute as to the contents of the Manuals, the terms of the master copy of the Manuals maintained by us shall be controlling. If you require or request additional copies of any of the Manuals, you agree to pay our then-current fee for each replacement volume of the Manuals required or requested. 8.2 Confidentiality of Information You shall not, during the term of this Agreement or thereafter, communicate, divulge, or use for the benefit of anyone else, any confidential information, knowledge, or know-how concerning the methods of operation of the Franchised Business which may be communicated to you, or of which you may be apprised, by virtue of your operation under the terms of this Agreement. You shall divulge such confidential information only to such of your employees as must have access to it in order to perform their employment responsibilities. Any and all matters, information, knowledge, know-how, techniques and other data which we designate as confidential shall be deemed confidential for purposes of this Agreement. 8.3 Irreparable Injury from Disclosure of Confidential Information You acknowledge that failure to comply with the requirements of this Section 8 will result in irreparable injury to us for which no adequate remedy at law may be available, and you consent to the issuance of, and agree to pay all court costs and reasonable attorneys' fees incurred by us in obtaining, without the posting of any bond, an ex parte or other order for injunctive or other legal or equitable relief with respect to the requirements of this Section 8. 8.4 Confidentiality Covenants from Individuals Associated with You You shall require any employee who may have access to any confidential information of ours to execute covenants that they will maintain the confidentiality of information they receive in connection with their association with you. Such covenants shall be in a form satisfactory to us, including, without limitation, specific identification of us as a third party beneficiary of such covenants with the independent right to enforce them. 21 Source: SOUPMAN, INC., 8-K, 8/14/2015 22 Source: SOUPMAN, INC., 8-K, 8/14/2015 23 Source: SOUPMAN, INC., 8-K, 8/14/2015 24 Source: SOUPMAN, INC., 8-K, 8/14/2015 In each of the foregoing cases, we (and any of our affiliates) will have all remedies allowed at law, including termination of your rights (and/or those of any person/company affiliated with you) and our (and/or our affiliates') obligations. No right or remedy which we may have (including termination) is exclusive of any other right or remedy provided under law or equity and we may pursue any rights and/or remedies available. 10.5 Our Right to Discontinue Services to You If you are in breach of any obligation under this Agreement, and we deliver to you a notice of termination as provided herein, we have the right to suspend our performance of any of our obligations under this Agreement including, without limitation, the sale or supply of any services or products for which we are an approved supplier to you and/or suspension of your webpage and/or listing on the System Website, until such time as you correct the breach. 10.6 Termination of this Agreement by You You shall have no right to terminate this Agreement. 10.7 Without Prejudice The termination of this Agreement shall be without prejudice to any remedy or cause of action which we may have against you for the recovery of any monies due us or any equipment or other property of ours, or any other right of ours to recover damages for any breach hereof. 10.8 Amendment Pursuant to Applicable Law Notwithstanding anything to the contrary contained in this Article, if any valid, applicable law or regulation of a competent governmental authority having jurisdiction over this franchise and the parties hereto shall limit our rights of termination under this Agreement or shall require longer notice periods than those set forth above, this Agreement is deemed amended to satisfy the minimum notice periods or restrictions upon such termination required by such laws and regulations; provided, however, that such constructive amendment shall not be deemed a concession by us that the grounds for termination set forth in this Agreement do not constitute \\\"good cause\\\" for termination within the meaning ascribed to that term by any applicable law or regulation. We shall not be precluded from contesting the validity, enforceability or application of such laws or regulations in any action, hearing or proceeding relating to this Agreement or the termination of this Agreement. 25 Source: SOUPMAN, INC., 8-K, 8/14/2015 26 Source: SOUPMAN, INC., 8-K, 8/14/2015 27 Source: SOUPMAN, INC., 8-K, 8/14/2015 28 Source: SOUPMAN, INC., 8-K, 8/14/2015 29 Source: SOUPMAN, INC., 8-K, 8/14/2015 30 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Public Notice of Independent Status You shall conspicuously identify yourself and the Franchised Business in all deali\", \"level\": 2, \"text\": \"14.2 Public Notice of Independent Status You shall conspicuously identify yourself and the Franchised Business in all dealings with your customers, contractors, suppliers, public officials, and others, as an independent master franchisee of ours, and shall place such notice of independent ownership in your Franchised Business and on all forms. We shall have the right to specify the language of any such notice. 14.3 Independent Contractor You acknowledge and agree that you are not authorized to make any contract, agreement, warranty, or representation on our behalf, or to incur any debt or other obligations in our name; and that we shall in no event assume liability for, or be deemed liable under this Agreement as a result of, any such action; nor shall we be liable by reason of any act or omission of yours in your conduct of the Franchised Business or for any claim or judgment arising therefrom against you or us. 14.4 Indemnification You shall indemnify and hold harmless to the fullest extent by law us, our affiliates and our respective directors, officers, employees, shareholders, and agents, (collectively the \\\"Indemnitees\\\") from any and all losses and expenses (as hereinafter defined) incurred in connection with any litigation or other form of adjudicatory procedure, claim, demand, investigation, or formal or informal inquiry (regardless of whether same is reduced to judgment) or any settlement thereof which arises directly or indirectly from, as a result of, or in connection with your operation of the Franchised Business including, but not limited to, claims arising as a result of the maintenance and operation of vehicles (collectively an \\\"event\\\"), and regardless of whether same resulted from any strict or vicarious liability imposed by law on the Indemnitees; provided, however, that this indemnity shall not apply to any liability arising from the gross negligence of the Indemnitees (except to the extent that joint liability is involved, in which event the indemnification provided herein shall extend to any finding of comparative negligence or contributory negligence attributable to you). For the purpose of this Section 14.4, the term \\\"losses and expenses\\\" shall be deemed to include compensatory, exemplary, or punitive damages; fines and penalties; attorneys' fees; experts' fees; court costs; costs associated with investigating and defending against claims; settlement amounts; judgments; compensation for damages to our reputation and goodwill; and all other costs associated with any of the foregoing losses and expenses. You shall give us prompt notice of any event of which you are aware for which indemnification is required and, at your expense and risk, we may elect to assume (but under no circumstance are obligated to undertake) the defense and/or settlement thereof, provided that we will seek your advice and counsel. Any assumption of ours shall not modify your indemnification obligation. We may, in our sole judgment, take such actions as we deem necessary and appropriate to investigate, defend, or settle any event or take other remedial or corrective actions with respect thereto as may be, in our sole judgment, necessary for the protection of the Indemnitees or the System. You shall defend us and each of our affiliates, officers, directors, shareholders, agents, and employees named in any lawsuit based on such loss or expenses and shall pay all costs and reasonable attorneys' fees associated with such defense. If we wish to retain our own counsel to defend any such action, you shall reimburse us for all reasonable costs and legal fees incurred by us for such defense. Said reimbursement shall be made to us in a timely manner upon demand as such fees are incurred by us and billed to you. 31 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPROVALS, WAIVERS AND NOTICES 15\", \"level\": 1, \"text\": \"15. APPROVALS, WAIVERS AND NOTICES 15.1 Obtaining Approvals Whenever this Agreement requires our prior approval or consent, you shall make a timely written request to us therefor, and such approval or consent must be obtained in writing. We make no warranties or guarantees upon which you may rely, and assume no liability or obligation to you by providing any waiver, approval, consent, or suggestion to you in connection with this Agreement, or by reason of any neglect, delay, or denial of any request therefor. 15.2 No Waiver No delay, waiver, omission, or forbearance on our part to exercise any right, option, duty, or power arising out of any breach or default by you, or by any other franchisee, of any of the terms, provisions, or covenants thereof, and no custom or practice by the parties at variance with the terms of this Agreement, shall constitute our waiver to enforce any such right, option, or power as against you, or as to a subsequent breach or default by you. Subsequent acceptance by us of any payments due to us under this Agreement shall not be deemed to be our waiver of any preceding or succeeding breach by you of any terms, covenants, or conditions of this Agreement. 15.3 Notices All notices or demands shall be in writing and shall be served in person, by Express Mail, by certified mail; by private overnight delivery; or by facsimile. Service shall be deemed conclusively made (a) at the time of service, if personally served; (b) twenty-four (24) hours (exclusive of weekends and national holidays) after deposit in the United States mail, properly addressed and postage prepaid, if served by Express Mail; (c) upon the earlier of actual receipt or three (3) calendar days after deposit in the United States mail, properly addressed and postage prepaid, return receipt requested, if served by certified mail; (d) twenty-four (24) hours after delivery by the party giving the notice, statement or demand if by private overnight delivery; and (e) at the time of transmission by facsimile, if such transmission occurs prior to 5:00 p.m. on a business day and a copy of such notice is mailed within twenty-four (24) hours after the transmission. Notices and demands shall be given to the respective parties at the following addresses, unless and until a different address has been designated by written notice to the other party: To Franchisor: Kiosk Concepts, Inc. 1110 South Avenue Staten Island, New York 10314 Attention: President Fax: With a copy to: Harold L. Kestenbaum, Esq. 90 Merrick Avenue, Suite 601 East Meadow, New York 11554 Fax: (516) 745-0293 To Master Franchisee: The Grilled Cheese Truck, Inc. 151 North Nob Hill Road, Suite 321 Fort Lauderdale, FL. 33324 Fax: 32 Source: SOUPMAN, INC., 8-K, 8/14/2015 With a copy to: Martin J. Brill, Esq. Levene, Neale, Bender, Yoo & Brill, LLP 10250 Constellation Blvd., Suite 1700 Los Angeles, CA 90067 Fax: (310 229-1244 Either party may change its address for the purpose of receiving notices, demands and other communications as herein provided by a written notice given in the manner aforesaid to the other party. 16. ENTIRE AGREEMENT; SEVERABILITY AND CONSTRUCTION 16.1 Entire Agreement This Agreement, any attachments hereto, and any ancillary agreements between you and us or any affiliate which are executed contemporaneously with this Agreement, constitute the entire and complete Agreement between us (and, if applicable, any affiliate) and you concerning the subject matter thereof, and supersede all prior agreements. You acknowledge that you are entering into this Agreement, and any ancillary agreements executed contemporaneously herewith, as a result of your own independent investigation of the business franchised hereby and not as a result of any representation made by us or persons associated with us, or other franchisees, which are contrary to the terms herein set forth or which are contrary to the terms of any Franchise Disclosure Document or other similar document required or permitted to be given to you pursuant to applicable law. Except for those permitted under this Agreement to be made unilaterally by us, no amendment, change, or variation from this Agreement shall be binding on either party unless mutually agreed to by the parties and executed by their authorized officers or agents in writing. Nothing in this Section 16.1 is intended to disclaim, or require you to waive reliance on, any representation made in the Franchise Disclosure Document (the \\\"FDD\\\") that we have provided to you, except with respect to specific contract terms and conditions set forth in the FDD that you have voluntarily waived during the course of franchise-sale negotiations. 16.2 Severability and Construction Except as expressly provided to the contrary herein, each section, paragraph, part, term, and provision of this Agreement shall be considered severable; and if, for any reason, any section, paragraph, part, term, provision, and/or covenant herein is determined to be invalid and contrary to, or in conflict with, any existing or future law or regulation by a court or agency having valid jurisdiction, such shall not impair the operation of, or have any other effect upon, such other portions, sections, paragraphs, parts, terms, provisions, and/or covenants of this Agreement as may remain otherwise intelligible; and the latter shall continue to be given full force and effect and bind the parties hereto; and the invalid portions, sections, paragraphs, parts, terms, provisions, and/or covenants shall be deemed not to be a part of this Agreement. Neither this Agreement or any uncertainty or ambiguity in this Agreement shall be construed or resolved against the drafter of this Agreement, whether under any rule of construction or otherwise. On the contrary, this Agreement has been review by all parties and shall be construed and interpreted according to the ordinary meaning of the words used to fairly accomplish the purposes and intentions of all parties to this Agreement. We and you intend that if any provision of this Agreement is susceptible to two or more constructions, one of which would render the provision enforceable and the other or others of which would render the provision unenforceable, the provision shall be given the meaning that renders it enforceable. 33 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 Source: SOUPMAN, INC., 8-K, 8/14/2015 IN WITNESS WHEREOF, the parties have executed this Agreement on the date first shown above. KIOSK CONCEPTS, INC.: By: Witness Name: Title: MASTER FRANCHISEE : THE GRILLED CHEESE TRUCK, INC. By: Witness Name: Title: 40 Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"SCHEDULE OF\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRINCIPALS (Not Applicable) ANY OTHER PERSON NOT LISTED IN THIS AGREEMENT WHO IS A SPOUSE, PARTNER, AN OFFICER, DIRECTOR, SHAREHOLDER, GENERAL PARTNER OR MEMBER OF MASTER FRANCHISEE: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship:\", \"level\": 1, \"text\": \"SCHEDULE OF PRINCIPALS (Not Applicable) ANY OTHER PERSON NOT LISTED IN THIS AGREEMENT WHO IS A SPOUSE, PARTNER, AN OFFICER, DIRECTOR, SHAREHOLDER, GENERAL PARTNER OR MEMBER OF MASTER FRANCHISEE: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Name: Address: Telephone: Relationship: Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"Attachment A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"to Master Franchise Agreement MASTER TERRITORY AND COMMENCEMENT DATE MASTER TERRITORY: North America COMMENCEMENT DATE: Upon approval of the State of New York. KIOSK CONCEPTS, INC. MASTER FRANCHISEE THE GRILLED CHEESE TRUCK, INC. By: By: Name: Name: Title: Title:\", \"level\": 1, \"text\": \"Attachment A to Master Franchise Agreement MASTER TERRITORY AND COMMENCEMENT DATE MASTER TERRITORY: North America COMMENCEMENT DATE: Upon approval of the State of New York. KIOSK CONCEPTS, INC. MASTER FRANCHISEE THE GRILLED CHEESE TRUCK, INC. By: By: Name: Name: Title: Title: Source: SOUPMAN, INC., 8-K, 8/14/2015\"}}, {\"id\": \"party:Kiosk Concepts, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Kiosk Concepts, Inc.\", \"role\": \"Franchisor\", \"address\": \"1110 South Avenue, Staten Island, New York 10314\"}}, {\"id\": \"party:The Grilled Cheese Truck, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"The Grilled Cheese Truck, Inc.\", \"role\": \"Master Franchisee\", \"address\": \"151 North Nob Hill Road, Suite 321, Fort Lauderdale, FL 33324\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"the _____ day of __________________, 2015 (the \\\"Effective Date\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Proprietary Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proprietary Marks\", \"text\": \"trademarks, trade names, service marks, slogans and logos which may be authorized in writing by us from time to time (collectively the \\\"Proprietary Marks\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System\", \"text\": \"the methods, procedures and products developed by us and our parent (the \\\"System\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Franchised Business\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Franchised Business\", \"text\": \"an independent business (the \\\"Franchised Business\\\") that sells and services The Original Soupman franchises (\\\"Unit Franchises\\\") to qualified individuals and business entities (\\\"Unit Franchisees\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Unit Franchises\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unit Franchises\", \"text\": \"The Original Soupman franchises (\\\"Unit Franchises\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Unit Franchisees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unit Franchisees\", \"text\": \"qualified individuals and business entities (\\\"Unit Franchisees\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Master Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Master Territory\", \"text\": \"the territory described on Attachment A attached to this Agreement and incorporated into this Agreement by reference (the \\\"Master Territory\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Commencement Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Commencement Date\", \"text\": \"the \\\"Commencement Date\\\" set forth on Attachment A hereto\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Minimum Development Quota\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Development Quota\", \"text\": \"the minimum number of The Original Soupman businesses as set forth on Attachment E hereto (the \\\"Minimum Development Quota\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Applicant\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicant\", \"text\": \"each applicant for the purchase of a Unit Franchise (an \\\"Applicant\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Unit Franchise Disclosure Document\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unit Franchise Disclosure Document\", \"text\": \"a Franchise Disclosure Document and all other related documents in accordance with the requirements of all federal and state regulatory agencies which now or hereafter may have jurisdiction over the sale of franchises in the Master Territory (a \\\"Unit Franchise Disclosure Document\\\")\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Solicitation Advertising\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Solicitation Advertising\", \"text\": \"advertising to solicit Applicants for the purchase of Unit Franchisees in the Master Territory (\\\"Solicitation Advertising\\\")\", \"definition_clause\": \"5.5.3\"}}, {\"id\": \"term:System Website\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System Website\", \"text\": \"a website or series of websites for the System to advertise, market and promote The Original Soupman businesses and the products and services they offer, the Unit Franchise and/or master franchise opportunity, and/or for any other purposes that we determine are appropriate for The Original Soupman businesses (collectively, the \\\"System Website\\\")\", \"definition_clause\": \"5.17\"}}, {\"id\": \"term:URL\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"URL\", \"text\": \"the domain name or uniform resource locator (\\\"URL\\\")\", \"definition_clause\": \"5.17\"}}, {\"id\": \"term:social media\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"social media\", \"text\": \"a website established or authorized by us (\\\"social media\\\" includes personal blogs, common social networks like Facebook and MySpace, professional networks like LinkedIn, live-blogging tools like Twitter, virtual worlds, file, audio and video-sharing sites, and other similar social networking or media sites or tools)\", \"definition_clause\": \"5.17\"}}, {\"id\": \"term:Intranet\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intranet\", \"text\": \"a private method of communication for use only by employees and master franchisees of ours, as well as Unit Franchisees in the System (an \\\"Intranet\\\")\", \"definition_clause\": \"5.17\"}}, {\"id\": \"term:Indemnitees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnitees\", \"text\": \"us, our affiliates and our respective directors, officers, employees, shareholders, and agents, (collectively the \\\"Indemnitees\\\")\", \"definition_clause\": \"14.2\"}}, {\"id\": \"term:event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"event\", \"text\": \"any litigation or other form of adjudicatory procedure, claim, demand, investigation, or formal or informal inquiry (regardless of whether same is reduced to judgment) or any settlement thereof which arises directly or indirectly from, as a result of, or in connection with your operation of the Franchised Business including, but not limited to, claims arising as a result of the maintenance and operation of vehicles (collectively an \\\"event\\\")\", \"definition_clause\": \"14.2\"}}, {\"id\": \"term:losses and expenses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"losses and expenses\", \"text\": \"For the purpose of this Section 14.4, the term \\\"losses and expenses\\\" shall be deemed to include compensatory, exemplary, or punitive damages; fines and penalties; attorneys' fees; experts' fees; court costs; costs associated with investigating and defending against claims; settlement amounts; judgments; compensation for damages to our reputation and goodwill; and all other costs associated with any of the foregoing losses and expenses.\", \"definition_clause\": \"14.2\"}}, {\"id\": \"term:FDD\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDD\", \"text\": \"the Franchise Disclosure Document (the \\\"FDD\\\")\", \"definition_clause\": \"15\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"25%\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:ten percent (10%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ten percent (10%)\"}}, {\"id\": \"value:$5,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$5,000\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:one hundred twenty (120) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred twenty (120) days\"}}, {\"id\": \"value:twenty-four (24) hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) hours\"}}, {\"id\": \"value:three (3) calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) calendar days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"1\", \"level\": 1, \"text\": \"1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"1.4\", \"title\": \"During the term of this Agreement, and subject to the terms and conditions hereof, STAAR hereby grants to Distributor, a\", \"level\": 2, \"text\": \"1.4 During the term of this Agreement, and subject to the terms and conditions hereof, STAAR hereby grants to Distributor, and Distributor hereby accepts, the limited, nontransferable, nonexclusive right and license to use the trade name, trademarks, and logos of STAAR (collectively, \\\"Trademarks\\\"), without the right to grant sublicenses, solely in connection with the marketing, distribution and sale of the Products in the Territory pursuant to this Agreement. Distributor shall use and display the Trademarks solely in the manner, form, design, color and layout agreed by STAAR in its sole discretion. Distributor shall not use the Trademarks as part of or in combination with Distributor's trade name or marks. Distributor shall only market, distribute and sell the Products under the Trademarks and shall not use the Trademarks in any advertising or promotional campaigns or otherwise, or use any confusingly similar names or logos, in any manner that, in STAAR's sole discretion, may be misleading or harmful to STAAR (or its affiliates). Subject to the limited use rights granted to Distributor in respect of the Trademarks under this Agreement, all powers that would be conferred on authorized users under other laws are expressly excluded. 1.5 The term \\\"Products\\\" shall mean those certain products, specified by brand name, manufactured and marketed under the Trademarks by STAAR that are listed on Exhibit A-1 hereto. STAAR may from time to time modify or change the Products on Exhibit A-1 in its sole discretion, and if so, will notify Distributor promptly thereof. In the event that STAAR discontinues a Product, it will provide at least thirty (30) days' prior written notice to Distributor. Distributor shall not modify, disassemble or reverse engineer any Product, in whole or in part. 1.6 The term \\\"Territory\\\" shall mean ________. Distributor shall not promote, market, distribute or sell the Products outside the Territory. 1.7 Except for the rights expressly granted to Distributor pursuant to Sections 1 and 2, Distributor acknowledges and agrees that STAAR reserves and retains all rights with respect to the marketing, distribution and sale of the Products in the Territory (and elsewhere). Notwithstanding any other provision hereof to the contrary, STAAR shall have the unrestricted right, at its sole discretion, directly or indirectly through third party distributors, to among other things (a) supply, market, distribute and sell any product in the Territory other than the Products, (b) supply, market, distribute and sell any Product in the Territory on an OEM basis under third party trademarks, and (c) market, distribute and sell the Products (or any other product) in any geographic region outside the Territory. 2. Business of Distributor Distributor is and shall remain an independent contractor. Distributor agrees that STAAR has granted it no authority to act or make any representations or warranties on behalf of STAAR. Distributor is at all times acting for its own account, and at its own expense. Distributor represents to STAAR that Distributor has trained and experienced personnel, facilities and other resources in the Territory in order to diligently, professionally and effectively market, distribute and sell the Products. Distributor shall comply with all applicable laws, statutes, regulations and treaties relating to the marketing, distribution and sale of the Products and the performance of its duties and obligations hereunder. Distributor shall be free to establish its own pricing for Products sold by Distributor and shall notify STAAR of its pricing, as in effect from time to time. 2 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 3 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 4 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 5 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 6 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 7 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 8 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 9 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 10 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"14.4\", \"title\": \"Upon any termination or expiration of this Agreement\", \"level\": 2, \"text\": \"14.4 Upon any termination or expiration of this Agreement: (a) All sums due to either party from the other shall be promptly paid; (b) Distributor orders received and accepted by STAAR prior to the effective date of the termination of this Agreement shall be fulfilled in accordance with their terms; (c) All property belonging to one party but in the custody of the other shall be returned; (d) STAAR shall have the option to repurchase any or all current and resalable Products in Distributor's inventory at eighty percent (80%) of Distributor's original net purchase price (reflecting a twenty percent (20%) restocking and administrative fee); (e) Distributor shall cease all display, advertising and use of STAAR trade names, trademarks (including the Trademarks), logos and designations, except uses on the Products which remain in Distributor's possession, and shall transfer all registrations and sponsorships for the Products to STAAR or its designee; and (f) The parties have considered the possibility that one or both parties will incur expenses in preparing for performance of this Agreement and that one or both parties will incur expenses and suffer losses as a result of termination, and the parties have nevertheless agreed that the terminating party shall not incur any liability whatsoever for any damage, loss or expense of any kind suffered or incurred by the other party (or for any compensation to the other party) arising from or incident to any termination or non-renewal of this Agreement by the terminating party pursuant to its terms, whether or not the terminating party is aware of any such damage, loss or expense. Without limiting the generality of the foregoing, upon any termination of this Agreement by either Party in accordance with its terms (or otherwise), in no event shall STAAR be required to pay to Distributor any \\\"good will\\\" or other payment of any nature or kind based on the sales, business development or other activities of Distributor during the term of this Agreement. Distributor, for itself and on behalf of each of its employees, hereby waives any rights which may be granted to it or them under the laws and regulations of the Territory or otherwise which are not granted to it or them by this Agreement. Termination is not the sole remedy under this Agreement, and, whether or not termination is effected, all other remedies shall remain available. 15. U.S. Laws and Regulations 15.1 Distributor acknowledges and agrees that it shall comply in all respects with all United States and local country laws, regulations and standards applicable to its activities under this Agreement, including but not limited to the exporting and importing requirements (including the prohibition of the re-export of Products and associated technical data) set forth in this Agreement and in applicable governmental regulations. 11 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 12 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"16.5\", \"title\": \"In connection with the Shared Personal Data, Distributor warrants that it\", \"level\": 2, \"text\": \"16.5 In connection with the Shared Personal Data, Distributor warrants that it: (a) has provided adequate notices to, and obtained valid consents from, the relevant individuals, in each case, to the extent necessary for STAAR and/or its service providers or agents to process the Shared Personal Data (including any sensitive personal data) in connection with this Agreement which may include the transfer of the Shared Personal Data to STAAR outside of the EEA; and (b) shall not, by act or omission, cause STAAR to violate any Data Protection Laws, notices provided to, or consents obtained from, data subjects as result of processing the Shared Personal Data in connection with this Agreement. 16.6 To the extent of any conflict in relation to personal data between the terms contained in this Section and the rest of the Agreement, then the terms of this Section shall control to the extent of such conflict. 17. Survival In addition to Distributor's obligation to pay STAAR all amounts due hereunder, the provisions under Sections 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 24 and 25 shall survive termination of the Agreement, as well as such other provisions which by their meaning and intent have applicability beyond the terms of this Agreement. 18. Publicity Distributor agrees that any publicity or advertising which shall be released by it in which STAAR is identified in connection with the Products shall be in accordance with the terms of this Agreement and with any information or data which STAAR has furnished in connections with this Agreement (or related to the Product). STAAR shall have the right to review and approve all such publicity and advertising prior to dissemination thereof. 19. Assignment Neither party may, directly or indirectly (including in connection with a change of control transaction), transfer or assign this Agreement or any of the rights or obligations hereunder without the prior written consent of the other; provided that STAAR may assign any of its rights and delegate any of its obligations hereunder to its subsidiaries and affiliated companies or in connection with a sale or transfer of all or substantially all of its business to which this Agreement relates, whether by merger, sale of assets or otherwise, without Distributor's prior written consent. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. 20. Integrated Agreement This Agreement constitutes the entire understanding and agreement between STAAR and Distributor regarding the subject matter hereof and terminates and supersedes all prior formal or informal understandings or agreements relating thereto. 13 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"21\", \"title\": \"Force Majeure Performance of the parties hereto of their respective obligations hereunder shall be subject to force maj\", \"level\": 1, \"text\": \"21. Force Majeure Performance of the parties hereto of their respective obligations hereunder shall be subject to force majeure and acts of God, including but not limited to insurrections, riots, wars and war-like operations, terrorist acts, explosions, governmental acts, epidemics, failure of contractors to perform, strikes, fires, accidents, acts of any public enemy, inability to obtain required materials, supplies, products or qualified labor, delay in transportation and any applicable law, regulation or restriction of any foreign, federal, state or local governmental entity or instrumentality. However, the parties hereto shall use their commercially reasonable efforts to avoid, remove or cure said circumstances. Any party temporarily excused for performances hereunder by any such circumstance shall resume performance with utmost dispatch when such circumstances are removed or cured. Any party claiming such circumstances as an excuse for delay in performance shall give prompt notice in writing thereof to the other party. Nothing herein and no contrary provisions of any law, regulation, or governmental pronouncement shall, however, relieve Distributor of its obligation to make the payments to STAAR required hereunder at the times and in the manner herein specified. 22. No Waiver No waiver by either party of any breach or default of any of the covenants or agreements herein contained shall be deemed a waiver as to any subsequent or similar breach or default. No right or remedy herein conferred upon either party is exclusive of any other right or remedy herein or by law or in equity provided or permitted. 23. Severability This Agreement is divisible, and provisions herein held to be violate of any applicable treaties, statutes or regulations of any governmental agency having jurisdiction shall effect only that portion held to be invalid or inoperative, and the remaining portions of this Agreement shall remain in full force and effect. 24. Notice Any notice required or permitted to be given hereunder shall be in writing and (a) delivered in person or by internationally-recognized express delivery or courier service (e.g., FedEx, DHL or UPS), (b) sent by facsimile, or (c) deposited in the mail registered or certified first class, postage prepaid and return receipt requested (provided that any notice given pursuant to clause (b) is also confirmed by the means described in clause (a) or (c)), to the address or facsimile number of the party appearing below its signature below or to such other address as such party from time to time may designate in writing in compliance with the terms hereof. Each notice shall be deemed given when so delivered personally, or sent by facsimile transmission, or, if sent by express delivery or courier service four (4) business days after being sent, or if mailed, ten (10) days after date of deposit in the mail. 25. Governing Law and Dispute Resolution 25.1 This Agreement, which is in English, shall be governed by and construed in accordance with the laws of the State of California without regard to the conflicts of laws principles thereof. The parties hereby expressly disclaim and exclude any applicable provisions of the United Nations Convention for the International Sales of Goods. 14 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"25.2\", \"title\": \"The parties waive their rights to seek remedies in court (except where the relief sought is an injunction or other equit\", \"level\": 2, \"text\": \"25.2 The parties waive their rights to seek remedies in court (except where the relief sought is an injunction or other equitable relief), including any right to a jury trial. Except in a case where the relief sought is an injunction or other equitable relief, the parties agree that any dispute between the parties arising out of, relating to or in connection with this Agreement, whether characterized or sounding in contract or tort or otherwise, shall be resolved exclusively through binding arbitration conducted in accordance with the Rules of Conciliation and Arbitration of the International Chamber of Commerce by one or more arbitrators appointed in accordance with the said Rules. The arbitration shall be held in Los Angeles, California, USA. Judgment upon the award rendered may be entered in any court having jurisdiction. Each party shall bear its own expenses of the arbitration, but the arbitration fees and costs shall be borne equally between the parties participating in the arbitration. Disputes shall not be resolved in any other forum or venue. 26. Counterparts This Agreement may be executed in duplicate counterparts, each of which shall be deemed to be an original and all of which counterparts shall together constitute one and the same instrument. IN WITNESS WHEREOF, STAAR and Distributor have caused their duly authorized representatives to execute this Distributorship Agreement on this __ day of ____, 20___. STAAR SURGICAL AG DISTRIBUTOR By: By: Name: Name: Title: Title: 15 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 EXHIBIT A-1 List of Products and Prices All prices in U.S. dollars, or such other currency as STAAR determines in its sole discretion. A-1-1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"EXHIBIT B\", \"title\": \"Minimum Product Quantities\", \"level\": 1, \"text\": \"EXHIBIT B Minimum Product Quantities B-1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}, {\"id\": \"EXHIBIT C\", \"title\": \"Foreign Corrupt Practices Certification I, _________, as the [__________] of ___________ hereby certify as follows: 1. I understand and will comply with the anti-bribery provisions of the U.S Foreign Corrupt Practices Act and the UK Bribery Act. Neither I, nor any person employed by me or my business or representing my business, has or will make, offer, promise or authorize, directly or indirectly, any payment or transfer of anything of value to any official, representative or employee of any government, government agency or instrumentality, for the purpose of influencing a decision by any of them to take actions favorable to STAAR Surgical Company or its subsidiaries (\\\"STAAR\\\") or represent them on any matter related directly or indirectly to the purchase of any of STAAR's products. 2. No officer, director, partner, owner, principle, employee or agent of my business is an official or employee of a governmental agency or instrumentality in a position to influence action or decisions regarding me or my business activities on behalf of STAAR and I will inform STAAR, by written notice, if, and as soon as , any such person assumes such a position as official or employee of a governmental agency or instrumentality while at the same time remaining an officer, director, partner, owner, principle, employee or agent of mine or my business at which time STAAR may elect to terminate this contract without any further liability to me or my business. 3. I will indemnify an hold harmless STAAR from any and all fines, damages, losses, costs and expenses (including without limitation reasonable attorneys' fees) incurred by STAAR as a result of any breach of this Certification by me. 4. I understand and agree that failure to comply with the terms of this Certification will entitle STAAR to terminate any and all if its contractual relationships with me and my business. DISTRIBUTOR: By: Officer Title: Print Name: Date:\", \"level\": 1, \"text\": \"EXHIBIT C Foreign Corrupt Practices Certification I, _________, as the [__________] of ___________ hereby certify as follows: 1. I understand and will comply with the anti-bribery provisions of the U.S Foreign Corrupt Practices Act and the UK Bribery Act. Neither I, nor any person employed by me or my business or representing my business, has or will make, offer, promise or authorize, directly or indirectly, any payment or transfer of anything of value to any official, representative or employee of any government, government agency or instrumentality, for the purpose of influencing a decision by any of them to take actions favorable to STAAR Surgical Company or its subsidiaries (\\\"STAAR\\\") or represent them on any matter related directly or indirectly to the purchase of any of STAAR's products. 2. No officer, director, partner, owner, principle, employee or agent of my business is an official or employee of a governmental agency or instrumentality in a position to influence action or decisions regarding me or my business activities on behalf of STAAR and I will inform STAAR, by written notice, if, and as soon as , any such person assumes such a position as official or employee of a governmental agency or instrumentality while at the same time remaining an officer, director, partner, owner, principle, employee or agent of mine or my business at which time STAAR may elect to terminate this contract without any further liability to me or my business. 3. I will indemnify an hold harmless STAAR from any and all fines, damages, losses, costs and expenses (including without limitation reasonable attorneys' fees) incurred by STAAR as a result of any breach of this Certification by me. 4. I understand and agree that failure to comply with the terms of this Certification will entitle STAAR to terminate any and all if its contractual relationships with me and my business. DISTRIBUTOR: By: Officer Title: Print Name: Date: C-1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of StaarSurgicalCompany_20180801_10-Q_EX-10.37_11289449_EX-10.37_Distributor Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"1\", \"level\": 1, \"text\": \"1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"During the term of this Agreement, and subject to the terms and conditions hereof, STAAR hereby grants to Distributor, a\", \"level\": 2, \"text\": \"1.4 During the term of this Agreement, and subject to the terms and conditions hereof, STAAR hereby grants to Distributor, and Distributor hereby accepts, the limited, nontransferable, nonexclusive right and license to use the trade name, trademarks, and logos of STAAR (collectively, \\\"Trademarks\\\"), without the right to grant sublicenses, solely in connection with the marketing, distribution and sale of the Products in the Territory pursuant to this Agreement. Distributor shall use and display the Trademarks solely in the manner, form, design, color and layout agreed by STAAR in its sole discretion. Distributor shall not use the Trademarks as part of or in combination with Distributor's trade name or marks. Distributor shall only market, distribute and sell the Products under the Trademarks and shall not use the Trademarks in any advertising or promotional campaigns or otherwise, or use any confusingly similar names or logos, in any manner that, in STAAR's sole discretion, may be misleading or harmful to STAAR (or its affiliates). Subject to the limited use rights granted to Distributor in respect of the Trademarks under this Agreement, all powers that would be conferred on authorized users under other laws are expressly excluded. 1.5 The term \\\"Products\\\" shall mean those certain products, specified by brand name, manufactured and marketed under the Trademarks by STAAR that are listed on Exhibit A-1 hereto. STAAR may from time to time modify or change the Products on Exhibit A-1 in its sole discretion, and if so, will notify Distributor promptly thereof. In the event that STAAR discontinues a Product, it will provide at least thirty (30) days' prior written notice to Distributor. Distributor shall not modify, disassemble or reverse engineer any Product, in whole or in part. 1.6 The term \\\"Territory\\\" shall mean ________. Distributor shall not promote, market, distribute or sell the Products outside the Territory. 1.7 Except for the rights expressly granted to Distributor pursuant to Sections 1 and 2, Distributor acknowledges and agrees that STAAR reserves and retains all rights with respect to the marketing, distribution and sale of the Products in the Territory (and elsewhere). Notwithstanding any other provision hereof to the contrary, STAAR shall have the unrestricted right, at its sole discretion, directly or indirectly through third party distributors, to among other things (a) supply, market, distribute and sell any product in the Territory other than the Products, (b) supply, market, distribute and sell any Product in the Territory on an OEM basis under third party trademarks, and (c) market, distribute and sell the Products (or any other product) in any geographic region outside the Territory. 2. Business of Distributor Distributor is and shall remain an independent contractor. Distributor agrees that STAAR has granted it no authority to act or make any representations or warranties on behalf of STAAR. Distributor is at all times acting for its own account, and at its own expense. Distributor represents to STAAR that Distributor has trained and experienced personnel, facilities and other resources in the Territory in order to diligently, professionally and effectively market, distribute and sell the Products. Distributor shall comply with all applicable laws, statutes, regulations and treaties relating to the marketing, distribution and sale of the Products and the performance of its duties and obligations hereunder. Distributor shall be free to establish its own pricing for Products sold by Distributor and shall notify STAAR of its pricing, as in effect from time to time. 2 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 3 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 4 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 5 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 6 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 7 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 8 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 9 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 10 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon any termination or expiration of this Agreement\", \"level\": 2, \"text\": \"14.4 Upon any termination or expiration of this Agreement: (a) All sums due to either party from the other shall be promptly paid; (b) Distributor orders received and accepted by STAAR prior to the effective date of the termination of this Agreement shall be fulfilled in accordance with their terms; (c) All property belonging to one party but in the custody of the other shall be returned; (d) STAAR shall have the option to repurchase any or all current and resalable Products in Distributor's inventory at eighty percent (80%) of Distributor's original net purchase price (reflecting a twenty percent (20%) restocking and administrative fee); (e) Distributor shall cease all display, advertising and use of STAAR trade names, trademarks (including the Trademarks), logos and designations, except uses on the Products which remain in Distributor's possession, and shall transfer all registrations and sponsorships for the Products to STAAR or its designee; and (f) The parties have considered the possibility that one or both parties will incur expenses in preparing for performance of this Agreement and that one or both parties will incur expenses and suffer losses as a result of termination, and the parties have nevertheless agreed that the terminating party shall not incur any liability whatsoever for any damage, loss or expense of any kind suffered or incurred by the other party (or for any compensation to the other party) arising from or incident to any termination or non-renewal of this Agreement by the terminating party pursuant to its terms, whether or not the terminating party is aware of any such damage, loss or expense. Without limiting the generality of the foregoing, upon any termination of this Agreement by either Party in accordance with its terms (or otherwise), in no event shall STAAR be required to pay to Distributor any \\\"good will\\\" or other payment of any nature or kind based on the sales, business development or other activities of Distributor during the term of this Agreement. Distributor, for itself and on behalf of each of its employees, hereby waives any rights which may be granted to it or them under the laws and regulations of the Territory or otherwise which are not granted to it or them by this Agreement. Termination is not the sole remedy under this Agreement, and, whether or not termination is effected, all other remedies shall remain available. 15. U.S. Laws and Regulations 15.1 Distributor acknowledges and agrees that it shall comply in all respects with all United States and local country laws, regulations and standards applicable to its activities under this Agreement, including but not limited to the exporting and importing requirements (including the prohibition of the re-export of Products and associated technical data) set forth in this Agreement and in applicable governmental regulations. 11 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 12 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"16.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In connection with the Shared Personal Data, Distributor warrants that it\", \"level\": 2, \"text\": \"16.5 In connection with the Shared Personal Data, Distributor warrants that it: (a) has provided adequate notices to, and obtained valid consents from, the relevant individuals, in each case, to the extent necessary for STAAR and/or its service providers or agents to process the Shared Personal Data (including any sensitive personal data) in connection with this Agreement which may include the transfer of the Shared Personal Data to STAAR outside of the EEA; and (b) shall not, by act or omission, cause STAAR to violate any Data Protection Laws, notices provided to, or consents obtained from, data subjects as result of processing the Shared Personal Data in connection with this Agreement. 16.6 To the extent of any conflict in relation to personal data between the terms contained in this Section and the rest of the Agreement, then the terms of this Section shall control to the extent of such conflict. 17. Survival In addition to Distributor's obligation to pay STAAR all amounts due hereunder, the provisions under Sections 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 24 and 25 shall survive termination of the Agreement, as well as such other provisions which by their meaning and intent have applicability beyond the terms of this Agreement. 18. Publicity Distributor agrees that any publicity or advertising which shall be released by it in which STAAR is identified in connection with the Products shall be in accordance with the terms of this Agreement and with any information or data which STAAR has furnished in connections with this Agreement (or related to the Product). STAAR shall have the right to review and approve all such publicity and advertising prior to dissemination thereof. 19. Assignment Neither party may, directly or indirectly (including in connection with a change of control transaction), transfer or assign this Agreement or any of the rights or obligations hereunder without the prior written consent of the other; provided that STAAR may assign any of its rights and delegate any of its obligations hereunder to its subsidiaries and affiliated companies or in connection with a sale or transfer of all or substantially all of its business to which this Agreement relates, whether by merger, sale of assets or otherwise, without Distributor's prior written consent. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. 20. Integrated Agreement This Agreement constitutes the entire understanding and agreement between STAAR and Distributor regarding the subject matter hereof and terminates and supersedes all prior formal or informal understandings or agreements relating thereto. 13 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure Performance of the parties hereto of their respective obligations hereunder shall be subject to force maj\", \"level\": 1, \"text\": \"21. Force Majeure Performance of the parties hereto of their respective obligations hereunder shall be subject to force majeure and acts of God, including but not limited to insurrections, riots, wars and war-like operations, terrorist acts, explosions, governmental acts, epidemics, failure of contractors to perform, strikes, fires, accidents, acts of any public enemy, inability to obtain required materials, supplies, products or qualified labor, delay in transportation and any applicable law, regulation or restriction of any foreign, federal, state or local governmental entity or instrumentality. However, the parties hereto shall use their commercially reasonable efforts to avoid, remove or cure said circumstances. Any party temporarily excused for performances hereunder by any such circumstance shall resume performance with utmost dispatch when such circumstances are removed or cured. Any party claiming such circumstances as an excuse for delay in performance shall give prompt notice in writing thereof to the other party. Nothing herein and no contrary provisions of any law, regulation, or governmental pronouncement shall, however, relieve Distributor of its obligation to make the payments to STAAR required hereunder at the times and in the manner herein specified. 22. No Waiver No waiver by either party of any breach or default of any of the covenants or agreements herein contained shall be deemed a waiver as to any subsequent or similar breach or default. No right or remedy herein conferred upon either party is exclusive of any other right or remedy herein or by law or in equity provided or permitted. 23. Severability This Agreement is divisible, and provisions herein held to be violate of any applicable treaties, statutes or regulations of any governmental agency having jurisdiction shall effect only that portion held to be invalid or inoperative, and the remaining portions of this Agreement shall remain in full force and effect. 24. Notice Any notice required or permitted to be given hereunder shall be in writing and (a) delivered in person or by internationally-recognized express delivery or courier service (e.g., FedEx, DHL or UPS), (b) sent by facsimile, or (c) deposited in the mail registered or certified first class, postage prepaid and return receipt requested (provided that any notice given pursuant to clause (b) is also confirmed by the means described in clause (a) or (c)), to the address or facsimile number of the party appearing below its signature below or to such other address as such party from time to time may designate in writing in compliance with the terms hereof. Each notice shall be deemed given when so delivered personally, or sent by facsimile transmission, or, if sent by express delivery or courier service four (4) business days after being sent, or if mailed, ten (10) days after date of deposit in the mail. 25. Governing Law and Dispute Resolution 25.1 This Agreement, which is in English, shall be governed by and construed in accordance with the laws of the State of California without regard to the conflicts of laws principles thereof. The parties hereby expressly disclaim and exclude any applicable provisions of the United Nations Convention for the International Sales of Goods. 14 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"25.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The parties waive their rights to seek remedies in court (except where the relief sought is an injunction or other equit\", \"level\": 2, \"text\": \"25.2 The parties waive their rights to seek remedies in court (except where the relief sought is an injunction or other equitable relief), including any right to a jury trial. Except in a case where the relief sought is an injunction or other equitable relief, the parties agree that any dispute between the parties arising out of, relating to or in connection with this Agreement, whether characterized or sounding in contract or tort or otherwise, shall be resolved exclusively through binding arbitration conducted in accordance with the Rules of Conciliation and Arbitration of the International Chamber of Commerce by one or more arbitrators appointed in accordance with the said Rules. The arbitration shall be held in Los Angeles, California, USA. Judgment upon the award rendered may be entered in any court having jurisdiction. Each party shall bear its own expenses of the arbitration, but the arbitration fees and costs shall be borne equally between the parties participating in the arbitration. Disputes shall not be resolved in any other forum or venue. 26. Counterparts This Agreement may be executed in duplicate counterparts, each of which shall be deemed to be an original and all of which counterparts shall together constitute one and the same instrument. IN WITNESS WHEREOF, STAAR and Distributor have caused their duly authorized representatives to execute this Distributorship Agreement on this __ day of ____, 20___. STAAR SURGICAL AG DISTRIBUTOR By: By: Name: Name: Title: Title: 15 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018 EXHIBIT A-1 List of Products and Prices All prices in U.S. dollars, or such other currency as STAAR determines in its sole discretion. A-1-1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Minimum Product Quantities\", \"level\": 1, \"text\": \"EXHIBIT B Minimum Product Quantities B-1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"EXHIBIT C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Foreign Corrupt Practices Certification I, _________, as the [__________] of ___________ hereby certify as follows: 1. I understand and will comply with the anti-bribery provisions of the U.S Foreign Corrupt Practices Act and the UK Bribery Act. Neither I, nor any person employed by me or my business or representing my business, has or will make, offer, promise or authorize, directly or indirectly, any payment or transfer of anything of value to any official, representative or employee of any government, government agency or instrumentality, for the purpose of influencing a decision by any of them to take actions favorable to STAAR Surgical Company or its subsidiaries (\\\"STAAR\\\") or represent them on any matter related directly or indirectly to the purchase of any of STAAR's products. 2. No officer, director, partner, owner, principle, employee or agent of my business is an official or employee of a governmental agency or instrumentality in a position to influence action or decisions regarding me or my business activities on behalf of STAAR and I will inform STAAR, by written notice, if, and as soon as , any such person assumes such a position as official or employee of a governmental agency or instrumentality while at the same time remaining an officer, director, partner, owner, principle, employee or agent of mine or my business at which time STAAR may elect to terminate this contract without any further liability to me or my business. 3. I will indemnify an hold harmless STAAR from any and all fines, damages, losses, costs and expenses (including without limitation reasonable attorneys' fees) incurred by STAAR as a result of any breach of this Certification by me. 4. I understand and agree that failure to comply with the terms of this Certification will entitle STAAR to terminate any and all if its contractual relationships with me and my business. DISTRIBUTOR: By: Officer Title: Print Name: Date:\", \"level\": 1, \"text\": \"EXHIBIT C Foreign Corrupt Practices Certification I, _________, as the [__________] of ___________ hereby certify as follows: 1. I understand and will comply with the anti-bribery provisions of the U.S Foreign Corrupt Practices Act and the UK Bribery Act. Neither I, nor any person employed by me or my business or representing my business, has or will make, offer, promise or authorize, directly or indirectly, any payment or transfer of anything of value to any official, representative or employee of any government, government agency or instrumentality, for the purpose of influencing a decision by any of them to take actions favorable to STAAR Surgical Company or its subsidiaries (\\\"STAAR\\\") or represent them on any matter related directly or indirectly to the purchase of any of STAAR's products. 2. No officer, director, partner, owner, principle, employee or agent of my business is an official or employee of a governmental agency or instrumentality in a position to influence action or decisions regarding me or my business activities on behalf of STAAR and I will inform STAAR, by written notice, if, and as soon as , any such person assumes such a position as official or employee of a governmental agency or instrumentality while at the same time remaining an officer, director, partner, owner, principle, employee or agent of mine or my business at which time STAAR may elect to terminate this contract without any further liability to me or my business. 3. I will indemnify an hold harmless STAAR from any and all fines, damages, losses, costs and expenses (including without limitation reasonable attorneys' fees) incurred by STAAR as a result of any breach of this Certification by me. 4. I understand and agree that failure to comply with the terms of this Certification will entitle STAAR to terminate any and all if its contractual relationships with me and my business. DISTRIBUTOR: By: Officer Title: Print Name: Date: C-1 Source: STAAR SURGICAL CO, 10-Q, 8/1/2018\"}}, {\"id\": \"party:STAAR\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"STAAR\", \"role\": \"Grantor\", \"address\": null}}, {\"id\": \"party:Distributor\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Distributor\", \"role\": \"Distributor\", \"address\": null}}, {\"id\": \"party:STAAR SURGICAL AG\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"STAAR SURGICAL AG\", \"role\": \"Grantor\", \"address\": null}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"the trade name, trademarks, and logos of STAAR (collectively, \\\"Trademarks\\\")\", \"definition_clause\": \"1.4\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"The term \\\"Products\\\" shall mean those certain products, specified by brand name, manufactured and marketed under the Trademarks by STAAR that are listed on Exhibit A-1 hereto.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"The term \\\"Territory\\\" shall mean ________.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:eighty percent (80%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"eighty percent (80%)\"}}, {\"id\": \"value:twenty percent (20%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"twenty percent (20%)\"}}, {\"id\": \"value:four (4) business days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four (4) business days\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\", \"level\": 1, \"text\": \"Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 2 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 3 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 4 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 5 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 6 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 7 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 8 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 9 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 10 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives. Todos Medical Ltd. Care G. B. Plus Ltd. /s/ Herman Weiss /s/ Assaf Gold Name: Herman Weiss Name: Assaf Gold Title: CEO Title: Manager Date: 20/12/2018 Date: 20/12/2018 Lists of Exhibits: Exhibit A: The Products Exhibit B: The Laboratory Exhibit C: Commercialization Timetable 11 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}, {\"id\": \"EXHIBIT A\", \"title\": \"THE PRODUCTS Each unit of Product consists of one Physician Kit and one Laboratory Kit. TM-B1 breast cancer screening test and TB-B2 breast cancer diagnostic test General Information: Physician Kit: Laboratory Kit: The Laboratory Kit consists of the Isolation Kit and the Analysis Kit. Isolation Kit: Item 7 (page 8) in the \\\"Isolation Kit\\\" are items that are not provided with the kit and the Reseller is responsible to purchase these items. Analysis Kit: Item 7 (page 8) in the \\\"Analysis Kit\\\" are the items that are not provided with the kit and the Reseller is responsible to purchase these items. Components with an expiration date: [please insert]\", \"level\": 1, \"text\": \"EXHIBIT A THE PRODUCTS Each unit of Product consists of one Physician Kit and one Laboratory Kit. TM-B1 breast cancer screening test and TB-B2 breast cancer diagnostic test General Information: Physician Kit: Laboratory Kit: The Laboratory Kit consists of the Isolation Kit and the Analysis Kit. Isolation Kit: Item 7 (page 8) in the \\\"Isolation Kit\\\" are items that are not provided with the kit and the Reseller is responsible to purchase these items. Analysis Kit: Item 7 (page 8) in the \\\"Analysis Kit\\\" are the items that are not provided with the kit and the Reseller is responsible to purchase these items. Components with an expiration date: [please insert] 12 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}, {\"id\": \"EXHIBIT B\", \"title\": \"THE LABORATORY [please insert description of the laboratory and its components]\", \"level\": 1, \"text\": \"EXHIBIT B THE LABORATORY [please insert description of the laboratory and its components] 13 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}, {\"id\": \"EXHIBIT C\", \"title\": \"COMMERCIALIZATION TIMETABLE Milestone Target Date Todos to obtain AMAR approval Q3 2019 Reseller to set-up a diagnostic Laboratory (internal or external) that complies with the requirements in the TM-B2 Isolation Kit Instruction for Use. Q3 2019 Reseller to commence 30-50 Women Pilot Trial. Isolation at Reseller's lab, and FTIR analysis at Todos's facility. Q3 2019 Reseller to commence commercial sales. Q4 2019 Todos to provide kits and computer analysis of files. Q4 2019 14\", \"level\": 1, \"text\": \"EXHIBIT C COMMERCIALIZATION TIMETABLE Milestone Target Date Todos to obtain AMAR approval Q3 2019 Reseller to set-up a diagnostic Laboratory (internal or external) that complies with the requirements in the TM-B2 Isolation Kit Instruction for Use. Q3 2019 Reseller to commence 30-50 Women Pilot Trial. Isolation at Reseller's lab, and FTIR analysis at Todos's facility. Q3 2019 Reseller to commence commercial sales. Q4 2019 Todos to provide kits and computer analysis of files. Q4 2019 14 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\", \"level\": 1, \"text\": \"Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 2 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 3 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 4 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 5 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 6 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 7 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 8 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 9 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 10 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives. Todos Medical Ltd. Care G. B. Plus Ltd. /s/ Herman Weiss /s/ Assaf Gold Name: Herman Weiss Name: Assaf Gold Title: CEO Title: Manager Date: 20/12/2018 Date: 20/12/2018 Lists of Exhibits: Exhibit A: The Products Exhibit B: The Laboratory Exhibit C: Commercialization Timetable 11 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE PRODUCTS Each unit of Product consists of one Physician Kit and one Laboratory Kit. TM-B1 breast cancer screening test and TB-B2 breast cancer diagnostic test General Information: Physician Kit: Laboratory Kit: The Laboratory Kit consists of the Isolation Kit and the Analysis Kit. Isolation Kit: Item 7 (page 8) in the \\\"Isolation Kit\\\" are items that are not provided with the kit and the Reseller is responsible to purchase these items. Analysis Kit: Item 7 (page 8) in the \\\"Analysis Kit\\\" are the items that are not provided with the kit and the Reseller is responsible to purchase these items. Components with an expiration date: [please insert]\", \"level\": 1, \"text\": \"EXHIBIT A THE PRODUCTS Each unit of Product consists of one Physician Kit and one Laboratory Kit. TM-B1 breast cancer screening test and TB-B2 breast cancer diagnostic test General Information: Physician Kit: Laboratory Kit: The Laboratory Kit consists of the Isolation Kit and the Analysis Kit. Isolation Kit: Item 7 (page 8) in the \\\"Isolation Kit\\\" are items that are not provided with the kit and the Reseller is responsible to purchase these items. Analysis Kit: Item 7 (page 8) in the \\\"Analysis Kit\\\" are the items that are not provided with the kit and the Reseller is responsible to purchase these items. Components with an expiration date: [please insert] 12 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"THE LABORATORY [please insert description of the laboratory and its components]\", \"level\": 1, \"text\": \"EXHIBIT B THE LABORATORY [please insert description of the laboratory and its components] 13 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}}, {\"id\": \"EXHIBIT C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMMERCIALIZATION TIMETABLE Milestone Target Date Todos to obtain AMAR approval Q3 2019 Reseller to set-up a diagnostic Laboratory (internal or external) that complies with the requirements in the TM-B2 Isolation Kit Instruction for Use. Q3 2019 Reseller to commence 30-50 Women Pilot Trial. Isolation at Reseller's lab, and FTIR analysis at Todos's facility. Q3 2019 Reseller to commence commercial sales. Q4 2019 Todos to provide kits and computer analysis of files. Q4 2019 14\", \"level\": 1, \"text\": \"EXHIBIT C COMMERCIALIZATION TIMETABLE Milestone Target Date Todos to obtain AMAR approval Q3 2019 Reseller to set-up a diagnostic Laboratory (internal or external) that complies with the requirements in the TM-B2 Isolation Kit Instruction for Use. Q3 2019 Reseller to commence 30-50 Women Pilot Trial. Isolation at Reseller's lab, and FTIR analysis at Todos's facility. Q3 2019 Reseller to commence commercial sales. Q4 2019 Todos to provide kits and computer analysis of files. Q4 2019 14 Source: TODOS MEDICAL LTD., 20-F, 3/28/2019\"}}, {\"id\": \"party:Todos Medical Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Todos Medical Ltd.\", \"role\": null, \"address\": null}}, {\"id\": \"party:Care G. B. Plus Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Care G. B. Plus Ltd.\", \"role\": \"Reseller\", \"address\": null}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"Each unit of Product consists of one Physician Kit and one Laboratory Kit.\", \"definition_clause\": \"EXHIBIT A\"}}, {\"id\": \"term:Laboratory Kit\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Laboratory Kit\", \"text\": \"The Laboratory Kit consists of the Isolation Kit and the Analysis Kit.\", \"definition_clause\": \"EXHIBIT A\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 2.6\", \"level\": 1, \"text\": \"Exhibit 2.6 FINAL VERSION FORM OF MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN PFIZER INC. AND UPJOHN INC. DATED AS OF [\u25cf] Source: UPJOHN INC, 10-12G, 1/21/2020 TABLE OF CONTENTS Page 1.\u2003\u202fDEFINITIONS 1\"}, {\"id\": \"2\", \"title\": \"SUPPLY OF PRODUCT 13\", \"level\": 1, \"text\": \"2.\u2003\u202fSUPPLY OF PRODUCT 13\"}, {\"id\": \"3\", \"title\": \"PRICE; PAYMENT; PRICE ADJUSTMENTS; TAXES 26\", \"level\": 1, \"text\": \"3.\u2003\u202fPRICE; PAYMENT; PRICE ADJUSTMENTS; TAXES 26\"}, {\"id\": \"4\", \"title\": \"MANUFACTURING STANDARDS AND QUALITY ASSURANCE 35\", \"level\": 1, \"text\": \"4.\u2003\u202fMANUFACTURING STANDARDS AND QUALITY ASSURANCE 35\"}, {\"id\": \"5\", \"title\": \"COVENANTS 43\", \"level\": 1, \"text\": \"5.\u2003\u202fCOVENANTS 43\"}, {\"id\": \"5.1\", \"title\": \"Mutual Covenants 43 5\", \"level\": 2, \"text\": \"5.1\u2003\u2002\u202fMutual Covenants 43 5.2\u2003\u2002\u202fManufacturer Covenants 44 5.3\u2003\u2002\u202fManufacturer's Social Responsibility 46 -ii- Source: UPJOHN INC, 10-12G, 1/21/2020 TABLE OF CONTENTS (continued) Page 5.4\u2003\u2002\u202fNotice of Material Events 46 5.5\u2003\u2002\u202fDisclaimer of Warranties 47\"}, {\"id\": \"6\", \"title\": \"ENVIRONMENTAL COVENANTS 47\", \"level\": 1, \"text\": \"6.\u2003\u202fENVIRONMENTAL COVENANTS 47\"}, {\"id\": \"7\", \"title\": \"TERM; TERMINATION 49\", \"level\": 1, \"text\": \"7.\u2003\u202fTERM; TERMINATION 49\"}, {\"id\": \"8\", \"title\": \"INTELLECTUAL PROPERTY 55\", \"level\": 1, \"text\": \"8.\u2003\u202fINTELLECTUAL PROPERTY 55\"}, {\"id\": \"8.1\", \"title\": \"Customer's Intellectual Property 55 8\", \"level\": 2, \"text\": \"8.1\u2003\u2002\u202fCustomer's Intellectual Property 55 8.2\u2003\u2002\u202fImprovements and Developments 55 8.3\u2003\u2002\u202fOwnership of Other Property 56 8.4\u2003\u2002\u202fLimited Right to Use 56\"}, {\"id\": \"9\", \"title\": \"JOINT ADVISORY COMMITTEE 56\", \"level\": 1, \"text\": \"9.\u2003\u202fJOINT ADVISORY COMMITTEE 56\"}, {\"id\": \"10\", \"title\": \"INDEMNIFICATION; LIMITATIONS OF LIABILITY 58\", \"level\": 1, \"text\": \"10.\u2002\u202fINDEMNIFICATION; LIMITATIONS OF LIABILITY 58 Source: UPJOHN INC, 10-12G, 1/21/2020 TABLE OF CONTENTS (continued) Page 11.\u2002\u202fINSURANCE 65\"}, {\"id\": \"11.1\", \"title\": \"Requirements to Maintain 65 11\", \"level\": 2, \"text\": \"11.1\u2003\u202fRequirements to Maintain 65 11.2\u2003\u202fAmounts and Limits 65\"}, {\"id\": \"12\", \"title\": \"CUSTOMER-SUPPLIED MATERIALS; BUY-SELL MATERIALS; TRANSITION 66\", \"level\": 1, \"text\": \"12.\u2002\u202fCUSTOMER-SUPPLIED MATERIALS; BUY-SELL MATERIALS; TRANSITION 66\"}, {\"id\": \"12.1\", \"title\": \"Supply; Rejection; Transition 66 12\", \"level\": 2, \"text\": \"12.1\u2003\u202fSupply; Rejection; Transition 66 12.2\u2003\u202fTitle and Risk of Loss 68 12.3\u2003\u202fReimbursement for Loss of Customer-Supplied Materials 68\"}, {\"id\": \"13\", \"title\": \"CONFIDENTIALITY 69\", \"level\": 1, \"text\": \"13.\u2002\u202fCONFIDENTIALITY 69\"}, {\"id\": \"14\", \"title\": \"SUPPLY CHAIN SECURITY 69\", \"level\": 1, \"text\": \"14.\u2002\u202fSUPPLY CHAIN SECURITY 69\"}, {\"id\": \"14.1\", \"title\": \"Supply Chain Representations 69 14\", \"level\": 2, \"text\": \"14.1\u2003\u202fSupply Chain Representations 69 14.2\u2003\u202fC-TPAT 69\"}, {\"id\": \"15\", \"title\": \"RECORDS AND AUDITS 70\", \"level\": 1, \"text\": \"15.\u2002\u202fRECORDS AND AUDITS 70\"}, {\"id\": \"15.1\", \"title\": \"Records 70 15\", \"level\": 2, \"text\": \"15.1\u2003\u202fRecords 70 15.2\u2003\u202fAudits 70\"}, {\"id\": \"16\", \"title\": \"NOTICES 71\", \"level\": 1, \"text\": \"16.\u2002\u202fNOTICES 71\"}, {\"id\": \"17\", \"title\": \"MISCELLANEOUS 71\", \"level\": 1, \"text\": \"17.\u2002\u202fMISCELLANEOUS 71 Source: UPJOHN INC, 10-12G, 1/21/2020 MANUFACTURING AND SUPPLY AGREEMENT THIS MANUFACTURING AND SUPPLY AGREEMENT (this \\\"Agreement\\\"), dated as of [\u25cf] (the \\\"Effective Date\\\"), is by and between Pfizer Inc., a Delaware corporation (hereinafter \\\"Manufacturer\\\"), and Upjohn Inc., a Delaware corporation (hereinafter \\\"Customer\\\"). Manufacturer and Customer may be referred to herein individually as a \\\"Party\\\" or collectively as the \\\"Parties\\\". W I T N E S S E T H: WHEREAS, Pfizer Inc. (\\\"Pluto\\\") and Upjohn Inc. (\\\"Spinco\\\") have entered into a Separation and Distribution Agreement, dated as of July 29, 2019 (as amended, modified or supplemented from time to time in accordance with its terms, the \\\"Separation Agreement\\\"), pursuant to which Pluto and Spinco have agreed to separate the Spinco Business from the Pluto Business so that, as of the Distribution Date, the Spinco Business shall be held by members of the Spinco Group and the Pluto Business is held by members of the Pluto Group (the \\\"Separation\\\"); WHEREAS, after the Separation, Spinco shall become a standalone publicly traded company, pursuant to the terms of the Separation Agreement and a Business Combination Agreement, dated as of July 29, 2019 (the \\\"Business Combination Agreement\\\"), by and among Pluto, Spinco, Mylan N.V., a public company with limited liability incorporated under the laws of the Netherlands, and certain of their Affiliates; and WHEREAS, in connection with the Separation, the Parties are entering into this Agreement, pursuant to which Customer desires to procure from Manufacturer, and Manufacturer desires to supply or cause one of its Affiliates to supply to Customer, Products for sale by Customer or its Affiliates in the Territory during the Term, upon the terms and subject to the conditions set forth herein. NOW, THEREFORE, in consideration of these premises and the covenants and agreements set forth herein, and intending to be legally bound thereby, the Parties hereby agree as follows: 1. Definitions. As used in this Agreement, the following capitalized terms shall have the meanings set forth below. Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to such terms in the Separation Agreement. 1.1 \\\"Accounting Method\\\" means U.S. Generally Accepted Accounting Principles (GAAP) or, if otherwise agreed by the Parties, an alternative accounting method used in the ordinary course of business. 1.2 \\\"Act\\\" means the U.S. Federal Food, Drug, and Cosmetic Act, as amended. 1.3 \\\"Action\\\" means any demand, action, claim, dispute, suit, countersuit, arbitration, inquiry, subpoena, proceeding or investigation of any nature (whether criminal, civil, legislative, administrative, regulatory, prosecutorial or otherwise) by or before any federal, state, local, foreign or international Governmental Authority or any arbitration or mediation tribunal. Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"1.112\", \"title\": \"\\\"Spinco\\\" shall have the meaning set forth in the Recitals\", \"level\": 2, \"text\": \"1.112 \\\"Spinco\\\" shall have the meaning set forth in the Recitals. 1.113 \\\"Standard Cost\\\" means, with respect to a given Product in a given Fiscal Year, an amount equal to: (a) the cost of Product Materials (including the cost of active ingredients, intermediates, semi-finished materials, excipients and primary and secondary packaging) associated with such Product (\\\"Standard Product Materials Cost\\\"); and (b) the Conversion Costs for such Product (\\\"Standard Conversion Cost\\\"), Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"2\", \"title\": \"Supply of Product\", \"level\": 1, \"text\": \"2. Supply of Product. 2.1 Agreement to Supply. (a) Affiliates and Facility Addenda. Either the entity designated above as Customer or any Affiliate of Customer and either the entity designated above as Manufacturer or any Affiliate of Manufacturer may enter into Facility Addenda under this Agreement. The entities that execute a Facility Addendum are also deemed to be \\\"Customer\\\" and \\\"Manufacturer\\\" (respectively) for all purposes of the Facility Addendum and this Agreement (with respect to the applicable Facility Addendum). (b) Supply Pursuant to Facility Addenda. During the Term of each Facility Addendum, Manufacturer shall manufacture and supply Product to Customer for the Territory applicable to such Product on the terms and subject to the conditions of this Agreement and the applicable Facility Addendum. The terms of this Agreement shall be incorporated by reference into each Facility Addendum that may be executed by the Parties or, as described in Section 2.1(a), their respective Affiliates. During the term of this Agreement, Customer may request that Manufacturer manufacture and supply to Customer clinical trial material, and the Parties shall negotiate in good faith the terms and conditions of such manufacturing and supply arrangement applying the terms and conditions of this Agreement to the extent mutually agreeable. (c) Hierarchy of Terms; Effect of Amendments. In the event of a conflict between the terms of any Facility Addendum and the terms of this Agreement, the terms of this Agreement shall govern and control, except to the extent that the applicable Facility Addendum expressly and specifically states an intent to supersede a specific section of this Agreement on a specific matter. Any amendment to the terms of this Agreement contained in a Facility Addendum shall be effective solely with respect to such Facility Addendum, and not with respect to this Agreement or any other Facility Addendum. Any amendment to the terms of this Agreement shall be effective with respect to all Facility Addenda. Except to the extent otherwise expressly stated in this Agreement, in the event of a conflict between the terms of this Agreement and the terms of the Separation Agreement, the terms of the Separation Agreement shall govern and control. (d) Use of Subcontractors. Subject to Section 2.2(a), Manufacturer shall manufacture and supply Product itself or through its Affiliates, in each case, at the applicable Facilities (and such other facilities as may be specified in the applicable Facility Addendum with respect to applicable Products). With respect to those Third-Party contractors, subcontractors or service providers used by Manufacturer or its Affiliates in the manufacturing or supply of a given Product immediately prior to the Effective Date, Manufacturer may engage such Third-Party contractors, subcontractors or -13- Source: UPJOHN INC, 10-12G, 1/21/2020 service providers to perform the same activities for such Product under this Agreement without first obtaining Customer's prior written consent. For the avoidance of doubt, the use of any Third-Party contractors, subcontractors or service providers other than in the manner expressly permitted pursuant to this Section 2.1(d) must be approved in advance in writing by Customer, such approval not to be unreasonably withheld, conditioned or delayed. Manufacturer shall be liable for all actions and omissions of its contractors, subcontractors and service providers, and any breach of the terms and conditions of this Agreement by such contractors, subcontractors or service providers shall be deemed a breach of the terms and conditions by Manufacturer under this Agreement. For the avoidance of doubt, as of the Effective Date, as between Manufacturer and Customer, Manufacturer will be solely responsible for maintaining and establishing relationships with the Third-Party contractors, subcontractors or service providers used in the manufacturing or supply of Product (other than the manufacturing or supply of Buy-Sell Materials or Customer-Supplied Materials). (e) Exclusivity. (i) Customer Exclusivity. During the Exclusivity Period, on a Product SKU-by-Product SKU and country-by-country basis within the applicable Territory, Customer shall purchase from Manufacturer, in accordance with the terms and conditions of this Agreement, at least the Exclusive Purchase Requirement of its requirements for such Product SKU in such country; provided, however, that In-Flight or Shared Volume Products shall be excluded from the exclusivity requirements set forth in this Section 2.1(e)(i). Following the Exclusivity Period (and during the Exclusivity Period, with respect to Product SKU quantities in excess of the Exclusive Purchase Requirement in accordance with the preceding sentence), nothing in this Agreement shall prevent Customer or any of its Affiliates from manufacturing Product for itself, or having Product manufactured by a Third Party, including in amounts in addition to the Purchase Orders for Product issued to Manufacturer in accordance with this Agreement. For clarity and notwithstanding anything contained herein, nothing in this Section 2.1(e)(i) (A) is intended to be inconsistent with Section 2.4(e)(i) or to otherwise indicate that Customer is subject to any requirement to purchase Product under this Agreement or (B) is intended to prevent Customer from qualifying a back-up supplier for any Product during the Exclusivity Period. -14- Source: UPJOHN INC, 10-12G, 1/21/2020 Subject to Section 2.2(b), Manufacturer shall devote adequate manufacturing capacity to be capable of manufacturing and supplying Product to Customer in accordance with the provisions of this Agreement and the Facility Addenda. Manufacturer shall promptly notify Customer if Manufacturer reasonably believes its existing capacity and demands thereon would prevent it from meeting Customer's anticipated Product requirements as set forth in any Forecast that conforms to the requirements set forth in Section 2.4. -15- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"2.4\", \"title\": \"Forecasts and Purchase Orders\", \"level\": 2, \"text\": \"2.4 Forecasts and Purchase Orders. (a) VMR Products Forecasting and Purchase Orders. With respect to the VMR Products, the processes and mechanisms by which Forecasts are prepared and Purchase Orders are issued shall be as set forth in the applicable Facility Addenda and the remainder of this Section 2.4 shall not apply with respect to such VMR Products as applicable. (b) Make to Order Product Forecasts. Except as otherwise set forth in a Facility Addendum, in each calendar month during the Term of a Facility Addendum, Customer shall provide to Manufacturer a rolling Product SKU-level forecast of its estimated requirements of Make to Order Products for the eighteen (18)-month period commencing with the month in which such forecast is provided (each, a \\\"Forecast\\\"). In the event Customer delivers a Forecast where the allocation of Product requirements over the time period of the Forecast are not consistent with historical trends, at Manufacturer's request, the Parties will meet to discuss the Forecast in good faith in the context of previous allocations of Product requirements. Such Forecasts represent Customer's reasonable estimates of the quantity of Products it will require during the applicable period covered by each such Forecast. Except as otherwise set forth in a Facility Addendum, each Forecast shall be a non-binding forecast and for informational purposes only, except that: (i) the portion of such Forecast covering the first three (3) calendar months reflected therein (the \\\"Binding Forecast Period\\\") shall be binding and shall constitute a firm order for the quantity of each Product specified therein (each, a \\\"Firm Order\\\"), (ii) each of months four (4) through six (6) of a given Forecast may not differ by more than twenty-five percent (25%) (whether positive or negative) from the quantity of such Product set forth in those months in the previous Forecast, and (iii) each of months seven (7) through twelve (12) of a given Forecast may not differ by more than fifty percent (50%) (whether positive or negative) from the quantity of such Product set forth in those months in the previous Forecast. For the avoidance of doubt, (1) this subsection (b) applies to Forecasts for API and Bulk Drug Product and (2) the Forecast with respect to Finished Product shall apply to the roll-up level of the Bulk Drug Product that is incorporated into the Finished Product. (c) Make to Order Purchase Orders. Manufacturer shall provide Product to Customer pursuant to Purchase Orders issued by Customer to Manufacturer, which Purchase Orders will be issued on a Product SKU-by-Product SKU basis, not to exceed one (1) Purchase Order per Product SKU per calendar month unless otherwise agreed between the Parties in advance in writing. No verbal communications or e-mail shall be construed to mean a commitment to purchase Product. Customer shall be required to order -16- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 place such Purchase Orders for such excess quantities in Increments above the Minimum Order Quantity as specified in the applicable Facility Addendum. As used herein, \\\"Batch Size\\\" means the production quantity for a given run of a Product SKU and \\\"Increments\\\" means the quantity step change above the applicable Minimum Order Quantity, in each case, as specified in the applicable Facility Addendum. (f) Acceptance and Rejection of Orders. Within ten (10) Business Days of receipt of a Purchase Order, Manufacturer may reject such Purchase Order by written notice to Customer only on the basis that it is inconsistent with the terms of this Agreement, including a Purchase Order containing (i) a delivery schedule that is inconsistent with Section 2.4(d), (ii) a Product quantity that is inconsistent with Section 2.4(e)(ii), (iii) a Product quantity that is less than the Firm Order for the applicable period or (iv) subject to Section 2.4(c), a Product quantity that is more than one hundred ten percent (110%) of the Forecast for the applicable period. Manufacturer shall be deemed to have accepted Customer's Purchase Order for Products in the event it either (a) indicates its acceptance of Customer's Purchase Order in writing or (b) does not indicate its rejection of a Purchase Order within ten (10) Business Days of receipt pursuant to this Section 2.4(f). (g) Changes to Purchase Orders. Purchase Orders, once submitted to Manufacturer, may be amended only by mutual written agreement of the Parties; provided that Manufacturer shall exercise its commercially reasonable efforts to comply with proposed amendments to Purchase Orders that Customer may request after sending a Purchase Order to Manufacturer. (h) Cancellations. In the event that Customer cancels all or part of a Purchase Order (provided that a cancellation shall be deemed to have occurred to the extent that Customer fails to issue a Purchase Order with respect to the full amount of Product contemplated by any portion of a Forecast with respect to the Binding Forecast Period) and such cancellation is not due to Manufacturer's breach of this Agreement or any Facility Addendum, Manufacturer will use good faith efforts to reallocate capacity and mitigate any resultant costs of such cancellation and, unless otherwise set forth with respect to the relevant cancelled Product under the applicable Facility Addendum, Customer will be charged for one hundred percent (100%) of any and all non-cancellable Third-Party costs actually and reasonably incurred by Manufacturer in accordance with this Agreement prior to cancellation for materials or services related to the cancelled portion of the Purchase Order for which reasonably acceptable documentation is submitted by Manufacturer to Customer. -18- Source: UPJOHN INC, 10-12G, 1/21/2020 (i) Conflicts. In the event of any conflict between the provisions of this Agreement and any Customer Purchase Order, Manufacturer's acceptance form or Manufacturer's invoice form or any similar such forms, the provisions of this Agreement shall govern and control. (j) Product Inventory as of Effective Date. Promptly following the Effective Date, Manufacturer shall provide Customer with a Product inventory report organized by Facility, lot number, remaining shelf life, and such other data points with respect to such Product inventory as Customer may request. For the avoidance of doubt, (i) Manufacturer shall be entitled to fill Purchase Orders with such inventory that complies with the terms and conditions of this Agreement, including Section 5.2, and (ii) the Parties shall meet to discuss in good faith the disposition of all such Product inventory that does not meet the criteria set forth in (i) above. 2.5 Failure to Supply. (a) Capacity Allocation. In the event that Manufacturer fails to manufacture and deliver Product in accordance with accepted Purchase Orders or applicable Specifications, Manufacturer shall notify Customer promptly, including details of the reasons for the failure and Manufacturer's estimated timeline of when the failure will be corrected. Manufacturer shall be solely responsible for undertaking commercially reasonable measures to minimize any shortage of Product delivered to Customer as a result of such manufacturing issues. If Manufacturer fails to manufacture and deliver Product in accordance with accepted Purchase Orders or applicable Specifications by the delivery date specified in the applicable Purchase Order(s) in accordance with Section 2.4(d), other than due to a Force Majeure Event, (i) for a period of two (2) or more months past such delivery date four (4) or more times in any rolling twelve (12) month period, or (ii) for a period of four (4) or more months past such delivery date on one occasion (each of (i) and (ii), a \\\"Triggering Event\\\"), then Manufacturer shall use its best efforts to allocate on a quarterly basis its manufacturing capacity and Product Materials to the manufacture and supply of Products for Customer on a ratable basis based on the use of each during the twelve (12)-month period immediately preceding such Triggering Event (or either (1) the Term of the applicable Facility Addendum, if the Term is less than twelve (12) months, or (2) such other period set forth in the applicable Facility Addendum); provided that (A) if Customer's Minimum Order Quantity for the applicable Product(s) exceeds its ratable allocation of manufacturing capacity or Product Materials (as applicable) for the applicable quarter, Customer shall continue to accrue its allocation of capacity until such quarter when Customer's allocation of capacity is equal to or greater than its accrued allocation of capacity and (B) this Section 2.5(a) shall not apply to the extent that Customer fails to timely provide adequate Customer-Supplied Materials or Buy-Sell Materials to Manufacturer in accordance with Section 12. For the avoidance of doubt, Manufacturer shall notify Customer promptly in writing of any anticipated Triggering Event when Manufacturer has reason to believe that such Triggering Event is likely to occur and provide such information with respect to such anticipated Triggering Event as Customer may reasonably request. -19- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) Suspension of the Exclusive Purchase Requirement. In the event of a Triggering Event, Customer's Exclusive Purchase Requirement with respect to each and every Product that is the subject of the Triggering Event shall be temporarily suspended until such time as Manufacturer notifies Customer that Manufacturer is able to resume the manufacture and supply of the subject Product(s) on the terms and conditions of this Agreement (such period referred to as the \\\"Exclusive Purchase Requirement Suspension Period\\\"); provided that, (i) during such Exclusive Purchase Requirement Suspension Period, Customer shall use commercially reasonable efforts to limit its orders for the subject Product(s) to the quantities specified in the last Forecast that preceded the Triggering Event for the applicable period(s) and promptly notify Manufacturer in the event and to the extent that Customer's orders exceed such quantities specified in such Forecast and (ii) Customer shall be entitled to take delivery of Product(s) ordered during the Exclusive Purchase Requirement Suspension Period even if such delivery is scheduled for or actually occurs subsequent to the Exclusive Purchase Requirement Suspension Period. (c) Modification of the Exclusive Purchase Requirement. Upon the expiration of the Exclusive Purchase Requirement Suspension Period, Customer shall use commercially reasonable efforts to resume ordering from Manufacturer, on a Product-by-Product basis, the subject Product(s) in accordance with Customer's Exclusive Purchase Requirement during the Exclusivity Period. (d) Business Continuity. Manufacturer shall maintain a written business continuity plan to be able to assure supply of Product to Customer in the event of a disruption to supply from the primary location or Facility of manufacture, including any disruption resulting from a Force Majeure Event and make such plan available from time to time upon Customer's request. (e) Remedies. Customer shall have the right to terminate this Agreement on an affected Product-by-affected Product basis immediately upon written notice to Manufacturer in the event a Triggering Event (under clause (ii) thereof) continues for more than one hundred and eighty (180) days. Customer shall also have the right to cancel orders for any quantities of Product affected by any Triggering Event effective upon notice to Manufacturer, and Customer shall have no further obligations to purchase any such cancelled quantities of Product. In the event a Triggering Event occurs during the Exclusivity Period, Manufacturer shall, at Manufacturer's cost and expense, provide such assistance as is reasonably requested by Customer to assist any alternate manufacturer in meeting Customer's requirements for the Product until Manufacturer has remedied the cause of such Triggering Event and is -20- Source: UPJOHN INC, 10-12G, 1/21/2020 able to supply Product to Customer in its requested quantities. Such assistance shall include providing, subject in all cases to Section 2.10(h), Technical Support in respect of the affected Product(s). In the event of a Triggering Event, Manufacturer shall be liable for any actual amounts that Customer is contractually required to pay to any Third-Party customer of Customer that result from Customer's inability to supply the affected Product to such Third-Party customer as a direct result of such Triggering Event; provided that (1) Customer shall provide to Manufacturer appropriate evidence of such amounts (including invoices from the applicable customers) and the applicable contractual requirements (redacted, in each case, of information pertaining to pricing and other commercial terms that are not directly related to the claimed amounts), it being understood and agreed that, upon request, Manufacturer will enter into customary confidentiality arrangements prior to such information being shared and (2) Manufacturer shall not be liable for any such amounts in the aggregate in any Fiscal Year in excess of the aggregate Conversion Cost Markup during such Fiscal Year with respect to all Products manufactured at the Facility that is the subject of the applicable Triggering Event. \\\"Conversion Cost Markup\\\" means, for a Product for any Fiscal Year, ten percent (10%) of the product of (A) Manufacturer's Standard Conversion Cost for such Product for such Fiscal Year and (B) the quantity of such Product ordered by Customer for delivery during such Fiscal Year. The rights of Customer set forth in this paragraph are in addition to any other rights set forth in this Agreement. 2.6 Delivery; Risk of Loss. (a) Delivery. Unless otherwise set forth in the applicable Facility Addendum, Manufacturer shall deliver Product to Customer FCA (Incoterms 2010) at the applicable Facility, and all Purchase Orders will be deemed to have been completed when the quantity of Product made available to Customer at the applicable Facility is between ninety percent (90%) and one hundred and ten percent (110%) of the quantity of Product set forth in any accepted Purchase Order (each such event, a \\\"Delivery\\\"). Delivery shall occur by or within the delivery date(s) set forth in the applicable Purchase Order or such other date as may be agreed to in writing by the Parties from time to time. Without limiting Customer's rights and remedies under Section 4.8, Manufacturer acknowledges and agrees that, unless such early Delivery was agreed upon by the Parties in writing, Manufacturer shall provide Customer with such data as Customer may reasonably request from time to time for measures of key performance indicators (KPI). (b) Certificates of Compliance. Manufacturer shall include certificates of compliance and certificates of analysis with all Delivery of Product or prior to Delivery upon reasonable request of Customer. -21- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Title. Unless otherwise set forth in the applicable Facility Addendum, title to Product and risk of loss or damage shall pass to Customer upon Delivery to Customer pursuant to Section 2.6(a). 2.7 Procurement of Materials. (a) Manufacturer shall order and maintain sufficient quantities of all Product Materials, including safety stock as required by the applicable Facility Addendum, to enable Manufacturer to manufacture and Deliver Product in accordance with its Delivery obligations under this Agreement and the applicable Facility Addendum. With respect to those Third Party suppliers of Product Materials used by Manufacturer or its Affiliates in the ordinary course in the manufacturing or supply of a given Product immediately prior to the Effective Date (\\\"Manufacturer Third Party Suppliers\\\"), Manufacturer shall be permitted to purchase solely the same Product Materials from such Manufacturer Third Party Suppliers in connection with its activities under this Agreement without first obtaining Customer's prior written consent. Any other Third-Party supplier for Product Materials (or procurement of a different Product Material from any Third-Party supplier) must be approved in advance in writing by Customer (such approval not to be unreasonably withheld, conditioned or delayed). For the avoidance of doubt, as of the Effective Date, as between Manufacturer and Customer, Manufacturer will be solely responsible for maintaining and establishing relationships with the Third-Party suppliers of Product Materials. The costs of all such Product Materials shall be included in the Price of the applicable Product. (b) Unless otherwise set forth in the applicable Facility Addendum for a specific Product, Customer shall have no liability for excess or obsolete Product Materials purchased by Manufacturer, (x) except as set forth in Section 2.4(h) or Section 7.9 or (y) unless the excess or obsolescence is caused by a change to the specifications for such Product Materials or the Specifications of a given Product in accordance with this Agreement after such Product Materials have been purchased by Manufacturer based upon a Firm Order or accepted Purchase Order). (c) Customer understands and acknowledges that (i) certain Product Materials have a limited shelf-life, are long lead time items, and are subject to minimum order quantities specified by the applicable supplier and (ii) Manufacturer will rely on the Firm Orders and Forecasts to order Product Materials required to meet the Firm Orders (plus safety stock for certain Product Materials of a Product as reasonably determined by Manufacturer). In addition, Customer understands that, to ensure an orderly supply of the Product Materials, Manufacturer may elect to purchase the Product Materials in sufficient volumes to meet the production requirements for Products during part or all of the forecasted periods; provided, however, that Customer shall not have any liability with respect to any purchase by Manufacturer or any of its Affiliates of labeling or packaging materials (including labels, cartons and leaflets) in excess of the amount required to meet the Firm Order applicable at such time plus the amount of applicable Product forecasted to be ordered in months four (4) through six (6) of the Forecast applicable at such time. -22- Source: UPJOHN INC, 10-12G, 1/21/2020 (d) Manufacturer must review with Customer any assessment made (or related action proposed to be taken) by Manufacturer related to rejection or destruction of any Customer-Supplied Materials, Buy-Sell Materials, Product, or Product Materials intended for Customer's Product to discuss viability for commercial use. 2.8 Product Samples. If representative lot samples of production batches of Product are requested by Customer in order to satisfy its obligations under applicable Law, including any regulatory requirements, or to any Governmental Authority, then Manufacturer shall provide Customer (or any such Third Party as Customer shall designate) with representative lot samples of each production batch of Product promptly upon Customer's request. Customer shall be entitled to review, upon reasonable prior written notice, all manufacturing Records relating to such samples, including all analytical procedures and cleaning validation relating to the equipment used in connection with the manufacture of the samples. Such Product samples shall be Delivered to Customer (or such Third Party as Customer shall designate) in accordance with the provisions set forth in Section 2.6(a) and at the Price as determined in accordance with the terms of Section 3. Customer shall pay for such samples when invoiced in accordance with Section 3.5. 2.9 Storage. Manufacturer will store Products, Buy-Sell Materials, Product Materials, and Customer-Supplied Materials in accordance with the requirements of the Quality Agreement. With respect to those Third-Party warehouses used by Manufacturer or its Affiliates in the ordinary course for the storage of a given Product, Buy-Sell Materials, Product Materials, or Customer-Supplied Materials immediately prior to the Effective Date, Manufacturer may engage such Third-Party warehouse to perform the solely same activities for such Product, Buy- Sell Materials, Product Materials, and Customer-Supplied Materials under this Agreement without first obtaining Customer's prior written consent. The use of any Third Party warehouse for the storage of any Product, Buy-Sell Materials, Product Materials, or Customer- Supplied Materials other than in the manner expressly permitted pursuant to this Section 2.9 must be approved in advance in writing by Customer, such approval not to be unreasonably withheld, conditioned or delayed. Manufacturer shall obtain the right for Customer to audit, at Customer's expense, any such Third-Party warehouse upon reasonable prior advance written notice and during normal business hours. Manufacturer has no obligation to store Product more than fifteen (15) Business Days following the requested delivery date for such Product; provided that (a) Manufacturer shall be obligated to store Product for such longer -23- Source: UPJOHN INC, 10-12G, 1/21/2020 period as may be reasonably necessary for Customer to arrange transportation for such Product in the event that Manufacturer experiences delays in the manufacture, release, or supply of a particular Product that results in the delivery of a quantity of Product that exceeds historical or Forecast quantities of Product for the applicable period and; (b) with respect to any Product that Customer reasonably believes should not be released by Manufacturer, Manufacturer shall store such Product until the Parties' definitive resolution pursuant to this Agreement and the Quality Agreement as to whether such Product should be released. At the expiration of the applicable time frame in the preceding sentence, notwithstanding any provision of this Section 2.9 to the contrary, Manufacturer may transport and store the subject Product at a Third-Party warehouse at Customer's expense. 2.10 Transitional Support. (a) On a Product-by-Product basis, Customer may elect, upon written notice to Manufacturer, for Manufacturer to provide Customer with reasonable technical support, as more fully set forth in this Section 2.10, to transfer production of a given Product or Products to a Customer facility or a facility of an alternative source of supply as designated by Customer (such support, \\\"Technical Support\\\" and such facility, the \\\"Receiving Site\\\"). Customer may make such election for Technical Support at any time during the Term (including in the event of a Triggering Event under Section 2.5(a) or in advance of any expiration of this Agreement) or promptly after the termination or expiration of this Agreement but in no event more than ninety (90) days following the effective date of such termination or expiration. Such reasonable Technical Support shall consist of: (i) supply of a technical package to facilitate the transfer of all relevant manufacturing information for such Product(s) to the Receiving Site, including formulation descriptions, manufacturing instructions, Specifications, methods, data required for applicable regulatory submissions and facility qualification, and material supplier information, as applicable, except for any information that is subject to confidentiality obligations owing to a Third Party; provided that the technical package will not include any manufacturing information, including formulation descriptions, manufacturing instructions, Specifications, methods and material supplier information, that is generally available to or known by the public, can be obtained on reasonable terms from Third Parties or is already available or being utilized by Customer or its Affiliate at one of Customer's or its Affiliate's facilities; (ii) host site visits to the Manufacturer's Facility by Customer to observe production of the applicable Product or Products, in each case, at a mutually agreed date and subject to confidentiality procedures or requirements as may be requested or implemented by Manufacturer; provided that the request for each such visit shall be made so as to allow for sufficient advance preparation time and can be accommodated in the requested timeframe without interruption to Manufacturer's routine production or operations; -24- Source: UPJOHN INC, 10-12G, 1/21/2020 (iii) performance of high-level consultation and answering reasonable queries for Customer through the transfer process; and (iv) provision of reasonable Product samples required under applicable Law for transfer activities. (b) Customer shall be responsible for identifying and requesting any and all Technical Support that is required from Manufacturer to assure such technology transfer is successful. (c) The Parties shall reasonably cooperate and mutually agree to facilitate the provision of any additional reasonable Technical Support with respect to the applicable Product or Products to Customer, including assistance through the transfer process, Manufacturer Personnel visits to the Receiving Site and training and troubleshooting during the Receiving Site's first production run of the applicable Product or Products, in each case, as and to the extent reasonably agreed by Manufacturer in each instance (and subject to Sections 2.10(d), 2.10(e) and 2.10(f)). (d) The Parties will work together in good faith to plan for upcoming and ongoing Technical Support needs and to accommodate such plans in order to maintain ongoing business continuity. In addition, Manufacturer shall have no obligation to hire or retain any individuals or make any capital expenditures in connection with Technical Support, and Manufacturer's obligation to provide Technical Support is contingent upon the continued employment by Manufacturer of those individuals capable of providing such Technical Support. Manufacturer may terminate its obligation to provide any Technical Support with respect to the applicable Product under this Agreement if Customer or any of its Affiliates hires any Manufacturer Personnel involved in providing Technical Support to Customer hereunder (without limiting any applicable non-solicitation obligations of Customer pursuant to the Business Combination Agreement). (e) Customer shall be solely responsible for any and all regulatory or other Governmental Authority requirements, activities and related costs and expenses that arise in conjunction with any Technical Support, technology transfer of production or production of each Product to or at the Receiving Site. These activities may also include, but are not limited to, creation of additional data or technical information, analytical method modifications or other work of a technical nature required to support regulatory queries or contemporary standards and guidelines driven by the manufacturing transfer (subject to Section 8.2). -25- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Subject to the limitations and conditions set forth in this Agreement, it is the intention of the Parties that the Price of each Product reflects one hundred percent (100%) of Manufacturer's Standard Product Materials Cost plus one hundred and ten percent (110%) of Manufacturer's Standard Conversion Cost of such Product. The Price for each Product will be set forth in the currency specified in the applicable Facility Addendum. (d) Changes to the Standard Cost Methodology. Manufacturer shall have the right to change the Standard Cost methodology once per Fiscal Year; provided that any change shall be consistent with the Accounting Method and applied across all products manufactured at the applicable Facility. If Manufacturer elects to change the Standard Cost methodology, Manufacturer shall calculate both (i) the revised Standard Cost using the methodology effective during the then-current Fiscal Year of the Term of the applicable Facility Addendum and (ii) the percentage change in Standard Cost caused by the change in methodology relative to the former methodology. If such Standard Cost methodology change results in an increase of Facility Conversion Cost for Products manufactured for Customer of more than two percent (2%), then Manufacturer shall revert to the former methodology for purposes of the calculation of Price during such Fiscal Year. 3.2 Price Adjustment. (a) Product Materials Adjustment. (i) On a Facility-by-Facility basis, with respect to each full Fiscal Year of the Term of the applicable Facility Addendum, the Price of each Product manufactured at the applicable Facility will be updated to reflect one hundred percent (100%) of the full estimated amount of the increase or decrease in the cost of Product Materials for each such Product. (ii) In each Fiscal Year of the Term of this Agreement, Manufacturer shall submit a report to Customer by no later than the end of the first quarter of such Fiscal Year setting out the Facility Actual Product Materials Cost with respect to each Facility for the prior Fiscal Year. In the event that the Facility Actual Product Materials Cost differs from the Facility Estimated Product Materials Cost, when adjusted to reflect actual volume, then Manufacturer shall issue either (A) an invoice to Customer for any amounts owed by Customer to Manufacturer or (B) a credit memo for amounts owed by Manufacturer to Customer reflecting the difference between the Price as invoiced and an adjusted Price for such Fiscal Year; -27- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 than eighty percent (80%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year or (b) greater than one hundred and twenty percent (120%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year, then the Price for such Product will be updated beginning with such Facility Conversion Cost Adjustment Fiscal Year to reflect the full estimated amount of the increase or decrease in Conversion Cost. (iii) Notwithstanding anything to the contrary in this Section 3.2(b), Manufacturer shall not have the ability to adjust the Price to reflect actual volume for Products in a Facility to the extent that Customer has reduced its demand for one or more Products in such Facility due to Manufacturer's breach of or other failure to supply under this Agreement or the applicable Facility Addendum. (iv) In each Fiscal Year following the first full Fiscal Year of the Term of this Agreement, Manufacturer shall submit a report to Customer by no later than the end of the first quarter of such Fiscal Year setting out the actual volume of Product for each Facility for the prior Fiscal Year. In the event that the actual Facility Conversion Costs demonstrate that the then applicable Facility Conversion Cost Threshold has been exceeded, and Manufacturer had not previously adjusted the applicable Price in accordance with this Section 3.2(b) to account for such adjustment, then Manufacturer shall either issue (A) an invoice to Customer for any amounts owed by Customer to Manufacturer or (B) a credit memo for amounts owed by Manufacturer to Customer reflecting the difference between the Price as invoiced and the adjusted Price for such Fiscal Year; provided, however, that any such adjustment made in accordance with the foregoing shall be subject in all cases to the provisions of Section 3.2(b)(iii). For clarity, any amount owed by Customer to Manufacturer or owed by Manufacturer to Customer shall be one hundred and ten percent (110%) of Manufacturer's Conversion Cost, reduced by a 20% allowance for variable costs. Customer shall pay all undisputed amounts due in the currency specified in the applicable Facility Addendum within sixty (60) calendar days from the date of the invoice. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall notify Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice shall not result in a waiver of any of Customer's rights under this Agreement. (c) Notwithstanding the above, the price for Buy-Sell Materials will be updated annually in each year following the first Fiscal Year to reflect one hundred percent (100%) of the full estimated amount of the cost of Buy-Sell Materials to Manufacturer. Customer may not change the price of Buy-Sell -29- Source: UPJOHN INC, 10-12G, 1/21/2020 materials during any Fiscal Year. Upon any notification by Customer to Manufacturer of any reduction in the price of Buy-Sell Materials for the upcoming Fiscal Year, Manufacturer shall submit to Customer an inventory of such Buy-Sell Materials on hand and a calculation of the positive difference between the aggregate price for such Buy-Sell Materials applying the price for the current Fiscal Year and the aggregate price for such Buy-Sell Materials applying the price for the upcoming Fiscal Year. Customer shall promptly and in no event later than sixty (60) days issue to Manufacturer a credit memo in the amount of such positive difference reflected in Manufacturer's notice. (d) The increases or decreases described in this Section 3.2 shall be determined by Manufacturer in a manner consistent with the accounting methodologies used by Manufacturer as of the Effective Date and shall be based on the applicable Forecasts provided by Customer in July of the applicable Fiscal Year and applied consistently across Manufacturer's entire manufacturing operations for the full Facility. (e) Manufacturer shall notify Customer of any estimated expected changes to Prices for the upcoming Fiscal Year by no later than June 1 of the then-current Fiscal Year and shall notify Customer of any actual changes to Prices for the upcoming Fiscal Year by no later than October 30 of the then-current Fiscal Year. Between June 1 and October 30, the Parties will engage in ongoing discussions to ensure that any final changes to Prices for the applicable Fiscal Year conform to the terms and conditions of this Agreement. Manufacturer will promptly respond to Customer's inquiries regarding any proposed changes to the Price of Products and provide reasonable documentation to Customer supporting the estimated or actual change in such Prices. Any actual, adjusted Price of each Product shall become effective on the first day of the first month of such upcoming Fiscal Year. (f) Any disputes relating to changes in Price for a given Product will be resolved pursuant to Section 3.4. 3.3 Cost Improvement. At Customer's reasonable request, Manufacturer and Customer agree to discuss in good faith the implementation of possible cost reduction opportunities with the objective to reduce the net Price of Product. Without limiting the generality of the foregoing, Manufacturer shall use commercially reasonable efforts to reduce the price of Product Materials. -30- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"3.4\", \"title\": \"Price Review and Audit Procedure\", \"level\": 2, \"text\": \"3.4 Price Review and Audit Procedure. (a) Manufacturer shall maintain complete and accurate Records that fairly reflect the relevant costs and calculations used to determine the Price of each Product and shall retain such Records for a period of not less than three (3) years after the applicable Product was manufactured and delivered hereunder. With respect to a Price change under Section 3.2 for any Product in an upcoming Fiscal Year, if Customer requests such a review in writing within thirty (30) days following notice to Customer of such change, then: (i) the Parties shall reasonably discuss and attempt to resolve any disagreement with respect thereto and (ii) if such disagreement is not resolved within thirty (30) days following commencement of such discussions, Customer shall have the right, no more than one (1) time per Fiscal Year each for the subject of (1) and (2) below and on no less than thirty (30) days' notice to Manufacturer, to appoint a reputable and internationally recognized independent Third-Party audit firm reasonably acceptable to Manufacturer (and which agrees to be bound by Manufacturer's customary confidentiality agreement) to audit such relevant Records, during normal business hours and on a confidential basis, to verify that, either (1) the change in the relevant Products' Price for an applicable Facility for the upcoming Fiscal Year, as applicable, or (2) the true-up determination with respect to (x) the estimated and actual Facility Conversion Costs of a Facility with respect to any Fiscal Year or (y) the Facility Estimated Product Materials Cost and the Facility Actual Product Materials Cost with respect to any Fiscal Year, was accurately and equitably calculated by Manufacturer in accordance with this Agreement; provided that Customer shall be deemed to have waived its right for such a review if Customer does not make such request within thirty (30) days following delivery of Manufacturer's notice to Customer of such increase. For the avoidance of doubt, any such audit initiated by Customer in accordance with clause (ii) above shall include in the scope of audit all of the Products manufactured at the applicable Facility, and not be limited in scope to the discrete Product(s) in question. Subject to Section 3.4(b)(2), Customer shall bear all costs and expenses of conducting such an audit, and such accounting firm shall work on an hourly or flat fee basis without a contingency fee or other performance or bonus fee. Such accounting firm shall, as promptly as practicable, provide in writing (I) a detailed report of such audit to Manufacturer and (II) a separate report limited to the Price for the subject Products in the relevant Fiscal Year as calculated by such accounting firm in accordance with this Agreement to Manufacturer and Customer. The Price for the Products during a Fiscal Year, as calculated by such accounting firm, absent any manifest error, shall be binding upon the Parties with respect to such increase or required payment, as applicable; provided that, within fifteen (15) days of receipt of the audit report, Manufacturer shall have the right to dispute such Price or calculation thereof by submitting written notice to Customer and the accounting firm accompanied by information supporting Manufacturer's position. Within thirty (30) days of receipt of Manufacturer's notice of dispute, the accounting firm shall issue its final findings with respect to the Price for the relevant Product in the relevant Fiscal Year and such decision, absent manifest error, shall be binding upon the Parties. -31- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) If, as a result of any audit by Customer pursuant to Section 3.4(a), the aggregate Price calculated by the accounting firm with respect to all Products manufactured at the applicable Facility for a Fiscal Year is: (i) less than ninety-five percent (95%) of the aggregate Price for all such Products established by Manufacturer pursuant to Section 3.2 for such Products during such Fiscal Year, then, if Customer has made payments to Manufacturer for such Products at the higher Price established by Manufacturer during such Fiscal Year, Manufacturer shall refund to Customer the overpayment made by Customer; or (ii) more than one hundred and five percent (105%) of the aggregate Price for all such Products established by Manufacturer pursuant to Section 3.2 for such Products during such Fiscal Year, then, if Customer has made payments to Manufacturer for such Products at the lower Price established by Manufacturer for such period, Customer shall promptly pay Manufacturer for the amount of the underpayment that should have been paid by Customer; in each case of clauses (i) and (ii), (1) such payment to be made within sixty (60) days of the owing Party's receipt of the relevant detailed report and final Price pursuant to Section 3.4(a) and (2) Manufacturer shall be responsible for payment of the applicable accounting firm's reasonable and actual fees in connection with such audit. 3.5 Invoices and Payment. Manufacturer shall submit invoices to Customer upon Delivery of Product. All invoices for Products will be in functional currency unless otherwise specified in the applicable Facility Addendum, and all undisputed payments hereunder shall be in full and be made without any withholding, offset or any other deductions. Manufacturer shall include the following information on all invoices: (a) the applicable Purchase Order number and billing address; (b) the quantity of Product delivered (and where applicable, the type, description or part number, if any); (c) the required delivery date specified in the applicable Purchase Order; (d) the actual date of Delivery; (e) the Price; (f) any applicable Taxes, transportation charges or other charges provided for in the applicable Purchase Order; (g) the applicable invoice number; and (h) the Delivery Facility, unless otherwise specified in the Facility Addendum. Subject to Customer's rights under Section 4.8 to reject Non-Complying Product or Product that is not otherwise Delivered in accordance with the terms of and conditions of this Agreement, Manufacturer shall invoice Customer for Product upon Delivery of the applicable Product in accordance with Section 2.6(a). Customer shall be obligated to pay only for actual quantities of -32- Source: UPJOHN INC, 10-12G, 1/21/2020 Product delivered. Unless otherwise set forth in the applicable Facility Addendum with respect to a particular Product or Products, Customer shall pay all undisputed amounts due in the currency specified in the applicable Facility Addendum within sixty (60) calendar days from the date of the invoice. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall notify Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice shall not result in a waiver of any of Customer's rights under this Agreement. If any payment required to be made under this Agreement is not made within twenty (20) days of the applicable date when such payment is due (the \\\"Late Payment Date\\\"), interest shall accrue on such past due amount from the Late Payment Date until the date payment is actually made at a quarterly rate equal to the lesser of (i) the Three-Month U.S. dollar LIBOR (Reuters Page LIBOR01) on the Late Payment Date (or the next Business Day if such Late Payment Date is not a Business Day), and (ii) the maximum rate permitted by applicable Law. Time for any payments hereunder shall be of the essence. 3.6 Taxes. (a) All sums payable under this Agreement are exclusive of any amount in respect of VAT. If any action of one Party (the \\\"Supplier\\\") under this Agreement constitutes, for VAT purposes, the making of a supply to another Party (or a member of that Party's Group) (the \\\"Recipient\\\") and VAT is or becomes chargeable on that supply, the Recipient shall pay to the Supplier, in addition to any amounts otherwise payable under this Agreement by the Recipient, a sum equal to the amount of the VAT chargeable on that supply against delivery to the Recipient of a valid VAT invoice issued in accordance with the laws and regulations of the applicable jurisdiction. (b) Without duplication of amounts covered by Section 3.6(a), Customer (or the applicable Affiliate) shall be responsible for all VAT, sales, goods and services, use, gross receipts, transfer, consumption and other similar Taxes (excluding, for clarity, Taxes imposed on net income, profits and gains and franchise Taxes), together with interest, penalties and additions thereto (\\\"Service Taxes\\\"), imposed by applicable taxing authorities on the direct sale of Products to Customer or any of its Affiliates or any payment hereunder; provided that such Service Taxes are shown on a valid invoice. If Manufacturer or any of its Affiliates is required to pay any part of such Service Taxes, Manufacturer shall provide Customer with evidence that such Service Taxes have been paid, and Customer (or its applicable Affiliate) shall reimburse Manufacturer for such Service Taxes. Manufacturer shall, upon the reasonable request of Customer, promptly revise any invoice to the extent such invoice was erroneously itemized or categorized. Each Party shall, and shall cause its Affiliates to, use commercially reasonable efforts to (i) minimize the amount of any Service Taxes imposed on the provision of Services hereunder, including by availing itself of any available exemptions from or reductions to any such -33- Source: UPJOHN INC, 10-12G, 1/21/2020 Service Taxes, and (ii) cooperate with the other Party in providing any information or documentation that may be reasonably necessary to minimize such Service Taxes or obtain such exemptions or reductions. If at any time Manufacturer (or any of its Affiliates) receives a refund (or credit or offset in lieu of a refund) of any Service Taxes borne by Customer (or any of its Affiliates), then Manufacturer or its Affiliate receiving such refund or utilizing such credit or offset shall promptly pay over the amount of such refund, credit or offset (net of all reasonable related out-of-pocket costs, expenses and Taxes incurred in respect thereof) to Customer or its applicable Affiliate, it being understood that Customer and its applicable Affiliate shall be liable for (x) any subsequent disallowance of such refund, credit or offset and any related interest, penalties or additions thereto and (y) any reasonable out-of- pocket costs and expenses related to such disallowance. (c) The Parties and their Affiliates shall reasonably cooperate to determine whether any Tax withholding applies to any amounts paid under this Agreement and, if so, shall further reasonably cooperate in (i) minimizing the amount of any such withholding Taxes, including by availing itself of any available exemptions from or reductions to any such withholding Taxes, (ii) providing any information or documentation that may be reasonably necessary to minimize such withholding Taxes or obtain such exemptions (including, without limitation, pursuant to any applicable double taxation or similar treaty) or (iii) receiving a refund of such withholding Taxes or claiming a Tax credit therefor. If any such withholding is required by applicable Law, the paying Party (or its applicable Affiliate) shall properly and timely withhold and remit such Taxes to the applicable taxing authority and use reasonable efforts to provide the other Party with a copy of any receipt (where it is common practice for the applicable taxing authority to provide such a receipt) or other documentation confirming such payment, and such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the receiving Party (or its applicable Affiliate). The paying Party (or its applicable Affiliate) shall not be required to \\\"gross up\\\" any amounts invoiced to the paying Party to account for, or otherwise compensate the receiving Party (or its applicable Affiliate) for, any Taxes that are required to be withheld under applicable Law. (d) Where a Party or any member of its Group is required by this Agreement to reimburse or indemnify the other Party or any member of its Group for any cost or expense, the reimbursing or indemnifying Party (or the applicable member of its Group) shall reimburse or indemnify the other Party (or the applicable member of its Group) for the full amount of the cost or expense, inclusive of any amounts in respect of VAT imposed on that amount to the extent properly reflected on a valid invoice, except to the extent that the reimbursed or indemnified Party reasonably determines that it (or such member of its Group), or a member of the same group as it (or such member of its Group) for VAT purposes, is entitled to credit for or repayment of that VAT from any relevant taxing authority. -34- Source: UPJOHN INC, 10-12G, 1/21/2020 (e) For purposes of this Agreement, and except as otherwise specifically provided in this Agreement, Tax matters shall be exclusively governed by the Tax Matters Agreement, and in the event of any inconsistency between the Tax Matters Agreement and this Agreement with respect to Tax matters, the Tax Matters Agreement shall control. 3.7 No Duplicative Payments. Notwithstanding anything to the contrary in this Agreement, no Party (or Affiliate thereof) shall enjoy a duplicative right, entitlement, obligation, or recovery with respect to any matter arising out of the same facts and circumstances. 4. Manufacturing Standards and Quality Assurance. 4.1 Quality Agreement. On a Facility-by-Facility and Product-by-Product basis, the Parties will comply with the requirements and provisions set forth in the Quality Agreement applicable to the applicable Facility and Product, the form of which has been attached hereto as Attachment B and, through such attachment, made a part hereof. In the event of a conflict between the terms of the applicable Quality Agreement and the terms of this Agreement, the terms of the Quality Agreement shall govern and control for all quality and regulatory compliance matters and the terms of this Agreement shall govern and control for all other matters. 4.2 Manufacturing Standards. Manufacturer shall manufacture and supply each Product (including disposing of all Waste and other materials) in accordance with all applicable Specifications, applicable Laws, requirements under the applicable Quality Agreement, and this Agreement. 4.3 Manufacturing Changes. (a) Discretionary Changes. Subject to Section 4.3(b), in the event that either Party desires to change, revise, modify or otherwise alter the Specifications, manufacturing processes, Product Materials, Buy-Sell Materials, Customer-Supplied Materials, or Facilities with respect to a given Product in any manner (each, a \\\"Manufacturing Change\\\"), the Party desiring the Manufacturing Change shall notify the other Party in writing of the proposed Manufacturing Change and the Parties will promptly meet to discuss, in good faith, the feasibility of implementing such Manufacturing Change and the allocation of costs between the Parties for such Manufacturing Change; provided that the requested Manufacturing Change will not be implemented unless and until the Parties mutually agree in writing to implement such Manufacturing Change. Unless otherwise agreed upon by the Parties, the Party requesting the Manufacturing Change will be responsible for, and will bear the costs of, any filings or other actions that either Party must take with the applicable Governmental Authority as a result of such Manufacturing Change. -35- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) Required Changes. If, at any time, a Manufacturing Change is required by a Governmental Authority in a country in which Regulatory Approval for a given Product has been granted, a Governmental Authority in a country in which Customer seeks to obtain Regulatory Approval for a given Product, or a Governmental Authority in the country in which the Facility that manufactures a given Product is located, then the Party that first has knowledge of the required Manufacturing Change shall notify the other Party in writing of such required Manufacturing Change, and Manufacturer will review such Manufacturing Change with Customer. Manufacturer will bear all costs and expenses associated with implementing the Manufacturing Change, unless such Manufacturing Change relates solely to a Product or Products manufactured for Customer (including any required labeling changes), in which case Customer will bear all costs and expenses associated with implementing such Manufacturing Change for such Product, including any changes to labeling or packaging, but only to the extent such costs are reasonable and documented. 4.4 Pest Control. Manufacturer shall manufacture all Products, and Manufacturer shall store all Product Materials, Buy-Sell Materials, Customer-Supplied Materials, and all Products, in a clean, dry area, free from insects and rodents, in a manner to prevent entry of foreign materials and contamination of Product. Manufacturer's pest control measures shall include the adequate cleaning of the Facility, control of food and drink, protection of Product from the environment, monitoring of flying and crawling pests and logs detailing findings and actions taken. Manufacturer's pest control program shall be detailed in a written procedure which complies with applicable Laws, including cGMPs, and which shall be subject to review and approval by Customer. If Customer has specific concerns about procedures in place at any Facility, Customer will present such issues in its audit findings and the Parties will discuss in good faith a mutually agreeable plan for resolution of such issues. Failure of Manufacturer to comply with this Section 4.4 shall be deemed a material breach of this Agreement. 4.5 Legal and Regulatory Filings and Requests. (a) Manufacturer shall reasonably cooperate with Customer in responding to all requests for information from, and in making all legally required filings with, Governmental Authorities in the Territory having jurisdiction to make such requests or require such filings. Manufacturer shall: (a) obtain and comply with all licenses, consents and permits required under applicable Laws in the Territory (and Manufacturer shall provide Customer with a -36- Source: UPJOHN INC, 10-12G, 1/21/2020 copy of all such licenses, consents and permits that are material upon Customer's reasonable request); and (b) comply with all applicable Laws in the Territory with respect to its manufacturing and packaging processes, the Facility or otherwise, to permit the performance of its obligations hereunder. Upon Customer's request, Manufacturer shall apply for and obtain Certificates of Pharmaceutical Production (\\\"CPP\\\") from the Governmental Authorities of the country where the Facility is located, such CPPs to be issued to countries where CPPs according to Customer's opinion are required. Manufacturer shall pay all reasonable costs necessary to obtain such CPPs and be entitled to be reimbursed against invoice by Customer at cost; provided that Manufacturer shall make good faith efforts to consolidate its invoices for such reimbursement for CPPs and submit to Customer on a Fiscal Year quarterly basis. (b) In the event that Customer wishes to extend the Territory with respect to a certain Product, Customer shall notify Manufacturer of such request and Manufacturer shall consider Customer's request in good faith. For the avoidance of doubt, in the event that the Parties agree to extend the Territory with respect to a certain Product, any resulting Manufacturing Change shall be treated as a discretionary Manufacturing Change and governed by Section 4.3(a). 4.6 Quality Tests and Checks. Manufacturer shall perform all bulk holding stability, manufacturing trials, validation (including, but not limited to, method, process and equipment cleaning validation), raw material, in-process, bulk finished product and stability (chemical and/or microbial) tests or checks required to assure the quality of a given Product and any tests or checks required by the Specifications, the Quality Agreement, applicable Facility Addendum or applicable Laws. With respect to any Product manufactured prior to Closing or located at a Facility as of Closing, Manufacturer shall maintain, continue and complete any and all such activities, tests and checks, including, without limitation, all ongoing stability testing. All costs associated with the performance of Manufacturer's obligations under this Section 4.6 (including with respect to any Product manufactured prior to Closing or located at a Facility as of Closing) are included in the Price of each Product and, accordingly, Manufacturer shall perform the foregoing at its cost and expense, without further reimbursement from Customer. Manufacturer shall obtain Product for these tests from batches of Product manufactured under this Agreement, and Manufacturer is responsible for providing all necessary technical, quality and operational resources. All tests and test results shall be performed, documented and summarized by Manufacturer in accordance with the Specifications, Quality Agreement, applicable Facility Addendum, applicable Laws and reasonable quality assurance requirements provided by Customer to Manufacturer in writing. Manufacturer shall maintain all production Records and disposition of each batch of Product. -37- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"4.7\", \"title\": \"Responsibility for Non-Complying Product\", \"level\": 2, \"text\": \"4.7 Responsibility for Non-Complying Product. Manufacturer shall not release any Product for Delivery to Customer that does not conform to the covenants set forth in Section 5.2(e) (such non-conforming Product, \\\"Non-Complying Product\\\"), without the prior written approval of Customer. Manufacturer shall quarantine all such Non-Complying Products and shall promptly submit to Customer a report detailing the nature of such non-compliance and Manufacturer's recommended disposition, including the investigation and testing done. Manufacturer shall also provide any additional information regarding such Non-Complying Product as may reasonably be requested by Customer. Customer shall not be required to pay for any Non-Complying Product or for the destruction or other disposition thereof (unless an investigation determines that the root cause for such Product being Non-Complying Product is Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Material). 4.8 Rejection of Non-Complying Product. (a) Customer's Ability to Reject. Customer may reject any Non-Complying Product or Product that is not delivered to Customer in accordance with this Agreement by providing written notice of such rejection to Manufacturer within seventy-five (75) days following Customer's receipt of any Delivery of Product hereunder; provided, however, that Customer may, until the expiry date for a Product, provide notice of rejection of any Delivery of such Product having (i) latent defects, (ii) any defects that are not reasonably discoverable by Customer through standard inspection and testing of Products or (iii) defects caused by the breach by Manufacturer of any of its representations or warranties under this Agreement (collectively, \\\"Latent Defects\\\"); provided, further, that, and notwithstanding the foregoing, Customer shall notify Manufacturer within sixty (60) days after Customer first becomes aware of any such Latent Defect. (b) Manufacturer's Ability to Reject. Manufacturer may reject any Non-Complying Product by (i) providing Customer with no less than sixty (60) days' prior written notice of Manufacturer's intention to reject such Non-Complying Product along with the documentation set forth in Section 4.7, (ii) meeting with Customer at Customer's request to discuss the basis for the proposed rejection of the subject Non-Complying Product, and (iii) providing Customer with notice of rejection in the event that Manufacturer rejects the subject Non- Complying Product at the end of such sixty (60) day period (or such other time frame as the parties may agree upon). (c) Manufacturer's Obligation; Replacement. Manufacturer shall respond to any rejection, defect notice or any quality-related complaint from Customer pursuant to Section 4.8(a) in a timely manner or such other time frame as may be specified in the applicable Quality Agreement. Manufacturer shall conduct an analysis of the causes of any such complaint, shall report to Customer on any corrective action taken and shall reasonably consider -38- Source: UPJOHN INC, 10-12G, 1/21/2020 Customer's suggestions related to such corrective action or other quality-related matters. Customer shall promptly return any Product (or portions thereof) rejected pursuant to Section 4.8(a) to Manufacturer at Manufacturer's expense. With respect to any Non- Complying Product rejected by Customer, in addition to any other rights or remedies of Customer hereunder, Customer may elect, in its sole discretion, upon written notice to Manufacturer to either (i) have Manufacturer replace any Non-Complying Product as soon as practicable at no additional charge to Customer; provided that (A) the Manufacturer shall replace such Non-Complying Product within a period of ninety (90) days beginning on the date that the Manufacturer confirms or a Third-Party laboratory determines that the subject Product is a Non-Complying Product, and (B) if Manufacturer fails to replace such Non-Complying Product within such ninety (90) day period, then a Triggering Event shall be deemed to have occurred and the provisions of Section 2.5 shall apply; or (ii) be reimbursed for the Price of the Non-Complying Product actually paid. Manufacturer shall reimburse Customer for the cost of all Customer-Supplied Materials used to manufacture any Non-Complying Product (unless such Product is a Non-Complying Product due to any Non-Complying Customer-Supplied Material, as applicable). (d) Independent Testing. If the Parties are unable to agree on whether Product rejected by Customer is Non-Complying Product, then Manufacturer may hire an independent Third-Party laboratory, subject to Customer's prior written approval of such laboratory, not to be unreasonably withheld, conditioned or delayed, to perform testing on such rejected Product in accordance with the Specifications, applicable Laws and the Quality Agreement, which Third Party laboratory shall promptly provide the results thereof to Customer and Manufacturer. Manufacturer must engage such Third-Party laboratory within the thirty (30) day period following Manufacturer's receipt of Customer's rejection notice. If Manufacturer fails to engage such Third-Party laboratory during such thirty (30) day period, then Manufacturer will be deemed to have waived its right to engage such Third-Party laboratory. The determination of such tests shall be binding upon the Parties for all purposes hereunder; provided that, if such tests are unable to determine whether or not such rejected Product is Non-Complying Product, or if Manufacturer does not engage such Third-Party laboratory within the thirty (30) day period, then such Product shall be deemed to be Non-Complying Product. If such tests determine that the rejected Product is, or such Product is so deemed to be, Non-Complying Product, then Manufacturer shall bear the costs of such tests and Customer's remedies with respect to Non-Complying Product as set forth in this Agreement shall apply to such Non-Complying Product. Otherwise, Customer shall (i) bear the costs of such tests and shall remain obligated to pay Manufacturer the Price for such Product in accordance with Section 3 and (ii) reimburse Manufacturer for any shipping charges paid by Manufacturer pursuant to Section 4.8(c) with respect to the return of such -39- Source: UPJOHN INC, 10-12G, 1/21/2020 Product to Manufacturer. Without limiting the foregoing obligations, if Customer reasonably requests in writing, then Manufacturer shall use commercially reasonable efforts to re-deliver such Product to Customer at Customer's expense. For the avoidance of doubt, provided that the Product conforms to the minimum shelf-life dating set forth in Section 5.2(e)(v) upon initial Delivery, such minimum shelf-life dating requirement shall not apply to the subject Product upon re-delivery in accordance with the immediately preceding sentence. (e) Survival. The provisions of this Section 4.8 shall survive termination or expiration of this Agreement or the applicable Facility Addendum. 4.9 Disposal of Rejected and Non-Complying Product. All Non-Complying Product and Product rejected pursuant to this Agreement shall be removed (if applicable) and disposed of by Manufacturer in accordance with all applicable Laws, and as approved in advance by Customer in writing (such disposal cost to be at Manufacturer's expense, unless it is subsequently determined that Customer wrongly rejected such Product pursuant to Section 4.8). Manufacturer shall make documentation relating to such disposition available to Customer upon Customer's reasonable request. Manufacturer shall not sell for salvage or for any other purpose any rejected or Non-Complying Product, without the prior written approval of Customer. Manufacturer shall destroy all Non-Complying Product prior to disposal and Manufacturer shall deface and render unreadable all words or symbols that identify Customer, including Customer's trademarks and logotypes that adorn any packaging containing such Product, prior to disposal of such Product. 4.10 Maintenance and Retention of Records. Manufacturer shall maintain detailed Records with respect to Product Materials, Buy-Sell Materials, and Customer-Supplied Materials usage and finished Product production in accordance with the Quality Agreement. 4.11 Government Inspections, Seizures and Recalls. (a) Notification; Initiation of Recalls. If (i) Manufacturer determines or comes to learn that a Product distributed to the market contains a latent defect or (ii) the FDA or any other Governmental Authority conducts an inspection at Manufacturer's Facility, seizes any Product, Buy-Sell Materials, Customer-Supplied Materials, or Product Materials, requests a Recall of any Product, Buy-Sell Materials, Customer-Supplied Materials, or Product Materials, or otherwise notifies Manufacturer of any violation or potential violation of any applicable Law at the Facility, or (iii) Customer notifies Manufacturer of its intent to initiate a Recall, then, with respect to each ((i)- (iii)), Manufacturer shall promptly notify Customer (as applicable) and shall take such actions as may be required under the Specifications or Quality -40- Source: UPJOHN INC, 10-12G, 1/21/2020 Agreement. As applicable, Manufacturer shall promptly send any reports relating to such inspections, Recalls, violations or potential violations of applicable Law to Customer; provided that Manufacturer may reasonably redact any such reports to protect its confidential and proprietary Information that does not relate to Products. In the event that any such Governmental Authority requests, but does not seize, a given Product in connection with any such inspection, Manufacturer shall, to the extent reasonably practicable and permitted by applicable Law (1) promptly notify Customer of such request, (2) satisfy such request only after receiving Customer's approval, (3) follow any reasonable procedures instructed by Customer in responding to such request and (4) promptly send any samples of the applicable Product requested by the Governmental Authority to Customer. Manufacturer shall give and permit full and unrestricted access to all or any of its premises at any time to any authorized representative of any Governmental Authority or any of its agents or advisers and shall cooperate fully with any such representatives, in each case, relating to any such inspection. Manufacturer shall not initiate any Recall of Product, except as provided in the Quality Agreement, without the prior written agreement by Customer. (b) Costs. In the event a Recall results from any breach by Manufacturer of this Agreement, including Recalls on account of a given Product containing a latent defect, in addition to any other rights or remedies available to Customer under this Agreement, Manufacturer shall reimburse Customer for Customer's costs and expenses associated with such Recall, including costs of materials supplied by Customer (including Customer-Supplied Materials), shipping costs, administrative costs associated with arranging and coordinating the Recall and all actual Third Party costs associated with the distribution of replacement Product; provided that Customer shall be solely responsible for all, and shall reimburse Manufacturer for Manufacturer's costs and expenses associated with any Recall to the extent such Recall does not result from a breach by Manufacturer of this Agreement (e.g., is due to any Non- Complying Customer-Supplied Material or Non-Complying Buy-Sell Material). 4.12 Inspections. Subject to the remainder of this Section 4.12, no more than once per calendar year, upon thirty (30) days' advance written notice to Manufacturer, Customer may physically inspect or audit (consistent with Section 15.2) the Facilities under this Section 4.12; provided that Customer will use good faith efforts to choose dates of inspection or audit that do not unreasonably interfere with the operation of Manufacturer's business; provided, further, that Customer shall consider in good faith any alternative dates of inspection or audit proposed by Manufacturer within five (5) days of Manufacturer's receipt of such notice (it being understood that nothing in this Section 4.12 shall require Customer to accept any such proposed alternative dates of inspection or audit). Notwithstanding the limits set forth in the -41- Source: UPJOHN INC, 10-12G, 1/21/2020 foregoing sentence, Customer may more frequently conduct \\\"for cause\\\" physical inspections or audits of a Facility with five (5) days' advance written notice to Manufacturer if Customer has reasonable cause to believe that an inspection or audit of such Facility is warranted because Manufacturer's activities with respect to such Facility are in breach of this Agreement, applicable Laws, the Quality Agreement or the applicable Facility Addendum. Any such inspection or audit shall include access to relevant Records (subject to the terms of Section 15.2) and Personnel and being present during, as applicable, start-up manufacturing operations, validation, cleaning, sampling, laboratory testing, warehouse receiving and storage, pack out and shipping. Manufacturer shall provide technical assistance and direction to Customer and its representatives at the Facility. Subject to the terms and conditions set forth herein, Customer may conduct, at its own expense, periodic quality audits, to ensure Manufacturer's compliance with the terms of this Agreement. Manufacturer shall cooperate with Customer's representatives for all of these purposes, and shall promptly correct any deficiencies noted during the audits. Any Records or information accessed or otherwise obtained by Customer or its representatives during any such inspection or audit or any visit at any Facility shall be deemed Manufacturer's confidential and proprietary Information and each representative of Customer will be subject to non-use and other confidentiality obligations substantially comparable to those set forth herein for Customer. 4.13 Segregation of Restricted Compounds. Unless otherwise set forth in a Facility Addendum with respect to a Product, Manufacturer shall not manufacture a Product using facilities or equipment shared with the following classes of product without prior consultation and agreement with Customer: (a) steroids, hormones, or otherwise highly active or toxic products that carry a likelihood of a serious adverse effect (e.g., carcinogenicity; anaphylaxis; reproductive and/or developmental toxicity; serious target organ toxicity) following a potential product cross-contamination or carry-over scenario, particularly at low exposure concentrations (i.e., with reference to an acceptable daily exposure (ADE) value or permitted daily exposure (PDE) value < 10 \u00b5g/day); (b) immunosuppressors where the ADE or PDE value < 10 \u00b5g/day; (c) live or infectious biological agents; (d) live or attenuated vaccines; (e) biotherapeutics where the ADE or PDE value < 10 \u00b5g/day and sufficient deactivation cannot be demonstrated; (f) products exclusive for animal use; (g) non-medicinal products; or (h) radiopharmaceuticals. Manufacturer shall not manufacture any highly sensitizing products, including beta-lactam antibiotics, as well as certain non-beta-lactam antibiotics, or otherwise highly sensitizing products that can elicit an immediate hypersensitivity reaction (Type I hypersensitivity; immunoglobulin E-mediated) in the same Facility as a Product. -42- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"4.14\", \"title\": \"Packaging Material\", \"level\": 2, \"text\": \"4.14 Packaging Material. Unless otherwise provided in the applicable Facility Addendum, Customer shall determine and be responsible for the text (including any logos or other graphics) for all packaging material used in connection with Product. Manufacturer shall assure that all packaging materials are accurate and consistent with Customer's specifications for such text or graphics, including such matters as placement, size and colors. Manufacturer shall promptly notify Customer of any errors or deficiencies in such provided packaging materials. 5. Covenants. 5.1 Mutual Covenants. Each Party hereby covenants to the other Party that it will perform its activities under this Agreement in full compliance with all applicable Global Trade Control Laws, including as follows: (a) unless a license or other authorization is first obtained, the issuance of which is not guaranteed, neither Party will knowingly transfer to the other Party any goods, software, technology or services that are (1) controlled at a level other than EAR99 under the U.S. Export Administration Regulations; (2) controlled under the U.S. International Traffic in Arms Regulations; (3) specifically identified as an E.U. Dual Use Item; or (4) on an applicable export control list of a foreign country; (b) prior to engaging in any activities in a Restricted Market, involving individuals ordinarily resident in a Restricted Market or including companies, organizations, or Governmental Authorities from or located in a Restricted Market in each case in connection with this Agreement, each Party must first notify the other Party (which notice, notwithstanding Section 17, shall be addressed to (a) Pluto at gtc@pfizer.com and (b) Spinco at [\u25cf]), who will review and, if compliant with Global Trade Control Laws, approve (subject to any appropriate conditions) such activities (such approval not to be unreasonably withheld or delayed), within five (5) Business Days of such notification; provided that (1) to the extent relating to U.S. sanctions or export controls, such notification and approval shall not be required if the activity contemplated would be permissible for U.S. persons subject to U.S. sanctions (including without limitation under a U.S. Department of the Treasury Office of Foreign Assets Control general license), and (2) once notification is made and approval is granted with respect to a specific counterparty in a Restricted Market, further notification and approval will not be required for future transactions or activities with the same counterparty (unless there is a change in circumstances, processes or intermediate parties, including, but not limited to, carriers, or otherwise a change to Global Trade Control Laws relevant to that Restricted Market or counterparty); provided that, notwithstanding the foregoing, neither Party shall undertake any of the activities described in this clause (2) without the prior written approval of the other Party; and -43- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) notwithstanding anything set forth in Section 4.14 to the contrary, for the purposes of any and all packaging and shipping of any goods, software, technology or services pursuant to the activities contemplated under this Agreement, Manufacturer will determine: (i) a classification under relevant import and export laws; (ii) the country of origin; and (iii) a value for customs; provided, however, that the Party acting as the importer of record (IOR) or exporter of record (EOR) shall have the right to request a review of any determination contemplated by clause (i), (ii) or (iii) above; provided, further, that if the IOR or EOR (as applicable) disagrees with such determination, then such Party shall maintain the right to refuse to export or import the applicable goods, software, technology or services. 5.2 Manufacturer Covenants. Manufacturer hereby covenants to Customer that: (a) The Facility and all equipment, tooling and molds utilized in the manufacture and supply of Product hereunder by or on behalf of Manufacturer shall, during the Term of this Agreement, be maintained in good operating condition and shall be maintained and operated in accordance with all applicable Laws. The manufacturing and storage operations, procedures and processes utilized in manufacture and supply of Product hereunder (including the Facility) shall be in full compliance with all applicable Laws, including cGMP and health and safety laws. (b) Manufacturer shall perform all of its obligations under this Agreement in compliance with the applicable Laws in the Territory. Manufacturer is in compliance and shall continue to comply, and shall cause its Personnel to comply, with all applicable Laws, including Laws requiring Serialization; provided that, with respect to compliance with Laws requiring Serialization, Customer shall reimburse Manufacturer for all investments made or costs incurred by Manufacturer in connection with any Serialization requirements specific to a given Product or Products (which, for clarity, shall not include Serialization requirements applicable to both Products and other products produced by Manufacturer in the Facility), but only to the extent such costs are reasonable and documented and are directed specifically with respect to a Product or Products. Manufacturer has and shall continue to have, and shall cause its Personnel to have, all professional licenses, consents, authorizations, permits, and certificates, and shall have and shall cause its Personnel to have completed all registrations and made such notifications as required by applicable Law for its performance of the services under this Agreement. (c) Manufacturer shall hold during the Term of this Agreement all licenses, permits and similar authorizations required by any Governmental Authority in the Territory for Manufacturer to perform its obligations under this Agreement. -44- Source: UPJOHN INC, 10-12G, 1/21/2020 (d) Manufacturer shall have good title to all Product supplied to Customer pursuant to this Agreement and shall pass such title to Customer (or its designee) free and clear of any security interests, liens, or other encumbrances. (e) Products furnished by Manufacturer to Customer under this Agreement: (i) shall be manufactured, packaged, labeled, handled, stored and Delivered in accordance with, shall be of the quality specified in, and shall conform upon Delivery to Customer (or its designee) to, the Specifications; (ii) shall be manufactured, packaged, labeled, handled, stored and Delivered in compliance with all applicable Laws including, without limitation, cGMPs, and in accordance with the Quality Agreement, this Agreement and the applicable Facility Addendum; (iii) shall not contain any Product Material that has not been used, handled or stored by or on behalf of Manufacturer in accordance with the Specifications, all applicable Laws, the Quality Agreement, this Agreement and the applicable Facility Addendum; (iv) shall not be adulterated or misbranded within the meaning of Sections 501 and 502, respectively, of the Act or any other applicable Law; and (v) shall, at the time Delivered, have at least a remaining shelf-life as specified in the applicable Facility Addendum. Notwithstanding the foregoing clauses (i) through (v) of this Section 5.2(e) or anything else contained in this Agreement or any Facility Addendum or Quality Agreement, Manufacturer shall have no liability under this Agreement (including under Section 4.11(b) or Section 10.1) or any Facility Addendum or Quality Agreement for any Non-Complying Product which is non-complying due to any Non-Complying Customer-Supplied Materials or Non-Complying Buy-Sell Materials. (f) Manufacturer has not and will not directly or indirectly offer or pay, or authorize such offer or payment, of any money or anything of value or improperly or corruptly seek to influence any Government Official or any other Person in order to gain an improper business advantage, and, has not accepted, and will not accept in the future, such a payment. Manufacturer will comply with the Anti-Bribery and Anti-Corruption Principles set forth in Attachment D. (g) Manufacturer shall ensure that it and its Personnel comply with the standard policies, regulations and directives listed on Attachment E and incorporated herein. -45- Source: UPJOHN INC, 10-12G, 1/21/2020 Manufacturer will promptly notify Customer of any actual or anticipated events of which Manufacturer is aware that have or would be reasonably expected to have a material effect on any Product or on its ability to manufacture or supply any Product in accordance with the provisions set forth herein, including any labor difficulties, strikes, shortages in materials, plant closings, interruptions in activity and the like. -46- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"5.5\", \"title\": \"Disclaimer of Warranties\", \"level\": 2, \"text\": \"5.5 Disclaimer of Warranties. EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, NEITHER PARTY MAKES NOR RECEIVES ANY WARRANTY OF ANY KIND, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT OF ANY FIRMWARE, SOFTWARE OR HARDWARE PROVIDED OR USED HEREUNDER, AND ANY REPRESENTATIONS OR WARRANTIES ARISING FROM COURSE OF DEALING, COURSE OF PERFORMANCE OR TRADE USAGE, AND ALL SUCH REPRESENTATIONS AND WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED. 6. Environmental Covenants. 6.1 Compliance with Environmental Laws. (a) Manufacturer shall perform all of its obligations herein in compliance with all Environmental Laws and all licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws. (b) Manufacturer shall be solely responsible for all Environmental Liabilities arising from its performance of this Agreement. 6.2 Permits, Licenses and Authorization. (a) Manufacturer shall be solely responsible for obtaining, and shall obtain in a timely manner, and maintain in good standing, all licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws, whether de novo documents or modifications to existing documents, which are necessary to perform the services hereunder, and shall bear all costs and expenses associated therewith. (b) Manufacturer shall provide copies of all material items referenced in Section 6.2(a) to Customer upon request by Customer and shall operate in compliance therewith. (c) Manufacturer shall provide Customer with reasonably prompt verbal notice, confirmed in writing within twenty-four (24) hours, in the event of any major incident, which shall include any event, occurrence, or circumstance, including any governmental or private action, which materially impacts or could materially impact Manufacturer's ability to fulfill its obligations under this Agreement. These include, but are not limited to: (i) material revocation or modification of any of the documents described in Section 6.2(a), -47- Source: UPJOHN INC, 10-12G, 1/21/2020 (ii) any action by Governmental Authorities that may reasonably lead to the material revocation or modification of Manufacturer's required permits, licenses, or authorizations, as listed above, (iii) any Third Party Claim against the management or ownership of the Facility that could reasonably materially impact Manufacturer's obligations under this Agreement, (iv) any fire, explosion, significant accident, or catastrophic Release of Hazardous Materials, or significant \\\"near miss\\\" incident, (v) any significant non-compliance with Environmental Laws and (vi) any environmental condition or operating practice that may reasonably be believed to present a significant threat to human health, safety or the environment. (d) Notwithstanding the requirements noted above, each Party, whether Customer or Manufacturer, is required to create and maintain: (i) required licenses, permits and agreements, including those necessary to affect imports, exports, and activities covered by economic sanctions regulations, including annual agreements for activities involving Restricted Markets; (ii) policies, procedures, controls, and systems to support compliance with Global Trade Control Laws; and (iii) agreements with Customs Brokers, freight forwarders, financial institutions, and other third parties, as necessary. 6.3 Generation of Hazardous Wastes. Without limiting other legally applicable requirements, Manufacturer shall prepare, execute and maintain, as the generator of Waste, all registrations, notices, shipping documents and manifests required under applicable Environmental Laws and in accordance therewith. Manufacturer shall utilize only reputable and lawful Waste transportation and disposal vendors, and shall not knowingly utilize any such vendor whose operations endanger human health or the environment. 6.4 Environmental Sustainability Information. Manufacturer will disclose to Customer, on an annual basis, its results with respect to any efforts to reduce greenhouse gas emissions, water consumption or the generation of waste associated with the performance of this Agreement, to the extent Manufacturer otherwise prepares such results. 6.5 Environmental and Health and Safety Reviews. (a) Manufacturer covenants that it will, to the Manufacturer's knowledge, completely and accurately disclose to Customer all material environmental and health and safety information regarding its Products (including an obligation to supplement this information, as necessary) during the Term of this Agreement, as reasonably requested by Customer. -48- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) Manufacturer shall permit Customer (at Customer's expense) to conduct reasonable annual reviews of the environmental and health and safety practices and performance of the Facilities with respect to the Products where Manufacturer's performance under this Agreement is occurring; provided that such review shall not include any invasive sampling at such Facilities and shall not unreasonably interfere with Manufacturer's operation of such Facilities. In connection with such reviews, Manufacturer shall reasonably assist in the completion of an environmental health and safety survey of Manufacturer or the scheduling of an environmental health and safety audit of the Facility, as applicable, in each case with respect to the Products. Customer shall share its findings (including any deficiencies) with Manufacturer as soon as practicable, Manufacturer shall have the sole right to report any such deficiencies to third parties and Manufacturer shall use commercially reasonable efforts to correct, at no expense to Customer, such deficiencies in its environmental and health and safety management practices with respect to the Products that are not in compliance with applicable Law or create significant risk to human health or the environment. Manufacturer acknowledges that such reviews conducted by Customer are for the benefit of Customer only; they are not a substitute for Manufacturer's own environmental and health and safety management obligations under this Agreement and accordingly, Manufacturer may not rely upon them. 7. Term; Termination. 7.1 Term of Agreement. Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"7.2\", \"title\": \"Term of Facility Addendum\", \"level\": 2, \"text\": \"7.2 Term of Facility Addendum. In the event that Manufacturer or any of its Affiliates, directly or indirectly, sells, assigns, leases, conveys, transfers or otherwise disposes of any Facility (a \\\"Facility Disposition\\\"), then Manufacturer shall immediately notify Customer of such event and Customer shall be entitled for a period of six (6) months after the receipt of such notice to terminate any Facility Addendum with respect to such Facility for cause immediately upon written notice to Manufacturer and, in the event Customer decides not to terminate the Facility Addendum for cause, Customer shall be entitled for a period of two (2) years (or such longer period in order to obtain approval for manufacture from all applicable Governmental Authorities) after -50- Source: UPJOHN INC, 10-12G, 1/21/2020 receipt of such notice to receive Technical Support at Manufacturer's sole cost to enable Customer to orderly transfer production of affected Product or Products to a Customer facility or an alternative facility as designated by Customer; provided that Manufacturer shall notify Customer of any proposed or planned Facility Disposition by Manufacturer or any of its Affiliates as soon as reasonably practicable and in any event no later than the date that is three (3) months prior to the effective date of such Facility Disposition. 7.5 Termination in Event of Insolvency. In the event that a Party hereto (a) becomes insolvent, or institutes or has instituted against it a petition for bankruptcy or is adjudicated bankrupt, (b) executes a bill of sale, deed of trust, or a general assignment for the benefit of creditors, (c) is dissolved or liquidated or (d) has a receiver appointed for the benefit of its creditors, or has a receiver appointed on account of insolvency (in the case of clauses (a)-(d), such Party shall be referred to as the \\\"Insolvent Party\\\"), then the Insolvent Party shall immediately notify the other Party of such event and such other Party shall be entitled to (i) terminate this Agreement or any and all Facility Addenda for cause immediately upon written notice to the Insolvent Party or (ii) request that the Insolvent Party or its successor provide adequate assurances of continued and future performance in form and substance acceptable to such other Party, which shall be provided by the Insolvent Party within ten (10) calendar days of such request, and the other Party may terminate this Agreement and any or all Facility Addenda for cause immediately upon written notice to the Insolvent Party in the event that the Insolvent Party fails to provide such assurances acceptable to the other Party within such ten (10) day period. 7.6 Termination for Breach of Anti-Bribery Representation. Customer may terminate this Agreement and any and all Facility Addenda effective immediately upon notice to Manufacturer, if Manufacturer (a) breaches any of the representations and warranties set forth in Section 5.2(f) or (b) Customer learns (i) that improper payments are being or have been made or offered to any Government Official or any other Person by Manufacturer or those acting on behalf of Manufacturer with respect to any obligations performed hereunder or (ii) that Manufacturer or those acting on behalf of Manufacturer with respect to the performance of any obligations hereunder has accepted any payment, item, or benefit, regardless of value, as an improper inducement to award, obtain or retain business or otherwise gain or grant an improper business advantage from or to any other Person or entity. Further, in the event of such termination, Manufacturer shall not be entitled to any further payment, regardless of any activities undertaken or agreements with additional Third Parties entered into by Manufacturer prior to such termination, and Manufacturer shall be liable for damages or remedies as provided by this Agreement, at Law or in equity. -51- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"8\", \"title\": \"Intellectual Property\", \"level\": 1, \"text\": \"8. Intellectual Property. 8.1 Customer's Intellectual Property. Customer hereby grants to Manufacturer a non-exclusive license during the Term to use any Customer Property and Customer-Owned Improvements and Developments solely in connection with Manufacturer performing its obligations under this Agreement or the Facility Addendum in accordance with the terms hereof or thereof, as applicable. Manufacturer shall not acquire any other right, title or interest in or to the Customer Property or Customer-Owned Improvements and Developments as a result of its performance hereunder, and any and all goodwill arising from Manufacturer's use of any Customer Property or Customer-Owned Improvements and Developments shall inure to the sole and exclusive benefit of Customer. 8.2 Improvements and Developments. (a) Each Party acknowledges and agrees that improvements or modifications to Customer Property may be made by or on behalf of Manufacturer (\\\"Improvements\\\"), and creative ideas, proprietary information, developments, or inventions may be developed under or in connection with this Agreement by or on behalf of Manufacturer (\\\"Developments\\\"), in each case either alone or in concert with Customer or Third Parties. (b) Manufacturer acknowledges and agrees that, as between the Parties, any Improvements or Developments that are specific to and otherwise solely relate to, the manufacturing, processing or packaging of Products (such Improvements and Developments, collectively, \\\"Customer-Owned Improvements and Developments\\\") shall be the exclusive property of Customer, and Customer shall own all rights, title and interest in and to such Customer-Owned Improvements and Developments. Manufacturer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Customer-Owned Improvements and Developments to Customer free and clear of any encumbrances, and Manufacturer agrees to execute, and shall cause its subcontractors and Personnel to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country. -55- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Customer acknowledges and agrees that, as between the Parties, all Improvements and Developments made by or on behalf of Manufacturer in the conduct of activities under this Agreement or a Facility Addendum other than Customer-Owned Improvements and Developments (such Improvements and Developments, collectively, \\\"Manufacturer-Owned Improvements and Developments\\\") shall be the exclusive property of Manufacturer, and Manufacturer shall own all rights, title and interest in and to such Manufacturer- Owned Improvements and Developments. Customer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Manufacturer-Owned Improvements and Developments to Manufacturer free and clear of any encumbrances, and Customer agrees to execute, and shall cause its Personnel and subcontractors to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country. 8.3 Ownership of Other Property. Unless otherwise agreed by the Parties or specified in the Separation Agreement, Customer is the sole owner of any and all tools, specifications, blueprints and designs directly owned and supplied or paid for by Customer (i.e., not any materials that are included in the Price of Product), and Manufacturer shall not use, transfer, loan or publicize any of the above, except as necessary for its performance under this Agreement. 8.4 Limited Right to Use. Subject to the provisions of Section 8.1, nothing set forth in this Agreement shall be construed to grant to Manufacturer any title, right or interest in or to any Intellectual Property controlled by Customer or any of its Affiliates. Use by Manufacturer of any such Intellectual Property shall be limited exclusively to its performance of this Agreement. 9. Joint Advisory Committee. 9.1 Formation and Role. The Parties shall, as soon as practicable but not later than within ninety (90) days after the Effective Date, form a joint advisory committee (the \\\"Joint Advisory Committee\\\" or \\\"JAC\\\"). The JAC will provide a forum for the good faith discussion of major matters related to this Agreement, including in particular (but not limited to) matters of commercial performance, supply, overall performance, capital investment and business planning (strategy and management), and the transition to Customer-Supplied Materials arrangements contemplated by Section 12.1(f), but also any other items, matters or activities, including with respect to any Facility. -56- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"9.2\", \"title\": \"Membership; Chairs\", \"level\": 2, \"text\": \"9.2 Membership; Chairs. (a) Membership. The JAC shall consist of up to five (5) representatives appointed by each Party in writing, or such other number of representatives as the Parties may agree in writing from time to time (each, a \\\"JAC Member\\\"). Either Party may invite any person that is not a JAC Member (including consultants and advisors of a Party) to participate in meetings of the JAC, without a right to participate in the discussions of the JAC, so long as (i) such person is under an appropriate obligation of confidentiality, (ii) the inviting Party provided at least three (3) Business Days' prior notice to the other Party identifying such person and (iii) the non- inviting Party does not reasonably object to such person participating in the discussions of the JAC prior to such meeting. (b) JAC Chairs. The JAC shall be co-chaired by one JAC Member of each Party (each, a \\\"JAC Chair\\\"), to be elected by the respective Party when naming its JAC Members. The JAC Chairs shall cooperate in good faith to: (i) notify the JAC Members of each Party of each JAC Meeting, which notice shall be provided at least thirty (30) calendar days in advance of such meeting (to the extent practicable) with respect to the ordinary quarterly JAC Meetings; (ii) collect and organize agenda items for each JAC Meeting, and circulate such agenda to all JAC Members at least two (2) Business Days prior to each meeting date; provided, however, that any JAC Member shall be free to propose additional topics to be included on such agenda, either prior to or in the course of any JAC Meeting; (iii) preside at JAC Meetings; and (iv) prepare the written minutes of each JAC Meeting and circulate such minutes for review and approval by the JAC Members of each Party, and identify action items to be carried out. 9.3 Meetings. (a) Ordinary JAC Meetings. During the Term of this Agreement, the JAC shall meet on a quarterly basis or as otherwise determined in writing by the Parties, and such meetings may be conducted in person, by videoconference or by telephone conference (each such meeting, a \\\"JAC Meeting\\\"). In-person meetings of the JAC will alternate between appropriate venues of each Party, as reasonably determined by the Parties. The Parties shall each bear all expenses of their respective representatives relating to their participation on the JAC. The members of the JAC also may convene or be polled or consulted from time to time by means of telecommunications, video or telephone conferences, electronic mail or correspondence, as deemed necessary or appropriate. (b) Additional JAC Meetings. Either Party may call an additional meeting of the JAC at any time upon twenty (20) Business Days' prior written notice if such Party reasonably determines that there is a need for discussions at the level of a JAC Meeting on top of the ordinary quarterly JAC Meetings, and reasonably specifies such grounds in its notice to the other Party. -57- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Provision of Information. Upon the request of the JAC Chairs or at least four (4) members of the JAC, each Party will provide written materials and information relating to matters within the purview of the JAC in advance of a JAC Meeting. In addition, the JAC shall be informed by each Party in good faith about any matters or issues within the purview of the JAC which a Party should reasonably deem to be of high importance for the other Party. 9.4 Areas of Responsibility. Subject to the terms of this Agreement, the JAC shall act as a forum to discuss in good faith in particular the following major items, matters and areas of interest: (a) Oversee, review and coordinate the activities of the Parties under this Agreement; (b) Each Facility's overall performance under this Agreement; and (c) Any other major matters, roles, obligations and responsibilities under this Agreement, to the extent any Party reasonably provides such matter to the JAC for discussion. 9.5 Advisory Role; No Decision-Making Authority. (a) Advisory Role. The JAC and its members shall only have an advisory role and shall discuss in good faith and provide to the Parties its opinion on the matters in its purview. The Parties agree to reasonably take into account the opinions and views expressed by the JAC and its members for performing their respective obligations under this Agreement. (b) No Decision-Making Authority. The JAC shall have no decision-making authority over the matters in its purview unless the Parties mutually decide in writing to delegate the decision-making authority on such specific item or matter to the JAC. Moreover, it shall not be within the authority of the JAC to (i) directly impose on either Party or its Affiliates any additional obligation(s) or a resolution on the Parties with respect to any dispute regarding the existence or extent/amount of any obligation, including payments obligations, under this Agreement, or to (ii) amend, modify or waive compliance with this Agreement. 10. Indemnification; Limitations of Liability. 10.1 Indemnification of Customer. (a) Subject to the provisions of this Section 10 and, for clarity, without limiting anything in the Separation Agreement or any other Ancillary Agreements, Manufacturer shall indemnify, defend and hold harmless Customer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of the heirs, executors, successors and assigns of any of the foregoing (each, a \\\"Customer Indemnified Party\\\") from and against any and all Losses of such Customer -58- Source: UPJOHN INC, 10-12G, 1/21/2020 Indemnified Parties to the extent relating to, arising out of or resulting from any Action of a Third Party arising out of or resulting from any of the following items (without duplication): (i) any breach by Manufacturer or its Personnel of this Agreement or any Facility Addendum; (ii) any injury or death of any Person due to any breach by Manufacturer or its Personnel of this Agreement or any Facility Addendum; (iii) the infringement or misappropriation of a Third Party's Intellectual Property by the use or practice by Manufacturer or its Affiliate of any Product manufacturing process that has been changed (including as to the facility in which such manufacturing process takes place) on or following the Effective Date without the written approval of Customer to make such change; (iv) Manufacturer's supply of Non-Complying Product under this Agreement; or (v) the gross negligence, fraud or willful misconduct of Manufacturer or its Personnel in connection with the performance or non-performance of this Agreement. (b) Notwithstanding the foregoing, Manufacturer shall not be liable for Losses described in Section 10.1(a) to the extent such Losses are: (i) caused by the gross negligence, fraud or willful misconduct of a Customer Indemnified Party in connection with the performance or non-performance of this Agreement; (ii) caused by the breach of any of the terms of this Agreement or a Facility Addendum by a Customer Indemnified Party, including in connection with the performance or non-performance of this Agreement or (iii) subject to Customer's indemnification obligations pursuant to Section 10.2. 10.2 Indemnification of Manufacturer. (a) Subject to the provisions of this Section 10 and, for clarity, without limiting anything in the Separation Agreement or any Ancillary Agreements, Customer shall indemnify, defend and hold harmless Manufacturer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of the heirs, executors, successors and assigns of any of the foregoing (each, a \\\"Manufacturer Indemnified Party\\\") from and against any and all Losses of such Manufacturer Indemnified Parties to the extent relating to, arising out of or resulting from any Action of a Third Party arising out of or resulting from any of the following items (without duplication): (i) any breach by Customer or its Personnel of this Agreement or any Facility Addendum; (ii) the gross negligence, fraud or willful misconduct of Customer or its Personnel in connection with the performance or non-performance of this Agreement; (iii) the infringement or misappropriation of a Third Party's Intellectual Property by the use or practice by Manufacturer or its Affiliate in performance of this Agreement of any Product manufacturing process that has been changed with the written approval of Customer to make such change; (iv) Customer's supply of Non-Complying Customer-Supplied Materials or Non-Complying Buy- Sell Materials under this Agreement; or (v) the use, sale, offer for sale, import or other commercialization of any Product (including any injury or death of any Person due to any of the foregoing in this clause (v)). -59- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 counsel for all Indemnitees if the claim for indemnification relates to or arises in connection with any criminal action, indictment or allegation or if such Third-Party Claim seeks an injunction or equitable relief against the Indemnitee (and not any Indemnifying Party or any of its Affiliates). Within thirty (30) days after the receipt of notice from an Indemnitee in accordance with Section 10.3(a) (or sooner, if the nature of such Third-Party Claim so requires), the Indemnifying Party shall notify the Indemnitee of its election whether the Indemnifying Party will assume responsibility for defending such Third-Party Claim, which election shall specify any reservations or exceptions to its defense. After notice from an Indemnifying Party to an Indemnitee of its election to assume the defense of a Third-Party Claim, such Indemnitee shall have the right to employ separate counsel and to participate in (but not control) the defense, compromise, or settlement thereof, but the fees and expenses of such counsel shall be the expense of such Indemnitee; provided, however, in the event that the Indemnifying Party has elected to assume the defense of the Third-Party Claim but has specified, and continues to assert, any reservations or exceptions in such notice, then, in such case, the reasonable fees and expenses of one separate counsel for all Indemnitees shall be borne by the Indemnifying Party; and provided further that the Indemnifying Party will pay the reasonable fees and expenses of such separate counsel if, based on the reasonable opinion of legal counsel to the Indemnitee, a conflict or potential conflict of interest exists between the Indemnifying Party and the Indemnitee which makes representation of both parties inappropriate under applicable standards of professional conduct. (c) If an Indemnifying Party elects not to assume responsibility for defending a Third-Party Claim, or fails to notify an Indemnitee of its election as provided in Section 10.3(b), then the applicable Indemnitee may defend such Third-Party Claim at the cost and expense of the Indemnifying Party to the extent indemnification is available under the terms of this Agreement. If an Indemnifying Party elects not to assume responsibility for defending a Third-Party Claim, or fails to notify an Indemnitee of its election as provided in Section 10.3(b), then, it shall not be a defense to any obligation of the Indemnifying Party to pay any amount in respect of such Third-Party Claim that the Indemnifying Party was not consulted in the defense thereof, that such Indemnifying Party's views or opinions as to the conduct of such defense were not accepted or adopted, that such Indemnifying Party does not approve of the quality or manner of the defense thereof or, subject to Section 10.3(d), that such Third-Party Claim was incurred by reason of a settlement rather than by a judgment or other determination of liability. (d) Neither Party may settle or compromise any Third-Party Claim for which either Party is seeking to be indemnified hereunder without the prior written consent of the other Party, which consent may not be unreasonably withheld, conditioned or delayed, unless such settlement or compromise is solely for monetary damages that are fully payable by the settling or compromising party, does not involve any admission, finding or determination of wrongdoing or violation of Law by the other Party and provides for a full, unconditional and irrevocable release of the other Party from all Liability in connection with the Third-Party Claim. -61- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"10.5\", \"title\": \"Indemnification Obligations Net of Insurance Proceeds and Other Amounts\", \"level\": 2, \"text\": \"10.5 Indemnification Obligations Net of Insurance Proceeds and Other Amounts. (a) The Parties intend that any Loss subject to indemnification or reimbursement pursuant to this Section 10 will be net of Insurance Proceeds or other amounts actually recovered (net of any out-of-pocket costs or expenses incurred in the collection thereof) from any Person by or on behalf of the Indemnitee in respect of any indemnifiable Liability. Accordingly, the amount that any Indemnifying Party is required to pay to any Indemnitee will be reduced by any Insurance Proceeds or other amounts actually recovered (net of any out-of-pocket costs or expenses incurred in the collection thereof) from any Person by or on behalf of such Indemnitee in respect of the related Loss. If an Indemnitee receives a payment (an \\\"Indemnity Payment\\\") required by this Agreement from an Indemnifying Party in respect of any Loss and subsequently receives Insurance Proceeds or any other amounts in respect of the related Loss, then the Indemnitee will pay to the Indemnifying Party an amount equal to the excess of the Indemnity Payment received over the amount of the Indemnity Payment that would have been due if the Insurance Proceeds or such other amounts (net of any out-of-pocket costs or expenses incurred in the collection thereof) had been received, realized or recovered before the Indemnity Payment was made. (b) An insurer that would otherwise be obligated to pay any claim shall not be relieved of the responsibility with respect thereto or, solely by virtue of any provisions contained in this Agreement, have any subrogation rights with respect thereto, it being expressly understood and agreed that no insurer or any other Third Party shall be entitled to a \\\"wind-fall\\\" (i.e., a benefit that such insurer or other Third Party would not be entitled to receive in the absence of the indemnification provisions) by virtue of the indemnification provisions hereof. Each Party shall, and shall cause the members of its Group to, use commercially reasonable efforts (taking into account the probability of success on the merits and the cost of expending such efforts, including attorneys' fees and expenses) to collect or recover any Insurance Proceeds that may be collectible or recoverable respecting the Liabilities for which indemnification may be available under this Section 10. Notwithstanding the foregoing, an Indemnifying Party may not delay making any indemnification payment required under the terms of this Agreement, or otherwise satisfying any indemnification obligation, pending the outcome of any Action to collect or recover Insurance Proceeds, and an Indemnitee need not attempt to collect any Insurance Proceeds prior to making a claim for indemnification or receiving any Indemnity Payment otherwise owed to it under this Agreement or any Ancillary Agreement. -63- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"10.6\", \"title\": \"Additional Matters\", \"level\": 2, \"text\": \"10.6 Additional Matters. (a) Indemnification payments in respect of any Liabilities for which an Indemnitee is entitled to indemnification under this Section 10 shall be paid reasonably promptly (but in any event within sixty (60) days of the final determination of the amount that the Indemnitee is entitled to indemnification under this Section 10) by the Indemnifying Party to the Indemnitee as such Liabilities are incurred upon demand by the Indemnitee, including reasonably satisfactory documentation setting forth the basis for the amount of such indemnification payment, documentation with respect to calculations made and consideration of any Insurance Proceeds that actually reduce the amount of such Liabilities. (b) If (i) a Party incurs any Liability arising out of this Agreement or any Ancillary Agreement; (ii) an adequate legal or equitable remedy is not available for any reason against the other Party to satisfy the Liability incurred by the incurring Party; and (iii) a legal or equitable remedy may be available to the other Party against a Third Party for such Liability, then the other Party shall use its commercially reasonable efforts to cooperate with the incurring Party, at the incurring Party's expense, to permit the incurring Party to obtain the benefits of such legal or equitable remedy against the Third Party. (c) If payment is made by or on behalf of any Indemnifying Party to any Indemnitee in connection with any Third-Party Claim, such Indemnifying Party shall be subrogated to and shall stand in the place of such Indemnitee as to any events or circumstances in respect of which such Indemnitee may have any right, defense or claim relating to such Third-Party Claim against any claimant or plaintiff asserting such Third-Party Claim or against any other Person. Such Indemnitee shall cooperate with such Indemnifying Party in a reasonable manner, and at the cost and expense of such Indemnifying Party, in prosecuting any subrogated right, defense or claim. (d) In the event of an Action in which the Indemnifying Party is not a named defendant, if either the Indemnitee or Indemnifying Party shall so request, the Parties shall endeavor to substitute the Indemnifying Party for the named defendant or otherwise add the Indemnifying Party as party thereto, if at all practicable. If such substitution or addition cannot be achieved for any reason or is not requested, the named defendant shall allow the Indemnifying Party to manage the Action as set forth in this Section 10, and the Indemnifying Party shall fully indemnify the named defendant against all costs of defending the Action (including court costs, sanctions imposed by a court, attorneys' fees, experts fees and all other external expenses), the costs of any judgment or settlement, and the cost of any interest or penalties relating to any judgment or settlement with respect to such Third-Party Claim. -64- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"11\", \"title\": \"Insurance\", \"level\": 1, \"text\": \"11. Insurance. 11.1 Requirements to Maintain. During the Term, Manufacturer shall self-insure or shall provide and maintain such insurance coverage, in minimum types and amounts as described below in this Section 11. (a) Any and all deductibles or retentions for such insurance policies shall be assumed by, for the account of, and at Manufacturer's sole risk. (b) To the extent of the liabilities assumed by Manufacturer under this Agreement, such insurance policies of Manufacturer shall be primary and non-contributing with respect to any other similar insurance policies available to Customer or its Affiliates. (c) Manufacturer shall furnish to Customer certificates of insurance (electronic is acceptable), evidencing the required insurance coverage, upon execution of this Agreement and annually, thereafter. 11.2 Amounts and Limits. The insurance required under this Section 11 shall be written for not less than any limits of liability specified herein or as required by applicable Law, whichever is greater. All insurance carriers shall have a minimum of \\\"A-\\\" A.M. Best rating. Manufacturer shall have the right to provide the total limits required by any combination of self-insurance, primary and umbrella/excess coverage; said insurance to include the following: (a) Insurance for liability under the workers' compensation or occupational disease Laws of any state of the United States (or be a qualified self-insurer in those states of the United States) or otherwise applicable with respect to Persons performing the services and employer's liability insurance covering all claims by or in respect to the employees of Manufacturer, providing: (i) Coverage for the statutory limits of all claims under the applicable State Workers' Compensation Act or Acts. If a Facility Addendum will result in exposures under the U.S. Longshore and Harbor Workers' Compensation Act and its amendments (work dockside or on water), the Jones Act (involving seamen, masters and crew of vessels) or the Federal Employers' Liability Act (railroad exposure), coverage shall be extended to include insurance coverages mandated thereby; (ii) Employer's liability insurance with a limit of not less than $1,000,000; (iii) Manufacturer warrants that all of its employees involved in this Agreement are covered by statutory workers' compensation; and -65- Source: UPJOHN INC, 10-12G, 1/21/2020 (iv) Where allowed by Applicable Law, Customer and its Affiliates shall be provided a waiver of subrogation, except for losses due to the sole negligence of Manufacturer. (b) Commercial general liability insurance with the following limits and forms/endorsements: Each Occurrence: $2,000,000 (i) Occurrence form including premises and operations coverage, property damage, liability, personal injury coverage, products and completed operations coverage, and transit. (ii) To the extent of Manufacturer's indemnification obligations, Customer and its Affiliates shall be additional insureds via ISO form CG20101185 or its equivalent. (c) Automobile and Truck Liability Insurance: $2,000,000 combined single limit for bodily injury and property damage arising out of all owned, non- owned and hired vehicles, including coverage for all automotive and truck equipment used in the performance of this Agreement and including the loading and unloading of same. (d) Umbrella (excess) liability coverage in an amount not less than $3,000,000 per occurrence and in the aggregate. (e) If Manufacturer has care, custody or control of Customer-Supplied Material, Manufacturer shall be responsible for any loss or damage to it and provide all risk property coverage at full replacement cost for property and at the costs-per-unit as specified in the Facility Addendum for inventory. 12. Customer-Supplied Materials; Buy-Sell Materials; Transition. 12.1 Supply; Rejection; Transition. (a) Customer shall at its own expense supply Manufacturer with the Customer-Supplied Materials identified in the applicable Facility Addendum. Customer shall supply Manufacturer with the Buy-Sell Materials at a price that Customer determines, subject to Section 3.2(c), and communicates to Manufacturer. At Customer's option, the Customer-Supplied Materials and Buy-Sell Materials may be delivered directly from Customer's Third-Party vendor to Manufacturer at the vendor's or Customer's expense. Customer or its vendor shall supply Manufacturer with a copy of the certificate of analysis for the Customer-Supplied Materials and Buy-Sell Materials no later than delivery of the Customer-Supplied Materials or Buy-Sell Materials to Manufacturer. Customer hereby covenants to Manufacturer that each Customer-Supplied Material and Buy-Sell Materials furnished by or on behalf of Customer to Manufacturer or its Affiliate or designee under -66- Source: UPJOHN INC, 10-12G, 1/21/2020 this Agreement will, upon delivery by Customer to Manufacturer pursuant to this Agreement, comply with, and have been used, handled and stored in accordance with, the specifications for such Customer-Supplied Materials or Buy-Sell Materials (as applicable), all applicable Laws, the Quality Agreement, this Agreement and the applicable Facility Addendum and otherwise have no defects. Manufacturer's obligations to manufacture and supply Product under this Agreement are subject to and conditioned upon Customer's timely delivery of Customer-Supplied Material and Buy-Sell Materials in accordance with this Section 12. (b) Manufacturer shall provide to Customer a monthly rolling forecast of its requirements for Customer-Supplied Materials and Buy-Sell Materials based upon Customer's Forecasts for Products, and Manufacturer shall issue to Customer \\\"pro forma\\\" purchase orders for Customer-Supplied Materials and actual purchase orders for Buy-Sell Materials, in each case, according to parameters included in the applicable Facility Addendum, including safety stock and lead time requirements. Manufacturer shall be responsible to receive, sample, store and maintain the inventory of such ordered Customer-Supplied Materials and Buy-Sell Materials at Manufacturer's Facility. (c) Within each calendar month during the Term, Manufacturer will provide a monthly inventory report of Customer-Supplied Materials substantially in the format attached as Attachment C to this Agreement. The Parties acknowledge and agree that the Manufacturer's timely providing the referenced monthly inventory report is a critical component of the Customer's Customer-Supplied Materials management program and further that any such failure on the part of Manufacturer to timely provide such monthly inventory report shall be addressed at the immediately following scheduled JAC Meeting. (d) Manufacturer may reject any Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Materials by (i) providing Customer with no less than sixty (60) days' prior written notice of Manufacturer's intention to reject along with the documentation setting forth in reasonable detail the basis for rejection, (ii) meeting with Customer at Customer's request to discuss the basis for the proposed rejection, and (iii) providing Customer with notice of rejection in the event that Manufacturer rejects the subject Non- Complying Buy-Sell Materials or Non-Complying Customer-Supplied Materials (as applicable) at the end of such sixty (60) day period (or such other time frame as the Parties may agree upon). (e) Customer shall submit invoices to Manufacturer upon delivery to Manufacturer or its applicable Affiliate of Buy-Sell Materials, and Manufacturer shall make payments with respect thereto, in accordance with the invoice and payment requirements set forth in Section 3.5, applied correlatively, and the parties shall discuss in good faith further requirements with respect to the supply of Buy-Sell Materials. -67- Source: UPJOHN INC, 10-12G, 1/21/2020 (f) Customer shall use its commercially reasonable efforts to convert all Buy-Sell Materials arrangements to Customer-Supplied Materials arrangements as promptly as practicable after the Effective Date; provided that Customer shall provide updates with respect to such efforts at each JAC Meeting until all such Buy-Sell Materials arrangements shall have been converted to Customer-Supplied Materials arrangements. 12.2 Title and Risk of Loss. (a) Title to the Customer-Supplied Materials supplied by Customer to Manufacturer shall remain with Customer; provided, however, that risk of loss shall pass to Manufacturer at the time Customer-Supplied Materials are delivered to the Manufacturer DDP (Incoterms 2010) at the applicable Facility. Manufacturer shall not use Customer-Supplied Materials for any purposes other than those related to the manufacture of a Product pursuant to this Agreement. (b) The risk of loss or damage to Customer-Supplied Materials during the possession thereof by Manufacturer shall be solely with Manufacturer. (c) Manufacturer shall insure or self-insure the Customer-Supplied Materials and Products while such is in Manufacturer's possession at an agreed-upon value. (d) The title and risk of loss for Buy-Sell Materials shall pass to Manufacturer upon delivery to the Manufacturer DDP (Incoterms 2010) at the applicable Facility. 12.3 Reimbursement for Loss of Customer-Supplied Materials. Manufacturer shall reimburse Customer for excess Customer-Supplied Materials used as a result of Manufacturer's failure to achieve the minimum average yield or usage (as applicable) set forth in the applicable Facility Addendum. During the first quarter of each Fiscal Year during the Term of this Agreement, Manufacturer will report to Customer the actual yield achieved for all Customer-Supplied Materials used during the previous calendar year on a Facility-by-Facility basis. If the achieved yield is lower than the minimum average yield specified in the applicable Facility Addendum on an aggregated basis for all Customer- Supplied Materials for each applicable Facility Addendum, then Manufacturer will reimburse to Customer the actual cost of the excess Customer-Supplied Materials used as set forth in the applicable Facility Addendum. For the avoidance of doubt, (a) rejected batches and all Customer-Supplied Material that is, for any reason other than a determination that such Customer-Supplied Materials are non-conforming, not incorporated into Product delivered hereunder, shall be included in the annual yield calculation and (b) Customer-Supplied Materials for which Manufacturer is responsible for reimbursing Customer pursuant to Section 4.11(b) shall not be included in the annual yield calculation. -68- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"13\", \"title\": \"Confidentiality\", \"level\": 1, \"text\": \"13. Confidentiality. The confidentiality obligations of the Parties and their respective Groups with respect to disclosures of information hereunder shall be governed, mutatis mutandis, by Section 6.08, Section 6.09 and Section 6.10 of the Separation Agreement. 14. Supply Chain Security. 14.1 Supply Chain Representations. Manufacturer represents, warrants and covenants to Customer that: Manufacturer has reviewed its supply chain security procedures and that these procedures and their implementation are, and shall remain during the Term of this Agreement, in accordance with the importer security criteria set forth by the \\\"C-TPAT.\\\" Manufacturer represents and warrants that it has developed and implemented, or shall develop and implement within sixty (60) calendar days of its execution of this Agreement, procedures for periodically reviewing and, if necessary, improving its supply chain security procedures to assure compliance with C-TPAT minimum security criteria. 14.2 C-TPAT. Manufacturer acknowledges that Customer is a certified member of C-TPAT. As a C-TPAT member, Customer is required to make periodic assessment of its international supply chain based upon C-TPAT security criteria. Manufacturer agrees to conduct and document an annual security audit at each of its Facilities and to take all necessary corrective actions to ensure the continued participation of Customer in C- TPAT. Manufacturer agrees to share with Customer the results of such annual audits and agrees to prepare and submit to Customer a report on the corrective actions taken in response thereto. In addition, Customer may audit Manufacturer's Records and Facilities for the purpose of verifying that Manufacturer's procedures are in accordance with the C-TPAT security criteria, and Manufacturer shall provide Customer with access to Manufacturer's Records and Facilities reasonably necessary for the purpose of conducting such audit. Manufacturer agrees to notify Customer of any event that has resulted in or threatens the loss of its C-TPAT Benefits (if it is a member of the C-TPAT program) or alternatively jeopardizes Customer's retention of its own C-TPAT Benefits. In an effort to secure each part of the supply chain, Manufacturer agrees to work in good faith to become a member of the C-TPAT program, if Manufacturer is organized or incorporated in the United States, Mexico or Canada, or the equivalent supply chain security program criteria administered by the customs administration in Manufacturer's home country if Manufacturer is not organized or incorporated in the United States, Mexico or Canada. -69- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"15\", \"title\": \"Records and Audits\", \"level\": 1, \"text\": \"15. Records and Audits. 15.1 Records. Manufacturer will maintain complete and accurate Records. Any Records that are financial in nature such as, but not limited to, time sheets, billing Records, invoices, payment applications, payments of consultants and subcontractors and receipts relating to reimbursable expenses shall be maintained in accordance with applicable Law in the jurisdiction in which the applicable Facility is located. Manufacturer shall maintain such Records for a period equal to the later of (x) three (3) years after the expiration or termination of this Agreement or the applicable Facility Addendum, (y) the expiration of the statute of limitation for the Tax period applicable to such Records, or (z) for such period as otherwise may be required by applicable Law (the \\\"Record Retention Period\\\"). 15.2 Audits. Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"16\", \"title\": \"Notices\", \"level\": 1, \"text\": \"16. Notices. All notices or other communications hereunder shall be deemed to have been duly given and made if in writing and (a) when served by personal delivery upon the Party for whom it is intended; (b) one (1) Business Day following the day sent by overnight courier, return receipt requested; (c) when sent by facsimile; provided that the facsimile is promptly confirmed; or (d) when sent by e-mail; provided that a copy of the same notice or other communication sent by e-mail is also sent by overnight courier, return receipt requested, personal delivery, or facsimile as provided herein, on the same day as such e-mail is sent, in each case to the Person at the address, facsimile number or e-mail address set forth below, or such other address, facsimile number or e-mail address as may be designated in writing hereafter, in the same manner, by such Person: If to Customer: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] with copy (which shall not constitute notice) to: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] If to Manufacturer: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] with a copy (which shall not constitute notice) to: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] Either Party may, by notice to the other Party, change the addresses and names applicable to such Party given above. 17. Miscellaneous. 17.1 Negotiations of Dispute. The dispute resolution procedures set forth in Article VII of the Separation Agreement shall apply mutatis mutandis with respect to any controversy, claim, counterclaim, dispute, difference or misunderstanding arising out of or relating to the interpretation or application of any term or provisions of this Agreement, a Purchase Order or Facility Addendum. Further, the requirement to attempt to resolve a dispute in accordance with this Section 17.1 does not affect a Party's right to terminate this Agreement or a Purchase Order as provided in Section 7 hereof, and neither Party shall be required to follow these procedures prior to terminating this Agreement. -71- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"17.2\", \"title\": \"Publicity\", \"level\": 2, \"text\": \"17.2 Publicity. Manufacturer shall not use the name, trade name, service marks, trademarks, trade dress or logos of Customer (or any of its Affiliates) in publicity releases, advertising or any other publication, nor identify Customer as a customer, without Customer's prior written consent in each instance. Customer shall not use the name, trade name, service marks, trademarks, trade dress or logos of Manufacturer (or any of its Affiliates) in publicity releases, advertising or any other publication, without Manufacturer's prior written consent in each instance. Nothing in this Section 17.2 shall or is intended to limit any Party's rights under the Separation Agreement or any Ancillary Agreement. 17.3 Governing Law and Venue. (a) This Agreement and all Actions (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance hereof or thereof shall be governed by and construed in accordance with the Law of the State of Delaware, without regard to any Laws or principles thereof that would result in the application of the Laws of any other jurisdiction. The Parties expressly waive any right they may have, now or in the future, to demand or seek the application of a governing Law other than the Law of the State of Delaware. (b) Each of the Parties hereby irrevocably and unconditionally submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware or, if such court shall not have jurisdiction, the United States District Court for the District of Delaware, and any appellate court from any appeal thereof, in any Action arising out of or relating to this Agreement or the transactions contemplated hereby, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such Action except in such courts, (ii) agrees that any claim in respect of any such Action may be heard and determined in the Court of Chancery of the State of Delaware or, to the extent permitted by Law, in such other courts, (iii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Action in the Court of Chancery of the State of Delaware or such other courts, (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such Action in the Court of Chancery of the State of Delaware or such other courts and (v) consents to service of process in the manner provided for notices in Section 16. Nothing in this Agreement will affect the right of any Party to serve process in any other manner permitted by Law. -72- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OF THE OTHER ANCILLARY AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING THE FINANCING). EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS VOLUNTARILY AND (IV) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 17.3(C). 17.4 Relationship of the Parties. The relationship hereby established between Customer and Manufacturer is solely that of independent contractors. Manufacturer has no authority to act or make any agreements or representations on behalf of Customer or its Affiliates. This Agreement is not intended to create, and shall not be construed as creating, between Manufacturer and Customer, the relationship of fiduciary, principal and agent, employer and employee, joint venturers, co-partners, or any other such relationship, the existence of which is expressly denied. No employee or agent engaged by Manufacturer shall be, or shall be deemed to be, an employee or agent of Customer and shall not be entitled to any benefits that Customer provides to its own employees. 17.5 Assignment; Binding Effect. (a) Except as otherwise provided in this Section 17.5, neither Party shall assign this Agreement or any rights, benefits or obligations under or relating to this Agreement, in each case whether by operation of law or otherwise, without the other Party's prior written consent (not to be unreasonably withheld, conditioned or delayed). (b) Either Party may assign its rights and obligations under this Agreement to one or more of its Affiliates without the other Party's consent; provided that such Affiliate remains at all times during the Term an Affiliate of such Party; provided, further, that no such assignment shall release such Party from its obligations under this Agreement. -73- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Customer may, without Manufacturer's consent, assign the rights and obligations of this Agreement (i) on a Product-by-Product basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of all or substantially all of its business to which such Product relates or in the event of such business's spin-off, merger or consolidation with another company or business entity or (ii) to any Third Party which acquires or succeeds to all or substantially all of the assets of the business of Customer to which this Agreement and the Facility Addenda relate (including in connection with such business's spin-off, merger or consolidation with another company or business entity). (d) Subject to Section 7.4, Manufacturer may, without Customer's consent, assign the rights and obligations of this Agreement (i) on a Facility-by-Facility basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of such Facility or (ii) to any Third Party which acquires or succeeds to all or substantially all of the assets of the business of Manufacturer to which this Agreement and the Facility Addendum relates (including in connection with such business's spin-off, merger or consolidation with another company or business entity). (e) Notwithstanding anything to the contrary in this Agreement, neither Party may assign this Agreement in whole or in part to a Restricted Party. (f) In the event of a permitted assignment, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors and permitted assigns. Any attempted assignment that contravenes the terms of this Agreement shall be void ab initio and of no force or effect. Notwithstanding anything contained in this Agreement, each Party hereby acknowledges and agrees that the other Party may perform any of its obligations, and exercise any of its rights, under this Agreement, any Facility Addendum and Quality Agreement through any of its Affiliates. 17.6 Force Majeure. Subject to Manufacturer's obligations under Section 2.5(a), no Party shall be liable for any failure to perform or any delays in performance, and no Party shall be deemed to be in breach or default of its obligations set forth in this Agreement, if, to the extent and for so long as, such failure or delay is due to any causes that are beyond its reasonable control and not to its acts or omissions, including, without limitation, such causes as acts of God, natural disasters, hurricane, flood, severe storm, earthquake, civil disturbance, lockout, riot, order of any court or administrative body, embargo, acts of Government, war (whether or not declared), acts of terrorism, or other similar causes (\\\"Force Majeure Event\\\"). For clarity, raw material price increases, unavailability of raw materials, and labor disputes shall not be deemed a Force Majeure Event. In the event of a Force Majeure Event, the Party prevented from or delayed in performing shall promptly give notice to the -74- Source: UPJOHN INC, 10-12G, 1/21/2020 other Party and shall use commercially reasonable efforts to avoid or minimize the delay. In the event that the delay continues for a period of at least sixty (60) calendar days, the Party affected by the other Party's delay may elect to (a) suspend performance and extend the time for performance for the duration of the Force Majeure Event or (b) cancel all or any part of the unperformed part of this Agreement or any Purchase Orders. 17.7 Severability. If any provision of this Agreement or the application of any provision thereof to any Person or circumstance, is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The Parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the Parties. 17.8 Non-Waiver; Remedies. Waiver by any Party of any default by the other Party of any provision of this Agreement shall not be deemed a waiver by the waiving Party of any subsequent or other default, nor shall it prejudice the rights of the other Party. No failure or delay by a Party in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof, nor shall a single or partial exercise thereof prejudice any other or further exercise thereof or the exercise of any other right, power or privilege. All remedies specified in this Agreement shall be cumulative and in addition to any other remedies provided at Law or in equity. 17.9 Further Documents. Each Party hereto agrees to execute such further documents and take such further steps as may be reasonably necessary or desirable to effectuate the purposes of this Agreement. 17.10 Forms. The Parties recognize that, during the Term of this Agreement, a Purchase Order acknowledgment form or similar routine document (collectively, \\\"Forms\\\") may be used to implement or administer provisions of this Agreement. The Parties agree that the terms of this Agreement shall govern and control in the event of any conflict between terms of this Agreement and the terms of such Forms, and any additional or different terms contained in such Forms shall not apply to this Agreement. -75- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"17.11\", \"title\": \"Headings; Interpretation\", \"level\": 2, \"text\": \"17.11 Headings; Interpretation. (a) The captions in this Agreement are for convenience only and shall not be considered a part of or affect the construction or interpretation of any provision of this Agreement. (b) The definitions in Section 1 shall apply equally to both the singular and plural forms of the terms defined. (c) Unless the context of this Agreement otherwise requires: (i) (A) words of any gender include each other gender and neuter form; (B) words using the singular or plural number also include the plural or singular number, respectively; (C) derivative forms of defined terms will have correlative meanings; (D) the terms \\\"hereof,\\\" \\\"herein,\\\" \\\"hereby,\\\" \\\"hereto,\\\" \\\"herewith,\\\" \\\"hereunder\\\" and derivative or similar words refer to this entire Agreement; (E) the terms \\\"Section\\\" and \\\"Attachment\\\" refer to the specified Section or Attachment of this Agreement and references to \\\"paragraphs\\\" or \\\"clauses\\\" shall be to separate paragraphs or clauses of the Section or subsection in which the reference occurs; (F) the words \\\"include,\\\" \\\"includes\\\" and \\\"including\\\" shall be deemed to be followed by the phrase \\\"without limitation\\\"; (G) the word \\\"or\\\" shall be disjunctive but not exclusive; and (H) the word \\\"from\\\" (when used in reference to a period of time) means \\\"from and including\\\" and the word \\\"through\\\" (when used in reference to a period of time) means \\\"through and including\\\"; (ii) references to any federal, state, local, or foreign statute or Law shall (A) include all rules and regulations promulgated thereunder and (B) be to that statute or Law as amended, modified or supplemented from time to time; and (iii) references to any Person include references to such Person's successors and permitted assigns, and in the case of any Governmental Authority, to any Person succeeding to its functions and capacities. (d) Whenever this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days are specified. If any action is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action may be deferred until the next Business Day. (e) The phrase \\\"to the extent\\\" shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply \\\"if.\\\" (f) The terms \\\"writing,\\\" \\\"written\\\" and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. (g) All monetary figures shall be in United States dollars unless otherwise specified. (h) All references to \\\"this Agreement\\\" or any \\\"Facility Addendum\\\" shall include any amendments, modifications or supplements thereto. -76- Source: UPJOHN INC, 10-12G, 1/21/2020\"}, {\"id\": \"17.12\", \"title\": \"Rules of Construction\", \"level\": 2, \"text\": \"17.12 Rules of Construction. The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent. The Parties acknowledge that each Party and its attorney has reviewed and participated in the drafting of this Agreement and that any rule of construction to the effect that any ambiguities are to be resolved against the drafting Party, or any similar rule operating against the drafter of an agreement, shall not be applicable to the construction or interpretation of this Agreement. 17.13 Counterparts. This Agreement may be executed in two (2) or more counterparts (including by electronic or .pdf transmission), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature page. 17.14 Amendments. No provisions of this Agreement shall be deemed waived, amended, supplemented or modified by any Party, unless such waiver, amendment, supplement or modification is in writing and signed by the authorized representative of the Party against whom it is sought to enforce such waiver, amendment, supplement or modification. 17.15 Entire Agreement. This Agreement, the Separation Agreement, the other Ancillary Agreements, including any related annexes, exhibits, schedules and attachments, as well as any other agreements and documents referred to herein and therein, shall together constitute the entire agreement between the Parties relating to the transactions contemplated hereby and supersede any other agreements, whether written or oral, that may have been made or entered into by or among any of the Parties or any of their respective Affiliates relating to the transactions contemplated hereby. [Signature Page Follows] -77- Source: UPJOHN INC, 10-12G, 1/21/2020 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed and delivered as of the date first written above. UPJOHN INC. PFIZER INC. By: By: Name: Name: Title: Title: [Signature Page to Manufacturing and Supply Agreement] Source: UPJOHN INC, 10-12G, 1/21/2020\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of UpjohnInc_20200121_10-12G_EX-2.6_11948692_EX-2.6_Manufacturing Agreement_ Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 2.6\", \"level\": 1, \"text\": \"Exhibit 2.6 FINAL VERSION FORM OF MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN PFIZER INC. AND UPJOHN INC. DATED AS OF [\u25cf] Source: UPJOHN INC, 10-12G, 1/21/2020 TABLE OF CONTENTS Page 1.\u2003\u202fDEFINITIONS 1\"}}, {\"id\": \"party:PFIZER INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"PFIZER INC.\", \"role\": \"Manufacturer\", \"address\": \"a Delaware corporation\"}}, {\"id\": \"party:UPJOHN INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"UPJOHN INC.\", \"role\": \"Customer\", \"address\": \"a Delaware corporation\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY OF PRODUCT 13\", \"level\": 1, \"text\": \"2.\u2003\u202fSUPPLY OF PRODUCT 13\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE; PAYMENT; PRICE ADJUSTMENTS; TAXES 26\", \"level\": 1, \"text\": \"3.\u2003\u202fPRICE; PAYMENT; PRICE ADJUSTMENTS; TAXES 26\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MANUFACTURING STANDARDS AND QUALITY ASSURANCE 35\", \"level\": 1, \"text\": \"4.\u2003\u202fMANUFACTURING STANDARDS AND QUALITY ASSURANCE 35\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COVENANTS 43\", \"level\": 1, \"text\": \"5.\u2003\u202fCOVENANTS 43\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Mutual Covenants 43 5\", \"level\": 2, \"text\": \"5.1\u2003\u2002\u202fMutual Covenants 43 5.2\u2003\u2002\u202fManufacturer Covenants 44 5.3\u2003\u2002\u202fManufacturer's Social Responsibility 46 -ii- Source: UPJOHN INC, 10-12G, 1/21/2020 TABLE OF CONTENTS (continued) Page 5.4\u2003\u2002\u202fNotice of Material Events 46 5.5\u2003\u2002\u202fDisclaimer of Warranties 47\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENVIRONMENTAL COVENANTS 47\", \"level\": 1, \"text\": \"6.\u2003\u202fENVIRONMENTAL COVENANTS 47\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM; TERMINATION 49\", \"level\": 1, \"text\": \"7.\u2003\u202fTERM; TERMINATION 49\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY 55\", \"level\": 1, \"text\": \"8.\u2003\u202fINTELLECTUAL PROPERTY 55\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Customer's Intellectual Property 55 8\", \"level\": 2, \"text\": \"8.1\u2003\u2002\u202fCustomer's Intellectual Property 55 8.2\u2003\u2002\u202fImprovements and Developments 55 8.3\u2003\u2002\u202fOwnership of Other Property 56 8.4\u2003\u2002\u202fLimited Right to Use 56\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"JOINT ADVISORY COMMITTEE 56\", \"level\": 1, \"text\": \"9.\u2003\u202fJOINT ADVISORY COMMITTEE 56\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION; LIMITATIONS OF LIABILITY 58\", \"level\": 1, \"text\": \"10.\u2002\u202fINDEMNIFICATION; LIMITATIONS OF LIABILITY 58 Source: UPJOHN INC, 10-12G, 1/21/2020 TABLE OF CONTENTS (continued) Page 11.\u2002\u202fINSURANCE 65\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Requirements to Maintain 65 11\", \"level\": 2, \"text\": \"11.1\u2003\u202fRequirements to Maintain 65 11.2\u2003\u202fAmounts and Limits 65\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CUSTOMER-SUPPLIED MATERIALS; BUY-SELL MATERIALS; TRANSITION 66\", \"level\": 1, \"text\": \"12.\u2002\u202fCUSTOMER-SUPPLIED MATERIALS; BUY-SELL MATERIALS; TRANSITION 66\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply; Rejection; Transition 66 12\", \"level\": 2, \"text\": \"12.1\u2003\u202fSupply; Rejection; Transition 66 12.2\u2003\u202fTitle and Risk of Loss 68 12.3\u2003\u202fReimbursement for Loss of Customer-Supplied Materials 68\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY 69\", \"level\": 1, \"text\": \"13.\u2002\u202fCONFIDENTIALITY 69\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY CHAIN SECURITY 69\", \"level\": 1, \"text\": \"14.\u2002\u202fSUPPLY CHAIN SECURITY 69\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply Chain Representations 69 14\", \"level\": 2, \"text\": \"14.1\u2003\u202fSupply Chain Representations 69 14.2\u2003\u202fC-TPAT 69\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RECORDS AND AUDITS 70\", \"level\": 1, \"text\": \"15.\u2002\u202fRECORDS AND AUDITS 70\"}}, {\"id\": \"15.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records 70 15\", \"level\": 2, \"text\": \"15.1\u2003\u202fRecords 70 15.2\u2003\u202fAudits 70\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES 71\", \"level\": 1, \"text\": \"16.\u2002\u202fNOTICES 71\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS 71\", \"level\": 1, \"text\": \"17.\u2002\u202fMISCELLANEOUS 71 Source: UPJOHN INC, 10-12G, 1/21/2020 MANUFACTURING AND SUPPLY AGREEMENT THIS MANUFACTURING AND SUPPLY AGREEMENT (this \\\"Agreement\\\"), dated as of [\u25cf] (the \\\"Effective Date\\\"), is by and between Pfizer Inc., a Delaware corporation (hereinafter \\\"Manufacturer\\\"), and Upjohn Inc., a Delaware corporation (hereinafter \\\"Customer\\\"). Manufacturer and Customer may be referred to herein individually as a \\\"Party\\\" or collectively as the \\\"Parties\\\". W I T N E S S E T H: WHEREAS, Pfizer Inc. (\\\"Pluto\\\") and Upjohn Inc. (\\\"Spinco\\\") have entered into a Separation and Distribution Agreement, dated as of July 29, 2019 (as amended, modified or supplemented from time to time in accordance with its terms, the \\\"Separation Agreement\\\"), pursuant to which Pluto and Spinco have agreed to separate the Spinco Business from the Pluto Business so that, as of the Distribution Date, the Spinco Business shall be held by members of the Spinco Group and the Pluto Business is held by members of the Pluto Group (the \\\"Separation\\\"); WHEREAS, after the Separation, Spinco shall become a standalone publicly traded company, pursuant to the terms of the Separation Agreement and a Business Combination Agreement, dated as of July 29, 2019 (the \\\"Business Combination Agreement\\\"), by and among Pluto, Spinco, Mylan N.V., a public company with limited liability incorporated under the laws of the Netherlands, and certain of their Affiliates; and WHEREAS, in connection with the Separation, the Parties are entering into this Agreement, pursuant to which Customer desires to procure from Manufacturer, and Manufacturer desires to supply or cause one of its Affiliates to supply to Customer, Products for sale by Customer or its Affiliates in the Territory during the Term, upon the terms and subject to the conditions set forth herein. NOW, THEREFORE, in consideration of these premises and the covenants and agreements set forth herein, and intending to be legally bound thereby, the Parties hereby agree as follows: 1. Definitions. As used in this Agreement, the following capitalized terms shall have the meanings set forth below. Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to such terms in the Separation Agreement. 1.1 \\\"Accounting Method\\\" means U.S. Generally Accepted Accounting Principles (GAAP) or, if otherwise agreed by the Parties, an alternative accounting method used in the ordinary course of business. 1.2 \\\"Act\\\" means the U.S. Federal Food, Drug, and Cosmetic Act, as amended. 1.3 \\\"Action\\\" means any demand, action, claim, dispute, suit, countersuit, arbitration, inquiry, subpoena, proceeding or investigation of any nature (whether criminal, civil, legislative, administrative, regulatory, prosecutorial or otherwise) by or before any federal, state, local, foreign or international Governmental Authority or any arbitration or mediation tribunal. Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"THIS MANUFACTURING AND SUPPLY AGREEMENT\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"[\u25cf]\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Manufacturer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacturer\", \"text\": \"Pfizer Inc., a Delaware corporation\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Customer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer\", \"text\": \"Upjohn Inc., a Delaware corporation\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"Manufacturer and Customer may be referred to herein individually as a \\\"Party\\\"\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"Manufacturer and Customer may be referred to herein collectively as the \\\"Parties\\\"\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Pluto\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Pluto\", \"text\": \"Pfizer Inc.\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Spinco\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Spinco\", \"text\": \"Upjohn Inc.\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Separation Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Separation Agreement\", \"text\": \"a Separation and Distribution Agreement, dated as of July 29, 2019 (as amended, modified or supplemented from time to time in accordance with its terms, the \\\"Separation Agreement\\\")\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Separation\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Separation\", \"text\": \"the Spinco Business shall be held by members of the Spinco Group and the Pluto Business is held by members of the Pluto Group\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Business Combination Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Combination Agreement\", \"text\": \"a Business Combination Agreement, dated as of July 29, 2019\", \"definition_clause\": \"17\"}}, {\"id\": \"party:Mylan N.V.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Mylan N.V.\", \"role\": null, \"address\": \"a public company with limited liability incorporated under the laws of the Netherlands\"}}, {\"id\": \"term:Accounting Method\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Accounting Method\", \"text\": \"means U.S. Generally Accepted Accounting Principles (GAAP) or, if otherwise agreed by the Parties, an alternative accounting method used in the ordinary course of business.\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Act\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Act\", \"text\": \"means the U.S. Federal Food, Drug, and Cosmetic Act, as amended.\", \"definition_clause\": \"17\"}}, {\"id\": \"term:Action\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Action\", \"text\": \"means any demand, action, claim, dispute, suit, countersuit, arbitration, inquiry, subpoena, proceeding or investigation of any nature (whether criminal, civil, legislative, administrative, regulatory, prosecutorial or otherwise) by or before any federal, state, local, foreign or international Governmental Authority or any arbitration or mediation tribunal.\", \"definition_clause\": \"17\"}}, {\"id\": \"1.112\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Spinco\\\" shall have the meaning set forth in the Recitals\", \"level\": 2, \"text\": \"1.112 \\\"Spinco\\\" shall have the meaning set forth in the Recitals. 1.113 \\\"Standard Cost\\\" means, with respect to a given Product in a given Fiscal Year, an amount equal to: (a) the cost of Product Materials (including the cost of active ingredients, intermediates, semi-finished materials, excipients and primary and secondary packaging) associated with such Product (\\\"Standard Product Materials Cost\\\"); and (b) the Conversion Costs for such Product (\\\"Standard Conversion Cost\\\"), Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Standard Cost\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Standard Cost\", \"text\": \"means, with respect to a given Product in a given Fiscal Year, an amount equal to: (a) the cost of Product Materials (including the cost of active ingredients, intermediates, semi-finished materials, excipients and primary and secondary packaging) associated with such Product (\\\"Standard Product Materials Cost\\\"); and (b) the Conversion Costs for such Product (\\\"Standard Conversion Cost\\\"),\", \"definition_clause\": \"1.112\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply of Product\", \"level\": 1, \"text\": \"2. Supply of Product. 2.1 Agreement to Supply. (a) Affiliates and Facility Addenda. Either the entity designated above as Customer or any Affiliate of Customer and either the entity designated above as Manufacturer or any Affiliate of Manufacturer may enter into Facility Addenda under this Agreement. The entities that execute a Facility Addendum are also deemed to be \\\"Customer\\\" and \\\"Manufacturer\\\" (respectively) for all purposes of the Facility Addendum and this Agreement (with respect to the applicable Facility Addendum). (b) Supply Pursuant to Facility Addenda. During the Term of each Facility Addendum, Manufacturer shall manufacture and supply Product to Customer for the Territory applicable to such Product on the terms and subject to the conditions of this Agreement and the applicable Facility Addendum. The terms of this Agreement shall be incorporated by reference into each Facility Addendum that may be executed by the Parties or, as described in Section 2.1(a), their respective Affiliates. During the term of this Agreement, Customer may request that Manufacturer manufacture and supply to Customer clinical trial material, and the Parties shall negotiate in good faith the terms and conditions of such manufacturing and supply arrangement applying the terms and conditions of this Agreement to the extent mutually agreeable. (c) Hierarchy of Terms; Effect of Amendments. In the event of a conflict between the terms of any Facility Addendum and the terms of this Agreement, the terms of this Agreement shall govern and control, except to the extent that the applicable Facility Addendum expressly and specifically states an intent to supersede a specific section of this Agreement on a specific matter. Any amendment to the terms of this Agreement contained in a Facility Addendum shall be effective solely with respect to such Facility Addendum, and not with respect to this Agreement or any other Facility Addendum. Any amendment to the terms of this Agreement shall be effective with respect to all Facility Addenda. Except to the extent otherwise expressly stated in this Agreement, in the event of a conflict between the terms of this Agreement and the terms of the Separation Agreement, the terms of the Separation Agreement shall govern and control. (d) Use of Subcontractors. Subject to Section 2.2(a), Manufacturer shall manufacture and supply Product itself or through its Affiliates, in each case, at the applicable Facilities (and such other facilities as may be specified in the applicable Facility Addendum with respect to applicable Products). With respect to those Third-Party contractors, subcontractors or service providers used by Manufacturer or its Affiliates in the manufacturing or supply of a given Product immediately prior to the Effective Date, Manufacturer may engage such Third-Party contractors, subcontractors or -13- Source: UPJOHN INC, 10-12G, 1/21/2020 service providers to perform the same activities for such Product under this Agreement without first obtaining Customer's prior written consent. For the avoidance of doubt, the use of any Third-Party contractors, subcontractors or service providers other than in the manner expressly permitted pursuant to this Section 2.1(d) must be approved in advance in writing by Customer, such approval not to be unreasonably withheld, conditioned or delayed. Manufacturer shall be liable for all actions and omissions of its contractors, subcontractors and service providers, and any breach of the terms and conditions of this Agreement by such contractors, subcontractors or service providers shall be deemed a breach of the terms and conditions by Manufacturer under this Agreement. For the avoidance of doubt, as of the Effective Date, as between Manufacturer and Customer, Manufacturer will be solely responsible for maintaining and establishing relationships with the Third-Party contractors, subcontractors or service providers used in the manufacturing or supply of Product (other than the manufacturing or supply of Buy-Sell Materials or Customer-Supplied Materials). (e) Exclusivity. (i) Customer Exclusivity. During the Exclusivity Period, on a Product SKU-by-Product SKU and country-by-country basis within the applicable Territory, Customer shall purchase from Manufacturer, in accordance with the terms and conditions of this Agreement, at least the Exclusive Purchase Requirement of its requirements for such Product SKU in such country; provided, however, that In-Flight or Shared Volume Products shall be excluded from the exclusivity requirements set forth in this Section 2.1(e)(i). Following the Exclusivity Period (and during the Exclusivity Period, with respect to Product SKU quantities in excess of the Exclusive Purchase Requirement in accordance with the preceding sentence), nothing in this Agreement shall prevent Customer or any of its Affiliates from manufacturing Product for itself, or having Product manufactured by a Third Party, including in amounts in addition to the Purchase Orders for Product issued to Manufacturer in accordance with this Agreement. For clarity and notwithstanding anything contained herein, nothing in this Section 2.1(e)(i) (A) is intended to be inconsistent with Section 2.4(e)(i) or to otherwise indicate that Customer is subject to any requirement to purchase Product under this Agreement or (B) is intended to prevent Customer from qualifying a back-up supplier for any Product during the Exclusivity Period. -14- Source: UPJOHN INC, 10-12G, 1/21/2020 Subject to Section 2.2(b), Manufacturer shall devote adequate manufacturing capacity to be capable of manufacturing and supplying Product to Customer in accordance with the provisions of this Agreement and the Facility Addenda. Manufacturer shall promptly notify Customer if Manufacturer reasonably believes its existing capacity and demands thereon would prevent it from meeting Customer's anticipated Product requirements as set forth in any Forecast that conforms to the requirements set forth in Section 2.4. -15- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Forecasts and Purchase Orders\", \"level\": 2, \"text\": \"2.4 Forecasts and Purchase Orders. (a) VMR Products Forecasting and Purchase Orders. With respect to the VMR Products, the processes and mechanisms by which Forecasts are prepared and Purchase Orders are issued shall be as set forth in the applicable Facility Addenda and the remainder of this Section 2.4 shall not apply with respect to such VMR Products as applicable. (b) Make to Order Product Forecasts. Except as otherwise set forth in a Facility Addendum, in each calendar month during the Term of a Facility Addendum, Customer shall provide to Manufacturer a rolling Product SKU-level forecast of its estimated requirements of Make to Order Products for the eighteen (18)-month period commencing with the month in which such forecast is provided (each, a \\\"Forecast\\\"). In the event Customer delivers a Forecast where the allocation of Product requirements over the time period of the Forecast are not consistent with historical trends, at Manufacturer's request, the Parties will meet to discuss the Forecast in good faith in the context of previous allocations of Product requirements. Such Forecasts represent Customer's reasonable estimates of the quantity of Products it will require during the applicable period covered by each such Forecast. Except as otherwise set forth in a Facility Addendum, each Forecast shall be a non-binding forecast and for informational purposes only, except that: (i) the portion of such Forecast covering the first three (3) calendar months reflected therein (the \\\"Binding Forecast Period\\\") shall be binding and shall constitute a firm order for the quantity of each Product specified therein (each, a \\\"Firm Order\\\"), (ii) each of months four (4) through six (6) of a given Forecast may not differ by more than twenty-five percent (25%) (whether positive or negative) from the quantity of such Product set forth in those months in the previous Forecast, and (iii) each of months seven (7) through twelve (12) of a given Forecast may not differ by more than fifty percent (50%) (whether positive or negative) from the quantity of such Product set forth in those months in the previous Forecast. For the avoidance of doubt, (1) this subsection (b) applies to Forecasts for API and Bulk Drug Product and (2) the Forecast with respect to Finished Product shall apply to the roll-up level of the Bulk Drug Product that is incorporated into the Finished Product. (c) Make to Order Purchase Orders. Manufacturer shall provide Product to Customer pursuant to Purchase Orders issued by Customer to Manufacturer, which Purchase Orders will be issued on a Product SKU-by-Product SKU basis, not to exceed one (1) Purchase Order per Product SKU per calendar month unless otherwise agreed between the Parties in advance in writing. No verbal communications or e-mail shall be construed to mean a commitment to purchase Product. Customer shall be required to order -16- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 place such Purchase Orders for such excess quantities in Increments above the Minimum Order Quantity as specified in the applicable Facility Addendum. As used herein, \\\"Batch Size\\\" means the production quantity for a given run of a Product SKU and \\\"Increments\\\" means the quantity step change above the applicable Minimum Order Quantity, in each case, as specified in the applicable Facility Addendum. (f) Acceptance and Rejection of Orders. Within ten (10) Business Days of receipt of a Purchase Order, Manufacturer may reject such Purchase Order by written notice to Customer only on the basis that it is inconsistent with the terms of this Agreement, including a Purchase Order containing (i) a delivery schedule that is inconsistent with Section 2.4(d), (ii) a Product quantity that is inconsistent with Section 2.4(e)(ii), (iii) a Product quantity that is less than the Firm Order for the applicable period or (iv) subject to Section 2.4(c), a Product quantity that is more than one hundred ten percent (110%) of the Forecast for the applicable period. Manufacturer shall be deemed to have accepted Customer's Purchase Order for Products in the event it either (a) indicates its acceptance of Customer's Purchase Order in writing or (b) does not indicate its rejection of a Purchase Order within ten (10) Business Days of receipt pursuant to this Section 2.4(f). (g) Changes to Purchase Orders. Purchase Orders, once submitted to Manufacturer, may be amended only by mutual written agreement of the Parties; provided that Manufacturer shall exercise its commercially reasonable efforts to comply with proposed amendments to Purchase Orders that Customer may request after sending a Purchase Order to Manufacturer. (h) Cancellations. In the event that Customer cancels all or part of a Purchase Order (provided that a cancellation shall be deemed to have occurred to the extent that Customer fails to issue a Purchase Order with respect to the full amount of Product contemplated by any portion of a Forecast with respect to the Binding Forecast Period) and such cancellation is not due to Manufacturer's breach of this Agreement or any Facility Addendum, Manufacturer will use good faith efforts to reallocate capacity and mitigate any resultant costs of such cancellation and, unless otherwise set forth with respect to the relevant cancelled Product under the applicable Facility Addendum, Customer will be charged for one hundred percent (100%) of any and all non-cancellable Third-Party costs actually and reasonably incurred by Manufacturer in accordance with this Agreement prior to cancellation for materials or services related to the cancelled portion of the Purchase Order for which reasonably acceptable documentation is submitted by Manufacturer to Customer. -18- Source: UPJOHN INC, 10-12G, 1/21/2020 (i) Conflicts. In the event of any conflict between the provisions of this Agreement and any Customer Purchase Order, Manufacturer's acceptance form or Manufacturer's invoice form or any similar such forms, the provisions of this Agreement shall govern and control. (j) Product Inventory as of Effective Date. Promptly following the Effective Date, Manufacturer shall provide Customer with a Product inventory report organized by Facility, lot number, remaining shelf life, and such other data points with respect to such Product inventory as Customer may request. For the avoidance of doubt, (i) Manufacturer shall be entitled to fill Purchase Orders with such inventory that complies with the terms and conditions of this Agreement, including Section 5.2, and (ii) the Parties shall meet to discuss in good faith the disposition of all such Product inventory that does not meet the criteria set forth in (i) above. 2.5 Failure to Supply. (a) Capacity Allocation. In the event that Manufacturer fails to manufacture and deliver Product in accordance with accepted Purchase Orders or applicable Specifications, Manufacturer shall notify Customer promptly, including details of the reasons for the failure and Manufacturer's estimated timeline of when the failure will be corrected. Manufacturer shall be solely responsible for undertaking commercially reasonable measures to minimize any shortage of Product delivered to Customer as a result of such manufacturing issues. If Manufacturer fails to manufacture and deliver Product in accordance with accepted Purchase Orders or applicable Specifications by the delivery date specified in the applicable Purchase Order(s) in accordance with Section 2.4(d), other than due to a Force Majeure Event, (i) for a period of two (2) or more months past such delivery date four (4) or more times in any rolling twelve (12) month period, or (ii) for a period of four (4) or more months past such delivery date on one occasion (each of (i) and (ii), a \\\"Triggering Event\\\"), then Manufacturer shall use its best efforts to allocate on a quarterly basis its manufacturing capacity and Product Materials to the manufacture and supply of Products for Customer on a ratable basis based on the use of each during the twelve (12)-month period immediately preceding such Triggering Event (or either (1) the Term of the applicable Facility Addendum, if the Term is less than twelve (12) months, or (2) such other period set forth in the applicable Facility Addendum); provided that (A) if Customer's Minimum Order Quantity for the applicable Product(s) exceeds its ratable allocation of manufacturing capacity or Product Materials (as applicable) for the applicable quarter, Customer shall continue to accrue its allocation of capacity until such quarter when Customer's allocation of capacity is equal to or greater than its accrued allocation of capacity and (B) this Section 2.5(a) shall not apply to the extent that Customer fails to timely provide adequate Customer-Supplied Materials or Buy-Sell Materials to Manufacturer in accordance with Section 12. For the avoidance of doubt, Manufacturer shall notify Customer promptly in writing of any anticipated Triggering Event when Manufacturer has reason to believe that such Triggering Event is likely to occur and provide such information with respect to such anticipated Triggering Event as Customer may reasonably request. -19- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) Suspension of the Exclusive Purchase Requirement. In the event of a Triggering Event, Customer's Exclusive Purchase Requirement with respect to each and every Product that is the subject of the Triggering Event shall be temporarily suspended until such time as Manufacturer notifies Customer that Manufacturer is able to resume the manufacture and supply of the subject Product(s) on the terms and conditions of this Agreement (such period referred to as the \\\"Exclusive Purchase Requirement Suspension Period\\\"); provided that, (i) during such Exclusive Purchase Requirement Suspension Period, Customer shall use commercially reasonable efforts to limit its orders for the subject Product(s) to the quantities specified in the last Forecast that preceded the Triggering Event for the applicable period(s) and promptly notify Manufacturer in the event and to the extent that Customer's orders exceed such quantities specified in such Forecast and (ii) Customer shall be entitled to take delivery of Product(s) ordered during the Exclusive Purchase Requirement Suspension Period even if such delivery is scheduled for or actually occurs subsequent to the Exclusive Purchase Requirement Suspension Period. (c) Modification of the Exclusive Purchase Requirement. Upon the expiration of the Exclusive Purchase Requirement Suspension Period, Customer shall use commercially reasonable efforts to resume ordering from Manufacturer, on a Product-by-Product basis, the subject Product(s) in accordance with Customer's Exclusive Purchase Requirement during the Exclusivity Period. (d) Business Continuity. Manufacturer shall maintain a written business continuity plan to be able to assure supply of Product to Customer in the event of a disruption to supply from the primary location or Facility of manufacture, including any disruption resulting from a Force Majeure Event and make such plan available from time to time upon Customer's request. (e) Remedies. Customer shall have the right to terminate this Agreement on an affected Product-by-affected Product basis immediately upon written notice to Manufacturer in the event a Triggering Event (under clause (ii) thereof) continues for more than one hundred and eighty (180) days. Customer shall also have the right to cancel orders for any quantities of Product affected by any Triggering Event effective upon notice to Manufacturer, and Customer shall have no further obligations to purchase any such cancelled quantities of Product. In the event a Triggering Event occurs during the Exclusivity Period, Manufacturer shall, at Manufacturer's cost and expense, provide such assistance as is reasonably requested by Customer to assist any alternate manufacturer in meeting Customer's requirements for the Product until Manufacturer has remedied the cause of such Triggering Event and is -20- Source: UPJOHN INC, 10-12G, 1/21/2020 able to supply Product to Customer in its requested quantities. Such assistance shall include providing, subject in all cases to Section 2.10(h), Technical Support in respect of the affected Product(s). In the event of a Triggering Event, Manufacturer shall be liable for any actual amounts that Customer is contractually required to pay to any Third-Party customer of Customer that result from Customer's inability to supply the affected Product to such Third-Party customer as a direct result of such Triggering Event; provided that (1) Customer shall provide to Manufacturer appropriate evidence of such amounts (including invoices from the applicable customers) and the applicable contractual requirements (redacted, in each case, of information pertaining to pricing and other commercial terms that are not directly related to the claimed amounts), it being understood and agreed that, upon request, Manufacturer will enter into customary confidentiality arrangements prior to such information being shared and (2) Manufacturer shall not be liable for any such amounts in the aggregate in any Fiscal Year in excess of the aggregate Conversion Cost Markup during such Fiscal Year with respect to all Products manufactured at the Facility that is the subject of the applicable Triggering Event. \\\"Conversion Cost Markup\\\" means, for a Product for any Fiscal Year, ten percent (10%) of the product of (A) Manufacturer's Standard Conversion Cost for such Product for such Fiscal Year and (B) the quantity of such Product ordered by Customer for delivery during such Fiscal Year. The rights of Customer set forth in this paragraph are in addition to any other rights set forth in this Agreement. 2.6 Delivery; Risk of Loss. (a) Delivery. Unless otherwise set forth in the applicable Facility Addendum, Manufacturer shall deliver Product to Customer FCA (Incoterms 2010) at the applicable Facility, and all Purchase Orders will be deemed to have been completed when the quantity of Product made available to Customer at the applicable Facility is between ninety percent (90%) and one hundred and ten percent (110%) of the quantity of Product set forth in any accepted Purchase Order (each such event, a \\\"Delivery\\\"). Delivery shall occur by or within the delivery date(s) set forth in the applicable Purchase Order or such other date as may be agreed to in writing by the Parties from time to time. Without limiting Customer's rights and remedies under Section 4.8, Manufacturer acknowledges and agrees that, unless such early Delivery was agreed upon by the Parties in writing, Manufacturer shall provide Customer with such data as Customer may reasonably request from time to time for measures of key performance indicators (KPI). (b) Certificates of Compliance. Manufacturer shall include certificates of compliance and certificates of analysis with all Delivery of Product or prior to Delivery upon reasonable request of Customer. -21- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Title. Unless otherwise set forth in the applicable Facility Addendum, title to Product and risk of loss or damage shall pass to Customer upon Delivery to Customer pursuant to Section 2.6(a). 2.7 Procurement of Materials. (a) Manufacturer shall order and maintain sufficient quantities of all Product Materials, including safety stock as required by the applicable Facility Addendum, to enable Manufacturer to manufacture and Deliver Product in accordance with its Delivery obligations under this Agreement and the applicable Facility Addendum. With respect to those Third Party suppliers of Product Materials used by Manufacturer or its Affiliates in the ordinary course in the manufacturing or supply of a given Product immediately prior to the Effective Date (\\\"Manufacturer Third Party Suppliers\\\"), Manufacturer shall be permitted to purchase solely the same Product Materials from such Manufacturer Third Party Suppliers in connection with its activities under this Agreement without first obtaining Customer's prior written consent. Any other Third-Party supplier for Product Materials (or procurement of a different Product Material from any Third-Party supplier) must be approved in advance in writing by Customer (such approval not to be unreasonably withheld, conditioned or delayed). For the avoidance of doubt, as of the Effective Date, as between Manufacturer and Customer, Manufacturer will be solely responsible for maintaining and establishing relationships with the Third-Party suppliers of Product Materials. The costs of all such Product Materials shall be included in the Price of the applicable Product. (b) Unless otherwise set forth in the applicable Facility Addendum for a specific Product, Customer shall have no liability for excess or obsolete Product Materials purchased by Manufacturer, (x) except as set forth in Section 2.4(h) or Section 7.9 or (y) unless the excess or obsolescence is caused by a change to the specifications for such Product Materials or the Specifications of a given Product in accordance with this Agreement after such Product Materials have been purchased by Manufacturer based upon a Firm Order or accepted Purchase Order). (c) Customer understands and acknowledges that (i) certain Product Materials have a limited shelf-life, are long lead time items, and are subject to minimum order quantities specified by the applicable supplier and (ii) Manufacturer will rely on the Firm Orders and Forecasts to order Product Materials required to meet the Firm Orders (plus safety stock for certain Product Materials of a Product as reasonably determined by Manufacturer). In addition, Customer understands that, to ensure an orderly supply of the Product Materials, Manufacturer may elect to purchase the Product Materials in sufficient volumes to meet the production requirements for Products during part or all of the forecasted periods; provided, however, that Customer shall not have any liability with respect to any purchase by Manufacturer or any of its Affiliates of labeling or packaging materials (including labels, cartons and leaflets) in excess of the amount required to meet the Firm Order applicable at such time plus the amount of applicable Product forecasted to be ordered in months four (4) through six (6) of the Forecast applicable at such time. -22- Source: UPJOHN INC, 10-12G, 1/21/2020 (d) Manufacturer must review with Customer any assessment made (or related action proposed to be taken) by Manufacturer related to rejection or destruction of any Customer-Supplied Materials, Buy-Sell Materials, Product, or Product Materials intended for Customer's Product to discuss viability for commercial use. 2.8 Product Samples. If representative lot samples of production batches of Product are requested by Customer in order to satisfy its obligations under applicable Law, including any regulatory requirements, or to any Governmental Authority, then Manufacturer shall provide Customer (or any such Third Party as Customer shall designate) with representative lot samples of each production batch of Product promptly upon Customer's request. Customer shall be entitled to review, upon reasonable prior written notice, all manufacturing Records relating to such samples, including all analytical procedures and cleaning validation relating to the equipment used in connection with the manufacture of the samples. Such Product samples shall be Delivered to Customer (or such Third Party as Customer shall designate) in accordance with the provisions set forth in Section 2.6(a) and at the Price as determined in accordance with the terms of Section 3. Customer shall pay for such samples when invoiced in accordance with Section 3.5. 2.9 Storage. Manufacturer will store Products, Buy-Sell Materials, Product Materials, and Customer-Supplied Materials in accordance with the requirements of the Quality Agreement. With respect to those Third-Party warehouses used by Manufacturer or its Affiliates in the ordinary course for the storage of a given Product, Buy-Sell Materials, Product Materials, or Customer-Supplied Materials immediately prior to the Effective Date, Manufacturer may engage such Third-Party warehouse to perform the solely same activities for such Product, Buy- Sell Materials, Product Materials, and Customer-Supplied Materials under this Agreement without first obtaining Customer's prior written consent. The use of any Third Party warehouse for the storage of any Product, Buy-Sell Materials, Product Materials, or Customer- Supplied Materials other than in the manner expressly permitted pursuant to this Section 2.9 must be approved in advance in writing by Customer, such approval not to be unreasonably withheld, conditioned or delayed. Manufacturer shall obtain the right for Customer to audit, at Customer's expense, any such Third-Party warehouse upon reasonable prior advance written notice and during normal business hours. Manufacturer has no obligation to store Product more than fifteen (15) Business Days following the requested delivery date for such Product; provided that (a) Manufacturer shall be obligated to store Product for such longer -23- Source: UPJOHN INC, 10-12G, 1/21/2020 period as may be reasonably necessary for Customer to arrange transportation for such Product in the event that Manufacturer experiences delays in the manufacture, release, or supply of a particular Product that results in the delivery of a quantity of Product that exceeds historical or Forecast quantities of Product for the applicable period and; (b) with respect to any Product that Customer reasonably believes should not be released by Manufacturer, Manufacturer shall store such Product until the Parties' definitive resolution pursuant to this Agreement and the Quality Agreement as to whether such Product should be released. At the expiration of the applicable time frame in the preceding sentence, notwithstanding any provision of this Section 2.9 to the contrary, Manufacturer may transport and store the subject Product at a Third-Party warehouse at Customer's expense. 2.10 Transitional Support. (a) On a Product-by-Product basis, Customer may elect, upon written notice to Manufacturer, for Manufacturer to provide Customer with reasonable technical support, as more fully set forth in this Section 2.10, to transfer production of a given Product or Products to a Customer facility or a facility of an alternative source of supply as designated by Customer (such support, \\\"Technical Support\\\" and such facility, the \\\"Receiving Site\\\"). Customer may make such election for Technical Support at any time during the Term (including in the event of a Triggering Event under Section 2.5(a) or in advance of any expiration of this Agreement) or promptly after the termination or expiration of this Agreement but in no event more than ninety (90) days following the effective date of such termination or expiration. Such reasonable Technical Support shall consist of: (i) supply of a technical package to facilitate the transfer of all relevant manufacturing information for such Product(s) to the Receiving Site, including formulation descriptions, manufacturing instructions, Specifications, methods, data required for applicable regulatory submissions and facility qualification, and material supplier information, as applicable, except for any information that is subject to confidentiality obligations owing to a Third Party; provided that the technical package will not include any manufacturing information, including formulation descriptions, manufacturing instructions, Specifications, methods and material supplier information, that is generally available to or known by the public, can be obtained on reasonable terms from Third Parties or is already available or being utilized by Customer or its Affiliate at one of Customer's or its Affiliate's facilities; (ii) host site visits to the Manufacturer's Facility by Customer to observe production of the applicable Product or Products, in each case, at a mutually agreed date and subject to confidentiality procedures or requirements as may be requested or implemented by Manufacturer; provided that the request for each such visit shall be made so as to allow for sufficient advance preparation time and can be accommodated in the requested timeframe without interruption to Manufacturer's routine production or operations; -24- Source: UPJOHN INC, 10-12G, 1/21/2020 (iii) performance of high-level consultation and answering reasonable queries for Customer through the transfer process; and (iv) provision of reasonable Product samples required under applicable Law for transfer activities. (b) Customer shall be responsible for identifying and requesting any and all Technical Support that is required from Manufacturer to assure such technology transfer is successful. (c) The Parties shall reasonably cooperate and mutually agree to facilitate the provision of any additional reasonable Technical Support with respect to the applicable Product or Products to Customer, including assistance through the transfer process, Manufacturer Personnel visits to the Receiving Site and training and troubleshooting during the Receiving Site's first production run of the applicable Product or Products, in each case, as and to the extent reasonably agreed by Manufacturer in each instance (and subject to Sections 2.10(d), 2.10(e) and 2.10(f)). (d) The Parties will work together in good faith to plan for upcoming and ongoing Technical Support needs and to accommodate such plans in order to maintain ongoing business continuity. In addition, Manufacturer shall have no obligation to hire or retain any individuals or make any capital expenditures in connection with Technical Support, and Manufacturer's obligation to provide Technical Support is contingent upon the continued employment by Manufacturer of those individuals capable of providing such Technical Support. Manufacturer may terminate its obligation to provide any Technical Support with respect to the applicable Product under this Agreement if Customer or any of its Affiliates hires any Manufacturer Personnel involved in providing Technical Support to Customer hereunder (without limiting any applicable non-solicitation obligations of Customer pursuant to the Business Combination Agreement). (e) Customer shall be solely responsible for any and all regulatory or other Governmental Authority requirements, activities and related costs and expenses that arise in conjunction with any Technical Support, technology transfer of production or production of each Product to or at the Receiving Site. These activities may also include, but are not limited to, creation of additional data or technical information, analytical method modifications or other work of a technical nature required to support regulatory queries or contemporary standards and guidelines driven by the manufacturing transfer (subject to Section 8.2). -25- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Subject to the limitations and conditions set forth in this Agreement, it is the intention of the Parties that the Price of each Product reflects one hundred percent (100%) of Manufacturer's Standard Product Materials Cost plus one hundred and ten percent (110%) of Manufacturer's Standard Conversion Cost of such Product. The Price for each Product will be set forth in the currency specified in the applicable Facility Addendum. (d) Changes to the Standard Cost Methodology. Manufacturer shall have the right to change the Standard Cost methodology once per Fiscal Year; provided that any change shall be consistent with the Accounting Method and applied across all products manufactured at the applicable Facility. If Manufacturer elects to change the Standard Cost methodology, Manufacturer shall calculate both (i) the revised Standard Cost using the methodology effective during the then-current Fiscal Year of the Term of the applicable Facility Addendum and (ii) the percentage change in Standard Cost caused by the change in methodology relative to the former methodology. If such Standard Cost methodology change results in an increase of Facility Conversion Cost for Products manufactured for Customer of more than two percent (2%), then Manufacturer shall revert to the former methodology for purposes of the calculation of Price during such Fiscal Year. 3.2 Price Adjustment. (a) Product Materials Adjustment. (i) On a Facility-by-Facility basis, with respect to each full Fiscal Year of the Term of the applicable Facility Addendum, the Price of each Product manufactured at the applicable Facility will be updated to reflect one hundred percent (100%) of the full estimated amount of the increase or decrease in the cost of Product Materials for each such Product. (ii) In each Fiscal Year of the Term of this Agreement, Manufacturer shall submit a report to Customer by no later than the end of the first quarter of such Fiscal Year setting out the Facility Actual Product Materials Cost with respect to each Facility for the prior Fiscal Year. In the event that the Facility Actual Product Materials Cost differs from the Facility Estimated Product Materials Cost, when adjusted to reflect actual volume, then Manufacturer shall issue either (A) an invoice to Customer for any amounts owed by Customer to Manufacturer or (B) a credit memo for amounts owed by Manufacturer to Customer reflecting the difference between the Price as invoiced and an adjusted Price for such Fiscal Year; -27- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 than eighty percent (80%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year or (b) greater than one hundred and twenty percent (120%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year, then the Price for such Product will be updated beginning with such Facility Conversion Cost Adjustment Fiscal Year to reflect the full estimated amount of the increase or decrease in Conversion Cost. (iii) Notwithstanding anything to the contrary in this Section 3.2(b), Manufacturer shall not have the ability to adjust the Price to reflect actual volume for Products in a Facility to the extent that Customer has reduced its demand for one or more Products in such Facility due to Manufacturer's breach of or other failure to supply under this Agreement or the applicable Facility Addendum. (iv) In each Fiscal Year following the first full Fiscal Year of the Term of this Agreement, Manufacturer shall submit a report to Customer by no later than the end of the first quarter of such Fiscal Year setting out the actual volume of Product for each Facility for the prior Fiscal Year. In the event that the actual Facility Conversion Costs demonstrate that the then applicable Facility Conversion Cost Threshold has been exceeded, and Manufacturer had not previously adjusted the applicable Price in accordance with this Section 3.2(b) to account for such adjustment, then Manufacturer shall either issue (A) an invoice to Customer for any amounts owed by Customer to Manufacturer or (B) a credit memo for amounts owed by Manufacturer to Customer reflecting the difference between the Price as invoiced and the adjusted Price for such Fiscal Year; provided, however, that any such adjustment made in accordance with the foregoing shall be subject in all cases to the provisions of Section 3.2(b)(iii). For clarity, any amount owed by Customer to Manufacturer or owed by Manufacturer to Customer shall be one hundred and ten percent (110%) of Manufacturer's Conversion Cost, reduced by a 20% allowance for variable costs. Customer shall pay all undisputed amounts due in the currency specified in the applicable Facility Addendum within sixty (60) calendar days from the date of the invoice. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall notify Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice shall not result in a waiver of any of Customer's rights under this Agreement. (c) Notwithstanding the above, the price for Buy-Sell Materials will be updated annually in each year following the first Fiscal Year to reflect one hundred percent (100%) of the full estimated amount of the cost of Buy-Sell Materials to Manufacturer. Customer may not change the price of Buy-Sell -29- Source: UPJOHN INC, 10-12G, 1/21/2020 materials during any Fiscal Year. Upon any notification by Customer to Manufacturer of any reduction in the price of Buy-Sell Materials for the upcoming Fiscal Year, Manufacturer shall submit to Customer an inventory of such Buy-Sell Materials on hand and a calculation of the positive difference between the aggregate price for such Buy-Sell Materials applying the price for the current Fiscal Year and the aggregate price for such Buy-Sell Materials applying the price for the upcoming Fiscal Year. Customer shall promptly and in no event later than sixty (60) days issue to Manufacturer a credit memo in the amount of such positive difference reflected in Manufacturer's notice. (d) The increases or decreases described in this Section 3.2 shall be determined by Manufacturer in a manner consistent with the accounting methodologies used by Manufacturer as of the Effective Date and shall be based on the applicable Forecasts provided by Customer in July of the applicable Fiscal Year and applied consistently across Manufacturer's entire manufacturing operations for the full Facility. (e) Manufacturer shall notify Customer of any estimated expected changes to Prices for the upcoming Fiscal Year by no later than June 1 of the then-current Fiscal Year and shall notify Customer of any actual changes to Prices for the upcoming Fiscal Year by no later than October 30 of the then-current Fiscal Year. Between June 1 and October 30, the Parties will engage in ongoing discussions to ensure that any final changes to Prices for the applicable Fiscal Year conform to the terms and conditions of this Agreement. Manufacturer will promptly respond to Customer's inquiries regarding any proposed changes to the Price of Products and provide reasonable documentation to Customer supporting the estimated or actual change in such Prices. Any actual, adjusted Price of each Product shall become effective on the first day of the first month of such upcoming Fiscal Year. (f) Any disputes relating to changes in Price for a given Product will be resolved pursuant to Section 3.4. 3.3 Cost Improvement. At Customer's reasonable request, Manufacturer and Customer agree to discuss in good faith the implementation of possible cost reduction opportunities with the objective to reduce the net Price of Product. Without limiting the generality of the foregoing, Manufacturer shall use commercially reasonable efforts to reduce the price of Product Materials. -30- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Forecast\", \"text\": \"a rolling Product SKU-level forecast of its estimated requirements of Make to Order Products for the eighteen (18)-month period commencing with the month in which such forecast is provided\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Binding Forecast Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Binding Forecast Period\", \"text\": \"the portion of such Forecast covering the first three (3) calendar months reflected therein\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Firm Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Firm Order\", \"text\": \"a firm order for the quantity of each Product specified therein\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Batch Size\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Batch Size\", \"text\": \"means the production quantity for a given run of a Product SKU\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Increments\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Increments\", \"text\": \"means the quantity step change above the applicable Minimum Order Quantity\", \"definition_clause\": \"2.4\"}}, {\"id\": \"value:18 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"eighteen (18)-month period\"}}, {\"id\": \"value:3 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) calendar months\"}}, {\"id\": \"value:25%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"twenty-five percent (25%)\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"value:10 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) Business Days\"}}, {\"id\": \"value:110%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one hundred ten percent (110%)\"}}, {\"id\": \"value:100%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one hundred percent (100%)\"}}, {\"id\": \"term:Triggering Event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Triggering Event\", \"text\": \"(i) for a period of two (2) or more months past such delivery date four (4) or more times in any rolling twelve (12) month period, or (ii) for a period of four (4) or more months past such delivery date on one occasion\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Exclusive Purchase Requirement Suspension Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Exclusive Purchase Requirement Suspension Period\", \"text\": \"such time as Manufacturer notifies Customer that Manufacturer is able to resume the manufacture and supply of the subject Product(s) on the terms and conditions of this Agreement\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Conversion Cost Markup\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Conversion Cost Markup\", \"text\": \"means, for a Product for any Fiscal Year, ten percent (10%) of the product of (A) Manufacturer's Standard Conversion Cost for such Product for such Fiscal Year and (B) the quantity of such Product ordered by Customer for delivery during such Fiscal Year.\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Delivery\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Delivery\", \"text\": \"when the quantity of Product made available to Customer at the applicable Facility is between ninety percent (90%) and one hundred and ten percent (110%) of the quantity of Product set forth in any accepted Purchase Order\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Manufacturer Third Party Suppliers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacturer Third Party Suppliers\", \"text\": \"those Third Party suppliers of Product Materials used by Manufacturer or its Affiliates in the ordinary course in the manufacturing or supply of a given Product immediately prior to the Effective Date\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Technical Support\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Technical Support\", \"text\": \"reasonable technical support, as more fully set forth in this Section 2.10, to transfer production of a given Product or Products to a Customer facility or a facility of an alternative source of supply as designated by Customer\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Receiving Site\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Receiving Site\", \"text\": \"a Customer facility or a facility of an alternative source of supply as designated by Customer\", \"definition_clause\": \"2.4\"}}, {\"id\": \"term:Forms\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Forms\", \"text\": \"a Purchase Order acknowledgment form or similar routine document\", \"definition_clause\": \"17.2\"}}, {\"id\": \"value:2 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) or more months\"}}, {\"id\": \"value:12 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) month period\"}}, {\"id\": \"value:4 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four (4) or more months\"}}, {\"id\": \"value:180 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred and eighty (180) days\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ten percent (10%)\"}}, {\"id\": \"value:90%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ninety percent (90%)\"}}, {\"id\": \"value:15 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) Business Days\"}}, {\"id\": \"value:90 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"value:2%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"two percent (2%)\"}}, {\"id\": \"value:80%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"eighty percent (80%)\"}}, {\"id\": \"value:120%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one hundred and twenty percent (120%)\"}}, {\"id\": \"value:20%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"20%\"}}, {\"id\": \"value:60 calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) calendar days\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price Review and Audit Procedure\", \"level\": 2, \"text\": \"3.4 Price Review and Audit Procedure. (a) Manufacturer shall maintain complete and accurate Records that fairly reflect the relevant costs and calculations used to determine the Price of each Product and shall retain such Records for a period of not less than three (3) years after the applicable Product was manufactured and delivered hereunder. With respect to a Price change under Section 3.2 for any Product in an upcoming Fiscal Year, if Customer requests such a review in writing within thirty (30) days following notice to Customer of such change, then: (i) the Parties shall reasonably discuss and attempt to resolve any disagreement with respect thereto and (ii) if such disagreement is not resolved within thirty (30) days following commencement of such discussions, Customer shall have the right, no more than one (1) time per Fiscal Year each for the subject of (1) and (2) below and on no less than thirty (30) days' notice to Manufacturer, to appoint a reputable and internationally recognized independent Third-Party audit firm reasonably acceptable to Manufacturer (and which agrees to be bound by Manufacturer's customary confidentiality agreement) to audit such relevant Records, during normal business hours and on a confidential basis, to verify that, either (1) the change in the relevant Products' Price for an applicable Facility for the upcoming Fiscal Year, as applicable, or (2) the true-up determination with respect to (x) the estimated and actual Facility Conversion Costs of a Facility with respect to any Fiscal Year or (y) the Facility Estimated Product Materials Cost and the Facility Actual Product Materials Cost with respect to any Fiscal Year, was accurately and equitably calculated by Manufacturer in accordance with this Agreement; provided that Customer shall be deemed to have waived its right for such a review if Customer does not make such request within thirty (30) days following delivery of Manufacturer's notice to Customer of such increase. For the avoidance of doubt, any such audit initiated by Customer in accordance with clause (ii) above shall include in the scope of audit all of the Products manufactured at the applicable Facility, and not be limited in scope to the discrete Product(s) in question. Subject to Section 3.4(b)(2), Customer shall bear all costs and expenses of conducting such an audit, and such accounting firm shall work on an hourly or flat fee basis without a contingency fee or other performance or bonus fee. Such accounting firm shall, as promptly as practicable, provide in writing (I) a detailed report of such audit to Manufacturer and (II) a separate report limited to the Price for the subject Products in the relevant Fiscal Year as calculated by such accounting firm in accordance with this Agreement to Manufacturer and Customer. The Price for the Products during a Fiscal Year, as calculated by such accounting firm, absent any manifest error, shall be binding upon the Parties with respect to such increase or required payment, as applicable; provided that, within fifteen (15) days of receipt of the audit report, Manufacturer shall have the right to dispute such Price or calculation thereof by submitting written notice to Customer and the accounting firm accompanied by information supporting Manufacturer's position. Within thirty (30) days of receipt of Manufacturer's notice of dispute, the accounting firm shall issue its final findings with respect to the Price for the relevant Product in the relevant Fiscal Year and such decision, absent manifest error, shall be binding upon the Parties. -31- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) If, as a result of any audit by Customer pursuant to Section 3.4(a), the aggregate Price calculated by the accounting firm with respect to all Products manufactured at the applicable Facility for a Fiscal Year is: (i) less than ninety-five percent (95%) of the aggregate Price for all such Products established by Manufacturer pursuant to Section 3.2 for such Products during such Fiscal Year, then, if Customer has made payments to Manufacturer for such Products at the higher Price established by Manufacturer during such Fiscal Year, Manufacturer shall refund to Customer the overpayment made by Customer; or (ii) more than one hundred and five percent (105%) of the aggregate Price for all such Products established by Manufacturer pursuant to Section 3.2 for such Products during such Fiscal Year, then, if Customer has made payments to Manufacturer for such Products at the lower Price established by Manufacturer for such period, Customer shall promptly pay Manufacturer for the amount of the underpayment that should have been paid by Customer; in each case of clauses (i) and (ii), (1) such payment to be made within sixty (60) days of the owing Party's receipt of the relevant detailed report and final Price pursuant to Section 3.4(a) and (2) Manufacturer shall be responsible for payment of the applicable accounting firm's reasonable and actual fees in connection with such audit. 3.5 Invoices and Payment. Manufacturer shall submit invoices to Customer upon Delivery of Product. All invoices for Products will be in functional currency unless otherwise specified in the applicable Facility Addendum, and all undisputed payments hereunder shall be in full and be made without any withholding, offset or any other deductions. Manufacturer shall include the following information on all invoices: (a) the applicable Purchase Order number and billing address; (b) the quantity of Product delivered (and where applicable, the type, description or part number, if any); (c) the required delivery date specified in the applicable Purchase Order; (d) the actual date of Delivery; (e) the Price; (f) any applicable Taxes, transportation charges or other charges provided for in the applicable Purchase Order; (g) the applicable invoice number; and (h) the Delivery Facility, unless otherwise specified in the Facility Addendum. Subject to Customer's rights under Section 4.8 to reject Non-Complying Product or Product that is not otherwise Delivered in accordance with the terms of and conditions of this Agreement, Manufacturer shall invoice Customer for Product upon Delivery of the applicable Product in accordance with Section 2.6(a). Customer shall be obligated to pay only for actual quantities of -32- Source: UPJOHN INC, 10-12G, 1/21/2020 Product delivered. Unless otherwise set forth in the applicable Facility Addendum with respect to a particular Product or Products, Customer shall pay all undisputed amounts due in the currency specified in the applicable Facility Addendum within sixty (60) calendar days from the date of the invoice. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall notify Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice shall not result in a waiver of any of Customer's rights under this Agreement. If any payment required to be made under this Agreement is not made within twenty (20) days of the applicable date when such payment is due (the \\\"Late Payment Date\\\"), interest shall accrue on such past due amount from the Late Payment Date until the date payment is actually made at a quarterly rate equal to the lesser of (i) the Three-Month U.S. dollar LIBOR (Reuters Page LIBOR01) on the Late Payment Date (or the next Business Day if such Late Payment Date is not a Business Day), and (ii) the maximum rate permitted by applicable Law. Time for any payments hereunder shall be of the essence. 3.6 Taxes. (a) All sums payable under this Agreement are exclusive of any amount in respect of VAT. If any action of one Party (the \\\"Supplier\\\") under this Agreement constitutes, for VAT purposes, the making of a supply to another Party (or a member of that Party's Group) (the \\\"Recipient\\\") and VAT is or becomes chargeable on that supply, the Recipient shall pay to the Supplier, in addition to any amounts otherwise payable under this Agreement by the Recipient, a sum equal to the amount of the VAT chargeable on that supply against delivery to the Recipient of a valid VAT invoice issued in accordance with the laws and regulations of the applicable jurisdiction. (b) Without duplication of amounts covered by Section 3.6(a), Customer (or the applicable Affiliate) shall be responsible for all VAT, sales, goods and services, use, gross receipts, transfer, consumption and other similar Taxes (excluding, for clarity, Taxes imposed on net income, profits and gains and franchise Taxes), together with interest, penalties and additions thereto (\\\"Service Taxes\\\"), imposed by applicable taxing authorities on the direct sale of Products to Customer or any of its Affiliates or any payment hereunder; provided that such Service Taxes are shown on a valid invoice. If Manufacturer or any of its Affiliates is required to pay any part of such Service Taxes, Manufacturer shall provide Customer with evidence that such Service Taxes have been paid, and Customer (or its applicable Affiliate) shall reimburse Manufacturer for such Service Taxes. Manufacturer shall, upon the reasonable request of Customer, promptly revise any invoice to the extent such invoice was erroneously itemized or categorized. Each Party shall, and shall cause its Affiliates to, use commercially reasonable efforts to (i) minimize the amount of any Service Taxes imposed on the provision of Services hereunder, including by availing itself of any available exemptions from or reductions to any such -33- Source: UPJOHN INC, 10-12G, 1/21/2020 Service Taxes, and (ii) cooperate with the other Party in providing any information or documentation that may be reasonably necessary to minimize such Service Taxes or obtain such exemptions or reductions. If at any time Manufacturer (or any of its Affiliates) receives a refund (or credit or offset in lieu of a refund) of any Service Taxes borne by Customer (or any of its Affiliates), then Manufacturer or its Affiliate receiving such refund or utilizing such credit or offset shall promptly pay over the amount of such refund, credit or offset (net of all reasonable related out-of-pocket costs, expenses and Taxes incurred in respect thereof) to Customer or its applicable Affiliate, it being understood that Customer and its applicable Affiliate shall be liable for (x) any subsequent disallowance of such refund, credit or offset and any related interest, penalties or additions thereto and (y) any reasonable out-of- pocket costs and expenses related to such disallowance. (c) The Parties and their Affiliates shall reasonably cooperate to determine whether any Tax withholding applies to any amounts paid under this Agreement and, if so, shall further reasonably cooperate in (i) minimizing the amount of any such withholding Taxes, including by availing itself of any available exemptions from or reductions to any such withholding Taxes, (ii) providing any information or documentation that may be reasonably necessary to minimize such withholding Taxes or obtain such exemptions (including, without limitation, pursuant to any applicable double taxation or similar treaty) or (iii) receiving a refund of such withholding Taxes or claiming a Tax credit therefor. If any such withholding is required by applicable Law, the paying Party (or its applicable Affiliate) shall properly and timely withhold and remit such Taxes to the applicable taxing authority and use reasonable efforts to provide the other Party with a copy of any receipt (where it is common practice for the applicable taxing authority to provide such a receipt) or other documentation confirming such payment, and such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the receiving Party (or its applicable Affiliate). The paying Party (or its applicable Affiliate) shall not be required to \\\"gross up\\\" any amounts invoiced to the paying Party to account for, or otherwise compensate the receiving Party (or its applicable Affiliate) for, any Taxes that are required to be withheld under applicable Law. (d) Where a Party or any member of its Group is required by this Agreement to reimburse or indemnify the other Party or any member of its Group for any cost or expense, the reimbursing or indemnifying Party (or the applicable member of its Group) shall reimburse or indemnify the other Party (or the applicable member of its Group) for the full amount of the cost or expense, inclusive of any amounts in respect of VAT imposed on that amount to the extent properly reflected on a valid invoice, except to the extent that the reimbursed or indemnified Party reasonably determines that it (or such member of its Group), or a member of the same group as it (or such member of its Group) for VAT purposes, is entitled to credit for or repayment of that VAT from any relevant taxing authority. -34- Source: UPJOHN INC, 10-12G, 1/21/2020 (e) For purposes of this Agreement, and except as otherwise specifically provided in this Agreement, Tax matters shall be exclusively governed by the Tax Matters Agreement, and in the event of any inconsistency between the Tax Matters Agreement and this Agreement with respect to Tax matters, the Tax Matters Agreement shall control. 3.7 No Duplicative Payments. Notwithstanding anything to the contrary in this Agreement, no Party (or Affiliate thereof) shall enjoy a duplicative right, entitlement, obligation, or recovery with respect to any matter arising out of the same facts and circumstances. 4. Manufacturing Standards and Quality Assurance. 4.1 Quality Agreement. On a Facility-by-Facility and Product-by-Product basis, the Parties will comply with the requirements and provisions set forth in the Quality Agreement applicable to the applicable Facility and Product, the form of which has been attached hereto as Attachment B and, through such attachment, made a part hereof. In the event of a conflict between the terms of the applicable Quality Agreement and the terms of this Agreement, the terms of the Quality Agreement shall govern and control for all quality and regulatory compliance matters and the terms of this Agreement shall govern and control for all other matters. 4.2 Manufacturing Standards. Manufacturer shall manufacture and supply each Product (including disposing of all Waste and other materials) in accordance with all applicable Specifications, applicable Laws, requirements under the applicable Quality Agreement, and this Agreement. 4.3 Manufacturing Changes. (a) Discretionary Changes. Subject to Section 4.3(b), in the event that either Party desires to change, revise, modify or otherwise alter the Specifications, manufacturing processes, Product Materials, Buy-Sell Materials, Customer-Supplied Materials, or Facilities with respect to a given Product in any manner (each, a \\\"Manufacturing Change\\\"), the Party desiring the Manufacturing Change shall notify the other Party in writing of the proposed Manufacturing Change and the Parties will promptly meet to discuss, in good faith, the feasibility of implementing such Manufacturing Change and the allocation of costs between the Parties for such Manufacturing Change; provided that the requested Manufacturing Change will not be implemented unless and until the Parties mutually agree in writing to implement such Manufacturing Change. Unless otherwise agreed upon by the Parties, the Party requesting the Manufacturing Change will be responsible for, and will bear the costs of, any filings or other actions that either Party must take with the applicable Governmental Authority as a result of such Manufacturing Change. -35- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) Required Changes. If, at any time, a Manufacturing Change is required by a Governmental Authority in a country in which Regulatory Approval for a given Product has been granted, a Governmental Authority in a country in which Customer seeks to obtain Regulatory Approval for a given Product, or a Governmental Authority in the country in which the Facility that manufactures a given Product is located, then the Party that first has knowledge of the required Manufacturing Change shall notify the other Party in writing of such required Manufacturing Change, and Manufacturer will review such Manufacturing Change with Customer. Manufacturer will bear all costs and expenses associated with implementing the Manufacturing Change, unless such Manufacturing Change relates solely to a Product or Products manufactured for Customer (including any required labeling changes), in which case Customer will bear all costs and expenses associated with implementing such Manufacturing Change for such Product, including any changes to labeling or packaging, but only to the extent such costs are reasonable and documented. 4.4 Pest Control. Manufacturer shall manufacture all Products, and Manufacturer shall store all Product Materials, Buy-Sell Materials, Customer-Supplied Materials, and all Products, in a clean, dry area, free from insects and rodents, in a manner to prevent entry of foreign materials and contamination of Product. Manufacturer's pest control measures shall include the adequate cleaning of the Facility, control of food and drink, protection of Product from the environment, monitoring of flying and crawling pests and logs detailing findings and actions taken. Manufacturer's pest control program shall be detailed in a written procedure which complies with applicable Laws, including cGMPs, and which shall be subject to review and approval by Customer. If Customer has specific concerns about procedures in place at any Facility, Customer will present such issues in its audit findings and the Parties will discuss in good faith a mutually agreeable plan for resolution of such issues. Failure of Manufacturer to comply with this Section 4.4 shall be deemed a material breach of this Agreement. 4.5 Legal and Regulatory Filings and Requests. (a) Manufacturer shall reasonably cooperate with Customer in responding to all requests for information from, and in making all legally required filings with, Governmental Authorities in the Territory having jurisdiction to make such requests or require such filings. Manufacturer shall: (a) obtain and comply with all licenses, consents and permits required under applicable Laws in the Territory (and Manufacturer shall provide Customer with a -36- Source: UPJOHN INC, 10-12G, 1/21/2020 copy of all such licenses, consents and permits that are material upon Customer's reasonable request); and (b) comply with all applicable Laws in the Territory with respect to its manufacturing and packaging processes, the Facility or otherwise, to permit the performance of its obligations hereunder. Upon Customer's request, Manufacturer shall apply for and obtain Certificates of Pharmaceutical Production (\\\"CPP\\\") from the Governmental Authorities of the country where the Facility is located, such CPPs to be issued to countries where CPPs according to Customer's opinion are required. Manufacturer shall pay all reasonable costs necessary to obtain such CPPs and be entitled to be reimbursed against invoice by Customer at cost; provided that Manufacturer shall make good faith efforts to consolidate its invoices for such reimbursement for CPPs and submit to Customer on a Fiscal Year quarterly basis. (b) In the event that Customer wishes to extend the Territory with respect to a certain Product, Customer shall notify Manufacturer of such request and Manufacturer shall consider Customer's request in good faith. For the avoidance of doubt, in the event that the Parties agree to extend the Territory with respect to a certain Product, any resulting Manufacturing Change shall be treated as a discretionary Manufacturing Change and governed by Section 4.3(a). 4.6 Quality Tests and Checks. Manufacturer shall perform all bulk holding stability, manufacturing trials, validation (including, but not limited to, method, process and equipment cleaning validation), raw material, in-process, bulk finished product and stability (chemical and/or microbial) tests or checks required to assure the quality of a given Product and any tests or checks required by the Specifications, the Quality Agreement, applicable Facility Addendum or applicable Laws. With respect to any Product manufactured prior to Closing or located at a Facility as of Closing, Manufacturer shall maintain, continue and complete any and all such activities, tests and checks, including, without limitation, all ongoing stability testing. All costs associated with the performance of Manufacturer's obligations under this Section 4.6 (including with respect to any Product manufactured prior to Closing or located at a Facility as of Closing) are included in the Price of each Product and, accordingly, Manufacturer shall perform the foregoing at its cost and expense, without further reimbursement from Customer. Manufacturer shall obtain Product for these tests from batches of Product manufactured under this Agreement, and Manufacturer is responsible for providing all necessary technical, quality and operational resources. All tests and test results shall be performed, documented and summarized by Manufacturer in accordance with the Specifications, Quality Agreement, applicable Facility Addendum, applicable Laws and reasonable quality assurance requirements provided by Customer to Manufacturer in writing. Manufacturer shall maintain all production Records and disposition of each batch of Product. -37- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"value:3 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) years\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:15 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:95%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"ninety-five percent (95%)\"}}, {\"id\": \"value:105%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one hundred and five percent (105%)\"}}, {\"id\": \"value:20 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) days\"}}, {\"id\": \"value:Three-Month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"Three-Month\"}}, {\"id\": \"term:Manufacturing Change\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacturing Change\", \"text\": \"change, revise, modify or otherwise alter the Specifications, manufacturing processes, Product Materials, Buy-Sell Materials, Customer-Supplied Materials, or Facilities with respect to a given Product in any manner\", \"definition_clause\": \"3.4\"}}, {\"id\": \"4.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Responsibility for Non-Complying Product\", \"level\": 2, \"text\": \"4.7 Responsibility for Non-Complying Product. Manufacturer shall not release any Product for Delivery to Customer that does not conform to the covenants set forth in Section 5.2(e) (such non-conforming Product, \\\"Non-Complying Product\\\"), without the prior written approval of Customer. Manufacturer shall quarantine all such Non-Complying Products and shall promptly submit to Customer a report detailing the nature of such non-compliance and Manufacturer's recommended disposition, including the investigation and testing done. Manufacturer shall also provide any additional information regarding such Non-Complying Product as may reasonably be requested by Customer. Customer shall not be required to pay for any Non-Complying Product or for the destruction or other disposition thereof (unless an investigation determines that the root cause for such Product being Non-Complying Product is Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Material).\"}}, {\"id\": \"term:Non-Complying Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Non-Complying Product\", \"text\": \"Product that does not conform to the covenants set forth in Section 5.2(e)\", \"definition_clause\": \"4.7\"}}, {\"id\": \"4.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Rejection of Non-Complying Product\", \"level\": 2, \"text\": \"4.8 Rejection of Non-Complying Product. (a) Customer's Ability to Reject. Customer may reject any Non-Complying Product or Product that is not delivered to Customer in accordance with this Agreement by providing written notice of such rejection to Manufacturer within seventy-five (75) days following Customer's receipt of any Delivery of Product hereunder; provided, however, that Customer may, until the expiry date for a Product, provide notice of rejection of any Delivery of such Product having (i) latent defects, (ii) any defects that are not reasonably discoverable by Customer through standard inspection and testing of Products or (iii) defects caused by the breach by Manufacturer of any of its representations or warranties under this Agreement (collectively, \\\"Latent Defects\\\"); provided, further, that, and notwithstanding the foregoing, Customer shall notify Manufacturer within sixty (60) days after Customer first becomes aware of any such Latent Defect. (b) Manufacturer's Ability to Reject. Manufacturer may reject any Non-Complying Product by (i) providing Customer with no less than sixty (60) days' prior written notice of Manufacturer's intention to reject such Non-Complying Product along with the documentation set forth in Section 4.7, (ii) meeting with Customer at Customer's request to discuss the basis for the proposed rejection of the subject Non-Complying Product, and (iii) providing Customer with notice of rejection in the event that Manufacturer rejects the subject Non- Complying Product at the end of such sixty (60) day period (or such other time frame as the parties may agree upon). (c) Manufacturer's Obligation; Replacement. Manufacturer shall respond to any rejection, defect notice or any quality-related complaint from Customer pursuant to Section 4.8(a) in a timely manner or such other time frame as may be specified in the applicable Quality Agreement. Manufacturer shall conduct an analysis of the causes of any such complaint, shall report to Customer on any corrective action taken and shall reasonably consider -38- Source: UPJOHN INC, 10-12G, 1/21/2020 Customer's suggestions related to such corrective action or other quality-related matters. Customer shall promptly return any Product (or portions thereof) rejected pursuant to Section 4.8(a) to Manufacturer at Manufacturer's expense. With respect to any Non- Complying Product rejected by Customer, in addition to any other rights or remedies of Customer hereunder, Customer may elect, in its sole discretion, upon written notice to Manufacturer to either (i) have Manufacturer replace any Non-Complying Product as soon as practicable at no additional charge to Customer; provided that (A) the Manufacturer shall replace such Non-Complying Product within a period of ninety (90) days beginning on the date that the Manufacturer confirms or a Third-Party laboratory determines that the subject Product is a Non-Complying Product, and (B) if Manufacturer fails to replace such Non-Complying Product within such ninety (90) day period, then a Triggering Event shall be deemed to have occurred and the provisions of Section 2.5 shall apply; or (ii) be reimbursed for the Price of the Non-Complying Product actually paid. Manufacturer shall reimburse Customer for the cost of all Customer-Supplied Materials used to manufacture any Non-Complying Product (unless such Product is a Non-Complying Product due to any Non-Complying Customer-Supplied Material, as applicable). (d) Independent Testing. If the Parties are unable to agree on whether Product rejected by Customer is Non-Complying Product, then Manufacturer may hire an independent Third-Party laboratory, subject to Customer's prior written approval of such laboratory, not to be unreasonably withheld, conditioned or delayed, to perform testing on such rejected Product in accordance with the Specifications, applicable Laws and the Quality Agreement, which Third Party laboratory shall promptly provide the results thereof to Customer and Manufacturer. Manufacturer must engage such Third-Party laboratory within the thirty (30) day period following Manufacturer's receipt of Customer's rejection notice. If Manufacturer fails to engage such Third-Party laboratory during such thirty (30) day period, then Manufacturer will be deemed to have waived its right to engage such Third-Party laboratory. The determination of such tests shall be binding upon the Parties for all purposes hereunder; provided that, if such tests are unable to determine whether or not such rejected Product is Non-Complying Product, or if Manufacturer does not engage such Third-Party laboratory within the thirty (30) day period, then such Product shall be deemed to be Non-Complying Product. If such tests determine that the rejected Product is, or such Product is so deemed to be, Non-Complying Product, then Manufacturer shall bear the costs of such tests and Customer's remedies with respect to Non-Complying Product as set forth in this Agreement shall apply to such Non-Complying Product. Otherwise, Customer shall (i) bear the costs of such tests and shall remain obligated to pay Manufacturer the Price for such Product in accordance with Section 3 and (ii) reimburse Manufacturer for any shipping charges paid by Manufacturer pursuant to Section 4.8(c) with respect to the return of such -39- Source: UPJOHN INC, 10-12G, 1/21/2020 Product to Manufacturer. Without limiting the foregoing obligations, if Customer reasonably requests in writing, then Manufacturer shall use commercially reasonable efforts to re-deliver such Product to Customer at Customer's expense. For the avoidance of doubt, provided that the Product conforms to the minimum shelf-life dating set forth in Section 5.2(e)(v) upon initial Delivery, such minimum shelf-life dating requirement shall not apply to the subject Product upon re-delivery in accordance with the immediately preceding sentence. (e) Survival. The provisions of this Section 4.8 shall survive termination or expiration of this Agreement or the applicable Facility Addendum. 4.9 Disposal of Rejected and Non-Complying Product. All Non-Complying Product and Product rejected pursuant to this Agreement shall be removed (if applicable) and disposed of by Manufacturer in accordance with all applicable Laws, and as approved in advance by Customer in writing (such disposal cost to be at Manufacturer's expense, unless it is subsequently determined that Customer wrongly rejected such Product pursuant to Section 4.8). Manufacturer shall make documentation relating to such disposition available to Customer upon Customer's reasonable request. Manufacturer shall not sell for salvage or for any other purpose any rejected or Non-Complying Product, without the prior written approval of Customer. Manufacturer shall destroy all Non-Complying Product prior to disposal and Manufacturer shall deface and render unreadable all words or symbols that identify Customer, including Customer's trademarks and logotypes that adorn any packaging containing such Product, prior to disposal of such Product. 4.10 Maintenance and Retention of Records. Manufacturer shall maintain detailed Records with respect to Product Materials, Buy-Sell Materials, and Customer-Supplied Materials usage and finished Product production in accordance with the Quality Agreement. 4.11 Government Inspections, Seizures and Recalls. (a) Notification; Initiation of Recalls. If (i) Manufacturer determines or comes to learn that a Product distributed to the market contains a latent defect or (ii) the FDA or any other Governmental Authority conducts an inspection at Manufacturer's Facility, seizes any Product, Buy-Sell Materials, Customer-Supplied Materials, or Product Materials, requests a Recall of any Product, Buy-Sell Materials, Customer-Supplied Materials, or Product Materials, or otherwise notifies Manufacturer of any violation or potential violation of any applicable Law at the Facility, or (iii) Customer notifies Manufacturer of its intent to initiate a Recall, then, with respect to each ((i)- (iii)), Manufacturer shall promptly notify Customer (as applicable) and shall take such actions as may be required under the Specifications or Quality -40- Source: UPJOHN INC, 10-12G, 1/21/2020 Agreement. As applicable, Manufacturer shall promptly send any reports relating to such inspections, Recalls, violations or potential violations of applicable Law to Customer; provided that Manufacturer may reasonably redact any such reports to protect its confidential and proprietary Information that does not relate to Products. In the event that any such Governmental Authority requests, but does not seize, a given Product in connection with any such inspection, Manufacturer shall, to the extent reasonably practicable and permitted by applicable Law (1) promptly notify Customer of such request, (2) satisfy such request only after receiving Customer's approval, (3) follow any reasonable procedures instructed by Customer in responding to such request and (4) promptly send any samples of the applicable Product requested by the Governmental Authority to Customer. Manufacturer shall give and permit full and unrestricted access to all or any of its premises at any time to any authorized representative of any Governmental Authority or any of its agents or advisers and shall cooperate fully with any such representatives, in each case, relating to any such inspection. Manufacturer shall not initiate any Recall of Product, except as provided in the Quality Agreement, without the prior written agreement by Customer. (b) Costs. In the event a Recall results from any breach by Manufacturer of this Agreement, including Recalls on account of a given Product containing a latent defect, in addition to any other rights or remedies available to Customer under this Agreement, Manufacturer shall reimburse Customer for Customer's costs and expenses associated with such Recall, including costs of materials supplied by Customer (including Customer-Supplied Materials), shipping costs, administrative costs associated with arranging and coordinating the Recall and all actual Third Party costs associated with the distribution of replacement Product; provided that Customer shall be solely responsible for all, and shall reimburse Manufacturer for Manufacturer's costs and expenses associated with any Recall to the extent such Recall does not result from a breach by Manufacturer of this Agreement (e.g., is due to any Non- Complying Customer-Supplied Material or Non-Complying Buy-Sell Material). 4.12 Inspections. Subject to the remainder of this Section 4.12, no more than once per calendar year, upon thirty (30) days' advance written notice to Manufacturer, Customer may physically inspect or audit (consistent with Section 15.2) the Facilities under this Section 4.12; provided that Customer will use good faith efforts to choose dates of inspection or audit that do not unreasonably interfere with the operation of Manufacturer's business; provided, further, that Customer shall consider in good faith any alternative dates of inspection or audit proposed by Manufacturer within five (5) days of Manufacturer's receipt of such notice (it being understood that nothing in this Section 4.12 shall require Customer to accept any such proposed alternative dates of inspection or audit). Notwithstanding the limits set forth in the -41- Source: UPJOHN INC, 10-12G, 1/21/2020 foregoing sentence, Customer may more frequently conduct \\\"for cause\\\" physical inspections or audits of a Facility with five (5) days' advance written notice to Manufacturer if Customer has reasonable cause to believe that an inspection or audit of such Facility is warranted because Manufacturer's activities with respect to such Facility are in breach of this Agreement, applicable Laws, the Quality Agreement or the applicable Facility Addendum. Any such inspection or audit shall include access to relevant Records (subject to the terms of Section 15.2) and Personnel and being present during, as applicable, start-up manufacturing operations, validation, cleaning, sampling, laboratory testing, warehouse receiving and storage, pack out and shipping. Manufacturer shall provide technical assistance and direction to Customer and its representatives at the Facility. Subject to the terms and conditions set forth herein, Customer may conduct, at its own expense, periodic quality audits, to ensure Manufacturer's compliance with the terms of this Agreement. Manufacturer shall cooperate with Customer's representatives for all of these purposes, and shall promptly correct any deficiencies noted during the audits. Any Records or information accessed or otherwise obtained by Customer or its representatives during any such inspection or audit or any visit at any Facility shall be deemed Manufacturer's confidential and proprietary Information and each representative of Customer will be subject to non-use and other confidentiality obligations substantially comparable to those set forth herein for Customer. 4.13 Segregation of Restricted Compounds. Unless otherwise set forth in a Facility Addendum with respect to a Product, Manufacturer shall not manufacture a Product using facilities or equipment shared with the following classes of product without prior consultation and agreement with Customer: (a) steroids, hormones, or otherwise highly active or toxic products that carry a likelihood of a serious adverse effect (e.g., carcinogenicity; anaphylaxis; reproductive and/or developmental toxicity; serious target organ toxicity) following a potential product cross-contamination or carry-over scenario, particularly at low exposure concentrations (i.e., with reference to an acceptable daily exposure (ADE) value or permitted daily exposure (PDE) value < 10 \u00b5g/day); (b) immunosuppressors where the ADE or PDE value < 10 \u00b5g/day; (c) live or infectious biological agents; (d) live or attenuated vaccines; (e) biotherapeutics where the ADE or PDE value < 10 \u00b5g/day and sufficient deactivation cannot be demonstrated; (f) products exclusive for animal use; (g) non-medicinal products; or (h) radiopharmaceuticals. Manufacturer shall not manufacture any highly sensitizing products, including beta-lactam antibiotics, as well as certain non-beta-lactam antibiotics, or otherwise highly sensitizing products that can elicit an immediate hypersensitivity reaction (Type I hypersensitivity; immunoglobulin E-mediated) in the same Facility as a Product. -42- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Latent Defects\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Latent Defects\", \"text\": \"(i) latent defects, (ii) any defects that are not reasonably discoverable by Customer through standard inspection and testing of Products or (iii) defects caused by the breach by Manufacturer of any of its representations or warranties under this Agreement\", \"definition_clause\": \"4.8\"}}, {\"id\": \"value:75 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"seventy-five (75) days\"}}, {\"id\": \"value:30 day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) day period\"}}, {\"id\": \"value:5 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"4.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Packaging Material\", \"level\": 2, \"text\": \"4.14 Packaging Material. Unless otherwise provided in the applicable Facility Addendum, Customer shall determine and be responsible for the text (including any logos or other graphics) for all packaging material used in connection with Product. Manufacturer shall assure that all packaging materials are accurate and consistent with Customer's specifications for such text or graphics, including such matters as placement, size and colors. Manufacturer shall promptly notify Customer of any errors or deficiencies in such provided packaging materials. 5. Covenants. 5.1 Mutual Covenants. Each Party hereby covenants to the other Party that it will perform its activities under this Agreement in full compliance with all applicable Global Trade Control Laws, including as follows: (a) unless a license or other authorization is first obtained, the issuance of which is not guaranteed, neither Party will knowingly transfer to the other Party any goods, software, technology or services that are (1) controlled at a level other than EAR99 under the U.S. Export Administration Regulations; (2) controlled under the U.S. International Traffic in Arms Regulations; (3) specifically identified as an E.U. Dual Use Item; or (4) on an applicable export control list of a foreign country; (b) prior to engaging in any activities in a Restricted Market, involving individuals ordinarily resident in a Restricted Market or including companies, organizations, or Governmental Authorities from or located in a Restricted Market in each case in connection with this Agreement, each Party must first notify the other Party (which notice, notwithstanding Section 17, shall be addressed to (a) Pluto at gtc@pfizer.com and (b) Spinco at [\u25cf]), who will review and, if compliant with Global Trade Control Laws, approve (subject to any appropriate conditions) such activities (such approval not to be unreasonably withheld or delayed), within five (5) Business Days of such notification; provided that (1) to the extent relating to U.S. sanctions or export controls, such notification and approval shall not be required if the activity contemplated would be permissible for U.S. persons subject to U.S. sanctions (including without limitation under a U.S. Department of the Treasury Office of Foreign Assets Control general license), and (2) once notification is made and approval is granted with respect to a specific counterparty in a Restricted Market, further notification and approval will not be required for future transactions or activities with the same counterparty (unless there is a change in circumstances, processes or intermediate parties, including, but not limited to, carriers, or otherwise a change to Global Trade Control Laws relevant to that Restricted Market or counterparty); provided that, notwithstanding the foregoing, neither Party shall undertake any of the activities described in this clause (2) without the prior written approval of the other Party; and -43- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) notwithstanding anything set forth in Section 4.14 to the contrary, for the purposes of any and all packaging and shipping of any goods, software, technology or services pursuant to the activities contemplated under this Agreement, Manufacturer will determine: (i) a classification under relevant import and export laws; (ii) the country of origin; and (iii) a value for customs; provided, however, that the Party acting as the importer of record (IOR) or exporter of record (EOR) shall have the right to request a review of any determination contemplated by clause (i), (ii) or (iii) above; provided, further, that if the IOR or EOR (as applicable) disagrees with such determination, then such Party shall maintain the right to refuse to export or import the applicable goods, software, technology or services. 5.2 Manufacturer Covenants. Manufacturer hereby covenants to Customer that: (a) The Facility and all equipment, tooling and molds utilized in the manufacture and supply of Product hereunder by or on behalf of Manufacturer shall, during the Term of this Agreement, be maintained in good operating condition and shall be maintained and operated in accordance with all applicable Laws. The manufacturing and storage operations, procedures and processes utilized in manufacture and supply of Product hereunder (including the Facility) shall be in full compliance with all applicable Laws, including cGMP and health and safety laws. (b) Manufacturer shall perform all of its obligations under this Agreement in compliance with the applicable Laws in the Territory. Manufacturer is in compliance and shall continue to comply, and shall cause its Personnel to comply, with all applicable Laws, including Laws requiring Serialization; provided that, with respect to compliance with Laws requiring Serialization, Customer shall reimburse Manufacturer for all investments made or costs incurred by Manufacturer in connection with any Serialization requirements specific to a given Product or Products (which, for clarity, shall not include Serialization requirements applicable to both Products and other products produced by Manufacturer in the Facility), but only to the extent such costs are reasonable and documented and are directed specifically with respect to a Product or Products. Manufacturer has and shall continue to have, and shall cause its Personnel to have, all professional licenses, consents, authorizations, permits, and certificates, and shall have and shall cause its Personnel to have completed all registrations and made such notifications as required by applicable Law for its performance of the services under this Agreement. (c) Manufacturer shall hold during the Term of this Agreement all licenses, permits and similar authorizations required by any Governmental Authority in the Territory for Manufacturer to perform its obligations under this Agreement. -44- Source: UPJOHN INC, 10-12G, 1/21/2020 (d) Manufacturer shall have good title to all Product supplied to Customer pursuant to this Agreement and shall pass such title to Customer (or its designee) free and clear of any security interests, liens, or other encumbrances. (e) Products furnished by Manufacturer to Customer under this Agreement: (i) shall be manufactured, packaged, labeled, handled, stored and Delivered in accordance with, shall be of the quality specified in, and shall conform upon Delivery to Customer (or its designee) to, the Specifications; (ii) shall be manufactured, packaged, labeled, handled, stored and Delivered in compliance with all applicable Laws including, without limitation, cGMPs, and in accordance with the Quality Agreement, this Agreement and the applicable Facility Addendum; (iii) shall not contain any Product Material that has not been used, handled or stored by or on behalf of Manufacturer in accordance with the Specifications, all applicable Laws, the Quality Agreement, this Agreement and the applicable Facility Addendum; (iv) shall not be adulterated or misbranded within the meaning of Sections 501 and 502, respectively, of the Act or any other applicable Law; and (v) shall, at the time Delivered, have at least a remaining shelf-life as specified in the applicable Facility Addendum. Notwithstanding the foregoing clauses (i) through (v) of this Section 5.2(e) or anything else contained in this Agreement or any Facility Addendum or Quality Agreement, Manufacturer shall have no liability under this Agreement (including under Section 4.11(b) or Section 10.1) or any Facility Addendum or Quality Agreement for any Non-Complying Product which is non-complying due to any Non-Complying Customer-Supplied Materials or Non-Complying Buy-Sell Materials. (f) Manufacturer has not and will not directly or indirectly offer or pay, or authorize such offer or payment, of any money or anything of value or improperly or corruptly seek to influence any Government Official or any other Person in order to gain an improper business advantage, and, has not accepted, and will not accept in the future, such a payment. Manufacturer will comply with the Anti-Bribery and Anti-Corruption Principles set forth in Attachment D. (g) Manufacturer shall ensure that it and its Personnel comply with the standard policies, regulations and directives listed on Attachment E and incorporated herein. -45- Source: UPJOHN INC, 10-12G, 1/21/2020 Manufacturer will promptly notify Customer of any actual or anticipated events of which Manufacturer is aware that have or would be reasonably expected to have a material effect on any Product or on its ability to manufacture or supply any Product in accordance with the provisions set forth herein, including any labor difficulties, strikes, shortages in materials, plant closings, interruptions in activity and the like. -46- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"value:5 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) Business Days\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimer of Warranties\", \"level\": 2, \"text\": \"5.5 Disclaimer of Warranties. EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, NEITHER PARTY MAKES NOR RECEIVES ANY WARRANTY OF ANY KIND, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT OF ANY FIRMWARE, SOFTWARE OR HARDWARE PROVIDED OR USED HEREUNDER, AND ANY REPRESENTATIONS OR WARRANTIES ARISING FROM COURSE OF DEALING, COURSE OF PERFORMANCE OR TRADE USAGE, AND ALL SUCH REPRESENTATIONS AND WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED. 6. Environmental Covenants. 6.1 Compliance with Environmental Laws. (a) Manufacturer shall perform all of its obligations herein in compliance with all Environmental Laws and all licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws. (b) Manufacturer shall be solely responsible for all Environmental Liabilities arising from its performance of this Agreement. 6.2 Permits, Licenses and Authorization. (a) Manufacturer shall be solely responsible for obtaining, and shall obtain in a timely manner, and maintain in good standing, all licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws, whether de novo documents or modifications to existing documents, which are necessary to perform the services hereunder, and shall bear all costs and expenses associated therewith. (b) Manufacturer shall provide copies of all material items referenced in Section 6.2(a) to Customer upon request by Customer and shall operate in compliance therewith. (c) Manufacturer shall provide Customer with reasonably prompt verbal notice, confirmed in writing within twenty-four (24) hours, in the event of any major incident, which shall include any event, occurrence, or circumstance, including any governmental or private action, which materially impacts or could materially impact Manufacturer's ability to fulfill its obligations under this Agreement. These include, but are not limited to: (i) material revocation or modification of any of the documents described in Section 6.2(a), -47- Source: UPJOHN INC, 10-12G, 1/21/2020 (ii) any action by Governmental Authorities that may reasonably lead to the material revocation or modification of Manufacturer's required permits, licenses, or authorizations, as listed above, (iii) any Third Party Claim against the management or ownership of the Facility that could reasonably materially impact Manufacturer's obligations under this Agreement, (iv) any fire, explosion, significant accident, or catastrophic Release of Hazardous Materials, or significant \\\"near miss\\\" incident, (v) any significant non-compliance with Environmental Laws and (vi) any environmental condition or operating practice that may reasonably be believed to present a significant threat to human health, safety or the environment. (d) Notwithstanding the requirements noted above, each Party, whether Customer or Manufacturer, is required to create and maintain: (i) required licenses, permits and agreements, including those necessary to affect imports, exports, and activities covered by economic sanctions regulations, including annual agreements for activities involving Restricted Markets; (ii) policies, procedures, controls, and systems to support compliance with Global Trade Control Laws; and (iii) agreements with Customs Brokers, freight forwarders, financial institutions, and other third parties, as necessary. 6.3 Generation of Hazardous Wastes. Without limiting other legally applicable requirements, Manufacturer shall prepare, execute and maintain, as the generator of Waste, all registrations, notices, shipping documents and manifests required under applicable Environmental Laws and in accordance therewith. Manufacturer shall utilize only reputable and lawful Waste transportation and disposal vendors, and shall not knowingly utilize any such vendor whose operations endanger human health or the environment. 6.4 Environmental Sustainability Information. Manufacturer will disclose to Customer, on an annual basis, its results with respect to any efforts to reduce greenhouse gas emissions, water consumption or the generation of waste associated with the performance of this Agreement, to the extent Manufacturer otherwise prepares such results. 6.5 Environmental and Health and Safety Reviews. (a) Manufacturer covenants that it will, to the Manufacturer's knowledge, completely and accurately disclose to Customer all material environmental and health and safety information regarding its Products (including an obligation to supplement this information, as necessary) during the Term of this Agreement, as reasonably requested by Customer. -48- Source: UPJOHN INC, 10-12G, 1/21/2020 (b) Manufacturer shall permit Customer (at Customer's expense) to conduct reasonable annual reviews of the environmental and health and safety practices and performance of the Facilities with respect to the Products where Manufacturer's performance under this Agreement is occurring; provided that such review shall not include any invasive sampling at such Facilities and shall not unreasonably interfere with Manufacturer's operation of such Facilities. In connection with such reviews, Manufacturer shall reasonably assist in the completion of an environmental health and safety survey of Manufacturer or the scheduling of an environmental health and safety audit of the Facility, as applicable, in each case with respect to the Products. Customer shall share its findings (including any deficiencies) with Manufacturer as soon as practicable, Manufacturer shall have the sole right to report any such deficiencies to third parties and Manufacturer shall use commercially reasonable efforts to correct, at no expense to Customer, such deficiencies in its environmental and health and safety management practices with respect to the Products that are not in compliance with applicable Law or create significant risk to human health or the environment. Manufacturer acknowledges that such reviews conducted by Customer are for the benefit of Customer only; they are not a substitute for Manufacturer's own environmental and health and safety management obligations under this Agreement and accordingly, Manufacturer may not rely upon them. 7. Term; Termination. 7.1 Term of Agreement. Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"value:24 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) hours\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term of Facility Addendum\", \"level\": 2, \"text\": \"7.2 Term of Facility Addendum. In the event that Manufacturer or any of its Affiliates, directly or indirectly, sells, assigns, leases, conveys, transfers or otherwise disposes of any Facility (a \\\"Facility Disposition\\\"), then Manufacturer shall immediately notify Customer of such event and Customer shall be entitled for a period of six (6) months after the receipt of such notice to terminate any Facility Addendum with respect to such Facility for cause immediately upon written notice to Manufacturer and, in the event Customer decides not to terminate the Facility Addendum for cause, Customer shall be entitled for a period of two (2) years (or such longer period in order to obtain approval for manufacture from all applicable Governmental Authorities) after -50- Source: UPJOHN INC, 10-12G, 1/21/2020 receipt of such notice to receive Technical Support at Manufacturer's sole cost to enable Customer to orderly transfer production of affected Product or Products to a Customer facility or an alternative facility as designated by Customer; provided that Manufacturer shall notify Customer of any proposed or planned Facility Disposition by Manufacturer or any of its Affiliates as soon as reasonably practicable and in any event no later than the date that is three (3) months prior to the effective date of such Facility Disposition. 7.5 Termination in Event of Insolvency. In the event that a Party hereto (a) becomes insolvent, or institutes or has instituted against it a petition for bankruptcy or is adjudicated bankrupt, (b) executes a bill of sale, deed of trust, or a general assignment for the benefit of creditors, (c) is dissolved or liquidated or (d) has a receiver appointed for the benefit of its creditors, or has a receiver appointed on account of insolvency (in the case of clauses (a)-(d), such Party shall be referred to as the \\\"Insolvent Party\\\"), then the Insolvent Party shall immediately notify the other Party of such event and such other Party shall be entitled to (i) terminate this Agreement or any and all Facility Addenda for cause immediately upon written notice to the Insolvent Party or (ii) request that the Insolvent Party or its successor provide adequate assurances of continued and future performance in form and substance acceptable to such other Party, which shall be provided by the Insolvent Party within ten (10) calendar days of such request, and the other Party may terminate this Agreement and any or all Facility Addenda for cause immediately upon written notice to the Insolvent Party in the event that the Insolvent Party fails to provide such assurances acceptable to the other Party within such ten (10) day period. 7.6 Termination for Breach of Anti-Bribery Representation. Customer may terminate this Agreement and any and all Facility Addenda effective immediately upon notice to Manufacturer, if Manufacturer (a) breaches any of the representations and warranties set forth in Section 5.2(f) or (b) Customer learns (i) that improper payments are being or have been made or offered to any Government Official or any other Person by Manufacturer or those acting on behalf of Manufacturer with respect to any obligations performed hereunder or (ii) that Manufacturer or those acting on behalf of Manufacturer with respect to the performance of any obligations hereunder has accepted any payment, item, or benefit, regardless of value, as an improper inducement to award, obtain or retain business or otherwise gain or grant an improper business advantage from or to any other Person or entity. Further, in the event of such termination, Manufacturer shall not be entitled to any further payment, regardless of any activities undertaken or agreements with additional Third Parties entered into by Manufacturer prior to such termination, and Manufacturer shall be liable for damages or remedies as provided by this Agreement, at Law or in equity. -51- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Facility Disposition\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Facility Disposition\", \"text\": \"sells, assigns, leases, conveys, transfers or otherwise disposes of any Facility\", \"definition_clause\": \"7.2\"}}, {\"id\": \"term:Insolvent Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Insolvent Party\", \"text\": \"a Party hereto (a) becomes insolvent, or institutes or has instituted against it a petition for bankruptcy or is adjudicated bankrupt, (b) executes a bill of sale, deed of trust, or a general assignment for the benefit of creditors, (c) is dissolved or liquidated or (d) has a receiver appointed for the benefit of its creditors, or has a receiver appointed on account of insolvency\", \"definition_clause\": \"7.2\"}}, {\"id\": \"value:6 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6) months\"}}, {\"id\": \"value:2 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) years\"}}, {\"id\": \"value:3 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) months\"}}, {\"id\": \"value:10 calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) calendar days\"}}, {\"id\": \"value:10 day period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) day period\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Intellectual Property\", \"level\": 1, \"text\": \"8. Intellectual Property. 8.1 Customer's Intellectual Property. Customer hereby grants to Manufacturer a non-exclusive license during the Term to use any Customer Property and Customer-Owned Improvements and Developments solely in connection with Manufacturer performing its obligations under this Agreement or the Facility Addendum in accordance with the terms hereof or thereof, as applicable. Manufacturer shall not acquire any other right, title or interest in or to the Customer Property or Customer-Owned Improvements and Developments as a result of its performance hereunder, and any and all goodwill arising from Manufacturer's use of any Customer Property or Customer-Owned Improvements and Developments shall inure to the sole and exclusive benefit of Customer. 8.2 Improvements and Developments. (a) Each Party acknowledges and agrees that improvements or modifications to Customer Property may be made by or on behalf of Manufacturer (\\\"Improvements\\\"), and creative ideas, proprietary information, developments, or inventions may be developed under or in connection with this Agreement by or on behalf of Manufacturer (\\\"Developments\\\"), in each case either alone or in concert with Customer or Third Parties. (b) Manufacturer acknowledges and agrees that, as between the Parties, any Improvements or Developments that are specific to and otherwise solely relate to, the manufacturing, processing or packaging of Products (such Improvements and Developments, collectively, \\\"Customer-Owned Improvements and Developments\\\") shall be the exclusive property of Customer, and Customer shall own all rights, title and interest in and to such Customer-Owned Improvements and Developments. Manufacturer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Customer-Owned Improvements and Developments to Customer free and clear of any encumbrances, and Manufacturer agrees to execute, and shall cause its subcontractors and Personnel to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country. -55- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Customer acknowledges and agrees that, as between the Parties, all Improvements and Developments made by or on behalf of Manufacturer in the conduct of activities under this Agreement or a Facility Addendum other than Customer-Owned Improvements and Developments (such Improvements and Developments, collectively, \\\"Manufacturer-Owned Improvements and Developments\\\") shall be the exclusive property of Manufacturer, and Manufacturer shall own all rights, title and interest in and to such Manufacturer- Owned Improvements and Developments. Customer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Manufacturer-Owned Improvements and Developments to Manufacturer free and clear of any encumbrances, and Customer agrees to execute, and shall cause its Personnel and subcontractors to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country. 8.3 Ownership of Other Property. Unless otherwise agreed by the Parties or specified in the Separation Agreement, Customer is the sole owner of any and all tools, specifications, blueprints and designs directly owned and supplied or paid for by Customer (i.e., not any materials that are included in the Price of Product), and Manufacturer shall not use, transfer, loan or publicize any of the above, except as necessary for its performance under this Agreement. 8.4 Limited Right to Use. Subject to the provisions of Section 8.1, nothing set forth in this Agreement shall be construed to grant to Manufacturer any title, right or interest in or to any Intellectual Property controlled by Customer or any of its Affiliates. Use by Manufacturer of any such Intellectual Property shall be limited exclusively to its performance of this Agreement. 9. Joint Advisory Committee. 9.1 Formation and Role. The Parties shall, as soon as practicable but not later than within ninety (90) days after the Effective Date, form a joint advisory committee (the \\\"Joint Advisory Committee\\\" or \\\"JAC\\\"). The JAC will provide a forum for the good faith discussion of major matters related to this Agreement, including in particular (but not limited to) matters of commercial performance, supply, overall performance, capital investment and business planning (strategy and management), and the transition to Customer-Supplied Materials arrangements contemplated by Section 12.1(f), but also any other items, matters or activities, including with respect to any Facility. -56- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Improvements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Improvements\", \"text\": \"improvements or modifications to Customer Property may be made by or on behalf of Manufacturer\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Developments\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Developments\", \"text\": \"creative ideas, proprietary information, developments, or inventions may be developed under or in connection with this Agreement by or on behalf of Manufacturer\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Customer-Owned Improvements and Developments\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer-Owned Improvements and Developments\", \"text\": \"any Improvements or Developments that are specific to and otherwise solely relate to, the manufacturing, processing or packaging of Products\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Manufacturer-Owned Improvements and Developments\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacturer-Owned Improvements and Developments\", \"text\": \"all Improvements and Developments made by or on behalf of Manufacturer in the conduct of activities under this Agreement or a Facility Addendum other than Customer-Owned Improvements and Developments\", \"definition_clause\": \"8\"}}, {\"id\": \"term:Joint Advisory Committee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Joint Advisory Committee\", \"text\": \"a joint advisory committee\", \"definition_clause\": \"8\"}}, {\"id\": \"term:JAC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"JAC\", \"text\": \"a joint advisory committee\", \"definition_clause\": \"8\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Membership; Chairs\", \"level\": 2, \"text\": \"9.2 Membership; Chairs. (a) Membership. The JAC shall consist of up to five (5) representatives appointed by each Party in writing, or such other number of representatives as the Parties may agree in writing from time to time (each, a \\\"JAC Member\\\"). Either Party may invite any person that is not a JAC Member (including consultants and advisors of a Party) to participate in meetings of the JAC, without a right to participate in the discussions of the JAC, so long as (i) such person is under an appropriate obligation of confidentiality, (ii) the inviting Party provided at least three (3) Business Days' prior notice to the other Party identifying such person and (iii) the non- inviting Party does not reasonably object to such person participating in the discussions of the JAC prior to such meeting. (b) JAC Chairs. The JAC shall be co-chaired by one JAC Member of each Party (each, a \\\"JAC Chair\\\"), to be elected by the respective Party when naming its JAC Members. The JAC Chairs shall cooperate in good faith to: (i) notify the JAC Members of each Party of each JAC Meeting, which notice shall be provided at least thirty (30) calendar days in advance of such meeting (to the extent practicable) with respect to the ordinary quarterly JAC Meetings; (ii) collect and organize agenda items for each JAC Meeting, and circulate such agenda to all JAC Members at least two (2) Business Days prior to each meeting date; provided, however, that any JAC Member shall be free to propose additional topics to be included on such agenda, either prior to or in the course of any JAC Meeting; (iii) preside at JAC Meetings; and (iv) prepare the written minutes of each JAC Meeting and circulate such minutes for review and approval by the JAC Members of each Party, and identify action items to be carried out. 9.3 Meetings. (a) Ordinary JAC Meetings. During the Term of this Agreement, the JAC shall meet on a quarterly basis or as otherwise determined in writing by the Parties, and such meetings may be conducted in person, by videoconference or by telephone conference (each such meeting, a \\\"JAC Meeting\\\"). In-person meetings of the JAC will alternate between appropriate venues of each Party, as reasonably determined by the Parties. The Parties shall each bear all expenses of their respective representatives relating to their participation on the JAC. The members of the JAC also may convene or be polled or consulted from time to time by means of telecommunications, video or telephone conferences, electronic mail or correspondence, as deemed necessary or appropriate. (b) Additional JAC Meetings. Either Party may call an additional meeting of the JAC at any time upon twenty (20) Business Days' prior written notice if such Party reasonably determines that there is a need for discussions at the level of a JAC Meeting on top of the ordinary quarterly JAC Meetings, and reasonably specifies such grounds in its notice to the other Party. -57- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Provision of Information. Upon the request of the JAC Chairs or at least four (4) members of the JAC, each Party will provide written materials and information relating to matters within the purview of the JAC in advance of a JAC Meeting. In addition, the JAC shall be informed by each Party in good faith about any matters or issues within the purview of the JAC which a Party should reasonably deem to be of high importance for the other Party. 9.4 Areas of Responsibility. Subject to the terms of this Agreement, the JAC shall act as a forum to discuss in good faith in particular the following major items, matters and areas of interest: (a) Oversee, review and coordinate the activities of the Parties under this Agreement; (b) Each Facility's overall performance under this Agreement; and (c) Any other major matters, roles, obligations and responsibilities under this Agreement, to the extent any Party reasonably provides such matter to the JAC for discussion. 9.5 Advisory Role; No Decision-Making Authority. (a) Advisory Role. The JAC and its members shall only have an advisory role and shall discuss in good faith and provide to the Parties its opinion on the matters in its purview. The Parties agree to reasonably take into account the opinions and views expressed by the JAC and its members for performing their respective obligations under this Agreement. (b) No Decision-Making Authority. The JAC shall have no decision-making authority over the matters in its purview unless the Parties mutually decide in writing to delegate the decision-making authority on such specific item or matter to the JAC. Moreover, it shall not be within the authority of the JAC to (i) directly impose on either Party or its Affiliates any additional obligation(s) or a resolution on the Parties with respect to any dispute regarding the existence or extent/amount of any obligation, including payments obligations, under this Agreement, or to (ii) amend, modify or waive compliance with this Agreement. 10. Indemnification; Limitations of Liability. 10.1 Indemnification of Customer. (a) Subject to the provisions of this Section 10 and, for clarity, without limiting anything in the Separation Agreement or any other Ancillary Agreements, Manufacturer shall indemnify, defend and hold harmless Customer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of the heirs, executors, successors and assigns of any of the foregoing (each, a \\\"Customer Indemnified Party\\\") from and against any and all Losses of such Customer -58- Source: UPJOHN INC, 10-12G, 1/21/2020 Indemnified Parties to the extent relating to, arising out of or resulting from any Action of a Third Party arising out of or resulting from any of the following items (without duplication): (i) any breach by Manufacturer or its Personnel of this Agreement or any Facility Addendum; (ii) any injury or death of any Person due to any breach by Manufacturer or its Personnel of this Agreement or any Facility Addendum; (iii) the infringement or misappropriation of a Third Party's Intellectual Property by the use or practice by Manufacturer or its Affiliate of any Product manufacturing process that has been changed (including as to the facility in which such manufacturing process takes place) on or following the Effective Date without the written approval of Customer to make such change; (iv) Manufacturer's supply of Non-Complying Product under this Agreement; or (v) the gross negligence, fraud or willful misconduct of Manufacturer or its Personnel in connection with the performance or non-performance of this Agreement. (b) Notwithstanding the foregoing, Manufacturer shall not be liable for Losses described in Section 10.1(a) to the extent such Losses are: (i) caused by the gross negligence, fraud or willful misconduct of a Customer Indemnified Party in connection with the performance or non-performance of this Agreement; (ii) caused by the breach of any of the terms of this Agreement or a Facility Addendum by a Customer Indemnified Party, including in connection with the performance or non-performance of this Agreement or (iii) subject to Customer's indemnification obligations pursuant to Section 10.2. 10.2 Indemnification of Manufacturer. (a) Subject to the provisions of this Section 10 and, for clarity, without limiting anything in the Separation Agreement or any Ancillary Agreements, Customer shall indemnify, defend and hold harmless Manufacturer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of the heirs, executors, successors and assigns of any of the foregoing (each, a \\\"Manufacturer Indemnified Party\\\") from and against any and all Losses of such Manufacturer Indemnified Parties to the extent relating to, arising out of or resulting from any Action of a Third Party arising out of or resulting from any of the following items (without duplication): (i) any breach by Customer or its Personnel of this Agreement or any Facility Addendum; (ii) the gross negligence, fraud or willful misconduct of Customer or its Personnel in connection with the performance or non-performance of this Agreement; (iii) the infringement or misappropriation of a Third Party's Intellectual Property by the use or practice by Manufacturer or its Affiliate in performance of this Agreement of any Product manufacturing process that has been changed with the written approval of Customer to make such change; (iv) Customer's supply of Non-Complying Customer-Supplied Materials or Non-Complying Buy- Sell Materials under this Agreement; or (v) the use, sale, offer for sale, import or other commercialization of any Product (including any injury or death of any Person due to any of the foregoing in this clause (v)). -59- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020 counsel for all Indemnitees if the claim for indemnification relates to or arises in connection with any criminal action, indictment or allegation or if such Third-Party Claim seeks an injunction or equitable relief against the Indemnitee (and not any Indemnifying Party or any of its Affiliates). Within thirty (30) days after the receipt of notice from an Indemnitee in accordance with Section 10.3(a) (or sooner, if the nature of such Third-Party Claim so requires), the Indemnifying Party shall notify the Indemnitee of its election whether the Indemnifying Party will assume responsibility for defending such Third-Party Claim, which election shall specify any reservations or exceptions to its defense. After notice from an Indemnifying Party to an Indemnitee of its election to assume the defense of a Third-Party Claim, such Indemnitee shall have the right to employ separate counsel and to participate in (but not control) the defense, compromise, or settlement thereof, but the fees and expenses of such counsel shall be the expense of such Indemnitee; provided, however, in the event that the Indemnifying Party has elected to assume the defense of the Third-Party Claim but has specified, and continues to assert, any reservations or exceptions in such notice, then, in such case, the reasonable fees and expenses of one separate counsel for all Indemnitees shall be borne by the Indemnifying Party; and provided further that the Indemnifying Party will pay the reasonable fees and expenses of such separate counsel if, based on the reasonable opinion of legal counsel to the Indemnitee, a conflict or potential conflict of interest exists between the Indemnifying Party and the Indemnitee which makes representation of both parties inappropriate under applicable standards of professional conduct. (c) If an Indemnifying Party elects not to assume responsibility for defending a Third-Party Claim, or fails to notify an Indemnitee of its election as provided in Section 10.3(b), then the applicable Indemnitee may defend such Third-Party Claim at the cost and expense of the Indemnifying Party to the extent indemnification is available under the terms of this Agreement. If an Indemnifying Party elects not to assume responsibility for defending a Third-Party Claim, or fails to notify an Indemnitee of its election as provided in Section 10.3(b), then, it shall not be a defense to any obligation of the Indemnifying Party to pay any amount in respect of such Third-Party Claim that the Indemnifying Party was not consulted in the defense thereof, that such Indemnifying Party's views or opinions as to the conduct of such defense were not accepted or adopted, that such Indemnifying Party does not approve of the quality or manner of the defense thereof or, subject to Section 10.3(d), that such Third-Party Claim was incurred by reason of a settlement rather than by a judgment or other determination of liability. (d) Neither Party may settle or compromise any Third-Party Claim for which either Party is seeking to be indemnified hereunder without the prior written consent of the other Party, which consent may not be unreasonably withheld, conditioned or delayed, unless such settlement or compromise is solely for monetary damages that are fully payable by the settling or compromising party, does not involve any admission, finding or determination of wrongdoing or violation of Law by the other Party and provides for a full, unconditional and irrevocable release of the other Party from all Liability in connection with the Third-Party Claim. -61- Source: UPJOHN INC, 10-12G, 1/21/2020 Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:JAC Member\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"JAC Member\", \"text\": \"up to five (5) representatives appointed by each Party in writing, or such other number of representatives as the Parties may agree in writing from time to time\", \"definition_clause\": \"9.2\"}}, {\"id\": \"term:JAC Chair\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"JAC Chair\", \"text\": \"one JAC Member of each Party\", \"definition_clause\": \"9.2\"}}, {\"id\": \"term:JAC Meeting\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"JAC Meeting\", \"text\": \"meetings may be conducted in person, by videoconference or by telephone conference\", \"definition_clause\": \"9.2\"}}, {\"id\": \"term:Customer Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer Indemnified Party\", \"text\": \"Customer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of the heirs, executors, successors and assigns of any of the foregoing\", \"definition_clause\": \"9.2\"}}, {\"id\": \"term:Manufacturer Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacturer Indemnified Party\", \"text\": \"Manufacturer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of the heirs, executors, successors and assigns of any of the foregoing\", \"definition_clause\": \"9.2\"}}, {\"id\": \"value:3 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) Business Days'\"}}, {\"id\": \"value:30 calendar days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) calendar days\"}}, {\"id\": \"value:2 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two (2) Business Days\"}}, {\"id\": \"value:20 Business Days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty (20) Business Days'\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification Obligations Net of Insurance Proceeds and Other Amounts\", \"level\": 2, \"text\": \"10.5 Indemnification Obligations Net of Insurance Proceeds and Other Amounts. (a) The Parties intend that any Loss subject to indemnification or reimbursement pursuant to this Section 10 will be net of Insurance Proceeds or other amounts actually recovered (net of any out-of-pocket costs or expenses incurred in the collection thereof) from any Person by or on behalf of the Indemnitee in respect of any indemnifiable Liability. Accordingly, the amount that any Indemnifying Party is required to pay to any Indemnitee will be reduced by any Insurance Proceeds or other amounts actually recovered (net of any out-of-pocket costs or expenses incurred in the collection thereof) from any Person by or on behalf of such Indemnitee in respect of the related Loss. If an Indemnitee receives a payment (an \\\"Indemnity Payment\\\") required by this Agreement from an Indemnifying Party in respect of any Loss and subsequently receives Insurance Proceeds or any other amounts in respect of the related Loss, then the Indemnitee will pay to the Indemnifying Party an amount equal to the excess of the Indemnity Payment received over the amount of the Indemnity Payment that would have been due if the Insurance Proceeds or such other amounts (net of any out-of-pocket costs or expenses incurred in the collection thereof) had been received, realized or recovered before the Indemnity Payment was made. (b) An insurer that would otherwise be obligated to pay any claim shall not be relieved of the responsibility with respect thereto or, solely by virtue of any provisions contained in this Agreement, have any subrogation rights with respect thereto, it being expressly understood and agreed that no insurer or any other Third Party shall be entitled to a \\\"wind-fall\\\" (i.e., a benefit that such insurer or other Third Party would not be entitled to receive in the absence of the indemnification provisions) by virtue of the indemnification provisions hereof. Each Party shall, and shall cause the members of its Group to, use commercially reasonable efforts (taking into account the probability of success on the merits and the cost of expending such efforts, including attorneys' fees and expenses) to collect or recover any Insurance Proceeds that may be collectible or recoverable respecting the Liabilities for which indemnification may be available under this Section 10. Notwithstanding the foregoing, an Indemnifying Party may not delay making any indemnification payment required under the terms of this Agreement, or otherwise satisfying any indemnification obligation, pending the outcome of any Action to collect or recover Insurance Proceeds, and an Indemnitee need not attempt to collect any Insurance Proceeds prior to making a claim for indemnification or receiving any Indemnity Payment otherwise owed to it under this Agreement or any Ancillary Agreement. -63- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Indemnity Payment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnity Payment\", \"text\": \"a payment required by this Agreement from an Indemnifying Party in respect of any Loss\", \"definition_clause\": \"10.5\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Additional Matters\", \"level\": 2, \"text\": \"10.6 Additional Matters. (a) Indemnification payments in respect of any Liabilities for which an Indemnitee is entitled to indemnification under this Section 10 shall be paid reasonably promptly (but in any event within sixty (60) days of the final determination of the amount that the Indemnitee is entitled to indemnification under this Section 10) by the Indemnifying Party to the Indemnitee as such Liabilities are incurred upon demand by the Indemnitee, including reasonably satisfactory documentation setting forth the basis for the amount of such indemnification payment, documentation with respect to calculations made and consideration of any Insurance Proceeds that actually reduce the amount of such Liabilities. (b) If (i) a Party incurs any Liability arising out of this Agreement or any Ancillary Agreement; (ii) an adequate legal or equitable remedy is not available for any reason against the other Party to satisfy the Liability incurred by the incurring Party; and (iii) a legal or equitable remedy may be available to the other Party against a Third Party for such Liability, then the other Party shall use its commercially reasonable efforts to cooperate with the incurring Party, at the incurring Party's expense, to permit the incurring Party to obtain the benefits of such legal or equitable remedy against the Third Party. (c) If payment is made by or on behalf of any Indemnifying Party to any Indemnitee in connection with any Third-Party Claim, such Indemnifying Party shall be subrogated to and shall stand in the place of such Indemnitee as to any events or circumstances in respect of which such Indemnitee may have any right, defense or claim relating to such Third-Party Claim against any claimant or plaintiff asserting such Third-Party Claim or against any other Person. Such Indemnitee shall cooperate with such Indemnifying Party in a reasonable manner, and at the cost and expense of such Indemnifying Party, in prosecuting any subrogated right, defense or claim. (d) In the event of an Action in which the Indemnifying Party is not a named defendant, if either the Indemnitee or Indemnifying Party shall so request, the Parties shall endeavor to substitute the Indemnifying Party for the named defendant or otherwise add the Indemnifying Party as party thereto, if at all practicable. If such substitution or addition cannot be achieved for any reason or is not requested, the named defendant shall allow the Indemnifying Party to manage the Action as set forth in this Section 10, and the Indemnifying Party shall fully indemnify the named defendant against all costs of defending the Action (including court costs, sanctions imposed by a court, attorneys' fees, experts fees and all other external expenses), the costs of any judgment or settlement, and the cost of any interest or penalties relating to any judgment or settlement with respect to such Third-Party Claim. -64- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 1, \"text\": \"11. Insurance. 11.1 Requirements to Maintain. During the Term, Manufacturer shall self-insure or shall provide and maintain such insurance coverage, in minimum types and amounts as described below in this Section 11. (a) Any and all deductibles or retentions for such insurance policies shall be assumed by, for the account of, and at Manufacturer's sole risk. (b) To the extent of the liabilities assumed by Manufacturer under this Agreement, such insurance policies of Manufacturer shall be primary and non-contributing with respect to any other similar insurance policies available to Customer or its Affiliates. (c) Manufacturer shall furnish to Customer certificates of insurance (electronic is acceptable), evidencing the required insurance coverage, upon execution of this Agreement and annually, thereafter. 11.2 Amounts and Limits. The insurance required under this Section 11 shall be written for not less than any limits of liability specified herein or as required by applicable Law, whichever is greater. All insurance carriers shall have a minimum of \\\"A-\\\" A.M. Best rating. Manufacturer shall have the right to provide the total limits required by any combination of self-insurance, primary and umbrella/excess coverage; said insurance to include the following: (a) Insurance for liability under the workers' compensation or occupational disease Laws of any state of the United States (or be a qualified self-insurer in those states of the United States) or otherwise applicable with respect to Persons performing the services and employer's liability insurance covering all claims by or in respect to the employees of Manufacturer, providing: (i) Coverage for the statutory limits of all claims under the applicable State Workers' Compensation Act or Acts. If a Facility Addendum will result in exposures under the U.S. Longshore and Harbor Workers' Compensation Act and its amendments (work dockside or on water), the Jones Act (involving seamen, masters and crew of vessels) or the Federal Employers' Liability Act (railroad exposure), coverage shall be extended to include insurance coverages mandated thereby; (ii) Employer's liability insurance with a limit of not less than $1,000,000; (iii) Manufacturer warrants that all of its employees involved in this Agreement are covered by statutory workers' compensation; and -65- Source: UPJOHN INC, 10-12G, 1/21/2020 (iv) Where allowed by Applicable Law, Customer and its Affiliates shall be provided a waiver of subrogation, except for losses due to the sole negligence of Manufacturer. (b) Commercial general liability insurance with the following limits and forms/endorsements: Each Occurrence: $2,000,000 (i) Occurrence form including premises and operations coverage, property damage, liability, personal injury coverage, products and completed operations coverage, and transit. (ii) To the extent of Manufacturer's indemnification obligations, Customer and its Affiliates shall be additional insureds via ISO form CG20101185 or its equivalent. (c) Automobile and Truck Liability Insurance: $2,000,000 combined single limit for bodily injury and property damage arising out of all owned, non- owned and hired vehicles, including coverage for all automotive and truck equipment used in the performance of this Agreement and including the loading and unloading of same. (d) Umbrella (excess) liability coverage in an amount not less than $3,000,000 per occurrence and in the aggregate. (e) If Manufacturer has care, custody or control of Customer-Supplied Material, Manufacturer shall be responsible for any loss or damage to it and provide all risk property coverage at full replacement cost for property and at the costs-per-unit as specified in the Facility Addendum for inventory. 12. Customer-Supplied Materials; Buy-Sell Materials; Transition. 12.1 Supply; Rejection; Transition. (a) Customer shall at its own expense supply Manufacturer with the Customer-Supplied Materials identified in the applicable Facility Addendum. Customer shall supply Manufacturer with the Buy-Sell Materials at a price that Customer determines, subject to Section 3.2(c), and communicates to Manufacturer. At Customer's option, the Customer-Supplied Materials and Buy-Sell Materials may be delivered directly from Customer's Third-Party vendor to Manufacturer at the vendor's or Customer's expense. Customer or its vendor shall supply Manufacturer with a copy of the certificate of analysis for the Customer-Supplied Materials and Buy-Sell Materials no later than delivery of the Customer-Supplied Materials or Buy-Sell Materials to Manufacturer. Customer hereby covenants to Manufacturer that each Customer-Supplied Material and Buy-Sell Materials furnished by or on behalf of Customer to Manufacturer or its Affiliate or designee under -66- Source: UPJOHN INC, 10-12G, 1/21/2020 this Agreement will, upon delivery by Customer to Manufacturer pursuant to this Agreement, comply with, and have been used, handled and stored in accordance with, the specifications for such Customer-Supplied Materials or Buy-Sell Materials (as applicable), all applicable Laws, the Quality Agreement, this Agreement and the applicable Facility Addendum and otherwise have no defects. Manufacturer's obligations to manufacture and supply Product under this Agreement are subject to and conditioned upon Customer's timely delivery of Customer-Supplied Material and Buy-Sell Materials in accordance with this Section 12. (b) Manufacturer shall provide to Customer a monthly rolling forecast of its requirements for Customer-Supplied Materials and Buy-Sell Materials based upon Customer's Forecasts for Products, and Manufacturer shall issue to Customer \\\"pro forma\\\" purchase orders for Customer-Supplied Materials and actual purchase orders for Buy-Sell Materials, in each case, according to parameters included in the applicable Facility Addendum, including safety stock and lead time requirements. Manufacturer shall be responsible to receive, sample, store and maintain the inventory of such ordered Customer-Supplied Materials and Buy-Sell Materials at Manufacturer's Facility. (c) Within each calendar month during the Term, Manufacturer will provide a monthly inventory report of Customer-Supplied Materials substantially in the format attached as Attachment C to this Agreement. The Parties acknowledge and agree that the Manufacturer's timely providing the referenced monthly inventory report is a critical component of the Customer's Customer-Supplied Materials management program and further that any such failure on the part of Manufacturer to timely provide such monthly inventory report shall be addressed at the immediately following scheduled JAC Meeting. (d) Manufacturer may reject any Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Materials by (i) providing Customer with no less than sixty (60) days' prior written notice of Manufacturer's intention to reject along with the documentation setting forth in reasonable detail the basis for rejection, (ii) meeting with Customer at Customer's request to discuss the basis for the proposed rejection, and (iii) providing Customer with notice of rejection in the event that Manufacturer rejects the subject Non- Complying Buy-Sell Materials or Non-Complying Customer-Supplied Materials (as applicable) at the end of such sixty (60) day period (or such other time frame as the Parties may agree upon). (e) Customer shall submit invoices to Manufacturer upon delivery to Manufacturer or its applicable Affiliate of Buy-Sell Materials, and Manufacturer shall make payments with respect thereto, in accordance with the invoice and payment requirements set forth in Section 3.5, applied correlatively, and the parties shall discuss in good faith further requirements with respect to the supply of Buy-Sell Materials. -67- Source: UPJOHN INC, 10-12G, 1/21/2020 (f) Customer shall use its commercially reasonable efforts to convert all Buy-Sell Materials arrangements to Customer-Supplied Materials arrangements as promptly as practicable after the Effective Date; provided that Customer shall provide updates with respect to such efforts at each JAC Meeting until all such Buy-Sell Materials arrangements shall have been converted to Customer-Supplied Materials arrangements. 12.2 Title and Risk of Loss. (a) Title to the Customer-Supplied Materials supplied by Customer to Manufacturer shall remain with Customer; provided, however, that risk of loss shall pass to Manufacturer at the time Customer-Supplied Materials are delivered to the Manufacturer DDP (Incoterms 2010) at the applicable Facility. Manufacturer shall not use Customer-Supplied Materials for any purposes other than those related to the manufacture of a Product pursuant to this Agreement. (b) The risk of loss or damage to Customer-Supplied Materials during the possession thereof by Manufacturer shall be solely with Manufacturer. (c) Manufacturer shall insure or self-insure the Customer-Supplied Materials and Products while such is in Manufacturer's possession at an agreed-upon value. (d) The title and risk of loss for Buy-Sell Materials shall pass to Manufacturer upon delivery to the Manufacturer DDP (Incoterms 2010) at the applicable Facility. 12.3 Reimbursement for Loss of Customer-Supplied Materials. Manufacturer shall reimburse Customer for excess Customer-Supplied Materials used as a result of Manufacturer's failure to achieve the minimum average yield or usage (as applicable) set forth in the applicable Facility Addendum. During the first quarter of each Fiscal Year during the Term of this Agreement, Manufacturer will report to Customer the actual yield achieved for all Customer-Supplied Materials used during the previous calendar year on a Facility-by-Facility basis. If the achieved yield is lower than the minimum average yield specified in the applicable Facility Addendum on an aggregated basis for all Customer- Supplied Materials for each applicable Facility Addendum, then Manufacturer will reimburse to Customer the actual cost of the excess Customer-Supplied Materials used as set forth in the applicable Facility Addendum. For the avoidance of doubt, (a) rejected batches and all Customer-Supplied Material that is, for any reason other than a determination that such Customer-Supplied Materials are non-conforming, not incorporated into Product delivered hereunder, shall be included in the annual yield calculation and (b) Customer-Supplied Materials for which Manufacturer is responsible for reimbursing Customer pursuant to Section 4.11(b) shall not be included in the annual yield calculation. -68- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"value:$1,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$1,000,000\"}}, {\"id\": \"value:$2,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$2,000,000\"}}, {\"id\": \"value:$3,000,000\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$3,000,000\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 1, \"text\": \"13. Confidentiality. The confidentiality obligations of the Parties and their respective Groups with respect to disclosures of information hereunder shall be governed, mutatis mutandis, by Section 6.08, Section 6.09 and Section 6.10 of the Separation Agreement. 14. Supply Chain Security. 14.1 Supply Chain Representations. Manufacturer represents, warrants and covenants to Customer that: Manufacturer has reviewed its supply chain security procedures and that these procedures and their implementation are, and shall remain during the Term of this Agreement, in accordance with the importer security criteria set forth by the \\\"C-TPAT.\\\" Manufacturer represents and warrants that it has developed and implemented, or shall develop and implement within sixty (60) calendar days of its execution of this Agreement, procedures for periodically reviewing and, if necessary, improving its supply chain security procedures to assure compliance with C-TPAT minimum security criteria. 14.2 C-TPAT. Manufacturer acknowledges that Customer is a certified member of C-TPAT. As a C-TPAT member, Customer is required to make periodic assessment of its international supply chain based upon C-TPAT security criteria. Manufacturer agrees to conduct and document an annual security audit at each of its Facilities and to take all necessary corrective actions to ensure the continued participation of Customer in C- TPAT. Manufacturer agrees to share with Customer the results of such annual audits and agrees to prepare and submit to Customer a report on the corrective actions taken in response thereto. In addition, Customer may audit Manufacturer's Records and Facilities for the purpose of verifying that Manufacturer's procedures are in accordance with the C-TPAT security criteria, and Manufacturer shall provide Customer with access to Manufacturer's Records and Facilities reasonably necessary for the purpose of conducting such audit. Manufacturer agrees to notify Customer of any event that has resulted in or threatens the loss of its C-TPAT Benefits (if it is a member of the C-TPAT program) or alternatively jeopardizes Customer's retention of its own C-TPAT Benefits. In an effort to secure each part of the supply chain, Manufacturer agrees to work in good faith to become a member of the C-TPAT program, if Manufacturer is organized or incorporated in the United States, Mexico or Canada, or the equivalent supply chain security program criteria administered by the customs administration in Manufacturer's home country if Manufacturer is not organized or incorporated in the United States, Mexico or Canada. -69- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records and Audits\", \"level\": 1, \"text\": \"15. Records and Audits. 15.1 Records. Manufacturer will maintain complete and accurate Records. Any Records that are financial in nature such as, but not limited to, time sheets, billing Records, invoices, payment applications, payments of consultants and subcontractors and receipts relating to reimbursable expenses shall be maintained in accordance with applicable Law in the jurisdiction in which the applicable Facility is located. Manufacturer shall maintain such Records for a period equal to the later of (x) three (3) years after the expiration or termination of this Agreement or the applicable Facility Addendum, (y) the expiration of the statute of limitation for the Tax period applicable to such Records, or (z) for such period as otherwise may be required by applicable Law (the \\\"Record Retention Period\\\"). 15.2 Audits. Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Record Retention Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Record Retention Period\", \"text\": \"a period equal to the later of (x) three (3) years after the expiration or termination of this Agreement or the applicable Facility Addendum, (y) the expiration of the statute of limitation for the Tax period applicable to such Records, or (z) for such period as otherwise may be required by applicable Law\", \"definition_clause\": \"15\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 1, \"text\": \"16. Notices. All notices or other communications hereunder shall be deemed to have been duly given and made if in writing and (a) when served by personal delivery upon the Party for whom it is intended; (b) one (1) Business Day following the day sent by overnight courier, return receipt requested; (c) when sent by facsimile; provided that the facsimile is promptly confirmed; or (d) when sent by e-mail; provided that a copy of the same notice or other communication sent by e-mail is also sent by overnight courier, return receipt requested, personal delivery, or facsimile as provided herein, on the same day as such e-mail is sent, in each case to the Person at the address, facsimile number or e-mail address set forth below, or such other address, facsimile number or e-mail address as may be designated in writing hereafter, in the same manner, by such Person: If to Customer: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] with copy (which shall not constitute notice) to: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] If to Manufacturer: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] with a copy (which shall not constitute notice) to: [INSERT NAME] [INSERT ADDRESS] ATTENTION: [INSERT NAME/TITLE] EMAIL ADDRESS: [INSERT E-MAIL ADDRESS] Either Party may, by notice to the other Party, change the addresses and names applicable to such Party given above. 17. Miscellaneous. 17.1 Negotiations of Dispute. The dispute resolution procedures set forth in Article VII of the Separation Agreement shall apply mutatis mutandis with respect to any controversy, claim, counterclaim, dispute, difference or misunderstanding arising out of or relating to the interpretation or application of any term or provisions of this Agreement, a Purchase Order or Facility Addendum. Further, the requirement to attempt to resolve a dispute in accordance with this Section 17.1 does not affect a Party's right to terminate this Agreement or a Purchase Order as provided in Section 7 hereof, and neither Party shall be required to follow these procedures prior to terminating this Agreement. -71- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"value:1 Business Day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) Business Day\"}}, {\"id\": \"17.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Publicity\", \"level\": 2, \"text\": \"17.2 Publicity. Manufacturer shall not use the name, trade name, service marks, trademarks, trade dress or logos of Customer (or any of its Affiliates) in publicity releases, advertising or any other publication, nor identify Customer as a customer, without Customer's prior written consent in each instance. Customer shall not use the name, trade name, service marks, trademarks, trade dress or logos of Manufacturer (or any of its Affiliates) in publicity releases, advertising or any other publication, without Manufacturer's prior written consent in each instance. Nothing in this Section 17.2 shall or is intended to limit any Party's rights under the Separation Agreement or any Ancillary Agreement. 17.3 Governing Law and Venue. (a) This Agreement and all Actions (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance hereof or thereof shall be governed by and construed in accordance with the Law of the State of Delaware, without regard to any Laws or principles thereof that would result in the application of the Laws of any other jurisdiction. The Parties expressly waive any right they may have, now or in the future, to demand or seek the application of a governing Law other than the Law of the State of Delaware. (b) Each of the Parties hereby irrevocably and unconditionally submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware or, if such court shall not have jurisdiction, the United States District Court for the District of Delaware, and any appellate court from any appeal thereof, in any Action arising out of or relating to this Agreement or the transactions contemplated hereby, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such Action except in such courts, (ii) agrees that any claim in respect of any such Action may be heard and determined in the Court of Chancery of the State of Delaware or, to the extent permitted by Law, in such other courts, (iii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Action in the Court of Chancery of the State of Delaware or such other courts, (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such Action in the Court of Chancery of the State of Delaware or such other courts and (v) consents to service of process in the manner provided for notices in Section 16. Nothing in this Agreement will affect the right of any Party to serve process in any other manner permitted by Law. -72- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OF THE OTHER ANCILLARY AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING THE FINANCING). EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS VOLUNTARILY AND (IV) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 17.3(C). 17.4 Relationship of the Parties. The relationship hereby established between Customer and Manufacturer is solely that of independent contractors. Manufacturer has no authority to act or make any agreements or representations on behalf of Customer or its Affiliates. This Agreement is not intended to create, and shall not be construed as creating, between Manufacturer and Customer, the relationship of fiduciary, principal and agent, employer and employee, joint venturers, co-partners, or any other such relationship, the existence of which is expressly denied. No employee or agent engaged by Manufacturer shall be, or shall be deemed to be, an employee or agent of Customer and shall not be entitled to any benefits that Customer provides to its own employees. 17.5 Assignment; Binding Effect. (a) Except as otherwise provided in this Section 17.5, neither Party shall assign this Agreement or any rights, benefits or obligations under or relating to this Agreement, in each case whether by operation of law or otherwise, without the other Party's prior written consent (not to be unreasonably withheld, conditioned or delayed). (b) Either Party may assign its rights and obligations under this Agreement to one or more of its Affiliates without the other Party's consent; provided that such Affiliate remains at all times during the Term an Affiliate of such Party; provided, further, that no such assignment shall release such Party from its obligations under this Agreement. -73- Source: UPJOHN INC, 10-12G, 1/21/2020 (c) Customer may, without Manufacturer's consent, assign the rights and obligations of this Agreement (i) on a Product-by-Product basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of all or substantially all of its business to which such Product relates or in the event of such business's spin-off, merger or consolidation with another company or business entity or (ii) to any Third Party which acquires or succeeds to all or substantially all of the assets of the business of Customer to which this Agreement and the Facility Addenda relate (including in connection with such business's spin-off, merger or consolidation with another company or business entity). (d) Subject to Section 7.4, Manufacturer may, without Customer's consent, assign the rights and obligations of this Agreement (i) on a Facility-by-Facility basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of such Facility or (ii) to any Third Party which acquires or succeeds to all or substantially all of the assets of the business of Manufacturer to which this Agreement and the Facility Addendum relates (including in connection with such business's spin-off, merger or consolidation with another company or business entity). (e) Notwithstanding anything to the contrary in this Agreement, neither Party may assign this Agreement in whole or in part to a Restricted Party. (f) In the event of a permitted assignment, this Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors and permitted assigns. Any attempted assignment that contravenes the terms of this Agreement shall be void ab initio and of no force or effect. Notwithstanding anything contained in this Agreement, each Party hereby acknowledges and agrees that the other Party may perform any of its obligations, and exercise any of its rights, under this Agreement, any Facility Addendum and Quality Agreement through any of its Affiliates. 17.6 Force Majeure. Subject to Manufacturer's obligations under Section 2.5(a), no Party shall be liable for any failure to perform or any delays in performance, and no Party shall be deemed to be in breach or default of its obligations set forth in this Agreement, if, to the extent and for so long as, such failure or delay is due to any causes that are beyond its reasonable control and not to its acts or omissions, including, without limitation, such causes as acts of God, natural disasters, hurricane, flood, severe storm, earthquake, civil disturbance, lockout, riot, order of any court or administrative body, embargo, acts of Government, war (whether or not declared), acts of terrorism, or other similar causes (\\\"Force Majeure Event\\\"). For clarity, raw material price increases, unavailability of raw materials, and labor disputes shall not be deemed a Force Majeure Event. In the event of a Force Majeure Event, the Party prevented from or delayed in performing shall promptly give notice to the -74- Source: UPJOHN INC, 10-12G, 1/21/2020 other Party and shall use commercially reasonable efforts to avoid or minimize the delay. In the event that the delay continues for a period of at least sixty (60) calendar days, the Party affected by the other Party's delay may elect to (a) suspend performance and extend the time for performance for the duration of the Force Majeure Event or (b) cancel all or any part of the unperformed part of this Agreement or any Purchase Orders. 17.7 Severability. If any provision of this Agreement or the application of any provision thereof to any Person or circumstance, is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The Parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the Parties. 17.8 Non-Waiver; Remedies. Waiver by any Party of any default by the other Party of any provision of this Agreement shall not be deemed a waiver by the waiving Party of any subsequent or other default, nor shall it prejudice the rights of the other Party. No failure or delay by a Party in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof, nor shall a single or partial exercise thereof prejudice any other or further exercise thereof or the exercise of any other right, power or privilege. All remedies specified in this Agreement shall be cumulative and in addition to any other remedies provided at Law or in equity. 17.9 Further Documents. Each Party hereto agrees to execute such further documents and take such further steps as may be reasonably necessary or desirable to effectuate the purposes of this Agreement. 17.10 Forms. The Parties recognize that, during the Term of this Agreement, a Purchase Order acknowledgment form or similar routine document (collectively, \\\"Forms\\\") may be used to implement or administer provisions of this Agreement. The Parties agree that the terms of this Agreement shall govern and control in the event of any conflict between terms of this Agreement and the terms of such Forms, and any additional or different terms contained in such Forms shall not apply to this Agreement. -75- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"term:Force Majeure Event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure Event\", \"text\": \"any causes that are beyond its reasonable control and not to its acts or omissions, including, without limitation, such causes as acts of God, natural disasters, hurricane, flood, severe storm, earthquake, civil disturbance, lockout, riot, order of any court or administrative body, embargo, acts of Government, war (whether or not declared), acts of terrorism, or other similar causes\", \"definition_clause\": \"17.2\"}}, {\"id\": \"17.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Headings; Interpretation\", \"level\": 2, \"text\": \"17.11 Headings; Interpretation. (a) The captions in this Agreement are for convenience only and shall not be considered a part of or affect the construction or interpretation of any provision of this Agreement. (b) The definitions in Section 1 shall apply equally to both the singular and plural forms of the terms defined. (c) Unless the context of this Agreement otherwise requires: (i) (A) words of any gender include each other gender and neuter form; (B) words using the singular or plural number also include the plural or singular number, respectively; (C) derivative forms of defined terms will have correlative meanings; (D) the terms \\\"hereof,\\\" \\\"herein,\\\" \\\"hereby,\\\" \\\"hereto,\\\" \\\"herewith,\\\" \\\"hereunder\\\" and derivative or similar words refer to this entire Agreement; (E) the terms \\\"Section\\\" and \\\"Attachment\\\" refer to the specified Section or Attachment of this Agreement and references to \\\"paragraphs\\\" or \\\"clauses\\\" shall be to separate paragraphs or clauses of the Section or subsection in which the reference occurs; (F) the words \\\"include,\\\" \\\"includes\\\" and \\\"including\\\" shall be deemed to be followed by the phrase \\\"without limitation\\\"; (G) the word \\\"or\\\" shall be disjunctive but not exclusive; and (H) the word \\\"from\\\" (when used in reference to a period of time) means \\\"from and including\\\" and the word \\\"through\\\" (when used in reference to a period of time) means \\\"through and including\\\"; (ii) references to any federal, state, local, or foreign statute or Law shall (A) include all rules and regulations promulgated thereunder and (B) be to that statute or Law as amended, modified or supplemented from time to time; and (iii) references to any Person include references to such Person's successors and permitted assigns, and in the case of any Governmental Authority, to any Person succeeding to its functions and capacities. (d) Whenever this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days are specified. If any action is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action may be deferred until the next Business Day. (e) The phrase \\\"to the extent\\\" shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply \\\"if.\\\" (f) The terms \\\"writing,\\\" \\\"written\\\" and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. (g) All monetary figures shall be in United States dollars unless otherwise specified. (h) All references to \\\"this Agreement\\\" or any \\\"Facility Addendum\\\" shall include any amendments, modifications or supplements thereto. -76- Source: UPJOHN INC, 10-12G, 1/21/2020\"}}, {\"id\": \"17.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Rules of Construction\", \"level\": 2, \"text\": \"17.12 Rules of Construction. The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent. The Parties acknowledge that each Party and its attorney has reviewed and participated in the drafting of this Agreement and that any rule of construction to the effect that any ambiguities are to be resolved against the drafting Party, or any similar rule operating against the drafter of an agreement, shall not be applicable to the construction or interpretation of this Agreement. 17.13 Counterparts. This Agreement may be executed in two (2) or more counterparts (including by electronic or .pdf transmission), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature page. 17.14 Amendments. No provisions of this Agreement shall be deemed waived, amended, supplemented or modified by any Party, unless such waiver, amendment, supplement or modification is in writing and signed by the authorized representative of the Party against whom it is sought to enforce such waiver, amendment, supplement or modification. 17.15 Entire Agreement. This Agreement, the Separation Agreement, the other Ancillary Agreements, including any related annexes, exhibits, schedules and attachments, as well as any other agreements and documents referred to herein and therein, shall together constitute the entire agreement between the Parties relating to the transactions contemplated hereby and supersede any other agreements, whether written or oral, that may have been made or entered into by or among any of the Parties or any of their respective Affiliates relating to the transactions contemplated hereby. [Signature Page Follows] -77- Source: UPJOHN INC, 10-12G, 1/21/2020 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed and delivered as of the date first written above. UPJOHN INC. PFIZER INC. By: By: Name: Name: Title: Title: [Signature Page to Manufacturing and Supply Agreement] Source: UPJOHN INC, 10-12G, 1/21/2020\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of VAPOTHERM, INC. - Manufacturing and Supply Agreement\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of VAPOTHERM, INC. - Manufacturing and Supply Agreement.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.14\", \"level\": 1, \"text\": \"Exhibit 10.14 [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. MANUFACTURING AND SUPPLY AGREEMENT DATED AS OF January 1, 2013 BETWEEN VAPOTHERM, INC. AND MEDICA, S.p.A. TABLE OF CONTENTS Page ARTICLE 1 SALE AND PURCHASE 1\"}, {\"id\": \"1.1\", \"title\": \"Supply of Cartridge 1 1\", \"level\": 2, \"text\": \"1.1 Supply of Cartridge 1 1.2 [* * *] 1 1.3 Purchase of Cartridge 1\"}, {\"id\": \"ARTICLE 2\", \"title\": \"FORECASTS; INVENTORY 1\", \"level\": 1, \"text\": \"ARTICLE 2 FORECASTS; INVENTORY 1\"}, {\"id\": \"2.1\", \"title\": \"Rolling Forecasts 1 2\", \"level\": 2, \"text\": \"2.1 Rolling Forecasts 1 2.2 Inventory 2\"}, {\"id\": \"ARTICLE 3\", \"title\": \"ORDERS, SHIPMENT, AND PAYMENT 2\", \"level\": 1, \"text\": \"ARTICLE 3 ORDERS, SHIPMENT, AND PAYMENT 2\"}, {\"id\": \"ARTICLE 4\", \"title\": \"QUALITY OF THE CARTRIDGE 4\", \"level\": 1, \"text\": \"ARTICLE 4 QUALITY OF THE CARTRIDGE 4\"}, {\"id\": \"ARTICLE 5\", \"title\": \"PRODUCTION PROCESS 5\", \"level\": 1, \"text\": \"ARTICLE 5 PRODUCTION PROCESS 5\"}, {\"id\": \"5.1\", \"title\": \"Joint Review Committee 5 5\", \"level\": 2, \"text\": \"5.1 Joint Review Committee 5 5.2 Process Development 5 5.3 Inventory of Raw Materials and Spare Parts 5 5.4 [* * *] 5 -i- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"ARTICLE 6\", \"title\": \"QUALITY SYSTEM 6\", \"level\": 1, \"text\": \"ARTICLE 6 QUALITY SYSTEM 6\"}, {\"id\": \"6.1\", \"title\": \"General Quality Statement 6 6\", \"level\": 2, \"text\": \"6.1 General Quality Statement 6 6.2 Quality System Changes 6 6.3 Vendor Quality 6 6.4 Vigilance System 6\"}, {\"id\": \"ARTICLE 7\", \"title\": \"OTHER OBLIGATIONS OF MEDICA 7\", \"level\": 1, \"text\": \"ARTICLE 7 OTHER OBLIGATIONS OF MEDICA 7\"}, {\"id\": \"7.1\", \"title\": \"Debarment Certification 7 7\", \"level\": 2, \"text\": \"7.1 Debarment Certification 7 7.2 Permits and Certifications 7 7.3 Manufacturing Problems 7 7.4 Insurance 7\"}, {\"id\": \"ARTICLE 8\", \"title\": \"INSPECITONS; RECORDS 8\", \"level\": 1, \"text\": \"ARTICLE 8 INSPECITONS; RECORDS 8\"}, {\"id\": \"8.1\", \"title\": \"Notification of Inquiries and Inspections 8 8\", \"level\": 2, \"text\": \"8.1 Notification of Inquiries and Inspections 8 8.2 Access to Medica Facilities and Records 8 8.3 Records 9\"}, {\"id\": \"ARTICLE 9\", \"title\": \"CARTRIDGE RECALLS 9\", \"level\": 1, \"text\": \"ARTICLE 9 CARTRIDGE RECALLS 9\"}, {\"id\": \"ARTICLE 10\", \"title\": \"PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY 10\", \"level\": 1, \"text\": \"ARTICLE 10 PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY 10\"}, {\"id\": \"ARTICLE 11\", \"title\": \"REPRESENTATIONS 12\", \"level\": 1, \"text\": \"ARTICLE 11 REPRESENTATIONS 12\"}, {\"id\": \"11.1\", \"title\": \"Representations of Medica 12 -ii-\", \"level\": 2, \"text\": \"11.1 Representations of Medica 12 -ii- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"11.2\", \"title\": \"Representations of Vapotherm 13\", \"level\": 2, \"text\": \"11.2 Representations of Vapotherm 13\"}, {\"id\": \"ARTICLE 12\", \"title\": \"INDEMNIFICATION 13\", \"level\": 1, \"text\": \"ARTICLE 12 INDEMNIFICATION 13\"}, {\"id\": \"12.1\", \"title\": \"Indemnification 13 12\", \"level\": 2, \"text\": \"12.1 Indemnification 13 12.2 Procedures Relating to Indemnification 14 12.3 No Liability for Consequential Damages 15 12.4 Limitation on Liability 15\"}, {\"id\": \"ARTICLE 13\", \"title\": \"TERM AND TERMINATION; BUSINESS CONTINUITY 15\", \"level\": 1, \"text\": \"ARTICLE 13 TERM AND TERMINATION; BUSINESS CONTINUITY 15\"}, {\"id\": \"13.1\", \"title\": \"Term 15 13\", \"level\": 2, \"text\": \"13.1 Term 15 13.2 Termination 16 13.3 Effect of Termination 17 13.4 Business Continuity 17\"}, {\"id\": \"ARTICLE 14\", \"title\": \"MISCELLANEOUS 18\", \"level\": 1, \"text\": \"ARTICLE 14 MISCELLANEOUS 18 [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (this \\\"Agreement\\\") is dated January 1st, 2013, between VAPOTHERM, INC., a Maryland corporation (\\\"Vapotherm\\\") and MEDICA S.p.A., an Italian company (\\\"Medica\\\"). WHEREAS, Vapotherm sells systems it has developed for delivering humidified, blended medical gas therapy (the \\\"System\\\"), which system includes a vapor transfer cartridge; WHEREAS, Vapotherm and Medica wish for Medica to manufacture [* * *] (each, a \\\"Cartridge\\\" and collectively, the \\\"Cartridges\\\") for Vapotherm for use in the System, using fiber provided by Medica as developed for the System and packaged as specified in Vapotherm Specification Exhibit D. NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which have hereby acknowledged, the parties therefore agree as follows:\"}, {\"id\": \"ARTICLE 1\", \"title\": \"SALE AND PURCHASE\", \"level\": 1, \"text\": \"ARTICLE 1 SALE AND PURCHASE\"}, {\"id\": \"1.1\", \"title\": \"Supply of Cartridge\", \"level\": 2, \"text\": \"1.1 Supply of Cartridge. Subject to the terms of this Agreement, Medica shall manufacture, in such quantities as Vapotherm orders, the Cartridge.\"}, {\"id\": \"1.2\", \"title\": \"[* * *]\", \"level\": 2, \"text\": \"1.2 [* * *]\"}, {\"id\": \"1.3\", \"title\": \"Purchase of Cartridge\", \"level\": 2, \"text\": \"1.3 Purchase of Cartridge. Subject to the terms of this Agreement, Vapotherm shall purchase from Medica Cartridges following regulatory approval.\"}, {\"id\": \"ARTICLE 2\", \"title\": \"FORECASTS; INVENTORY\", \"level\": 1, \"text\": \"ARTICLE 2 FORECASTS; INVENTORY\"}, {\"id\": \"2.1\", \"title\": \"Rolling Forecasts\", \"level\": 2, \"text\": \"2.1 Rolling Forecasts. Attached hereto and incorporated herein by reference as Exhibit A-2 is Vapotherm's initial forecast of Cartridges that Vapotherm will purchase for delivery on a monthly basis in calendar year 2013 (the \\\"Initial Forecast\\\"). On or prior to January 1, 2013 (the \\\"Forecast Initiation Date\\\"), Vapotherm shall deliver to Medica a forecast of Cartridge demand in each of the [* * *] consecutive months beginning one month following the FID. On or prior to one month following the FID, Vapotherm shall provide a forecast for the next [* * *] consecutive months beginning [* * *] months following the FID. On or prior to the first day of each subsequent month, Vapotherm shall deliver to Medica an update to its previously submitted forecast of its expected purchases of Cartridges (each forecast delivered pursuant to this Section 2.l(a), a \\\"Rolling Forecast\\\"). [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (a) Vapotherm will place a firm Purchase Order for the following [* * *] months. Every month there after, Vapotherm will placed a PO for the following month to maintain a rolling [* * *] month commitment. (b) The forecast for any month specified in any Rolling Forecast may not be less than the total number of Cartridges for which Vapotherm, prior to delivery of that Rolling Forecast to Medica in accordance with Section 2.l(a), has submitted purchase orders in accordance with Section 3.2 specifying a delivery date in that month.\"}, {\"id\": \"2.2\", \"title\": \"Inventory\", \"level\": 2, \"text\": \"2.2 Inventory. During the Term, Medica shall at all times maintain as safety stock that quantity of Cartridges equal to one (1) times the monthly average number of Cartridges ordered by Vapotherm during the immediately preceding [* * *] months.\"}, {\"id\": \"ARTICLE 3\", \"title\": \"ORDERS, SHIPMENT, AND PAYMENT\", \"level\": 1, \"text\": \"ARTICLE 3 ORDERS, SHIPMENT, AND PAYMENT\"}, {\"id\": \"3.1\", \"title\": \"Price\", \"level\": 2, \"text\": \"3.1 Price. The price paid by Vapotherm for any given shipment of Cartridges during the Initial Term is as stated in Exhibit A-1. No later than [* * *] days prior to the end of the Initial Term and each Renewal Term, Medica shall provide Vapotherm with reasonable documentation of its actual and direct costs in manufacturing the Cartridges (the \\\"Costs\\\"). The parties will then negotiate in good faith the Cartridge prices for the subsequent\"}, {\"id\": \"3.2\", \"title\": \"Purchase Orders\", \"level\": 2, \"text\": \"3.2 Purchase Orders. (a) Each purchase order that Vapotherm places for Cartridges must be in the form attached as Exhibit B and must specify (1) how many Cartridges are desired, (2) the one or more places to which, and the manner and date by which, delivery is to be made, and (3) the applicable price per Cartridge. Vapotherm shall deliver all purchase orders by facsimile, or by one of the means specified in Section 14.8 for giving notice, to Medica at the following address and facsimile number or as otherwise instructed by Medica: Medica S.p.A. Via Degli Artigiani, 7 41036 Medolla (MO) Italy Attention: Daniele Giubertoni MKTG & Sales Manager Facsimile: 39-0535-52605 E-mail: daniele.giubertoni@medica.it (b) Vapotherm shall order for delivery in any given month an aggregate number of Cartridges equal to at least [* * *]% of the final amount forecast for that month in the Rolling Forecasts (that quantity, the \\\"Final Forecast Quantity\\\"). Vapotherm may order for delivery in any given Quarter an aggregate quantity of Cartridge not exceeding [* * *]% of the Final Forecast Quantity. Only with Medica's written consent may Vapotherm order for delivery in any given Quarter an aggregate number of Cartridges exceeding [* * *]% of the aggregate Final Forecast Quantity for the months in such Quarter. -2- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) Vapotherm shall deliver each purchase order for quantities of the Cartridge at least [* * *] in advance of the delivery date specified in that purchase order. (d) If Vapotherm delivers any purchase order with less lead time than is required under Section 3.2(c), then Medica shall use [* * *] efforts to fill that purchase order but will not be liable to Vapotherm if despite those best efforts they fail to do so. (e) Medica shall acknowledge and accept in writing on behalf of Medica any purchase order that Vapotherm places for Cartridges. Any such purchase order will be deemed accepted by Medica if Medica does not reject it by written notice to Vapotherm delivered within [* * *] Business Days of Medica's receiving that purchase order. Medica may not reject any purchase order that complies with the provisions of Article 3. If the terms of any purchase are inconsistent with the terms of this Agreement, the terms of this Agreement will control.\"}, {\"id\": \"3.3\", \"title\": \"Delivery\", \"level\": 2, \"text\": \"3.3 Delivery. Each shipment of Cartridges will be delivered by [* * *] to the applicable Vapotherm manufacturing facility or retained in Medica's warehouse facility, in accordance with Vapotherm instructions for each shipment. Medica shall deliver by the delivery date specified in a purchase order all of the Cartridges specified in that purchase order. Vapotherm is only required to pay for Cartridges actually delivered. Medica shall make shipping arrangements with carriers designated in writing by Vapotherm from the [* * *] point to points specified by Vapotherm, under the arrangements that Vapotherm has with those carriers.\"}, {\"id\": \"3.4\", \"title\": \"[* * *]\", \"level\": 2, \"text\": \"3.4 [* * *]\"}, {\"id\": \"3.5\", \"title\": \"Delay in Delivery\", \"level\": 2, \"text\": \"3.5 Delay in Delivery. If for any reason other than an Event of Force Majeure, Medica delivers any shipment of Cartridges later than the date of delivery set out in the applicable purchase order, Vapotherm will be entitled to the following as an alternative, in its sole discretion, to its rights under Section 3.6 and Section 13.2(a): (1) a [* * *]% reduction in the price of each Cartridge in the shipment for every [* * *] the shipment is delayed (from the Required Ship Date specified in the Purchase Order) to a maximum of [* * *]%.\"}, {\"id\": \"3.6\", \"title\": \"Delivery Default Rights\", \"level\": 2, \"text\": \"3.6 Delivery Default Rights. If more than [* * *] days have passed since the delivery date for any Cartridges and Medica has, for any reason other than an Event of Force Majeure, failed to deliver those Cartridges, then, in addition to any other remedies it might have under this Agreement or by law, Vapotherm may cancel that purchase order or the portion thereof relating to those cartridges, as applicable.\"}, {\"id\": \"3.7\", \"title\": \"Invoices and Payment Terms\", \"level\": 2, \"text\": \"3.7 Invoices and Payment Terms. On delivery by Medica of a shipment of Cartridges in accordance with Section 3.3, Medica shall issue to Vapotherm an invoice for that shipment stating a price consistent with the terms of this Agreement. Vapotherm shall pay each such invoice in full within [* * *] Calendar Days from the date of invoice, unless Vapotherm has rejected the shipment in question in accordance with Section 4.2. -3- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"3.8\", \"title\": \"Delay in Payment\", \"level\": 2, \"text\": \"3.8 Delay in Payment. Upon delay of payment beyond [* * *] days from invoice date, Medica at its' sole discretion may levy an increase to the net transfer price a [* * *]% per week to a maximum of [* * *]%.\"}, {\"id\": \"ARTICLE 4\", \"title\": \"QUALITY OF THE CARTRIDGE\", \"level\": 1, \"text\": \"ARTICLE 4 QUALITY OF THE CARTRIDGE\"}, {\"id\": \"4.1\", \"title\": \"Conformity with Specifications\", \"level\": 2, \"text\": \"4.1 Conformity with Specifications. Any Cartridges that Medica manufactures under this Agreement must conform to the specifications in Exhibit D (the \\\"Specifications\\\") and (2) be manufactured, labeled, packaged, stored, and tested (while in the possession of, stored by, or under the control of Medica) in accordance with cGMP. Medica shall provide adequate packaging for protection during normal shipping and handling environments.\"}, {\"id\": \"4.2\", \"title\": \"Conditions to Rejection\", \"level\": 2, \"text\": \"4.2 Conditions to Rejection. In order to be entitled to reject any Cartridge, Vapotherm must notify Medica of any failure of the Cartridge to meet the Specifications or otherwise comply with this Agreement. Misuse or improper storage will not be grounds for rejection.\"}, {\"id\": \"4.3\", \"title\": \"Rejection\", \"level\": 2, \"text\": \"4.3 Rejection. Vapotherm may reject any Cartridge that does not meet the Specifications or otherwise comply with this Agreement (any such Cartridge, a \\\"Nonconforming Cartridge\\\"). If Medica accepts that Vapotherm was entitled to reject the Nonconforming Cartridge(s) and Vapotherm has already paid the purchase price for the Nonconforming Cartridge(s), then, within [* * *] Calendar Days after receiving notice from Vapotherm under Section 4.2, Medica shall, at Vapotherm's election, either replace the Nonconforming Cartridge(s) at no additional cost to Vapotherm or reimburse Vapotherm for the purchase price of the Nonconforming Cartridge(s) via wire transfer. Further, if Medica accepts that Vapotherm was entitled to reject the Nonconforming Cartridge(s) and Vapotherm has not already paid the purchase price for the Nonconforming Cartridge(s), then, within [* * *] Calendar Days after receiving notice from Vapotherm under Section 4.2, Medical shall, at Vapotherm's election, either replace the Nonconforming Cartridge(s) at no additional to Vapotherm beyond the original purchase price charged to Vapotherm for the Nonconforming Cartridge(s) or cancel that purchase order or the portion thereof relating to the Nonconforming Cartridge(s), s applicable. (b) If Medica does not agree that one or more Cartridges constitute Nonconforming Cartridges, the Joint Review Committee, consisting of quality assurance representatives from both companies, must consider the matter. If after consideration by the Joint Review Committee the parties are unable to reach agreement within [* * *] Calendar Days after the date Medica received notice from Vapotherm under Section 4.2, they shall submit the dispute to arbitration in accordance with Section 14.5. -4- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"4.4\", \"title\": \"Nonconformity Default Rights\", \"level\": 2, \"text\": \"4.4 Nonconformity Default Rights. If for any reason other than an event of Force Majeure Medica (1) fails to replace any Nonconforming Cartridge as required by Section 4.3 or (2) fails to replace any Nonconforming Cartridge within [* * *] Business Days after a dispute regarding whether any rejected quantity of Cartridge constitutes Nonconforming Cartridge is decided in Vapotherm's favor, then, in addition to any other remedies it might have under this Agreement or by law, Vapotherm may cancel that purchase order or the portion thereof of relating to the Nonconforming Cartridge, as applicable.\"}, {\"id\": \"4.5\", \"title\": \"Acceptance of Cartridges\", \"level\": 2, \"text\": \"4.5 Acceptance of Cartridges. If Vapotherm does not notify Medica that one or more Cartridges do not meet the Specifications or otherwise fail to comply with this Agreement, those Cartridges will be deemed to have been accepted by Vapotherm as being fully compliant with the Specifications and this Agreement.\"}, {\"id\": \"4.6\", \"title\": \"Quality Monitoring\", \"level\": 2, \"text\": \"4.6 Quality Monitoring. Medica will periodically sample and trend the Cartridge performance in accordance with specification and Medica's internal production tests to monitor process and product control. Medica will share the results with Vapotherm as part of the Production Process as outlined in Article 5.\"}, {\"id\": \"4.7\", \"title\": \"If Medica becomes aware of any Cartridge problem that could endanger patient health, Medica will report the problem to V\", \"level\": 2, \"text\": \"4.7 If Medica becomes aware of any Cartridge problem that could endanger patient health, Medica will report the problem to Vapotherm within 24 hours.\"}, {\"id\": \"ARTICLE 5\", \"title\": \"PRODUCTION PROCESS\", \"level\": 1, \"text\": \"ARTICLE 5 PRODUCTION PROCESS\"}, {\"id\": \"5.1\", \"title\": \"Joint Review Committee\", \"level\": 2, \"text\": \"5.1 Joint Review Committee. The parties shall establish and hold teleconference meetings of a Joint Review Committee annually. The Joint Review Committee shall consist of six (6) members, including the head of each party's engineering, quality assurance and material management divisions or their designees.\"}, {\"id\": \"5.2\", \"title\": \"Process Development\", \"level\": 2, \"text\": \"5.2 Process Development. Medica shall use [* * *] efforts to develop technical know-how that would permit them to manufacture the Cartridge less expensively and shall no less than semiannually furnish the Joint Review Committee with a detailed report as to their progress in this area. Vapotherm and Medica shall at the time of each report determine jointly the actions to be taken with respect to these findings.\"}, {\"id\": \"5.3\", \"title\": \"Inventory of Raw Materials and Spare Parts\", \"level\": 2, \"text\": \"5.3 Inventory of Raw Materials and Spare Parts. Medica shall at all times use best efforts to efficiently manage their inventories of raw materials so as to enable Medica to meet Vapotherm's demand as specified in the Rolling Forecasts. Medica shall also maintain, consistent with the manufacturer's recommendations, an inventory of spare parts of all equipment they use to manufacture the Cartridge.\"}, {\"id\": \"5.4\", \"title\": \"[* * *] -5-\", \"level\": 2, \"text\": \"5.4 [* * *] -5- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"ARTICLE 6\", \"title\": \"QUALITY SYSTEM\", \"level\": 1, \"text\": \"ARTICLE 6 QUALITY SYSTEM\"}, {\"id\": \"6.1\", \"title\": \"General Quality Statement\", \"level\": 2, \"text\": \"6.1 General Quality Statement. The Cartridges shall be manufactured, assembled and tested in compliance with (a) the Specifications, (b) Vapotherm supplied specifications and documentation; (c) relevant ISO and FDA standards, guidelines and regulations, but not limited to ISO 13485, US 21CFR 820 FDA (\\\"QSR\\\"), EU MDD 93/43 and Canadian MDR (d) Medica's design and manufacturing policies followed by Medica as of the date hereof (\\\"Medica's Quality System\\\"), and (e) applicable U.S. and foreign Laws, including but not limited to FDA standards, guidelines and regulations. During the Term and notwithstanding Section 6.2 below, Medica shall not make any material change to the Specifications or Medica's Quality System without Vapotherm's prior written approval. For purposes of this Section 6.1, a material change to either the Specifications or Medica's Quality System shall mean any change that could have a material adverse effect on the safety or efficacy of the Cartridges or System, or that would be reasonably likely to have a material effect on the proper integration of the Cartridges or System.\"}, {\"id\": \"6.2\", \"title\": \"Quality System Changes\", \"level\": 2, \"text\": \"6.2 Quality System Changes. Any changes to the status of the Medica Quality System shall be reported to Vapotherm Quality Assurance and Vapotherm Executive Management by sending notice in accordance with Section 14.8 within 72 hours. Status changes may include, but not be limited to the following: (a) ISO Certifications or CE Marking status charges; (b) Process or material failures, including significant vendor related failures or relevant vendor terminations due to quality related issues; and (c) Specification changes for supplemental manufacturing processes, equipment, or materials.\"}, {\"id\": \"6.3\", \"title\": \"Vendor Quality\", \"level\": 2, \"text\": \"6.3 Vendor Quality. The quality ratings of vendors that supply Medica with materials used in the manufacture/assembly and/or testing of the Cartridges shall be reported to Vapotherm Quality Assurance in a manner consistent with the Medica Quality System. Any collective actions, regulatory holds, suspensions, or terminations of vendors related to the Cartridges shall be reported to Vapotherm Quality Assurance in a timely manner.\"}, {\"id\": \"6.4\", \"title\": \"Vigilance System\", \"level\": 2, \"text\": \"6.4 Vigilance System. Vapotherm has an established Authorized Representative to communicate complaints and vigilance reports that results from the use of the Cartridges. (a) Complaint investigations shall be a shared process between Medica (QA, manufacturing, and engineering) and Vapotherm (QA, Manufacturing, and R&D). (b) All investigation reports shall be issued jointly and in a timely manner to satisfy the requirements for vigilance reporting (when necessary). -6- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) When a complaint is determined to be a vigilance reportable event then Vapotherm shall be responsible for administering and reporting to both Medica and the necessary competent authorities any Cartridge related vigilance incidents within [* * *] days or as outlined in the Vapotherm Quality System. (d) Vapotherm shall copy in writing via email or facsimile to Medica Quality Assurance within 24-48 hours on all and any vigilance reporting, including health outcome, relationship between the incidents, and timeliness of reporting the vigilance incident to the Competent Authorities.\"}, {\"id\": \"ARTICLE 7\", \"title\": \"OTHER OBLIGATIONS OF MEDICA\", \"level\": 1, \"text\": \"ARTICLE 7 OTHER OBLIGATIONS OF MEDICA\"}, {\"id\": \"7.1\", \"title\": \"Debarment Certification\", \"level\": 2, \"text\": \"7.1 Debarment Certification. Medica hereby agrees to review the United States Department of Health and Human Services Office of the Inspector General and General Services Administration exclusion lists upon initially hiring and annually thereafter to ensure that any employee or manager responsible for providing services under is not excluded from any United States Federal or State health care program. Medica hereby represents and warrants that neither it, nor any of its officers, directors, or managers, or employees are currently excluded from, or have ever been excluded from, any United States Federal or State health care program or, if previously excluded, have been fully reinstated, in which case Medica shall provide Vapotherm written proof of such reinstatement and such other information as Vapotherm may require describing the reasons for the prior exclusion. Medica shall immediately notify Vapotherm, in writing, in the event that it knows, or has reason to know, that any United States Federal or State health care program has initiated proceedings to sanction, bar, suspend or exclude Medica, or any of its officers, directors, managers or employees. If Medica fails to comply with any of the foregoing provisions, Vapotherm may terminate the Agreement immediately upon written notice to Medica.\"}, {\"id\": \"7.2\", \"title\": \"Permits and Certifications\", \"level\": 2, \"text\": \"7.2 Permits and Certifications. Medica currently has all Permits and Certifications necessary to enable it to perform all its obligations under this Agreement. At all times during the Term Medica shall maintain those Permits and secure any additional Permits that become necessary.\"}, {\"id\": \"7.3\", \"title\": \"Manufacturing Problems\", \"level\": 2, \"text\": \"7.3 Manufacturing Problems. Medica shall promptly notify Vapotherm if it experiences any significant problems in manufacturing Cartridges, shall use [* * *] efforts to resolve those problems, and shall keep Vapotherm informed of the status of those efforts.\"}, {\"id\": \"7.4\", \"title\": \"Insurance\", \"level\": 2, \"text\": \"7.4 Insurance. Medica shall at its cost obtain and maintain one or more insurance policies providing coverage of at least Euro [* * *] in the aggregate that cover Medica for fire, theft, fidelity, product liability, and any and all potential claims, suits, losses, expenses, or damages arising out of Medica's obligations under this Agreement. At Vapotherm's request to Medica from time to time, Medica shall furnish Vapotherm with certification of insurance evidencing that insurance and shall provide at least [* * *] Business Days prior written notice to Vapotherm of any cancellation of or decrease in the dollar amount of coverage provided by any such policy. Vapotherm shall have the right to maintain such insurance coverage on Vapotherm's behalf and at Vapotherm' s expense in the event of nonpayment of premiums or lapse of coverage. -7- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (b) Vapotherm shall at its cost obtain and maintain product-liability insurance coverage in the amount of $[* * *] in relation to the Cartridge. At the request of Medica from time to time, Vapotherm shall famish Medica with certification of insurance evidencing that insurance and shall endeavour to provide at least [* * *] Business Days prior written notice to Medica of any cancellation of or decrease in the amount of coverage provided by any such policy.\"}, {\"id\": \"ARTICLE 8\", \"title\": \"INSPECITONS; RECORDS\", \"level\": 1, \"text\": \"ARTICLE 8 INSPECITONS; RECORDS\"}, {\"id\": \"8.1\", \"title\": \"Notification of Inquiries and Inspections\", \"level\": 2, \"text\": \"8.1 Notification of Inquiries and Inspections. Medica shall notify Vapotherm within [* * *] Business Days of any written or oral inquiries, notifications, or inspection activity by any Governmental Authority in regard to Medica's manufacture of Cartridges. Medica shall permit up to two individuals selected by Vapotherm to attend any such inspections and shall provide Vapotherm with an accurate and reasonably complete description of any such inquiries, notifications, or inspections. Medica shall also furnish to Vapotherm (1) within [* * *] Business Days after receipt any report or correspondence issued by any Governmental Authority in connection with any such inquiries, notifications, or inspections, and (2) not later than [* * *] Business Days prior to the time Medica proposes to send it, a copy of any proposed response or explanation relating to any such inquiries, notifications, or inspections or any report or correspondence issued by any Governmental Authority in connection therewith (each, a \\\"Proposed Response\\\"), in each case redacted of trade secrets or other confidential or proprietary information of Medica that are unrelated to Medica's obligations under this Agreement or are unrelated to manufacture of Cartridges. Medica shall discuss with Vapotherm any Proposed Response and shall incorporate in that Proposed Response any reasonable comments provided by Vapotherm with respect to that Proposed Response. After filing a response with any Governmental Authority, Medica shall within [* * *] Business Days notify Vapotherm of any further contacts with that Governmental Authority with respect to that response.\"}, {\"id\": \"8.2\", \"title\": \"Access to Medica Facilities and Records\", \"level\": 2, \"text\": \"8.2 Access to Medica Facilities and Records. Medica shall at Vapotherm's request give Vapotherm and any designee of Vapotherm reasonable access to Medica's facilities, procedures, and books and records, including Medica's protocols, standard operating procedures (SOPs), equipment specifications, and manufacturing records, for purposes of (1) observing manufacturing, operations and (2) auditing and inspecting Medica's facilities for compliance with applicable Laws and the terms of this Agreement. Vapotherm acknowledges that it and its designee may be permitted only to review, rather than obtain copies of, certain proprietary documents of Medica; Medica shall at Vapotherm's request provide Vapotherm with a copy of any other document that Vapotherm requests provided it is reasonable and applicable to the Cartridges or System. -8- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"8.3\", \"title\": \"Records\", \"level\": 2, \"text\": \"8.3 Records. Medica shall maintain all records necessary to evidence compliance with all applicable Laws and other requirements of applicable Governmental Authorities relating to the manufacture of the Cartridge. Medica shall also maintain records with respect to its costs, obligations, and performance under this Agreement. All such records shall be maintained for a period of not less than two years from the date of expiration of each Cartridge batch to which those records pertain, or such longer period as may be required by Law or cGMPs.\"}, {\"id\": \"ARTICLE 9\", \"title\": \"CARTRIDGE RECALLS\", \"level\": 1, \"text\": \"ARTICLE 9 CARTRIDGE RECALLS\"}, {\"id\": \"9.1\", \"title\": \"Cartridge Recalls\", \"level\": 2, \"text\": \"9.1 Cartridge Recalls. If any Governmental Authority withdraws its approval to sell the Cartridge in any country or issues a directive or request that some or all Cartridges be recalled for safety reasons relating to the Cartridge or Vapotherm reasonably determines that some or all Cartridges should be recalled, and if that recall is due to any reason other than Medica having manufactured Cartridges that fail to conform to the Specifications or that was not manufactured in accordance with any applicable Laws, Vapotherm shall pay all costs, including Medica's reasonable out-of-pocket expenses, associated with that recall. Those actions may include developing reports on records pertaining to the lot traceability, assist in conducting an investigation to rule out a root cause for failure and other related activities requiring Medica's resources. Vapotherm shall provide Medica in writing specific instructions as to actions required. Medical shall in good faith provide an estimate for expenses if the request has material burden.\"}, {\"id\": \"9.2\", \"title\": \"Notice of Events that May Lead to Cartridge Recall\", \"level\": 2, \"text\": \"9.2 Notice of Events that May Lead to Cartridge Recall. Medica, on the one hand, and Vapotherm, on the other hand, shall keep each other fully and promptly informed of any notification, event, or other information, whether received directly or indirectly, that might affect the marketability, safety or effectiveness of the Cartridge or might result in a recall of any Cartridges by any Governmental Authority.\"}, {\"id\": \"9.3\", \"title\": \"Recall Due to Breach By Medica\", \"level\": 2, \"text\": \"9.3 Recall Due to Breach By Medica. If there occurs any Cartridge recall that is due to Medica having manufactured one or more Cartridges that fail to conform to the Specifications or that were not manufactured in accordance with any applicable Laws, Medica will be responsible for the costs of that recall. Medica shall promptly, at the election of Vapotherm, compensate Vapotherm for the Cartridge so recalled by either replacing without charge Cartridges recalled or refunding Vapotherm the price paid by Vapotherm to Medica for the Cartridges recalled, plus freight, insurance, sales taxes, and all other costs duties, fees, and expenses paid by Vapotherm in connection with such recall.\"}, {\"id\": \"9.4\", \"title\": \"Definition of Recall\", \"level\": 2, \"text\": \"9.4 Definition of Recall. For purposes of this Article 8, \\\"recall\\\" means any action by Vapotherm or any of its Affiliates, or either Medica or any of its Affiliates, to recover title or possession or halt distribution or use of any Cartridges sold or shipped to any other Persons. The term \\\"recall\\\" also applies to Cartridge that would have been subject to recall if it had been sold or shipped. -9- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"9.5\", \"title\": \"Recall Process\", \"level\": 2, \"text\": \"9.5 Recall Process. The purpose of initiating a \\\"recall\\\", either party will notify the other party immediately regarding the need within 24 hrs. Vapotherm will be responsible for notifying the appropriate regulatory bodies with respect to the Cartridge. Medica will provide best efforts to support Vapotherm with the appropriate regulatory documentation in an timely fashion. Medica will make efforts to conduct the necessary investigations as it pertains to the Cartridge and report factual data has required. Medica will also take necessary efforts to take the appropriate corrective action and make best efforts to remedy the disruption in supply.\"}, {\"id\": \"ARTICLE 10\", \"title\": \"PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY\", \"level\": 1, \"text\": \"ARTICLE 10 PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY\"}, {\"id\": \"10.1\", \"title\": \"Publicity\", \"level\": 2, \"text\": \"10.1 Publicity. Except as required by Law or the standards of any securities or regulatory authority, including without limitation the National Association of Securities Dealers, Medica and Vapotherm may not make any official press release, announcement, or other formal publicity relating to the transactions that are the subject of this Agreement without first obtaining in each case the prior written consent of Vapotherm and Medica, respectively (which consent may not be unreasonably withheld). If any party is required to file this Agreement with the Securities and Exchange Commission or another applicable securities regulatory authority, that party must seek confidential treatment for any provisions of this Agreement that either party believes would disclose trade secrets, confidential commercial, or financial information and thereby impair the value of the contractual rights represented by this Agreement or provide detailed commercial and financial information to competitors or other Persons. Except as required by Law or the standards of any securities regulatory authority, Medica and Vapotherm may not use the name Vapotherm and Medica, respectively, or the name of any director, officer or employee thereof or any adaptation thereof without the prior written approval of Vapotherm and Medica, respectively. (b) Medica shall send to Vapotherm for its approval at least [* * *] Business Days before it is filed or submitted any publication, abstract, or patent application resulting from this Agreement. The authorship on any publication or abstract will be determined by agreement of the parties or as deemed scientifically appropriate. Any publication resulting from this Agreement will be delayed or prohibited if, in Vapotherm's reasonable opinion, delay or prohibition is required in order to file or procure patent application or rights protection in respect of any invention or discovery arising from this Agreement. Publication by Medica of any information relating to the Cartridge is subject to the provisions of Section 10.2.\"}, {\"id\": \"10.2\", \"title\": \"Confidentiality\", \"level\": 2, \"text\": \"10.2 Confidentiality. It is contemplated that Medica may from time to time disclose Confidential Information to Vapotherm, or vice versa. Medica shall disclose such Vapotherm Confidential Information and shall not use any Vapotherm Confidential Information other than in connection with performing its obligations hereunder, and Vapotherm shall not disclose Medica Confidential Information and shall not use any Medica Confidential Information other than in connection with performing its obligations hereunder. (b) A party receiving Confidential Information shall only disclose it to those of its Representatives who need to review that Confidential Information in connection with that party's performance of its obligations and evaluation of its rights under this Agreement. Any party who so discloses any Confidential Information pursuant to this Section 10.2(b) shall (1) inform those Representatives of the confidential nature of that Confidential Information, and (2) direct those Representatives to keep that Confidential Information confidential. -10- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) The provisions of this Section 10.2 will survive termination or expiration of this Agreement and will continue for a period of 5 years from the date of that termination or expiration.\"}, {\"id\": \"10.3\", \"title\": \"Pre-existing and Independently Developed Intellectual Property\", \"level\": 2, \"text\": \"10.3 Pre-existing and Independently Developed Intellectual Property. Each party is and shall remain the owner of its Intellectual Property in existence as of the Effective Date and all such rights that a party acquires or develops independent of this Agreement (\\\"Baseline IP\\\").\"}, {\"id\": \"10.4\", \"title\": \"Ownership\", \"level\": 2, \"text\": \"10.4 Ownership. (a) Except as specified elsewhere in Section 10.4, all rights in patents, inventions, processes, discoveries, and other research materials and any other novel or valuable information reflected in any medium that arise or are created during the course of this Agreement are the property of the creating party. (b) Any additions, improvements and enhancements to Vapotherm Baseline IP which are made during the course of this Agreement shall solely be the property of Vapotherm (\\\"Vapotherm Inventions\\\"). (c) Any additions, improvements and enhancements to Medica Baseline IP which are made during the course of this Agreement shall solely be the property of Medica (\\\"Medica Inventions\\\"). (d) It is understood and agreed that Vapotherm shall be free and without restriction to develop, market, license, and sell products and technology as it may see fit (including products and technology that may) or may not compete with the Cartridges), provided that Vapotherm strictly and fully complies with its obligations concerning Medica Confidential Information under Section 10.2 (Confidentiality). (e) It is understood and agreed that Medica shall be free and without restriction to develop, market, license, and sell products and technology based on Medica proprietary membrane with an intended use different from oxygen delivery humidification for patients.\"}, {\"id\": \"10.5\", \"title\": \"[* * *]\", \"level\": 2, \"text\": \"10.5 [* * *] (b) [* * *]\"}, {\"id\": \"10.6\", \"title\": \"Reservation of All Other Rights\", \"level\": 2, \"text\": \"10.6 Reservation of All Other Rights. Except as expressly set forth in this Agreement, nothing contained herein may be construed as doing the following: -11- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (a) Giving Medica any rights to any Intellectual Property of Vapotherm or any other proprietary technology of Vapotherm (whether Vapotherm Baseline IP or Vapotherm Inventions arising in connection with this Agreement), including without limitation any of Vapotherm's patent rights relating to the design, development, testing, use and sale of the System or the Cartridge; or (b) Giving Vapotherm any rights to any Intellectual Property of Medica or any other proprietary technology of Medica (whether Medica Baseline IP or Medica Inventions arising in connection with this Agreement).\"}, {\"id\": \"ARTICLE 11\", \"title\": \"REPRESENTATIONS\", \"level\": 1, \"text\": \"ARTICLE 11 REPRESENTATIONS\"}, {\"id\": \"11.1\", \"title\": \"Representations of Medica\", \"level\": 2, \"text\": \"11.1 Representations of Medica. Medica represents to Vapotherm as follows: (a) Medica is a corporation validly existing under the laws of its jurisdiction of organization with the power to own all of its properties and assets and to carry on its business as it is currently being conducted. (b) Medica has the power to execute and deliver this Agreement and to perform its obligations under this Agreement. (c) Medica's Chief Executive Officer, or Amministratore Unico (AU), has duly authorized Medica to execute and deliver this Agreement and perform its obligations under this Agreement, and no other corporate proceedings of Medica are necessary with respect thereto. (d) This Agreement constitutes its valid and binding obligation, enforceable in accordance with its terms, except as enforceability is limited by (A) any applicable bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors' rights generally, or (B) general principles of equity, whether considered in a proceeding in equity or at law. (e) Medica is not required to obtain the Consent of any Person, including the Consent of any party to any Contract to which it is a party, in connection with execution and delivery of this Agreement and performance of its obligations under this Agreement. (f) Medica is the rightful owner or licensee of any Intellectual Property that it may use in performing its obligations under this Agreement. (g) To Medica's knowledge, the Medica Baseline IP does not infringe or violate any patent, copyright, trademark, or any other proprietary right of a third party. (h) Medica's execution and delivery of this Agreement and performance of its obligations under this Agreement do not (A) violate any provision of its articles of incorporation or by-laws, as applicable, as currently in effect, (B) conflict with, result in a breach of, constitute a default under (or an event which, with notice or lapse of time or both, would constitute a default under), accelerate the performance required by, result in the creation of any Lien upon any of its properties or assets under, or create in any party the right to accelerate, terminate, modify, or cancel, or require any notice under, any Contract to which it is a party or by which any of its properties or assets are bound, or (C) violate any Law or Order currently in effect to which it is subject. -12- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"11.2\", \"title\": \"Representations of Vapotherm\", \"level\": 2, \"text\": \"11.2 Representations of Vapotherm. Vapotherm represents to Medica as follows; (a) Vapotherm is a corporation validly existing and in good standing under the law of the State of Maryland with the power to own all of its properties and assets and to carry on its business as it is currently being conducted. (b) Vapotherm has the power to execute and deliver this Agreement and to perform its obligations under this Agreement. (c) This Agreement constitutes the valid and binding obligation of Vapotherm, enforceable in accordance with its terms, except as enforceability is limited by (A) any applicable bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors' rights generally, or (B) general principles of equity, whether considered in a proceeding in equity or at law. (d) Vapotherm's execution and delivery of this Agreement and performance of its obligations under this Agreement do not (A) violate any provision of Vapotherm's articles of incorporation or by-laws as currently in effect, or (B) violate any Law or Order currently in effect to which Vapotherm is subject.\"}, {\"id\": \"ARTICLE 12\", \"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"ARTICLE 12 INDEMNIFICATION\"}, {\"id\": \"12.1\", \"title\": \"Indemnification\", \"level\": 2, \"text\": \"12.1 Indemnification. Medica shall indemnify Vapotherm, each Affiliate of Vapotherm, each Representative of Vapotherm, and the heirs, executors, successors, and assigns of any of the foregoing, against the following Indemnifiable Losses: a. Indemnifiable Losses arising out of or relating to a claim made for bodily injury, including death, or property damage to the extent that such claim arises out of or results from the failure of the Cartridges to comply with the Specifications or Medica's failure to comply with Medica's Quality System; b. Indemnifiable Losses arising out of or relating to any claim, demand, action or proceeding based upon infringement of a patent, trademark, copyright or trade secret, or similar intellectual property rights as a result of Vapotherm's marketing, promotion or distribution of the Cartridges; c. Indemnifiable Losses arising out of relating to any breach of this Agreement by Medica or any negligent or fraudulent act or willful misconduct of Medica or its employees, other agents, subcontractors or representatives in connection with this Agreement; or -13- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"d\", \"title\": \"Indemnifiable Losses arising out of or relating to any inaccuracy in any representations of Medica contained in this Ag\", \"level\": 1, \"text\": \"d. Indemnifiable Losses arising out of or relating to any inaccuracy in any representations of Medica contained in this Agreement. (b) Vapotherm shall indemnify each Medica Entity, each Affiliate of each Medica Entity, each Representative of each Medica Entity, and the heirs, executors, successors, and assigns of any of the foregoing, against the following Indemnifiable Losses: (i) Indemnifiable Losses arising out of or relating to any claim, demand, action or proceeding based upon infringement of a patent, trademark, copyright or trade secret, or similar intellectual property rights as a result of Vapotherm's marketing, promotion or distribution of the System, except to the extent such claim, demand, action or proceeding arising out of or relates to the Cartridge; (ii) Indemnifiable Losses arising out of or relating to any breach of this Agreement by Vapotherm or any negligent or fraudulent act or willful misconduct of Vapotherm or its employees, other agents, subcontractors or representatives in connection with this Agreement; or (iii) Indemnifiable Losses arising out of or relating to any inaccuracy in any representations of Vapotherm contained in this Agreement.\"}, {\"id\": \"12.2\", \"title\": \"Procedures Relating to Indemnification\", \"level\": 2, \"text\": \"12.2 Procedures Relating to Indemnification. In order to be entitled to indemnification under this Article 12 in connection with an Indemnifiable Loss, the party seeking indemnification (the \\\"Indemnified Party\\\") must: (1) notify the party obligated to indemnify it (the \\\"Indemnifying Party\\\") in writing, and in reasonable detail, of any third party claims, demands, lawsuits, proceedings or action (\\\"Third Party Claims\\\") as soon as possible but in any event within [* * *] Business Days after receipt of notice of that Third Party Claim; and (2) deliver to the Indemnifying Party as soon as possible but in any event within [* * *] Business Days after the Indemnified Party receives a copy of all notices and documents (including court papers) delivered to that Indemnified Party relating to that Third Party Claim. (b) In the event of a Third Party Claim against an Indemnified Party, the Indemnifying Party may participate in the defense of that Third Party Claim and, if it so chooses, assume at its expense the defense of that Third Party Claim with counsel selected by the Indemnifying Party and reasonably satisfactory to the Indemnified Party. If the Indemnifying Party so elects to assume the defense of a Third Party Claim, the Indemnifying Party will not be liable to the Indemnified Party for any legal expenses subsequently incurred by the Indemnified Party in connection with the defense of that Third Party Claim, except that if, under applicable standards of professional conduct, there exists a conflict on any significant issue between the Indemnified Party mid the Indemnifying Party in connection with that Third Party Claim, the -14- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Indemnifying Party shall pay the reasonable fees and expenses of one additional counsel to act with respect to that issue to the extent necessary to resolve that conflict. If the Indemnifying Party assumes defense of any Third Party Claim, the Indemnified Party will be entitled to participate in the defense of that Third Party Claim and to employ counsel, at its own expense, separate from counsel employed by the Indemnifying Party, it being understood that the Indemnifying Party will be entitled to control that defense. The Indemnifying Party will be liable for the fees and expenses of counsel employed by the Indemnified Party for any period during which the Indemnifying Party did not assume the defense of any Third Party Claim (other than during any period in which the Indemnified Party failed to give notice of the Third Party Claim as provided above and a reasonable period after such notice). If the Indemnifying Party chooses to defend or prosecute a Third Party Claim, all the parties shall cooperate in the defense or prosecution of that Third Party Claim, including by retaining and providing to the Indemnifying Party records and information reasonably relevant to that Third Party Claim, and making employees available on a reasonably convenient basis. If the Indemnifying Party chooses to defend or prosecute any Third Party Claim, the Indemnified Party will agree to any settlement, compromise or discharge of that Third Party Claim that the Indemnifying Party recommends, except that the Indemnifying Party may not without the Indemnified Party's prior written consent agree to entry of any judgment or enter into any settlement that provides for injunctive or other non-monetary relief affecting the Indemnified Party or that does not include as a unconditional term that each claimant or plaintiff give to the Indemnified Party a release from all liability with respect to that Third Party Claim. Whether or not the Indemnifying Party has assumed the defense of a Third Party Claim, the Indemnified Party shall not admit any liability with respect to, or settle, compromise or discharge, that Third Party Claim without the Indemnifying Party's prior written consent.\"}, {\"id\": \"12.3\", \"title\": \"No Liability for Consequential Damages\", \"level\": 2, \"text\": \"12.3 No Liability for Consequential Damages. No party will be liable to any other for any indirect, consequential, or special damages or for loss of profits. This limitation does not, however, apply to any obligation of either party to indemnify the other in connection with any Indemnifiable Loss.\"}, {\"id\": \"12.4\", \"title\": \"Limitation on Liability\", \"level\": 2, \"text\": \"12.4 Limitation on Liability. Notwithstanding any other provision contained in this Agreement, each party's maximum aggregate liability to the other party for any and all causes whatsoever, and each party's remedy, regardless of the form of action, whether in contract or tort, including negligence, and whether or not pursuant to the indemnification provisions contained in Section 12 and whether or not such party is notified of the possibility of damage to the other party, shall be limited to $[* * *]. ARTICLE 13 TERM AND TERMINATION; BUSINESS CONTINUITY\"}, {\"id\": \"13.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"13.1 Term. The term of this Agreement is three years from and including the date of this Agreement (the \\\"Initial Term\\\"), with automatic renewal for additional successive one-year terms (each a \\\"Renewal Term\\\" and together wit the Initial Term, the \\\"Term\\\") unless no later than [* * *] days prior to the end of the Initial Term, or any Renewal Term either party notifies the other that it wishes to terminate this Agreement effective the end of the Initial Term or that Renewal Term, as applicable. -15- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (b) The parties may terminate this Agreement at any time by written agreement.\"}, {\"id\": \"13.3\", \"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"13.3 Effect of Termination. (a) Upon any termination (including expiration) of this Agreement, each party shall return to the other party all documents and other tangible items to it or its employees or agents have received or created pursuant to this Agreement pertaining, referring, or relating to Confidential Information of the other party. (c) Upon any termination (including expiration) of this Agreement, Vapotherm shall pay to Medica, and Medica shall pay to Vapotherm, all amounts payable up to the date of termination but not yet paid. (d) The termination or expiration of this Agreement shall not relieve either party of its responsibility to comply in all material respects with any statutory or regulatory requirements associated with the System and/or the Cartridges.\"}, {\"id\": \"13.4\", \"title\": \"Business Continuity\", \"level\": 2, \"text\": \"13.4 Business Continuity. Medica agrees to have the capability to manufacture in either (2) facilities of the Medica Group in the event of disruption for any reason and deliver the Cartridges within [* * *] weeks.\"}, {\"id\": \"13.4.1\", \"title\": \"Medica agrees to maintain [* * *] weeks [* * *] of inventory in the event of business disruption consistent with section\", \"level\": 3, \"text\": \"13.4.1 Medica agrees to maintain [* * *] weeks [* * *] of inventory in the event of business disruption consistent with section 2 of the agreement.\"}, {\"id\": \"13.4.2\", \"title\": \"Notwithstanding anything to the contrary in this Agreement, Medica shall neither enter into an agreement to nor shall co\", \"level\": 3, \"text\": \"13.4.2 Notwithstanding anything to the contrary in this Agreement, Medica shall neither enter into an agreement to nor shall consummate (a) any Change of Control or (b) any sale of all or substantially all of its assets relating to the manufacture of the Cartridges unless (a) it provides Vapotherm written notice of any such proposed transaction, which notice shall include the specific terms and conditions of the proposed transaction, including the identify of the proposed acquirer, (b) Medica offers to enter into such transaction with Vapotherm on substantially the same terms and conditions, and (c) with [* * *] days of such notice, Vapotherm declines to accept such offer. For purposes of this Agreement, \\\"Change of Control\\\" means (i) the acquisition, directly or indirectly, by any person or group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) that is not a subsidiary or Affiliate -17- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (as defined below) of Medica of the beneficial ownership of securities of Medica possessing more than fifty percent (50%) of the total combined voting power of all outstanding securities of Medica; (ii) a merger or consolidation in which neither Medica nor a subsidiary or Affiliate of Medica is the surviving entity; (iii) a reverse merger in which Medica is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of Medica's outstanding securities are transferred to or acquired by a person or persons different from the persons holding those securities immediately prior to such merger and where such persons are not a subsidiary or Affiliate of Medica; or (iv) the sale, transfer or other disposition of all or substantially all of the assets of Medica to a person or entity that is not a subsidiary or Affiliate of Medica. ARTICLE 14 MISCELLANEOUS\"}, {\"id\": \"14.1\", \"title\": \"Definitions\", \"level\": 2, \"text\": \"14.1 Definitions. When used in this Agreement, the following terms have the - following meanings: \\\"Affiliate\\\" means, with respect to any given Person, any other Person at the time directly or indirectly controlling, controlled by or under common control with that Person, or (2) any director, officer or employee of that Person. For purposes of this Agreement, \\\"control\\\" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. \\\"Business Day\\\" means any Monday, Tuesday, Wednesday, Thursday, or Friday that is not a day on which banking institutions in the State of New York authorized by law, regulation or executive order to close. \\\"cGMPs\\\" means current Good Manufacturing Practices (as provided for, respectively, in the Rules Governing Medicinal Products in the European Community Volume 4 (Guide to Good Manufacturing Practice for Medicinal Products) and by the FDA as set out in 21 C.F.R. 210 and 21 C.F.R. 211, as amended from time to time). \\\"Confidential Information\\\" means all data, specifications, training, and any other know-how related to the design, development, manufacture, or performance of the System or the Cartridge, the customers, finances, methods, research, processes or procedures of a party, as well as all other information and data provided by either party to the other party pursuant to this Agreement (i) in written or other tangible medium and marked as confidential, or (ii) if disclosed orally or displayed, confirmed in writing within [* * *] Business Days after disclosure and marked as confidential, or (iii) that by the nature of the information or the circumstances surrounding disclosure, should in good faith be treated as confidential, except that the term \\\"Confidential Information\\\" does not include the following: (1) information that is or becomes generally available to the public other than as a result of a breach of this Agreement by the receiving party or its Representatives; -18- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (2) information that was within the receiving party's possession or knowledge prior to its being furnished to the receiving party by or on behalf of the disclosing party, on condition that the source of that information was not bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the disclosing party or any other Person with respect to that information; (3) information that is or becomes available to the receiving party on a non-confidential basis from a source other than the disclosing party or any of its Representatives, on condition that that source was not bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the disclosing party or any other Person with respect to that information; (4) information that is independently developed by the receiving party without use of Confidential Information and otherwise in a manner not .inconsistent -with this Agreement; or (5) information that is required to be disclosed by law, provided that the disclosing Party is promptly notified by the receiving Party in order to provide the disclosing Party an opportunity to seek a protective order or other relief. \\\"Consent\\\" means any approval, consent, ratification, filing, declaration, registration, waiver, or other authorization. \\\"Contract\\\" means any oral or written agreement, contract, obligation, promise, arrangement, or undertaking that is legally binding. \\\"Event of Insolvency\\\" with respect to any Person means any of the following: (1) the institution by that Person of proceedings under the United States Bankruptcy Code, or any other applicable U.S. federal or state Law or any applicable foreign Law seeking an order for relief; (2) the consent of that Person to the institution of bankruptcy or insolvency proceedings against that Person; (3) the filing by that Person of a petition seeking reorganization or release under the Federal Bankruptcy Reform Act or any other applicable U.S. federal or state Law or applicable foreign Law, or the consent by that Person to the filing of any such petition or to the appointment of a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of that Person or of any substantial part of the property of that Person; (4) the making by that Person of an assignment for the benefit of creditors; -19- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (5) admission by that Person of its inability to pay its debts generally as they become due; (6) the entry of a decree or order by a court having jurisdiction adjudging that Person bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of that Person under the U.S. Bankruptcy Code or any other applicable U.S. federal or state Law or any applicable foreign Law, or appointing a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of that Person, or of any substantial part of the property of that Person, or ordering the winding up or liquidation of the affairs of that Person, and (A) that Person consents to that decree or order or (B) that decree or order remains unstayed and in effect for more than [* * *] consecutive days. \\\"FDA\\\" means the U.S. Food and Drug Administration. \\\"FOB\\\" means \\\"Free on Board,\\\" as that term is defined in INCOTERMS 2000, \\\"Governmental Authority\\\" means any (1) nation, state, comity, city, town, village, district, or other jurisdiction of any nature, (2) federal, state, local, municipal, or other government, whether U.S. or foreign, (3) governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal, including an arbitral tribunal), (4) multi-national organization or body including the EU and notified bodies, or (5) body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulator)', or taxing power of any nature. \\\"Indemnifiable Losses\\\" means all losses, liabilities, taxes, damages, deficiencies, obligations, fines, expenses, judgments or settlements resulting from Third Party Claims that are incurred or suffered by an Indemnified Party, including interest and penalties with respect thereto and out-of-pocket expenses and reasonable attorneys' and accountants' and experts' fees and expenses incurred in the investigation or defense of any of the same or in asserting, preserving or enforcing any of the Indemnified Party's rights hereunder, net of any amounts recovered or recoverable under any insurance policy. \\\"Intellectual Property\\\" means, with respect to any Person, all unpatented ideas, inventions, processes, discoveries trademarks, patents, copyrights, and any applications for registration thereof, and trade secrets and know-how of that Person, whether owned, used, or licensed by that Person as licensee or licensor. \\\"Law\\\" means any federal, state, local, municipal, foreign, international, multinational, or other administrative order, constitution, law, ordinance, principle of common law, regulation, statute, or treaty. \\\"Lien\\\" means any charge, claim, community property interest, condition, equitable interest, lien, option, pledge, security interest, right of first refusal, or restriction of any kind, including any restriction on use, voting, transfer, receipt of income, or exercise of any other attribute of ownership. -20- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. \\\"Month\\\" means any of the twelve months of a year. \\\"Order\\\" means any award, decision, injunction, judgment, order, ruling, subpoena, or verdict of any court, arbitral tribunal, administrative agency, or other Governmental Authority. \\\"Person\\\" means any individual, corporation (including any non-profit corporation), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, labor union, Governmental Authority or other entity. \\\"Representative\\\" means, with respect to a particular Person, any director, officer, employee, agent, consultant, advisor, or other representative of that Person, including legal counsel, accountants, and financial advisors. \\\"Year\\\" means (1) the period commencing with the date of this Agreement and ending on November 7th 2009, (2) any subsequent 12-month period commencing on January 1st and ending on December 31st, and (3) the period beginning January 1st of the year in which this Agreement expires or is terminated and ending on the date this Agreement expires or is terminated.\"}, {\"id\": \"14.2\", \"title\": \"Further Assurances\", \"level\": 2, \"text\": \"14.2 Further Assurances. At any time or from time to time from the date of this Agreement, Medica, on the one hand, and Vapotherm, on the other hand, shall at the request, and at the expense, of the other do the following: (1) to the extent consistent with this Agreement deliver to the other such records, data, or other documents requested by the other; and (2) take or cause to be taken all such other actions as are reasonably necessary or desirable in order to permit the other to obtain the full benefits of this Agreement.\"}, {\"id\": \"14.3\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"14.3 Governing Law. This Agreement is governed by the laws of the State of New York without giving effect to principles of conflict of laws.\"}, {\"id\": \"14.4\", \"title\": \"Dispute Resolution\", \"level\": 2, \"text\": \"14.4 Dispute Resolution. The parties shall attempt in good faith to resolve any controversy or claim that may arise concerning their respective rights and obligations under this Agreement. If they are unable to do so within [* * *] Business Days from the date that controversy or claim arose, they shall refer the controversy or claim to the AU of Medica and the CEO of Vapotherm, who shall meet in person or telephonically within [* * *] Business Days of being requested to do so and shall in good faith attempt to resolve the dispute. If the controversy or claim cannot then be solved, the parties hereby agree first to try in good faith to settle the dispute by mediation administered by the American arbitration Association at its New York City offices before resorting to arbitration. -21- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"14.5\", \"title\": \"Arbitration\", \"level\": 2, \"text\": \"14.5 Arbitration. Any controversy or claim arising out of or relating to this Agreement or the applicability of this Section 14.5 that is not resolved pursuant to Section 14.4 will be determined by arbitration in accordance with the International Arbitration Rules of the American Arbitration Association. Unless the parties agree otherwise the number of arbitrators will be three, each of whom will be appointed by the American Arbitration Association. One arbitrator must be a lawyer, the second must be an expert in financial matters, and the third must have expertise in the manufacture of hemodialysis products. The place of arbitration will be Washington, D.C., U.S.A. The language of the arbitration will be English. Prior to the commencement of hearings, each of the arbitrators appointed must provide an oath or undertaking of impartiality. Judgment upon the award rendered by the arbitrators may be entered by any court having jurisdiction thereof. The cost of any such arbitration will be divided equally between Vapotherm, on the one hand, and Medica, on the other hand, with each party bearing its own attorneys' fees and costs.\"}, {\"id\": \"14.6\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"14.6 Force Majeure. No party will be responsible to the other under this Agreement for failure or delay in performing any obligations under this Agreement, other than payment obligations, due to factors beyond its control, including without limitation any war, fire, earthquake, or other natural catastrophe, or any act of God, but excluding labor disputes involving all or any part of the work force of that party (each such factor, an \\\"Event of Force Majeure\\\"). Upon the occurrence of an Event of Force Majeure, the party failing or delaying performance shall promptly notify the other party in writing, setting forth the nature of the occurrence, its expected duration, and how that party's performance is affected. Any party subject to an Event of Force Majeure shall use commercially reasonable efforts to resume performing its obligations under this Agreement as soon as practicable. Except as provided in Section 14.6(b), if an Event of Force Majeure occurs, the affected party' will be excused from performing and the time for performance will be extended as long as that party is unable to perform as result of the Event of Force Majeure. (b) If any Event of Force Majeure prevents Medica from delivering any shipment of Cartridges for more than [* * *] Business Days beyond the scheduled delivery date, then Vapotherm may cancel its order without incurring any liability to Medica with respect thereto.\"}, {\"id\": \"14.7\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"14.7 Assignment. This Agreement inures to the benefit of and is binding upon the successors and assignees of the parties. Neither party may assign any of its rights or obligations under this Agreement without the prior written consent of the other except that: (1) Vapotherm may assign this Agreement or transfer its rights and obligations under this Agreement to an Affiliate of Vapotherm or a successor to all or substantially all of its assets or business relating to this-Agreement, whether by sale, merger, operation of law, or otherwise.\"}, {\"id\": \"14.8\", \"title\": \"Notices\", \"level\": 2, \"text\": \"14.8 Notices. Every notice or other communication required or contemplated by this Agreement must be in writing and sent by one of the following methods: (1) personal delivery, in which case delivery will be deemed to occur the day of delivery; -22- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (2) by a recognized overnight delivery service such as Federal Express or DHL Worldwide Express, in which case delivery will be deemed to occur the day of delivery. (b) In each case, a notice or other communication sent to a party must be directed to the address for that party set forth below, or to another address designated by that party by written notice. All notices to be given by a Medica Entity may be given on its behalf by the other Medica Entity following consultation between Medica. If to: Vapotherm Inc. 198 Log Canoe Circle Stevensville MD 21666 Attention: CFO with a copy to: Hogan & Hartson L.L.P. 555 13t h Street, N.W., Washington, D.C. 20004-1009 Attention: Stephen J. Zempolich, Esq. if to Medica: Medica S.p.A. Via Degli Artigiani, 7 41036 Medolla (MO) Italy Attention: Luciano Fecondini\"}, {\"id\": \"14.9\", \"title\": \"Severability\", \"level\": 2, \"text\": \"14.9 Severability. If any provision of this Agreement is held unenforceable by any court of competent jurisdiction, all other provisions of this Agreement will remain effective. If any provision of this Agreement is held to be unenforceable only in part or degree, it will remain effective to the extent not held unenforceable.\"}, {\"id\": \"14.10\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"14.10 Entire Agreement. This Agreement constitutes the entire agreement of the parties pertaining to the subject matter of this Agreement. It supersedes all prior agreements of the parties, whether oral or written, pertaining to the subject matter of this Agreement.\"}, {\"id\": \"14.11\", \"title\": \"Amendment\", \"level\": 2, \"text\": \"14.11 Amendment. This Agreement may not be amended except by an instrument in writing signed on behalf of both parties.\"}, {\"id\": \"14.12\", \"title\": \"Independent Contractor\", \"level\": 2, \"text\": \"14.12 Independent Contractor. Nothing in this Agreement creates, or will be deemed to create, a partnership or the relationship of principal and agent or employer and employee between the parties. Each party agrees to perform under this Agreement solely as an independent contractor,\"}, {\"id\": \"14.13\", \"title\": \"Counterparts\", \"level\": 2, \"text\": \"14.13 Counterparts. This Agreement may be executed in counterparts, each of which is an original and all of which together constitute one and the same instrument. -23- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"14.14\", \"title\": \"Compliance with Laws\", \"level\": 2, \"text\": \"14.14 Compliance with Laws. Vapotherm and Medica shall each comply in all material respects with all applicable Laws that pertain to the activities for which Vapotherm and Medica are each responsible under this Agreement and, except as provided for herein, shall bear their own cost and expense of complying therewith. -24- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. IN WITNESS WHEREOF, each of the undersigned have caused this Manufacturing and Supply Agreement to be duly executed and delivered in their name and on their behalf as of the date first set forth above. VAPOTHERM, INC. By: /s/ Joseph Army Name: Joseph Army Title: President & CEO MEDICA S.p.A By: /s/ Luciano Fecondini Name: Luciano Fecondini Title: Amministratore Unico [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit A-1 Price Schedule: in EURO (Euro) [* * *] Exhibit A-2: Forecast [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit B: Purchase Order Form Example [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}, {\"id\": \"Exhibit C\", \"title\": \"- Vapotherm Tools\", \"level\": 1, \"text\": \"Exhibit C - Vapotherm Tools [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit D: [* * *] Purchase Specifications [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of VAPOTHERM, INC. - Manufacturing and Supply Agreement\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.14\", \"level\": 1, \"text\": \"Exhibit 10.14 [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. MANUFACTURING AND SUPPLY AGREEMENT DATED AS OF January 1, 2013 BETWEEN VAPOTHERM, INC. AND MEDICA, S.p.A. TABLE OF CONTENTS Page ARTICLE 1 SALE AND PURCHASE 1\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply of Cartridge 1 1\", \"level\": 2, \"text\": \"1.1 Supply of Cartridge 1 1.2 [* * *] 1 1.3 Purchase of Cartridge 1\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORECASTS; INVENTORY 1\", \"level\": 1, \"text\": \"ARTICLE 2 FORECASTS; INVENTORY 1\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Rolling Forecasts 1 2\", \"level\": 2, \"text\": \"2.1 Rolling Forecasts 1 2.2 Inventory 2\"}}, {\"id\": \"ARTICLE 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDERS, SHIPMENT, AND PAYMENT 2\", \"level\": 1, \"text\": \"ARTICLE 3 ORDERS, SHIPMENT, AND PAYMENT 2\"}}, {\"id\": \"ARTICLE 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"QUALITY OF THE CARTRIDGE 4\", \"level\": 1, \"text\": \"ARTICLE 4 QUALITY OF THE CARTRIDGE 4\"}}, {\"id\": \"ARTICLE 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCTION PROCESS 5\", \"level\": 1, \"text\": \"ARTICLE 5 PRODUCTION PROCESS 5\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Joint Review Committee 5 5\", \"level\": 2, \"text\": \"5.1 Joint Review Committee 5 5.2 Process Development 5 5.3 Inventory of Raw Materials and Spare Parts 5 5.4 [* * *] 5 -i- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"QUALITY SYSTEM 6\", \"level\": 1, \"text\": \"ARTICLE 6 QUALITY SYSTEM 6\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General Quality Statement 6 6\", \"level\": 2, \"text\": \"6.1 General Quality Statement 6 6.2 Quality System Changes 6 6.3 Vendor Quality 6 6.4 Vigilance System 6\"}}, {\"id\": \"ARTICLE 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OTHER OBLIGATIONS OF MEDICA 7\", \"level\": 1, \"text\": \"ARTICLE 7 OTHER OBLIGATIONS OF MEDICA 7\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Debarment Certification 7 7\", \"level\": 2, \"text\": \"7.1 Debarment Certification 7 7.2 Permits and Certifications 7 7.3 Manufacturing Problems 7 7.4 Insurance 7\"}}, {\"id\": \"ARTICLE 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSPECITONS; RECORDS 8\", \"level\": 1, \"text\": \"ARTICLE 8 INSPECITONS; RECORDS 8\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notification of Inquiries and Inspections 8 8\", \"level\": 2, \"text\": \"8.1 Notification of Inquiries and Inspections 8 8.2 Access to Medica Facilities and Records 8 8.3 Records 9\"}}, {\"id\": \"ARTICLE 9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CARTRIDGE RECALLS 9\", \"level\": 1, \"text\": \"ARTICLE 9 CARTRIDGE RECALLS 9\"}}, {\"id\": \"ARTICLE 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY 10\", \"level\": 1, \"text\": \"ARTICLE 10 PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY 10\"}}, {\"id\": \"ARTICLE 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS 12\", \"level\": 1, \"text\": \"ARTICLE 11 REPRESENTATIONS 12\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations of Medica 12 -ii-\", \"level\": 2, \"text\": \"11.1 Representations of Medica 12 -ii- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations of Vapotherm 13\", \"level\": 2, \"text\": \"11.2 Representations of Vapotherm 13\"}}, {\"id\": \"ARTICLE 12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION 13\", \"level\": 1, \"text\": \"ARTICLE 12 INDEMNIFICATION 13\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification 13 12\", \"level\": 2, \"text\": \"12.1 Indemnification 13 12.2 Procedures Relating to Indemnification 14 12.3 No Liability for Consequential Damages 15 12.4 Limitation on Liability 15\"}}, {\"id\": \"ARTICLE 13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION; BUSINESS CONTINUITY 15\", \"level\": 1, \"text\": \"ARTICLE 13 TERM AND TERMINATION; BUSINESS CONTINUITY 15\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term 15 13\", \"level\": 2, \"text\": \"13.1 Term 15 13.2 Termination 16 13.3 Effect of Termination 17 13.4 Business Continuity 17\"}}, {\"id\": \"ARTICLE 14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS 18\", \"level\": 1, \"text\": \"ARTICLE 14 MISCELLANEOUS 18 [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (this \\\"Agreement\\\") is dated January 1st, 2013, between VAPOTHERM, INC., a Maryland corporation (\\\"Vapotherm\\\") and MEDICA S.p.A., an Italian company (\\\"Medica\\\"). WHEREAS, Vapotherm sells systems it has developed for delivering humidified, blended medical gas therapy (the \\\"System\\\"), which system includes a vapor transfer cartridge; WHEREAS, Vapotherm and Medica wish for Medica to manufacture [* * *] (each, a \\\"Cartridge\\\" and collectively, the \\\"Cartridges\\\") for Vapotherm for use in the System, using fiber provided by Medica as developed for the System and packaged as specified in Vapotherm Specification Exhibit D. NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which have hereby acknowledged, the parties therefore agree as follows:\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Manufacturing and Supply Agreement (this \\\"Agreement\\\")\", \"definition_clause\": \"ARTICLE 14\"}}, {\"id\": \"party:VAPOTHERM, INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"VAPOTHERM, INC.\", \"role\": \"Vapotherm\", \"address\": \"198 Log Canoe Circle Stevensville MD 21666\"}}, {\"id\": \"party:MEDICA S.p.A.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"MEDICA S.p.A.\", \"role\": \"Medica\", \"address\": \"Via Degli Artigiani, 7 41036 Medolla (MO) Italy\"}}, {\"id\": \"term:System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"System\", \"text\": \"Vapotherm sells systems it has developed for delivering humidified, blended medical gas therapy (the \\\"System\\\"), which system includes a vapor transfer cartridge;\", \"definition_clause\": \"ARTICLE 14\"}}, {\"id\": \"term:Cartridge\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cartridge\", \"text\": \"(each, a \\\"Cartridge\\\" and collectively, the \\\"Cartridges\\\")\", \"definition_clause\": \"ARTICLE 14\"}}, {\"id\": \"term:Cartridges\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cartridges\", \"text\": \"(each, a \\\"Cartridge\\\" and collectively, the \\\"Cartridges\\\")\", \"definition_clause\": \"ARTICLE 14\"}}, {\"id\": \"ARTICLE 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SALE AND PURCHASE\", \"level\": 1, \"text\": \"ARTICLE 1 SALE AND PURCHASE\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply of Cartridge\", \"level\": 2, \"text\": \"1.1 Supply of Cartridge. Subject to the terms of this Agreement, Medica shall manufacture, in such quantities as Vapotherm orders, the Cartridge.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[* * *]\", \"level\": 2, \"text\": \"1.2 [* * *]\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase of Cartridge\", \"level\": 2, \"text\": \"1.3 Purchase of Cartridge. Subject to the terms of this Agreement, Vapotherm shall purchase from Medica Cartridges following regulatory approval.\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORECASTS; INVENTORY\", \"level\": 1, \"text\": \"ARTICLE 2 FORECASTS; INVENTORY\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Rolling Forecasts\", \"level\": 2, \"text\": \"2.1 Rolling Forecasts. Attached hereto and incorporated herein by reference as Exhibit A-2 is Vapotherm's initial forecast of Cartridges that Vapotherm will purchase for delivery on a monthly basis in calendar year 2013 (the \\\"Initial Forecast\\\"). On or prior to January 1, 2013 (the \\\"Forecast Initiation Date\\\"), Vapotherm shall deliver to Medica a forecast of Cartridge demand in each of the [* * *] consecutive months beginning one month following the FID. On or prior to one month following the FID, Vapotherm shall provide a forecast for the next [* * *] consecutive months beginning [* * *] months following the FID. On or prior to the first day of each subsequent month, Vapotherm shall deliver to Medica an update to its previously submitted forecast of its expected purchases of Cartridges (each forecast delivered pursuant to this Section 2.l(a), a \\\"Rolling Forecast\\\"). [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (a) Vapotherm will place a firm Purchase Order for the following [* * *] months. Every month there after, Vapotherm will placed a PO for the following month to maintain a rolling [* * *] month commitment. (b) The forecast for any month specified in any Rolling Forecast may not be less than the total number of Cartridges for which Vapotherm, prior to delivery of that Rolling Forecast to Medica in accordance with Section 2.l(a), has submitted purchase orders in accordance with Section 3.2 specifying a delivery date in that month.\"}}, {\"id\": \"term:Initial Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Forecast\", \"text\": \"Vapotherm's initial forecast of Cartridges that Vapotherm will purchase for delivery on a monthly basis in calendar year 2013 (the \\\"Initial Forecast\\\").\", \"definition_clause\": \"2.1\"}}, {\"id\": \"term:Forecast Initiation Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Forecast Initiation Date\", \"text\": \"On or prior to January 1, 2013 (the \\\"Forecast Initiation Date\\\"),\", \"definition_clause\": \"2.1\"}}, {\"id\": \"value:one month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one month\"}}, {\"id\": \"term:Rolling Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Rolling Forecast\", \"text\": \"(each forecast delivered pursuant to this Section 2.l(a), a \\\"Rolling Forecast\\\")\", \"definition_clause\": \"2.1\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Inventory\", \"level\": 2, \"text\": \"2.2 Inventory. During the Term, Medica shall at all times maintain as safety stock that quantity of Cartridges equal to one (1) times the monthly average number of Cartridges ordered by Vapotherm during the immediately preceding [* * *] months.\"}}, {\"id\": \"ARTICLE 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDERS, SHIPMENT, AND PAYMENT\", \"level\": 1, \"text\": \"ARTICLE 3 ORDERS, SHIPMENT, AND PAYMENT\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price\", \"level\": 2, \"text\": \"3.1 Price. The price paid by Vapotherm for any given shipment of Cartridges during the Initial Term is as stated in Exhibit A-1. No later than [* * *] days prior to the end of the Initial Term and each Renewal Term, Medica shall provide Vapotherm with reasonable documentation of its actual and direct costs in manufacturing the Cartridges (the \\\"Costs\\\"). The parties will then negotiate in good faith the Cartridge prices for the subsequent\"}}, {\"id\": \"term:Costs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Costs\", \"text\": \"Medica shall provide Vapotherm with reasonable documentation of its actual and direct costs in manufacturing the Cartridges (the \\\"Costs\\\").\", \"definition_clause\": \"3.1\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Orders\", \"level\": 2, \"text\": \"3.2 Purchase Orders. (a) Each purchase order that Vapotherm places for Cartridges must be in the form attached as Exhibit B and must specify (1) how many Cartridges are desired, (2) the one or more places to which, and the manner and date by which, delivery is to be made, and (3) the applicable price per Cartridge. Vapotherm shall deliver all purchase orders by facsimile, or by one of the means specified in Section 14.8 for giving notice, to Medica at the following address and facsimile number or as otherwise instructed by Medica: Medica S.p.A. Via Degli Artigiani, 7 41036 Medolla (MO) Italy Attention: Daniele Giubertoni MKTG & Sales Manager Facsimile: 39-0535-52605 E-mail: daniele.giubertoni@medica.it (b) Vapotherm shall order for delivery in any given month an aggregate number of Cartridges equal to at least [* * *]% of the final amount forecast for that month in the Rolling Forecasts (that quantity, the \\\"Final Forecast Quantity\\\"). Vapotherm may order for delivery in any given Quarter an aggregate quantity of Cartridge not exceeding [* * *]% of the Final Forecast Quantity. Only with Medica's written consent may Vapotherm order for delivery in any given Quarter an aggregate number of Cartridges exceeding [* * *]% of the aggregate Final Forecast Quantity for the months in such Quarter. -2- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) Vapotherm shall deliver each purchase order for quantities of the Cartridge at least [* * *] in advance of the delivery date specified in that purchase order. (d) If Vapotherm delivers any purchase order with less lead time than is required under Section 3.2(c), then Medica shall use [* * *] efforts to fill that purchase order but will not be liable to Vapotherm if despite those best efforts they fail to do so. (e) Medica shall acknowledge and accept in writing on behalf of Medica any purchase order that Vapotherm places for Cartridges. Any such purchase order will be deemed accepted by Medica if Medica does not reject it by written notice to Vapotherm delivered within [* * *] Business Days of Medica's receiving that purchase order. Medica may not reject any purchase order that complies with the provisions of Article 3. If the terms of any purchase are inconsistent with the terms of this Agreement, the terms of this Agreement will control.\"}}, {\"id\": \"term:Final Forecast Quantity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Final Forecast Quantity\", \"text\": \"Vapotherm shall order for delivery in any given month an aggregate number of Cartridges equal to at least [* * *]% of the final amount forecast for that month in the Rolling Forecasts (that quantity, the \\\"Final Forecast Quantity\\\").\", \"definition_clause\": \"3.2\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery\", \"level\": 2, \"text\": \"3.3 Delivery. Each shipment of Cartridges will be delivered by [* * *] to the applicable Vapotherm manufacturing facility or retained in Medica's warehouse facility, in accordance with Vapotherm instructions for each shipment. Medica shall deliver by the delivery date specified in a purchase order all of the Cartridges specified in that purchase order. Vapotherm is only required to pay for Cartridges actually delivered. Medica shall make shipping arrangements with carriers designated in writing by Vapotherm from the [* * *] point to points specified by Vapotherm, under the arrangements that Vapotherm has with those carriers.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[* * *]\", \"level\": 2, \"text\": \"3.4 [* * *]\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delay in Delivery\", \"level\": 2, \"text\": \"3.5 Delay in Delivery. If for any reason other than an Event of Force Majeure, Medica delivers any shipment of Cartridges later than the date of delivery set out in the applicable purchase order, Vapotherm will be entitled to the following as an alternative, in its sole discretion, to its rights under Section 3.6 and Section 13.2(a): (1) a [* * *]% reduction in the price of each Cartridge in the shipment for every [* * *] the shipment is delayed (from the Required Ship Date specified in the Purchase Order) to a maximum of [* * *]%.\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery Default Rights\", \"level\": 2, \"text\": \"3.6 Delivery Default Rights. If more than [* * *] days have passed since the delivery date for any Cartridges and Medica has, for any reason other than an Event of Force Majeure, failed to deliver those Cartridges, then, in addition to any other remedies it might have under this Agreement or by law, Vapotherm may cancel that purchase order or the portion thereof relating to those cartridges, as applicable.\"}}, {\"id\": \"3.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Invoices and Payment Terms\", \"level\": 2, \"text\": \"3.7 Invoices and Payment Terms. On delivery by Medica of a shipment of Cartridges in accordance with Section 3.3, Medica shall issue to Vapotherm an invoice for that shipment stating a price consistent with the terms of this Agreement. Vapotherm shall pay each such invoice in full within [* * *] Calendar Days from the date of invoice, unless Vapotherm has rejected the shipment in question in accordance with Section 4.2. -3- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"3.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delay in Payment\", \"level\": 2, \"text\": \"3.8 Delay in Payment. Upon delay of payment beyond [* * *] days from invoice date, Medica at its' sole discretion may levy an increase to the net transfer price a [* * *]% per week to a maximum of [* * *]%.\"}}, {\"id\": \"ARTICLE 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"QUALITY OF THE CARTRIDGE\", \"level\": 1, \"text\": \"ARTICLE 4 QUALITY OF THE CARTRIDGE\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Conformity with Specifications\", \"level\": 2, \"text\": \"4.1 Conformity with Specifications. Any Cartridges that Medica manufactures under this Agreement must conform to the specifications in Exhibit D (the \\\"Specifications\\\") and (2) be manufactured, labeled, packaged, stored, and tested (while in the possession of, stored by, or under the control of Medica) in accordance with cGMP. Medica shall provide adequate packaging for protection during normal shipping and handling environments.\"}}, {\"id\": \"term:Specifications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specifications\", \"text\": \"Any Cartridges that Medica manufactures under this Agreement must conform to the specifications in Exhibit D (the \\\"Specifications\\\")\", \"definition_clause\": \"4.1\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Conditions to Rejection\", \"level\": 2, \"text\": \"4.2 Conditions to Rejection. In order to be entitled to reject any Cartridge, Vapotherm must notify Medica of any failure of the Cartridge to meet the Specifications or otherwise comply with this Agreement. Misuse or improper storage will not be grounds for rejection.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Rejection\", \"level\": 2, \"text\": \"4.3 Rejection. Vapotherm may reject any Cartridge that does not meet the Specifications or otherwise comply with this Agreement (any such Cartridge, a \\\"Nonconforming Cartridge\\\"). If Medica accepts that Vapotherm was entitled to reject the Nonconforming Cartridge(s) and Vapotherm has already paid the purchase price for the Nonconforming Cartridge(s), then, within [* * *] Calendar Days after receiving notice from Vapotherm under Section 4.2, Medica shall, at Vapotherm's election, either replace the Nonconforming Cartridge(s) at no additional cost to Vapotherm or reimburse Vapotherm for the purchase price of the Nonconforming Cartridge(s) via wire transfer. Further, if Medica accepts that Vapotherm was entitled to reject the Nonconforming Cartridge(s) and Vapotherm has not already paid the purchase price for the Nonconforming Cartridge(s), then, within [* * *] Calendar Days after receiving notice from Vapotherm under Section 4.2, Medical shall, at Vapotherm's election, either replace the Nonconforming Cartridge(s) at no additional to Vapotherm beyond the original purchase price charged to Vapotherm for the Nonconforming Cartridge(s) or cancel that purchase order or the portion thereof relating to the Nonconforming Cartridge(s), s applicable. (b) If Medica does not agree that one or more Cartridges constitute Nonconforming Cartridges, the Joint Review Committee, consisting of quality assurance representatives from both companies, must consider the matter. If after consideration by the Joint Review Committee the parties are unable to reach agreement within [* * *] Calendar Days after the date Medica received notice from Vapotherm under Section 4.2, they shall submit the dispute to arbitration in accordance with Section 14.5. -4- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"term:Nonconforming Cartridge\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Nonconforming Cartridge\", \"text\": \"Vapotherm may reject any Cartridge that does not meet the Specifications or otherwise comply with this Agreement (any such Cartridge, a \\\"Nonconforming Cartridge\\\").\", \"definition_clause\": \"4.3\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonconformity Default Rights\", \"level\": 2, \"text\": \"4.4 Nonconformity Default Rights. If for any reason other than an event of Force Majeure Medica (1) fails to replace any Nonconforming Cartridge as required by Section 4.3 or (2) fails to replace any Nonconforming Cartridge within [* * *] Business Days after a dispute regarding whether any rejected quantity of Cartridge constitutes Nonconforming Cartridge is decided in Vapotherm's favor, then, in addition to any other remedies it might have under this Agreement or by law, Vapotherm may cancel that purchase order or the portion thereof of relating to the Nonconforming Cartridge, as applicable.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Acceptance of Cartridges\", \"level\": 2, \"text\": \"4.5 Acceptance of Cartridges. If Vapotherm does not notify Medica that one or more Cartridges do not meet the Specifications or otherwise fail to comply with this Agreement, those Cartridges will be deemed to have been accepted by Vapotherm as being fully compliant with the Specifications and this Agreement.\"}}, {\"id\": \"4.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Quality Monitoring\", \"level\": 2, \"text\": \"4.6 Quality Monitoring. Medica will periodically sample and trend the Cartridge performance in accordance with specification and Medica's internal production tests to monitor process and product control. Medica will share the results with Vapotherm as part of the Production Process as outlined in Article 5.\"}}, {\"id\": \"4.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Medica becomes aware of any Cartridge problem that could endanger patient health, Medica will report the problem to V\", \"level\": 2, \"text\": \"4.7 If Medica becomes aware of any Cartridge problem that could endanger patient health, Medica will report the problem to Vapotherm within 24 hours.\"}}, {\"id\": \"value:24 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"24 hours\"}}, {\"id\": \"ARTICLE 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCTION PROCESS\", \"level\": 1, \"text\": \"ARTICLE 5 PRODUCTION PROCESS\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Joint Review Committee\", \"level\": 2, \"text\": \"5.1 Joint Review Committee. The parties shall establish and hold teleconference meetings of a Joint Review Committee annually. The Joint Review Committee shall consist of six (6) members, including the head of each party's engineering, quality assurance and material management divisions or their designees.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Process Development\", \"level\": 2, \"text\": \"5.2 Process Development. Medica shall use [* * *] efforts to develop technical know-how that would permit them to manufacture the Cartridge less expensively and shall no less than semiannually furnish the Joint Review Committee with a detailed report as to their progress in this area. Vapotherm and Medica shall at the time of each report determine jointly the actions to be taken with respect to these findings.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Inventory of Raw Materials and Spare Parts\", \"level\": 2, \"text\": \"5.3 Inventory of Raw Materials and Spare Parts. Medica shall at all times use best efforts to efficiently manage their inventories of raw materials so as to enable Medica to meet Vapotherm's demand as specified in the Rolling Forecasts. Medica shall also maintain, consistent with the manufacturer's recommendations, an inventory of spare parts of all equipment they use to manufacture the Cartridge.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[* * *] -5-\", \"level\": 2, \"text\": \"5.4 [* * *] -5- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"QUALITY SYSTEM\", \"level\": 1, \"text\": \"ARTICLE 6 QUALITY SYSTEM\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General Quality Statement\", \"level\": 2, \"text\": \"6.1 General Quality Statement. The Cartridges shall be manufactured, assembled and tested in compliance with (a) the Specifications, (b) Vapotherm supplied specifications and documentation; (c) relevant ISO and FDA standards, guidelines and regulations, but not limited to ISO 13485, US 21CFR 820 FDA (\\\"QSR\\\"), EU MDD 93/43 and Canadian MDR (d) Medica's design and manufacturing policies followed by Medica as of the date hereof (\\\"Medica's Quality System\\\"), and (e) applicable U.S. and foreign Laws, including but not limited to FDA standards, guidelines and regulations. During the Term and notwithstanding Section 6.2 below, Medica shall not make any material change to the Specifications or Medica's Quality System without Vapotherm's prior written approval. For purposes of this Section 6.1, a material change to either the Specifications or Medica's Quality System shall mean any change that could have a material adverse effect on the safety or efficacy of the Cartridges or System, or that would be reasonably likely to have a material effect on the proper integration of the Cartridges or System.\"}}, {\"id\": \"term:Medica's Quality System\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Medica's Quality System\", \"text\": \"Medica's design and manufacturing policies followed by Medica as of the date hereof (\\\"Medica's Quality System\\\"),\", \"definition_clause\": \"6.1\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Quality System Changes\", \"level\": 2, \"text\": \"6.2 Quality System Changes. Any changes to the status of the Medica Quality System shall be reported to Vapotherm Quality Assurance and Vapotherm Executive Management by sending notice in accordance with Section 14.8 within 72 hours. Status changes may include, but not be limited to the following: (a) ISO Certifications or CE Marking status charges; (b) Process or material failures, including significant vendor related failures or relevant vendor terminations due to quality related issues; and (c) Specification changes for supplemental manufacturing processes, equipment, or materials.\"}}, {\"id\": \"value:72 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"72 hours\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Vendor Quality\", \"level\": 2, \"text\": \"6.3 Vendor Quality. The quality ratings of vendors that supply Medica with materials used in the manufacture/assembly and/or testing of the Cartridges shall be reported to Vapotherm Quality Assurance in a manner consistent with the Medica Quality System. Any collective actions, regulatory holds, suspensions, or terminations of vendors related to the Cartridges shall be reported to Vapotherm Quality Assurance in a timely manner.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Vigilance System\", \"level\": 2, \"text\": \"6.4 Vigilance System. Vapotherm has an established Authorized Representative to communicate complaints and vigilance reports that results from the use of the Cartridges. (a) Complaint investigations shall be a shared process between Medica (QA, manufacturing, and engineering) and Vapotherm (QA, Manufacturing, and R&D). (b) All investigation reports shall be issued jointly and in a timely manner to satisfy the requirements for vigilance reporting (when necessary). -6- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) When a complaint is determined to be a vigilance reportable event then Vapotherm shall be responsible for administering and reporting to both Medica and the necessary competent authorities any Cartridge related vigilance incidents within [* * *] days or as outlined in the Vapotherm Quality System. (d) Vapotherm shall copy in writing via email or facsimile to Medica Quality Assurance within 24-48 hours on all and any vigilance reporting, including health outcome, relationship between the incidents, and timeliness of reporting the vigilance incident to the Competent Authorities.\"}}, {\"id\": \"value:24-48 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"24-48 hours\"}}, {\"id\": \"ARTICLE 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OTHER OBLIGATIONS OF MEDICA\", \"level\": 1, \"text\": \"ARTICLE 7 OTHER OBLIGATIONS OF MEDICA\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Debarment Certification\", \"level\": 2, \"text\": \"7.1 Debarment Certification. Medica hereby agrees to review the United States Department of Health and Human Services Office of the Inspector General and General Services Administration exclusion lists upon initially hiring and annually thereafter to ensure that any employee or manager responsible for providing services under is not excluded from any United States Federal or State health care program. Medica hereby represents and warrants that neither it, nor any of its officers, directors, or managers, or employees are currently excluded from, or have ever been excluded from, any United States Federal or State health care program or, if previously excluded, have been fully reinstated, in which case Medica shall provide Vapotherm written proof of such reinstatement and such other information as Vapotherm may require describing the reasons for the prior exclusion. Medica shall immediately notify Vapotherm, in writing, in the event that it knows, or has reason to know, that any United States Federal or State health care program has initiated proceedings to sanction, bar, suspend or exclude Medica, or any of its officers, directors, managers or employees. If Medica fails to comply with any of the foregoing provisions, Vapotherm may terminate the Agreement immediately upon written notice to Medica.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Permits and Certifications\", \"level\": 2, \"text\": \"7.2 Permits and Certifications. Medica currently has all Permits and Certifications necessary to enable it to perform all its obligations under this Agreement. At all times during the Term Medica shall maintain those Permits and secure any additional Permits that become necessary.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Manufacturing Problems\", \"level\": 2, \"text\": \"7.3 Manufacturing Problems. Medica shall promptly notify Vapotherm if it experiences any significant problems in manufacturing Cartridges, shall use [* * *] efforts to resolve those problems, and shall keep Vapotherm informed of the status of those efforts.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 2, \"text\": \"7.4 Insurance. Medica shall at its cost obtain and maintain one or more insurance policies providing coverage of at least Euro [* * *] in the aggregate that cover Medica for fire, theft, fidelity, product liability, and any and all potential claims, suits, losses, expenses, or damages arising out of Medica's obligations under this Agreement. At Vapotherm's request to Medica from time to time, Medica shall furnish Vapotherm with certification of insurance evidencing that insurance and shall provide at least [* * *] Business Days prior written notice to Vapotherm of any cancellation of or decrease in the dollar amount of coverage provided by any such policy. Vapotherm shall have the right to maintain such insurance coverage on Vapotherm's behalf and at Vapotherm' s expense in the event of nonpayment of premiums or lapse of coverage. -7- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (b) Vapotherm shall at its cost obtain and maintain product-liability insurance coverage in the amount of $[* * *] in relation to the Cartridge. At the request of Medica from time to time, Vapotherm shall famish Medica with certification of insurance evidencing that insurance and shall endeavour to provide at least [* * *] Business Days prior written notice to Medica of any cancellation of or decrease in the amount of coverage provided by any such policy.\"}}, {\"id\": \"ARTICLE 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSPECITONS; RECORDS\", \"level\": 1, \"text\": \"ARTICLE 8 INSPECITONS; RECORDS\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notification of Inquiries and Inspections\", \"level\": 2, \"text\": \"8.1 Notification of Inquiries and Inspections. Medica shall notify Vapotherm within [* * *] Business Days of any written or oral inquiries, notifications, or inspection activity by any Governmental Authority in regard to Medica's manufacture of Cartridges. Medica shall permit up to two individuals selected by Vapotherm to attend any such inspections and shall provide Vapotherm with an accurate and reasonably complete description of any such inquiries, notifications, or inspections. Medica shall also furnish to Vapotherm (1) within [* * *] Business Days after receipt any report or correspondence issued by any Governmental Authority in connection with any such inquiries, notifications, or inspections, and (2) not later than [* * *] Business Days prior to the time Medica proposes to send it, a copy of any proposed response or explanation relating to any such inquiries, notifications, or inspections or any report or correspondence issued by any Governmental Authority in connection therewith (each, a \\\"Proposed Response\\\"), in each case redacted of trade secrets or other confidential or proprietary information of Medica that are unrelated to Medica's obligations under this Agreement or are unrelated to manufacture of Cartridges. Medica shall discuss with Vapotherm any Proposed Response and shall incorporate in that Proposed Response any reasonable comments provided by Vapotherm with respect to that Proposed Response. After filing a response with any Governmental Authority, Medica shall within [* * *] Business Days notify Vapotherm of any further contacts with that Governmental Authority with respect to that response.\"}}, {\"id\": \"term:Proposed Response\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Proposed Response\", \"text\": \"a copy of any proposed response or explanation relating to any such inquiries, notifications, or inspections or any report or correspondence issued by any Governmental Authority in connection therewith (each, a \\\"Proposed Response\\\"),\", \"definition_clause\": \"8.1\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Access to Medica Facilities and Records\", \"level\": 2, \"text\": \"8.2 Access to Medica Facilities and Records. Medica shall at Vapotherm's request give Vapotherm and any designee of Vapotherm reasonable access to Medica's facilities, procedures, and books and records, including Medica's protocols, standard operating procedures (SOPs), equipment specifications, and manufacturing records, for purposes of (1) observing manufacturing, operations and (2) auditing and inspecting Medica's facilities for compliance with applicable Laws and the terms of this Agreement. Vapotherm acknowledges that it and its designee may be permitted only to review, rather than obtain copies of, certain proprietary documents of Medica; Medica shall at Vapotherm's request provide Vapotherm with a copy of any other document that Vapotherm requests provided it is reasonable and applicable to the Cartridges or System. -8- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records\", \"level\": 2, \"text\": \"8.3 Records. Medica shall maintain all records necessary to evidence compliance with all applicable Laws and other requirements of applicable Governmental Authorities relating to the manufacture of the Cartridge. Medica shall also maintain records with respect to its costs, obligations, and performance under this Agreement. All such records shall be maintained for a period of not less than two years from the date of expiration of each Cartridge batch to which those records pertain, or such longer period as may be required by Law or cGMPs.\"}}, {\"id\": \"value:two years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two years\"}}, {\"id\": \"ARTICLE 9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CARTRIDGE RECALLS\", \"level\": 1, \"text\": \"ARTICLE 9 CARTRIDGE RECALLS\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cartridge Recalls\", \"level\": 2, \"text\": \"9.1 Cartridge Recalls. If any Governmental Authority withdraws its approval to sell the Cartridge in any country or issues a directive or request that some or all Cartridges be recalled for safety reasons relating to the Cartridge or Vapotherm reasonably determines that some or all Cartridges should be recalled, and if that recall is due to any reason other than Medica having manufactured Cartridges that fail to conform to the Specifications or that was not manufactured in accordance with any applicable Laws, Vapotherm shall pay all costs, including Medica's reasonable out-of-pocket expenses, associated with that recall. Those actions may include developing reports on records pertaining to the lot traceability, assist in conducting an investigation to rule out a root cause for failure and other related activities requiring Medica's resources. Vapotherm shall provide Medica in writing specific instructions as to actions required. Medical shall in good faith provide an estimate for expenses if the request has material burden.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notice of Events that May Lead to Cartridge Recall\", \"level\": 2, \"text\": \"9.2 Notice of Events that May Lead to Cartridge Recall. Medica, on the one hand, and Vapotherm, on the other hand, shall keep each other fully and promptly informed of any notification, event, or other information, whether received directly or indirectly, that might affect the marketability, safety or effectiveness of the Cartridge or might result in a recall of any Cartridges by any Governmental Authority.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recall Due to Breach By Medica\", \"level\": 2, \"text\": \"9.3 Recall Due to Breach By Medica. If there occurs any Cartridge recall that is due to Medica having manufactured one or more Cartridges that fail to conform to the Specifications or that were not manufactured in accordance with any applicable Laws, Medica will be responsible for the costs of that recall. Medica shall promptly, at the election of Vapotherm, compensate Vapotherm for the Cartridge so recalled by either replacing without charge Cartridges recalled or refunding Vapotherm the price paid by Vapotherm to Medica for the Cartridges recalled, plus freight, insurance, sales taxes, and all other costs duties, fees, and expenses paid by Vapotherm in connection with such recall.\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definition of Recall\", \"level\": 2, \"text\": \"9.4 Definition of Recall. For purposes of this Article 8, \\\"recall\\\" means any action by Vapotherm or any of its Affiliates, or either Medica or any of its Affiliates, to recover title or possession or halt distribution or use of any Cartridges sold or shipped to any other Persons. The term \\\"recall\\\" also applies to Cartridge that would have been subject to recall if it had been sold or shipped. -9- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"term:recall\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"recall\", \"text\": \"For purposes of this Article 8, \\\"recall\\\" means any action by Vapotherm or any of its Affiliates, or either Medica or any of its Affiliates, to recover title or possession or halt distribution or use of any Cartridges sold or shipped to any other Persons. The term \\\"recall\\\" also applies to Cartridge that would have been subject to recall if it had been sold or shipped.\", \"definition_clause\": \"9.4\"}}, {\"id\": \"9.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recall Process\", \"level\": 2, \"text\": \"9.5 Recall Process. The purpose of initiating a \\\"recall\\\", either party will notify the other party immediately regarding the need within 24 hrs. Vapotherm will be responsible for notifying the appropriate regulatory bodies with respect to the Cartridge. Medica will provide best efforts to support Vapotherm with the appropriate regulatory documentation in an timely fashion. Medica will make efforts to conduct the necessary investigations as it pertains to the Cartridge and report factual data has required. Medica will also take necessary efforts to take the appropriate corrective action and make best efforts to remedy the disruption in supply.\"}}, {\"id\": \"value:24 hrs\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"24 hrs\"}}, {\"id\": \"ARTICLE 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY\", \"level\": 1, \"text\": \"ARTICLE 10 PUBLICITY; CONFIDENTIALITY; INTELLECTUAL PROPERTY\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Publicity\", \"level\": 2, \"text\": \"10.1 Publicity. Except as required by Law or the standards of any securities or regulatory authority, including without limitation the National Association of Securities Dealers, Medica and Vapotherm may not make any official press release, announcement, or other formal publicity relating to the transactions that are the subject of this Agreement without first obtaining in each case the prior written consent of Vapotherm and Medica, respectively (which consent may not be unreasonably withheld). If any party is required to file this Agreement with the Securities and Exchange Commission or another applicable securities regulatory authority, that party must seek confidential treatment for any provisions of this Agreement that either party believes would disclose trade secrets, confidential commercial, or financial information and thereby impair the value of the contractual rights represented by this Agreement or provide detailed commercial and financial information to competitors or other Persons. Except as required by Law or the standards of any securities regulatory authority, Medica and Vapotherm may not use the name Vapotherm and Medica, respectively, or the name of any director, officer or employee thereof or any adaptation thereof without the prior written approval of Vapotherm and Medica, respectively. (b) Medica shall send to Vapotherm for its approval at least [* * *] Business Days before it is filed or submitted any publication, abstract, or patent application resulting from this Agreement. The authorship on any publication or abstract will be determined by agreement of the parties or as deemed scientifically appropriate. Any publication resulting from this Agreement will be delayed or prohibited if, in Vapotherm's reasonable opinion, delay or prohibition is required in order to file or procure patent application or rights protection in respect of any invention or discovery arising from this Agreement. Publication by Medica of any information relating to the Cartridge is subject to the provisions of Section 10.2.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 2, \"text\": \"10.2 Confidentiality. It is contemplated that Medica may from time to time disclose Confidential Information to Vapotherm, or vice versa. Medica shall disclose such Vapotherm Confidential Information and shall not use any Vapotherm Confidential Information other than in connection with performing its obligations hereunder, and Vapotherm shall not disclose Medica Confidential Information and shall not use any Medica Confidential Information other than in connection with performing its obligations hereunder. (b) A party receiving Confidential Information shall only disclose it to those of its Representatives who need to review that Confidential Information in connection with that party's performance of its obligations and evaluation of its rights under this Agreement. Any party who so discloses any Confidential Information pursuant to this Section 10.2(b) shall (1) inform those Representatives of the confidential nature of that Confidential Information, and (2) direct those Representatives to keep that Confidential Information confidential. -10- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (c) The provisions of this Section 10.2 will survive termination or expiration of this Agreement and will continue for a period of 5 years from the date of that termination or expiration.\"}}, {\"id\": \"value:5 years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"5 years\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Pre-existing and Independently Developed Intellectual Property\", \"level\": 2, \"text\": \"10.3 Pre-existing and Independently Developed Intellectual Property. Each party is and shall remain the owner of its Intellectual Property in existence as of the Effective Date and all such rights that a party acquires or develops independent of this Agreement (\\\"Baseline IP\\\").\"}}, {\"id\": \"term:Baseline IP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Baseline IP\", \"text\": \"Each party is and shall remain the owner of its Intellectual Property in existence as of the Effective Date and all such rights that a party acquires or develops independent of this Agreement (\\\"Baseline IP\\\").\", \"definition_clause\": \"10.3\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership\", \"level\": 2, \"text\": \"10.4 Ownership. (a) Except as specified elsewhere in Section 10.4, all rights in patents, inventions, processes, discoveries, and other research materials and any other novel or valuable information reflected in any medium that arise or are created during the course of this Agreement are the property of the creating party. (b) Any additions, improvements and enhancements to Vapotherm Baseline IP which are made during the course of this Agreement shall solely be the property of Vapotherm (\\\"Vapotherm Inventions\\\"). (c) Any additions, improvements and enhancements to Medica Baseline IP which are made during the course of this Agreement shall solely be the property of Medica (\\\"Medica Inventions\\\"). (d) It is understood and agreed that Vapotherm shall be free and without restriction to develop, market, license, and sell products and technology as it may see fit (including products and technology that may) or may not compete with the Cartridges), provided that Vapotherm strictly and fully complies with its obligations concerning Medica Confidential Information under Section 10.2 (Confidentiality). (e) It is understood and agreed that Medica shall be free and without restriction to develop, market, license, and sell products and technology based on Medica proprietary membrane with an intended use different from oxygen delivery humidification for patients.\"}}, {\"id\": \"term:Vapotherm Inventions\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Vapotherm Inventions\", \"text\": \"Any additions, improvements and enhancements to Vapotherm Baseline IP which are made during the course of this Agreement shall solely be the property of Vapotherm (\\\"Vapotherm Inventions\\\").\", \"definition_clause\": \"10.4\"}}, {\"id\": \"term:Medica Inventions\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Medica Inventions\", \"text\": \"Any additions, improvements and enhancements to Medica Baseline IP which are made during the course of this Agreement shall solely be the property of Medica (\\\"Medica Inventions\\\").\", \"definition_clause\": \"10.4\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[* * *]\", \"level\": 2, \"text\": \"10.5 [* * *] (b) [* * *]\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reservation of All Other Rights\", \"level\": 2, \"text\": \"10.6 Reservation of All Other Rights. Except as expressly set forth in this Agreement, nothing contained herein may be construed as doing the following: -11- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (a) Giving Medica any rights to any Intellectual Property of Vapotherm or any other proprietary technology of Vapotherm (whether Vapotherm Baseline IP or Vapotherm Inventions arising in connection with this Agreement), including without limitation any of Vapotherm's patent rights relating to the design, development, testing, use and sale of the System or the Cartridge; or (b) Giving Vapotherm any rights to any Intellectual Property of Medica or any other proprietary technology of Medica (whether Medica Baseline IP or Medica Inventions arising in connection with this Agreement).\"}}, {\"id\": \"ARTICLE 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS\", \"level\": 1, \"text\": \"ARTICLE 11 REPRESENTATIONS\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations of Medica\", \"level\": 2, \"text\": \"11.1 Representations of Medica. Medica represents to Vapotherm as follows: (a) Medica is a corporation validly existing under the laws of its jurisdiction of organization with the power to own all of its properties and assets and to carry on its business as it is currently being conducted. (b) Medica has the power to execute and deliver this Agreement and to perform its obligations under this Agreement. (c) Medica's Chief Executive Officer, or Amministratore Unico (AU), has duly authorized Medica to execute and deliver this Agreement and perform its obligations under this Agreement, and no other corporate proceedings of Medica are necessary with respect thereto. (d) This Agreement constitutes its valid and binding obligation, enforceable in accordance with its terms, except as enforceability is limited by (A) any applicable bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors' rights generally, or (B) general principles of equity, whether considered in a proceeding in equity or at law. (e) Medica is not required to obtain the Consent of any Person, including the Consent of any party to any Contract to which it is a party, in connection with execution and delivery of this Agreement and performance of its obligations under this Agreement. (f) Medica is the rightful owner or licensee of any Intellectual Property that it may use in performing its obligations under this Agreement. (g) To Medica's knowledge, the Medica Baseline IP does not infringe or violate any patent, copyright, trademark, or any other proprietary right of a third party. (h) Medica's execution and delivery of this Agreement and performance of its obligations under this Agreement do not (A) violate any provision of its articles of incorporation or by-laws, as applicable, as currently in effect, (B) conflict with, result in a breach of, constitute a default under (or an event which, with notice or lapse of time or both, would constitute a default under), accelerate the performance required by, result in the creation of any Lien upon any of its properties or assets under, or create in any party the right to accelerate, terminate, modify, or cancel, or require any notice under, any Contract to which it is a party or by which any of its properties or assets are bound, or (C) violate any Law or Order currently in effect to which it is subject. -12- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representations of Vapotherm\", \"level\": 2, \"text\": \"11.2 Representations of Vapotherm. Vapotherm represents to Medica as follows; (a) Vapotherm is a corporation validly existing and in good standing under the law of the State of Maryland with the power to own all of its properties and assets and to carry on its business as it is currently being conducted. (b) Vapotherm has the power to execute and deliver this Agreement and to perform its obligations under this Agreement. (c) This Agreement constitutes the valid and binding obligation of Vapotherm, enforceable in accordance with its terms, except as enforceability is limited by (A) any applicable bankruptcy, insolvency, reorganization, moratorium or similar law affecting creditors' rights generally, or (B) general principles of equity, whether considered in a proceeding in equity or at law. (d) Vapotherm's execution and delivery of this Agreement and performance of its obligations under this Agreement do not (A) violate any provision of Vapotherm's articles of incorporation or by-laws as currently in effect, or (B) violate any Law or Order currently in effect to which Vapotherm is subject.\"}}, {\"id\": \"ARTICLE 12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 1, \"text\": \"ARTICLE 12 INDEMNIFICATION\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification\", \"level\": 2, \"text\": \"12.1 Indemnification. Medica shall indemnify Vapotherm, each Affiliate of Vapotherm, each Representative of Vapotherm, and the heirs, executors, successors, and assigns of any of the foregoing, against the following Indemnifiable Losses: a. Indemnifiable Losses arising out of or relating to a claim made for bodily injury, including death, or property damage to the extent that such claim arises out of or results from the failure of the Cartridges to comply with the Specifications or Medica's failure to comply with Medica's Quality System; b. Indemnifiable Losses arising out of or relating to any claim, demand, action or proceeding based upon infringement of a patent, trademark, copyright or trade secret, or similar intellectual property rights as a result of Vapotherm's marketing, promotion or distribution of the Cartridges; c. Indemnifiable Losses arising out of or relating to any breach of this Agreement by Medica or any negligent or fraudulent act or willful misconduct of Medica or its employees, other agents, subcontractors or representatives in connection with this Agreement; or -13- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"d\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnifiable Losses arising out of or relating to any inaccuracy in any representations of Medica contained in this Ag\", \"level\": 1, \"text\": \"d. Indemnifiable Losses arising out of or relating to any inaccuracy in any representations of Medica contained in this Agreement. (b) Vapotherm shall indemnify each Medica Entity, each Affiliate of each Medica Entity, each Representative of each Medica Entity, and the heirs, executors, successors, and assigns of any of the foregoing, against the following Indemnifiable Losses: (i) Indemnifiable Losses arising out of or relating to any claim, demand, action or proceeding based upon infringement of a patent, trademark, copyright or trade secret, or similar intellectual property rights as a result of Vapotherm's marketing, promotion or distribution of the System, except to the extent such claim, demand, action or proceeding arising out of or relates to the Cartridge; (ii) Indemnifiable Losses arising out of or relating to any breach of this Agreement by Vapotherm or any negligent or fraudulent act or willful misconduct of Vapotherm or its employees, other agents, subcontractors or representatives in connection with this Agreement; or (iii) Indemnifiable Losses arising out of or relating to any inaccuracy in any representations of Vapotherm contained in this Agreement.\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Procedures Relating to Indemnification\", \"level\": 2, \"text\": \"12.2 Procedures Relating to Indemnification. In order to be entitled to indemnification under this Article 12 in connection with an Indemnifiable Loss, the party seeking indemnification (the \\\"Indemnified Party\\\") must: (1) notify the party obligated to indemnify it (the \\\"Indemnifying Party\\\") in writing, and in reasonable detail, of any third party claims, demands, lawsuits, proceedings or action (\\\"Third Party Claims\\\") as soon as possible but in any event within [* * *] Business Days after receipt of notice of that Third Party Claim; and (2) deliver to the Indemnifying Party as soon as possible but in any event within [* * *] Business Days after the Indemnified Party receives a copy of all notices and documents (including court papers) delivered to that Indemnified Party relating to that Third Party Claim. (b) In the event of a Third Party Claim against an Indemnified Party, the Indemnifying Party may participate in the defense of that Third Party Claim and, if it so chooses, assume at its expense the defense of that Third Party Claim with counsel selected by the Indemnifying Party and reasonably satisfactory to the Indemnified Party. If the Indemnifying Party so elects to assume the defense of a Third Party Claim, the Indemnifying Party will not be liable to the Indemnified Party for any legal expenses subsequently incurred by the Indemnified Party in connection with the defense of that Third Party Claim, except that if, under applicable standards of professional conduct, there exists a conflict on any significant issue between the Indemnified Party mid the Indemnifying Party in connection with that Third Party Claim, the -14- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Indemnifying Party shall pay the reasonable fees and expenses of one additional counsel to act with respect to that issue to the extent necessary to resolve that conflict. If the Indemnifying Party assumes defense of any Third Party Claim, the Indemnified Party will be entitled to participate in the defense of that Third Party Claim and to employ counsel, at its own expense, separate from counsel employed by the Indemnifying Party, it being understood that the Indemnifying Party will be entitled to control that defense. The Indemnifying Party will be liable for the fees and expenses of counsel employed by the Indemnified Party for any period during which the Indemnifying Party did not assume the defense of any Third Party Claim (other than during any period in which the Indemnified Party failed to give notice of the Third Party Claim as provided above and a reasonable period after such notice). If the Indemnifying Party chooses to defend or prosecute a Third Party Claim, all the parties shall cooperate in the defense or prosecution of that Third Party Claim, including by retaining and providing to the Indemnifying Party records and information reasonably relevant to that Third Party Claim, and making employees available on a reasonably convenient basis. If the Indemnifying Party chooses to defend or prosecute any Third Party Claim, the Indemnified Party will agree to any settlement, compromise or discharge of that Third Party Claim that the Indemnifying Party recommends, except that the Indemnifying Party may not without the Indemnified Party's prior written consent agree to entry of any judgment or enter into any settlement that provides for injunctive or other non-monetary relief affecting the Indemnified Party or that does not include as a unconditional term that each claimant or plaintiff give to the Indemnified Party a release from all liability with respect to that Third Party Claim. Whether or not the Indemnifying Party has assumed the defense of a Third Party Claim, the Indemnified Party shall not admit any liability with respect to, or settle, compromise or discharge, that Third Party Claim without the Indemnifying Party's prior written consent.\"}}, {\"id\": \"term:Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnified Party\", \"text\": \"the party seeking indemnification (the \\\"Indemnified Party\\\")\", \"definition_clause\": \"12.2\"}}, {\"id\": \"term:Indemnifying Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnifying Party\", \"text\": \"notify the party obligated to indemnify it (the \\\"Indemnifying Party\\\")\", \"definition_clause\": \"12.2\"}}, {\"id\": \"term:Third Party Claims\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party Claims\", \"text\": \"any third party claims, demands, lawsuits, proceedings or action (\\\"Third Party Claims\\\")\", \"definition_clause\": \"12.2\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Liability for Consequential Damages\", \"level\": 2, \"text\": \"12.3 No Liability for Consequential Damages. No party will be liable to any other for any indirect, consequential, or special damages or for loss of profits. This limitation does not, however, apply to any obligation of either party to indemnify the other in connection with any Indemnifiable Loss.\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Limitation on Liability\", \"level\": 2, \"text\": \"12.4 Limitation on Liability. Notwithstanding any other provision contained in this Agreement, each party's maximum aggregate liability to the other party for any and all causes whatsoever, and each party's remedy, regardless of the form of action, whether in contract or tort, including negligence, and whether or not pursuant to the indemnification provisions contained in Section 12 and whether or not such party is notified of the possibility of damage to the other party, shall be limited to $[* * *]. ARTICLE 13 TERM AND TERMINATION; BUSINESS CONTINUITY\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"13.1 Term. The term of this Agreement is three years from and including the date of this Agreement (the \\\"Initial Term\\\"), with automatic renewal for additional successive one-year terms (each a \\\"Renewal Term\\\" and together wit the Initial Term, the \\\"Term\\\") unless no later than [* * *] days prior to the end of the Initial Term, or any Renewal Term either party notifies the other that it wishes to terminate this Agreement effective the end of the Initial Term or that Renewal Term, as applicable. -15- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (b) The parties may terminate this Agreement at any time by written agreement.\"}}, {\"id\": \"value:three years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three years\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"The term of this Agreement is three years from and including the date of this Agreement (the \\\"Initial Term\\\"),\", \"definition_clause\": \"13.1\"}}, {\"id\": \"value:one-year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one-year\"}}, {\"id\": \"term:Renewal Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Term\", \"text\": \"with automatic renewal for additional successive one-year terms (each a \\\"Renewal Term\\\" and together wit the Initial Term, the \\\"Term\\\")\", \"definition_clause\": \"13.1\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"with automatic renewal for additional successive one-year terms (each a \\\"Renewal Term\\\" and together wit the Initial Term, the \\\"Term\\\")\", \"definition_clause\": \"13.1\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"13.3 Effect of Termination. (a) Upon any termination (including expiration) of this Agreement, each party shall return to the other party all documents and other tangible items to it or its employees or agents have received or created pursuant to this Agreement pertaining, referring, or relating to Confidential Information of the other party. (c) Upon any termination (including expiration) of this Agreement, Vapotherm shall pay to Medica, and Medica shall pay to Vapotherm, all amounts payable up to the date of termination but not yet paid. (d) The termination or expiration of this Agreement shall not relieve either party of its responsibility to comply in all material respects with any statutory or regulatory requirements associated with the System and/or the Cartridges.\"}}, {\"id\": \"13.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Business Continuity\", \"level\": 2, \"text\": \"13.4 Business Continuity. Medica agrees to have the capability to manufacture in either (2) facilities of the Medica Group in the event of disruption for any reason and deliver the Cartridges within [* * *] weeks.\"}}, {\"id\": \"13.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Medica agrees to maintain [* * *] weeks [* * *] of inventory in the event of business disruption consistent with section\", \"level\": 3, \"text\": \"13.4.1 Medica agrees to maintain [* * *] weeks [* * *] of inventory in the event of business disruption consistent with section 2 of the agreement.\"}}, {\"id\": \"13.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notwithstanding anything to the contrary in this Agreement, Medica shall neither enter into an agreement to nor shall co\", \"level\": 3, \"text\": \"13.4.2 Notwithstanding anything to the contrary in this Agreement, Medica shall neither enter into an agreement to nor shall consummate (a) any Change of Control or (b) any sale of all or substantially all of its assets relating to the manufacture of the Cartridges unless (a) it provides Vapotherm written notice of any such proposed transaction, which notice shall include the specific terms and conditions of the proposed transaction, including the identify of the proposed acquirer, (b) Medica offers to enter into such transaction with Vapotherm on substantially the same terms and conditions, and (c) with [* * *] days of such notice, Vapotherm declines to accept such offer. For purposes of this Agreement, \\\"Change of Control\\\" means (i) the acquisition, directly or indirectly, by any person or group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) that is not a subsidiary or Affiliate -17- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (as defined below) of Medica of the beneficial ownership of securities of Medica possessing more than fifty percent (50%) of the total combined voting power of all outstanding securities of Medica; (ii) a merger or consolidation in which neither Medica nor a subsidiary or Affiliate of Medica is the surviving entity; (iii) a reverse merger in which Medica is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of Medica's outstanding securities are transferred to or acquired by a person or persons different from the persons holding those securities immediately prior to such merger and where such persons are not a subsidiary or Affiliate of Medica; or (iv) the sale, transfer or other disposition of all or substantially all of the assets of Medica to a person or entity that is not a subsidiary or Affiliate of Medica. ARTICLE 14 MISCELLANEOUS\"}}, {\"id\": \"term:Change of Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change of Control\", \"text\": \"For purposes of this Agreement, \\\"Change of Control\\\" means (i) the acquisition, directly or indirectly, by any person or group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) that is not a subsidiary or Affiliate -17- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (as defined below) of Medica of the beneficial ownership of securities of Medica possessing more than fifty percent (50%) of the total combined voting power of all outstanding securities of Medica; (ii) a merger or consolidation in which neither Medica nor a subsidiary or Affiliate of Medica is the surviving entity; (iii) a reverse merger in which Medica is the surviving entity but in which securities possessing more than fifty percent (50%) of the total combined voting power of Medica's outstanding securities are transferred to or acquired by a person or persons different from the persons holding those securities immediately prior to such merger and where such persons are not a subsidiary or Affiliate of Medica; or (iv) the sale, transfer or other disposition of all or substantially all of the assets of Medica to a person or entity that is not a subsidiary or Affiliate of Medica.\", \"definition_clause\": \"13.4.2\"}}, {\"id\": \"value:fifty percent (50%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Definitions\", \"level\": 2, \"text\": \"14.1 Definitions. When used in this Agreement, the following terms have the - following meanings: \\\"Affiliate\\\" means, with respect to any given Person, any other Person at the time directly or indirectly controlling, controlled by or under common control with that Person, or (2) any director, officer or employee of that Person. For purposes of this Agreement, \\\"control\\\" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. \\\"Business Day\\\" means any Monday, Tuesday, Wednesday, Thursday, or Friday that is not a day on which banking institutions in the State of New York authorized by law, regulation or executive order to close. \\\"cGMPs\\\" means current Good Manufacturing Practices (as provided for, respectively, in the Rules Governing Medicinal Products in the European Community Volume 4 (Guide to Good Manufacturing Practice for Medicinal Products) and by the FDA as set out in 21 C.F.R. 210 and 21 C.F.R. 211, as amended from time to time). \\\"Confidential Information\\\" means all data, specifications, training, and any other know-how related to the design, development, manufacture, or performance of the System or the Cartridge, the customers, finances, methods, research, processes or procedures of a party, as well as all other information and data provided by either party to the other party pursuant to this Agreement (i) in written or other tangible medium and marked as confidential, or (ii) if disclosed orally or displayed, confirmed in writing within [* * *] Business Days after disclosure and marked as confidential, or (iii) that by the nature of the information or the circumstances surrounding disclosure, should in good faith be treated as confidential, except that the term \\\"Confidential Information\\\" does not include the following: (1) information that is or becomes generally available to the public other than as a result of a breach of this Agreement by the receiving party or its Representatives; -18- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (2) information that was within the receiving party's possession or knowledge prior to its being furnished to the receiving party by or on behalf of the disclosing party, on condition that the source of that information was not bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the disclosing party or any other Person with respect to that information; (3) information that is or becomes available to the receiving party on a non-confidential basis from a source other than the disclosing party or any of its Representatives, on condition that that source was not bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the disclosing party or any other Person with respect to that information; (4) information that is independently developed by the receiving party without use of Confidential Information and otherwise in a manner not .inconsistent -with this Agreement; or (5) information that is required to be disclosed by law, provided that the disclosing Party is promptly notified by the receiving Party in order to provide the disclosing Party an opportunity to seek a protective order or other relief. \\\"Consent\\\" means any approval, consent, ratification, filing, declaration, registration, waiver, or other authorization. \\\"Contract\\\" means any oral or written agreement, contract, obligation, promise, arrangement, or undertaking that is legally binding. \\\"Event of Insolvency\\\" with respect to any Person means any of the following: (1) the institution by that Person of proceedings under the United States Bankruptcy Code, or any other applicable U.S. federal or state Law or any applicable foreign Law seeking an order for relief; (2) the consent of that Person to the institution of bankruptcy or insolvency proceedings against that Person; (3) the filing by that Person of a petition seeking reorganization or release under the Federal Bankruptcy Reform Act or any other applicable U.S. federal or state Law or applicable foreign Law, or the consent by that Person to the filing of any such petition or to the appointment of a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of that Person or of any substantial part of the property of that Person; (4) the making by that Person of an assignment for the benefit of creditors; -19- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (5) admission by that Person of its inability to pay its debts generally as they become due; (6) the entry of a decree or order by a court having jurisdiction adjudging that Person bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of that Person under the U.S. Bankruptcy Code or any other applicable U.S. federal or state Law or any applicable foreign Law, or appointing a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of that Person, or of any substantial part of the property of that Person, or ordering the winding up or liquidation of the affairs of that Person, and (A) that Person consents to that decree or order or (B) that decree or order remains unstayed and in effect for more than [* * *] consecutive days. \\\"FDA\\\" means the U.S. Food and Drug Administration. \\\"FOB\\\" means \\\"Free on Board,\\\" as that term is defined in INCOTERMS 2000, \\\"Governmental Authority\\\" means any (1) nation, state, comity, city, town, village, district, or other jurisdiction of any nature, (2) federal, state, local, municipal, or other government, whether U.S. or foreign, (3) governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal, including an arbitral tribunal), (4) multi-national organization or body including the EU and notified bodies, or (5) body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulator)', or taxing power of any nature. \\\"Indemnifiable Losses\\\" means all losses, liabilities, taxes, damages, deficiencies, obligations, fines, expenses, judgments or settlements resulting from Third Party Claims that are incurred or suffered by an Indemnified Party, including interest and penalties with respect thereto and out-of-pocket expenses and reasonable attorneys' and accountants' and experts' fees and expenses incurred in the investigation or defense of any of the same or in asserting, preserving or enforcing any of the Indemnified Party's rights hereunder, net of any amounts recovered or recoverable under any insurance policy. \\\"Intellectual Property\\\" means, with respect to any Person, all unpatented ideas, inventions, processes, discoveries trademarks, patents, copyrights, and any applications for registration thereof, and trade secrets and know-how of that Person, whether owned, used, or licensed by that Person as licensee or licensor. \\\"Law\\\" means any federal, state, local, municipal, foreign, international, multinational, or other administrative order, constitution, law, ordinance, principle of common law, regulation, statute, or treaty. \\\"Lien\\\" means any charge, claim, community property interest, condition, equitable interest, lien, option, pledge, security interest, right of first refusal, or restriction of any kind, including any restriction on use, voting, transfer, receipt of income, or exercise of any other attribute of ownership. -20- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. \\\"Month\\\" means any of the twelve months of a year. \\\"Order\\\" means any award, decision, injunction, judgment, order, ruling, subpoena, or verdict of any court, arbitral tribunal, administrative agency, or other Governmental Authority. \\\"Person\\\" means any individual, corporation (including any non-profit corporation), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, labor union, Governmental Authority or other entity. \\\"Representative\\\" means, with respect to a particular Person, any director, officer, employee, agent, consultant, advisor, or other representative of that Person, including legal counsel, accountants, and financial advisors. \\\"Year\\\" means (1) the period commencing with the date of this Agreement and ending on November 7th 2009, (2) any subsequent 12-month period commencing on January 1st and ending on December 31st, and (3) the period beginning January 1st of the year in which this Agreement expires or is terminated and ending on the date this Agreement expires or is terminated.\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"\\\"Affiliate\\\" means, with respect to any given Person, any other Person at the time directly or indirectly controlling, controlled by or under common control with that Person, or (2) any director, officer or employee of that Person.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"control\", \"text\": \"For purposes of this Agreement, \\\"control\\\" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"\\\"Business Day\\\" means any Monday, Tuesday, Wednesday, Thursday, or Friday that is not a day on which banking institutions in the State of New York authorized by law, regulation or executive order to close.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:cGMPs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"cGMPs\", \"text\": \"\\\"cGMPs\\\" means current Good Manufacturing Practices (as provided for, respectively, in the Rules Governing Medicinal Products in the European Community Volume 4 (Guide to Good Manufacturing Practice for Medicinal Products) and by the FDA as set out in 21 C.F.R. 210 and 21 C.F.R. 211, as amended from time to time).\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"\\\"Confidential Information\\\" means all data, specifications, training, and any other know-how related to the design, development, manufacture, or performance of the System or the Cartridge, the customers, finances, methods, research, processes or procedures of a party, as well as all other information and data provided by either party to the other party pursuant to this Agreement (i) in written or other tangible medium and marked as confidential, or (ii) if disclosed orally or displayed, confirmed in writing within [* * *] Business Days after disclosure and marked as confidential, or (iii) that by the nature of the information or the circumstances surrounding disclosure, should in good faith be treated as confidential, except that the term \\\"Confidential Information\\\" does not include the following: (1) information that is or becomes generally available to the public other than as a result of a breach of this Agreement by the receiving party or its Representatives; -18- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (2) information that was within the receiving party's possession or knowledge prior to its being furnished to the receiving party by or on behalf of the disclosing party, on condition that the source of that information was not bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the disclosing party or any other Person with respect to that information; (3) information that is or becomes available to the receiving party on a non-confidential basis from a source other than the disclosing party or any of its Representatives, on condition that that source was not bound by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the disclosing party or any other Person with respect to that information; (4) information that is independently developed by the receiving party without use of Confidential Information and otherwise in a manner not .inconsistent -with this Agreement; or (5) information that is required to be disclosed by law, provided that the disclosing Party is promptly notified by the receiving Party in order to provide the disclosing Party an opportunity to seek a protective order or other relief.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Consent\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Consent\", \"text\": \"\\\"Consent\\\" means any approval, consent, ratification, filing, declaration, registration, waiver, or other authorization.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Contract\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract\", \"text\": \"\\\"Contract\\\" means any oral or written agreement, contract, obligation, promise, arrangement, or undertaking that is legally binding.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Event of Insolvency\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Event of Insolvency\", \"text\": \"\\\"Event of Insolvency\\\" with respect to any Person means any of the following: (1) the institution by that Person of proceedings under the United States Bankruptcy Code, or any other applicable U.S. federal or state Law or any applicable foreign Law seeking an order for relief; (2) the consent of that Person to the institution of bankruptcy or insolvency proceedings against that Person; (3) the filing by that Person of a petition seeking reorganization or release under the Federal Bankruptcy Reform Act or any other applicable U.S. federal or state Law or applicable foreign Law, or the consent by that Person to the filing of any such petition or to the appointment of a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of that Person or of any substantial part of the property of that Person; (4) the making by that Person of an assignment for the benefit of creditors; -19- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (5) admission by that Person of its inability to pay its debts generally as they become due; (6) the entry of a decree or order by a court having jurisdiction adjudging that Person bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in respect of that Person under the U.S. Bankruptcy Code or any other applicable U.S. federal or state Law or any applicable foreign Law, or appointing a receiver, liquidator, assignee, trustee, sequestrator (or other similar official) of that Person, or of any substantial part of the property of that Person, or ordering the winding up or liquidation of the affairs of that Person, and (A) that Person consents to that decree or order or (B) that decree or order remains unstayed and in effect for more than [* * *] consecutive days.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:FDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDA\", \"text\": \"\\\"FDA\\\" means the U.S. Food and Drug Administration.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:FOB\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FOB\", \"text\": \"\\\"FOB\\\" means \\\"Free on Board,\\\" as that term is defined in INCOTERMS 2000,\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Governmental Authority\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Governmental Authority\", \"text\": \"\\\"Governmental Authority\\\" means any (1) nation, state, comity, city, town, village, district, or other jurisdiction of any nature, (2) federal, state, local, municipal, or other government, whether U.S. or foreign, (3) governmental or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal, including an arbitral tribunal), (4) multi-national organization or body including the EU and notified bodies, or (5) body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulator)', or taxing power of any nature.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Indemnifiable Losses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnifiable Losses\", \"text\": \"\\\"Indemnifiable Losses\\\" means all losses, liabilities, taxes, damages, deficiencies, obligations, fines, expenses, judgments or settlements resulting from Third Party Claims that are incurred or suffered by an Indemnified Party, including interest and penalties with respect thereto and out-of-pocket expenses and reasonable attorneys' and accountants' and experts' fees and expenses incurred in the investigation or defense of any of the same or in asserting, preserving or enforcing any of the Indemnified Party's rights hereunder, net of any amounts recovered or recoverable under any insurance policy.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Intellectual Property\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property\", \"text\": \"\\\"Intellectual Property\\\" means, with respect to any Person, all unpatented ideas, inventions, processes, discoveries trademarks, patents, copyrights, and any applications for registration thereof, and trade secrets and know-how of that Person, whether owned, used, or licensed by that Person as licensee or licensor.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Law\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Law\", \"text\": \"\\\"Law\\\" means any federal, state, local, municipal, foreign, international, multinational, or other administrative order, constitution, law, ordinance, principle of common law, regulation, statute, or treaty.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Lien\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Lien\", \"text\": \"\\\"Lien\\\" means any charge, claim, community property interest, condition, equitable interest, lien, option, pledge, security interest, right of first refusal, or restriction of any kind, including any restriction on use, voting, transfer, receipt of income, or exercise of any other attribute of ownership.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Month\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Month\", \"text\": \"\\\"Month\\\" means any of the twelve months of a year.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Order\", \"text\": \"\\\"Order\\\" means any award, decision, injunction, judgment, order, ruling, subpoena, or verdict of any court, arbitral tribunal, administrative agency, or other Governmental Authority.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Person\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Person\", \"text\": \"\\\"Person\\\" means any individual, corporation (including any non-profit corporation), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, labor union, Governmental Authority or other entity.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Representative\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Representative\", \"text\": \"\\\"Representative\\\" means, with respect to a particular Person, any director, officer, employee, agent, consultant, advisor, or other representative of that Person, including legal counsel, accountants, and financial advisors.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"term:Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Year\", \"text\": \"\\\"Year\\\" means (1) the period commencing with the date of this Agreement and ending on November 7th 2009, (2) any subsequent 12-month period commencing on January 1st and ending on December 31st, and (3) the period beginning January 1st of the year in which this Agreement expires or is terminated and ending on the date this Agreement expires or is terminated.\", \"definition_clause\": \"14.1\"}}, {\"id\": \"value:12-month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"12-month\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Further Assurances\", \"level\": 2, \"text\": \"14.2 Further Assurances. At any time or from time to time from the date of this Agreement, Medica, on the one hand, and Vapotherm, on the other hand, shall at the request, and at the expense, of the other do the following: (1) to the extent consistent with this Agreement deliver to the other such records, data, or other documents requested by the other; and (2) take or cause to be taken all such other actions as are reasonably necessary or desirable in order to permit the other to obtain the full benefits of this Agreement.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"14.3 Governing Law. This Agreement is governed by the laws of the State of New York without giving effect to principles of conflict of laws.\"}}, {\"id\": \"14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Dispute Resolution\", \"level\": 2, \"text\": \"14.4 Dispute Resolution. The parties shall attempt in good faith to resolve any controversy or claim that may arise concerning their respective rights and obligations under this Agreement. If they are unable to do so within [* * *] Business Days from the date that controversy or claim arose, they shall refer the controversy or claim to the AU of Medica and the CEO of Vapotherm, who shall meet in person or telephonically within [* * *] Business Days of being requested to do so and shall in good faith attempt to resolve the dispute. If the controversy or claim cannot then be solved, the parties hereby agree first to try in good faith to settle the dispute by mediation administered by the American arbitration Association at its New York City offices before resorting to arbitration. -21- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Arbitration\", \"level\": 2, \"text\": \"14.5 Arbitration. Any controversy or claim arising out of or relating to this Agreement or the applicability of this Section 14.5 that is not resolved pursuant to Section 14.4 will be determined by arbitration in accordance with the International Arbitration Rules of the American Arbitration Association. Unless the parties agree otherwise the number of arbitrators will be three, each of whom will be appointed by the American Arbitration Association. One arbitrator must be a lawyer, the second must be an expert in financial matters, and the third must have expertise in the manufacture of hemodialysis products. The place of arbitration will be Washington, D.C., U.S.A. The language of the arbitration will be English. Prior to the commencement of hearings, each of the arbitrators appointed must provide an oath or undertaking of impartiality. Judgment upon the award rendered by the arbitrators may be entered by any court having jurisdiction thereof. The cost of any such arbitration will be divided equally between Vapotherm, on the one hand, and Medica, on the other hand, with each party bearing its own attorneys' fees and costs.\"}}, {\"id\": \"14.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"14.6 Force Majeure. No party will be responsible to the other under this Agreement for failure or delay in performing any obligations under this Agreement, other than payment obligations, due to factors beyond its control, including without limitation any war, fire, earthquake, or other natural catastrophe, or any act of God, but excluding labor disputes involving all or any part of the work force of that party (each such factor, an \\\"Event of Force Majeure\\\"). Upon the occurrence of an Event of Force Majeure, the party failing or delaying performance shall promptly notify the other party in writing, setting forth the nature of the occurrence, its expected duration, and how that party's performance is affected. Any party subject to an Event of Force Majeure shall use commercially reasonable efforts to resume performing its obligations under this Agreement as soon as practicable. Except as provided in Section 14.6(b), if an Event of Force Majeure occurs, the affected party' will be excused from performing and the time for performance will be extended as long as that party is unable to perform as result of the Event of Force Majeure. (b) If any Event of Force Majeure prevents Medica from delivering any shipment of Cartridges for more than [* * *] Business Days beyond the scheduled delivery date, then Vapotherm may cancel its order without incurring any liability to Medica with respect thereto.\"}}, {\"id\": \"term:Event of Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Event of Force Majeure\", \"text\": \"(each such factor, an \\\"Event of Force Majeure\\\")\", \"definition_clause\": \"14.6\"}}, {\"id\": \"14.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"14.7 Assignment. This Agreement inures to the benefit of and is binding upon the successors and assignees of the parties. Neither party may assign any of its rights or obligations under this Agreement without the prior written consent of the other except that: (1) Vapotherm may assign this Agreement or transfer its rights and obligations under this Agreement to an Affiliate of Vapotherm or a successor to all or substantially all of its assets or business relating to this-Agreement, whether by sale, merger, operation of law, or otherwise.\"}}, {\"id\": \"14.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"14.8 Notices. Every notice or other communication required or contemplated by this Agreement must be in writing and sent by one of the following methods: (1) personal delivery, in which case delivery will be deemed to occur the day of delivery; -22- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. (2) by a recognized overnight delivery service such as Federal Express or DHL Worldwide Express, in which case delivery will be deemed to occur the day of delivery. (b) In each case, a notice or other communication sent to a party must be directed to the address for that party set forth below, or to another address designated by that party by written notice. All notices to be given by a Medica Entity may be given on its behalf by the other Medica Entity following consultation between Medica. If to: Vapotherm Inc. 198 Log Canoe Circle Stevensville MD 21666 Attention: CFO with a copy to: Hogan & Hartson L.L.P. 555 13t h Street, N.W., Washington, D.C. 20004-1009 Attention: Stephen J. Zempolich, Esq. if to Medica: Medica S.p.A. Via Degli Artigiani, 7 41036 Medolla (MO) Italy Attention: Luciano Fecondini\"}}, {\"id\": \"14.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"14.9 Severability. If any provision of this Agreement is held unenforceable by any court of competent jurisdiction, all other provisions of this Agreement will remain effective. If any provision of this Agreement is held to be unenforceable only in part or degree, it will remain effective to the extent not held unenforceable.\"}}, {\"id\": \"14.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"14.10 Entire Agreement. This Agreement constitutes the entire agreement of the parties pertaining to the subject matter of this Agreement. It supersedes all prior agreements of the parties, whether oral or written, pertaining to the subject matter of this Agreement.\"}}, {\"id\": \"14.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Amendment\", \"level\": 2, \"text\": \"14.11 Amendment. This Agreement may not be amended except by an instrument in writing signed on behalf of both parties.\"}}, {\"id\": \"14.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Independent Contractor\", \"level\": 2, \"text\": \"14.12 Independent Contractor. Nothing in this Agreement creates, or will be deemed to create, a partnership or the relationship of principal and agent or employer and employee between the parties. Each party agrees to perform under this Agreement solely as an independent contractor,\"}}, {\"id\": \"14.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 2, \"text\": \"14.13 Counterparts. This Agreement may be executed in counterparts, each of which is an original and all of which together constitute one and the same instrument. -23- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"14.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Laws\", \"level\": 2, \"text\": \"14.14 Compliance with Laws. Vapotherm and Medica shall each comply in all material respects with all applicable Laws that pertain to the activities for which Vapotherm and Medica are each responsible under this Agreement and, except as provided for herein, shall bear their own cost and expense of complying therewith. -24- [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. IN WITNESS WHEREOF, each of the undersigned have caused this Manufacturing and Supply Agreement to be duly executed and delivered in their name and on their behalf as of the date first set forth above. VAPOTHERM, INC. By: /s/ Joseph Army Name: Joseph Army Title: President & CEO MEDICA S.p.A By: /s/ Luciano Fecondini Name: Luciano Fecondini Title: Amministratore Unico [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit A-1 Price Schedule: in EURO (Euro) [* * *] Exhibit A-2: Forecast [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit B: Purchase Order Form Example [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}, {\"id\": \"Exhibit C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- Vapotherm Tools\", \"level\": 1, \"text\": \"Exhibit C - Vapotherm Tools [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Exhibit D: [* * *] Purchase Specifications [* * *] [* * *] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of VAXCYTE,INC_05_22_2020-EX-10.19-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of VAXCYTE,INC_05_22_2020-EX-10.19-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.19\", \"level\": 1, \"text\": \"Exhibit 10.19 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. SUPPLY AGREEMENT This SUPPLY AGREEMENT (\\\"Supply Agreement\\\") is made as of May 29, 2018 (the \\\"Effective Date\\\") by and between SutroVax, Inc., a Delaware corporation having principal offices at 353 Hatch Dr., Foster City, CA 94404 (\\\"SutroVax\\\") and Sutro Biopharma, Inc., a Delaware corporation, having principal offices at 310 Utah Ave, Suite 150, South San Francisco, CA, 94080 (\\\"Sutro\\\"). SutroVax and Sutro may be referred to herein by name or individually, as a \\\"Party\\\" and collectively, as the \\\"Parties.\\\" BACKGROUND A. Sutro controls certain proprietary technology which permits cell-free expression of proteins, and Sutro licensed such technology to SutroVax under that certain Amended and Restated SutroVax Agreement dated as of October 12, 2015 (the \\\"License Agreement\\\"). B. SutroVax is a vaccine company primarily in the business of developing, manufacturing and marketing vaccine products; and\"}, {\"id\": \"C\", \"title\": \"SutroVax desires to purchase from Sutro, and Sutro desires to supply to SutroVax, the Extracts and Custom Reagents (as\", \"level\": 1, \"text\": \"C. SutroVax desires to purchase from Sutro, and Sutro desires to supply to SutroVax, the Extracts and Custom Reagents (as defined below) upon the terms and subject to the conditions set forth herein. NOW, THEREFORE, in consideration of the covenants, conditions and undertakings hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows: AGREEMENT ARTICLE 1 DEFINITIONS/ INTERPRETATION For the purposes of this Supply Agreement, the following capitalized words and phrases shall have the following meanings:\"}, {\"id\": \"1.1\", \"title\": \"\\\"Affiliate\\\" means, with respect to either Party, any business entity controlling, controlled by, or under common control\", \"level\": 2, \"text\": \"1.1 \\\"Affiliate\\\" means, with respect to either Party, any business entity controlling, controlled by, or under common control with such Party. For the purpose of this definition only, \\\"control\\\" means (i) the possession, directly or indirectly, of the power to direct the management or policies of a business entity, whether through the ownership of voting securities, by contract or otherwise, or (ii) the ownership, directly or indirectly, of at least fifty percent (50%) of the voting securities or other ownership interest of a business entity. Notwithstanding the above, in no event shall Sutro (or any entity that would be an Affiliate of SutroVax solely because it is an Affiliate of Sutro) be deemed an Affiliate of SutroVax, or SutroVax (or any entity that would be an Affiliate of Sutro solely because it is an Affiliate of SutroVax) an Affiliate of Sutro.\"}, {\"id\": \"1.2\", \"title\": \"\\\"Applicable Law\\\" means all laws, ordinances, rules, rulings, directives and regulations of any Governmental Authority th\", \"level\": 2, \"text\": \"1.2 \\\"Applicable Law\\\" means all laws, ordinances, rules, rulings, directives and regulations of any Governmental Authority that apply to the development, manufacture or supply of any Product or the other activities contemplated under this Supply Agreement, including (i) all applicable federal, state and local laws, rules and regulations; (ii) the U.S. Federal Food, Drug and Cosmetic Act; (iii) regulations and guidelines of the FDA and other Regulatory Authorities, including cGMPs, if applicable; and (iv) any applicable non-U.S. equivalents of any of the foregoing, including guidelines of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (as amended from time to time).\"}, {\"id\": \"1.3\", \"title\": \"\\\"cGMPs\\\" means current good manufacturing practices and standards as set forth (and as amended from time to time) in the\", \"level\": 2, \"text\": \"1.3 \\\"cGMPs\\\" means current good manufacturing practices and standards as set forth (and as amended from time to time) in the current Good Manufacturing Practice Regulations of the U.S. Code of Federal Regulations, including 21 C.F.R. Sections 210 and 211, the European Community Directive 2003/94/EC and the ICH Harmonised Tripartite Guideline, Good Manufacturing Practice Guides for Active Pharmaceutical Ingredients (Q7).\"}, {\"id\": \"1.4\", \"title\": \"\\\"Components\\\" means any product or material used in the Manufacture of the Products including the packaging materials\", \"level\": 2, \"text\": \"1.4 \\\"Components\\\" means any product or material used in the Manufacture of the Products including the packaging materials.\"}, {\"id\": \"1.5\", \"title\": \"\\\"Extract\\\" means Sutro's extract derived from strains of E\", \"level\": 2, \"text\": \"1.5 \\\"Extract\\\" means Sutro's extract derived from strains of E. coli identified on Schedule 1 attached hereto, as may be amended from time to time in accordance with Section 12.7, and any new versions and improvements thereof that may be included in Schedule 1 by written agreement of the Parties in accordance with Section 12.7.\"}, {\"id\": \"1.6\", \"title\": \"\\\"Facility\\\" or \\\"Facilities\\\" means the facilities where Product will be Manufactured as set forth in Schedule 1\", \"level\": 2, \"text\": \"1.6 \\\"Facility\\\" or \\\"Facilities\\\" means the facilities where Product will be Manufactured as set forth in Schedule 1. Schedule 1 may be amended from time to time in accordance with this Supply Agreement to add or remove facilities.\"}, {\"id\": \"1.7\", \"title\": \"\\\"FDA\\\" means the United States Food and Drug Administration, or any successor agency thereto performing similar functions\", \"level\": 2, \"text\": \"1.7 \\\"FDA\\\" means the United States Food and Drug Administration, or any successor agency thereto performing similar functions.\"}, {\"id\": \"1.8\", \"title\": \"\\\"Fully Burdened Manufacturing Costs\\\" means, with respect to a Product, Sutro's costs of manufacturing such Product, whic\", \"level\": 2, \"text\": \"1.8 \\\"Fully Burdened Manufacturing Costs\\\" means, with respect to a Product, Sutro's costs of manufacturing such Product, which manufacturing costs shall mean: (a) [***], and (b) [***], in each case to the extent directly allocated to and incurred in the manufacture by Sutro of such Product supplied to SutroVax, its Affiliates and Sublicensees. Fully Burdened Manufacturing Costs shall not include any [***] and shall be calculated in accordance with the foregoing, GAAP and Sutro's policies and procedures for its other products, in each case consistently applied (and such plant operations and support services costs shall be allocated consistent with GAAP and other products of Sutro in that facility).\"}, {\"id\": \"1.9\", \"title\": \"\\\"Governmental Authority\\\" means any court, agency, department, authority or other instrumentality of any nation, state, c\", \"level\": 2, \"text\": \"1.9 \\\"Governmental Authority\\\" means any court, agency, department, authority or other instrumentality of any nation, state, country, city or other political subdivision, including any Regulatory Authority.\"}, {\"id\": \"1.10\", \"title\": \"\\\"Manufacture\\\" or \\\"Manufacturing\\\" means the processes and procedures for the supply of the Products, including, (a) the s\", \"level\": 2, \"text\": \"1.10 \\\"Manufacture\\\" or \\\"Manufacturing\\\" means the processes and procedures for the supply of the Products, including, (a) the supply and quality control of the Components; (b) the manufacture of the Products in bulk; (c) the Packaging and labeling of the Products; (d) the quality control of the Products; and (e) the storage of the Products until shipment.\"}, {\"id\": \"1.11\", \"title\": \"\\\"Package\\\" or \\\"Packaging\\\" means packaging Product(s) in accordance with applicable Specifications\", \"level\": 2, \"text\": \"1.11 \\\"Package\\\" or \\\"Packaging\\\" means packaging Product(s) in accordance with applicable Specifications.\"}, {\"id\": \"1.12\", \"title\": \"\\\"Person\\\" means an individual, a corporation, a partnership, an association, a trust or other entity or organization, inc\", \"level\": 2, \"text\": \"1.12 \\\"Person\\\" means an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or political subdivision or an agency thereof.\"}, {\"id\": \"1.13\", \"title\": \"\\\"Price\\\" means the price to be paid by SutroVax for each Product as set forth on Schedule 1 of this Supply Agreement and\", \"level\": 2, \"text\": \"1.13 \\\"Price\\\" means the price to be paid by SutroVax for each Product as set forth on Schedule 1 of this Supply Agreement and as may be modified from time to time in accordance with Section 3.2.\"}, {\"id\": \"1.14\", \"title\": \"\\\"Product(s)\\\" means the Extract and Custom Reagents\", \"level\": 2, \"text\": \"1.14 \\\"Product(s)\\\" means the Extract and Custom Reagents.\"}, {\"id\": \"1.15\", \"title\": \"\\\"Custom Reagents\\\" means Sutro's custom reagents identified on Schedule 1 attached hereto, and any new versions and impro\", \"level\": 2, \"text\": \"1.15 \\\"Custom Reagents\\\" means Sutro's custom reagents identified on Schedule 1 attached hereto, and any new versions and improvements thereof that may be included in Schedule 1 by written agreement of the Parties in accordance with Section 12.7.\"}, {\"id\": \"1.16\", \"title\": \"\\\"Regulatory Approval\\\" means, with respect to a product, all approvals, licenses, registrations or authorizations necessa\", \"level\": 2, \"text\": \"1.16 \\\"Regulatory Approval\\\" means, with respect to a product, all approvals, licenses, registrations or authorizations necessary to market and sell such product in a particular jurisdiction in the Territory (including applicable approvals of labeling, price and reimbursement for such product in such jurisdiction).\"}, {\"id\": \"1.17\", \"title\": \"\\\"Regulatory Authority\\\" means any federal, national, multinational, state, provincial or local regulatory agency, departm\", \"level\": 2, \"text\": \"1.17 \\\"Regulatory Authority\\\" means any federal, national, multinational, state, provincial or local regulatory agency, department, bureau or other governmental entity, including the FDA, with authority over the development, Manufacture or commercialization (including approval of Regulatory Approvals) of any Product(s) in any jurisdiction in the Territory.\"}, {\"id\": \"1.18\", \"title\": \"\\\"Regulatory Materials\\\" means regulatory applications, submissions, notifications, communications, correspondence, regist\", \"level\": 2, \"text\": \"1.18 \\\"Regulatory Materials\\\" means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals and/or other filings made to, received from or otherwise conducted with a Regulatory Authority (including minutes of meeting with Regulatory Authorities) that are necessary or reasonably desirable to access in connection with the development, manufacture, marketing, sale or other commercialization of any Product in a particular country or regulatory jurisdiction. Regulatory Materials include, without limitation, INDs, NDAs, BLAs, clinical trial applications, marketing approval applications and applications for pricing approvals.\"}, {\"id\": \"1.19\", \"title\": \"\\\"Required Standards\\\" means Applicable Law, the Specifications, and the warranties given by Sutro in Section 7\", \"level\": 2, \"text\": \"1.19 \\\"Required Standards\\\" means Applicable Law, the Specifications, and the warranties given by Sutro in Section 7.3, provided that Required Standards shall not include compliance with cGMPs for Custom Reagents, Extract identified as \\\"research grade\\\" Extract or Other Extracts.\"}, {\"id\": \"1.20\", \"title\": \"\\\"Specifications\\\" means, with respect to a Product or applicable Component thereof, all written product, regulatory, Manu\", \"level\": 2, \"text\": \"1.20 \\\"Specifications\\\" means, with respect to a Product or applicable Component thereof, all written product, regulatory, Manufacturing, release criterion, quality control and quality assurance procedures, processes, practices, standards, instructions and specifications applicable to the Manufacture of such Product or Component, as agreed to by the Parties in writing from time to time. The initial Specifications for the Products are attached hereto as Schedule 2.\"}, {\"id\": \"1.21\", \"title\": \"\\\"SutroVax CMO\\\" means any contract manufacturer responsible for supplying or manufacturing a Vaccine Composition on behal\", \"level\": 2, \"text\": \"1.21 \\\"SutroVax CMO\\\" means any contract manufacturer responsible for supplying or manufacturing a Vaccine Composition on behalf of SutroVax or its Affiliates, selected in accordance with Section .2.\"}, {\"id\": \"1.22\", \"title\": \"\\\"Territory\\\" means worldwide\", \"level\": 2, \"text\": \"1.22 \\\"Territory\\\" means worldwide.\"}, {\"id\": \"1.23\", \"title\": \"\\\"Third Party\\\" means any Person other than SutroVax, Sutro, or their respective Affiliates\", \"level\": 2, \"text\": \"1.23 \\\"Third Party\\\" means any Person other than SutroVax, Sutro, or their respective Affiliates.\"}, {\"id\": \"1.24\", \"title\": \"Additional Definitions\", \"level\": 2, \"text\": \"1.24 Additional Definitions. Each of the following terms shall have the meaning described in the corresponding Section of this Supply Agreement indicated below:\"}, {\"id\": \"1.25\", \"title\": \"Interpretation\", \"level\": 2, \"text\": \"1.25 Interpretation. The captions and headings to this Supply Agreement are for convenience only, and are to be of no force or effect in construing or interpreting any of the provisions of this Supply Agreement. Unless specified to the contrary, references to Articles, Sections, Schedules or Exhibits mean the particular Articles, Sections, Schedules or Exhibits to this Supply Agreement and references to this Supply Agreement include all Schedules and Exhibits hereto. Unless context clearly requires otherwise, whenever used in this Supply Agreement: (i) the words \\\"include\\\" or \\\"including\\\" shall be construed as incorporating, also, \\\"but not limited to\\\" or \\\"without limitation;\\\" (ii) the word \\\"or\\\" shall have its inclusive meaning of \\\"and/or;\\\" (iii) the word \\\"notice\\\" shall require notice in writing (whether or not specifically stated) and shall include notices, consents, approvals and other written communications contemplated under this Supply Agreement; (iv) the words \\\"hereof,\\\" \\\"herein,\\\" \\\"hereunder,\\\" \\\"hereby\\\" and derivative or similar words refer to this Supply Agreement (including any Schedules and Exhibits); (v) provisions that require that a Party or the Parties \\\"agree,\\\" \\\"consent\\\" or \\\"approve\\\" or the like shall require that such agreement, consent or approval be specific and in writing; (vi) words of any gender include the other gender; (vii) words using the singular or plural number also include the plural or singular number, respectively; (viii) references to any specific law, or article, section or other division thereof, shall be deemed to include the then-current amendments thereto or any replacement thereof; (ix) neither Party shall be deemed to be acting \\\"under the authority\\\" of the other Party; and (x) any capitalized terms used and not defined in this Supply Agreement shall have the meaning set forth in the License Agreement.\"}, {\"id\": \"ARTICLE 2\", \"title\": \"SUPPLY\", \"level\": 1, \"text\": \"ARTICLE 2 SUPPLY\"}, {\"id\": \"2.1\", \"title\": \"Supply\", \"level\": 2, \"text\": \"2.1 Supply. Pursuant to the terms and conditions of this Supply Agreement, Sutro agrees that it will Manufacture the Product(s) at the Facility(ies) for SutroVax and shall supply the Product(s) to SutroVax, its Affiliates, and any SutroVax CMO, for purposes of production of Vaccine Compositions (including development of processes for the production of Vaccine Compositions), solely for non-clinical research purposes or in Phase I or Phase II clinical trials of such Vaccine Compositions..\"}, {\"id\": \"2.2\", \"title\": \"Transfer of Product\", \"level\": 2, \"text\": \"2.2 Transfer of Product. Subject to Section 2.1, SutroVax may transfer Products to SutroVax CMOs selected by SutroVax and that are reasonably acceptable to Sutro (the acceptance of which by Sutro not to be unreasonably withheld, conditioned or delayed) or previously approved by Sutro.\"}, {\"id\": \"2.3\", \"title\": \"Work Orders\", \"level\": 2, \"text\": \"2.3 Work Orders. From time to time, Sutro and SutroVax may execute one or more work orders, that describe the Product to be Manufactured, the quantities of each Product to be Manufactured and supplied to SutroVax, the Price to be charged by Sutro (which shall be as set forth in Section 3.2) and paid by SutroVax for the Product, and the delivery date(s) for such Product, (as executed, a \\\"Work Order\\\"). Each Work Order will expressly refer to this Supply Agreement, will form a part of this Supply Agreement, and will be subject to the terms and conditions contained herein. Sutro shall not unreasonably withhold its agreement to any proposed Work Order requested by SutroVax. Sutro shall be obligated to execute proposed Work Orders requested by SutroVax (except with respect to Other Extracts) with respect to quantities in such proposed Work Order for delivery at least [***] months after SutroVax's request to the extent such quantities of Product (when added to the quantities of such Product in Work Orders previously agreed between the Parties for delivery within the one (1) calendar year period prior to the requested delivery date of the proposed Work Order) are less than (a) [***] liters with respect to Extract or (b) a corresponding amount of each Custom Reagent to support use of [***] liters of Extract. Sutro shall notify SutroVax as soon as possible if Sutro believes it will be unable to deliver Product in accordance with the applicable Work Order. Sutro's providing of such notification shall not be interpreted in any manner as relieving Sutro of its obligations under this Supply Agreement, nor shall it prevent SutroVax from pursuing any and all rights and remedies SutroVax may have based on Sutro's failure to be able to deliver any Product in accordance with the terms of this Supply Agreement.\"}, {\"id\": \"2.4\", \"title\": \"Orders\", \"level\": 2, \"text\": \"2.4 Orders.\"}, {\"id\": \"2.4.1\", \"title\": \"Purchase Orders\", \"level\": 3, \"text\": \"2.4.1 Purchase Orders. Once both parties have executed a Work Order, SutroVax shall place a purchase order for the amounts of Products to be purchased under such Work Order with delivery dates for such amounts consistent with such Work Order. Additionally, SutroVax may from time to time place purchase orders for additional quantities specifying requested delivery dates in accordance with reasonable delivery schedules and lead times; in each case, as may be agreed upon from time to time by the Parties. Each purchase order placed by SutroVax shall specify the quantity of Product, destination(s) and requested delivery dates. Sutro shall promptly accept all purchase orders with respect to the amounts of Products to be purchased under the applicable Work Order and shall accept or reject any amount in the purchase order in excess of the amounts of Products to be purchased under the applicable Work Order and all other purchase orders for Product submitted by SutroVax in accordance with this Article 2 within [***] days from receipt of the order; provided however that Sutro shall use Commercially Reasonable Efforts to accept such amounts and purchase orders. Accepted purchase orders may not be cancelled without the prior written agreement of both Parties except as set forth in Sections 2.5. Unless otherwise directed by SutroVax, Sutro shall fill all accepted purchase orders for Product in accordance with the requested due dates as set forth in further detail in Section 2.9.2.\"}, {\"id\": \"2.4.2\", \"title\": \"No Conflicting Terms\", \"level\": 3, \"text\": \"2.4.2 No Conflicting Terms. The terms and conditions of this Supply Agreement shall be controlling over any conflicting terms and conditions stated in SutroVax's purchase order or Sutro's invoice, confirmation or other standardized document. Any purchase order, order acknowledgement, invoice, proposal or other document which conflicts with or adds to the terms and conditions of this Supply Agreement with respect to the Manufacture and supply of Product for the Territory is hereby rejected, unless the Parties mutually agree to the contrary in writing.\"}, {\"id\": \"2.4.3\", \"title\": \"Initial Order\", \"level\": 3, \"text\": \"2.4.3 Initial Order. Notwithstanding Section 2.3 or this Section 2.4, Sutro accepts and agrees to fulfil the order previously placed by or on behalf of SutroVax (or to be placed by or on behalf of SutroVax, if no already placed) for the quantities of Product set forth in Schedule 3 by the delivery date set forth therein (the \\\"Initial Order\\\").\"}, {\"id\": \"2.5\", \"title\": \"Cancellation\", \"level\": 2, \"text\": \"2.5 Cancellation. Notwithstanding anything herein to the contrary, SutroVax may not modify or cancel purchase orders with respect to the amounts of Product to be purchased under the applicable Work Order, however SutroVax may modify or cancel other purchase orders (including amounts in a purchase order in excess of the amounts of Product to be purchased under the applicable Work Order) for the Products provided that such modification or change is made further in advance of the originally requested delivery date than the required lead time, where the agreed required lead time for the applicable purchase order has been evidenced in writing (including, for example, by email) between the Parties.\"}, {\"id\": \"2.6\", \"title\": \"Delivery and Risk of Loss\", \"level\": 2, \"text\": \"2.6 Delivery and Risk of Loss. Sutro shall mark Product for delivery to the destination(s) specified by SutroVax. All shipments of Product(s) shall be delivered [***] (lncoterms 2010) Sutro Facility. Title and risk of loss and damage to the Product(s) shall remain with Sutro until the Product(s) are delivered in accordance with the foregoing, at which time title and risk ofloss and damage to the Product(s) shall pass to SutroVax. SutroVax will arrange for shipping from Sutro's Facility to the destination specified by SutroVax at SutroVax's cost and expense.\"}, {\"id\": \"2.7\", \"title\": \"Packaging\", \"level\": 2, \"text\": \"2.7 Packaging. Sutro shall provide the Product to SutroVax in Packaged form in accordance with the Required Standards.\"}, {\"id\": \"2.8\", \"title\": \"Conformance to Required Standards\", \"level\": 2, \"text\": \"2.8 Conformance to Required Standards. Sutro shall Manufacture the Product(s) in accordance with the Required Standards, as the same may be amended or supplemented from time to time. Each Party shall keep the other promptly and fully advised of any new requirements of the applicable Regulatory Authority or Applicable Law of which it becomes aware and Sutro shall promptly implement such requirements as described in Section 6.6.\"}, {\"id\": \"2.9\", \"title\": \"Supply and Delivery\", \"level\": 2, \"text\": \"2.9 Supply and Delivery.\"}, {\"id\": \"2.9.1\", \"title\": \"Shortage\", \"level\": 3, \"text\": \"2.9.1 Shortage. Sutro shall use reasonable efforts to promptly notify SutroVax in writing in the event that Sutro is unable or anticipates that it will be unable to supply compliant Product in accordance with the requirements of this Supply Agreement, including the Quality Agreement and all Required Standards, and each Work Order. Sutro shall use Commercially Reasonable Efforts to overcome any inability or anticipated inability to so supply compliant Product to SutroVax.\"}, {\"id\": \"2.10\", \"title\": \"Allocation\", \"level\": 2, \"text\": \"2.10 Allocation. Without limiting any other rights or remedies available to SutroVax, if the demand for a Product in aggregate exceeds available supply or Sutro otherwise concludes that it may be unable to supply a Product in accordance with the requirements of this Supply Agreement in the quantities and within the time periods specified in each Work Order and the corresponding purchase orders that have been accepted by Sutro, Sutro shall immediately notify SutroVax of such shortfall (or anticipated shortfall), and shall use Commercially Reasonable Efforts to procure Components and capacity adequate to meet accepted purchase orders and supply compliant Product in accordance with the requirements of this Supply Agreement. Sutro shall allocate its available Components and manufacturing capacity to provide SutroVax with quantities of such Product at least equal to the greater of (a) [***] of the amount of Product (or products equivalent to Product) that Sutro allocates for itself and its Affiliates (but in no event less than [***] liters of Extract per month and the minimum allocation volume set out in Schedule 1 of each Custom Reagent per month), provided that SutroVax demonstrates actual need for the applicable quantities of Extract, and (b) the [***]. Without limiting the foregoing, if there is a shortage of supply of Product, Sutro shall provide Product to SutroVax for any quantities of Product ordered by SutroVax in accordance with the applicable Work Order or purchase order in priority to any subsequent Third Party purchase orders, but not in priority to any Third Party purchase orders or other binding commitment placed before placement of the applicable SutroVax Work Order or purchase order.\"}, {\"id\": \"2.11\", \"title\": \"Short Dated Product\", \"level\": 2, \"text\": \"2.11 Short Dated Product. Sutro agrees to ship all Product(s) so that they are delivered to SutroVax and will remain compliant with the Specifications for at least [***] months from the date of delivery in accordance with this Supply Agreement.\"}, {\"id\": \"2.12\", \"title\": \"Subcontracting by Sutro\", \"level\": 2, \"text\": \"2.12 Subcontracting by Sutro. Sutro shall (a) ensure that any subcontractor or delegatee of Sutro's obligations under this Supply Agreement has and maintains all appropriate qualifications; (b) enter into a quality agreement with each such subcontractor and delegatee which terms are similar to the terms of the Quality Agreement between SutroVax and Sutro; and (c) be responsible for each subcontractor's and delegatee's performance hereunder (including performance or non-performance by such subcontractor or delegatee that would constitute a breach of this Supply Agreement or such quality agreement if conducted by Sutro) as if Sutro were itself performing such activities. Sutro shall not subcontract the Manufacture of Product to a Third Party without SutroVax's prior consent other than to an Alternate Supplier as expressly set forth in Section 2.15.\"}, {\"id\": \"2.13\", \"title\": \"CMOs\", \"level\": 2, \"text\": \"2.13 CMOs. Notwithstanding anything to the contrary in this Supply Agreement, SutroVax shall have the rights to purchase Available Extracts and Extracts from CMOs (as defined in the License Agreement) to the extent provided in section 3.1 of the License Agreement.\"}, {\"id\": \"2.14\", \"title\": \"Phase 3/Commercial Supply Agreement\", \"level\": 2, \"text\": \"2.14 Phase 3/Commercial Supply Agreement. If requested by SutroVax in writing (which request shall not be made prior to [***]), the Parties shall negotiate in good faith reasonable terms and conditions of an agreement for the supply by Sutro of the Products for the production of Vaccine Compositions for use in phase 3 clinical studies and for commercial purposes (\\\"Phase 3/Commercial Supply Agreement\\\"). The price for the Products Manufactured by Sutro under the Phase 3/Commercial Supply Agreement shall not exceed [***] of the Fully Burdened Manufacturing Cost thereof. If the Parties have not entered into the Phase 3/Commercial Supply Agreement within [***] after SutroVax's request to negotiate the Phase 3/Commercial Supply Agreement, upon either Party's request by written notice to the other Party the terms and conditions of the Phase 3/Commercial Supply Agreement shall be determined by binding arbitration in accordance with the procedures set forth in Section 11.4. Upon the selection of one draft Phase 3/Commercial Supply Agreement by the arbitrator pursuant to Section 11.4, unless SutroVax elects not to enter into such Phase 3/Commercial Supply Agreement by written notice thereof to Sutro within [***] days after such selection, the Parties shall execute the definitive Phase 3/Commercial Supply Agreement selected by the arbitrator (but excluding, for clarity, any provision granting to SutroVax or its Affiliates or Sublicensees any right to obtain or use any Sutro Core Know-How); and if SutroVax elects to not enter into the Phase 3/Commercial Supply Agreement selected by the arbitrator by providing notice thereof within such [***] day period, then neither Party shall be obligated to enter into the Phase 3/Commercial Supply Agreement.\"}, {\"id\": \"2.15\", \"title\": \"Qualification of Alternate Supplier\", \"level\": 2, \"text\": \"2.15 Qualification of Alternate Supplier.\"}, {\"id\": \"2.15.1\", \"title\": \"Transfer Addendum\", \"level\": 3, \"text\": \"2.15.1 Transfer Addendum. (a) Transfer Addendum. Upon SutroVax' written request, the Parties agree to negotiate in good faith an addendum to this Supply Agreement setting forth the terms and conditions pursuant to which Sutro will conduct a Process Transfer to a Third Party contract manufacturer (\\\"CMO\\\") and/or engage such CMO to establish Capacity to Manufacture Extract (as Process Transfer and Capacity are defined below), in each case for the Manufacture and supply of such Extract for SutroVax' (or its Affiliate's or SutroVax CMO's) use to manufacture Vaccine Compositions, consistent with the remainder of this Section 2.15 (such addendum, a \\\"Transfer Addendum\\\"). As requested by SutroVax, this procedure may also be used in the event that SutroVax wishes Sutro to conduct a Process Transfer to a Third Party CMO in order to establish Capacity to Manufacture Custom Reagents. In connection with such request, SutroVax shall provide to Sutro a description of the desired Process Transfer and/or Capacity, including timing and other requirements thereof. Such Transfer Addendum shall: (i) include a plan and budget for the conduct of the Process Transfer and/or establishment of such Capacity, which shall include amounts charged by the CMO (as defined further below, the \\\"Alternate Supplier\\\") to receive and conduct such Process Transfer and/or establish such Capacity, as well as reasonable FTE costs for Sutro personnel performing and managing technology transfer activities in accordance with the Transfer Addendum\u00b7 (ii) require SutroVax to fund the costs incurred by Sutro to conduct Process Transfer and/or establish such Capacity in accordance with such budget; (iii) provide for initiation and completion of the Process Transfer and establishment of Capacity as requested by SutroVax, to the extent possible; (iv) to the extent requested by SutroVax, be designed to enable the Alternate Supplier to Manufacture Extract of suitable quality for use in Phase 3 clinical trials and commercialization of a Vaccine Composition at a capacity to support SutroVax' projected commercial requirements for Extract (or other capacity identified by SutroVax in connection with the negotiation of the Transfer Addendum), as requested by SutroVax; (v) require the Parties to fully cooperate to verify that the Extract supplied by the Alternate Supplier meets the Specifications, to validate the Manufacturing process implemented at the Alternate Supplier and to qualify the Alternate Supplier, in each case to supply Extract for SutroVax' use in Phase 3 clinical trials and commercialization of a Vaccine Composition (collectively, with respect to Capacity established, \\\"Validating\\\" such Capacity); (vi) include mechanisms for keeping SutroVax fully informed, at scheduled intervals not to exceed once per quarter, of the progress of the Process Transfer and establishing such Capacity, as applicable, including with respect to the anticipated date for qualifying the Alternate Supplier and any changes to such anticipated date; (vii) provide a right for SutroVax to modify the timing of or terminate the Process Transfer, Capacity or specified aspects thereof on reasonable notice, subject to SutroVax' agreement to bear any resulting termination or cancellation fees charged by the Alternative Supplier; and (viii) include a mechanism for Sutro to cooperate with SutroVax and keep SutroVax reasonably informed with respect to Sutro's negotiation of an agreement with a potential Alternate Supplier for a Process Transfer and/or establishment of Capacity, including with respect to pricing for Extract from the Alternate Supplier to Sutro and any commitments to purchase quantities of Extract from the Alternate Supplier that SutroVax would be obligated to assume (e.g., in connection with establishing Capacity), if any, and require Sutro to obtain SutroVax' approval (not to be withheld unreasonably) of the terms of such agreement prior to entering into such agreement to the extent that the terms apply to SutroVax (it being understood that Sutro may redact any terms that are not relevant to SutroVax). (b) Scope. As used above, \\\"Process Transfer\\\" means a technology transfer of Sutro's know-how and information as is necessary or useful for the Third Party CMO to Manufacture in its own facilities Extract that meets SutroVax' requirements, including any such information and know-how as would be needed for such CMO to scale up such Manufacture to the requested commercial volumes. To establish \\\"Capacity\\\" means that the CMO would take such actions as are necessary (including validation and if necessary adapting or reserving existing facilities, establishing new facilities and/or procuring necessary equipment) to Manufacture Extract meeting SutroVax' requirements for Phase 3 and commercial supply in such quantities as SutroVax designates. It is understood that SutroVax may request that the Process Transfer and establishment of Capacity be undertaken in separate steps, for example by undertaking an initial Process Transfer to demonstrate the CMO's ability to Manufacture Extract, and then later establishing Capacity for Phase 3 and commercial supply, as requested by SutroVax in accordance with Section 2.15.1(a) (i.e., in separate requests). (c) Selection of Alternate Supplier. The \\\"Alternate Supplier\\\" will be selected by Sutro, provided that Sutro must select an \\\"Alternate Supplier\\\" that is substantially similar to those CMOs identified on Schedule 2.15.1 hereto and provided further that SutroVax shall have the right to veto such selection based only on a genuine and material conflict of interest between SutroVax and the Alternate Supplier. Additional CMOs may be added to Schedule 2.15.1 by Sutro with SutroVax's approval (not to be withheld unreasonably). (d) Alternate Supplier as Subcontractor. It is understood that the Alternate Supplier established under the Transfer Addendum shall operate as a subcontractor of Sutro under this Supply Agreement and the Phase 3/Commercial Supply Agreement, and as such SutroVax will order from Sutro thereunder any Extract to be Manufactured by such Alternate Supplier. Subject to the foregoing, the Transfer Addendum and the Phase 3/Commercial Supply Agreement will include reasonable and customary rights for SutroVax to conduct audits/inspections, site visits, quarterly meetings, each such audit/inspection, site visit and quarterly meeting to be coordinated by Sutro and to occur in the presence of a representative for Sutro and SutroVax, in connection with the Alternate Supplier's manufacture of Extract for supply to SutroVax. For clarity, SutroVax shall not conduct any business discussions for the supply of Extract with the Alternate Supplier in a manner that induces the Alternate Supplier to breach its agreement with Sutro. Notwithstanding the foregoing, in the event Sutro undergoes a Change of Control or Sutro permits any third party to acquire Extract directly from an Alternate Supplier established under the Transfer Addendum, then SutroVax shall thereafter have the right to establish a supply agreement with and obtain supply of Extract directly from such Alternate Supplier. (e) Quotations. Upon SutroVax's request (which request, for clarity, may be before a request to negotiate a Transfer Addendum), Sutro shall seek quotations from one or more Third Party CMO(s) for such a Process Transfer and/or establishment of such Capacity, in each case as requested by SutroVax, and the Parties shall reasonably cooperate to establish requests for quotations for such purposes. (f) Arbitration. If the Parties have not agreed upon a Transfer Addendum within [***] after SutroVax' request, upon SutroVax' request by written notice to Sutro, the terms and conditions of the Transfer Addendum shall be determined by binding arbitration in accordance with the procedures set forth in Section 11.4. For clarity, however, it is understood that a Transfer Addendum shall not include any provision granting to SutroVax or its Affiliates or Sublicens.ee s any right to obtain or use any Sutro Core Know-How.\"}, {\"id\": \"2.15.2\", \"title\": \"Source of Supply\", \"level\": 3, \"text\": \"2.15.2 Source of Supply. It is understood that after the Alternate Supplier is qualified, SutroVax shall have the right under this Supply Agreement and the Phase 3/Commercial Supply Agreement to specify whether Extract ordered from Sutro pursuant to this Agreement or the Phase 3/Commercial Supply Agreement will be Manufactured at Sutro's Facility or at the Alternate Supplier's facilities (and to the extent Extract from the Alternate Supplier is ordered under this Supply Agreement or the Phase 3/Commercial Supply Agreement, the facility of the Alternate Supplier shall be deemed a Facility for purposes of this Supply Agreement and the Phase 3/Commercial Supply Agreement). Notwithstanding the foregoing, to the extent the FDA and EMA have confirmed that Extract manufactured at Sutro's Facility and the Alternate Supplier's Facility are interchangeable and can be supplied from either such Facility without any additional regulatory requirements or regulatory delay with respect to the applicable Vaccine Composition, and such Extract otherwise meets SutroVax' requirements, then with SutroVax' consent (not to be withheld unreasonably) Sutro may supply Extract from either Sutro's Facility or the Alternate Supplier's Facility.\"}, {\"id\": \"2.15.3\", \"title\": \"Price\", \"level\": 3, \"text\": \"2.15.3 Price. To the extent Sutro or its Affiliate Manufactures Extract supplied to SutroVax, the Price (per unit volume or unit weight) under this Supply Agreement and the Phase 3/Commercial Supply Agreement for such Extract shall not exceed [***] of the Fully Burdened Manufacturing Costs of such Extract; and to the extent the Extract to be supplied to SutroVax is Manufactured by a Third Party (including the Alternate Supplier), the Price to be charged to SutroVax under this Supply Agreement and the Phase 3/Commercial Supply Agreement for such Extract shall equal the amount Sutro paid such Third Party for such Extract (\\\"OOP Cost\\\") plus an amount reasonably calculated to cover Sutro's FTE costs to procure and manage the relationship with such Third Party, such amount not to exceed [***] of the OOP Cost for such Extract. To the extent that Sutro or its Affiliate receives any portion of the amounts paid to such Third Party to Manufacture Extract (e.g., as a profit share or otherwise), the Price to be charged SutroVax shall be the lesser of i) [***], or ii) [***]; in either case, [***]. For clarity, Section 3.4 of the License Agreement shall apply with respect to the Alternate Supplier.\"}, {\"id\": \"2.15.4\", \"title\": \"Sutro/Third Party use of Alternate Supplier\", \"level\": 3, \"text\": \"2.15.4 Sutro/Third Party use of Alternate Supplier. Once the Alternate Supplier is qualified pursuant to this Section 2.15, SutroVax shall have the first right (as between SutroVax and Sutro or Third Parties supplied or authorized by Sutro) to obtain Extract Manufactured by the Alternate Supplier up to the Capacity established pursuant to the Transfer Addendum for a period ending the later of [***] or [***], and provided SutroVax commits to [***] or [***].\"}, {\"id\": \"2.17\", \"title\": \"Manufacture of Custom Reagents\", \"level\": 2, \"text\": \"2.17 Manufacture of Custom Reagents. For clarity, SutroVax may Manufacture Custom Reagents itself or obtain supply thereof through a Third Party independent of this Supply Agreement and nothing in this Supply Agreement is intended to restrict SutroVax from doing so. Upon SutroVax's request, and subject to the remainder of the terms of this Section 2.17, Sutro shall (a) transfer to SutroVax or a contract manufacturer designated by SutroVax (which contract manufacturer is reasonably acceptable to Sutro, the approval of which shall not be unreasonably withheld, conditions or delayed by Sutro) as soon as reasonably practicable the process to Manufacture each Custom Reagent and the items of Sutro Know-How reasonably necessary for SutroVax or its designee to Manufacture each Custom Reagent, including cell lines, standard operating procedures, protocols, batch records, analytical method standard operating procedures and analytical method transfer protocols and (b) make Sutro Personnel reasonably available to SutroVax or its designee for scientific and technical explanations and on-site support that may reasonably be requested by SutroVax or its designee to Manufacture the Custom Reagents; provided however, that SutroVax shall fully reimburse Sutro for all documented time spent by Sutro's personnel to perform such transfer (on an FTE basis, each such FTE charged at an annual rate of [***]) and out-of-pocket costs incurred by Sutro in connection with all of the activities under the preceding sub-clauses (a) and (b), in accordance with a budget reasonably approved in advance by SutroVax. Upon such SutroVax request, Sutro and SutroVax shall, within [***] days, agree on a scope of work for such transfer, including scale, timeline, estimated budget, and required materials; both parties shall use reasonable efforts to complete the transfer as soon as reasonably practical. If requested by SutroVax (including if such request is prior to agreement on a scope of work), Sutro shall promptly transfer to SutroVax or its designee the cell lines, manufacturing instructions and analytical methods used for Manufacture of each Custom Reagent. For clarity, SutroVax shall have the right to enter into an agreement directly with such designee for the Manufacture and supply of Custom Reagents directly to SutroVax, its Affiliates, and any SutroVax CMO and, upon SutroVax's request, to the extent necessary, Sutro shall authorize such designee to enter into such agreement with SutroVax and perform such activities. For further clarity, Sutro shall not be responsible for any damages resulting from delay or failure in establishing the processes for Manufacture of Custom Reagents at SutroVax's designee resulting from action or inaction on the part of the designee or to the extent beyond Sutro's control. SutroVax shall have the right to obtain from such designee such items of Sutro Know-How transferred to such designee and use such items in connection with the exercise of its rights pursuant to the License Agreement, including for the Manufacture of Custom Reagents and the management of such designee. SutroVax shall use such Sutro Know-How transferred under this Section 2.17 (to the extent it is Discloser's Information of Sutro and does not meet one or more the criteria in clause (a) through (e) of Section 10.1 of the License Agreement) only for the Manufacture of Custom Reagents or otherwise within the scope of rights and licenses granted SutroVax in the License Agreement. In case of such a transfer to SutroVax or its designee, SutroVax will share with Sutro (i) the proposed process for manufacture of Custom Reagents through a Third Party so that Sutro may provide feedback and ensure that the process and Specifications are consistent with Sutro's process, and (ii) all regulatory submissions (including DMFs with respect to Custom Reagents) at least [***] days in advance of their intended date of submission to a Regulatory Authority in the Territory, and shall take into account Sutro's feedback to ensure alignment with Sutro's regulatory submissions and Regulatory Approvals with respect to Custom Reagents. Following completion of the transfer set forth above, Sutro shall provide reasonable support for the use of Third Party Custom Reagents in conjunction with Extract supplied by or on behalf of Sutro. In addition, Extract supplied by Sutro that conforms to the Required Standards when tested with Custom Reagents supplied by Sutro but not with Custom Reagents manufactured under this Section shall be deemed to conform to the Required Standards and SutroVax may not reject such Extract as a result of such non-conformance to the Required Standards when tested with Custom Reagents. SutroVax shall not prevent Sutro from separately contracting with the contract manufacturer for Manufacture of Custom Reagents for use on its own behalf or on behalf of other third parties.\"}, {\"id\": \"2.18\", \"title\": \"Sutro Core Know-How\", \"level\": 2, \"text\": \"2.18 Sutro Core Know-How. Notwithstanding anything to the contrary, except as set forth in Section 15.3 of the License Agreement, in no event shall SutroVax, its Affiliates or Sublicensees have the right to access any Sutro Core Know-How (as defined in the License Agreement), whether directly from Sutro or its Affiliates or through a CMO or otherwise, and SutroVax, its Affiliates and Sublicensees shall not require, request or solicit any CMO to deliver any Sutro Core Know-How to SutroVax, its Affiliates and/or its Sublicensees, and no agreement between any CMO and Sutro, its Affiliates and Subsidiaries shall contain any provision granting to SutroVax or its Affiliates or Sublicensees any right to obtain or use any Sutro Core Know-How. Without limiting the foregoing, in the event any item of Sutro Core Know-How is delivered to SutroVax, its Affiliates and/or its Sublicensees (except as set forth in Section 15.3 of the License Agreement), SutroVax, its Affiliates and Sublicensees shall immediately return such item to Sutro. Notwithstanding the foregoing, to the extent SutroVax or any of its Affiliates or Sublicensees is required by a Regulatory Authority (or Applicable Law) in the United States, Europe or Japan to confidentially disclose, as part of the applicable regulatory filings with respect to a Vaccine Composition, any Sutro Core Know-How (for clarity, excluding any tangible embodiments of such Sutro Core Know-How other than information and documentation), Sutro shall, upon SutroVax's written request, confidentially disclose such Sutro Core Know-How as part of the applicable regulatory filings, subject to the payment obligations set forth in Section 5.4 of the License Agreement.\"}, {\"id\": \"2.19\", \"title\": \"Express Rights\", \"level\": 2, \"text\": \"2.19 Express Rights. Except as expressly set forth in this Supply Agreement, no rights or licenses are granted to SutroVax under this Supply Agreement.\"}, {\"id\": \"2.20\", \"title\": \"Extract Requirements\", \"level\": 2, \"text\": \"2.20 Extract Requirements. SutroVax agrees to purchase all its requirements of Extract from Sutro in accordance with this Agreement, except to the extent SutroVax is allowed to purchase Extract from (a) Alternate Suppliers engaged by Sutro in accordance with Section 2.15 of this Agreement; (b) a CMO engaged or established and authorized by Sutro under Section 3.l(d) of the License Agreement; or (c) a CMO authorized by Sutro under Section 3.l(e) of the License Agreement. Manufacturing of Extracts in breach of this Section 2.20 shall be deemed a material breach of this Agreement and the License Agreement by SutroVax.\"}, {\"id\": \"ARTICLE 3\", \"title\": \"PRICING AND PAYMENT\", \"level\": 1, \"text\": \"ARTICLE 3 PRICING AND PAYMENT\"}, {\"id\": \"3.1\", \"title\": \"Invoices\", \"level\": 2, \"text\": \"3.1 Invoices. Sutro shall invoice SutroVax at the time of each shipment of Product(s) for the Price for such shipment. SutroVax will pay such invoices within [***] days of receipt of invoice (including all required documentation) by SutroVax.\"}, {\"id\": \"3.2\", \"title\": \"Prices\", \"level\": 2, \"text\": \"3.2 Prices. The Prices for the Products shall not exceed [***] of the Fully Burdened Manufacturing Costs of such Product at the time such Product is manufactured and shall be set forth in the applicable Work Order. Upon SutroVax's request from time-to-time, Sutro shall disclose to SutroVax the then- current Price for Product. The Price for the Products as of the Effective Date is set forth in Schedule 1.\"}, {\"id\": \"3.3\", \"title\": \"Recordkeeping\", \"level\": 2, \"text\": \"3.3 Recordkeeping. During the Term and for [***] years thereafter, or for such longer period as may be required by Applicable Law, Sutro shall prepare and retain, and shall cause its subcontractors to prepare and retain, accurate books and records related to transactions made pursuant to this Supply Agreement and Prices. Such records shall be made available for reasonable review, audit and inspection upon reasonable notice and with reasonable frequency, upon SutroVax's request for the purpose of verifying Sutro's calculations of amounts due hereunder, the basis for such calculations (including Sutro's calculation of the Fully Burdened Manufacturing Costs) or payments and Sutro's compliance with the terms and conditions of this Supply Agreement. Audits and inspections may be conducted by SutroVax's own personnel or retained consultant(s), subject to the confidentiality obligations set forth in this Supply Agreement.\"}, {\"id\": \"3.4\", \"title\": \"Taxes\", \"level\": 2, \"text\": \"3.4 Taxes. The Prices are exclusive of all Taxes. SutroVax will pay all taxes and duties that are assessed by any national, federal, state or local governmental authority on SutroVax's purchase or use of the Products, including, without limitation, sales, use, excise, value-added and withholding taxes, but excluding any taxes based on Sutro's income or gross receipts (collectively, \\\"Taxes\\\"). Sutro will separately identify all such Taxes on Sutro's invoice.\"}, {\"id\": \"ARTICLE 4\", \"title\": \"PRODUCT TESTING\", \"level\": 1, \"text\": \"ARTICLE 4 PRODUCT TESTING\"}, {\"id\": \"4.1\", \"title\": \"Product Testing and Inspections\", \"level\": 2, \"text\": \"4.1 Product Testing and Inspections. Each shipment of Product shall be accompanied by a certificate of analysis describing all current requirements of the Specifications and results of tests performed on such Product and a certificate of conformity certifying that the quantities of Product supplied have been Manufactured, controlled and released according to the Required Standards (\\\"COA/COC\\\") as set forth in the applicable Quality Agreement (subject to SutroVax's conduct of the SutroVax Activity Test to confirm Extract meets the SutroVax Activity Criteria). The COA/COC acceptance criteria for each Product shall be set forth in the Specification for such Product. Two of the tests and corresponding COA/COC acceptance criteria for the Extract shall be the performance of a productivity (Activity) test of the applicable Sutro protein (the \\\"Sutro Activity Test\\\" and \\\"Sutro Activity Criteria\\\") and the performance of a productivity (activity) test of the applicable Vaccine Composition (the \\\"SutroVax Activity Test\\\" and \\\"SutroVax Activity Criteria\\\"). Sutro shall perform the Sutro Activity Test to confirm that all shipments of Extract meet the Sutro Activity Criteria and SutroVax (or its designee) shall perform the SutroVax Activity Test to confirm that all shipments of Extract meet the SutroVax Activity Criteria. Sutro will also provide SutroVax with Material Safety Data Sheets (\\\"MSDS\\\") or an equivalent instrument recognized by the applicable Regulatory Authority as required for the Product(s), and updates of the same as necessary.\"}, {\"id\": \"4.2\", \"title\": \"Acceptance/Rejection of Non-Conforming Goods\", \"level\": 2, \"text\": \"4.2 Acceptance/Rejection of Non-Conforming Goods. SutroVax or its designee shall have a period of [***] calendar days from the date of delivery of the Product(s) in accordance with Section 2.6 and the COA/COCs or the equivalent instrument recognized by the applicable Regulatory Authority for such Product(s) (\\\"Acceptance Period\\\"), to inspect any shipment of Product(s) and conduct the SutroVax Activity Test to determine whether such shipment conforms to the Required Standards. If SutroVax determines that the Product(s) do not conform to the Required Standards, it hall notify Sutro within the Acceptance Period, and, if requested by Sutro, SutroVax shall ship a sample of such non-conforming Product(s) to Sutro at Sutro's expense. SutroVax's failure to notify Sutro of the non-conformity within the Acceptance Period will be deemed for purposes of this Supply Agreement to constitute SutroVax's acceptance of such shipment, provided, however, that such acceptance shall be subject to SutroVax's right to reject Product(s) until [***] days from the delivery date of the applicable Product, in each case, due to discovery by SutroVax or SutroVax's Affiliates or designees that the applicable Product does not conform to the Required Standards and such non-conformance could not reasonably be discovered within the Acceptance Period (\\\"Latent Defects\\\") provided that SutroVax gives Sutro with written notice of such Latent Defect within [***] days of SutroVax or any SutroVax Affiliate or designee becoming aware of such defect.\"}, {\"id\": \"4.3\", \"title\": \"Disputes Regarding Conformance to Required Standards\", \"level\": 2, \"text\": \"4.3 Disputes Regarding Conformance to Required Standards. If Sutro does not agree with SutroVax's determination that Product fails to conform to the Required Standards, then Sutro shall so notify SutroVax in writing within [***] days of its receipt of SutroVax's notice of non-conformity with respect to such Product and (if requested) Product sample. Sutro and SutroVax shall use reasonable efforts to resolve such disagreement as promptly as possible. Without limiting the foregoing, Sutro and SutroVax shall discuss in good faith mutually acceptable testing procedures pursuant to which both Sutro and SutroVax will re-test a sample of the disputed Product to determine whether such Product meets the Required Standards. Notwithstanding the foregoing, in the event that Sutro and SutroVax are unable to resolve such disagreement within [***] days of the date of the applicable rejection notice, either Party may submit a sample of the allegedly non-conforming Product for testing and a determination as to whether or not such Product conforms to the Required Standards to an independent testing organization, or to a consultant of recognized repute within the United States pharmaceutical industry, in either case mutually agreed upon by the Parties (such organization or consultant, the \\\"Laboratory\\\"), the appointment of which shall not be unreasonably withheld or delayed by either Party. The determination of the Laboratory with respect to all or part of any shipment of Product shall be final and binding upon the Parties. The fees and expenses of the Laboratory making such determination shall be borne by Sutro, in the event that the Laboratory determines that the Product was non-conforming and by SutroVax, in the event that the Laboratory determines that the Product did conform to the Required Standards.\"}, {\"id\": \"4.4\", \"title\": \"Return and Replacement of Non-Conforming Goods\", \"level\": 2, \"text\": \"4.4 Return and Replacement of Non-Conforming Goods. Product that is either rejected by SutroVax as not meeting the Required Standards, or that is determined by the Laboratory not to meet such Required Standards, shall, [***], be returned by SutroVax to Sutro, or destroyed pursuant to Applicable Law, at Sutro's reasonable expense. Sutro shall replace any non-conforming Product(s) within the shortest possible time. SutroVax shall have no responsibility to Sutro for the amounts invoiced for non-conforming Product(s), and shall be credited for any amounts paid, but shall pay Sutro the applicable Price for the replacement Product(s) under the terms of Section 3.1.\"}, {\"id\": \"ARTICLE 5\", \"title\": \"INSPECTION\", \"level\": 1, \"text\": \"ARTICLE 5 INSPECTION\"}, {\"id\": \"5.1\", \"title\": \"Right to Audit\", \"level\": 2, \"text\": \"5.1 Right to Audit. During the Term and the [***] period thereafter, SutroVax or a SutroVax Affiliate may, during normal working hours and upon reasonable advance notice perform site audits and inspect, or request information relating to, Sutro's or its subcontractor's Facilities and records directly or indirectly involved in the performance of this Supply Agreement or related to the Product(s). Such requests should be made in writing and Sutro will allow for such audits or inspection to occur within [***] days from request (excepting for cause audits) for Sutro's Facilities and within [***] days' from request (excepting for cause audits) for Sutro's subcontractor's facilities. Reasonable advance notice for audits for cause shall not require more than [***] advance notice. During such an inspection or request for information the inspectors may inquire about the progress of the work being carried out by Sutro or its subcontractor, and are in particular but not exclusively authorized to:\"}, {\"id\": \"5.1.1\", \"title\": \"Inspect the Facilities, documents and equipment used, or to be used, in the Manufacture of the Product(s);\", \"level\": 3, \"text\": \"5.1.1 Inspect the Facilities, documents and equipment used, or to be used, in the Manufacture of the Product(s);\"}, {\"id\": \"5.1.2\", \"title\": \"Verify the qualifications of the employees and subcontractors carrying out such work and their use of the relevant equip\", \"level\": 3, \"text\": \"5.1.2 Verify the qualifications of the employees and subcontractors carrying out such work and their use of the relevant equipment;\"}, {\"id\": \"5.1.3\", \"title\": \"Evaluate all scientific techniques used by Sutro, its subcontractors and their respective employees in the performance o\", \"level\": 3, \"text\": \"5.1.3 Evaluate all scientific techniques used by Sutro, its subcontractors and their respective employees in the performance of this Supply Agreement and the procedures used in the creation and storage of samples of the Product(s), provided that nothing in this Section 5.1.3 shall require Sutroto disclose any Sutro Core Know-How;\"}, {\"id\": \"5.1.4\", \"title\": \"Verify and evaluate information relating to the utilization of the Manufacturing capacity of Sutro's Facilities or its s\", \"level\": 3, \"text\": \"5.1.4 Verify and evaluate information relating to the utilization of the Manufacturing capacity of Sutro's Facilities or its subcontractor's Facilities;\"}, {\"id\": \"5.1.5\", \"title\": \"Review correspondence, reports, filings and other documents from Regulatory Authorities to the extent related to the Man\", \"level\": 3, \"text\": \"5.1.5 Review correspondence, reports, filings and other documents from Regulatory Authorities to the extent related to the Manufacturing activities hereunder;\"}, {\"id\": \"5.1.6\", \"title\": \"Evaluate the implementation of all Manufacturing and process changes made with respect to the Product, including pursuan\", \"level\": 3, \"text\": \"5.1.6 Evaluate the implementation of all Manufacturing and process changes made with respect to the Product, including pursuant to any corrective action plan; and\"}, {\"id\": \"5.1.7\", \"title\": \"Ascertain compliance with Applicable Laws, the Specifications and this Supply Agreement\", \"level\": 3, \"text\": \"5.1.7 Ascertain compliance with Applicable Laws, the Specifications and this Supply Agreement.\"}, {\"id\": \"5.2\", \"title\": \"Access\", \"level\": 2, \"text\": \"5.2 Access. Sutro shall provide SutroVax's and its Affiliate's and Sublicensee's inspectors with access to its Facilities, and information related to such Facilities, in order that the inspectors may carry out the inspections or inquiries referred to in the provisions of this Article 5. For the avoidance of doubt, neither SutroVax nor any of its Affiliates or Sublicensees (or their respective inspectors) shall have the right to observe the Manufacture of the Extract or be present at Sutro and its subcontractors' Facilities at such times when Extract is being Manufactured. Sutro shall use Commercially Reasonable Efforts to obtain from its subcontractors commitments similar to those contemplated in this Section 5.2. Audits and inspections may be conducted by SutroVax's own personnel or retained consultant(s), subject to the confidentiality obligations set forth in this Supply Agreement.\"}, {\"id\": \"5.3\", \"title\": \"Sutro Audits\", \"level\": 2, \"text\": \"5.3 Sutro Audits. Without limiting the foregoing; Sutro is responsible for auditing the facilities of the suppliers of Components, if any, periodically, and Sutro agrees to provide SutroVax, upon SutroVax's request with a current copy of the audit report of such facilities and to incorporate SutroVax's comments with respect to any corrective action plan related to the Product.\"}, {\"id\": \"ARTICLE 6\", \"title\": \"REGULATORY AND QUALITY RESPONSIBILITIES\", \"level\": 1, \"text\": \"ARTICLE 6 REGULATORY AND QUALITY RESPONSIBILITIES\"}, {\"id\": \"6.1\", \"title\": \"Regulatory Responsibilities\", \"level\": 2, \"text\": \"6.1 Regulatory Responsibilities. Sutro shall obtain and maintain any and all regulatory and governmental permits, licenses and approvals that are necessary for Sutro to Manufacture the Product(s) for SutroVax or its Affiliates in accordance with the terms of this Supply Agreement and Applicable Law. As between the Parties, SutroVax shall have the sole responsibility for all Regulatory Approvals of the Vaccine Compositions.\"}, {\"id\": \"6.2\", \"title\": \"Right of Reference; Drug Master Files\", \"level\": 2, \"text\": \"6.2 Right of Reference; Drug Master Files. Sutro shall (a) file Drug Master File(s) for the Products with the FDA as requested by SutroVax, and with Regulatory Authorities in the European Union (including the United Kingdom) and Japan in accordance with timelines to be mutually agreed upon (such agreement not to be unreasonably withheld by either Party) (provided at SutroVax's request, Sutro shall do so within [***] of SutroVax's request using Regulatory Filings that comprise versions of the DMF(s) filed with the FDA that have been reformatted to comply with EU and Japanese requirements), and (b) provide the appropriate authorizations to such Regulatory Authority(ies) allowing the Regulatory Authority the right to review and SutroVax or its designee to reference such Drug Master File(s) in support of (and other Regulatory Materials, to the extent necessary to support) an application for Regulatory Approval submitted by SutroVax (or its permitted designee) for any Vaccine Composition produced using the Product the subject of the applicable Drug Master File (it being understood that SutroVax, its Affiliates\u00b7 and Sublicensees shall not have access to the information contained in such Drug Master Files (or other confidential Regulatory Materials submitted for a similar purpose as a Drug Master File (e.g., a clinical trial application for such purpose in the European Union)) as a result of such authorization and right to reference). Sutro shall file such Drug Master File in coordination with SutroVax's efforts to file and prosecute the applicable regulatory filings to such Regulatory Authority and Sutro shall be responsible, at SutroVax's sole expense (subject to a budget reasonably approved in advance by SutroVax), for providing the applicable Regulatory Authorities with such additional data as they may request (which may in some cases require Sutro to conduct additional studies), and for correcting any deficiencies of such Drug Master File identified by such Regulatory Authority, in each case in a reasonably prompt and efficient manner so as to prevent any delay in obtaining Regulatory Approvals for any Vaccine Composition based on such Drug Master File. In addition, Sutro shall be responsible for maintaining such Drug Master File in accordance with applicable Laws as necessary to support filing and prosecuting the applicable regulatory filing(s) and obtaining and maintaining the applicable Regulatory Approval(s) for Vaccine Compositions produced using the Products. For further clarity, to the extent Sutro discloses. Sutro Know- How to SutroVax, SutroVax shall have the right to include (and authorize the inclusion of) such Sutro Know-How in Regulatory Materials to the extent it is necessary or useful for the purpose of obtaining Regulatory Approval of a Vaccine Composition. Sutro's obligations under this Section 6.2 shall [***]. Sutro shall cause its personnel to record time spent performing such activities to a job code specific to such activities. For purposes of this Article 6 \\\"Drug Master File\\\" or \\\"DMF\\\" means a submission to a Regulatory Authority of information concerning the chemistry, manufacturing and controls (\\\"CMC\\\") of the Products to permit such Regulatory Authority to review this information in support of any application for Regulatory Approval for a product submitted by a party that has been granted a right to reference such submission without disclosing the contents of such submission to such party. Sutro shall file DMF(s) for the Products with other Regulatory Authorities in the Territory in accordance with the terms and conditions of the Phase 3/Commercial Supply Agreement referenced in Section 2.14 (and, for clarity, shall file DMF(s) for the Products with Regulatory Authorities in the European Union (including the United Kingdom) and Japan as necessary to comply with the requirements of such Regulatory Authorities, to the extent not filed under this Supply Agreement).\"}, {\"id\": \"6.2.1\", \"title\": \"Compliance\", \"level\": 3, \"text\": \"6.2.1 Compliance. Subject to the foregoing, Sutro shall provide the information set forth under this Section 6.2 in a timely manner and compliant with the reporting requirements of the Regulatory Authorities.\"}, {\"id\": \"6.2.2\", \"title\": \"Safety Data\", \"level\": 3, \"text\": \"6.2.2 Safety Data. Each Party understands and acknowledges that the other Party and its Affiliates and respective licensees or sublicensees may need to access and utilize and include certain safety data (e.g., adverse event reports) pertaining to product made using Products that is generated or received by such Party and its Affiliates and respective licensees or sublicensees in its Regulatory Materials in its respective Territory as required by applicable Laws. Each Party shall have the right to share any and all such safety data generated by the other Party or the other Party's Affiliates or licensees or sublicensees with its Affiliates and Third Parties (including its licensees and sublicensees) as permitted under section 10.2 of the License Agreement.\"}, {\"id\": \"6.2.3\", \"title\": \"Cooperation\", \"level\": 3, \"text\": \"6.2.3 Cooperation. Each Party agrees to (i) make its personnel reasonably available at their respective places of employment to consult with the other Party on issues related to the activities conducted in accordance with this Article 6 or otherwise relating to the development of the Products or Vaccine Compositions and thereafter in connection with any request from any Regulatory Authority, including with respect to regulatory, scientific, technical and clinical testing issues, or otherwise, throughout the Term, and (ii) otherwise provide such assistance as may be reasonably requested by the other from time-to-time in connection with the activities to be conducted under this Article 6 or otherwise relating to the development of the Vaccine Compositions or Products.\"}, {\"id\": \"6.3\", \"title\": \"Recalls\", \"level\": 2, \"text\": \"6.3 Recalls. Each of SutroVax and Sutro will immediately inform the other in writing if it believes one or more lots of any Product(s), or any products made by Sutro or its licensees using the Products (to the extent such products are made using Products from the same batch provided to SutroVax), or any Vaccine Compositions should be subject to recall from distribution, withdrawal or some other field action, or that potential adulteration, misbranding, and/or other issues have arisen that relate to the safety or efficacy of such Product. SutroVax shall have the final decision-making authority as to any such recall or field action and the sole right to initiate any such recall or field action with respect to Vaccine Compositions made using the Products. Sutro shall cooperate in the conduct of any recall or field action with respect to the Vaccine Compositions as reasonably requested by SutroVax. In the event it is determined that such a recall resulted from a breach by either Party of any of its representations, warranties, duties or obligations under this Supply Agreement, such Party shall be responsible for the costs of the recall and shall reimburse the other Party as necessary; provided that if both Parties share responsibility with respect to such recall, the costs shall be shared in the ratio of the Parties' contributory responsibility.\"}, {\"id\": \"6.4\", \"title\": \"Retention of Samples\", \"level\": 2, \"text\": \"6.4 Retention of Samples. Sutro shall prepare and retain, and shall cause its subcontractors to prepare and retain, such samples and records in respect of the Product(s) and the Manufacture thereof as are required by Applicable Law (including, as applicable, cGMPs).\"}, {\"id\": \"6.5\", \"title\": \"Regulatory Authority Inspections and Correspondence\", \"level\": 2, \"text\": \"6.5 Regulatory Authority Inspections and Correspondence. Sutro shall permit Regulatory Authorities to conduct such inspections of any Facility at which any of the Manufacturing activities relating to the Product(s) are performed, as such Regulatory Authorities may request, including pre-approval inspections,\u00b7 and shall cooperate with such Regulatory Authorities with respect to such inspections and any related matters, in each case that is related to the Manufacture of Product(s). Sutro shall give SutroVax or its Affiliates prior written notice of any such inspections, and shall keep SutroVax informed about the results and conclusions of each such regulatory inspection, including actions taken by Sutro to remedy conditions cited in such inspections. Sutro shall provide SutroVax with copies of any written inspection reports issued by anyRegulatory Authority and all correspondence between Sutro and any Regulatory Authority with respect thereto, including any notices of observation and all related correspondence, in each case relating to the Product(s) or its Manufacture or to general manufacturing concerns (e.g., facility compliance or the like) that are reasonably likely to impact the Product(s) to the extent such general manufacturing matters would be reasonably expected to have a material effect on the manufacture of Vaccine Compositions; provided that Sutro may redact from any such report and correspondence any Sutro Core Know-How and any information subject to an obligation of confidentiality to a Third Party. In addition, Sutro agrees to promptly notify and provide SutroVax copies of any material request, directive, or other written communication to or from Regulatory Authorities related to the Product or its Manufacture that would reasonably be expected to have a material effect on the manufacture of Vaccine Compositions (it being understood that SutroVax, its Affiliates and Sublicensees shall not have access to Sutro Core Know How (which Sutro may redact from such reports or correspondence provided to SutroVax) or Sutro's Drug Master Files or other confidential Regulatory Materials submitted for a similar purpose as a Drug Master File). Sutro shall provide SutroVax with a copy of the applicable portion of any correspondence made by Sutro to a Regulatory Authority for review and comment prior to submission to the applicable Regulatory Authority solely to the extent such correspondence made by Sutro is related to SutroVax or is in response to a request, directive or correspondence from the applicable Regulatory Authority regarding SutroVax or a Vaccine Composition (e.g., in response to a report regarding a pre- approval inspection for SutroVax). Sutro will consider in good faith any comments received from SutroVax within the time period indicated by Sutro (which shall not be less than [***], to the extent consistent with the require timeline for Sutro's response) with respect to any matter that relates to SutroVax. In addition, Sutro shall notify SutroVax of any occurrences or information that arise out of Sutro's Manufacturing activities that have, or could reasonably be expected to have, adverse regulatory compliance or reporting consequences concerning any Product(s) or which might otherwise be reasonably expected to adversely affect the supply by Sutro of Product(s) to SutroVax.\"}, {\"id\": \"6.6\", \"title\": \"Changes or Modifications in Manufacturing Activities\", \"level\": 2, \"text\": \"6.6 Changes or Modifications in Manufacturing Activities. Sutro shall not make any changes to the Specifications, processes, Facilities, raw materials, raw material suppliers or any other item that would affect the Manufacturing activities related to the Product (a \\\"Manufacturing Change\\\") that (a) would require a change to the applicable Drug Master File, (b) would be reasonably expected to cause SutroVax to be materially delayed obtaining any Regulatory Approval with respect to Vaccine Compositions or (c) causes the Product to not meet the Specification therefor (including the Activity Test with respect to Extract); without SutroVax's prior written consent (not to be unreasonably withheld, conditioned or delated). Notwithstanding the foregoing, Sutro shall promptly make and implement such changes as are required by Applicable Law provided that, prior to implementation, Sutro shall provide notice thereof to SutroVax and confer with SutroVax with respect to its timelines, estimated effect on Price and other issues regarding such implementation. Sutro shall provide SutroVax at least [***] days' written notice prior to implementing any Manufacturing Change. Sutro shall not make any change to the Specification for a Product without SutroVax's prior written consent. In addition, SutroVax shall have the right to request changes in or modifications to the Specifications and Sutro will consider in good faith any such requested changes or modifications. All such changes or modifications shall be documented in writing and shall be signed by an authorized representative of SutroVax and Sutro. If such changes or modifications result in a material change in Sutro's Manufacturing costs or lead times, the Parties shall agree upon an appropriate adjustment to the Price or in the delivery schedules, as the case may be, for Product(s) to be provided by Sutro hereunder. Sutro shall promptly implement any agreed upon changes to the Specifications.\"}, {\"id\": \"6.7\", \"title\": \"Quality Agreement\", \"level\": 2, \"text\": \"6.7 Quality Agreement. As soon as reasonably practicable after the Effective Date, the Parties shall enter into a quality agreement governing Sutro's supply of Products (the \\\"Quality Agreement\\\"), which Quality Agreement shall include the Specifications for the Product(s) consistent with the Specifications set forth in Schedule 2. Accordingly, to permit the Quality Agreement to be finalized within such period, Sutro shall provide SutroVax or its designee access to Sutro's Facilities and records to enable SutroVax or its designee to complete an audit pursuant to Section 5.1 within [***] days after the Effective Date.\"}, {\"id\": \"ARTICLE 7\", \"title\": \"REPRESENTATION AND WARRANTIES\", \"level\": 1, \"text\": \"ARTICLE 7 REPRESENTATION AND WARRANTIES\"}, {\"id\": \"7.1\", \"title\": \"SutroVax Warranties and Representations\", \"level\": 2, \"text\": \"7.1 SutroVax Warranties and Representations. SutroVax represents and warrants the following:\"}, {\"id\": \"7.1.1\", \"title\": \"SutroVax is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware\", \"level\": 3, \"text\": \"7.1.1 SutroVax is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.\"}, {\"id\": \"7.1.2\", \"title\": \"SutroVax has all requisite power and authority to enter into this Supply Agreement\", \"level\": 3, \"text\": \"7.1.2 SutroVax has all requisite power and authority to enter into this Supply Agreement. The person signing this Supply Agreement has the necessary corporate authority to legally bind SutroVax to the terms set forth herein.\"}, {\"id\": \"7.1.3\", \"title\": \"SutroVax's execution of this Supply Agreement and performance of the terms set forth herein will not cause SutroVax to b\", \"level\": 3, \"text\": \"7.1.3 SutroVax's execution of this Supply Agreement and performance of the terms set forth herein will not cause SutroVax to be in conflict with or constitute a breach of its organizational documents nor any other agreement, court order, consent decree or other arrangement, whether written or oral, by which it is bound.\"}, {\"id\": \"7.1.4\", \"title\": \"SutroVax's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Appl\", \"level\": 3, \"text\": \"7.1.4 SutroVax's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Applicable Law in all material respects.\"}, {\"id\": \"7.1.5\", \"title\": \"This Supply Agreement is its legal, valid and binding obligation, enforceable against SutroVax in accordance with the te\", \"level\": 3, \"text\": \"7.1.5 This Supply Agreement is its legal, valid and binding obligation, enforceable against SutroVax in accordance with the terms and conditions hereof, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally or by the principles governing the availability of equitable remedies.\"}, {\"id\": \"7.2\", \"title\": \"Sutro Warranties and Representations\", \"level\": 2, \"text\": \"7.2 Sutro Warranties and Representations. Sutro represents and warrants the following:\"}, {\"id\": \"7.2.1\", \"title\": \"Sutro is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware\", \"level\": 3, \"text\": \"7.2.1 Sutro is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.\"}, {\"id\": \"7.2.2\", \"title\": \"Sutro has all requisite power and authority to enter into this Supply Agreement and has the requisite skill, knowledge,\", \"level\": 3, \"text\": \"7.2.2 Sutro has all requisite power and authority to enter into this Supply Agreement and has the requisite skill, knowledge, staffing, financial resources, capacity and ability to carry out its obligations hereunder. The person signing this Supply Agreement has the necessary authority to legally bind Sutro to the terms set forth herein.\"}, {\"id\": \"7.2.3\", \"title\": \"Sutro's execution of this Supply Agreement and performance of the terms set forth herein will not cause Sutro to be in c\", \"level\": 3, \"text\": \"7.2.3 Sutro's execution of this Supply Agreement and performance of the terms set forth herein will not cause Sutro to be in conflict with or constitute a breach of its organizational documents nor any other agreement, court order, consent decree or other arrangement, whether written or oral, by which it is bound.\"}, {\"id\": \"7.2.4\", \"title\": \"Sutro's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Applica\", \"level\": 3, \"text\": \"7.2.4 Sutro's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Applicable Law in all material respects.\"}, {\"id\": \"7.2.5\", \"title\": \"Sutro has and will maintain throughout the Term all permits, licenses, registrations and other forms of governmental aut\", \"level\": 3, \"text\": \"7.2.5 Sutro has and will maintain throughout the Term all permits, licenses, registrations and other forms of governmental authorization. and approval as required by Applicable Law in order for Sutro to execute and deliver this Supply Agreement and to perform its obligations hereunder in accordance with all Applicable Law.\"}, {\"id\": \"7.2.6\", \"title\": \"as of the Effective Date, to the best of Sutro's knowledge, the practice of the Sutro Platform, including the use of the\", \"level\": 3, \"text\": \"7.2.6 as of the Effective Date, to the best of Sutro's knowledge, the practice of the Sutro Platform, including the use of the Products, does not infringe any Third Party patents.\"}, {\"id\": \"7.2\", \"title\": \"7 7\", \"level\": 2, \"text\": \"7.2.7 7.2.7 Sutro is not debarred and Sutro has not and will not use in any capacity the services of any person debarred under subsection 306(a) or (b) of the U.S. Generic Drug Enforcement Act of 1992, or other Applicable Law, nor have debarment proceedings against Sutro or any of its employees or permitted subcontractors been commenced.\"}, {\"id\": \"7.2.8\", \"title\": \"This Supply Agreement is its legal, valid and binding obligation, enforceable against Sutro in accordance with the terms\", \"level\": 3, \"text\": \"7.2.8 This Supply Agreement is its legal, valid and binding obligation, enforceable against Sutro in accordance with the terms and conditions hereof, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally or by the principles governing the availability of equitable remedies.\"}, {\"id\": \"7.2.9\", \"title\": \"As of the Effective Date, there are no claims, judgments or settlements against or owed by Sutro or its Affiliates, or p\", \"level\": 3, \"text\": \"7.2.9 As of the Effective Date, there are no claims, judgments or settlements against or owed by Sutro or its Affiliates, or pending or, to the best of Sutro's knowledge, threatened claims or litigation, relating to the Product(s).\"}, {\"id\": \"7.3\", \"title\": \"Product Warranties\", \"level\": 2, \"text\": \"7.3 Product Warranties. Sutro represents and warrants that:\"}, {\"id\": \"7.3.1\", \"title\": \"Sutro's Facility and all Product (as delivered in accordance with Section 2\", \"level\": 3, \"text\": \"7.3.1 Sutro's Facility and all Product (as delivered in accordance with Section 2.1 and until the expiration date thereof) supplied hereunder (and the Manufacture thereof) shall comply with this Supply Agreement, all Applicable Law (including cGMPs, if applicable),\u00b7be free from defects in material and workmanship, and meet all Specifications.\"}, {\"id\": \"7.3.2\", \"title\": \"Title to all Product(s) provided under this Supply Agreement shall pass to SutroVax as set forth in Section 2\", \"level\": 3, \"text\": \"7.3.2 Title to all Product(s) provided under this Supply Agreement shall pass to SutroVax as set forth in Section 2.6, free and clear of any security interest, lien, or other encumbrance.\"}, {\"id\": \"7.4\", \"title\": \"Disclaimer\", \"level\": 2, \"text\": \"7.4 Disclaimer. EACH PARTY AGREES AND ACKNOWLEDGES THAT, EXCEPT AS SET FORTH IN THIS ARTICLE 7, NEITHER PARTY MAKES ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND WHATSOEVER, IMPLIED OR STATUTORY, AND EACH PARTY HEREBY EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, IMPLIED OR STATUTORY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AGAINST NON-INFRINGEMENT OR THE LIKE, OR ARISING FROM COURSE OF PERFORMANCE.\"}, {\"id\": \"ARTICLE 8\", \"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"ARTICLE 8 CONFIDENTIALITY\"}, {\"id\": \"8.1\", \"title\": \"Article 10 of the License Agreement (Confidentiality) is hereby incorporated into this Supply Agreement by reference\", \"level\": 2, \"text\": \"8.1 Article 10 of the License Agreement (Confidentiality) is hereby incorporated into this Supply Agreement by reference. The terms and provisions of this Supply Agreement (which shall be the Discloser's Information of both Parties) and all other information and data, including all notes, books, papers, diagrams, documents, reports, e-mail, memoranda, visual observations, oral communications and all other data or information in whatever form, that one Party or any of its Affiliates or representatives supplies or otherwise makes available to the other Party or its Affiliates or representatives pursuant to this Supply Agreement shall be deemed Discloser's Information pursuant to Article 10 of the License Agreement.\"}, {\"id\": \"ARTICLE 9\", \"title\": \"INDEMNIFICATION AND INSURANCE\", \"level\": 1, \"text\": \"ARTICLE 9 INDEMNIFICATION AND INSURANCE\"}, {\"id\": \"9.1\", \"title\": \"Indemnification\", \"level\": 2, \"text\": \"9.1 Indemnification.\"}, {\"id\": \"9.1.1\", \"title\": \"Indemnification by Sutro\", \"level\": 3, \"text\": \"9.1.1 Indemnification by Sutro. Sutro hereby agrees, at its sole cost and expense, to defend, hold harmless and indemnify, to the extent permitted by Applicable Law, (collectively, \\\"Indemnify\\\") SutroVax and its Affiliates and their respective agents, directors, officers and employees of such Persons and the respective successors and assigns of any of the foregoing (the \\\"SutroVax Indemnitees\\\") from and against any and all liabilities, damages, penalties, fines, costs and expenses (including, reasonable attorneys' fees and other expenses of litigation) (collectively, \\\"Liabilities\\\") resulting from suits, claims, actions and demands, in each case brought by a Third Party (each, a \\\"Third-Party Claim\\\") against any SutroVax Indemnitee and arising from or occurring as a result of: [***]. Sutro's obligation to Indemnify the SutroVax Indemnitees pursuant to this Section 9.1.1 shall not apply to the extent that any such Liabilities are the result of a material breach by SutroVax of its obligations, representations, warranties or covenants under this Supply Agreement or the License Agreement or any SutroVax Indemnitee' s negligence or willful misconduct.\"}, {\"id\": \"9.1.2\", \"title\": \"Indemnification by SutroVax\", \"level\": 3, \"text\": \"9.1.2 Indemnification by SutroVax. SutroVax hereby agrees to Indemnify Sutro and its agents, directors, officers and employees and the respective successors and assigns of any of the foregoing (the \\\"Sutro lndemnitees\\\") from and against any and all Liabilities resulting from Third-Party Claims against any Sutro Indemnitee arising from or occurring as a result of: [***]. SutroVax's obligation to Indemnify the Sutro Indemnitees pursuant to this Section 9.1.2 shall not apply to the extent that any such Liabilities are the result of a material breach by Sutro of its obligations, representations, warranties or covenants under this Supply Agreement or the License Agreement or any Sutro Indemnitee's negligence or willful misconduct.\"}, {\"id\": \"9.1.3\", \"title\": \"Procedure\", \"level\": 3, \"text\": \"9.1.3 Procedure. To be eligible to be Indemnified hereunder, the indemnified Person shall provide the indemnifying Party with prompt written notice of the Third-Party Claim giving rise to the indemnification obligation pursuant to this Section 9.1 and the right to control the defense (with the reasonable cooperation of the indemnified Person) or settlement any such claim; provided, however, that the indemnifying Party shall not enter into any settlement that admits fault, wrongdoing or damages without the indemnified Person's written consent, such consent not to be unreasonably withheld or delayed. The indemnified Person shall have the right to join, but not to control, at its own expense and with counsel of its choice, the defense of any claim or suit that has been assumed by the indemnifying Party.\"}, {\"id\": \"9.2\", \"title\": \"Insurance\", \"level\": 2, \"text\": \"9.2 Insurance. Each Party shall procure and maintain insurance, including clinical trials and product liability insurance, adequate to cover its obligations hereunder and consistent with normal business practices of prudent companies similarly situated at all times during which any Product or Vaccine Compositions is being clinically tested in human subjects or commercially distributed or sold by such Party. It is understood that such insurance shall not be construed to create a limit of either Party's liability or indemnification obligations under this Article 9, or that the maintenance of such insurance shall not be construed to relieve either Party of its other obligations under this Supply Agreement. Each Party shall provide the other with written evidence of such insurance upon request. Each Party shall provide the other with written notice at least [***] days prior to the cancellation, non renewal or material change in such insurance.\"}, {\"id\": \"9.3\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"9.3 LIMITATION OF LIABILITY. EXCEPT (I) WITH RESPECT TO ANY BREACH OF ARTICLE 8 (CONFIDENTIALITY), (II) FOR THIRD PARTY PENALTIES, COSTS AND EXPENSES AS SET FORTH IN SECTION 2.9, OR (III) FOR [***], TO THE MAXIMUM EXTENT PERMITTED BY LAW, (A) NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, WHETHER LIABILITY IS ASSERTED IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER THEORY OR FORM OF ACTION, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY THEREOF; AND (B) EACH PARTY'S TOTAL LIABILITY TO THE OTHER PARTY UNDER THIS SUPPLY AGREEMENT SHALL NOT EXCEED [***]. SUTRO'S LIABITY TO SUTROVAX FOR THIRD PARTY PENALTIES, COSTS AND EXPENSES UNDER SECTION 2.9 SHALL NOT EXCEED [***].\"}, {\"id\": \"ARTICLE 10\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 10 TERM AND TERMINATION\"}, {\"id\": \"10.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"10.1 Term. The term of this Supply Agreement shall begin on the Effective Date first set forth above and shall remain in effect until the later of (a) July 31, 2021 or (b) the date that the Parties enter into the Phase 3/Commercial Supply Agreement and Sutro is supplying to SutroVax each Product under the Phase 3/Commercial Supply Agreement (the \\\"Term\\\"), unless it is terminated earlier in accordance with Section 10.2.\"}, {\"id\": \"10.2\", \"title\": \"Termination\", \"level\": 2, \"text\": \"10.2 Termination. Notwithstanding anything to the contrary in this Supply Agreement, this Supply Agreement may be terminated:\"}, {\"id\": \"10.2.1\", \"title\": \"in its entirety or with respect to one or more Products, on a Product-by-Product basis, by mutual written consent of Sut\", \"level\": 3, \"text\": \"10.2.1 in its entirety or with respect to one or more Products, on a Product-by-Product basis, by mutual written consent of Sutro and SutroVax;\"}, {\"id\": \"10.2.2\", \"title\": \"in its entirety by a Party if the other Party materially breaches any of the material terms, conditions or agreements co\", \"level\": 3, \"text\": \"10.2.2 in its entirety by a Party if the other Party materially breaches any of the material terms, conditions or agreements contained in this Supply Agreement to be kept, observed or performed by the other Party, by giving the Party who committed the breach [***] days' prior written notice, unless the notified Party shall have cured the breach within such [***]-day period; and\"}, {\"id\": \"10.2.3\", \"title\": \"in its entirety or with respect to one or more Products, on a Product-by-Product basis, by SutroVax upon [***] days' pri\", \"level\": 3, \"text\": \"10.2.3 in its entirety or with respect to one or more Products, on a Product-by-Product basis, by SutroVax upon [***] days' prior written notice to Sutro for any reason.\"}, {\"id\": \"10.3\", \"title\": \"Effects of Termination\", \"level\": 2, \"text\": \"10.3 Effects of Termination. Upon the expiration of the Term or termination of this Supply Agreement, in its entirety or with respect to one or more Products, this Supply Agreement shall, except as otherwise provided in this Section 10.3 or Section 10.5, be of no further force or effect; provided, however, that (a) in the event this Supply Agreement is terminated by SutroVax pursuant to Section 10.2.3 and there are outstanding Work Orders or other purchase orders accepted by Sutro that would not be fulfilled as a result of such termination, SutroVax shall reimburse Sutro for all supplies and materials purchased by Sutro and time incurred by Sutro personnel (to the extent incurred solely for manufacture of Product for SutroVax) for the manufacture, or preparation for the manufacture, of Products for any Work Orders placed by SutroVax and any other purchase orders accepted by Sutro prior to such expiration or termination, in each case to the extent Sutro cannot otherwise reasonably mitigate such the costs and expenses of such supplies, materials and time (e.g., by use of resulting supplies, materials and work-in-progress Product for other purposes); provided that to the extent SutroVax pays for any supplies or materials, upon SutroVax's request Sutro shall promptly transfer and deliver such supplies and materials to SutroVax; and (b) if this Supply Agreement is terminated with respect to one or more Products, but not all Products, then this Supply Agreement shall continue in full force and effect with respect to the applicable Product(s) for which it is not terminated.\"}, {\"id\": \"10.4\", \"title\": \"Nonexclusive Remedy\", \"level\": 2, \"text\": \"10.4 Nonexclusive Remedy. Exercise of any right of termination afforded to either Party under this Supply Agreement (i) shall not prejudice any other legal rights or remedies either Party have against the other in respect of any breach of the terms and conditions of this Supply Agreement, and (ii) shall be without any obligation or liability arising from such termination other than such obligations expressly arising from termination of this Supply Agreement.\"}, {\"id\": \"ARTICLE 11\", \"title\": \"DISPUTE RESOLUTION\", \"level\": 1, \"text\": \"ARTICLE 11 DISPUTE RESOLUTION\"}, {\"id\": \"11.1\", \"title\": \"Principal Contacts\", \"level\": 2, \"text\": \"11.1 Principal Contacts. Each Party will appoint an individual employed by it to serve as its \\\"Principal Contact\\\" for purposes of this Supply Agreement. Either Party may from time to time replace its Principal Contact with a different employee, but unless required due to events beyond its control, neither Party will replace its Principal Contact without at least [***] days prior notice to the other Party. The two Principal Contacts shall communicate with each other regularly during the Term as the Parties may agree or as the Principal Contacts shall mutually determine to be useful.\"}, {\"id\": \"11.4\", \"title\": \"Baseball Arbitration\", \"level\": 2, \"text\": \"11.4 Baseball Arbitration. In the event (a) the Parties do not enter into a Phase 3/Commercial Supply Agreement as described in Section 2.14 or (b) the Parties do not enter into a Transfer Addendum as described in Section 2.15 (\\\"Disputed Matter\\\"), then upon either Party's request with respect to the Disputed Matter in clause (a) or SutroVax's request with respect to the Disputed Matter in clause (b), such Disputed Matter shall be resolved by binding arbitration conducted pursuant to Section 11.3, except that the procedures for the conduct of such arbitration shall be as follows:\"}, {\"id\": \"11.4.1\", \"title\": \"Each Party shall provide the arbitrator and the other Party with a written report setting forth its position with respec\", \"level\": 3, \"text\": \"11.4.1 Each Party shall provide the arbitrator and the other Party with a written report setting forth its position with respect to the substance of such Disputed Matter and a full draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, and may submit a revised report, position and draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, to the arbitrator within [***] days of receiving the other Party's report and draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable. If so requested by the arbitrator, each Party shall make oral and/or other written submissions to the arbitrator in accordance with procedures to be established by the arbitrator; provided that other Party shall have the right to be present during any oral submissions. The arbitrator shall select one of the Party's draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, as his or her decision, based on what is most reasonable and equitable to each of the Parties under the circumstances and reflective of reasonable and customary terms in the biopharmaceutical industry for agreements of this type and most closely reflects the Parties' intent as expressed in this Supply Agreement and the License Agreement, and shall not have the authority to render any substantive decision other than to so select the draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, of Sutro or SutroVax (as initially submitted, or as revised in accordance with the foregoing, as applicable). For clarity, it is understood that the Parties intend the arbitration under this Section 11.4 to be a \\\"baseball arbitration\\\" type proceeding; and the arbitrator may fashion such detailed procedures as the arbitrator considers appropriate to implement this intent. Notwithstanding anything to the contrary, in no event shall the Phase 3/Commercial Supply Agreement or Transfer Addendum contain any provision granting to SutroVax or its Affiliates or Sublicensees any right to obtain or use any Sutro Core Know-How.\"}, {\"id\": \"11.4.2\", \"title\": \"In any arbitration under this Section 11\", \"level\": 3, \"text\": \"11.4.2 In any arbitration under this Section 11.4, the arbitrator and the Parties shall use their best efforts to resolve such Disputed Matter within [***] days after the selection of the arbitrator, or as soon thereafter as is practicable.\"}, {\"id\": \"ARTICLE 12\", \"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"ARTICLE 12 MISCELLANEOUS\"}, {\"id\": \"12.1\", \"title\": \"Expenses\", \"level\": 2, \"text\": \"12.1 Expenses. Except as otherwise expressly provided herein, each Party shall bear its own costs, fees and expenses incurred by such Party in connection with this Supply Agreement.\"}, {\"id\": \"12.2\", \"title\": \"Licenses and Permits\", \"level\": 2, \"text\": \"12.2 Licenses and Permits. Each Party shall, at its sole cost and expense, maintain in full force and affect all necessary licenses, permits, and other authorizations required by Applicable Law in order to carry out its duties and obligations hereunder.\"}, {\"id\": \"12.3\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"12.3 Force Majeure. No Party shall be liable for a failure or delay in performing any of its obligations under this Supply Agreement if, but only to the extent that such failure or delay is due to causes beyond the reasonable control of the affected Party, including: (a) acts of God; (b) fire, explosion, or unusually severe weather; (c) war, invasion, riot, terrorism, or other civil unrest; (d) governmental laws, orders, restrictions, actions, embargo or blockages; (e) national or regional emergency; (f) strikes or industrial disputes at a national level which directly impact the affected Party's performance under this Supply Agreement; or (g) other similar cause outside of the reasonable control of such Party (\\\"Force Majeure\\\"); provided that the Party affected shall promptly notify the other of the Force Majeure condition and shall use reasonable efforts to eliminate, cure or overcome any such causes and resume performance of its obligations as soon as possible. If the performance of any obligation of a Party under this Supply Agreement is delayed owing to such a Force Majeure for any continuous period of more than [***] days, the other Party shall have the right to terminate this Supply Agreement.\"}, {\"id\": \"12.4\", \"title\": \"Neither Party may assign or transfer this Supply Agreement, including by merger, operation of law, or otherwise, without\", \"level\": 2, \"text\": \"12.4 Neither Party may assign or transfer this Supply Agreement, including by merger, operation of law, or otherwise, without the other Party's prior written consent (which shall not be withheld unreasonably) except each Party may assign this Supply Agreement without the other Party's consent in the case of assignment or transfer to a Third Party that succeeds to all or substantially all of the assigning Party's business and assets relating to the subject matter of this Supply Agreement, whether by sale, merger, operation of law or otherwise. Any attempted assignment by a Party in violation of this Section without the written consent of the other Party will be null and void. Except as above limited, this Supply Agreement is binding upon and will inure to the benefit of each of the Parties, its successors and assigns. Without limiting the foregoing, in the event that a Party is acquired, the acquiring Party shall agree in writing to abide by the terms of this Supply Agreement. Sutro agrees that if it assigns the License Agreement to any successor as allowed under section 15.1 of the License Agreement, it will also assign to such successor this Supply Agreement in accordance with this Section 12.4.\"}, {\"id\": \"12.5\", \"title\": \"This Supply Agreement incorporates the Exhibits referenced herein\", \"level\": 2, \"text\": \"12.5 This Supply Agreement incorporates the Exhibits referenced herein. This Supply Agreement, together with the License Agreement, constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, between the Parties hereto with respect to its subject matter. To the extent of any conflict between this Agreement and the License Agreement, the License Agreement shall govern and control.\"}, {\"id\": \"12.6\", \"title\": \"All notices, requests or other communication provided for or permitted hereunder shall be given in writing and shall be\", \"level\": 2, \"text\": \"12.6 All notices, requests or other communication provided for or permitted hereunder shall be given in writing and shall be hand delivered or sent by confirmed facsimile, reputable courier or by registered or certified mail, postage prepaid, return receipt requested, to the address set forth below, or to such other address of which either Party may inform the other in writing. Notices will be deemed delivered on the earliest of transmission by facsimile, actual receipt or [***] days after mailing as described herein. If to Sutro: Sutro Biopharma, Inc. 310 Utah Ave., Suite 150 South San Francisco, CA 94080 Attention: Chief Executive Officer If to SutroVax: SutroVax, Inc. 353 Hatch Dr. Foster City, CA 94404 Attention: Chief Executive Officer\"}, {\"id\": \"12.7\", \"title\": \"This Supply Agreement may be amended, modified or waived only in a writing signed by the Party or Parties to be bound th\", \"level\": 2, \"text\": \"12.7 This Supply Agreement may be amended, modified or waived only in a writing signed by the Party or Parties to be bound thereby.\"}, {\"id\": \"12.8\", \"title\": \"If any provision of this Supply Agreement shall be held invalid, illegal or unenforceable, such provision shall be enfor\", \"level\": 2, \"text\": \"12.8 If any provision of this Supply Agreement shall be held invalid, illegal or unenforceable, such provision shall be enforced to the maximum extent permitted by law and the Parties' fundamental intentions hereunder, and the remaining provisions shall not be affected or impaired.\"}, {\"id\": \"12.9\", \"title\": \"Nothing herein contained shall constitute this a joint venture agreement and nothing herein shall constitute any Party a\", \"level\": 2, \"text\": \"12.9 Nothing herein contained shall constitute this a joint venture agreement and nothing herein shall constitute any Party as a partner, principal or agent of any other, this being an agreement between independent contracting entities. Except as expressly set forth herein, no Party shall have the authority to bind any other in any respect whatsoever to Third Parties. Except as provided herein, nothing contained in this Supply Agreement shall be construed as conferring any right on any Party to use any name, trade name, trademark or other designation of any other Party hereto, unless the express, written permission of such other Party has been obtained.\"}, {\"id\": \"12.10\", \"title\": \"This Supply Agreement has been submitted to the scrutiny of, and has been negotiated by, both Parties and their counsel,\", \"level\": 2, \"text\": \"12.10 This Supply Agreement has been submitted to the scrutiny of, and has been negotiated by, both Parties and their counsel, and shall be given a fair and reasonable interpretation in accordance with its terms, without consideration or weight being given to any such term's having been drafted by any Party or its counsel.\"}, {\"id\": \"12.11\", \"title\": \"This Supply Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Cali\", \"level\": 2, \"text\": \"12.11 This Supply Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of California, without regard to any conflict of laws rules to the contrary.\"}, {\"id\": \"12.12\", \"title\": \"Each Party acknowledges that the other Party may likely suffer irreparable harm from such Party's breach or threatened b\", \"level\": 2, \"text\": \"12.12 Each Party acknowledges that the other Party may likely suffer irreparable harm from such Party's breach or threatened breach of this Agreement and the other Party, in such cases, would therefore be entitled, without waiving any other right or remedy available to, to injunctive relief (including specific performance) without the requirement to post a bond, provided the waiver by such Party of the other Party's requirement to post a bond shall expire on the Change of Control of the other Party, and each party agrees that the arbitrator selected under Section 11.3 shall have the power to grant such injunctive relief (or order specific performance). The Parties shall comply with any such injunctive relief (including specific performance) ordered by the arbitrator and agree that such order may, to the extent not precluded by applicable law, be enforceable as a final award in any court of competent jurisdiction.\"}, {\"id\": \"12.13\", \"title\": \"This Supply Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but al\", \"level\": 2, \"text\": \"12.13 This Supply Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Facsimile and other electronically scanned signatures shall have the same effect as their originals. [The remainder of this page is left intentionally blank] IN WITNESS WHEREOF, the Parties have caused this Supply Agreement to be executed by their respective duly authorized officers as of the Effective Date, each copy of which will for all purposes be deemed to be an original. SUTRO BIOPHARMA, INC. SUTROVAX, INC. By: /s/ William J. Newell By: /s/ Grant E. Pickering Name: William J. Newell Name: Grant E. Pickering Title: CEO Title: President & CEO SCHEDULE 1 PRODUCTS AND PRICE [***] SCHEDULE2 SPECIFICATIONS {6 pages omitted} [***] SCHEDULE3 INITIAL ORDER [***] SCHEDULE 2.15.1 REPRESENTATIVE CMOS [***]\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of VAXCYTE,INC_05_22_2020-EX-10.19-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.19\", \"level\": 1, \"text\": \"Exhibit 10.19 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. SUPPLY AGREEMENT This SUPPLY AGREEMENT (\\\"Supply Agreement\\\") is made as of May 29, 2018 (the \\\"Effective Date\\\") by and between SutroVax, Inc., a Delaware corporation having principal offices at 353 Hatch Dr., Foster City, CA 94404 (\\\"SutroVax\\\") and Sutro Biopharma, Inc., a Delaware corporation, having principal offices at 310 Utah Ave, Suite 150, South San Francisco, CA, 94080 (\\\"Sutro\\\"). SutroVax and Sutro may be referred to herein by name or individually, as a \\\"Party\\\" and collectively, as the \\\"Parties.\\\" BACKGROUND A. Sutro controls certain proprietary technology which permits cell-free expression of proteins, and Sutro licensed such technology to SutroVax under that certain Amended and Restated SutroVax Agreement dated as of October 12, 2015 (the \\\"License Agreement\\\"). B. SutroVax is a vaccine company primarily in the business of developing, manufacturing and marketing vaccine products; and\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SutroVax desires to purchase from Sutro, and Sutro desires to supply to SutroVax, the Extracts and Custom Reagents (as\", \"level\": 1, \"text\": \"C. SutroVax desires to purchase from Sutro, and Sutro desires to supply to SutroVax, the Extracts and Custom Reagents (as defined below) upon the terms and subject to the conditions set forth herein. NOW, THEREFORE, in consideration of the covenants, conditions and undertakings hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows: AGREEMENT ARTICLE 1 DEFINITIONS/ INTERPRETATION For the purposes of this Supply Agreement, the following capitalized words and phrases shall have the following meanings:\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Affiliate\\\" means, with respect to either Party, any business entity controlling, controlled by, or under common control\", \"level\": 2, \"text\": \"1.1 \\\"Affiliate\\\" means, with respect to either Party, any business entity controlling, controlled by, or under common control with such Party. For the purpose of this definition only, \\\"control\\\" means (i) the possession, directly or indirectly, of the power to direct the management or policies of a business entity, whether through the ownership of voting securities, by contract or otherwise, or (ii) the ownership, directly or indirectly, of at least fifty percent (50%) of the voting securities or other ownership interest of a business entity. Notwithstanding the above, in no event shall Sutro (or any entity that would be an Affiliate of SutroVax solely because it is an Affiliate of Sutro) be deemed an Affiliate of SutroVax, or SutroVax (or any entity that would be an Affiliate of Sutro solely because it is an Affiliate of SutroVax) an Affiliate of Sutro.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Applicable Law\\\" means all laws, ordinances, rules, rulings, directives and regulations of any Governmental Authority th\", \"level\": 2, \"text\": \"1.2 \\\"Applicable Law\\\" means all laws, ordinances, rules, rulings, directives and regulations of any Governmental Authority that apply to the development, manufacture or supply of any Product or the other activities contemplated under this Supply Agreement, including (i) all applicable federal, state and local laws, rules and regulations; (ii) the U.S. Federal Food, Drug and Cosmetic Act; (iii) regulations and guidelines of the FDA and other Regulatory Authorities, including cGMPs, if applicable; and (iv) any applicable non-U.S. equivalents of any of the foregoing, including guidelines of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (as amended from time to time).\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"cGMPs\\\" means current good manufacturing practices and standards as set forth (and as amended from time to time) in the\", \"level\": 2, \"text\": \"1.3 \\\"cGMPs\\\" means current good manufacturing practices and standards as set forth (and as amended from time to time) in the current Good Manufacturing Practice Regulations of the U.S. Code of Federal Regulations, including 21 C.F.R. Sections 210 and 211, the European Community Directive 2003/94/EC and the ICH Harmonised Tripartite Guideline, Good Manufacturing Practice Guides for Active Pharmaceutical Ingredients (Q7).\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Components\\\" means any product or material used in the Manufacture of the Products including the packaging materials\", \"level\": 2, \"text\": \"1.4 \\\"Components\\\" means any product or material used in the Manufacture of the Products including the packaging materials.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Extract\\\" means Sutro's extract derived from strains of E\", \"level\": 2, \"text\": \"1.5 \\\"Extract\\\" means Sutro's extract derived from strains of E. coli identified on Schedule 1 attached hereto, as may be amended from time to time in accordance with Section 12.7, and any new versions and improvements thereof that may be included in Schedule 1 by written agreement of the Parties in accordance with Section 12.7.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Facility\\\" or \\\"Facilities\\\" means the facilities where Product will be Manufactured as set forth in Schedule 1\", \"level\": 2, \"text\": \"1.6 \\\"Facility\\\" or \\\"Facilities\\\" means the facilities where Product will be Manufactured as set forth in Schedule 1. Schedule 1 may be amended from time to time in accordance with this Supply Agreement to add or remove facilities.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"FDA\\\" means the United States Food and Drug Administration, or any successor agency thereto performing similar functions\", \"level\": 2, \"text\": \"1.7 \\\"FDA\\\" means the United States Food and Drug Administration, or any successor agency thereto performing similar functions.\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Fully Burdened Manufacturing Costs\\\" means, with respect to a Product, Sutro's costs of manufacturing such Product, whic\", \"level\": 2, \"text\": \"1.8 \\\"Fully Burdened Manufacturing Costs\\\" means, with respect to a Product, Sutro's costs of manufacturing such Product, which manufacturing costs shall mean: (a) [***], and (b) [***], in each case to the extent directly allocated to and incurred in the manufacture by Sutro of such Product supplied to SutroVax, its Affiliates and Sublicensees. Fully Burdened Manufacturing Costs shall not include any [***] and shall be calculated in accordance with the foregoing, GAAP and Sutro's policies and procedures for its other products, in each case consistently applied (and such plant operations and support services costs shall be allocated consistent with GAAP and other products of Sutro in that facility).\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Governmental Authority\\\" means any court, agency, department, authority or other instrumentality of any nation, state, c\", \"level\": 2, \"text\": \"1.9 \\\"Governmental Authority\\\" means any court, agency, department, authority or other instrumentality of any nation, state, country, city or other political subdivision, including any Regulatory Authority.\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Manufacture\\\" or \\\"Manufacturing\\\" means the processes and procedures for the supply of the Products, including, (a) the s\", \"level\": 2, \"text\": \"1.10 \\\"Manufacture\\\" or \\\"Manufacturing\\\" means the processes and procedures for the supply of the Products, including, (a) the supply and quality control of the Components; (b) the manufacture of the Products in bulk; (c) the Packaging and labeling of the Products; (d) the quality control of the Products; and (e) the storage of the Products until shipment.\"}}, {\"id\": \"1.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Package\\\" or \\\"Packaging\\\" means packaging Product(s) in accordance with applicable Specifications\", \"level\": 2, \"text\": \"1.11 \\\"Package\\\" or \\\"Packaging\\\" means packaging Product(s) in accordance with applicable Specifications.\"}}, {\"id\": \"1.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Person\\\" means an individual, a corporation, a partnership, an association, a trust or other entity or organization, inc\", \"level\": 2, \"text\": \"1.12 \\\"Person\\\" means an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or political subdivision or an agency thereof.\"}}, {\"id\": \"1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Price\\\" means the price to be paid by SutroVax for each Product as set forth on Schedule 1 of this Supply Agreement and\", \"level\": 2, \"text\": \"1.13 \\\"Price\\\" means the price to be paid by SutroVax for each Product as set forth on Schedule 1 of this Supply Agreement and as may be modified from time to time in accordance with Section 3.2.\"}}, {\"id\": \"1.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Product(s)\\\" means the Extract and Custom Reagents\", \"level\": 2, \"text\": \"1.14 \\\"Product(s)\\\" means the Extract and Custom Reagents.\"}}, {\"id\": \"1.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Custom Reagents\\\" means Sutro's custom reagents identified on Schedule 1 attached hereto, and any new versions and impro\", \"level\": 2, \"text\": \"1.15 \\\"Custom Reagents\\\" means Sutro's custom reagents identified on Schedule 1 attached hereto, and any new versions and improvements thereof that may be included in Schedule 1 by written agreement of the Parties in accordance with Section 12.7.\"}}, {\"id\": \"1.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Approval\\\" means, with respect to a product, all approvals, licenses, registrations or authorizations necessa\", \"level\": 2, \"text\": \"1.16 \\\"Regulatory Approval\\\" means, with respect to a product, all approvals, licenses, registrations or authorizations necessary to market and sell such product in a particular jurisdiction in the Territory (including applicable approvals of labeling, price and reimbursement for such product in such jurisdiction).\"}}, {\"id\": \"1.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Authority\\\" means any federal, national, multinational, state, provincial or local regulatory agency, departm\", \"level\": 2, \"text\": \"1.17 \\\"Regulatory Authority\\\" means any federal, national, multinational, state, provincial or local regulatory agency, department, bureau or other governmental entity, including the FDA, with authority over the development, Manufacture or commercialization (including approval of Regulatory Approvals) of any Product(s) in any jurisdiction in the Territory.\"}}, {\"id\": \"1.18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Materials\\\" means regulatory applications, submissions, notifications, communications, correspondence, regist\", \"level\": 2, \"text\": \"1.18 \\\"Regulatory Materials\\\" means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals and/or other filings made to, received from or otherwise conducted with a Regulatory Authority (including minutes of meeting with Regulatory Authorities) that are necessary or reasonably desirable to access in connection with the development, manufacture, marketing, sale or other commercialization of any Product in a particular country or regulatory jurisdiction. Regulatory Materials include, without limitation, INDs, NDAs, BLAs, clinical trial applications, marketing approval applications and applications for pricing approvals.\"}}, {\"id\": \"1.19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Required Standards\\\" means Applicable Law, the Specifications, and the warranties given by Sutro in Section 7\", \"level\": 2, \"text\": \"1.19 \\\"Required Standards\\\" means Applicable Law, the Specifications, and the warranties given by Sutro in Section 7.3, provided that Required Standards shall not include compliance with cGMPs for Custom Reagents, Extract identified as \\\"research grade\\\" Extract or Other Extracts.\"}}, {\"id\": \"1.20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Specifications\\\" means, with respect to a Product or applicable Component thereof, all written product, regulatory, Manu\", \"level\": 2, \"text\": \"1.20 \\\"Specifications\\\" means, with respect to a Product or applicable Component thereof, all written product, regulatory, Manufacturing, release criterion, quality control and quality assurance procedures, processes, practices, standards, instructions and specifications applicable to the Manufacture of such Product or Component, as agreed to by the Parties in writing from time to time. The initial Specifications for the Products are attached hereto as Schedule 2.\"}}, {\"id\": \"1.21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"SutroVax CMO\\\" means any contract manufacturer responsible for supplying or manufacturing a Vaccine Composition on behal\", \"level\": 2, \"text\": \"1.21 \\\"SutroVax CMO\\\" means any contract manufacturer responsible for supplying or manufacturing a Vaccine Composition on behalf of SutroVax or its Affiliates, selected in accordance with Section .2.\"}}, {\"id\": \"1.22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Territory\\\" means worldwide\", \"level\": 2, \"text\": \"1.22 \\\"Territory\\\" means worldwide.\"}}, {\"id\": \"1.23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party\\\" means any Person other than SutroVax, Sutro, or their respective Affiliates\", \"level\": 2, \"text\": \"1.23 \\\"Third Party\\\" means any Person other than SutroVax, Sutro, or their respective Affiliates.\"}}, {\"id\": \"1.24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Additional Definitions\", \"level\": 2, \"text\": \"1.24 Additional Definitions. Each of the following terms shall have the meaning described in the corresponding Section of this Supply Agreement indicated below:\"}}, {\"id\": \"1.25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Interpretation\", \"level\": 2, \"text\": \"1.25 Interpretation. The captions and headings to this Supply Agreement are for convenience only, and are to be of no force or effect in construing or interpreting any of the provisions of this Supply Agreement. Unless specified to the contrary, references to Articles, Sections, Schedules or Exhibits mean the particular Articles, Sections, Schedules or Exhibits to this Supply Agreement and references to this Supply Agreement include all Schedules and Exhibits hereto. Unless context clearly requires otherwise, whenever used in this Supply Agreement: (i) the words \\\"include\\\" or \\\"including\\\" shall be construed as incorporating, also, \\\"but not limited to\\\" or \\\"without limitation;\\\" (ii) the word \\\"or\\\" shall have its inclusive meaning of \\\"and/or;\\\" (iii) the word \\\"notice\\\" shall require notice in writing (whether or not specifically stated) and shall include notices, consents, approvals and other written communications contemplated under this Supply Agreement; (iv) the words \\\"hereof,\\\" \\\"herein,\\\" \\\"hereunder,\\\" \\\"hereby\\\" and derivative or similar words refer to this Supply Agreement (including any Schedules and Exhibits); (v) provisions that require that a Party or the Parties \\\"agree,\\\" \\\"consent\\\" or \\\"approve\\\" or the like shall require that such agreement, consent or approval be specific and in writing; (vi) words of any gender include the other gender; (vii) words using the singular or plural number also include the plural or singular number, respectively; (viii) references to any specific law, or article, section or other division thereof, shall be deemed to include the then-current amendments thereto or any replacement thereof; (ix) neither Party shall be deemed to be acting \\\"under the authority\\\" of the other Party; and (x) any capitalized terms used and not defined in this Supply Agreement shall have the meaning set forth in the License Agreement.\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY\", \"level\": 1, \"text\": \"ARTICLE 2 SUPPLY\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply\", \"level\": 2, \"text\": \"2.1 Supply. Pursuant to the terms and conditions of this Supply Agreement, Sutro agrees that it will Manufacture the Product(s) at the Facility(ies) for SutroVax and shall supply the Product(s) to SutroVax, its Affiliates, and any SutroVax CMO, for purposes of production of Vaccine Compositions (including development of processes for the production of Vaccine Compositions), solely for non-clinical research purposes or in Phase I or Phase II clinical trials of such Vaccine Compositions..\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer of Product\", \"level\": 2, \"text\": \"2.2 Transfer of Product. Subject to Section 2.1, SutroVax may transfer Products to SutroVax CMOs selected by SutroVax and that are reasonably acceptable to Sutro (the acceptance of which by Sutro not to be unreasonably withheld, conditioned or delayed) or previously approved by Sutro.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Work Orders\", \"level\": 2, \"text\": \"2.3 Work Orders. From time to time, Sutro and SutroVax may execute one or more work orders, that describe the Product to be Manufactured, the quantities of each Product to be Manufactured and supplied to SutroVax, the Price to be charged by Sutro (which shall be as set forth in Section 3.2) and paid by SutroVax for the Product, and the delivery date(s) for such Product, (as executed, a \\\"Work Order\\\"). Each Work Order will expressly refer to this Supply Agreement, will form a part of this Supply Agreement, and will be subject to the terms and conditions contained herein. Sutro shall not unreasonably withhold its agreement to any proposed Work Order requested by SutroVax. Sutro shall be obligated to execute proposed Work Orders requested by SutroVax (except with respect to Other Extracts) with respect to quantities in such proposed Work Order for delivery at least [***] months after SutroVax's request to the extent such quantities of Product (when added to the quantities of such Product in Work Orders previously agreed between the Parties for delivery within the one (1) calendar year period prior to the requested delivery date of the proposed Work Order) are less than (a) [***] liters with respect to Extract or (b) a corresponding amount of each Custom Reagent to support use of [***] liters of Extract. Sutro shall notify SutroVax as soon as possible if Sutro believes it will be unable to deliver Product in accordance with the applicable Work Order. Sutro's providing of such notification shall not be interpreted in any manner as relieving Sutro of its obligations under this Supply Agreement, nor shall it prevent SutroVax from pursuing any and all rights and remedies SutroVax may have based on Sutro's failure to be able to deliver any Product in accordance with the terms of this Supply Agreement.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Orders\", \"level\": 2, \"text\": \"2.4 Orders.\"}}, {\"id\": \"2.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Purchase Orders\", \"level\": 3, \"text\": \"2.4.1 Purchase Orders. Once both parties have executed a Work Order, SutroVax shall place a purchase order for the amounts of Products to be purchased under such Work Order with delivery dates for such amounts consistent with such Work Order. Additionally, SutroVax may from time to time place purchase orders for additional quantities specifying requested delivery dates in accordance with reasonable delivery schedules and lead times; in each case, as may be agreed upon from time to time by the Parties. Each purchase order placed by SutroVax shall specify the quantity of Product, destination(s) and requested delivery dates. Sutro shall promptly accept all purchase orders with respect to the amounts of Products to be purchased under the applicable Work Order and shall accept or reject any amount in the purchase order in excess of the amounts of Products to be purchased under the applicable Work Order and all other purchase orders for Product submitted by SutroVax in accordance with this Article 2 within [***] days from receipt of the order; provided however that Sutro shall use Commercially Reasonable Efforts to accept such amounts and purchase orders. Accepted purchase orders may not be cancelled without the prior written agreement of both Parties except as set forth in Sections 2.5. Unless otherwise directed by SutroVax, Sutro shall fill all accepted purchase orders for Product in accordance with the requested due dates as set forth in further detail in Section 2.9.2.\"}}, {\"id\": \"2.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Conflicting Terms\", \"level\": 3, \"text\": \"2.4.2 No Conflicting Terms. The terms and conditions of this Supply Agreement shall be controlling over any conflicting terms and conditions stated in SutroVax's purchase order or Sutro's invoice, confirmation or other standardized document. Any purchase order, order acknowledgement, invoice, proposal or other document which conflicts with or adds to the terms and conditions of this Supply Agreement with respect to the Manufacture and supply of Product for the Territory is hereby rejected, unless the Parties mutually agree to the contrary in writing.\"}}, {\"id\": \"2.4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Initial Order\", \"level\": 3, \"text\": \"2.4.3 Initial Order. Notwithstanding Section 2.3 or this Section 2.4, Sutro accepts and agrees to fulfil the order previously placed by or on behalf of SutroVax (or to be placed by or on behalf of SutroVax, if no already placed) for the quantities of Product set forth in Schedule 3 by the delivery date set forth therein (the \\\"Initial Order\\\").\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cancellation\", \"level\": 2, \"text\": \"2.5 Cancellation. Notwithstanding anything herein to the contrary, SutroVax may not modify or cancel purchase orders with respect to the amounts of Product to be purchased under the applicable Work Order, however SutroVax may modify or cancel other purchase orders (including amounts in a purchase order in excess of the amounts of Product to be purchased under the applicable Work Order) for the Products provided that such modification or change is made further in advance of the originally requested delivery date than the required lead time, where the agreed required lead time for the applicable purchase order has been evidenced in writing (including, for example, by email) between the Parties.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery and Risk of Loss\", \"level\": 2, \"text\": \"2.6 Delivery and Risk of Loss. Sutro shall mark Product for delivery to the destination(s) specified by SutroVax. All shipments of Product(s) shall be delivered [***] (lncoterms 2010) Sutro Facility. Title and risk of loss and damage to the Product(s) shall remain with Sutro until the Product(s) are delivered in accordance with the foregoing, at which time title and risk ofloss and damage to the Product(s) shall pass to SutroVax. SutroVax will arrange for shipping from Sutro's Facility to the destination specified by SutroVax at SutroVax's cost and expense.\"}}, {\"id\": \"2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Packaging\", \"level\": 2, \"text\": \"2.7 Packaging. Sutro shall provide the Product to SutroVax in Packaged form in accordance with the Required Standards.\"}}, {\"id\": \"2.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Conformance to Required Standards\", \"level\": 2, \"text\": \"2.8 Conformance to Required Standards. Sutro shall Manufacture the Product(s) in accordance with the Required Standards, as the same may be amended or supplemented from time to time. Each Party shall keep the other promptly and fully advised of any new requirements of the applicable Regulatory Authority or Applicable Law of which it becomes aware and Sutro shall promptly implement such requirements as described in Section 6.6.\"}}, {\"id\": \"2.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply and Delivery\", \"level\": 2, \"text\": \"2.9 Supply and Delivery.\"}}, {\"id\": \"2.9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shortage\", \"level\": 3, \"text\": \"2.9.1 Shortage. Sutro shall use reasonable efforts to promptly notify SutroVax in writing in the event that Sutro is unable or anticipates that it will be unable to supply compliant Product in accordance with the requirements of this Supply Agreement, including the Quality Agreement and all Required Standards, and each Work Order. Sutro shall use Commercially Reasonable Efforts to overcome any inability or anticipated inability to so supply compliant Product to SutroVax.\"}}, {\"id\": \"2.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Allocation\", \"level\": 2, \"text\": \"2.10 Allocation. Without limiting any other rights or remedies available to SutroVax, if the demand for a Product in aggregate exceeds available supply or Sutro otherwise concludes that it may be unable to supply a Product in accordance with the requirements of this Supply Agreement in the quantities and within the time periods specified in each Work Order and the corresponding purchase orders that have been accepted by Sutro, Sutro shall immediately notify SutroVax of such shortfall (or anticipated shortfall), and shall use Commercially Reasonable Efforts to procure Components and capacity adequate to meet accepted purchase orders and supply compliant Product in accordance with the requirements of this Supply Agreement. Sutro shall allocate its available Components and manufacturing capacity to provide SutroVax with quantities of such Product at least equal to the greater of (a) [***] of the amount of Product (or products equivalent to Product) that Sutro allocates for itself and its Affiliates (but in no event less than [***] liters of Extract per month and the minimum allocation volume set out in Schedule 1 of each Custom Reagent per month), provided that SutroVax demonstrates actual need for the applicable quantities of Extract, and (b) the [***]. Without limiting the foregoing, if there is a shortage of supply of Product, Sutro shall provide Product to SutroVax for any quantities of Product ordered by SutroVax in accordance with the applicable Work Order or purchase order in priority to any subsequent Third Party purchase orders, but not in priority to any Third Party purchase orders or other binding commitment placed before placement of the applicable SutroVax Work Order or purchase order.\"}}, {\"id\": \"2.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Short Dated Product\", \"level\": 2, \"text\": \"2.11 Short Dated Product. Sutro agrees to ship all Product(s) so that they are delivered to SutroVax and will remain compliant with the Specifications for at least [***] months from the date of delivery in accordance with this Supply Agreement.\"}}, {\"id\": \"2.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subcontracting by Sutro\", \"level\": 2, \"text\": \"2.12 Subcontracting by Sutro. Sutro shall (a) ensure that any subcontractor or delegatee of Sutro's obligations under this Supply Agreement has and maintains all appropriate qualifications; (b) enter into a quality agreement with each such subcontractor and delegatee which terms are similar to the terms of the Quality Agreement between SutroVax and Sutro; and (c) be responsible for each subcontractor's and delegatee's performance hereunder (including performance or non-performance by such subcontractor or delegatee that would constitute a breach of this Supply Agreement or such quality agreement if conducted by Sutro) as if Sutro were itself performing such activities. Sutro shall not subcontract the Manufacture of Product to a Third Party without SutroVax's prior consent other than to an Alternate Supplier as expressly set forth in Section 2.15.\"}}, {\"id\": \"2.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CMOs\", \"level\": 2, \"text\": \"2.13 CMOs. Notwithstanding anything to the contrary in this Supply Agreement, SutroVax shall have the rights to purchase Available Extracts and Extracts from CMOs (as defined in the License Agreement) to the extent provided in section 3.1 of the License Agreement.\"}}, {\"id\": \"2.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Phase 3/Commercial Supply Agreement\", \"level\": 2, \"text\": \"2.14 Phase 3/Commercial Supply Agreement. If requested by SutroVax in writing (which request shall not be made prior to [***]), the Parties shall negotiate in good faith reasonable terms and conditions of an agreement for the supply by Sutro of the Products for the production of Vaccine Compositions for use in phase 3 clinical studies and for commercial purposes (\\\"Phase 3/Commercial Supply Agreement\\\"). The price for the Products Manufactured by Sutro under the Phase 3/Commercial Supply Agreement shall not exceed [***] of the Fully Burdened Manufacturing Cost thereof. If the Parties have not entered into the Phase 3/Commercial Supply Agreement within [***] after SutroVax's request to negotiate the Phase 3/Commercial Supply Agreement, upon either Party's request by written notice to the other Party the terms and conditions of the Phase 3/Commercial Supply Agreement shall be determined by binding arbitration in accordance with the procedures set forth in Section 11.4. Upon the selection of one draft Phase 3/Commercial Supply Agreement by the arbitrator pursuant to Section 11.4, unless SutroVax elects not to enter into such Phase 3/Commercial Supply Agreement by written notice thereof to Sutro within [***] days after such selection, the Parties shall execute the definitive Phase 3/Commercial Supply Agreement selected by the arbitrator (but excluding, for clarity, any provision granting to SutroVax or its Affiliates or Sublicensees any right to obtain or use any Sutro Core Know-How); and if SutroVax elects to not enter into the Phase 3/Commercial Supply Agreement selected by the arbitrator by providing notice thereof within such [***] day period, then neither Party shall be obligated to enter into the Phase 3/Commercial Supply Agreement.\"}}, {\"id\": \"2.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Qualification of Alternate Supplier\", \"level\": 2, \"text\": \"2.15 Qualification of Alternate Supplier.\"}}, {\"id\": \"2.15.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transfer Addendum\", \"level\": 3, \"text\": \"2.15.1 Transfer Addendum. (a) Transfer Addendum. Upon SutroVax' written request, the Parties agree to negotiate in good faith an addendum to this Supply Agreement setting forth the terms and conditions pursuant to which Sutro will conduct a Process Transfer to a Third Party contract manufacturer (\\\"CMO\\\") and/or engage such CMO to establish Capacity to Manufacture Extract (as Process Transfer and Capacity are defined below), in each case for the Manufacture and supply of such Extract for SutroVax' (or its Affiliate's or SutroVax CMO's) use to manufacture Vaccine Compositions, consistent with the remainder of this Section 2.15 (such addendum, a \\\"Transfer Addendum\\\"). As requested by SutroVax, this procedure may also be used in the event that SutroVax wishes Sutro to conduct a Process Transfer to a Third Party CMO in order to establish Capacity to Manufacture Custom Reagents. In connection with such request, SutroVax shall provide to Sutro a description of the desired Process Transfer and/or Capacity, including timing and other requirements thereof. Such Transfer Addendum shall: (i) include a plan and budget for the conduct of the Process Transfer and/or establishment of such Capacity, which shall include amounts charged by the CMO (as defined further below, the \\\"Alternate Supplier\\\") to receive and conduct such Process Transfer and/or establish such Capacity, as well as reasonable FTE costs for Sutro personnel performing and managing technology transfer activities in accordance with the Transfer Addendum\u00b7 (ii) require SutroVax to fund the costs incurred by Sutro to conduct Process Transfer and/or establish such Capacity in accordance with such budget; (iii) provide for initiation and completion of the Process Transfer and establishment of Capacity as requested by SutroVax, to the extent possible; (iv) to the extent requested by SutroVax, be designed to enable the Alternate Supplier to Manufacture Extract of suitable quality for use in Phase 3 clinical trials and commercialization of a Vaccine Composition at a capacity to support SutroVax' projected commercial requirements for Extract (or other capacity identified by SutroVax in connection with the negotiation of the Transfer Addendum), as requested by SutroVax; (v) require the Parties to fully cooperate to verify that the Extract supplied by the Alternate Supplier meets the Specifications, to validate the Manufacturing process implemented at the Alternate Supplier and to qualify the Alternate Supplier, in each case to supply Extract for SutroVax' use in Phase 3 clinical trials and commercialization of a Vaccine Composition (collectively, with respect to Capacity established, \\\"Validating\\\" such Capacity); (vi) include mechanisms for keeping SutroVax fully informed, at scheduled intervals not to exceed once per quarter, of the progress of the Process Transfer and establishing such Capacity, as applicable, including with respect to the anticipated date for qualifying the Alternate Supplier and any changes to such anticipated date; (vii) provide a right for SutroVax to modify the timing of or terminate the Process Transfer, Capacity or specified aspects thereof on reasonable notice, subject to SutroVax' agreement to bear any resulting termination or cancellation fees charged by the Alternative Supplier; and (viii) include a mechanism for Sutro to cooperate with SutroVax and keep SutroVax reasonably informed with respect to Sutro's negotiation of an agreement with a potential Alternate Supplier for a Process Transfer and/or establishment of Capacity, including with respect to pricing for Extract from the Alternate Supplier to Sutro and any commitments to purchase quantities of Extract from the Alternate Supplier that SutroVax would be obligated to assume (e.g., in connection with establishing Capacity), if any, and require Sutro to obtain SutroVax' approval (not to be withheld unreasonably) of the terms of such agreement prior to entering into such agreement to the extent that the terms apply to SutroVax (it being understood that Sutro may redact any terms that are not relevant to SutroVax). (b) Scope. As used above, \\\"Process Transfer\\\" means a technology transfer of Sutro's know-how and information as is necessary or useful for the Third Party CMO to Manufacture in its own facilities Extract that meets SutroVax' requirements, including any such information and know-how as would be needed for such CMO to scale up such Manufacture to the requested commercial volumes. To establish \\\"Capacity\\\" means that the CMO would take such actions as are necessary (including validation and if necessary adapting or reserving existing facilities, establishing new facilities and/or procuring necessary equipment) to Manufacture Extract meeting SutroVax' requirements for Phase 3 and commercial supply in such quantities as SutroVax designates. It is understood that SutroVax may request that the Process Transfer and establishment of Capacity be undertaken in separate steps, for example by undertaking an initial Process Transfer to demonstrate the CMO's ability to Manufacture Extract, and then later establishing Capacity for Phase 3 and commercial supply, as requested by SutroVax in accordance with Section 2.15.1(a) (i.e., in separate requests). (c) Selection of Alternate Supplier. The \\\"Alternate Supplier\\\" will be selected by Sutro, provided that Sutro must select an \\\"Alternate Supplier\\\" that is substantially similar to those CMOs identified on Schedule 2.15.1 hereto and provided further that SutroVax shall have the right to veto such selection based only on a genuine and material conflict of interest between SutroVax and the Alternate Supplier. Additional CMOs may be added to Schedule 2.15.1 by Sutro with SutroVax's approval (not to be withheld unreasonably). (d) Alternate Supplier as Subcontractor. It is understood that the Alternate Supplier established under the Transfer Addendum shall operate as a subcontractor of Sutro under this Supply Agreement and the Phase 3/Commercial Supply Agreement, and as such SutroVax will order from Sutro thereunder any Extract to be Manufactured by such Alternate Supplier. Subject to the foregoing, the Transfer Addendum and the Phase 3/Commercial Supply Agreement will include reasonable and customary rights for SutroVax to conduct audits/inspections, site visits, quarterly meetings, each such audit/inspection, site visit and quarterly meeting to be coordinated by Sutro and to occur in the presence of a representative for Sutro and SutroVax, in connection with the Alternate Supplier's manufacture of Extract for supply to SutroVax. For clarity, SutroVax shall not conduct any business discussions for the supply of Extract with the Alternate Supplier in a manner that induces the Alternate Supplier to breach its agreement with Sutro. Notwithstanding the foregoing, in the event Sutro undergoes a Change of Control or Sutro permits any third party to acquire Extract directly from an Alternate Supplier established under the Transfer Addendum, then SutroVax shall thereafter have the right to establish a supply agreement with and obtain supply of Extract directly from such Alternate Supplier. (e) Quotations. Upon SutroVax's request (which request, for clarity, may be before a request to negotiate a Transfer Addendum), Sutro shall seek quotations from one or more Third Party CMO(s) for such a Process Transfer and/or establishment of such Capacity, in each case as requested by SutroVax, and the Parties shall reasonably cooperate to establish requests for quotations for such purposes. (f) Arbitration. If the Parties have not agreed upon a Transfer Addendum within [***] after SutroVax' request, upon SutroVax' request by written notice to Sutro, the terms and conditions of the Transfer Addendum shall be determined by binding arbitration in accordance with the procedures set forth in Section 11.4. For clarity, however, it is understood that a Transfer Addendum shall not include any provision granting to SutroVax or its Affiliates or Sublicens.ee s any right to obtain or use any Sutro Core Know-How.\"}}, {\"id\": \"2.15.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Source of Supply\", \"level\": 3, \"text\": \"2.15.2 Source of Supply. It is understood that after the Alternate Supplier is qualified, SutroVax shall have the right under this Supply Agreement and the Phase 3/Commercial Supply Agreement to specify whether Extract ordered from Sutro pursuant to this Agreement or the Phase 3/Commercial Supply Agreement will be Manufactured at Sutro's Facility or at the Alternate Supplier's facilities (and to the extent Extract from the Alternate Supplier is ordered under this Supply Agreement or the Phase 3/Commercial Supply Agreement, the facility of the Alternate Supplier shall be deemed a Facility for purposes of this Supply Agreement and the Phase 3/Commercial Supply Agreement). Notwithstanding the foregoing, to the extent the FDA and EMA have confirmed that Extract manufactured at Sutro's Facility and the Alternate Supplier's Facility are interchangeable and can be supplied from either such Facility without any additional regulatory requirements or regulatory delay with respect to the applicable Vaccine Composition, and such Extract otherwise meets SutroVax' requirements, then with SutroVax' consent (not to be withheld unreasonably) Sutro may supply Extract from either Sutro's Facility or the Alternate Supplier's Facility.\"}}, {\"id\": \"2.15.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price\", \"level\": 3, \"text\": \"2.15.3 Price. To the extent Sutro or its Affiliate Manufactures Extract supplied to SutroVax, the Price (per unit volume or unit weight) under this Supply Agreement and the Phase 3/Commercial Supply Agreement for such Extract shall not exceed [***] of the Fully Burdened Manufacturing Costs of such Extract; and to the extent the Extract to be supplied to SutroVax is Manufactured by a Third Party (including the Alternate Supplier), the Price to be charged to SutroVax under this Supply Agreement and the Phase 3/Commercial Supply Agreement for such Extract shall equal the amount Sutro paid such Third Party for such Extract (\\\"OOP Cost\\\") plus an amount reasonably calculated to cover Sutro's FTE costs to procure and manage the relationship with such Third Party, such amount not to exceed [***] of the OOP Cost for such Extract. To the extent that Sutro or its Affiliate receives any portion of the amounts paid to such Third Party to Manufacture Extract (e.g., as a profit share or otherwise), the Price to be charged SutroVax shall be the lesser of i) [***], or ii) [***]; in either case, [***]. For clarity, Section 3.4 of the License Agreement shall apply with respect to the Alternate Supplier.\"}}, {\"id\": \"2.15.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro/Third Party use of Alternate Supplier\", \"level\": 3, \"text\": \"2.15.4 Sutro/Third Party use of Alternate Supplier. Once the Alternate Supplier is qualified pursuant to this Section 2.15, SutroVax shall have the first right (as between SutroVax and Sutro or Third Parties supplied or authorized by Sutro) to obtain Extract Manufactured by the Alternate Supplier up to the Capacity established pursuant to the Transfer Addendum for a period ending the later of [***] or [***], and provided SutroVax commits to [***] or [***].\"}}, {\"id\": \"2.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Manufacture of Custom Reagents\", \"level\": 2, \"text\": \"2.17 Manufacture of Custom Reagents. For clarity, SutroVax may Manufacture Custom Reagents itself or obtain supply thereof through a Third Party independent of this Supply Agreement and nothing in this Supply Agreement is intended to restrict SutroVax from doing so. Upon SutroVax's request, and subject to the remainder of the terms of this Section 2.17, Sutro shall (a) transfer to SutroVax or a contract manufacturer designated by SutroVax (which contract manufacturer is reasonably acceptable to Sutro, the approval of which shall not be unreasonably withheld, conditions or delayed by Sutro) as soon as reasonably practicable the process to Manufacture each Custom Reagent and the items of Sutro Know-How reasonably necessary for SutroVax or its designee to Manufacture each Custom Reagent, including cell lines, standard operating procedures, protocols, batch records, analytical method standard operating procedures and analytical method transfer protocols and (b) make Sutro Personnel reasonably available to SutroVax or its designee for scientific and technical explanations and on-site support that may reasonably be requested by SutroVax or its designee to Manufacture the Custom Reagents; provided however, that SutroVax shall fully reimburse Sutro for all documented time spent by Sutro's personnel to perform such transfer (on an FTE basis, each such FTE charged at an annual rate of [***]) and out-of-pocket costs incurred by Sutro in connection with all of the activities under the preceding sub-clauses (a) and (b), in accordance with a budget reasonably approved in advance by SutroVax. Upon such SutroVax request, Sutro and SutroVax shall, within [***] days, agree on a scope of work for such transfer, including scale, timeline, estimated budget, and required materials; both parties shall use reasonable efforts to complete the transfer as soon as reasonably practical. If requested by SutroVax (including if such request is prior to agreement on a scope of work), Sutro shall promptly transfer to SutroVax or its designee the cell lines, manufacturing instructions and analytical methods used for Manufacture of each Custom Reagent. For clarity, SutroVax shall have the right to enter into an agreement directly with such designee for the Manufacture and supply of Custom Reagents directly to SutroVax, its Affiliates, and any SutroVax CMO and, upon SutroVax's request, to the extent necessary, Sutro shall authorize such designee to enter into such agreement with SutroVax and perform such activities. For further clarity, Sutro shall not be responsible for any damages resulting from delay or failure in establishing the processes for Manufacture of Custom Reagents at SutroVax's designee resulting from action or inaction on the part of the designee or to the extent beyond Sutro's control. SutroVax shall have the right to obtain from such designee such items of Sutro Know-How transferred to such designee and use such items in connection with the exercise of its rights pursuant to the License Agreement, including for the Manufacture of Custom Reagents and the management of such designee. SutroVax shall use such Sutro Know-How transferred under this Section 2.17 (to the extent it is Discloser's Information of Sutro and does not meet one or more the criteria in clause (a) through (e) of Section 10.1 of the License Agreement) only for the Manufacture of Custom Reagents or otherwise within the scope of rights and licenses granted SutroVax in the License Agreement. In case of such a transfer to SutroVax or its designee, SutroVax will share with Sutro (i) the proposed process for manufacture of Custom Reagents through a Third Party so that Sutro may provide feedback and ensure that the process and Specifications are consistent with Sutro's process, and (ii) all regulatory submissions (including DMFs with respect to Custom Reagents) at least [***] days in advance of their intended date of submission to a Regulatory Authority in the Territory, and shall take into account Sutro's feedback to ensure alignment with Sutro's regulatory submissions and Regulatory Approvals with respect to Custom Reagents. Following completion of the transfer set forth above, Sutro shall provide reasonable support for the use of Third Party Custom Reagents in conjunction with Extract supplied by or on behalf of Sutro. In addition, Extract supplied by Sutro that conforms to the Required Standards when tested with Custom Reagents supplied by Sutro but not with Custom Reagents manufactured under this Section shall be deemed to conform to the Required Standards and SutroVax may not reject such Extract as a result of such non-conformance to the Required Standards when tested with Custom Reagents. SutroVax shall not prevent Sutro from separately contracting with the contract manufacturer for Manufacture of Custom Reagents for use on its own behalf or on behalf of other third parties.\"}}, {\"id\": \"2.18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro Core Know-How\", \"level\": 2, \"text\": \"2.18 Sutro Core Know-How. Notwithstanding anything to the contrary, except as set forth in Section 15.3 of the License Agreement, in no event shall SutroVax, its Affiliates or Sublicensees have the right to access any Sutro Core Know-How (as defined in the License Agreement), whether directly from Sutro or its Affiliates or through a CMO or otherwise, and SutroVax, its Affiliates and Sublicensees shall not require, request or solicit any CMO to deliver any Sutro Core Know-How to SutroVax, its Affiliates and/or its Sublicensees, and no agreement between any CMO and Sutro, its Affiliates and Subsidiaries shall contain any provision granting to SutroVax or its Affiliates or Sublicensees any right to obtain or use any Sutro Core Know-How. Without limiting the foregoing, in the event any item of Sutro Core Know-How is delivered to SutroVax, its Affiliates and/or its Sublicensees (except as set forth in Section 15.3 of the License Agreement), SutroVax, its Affiliates and Sublicensees shall immediately return such item to Sutro. Notwithstanding the foregoing, to the extent SutroVax or any of its Affiliates or Sublicensees is required by a Regulatory Authority (or Applicable Law) in the United States, Europe or Japan to confidentially disclose, as part of the applicable regulatory filings with respect to a Vaccine Composition, any Sutro Core Know-How (for clarity, excluding any tangible embodiments of such Sutro Core Know-How other than information and documentation), Sutro shall, upon SutroVax's written request, confidentially disclose such Sutro Core Know-How as part of the applicable regulatory filings, subject to the payment obligations set forth in Section 5.4 of the License Agreement.\"}}, {\"id\": \"2.19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Express Rights\", \"level\": 2, \"text\": \"2.19 Express Rights. Except as expressly set forth in this Supply Agreement, no rights or licenses are granted to SutroVax under this Supply Agreement.\"}}, {\"id\": \"2.20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Extract Requirements\", \"level\": 2, \"text\": \"2.20 Extract Requirements. SutroVax agrees to purchase all its requirements of Extract from Sutro in accordance with this Agreement, except to the extent SutroVax is allowed to purchase Extract from (a) Alternate Suppliers engaged by Sutro in accordance with Section 2.15 of this Agreement; (b) a CMO engaged or established and authorized by Sutro under Section 3.l(d) of the License Agreement; or (c) a CMO authorized by Sutro under Section 3.l(e) of the License Agreement. Manufacturing of Extracts in breach of this Section 2.20 shall be deemed a material breach of this Agreement and the License Agreement by SutroVax.\"}}, {\"id\": \"ARTICLE 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICING AND PAYMENT\", \"level\": 1, \"text\": \"ARTICLE 3 PRICING AND PAYMENT\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Invoices\", \"level\": 2, \"text\": \"3.1 Invoices. Sutro shall invoice SutroVax at the time of each shipment of Product(s) for the Price for such shipment. SutroVax will pay such invoices within [***] days of receipt of invoice (including all required documentation) by SutroVax.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prices\", \"level\": 2, \"text\": \"3.2 Prices. The Prices for the Products shall not exceed [***] of the Fully Burdened Manufacturing Costs of such Product at the time such Product is manufactured and shall be set forth in the applicable Work Order. Upon SutroVax's request from time-to-time, Sutro shall disclose to SutroVax the then- current Price for Product. The Price for the Products as of the Effective Date is set forth in Schedule 1.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recordkeeping\", \"level\": 2, \"text\": \"3.3 Recordkeeping. During the Term and for [***] years thereafter, or for such longer period as may be required by Applicable Law, Sutro shall prepare and retain, and shall cause its subcontractors to prepare and retain, accurate books and records related to transactions made pursuant to this Supply Agreement and Prices. Such records shall be made available for reasonable review, audit and inspection upon reasonable notice and with reasonable frequency, upon SutroVax's request for the purpose of verifying Sutro's calculations of amounts due hereunder, the basis for such calculations (including Sutro's calculation of the Fully Burdened Manufacturing Costs) or payments and Sutro's compliance with the terms and conditions of this Supply Agreement. Audits and inspections may be conducted by SutroVax's own personnel or retained consultant(s), subject to the confidentiality obligations set forth in this Supply Agreement.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 2, \"text\": \"3.4 Taxes. The Prices are exclusive of all Taxes. SutroVax will pay all taxes and duties that are assessed by any national, federal, state or local governmental authority on SutroVax's purchase or use of the Products, including, without limitation, sales, use, excise, value-added and withholding taxes, but excluding any taxes based on Sutro's income or gross receipts (collectively, \\\"Taxes\\\"). Sutro will separately identify all such Taxes on Sutro's invoice.\"}}, {\"id\": \"ARTICLE 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT TESTING\", \"level\": 1, \"text\": \"ARTICLE 4 PRODUCT TESTING\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Testing and Inspections\", \"level\": 2, \"text\": \"4.1 Product Testing and Inspections. Each shipment of Product shall be accompanied by a certificate of analysis describing all current requirements of the Specifications and results of tests performed on such Product and a certificate of conformity certifying that the quantities of Product supplied have been Manufactured, controlled and released according to the Required Standards (\\\"COA/COC\\\") as set forth in the applicable Quality Agreement (subject to SutroVax's conduct of the SutroVax Activity Test to confirm Extract meets the SutroVax Activity Criteria). The COA/COC acceptance criteria for each Product shall be set forth in the Specification for such Product. Two of the tests and corresponding COA/COC acceptance criteria for the Extract shall be the performance of a productivity (Activity) test of the applicable Sutro protein (the \\\"Sutro Activity Test\\\" and \\\"Sutro Activity Criteria\\\") and the performance of a productivity (activity) test of the applicable Vaccine Composition (the \\\"SutroVax Activity Test\\\" and \\\"SutroVax Activity Criteria\\\"). Sutro shall perform the Sutro Activity Test to confirm that all shipments of Extract meet the Sutro Activity Criteria and SutroVax (or its designee) shall perform the SutroVax Activity Test to confirm that all shipments of Extract meet the SutroVax Activity Criteria. Sutro will also provide SutroVax with Material Safety Data Sheets (\\\"MSDS\\\") or an equivalent instrument recognized by the applicable Regulatory Authority as required for the Product(s), and updates of the same as necessary.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Acceptance/Rejection of Non-Conforming Goods\", \"level\": 2, \"text\": \"4.2 Acceptance/Rejection of Non-Conforming Goods. SutroVax or its designee shall have a period of [***] calendar days from the date of delivery of the Product(s) in accordance with Section 2.6 and the COA/COCs or the equivalent instrument recognized by the applicable Regulatory Authority for such Product(s) (\\\"Acceptance Period\\\"), to inspect any shipment of Product(s) and conduct the SutroVax Activity Test to determine whether such shipment conforms to the Required Standards. If SutroVax determines that the Product(s) do not conform to the Required Standards, it hall notify Sutro within the Acceptance Period, and, if requested by Sutro, SutroVax shall ship a sample of such non-conforming Product(s) to Sutro at Sutro's expense. SutroVax's failure to notify Sutro of the non-conformity within the Acceptance Period will be deemed for purposes of this Supply Agreement to constitute SutroVax's acceptance of such shipment, provided, however, that such acceptance shall be subject to SutroVax's right to reject Product(s) until [***] days from the delivery date of the applicable Product, in each case, due to discovery by SutroVax or SutroVax's Affiliates or designees that the applicable Product does not conform to the Required Standards and such non-conformance could not reasonably be discovered within the Acceptance Period (\\\"Latent Defects\\\") provided that SutroVax gives Sutro with written notice of such Latent Defect within [***] days of SutroVax or any SutroVax Affiliate or designee becoming aware of such defect.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disputes Regarding Conformance to Required Standards\", \"level\": 2, \"text\": \"4.3 Disputes Regarding Conformance to Required Standards. If Sutro does not agree with SutroVax's determination that Product fails to conform to the Required Standards, then Sutro shall so notify SutroVax in writing within [***] days of its receipt of SutroVax's notice of non-conformity with respect to such Product and (if requested) Product sample. Sutro and SutroVax shall use reasonable efforts to resolve such disagreement as promptly as possible. Without limiting the foregoing, Sutro and SutroVax shall discuss in good faith mutually acceptable testing procedures pursuant to which both Sutro and SutroVax will re-test a sample of the disputed Product to determine whether such Product meets the Required Standards. Notwithstanding the foregoing, in the event that Sutro and SutroVax are unable to resolve such disagreement within [***] days of the date of the applicable rejection notice, either Party may submit a sample of the allegedly non-conforming Product for testing and a determination as to whether or not such Product conforms to the Required Standards to an independent testing organization, or to a consultant of recognized repute within the United States pharmaceutical industry, in either case mutually agreed upon by the Parties (such organization or consultant, the \\\"Laboratory\\\"), the appointment of which shall not be unreasonably withheld or delayed by either Party. The determination of the Laboratory with respect to all or part of any shipment of Product shall be final and binding upon the Parties. The fees and expenses of the Laboratory making such determination shall be borne by Sutro, in the event that the Laboratory determines that the Product was non-conforming and by SutroVax, in the event that the Laboratory determines that the Product did conform to the Required Standards.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Return and Replacement of Non-Conforming Goods\", \"level\": 2, \"text\": \"4.4 Return and Replacement of Non-Conforming Goods. Product that is either rejected by SutroVax as not meeting the Required Standards, or that is determined by the Laboratory not to meet such Required Standards, shall, [***], be returned by SutroVax to Sutro, or destroyed pursuant to Applicable Law, at Sutro's reasonable expense. Sutro shall replace any non-conforming Product(s) within the shortest possible time. SutroVax shall have no responsibility to Sutro for the amounts invoiced for non-conforming Product(s), and shall be credited for any amounts paid, but shall pay Sutro the applicable Price for the replacement Product(s) under the terms of Section 3.1.\"}}, {\"id\": \"ARTICLE 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSPECTION\", \"level\": 1, \"text\": \"ARTICLE 5 INSPECTION\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Right to Audit\", \"level\": 2, \"text\": \"5.1 Right to Audit. During the Term and the [***] period thereafter, SutroVax or a SutroVax Affiliate may, during normal working hours and upon reasonable advance notice perform site audits and inspect, or request information relating to, Sutro's or its subcontractor's Facilities and records directly or indirectly involved in the performance of this Supply Agreement or related to the Product(s). Such requests should be made in writing and Sutro will allow for such audits or inspection to occur within [***] days from request (excepting for cause audits) for Sutro's Facilities and within [***] days' from request (excepting for cause audits) for Sutro's subcontractor's facilities. Reasonable advance notice for audits for cause shall not require more than [***] advance notice. During such an inspection or request for information the inspectors may inquire about the progress of the work being carried out by Sutro or its subcontractor, and are in particular but not exclusively authorized to:\"}}, {\"id\": \"5.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Inspect the Facilities, documents and equipment used, or to be used, in the Manufacture of the Product(s);\", \"level\": 3, \"text\": \"5.1.1 Inspect the Facilities, documents and equipment used, or to be used, in the Manufacture of the Product(s);\"}}, {\"id\": \"5.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Verify the qualifications of the employees and subcontractors carrying out such work and their use of the relevant equip\", \"level\": 3, \"text\": \"5.1.2 Verify the qualifications of the employees and subcontractors carrying out such work and their use of the relevant equipment;\"}}, {\"id\": \"5.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Evaluate all scientific techniques used by Sutro, its subcontractors and their respective employees in the performance o\", \"level\": 3, \"text\": \"5.1.3 Evaluate all scientific techniques used by Sutro, its subcontractors and their respective employees in the performance of this Supply Agreement and the procedures used in the creation and storage of samples of the Product(s), provided that nothing in this Section 5.1.3 shall require Sutroto disclose any Sutro Core Know-How;\"}}, {\"id\": \"5.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Verify and evaluate information relating to the utilization of the Manufacturing capacity of Sutro's Facilities or its s\", \"level\": 3, \"text\": \"5.1.4 Verify and evaluate information relating to the utilization of the Manufacturing capacity of Sutro's Facilities or its subcontractor's Facilities;\"}}, {\"id\": \"5.1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Review correspondence, reports, filings and other documents from Regulatory Authorities to the extent related to the Man\", \"level\": 3, \"text\": \"5.1.5 Review correspondence, reports, filings and other documents from Regulatory Authorities to the extent related to the Manufacturing activities hereunder;\"}}, {\"id\": \"5.1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Evaluate the implementation of all Manufacturing and process changes made with respect to the Product, including pursuan\", \"level\": 3, \"text\": \"5.1.6 Evaluate the implementation of all Manufacturing and process changes made with respect to the Product, including pursuant to any corrective action plan; and\"}}, {\"id\": \"5.1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ascertain compliance with Applicable Laws, the Specifications and this Supply Agreement\", \"level\": 3, \"text\": \"5.1.7 Ascertain compliance with Applicable Laws, the Specifications and this Supply Agreement.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Access\", \"level\": 2, \"text\": \"5.2 Access. Sutro shall provide SutroVax's and its Affiliate's and Sublicensee's inspectors with access to its Facilities, and information related to such Facilities, in order that the inspectors may carry out the inspections or inquiries referred to in the provisions of this Article 5. For the avoidance of doubt, neither SutroVax nor any of its Affiliates or Sublicensees (or their respective inspectors) shall have the right to observe the Manufacture of the Extract or be present at Sutro and its subcontractors' Facilities at such times when Extract is being Manufactured. Sutro shall use Commercially Reasonable Efforts to obtain from its subcontractors commitments similar to those contemplated in this Section 5.2. Audits and inspections may be conducted by SutroVax's own personnel or retained consultant(s), subject to the confidentiality obligations set forth in this Supply Agreement.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro Audits\", \"level\": 2, \"text\": \"5.3 Sutro Audits. Without limiting the foregoing; Sutro is responsible for auditing the facilities of the suppliers of Components, if any, periodically, and Sutro agrees to provide SutroVax, upon SutroVax's request with a current copy of the audit report of such facilities and to incorporate SutroVax's comments with respect to any corrective action plan related to the Product.\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REGULATORY AND QUALITY RESPONSIBILITIES\", \"level\": 1, \"text\": \"ARTICLE 6 REGULATORY AND QUALITY RESPONSIBILITIES\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Responsibilities\", \"level\": 2, \"text\": \"6.1 Regulatory Responsibilities. Sutro shall obtain and maintain any and all regulatory and governmental permits, licenses and approvals that are necessary for Sutro to Manufacture the Product(s) for SutroVax or its Affiliates in accordance with the terms of this Supply Agreement and Applicable Law. As between the Parties, SutroVax shall have the sole responsibility for all Regulatory Approvals of the Vaccine Compositions.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Right of Reference; Drug Master Files\", \"level\": 2, \"text\": \"6.2 Right of Reference; Drug Master Files. Sutro shall (a) file Drug Master File(s) for the Products with the FDA as requested by SutroVax, and with Regulatory Authorities in the European Union (including the United Kingdom) and Japan in accordance with timelines to be mutually agreed upon (such agreement not to be unreasonably withheld by either Party) (provided at SutroVax's request, Sutro shall do so within [***] of SutroVax's request using Regulatory Filings that comprise versions of the DMF(s) filed with the FDA that have been reformatted to comply with EU and Japanese requirements), and (b) provide the appropriate authorizations to such Regulatory Authority(ies) allowing the Regulatory Authority the right to review and SutroVax or its designee to reference such Drug Master File(s) in support of (and other Regulatory Materials, to the extent necessary to support) an application for Regulatory Approval submitted by SutroVax (or its permitted designee) for any Vaccine Composition produced using the Product the subject of the applicable Drug Master File (it being understood that SutroVax, its Affiliates\u00b7 and Sublicensees shall not have access to the information contained in such Drug Master Files (or other confidential Regulatory Materials submitted for a similar purpose as a Drug Master File (e.g., a clinical trial application for such purpose in the European Union)) as a result of such authorization and right to reference). Sutro shall file such Drug Master File in coordination with SutroVax's efforts to file and prosecute the applicable regulatory filings to such Regulatory Authority and Sutro shall be responsible, at SutroVax's sole expense (subject to a budget reasonably approved in advance by SutroVax), for providing the applicable Regulatory Authorities with such additional data as they may request (which may in some cases require Sutro to conduct additional studies), and for correcting any deficiencies of such Drug Master File identified by such Regulatory Authority, in each case in a reasonably prompt and efficient manner so as to prevent any delay in obtaining Regulatory Approvals for any Vaccine Composition based on such Drug Master File. In addition, Sutro shall be responsible for maintaining such Drug Master File in accordance with applicable Laws as necessary to support filing and prosecuting the applicable regulatory filing(s) and obtaining and maintaining the applicable Regulatory Approval(s) for Vaccine Compositions produced using the Products. For further clarity, to the extent Sutro discloses. Sutro Know- How to SutroVax, SutroVax shall have the right to include (and authorize the inclusion of) such Sutro Know-How in Regulatory Materials to the extent it is necessary or useful for the purpose of obtaining Regulatory Approval of a Vaccine Composition. Sutro's obligations under this Section 6.2 shall [***]. Sutro shall cause its personnel to record time spent performing such activities to a job code specific to such activities. For purposes of this Article 6 \\\"Drug Master File\\\" or \\\"DMF\\\" means a submission to a Regulatory Authority of information concerning the chemistry, manufacturing and controls (\\\"CMC\\\") of the Products to permit such Regulatory Authority to review this information in support of any application for Regulatory Approval for a product submitted by a party that has been granted a right to reference such submission without disclosing the contents of such submission to such party. Sutro shall file DMF(s) for the Products with other Regulatory Authorities in the Territory in accordance with the terms and conditions of the Phase 3/Commercial Supply Agreement referenced in Section 2.14 (and, for clarity, shall file DMF(s) for the Products with Regulatory Authorities in the European Union (including the United Kingdom) and Japan as necessary to comply with the requirements of such Regulatory Authorities, to the extent not filed under this Supply Agreement).\"}}, {\"id\": \"6.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance\", \"level\": 3, \"text\": \"6.2.1 Compliance. Subject to the foregoing, Sutro shall provide the information set forth under this Section 6.2 in a timely manner and compliant with the reporting requirements of the Regulatory Authorities.\"}}, {\"id\": \"6.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Safety Data\", \"level\": 3, \"text\": \"6.2.2 Safety Data. Each Party understands and acknowledges that the other Party and its Affiliates and respective licensees or sublicensees may need to access and utilize and include certain safety data (e.g., adverse event reports) pertaining to product made using Products that is generated or received by such Party and its Affiliates and respective licensees or sublicensees in its Regulatory Materials in its respective Territory as required by applicable Laws. Each Party shall have the right to share any and all such safety data generated by the other Party or the other Party's Affiliates or licensees or sublicensees with its Affiliates and Third Parties (including its licensees and sublicensees) as permitted under section 10.2 of the License Agreement.\"}}, {\"id\": \"6.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cooperation\", \"level\": 3, \"text\": \"6.2.3 Cooperation. Each Party agrees to (i) make its personnel reasonably available at their respective places of employment to consult with the other Party on issues related to the activities conducted in accordance with this Article 6 or otherwise relating to the development of the Products or Vaccine Compositions and thereafter in connection with any request from any Regulatory Authority, including with respect to regulatory, scientific, technical and clinical testing issues, or otherwise, throughout the Term, and (ii) otherwise provide such assistance as may be reasonably requested by the other from time-to-time in connection with the activities to be conducted under this Article 6 or otherwise relating to the development of the Vaccine Compositions or Products.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recalls\", \"level\": 2, \"text\": \"6.3 Recalls. Each of SutroVax and Sutro will immediately inform the other in writing if it believes one or more lots of any Product(s), or any products made by Sutro or its licensees using the Products (to the extent such products are made using Products from the same batch provided to SutroVax), or any Vaccine Compositions should be subject to recall from distribution, withdrawal or some other field action, or that potential adulteration, misbranding, and/or other issues have arisen that relate to the safety or efficacy of such Product. SutroVax shall have the final decision-making authority as to any such recall or field action and the sole right to initiate any such recall or field action with respect to Vaccine Compositions made using the Products. Sutro shall cooperate in the conduct of any recall or field action with respect to the Vaccine Compositions as reasonably requested by SutroVax. In the event it is determined that such a recall resulted from a breach by either Party of any of its representations, warranties, duties or obligations under this Supply Agreement, such Party shall be responsible for the costs of the recall and shall reimburse the other Party as necessary; provided that if both Parties share responsibility with respect to such recall, the costs shall be shared in the ratio of the Parties' contributory responsibility.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Retention of Samples\", \"level\": 2, \"text\": \"6.4 Retention of Samples. Sutro shall prepare and retain, and shall cause its subcontractors to prepare and retain, such samples and records in respect of the Product(s) and the Manufacture thereof as are required by Applicable Law (including, as applicable, cGMPs).\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Authority Inspections and Correspondence\", \"level\": 2, \"text\": \"6.5 Regulatory Authority Inspections and Correspondence. Sutro shall permit Regulatory Authorities to conduct such inspections of any Facility at which any of the Manufacturing activities relating to the Product(s) are performed, as such Regulatory Authorities may request, including pre-approval inspections,\u00b7 and shall cooperate with such Regulatory Authorities with respect to such inspections and any related matters, in each case that is related to the Manufacture of Product(s). Sutro shall give SutroVax or its Affiliates prior written notice of any such inspections, and shall keep SutroVax informed about the results and conclusions of each such regulatory inspection, including actions taken by Sutro to remedy conditions cited in such inspections. Sutro shall provide SutroVax with copies of any written inspection reports issued by anyRegulatory Authority and all correspondence between Sutro and any Regulatory Authority with respect thereto, including any notices of observation and all related correspondence, in each case relating to the Product(s) or its Manufacture or to general manufacturing concerns (e.g., facility compliance or the like) that are reasonably likely to impact the Product(s) to the extent such general manufacturing matters would be reasonably expected to have a material effect on the manufacture of Vaccine Compositions; provided that Sutro may redact from any such report and correspondence any Sutro Core Know-How and any information subject to an obligation of confidentiality to a Third Party. In addition, Sutro agrees to promptly notify and provide SutroVax copies of any material request, directive, or other written communication to or from Regulatory Authorities related to the Product or its Manufacture that would reasonably be expected to have a material effect on the manufacture of Vaccine Compositions (it being understood that SutroVax, its Affiliates and Sublicensees shall not have access to Sutro Core Know How (which Sutro may redact from such reports or correspondence provided to SutroVax) or Sutro's Drug Master Files or other confidential Regulatory Materials submitted for a similar purpose as a Drug Master File). Sutro shall provide SutroVax with a copy of the applicable portion of any correspondence made by Sutro to a Regulatory Authority for review and comment prior to submission to the applicable Regulatory Authority solely to the extent such correspondence made by Sutro is related to SutroVax or is in response to a request, directive or correspondence from the applicable Regulatory Authority regarding SutroVax or a Vaccine Composition (e.g., in response to a report regarding a pre- approval inspection for SutroVax). Sutro will consider in good faith any comments received from SutroVax within the time period indicated by Sutro (which shall not be less than [***], to the extent consistent with the require timeline for Sutro's response) with respect to any matter that relates to SutroVax. In addition, Sutro shall notify SutroVax of any occurrences or information that arise out of Sutro's Manufacturing activities that have, or could reasonably be expected to have, adverse regulatory compliance or reporting consequences concerning any Product(s) or which might otherwise be reasonably expected to adversely affect the supply by Sutro of Product(s) to SutroVax.\"}}, {\"id\": \"6.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Changes or Modifications in Manufacturing Activities\", \"level\": 2, \"text\": \"6.6 Changes or Modifications in Manufacturing Activities. Sutro shall not make any changes to the Specifications, processes, Facilities, raw materials, raw material suppliers or any other item that would affect the Manufacturing activities related to the Product (a \\\"Manufacturing Change\\\") that (a) would require a change to the applicable Drug Master File, (b) would be reasonably expected to cause SutroVax to be materially delayed obtaining any Regulatory Approval with respect to Vaccine Compositions or (c) causes the Product to not meet the Specification therefor (including the Activity Test with respect to Extract); without SutroVax's prior written consent (not to be unreasonably withheld, conditioned or delated). Notwithstanding the foregoing, Sutro shall promptly make and implement such changes as are required by Applicable Law provided that, prior to implementation, Sutro shall provide notice thereof to SutroVax and confer with SutroVax with respect to its timelines, estimated effect on Price and other issues regarding such implementation. Sutro shall provide SutroVax at least [***] days' written notice prior to implementing any Manufacturing Change. Sutro shall not make any change to the Specification for a Product without SutroVax's prior written consent. In addition, SutroVax shall have the right to request changes in or modifications to the Specifications and Sutro will consider in good faith any such requested changes or modifications. All such changes or modifications shall be documented in writing and shall be signed by an authorized representative of SutroVax and Sutro. If such changes or modifications result in a material change in Sutro's Manufacturing costs or lead times, the Parties shall agree upon an appropriate adjustment to the Price or in the delivery schedules, as the case may be, for Product(s) to be provided by Sutro hereunder. Sutro shall promptly implement any agreed upon changes to the Specifications.\"}}, {\"id\": \"6.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Quality Agreement\", \"level\": 2, \"text\": \"6.7 Quality Agreement. As soon as reasonably practicable after the Effective Date, the Parties shall enter into a quality agreement governing Sutro's supply of Products (the \\\"Quality Agreement\\\"), which Quality Agreement shall include the Specifications for the Product(s) consistent with the Specifications set forth in Schedule 2. Accordingly, to permit the Quality Agreement to be finalized within such period, Sutro shall provide SutroVax or its designee access to Sutro's Facilities and records to enable SutroVax or its designee to complete an audit pursuant to Section 5.1 within [***] days after the Effective Date.\"}}, {\"id\": \"ARTICLE 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATION AND WARRANTIES\", \"level\": 1, \"text\": \"ARTICLE 7 REPRESENTATION AND WARRANTIES\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SutroVax Warranties and Representations\", \"level\": 2, \"text\": \"7.1 SutroVax Warranties and Representations. SutroVax represents and warrants the following:\"}}, {\"id\": \"7.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SutroVax is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware\", \"level\": 3, \"text\": \"7.1.1 SutroVax is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.\"}}, {\"id\": \"7.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SutroVax has all requisite power and authority to enter into this Supply Agreement\", \"level\": 3, \"text\": \"7.1.2 SutroVax has all requisite power and authority to enter into this Supply Agreement. The person signing this Supply Agreement has the necessary corporate authority to legally bind SutroVax to the terms set forth herein.\"}}, {\"id\": \"7.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SutroVax's execution of this Supply Agreement and performance of the terms set forth herein will not cause SutroVax to b\", \"level\": 3, \"text\": \"7.1.3 SutroVax's execution of this Supply Agreement and performance of the terms set forth herein will not cause SutroVax to be in conflict with or constitute a breach of its organizational documents nor any other agreement, court order, consent decree or other arrangement, whether written or oral, by which it is bound.\"}}, {\"id\": \"7.1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SutroVax's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Appl\", \"level\": 3, \"text\": \"7.1.4 SutroVax's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Applicable Law in all material respects.\"}}, {\"id\": \"7.1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement is its legal, valid and binding obligation, enforceable against SutroVax in accordance with the te\", \"level\": 3, \"text\": \"7.1.5 This Supply Agreement is its legal, valid and binding obligation, enforceable against SutroVax in accordance with the terms and conditions hereof, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally or by the principles governing the availability of equitable remedies.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro Warranties and Representations\", \"level\": 2, \"text\": \"7.2 Sutro Warranties and Representations. Sutro represents and warrants the following:\"}}, {\"id\": \"7.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware\", \"level\": 3, \"text\": \"7.2.1 Sutro is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.\"}}, {\"id\": \"7.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro has all requisite power and authority to enter into this Supply Agreement and has the requisite skill, knowledge,\", \"level\": 3, \"text\": \"7.2.2 Sutro has all requisite power and authority to enter into this Supply Agreement and has the requisite skill, knowledge, staffing, financial resources, capacity and ability to carry out its obligations hereunder. The person signing this Supply Agreement has the necessary authority to legally bind Sutro to the terms set forth herein.\"}}, {\"id\": \"7.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro's execution of this Supply Agreement and performance of the terms set forth herein will not cause Sutro to be in c\", \"level\": 3, \"text\": \"7.2.3 Sutro's execution of this Supply Agreement and performance of the terms set forth herein will not cause Sutro to be in conflict with or constitute a breach of its organizational documents nor any other agreement, court order, consent decree or other arrangement, whether written or oral, by which it is bound.\"}}, {\"id\": \"7.2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Applica\", \"level\": 3, \"text\": \"7.2.4 Sutro's execution of this Supply Agreement and performance hereunder are in, and will be in, compliance with any Applicable Law in all material respects.\"}}, {\"id\": \"7.2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro has and will maintain throughout the Term all permits, licenses, registrations and other forms of governmental aut\", \"level\": 3, \"text\": \"7.2.5 Sutro has and will maintain throughout the Term all permits, licenses, registrations and other forms of governmental authorization. and approval as required by Applicable Law in order for Sutro to execute and deliver this Supply Agreement and to perform its obligations hereunder in accordance with all Applicable Law.\"}}, {\"id\": \"7.2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"as of the Effective Date, to the best of Sutro's knowledge, the practice of the Sutro Platform, including the use of the\", \"level\": 3, \"text\": \"7.2.6 as of the Effective Date, to the best of Sutro's knowledge, the practice of the Sutro Platform, including the use of the Products, does not infringe any Third Party patents.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"7 7\", \"level\": 2, \"text\": \"7.2.7 7.2.7 Sutro is not debarred and Sutro has not and will not use in any capacity the services of any person debarred under subsection 306(a) or (b) of the U.S. Generic Drug Enforcement Act of 1992, or other Applicable Law, nor have debarment proceedings against Sutro or any of its employees or permitted subcontractors been commenced.\"}}, {\"id\": \"7.2.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement is its legal, valid and binding obligation, enforceable against Sutro in accordance with the terms\", \"level\": 3, \"text\": \"7.2.8 This Supply Agreement is its legal, valid and binding obligation, enforceable against Sutro in accordance with the terms and conditions hereof, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors' rights generally or by the principles governing the availability of equitable remedies.\"}}, {\"id\": \"7.2.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"As of the Effective Date, there are no claims, judgments or settlements against or owed by Sutro or its Affiliates, or p\", \"level\": 3, \"text\": \"7.2.9 As of the Effective Date, there are no claims, judgments or settlements against or owed by Sutro or its Affiliates, or pending or, to the best of Sutro's knowledge, threatened claims or litigation, relating to the Product(s).\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Warranties\", \"level\": 2, \"text\": \"7.3 Product Warranties. Sutro represents and warrants that:\"}}, {\"id\": \"7.3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Sutro's Facility and all Product (as delivered in accordance with Section 2\", \"level\": 3, \"text\": \"7.3.1 Sutro's Facility and all Product (as delivered in accordance with Section 2.1 and until the expiration date thereof) supplied hereunder (and the Manufacture thereof) shall comply with this Supply Agreement, all Applicable Law (including cGMPs, if applicable),\u00b7be free from defects in material and workmanship, and meet all Specifications.\"}}, {\"id\": \"7.3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Title to all Product(s) provided under this Supply Agreement shall pass to SutroVax as set forth in Section 2\", \"level\": 3, \"text\": \"7.3.2 Title to all Product(s) provided under this Supply Agreement shall pass to SutroVax as set forth in Section 2.6, free and clear of any security interest, lien, or other encumbrance.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimer\", \"level\": 2, \"text\": \"7.4 Disclaimer. EACH PARTY AGREES AND ACKNOWLEDGES THAT, EXCEPT AS SET FORTH IN THIS ARTICLE 7, NEITHER PARTY MAKES ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND WHATSOEVER, IMPLIED OR STATUTORY, AND EACH PARTY HEREBY EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, IMPLIED OR STATUTORY, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AGAINST NON-INFRINGEMENT OR THE LIKE, OR ARISING FROM COURSE OF PERFORMANCE.\"}}, {\"id\": \"ARTICLE 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIALITY\", \"level\": 1, \"text\": \"ARTICLE 8 CONFIDENTIALITY\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Article 10 of the License Agreement (Confidentiality) is hereby incorporated into this Supply Agreement by reference\", \"level\": 2, \"text\": \"8.1 Article 10 of the License Agreement (Confidentiality) is hereby incorporated into this Supply Agreement by reference. The terms and provisions of this Supply Agreement (which shall be the Discloser's Information of both Parties) and all other information and data, including all notes, books, papers, diagrams, documents, reports, e-mail, memoranda, visual observations, oral communications and all other data or information in whatever form, that one Party or any of its Affiliates or representatives supplies or otherwise makes available to the other Party or its Affiliates or representatives pursuant to this Supply Agreement shall be deemed Discloser's Information pursuant to Article 10 of the License Agreement.\"}}, {\"id\": \"ARTICLE 9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION AND INSURANCE\", \"level\": 1, \"text\": \"ARTICLE 9 INDEMNIFICATION AND INSURANCE\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification\", \"level\": 2, \"text\": \"9.1 Indemnification.\"}}, {\"id\": \"9.1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification by Sutro\", \"level\": 3, \"text\": \"9.1.1 Indemnification by Sutro. Sutro hereby agrees, at its sole cost and expense, to defend, hold harmless and indemnify, to the extent permitted by Applicable Law, (collectively, \\\"Indemnify\\\") SutroVax and its Affiliates and their respective agents, directors, officers and employees of such Persons and the respective successors and assigns of any of the foregoing (the \\\"SutroVax Indemnitees\\\") from and against any and all liabilities, damages, penalties, fines, costs and expenses (including, reasonable attorneys' fees and other expenses of litigation) (collectively, \\\"Liabilities\\\") resulting from suits, claims, actions and demands, in each case brought by a Third Party (each, a \\\"Third-Party Claim\\\") against any SutroVax Indemnitee and arising from or occurring as a result of: [***]. Sutro's obligation to Indemnify the SutroVax Indemnitees pursuant to this Section 9.1.1 shall not apply to the extent that any such Liabilities are the result of a material breach by SutroVax of its obligations, representations, warranties or covenants under this Supply Agreement or the License Agreement or any SutroVax Indemnitee' s negligence or willful misconduct.\"}}, {\"id\": \"9.1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification by SutroVax\", \"level\": 3, \"text\": \"9.1.2 Indemnification by SutroVax. SutroVax hereby agrees to Indemnify Sutro and its agents, directors, officers and employees and the respective successors and assigns of any of the foregoing (the \\\"Sutro lndemnitees\\\") from and against any and all Liabilities resulting from Third-Party Claims against any Sutro Indemnitee arising from or occurring as a result of: [***]. SutroVax's obligation to Indemnify the Sutro Indemnitees pursuant to this Section 9.1.2 shall not apply to the extent that any such Liabilities are the result of a material breach by Sutro of its obligations, representations, warranties or covenants under this Supply Agreement or the License Agreement or any Sutro Indemnitee's negligence or willful misconduct.\"}}, {\"id\": \"9.1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Procedure\", \"level\": 3, \"text\": \"9.1.3 Procedure. To be eligible to be Indemnified hereunder, the indemnified Person shall provide the indemnifying Party with prompt written notice of the Third-Party Claim giving rise to the indemnification obligation pursuant to this Section 9.1 and the right to control the defense (with the reasonable cooperation of the indemnified Person) or settlement any such claim; provided, however, that the indemnifying Party shall not enter into any settlement that admits fault, wrongdoing or damages without the indemnified Person's written consent, such consent not to be unreasonably withheld or delayed. The indemnified Person shall have the right to join, but not to control, at its own expense and with counsel of its choice, the defense of any claim or suit that has been assumed by the indemnifying Party.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 2, \"text\": \"9.2 Insurance. Each Party shall procure and maintain insurance, including clinical trials and product liability insurance, adequate to cover its obligations hereunder and consistent with normal business practices of prudent companies similarly situated at all times during which any Product or Vaccine Compositions is being clinically tested in human subjects or commercially distributed or sold by such Party. It is understood that such insurance shall not be construed to create a limit of either Party's liability or indemnification obligations under this Article 9, or that the maintenance of such insurance shall not be construed to relieve either Party of its other obligations under this Supply Agreement. Each Party shall provide the other with written evidence of such insurance upon request. Each Party shall provide the other with written notice at least [***] days prior to the cancellation, non renewal or material change in such insurance.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"9.3 LIMITATION OF LIABILITY. EXCEPT (I) WITH RESPECT TO ANY BREACH OF ARTICLE 8 (CONFIDENTIALITY), (II) FOR THIRD PARTY PENALTIES, COSTS AND EXPENSES AS SET FORTH IN SECTION 2.9, OR (III) FOR [***], TO THE MAXIMUM EXTENT PERMITTED BY LAW, (A) NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, WHETHER LIABILITY IS ASSERTED IN CONTRACT, TORT (INCLUDING NEGLIGENCE), STRICT LIABILITY, OR ANY OTHER THEORY OR FORM OF ACTION, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY THEREOF; AND (B) EACH PARTY'S TOTAL LIABILITY TO THE OTHER PARTY UNDER THIS SUPPLY AGREEMENT SHALL NOT EXCEED [***]. SUTRO'S LIABITY TO SUTROVAX FOR THIRD PARTY PENALTIES, COSTS AND EXPENSES UNDER SECTION 2.9 SHALL NOT EXCEED [***].\"}}, {\"id\": \"ARTICLE 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 10 TERM AND TERMINATION\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"10.1 Term. The term of this Supply Agreement shall begin on the Effective Date first set forth above and shall remain in effect until the later of (a) July 31, 2021 or (b) the date that the Parties enter into the Phase 3/Commercial Supply Agreement and Sutro is supplying to SutroVax each Product under the Phase 3/Commercial Supply Agreement (the \\\"Term\\\"), unless it is terminated earlier in accordance with Section 10.2.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination\", \"level\": 2, \"text\": \"10.2 Termination. Notwithstanding anything to the contrary in this Supply Agreement, this Supply Agreement may be terminated:\"}}, {\"id\": \"10.2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"in its entirety or with respect to one or more Products, on a Product-by-Product basis, by mutual written consent of Sut\", \"level\": 3, \"text\": \"10.2.1 in its entirety or with respect to one or more Products, on a Product-by-Product basis, by mutual written consent of Sutro and SutroVax;\"}}, {\"id\": \"10.2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"in its entirety by a Party if the other Party materially breaches any of the material terms, conditions or agreements co\", \"level\": 3, \"text\": \"10.2.2 in its entirety by a Party if the other Party materially breaches any of the material terms, conditions or agreements contained in this Supply Agreement to be kept, observed or performed by the other Party, by giving the Party who committed the breach [***] days' prior written notice, unless the notified Party shall have cured the breach within such [***]-day period; and\"}}, {\"id\": \"10.2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"in its entirety or with respect to one or more Products, on a Product-by-Product basis, by SutroVax upon [***] days' pri\", \"level\": 3, \"text\": \"10.2.3 in its entirety or with respect to one or more Products, on a Product-by-Product basis, by SutroVax upon [***] days' prior written notice to Sutro for any reason.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effects of Termination\", \"level\": 2, \"text\": \"10.3 Effects of Termination. Upon the expiration of the Term or termination of this Supply Agreement, in its entirety or with respect to one or more Products, this Supply Agreement shall, except as otherwise provided in this Section 10.3 or Section 10.5, be of no further force or effect; provided, however, that (a) in the event this Supply Agreement is terminated by SutroVax pursuant to Section 10.2.3 and there are outstanding Work Orders or other purchase orders accepted by Sutro that would not be fulfilled as a result of such termination, SutroVax shall reimburse Sutro for all supplies and materials purchased by Sutro and time incurred by Sutro personnel (to the extent incurred solely for manufacture of Product for SutroVax) for the manufacture, or preparation for the manufacture, of Products for any Work Orders placed by SutroVax and any other purchase orders accepted by Sutro prior to such expiration or termination, in each case to the extent Sutro cannot otherwise reasonably mitigate such the costs and expenses of such supplies, materials and time (e.g., by use of resulting supplies, materials and work-in-progress Product for other purposes); provided that to the extent SutroVax pays for any supplies or materials, upon SutroVax's request Sutro shall promptly transfer and deliver such supplies and materials to SutroVax; and (b) if this Supply Agreement is terminated with respect to one or more Products, but not all Products, then this Supply Agreement shall continue in full force and effect with respect to the applicable Product(s) for which it is not terminated.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nonexclusive Remedy\", \"level\": 2, \"text\": \"10.4 Nonexclusive Remedy. Exercise of any right of termination afforded to either Party under this Supply Agreement (i) shall not prejudice any other legal rights or remedies either Party have against the other in respect of any breach of the terms and conditions of this Supply Agreement, and (ii) shall be without any obligation or liability arising from such termination other than such obligations expressly arising from termination of this Supply Agreement.\"}}, {\"id\": \"ARTICLE 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISPUTE RESOLUTION\", \"level\": 1, \"text\": \"ARTICLE 11 DISPUTE RESOLUTION\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Principal Contacts\", \"level\": 2, \"text\": \"11.1 Principal Contacts. Each Party will appoint an individual employed by it to serve as its \\\"Principal Contact\\\" for purposes of this Supply Agreement. Either Party may from time to time replace its Principal Contact with a different employee, but unless required due to events beyond its control, neither Party will replace its Principal Contact without at least [***] days prior notice to the other Party. The two Principal Contacts shall communicate with each other regularly during the Term as the Parties may agree or as the Principal Contacts shall mutually determine to be useful.\"}}, {\"id\": \"11.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Baseball Arbitration\", \"level\": 2, \"text\": \"11.4 Baseball Arbitration. In the event (a) the Parties do not enter into a Phase 3/Commercial Supply Agreement as described in Section 2.14 or (b) the Parties do not enter into a Transfer Addendum as described in Section 2.15 (\\\"Disputed Matter\\\"), then upon either Party's request with respect to the Disputed Matter in clause (a) or SutroVax's request with respect to the Disputed Matter in clause (b), such Disputed Matter shall be resolved by binding arbitration conducted pursuant to Section 11.3, except that the procedures for the conduct of such arbitration shall be as follows:\"}}, {\"id\": \"11.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each Party shall provide the arbitrator and the other Party with a written report setting forth its position with respec\", \"level\": 3, \"text\": \"11.4.1 Each Party shall provide the arbitrator and the other Party with a written report setting forth its position with respect to the substance of such Disputed Matter and a full draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, and may submit a revised report, position and draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, to the arbitrator within [***] days of receiving the other Party's report and draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable. If so requested by the arbitrator, each Party shall make oral and/or other written submissions to the arbitrator in accordance with procedures to be established by the arbitrator; provided that other Party shall have the right to be present during any oral submissions. The arbitrator shall select one of the Party's draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, as his or her decision, based on what is most reasonable and equitable to each of the Parties under the circumstances and reflective of reasonable and customary terms in the biopharmaceutical industry for agreements of this type and most closely reflects the Parties' intent as expressed in this Supply Agreement and the License Agreement, and shall not have the authority to render any substantive decision other than to so select the draft Phase 3/Commercial Supply Agreement or Transfer Addendum, as applicable, of Sutro or SutroVax (as initially submitted, or as revised in accordance with the foregoing, as applicable). For clarity, it is understood that the Parties intend the arbitration under this Section 11.4 to be a \\\"baseball arbitration\\\" type proceeding; and the arbitrator may fashion such detailed procedures as the arbitrator considers appropriate to implement this intent. Notwithstanding anything to the contrary, in no event shall the Phase 3/Commercial Supply Agreement or Transfer Addendum contain any provision granting to SutroVax or its Affiliates or Sublicensees any right to obtain or use any Sutro Core Know-How.\"}}, {\"id\": \"11.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In any arbitration under this Section 11\", \"level\": 3, \"text\": \"11.4.2 In any arbitration under this Section 11.4, the arbitrator and the Parties shall use their best efforts to resolve such Disputed Matter within [***] days after the selection of the arbitrator, or as soon thereafter as is practicable.\"}}, {\"id\": \"ARTICLE 12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"ARTICLE 12 MISCELLANEOUS\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Expenses\", \"level\": 2, \"text\": \"12.1 Expenses. Except as otherwise expressly provided herein, each Party shall bear its own costs, fees and expenses incurred by such Party in connection with this Supply Agreement.\"}}, {\"id\": \"12.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licenses and Permits\", \"level\": 2, \"text\": \"12.2 Licenses and Permits. Each Party shall, at its sole cost and expense, maintain in full force and affect all necessary licenses, permits, and other authorizations required by Applicable Law in order to carry out its duties and obligations hereunder.\"}}, {\"id\": \"12.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"12.3 Force Majeure. No Party shall be liable for a failure or delay in performing any of its obligations under this Supply Agreement if, but only to the extent that such failure or delay is due to causes beyond the reasonable control of the affected Party, including: (a) acts of God; (b) fire, explosion, or unusually severe weather; (c) war, invasion, riot, terrorism, or other civil unrest; (d) governmental laws, orders, restrictions, actions, embargo or blockages; (e) national or regional emergency; (f) strikes or industrial disputes at a national level which directly impact the affected Party's performance under this Supply Agreement; or (g) other similar cause outside of the reasonable control of such Party (\\\"Force Majeure\\\"); provided that the Party affected shall promptly notify the other of the Force Majeure condition and shall use reasonable efforts to eliminate, cure or overcome any such causes and resume performance of its obligations as soon as possible. If the performance of any obligation of a Party under this Supply Agreement is delayed owing to such a Force Majeure for any continuous period of more than [***] days, the other Party shall have the right to terminate this Supply Agreement.\"}}, {\"id\": \"12.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither Party may assign or transfer this Supply Agreement, including by merger, operation of law, or otherwise, without\", \"level\": 2, \"text\": \"12.4 Neither Party may assign or transfer this Supply Agreement, including by merger, operation of law, or otherwise, without the other Party's prior written consent (which shall not be withheld unreasonably) except each Party may assign this Supply Agreement without the other Party's consent in the case of assignment or transfer to a Third Party that succeeds to all or substantially all of the assigning Party's business and assets relating to the subject matter of this Supply Agreement, whether by sale, merger, operation of law or otherwise. Any attempted assignment by a Party in violation of this Section without the written consent of the other Party will be null and void. Except as above limited, this Supply Agreement is binding upon and will inure to the benefit of each of the Parties, its successors and assigns. Without limiting the foregoing, in the event that a Party is acquired, the acquiring Party shall agree in writing to abide by the terms of this Supply Agreement. Sutro agrees that if it assigns the License Agreement to any successor as allowed under section 15.1 of the License Agreement, it will also assign to such successor this Supply Agreement in accordance with this Section 12.4.\"}}, {\"id\": \"12.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement incorporates the Exhibits referenced herein\", \"level\": 2, \"text\": \"12.5 This Supply Agreement incorporates the Exhibits referenced herein. This Supply Agreement, together with the License Agreement, constitutes the entire agreement and supersedes all prior agreements and understandings, both written and oral, between the Parties hereto with respect to its subject matter. To the extent of any conflict between this Agreement and the License Agreement, the License Agreement shall govern and control.\"}}, {\"id\": \"12.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All notices, requests or other communication provided for or permitted hereunder shall be given in writing and shall be\", \"level\": 2, \"text\": \"12.6 All notices, requests or other communication provided for or permitted hereunder shall be given in writing and shall be hand delivered or sent by confirmed facsimile, reputable courier or by registered or certified mail, postage prepaid, return receipt requested, to the address set forth below, or to such other address of which either Party may inform the other in writing. Notices will be deemed delivered on the earliest of transmission by facsimile, actual receipt or [***] days after mailing as described herein. If to Sutro: Sutro Biopharma, Inc. 310 Utah Ave., Suite 150 South San Francisco, CA 94080 Attention: Chief Executive Officer If to SutroVax: SutroVax, Inc. 353 Hatch Dr. Foster City, CA 94404 Attention: Chief Executive Officer\"}}, {\"id\": \"12.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement may be amended, modified or waived only in a writing signed by the Party or Parties to be bound th\", \"level\": 2, \"text\": \"12.7 This Supply Agreement may be amended, modified or waived only in a writing signed by the Party or Parties to be bound thereby.\"}}, {\"id\": \"12.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If any provision of this Supply Agreement shall be held invalid, illegal or unenforceable, such provision shall be enfor\", \"level\": 2, \"text\": \"12.8 If any provision of this Supply Agreement shall be held invalid, illegal or unenforceable, such provision shall be enforced to the maximum extent permitted by law and the Parties' fundamental intentions hereunder, and the remaining provisions shall not be affected or impaired.\"}}, {\"id\": \"12.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing herein contained shall constitute this a joint venture agreement and nothing herein shall constitute any Party a\", \"level\": 2, \"text\": \"12.9 Nothing herein contained shall constitute this a joint venture agreement and nothing herein shall constitute any Party as a partner, principal or agent of any other, this being an agreement between independent contracting entities. Except as expressly set forth herein, no Party shall have the authority to bind any other in any respect whatsoever to Third Parties. Except as provided herein, nothing contained in this Supply Agreement shall be construed as conferring any right on any Party to use any name, trade name, trademark or other designation of any other Party hereto, unless the express, written permission of such other Party has been obtained.\"}}, {\"id\": \"12.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement has been submitted to the scrutiny of, and has been negotiated by, both Parties and their counsel,\", \"level\": 2, \"text\": \"12.10 This Supply Agreement has been submitted to the scrutiny of, and has been negotiated by, both Parties and their counsel, and shall be given a fair and reasonable interpretation in accordance with its terms, without consideration or weight being given to any such term's having been drafted by any Party or its counsel.\"}}, {\"id\": \"12.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Cali\", \"level\": 2, \"text\": \"12.11 This Supply Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of California, without regard to any conflict of laws rules to the contrary.\"}}, {\"id\": \"12.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each Party acknowledges that the other Party may likely suffer irreparable harm from such Party's breach or threatened b\", \"level\": 2, \"text\": \"12.12 Each Party acknowledges that the other Party may likely suffer irreparable harm from such Party's breach or threatened breach of this Agreement and the other Party, in such cases, would therefore be entitled, without waiving any other right or remedy available to, to injunctive relief (including specific performance) without the requirement to post a bond, provided the waiver by such Party of the other Party's requirement to post a bond shall expire on the Change of Control of the other Party, and each party agrees that the arbitrator selected under Section 11.3 shall have the power to grant such injunctive relief (or order specific performance). The Parties shall comply with any such injunctive relief (including specific performance) ordered by the arbitrator and agree that such order may, to the extent not precluded by applicable law, be enforceable as a final award in any court of competent jurisdiction.\"}}, {\"id\": \"12.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Supply Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but al\", \"level\": 2, \"text\": \"12.13 This Supply Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Facsimile and other electronically scanned signatures shall have the same effect as their originals. [The remainder of this page is left intentionally blank] IN WITNESS WHEREOF, the Parties have caused this Supply Agreement to be executed by their respective duly authorized officers as of the Effective Date, each copy of which will for all purposes be deemed to be an original. SUTRO BIOPHARMA, INC. SUTROVAX, INC. By: /s/ William J. Newell By: /s/ Grant E. Pickering Name: William J. Newell Name: Grant E. Pickering Title: CEO Title: President & CEO SCHEDULE 1 PRODUCTS AND PRICE [***] SCHEDULE2 SPECIFICATIONS {6 pages omitted} [***] SCHEDULE3 INITIAL ORDER [***] SCHEDULE 2.15.1 REPRESENTATIVE CMOS [***]\"}}, {\"id\": \"party:SutroVax, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"SutroVax, Inc.\", \"role\": \"SutroVax\", \"address\": \"353 Hatch Dr., Foster City, CA 94404\"}}, {\"id\": \"party:Sutro Biopharma, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Sutro Biopharma, Inc.\", \"role\": \"Sutro\", \"address\": \"310 Utah Ave, Suite 150, South San Francisco, CA, 94080\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"term:Supply Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Supply Agreement\", \"text\": \"This SUPPLY AGREEMENT (\\\"Supply Agreement\\\") is made as of May 29, 2018 (the \\\"Effective Date\\\") by and between SutroVax, Inc., a Delaware corporation having principal offices at 353 Hatch Dr., Foster City, CA 94404 (\\\"SutroVax\\\") and Sutro Biopharma, Inc., a Delaware corporation, having principal offices at 310 Utah Ave, Suite 150, South San Francisco, CA, 94080 (\\\"Sutro\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"This SUPPLY AGREEMENT (\\\"Supply Agreement\\\") is made as of May 29, 2018 (the \\\"Effective Date\\\") by and between SutroVax, Inc., a Delaware corporation having principal offices at 353 Hatch Dr., Foster City, CA 94404 (\\\"SutroVax\\\") and Sutro Biopharma, Inc., a Delaware corporation, having principal offices at 310 Utah Ave, Suite 150, South San Francisco, CA, 94080 (\\\"Sutro\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Party\", \"text\": \"SutroVax and Sutro may be referred to herein by name or individually, as a \\\"Party\\\" and collectively, as the \\\"Parties.\\\"\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:License Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"License Agreement\", \"text\": \"Sutro controls certain proprietary technology which permits cell-free expression of proteins, and Sutro licensed such technology to SutroVax under that certain Amended and Restated SutroVax Agreement dated as of October 12, 2015 (the \\\"License Agreement\\\").\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"1.1 \\\"Affiliate\\\" means, with respect to either Party, any business entity controlling, controlled by, or under common control with such Party. For the purpose of this definition only, \\\"control\\\" means (i) the possession, directly or indirectly, of the power to direct the management or policies of a business entity, whether through the ownership of voting securities, by contract or otherwise, or (ii) the ownership, directly or indirectly, of at least fifty percent (50%) of the voting securities or other ownership interest of a business entity. Notwithstanding the above, in no event shall Sutro (or any entity that would be an Affiliate of SutroVax solely because it is an Affiliate of Sutro) be deemed an Affiliate of SutroVax, or SutroVax (or any entity that would be an Affiliate of Sutro solely because it is an Affiliate of SutroVax) an Affiliate of Sutro.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Applicable Law\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicable Law\", \"text\": \"1.2 \\\"Applicable Law\\\" means all laws, ordinances, rules, rulings, directives and regulations of any Governmental Authority that apply to the development, manufacture or supply of any Product or the other activities contemplated under this Supply Agreement, including (i) all applicable federal, state and local laws, rules and regulations; (ii) the U.S. Federal Food, Drug and Cosmetic Act; (iii) regulations and guidelines of the FDA and other Regulatory Authorities, including cGMPs, if applicable; and (iv) any applicable non-U.S. equivalents of any of the foregoing, including guidelines of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (as amended from time to time).\", \"definition_clause\": \"1.2\"}}, {\"id\": \"term:cGMPs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"cGMPs\", \"text\": \"1.3 \\\"cGMPs\\\" means current good manufacturing practices and standards as set forth (and as amended from time to time) in the current Good Manufacturing Practice Regulations of the U.S. Code of Federal Regulations, including 21 C.F.R. Sections 210 and 211, the European Community Directive 2003/94/EC and the ICH Harmonised Tripartite Guideline, Good Manufacturing Practice Guides for Active Pharmaceutical Ingredients (Q7).\", \"definition_clause\": \"1.3\"}}, {\"id\": \"term:Components\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Components\", \"text\": \"1.4 \\\"Components\\\" means any product or material used in the Manufacture of the Products including the packaging materials.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"term:Extract\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Extract\", \"text\": \"1.5 \\\"Extract\\\" means Sutro's extract derived from strains of E. coli identified on Schedule 1 attached hereto, as may be amended from time to time in accordance with Section 12.7, and any new versions and improvements thereof that may be included in Schedule 1 by written agreement of the Parties in accordance with Section 12.7.\", \"definition_clause\": \"1.5\"}}, {\"id\": \"term:Facility\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Facility\", \"text\": \"1.6 \\\"Facility\\\" or \\\"Facilities\\\" means the facilities where Product will be Manufactured as set forth in Schedule 1. Schedule 1 may be amended from time to time in accordance with this Supply Agreement to add or remove facilities.\", \"definition_clause\": \"1.6\"}}, {\"id\": \"term:FDA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"FDA\", \"text\": \"1.7 \\\"FDA\\\" means the United States Food and Drug Administration, or any successor agency thereto performing similar functions.\", \"definition_clause\": \"1.7\"}}, {\"id\": \"term:Fully Burdened Manufacturing Costs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fully Burdened Manufacturing Costs\", \"text\": \"1.8 \\\"Fully Burdened Manufacturing Costs\\\" means, with respect to a Product, Sutro's costs of manufacturing such Product, which manufacturing costs shall mean: (a) [***], and (b) [***], in each case to the extent directly allocated to and incurred in the manufacture by Sutro of such Product supplied to SutroVax, its Affiliates and Sublicensees. Fully Burdened Manufacturing Costs shall not include any [***] and shall be calculated in accordance with the foregoing, GAAP and Sutro's policies and procedures for its other products, in each case consistently applied (and such plant operations and support services costs shall be allocated consistent with GAAP and other products of Sutro in that facility).\", \"definition_clause\": \"1.8\"}}, {\"id\": \"term:Governmental Authority\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Governmental Authority\", \"text\": \"1.9 \\\"Governmental Authority\\\" means any court, agency, department, authority or other instrumentality of any nation, state, country, city or other political subdivision, including any Regulatory Authority.\", \"definition_clause\": \"1.9\"}}, {\"id\": \"term:Manufacture\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacture\", \"text\": \"1.10 \\\"Manufacture\\\" or \\\"Manufacturing\\\" means the processes and procedures for the supply of the Products, including, (a) the supply and quality control of the Components; (b) the manufacture of the Products in bulk; (c) the Packaging and labeling of the Products; (d) the quality control of the Products; and (e) the storage of the Products until shipment.\", \"definition_clause\": \"1.10\"}}, {\"id\": \"term:Package\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Package\", \"text\": \"1.11 \\\"Package\\\" or \\\"Packaging\\\" means packaging Product(s) in accordance with applicable Specifications.\", \"definition_clause\": \"1.11\"}}, {\"id\": \"term:Person\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Person\", \"text\": \"1.12 \\\"Person\\\" means an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or political subdivision or an agency thereof.\", \"definition_clause\": \"1.12\"}}, {\"id\": \"term:Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Price\", \"text\": \"1.13 \\\"Price\\\" means the price to be paid by SutroVax for each Product as set forth on Schedule 1 of this Supply Agreement and as may be modified from time to time in accordance with Section 3.2.\", \"definition_clause\": \"1.13\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"1.14 \\\"Product(s)\\\" means the Extract and Custom Reagents.\", \"definition_clause\": \"1.14\"}}, {\"id\": \"term:Custom Reagents\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Custom Reagents\", \"text\": \"1.15 \\\"Custom Reagents\\\" means Sutro's custom reagents identified on Schedule 1 attached hereto, and any new versions and improvements thereof that may be included in Schedule 1 by written agreement of the Parties in accordance with Section 12.7.\", \"definition_clause\": \"1.15\"}}, {\"id\": \"term:Regulatory Approval\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Approval\", \"text\": \"1.16 \\\"Regulatory Approval\\\" means, with respect to a product, all approvals, licenses, registrations or authorizations necessary to market and sell such product in a particular jurisdiction in the Territory (including applicable approvals of labeling, price and reimbursement for such product in such jurisdiction).\", \"definition_clause\": \"1.16\"}}, {\"id\": \"term:Regulatory Authority\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Authority\", \"text\": \"1.17 \\\"Regulatory Authority\\\" means any federal, national, multinational, state, provincial or local regulatory agency, department, bureau or other governmental entity, including the FDA, with authority over the development, Manufacture or commercialization (including approval of Regulatory Approvals) of any Product(s) in any jurisdiction in the Territory.\", \"definition_clause\": \"1.17\"}}, {\"id\": \"term:Regulatory Materials\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Materials\", \"text\": \"1.18 \\\"Regulatory Materials\\\" means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals and/or other filings made to, received from or otherwise conducted with a Regulatory Authority (including minutes of meeting with Regulatory Authorities) that are necessary or reasonably desirable to access in connection with the development, manufacture, marketing, sale or other commercialization of any Product in a particular country or regulatory jurisdiction. Regulatory Materials include, without limitation, INDs, NDAs, BLAs, clinical trial applications, marketing approval applications and applications for pricing approvals.\", \"definition_clause\": \"1.18\"}}, {\"id\": \"term:Required Standards\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Required Standards\", \"text\": \"1.19 \\\"Required Standards\\\" means Applicable Law, the Specifications, and the warranties given by Sutro in Section 7.3, provided that Required Standards shall not include compliance with cGMPs for Custom Reagents, Extract identified as \\\"research grade\\\" Extract or Other Extracts.\", \"definition_clause\": \"1.19\"}}, {\"id\": \"term:Specifications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specifications\", \"text\": \"1.20 \\\"Specifications\\\" means, with respect to a Product or applicable Component thereof, all written product, regulatory, Manufacturing, release criterion, quality control and quality assurance procedures, processes, practices, standards, instructions and specifications applicable to the Manufacture of such Product or Component, as agreed to by the Parties in writing from time to time. The initial Specifications for the Products are attached hereto as Schedule 2.\", \"definition_clause\": \"1.20\"}}, {\"id\": \"term:SutroVax CMO\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SutroVax CMO\", \"text\": \"1.21 \\\"SutroVax CMO\\\" means any contract manufacturer responsible for supplying or manufacturing a Vaccine Composition on behalf of SutroVax or its Affiliates, selected in accordance with Section .2.\", \"definition_clause\": \"1.21\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"1.22 \\\"Territory\\\" means worldwide.\", \"definition_clause\": \"1.22\"}}, {\"id\": \"term:Third Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party\", \"text\": \"1.23 \\\"Third Party\\\" means any Person other than SutroVax, Sutro, or their respective Affiliates.\", \"definition_clause\": \"1.23\"}}, {\"id\": \"term:Work Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Work Order\", \"text\": \"From time to time, Sutro and SutroVax may execute one or more work orders, that describe the Product to be Manufactured, the quantities of each Product to be Manufactured and supplied to SutroVax, the Price to be charged by Sutro (which shall be as set forth in Section 3.2) and paid by SutroVax for the Product, and the delivery date(s) for such Product, (as executed, a \\\"Work Order\\\").\", \"definition_clause\": \"2.3\"}}, {\"id\": \"term:Initial Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Order\", \"text\": \"Notwithstanding Section 2.3 or this Section 2.4, Sutro accepts and agrees to fulfil the order previously placed by or on behalf of SutroVax (or to be placed by or on behalf of SutroVax, if no already placed) for the quantities of Product set forth in Schedule 3 by the delivery date set forth therein (the \\\"Initial Order\\\").\", \"definition_clause\": \"2.4.3\"}}, {\"id\": \"term:Phase 3/Commercial Supply Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Phase 3/Commercial Supply Agreement\", \"text\": \"If requested by SutroVax in writing (which request shall not be made prior to [***]), the Parties shall negotiate in good faith reasonable terms and conditions of an agreement for the supply by Sutro of the Products for the production of Vaccine Compositions for use in phase 3 clinical studies and for commercial purposes (\\\"Phase 3/Commercial Supply Agreement\\\").\", \"definition_clause\": \"2.14\"}}, {\"id\": \"term:CMO\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"CMO\", \"text\": \"Upon SutroVax' written request, the Parties agree to negotiate in good faith an addendum to this Supply Agreement setting forth the terms and conditions pursuant to which Sutro will conduct a Process Transfer to a Third Party contract manufacturer (\\\"CMO\\\") and/or engage such CMO to establish Capacity to Manufacture Extract (as Process Transfer and Capacity are defined below), in each case for the Manufacture and supply of such Extract for SutroVax' (or its Affiliate's or SutroVax CMO's) use to manufacture Vaccine Compositions, consistent with the remainder of this Section 2.15 (such addendum, a \\\"Transfer Addendum\\\").\", \"definition_clause\": \"2.15.1\"}}, {\"id\": \"term:Transfer Addendum\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Transfer Addendum\", \"text\": \"Upon SutroVax' written request, the Parties agree to negotiate in good faith an addendum to this Supply Agreement setting forth the terms and conditions pursuant to which Sutro will conduct a Process Transfer to a Third Party contract manufacturer (\\\"CMO\\\") and/or engage such CMO to establish Capacity to Manufacture Extract (as Process Transfer and Capacity are defined below), in each case for the Manufacture and supply of such Extract for SutroVax' (or its Affiliate's or SutroVax CMO's) use to manufacture Vaccine Compositions, consistent with the remainder of this Section 2.15 (such addendum, a \\\"Transfer Addendum\\\").\", \"definition_clause\": \"2.15.1\"}}, {\"id\": \"term:Alternate Supplier\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Alternate Supplier\", \"text\": \"Such Transfer Addendum shall: (i) include a plan and budget for the conduct of the Process Transfer and/or establishment of such Capacity, which shall include amounts charged by the CMO (as defined further below, the \\\"Alternate Supplier\\\") to receive and conduct such Process Transfer and/or establish such Capacity, as well as reasonable FTE costs for Sutro personnel performing and managing technology transfer activities in accordance with the Transfer Addendum\u00b7 (ii) require SutroVax to fund the costs incurred by Sutro to conduct Process Transfer and/or establish such Capacity in accordance with such budget; (iii) provide for initiation and completion of the Process Transfer and establishment of Capacity as requested by SutroVax, to the extent possible; (iv) to the extent requested by SutroVax, be designed to enable the Alternate Supplier to Manufacture Extract of suitable quality for use in Phase 3 clinical trials and commercialization of a Vaccine Composition at a capacity to support SutroVax' projected commercial requirements for Extract (or other capacity identified by SutroVax in connection with the negotiation of the Transfer Addendum), as requested by SutroVax; (v) require the Parties to fully cooperate to verify that the Extract supplied by the Alternate Supplier meets the Specifications, to validate the Manufacturing process implemented at the Alternate Supplier and to qualify the Alternate Supplier, in each case to supply Extract for SutroVax' use in Phase 3 clinical trials and commercialization of a Vaccine Composition (collectively, with respect to Capacity established, \\\"Validating\\\" such Capacity); (vi) include mechanisms for keeping SutroVax fully informed, at scheduled intervals not to exceed once per quarter, of the progress of the Process Transfer and establishing such Capacity, as applicable, including with respect to the anticipated date for qualifying the Alternate Supplier and any changes to such anticipated date; (vii) provide a right for SutroVax to modify the timing of or terminate the Process Transfer, Capacity or specified aspects thereof on reasonable notice, subject to SutroVax' agreement to bear any resulting termination or cancellation fees charged by the Alternative Supplier; and (viii) include a mechanism for Sutro to cooperate with SutroVax and keep SutroVax reasonably informed with respect to Sutro's negotiation of an agreement with a potential Alternate Supplier for a Process Transfer and/or establishment of Capacity, including with respect to pricing for Extract from the Alternate Supplier to Sutro and any commitments to purchase quantities of Extract from the Alternate Supplier that SutroVax would be obligated to assume (e.g., in connection with establishing Capacity), if any, and require Sutro to obtain SutroVax' approval (not to be withheld unreasonably) of the terms of such agreement prior to entering into such agreement to the extent that the terms apply to SutroVax (it being understood that Sutro may redact any terms that are not relevant to SutroVax).\", \"definition_clause\": \"2.15.1\"}}, {\"id\": \"term:Validating\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Validating\", \"text\": \"(v) require the Parties to fully cooperate to verify that the Extract supplied by the Alternate Supplier meets the Specifications, to validate the Manufacturing process implemented at the Alternate Supplier and to qualify the Alternate Supplier, in each case to supply Extract for SutroVax' use in Phase 3 clinical trials and commercialization of a Vaccine Composition (collectively, with respect to Capacity established, \\\"Validating\\\" such Capacity);\", \"definition_clause\": \"2.15.1\"}}, {\"id\": \"term:Process Transfer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Process Transfer\", \"text\": \"As used above, \\\"Process Transfer\\\" means a technology transfer of Sutro's know-how and information as is necessary or useful for the Third Party CMO to Manufacture in its own facilities Extract that meets SutroVax' requirements, including any such information and know-how as would be needed for such CMO to scale up such Manufacture to the requested commercial volumes.\", \"definition_clause\": \"2.15.1\"}}, {\"id\": \"term:Capacity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Capacity\", \"text\": \"To establish \\\"Capacity\\\" means that the CMO would take such actions as are necessary (including validation and if necessary adapting or reserving existing facilities, establishing new facilities and/or procuring necessary equipment) to Manufacture Extract meeting SutroVax' requirements for Phase 3 and commercial supply in such quantities as SutroVax designates.\", \"definition_clause\": \"2.15.1\"}}, {\"id\": \"term:Taxes\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Taxes\", \"text\": \"3.4 Taxes. The Prices are exclusive of all Taxes. SutroVax will pay all taxes and duties that are assessed by any national, federal, state or local governmental authority on SutroVax's purchase or use of the Products, including, without limitation, sales, use, excise, value-added and withholding taxes, but excluding any taxes based on Sutro's income or gross receipts (collectively, \\\"Taxes\\\"). Sutro will separately identify all such Taxes on Sutro's invoice.\", \"definition_clause\": \"3.4\"}}, {\"id\": \"term:COA/COC\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"COA/COC\", \"text\": \"Each shipment of Product shall be accompanied by a certificate of analysis describing all current requirements of the Specifications and results of tests performed on such Product and a certificate of conformity certifying that the quantities of Product supplied have been Manufactured, controlled and released according to the Required Standards (\\\"COA/COC\\\") as set forth in the applicable Quality Agreement (subject to SutroVax's conduct of the SutroVax Activity Test to confirm Extract meets the SutroVax Activity Criteria).\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:Sutro Activity Test\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sutro Activity Test\", \"text\": \"Two of the tests and corresponding COA/COC acceptance criteria for the Extract shall be the performance of a productivity (Activity) test of the applicable Sutro protein (the \\\"Sutro Activity Test\\\" and \\\"Sutro Activity Criteria\\\") and the performance of a productivity (activity) test of the applicable Vaccine Composition (the \\\"SutroVax Activity Test\\\" and \\\"SutroVax Activity Criteria\\\").\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:Sutro Activity Criteria\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sutro Activity Criteria\", \"text\": \"Two of the tests and corresponding COA/COC acceptance criteria for the Extract shall be the performance of a productivity (Activity) test of the applicable Sutro protein (the \\\"Sutro Activity Test\\\" and \\\"Sutro Activity Criteria\\\") and the performance of a productivity (activity) test of the applicable Vaccine Composition (the \\\"SutroVax Activity Test\\\" and \\\"SutroVax Activity Criteria\\\").\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:SutroVax Activity Test\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SutroVax Activity Test\", \"text\": \"Two of the tests and corresponding COA/COC acceptance criteria for the Extract shall be the performance of a productivity (Activity) test of the applicable Sutro protein (the \\\"Sutro Activity Test\\\" and \\\"Sutro Activity Criteria\\\") and the performance of a productivity (activity) test of the applicable Vaccine Composition (the \\\"SutroVax Activity Test\\\" and \\\"SutroVax Activity Criteria\\\").\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:SutroVax Activity Criteria\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SutroVax Activity Criteria\", \"text\": \"Two of the tests and corresponding COA/COC acceptance criteria for the Extract shall be the performance of a productivity (Activity) test of the applicable Sutro protein (the \\\"Sutro Activity Test\\\" and \\\"Sutro Activity Criteria\\\") and the performance of a productivity (activity) test of the applicable Vaccine Composition (the \\\"SutroVax Activity Test\\\" and \\\"SutroVax Activity Criteria\\\").\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:MSDS\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MSDS\", \"text\": \"Sutro will also provide SutroVax with Material Safety Data Sheets (\\\"MSDS\\\") or an equivalent instrument recognized by the applicable Regulatory Authority as required for the Product(s), and updates of the same as necessary.\", \"definition_clause\": \"4.1\"}}, {\"id\": \"term:Acceptance Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Acceptance Period\", \"text\": \"SutroVax or its designee shall have a period of [***] calendar days from the date of delivery of the Product(s) in accordance with Section 2.6 and the COA/COCs or the equivalent instrument recognized by the applicable Regulatory Authority for such Product(s) (\\\"Acceptance Period\\\"), to inspect any shipment of Product(s) and conduct the SutroVax Activity Test to determine whether such shipment conforms to the Required Standards.\", \"definition_clause\": \"4.2\"}}, {\"id\": \"term:Latent Defects\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Latent Defects\", \"text\": \"SutroVax's failure to notify Sutro of the non-conformity within the Acceptance Period will be deemed for purposes of this Supply Agreement to constitute SutroVax's acceptance of such shipment, provided, however, that such acceptance shall be subject to SutroVax's right to reject Product(s) until [***] days from the delivery date of the applicable Product, in each case, due to discovery by SutroVax or SutroVax's Affiliates or designees that the applicable Product does not conform to the Required Standards and such non-conformance could not reasonably be discovered within the Acceptance Period (\\\"Latent Defects\\\") provided that SutroVax gives Sutro with written notice of such Latent Defect within [***] days of SutroVax or any SutroVax Affiliate or designee becoming aware of such defect.\", \"definition_clause\": \"4.2\"}}, {\"id\": \"term:Laboratory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Laboratory\", \"text\": \"Notwithstanding the foregoing, in the event that Sutro and SutroVax are unable to resolve such disagreement within [***] days of the date of the applicable rejection notice, either Party may submit a sample of the allegedly non-conforming Product for testing and a determination as to whether or not such Product conforms to the Required Standards to an independent testing organization, or to a consultant of recognized repute within the United States pharmaceutical industry, in either case mutually agreed upon by the Parties (such organization or consultant, the \\\"Laboratory\\\"), the appointment of which shall not be unreasonably withheld or delayed by either Party.\", \"definition_clause\": \"4.3\"}}, {\"id\": \"term:Drug Master File\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Drug Master File\", \"text\": \"For purposes of this Article 6 \\\"Drug Master File\\\" or \\\"DMF\\\" means a submission to a Regulatory Authority of information concerning the chemistry, manufacturing and controls (\\\"CMC\\\") of the Products to permit such Regulatory Authority to review this information in support of any application for Regulatory Approval for a product submitted by a party that has been granted a right to reference such submission without disclosing the contents of such submission to such party.\", \"definition_clause\": \"6.2\"}}, {\"id\": \"term:Manufacturing Change\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacturing Change\", \"text\": \"Sutro shall not make any changes to the Specifications, processes, Facilities, raw materials, raw material suppliers or any other item that would affect the Manufacturing activities related to the Product (a \\\"Manufacturing Change\\\") that (a) would require a change to the applicable Drug Master File, (b) would be reasonably expected to cause SutroVax to be materially delayed obtaining any Regulatory Approval with respect to Vaccine Compositions or (c) causes the Product to not meet the Specification therefor (including the Activity Test with respect to Extract); without SutroVax's prior written consent (not to be unreasonably withheld, conditioned or delated).\", \"definition_clause\": \"6.6\"}}, {\"id\": \"term:Quality Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Quality Agreement\", \"text\": \"As soon as reasonably practicable after the Effective Date, the Parties shall enter into a quality agreement governing Sutro's supply of Products (the \\\"Quality Agreement\\\"), which Quality Agreement shall include the Specifications for the Product(s) consistent with the Specifications set forth in Schedule 2.\", \"definition_clause\": \"6.7\"}}, {\"id\": \"term:Indemnify\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Indemnify\", \"text\": \"Sutro hereby agrees, at its sole cost and expense, to defend, hold harmless and indemnify, to the extent permitted by Applicable Law, (collectively, \\\"Indemnify\\\") SutroVax and its Affiliates and their respective agents, directors, officers and employees of such Persons and the respective successors and assigns of any of the foregoing (the \\\"SutroVax Indemnitees\\\") from and against any and all liabilities, damages, penalties, fines, costs and expenses (including, reasonable attorneys' fees and other expenses of litigation) (collectively, \\\"Liabilities\\\") resulting from suits, claims, actions and demands, in each case brought by a Third Party (each, a \\\"Third-Party Claim\\\") against any SutroVax Indemnitee and arising from or occurring as a result of: [***].\", \"definition_clause\": \"9.1.1\"}}, {\"id\": \"term:SutroVax Indemnitees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"SutroVax Indemnitees\", \"text\": \"Sutro hereby agrees, at its sole cost and expense, to defend, hold harmless and indemnify, to the extent permitted by Applicable Law, (collectively, \\\"Indemnify\\\") SutroVax and its Affiliates and their respective agents, directors, officers and employees of such Persons and the respective successors and assigns of any of the foregoing (the \\\"SutroVax Indemnitees\\\") from and against any and all liabilities, damages, penalties, fines, costs and expenses (including, reasonable attorneys' fees and other expenses of litigation) (collectively, \\\"Liabilities\\\") resulting from suits, claims, actions and demands, in each case brought by a Third Party (each, a \\\"Third-Party Claim\\\") against any SutroVax Indemnitee and arising from or occurring as a result of: [***].\", \"definition_clause\": \"9.1.1\"}}, {\"id\": \"term:Liabilities\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Liabilities\", \"text\": \"Sutro hereby agrees, at its sole cost and expense, to defend, hold harmless and indemnify, to the extent permitted by Applicable Law, (collectively, \\\"Indemnify\\\") SutroVax and its Affiliates and their respective agents, directors, officers and employees of such Persons and the respective successors and assigns of any of the foregoing (the \\\"SutroVax Indemnitees\\\") from and against any and all liabilities, damages, penalties, fines, costs and expenses (including, reasonable attorneys' fees and other expenses of litigation) (collectively, \\\"Liabilities\\\") resulting from suits, claims, actions and demands, in each case brought by a Third Party (each, a \\\"Third-Party Claim\\\") against any SutroVax Indemnitee and arising from or occurring as a result of: [***].\", \"definition_clause\": \"9.1.1\"}}, {\"id\": \"term:Third-Party Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third-Party Claim\", \"text\": \"Sutro hereby agrees, at its sole cost and expense, to defend, hold harmless and indemnify, to the extent permitted by Applicable Law, (collectively, \\\"Indemnify\\\") SutroVax and its Affiliates and their respective agents, directors, officers and employees of such Persons and the respective successors and assigns of any of the foregoing (the \\\"SutroVax Indemnitees\\\") from and against any and all liabilities, damages, penalties, fines, costs and expenses (including, reasonable attorneys' fees and other expenses of litigation) (collectively, \\\"Liabilities\\\") resulting from suits, claims, actions and demands, in each case brought by a Third Party (each, a \\\"Third-Party Claim\\\") against any SutroVax Indemnitee and arising from or occurring as a result of: [***].\", \"definition_clause\": \"9.1.1\"}}, {\"id\": \"term:Sutro Indemnitees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Sutro Indemnitees\", \"text\": \"SutroVax hereby agrees to Indemnify Sutro and its agents, directors, officers and employees and the respective successors and assigns of any of the foregoing (the \\\"Sutro lndemnitees\\\") from and against any and all Liabilities resulting from Third-Party Claims against any Sutro Indemnitee arising from or occurring as a result of: [***].\", \"definition_clause\": \"9.1.2\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"10.1 Term. The term of this Supply Agreement shall begin on the Effective Date first set forth above and shall remain in effect until the later of (a) July 31, 2021 or (b) the date that the Parties enter into the Phase 3/Commercial Supply Agreement and Sutro is supplying to SutroVax each Product under the Phase 3/Commercial Supply Agreement (the \\\"Term\\\"), unless it is terminated earlier in accordance with Section 10.2.\", \"definition_clause\": \"10.1\"}}, {\"id\": \"term:Principal Contact\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Principal Contact\", \"text\": \"11.1 Principal Contacts. Each Party will appoint an individual employed by it to serve as its \\\"Principal Contact\\\" for purposes of this Supply Agreement. Either Party may from time to time replace its Principal Contact with a different employee, but unless required due to events beyond its control, neither Party will replace its Principal Contact without at least [***] days prior notice to the other Party. The two Principal Contacts shall communicate with each other regularly during the Term as the Parties may agree or as the Principal Contacts shall mutually determine to be useful.\", \"definition_clause\": \"11.1\"}}, {\"id\": \"term:Disputed Matter\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Disputed Matter\", \"text\": \"In the event (a) the Parties do not enter into a Phase 3/Commercial Supply Agreement as described in Section 2.14 or (b) the Parties do not enter into a Transfer Addendum as described in Section 2.15 (\\\"Disputed Matter\\\"), then upon either Party's request with respect to the Disputed Matter in clause (a) or SutroVax's request with respect to the Disputed Matter in clause (b), such Disputed Matter shall be resolved by binding arbitration conducted pursuant to Section 11.3, except that the procedures for the conduct of such arbitration shall be as follows:\", \"definition_clause\": \"11.4\"}}, {\"id\": \"term:Force Majeure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure\", \"text\": \"No Party shall be liable for a failure or delay in performing any of its obligations under this Supply Agreement if, but only to the extent that such failure or delay is due to causes beyond the reasonable control of the affected Party, including: (a) acts of God; (b) fire, explosion, or unusually severe weather; (c) war, invasion, riot, terrorism, or other civil unrest; (d) governmental laws, orders, restrictions, actions, embargo or blockages; (e) national or regional emergency; (f) strikes or industrial disputes at a national level which directly impact the affected Party's performance under this Supply Agreement; or (g) other similar cause outside of the reasonable control of such Party (\\\"Force Majeure\\\"); provided that the Party affected shall promptly notify the other of the Force Majeure condition and shall use reasonable efforts to eliminate, cure or overcome any such causes and resume performance of its obligations as soon as possible.\", \"definition_clause\": \"12.3\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of VERICELCORP_08_06_2019-EX-10.10-SUPPLY AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of VERICELCORP_08_06_2019-EX-10.10-SUPPLY AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"Exhibit 10.10\", \"level\": 1, \"text\": \"Exhibit 10.10 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH \\\"[***]\\\". SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. SUPPLY AGREEMENT by and between MEDIWOUND LTD. and VERICEL CORPORATION May 6, 2019 TABLE OF CONTENTS Page\"}, {\"id\": \"ARTICLE 1\", \"title\": \"DEFINITIONS 1\", \"level\": 1, \"text\": \"ARTICLE 1 DEFINITIONS 1\"}, {\"id\": \"ARTICLE 2\", \"title\": \"SUPPLY OF PRODUCTS 5\", \"level\": 1, \"text\": \"ARTICLE 2 SUPPLY OF PRODUCTS 5\"}, {\"id\": \"5.1\", \"title\": \"Supply Price 19 5\", \"level\": 2, \"text\": \"5.1 Supply Price 19 5.2 Price Mechanics 19 5.3 Cost Savings 19 5.4 Payments 20 ii 9012190/26\"}, {\"id\": \"5.5\", \"title\": \"Late Payments 20 5\", \"level\": 2, \"text\": \"5.5 Late Payments 20 5.6 Taxes 20\"}, {\"id\": \"ARTICLE 6\", \"title\": \"REPRESENTATIONS, WARRANTIES AND COVENANTS 21\", \"level\": 1, \"text\": \"ARTICLE 6 REPRESENTATIONS, WARRANTIES AND COVENANTS 21\"}, {\"id\": \"9.1\", \"title\": \"Manufacturing License Grant 27 9\", \"level\": 2, \"text\": \"9.1 Manufacturing License Grant 27 9.2 Trademarks License Grant. 27 9.3 Ownership 27 ARTICLE 10 FORCE MAJEURE 27\"}, {\"id\": \"10.1\", \"title\": \"Excusing Performance 27 10\", \"level\": 2, \"text\": \"10.1 Excusing Performance 27 10.2 Notice of Force Majeure Event 27 10.3 Resumption; Termination 27 ARTICLE 11 MISCELLANEOUS 28 iii 9012190/26 iv 9012190/26 SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (the \\\"Agreement\\\") is entered into as of May 6, 2019 (the \\\"Effective Date\\\"), by and between Vericel Corporation, a corporation organized and existing under the laws of Michigan and having a principal place of business at 64 Sidney Street, Cambridge, MA 02139 (\\\"Vericel\\\") and MediWound Ltd., a corporation organized and existing under the laws of Israel and having a principal place of business at 42 Hayarkon Street, Yavne, Israel 8122745 (\\\"MediWound\\\"). Vericel and MediWound may each be referred to herein individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\" RECITALS WHEREAS, Vericel and MediWound are parties to that certain License Agreement of even date herewith (the \\\"License Agreement\\\"), pursuant to which Vericel acquired an exclusive license to certain rights from MediWound; and WHEREAS, in connection with the License Agreement, the Parties contemplate that during the Term, MediWound will provide certain manufacturing and other related services to Vericel in accordance with the terms and conditions set forth herein. NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:\"}, {\"id\": \"Article 1\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"Article 1 DEFINITIONS The following terms have the meanings set forth below. Capitalized terms which are used but not defined herein have the meanings ascribed to such terms in the License Agreement.\"}, {\"id\": \"1.1\", \"title\": \"\\\"Additional Service\\\" shall mean any service in addition to the Manufacture of a Product, as such services are identified\", \"level\": 2, \"text\": \"1.1 \\\"Additional Service\\\" shall mean any service in addition to the Manufacture of a Product, as such services are identified on Exhibit B attached hereto, or such other service as may be requested by Vericel and agreed to by MediWound from time to time.\"}, {\"id\": \"1.2\", \"title\": \"\\\"Additional Service Fee\\\" shall mean the fee, cost and/or expense to be paid by Vericel to MediWound for the performance\", \"level\": 2, \"text\": \"1.2 \\\"Additional Service Fee\\\" shall mean the fee, cost and/or expense to be paid by Vericel to MediWound for the performance of Additional Services, as such fee, cost and/or expense is agreed to by Vericel and MediWound in writing in respect of such Additional Services (plus VAT or similar taxes, if applicable).\"}, {\"id\": \"1.3\", \"title\": \"\\\"Agreement\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.3 \\\"Agreement\\\" has the meaning set forth in the Preamble.\"}, {\"id\": \"1.4\", \"title\": \"\\\"Batch\\\" shall mean one (1) production lot of a Product\", \"level\": 2, \"text\": \"1.4 \\\"Batch\\\" shall mean one (1) production lot of a Product.\"}, {\"id\": \"1.5\", \"title\": \"\\\"Binding Forecast\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.5 \\\"Binding Forecast\\\" has the meaning set forth in Section 2.8(a).\"}, {\"id\": \"1.6\", \"title\": \"\\\"Binding Orders\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.6 \\\"Binding Orders\\\" has the meaning set forth in Section 2.8(b).\"}, {\"id\": \"1.7\", \"title\": \"\\\"BLA\\\" means (a) a Biologics License Application as defined in the FD&C Act and the regulations promulgated thereunder, o\", \"level\": 2, \"text\": \"1.7 \\\"BLA\\\" means (a) a Biologics License Application as defined in the FD&C Act and the regulations promulgated thereunder, or (b) any equivalent or comparable application, registration or certification in any other country or region in the Territory.\"}, {\"id\": \"1\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"1 9012190/26\"}, {\"id\": \"1.8\", \"title\": \"\\\"Bulk Vehicle Gel\\\" means the formulated NexoBrid product gel in bulk form, prior to filling and finishing, as further de\", \"level\": 2, \"text\": \"1.8 \\\"Bulk Vehicle Gel\\\" means the formulated NexoBrid product gel in bulk form, prior to filling and finishing, as further described in the applicable Specifications.\"}, {\"id\": \"1.9\", \"title\": \"\\\"Business Day\\\" means a day other than a Friday, Saturday, Sunday or bank or other public holiday in New York, New York o\", \"level\": 2, \"text\": \"1.9 \\\"Business Day\\\" means a day other than a Friday, Saturday, Sunday or bank or other public holiday in New York, New York or Yavne, Israel.\"}, {\"id\": \"1.10\", \"title\": \"\\\"cGMP\\\" means the then-current good manufacturing practices for pharmaceuticals, as set forth in the United States Federa\", \"level\": 2, \"text\": \"1.10 \\\"cGMP\\\" means the then-current good manufacturing practices for pharmaceuticals, as set forth in the United States Federal Food, Drug, and Cosmetic Act, as amended, and applicable regulations promulgated thereunder, as amended from time to time, and such equivalent or similar standards for good manufacturing practice as are required by other Governmental Authorities in countries in which Products are intended to be manufactured or sold.\"}, {\"id\": \"1.11\", \"title\": \"\\\"Change Notification Period\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.11 \\\"Change Notification Period\\\" has the meaning set forth in Section 4.1.\"}, {\"id\": \"1.12\", \"title\": \"\\\"Confidential Information\\\" has the meaning set forth in the License Agreement insofar as such information is disclosed p\", \"level\": 2, \"text\": \"1.12 \\\"Confidential Information\\\" has the meaning set forth in the License Agreement insofar as such information is disclosed pursuant to this Agreement. The terms of this Agreement are the Confidential Information of both Parties, subject to Section 11.15.\"}, {\"id\": \"1.13\", \"title\": \"\\\"Conforming Product\\\" means, with respect to the applicable Product, that, as of the date of delivery to Vericel or its d\", \"level\": 2, \"text\": \"1.13 \\\"Conforming Product\\\" means, with respect to the applicable Product, that, as of the date of delivery to Vericel or its designated Affiliate or contractor in accordance with Section 2.9(c) hereof, such Product (a) meets, and was Manufactured in accordance with, the applicable Specifications, Regulatory Standards (including cGMP where applicable) and the requirements set forth in the Quality Agreement, (b) is free from defects in materials and workmanship, (c) is not adulterated or misbranded within the meaning of the FD&C Act (or similar requirements of the countries for which the Product will be distributed), and (d) is not an article which may not, under the provisions of the FD&C Act, be introduced into interstate commerce.\"}, {\"id\": \"1.14\", \"title\": \"\\\"Cost Savings Change\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.14 \\\"Cost Savings Change\\\" has the meaning set forth in Section 5.3.\"}, {\"id\": \"1.15\", \"title\": \"\\\"Discretionary Manufacturing Changes\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.15 \\\"Discretionary Manufacturing Changes\\\" has the meaning set forth in Section 4.1.\"}, {\"id\": \"1.16\", \"title\": \"\\\"Effective Date\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.16 \\\"Effective Date\\\" has the meaning set forth in the Preamble.\"}, {\"id\": \"1.17\", \"title\": \"\\\"Excess Amount\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.17 \\\"Excess Amount\\\" has the meaning set forth in Section 2.8(b).\"}, {\"id\": \"1.18\", \"title\": \"\\\"Facility\\\" means MediWound facility located at 42 Hayarkon Street, Yavne, Israel 8122745 and any other facility approved\", \"level\": 2, \"text\": \"1.18 \\\"Facility\\\" means MediWound facility located at 42 Hayarkon Street, Yavne, Israel 8122745 and any other facility approved by Vericel in accordance with Section 2.6.\"}, {\"id\": \"1.19\", \"title\": \"\\\"Finished Product\\\" means finished NexoBrid product, comprising the Intermediate Drug Product filled into unit packages a\", \"level\": 2, \"text\": \"1.19 \\\"Finished Product\\\" means finished NexoBrid product, comprising the Intermediate Drug Product filled into unit packages and Bulk Vehicle Gel filled into unit packages and sterilized, including labeling and packaging, as further described in the applicable Specifications.\"}, {\"id\": \"2\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"2 9012190/26\"}, {\"id\": \"1.20\", \"title\": \"\\\"First Commercial Sale\\\" means, with respect to any Licensed Product and with respect to any country of the Territory, th\", \"level\": 2, \"text\": \"1.20 \\\"First Commercial Sale\\\" means, with respect to any Licensed Product and with respect to any country of the Territory, the first sale of such Licensed Product by Vericel or an Affiliate or Sublicensee of Vericel to a Third Party in such country after such Licensed Product has been granted Regulatory Approval by the appropriate Regulatory Authority(ies) for such country.\"}, {\"id\": \"1.21\", \"title\": \"\\\"Force Majeure Event\\\" has the meaning set forth in Section 10\", \"level\": 2, \"text\": \"1.21 \\\"Force Majeure Event\\\" has the meaning set forth in Section 10.1.\"}, {\"id\": \"1.22\", \"title\": \"\\\"Initial Term\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.22 \\\"Initial Term\\\" has the meaning set forth in Section 8.1.\"}, {\"id\": \"1.23\", \"title\": \"\\\"Intermediate Drug Product\\\" means the formulated Intermediate Drug Substance as a bulk lyophilized powder, prior to fill\", \"level\": 2, \"text\": \"1.23 \\\"Intermediate Drug Product\\\" means the formulated Intermediate Drug Substance as a bulk lyophilized powder, prior to filling and finishing, for use in the Product, as further described in the applicable Specifications.\"}, {\"id\": \"1.24\", \"title\": \"\\\"Intermediate Drug Substance\\\" means formulated mixture of proteolytic enzymes enriched in bromelain in solution manufact\", \"level\": 2, \"text\": \"1.24 \\\"Intermediate Drug Substance\\\" means formulated mixture of proteolytic enzymes enriched in bromelain in solution manufactured for use in manufacturing the Intermediate Drug Product.\"}, {\"id\": \"1.25\", \"title\": \"\\\"Key Material\\\" means, with respect to a given Product, those key Materials for the Manufacture of such Product as design\", \"level\": 2, \"text\": \"1.25 \\\"Key Material\\\" means, with respect to a given Product, those key Materials for the Manufacture of such Product as designated by the Parties. Schedule 1.26 will include a list of the then-current Key Materials, as designated by the Parties, which will be updated by the Parties from time to time during the Term to reflect additions and deletions thereof.\"}, {\"id\": \"1.26\", \"title\": \"\\\"Key Materials Suppliers\\\" means, with respect to a given Product, the entities that MediWound, its Affiliate or its Thir\", \"level\": 2, \"text\": \"1.26 \\\"Key Materials Suppliers\\\" means, with respect to a given Product, the entities that MediWound, its Affiliate or its Third Party manufacturer has engaged (whether as of the Effective Date or from time to time during the Term) to manufacture, supply, furnish or provide the Key Materials for such Product. Schedule 1.26 will include a list of the then-current Key Materials Suppliers for each Product, which will be updated by MediWound from time to time during the Term to reflect additions and deletions thereof.\"}, {\"id\": \"1.27\", \"title\": \"\\\"Latent Defect\\\" means, with respect to a Product supplied by MediWound to Vericel hereunder, a defect existing at the ti\", \"level\": 2, \"text\": \"1.27 \\\"Latent Defect\\\" means, with respect to a Product supplied by MediWound to Vericel hereunder, a defect existing at the time of delivery of such Product to Vericel that causes such Product to fail to conform to the corresponding Product Warranty for such Product, which defect is not reasonably obvious to Vericel upon inspection of such Product during the [***] period pursuant to Section 2.12 following such delivery but is discovered at a later time.\"}, {\"id\": \"1.28\", \"title\": \"\\\"Liability\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.28 \\\"Liability\\\" has the meaning set forth in Section 7.1.\"}, {\"id\": \"1.29\", \"title\": \"\\\"License Agreement\\\" has the meaning set forth in the recitals of this Agreement\", \"level\": 2, \"text\": \"1.29 \\\"License Agreement\\\" has the meaning set forth in the recitals of this Agreement.\"}, {\"id\": \"1.30\", \"title\": \"\\\"Manufacture\\\" or \\\"Manufacturing\\\" means to make, produce, manufacture, process, fill, finish, package, label, perform qua\", \"level\": 2, \"text\": \"1.30 \\\"Manufacture\\\" or \\\"Manufacturing\\\" means to make, produce, manufacture, process, fill, finish, package, label, perform quality assurance testing, release a compound or product or any component thereof. When used as a noun, \\\"Manufacture\\\" or \\\"Manufacturing\\\" means any and all activities involved in Manufacturing a compound or product or any component thereof.\"}, {\"id\": \"3\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"3 9012190/26\"}, {\"id\": \"1.31\", \"title\": \"\\\"Materials\\\" means, with respect to a given Product, all raw materials, Bulk Vehicle Gel (where MediWound is supplying a\", \"level\": 2, \"text\": \"1.31 \\\"Materials\\\" means, with respect to a given Product, all raw materials, Bulk Vehicle Gel (where MediWound is supplying a Product other than Bulk Vehicle Gel), Intermediate Drug Product (where MediWound is supplying a Product other than Intermediate Drug Product), supplies, components, excipients, and intermediates, labels and packaging materials necessary to Manufacture and ship such Product in accordance with the applicable Specifications.\"}, {\"id\": \"1.32\", \"title\": \"\\\"Maximum Capacity\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.32 \\\"Maximum Capacity\\\" has the meaning set forth in Section 2.6.\"}, {\"id\": \"1.33\", \"title\": \"\\\"MediWound\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.33 \\\"MediWound\\\" has the meaning set forth in the Preamble.\"}, {\"id\": \"1.34\", \"title\": \"\\\"MediWound Indemnified Party\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.34 \\\"MediWound Indemnified Party\\\" has the meaning set forth in Section 7.2.\"}, {\"id\": \"1.35\", \"title\": \"\\\"Minimum Shelf Life\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.35 \\\"Minimum Shelf Life\\\" has the meaning set forth in Section 2.10.\"}, {\"id\": \"1.36\", \"title\": \"\\\"Non-Conforming Product\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.36 \\\"Non-Conforming Product\\\" has the meaning set forth in Section 2.12.\"}, {\"id\": \"1.37\", \"title\": \"\\\"Parties\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.37 \\\"Parties\\\" has the meaning set forth in the Preamble.\"}, {\"id\": \"1.38\", \"title\": \"\\\"Product\\\" means, as applicable, the (a) Intermediate Drug Product, (b) Bulk Vehicle Gel and (c) Finished Product\", \"level\": 2, \"text\": \"1.38 \\\"Product\\\" means, as applicable, the (a) Intermediate Drug Product, (b) Bulk Vehicle Gel and (c) Finished Product.\"}, {\"id\": \"1.39\", \"title\": \"\\\"Product Warranty\\\" has the meaning set forth in Section 6\", \"level\": 2, \"text\": \"1.39 \\\"Product Warranty\\\" has the meaning set forth in Section 6.3.\"}, {\"id\": \"1.40\", \"title\": \"\\\"Purchase Order\\\" shall mean a firm, written order for purchase of one or more Products submitted by Vericel to MediWound\", \"level\": 2, \"text\": \"1.40 \\\"Purchase Order\\\" shall mean a firm, written order for purchase of one or more Products submitted by Vericel to MediWound that complies with the terms and conditions of this Agreement.\"}, {\"id\": \"1.41\", \"title\": \"\\\"Quality Agreement\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.41 \\\"Quality Agreement\\\" has the meaning set forth in Section 3.8.\"}, {\"id\": \"1.42\", \"title\": \"\\\"Recall\\\" means a recall, withdrawal or field correction of a Product\", \"level\": 2, \"text\": \"1.42 \\\"Recall\\\" means a recall, withdrawal or field correction of a Product.\"}, {\"id\": \"1.43\", \"title\": \"\\\"Regulatory Change\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.43 \\\"Regulatory Change\\\" has the meaning set forth in Section 4.4.\"}, {\"id\": \"1.44\", \"title\": \"\\\"Regulatory Standards\\\" means all applicable Laws within the Territory applicable to the Manufacturing and shipment of th\", \"level\": 2, \"text\": \"1.44 \\\"Regulatory Standards\\\" means all applicable Laws within the Territory applicable to the Manufacturing and shipment of the Product or any aspect thereof and the obligations of MediWound hereunder, including, without limitation, (a) the FD&C Act (or similar requirements of the countries for which the Product will be distributed), (b) cGMPs, and (c) the rules and regulations promulgated under or by a Regulatory Authority or any successor agency or other comparable agency thereto as each may be amended from time to time.\"}, {\"id\": \"1.45\", \"title\": \"\\\"Remediation Plan\\\" means a reasonably detailed corrective action plan that would outline remediation of a Supply Failure\", \"level\": 2, \"text\": \"1.45 \\\"Remediation Plan\\\" means a reasonably detailed corrective action plan that would outline remediation of a Supply Failure that include the date by which MediWound will implement such remediation and remedy such Supply Failure.\"}, {\"id\": \"1.46\", \"title\": \"\\\"Renewal Term\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.46 \\\"Renewal Term\\\" has the meaning set forth in Section 8.1.\"}, {\"id\": \"1.47\", \"title\": \"\\\"Rolling Forecast\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.47 \\\"Rolling Forecast\\\" has the meaning set forth in Section 2.8(a).\"}, {\"id\": \"4\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"4 9012190/26\"}, {\"id\": \"1.48\", \"title\": \"\\\"Safety Stock\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.48 \\\"Safety Stock\\\" has the meaning set forth in Section 2.11.\"}, {\"id\": \"1.49\", \"title\": \"\\\"Second Source\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.49 \\\"Second Source\\\" has the meaning set forth in Section 2.7.\"}, {\"id\": \"1.50\", \"title\": \"\\\"Specifications\\\" means, with respect to a given Product, the written specifications for such Product set forth in the ap\", \"level\": 2, \"text\": \"1.50 \\\"Specifications\\\" means, with respect to a given Product, the written specifications for such Product set forth in the applicable Regulatory Approval corresponding thereto as defined in the Quality Agreement, which specifications may be amended from time to time in accordance with this Agreement.\"}, {\"id\": \"1.51\", \"title\": \"\\\"Suppliers\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.51 \\\"Suppliers\\\" has the meaning set forth in Section 2.3.\"}, {\"id\": \"1.52\", \"title\": \"\\\"Supply Failure\\\" means, with respect to a given Product, MediWound's failure to timely deliver to Vericel (i) at least [\", \"level\": 2, \"text\": \"1.52 \\\"Supply Failure\\\" means, with respect to a given Product, MediWound's failure to timely deliver to Vericel (i) at least [***] of the quantity of such Product ordered in accordance with the Binding Orders for such Product (for avoidance of doubt, in determining the percentage of Product delivered for purposes of this clause (i), only Product that conforms to the Product Warranty and is delivered by MediWound in accordance with this Agreement, shall be included), as measured over a period of any [***], or (ii) a cessation or suspension of Manufacturing of Product by MediWound that is not cured by MediWound in accordance with Section 2.14, that is reasonably likely to result in a failure by MediWound to timely deliver Product to Vericel as described in the foregoing clause (i), that, in either case (the foregoing clause (i) or clause (ii)), is not caused by a breach of this Agreement by Vericel.\"}, {\"id\": \"1.53\", \"title\": \"\\\"Supply Price\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.53 \\\"Supply Price\\\" has the meaning set forth in Section 5.1.\"}, {\"id\": \"1.54\", \"title\": \"\\\"Term\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.54 \\\"Term\\\" has the meaning set forth in Section 8.1.\"}, {\"id\": \"1.55\", \"title\": \"\\\"Territory\\\" means the United States, Canada and Mexico\", \"level\": 2, \"text\": \"1.55 \\\"Territory\\\" means the United States, Canada and Mexico.\"}, {\"id\": \"1.56\", \"title\": \"\\\"Third Party\\\" shall mean any Person other than Vericel, MediWound or their respective Affiliates\", \"level\": 2, \"text\": \"1.56 \\\"Third Party\\\" shall mean any Person other than Vericel, MediWound or their respective Affiliates.\"}, {\"id\": \"1.57\", \"title\": \"\\\"Third Party Claims\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.57 \\\"Third Party Claims\\\" has the meaning set forth in Section 7.1.\"}, {\"id\": \"1.58\", \"title\": \"\\\"Third Party Supply Agreement\\\" means any agreement between MediWound (or any of its Affiliates) and any Third Party that\", \"level\": 2, \"text\": \"1.58 \\\"Third Party Supply Agreement\\\" means any agreement between MediWound (or any of its Affiliates) and any Third Party that relates to Manufacture or supply of a Licensed Product.\"}, {\"id\": \"1.59\", \"title\": \"\\\"Vericel\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.59 \\\"Vericel\\\" has the meaning set forth in the Preamble.\"}, {\"id\": \"1.60\", \"title\": \"\\\"Vericel Indemnified Party\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.60 \\\"Vericel Indemnified Party\\\" has the meaning set forth in Section 7.1.\"}, {\"id\": \"ARTICLE 2\", \"title\": \"SUPPLY OF PRODUCTS\", \"level\": 1, \"text\": \"ARTICLE 2 SUPPLY OF PRODUCTS\"}, {\"id\": \"2.1\", \"title\": \"Scope of Agreement\", \"level\": 2, \"text\": \"2.1 Scope of Agreement. Subject to the terms and conditions of this Agreement, MediWound shall Manufacture (or have Manufactured) Product for clinical and commercial use by Vericel and perform the Additional Services as required for completion of the activities\"}, {\"id\": \"5\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"5 9012190/26 contemplated under this Agreement and the License Agreement in accordance with the applicable Specifications, Regulatory Standards and the Quality Agreement. MediWound shall Manufacture and supply Product in exchange for the Supply Price and shall perform the Additional Services for the Additional Service Fees.\"}, {\"id\": \"2.2\", \"title\": \"Exclusive Supply\", \"level\": 2, \"text\": \"2.2 Exclusive Supply. During the first five (5) years of the Term, with respect to the Bulk Vehicle Gel, Intermediate Drug Product and Finished Product, Vericel shall order and purchase such Products exclusively from MediWound in accordance with the terms of this Agreement; provided, however, Vericel may Manufacture or have Manufactured the Products (a) upon the occurrence of a Supply Failure with respect to any Product hereunder, or (b) as otherwise permitted under the terms of the License Agreement or this Agreement. The Parties agree that nothing in this Section 2.2 is intended to limit the identification, evaluation, technology transfer or validation by Vericel of (x) a Second Source for the Manufacture and supply of Product or (y) a provider of filling and packaging services for Product, and that such activities are expressly permitted hereunder.\"}, {\"id\": \"2.3\", \"title\": \"Materials\", \"level\": 2, \"text\": \"2.3 Materials. MediWound shall purchase at its cost and expense all Materials required for Manufacture by MediWound of the Product for supply to Vericel for the Territory pursuant to this Agreement. Any and all forecasts and purchase orders for such Materials shall be placed at MediWound's sole expense and under its sole responsibility. MediWound shall place such purchase orders on a timely basis in order to avoid any undue delay, interruption or other discontinuance in the Manufacture or delivery of the Product. MediWound shall manage and be responsible for all contracts or other arrangements with MediWound's suppliers of Materials (\\\"Suppliers\\\"). Subject to the terms of this Agreement and the Quality Agreement, as between the Parties, MediWound shall be responsible and have liability for all actions and omissions of, and the failure to comply with the applicable terms of this Agreement, applicable Law or Regulatory Standards by the Suppliers in performance of Manufacturing activities for the supply of Products to Vericel for the Territory on behalf of MediWound hereunder. MediWound shall ensure that all Materials conform to the terms of this Agreement, including the applicable Specifications and to the terms of the Quality Agreement.\"}, {\"id\": \"2.4\", \"title\": \"Labeling\", \"level\": 2, \"text\": \"2.4 Labeling. Vericel shall be responsible for supplying MediWound with copy for labeling. Upon its receipt of labeling copy from Vericel, MediWound shall provide artwork of the labeling to Vericel for its review and approval. Vericel's review time shall not exceed [***] after its receipt of the artwork from MediWound. In the event that Vericel requests any changes to the labeling, MediWound shall make such changes as promptly as possible and return such labeling artwork to Vericel for its final review and approval, which it shall complete with [***] after its receipt of the modified artwork. MediWound shall be responsible for ordering, at its expense, sufficient quantities of labeling as forecasted to be required, based upon the [***] of the then-current Rolling Forecast. MediWound shall store the labeling as required by Regulatory Standards and shall use the labeling in Product packaging as set forth in the Specifications. Vericel shall be permitted to require changes to the labeling artwork from time-to-time at its cost, but will be required to reimburse MediWound for the cost of any quantities of labeling procured by MediWound that is rendered unusable by such changes, up to the quantities of labeling as\"}, {\"id\": \"6\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"6 9012190/26 forecasted to be required, based upon the [***] of the then-current Rolling Forecast as of the date of such change by Vericel of the labeling artwork. [***].\"}, {\"id\": \"2.5\", \"title\": \"Subcontracting\", \"level\": 2, \"text\": \"2.5 Subcontracting. (a) [***]. No Third Party service provider or subcontractor shall be provided with Vericel's Confidential Information without first executing a confidentiality agreement that contains terms and conditions that are at least as protective as the confidentiality terms, conditions and restrictions set forth in this Agreement. Notwithstanding the foregoing, MediWound shall remain liable for the performance of all Third Party subcontractors and its Affiliates under this Agreement. (b) MediWound shall use commercially reasonable efforts to ensure that any Third Party Supply Agreement [***]. (c) If the forecasting or order timing or other provisions of a Third Party Supply Agreement do not align with the corresponding provisions of this Agreement then the Parties shall discuss in good faith appropriate modifications to this Agreement or to such Third Party Supply Agreement, to bring the relevant provisions into alignment; provided, however, that Vericel or MediWound shall have no obligation to agree to any amendment to this Agreement or such Third Party Supply Agreement that can reasonably be expected to materially disadvantage Vericel or MediWound, respectively.\"}, {\"id\": \"2.6\", \"title\": \"Facilities\", \"level\": 2, \"text\": \"2.6 Facilities. (a) Current and Expanded Capacity. The Parties agree and acknowledge that, as of the Effective Date, MediWound's current Facility can fill orders from Vericel for use in the Territory up to [***] of Intermediate Drug Product, whether provided in that form or in the form of the equivalent amount of Finished Product within a calendar year (\\\"Maximum Capacity\\\"). The Parties agree and acknowledge that the Facility will require either expansion or modification (which may include moving to or adding another location) to meet future capacity requirements for the Product. By no later than [***], MediWound shall fund, at its sole cost, the expansion of its annual manufacturing capacity to be [***] of Intermediate Drug Product (whether provided in that form or in the form of the equivalent amount of Finished Product). The Parties will in good faith review existing market research to mutually agree on peak anticipated volume prior to [***]. After the foregoing expansion, the expanded capacity shall be deemed the \\\"Maximum Capacity\\\" for purposes of this Agreement. As part of the expansion of the Facility, the Parties will discuss any shut down or transfer to another facility made in connection therewith. (b) Shut-Down or Expansion of Facility; Transfer to Another Facility. In the event that MediWound desires to cease or shut down operations at a Facility, expand or modify a Facility, or transfer the Manufacturing of a Product to another facility which would reasonably be anticipated to result in inability (permanent or temporary) of MediWound to Manufacture, supply or otherwise perform its obligations hereunder, MediWound shall provide prior written notice to Vericel within the applicable Change Notification Period of such planned shut-down, cessation, expansion, modification or transfer. During such Change Notification Period, Vericel\"}, {\"id\": \"7\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"7 9012190/26 will have the right to order, and in such case MediWound will manufacture, up to [***] of quantities of Product set forth in the Rolling Forecast with respect to such Change Notification Period which in any event will not exceed the Maximum Capacity. Notwithstanding the foregoing, MediWound shall remain obligated to supply Product at the then current Facility and will not supply Product to Vericel from a new facility unless and until MediWound can perform the Manufacturing and supply Product from such new Facility in accordance with the terms of this Agreement and any modifications to the regulatory filings for such Product are approved by the relevant Regulatory Authorities. MediWound shall bear all costs incurred in connection with the shut-down, cessation, expansion or modification of the Facility or transfer of the Manufacturing of a Product to a new facility pursuant to this Section 2.6(b), including any costs associated with changes to the regulatory filings. Once such new facility is able to Manufacture in accordance with the terms of this Agreement and all required regulatory changes have been approved, such new facility shall be the Facility for purposes of such Product under this Agreement.\"}, {\"id\": \"2.7\", \"title\": \"Establishment of Second Source\", \"level\": 2, \"text\": \"2.7 Establishment of Second Source. (a) Within [***] of the Effective Date, MediWound must provide Vericel with true and accurate copies of all documents consistent with Schedule 2.7. If MediWound does not provide all documents within [***] of the Effective Date, Vericel's obligation under Section 8.1 regarding the time period to provide MediWound with a notice of an extension of the Initial Term shall be extended by the amount of time beyond [***] taken by MediWound to provide the required documents. (b) Within [***] of a request by Vericel to initiate technology transfer or as soon as reasonably practicable upon request by Vericel in connection with a Supply Failure, MediWound shall provide Vericel, at Vericel's cost consistent with Schedule 4.5, with information necessary for Vericel to qualify a second or back-up supplier identified by Vericel for the Manufacture and supply of Product (a \\\"Second Source\\\") and facilitate technology transfer to such Second Source so that Vericel can consistently manufacture intermediate and final product that meets all specifications. MediWound will notify the IIA in accordance with applicable Israeli Laws upon the commencement of Manufacture of Product by such Second Source. MediWound will provide Vericel with access to the manufacturing process and information and any and all original processes, records, and any other information required to manufacture, package and test the Product in accordance with the Specifications. Second Source manufacturers shall be permitted to manufacture Product for Vericel, its Affiliates and Sublicensees as provided in Section 9.1 and the License Agreement; provided that such Second Source manufacturers: [***].\"}, {\"id\": \"2.8\", \"title\": \"Forecasting and Ordering\", \"level\": 2, \"text\": \"2.8 Forecasting and Ordering. (a) Forecasting. Vericel shall furnish MediWound with a [***] rolling forecast of the quantities of each Product that Vericel intends to order during the succeeding [***] period (each, a \\\"Rolling Forecast\\\") which in any event will not exceed the Maximum Capacity for the Binding Forecast. No later than [***] after the filing of a BLA, Vericel shall\"}, {\"id\": \"8\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"8 9012190/26 furnish MediWound the first rolling Forecast. Subject to this Section 2.8, the [***] of each Rolling Forecast shall constitute a binding order for the quantities of Product specified (\\\"Binding Forecast\\\"). The remaining [***] of each Rolling Forecast shall be non-binding, but shall represent Vericel's good faith estimate, as of the date of its submission of the Rolling Forecast, of its forecasted requirements of the Product during such period. MediWound shall maintain at all times the manufacturing capacity at the relevant Facility to manufacture [***] of the quantities of Product set forth in the current Calendar Year of the Rolling Forecast (as was set forth at the Rolling Forecast submitted immediately prior to the beginning of such Calendar Year) which in any event will not exceed the Maximum Capacity. (b) Purchase Orders. On a Calendar Quarter basis, Vericel shall issue at least one Purchase Order for the number and unit size of each Product specified in the Binding Forecast. Vericel is not limited to one Purchase Order per Calendar Quarter. Each Purchase Order shall specify (i) a purchase order number; (ii) the quantity of units of each Product to be Manufactured; and (iii) the requested delivery date of such Product (which in no event shall be earlier than [***] days following the date the applicable Purchase Order was received by MediWound). MediWound shall respond to each Purchase Order within [***] of receipt by: (i) accepting such Purchase Order if it conforms to the requirements of this Agreement or (ii) notifying Vericel if such Purchase Order does not conform to the requirements of this Agreement. If MediWound timely notifies Vericel that a Purchase Order does not conform to the requirements of this Agreement, the Parties shall confer as soon as reasonably practicable to resolve any issues related to such purported nonconformity. If MediWound fails to respond to a Purchase Order that is consistent with the Binding Forecast within [***] after receiving it, Vericel will, within [***] thereafter, confirm with MediWound that such Purchase Order was received by MediWound, and if such Purchase Order is consistent with the Binding Forecast and was properly submitted by Vericel in accordance with this Section 2.8(b), MediWound shall be deemed to have accepted such Purchase Order (\\\"Binding Order\\\") as of the date of MediWound's receipt of such Purchase Order. If a Purchase Order contains quantities of Products in excess of the quantity of such Product forecasted for such quarter (as was set forth at the Rolling Forecast submitted immediately prior to the beginning of such Calendar Year) by an amount greater than [***] of the Binding Forecast (\\\"Excess Amount\\\"), MediWound will accept the Purchase Order up to, but not including the Excess Amount which in any event will not exceed the Maximum Capacity. Should Vericel place a Purchase Order to procure a given Product in a given Calendar Quarter which includes an Excess Amount, MediWound shall use commercially reasonable efforts to meet Vericel's request. If there is a conflict between this Agreement and any Purchase Order, this Agreement shall govern. (c) Minimum Purchase Obligation. In each Calendar Year following Vericel's submission of the first Rolling Forecast, Vericel shall issue Purchase Orders for at least [***] of the quantities of each Product set forth in the current Calendar Year of the Rolling Forecast (as was set forth at the Rolling Forecast submitted immediately prior to the beginning of such Calendar Year). (d) BARDA. As of the Effective Date, MediWound is a party to BARDA Contract HHSO100201500035C and BARDA Contract HHSO100201800023C (collectively, the\"}, {\"id\": \"9\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"9 9012190/26 \\\"BARDA Agreements\\\") with the Biomedical Advanced Research and Development Authority (\\\"BARDA\\\"). The Parties agree that until commercial obligations under such BARDA Agreements are transferred to Vericel, MediWound shall remain responsible for the supply and other obligations and shall manage the forecasts and production schedule for such BARDA Agreements. During such period, any Product ordered by BARDA from MediWound will not be included in Purchase Orders, Binding Orders, Rolling Forecasts or the minimum purchase obligation set forth in Section 2.8(c); provided that the Product ordered by BARDA from MediWound will be included in the Maximum Capacity and thus the applicable Maximum Capacity for the Binding Orders will be adjusted accordingly. If and when commercial obligations under such BARDA Agreements are transferred to Vericel, then Vericel shall become responsible for including the applicable purchases by BARDA in its Purchase Orders, Binding Orders and Rolling Forecasts and such purchases will be included in the Maximum Capacity and the minimum purchase obligation set forth in Section 2.8(c).\"}, {\"id\": \"2.9\", \"title\": \"Delivery\", \"level\": 2, \"text\": \"2.9 Delivery. (a) Shipping. MediWound shall only ship Products that have been Manufactured and released in accordance with the Specifications. Unless agreed in advance by Vericel and MediWound in writing, MediWound shall not ship (or permit such Third Party packager to ship) any Products prior to approval and release by MediWound in accordance with the Quality Agreement and Regulatory Standards. Unless otherwise agreed upon by the Parties, Products shall be delivered to Vericel Ex-Works (Incoterms 2010), at MediWound's facility (the \\\"Delivery Site\\\") at which point, the title and risk of loss shall transfer to Vericel which shall transfer the Products from the Delivery Site in accordance with cGMP as applicable. MediWound shall notify (or cause such Third Party packager to notify) Vericel at least [***] prior to any shipment of Products. (b) Delivery Amount. MediWound shall deliver Product within [***] of the units set out on the relevant Purchase Order. To the extent that a delivery is in excess of [***] of the amount set out on the relevant Purchase Order, Vericel may accept such excess Product provided that if Vericel accepts such excess, Vericel shall be entitled, (i) where commercially reasonable for Vericel, to vary the delivery date agreed between Vericel and MediWound in accordance with Section 2.8 for the immediately following shipment(s) of the applicable Product to the extent reasonably required due to the acceptance of such excess, and (ii) to reduce subsequent Purchase Orders and take credits for the amount of excess Product received against the minimum purchase obligation set forth in Section 2.8(c). To the extent that a delivery is less than [***] but at least [***] of the amount set out on the relevant Purchase Order, Vericel shall accept such delivery and shall be entitled, (A) where commercially reasonable for Vericel, to vary the delivery date agreed between Vericel and MediWound in accordance with Section 2.8 for the immediately following shipment(s) of the applicable Product due to the acceptance of such delivery, and (B) to increase subsequent Purchase Orders with the applicable shortage quantities. (c) On Time Delivery. MediWound's performance with respect to \\\"on time delivery\\\" will be measured as delivery to Vericel [***] before or after the delivery date agreed\"}, {\"id\": \"10\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"10 9012190/26 between Vericel and MediWound in accordance with Section 2.8; provided that MediWound shall be deemed to have made a delivery during the \\\"on time delivery\\\" window if the delay in delivery to Vericel is due to Vericel's failure to comply with its obligations under this Agreement (including in connection with Vericel's review of the Batch records).\"}, {\"id\": \"2.10\", \"title\": \"Dating\", \"level\": 2, \"text\": \"2.10 Dating. The remaining shelf-life for each Product for the Territory shall be at least [***] of the FDA approved shelf-life of such Product, as measured from the time of delivery of such Product to Vericel (the \\\"Minimum Shelf Life\\\").\"}, {\"id\": \"2.11\", \"title\": \"Safety Stock\", \"level\": 2, \"text\": \"2.11 Safety Stock. MediWound shall be entitled to meet its obligation to maintain as safety stock not less than [***] of the Rolling Forecast demand of stock of each of the Key Materials (the \\\"Safety Stock\\\") so long as the Minimum Shelf Life has been satisfied by holding either Product or an equivalent quantity of Materials, or a mixture of the two. The Parties will cooperate to set minimum inventory levels of Key Materials held by Key Materials Suppliers. Vericel shall maintain an inventory of [***] supply of unlabeled or labeled Finished Product in order to supply its commercial requirements in accordance with the Rolling Forecast, which may be stored at Facility at Vericel's option, cost and risk.\"}, {\"id\": \"2.12\", \"title\": \"Non-Conforming Product\", \"level\": 2, \"text\": \"2.12 Non-Conforming Product. (a) Rejection Notice. Unless otherwise mutually agreed by the Parties in writing, within [***] after receipt of a delivery of Product hereunder, Vericel shall give MediWound written notice of rejection (\\\"Rejection Notice\\\") (i) if the Product does not constitute Conforming Product (\\\"Non-Conforming Product\\\") or (ii) of any shortage in quantity of such delivery of Product. Any such Rejection Notice provided with respect to any quantity of Product shall be deemed to apply to the full Batch of such Product unless otherwise specified by Vericel. Vericel shall be deemed to have accepted such shipment of Product as Conforming Product and any shortage in quantity if it does not provide Rejection Notice within [***] after receipt of delivery describing the reasons for such rejections in reasonable detail, provided, however, that such [***] period shall not apply to any Latent Defects, in which case Vericel shall notify MediWound of any such failure as soon as reasonably possible, but in any event within [***] after the Latent Defect is confirmed by Vericel and prior to expiration of the shelf-life for such Product. (b) Disputes. In the event that MediWound disagrees with Vericel's claim that Product fails to constitute Conforming Product, then the Parties shall promptly attempt to resolve such dispute. If the Parties cannot resolve such dispute, a sample of such Product shall be submitted by MediWound and Vericel to a mutually agreeable qualified Third Party laboratory for testing against the applicable Specifications, Regulatory Standards and other standards and controls in the Quality Agreement and the test results obtained by such laboratory shall be final and controlling (absent manifest error). Test results must be furnished to both Parties within [***] of concluding such testing. The fees and expenses of such laboratory testing and any obsolescence due to short dating shall be borne entirely by the Party whose original Product analysis was in error.\"}, {\"id\": \"11\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"11 9012190/26 (c) Remedy. On receipt of Vericel's Rejection Notice pursuant to Section 2.12(a), subject to Section 2.12(b), MediWound shall, [***] (except if such Non-Conforming Product is due to MediWound's gross negligence or willful misconduct): (i) deliver the appropriate shortage quantities of Conforming Product as promptly as possible, at no additional cost or expense (including, without limitation, freight costs) to Vericel; (ii) replace the Non-Conforming Product with Conforming Product as promptly as possible, at no additional cost or expense (including, without limitation, freight costs) to Vericel; or (iii) promptly grant Vericel a credit in an amount equal to the amount paid or payable by Vericel with respect to reasonable out of pocket expenses directly associated with the Non-Conforming Product to the extent applicable (e.g. shipment costs, destruction fees, and restocking fees) and any such shortage or Non-Conforming Product, including, without limitation, but solely in the case of Non-Conforming Product, expenses associated with destruction or return at MediWound's instruction. This subsection (iii) shall additionally apply in the event Vericel elects as its option the foregoing (i) or (ii), as applicable, and such delivery or replace of Product thereunder is not practicable within a reasonable period of time (as reasonably determined by MediWound).\"}, {\"id\": \"2.13\", \"title\": \"Shortages\", \"level\": 2, \"text\": \"2.13 Shortages. (a) Without limiting any other rights or remedies available to Vericel, in the event of any shortage in the supply of any Materials or Product, or if MediWound is for any other reason unable to supply Product in compliance with the terms of this Agreement, then MediWound will promptly notify Vericel and, in the event such inability is caused by a shortage of any Materials and/or capacity required for the Manufacture of any Product, will take all commercially reasonable steps to (i) procure adequate quantities of Materials from Third Party suppliers reasonably acceptable to Vericel, and (ii) use commercially reasonable efforts to fulfill all Binding Orders for Product. (b) Prior to a Second Source commencing supply of Product, in the event of a shortage of (i) any Materials required to Manufacture Product or (ii) Product, MediWound will allocate the available Materials to the Manufacture of Product for sale to Vericel and will allocate the available Product for sale to Vericel, in each case ((i) or (ii)), to the extent any Binding Orders then in place prior to allocating such materials to the Manufacture of any other product (including EscharEx), or for any entity other than Vericel. (c) After a Second Source commences supply of Product, in the event of a shortage of Materials or Product, MediWound will allocate to Vericel its pro rata share of MediWound's supply of the same in a manner no less favorable than those of its equivalently situated customers or MediWound's own similarly situated products.\"}, {\"id\": \"12\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"12 9012190/26 (d) The Parties will cooperate to discuss expansion plans, address capacity and any other product supply issues, including efficient use of resources, manufacturing schedules and shipping schedules.\"}, {\"id\": \"2.14\", \"title\": \"Supply Failures\", \"level\": 2, \"text\": \"2.14 Supply Failures. In the event that MediWound becomes aware of the existence of a situation that may lead to a Supply Failure, then MediWound shall promptly (and in no event later than [***] from the date of such awareness) notify Vericel of the particular circumstances. MediWound and Vericel shall promptly discuss how to resolve such circumstances in an effort to avoid or mitigate such potential Supply Failure. MediWound shall investigate the root cause of the anticipated Supply Failure and prepare and provide to Vericel a Remediation Plan within [***] of MediWound's notice to Vericel. If the Remediation Plan is acceptable to Vericel, and MediWound is able to reasonably assure Vericel of MediWound's ability to Manufacture Product and, thereby, (a) avoid a Supply Failure or (b) supply Product in accordance with the Rolling Forecast within [***], then MediWound shall continue to Manufacture Product for Vericel. In all other cases, Vericel shall be permitted to take such measures as are reasonably determined in good faith by Vericel to ensure the supply of Product to the marketplace including cancelling or revising outstanding Purchase Orders and, at Vericel's option, Vericel's obligations under Section 2.8(a), (b) and (c) shall be deemed terminated.\"}, {\"id\": \"ARTICLE 3\", \"title\": \"COMPLIANCE, QUALITY AND ENVIRONMENTAL\", \"level\": 1, \"text\": \"ARTICLE 3 COMPLIANCE, QUALITY AND ENVIRONMENTAL\"}, {\"id\": \"3.1\", \"title\": \"Certificates of Analysis; Release\", \"level\": 2, \"text\": \"3.1 Certificates of Analysis; Release. MediWound shall perform, or cause to be performed testing and other activities on each Batch of Product Manufactured pursuant to this Agreement before delivery to Vericel or Vericel's designated Affiliate or contractor and consistent with the testing and procedures specified in the Quality Agreement. In the event of any change in Specifications, the certificate of analysis shall contain the required information in accordance with the then-approved release tests in conjunction with applicable change control procedures in accordance with this Agreement and the Quality Agreement. MediWound shall send, or cause to be sent, such certificates to Vericel prior to delivery of each such Batch unless otherwise agreed by the Parties in writing or specified in the Quality Agreement.\"}, {\"id\": \"3.2\", \"title\": \"Records\", \"level\": 2, \"text\": \"3.2 Records. MediWound shall maintain and shall cause each Supplier to maintain all Manufacturing records, including packaging, analytical and stability records, all records of shipment, and all validation data relating to the Product Manufactured and supplied to Vericel hereunder for the Territory to the extent and for the time periods required by applicable Regulatory Standards with respect to such Product. MediWound shall make such records and data available for Vericel's review on Vericel's reasonable request as mutually agreed by the Parties.\"}, {\"id\": \"3.3\", \"title\": \"Regulatory Compliance\", \"level\": 2, \"text\": \"3.3 Regulatory Compliance. MediWound shall advise Vericel promptly, but in any event within [***] on becoming aware of an authorized agent of a Regulatory Authority visit or inspection to its or any of the Suppliers' Facilities where the Products are being Manufactured for supply to Vericel for the Territory hereunder and in connection with the Manufacturing of the Products. MediWound agrees to use commercially reasonable efforts to permit one or more\"}, {\"id\": \"13\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"13 9012190/26 Vericel representatives to be present for all or part of such visit or inspection if Vericel so requests. MediWound shall use commercially reasonable efforts to furnish to Vericel a copy of all material information supplied and/or issued by any Regulatory Authority to the extent that such report relates to the Manufacture or supply of Product to Vericel for the Territory, or the ability of MediWound or the Suppliers to so Manufacture or supply hereunder, within [***] of its receipt of such information. Before MediWound or any Supplier responds to any Regulatory Authority where such correspondence would reasonably be expected to have a material impact on the Manufacture or supply of Product to Vericel for the Territory, Vericel will be provided a reasonable opportunity, unless prohibited by applicable Law, to review and comment on the portion of such response related thereto, provided that Vericel shall conduct such review and provide such comments reasonably in advance of when any such response is due to such Regulatory Authority, and further provided that nothing herein, including failure by Vericel to provide such timely review and comment, shall in any way restrict MediWound or its Suppliers from taking, and MediWound and its Suppliers shall at all times be permitted to take, such actions or inactions necessary for its and their compliance with applicable Law. With respect to any and all requirements of a Regulatory Authority for the Manufacture of Product for Commercialization in the Territory following the First Commercial Sale of the Product in a country in the Territory, the Parties shall discuss in good faith such requirements and allocation of responsibility between the Parties.\"}, {\"id\": \"3.4\", \"title\": \"Audit\", \"level\": 2, \"text\": \"3.4 Audit. (a) Vericel shall have the right from time to time during the Term of this Agreement, but not more than [***] (unless (i) otherwise agreed between the Parties or (ii) if Section 3.4(b) below applies) during normal business hours and upon not less than [***] prior notice (unless Section 3.4(b)(iv) applies), to enter and inspect any Facility and any related utilities and/or services used in Manufacturing Product in order to carry out a cGMP quality and compliance audit of those parts of the Facility involved in or which could have any impact on Manufacture of such Product (including those used for storing, warehousing and/or testing and utilities), including for the purpose of confirming that no types of product which could reasonably be expected to impact the quality of the Product are being manufactured on site in deviation of cGMP. (b) In addition to the rights set out in Section 3.4(a), where (i) any audit carried out in accordance with this Section 3.4 has identified any breach of this Agreement, (ii) Vericel has a reasonable basis to suspect a breach of this Agreement, (iii) any previous audit carried out in accordance with this Section 3.4 has identified any major or critical findings, or (iv) if such audit is in response to or following an audit from a regulatory agency, and such audit resulted in a 483 or equivalent citation, then Vericel shall have the right to carry out, upon reasonable prior notice and during normal business hours, follow up compliance audit(s). (c) MediWound shall be solely responsible for ensuring the cGMP compliance status of subcontractors (where such subcontractors are carrying out activities to which cGMP applies) used in relation to the performance of its obligations under this Agreement.\"}, {\"id\": \"14\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"14 9012190/26 (d) MediWound shall use commercially reasonable efforts to procure the right for Vericel to have the same inspection rights described in this Section 3.4 at the premises of any such subcontractor, and if unable to procure such rights, shall carry out such audits itself and shall report its non-confidential findings to Vericel. (e) The above obligations of MediWound and rights of Vericel shall apply, mutatis mutandis, to the rights of MediWound and obligations of Vericel with respect to the undertaking of Vericel and its Affiliates, Sublicensees and Distributors to comply with the cGMP as applicable to their activities and the related audit rights to ensure such compliance.\"}, {\"id\": \"3.5\", \"title\": \"Results of Audits and /or Regulatory Inspection\", \"level\": 2, \"text\": \"3.5 Results of Audits and /or Regulatory Inspection. Observations and conclusions of Vericel's audits will be issued to MediWound, which materials shall be deemed Confidential Information, provided that any Confidential Information of MediWound contained therein or upon which such observations and conclusions are based shall remain the Confidential Information of MediWound. MediWound and Vericel shall, at Vericel's expense (unless the result is due to a material breach of MediWound of any of its obligations under this Agreement), (a) cooperate to determine the cause for any identified issues, (b) work together in good faith to develop a corrective action, and (c) endeavor to implement such corrective action within a mutually agreed time period thereafter.\"}, {\"id\": \"3.6\", \"title\": \"Regulatory Information\", \"level\": 2, \"text\": \"3.6 Regulatory Information. MediWound shall promptly disclose to Vericel, upon its request, information in MediWound's possession required for Vericel to obtain and maintain any and all needed permits, approvals, or licenses issued by any and all Regulatory Authorities relating to the Manufacture, storage, packaging, and sale of a Product, as the case may be. MediWound shall use reasonable commercial efforts to cause Suppliers to, provide to Vericel in a reasonable, timely manner (including within a reasonable period prior to the due date of Vericel's annual report to an applicable Regulatory Authority with respect to the Product), all information in its or their respective possession which Vericel requires regarding the Product in order to comply with such Regulatory Standards. MediWound shall provide new regulatory correspondence related to the Product as soon as possible but in no event less than [***].\"}, {\"id\": \"3.7\", \"title\": \"Recall\", \"level\": 2, \"text\": \"3.7 Recall. Any decision to initiate a Recall of a Product in a country in the Territory shall be made by the marketing approval holder and shall be made in compliance with and to the extent permitted by applicable Law, after consultation between the Parties. Vericel's and its Affiliates', Sublicensees' and Distributors' costs (including internal costs of Vericel) associated with any such Recall shall be borne solely by Vericel (including refunds to customers); provided, however, that all out of pocket expenses associated with a Recall (including those of Vericel and its Affiliates, Sublicensees and Distributors and refunds to customers) shall be borne solely by MediWound to the extent such Recall (a) arises from or is caused directly by any breach by MediWound of this Agreement, the License Agreement or the Quality Agreement, or MediWound's or any of its Affiliates', Suppliers' or subcontractors' negligence or willful misconduct; or (b) resulting directly from MediWound's failure to supply Product that conforms to the applicable Product Warranty. MediWound shall cooperate in the implementation of any Recall of Product in the Territory, as required by applicable Law or reasonably requested by Vericel and, for such a Recall, the cost of such cooperation shall be at Vericel's reasonable\"}, {\"id\": \"15\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"15 9012190/26 expense (except to the extent the Recall results from the matters described in the foregoing clauses (a) or (b)).\"}, {\"id\": \"3.8\", \"title\": \"Quality Agreement\", \"level\": 2, \"text\": \"3.8 Quality Agreement. Each Party shall perform the duties required of it pursuant to a quality agreement to be entered into by the Parties within [***] of the execution of this Agreement (the \\\"Quality Agreement\\\"). To the extent the Quality Agreement either conflicts with this Agreement or is silent on an issue addressed, this Agreement shall control, except to the extent the matter is strictly a quality matter, in which event the Quality Agreement shall supersede this Agreement solely with respect to such quality matter.\"}, {\"id\": \"ARTICLE 4\", \"title\": \"CHANGES\", \"level\": 1, \"text\": \"ARTICLE 4 CHANGES\"}, {\"id\": \"4.1\", \"title\": \"Changes\", \"level\": 2, \"text\": \"4.1 Changes. MediWound shall not change the Specifications or Manufacturing process for the Manufacture of Product for supply to Vericel for the Territory hereunder except as expressly permitted pursuant to this Article 4. Each Party shall notify the other Party of any change in the Regulatory Standards applicable to the Manufacturing of Product for the supply to Vericel for the Territory that could reasonably affect the obligations of MediWound under this Agreement. All changes shall include an assessment of the need for regulatory submission and approval by a method to be defined in the Quality Agreement. The applicable notification period for any change or proposed change by a Party to the Manufacturing process or Specifications for a Product or Key Materials, the Facility and other Manufacturing changes (the \\\"Change Notification Period\\\") is set forth on Schedule 4.1.\"}, {\"id\": \"4.3\", \"title\": \"Discretionary Manufacturing Changes\", \"level\": 2, \"text\": \"4.3 Discretionary Manufacturing Changes. Vericel may propose changes to the Specifications or Manufacturing process for the supply of Product to Vericel for the Territory that are not Regulatory Changes (any such change, a \\\"Discretionary Manufacturing Change\\\"). If agreed to by MediWound, MediWound or its Suppliers will use commercially reasonable efforts to make such proposed changes, and Vericel will bear [***] of the costs associated with such changes. MediWound may propose changes to the Specifications or Manufacturing process for the supply of Product for the Territory that are not Regulatory Changes. MediWound shall propose any such Discretionary Manufacturing Change in accordance with the applicable\"}, {\"id\": \"16\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"16 9012190/26 Change Notification Period prior to the proposed implementation. [***]. Vericel shall, within [***] of receipt of MediWound's notice, notify MediWound in writing whether Vericel accepts or rejects the proposed change, such consent not to be unreasonably withheld, conditioned or delayed unless consultations with regulatory authorities are required to assess the impact of such proposed change.\"}, {\"id\": \"4.4\", \"title\": \"Regulatory Changes\", \"level\": 2, \"text\": \"4.4 Regulatory Changes. (a) Notwithstanding any other provision under this Agreement to the contrary, if either Party receives notice, or is otherwise informed of, any change to the Manufacturing process or Specifications for a Product or Key Materials, the Facility or any change that has an impact of the obligations of Vericel or MediWound under this Agreement that is required by applicable Law or that is otherwise required by any applicable Regulatory Authority (any such change, a \\\"Regulatory Change\\\"), such Party shall promptly deliver notice thereof to the other Party. Within the applicable Change Notification Period, MediWound shall notify Vericel in writing of MediWound's good faith and reasonable determination as to (i) whether MediWound is technically able to comply with such Regulatory Change, (ii) whether the Regulatory Change would adversely affect MediWound's ability to timely manufacture and supply any Product supplied hereunder and (iii) the costs to implement such Regulatory Change. MediWound shall use commercially reasonable efforts to cause Key Material Suppliers to provide such notice of any Regulatory Change to MediWound or Vericel. (b) If MediWound determines it is technically unable to comply with the Regulatory Change at the Facility in the timeframe required by the applicable Regulatory Authority, then, in MediWound's discretion, it shall have the right to transfer the Manufacturing of the applicable Product to an alternative facility of MediWound that is qualified and approved for Manufacturing such Product in accordance with this Agreement, if available. In the event MediWound is unable to supply Product as a result of such Regulatory Change, Vericel, in its sole discretion, shall be entitled to source all or any portion of Vericel's requirements of the applicable Product, until MediWound regains the ability to supply Product, from a Third Party, including from the Second Source. Notwithstanding anything to the contrary contained in this Agreement, if as a result of a Regulatory Change, MediWound is unable to Manufacture and supply a Product to Vericel, Vericel shall be entitled to source such Product, until MediWound regains the ability to supply Product, from a Third Party or Second Source in accordance with this Section 4.4(b), in which case MediWound shall use commercially reasonable efforts to provide Vericel with reasonable technical assistance with regard to transferring the technology relating to the Product to such Third Party, and the Parties shall discuss the allocation of such costs related to such transfer, including MediWound's expenses and any incremental costs of supply of such Product and Materials from such Third Party consistent with Schedule 4.5. (c) If MediWound determines it is technically able to implement a Regulatory Change required by a Regulatory Authority in the Territory, the costs for such Regulatory Change shall be borne by Vericel consistent with Schedule 4.5.\"}, {\"id\": \"17\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"17 9012190/26\"}, {\"id\": \"4.5\", \"title\": \"Ongoing Regulatory Assistance\", \"level\": 2, \"text\": \"4.5 Ongoing Regulatory Assistance. Within [***] following Vericel's request, MediWound shall provide technical data and assistance in answering Vericel's questions (a) for regulatory filings and for process changes initiated by MediWound at no cost to Vericel, (b) for process changes initiated by Vericel at the cost of Vericel for the applicable number of hours at a Full Time Equivalent rate described in Schedule 4.5, (c) for new regulatory registrations, which shall be at Vericel's cost, and (d) for periodic regulatory reporting and questions from regulatory authorities, which shall be at the cost of Vericel.\"}, {\"id\": \"ARTICLE 5\", \"title\": \"PRICE AND PAYMENT TERMS\", \"level\": 1, \"text\": \"ARTICLE 5 PRICE AND PAYMENT TERMS\"}, {\"id\": \"5.1\", \"title\": \"Supply Price\", \"level\": 2, \"text\": \"5.1 Supply Price. On a Product-by-Product basis, the price payable in U.S. Dollars by Vericel for supply of such Product for a given Calendar Year shall be as set forth on a per unit basis on Exhibit A (with respect to each Product, the \\\"Supply Price\\\"), which shall be updated on a Calendar Year basis in accordance with Section 5.2 below.\"}, {\"id\": \"5.2\", \"title\": \"Price Mechanics\", \"level\": 2, \"text\": \"5.2 Price Mechanics. (a) Beginning on [***] (each, a \\\"Re-Pricing Date\\\"), MediWound may annually increase the Supply Price for a Calendar Year in accordance with the terms of this Section 5.2. MediWound may increase the Supply Price for a Calendar Year if the United States Producer Price Index (Chemical Manufacturing) published by the Bureau of Labor Statistics (the \\\"PPI\\\") [***] and (b) in the event the PPI [***]. MediWound shall give Vericel at least [***] prior written notice of any such adjustment to the Supply Price. (b) In addition to the foregoing price adjustment mechanism, MediWound may propose an adjustment to the Supply Price to reflect changes that substantially affect MediWound's costs or ability to supply Product. MediWound shall provide Vericel with written notice of such changes and its proposed adjustment and provide appropriate documentation demonstrating that the price adjustment is required. Following Vericel's receipt of such notice and documentation, the Parties will engage in good faith discussions to negotiate a mutually agreed upon adjustment to the Supply Price, if any. (c) Unless otherwise agreed by the Parties, the adjusted Supply Price will be the Supply Price for the next applicable Purchase Order placed after Vericel's receipt of notification of the adjusted Supply Price, and shall apply to each Purchase Order placed thereafter until the next adjustment is made (if any) in accordance with the above mechanism.\"}, {\"id\": \"5.3\", \"title\": \"Cost Savings\", \"level\": 2, \"text\": \"5.3 Cost Savings. Either Party may propose changes to any Manufacturing process in order to obtain efficiencies and cost savings in such process (\\\"Cost Savings Change\\\"). The proposing Party shall submit to the other Party a proposal detailing the Cost Savings Change, the implementation of such Cost Savings Change, and the analysis of the expected efficiencies and cost savings from such Cost Savings Change. If Vericel proposes a Cost Savings Change and (a) MediWound determines it is technically able to implement the Cost Savings Change, (b) the Cost Savings Change would not materially adversely affect the applicable Facility, and (c) Vericel agrees to pay the costs to implement such Costs Saving Change as an Additional Service Fee,\"}, {\"id\": \"18\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"18 9012190/26 MediWound shall agree to implement such proposed change which MediWound shall not unreasonably decline to implement. If MediWound proposes a Cost Savings Change and the Parties agree to its implementation, (i) Vericel shall pay MediWound the agreed amount to implement such change as an Additional Service Fee prior to the implementation of such Cost Savings Change; and (ii) MediWound shall make its reasonable commercial efforts to implement such Cost Savings Change pursuant to a mutually agreed upon schedule. In the event cost savings are actually achieved, then the cost saving will be [***] between the Parties (i.e. [***] of the cost savings shall be added to the new discounted Supply Price).\"}, {\"id\": \"5.4\", \"title\": \"Payments\", \"level\": 2, \"text\": \"5.4 Payments. Unless specified otherwise, any payment to be made by Vericel under this Agreement shall be made within [***] from date of invoice. It is hereby agreed that the invoice with respect to any shipment will be issued upon the delivery date. The Parties' respective rights and responsibilities under Sections 5.6.5 and 5.6.6 of the License Agreement shall apply as such Section pertains to the Parties' performance under this Agreement, and are hereby incorporated by reference.\"}, {\"id\": \"5.5\", \"title\": \"Late Payments\", \"level\": 2, \"text\": \"5.5 Late Payments. Any payments due under this Agreement shall be due on such date as specified in this Agreement and, in the event such date is not a Business Day, then the next succeeding Business Day. In the event that any payment due under this Agreement is not made when due, the amount due shall accrue interest beginning on the [***] following the date on which such payment was due, calculated at the [***] for the due date, or, if lower, the maximum rate permitted by law, calculated from the due date until paid in full. Each payment made after the due date shall be accompanied by all interest so accrued. Notwithstanding the foregoing, a Party shall have recourse to any other remedy available at law or in equity with respect to any delinquent payment, subject to the terms of this Agreement.\"}, {\"id\": \"5.6\", \"title\": \"Taxes\", \"level\": 2, \"text\": \"5.6 Taxes. Vericel shall be responsible for the payment of any value added or similar tax (but excluding, for avoidance of doubt, any tax on the income of MediWound) on the Products delivered by MediWound to Vericel, to the extent such taxes are itemized and included on a valid invoice and required to be collected from Vericel under applicable Law. In addition, in the event any payments made by Vericel pursuant to this Agreement become subject to withholding taxes under the Laws or regulations of any jurisdiction or Governmental Authority, Vericel shall deduct and withhold the amount of such taxes for the account of MediWound to the extent required by applicable Laws or regulations; such amounts payable to MediWound shall be reduced by the amount of taxes deducted and withheld; and Vericel shall pay the amounts of such taxes to the proper Governmental Authority in a timely manner and transmit to MediWound an official tax certificate or other evidence of such tax obligations together with proof of payment from the relevant Governmental Authority of all amounts deducted and withheld. Any such withholding taxes required under applicable Laws or regulations to be paid or withheld shall be an expense of, and borne solely by, MediWound. Each Party agrees to cooperate with the other Party in claiming refunds or exemptions from such deductions or withholdings under any relevant agreement or treaty which is in effect. The Parties shall discuss applicable mechanisms for minimizing such taxes to the extent possible in compliance with applicable Laws. Vericel will provide MediWound with reasonable assistance to enable MediWound to recover such taxes as permitted by applicable Laws or regulations.\"}, {\"id\": \"19\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"19 9012190/26\"}, {\"id\": \"ARTICLE 6\", \"title\": \"REPRESENTATIONS, WARRANTIES AND COVENANTS\", \"level\": 1, \"text\": \"ARTICLE 6 REPRESENTATIONS, WARRANTIES AND COVENANTS\"}, {\"id\": \"6.1\", \"title\": \"Mutual Representations and Warranties\", \"level\": 2, \"text\": \"6.1 Mutual Representations and Warranties. As of the Effective Date unless otherwise specified, each of MediWound and Vericel hereby represents and warrants to the other Party that: (a) it is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization; (b) the execution, delivery and performance of this Agreement by such Party has been duly authorized by all requisite action under the provisions of its charter, bylaws and other organizational documents, and does not require any action or approval by any of its shareholders or other holders of its voting securities or voting interests; (c) it has the power and authority to execute and deliver this Agreement and to perform its obligations hereunder; (d) this Agreement has been duly executed and is a legal, valid and binding obligation on each Party, enforceable against such Party in accordance with its terms; and (e) the execution, delivery and performance by such Party of this Agreement and its compliance with the terms and provisions hereof does not and will not conflict with or result in a breach of or default under any agreement or arrangement with any Third Party existing as of the Effective Date.\"}, {\"id\": \"6.2\", \"title\": \"Compliance with Law\", \"level\": 2, \"text\": \"6.2 Compliance with Law. During the Term of this Agreement, each Party shall comply in all material respects with all applicable Laws (including Regulatory Standards, cGMP as applicable to MediWound and cGMP to the extent applicable to Vericel) applicable to its performance under this Agreement.\"}, {\"id\": \"6.3\", \"title\": \"Product Warranty\", \"level\": 2, \"text\": \"6.3 Product Warranty. MediWound represents and warrants to Vericel that, at the time of delivery of the given Product to the Delivery Site pursuant to Section 2.9(c), such Product so delivered pursuant to this Agreement will constitute Conforming Product and, except with respect to Section 2.13, will have a shelf life equal to or exceeding the Minimum Shelf Life (the \\\"Product Warranty\\\").\"}, {\"id\": \"6.4\", \"title\": \"No Liens\", \"level\": 2, \"text\": \"6.4 No Liens. MediWound represents, warrants and covenants that all Product delivered to Vericel (or its designated Affiliate or contractor) pursuant to this Agreement will, at the time of such delivery, be free and clear of all liens, encumbrances, security interests and other encumbrances.\"}, {\"id\": \"6.5\", \"title\": \"Debarment\", \"level\": 2, \"text\": \"6.5 Debarment. As of the Effective Date hereof and at all times during the Term of the Agreement, each Party represents and warrants to the other Party that neither it nor, to its knowledge, any of its existing subcontractors or Suppliers, is debarred as of the Effective Date, and neither it nor any of its subcontractors or Suppliers shall, during the Term, use in any\"}, {\"id\": \"20\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"20 9012190/26 capacity the services of any Person debarred by any Regulatory Authority, including under Subsection 306(a) or (b) of the Generic Drug Enforcement Act of 1992 or any other equivalent Regulatory Standard. In the event either Party learns that it, any of its employees or contractors, any Supplier or any of a Supplier's employees or contractors has been debarred, it shall notify the other Party promptly, and in any event within [***] of learning of such debarment. In the event that MediWound, any of its employees or contractors, any Supplier or any of a Supplier's employees or contractors has been debarred, MediWound shall immediately remove or have removed such Person from thereafter performing Manufacturing or supply activities under this Agreement with respect to the Product upon learning of such debarment. In the event that Vericel, any of its employees or contractors, any Sublicensee or any of such Sublicensee's employees or contractors has been debarred, it shall immediately remove or have removed such Person from thereafter performing distribution activities under this Agreement with respect to the Product upon learning of such debarment.\"}, {\"id\": \"ARTICLE 7\", \"title\": \"INDEMNITY, INSURANCE\", \"level\": 1, \"text\": \"ARTICLE 7 INDEMNITY, INSURANCE\"}, {\"id\": \"7.1\", \"title\": \"Indemnification by MediWound\", \"level\": 2, \"text\": \"7.1 Indemnification by MediWound. MediWound will indemnify, defend and hold harmless Vericel, its Affiliates, Sublicensees, contractors, Distributors and each of its and their respective employees, officers, directors and agents (each, a \\\"Vericel Indemnified Party\\\") from and against any and all liability, loss, damage, expense (including reasonable attorneys' fees and expenses) and cost (collectively, \\\"Liability\\\") that the Vericel Indemnified Party may be required to pay to one or more Third Parties resulting from or arising out of: (a) the material breach by MediWound of any of its representations, warranties or covenants set forth in Article 6; (b) any Recall or withdrawal of Product to the extent attributable to MediWound's breach of this Agreement or the Quality Agreement; or (c) the gross negligence or willful misconduct of MediWound or any subcontractor or Supplier acting on behalf of MediWound relating to its activities in connection with this Agreement; except, in each case, to the extent (y) caused by the negligence, recklessness or intentional acts of Vericel or any Vericel Indemnified Party or (z) Vericel is required to indemnify MediWound pursuant to Section 7.2.\"}, {\"id\": \"7.2\", \"title\": \"Indemnification by Vericel\", \"level\": 2, \"text\": \"7.2 Indemnification by Vericel. Vericel will indemnify, defend and hold harmless MediWound, each of its Affiliates, and each of its and its Affiliates' employees, officers, directors and agents (each, a \\\"MediWound Indemnified Party\\\") from and against any and all Liability that the MediWound Indemnified Party may be required to pay to one or more Third Parties (other than shareholders of MediWound or its Affiliates) resulting from or arising out of: (a) the material breach by Vericel of any of its representations, warranties or covenants set forth in Article 6;\"}, {\"id\": \"21\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"21 9012190/26 (b) any Recall or withdrawal of Product to the extent attributable to Vericel's breach of this Agreement or the Quality Agreement; or (c) the gross negligence or willful misconduct of Vericel or any subcontractor or Supplier acting on behalf of Vericel relating to its activities in connection with this Agreement; except, in each case, to the extent (y) caused by the negligence, recklessness or intentional acts of MediWound or any MediWound Indemnified Party or (z) MediWound is required to indemnify Vericel pursuant to Section 7.1.\"}, {\"id\": \"7.3\", \"title\": \"No Right of Indemnification under License Agreement\", \"level\": 2, \"text\": \"7.3 No Right of Indemnification under License Agreement. No right of indemnification shall exist under the License Agreement for claims arising out of the performance of this Agreement, it being the intent of the Parties that such claims shall be solely governed by the provisions of this Agreement and, for the avoidance of doubt, except as set forth in Section 7.6, no limits on indemnification or liability set forth in the License Agreement shall apply to this Agreement.\"}, {\"id\": \"7.4\", \"title\": \"Procedure\", \"level\": 2, \"text\": \"7.4 Procedure. (a) Notice. Each Party will notify the other Party in writing in the event it becomes aware of a claim for which indemnification may be sought hereunder. In the event that any Third Party asserts a claim or other proceeding (including any governmental investigation) with respect to any matter for which a Party (the \\\"Indemnified Party\\\") is entitled to indemnification hereunder (a \\\"Third Party Claim\\\"), then the Indemnified Party shall promptly notify the Party obligated to indemnify the Indemnified Party (the \\\"Indemnifying Party\\\") thereof; provided, however, that no delay on the part of the Indemnified Party in notifying the Indemnifying Party shall relieve the Indemnifying Party from any obligation hereunder unless (and then only to the extent that) the Indemnifying Party is prejudiced thereby. (b) Control. The Indemnifying Party shall have the right, exercisable by notice to the Indemnified Party within [***] after receipt of notice from the Indemnified Party of the commencement of or assertion of any Third Party Claim, to assume direction and control of the defense, litigation, settlement, appeal or other disposition of the Third Party Claim (including the right to settle the claim solely for monetary consideration) with counsel selected by the Indemnifying Party and reasonably acceptable to the Indemnified Party; provided that (i) the Indemnifying Party has sufficient financial resources, in the reasonable judgment of the Indemnified Party, to satisfy the amount of any adverse monetary judgment that is sought, (ii) the Third Party Claim seeks solely monetary damages and (iii) the Indemnifying Party expressly agrees in writing that as between the Indemnifying Party and the Indemnified Party, the Indemnifying Party shall be solely obligated to satisfy and discharge the Third Party Claim in full (the conditions set forth in clauses (i), (ii) and (iii) above are collectively referred to as the \\\"Litigation Conditions\\\"). Within [***] after the Indemnifying Party has given notice to the Indemnified Party of its exercise of its right to defend a Third Party Claim, the Indemnified Party shall give notice to the Indemnifying Party of any objection thereto based upon the Litigation Conditions. If the Indemnified Party reasonably so objects, the Indemnified Party shall continue to defend the Third Party Claim, at the expense of the Indemnifying Party, until such time as\"}, {\"id\": \"22\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"22 9012190/26 such objection is withdrawn. If no such notice is given, or if any such objection is withdrawn, the Indemnifying Party shall be entitled, at its sole cost and expense, to assume direction and control of such defense, with counsel selected by the Indemnifying Party and reasonably acceptable to the Indemnified Party. During such time as the Indemnifying Party is controlling the defense of such Third Party Claim, the Indemnified Party shall cooperate, and shall cause its Affiliates and agents to cooperate upon request of the Indemnifying Party, in the defense or prosecution of the Third Party Claim, including by furnishing such records, information and testimony and attending such conferences, discovery proceedings, hearings, trials or appeals as may reasonably be requested by the Indemnifying Party. In the event that the Indemnifying Party does not satisfy the Litigation Conditions or does not notify the Indemnified Party of the Indemnifying Party's intent to defend any Third Party Claim within [***] after notice thereof, the Indemnified Party may (without further notice to the Indemnifying Party) undertake the defense thereof with counsel of its choice and at the Indemnifying Party's expense (including reasonable, out-of-pocket attorneys' fees and costs and expenses of enforcement or defense). The Indemnifying Party or the Indemnified Party, as the case may be, shall have the right to join in (including the right to conduct discovery, interview and examine witnesses and participate in all settlement conferences), but not control, at its own expense, the defense of any Third Party Claim that the other party is defending as provided in this Agreement. (c) Settlement. The Indemnifying Party shall not, without the prior written consent of the Indemnified Party, enter into any compromise or settlement that commits the Indemnified Party to take, or to forbear to take, any action. The Indemnified Party shall have the sole and exclusive right to settle any Third Party Claim, on such terms and conditions as it deems reasonably appropriate, to the extent such Third Party Claim involves equitable or other non-monetary relief, but shall not have the right to settle such Third Party Claim to the extent such Third Party Claim involves monetary damages without the prior written consent of the Indemnifying Party. Each of the Indemnifying Party and the Indemnified Party shall not make any admission of liability in respect of any Third Party Claim without the prior written consent of the other party, and the Indemnified Party shall use reasonable efforts to mitigate liabilities arising from such Third Party Claim.\"}, {\"id\": \"7.5\", \"title\": \"Disclaimer\", \"level\": 2, \"text\": \"7.5 Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES, AND EACH PARTY EXPRESSLY DISCLAIMS, ANY AND ALL REPRESENTATIONS OR WARRANTIES OF ANY KIND, WITH RESPECT TO THIS AGREEMENT (INCLUDING THE MANUFACTURE AND SUPPLY OF PRODUCT HEREUNDER), EXPRESS, IMPLIED OR STATUTORY, INCLUDING, ANY WARRANTY OF TITLE, NON-INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.\"}, {\"id\": \"7.6\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"7.6 LIMITATION OF LIABILITY. NEITHER PARTY SHALL BE LIABLE FOR ANY SPECIAL, INCIDENTAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES OF ANY KIND (INCLUDING LOST PROFITS) REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT, NEGLIGENCE, BREACH OF STATUTORY DUTY OR OTHERWISE, SUFFERED BY THE OTHER PARTY, EVEN IF THAT PARTY HAS BEEN INFORMED OF THE POSSIBILITY OF ANY SUCH DAMAGES IN ADVANCE. [***].\"}, {\"id\": \"23\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"23 9012190/26\"}, {\"id\": \"7.7\", \"title\": \"Insurance\", \"level\": 2, \"text\": \"7.7 Insurance. For the duration of this Agreement and for a period of [***] following its termination, each Party agrees to obtain and maintain, during the Term, commercial general liability insurance, including product liability insurance, with reputable and financially secure insurance carriers (or pursuant to a program of self-insurance reasonably satisfactory to the other Party) to cover its indemnification obligations under Section 7.1 or Section 7.2, as applicable, in each case with limits of not less than [***] per occurrence and in the aggregate. Insurance shall be procured with carriers having an A.M. Best Rating of A-VII or better.\"}, {\"id\": \"ARTICLE 8\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 8 TERM AND TERMINATION\"}, {\"id\": \"8.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"8.1 Term. The term of this Agreement will commence upon the Effective Date and will continue until the fifth (5th) anniversary of the Effective Date, unless earlier terminated or extended under this Article 8 (the \\\"Initial Term\\\"). At least twenty-four (24) months from the end of the Initial Term, Vericel shall provide MediWound notice whether Vericel elects to extend the Initial Term of the Agreement by an additional twenty four (24) months. After the Initial Term (including any extension thereto made in accordance with the preceding sentence), the Agreement may be extended on a yearly basis up to ten (10) years at Vericel's sole discretion, with renewal notice to be provided to MediWound no later than twelve (12) months prior to the expiry of any yearly extension (the \\\"Renewal Term\\\", and the Initial Term, together with the Renewal Term, if any, the \\\"Term\\\"); provided that unless otherwise agreed by the Parties, the Term of this Agreement (including the Initial Term, any extension of the Initial Term and any Renewal Terms) shall be no more than fifteen (15) years in total.\"}, {\"id\": \"8.2\", \"title\": \"Automatic Termination\", \"level\": 2, \"text\": \"8.2 Automatic Termination. This Agreement will automatically immediately terminate in the event of the expiration or termination of the License Agreement.\"}, {\"id\": \"8.3\", \"title\": \"Termination for Breach\", \"level\": 2, \"text\": \"8.3 Termination for Breach. Subject to the provisions of Article 10 below, either Party may terminate this Agreement in its entirety if the other Party materially breaches a material provision and does not cure such breach, or does not take reasonable steps required under the circumstances to cure such breach going forward, within [***] after receiving notice of the breach.\"}, {\"id\": \"8.4\", \"title\": \"Termination by Vericel\", \"level\": 2, \"text\": \"8.4 Termination by Vericel. Following the Initial Term, Vericel may, without penalty or prejudice to any other rights or remedies Vericel may have, in its sole discretion terminate or reduce the scope of any individual activities contemplated by this Agreement or any Additional Service or with respect to any Product or terminate this Agreement as a whole with or without cause, upon [***] prior written notice of such termination or reduction (which such written notice may be provided during the Initial Term).\"}, {\"id\": \"8.5\", \"title\": \"Termination by MediWound\", \"level\": 2, \"text\": \"8.5 Termination by MediWound. Following the Initial Term, MediWound may terminate this Agreement by notice in writing to Vericel upon on at least [***] advanced written notice (or such longer period of time as reasonably necessary to avoid a supply disruption) if MediWound determines to cease Manufacturing the applicable Product for the Territory, but in such case MediWound will reasonably cooperate with Vericel to enable Vericel to establish its own source for the Product (including, to the extent requested by Vericel and within\"}, {\"id\": \"24\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"24 9012190/26 MediWound's ability to do so, by transferring MediWound's applicable Third Party manufacturing relationships to Vericel).\"}, {\"id\": \"8.6\", \"title\": \"Effects of Termination\", \"level\": 2, \"text\": \"8.6 Effects of Termination. Any expiration or termination of this Agreement shall not affect any claims that have accrued or outstanding obligations or payments due hereunder prior to such termination or expiration, nor shall it prejudice any other remedies that the Parties may have under this Agreement. In addition, upon the expiration or earlier termination of this Agreement: (a) if Vericel terminates the Agreement for breach or MediWound terminates in accordance with Section 8.5, Vericel shall have the option of [***] (b) Vericel shall pay to MediWound: (i) all amounts outstanding and remaining to be paid for Product supplied prior to such expiration or termination or under any other obligation under the Agreement; (ii) all amounts for Product in the Binding Forecasts and Binding Orders prior to the expiration or termination, provided that MediWound delivers such Product in accordance with the terms of this Agreement; (iii) all amounts representing the purchase by MediWound of Materials in reliance upon the Binding Forecasts and Binding Orders (if MediWound is unable to cancel (without incurring any costs) or otherwise use such Materials); and (iv) all amounts representing remaining inventory of Product and all Product work in process undertaken in accordance with the Binding Forecasts or Binding Orders or undertaken otherwise in accordance with the terms of this Agreement. (c) Following expiration of the Royalty Term (as defined in the License Agreement) for any Licensed Product in a given country, the license granted to Vericel under Section 9.1 of this Agreement with respect to such Licensed Product in such country shall automatically become fully paid-up, perpetual, irrevocable and royalty-free.\"}, {\"id\": \"ARTICLE 9\", \"title\": \"INTELLECTUAL PROPERTY RIGHTS\", \"level\": 1, \"text\": \"ARTICLE 9 INTELLECTUAL PROPERTY RIGHTS\"}, {\"id\": \"9.1\", \"title\": \"Manufacturing License Grant\", \"level\": 2, \"text\": \"9.1 Manufacturing License Grant. Subject to the terms herein, MediWound hereby grants to Vericel a non-exclusive, sublicensable (subject to Section 4.2 of the License Agreement) license under the MediWound Technology and MediWound's interest in the Joint Technology, to Manufacture and have Manufactured Licensed Products in the Territory for use in the Field in the Territory.\"}, {\"id\": \"9.2\", \"title\": \"Trademarks License Grant\", \"level\": 2, \"text\": \"9.2 Trademarks License Grant. MediWound hereby grants to Vericel an exclusive (even as to MediWound), sublicensable, royalty- free, fully paid-up, license in the Territory to use the Licensed Trademarks (as defined in the License Agreement) and a non- exclusive, sublicensable, royalty-free, fully paid-up, license to use the MediWound name and trademark, in\"}, {\"id\": \"25\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"25 9012190/26 each case, in connection with the Manufacture of Licensed Products in or for the Territory. All uses of the Licensed Trademarks by Vericel (and its Affiliates, Sublicensees and Distributors) in connection with the Manufacture of Licensed Products in or for the Territory shall be in accordance with Regulatory Approvals and all applicable Laws and MediWound's quality control guidelines for the Licensed Trademarks, as may be amended from time to time. Vericel (and its Affiliates) shall only use the Licensed Trademarks licensed hereunder in connection with the Manufacture of Licensed Products in the Territory. Vericel shall not (and shall cause its Affiliates, Sublicensee and Distributors not to) use such Licensed Trademarks to identify, or in connection with the marketing of, any other products.\"}, {\"id\": \"9.1\", \"title\": \"Ownership\", \"level\": 2, \"text\": \"9.1 Ownership. Ownership of all inventions and discoveries made by the Parties in the course of Manufacturing and supply of the Product hereunder (including Manufacture and supply of Product) shall be determined in accordance with the terms of the License Agreement.\"}, {\"id\": \"ARTICLE 10\", \"title\": \"FORCE MAJEURE\", \"level\": 1, \"text\": \"ARTICLE 10 FORCE MAJEURE\"}, {\"id\": \"10.1\", \"title\": \"Excusing Performance\", \"level\": 2, \"text\": \"10.1 Excusing Performance. Neither Party shall be liable for the failure to perform its obligations under this Agreement to the extent such failure is due to events beyond the reasonable control of the non-performing Party, including fires, floods, earthquakes, hurricanes, embargoes, shortages, epidemics, quarantines, war, acts of war (whether war be declared or not), terrorist acts, insurrections, riots, civil commotion, strikes, lockouts or other labor disturbances involving the workforce of any Third Party, or acts of God (a \\\"Force Majeure Event\\\"). Notwithstanding anything to the contrary herein, the occurrence of a Force Majeure Event will not excuse or prevent a failure of MediWound to deliver Product from being deemed a \\\"Supply Failure\\\" or otherwise limit Vericel's rights, to the extent applicable, under Section 2.13.\"}, {\"id\": \"10.2\", \"title\": \"Notice of Force Majeure Event\", \"level\": 2, \"text\": \"10.2 Notice of Force Majeure Event. A Party claiming a right to be excused from performance under Section 10.1 shall immediately notify the other Party in writing of the extent of its inability to perform, which notice shall specify the Force Majeure Event and the estimated likely period of time during which its performance will be affected.\"}, {\"id\": \"10.3\", \"title\": \"Resumption; Termination\", \"level\": 2, \"text\": \"10.3 Resumption; Termination. A non-performing Party as a result of a Force Majeure Event shall use reasonable best efforts, at its own expense, to eliminate the Force Majeure Event and to mitigate the effect of such cause and resume performance under this Agreement, in each case, as soon as practicable and for as long as such Force Majeure Event continues. Further, consistent with diligent risk management practices, MediWound will keep current a risk management program. If MediWound is affected by any Force Majeure Event, MediWound agrees to perform its obligations under this Section 10.3 to mitigate the effect thereof and resume performance under this Agreement in the same manner as MediWound would use to resolve any similar disruptions affecting its own products (including EscharEx). MediWound shall use reasonable best efforts to ensure that the impact of the Force Majeure Event shall not be relatively greater for Vericel than it is for MediWound with respect to MediWound's products (including EscharEx).\"}, {\"id\": \"26\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"26 9012190/26\"}, {\"id\": \"ARTICLE 11\", \"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"ARTICLE 11 MISCELLANEOUS\"}, {\"id\": \"11.1\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"11.1 Assignment. Neither this Agreement nor any interest hereunder shall be assignable by a Party without the prior written consent of the other Party, except as follows: (a) such Party may assign its rights and obligations under this Agreement to any of its Affiliates, provided that the assignee shall expressly agree to be bound by such Party's obligations under this Agreement and that such Party shall remain liable for all of its rights and obligations under this Agreement, and (b) either Party may assign its rights and obligations hereunder to a Third Party in connection with a permitted assignment or other permitted transfer of the License Agreement. Each Party shall promptly notify the other Party of any assignment or transfer under the provisions of this Section 11.1. This Agreement shall be binding upon the successors and permitted assigns of the Parties and the name of a Party appearing herein shall be deemed to include the names of such Party's successors and permitted assigns to the extent necessary to carry out the intent of this Agreement. Any assignment not in accordance with this Section 11.1 shall be void.\"}, {\"id\": \"11.2\", \"title\": \"Further Actions\", \"level\": 2, \"text\": \"11.2 Further Actions. Each Party agrees to execute, acknowledge and deliver such further instruments, and to do all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of the Agreement.\"}, {\"id\": \"11.3\", \"title\": \"Notices\", \"level\": 2, \"text\": \"11.3 Notices. Any notice or notification required or permitted to be provided pursuant to the terms and conditions of this Agreement (including any notice of force majeure, breach, termination, change of address, etc.) shall be in writing and shall be deemed given upon receipt if delivered personally or by facsimile transmission (receipt verified), five days after deposited in the mail if mailed by registered or certified mail (return receipt requested) postage prepaid, or on the next Business Day if sent by overnight delivery using a nationally recognized express courier service and specifying next Business Day delivery (receipt verified), to the Parties at the following addresses or facsimile numbers (or at such other address or facsimile number for a Party as shall be specified by like notice, provided, however, that notices of a change of address shall be effective only upon receipt thereof): All correspondence to Vericel shall be addressed as follows: Vericel Corporation 64 Sidney Street Cambridge, Massachusetts 02139 Attention: Chief Financial Officer with a copy to: General Counsel All correspondence to MediWound shall be addressed as follows:\"}, {\"id\": \"27\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"27 9012190/26 MediWound Ltd. 42 Hayarkon Street Yavne, Israel 8122745 Attention: Chief Financial Officer with a copy to: General Counsel\"}, {\"id\": \"11.4\", \"title\": \"Amendment\", \"level\": 2, \"text\": \"11.4 Amendment. No amendment, modification or supplement of any provision of this Agreement shall be valid or effective unless made in writing and signed by a duly authorized officer of each Party.\"}, {\"id\": \"11.5\", \"title\": \"Waiver\", \"level\": 2, \"text\": \"11.5 Waiver. No provision of this Agreement shall be waived by any act, omission or knowledge of a Party or its agents or employees except by an instrument in writing expressly waiving such provision and signed by a duly authorized officer of the waiving Party. The waiver by either of the Parties of any breach of any provision hereof by the other Party shall not be construed to be a waiver of any succeeding breach of such provision or a waiver of the provision itself.\"}, {\"id\": \"11.6\", \"title\": \"Severability\", \"level\": 2, \"text\": \"11.6 Severability. If any clause or portion thereof in this Agreement is for any reason held to be invalid, illegal or unenforceable, the same shall not affect any other portion of this Agreement, as it is the intent of the Parties that this Agreement shall be construed in such fashion as to maintain its existence, validity and enforceability to the greatest extent possible. In any such event, this Agreement shall be construed as if such clause of portion thereof had never been contained in this Agreement, and there shall be deemed substituted therefor such provision as will most nearly carry out the intent of the Parties as expressed in this Agreement to the fullest extent permitted by applicable Law.\"}, {\"id\": \"11.7\", \"title\": \"Descriptive Headings\", \"level\": 2, \"text\": \"11.7 Descriptive Headings. The descriptive headings of this Agreement are for convenience only and shall be of no force or effect in construing or interpreting any of the provisions of this Agreement.\"}, {\"id\": \"11.8\", \"title\": \"Interpretation\", \"level\": 2, \"text\": \"11.8 Interpretation. Except where the context expressly requires otherwise, (a) the use of any gender herein shall be deemed to encompass references to either or both genders, and the use of the singular shall be deemed to include the plural (and vice versa), (b) the words \\\"include\\\", \\\"includes\\\" and \\\"including\\\" shall be deemed to be followed by the phrase \\\"without limitation\\\", (c) the word \\\"will\\\" shall be construed to have the same meaning and effect as the word \\\"shall\\\", (d) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (e) any reference herein to any Person shall be construed to include the Person's successors and assigns, (f) the words \\\"herein\\\", \\\"hereof\\\" and \\\"hereunder\\\", and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (g) all references herein to Sections, Exhibits or Schedules shall be construed to refer to Sections, Exhibits or Schedules of\"}, {\"id\": \"28\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"28 9012190/26 this Agreement, and references to this Agreement include all Exhibits and Schedules hereto, (h) the word \\\"notice\\\" means notice in writing (whether or not specifically stated) and shall include notices, consents, approvals and other written communications contemplated under this Agreement, (i) provisions that require that a Party, the Parties or any committee hereunder \\\"agree,\\\" \\\"consent\\\" or \\\"approve\\\" or the like shall require that such agreement, consent or approval be specific and in writing, whether by written agreement, letter, approved minutes or otherwise (but excluding e-mail and instant messaging), (j) references to any specific law, rule or regulation, or article, section or other division thereof, shall be deemed to include the then-current amendments thereto or any replacement or successor law, rule or regulation thereof, and (k) the term \\\"or\\\" shall be interpreted in the inclusive sense commonly associated with the term \\\"and/or.\\\"\"}, {\"id\": \"11.9\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"11.9 Governing Law. This Agreement, and all claims arising under or in connection therewith, shall be governed by and interpreted in accordance with the substantive laws of the State of New York, without regard to conflict of law principles thereof.\"}, {\"id\": \"11.10\", \"title\": \"Consent to Jurisdiction\", \"level\": 2, \"text\": \"11.10 Consent to Jurisdiction. In the event of any dispute arising out of or relating to this Agreement other than a dispute arising under Section 2.7(b), the affected Party shall notify the other Party, and the parties shall attempt in good faith to resolve the matter within [***] after the date of such notice (the \\\"Notice Date\\\"). Any disputes not resolved by good faith discussions shall be referred to senior executives of each party, who shall meet at a mutually acceptable time and location within [***] after the Notice Date and attempt to negotiate a settlement. If the matter remains unresolved within [***] after the Notice Date, each Party to this Agreement hereby (a) irrevocably submits to the exclusive jurisdiction of the state courts of the State of New York or the United States District Court for the Southern District of New York for the purpose of any and all actions, suits or proceedings arising in whole or in part out of, related to, based upon or in connection with this Agreement or the subject matter hereof, (b) waives to the extent not prohibited by applicable Law, and agrees not to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such action brought in one of the above-named courts should be dismissed on grounds of forum non conveniens, should be transferred to any court other than one of the above-named courts, or should be stayed by reason of the pendency of some other proceeding in any other court other than one of the above-named courts, or that this Agreement or the subject matter hereof may not be enforced in or by such court, and (c) agrees not to commence any such action other than before one of the above-named courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of any such action to any court other than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, MediWound agrees that a final judgement in an action, suit or proceeding brought in one of the above-named courts may be enforced by Vericel in the competent courts of the State of Israel by suit on such judgment or in any other manner provided by applicable Law.\"}, {\"id\": \"11.11\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"11.11 Entire Agreement. This Agreement together with the License Agreement and the Quality Agreement, constitutes and contains the complete, final and exclusive understanding and\"}, {\"id\": \"29\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"29 9012190/26 agreement of the Parties and cancels and supersedes any and all prior negotiations, correspondence, understandings and agreements, whether oral or written, between the Parties respecting the subject matter hereof and thereof.\"}, {\"id\": \"11.12\", \"title\": \"Representation by Legal Counsel\", \"level\": 2, \"text\": \"11.12 Representation by Legal Counsel. Each Party hereto represents that it has been represented by legal counsel in connection with this Agreement and acknowledges that it has participated in the drafting hereof. In interpreting and applying the terms and provisions of this Agreement, the Parties agree that no presumption shall exist or be implied against the Party which drafted such terms and provisions.\"}, {\"id\": \"11.13\", \"title\": \"Counterparts\", \"level\": 2, \"text\": \"11.13 Counterparts. This Agreement may be executed in two counterparts, each of which shall be an original and both of which shall constitute together the same document. Counterparts may be signed and delivered by facsimile or PDF file, each of which shall be binding when received by the applicable Party.\"}, {\"id\": \"11.14\", \"title\": \"No Third Party Rights or Obligations\", \"level\": 2, \"text\": \"11.14 No Third Party Rights or Obligations. No provision of this Agreement shall be deemed or construed in any way to result in the creation of any rights or obligation in any Person not a Party to this Agreement.\"}, {\"id\": \"11.15\", \"title\": \"Confidentiality\", \"level\": 2, \"text\": \"11.15 Confidentiality. (a) Section 7 of the License Agreement shall govern the use and disclosure of information disclosed by the Parties under this Agreement. Either Party may disclose the terms of this Agreement to the extent required, in the reasonable opinion of such Party's legal counsel, to comply with applicable Law, including the rules and regulations promulgated by the United States Securities and Exchange Commission or any equivalent governmental agency in any country in the Territory. Before disclosing this Agreement or any of the terms hereof pursuant to this Section 11.15(a), the Parties will consult with one another on the terms of this Agreement to be redacted in making any such disclosure (which, at a minimum, shall include redaction of certain financial terms), with the disclosing Party providing as much advance notice as is feasible under the circumstances, and giving consideration to the comments of the other Party. Further, if a Party discloses this Agreement or any of the terms hereof in accordance with this Section 11.15(a), such Party shall, at its own expense, seek such confidential treatment of confidential portions of this Agreement, as may be reasonably requested by the other Party. (b) No Party to this Agreement shall originate any publicity, news release or other similar public announcement, written or oral, whether relating to this Agreement or any documents or transactions contemplated hereby or the existence of any arrangement between the Parties, without the prior written consent of the other Party whether or not named in such publicity, news release or other similar public announcement, except to the extent permitted under the License Agreement.\"}, {\"id\": \"11.16\", \"title\": \"Bankruptcy\", \"level\": 2, \"text\": \"11.16 Bankruptcy. All rights and licenses granted under or pursuant to this Agreement by a Party to the other are and will otherwise be deemed to be, for purposes of Section 365(n) of the Bankruptcy Code, licenses of right to \\\"intellectual property\\\" as defined under Section 101 of the Bankruptcy Code. The Parties agree that Vericel and its Sublicensees,\"}, {\"id\": \"30\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"30 9012190/26 as Sublicensees of such rights under this Agreement, will retain and may fully exercise all of their rights and elections under the Bankruptcy Code and any foreign counterpart thereto. [SIGNATURE PAGE FOLLOWS]\"}, {\"id\": \"31\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"31 9012190/26 IN WITNESS WHEREOF, the Parties hereto have each caused this Agreement to be duly executed as of the Effective Date. MEDIWOUND LTD. By: /s/ Stephen T. Wills Name: Stephen T. Wills Title: Chairman VERICEL CORPORATION By: /s/ Dominick Colangelo Name: Dominick Colangelo Title: President & CEO\"}, {\"id\": \"32\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"32 9012190/26 SCHEDULE 1.26 KEY MATERIALS & KEY MATERIALS SUPPLIERS Bromelain special Production - CBC Taiwan [***] [***]\"}, {\"id\": \"33\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"33 9012190/26 SCHEDULE 2.7 TECHNOLOGY TRANSFER DOCUMENTATION Technology Transfer documents include but are not limited to [***]\"}, {\"id\": \"34\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"34 9012190/26 SCHEDULE 4.1 CHANGE NOTIFICATION Category of Change Minimum Notification prior to effectiveness of implementation of the change Section 4.2 : Changes in Facility Major - Changes to facility have the potential to have an adverse effect on product quality that requires BLA Prior Approval Supplement. [***] \u2022 Moderate - Changes to facility have a moderate potential to have an adverse effect on product quality that requires Notification to the Regulatory Authority (e.g., CBE, CBE-30) [***] \u2022 Minor - Changes to facility have minimal potential to have an adverse effect on product quality that requires annual or periodic reporting to the FDA. [***] Section 4.3: Discretionary Manufacturing changes \u2022 Major - Changes have the potential to have an adverse effect on product quality that requires BLA Prior Approval Supplement. [***] \u2022 Moderate - Changes have a moderate potential to have an adverse effect on product quality that requires Notification to the Regulatory Authority (e.g., CBE, CBE-30). [***]\"}, {\"id\": \"35\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"35 9012190/26 Category of Change Minimum Notification prior to effectiveness of implementation of the change \u2022 Minor - Changes have minimal potential to have an adverse effect on product quality that requires annual or periodic reporting to the FDA. [***] \u2022 None - Changes have no potential to have an adverse effect on product quality and has no regulatory impact. \u2022 Example o Clarification of internal SOPs [***]\"}, {\"id\": \"Section 4.4\", \"title\": \"Changes required by a Regulatory Authority [***]\", \"level\": 2, \"text\": \"Section 4.4 Changes required by a Regulatory Authority [***] Example Timeline for Major Change (BLA Prior Approval Supplement Required) Vericel Evaluation: [***] Pre-Submission discussions with FDA and/or BARDA: [***] Testing (presumes rate limitation is stability testing of > 6 months): [***] Submission drafting: [***] FDA Review: [***] Implementation: [***] Example Timeline for Moderate Change (BLA CBE-30 Required) Vericel Evaluation: [***] Testing: [***] Submission drafting: [***] FDA Review: [***] Implementation: [***]\"}, {\"id\": \"36\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"36 9012190/26 SCHEDULE 4.5 FULL-TIME EQUIVALENT FTE Rates for Reimbursement of Preapproved Activities Completed by MediWound per Section 4.5: The FTE rate will be capped per [***]. MediWound personnel will be reimbursed at the designated FTE with an overhead of [***]. Consultants' costs will be reimbursed only if pre-approved by Vericel before any work is conducted. [***]. Subcontractor costs will be reimbursed only if pre-approved by Vericel before any work is conducted. [***]. Total invoices including FTE wages, applicable overhead, consultant costs and subcontractor costs will be subject [***].\"}, {\"id\": \"37\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"37 9012190/26 EXHIBIT A UNIT PRICES \u25e6 5 gram units of Finished Product at [***] per unit \u25e6 2 gram units of Finished Product at [***] per unit\"}, {\"id\": \"38\", \"title\": \"9012190/26\", \"level\": 1, \"text\": \"38 9012190/26 EXHIBIT B ADDITIONAL SERVICES ADDITIONAL SERVICE COST Other Additional Services At the FTE Rates set forth on Schedule 4.5 39 9012190/26\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of VERICELCORP_08_06_2019-EX-10.10-SUPPLY AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exhibit 10.10\", \"level\": 1, \"text\": \"Exhibit 10.10 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH \\\"[***]\\\". SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. SUPPLY AGREEMENT by and between MEDIWOUND LTD. and VERICEL CORPORATION May 6, 2019 TABLE OF CONTENTS Page\"}}, {\"id\": \"ARTICLE 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS 1\", \"level\": 1, \"text\": \"ARTICLE 1 DEFINITIONS 1\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY OF PRODUCTS 5\", \"level\": 1, \"text\": \"ARTICLE 2 SUPPLY OF PRODUCTS 5\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply Price 19 5\", \"level\": 2, \"text\": \"5.1 Supply Price 19 5.2 Price Mechanics 19 5.3 Cost Savings 19 5.4 Payments 20 ii 9012190/26\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Late Payments 20 5\", \"level\": 2, \"text\": \"5.5 Late Payments 20 5.6 Taxes 20\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS, WARRANTIES AND COVENANTS 21\", \"level\": 1, \"text\": \"ARTICLE 6 REPRESENTATIONS, WARRANTIES AND COVENANTS 21\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Manufacturing License Grant 27 9\", \"level\": 2, \"text\": \"9.1 Manufacturing License Grant 27 9.2 Trademarks License Grant. 27 9.3 Ownership 27 ARTICLE 10 FORCE MAJEURE 27\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Excusing Performance 27 10\", \"level\": 2, \"text\": \"10.1 Excusing Performance 27 10.2 Notice of Force Majeure Event 27 10.3 Resumption; Termination 27 ARTICLE 11 MISCELLANEOUS 28 iii 9012190/26 iv 9012190/26 SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (the \\\"Agreement\\\") is entered into as of May 6, 2019 (the \\\"Effective Date\\\"), by and between Vericel Corporation, a corporation organized and existing under the laws of Michigan and having a principal place of business at 64 Sidney Street, Cambridge, MA 02139 (\\\"Vericel\\\") and MediWound Ltd., a corporation organized and existing under the laws of Israel and having a principal place of business at 42 Hayarkon Street, Yavne, Israel 8122745 (\\\"MediWound\\\"). Vericel and MediWound may each be referred to herein individually as a \\\"Party\\\" and collectively as the \\\"Parties.\\\" RECITALS WHEREAS, Vericel and MediWound are parties to that certain License Agreement of even date herewith (the \\\"License Agreement\\\"), pursuant to which Vericel acquired an exclusive license to certain rights from MediWound; and WHEREAS, in connection with the License Agreement, the Parties contemplate that during the Term, MediWound will provide certain manufacturing and other related services to Vericel in accordance with the terms and conditions set forth herein. NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:\"}}, {\"id\": \"party:Vericel Corporation\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Vericel Corporation\", \"role\": \"Vericel\", \"address\": \"64 Sidney Street, Cambridge, MA 02139\"}}, {\"id\": \"party:MediWound Ltd.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"MediWound Ltd.\", \"role\": \"MediWound\", \"address\": \"42 Hayarkon Street, Yavne, Israel 8122745\"}}, {\"id\": \"Article 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"Article 1 DEFINITIONS The following terms have the meanings set forth below. Capitalized terms which are used but not defined herein have the meanings ascribed to such terms in the License Agreement.\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Additional Service\\\" shall mean any service in addition to the Manufacture of a Product, as such services are identified\", \"level\": 2, \"text\": \"1.1 \\\"Additional Service\\\" shall mean any service in addition to the Manufacture of a Product, as such services are identified on Exhibit B attached hereto, or such other service as may be requested by Vericel and agreed to by MediWound from time to time.\"}}, {\"id\": \"term:Additional Service\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Additional Service\", \"text\": \"\\\"Additional Service\\\" shall mean any service in addition to the Manufacture of a Product, as such services are identified on Exhibit B attached hereto, or such other service as may be requested by Vericel and agreed to by MediWound from time to time.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Additional Service Fee\\\" shall mean the fee, cost and/or expense to be paid by Vericel to MediWound for the performance\", \"level\": 2, \"text\": \"1.2 \\\"Additional Service Fee\\\" shall mean the fee, cost and/or expense to be paid by Vericel to MediWound for the performance of Additional Services, as such fee, cost and/or expense is agreed to by Vericel and MediWound in writing in respect of such Additional Services (plus VAT or similar taxes, if applicable).\"}}, {\"id\": \"term:Additional Service Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Additional Service Fee\", \"text\": \"\\\"Additional Service Fee\\\" shall mean the fee, cost and/or expense to be paid by Vericel to MediWound for the performance of Additional Services, as such fee, cost and/or expense is agreed to by Vericel and MediWound in writing in respect of such Additional Services (plus VAT or similar taxes, if applicable).\", \"definition_clause\": \"1.2\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Agreement\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.3 \\\"Agreement\\\" has the meaning set forth in the Preamble.\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"\\\"Agreement\\\" has the meaning set forth in the Preamble.\", \"definition_clause\": \"1.3\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Batch\\\" shall mean one (1) production lot of a Product\", \"level\": 2, \"text\": \"1.4 \\\"Batch\\\" shall mean one (1) production lot of a Product.\"}}, {\"id\": \"term:Batch\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Batch\", \"text\": \"\\\"Batch\\\" shall mean one (1) production lot of a Product.\", \"definition_clause\": \"1.4\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Binding Forecast\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.5 \\\"Binding Forecast\\\" has the meaning set forth in Section 2.8(a).\"}}, {\"id\": \"term:Binding Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Binding Forecast\", \"text\": \"\\\"Binding Forecast\\\" has the meaning set forth in Section 2.8(a).\", \"definition_clause\": \"1.5\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Binding Orders\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.6 \\\"Binding Orders\\\" has the meaning set forth in Section 2.8(b).\"}}, {\"id\": \"term:Binding Orders\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Binding Orders\", \"text\": \"\\\"Binding Orders\\\" has the meaning set forth in Section 2.8(b).\", \"definition_clause\": \"1.6\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"BLA\\\" means (a) a Biologics License Application as defined in the FD&C Act and the regulations promulgated thereunder, o\", \"level\": 2, \"text\": \"1.7 \\\"BLA\\\" means (a) a Biologics License Application as defined in the FD&C Act and the regulations promulgated thereunder, or (b) any equivalent or comparable application, registration or certification in any other country or region in the Territory.\"}}, {\"id\": \"term:BLA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"BLA\", \"text\": \"\\\"BLA\\\" means (a) a Biologics License Application as defined in the FD&C Act and the regulations promulgated thereunder, or (b) any equivalent or comparable application, registration or certification in any other country or region in the Territory.\", \"definition_clause\": \"1.7\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"1 9012190/26\"}}, {\"id\": \"1.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Bulk Vehicle Gel\\\" means the formulated NexoBrid product gel in bulk form, prior to filling and finishing, as further de\", \"level\": 2, \"text\": \"1.8 \\\"Bulk Vehicle Gel\\\" means the formulated NexoBrid product gel in bulk form, prior to filling and finishing, as further described in the applicable Specifications.\"}}, {\"id\": \"term:Bulk Vehicle Gel\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Bulk Vehicle Gel\", \"text\": \"\\\"Bulk Vehicle Gel\\\" means the formulated NexoBrid product gel in bulk form, prior to filling and finishing, as further described in the applicable Specifications.\", \"definition_clause\": \"1.8\"}}, {\"id\": \"1.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Business Day\\\" means a day other than a Friday, Saturday, Sunday or bank or other public holiday in New York, New York o\", \"level\": 2, \"text\": \"1.9 \\\"Business Day\\\" means a day other than a Friday, Saturday, Sunday or bank or other public holiday in New York, New York or Yavne, Israel.\"}}, {\"id\": \"term:Business Day\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Business Day\", \"text\": \"\\\"Business Day\\\" means a day other than a Friday, Saturday, Sunday or bank or other public holiday in New York, New York or Yavne, Israel.\", \"definition_clause\": \"1.9\"}}, {\"id\": \"1.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"cGMP\\\" means the then-current good manufacturing practices for pharmaceuticals, as set forth in the United States Federa\", \"level\": 2, \"text\": \"1.10 \\\"cGMP\\\" means the then-current good manufacturing practices for pharmaceuticals, as set forth in the United States Federal Food, Drug, and Cosmetic Act, as amended, and applicable regulations promulgated thereunder, as amended from time to time, and such equivalent or similar standards for good manufacturing practice as are required by other Governmental Authorities in countries in which Products are intended to be manufactured or sold.\"}}, {\"id\": \"term:cGMP\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"cGMP\", \"text\": \"\\\"cGMP\\\" means the then-current good manufacturing practices for pharmaceuticals, as set forth in the United States Federal Food, Drug, and Cosmetic Act, as amended, and applicable regulations promulgated thereunder, as amended from time to time, and such equivalent or similar standards for good manufacturing practice as are required by other Governmental Authorities in countries in which Products are intended to be manufactured or sold.\", \"definition_clause\": \"1.10\"}}, {\"id\": \"1.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Change Notification Period\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.11 \\\"Change Notification Period\\\" has the meaning set forth in Section 4.1.\"}}, {\"id\": \"term:Change Notification Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change Notification Period\", \"text\": \"\\\"Change Notification Period\\\" has the meaning set forth in Section 4.1.\", \"definition_clause\": \"1.11\"}}, {\"id\": \"1.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Confidential Information\\\" has the meaning set forth in the License Agreement insofar as such information is disclosed p\", \"level\": 2, \"text\": \"1.12 \\\"Confidential Information\\\" has the meaning set forth in the License Agreement insofar as such information is disclosed pursuant to this Agreement. The terms of this Agreement are the Confidential Information of both Parties, subject to Section 11.15.\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"\\\"Confidential Information\\\" has the meaning set forth in the License Agreement insofar as such information is disclosed pursuant to this Agreement. The terms of this Agreement are the Confidential Information of both Parties, subject to Section 11.15.\", \"definition_clause\": \"1.12\"}}, {\"id\": \"1.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Conforming Product\\\" means, with respect to the applicable Product, that, as of the date of delivery to Vericel or its d\", \"level\": 2, \"text\": \"1.13 \\\"Conforming Product\\\" means, with respect to the applicable Product, that, as of the date of delivery to Vericel or its designated Affiliate or contractor in accordance with Section 2.9(c) hereof, such Product (a) meets, and was Manufactured in accordance with, the applicable Specifications, Regulatory Standards (including cGMP where applicable) and the requirements set forth in the Quality Agreement, (b) is free from defects in materials and workmanship, (c) is not adulterated or misbranded within the meaning of the FD&C Act (or similar requirements of the countries for which the Product will be distributed), and (d) is not an article which may not, under the provisions of the FD&C Act, be introduced into interstate commerce.\"}}, {\"id\": \"term:Conforming Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Conforming Product\", \"text\": \"\\\"Conforming Product\\\" means, with respect to the applicable Product, that, as of the date of delivery to Vericel or its designated Affiliate or contractor in accordance with Section 2.9(c) hereof, such Product (a) meets, and was Manufactured in accordance with, the applicable Specifications, Regulatory Standards (including cGMP where applicable) and the requirements set forth in the Quality Agreement, (b) is free from defects in materials and workmanship, (c) is not adulterated or misbranded within the meaning of the FD&C Act (or similar requirements of the countries for which the Product will be distributed), and (d) is not an article which may not, under the provisions of the FD&C Act, be introduced into interstate commerce.\", \"definition_clause\": \"1.13\"}}, {\"id\": \"1.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Cost Savings Change\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.14 \\\"Cost Savings Change\\\" has the meaning set forth in Section 5.3.\"}}, {\"id\": \"term:Cost Savings Change\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Cost Savings Change\", \"text\": \"\\\"Cost Savings Change\\\" has the meaning set forth in Section 5.3.\", \"definition_clause\": \"1.14\"}}, {\"id\": \"1.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Discretionary Manufacturing Changes\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.15 \\\"Discretionary Manufacturing Changes\\\" has the meaning set forth in Section 4.1.\"}}, {\"id\": \"term:Discretionary Manufacturing Changes\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Discretionary Manufacturing Changes\", \"text\": \"\\\"Discretionary Manufacturing Changes\\\" has the meaning set forth in Section 4.1.\", \"definition_clause\": \"1.15\"}}, {\"id\": \"1.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Effective Date\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.16 \\\"Effective Date\\\" has the meaning set forth in the Preamble.\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"\\\"Effective Date\\\" has the meaning set forth in the Preamble.\", \"definition_clause\": \"1.16\"}}, {\"id\": \"1.17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Excess Amount\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.17 \\\"Excess Amount\\\" has the meaning set forth in Section 2.8(b).\"}}, {\"id\": \"term:Excess Amount\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Excess Amount\", \"text\": \"\\\"Excess Amount\\\" has the meaning set forth in Section 2.8(b).\", \"definition_clause\": \"1.17\"}}, {\"id\": \"1.18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Facility\\\" means MediWound facility located at 42 Hayarkon Street, Yavne, Israel 8122745 and any other facility approved\", \"level\": 2, \"text\": \"1.18 \\\"Facility\\\" means MediWound facility located at 42 Hayarkon Street, Yavne, Israel 8122745 and any other facility approved by Vericel in accordance with Section 2.6.\"}}, {\"id\": \"term:Facility\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Facility\", \"text\": \"\\\"Facility\\\" means MediWound facility located at 42 Hayarkon Street, Yavne, Israel 8122745 and any other facility approved by Vericel in accordance with Section 2.6.\", \"definition_clause\": \"1.18\"}}, {\"id\": \"1.19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Finished Product\\\" means finished NexoBrid product, comprising the Intermediate Drug Product filled into unit packages a\", \"level\": 2, \"text\": \"1.19 \\\"Finished Product\\\" means finished NexoBrid product, comprising the Intermediate Drug Product filled into unit packages and Bulk Vehicle Gel filled into unit packages and sterilized, including labeling and packaging, as further described in the applicable Specifications.\"}}, {\"id\": \"term:Finished Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Finished Product\", \"text\": \"\\\"Finished Product\\\" means finished NexoBrid product, comprising the Intermediate Drug Product filled into unit packages and Bulk Vehicle Gel filled into unit packages and sterilized, including labeling and packaging, as further described in the applicable Specifications.\", \"definition_clause\": \"1.19\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"2 9012190/26\"}}, {\"id\": \"1.20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"First Commercial Sale\\\" means, with respect to any Licensed Product and with respect to any country of the Territory, th\", \"level\": 2, \"text\": \"1.20 \\\"First Commercial Sale\\\" means, with respect to any Licensed Product and with respect to any country of the Territory, the first sale of such Licensed Product by Vericel or an Affiliate or Sublicensee of Vericel to a Third Party in such country after such Licensed Product has been granted Regulatory Approval by the appropriate Regulatory Authority(ies) for such country.\"}}, {\"id\": \"term:First Commercial Sale\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"First Commercial Sale\", \"text\": \"\\\"First Commercial Sale\\\" means, with respect to any Licensed Product and with respect to any country of the Territory, the first sale of such Licensed Product by Vericel or an Affiliate or Sublicensee of Vericel to a Third Party in such country after such Licensed Product has been granted Regulatory Approval by the appropriate Regulatory Authority(ies) for such country.\", \"definition_clause\": \"1.20\"}}, {\"id\": \"1.21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Force Majeure Event\\\" has the meaning set forth in Section 10\", \"level\": 2, \"text\": \"1.21 \\\"Force Majeure Event\\\" has the meaning set forth in Section 10.1.\"}}, {\"id\": \"term:Force Majeure Event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Force Majeure Event\", \"text\": \"\\\"Force Majeure Event\\\" has the meaning set forth in Section 10.1.\", \"definition_clause\": \"1.21\"}}, {\"id\": \"1.22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Initial Term\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.22 \\\"Initial Term\\\" has the meaning set forth in Section 8.1.\"}}, {\"id\": \"term:Initial Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Initial Term\", \"text\": \"\\\"Initial Term\\\" has the meaning set forth in Section 8.1.\", \"definition_clause\": \"1.22\"}}, {\"id\": \"1.23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Intermediate Drug Product\\\" means the formulated Intermediate Drug Substance as a bulk lyophilized powder, prior to fill\", \"level\": 2, \"text\": \"1.23 \\\"Intermediate Drug Product\\\" means the formulated Intermediate Drug Substance as a bulk lyophilized powder, prior to filling and finishing, for use in the Product, as further described in the applicable Specifications.\"}}, {\"id\": \"term:Intermediate Drug Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intermediate Drug Product\", \"text\": \"\\\"Intermediate Drug Product\\\" means the formulated Intermediate Drug Substance as a bulk lyophilized powder, prior to filling and finishing, for use in the Product, as further described in the applicable Specifications.\", \"definition_clause\": \"1.23\"}}, {\"id\": \"1.24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Intermediate Drug Substance\\\" means formulated mixture of proteolytic enzymes enriched in bromelain in solution manufact\", \"level\": 2, \"text\": \"1.24 \\\"Intermediate Drug Substance\\\" means formulated mixture of proteolytic enzymes enriched in bromelain in solution manufactured for use in manufacturing the Intermediate Drug Product.\"}}, {\"id\": \"term:Intermediate Drug Substance\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intermediate Drug Substance\", \"text\": \"\\\"Intermediate Drug Substance\\\" means formulated mixture of proteolytic enzymes enriched in bromelain in solution manufactured for use in manufacturing the Intermediate Drug Product.\", \"definition_clause\": \"1.24\"}}, {\"id\": \"1.25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Key Material\\\" means, with respect to a given Product, those key Materials for the Manufacture of such Product as design\", \"level\": 2, \"text\": \"1.25 \\\"Key Material\\\" means, with respect to a given Product, those key Materials for the Manufacture of such Product as designated by the Parties. Schedule 1.26 will include a list of the then-current Key Materials, as designated by the Parties, which will be updated by the Parties from time to time during the Term to reflect additions and deletions thereof.\"}}, {\"id\": \"term:Key Material\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Key Material\", \"text\": \"\\\"Key Material\\\" means, with respect to a given Product, those key Materials for the Manufacture of such Product as designated by the Parties. Schedule 1.26 will include a list of the then-current Key Materials, as designated by the Parties, which will be updated by the Parties from time to time during the Term to reflect additions and deletions thereof.\", \"definition_clause\": \"1.25\"}}, {\"id\": \"1.26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Key Materials Suppliers\\\" means, with respect to a given Product, the entities that MediWound, its Affiliate or its Thir\", \"level\": 2, \"text\": \"1.26 \\\"Key Materials Suppliers\\\" means, with respect to a given Product, the entities that MediWound, its Affiliate or its Third Party manufacturer has engaged (whether as of the Effective Date or from time to time during the Term) to manufacture, supply, furnish or provide the Key Materials for such Product. Schedule 1.26 will include a list of the then-current Key Materials Suppliers for each Product, which will be updated by MediWound from time to time during the Term to reflect additions and deletions thereof.\"}}, {\"id\": \"term:Key Materials Suppliers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Key Materials Suppliers\", \"text\": \"\\\"Key Materials Suppliers\\\" means, with respect to a given Product, the entities that MediWound, its Affiliate or its Third Party manufacturer has engaged (whether as of the Effective Date or from time to time during the Term) to manufacture, supply, furnish or provide the Key Materials for such Product. Schedule 1.26 will include a list of the then-current Key Materials Suppliers for each Product, which will be updated by MediWound from time to time during the Term to reflect additions and deletions thereof.\", \"definition_clause\": \"1.26\"}}, {\"id\": \"1.27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Latent Defect\\\" means, with respect to a Product supplied by MediWound to Vericel hereunder, a defect existing at the ti\", \"level\": 2, \"text\": \"1.27 \\\"Latent Defect\\\" means, with respect to a Product supplied by MediWound to Vericel hereunder, a defect existing at the time of delivery of such Product to Vericel that causes such Product to fail to conform to the corresponding Product Warranty for such Product, which defect is not reasonably obvious to Vericel upon inspection of such Product during the [***] period pursuant to Section 2.12 following such delivery but is discovered at a later time.\"}}, {\"id\": \"term:Latent Defect\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Latent Defect\", \"text\": \"\\\"Latent Defect\\\" means, with respect to a Product supplied by MediWound to Vericel hereunder, a defect existing at the time of delivery of such Product to Vericel that causes such Product to fail to conform to the corresponding Product Warranty for such Product, which defect is not reasonably obvious to Vericel upon inspection of such Product during the [***] period pursuant to Section 2.12 following such delivery but is discovered at a later time.\", \"definition_clause\": \"1.27\"}}, {\"id\": \"1.28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Liability\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.28 \\\"Liability\\\" has the meaning set forth in Section 7.1.\"}}, {\"id\": \"term:Liability\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Liability\", \"text\": \"\\\"Liability\\\" has the meaning set forth in Section 7.1.\", \"definition_clause\": \"1.28\"}}, {\"id\": \"1.29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"License Agreement\\\" has the meaning set forth in the recitals of this Agreement\", \"level\": 2, \"text\": \"1.29 \\\"License Agreement\\\" has the meaning set forth in the recitals of this Agreement.\"}}, {\"id\": \"term:License Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"License Agreement\", \"text\": \"\\\"License Agreement\\\" has the meaning set forth in the recitals of this Agreement.\", \"definition_clause\": \"1.29\"}}, {\"id\": \"1.30\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Manufacture\\\" or \\\"Manufacturing\\\" means to make, produce, manufacture, process, fill, finish, package, label, perform qua\", \"level\": 2, \"text\": \"1.30 \\\"Manufacture\\\" or \\\"Manufacturing\\\" means to make, produce, manufacture, process, fill, finish, package, label, perform quality assurance testing, release a compound or product or any component thereof. When used as a noun, \\\"Manufacture\\\" or \\\"Manufacturing\\\" means any and all activities involved in Manufacturing a compound or product or any component thereof.\"}}, {\"id\": \"term:Manufacture\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Manufacture\", \"text\": \"\\\"Manufacture\\\" or \\\"Manufacturing\\\" means to make, produce, manufacture, process, fill, finish, package, label, perform quality assurance testing, release a compound or product or any component thereof. When used as a noun, \\\"Manufacture\\\" or \\\"Manufacturing\\\" means any and all activities involved in Manufacturing a compound or product or any component thereof.\", \"definition_clause\": \"1.30\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"3 9012190/26\"}}, {\"id\": \"1.31\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Materials\\\" means, with respect to a given Product, all raw materials, Bulk Vehicle Gel (where MediWound is supplying a\", \"level\": 2, \"text\": \"1.31 \\\"Materials\\\" means, with respect to a given Product, all raw materials, Bulk Vehicle Gel (where MediWound is supplying a Product other than Bulk Vehicle Gel), Intermediate Drug Product (where MediWound is supplying a Product other than Intermediate Drug Product), supplies, components, excipients, and intermediates, labels and packaging materials necessary to Manufacture and ship such Product in accordance with the applicable Specifications.\"}}, {\"id\": \"term:Materials\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Materials\", \"text\": \"\\\"Materials\\\" means, with respect to a given Product, all raw materials, Bulk Vehicle Gel (where MediWound is supplying a Product other than Bulk Vehicle Gel), Intermediate Drug Product (where MediWound is supplying a Product other than Intermediate Drug Product), supplies, components, excipients, and intermediates, labels and packaging materials necessary to Manufacture and ship such Product in accordance with the applicable Specifications.\", \"definition_clause\": \"1.31\"}}, {\"id\": \"1.32\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Maximum Capacity\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.32 \\\"Maximum Capacity\\\" has the meaning set forth in Section 2.6.\"}}, {\"id\": \"term:Maximum Capacity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Maximum Capacity\", \"text\": \"\\\"Maximum Capacity\\\" has the meaning set forth in Section 2.6.\", \"definition_clause\": \"1.32\"}}, {\"id\": \"1.33\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"MediWound\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.33 \\\"MediWound\\\" has the meaning set forth in the Preamble.\"}}, {\"id\": \"term:MediWound\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MediWound\", \"text\": \"\\\"MediWound\\\" has the meaning set forth in the Preamble.\", \"definition_clause\": \"1.33\"}}, {\"id\": \"1.34\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"MediWound Indemnified Party\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.34 \\\"MediWound Indemnified Party\\\" has the meaning set forth in Section 7.2.\"}}, {\"id\": \"term:MediWound Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"MediWound Indemnified Party\", \"text\": \"\\\"MediWound Indemnified Party\\\" has the meaning set forth in Section 7.2.\", \"definition_clause\": \"1.34\"}}, {\"id\": \"1.35\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Minimum Shelf Life\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.35 \\\"Minimum Shelf Life\\\" has the meaning set forth in Section 2.10.\"}}, {\"id\": \"term:Minimum Shelf Life\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Minimum Shelf Life\", \"text\": \"\\\"Minimum Shelf Life\\\" has the meaning set forth in Section 2.10.\", \"definition_clause\": \"1.35\"}}, {\"id\": \"1.36\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Non-Conforming Product\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.36 \\\"Non-Conforming Product\\\" has the meaning set forth in Section 2.12.\"}}, {\"id\": \"term:Non-Conforming Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Non-Conforming Product\", \"text\": \"\\\"Non-Conforming Product\\\" has the meaning set forth in Section 2.12.\", \"definition_clause\": \"1.36\"}}, {\"id\": \"1.37\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Parties\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.37 \\\"Parties\\\" has the meaning set forth in the Preamble.\"}}, {\"id\": \"term:Parties\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Parties\", \"text\": \"\\\"Parties\\\" has the meaning set forth in the Preamble.\", \"definition_clause\": \"1.37\"}}, {\"id\": \"1.38\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Product\\\" means, as applicable, the (a) Intermediate Drug Product, (b) Bulk Vehicle Gel and (c) Finished Product\", \"level\": 2, \"text\": \"1.38 \\\"Product\\\" means, as applicable, the (a) Intermediate Drug Product, (b) Bulk Vehicle Gel and (c) Finished Product.\"}}, {\"id\": \"term:Product\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product\", \"text\": \"\\\"Product\\\" means, as applicable, the (a) Intermediate Drug Product, (b) Bulk Vehicle Gel and (c) Finished Product.\", \"definition_clause\": \"1.38\"}}, {\"id\": \"1.39\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Product Warranty\\\" has the meaning set forth in Section 6\", \"level\": 2, \"text\": \"1.39 \\\"Product Warranty\\\" has the meaning set forth in Section 6.3.\"}}, {\"id\": \"term:Product Warranty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Product Warranty\", \"text\": \"\\\"Product Warranty\\\" has the meaning set forth in Section 6.3.\", \"definition_clause\": \"1.39\"}}, {\"id\": \"1.40\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Purchase Order\\\" shall mean a firm, written order for purchase of one or more Products submitted by Vericel to MediWound\", \"level\": 2, \"text\": \"1.40 \\\"Purchase Order\\\" shall mean a firm, written order for purchase of one or more Products submitted by Vericel to MediWound that complies with the terms and conditions of this Agreement.\"}}, {\"id\": \"term:Purchase Order\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Purchase Order\", \"text\": \"\\\"Purchase Order\\\" shall mean a firm, written order for purchase of one or more Products submitted by Vericel to MediWound that complies with the terms and conditions of this Agreement.\", \"definition_clause\": \"1.40\"}}, {\"id\": \"1.41\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Quality Agreement\\\" has the meaning set forth in Section 3\", \"level\": 2, \"text\": \"1.41 \\\"Quality Agreement\\\" has the meaning set forth in Section 3.8.\"}}, {\"id\": \"term:Quality Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Quality Agreement\", \"text\": \"\\\"Quality Agreement\\\" has the meaning set forth in Section 3.8.\", \"definition_clause\": \"1.41\"}}, {\"id\": \"1.42\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Recall\\\" means a recall, withdrawal or field correction of a Product\", \"level\": 2, \"text\": \"1.42 \\\"Recall\\\" means a recall, withdrawal or field correction of a Product.\"}}, {\"id\": \"term:Recall\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Recall\", \"text\": \"\\\"Recall\\\" means a recall, withdrawal or field correction of a Product.\", \"definition_clause\": \"1.42\"}}, {\"id\": \"1.43\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Change\\\" has the meaning set forth in Section 4\", \"level\": 2, \"text\": \"1.43 \\\"Regulatory Change\\\" has the meaning set forth in Section 4.4.\"}}, {\"id\": \"term:Regulatory Change\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Change\", \"text\": \"\\\"Regulatory Change\\\" has the meaning set forth in Section 4.4.\", \"definition_clause\": \"1.43\"}}, {\"id\": \"1.44\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Regulatory Standards\\\" means all applicable Laws within the Territory applicable to the Manufacturing and shipment of th\", \"level\": 2, \"text\": \"1.44 \\\"Regulatory Standards\\\" means all applicable Laws within the Territory applicable to the Manufacturing and shipment of the Product or any aspect thereof and the obligations of MediWound hereunder, including, without limitation, (a) the FD&C Act (or similar requirements of the countries for which the Product will be distributed), (b) cGMPs, and (c) the rules and regulations promulgated under or by a Regulatory Authority or any successor agency or other comparable agency thereto as each may be amended from time to time.\"}}, {\"id\": \"term:Regulatory Standards\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Regulatory Standards\", \"text\": \"\\\"Regulatory Standards\\\" means all applicable Laws within the Territory applicable to the Manufacturing and shipment of the Product or any aspect thereof and the obligations of MediWound hereunder, including, without limitation, (a) the FD&C Act (or similar requirements of the countries for which the Product will be distributed), (b) cGMPs, and (c) the rules and regulations promulgated under or by a Regulatory Authority or any successor agency or other comparable agency thereto as each may be amended from time to time.\", \"definition_clause\": \"1.44\"}}, {\"id\": \"1.45\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Remediation Plan\\\" means a reasonably detailed corrective action plan that would outline remediation of a Supply Failure\", \"level\": 2, \"text\": \"1.45 \\\"Remediation Plan\\\" means a reasonably detailed corrective action plan that would outline remediation of a Supply Failure that include the date by which MediWound will implement such remediation and remedy such Supply Failure.\"}}, {\"id\": \"term:Remediation Plan\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Remediation Plan\", \"text\": \"\\\"Remediation Plan\\\" means a reasonably detailed corrective action plan that would outline remediation of a Supply Failure that include the date by which MediWound will implement such remediation and remedy such Supply Failure.\", \"definition_clause\": \"1.45\"}}, {\"id\": \"1.46\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Renewal Term\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.46 \\\"Renewal Term\\\" has the meaning set forth in Section 8.1.\"}}, {\"id\": \"term:Renewal Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Renewal Term\", \"text\": \"\\\"Renewal Term\\\" has the meaning set forth in Section 8.1.\", \"definition_clause\": \"1.46\"}}, {\"id\": \"1.47\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Rolling Forecast\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.47 \\\"Rolling Forecast\\\" has the meaning set forth in Section 2.8(a).\"}}, {\"id\": \"term:Rolling Forecast\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Rolling Forecast\", \"text\": \"\\\"Rolling Forecast\\\" has the meaning set forth in Section 2.8(a).\", \"definition_clause\": \"1.47\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"4 9012190/26\"}}, {\"id\": \"1.48\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Safety Stock\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.48 \\\"Safety Stock\\\" has the meaning set forth in Section 2.11.\"}}, {\"id\": \"term:Safety Stock\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Safety Stock\", \"text\": \"\\\"Safety Stock\\\" has the meaning set forth in Section 2.11.\", \"definition_clause\": \"1.48\"}}, {\"id\": \"1.49\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Second Source\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.49 \\\"Second Source\\\" has the meaning set forth in Section 2.7.\"}}, {\"id\": \"term:Second Source\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Second Source\", \"text\": \"\\\"Second Source\\\" has the meaning set forth in Section 2.7.\", \"definition_clause\": \"1.49\"}}, {\"id\": \"1.50\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Specifications\\\" means, with respect to a given Product, the written specifications for such Product set forth in the ap\", \"level\": 2, \"text\": \"1.50 \\\"Specifications\\\" means, with respect to a given Product, the written specifications for such Product set forth in the applicable Regulatory Approval corresponding thereto as defined in the Quality Agreement, which specifications may be amended from time to time in accordance with this Agreement.\"}}, {\"id\": \"term:Specifications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specifications\", \"text\": \"\\\"Specifications\\\" means, with respect to a given Product, the written specifications for such Product set forth in the applicable Regulatory Approval corresponding thereto as defined in the Quality Agreement, which specifications may be amended from time to time in accordance with this Agreement.\", \"definition_clause\": \"1.50\"}}, {\"id\": \"1.51\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Suppliers\\\" has the meaning set forth in Section 2\", \"level\": 2, \"text\": \"1.51 \\\"Suppliers\\\" has the meaning set forth in Section 2.3.\"}}, {\"id\": \"term:Suppliers\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Suppliers\", \"text\": \"\\\"Suppliers\\\" has the meaning set forth in Section 2.3.\", \"definition_clause\": \"1.51\"}}, {\"id\": \"1.52\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Supply Failure\\\" means, with respect to a given Product, MediWound's failure to timely deliver to Vericel (i) at least [\", \"level\": 2, \"text\": \"1.52 \\\"Supply Failure\\\" means, with respect to a given Product, MediWound's failure to timely deliver to Vericel (i) at least [***] of the quantity of such Product ordered in accordance with the Binding Orders for such Product (for avoidance of doubt, in determining the percentage of Product delivered for purposes of this clause (i), only Product that conforms to the Product Warranty and is delivered by MediWound in accordance with this Agreement, shall be included), as measured over a period of any [***], or (ii) a cessation or suspension of Manufacturing of Product by MediWound that is not cured by MediWound in accordance with Section 2.14, that is reasonably likely to result in a failure by MediWound to timely deliver Product to Vericel as described in the foregoing clause (i), that, in either case (the foregoing clause (i) or clause (ii)), is not caused by a breach of this Agreement by Vericel.\"}}, {\"id\": \"term:Supply Failure\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Supply Failure\", \"text\": \"\\\"Supply Failure\\\" means, with respect to a given Product, MediWound's failure to timely deliver to Vericel (i) at least [***] of the quantity of such Product ordered in accordance with the Binding Orders for such Product (for avoidance of doubt, in determining the percentage of Product delivered for purposes of this clause (i), only Product that conforms to the Product Warranty and is delivered by MediWound in accordance with this Agreement, shall be included), as measured over a period of any [***], or (ii) a cessation or suspension of Manufacturing of Product by MediWound that is not cured by MediWound in accordance with Section 2.14, that is reasonably likely to result in a failure by MediWound to timely deliver Product to Vericel as described in the foregoing clause (i), that, in either case (the foregoing clause (i) or clause (ii)), is not caused by a breach of this Agreement by Vericel.\", \"definition_clause\": \"1.52\"}}, {\"id\": \"1.53\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Supply Price\\\" has the meaning set forth in Section 5\", \"level\": 2, \"text\": \"1.53 \\\"Supply Price\\\" has the meaning set forth in Section 5.1.\"}}, {\"id\": \"term:Supply Price\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Supply Price\", \"text\": \"\\\"Supply Price\\\" has the meaning set forth in Section 5.1.\", \"definition_clause\": \"1.53\"}}, {\"id\": \"1.54\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Term\\\" has the meaning set forth in Section 8\", \"level\": 2, \"text\": \"1.54 \\\"Term\\\" has the meaning set forth in Section 8.1.\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"\\\"Term\\\" has the meaning set forth in Section 8.1.\", \"definition_clause\": \"1.54\"}}, {\"id\": \"1.55\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Territory\\\" means the United States, Canada and Mexico\", \"level\": 2, \"text\": \"1.55 \\\"Territory\\\" means the United States, Canada and Mexico.\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"\\\"Territory\\\" means the United States, Canada and Mexico.\", \"definition_clause\": \"1.55\"}}, {\"id\": \"1.56\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party\\\" shall mean any Person other than Vericel, MediWound or their respective Affiliates\", \"level\": 2, \"text\": \"1.56 \\\"Third Party\\\" shall mean any Person other than Vericel, MediWound or their respective Affiliates.\"}}, {\"id\": \"term:Third Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party\", \"text\": \"\\\"Third Party\\\" shall mean any Person other than Vericel, MediWound or their respective Affiliates.\", \"definition_clause\": \"1.56\"}}, {\"id\": \"1.57\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party Claims\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.57 \\\"Third Party Claims\\\" has the meaning set forth in Section 7.1.\"}}, {\"id\": \"term:Third Party Claims\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party Claims\", \"text\": \"\\\"Third Party Claims\\\" has the meaning set forth in Section 7.1.\", \"definition_clause\": \"1.57\"}}, {\"id\": \"1.58\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Third Party Supply Agreement\\\" means any agreement between MediWound (or any of its Affiliates) and any Third Party that\", \"level\": 2, \"text\": \"1.58 \\\"Third Party Supply Agreement\\\" means any agreement between MediWound (or any of its Affiliates) and any Third Party that relates to Manufacture or supply of a Licensed Product.\"}}, {\"id\": \"term:Third Party Supply Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party Supply Agreement\", \"text\": \"\\\"Third Party Supply Agreement\\\" means any agreement between MediWound (or any of its Affiliates) and any Third Party that relates to Manufacture or supply of a Licensed Product.\", \"definition_clause\": \"1.58\"}}, {\"id\": \"1.59\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Vericel\\\" has the meaning set forth in the Preamble\", \"level\": 2, \"text\": \"1.59 \\\"Vericel\\\" has the meaning set forth in the Preamble.\"}}, {\"id\": \"term:Vericel\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Vericel\", \"text\": \"\\\"Vericel\\\" has the meaning set forth in the Preamble.\", \"definition_clause\": \"1.59\"}}, {\"id\": \"1.60\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"\\\"Vericel Indemnified Party\\\" has the meaning set forth in Section 7\", \"level\": 2, \"text\": \"1.60 \\\"Vericel Indemnified Party\\\" has the meaning set forth in Section 7.1.\"}}, {\"id\": \"term:Vericel Indemnified Party\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Vericel Indemnified Party\", \"text\": \"\\\"Vericel Indemnified Party\\\" has the meaning set forth in Section 7.1.\", \"definition_clause\": \"1.60\"}}, {\"id\": \"ARTICLE 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUPPLY OF PRODUCTS\", \"level\": 1, \"text\": \"ARTICLE 2 SUPPLY OF PRODUCTS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Scope of Agreement\", \"level\": 2, \"text\": \"2.1 Scope of Agreement. Subject to the terms and conditions of this Agreement, MediWound shall Manufacture (or have Manufactured) Product for clinical and commercial use by Vericel and perform the Additional Services as required for completion of the activities\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"5 9012190/26 contemplated under this Agreement and the License Agreement in accordance with the applicable Specifications, Regulatory Standards and the Quality Agreement. MediWound shall Manufacture and supply Product in exchange for the Supply Price and shall perform the Additional Services for the Additional Service Fees.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exclusive Supply\", \"level\": 2, \"text\": \"2.2 Exclusive Supply. During the first five (5) years of the Term, with respect to the Bulk Vehicle Gel, Intermediate Drug Product and Finished Product, Vericel shall order and purchase such Products exclusively from MediWound in accordance with the terms of this Agreement; provided, however, Vericel may Manufacture or have Manufactured the Products (a) upon the occurrence of a Supply Failure with respect to any Product hereunder, or (b) as otherwise permitted under the terms of the License Agreement or this Agreement. The Parties agree that nothing in this Section 2.2 is intended to limit the identification, evaluation, technology transfer or validation by Vericel of (x) a Second Source for the Manufacture and supply of Product or (y) a provider of filling and packaging services for Product, and that such activities are expressly permitted hereunder.\"}}, {\"id\": \"value:five (5) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) years\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Materials\", \"level\": 2, \"text\": \"2.3 Materials. MediWound shall purchase at its cost and expense all Materials required for Manufacture by MediWound of the Product for supply to Vericel for the Territory pursuant to this Agreement. Any and all forecasts and purchase orders for such Materials shall be placed at MediWound's sole expense and under its sole responsibility. MediWound shall place such purchase orders on a timely basis in order to avoid any undue delay, interruption or other discontinuance in the Manufacture or delivery of the Product. MediWound shall manage and be responsible for all contracts or other arrangements with MediWound's suppliers of Materials (\\\"Suppliers\\\"). Subject to the terms of this Agreement and the Quality Agreement, as between the Parties, MediWound shall be responsible and have liability for all actions and omissions of, and the failure to comply with the applicable terms of this Agreement, applicable Law or Regulatory Standards by the Suppliers in performance of Manufacturing activities for the supply of Products to Vericel for the Territory on behalf of MediWound hereunder. MediWound shall ensure that all Materials conform to the terms of this Agreement, including the applicable Specifications and to the terms of the Quality Agreement.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Labeling\", \"level\": 2, \"text\": \"2.4 Labeling. Vericel shall be responsible for supplying MediWound with copy for labeling. Upon its receipt of labeling copy from Vericel, MediWound shall provide artwork of the labeling to Vericel for its review and approval. Vericel's review time shall not exceed [***] after its receipt of the artwork from MediWound. In the event that Vericel requests any changes to the labeling, MediWound shall make such changes as promptly as possible and return such labeling artwork to Vericel for its final review and approval, which it shall complete with [***] after its receipt of the modified artwork. MediWound shall be responsible for ordering, at its expense, sufficient quantities of labeling as forecasted to be required, based upon the [***] of the then-current Rolling Forecast. MediWound shall store the labeling as required by Regulatory Standards and shall use the labeling in Product packaging as set forth in the Specifications. Vericel shall be permitted to require changes to the labeling artwork from time-to-time at its cost, but will be required to reimburse MediWound for the cost of any quantities of labeling procured by MediWound that is rendered unusable by such changes, up to the quantities of labeling as\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"6 9012190/26 forecasted to be required, based upon the [***] of the then-current Rolling Forecast as of the date of such change by Vericel of the labeling artwork. [***].\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subcontracting\", \"level\": 2, \"text\": \"2.5 Subcontracting. (a) [***]. No Third Party service provider or subcontractor shall be provided with Vericel's Confidential Information without first executing a confidentiality agreement that contains terms and conditions that are at least as protective as the confidentiality terms, conditions and restrictions set forth in this Agreement. Notwithstanding the foregoing, MediWound shall remain liable for the performance of all Third Party subcontractors and its Affiliates under this Agreement. (b) MediWound shall use commercially reasonable efforts to ensure that any Third Party Supply Agreement [***]. (c) If the forecasting or order timing or other provisions of a Third Party Supply Agreement do not align with the corresponding provisions of this Agreement then the Parties shall discuss in good faith appropriate modifications to this Agreement or to such Third Party Supply Agreement, to bring the relevant provisions into alignment; provided, however, that Vericel or MediWound shall have no obligation to agree to any amendment to this Agreement or such Third Party Supply Agreement that can reasonably be expected to materially disadvantage Vericel or MediWound, respectively.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Facilities\", \"level\": 2, \"text\": \"2.6 Facilities. (a) Current and Expanded Capacity. The Parties agree and acknowledge that, as of the Effective Date, MediWound's current Facility can fill orders from Vericel for use in the Territory up to [***] of Intermediate Drug Product, whether provided in that form or in the form of the equivalent amount of Finished Product within a calendar year (\\\"Maximum Capacity\\\"). The Parties agree and acknowledge that the Facility will require either expansion or modification (which may include moving to or adding another location) to meet future capacity requirements for the Product. By no later than [***], MediWound shall fund, at its sole cost, the expansion of its annual manufacturing capacity to be [***] of Intermediate Drug Product (whether provided in that form or in the form of the equivalent amount of Finished Product). The Parties will in good faith review existing market research to mutually agree on peak anticipated volume prior to [***]. After the foregoing expansion, the expanded capacity shall be deemed the \\\"Maximum Capacity\\\" for purposes of this Agreement. As part of the expansion of the Facility, the Parties will discuss any shut down or transfer to another facility made in connection therewith. (b) Shut-Down or Expansion of Facility; Transfer to Another Facility. In the event that MediWound desires to cease or shut down operations at a Facility, expand or modify a Facility, or transfer the Manufacturing of a Product to another facility which would reasonably be anticipated to result in inability (permanent or temporary) of MediWound to Manufacture, supply or otherwise perform its obligations hereunder, MediWound shall provide prior written notice to Vericel within the applicable Change Notification Period of such planned shut-down, cessation, expansion, modification or transfer. During such Change Notification Period, Vericel\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"7 9012190/26 will have the right to order, and in such case MediWound will manufacture, up to [***] of quantities of Product set forth in the Rolling Forecast with respect to such Change Notification Period which in any event will not exceed the Maximum Capacity. Notwithstanding the foregoing, MediWound shall remain obligated to supply Product at the then current Facility and will not supply Product to Vericel from a new facility unless and until MediWound can perform the Manufacturing and supply Product from such new Facility in accordance with the terms of this Agreement and any modifications to the regulatory filings for such Product are approved by the relevant Regulatory Authorities. MediWound shall bear all costs incurred in connection with the shut-down, cessation, expansion or modification of the Facility or transfer of the Manufacturing of a Product to a new facility pursuant to this Section 2.6(b), including any costs associated with changes to the regulatory filings. Once such new facility is able to Manufacture in accordance with the terms of this Agreement and all required regulatory changes have been approved, such new facility shall be the Facility for purposes of such Product under this Agreement.\"}}, {\"id\": \"2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Establishment of Second Source\", \"level\": 2, \"text\": \"2.7 Establishment of Second Source. (a) Within [***] of the Effective Date, MediWound must provide Vericel with true and accurate copies of all documents consistent with Schedule 2.7. If MediWound does not provide all documents within [***] of the Effective Date, Vericel's obligation under Section 8.1 regarding the time period to provide MediWound with a notice of an extension of the Initial Term shall be extended by the amount of time beyond [***] taken by MediWound to provide the required documents. (b) Within [***] of a request by Vericel to initiate technology transfer or as soon as reasonably practicable upon request by Vericel in connection with a Supply Failure, MediWound shall provide Vericel, at Vericel's cost consistent with Schedule 4.5, with information necessary for Vericel to qualify a second or back-up supplier identified by Vericel for the Manufacture and supply of Product (a \\\"Second Source\\\") and facilitate technology transfer to such Second Source so that Vericel can consistently manufacture intermediate and final product that meets all specifications. MediWound will notify the IIA in accordance with applicable Israeli Laws upon the commencement of Manufacture of Product by such Second Source. MediWound will provide Vericel with access to the manufacturing process and information and any and all original processes, records, and any other information required to manufacture, package and test the Product in accordance with the Specifications. Second Source manufacturers shall be permitted to manufacture Product for Vericel, its Affiliates and Sublicensees as provided in Section 9.1 and the License Agreement; provided that such Second Source manufacturers: [***].\"}}, {\"id\": \"2.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Forecasting and Ordering\", \"level\": 2, \"text\": \"2.8 Forecasting and Ordering. (a) Forecasting. Vericel shall furnish MediWound with a [***] rolling forecast of the quantities of each Product that Vericel intends to order during the succeeding [***] period (each, a \\\"Rolling Forecast\\\") which in any event will not exceed the Maximum Capacity for the Binding Forecast. No later than [***] after the filing of a BLA, Vericel shall\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"8 9012190/26 furnish MediWound the first rolling Forecast. Subject to this Section 2.8, the [***] of each Rolling Forecast shall constitute a binding order for the quantities of Product specified (\\\"Binding Forecast\\\"). The remaining [***] of each Rolling Forecast shall be non-binding, but shall represent Vericel's good faith estimate, as of the date of its submission of the Rolling Forecast, of its forecasted requirements of the Product during such period. MediWound shall maintain at all times the manufacturing capacity at the relevant Facility to manufacture [***] of the quantities of Product set forth in the current Calendar Year of the Rolling Forecast (as was set forth at the Rolling Forecast submitted immediately prior to the beginning of such Calendar Year) which in any event will not exceed the Maximum Capacity. (b) Purchase Orders. On a Calendar Quarter basis, Vericel shall issue at least one Purchase Order for the number and unit size of each Product specified in the Binding Forecast. Vericel is not limited to one Purchase Order per Calendar Quarter. Each Purchase Order shall specify (i) a purchase order number; (ii) the quantity of units of each Product to be Manufactured; and (iii) the requested delivery date of such Product (which in no event shall be earlier than [***] days following the date the applicable Purchase Order was received by MediWound). MediWound shall respond to each Purchase Order within [***] of receipt by: (i) accepting such Purchase Order if it conforms to the requirements of this Agreement or (ii) notifying Vericel if such Purchase Order does not conform to the requirements of this Agreement. If MediWound timely notifies Vericel that a Purchase Order does not conform to the requirements of this Agreement, the Parties shall confer as soon as reasonably practicable to resolve any issues related to such purported nonconformity. If MediWound fails to respond to a Purchase Order that is consistent with the Binding Forecast within [***] after receiving it, Vericel will, within [***] thereafter, confirm with MediWound that such Purchase Order was received by MediWound, and if such Purchase Order is consistent with the Binding Forecast and was properly submitted by Vericel in accordance with this Section 2.8(b), MediWound shall be deemed to have accepted such Purchase Order (\\\"Binding Order\\\") as of the date of MediWound's receipt of such Purchase Order. If a Purchase Order contains quantities of Products in excess of the quantity of such Product forecasted for such quarter (as was set forth at the Rolling Forecast submitted immediately prior to the beginning of such Calendar Year) by an amount greater than [***] of the Binding Forecast (\\\"Excess Amount\\\"), MediWound will accept the Purchase Order up to, but not including the Excess Amount which in any event will not exceed the Maximum Capacity. Should Vericel place a Purchase Order to procure a given Product in a given Calendar Quarter which includes an Excess Amount, MediWound shall use commercially reasonable efforts to meet Vericel's request. If there is a conflict between this Agreement and any Purchase Order, this Agreement shall govern. (c) Minimum Purchase Obligation. In each Calendar Year following Vericel's submission of the first Rolling Forecast, Vericel shall issue Purchase Orders for at least [***] of the quantities of each Product set forth in the current Calendar Year of the Rolling Forecast (as was set forth at the Rolling Forecast submitted immediately prior to the beginning of such Calendar Year). (d) BARDA. As of the Effective Date, MediWound is a party to BARDA Contract HHSO100201500035C and BARDA Contract HHSO100201800023C (collectively, the\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"9 9012190/26 \\\"BARDA Agreements\\\") with the Biomedical Advanced Research and Development Authority (\\\"BARDA\\\"). The Parties agree that until commercial obligations under such BARDA Agreements are transferred to Vericel, MediWound shall remain responsible for the supply and other obligations and shall manage the forecasts and production schedule for such BARDA Agreements. During such period, any Product ordered by BARDA from MediWound will not be included in Purchase Orders, Binding Orders, Rolling Forecasts or the minimum purchase obligation set forth in Section 2.8(c); provided that the Product ordered by BARDA from MediWound will be included in the Maximum Capacity and thus the applicable Maximum Capacity for the Binding Orders will be adjusted accordingly. If and when commercial obligations under such BARDA Agreements are transferred to Vericel, then Vericel shall become responsible for including the applicable purchases by BARDA in its Purchase Orders, Binding Orders and Rolling Forecasts and such purchases will be included in the Maximum Capacity and the minimum purchase obligation set forth in Section 2.8(c).\"}}, {\"id\": \"2.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery\", \"level\": 2, \"text\": \"2.9 Delivery. (a) Shipping. MediWound shall only ship Products that have been Manufactured and released in accordance with the Specifications. Unless agreed in advance by Vericel and MediWound in writing, MediWound shall not ship (or permit such Third Party packager to ship) any Products prior to approval and release by MediWound in accordance with the Quality Agreement and Regulatory Standards. Unless otherwise agreed upon by the Parties, Products shall be delivered to Vericel Ex-Works (Incoterms 2010), at MediWound's facility (the \\\"Delivery Site\\\") at which point, the title and risk of loss shall transfer to Vericel which shall transfer the Products from the Delivery Site in accordance with cGMP as applicable. MediWound shall notify (or cause such Third Party packager to notify) Vericel at least [***] prior to any shipment of Products. (b) Delivery Amount. MediWound shall deliver Product within [***] of the units set out on the relevant Purchase Order. To the extent that a delivery is in excess of [***] of the amount set out on the relevant Purchase Order, Vericel may accept such excess Product provided that if Vericel accepts such excess, Vericel shall be entitled, (i) where commercially reasonable for Vericel, to vary the delivery date agreed between Vericel and MediWound in accordance with Section 2.8 for the immediately following shipment(s) of the applicable Product to the extent reasonably required due to the acceptance of such excess, and (ii) to reduce subsequent Purchase Orders and take credits for the amount of excess Product received against the minimum purchase obligation set forth in Section 2.8(c). To the extent that a delivery is less than [***] but at least [***] of the amount set out on the relevant Purchase Order, Vericel shall accept such delivery and shall be entitled, (A) where commercially reasonable for Vericel, to vary the delivery date agreed between Vericel and MediWound in accordance with Section 2.8 for the immediately following shipment(s) of the applicable Product due to the acceptance of such delivery, and (B) to increase subsequent Purchase Orders with the applicable shortage quantities. (c) On Time Delivery. MediWound's performance with respect to \\\"on time delivery\\\" will be measured as delivery to Vericel [***] before or after the delivery date agreed\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"10 9012190/26 between Vericel and MediWound in accordance with Section 2.8; provided that MediWound shall be deemed to have made a delivery during the \\\"on time delivery\\\" window if the delay in delivery to Vericel is due to Vericel's failure to comply with its obligations under this Agreement (including in connection with Vericel's review of the Batch records).\"}}, {\"id\": \"2.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Dating\", \"level\": 2, \"text\": \"2.10 Dating. The remaining shelf-life for each Product for the Territory shall be at least [***] of the FDA approved shelf-life of such Product, as measured from the time of delivery of such Product to Vericel (the \\\"Minimum Shelf Life\\\").\"}}, {\"id\": \"2.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Safety Stock\", \"level\": 2, \"text\": \"2.11 Safety Stock. MediWound shall be entitled to meet its obligation to maintain as safety stock not less than [***] of the Rolling Forecast demand of stock of each of the Key Materials (the \\\"Safety Stock\\\") so long as the Minimum Shelf Life has been satisfied by holding either Product or an equivalent quantity of Materials, or a mixture of the two. The Parties will cooperate to set minimum inventory levels of Key Materials held by Key Materials Suppliers. Vericel shall maintain an inventory of [***] supply of unlabeled or labeled Finished Product in order to supply its commercial requirements in accordance with the Rolling Forecast, which may be stored at Facility at Vericel's option, cost and risk.\"}}, {\"id\": \"2.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Non-Conforming Product\", \"level\": 2, \"text\": \"2.12 Non-Conforming Product. (a) Rejection Notice. Unless otherwise mutually agreed by the Parties in writing, within [***] after receipt of a delivery of Product hereunder, Vericel shall give MediWound written notice of rejection (\\\"Rejection Notice\\\") (i) if the Product does not constitute Conforming Product (\\\"Non-Conforming Product\\\") or (ii) of any shortage in quantity of such delivery of Product. Any such Rejection Notice provided with respect to any quantity of Product shall be deemed to apply to the full Batch of such Product unless otherwise specified by Vericel. Vericel shall be deemed to have accepted such shipment of Product as Conforming Product and any shortage in quantity if it does not provide Rejection Notice within [***] after receipt of delivery describing the reasons for such rejections in reasonable detail, provided, however, that such [***] period shall not apply to any Latent Defects, in which case Vericel shall notify MediWound of any such failure as soon as reasonably possible, but in any event within [***] after the Latent Defect is confirmed by Vericel and prior to expiration of the shelf-life for such Product. (b) Disputes. In the event that MediWound disagrees with Vericel's claim that Product fails to constitute Conforming Product, then the Parties shall promptly attempt to resolve such dispute. If the Parties cannot resolve such dispute, a sample of such Product shall be submitted by MediWound and Vericel to a mutually agreeable qualified Third Party laboratory for testing against the applicable Specifications, Regulatory Standards and other standards and controls in the Quality Agreement and the test results obtained by such laboratory shall be final and controlling (absent manifest error). Test results must be furnished to both Parties within [***] of concluding such testing. The fees and expenses of such laboratory testing and any obsolescence due to short dating shall be borne entirely by the Party whose original Product analysis was in error.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"11 9012190/26 (c) Remedy. On receipt of Vericel's Rejection Notice pursuant to Section 2.12(a), subject to Section 2.12(b), MediWound shall, [***] (except if such Non-Conforming Product is due to MediWound's gross negligence or willful misconduct): (i) deliver the appropriate shortage quantities of Conforming Product as promptly as possible, at no additional cost or expense (including, without limitation, freight costs) to Vericel; (ii) replace the Non-Conforming Product with Conforming Product as promptly as possible, at no additional cost or expense (including, without limitation, freight costs) to Vericel; or (iii) promptly grant Vericel a credit in an amount equal to the amount paid or payable by Vericel with respect to reasonable out of pocket expenses directly associated with the Non-Conforming Product to the extent applicable (e.g. shipment costs, destruction fees, and restocking fees) and any such shortage or Non-Conforming Product, including, without limitation, but solely in the case of Non-Conforming Product, expenses associated with destruction or return at MediWound's instruction. This subsection (iii) shall additionally apply in the event Vericel elects as its option the foregoing (i) or (ii), as applicable, and such delivery or replace of Product thereunder is not practicable within a reasonable period of time (as reasonably determined by MediWound).\"}}, {\"id\": \"2.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Shortages\", \"level\": 2, \"text\": \"2.13 Shortages. (a) Without limiting any other rights or remedies available to Vericel, in the event of any shortage in the supply of any Materials or Product, or if MediWound is for any other reason unable to supply Product in compliance with the terms of this Agreement, then MediWound will promptly notify Vericel and, in the event such inability is caused by a shortage of any Materials and/or capacity required for the Manufacture of any Product, will take all commercially reasonable steps to (i) procure adequate quantities of Materials from Third Party suppliers reasonably acceptable to Vericel, and (ii) use commercially reasonable efforts to fulfill all Binding Orders for Product. (b) Prior to a Second Source commencing supply of Product, in the event of a shortage of (i) any Materials required to Manufacture Product or (ii) Product, MediWound will allocate the available Materials to the Manufacture of Product for sale to Vericel and will allocate the available Product for sale to Vericel, in each case ((i) or (ii)), to the extent any Binding Orders then in place prior to allocating such materials to the Manufacture of any other product (including EscharEx), or for any entity other than Vericel. (c) After a Second Source commences supply of Product, in the event of a shortage of Materials or Product, MediWound will allocate to Vericel its pro rata share of MediWound's supply of the same in a manner no less favorable than those of its equivalently situated customers or MediWound's own similarly situated products.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"12 9012190/26 (d) The Parties will cooperate to discuss expansion plans, address capacity and any other product supply issues, including efficient use of resources, manufacturing schedules and shipping schedules.\"}}, {\"id\": \"2.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply Failures\", \"level\": 2, \"text\": \"2.14 Supply Failures. In the event that MediWound becomes aware of the existence of a situation that may lead to a Supply Failure, then MediWound shall promptly (and in no event later than [***] from the date of such awareness) notify Vericel of the particular circumstances. MediWound and Vericel shall promptly discuss how to resolve such circumstances in an effort to avoid or mitigate such potential Supply Failure. MediWound shall investigate the root cause of the anticipated Supply Failure and prepare and provide to Vericel a Remediation Plan within [***] of MediWound's notice to Vericel. If the Remediation Plan is acceptable to Vericel, and MediWound is able to reasonably assure Vericel of MediWound's ability to Manufacture Product and, thereby, (a) avoid a Supply Failure or (b) supply Product in accordance with the Rolling Forecast within [***], then MediWound shall continue to Manufacture Product for Vericel. In all other cases, Vericel shall be permitted to take such measures as are reasonably determined in good faith by Vericel to ensure the supply of Product to the marketplace including cancelling or revising outstanding Purchase Orders and, at Vericel's option, Vericel's obligations under Section 2.8(a), (b) and (c) shall be deemed terminated.\"}}, {\"id\": \"ARTICLE 3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE, QUALITY AND ENVIRONMENTAL\", \"level\": 1, \"text\": \"ARTICLE 3 COMPLIANCE, QUALITY AND ENVIRONMENTAL\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Certificates of Analysis; Release\", \"level\": 2, \"text\": \"3.1 Certificates of Analysis; Release. MediWound shall perform, or cause to be performed testing and other activities on each Batch of Product Manufactured pursuant to this Agreement before delivery to Vericel or Vericel's designated Affiliate or contractor and consistent with the testing and procedures specified in the Quality Agreement. In the event of any change in Specifications, the certificate of analysis shall contain the required information in accordance with the then-approved release tests in conjunction with applicable change control procedures in accordance with this Agreement and the Quality Agreement. MediWound shall send, or cause to be sent, such certificates to Vericel prior to delivery of each such Batch unless otherwise agreed by the Parties in writing or specified in the Quality Agreement.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Records\", \"level\": 2, \"text\": \"3.2 Records. MediWound shall maintain and shall cause each Supplier to maintain all Manufacturing records, including packaging, analytical and stability records, all records of shipment, and all validation data relating to the Product Manufactured and supplied to Vericel hereunder for the Territory to the extent and for the time periods required by applicable Regulatory Standards with respect to such Product. MediWound shall make such records and data available for Vericel's review on Vericel's reasonable request as mutually agreed by the Parties.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Compliance\", \"level\": 2, \"text\": \"3.3 Regulatory Compliance. MediWound shall advise Vericel promptly, but in any event within [***] on becoming aware of an authorized agent of a Regulatory Authority visit or inspection to its or any of the Suppliers' Facilities where the Products are being Manufactured for supply to Vericel for the Territory hereunder and in connection with the Manufacturing of the Products. MediWound agrees to use commercially reasonable efforts to permit one or more\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"13 9012190/26 Vericel representatives to be present for all or part of such visit or inspection if Vericel so requests. MediWound shall use commercially reasonable efforts to furnish to Vericel a copy of all material information supplied and/or issued by any Regulatory Authority to the extent that such report relates to the Manufacture or supply of Product to Vericel for the Territory, or the ability of MediWound or the Suppliers to so Manufacture or supply hereunder, within [***] of its receipt of such information. Before MediWound or any Supplier responds to any Regulatory Authority where such correspondence would reasonably be expected to have a material impact on the Manufacture or supply of Product to Vericel for the Territory, Vericel will be provided a reasonable opportunity, unless prohibited by applicable Law, to review and comment on the portion of such response related thereto, provided that Vericel shall conduct such review and provide such comments reasonably in advance of when any such response is due to such Regulatory Authority, and further provided that nothing herein, including failure by Vericel to provide such timely review and comment, shall in any way restrict MediWound or its Suppliers from taking, and MediWound and its Suppliers shall at all times be permitted to take, such actions or inactions necessary for its and their compliance with applicable Law. With respect to any and all requirements of a Regulatory Authority for the Manufacture of Product for Commercialization in the Territory following the First Commercial Sale of the Product in a country in the Territory, the Parties shall discuss in good faith such requirements and allocation of responsibility between the Parties.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Audit\", \"level\": 2, \"text\": \"3.4 Audit. (a) Vericel shall have the right from time to time during the Term of this Agreement, but not more than [***] (unless (i) otherwise agreed between the Parties or (ii) if Section 3.4(b) below applies) during normal business hours and upon not less than [***] prior notice (unless Section 3.4(b)(iv) applies), to enter and inspect any Facility and any related utilities and/or services used in Manufacturing Product in order to carry out a cGMP quality and compliance audit of those parts of the Facility involved in or which could have any impact on Manufacture of such Product (including those used for storing, warehousing and/or testing and utilities), including for the purpose of confirming that no types of product which could reasonably be expected to impact the quality of the Product are being manufactured on site in deviation of cGMP. (b) In addition to the rights set out in Section 3.4(a), where (i) any audit carried out in accordance with this Section 3.4 has identified any breach of this Agreement, (ii) Vericel has a reasonable basis to suspect a breach of this Agreement, (iii) any previous audit carried out in accordance with this Section 3.4 has identified any major or critical findings, or (iv) if such audit is in response to or following an audit from a regulatory agency, and such audit resulted in a 483 or equivalent citation, then Vericel shall have the right to carry out, upon reasonable prior notice and during normal business hours, follow up compliance audit(s). (c) MediWound shall be solely responsible for ensuring the cGMP compliance status of subcontractors (where such subcontractors are carrying out activities to which cGMP applies) used in relation to the performance of its obligations under this Agreement.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"14 9012190/26 (d) MediWound shall use commercially reasonable efforts to procure the right for Vericel to have the same inspection rights described in this Section 3.4 at the premises of any such subcontractor, and if unable to procure such rights, shall carry out such audits itself and shall report its non-confidential findings to Vericel. (e) The above obligations of MediWound and rights of Vericel shall apply, mutatis mutandis, to the rights of MediWound and obligations of Vericel with respect to the undertaking of Vericel and its Affiliates, Sublicensees and Distributors to comply with the cGMP as applicable to their activities and the related audit rights to ensure such compliance.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Results of Audits and /or Regulatory Inspection\", \"level\": 2, \"text\": \"3.5 Results of Audits and /or Regulatory Inspection. Observations and conclusions of Vericel's audits will be issued to MediWound, which materials shall be deemed Confidential Information, provided that any Confidential Information of MediWound contained therein or upon which such observations and conclusions are based shall remain the Confidential Information of MediWound. MediWound and Vericel shall, at Vericel's expense (unless the result is due to a material breach of MediWound of any of its obligations under this Agreement), (a) cooperate to determine the cause for any identified issues, (b) work together in good faith to develop a corrective action, and (c) endeavor to implement such corrective action within a mutually agreed time period thereafter.\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Information\", \"level\": 2, \"text\": \"3.6 Regulatory Information. MediWound shall promptly disclose to Vericel, upon its request, information in MediWound's possession required for Vericel to obtain and maintain any and all needed permits, approvals, or licenses issued by any and all Regulatory Authorities relating to the Manufacture, storage, packaging, and sale of a Product, as the case may be. MediWound shall use reasonable commercial efforts to cause Suppliers to, provide to Vericel in a reasonable, timely manner (including within a reasonable period prior to the due date of Vericel's annual report to an applicable Regulatory Authority with respect to the Product), all information in its or their respective possession which Vericel requires regarding the Product in order to comply with such Regulatory Standards. MediWound shall provide new regulatory correspondence related to the Product as soon as possible but in no event less than [***].\"}}, {\"id\": \"3.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Recall\", \"level\": 2, \"text\": \"3.7 Recall. Any decision to initiate a Recall of a Product in a country in the Territory shall be made by the marketing approval holder and shall be made in compliance with and to the extent permitted by applicable Law, after consultation between the Parties. Vericel's and its Affiliates', Sublicensees' and Distributors' costs (including internal costs of Vericel) associated with any such Recall shall be borne solely by Vericel (including refunds to customers); provided, however, that all out of pocket expenses associated with a Recall (including those of Vericel and its Affiliates, Sublicensees and Distributors and refunds to customers) shall be borne solely by MediWound to the extent such Recall (a) arises from or is caused directly by any breach by MediWound of this Agreement, the License Agreement or the Quality Agreement, or MediWound's or any of its Affiliates', Suppliers' or subcontractors' negligence or willful misconduct; or (b) resulting directly from MediWound's failure to supply Product that conforms to the applicable Product Warranty. MediWound shall cooperate in the implementation of any Recall of Product in the Territory, as required by applicable Law or reasonably requested by Vericel and, for such a Recall, the cost of such cooperation shall be at Vericel's reasonable\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"15 9012190/26 expense (except to the extent the Recall results from the matters described in the foregoing clauses (a) or (b)).\"}}, {\"id\": \"3.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Quality Agreement\", \"level\": 2, \"text\": \"3.8 Quality Agreement. Each Party shall perform the duties required of it pursuant to a quality agreement to be entered into by the Parties within [***] of the execution of this Agreement (the \\\"Quality Agreement\\\"). To the extent the Quality Agreement either conflicts with this Agreement or is silent on an issue addressed, this Agreement shall control, except to the extent the matter is strictly a quality matter, in which event the Quality Agreement shall supersede this Agreement solely with respect to such quality matter.\"}}, {\"id\": \"ARTICLE 4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CHANGES\", \"level\": 1, \"text\": \"ARTICLE 4 CHANGES\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Changes\", \"level\": 2, \"text\": \"4.1 Changes. MediWound shall not change the Specifications or Manufacturing process for the Manufacture of Product for supply to Vericel for the Territory hereunder except as expressly permitted pursuant to this Article 4. Each Party shall notify the other Party of any change in the Regulatory Standards applicable to the Manufacturing of Product for the supply to Vericel for the Territory that could reasonably affect the obligations of MediWound under this Agreement. All changes shall include an assessment of the need for regulatory submission and approval by a method to be defined in the Quality Agreement. The applicable notification period for any change or proposed change by a Party to the Manufacturing process or Specifications for a Product or Key Materials, the Facility and other Manufacturing changes (the \\\"Change Notification Period\\\") is set forth on Schedule 4.1.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Discretionary Manufacturing Changes\", \"level\": 2, \"text\": \"4.3 Discretionary Manufacturing Changes. Vericel may propose changes to the Specifications or Manufacturing process for the supply of Product to Vericel for the Territory that are not Regulatory Changes (any such change, a \\\"Discretionary Manufacturing Change\\\"). If agreed to by MediWound, MediWound or its Suppliers will use commercially reasonable efforts to make such proposed changes, and Vericel will bear [***] of the costs associated with such changes. MediWound may propose changes to the Specifications or Manufacturing process for the supply of Product for the Territory that are not Regulatory Changes. MediWound shall propose any such Discretionary Manufacturing Change in accordance with the applicable\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"16 9012190/26 Change Notification Period prior to the proposed implementation. [***]. Vericel shall, within [***] of receipt of MediWound's notice, notify MediWound in writing whether Vericel accepts or rejects the proposed change, such consent not to be unreasonably withheld, conditioned or delayed unless consultations with regulatory authorities are required to assess the impact of such proposed change.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Regulatory Changes\", \"level\": 2, \"text\": \"4.4 Regulatory Changes. (a) Notwithstanding any other provision under this Agreement to the contrary, if either Party receives notice, or is otherwise informed of, any change to the Manufacturing process or Specifications for a Product or Key Materials, the Facility or any change that has an impact of the obligations of Vericel or MediWound under this Agreement that is required by applicable Law or that is otherwise required by any applicable Regulatory Authority (any such change, a \\\"Regulatory Change\\\"), such Party shall promptly deliver notice thereof to the other Party. Within the applicable Change Notification Period, MediWound shall notify Vericel in writing of MediWound's good faith and reasonable determination as to (i) whether MediWound is technically able to comply with such Regulatory Change, (ii) whether the Regulatory Change would adversely affect MediWound's ability to timely manufacture and supply any Product supplied hereunder and (iii) the costs to implement such Regulatory Change. MediWound shall use commercially reasonable efforts to cause Key Material Suppliers to provide such notice of any Regulatory Change to MediWound or Vericel. (b) If MediWound determines it is technically unable to comply with the Regulatory Change at the Facility in the timeframe required by the applicable Regulatory Authority, then, in MediWound's discretion, it shall have the right to transfer the Manufacturing of the applicable Product to an alternative facility of MediWound that is qualified and approved for Manufacturing such Product in accordance with this Agreement, if available. In the event MediWound is unable to supply Product as a result of such Regulatory Change, Vericel, in its sole discretion, shall be entitled to source all or any portion of Vericel's requirements of the applicable Product, until MediWound regains the ability to supply Product, from a Third Party, including from the Second Source. Notwithstanding anything to the contrary contained in this Agreement, if as a result of a Regulatory Change, MediWound is unable to Manufacture and supply a Product to Vericel, Vericel shall be entitled to source such Product, until MediWound regains the ability to supply Product, from a Third Party or Second Source in accordance with this Section 4.4(b), in which case MediWound shall use commercially reasonable efforts to provide Vericel with reasonable technical assistance with regard to transferring the technology relating to the Product to such Third Party, and the Parties shall discuss the allocation of such costs related to such transfer, including MediWound's expenses and any incremental costs of supply of such Product and Materials from such Third Party consistent with Schedule 4.5. (c) If MediWound determines it is technically able to implement a Regulatory Change required by a Regulatory Authority in the Territory, the costs for such Regulatory Change shall be borne by Vericel consistent with Schedule 4.5.\"}}, {\"id\": \"17\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"17 9012190/26\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ongoing Regulatory Assistance\", \"level\": 2, \"text\": \"4.5 Ongoing Regulatory Assistance. Within [***] following Vericel's request, MediWound shall provide technical data and assistance in answering Vericel's questions (a) for regulatory filings and for process changes initiated by MediWound at no cost to Vericel, (b) for process changes initiated by Vericel at the cost of Vericel for the applicable number of hours at a Full Time Equivalent rate described in Schedule 4.5, (c) for new regulatory registrations, which shall be at Vericel's cost, and (d) for periodic regulatory reporting and questions from regulatory authorities, which shall be at the cost of Vericel.\"}}, {\"id\": \"ARTICLE 5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE AND PAYMENT TERMS\", \"level\": 1, \"text\": \"ARTICLE 5 PRICE AND PAYMENT TERMS\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Supply Price\", \"level\": 2, \"text\": \"5.1 Supply Price. On a Product-by-Product basis, the price payable in U.S. Dollars by Vericel for supply of such Product for a given Calendar Year shall be as set forth on a per unit basis on Exhibit A (with respect to each Product, the \\\"Supply Price\\\"), which shall be updated on a Calendar Year basis in accordance with Section 5.2 below.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Price Mechanics\", \"level\": 2, \"text\": \"5.2 Price Mechanics. (a) Beginning on [***] (each, a \\\"Re-Pricing Date\\\"), MediWound may annually increase the Supply Price for a Calendar Year in accordance with the terms of this Section 5.2. MediWound may increase the Supply Price for a Calendar Year if the United States Producer Price Index (Chemical Manufacturing) published by the Bureau of Labor Statistics (the \\\"PPI\\\") [***] and (b) in the event the PPI [***]. MediWound shall give Vericel at least [***] prior written notice of any such adjustment to the Supply Price. (b) In addition to the foregoing price adjustment mechanism, MediWound may propose an adjustment to the Supply Price to reflect changes that substantially affect MediWound's costs or ability to supply Product. MediWound shall provide Vericel with written notice of such changes and its proposed adjustment and provide appropriate documentation demonstrating that the price adjustment is required. Following Vericel's receipt of such notice and documentation, the Parties will engage in good faith discussions to negotiate a mutually agreed upon adjustment to the Supply Price, if any. (c) Unless otherwise agreed by the Parties, the adjusted Supply Price will be the Supply Price for the next applicable Purchase Order placed after Vericel's receipt of notification of the adjusted Supply Price, and shall apply to each Purchase Order placed thereafter until the next adjustment is made (if any) in accordance with the above mechanism.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Cost Savings\", \"level\": 2, \"text\": \"5.3 Cost Savings. Either Party may propose changes to any Manufacturing process in order to obtain efficiencies and cost savings in such process (\\\"Cost Savings Change\\\"). The proposing Party shall submit to the other Party a proposal detailing the Cost Savings Change, the implementation of such Cost Savings Change, and the analysis of the expected efficiencies and cost savings from such Cost Savings Change. If Vericel proposes a Cost Savings Change and (a) MediWound determines it is technically able to implement the Cost Savings Change, (b) the Cost Savings Change would not materially adversely affect the applicable Facility, and (c) Vericel agrees to pay the costs to implement such Costs Saving Change as an Additional Service Fee,\"}}, {\"id\": \"18\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"18 9012190/26 MediWound shall agree to implement such proposed change which MediWound shall not unreasonably decline to implement. If MediWound proposes a Cost Savings Change and the Parties agree to its implementation, (i) Vericel shall pay MediWound the agreed amount to implement such change as an Additional Service Fee prior to the implementation of such Cost Savings Change; and (ii) MediWound shall make its reasonable commercial efforts to implement such Cost Savings Change pursuant to a mutually agreed upon schedule. In the event cost savings are actually achieved, then the cost saving will be [***] between the Parties (i.e. [***] of the cost savings shall be added to the new discounted Supply Price).\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payments\", \"level\": 2, \"text\": \"5.4 Payments. Unless specified otherwise, any payment to be made by Vericel under this Agreement shall be made within [***] from date of invoice. It is hereby agreed that the invoice with respect to any shipment will be issued upon the delivery date. The Parties' respective rights and responsibilities under Sections 5.6.5 and 5.6.6 of the License Agreement shall apply as such Section pertains to the Parties' performance under this Agreement, and are hereby incorporated by reference.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Late Payments\", \"level\": 2, \"text\": \"5.5 Late Payments. Any payments due under this Agreement shall be due on such date as specified in this Agreement and, in the event such date is not a Business Day, then the next succeeding Business Day. In the event that any payment due under this Agreement is not made when due, the amount due shall accrue interest beginning on the [***] following the date on which such payment was due, calculated at the [***] for the due date, or, if lower, the maximum rate permitted by law, calculated from the due date until paid in full. Each payment made after the due date shall be accompanied by all interest so accrued. Notwithstanding the foregoing, a Party shall have recourse to any other remedy available at law or in equity with respect to any delinquent payment, subject to the terms of this Agreement.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 2, \"text\": \"5.6 Taxes. Vericel shall be responsible for the payment of any value added or similar tax (but excluding, for avoidance of doubt, any tax on the income of MediWound) on the Products delivered by MediWound to Vericel, to the extent such taxes are itemized and included on a valid invoice and required to be collected from Vericel under applicable Law. In addition, in the event any payments made by Vericel pursuant to this Agreement become subject to withholding taxes under the Laws or regulations of any jurisdiction or Governmental Authority, Vericel shall deduct and withhold the amount of such taxes for the account of MediWound to the extent required by applicable Laws or regulations; such amounts payable to MediWound shall be reduced by the amount of taxes deducted and withheld; and Vericel shall pay the amounts of such taxes to the proper Governmental Authority in a timely manner and transmit to MediWound an official tax certificate or other evidence of such tax obligations together with proof of payment from the relevant Governmental Authority of all amounts deducted and withheld. Any such withholding taxes required under applicable Laws or regulations to be paid or withheld shall be an expense of, and borne solely by, MediWound. Each Party agrees to cooperate with the other Party in claiming refunds or exemptions from such deductions or withholdings under any relevant agreement or treaty which is in effect. The Parties shall discuss applicable mechanisms for minimizing such taxes to the extent possible in compliance with applicable Laws. Vericel will provide MediWound with reasonable assistance to enable MediWound to recover such taxes as permitted by applicable Laws or regulations.\"}}, {\"id\": \"19\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"19 9012190/26\"}}, {\"id\": \"ARTICLE 6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPRESENTATIONS, WARRANTIES AND COVENANTS\", \"level\": 1, \"text\": \"ARTICLE 6 REPRESENTATIONS, WARRANTIES AND COVENANTS\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Mutual Representations and Warranties\", \"level\": 2, \"text\": \"6.1 Mutual Representations and Warranties. As of the Effective Date unless otherwise specified, each of MediWound and Vericel hereby represents and warrants to the other Party that: (a) it is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization; (b) the execution, delivery and performance of this Agreement by such Party has been duly authorized by all requisite action under the provisions of its charter, bylaws and other organizational documents, and does not require any action or approval by any of its shareholders or other holders of its voting securities or voting interests; (c) it has the power and authority to execute and deliver this Agreement and to perform its obligations hereunder; (d) this Agreement has been duly executed and is a legal, valid and binding obligation on each Party, enforceable against such Party in accordance with its terms; and (e) the execution, delivery and performance by such Party of this Agreement and its compliance with the terms and provisions hereof does not and will not conflict with or result in a breach of or default under any agreement or arrangement with any Third Party existing as of the Effective Date.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Law\", \"level\": 2, \"text\": \"6.2 Compliance with Law. During the Term of this Agreement, each Party shall comply in all material respects with all applicable Laws (including Regulatory Standards, cGMP as applicable to MediWound and cGMP to the extent applicable to Vericel) applicable to its performance under this Agreement.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Warranty\", \"level\": 2, \"text\": \"6.3 Product Warranty. MediWound represents and warrants to Vericel that, at the time of delivery of the given Product to the Delivery Site pursuant to Section 2.9(c), such Product so delivered pursuant to this Agreement will constitute Conforming Product and, except with respect to Section 2.13, will have a shelf life equal to or exceeding the Minimum Shelf Life (the \\\"Product Warranty\\\").\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Liens\", \"level\": 2, \"text\": \"6.4 No Liens. MediWound represents, warrants and covenants that all Product delivered to Vericel (or its designated Affiliate or contractor) pursuant to this Agreement will, at the time of such delivery, be free and clear of all liens, encumbrances, security interests and other encumbrances.\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Debarment\", \"level\": 2, \"text\": \"6.5 Debarment. As of the Effective Date hereof and at all times during the Term of the Agreement, each Party represents and warrants to the other Party that neither it nor, to its knowledge, any of its existing subcontractors or Suppliers, is debarred as of the Effective Date, and neither it nor any of its subcontractors or Suppliers shall, during the Term, use in any\"}}, {\"id\": \"20\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"20 9012190/26 capacity the services of any Person debarred by any Regulatory Authority, including under Subsection 306(a) or (b) of the Generic Drug Enforcement Act of 1992 or any other equivalent Regulatory Standard. In the event either Party learns that it, any of its employees or contractors, any Supplier or any of a Supplier's employees or contractors has been debarred, it shall notify the other Party promptly, and in any event within [***] of learning of such debarment. In the event that MediWound, any of its employees or contractors, any Supplier or any of a Supplier's employees or contractors has been debarred, MediWound shall immediately remove or have removed such Person from thereafter performing Manufacturing or supply activities under this Agreement with respect to the Product upon learning of such debarment. In the event that Vericel, any of its employees or contractors, any Sublicensee or any of such Sublicensee's employees or contractors has been debarred, it shall immediately remove or have removed such Person from thereafter performing distribution activities under this Agreement with respect to the Product upon learning of such debarment.\"}}, {\"id\": \"ARTICLE 7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNITY, INSURANCE\", \"level\": 1, \"text\": \"ARTICLE 7 INDEMNITY, INSURANCE\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification by MediWound\", \"level\": 2, \"text\": \"7.1 Indemnification by MediWound. MediWound will indemnify, defend and hold harmless Vericel, its Affiliates, Sublicensees, contractors, Distributors and each of its and their respective employees, officers, directors and agents (each, a \\\"Vericel Indemnified Party\\\") from and against any and all liability, loss, damage, expense (including reasonable attorneys' fees and expenses) and cost (collectively, \\\"Liability\\\") that the Vericel Indemnified Party may be required to pay to one or more Third Parties resulting from or arising out of: (a) the material breach by MediWound of any of its representations, warranties or covenants set forth in Article 6; (b) any Recall or withdrawal of Product to the extent attributable to MediWound's breach of this Agreement or the Quality Agreement; or (c) the gross negligence or willful misconduct of MediWound or any subcontractor or Supplier acting on behalf of MediWound relating to its activities in connection with this Agreement; except, in each case, to the extent (y) caused by the negligence, recklessness or intentional acts of Vericel or any Vericel Indemnified Party or (z) Vericel is required to indemnify MediWound pursuant to Section 7.2.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Indemnification by Vericel\", \"level\": 2, \"text\": \"7.2 Indemnification by Vericel. Vericel will indemnify, defend and hold harmless MediWound, each of its Affiliates, and each of its and its Affiliates' employees, officers, directors and agents (each, a \\\"MediWound Indemnified Party\\\") from and against any and all Liability that the MediWound Indemnified Party may be required to pay to one or more Third Parties (other than shareholders of MediWound or its Affiliates) resulting from or arising out of: (a) the material breach by Vericel of any of its representations, warranties or covenants set forth in Article 6;\"}}, {\"id\": \"21\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"21 9012190/26 (b) any Recall or withdrawal of Product to the extent attributable to Vericel's breach of this Agreement or the Quality Agreement; or (c) the gross negligence or willful misconduct of Vericel or any subcontractor or Supplier acting on behalf of Vericel relating to its activities in connection with this Agreement; except, in each case, to the extent (y) caused by the negligence, recklessness or intentional acts of MediWound or any MediWound Indemnified Party or (z) MediWound is required to indemnify Vericel pursuant to Section 7.1.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Right of Indemnification under License Agreement\", \"level\": 2, \"text\": \"7.3 No Right of Indemnification under License Agreement. No right of indemnification shall exist under the License Agreement for claims arising out of the performance of this Agreement, it being the intent of the Parties that such claims shall be solely governed by the provisions of this Agreement and, for the avoidance of doubt, except as set forth in Section 7.6, no limits on indemnification or liability set forth in the License Agreement shall apply to this Agreement.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Procedure\", \"level\": 2, \"text\": \"7.4 Procedure. (a) Notice. Each Party will notify the other Party in writing in the event it becomes aware of a claim for which indemnification may be sought hereunder. In the event that any Third Party asserts a claim or other proceeding (including any governmental investigation) with respect to any matter for which a Party (the \\\"Indemnified Party\\\") is entitled to indemnification hereunder (a \\\"Third Party Claim\\\"), then the Indemnified Party shall promptly notify the Party obligated to indemnify the Indemnified Party (the \\\"Indemnifying Party\\\") thereof; provided, however, that no delay on the part of the Indemnified Party in notifying the Indemnifying Party shall relieve the Indemnifying Party from any obligation hereunder unless (and then only to the extent that) the Indemnifying Party is prejudiced thereby. (b) Control. The Indemnifying Party shall have the right, exercisable by notice to the Indemnified Party within [***] after receipt of notice from the Indemnified Party of the commencement of or assertion of any Third Party Claim, to assume direction and control of the defense, litigation, settlement, appeal or other disposition of the Third Party Claim (including the right to settle the claim solely for monetary consideration) with counsel selected by the Indemnifying Party and reasonably acceptable to the Indemnified Party; provided that (i) the Indemnifying Party has sufficient financial resources, in the reasonable judgment of the Indemnified Party, to satisfy the amount of any adverse monetary judgment that is sought, (ii) the Third Party Claim seeks solely monetary damages and (iii) the Indemnifying Party expressly agrees in writing that as between the Indemnifying Party and the Indemnified Party, the Indemnifying Party shall be solely obligated to satisfy and discharge the Third Party Claim in full (the conditions set forth in clauses (i), (ii) and (iii) above are collectively referred to as the \\\"Litigation Conditions\\\"). Within [***] after the Indemnifying Party has given notice to the Indemnified Party of its exercise of its right to defend a Third Party Claim, the Indemnified Party shall give notice to the Indemnifying Party of any objection thereto based upon the Litigation Conditions. If the Indemnified Party reasonably so objects, the Indemnified Party shall continue to defend the Third Party Claim, at the expense of the Indemnifying Party, until such time as\"}}, {\"id\": \"22\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"22 9012190/26 such objection is withdrawn. If no such notice is given, or if any such objection is withdrawn, the Indemnifying Party shall be entitled, at its sole cost and expense, to assume direction and control of such defense, with counsel selected by the Indemnifying Party and reasonably acceptable to the Indemnified Party. During such time as the Indemnifying Party is controlling the defense of such Third Party Claim, the Indemnified Party shall cooperate, and shall cause its Affiliates and agents to cooperate upon request of the Indemnifying Party, in the defense or prosecution of the Third Party Claim, including by furnishing such records, information and testimony and attending such conferences, discovery proceedings, hearings, trials or appeals as may reasonably be requested by the Indemnifying Party. In the event that the Indemnifying Party does not satisfy the Litigation Conditions or does not notify the Indemnified Party of the Indemnifying Party's intent to defend any Third Party Claim within [***] after notice thereof, the Indemnified Party may (without further notice to the Indemnifying Party) undertake the defense thereof with counsel of its choice and at the Indemnifying Party's expense (including reasonable, out-of-pocket attorneys' fees and costs and expenses of enforcement or defense). The Indemnifying Party or the Indemnified Party, as the case may be, shall have the right to join in (including the right to conduct discovery, interview and examine witnesses and participate in all settlement conferences), but not control, at its own expense, the defense of any Third Party Claim that the other party is defending as provided in this Agreement. (c) Settlement. The Indemnifying Party shall not, without the prior written consent of the Indemnified Party, enter into any compromise or settlement that commits the Indemnified Party to take, or to forbear to take, any action. The Indemnified Party shall have the sole and exclusive right to settle any Third Party Claim, on such terms and conditions as it deems reasonably appropriate, to the extent such Third Party Claim involves equitable or other non-monetary relief, but shall not have the right to settle such Third Party Claim to the extent such Third Party Claim involves monetary damages without the prior written consent of the Indemnifying Party. Each of the Indemnifying Party and the Indemnified Party shall not make any admission of liability in respect of any Third Party Claim without the prior written consent of the other party, and the Indemnified Party shall use reasonable efforts to mitigate liabilities arising from such Third Party Claim.\"}}, {\"id\": \"7.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclaimer\", \"level\": 2, \"text\": \"7.5 Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, NEITHER PARTY MAKES, AND EACH PARTY EXPRESSLY DISCLAIMS, ANY AND ALL REPRESENTATIONS OR WARRANTIES OF ANY KIND, WITH RESPECT TO THIS AGREEMENT (INCLUDING THE MANUFACTURE AND SUPPLY OF PRODUCT HEREUNDER), EXPRESS, IMPLIED OR STATUTORY, INCLUDING, ANY WARRANTY OF TITLE, NON-INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.\"}}, {\"id\": \"7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"7.6 LIMITATION OF LIABILITY. NEITHER PARTY SHALL BE LIABLE FOR ANY SPECIAL, INCIDENTAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES OF ANY KIND (INCLUDING LOST PROFITS) REGARDLESS OF THE FORM OF ACTION, WHETHER IN CONTRACT, TORT, NEGLIGENCE, BREACH OF STATUTORY DUTY OR OTHERWISE, SUFFERED BY THE OTHER PARTY, EVEN IF THAT PARTY HAS BEEN INFORMED OF THE POSSIBILITY OF ANY SUCH DAMAGES IN ADVANCE. [***].\"}}, {\"id\": \"23\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"23 9012190/26\"}}, {\"id\": \"7.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Insurance\", \"level\": 2, \"text\": \"7.7 Insurance. For the duration of this Agreement and for a period of [***] following its termination, each Party agrees to obtain and maintain, during the Term, commercial general liability insurance, including product liability insurance, with reputable and financially secure insurance carriers (or pursuant to a program of self-insurance reasonably satisfactory to the other Party) to cover its indemnification obligations under Section 7.1 or Section 7.2, as applicable, in each case with limits of not less than [***] per occurrence and in the aggregate. Insurance shall be procured with carriers having an A.M. Best Rating of A-VII or better.\"}}, {\"id\": \"ARTICLE 8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"ARTICLE 8 TERM AND TERMINATION\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"8.1 Term. The term of this Agreement will commence upon the Effective Date and will continue until the fifth (5th) anniversary of the Effective Date, unless earlier terminated or extended under this Article 8 (the \\\"Initial Term\\\"). At least twenty-four (24) months from the end of the Initial Term, Vericel shall provide MediWound notice whether Vericel elects to extend the Initial Term of the Agreement by an additional twenty four (24) months. After the Initial Term (including any extension thereto made in accordance with the preceding sentence), the Agreement may be extended on a yearly basis up to ten (10) years at Vericel's sole discretion, with renewal notice to be provided to MediWound no later than twelve (12) months prior to the expiry of any yearly extension (the \\\"Renewal Term\\\", and the Initial Term, together with the Renewal Term, if any, the \\\"Term\\\"); provided that unless otherwise agreed by the Parties, the Term of this Agreement (including the Initial Term, any extension of the Initial Term and any Renewal Terms) shall be no more than fifteen (15) years in total.\"}}, {\"id\": \"value:fifth (5th) anniversary\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifth (5th) anniversary\"}}, {\"id\": \"value:twenty-four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty-four (24) months\"}}, {\"id\": \"value:twenty four (24) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twenty four (24) months\"}}, {\"id\": \"value:ten (10) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) years\"}}, {\"id\": \"value:twelve (12) months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"twelve (12) months\"}}, {\"id\": \"value:fifteen (15) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) years\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Automatic Termination\", \"level\": 2, \"text\": \"8.2 Automatic Termination. This Agreement will automatically immediately terminate in the event of the expiration or termination of the License Agreement.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for Breach\", \"level\": 2, \"text\": \"8.3 Termination for Breach. Subject to the provisions of Article 10 below, either Party may terminate this Agreement in its entirety if the other Party materially breaches a material provision and does not cure such breach, or does not take reasonable steps required under the circumstances to cure such breach going forward, within [***] after receiving notice of the breach.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination by Vericel\", \"level\": 2, \"text\": \"8.4 Termination by Vericel. Following the Initial Term, Vericel may, without penalty or prejudice to any other rights or remedies Vericel may have, in its sole discretion terminate or reduce the scope of any individual activities contemplated by this Agreement or any Additional Service or with respect to any Product or terminate this Agreement as a whole with or without cause, upon [***] prior written notice of such termination or reduction (which such written notice may be provided during the Initial Term).\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination by MediWound\", \"level\": 2, \"text\": \"8.5 Termination by MediWound. Following the Initial Term, MediWound may terminate this Agreement by notice in writing to Vericel upon on at least [***] advanced written notice (or such longer period of time as reasonably necessary to avoid a supply disruption) if MediWound determines to cease Manufacturing the applicable Product for the Territory, but in such case MediWound will reasonably cooperate with Vericel to enable Vericel to establish its own source for the Product (including, to the extent requested by Vericel and within\"}}, {\"id\": \"24\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"24 9012190/26 MediWound's ability to do so, by transferring MediWound's applicable Third Party manufacturing relationships to Vericel).\"}}, {\"id\": \"8.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effects of Termination\", \"level\": 2, \"text\": \"8.6 Effects of Termination. Any expiration or termination of this Agreement shall not affect any claims that have accrued or outstanding obligations or payments due hereunder prior to such termination or expiration, nor shall it prejudice any other remedies that the Parties may have under this Agreement. In addition, upon the expiration or earlier termination of this Agreement: (a) if Vericel terminates the Agreement for breach or MediWound terminates in accordance with Section 8.5, Vericel shall have the option of [***] (b) Vericel shall pay to MediWound: (i) all amounts outstanding and remaining to be paid for Product supplied prior to such expiration or termination or under any other obligation under the Agreement; (ii) all amounts for Product in the Binding Forecasts and Binding Orders prior to the expiration or termination, provided that MediWound delivers such Product in accordance with the terms of this Agreement; (iii) all amounts representing the purchase by MediWound of Materials in reliance upon the Binding Forecasts and Binding Orders (if MediWound is unable to cancel (without incurring any costs) or otherwise use such Materials); and (iv) all amounts representing remaining inventory of Product and all Product work in process undertaken in accordance with the Binding Forecasts or Binding Orders or undertaken otherwise in accordance with the terms of this Agreement. (c) Following expiration of the Royalty Term (as defined in the License Agreement) for any Licensed Product in a given country, the license granted to Vericel under Section 9.1 of this Agreement with respect to such Licensed Product in such country shall automatically become fully paid-up, perpetual, irrevocable and royalty-free.\"}}, {\"id\": \"ARTICLE 9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY RIGHTS\", \"level\": 1, \"text\": \"ARTICLE 9 INTELLECTUAL PROPERTY RIGHTS\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Manufacturing License Grant\", \"level\": 2, \"text\": \"9.1 Manufacturing License Grant. Subject to the terms herein, MediWound hereby grants to Vericel a non-exclusive, sublicensable (subject to Section 4.2 of the License Agreement) license under the MediWound Technology and MediWound's interest in the Joint Technology, to Manufacture and have Manufactured Licensed Products in the Territory for use in the Field in the Territory.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademarks License Grant\", \"level\": 2, \"text\": \"9.2 Trademarks License Grant. MediWound hereby grants to Vericel an exclusive (even as to MediWound), sublicensable, royalty- free, fully paid-up, license in the Territory to use the Licensed Trademarks (as defined in the License Agreement) and a non- exclusive, sublicensable, royalty-free, fully paid-up, license to use the MediWound name and trademark, in\"}}, {\"id\": \"25\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"25 9012190/26 each case, in connection with the Manufacture of Licensed Products in or for the Territory. All uses of the Licensed Trademarks by Vericel (and its Affiliates, Sublicensees and Distributors) in connection with the Manufacture of Licensed Products in or for the Territory shall be in accordance with Regulatory Approvals and all applicable Laws and MediWound's quality control guidelines for the Licensed Trademarks, as may be amended from time to time. Vericel (and its Affiliates) shall only use the Licensed Trademarks licensed hereunder in connection with the Manufacture of Licensed Products in the Territory. Vericel shall not (and shall cause its Affiliates, Sublicensee and Distributors not to) use such Licensed Trademarks to identify, or in connection with the marketing of, any other products.\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Ownership\", \"level\": 2, \"text\": \"9.1 Ownership. Ownership of all inventions and discoveries made by the Parties in the course of Manufacturing and supply of the Product hereunder (including Manufacture and supply of Product) shall be determined in accordance with the terms of the License Agreement.\"}}, {\"id\": \"ARTICLE 10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE\", \"level\": 1, \"text\": \"ARTICLE 10 FORCE MAJEURE\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Excusing Performance\", \"level\": 2, \"text\": \"10.1 Excusing Performance. Neither Party shall be liable for the failure to perform its obligations under this Agreement to the extent such failure is due to events beyond the reasonable control of the non-performing Party, including fires, floods, earthquakes, hurricanes, embargoes, shortages, epidemics, quarantines, war, acts of war (whether war be declared or not), terrorist acts, insurrections, riots, civil commotion, strikes, lockouts or other labor disturbances involving the workforce of any Third Party, or acts of God (a \\\"Force Majeure Event\\\"). Notwithstanding anything to the contrary herein, the occurrence of a Force Majeure Event will not excuse or prevent a failure of MediWound to deliver Product from being deemed a \\\"Supply Failure\\\" or otherwise limit Vericel's rights, to the extent applicable, under Section 2.13.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notice of Force Majeure Event\", \"level\": 2, \"text\": \"10.2 Notice of Force Majeure Event. A Party claiming a right to be excused from performance under Section 10.1 shall immediately notify the other Party in writing of the extent of its inability to perform, which notice shall specify the Force Majeure Event and the estimated likely period of time during which its performance will be affected.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Resumption; Termination\", \"level\": 2, \"text\": \"10.3 Resumption; Termination. A non-performing Party as a result of a Force Majeure Event shall use reasonable best efforts, at its own expense, to eliminate the Force Majeure Event and to mitigate the effect of such cause and resume performance under this Agreement, in each case, as soon as practicable and for as long as such Force Majeure Event continues. Further, consistent with diligent risk management practices, MediWound will keep current a risk management program. If MediWound is affected by any Force Majeure Event, MediWound agrees to perform its obligations under this Section 10.3 to mitigate the effect thereof and resume performance under this Agreement in the same manner as MediWound would use to resolve any similar disruptions affecting its own products (including EscharEx). MediWound shall use reasonable best efforts to ensure that the impact of the Force Majeure Event shall not be relatively greater for Vericel than it is for MediWound with respect to MediWound's products (including EscharEx).\"}}, {\"id\": \"26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"26 9012190/26\"}}, {\"id\": \"ARTICLE 11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MISCELLANEOUS\", \"level\": 1, \"text\": \"ARTICLE 11 MISCELLANEOUS\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"11.1 Assignment. Neither this Agreement nor any interest hereunder shall be assignable by a Party without the prior written consent of the other Party, except as follows: (a) such Party may assign its rights and obligations under this Agreement to any of its Affiliates, provided that the assignee shall expressly agree to be bound by such Party's obligations under this Agreement and that such Party shall remain liable for all of its rights and obligations under this Agreement, and (b) either Party may assign its rights and obligations hereunder to a Third Party in connection with a permitted assignment or other permitted transfer of the License Agreement. Each Party shall promptly notify the other Party of any assignment or transfer under the provisions of this Section 11.1. This Agreement shall be binding upon the successors and permitted assigns of the Parties and the name of a Party appearing herein shall be deemed to include the names of such Party's successors and permitted assigns to the extent necessary to carry out the intent of this Agreement. Any assignment not in accordance with this Section 11.1 shall be void.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Further Actions\", \"level\": 2, \"text\": \"11.2 Further Actions. Each Party agrees to execute, acknowledge and deliver such further instruments, and to do all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of the Agreement.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"11.3 Notices. Any notice or notification required or permitted to be provided pursuant to the terms and conditions of this Agreement (including any notice of force majeure, breach, termination, change of address, etc.) shall be in writing and shall be deemed given upon receipt if delivered personally or by facsimile transmission (receipt verified), five days after deposited in the mail if mailed by registered or certified mail (return receipt requested) postage prepaid, or on the next Business Day if sent by overnight delivery using a nationally recognized express courier service and specifying next Business Day delivery (receipt verified), to the Parties at the following addresses or facsimile numbers (or at such other address or facsimile number for a Party as shall be specified by like notice, provided, however, that notices of a change of address shall be effective only upon receipt thereof): All correspondence to Vericel shall be addressed as follows: Vericel Corporation 64 Sidney Street Cambridge, Massachusetts 02139 Attention: Chief Financial Officer with a copy to: General Counsel All correspondence to MediWound shall be addressed as follows:\"}}, {\"id\": \"value:five days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five days\"}}, {\"id\": \"27\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"27 9012190/26 MediWound Ltd. 42 Hayarkon Street Yavne, Israel 8122745 Attention: Chief Financial Officer with a copy to: General Counsel\"}}, {\"id\": \"11.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Amendment\", \"level\": 2, \"text\": \"11.4 Amendment. No amendment, modification or supplement of any provision of this Agreement shall be valid or effective unless made in writing and signed by a duly authorized officer of each Party.\"}}, {\"id\": \"11.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Waiver\", \"level\": 2, \"text\": \"11.5 Waiver. No provision of this Agreement shall be waived by any act, omission or knowledge of a Party or its agents or employees except by an instrument in writing expressly waiving such provision and signed by a duly authorized officer of the waiving Party. The waiver by either of the Parties of any breach of any provision hereof by the other Party shall not be construed to be a waiver of any succeeding breach of such provision or a waiver of the provision itself.\"}}, {\"id\": \"11.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"11.6 Severability. If any clause or portion thereof in this Agreement is for any reason held to be invalid, illegal or unenforceable, the same shall not affect any other portion of this Agreement, as it is the intent of the Parties that this Agreement shall be construed in such fashion as to maintain its existence, validity and enforceability to the greatest extent possible. In any such event, this Agreement shall be construed as if such clause of portion thereof had never been contained in this Agreement, and there shall be deemed substituted therefor such provision as will most nearly carry out the intent of the Parties as expressed in this Agreement to the fullest extent permitted by applicable Law.\"}}, {\"id\": \"11.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Descriptive Headings\", \"level\": 2, \"text\": \"11.7 Descriptive Headings. The descriptive headings of this Agreement are for convenience only and shall be of no force or effect in construing or interpreting any of the provisions of this Agreement.\"}}, {\"id\": \"11.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Interpretation\", \"level\": 2, \"text\": \"11.8 Interpretation. Except where the context expressly requires otherwise, (a) the use of any gender herein shall be deemed to encompass references to either or both genders, and the use of the singular shall be deemed to include the plural (and vice versa), (b) the words \\\"include\\\", \\\"includes\\\" and \\\"including\\\" shall be deemed to be followed by the phrase \\\"without limitation\\\", (c) the word \\\"will\\\" shall be construed to have the same meaning and effect as the word \\\"shall\\\", (d) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (e) any reference herein to any Person shall be construed to include the Person's successors and assigns, (f) the words \\\"herein\\\", \\\"hereof\\\" and \\\"hereunder\\\", and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (g) all references herein to Sections, Exhibits or Schedules shall be construed to refer to Sections, Exhibits or Schedules of\"}}, {\"id\": \"28\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"28 9012190/26 this Agreement, and references to this Agreement include all Exhibits and Schedules hereto, (h) the word \\\"notice\\\" means notice in writing (whether or not specifically stated) and shall include notices, consents, approvals and other written communications contemplated under this Agreement, (i) provisions that require that a Party, the Parties or any committee hereunder \\\"agree,\\\" \\\"consent\\\" or \\\"approve\\\" or the like shall require that such agreement, consent or approval be specific and in writing, whether by written agreement, letter, approved minutes or otherwise (but excluding e-mail and instant messaging), (j) references to any specific law, rule or regulation, or article, section or other division thereof, shall be deemed to include the then-current amendments thereto or any replacement or successor law, rule or regulation thereof, and (k) the term \\\"or\\\" shall be interpreted in the inclusive sense commonly associated with the term \\\"and/or.\\\"\"}}, {\"id\": \"11.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"11.9 Governing Law. This Agreement, and all claims arising under or in connection therewith, shall be governed by and interpreted in accordance with the substantive laws of the State of New York, without regard to conflict of law principles thereof.\"}}, {\"id\": \"11.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Consent to Jurisdiction\", \"level\": 2, \"text\": \"11.10 Consent to Jurisdiction. In the event of any dispute arising out of or relating to this Agreement other than a dispute arising under Section 2.7(b), the affected Party shall notify the other Party, and the parties shall attempt in good faith to resolve the matter within [***] after the date of such notice (the \\\"Notice Date\\\"). Any disputes not resolved by good faith discussions shall be referred to senior executives of each party, who shall meet at a mutually acceptable time and location within [***] after the Notice Date and attempt to negotiate a settlement. If the matter remains unresolved within [***] after the Notice Date, each Party to this Agreement hereby (a) irrevocably submits to the exclusive jurisdiction of the state courts of the State of New York or the United States District Court for the Southern District of New York for the purpose of any and all actions, suits or proceedings arising in whole or in part out of, related to, based upon or in connection with this Agreement or the subject matter hereof, (b) waives to the extent not prohibited by applicable Law, and agrees not to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such action brought in one of the above-named courts should be dismissed on grounds of forum non conveniens, should be transferred to any court other than one of the above-named courts, or should be stayed by reason of the pendency of some other proceeding in any other court other than one of the above-named courts, or that this Agreement or the subject matter hereof may not be enforced in or by such court, and (c) agrees not to commence any such action other than before one of the above-named courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of any such action to any court other than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, MediWound agrees that a final judgement in an action, suit or proceeding brought in one of the above-named courts may be enforced by Vericel in the competent courts of the State of Israel by suit on such judgment or in any other manner provided by applicable Law.\"}}, {\"id\": \"11.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"11.11 Entire Agreement. This Agreement together with the License Agreement and the Quality Agreement, constitutes and contains the complete, final and exclusive understanding and\"}}, {\"id\": \"29\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"29 9012190/26 agreement of the Parties and cancels and supersedes any and all prior negotiations, correspondence, understandings and agreements, whether oral or written, between the Parties respecting the subject matter hereof and thereof.\"}}, {\"id\": \"11.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Representation by Legal Counsel\", \"level\": 2, \"text\": \"11.12 Representation by Legal Counsel. Each Party hereto represents that it has been represented by legal counsel in connection with this Agreement and acknowledges that it has participated in the drafting hereof. In interpreting and applying the terms and provisions of this Agreement, the Parties agree that no presumption shall exist or be implied against the Party which drafted such terms and provisions.\"}}, {\"id\": \"11.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 2, \"text\": \"11.13 Counterparts. This Agreement may be executed in two counterparts, each of which shall be an original and both of which shall constitute together the same document. Counterparts may be signed and delivered by facsimile or PDF file, each of which shall be binding when received by the applicable Party.\"}}, {\"id\": \"11.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Third Party Rights or Obligations\", \"level\": 2, \"text\": \"11.14 No Third Party Rights or Obligations. No provision of this Agreement shall be deemed or construed in any way to result in the creation of any rights or obligation in any Person not a Party to this Agreement.\"}}, {\"id\": \"11.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 2, \"text\": \"11.15 Confidentiality. (a) Section 7 of the License Agreement shall govern the use and disclosure of information disclosed by the Parties under this Agreement. Either Party may disclose the terms of this Agreement to the extent required, in the reasonable opinion of such Party's legal counsel, to comply with applicable Law, including the rules and regulations promulgated by the United States Securities and Exchange Commission or any equivalent governmental agency in any country in the Territory. Before disclosing this Agreement or any of the terms hereof pursuant to this Section 11.15(a), the Parties will consult with one another on the terms of this Agreement to be redacted in making any such disclosure (which, at a minimum, shall include redaction of certain financial terms), with the disclosing Party providing as much advance notice as is feasible under the circumstances, and giving consideration to the comments of the other Party. Further, if a Party discloses this Agreement or any of the terms hereof in accordance with this Section 11.15(a), such Party shall, at its own expense, seek such confidential treatment of confidential portions of this Agreement, as may be reasonably requested by the other Party. (b) No Party to this Agreement shall originate any publicity, news release or other similar public announcement, written or oral, whether relating to this Agreement or any documents or transactions contemplated hereby or the existence of any arrangement between the Parties, without the prior written consent of the other Party whether or not named in such publicity, news release or other similar public announcement, except to the extent permitted under the License Agreement.\"}}, {\"id\": \"11.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Bankruptcy\", \"level\": 2, \"text\": \"11.16 Bankruptcy. All rights and licenses granted under or pursuant to this Agreement by a Party to the other are and will otherwise be deemed to be, for purposes of Section 365(n) of the Bankruptcy Code, licenses of right to \\\"intellectual property\\\" as defined under Section 101 of the Bankruptcy Code. The Parties agree that Vericel and its Sublicensees,\"}}, {\"id\": \"30\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"30 9012190/26 as Sublicensees of such rights under this Agreement, will retain and may fully exercise all of their rights and elections under the Bankruptcy Code and any foreign counterpart thereto. [SIGNATURE PAGE FOLLOWS]\"}}, {\"id\": \"31\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"31 9012190/26 IN WITNESS WHEREOF, the Parties hereto have each caused this Agreement to be duly executed as of the Effective Date. MEDIWOUND LTD. By: /s/ Stephen T. Wills Name: Stephen T. Wills Title: Chairman VERICEL CORPORATION By: /s/ Dominick Colangelo Name: Dominick Colangelo Title: President & CEO\"}}, {\"id\": \"32\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"32 9012190/26 SCHEDULE 1.26 KEY MATERIALS & KEY MATERIALS SUPPLIERS Bromelain special Production - CBC Taiwan [***] [***]\"}}, {\"id\": \"33\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"33 9012190/26 SCHEDULE 2.7 TECHNOLOGY TRANSFER DOCUMENTATION Technology Transfer documents include but are not limited to [***]\"}}, {\"id\": \"34\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"34 9012190/26 SCHEDULE 4.1 CHANGE NOTIFICATION Category of Change Minimum Notification prior to effectiveness of implementation of the change Section 4.2 : Changes in Facility Major - Changes to facility have the potential to have an adverse effect on product quality that requires BLA Prior Approval Supplement. [***] \u2022 Moderate - Changes to facility have a moderate potential to have an adverse effect on product quality that requires Notification to the Regulatory Authority (e.g., CBE, CBE-30) [***] \u2022 Minor - Changes to facility have minimal potential to have an adverse effect on product quality that requires annual or periodic reporting to the FDA. [***] Section 4.3: Discretionary Manufacturing changes \u2022 Major - Changes have the potential to have an adverse effect on product quality that requires BLA Prior Approval Supplement. [***] \u2022 Moderate - Changes have a moderate potential to have an adverse effect on product quality that requires Notification to the Regulatory Authority (e.g., CBE, CBE-30). [***]\"}}, {\"id\": \"35\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"35 9012190/26 Category of Change Minimum Notification prior to effectiveness of implementation of the change \u2022 Minor - Changes have minimal potential to have an adverse effect on product quality that requires annual or periodic reporting to the FDA. [***] \u2022 None - Changes have no potential to have an adverse effect on product quality and has no regulatory impact. \u2022 Example o Clarification of internal SOPs [***]\"}}, {\"id\": \"Section 4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Changes required by a Regulatory Authority [***]\", \"level\": 2, \"text\": \"Section 4.4 Changes required by a Regulatory Authority [***] Example Timeline for Major Change (BLA Prior Approval Supplement Required) Vericel Evaluation: [***] Pre-Submission discussions with FDA and/or BARDA: [***] Testing (presumes rate limitation is stability testing of > 6 months): [***] Submission drafting: [***] FDA Review: [***] Implementation: [***] Example Timeline for Moderate Change (BLA CBE-30 Required) Vericel Evaluation: [***] Testing: [***] Submission drafting: [***] FDA Review: [***] Implementation: [***]\"}}, {\"id\": \"value:> 6 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"> 6 months\"}}, {\"id\": \"36\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"36 9012190/26 SCHEDULE 4.5 FULL-TIME EQUIVALENT FTE Rates for Reimbursement of Preapproved Activities Completed by MediWound per Section 4.5: The FTE rate will be capped per [***]. MediWound personnel will be reimbursed at the designated FTE with an overhead of [***]. Consultants' costs will be reimbursed only if pre-approved by Vericel before any work is conducted. [***]. Subcontractor costs will be reimbursed only if pre-approved by Vericel before any work is conducted. [***]. Total invoices including FTE wages, applicable overhead, consultant costs and subcontractor costs will be subject [***].\"}}, {\"id\": \"37\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"37 9012190/26 EXHIBIT A UNIT PRICES \u25e6 5 gram units of Finished Product at [***] per unit \u25e6 2 gram units of Finished Product at [***] per unit\"}}, {\"id\": \"38\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"9012190/26\", \"level\": 1, \"text\": \"38 9012190/26 EXHIBIT B ADDITIONAL SERVICES ADDITIONAL SERVICE COST Other Additional Services At the FTE Rates set forth on Schedule 4.5 39 9012190/26\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 1, \"text\": \"DISTRIBUTOR AGREEMENT This Agreement is made and entered into this 7th day of April, 2003 (the \\\"Effective Date\\\"), by and between Wireless Links Inc, a Pennsylvania corporation having its principal place of business at 1050 Wall Street, Suite 202, Lyndhurst, New Jersey 07071 (hereinafter called \\\"WLI\\\"), and Jaguar Investments, Inc. and its affiliates, a Nevada corporation, having its principal place of business at 10400 Griffin Rd., Suite 101, Ft. Lauderdale, Florida 33328 (hereinafter called \\\"Power2Ship\\\") with reference to the following facts: Whereas WLI is engaged in the design and development, manufacture, importation, distribution, resale, service and support of mobile data and GPS based information products and services; Whereas Power2Ship is engaged in the business of collecting, processing and disseminating logistics information and providing other transportation-related products and services to shippers and carriers of freight and Whereas Power2Ship desires to become a distributor of certain of WLI's products and services on the terms and conditions hereinafter set forth. NOW, THEREFORE; in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto do hereby agree as follows:\"}, {\"id\": \"1\", \"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT\"}, {\"id\": \"1.1\", \"title\": \"WLI hereby grants to Power2Ship the non-exclusive right and license to distribute certain WLI's products and services (\", \"level\": 2, \"text\": \"1.1. WLI hereby grants to Power2Ship the non-exclusive right and license to distribute certain WLI's products and services (the \\\"Products\\\" or \\\"Units\\\") and software programs (\\\"Licensed Programs\\\") to Power2Ship's customers (which are end users) located in North America. \\\"Products\\\" or \\\"Units\\\" in this Agreement are limited to WLI's G3001 GPSLink mobile terminal as defined in Section 1.2. \\\"Licensed Programs\\\" in this Agreement are limited to WLI's MidLink Middleware software and G3001 programming tools. Further, Power2Ship shall also be authorized to resell other WLI products, services and support programs subject to separate written amendments to be made by the parties to this Agreement. WLI reserves the right to add additional products and to delete obsolete or superseded products at any time during the term of this Agreement upon sixty (60) days prior written notice to Power2Ship.\"}, {\"id\": \"1.2\", \"title\": \"G3001 GPSLink is a fully functional device including GPS receiver with an integrated CDPD or GPRS modem including 4 dry\", \"level\": 2, \"text\": \"1.2. G3001 GPSLink is a fully functional device including GPS receiver with an integrated CDPD or GPRS modem including 4 dry contact alarm inputs and one contact output and a DB9 connector for serial connection to a PDA. When integrated with MidLink middleware the G3001 can integrate to any third party software application subject to specifications published from time to time by WLI and available for download from the WLI web site.\"}, {\"id\": \"1.3\", \"title\": \"The Products and Licensed Programs shall be sold by Power2Ship to its customers pursuant to WLI's standard warranty and\", \"level\": 2, \"text\": \"1.3. The Products and Licensed Programs shall be sold by Power2Ship to its customers pursuant to WLI's standard warranty and software license agreements.\"}, {\"id\": \"1.4\", \"title\": \"Power2Ship may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement t\", \"level\": 2, \"text\": \"1.4. Power2Ship may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement to one or more of its subsidiaries in which it owns at least 50.1% of the actual equity of the subsidiary on a fully diluted basis and as long as Power2Ship remains the guarantor for the payments and terms and conditions of this Agreement (individually, a \\\"Subsidiary\\\"). Each Subsidiary shall thereafter have the rights and obligations of Power2Ship hereunder with respect to all terms and conditions of this agreement as if such Subsidiary had entered into this Agreement directly with WLI.\"}, {\"id\": \"1.5\", \"title\": \"If Power2Ship merges with another company and/or changes its name, this Agreement will survive the merger and/or name c\", \"level\": 2, \"text\": \"1.5. If Power2Ship merges with another company and/or changes its name, this Agreement will survive the merger and/or name change and the new entity will assume all the rights and obligations of Power2Ship pursuant to this Agreement.\"}, {\"id\": \"1.6\", \"title\": \"WLI may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement to any s\", \"level\": 2, \"text\": \"1.6. WLI may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement to any subsidiary in which it owns at least 50.1% of the equity on a fully diluted basis.\"}, {\"id\": \"1.7\", \"title\": \"Power2Ship acknowledges that it has already integrated the G3001 packaged with the MidLink middleware into its applicat\", \"level\": 2, \"text\": \"1.7. Power2Ship acknowledges that it has already integrated the G3001 packaged with the MidLink middleware into its application tested it and found it to meet its requirements.\"}, {\"id\": \"2\", \"title\": \"TERM\", \"level\": 1, \"text\": \"2. TERM\"}, {\"id\": \"2.1\", \"title\": \"Unless otherwise terminated as provided herein, the initial term of this Agreement shall be three (3) years from the Ef\", \"level\": 2, \"text\": \"2.1. Unless otherwise terminated as provided herein, the initial term of this Agreement shall be three (3) years from the Effective Date and shall thereafter be automatically renewed for subsequent one (1) year periods unless either party notifies the other in writing of its election not to renew the Agreement at least one hundred twenty (120) days prior to the expiration of the then-current term. Should this Agreement be terminated by either party for any reason, the obligations of the parties to each other as set forth herein will survive any termination.\"}, {\"id\": \"3\", \"title\": \"PRICES\", \"level\": 1, \"text\": \"3. PRICES\"}, {\"id\": \"3.1\", \"title\": \"Subject to Section 3\", \"level\": 2, \"text\": \"3.1. Subject to Section 3.6 below the price of the Product, excluding the Licensed Programs, is $[*] per Unit. The total price for both of the Licensed Programs together is $[*] per month per Product (\\\"License Fee\\\"). The License Fee shall begin on the date the Product is shipped to a customer and shall be paid by Power2Ship to WLI by the 7th of each month for the prior month (prorated if the Unit was shipped during the prior month) and shall continue for as long as the Product is active on any wireless network. Notwithstanding the foregoing, Power2Ship is obligated to pay the License Fee to WLI for a minimum of 36 months.\"}, {\"id\": \"3.2\", \"title\": \"Once the monthly License Fee for a particular Unit has started, it will continue for a minimum of 36 consecutive months\", \"level\": 2, \"text\": \"3.2. Once the monthly License Fee for a particular Unit has started, it will continue for a minimum of 36 consecutive months with the only exception being that should Power2Ship uninstall a particular Unit from one customer and install it at another customer, Power2Ship is permitted to suspend the monthly License Fee for that particular Unit for a maximum of 2 months during the life of this Agreement. This suspension of the License Fee is permitted only once per a particular Unit during the life of the Agreement (i.e., the suspension can't occur in two non-consecutive months). Units that are suspended for less than thirty consecutive days are not considered suspended.\"}, {\"id\": \"3.3\", \"title\": \"Once Power2Ship has paid WLI the License Fee for a minimum of 36 months for a particular Unit, Power2Ship may discontin\", \"level\": 2, \"text\": \"3.3. Once Power2Ship has paid WLI the License Fee for a minimum of 36 months for a particular Unit, Power2Ship may discontinue paying the month License Fee only if that particular Unit has been deactivated from the wireless network. If a Unit is deactivated after 36 months and subsequently is reactivated, Power2Ship must restart the payment of the License Fee for as long as that particular Unit remains active on the wireless network.\"}, {\"id\": \"3.4\", \"title\": \"The $[*] hardware price per Unit is based on a single order of a minimum of 1000 Units and manufacturing of a minimum 5\", \"level\": 2, \"text\": \"3.4. The $[*] hardware price per Unit is based on a single order of a minimum of 1000 Units and manufacturing of a minimum 500 Units. At the time of placing the order with WLI, Power2Ship must pay the full purchase price of $[*] per Unit. The delivery time is 8-10 weeks starting with the date the payment is received by WLI. -------- ------- RH JS 6/7/2002 Page 1 of 9\"}, {\"id\": \"3.5\", \"title\": \"To shorten the delivery time to 3-4 weeks, Power2Ship has the option to purchase all the key components for $[*] per Un\", \"level\": 2, \"text\": \"3.5. To shorten the delivery time to 3-4 weeks, Power2Ship has the option to purchase all the key components for $[*] per Unit and have them stored at no charge by WLI on behalf of Power2Ship so they can be available for immediate manufacturing when Power2Ship places an order. If this option is exercised, when Power2ship places an order to authorize Units to be manufactured it will pay with the $[*] balance per Unit at the time of such order.\"}, {\"id\": \"3.6\", \"title\": \"Power2ship has the option to order Units in lower quantities at higher Unit prices as follows\", \"level\": 2, \"text\": \"3.6. Power2ship has the option to order Units in lower quantities at higher Unit prices as follows: 100 to 299 Unit at $[*]; 300 to 499 Units at $[*] and; 500 to 999 Units at $[*]. The only exception to this will be the first order of 100 Units at a Unit price of $[*] if the order is placed no later than April 4, 2003.\"}, {\"id\": \"3.7\", \"title\": \"The Unit prices and monthly License Fees of $[*] can't be increased by WLI under the terms of this Agreement\", \"level\": 2, \"text\": \"3.7. The Unit prices and monthly License Fees of $[*] can't be increased by WLI under the terms of this Agreement.\"}, {\"id\": \"3.8\", \"title\": \"Unless otherwise stated in writing by WLI, all prices quoted shall be exclusive of state and local use, sales and prope\", \"level\": 2, \"text\": \"3.8. Unless otherwise stated in writing by WLI, all prices quoted shall be exclusive of state and local use, sales and property taxes. Power2Ship agrees to be responsible for any such taxes incurred as a result of its purchase of Products from WLI, unless Power2Ship shall have presented WLI with an exemption certificate.\"}, {\"id\": \"3.9\", \"title\": \"Power2Ship may purchase dual antennas with a \\\" screw for the Units from WLI at the following unit prices\", \"level\": 2, \"text\": \"3.9. Power2Ship may purchase dual antennas with a \\\" screw for the Units from WLI at the following unit prices: $[*] when purchased in quantities of 100 to 499; $[*] when purchased in quantities of 500 to 999 and; $[*] when purchased in quantities of 1000 or more. Terms of payment for the antennas are [*]% upon placing the order with WLI and the balance when the antennas are ready to be shipped to Power2Ship. A lead time of at least four weeks is required for delivery.\"}, {\"id\": \"3.10\", \"title\": \"Power2Ship will pay WLI 10% of any activation commissions (\\\"Unit Commissions\\\"), if any, it receives as a result of any\", \"level\": 2, \"text\": \"3.10. Power2Ship will pay WLI 10% of any activation commissions (\\\"Unit Commissions\\\"), if any, it receives as a result of any Unit activated on a specific wireless network. The payment will be paid on the 7th of every month for any Unit Commissions received by Power2Ship during the previous month. Power2Ship will provide with the payment a report of the total number of activations during the month and the amount received per activation.\"}, {\"id\": \"3.11\", \"title\": \"All prices are FOB WLI offices in NJ\", \"level\": 2, \"text\": \"3.11. All prices are FOB WLI offices in NJ.\"}, {\"id\": \"4\", \"title\": \"RESERVATION OF TITLE; COPYRIGHT; CONFIDENTIALITY\", \"level\": 1, \"text\": \"4. RESERVATION OF TITLE; COPYRIGHT; CONFIDENTIALITY\"}, {\"id\": \"4.1\", \"title\": \"Licensed Programs are provided solely in executable files\", \"level\": 2, \"text\": \"4.1. Licensed Programs are provided solely in executable files. This Agreement does not provide Power2Ship with title or ownership of the Licensed Programs, but only a limited right to sub-license the Licensed Programs. The Licensed Programs are, and shall remain, the property of WLI and certain third-party licensors who have authorized WLI to incorporate their software into the Licensed Programs.\"}, {\"id\": \"4.2\", \"title\": \"Power2Ship acknowledges that the programs, software information, and user materials included in the Licensed Programs c\", \"level\": 2, \"text\": \"4.2. Power2Ship acknowledges that the programs, software information, and user materials included in the Licensed Programs contain confidential information and trade secrets, which WLI has entrusted to Power2Ship in confidence to use only as expressly permitted by this Agreement. Power2Ship acknowledges that WLI claims and reserves all rights and benefits afforded under federal law in the programs, software information, and user materials included in the Licensed Programs as copyrighted works.\"}, {\"id\": \"4.3\", \"title\": \"The MidLink software is licensed to Power2Ship for the exclusive use with WLI's products\", \"level\": 2, \"text\": \"4.3. The MidLink software is licensed to Power2Ship for the exclusive use with WLI's products. Power2ship commits not to connect to WLI's MidLink software using any other wireless devices and /or terminal (s) and /or GPS devices other than WLI branded products.\"}, {\"id\": \"4.4\", \"title\": \"Power2Ship shall protect the programs, software information, and user materials included in the Licensed Programs as co\", \"level\": 2, \"text\": \"4.4. Power2Ship shall protect the programs, software information, and user materials included in the Licensed Programs as confidential information and trade secrets. Power2Ship shall not, at any time, disclose such confidential information and trade secrets to any other person, firm, organization, or employee that does not (consistent with Power2Ship's right of use hereunder) need to obtain access to the Licensed Programs. Power2Ship shall devote its best efforts to ensure that all Power2Ship's personnel and all other persons afforded access to the Licensed Programs by Power2Ship protect the Licensed Programs as trade secrets and confidential information and refrain from any use or disclosure in any manner not expressly permitted by this Agreement. These restrictions shall not apply to information (1) generally known to the public or obtainable from public sources; (2) readily apparent from the keyboard operation, visual display, or output reports of the Licensed Programs; (3) previously in the possession of Power2Ship or subsequently developed or acquired without reliance on the Licensed Programs; or (4) approved by WLI for release without restriction.\"}, {\"id\": \"4.5\", \"title\": \"Restrictions on Use of Licensed Programs and Products\", \"level\": 2, \"text\": \"4.5. Restrictions on Use of Licensed Programs and Products. The programs, software information and user materials included in the Licensed Programs and Products may not be decomposed, reverse engineered, reprinted, transcribed, extracted or reproduced, in whole or in part, without the prior written consent of WLI. Power2Ship shall not in any way modify or alter the Licensed Programs without the prior written consent of WLI.\"}, {\"id\": \"4.6\", \"title\": \"Survival of Obligations\", \"level\": 2, \"text\": \"4.6. Survival of Obligations. Power2Ship's obligations under Section 4 of this Agreement shall survive the termination of this Agreement.\"}, {\"id\": \"4.7\", \"title\": \"Specific Performance and Injunctive Relief\", \"level\": 2, \"text\": \"4.7. Specific Performance and Injunctive Relief. Power2Ship agrees and acknowledges that, in the event of any breach directly or indirectly by Power2Ship of any provision of this Section 4, monetary damages will not afford WLI an adequate remedy, and irreparable harm may be presumed. Accordingly, WLI shall be entitled to receive injunctive relief from a court of competent jurisdiction for any such breach by Power2Ship.\"}, {\"id\": \"4.8\", \"title\": \"Confidentiality\", \"level\": 2, \"text\": \"4.8. Confidentiality. Power2Ship acknowledges that the Licensed Programs and all copies thereof are proprietary, confidential and a trade secret of WLI and the exclusive title shall remain with WLI. All applicable rights to copyrights, patents, trademarks, trade names, logos and identifying slogans and other intellectual property rights in the products are the exclusive property of WLI and Power2Ship shall not contest such ownership. Power2Ship is committing directly or indirectly not to copy and/or not to reverse engineer any of WLI's software and/or hardware products. Power2Ship shall be responsible for any breach of this Section by its employees, agents, subcontractors or consultants. WLI acknowledges that the conceptual functionality of its Unit is in the public domain and this paragraph does not cover the Unit's actual functionality. But this Section 4.8 shall apply to the proprietary WLI implementation and technology.\"}, {\"id\": \"5\", \"title\": \"ORDER PROCEDURE AND MANDATORY REPORTS BY POWER2SHIP\", \"level\": 1, \"text\": \"5. ORDER PROCEDURE AND MANDATORY REPORTS BY POWER2SHIP\"}, {\"id\": \"5.1\", \"title\": \"Power2Ship shall place individual written purchase orders for Products from time to time during the term of this Agreem\", \"level\": 2, \"text\": \"5.1. Power2Ship shall place individual written purchase orders for Products from time to time during the term of this Agreement. Each purchase order placed by Power2Ship shall contain the following minimum information: (i) identification of each Product ordered by model number, quantity and price; (ii) shipping instructions and destinations; and (iii) requested delivery date for each Product. Power2Ship will pay for shipping cost from WLI offices in NJ to any destination. -------- ------- RH JS Page 2\"}, {\"id\": \"5.2\", \"title\": \"Any Units shipped by WLI directly to a customer of Power2ship as per Power2Ship's instruction is considered activated a\", \"level\": 2, \"text\": \"5.2. Any Units shipped by WLI directly to a customer of Power2ship as per Power2Ship's instruction is considered activated at the date of the shipment and the $[*] monthly License Fee will start as of that date .\"}, {\"id\": \"5.3\", \"title\": \"Once an order is placed by Power2Ship, such order can't be cancelled and delivery dates for Units can't be rescheduled\", \"level\": 2, \"text\": \"5.3. Once an order is placed by Power2Ship, such order can't be cancelled and delivery dates for Units can't be rescheduled.\"}, {\"id\": \"5.4\", \"title\": \"When Products are ordered for the GPRS network, Power2Ship must provide one SIM card for every Unit ordered within a ma\", \"level\": 2, \"text\": \"5.4. When Products are ordered for the GPRS network, Power2Ship must provide one SIM card for every Unit ordered within a maximum of two weeks from the date of order. The Sim Cards have to be placed and tested in the Unit as they are being manufactured at the factory. Failure to provide the SIM cards in time will require re-opening and re-test of the Units in the US at a cost of $[*] per Unit to be paid by Power2Ship.\"}, {\"id\": \"5.5\", \"title\": \"Every Unit has a serial number\", \"level\": 2, \"text\": \"5.5. Every Unit has a serial number. Power2Ship must provide WLI with a weekly report listing the serial number of every Unit shipped to a customer during the prior week.\"}, {\"id\": \"5.6\", \"title\": \"Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units suspended during the\", \"level\": 2, \"text\": \"5.6. Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units suspended during the prior week and that includes the SIM # and ID, date of return, name of returning customer and reason for return.\"}, {\"id\": \"5.7\", \"title\": \"Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units reactivated (i\", \"level\": 2, \"text\": \"5.7. Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units reactivated (i.e., after having previously been suspended) during the prior week.\"}, {\"id\": \"5.8\", \"title\": \"The weekly reports in Section 5\", \"level\": 2, \"text\": \"5.8. The weekly reports in Section 5.5, 5.6 and 5.7 must be sent to WLI every Monday. The weekly reports are to be sent in Excel file format via e-mail. The report must be sent even if there is no activity during the prior week.\"}, {\"id\": \"5.9\", \"title\": \"Power2Ship must provide WLI with a complete copy of its monthly airtime bill for the Units as received by the respectiv\", \"level\": 2, \"text\": \"5.9. Power2Ship must provide WLI with a complete copy of its monthly airtime bill for the Units as received by the respective wireless operators (T-Mobile, Verizon, AT&T, etc.). Power2Ship is required to keep all the WLI Unit activations on every wireless network on a separate account from any other vendor's brand used by Power2Ship. Every such monthly invoice (one per operator) must be submitted to WLI within 7 days from the date it is received by Power2Ship and the invoice must include all pages listed on the invoice (example 7of 7 pages). Power2Ship's Chief Executive Officer or Chief Financial Officer must confirm in writing to WLI every quarter that the account numbers under which the WLI Units are being activated on the various networks are the only accounts under which the WLI units are activated.\"}, {\"id\": \"6\", \"title\": \"DELIVERY, TITLE AND RISK OF LOSS\", \"level\": 1, \"text\": \"6. DELIVERY, TITLE AND RISK OF LOSS\"}, {\"id\": \"6.1\", \"title\": \"Delivery shall be F\", \"level\": 2, \"text\": \"6.1. Delivery shall be F.O.B. WLI's facility in Lyndhurst, New Jersey. WLI shall use its reasonable efforts to deliver Products to Power2Ship on the date of delivery specified by Power2Ship. WLI will use its reasonable efforts to notify Power2Ship of any delays in scheduled delivery dates.\"}, {\"id\": \"6.2\", \"title\": \"Title to the Products and the risk of loss or damage shall pass to Power2Ship upon delivery of the Products to Power2Sh\", \"level\": 2, \"text\": \"6.2. Title to the Products and the risk of loss or damage shall pass to Power2Ship upon delivery of the Products to Power2Ship or its shipping company of choice. In the event of any loss of or damage to the Products following delivery to the carrier, WLI shall, upon request, cooperate with Power2Ship in connection with the proof of loss claim presented by Power2Ship to the carrier and/or insurer.\"}, {\"id\": \"6.3\", \"title\": \"Power2Ship shall bear the entire risk of loss or damage to the Units and any other equipment purchased from WLI (collec\", \"level\": 2, \"text\": \"6.3. Power2Ship shall bear the entire risk of loss or damage to the Units and any other equipment purchased from WLI (collectively the \\\"Equipment\\\") after installation of the Equipment in the customers' vehicles. The occurrence of any such loss or damage shall not permit Power2Ship to delay or reduce the payment of any fees prescribed under this agreement unless Power2Ship presents WLI with proof of a claim to an insurance company and, in such case, Power2Ship should replace the lost or damaged Equipment within a maximum of 60 days and resume the payment of monthly License Fees to WLI. Power2Ship is advised to obtain and maintain property and casualty insurance for the Equipment against all risks of loss or damage. The amount of such insurance shall not be less than the replacement cost of the Equipment.\"}, {\"id\": \"6.4\", \"title\": \"Power2Ship is responsible for maintaining and storing in a safe and secure location backup copies of all data files Pow\", \"level\": 2, \"text\": \"6.4. Power2Ship is responsible for maintaining and storing in a safe and secure location backup copies of all data files Power2Ship may place in the System. In no event shall WLI be liable for loss or destruction of Power2Ship's data files for any reason.\"}, {\"id\": \"7\", \"title\": \"PAYMENT\", \"level\": 1, \"text\": \"7. PAYMENT\"}, {\"id\": \"7.1\", \"title\": \"Power2Ship must pay WLI for the Products in full on the day it submits a PO (i\", \"level\": 2, \"text\": \"7.1. Power2Ship must pay WLI for the Products in full on the day it submits a PO (i.e., the PO is not valid unless accompanied by payment in full).\"}, {\"id\": \"7.2\", \"title\": \"The payment of the optional antenna is 50% with the purchase order and 50% when the antennas are ready to be shipped to\", \"level\": 2, \"text\": \"7.2. The payment of the optional antenna is 50% with the purchase order and 50% when the antennas are ready to be shipped to Power2Ship.\"}, {\"id\": \"7.3\", \"title\": \"Monthly License Fees must be paid no later then the 7th of the month for all Units active during the previous month\", \"level\": 2, \"text\": \"7.3. Monthly License Fees must be paid no later then the 7th of the month for all Units active during the previous month. For example, on the 7th of July Power2Ship will pay for Units that were active in June.\"}, {\"id\": \"7.4\", \"title\": \"The purchase price for the Unit does not include repair beyond the first year limited warranty\", \"level\": 2, \"text\": \"7.4. The purchase price for the Unit does not include repair beyond the first year limited warranty. The renewal of the limited warranty after the first year is at the option of the customer, but in any case, Unit failure does not relieve Power2Ship of its obligation to pay the monthly License Fees to WLI for that Unit. The first year limited warranty starts on the day of the activation of the Unit on a wireless network. As a distributor, Power2Ship should keep a minimum number of Units in stock for immediate replacement for its customers.\"}, {\"id\": \"7.5\", \"title\": \"This Agreement is separate and apart from the contract between Power2Ship and its customer\", \"level\": 2, \"text\": \"7.5. This Agreement is separate and apart from the contract between Power2Ship and its customer. Failure of the customer to pay Power2Ship, for whatever reason, does not affect the obligation of Power2Ship to pay its contractual obligations to WLI.\"}, {\"id\": \"7.6\", \"title\": \"If an invoice is past due by more than 30 days, WLI may discontinue providing technical support to Power2Ship until the\", \"level\": 2, \"text\": \"7.6. If an invoice is past due by more than 30 days, WLI may discontinue providing technical support to Power2Ship until the invoice is paid. If Power2Ship does not make payment of any amount due and payable hereunder within 60 days of the date of invoice, WLI (without prejudice to any other remedy) shall be entitled to interest on all past due amounts at the lower of eighteen percent (18%) per annum or the highest rate permitted by law, plus reimbursement of all costs incurred in collecting such amounts, including court costs and reasonable attorney fees.\"}, {\"id\": \"8\", \"title\": \"LICENSED SOFTWARE ACCESS AND AUDIT\", \"level\": 1, \"text\": \"8. LICENSED SOFTWARE ACCESS AND AUDIT\"}, {\"id\": \"8.1\", \"title\": \"Should a dispute occur concerning the number of Units that Power2Ship has activated with its customer, WLI may designat\", \"level\": 2, \"text\": \"8.1. Should a dispute occur concerning the number of Units that Power2Ship has activated with its customer, WLI may designate an independent certified public accountant who may audit Power2Ship's books and records concerning sales of Units and of Licensed Software under this Agreement. Said examination shall be at WLI's sole cost and expense during normal business hours and upon reasonable notice, and may not be conducted more than once annually; provided, however, -------- ------- that if such audit reveals an underpayment by Power2Ship of more than 10% for the period audited, Power2Ship shall pay WLI's actual costs and expenses for performing such audit.\"}, {\"id\": \"8.2\", \"title\": \"WLI, at its own discretion, may visit Power2Ship's warehouse at normal business hours to verify the actual number of Un\", \"level\": 2, \"text\": \"8.2. WLI, at its own discretion, may visit Power2Ship's warehouse at normal business hours to verify the actual number of Units in inventory and/or the number of Units suspended. -------- ------- RH JS Page 3\"}, {\"id\": \"8.3\", \"title\": \"Power2Ship commits to allow WLI free access to its MidLink software via the Internet for ongoing maintenance and update\", \"level\": 2, \"text\": \"8.3. Power2Ship commits to allow WLI free access to its MidLink software via the Internet for ongoing maintenance and updates.\"}, {\"id\": \"9\", \"title\": \"PRODUCT INFORMATION OBLIGATIONS\", \"level\": 1, \"text\": \"9. PRODUCT INFORMATION OBLIGATIONS\"}, {\"id\": \"9.1\", \"title\": \"Product Descriptions and Technical Support Requirements\", \"level\": 2, \"text\": \"9.1. Product Descriptions and Technical Support Requirements. WLI shall provide Power2Ship with integration documentation and programming information for its Unit.\"}, {\"id\": \"9.2\", \"title\": \"Warranty Return Procedure\", \"level\": 2, \"text\": \"9.2. Warranty Return Procedure. WLI's warranty return procedure is set forth in Exhibit A.\"}, {\"id\": \"10\", \"title\": \"TECHNICAL INFORMATION AND SERVICES\", \"level\": 1, \"text\": \"10. TECHNICAL INFORMATION AND SERVICES\"}, {\"id\": \"10.1\", \"title\": \"WLI shall provide, at no cost to Power2Ship, reasonable training, including but not limited to, training of Power2Ship'\", \"level\": 2, \"text\": \"10.1. WLI shall provide, at no cost to Power2Ship, reasonable training, including but not limited to, training of Power2Ship's sales and technical personnel, to enable Power2Ship to meets its obligations under this Agreement, including its obligation to provide service or support to end-users following termination of this Agreement.\"}, {\"id\": \"10.2\", \"title\": \"Power2Ship is committed to provide technical support and service for WLI's Products sold by Power2Ship to its customers\", \"level\": 2, \"text\": \"10.2. Power2Ship is committed to provide technical support and service for WLI's Products sold by Power2Ship to its customers.\"}, {\"id\": \"10.3\", \"title\": \"Power2Ship will receive the first customer call and will have to maintain a minimum inventory level of spare Units to s\", \"level\": 2, \"text\": \"10.3. Power2Ship will receive the first customer call and will have to maintain a minimum inventory level of spare Units to service its customers within 48 hours. WLI will support an end-user only upon Power2Ship's request and only after Power2Ship has tried to provide the support and has failed to fix the problem. WLI will not be involved in any end-user training.\"}, {\"id\": \"10.4\", \"title\": \"Power2Ship will maintain a minimum level of inventory of the Product for service purposes, which the parties estimate t\", \"level\": 2, \"text\": \"10.4. Power2Ship will maintain a minimum level of inventory of the Product for service purposes, which the parties estimate to be 1% of the aggregate number of Units active on any wireless network at any given time.\"}, {\"id\": \"11\", \"title\": \"WARRANTY AND INDEMNIFICATION\", \"level\": 1, \"text\": \"11. WARRANTY AND INDEMNIFICATION\"}, {\"id\": \"11.1\", \"title\": \"WLI warrants the Products pursuant to the terms of its hardware limited warranty and limited software warranty set fort\", \"level\": 2, \"text\": \"11.1. WLI warrants the Products pursuant to the terms of its hardware limited warranty and limited software warranty set forth in Exhibit B hereto. Subject to the terms and conditions of Exhibit A, WLI agrees, in its sole discretion, to repair or replace at its sole cost and expense, any defective Products or parts thereof which are returned to it within the applicable warranty period, provided that the Products have not been altered or repaired other than with authorization from WLI and by its approved procedures; that the Products have not been subjected to misuse, improper maintenance, negligence or accident; that the Products have not been damaged by excessive physical or electrical stress; and that the Products have not had their serial number or any part thereof altered, defaced or removed.\"}, {\"id\": \"11.2\", \"title\": \"The warranty and remedies set forth in Exhibit B are exclusive and in lieu of any other warranties or remedies, express\", \"level\": 2, \"text\": \"11.2. The warranty and remedies set forth in Exhibit B are exclusive and in lieu of any other warranties or remedies, express or implied, including the implied warranties of merchantability and fitness for intended or particular purpose. The liability of WLI to Power2Ship for any claim whatsoever related to the Products or the Licensed Programs or this Agreement, including any cause of action in contract, tort, or strict liability, shall not exceed the total amount payable under this Agreement by Power2Ship to WLI within the most recent six-month period for the Licensed Programs (if such claim relates to the Licensed Programs), or for the WLI Products (if such claim relates to the WLI Products). Under no circumstances shall WLI be liable to Power2Ship or to any other person or entity for any incidental, special or consequential damages whether arising out of breach of warranty, breach of contract or otherwise even if WLI has been advised of the possibility of such claims or demands.\"}, {\"id\": \"11.3\", \"title\": \"To the extent not otherwise provided herein, WLI agrees to defend, indemnify and hold harmless Power2Ship from and agai\", \"level\": 2, \"text\": \"11.3. To the extent not otherwise provided herein, WLI agrees to defend, indemnify and hold harmless Power2Ship from and against (a) any claim by a third party that a Product supplied hereunder did not conform to WLI's warranty when received by Power2Ship or that WLI failed on request to provide warranty service in accordance with WLI's applicable warranty statement or (b) any claim arising under Section 14 of this Agreement. Power2Ship shall be reimbursed for any actual loss, liability or damage suffered or incurred by Power2Ship and for all reasonable costs and expenses (including reasonable attorneys' fees) incurred by Power2Ship in connection with any action, suit, proceeding, demand, assessment or judgment incident to any of the matters indemnified against in this provision provided that Power2Ship immediately notifies WLI as to the institution of such suit, gives or obtains for WLI such authority as may be necessary for WLI to defend same, and supplies WLI such further information and assistance for the defense thereof as WLI may reasonably require and request. WLI shall have no obligation under this section, and shall have no liability to Power2Ship, if such claim arises due to the alteration or modification of any Product without the prior written consent of WLI.\"}, {\"id\": \"11.4\", \"title\": \"Power2Ship shall defend, indemnify and hold harmless WLI from all liability and claims whatsoever for any injury to per\", \"level\": 2, \"text\": \"11.4. Power2Ship shall defend, indemnify and hold harmless WLI from all liability and claims whatsoever for any injury to persons or property or for any loss, expense, or damage incurred by any of Power2Ship's personnel or invitees or by any other person or party (except agents or employees of WLI) arising as a result of or in connection with Power2Ship's acquisition or use of the Products and Licensed Programs or WLI 's performance of its obligations or exercise of its rights hereunder except for those claims which are the result of the willful acts or gross negligence of WLI.\"}, {\"id\": \"12\", \"title\": \"INTELLECTUAL PROPERTY RIGHTS INDEMNIFICATION\", \"level\": 1, \"text\": \"12. INTELLECTUAL PROPERTY RIGHTS INDEMNIFICATION\"}, {\"id\": \"12.1\", \"title\": \"WLI represents and warrants that\", \"level\": 2, \"text\": \"12.1. WLI represents and warrants that: (i) it owns all right, title and interest in and to the Products necessary to enter into and perform its obligations to Power2Ship hereunder, and (ii) no Product or Licensed Programs sold to Power2Ship during the term of this Agreement, nor the use of any such Product or Licensed Program, nor anything in or contemplated by this Agreement, infringes upon the Intellectual Rights (as defined herein) of any other person or entity, and no suit or proceeding is pending or threatened alleging that any Product or Licensed program, or the use thereof, infringes upon any Intellectual Rights. As used herein, the term \\\"Intellectual Right\\\" means any rights relating to any trademark, trade name, service mark, copyright, patent, trade secret or other proprietary right.\"}, {\"id\": \"13\", \"title\": \"USE OF TRADEMARKS\", \"level\": 1, \"text\": \"13. USE OF TRADEMARKS\"}, {\"id\": \"13.1\", \"title\": \"Power2Ship shall not acquire any right to or interest in any trademark or trade name owned or used by WLI\", \"level\": 2, \"text\": \"13.1. Power2Ship shall not acquire any right to or interest in any trademark or trade name owned or used by WLI. Power2Ship may use for purposes of this Agreement such trademarks and trade names as appear on the Products and on promotional materials therefore when received by Power2Ship from WLI.\"}, {\"id\": \"13.2\", \"title\": \"Power2Ship acknowledges that WLI and its affiliates are the owners and/or licensees of the trademarks, service marks, c\", \"level\": 2, \"text\": \"13.2. Power2Ship acknowledges that WLI and its affiliates are the owners and/or licensees of the trademarks, service marks, commercial symbols and trade names used by WLI. Power2Ship shall not contest the right of WLI and its affiliates to the use of any trademarks, service marks, commercial symbols or trade names used or claimed by WLI.\"}, {\"id\": \"13.3\", \"title\": \"All WLI's use of Power2Ship's company name, logos, trademarks or other registered identifiers must meet Power2Ship's co\", \"level\": 2, \"text\": \"13.3. All WLI's use of Power2Ship's company name, logos, trademarks or other registered identifiers must meet Power2Ship's corporate communications standards and must have Power2Ship's written approval prior to such use by WLI. All Power2Ship's use of WLI's company name, logos, trademarks or other registered identifiers must meet WLI's corporate communications standards and must have WLI's written approval prior to such use by WLI. -------- ------- RH JS Page 4\"}, {\"id\": \"13.4\", \"title\": \"Power2Ship shall have the right to place its trademarks on the Products but shall not obscure any WLI trademarks\", \"level\": 2, \"text\": \"13.4. Power2Ship shall have the right to place its trademarks on the Products but shall not obscure any WLI trademarks.\"}, {\"id\": \"14\", \"title\": \"TERMINATION\", \"level\": 1, \"text\": \"14. TERMINATION\"}, {\"id\": \"14.1\", \"title\": \"Termination for Cause by WLI WLI may, upon written notice, terminate this Agreement at any time in the event that (a) P\", \"level\": 2, \"text\": \"14.1. Termination for Cause by WLI WLI may, upon written notice, terminate this Agreement at any time in the event that (a) Power2Ship defaults or otherwise fails to perform any obligation, warranty, duty, responsibility or other term or condition of this Agreement, including failure to make a payment when due and such default or failure continues unremedied for a period fifteen (15) days after such notice; (b) Power2Ship ceases permanently to carry on its present business, except as a result of a bona fide reorganization in the course of which the Agreement is transferred to a successor company of equal or greater financial resources carrying on substantially the same business; (c) Power2Ship makes an assignment for the benefit of creditors; or admits in writing its inability to pay debts as they mature; or a trustee or receiver of Power2Ship, or of any substantial part of Power2Ship's assets, is appointed by any court; or a proceeding is instituted by or against Power2Ship under any provision of the United States Bankruptcy Code or any other law affecting the rights of creditors and such proceeding is acquiesced in or is not dismissed within sixty (60) days; or (d) WLI's continued performance under this Agreement would cause it to be in violation of (i) any order of any court or regulatory agency having jurisdiction over WLI, or (ii) any law, statute, ordinance or regulation to which WLI is subject.\"}, {\"id\": \"14.2\", \"title\": \"Termination for Cause by Power2Ship\", \"level\": 2, \"text\": \"14.2. Termination for Cause by Power2Ship. Power2Ship may, upon written notice, terminate this Agreement at any time in the event that (a) WLI defaults or otherwise fails to perform any obligation, warranty, duty, responsibility or other term or condition of this Agreement, including failure to pay a refund when due and such default or failure continues unremedied for a period fifteen (15) days after such notice; (b) WLI ceases permanently to carry on its present business, except as a result of a bona fide reorganization in the course of which the Agreement is transferred to a successor company of equal or greater financial resources carrying on substantially the same business; (c) WLI makes an assignment for the benefit of creditors; or admits in writing its inability to pay debts as they mature; or a trustee or receiver of WLI, or of any substantial part of WLI's assets, is appointed by any court; or a proceeding is instituted by or against WLI under any provision of the United States Bankruptcy Code or any other law affecting the rights of creditors and such proceeding is acquiesced in or is not dismissed within sixty (60) days; or (d) Power2Ship's continued performance under this Agreement would cause it to be in violation of (i) any order of any court or regulatory agency having jurisdiction over Power2Ship, or (ii) any law, statute, ordinance or regulation to which Power2Ship is subject.\"}, {\"id\": \"14.3\", \"title\": \"Termination of this Agreement shall not release either party from the obligation to pay any sums to the other party whe\", \"level\": 2, \"text\": \"14.3. Termination of this Agreement shall not release either party from the obligation to pay any sums to the other party whether then or thereafter due or operate to discharge any liability which has been incurred prior to the effective date of such termination.\"}, {\"id\": \"14.4\", \"title\": \"Upon expiration of this Agreement or termination by either party, Power2Ship may sell off any remaining inventory of th\", \"level\": 2, \"text\": \"14.4. Upon expiration of this Agreement or termination by either party, Power2Ship may sell off any remaining inventory of the Products or Licensed Software acquired prior to termination.\"}, {\"id\": \"14.5\", \"title\": \"Neither party shall be liable to the other party for any special, incidental, or consequential damages arising in conne\", \"level\": 2, \"text\": \"14.5. Neither party shall be liable to the other party for any special, incidental, or consequential damages arising in connection with, or out of termination of, this agreement.\"}, {\"id\": \"15\", \"title\": \"NOTICES\", \"level\": 1, \"text\": \"15. NOTICES Any notice or communication given pursuant to this Agreement shall be in writing, delivered in person or may be telegraphed, telexed, sent by facsimile transmission or United States certified, registered or express mail, Federal Express or other private courier, postage prepaid, return receipt requested in the event of delivery by mail. In the event notice shall be given by facsimile transmission an original of such notice shall simultaneously be deposited in United States mail, postage prepaid, or sent by Federal Express or other private courier, addressed as hereinafter required. Notices shall be given to the parties addressed as set forth in the first paragraph of the Agreement or at such other address as the parties may from time to time designate by notice hereunder. Notices shall be given when delivered personally, or when telegraphed, telexed or sent by facsimile transmission if sent during regular business hours of the recipient and if not, on the next following business day or if mailed, at midnight on the third business day after the date of mailing or if sent by Federal Express or by other private courier on the next following business day. If to WLI: Wireless Links, Inc. Attention: Joe Shayovitch 1050 Wall Street Suite 320 Lyndhurst, New Jersey 07071 Facsimile No. 201-531-9795 If to Power2Ship: Freight Rate, Inc. Attention: Richard Hersh 10400 Griffin Rd., Suite 101 Ft. Lauderdale, FL 33328\"}, {\"id\": \"16\", \"title\": \"GENERAL\", \"level\": 1, \"text\": \"16. GENERAL\"}, {\"id\": \"16.1\", \"title\": \"This Agreement, its interpretation and construction, and the remedies for its enforcement or breach are to be applied i\", \"level\": 2, \"text\": \"16.1. This Agreement, its interpretation and construction, and the remedies for its enforcement or breach are to be applied in accordance with the laws of the State of New Jersey.\"}, {\"id\": \"16.2\", \"title\": \"Failure on any occasion by WLI or Power2Ship to enforce any term or condition of this Agreement shall not prevent or ba\", \"level\": 2, \"text\": \"16.2. Failure on any occasion by WLI or Power2Ship to enforce any term or condition of this Agreement shall not prevent or bar enforcement on any other occasion.\"}, {\"id\": \"16.3\", \"title\": \"Neither party shall be deemed to be in default of any provision hereof or be liable for any delay, failure in performan\", \"level\": 2, \"text\": \"16.3. Neither party shall be deemed to be in default of any provision hereof or be liable for any delay, failure in performance or interruption of service resulting directly or indirectly from act of war, act of God, act of civil or military authority, civil disturbance or any other cause beyond its reasonable control.\"}, {\"id\": \"16.4\", \"title\": \"The relationship between WLI and Power2Ship is that of independent contractors\", \"level\": 2, \"text\": \"16.4. The relationship between WLI and Power2Ship is that of independent contractors. Neither party, nor its agents or its employees shall be deemed to be the agent of the other party. Neither party shall have the right to bind the other party, transact any business in the other party's name or in its behalf or incur any liability for or on behalf of the other party.\"}, {\"id\": \"16.5\", \"title\": \"Neither WLI nor Power2Ship shall intentionally disclose, and each party shall use reasonable efforts to prohibit, the u\", \"level\": 2, \"text\": \"16.5. Neither WLI nor Power2Ship shall intentionally disclose, and each party shall use reasonable efforts to prohibit, the unintentional disclosure to any third party of any confidential or proprietary information of the other party during the term of this Agreement and for a period of one (1) year thereafter.\"}, {\"id\": \"16.6\", \"title\": \"The headings to the paragraphs of this Agreement are included merely for convenience of reference and shall not affect\", \"level\": 2, \"text\": \"16.6. The headings to the paragraphs of this Agreement are included merely for convenience of reference and shall not affect the meaning of the language included therein.\"}, {\"id\": \"16.7\", \"title\": \"No provisions of this Agreement may be altered or amended unless such alteration or amendment is in writing and execute\", \"level\": 2, \"text\": \"16.7. No provisions of this Agreement may be altered or amended unless such alteration or amendment is in writing and executed by duly authorized officers of both parties, except where otherwise specifically provided for in this Agreement.\"}, {\"id\": \"16.8\", \"title\": \"The covenants contained in this Agreement which, by their terms, require or contemplate performance by the parties afte\", \"level\": 2, \"text\": \"16.8. The covenants contained in this Agreement which, by their terms, require or contemplate performance by the parties after the expiration or termination of this Agreement shall be enforceable notwithstanding said expiration or termination.\"}, {\"id\": \"16.9\", \"title\": \"This Agreement (including all Exhibits hereto), constitutes the entire Agreement and understanding between the parties\", \"level\": 2, \"text\": \"16.9. This Agreement (including all Exhibits hereto), constitutes the entire Agreement and understanding between the parties relating to the subject matter hereof, supersedes all other agreements, oral or written, heretofore made between the parties with respect to such subject matter, supersedes the standard terms and conditions in Power2Ship's purchase order form and WLI's quotation, invoice or acknowledgment form, and supersedes any other terms or conditions of purchase proposed by Power2Ship or WLI. This Agreement may not be assigned by either party without the prior written consent of the other party. If any provision in this Agreement should be held illegal or unenforceable, no other provision of this Agreement shall be affected. -------- ------- RH JS Page 5 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first written above. Wireless Links, Inc. Jaguar Investments, Inc. By: By: ------------------------- ----------------------------- Its: Its: Chief Executive Officer ------------------------ ---------------------------- -------- ------- RH JS Page 6 EXHIBIT A PRODUCT WARRANTY INFORMATION WARRANTY A) HARDWARE LIMITED WARRANTY - WLI will provide a one year limited warranty for its hardware products as per the terms and conditions described in \\\"Attachment B\\\". The first year warranty starts with the date of shipment and terminates on the anniversary of the first year. B) Extended limited warranty beyond the first year is available at the same terms and conditions described in \\\"Attachment B \\\". The second year Limited warranty price will be determined between the parties based on the total number of units to be under warranty in a particular year. - The Warranty is a limited warranty that does not cover damage caused by improper use, abuse or use for other than intended purposes. The Warranty does not cover LCD screen or batteries. See Attachment B, Limited Warranty for the Acknowledger(TM) and related accessories. - The parties understand and agree that WLI does not warrant any part of the Peripheral equipment that is not sold directly by WLI - Within 14 days from discovery of a defect, the Integrator shall notify WLI in writing of said defect. Said notice of defect shall contain a reasonably detailed description of the defect as determinable by the Integrator. Said notice shall also indicate the serial numbers of all Acknowledgers and the release levels of software in which the defect was discovered.\"}, {\"id\": \"C\", \"title\": \"DEFECTIVE EQUIPMENT RETURN\", \"level\": 1, \"text\": \"C) DEFECTIVE EQUIPMENT RETURN. Defective equipment will be returned promptly to WLI's repair centre at the Power2Ship cost. The integrator will return for repair products under warranty and will pay the shipping cost to WLI and will carry the risk of loss until the package has been delivered to WLI. WLI will pay the shipping cost back via standard \\\"UPS ground\\\" and will carry the risk of loss until the package is delivered to the integrator. For each unit, prior to return Power2Ship must send WLI a description of the problem including the serial number and date of shipping and date of purchase. Every return must have a Return Merchandise Authorisation number (RMA) as issued by WLI. Replacement or repaired units will be returned to the Integrator within 14 working days of receipt of a defective unit at WLI's cost.\"}, {\"id\": \"D\", \"title\": \"LIMITED WARRANTY OF LICENSED PROGRAMS\", \"level\": 1, \"text\": \"D) LIMITED WARRANTY OF LICENSED PROGRAMS. WLI warrants, for the benefit of the Integrator only, that at the time Integrator's license of Licensed Programs commences, WLI has the right and authority to license the Licensed Programs to Integrator, and the Licensed Programs conform in all material respects to any specifications supplied to Integrator in writing by WLI. WLI does not warrant that the Licensed Programs can be used without interruption or that they are error-free. Any implied warranties of the Licensed Software are LIMITED to one year starting from the date it was shipped to the integrator or starting with the date specified as the starting date in the leasing and / or purchase agreement with the Integrator. If the date is different then the shipping date to the integrator the integrator has to provide a copy of the agreement with the Integrator to verify the start of warranty. E) CORRECTIONS AND UPDATES OF LICENSED PROGRAMS. WLI shall maintain the accuracy of the Licensed Programs by making a reasonable attempt to correct any programming or database errors that Integrator brings to WLI attention. In addition, WLI from time to time may furnish Integrator with further releases of the Licensed Programs to provide corrections of significant programming or database errors and updates of database information. WLI obtains the information contained in the database of the Licensed Programs from established outside sources, and WLI makes every effort to keep the information up-to-date, but it cannot guarantee absolute accuracy and timeliness. After the expiration of the initial term of this Agreement, WLI shall provide any correction and update assistance only on mutually acceptable terms at WLI's customary rates then in effect. WLI reserves the right to make modifications and enhancements of the Licensed Programs (other than simple corrections and updates -------- ------- RH JS Page 7\"}, {\"id\": \"EXHIBIT B\", \"title\": \"End User Warranty\", \"level\": 1, \"text\": \"EXHIBIT B End User Warranty LIMITED WARRANTY FOR THE ACKNOWLEDGER(TM) AND RELATED ACCESSORIES ----------------------------------------------------------------- Wireless Links (WLI) warrants to the original end user purchaser (\\\"You\\\") that the Equipment will be free from defects in workmanship and materials (\\\"Limited Warranty\\\") for a period of one (1) year from the date of the purchase of the Equipment (the \\\"Warranty Period\\\"). This limited warranty does not&sbsp;apply to normal wear and tear and does not cover repair or replacement of Equipment damaged by misuse, accident, abuse, neglect, misapplication, alteration of any kind (including upgrades and expansions)' disaster or defects due to repairs or modifications made by anyone other than the Manufacturer or its authorized service representative. In addition, this limited warranty does not apply to physical damage of any nature whatsoever to the surface of the display, to the surface of the signature pad of the Equipment or to any data stored within the Equipment. WLI shall not have any liability whatsoever with respect to any data stored within the Equipment. Before returning any Equipment under this limited warranty, call WLI and request a return merchandise authorization number (RMA - number)' then ship the Equipment in the original packaging or its equivalent to the location designated by WLI accompanied by proof of purchase, a brief written explanation of the defects, the RMA Number and a return shipment address. WLI at its discretion will repair or replace the Equipment in accordance with the terms of this limited warranty and send it back to you. You are responsible for the cost of shipping the Equipment to the location designated by WLI and the risk of loss or damage in transit. WLI will bear the cost of return shipment to you and the risk of loss or damage during such return shipment. REPAIR OR REPLACEMENT BY WLI AS PROVIDED IN THIS LIMITED WARRANTY IS YOUR EXCLUSIVE REMEDY UNDER THIS LIMITED WARRANTY. WLI SHALL NOT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES. WLI DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, OR STATUTORY INCLUDING BUT NOT LIMITED TO, ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR ANY WARRANTY ARISING OUT OF ANY PROPOSAL, SPECIFICATION OR SAMPLE. ANY SOFTWARE PROVIDED WITH THE EQUIPMENT IS PROVIDED UNDER A SEPARATE SOFTWARE LICENSE AGREEMENT. -------- ------- RH JS Page 8 EXHIBIT C-2 END-USER PROGRAM LICENSE AGREEMENT WIRELESS LINKS (WLI) SOFTWARE LICENSE AGREEMENT ---------------------------------------------------- Licensed Programs are provided solely in executable files and consist of the following programs: MidLink (WLI's middleware), MapLink, and all G3001 related programming tools,\"}, {\"id\": \"1\", \"title\": \"RESERVATION OF TITLE\", \"level\": 1, \"text\": \"1. RESERVATION OF TITLE. This Agreement does not provide the Power2Ship (you) with title or ownership of the Licensed Programs, but only a right of limited use of one copy per software package per license. The Licensed Programs are, and shall remain, the property of Wireless Links and certain third-party licensers who have authorized Wireless Links to incorporate their software into the System. Subject to a distribution agreement the Power2Ship (you) can redistribute the licensed products but you can't reproduce the Licensed Programs.\"}, {\"id\": \"2\", \"title\": \"COPYRIGHT PROTECTION\", \"level\": 1, \"text\": \"2. COPYRIGHT PROTECTION. Power2Ship acknowledges that the programs, software information, and user materials included in the Licensed Programs contain confidential information and trade secrets, which WLI(TM) has entrusted to Power2Ship in confidence to use only as expressly permitted by this Agreement. Power2Ship acknowledges that Wireless Links claims and reserves all rights and benefits afforded under federal law in the programs, database information, and user materials included in the Licensed Programs as copyrighted works.\"}, {\"id\": \"3\", \"title\": \"PRESERVATION OF SECRECY AND CONFIDENTIALITY\", \"level\": 1, \"text\": \"3. PRESERVATION OF SECRECY AND CONFIDENTIALITY. Power2Ship shall protect the programs, database information, and user materials include din the Licensed Programs as confidential information and trade secrets. Power2Ship shall not, at any time, disclose such confidential information and trade secrets to any other person, firm, organization, or employee that does not (consistent with Power2Ship's right of use hereunder) need to obtain access to the Licensed Programs. Power2Ship shall devote its best efforts to ensure that all Power2Ship's personnel and all other persons afforded access to the Licensed Programs by Power2Ship protect the Licensed Programs as trade secrets and confidential information and refrain from any use of disclosure in any manner not expressly permitted by this Agreement. These restrictions shall not apply to information (1) generally know to the public of obtainable from public sources; (2) readily apparent from the keyboard operation, visual display, or output reports of the Licensed Program; (3) previously in the possession of Power2Ship or subsequently developed or acquired without reliance on the Licensed programs; or (4) approved by WLI for release without restriction.\"}, {\"id\": \"4\", \"title\": \"RESTRICTIONS ON USE OF LICENSED PROGRAMS\", \"level\": 1, \"text\": \"4. RESTRICTIONS ON USE OF LICENSED PROGRAMS. The programs, software information, and user materials included in the Licensed Programs may not be decompiled, reverse engineered, reprinted, transcribed, extracted, or reproduced, in whole or in part, without the prior written consent of WLI. Power2Ship shall not in any way modify or alter the Licensed Programs without the prior written consent of WLI.\"}, {\"id\": \"5\", \"title\": \"SURVIVALS OF OBLIGATIONS; RETURN OF PROGRAMS\", \"level\": 1, \"text\": \"5. SURVIVALS OF OBLIGATIONS; RETURN OF PROGRAMS. Power2Ship's obligations under this Agreement shall remain in effect for as long as Power2Ship continues to use the Licensed Programs. Power2Ship shall promptly return all materials and documentation relating to the Licensed Programs provided by WLI upon (1) termination of either this Agreement of Power2Ship's license of the Licensed Programs, for any reason, or (2) discontinuance or abandonment of Power2Ship's use or control of the Licensed Programs.\"}, {\"id\": \"6\", \"title\": \"POWER2SHIP'S DATA FILES\", \"level\": 1, \"text\": \"6. POWER2SHIP'S DATA FILES. Power2Ship is responsible for maintaining and storing in a safe and secure location backup copies of all data files Power2Ship may place in the System. In no event shall WLI(TM) be liable for loss or destruction of Power2Ship's data files for any reason.\"}, {\"id\": \"7\", \"title\": \"LIMITED WARRANTY ON LICENSED PROGRAMS\", \"level\": 1, \"text\": \"7. LIMITED WARRANTY ON LICENSED PROGRAMS. WLI(TM) warrants, for the benefit of Power2Ship only, that at the time Power2Ship's license of Licensed Programs commences, WLI(TM) has the right and authority to license the Licensed Programs to Power2Ship, and the Licensed Programs conform in all material respects to any specification supplied to Power2Ship in writing by WLI(TM). WLI(TM) does not warrant that the Licensed Programs can be used without interruption or that they are error-free. Any implied warranties of the Licensed Software are LIMITED to one year starting from the date of purchase or for the period described in the contractual agreement with the Power2Ship. For best and fast service WLI recommends to Power2Ship to install on the server NT computer a modem fax with PC-Anywhere software and a dedicated phone line to allow WLI to dial in for routine maintenance.\"}, {\"id\": \"8\", \"title\": \"CORRECTIONS AND UPDATES OF LICENSED PROGRAMS\", \"level\": 1, \"text\": \"8. CORRECTIONS AND UPDATES OF LICENSED PROGRAMS. WLI shall maintain the accuracy of the Licensed Programs by using its best endeavors to correct any programming or database errors that Power2Ship brings to WLI(TM)'s attention. In addition, during the warranty period and/or duration of this agreement WLI from time to time may furnish Power2Ship with further releases of the Licensed Programs to provide corrections of significant programming or software errors. After the expiration of this agreement, WLI shall provide any correction and update assistance only on mutually acceptable terms at WLI's customary rates then in effect. WLI(TM) reserves the right to make optional modifications and enhancements of the Licensed Programs (other than simple corrections and updates) available only at additional charges. -------- ------- RH JS Page 9\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of VISIUMTECHNOLOGIES,INC_10_20_2004-EX-10.20-DISTRIBUTOR AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTOR AGREEMENT\", \"level\": 1, \"text\": \"DISTRIBUTOR AGREEMENT This Agreement is made and entered into this 7th day of April, 2003 (the \\\"Effective Date\\\"), by and between Wireless Links Inc, a Pennsylvania corporation having its principal place of business at 1050 Wall Street, Suite 202, Lyndhurst, New Jersey 07071 (hereinafter called \\\"WLI\\\"), and Jaguar Investments, Inc. and its affiliates, a Nevada corporation, having its principal place of business at 10400 Griffin Rd., Suite 101, Ft. Lauderdale, Florida 33328 (hereinafter called \\\"Power2Ship\\\") with reference to the following facts: Whereas WLI is engaged in the design and development, manufacture, importation, distribution, resale, service and support of mobile data and GPS based information products and services; Whereas Power2Ship is engaged in the business of collecting, processing and disseminating logistics information and providing other transportation-related products and services to shippers and carriers of freight and Whereas Power2Ship desires to become a distributor of certain of WLI's products and services on the terms and conditions hereinafter set forth. NOW, THEREFORE; in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto do hereby agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT\", \"level\": 1, \"text\": \"1. APPOINTMENT\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WLI hereby grants to Power2Ship the non-exclusive right and license to distribute certain WLI's products and services (\", \"level\": 2, \"text\": \"1.1. WLI hereby grants to Power2Ship the non-exclusive right and license to distribute certain WLI's products and services (the \\\"Products\\\" or \\\"Units\\\") and software programs (\\\"Licensed Programs\\\") to Power2Ship's customers (which are end users) located in North America. \\\"Products\\\" or \\\"Units\\\" in this Agreement are limited to WLI's G3001 GPSLink mobile terminal as defined in Section 1.2. \\\"Licensed Programs\\\" in this Agreement are limited to WLI's MidLink Middleware software and G3001 programming tools. Further, Power2Ship shall also be authorized to resell other WLI products, services and support programs subject to separate written amendments to be made by the parties to this Agreement. WLI reserves the right to add additional products and to delete obsolete or superseded products at any time during the term of this Agreement upon sixty (60) days prior written notice to Power2Ship.\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"G3001 GPSLink is a fully functional device including GPS receiver with an integrated CDPD or GPRS modem including 4 dry\", \"level\": 2, \"text\": \"1.2. G3001 GPSLink is a fully functional device including GPS receiver with an integrated CDPD or GPRS modem including 4 dry contact alarm inputs and one contact output and a DB9 connector for serial connection to a PDA. When integrated with MidLink middleware the G3001 can integrate to any third party software application subject to specifications published from time to time by WLI and available for download from the WLI web site.\"}}, {\"id\": \"1.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Products and Licensed Programs shall be sold by Power2Ship to its customers pursuant to WLI's standard warranty and\", \"level\": 2, \"text\": \"1.3. The Products and Licensed Programs shall be sold by Power2Ship to its customers pursuant to WLI's standard warranty and software license agreements.\"}}, {\"id\": \"1.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement t\", \"level\": 2, \"text\": \"1.4. Power2Ship may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement to one or more of its subsidiaries in which it owns at least 50.1% of the actual equity of the subsidiary on a fully diluted basis and as long as Power2Ship remains the guarantor for the payments and terms and conditions of this Agreement (individually, a \\\"Subsidiary\\\"). Each Subsidiary shall thereafter have the rights and obligations of Power2Ship hereunder with respect to all terms and conditions of this agreement as if such Subsidiary had entered into this Agreement directly with WLI.\"}}, {\"id\": \"1.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If Power2Ship merges with another company and/or changes its name, this Agreement will survive the merger and/or name c\", \"level\": 2, \"text\": \"1.5. If Power2Ship merges with another company and/or changes its name, this Agreement will survive the merger and/or name change and the new entity will assume all the rights and obligations of Power2Ship pursuant to this Agreement.\"}}, {\"id\": \"1.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WLI may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement to any s\", \"level\": 2, \"text\": \"1.6. WLI may, at any time during the term of this Agreement, assign its rights and obligations under this Agreement to any subsidiary in which it owns at least 50.1% of the equity on a fully diluted basis.\"}}, {\"id\": \"1.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship acknowledges that it has already integrated the G3001 packaged with the MidLink middleware into its applicat\", \"level\": 2, \"text\": \"1.7. Power2Ship acknowledges that it has already integrated the G3001 packaged with the MidLink middleware into its application tested it and found it to meet its requirements.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM\", \"level\": 1, \"text\": \"2. TERM\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unless otherwise terminated as provided herein, the initial term of this Agreement shall be three (3) years from the Ef\", \"level\": 2, \"text\": \"2.1. Unless otherwise terminated as provided herein, the initial term of this Agreement shall be three (3) years from the Effective Date and shall thereafter be automatically renewed for subsequent one (1) year periods unless either party notifies the other in writing of its election not to renew the Agreement at least one hundred twenty (120) days prior to the expiration of the then-current term. Should this Agreement be terminated by either party for any reason, the obligations of the parties to each other as set forth herein will survive any termination.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICES\", \"level\": 1, \"text\": \"3. PRICES\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Section 3\", \"level\": 2, \"text\": \"3.1. Subject to Section 3.6 below the price of the Product, excluding the Licensed Programs, is $[*] per Unit. The total price for both of the Licensed Programs together is $[*] per month per Product (\\\"License Fee\\\"). The License Fee shall begin on the date the Product is shipped to a customer and shall be paid by Power2Ship to WLI by the 7th of each month for the prior month (prorated if the Unit was shipped during the prior month) and shall continue for as long as the Product is active on any wireless network. Notwithstanding the foregoing, Power2Ship is obligated to pay the License Fee to WLI for a minimum of 36 months.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Once the monthly License Fee for a particular Unit has started, it will continue for a minimum of 36 consecutive months\", \"level\": 2, \"text\": \"3.2. Once the monthly License Fee for a particular Unit has started, it will continue for a minimum of 36 consecutive months with the only exception being that should Power2Ship uninstall a particular Unit from one customer and install it at another customer, Power2Ship is permitted to suspend the monthly License Fee for that particular Unit for a maximum of 2 months during the life of this Agreement. This suspension of the License Fee is permitted only once per a particular Unit during the life of the Agreement (i.e., the suspension can't occur in two non-consecutive months). Units that are suspended for less than thirty consecutive days are not considered suspended.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Once Power2Ship has paid WLI the License Fee for a minimum of 36 months for a particular Unit, Power2Ship may discontin\", \"level\": 2, \"text\": \"3.3. Once Power2Ship has paid WLI the License Fee for a minimum of 36 months for a particular Unit, Power2Ship may discontinue paying the month License Fee only if that particular Unit has been deactivated from the wireless network. If a Unit is deactivated after 36 months and subsequently is reactivated, Power2Ship must restart the payment of the License Fee for as long as that particular Unit remains active on the wireless network.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The $[*] hardware price per Unit is based on a single order of a minimum of 1000 Units and manufacturing of a minimum 5\", \"level\": 2, \"text\": \"3.4. The $[*] hardware price per Unit is based on a single order of a minimum of 1000 Units and manufacturing of a minimum 500 Units. At the time of placing the order with WLI, Power2Ship must pay the full purchase price of $[*] per Unit. The delivery time is 8-10 weeks starting with the date the payment is received by WLI. -------- ------- RH JS 6/7/2002 Page 1 of 9\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To shorten the delivery time to 3-4 weeks, Power2Ship has the option to purchase all the key components for $[*] per Un\", \"level\": 2, \"text\": \"3.5. To shorten the delivery time to 3-4 weeks, Power2Ship has the option to purchase all the key components for $[*] per Unit and have them stored at no charge by WLI on behalf of Power2Ship so they can be available for immediate manufacturing when Power2Ship places an order. If this option is exercised, when Power2ship places an order to authorize Units to be manufactured it will pay with the $[*] balance per Unit at the time of such order.\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2ship has the option to order Units in lower quantities at higher Unit prices as follows\", \"level\": 2, \"text\": \"3.6. Power2ship has the option to order Units in lower quantities at higher Unit prices as follows: 100 to 299 Unit at $[*]; 300 to 499 Units at $[*] and; 500 to 999 Units at $[*]. The only exception to this will be the first order of 100 Units at a Unit price of $[*] if the order is placed no later than April 4, 2003.\"}}, {\"id\": \"3.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The Unit prices and monthly License Fees of $[*] can't be increased by WLI under the terms of this Agreement\", \"level\": 2, \"text\": \"3.7. The Unit prices and monthly License Fees of $[*] can't be increased by WLI under the terms of this Agreement.\"}}, {\"id\": \"3.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Unless otherwise stated in writing by WLI, all prices quoted shall be exclusive of state and local use, sales and prope\", \"level\": 2, \"text\": \"3.8. Unless otherwise stated in writing by WLI, all prices quoted shall be exclusive of state and local use, sales and property taxes. Power2Ship agrees to be responsible for any such taxes incurred as a result of its purchase of Products from WLI, unless Power2Ship shall have presented WLI with an exemption certificate.\"}}, {\"id\": \"3.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship may purchase dual antennas with a \\\" screw for the Units from WLI at the following unit prices\", \"level\": 2, \"text\": \"3.9. Power2Ship may purchase dual antennas with a \\\" screw for the Units from WLI at the following unit prices: $[*] when purchased in quantities of 100 to 499; $[*] when purchased in quantities of 500 to 999 and; $[*] when purchased in quantities of 1000 or more. Terms of payment for the antennas are [*]% upon placing the order with WLI and the balance when the antennas are ready to be shipped to Power2Ship. A lead time of at least four weeks is required for delivery.\"}}, {\"id\": \"3.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship will pay WLI 10% of any activation commissions (\\\"Unit Commissions\\\"), if any, it receives as a result of any\", \"level\": 2, \"text\": \"3.10. Power2Ship will pay WLI 10% of any activation commissions (\\\"Unit Commissions\\\"), if any, it receives as a result of any Unit activated on a specific wireless network. The payment will be paid on the 7th of every month for any Unit Commissions received by Power2Ship during the previous month. Power2Ship will provide with the payment a report of the total number of activations during the month and the amount received per activation.\"}}, {\"id\": \"3.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All prices are FOB WLI offices in NJ\", \"level\": 2, \"text\": \"3.11. All prices are FOB WLI offices in NJ.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESERVATION OF TITLE; COPYRIGHT; CONFIDENTIALITY\", \"level\": 1, \"text\": \"4. RESERVATION OF TITLE; COPYRIGHT; CONFIDENTIALITY\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Licensed Programs are provided solely in executable files\", \"level\": 2, \"text\": \"4.1. Licensed Programs are provided solely in executable files. This Agreement does not provide Power2Ship with title or ownership of the Licensed Programs, but only a limited right to sub-license the Licensed Programs. The Licensed Programs are, and shall remain, the property of WLI and certain third-party licensors who have authorized WLI to incorporate their software into the Licensed Programs.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship acknowledges that the programs, software information, and user materials included in the Licensed Programs c\", \"level\": 2, \"text\": \"4.2. Power2Ship acknowledges that the programs, software information, and user materials included in the Licensed Programs contain confidential information and trade secrets, which WLI has entrusted to Power2Ship in confidence to use only as expressly permitted by this Agreement. Power2Ship acknowledges that WLI claims and reserves all rights and benefits afforded under federal law in the programs, software information, and user materials included in the Licensed Programs as copyrighted works.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The MidLink software is licensed to Power2Ship for the exclusive use with WLI's products\", \"level\": 2, \"text\": \"4.3. The MidLink software is licensed to Power2Ship for the exclusive use with WLI's products. Power2ship commits not to connect to WLI's MidLink software using any other wireless devices and /or terminal (s) and /or GPS devices other than WLI branded products.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship shall protect the programs, software information, and user materials included in the Licensed Programs as co\", \"level\": 2, \"text\": \"4.4. Power2Ship shall protect the programs, software information, and user materials included in the Licensed Programs as confidential information and trade secrets. Power2Ship shall not, at any time, disclose such confidential information and trade secrets to any other person, firm, organization, or employee that does not (consistent with Power2Ship's right of use hereunder) need to obtain access to the Licensed Programs. Power2Ship shall devote its best efforts to ensure that all Power2Ship's personnel and all other persons afforded access to the Licensed Programs by Power2Ship protect the Licensed Programs as trade secrets and confidential information and refrain from any use or disclosure in any manner not expressly permitted by this Agreement. These restrictions shall not apply to information (1) generally known to the public or obtainable from public sources; (2) readily apparent from the keyboard operation, visual display, or output reports of the Licensed Programs; (3) previously in the possession of Power2Ship or subsequently developed or acquired without reliance on the Licensed Programs; or (4) approved by WLI for release without restriction.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Restrictions on Use of Licensed Programs and Products\", \"level\": 2, \"text\": \"4.5. Restrictions on Use of Licensed Programs and Products. The programs, software information and user materials included in the Licensed Programs and Products may not be decomposed, reverse engineered, reprinted, transcribed, extracted or reproduced, in whole or in part, without the prior written consent of WLI. Power2Ship shall not in any way modify or alter the Licensed Programs without the prior written consent of WLI.\"}}, {\"id\": \"4.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Survival of Obligations\", \"level\": 2, \"text\": \"4.6. Survival of Obligations. Power2Ship's obligations under Section 4 of this Agreement shall survive the termination of this Agreement.\"}}, {\"id\": \"4.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Specific Performance and Injunctive Relief\", \"level\": 2, \"text\": \"4.7. Specific Performance and Injunctive Relief. Power2Ship agrees and acknowledges that, in the event of any breach directly or indirectly by Power2Ship of any provision of this Section 4, monetary damages will not afford WLI an adequate remedy, and irreparable harm may be presumed. Accordingly, WLI shall be entitled to receive injunctive relief from a court of competent jurisdiction for any such breach by Power2Ship.\"}}, {\"id\": \"4.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Confidentiality\", \"level\": 2, \"text\": \"4.8. Confidentiality. Power2Ship acknowledges that the Licensed Programs and all copies thereof are proprietary, confidential and a trade secret of WLI and the exclusive title shall remain with WLI. All applicable rights to copyrights, patents, trademarks, trade names, logos and identifying slogans and other intellectual property rights in the products are the exclusive property of WLI and Power2Ship shall not contest such ownership. Power2Ship is committing directly or indirectly not to copy and/or not to reverse engineer any of WLI's software and/or hardware products. Power2Ship shall be responsible for any breach of this Section by its employees, agents, subcontractors or consultants. WLI acknowledges that the conceptual functionality of its Unit is in the public domain and this paragraph does not cover the Unit's actual functionality. But this Section 4.8 shall apply to the proprietary WLI implementation and technology.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ORDER PROCEDURE AND MANDATORY REPORTS BY POWER2SHIP\", \"level\": 1, \"text\": \"5. ORDER PROCEDURE AND MANDATORY REPORTS BY POWER2SHIP\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship shall place individual written purchase orders for Products from time to time during the term of this Agreem\", \"level\": 2, \"text\": \"5.1. Power2Ship shall place individual written purchase orders for Products from time to time during the term of this Agreement. Each purchase order placed by Power2Ship shall contain the following minimum information: (i) identification of each Product ordered by model number, quantity and price; (ii) shipping instructions and destinations; and (iii) requested delivery date for each Product. Power2Ship will pay for shipping cost from WLI offices in NJ to any destination. -------- ------- RH JS Page 2\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Any Units shipped by WLI directly to a customer of Power2ship as per Power2Ship's instruction is considered activated a\", \"level\": 2, \"text\": \"5.2. Any Units shipped by WLI directly to a customer of Power2ship as per Power2Ship's instruction is considered activated at the date of the shipment and the $[*] monthly License Fee will start as of that date .\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Once an order is placed by Power2Ship, such order can't be cancelled and delivery dates for Units can't be rescheduled\", \"level\": 2, \"text\": \"5.3. Once an order is placed by Power2Ship, such order can't be cancelled and delivery dates for Units can't be rescheduled.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"When Products are ordered for the GPRS network, Power2Ship must provide one SIM card for every Unit ordered within a ma\", \"level\": 2, \"text\": \"5.4. When Products are ordered for the GPRS network, Power2Ship must provide one SIM card for every Unit ordered within a maximum of two weeks from the date of order. The Sim Cards have to be placed and tested in the Unit as they are being manufactured at the factory. Failure to provide the SIM cards in time will require re-opening and re-test of the Units in the US at a cost of $[*] per Unit to be paid by Power2Ship.\"}}, {\"id\": \"5.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Every Unit has a serial number\", \"level\": 2, \"text\": \"5.5. Every Unit has a serial number. Power2Ship must provide WLI with a weekly report listing the serial number of every Unit shipped to a customer during the prior week.\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units suspended during the\", \"level\": 2, \"text\": \"5.6. Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units suspended during the prior week and that includes the SIM # and ID, date of return, name of returning customer and reason for return.\"}}, {\"id\": \"5.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units reactivated (i\", \"level\": 2, \"text\": \"5.7. Power2Ship must provide a separate weekly report to WLI that lists the serial number of any Units reactivated (i.e., after having previously been suspended) during the prior week.\"}}, {\"id\": \"5.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The weekly reports in Section 5\", \"level\": 2, \"text\": \"5.8. The weekly reports in Section 5.5, 5.6 and 5.7 must be sent to WLI every Monday. The weekly reports are to be sent in Excel file format via e-mail. The report must be sent even if there is no activity during the prior week.\"}}, {\"id\": \"5.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship must provide WLI with a complete copy of its monthly airtime bill for the Units as received by the respectiv\", \"level\": 2, \"text\": \"5.9. Power2Ship must provide WLI with a complete copy of its monthly airtime bill for the Units as received by the respective wireless operators (T-Mobile, Verizon, AT&T, etc.). Power2Ship is required to keep all the WLI Unit activations on every wireless network on a separate account from any other vendor's brand used by Power2Ship. Every such monthly invoice (one per operator) must be submitted to WLI within 7 days from the date it is received by Power2Ship and the invoice must include all pages listed on the invoice (example 7of 7 pages). Power2Ship's Chief Executive Officer or Chief Financial Officer must confirm in writing to WLI every quarter that the account numbers under which the WLI Units are being activated on the various networks are the only accounts under which the WLI units are activated.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DELIVERY, TITLE AND RISK OF LOSS\", \"level\": 1, \"text\": \"6. DELIVERY, TITLE AND RISK OF LOSS\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery shall be F\", \"level\": 2, \"text\": \"6.1. Delivery shall be F.O.B. WLI's facility in Lyndhurst, New Jersey. WLI shall use its reasonable efforts to deliver Products to Power2Ship on the date of delivery specified by Power2Ship. WLI will use its reasonable efforts to notify Power2Ship of any delays in scheduled delivery dates.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Title to the Products and the risk of loss or damage shall pass to Power2Ship upon delivery of the Products to Power2Sh\", \"level\": 2, \"text\": \"6.2. Title to the Products and the risk of loss or damage shall pass to Power2Ship upon delivery of the Products to Power2Ship or its shipping company of choice. In the event of any loss of or damage to the Products following delivery to the carrier, WLI shall, upon request, cooperate with Power2Ship in connection with the proof of loss claim presented by Power2Ship to the carrier and/or insurer.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship shall bear the entire risk of loss or damage to the Units and any other equipment purchased from WLI (collec\", \"level\": 2, \"text\": \"6.3. Power2Ship shall bear the entire risk of loss or damage to the Units and any other equipment purchased from WLI (collectively the \\\"Equipment\\\") after installation of the Equipment in the customers' vehicles. The occurrence of any such loss or damage shall not permit Power2Ship to delay or reduce the payment of any fees prescribed under this agreement unless Power2Ship presents WLI with proof of a claim to an insurance company and, in such case, Power2Ship should replace the lost or damaged Equipment within a maximum of 60 days and resume the payment of monthly License Fees to WLI. Power2Ship is advised to obtain and maintain property and casualty insurance for the Equipment against all risks of loss or damage. The amount of such insurance shall not be less than the replacement cost of the Equipment.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship is responsible for maintaining and storing in a safe and secure location backup copies of all data files Pow\", \"level\": 2, \"text\": \"6.4. Power2Ship is responsible for maintaining and storing in a safe and secure location backup copies of all data files Power2Ship may place in the System. In no event shall WLI be liable for loss or destruction of Power2Ship's data files for any reason.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT\", \"level\": 1, \"text\": \"7. PAYMENT\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship must pay WLI for the Products in full on the day it submits a PO (i\", \"level\": 2, \"text\": \"7.1. Power2Ship must pay WLI for the Products in full on the day it submits a PO (i.e., the PO is not valid unless accompanied by payment in full).\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The payment of the optional antenna is 50% with the purchase order and 50% when the antennas are ready to be shipped to\", \"level\": 2, \"text\": \"7.2. The payment of the optional antenna is 50% with the purchase order and 50% when the antennas are ready to be shipped to Power2Ship.\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Monthly License Fees must be paid no later then the 7th of the month for all Units active during the previous month\", \"level\": 2, \"text\": \"7.3. Monthly License Fees must be paid no later then the 7th of the month for all Units active during the previous month. For example, on the 7th of July Power2Ship will pay for Units that were active in June.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The purchase price for the Unit does not include repair beyond the first year limited warranty\", \"level\": 2, \"text\": \"7.4. The purchase price for the Unit does not include repair beyond the first year limited warranty. The renewal of the limited warranty after the first year is at the option of the customer, but in any case, Unit failure does not relieve Power2Ship of its obligation to pay the monthly License Fees to WLI for that Unit. The first year limited warranty starts on the day of the activation of the Unit on a wireless network. As a distributor, Power2Ship should keep a minimum number of Units in stock for immediate replacement for its customers.\"}}, {\"id\": \"7.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement is separate and apart from the contract between Power2Ship and its customer\", \"level\": 2, \"text\": \"7.5. This Agreement is separate and apart from the contract between Power2Ship and its customer. Failure of the customer to pay Power2Ship, for whatever reason, does not affect the obligation of Power2Ship to pay its contractual obligations to WLI.\"}}, {\"id\": \"7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If an invoice is past due by more than 30 days, WLI may discontinue providing technical support to Power2Ship until the\", \"level\": 2, \"text\": \"7.6. If an invoice is past due by more than 30 days, WLI may discontinue providing technical support to Power2Ship until the invoice is paid. If Power2Ship does not make payment of any amount due and payable hereunder within 60 days of the date of invoice, WLI (without prejudice to any other remedy) shall be entitled to interest on all past due amounts at the lower of eighteen percent (18%) per annum or the highest rate permitted by law, plus reimbursement of all costs incurred in collecting such amounts, including court costs and reasonable attorney fees.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSED SOFTWARE ACCESS AND AUDIT\", \"level\": 1, \"text\": \"8. LICENSED SOFTWARE ACCESS AND AUDIT\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Should a dispute occur concerning the number of Units that Power2Ship has activated with its customer, WLI may designat\", \"level\": 2, \"text\": \"8.1. Should a dispute occur concerning the number of Units that Power2Ship has activated with its customer, WLI may designate an independent certified public accountant who may audit Power2Ship's books and records concerning sales of Units and of Licensed Software under this Agreement. Said examination shall be at WLI's sole cost and expense during normal business hours and upon reasonable notice, and may not be conducted more than once annually; provided, however, -------- ------- that if such audit reveals an underpayment by Power2Ship of more than 10% for the period audited, Power2Ship shall pay WLI's actual costs and expenses for performing such audit.\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WLI, at its own discretion, may visit Power2Ship's warehouse at normal business hours to verify the actual number of Un\", \"level\": 2, \"text\": \"8.2. WLI, at its own discretion, may visit Power2Ship's warehouse at normal business hours to verify the actual number of Units in inventory and/or the number of Units suspended. -------- ------- RH JS Page 3\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship commits to allow WLI free access to its MidLink software via the Internet for ongoing maintenance and update\", \"level\": 2, \"text\": \"8.3. Power2Ship commits to allow WLI free access to its MidLink software via the Internet for ongoing maintenance and updates.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT INFORMATION OBLIGATIONS\", \"level\": 1, \"text\": \"9. PRODUCT INFORMATION OBLIGATIONS\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Product Descriptions and Technical Support Requirements\", \"level\": 2, \"text\": \"9.1. Product Descriptions and Technical Support Requirements. WLI shall provide Power2Ship with integration documentation and programming information for its Unit.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Warranty Return Procedure\", \"level\": 2, \"text\": \"9.2. Warranty Return Procedure. WLI's warranty return procedure is set forth in Exhibit A.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TECHNICAL INFORMATION AND SERVICES\", \"level\": 1, \"text\": \"10. TECHNICAL INFORMATION AND SERVICES\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WLI shall provide, at no cost to Power2Ship, reasonable training, including but not limited to, training of Power2Ship'\", \"level\": 2, \"text\": \"10.1. WLI shall provide, at no cost to Power2Ship, reasonable training, including but not limited to, training of Power2Ship's sales and technical personnel, to enable Power2Ship to meets its obligations under this Agreement, including its obligation to provide service or support to end-users following termination of this Agreement.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship is committed to provide technical support and service for WLI's Products sold by Power2Ship to its customers\", \"level\": 2, \"text\": \"10.2. Power2Ship is committed to provide technical support and service for WLI's Products sold by Power2Ship to its customers.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship will receive the first customer call and will have to maintain a minimum inventory level of spare Units to s\", \"level\": 2, \"text\": \"10.3. Power2Ship will receive the first customer call and will have to maintain a minimum inventory level of spare Units to service its customers within 48 hours. WLI will support an end-user only upon Power2Ship's request and only after Power2Ship has tried to provide the support and has failed to fix the problem. WLI will not be involved in any end-user training.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship will maintain a minimum level of inventory of the Product for service purposes, which the parties estimate t\", \"level\": 2, \"text\": \"10.4. Power2Ship will maintain a minimum level of inventory of the Product for service purposes, which the parties estimate to be 1% of the aggregate number of Units active on any wireless network at any given time.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTY AND INDEMNIFICATION\", \"level\": 1, \"text\": \"11. WARRANTY AND INDEMNIFICATION\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WLI warrants the Products pursuant to the terms of its hardware limited warranty and limited software warranty set fort\", \"level\": 2, \"text\": \"11.1. WLI warrants the Products pursuant to the terms of its hardware limited warranty and limited software warranty set forth in Exhibit B hereto. Subject to the terms and conditions of Exhibit A, WLI agrees, in its sole discretion, to repair or replace at its sole cost and expense, any defective Products or parts thereof which are returned to it within the applicable warranty period, provided that the Products have not been altered or repaired other than with authorization from WLI and by its approved procedures; that the Products have not been subjected to misuse, improper maintenance, negligence or accident; that the Products have not been damaged by excessive physical or electrical stress; and that the Products have not had their serial number or any part thereof altered, defaced or removed.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The warranty and remedies set forth in Exhibit B are exclusive and in lieu of any other warranties or remedies, express\", \"level\": 2, \"text\": \"11.2. The warranty and remedies set forth in Exhibit B are exclusive and in lieu of any other warranties or remedies, express or implied, including the implied warranties of merchantability and fitness for intended or particular purpose. The liability of WLI to Power2Ship for any claim whatsoever related to the Products or the Licensed Programs or this Agreement, including any cause of action in contract, tort, or strict liability, shall not exceed the total amount payable under this Agreement by Power2Ship to WLI within the most recent six-month period for the Licensed Programs (if such claim relates to the Licensed Programs), or for the WLI Products (if such claim relates to the WLI Products). Under no circumstances shall WLI be liable to Power2Ship or to any other person or entity for any incidental, special or consequential damages whether arising out of breach of warranty, breach of contract or otherwise even if WLI has been advised of the possibility of such claims or demands.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"To the extent not otherwise provided herein, WLI agrees to defend, indemnify and hold harmless Power2Ship from and agai\", \"level\": 2, \"text\": \"11.3. To the extent not otherwise provided herein, WLI agrees to defend, indemnify and hold harmless Power2Ship from and against (a) any claim by a third party that a Product supplied hereunder did not conform to WLI's warranty when received by Power2Ship or that WLI failed on request to provide warranty service in accordance with WLI's applicable warranty statement or (b) any claim arising under Section 14 of this Agreement. Power2Ship shall be reimbursed for any actual loss, liability or damage suffered or incurred by Power2Ship and for all reasonable costs and expenses (including reasonable attorneys' fees) incurred by Power2Ship in connection with any action, suit, proceeding, demand, assessment or judgment incident to any of the matters indemnified against in this provision provided that Power2Ship immediately notifies WLI as to the institution of such suit, gives or obtains for WLI such authority as may be necessary for WLI to defend same, and supplies WLI such further information and assistance for the defense thereof as WLI may reasonably require and request. WLI shall have no obligation under this section, and shall have no liability to Power2Ship, if such claim arises due to the alteration or modification of any Product without the prior written consent of WLI.\"}}, {\"id\": \"11.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship shall defend, indemnify and hold harmless WLI from all liability and claims whatsoever for any injury to per\", \"level\": 2, \"text\": \"11.4. Power2Ship shall defend, indemnify and hold harmless WLI from all liability and claims whatsoever for any injury to persons or property or for any loss, expense, or damage incurred by any of Power2Ship's personnel or invitees or by any other person or party (except agents or employees of WLI) arising as a result of or in connection with Power2Ship's acquisition or use of the Products and Licensed Programs or WLI 's performance of its obligations or exercise of its rights hereunder except for those claims which are the result of the willful acts or gross negligence of WLI.\"}}, {\"id\": \"12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY RIGHTS INDEMNIFICATION\", \"level\": 1, \"text\": \"12. INTELLECTUAL PROPERTY RIGHTS INDEMNIFICATION\"}}, {\"id\": \"12.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WLI represents and warrants that\", \"level\": 2, \"text\": \"12.1. WLI represents and warrants that: (i) it owns all right, title and interest in and to the Products necessary to enter into and perform its obligations to Power2Ship hereunder, and (ii) no Product or Licensed Programs sold to Power2Ship during the term of this Agreement, nor the use of any such Product or Licensed Program, nor anything in or contemplated by this Agreement, infringes upon the Intellectual Rights (as defined herein) of any other person or entity, and no suit or proceeding is pending or threatened alleging that any Product or Licensed program, or the use thereof, infringes upon any Intellectual Rights. As used herein, the term \\\"Intellectual Right\\\" means any rights relating to any trademark, trade name, service mark, copyright, patent, trade secret or other proprietary right.\"}}, {\"id\": \"13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"USE OF TRADEMARKS\", \"level\": 1, \"text\": \"13. USE OF TRADEMARKS\"}}, {\"id\": \"13.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship shall not acquire any right to or interest in any trademark or trade name owned or used by WLI\", \"level\": 2, \"text\": \"13.1. Power2Ship shall not acquire any right to or interest in any trademark or trade name owned or used by WLI. Power2Ship may use for purposes of this Agreement such trademarks and trade names as appear on the Products and on promotional materials therefore when received by Power2Ship from WLI.\"}}, {\"id\": \"13.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship acknowledges that WLI and its affiliates are the owners and/or licensees of the trademarks, service marks, c\", \"level\": 2, \"text\": \"13.2. Power2Ship acknowledges that WLI and its affiliates are the owners and/or licensees of the trademarks, service marks, commercial symbols and trade names used by WLI. Power2Ship shall not contest the right of WLI and its affiliates to the use of any trademarks, service marks, commercial symbols or trade names used or claimed by WLI.\"}}, {\"id\": \"13.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"All WLI's use of Power2Ship's company name, logos, trademarks or other registered identifiers must meet Power2Ship's co\", \"level\": 2, \"text\": \"13.3. All WLI's use of Power2Ship's company name, logos, trademarks or other registered identifiers must meet Power2Ship's corporate communications standards and must have Power2Ship's written approval prior to such use by WLI. All Power2Ship's use of WLI's company name, logos, trademarks or other registered identifiers must meet WLI's corporate communications standards and must have WLI's written approval prior to such use by WLI. -------- ------- RH JS Page 4\"}}, {\"id\": \"13.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Power2Ship shall have the right to place its trademarks on the Products but shall not obscure any WLI trademarks\", \"level\": 2, \"text\": \"13.4. Power2Ship shall have the right to place its trademarks on the Products but shall not obscure any WLI trademarks.\"}}, {\"id\": \"14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION\", \"level\": 1, \"text\": \"14. TERMINATION\"}}, {\"id\": \"14.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for Cause by WLI WLI may, upon written notice, terminate this Agreement at any time in the event that (a) P\", \"level\": 2, \"text\": \"14.1. Termination for Cause by WLI WLI may, upon written notice, terminate this Agreement at any time in the event that (a) Power2Ship defaults or otherwise fails to perform any obligation, warranty, duty, responsibility or other term or condition of this Agreement, including failure to make a payment when due and such default or failure continues unremedied for a period fifteen (15) days after such notice; (b) Power2Ship ceases permanently to carry on its present business, except as a result of a bona fide reorganization in the course of which the Agreement is transferred to a successor company of equal or greater financial resources carrying on substantially the same business; (c) Power2Ship makes an assignment for the benefit of creditors; or admits in writing its inability to pay debts as they mature; or a trustee or receiver of Power2Ship, or of any substantial part of Power2Ship's assets, is appointed by any court; or a proceeding is instituted by or against Power2Ship under any provision of the United States Bankruptcy Code or any other law affecting the rights of creditors and such proceeding is acquiesced in or is not dismissed within sixty (60) days; or (d) WLI's continued performance under this Agreement would cause it to be in violation of (i) any order of any court or regulatory agency having jurisdiction over WLI, or (ii) any law, statute, ordinance or regulation to which WLI is subject.\"}}, {\"id\": \"14.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for Cause by Power2Ship\", \"level\": 2, \"text\": \"14.2. Termination for Cause by Power2Ship. Power2Ship may, upon written notice, terminate this Agreement at any time in the event that (a) WLI defaults or otherwise fails to perform any obligation, warranty, duty, responsibility or other term or condition of this Agreement, including failure to pay a refund when due and such default or failure continues unremedied for a period fifteen (15) days after such notice; (b) WLI ceases permanently to carry on its present business, except as a result of a bona fide reorganization in the course of which the Agreement is transferred to a successor company of equal or greater financial resources carrying on substantially the same business; (c) WLI makes an assignment for the benefit of creditors; or admits in writing its inability to pay debts as they mature; or a trustee or receiver of WLI, or of any substantial part of WLI's assets, is appointed by any court; or a proceeding is instituted by or against WLI under any provision of the United States Bankruptcy Code or any other law affecting the rights of creditors and such proceeding is acquiesced in or is not dismissed within sixty (60) days; or (d) Power2Ship's continued performance under this Agreement would cause it to be in violation of (i) any order of any court or regulatory agency having jurisdiction over Power2Ship, or (ii) any law, statute, ordinance or regulation to which Power2Ship is subject.\"}}, {\"id\": \"14.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination of this Agreement shall not release either party from the obligation to pay any sums to the other party whe\", \"level\": 2, \"text\": \"14.3. Termination of this Agreement shall not release either party from the obligation to pay any sums to the other party whether then or thereafter due or operate to discharge any liability which has been incurred prior to the effective date of such termination.\"}}, {\"id\": \"14.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Upon expiration of this Agreement or termination by either party, Power2Ship may sell off any remaining inventory of th\", \"level\": 2, \"text\": \"14.4. Upon expiration of this Agreement or termination by either party, Power2Ship may sell off any remaining inventory of the Products or Licensed Software acquired prior to termination.\"}}, {\"id\": \"14.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party shall be liable to the other party for any special, incidental, or consequential damages arising in conne\", \"level\": 2, \"text\": \"14.5. Neither party shall be liable to the other party for any special, incidental, or consequential damages arising in connection with, or out of termination of, this agreement.\"}}, {\"id\": \"15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 1, \"text\": \"15. NOTICES Any notice or communication given pursuant to this Agreement shall be in writing, delivered in person or may be telegraphed, telexed, sent by facsimile transmission or United States certified, registered or express mail, Federal Express or other private courier, postage prepaid, return receipt requested in the event of delivery by mail. In the event notice shall be given by facsimile transmission an original of such notice shall simultaneously be deposited in United States mail, postage prepaid, or sent by Federal Express or other private courier, addressed as hereinafter required. Notices shall be given to the parties addressed as set forth in the first paragraph of the Agreement or at such other address as the parties may from time to time designate by notice hereunder. Notices shall be given when delivered personally, or when telegraphed, telexed or sent by facsimile transmission if sent during regular business hours of the recipient and if not, on the next following business day or if mailed, at midnight on the third business day after the date of mailing or if sent by Federal Express or by other private courier on the next following business day. If to WLI: Wireless Links, Inc. Attention: Joe Shayovitch 1050 Wall Street Suite 320 Lyndhurst, New Jersey 07071 Facsimile No. 201-531-9795 If to Power2Ship: Freight Rate, Inc. Attention: Richard Hersh 10400 Griffin Rd., Suite 101 Ft. Lauderdale, FL 33328\"}}, {\"id\": \"16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 1, \"text\": \"16. GENERAL\"}}, {\"id\": \"16.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement, its interpretation and construction, and the remedies for its enforcement or breach are to be applied i\", \"level\": 2, \"text\": \"16.1. This Agreement, its interpretation and construction, and the remedies for its enforcement or breach are to be applied in accordance with the laws of the State of New Jersey.\"}}, {\"id\": \"16.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Failure on any occasion by WLI or Power2Ship to enforce any term or condition of this Agreement shall not prevent or ba\", \"level\": 2, \"text\": \"16.2. Failure on any occasion by WLI or Power2Ship to enforce any term or condition of this Agreement shall not prevent or bar enforcement on any other occasion.\"}}, {\"id\": \"16.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither party shall be deemed to be in default of any provision hereof or be liable for any delay, failure in performan\", \"level\": 2, \"text\": \"16.3. Neither party shall be deemed to be in default of any provision hereof or be liable for any delay, failure in performance or interruption of service resulting directly or indirectly from act of war, act of God, act of civil or military authority, civil disturbance or any other cause beyond its reasonable control.\"}}, {\"id\": \"16.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The relationship between WLI and Power2Ship is that of independent contractors\", \"level\": 2, \"text\": \"16.4. The relationship between WLI and Power2Ship is that of independent contractors. Neither party, nor its agents or its employees shall be deemed to be the agent of the other party. Neither party shall have the right to bind the other party, transact any business in the other party's name or in its behalf or incur any liability for or on behalf of the other party.\"}}, {\"id\": \"16.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Neither WLI nor Power2Ship shall intentionally disclose, and each party shall use reasonable efforts to prohibit, the u\", \"level\": 2, \"text\": \"16.5. Neither WLI nor Power2Ship shall intentionally disclose, and each party shall use reasonable efforts to prohibit, the unintentional disclosure to any third party of any confidential or proprietary information of the other party during the term of this Agreement and for a period of one (1) year thereafter.\"}}, {\"id\": \"16.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The headings to the paragraphs of this Agreement are included merely for convenience of reference and shall not affect\", \"level\": 2, \"text\": \"16.6. The headings to the paragraphs of this Agreement are included merely for convenience of reference and shall not affect the meaning of the language included therein.\"}}, {\"id\": \"16.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No provisions of this Agreement may be altered or amended unless such alteration or amendment is in writing and execute\", \"level\": 2, \"text\": \"16.7. No provisions of this Agreement may be altered or amended unless such alteration or amendment is in writing and executed by duly authorized officers of both parties, except where otherwise specifically provided for in this Agreement.\"}}, {\"id\": \"16.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The covenants contained in this Agreement which, by their terms, require or contemplate performance by the parties afte\", \"level\": 2, \"text\": \"16.8. The covenants contained in this Agreement which, by their terms, require or contemplate performance by the parties after the expiration or termination of this Agreement shall be enforceable notwithstanding said expiration or termination.\"}}, {\"id\": \"16.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"This Agreement (including all Exhibits hereto), constitutes the entire Agreement and understanding between the parties\", \"level\": 2, \"text\": \"16.9. This Agreement (including all Exhibits hereto), constitutes the entire Agreement and understanding between the parties relating to the subject matter hereof, supersedes all other agreements, oral or written, heretofore made between the parties with respect to such subject matter, supersedes the standard terms and conditions in Power2Ship's purchase order form and WLI's quotation, invoice or acknowledgment form, and supersedes any other terms or conditions of purchase proposed by Power2Ship or WLI. This Agreement may not be assigned by either party without the prior written consent of the other party. If any provision in this Agreement should be held illegal or unenforceable, no other provision of this Agreement shall be affected. -------- ------- RH JS Page 5 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first written above. Wireless Links, Inc. Jaguar Investments, Inc. By: By: ------------------------- ----------------------------- Its: Its: Chief Executive Officer ------------------------ ---------------------------- -------- ------- RH JS Page 6 EXHIBIT A PRODUCT WARRANTY INFORMATION WARRANTY A) HARDWARE LIMITED WARRANTY - WLI will provide a one year limited warranty for its hardware products as per the terms and conditions described in \\\"Attachment B\\\". The first year warranty starts with the date of shipment and terminates on the anniversary of the first year. B) Extended limited warranty beyond the first year is available at the same terms and conditions described in \\\"Attachment B \\\". The second year Limited warranty price will be determined between the parties based on the total number of units to be under warranty in a particular year. - The Warranty is a limited warranty that does not cover damage caused by improper use, abuse or use for other than intended purposes. The Warranty does not cover LCD screen or batteries. See Attachment B, Limited Warranty for the Acknowledger(TM) and related accessories. - The parties understand and agree that WLI does not warrant any part of the Peripheral equipment that is not sold directly by WLI - Within 14 days from discovery of a defect, the Integrator shall notify WLI in writing of said defect. Said notice of defect shall contain a reasonably detailed description of the defect as determinable by the Integrator. Said notice shall also indicate the serial numbers of all Acknowledgers and the release levels of software in which the defect was discovered.\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFECTIVE EQUIPMENT RETURN\", \"level\": 1, \"text\": \"C) DEFECTIVE EQUIPMENT RETURN. Defective equipment will be returned promptly to WLI's repair centre at the Power2Ship cost. The integrator will return for repair products under warranty and will pay the shipping cost to WLI and will carry the risk of loss until the package has been delivered to WLI. WLI will pay the shipping cost back via standard \\\"UPS ground\\\" and will carry the risk of loss until the package is delivered to the integrator. For each unit, prior to return Power2Ship must send WLI a description of the problem including the serial number and date of shipping and date of purchase. Every return must have a Return Merchandise Authorisation number (RMA) as issued by WLI. Replacement or repaired units will be returned to the Integrator within 14 working days of receipt of a defective unit at WLI's cost.\"}}, {\"id\": \"D\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITED WARRANTY OF LICENSED PROGRAMS\", \"level\": 1, \"text\": \"D) LIMITED WARRANTY OF LICENSED PROGRAMS. WLI warrants, for the benefit of the Integrator only, that at the time Integrator's license of Licensed Programs commences, WLI has the right and authority to license the Licensed Programs to Integrator, and the Licensed Programs conform in all material respects to any specifications supplied to Integrator in writing by WLI. WLI does not warrant that the Licensed Programs can be used without interruption or that they are error-free. Any implied warranties of the Licensed Software are LIMITED to one year starting from the date it was shipped to the integrator or starting with the date specified as the starting date in the leasing and / or purchase agreement with the Integrator. If the date is different then the shipping date to the integrator the integrator has to provide a copy of the agreement with the Integrator to verify the start of warranty. E) CORRECTIONS AND UPDATES OF LICENSED PROGRAMS. WLI shall maintain the accuracy of the Licensed Programs by making a reasonable attempt to correct any programming or database errors that Integrator brings to WLI attention. In addition, WLI from time to time may furnish Integrator with further releases of the Licensed Programs to provide corrections of significant programming or database errors and updates of database information. WLI obtains the information contained in the database of the Licensed Programs from established outside sources, and WLI makes every effort to keep the information up-to-date, but it cannot guarantee absolute accuracy and timeliness. After the expiration of the initial term of this Agreement, WLI shall provide any correction and update assistance only on mutually acceptable terms at WLI's customary rates then in effect. WLI reserves the right to make modifications and enhancements of the Licensed Programs (other than simple corrections and updates -------- ------- RH JS Page 7\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"End User Warranty\", \"level\": 1, \"text\": \"EXHIBIT B End User Warranty LIMITED WARRANTY FOR THE ACKNOWLEDGER(TM) AND RELATED ACCESSORIES ----------------------------------------------------------------- Wireless Links (WLI) warrants to the original end user purchaser (\\\"You\\\") that the Equipment will be free from defects in workmanship and materials (\\\"Limited Warranty\\\") for a period of one (1) year from the date of the purchase of the Equipment (the \\\"Warranty Period\\\"). This limited warranty does not&sbsp;apply to normal wear and tear and does not cover repair or replacement of Equipment damaged by misuse, accident, abuse, neglect, misapplication, alteration of any kind (including upgrades and expansions)' disaster or defects due to repairs or modifications made by anyone other than the Manufacturer or its authorized service representative. In addition, this limited warranty does not apply to physical damage of any nature whatsoever to the surface of the display, to the surface of the signature pad of the Equipment or to any data stored within the Equipment. WLI shall not have any liability whatsoever with respect to any data stored within the Equipment. Before returning any Equipment under this limited warranty, call WLI and request a return merchandise authorization number (RMA - number)' then ship the Equipment in the original packaging or its equivalent to the location designated by WLI accompanied by proof of purchase, a brief written explanation of the defects, the RMA Number and a return shipment address. WLI at its discretion will repair or replace the Equipment in accordance with the terms of this limited warranty and send it back to you. You are responsible for the cost of shipping the Equipment to the location designated by WLI and the risk of loss or damage in transit. WLI will bear the cost of return shipment to you and the risk of loss or damage during such return shipment. REPAIR OR REPLACEMENT BY WLI AS PROVIDED IN THIS LIMITED WARRANTY IS YOUR EXCLUSIVE REMEDY UNDER THIS LIMITED WARRANTY. WLI SHALL NOT BE LIABLE FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES. WLI DISCLAIMS ALL OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, OR STATUTORY INCLUDING BUT NOT LIMITED TO, ALL IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR ANY WARRANTY ARISING OUT OF ANY PROPOSAL, SPECIFICATION OR SAMPLE. ANY SOFTWARE PROVIDED WITH THE EQUIPMENT IS PROVIDED UNDER A SEPARATE SOFTWARE LICENSE AGREEMENT. -------- ------- RH JS Page 8 EXHIBIT C-2 END-USER PROGRAM LICENSE AGREEMENT WIRELESS LINKS (WLI) SOFTWARE LICENSE AGREEMENT ---------------------------------------------------- Licensed Programs are provided solely in executable files and consist of the following programs: MidLink (WLI's middleware), MapLink, and all G3001 related programming tools,\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESERVATION OF TITLE\", \"level\": 1, \"text\": \"1. RESERVATION OF TITLE. This Agreement does not provide the Power2Ship (you) with title or ownership of the Licensed Programs, but only a right of limited use of one copy per software package per license. The Licensed Programs are, and shall remain, the property of Wireless Links and certain third-party licensers who have authorized Wireless Links to incorporate their software into the System. Subject to a distribution agreement the Power2Ship (you) can redistribute the licensed products but you can't reproduce the Licensed Programs.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COPYRIGHT PROTECTION\", \"level\": 1, \"text\": \"2. COPYRIGHT PROTECTION. Power2Ship acknowledges that the programs, software information, and user materials included in the Licensed Programs contain confidential information and trade secrets, which WLI(TM) has entrusted to Power2Ship in confidence to use only as expressly permitted by this Agreement. Power2Ship acknowledges that Wireless Links claims and reserves all rights and benefits afforded under federal law in the programs, database information, and user materials included in the Licensed Programs as copyrighted works.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRESERVATION OF SECRECY AND CONFIDENTIALITY\", \"level\": 1, \"text\": \"3. PRESERVATION OF SECRECY AND CONFIDENTIALITY. Power2Ship shall protect the programs, database information, and user materials include din the Licensed Programs as confidential information and trade secrets. Power2Ship shall not, at any time, disclose such confidential information and trade secrets to any other person, firm, organization, or employee that does not (consistent with Power2Ship's right of use hereunder) need to obtain access to the Licensed Programs. Power2Ship shall devote its best efforts to ensure that all Power2Ship's personnel and all other persons afforded access to the Licensed Programs by Power2Ship protect the Licensed Programs as trade secrets and confidential information and refrain from any use of disclosure in any manner not expressly permitted by this Agreement. These restrictions shall not apply to information (1) generally know to the public of obtainable from public sources; (2) readily apparent from the keyboard operation, visual display, or output reports of the Licensed Program; (3) previously in the possession of Power2Ship or subsequently developed or acquired without reliance on the Licensed programs; or (4) approved by WLI for release without restriction.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESTRICTIONS ON USE OF LICENSED PROGRAMS\", \"level\": 1, \"text\": \"4. RESTRICTIONS ON USE OF LICENSED PROGRAMS. The programs, software information, and user materials included in the Licensed Programs may not be decompiled, reverse engineered, reprinted, transcribed, extracted, or reproduced, in whole or in part, without the prior written consent of WLI. Power2Ship shall not in any way modify or alter the Licensed Programs without the prior written consent of WLI.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SURVIVALS OF OBLIGATIONS; RETURN OF PROGRAMS\", \"level\": 1, \"text\": \"5. SURVIVALS OF OBLIGATIONS; RETURN OF PROGRAMS. Power2Ship's obligations under this Agreement shall remain in effect for as long as Power2Ship continues to use the Licensed Programs. Power2Ship shall promptly return all materials and documentation relating to the Licensed Programs provided by WLI upon (1) termination of either this Agreement of Power2Ship's license of the Licensed Programs, for any reason, or (2) discontinuance or abandonment of Power2Ship's use or control of the Licensed Programs.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"POWER2SHIP'S DATA FILES\", \"level\": 1, \"text\": \"6. POWER2SHIP'S DATA FILES. Power2Ship is responsible for maintaining and storing in a safe and secure location backup copies of all data files Power2Ship may place in the System. In no event shall WLI(TM) be liable for loss or destruction of Power2Ship's data files for any reason.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITED WARRANTY ON LICENSED PROGRAMS\", \"level\": 1, \"text\": \"7. LIMITED WARRANTY ON LICENSED PROGRAMS. WLI(TM) warrants, for the benefit of Power2Ship only, that at the time Power2Ship's license of Licensed Programs commences, WLI(TM) has the right and authority to license the Licensed Programs to Power2Ship, and the Licensed Programs conform in all material respects to any specification supplied to Power2Ship in writing by WLI(TM). WLI(TM) does not warrant that the Licensed Programs can be used without interruption or that they are error-free. Any implied warranties of the Licensed Software are LIMITED to one year starting from the date of purchase or for the period described in the contractual agreement with the Power2Ship. For best and fast service WLI recommends to Power2Ship to install on the server NT computer a modem fax with PC-Anywhere software and a dedicated phone line to allow WLI to dial in for routine maintenance.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CORRECTIONS AND UPDATES OF LICENSED PROGRAMS\", \"level\": 1, \"text\": \"8. CORRECTIONS AND UPDATES OF LICENSED PROGRAMS. WLI shall maintain the accuracy of the Licensed Programs by using its best endeavors to correct any programming or database errors that Power2Ship brings to WLI(TM)'s attention. In addition, during the warranty period and/or duration of this agreement WLI from time to time may furnish Power2Ship with further releases of the Licensed Programs to provide corrections of significant programming or software errors. After the expiration of this agreement, WLI shall provide any correction and update assistance only on mutually acceptable terms at WLI's customary rates then in effect. WLI(TM) reserves the right to make optional modifications and enhancements of the Licensed Programs (other than simple corrections and updates) available only at additional charges. -------- ------- RH JS Page 9\"}}, {\"id\": \"party:Wireless Links Inc\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Wireless Links Inc\", \"role\": \"WLI\", \"address\": \"1050 Wall Street, Suite 202, Lyndhurst, New Jersey 07071\"}}, {\"id\": \"party:Jaguar Investments, Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Jaguar Investments, Inc.\", \"role\": \"Power2Ship\", \"address\": \"10400 Griffin Rd., Suite 101, Ft. Lauderdale, Florida 33328\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"this 7th day of April, 2003\", \"definition_clause\": \"para_1\"}}, {\"id\": \"term:Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Products\", \"text\": \"certain WLI's products and services, limited to WLI's G3001 GPSLink mobile terminal as defined in Section 1.2\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Units\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Units\", \"text\": \"certain WLI's products and services, limited to WLI's G3001 GPSLink mobile terminal as defined in Section 1.2\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Licensed Programs\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Licensed Programs\", \"text\": \"software programs, limited to WLI's MidLink Middleware software and G3001 programming tools\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Subsidiary\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Subsidiary\", \"text\": \"one or more of its subsidiaries in which it owns at least 50.1% of the actual equity of the subsidiary on a fully diluted basis and as long as Power2Ship remains the guarantor for the payments and terms and conditions of this Agreement\", \"definition_clause\": \"1.4\"}}, {\"id\": \"term:License Fee\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"License Fee\", \"text\": \"$[*] per month per Product\", \"definition_clause\": \"3.1\"}}, {\"id\": \"term:Unit Commissions\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Unit Commissions\", \"text\": \"any activation commissions, if any, it receives as a result of any Unit activated on a specific wireless network\", \"definition_clause\": \"3.10\"}}, {\"id\": \"term:Equipment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Equipment\", \"text\": \"the Units and any other equipment purchased from WLI\", \"definition_clause\": \"6.3\"}}, {\"id\": \"term:Intellectual Right\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Right\", \"text\": \"any rights relating to any trademark, trade name, service mark, copyright, patent, trade secret or other proprietary right\", \"definition_clause\": \"12.1\"}}, {\"id\": \"term:You\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"You\", \"text\": \"the original end user purchaser\", \"definition_clause\": \"EXHIBIT B\"}}, {\"id\": \"term:Limited Warranty\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Limited Warranty\", \"text\": \"free from defects in workmanship and materials\", \"definition_clause\": \"EXHIBIT B\"}}, {\"id\": \"term:Warranty Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Warranty Period\", \"text\": \"a period of one (1) year from the date of the purchase of the Equipment\", \"definition_clause\": \"EXHIBIT B\"}}, {\"id\": \"value:sixty (60) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"sixty (60) days\"}}, {\"id\": \"value:50.1%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50.1%\"}}, {\"id\": \"value:three (3) years\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"three (3) years\"}}, {\"id\": \"value:one (1) year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one (1) year\"}}, {\"id\": \"value:one hundred twenty (120) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one hundred twenty (120) days\"}}, {\"id\": \"value:$[*]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$[*]\"}}, {\"id\": \"value:36 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"36 months\"}}, {\"id\": \"value:36 consecutive months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"36 consecutive months\"}}, {\"id\": \"value:2 months\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"2 months\"}}, {\"id\": \"value:thirty consecutive days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty consecutive days\"}}, {\"id\": \"value:8-10 weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"8-10 weeks\"}}, {\"id\": \"value:3-4 weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"3-4 weeks\"}}, {\"id\": \"value:four weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"four weeks\"}}, {\"id\": \"value:[*]%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"[*]%\"}}, {\"id\": \"value:10%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"10%\"}}, {\"id\": \"value:two weeks\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"two weeks\"}}, {\"id\": \"value:7 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"7 days\"}}, {\"id\": \"value:60 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"60 days\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"50%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:eighteen percent (18%)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"eighteen percent (18%)\"}}, {\"id\": \"value:48 hours\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"48 hours\"}}, {\"id\": \"value:1%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"1%\"}}, {\"id\": \"value:six-month\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six-month\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"value:third business day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"third business day\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:14 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"14 days\"}}, {\"id\": \"value:14 working days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"14 working days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of WHITESMOKE,INC_11_08_2011-EX-10.26-PROMOTION AND DISTRIBUTION AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of WHITESMOKE,INC_11_08_2011-EX-10.26-PROMOTION AND DISTRIBUTION AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"Exhibit 10.26\", \"title\": \"CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK [*], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PROMOTION AND DISTRIBUTION AGREEMENT This Promotion and Distribution Agreement including all exhibits (collectively referred to as the \\\"Agreement\\\"), effective as of 1 August 2011 (the \\\"Effective Date\\\"), is made by and between Whitesmoke Inc., with registered offices/principle place of business at 501 Silverside Road, Suite 105, Wilmington DE 19809, USA, (\\\"Distributor\\\"), and Google Inc whose principle place of business is at 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (\\\"Google\\\").\", \"level\": 2, \"text\": \"Exhibit 10.26 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK [*], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PROMOTION AND DISTRIBUTION AGREEMENT This Promotion and Distribution Agreement including all exhibits (collectively referred to as the \\\"Agreement\\\"), effective as of 1 August 2011 (the \\\"Effective Date\\\"), is made by and between Whitesmoke Inc., with registered offices/principle place of business at 501 Silverside Road, Suite 105, Wilmington DE 19809, USA, (\\\"Distributor\\\"), and Google Inc whose principle place of business is at 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (\\\"Google\\\"). \\\"Bundle\\\" means the Distribution Products bundled with the Distributor App(s). \\\"Chrome Browser\\\" means the machine-readable binary code version of the Google Chrome browser provided to Distributor in connection with this Agreement, and any modifications or updates to it that Google may provide to Distributor. \\\"Chrome Browser Installer\\\" means: (a) the machine-readable binary code version of the installer provided to Distributor in connection with this Agreement that installs the Chrome Browser, and any modifications, updates or upgrades to it that Google may provide to Distributor; and (b) the Chrome Browser Criteria Checker. \\\"Chrome Use Event\\\" means an event that indicates an [* ] has occurred. \\\"Chrome Server Communication\\\" means a communication that, as determined solely by Google, is sent for the purpose of indicating that an End User: (a) is [* ] to the [* ]; and (b) has kept the [* ] open for a minimum of [* ] during a [* ] (whether during the [* ] or a [* ] of the Chrome Browser). \\\"Criteria Checker\\\" means a set of software routines (and any updates to them) provided to Distributor by Google, as part of a software library, that check certain criteria (as determined by Google and modified by Google from time to time) to determine if the Chrome Browser or Google Toolbar (as applicable) can be installed on an End User's operating system. Accordingly, \\\"Chrome Browser Criteria Checker\\\" means the Criteria Checker provided by Google in respect of the Chrome Browser and \\\"Google Toolbar Criteria Checker\\\" means the Criteria Checker provided by Google in respect of the Google Toolbar. \\\"Distributor App(s)\\\" means the following application (and successor versions of such software): the trial version of the WhiteSmoke Writer (currently called WhiteSmoke 2011) available on a worldwide basis, but for the avoidance of doubt shall not mean any other products of Distributor, including without limitation the full paid version of Whitesmoke Writer or any version of Whitesmoke \\\"Translator\\\" software, regardless of whether Whitesmoke Writer incorporates any translation functionality. *Confidential treatment requested Google Confidential\"}, {\"id\": \"1\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"1. DEFINITIONS\"}, {\"id\": \"1.1\", \"title\": \"In this Agreement unless expressly stated otherwise\", \"level\": 2, \"text\": \"1.1 In this Agreement unless expressly stated otherwise: - 1 - \\\"Distribution Products\\\" means: \\\"End User\\\" means an end user customer of Distributor who is located in the Territory. \\\"EULA\\\" means the end user license agreement applicable to a Product, which end user license agreement may be updated or modified by Google in its sole discretion from time to time. \\\"False\\\" means a \\\"false\\\" response (or equivalent negative response) given by the Criteria Checker. \\\"Google Program Guidelines\\\" means the policy and implementation guidelines applicable to the Products as updated by Google and provided to Distributor from time to time. \\\"Google Toolbar\\\" means the machine-readable binary code version of the Google toolbar for Internet Explorer provided to Distributor in connection with this Agreement, and any modifications or updates to it that Google may provide to Distributor. \\\"Google Toolbar Installer\\\" means: (a) the machine-readable binary code version of the installer provided to Distributor in connection with this Agreement that installs the Google Toolbar, and any modifications, updates or upgrades to it that Google may provide to Distributor; and (b) the Google Toolbar Criteria Checker. \\\"Google Trademarks\\\" means all names, trade names, trademarks, and logos used by Google in connection with the Products. \\\"Group Company\\\" means in relation to each of the parties: \\\"Install Completed\\\" occurs when an End User has completed the install process for a Bundle and the install completed screen is shown to the End User in accordance with Exhibit B. (a) as at the Effective Date, the Google Toolbar Installer and the Chrome Browser Installer; and (b) if Distributor notifies Google at any time after the Effective Date that it wishes to bundle the full Google Toolbar and Google provides its approval in writing (including email), the Google Toolbar; and (c) if Distributor notifies Google at any time after the Effective Date that it wishes to bundle the full Chrome Browser and Google provides its approval in writing (including email), the Chrome Browser. (a) any parent company of that party; and (b) any corporate body of which that party directly or indirectly has control or which is directly or indirectly controlled by the same person or group of persons as that party. - 2 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"1.2\", \"title\": \"In this Agreement, the words \\\"include\\\" and \\\"including\\\" will not limit the generality of any words preceding them\", \"level\": 2, \"text\": \"1.2 In this Agreement, the words \\\"include\\\" and \\\"including\\\" will not limit the generality of any words preceding them.\"}, {\"id\": \"2\", \"title\": \"LICENSE GRANTS AND RESTRICTIONS\", \"level\": 1, \"text\": \"2. LICENSE GRANTS AND RESTRICTIONS\"}, {\"id\": \"2.1\", \"title\": \"Products License Grant\", \"level\": 2, \"text\": \"2.1 Products License Grant. Subject to the terms and conditions of this Agreement, Google grants to Distributor a [* ] license during the Term to: (a) bundle the Distribution Products, in machine-readable binary code format only, solely with Distributor App(s); (b) distribute Bundles directly (or indirectly, subject to Clause 2.2 (Third Party Distribution)) to End Users in the Territory; (c) when indicated by the applicable Criteria Checker and requested by the End User in accordance with clause 3.2 (Form of Distribution Offering), install the Chrome Browser or the Google Toolbar (as applicable) on the End User's system using the Google Installers; and (d) reproduce (or have reproduced by Third Party Distributors as defined in Clause 2.2 (Third Party Distribution)), the Distribution Products to the extent necessary to exercise the rights granted in (a), (b) and (c). - 3 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"2.2\", \"title\": \"Third Party Distribution\", \"level\": 2, \"text\": \"2.2 Third Party Distribution. Distributor may distribute Bundles to third parties solely for redistribution of such Bundles by those third parties directly to End Users (such third parties, \\\"Third Party Distributors\\\"); provided that: (a) in connection with any and all such offers or distributions, Distributor shall, and shall ensure that each Third Party Distributor shall, distribute Bundles in a manner that is no less protective of the Products and Google than the terms of this Agreement, and (b) Google in its sole discretion may direct Distributor to cease distributing Bundles to any Third Party Distributor that in Google's sole discretion would either: (i) harm or devalue Google's business, brand or name, or (ii) violate Google's privacy policy, and Distributor shall cause any such Third Party Distributor to cease distribution of Bundles as soon as practicable but in no event longer than [ * ] following receipt of such request from Google. Distributor shall ensure that no Third Party Distributor bundles anything in or with Bundles without Google's prior written approval, and if Google grants its approval, Distributor shall provide Google with information about any such bundling arrangements at Google's request.\"}, {\"id\": \"2.3\", \"title\": \"License Grant Restrictions\", \"level\": 2, \"text\": \"2.3 License Grant Restrictions. Distributor shall not, and shall not allow any third party to (except to the extent that such prohibitions are not permitted by law): (a) disassemble, de-compile or otherwise reverse engineer the Products or otherwise attempt to learn the source code or algorithms underlying the Products; (b) modify the Products, create derivative works from or based on the Products; (c) except as expressly set out in this Agreement, provide, sell, license, distribute, lease, lend, or disclose the Products to any third party; (d) use the Products for timeshare, service bureau, or other unauthorised purposes; or (e) exceed the scope of any license granted to Distributor under this Agreement.\"}, {\"id\": \"2.4\", \"title\": \"Trademark License and Use\", \"level\": 2, \"text\": \"2.4 Trademark License and Use. Subject to the terms and conditions of this Agreement, Google grants to Distributor a limited, [ * ] license during the Term to use the Google Trademarks, in accordance with Google's trademark usage guidelines, solely to market and promote the Products consistent with this Agreement, provided that all use of the Google Trademarks shall be subject to Google's prior review and advance written consent. All uses of the Google Trademarks, and all goodwill associated therewith, shall inure solely to the benefit of Google.\"}, {\"id\": \"2.5\", \"title\": \"Trademark Restrictions\", \"level\": 2, \"text\": \"2.5 Trademark Restrictions. Distributor shall not remove, modify, adapt, or prepare derivative works of any Google Trademarks or Google copyright notices, or other Google proprietary rights notices.\"}, {\"id\": \"2.6\", \"title\": \"Updated Versions of Distribution Products\", \"level\": 2, \"text\": \"2.6 Updated Versions of Distribution Products. Google may request that Distributor distribute the latest version of the Distribution Products. Distributor shall begin such distribution within [ * ] following Google's request.\"}, {\"id\": \"3\", \"title\": \"DISTRIBUTION AND OTHER OBLIGATIONS\", \"level\": 1, \"text\": \"3. DISTRIBUTION AND OTHER OBLIGATIONS\"}, {\"id\": \"3.1\", \"title\": \"Delivery\", \"level\": 2, \"text\": \"3.1 Delivery. Google shall deliver the Distribution Products electronically to Distributor at a [ * ] following the Effective Date and prior to Launch (as defined in Clause 3.4 (Launch)). - 4 - User to review such EULA via a hyperlink to such EULA: and (c) a button on which each End User may click indicating agreement to the terms of such EULA. In the event that an End User does not affirmatively agree to install the Google Toolbar or Chrome Browser, by clicking on the button to agree to the terms of the applicable EULA, then the Google Toolbar or Chrome Browser (as applicable) shall not be installed on such End User's computer. *Confidential treatment requested Google Confidential\"}, {\"id\": \"3.2\", \"title\": \"Form of Distribution Offering\", \"level\": 2, \"text\": \"3.2 Form of Distribution Offering. Distributor shall ensure that the form of any offering of the Products by Distributor, including the timing, relative and absolute placement, visual presentation to End Users, initial launch of the Products (and any modifications to them) and the presentation of any other applications or products offered with the Products, conforms to the Google Program Guidelines and to Exhibit B of this Agreement. Except as set out in Clause 2 (Licence Grant and Restrictions) and except for End Users as expressly set out in this Agreement, Distributor shall not offer or distribute the Products to any third party. If, during the Term, Exhibit B and the Google Program Guidelines conflict, Exhibit B will take precedence with respect to the conflicting terms.\"}, {\"id\": \"3.3\", \"title\": \"Guidelines for Applications\", \"level\": 2, \"text\": \"3.3 Guidelines for Applications. Distributor shall comply, and shall ensure that each Third Party Distributor complies, with the Guidelines for Applications set out in Exhibit C.\"}, {\"id\": \"3.4\", \"title\": \"Launch\", \"level\": 2, \"text\": \"3.4 Launch. Distributor shall begin distribution of Bundles in accordance with this Agreement (\\\"Launch\\\") within [ * ] days following the Effective Date (the date of such Launch, the \\\"Launch Date\\\"). Beginning on the Launch Date and continuing throughout the Term, Distributor shall ensure that [ * ]Distributor App distributed by or on behalf of Distributor is bundled with the Distribution Products as set out in this Agreement.\"}, {\"id\": \"3.5\", \"title\": \"Exclusivity\", \"level\": 2, \"text\": \"3.5 Exclusivity. (a) [ * ] (b) [ * ].\"}, {\"id\": \"3.6\", \"title\": \"EULA\", \"level\": 2, \"text\": \"3.6 EULA. In connection with Distributor's distribution of the Products under this Agreement, and before the Google Toolbar or Chrome Browser can be installed by an End User, Distributor shall provide each End User with: (a) a clear statement inviting the End User to agree to the terms of the applicable EULA; (b) the opportunity for each End\"}, {\"id\": \"3.7\", \"title\": \"Accurate Reproduction\", \"level\": 2, \"text\": \"3.7 Accurate Reproduction. Distributor agrees that in connection with its exercise of the right granted in Clause 2.1 (Products Licence Grant) it shall accurately reproduce the Distribution Products and shall not: (a) modify any Product (including modify the Chrome Browser or Google Toolbar configuration files or registry settings); or (b) insert into the Products any viruses, worms, date bombs, time bombs, or other code that is specifically designed to cause the Products to cease operating, or to damage, interrupt, or interfere with any Products or End User data.\"}, {\"id\": \"3.8\", \"title\": \"[ * ]\", \"level\": 2, \"text\": \"3.8 [ * ]. During the Term and for a period of [ * ] following the expiration or termination of this Agreement, Distributor shall not, and shall not engage any third party to: (a) restrict, modify, or reconfigure in any manner any of the Products that have been installed by End Users (such End Users, \\\"Installed Base End Users\\\") in connection with this Agreement; or (b) engage in activities that encourage Installed Base End Users to modify, uninstall or reconfigure any or the Products. - 5 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"3.9\", \"title\": \"Reporting\", \"level\": 2, \"text\": \"3.9 Reporting. (a) By Distributor. During the Term, Distributor shall, on a [ * ] basis, no later than the [ * ] of the following [ * ], provide Google with a report identifying, on a country-by-country basis, the total number of: (i) Bundles distributed; (ii) Installs Completed; (iii) Google Toolbar offers presented to End Users; and (iv) Chrome Browser offers presented to End Users, in the preceding [ * ]. (b) By Google. During the Term, Google shall on a [ * ] basis, provide Distributor with a report of the [ * ] of [ * ] and [ * ] in the preceding [ * ] broken down on a [ * ] basis and by the [ * ] in Exhibit A. (c) Parameters. Distributor acknowledges, and shall cooperate with Google to [ * ] that: (i) [ * ]: (A) are determined on a [ * ] (B) are only [ * ]; (C) do not include [ * ] from computers on which another [ * ] of the [ * ] is [ * ]; and (D) do not include use of the [ * ] in any [ * ] other than [ * ]. (ii) [ * ] do not include: (A) [ * ] that has been [ * ], (B) [ * ] or [ * ] in any area other than in the [ * ], or (C) any other [ * ] of the [ * ] designed to artificially [ * ]. (iii) [ * ]: (A) are determined on a [ * ]; (B) are only [ * ]; (C) are not sent in response to [ * ] from computers on which another [ * ] of the [ * ] is [ * ]; and (D) are sent only in response to [ * ] from computers that meet the [ * ] requirements as determined by the [ * ]. (d) Records and Audit Rights. Distributor will keep and maintain complete and accurate books, records, and accounts relating to this Agreement. During the Term, and for a period of [ * ] thereafter, Google may audit Distributor's relevant records to confirm Distributor's compliance with this Agreement. Google's auditor will only have access to those books and records of Distributor which are reasonably necessary to confirm such compliance.\"}, {\"id\": \"4\", \"title\": \"PAYMENT TERMS\", \"level\": 1, \"text\": \"4. PAYMENT TERMS\"}, {\"id\": \"4.1\", \"title\": \"Payments\", \"level\": 2, \"text\": \"4.1 Payments. Subject to Clause 4.2, during the Term on a [ * ] basis, Google shall pay to Distributor the applicable payment set out in Exhibit A for each [ * ] and each [ * ] that occurred during the previous [ * ]. Google shall determine the [ * ] in respect of which each [ * ] and [ * ] took [ * ] (using the relevant [ * ]). Notwithstanding the foregoing, in no event will the [ * ] of [ * ] by Google to Distributor for all [ * ] and all [ * ] in respect of [ * ] (as set out in Exhibit A) exceed [ * ] ([ * ]) of the [ * ] to Distributor for such [ * ].\"}, {\"id\": \"4.2\", \"title\": \"[ * ]\", \"level\": 2, \"text\": \"4.2 [ * ]. Notwithstanding anything to the contrary, in no event shall the [ * ] paid or payable to Distributor by Google pursuant to Clause 4.1 (Payments) exceed the [ * ]. Google shall have the right, at its sole option, to increase the [ * ] by providing written notice to Distributor no later than [ * ] prior to the end of the Term. The foregoing sentence shall not relieve Google of any payment obligations that have accrued prior to the achievement of the [ * ].\"}, {\"id\": \"4.3\", \"title\": \"Payment Terms\", \"level\": 2, \"text\": \"4.3 Payment Terms. All payments under this Agreement shall be made in [ * ] in the [ * ] following the [ * ] for which the payments are applicable. The party receiving payment will be responsible for any bank charges assessed by the recipient's bank. In addition to other rights and remedies Google may have, Google may offset any payment obligations to Distributor that Google may incur under this Agreement against any product or service fees owed to Google and not yet paid by Distributor under any agreement between Distributor and Google. Google may also withhold and offset against its payment obligations under this Agreement, or require Distributor to pay to Google within [ * ] of any invoice, any amounts Google [ * ] overpaid to Distributor in prior periods. - 6 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"4.4\", \"title\": \"Taxes\", \"level\": 2, \"text\": \"4.4 Taxes. All payments under this Agreement are exclusive of taxes imposed by any governmental entity. Google shall pay any applicable taxes imposed by governmental agencies with respect to the transactions under this Agreement other than taxes based upon Distributor's income. Google shall promptly provide to Distributor a copy of an official tax receipt or other appropriate evidence of any taxes imposed on payments made under this Agreement. When Distributor has the legal obligation to collect any applicable taxes, the appropriate amount shall be invoiced to and paid by Google unless Google provides Distributor with a valid tax exemption certificate authorised by the appropriate taxing authority.\"}, {\"id\": \"4.5\", \"title\": \"Interest\", \"level\": 2, \"text\": \"4.5 Interest. Distributor may charge interest at the rate of [ * ] above the base rate of Barclays Bank PLC from time to time, from the due date until the date of actual payment, whether before or after judgment, on any payment pursuant to this Clause 4 (Payment Terms) which is overdue.\"}, {\"id\": \"5\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"5. TERM AND TERMINATION\"}, {\"id\": \"5.1\", \"title\": \"Term\", \"level\": 2, \"text\": \"5.1 Term. This Agreement shall commence on the Effective Date and, unless earlier terminated as set out in this Agreement, shall continue for the Term.\"}, {\"id\": \"5.2\", \"title\": \"Termination for breach\", \"level\": 2, \"text\": \"5.2 Termination for breach. A party may suspend performance and/or terminate this Agreement, with immediate effect, if the other party: (a) is in material breach of this Agreement where the breach is incapable of remedy; or (b) is in material breach of this Agreement where the breach is capable of remedy and fails to remedy that breach within thirty (30) days after receiving written notice of such breach.\"}, {\"id\": \"5.3\", \"title\": \"Termination for insolvency\", \"level\": 2, \"text\": \"5.3 Termination for insolvency. A party may suspend performance and/or terminate this Agreement with immediate effect, if: (a) the other party enters into an arrangement or composition with or for the benefit of its creditors, goes into administration, receivership or administrative receivership, is declared bankrupt or insolvent or is dissolved or otherwise ceases to carry on business; or (b) any analogous event happens to the other party in any jurisdiction in which it is incorporated or resident or in which it carries on business or has assets.\"}, {\"id\": \"5.4\", \"title\": \"Change of Control\", \"level\": 2, \"text\": \"5.4 Change of Control. [ * ] may terminate this Agreement immediately upon written notice if there is a Change of Control of [ * ]. In this Clause the term \\\"Control\\\" shall mean the possession by any person(s) directly or indirectly of the power to direct or cause the direction of another person and \\\"Change of Control\\\" is to be construed accordingly. [ * ] expected to experience, or [ * ] is experiencing, such Change of Control shall notify [ * ] in writing of this before or within [ * ] after the Change of Control. If [ * ] has not exercised its right of termination under this Clause within [ * ] following the later of (i) the receipt of notice of [ * ] Change of Control or (ii) the Change of Control event, that [ * ]. The parties acknowledge that as at the Effective Date, [ * ] may [ * ] its [ * ]. [ * ] agrees not to exercise its termination right under this clause 5.4 if [ * ], provided that following [ * ]: - 7 - For the avoidance of doubt, if following [ * ] there is a transfer of shareholding or interests in Distributor to any existing or new shareholder(s) which results in any person or persons subsequently gaining Control of Distributor, then Google may exercise its right to terminate in accordance with this clause 5.4.. *Confidential treatment requested Google Confidential\"}, {\"id\": \"5.4.1\", \"title\": \"no one person Controls [ * ] (other than an[ * ] which is not a [ * ] of [ * ] (as determined by [ * ]in its sole discr\", \"level\": 3, \"text\": \"5.4.1. no one person Controls [ * ] (other than an[ * ] which is not a [ * ] of [ * ] (as determined by [ * ]in its sole discretion)); and\"}, {\"id\": \"5.4.2\", \"title\": \"no [ * ] of [ * ] (as determined by [ * ] in its sole discretion) holds a [ * ] or [ * ] in [ * ]\", \"level\": 3, \"text\": \"5.4.2. no [ * ] of [ * ] (as determined by [ * ] in its sole discretion) holds a [ * ] or [ * ] in [ * ].\"}, {\"id\": \"5.6\", \"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"5.6 Effect of Termination. Upon expiration or termination of this Agreement: (a) all rights and licenses granted under this Agreement shall immediately cease; (b) Distributor shall (and shall ensure that any Third Party Distributors shall) immediately stop reproducing the Products and offering or distributing Bundles; (c) Distributor shall return or destroy (and a duly appointed officer of Distributor shall certify to such destruction) all copies of the Products and any other Google Confidential Information in its possession; and (d) the fees payable to Distributor shall immediately cease accruing and Google shall within [ * ] following such expiration or termination pay to Distributor any undisputed amounts which have accrued from the time of the most recent payment to Distributor through the date of termination or expiration of this Agreement. Clauses 5.6 (Effect of Termination), 6 (Confidential Information), 7 (Proprietary Rights), 9 (Limitation of Liability), 10 (Indemnification) and 11 (General) shall survive the termination or expiration of this Agreement. - 8 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"6\", \"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"6. CONFIDENTIAL INFORMATION\"}, {\"id\": \"6.1\", \"title\": \"In this Agreement, \\\"Confidential Information\\\" means information disclosed by (or on behalf of) one party to the other pa\", \"level\": 2, \"text\": \"6.1 In this Agreement, \\\"Confidential Information\\\" means information disclosed by (or on behalf of) one party to the other party under this Agreement that is marked as confidential or, from its nature, content or the circumstances in which it is disclosed, might reasonably be supposed to be confidential, including the terms and conditions (including the Exhibits) of this Agreement. It does not include information that the recipient already knew, that becomes public through no fault of the recipient, that was independently developed by the recipient or that was lawfully given to the recipient by a third party.\"}, {\"id\": \"6.2\", \"title\": \"The recipient of any Confidential Information shall not disclose that Confidential Information, except to Group Companie\", \"level\": 2, \"text\": \"6.2 The recipient of any Confidential Information shall not disclose that Confidential Information, except to Group Companies, employees and/or professional advisors who need to know it and who have agreed in writing (or in the case of professional advisors are otherwise bound) to keep it confidential. The recipient shall ensure that those people and entities: (a) use such Confidential Information only to exercise rights and fulfill obligations under this Agreement, and (b) keep such Confidential Information confidential. The recipient may also disclose Confidential Information when required by law, or the regulation or rule of a major US stock exchange or the United States Securities and Exchange Commission, after giving reasonable notice to the discloser, such notice to be sufficient to give the discloser: (i) the opportunity to seek confidential treatment, a protective order or similar remedies or relief prior to disclosure (if applicable) and (ii) (where any disclosure is necessary) time to consult on and approve the form and content of the relevant disclosure. The parties shall then promptly discuss and agree in good faith on the form and content of the disclosure (each acting reasonably).\"}, {\"id\": \"7\", \"title\": \"PROPRIETARY RIGHTS\", \"level\": 1, \"text\": \"7. PROPRIETARY RIGHTS\"}, {\"id\": \"7.1\", \"title\": \"Distributor acknowledges that Google and/or its licensors own all right, title and interest, including all Intellectual\", \"level\": 2, \"text\": \"7.1 Distributor acknowledges that Google and/or its licensors own all right, title and interest, including all Intellectual Property Rights in and to the Products and the Google Trademarks and all modifications to them. Distributor has, and shall acquire, no rights in the foregoing except those expressly granted by this Agreement. Google shall not be restricted from selling, licensing, modifying, or otherwise distributing the Products and/or the Google Trademarks to any third party.\"}, {\"id\": \"7.2\", \"title\": \"Google acknowledges that Distributor and/or its licensors own all right, title and interest, including all Intellectual\", \"level\": 2, \"text\": \"7.2 Google acknowledges that Distributor and/or its licensors own all right, title and interest, including all Intellectual Property Rights, in and to the Distributor Apps and all [ * ] to [ * ]. Except as expressly set forth in this Agreement, Distributor shall not be [ * ]from [ * ], or otherwise [ * ]the Distributor App(s) or other products of Distributor to [ * ].\"}, {\"id\": \"8\", \"title\": \"WARRANTIES\", \"level\": 1, \"text\": \"8. WARRANTIES\"}, {\"id\": \"8.1\", \"title\": \"Each party warrants to the other that it will use reasonable care and skill in complying with its obligations under this\", \"level\": 2, \"text\": \"8.1 Each party warrants to the other that it will use reasonable care and skill in complying with its obligations under this Agreement. Distributor also represents and warrants that it will undertake commercially reasonable endeavours in good faith to comply with Google's business partner due diligence process including providing requested information. - 9 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"8.2\", \"title\": \"Google warrants that the Distribution Products will for a period of [ * ] from the date of their supply to Distributor b\", \"level\": 2, \"text\": \"8.2 Google warrants that the Distribution Products will for a period of [ * ] from the date of their supply to Distributor be free from any defect which has a materially adverse effect on their use or operation.\"}, {\"id\": \"8.3\", \"title\": \"If any of the warranties in Clause 8\", \"level\": 2, \"text\": \"8.3 If any of the warranties in Clause 8.1 or 8.2 is breached by Google, Distributor must tell Google as soon as possible. Distributor must give Google a reasonable time to fix the problem and (if necessary) to supply Distributor with a corrected or replacement version of the Distribution Product or a way to work-around the problem that is not materially detrimental to Distributor, or to re-perform any relevant services. This will be done without any additional charge to Distributor. If Google is able to do this within a reasonable time, Google will have no other obligations or liability in relation to that breach.\"}, {\"id\": \"8.4\", \"title\": \"Google will not be liable for breach of any of the warranties or other terms in this Agreement to the extent that the br\", \"level\": 2, \"text\": \"8.4 Google will not be liable for breach of any of the warranties or other terms in this Agreement to the extent that the breach arises from: (a) use of the Products other than in accordance with normal operating procedures; (b) any alterations or maintenance to the Products done by anyone other than Google or someone authorised by Google; (c) any problem with a computer on which the Products are installed, or with any equipment connected to that computer or any other software which is installed on that computer; (d) any abnormal or incorrect operating conditions; or (e) use of the Products in combination with any other hardware or software, unless this use has been approved by Google in writing.\"}, {\"id\": \"8.5\", \"title\": \"Distributor will comply with all applicable commercial and public anti-bribery laws, including, without limitation, the\", \"level\": 2, \"text\": \"8.5 Distributor will comply with all applicable commercial and public anti-bribery laws, including, without limitation, the UK's Bribery Act 2010 and the U.S. Foreign Corrupt Practices Act of 1977 (\\\"Anti-Bribery Laws\\\"), which prohibit (amongst other things) corrupt offers of anything of value, either directly or indirectly, to a government official to obtain or keep business. ''Government officials\\\" include any government employee, candidate for public office, and employee of government-owned or government-controlled companies, public international organisations, and political parties. Furthermore, Distributor will not make any facilitation payments, which are payments to induce officials to perform routine functions they are otherwise obligated to perform.\"}, {\"id\": \"8.6\", \"title\": \"No conditions, warranties or other terms apply to the Products, [ * ] or to any other goods or services supplied under t\", \"level\": 2, \"text\": \"8.6 No conditions, warranties or other terms apply to the Products, [ * ] or to any other goods or services supplied under this Agreement unless expressly set out in this Agreement. Subject to Clause 9.1, no implied conditions, warranties or other terms apply (including any implied terms as to satisfactory quality, fitness for purpose or conformance with description).\"}, {\"id\": \"9\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"9. LIMITATION OF LIABILITY\"}, {\"id\": \"9.1\", \"title\": \"Nothing in this Agreement shall exclude or limit either party's liability for\", \"level\": 2, \"text\": \"9.1 Nothing in this Agreement shall exclude or limit either party's liability for: (a) death or personal injury resulting from the negligence of either party or their servants, agents or employees; (b) fraud or fraudulent misrepresentation; - 10 - In this Clause 9.4, \\\"Contract Year\\\" means a period of one year starting on the Effective Date or the relevant anniversary of the Effective Date (as appropriate). If the amount referred to in (b) above cannot be calculated accurately at the time the relevant liability is to be assessed (the \\\"Applicable Time\\\"), it shall be calculated on a pro-rata basis as X/Y x Z. Where: X = the total sum paid and payable to the Distributor pursuant to Clause 4 in the relevant Contract Year prior to the Applicable Time; Y = the number of days elapsed in the relevant Contract Year prior to the Applicable Time; and Z = 365 *Confidential treatment requested Google Confidential (c) breach of any implied condition as to title or quiet enjoyment; and (d) misuse of confidential information.\"}, {\"id\": \"9.2\", \"title\": \"Nothing in this Agreement shall exclude or limit either party's liability under Clause 10 (Indemnities), or Distributor'\", \"level\": 2, \"text\": \"9.2 Nothing in this Agreement shall exclude or limit either party's liability under Clause 10 (Indemnities), or Distributor's liability under Clause 2 (License Grants and Restrictions), Clause 3.5 (Exclusivity), Clause 3.6 (End User License Agreement) and Clause 3.7 (Accurate Reproduction) or Clause [ * ].\"}, {\"id\": \"9.3\", \"title\": \"Subject to Clauses 9\", \"level\": 2, \"text\": \"9.3 Subject to Clauses 9.1 and 9.2, neither party shall be liable under this Agreement (whether in contract, tort or otherwise) for any: (a) loss of anticipated savings; (b) loss of business opportunity (which for the avoidance of doubt shall not include loss of advertising revenue); (c) loss of or corruption of data; (d) loss or damage resulting from third party claims; or (e) indirect or consequential losses;\\n suffered or incurred by the other party (whether or not such losses were within the contemplation of the parties at the date of this Agreement).\"}, {\"id\": \"9.4\", \"title\": \"Subject to Clauses 9\", \"level\": 2, \"text\": \"9.4 Subject to Clauses 9.1 and 9.2, each party's total liability under or in connection with this Agreement (whether in contract, tort or otherwise) arising in any Contract Year is limited to the greater of: (a) [ * ] Euros ([ * ] Euros); and (b) [ * ]% of the total payment due to the Distributor in the relevant Contract Year pursuant to Clause 4 (Payment Terms). - 11 - By Distributor. User claim arising out of or resulting from such End Users use of any Distributor App(s), including any actions or claims in product liability, tort, contract or equity. *Confidential treatment requested Google Confidential\"}, {\"id\": \"10\", \"title\": \"INDEMNIFICATION BY GOOGLE\", \"level\": 1, \"text\": \"10. INDEMNIFICATION BY GOOGLE.\"}, {\"id\": \"10.1\", \"title\": \"Google [ * ] and will indemnify Distributor against all liabilities, costs, damages and expenses (including settlement c\", \"level\": 2, \"text\": \"10.1 Google [ * ] and will indemnify Distributor against all liabilities, costs, damages and expenses (including settlement costs approved in writing by Google and reasonable legal fees [ * ]) suffered or incurred by Distributor arising from any claim from a third party that any Products or any Google Trademark infringe(s) any copyright, trade secret or trademark of such third party (an \\\"IP Claim\\\"), provided that Distributor: (a) promptly notifies Google; (b) provides Google with reasonable information, assistance and cooperation in responding to and, where applicable, defending such IP Claim; and (c) gives Google full control and sole authority over the defence and settlement of such IP Claim. Distributor may appoint its own supervising counsel of its choice at its own expense.\"}, {\"id\": \"10.2\", \"title\": \"Google will not have any obligations or liability under this Clause 10 in relation to any IP Claim arising from\", \"level\": 2, \"text\": \"10.2 Google will not have any obligations or liability under this Clause 10 in relation to any IP Claim arising from: (a) use of the Products or Google Trademarks in a modified form or in combination with materials not furnished by Google; (b) use of the Products or Google Trademarks other than in accordance with this Agreement; or (c) any content, information or data provided to Google by Distributor, End Users or any other third parties;\"}, {\"id\": \"10.3\", \"title\": \"Google may (at its sole discretion) suspend Distributors distribution or use of the Products or the Google Trademarks wh\", \"level\": 2, \"text\": \"10.3 Google may (at its sole discretion) suspend Distributors distribution or use of the Products or the Google Trademarks which are alleged, or believed by Google, to infringe any third party's Intellectual Property Rights, or modify such items to make them non-infringing. if any suspension under this Clause continues for more than 30 days, Distributor may, at any time until use of the distribution or use of the Products or the Google Trademarks is reinstated, terminate this Agreement immediately upon written notice. [ * ] will use reasonable endeavours to [ * ] with [ * ] (to the extent it is practicable to do so) of the [ * ] or [ * ].\"}, {\"id\": \"10.4\", \"title\": \"Distributor [ * ] and will indemnify Google against all liabilities, costs, damages and expenses (including settlement c\", \"level\": 2, \"text\": \"10.4 Distributor [ * ] and will indemnify Google against all liabilities, costs, damages and expenses (including settlement costs approved in writing by Distributor and reasonable legal fees [ * ]) suffered or incurred by Google or any Google Group Company arising from: (a) Distributor's improper (ie not in accordance with the requirements of this Agreement including the Exhibits) or unauthorised, replication, packaging, marketing, distribution, or installation of the Products, including any breach of Clause 8.5 and any claims based on representations, warranties, or misrepresentations made by Distributor, (b) any claim from a third party that the Distributor App(s) infringe any third party copyright, trademark, or trade secret, or (c) any End - 12 - *Confidential treatment requested Google Confidential\"}, {\"id\": \"10.5\", \"title\": \"The indemnification obligations set out in Clause 10\", \"level\": 2, \"text\": \"10.5 The indemnification obligations set out in Clause 10.4(b) shall exist only if Google: (a) promptly notifies Distributor of such claim, (b) provides Distributor with reasonable information, assistance and cooperation in responding to and, where applicable, defending the lawsuit or proceeding, and (c) gives Distributor full control and sole authority over the defense and settlement of such claim. Google may join in defense with counsel of its choice at its own expense.\"}, {\"id\": \"10.6\", \"title\": \"The foregoing Clauses 10\", \"level\": 2, \"text\": \"10.6 The foregoing Clauses 10.1 to 10.5 states the parties' entire liability and exclusive remedy with respect to infringement of a third party's Intellectual Property Rights.\"}, {\"id\": \"11\", \"title\": \"GENERAL\", \"level\": 1, \"text\": \"11. GENERAL\"}, {\"id\": \"11.1\", \"title\": \"Publicity\", \"level\": 2, \"text\": \"11.1 Publicity. Subject to clause 6 (Confidential Information), neither party may make any public statement regarding the relationship contemplated by this Agreement without the other's prior written approval.\"}, {\"id\": \"11.2\", \"title\": \"Notices\", \"level\": 2, \"text\": \"11.2 Notices. All notices of termination or breach must be in English, in writing, addressed to the other party's Legal Department and sent to Distributor's address set out at the head of this Agreement or to [ * ] (as applicable) or such other address as either party has notified the other in accordance with this Clause. All notices shall be deemed to have been given on receipt as verified by written or automated receipt or electronic log (as applicable). All other notices must be in English, in writing, addressed to the other party's primary contact and sent to their then current postal address or email address.\"}, {\"id\": \"11.3\", \"title\": \"Assignment\", \"level\": 2, \"text\": \"11.3 Assignment. [ * ] may [ * ]any of its rights or obligations under this Agreement without the prior written consent of [ * ]. For the avoidance of doubt, a Change of Control shall be deemed an assignment hereunder unless [ * ] does not exercise its [ * ].\"}, {\"id\": \"11.4\", \"title\": \"Force Majeure\", \"level\": 2, \"text\": \"11.4 Force Majeure. Neither party shall be liable for failure to perform or delay in performing any obligation under this Agreement if the failure or delay is caused by any circumstances beyond its reasonable control.\"}, {\"id\": \"11.5\", \"title\": \"Compliance with Export Laws\", \"level\": 2, \"text\": \"11.5 Compliance with Export Laws. Distributor shall comply with all applicable export and re-export control laws and regulations (\\\"Export Laws\\\"), which the parties agree include: (a) the Export Administration Regulations maintained by the U.S. Department of Commerce, (b) trade and economic sanctions maintained by the U.S. Treasury Department's Office of Foreign Assets Control, and (c) the International Traffic in Arms Regulations maintained by the U.S. Department of State. Unless Distributor obtains prior authorisation required by applicable Export Laws, Distributor shall not export any Product to Cuba, Iran, North Korea, Sudan or Syria.\"}, {\"id\": \"11.6\", \"title\": \"No Waiver\", \"level\": 2, \"text\": \"11.6 No Waiver. Failure or delay in exercising any right or remedy under this Agreement shall not constitute a waiver of such (or any other) right or remedy.\"}, {\"id\": \"11.7\", \"title\": \"Severability\", \"level\": 2, \"text\": \"11.7 Severability. The invalidity, illegality or unenforceability of any term (or part of a term) of this Agreement shall not affect the continuation in force of the remainder of the term (if any) and this Agreement.\"}, {\"id\": \"11.8\", \"title\": \"No Agency\", \"level\": 2, \"text\": \"11.8 No Agency. Except as expressly stated otherwise, nothing in this Agreement shall create an agency, partnership or joint venture of any kind between the parties.\"}, {\"id\": \"11.9\", \"title\": \"No Third-Party Beneficiaries\", \"level\": 2, \"text\": \"11.9 No Third-Party Beneficiaries. Except as expressly stated otherwise, nothing in this Agreement shall create or confer any rights or other benefits in favour of any person other than the parties to this Agreement. - 13 - Signed by the parties on the dates shown below. *Confidential treatment requested Google Confidential\"}, {\"id\": \"11.10\", \"title\": \"Governing Law\", \"level\": 2, \"text\": \"11.10 Governing Law. This Agreement is governed by English law and the parties submit to the exclusive jurisdiction of the English courts in relation to any dispute (contractual or non-contractual) concerning this Agreement save that either party may apply to any court for an injunction or other relief to protect its Intellectual Property Rights. If this Agreement is translated into any other language, if there is conflict the English text will take precedence.\"}, {\"id\": \"11.11\", \"title\": \"Counterparts\", \"level\": 2, \"text\": \"11.11 Counterparts. The parties may execute this agreement in counterparts, which taken together will constitute one instrument.\"}, {\"id\": \"11.12\", \"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"11.12 Entire Agreement. Subject to Clause 9.1, this Agreement sets out all terms agreed between the parties in relation to its subject matter and supersedes all previous agreements between the parties relating to the same. In entering into this Agreement neither party has relied on any statement, representation or warranty not expressly set out in this Agreement. DISTRIBUTOR GOOGLE INC /[ * ] /s/ [ * ] By By [ * ] [ * ] Name Name [ * ] [ * ] Title Title [ * ] [ * ] Date Date - 14 -\"}, {\"id\": \"EXHIBIT A\", \"title\": \"Payments\", \"level\": 1, \"text\": \"EXHIBIT A Payments *[ * ] ** [ * ]. *Confidential treatment requested Google Confidential [ * ] [ * ] [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ]** [ * ]* $ [ * ] - 15 -\"}, {\"id\": \"EXHIBIT B\", \"title\": \"Process Flow\", \"level\": 1, \"text\": \"EXHIBIT B Process Flow - 16 - Form of Offering 1 - WhiteSmoke Welcome Screen - 17 -\"}, {\"id\": \"2\", \"title\": \"Toolbar offer lf [ * ] Criteria Checker has returned \\\"True\\\"\", \"level\": 1, \"text\": \"2-Toolbar offer lf [ * ] Criteria Checker has returned \\\"True\\\" *Confidential treatment requested - 18 -\"}, {\"id\": \"3\", \"title\": \"Chrome offer If [ * ] Criteria Checker has not returned 'True\\\" AND [ * ] Criteria Checker has returned \\\"True\\\"\", \"level\": 1, \"text\": \"3-Chrome offer If [ * ] Criteria Checker has not returned 'True\\\" AND [ * ] Criteria Checker has returned \\\"True\\\" *Confidential treatment requested - 19 -\"}, {\"id\": \"4\", \"title\": \"- Installation Progress\", \"level\": 1, \"text\": \"4 - Installation Progress Google Confidential - 20 -\"}, {\"id\": \"5\", \"title\": \"- Chrome First Launch If Chrome has been installed\", \"level\": 1, \"text\": \"5 - Chrome First Launch If Chrome has been installed Criteria Checker During the Term, for each End User who installs the Distributor App, Distributor shall use the [ * ] Criteria Checker to determine if [ * ] can be offered to such End User. If the [ * ] Criteria Checker returns True, Distributor shall offer the End User the opportunity to install the [ * ] in conjunction with the Distributor App. If the [ * ] Criteria Checker returns False Distributor shall: a) not offer the End User the opportunity to install the [ * ] and b) use the [ * ] Criteria Checker to determine whether the [ * ] can be offered to such End User. If the [ * ] Criteria Checker returns True, Distributor shall offer the End User the opportunity to install the [ * ] in conjunction with the Distributor App. If the [ * ] Criteria Checker returns False, Distributor shall not offer such End User the opportunity to install the [ * ]. Prior to Launch, Distributor shall obtain Google's approval of the parameters Distributor uses to call the [ * ] Criteria Checker and [ * ] Criteria Checker Chrome Browser Auto Launch. Distributor shall ensure that the first launch of the Chrome Browser following installation of the Chrome Browser complies with each of the following requirements (the \\\"Chrome Launch Requirements\\\"): (a) The Chrome Browser shall auto-launch immediately prior to the launch of the Distributor App, no earlier and no later. *Confidential treatment requested - 21 - (b) No advertisements, offers, or other communications shall appear between launch of a Distributor App and launch of the Chrome Browser. (c) Upon launch of the Chrome Browser, the Chrome Browser shall immediately appear on the End User's computer desktop exactly as shown in this Exhibit B. Without limiting the preceding sentence, each of the following shall appear on the End User's desktop exactly as shown in this Exhibit B: (i) the location and size of the Chrome Browser window and the Distributor App window, (ii) the z-order of the Distributor App and the Chrome Browser, and (iii) the number and content of the tabs in the Chrome Browser (i.e., the Chrome Browser shall contain exactly two (2) tabs, with the first tab set to google.com, and the second tab set to http://tools.google.com/chrome/intlfen-US/welcome.html (or such other url as Google may specify). In no event shall the Chrome Browser window be minimized. Notwithstanding the foregoing, Distributor may modify the content and design of the Distributor App window provided that Distributor complies with the other restrictions in this Agreement and obtains Google's prior consent. (d) The tabs in the Chrome Browser and the Omnibox shall be clearly visible to the End User as shown in this Exhibit B, regardless of the resolution of the End User's monitor. In no event shall the tabs in the Chrome Browser or the Omnibox be hidden behind a Distributor App. (e) Distributor shall implement (or, if implemented by Google, Distributor shall not modify) the six-month flag (i.e., the functionality that prevents an End User from receiving more than one (1) offer for the Chrome Browser within any six (6)-month period) unless Google has provided written confirmation (including by email) that the 6-months flag can be turned off. Note that this authorisation may be revoked at any time and Distributor shall then include the 6 months flag again in future builds. - 22 -\"}, {\"id\": \"EXHIBIT C\", \"title\": \"Guidelines for Applications Bundled with Google Applications Google has observed a significant increase in the number of reports of software that is engaging in deceptive, malicious and other annoying practices that significantly diminish user perception and enjoyment of the internet. These practices include but are not limited to installing software on computers without obtaining informed end user consent (the so-called \\\"drive-by download\\\"), inundating end users with advertisements without adequate attribution or labeling, exposing users to pornographic material without obtaining informed end user consent, obtaining or transmitting personal information about an end user without obtaining informed end user consent, and interfering with an end user's ability to easily uninstall applications the end user does not wish to be on his or her computer. Google does not wish to be associated with these types of practices. Accordingly, Google has developed the Guidelines set forth below to prevent its trademark, other intellectual property, and services from being used in connection with these practices. Google believes that these Guidelines are necessary to protect Google from any allegation that it has contributed to practices that might be viewed as unlawful or actionable; to preserve the reputation of Google as a provider of trusted software and services in a manner that is beneficial and fair to users and other constituents; and to stem the rising incidence of practices that harm users and diminish the perceived value and reliability of the internet, which are essential to Google's business. With this objective in mind, Google has established the following Guidelines to apply to customer Applications that are bundled with any Google Application. Except to the extent Google has otherwise specifically agreed in writing, Google does not grant permission to, and you will not, bundle any Application with a Google Application unless you ensure that any such Application specified in the agreement between you and Google that incorporated these Guidelines complies with these Guidelines. For the avoidance of doubt, by these Guidelines Google does not intend to, and does not, impose any restrictions on what you may do with any Application that is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services; you remain free to sell any Application you wish (whether or not it complies with these Guidelines) so long as it is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services. In these Guidelines: (a) \\\"you\\\" and \\\"your\\\" refer to the legal entity(ies) that has entered into the contract with Google into which these Guidelines are incorporated, as well as any person or entity acting on your behalf; and (b) \\\"Application\\\" means any application, plug-in, helper, component or other executable code that runs on a user's computer, examples of which include those that provide browser helper objects, instant messaging, chat, email, data, file viewing, media playing, file sharing, games, internet navigation, search and other services. Google Confidential\", \"level\": 1, \"text\": \"EXHIBIT C Guidelines for Applications Bundled with Google Applications Google has observed a significant increase in the number of reports of software that is engaging in deceptive, malicious and other annoying practices that significantly diminish user perception and enjoyment of the internet. These practices include but are not limited to installing software on computers without obtaining informed end user consent (the so-called \\\"drive-by download\\\"), inundating end users with advertisements without adequate attribution or labeling, exposing users to pornographic material without obtaining informed end user consent, obtaining or transmitting personal information about an end user without obtaining informed end user consent, and interfering with an end user's ability to easily uninstall applications the end user does not wish to be on his or her computer. Google does not wish to be associated with these types of practices. Accordingly, Google has developed the Guidelines set forth below to prevent its trademark, other intellectual property, and services from being used in connection with these practices. Google believes that these Guidelines are necessary to protect Google from any allegation that it has contributed to practices that might be viewed as unlawful or actionable; to preserve the reputation of Google as a provider of trusted software and services in a manner that is beneficial and fair to users and other constituents; and to stem the rising incidence of practices that harm users and diminish the perceived value and reliability of the internet, which are essential to Google's business. With this objective in mind, Google has established the following Guidelines to apply to customer Applications that are bundled with any Google Application. Except to the extent Google has otherwise specifically agreed in writing, Google does not grant permission to, and you will not, bundle any Application with a Google Application unless you ensure that any such Application specified in the agreement between you and Google that incorporated these Guidelines complies with these Guidelines. For the avoidance of doubt, by these Guidelines Google does not intend to, and does not, impose any restrictions on what you may do with any Application that is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services; you remain free to sell any Application you wish (whether or not it complies with these Guidelines) so long as it is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services. In these Guidelines: (a) \\\"you\\\" and \\\"your\\\" refer to the legal entity(ies) that has entered into the contract with Google into which these Guidelines are incorporated, as well as any person or entity acting on your behalf; and (b) \\\"Application\\\" means any application, plug-in, helper, component or other executable code that runs on a user's computer, examples of which include those that provide browser helper objects, instant messaging, chat, email, data, file viewing, media playing, file sharing, games, internet navigation, search and other services. Google Confidential - 23 - Google welcomes input about these Guidelines from you and from other interested parties, and is always willing to consider revisions as appropriate to encourage innovation while protecting against deceptive, unfair and harmful practices. Accordingly, Google may update these Guidelines, including the Attachments, from time to time as provided in Section 10 below. If you have any questions about these Guidelines, please do not hesitate to discuss them with your Google account manager. Google Confidential - 24 -\"}, {\"id\": \"1\", \"title\": \"General\", \"level\": 1, \"text\": \"1. General. 1.1 Approval and Ongoing Compliance. You may bundle Google Applications with Applications only to the extent permitted in the signed written agreement into which these Guidelines have been incorporated. In such instance, you must ensure that your Application both (1) has been approved by Google for the purpose of being bundled with Google Applications in writing in advance, and (2) complies at all times with the requirements outlined herein. To obtain Google's approval for any Applications not expressly approved in your agreement, you must submit a written request. 1.2 No Google Branding or Attribution. Your Application, and any related collateral material (including any Web pages promoting your Application or from which your Application is made available), must not contain any Google branding, trademarks or attribution unless (and then only to the extent) Google expressly consents otherwise in writing. In addition, queries entered into Applications may not resolve to a results page that contains any Google branding, trademarks or attribution unless (and then only to the extent) Google expressly consents otherwise in writing. 2. Prohibited Content. You may not bundle any Google Application with an Application that: (a) contains any viruses, worms, trojan horses, or the like; and (b) is distributed primarily for the purpose of (i) distributing pornographic, obscene, excessively profane, gambling-related, deceptive, fraudulent or illegal content, or (ii) distributing content related to \\\"hacking\\\" or \\\"cracking.\\\" 3. Prohibited Behavior. You may not bundle any Google Application with an Application that engages in deceptive, unfair, harassing or otherwise annoying practices. For example, the Application may not: Google Confidential (a) use, or permit an unaffiliated person to use, an end user's computer system for any purpose not understood and affirmatively consented to by the end user (including, without limitation, for purposes of consuming bandwidth or computer resources, sending email messages, launching denial of service attacks, accruing toll charges through a dialer or obtaining personal information from an end user's computer such as login, password, account or other information personal to the end user); (b) intentionally create or exploit any security vulnerabilities in end user computers; (c) trigger pop-ups, pop-unders, exit windows, or similar obstructive or intrusive functionality, that materially interfere with an end user's Web navigation or browsing or the use of his or her computer; (d) repeatedly ask an end user to take, or try to deceive an end user into taking, an action that the end user has previously declined to take (such as repeatedly asking an end user to change his or her home page or some other setting or configuration); - 25 -\"}, {\"id\": \"4\", \"title\": \"Disclosure and Consent\", \"level\": 1, \"text\": \"4. Disclosure and Consent. 4.1 Disclosure and Consent before Installation. You may not bundle any Google Application with any Application unless you (and your distribution and bundling partners, if applicable under the terms of the agreement between you and Google that incorporates these Guidelines) design the installation of any such Application in a manner that ensures that it is installed by end users in a knowing and willful manner - e.g., no \\\"drive-by' downloads or installs. By \\\"distribution partner\\\" we mean any third party who distributes your Application and by \\\"bundling partner\\\" we mean any third party who installs your Application in combination with or alongside one or more other Applications. At a minimum, compliance with this provision requires that, prior to installing your Application, you and any third party distributing or bundling your Application:\"}, {\"id\": \"4.2\", \"title\": \"Disclosure and Consent for Collection and Transmission of Personally Identifiable information\", \"level\": 2, \"text\": \"4.2 Disclosure and Consent for Collection and Transmission of Personally Identifiable information. You may not bundle any Google Application with any Application that (1) collects or transmits to any entity other than the end user personally identifiable information, or (2) collects or transmits information related to a user's computer or Internet usage or activity in a manner that could collect or transmit such user's personally identifiable information (such as through keystroke logging), unless prior to the first occurrence of any such collection or transmission you: Google Confidential (e) redirect browser traffic away from valid DNS entries (except that your Application may direct unresolved URLs to an alternative URL designated by you, provided that the page to which the end user resolves adequately informs the end user that you and your Application are the source of that page); (f) interfere with the browser default search functionality (except that your Application may permit an end user to change his or her default search engine with proper disclosure, consent and attribution as provided below); or (g) engage in activity that violates any applicable Jaw or regulation. (a) first, fully, accurately, clearly and conspicuously disclose to end users: (i) that they are installing an application, (ii) the name of the Application, identifying you as the entity responsible for it, and (iii) the principal and significant features and functionality of the Application; and (b) then, obtain the end user's affirmative consent to install the Application. (a) first, fully, accurately, clearly and conspicuously disclose: - 26 -\"}, {\"id\": \"4.3\", \"title\": \"Disclosure and Consent for Setting Changes\", \"level\": 2, \"text\": \"4.3 Disclosure and Consent for Setting Changes. You may not bundle any Google Application with any Application that makes a change to any operating system or Application data setting which will impact the user experience of other Applications (e.g., changing the browser default home page or changing the default application for a file type, such as the default email, browser or media player application), unless prior to making such change you: Notwithstanding the foregoing, (i) no disclosure and consent need be made for changes to operating system or Application data settings that have only a minor impact on user experience, such as adding a small number of bookmarks to the browser menu or adding an item to a start menu, and (ii) the disclosure and consent requirements of this Section 4.3 will not apply to those setting changes that may be made prior to sale to the end user. 4.4 Method of Disclosure and Consent. In order to satisfy the requirements above, the disclosure of the items specified above (a) must be provided in both (1) the End User License Agreement (EULA) or privacy policy (to the extent required by law or otherwise by industry custom) and (2) separately from the EULA and/or privacy policy (e.g. in installation screens or message boxes, as the case may be), and (b) must be designed so that it will be read by, adequately inform and evidence the consent of a typical Internet user. See Attachment 1 for sample disclosure and consent implementations that would satisfy certain of the requirements above. 4.5 EULA and Privacy Policy. You may not bundle any Google Application with any Application unless it conforms, and is distributed pursuant to a EULA that conforms, with all applicable laws and regulations. In addition, you and your Application must comply with the agreements and representations you make with your end users in your EULA and privacy policy. Your privacy policy must be accessible from your Application in an easily found location. If your Application collects or transmits any other information related to the user's use of his or her computer, but not required to be disclosed and consented to pursuant to Section 4.2, then the collection and use of such other information must be disclosed in your privacy policy. Google Confidential (i) the type of information collected (described with specificity in the case of personally identifiable information), (ii) the method of collection (e.g. by registration, etc.), and (iii) the location of (i.e., a link to) the privacy policy that governs the collection, use and disclosure of the information; and (b) then, obtain the end user's affirmative consent to such collection and/or transmission. (a) first, fully, accurately, clearly and conspicuously disclose the change in a manner that will explain the practical effect of such change; and (b) then, obtain the end user's affirmative consent to make such change. - 27 -\"}, {\"id\": \"5\", \"title\": \"Transparency\", \"level\": 1, \"text\": \"5. Transparency. Neither you nor any of your third party distribution or bundling partners may mislead end users or create end user confusion with regard to the source or owner of an Application or any portion of its purpose, functionality or features. For example, all elements of your Application that are visible to the end user must clearly identify their source through its branding and attribution, and that identification, whatever form it takes, must correspond to the identification of your application in the menu that permits end users to remove programs. You must clearly label advertisements provided by your Application (if any) as such and clearly identify your Application as the source of those advertisements. In addition, if your Application modifies the operation or display of other applications or Web sites (other than Web sites that you own), then in each instance you must clearly and conspicuously attribute the source of that modification to your Application (as distinct from the application or Web site modified) in a manner that will inform a typical Internet user; provided that this requirement will not apply to modifications for which you obtain disclosure and consent pursuant to Section 4.3. See Attachment 1 for examples of modifications that are clearly and conspicuously disclosed to end users. 6. Deactivation. You may not bundle any Google Application with any Application that impairs an end user's ability to change any preferences or settings set by the Application in accordance with the way that such preferences or settings ordinarily may be changed by the applicable Application. Once disabled by an end user, your Application may not be re-enabled without an affirmative action by the end user to explicitly re- enable your application. Accordingly, no use, update, installation or re-enablement of a separate Application, and no code downloaded as a result of browsing a Web site, may operate to re-enable your Application. Your Application must permit end users to uninstall it (in the customary place the applicable operating system has designated for adding or removing programs, e.g., Add/Remove Programs control panel in Windows) in a straightforward manner, without undue effort or skill. In addition, your Application, when running, must provide (in an easily found location) clear and concise instructions on how it may be uninstalled. Once uninstalled, your Application must not leave behind any functionality or design elements, and all setting changes made by the application, but not explicitly agreed to by the end user, should be reversed to the extent practicable. 7. Bundling of Applications. In addition to the requirements set forth in the agreement between you and Google that incorporates these Guidelines, in order for you to bundle any Application with a Google Application must satisfy each of the following requirements: Google Confidential (a) the end user is made aware of all of the Applications included in the bundle prior to any installation; (b) all such Applications included in the bundle or download comply with the provisions of Section 2 through 6 of these Guidelines; (c) if Applications in a bundle in which you are participating are supported in part by revenue generated by advertising displayed in another independent Application included in that bundle and the continued use of the Application is conditioned on such other independent Application remaining installed and active on the end user's computer, the end user must be made aware of that relationship; and - 28 -\"}, {\"id\": \"8\", \"title\": \"Information and Assistance\", \"level\": 1, \"text\": \"8. Information and Assistance. Subject to any confidentiality obligations owed to third parties, you must provide Google with such information as Google may reasonably request about the distribution of those of your Applications that are bundled with any Google Application. For example, we may ask you to share with us: (a) the means by and/or the locations from which your Applications are distributed; or (b) the identity of any applications included in any of your bundling relationships (and the entities responsible for such applications). In addition, you must provide such assistance as Google may reasonably request to investigate and stop potential violations of these Guidelines that may be connected to your Application, including by way of using such number of identifiers and other tracking parameters as Google may reasonably request. This would include providing Google with \\\"golden masters\\\" of any bundle or other distribution that includes your Application, or working with Google to stop any entities that may be financially benefiting from your Application from engaging in any of these proscribed practices. You understand, however, that Google has no obligation to provide support to end users of your Application. For the avoidance of doubt, these information and assistance rights do not extend to any of your Applications that are not used to access Google services, bundled with a Google Application, or bundled with an Application that accesses Google services. 9. Legal. You must maintain ownership and control of your Application at all times to the extent required to practically and legally enforce the requirements of these guidelines. If you are seeking to permit a third party Application to be bundled with a Google Application, then you must also obtain Google's written approval of that third party Application (in addition to the approval required for your Application). If Google approves the third party Application, you are responsible for ensuring that such third party Application also complies with these Guidelines. Special indemnity and other suspension and/or termination provisions may apply. These are addressed in your agreement with Google. 10. Updates. 10.1 General. As mentioned above, Google may update these Guidelines, including the Attachments, from time to time; provided, however, that no updates will be effective until Google provides you with thirty (30) days' written notice thereof. Once you receive that notice (the date on which you receive such notice, the \\\"Update Notice Date\\\"), you will be required to bring your Application into compliance within thirty (30) days Google Confidential (d) either (1) the bundle must provide for a master uninstaller that will enable the end user to uninstall every Application in the bundle without undue effort or skill, or (2) if no master uninstaller is provided, the de-installation of any Application may not be dependent or conditioned upon the de-installation of any other Application included in the bundle. - 29 -\"}, {\"id\": \"10.2\", \"title\": \"Extended Compliance Period\", \"level\": 2, \"text\": \"10.2 Extended Compliance Period. If, solely as a result of an updated requirement, one or more of your Applications no longer complies with these Guidelines, as updated, and you are incapable of bringing such Application into compliance prior to the scheduled effective date of such update (the \\\"Update Effective Date\\\"), you agree to provide Google with written notice thereof as soon as reasonably practicable, but in any event no later than the Update Effective Date, identifying the Application and the reasons why it may not be brought into compliance prior to the Update Effective Date, and providing such other detail as Google may reasonably request with respect thereto (consistent in any event with your confidentiality obligations). Thereafter, the parties will consult, and you agree to will work, diligently and in good faith to develop and execute a plan to bring such Application into compliance with these Guidelines, as updated, as soon as reasonably practicable, but in any event within ninety (90) days of the Update Notice Date (the \\\"Maximum Compliance Period\\\"). You agree that you will provide Google with such information as Google reasonably requests during this period to keep Google apprised of your progress in bringing your Application into compliance. Notwithstanding the foregoing (but subject to the next sentence), in no event may a new requirement provided for in any update to these Guidelines require you to take any action which would violate the terms of any agreement between you and any unaffiliated third party that is in effect on the date that Google delivers notice of the proposed update. In any event, if you are unable to bring any Application into compliance during the Maximum Compliance Period, Google may elect, by providing at least thirty (30) days prior written notice, to require you to cease bundling either the specific non-conforming Application or those versions of the Application which are, or are distributed, in violation of the Guidelines, as updated; it being understood that, at such time, you will be entitled to procure services from an alternative source for those Applications (or versions thereof) with respect to which Google has exercised such election. Google Confidential - 30 -\"}, {\"id\": \"Attachment 1\", \"title\": \"Prohibited Behavior and Content The application may not impact the display of other applications unless you provide clear disclosure in each instance\", \"level\": 1, \"text\": \"Attachment 1 Prohibited Behavior and Content The application may not impact the display of other applications unless you provide clear disclosure in each instance Google Confidential - 31 - Google Confidential - 32 - Disclosure and Consent Clear and conspicuous disclosure is required prior to download or install: what it is, what it does, and how it will be displayed to the end user Disclosure and Consent Describe type, method, and use of personal information, if applicable. Point user to privacy policy Google Confidential - 33 - Google Confidential - 34 - Branding & Attribution The visible elements of the application should be easily identifiable to the end user Google Confidential - 35 - Implementation, Transparency and Deactivation The Application must permit end users to uninstall it in the customary place the applicable operating system has designated for adding or removing programs (e.g., Add/Remove Programs control panel in Windows) in a straightforward manner Google Confidential - 36 - Google Confidential - 37 - Implementation, Transparency and Deactivation The Application must contain (in an easily found location) clear and concise instructions on how it may be uninstalled Google Confidential - 38 - Bundling of Applications When bundling, the end user must be made aware of all the applications included prior to installation. Google Confidential - 39 - Bundling of Applications When bundling, the end user must be made aware of advertising revenue relationships to other applications, if the continued use of the primary application is conditioned on the other applications being installed and active on the end user's computer Google Confidential - 40 -\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of WHITESMOKE,INC_11_08_2011-EX-10.26-PROMOTION AND DISTRIBUTION AGREEMENT\", \"nodes\": [{\"id\": \"Exhibit 10.26\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK [*], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PROMOTION AND DISTRIBUTION AGREEMENT This Promotion and Distribution Agreement including all exhibits (collectively referred to as the \\\"Agreement\\\"), effective as of 1 August 2011 (the \\\"Effective Date\\\"), is made by and between Whitesmoke Inc., with registered offices/principle place of business at 501 Silverside Road, Suite 105, Wilmington DE 19809, USA, (\\\"Distributor\\\"), and Google Inc whose principle place of business is at 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (\\\"Google\\\").\", \"level\": 2, \"text\": \"Exhibit 10.26 CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK [*], HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PROMOTION AND DISTRIBUTION AGREEMENT This Promotion and Distribution Agreement including all exhibits (collectively referred to as the \\\"Agreement\\\"), effective as of 1 August 2011 (the \\\"Effective Date\\\"), is made by and between Whitesmoke Inc., with registered offices/principle place of business at 501 Silverside Road, Suite 105, Wilmington DE 19809, USA, (\\\"Distributor\\\"), and Google Inc whose principle place of business is at 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (\\\"Google\\\"). \\\"Bundle\\\" means the Distribution Products bundled with the Distributor App(s). \\\"Chrome Browser\\\" means the machine-readable binary code version of the Google Chrome browser provided to Distributor in connection with this Agreement, and any modifications or updates to it that Google may provide to Distributor. \\\"Chrome Browser Installer\\\" means: (a) the machine-readable binary code version of the installer provided to Distributor in connection with this Agreement that installs the Chrome Browser, and any modifications, updates or upgrades to it that Google may provide to Distributor; and (b) the Chrome Browser Criteria Checker. \\\"Chrome Use Event\\\" means an event that indicates an [* ] has occurred. \\\"Chrome Server Communication\\\" means a communication that, as determined solely by Google, is sent for the purpose of indicating that an End User: (a) is [* ] to the [* ]; and (b) has kept the [* ] open for a minimum of [* ] during a [* ] (whether during the [* ] or a [* ] of the Chrome Browser). \\\"Criteria Checker\\\" means a set of software routines (and any updates to them) provided to Distributor by Google, as part of a software library, that check certain criteria (as determined by Google and modified by Google from time to time) to determine if the Chrome Browser or Google Toolbar (as applicable) can be installed on an End User's operating system. Accordingly, \\\"Chrome Browser Criteria Checker\\\" means the Criteria Checker provided by Google in respect of the Chrome Browser and \\\"Google Toolbar Criteria Checker\\\" means the Criteria Checker provided by Google in respect of the Google Toolbar. \\\"Distributor App(s)\\\" means the following application (and successor versions of such software): the trial version of the WhiteSmoke Writer (currently called WhiteSmoke 2011) available on a worldwide basis, but for the avoidance of doubt shall not mean any other products of Distributor, including without limitation the full paid version of Whitesmoke Writer or any version of Whitesmoke \\\"Translator\\\" software, regardless of whether Whitesmoke Writer incorporates any translation functionality. *Confidential treatment requested Google Confidential\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"1. DEFINITIONS\"}}, {\"id\": \"1.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In this Agreement unless expressly stated otherwise\", \"level\": 2, \"text\": \"1.1 In this Agreement unless expressly stated otherwise: - 1 - \\\"Distribution Products\\\" means: \\\"End User\\\" means an end user customer of Distributor who is located in the Territory. \\\"EULA\\\" means the end user license agreement applicable to a Product, which end user license agreement may be updated or modified by Google in its sole discretion from time to time. \\\"False\\\" means a \\\"false\\\" response (or equivalent negative response) given by the Criteria Checker. \\\"Google Program Guidelines\\\" means the policy and implementation guidelines applicable to the Products as updated by Google and provided to Distributor from time to time. \\\"Google Toolbar\\\" means the machine-readable binary code version of the Google toolbar for Internet Explorer provided to Distributor in connection with this Agreement, and any modifications or updates to it that Google may provide to Distributor. \\\"Google Toolbar Installer\\\" means: (a) the machine-readable binary code version of the installer provided to Distributor in connection with this Agreement that installs the Google Toolbar, and any modifications, updates or upgrades to it that Google may provide to Distributor; and (b) the Google Toolbar Criteria Checker. \\\"Google Trademarks\\\" means all names, trade names, trademarks, and logos used by Google in connection with the Products. \\\"Group Company\\\" means in relation to each of the parties: \\\"Install Completed\\\" occurs when an End User has completed the install process for a Bundle and the install completed screen is shown to the End User in accordance with Exhibit B. (a) as at the Effective Date, the Google Toolbar Installer and the Chrome Browser Installer; and (b) if Distributor notifies Google at any time after the Effective Date that it wishes to bundle the full Google Toolbar and Google provides its approval in writing (including email), the Google Toolbar; and (c) if Distributor notifies Google at any time after the Effective Date that it wishes to bundle the full Chrome Browser and Google provides its approval in writing (including email), the Chrome Browser. (a) any parent company of that party; and (b) any corporate body of which that party directly or indirectly has control or which is directly or indirectly controlled by the same person or group of persons as that party. - 2 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"1.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In this Agreement, the words \\\"include\\\" and \\\"including\\\" will not limit the generality of any words preceding them\", \"level\": 2, \"text\": \"1.2 In this Agreement, the words \\\"include\\\" and \\\"including\\\" will not limit the generality of any words preceding them.\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSE GRANTS AND RESTRICTIONS\", \"level\": 1, \"text\": \"2. LICENSE GRANTS AND RESTRICTIONS\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Products License Grant\", \"level\": 2, \"text\": \"2.1 Products License Grant. Subject to the terms and conditions of this Agreement, Google grants to Distributor a [* ] license during the Term to: (a) bundle the Distribution Products, in machine-readable binary code format only, solely with Distributor App(s); (b) distribute Bundles directly (or indirectly, subject to Clause 2.2 (Third Party Distribution)) to End Users in the Territory; (c) when indicated by the applicable Criteria Checker and requested by the End User in accordance with clause 3.2 (Form of Distribution Offering), install the Chrome Browser or the Google Toolbar (as applicable) on the End User's system using the Google Installers; and (d) reproduce (or have reproduced by Third Party Distributors as defined in Clause 2.2 (Third Party Distribution)), the Distribution Products to the extent necessary to exercise the rights granted in (a), (b) and (c). - 3 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Third Party Distribution\", \"level\": 2, \"text\": \"2.2 Third Party Distribution. Distributor may distribute Bundles to third parties solely for redistribution of such Bundles by those third parties directly to End Users (such third parties, \\\"Third Party Distributors\\\"); provided that: (a) in connection with any and all such offers or distributions, Distributor shall, and shall ensure that each Third Party Distributor shall, distribute Bundles in a manner that is no less protective of the Products and Google than the terms of this Agreement, and (b) Google in its sole discretion may direct Distributor to cease distributing Bundles to any Third Party Distributor that in Google's sole discretion would either: (i) harm or devalue Google's business, brand or name, or (ii) violate Google's privacy policy, and Distributor shall cause any such Third Party Distributor to cease distribution of Bundles as soon as practicable but in no event longer than [ * ] following receipt of such request from Google. Distributor shall ensure that no Third Party Distributor bundles anything in or with Bundles without Google's prior written approval, and if Google grants its approval, Distributor shall provide Google with information about any such bundling arrangements at Google's request.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"License Grant Restrictions\", \"level\": 2, \"text\": \"2.3 License Grant Restrictions. Distributor shall not, and shall not allow any third party to (except to the extent that such prohibitions are not permitted by law): (a) disassemble, de-compile or otherwise reverse engineer the Products or otherwise attempt to learn the source code or algorithms underlying the Products; (b) modify the Products, create derivative works from or based on the Products; (c) except as expressly set out in this Agreement, provide, sell, license, distribute, lease, lend, or disclose the Products to any third party; (d) use the Products for timeshare, service bureau, or other unauthorised purposes; or (e) exceed the scope of any license granted to Distributor under this Agreement.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademark License and Use\", \"level\": 2, \"text\": \"2.4 Trademark License and Use. Subject to the terms and conditions of this Agreement, Google grants to Distributor a limited, [ * ] license during the Term to use the Google Trademarks, in accordance with Google's trademark usage guidelines, solely to market and promote the Products consistent with this Agreement, provided that all use of the Google Trademarks shall be subject to Google's prior review and advance written consent. All uses of the Google Trademarks, and all goodwill associated therewith, shall inure solely to the benefit of Google.\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Trademark Restrictions\", \"level\": 2, \"text\": \"2.5 Trademark Restrictions. Distributor shall not remove, modify, adapt, or prepare derivative works of any Google Trademarks or Google copyright notices, or other Google proprietary rights notices.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Updated Versions of Distribution Products\", \"level\": 2, \"text\": \"2.6 Updated Versions of Distribution Products. Google may request that Distributor distribute the latest version of the Distribution Products. Distributor shall begin such distribution within [ * ] following Google's request.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTION AND OTHER OBLIGATIONS\", \"level\": 1, \"text\": \"3. DISTRIBUTION AND OTHER OBLIGATIONS\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Delivery\", \"level\": 2, \"text\": \"3.1 Delivery. Google shall deliver the Distribution Products electronically to Distributor at a [ * ] following the Effective Date and prior to Launch (as defined in Clause 3.4 (Launch)). - 4 - User to review such EULA via a hyperlink to such EULA: and (c) a button on which each End User may click indicating agreement to the terms of such EULA. In the event that an End User does not affirmatively agree to install the Google Toolbar or Chrome Browser, by clicking on the button to agree to the terms of the applicable EULA, then the Google Toolbar or Chrome Browser (as applicable) shall not be installed on such End User's computer. *Confidential treatment requested Google Confidential\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Form of Distribution Offering\", \"level\": 2, \"text\": \"3.2 Form of Distribution Offering. Distributor shall ensure that the form of any offering of the Products by Distributor, including the timing, relative and absolute placement, visual presentation to End Users, initial launch of the Products (and any modifications to them) and the presentation of any other applications or products offered with the Products, conforms to the Google Program Guidelines and to Exhibit B of this Agreement. Except as set out in Clause 2 (Licence Grant and Restrictions) and except for End Users as expressly set out in this Agreement, Distributor shall not offer or distribute the Products to any third party. If, during the Term, Exhibit B and the Google Program Guidelines conflict, Exhibit B will take precedence with respect to the conflicting terms.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Guidelines for Applications\", \"level\": 2, \"text\": \"3.3 Guidelines for Applications. Distributor shall comply, and shall ensure that each Third Party Distributor complies, with the Guidelines for Applications set out in Exhibit C.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Launch\", \"level\": 2, \"text\": \"3.4 Launch. Distributor shall begin distribution of Bundles in accordance with this Agreement (\\\"Launch\\\") within [ * ] days following the Effective Date (the date of such Launch, the \\\"Launch Date\\\"). Beginning on the Launch Date and continuing throughout the Term, Distributor shall ensure that [ * ]Distributor App distributed by or on behalf of Distributor is bundled with the Distribution Products as set out in this Agreement.\"}}, {\"id\": \"3.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Exclusivity\", \"level\": 2, \"text\": \"3.5 Exclusivity. (a) [ * ] (b) [ * ].\"}}, {\"id\": \"3.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EULA\", \"level\": 2, \"text\": \"3.6 EULA. In connection with Distributor's distribution of the Products under this Agreement, and before the Google Toolbar or Chrome Browser can be installed by an End User, Distributor shall provide each End User with: (a) a clear statement inviting the End User to agree to the terms of the applicable EULA; (b) the opportunity for each End\"}}, {\"id\": \"3.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Accurate Reproduction\", \"level\": 2, \"text\": \"3.7 Accurate Reproduction. Distributor agrees that in connection with its exercise of the right granted in Clause 2.1 (Products Licence Grant) it shall accurately reproduce the Distribution Products and shall not: (a) modify any Product (including modify the Chrome Browser or Google Toolbar configuration files or registry settings); or (b) insert into the Products any viruses, worms, date bombs, time bombs, or other code that is specifically designed to cause the Products to cease operating, or to damage, interrupt, or interfere with any Products or End User data.\"}}, {\"id\": \"3.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[ * ]\", \"level\": 2, \"text\": \"3.8 [ * ]. During the Term and for a period of [ * ] following the expiration or termination of this Agreement, Distributor shall not, and shall not engage any third party to: (a) restrict, modify, or reconfigure in any manner any of the Products that have been installed by End Users (such End Users, \\\"Installed Base End Users\\\") in connection with this Agreement; or (b) engage in activities that encourage Installed Base End Users to modify, uninstall or reconfigure any or the Products. - 5 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"3.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reporting\", \"level\": 2, \"text\": \"3.9 Reporting. (a) By Distributor. During the Term, Distributor shall, on a [ * ] basis, no later than the [ * ] of the following [ * ], provide Google with a report identifying, on a country-by-country basis, the total number of: (i) Bundles distributed; (ii) Installs Completed; (iii) Google Toolbar offers presented to End Users; and (iv) Chrome Browser offers presented to End Users, in the preceding [ * ]. (b) By Google. During the Term, Google shall on a [ * ] basis, provide Distributor with a report of the [ * ] of [ * ] and [ * ] in the preceding [ * ] broken down on a [ * ] basis and by the [ * ] in Exhibit A. (c) Parameters. Distributor acknowledges, and shall cooperate with Google to [ * ] that: (i) [ * ]: (A) are determined on a [ * ] (B) are only [ * ]; (C) do not include [ * ] from computers on which another [ * ] of the [ * ] is [ * ]; and (D) do not include use of the [ * ] in any [ * ] other than [ * ]. (ii) [ * ] do not include: (A) [ * ] that has been [ * ], (B) [ * ] or [ * ] in any area other than in the [ * ], or (C) any other [ * ] of the [ * ] designed to artificially [ * ]. (iii) [ * ]: (A) are determined on a [ * ]; (B) are only [ * ]; (C) are not sent in response to [ * ] from computers on which another [ * ] of the [ * ] is [ * ]; and (D) are sent only in response to [ * ] from computers that meet the [ * ] requirements as determined by the [ * ]. (d) Records and Audit Rights. Distributor will keep and maintain complete and accurate books, records, and accounts relating to this Agreement. During the Term, and for a period of [ * ] thereafter, Google may audit Distributor's relevant records to confirm Distributor's compliance with this Agreement. Google's auditor will only have access to those books and records of Distributor which are reasonably necessary to confirm such compliance.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT TERMS\", \"level\": 1, \"text\": \"4. PAYMENT TERMS\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payments\", \"level\": 2, \"text\": \"4.1 Payments. Subject to Clause 4.2, during the Term on a [ * ] basis, Google shall pay to Distributor the applicable payment set out in Exhibit A for each [ * ] and each [ * ] that occurred during the previous [ * ]. Google shall determine the [ * ] in respect of which each [ * ] and [ * ] took [ * ] (using the relevant [ * ]). Notwithstanding the foregoing, in no event will the [ * ] of [ * ] by Google to Distributor for all [ * ] and all [ * ] in respect of [ * ] (as set out in Exhibit A) exceed [ * ] ([ * ]) of the [ * ] to Distributor for such [ * ].\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"[ * ]\", \"level\": 2, \"text\": \"4.2 [ * ]. Notwithstanding anything to the contrary, in no event shall the [ * ] paid or payable to Distributor by Google pursuant to Clause 4.1 (Payments) exceed the [ * ]. Google shall have the right, at its sole option, to increase the [ * ] by providing written notice to Distributor no later than [ * ] prior to the end of the Term. The foregoing sentence shall not relieve Google of any payment obligations that have accrued prior to the achievement of the [ * ].\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payment Terms\", \"level\": 2, \"text\": \"4.3 Payment Terms. All payments under this Agreement shall be made in [ * ] in the [ * ] following the [ * ] for which the payments are applicable. The party receiving payment will be responsible for any bank charges assessed by the recipient's bank. In addition to other rights and remedies Google may have, Google may offset any payment obligations to Distributor that Google may incur under this Agreement against any product or service fees owed to Google and not yet paid by Distributor under any agreement between Distributor and Google. Google may also withhold and offset against its payment obligations under this Agreement, or require Distributor to pay to Google within [ * ] of any invoice, any amounts Google [ * ] overpaid to Distributor in prior periods. - 6 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Taxes\", \"level\": 2, \"text\": \"4.4 Taxes. All payments under this Agreement are exclusive of taxes imposed by any governmental entity. Google shall pay any applicable taxes imposed by governmental agencies with respect to the transactions under this Agreement other than taxes based upon Distributor's income. Google shall promptly provide to Distributor a copy of an official tax receipt or other appropriate evidence of any taxes imposed on payments made under this Agreement. When Distributor has the legal obligation to collect any applicable taxes, the appropriate amount shall be invoiced to and paid by Google unless Google provides Distributor with a valid tax exemption certificate authorised by the appropriate taxing authority.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Interest\", \"level\": 2, \"text\": \"4.5 Interest. Distributor may charge interest at the rate of [ * ] above the base rate of Barclays Bank PLC from time to time, from the due date until the date of actual payment, whether before or after judgment, on any payment pursuant to this Clause 4 (Payment Terms) which is overdue.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"5. TERM AND TERMINATION\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Term\", \"level\": 2, \"text\": \"5.1 Term. This Agreement shall commence on the Effective Date and, unless earlier terminated as set out in this Agreement, shall continue for the Term.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for breach\", \"level\": 2, \"text\": \"5.2 Termination for breach. A party may suspend performance and/or terminate this Agreement, with immediate effect, if the other party: (a) is in material breach of this Agreement where the breach is incapable of remedy; or (b) is in material breach of this Agreement where the breach is capable of remedy and fails to remedy that breach within thirty (30) days after receiving written notice of such breach.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Termination for insolvency\", \"level\": 2, \"text\": \"5.3 Termination for insolvency. A party may suspend performance and/or terminate this Agreement with immediate effect, if: (a) the other party enters into an arrangement or composition with or for the benefit of its creditors, goes into administration, receivership or administrative receivership, is declared bankrupt or insolvent or is dissolved or otherwise ceases to carry on business; or (b) any analogous event happens to the other party in any jurisdiction in which it is incorporated or resident or in which it carries on business or has assets.\"}}, {\"id\": \"5.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Change of Control\", \"level\": 2, \"text\": \"5.4 Change of Control. [ * ] may terminate this Agreement immediately upon written notice if there is a Change of Control of [ * ]. In this Clause the term \\\"Control\\\" shall mean the possession by any person(s) directly or indirectly of the power to direct or cause the direction of another person and \\\"Change of Control\\\" is to be construed accordingly. [ * ] expected to experience, or [ * ] is experiencing, such Change of Control shall notify [ * ] in writing of this before or within [ * ] after the Change of Control. If [ * ] has not exercised its right of termination under this Clause within [ * ] following the later of (i) the receipt of notice of [ * ] Change of Control or (ii) the Change of Control event, that [ * ]. The parties acknowledge that as at the Effective Date, [ * ] may [ * ] its [ * ]. [ * ] agrees not to exercise its termination right under this clause 5.4 if [ * ], provided that following [ * ]: - 7 - For the avoidance of doubt, if following [ * ] there is a transfer of shareholding or interests in Distributor to any existing or new shareholder(s) which results in any person or persons subsequently gaining Control of Distributor, then Google may exercise its right to terminate in accordance with this clause 5.4.. *Confidential treatment requested Google Confidential\"}}, {\"id\": \"5.4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"no one person Controls [ * ] (other than an[ * ] which is not a [ * ] of [ * ] (as determined by [ * ]in its sole discr\", \"level\": 3, \"text\": \"5.4.1. no one person Controls [ * ] (other than an[ * ] which is not a [ * ] of [ * ] (as determined by [ * ]in its sole discretion)); and\"}}, {\"id\": \"5.4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"no [ * ] of [ * ] (as determined by [ * ] in its sole discretion) holds a [ * ] or [ * ] in [ * ]\", \"level\": 3, \"text\": \"5.4.2. no [ * ] of [ * ] (as determined by [ * ] in its sole discretion) holds a [ * ] or [ * ] in [ * ].\"}}, {\"id\": \"5.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Effect of Termination\", \"level\": 2, \"text\": \"5.6 Effect of Termination. Upon expiration or termination of this Agreement: (a) all rights and licenses granted under this Agreement shall immediately cease; (b) Distributor shall (and shall ensure that any Third Party Distributors shall) immediately stop reproducing the Products and offering or distributing Bundles; (c) Distributor shall return or destroy (and a duly appointed officer of Distributor shall certify to such destruction) all copies of the Products and any other Google Confidential Information in its possession; and (d) the fees payable to Distributor shall immediately cease accruing and Google shall within [ * ] following such expiration or termination pay to Distributor any undisputed amounts which have accrued from the time of the most recent payment to Distributor through the date of termination or expiration of this Agreement. Clauses 5.6 (Effect of Termination), 6 (Confidential Information), 7 (Proprietary Rights), 9 (Limitation of Liability), 10 (Indemnification) and 11 (General) shall survive the termination or expiration of this Agreement. - 8 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CONFIDENTIAL INFORMATION\", \"level\": 1, \"text\": \"6. CONFIDENTIAL INFORMATION\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"In this Agreement, \\\"Confidential Information\\\" means information disclosed by (or on behalf of) one party to the other pa\", \"level\": 2, \"text\": \"6.1 In this Agreement, \\\"Confidential Information\\\" means information disclosed by (or on behalf of) one party to the other party under this Agreement that is marked as confidential or, from its nature, content or the circumstances in which it is disclosed, might reasonably be supposed to be confidential, including the terms and conditions (including the Exhibits) of this Agreement. It does not include information that the recipient already knew, that becomes public through no fault of the recipient, that was independently developed by the recipient or that was lawfully given to the recipient by a third party.\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The recipient of any Confidential Information shall not disclose that Confidential Information, except to Group Companie\", \"level\": 2, \"text\": \"6.2 The recipient of any Confidential Information shall not disclose that Confidential Information, except to Group Companies, employees and/or professional advisors who need to know it and who have agreed in writing (or in the case of professional advisors are otherwise bound) to keep it confidential. The recipient shall ensure that those people and entities: (a) use such Confidential Information only to exercise rights and fulfill obligations under this Agreement, and (b) keep such Confidential Information confidential. The recipient may also disclose Confidential Information when required by law, or the regulation or rule of a major US stock exchange or the United States Securities and Exchange Commission, after giving reasonable notice to the discloser, such notice to be sufficient to give the discloser: (i) the opportunity to seek confidential treatment, a protective order or similar remedies or relief prior to disclosure (if applicable) and (ii) (where any disclosure is necessary) time to consult on and approve the form and content of the relevant disclosure. The parties shall then promptly discuss and agree in good faith on the form and content of the disclosure (each acting reasonably).\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROPRIETARY RIGHTS\", \"level\": 1, \"text\": \"7. PROPRIETARY RIGHTS\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor acknowledges that Google and/or its licensors own all right, title and interest, including all Intellectual\", \"level\": 2, \"text\": \"7.1 Distributor acknowledges that Google and/or its licensors own all right, title and interest, including all Intellectual Property Rights in and to the Products and the Google Trademarks and all modifications to them. Distributor has, and shall acquire, no rights in the foregoing except those expressly granted by this Agreement. Google shall not be restricted from selling, licensing, modifying, or otherwise distributing the Products and/or the Google Trademarks to any third party.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Google acknowledges that Distributor and/or its licensors own all right, title and interest, including all Intellectual\", \"level\": 2, \"text\": \"7.2 Google acknowledges that Distributor and/or its licensors own all right, title and interest, including all Intellectual Property Rights, in and to the Distributor Apps and all [ * ] to [ * ]. Except as expressly set forth in this Agreement, Distributor shall not be [ * ]from [ * ], or otherwise [ * ]the Distributor App(s) or other products of Distributor to [ * ].\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WARRANTIES\", \"level\": 1, \"text\": \"8. WARRANTIES\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Each party warrants to the other that it will use reasonable care and skill in complying with its obligations under this\", \"level\": 2, \"text\": \"8.1 Each party warrants to the other that it will use reasonable care and skill in complying with its obligations under this Agreement. Distributor also represents and warrants that it will undertake commercially reasonable endeavours in good faith to comply with Google's business partner due diligence process including providing requested information. - 9 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Google warrants that the Distribution Products will for a period of [ * ] from the date of their supply to Distributor b\", \"level\": 2, \"text\": \"8.2 Google warrants that the Distribution Products will for a period of [ * ] from the date of their supply to Distributor be free from any defect which has a materially adverse effect on their use or operation.\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"If any of the warranties in Clause 8\", \"level\": 2, \"text\": \"8.3 If any of the warranties in Clause 8.1 or 8.2 is breached by Google, Distributor must tell Google as soon as possible. Distributor must give Google a reasonable time to fix the problem and (if necessary) to supply Distributor with a corrected or replacement version of the Distribution Product or a way to work-around the problem that is not materially detrimental to Distributor, or to re-perform any relevant services. This will be done without any additional charge to Distributor. If Google is able to do this within a reasonable time, Google will have no other obligations or liability in relation to that breach.\"}}, {\"id\": \"8.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Google will not be liable for breach of any of the warranties or other terms in this Agreement to the extent that the br\", \"level\": 2, \"text\": \"8.4 Google will not be liable for breach of any of the warranties or other terms in this Agreement to the extent that the breach arises from: (a) use of the Products other than in accordance with normal operating procedures; (b) any alterations or maintenance to the Products done by anyone other than Google or someone authorised by Google; (c) any problem with a computer on which the Products are installed, or with any equipment connected to that computer or any other software which is installed on that computer; (d) any abnormal or incorrect operating conditions; or (e) use of the Products in combination with any other hardware or software, unless this use has been approved by Google in writing.\"}}, {\"id\": \"8.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor will comply with all applicable commercial and public anti-bribery laws, including, without limitation, the\", \"level\": 2, \"text\": \"8.5 Distributor will comply with all applicable commercial and public anti-bribery laws, including, without limitation, the UK's Bribery Act 2010 and the U.S. Foreign Corrupt Practices Act of 1977 (\\\"Anti-Bribery Laws\\\"), which prohibit (amongst other things) corrupt offers of anything of value, either directly or indirectly, to a government official to obtain or keep business. ''Government officials\\\" include any government employee, candidate for public office, and employee of government-owned or government-controlled companies, public international organisations, and political parties. Furthermore, Distributor will not make any facilitation payments, which are payments to induce officials to perform routine functions they are otherwise obligated to perform.\"}}, {\"id\": \"8.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No conditions, warranties or other terms apply to the Products, [ * ] or to any other goods or services supplied under t\", \"level\": 2, \"text\": \"8.6 No conditions, warranties or other terms apply to the Products, [ * ] or to any other goods or services supplied under this Agreement unless expressly set out in this Agreement. Subject to Clause 9.1, no implied conditions, warranties or other terms apply (including any implied terms as to satisfactory quality, fitness for purpose or conformance with description).\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 1, \"text\": \"9. LIMITATION OF LIABILITY\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing in this Agreement shall exclude or limit either party's liability for\", \"level\": 2, \"text\": \"9.1 Nothing in this Agreement shall exclude or limit either party's liability for: (a) death or personal injury resulting from the negligence of either party or their servants, agents or employees; (b) fraud or fraudulent misrepresentation; - 10 - In this Clause 9.4, \\\"Contract Year\\\" means a period of one year starting on the Effective Date or the relevant anniversary of the Effective Date (as appropriate). If the amount referred to in (b) above cannot be calculated accurately at the time the relevant liability is to be assessed (the \\\"Applicable Time\\\"), it shall be calculated on a pro-rata basis as X/Y x Z. Where: X = the total sum paid and payable to the Distributor pursuant to Clause 4 in the relevant Contract Year prior to the Applicable Time; Y = the number of days elapsed in the relevant Contract Year prior to the Applicable Time; and Z = 365 *Confidential treatment requested Google Confidential (c) breach of any implied condition as to title or quiet enjoyment; and (d) misuse of confidential information.\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Nothing in this Agreement shall exclude or limit either party's liability under Clause 10 (Indemnities), or Distributor'\", \"level\": 2, \"text\": \"9.2 Nothing in this Agreement shall exclude or limit either party's liability under Clause 10 (Indemnities), or Distributor's liability under Clause 2 (License Grants and Restrictions), Clause 3.5 (Exclusivity), Clause 3.6 (End User License Agreement) and Clause 3.7 (Accurate Reproduction) or Clause [ * ].\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Clauses 9\", \"level\": 2, \"text\": \"9.3 Subject to Clauses 9.1 and 9.2, neither party shall be liable under this Agreement (whether in contract, tort or otherwise) for any: (a) loss of anticipated savings; (b) loss of business opportunity (which for the avoidance of doubt shall not include loss of advertising revenue); (c) loss of or corruption of data; (d) loss or damage resulting from third party claims; or (e) indirect or consequential losses;\\n suffered or incurred by the other party (whether or not such losses were within the contemplation of the parties at the date of this Agreement).\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Subject to Clauses 9\", \"level\": 2, \"text\": \"9.4 Subject to Clauses 9.1 and 9.2, each party's total liability under or in connection with this Agreement (whether in contract, tort or otherwise) arising in any Contract Year is limited to the greater of: (a) [ * ] Euros ([ * ] Euros); and (b) [ * ]% of the total payment due to the Distributor in the relevant Contract Year pursuant to Clause 4 (Payment Terms). - 11 - By Distributor. User claim arising out of or resulting from such End Users use of any Distributor App(s), including any actions or claims in product liability, tort, contract or equity. *Confidential treatment requested Google Confidential\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION BY GOOGLE\", \"level\": 1, \"text\": \"10. INDEMNIFICATION BY GOOGLE.\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Google [ * ] and will indemnify Distributor against all liabilities, costs, damages and expenses (including settlement c\", \"level\": 2, \"text\": \"10.1 Google [ * ] and will indemnify Distributor against all liabilities, costs, damages and expenses (including settlement costs approved in writing by Google and reasonable legal fees [ * ]) suffered or incurred by Distributor arising from any claim from a third party that any Products or any Google Trademark infringe(s) any copyright, trade secret or trademark of such third party (an \\\"IP Claim\\\"), provided that Distributor: (a) promptly notifies Google; (b) provides Google with reasonable information, assistance and cooperation in responding to and, where applicable, defending such IP Claim; and (c) gives Google full control and sole authority over the defence and settlement of such IP Claim. Distributor may appoint its own supervising counsel of its choice at its own expense.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Google will not have any obligations or liability under this Clause 10 in relation to any IP Claim arising from\", \"level\": 2, \"text\": \"10.2 Google will not have any obligations or liability under this Clause 10 in relation to any IP Claim arising from: (a) use of the Products or Google Trademarks in a modified form or in combination with materials not furnished by Google; (b) use of the Products or Google Trademarks other than in accordance with this Agreement; or (c) any content, information or data provided to Google by Distributor, End Users or any other third parties;\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Google may (at its sole discretion) suspend Distributors distribution or use of the Products or the Google Trademarks wh\", \"level\": 2, \"text\": \"10.3 Google may (at its sole discretion) suspend Distributors distribution or use of the Products or the Google Trademarks which are alleged, or believed by Google, to infringe any third party's Intellectual Property Rights, or modify such items to make them non-infringing. if any suspension under this Clause continues for more than 30 days, Distributor may, at any time until use of the distribution or use of the Products or the Google Trademarks is reinstated, terminate this Agreement immediately upon written notice. [ * ] will use reasonable endeavours to [ * ] with [ * ] (to the extent it is practicable to do so) of the [ * ] or [ * ].\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Distributor [ * ] and will indemnify Google against all liabilities, costs, damages and expenses (including settlement c\", \"level\": 2, \"text\": \"10.4 Distributor [ * ] and will indemnify Google against all liabilities, costs, damages and expenses (including settlement costs approved in writing by Distributor and reasonable legal fees [ * ]) suffered or incurred by Google or any Google Group Company arising from: (a) Distributor's improper (ie not in accordance with the requirements of this Agreement including the Exhibits) or unauthorised, replication, packaging, marketing, distribution, or installation of the Products, including any breach of Clause 8.5 and any claims based on representations, warranties, or misrepresentations made by Distributor, (b) any claim from a third party that the Distributor App(s) infringe any third party copyright, trademark, or trade secret, or (c) any End - 12 - *Confidential treatment requested Google Confidential\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The indemnification obligations set out in Clause 10\", \"level\": 2, \"text\": \"10.5 The indemnification obligations set out in Clause 10.4(b) shall exist only if Google: (a) promptly notifies Distributor of such claim, (b) provides Distributor with reasonable information, assistance and cooperation in responding to and, where applicable, defending the lawsuit or proceeding, and (c) gives Distributor full control and sole authority over the defense and settlement of such claim. Google may join in defense with counsel of its choice at its own expense.\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"The foregoing Clauses 10\", \"level\": 2, \"text\": \"10.6 The foregoing Clauses 10.1 to 10.5 states the parties' entire liability and exclusive remedy with respect to infringement of a third party's Intellectual Property Rights.\"}}, {\"id\": \"11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL\", \"level\": 1, \"text\": \"11. GENERAL\"}}, {\"id\": \"11.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Publicity\", \"level\": 2, \"text\": \"11.1 Publicity. Subject to clause 6 (Confidential Information), neither party may make any public statement regarding the relationship contemplated by this Agreement without the other's prior written approval.\"}}, {\"id\": \"11.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Notices\", \"level\": 2, \"text\": \"11.2 Notices. All notices of termination or breach must be in English, in writing, addressed to the other party's Legal Department and sent to Distributor's address set out at the head of this Agreement or to [ * ] (as applicable) or such other address as either party has notified the other in accordance with this Clause. All notices shall be deemed to have been given on receipt as verified by written or automated receipt or electronic log (as applicable). All other notices must be in English, in writing, addressed to the other party's primary contact and sent to their then current postal address or email address.\"}}, {\"id\": \"11.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Assignment\", \"level\": 2, \"text\": \"11.3 Assignment. [ * ] may [ * ]any of its rights or obligations under this Agreement without the prior written consent of [ * ]. For the avoidance of doubt, a Change of Control shall be deemed an assignment hereunder unless [ * ] does not exercise its [ * ].\"}}, {\"id\": \"11.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Force Majeure\", \"level\": 2, \"text\": \"11.4 Force Majeure. Neither party shall be liable for failure to perform or delay in performing any obligation under this Agreement if the failure or delay is caused by any circumstances beyond its reasonable control.\"}}, {\"id\": \"11.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Compliance with Export Laws\", \"level\": 2, \"text\": \"11.5 Compliance with Export Laws. Distributor shall comply with all applicable export and re-export control laws and regulations (\\\"Export Laws\\\"), which the parties agree include: (a) the Export Administration Regulations maintained by the U.S. Department of Commerce, (b) trade and economic sanctions maintained by the U.S. Treasury Department's Office of Foreign Assets Control, and (c) the International Traffic in Arms Regulations maintained by the U.S. Department of State. Unless Distributor obtains prior authorisation required by applicable Export Laws, Distributor shall not export any Product to Cuba, Iran, North Korea, Sudan or Syria.\"}}, {\"id\": \"11.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Waiver\", \"level\": 2, \"text\": \"11.6 No Waiver. Failure or delay in exercising any right or remedy under this Agreement shall not constitute a waiver of such (or any other) right or remedy.\"}}, {\"id\": \"11.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Severability\", \"level\": 2, \"text\": \"11.7 Severability. The invalidity, illegality or unenforceability of any term (or part of a term) of this Agreement shall not affect the continuation in force of the remainder of the term (if any) and this Agreement.\"}}, {\"id\": \"11.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Agency\", \"level\": 2, \"text\": \"11.8 No Agency. Except as expressly stated otherwise, nothing in this Agreement shall create an agency, partnership or joint venture of any kind between the parties.\"}}, {\"id\": \"11.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"No Third-Party Beneficiaries\", \"level\": 2, \"text\": \"11.9 No Third-Party Beneficiaries. Except as expressly stated otherwise, nothing in this Agreement shall create or confer any rights or other benefits in favour of any person other than the parties to this Agreement. - 13 - Signed by the parties on the dates shown below. *Confidential treatment requested Google Confidential\"}}, {\"id\": \"11.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Governing Law\", \"level\": 2, \"text\": \"11.10 Governing Law. This Agreement is governed by English law and the parties submit to the exclusive jurisdiction of the English courts in relation to any dispute (contractual or non-contractual) concerning this Agreement save that either party may apply to any court for an injunction or other relief to protect its Intellectual Property Rights. If this Agreement is translated into any other language, if there is conflict the English text will take precedence.\"}}, {\"id\": \"11.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Counterparts\", \"level\": 2, \"text\": \"11.11 Counterparts. The parties may execute this agreement in counterparts, which taken together will constitute one instrument.\"}}, {\"id\": \"11.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Entire Agreement\", \"level\": 2, \"text\": \"11.12 Entire Agreement. Subject to Clause 9.1, this Agreement sets out all terms agreed between the parties in relation to its subject matter and supersedes all previous agreements between the parties relating to the same. In entering into this Agreement neither party has relied on any statement, representation or warranty not expressly set out in this Agreement. DISTRIBUTOR GOOGLE INC /[ * ] /s/ [ * ] By By [ * ] [ * ] Name Name [ * ] [ * ] Title Title [ * ] [ * ] Date Date - 14 -\"}}, {\"id\": \"EXHIBIT A\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Payments\", \"level\": 1, \"text\": \"EXHIBIT A Payments *[ * ] ** [ * ]. *Confidential treatment requested Google Confidential [ * ] [ * ] [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ] [ * ] $ [ * ] [ * ]** [ * ]* $ [ * ] - 15 -\"}}, {\"id\": \"EXHIBIT B\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Process Flow\", \"level\": 1, \"text\": \"EXHIBIT B Process Flow - 16 - Form of Offering 1 - WhiteSmoke Welcome Screen - 17 -\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Toolbar offer lf [ * ] Criteria Checker has returned \\\"True\\\"\", \"level\": 1, \"text\": \"2-Toolbar offer lf [ * ] Criteria Checker has returned \\\"True\\\" *Confidential treatment requested - 18 -\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Chrome offer If [ * ] Criteria Checker has not returned 'True\\\" AND [ * ] Criteria Checker has returned \\\"True\\\"\", \"level\": 1, \"text\": \"3-Chrome offer If [ * ] Criteria Checker has not returned 'True\\\" AND [ * ] Criteria Checker has returned \\\"True\\\" *Confidential treatment requested - 19 -\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- Installation Progress\", \"level\": 1, \"text\": \"4 - Installation Progress Google Confidential - 20 -\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"- Chrome First Launch If Chrome has been installed\", \"level\": 1, \"text\": \"5 - Chrome First Launch If Chrome has been installed Criteria Checker During the Term, for each End User who installs the Distributor App, Distributor shall use the [ * ] Criteria Checker to determine if [ * ] can be offered to such End User. If the [ * ] Criteria Checker returns True, Distributor shall offer the End User the opportunity to install the [ * ] in conjunction with the Distributor App. If the [ * ] Criteria Checker returns False Distributor shall: a) not offer the End User the opportunity to install the [ * ] and b) use the [ * ] Criteria Checker to determine whether the [ * ] can be offered to such End User. If the [ * ] Criteria Checker returns True, Distributor shall offer the End User the opportunity to install the [ * ] in conjunction with the Distributor App. If the [ * ] Criteria Checker returns False, Distributor shall not offer such End User the opportunity to install the [ * ]. Prior to Launch, Distributor shall obtain Google's approval of the parameters Distributor uses to call the [ * ] Criteria Checker and [ * ] Criteria Checker Chrome Browser Auto Launch. Distributor shall ensure that the first launch of the Chrome Browser following installation of the Chrome Browser complies with each of the following requirements (the \\\"Chrome Launch Requirements\\\"): (a) The Chrome Browser shall auto-launch immediately prior to the launch of the Distributor App, no earlier and no later. *Confidential treatment requested - 21 - (b) No advertisements, offers, or other communications shall appear between launch of a Distributor App and launch of the Chrome Browser. (c) Upon launch of the Chrome Browser, the Chrome Browser shall immediately appear on the End User's computer desktop exactly as shown in this Exhibit B. Without limiting the preceding sentence, each of the following shall appear on the End User's desktop exactly as shown in this Exhibit B: (i) the location and size of the Chrome Browser window and the Distributor App window, (ii) the z-order of the Distributor App and the Chrome Browser, and (iii) the number and content of the tabs in the Chrome Browser (i.e., the Chrome Browser shall contain exactly two (2) tabs, with the first tab set to google.com, and the second tab set to http://tools.google.com/chrome/intlfen-US/welcome.html (or such other url as Google may specify). In no event shall the Chrome Browser window be minimized. Notwithstanding the foregoing, Distributor may modify the content and design of the Distributor App window provided that Distributor complies with the other restrictions in this Agreement and obtains Google's prior consent. (d) The tabs in the Chrome Browser and the Omnibox shall be clearly visible to the End User as shown in this Exhibit B, regardless of the resolution of the End User's monitor. In no event shall the tabs in the Chrome Browser or the Omnibox be hidden behind a Distributor App. (e) Distributor shall implement (or, if implemented by Google, Distributor shall not modify) the six-month flag (i.e., the functionality that prevents an End User from receiving more than one (1) offer for the Chrome Browser within any six (6)-month period) unless Google has provided written confirmation (including by email) that the 6-months flag can be turned off. Note that this authorisation may be revoked at any time and Distributor shall then include the 6 months flag again in future builds. - 22 -\"}}, {\"id\": \"EXHIBIT C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Guidelines for Applications Bundled with Google Applications Google has observed a significant increase in the number of reports of software that is engaging in deceptive, malicious and other annoying practices that significantly diminish user perception and enjoyment of the internet. These practices include but are not limited to installing software on computers without obtaining informed end user consent (the so-called \\\"drive-by download\\\"), inundating end users with advertisements without adequate attribution or labeling, exposing users to pornographic material without obtaining informed end user consent, obtaining or transmitting personal information about an end user without obtaining informed end user consent, and interfering with an end user's ability to easily uninstall applications the end user does not wish to be on his or her computer. Google does not wish to be associated with these types of practices. Accordingly, Google has developed the Guidelines set forth below to prevent its trademark, other intellectual property, and services from being used in connection with these practices. Google believes that these Guidelines are necessary to protect Google from any allegation that it has contributed to practices that might be viewed as unlawful or actionable; to preserve the reputation of Google as a provider of trusted software and services in a manner that is beneficial and fair to users and other constituents; and to stem the rising incidence of practices that harm users and diminish the perceived value and reliability of the internet, which are essential to Google's business. With this objective in mind, Google has established the following Guidelines to apply to customer Applications that are bundled with any Google Application. Except to the extent Google has otherwise specifically agreed in writing, Google does not grant permission to, and you will not, bundle any Application with a Google Application unless you ensure that any such Application specified in the agreement between you and Google that incorporated these Guidelines complies with these Guidelines. For the avoidance of doubt, by these Guidelines Google does not intend to, and does not, impose any restrictions on what you may do with any Application that is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services; you remain free to sell any Application you wish (whether or not it complies with these Guidelines) so long as it is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services. In these Guidelines: (a) \\\"you\\\" and \\\"your\\\" refer to the legal entity(ies) that has entered into the contract with Google into which these Guidelines are incorporated, as well as any person or entity acting on your behalf; and (b) \\\"Application\\\" means any application, plug-in, helper, component or other executable code that runs on a user's computer, examples of which include those that provide browser helper objects, instant messaging, chat, email, data, file viewing, media playing, file sharing, games, internet navigation, search and other services. Google Confidential\", \"level\": 1, \"text\": \"EXHIBIT C Guidelines for Applications Bundled with Google Applications Google has observed a significant increase in the number of reports of software that is engaging in deceptive, malicious and other annoying practices that significantly diminish user perception and enjoyment of the internet. These practices include but are not limited to installing software on computers without obtaining informed end user consent (the so-called \\\"drive-by download\\\"), inundating end users with advertisements without adequate attribution or labeling, exposing users to pornographic material without obtaining informed end user consent, obtaining or transmitting personal information about an end user without obtaining informed end user consent, and interfering with an end user's ability to easily uninstall applications the end user does not wish to be on his or her computer. Google does not wish to be associated with these types of practices. Accordingly, Google has developed the Guidelines set forth below to prevent its trademark, other intellectual property, and services from being used in connection with these practices. Google believes that these Guidelines are necessary to protect Google from any allegation that it has contributed to practices that might be viewed as unlawful or actionable; to preserve the reputation of Google as a provider of trusted software and services in a manner that is beneficial and fair to users and other constituents; and to stem the rising incidence of practices that harm users and diminish the perceived value and reliability of the internet, which are essential to Google's business. With this objective in mind, Google has established the following Guidelines to apply to customer Applications that are bundled with any Google Application. Except to the extent Google has otherwise specifically agreed in writing, Google does not grant permission to, and you will not, bundle any Application with a Google Application unless you ensure that any such Application specified in the agreement between you and Google that incorporated these Guidelines complies with these Guidelines. For the avoidance of doubt, by these Guidelines Google does not intend to, and does not, impose any restrictions on what you may do with any Application that is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services; you remain free to sell any Application you wish (whether or not it complies with these Guidelines) so long as it is not bundled with a Google Application, bundled with an Application that accesses Google services, or used to access Google services. In these Guidelines: (a) \\\"you\\\" and \\\"your\\\" refer to the legal entity(ies) that has entered into the contract with Google into which these Guidelines are incorporated, as well as any person or entity acting on your behalf; and (b) \\\"Application\\\" means any application, plug-in, helper, component or other executable code that runs on a user's computer, examples of which include those that provide browser helper objects, instant messaging, chat, email, data, file viewing, media playing, file sharing, games, internet navigation, search and other services. Google Confidential - 23 - Google welcomes input about these Guidelines from you and from other interested parties, and is always willing to consider revisions as appropriate to encourage innovation while protecting against deceptive, unfair and harmful practices. Accordingly, Google may update these Guidelines, including the Attachments, from time to time as provided in Section 10 below. If you have any questions about these Guidelines, please do not hesitate to discuss them with your Google account manager. Google Confidential - 24 -\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"General\", \"level\": 1, \"text\": \"1. General. 1.1 Approval and Ongoing Compliance. You may bundle Google Applications with Applications only to the extent permitted in the signed written agreement into which these Guidelines have been incorporated. In such instance, you must ensure that your Application both (1) has been approved by Google for the purpose of being bundled with Google Applications in writing in advance, and (2) complies at all times with the requirements outlined herein. To obtain Google's approval for any Applications not expressly approved in your agreement, you must submit a written request. 1.2 No Google Branding or Attribution. Your Application, and any related collateral material (including any Web pages promoting your Application or from which your Application is made available), must not contain any Google branding, trademarks or attribution unless (and then only to the extent) Google expressly consents otherwise in writing. In addition, queries entered into Applications may not resolve to a results page that contains any Google branding, trademarks or attribution unless (and then only to the extent) Google expressly consents otherwise in writing. 2. Prohibited Content. You may not bundle any Google Application with an Application that: (a) contains any viruses, worms, trojan horses, or the like; and (b) is distributed primarily for the purpose of (i) distributing pornographic, obscene, excessively profane, gambling-related, deceptive, fraudulent or illegal content, or (ii) distributing content related to \\\"hacking\\\" or \\\"cracking.\\\" 3. Prohibited Behavior. You may not bundle any Google Application with an Application that engages in deceptive, unfair, harassing or otherwise annoying practices. For example, the Application may not: Google Confidential (a) use, or permit an unaffiliated person to use, an end user's computer system for any purpose not understood and affirmatively consented to by the end user (including, without limitation, for purposes of consuming bandwidth or computer resources, sending email messages, launching denial of service attacks, accruing toll charges through a dialer or obtaining personal information from an end user's computer such as login, password, account or other information personal to the end user); (b) intentionally create or exploit any security vulnerabilities in end user computers; (c) trigger pop-ups, pop-unders, exit windows, or similar obstructive or intrusive functionality, that materially interfere with an end user's Web navigation or browsing or the use of his or her computer; (d) repeatedly ask an end user to take, or try to deceive an end user into taking, an action that the end user has previously declined to take (such as repeatedly asking an end user to change his or her home page or some other setting or configuration); - 25 -\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclosure and Consent\", \"level\": 1, \"text\": \"4. Disclosure and Consent. 4.1 Disclosure and Consent before Installation. You may not bundle any Google Application with any Application unless you (and your distribution and bundling partners, if applicable under the terms of the agreement between you and Google that incorporates these Guidelines) design the installation of any such Application in a manner that ensures that it is installed by end users in a knowing and willful manner - e.g., no \\\"drive-by' downloads or installs. By \\\"distribution partner\\\" we mean any third party who distributes your Application and by \\\"bundling partner\\\" we mean any third party who installs your Application in combination with or alongside one or more other Applications. At a minimum, compliance with this provision requires that, prior to installing your Application, you and any third party distributing or bundling your Application:\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclosure and Consent for Collection and Transmission of Personally Identifiable information\", \"level\": 2, \"text\": \"4.2 Disclosure and Consent for Collection and Transmission of Personally Identifiable information. You may not bundle any Google Application with any Application that (1) collects or transmits to any entity other than the end user personally identifiable information, or (2) collects or transmits information related to a user's computer or Internet usage or activity in a manner that could collect or transmit such user's personally identifiable information (such as through keystroke logging), unless prior to the first occurrence of any such collection or transmission you: Google Confidential (e) redirect browser traffic away from valid DNS entries (except that your Application may direct unresolved URLs to an alternative URL designated by you, provided that the page to which the end user resolves adequately informs the end user that you and your Application are the source of that page); (f) interfere with the browser default search functionality (except that your Application may permit an end user to change his or her default search engine with proper disclosure, consent and attribution as provided below); or (g) engage in activity that violates any applicable Jaw or regulation. (a) first, fully, accurately, clearly and conspicuously disclose to end users: (i) that they are installing an application, (ii) the name of the Application, identifying you as the entity responsible for it, and (iii) the principal and significant features and functionality of the Application; and (b) then, obtain the end user's affirmative consent to install the Application. (a) first, fully, accurately, clearly and conspicuously disclose: - 26 -\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Disclosure and Consent for Setting Changes\", \"level\": 2, \"text\": \"4.3 Disclosure and Consent for Setting Changes. You may not bundle any Google Application with any Application that makes a change to any operating system or Application data setting which will impact the user experience of other Applications (e.g., changing the browser default home page or changing the default application for a file type, such as the default email, browser or media player application), unless prior to making such change you: Notwithstanding the foregoing, (i) no disclosure and consent need be made for changes to operating system or Application data settings that have only a minor impact on user experience, such as adding a small number of bookmarks to the browser menu or adding an item to a start menu, and (ii) the disclosure and consent requirements of this Section 4.3 will not apply to those setting changes that may be made prior to sale to the end user. 4.4 Method of Disclosure and Consent. In order to satisfy the requirements above, the disclosure of the items specified above (a) must be provided in both (1) the End User License Agreement (EULA) or privacy policy (to the extent required by law or otherwise by industry custom) and (2) separately from the EULA and/or privacy policy (e.g. in installation screens or message boxes, as the case may be), and (b) must be designed so that it will be read by, adequately inform and evidence the consent of a typical Internet user. See Attachment 1 for sample disclosure and consent implementations that would satisfy certain of the requirements above. 4.5 EULA and Privacy Policy. You may not bundle any Google Application with any Application unless it conforms, and is distributed pursuant to a EULA that conforms, with all applicable laws and regulations. In addition, you and your Application must comply with the agreements and representations you make with your end users in your EULA and privacy policy. Your privacy policy must be accessible from your Application in an easily found location. If your Application collects or transmits any other information related to the user's use of his or her computer, but not required to be disclosed and consented to pursuant to Section 4.2, then the collection and use of such other information must be disclosed in your privacy policy. Google Confidential (i) the type of information collected (described with specificity in the case of personally identifiable information), (ii) the method of collection (e.g. by registration, etc.), and (iii) the location of (i.e., a link to) the privacy policy that governs the collection, use and disclosure of the information; and (b) then, obtain the end user's affirmative consent to such collection and/or transmission. (a) first, fully, accurately, clearly and conspicuously disclose the change in a manner that will explain the practical effect of such change; and (b) then, obtain the end user's affirmative consent to make such change. - 27 -\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Transparency\", \"level\": 1, \"text\": \"5. Transparency. Neither you nor any of your third party distribution or bundling partners may mislead end users or create end user confusion with regard to the source or owner of an Application or any portion of its purpose, functionality or features. For example, all elements of your Application that are visible to the end user must clearly identify their source through its branding and attribution, and that identification, whatever form it takes, must correspond to the identification of your application in the menu that permits end users to remove programs. You must clearly label advertisements provided by your Application (if any) as such and clearly identify your Application as the source of those advertisements. In addition, if your Application modifies the operation or display of other applications or Web sites (other than Web sites that you own), then in each instance you must clearly and conspicuously attribute the source of that modification to your Application (as distinct from the application or Web site modified) in a manner that will inform a typical Internet user; provided that this requirement will not apply to modifications for which you obtain disclosure and consent pursuant to Section 4.3. See Attachment 1 for examples of modifications that are clearly and conspicuously disclosed to end users. 6. Deactivation. You may not bundle any Google Application with any Application that impairs an end user's ability to change any preferences or settings set by the Application in accordance with the way that such preferences or settings ordinarily may be changed by the applicable Application. Once disabled by an end user, your Application may not be re-enabled without an affirmative action by the end user to explicitly re- enable your application. Accordingly, no use, update, installation or re-enablement of a separate Application, and no code downloaded as a result of browsing a Web site, may operate to re-enable your Application. Your Application must permit end users to uninstall it (in the customary place the applicable operating system has designated for adding or removing programs, e.g., Add/Remove Programs control panel in Windows) in a straightforward manner, without undue effort or skill. In addition, your Application, when running, must provide (in an easily found location) clear and concise instructions on how it may be uninstalled. Once uninstalled, your Application must not leave behind any functionality or design elements, and all setting changes made by the application, but not explicitly agreed to by the end user, should be reversed to the extent practicable. 7. Bundling of Applications. In addition to the requirements set forth in the agreement between you and Google that incorporates these Guidelines, in order for you to bundle any Application with a Google Application must satisfy each of the following requirements: Google Confidential (a) the end user is made aware of all of the Applications included in the bundle prior to any installation; (b) all such Applications included in the bundle or download comply with the provisions of Section 2 through 6 of these Guidelines; (c) if Applications in a bundle in which you are participating are supported in part by revenue generated by advertising displayed in another independent Application included in that bundle and the continued use of the Application is conditioned on such other independent Application remaining installed and active on the end user's computer, the end user must be made aware of that relationship; and - 28 -\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Information and Assistance\", \"level\": 1, \"text\": \"8. Information and Assistance. Subject to any confidentiality obligations owed to third parties, you must provide Google with such information as Google may reasonably request about the distribution of those of your Applications that are bundled with any Google Application. For example, we may ask you to share with us: (a) the means by and/or the locations from which your Applications are distributed; or (b) the identity of any applications included in any of your bundling relationships (and the entities responsible for such applications). In addition, you must provide such assistance as Google may reasonably request to investigate and stop potential violations of these Guidelines that may be connected to your Application, including by way of using such number of identifiers and other tracking parameters as Google may reasonably request. This would include providing Google with \\\"golden masters\\\" of any bundle or other distribution that includes your Application, or working with Google to stop any entities that may be financially benefiting from your Application from engaging in any of these proscribed practices. You understand, however, that Google has no obligation to provide support to end users of your Application. For the avoidance of doubt, these information and assistance rights do not extend to any of your Applications that are not used to access Google services, bundled with a Google Application, or bundled with an Application that accesses Google services. 9. Legal. You must maintain ownership and control of your Application at all times to the extent required to practically and legally enforce the requirements of these guidelines. If you are seeking to permit a third party Application to be bundled with a Google Application, then you must also obtain Google's written approval of that third party Application (in addition to the approval required for your Application). If Google approves the third party Application, you are responsible for ensuring that such third party Application also complies with these Guidelines. Special indemnity and other suspension and/or termination provisions may apply. These are addressed in your agreement with Google. 10. Updates. 10.1 General. As mentioned above, Google may update these Guidelines, including the Attachments, from time to time; provided, however, that no updates will be effective until Google provides you with thirty (30) days' written notice thereof. Once you receive that notice (the date on which you receive such notice, the \\\"Update Notice Date\\\"), you will be required to bring your Application into compliance within thirty (30) days Google Confidential (d) either (1) the bundle must provide for a master uninstaller that will enable the end user to uninstall every Application in the bundle without undue effort or skill, or (2) if no master uninstaller is provided, the de-installation of any Application may not be dependent or conditioned upon the de-installation of any other Application included in the bundle. - 29 -\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Extended Compliance Period\", \"level\": 2, \"text\": \"10.2 Extended Compliance Period. If, solely as a result of an updated requirement, one or more of your Applications no longer complies with these Guidelines, as updated, and you are incapable of bringing such Application into compliance prior to the scheduled effective date of such update (the \\\"Update Effective Date\\\"), you agree to provide Google with written notice thereof as soon as reasonably practicable, but in any event no later than the Update Effective Date, identifying the Application and the reasons why it may not be brought into compliance prior to the Update Effective Date, and providing such other detail as Google may reasonably request with respect thereto (consistent in any event with your confidentiality obligations). Thereafter, the parties will consult, and you agree to will work, diligently and in good faith to develop and execute a plan to bring such Application into compliance with these Guidelines, as updated, as soon as reasonably practicable, but in any event within ninety (90) days of the Update Notice Date (the \\\"Maximum Compliance Period\\\"). You agree that you will provide Google with such information as Google reasonably requests during this period to keep Google apprised of your progress in bringing your Application into compliance. Notwithstanding the foregoing (but subject to the next sentence), in no event may a new requirement provided for in any update to these Guidelines require you to take any action which would violate the terms of any agreement between you and any unaffiliated third party that is in effect on the date that Google delivers notice of the proposed update. In any event, if you are unable to bring any Application into compliance during the Maximum Compliance Period, Google may elect, by providing at least thirty (30) days prior written notice, to require you to cease bundling either the specific non-conforming Application or those versions of the Application which are, or are distributed, in violation of the Guidelines, as updated; it being understood that, at such time, you will be entitled to procure services from an alternative source for those Applications (or versions thereof) with respect to which Google has exercised such election. Google Confidential - 30 -\"}}, {\"id\": \"Attachment 1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Prohibited Behavior and Content The application may not impact the display of other applications unless you provide clear disclosure in each instance\", \"level\": 1, \"text\": \"Attachment 1 Prohibited Behavior and Content The application may not impact the display of other applications unless you provide clear disclosure in each instance Google Confidential - 31 - Google Confidential - 32 - Disclosure and Consent Clear and conspicuous disclosure is required prior to download or install: what it is, what it does, and how it will be displayed to the end user Disclosure and Consent Describe type, method, and use of personal information, if applicable. Point user to privacy policy Google Confidential - 33 - Google Confidential - 34 - Branding & Attribution The visible elements of the application should be easily identifiable to the end user Google Confidential - 35 - Implementation, Transparency and Deactivation The Application must permit end users to uninstall it in the customary place the applicable operating system has designated for adding or removing programs (e.g., Add/Remove Programs control panel in Windows) in a straightforward manner Google Confidential - 36 - Google Confidential - 37 - Implementation, Transparency and Deactivation The Application must contain (in an easily found location) clear and concise instructions on how it may be uninstalled Google Confidential - 38 - Bundling of Applications When bundling, the end user must be made aware of all the applications included prior to installation. Google Confidential - 39 - Bundling of Applications When bundling, the end user must be made aware of advertising revenue relationships to other applications, if the continued use of the primary application is conditioned on the other applications being installed and active on the end user's computer Google Confidential - 40 -\"}}, {\"id\": \"party:Whitesmoke Inc.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Whitesmoke Inc.\", \"role\": \"Distributor\", \"address\": \"501 Silverside Road, Suite 105, Wilmington DE 19809, USA\"}}, {\"id\": \"party:Google Inc\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"Google Inc\", \"role\": \"Google\", \"address\": \"1600 Amphitheatre Parkway, Mountain View, CA 94043, USA\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"This Promotion and Distribution Agreement including all exhibits\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"1 August 2011\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Bundle\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Bundle\", \"text\": \"the Distribution Products bundled with the Distributor App(s).\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Chrome Browser\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Chrome Browser\", \"text\": \"the machine-readable binary code version of the Google Chrome browser provided to Distributor in connection with this Agreement, and any modifications or updates to it that Google may provide to Distributor.\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Chrome Browser Installer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Chrome Browser Installer\", \"text\": \"(a) the machine-readable binary code version of the installer provided to Distributor in connection with this Agreement that installs the Chrome Browser, and any modifications, updates or upgrades to it that Google may provide to Distributor; and (b) the Chrome Browser Criteria Checker.\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Chrome Use Event\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Chrome Use Event\", \"text\": \"an event that indicates an [* ] has occurred.\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Chrome Server Communication\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Chrome Server Communication\", \"text\": \"a communication that, as determined solely by Google, is sent for the purpose of indicating that an End User: (a) is [* ] to the [* ]; and (b) has kept the [* ] open for a minimum of [* ] during a [* ] (whether during the [* ] or a [* ] of the Chrome Browser).\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Criteria Checker\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Criteria Checker\", \"text\": \"a set of software routines (and any updates to them) provided to Distributor by Google, as part of a software library, that check certain criteria (as determined by Google and modified by Google from time to time) to determine if the Chrome Browser or Google Toolbar (as applicable) can be installed on an End User's operating system.\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Chrome Browser Criteria Checker\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Chrome Browser Criteria Checker\", \"text\": \"the Criteria Checker provided by Google in respect of the Chrome Browser\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Google Toolbar Criteria Checker\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Google Toolbar Criteria Checker\", \"text\": \"the Criteria Checker provided by Google in respect of the Google Toolbar.\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Distributor App(s)\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distributor App(s)\", \"text\": \"the following application (and successor versions of such software): the trial version of the WhiteSmoke Writer (currently called WhiteSmoke 2011) available on a worldwide basis, but for the avoidance of doubt shall not mean any other products of Distributor, including without limitation the full paid version of Whitesmoke Writer or any version of Whitesmoke \\\"Translator\\\" software, regardless of whether Whitesmoke Writer incorporates any translation functionality.\", \"definition_clause\": \"Exhibit 10.26\"}}, {\"id\": \"term:Distribution Products\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Distribution Products\", \"text\": \"(a) as at the Effective Date, the Google Toolbar Installer and the Chrome Browser Installer; and (b) if Distributor notifies Google at any time after the Effective Date that it wishes to bundle the full Google Toolbar and Google provides its approval in writing (including email), the Google Toolbar; and (c) if Distributor notifies Google at any time after the Effective Date that it wishes to bundle the full Chrome Browser and Google provides its approval in writing (including email), the Chrome Browser.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:End User\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"End User\", \"text\": \"an end user customer of Distributor who is located in the Territory.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:EULA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"EULA\", \"text\": \"the end user license agreement applicable to a Product, which end user license agreement may be updated or modified by Google in its sole discretion from time to time.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:False\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"False\", \"text\": \"a \\\"false\\\" response (or equivalent negative response) given by the Criteria Checker.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Google Program Guidelines\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Google Program Guidelines\", \"text\": \"the policy and implementation guidelines applicable to the Products as updated by Google and provided to Distributor from time to time.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Google Toolbar\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Google Toolbar\", \"text\": \"the machine-readable binary code version of the Google toolbar for Internet Explorer provided to Distributor in connection with this Agreement, and any modifications or updates to it that Google may provide to Distributor.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Google Toolbar Installer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Google Toolbar Installer\", \"text\": \"(a) the machine-readable binary code version of the installer provided to Distributor in connection with this Agreement that installs the Google Toolbar, and any modifications, updates or upgrades to it that Google may provide to Distributor; and (b) the Google Toolbar Criteria Checker.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Google Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Google Trademarks\", \"text\": \"all names, trade names, trademarks, and logos used by Google in connection with the Products.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Group Company\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Group Company\", \"text\": \"in relation to each of the parties: (a) any parent company of that party; and (b) any corporate body of which that party directly or indirectly has control or which is directly or indirectly controlled by the same person or group of persons as that party.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Install Completed\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Install Completed\", \"text\": \"occurs when an End User has completed the install process for a Bundle and the install completed screen is shown to the End User in accordance with Exhibit B.\", \"definition_clause\": \"1.1\"}}, {\"id\": \"term:Third Party Distributors\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Third Party Distributors\", \"text\": \"third parties solely for redistribution of such Bundles by those third parties directly to End Users\", \"definition_clause\": \"2.2\"}}, {\"id\": \"term:Launch\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Launch\", \"text\": \"distribution of Bundles in accordance with this Agreement\", \"definition_clause\": \"3.4\"}}, {\"id\": \"term:Launch Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Launch Date\", \"text\": \"the date of such Launch\", \"definition_clause\": \"3.4\"}}, {\"id\": \"term:Installed Base End Users\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Installed Base End Users\", \"text\": \"End Users who have had Products installed on their systems in connection with this Agreement\", \"definition_clause\": \"3.8\"}}, {\"id\": \"term:Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Control\", \"text\": \"the possession by any person(s) directly or indirectly of the power to direct or cause the direction of another person\", \"definition_clause\": \"5.4\"}}, {\"id\": \"term:Change of Control\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Change of Control\", \"text\": \"a change in the person(s) who possess the power to direct or cause the direction of another person, to be construed accordingly.\", \"definition_clause\": \"5.4\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"information disclosed by (or on behalf of) one party to the other party under this Agreement that is marked as confidential or, from its nature, content or the circumstances in which it is disclosed, might reasonably be supposed to be confidential, including the terms and conditions (including the Exhibits) of this Agreement. It does not include information that the recipient already knew, that becomes public through no fault of the recipient, that was independently developed by the recipient or that was lawfully given to the recipient by a third party.\", \"definition_clause\": \"6.1\"}}, {\"id\": \"term:Anti-Bribery Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Anti-Bribery Laws\", \"text\": \"the UK's Bribery Act 2010 and the U.S. Foreign Corrupt Practices Act of 1977\", \"definition_clause\": \"8.5\"}}, {\"id\": \"term:Government officials\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Government officials\", \"text\": \"any government employee, candidate for public office, and employee of government-owned or government-controlled companies, public international organisations, and political parties.\", \"definition_clause\": \"8.5\"}}, {\"id\": \"term:Contract Year\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Contract Year\", \"text\": \"a period of one year starting on the Effective Date or the relevant anniversary of the Effective Date (as appropriate).\", \"definition_clause\": \"9.1\"}}, {\"id\": \"term:Applicable Time\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Applicable Time\", \"text\": \"the time the relevant liability is to be assessed\", \"definition_clause\": \"9.1\"}}, {\"id\": \"term:IP Claim\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"IP Claim\", \"text\": \"any claim from a third party that any Products or any Google Trademark infringe(s) any copyright, trade secret or trademark of such third party\", \"definition_clause\": \"10.1\"}}, {\"id\": \"term:Export Laws\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Export Laws\", \"text\": \"all applicable export and re-export control laws and regulations\", \"definition_clause\": \"11.5\"}}, {\"id\": \"term:you\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"you\", \"text\": \"the legal entity(ies) that has entered into the contract with Google into which these Guidelines are incorporated, as well as any person or entity acting on your behalf\", \"definition_clause\": \"EXHIBIT C\"}}, {\"id\": \"term:your\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"your\", \"text\": \"the legal entity(ies) that has entered into the contract with Google into which these Guidelines are incorporated, as well as any person or entity acting on your behalf\", \"definition_clause\": \"EXHIBIT C\"}}, {\"id\": \"term:Application\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Application\", \"text\": \"any application, plug-in, helper, component or other executable code that runs on a user's computer, examples of which include those that provide browser helper objects, instant messaging, chat, email, data, file viewing, media playing, file sharing, games, internet navigation, search and other services.\", \"definition_clause\": \"EXHIBIT C\"}}, {\"id\": \"term:distribution partner\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"distribution partner\", \"text\": \"any third party who distributes your Application\", \"definition_clause\": \"4\"}}, {\"id\": \"term:bundling partner\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"bundling partner\", \"text\": \"any third party who installs your Application in combination with or alongside one or more other Applications.\", \"definition_clause\": \"4\"}}, {\"id\": \"term:Update Notice Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Update Notice Date\", \"text\": \"the date on which you receive notice of an update to the Guidelines\", \"definition_clause\": \"10.2\"}}, {\"id\": \"term:Update Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Update Effective Date\", \"text\": \"the scheduled effective date of such update\", \"definition_clause\": \"10.2\"}}, {\"id\": \"term:Maximum Compliance Period\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Maximum Compliance Period\", \"text\": \"ninety (90) days of the Update Notice Date\", \"definition_clause\": \"10.2\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"value:one year\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"one year\"}}, {\"id\": \"value:[ * ] Euros\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"[ * ] Euros\"}}, {\"id\": \"value:[ * ]%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"[ * ]%\"}}, {\"id\": \"value:30 days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"30 days\"}}, {\"id\": \"value:$ [ * ]\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"$ [ * ]\"}}, {\"id\": \"value:six (6)-month period\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"six (6)-month period\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}]}\n"}
{"prompt": "\n### System:\nRespond with **raw JSON** only \u2013 no Markdown, no prose.\n\n### User:\nYou are a legal-entity extractor. \nExtract ALL nodes of type **CLAUSE, DEFINED_TERM, PARTY, VALUE** from the contract below.\n\nINPUT = ONE contract encoded as JSON: {contract_id, metadata, clauses:[\u2026]} \nOUTPUT = ONE JSON object with exactly **two keys**: `contract_id`, `nodes`. \n **DO NOT GENERATE EDGES.**\n\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\nNODE SCHEMAS\n\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\n\u2022 CLAUSE { \"id\":\"\", \"type\":\"CLAUSE\", \"attrs\":{ \"title\":\"\", \"level\":, \"text\":\"\" } }\n\u2022 DEFINED_TERM { \"id\":\"term:\", \"type\":\"DEFINED_TERM\", \"attrs\":{ \"term\":\"\", \"text\":\"\", \"definition_clause\":\"\" } }\n\u2022 PARTY { \"id\":\"party:\", \"type\":\"PARTY\", \"attrs\":{ \"text\":\"\", \"role\":\"\", \"address\":\"\" } }\n\u2022 VALUE { \"id\":\"value:\", \"type\":\"VALUE\", \"attrs\":{ \"type\":\"Currency|Percentage|Days\", \"text\":\"\" } }\n\nRULES \n1. **CLAUSE** \u2013 one node per clause. \n2. **DEFINED_TERM** \u2013 only from \u201cDefinitions\u201d sections; include `definition_clause`. \n3. **PARTY** \u2013 each named entity (e.g., \u201cACME Corp.\u201d). \n4. **VALUE** \u2013 monetary amounts, percentages, or durations. \n5. `id` values must be unique within `nodes`.\n\n{\"contract_id\": \"Copy of WORLDWIDESTRATEGIESINC_11_02_2005-EX-10-RESELLER AGREEMENT\", \"metadata\": {\"source\": \"CUAD\", \"file_name\": \"Copy of WORLDWIDESTRATEGIESINC_11_02_2005-EX-10-RESELLER AGREEMENT.txt\"}, \"clauses\": [{\"id\": \"para_1\", \"title\": \"EXHIBIT 10.2\", \"level\": 1, \"text\": \"EXHIBIT 10.2 TOUCHSTAR SOFTWARE CORPORATION RESELLER AGREEMENT DATED SEPTEMBER 14, 2005 TOUCHSTAR SOFTWARE CORPORATION RESELLER AGREEMENT This Reseller Agreement is made and entered into as of this 14 day of SEPTEMBER, 200_ (the \\\"Effective Date\\\"), by and between TOUCHSTAR SOFTWARE CORPORATION, a Delaware corporation with its principal place of business at 3025 South Parker Road, Suite 925, Aurora, Colorado 80014, United States (\\\"TouchStar\\\"), and WORLDWIDE STRATEGIES, a NEVADA corporation, with its principal place of business at 3801-E FLORIDA AVE STE 400 DENVER, CO 80210 (\\\"Reseller\\\"). RECITALS A. TouchStar produces and distributes the TouchStar Software and provides the related Support Services. B. Reseller has represented to TouchStar that it possesses experience, knowledge, and skill in the calling service industry and has the capability to effectively market and distribute the TouchStar Software and Support Services in the Territory.\"}, {\"id\": \"C\", \"title\": \"Reseller desires to market and distribute the TouchStar Software to Customers as a non-exclusive value added reseller i\", \"level\": 1, \"text\": \"C. Reseller desires to market and distribute the TouchStar Software to Customers as a non-exclusive value added reseller in the Territory pursuant to the terms contained in this Agreement. AGREEMENT NOW, THEREFORE, in consideration of the foregoing and the mutual promises set forth in this Agreement, and intending legally to be bound hereby, the parties agree as follows:\"}, {\"id\": \"1\", \"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"1. DEFINITIONS. In addition to the terms defined elsewhere in this Agreement, the following terms shall have the meanings set forth below (such meanings to be equally applicable to the singular as well as the plural forms of the terms defined): \\\"AAA\\\" has the meaning ascribed to that term in Section 10.12(b) of this Agreement. \\\"AAA Rules\\\" has the meaning ascribed to that term in Section 10.12(b) of this Agreement. \\\"Affiliate\\\" as used in this Agreement with respect to an Entity, means any person controlling, controlled by or under common control with such Entity. For the purpose of this definition, \\\"control\\\" means the possession, directly or indirectly, of the power to direct or cause the direction of an Entity, whether through the ownership of voting securities or otherwise. \\\"Agreement\\\" means this Reseller Agreement and the Exhibits attached hereto as the same may be amended from time to time in accordance with the terms set forth herein. Rev 3/05 \\\"Ancillary Software\\\" has the meaning ascribed to that term in Section 4.13 of this Agreement. \\\"Annual Marketing Plan\\\" has the meaning ascribed to that term in Section 4.3 of this Agreement. \\\"Assessment\\\" has the meaning ascribed to that term in Section 6.2 of this Agreement. \\\"Confidential Information\\\" means any and all trade secrets and other confidential information and know-how related directly or indirectly to TouchStar's business or its products, including inventions, materials, formulae, confidential research, technical information, technology, general know-how, patterns, specifications, systems data, equipment, operating standards and procedures, developments and improvements, computer programs, operating systems, source code, object code, middleware, firmware, information regarding projects, programs and sales, names and addresses of past and present customers, pricing data, internal procedures, systems, methods forms, manuals, financial data, price lists, customer service information, marketing information, and all other information relating to TouchStar, the TouchStar Software, Support Services, or other products or services of TouchStar that is not generally known to the public. &bbsp; \\\"Copyrights\\\" means all right, title, and interest of TouchStar in and to all copyrights and rights and interests in copyrights and works protectible by copyright, whether now owned or hereafter acquired or created by TouchStar (in whole or in part) and all renewals and extensions thereof, throughout the universe and in perpetuity, whether or not registered or recorded in the United States Copyright Office or in the copyright office or agency of any other country or jurisdiction and including all works based upon, incorporated in, derived from, incorporating or relating to all works covered by copyright, including copyrights or rights or interests in copyrights registered or recorded in the United States Copyright Office or in the copyright office or agency of any other country or jurisdiction. \\\"Customer\\\" means a third party end-user with headquarter offices in the Territory to whom or to which Reseller resells or causes the resale of the TouchStar Software and Support Services. \\\"Dollars\\\" or \\\"US$\\\" means the lawful currency of the United States. \\\"Effective Date\\\" has the meaning ascribed to that term in the introductory paragraph of this Agreement. \\\"Entity\\\" means any general partnership (including a limited liability partnership), limited partnership (including a limited liability limited partnership), limited liability company, corporation, joint venture, trust, business trust, cooperative, association or any foreign trust or foreign business organization. \\\"Fees\\\" means the installation fees, licensing fees and support service fees owed by Reseller to TouchStar, as set forth on EXHIBIT A. 2 \\\"Government Controls\\\" means economic and other sanctions instituted by a Governmental Body related to certain transactions, such as the transfer of technology and technical data, the transfer of funds, the provisions of goods and services, and other dealings, including, but not limited to, sanctions administered by the United States government pursuant to the United States Export Administration Act, the United States Arms Export Control Act, the International Emergency Economic Powers Act, the United States Foreign Corrupt Practices Act of 1977, all as amended, and the USA PATRIOT Act, and the regulations promulgated thereunder and certain regulations promulgated by the United States Department of Treasury. \\\"Governmental Body\\\" means any (a) nation, state, country, or other jurisdiction of any nature, (b) national, federal, state, local, municipal, foreign, or other government, governmental, or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal), or (c) body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature. \\\"Intellectual Property Rights\\\" means the Confidential Information of TouchStar, the Copyrights, the Patents, and the Trademarks. \\\"Legal Requirements\\\" means any national, federal, state, local, municipal, foreign, international, multinational, or other administrative order, law, constitutional law, ordinance, principle of law, regulation, statute, treaty, directive or decree, including Government Controls. \\\"License Agreement\\\" means the license agreement to be provided to each Customer with regard to the use by such Customer of the TouchStar Software, in the form of EXHIBIT B, attached to this Agreement. \\\"Licenses\\\" means those software and other licenses from third parties necessary lawfully to provide the Support Services. \\\"Marketing Materials\\\" has the meaning ascribed to that term in Section 3.2 of this Agreement. \\\"Other Reseller\\\" means any person or Entity acceptable to TouchStar in its sole discretion with whom or with which Reseller enters into an Other Reseller Agreement to promote, market, distribute, license and sell the TouchStar Software and Support Services to Customers in the Territory; PROVIDED that such person or Entity shall not be an end-user of either the TouchStar Software or the Support Services. \\\"Other Reseller Agreement\\\" has the meaning ascribed to that term in\"}, {\"id\": \"Section 2\", \"title\": \"2(a)(i) of this Agreement\", \"level\": 1, \"text\": \"Section 2.2(a)(i) of this Agreement. \\\"Patents\\\" means (a) all right, title and interest of TouchStar in and to all applicable Letters Patent and applications for Letters Patent and the inventions described therein and any Letters Patent which may issue therefrom and which have been or may have been filed in the United States or in any other country for any such inventions or for any improvements, reissues, divisions, continuations, renewals, additions, extensions, substitutes, continuations-in-part which may be made, filed, or 3 granted on any of them, including the rights to all benefits therefrom arising under the International Convention for the Protection of Industrial Property or any other international treaty affecting such rights; (b) any right, title and interest of TouchStar in any utility model, design registration, trade secret, confidential research, development and commercial information, know-how, technical information, engineering, practical information, patterns, specifications, formulae, manufacturing procedures, quality control, data and procedures, systems' data, software programs, equipment, operating standards and applications, developments, and improvements; and (c) any rights to licenses or other benefits under any Letters Patent, applications for Letters Patent and/or invention, utility model registration, design registration and inventor's certificate anywhere in the world, whether or not patentable, which are obtained by TouchStar or to which TouchStar becomes entitled during the term of this Agreement. \\\"Private Label Software\\\" has the meaning ascribed to that term in Section 7.2 of this Agreement. \\\"Quotas\\\" has the meaning ascribed to that term in Section 4.11 of this Agreement. \\\"Registered Leads\\\" has the meaning ascribed to that term in Section 2.6 of this Agreement. \\\"Reseller\\\" has the meaning ascribed to that term in the introductory paragraph of this Agreement, including its legal representatives, successors, and assigns. \\\"Reseller Marks\\\" has the meaning ascribed to that term in Section 7.2 of this Agreement. \\\"Reverse Engineer\\\" means translate, disassemble, decompile, analyze, reverse engineer or reverse program, or otherwise attempt to derive the code or programming for the TouchStar Software or the Private Label Software. \\\"Specifications\\\" has the meaning ascribed to that term in Section 3.4(a) of this Agreement. \\\"Support Services\\\" means those support services related to the TouchStar Software as described in the attached EXHIBIT C. \\\"Technical Prerequisites\\\" has the meaning ascribed to that term in Section 3.4(b) of this Agreement. \\\"Term\\\" has the meaning ascribed to that term in Section 8.1 of this Agreement. \\\"Territory\\\" means the geographical region described in the attached EXHIBIT D. \\\"TouchStar\\\" has the meaning ascribed to that term in the introductory paragraph of this Agreement, including its legal representatives, successors, and assigns. \\\"TouchStar Intellectual Property Rights\\\" means the Copyrights, the Patents, and the Trademarks. 4 \\\"TouchStar Software\\\" means the software necessary for the operation of call center systems which is being licensed by TouchStar pursuant to this Agreement. In the event that TouchStar develops Private Label Software for Reseller, the term \\\"TouchStar Software,\\\" when the context so requires, shall include Private Label Software. \\\"Trademarks\\\" means all right, title and interest of TouchStar in and to (a) all trademarks, trade names, trade styles, service marks, logos, trade dress, unpatentable designs, and designations and indicia of any kind, now existing or hereafter adopted or acquired, and all registrations and recordings thereof, including applications, registrations, and recordings in the United States Patent and Trademark Office or in any similar office or agency of the United States, any state thereof, any other country or jurisdiction or any political subdivision thereof, all whether now owned or hereafter acquired by TouchStar and all reissues, extensions, or renewals thereof, and (b) any licenses of or licensing agreements (including registered user agreements) pertaining to any of the foregoing, together with all amendments, supplements, modifications or extensions thereof. \\\"United States\\\" means the United States of America and its territories and possessions.\"}, {\"id\": \"2\", \"title\": \"APPOINTMENT OF RESELLER\", \"level\": 1, \"text\": \"2. APPOINTMENT OF RESELLER.\"}, {\"id\": \"2.1\", \"title\": \"NONEXCLUSIVE RESELLER\", \"level\": 2, \"text\": \"2.1 NONEXCLUSIVE RESELLER. Subject to applicable Legal Requirements: (a) TouchStar hereby appoints Reseller as its nonexclusive value- added reseller for the limited purposes of promoting, marketing, distributing, licensing and selling the TouchStar Software and Support Services in the Territory, and Reseller accepts the appointment as such. Reseller shall have the right under this Agreement to promote, market, distribute, license and sell the TouchStar Software and Support Services to Customers in the Territory. TouchStar reserves the right to provide the TouchStar Software and Support Services to other customers in the Territory and/or to appoint additional distributors or representatives in all or any part of the Territory.\"}, {\"id\": \"2.2\", \"title\": \"OTHER RESELLERS\", \"level\": 2, \"text\": \"2.2 OTHER RESELLERS. Subject to applicable Legal Requirements and to the provisions of this Section 2.2: (a) Reseller may promote, market, distribute, license and sell TouchStar Software and Support Services in the Territory through Other Resellers; PROVIDED that: (i) Reseller notifies TouchStar in writing in respect of each Other Reseller that Reseller intends to use to promote, market, distribute, license and sell TouchStar Software and Support Services in the Territory; (ii) TouchStar approves in writing each Other Reseller that Reseller intends to use to promote, market, distribute, license and sell TouchStar Software and Support Services in the Territory, which approval TouchStar may grant in its sole discretion; 5 (iii) Reseller enters into a binding written agreement with each Other Reseller (the \\\"Other Reseller Agreement\\\"), which Other Reseller Agreement incorporates the terms, conditions, duties, rights and obligations of this Agreement; (iv) Reseller provides to TouchStar a fully executed copy of each Other Reseller Agreement; (v) each Other Reseller shall promote, market, distribute, license and sell the TouchStar Software and the Support Services only in the Territory and only in accordance with the provisions of this Agreement, including, but not limited to, delivery of License Agreements to Customers, and compliance with Legal Requirements and Government Controls; and (vi) Reseller shall terminate any Other Reseller Agreement in the event that the Other Reseller to whom or to which the Other Reseller Agreement relates fails to comply with the terms and conditions of such Other Reseller Agreement or this Agreement. Any Other Reseller shall obtain the TouchStar Software and the Support Services directly from the Reseller. (b) Reseller shall be responsible for all actions of Other Resellers with regard to the promotion, marketing, distribution, licensing and sale of TouchStar Software. Reseller shall be liable for any unauthorized or illegal use of the TouchStar Software by any Other Reseller, including, but not limited to, any actions or attempts to Reverse Engineer the TouchStar Software and any promotion, marketing, distribution, licensing or sale of the TouchStar Software in violation of Government Controls or other Legal Requirements. (c) No Other Reseller shall have the right to use, copy, modify, alter or Reverse Engineer any TouchStar Software whatsoever, and Reseller shall take all necessary steps to ensure that all acts or any Other Reseller related in any way to the TouchStar Software are consistent with the terms and conditions of this Agreement.\"}, {\"id\": \"2.3\", \"title\": \"RESELLER'S OBLIGATION NOT TO COMPETE\", \"level\": 2, \"text\": \"2.3 RESELLER'S OBLIGATION NOT TO COMPETE. Reseller shall not obtain the TouchStar Software or Support Services (or any software or services which compete with the TouchStar Software) for sale from any Entity other than TouchStar or its authorized agents. Nothing contained in this Agreement is intended to limit Reseller from responding to unsolicited requests from Customers from outside of the Territory; PROVIDED, HOWEVER, that Reseller shall (a) immediately notify TouchStar upon receipt of any such request and (b) not seek customers of TouchStar Software or Support Services in any other location other than in the Territory. Reseller shall not sell TouchStar Software or Support Services to any person or Entity outside the Territory or within the Territory if, to Reseller's knowledge, any such person or Entity intends to resell the TouchStar Software or Support Services outside of the Territory. Reseller shall not import, promote, distribute, license, market or sell any products in 6 the Territory which directly compete with the TouchStar Software or Support Services.\"}, {\"id\": \"2.4\", \"title\": \"CHANGES IN TOUCHSTAR SOFTWARE AND SUPPORT SERVICES\", \"level\": 2, \"text\": \"2.4 CHANGES IN TOUCHSTAR SOFTWARE AND SUPPORT SERVICES. TouchStar shall have the right at any time and from time to time, in its sole discretion, (a) to change the TouchStar Software or Support Services included within the scope of this Agreement by providing written notice to Reseller at least thirty (30) days prior to the date the change becomes effective and (b) to change the design, capabilities or other characteristics of the TouchStar Software or Support Services, or discontinue the production or marketing of all or any portion of the TouchStar Software or Support Services, without prior notice of any kind. Upgrades and enhancements to the TouchStar Software or Support Services shall automatically be deemed included as TouchStar Software or Support Services, as applicable, unless TouchStar notifies Reseller otherwise.\"}, {\"id\": \"2.5\", \"title\": \"USE OF TOUCHSTAR SOFTWARE\", \"level\": 2, \"text\": \"2.5 USE OF TOUCHSTAR SOFTWARE. (a) TouchStar hereby grants to Reseller, with the additional right to grant to Other Resellers who or which enter into an Other Reseller Agreement, the nontransferable and nonexclusive right and license to use one copy of the TouchStar Software as necessary to demonstrate the TouchStar Software to potential Customers in the Territory. Reseller shall not copy, modify, alter, Reverse Engineer or transfer, electronically or otherwise, any TouchStar Software. (b) TouchStar reserves the absolute right, without providing notice to Reseller, to include software code or other markings in the TouchStar Software (and the Private Label Software) to assist TouchStar in monitoring the compliance by Reseller and Other Resellers with their respective obligations not to copy, modify, alter, modify or Reverse Engineer the TouchStar Software. In addition, in order to protect TouchStar's rights in and to the TouchStar Software, THE TOUCHSTAR SOFTWARE MAY CONTAIN A PROPRIETARY SCHEME THAT ALLOWS TOUCHSTAR TO DISABLE USE OF THE TOUCHSTAR SOFTWARE BY RESELLER, ANY OTHER RESELLER, OR CUSTOMER. TOUCHSTAR MAY DISABLE THE TOUCHSTAR SOFTWARE IN THE EVENT THAT TOUCHSTAR DISCOVERS THAT RESELLER OR ANY OTHER RESELLER HAS, OR HAS ATTEMPTED TO, COPY, MODIFY, ALTER OR REVERSE ENGINEER THE TOUCHSTAR SOFTWARE.\"}, {\"id\": \"2.6\", \"title\": \"LEADS FOR TOUCHSTAR SOFTWARE\", \"level\": 2, \"text\": \"2.6 LEADS FOR TOUCHSTAR SOFTWARE. Reseller shall solicit orders for TouchStar Software from potential Customers and shall submit such leads in writing to TouchStar (the \\\"Registered Leads\\\"). No Registered Leads shall be binding on TouchStar until accepted by TouchStar, and TouchStar reserves the right to reject any order or to cancel the same or any part of it after acceptance, for credit or for any other reason whatsoever deemed by TouchStar to be sufficient. Each Registered Lead shall include: (a) the name, address and telephone number of the Customer; (b) a list of the TouchStar Software and Support Services to be provided; (c) the delivery address for 7 the TouchStar Software, whether to Reseller or Customer; (d) the proposed shipment date; and (e) a reference to this Agreement.\"}, {\"id\": \"2.7\", \"title\": \"LEAD TIMES\", \"level\": 2, \"text\": \"2.7 LEAD TIMES. Registered Leads shall be submitted at least thirty (30) days prior to the requested shipping date for any TouchStar Software or Support Services.\"}, {\"id\": \"3\", \"title\": \"TOUCHSTAR'S DUTIES\", \"level\": 1, \"text\": \"3. TOUCHSTAR'S DUTIES.\"}, {\"id\": \"3.1\", \"title\": \"AVAILABILITY OF SUPPORT SERVICES\", \"level\": 2, \"text\": \"3.1 AVAILABILITY OF SUPPORT SERVICES. TouchStar shall use reasonable commercial efforts to maintain or cause to be maintained the availability of the TouchStar Software and Support Services to Customers in the Territory.\"}, {\"id\": \"3.2\", \"title\": \"MARKETING AND PROMOTIONAL LITERATURE\", \"level\": 2, \"text\": \"3.2 MARKETING AND PROMOTIONAL LITERATURE. TouchStar shall provide to Reseller marketing presentations and other literature prepared by TouchStar in the ordinary course of business describing the TouchStar Software and Support Services in order to assist Reseller in the marketing of the Support Services in the Territory (the \\\"Marketing Materials\\\"). The Marketing Materials will contain some or all of the Trademarks. Reseller may include its trademarks, service marks or other logos on the Marketing Materials; provided that Reseller may not remove, replace or otherwise modify the Trademarks included on such Marketing Materials.\"}, {\"id\": \"3.3\", \"title\": \"LICENSES\", \"level\": 2, \"text\": \"3.3 LICENSES. TouchStar shall grant to Reseller those Licenses necessary for Reseller to provide Support Services to Customers. TouchStar shall charge to Reseller the cost incurred by TouchStar to obtain such Licenses.\"}, {\"id\": \"3.4\", \"title\": \"INSTALLATION\", \"level\": 2, \"text\": \"3.4 INSTALLATION. (a) At the request and on behalf of Reseller and any Other Reseller, TouchStar will install call center systems at Customer locations; PROVIDED that (i) TouchStar and Reseller or any Other Reseller, as applicable, agree in writing on the configuration of such call center systems (the \\\"Specifications\\\") and (ii) Reseller and any Other Reseller informs the Customer that TouchStar is installing the call center system on behalf of such Reseller or any Other Reseller. (b) TouchStar will use reasonable commercial efforts to install the call center system on behalf of Reseller or any Other Reseller in a timely fashion. However, TouchStar and Reseller or any Other Reseller recognize and agree that the installation of the call center system depends on (i) TouchStar receiving certain information and data from Customer, (ii) Customer providing on a timely basis the necessary technical prerequisites for the installation of the call center system, such as T-1 lines, cabling and workstations (the \\\"Technical Prerequisites\\\"), and (iii) the number and type of any change orders requested by the Customer during the installation of the call center system. TouchStar will not be responsible for any delays in the installation of the call center system based on whole or in part on (i) delays by the Customer in providing information and data to TouchStar required for the installation of the call center system, (ii) the delay or failure by the Customer 8 to provide the Technical prerequisites, and (iii) any change orders requested with regard to the call center system.\"}, {\"id\": \"4\", \"title\": \"RESELLER'S DUTIES\", \"level\": 1, \"text\": \"4. RESELLER'S DUTIES.\"}, {\"id\": \"4.1\", \"title\": \"TECHNICAL AND SALES CAPABILITIES\", \"level\": 2, \"text\": \"4.1 TECHNICAL AND SALES CAPABILITIES. Reseller acknowledges that the proper marketing and support of the TouchStar Software and Support Services requires substantial expertise and commitment. Reseller shall at all times during the term of this Agreement, at its expense, maintain the ability (a) to provide competent and adequate technical assistance, service and support, (b) to explain in detail to its Customers the features and capabilities of the Support Services, (c) to assist Customers in determining which configuration of the Support Services will best meet their particular needs and desires, and (d) otherwise to carry out its obligations under this Agreement.\"}, {\"id\": \"4.2\", \"title\": \"DISTRIBUTION OF TOUCHSTAR SOFTWARE AND SUPPORT SERVICES\", \"level\": 2, \"text\": \"4.2 DISTRIBUTION OF TOUCHSTAR SOFTWARE AND SUPPORT SERVICES. Reseller shall use its best endeavors to vigorously promote and resell the TouchStar Software and Support Services within the Territory.\"}, {\"id\": \"4.3\", \"title\": \"MARKETING PLAN\", \"level\": 2, \"text\": \"4.3 MARKETING PLAN. Reseller shall be responsible for developing and implementing an annual marketing plan and system for reselling the TouchStar Software and the Support Services (the \\\"Annual Marketing Plan\\\"), which Annual Marketing Plan shall, prior to any use by Reseller, be approved by TouchStar. The Annual Marketing Plan shall be submitted to TouchStar no later than thirty (30) days after the Effective Date.\"}, {\"id\": \"4.4\", \"title\": \"MARKETING PRACTICES\", \"level\": 2, \"text\": \"4.4 MARKETING PRACTICES. Reseller shall at all times conduct its business in a manner that reflects favorably on the TouchStar Software, the Support Services and upon TouchStar's name, goodwill, and reputation. Reseller shall demonstrate and otherwise represent the TouchStar Software and the Support Services fairly in comparison with competitive products and shall not make any false or misleading comparisons or representations regarding the TouchStar Software or the Support Services or any representations relating to the TouchStar Software or the Support Services that are inconsistent with TouchStar's product literature, or warranties. Reseller shall not engage in any illegal, deceptive, misleading, or unethical practices that may be detrimental to TouchStar.\"}, {\"id\": \"4.5\", \"title\": \"PRODUCT LITERATURE\", \"level\": 2, \"text\": \"4.5 PRODUCT LITERATURE. Subject to the provisions of Section 3.2, Reseller &bbsp; shall have the right to use and distribute the Marketing Literature to Customers. In the event Reseller desires to use, in connection with sales of the Support Services, any literature, technical data, price lists, promotional materials, or similar materials (including, for example, any materials written in any language other than English) other than the Marketing Materials, Reseller shall prepare such materials at its expense. All such materials shall be submitted to TouchStar for approval, and Reseller shall not use, in connection with the sale of the Support Services, any materials that have not been prepared or approved by TouchStar.\"}, {\"id\": \"4.6\", \"title\": \"CUSTOMER ASSISTANCE\", \"level\": 2, \"text\": \"4.6 CUSTOMER ASSISTANCE. Reseller, at its expense, shall provide assistance to its Customers in connection with the TouchStar Software and Support Services, 9 including installation assistance, direction regarding the operation of the TouchStar Software and Support Services, and other similar assistance.\"}, {\"id\": \"4.7\", \"title\": \"SOFTWARE LICENSE AGREEMENT\", \"level\": 2, \"text\": \"4.7 SOFTWARE LICENSE AGREEMENT. Reseller and each Other Reseller shall deliver to each Customer a copy of the License Agreement. TouchStar shall have the right to modify the terms and conditions of the License Agreement from time to time, in the sole discretion of TouchStar. Upon request from TouchStar, Reseller and each Other Reseller shall deliver the License Agreement prior to delivery of the TouchStar Software and Support Services. Reseller shall provide TouchStar with the name and address of each Customer who or which receives a copy of the License Agreement, whether from Reseller or from an Other Reseller.\"}, {\"id\": \"4.8\", \"title\": \"REPORTS, FORECASTS\", \"level\": 2, \"text\": \"4.8 REPORTS, FORECASTS. As frequently as TouchStar reasonably requests (but in no event less than quarterly), Reseller shall provide to TouchStar written reports showing (a) Reseller's current Customers for TouchStar Software and Support Services, (b) forecasts of Reseller's anticipated orders for TouchStar Software and Support Services, and (c) any other information regarding the TouchStar Software and Support Services and the resale of TouchStar Software and Support Services that TouchStar reasonably requests. All expenses associated with such written reports shall be borne by Reseller.\"}, {\"id\": \"4.9\", \"title\": \"NOTIFICATION\", \"level\": 2, \"text\": \"4.9 NOTIFICATION. Reseller shall report promptly to TouchStar concerning any market information that comes to Reseller's attention regarding TouchStar, the TouchStar Software or the Support Services, including information regarding TouchStar's market position and the competitiveness of the TouchStar Software or the Support Services in the marketplace. Reseller shall report promptly to TouchStar all claimed or suspected defects in the TouchStar Software or Support Services and shall notify TouchStar in writing of any claim or proceeding involving the TouchStar Software or Support Services within five (5) days after Reseller learns of the claim or proceeding.\"}, {\"id\": \"4.10\", \"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"4.10 COMPLIANCE WITH LAWS. Reseller and each Other Reseller shall conduct its business in compliance with all applicable laws and regulations in any way related to the Support Services, and performance of Reseller's duties under this Agreement. Without limiting the generality of the foregoing, Reseller shall: (a) Comply with all applicable international, national, regional and local laws and rules in and of the Territory now in effect or hereafter enacted or issued relating to the TouchStar Software and the Support Services; (b) Comply with any requirement for the registration or recording of this Agreement with any Governmental Body in the Territory; (c) Give proper weight and consideration to the interests of TouchStar in all dealings; (d) Comply at all times, and cause persons under its control to comply at all times, with any and all Government Controls and other Legal Requirements; 10 (e) Refrain from any action or omission which will cause TouchStar to be in violation of any law of any jurisdiction in the Territory or of any other Legal Requirement, including Government Controls.\"}, {\"id\": \"4.11\", \"title\": \"PERFORMANCE QUOTAS\", \"level\": 2, \"text\": \"4.11 PERFORMANCE QUOTAS. Each Annual Marketing Plan developed by Reseller during the term of this Agreement and any extension thereof shall contain quotas mutually agreed between TouchStar and Reseller for the sale by Reseller of TouchStar Software and Support Services in the Territory for the year to which such Annual Marketing Plan relates (the \\\"Quotas\\\"). Reseller acknowledges that meeting the Quotas is an essential element of this Agreement and that this Agreement may be terminated by TouchStar if, in TouchStar's reasonable opinion, Reseller will not meet the Quotas during the Term or any extension thereof.\"}, {\"id\": \"4.12\", \"title\": \"INSURANCE\", \"level\": 2, \"text\": \"4.12 INSURANCE. At a minimum, Reseller will subscribe for and maintain during the Term and for a period of two (2) years thereafter, commercial general liability insurance and errors and omission insurance in minimum amounts of Two Million Dollars (US$2,000,000) per occurrence. Reseller will cause its insurance agent or broker to issue and deliver to TouchStar certified copies of certificates evidencing that insurance coverage of the required types and limits are in full force and effect. Reseller will ensure that any persons or entities engaged by or employed by it will carry and maintain such insurance coverage. Each policy will include a provision requiring notice to the other party at least thirty (30) days prior to any cancellation, non-renewal, or material modification of the policy and will require that each policy will name TouchStar as an additional insured.\"}, {\"id\": \"4.13\", \"title\": \"ANCILLARY SOFTWARE\", \"level\": 2, \"text\": \"4.13 ANCILLARY SOFTWARE. Reseller shall have the right to develop ancillary software compatible with the TouchStar Software for the use of its Customers, including, but not limited to translations of the TouchStar Software for use in languages other than English (the \\\"Ancillary Software\\\"). In the event Reseller decides to develop Ancillary Software, Reseller shall give TouchStar thirty (30) days notice of its intent to develop the Ancillary Software. TouchStar, at its sole discretion may decide to assist with the development of the Ancillary Software. TouchStar shall own all Ancillary Software.\"}, {\"id\": \"4.14\", \"title\": \"TECHNICAL PREREQUISITES\", \"level\": 2, \"text\": \"4.14 TECHNICAL PREREQUISITES. In the event that TouchStar installs call center systems on behalf of Reseller, Reseller shall provide to TouchStar any and all information on Technical Prerequisites reasonably requested by TouchStar in order to assist TouchStar in the installation of the applicable call center system.\"}, {\"id\": \"4.15\", \"title\": \"COVENANT NOT TO SOLICIT\", \"level\": 2, \"text\": \"4.15 COVENANT NOT TO SOLICIT. During the Term, and for a period of one year following the termination or expiration of this Agreement, Reseller will not, directly or indirectly, make an offer of employment to any current employee of TouchStar or otherwise encourage or solicit any current employee of TouchStar to leave the employ of TouchStar for any reason, or to devote less than all of such employee's efforts to the affairs of TouchStar, without (a) the prior written agreement of TouchStar, which TouchStar may grant in its sole discretion, and (b) the payment by Reseller to TouchStar of a mutually agreeable severance fee. Reseller will not make an offer of 11 employment to any former employee of TouchStar for a period of four (4) months after such employee leaves the employ of TouchStar. In the event that a court of competent jurisdiction refuses to enforce all or any portion of this Section 4.15, then such unenforceable portion will be eliminated or modified, but only to the extent necessary to permit the remaining portion of this Section 4.15 to be enforced. In the event that any provisions of this Section 4.15 are deemed to exceed the time, geographic or scope limitations permitted by applicable law, such provisions will be reformed to the maximum time, geographic or scope limitations, as the case may be, permitted by applicable law.\"}, {\"id\": \"5\", \"title\": \"TECHNICAL ASSISTANCE\", \"level\": 1, \"text\": \"5. TECHNICAL ASSISTANCE.\"}, {\"id\": \"5.1\", \"title\": \"TOUCHSTAR SOFTWARE INFORMATION\", \"level\": 2, \"text\": \"5.1 TOUCHSTAR SOFTWARE INFORMATION. TouchStar shall make available to Reseller in English such technical information relating to the TouchStar Software as it makes available to its other Resellers generally. Reseller is not entitled to receive any source code or other technical information relating to the TouchStar Software.\"}, {\"id\": \"5.2\", \"title\": \"UPGRADE OF RESELLER'S CUSTOMERS\", \"level\": 2, \"text\": \"5.2 UPGRADE OF RESELLER'S CUSTOMERS. Reseller shall use reasonable commercial efforts to upgrade the software used by its Customers prior to the Effective Date to the TouchStar Software. At Reseller's request, TouchStar shall provide to Reseller and its employees assistance relating to the upgrade of software used by Reseller's Customers as of the Effective Date.\"}, {\"id\": \"5.3\", \"title\": \"ADDITIONAL ASSISTANCE\", \"level\": 2, \"text\": \"5.3 ADDITIONAL ASSISTANCE. TouchStar shall provide to Reseller, the Other Resellers, and its and their employees assistance relating to the TouchStar Software as reasonably requested by Reseller, but in any event in an amount not to exceed twenty (20) hours of assistance per month. In the event TouchStar provides assistance to Reseller related to technical aspects of the TouchStar Software or related to the preparation of literature, technical aspects of the TouchStar Software or related to the preparation of literature, technical materials or promotional materials, Reseller shall promptly reimburse TouchStar for any out-of-pocket expenses incurred by TouchStar in connection with rendering such assistance, including all travel expenses, lodging, and meals. TouchStar may also charge reasonably hourly or per diem rates for some or all of the services rendered under this provision, provided that TouchStar notifies Reseller before the services are rendered of the rates that will apply to the services. Nothing in this Section 5.3 shall be construed to obligate TouchStar to provide assistance of any kind to Reseller. In the event TouchStar agrees to provide assistance, the assistance shall at all times be subject to the availability of TouchStar's personnel.\"}, {\"id\": \"6\", \"title\": \"TERMS AND CONDITIONS OF SALE\", \"level\": 1, \"text\": \"6. TERMS AND CONDITIONS OF SALE.\"}, {\"id\": \"6.1\", \"title\": \"PRICE AND PAYMENT\", \"level\": 2, \"text\": \"6.1 PRICE AND PAYMENT. (a) TouchStar shall sell the TouchStar Software and Support Services, and provide for the installation of call center systems, for the Fees. The Fees shall be valid only for TouchStar Software and Support Services sold by Reseller or Other Resellers to Customers, and the installation of call center systems on 12 behalf of Reseller and any Other Resellers at Customer locations, in the Territory during the Term. TouchStar shall have the right at any time and from time to time to change the Fees by providing to Reseller written notice at least thirty (30) days prior to the date the change becomes effective. TouchStar may change the Fees from time to time in its sole discretion; PROVIDED, HOWEVER, that new Fees shall not apply to any agreement to provide Support Services accepted by TouchStar before Reseller receives notice of the change. (b) TouchStar will invoice Reseller for payment of the Fee incurred within ten (10) days after the end of each billable month. Payment of the Fees shall be due and payable within ten (10) days of the date of the invoice. All or any portion of the Fees not paid when due shall bear interest at the rate of one and one-half (1.5%) per month, calculated from the date such payment is due until the date on which such payment is made, inclusive; PROVIDED, HOWEVER, that if such interest rate exceeds the amount allowed by applicable law, then the interest rate shall be adjusted to reflect the maximum amount allowed by such applicable law.\"}, {\"id\": \"6.2\", \"title\": \"ASSESSMENTS\", \"level\": 2, \"text\": \"6.2 ASSESSMENTS. Reseller shall pay when due, and indemnify and hold TouchStar harmless from any and all taxes, value added taxes, general service taxes, duties, assessments and other fees associated with the providing by Reseller of the TouchStar Software and the Support Services, and the installation of call center systems on behalf of Reseller, to Customers in the Territory pursuant to this Agreement (\\\"Assessments\\\"). If Reseller fails to pay any Assessments when due, and TouchStar receives any Assessment from any Governmental Body, then TouchStar shall give written notice of the Assessment to Reseller. Failure by Reseller immediately to pay such Assessment may, in TouchStar's sole discretion, result in the immediate termination of this Agreement.\"}, {\"id\": \"6.3\", \"title\": \"OTHER TERMS AND CONDITIONS\", \"level\": 2, \"text\": \"6.3 OTHER TERMS AND CONDITIONS. The terms and conditions of this Agreement and of the applicable TouchStar invoice or confirmation shall apply to all TouchStar Software and Support Services, and the installation of call center systems, provided by TouchStar under this Agreement. Terms in Reseller's purchase orders and other printed forms shall not apply to any order, notwithstanding TouchStar's acknowledgment or acceptance of the order. In the event of any conflict between the terms of this Agreement and any standard forms of either TouchStar or Reseller, the terms of this Agreement shall govern. Reseller shall not, and is not authorized to, make any warranties as to the TouchStar Software and Support Services, or with regard to the installation of call center systems by TouchStar, and any warranties exceeding the scope of TouchStar warranties shall be null and void, subject only to contrary legal requirements applicable to the Territory.\"}, {\"id\": \"6.4\", \"title\": \"LIMITED WARRANTY\", \"level\": 2, \"text\": \"6.4 LIMITED WARRANTY. TouchStar warrants that (a) with regard to the TouchStar Software, (i) TouchStar will convey good title to the TouchStar Software free and clear of any claims, liens, security agreements or other encumbrances and (ii) for a period of ninety (90) days after delivery, the TouchStar Software will perform in all 13 material respects with the specifications contained in TouchStar's technical literature with regard to the TouchStar Software, (b) the Support Services will be provided in a good and workmanlike manner consistent with industry practices, and (c) with regard to call center systems installed by TouchStar, (i) TouchStar will convey good title to the call center system free and clear of any claims, liens, security agreements or other encumbrances and (ii) the call center system will be installed in a good and workmanlike manner substantially in conformance with the Specifications. EXCEPT AS PROVIDED IN THIS SECTION 6.4, TOUCHSTAR DOES NOT WARRANT THE TOUCHSTAR SOFTWARE OR SUPPORT SERVICES, OR THE INSTALLATION OF ANY CALL CENTER SYSTEM, TO RESELLER, ANY OTHER RESELLER OR ANY CUSTOMER. TOUCHSTAR MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, RELATING THERETO. TOUCHSTAR IS UNAWARE OF THE USE OF ANY CALL CENTER SYSTEM INSTALLED&bbsp;BY TOUCHSTAR. TOUCHSTAR MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND WHATSOEVER WITH REGARD TO THE USE OF ANY CALL CENTER SYSTEM, INCLUIDNG WHETHER THE USE OF THE CALL CENTER SYSTEM CONFORMS TO APPLICABLE FEDERAL, STATE AND LOCAL LAWS. RESELLER BEARS SOLE RESPONSIBILITY TO DETERMINE WHETHER THE USE OF A CALL CENTER SYSTEM BY A CUSTOMER COMPLIES WITH APPLICABLE FEDERAL STATE AND LOCAL LAWS. SHOULD APPLICABLE LAW NOT PERMIT THE FOREGOING EXCLUSION OF EXPRESS OR IMPLIED WARRANTIES, THEN TOUCHSTAR HEREBY GRANTS THE MINIMUM EXPRESS AND IMPLIED WARRANTIES REQUIRED BY SUCH APPLICABLE LAW.\"}, {\"id\": \"6.5\", \"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"6.5 LIMITATION OF LIABILITY. IN NO EVENT SHALL TOUCHSTAR BE LIABLE TO RESELLER, ANY OTHER RESELLER OR ANY CUSTOMER BY REASON OF ANY REPRESENTATION OR IMPLIED WARRANTY, CONDITION, OTHER TERM, OR ANY DUTY AT COMMON LAW, OR UNDER THE TERMS OF THIS AGREEMENT, FOR ANY DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL OR PUNITIVE LOSS OR DAMAGE (WHETHER FOR LOSS OF PROFIT OR OTHERWISE) ARISING OUT OF OR IN CONNECTION WITH ANY ACT OR OMISSION OF TOUCHSTAR RELATING TO THE DEVELOPMENT, MANUFACTURE, OR SUPPLY OF THE TOUCHSTAR SOFTWARE, THE SERVICES, OR THE INSTALLATION OF ANY CALL CENTER SYSTEM, THEIR RESALE BY RESELLER, OR THEIR USE BY ANY CUSTOMER OR OTHER END USER. TOUCHSTAR SHALL NOT BE LIABLE FOR THE PROVISION OF SERVICES BY RESELLER OR ANY OTHER RESELLER, OR ANY ALTERATIONS OR MODIFICATIONS BY RESELLER TO THE TOUCHSTAR SOFTWARE OR ANY CALL CENTER SYSTEM. THE SOLE OBLIGATION OF TOUCHSTAR, AND THE SOLE REMEDY OF RESELLER OR ANY OTHER RESELLER, UNDER THIS AGREEMENT SHALL BE (A) WITH REGARD TO THE TOUCHSTAR SOFTWARE OR ANY CALL CENTER SYSTEM, THE REPLACEMENT OR REPAIR OF THE TOUCHSTAR SOFTWARE OR THE CALL CENTER SYSTEM OR, AT THE OPTION OF TOUCHSTAR, THE RETURN OF THE PURCHASE PRICE PAID BY RESELLER 14 FOR SUCH TOUCHSTAR SOFTWARE OR CALL CENTER SYSTEM AND (B) WITH REGARD TO SERVICES, THE REPERFORMANCE OF THE SERVICES.\"}, {\"id\": \"7\", \"title\": \"INTELLECTUAL PROPERTY RIGHTS\", \"level\": 1, \"text\": \"7. INTELLECTUAL PROPERTY RIGHTS.\"}, {\"id\": \"7.1\", \"title\": \"OWNERSHIP OF INTELLECTUAL PROPERTY\", \"level\": 2, \"text\": \"7.1 OWNERSHIP OF INTELLECTUAL PROPERTY. (a) Reseller acknowledges that TouchStar owns or has rights to license the intellectual property and proprietary rights in, to, and relating to the TouchStar Software and Support Services, including, but not limited to, the Intellectual Property Rights. (b) To the extent that Reseller or any Other Reseller is deemed to be the owner of all or any portion of the TouchStar Software, any Intellectual Property Rights of TouchStar or any Ancillary Software, or any improvements or intellectual property rights related thereto pursuant to applicable law, Reseller (i) hereby assigns exclusively to TouchStar all rights of Reseller in and to such Software and any improvements and intellectual property rights related thereto royalty-free and exclusively and (ii) shall include in any Other Reseller Agreement provision by which any Other Reseller grants to TouchStar an exclusive, perpetual, irrevocable, royalty-free assignment of all deemed rights of such Other Reseller in and to such TouchStar Software, Ancillary Software and Intellectual Property Rights. Reseller shall execute, and shall cause any Other Reseller to execute, any such documents and instruments necessary to vest in TouchStar the deemed ownership rights of Reseller or Other Reseller in and to any TouchStar Software, Ancillary Software or Intellectual Property Rights, and any improvements or intellectual property rights related thereto.\"}, {\"id\": \"7.2\", \"title\": \"PRIVATE LABELING\", \"level\": 2, \"text\": \"7.2 PRIVATE LABELING. At the request of Reseller, TouchStar shall use reasonable commercial efforts to provide a private label version of the TouchStar Software (the \\\"Private Label Software\\\") using logos, trademarks, trade names or service marks owned by Reseller or to which Reseller has exclusive rights (the \\\"Reseller Marks\\\"). Reseller represents and warrants that Reseller has valid legal ownership and other exclusive rights to the Reseller Marks. Reseller grants to TouchStar a right and license to use the Reseller Marks in the preparation of the Private Label Software. Reseller shall have the right to promote, market, distribute and resell the Private Label Software pursuant to the terms and conditions of this Agreement. Reseller shall reimburse TouchStar for all costs and expenses incurred by TouchStar in making the Private Label Software available to Reseller. Except for the Reseller Marks, TouchStar shall retain all right, title and interest in and to the Private Label Software. Reseller shall indemnify, defend and hold harmless TouchStar, its Affiliates, and its and their respective directors, officers, employees, agents and representatives from and against any and all claims, suits, proceedings, costs and expenses arising out of or relating to the use by TouchStar of the Reseller Marks. TouchStar may include in the Private Label Software a legend to the effect that TouchStar owns the Private Label Software. 15\"}, {\"id\": \"7.3\", \"title\": \"USE OF TOUCHSTAR INTELLECTUAL PROPERTY RIGHTS\", \"level\": 2, \"text\": \"7.3 USE OF TOUCHSTAR INTELLECTUAL PROPERTY RIGHTS. Reseller shall use the Intellectual Property Rights only to refer to the TouchStar Software in accordance with TouchStar's policies as announced from time to time. In particular, and without limitation, Reseller shall not (a) remove Trademarks from any Marketing Materials, (b) include any Trademarks or other Intellectual Property Rights in any promotional literature prepared by Reseller without the express written consent of TouchStar; (c) dispute or deny the validity of any of the Intellectual Property Rights (including any attempt to register or record the same in any jurisdiction), (d) do any act or omit to do any act whereby TouchStar's right, title, and interest in the Intellectual Property Rights may become invalidated or otherwise adversely affected, (e) alter, remove, destroy, conceal, or tamper with any Trademarks, (f) use any Intellectual Property Rights in any way which might prejudice their distinctiveness or validity or goodwill of TouchStar therein, (g) use in relation to Support Services any patents, copyrights, trademarks, or trade names other than the Intellectual Property Rights without TouchStar's prior written consent, or (h) use in the Territory any trademarks or trade names so resembling any Trademark of TouchStar as to be likely to cause confusion or deception. Upon expiration or termination of this Agreement, Reseller shall immediately cease all use of the Intellectual Property Rights and shall not thereafter use any of them or any intellectual property rights confusingly similar to the Intellectual Property Rights.\"}, {\"id\": \"7.4\", \"title\": \"USE OF CONFIDENTIAL INFORMATION\", \"level\": 2, \"text\": \"7.4 USE OF CONFIDENTIAL INFORMATION. Reseller acknowledges that it may receive, during the term of this Agreement, certain Confidential Information belonging to TouchStar. Reseller recognizes that such Confidential Information is proprietary to TouchStar and very valuable, having involved the expenditure of substantial amounts of money and the use of skilled experts over a long period of time. Reseller shall hold TouchStar's Confidential Information in strict confidence and shall not use or disclose any Confidential Information, or permit any person to examine or copy any Confidential Information, regardless of the manner in which Reseller gained access to it, except as necessary for the performance of Reseller's obligations under this Agreement.\"}, {\"id\": \"7.5\", \"title\": \"PROTECTION OF CONFIDENTIAL INFORMATION\", \"level\": 2, \"text\": \"7.5 PROTECTION OF CONFIDENTIAL INFORMATION. Reseller shall protect TouchStar's Confidential Information with the utmost care and shall cause its employees, agents, and independent contractors having access to such Confidential Information to sign confidentiality agreements requiring them to comply with all the terms of this Article 7.\"}, {\"id\": \"7.6\", \"title\": \"INFRINGEMENT CLAIMS\", \"level\": 2, \"text\": \"7.6 INFRINGEMENT CLAIMS. Reseller shall promptly notify TouchStar of any known or suspected breach of the Intellectual Property Rights and shall cooperate (without charge for personal time incurred) in TouchStar's efforts to protect such TouchStar Intellectual Property Rights. TouchStar shall defend any action brought against Reseller based on an allegation that any TouchStar Software infringes a United States or foreign Patent, Copyright, or Trademark, and TouchStar shall pay all costs and damages made in settlement or awarded as a result of any such action. If a final injunction shall be obtained in any such action restraining use of the TouchStar Software by any Customer, or if TouchStar believes that any TouchStar Software is 16 likely to become the subject of a claim of infringement, TouchStar shall, at its option and at its expense, (a) procure for Reseller's Customer the right to continue using the TouchStar Software, (b) replace or modify the TouchStar Software so that it becomes non-infringing, or (c) repurchase the TouchStar Software on a depreciated (five-year straight line) basis. Notwithstanding the foregoing, TouchStar shall have no obligation with respect to any action brought against Reseller based on an allegation of Patent, Copyright, or Trademark infringement unless TouchStar is promptly notified by Reseller in writing of such action and is allowed complete control of the defense of such action and all negotiations for its settlement or compromise. This Section 7.6 states TouchStar's entire liability with respect to infringement of Patents, Copyrights, or Trademarks.\"}, {\"id\": \"7.7\", \"title\": \"EQUITABLE REMEDIES\", \"level\": 2, \"text\": \"7.7 EQUITABLE REMEDIES. Reseller acknowledges that TouchStar will be irreparably harmed by any breach of the provisions of this Section 7. Therefore, in addition to any other remedies that TouchStar may have, TouchStar shall be entitled to an injunction, issued by any court of competent jurisdiction, wherever located, restraining any violation of this Section 7 or specified performance if applicable. Reseller hereby waives, with respect to any future dispute related to this Section 7, any defense based on the argument that TouchStar will not be irreparably harmed by a breach or that TouchStar has available to it an adequate remedy for damages.\"}, {\"id\": \"7.8\", \"title\": \"RESELLER'S OBLIGATIONS AS TO CONFIDENTIAL INFORMATION AFTER TERMINATION\", \"level\": 2, \"text\": \"7.8 RESELLER'S OBLIGATIONS AS TO CONFIDENTIAL INFORMATION AFTER TERMINATION. All obligations of Reseller relating to TouchStar Confidential Information shall survive the expiration or termination of this Agreement. Promptly upon expiration or termination of this Agreement, Reseller shall not have a right of retention with respect to, and shall return to TouchStar, all materials in Reseller's possession or control that represent or contain Confidential Information, including all memoranda, computer programs, documents, notes, and every other medium. Reseller shall not retain for its own use or the use of any third party any such materials or any copies thereof.\"}, {\"id\": \"8\", \"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"8. TERM AND TERMINATION.\"}, {\"id\": \"8.1\", \"title\": \"TERM OF AGREEMENT\", \"level\": 2, \"text\": \"8.1 TERM OF AGREEMENT. This Agreement shall continue in force for a term of twelve (12) months from the Effective Date, unless terminated earlier under the provisions of this Article 8 (the \\\"Term\\\"); PROVIDED that TouchStar shall have the right to terminate this Agreement at any time after the Effective Date upon not less than fifteen (15) days' prior written notice to Reseller. Prior to the end of the Term, each of TouchStar and Reseller may notify the other if it desires to negotiate a further agreement by written request received at least ninety (90) days in advance of the termination of this Agreement. If both parties desire to negotiate a further agreement, they may consider the terms of this Agreement in coming to an understanding. Nothing in this Agreement shall be construed to obligate either party to renew or extend the term of this Agreement. Renewals for additional terms, if any, shall not cause this Agreement to be construed as an agreement of indefinite duration.\"}, {\"id\": \"8.2\", \"title\": \"TERMINATION AT TOUCHSTAR OPTION\", \"level\": 2, \"text\": \"8.2 TERMINATION AT TOUCHSTAR OPTION. TouchStar may terminate this Agreement upon the occurrence and continuation of any of the following events, with the understanding 17 that, if no cure period specifically is stated with regard to an event, then no cure period for such event applies: (a) Reseller fails to make any payment of Fees due to TouchStar under this Agreement and such failure remains unremedied for a period of ten (10) days; (b) Reseller breaches any of its other obligations under this Agreement and such breach remains unremedied for a period of thirty (30) days; (c) Reseller or any Other Reseller takes any action to Reverse Engineer the TouchStar Software; (d) Reseller fails to comply with applicable Legal Requirements, including Government Controls; (e) Reseller fails to reach the Quotas established by the parties; (f) Reseller repeatedly breaches any of its obligations under this Agreement, even though Reseller remedies each such breach within the applicable time period specified above; (g) Reseller fails to execute an Other Reseller Agreement with any Other Reseller; (h) Reseller or any Other Reseller fails to deliver a License Agreement to a Customer; (i) Reseller fails to indemnify TouchStar, its Affiliates and its and their respective directors, officers, employees, agents and representatives for any claims related to or arising under any Other Reseller Agreement or the use by TouchStar of the Reseller Marks; (j) Reseller is negligent in the fulfillment of its obligations to market and resell the TouchStar Software; (k) Reseller breaches any of its obligations relating to the Intellectual Property Rights or Confidential Information; (l) Reseller, any of Reseller's officers, directors, or shareholders, or any entity controlling, controlled by or under common control with Reseller promotes, sells, or offers for sale any product or other item that is, in TouchStar's reasonable opinion, competitive with or capable of being substituted for any of the TouchStar Software; or Reseller engages in overt or subvert forms of boycott of the TouchStar Software, including the offer for sale of any product or other item that is, in TouchStar's reasonable opinion, competitive with or capable of being substituted for any of the TouchStar Software; (m) In the event of a sale, conveyance, transfer or other disposition, in any transaction or series of transactions that results, directly or indirectly, in a 18 change of fifty percent (50%) or more of the aggregate voting power in Reseller as such existed on and as of the Effective Date; (n) Reseller is merged or consolidated with any other entity or there is a substantial change in the management or control of Reseller; or (o) Reseller ceases to function as a going concern or ceases to conduct its operations in the normal course of business or any of its directors, shareholders, or officers is convicted of a criminal offense or engages in any other act that in TouchStar's opinion could have an adverse effect upon TouchStar's reputation and goodwill.\"}, {\"id\": \"8.3\", \"title\": \"SUSPENSION OF TOUCHSTAR OBLIGATIONS\", \"level\": 2, \"text\": \"8.3 SUSPENSION OF TOUCHSTAR OBLIGATIONS. Immediately upon the occurrence of any breach by Reseller of any of its obligations under this Agreement or upon the occurrence of any event or circumstance identified in Section 7.3 of this Agreement, all of TouchStar's obligations to provide Support Services shall be suspended and such obligations shall remain suspended until the event or circumstance giving rise to the suspension has been corrected to TouchStar's satisfaction.\"}, {\"id\": \"9\", \"title\": \"DUTIES UPON TERMINATION\", \"level\": 1, \"text\": \"9. DUTIES UPON TERMINATION. In addition to any other provision of this Agreement which is designated in Section 8.6 as a provision surviving termination, the following shall apply:\"}, {\"id\": \"9.1\", \"title\": \"CUSTOMER AGREEMENTS\", \"level\": 2, \"text\": \"9.1 CUSTOMER AGREEMENTS. (a) In the event that (i) TouchStar terminates this Agreement in accordance with any one or more of the provisions of Section 8.2 or (ii) Reseller elects not to enter into a new agreement with TouchStar pursuant to Section 8.1, all Customer Agreements with Customers shall be transferred by Reseller to TouchStar. (b) In the event that (i) TouchStar elects not to enter into a new agreement with Reseller pursuant to Section 8.2 or (ii) Reseller terminates this Agreement in accordance with the provisions of Section 8.3, Reseller shall retain all Customer Agreements with Customers and TouchStar shall continue to provide Support Services under such Customer Agreements for the remaining term of such Customer Agreements. &bbsp; 19\"}, {\"id\": \"9.2\", \"title\": \"REFERRALS BY RESELLER\", \"level\": 2, \"text\": \"9.2 REFERRALS BY RESELLER. In the event that (a) TouchStar terminates this Agreement in accordance with any one or more of the provisions of Section 8.2 or (b) Reseller elects not to enter into a new agreement with TouchStar pursuant to Section 8.1, Reseller shall refer to TouchStar or TouchStar's designee all inquiries and orders received by Reseller pertaining to the purchase of Support Services.\"}, {\"id\": \"9.3\", \"title\": \"PAYMENT OF FEES\", \"level\": 2, \"text\": \"9.3 PAYMENT OF FEES. (a) In the event that this Agreement terminates or expires pursuant to Section 8.1(a), Reseller immediately shall pay to TouchStar all Fees outstanding on and as of the date of termination or expiration of this Agreement. (b) In the event that this Agreement terminates or expires pursuant to Section 8.1(b), Reseller shall continue to pay all Fees in accordance with the provisions of Section 6.2.\"}, {\"id\": \"9.4\", \"title\": \"INTELLECTUAL PROPERTY RIGHTS\", \"level\": 2, \"text\": \"9.4 INTELLECTUAL PROPERTY RIGHTS. Reseller immediately shall stop the use of Marketing Materials and Intellectual Property Rights, and shall return any unused Marketing Materials and all physical media upon which Intellectual Property Rights are contained by TouchStar.\"}, {\"id\": \"9.5\", \"title\": \"SHIPMENTS FOLLOWING NOTICE OF TERMINATION\", \"level\": 2, \"text\": \"9.5 SHIPMENTS FOLLOWING NOTICE OF TERMINATION. The expiration or termination of this Agreement shall not relieve TouchStar of its continuing obligation to ship TouchStar Software pursuant to any purchase orders accepted by TouchStar prior to the notice of termination, nor shall it relieve Reseller of its continuing obligation to accept and pay for such TouchStar Software; PROVIDED, HOWEVER, that with respect to all TouchStar Software shipped after any notice of termination, Reseller shall make payment prior to shipment on terms and conditions and by means satisfactory to TouchStar, notwithstanding any credit terms that may have been available to Reseller prior to such notice of termination.\"}, {\"id\": \"9.6\", \"title\": \"LIABILITY UPON TERMINATION\", \"level\": 2, \"text\": \"9.6 LIABILITY UPON TERMINATION. TouchStar shall have no liability to Reseller or any Other Reseller by reason of the termination or expiration of this Agreement for compensation, reimbursement, or damages of any kind, including any loss of prospective profits on anticipated sales, loss of goodwill, or investments made in reliance on this Agreement. Reseller acknowledges that it has received no assurances from TouchStar that its business relationship with TouchStar will continue beyond the term established in this Agreement, or that it will obtain any anticipated amounts of profits in connection with this Agreement, or that it will recoup its investment in the promotion of the TouchStar Software. Reseller also acknowledges that Reseller's failure to reach the Quotas will have a significant adverse impact on TouchStar's goodwill in the Territory, and that if Reseller is terminated because of failure to meet the Quotas, then Reseller will not be entitled to compensation of any kind (beyond the notice period set forth in this Agreement), since the damage to &sbsp; TouchStar's goodwill is likely to be at least as great as any losses Reseller might incur as a result of the termination. However, these provisions apply only to damages that are attributable to the expiration or termination of this Agreement and shall not affect any amount due 20 under this Agreement or the right of either party to seek damages directly attributable to any breach.\"}, {\"id\": \"10\", \"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"10. GENERAL PROVISIONS.\"}, {\"id\": \"10.1\", \"title\": \"RELATIONSHIP BETWEEN THE PARTIES\", \"level\": 2, \"text\": \"10.1 RELATIONSHIP BETWEEN THE PARTIES. Neither party to this Agreement and none of their respective agents, employees, representatives or independent contractors shall (a) be considered an agent, employee, or representative of the other party for any purpose whatsoever, (b) have any authority to make any agreement or commitment for the other party or to incur liability or obligation in the other party's name or on its behalf, or (c) represent to third parties that any of them has any right so to bind the other party hereto, it being intended that each party shall remain an independent contractor responsible only for its own actions. Nothing contained in this Agreement shall be construed or interpreted as creating an agency, partnership, or joint venture relationship between the parties.\"}, {\"id\": \"10.2\", \"title\": \"RESELLER REPRESENTATION, WARRANTY AND UNDERTAKING\", \"level\": 2, \"text\": \"10.2 RESELLER REPRESENTATION, WARRANTY AND UNDERTAKING. Reseller (a) represents and warrants that (i) it is a corporation duly organized and existing under the laws of the jurisdiction of its incorporation with all necessary corporate power and authority to execute, deliver, and perform its obligations under this Agreement, and that the execution, delivery, and performance of its obligations under this Agreement have been duly authorized by all requisite corporate action of Reseller and all Legal Requirements of Governmental Bodies, (ii) it has the requisite skill and knowledge necessary to perform its obligations under this Agreement, (iii) that it currently is not in violation of any Legal Requirements, and (iv) no current employee or shareholder of TouchStar has an ownership interest in Reseller or any affiliate or related entity of Reseller; and (b) covenants that, during the Term, it (i) shall use its best endeavors to maintain its corporate identity and remain in existence under the organizing laws of its jurisdiction and (ii) promptly notify TouchStar in the event that any employee or shareholder of TouchStar obtains an ownership interest in Reseller or any affiliate or related entity of Reseller.\"}, {\"id\": \"10.3\", \"title\": \"NOTICES\", \"level\": 2, \"text\": \"10.3 NOTICES. Without precluding any other sufficient form of notice, all notices, demands, or other communications under this Agreement shall be deemed given if sent by registered airmail, facsimile, hand delivery, or express courier to the address of the party as set out in this Agreement or to another address specified by the party. All notices, demands, and other communications in connection with this Agreement shall be written in the English language.\"}, {\"id\": \"10.4\", \"title\": \"ENTIRE AGREEMENT\", \"level\": 2, \"text\": \"10.4 ENTIRE AGREEMENT. This Agreement constitutes the entire agreement between the parties pertaining to its subject matter, and it supersedes any and all written or oral agreements previously existing between the parties with respect to such subject matter. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing by both parties.\"}, {\"id\": \"10.5\", \"title\": \"WAIVER\", \"level\": 2, \"text\": \"10.5 WAIVER. Either party's failure to insist on strict performance of any provision of this Agreement shall not be deemed a waiver of any of its rights or remedies, nor shall it relieve the other party from performing any subsequent obligation strictly in 21 accordance with the terms of this Agreement. No waiver shall be effective unless it is in writing and signed by the party against whom enforcement is sought. Such waiver shall be limited to provisions of this Agreement specifically referred to therein and shall not be deemed a waiver of any other provision. No waiver shall constitute a continuing waiver unless the writing states otherwise.\"}, {\"id\": \"10.6\", \"title\": \"SUCCESSORS AND ASSIGNS\", \"level\": 2, \"text\": \"10.6 SUCCESSORS AND ASSIGNS. This Agreement shall inure to the benefit of, and shall be binding upon, the respective heirs, legal representatives, successors, and assigns of each of the parties.\"}, {\"id\": \"10.7\", \"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"10.7 ASSIGNMENT. (a) TouchStar may assign this Agreement and the rights and responsibilities under this Agreement to an Affiliate upon written notice to Reseller. (b) Except for the rights of TouchStar under Section 10.7(a), this Agreement may not be assigned by either party without the prior written consent of the other. Any attempted assignment in violation of this provision shall be void and shall be deemed a breach of this Agreement.\"}, {\"id\": \"10.8\", \"title\": \"INDEMNIFICATION\", \"level\": 2, \"text\": \"10.8 INDEMNIFICATION. Reseller shall be solely responsible for, and shall indemnify TouchStar, its officers, directors, employees, and agents against, and hold each of them harmless from, any and all claims (including without limitation, all damages (whether direct, indirect, incidental, criminal, special, or punitive), losses, liabilities, expenses, costs, and attorneys' fees related to such claims) resulting from (a) the negligent or willful failure of Reseller to comply with its obligations hereunder, (b) the acts or omissions of Reseller, its officers, directors, employees, or agents during the term of this Agreement or thereafter, (c) any express or implied representation or warranty made by Reseller or any of its officers, directors, employees or agents with regard to the TouchStar Software or the Support Services not contained in written literature of TouchStar or specifically authorized by TouchStar in writing, and (c) the installation of a call center system by TouchStar on behalf of Reseller or any Other Reseller and the use of the TouchStar Software in the operation of a call center system, unless caused by the gross negligence or willful misconduct of TouchStar.\"}, {\"id\": \"10.9\", \"title\": \"SECTION HEADINGS; CONSTRUCTION\", \"level\": 2, \"text\": \"10.9 SECTION HEADINGS; CONSTRUCTION. The section headings in this Agreement are included for convenience only and shall not be deemed to limit or otherwise affect the construction of any of its provisions. The word \\\"including\\\" shall be ascribed a non-exclusive meaning unless followed by the word \\\"only.\\\"\"}, {\"id\": \"10.10\", \"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"10.10 SEVERABILITY. In the event that any of the provisions of this Agreement shall be held by a court, arbitral panel, or tribunal of competent jurisdiction to be unenforceable, such provision will be enforced to the maximum extent permissible and the remaining portions of this Agreement shall remain in full force and effect.\"}, {\"id\": \"10.11\", \"title\": \"PARTIES IN INTEREST\", \"level\": 2, \"text\": \"10.11 PARTIES IN INTEREST. Nothing in this Agreement is intended to confer any rights or remedies on any persons other than the parties to it. This Agreement shall not be construed to relieve or discharge any obligations or liabilities of third persons, nor 22 shall it be construed to give third persons any right of subrogation or action over against any party to this Agreement.\"}, {\"id\": \"10.12\", \"title\": \"GOVERNING LAW AND ARBITRATION\", \"level\": 2, \"text\": \"10.12 GOVERNING LAW AND ARBITRATION. (a) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF COLORADO, UNITED STATES, WITHOUT REGARD TO ITS PRINCIPLES REGARDING CONFLICT OF LAWS. (b) ARBITRATION. Any dispute arising out of or relating to this Agreement, including, without limitation, the interpretation of any provision of this Agreement or the breach, termination or invalidity of this Agreement that cannot reasonably be resolved by the Parties shall be settled exclusively and finally by binding arbitration under the International Arbitration Rules of the American Arbitration Association in effect on and as of the date of this Agreement (the \\\"AAA Rules\\\"), except as such AAA Rules are modified pursuant to this Section 10.12(b). (i) The arbitration shall be conducted before a panel of three (3) arbitrators, each of whom shall be fluent in English and shall have knowledge in the call center industry. TouchStar shall appoint one (1) arbitrator, Customer shall appoint one (1) arbitrator, and the third arbitrator shall be selected by the two (2) arbitrators so appointed; PROVIDED, HOWEVER, that if the two (2) arbitrators appointed by the parties fail to select the third arbitrator within thirty (30) days after the date on which the last of such two (2) arbitrators are appointed, then the third arbitrator shall be appointed by the administrator in accordance with the AAA Rules. The third arbitrator, regardless of how selected, shall chair the arbitration panel. (ii) Once the arbitrators are impaneled, if (A) an arbitrator withdraws after a challenge, (B) the administrator sustains a challenge and removes an arbitrator, (C) an arbitrator dies, or (D) an arbitrator otherwise resigns or is removed, then the party which appointed such arbitrator shall appoint a replacement arbitrator within thirty (30) days in accordance with the procedures set forth in Section 10.12(b)(i). (iii) The arbitration shall be conducted in Denver, Colorado, United States. The arbitration shall be conducted in English; PROVIDED, that either party, at its cost, may provide for the simultaneous translation of the arbitration into a language other than English. (iv) No less than thirty (30) days prior to the date on which the arbitration proceeding is to begin, each party shall submit to the other party the documents, in English, and list of witnesses it 23 intends to use in the arbitration. At any oral hearing of evidence in connection with the arbitration, each party or its legal counsel shall have the right to examine witnesses and to cross-examine the witnesses of the opposing party. (v) The arbitrators shall apply the substantive law of the State of Colorado to any decision issued by the arbitration panel, and the arbitrators shall be so instructed. The arbitrators shall issue a written opinion stating the findings of fact and the conclusions of law upon which the decision is based. The decision of the arbitrators shall be final and binding. Judgment on such award may be entered in any court of appropriate jurisdiction, or application may be made to that court for a judicial acceptance of the award and an order of enforcement, as the party seeking to enforce that award may elect. Any arbitration award for money damages shall be in Dollars. Other than pursuant to this Section 10.12(b)(v), the arbitration award shall not include any indirect, incidental, special, consequential, or punitive damages and the arbitrators shall be so instructed. (vi) Any arbitration award pursuant to this Section 10.12(b) shall be subject to the United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards of 1958. (c) JURISDICTION AND VENUE FOR INTERIM RELIEF. Notwithstanding the provisions of Section 10.12(b), each party shall have the right to bring an action in a court of competent jurisdiction of any equitable or other relief as may be necessary to protect the rights of such party under this Agreement. (d) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, PROCEEDING, CLAIM OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ITS INTERPRETATIONS.\"}, {\"id\": \"10.13\", \"title\": \"GOVERNING LANGUAGE\", \"level\": 2, \"text\": \"10.13 GOVERNING LANGUAGE. The governing language of this Agreement shall be English. If this Agreement is translated into a language other than English, then the English version shall prevail.\"}, {\"id\": \"10.14\", \"title\": \"EXCLUSION OF UNITED NATIONS CONVENTION\", \"level\": 2, \"text\": \"10.14 EXCLUSION OF UNITED NATIONS CONVENTION. The United Nations Convention on Contracts for the International Sale of Goods is hereby excluded from application to this Agreement.\"}, {\"id\": \"10.15\", \"title\": \"FORCE MAJEURE\", \"level\": 2, \"text\": \"10.15 FORCE MAJEURE. Neither party shall be responsible for any failure to perform due to unforeseen circumstances or to causes beyond that party's control, including but not limited to acts of God, war, riot, acts of terrorism, embargoes, acts of civil or military authorities, compliance with governmental laws, rules or regulations, failure of telecommunications connectivity beyond the reasonable control of the parties, 24 accidents, strikes, labor disputes, or shortages. Failure to perform shall be excused during the continuance of such circumstances, but this Agreement shall otherwise remain in effect.\"}, {\"id\": \"10.16\", \"title\": \"PUBLICITY; DISCLOSURES\", \"level\": 2, \"text\": \"10.16 PUBLICITY; DISCLOSURES. Except as expressly provided herein and except to the extent required by applicable law, no news releases or other public disclosures relating to this Agreement, its existence or its subject matter, including without limitation, photographs, public announcements or confirmation of the same, shall be made by either party without the prior written approval of the other party. [SIGNATURE PAGE FOLLOWS] 25 IN WITNESS OF THE FOREGOING, the parties have caused this Agreement to be signed by their respective duly authorized representatives all as of the Effective Date. WORLDWIDE STRATEGIES INC. TOUCHSTAR SOFTWARE CORPORATION By: /s/ JAMES P.R. SAMUELS By: /s/ SHAWN SUHRSTEDT ---------------------------- ----------------------------- Title: PRESIDENT Title: CFO ------------------------- --------------------------- Date: SEPT 14-2005 Date: 9/15/5 -------------------------- ---------------------------- 26\"}]}\n\n### Assistant:\n", "completion": "{\"contract_id\": \"Copy of WORLDWIDESTRATEGIESINC_11_02_2005-EX-10-RESELLER AGREEMENT\", \"nodes\": [{\"id\": \"para_1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXHIBIT 10.2\", \"level\": 1, \"text\": \"EXHIBIT 10.2 TOUCHSTAR SOFTWARE CORPORATION RESELLER AGREEMENT DATED SEPTEMBER 14, 2005 TOUCHSTAR SOFTWARE CORPORATION RESELLER AGREEMENT This Reseller Agreement is made and entered into as of this 14 day of SEPTEMBER, 200_ (the \\\"Effective Date\\\"), by and between TOUCHSTAR SOFTWARE CORPORATION, a Delaware corporation with its principal place of business at 3025 South Parker Road, Suite 925, Aurora, Colorado 80014, United States (\\\"TouchStar\\\"), and WORLDWIDE STRATEGIES, a NEVADA corporation, with its principal place of business at 3801-E FLORIDA AVE STE 400 DENVER, CO 80210 (\\\"Reseller\\\"). RECITALS A. TouchStar produces and distributes the TouchStar Software and provides the related Support Services. B. Reseller has represented to TouchStar that it possesses experience, knowledge, and skill in the calling service industry and has the capability to effectively market and distribute the TouchStar Software and Support Services in the Territory.\"}}, {\"id\": \"party:TOUCHSTAR SOFTWARE CORPORATION\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"TOUCHSTAR SOFTWARE CORPORATION\", \"role\": \"TouchStar\", \"address\": \"3025 South Parker Road, Suite 925, Aurora, Colorado 80014, United States\"}}, {\"id\": \"party:WORLDWIDE STRATEGIES INC.\", \"type\": \"PARTY\", \"attrs\": {\"text\": \"WORLDWIDE STRATEGIES\", \"role\": \"Reseller\", \"address\": \"3801-E FLORIDA AVE STE 400 DENVER, CO 80210\"}}, {\"id\": \"value:14 day\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"14 day\"}}, {\"id\": \"C\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"Reseller desires to market and distribute the TouchStar Software to Customers as a non-exclusive value added reseller i\", \"level\": 1, \"text\": \"C. Reseller desires to market and distribute the TouchStar Software to Customers as a non-exclusive value added reseller in the Territory pursuant to the terms contained in this Agreement. AGREEMENT NOW, THEREFORE, in consideration of the foregoing and the mutual promises set forth in this Agreement, and intending legally to be bound hereby, the parties agree as follows:\"}}, {\"id\": \"1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DEFINITIONS\", \"level\": 1, \"text\": \"1. DEFINITIONS. In addition to the terms defined elsewhere in this Agreement, the following terms shall have the meanings set forth below (such meanings to be equally applicable to the singular as well as the plural forms of the terms defined): \\\"AAA\\\" has the meaning ascribed to that term in Section 10.12(b) of this Agreement. \\\"AAA Rules\\\" has the meaning ascribed to that term in Section 10.12(b) of this Agreement. \\\"Affiliate\\\" as used in this Agreement with respect to an Entity, means any person controlling, controlled by or under common control with such Entity. For the purpose of this definition, \\\"control\\\" means the possession, directly or indirectly, of the power to direct or cause the direction of an Entity, whether through the ownership of voting securities or otherwise. \\\"Agreement\\\" means this Reseller Agreement and the Exhibits attached hereto as the same may be amended from time to time in accordance with the terms set forth herein. Rev 3/05 \\\"Ancillary Software\\\" has the meaning ascribed to that term in Section 4.13 of this Agreement. \\\"Annual Marketing Plan\\\" has the meaning ascribed to that term in Section 4.3 of this Agreement. \\\"Assessment\\\" has the meaning ascribed to that term in Section 6.2 of this Agreement. \\\"Confidential Information\\\" means any and all trade secrets and other confidential information and know-how related directly or indirectly to TouchStar's business or its products, including inventions, materials, formulae, confidential research, technical information, technology, general know-how, patterns, specifications, systems data, equipment, operating standards and procedures, developments and improvements, computer programs, operating systems, source code, object code, middleware, firmware, information regarding projects, programs and sales, names and addresses of past and present customers, pricing data, internal procedures, systems, methods forms, manuals, financial data, price lists, customer service information, marketing information, and all other information relating to TouchStar, the TouchStar Software, Support Services, or other products or services of TouchStar that is not generally known to the public. &bbsp; \\\"Copyrights\\\" means all right, title, and interest of TouchStar in and to all copyrights and rights and interests in copyrights and works protectible by copyright, whether now owned or hereafter acquired or created by TouchStar (in whole or in part) and all renewals and extensions thereof, throughout the universe and in perpetuity, whether or not registered or recorded in the United States Copyright Office or in the copyright office or agency of any other country or jurisdiction and including all works based upon, incorporated in, derived from, incorporating or relating to all works covered by copyright, including copyrights or rights or interests in copyrights registered or recorded in the United States Copyright Office or in the copyright office or agency of any other country or jurisdiction. \\\"Customer\\\" means a third party end-user with headquarter offices in the Territory to whom or to which Reseller resells or causes the resale of the TouchStar Software and Support Services. \\\"Dollars\\\" or \\\"US$\\\" means the lawful currency of the United States. \\\"Effective Date\\\" has the meaning ascribed to that term in the introductory paragraph of this Agreement. \\\"Entity\\\" means any general partnership (including a limited liability partnership), limited partnership (including a limited liability limited partnership), limited liability company, corporation, joint venture, trust, business trust, cooperative, association or any foreign trust or foreign business organization. \\\"Fees\\\" means the installation fees, licensing fees and support service fees owed by Reseller to TouchStar, as set forth on EXHIBIT A. 2 \\\"Government Controls\\\" means economic and other sanctions instituted by a Governmental Body related to certain transactions, such as the transfer of technology and technical data, the transfer of funds, the provisions of goods and services, and other dealings, including, but not limited to, sanctions administered by the United States government pursuant to the United States Export Administration Act, the United States Arms Export Control Act, the International Emergency Economic Powers Act, the United States Foreign Corrupt Practices Act of 1977, all as amended, and the USA PATRIOT Act, and the regulations promulgated thereunder and certain regulations promulgated by the United States Department of Treasury. \\\"Governmental Body\\\" means any (a) nation, state, country, or other jurisdiction of any nature, (b) national, federal, state, local, municipal, foreign, or other government, governmental, or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal), or (c) body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature. \\\"Intellectual Property Rights\\\" means the Confidential Information of TouchStar, the Copyrights, the Patents, and the Trademarks. \\\"Legal Requirements\\\" means any national, federal, state, local, municipal, foreign, international, multinational, or other administrative order, law, constitutional law, ordinance, principle of law, regulation, statute, treaty, directive or decree, including Government Controls. \\\"License Agreement\\\" means the license agreement to be provided to each Customer with regard to the use by such Customer of the TouchStar Software, in the form of EXHIBIT B, attached to this Agreement. \\\"Licenses\\\" means those software and other licenses from third parties necessary lawfully to provide the Support Services. \\\"Marketing Materials\\\" has the meaning ascribed to that term in Section 3.2 of this Agreement. \\\"Other Reseller\\\" means any person or Entity acceptable to TouchStar in its sole discretion with whom or with which Reseller enters into an Other Reseller Agreement to promote, market, distribute, license and sell the TouchStar Software and Support Services to Customers in the Territory; PROVIDED that such person or Entity shall not be an end-user of either the TouchStar Software or the Support Services. \\\"Other Reseller Agreement\\\" has the meaning ascribed to that term in\"}}, {\"id\": \"term:AAA\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AAA\", \"text\": \"has the meaning ascribed to that term in Section 10.12(b) of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:AAA Rules\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"AAA Rules\", \"text\": \"has the meaning ascribed to that term in Section 10.12(b) of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Affiliate\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Affiliate\", \"text\": \"as used in this Agreement with respect to an Entity, means any person controlling, controlled by or under common control with such Entity. For the purpose of this definition, \\\"control\\\" means the possession, directly or indirectly, of the power to direct or cause the direction of an Entity, whether through the ownership of voting securities or otherwise.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Agreement\", \"text\": \"means this Reseller Agreement and the Exhibits attached hereto as the same may be amended from time to time in accordance with the terms set forth herein.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Ancillary Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Ancillary Software\", \"text\": \"has the meaning ascribed to that term in Section 4.13 of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Annual Marketing Plan\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Annual Marketing Plan\", \"text\": \"has the meaning ascribed to that term in Section 4.3 of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Assessment\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Assessment\", \"text\": \"has the meaning ascribed to that term in Section 6.2 of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Confidential Information\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Confidential Information\", \"text\": \"means any and all trade secrets and other confidential information and know-how related directly or indirectly to TouchStar's business or its products, including inventions, materials, formulae, confidential research, technical information, technology, general know-how, patterns, specifications, systems data, equipment, operating standards and procedures, developments and improvements, computer programs, operating systems, source code, object code, middleware, firmware, information regarding projects, programs and sales, names and addresses of past and present customers, pricing data, internal procedures, systems, methods forms, manuals, financial data, price lists, customer service information, marketing information, and all other information relating to TouchStar, the TouchStar Software, Support Services, or other products or services of TouchStar that is not generally known to the public.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Copyrights\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Copyrights\", \"text\": \"means all right, title, and interest of TouchStar in and to all copyrights and rights and interests in copyrights and works protectible by copyright, whether now owned or hereafter acquired or created by TouchStar (in whole or in part) and all renewals and extensions thereof, throughout the universe and in perpetuity, whether or not registered or recorded in the United States Copyright Office or in the copyright office or agency of any other country or jurisdiction and including all works based upon, incorporated in, derived from, incorporating or relating to all works covered by copyright, including copyrights or rights or interests in copyrights registered or recorded in the United States Copyright Office or in the copyright office or agency of any other country or jurisdiction.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Customer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Customer\", \"text\": \"means a third party end-user with headquarter offices in the Territory to whom or to which Reseller resells or causes the resale of the TouchStar Software and Support Services.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Dollars\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Dollars\", \"text\": \"means the lawful currency of the United States.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:US$\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"US$\", \"text\": \"means the lawful currency of the United States.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Effective Date\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Effective Date\", \"text\": \"has the meaning ascribed to that term in the introductory paragraph of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Entity\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Entity\", \"text\": \"means any general partnership (including a limited liability partnership), limited partnership (including a limited liability limited partnership), limited liability company, corporation, joint venture, trust, business trust, cooperative, association or any foreign trust or foreign business organization.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Fees\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Fees\", \"text\": \"means the installation fees, licensing fees and support service fees owed by Reseller to TouchStar, as set forth on EXHIBIT A.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Government Controls\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Government Controls\", \"text\": \"means economic and other sanctions instituted by a Governmental Body related to certain transactions, such as the transfer of technology and technical data, the transfer of funds, the provisions of goods and services, and other dealings, including, but not limited to, sanctions administered by the United States government pursuant to the United States Export Administration Act, the United States Arms Export Control Act, the International Emergency Economic Powers Act, the United States Foreign Corrupt Practices Act of 1977, all as amended, and the USA PATRIOT Act, and the regulations promulgated thereunder and certain regulations promulgated by the United States Department of Treasury.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Governmental Body\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Governmental Body\", \"text\": \"means any (a) nation, state, country, or other jurisdiction of any nature, (b) national, federal, state, local, municipal, foreign, or other government, governmental, or quasi-governmental authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal), or (c) body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any nature.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Intellectual Property Rights\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Intellectual Property Rights\", \"text\": \"means the Confidential Information of TouchStar, the Copyrights, the Patents, and the Trademarks.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Legal Requirements\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Legal Requirements\", \"text\": \"means any national, federal, state, local, municipal, foreign, international, multinational, or other administrative order, law, constitutional law, ordinance, principle of law, regulation, statute, treaty, directive or decree, including Government Controls.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:License Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"License Agreement\", \"text\": \"means the license agreement to be provided to each Customer with regard to the use by such Customer of the TouchStar Software, in the form of EXHIBIT B, attached to this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Licenses\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Licenses\", \"text\": \"means those software and other licenses from third parties necessary lawfully to provide the Support Services.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Marketing Materials\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Marketing Materials\", \"text\": \"has the meaning ascribed to that term in Section 3.2 of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Other Reseller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Other Reseller\", \"text\": \"means any person or Entity acceptable to TouchStar in its sole discretion with whom or with which Reseller enters into an Other Reseller Agreement to promote, market, distribute, license and sell the TouchStar Software and Support Services to Customers in the Territory; PROVIDED that such person or Entity shall not be an end-user of either the TouchStar Software or the Support Services.\", \"definition_clause\": \"1\"}}, {\"id\": \"term:Other Reseller Agreement\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Other Reseller Agreement\", \"text\": \"has the meaning ascribed to that term in Section 2(a)(i) of this Agreement.\", \"definition_clause\": \"1\"}}, {\"id\": \"Section 2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"2(a)(i) of this Agreement\", \"level\": 1, \"text\": \"Section 2.2(a)(i) of this Agreement. \\\"Patents\\\" means (a) all right, title and interest of TouchStar in and to all applicable Letters Patent and applications for Letters Patent and the inventions described therein and any Letters Patent which may issue therefrom and which have been or may have been filed in the United States or in any other country for any such inventions or for any improvements, reissues, divisions, continuations, renewals, additions, extensions, substitutes, continuations-in-part which may be made, filed, or 3 granted on any of them, including the rights to all benefits therefrom arising under the International Convention for the Protection of Industrial Property or any other international treaty affecting such rights; (b) any right, title and interest of TouchStar in any utility model, design registration, trade secret, confidential research, development and commercial information, know-how, technical information, engineering, practical information, patterns, specifications, formulae, manufacturing procedures, quality control, data and procedures, systems' data, software programs, equipment, operating standards and applications, developments, and improvements; and (c) any rights to licenses or other benefits under any Letters Patent, applications for Letters Patent and/or invention, utility model registration, design registration and inventor's certificate anywhere in the world, whether or not patentable, which are obtained by TouchStar or to which TouchStar becomes entitled during the term of this Agreement. \\\"Private Label Software\\\" has the meaning ascribed to that term in Section 7.2 of this Agreement. \\\"Quotas\\\" has the meaning ascribed to that term in Section 4.11 of this Agreement. \\\"Registered Leads\\\" has the meaning ascribed to that term in Section 2.6 of this Agreement. \\\"Reseller\\\" has the meaning ascribed to that term in the introductory paragraph of this Agreement, including its legal representatives, successors, and assigns. \\\"Reseller Marks\\\" has the meaning ascribed to that term in Section 7.2 of this Agreement. \\\"Reverse Engineer\\\" means translate, disassemble, decompile, analyze, reverse engineer or reverse program, or otherwise attempt to derive the code or programming for the TouchStar Software or the Private Label Software. \\\"Specifications\\\" has the meaning ascribed to that term in Section 3.4(a) of this Agreement. \\\"Support Services\\\" means those support services related to the TouchStar Software as described in the attached EXHIBIT C. \\\"Technical Prerequisites\\\" has the meaning ascribed to that term in Section 3.4(b) of this Agreement. \\\"Term\\\" has the meaning ascribed to that term in Section 8.1 of this Agreement. \\\"Territory\\\" means the geographical region described in the attached EXHIBIT D. \\\"TouchStar\\\" has the meaning ascribed to that term in the introductory paragraph of this Agreement, including its legal representatives, successors, and assigns. \\\"TouchStar Intellectual Property Rights\\\" means the Copyrights, the Patents, and the Trademarks. 4 \\\"TouchStar Software\\\" means the software necessary for the operation of call center systems which is being licensed by TouchStar pursuant to this Agreement. In the event that TouchStar develops Private Label Software for Reseller, the term \\\"TouchStar Software,\\\" when the context so requires, shall include Private Label Software. \\\"Trademarks\\\" means all right, title and interest of TouchStar in and to (a) all trademarks, trade names, trade styles, service marks, logos, trade dress, unpatentable designs, and designations and indicia of any kind, now existing or hereafter adopted or acquired, and all registrations and recordings thereof, including applications, registrations, and recordings in the United States Patent and Trademark Office or in any similar office or agency of the United States, any state thereof, any other country or jurisdiction or any political subdivision thereof, all whether now owned or hereafter acquired by TouchStar and all reissues, extensions, or renewals thereof, and (b) any licenses of or licensing agreements (including registered user agreements) pertaining to any of the foregoing, together with all amendments, supplements, modifications or extensions thereof. \\\"United States\\\" means the United States of America and its territories and possessions.\"}}, {\"id\": \"term:Patents\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Patents\", \"text\": \"means (a) all right, title and interest of TouchStar in and to all applicable Letters Patent and applications for Letters Patent and the inventions described therein and any Letters Patent which may issue therefrom and which have been or may have been filed in the United States or in any other country for any such inventions or for any improvements, reissues, divisions, continuations, renewals, additions, extensions, substitutes, continuations-in-part which may be made, filed, or 3 granted on any of them, including the rights to all benefits therefrom arising under the International Convention for the Protection of Industrial Property or any other international treaty affecting such rights; (b) any right, title and interest of TouchStar in any utility model, design registration, trade secret, confidential research, development and commercial information, know-how, technical information, engineering, practical information, patterns, specifications, formulae, manufacturing procedures, quality control, data and procedures, systems' data, software programs, equipment, operating standards and applications, developments, and improvements; and (c) any rights to licenses or other benefits under any Letters Patent, applications for Letters Patent and/or invention, utility model registration, design registration and inventor's certificate anywhere in the world, whether or not patentable, which are obtained by TouchStar or to which TouchStar becomes entitled during the term of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Private Label Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Private Label Software\", \"text\": \"has the meaning ascribed to that term in Section 7.2 of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Quotas\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Quotas\", \"text\": \"has the meaning ascribed to that term in Section 4.11 of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Registered Leads\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Registered Leads\", \"text\": \"has the meaning ascribed to that term in Section 2.6 of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Reseller\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reseller\", \"text\": \"has the meaning ascribed to that term in the introductory paragraph of this Agreement, including its legal representatives, successors, and assigns.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Reseller Marks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reseller Marks\", \"text\": \"has the meaning ascribed to that term in Section 7.2 of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Reverse Engineer\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Reverse Engineer\", \"text\": \"means translate, disassemble, decompile, analyze, reverse engineer or reverse program, or otherwise attempt to derive the code or programming for the TouchStar Software or the Private Label Software.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Specifications\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Specifications\", \"text\": \"has the meaning ascribed to that term in Section 3.4(a) of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Support Services\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Support Services\", \"text\": \"means those support services related to the TouchStar Software as described in the attached EXHIBIT C.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Technical Prerequisites\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Technical Prerequisites\", \"text\": \"has the meaning ascribed to that term in Section 3.4(b) of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Term\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Term\", \"text\": \"has the meaning ascribed to that term in Section 8.1 of this Agreement.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Territory\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Territory\", \"text\": \"means the geographical region described in the attached EXHIBIT D.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:TouchStar\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TouchStar\", \"text\": \"has the meaning ascribed to that term in the introductory paragraph of this Agreement, including its legal representatives, successors, and assigns.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:TouchStar Intellectual Property Rights\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TouchStar Intellectual Property Rights\", \"text\": \"means the Copyrights, the Patents, and the Trademarks.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:TouchStar Software\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"TouchStar Software\", \"text\": \"means the software necessary for the operation of call center systems which is being licensed by TouchStar pursuant to this Agreement. In the event that TouchStar develops Private Label Software for Reseller, the term \\\"TouchStar Software,\\\" when the context so requires, shall include Private Label Software.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:Trademarks\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"Trademarks\", \"text\": \"means all right, title and interest of TouchStar in and to (a) all trademarks, trade names, trade styles, service marks, logos, trade dress, unpatentable designs, and designations and indicia of any kind, now existing or hereafter adopted or acquired, and all registrations and recordings thereof, including applications, registrations, and recordings in the United States Patent and Trademark Office or in any similar office or agency of the United States, any state thereof, any other country or jurisdiction or any political subdivision thereof, all whether now owned or hereafter acquired by TouchStar and all reissues, extensions, or renewals thereof, and (b) any licenses of or licensing agreements (including registered user agreements) pertaining to any of the foregoing, together with all amendments, supplements, modifications or extensions thereof.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"term:United States\", \"type\": \"DEFINED_TERM\", \"attrs\": {\"term\": \"United States\", \"text\": \"means the United States of America and its territories and possessions.\", \"definition_clause\": \"Section 2\"}}, {\"id\": \"2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"APPOINTMENT OF RESELLER\", \"level\": 1, \"text\": \"2. APPOINTMENT OF RESELLER.\"}}, {\"id\": \"2.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NONEXCLUSIVE RESELLER\", \"level\": 2, \"text\": \"2.1 NONEXCLUSIVE RESELLER. Subject to applicable Legal Requirements: (a) TouchStar hereby appoints Reseller as its nonexclusive value- added reseller for the limited purposes of promoting, marketing, distributing, licensing and selling the TouchStar Software and Support Services in the Territory, and Reseller accepts the appointment as such. Reseller shall have the right under this Agreement to promote, market, distribute, license and sell the TouchStar Software and Support Services to Customers in the Territory. TouchStar reserves the right to provide the TouchStar Software and Support Services to other customers in the Territory and/or to appoint additional distributors or representatives in all or any part of the Territory.\"}}, {\"id\": \"2.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OTHER RESELLERS\", \"level\": 2, \"text\": \"2.2 OTHER RESELLERS. Subject to applicable Legal Requirements and to the provisions of this Section 2.2: (a) Reseller may promote, market, distribute, license and sell TouchStar Software and Support Services in the Territory through Other Resellers; PROVIDED that: (i) Reseller notifies TouchStar in writing in respect of each Other Reseller that Reseller intends to use to promote, market, distribute, license and sell TouchStar Software and Support Services in the Territory; (ii) TouchStar approves in writing each Other Reseller that Reseller intends to use to promote, market, distribute, license and sell TouchStar Software and Support Services in the Territory, which approval TouchStar may grant in its sole discretion; 5 (iii) Reseller enters into a binding written agreement with each Other Reseller (the \\\"Other Reseller Agreement\\\"), which Other Reseller Agreement incorporates the terms, conditions, duties, rights and obligations of this Agreement; (iv) Reseller provides to TouchStar a fully executed copy of each Other Reseller Agreement; (v) each Other Reseller shall promote, market, distribute, license and sell the TouchStar Software and the Support Services only in the Territory and only in accordance with the provisions of this Agreement, including, but not limited to, delivery of License Agreements to Customers, and compliance with Legal Requirements and Government Controls; and (vi) Reseller shall terminate any Other Reseller Agreement in the event that the Other Reseller to whom or to which the Other Reseller Agreement relates fails to comply with the terms and conditions of such Other Reseller Agreement or this Agreement. Any Other Reseller shall obtain the TouchStar Software and the Support Services directly from the Reseller. (b) Reseller shall be responsible for all actions of Other Resellers with regard to the promotion, marketing, distribution, licensing and sale of TouchStar Software. Reseller shall be liable for any unauthorized or illegal use of the TouchStar Software by any Other Reseller, including, but not limited to, any actions or attempts to Reverse Engineer the TouchStar Software and any promotion, marketing, distribution, licensing or sale of the TouchStar Software in violation of Government Controls or other Legal Requirements. (c) No Other Reseller shall have the right to use, copy, modify, alter or Reverse Engineer any TouchStar Software whatsoever, and Reseller shall take all necessary steps to ensure that all acts or any Other Reseller related in any way to the TouchStar Software are consistent with the terms and conditions of this Agreement.\"}}, {\"id\": \"2.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER'S OBLIGATION NOT TO COMPETE\", \"level\": 2, \"text\": \"2.3 RESELLER'S OBLIGATION NOT TO COMPETE. Reseller shall not obtain the TouchStar Software or Support Services (or any software or services which compete with the TouchStar Software) for sale from any Entity other than TouchStar or its authorized agents. Nothing contained in this Agreement is intended to limit Reseller from responding to unsolicited requests from Customers from outside of the Territory; PROVIDED, HOWEVER, that Reseller shall (a) immediately notify TouchStar upon receipt of any such request and (b) not seek customers of TouchStar Software or Support Services in any other location other than in the Territory. Reseller shall not sell TouchStar Software or Support Services to any person or Entity outside the Territory or within the Territory if, to Reseller's knowledge, any such person or Entity intends to resell the TouchStar Software or Support Services outside of the Territory. Reseller shall not import, promote, distribute, license, market or sell any products in 6 the Territory which directly compete with the TouchStar Software or Support Services.\"}}, {\"id\": \"2.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CHANGES IN TOUCHSTAR SOFTWARE AND SUPPORT SERVICES\", \"level\": 2, \"text\": \"2.4 CHANGES IN TOUCHSTAR SOFTWARE AND SUPPORT SERVICES. TouchStar shall have the right at any time and from time to time, in its sole discretion, (a) to change the TouchStar Software or Support Services included within the scope of this Agreement by providing written notice to Reseller at least thirty (30) days prior to the date the change becomes effective and (b) to change the design, capabilities or other characteristics of the TouchStar Software or Support Services, or discontinue the production or marketing of all or any portion of the TouchStar Software or Support Services, without prior notice of any kind. Upgrades and enhancements to the TouchStar Software or Support Services shall automatically be deemed included as TouchStar Software or Support Services, as applicable, unless TouchStar notifies Reseller otherwise.\"}}, {\"id\": \"value:thirty (30) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"thirty (30) days\"}}, {\"id\": \"2.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"USE OF TOUCHSTAR SOFTWARE\", \"level\": 2, \"text\": \"2.5 USE OF TOUCHSTAR SOFTWARE. (a) TouchStar hereby grants to Reseller, with the additional right to grant to Other Resellers who or which enter into an Other Reseller Agreement, the nontransferable and nonexclusive right and license to use one copy of the TouchStar Software as necessary to demonstrate the TouchStar Software to potential Customers in the Territory. Reseller shall not copy, modify, alter, Reverse Engineer or transfer, electronically or otherwise, any TouchStar Software. (b) TouchStar reserves the absolute right, without providing notice to Reseller, to include software code or other markings in the TouchStar Software (and the Private Label Software) to assist TouchStar in monitoring the compliance by Reseller and Other Resellers with their respective obligations not to copy, modify, alter, modify or Reverse Engineer the TouchStar Software. In addition, in order to protect TouchStar's rights in and to the TouchStar Software, THE TOUCHSTAR SOFTWARE MAY CONTAIN A PROPRIETARY SCHEME THAT ALLOWS TOUCHSTAR TO DISABLE USE OF THE TOUCHSTAR SOFTWARE BY RESELLER, ANY OTHER RESELLER, OR CUSTOMER. TOUCHSTAR MAY DISABLE THE TOUCHSTAR SOFTWARE IN THE EVENT THAT TOUCHSTAR DISCOVERS THAT RESELLER OR ANY OTHER RESELLER HAS, OR HAS ATTEMPTED TO, COPY, MODIFY, ALTER OR REVERSE ENGINEER THE TOUCHSTAR SOFTWARE.\"}}, {\"id\": \"2.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LEADS FOR TOUCHSTAR SOFTWARE\", \"level\": 2, \"text\": \"2.6 LEADS FOR TOUCHSTAR SOFTWARE. Reseller shall solicit orders for TouchStar Software from potential Customers and shall submit such leads in writing to TouchStar (the \\\"Registered Leads\\\"). No Registered Leads shall be binding on TouchStar until accepted by TouchStar, and TouchStar reserves the right to reject any order or to cancel the same or any part of it after acceptance, for credit or for any other reason whatsoever deemed by TouchStar to be sufficient. Each Registered Lead shall include: (a) the name, address and telephone number of the Customer; (b) a list of the TouchStar Software and Support Services to be provided; (c) the delivery address for 7 the TouchStar Software, whether to Reseller or Customer; (d) the proposed shipment date; and (e) a reference to this Agreement.\"}}, {\"id\": \"2.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LEAD TIMES\", \"level\": 2, \"text\": \"2.7 LEAD TIMES. Registered Leads shall be submitted at least thirty (30) days prior to the requested shipping date for any TouchStar Software or Support Services.\"}}, {\"id\": \"3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TOUCHSTAR'S DUTIES\", \"level\": 1, \"text\": \"3. TOUCHSTAR'S DUTIES.\"}}, {\"id\": \"3.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"AVAILABILITY OF SUPPORT SERVICES\", \"level\": 2, \"text\": \"3.1 AVAILABILITY OF SUPPORT SERVICES. TouchStar shall use reasonable commercial efforts to maintain or cause to be maintained the availability of the TouchStar Software and Support Services to Customers in the Territory.\"}}, {\"id\": \"3.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING AND PROMOTIONAL LITERATURE\", \"level\": 2, \"text\": \"3.2 MARKETING AND PROMOTIONAL LITERATURE. TouchStar shall provide to Reseller marketing presentations and other literature prepared by TouchStar in the ordinary course of business describing the TouchStar Software and Support Services in order to assist Reseller in the marketing of the Support Services in the Territory (the \\\"Marketing Materials\\\"). The Marketing Materials will contain some or all of the Trademarks. Reseller may include its trademarks, service marks or other logos on the Marketing Materials; provided that Reseller may not remove, replace or otherwise modify the Trademarks included on such Marketing Materials.\"}}, {\"id\": \"3.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LICENSES\", \"level\": 2, \"text\": \"3.3 LICENSES. TouchStar shall grant to Reseller those Licenses necessary for Reseller to provide Support Services to Customers. TouchStar shall charge to Reseller the cost incurred by TouchStar to obtain such Licenses.\"}}, {\"id\": \"3.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSTALLATION\", \"level\": 2, \"text\": \"3.4 INSTALLATION. (a) At the request and on behalf of Reseller and any Other Reseller, TouchStar will install call center systems at Customer locations; PROVIDED that (i) TouchStar and Reseller or any Other Reseller, as applicable, agree in writing on the configuration of such call center systems (the \\\"Specifications\\\") and (ii) Reseller and any Other Reseller informs the Customer that TouchStar is installing the call center system on behalf of such Reseller or any Other Reseller. (b) TouchStar will use reasonable commercial efforts to install the call center system on behalf of Reseller or any Other Reseller in a timely fashion. However, TouchStar and Reseller or any Other Reseller recognize and agree that the installation of the call center system depends on (i) TouchStar receiving certain information and data from Customer, (ii) Customer providing on a timely basis the necessary technical prerequisites for the installation of the call center system, such as T-1 lines, cabling and workstations (the \\\"Technical Prerequisites\\\"), and (iii) the number and type of any change orders requested by the Customer during the installation of the call center system. TouchStar will not be responsible for any delays in the installation of the call center system based on whole or in part on (i) delays by the Customer in providing information and data to TouchStar required for the installation of the call center system, (ii) the delay or failure by the Customer 8 to provide the Technical prerequisites, and (iii) any change orders requested with regard to the call center system.\"}}, {\"id\": \"4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER'S DUTIES\", \"level\": 1, \"text\": \"4. RESELLER'S DUTIES.\"}}, {\"id\": \"4.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TECHNICAL AND SALES CAPABILITIES\", \"level\": 2, \"text\": \"4.1 TECHNICAL AND SALES CAPABILITIES. Reseller acknowledges that the proper marketing and support of the TouchStar Software and Support Services requires substantial expertise and commitment. Reseller shall at all times during the term of this Agreement, at its expense, maintain the ability (a) to provide competent and adequate technical assistance, service and support, (b) to explain in detail to its Customers the features and capabilities of the Support Services, (c) to assist Customers in determining which configuration of the Support Services will best meet their particular needs and desires, and (d) otherwise to carry out its obligations under this Agreement.\"}}, {\"id\": \"4.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DISTRIBUTION OF TOUCHSTAR SOFTWARE AND SUPPORT SERVICES\", \"level\": 2, \"text\": \"4.2 DISTRIBUTION OF TOUCHSTAR SOFTWARE AND SUPPORT SERVICES. Reseller shall use its best endeavors to vigorously promote and resell the TouchStar Software and Support Services within the Territory.\"}}, {\"id\": \"4.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING PLAN\", \"level\": 2, \"text\": \"4.3 MARKETING PLAN. Reseller shall be responsible for developing and implementing an annual marketing plan and system for reselling the TouchStar Software and the Support Services (the \\\"Annual Marketing Plan\\\"), which Annual Marketing Plan shall, prior to any use by Reseller, be approved by TouchStar. The Annual Marketing Plan shall be submitted to TouchStar no later than thirty (30) days after the Effective Date.\"}}, {\"id\": \"4.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"MARKETING PRACTICES\", \"level\": 2, \"text\": \"4.4 MARKETING PRACTICES. Reseller shall at all times conduct its business in a manner that reflects favorably on the TouchStar Software, the Support Services and upon TouchStar's name, goodwill, and reputation. Reseller shall demonstrate and otherwise represent the TouchStar Software and the Support Services fairly in comparison with competitive products and shall not make any false or misleading comparisons or representations regarding the TouchStar Software or the Support Services or any representations relating to the TouchStar Software or the Support Services that are inconsistent with TouchStar's product literature, or warranties. Reseller shall not engage in any illegal, deceptive, misleading, or unethical practices that may be detrimental to TouchStar.\"}}, {\"id\": \"4.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRODUCT LITERATURE\", \"level\": 2, \"text\": \"4.5 PRODUCT LITERATURE. Subject to the provisions of Section 3.2, Reseller &bbsp; shall have the right to use and distribute the Marketing Literature to Customers. In the event Reseller desires to use, in connection with sales of the Support Services, any literature, technical data, price lists, promotional materials, or similar materials (including, for example, any materials written in any language other than English) other than the Marketing Materials, Reseller shall prepare such materials at its expense. All such materials shall be submitted to TouchStar for approval, and Reseller shall not use, in connection with the sale of the Support Services, any materials that have not been prepared or approved by TouchStar.\"}}, {\"id\": \"4.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CUSTOMER ASSISTANCE\", \"level\": 2, \"text\": \"4.6 CUSTOMER ASSISTANCE. Reseller, at its expense, shall provide assistance to its Customers in connection with the TouchStar Software and Support Services, 9 including installation assistance, direction regarding the operation of the TouchStar Software and Support Services, and other similar assistance.\"}}, {\"id\": \"4.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SOFTWARE LICENSE AGREEMENT\", \"level\": 2, \"text\": \"4.7 SOFTWARE LICENSE AGREEMENT. Reseller and each Other Reseller shall deliver to each Customer a copy of the License Agreement. TouchStar shall have the right to modify the terms and conditions of the License Agreement from time to time, in the sole discretion of TouchStar. Upon request from TouchStar, Reseller and each Other Reseller shall deliver the License Agreement prior to delivery of the TouchStar Software and Support Services. Reseller shall provide TouchStar with the name and address of each Customer who or which receives a copy of the License Agreement, whether from Reseller or from an Other Reseller.\"}}, {\"id\": \"4.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REPORTS, FORECASTS\", \"level\": 2, \"text\": \"4.8 REPORTS, FORECASTS. As frequently as TouchStar reasonably requests (but in no event less than quarterly), Reseller shall provide to TouchStar written reports showing (a) Reseller's current Customers for TouchStar Software and Support Services, (b) forecasts of Reseller's anticipated orders for TouchStar Software and Support Services, and (c) any other information regarding the TouchStar Software and Support Services and the resale of TouchStar Software and Support Services that TouchStar reasonably requests. All expenses associated with such written reports shall be borne by Reseller.\"}}, {\"id\": \"4.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTIFICATION\", \"level\": 2, \"text\": \"4.9 NOTIFICATION. Reseller shall report promptly to TouchStar concerning any market information that comes to Reseller's attention regarding TouchStar, the TouchStar Software or the Support Services, including information regarding TouchStar's market position and the competitiveness of the TouchStar Software or the Support Services in the marketplace. Reseller shall report promptly to TouchStar all claimed or suspected defects in the TouchStar Software or Support Services and shall notify TouchStar in writing of any claim or proceeding involving the TouchStar Software or Support Services within five (5) days after Reseller learns of the claim or proceeding.\"}}, {\"id\": \"value:five (5) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"five (5) days\"}}, {\"id\": \"4.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COMPLIANCE WITH LAWS\", \"level\": 2, \"text\": \"4.10 COMPLIANCE WITH LAWS. Reseller and each Other Reseller shall conduct its business in compliance with all applicable laws and regulations in any way related to the Support Services, and performance of Reseller's duties under this Agreement. Without limiting the generality of the foregoing, Reseller shall: (a) Comply with all applicable international, national, regional and local laws and rules in and of the Territory now in effect or hereafter enacted or issued relating to the TouchStar Software and the Support Services; (b) Comply with any requirement for the registration or recording of this Agreement with any Governmental Body in the Territory; (c) Give proper weight and consideration to the interests of TouchStar in all dealings; (d) Comply at all times, and cause persons under its control to comply at all times, with any and all Government Controls and other Legal Requirements; 10 (e) Refrain from any action or omission which will cause TouchStar to be in violation of any law of any jurisdiction in the Territory or of any other Legal Requirement, including Government Controls.\"}}, {\"id\": \"4.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PERFORMANCE QUOTAS\", \"level\": 2, \"text\": \"4.11 PERFORMANCE QUOTAS. Each Annual Marketing Plan developed by Reseller during the term of this Agreement and any extension thereof shall contain quotas mutually agreed between TouchStar and Reseller for the sale by Reseller of TouchStar Software and Support Services in the Territory for the year to which such Annual Marketing Plan relates (the \\\"Quotas\\\"). Reseller acknowledges that meeting the Quotas is an essential element of this Agreement and that this Agreement may be terminated by TouchStar if, in TouchStar's reasonable opinion, Reseller will not meet the Quotas during the Term or any extension thereof.\"}}, {\"id\": \"4.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INSURANCE\", \"level\": 2, \"text\": \"4.12 INSURANCE. At a minimum, Reseller will subscribe for and maintain during the Term and for a period of two (2) years thereafter, commercial general liability insurance and errors and omission insurance in minimum amounts of Two Million Dollars (US$2,000,000) per occurrence. Reseller will cause its insurance agent or broker to issue and deliver to TouchStar certified copies of certificates evidencing that insurance coverage of the required types and limits are in full force and effect. Reseller will ensure that any persons or entities engaged by or employed by it will carry and maintain such insurance coverage. Each policy will include a provision requiring notice to the other party at least thirty (30) days prior to any cancellation, non-renewal, or material modification of the policy and will require that each policy will name TouchStar as an additional insured.\"}}, {\"id\": \"value:Two Million Dollars (US$2,000,000)\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Currency\", \"text\": \"Two Million Dollars (US$2,000,000)\"}}, {\"id\": \"4.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ANCILLARY SOFTWARE\", \"level\": 2, \"text\": \"4.13 ANCILLARY SOFTWARE. Reseller shall have the right to develop ancillary software compatible with the TouchStar Software for the use of its Customers, including, but not limited to translations of the TouchStar Software for use in languages other than English (the \\\"Ancillary Software\\\"). In the event Reseller decides to develop Ancillary Software, Reseller shall give TouchStar thirty (30) days notice of its intent to develop the Ancillary Software. TouchStar, at its sole discretion may decide to assist with the development of the Ancillary Software. TouchStar shall own all Ancillary Software.\"}}, {\"id\": \"4.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TECHNICAL PREREQUISITES\", \"level\": 2, \"text\": \"4.14 TECHNICAL PREREQUISITES. In the event that TouchStar installs call center systems on behalf of Reseller, Reseller shall provide to TouchStar any and all information on Technical Prerequisites reasonably requested by TouchStar in order to assist TouchStar in the installation of the applicable call center system.\"}}, {\"id\": \"4.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"COVENANT NOT TO SOLICIT\", \"level\": 2, \"text\": \"4.15 COVENANT NOT TO SOLICIT. During the Term, and for a period of one year following the termination or expiration of this Agreement, Reseller will not, directly or indirectly, make an offer of employment to any current employee of TouchStar or otherwise encourage or solicit any current employee of TouchStar to leave the employ of TouchStar for any reason, or to devote less than all of such employee's efforts to the affairs of TouchStar, without (a) the prior written agreement of TouchStar, which TouchStar may grant in its sole discretion, and (b) the payment by Reseller to TouchStar of a mutually agreeable severance fee. Reseller will not make an offer of 11 employment to any former employee of TouchStar for a period of four (4) months after such employee leaves the employ of TouchStar. In the event that a court of competent jurisdiction refuses to enforce all or any portion of this Section 4.15, then such unenforceable portion will be eliminated or modified, but only to the extent necessary to permit the remaining portion of this Section 4.15 to be enforced. In the event that any provisions of this Section 4.15 are deemed to exceed the time, geographic or scope limitations permitted by applicable law, such provisions will be reformed to the maximum time, geographic or scope limitations, as the case may be, permitted by applicable law.\"}}, {\"id\": \"5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TECHNICAL ASSISTANCE\", \"level\": 1, \"text\": \"5. TECHNICAL ASSISTANCE.\"}}, {\"id\": \"5.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TOUCHSTAR SOFTWARE INFORMATION\", \"level\": 2, \"text\": \"5.1 TOUCHSTAR SOFTWARE INFORMATION. TouchStar shall make available to Reseller in English such technical information relating to the TouchStar Software as it makes available to its other Resellers generally. Reseller is not entitled to receive any source code or other technical information relating to the TouchStar Software.\"}}, {\"id\": \"5.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"UPGRADE OF RESELLER'S CUSTOMERS\", \"level\": 2, \"text\": \"5.2 UPGRADE OF RESELLER'S CUSTOMERS. Reseller shall use reasonable commercial efforts to upgrade the software used by its Customers prior to the Effective Date to the TouchStar Software. At Reseller's request, TouchStar shall provide to Reseller and its employees assistance relating to the upgrade of software used by Reseller's Customers as of the Effective Date.\"}}, {\"id\": \"5.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ADDITIONAL ASSISTANCE\", \"level\": 2, \"text\": \"5.3 ADDITIONAL ASSISTANCE. TouchStar shall provide to Reseller, the Other Resellers, and its and their employees assistance relating to the TouchStar Software as reasonably requested by Reseller, but in any event in an amount not to exceed twenty (20) hours of assistance per month. In the event TouchStar provides assistance to Reseller related to technical aspects of the TouchStar Software or related to the preparation of literature, technical aspects of the TouchStar Software or related to the preparation of literature, technical materials or promotional materials, Reseller shall promptly reimburse TouchStar for any out-of-pocket expenses incurred by TouchStar in connection with rendering such assistance, including all travel expenses, lodging, and meals. TouchStar may also charge reasonably hourly or per diem rates for some or all of the services rendered under this provision, provided that TouchStar notifies Reseller before the services are rendered of the rates that will apply to the services. Nothing in this Section 5.3 shall be construed to obligate TouchStar to provide assistance of any kind to Reseller. In the event TouchStar agrees to provide assistance, the assistance shall at all times be subject to the availability of TouchStar's personnel.\"}}, {\"id\": \"6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMS AND CONDITIONS OF SALE\", \"level\": 1, \"text\": \"6. TERMS AND CONDITIONS OF SALE.\"}}, {\"id\": \"6.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRICE AND PAYMENT\", \"level\": 2, \"text\": \"6.1 PRICE AND PAYMENT. (a) TouchStar shall sell the TouchStar Software and Support Services, and provide for the installation of call center systems, for the Fees. The Fees shall be valid only for TouchStar Software and Support Services sold by Reseller or Other Resellers to Customers, and the installation of call center systems on 12 behalf of Reseller and any Other Resellers at Customer locations, in the Territory during the Term. TouchStar shall have the right at any time and from time to time to change the Fees by providing to Reseller written notice at least thirty (30) days prior to the date the change becomes effective. TouchStar may change the Fees from time to time in its sole discretion; PROVIDED, HOWEVER, that new Fees shall not apply to any agreement to provide Support Services accepted by TouchStar before Reseller receives notice of the change. (b) TouchStar will invoice Reseller for payment of the Fee incurred within ten (10) days after the end of each billable month. Payment of the Fees shall be due and payable within ten (10) days of the date of the invoice. All or any portion of the Fees not paid when due shall bear interest at the rate of one and one-half (1.5%) per month, calculated from the date such payment is due until the date on which such payment is made, inclusive; PROVIDED, HOWEVER, that if such interest rate exceeds the amount allowed by applicable law, then the interest rate shall be adjusted to reflect the maximum amount allowed by such applicable law.\"}}, {\"id\": \"value:ten (10) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ten (10) days\"}}, {\"id\": \"value:1.5%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"one and one-half (1.5%)\"}}, {\"id\": \"6.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSESSMENTS\", \"level\": 2, \"text\": \"6.2 ASSESSMENTS. Reseller shall pay when due, and indemnify and hold TouchStar harmless from any and all taxes, value added taxes, general service taxes, duties, assessments and other fees associated with the providing by Reseller of the TouchStar Software and the Support Services, and the installation of call center systems on behalf of Reseller, to Customers in the Territory pursuant to this Agreement (\\\"Assessments\\\"). If Reseller fails to pay any Assessments when due, and TouchStar receives any Assessment from any Governmental Body, then TouchStar shall give written notice of the Assessment to Reseller. Failure by Reseller immediately to pay such Assessment may, in TouchStar's sole discretion, result in the immediate termination of this Agreement.\"}}, {\"id\": \"6.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OTHER TERMS AND CONDITIONS\", \"level\": 2, \"text\": \"6.3 OTHER TERMS AND CONDITIONS. The terms and conditions of this Agreement and of the applicable TouchStar invoice or confirmation shall apply to all TouchStar Software and Support Services, and the installation of call center systems, provided by TouchStar under this Agreement. Terms in Reseller's purchase orders and other printed forms shall not apply to any order, notwithstanding TouchStar's acknowledgment or acceptance of the order. In the event of any conflict between the terms of this Agreement and any standard forms of either TouchStar or Reseller, the terms of this Agreement shall govern. Reseller shall not, and is not authorized to, make any warranties as to the TouchStar Software and Support Services, or with regard to the installation of call center systems by TouchStar, and any warranties exceeding the scope of TouchStar warranties shall be null and void, subject only to contrary legal requirements applicable to the Territory.\"}}, {\"id\": \"6.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITED WARRANTY\", \"level\": 2, \"text\": \"6.4 LIMITED WARRANTY. TouchStar warrants that (a) with regard to the TouchStar Software, (i) TouchStar will convey good title to the TouchStar Software free and clear of any claims, liens, security agreements or other encumbrances and (ii) for a period of ninety (90) days after delivery, the TouchStar Software will perform in all 13 material respects with the specifications contained in TouchStar's technical literature with regard to the TouchStar Software, (b) the Support Services will be provided in a good and workmanlike manner consistent with industry practices, and (c) with regard to call center systems installed by TouchStar, (i) TouchStar will convey good title to the call center system free and clear of any claims, liens, security agreements or other encumbrances and (ii) the call center system will be installed in a good and workmanlike manner substantially in conformance with the Specifications. EXCEPT AS PROVIDED IN THIS SECTION 6.4, TOUCHSTAR DOES NOT WARRANT THE TOUCHSTAR SOFTWARE OR SUPPORT SERVICES, OR THE INSTALLATION OF ANY CALL CENTER SYSTEM, TO RESELLER, ANY OTHER RESELLER OR ANY CUSTOMER. TOUCHSTAR MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, RELATING THERETO. TOUCHSTAR IS UNAWARE OF THE USE OF ANY CALL CENTER SYSTEM INSTALLED&bbsp;BY TOUCHSTAR. TOUCHSTAR MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND WHATSOEVER WITH REGARD TO THE USE OF ANY CALL CENTER SYSTEM, INCLUIDNG WHETHER THE USE OF THE CALL CENTER SYSTEM CONFORMS TO APPLICABLE FEDERAL, STATE AND LOCAL LAWS. RESELLER BEARS SOLE RESPONSIBILITY TO DETERMINE WHETHER THE USE OF A CALL CENTER SYSTEM BY A CUSTOMER COMPLIES WITH APPLICABLE FEDERAL STATE AND LOCAL LAWS. SHOULD APPLICABLE LAW NOT PERMIT THE FOREGOING EXCLUSION OF EXPRESS OR IMPLIED WARRANTIES, THEN TOUCHSTAR HEREBY GRANTS THE MINIMUM EXPRESS AND IMPLIED WARRANTIES REQUIRED BY SUCH APPLICABLE LAW.\"}}, {\"id\": \"value:ninety (90) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"ninety (90) days\"}}, {\"id\": \"6.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIMITATION OF LIABILITY\", \"level\": 2, \"text\": \"6.5 LIMITATION OF LIABILITY. IN NO EVENT SHALL TOUCHSTAR BE LIABLE TO RESELLER, ANY OTHER RESELLER OR ANY CUSTOMER BY REASON OF ANY REPRESENTATION OR IMPLIED WARRANTY, CONDITION, OTHER TERM, OR ANY DUTY AT COMMON LAW, OR UNDER THE TERMS OF THIS AGREEMENT, FOR ANY DIRECT, INDIRECT, SPECIAL, CONSEQUENTIAL OR PUNITIVE LOSS OR DAMAGE (WHETHER FOR LOSS OF PROFIT OR OTHERWISE) ARISING OUT OF OR IN CONNECTION WITH ANY ACT OR OMISSION OF TOUCHSTAR RELATING TO THE DEVELOPMENT, MANUFACTURE, OR SUPPLY OF THE TOUCHSTAR SOFTWARE, THE SERVICES, OR THE INSTALLATION OF ANY CALL CENTER SYSTEM, THEIR RESALE BY RESELLER, OR THEIR USE BY ANY CUSTOMER OR OTHER END USER. TOUCHSTAR SHALL NOT BE LIABLE FOR THE PROVISION OF SERVICES BY RESELLER OR ANY OTHER RESELLER, OR ANY ALTERATIONS OR MODIFICATIONS BY RESELLER TO THE TOUCHSTAR SOFTWARE OR ANY CALL CENTER SYSTEM. THE SOLE OBLIGATION OF TOUCHSTAR, AND THE SOLE REMEDY OF RESELLER OR ANY OTHER RESELLER, UNDER THIS AGREEMENT SHALL BE (A) WITH REGARD TO THE TOUCHSTAR SOFTWARE OR ANY CALL CENTER SYSTEM, THE REPLACEMENT OR REPAIR OF THE TOUCHSTAR SOFTWARE OR THE CALL CENTER SYSTEM OR, AT THE OPTION OF TOUCHSTAR, THE RETURN OF THE PURCHASE PRICE PAID BY RESELLER 14 FOR SUCH TOUCHSTAR SOFTWARE OR CALL CENTER SYSTEM AND (B) WITH REGARD TO SERVICES, THE REPERFORMANCE OF THE SERVICES.\"}}, {\"id\": \"7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY RIGHTS\", \"level\": 1, \"text\": \"7. INTELLECTUAL PROPERTY RIGHTS.\"}}, {\"id\": \"7.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"OWNERSHIP OF INTELLECTUAL PROPERTY\", \"level\": 2, \"text\": \"7.1 OWNERSHIP OF INTELLECTUAL PROPERTY. (a) Reseller acknowledges that TouchStar owns or has rights to license the intellectual property and proprietary rights in, to, and relating to the TouchStar Software and Support Services, including, but not limited to, the Intellectual Property Rights. (b) To the extent that Reseller or any Other Reseller is deemed to be the owner of all or any portion of the TouchStar Software, any Intellectual Property Rights of TouchStar or any Ancillary Software, or any improvements or intellectual property rights related thereto pursuant to applicable law, Reseller (i) hereby assigns exclusively to TouchStar all rights of Reseller in and to such Software and any improvements and intellectual property rights related thereto royalty-free and exclusively and (ii) shall include in any Other Reseller Agreement provision by which any Other Reseller grants to TouchStar an exclusive, perpetual, irrevocable, royalty-free assignment of all deemed rights of such Other Reseller in and to such TouchStar Software, Ancillary Software and Intellectual Property Rights. Reseller shall execute, and shall cause any Other Reseller to execute, any such documents and instruments necessary to vest in TouchStar the deemed ownership rights of Reseller or Other Reseller in and to any TouchStar Software, Ancillary Software or Intellectual Property Rights, and any improvements or intellectual property rights related thereto.\"}}, {\"id\": \"7.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PRIVATE LABELING\", \"level\": 2, \"text\": \"7.2 PRIVATE LABELING. At the request of Reseller, TouchStar shall use reasonable commercial efforts to provide a private label version of the TouchStar Software (the \\\"Private Label Software\\\") using logos, trademarks, trade names or service marks owned by Reseller or to which Reseller has exclusive rights (the \\\"Reseller Marks\\\"). Reseller represents and warrants that Reseller has valid legal ownership and other exclusive rights to the Reseller Marks. Reseller grants to TouchStar a right and license to use the Reseller Marks in the preparation of the Private Label Software. Reseller shall have the right to promote, market, distribute and resell the Private Label Software pursuant to the terms and conditions of this Agreement. Reseller shall reimburse TouchStar for all costs and expenses incurred by TouchStar in making the Private Label Software available to Reseller. Except for the Reseller Marks, TouchStar shall retain all right, title and interest in and to the Private Label Software. Reseller shall indemnify, defend and hold harmless TouchStar, its Affiliates, and its and their respective directors, officers, employees, agents and representatives from and against any and all claims, suits, proceedings, costs and expenses arising out of or relating to the use by TouchStar of the Reseller Marks. TouchStar may include in the Private Label Software a legend to the effect that TouchStar owns the Private Label Software. 15\"}}, {\"id\": \"7.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"USE OF TOUCHSTAR INTELLECTUAL PROPERTY RIGHTS\", \"level\": 2, \"text\": \"7.3 USE OF TOUCHSTAR INTELLECTUAL PROPERTY RIGHTS. Reseller shall use the Intellectual Property Rights only to refer to the TouchStar Software in accordance with TouchStar's policies as announced from time to time. In particular, and without limitation, Reseller shall not (a) remove Trademarks from any Marketing Materials, (b) include any Trademarks or other Intellectual Property Rights in any promotional literature prepared by Reseller without the express written consent of TouchStar; (c) dispute or deny the validity of any of the Intellectual Property Rights (including any attempt to register or record the same in any jurisdiction), (d) do any act or omit to do any act whereby TouchStar's right, title, and interest in the Intellectual Property Rights may become invalidated or otherwise adversely affected, (e) alter, remove, destroy, conceal, or tamper with any Trademarks, (f) use any Intellectual Property Rights in any way which might prejudice their distinctiveness or validity or goodwill of TouchStar therein, (g) use in relation to Support Services any patents, copyrights, trademarks, or trade names other than the Intellectual Property Rights without TouchStar's prior written consent, or (h) use in the Territory any trademarks or trade names so resembling any Trademark of TouchStar as to be likely to cause confusion or deception. Upon expiration or termination of this Agreement, Reseller shall immediately cease all use of the Intellectual Property Rights and shall not thereafter use any of them or any intellectual property rights confusingly similar to the Intellectual Property Rights.\"}}, {\"id\": \"7.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"USE OF CONFIDENTIAL INFORMATION\", \"level\": 2, \"text\": \"7.4 USE OF CONFIDENTIAL INFORMATION. Reseller acknowledges that it may receive, during the term of this Agreement, certain Confidential Information belonging to TouchStar. Reseller recognizes that such Confidential Information is proprietary to TouchStar and very valuable, having involved the expenditure of substantial amounts of money and the use of skilled experts over a long period of time. Reseller shall hold TouchStar's Confidential Information in strict confidence and shall not use or disclose any Confidential Information, or permit any person to examine or copy any Confidential Information, regardless of the manner in which Reseller gained access to it, except as necessary for the performance of Reseller's obligations under this Agreement.\"}}, {\"id\": \"7.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PROTECTION OF CONFIDENTIAL INFORMATION\", \"level\": 2, \"text\": \"7.5 PROTECTION OF CONFIDENTIAL INFORMATION. Reseller shall protect TouchStar's Confidential Information with the utmost care and shall cause its employees, agents, and independent contractors having access to such Confidential Information to sign confidentiality agreements requiring them to comply with all the terms of this Article 7.\"}}, {\"id\": \"7.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INFRINGEMENT CLAIMS\", \"level\": 2, \"text\": \"7.6 INFRINGEMENT CLAIMS. Reseller shall promptly notify TouchStar of any known or suspected breach of the Intellectual Property Rights and shall cooperate (without charge for personal time incurred) in TouchStar's efforts to protect such TouchStar Intellectual Property Rights. TouchStar shall defend any action brought against Reseller based on an allegation that any TouchStar Software infringes a United States or foreign Patent, Copyright, or Trademark, and TouchStar shall pay all costs and damages made in settlement or awarded as a result of any such action. If a final injunction shall be obtained in any such action restraining use of the TouchStar Software by any Customer, or if TouchStar believes that any TouchStar Software is 16 likely to become the subject of a claim of infringement, TouchStar shall, at its option and at its expense, (a) procure for Reseller's Customer the right to continue using the TouchStar Software, (b) replace or modify the TouchStar Software so that it becomes non-infringing, or (c) repurchase the TouchStar Software on a depreciated (five-year straight line) basis. Notwithstanding the foregoing, TouchStar shall have no obligation with respect to any action brought against Reseller based on an allegation of Patent, Copyright, or Trademark infringement unless TouchStar is promptly notified by Reseller in writing of such action and is allowed complete control of the defense of such action and all negotiations for its settlement or compromise. This Section 7.6 states TouchStar's entire liability with respect to infringement of Patents, Copyrights, or Trademarks.\"}}, {\"id\": \"7.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EQUITABLE REMEDIES\", \"level\": 2, \"text\": \"7.7 EQUITABLE REMEDIES. Reseller acknowledges that TouchStar will be irreparably harmed by any breach of the provisions of this Section 7. Therefore, in addition to any other remedies that TouchStar may have, TouchStar shall be entitled to an injunction, issued by any court of competent jurisdiction, wherever located, restraining any violation of this Section 7 or specified performance if applicable. Reseller hereby waives, with respect to any future dispute related to this Section 7, any defense based on the argument that TouchStar will not be irreparably harmed by a breach or that TouchStar has available to it an adequate remedy for damages.\"}}, {\"id\": \"7.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER'S OBLIGATIONS AS TO CONFIDENTIAL INFORMATION AFTER TERMINATION\", \"level\": 2, \"text\": \"7.8 RESELLER'S OBLIGATIONS AS TO CONFIDENTIAL INFORMATION AFTER TERMINATION. All obligations of Reseller relating to TouchStar Confidential Information shall survive the expiration or termination of this Agreement. Promptly upon expiration or termination of this Agreement, Reseller shall not have a right of retention with respect to, and shall return to TouchStar, all materials in Reseller's possession or control that represent or contain Confidential Information, including all memoranda, computer programs, documents, notes, and every other medium. Reseller shall not retain for its own use or the use of any third party any such materials or any copies thereof.\"}}, {\"id\": \"8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM AND TERMINATION\", \"level\": 1, \"text\": \"8. TERM AND TERMINATION.\"}}, {\"id\": \"8.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERM OF AGREEMENT\", \"level\": 2, \"text\": \"8.1 TERM OF AGREEMENT. This Agreement shall continue in force for a term of twelve (12) months from the Effective Date, unless terminated earlier under the provisions of this Article 8 (the \\\"Term\\\"); PROVIDED that TouchStar shall have the right to terminate this Agreement at any time after the Effective Date upon not less than fifteen (15) days' prior written notice to Reseller. Prior to the end of the Term, each of TouchStar and Reseller may notify the other if it desires to negotiate a further agreement by written request received at least ninety (90) days in advance of the termination of this Agreement. If both parties desire to negotiate a further agreement, they may consider the terms of this Agreement in coming to an understanding. Nothing in this Agreement shall be construed to obligate either party to renew or extend the term of this Agreement. Renewals for additional terms, if any, shall not cause this Agreement to be construed as an agreement of indefinite duration.\"}}, {\"id\": \"value:fifteen (15) days\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Days\", \"text\": \"fifteen (15) days\"}}, {\"id\": \"8.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"TERMINATION AT TOUCHSTAR OPTION\", \"level\": 2, \"text\": \"8.2 TERMINATION AT TOUCHSTAR OPTION. TouchStar may terminate this Agreement upon the occurrence and continuation of any of the following events, with the understanding 17 that, if no cure period specifically is stated with regard to an event, then no cure period for such event applies: (a) Reseller fails to make any payment of Fees due to TouchStar under this Agreement and such failure remains unremedied for a period of ten (10) days; (b) Reseller breaches any of its other obligations under this Agreement and such breach remains unremedied for a period of thirty (30) days; (c) Reseller or any Other Reseller takes any action to Reverse Engineer the TouchStar Software; (d) Reseller fails to comply with applicable Legal Requirements, including Government Controls; (e) Reseller fails to reach the Quotas established by the parties; (f) Reseller repeatedly breaches any of its obligations under this Agreement, even though Reseller remedies each such breach within the applicable time period specified above; (g) Reseller fails to execute an Other Reseller Agreement with any Other Reseller; (h) Reseller or any Other Reseller fails to deliver a License Agreement to a Customer; (i) Reseller fails to indemnify TouchStar, its Affiliates and its and their respective directors, officers, employees, agents and representatives for any claims related to or arising under any Other Reseller Agreement or the use by TouchStar of the Reseller Marks; (j) Reseller is negligent in the fulfillment of its obligations to market and resell the TouchStar Software; (k) Reseller breaches any of its obligations relating to the Intellectual Property Rights or Confidential Information; (l) Reseller, any of Reseller's officers, directors, or shareholders, or any entity controlling, controlled by or under common control with Reseller promotes, sells, or offers for sale any product or other item that is, in TouchStar's reasonable opinion, competitive with or capable of being substituted for any of the TouchStar Software; or Reseller engages in overt or subvert forms of boycott of the TouchStar Software, including the offer for sale of any product or other item that is, in TouchStar's reasonable opinion, competitive with or capable of being substituted for any of the TouchStar Software; (m) In the event of a sale, conveyance, transfer or other disposition, in any transaction or series of transactions that results, directly or indirectly, in a 18 change of fifty percent (50%) or more of the aggregate voting power in Reseller as such existed on and as of the Effective Date; (n) Reseller is merged or consolidated with any other entity or there is a substantial change in the management or control of Reseller; or (o) Reseller ceases to function as a going concern or ceases to conduct its operations in the normal course of business or any of its directors, shareholders, or officers is convicted of a criminal offense or engages in any other act that in TouchStar's opinion could have an adverse effect upon TouchStar's reputation and goodwill.\"}}, {\"id\": \"value:50%\", \"type\": \"VALUE\", \"attrs\": {\"type\": \"Percentage\", \"text\": \"fifty percent (50%)\"}}, {\"id\": \"8.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUSPENSION OF TOUCHSTAR OBLIGATIONS\", \"level\": 2, \"text\": \"8.3 SUSPENSION OF TOUCHSTAR OBLIGATIONS. Immediately upon the occurrence of any breach by Reseller of any of its obligations under this Agreement or upon the occurrence of any event or circumstance identified in Section 7.3 of this Agreement, all of TouchStar's obligations to provide Support Services shall be suspended and such obligations shall remain suspended until the event or circumstance giving rise to the suspension has been corrected to TouchStar's satisfaction.\"}}, {\"id\": \"9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"DUTIES UPON TERMINATION\", \"level\": 1, \"text\": \"9. DUTIES UPON TERMINATION. In addition to any other provision of this Agreement which is designated in Section 8.6 as a provision surviving termination, the following shall apply:\"}}, {\"id\": \"9.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"CUSTOMER AGREEMENTS\", \"level\": 2, \"text\": \"9.1 CUSTOMER AGREEMENTS. (a) In the event that (i) TouchStar terminates this Agreement in accordance with any one or more of the provisions of Section 8.2 or (ii) Reseller elects not to enter into a new agreement with TouchStar pursuant to Section 8.1, all Customer Agreements with Customers shall be transferred by Reseller to TouchStar. (b) In the event that (i) TouchStar elects not to enter into a new agreement with Reseller pursuant to Section 8.2 or (ii) Reseller terminates this Agreement in accordance with the provisions of Section 8.3, Reseller shall retain all Customer Agreements with Customers and TouchStar shall continue to provide Support Services under such Customer Agreements for the remaining term of such Customer Agreements. &bbsp; 19\"}}, {\"id\": \"9.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"REFERRALS BY RESELLER\", \"level\": 2, \"text\": \"9.2 REFERRALS BY RESELLER. In the event that (a) TouchStar terminates this Agreement in accordance with any one or more of the provisions of Section 8.2 or (b) Reseller elects not to enter into a new agreement with TouchStar pursuant to Section 8.1, Reseller shall refer to TouchStar or TouchStar's designee all inquiries and orders received by Reseller pertaining to the purchase of Support Services.\"}}, {\"id\": \"9.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PAYMENT OF FEES\", \"level\": 2, \"text\": \"9.3 PAYMENT OF FEES. (a) In the event that this Agreement terminates or expires pursuant to Section 8.1(a), Reseller immediately shall pay to TouchStar all Fees outstanding on and as of the date of termination or expiration of this Agreement. (b) In the event that this Agreement terminates or expires pursuant to Section 8.1(b), Reseller shall continue to pay all Fees in accordance with the provisions of Section 6.2.\"}}, {\"id\": \"9.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INTELLECTUAL PROPERTY RIGHTS\", \"level\": 2, \"text\": \"9.4 INTELLECTUAL PROPERTY RIGHTS. Reseller immediately shall stop the use of Marketing Materials and Intellectual Property Rights, and shall return any unused Marketing Materials and all physical media upon which Intellectual Property Rights are contained by TouchStar.\"}}, {\"id\": \"9.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SHIPMENTS FOLLOWING NOTICE OF TERMINATION\", \"level\": 2, \"text\": \"9.5 SHIPMENTS FOLLOWING NOTICE OF TERMINATION. The expiration or termination of this Agreement shall not relieve TouchStar of its continuing obligation to ship TouchStar Software pursuant to any purchase orders accepted by TouchStar prior to the notice of termination, nor shall it relieve Reseller of its continuing obligation to accept and pay for such TouchStar Software; PROVIDED, HOWEVER, that with respect to all TouchStar Software shipped after any notice of termination, Reseller shall make payment prior to shipment on terms and conditions and by means satisfactory to TouchStar, notwithstanding any credit terms that may have been available to Reseller prior to such notice of termination.\"}}, {\"id\": \"9.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"LIABILITY UPON TERMINATION\", \"level\": 2, \"text\": \"9.6 LIABILITY UPON TERMINATION. TouchStar shall have no liability to Reseller or any Other Reseller by reason of the termination or expiration of this Agreement for compensation, reimbursement, or damages of any kind, including any loss of prospective profits on anticipated sales, loss of goodwill, or investments made in reliance on this Agreement. Reseller acknowledges that it has received no assurances from TouchStar that its business relationship with TouchStar will continue beyond the term established in this Agreement, or that it will obtain any anticipated amounts of profits in connection with this Agreement, or that it will recoup its investment in the promotion of the TouchStar Software. Reseller also acknowledges that Reseller's failure to reach the Quotas will have a significant adverse impact on TouchStar's goodwill in the Territory, and that if Reseller is terminated because of failure to meet the Quotas, then Reseller will not be entitled to compensation of any kind (beyond the notice period set forth in this Agreement), since the damage to &sbsp; TouchStar's goodwill is likely to be at least as great as any losses Reseller might incur as a result of the termination. However, these provisions apply only to damages that are attributable to the expiration or termination of this Agreement and shall not affect any amount due 20 under this Agreement or the right of either party to seek damages directly attributable to any breach.\"}}, {\"id\": \"10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GENERAL PROVISIONS\", \"level\": 1, \"text\": \"10. GENERAL PROVISIONS.\"}}, {\"id\": \"10.1\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RELATIONSHIP BETWEEN THE PARTIES\", \"level\": 2, \"text\": \"10.1 RELATIONSHIP BETWEEN THE PARTIES. Neither party to this Agreement and none of their respective agents, employees, representatives or independent contractors shall (a) be considered an agent, employee, or representative of the other party for any purpose whatsoever, (b) have any authority to make any agreement or commitment for the other party or to incur liability or obligation in the other party's name or on its behalf, or (c) represent to third parties that any of them has any right so to bind the other party hereto, it being intended that each party shall remain an independent contractor responsible only for its own actions. Nothing contained in this Agreement shall be construed or interpreted as creating an agency, partnership, or joint venture relationship between the parties.\"}}, {\"id\": \"10.2\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"RESELLER REPRESENTATION, WARRANTY AND UNDERTAKING\", \"level\": 2, \"text\": \"10.2 RESELLER REPRESENTATION, WARRANTY AND UNDERTAKING. Reseller (a) represents and warrants that (i) it is a corporation duly organized and existing under the laws of the jurisdiction of its incorporation with all necessary corporate power and authority to execute, deliver, and perform its obligations under this Agreement, and that the execution, delivery, and performance of its obligations under this Agreement have been duly authorized by all requisite corporate action of Reseller and all Legal Requirements of Governmental Bodies, (ii) it has the requisite skill and knowledge necessary to perform its obligations under this Agreement, (iii) that it currently is not in violation of any Legal Requirements, and (iv) no current employee or shareholder of TouchStar has an ownership interest in Reseller or any affiliate or related entity of Reseller; and (b) covenants that, during the Term, it (i) shall use its best endeavors to maintain its corporate identity and remain in existence under the organizing laws of its jurisdiction and (ii) promptly notify TouchStar in the event that any employee or shareholder of TouchStar obtains an ownership interest in Reseller or any affiliate or related entity of Reseller.\"}}, {\"id\": \"10.3\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"NOTICES\", \"level\": 2, \"text\": \"10.3 NOTICES. Without precluding any other sufficient form of notice, all notices, demands, or other communications under this Agreement shall be deemed given if sent by registered airmail, facsimile, hand delivery, or express courier to the address of the party as set out in this Agreement or to another address specified by the party. All notices, demands, and other communications in connection with this Agreement shall be written in the English language.\"}}, {\"id\": \"10.4\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ENTIRE AGREEMENT\", \"level\": 2, \"text\": \"10.4 ENTIRE AGREEMENT. This Agreement constitutes the entire agreement between the parties pertaining to its subject matter, and it supersedes any and all written or oral agreements previously existing between the parties with respect to such subject matter. No supplement, modification, or amendment of this Agreement shall be binding unless executed in writing by both parties.\"}}, {\"id\": \"10.5\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"WAIVER\", \"level\": 2, \"text\": \"10.5 WAIVER. Either party's failure to insist on strict performance of any provision of this Agreement shall not be deemed a waiver of any of its rights or remedies, nor shall it relieve the other party from performing any subsequent obligation strictly in 21 accordance with the terms of this Agreement. No waiver shall be effective unless it is in writing and signed by the party against whom enforcement is sought. Such waiver shall be limited to provisions of this Agreement specifically referred to therein and shall not be deemed a waiver of any other provision. No waiver shall constitute a continuing waiver unless the writing states otherwise.\"}}, {\"id\": \"10.6\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SUCCESSORS AND ASSIGNS\", \"level\": 2, \"text\": \"10.6 SUCCESSORS AND ASSIGNS. This Agreement shall inure to the benefit of, and shall be binding upon, the respective heirs, legal representatives, successors, and assigns of each of the parties.\"}}, {\"id\": \"10.7\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"ASSIGNMENT\", \"level\": 2, \"text\": \"10.7 ASSIGNMENT. (a) TouchStar may assign this Agreement and the rights and responsibilities under this Agreement to an Affiliate upon written notice to Reseller. (b) Except for the rights of TouchStar under Section 10.7(a), this Agreement may not be assigned by either party without the prior written consent of the other. Any attempted assignment in violation of this provision shall be void and shall be deemed a breach of this Agreement.\"}}, {\"id\": \"10.8\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"INDEMNIFICATION\", \"level\": 2, \"text\": \"10.8 INDEMNIFICATION. Reseller shall be solely responsible for, and shall indemnify TouchStar, its officers, directors, employees, and agents against, and hold each of them harmless from, any and all claims (including without limitation, all damages (whether direct, indirect, incidental, criminal, special, or punitive), losses, liabilities, expenses, costs, and attorneys' fees related to such claims) resulting from (a) the negligent or willful failure of Reseller to comply with its obligations hereunder, (b) the acts or omissions of Reseller, its officers, directors, employees, or agents during the term of this Agreement or thereafter, (c) any express or implied representation or warranty made by Reseller or any of its officers, directors, employees or agents with regard to the TouchStar Software or the Support Services not contained in written literature of TouchStar or specifically authorized by TouchStar in writing, and (c) the installation of a call center system by TouchStar on behalf of Reseller or any Other Reseller and the use of the TouchStar Software in the operation of a call center system, unless caused by the gross negligence or willful misconduct of TouchStar.\"}}, {\"id\": \"10.9\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SECTION HEADINGS; CONSTRUCTION\", \"level\": 2, \"text\": \"10.9 SECTION HEADINGS; CONSTRUCTION. The section headings in this Agreement are included for convenience only and shall not be deemed to limit or otherwise affect the construction of any of its provisions. The word \\\"including\\\" shall be ascribed a non-exclusive meaning unless followed by the word \\\"only.\\\"\"}}, {\"id\": \"10.10\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"SEVERABILITY\", \"level\": 2, \"text\": \"10.10 SEVERABILITY. In the event that any of the provisions of this Agreement shall be held by a court, arbitral panel, or tribunal of competent jurisdiction to be unenforceable, such provision will be enforced to the maximum extent permissible and the remaining portions of this Agreement shall remain in full force and effect.\"}}, {\"id\": \"10.11\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PARTIES IN INTEREST\", \"level\": 2, \"text\": \"10.11 PARTIES IN INTEREST. Nothing in this Agreement is intended to confer any rights or remedies on any persons other than the parties to it. This Agreement shall not be construed to relieve or discharge any obligations or liabilities of third persons, nor 22 shall it be construed to give third persons any right of subrogation or action over against any party to this Agreement.\"}}, {\"id\": \"10.12\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LAW AND ARBITRATION\", \"level\": 2, \"text\": \"10.12 GOVERNING LAW AND ARBITRATION. (a) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF COLORADO, UNITED STATES, WITHOUT REGARD TO ITS PRINCIPLES REGARDING CONFLICT OF LAWS. (b) ARBITRATION. Any dispute arising out of or relating to this Agreement, including, without limitation, the interpretation of any provision of this Agreement or the breach, termination or invalidity of this Agreement that cannot reasonably be resolved by the Parties shall be settled exclusively and finally by binding arbitration under the International Arbitration Rules of the American Arbitration Association in effect on and as of the date of this Agreement (the \\\"AAA Rules\\\"), except as such AAA Rules are modified pursuant to this Section 10.12(b). (i) The arbitration shall be conducted before a panel of three (3) arbitrators, each of whom shall be fluent in English and shall have knowledge in the call center industry. TouchStar shall appoint one (1) arbitrator, Customer shall appoint one (1) arbitrator, and the third arbitrator shall be selected by the two (2) arbitrators so appointed; PROVIDED, HOWEVER, that if the two (2) arbitrators appointed by the parties fail to select the third arbitrator within thirty (30) days after the date on which the last of such two (2) arbitrators are appointed, then the third arbitrator shall be appointed by the administrator in accordance with the AAA Rules. The third arbitrator, regardless of how selected, shall chair the arbitration panel. (ii) Once the arbitrators are impaneled, if (A) an arbitrator withdraws after a challenge, (B) the administrator sustains a challenge and removes an arbitrator, (C) an arbitrator dies, or (D) an arbitrator otherwise resigns or is removed, then the party which appointed such arbitrator shall appoint a replacement arbitrator within thirty (30) days in accordance with the procedures set forth in Section 10.12(b)(i). (iii) The arbitration shall be conducted in Denver, Colorado, United States. The arbitration shall be conducted in English; PROVIDED, that either party, at its cost, may provide for the simultaneous translation of the arbitration into a language other than English. (iv) No less than thirty (30) days prior to the date on which the arbitration proceeding is to begin, each party shall submit to the other party the documents, in English, and list of witnesses it 23 intends to use in the arbitration. At any oral hearing of evidence in connection with the arbitration, each party or its legal counsel shall have the right to examine witnesses and to cross-examine the witnesses of the opposing party. (v) The arbitrators shall apply the substantive law of the State of Colorado to any decision issued by the arbitration panel, and the arbitrators shall be so instructed. The arbitrators shall issue a written opinion stating the findings of fact and the conclusions of law upon which the decision is based. The decision of the arbitrators shall be final and binding. Judgment on such award may be entered in any court of appropriate jurisdiction, or application may be made to that court for a judicial acceptance of the award and an order of enforcement, as the party seeking to enforce that award may elect. Any arbitration award for money damages shall be in Dollars. Other than pursuant to this Section 10.12(b)(v), the arbitration award shall not include any indirect, incidental, special, consequential, or punitive damages and the arbitrators shall be so instructed. (vi) Any arbitration award pursuant to this Section 10.12(b) shall be subject to the United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards of 1958. (c) JURISDICTION AND VENUE FOR INTERIM RELIEF. Notwithstanding the provisions of Section 10.12(b), each party shall have the right to bring an action in a court of competent jurisdiction of any equitable or other relief as may be necessary to protect the rights of such party under this Agreement. (d) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, PROCEEDING, CLAIM OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ITS INTERPRETATIONS.\"}}, {\"id\": \"10.13\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"GOVERNING LANGUAGE\", \"level\": 2, \"text\": \"10.13 GOVERNING LANGUAGE. The governing language of this Agreement shall be English. If this Agreement is translated into a language other than English, then the English version shall prevail.\"}}, {\"id\": \"10.14\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"EXCLUSION OF UNITED NATIONS CONVENTION\", \"level\": 2, \"text\": \"10.14 EXCLUSION OF UNITED NATIONS CONVENTION. The United Nations Convention on Contracts for the International Sale of Goods is hereby excluded from application to this Agreement.\"}}, {\"id\": \"10.15\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"FORCE MAJEURE\", \"level\": 2, \"text\": \"10.15 FORCE MAJEURE. Neither party shall be responsible for any failure to perform due to unforeseen circumstances or to causes beyond that party's control, including but not limited to acts of God, war, riot, acts of terrorism, embargoes, acts of civil or military authorities, compliance with governmental laws, rules or regulations, failure of telecommunications connectivity beyond the reasonable control of the parties, 24 accidents, strikes, labor disputes, or shortages. Failure to perform shall be excused during the continuance of such circumstances, but this Agreement shall otherwise remain in effect.\"}}, {\"id\": \"10.16\", \"type\": \"CLAUSE\", \"attrs\": {\"title\": \"PUBLICITY; DISCLOSURES\", \"level\": 2, \"text\": \"10.16 PUBLICITY; DISCLOSURES. Except as expressly provided herein and except to the extent required by applicable law, no news releases or other public disclosures relating to this Agreement, its existence or its subject matter, including without limitation, photographs, public announcements or confirmation of the same, shall be made by either party without the prior written approval of the other party. [SIGNATURE PAGE FOLLOWS] 25 IN WITNESS OF THE FOREGOING, the parties have caused this Agreement to be signed by their respective duly authorized representatives all as of the Effective Date. WORLDWIDE STRATEGIES INC. TOUCHSTAR SOFTWARE CORPORATION By: /s/ JAMES P.R. SAMUELS By: /s/ SHAWN SUHRSTEDT ---------------------------- ----------------------------- Title: PRESIDENT Title: CFO ------------------------- --------------------------- Date: SEPT 14-2005 Date: 9/15/5 -------------------------- ---------------------------- 26\"}}]}\n"}